https://www.themednet.org/what-are-the-most-effective-strategies-for-managing-weight-gain-associated-with-antipsychotic-medications weekly 0.8 https://www.themednet.org/what-margins-do-you-use-for-gbm-volume-delineation weekly 0.8 https://www.themednet.org/how-do-you-manage-hot-flashes-in-men-with-prostate-cancer-on-androgen-deprivation-therapy weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gi-cancers-from-asco-2025 weekly 0.8 https://www.themednet.org/what-is-the-key-to-becoming-an-outstanding-radiation-oncologist weekly 0.8 https://www.themednet.org/how-do-you-treat-decreased-libido-from-ssris weekly 0.8 https://www.themednet.org/what-are-best-practices-for-oncologists-during-the-national-platinum-shortage weekly 0.8 https://www.themednet.org/do-you-start-an-anti-seizure-medication-in-a-patient-with-a-first-unprovoked-nocturnal-seizure-with-a-normal-exam-imaging-and-eeg-or-wait-until-the-second-seizure weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-medical-oncology-from-sabcs-2024 weekly 0.8 https://www.themednet.org/what-are-best-practices-for-radiation-oncology-patient-and-staff-precautions-with-the-covid-19-pandemic weekly 0.8 https://www.themednet.org/is-it-acceptable-to-treat-newly-diagnosed-small-cell-lung-cancer-with-limited-brain-metastasis-with-upfront-srs weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-thoracic-cancers-from-asco-2025 weekly 0.8 https://www.themednet.org/what-pharmacological-management-do-you-consider-for-self-injurious-behavior-in-patients-with-autism-spectrum-disorder weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-refractory-schizophrenia-which-has-not-responded-to-multiple-antipsychotic-trials-including-clozapine weekly 0.8 https://www.themednet.org/do-you-believe-that-buspirone-is-ineffective-in-patients-who-are-previously-treated-with-benzodiazepines weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-ssris-to-treat-bipolar-depression weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-hematologic-malignancies-from-ash-2024 weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-breast-cancer-from-asco-2022 weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-on-anti-tnf-with-positive-quantiferon-previously-negative-with-negative-chest-x-ray-and-no-symptoms weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-therapy-for-resected-lung-adenocarcinoma-that-was-found-unexpectedly-postop-to-be-n2 weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-breast-cancer-from-asco-2024 weekly 0.8 https://www.themednet.org/how-do-you-approach-managing-nausea-and-gi-side-effects-when-initiating-methotrexate weekly 0.8 https://www.themednet.org/when-do-you-recommend-acamprosate-vs-naltrexone-for-medication-assisted-therapy-in-alcohol-use-disorder weekly 0.8 https://www.themednet.org/what-is-your-approach-during-dccv-if-you-have-an-obese-patient-with-atrial-fibrillation-refractory-to-up-to-3-360-j-shocks weekly 0.8 https://www.themednet.org/how-do-you-approach-a-treatment-relationship-with-a-patient-who-is-non-adherent-to-recommendations-and-also-is-not-interested-in-transfer-to-another-practitioner weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-treatment-for-chronic-fatigue-in-patients-with-long-covid-19 weekly 0.8 https://www.themednet.org/how-do-you-explain-fleeting-post-rt-breast-pain-to-patients-and-what-do-you-recommend-as-management weekly 0.8 https://www.themednet.org/how-do-you-manage-problematic-disinhibited-behaviors-in-patients-with-neurocognitive-disorders weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-profound-dyspareunia-after-pelvic-radiation-for-anal-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-treatment-regimen-for-patients-with-untreated-transplant-ineligible-mm weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-esmo-2023-2 weekly 0.8 https://www.themednet.org/what-is-a-safe-and-effective-dose-and-fractionation-for-palliating-head-and-neck-cancer weekly 0.8 https://www.themednet.org/is-it-acceptable-to-treat-patients-with-limited-asymptomatic-brain-metastases-and-egfr-mutant-nsclc-with-upfront-tki weekly 0.8 https://www.themednet.org/is-there-harm-in-doing-a-radiation-oncology-fellowship weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-sgo-2022 weekly 0.8 https://www.themednet.org/what-is-the-preferred-second-line-systemic-therapy-for-nsclc-patients-following-first-line-chemoimmunotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-stimulant-related-insomnia-for-pediatric-patients-who-are-otherwise-good-responses-to-low-dose-stimulant-treatment-for-adhd weekly 0.8 https://www.themednet.org/how-soon-after-excising-a-keloid-do-you-inject-kenalog weekly 0.8 https://www.themednet.org/what-medications-best-treat-intermittent-explosive-disorder weekly 0.8 https://www.themednet.org/how-do-you-decide-where-to-place-the-lpi-for-angle-closure-glaucoma weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-myeloma-from-ash-2025 weekly 0.8 https://www.themednet.org/how-do-you-counsel-cancer-patients-when-they-ask-if-they-should-avoid-sugar weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-thoracic-cancers-from-asco-2026 weekly 0.8 https://www.themednet.org/what-is-the-best-advice-you-received-as-a-young-attending weekly 0.8 https://www.themednet.org/what-mucosal-surfaces-do-you-commonly-cover-with-hpv-positive-squamous-cell-carcinoma-of-the-head-and-neck-of-unknown-primary weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gi-cancers-from-asco-2024 weekly 0.8 https://www.themednet.org/are-any-centers-routinely-using-55-gy-in-20-fractions-with-chemotherapy-for-definitive-treatment-of-head-and-neck-cancer-following-presentation-of-the-hypno-study weekly 0.8 https://www.themednet.org/in-patients-with-metastatic-hormone-receptor-positive-her2-low-breast-cancer-how-many-and-which-lines-of-therapy-would-you-recommend-prior-to-using-trastuzumab-deruxtecan weekly 0.8 https://www.themednet.org/how-do-you-reconcile-discrepancies-in-clinical-prostate-cancer-staging-with-ajcc-and-nccn weekly 0.8 https://www.themednet.org/based-on-the-sentina-trial-is-it-reasonable-to-allow-for-axillary-assessment-via-slnb-alone-without-axillary-dissection-after-neoadjuvant-chemotherapy-for-an-upfront-clinically-node-positive-patient weekly 0.8 https://www.themednet.org/should-we-be-stopping-new-starts-of-patients-who-can-be-triaged-for-2-3-months-like-prostate-cancers-on-adt-when-significant-community-spread-of-covid-19-is-detectable-in-our-area weekly 0.8 https://www.themednet.org/for-a-patient-with-metastatic-nsclc-pd-l1-50-after-progression-on-first-line-checkpoint-inhibitor-do-you-prefer-chemotherapy-alone-or-chemotherapy-added-to-the-immunotherapy weekly 0.8 https://www.themednet.org/how-long-would-you-wait-before-considering-additional-treatment-to-the-same-site-if-bone-metastasis-pain-fails-to-improve-after-8-gy-x-1-fraction weekly 0.8 https://www.themednet.org/what-treatment-do-you-recommend-for-patients-with-meralgia-paresthetica weekly 0.8 https://www.themednet.org/how-would-you-treat-an-elderly-newly-diagnosed-tdlbcl-that-has-previously-seen-r-chop-and-bendamustine-obinutuzumab-prior-to-the-transformative-event weekly 0.8 https://www.themednet.org/what-are-magic-mouthwash-alternatives-that-you-would-recommend weekly 0.8 https://www.themednet.org/is-it-appropriate-to-dose-de-escalate-in-low-risk-hpv-scc-of-the-oropharynx-outside-of-a-clinical-trial-setting weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-therapy-in-metastatic-alk-nsclc weekly 0.8 https://www.themednet.org/what-is-your-approach-to-recommending-bright-light-therapy-devices-to-patients-with-seasonal-depressive-disorders weekly 0.8 https://www.themednet.org/when-do-you-recommend-neuropsychological-testing-in-adults-being-evaluated-for-adhd weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-an-sle-patient-with-refractory-mucocutaneous-ulcerations-and-lichenoid-skin-eruption-despite-treatment-with-mmf-aza-benlysta-saphnelo-rituximab-and-jak-inhibitors weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-classical-hematology-from-ash-2024 weekly 0.8 https://www.themednet.org/how-do-you-optimize-retinopathy-screening-schedules-for-patients-on-hydroxychloroquine-while-also-prioritizing-cost-effectiveness weekly 0.8 https://www.themednet.org/what-would-be-your-approach-to-managing-social-anxiety-in-teenage-patients-with-adhd-doing-well-in-regards-to-academic-functioning-with-their-stimulant-medications weekly 0.8 https://www.themednet.org/what-is-your-approach-to-glp-1-agonists-as-a-psychiatrist-in-patients-who-are-overweight-or-have-eating-related-disorders weekly 0.8 https://www.themednet.org/what-types-of-cardiac-conduction-abnormalities-would-lead-you-to-avoid-using-tricyclic-antidepressants weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-asco-gi-2025 weekly 0.8 https://www.themednet.org/how-do-you-treat-nocturnal-leg-cramps weekly 0.8 https://www.themednet.org/how-do-you-approach-weaning-patients-off-of-buprenorphine weekly 0.8 https://www.themednet.org/what-screening-tools-or-signs-do-you-use-to-predict-if-a-cancer-patient-is-near-end-of-life weekly 0.8 https://www.themednet.org/what-is-your-approach-to-using-multifocal-or-extended-depth-of-focus-iols-in-patients-with-preperimetric-glaucoma weekly 0.8 https://www.themednet.org/would-you-use-voclosporin-or-belimumab-as-adjunctive-therapy-for-treatment-of-lupus-nephritis weekly 0.8 https://www.themednet.org/at-what-psa-level-do-you-offer-early-salvage-radiotherapy weekly 0.8 https://www.themednet.org/how-do-you-decide-which-immunotherapy-agent-to-utilize-for-1st-line-in-pd-l1-high-50-nsclc weekly 0.8 https://www.themednet.org/is-60-gy-in-40-fractions-bid-an-appropriate-regimen-to-use-for-ls-sclc-now weekly 0.8 https://www.themednet.org/what-is-your-response-to-the-question-is-this-terminal weekly 0.8 https://www.themednet.org/should-i-treat-a-patient-who-doesnt-know-she-has-cancer weekly 0.8 https://www.themednet.org/in-light-of-the-amaros-trial-how-do-you-decide-between-alnd-vs-axillary-rt weekly 0.8 https://www.themednet.org/would-you-consider-sbrt-for-an-inoperable-t1-t2-n0-sclc weekly 0.8 https://www.themednet.org/do-you-recommend-prostate-rt-for-patients-with-metastatic-m1-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-glioblastoma-presenting-with-leptomeningeal-dissemination weekly 0.8 https://www.themednet.org/how-does-topiramate-fit-into-your-treatment-paradigm-for-prevention-of-episodic-migraine weekly 0.8 https://www.themednet.org/when-do-you-consider-lithium-for-early-intervention-in-those-identified-to-be-at-risk-for-bipolar-disorder weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-breast-cancer-from-asco-2025 weekly 0.8 https://www.themednet.org/how-do-you-interpret-recent-large-retrospective-analyses-comparing-radical-prostatectomy-vs-radiation-for-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-respond-to-early-refill-requests-for-stimulants-in-stable-patients-who-report-lost-or-stolen-medication weekly 0.8 https://www.themednet.org/what-is-the-best-approach-for-single-vessel-mid-lad-cto-in-patient-with-preserved-ef-and-no-anginal-symptoms weekly 0.8 https://www.themednet.org/do-you-prescribe-linezolid-to-patients-who-are-concomitantly-on-an-ssri weekly 0.8 https://www.themednet.org/for-outpatients-undergoing-a-kidney-biopsy-do-you-routinely-recommend-an-overnight-admission-for-continued-hemoglobin-monitoring weekly 0.8 https://www.themednet.org/do-you-start-systemic-therapy-for-patients-with-previously-localized-hr-breast-cancer-developing-solitary-bone-metastasis-which-is-now-triple-negative-if-there-are-no-other-sites-of-disease-after-metastasis-directed-radiation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-addressing-dementia-related-agitation-for-patients-living-at-home-with-family weekly 0.8 https://www.themednet.org/what-ctv-expansions-do-you-use-for-nsclc-with-conventional-chemoradiation-and-do-you-do-different-expansions-based-on-specific-histologies weekly 0.8 https://www.themednet.org/how-do-you-treat-a-locally-advanced-cervix-cancer-in-a-patient-who-declines-brachytherapy weekly 0.8 https://www.themednet.org/can-a-dihydropyridine-calcium-channel-blocker-ccb-like-amlodipine-be-prescribed-in-addition-to-a-non-dihydropyridine-ccb-such-as-diltiazem-or-verapamil-for-treating-hypertension weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-thoracic-cancers-from-asco-2024 weekly 0.8 https://www.themednet.org/what-duration-androgen-deprivation-do-you-recommend-with-salvage-pelvic-radiotherapy-for-pelvic-node-relapse-after-prostatectomy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-large-area-of-multiple-recurrent-cutaneous-squamous-cell-carcinomas-of-the-scalp-with-ulcerations-and-non-healing-areas-despite-cryotherapy-multiple-mohs-procedures-and-5-fu weekly 0.8 https://www.themednet.org/what-factors-do-you-use-to-decide-between-ribociclib-and-abemaciclib-for-high-risk-hr-her2-early-breast-cancer weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-astro-2022 weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-ash-2022 weekly 0.8 https://www.themednet.org/when-do-you-consider-using-disulfiram-in-patients-with-alcohol-use-disorder weekly 0.8 https://www.themednet.org/how-do-you-formulate-and-diagnose-patients-with-chronic-psychosis-that-developed-after-methamphetamine-use-but-persists-after-cessation-of-use weekly 0.8 https://www.themednet.org/when-do-you-recommend-patients-get-vaccinations-with-respect-to-their-rt-course weekly 0.8 https://www.themednet.org/when-discussing-definitive-prostate-radiation-how-do-you-respond-to-patients-who-mention-that-they-heard-that-surgery-is-more-difficult-after-radiation-treatment weekly 0.8 https://www.themednet.org/how-would-you-best-manage-a-medically-inoperable-oral-cavity-squamous-cell-carcinoma-that-is-locally-advanced-and-node-positive-with-likely-extranodal-extension weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-urothelial-cancer-and-25-plasmacytoid-variant-who-has-a-solitary-recurrence-in-rectum-1-year-after-neoadjuvant-chemotherapy-and-radical-cystectomy weekly 0.8 https://www.themednet.org/what-duration-of-dual-antiplatelet-therapy-do-you-use-for-secondary-prevention-of-ischemic-stroke-due-to-intracranial-atherosclerotic-disease weekly 0.8 https://www.themednet.org/do-you-always-pursue-stroke-work-up-in-patients-diagnosed-with-transient-global-amnesia weekly 0.8 https://www.themednet.org/how-does-data-from-the-himalaya-trial-impact-your-first-line-treatment-selection-for-advanced-hcc weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-asco-gi-2023 weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-hematologic-malignancies-from-asco-2023 weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-pyoderma-gangrenosum-recalcitrant-to-oral-steroids weekly 0.8 https://www.themednet.org/is-a-daily-prophylactic-dose-of-aspirin-appropriate-for-patients-with-coronary-artery-calcification-by-chest-ct-or-an-elevated-calcium-score weekly 0.8 https://www.themednet.org/what-is-your-approach-to-cancer-patients-who-inquire-about-alternative-or-complementary-treatments weekly 0.8 https://www.themednet.org/how-do-you-approach-follow-up-of-young-patients-with-isolated-ana-but-no-current-clinical-signs-or-symptoms-of-sle weekly 0.8 https://www.themednet.org/do-you-still-recommend-sbrt-for-oligometastatic-and-oligoprogressive-breast-cancer-after-the-abstracts-of-the-br002-and-curb-respectively weekly 0.8 https://www.themednet.org/should-intervention-be-considered-for-an-intermediate-flow-limiting-coronary-lesion-that-does-not-correlate-with-perfusion-defects-on-stress-testing-in-a-patient-with-atypical-anginal-symptoms weekly 0.8 https://www.themednet.org/what-preventive-medications-do-you-recommend-for-patients-with-cluster-headaches weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-sgo-2023 weekly 0.8 https://www.themednet.org/what-topical-therapies-and-procedures-do-you-recommend-for-improving-facial-pore-size weekly 0.8 https://www.themednet.org/how-soon-after-spaceoar-placement-can-radiation-planning-ct-be-performed weekly 0.8 https://www.themednet.org/when-do-you-incorporate-lyrica-into-the-treatment-strategy-for-patients-with-restless-leg-syndrome weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-in-her-50s-with-figo-ia-clear-cell-carcinoma-of-the-endometrium-with-extensive-lvsi-and-itcs-in-an-obturator-node-after-6-cycles-of-carbo-taxol weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gi-cancers-from-asco-2023 weekly 0.8 https://www.themednet.org/whats-the-best-approach-for-severe-calcinosis-cutis-in-a-patient-with-dermatomyositis-who-is-unresponsive-to-diltiazem-and-colchicine weekly 0.8 https://www.themednet.org/do-you-prefer-to-use-the-fast-or-fast-forward-regimen-when-treating-stage-i-breast-cancer-with-an-ultra-hypofractionated-approach weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-epilepsy-who-are-interested-in-purchasing-a-seizure-dog weekly 0.8 https://www.themednet.org/do-you-recommend-avoiding-radial-artery-access-for-cardiac-catheterization-to-preserve-potential-future-dialysis-access-sites-in-patients-with-advanced-ckd weekly 0.8 https://www.themednet.org/do-you-recommend-ct-perfusion-in-patients-presenting-with-symptoms-of-acute-stroke-before-6-hours weekly 0.8 https://www.themednet.org/how-do-you-address-akathisia-for-patients-who-have-had-otherwise-an-excellent-response-to-their-antipsychotic-treatment weekly 0.8 https://www.themednet.org/what-is-your-preferred-dose-to-gross-lymph-nodes-when-treating-non-metastatic-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/is-there-a-serum-phosphorus-level-you-would-consider-too-low-to-safely-perform-hemodialysis weekly 0.8 https://www.themednet.org/would-you-ever-offer-definitive-xrt-in-a-patient-with-an-elevated-psa-assume-over-30-but-who-refuses-prostate-biopsy weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-with-xrt-after-local-recurrence-after-prostate-cryoablation weekly 0.8 https://www.themednet.org/do-you-allow-your-ctv-expansion-to-go-into-lung-for-imrt-esophagus-cases-or-do-you-crop-ctv-expansion-out-of-lung weekly 0.8 https://www.themednet.org/do-you-recommend-checking-anti-drug-antibodies-for-patients-on-tnf-inhibitors weekly 0.8 https://www.themednet.org/how-do-you-decide-between-checkpoint-monotherapy-versus-chemo-immunotherapy-approach-for-patients-with-pd-l1-high-50-nsclc weekly 0.8 https://www.themednet.org/when-do-you-use-seizure-prophylaxis-in-patients-on-clozapine weekly 0.8 https://www.themednet.org/how-do-you-navigate-c-2-refills-in-patients-who-are-stable-in-their-treatment-and-do-not-otherwise-need-to-be-clinically-seen-monthly weekly 0.8 https://www.themednet.org/how-do-you-approach-anxiety-management-for-patients-who-have-been-on-long-term-years-or-more-daily-benzodiazepines weekly 0.8 https://www.themednet.org/how-do-you-manage-emotional-blunting-due-to-ssris-snris weekly 0.8 https://www.themednet.org/would-you-be-comfortable-using-isotretinoin-in-a-female-teenage-patient-who-has-a-history-of-depression-that-is-now-stable-but-with-a-prior-suicide-attempt-two-years-ago weekly 0.8 https://www.themednet.org/how-do-you-use-cd4-in-clinical-practice-in-management-of-patients-living-with-hiv weekly 0.8 https://www.themednet.org/do-you-find-onabotulinumtoxina-injections-effective-for-the-treatment-of-trigeminal-neuralgia weekly 0.8 https://www.themednet.org/what-is-the-utility-of-a-hypercoagulability-workup-in-recurrent-cryptogenic-stroke-and-what-specific-tests-would-you-recommend weekly 0.8 https://www.themednet.org/what-strategies-have-you-found-most-effective-for-supporting-weight-loss-in-patients-with-bipolar-disorder-while-minimizing-the-risk-of-mood-destabilization weekly 0.8 https://www.themednet.org/how-do-you-typically-manage-the-use-of-intravitreal-antibiotics-during-globe-repair weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-breast-cancer-from-asco-2026 weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-hematologic-malignancies-from-asco-2026 weekly 0.8 https://www.themednet.org/what-is-your-radiotherapy-plan-for-a-pt-with-favorable-intermediate-risk-pca-who-has-73-cc-prostate-on-mri-63-cc-on-us weekly 0.8 https://www.themednet.org/do-you-avoid-triptans-in-patients-on-ssris-due-to-the-potential-risk-of-serotonin-syndrome weekly 0.8 https://www.themednet.org/can-you-do-you-use-an-androgen-receptor-blocker-alone-in-patients-with-metastatic-hormone-sensitive-prostate-cancer-who-cannot-tolerate-gnrh-directed-therapy weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-ash-2023 weekly 0.8 https://www.themednet.org/when-would-you-consider-amivantamab-lazertinib-combo-for-first-line-in-egfr-mutated-metastatic-nsclc weekly 0.8 https://www.themednet.org/what-is-your-approach-to-dvt-prophylaxis-in-patients-who-require-ivig-but-are-at-increased-risk-for-thrombotic-events weekly 0.8 https://www.themednet.org/how-do-you-manage-the-thickened-secretions-secondary-to-xerostomia-during-head-and-neck-radiation weekly 0.8 https://www.themednet.org/does-anyone-utilize-p2y12-assays-to-determine-if-clopidogrel-may-be-ineffective-when-used-for-dapt weekly 0.8 https://www.themednet.org/following-left-main-bifurcation-stenting-do-you-routinely-proceed-with-kissing-balloon-inflation-of-the-side-branch-either-lcx-or-lad weekly 0.8 https://www.themednet.org/do-you-use-standard-dose-or-meningitis-dosing-of-antibiotics-when-treating-epidural-abscesses-in-the-absence-of-cns-symptoms weekly 0.8 https://www.themednet.org/is-it-acceptable-to-use-once-daily-fractionation-for-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/how-do-you-treat-women-who-have-breast-conserving-surgery-with-positive-sentinel-node-s-and-no-axillary-dissection weekly 0.8 https://www.themednet.org/is-pmrt-considered-the-standard-of-care-in-women-with-1-3-positive-axillary-lymph-nodes weekly 0.8 https://www.themednet.org/should-i-avoid-prescribing-lidocaine-containing-magic-mouthwash-to-head-and-neck-cancer-patients weekly 0.8 https://www.themednet.org/do-you-use-either-memantine-or-hippocampal-sparing-technique-to-preserve-cognitive-function-when-giving-whole-brain-radiotherapy weekly 0.8 https://www.themednet.org/what-is-the-best-way-to-treat-a-small-brainstem-met-with-stereotactic-radiosurgery weekly 0.8 https://www.themednet.org/should-lung-sbrt-fractions-be-delivered-on-consecutive-days-every-other-day-or-perhaps-an-even-more-prolonged-schedule weekly 0.8 https://www.themednet.org/for-locally-advanced-breast-cancer-to-what-dose-do-you-treat-undissected-clinically-positive-level-iii-axilla-scv-or-im-nodes weekly 0.8 https://www.themednet.org/is-long-term-adt-now-the-standard-of-care-with-salvage-prostate-bed-rt weekly 0.8 https://www.themednet.org/would-you-withhold-whole-brain-radiation-therapy-for-pts-with-brain-metastases-from-nsclc-unsuitable-for-resection-or-stereotactic-radiotherapy weekly 0.8 https://www.themednet.org/how-do-you-manage-bruising-in-patients-on-ibrutinib weekly 0.8 https://www.themednet.org/how-do-you-manage-grade-3-dermatitis-during-chemoradiation-therapy-for-anal-cancer weekly 0.8 https://www.themednet.org/how-do-you-sequence-radiation-and-capecitabine-in-breast-cancer-patients-receiving-adjuvant-capecitabine-for-residual-disease-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-who-continue-to-experience-pruritus-and-ongoing-concern-for-persistent-scabies-despite-having-completed-appropriate-treatment weekly 0.8 https://www.themednet.org/how-do-you-approach-cataract-surgery-in-a-patient-with-a-history-of-radial-keratotomy-rk-who-desires-postoperative-independence-from-glasses weekly 0.8 https://www.themednet.org/do-you-have-a-preference-between-an-acei-and-arb-when-initiating-therapy-for-a-patient-with-diabetic-kidney-disease-albuminuria-and-hypertension weekly 0.8 https://www.themednet.org/how-do-you-evaluate-and-manage-brain-fog-in-patients-with-underlying-rheumatic-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-anxious-children-who-are-somatically-focused-and-do-not-tolerate-ssris weekly 0.8 https://www.themednet.org/what-are-your-go-to-options-for-managing-icu-delirium-in-patients-with-contraindications-to-antipsychotics weekly 0.8 https://www.themednet.org/how-do-you-approach-stimulant-prescribing-for-adhd-in-a-patient-with-auditory-hallucinations-that-can-be-command-in-nature-suicide-who-will-not-take-an-antipsychotic-medication weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-chronic-gi-bleeding-from-avms-in-an-elderly-patient-on-doac-for-atrial-fibrillation weekly 0.8 https://www.themednet.org/how-should-the-use-of-the-decisiondx-melanoma-test-be-integrated-into-clinical-practice-to-potentially-avoid-sentinel-lymph-node-biopsy weekly 0.8 https://www.themednet.org/would-you-consider-adding-adjuvant-ribociclib-for-a-patient-who-has-already-received-2-years-of-endocrine-therapy-and-is-eligible-for-ribociclib-according-to-the-natalee-trial weekly 0.8 https://www.themednet.org/do-you-discontinue-amlodipine-or-use-an-alternative-approach-to-manage-peripheral-edema-when-it-occurs-as-a-side-effect-of-the-medication weekly 0.8 https://www.themednet.org/how-do-you-decide-between-anticoagulation-and-observation-for-an-incidentally-detected-subsegmental-pulmonary-embolism-in-elderly-patients-with-a-history-of-gastrointestinal-bleeding weekly 0.8 https://www.themednet.org/when-if-ever-will-you-utilize-t-dm1-in-metastatic-her2-breast-cancer-given-trastuzumab-deruxtecans-significantly-improved-efficacy-vs-t-dm1 weekly 0.8 https://www.themednet.org/how-would-you-alter-your-ptv-margins-for-a-lung-sbrt-target-adjacent-to-the-rib weekly 0.8 https://www.themednet.org/for-head-and-neck-cancer-radiation-requiring-boost-do-you-plan-using-simultaneous-integrated-boost-technique-vs-cone-down-technique weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-depression-about-the-role-exercise-may-play-in-alleviating-depressive-symptoms weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-breast-cancer-from-esmo-2025 weekly 0.8 https://www.themednet.org/what-should-the-ldl-target-be-in-patients-with-prediabetes-and-high-lipoprotein-a-with-family-history-of-coronary-artery-disease weekly 0.8 https://www.themednet.org/when-do-you-check-vitamin-d-levels-in-patients-with-depressive-symptoms weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-hematologic-malignancies-from-ash-2025 weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-patient-concerned-about-receiving-imrt-rather-than-impt-for-oropharyngeal-cancer weekly 0.8 https://www.themednet.org/in-older-adults-with-mild-cognitive-impairment-do-you-ever-prescribe-cholinesterase-inhibitors-and-or-memantine weekly 0.8 https://www.themednet.org/what-is-your-approach-in-counseling-a-patient-with-delusions-of-parasitosis weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-interested-in-estrogen-containing-oral-contraceptives-who-have-migraine-with-aura weekly 0.8 https://www.themednet.org/how-would-you-work-up-a-patient-with-prostate-cancer-with-bone-scan-suspicious-for-metastatic-disease-and-a-negative-psma-pet-ct weekly 0.8 https://www.themednet.org/in-antiphospholipid-syndrome-with-recurrent-strokes-would-you-consider-adding-antiplatelets-to-warfarin weekly 0.8 https://www.themednet.org/how-would-you-treat-pelvic-node-recurrence-after-prior-rp-and-adjuvant-xrt-prostate-bed-only weekly 0.8 https://www.themednet.org/do-you-recommend-life-long-aspirin-81-mg-daily-for-non-specific-t2-white-matter-hyper-intensities-on-mri-brain weekly 0.8 https://www.themednet.org/what-pre-operative-features-in-pseudoexfoliation-patients-do-you-feel-correlate-with-intra-op-zonulopathy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-rem-behavior-disorder-not-adequately-treated-with-melatonin-and-clonazepam weekly 0.8 https://www.themednet.org/how-do-you-approach-the-discussion-of-omission-vs-inclusion-of-adjuvant-radiation-in-patients-with-low-to-intermediate-grade-dcis weekly 0.8 https://www.themednet.org/considering-the-surgical-margins-used-in-tors-is-it-necessary-to-cover-the-entire-tongue-base-with-an-elective-dose-in-imrt-of-ct1-3-hpv-squamous-cell-carcinoma-grossly-involving-one-side-of-the-base-of-tongue weekly 0.8 https://www.themednet.org/what-duration-of-adt-do-you-recommend-for-a-patient-with-otherwise-favorable-intermediate-risk-features-but-a-mpmri-showing-gross-extracapsular-extension weekly 0.8 https://www.themednet.org/how-should-you-manage-a-coronavirus-infected-suspected-patient-who-is-receiving-radiotherapy-and-cannot-interrupt-or-delay-their-cancer-treatment weekly 0.8 https://www.themednet.org/is-it-reasonable-to-offer-observation-with-mri-rather-than-immediate-pci-for-patients-with-limited-stage-sclc weekly 0.8 https://www.themednet.org/how-does-the-presence-of-interstitial-lung-disease-affect-your-decision-to-offer-sbrt-for-early-stage-nsclc weekly 0.8 https://www.themednet.org/for-patients-with-triple-negative-breast-cancer-who-have-a-minimal-response-to-neoadjuvant-chemotherapy-do-you-do-additional-testing-to-sub-categorize-the-cancer-and-find-a-potential-target-e-g-androgen-receptor-etc weekly 0.8 https://www.themednet.org/are-weekly-port-films-or-daily-cone-beams-considered-standard-of-care-for-3d-breast-treatment weekly 0.8 https://www.themednet.org/is-it-appropriate-to-use-photon-energies-above-15-mv-for-prostate-sbrt weekly 0.8 https://www.themednet.org/how-do-you-talk-to-patients-about-clinical-trials weekly 0.8 https://www.themednet.org/how-do-you-counsel-young-and-educated-patients-with-non-metastatic-breast-cancer-who-choose-non-proven-natural-treatments-over-standard-therapy weekly 0.8 https://www.themednet.org/how-do-you-treat-a-patient-with-widely-metastatic-non-t790m-mutated-egfr-exon-20-insertion-mutated-lung-cancer weekly 0.8 https://www.themednet.org/for-patients-with-high-risk-metastatic-castration-sensitive-prostate-cancer-who-have-completed-upfront-adt-docetaxel-would-you-consider-starting-abiraterone-in-addition-to-adt-while-the-disease-is-still-castration-sensitive weekly 0.8 https://www.themednet.org/do-you-ever-consider-local-therapy-to-oligometastatic-hormone-receptor-positive-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-her-2-directed-therapy-in-a-patient-who-developed-cardiotoxicity-following-neoadjuvant-tc-hp weekly 0.8 https://www.themednet.org/would-you-initiate-radiation-before-chemotherapy-for-the-treatment-of-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/are-there-situations-in-which-you-would-definitely-recommend-radiation-in-an-elderly-patient-with-er-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/for-patients-with-clinically-node-positive-prostate-cancer-would-you-consider-adding-a-brachytherapy-boost-to-external-beam-radiation-and-adt weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-would-you-recommend-for-post-operative-treatment-of-an-isolated-femur-metastasis-after-surgical-stabilization weekly 0.8 https://www.themednet.org/do-you-perform-pdl1-and-molecular-testing-for-patients-with-stages-i-iii-nsclc weekly 0.8 https://www.themednet.org/would-you-recommend-radiation-planning-with-air-tissue-expanders-in-patients-who-will-receive-pmrt weekly 0.8 https://www.themednet.org/are-there-any-known-issues-related-to-radiation-in-the-setting-of-vitiligo weekly 0.8 https://www.themednet.org/do-you-typically-recommend-avoiding-neupogen-during-radiation-treatments weekly 0.8 https://www.themednet.org/what-anesthetic-spray-do-you-use-if-any-for-numbing-the-nasal-passages-when-performing-nasolaryngoscopy weekly 0.8 https://www.themednet.org/what-is-the-role-for-liquid-biopsy-for-patients-with-newly-diagnosed-metastatic-nsclc weekly 0.8 https://www.themednet.org/how-do-you-incorporate-car-t-cell-therapy-for-dlbcl-in-transplant-eligible-patients weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-in-deciding-whether-or-not-to-treat-the-pelvis-in-prostate-cancer weekly 0.8 https://www.themednet.org/in-what-situations-can-short-course-rt-5-gy-x-5fx-be-used-instead-of-chemort-for-rectal-cancer weekly 0.8 https://www.themednet.org/what-dose-do-you-typically-prescribe-to-the-primary-tumor-for-definitive-treatment-of-squamous-cell-carcinoma-of-the-anal-canal-given-concurrently-with-chemotherapy weekly 0.8 https://www.themednet.org/do-you-advise-patients-to-avoid-deodorant-during-breast-radiotherapy weekly 0.8 https://www.themednet.org/is-astros-recommendation-to-avoid-whole-brain-radiotherapy-following-srs-for-limited-brain-metastases-practical-for-patients-treated-in-the-community-setting weekly 0.8 https://www.themednet.org/what-is-the-standard-rt-dose-in-locally-advanced-nsclc-with-concurrent-chemotherapy weekly 0.8 https://www.themednet.org/is-there-an-age-cut-off-below-you-would-not-treat-a-keloid-with-radiation-post-surgical-excision weekly 0.8 https://www.themednet.org/is-there-evidence-to-support-partial-breast-irradiation-with-daily-fractionation weekly 0.8 https://www.themednet.org/what-options-do-you-have-when-a-patient-has-urinary-obstruction-during-radiation-treatment weekly 0.8 https://www.themednet.org/should-consolidative-rt-for-extensive-stage-sclc-be-given-before-after-or-concurrently-with-pci weekly 0.8 https://www.themednet.org/how-should-radiation-oncologists-respond-to-the-recent-meta-analysis-concluding-that-prostate-cancer-specific-mortality-is-lower-following-prostatectomy-vs-radiation-therapy weekly 0.8 https://www.themednet.org/how-do-you-apply-the-concept-of-a-lumpectomy-bed-boost-in-the-setting-of-oncoplastic-surgery weekly 0.8 https://www.themednet.org/in-the-era-of-mri-and-other-advanced-imaging-do-you-still-routinely-perform-a-digital-rectal-exam-on-every-prostate-cancer-patient weekly 0.8 https://www.themednet.org/what-is-your-preferred-dose-and-fractionation-schedule-for-a-patient-with-a-stage-iii-non-small-cell-lung-cancer-whose-comorbidities-preclude-chemotherapy-but-has-good-enough-performance-status-to-warrant-an-attempt-at-longer-term-local-control weekly 0.8 https://www.themednet.org/do-you-have-a-certain-tumor-size-threshold-in-which-you-change-chemotherapy-recommendations-for-a-small-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/should-definitive-radiotherapy-and-adt-be-offered-to-patients-with-psa-100-who-have-no-evidence-of-metastatic-disease weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-do-you-use-in-the-setting-of-head-and-neck-reirradiation weekly 0.8 https://www.themednet.org/is-pembrolizumab-carboplatin-pemetrexed-an-acceptable-initial-therapy-for-metastatic-non-squamous-nsclc-regardless-of-pd-l1-status weekly 0.8 https://www.themednet.org/do-you-ever-utilize-an-anthracycline-based-regimen-rather-than-a-non-anthracycline-based-regimen-for-patients-with-locally-advanced-her2-positive-breast-cancer weekly 0.8 https://www.themednet.org/when-treating-two-primary-early-stage-lung-cancers-with-sbrt-do-you-treat-both-at-the-same-time-or-stage-your-treatment weekly 0.8 https://www.themednet.org/are-you-ordering-egfr-testing-on-all-patients-with-nsclc-after-complete-resection-in-light-of-adaura weekly 0.8 https://www.themednet.org/how-do-you-decide-on-2nd-line-therapy-in-a-patient-with-her2-metastatic-esophageal-gastric-cancer-who-progresses-after-initial-response-to-trastuzumab-based-chemotherapy weekly 0.8 https://www.themednet.org/in-a-very-young-woman-who-is-s-p-mastectomy-for-a-small-high-grade-her2-positive-breast-cancer-with-a-micromet-in-a-sentinel-node-would-you-favor-completion-axillary-dissection-or-pmrt-or-close-surveillance weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-therapy-for-a-patient-with-intraheptic-cholangiocarcinoma-with-an-isolated-metastasis-who-has-undergone-complete-surgical-resection-and-is-ned weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-on-atezolizumab-bevacizumab-with-advanced-hcc-who-develop-arterial-thrombosis weekly 0.8 https://www.themednet.org/would-you-treat-a-premenopausal-woman-with-t2n0-er-pr-15-20-her2-breast-cancer-with-neoadjuvant-chemotherapy-like-a-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/would-you-offer-salvage-prostate-reirradiation-with-a-rising-psa-but-negative-biopsies weekly 0.8 https://www.themednet.org/would-you-use-t-dxd-or-capecitabine-trastuzumab-tucatinib-for-her2-metastatic-breast-cancer-with-predominantly-cns-progression-after-thp weekly 0.8 https://www.themednet.org/how-long-would-you-continue-second-line-maintenance-parp-inhibitor-in-a-patient-with-recurrent-stage-iv-brca-ovarian-cancer-who-had-cr-and-remains-ned weekly 0.8 https://www.themednet.org/do-you-recommend-adjuvant-adt-instead-of-neoadjuvant-adt-with-prostate-rt weekly 0.8 https://www.themednet.org/in-ls-sclc-for-a-patient-with-positive-mediastinal-ln-but-pet-negative-ipsilateral-hilum-would-you-treat-the-hilum weekly 0.8 https://www.themednet.org/what-is-your-current-practice-for-obtaining-pd-l1-and-mutation-testing-for-newly-diagnosed-metastatic-nsclc weekly 0.8 https://www.themednet.org/how-do-you-sequence-pharmacologic-treatments-for-primary-insomnia weekly 0.8 https://www.themednet.org/what-early-stage-breast-cancer-patients-would-you-give-ioert weekly 0.8 https://www.themednet.org/do-you-routinely-check-g6pd-level-prior-to-initiation-of-hydroxychloroquine weekly 0.8 https://www.themednet.org/do-you-have-a-maximum-size-cutoff-for-lung-sbrt-in-central-nsclc weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-disseminated-granuloma-annulare weekly 0.8 https://www.themednet.org/what-are-preferred-sleep-aids-in-elderly-patients-with-dementia weekly 0.8 https://www.themednet.org/do-you-always-obtain-psma-pet-as-initial-staging-for-high-risk-and-very-high-risk-localized-prostate-cancer-patients weekly 0.8 https://www.themednet.org/do-you-consider-nsclc-with-multistation-n2-involvement-appropriate-for-treatment-with-neoadjuvant-chemoimmunotherapy-followed-by-surgery weekly 0.8 https://www.themednet.org/do-you-follow-gog-astro-or-portec-recommendations-for-adjuvant-therapy-in-stage-i-endometrial-cancer-patients weekly 0.8 https://www.themednet.org/how-should-molecular-studies-in-particular-the-presence-of-pole-or-p53-mutations-be-incorporated-into-the-decision-to-treat-an-intermediate-risk-endometrial-cancer-patient-with-adjuvant-therapy-after-hysterectomy weekly 0.8 https://www.themednet.org/is-the-phase-2-data-regarding-neoadjuvant-cemiplimab-in-cutaneous-squamous-cell-carcinoma-sufficient-to-adopt-for-all-patients-or-will-you-await-phase-3-data weekly 0.8 https://www.themednet.org/would-you-escalate-treatment-for-a-clinically-stable-asymptomatic-lupus-patient-with-persistent-leukopenia-neutropenia-already-on-hydroxychloroquine weekly 0.8 https://www.themednet.org/how-do-you-approach-the-discussion-with-a-patient-who-is-seeking-proton-therapy-for-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-boosting-a-vaginal-cuff-recurrence-of-cervical-cancer-with-brachytherapy-that-is-tethered-to-small-bowel weekly 0.8 https://www.themednet.org/would-you-recommend-delaying-left-heart-catheterization-until-development-of-eskd-in-a-patient-with-ckd-stage-5-and-stable-coronary-artery-disease-given-concern-for-contrast-induced-nephropathy weekly 0.8 https://www.themednet.org/would-you-check-anca-titers-in-a-patient-with-a-history-of-pr-3-anca-glomerulonephritis-in-remission-and-a-stable-creatinine-but-with-recurrent-microscopic-hematuria weekly 0.8 https://www.themednet.org/how-would-you-treat-a-synchronous-low-rectal-adenocarcinoma-and-anal-squamous-cell-carcinoma-with-involved-pelvic-and-inguinal-nodes weekly 0.8 https://www.themednet.org/for-elderly-patients-i-e-older-than-80-with-only-one-documented-episode-of-paroxysmal-atrial-fibrillation-following-a-stress-event-such-as-acute-illness-steroid-administration-and-a-chadsvasc-score-greater-than-1-how-would-you-counsel-them-on-the-risks-be weekly 0.8 https://www.themednet.org/can-you-use-leflunomide-and-rituximab-in-a-patient-with-both-multiple-sclerosis-and-rheumatoid-arthritis weekly 0.8 https://www.themednet.org/how-do-you-go-about-switching-from-one-dmard-to-another-in-patients-with-dermatomyositis-that-remains-active weekly 0.8 https://www.themednet.org/in-what-cases-of-t3n0-glottic-scc-would-you-omit-chemotherapy-and-offer-radiation-alone weekly 0.8 https://www.themednet.org/when-would-you-recommend-prescribing-an-asthmatic-patient-budesonide-salbutamol-rather-than-budesonide-formoterol weekly 0.8 https://www.themednet.org/how-do-you-approach-switching-from-methadone-to-buprenorphine-naloxone-for-patients-who-want-to-change-medication-management-for-opioid-use-disorder weekly 0.8 https://www.themednet.org/when-do-you-consider-lamotrigine-in-bipolar-depression weekly 0.8 https://www.themednet.org/would-you-consider-adding-niacin-to-the-lipid-lowering-regimen-in-statin-intolerant-patients-who-cannot-afford-pcsk9i-or-bempedoic-acid weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gu-cancers-from-asco-2024 weekly 0.8 https://www.themednet.org/how-frequently-do-you-recommend-flushing-a-peritoneal-dialysis-catheter-for-patients-with-eskd-who-are-hospitalized-and-are-not-currently-undergoing-peritoneal-dialysis weekly 0.8 https://www.themednet.org/after-r1-resection-of-a-locally-advanced-node-positive-neuroendocrine-tumor-of-the-terminal-ilium-would-you-offer-adjuvant-radiation-therapy weekly 0.8 https://www.themednet.org/given-the-results-of-lu002-presented-at-asco-2024-are-there-situations-and-or-patient-subgroups-who-still-derive-benefit-from-local-consolidative-therapy-for-oligometastatic-nsclc weekly 0.8 https://www.themednet.org/is-it-necessary-to-prescribe-a-steroid-taper-after-two-weeks-of-high-dose-prednisone-60-mg-daily weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-when-managing-patients-with-relapsing-lupus-nephritis-who-previously-achieved-remission-with-mycophenolate-and-steroids weekly 0.8 https://www.themednet.org/do-you-hold-endocrine-therapy-during-adjuvant-breast-radiotherapy weekly 0.8 https://www.themednet.org/do-you-recommend-fluid-restriction-in-addition-to-other-management-strategies-for-patients-with-hyponatremia-due-to-siadh weekly 0.8 https://www.themednet.org/do-you-offer-rt-both-to-the-prostate-and-synchronous-oligometastases-in-de-novo-oligometastatic-prostate-cancer weekly 0.8 https://www.themednet.org/would-you-consider-circulating-dna-assay-in-resected-node-negative-deficient-mmr-colon-cancer-off-trial-to-guide-your-treatment weekly 0.8 https://www.themednet.org/do-you-routinely-prescribe-an-anticholinergic-agent-for-eps-prophylaxis-when-starting-or-continuing-antipsychotics-or-do-you-prefer-to-use-it-only-as-needed-prn-if-when-symptoms-develop weekly 0.8 https://www.themednet.org/what-is-your-preferred-monotherapy-antiplatelet-agent-to-continue-after-completion-of-dapt-post-pci-for-patients-with-stable-ischemic-heart-disease weekly 0.8 https://www.themednet.org/for-how-long-do-you-recommend-treatment-for-latent-tuberculosis-prior-to-initiation-of-anti-tnf-therapy weekly 0.8 https://www.themednet.org/is-there-a-role-for-beta-lactams-as-step-down-oral-therapy-for-uncomplicated-gram-negative-bacteremia weekly 0.8 https://www.themednet.org/for-patients-with-resected-colon-cancer-to-what-extent-would-you-adapt-adjuvant-chemotherapy-if-ctdna-results-dont-correspond-with-your-initial-treatment-recommendation weekly 0.8 https://www.themednet.org/would-you-cover-regional-nodes-in-an-early-stage-breast-cancer-with-a-non-mapping-sentinel-lymph-node weekly 0.8 https://www.themednet.org/in-patients-who-are-on-3-of-the-4-pillars-of-hf-therapy-for-hfref-would-you-add-the-4th-pillar-if-they-are-no-longer-in-symptomatic-hf-and-lvef-normalizes weekly 0.8 https://www.themednet.org/what-are-alternate-approaches-to-medical-therapy-and-or-interventions-to-consider-in-patients-with-refractory-severe-coronary-vasospasm-despite-short-acting-nitrates-calcium-channel-blockers-l-arginine-and-clonidine weekly 0.8 https://www.themednet.org/what-is-your-approach-to-secondary-stroke-prevention-in-patients-with-atrial-fibrillation-and-intracranial-stenosis-70 weekly 0.8 https://www.themednet.org/how-do-you-approach-breast-rt-in-a-patient-with-a-recent-history-of-ipsilateral-thoracic-irradiation weekly 0.8 https://www.themednet.org/what-would-be-the-clinical-role-of-sglt-2-inhibitors-for-lupus-nephritis-given-it-has-an-indication-for-proteinuria-related-to-ckd weekly 0.8 https://www.themednet.org/do-you-recommend-alpha-lipoic-acid-to-patients-with-diabetic-polyneuropathy weekly 0.8 https://www.themednet.org/what-is-your-standard-approach-i-e-choice-of-medication-type-of-sheath-in-the-cath-lab-to-reduce-the-likelihood-of-radial-artery-spasm weekly 0.8 https://www.themednet.org/does-an-esophageal-stent-impact-your-radiation-treatment-plan-for-a-patient-with-non-metastatic-ge-junction-adenocarcinoma weekly 0.8 https://www.themednet.org/do-you-recommend-utilizing-daratumumab-in-the-maintenance-phase-after-a-quadruplet-induction-for-transplant-eligible-multiple-myeloma weekly 0.8 https://www.themednet.org/do-you-typically-screen-patients-for-antiphospholipid-antibodies-in-autoimmune-diseases-besides-lupus-in-the-absence-of-a-clotting-event weekly 0.8 https://www.themednet.org/do-you-add-a-separate-dose-of-losartan-for-patients-with-heart-disease-and-proteinuric-kidney-disease-who-are-on-maximal-doses-of-sacubitril-valsartan-but-continue-to-experience-proteinuria weekly 0.8 https://www.themednet.org/when-performing-gyn-hdr-brachytherapy-with-freehand-needles-what-strategies-do-you-employ-to-immobilize-the-needles-and-prevent-changes-to-your-implant weekly 0.8 https://www.themednet.org/how-do-you-decide-between-ordering-coronary-calcium-scoring-versus-coronary-cta-in-asymptomatic-patients-with-low-to-moderate-risk-for-cad weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-who-finished-chemort-for-head-and-neck-cancer-and-loses-10-body-weight-within-2-weeks-post-treatment weekly 0.8 https://www.themednet.org/do-you-typically-screen-every-patient-with-headaches-after-the-age-of-60-with-esr weekly 0.8 https://www.themednet.org/how-frequently-do-you-obtain-lipoprotein-a-levels-on-asymptomatic-patients-without-a-prior-history-of-cad weekly 0.8 https://www.themednet.org/how-do-you-advise-an-eskd-patient-who-wants-to-drink-pickle-juice-to-reduce-intradialytic-muscle-cramps weekly 0.8 https://www.themednet.org/how-would-you-treat-a-p16-squamous-cell-carcinoma-confined-in-the-recto-vaginal-septum-with-no-suspicious-adenopathy-on-pet-or-mri weekly 0.8 https://www.themednet.org/how-do-you-respond-to-a-patient-who-asks-why-do-i-still-need-breast-radiation-after-chemotherapy-if-chemotherapy-treats-the-whole-body weekly 0.8 https://www.themednet.org/when-do-you-consider-the-addition-of-concurrent-pembrolizumab-to-breast-irradiation weekly 0.8 https://www.themednet.org/when-recommending-salvage-rt-post-prostatectomy-for-an-ultra-sensitive-psa-level-0-1-do-you-still-recommend-concurrent-hormonal-therapy weekly 0.8 https://www.themednet.org/for-gross-hematuria-from-a-primary-bladder-tumor-what-palliative-radiation-regimen-would-you-recommend weekly 0.8 https://www.themednet.org/when-utilizing-hypofractionated-radiotherapy-in-the-post-mastectomy-setting-are-the-nodal-regions-dose-painted-to-a-different-dose-or-the-same-dose-as-the-chest-wall-reconstructed-breast weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gu-cancers-from-astro-2024 weekly 0.8 https://www.themednet.org/in-patients-with-post-mi-lv-thrombus-which-resolves-after-3-6-months-of-anticoagulation-would-you-consider-surveillance-imaging-for-thrombus-recurrence-if-there-is-persistent-apical-akinesis weekly 0.8 https://www.themednet.org/how-do-you-manage-lamotrigine-or-lithium-induced-acne weekly 0.8 https://www.themednet.org/when-do-you-use-snris-or-norepinephrine-reuptake-inhibitors-e-g-atomoxetine-for-the-treatment-of-adhd weekly 0.8 https://www.themednet.org/what-is-the-most-impactful-career-advice-you-have-received-from-a-colleague-or-mentor weekly 0.8 https://www.themednet.org/have-you-observed-adverse-mental-health-side-effects-in-patients-who-start-montelukast weekly 0.8 https://www.themednet.org/when-do-you-recommend-srt-if-ever-for-small-sccs-and-bccs weekly 0.8 https://www.themednet.org/how-do-you-treat-disruptive-mood-dysregulation-disorder weekly 0.8 https://www.themednet.org/what-duration-of-antibiotic-therapy-do-you-use-for-a-loculated-parapneumonic-effusion-that-does-not-meet-criteria-for-empyema weekly 0.8 https://www.themednet.org/how-would-you-optimally-boost-patients-with-high-or-very-high-risk-prostate-cancer-receiving-definitive-radiotherapy-in-2025 weekly 0.8 https://www.themednet.org/what-doses-of-lithium-have-you-found-effective-in-reducing-suicidal-ideation weekly 0.8 https://www.themednet.org/what-steroid-regimen-do-you-typically-use-for-induction-therapy-in-patients-with-lupus-nephritis weekly 0.8 https://www.themednet.org/in-light-of-recent-measles-outbreaks-in-the-us-would-you-recommend-an-mmr-booster-for-immunocompetent-patients-born-before-1957 weekly 0.8 https://www.themednet.org/what-approaches-have-you-found-most-helpful-for-concurrent-severe-major-depressive-disorder-and-alcohol-use-disorder weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-asco-gu-2025-2 weekly 0.8 https://www.themednet.org/how-do-you-manage-daytime-somnolence-without-a-clear-cause weekly 0.8 https://www.themednet.org/what-is-the-optimal-timing-for-pet-ct-to-assess-disease-and-treatment-response-with-nivo-avd weekly 0.8 https://www.themednet.org/how-do-you-screen-for-unrecognized-bipolar-disorder-before-initiating-antidepressant-therapy-in-a-patient-presenting-with-a-new-depressive-episode weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gi-cancers-from-asco-2026 weekly 0.8 https://www.themednet.org/what-would-you-tell-to-a-trainee-who-is-interested-in-pursuing-a-career-in-geriatric-medicine-but-is-concerned-about-the-relatively-low-number-of-people-who-enter-match-into-the-field weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-patient-with-nccn-favorable-intermediate-prostate-cancer-but-a-high-risk-decipher-score weekly 0.8 https://www.themednet.org/based-on-new-data-from-asco2019-would-you-consider-gefitinib-chemotherapy-instead-of-osimertinib-frontline-for-egfrm-metastatic-nsclc-pts weekly 0.8 https://www.themednet.org/how-do-you-manage-local-mesenteric-lymph-node-recurrence-of-colon-cancer-after-surgery-and-adjuvant-therapy weekly 0.8 https://www.themednet.org/as-consolidative-thoracic-radiation-ctrt-was-prohibited-on-the-seminal-chemoimmunotherapy-trials-in-es-sclc-how-do-you-approach-ctrt-in-practice weekly 0.8 https://www.themednet.org/would-you-hold-off-on-whole-brain-radiotherapy-for-a-patient-with-metastatic-nsclc-and-multiple-asymptomatic-brain-metastases-and-will-be-starting-immunotherapy weekly 0.8 https://www.themednet.org/would-you-skip-adjuvant-rt-in-post-prostatectomy-patients weekly 0.8 https://www.themednet.org/what-treatment-would-you-consider-for-es-sclc-that-is-refractory-to-first-line-platinum-plus-immunotherapy weekly 0.8 https://www.themednet.org/what-therapy-do-you-usually-choose-in-patients-with-previously-treated-follicular-lymphoma-who-experience-early-relapse-2-years weekly 0.8 https://www.themednet.org/would-you-offer-first-line-atezolizumab-plus-bevacizumab-in-unresectable-metastatic-hepatocellular-carcinoma-based-on-the-imbrave-150-data weekly 0.8 https://www.themednet.org/what-screening-criteria-do-you-use-to-give-patients-iv-contrast-for-the-ct-sim weekly 0.8 https://www.themednet.org/do-you-recommend-treating-pre-chemo-volumes-to-full-prescription-dose-for-locally-advanced-nasopharyngeal-cancer-following-induction-chemotherapy weekly 0.8 https://www.themednet.org/would-you-recommend-extended-adjuvant-endocrine-therapy-if-a-patient-tolerated-5-years-thus-far-but-breast-cancer-index-bci-shows-a-high-risk-of-recurrence-with-low-likelihood-of-benefit-from-extended-therapy weekly 0.8 https://www.themednet.org/how-will-your-management-of-head-and-neck-cancers-change-with-the-covid-19-pandemic weekly 0.8 https://www.themednet.org/are-there-scenarios-that-new-visits-consults-with-patients-can-be-done-virtually-amidst-the-covid-19-outbreak weekly 0.8 https://www.themednet.org/why-is-accelerated-hyperfractionated-rt-still-being-performed-in-nrg-trials-such-as-hn005 weekly 0.8 https://www.themednet.org/what-is-the-most-appropriate-dose-fractionation-for-an-early-stage-progressive-cutaneous-squamous-cell-carcinoma-of-the-nose-in-an-elderly-frail-patient-in-the-setting-of-the-covid-19-pandemic weekly 0.8 https://www.themednet.org/how-do-you-manage-symptomatic-radiation-necrosis-not-responsive-to-steroids weekly 0.8 https://www.themednet.org/what-is-your-preferred-second-line-treatment-for-advanced-hepatocellular-carcinoma-after-progression-on-atezolizumab-and-bevacizumab weekly 0.8 https://www.themednet.org/should-3-years-of-adjuvant-osimertinib-be-the-standard-of-care-for-resected-stage-ib-iiia-egfrm-nsclc weekly 0.8 https://www.themednet.org/should-special-precautions-be-taken-patients-with-ehlers-danlos-syndrome-receiving-radiation-therapy weekly 0.8 https://www.themednet.org/what-head-and-neck-subsites-would-you-treat-for-a-scc-of-multiple-ipsilateral-neck-nodes-clinical-ece-no-contralateral-nodes-with-unknown-primary-origin-site-despite-full-workup weekly 0.8 https://www.themednet.org/when-do-you-refer-a-patient-with-difficult-to-treat-depression-for-esketamine-nasal-spray-versus-iv-ketamine-treatment weekly 0.8 https://www.themednet.org/in-eyes-with-chronic-dme-despite-frequent-anti-vegf-what-is-your-threshold-to-add-or-switch-to-intravitreal-steroid-therapy weekly 0.8 https://www.themednet.org/what-do-you-recommend-as-a-first-line-antidepressant-in-patients-with-major-depressive-disorder-and-migraines weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gu-cancers-from-esmo-2025 weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-medical-oncology-from-sabcs-2025 weekly 0.8 https://www.themednet.org/how-will-the-loretta-and-comet-trials-influence-your-treatment-of-low-risk-dcis weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-asco-gi-2026 weekly 0.8 https://www.themednet.org/how-do-you-discuss-lithium-with-patients-who-are-hesitant-due-to-concerns-about-side-effects-or-monitoring-requirements weekly 0.8 https://www.themednet.org/what-medications-do-you-recommend-for-a-patient-with-adhd-and-anxiety-who-becomes-more-anxious-on-a-stimulant weekly 0.8 https://www.themednet.org/how-do-the-findings-from-the-inavo120-trial-influence-your-decision-making-process-for-selecting-subsequent-lines-of-therapy-in-patients-who-have-relapsed-after-adjuvant-cdk4-6-inhibition weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-d-mannose-or-probiotics-for-patients-with-recurrent-urinary-tract-infections weekly 0.8 https://www.themednet.org/what-treatment-and-management-recommendations-do-you-have-for-amphetamine-induced-skin-picking-disorder-without-insight weekly 0.8 https://www.themednet.org/what-are-your-considerations-when-treating-insomnia-in-perimenopausal-patients-with-comorbid-anxiety-or-mood-disorders-1 weekly 0.8 https://www.themednet.org/do-you-still-use-the-urinary-anion-gap-to-estimate-renal-ammonium-excretion-in-patients-with-a-non-anion-gap-metabolic-acidosis-given-its-limitations weekly 0.8 https://www.themednet.org/how-do-you-approach-antidepressant-selection-in-patients-with-prominent-fatigue-but-minimal-mood-symptoms weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gu-cancers-from-asco-2025 weekly 0.8 https://www.themednet.org/how-do-you-manage-anticoagulation-antiplatelet-therapies-with-strong-indications-for-uninterrupted-therapy-in-setting-of-urgent-procedures weekly 0.8 https://www.themednet.org/would-you-start-hydroxychloroquine-or-another-dmard-in-a-mid-20s-female-patient-with-positive-ana-ssa-ssb-and-dsdna-whose-only-clinical-manifestation-is-intermittent-parotid-gland-swelling weekly 0.8 https://www.themednet.org/do-you-consider-using-buspirone-for-the-management-of-anxiety-in-older-patients weekly 0.8 https://www.themednet.org/based-on-the-results-of-calgb-80803-would-you-consider-induction-and-or-concurrent-folfox-in-neoadjuvant-treatment-of-esophageal-adenocarcinoma weekly 0.8 https://www.themednet.org/in-high-or-very-high-risk-prostate-cancer-do-you-utilize-combined-androgen-blockade-in-patients-receiving-definitive-rt weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-for-ct4-stage-iiic-colorectal-cancer-that-is-d-mmr-and-not-amenable-to-surgery-due-to-volume-of-disease weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-cisplatin-gemcitabine-or-nivolumab-in-a-patient-with-muscle-invasive-bladder-ca-who-proceeded-to-radical-cystectomy-first weekly 0.8 https://www.themednet.org/in-clearly-resectable-pancreatic-adenocarcinoma-with-no-arterial-or-venous-involvement-is-there-a-role-for-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-regimen-for-pdl1-negative-squamous-cell-lung-cancer weekly 0.8 https://www.themednet.org/how-far-can-you-dose-reduce-abemaciclib-for-a-patient-who-is-having-toxicity-at-starting-doses weekly 0.8 https://www.themednet.org/does-the-magnitude-of-benefit-with-2-years-of-adjuvant-abemaciclib-outweigh-side-effects-given-that-many-patients-will-receive-cdk-4-6-inhibitors-at-breast-cancer-recurrence-precluding-os-benefits weekly 0.8 https://www.themednet.org/in-metastatic-tnbc-with-germline-or-somatic-brca-mutation-when-is-the-preferred-time-to-introduce-a-parp-inhibitor weekly 0.8 https://www.themednet.org/if-a-braf-mutated-melanoma-patient-developed-metastatic-disease-progression-on-adjuvant-anti-pd-1-monotherapy-do-you-recommend-switching-to-braf-mek-targeted-therapy-or-combination-immunotherapy weekly 0.8 https://www.themednet.org/do-you-treat-synchronous-bilateral-breast-cancers-with-rt-simultaneously-or-sequentially weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-asco-gi-2022 weekly 0.8 https://www.themednet.org/what-is-the-optimal-treatment-for-a-locally-advanced-rectal-cancer-on-the-anterior-wall-abutting-the-prostate-in-a-medically-inoperable-patient-with-a-remote-history-of-ldr-brachytherapy-for-low-risk-prostate-cancer weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-asco-gu-2022 weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-chronic-migraine-as-well-as-medication-overuse-headaches weekly 0.8 https://www.themednet.org/how-do-you-select-which-patients-with-h-n-primary-tumors-benefit-from-proton-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-the-parotid-volume-for-a-pet-avid-intra-parotid-node-when-planning-definitive-chemo-radiation-for-a-locally-advanced-squamous-cell-carcinoma-of-the-oropharynx weekly 0.8 https://www.themednet.org/how-do-you-manage-axillary-hyperhidrosis-that-is-refractory-to-oral-glycopyrrolate-and-aluminum-based-antiperspirants-in-patients-with-neuromuscular-disorders weekly 0.8 https://www.themednet.org/in-patients-with-severe-asthma-who-are-candidates-for-biologics-do-you-put-them-on-an-ics-laba-lama-rather-than-high-dose-ics-laba weekly 0.8 https://www.themednet.org/would-you-offer-hypofractionated-radiation-regimens-for-a-young-patient-with-glioblastoma-with-good-performance-status-but-travel-concerns-making-6-weeks-of-radiation-difficult weekly 0.8 https://www.themednet.org/for-patients-admitted-while-taking-chronic-outpatient-opioids-how-do-you-decide-whether-to-resume-their-baseline-opioid-regimen-at-discharge-versus-tapering-or-modifying-therapy-during-hospitalization weekly 0.8 https://www.themednet.org/what-are-some-methods-to-deal-with-iop-elevations-with-intravitreal-injections-in-a-patient-without-glaucomatous-damage-that-does-not-want-to-have-ac-taps-with-each-injection weekly 0.8 https://www.themednet.org/would-you-consider-transition-to-cabotegravir-rilpivirine-injectable-regimen-in-a-patient-living-with-hiv-who-is-well-suppressed-on-bic-ftc-taf-since-initial-diagnosis-in-colombia-in-2022-at-which-time-her-viral-load-was-in-the-400s-precluding-genotypic-r weekly 0.8 https://www.themednet.org/are-their-still-clinical-situations-in-which-you-deliberately-treat-patients-with-a-doac-besides-apixaban weekly 0.8 https://www.themednet.org/do-you-perform-routine-screening-for-latent-tuberculosis-in-a-patient-who-resides-in-the-united-states-has-frequent-1-2-week-trips-to-see-family-in-a-highly-endemic-country-but-who-otherwise-has-no-significant-risk-factors-or-high-risk-exposure-activities weekly 0.8 https://www.themednet.org/what-approaches-have-you-found-to-be-been-helpful-for-epic-dreaming-syndrome weekly 0.8 https://www.themednet.org/how-are-you-interpreting-the-early-rasolute-302-trial-findings-daraxonrasib-in-metastatic-pdac weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-thoracic-cancers-from-asco-2022 weekly 0.8 https://www.themednet.org/do-you-use-vitamin-b6-to-help-with-keppra-irritability weekly 0.8 https://www.themednet.org/when-do-you-begin-antifibrotic-therapy-for-a-patient-with-newly-diagnosed-ild-that-is-not-ipf weekly 0.8 https://www.themednet.org/is-s1800a-data-sufficient-to-adopt-ramucirumab-pembrolizumab-in-your-clinical-practice-immediately-or-is-phase-3-data-needed weekly 0.8 https://www.themednet.org/how-slowly-do-you-taper-a-dopamine-agonist-to-prevent-dopamine-agonist-withdrawal-syndrome-daws weekly 0.8 https://www.themednet.org/do-you-transition-to-a-topical-retinoid-after-a-patient-completes-a-course-of-isotretinoin weekly 0.8 https://www.themednet.org/do-you-prefer-cdk-4-6-inhibitor-or-parp-inhibitor-as-first-line-treatment-in-a-patient-with-hr-her2-neg-relapsed-metastatic-brca-positive-breast-cancer-who-had-previous-adjuvant-chemotherapy-and-developed-metastatic-recurrence-while-on-ai weekly 0.8 https://www.themednet.org/would-you-give-checkpoint-inhibitor-therapy-to-a-cancer-patient-with-known-dermatomyositis-given-the-association-of-checkpoint-inhibitor-associated-myocarditis-myasthenia-gravis-and-myositis weekly 0.8 https://www.themednet.org/how-would-you-manage-simultaneous-locally-advanced-nsclc-and-locally-advanced-head-and-neck-cancer weekly 0.8 https://www.themednet.org/for-a-patient-with-well-differentiated-de-novo-triple-positive-metastatic-breast-cancer-who-did-not-respond-to-thp-do-you-sequence-all-available-her2-targeted-options-before-endocrine-therapy weekly 0.8 https://www.themednet.org/considering-only-cerebrovascular-indications-are-there-circumstances-in-which-you-would-use-aspirin-along-with-a-doac-in-patients-with-atrial-fibrillation-and-stroke weekly 0.8 https://www.themednet.org/what-factors-do-you-take-into-account-when-deciding-to-offer-spaceoar-to-patients-with-prostate-cancer-planning-to-undergo-radiation-therapy weekly 0.8 https://www.themednet.org/if-you-must-start-adjuvant-radiation-more-than-6-8-weeks-postoperatively-whether-due-to-complications-or-healing-do-you-accelerate-treatment-in-any-way weekly 0.8 https://www.themednet.org/how-do-you-approach-biologic-initiation-in-patients-with-inflammatory-arthritis-and-repeatedly-indeterminate-quantiferon weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-driving-who-have-pnea weekly 0.8 https://www.themednet.org/what-salvage-chemotherapy-if-any-would-you-recommend-for-a-patient-with-primary-refractory-dlbcl-who-progressed-after-two-cycles-of-r-chop weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-history-of-stage-i-seminoma-s-p-orchiectomy-with-enlarging-periaortic-node-and-normal-tumor-markers-on-surveillance weekly 0.8 https://www.themednet.org/how-do-you-manage-treat-acute-radiation-induced-enteritis weekly 0.8 https://www.themednet.org/would-you-consider-the-use-of-rilonacept-to-treat-refractory-pericarditis-in-lupus weekly 0.8 https://www.themednet.org/would-you-ever-recommend-testosterone-replacement-for-men-with-incomplete-t-recovery-after-adt-for-prostate-cancer weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gi-cancers-from-asco-2022 weekly 0.8 https://www.themednet.org/how-does-one-interpret-the-lumina-trial-in-the-florence-apbi-era weekly 0.8 https://www.themednet.org/do-you-ever-prophylactically-treat-an-asymptomatic-bone-metastasis-to-prevent-or-delay-risk-of-pathologic-fracture weekly 0.8 https://www.themednet.org/how-would-you-approach-treating-patients-with-biopsy-proven-hailey-hailey-disease-refractory-to-multiple-oral-therapies-i-e-tetracyclines-naltrexone-apremilast-glycopyrrolate-cellcept-and-requiring-monthly-steroid-tapers-for-disease-flares weekly 0.8 https://www.themednet.org/how-do-you-approach-selecting-biologic-therapy-vs-non-biologic-dmard-such-as-methotrexate-as-initial-therapy-in-patients-with-new-ra-diagnosis-with-significant-erosive-disease weekly 0.8 https://www.themednet.org/how-have-you-incorporated-gene-expression-profiling-tests-for-melanoma-or-scc-into-your-practice-and-has-it-changed-your-approach-to-treatment-and-or-monitoring weekly 0.8 https://www.themednet.org/how-will-you-decide-who-to-offer-ramucirumab-pembro-after-progression-on-chemoimmunotherapy weekly 0.8 https://www.themednet.org/what-dosing-range-of-oral-minoxidil-do-you-prescribe-for-patients-with-hair-loss weekly 0.8 https://www.themednet.org/how-do-you-manage-aeds-in-patients-with-malignant-brain-tumors weekly 0.8 https://www.themednet.org/what-skin-care-regimen-do-you-prefer-during-radiation-for-patients-with-inflammatory-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-locally-advanced-adenocarcinoma-of-the-base-of-tongue weekly 0.8 https://www.themednet.org/would-you-discontinue-romosozumab-in-a-patient-who-develops-a-hemorrhagic-stroke-while-on-therapy weekly 0.8 https://www.themednet.org/do-you-favor-aspirin-or-p2y12-inhibitor-monotherapy-following-completion-of-12-months-of-dapt-post-pci-in-patients-with-elevated-bleeding-risk weekly 0.8 https://www.themednet.org/in-an-early-stage-breast-cancer-post-neoadjuvant-chemotherapy-do-you-repeat-er-pr-and-her2-status-on-the-surgical-specimen-if-there-is-residual-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-rt-coverage-of-an-abdominopelvic-lymph-node-in-the-oligometastatic-or-oligorecurrent-setting weekly 0.8 https://www.themednet.org/what-volumes-would-you-cover-for-ct3n0-ypt2n0-breast-cancer-s-p-neoadjuvant-chemotherapy-and-lumpectomy-slnb weekly 0.8 https://www.themednet.org/what-alternative-antibiotics-or-other-therapies-do-you-recommend-for-patients-with-papulopustular-rosacea-and-a-tetracycline-allergy weekly 0.8 https://www.themednet.org/do-you-use-liver-sbrt-to-areas-previously-treated-with-y90-and-subsequently-failed weekly 0.8 https://www.themednet.org/how-clinically-meaningful-are-the-differences-in-the-primary-outcome-between-treatment-and-placebo-groups-in-the-centaur-trial weekly 0.8 https://www.themednet.org/do-you-screen-for-interstitial-lung-disease-in-patients-with-newly-diagnosed-polymyositis-or-dermatomyositis-in-the-absence-of-respiratory-symptoms weekly 0.8 https://www.themednet.org/how-do-you-decide-among-approved-cdk4-6-inhibitors-for-first-line-treatment-of-patients-with-metastatic-hr-breast-cancer-now-that-os-analyses-are-available-in-monaleesa-2-monarch-3-and-paloma-2 weekly 0.8 https://www.themednet.org/is-it-ever-appropriate-to-restart-bipshosphonates-following-a-drug-holiday-in-a-patient-with-a-prior-atypical-hip-fracture weekly 0.8 https://www.themednet.org/what-is-your-preferred-method-for-adding-bolus-at-ct-sim-or-virtual-bolus weekly 0.8 https://www.themednet.org/what-would-be-the-differential-and-initial-workup-for-tongue-fasciculation weekly 0.8 https://www.themednet.org/when-do-you-deem-it-reasonable-to-transition-outpatient-management-of-a-kidney-transplant-patient-to-general-nephrology weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-sabcs-2022 weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-a-low-alkaline-phosphatase weekly 0.8 https://www.themednet.org/what-is-your-approach-when-surgeons-want-to-stop-hydroxychloroquine-prior-to-surgery weekly 0.8 https://www.themednet.org/how-do-you-treat-snuc weekly 0.8 https://www.themednet.org/do-you-obtain-mri-for-cutaneous-scc-with-microscopic-pni-to-assess-for-gross-perineural-tumor-spread weekly 0.8 https://www.themednet.org/in-a-patient-with-a-mid-esophageal-squamous-cell-carcinoma-with-tracheal-invasion-confirmed-on-bronchoscopy-would-you-treat-with-definitive-chemo-radiation-with-curative-intent weekly 0.8 https://www.themednet.org/how-are-you-clinically-incorporating-the-data-presented-from-rt-charm-at-astro-2024 weekly 0.8 https://www.themednet.org/what-is-the-lowest-maintenance-dose-you-will-use-if-a-patient-continues-to-have-anaphylaxis-when-trying-to-achieve-maintenance-dosing weekly 0.8 https://www.themednet.org/is-there-a-role-for-use-of-jak-inhibitors-instead-of-corticosteroids-to-induce-clinical-remission-in-those-with-severe-ulcerative-colitis weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-taking-a-glp-1-agonist-for-weight-loss-who-continues-to-have-symptoms-i-e-nausea-vomiting-related-to-reduced-gi-motility-despite-dose-adjustments weekly 0.8 https://www.themednet.org/what-is-the-stepwise-investigation-of-patients-suspected-of-inflammatory-myopathy weekly 0.8 https://www.themednet.org/what-diet-do-you-recommend-for-patients-with-inflammatory-bowel-disease weekly 0.8 https://www.themednet.org/what-clinical-or-logistical-factors-influence-your-choice-of-anti-cd38-antibody-in-first-line-treatment-of-multiple-myeloma weekly 0.8 https://www.themednet.org/how-do-you-manage-obsessive-compulsive-disorder-refractory-to-high-dose-ssri-and-cognitive-behavioral-therapy weekly 0.8 https://www.themednet.org/how-does-premorbid-dementia-affect-your-decision-to-offer-acute-stroke-intervention weekly 0.8 https://www.themednet.org/what-systemic-therapy-would-you-use-in-t3n1m1-mmr-proficient-rectal-cancer-with-solitary-liver-lesion-when-going-for-curative-intent-chemo-short-course-rt-resection-of-primary-and-liver-met weekly 0.8 https://www.themednet.org/for-a-patient-with-known-cad-and-low-baseline-hdl-would-a-pcsk9-inhibitor-be-a-better-option-than-a-statin-given-concerns-for-paradoxical-lowering-of-hdl-levels-with-statin-therapy-that-we-can-encounter-in-the-outpatient-clinical-setting weekly 0.8 https://www.themednet.org/would-you-consider-delaying-tarlatamab-initiation-in-a-patient-with-es-sclc-who-recently-completed-rt-for-cns-disease-given-the-concern-for-immune-effector-cell-associated-neurotoxicity-syndrome-icans weekly 0.8 https://www.themednet.org/what-is-the-role-of-the-rheumatologist-in-recommending-and-providing-glp-1-medications-to-their-patients-given-the-benefits-across-many-disease-domains-including-osteoarthritis weekly 0.8 https://www.themednet.org/do-you-use-any-alternative-or-non-fda-approved-treatments-for-smoking-cessation weekly 0.8 https://www.themednet.org/for-patients-with-newly-diagnosed-vte-on-iv-heparin-planned-for-transition-to-doac-would-you-start-at-the-loading-or-maintenance-doac-dose weekly 0.8 https://www.themednet.org/why-is-there-a-benefit-of-adt-for-high-risk-prostate-cancer-treated-with-radiation-yet-no-large-trials-describing-benefit-of-adjuvant-adt-after-radical-prostatectomy weekly 0.8 https://www.themednet.org/how-do-you-use-gut-microbiome-or-gut-microbiota-analysis-in-your-clinical-practice-if-at-all weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-benzodiazepines-in-patients-with-chronic-medical-illnesses-that-may-be-susceptible-to-respiratory-compromise-e-g-chf-copd-ild weekly 0.8 https://www.themednet.org/do-you-regularly-perform-pharmacogenomic-testing-for-patients-prior-to-starting-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-high-titer-ana-and-a-new-diagnosis-of-itp-but-no-other-signs-or-symptoms-suggestive-of-active-rheumatologic-disease weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-radiation-oncology-from-sabcs-2024 weekly 0.8 https://www.themednet.org/do-you-plan-to-extrapolate-from-the-niagara-trial-regarding-peri-operative-durvalumab-cis-gem-to-treat-upper-tract-urothelial-carcinoma weekly 0.8 https://www.themednet.org/what-medications-do-you-find-helpful-to-reduce-drooling-associated-with-antipsychotics weekly 0.8 https://www.themednet.org/how-long-do-you-recommend-that-a-patient-wear-a-mask-when-resuming-biologic-infusions-following-a-recent-upper-respiratory-infection weekly 0.8 https://www.themednet.org/do-you-routinely-use-two-empiric-antibiotics-to-cover-for-pseudomonas-aeruginosa-in-the-management-of-cf-exacerbations weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-bone-marrow-involvement-in-sarcoidosis weekly 0.8 https://www.themednet.org/what-strategies-have-you-found-helpful-to-manage-ssri-associated-night-sweats weekly 0.8 https://www.themednet.org/do-you-recommend-any-medical-management-for-patients-with-evidence-of-intracranial-atherosclerosis-without-evidence-for-stroke weekly 0.8 https://www.themednet.org/when-treating-rectal-cancer-with-tnt-and-induction-chemotherapy-first-do-you-repeat-pelvic-mri-prior-to-planning-for-chemoradiation weekly 0.8 https://www.themednet.org/what-treatment-sequence-do-you-follow-for-patients-with-rectal-cancer-who-are-candidates-for-both-prospect-and-tnt-watch-and-wait weekly 0.8 https://www.themednet.org/would-you-omit-a-lumpectomy-boost-in-a-younger-patient-50-y-with-a-primary-tumor-that-is-otherwise-favorable weekly 0.8 https://www.themednet.org/how-do-you-monitor-for-pulmonary-toxicity-for-patients-on-trastuzumab-deruxtecan weekly 0.8 https://www.themednet.org/do-you-offer-rni-to-a-t1n0-breast-cancer-patient-who-underwent-inadequate-axillary-dissection weekly 0.8 https://www.themednet.org/what-adjuvant-treatment-would-you-recommend-for-a-stage-i-her2-positive-breast-cancer-with-grade-3-neuropathy-from-previous-taxane-treatment weekly 0.8 https://www.themednet.org/are-you-treating-patients-with-ret-fusion-metastatic-nsclc-with-ret-inhibitors-as-the-first-line-of-therapy-regardless-of-pd-l1-expression weekly 0.8 https://www.themednet.org/what-do-you-use-to-treat-uveitis-refractory-to-conventional-synthetic-dmards-and-tnf-inhibitors weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-nivolumab-to-be-the-standard-of-care-in-stage-ii-iii-esophageal-ge-junction-cancer-after-completion-of-neoadjuvant-chemoradiotherapy-and-surgery weekly 0.8 https://www.themednet.org/would-you-change-your-approach-to-adjuvant-radiation-for-an-incompletely-staged-at-least-ib-grade-1-endometrial-cancer-if-a-uterine-perforation-occurred-at-time-of-surgery weekly 0.8 https://www.themednet.org/which-patients-with-breast-cancer-do-you-treat-with-deep-inspiration-breath-hold-dibh weekly 0.8 https://www.themednet.org/is-2-gy-x-2-or-the-boom-boom-regimen-appropriate-for-treating-patients-with-low-volume-stage-i-malt-lymphoma weekly 0.8 https://www.themednet.org/what-duration-of-adt-do-you-recommend-for-a-patient-with-locally-treated-prostate-cancer-who-undergoes-metastasis-directed-radiation-therapy-to-a-single-oligometastatic-bone-lesion weekly 0.8 https://www.themednet.org/are-you-recommending-the-mrna-covid-19-vaccines-to-your-patients-with-immune-mediated-inflammatory-diseases weekly 0.8 https://www.themednet.org/would-you-consider-treating-a-patient-who-has-an-unresectable-slowly-growing-pet-avid-lung-mass-with-concurrent-chemo-rt-when-multiple-biopsy-attempts-have-only-resulted-in-pathology-suspicious-for-adenocarcinoma-of-the-lung weekly 0.8 https://www.themednet.org/would-you-continue-cemiplimab-adjuvantly-following-resection-of-initially-unresectable-cutaneous-squamous-cell-carcinoma-treated-with-downstaging-immunotherapy weekly 0.8 https://www.themednet.org/does-stage-of-resected-egfrm-nsclc-impact-your-treatment-decisions-for-use-of-adjuvant-osimertinib weekly 0.8 https://www.themednet.org/would-you-offer-pci-to-a-patient-with-ls-sclc-who-presented-initially-with-paraneoplastic-syndrome-encephalomyelitis-but-had-no-neurocognitive-sequelae-after-chemoradiation weekly 0.8 https://www.themednet.org/would-you-give-anthracycline-chemotherapy-to-a-patient-with-hr-her2-negative-inflammatory-breast-cancer-who-has-history-of-cardiomyopathy-with-lvh-and-moderately-reduced-ef-but-most-recent-echo-shows-improvement-to-normal-or-near-normal-ejection-fraction weekly 0.8 https://www.themednet.org/why-are-skin-reactions-better-with-hypofx-breast-rt-vs-standard-fx-breast-rt weekly 0.8 https://www.themednet.org/for-patients-with-ret-fusion-nsclc-who-progress-on-ret-inhibitors-do-you-repeat-tumor-molecular-profiling-before-selecting-subsequent-therapy weekly 0.8 https://www.themednet.org/what-second-line-treatment-would-you-consider-in-patients-with-es-sclc-with-recurrence-after-front-line-chemo-immunotherapy weekly 0.8 https://www.themednet.org/will-you-offer-adjuvant-nivolumab-for-high-risk-muscle-invasive-bladder-cancer-based-on-results-of-checkmate-274 weekly 0.8 https://www.themednet.org/do-you-routinely-utilize-g-csf-as-primary-prophylaxis-in-patients-receiving-mfolfirinox-or-folfoxiri weekly 0.8 https://www.themednet.org/is-there-any-evidence-that-patients-with-metastatic-nsclc-with-kras-g12c-mutations-benefit-less-from-treatment-with-immunotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-brain-metastases-of-varying-sizes-with-srs weekly 0.8 https://www.themednet.org/how-would-you-approach-mantle-cell-lymphoma-in-very-elderly-patients weekly 0.8 https://www.themednet.org/are-you-selecting-any-specific-patient-cohort-with-metastatic-nsclc-for-treatment-with-the-checkmate-9la-protocol-of-ipilimumab-nivolumab-2-cycles-of-chemotherapy weekly 0.8 https://www.themednet.org/what-do-you-routinely-recommend-for-non-pharmacologic-management-of-essential-tremor weekly 0.8 https://www.themednet.org/for-a-patient-with-mm-progressing-on-a-daratumumab-based-regimen-is-it-preferable-to-entirely-switch-drug-class-or-is-another-monoclonal-antibody-such-as-isatuximab-an-acceptable-next-step weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-therapy-for-ros1-rearranged-metastatic-nsclc-without-cns-mets weekly 0.8 https://www.themednet.org/what-makes-a-daily-huddle-successful weekly 0.8 https://www.themednet.org/should-we-start-performing-universal-germline-mutation-testing-for-all-newly-diagnosed-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-sequence-capecitabine-and-olaparib-if-at-all-in-patients-with-brca-tnbc-and-residual-disease-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-recommend-for-a-small-basal-cell-carcinoma-of-the-nasal-ala-in-a-patient-with-poor-performance-status-or-transportation-difficulties weekly 0.8 https://www.themednet.org/how-would-you-treat-recurrent-unresectable-skin-nodules-on-the-chest-wall-after-mastectomy-and-axillary-lymph-node-dissection weekly 0.8 https://www.themednet.org/would-you-offer-further-systemic-therapy-to-a-patient-with-triple-negative-breast-cancer-treated-with-neoadjuvant-chemotherapy-bct-and-adjuvant-xeloda-who-has-a-local-failure-while-receiving-xeloda weekly 0.8 https://www.themednet.org/how-are-you-using-predictive-tests-such-as-dcisionrt-preludedx-or-oncotypedx-dcis-in-the-management-of-dcis weekly 0.8 https://www.themednet.org/can-acalabrutinib-be-used-after-ibrutinib-failure-in-relapsed-refractory-mantle-cell-lymphoma weekly 0.8 https://www.themednet.org/would-you-consider-doing-oncotype-for-a-locoregional-recurrence-of-er-positive-breast-cancer weekly 0.8 https://www.themednet.org/would-you-consider-using-daratumumab-in-the-first-line-setting-for-non-transplant-eligible-multiple-myeloma weekly 0.8 https://www.themednet.org/do-you-routinely-check-echocardiograms-for-patients-getting-her2-directed-therapy-for-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-early-stage-anal-or-anal-margin-cancer-that-is-locally-excised-with-negative-but-close-margins-when-going-back-for-wider-margins-would-require-an-apr weekly 0.8 https://www.themednet.org/how-soon-after-completing-radiation-should-anti-estrogen-medication-start weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-therapy-for-patients-with-newly-diagnosed-intermediate-or-poor-risk-metastatic-clear-cell-rcc weekly 0.8 https://www.themednet.org/how-would-you-suggest-to-radiate-a-kaposis-sarcoma weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-loratadine-for-pegfilgrastim-pain weekly 0.8 https://www.themednet.org/when-do-you-consider-employing-the-4-week-dosing-schedule-for-nivolumab weekly 0.8 https://www.themednet.org/can-oncotype-be-used-in-women-with-er-positive-1-3-lymph-node-positive-disease-with-extracapsular-extension weekly 0.8 https://www.themednet.org/what-is-the-utility-of-a-biopsy-in-the-setting-of-an-elevated-post-prostatectomy-psa-and-imaging-noting-a-local-prostate-bed-recurrence weekly 0.8 https://www.themednet.org/based-on-the-recent-guidelines-should-prostate-sbrt-dose-be-no-higher-than-3625-cgy-in-5-fractions weekly 0.8 https://www.themednet.org/is-there-a-role-for-unilateral-hippocampal-sparing weekly 0.8 https://www.themednet.org/how-do-you-determine-your-treatment-volumes-when-treating-with-chemoradiation-for-bladder-cancer weekly 0.8 https://www.themednet.org/what-are-the-indications-to-treat-dupuytrens-disease-with-radiation weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-a-subtotally-resected-low-grade-glioma-in-a-young-patient weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-for-stage-iii-nsclc-with-single-station-n2-disease-amenable-to-lobectomy weekly 0.8 https://www.themednet.org/for-patients-you-treat-with-ldr-prostate-brachytherapy-how-do-you-sequence-treatment-with-external-beam-radiation-therapy weekly 0.8 https://www.themednet.org/in-which-oropharynx-patients-would-you-recommend-tors-vs-upfront-rt-or-chemo-rt weekly 0.8 https://www.themednet.org/for-patients-with-inoperable-stage-iii-nsclc-who-are-unable-to-receive-or-refuse-definitive-chemoradiation-how-do-you-decide-among-radiation-alone-pembrolizumab-alone-or-radiation-followed-by-either-pembrolizumab-or-durvalumab weekly 0.8 https://www.themednet.org/what-dose-of-radiation-do-you-use-for-neoadjuvant-chemoradiation-in-esophageal-cancer weekly 0.8 https://www.themednet.org/what-is-your-criteria-for-a-prophylactic-peg-tube-in-patients-initiating-head-and-neck-radiotherapy weekly 0.8 https://www.themednet.org/do-you-give-vaginal-cuff-brachytherapy-and-or-whole-pelvis-for-patients-with-stage-iii-endometrial-adenocarcinoma weekly 0.8 https://www.themednet.org/can-i-treat-breast-nodal-volumes-with-hypofractionation weekly 0.8 https://www.themednet.org/what-type-of-igrt-do-you-use-for-external-beam-partial-breast-irradiation weekly 0.8 https://www.themednet.org/is-there-really-substantial-evidence-to-avoid-central-lesions-for-sbrt weekly 0.8 https://www.themednet.org/would-you-consider-offering-salvage-radiation-to-a-patient-with-castrate-resistant-prostate-cancer-who-has-never-had-local-therapy-and-has-no-evidence-of-lymph-node-or-distant-metastasis weekly 0.8 https://www.themednet.org/what-do-you-do-for-physician-approval-of-igrt-images weekly 0.8 https://www.themednet.org/do-you-forgo-adjuvant-radiotherapy-for-men-with-pt3-prostate-cancer-who-have-significant-urinary-incontinence weekly 0.8 https://www.themednet.org/what-is-your-thought-process-for-dose-prescriptions-when-treating-abdominal-pelvic-lymph-node-oligometastasis-with-sbrt weekly 0.8 https://www.themednet.org/do-you-always-use-a-bolus-when-treating-with-postmastectomy-radiotherapy weekly 0.8 https://www.themednet.org/when-do-you-consider-it-too-late-after-lumpectomy-to-offer-adjuvant-whole-breast-radiotherapy weekly 0.8 https://www.themednet.org/do-you-recommend-hypofractionated-canadian-fractionation-for-in-situ-ductal-cancer weekly 0.8 https://www.themednet.org/do-you-avoid-hypofractionated-regimen-for-grade-3-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-cutoff-for-the-maximum-number-and-size-of-brain-metastases-that-you-will-treat-with-srs weekly 0.8 https://www.themednet.org/is-there-an-effective-treatment-for-severe-radiation-fibrosis-of-the-skin-after-radiotherapy-to-the-breast-or-other-areas weekly 0.8 https://www.themednet.org/do-you-treat-rectosigmoid-upper-rectal-cancers-with-neoadjuvant-chemoradiation weekly 0.8 https://www.themednet.org/after-completing-srs-for-brain-mets-how-long-should-the-medical-oncologist-wait-before-starting-chemotherapy weekly 0.8 https://www.themednet.org/is-there-an-age-cutoff-you-use-to-determine-when-you-will-offer-standard-vs-hypofractionated-breast-radiation-in-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/will-you-treat-brain-mets-with-srs-in-patients-who-cannot-undergo-mri weekly 0.8 https://www.themednet.org/do-you-test-your-esophageal-and-gastric-specimens-for-her2-using-ihc-fish-or-both weekly 0.8 https://www.themednet.org/will-the-recent-publication-of-the-ma-20-and-eortc-22922-studies-in-nejm-showing-no-survival-advantage-from-regional-nodal-irradiation-in-early-stage-breast-cancer-patient-following-surgery-change-your-standard-of-care-for-these-patients weekly 0.8 https://www.themednet.org/which-patients-would-you-offer-a-watch-and-wait-approach-versus-surgical-resection-after-chemoradiotherapy-for-patients-with-rectal-cancer weekly 0.8 https://www.themednet.org/what-dose-volume-constraint-should-be-used-for-the-normal-brain-parenchyma-in-a-patient-receiving-5-fraction-sbrt weekly 0.8 https://www.themednet.org/when-is-the-coverage-of-tracheostomy-site-required-for-head-neck-cancer-radiation-therapy-and-to-what-dose weekly 0.8 https://www.themednet.org/in-light-of-the-recently-published-lap07-trial-what-is-the-role-of-radiation-in-unresectable-pancreatic-cancer weekly 0.8 https://www.themednet.org/should-local-consolidative-therapy-be-offered-to-patients-with-oligometastatic-nsclc-who-do-not-progress-after-induction-systemic-therapy weekly 0.8 https://www.themednet.org/when-do-you-choose-a-non-anthracycline-containing-regimen-such-as-docetaxel-cyclophosphamide-for-patients-with-hormone-receptor-positive-her2-negative-breast-cancer-who-warrant-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-is-the-most-appropriate-radiation-dose-and-volume-for-elderly-and-or-frail-patients-with-advanced-scc-of-the-anal-canal-not-receiving-chemotherapy-to-attain-durable-local-control weekly 0.8 https://www.themednet.org/how-should-the-outcomes-and-qol-results-of-the-protect-trial-be-interpreted weekly 0.8 https://www.themednet.org/for-cll-patients-with-high-risk-cytogenetics-on-ibrutinib-who-develop-a-cardiac-event-such-as-an-mi-would-you-continue-ibrutinib weekly 0.8 https://www.themednet.org/do-you-recommend-omitting-radiation-therapy-in-young-women-with-favorable-dcis weekly 0.8 https://www.themednet.org/when-and-how-are-you-incorporating-tumor-sequencing-to-plan-treatment-of-metastatic-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-intensify-treatment-for-patients-with-double-hit-lymphoma-or-double-expressor-lymphoma weekly 0.8 https://www.themednet.org/what-is-your-technique-for-mri-to-ct-fusion-for-intracranial-srs-planning weekly 0.8 https://www.themednet.org/what-strategies-do-you-employ-to-mitigate-mucositis-related-pain-during-the-treatment-of-head-and-neck-cancer weekly 0.8 https://www.themednet.org/when-do-you-consider-her2-targeting-antibody-drug-conjugates-in-the-first-line-setting-for-metastatic-her2-positive-er-negative-breast-cancer weekly 0.8 https://www.themednet.org/would-you-use-sequential-cdk-4-6-inhibitors-in-hr-positive-metastatic-breast-ca-in-successive-lines-of-therapy weekly 0.8 https://www.themednet.org/when-utilizing-the-canadian-regimen-of-4256cgy-16-fxn-what-boost-dose-and-fractionation-are-you-using weekly 0.8 https://www.themednet.org/when-should-you-use-single-fraction-radiotherapy-for-spinal-cord-compression weekly 0.8 https://www.themednet.org/how-do-you-simulate-and-treat-a-prostate-cancer-patient-with-a-persistently-full-rectum weekly 0.8 https://www.themednet.org/how-do-you-utilize-genomic-testing-in-hr-positive-breast-cancer-to-make-recommendations-regarding-the-duration-of-endocrine-therapy weekly 0.8 https://www.themednet.org/is-there-a-risk-of-increased-side-effects-with-combined-radiation-and-ibrutinib-therapy weekly 0.8 https://www.themednet.org/how-would-you-treat-node-positive-pn-prostate-cancer-with-undetectable-post-op-psa-after-radical-prostatectomy-and-pelvic-lnd weekly 0.8 https://www.themednet.org/how-will-your-approach-to-screening-and-diagnosis-of-early-dementia-change-given-newly-available-therapies-for-early-alzheimers-disease weekly 0.8 https://www.themednet.org/in-oligometastatic-nsclc-with-a-solitary-brain-metastasis-and-lung-primary-amenable-to-sbrt-how-would-you-sequence-first-line-systemic-therapy-versus-local-therapy-to-the-lung-after-treatment-of-the-cns-metastasis weekly 0.8 https://www.themednet.org/what-is-your-preferred-third-antimicrobial-agent-for-a-patient-with-treatment-naive-pulmonary-mac-without-cavitary-disease-and-strict-contraindications-to-utilization-of-rifampin-or-rifabutin weekly 0.8 https://www.themednet.org/do-you-add-adjunctive-gentamicin-and-or-rifampin-for-treatment-of-prosthetic-valve-staphylococcus-aureus-endocarditis weekly 0.8 https://www.themednet.org/in-what-clinical-situations-do-you-order-navdx weekly 0.8 https://www.themednet.org/how-do-you-approach-pityriasis-rubra-pilaris-that-is-retinoid-resistant weekly 0.8 https://www.themednet.org/how-would-you-manage-a-left-sided-triple-negative-breast-cancer-with-a-concurrent-left-sided-locally-advanced-non-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/has-your-management-of-severe-hyponatremia-changed-after-a-recent-observational-study-described-higher-in-hospital-mortality-for-sodium-correction-of-6-meq-l-compared-to-6-10-meq-l-in-the-first-24-hours weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-astro-2023 weekly 0.8 https://www.themednet.org/in-what-situations-would-you-treat-a-rectal-mass-as-cancer-despite-negative-biopsies weekly 0.8 https://www.themednet.org/is-there-a-role-for-chemotherapy-and-or-vaginal-cuff-boost-to-ebrt-in-figo-ib1-cervical-adenocarcinoma-status-post-total-hysterectomy weekly 0.8 https://www.themednet.org/in-patients-with-suspected-rcvs-is-there-a-role-for-preventative-ccb-if-headache-has-resolved-now-asymptomatic weekly 0.8 https://www.themednet.org/what-are-your-practical-considerations-for-incorporating-bispecific-antibody-therapy-into-treatment-of-relapsed-dlbcl weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-biochemical-evidence-of-primary-hyperparathyroidism-but-normal-parathyroid-scan weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-planning-for-lung-sbrt-in-a-patient-with-a-lesion-within-1-cm-of-a-defibrillator weekly 0.8 https://www.themednet.org/in-patients-with-both-esr1-and-pik3ca-mutations-who-have-progressed-on-ai-cdk4-6-inhibitor-how-are-you-deciding-the-treatment-sequence-of-next-line-therapies weekly 0.8 https://www.themednet.org/what-treatment-modalities-have-you-had-success-with-for-treating-recalcitrant-warts weekly 0.8 https://www.themednet.org/what-is-a-reasonable-length-of-time-for-systemic-anticoagulation-in-patients-presenting-with-mi-in-the-setting-of-coronary-artery-aneurysm-with-large-thrombus-formation weekly 0.8 https://www.themednet.org/do-you-find-adding-fludrocortisone-helpful-in-treating-persistent-hypotension-in-hd-patients-already-on-midodrine-and-without-evidence-of-adrenal-insufficiency weekly 0.8 https://www.themednet.org/do-you-refer-all-patients-with-new-findings-of-cns-or-epidural-mets-tumor-to-ed-for-evaluation-or-are-there-some-that-can-be-managed-completely-outpatient weekly 0.8 https://www.themednet.org/in-a-young-patient-with-recurrent-low-grade-glioma-s-p-gross-total-resection-is-there-any-role-for-further-observation-instead-of-radiation-and-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-stage-ii-colon-cancer-with-negative-ctdna-but-markedly-elevated-cea-level-post-colectomy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-less-than-40-years-old-with-an-incidentally-found-lgg-idh-mutated-1p19q-intact-s-p-str weekly 0.8 https://www.themednet.org/would-you-recommend-sbrt-in-the-adjuvant-settings-for-a-solitary-metastasis-focus-in-the-abdominal-wall-resected-to-r1-in-a-young-and-healthy-patient-with-clear-cell-ovarian-cancer weekly 0.8 https://www.themednet.org/do-you-still-order-mpmri-for-staging-of-prostate-cancer-in-addition-to-pet-psma weekly 0.8 https://www.themednet.org/how-would-you-approach-a-pulmonary-renal-pr3-anca-vasculitis-patient-who-has-persistent-re-narrowing-of-mainstem-bronchus-after-several-dilatation-and-stenting-procedures-with-other-anca-features-well-controlled-on-rituximab-avacopan weekly 0.8 https://www.themednet.org/do-you-grade-severity-of-osa-by-ahi-or-rdi weekly 0.8 https://www.themednet.org/what-treatment-modalities-have-you-had-success-with-for-treating-sebaceous-hyperplasia weekly 0.8 https://www.themednet.org/do-you-recommend-continuous-glucose-monitoring-for-patients-with-type-2-diabetes-who-are-not-on-insulin weekly 0.8 https://www.themednet.org/do-you-use-a-phosphate-binder-to-manage-inpatient-hyperphosphatemia-in-patients-with-aki-who-have-no-history-of-ckd weekly 0.8 https://www.themednet.org/how-do-you-avoid-epilation-in-patients-hoping-to-preserve-their-facial-hair-during-radiotherapy weekly 0.8 https://www.themednet.org/is-there-any-role-for-palliative-radiation-in-patients-who-are-intubated-due-to-malignant-airway-obstruction weekly 0.8 https://www.themednet.org/when-do-you-consider-stopping-denosumab-when-a-patient-with-osteoporosis-is-otherwise-tolerating-it-without-issues weekly 0.8 https://www.themednet.org/would-you-give-tnk-or-ivt-to-a-patient-with-proximal-occlusion-and-an-nihss-of-0-3-non-disabling weekly 0.8 https://www.themednet.org/what-are-the-reasons-for-sle-specific-labs-to-turn-negative weekly 0.8 https://www.themednet.org/what-is-your-approach-for-treating-locally-advanced-gastric-type-adenocarcinoma-of-the-cervix weekly 0.8 https://www.themednet.org/how-do-you-approach-external-beam-rt-to-the-thyroid-bed-for-resected-recurrent-thyroid-cancer-in-a-patient-with-previous-history-of-150mci-of-radioactive-iodine weekly 0.8 https://www.themednet.org/should-perfusion-imaging-be-the-standard-of-care-in-cases-of-a-severe-symptomatic-intracranial-stenosis weekly 0.8 https://www.themednet.org/what-radiation-dose-is-a-risk-for-damaging-function-or-active-leads-from-a-pacemaker weekly 0.8 https://www.themednet.org/how-do-you-approach-a-negative-ana-and-positive-dsdna-in-patients-with-arthralgia-hair-loss-or-other-uctd-features weekly 0.8 https://www.themednet.org/how-would-you-treat-an-elderly-patient-ecog-0-1-with-locally-advanced-rectal-cancer-and-synchronous-merkel-cell-cancer-of-the-extremity-requiring-adjuvant-rt weekly 0.8 https://www.themednet.org/how-does-decipher-score-inform-your-practice-for-treating-pelvic-nodes-in-otherwise-favorable-intermediate-risk-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-diagnose-and-treat-patients-with-cervicogenic-headache weekly 0.8 https://www.themednet.org/would-you-ever-consider-focal-brachytherapy-treatment-in-a-patient-who-have-in-prostate-recurrences-after-rt weekly 0.8 https://www.themednet.org/would-you-consider-chemoradiation-chemotherapy-as-in-portec-3-regimen-for-p53-mutated-stage-ia-endometrial-cancer-though-this-trial-did-not-include-those-with-stage-ia-disease weekly 0.8 https://www.themednet.org/for-patients-with-microcytosis-mcv-75-79-and-normal-hb-low-tibc-and-normal-ferritin-do-you-always-rule-out-thalassemia weekly 0.8 https://www.themednet.org/do-you-diagnose-obstruction-by-the-criteria-of-fev1-fvc-70-or-lln weekly 0.8 https://www.themednet.org/do-you-typically-recommend-inpatient-stroke-evaluation-for-patients-with-incidentally-found-asymptomatic-stroke-on-outpatient-imaging weekly 0.8 https://www.themednet.org/what-non-variceal-egd-findings-if-any-deter-you-from-using-atezo-bev-in-patients-with-advanced-hcc weekly 0.8 https://www.themednet.org/given-recent-trials-for-the-management-of-atrial-fibrillation-with-an-early-ablation-strategy-for-example-east-afnet-4-early-af-progressive-af-stop-af-what-is-your-approach-to-determining-the-appropriate-timing-for-ablation-in-patients-with-atrial-fibrill weekly 0.8 https://www.themednet.org/would-you-recommend-radiation-to-a-painful-rib-fracture-in-a-patient-with-multiple-myeloma-on-systemic-therapy-with-ongoing-response-to-treatment weekly 0.8 https://www.themednet.org/what-is-the-optimal-duration-of-adt-for-unfavorable-intermediate-risk-or-high-risk-localized-prostate-cancer-treated-with-sbrt-instead-of-conventionally-fractionated-or-hypofractionated-rt weekly 0.8 https://www.themednet.org/if-an-average-risk-physically-fit-resected-stage-ii-colon-cancer-patient-has-a-positive-signatera-result-3-2-mtm-ml-would-you-recommend-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/given-patients-with-substantial-lvsi-experience-a-pelvic-recurrence-rate-of-25-how-do-you-counsel-patients-with-stage-ia-endometrioid-endometrial-cancer-with-lvsi-regarding-the-relative-risks-benefits-of-ebrt-versus-vbt-alone weekly 0.8 https://www.themednet.org/is-there-any-contraindication-to-the-use-of-ezetimibe-in-patients-with-a-history-of-statin-induced-necrotizing-myopathy weekly 0.8 https://www.themednet.org/how-do-you-manage-diarrhea-in-a-patient-with-ctd-ild-on-mmf-who-was-recently-started-on-full-dose-nintedanib weekly 0.8 https://www.themednet.org/how-are-you-approaching-patients-with-early-stage-nsclc-who-progress-on-neoadjuvant-chemo-immunotherapy-and-are-no-longer-surgical-candidates weekly 0.8 https://www.themednet.org/what-role-do-anti-seizure-medication-levels-such-as-levetiracetam-serve-in-seizure-free-patients weekly 0.8 https://www.themednet.org/what-is-your-approach-to-using-nintedanib-in-patients-on-baseline-immunosuppression weekly 0.8 https://www.themednet.org/what-treatments-have-you-found-most-effective-in-removing-syringomas weekly 0.8 https://www.themednet.org/do-you-typically-obtain-an-eeg-in-patients-undergoing-workup-for-cognitive-dysfunction weekly 0.8 https://www.themednet.org/what-rates-of-breast-not-arm-lymphedema-would-you-quote-to-patients-post-lumpectomy-and-adjuvant-radiation weekly 0.8 https://www.themednet.org/how-do-you-manage-incidentally-found-venous-sinus-thrombosis weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-morbid-obesity-who-presents-with-new-symptomatic-pulmonary-embolism-a-few-days-after-he-was-started-on-doac-for-dvt weekly 0.8 https://www.themednet.org/how-would-you-simulate-and-ensure-set-up-reproducibility-for-a-patient-with-head-and-neck-cancer-and-severe-claustrophobia-and-unable-to-tolerate-a-thermoplastic-mask weekly 0.8 https://www.themednet.org/is-the-increase-in-rfs-seen-with-adjuvant-atezo-bev-in-imbrave050-enough-to-change-practice-in-resected-hcc weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-thoracic-cancers-from-asco-2023 weekly 0.8 https://www.themednet.org/what-is-your-approach-to-immunomodulatory-treatment-in-patients-with-sjogrens-syndrome-who-have-active-serologies-i-e-elevated-esr-hypergammaglobulinemia-hypocomplementemia-but-minimal-symptoms weekly 0.8 https://www.themednet.org/is-your-standard-of-care-for-newly-diagnosed-advanced-classical-hodgkin-now-nivolumab-avd-based-on-swog-1826 weekly 0.8 https://www.themednet.org/how-do-you-manage-a-seminal-vesicle-recurrence-after-prostate-brachytherapy weekly 0.8 https://www.themednet.org/should-teprotumumab-be-used-in-patients-with-active-moderate-graves-thyroid-eye-disease-in-the-absence-of-proptosis weekly 0.8 https://www.themednet.org/in-patients-with-nasopharyngeal-scc-that-have-an-excellent-response-to-induction-chemo-do-you-alter-your-chemo-rt-dose-volumes-in-any-way weekly 0.8 https://www.themednet.org/what-are-your-image-guidance-instructions-for-post-op-endometrial-cancer-ebrt weekly 0.8 https://www.themednet.org/in-a-patient-with-very-high-risk-prostate-cancer-opting-for-prostatectomy-when-if-ever-do-you-recommend-neoadjuvant-adt weekly 0.8 https://www.themednet.org/do-you-continue-to-use-botox-to-treat-chronic-migraine-in-a-patient-who-becomes-pregnant weekly 0.8 https://www.themednet.org/in-a-patient-with-history-of-successfully-treated-locally-advanced-h-n-cancer-how-do-you-discern-between-a-metachronous-second-primary-locally-advanced-lung-scc-vs-metastatic-head-and-neck-scc weekly 0.8 https://www.themednet.org/what-rectal-spacer-do-you-recommend-for-prostate-cancer-patients weekly 0.8 https://www.themednet.org/what-leads-you-to-consider-prescribing-a-nasal-spray-formulation-for-the-treatment-of-acute-migraine weekly 0.8 https://www.themednet.org/would-you-consider-a-brca-carrier-patient-for-kidney-transplantation weekly 0.8 https://www.themednet.org/is-there-a-role-for-empiric-scabies-treatment-in-itchy-patients-without-clear-clinical-signs-of-scabies weekly 0.8 https://www.themednet.org/do-you-initiate-peritoneal-dialysis-with-an-incremental-strategy-to-ease-patients-into-their-treatment-even-though-it-might-lead-to-frequent-lab-monitoring-and-the-risk-of-underdialysis weekly 0.8 https://www.themednet.org/how-do-you-manage-atopic-dermatitis-in-pediatric-patients-who-has-failed-dupilumab weekly 0.8 https://www.themednet.org/when-do-you-choose-to-switch-to-antidepressants-vs-augmentation-in-treatment-resistant-depression weekly 0.8 https://www.themednet.org/in-what-cases-do-you-recommend-the-use-of-gabapentin-for-off-label-use-in-alcohol-use-disorder weekly 0.8 https://www.themednet.org/do-you-obtain-an-mslt-or-start-empiric-therapy-with-modafinil-in-patients-with-residual-excessive-daytime-sleepiness-despite-optimal-adherence-to-pap-therapy weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-with-evidence-of-prostate-cancer-who-refuses-biopsy weekly 0.8 https://www.themednet.org/is-moderately-hypofractionated-rt-using-60-gy-20fx-with-concurrent-chemotherapy-appropriate-for-unresectable-stage-iii-nsclc weekly 0.8 https://www.themednet.org/would-you-treat-someone-following-flame-protocol-for-prostate-cancer-without-fiducials-if-using-daily-cbct weekly 0.8 https://www.themednet.org/is-it-worth-getting-a-calcium-score-on-a-patient-who-is-already-on-statin-therapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-monitoring-of-inflammatory-markers-during-treatment-of-native-vertebral-osteomyelitis weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-hematologic-malignancies-from-asco-2024 weekly 0.8 https://www.themednet.org/how-would-you-palliate-a-large-symptomatic-vaginal-melanoma-recurrence-with-limited-small-pelvic-lymph-node-metastases weekly 0.8 https://www.themednet.org/when-pursuing-complex-pci-of-the-rca-especially-when-lesion-preparation-is-required-when-do-you-consider-placing-a-transvenous-pacemaker-in-anticipation-of-conduction-abnormalities weekly 0.8 https://www.themednet.org/what-approaches-do-you-take-to-prevent-worsening-kidney-function-for-patients-with-chronic-kidney-disease-who-have-an-upcoming-outpatient-ct-scan-with-iodinated-contrast weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-diagnosed-with-squamous-carcinoma-involving-the-entire-length-of-the-vagina-and-extends-into-the-vulva-introitus-who-has-severe-vaginal-stenosis weekly 0.8 https://www.themednet.org/is-there-a-role-for-routine-stress-testing-in-intermediate-high-risk-cad-patients-with-a-significantly-elevated-coronary-calcium-score-who-are-otherwise-asymptomatic weekly 0.8 https://www.themednet.org/would-you-stop-an-ace-inhibitor-arb-or-instead-initiate-a-potassium-binder-to-manage-hyperkalemia-in-a-patient-with-proteinuric-ckd-stage-5-who-is-on-an-acei-arb weekly 0.8 https://www.themednet.org/how-would-you-approach-patients-with-high-risk-mucoepidermoid-carcinoma-high-grade-of-the-parotid-gland-for-optimal-adjuvant-treatment weekly 0.8 https://www.themednet.org/what-60-minute-cortisol-threshold-value-do-you-use-for-diagnosis-of-adrenal-insufficiency-after-acth-stimulation weekly 0.8 https://www.themednet.org/for-a-young-female-40-with-hr-her2-ct1-2n1-ypt1an0-s-p-mastectomy-with-slnb-would-you-offer-pmrt weekly 0.8 https://www.themednet.org/when-do-you-start-adt-for-a-patient-with-a-new-diagnosis-of-node-positive-prostate-cancer-receiving-radiation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-initiating-spironolactone-in-patients-with-end-stage-kidney-disease-and-heart-failure weekly 0.8 https://www.themednet.org/how-does-apoe4-status-affect-your-clinical-decision-making-in-patients-who-may-be-eligible-for-anti-amyloid-therapies-for-early-alzheimers-disease weekly 0.8 https://www.themednet.org/how-would-you-approach-sbrt-in-a-pacemaker-dependent-elderly-patient-with-stage-i-nsclc-whose-sbrt-plan-dmax-exceeds-the-pacemaker-tolerance weekly 0.8 https://www.themednet.org/what-precautions-should-be-taken-when-discharging-a-patient-from-the-medical-setting-on-new-medication-assisted-therapy-for-alcohol-use-disorder weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-positive-ppd-or-igra-in-a-patient-with-well-controlled-hiv-without-significant-tb-risk-factors weekly 0.8 https://www.themednet.org/how-should-you-approach-treating-curable-laryngeal-cancer-with-chemo-rt-in-a-patient-who-had-a-myocardial-infarction-during-treatment-and-requires-cabg-given-the-cardiotoxicity-of-cisplatin-and-5fu-carboplatin weekly 0.8 https://www.themednet.org/in-ischemic-stroke-patients-with-low-ldl-levels-30-50-mg-dl-would-you-consider-lowering-ldl-levels-to-lower-values-without-concern-for-any-side-effects weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-sarcoidosis-who-cannot-tolerate-steroids-and-who-is-developing-ild weekly 0.8 https://www.themednet.org/what-is-your-approach-to-tnt-sequencing-for-locally-advanced-rectal-primaries-with-low-volume-metastatic-disease-to-liver weekly 0.8 https://www.themednet.org/what-is-your-approach-to-monitoring-patients-referred-for-high-titer-rf-and-ccp-but-without-active-symptoms-of-inflammatory-arthritis weekly 0.8 https://www.themednet.org/how-do-you-approach-requests-from-attorneys-to-complete-paperwork-supporting-your-patients-application-for-long-term-disability weekly 0.8 https://www.themednet.org/would-you-consider-starting-a-stimulant-in-an-inpatient-or-crisis-setting-for-patients-whose-severe-behavioral-issues-are-due-to-untreated-adhd weekly 0.8 https://www.themednet.org/in-the-psychiatric-er-how-do-you-address-the-issue-of-child-adolescent-patients-being-left-there-by-parents-caregivers-guardians-and-becoming-extended-stay-patients-sometimes-spending-weeks-to-months-in-the-psych-er weekly 0.8 https://www.themednet.org/how-will-you-treat-a-cutaneous-skin-cancer-of-the-face-who-has-left-ipsilateral-cervical-ln-s-p-dissection-however-has-extracapsular-extension-and-within-2-weeks-has-right-cervical-ln-will-you-start-with-cemiplimab-given-aggressive-nature-and-repeat-ct-in weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-asco-gu-2026 weekly 0.8 https://www.themednet.org/for-iron-deficiency-anemia-due-to-heavy-menstrual-bleeding-what-is-your-preferred-method-of-controlling-heavy-menses weekly 0.8 https://www.themednet.org/do-you-routinely-discontinue-sglt2-inhibitors-during-febrile-illness-or-acute-infection-in-patients-with-diabetic-kidney-disease-due-to-concern-for-volume-depletion weekly 0.8 https://www.themednet.org/for-early-stage-vulvar-cancer-that-is-clinically-radiographically-node-negative-with-no-surgical-lymph-node-evaluation-e-g-patient-or-surgeon-refusal-would-elective-nodal-irradiation-be-reasonable-in-the-absence-of-risk-factors-warranting-treatment-to-the weekly 0.8 https://www.themednet.org/do-you-treat-diabetic-foot-osteomyelitis-without-surgical-resection-with-a-fixed-6-week-antibiotic-course-or-do-you-shorten-duration-based-on-clinical-and-inflammatory-marker-response weekly 0.8 https://www.themednet.org/what-is-the-details-of-radiotherapy-approach-for-a-post-prostatectomy-patient-with-avid-pelvic-ln-what-would-be-your-dose-fractionation weekly 0.8 https://www.themednet.org/how-would-you-approach-managing-a-patient-with-chronic-arthralgias-bilateral-hand-weakness-with-an-ana-of-1-160-and-low-positive-ssb-with-all-other-enas-and-emg-ncs-negative-and-normal-complement-levels-immunoglobulins-and-inflammatory-markers weekly 0.8 https://www.themednet.org/how-would-you-manage-locally-advanced-resectable-gastric-cancer-that-is-msi-h weekly 0.8 https://www.themednet.org/when-a-patient-with-afib-with-rvr-has-broderline-low-blood-pressure-and-cannot-tolerate-beta-blockers-how-do-you-approach-rhythm-control-with-amiodarone-if-the-patient-is-not-chronically-on-anticoagulation-despite-high-chads-vasc-score weekly 0.8 https://www.themednet.org/would-you-ever-consider-treating-a-patient-with-locally-advanced-nsclc-with-sbrt-to-the-primary-tumor-plus-conventional-mediastinal-chemoradiation weekly 0.8 https://www.themednet.org/what-non-pharmacologic-interventions-or-resources-do-you-recommend-for-parents-of-patients-with-severe-anxiety weekly 0.8 https://www.themednet.org/given-the-recently-published-results-of-peace-2-under-what-scenario-would-you-offer-pelvic-radiotherapy-for-high-risk-very-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-monoclonal-b-cell-lymphocytosis-and-adenopathy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-synchronous-hpv-mediated-bilateral-tonsil-primary-with-ipsilateral-lymph-nodes-who-cannot-receive-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-are-hesitant-to-try-behavioral-therapies-for-insomnia-instead-of-starting-a-sleep-medication weekly 0.8 https://www.themednet.org/what-is-your-response-when-a-high-functioning-adolescent-with-mild-asd-features-asks-for-an-autism-diagnosis weekly 0.8 https://www.themednet.org/how-do-you-typically-manage-a-patient-with-a-single-positive-blood-culture-from-two-sets-growing-candida-species-in-a-stable-patient-without-prosthetic-devices-or-material weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-deciding-to-treat-iga-nephropathy-with-immunosuppression-in-a-patient-with-cirrhosis-given-the-possibility-that-iga-nephropathy-could-be-secondary-to-cirrhosis weekly 0.8 https://www.themednet.org/in-a-patient-with-de-novo-stage-iv-breast-carcinoma-harboring-an-rb1-q395-nonsense-mutation-would-treatment-with-a-cdk4-6-inhibitor-be-appropriate-or-should-it-be-avoided-due-to-likely-resistance weekly 0.8 https://www.themednet.org/how-would-you-decide-between-escalation-to-clozapine-vs-xanomeline-tropsium-cobenfy-for-treatment-resistant-schizophrenia weekly 0.8 https://www.themednet.org/what-are-some-practical-tips-for-eliciting-an-accurate-history-of-raynauds-phenomenon-in-patients-being-assessed-for-ctd weekly 0.8 https://www.themednet.org/how-do-you-approach-a-case-of-apparent-worsening-catatonia-despite-high-dose-benzodiazepines-and-ongoing-ect weekly 0.8 https://www.themednet.org/in-patients-with-iron-deficiency-due-to-history-of-gastric-bypass-or-ibd-would-you-consider-oral-iron-therapy-if-the-iron-deficiency-anemia-is-mild weekly 0.8 https://www.themednet.org/would-you-consider-off-label-iv-thrombolysis-in-patients-taking-a-doac-and-presenting-with-disabling-acute-ischemic-stroke-within-the-window weekly 0.8 https://www.themednet.org/if-methotrexate-is-contraindicated-or-not-tolerated-what-systemic-treatments-do-you-use-for-generalized-morphea-2 weekly 0.8 https://www.themednet.org/when-do-you-treat-heterotopic-ossification-with-radiation-pre-operatively weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-classical-hematology-from-ash-2025 weekly 0.8 https://www.themednet.org/have-you-used-karius-to-work-up-fevers-in-the-hospital-when-the-source-remains-unknown weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-asymptomatic-bacteriuria-in-an-elderly-patient-without-clear-urinary-symptoms-but-with-cognitive-changes-and-falls weekly 0.8 https://www.themednet.org/do-you-feel-there-are-medical-advantages-to-flacs-and-if-so-what-are-they-and-how-often-are-you-offering-flacs-to-patients weekly 0.8 https://www.themednet.org/when-if-ever-do-you-consider-increasing-adderall-above-the-fda-approved-maximum-daily-dose-of-40-mg-for-adult-patients weekly 0.8 https://www.themednet.org/what-have-you-found-helpful-in-counseling-patients-with-migraine-reluctant-to-take-preventative-medications weekly 0.8 https://www.themednet.org/do-you-ever-treat-cervical-nodes-above-the-standard-supraclavicular-field-for-breast-cancer-patients weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gu-cancers-from-asco-2026 weekly 0.8 https://www.themednet.org/have-you-found-aripiprazole-effective-for-treatment-of-psychosis-and-bipolar-mania-in-practice weekly 0.8 https://www.themednet.org/What-is-your-preferred-antipsychotic-for-augmenting-treatment-of-major-depressive-disorder weekly 0.8 https://www.themednet.org/in-a-patient-with-refractory-oab-whos-failed-botox-once-due-to-inadequate-response-do-you-increase-the-dose-switch-to-sacral-neuromodulation-or-retry-and-what-actually-drives-that-decision weekly 0.8 https://www.themednet.org/is-there-ever-a-role-for-adjuvant-chemotherapy-and-or-immunotherapy-for-early-stage-n0-non-small-cell-lung-cancer-treated-with-sbrt-alone weekly 0.8 https://www.themednet.org/for-resected-oral-cavity-squamous-cell-carcinoma-with-indication-for-adjuvant-radiotherapy-to-the-primary-tumor-bed-would-you-routinely-include-ipsilateral-and-or-contralateral-nodes-even-with-a-pn0-elective-neck-dissection weekly 0.8 https://www.themednet.org/how-do-you-approach-a-stage-iiic-triple-positive-idc-s-p-neoadjuvant-tch-and-p-lumpectomy-and-alnd-with-significant-residual-disease-at-the-time-of-surgery weekly 0.8 https://www.themednet.org/how-do-you-manage-rectal-wall-infiltration-during-a-rectal-spacer-procedure weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-do-you-give-after-surgery-to-patients-with-gastric-ca-who-undergo-3-cycles-of-flot-with-no-tumor-effect-on-pathology-and-maintain-good-ps weekly 0.8 https://www.themednet.org/do-you-recommend-switching-from-chemotherapy-to-ai-cdk4-6-inhibitor-after-resolution-of-visceral-crisis-in-a-patient-with-hr-her2-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/what-is-the-role-of-postoperative-radiation-therapy-after-complete-resection-of-a-high-grade-spermatic-cord-sarcoma weekly 0.8 https://www.themednet.org/in-the-setting-of-prior-salvage-radiation-therapy-for-rising-psa-post-prostatectomy-can-there-be-any-role-of-additional-radiation-therapy-for-isolated-local-recurrence-in-the-bladder-neck-prostate-bed weekly 0.8 https://www.themednet.org/how-would-you-approach-a-post-menopausal-women-with-recurrent-er-pr-her2-breast-cancer-only-in-the-axillary-lymph-nodes weekly 0.8 https://www.themednet.org/do-you-use-bolus-for-the-lumpectomy-cavity-boost-when-the-seroma-is-within-5mm-of-the-skin weekly 0.8 https://www.themednet.org/would-you-consider-first-line-folfoxiri-and-cetuximab-or-panitumumab-for-physically-fit-patients-with-metastatic-ras-braf-wt-colon-cancer weekly 0.8 https://www.themednet.org/are-there-particular-subgroups-of-patients-with-glioblastoma-who-derive-the-most-benefit-from-ttfields weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-for-patients-with-alk-mnsclc-who-have-multifocal-or-leptomeningeal-cns-progression-while-on-first-line-targeted-therapy weekly 0.8 https://www.themednet.org/what-dose-do-you-use-to-palliate-multiple-myeloma-in-a-vertebral-body weekly 0.8 https://www.themednet.org/how-do-you-incorporate-ttfields-into-your-clinical-practice weekly 0.8 https://www.themednet.org/how-do-you-explain-progression-free-survival-to-patients weekly 0.8 https://www.themednet.org/given-the-final-results-of-gog258-what-regimen-do-you-recommend-use-to-treat-stage-iii-endometrial-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-breast-lymphedema-after-radiation weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-receiving-head-and-neck-radiation-regarding-its-impact-on-both-existing-and-future-dental-work weekly 0.8 https://www.themednet.org/should-we-delay-adjuvant-breast-radiotherapy-for-early-stage-breast-cancers-as-the-covid-19-situation-evolves weekly 0.8 https://www.themednet.org/what-neoadjuvant-therapy-would-you-choose-for-a-post-menopausal-woman-with-er-negative-pr-positive-high-grade-node-negative-breast-cancer weekly 0.8 https://www.themednet.org/can-we-use-a-linear-accelerator-to-sterilize-ppe weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-hr-her2-metastatic-breast-cancer-who-is-endocrine-resistant-with-bone-marrow-involvement-and-pancytopenia weekly 0.8 https://www.themednet.org/what-is-the-best-approach-for-patients-with-dlbcl-with-early-relapse-6-months-after-initially-attaining-a-cr-with-6-cycles-rchop weekly 0.8 https://www.themednet.org/what-do-you-consider-a-curative-radiation-dose-for-a-sarcoma weekly 0.8 https://www.themednet.org/what-is-your-preferred-frontline-treatment-for-cll-in-young-patients-50-years-old weekly 0.8 https://www.themednet.org/how-do-you-approach-the-decision-of-whether-and-when-to-initiate-therapy-in-patients-who-remain-covid-19-positive-2-weeks-after-infection-but-are-asymptomatic-from-the-virus weekly 0.8 https://www.themednet.org/what-is-your-preferred-fsrs-dose-fractionation-for-large-brain-metastases weekly 0.8 https://www.themednet.org/how-do-you-screen-rheumatoid-arthritis-patients-for-lung-disease-modality-frequency-patient-selection weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-who-develops-pleural-and-skin-metastases-shortly-after-completing-neoadjuvant-ddac-t-and-surgery-for-a-locally-advanced-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/for-locally-advanced-rectal-cancer-would-you-consider-utilizing-the-rapido-trial-approach-of-short-course-radiation-followed-by-neoadjuvant-chemotherapy-prior-to-surgery weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-who-has-an-ischemic-stroke-while-on-clopidogrel-despite-strict-compliance-and-normal-results-on-clopidogrel-response-assay weekly 0.8 https://www.themednet.org/what-is-your-approach-to-locally-advanced-pancreatic-cancer-that-has-not-progressed-after-neoadjuvant-chemotherapy-chemoradiation-but-remains-unresectable weekly 0.8 https://www.themednet.org/in-patients-who-receive-neoadjuvant-pembrolizumab-and-chemotherapy-for-tnbc-how-will-you-manage-adjuvant-treatment-if-they-have-a-germline-brca-mutation weekly 0.8 https://www.themednet.org/do-you-offer-parp-inhibitor-maintenance-retreatment-of-platinum-sensitive-relapsed-high-grade-serous-ovarian-cancer-in-patients-who-had-a-complete-response-to-their-most-recent-platinum-based-chemo weekly 0.8 https://www.themednet.org/what-factors-do-you-take-into-account-for-recommending-venetoclax-obtinutuzumab-vs-btk-inhibitors-vs-chemotherapy-in-front-line-therapy-for-cll weekly 0.8 https://www.themednet.org/when-offering-palliative-radiation-for-breast-cancer-what-dose-fractionation-do-you-prefer-and-in-what-subset-of-patients-do-you-believe-derive-the-most-benefit weekly 0.8 https://www.themednet.org/when-if-ever-would-you-consider-use-of-nivo-ipi-for-favorable-risk-metastatic-ccrcc weekly 0.8 https://www.themednet.org/do-you-treat-the-normal-pancreas-as-an-organ-at-risk-when-delivering-abdominal-radiation-therapy weekly 0.8 https://www.themednet.org/do-you-utilize-genetic-testing-to-guide-adt-for-men-receiving-xrt-for-intermediate-or-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/what-resection-margins-are-required-for-dcis-with-a-component-of-invasive-disease weekly 0.8 https://www.themednet.org/in-a-patient-with-a-history-of-prior-bcs-rt-for-early-stage-breast-cancer-who-is-now-s-p-repeat-lumpectomy-for-a-low-risk-in-breast-recurrence-what-dose-fractionation-regimens-are-appropriate-for-reirradiation weekly 0.8 https://www.themednet.org/which-patients-with-muscle-invasive-bladder-cancer-will-you-treat-with-adjuvant-nivolumab weekly 0.8 https://www.themednet.org/when-staging-prostate-cancer-does-mri-pelvis-prostate-replace-ct-a-p weekly 0.8 https://www.themednet.org/what-are-some-alternatives-to-dexamethasone-for-brain-edema-in-patients-who-are-allergic-have-an-intolerance-or-refuse-the-medication weekly 0.8 https://www.themednet.org/what-is-your-approach-to-severe-discoid-lupus-refractory-to-conventional-topical-and-systemic-therapies weekly 0.8 https://www.themednet.org/how-do-you-complete-brain-death-testing-in-patients-who-cannot-tolerate-apnea-testing-and-are-unable-to-transport-for-ancillary-testing weekly 0.8 https://www.themednet.org/what-dosing-range-of-spironolactone-do-you-prescribe-for-hormonal-acne weekly 0.8 https://www.themednet.org/would-a-her2-mutation-on-ngs-of-a-biopsy-of-a-breast-cancer-liver-metastasis-change-your-management-if-the-met-is-her2-by-ihc-with-the-initial-localized-disease-being-her2 weekly 0.8 https://www.themednet.org/what-is-the-optimal-interval-between-vaginal-cuff-brachytherapy-sessions weekly 0.8 https://www.themednet.org/how-would-you-manage-active-axial-spondyloarthritis-in-a-patient-with-recent-5-years-solid-malignancy-who-completed-chemotherapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-imaging-modality-for-determining-infarct-core-when-evaluating-acute-stroke-cases weekly 0.8 https://www.themednet.org/does-receipt-of-chemoimmunotherapy-for-ls-sclc-impact-your-recommendation-for-pci weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-pursue-malignancy-workup-for-patients-with-cryptogenic-stroke weekly 0.8 https://www.themednet.org/what-strategies-do-you-use-for-patients-on-medications-for-adhd-who-experience-afternoon-rebound-withdrawal weekly 0.8 https://www.themednet.org/what-has-been-your-experience-using-mindfulness-based-interventions-for-patients-with-somatic-anxiety-symptoms weekly 0.8 https://www.themednet.org/how-does-neoadjuvant-chemo-immunotherapy-impact-your-decision-on-hypofractionation-dose-fractionation-for-locally-advanced-nsclc-now-getting-rt-alone weekly 0.8 https://www.themednet.org/is-there-any-indication-for-ivig-in-immunocompromised-patients-with-only-decreased-igm-and-or-iga-levels weekly 0.8 https://www.themednet.org/how-do-you-approach-caring-for-patients-admitted-with-decompensated-chf-but-who-also-exhibit-hypotension-and-do-not-have-overt-signs-of-hypervolemia-on-exam weekly 0.8 https://www.themednet.org/when-do-you-consider-adding-steroids-alongside-intravenous-antibiotics-for-patients-with-orbital-cellulitis weekly 0.8 https://www.themednet.org/how-do-you-determine-the-appropriate-toric-iol-when-there-is-a-discrepancy-in-axis-or-cylinder-power-between-optical-biometry-and-corneal-tomography-during-preoperative-evaluation weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-ampicillin-ceftriaxone-for-prosthetic-valve-endocarditis-due-to-ampicillin-susceptible-enterococcus-faecium weekly 0.8 https://www.themednet.org/what-salvage-ebrt-dose-would-you-recommend-for-radiation-naive-patients-with-hodgkins-lymphoma-who-are-refractory-to-chemotherapy-and-immunotherapy-and-decline-to-undergo-transplant weekly 0.8 https://www.themednet.org/how-would-you-approach-diagnosis-of-a-patient-with-recurrent-episodes-of-abdominal-pain-severe-myalgias-low-grade-fevers-and-urticaria weekly 0.8 https://www.themednet.org/can-a-psa-bounce-be-seen-shortly-after-sbrt-to-prostate-cancer-oligometastases-while-on-androgen-deprivation-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-effectively-diagnosing-adhd-within-the-time-constraints-of-outpatient-practice weekly 0.8 https://www.themednet.org/how-do-you-view-the-risk-of-tardive-dysinesia-and-other-side-effects-in-your-female-patients-with-treatment-resistant-depression-who-are-stable-on-an-atypical-antipsychotic weekly 0.8 https://www.themednet.org/is-it-still-significant-to-denote-the-etiology-of-ild-in-a-patient-with-ppf weekly 0.8 https://www.themednet.org/would-you-consider-adding-gabapentin-off-label-for-use-in-the-treatment-of-glioblastoma-at-this-time weekly 0.8 https://www.themednet.org/for-children-under-the-age-of-7-with-adhd-who-continue-to-have-significant-impairment-with-behavioral-interventions-how-do-you-decide-between-starting-with-a-stimulant-vs-starting-with-an-alpha-agonist weekly 0.8 https://www.themednet.org/given-the-final-publication-of-nsabp-b-51-for-which-patients-meeting-trial-eligibility-would-you-still-recommend-regional-nodal-irradiation weekly 0.8 https://www.themednet.org/if-a-patient-has-chronic-spontaneous-urticaria-refractory-to-xolair-and-is-already-on-plaquenil-do-you-stop-plaquenil-and-then-initiate-cyclosporine-or-do-you-co-administer-and-then-gradually-stop-plaquenil-over-time weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-hematology-from-asco-2025 weekly 0.8 https://www.themednet.org/in-a-patient-with-negative-hep-b-surface-ag-hep-b-surface-antibody-and-hep-b-core-antibody-serologies-do-you-initiate-antiviral-prophylaxis-e-g-entecavir-prior-to-starting-rituximab weekly 0.8 https://www.themednet.org/why-does-nccn-still-not-recommend-using-circulating-tumor-dna-to-guide-adjuvant-chemotherapy-in-stage-ii-colon-cancer-when-colon-cancer-experts-are-currently-embracing-the-practice weekly 0.8 https://www.themednet.org/in-a-patient-with-esophageal-cancer-with-lymph-node-involvement-would-you-consider-treating-with-definitive-chemo-radiation-if-they-have-a-single-area-of-retroperitoneal-metastasis weekly 0.8 https://www.themednet.org/can-amplify-data-be-extrapolated-to-use-of-other-btkis-in-combination-with-venetoclax-or-would-you-only-ever-use-acalabrutinib-venetoclax-in-first-line weekly 0.8 https://www.themednet.org/what-is-your-follow-up-protocol-with-the-light-adjustable-lenses weekly 0.8 https://www.themednet.org/how-do-you-explain-the-use-of-an-ai-scribe-to-patients-the-first-time-it-is-used-in-their-care weekly 0.8 https://www.themednet.org/how-do-you-treat-idiopathic-hypersomnia-inadequately-responding-to-modafinil weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-use-of-glp-1-agonists-in-older-adults-with-diabetes-with-or-at-risk-of-sarcopenia weekly 0.8 https://www.themednet.org/when-do-you-consider-the-use-of-n-acetylcysteine-nac-in-patients-with-trichotillomania weekly 0.8 https://www.themednet.org/when-and-how-do-you-approach-prescribing-viloxazine-for-patients-with-adhd weekly 0.8 https://www.themednet.org/what-is-your-approach-to-refractory-oral-ulcers-in-sle weekly 0.8 https://www.themednet.org/how-do-you-approach-restarting-immunotherapy-in-a-patient-with-metastatic-melanoma-who-previously-developed-immune-mediated-hepatitis-grade-3-with-liver-enzymes-now-back-to-baseline-levels weekly 0.8 https://www.themednet.org/do-you-prefer-to-simultaneously-start-an-acei-arb-and-sglt2i-or-initiate-one-prior-to-the-other-in-a-patient-with-proteinuria-secondary-to-diabetic-kidney-disease weekly 0.8 https://www.themednet.org/for-a-patient-who-has-vaginal-cuff-recurrence-6-months-after-adjuvant-pelvic-radiotherapy-to-a-dose-of-45-gy-how-would-you-approach-management weekly 0.8 https://www.themednet.org/how-do-you-manage-cannabinoids-ex-medicinal-recreational-in-dermatology weekly 0.8 https://www.themednet.org/in-which-patients-do-you-utilize-a-breast-mri-as-part-of-the-initial-workup-for-breast-cancer weekly 0.8 https://www.themednet.org/do-you-use-pth-levels-to-help-differentiate-ckd-from-aki-in-patients-who-are-being-evaluated-for-an-elevated-creatinine-level-and-who-lack-long-term-lab-data weekly 0.8 https://www.themednet.org/what-do-you-think-about-using-conventional-thoracic-imaging-methods-e-g-x-ray-ct-etc-to-determine-if-a-pleural-effusion-is-of-adequate-size-to-consider-thoracentesis weekly 0.8 https://www.themednet.org/is-the-currently-available-data-from-inavo-sufficient-to-adopt-this-as-a-new-standard-of-care-for-all-patients-or-are-you-awaiting-overall-survival-and-or-pros weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-alcohol-use-disorder-who-express-interest-in-moderation-rather-than-full-abstinence weekly 0.8 https://www.themednet.org/would-you-consider-omitting-adjuvant-durvalumab-in-mibc-to-limit-overtreatment-in-patients-who-may-not-benefit-or-those-who-have-achieved-maximal-benefit-after-neoadjuvant-gem-cis-durva weekly 0.8 https://www.themednet.org/how-should-rheumatologists-address-the-impact-on-patients-who-are-initially-diagnosed-with-sle-based-on-positive-ana-but-later-reclassified-as-having-uctd weekly 0.8 https://www.themednet.org/what-is-your-management-approach-for-car-t-induced-motor-neurologic-deficits-cyclophosphamide-ivig-steroids-etc-and-any-prophylactic-approach-to-an-early-rapid-rise-in-absolute-lymphocyte-count-post-car-t-infusion weekly 0.8 https://www.themednet.org/what-are-the-clinical-indications-for-performing-a-second-laser-peripheral-iridotomy-lpi-instead-of-proceeding-directly-with-cataract-surgery weekly 0.8 https://www.themednet.org/what-are-your-concerns-regarding-long-term-stimulant-use-in-geriatric-patients-with-adhd weekly 0.8 https://www.themednet.org/how-do-you-decide-on-the-speed-and-target-of-blood-pressure-reduction-for-spontaneous-intracranial-hemorrhage weekly 0.8 https://www.themednet.org/what-have-been-your-experiences-with-anti-cgrp-therapies-for-hemiplegic-migraine weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-immunotherapy-for-a-patient-with-high-risk-merkel-cell-carcinoma-following-definitive-surgical-resection-and-adjuvant-radiation-therapy weekly 0.8 https://www.themednet.org/does-asc4first-data-justify-the-use-of-first-line-asciminib-for-all-newly-diagnosed-cml-over-other-tkis-considering-that-post-progression-survival-data-is-not-yet-mature weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-pagets-disease-of-bone-with-elevated-alkaline-phosphatase-and-history-of-chronic-kidney-disease weekly 0.8 https://www.themednet.org/how-often-do-you-recommend-ophthalmologic-screening-exams-for-patients-with-sarcoidosis weekly 0.8 https://www.themednet.org/when-do-you-consider-ultrahigh-dose-methylcobalamin-injections-for-als weekly 0.8 https://www.themednet.org/how-do-you-approach-iol-calculations-and-selection-in-patients-with-keratoconus-based-on-disease-severity weekly 0.8 https://www.themednet.org/which-iol-do-you-prefer-for-patients-with-a-history-of-hyperopic-lasik-to-minimize-the-risk-of-inducing-spherical-aberration weekly 0.8 https://www.themednet.org/do-you-recommend-providing-supplemental-oxygen-for-patients-with-a-pneumothorax-in-the-absence-of-hypoxemia weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-good-relief-but-intolerable-chest-tightness-with-sumatriptan weekly 0.8 https://www.themednet.org/when-do-you-consider-thrombectomy-for-patients-with-lvo-and-carotid-dissection weekly 0.8 https://www.themednet.org/in-which-cases-of-post-injection-endophthalmitis-should-early-vitrectomy-be-considered-if-there-is-little-to-no-improvement-48-hours-after-a-tap-and-inject-and-there-is-no-organism-isolated weekly 0.8 https://www.themednet.org/what-is-your-medication-of-choice-when-considering-outpatient-alcohol-withdrawal-management-diazepam-vs-chlordiazepoxide-vs-lorazepam weekly 0.8 https://www.themednet.org/in-light-of-the-recent-data-indicating-increased-late-grade-3-to-5-toxicities-ltox3-after-hypofractionated-salvage-radiation-therapy-will-you-continue-to-offer-these-regimes-to-patients weekly 0.8 https://www.themednet.org/what-supportive-care-measures-do-you-prioritize-to-manage-or-prevent-toxicity-in-patients-receiving-dato-dxd weekly 0.8 https://www.themednet.org/what-factors-guide-your-decision-to-perform-subretinal-fluid-drainage-during-primary-scleral-buckle-surgery-for-a-rhegmatogenous-retinal-detachment weekly 0.8 https://www.themednet.org/what-is-your-threshold-for-writing-disability-letters-for-patients-with-personality-disorders weekly 0.8 https://www.themednet.org/would-you-recommend-crrt-instead-of-intermittent-hemodialysis-to-prevent-lithium-rebound-in-a-patient-with-lithium-toxicity-after-an-initial-intermittent-hemodialysis-session weekly 0.8 https://www.themednet.org/how-do-you-reconcile-data-from-the-patina-trial-and-destiny-breast09-with-respect-to-cdk4-6-inhibitor-maintenance-in-metastatic-er-her2-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-large-fungating-squamous-cell-carcinoma-of-the-auricle-if-surgical-management-is-not-desired-by-the-patient weekly 0.8 https://www.themednet.org/how-do-you-address-non-adherence-to-medical-treatment-in-adolescent-and-young-adult-oncology-patients-due-to-mental-illness-such-as-depression weekly 0.8 https://www.themednet.org/how-do-you-approach-the-second-line-treatment-for-a-patient-with-high-risk-myeloma-relapse-early-post-autohct-after-dara-rvd-induction weekly 0.8 https://www.themednet.org/at-what-point-do-you-consider-referring-for-neuromodulatory-treatments-tms-deep-brain-stimulation-for-treatment-refractory-ocd weekly 0.8 https://www.themednet.org/how-would-you-approach-reirradiation-in-a-patient-with-a-history-of-whole-breast-rt-many-years-ago-now-with-a-small-intermediate-grade-dcis-s-p-lumpectomy-with-an-elevated-dcisionrt weekly 0.8 https://www.themednet.org/would-you-initiate-urgent-start-peritoneal-dialysis-for-a-patient-with-uremic-symptoms-who-plans-to-pursue-long-term-hemodialysis-but-currently-lacks-an-av-access-to-avoid-using-a-temporary-dialysis-catheter-until-they-can-obtain-a-functioning-av-access weekly 0.8 https://www.themednet.org/what-sbrt-dose-would-you-give-to-a-single-external-iliac-lymph-node-recurrence-1-cm-size-for-a-patient-previously-treated-with-salvage-radiation-to-the-pelvis weekly 0.8 https://www.themednet.org/when-do-you-consider-writing-an-emotional-support-animal-esa-letter-for-patients-with-psychiatric-illness weekly 0.8 https://www.themednet.org/under-what-circumstance-would-you-order-dalbavancin-instead-of-vancomycin-or-daptomycin-for-mrsa-endocarditis weekly 0.8 https://www.themednet.org/what-is-the-role-of-skin-biopsy-for-evaluating-small-fiber-neuropathy-in-patients-with-rheumatic-disease-who-have-treatment-recalcitrant-pain weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-mild-to-moderate-depression-interested-in-using-st-johns-wort weekly 0.8 https://www.themednet.org/have-you-experienced-any-significant-refractive-regression-years-after-the-final-lock-in-for-light-adjustable-lenses weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-fibromyalgia-who-are-reluctant-to-consider-a-psychiatric-component-to-their-illness-but-present-with-clear-mood-or-anxiety-symptoms weekly 0.8 https://www.themednet.org/how-often-do-you-recommend-performing-an-advanced-lipid-panel-for-monitoring-of-lipid-lowering-therapy weekly 0.8 https://www.themednet.org/at-what-time-points-during-a-patients-treatment-for-metastatic-er-breast-cancer-are-you-checking-liquid-ngs-for-endocrine-pathway-alterations weekly 0.8 https://www.themednet.org/what-are-some-practical-tips-for-when-a-patients-consistently-stated-goals-of-care-do-not-correlate-with-their-actions weekly 0.8 https://www.themednet.org/do-you-consider-co-prescribing-hormone-therapy-and-anticoagulation-in-a-patient-with-prior-dvt-and-uncontrollable-vsm-uncontrolled-by-non-hormonal-therapies weekly 0.8 https://www.themednet.org/are-you-planning-to-start-running-ihc-her2-testing-on-all-tumor-types-even-those-where-her2-overexpression-is-less-typical-in-light-of-tumor-agnostic-approval-of-trastuzumab-deruxtecan weekly 0.8 https://www.themednet.org/would-you-continue-tarlatamab-in-cns-only-progression-of-small-cell-cancer-if-there-is-no-systemic-disease weekly 0.8 https://www.themednet.org/would-you-proceed-with-renal-transplant-in-a-patient-with-lupus-nephritis-who-has-progressed-to-esrd-and-is-clinically-stable-but-has-persistently-elevated-dsdna-and-low-complements-despite-appropriate-doses-of-hydroxychloroquine-and-mycophenolate weekly 0.8 https://www.themednet.org/in-patients-with-corneal-edema-and-a-glaucoma-drainage-tube-placed-in-the-ac-under-what-circumstances-would-you-consider-repositioning-the-tube-in-the-sulcus-first-versus-proceeding-directly-with-endothelial-keratoplasty-alone weekly 0.8 https://www.themednet.org/what-is-your-approach-to-tardive-dyskinesia-when-vmat2-inhibitors-are-ineffective-or-unaffordable weekly 0.8 https://www.themednet.org/how-many-days-after-an-avf-clots-do-you-determine-that-attempting-a-declot-procedure-is-no-longer-worthwhile weekly 0.8 https://www.themednet.org/when-do-you-start-adjuvant-radiation-with-areas-of-delayed-wound-healing-after-reduction-mammoplasty weekly 0.8 https://www.themednet.org/over-what-timeline-do-you-typically-try-to-escalate-your-ln-patients-to-triple-therapy weekly 0.8 https://www.themednet.org/do-you-forgo-adrenal-imaging-in-a-patient-with-primary-hyperaldosteronism-who-has-decided-against-surgery weekly 0.8 https://www.themednet.org/in-light-of-aizer-et-al-data-presented-at-asco-2025-what-is-your-threshold-for-offering-srs-srt-in-patients-with-multiple-brain-metastases weekly 0.8 https://www.themednet.org/what-treatments-after-appropriate-dose-reductions-delays-do-you-offer-for-patients-with-oxaliplatin-induced-cold-allodynia-dysesthesia weekly 0.8 https://www.themednet.org/would-you-stop-dupixent-in-an-asthma-patient-who-has-good-asthma-control-and-notes-improvement-in-loss-of-smell-but-shows-notable-eosinophil-elevation-after-4-5-doses-of-the-medication weekly 0.8 https://www.themednet.org/do-you-routinely-order-a-pre-operative-tte-in-patients-with-apparently-compensated-chf-but-who-have-not-had-an-echocardiogram-in-some-time weekly 0.8 https://www.themednet.org/what-approaches-have-you-used-to-reduce-boarding-times-for-patients-in-the-emergency-department-awaiting-inpatient-psychiatric-admission weekly 0.8 https://www.themednet.org/how-do-you-select-between-antipsychotics-in-the-treatment-of-delirium-refractory-to-nonpharmacological-management-in-hospitalized-older-adults-with-dementia weekly 0.8 https://www.themednet.org/how-do-you-incorporate-rating-scales-such-as-the-phq-9-into-your-treatment-of-major-depressive-disorder weekly 0.8 https://www.themednet.org/how-would-you-manage-an-isolated-nodal-recurrence-of-breast-cancer-in-a-patient-with-a-prior-history-of-mantle-field-radiation weekly 0.8 https://www.themednet.org/when-do-you-consider-the-use-of-lumateperone-to-treat-schizophrenia-spectrum-disorders weekly 0.8 https://www.themednet.org/how-do-you-gain-access-to-quinacrine-and-what-has-your-recent-experience-been weekly 0.8 https://www.themednet.org/do-you-wait-to-treat-small-asymptomatic-brain-metastases-until-they-reach-a-certain-size weekly 0.8 https://www.themednet.org/have-you-seen-an-increase-in-rectal-spasms-with-short-course-vs-long-course-radiation-for-rectal-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-a-patient-who-during-a-hospitalization-was-initially-diagnosed-with-ttp-and-treated-with-plex-with-good-response-but-renal-biopsy-then-resulted-class-iv-ln-along-with-changes-of-thrombotic-microangiopathy weekly 0.8 https://www.themednet.org/how-do-you-interpret-elevations-in-esr-and-crp-in-the-setting-of-increased-bmi weekly 0.8 https://www.themednet.org/is-it-acceptable-to-offer-26-gy-in-5-fractions-for-apbi-rather-than-whole-breast-rt weekly 0.8 https://www.themednet.org/how-do-you-manage-occlusive-bilateral-retinal-vasculitis-with-isolated-lupus-anticoagulant-positivity weekly 0.8 https://www.themednet.org/how-do-you-recommend-tapering-ivig-in-patients-whose-inflammatory-myositis-has-achieved-remission weekly 0.8 https://www.themednet.org/would-you-ever-omit-adjuvant-radiation-for-a-patient-with-rectal-cancer-originally-staged-ct1n0-but-found-to-be-pt1n1-after-surgery weekly 0.8 https://www.themednet.org/when-do-you-consider-replanning-patient-if-body-contour-is-off-on-cbct-but-ptv-is-aligned-to-prostate weekly 0.8 https://www.themednet.org/have-the-final-results-of-the-opera-trial-changed-the-way-you-approach-organ-preservation-in-rectal-cancer weekly 0.8 https://www.themednet.org/what-isotope-and-dose-do-you-prefer-for-prostate-brachytherapy-monotherapy weekly 0.8 https://www.themednet.org/would-you-recommend-genetic-polymorphic-testing-before-the-initiation-of-antiplatelet-medication-in-patients-with-icad weekly 0.8 https://www.themednet.org/what-is-your-preferred-chemotherapy-when-dealing-with-hepatic-visceral-crisis-in-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/is-concomitant-use-of-azathioprine-and-febuxostat-safe-from-a-bone-marrow-toxicity-standpoint weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-a-patient-with-a-new-diagnosis-of-cardiomyopathy-in-pregnancy-without-clinical-signs-of-heart-failure weekly 0.8 https://www.themednet.org/when-treating-with-electrons-what-is-your-approach-to-skin-collimation-to-reduce-penumbra-next-to-structures-such-as-the-eye weekly 0.8 https://www.themednet.org/is-there-a-rationale-for-treating-medically-inoperable-stage-i-iii-breast-cancer-patients-with-rt-alone weekly 0.8 https://www.themednet.org/how-do-you-manage-postoperative-head-and-neck-cancer-patients-who-have-difficulty-completing-simulation-due-to-copious-secretions weekly 0.8 https://www.themednet.org/do-you-change-your-monitoring-strategy-for-a-high-risk-prostate-cancer-after-xrt-if-the-initial-psas-have-never-been-very-high weekly 0.8 https://www.themednet.org/what-treatment-regimen-for-uva-1-have-you-found-most-helpful-in-treating-sclerotic-diseases-e-g-morphea-scleroderma weekly 0.8 https://www.themednet.org/how-do-you-approach-the-discussion-and-decision-making-regarding-surgery-vs-sbrt-for-stage-i-nsclc-in-patients-who-are-candidates-for-both weekly 0.8 https://www.themednet.org/would-you-offer-fast-forward-for-a-metastatic-breast-cancer-patient-with-breast-implants-needing-palliation-of-symptomatic-breast-lesions weekly 0.8 https://www.themednet.org/what-biologic-for-psoriasis-do-you-prescribe-most-often-in-patients-with-a-history-of-malignancy weekly 0.8 https://www.themednet.org/when-would-it-be-reasonable-to-consider-enhanced-external-counter-pulsation-therapy-in-patients-with-refractory-angina-despite-maximally-tolerated-anti-anginal-therapy weekly 0.8 https://www.themednet.org/when-would-you-offer-radiation-for-poorly-differentiated-thyroid-cancer weekly 0.8 https://www.themednet.org/will-you-give-perioperative-chemotherapy-with-egfr-inhibitors-for-stage-iv-left-sided-ras-braf-wt-colorectal-cancer-with-resectable-borderline-resectable-liver-metastases-given-discordant-paradigm-vs-new-epoc-trial-results weekly 0.8 https://www.themednet.org/do-you-use-prednisone-in-the-management-of-patients-with-persistent-respiratory-symptoms-following-acute-covid-19-infection weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-regarding-timing-of-dentures-after-definitive-post-operative-h-n-radiation-with-pre-treament-tooth-extractions weekly 0.8 https://www.themednet.org/how-do-you-approach-brain-srs-for-patients-currently-receiving-trastuzumab-deruxtecan-with-progressive-brain-lesions weekly 0.8 https://www.themednet.org/for-patients-with-metastatic-her2-null-breast-cancer-do-you-offer-trastuzumab-deruxtecan-based-on-the-daisy-trial-results weekly 0.8 https://www.themednet.org/do-you-recommend-routinely-getting-periodic-24-hour-urine-monoclonal-protein-study-for-patients-with-active-multiple-myeloma weekly 0.8 https://www.themednet.org/do-you-use-fviii-levels-to-differentiate-between-dic-and-coagulopathy-of-liver-disease weekly 0.8 https://www.themednet.org/are-you-routinely-using-neoadjuvant-cemiplimab-for-cutaneous-squamous-cell-carcinoma-of-any-site weekly 0.8 https://www.themednet.org/what-is-the-current-recommendation-for-using-thiazide-diuretics-in-patients-with-calcium-oxalate-stone-disease-given-the-negative-results-of-the-nostone-trial weekly 0.8 https://www.themednet.org/what-uterine-risk-factors-do-you-consider-when-recommending-vbt-boost-after-ebrt weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-chemo-io-olaparib-for-patients-with-occult-stage-iii-disease-identified-after-staging-surgery-with-no-measurable-residual-disease weekly 0.8 https://www.themednet.org/despite-the-paucity-of-strong-data-showing-benefit-of-chemotherapy-radiotherapy-in-patients-with-stage-i-ii-high-risk-histology-endometrial-cancer-if-you-recommend-treatment-with-both-modalities-how-do-you-determine-treatment-schedule weekly 0.8 https://www.themednet.org/do-you-recommend-axillary-dissection-for-women-with-er-breast-cancer-and-low-risk-oncotype-or-mammaprint-if-single-node-positive-with-only-1-2-sln-removed-to-ensure-4-nodes-positive weekly 0.8 https://www.themednet.org/how-well-does-left-chest-wall-electron-chest-wall-rt-compare-with-imrt-with-with-respect-to-heart-and-lung-radiation-doses weekly 0.8 https://www.themednet.org/what-is-your-preferred-dose-and-fractionation-for-muscle-invasive-bladder-cancer-and-how-do-you-decide-between-them weekly 0.8 https://www.themednet.org/do-you-recommend-placement-of-a-backup-av-fistula-in-an-advanced-ckd-patient-who-is-planning-to-do-peritoneal-dialysis weekly 0.8 https://www.themednet.org/in-patients-with-advanced-endometrial-cancer-who-you-plan-to-treat-with-chemotherapy-immunotherapy-per-gy018-or-ruby-how-and-when-do-you-utilize-adjuvant-ebrt-and-or-brachytherapy weekly 0.8 https://www.themednet.org/what-is-the-optimal-approach-for-a-younger-female-with-borderline-resectable-cervix-cancer-who-may-need-adjuvant-radiation-in-light-of-a-medical-history-significant-for-ulcerative-colitis weekly 0.8 https://www.themednet.org/do-you-generally-recommend-starting-nintedanib-prior-to-immunosuppressive-therapy-in-a-patient-with-ctd-ild weekly 0.8 https://www.themednet.org/do-you-ever-utilize-short-course-radiation-when-lateral-pelvic-extra-mesorectal-lymph-nodes-are-involved weekly 0.8 https://www.themednet.org/would-you-consider-using-ivig-for-pots-in-the-absence-of-any-clear-autoimmune-condition-or-abnormal-antibodies weekly 0.8 https://www.themednet.org/what-is-your-strategy-for-treating-persistent-headaches-in-the-aftermath-of-subarachnoid-hemorrhage weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-who-has-well-controlled-sle-on-hcq-but-develops-cotton-wool-spots-on-routine-ophthalmologic-screening weekly 0.8 https://www.themednet.org/how-do-you-determine-when-to-wean-patients-with-idiopathic-intracranial-hypertension-off-of-acetazolamide weekly 0.8 https://www.themednet.org/how-should-parp-inhibitors-be-incorporated-into-clinical-practice-in-later-line-maintenance-of-platinum-sensitive-ovarian-cancer-for-parp-inhibitor-naive-patients weekly 0.8 https://www.themednet.org/how-would-you-approach-a-ct4-cn2-22-cm-in-size-tnbc-that-shrank-to-9-cm-with-kn-522-regimen-but-remains-inoperable-at-the-end-of-treatment weekly 0.8 https://www.themednet.org/how-does-a-history-of-radiation-pneumonitis-impact-your-decision-on-future-lung-sbrt weekly 0.8 https://www.themednet.org/what-factors-do-you-use-to-decide-between-trastuzumab-deruxtecan-and-sacituzumab-govitecan-in-her2-low-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/will-you-offer-patients-urea-based-creams-or-topical-diclofenac-for-hand-foot-prophylaxis-with-capecitabine-after-the-d-torch-trial-results weekly 0.8 https://www.themednet.org/do-you-continue-belimumab-throughout-pregnancy weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-breast-cancer-from-asco-2023 weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gynecologic-cancers-from-asco-2023 weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gu-cancers-from-asco-2023 weekly 0.8 https://www.themednet.org/how-often-do-you-monitor-labs-in-patients-taking-methotrexate weekly 0.8 https://www.themednet.org/would-you-offer-rni-for-young-patient-with-ct3n0-triple-negative-breast-cancer-that-had-progression-of-disease-during-neoadjuvant-chemotherapy-followed-by-mastectomy-and-sentinel-node-biopsy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-mitigating-the-infection-risk-with-bispecific-antibodies-in-multiple-myeloma weekly 0.8 https://www.themednet.org/how-aggressive-would-you-be-in-irradiating-asymptomatic-bone-metastases-in-a-patient-with-metastatic-prostate-cancer weekly 0.8 https://www.themednet.org/for-patients-with-acute-ischemic-stroke-and-bp-185-110-at-what-point-do-you-consider-persistently-elevated-bp-too-refractory-to-safely-give-thrombolysis weekly 0.8 https://www.themednet.org/do-you-recommend-using-a-risk-equation-or-egfr-alone-in-deciding-when-to-refer-a-patient-with-advanced-ckd-for-vascular-access-placement weekly 0.8 https://www.themednet.org/would-you-avoid-combining-jak-inhibitors-with-ivig-given-the-risk-of-thromboembolism weekly 0.8 https://www.themednet.org/do-you-recommend-holding-metformin-in-a-patient-with-chronic-kidney-disease-who-has-an-upcoming-ct-contrast-study weekly 0.8 https://www.themednet.org/does-your-goal-rate-of-correction-in-patients-with-chronic-hypoosmolar-hyponatremia-differ-based-on-the-degree-of-hypoosmolarity weekly 0.8 https://www.themednet.org/in-patients-with-perianal-squamous-cell-carcinoma-extending-to-the-vulva-would-you-cover-the-entire-vulva-or-would-generous-margins-on-the-gross-disease-suffice weekly 0.8 https://www.themednet.org/what-are-the-differential-and-workup-for-a-patient-with-findings-suggestive-of-idiopathic-intracranial-hypertension-without-papilledema-on-examination weekly 0.8 https://www.themednet.org/would-you-ever-consider-repeating-chemoradiation-for-patients-with-locally-recurrent-small-cell-lung-cancer-after-prior-chemoradiation-for-ls-sclc weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-or-radiation-to-a-resected-mss-t3n0-high-rectal-lesion-with-low-anterior-resection-without-pre-op-therapy weekly 0.8 https://www.themednet.org/how-do-we-reconcile-what-appears-to-be-a-more-aggressive-surgical-resection-for-dcis-than-for-invasive-disease weekly 0.8 https://www.themednet.org/would-you-add-adt-to-ebrt-for-favorable-intermediate-risk-patients-with-t1c-prostate-cancer-by-dre-and-bilateral-prostatic-lobe-involvement-by-mri weekly 0.8 https://www.themednet.org/does-the-path-length-of-vaginal-cuff-cylinder-brachytherapy-treatment-as-adjuvant-therapy-for-endometrial-cancer-vary-based-on-histology-serous-etc weekly 0.8 https://www.themednet.org/when-would-you-consider-performing-direct-implantation-versus-prior-dilatation-with-balloon-aortic-valvuloplasty-during-tavr weekly 0.8 https://www.themednet.org/when-would-you-consider-treating-an-asymptomatic-patient-with-follicular-lymphoma weekly 0.8 https://www.themednet.org/what-treatment-would-you-recommend-for-dcis-incidentally-found-in-pathologic-specimen-following-breast-reduction-surgery weekly 0.8 https://www.themednet.org/what-is-your-approach-to-monitoring-for-recovery-in-a-patient-with-non-oliguric-aki-requiring-dialysis weekly 0.8 https://www.themednet.org/would-you-consider-the-use-of-doxycycline-or-minocycline-in-the-management-of-ra weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-igg4rd-with-past-pulmonary-involvement-biopsy-proven-managed-with-steroids-alone-now-with-new-hematuria-proteinuria-but-stable-renal-function weekly 0.8 https://www.themednet.org/how-would-you-approach-a-mediastinal-only-presentation-of-squamous-cell-carcinoma-of-the-lung-s-p-lymph-node-biopsy-consistent-with-lung-origin-with-pet-positive-for-only-mediastinal-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-in-deciding-on-definitive-therapy-for-locally-advanced-hpv-negative-head-and-neck-cancer-unsuitable-for-standard-cisplatin-based-chemo weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-tdm-1-to-a-patient-with-residual-disease-after-neoadjuvant-treatment-for-biopsy-proven-her2-positive-breast-cancer-although-residual-tumor-biopsy-shows-discordance-with-her2-negative-status weekly 0.8 https://www.themednet.org/how-do-you-treat-a-large-resected-ex-pleomorphic-adenoma-with-unknown-margin-status-due-to-tumor-fragmentation weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-ask-if-there-are-any-dietary-modifications-they-can-make-to-help-control-their-autoimmune-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-to-definitive-radiation-for-p16-ct2n1m0-ajcc-8th-ed-base-of-tongue-scc weekly 0.8 https://www.themednet.org/what-techniques-do-you-typically-use-for-a-photon-breast-boost weekly 0.8 https://www.themednet.org/how-do-you-contour-proximal-sv-for-definitive-prostate-ebrt weekly 0.8 https://www.themednet.org/what-first-line-therapeutic-regimen-do-you-consider-most-appropriate-for-metastatic-clear-cell-renal-carcinoma-presenting-with-brain-metastasis-and-vasogenic-edema weekly 0.8 https://www.themednet.org/when-would-you-offer-post-operative-therapy-to-a-resected-non-melanomatous-skin-cancer-with-a-solitary-positive-node weekly 0.8 https://www.themednet.org/do-you-refer-all-of-your-patients-for-egd-prior-to-initiation-of-atezolizumab-bevacizumab-for-advanced-hcc weekly 0.8 https://www.themednet.org/is-there-a-role-for-radiation-therapy-in-the-treatment-of-a-lymphoproliferative-disorder-involving-the-orbit weekly 0.8 https://www.themednet.org/would-you-consider-treatment-with-sacituzumab-in-triple-negative-metastatic-breast-cancer-if-there-has-been-progression-on-irinotecan weekly 0.8 https://www.themednet.org/is-antiplatelet-or-anticoagulant-therapy-preferred-for-the-secondary-prophylaxis-of-cryptogenic-stroke-in-a-patient-with-underlying-malignancy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-a-curable-breast-cancer-that-there-is-no-indication-for-additional-surveillance-imaging-after-treatment-other-than-continuing-annual-mammograms weekly 0.8 https://www.themednet.org/how-would-you-treat-a-second-hpv-related-oropharyngeal-squamous-cell-cancer-in-a-patient-previoulsy-treated-and-cured-of-a-hpv-related-scc-of-the-tonsil-treated-with-chemoradiation weekly 0.8 https://www.themednet.org/how-do-you-approach-postoperative-radiation-for-small-oral-cavity-cancers-cases-with-limited-risk-factors weekly 0.8 https://www.themednet.org/do-hemoglobin-s-levels-always-correlate-with-scd-phenotype weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-a-patient-with-symptomatic-iron-deficiency-anemia-who-is-intolerant-of-iron weekly 0.8 https://www.themednet.org/how-would-you-treat-osteosarcoma-that-has-relapsed-with-unresectable-pulmonary-metastatic-disease weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-pancreatic-adenocarcinoma-who-completed-6-months-of-adjuvant-chemotherapy-without-evidence-of-disease-on-imaging-but-an-elevated-ca-19-9 weekly 0.8 https://www.themednet.org/how-does-the-lack-of-mandated-pet-or-brain-mri-in-the-adaura-trial-impact-your-interpretation-of-the-results weekly 0.8 https://www.themednet.org/how-will-the-adaura-study-impact-your-use-of-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/should-we-consider-radiation-therapy-for-patients-with-n2-egfrm-nsclc-who-will-receive-osimertinib-though-rt-was-excluded-on-adaura weekly 0.8 https://www.themednet.org/what-is-your-practice-for-the-use-of-bolus-in-patients-with-breast-cancer-who-had-mastectomy-and-expander-placement weekly 0.8 https://www.themednet.org/for-metastatic-clear-cell-rcc-would-you-consider-cabozantinib-nivolumab-after-progression-on-first-line-ipilimumab-nivolumab weekly 0.8 https://www.themednet.org/what-factors-impact-your-decision-to-include-bevacizumab-with-primary-chemotherapy-for-patients-with-brca-or-hrd-ovarian-cancer weekly 0.8 https://www.themednet.org/are-there-any-molecular-predictors-for-response-to-chemoimmunotherapy-for-patients-with-es-sclc weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-patients-with-widespread-es-sclc-with-a-poor-performance-status weekly 0.8 https://www.themednet.org/do-you-offer-ultra-hypofractionated-5-fraction-rt-regimens-for-dcis-s-p-lumpectomy weekly 0.8 https://www.themednet.org/do-you-utilize-d-dimer-to-inform-anticoagulation-duration-in-the-treatment-of-vte weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-new-fdg-avid-retroperitoneal-lymph-nodes-after-completing-definitive-chemoradiation-for-stage-iii-anal-canal-cancer weekly 0.8 https://www.themednet.org/for-gyn-cancers-receiving-chemoradiation-how-high-can-you-boost-grossly-positive-nodes-with-sib-if-not-near-bowel weekly 0.8 https://www.themednet.org/for-patients-with-egfr-mutation-positive-nsclc-who-progress-on-first-line-tki-without-actionable-resistance-mechanisms-would-you-consider-chemotherapy-targeted-therapy-as-a-second-line-option-or-chemotherapy-immunotherapy weekly 0.8 https://www.themednet.org/how-do-you-think-about-sequencing-therapy-for-a-patient-with-alk-metastatic-nsclc-given-the-available-options weekly 0.8 https://www.themednet.org/how-do-you-manage-alk-inhibitor-aes-which-are-low-grade-but-significantly-impact-patient-qol-over-time weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-discordant-mutation-testing-in-liquid-vs-tissue-biopsy-for-mnsclc weekly 0.8 https://www.themednet.org/what-treatment-would-you-offer-for-a-patient-with-unresectable-triple-negative-breast-ca-who-remains-unresectable-after-completion-of-dd-ac-t weekly 0.8 https://www.themednet.org/would-you-consider-adding-abiraterone-or-docetaxel-in-patients-with-high-risk-prostate-cancer-whose-psa-does-not-become-undetectable-after-adt-and-radiotherapy-with-castrate-level-testosterone weekly 0.8 https://www.themednet.org/how-would-you-manage-a-papillary-thyroid-carcinoma-incidentally-found-on-planning-ct-for-t1-glottic-cancer weekly 0.8 https://www.themednet.org/what-is-current-practice-for-sparing-a-tissue-strip-in-extremity-radiation weekly 0.8 https://www.themednet.org/what-adjuvant-systemic-therapy-would-you-offer-to-a-healthy-elderly-woman-with-a-5mm-node-negative-grade-2-hr-her2-invasive-lobular-carcinoma weekly 0.8 https://www.themednet.org/what-factors-would-guide-your-decision-to-safely-resume-anticoagulation-for-atrial-fibrillation-following-a-recent-intracranial-hemorrhage-2 weekly 0.8 https://www.themednet.org/how-do-you-approach-pjp-prophylaxis-in-patients-with-rheumatic-disease-on-corticosteroids weekly 0.8 https://www.themednet.org/what-first-line-regimen-for-metastatic-esophageal-or-gej-adenocarcinoma-would-you-use-in-an-elderly-patient-80-with-medical-comorbidities weekly 0.8 https://www.themednet.org/how-do-you-approach-and-manage-anorexia-and-appetite-loss-in-people-with-advanced-cancer weekly 0.8 https://www.themednet.org/do-you-give-cetuximab-concurrently-with-sbrt-for-recurrent-head-and-neck-cancers-previous-treated-with-definitive-radiation weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-treatment-for-metastatic-melanoma-in-a-patient-with-a-BRAF-mutation weekly 0.8 https://www.themednet.org/would-you-ever-recommend-post-op-crt-for-gastric-adenocarcinoma-treated-with-upfront-surgery-and-d2-resection-with-r0 weekly 0.8 https://www.themednet.org/are-there-any-circumstances-in-which-you-would-recommend-adjuvant-chemoradiation-for-resected-olfactory-neuroblastoma weekly 0.8 https://www.themednet.org/how-would-you-treat-an-isolated-para-aortic-node-recurrence-1-5-years-after-receiving-primary-chemoradiation-for-locally-advanced-cervical-cancer weekly 0.8 https://www.themednet.org/can-immunotherapy-alone-or-with-chemo-be-considered-for-ros1-nsclc-after-exhausting-ros1-targeted-therapy-options weekly 0.8 https://www.themednet.org/how-do-you-manage-steroid-refractory-immune-checkpoint-inhibitor-induced-pneumonitis weekly 0.8 https://www.themednet.org/for-non-metastatic-mibc-patients-with-incomplete-debulking-turbt-who-are-not-surgical-candidates-for-cystectomy-or-repeat-turbt-would-you-try-chemort-or-proceed-directly-to-systemic-treatment weekly 0.8 https://www.themednet.org/can-adjuvant-nivolumab-for-bladder-ca-as-per-checkmate-274-be-extrapolated-for-the-concurrent-chemort-bladder-preservation-setting weekly 0.8 https://www.themednet.org/what-margins-ctv-and-ptv-do-you-use-for-palliation-when-using-quad-shot-regimen weekly 0.8 https://www.themednet.org/when-do-you-consider-tapering-tocilizumab-in-patients-with-gca-in-remission weekly 0.8 https://www.themednet.org/are-you-using-genomic-classifiers-to-diagnose-uip-when-imaging-is-indeterminate-or-suggestive-of-an-alternate-diagnosis weekly 0.8 https://www.themednet.org/in-the-neoadjuvant-setting-how-would-you-treat-a-premenopausal-woman-with-a-3-cm-er-pr-weakly-positive-her-2-negative-grade-3-breast-cancer-with-clinical-n1-node-which-shows-basal-type-on-mammaprint weekly 0.8 https://www.themednet.org/what-adjuvant-chemotherapy-would-you-recommend-in-a-elderly-patient-with-resected-stage-iii-colon-cancer-with-mmr-deficiency-with-mlh1-promoter-hypermethlation weekly 0.8 https://www.themednet.org/would-you-consider-the-use-of-low-dose-naltrexone-in-patients-with-fibromyalgia-and-or-type-2-lupus-symptoms weekly 0.8 https://www.themednet.org/are-there-certain-sedatives-or-anti-epileptic-meds-to-avoid-in-patients-with-idd weekly 0.8 https://www.themednet.org/how-long-would-you-recommend-that-a-patient-continues-guselkumab-prior-to-deciding-that-the-therapy-is-not-effective weekly 0.8 https://www.themednet.org/would-you-consider-the-use-of-dual-antifibrotic-therapy-nintedanib-and-pirfenidone-together-for-progressive-fibrosing-ild weekly 0.8 https://www.themednet.org/will-you-offer-cetuximab-or-panitumumab-with-folfox-in-patients-with-metastatic-left-sided-ras-braf-wt-mss-colon-cancer-instead-of-bevacizumab weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-hematologic-malignancies-from-asco-2022 weekly 0.8 https://www.themednet.org/how-will-you-approach-treatment-sequencing-and-use-of-trastuzumab-deruxtecan-in-hormone-receptor-negative-her2-low-breast-cancer weekly 0.8 https://www.themednet.org/when-defining-her2-low-status-in-breast-cancer-are-there-certain-ihc-assays-techniques-that-are-preferred weekly 0.8 https://www.themednet.org/have-the-results-of-the-opra-trial-influenced-your-decision-to-recommend-long-course-chemoradiation-vs-short-course-radiation-therapy-for-patients-receiving-tnt-who-intend-to-undergo-surgery weekly 0.8 https://www.themednet.org/if-there-is-her2-low-discordance-between-primary-and-subsequent-breast-cancer-biopsies-in-which-scenarios-would-you-choose-to-use-trastuzumab-deruxtecan weekly 0.8 https://www.themednet.org/what-can-prostate-patients-do-for-sexual-function-while-on-adt weekly 0.8 https://www.themednet.org/does-the-overall-conclusion-of-the-chance-2-trial-make-ticagrelor-asa-a-worthwhile-transition-given-the-data-showing-cumulative-hazard-of-stroke-diverged-during-the-first-week-and-was-subsequently-similar-which-suggests-the-benefit-of-ticagrelor-over-clop weekly 0.8 https://www.themednet.org/how-frequently-do-you-check-aed-levels-in-patients-with-stable-epilepsy weekly 0.8 https://www.themednet.org/would-you-offer-hypofractionated-pmrt-to-a-pathologic-t2n1a-brca-positive-patient weekly 0.8 https://www.themednet.org/how-would-you-deliver-whole-breast-radiotherapy-in-someone-who-cannot-raise-their-ipsilateral-arm-above-their-head-due-to-recent-shoulder-replacement-surgery weekly 0.8 https://www.themednet.org/would-you-start-anticoagulation-in-a-patient-with-a-history-of-cva-1-year-ago-and-high-risk-apl-profile-who-was-never-started-on-anticoagulation-but-is-now-presenting-for-follow-up-and-without-recurrent-thrombotic-events weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-acute-development-of-radiation-changes-around-the-target-while-undergoing-a-course-of-lung-sbrt weekly 0.8 https://www.themednet.org/do-you-typically-consider-botox-for-patients-with-tmj weekly 0.8 https://www.themednet.org/how-do-you-approach-rising-psa-many-years-after-prostatectomy-with-negative-psma-pet weekly 0.8 https://www.themednet.org/how-would-positive-ctdna-results-after-12-cycles-of-adjuvant-folfox-affect-your-management-for-patients-with-colon-cancer weekly 0.8 https://www.themednet.org/what-clinical-factors-influence-your-first-line-treatment-selection-in-advanced-hcc weekly 0.8 https://www.themednet.org/what-recommendations-do-you-provide-to-patients-with-sensitive-skin-that-can-not-tolerate-retinoids-more-than-a-few-times-per-week weekly 0.8 https://www.themednet.org/what-topical-therapies-do-you-find-are-most-effective-for-treating-inverse-psoriasis-in-areas-of-the-body-with-thinner-skin weekly 0.8 https://www.themednet.org/what-induction-regimen-would-you-choose-for-a-patient-with-newly-diagnosed-multiple-myeloma-with-incidental-amyloidosis-noted-on-bone-marrow-biopsy-but-with-no-end-organ-damage-as-a-result-of-amyloid-deposition weekly 0.8 https://www.themednet.org/how-do-you-manage-an-elderly-high-risk-prostate-cancer-patient-who-refuses-any-local-therapy weekly 0.8 https://www.themednet.org/do-you-typically-recommend-four-factor-prothrombin-complex-concentrate-versus-fresh-frozen-plasma-for-inr-correction-in-patients-with-vitamin-k-antagonist-associated-spontaneous-ich weekly 0.8 https://www.themednet.org/can-durvalumab-incorporation-to-gem-cis-for-advanced-btcs-allow-for-earlier-discontinuation-of-cytotoxic-chemotherapy-in-patients-exhibiting-response weekly 0.8 https://www.themednet.org/how-do-you-manage-colorectal-tumors-that-have-components-in-the-colon-and-rectum-on-mri weekly 0.8 https://www.themednet.org/what-is-your-approach-to-volume-resuscitation-in-patients-with-obvious-septic-shock-but-also-with-a-component-of-suspected-cardiogenic-shock weekly 0.8 https://www.themednet.org/how-do-you-manage-multiple-brain-metastases-from-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/how-do-you-decide-between-fcrn-inhibitors-and-complement-inhibitors-for-treatment-refractory-achr-positive-myasthenia-gravis weekly 0.8 https://www.themednet.org/what-lab-monitoring-and-frequency-do-you-recommend-in-an-otherwise-healthy-young-patient-on-biologics-for-psoriasis weekly 0.8 https://www.themednet.org/what-ekg-findings-are-most-concerning-when-screening-asymptomatic-athletes-in-the-outpatient-setting weekly 0.8 https://www.themednet.org/how-do-you-manage-a-doac-if-interested-in-testing-for-lupus-anticoagulant weekly 0.8 https://www.themednet.org/when-if-ever-would-you-consider-dose-de-escalation-for-hpv-associated-non-oropharyngeal-hnscc weekly 0.8 https://www.themednet.org/when-do-you-consider-intrathecal-baclofen-pump-in-patients-with-acquired-spasticity weekly 0.8 https://www.themednet.org/how-would-you-approach-a-laryngeal-adenoid-cystic-carcinoma-in-a-patient-seeking-larynx-preservation weekly 0.8 https://www.themednet.org/what-is-your-threshold-to-diagnose-light-chain-mgus-with-only-a-slight-elevation-in-the-light-chain-ratio-in-a-patient-without-other-crab-symptoms-and-no-m-spike weekly 0.8 https://www.themednet.org/have-you-found-fcrn-inhibitors-effective-for-weaning-off-or-replacing-ivig-for-the-treatment-of-refractory-seropositive-myasthenia-gravis weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-hand-dermatitis-recalcitrant-to-potent-topical-steroids weekly 0.8 https://www.themednet.org/how-would-you-approach-an-ulcerative-non-melanomatous-skin-cancer-of-the-lower-extremity-s-p-mohs-surgery-with-gross-disease-left-behind weekly 0.8 https://www.themednet.org/would-you-cover-elective-nodal-regions-in-a-patient-with-high-risk-cutaneous-scc-of-the-right-medial-forehead-with-clinically-negative-lymph-nodes-s-p-wle-with-graft weekly 0.8 https://www.themednet.org/what-is-the-general-approach-for-hpv-opscc-who-present-with-distant-metastases weekly 0.8 https://www.themednet.org/when-treating-sialorrhea-in-als-patients-what-treatment-schedule-do-you-use weekly 0.8 https://www.themednet.org/is-it-ethical-to-still-prescribe-conventionally-fractionated-treatments-for-breast-cancer-prostate-cancer-and-osseous-metastatic-disease-for-patients-that-do-not-have-contraindications-to-hypofractionation weekly 0.8 https://www.themednet.org/would-you-offer-palliative-re-irradiation-to-the-sacrum-for-a-patient-with-a-prior-history-of-rt-for-rectal-cancer weekly 0.8 https://www.themednet.org/what-methods-do-you-use-to-prophylactically-reduce-radiation-dermatitis-for-head-and-neck-irradiation weekly 0.8 https://www.themednet.org/what-pathological-factors-do-you-use-to-consider-treatment-of-the-axillary-level-i-ii-after-an-axillary-dissection weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-synchronous-locally-advanced-rectal-adenocarcinoma-t3n2-and-a-large-t2n0-adenocarcinoma-of-mid-and-distal-esophagus weekly 0.8 https://www.themednet.org/would-you-omit-pelvic-xrt-in-a-high-risk-prostate-patient-with-negative-nodal-uptake-on-psma-but-has-risk-of-nodal-involvement-15-by-nomogram weekly 0.8 https://www.themednet.org/would-you-consider-ai-alone-over-cdk4-6-inhibitor-combinations-in-older-patients-with-breast-cancer-considering-the-subgroup-analyses-from-monaleesa-2-suggest-less-benefit-in-patients-over-65 weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-acr-2022 weekly 0.8 https://www.themednet.org/what-is-your-approach-to-immunosuppression-in-patients-with-recurrent-peripheral-ulcerative-keratitis-or-marginal-keratitis-who-have-active-disease-despite-steroid-therapy-and-no-current-evidence-of-rheumatologic-disease weekly 0.8 https://www.themednet.org/do-you-perform-an-mri-after-spaceoar-vue-placement-if-you-already-have-a-pre-procedural-mri-and-are-not-doing-a-flame-style-boost weekly 0.8 https://www.themednet.org/what-percentage-of-your-patients-receive-hydrogel-spaceoar weekly 0.8 https://www.themednet.org/what-is-your-approach-to-timing-of-medications-like-rituximab-and-cyclophosphamide-around-plasmapheresis-in-patients-on-daily-plex weekly 0.8 https://www.themednet.org/where-do-you-place-romosozumab-in-your-treatment-sequence-for-osteoporosis-management weekly 0.8 https://www.themednet.org/what-is-your-approach-to-systemic-anticoagulation-for-patients-with-hypoalbuminemia-and-nephrotic-syndrome-secondary-to-a-non-membranous-nephropathy-condition weekly 0.8 https://www.themednet.org/how-do-you-approach-the-workup-of-transverse-myelitis-without-any-abnormality-on-spine-mri weekly 0.8 https://www.themednet.org/how-would-you-manage-an-endometrial-adeno-abdominal-wall-recurrence-at-the-port-site-from-prior-laparoscopic-surgery weekly 0.8 https://www.themednet.org/how-do-you-approach-low-to-moderate-titer-of-apls-when-working-up-unprovoked-dvt-if-it-is-persistent-on-repeat-testing weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-ra-patients-with-history-of-organ-transplant-already-on-immunosuppressive-therapy-such-as-cyclosporine-or-cellcept weekly 0.8 https://www.themednet.org/how-do-you-risk-stratify-patients-with-mri-guided-prostate-biopsies weekly 0.8 https://www.themednet.org/how-do-you-approach-the-workup-for-a-patient-with-persistently-elevated-inflammatory-markers-crp-and-esr-whose-history-and-exam-do-not-point-to-a-clear-cause weekly 0.8 https://www.themednet.org/what-treatments-have-you-found-to-be-most-effective-in-treating-oral-lichen-planus weekly 0.8 https://www.themednet.org/which-imaging-modality-do-you-prefer-when-monitoring-disease-status-for-patients-with-prostate-cancer-undergoing-177-lu-psma-treatment weekly 0.8 https://www.themednet.org/how-would-you-approach-de-novo-metastatic-castrate-sensitive-prostate-cancer-with-extensive-locoregional-spread-causing-rectal-compression-retroperitoneal-lymphadenopathy-and-psa-3000-but-no-visceral-or-bone-metastases weekly 0.8 https://www.themednet.org/do-you-recommend-adding-moonstone-supplements-for-patients-with-recurrent-calcium-oxalate-nephrolithiasis-who-are-on-potassium-citrate-but-continue-to-have-hypocitraturia weekly 0.8 https://www.themednet.org/what-is-the-expected-timeframe-for-the-development-of-radiation-myelitis-and-therapies-that-have-helped-with-neurologic-symptoms weekly 0.8 https://www.themednet.org/how-do-you-manage-significant-gas-in-patients-undergoing-pelvic-radiotherapy weekly 0.8 https://www.themednet.org/do-you-generally-prefer-to-continue-hydroxychloroquine-in-lupus-patients-who-develop-esrd-despite-the-low-likelihood-of-clinically-active-disease-in-this-patient-population weekly 0.8 https://www.themednet.org/what-systemic-therapy-and-dose-adjustments-would-you-implement-for-patients-with-pancreas-cancer-and-cirrhosis-with-pancytopenia weekly 0.8 https://www.themednet.org/do-you-use-doac-in-patients-with-mild-or-moderate-rheumatic-mitral-stenosis weekly 0.8 https://www.themednet.org/how-do-you-approach-antidepressant-choices-for-patients-with-generalized-anxiety-disorder-when-the-patient-reports-excessive-sedation-on-low-doses-of-ssris weekly 0.8 https://www.themednet.org/what-is-the-best-approach-to-treatment-for-cenestopathies-sensation-of-electric-current-in-patients-brain-accompanied-by-anxiety-and-inability-to-sleep weekly 0.8 https://www.themednet.org/for-a-patient-post-prostatectomy-with-a-high-psa-1-a-negative-mri-pelvis-and-a-negative-psma-pet-scan-do-you-pursue-any-other-imaging weekly 0.8 https://www.themednet.org/do-you-continue-shots-when-a-patient-transfers-under-your-care-and-has-been-receiving-less-than-effective-doses-of-ait-but-insist-they-have-been-effective weekly 0.8 https://www.themednet.org/are-there-any-potentially-successful-pharmacologic-interventions-instead-of-cbt-or-behavioral-interventions-alone-for-schizoid-personality-disorder weekly 0.8 https://www.themednet.org/what-is-the-best-treatment-option-for-a-patient-with-bipolar-disorder-who-stopped-her-medication-at-the-start-of-pregnancy-and-is-now-at-the-end-of-2nd-trimester weekly 0.8 https://www.themednet.org/what-do-you-do-when-a-patient-experiences-multiple-rounds-of-antidepressant-related-tachyphylaxis weekly 0.8 https://www.themednet.org/is-active-cocaine-or-methamphetamine-use-a-contraindication-to-implanting-defibrillators weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gu-cancers-from-esmo-2024 weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-breast-cancer-from-esmo-2024 weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-breast-cancer-from-astro-2024 weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gi-cancers-from-astro-2024 weekly 0.8 https://www.themednet.org/what-workup-do-you-recommend-for-patients-requiring-higher-than-expected-levothyroxine-doses-for-their-weight weekly 0.8 https://www.themednet.org/when-do-you-test-for-myasthenia-antibodies-beyond-achr-and-musk weekly 0.8 https://www.themednet.org/do-you-find-that-hydroxyzine-worsens-cognitive-symptoms-in-patients-who-are-already-susceptible-to-cognitive-impairment weekly 0.8 https://www.themednet.org/how-would-you-manage-symptomatic-bilateral-subsegmental-pe-developed-after-long-air-travel weekly 0.8 https://www.themednet.org/would-you-avoid-sglt2-inhibitors-in-patients-with-urinary-incontinence-requiring-incontinence-briefs-due-to-concern-with-genitourinary-hygiene-and-risk-for-infections weekly 0.8 https://www.themednet.org/would-you-favor-radiation-or-immune-modulating-treatment-like-imiquimod-to-treat-an-uncomplicated-basal-cell-carcinoma-on-the-nose-in-an-elderly-patient-for-whom-youd-like-to-avoid-surgery weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-regarding-risks-of-cannabis-use weekly 0.8 https://www.themednet.org/do-you-give-chronic-antibiotic-prophylaxis-for-recurrent-utis-including-pseudomonas-aeruginosa-in-a-patient-with-retained-ureteral-stents weekly 0.8 https://www.themednet.org/do-you-need-renal-biopsy-before-sbrt-for-rcc-suspicious-cancer weekly 0.8 https://www.themednet.org/how-frequently-and-in-which-situations-do-you-use-quantitative-eeg-for-the-detection-and-or-monitoring-of-delayed-cerebral-ischemia-after-aneurysmal-sah weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-a-patient-with-solid-food-esophageal-dysphagia-and-gerd-without-a-detectable-esophageal-stricture-on-upper-endoscopy weekly 0.8 https://www.themednet.org/how-if-at-all-does-your-systemic-therapy-management-differ-between-her2-breast-cancer-patients-with-active-cns-metastases-compared-to-those-with-stable-treated-cns-metastases weekly 0.8 https://www.themednet.org/would-you-utilize-rituximab-or-dupilumab-for-treatment-resistant-bullous-pemphigoid weekly 0.8 https://www.themednet.org/have-you-used-topical-rapamycin-sirolimus-for-tsc-related-angiofibromas weekly 0.8 https://www.themednet.org/how-do-you-treat-patients-with-comorbid-bipolar-disorder-and-adhd weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-develop-dvt-or-atrial-fibrillation-requiring-anticoagulation-when-being-treated-with-lecanemab-or-donanemab weekly 0.8 https://www.themednet.org/what-pharmacologic-therapy-if-any-do-you-recommend-for-treatment-of-borderline-personality-disorder weekly 0.8 https://www.themednet.org/is-moderate-intensity-statin-plus-ezetimibe-just-as-effective-as-high-intensity-statin-monotherapy-in-preventing-major-cardiovascular-events weekly 0.8 https://www.themednet.org/what-are-the-main-practical-factors-to-consider-when-using-bispecific-antibody-therapy-tarlatamab-for-extensive-stage-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/in-light-of-recent-trials-evaluating-npo-before-cath-chow-now-scoff-etc-are-centers-still-restricting-oral-intake-pre-procedure weekly 0.8 https://www.themednet.org/what-is-your-preferred-iron-loading-strategy-for-patients-with-anemia-of-chronic-kidney-disease weekly 0.8 https://www.themednet.org/does-your-hospital-or-institution-have-an-antimicrobial-stewardship-program-asp-which-oversees-id-physicians-and-if-so-does-the-asp-have-the-authority-to-refuse-an-antibiotic-prescribed-by-an-id-consultant weekly 0.8 https://www.themednet.org/what-are-your-recommendations-for-managing-perivascular-dermatitis-with-eosinophils-unresponsive-to-high-dose-antihistamines-a-prednisone-taper-and-topical-steroids weekly 0.8 https://www.themednet.org/in-a-patient-with-brca2-mutation-and-contralateral-axillary-recurrence-of-er-idc-with-an-esr1-ccdc170-fusion-on-ngs-testing-would-you-use-standard-adjuvant-ai-therapy-or-consider-adjuvant-serd-therapy-fulvestrant-elacestrant weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-in-a-patient-unable-to-fill-their-bladder-during-prostate-radiotherapy weekly 0.8 https://www.themednet.org/are-there-any-adverse-risk-factors-in-stage-i-colon-cancer-that-would-warrant-ctdna-testing weekly 0.8 https://www.themednet.org/what-leads-you-to-suspect-that-a-foot-drop-is-secondary-to-a-myopathy-rather-than-a-neuropathic-process weekly 0.8 https://www.themednet.org/how-do-you-decide-to-use-migs-versus-traditional-surgical-options-like-trabeculectomy-or-tube-shunt-placement-in-the-management-of-glaucoma weekly 0.8 https://www.themednet.org/what-is-your-recommended-sequence-of-therapies-for-achieving-optimal-proteinuria-reduction-in-iga-nephropathy-especially-in-light-of-the-recent-approvals-of-sparsentan-delayed-release-budesonide-and-iptacopan weekly 0.8 https://www.themednet.org/do-you-typically-give-gi-prophylaxis-when-providing-patients-with-steroid-taper-for-status-migrainosus weekly 0.8 https://www.themednet.org/do-you-recommend-increased-screening-for-hypercortisolism-in-older-patients-given-recent-evidence-that-older-patients-do-not-commonly-display-hallmark-symptoms-of-cushings-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-pharmacologic-management-of-ocd-in-patients-with-comorbid-bipolar-disorder-particularly-when-considering-ssris-or-clomipramine weekly 0.8 https://www.themednet.org/should-long-acting-subcutaneous-insulin-be-started-upfront-in-addition-to-regular-insulin-infusion-for-patients-with-diabetic-ketoacidosis weekly 0.8 https://www.themednet.org/when-do-you-recommend-limited-or-targeted-respiratory-pathogen-testing-versus-a-full-respiratory-pathogen-panel-in-a-patient-presenting-with-uri-symptoms weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-therapy-for-resected-stage-i-ewing-sarcoma-of-the-kidney weekly 0.8 https://www.themednet.org/how-do-you-follow-manage-patients-with-metastatic-prostate-cancer-with-undetectable-psa-and-castration-sensitive-but-active-disease-on-psma-pet weekly 0.8 https://www.themednet.org/do-you-have-any-strategies-for-increasing-yield-while-doing-bronchoscopic-biopsy-with-ebus weekly 0.8 https://www.themednet.org/do-you-recommend-treating-candida-albicans-on-urine-culture-from-an-indwelling-catheter-in-a-patient-with-septic-shock weekly 0.8 https://www.themednet.org/how-will-the-removal-of-the-clozapine-rems-requirement-change-your-clinical-practice weekly 0.8 https://www.themednet.org/would-you-recommend-starting-tolvaptan-at-7-5-mg-per-day-which-is-half-the-typical-starting-dose-to-reduce-the-risk-of-overcorrection-in-an-inpatient-with-siadh-and-a-serum-sodium-level-of-122-meq-l weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-class-iii-and-v-lupus-nephritis-already-on-hcq-mmf-voclosporin-and-losartan-but-has-continued-proteinuria-not-yet-attaining-complete-renal-response weekly 0.8 https://www.themednet.org/how-would-you-counsel-patients-with-personal-or-family-histories-of-autoimmune-disease-on-immune-checkpoint-inhibitor-therapy-for-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/which-migs-procedure-do-you-believe-provides-the-most-sustainable-iop-reduction-when-performed-alongside-cataract-surgery weekly 0.8 https://www.themednet.org/what-is-your-preferred-surgical-intervention-for-lagophthalmos-secondary-to-a-facial-paralysis-and-signs-of-exposure-keratopathy weekly 0.8 https://www.themednet.org/when-do-you-add-a-third-field-for-import-low-style-partial-breast-irradiation weekly 0.8 https://www.themednet.org/what-are-the-current-clinical-practices-for-tee-to-guide-cardioversion-and-anticoagulation-duration-post-cardioversion-for-afib-flutter-in-patients-following-left-atrial-appendage-closure weekly 0.8 https://www.themednet.org/is-there-a-point-at-which-further-reduction-in-amyloid-burden-is-no-longer-clinically-meaningful-or-should-the-goal-always-be-as-much-reduction-as-possible weekly 0.8 https://www.themednet.org/would-you-offer-any-degree-of-hypofractionation-with-concurrent-chemotherapy-for-nsclc weekly 0.8 https://www.themednet.org/what-is-your-preferred-neoadjuvant-chemotherapy-regimen-for-borderline-resectable-pancreatic-ductal-adenocarcinoma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-myelofibrosis-in-accelerated-phase-blast-percentage-10-19-in-a-transplant-eligible-patient weekly 0.8 https://www.themednet.org/would-you-consider-utilizing-a-tnf-inhibitor-in-a-patient-with-ra-sle-overlap-who-has-already-tried-methotrexate-hydroxychloroquine-and-abatacept weekly 0.8 https://www.themednet.org/for-patients-with-solitary-plasmacytoma-of-the-ureter-undergoing-definitive-xrt-40-50-gy-what-dose-constraint-do-you-use-for-the-ureter weekly 0.8 https://www.themednet.org/is-there-a-role-for-dual-antibiotic-treatment-with-ethambutol-and-macrolide-only-as-opposed-to-three-drug-antibiotic-therapy-in-the-treatment-of-treatment-naive-pulmonary-mac-without-cavitary-disease weekly 0.8 https://www.themednet.org/given-recent-data-for-use-of-doxycycline-as-post-exposure-std-prophylaxis-how-have-you-applied-its-use-in-clinical-practice weekly 0.8 https://www.themednet.org/do-you-use-specific-scalp-dosimetry-constraints-to-prevent-chronic-alopecia-when-treating-partial-brain-volumes-with-vmat weekly 0.8 https://www.themednet.org/in-patients-presenting-with-acs-and-multivessel-disease-when-do-you-favor-immediate-versus-delayed-complete-revascularization weekly 0.8 https://www.themednet.org/how-would-you-treat-node-positive-prostate-cancer-with-only-a-single-peri-rectal-node-on-psma-pet-but-no-other-nodal-basins-involved weekly 0.8 https://www.themednet.org/do-you-offer-apbi-for-patients-with-invasive-disease-if-there-is-high-grade-dcis-present-in-the-lumpectomy-specimen weekly 0.8 https://www.themednet.org/do-you-consider-bleeding-risk-in-elderly-frail-patients-with-atrial-fibrillation-to-be-similar-for-all-noacs weekly 0.8 https://www.themednet.org/what-induction-regimen-do-you-choose-for-high-risk-newly-diagnosed-multiple-myeloma-in-light-of-the-recent-high-risk-focused-studies weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-severe-mucositis-receiving-chemo-radiation-for-head-and-neck-cancer-with-regards-to-empiric-antifungal-or-antiviral-treatment weekly 0.8 https://www.themednet.org/should-rectal-spacing-only-be-considered-routinely-for-patients-who-are-at-elevated-risk-of-rectal-toxicity weekly 0.8 https://www.themednet.org/for-a-patient-with-may-thurner-syndrome-and-dvt-would-you-recommend-anticoagulation-for-3-6-months-or-indefinitely weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-locally-advanced-malignancies-who-have-ecog-3-4 weekly 0.8 https://www.themednet.org/would-you-change-an-elderly-frail-patient-with-atrial-fibrillation-who-is-already-on-a-noac-to-vka-treatment weekly 0.8 https://www.themednet.org/is-dyspnea-without-radiation-pneumonitis-a-side-effect-of-lung-radiation weekly 0.8 https://www.themednet.org/what-would-be-the-clinical-benefit-of-multiphase-cta-over-ctp-1 weekly 0.8 https://www.themednet.org/would-you-irradiate-the-elective-pelvis-of-a-patient-with-high-risk-prostate-cancer-in-the-setting-of-osteoporosis-and-sacral-insufficiency-fractures weekly 0.8 https://www.themednet.org/are-there-instances-when-you-do-not-recommend-tunneled-dialysis-catheter-exchange-in-patients-on-hemodialysis-who-are-found-to-have-bacteremia weekly 0.8 https://www.themednet.org/what-is-your-loading-dose-goal-and-typical-loading-regimen-for-po-amiodarone-in-patients-with-atrial-fibrillation weekly 0.8 https://www.themednet.org/do-you-routinely-obtain-a-spine-mri-for-all-patients-planned-for-palliative-spine-rt weekly 0.8 https://www.themednet.org/at-what-point-do-you-consider-a-patient-to-have-relapsing-pmr weekly 0.8 https://www.themednet.org/what-characteristics-make-a-pmr-patient-a-good-candidate-for-sarilumab weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-cervical-cancer-who-has-fdg-uptake-in-bilateral-ischial-tuberosities-with-lytic-areas-on-ct-correlate-and-also-has-a-history-suspicious-for-untreated-polymyalgia-rheumatica-with-chronic-symptoms-in-the-same-anatomic-locati weekly 0.8 https://www.themednet.org/would-you-consider-eliminating-pmrt-to-the-chest-wall-in-select-cases-of-t3n0-breast-cancer weekly 0.8 https://www.themednet.org/are-you-offering-glp-1-agonists-to-patients-with-ckd-and-diabetes-mellitus weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-aha-2023 weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-figo-2018-ia-g3-endometrioid-adenocarcinoma-with-substantial-lvsi-and-was-n-with-adequate-nodal-staging weekly 0.8 https://www.themednet.org/what-dose-are-you-routinely-using-for-adjuvant-rt-for-intermediate-risk-p16-scc-of-the-opx-s-p-tors weekly 0.8 https://www.themednet.org/when-contouring-locally-advanced-nsclc-how-do-you-define-your-itv-if-your-igtv-overlaps-with-an-oar weekly 0.8 https://www.themednet.org/in-light-of-the-nsabp-b-51-data-presented-at-sabcs-will-you-defer-rni-in-all-patients-with-negative-nodes-after-chemotherapy weekly 0.8 https://www.themednet.org/for-patients-with-large-partially-or-nearly-obstructing-rectal-cancers-how-do-you-sequence-tnt-in-order-to-avoid-complete-obstruction-and-surgical-diversion weekly 0.8 https://www.themednet.org/would-you-offer-chemotherapy-to-an-elderly-patient-with-msi-h-stage-3-colon-cancer-who-cannot-tolerate-oxaliplatin weekly 0.8 https://www.themednet.org/would-you-consider-using-doacs-as-a-bridge-to-warfarin-instead-of-heparin-or-lmwh weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-sabcs-2023 weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-hla-b27-associated-recurrent-uveitis-and-inflammatory-back-pain-with-a-recent-history-of-melanoma weekly 0.8 https://www.themednet.org/what-is-the-maximum-diuretic-regimen-recommended-in-patients-with-end-stage-kidney-disease-who-have-residual-renal-function-and-volume-overload weekly 0.8 https://www.themednet.org/would-you-use-romosozumab-in-a-patient-with-a-cardiovascular-event-more-than-2-years-prior weekly 0.8 https://www.themednet.org/in-patients-with-egfr-mutant-l858r-stage-iii-nsclc-who-are-unresectable-due-to-multistation-n2-disease-would-you-consider-upfront-osimertinib-over-definitive-intent-ccrt weekly 0.8 https://www.themednet.org/would-you-recommend-tnk-or-dapt-in-patients-with-stroke-like-symptoms-and-nihss-less-than-5-presenting-within-4-5-hours weekly 0.8 https://www.themednet.org/when-do-you-consider-elective-pelvic-nodal-irradiation-for-unfavorable-intermediate-risk-prostate-cancer weekly 0.8 https://www.themednet.org/in-what-scenario-would-you-recommend-induction-chemotherapy-prior-to-chemo-radiation-in-head-and-neck-cancers-and-what-would-be-the-preferred-regimen weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-grovers-disease-transient-acantholytic-dermatosis-that-has-failed-topical-steroids weekly 0.8 https://www.themednet.org/how-do-you-choose-between-the-different-vitamin-d-analogs-for-patients-with-ckd-an-elevated-pth-and-a-normal-25-hydroxy-vitamin-d-level weekly 0.8 https://www.themednet.org/after-the-results-of-rtog-0232-would-you-be-comfortable-treating-unfavorable-intermediate-risk-prostate-cancer-with-brachytherapy-monotherapy weekly 0.8 https://www.themednet.org/do-you-recommend-switching-from-tacrolimus-to-cyclosporine-in-a-kidney-transplant-patient-diagnosed-with-ptld weekly 0.8 https://www.themednet.org/for-which-patients-with-calciphylaxis-would-you-recommend-a-parathyroidectomy weekly 0.8 https://www.themednet.org/do-you-favor-timely-bronchoscopy-for-diagnostics-over-close-surveillance-in-mildly-symptomatic-patients-with-ct-findings-suspicious-for-ntm-infection-who-are-not-able-to-expectorate weekly 0.8 https://www.themednet.org/would-you-administer-iv-thrombolysis-in-a-patient-presenting-with-disabling-stroke-symptoms-while-on-anti-amyloid-therapy weekly 0.8 https://www.themednet.org/how-do-you-make-the-decision-to-empirically-treat-for-gca-when-a-patient-is-referred-but-cannot-be-immediately-seen-in-clinic weekly 0.8 https://www.themednet.org/what-do-you-recommend-for-patients-with-stage-3-msi-h-colorectal-cancer-who-are-ineligible-for-oxaliplatin-based-adjuvant-therapy weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-asco-gu-2024 weekly 0.8 https://www.themednet.org/what-is-the-role-for-iothalamate-clearance-testing-for-glomerular-filtration-estimation-in-patients-with-chronic-kidney-disease weekly 0.8 https://www.themednet.org/do-you-transition-to-oral-antibiotics-to-treat-uncomplicated-staphylococcus-aureus-bacteremia-after-patients-have-improved-with-intravenous-antibiotic-therapy weekly 0.8 https://www.themednet.org/how-do-you-manage-seemingly-treatment-resistant-chronic-migraine weekly 0.8 https://www.themednet.org/how-do-you-manage-favorable-intermediate-risk-prostate-cancer-patients-that-have-a-pirads-5-lesion-that-was-most-likely-missed-in-the-template-biopsy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-nephrology-referral-for-patients-with-lupus-nephritis weekly 0.8 https://www.themednet.org/how-long-are-you-comfortable-with-keeping-pediatric-patients-on-oral-antibiotics-for-acne weekly 0.8 https://www.themednet.org/what-dose-do-you-use-for-single-fraction-sbrt-when-treating-a-small-peripheral-early-stage-nsclc weekly 0.8 https://www.themednet.org/what-are-your-strategies-for-safely-prescribing-peritoneal-dialysis-for-patients-who-have-pets-at-home weekly 0.8 https://www.themednet.org/in-which-patients-with-early-stage-rectal-cancer-treated-according-to-the-prospect-paradigm-do-you-recommend-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/would-you-recommend-radiotherapy-to-upper-tract-urothelial-carcinoma-in-an-inoperable-patient weekly 0.8 https://www.themednet.org/when-is-it-too-far-out-from-crt-to-the-chest-to-be-considered-for-pci-for-limited-stage-sclc weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-endocrine-therapy-in-high-risk-premenopausal-women-with-er-pr-her2-breast-cancer weekly 0.8 https://www.themednet.org/would-you-offer-prostate-specific-pet-imaging-e-g-axumin-or-psma-pet-in-a-post-rt-prostate-cancer-patient-that-has-a-rising-psa-that-has-not-yet-met-failure-criteria weekly 0.8 https://www.themednet.org/how-would-you-approach-an-isolated-prostate-recurrence-of-high-risk-prostate-cancer-following-definitive-ebrt weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-chemotherapy-to-a-post-menopausal-woman-with-strongly-er-pr-positive-locally-advanced-lobular-carcinoma-with-3-axillary-lns weekly 0.8 https://www.themednet.org/is-surgery-preferable-over-sbrt-for-peripheral-nsclc-invading-into-ribs weekly 0.8 https://www.themednet.org/what-is-your-preferred-chemotherapy-regimen-to-give-concurrently-with-radiation-for-unresectable-stage-3-nsclc weekly 0.8 https://www.themednet.org/would-you-offer-hypofractionation-to-a-patient-in-the-salvage-adjuvant-post-prostatectomy-setting-outside-of-a-clinical-trial weekly 0.8 https://www.themednet.org/how-do-you-treat-the-chest-wall-after-mastectomy-with-an-expander weekly 0.8 https://www.themednet.org/how-do-you-treat-inoperable-t1-2n0-apical-lung-cancers-near-the-brachial-plexus-but-without-extension-outside-the-lung weekly 0.8 https://www.themednet.org/if-a-stage-i-laryngeal-cancer-completely-responds-to-fu-based-chemotherapy-given-for-another-malignancy-would-you-consider-observation weekly 0.8 https://www.themednet.org/do-you-hold-palbociclib-or-another-cdk4-6-inhibitor-in-a-patient-with-metastatic-hr-breast-cancer-while-receiving-palliative-radiation weekly 0.8 https://www.themednet.org/what-techniques-do-you-use-to-address-fertility-preservation-in-young-female-patients-being-treated-with-chemoradiation-therapy-for-anal-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-a-tumor-that-has-been-reported-as-her2-amplified-based-on-ihc-3-but-further-testing-with-fish-is-negative weekly 0.8 https://www.themednet.org/are-prostate-pet-scans-axumin-psma-etc-still-useful-for-patients-on-androgen-suppression-therapy weekly 0.8 https://www.themednet.org/for-patients-with-advanced-gastric-gej-cancer-expressing-pdl1-is-there-data-to-support-frontline-pembrolizumab weekly 0.8 https://www.themednet.org/in-classical-hodgkins-lymphoma-patients-with-a-postive-pet-after-2-cycles-are-you-routinely-transitioning-to-escalated-beacopp weekly 0.8 https://www.themednet.org/do-you-give-systemic-therapy-for-triple-negative-breast-cancer-with-brain-metastasis-and-no-other-sites-of-disease weekly 0.8 https://www.themednet.org/under-what-circumstances-do-you-consider-double-autologous-stem-cell-transplants-for-patients-with-multiple-myeloma weekly 0.8 https://www.themednet.org/based-on-tailorx-what-will-be-your-approach-to-a-pre-menopausal-woman-with-a-recurrence-score-16-25 weekly 0.8 https://www.themednet.org/would-you-try-abemaciclib-in-a-woman-on-fulvestrant-and-palbociclib-with-good-systemic-control-but-progression-in-the-brain weekly 0.8 https://www.themednet.org/what-volume-would-you-treat-after-solitary-axillary-nodal-recurrence-after-previous-lumpectomy-in-a-breast-cancer-patient-without-prior-radiotherapy weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-woman-with-a-brca1-vus-with-a-high-risk-personal-history-of-breast-cancer weekly 0.8 https://www.themednet.org/when-if-ever-would-you-choose-a-two-drug-regimen-with-rd-instead-of-three-drug-regimen-vrd-in-patients-with-mm-not-eligible-for-transplant weekly 0.8 https://www.themednet.org/what-is-the-best-way-to-manage-severe-claustrophobia-and-anxiety-for-thermoplastic-masks weekly 0.8 https://www.themednet.org/would-you-ever-recommend-pmrt-to-the-chest-wall-alone-without-nodal-radiation-for-invasive-or-in-situ-breast-disease weekly 0.8 https://www.themednet.org/for-an-early-stage-estrogen-receptor-positive-breast-cancer-in-an-elderly-patient-would-you-recommend-hormonal-therapy-alone-radiation-alone-or-both weekly 0.8 https://www.themednet.org/which-adjuvant-treatment-s-would-you-recommend-for-an-incompletely-resected-high-grade-osteoblastic-osteosarcoma-of-the-jaw weekly 0.8 https://www.themednet.org/do-you-consider-dermal-invasion-an-indication-for-pmrt-in-the-absence-of-other-risk-factors weekly 0.8 https://www.themednet.org/would-you-send-a-lung-cancer-patient-for-genetic-counseling-germline-mutation-testing-if-they-are-harboring-mutations-in-ngs-with-variation-allele-frequency-between-50 weekly 0.8 https://www.themednet.org/would-you-consider-hypofractionated-weekly-whole-breast-irradiation-for-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-squamous-cell-carcinoma-of-anal-canal-with-ano-vaginal-fistula weekly 0.8 https://www.themednet.org/would-you-extrapolate-data-from-pacific-trial-for-unresectable-disease-to-consider-consolidation-therapy-with-durvalumab-for-stage-iii-nsclc-with-single-station-n2-disease-amenable-to-lobectomy weekly 0.8 https://www.themednet.org/is-mri-necessary-to-distinguish-prostate-from-rectal-spacer-spaceoar-when-planning-for-definitive-prostate-radiation-therapy weekly 0.8 https://www.themednet.org/if-you-are-treating-a-patient-with-palliative-radiation-for-hemoptysis-do-you-require-chemotherapy-to-be-held weekly 0.8 https://www.themednet.org/are-you-using-the-new-figo-2018-staging-or-waiting-until-it-is-incorporated-into-the-next-ajcc-edition weekly 0.8 https://www.themednet.org/do-you-have-a-size-criteria-when-treating-lung-oligometastases-with-sbrt weekly 0.8 https://www.themednet.org/how-do-you-approach-dosing-for-post-op-hnscc-nodal-regions-with-ece weekly 0.8 https://www.themednet.org/how-would-you-treat-an-elderly-patient-with-squamous-cell-carcinoma-of-the-anus-who-is-not-a-chemotherapy-candidate weekly 0.8 https://www.themednet.org/in-a-patient-with-borderline-resectable-pancreatic-adenocarcinoma-who-received-neoadjuvant-folfirinox-followed-by-resection-that-demonstrated-residual-disease-how-do-you-proceed-in-the-adjuvant-setting weekly 0.8 https://www.themednet.org/what-is-the-role-of-adjuvant-radiation-in-r0-node-positive-resected-pancreatic-adenocarcinoma-in-light-of-the-recently-presented-rtog-0848-abstract-1 weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-who-presents-with-a-tracheoesophageal-fistula-from-a-lung-or-esophageal-primary-that-is-non-metastatic weekly 0.8 https://www.themednet.org/when-a-large-malignant-appearing-gi-mass-is-encountered-on-endoscopy-but-biopsies-show-dysplasia-or-carcinoma-in-situ-would-you-recommend-additional-biopsies-or-proceed-with-treatment-for-invasive-cancer weekly 0.8 https://www.themednet.org/what-are-your-recommendations-for-holding-bevacizumab-before-and-after-sbrt-to-the-lung weekly 0.8 https://www.themednet.org/do-you-ever-use-vmat-for-breast-cancer weekly 0.8 https://www.themednet.org/what-dose-do-you-prescribe-when-treating-the-prostate-in-patients-with-low-metastatic-burden-and-what-are-your-dose-constraints weekly 0.8 https://www.themednet.org/what-interventions-besides-lubricants-do-you-advise-to-improve-sexual-satisfaction-for-patients-s-p-chemoxrt-for-cervical-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-chemotherapy-in-early-stage-er-breast-cancer-who-developed-pneumonitis-on-ddac weekly 0.8 https://www.themednet.org/how-does-the-recent-publication-of-rtog-0813-affect-your-management-of-centrally-located-lung-tumors weekly 0.8 https://www.themednet.org/how-do-you-sequence-thoracic-consolidation-rt-and-pci-with-incorporation-of-immunotherapy-in-es-sclc weekly 0.8 https://www.themednet.org/in-which-situations-can-you-spare-the-contralateral-neck-for-oropharyngeal-carcinoma weekly 0.8 https://www.themednet.org/is-there-a-current-standard-of-care-dose-and-fractionation-in-treating-lung-cancer-with-sbrt weekly 0.8 https://www.themednet.org/how-can-i-maximize-my-efficiency-in-the-clinic weekly 0.8 https://www.themednet.org/what-is-your-first-line-strategy-in-managing-acute-esophagitis-during-thoracic-rt weekly 0.8 https://www.themednet.org/is-it-acceptable-to-treat-glioblastoma-with-upfront-srs-instead-of-fractionated-external-beam-rt weekly 0.8 https://www.themednet.org/for-patients-with-high-risk-prostate-cancer-is-there-data-to-support-increased-morbidity-such-as-increased-urethral-strictures-or-cystitis-when-given-postprostatectomy-xrt-as-opposed-to-definitive-xrt weekly 0.8 https://www.themednet.org/do-you-treat-inguinal-lymph-nodes-for-rectal-cancers-involving-the-anal-canal weekly 0.8 https://www.themednet.org/what-is-your-technique-to-calculate-the-vaginal-surface-dose-in-gyn-intracavitary-brachytherapy weekly 0.8 https://www.themednet.org/do-you-treat-pelvic-lymph-node-positive-prostate-cancer-with-definitive-radiotherapy weekly 0.8 https://www.themednet.org/in-early-well-lateralized-scca-of-the-tongue-pt1-2n0-should-the-contralateral-neck-be-radiated weekly 0.8 https://www.themednet.org/in-patients-receiving-pmrt-do-you-perform-a-boost-if-they-have-had-reconstruction-tissue-expanders weekly 0.8 https://www.themednet.org/what-follow-up-imaging-do-you-recommend-after-sbrt-sabr-for-lung-cancer weekly 0.8 https://www.themednet.org/do-you-give-chemotherapy-to-women-with-clinical-features-of-high-risk-breast-cancer-but-a-low-oncotype-dx-score weekly 0.8 https://www.themednet.org/what-is-your-strategy-for-managing-radiation-dermatitis-in-breast-cancer-in-the-prophylactic-erythema-dry-desquamation-and-moist-desquamation-stages weekly 0.8 https://www.themednet.org/is-post-mastectomy-chest-wall-radiotherapy-indicated-for-dcis-with-very-close-1-mm-or-positive-margins weekly 0.8 https://www.themednet.org/is-it-acceptable-to-use-sbrt-for-prostate-bed-rt weekly 0.8 https://www.themednet.org/would-you-hypofractionate-breast-cancer-patients-with-25-cm-separation weekly 0.8 https://www.themednet.org/what-is-the-optimal-safest-regimen-for-re-irradiation-of-a-partial-chest-wall-following-surgical-resection-of-an-isolated-chest-wall-recurrence weekly 0.8 https://www.themednet.org/what-v5-dose-constraint-best-correlates-with-late-lung-toxicity-following-definitive-chemo-radiation-for-lung-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-volumes-and-dosing-when-using-sbrt-for-a-biopsy-proven-nsclc-lung-nodule-with-a-central-solid-component-and-surrounding-ground-glass-opacity-ggo-appearance weekly 0.8 https://www.themednet.org/when-deciding-whether-to-include-an-imn-field-in-a-pmrt-case-what-do-you-consider-a-safe-dose-to-the-heart-that-you-are-willing-to-accept weekly 0.8 https://www.themednet.org/does-the-molecular-subtype-of-breast-cancer-influence-your-decision-to-give-hypofractionated-radiotherapy weekly 0.8 https://www.themednet.org/do-you-treat-inguinal-lymph-nodes-for-patients-with-low-lying-vaginal-cancers weekly 0.8 https://www.themednet.org/in-a-surgically-staged-grade-1-stage-ii-endometrial-adenocarcinoma-with-no-other-high-risk-factors-would-you-treat-with-brachytherapy-alone-or-add-on-the-pelvic-rt weekly 0.8 https://www.themednet.org/what-is-an-acceptable-distance-between-tumor-and-heart-or-aorta-to-treat-a-non-small-cell-lung-cancer-with-sbrt weekly 0.8 https://www.themednet.org/do-you-recommend-altered-fractionation-when-using-cetuximab-with-head-and-neck-rt weekly 0.8 https://www.themednet.org/what-are-reasonable-sbrt-dose-constraints-for-the-lumbosacral-plexus weekly 0.8 https://www.themednet.org/in-what-setting-is-pmrt-indicated-for-t1-2n0-breast-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-neoadjuvant-chemotherapy-or-induction-chemo-chemort-for-borderline-resectable-pancreatic-cancer weekly 0.8 https://www.themednet.org/how-do-you-incorporate-pci-into-your-management-of-patients-with-extensive-stage-sclc weekly 0.8 https://www.themednet.org/when-is-lanreotide-preferred-over-octreotide-in-gi-neuroendocrine-tumors weekly 0.8 https://www.themednet.org/should-ultra-short-course-rt-be-standard-for-elderly-or-poor-performance-status-patients-with-glioblastoma weekly 0.8 https://www.themednet.org/do-you-recommend-carotid-ultrasound-screening-at-some-point-post-definitive-h-n-xrt weekly 0.8 https://www.themednet.org/is-liver-radiotherapy-contraindicated-in-patients-with-child-pugh-c-liver-function weekly 0.8 https://www.themednet.org/how-long-after-resection-for-brain-metastasis-do-you-wait-to-request-a-radiation-planning-mri weekly 0.8 https://www.themednet.org/is-there-a-role-for-docetaxel-for-men-with-high-risk-prostate-cancer-receiving-radiation-and-androgen-deprivation-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-retreatment-of-a-small-central-lung-lesion-after-an-infield-recurrence-within-the-high-dose-region-after-conventionally-fractionated-chemort weekly 0.8 https://www.themednet.org/what-is-the-optimal-treatment-of-medically-inoperable-t3n0-non-small-cell-lung-cancer-that-is-too-large-for-standard-sbrt weekly 0.8 https://www.themednet.org/are-chek2-mutations-a-contraindication-for-breast-conservation-therapy-with-lumpectomy-rt weekly 0.8 https://www.themednet.org/what-are-your-criteria-to-determine-if-there-is-a-local-failure-versus-post-treatment-changes-after-sbrt-for-inoperable-early-stage-nsclc weekly 0.8 https://www.themednet.org/what-is-the-management-of-locally-recurrent-brain-metastases-that-has-undergone-multiple-resections-and-previous-cavity-srs weekly 0.8 https://www.themednet.org/do-you-use-a-tumor-bed-boost-following-whole-breast-irradiation-for-patients-with-dcis weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-an-early-stage-non-small-cell-lung-cancer-limited-to-an-endobronchial-location-non-obstructing-in-a-patient-that-is-not-considered-operable-due-to-medical-comorbidities weekly 0.8 https://www.themednet.org/do-you-omit-adjuvant-radiotherapy-in-t4a-laryngeal-scc-with-favorable-prognostic-factors weekly 0.8 https://www.themednet.org/what-do-you-recommend-for-patients-who-experience-anorexia-due-to-loss-of-appetite weekly 0.8 https://www.themednet.org/what-technique-total-dose-and-fractionation-do-you-use-for-dcis-following-lumpectomy-with-2-mm-negative-margins-which-are-not-re-excised weekly 0.8 https://www.themednet.org/do-you-use-denosumab-for-castration-sensitive-prostate-cancer-with-osseous-metastases weekly 0.8 https://www.themednet.org/how-do-you-manage-anticoagulation-for-patients-with-dvt-pe-who-have-brain-metastases weekly 0.8 https://www.themednet.org/in-patients-receiving-neoadjuvant-crt-for-cn-rectal-cancer-do-you-expand-your-elective-nodal-volumes-to-include-the-external-iliac-chain-or-to-extend-more-superiorly-along-the-common-iliac-chain weekly 0.8 https://www.themednet.org/do-you-preform-elective-nodal-irradiation-in-patients-with-locally-advanced-nsclc-who-are-not-candidates-for-or-refuse-chemotherapy weekly 0.8 https://www.themednet.org/in-what-situations-do-you-treat-the-elective-neck-for-patients-with-resected-esthesioneuroblastomas weekly 0.8 https://www.themednet.org/do-you-counsel-patients-on-the-risk-of-dementia-following-androgen-deprivation-therapy-for-prostate-cancer weekly 0.8 https://www.themednet.org/when-treating-an-intact-whole-breast-with-hypofractionated-radiation-how-do-you-approach-boost-dosing-in-the-case-of-a-close-margin weekly 0.8 https://www.themednet.org/do-you-place-asymptomatic-patients-being-treated-for-brain-metastasis-with-srs-on-prophylactic-steroids weekly 0.8 https://www.themednet.org/would-you-treat-an-inoperable-5-cm-nsclc-tumor-involving-the-hilum-with-sbrt weekly 0.8 https://www.themednet.org/if-an-asymptomatic-patient-requires-a-delay-up-to-a-week-before-starting-chemotherapy-for-stage-iii-lung-cancer-do-you-also-push-back-the-radiation-start-date weekly 0.8 https://www.themednet.org/is-it-ever-appropriate-to-treat-just-the-ipsilateral-oropharynx-and-neck-for-head-and-neck-cancer-of-unknown-primary weekly 0.8 https://www.themednet.org/for-patients-with-rcc-who-respond-to-pd-1-blockade-do-you-ever-discuss-stopping-treatment weekly 0.8 https://www.themednet.org/how-stringent-or-flexible-are-you-with-concurrent-chemotherapy-and-radiation-starting-on-the-same-day-in-the-definitive-crt-setting-for-hn-patients weekly 0.8 https://www.themednet.org/what-is-appropriate-local-salvage-therapy-after-prostate-brachytherapy-failure weekly 0.8 https://www.themednet.org/how-do-you-sequence-chemotherapy-with-radiotherapy-for-advanced-endometrial-cancer weekly 0.8 https://www.themednet.org/when-you-do-recommend-conventional-fractionation-over-moderate-hypofractionation-for-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-ever-withhold-pci-for-elderly-patients-with-limited-stage-sclc weekly 0.8 https://www.themednet.org/would-especially-young-age-eg-20s-influence-your-recommendation-for-breast-conservation-vs-mastectomy-in-an-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/what-situations-do-you-use-imrt-vs-4-field-box-technique-or-visa-versa-for-patients-with-an-intact-cervix-with-no-pelvic-or-para-aortic-nodal-involvement weekly 0.8 https://www.themednet.org/what-are-the-safest-dose-constraints-for-moderately-hypofractionated-prostate-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-therapy-for-patients-with-er-negative-pr-positive-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-left-sided-pmrt-in-patients-with-on-going-cardiac-issues-ie-cardiomyopathy-heart-failure-coronary-heart-disease weekly 0.8 https://www.themednet.org/what-dose-constraint-if-any-do-you-use-for-the-diaphragm-when-treating-liver-or-lung-tumors-with-sbrt weekly 0.8 https://www.themednet.org/outside-of-a-clinical-trial-what-is-your-standard-approach-for-platinum-refractory-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/do-you-boost-involved-mesorectal-nodes-in-node-positive-prostate-cancer weekly 0.8 https://www.themednet.org/in-which-patients-with-stage-1-triple-negative-breast-cancer-would-you-utilize-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/when-is-it-appropriate-to-recommend-sbrt-directed-to-sites-of-oligometastasis-ex-single-adrenal-met-for-a-patient-with-extensive-stage-small-cell-s-p-chemo-and-pci weekly 0.8 https://www.themednet.org/what-is-the-optimal-duration-of-adt-in-high-risk-prostate-cancer-treated-with-rt-adt weekly 0.8 https://www.themednet.org/when-if-ever-would-you-use-fulvestrant-up-front-instead-of-an-aromatase-inhibitor-for-er-or-pr-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/can-pre-op-chemort-be-used-to-potentially-downstage-an-early-stage-rectal-cancer-i-e-t2-n0-for-a-sphincter-sparing-operation weekly 0.8 https://www.themednet.org/does-incidental-seminal-vesicle-invasion-on-rt-planning-mri-for-an-otherwise-ct1-t2-patient-influence-your-recommendation-on-adt-or-pelvic-fields weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-distal-rectal-adenocarcinoma-involving-the-anal-canal-and-a-single-non-bulky-inguinal-nodal-metastasis weekly 0.8 https://www.themednet.org/when-would-you-recommend-adjuvant-radiation-therapy-for-a-patient-with-a-completely-resected-negative-margins-dermatofibrosarcoma-protuberans weekly 0.8 https://www.themednet.org/how-would-you-manage-dysphagia-and-odynophagia-in-an-otherwise-healthy-patient-with-newly-diagnosed-metastatic-esophageal-cancer-with-a-large-primary-in-the-mid-to-distal-esophagus weekly 0.8 https://www.themednet.org/what-fractionation-do-you-use-for-consolidative-chest-rt-in-extensive-stage-sclc weekly 0.8 https://www.themednet.org/how-does-the-finding-of-incidental-proximal-seminal-vesicle-invasion-on-mpmri-alter-your-recommendation-for-brachytherapy-in-a-patient-with-prostate-cancer-who-was-initially-a-candidate weekly 0.8 https://www.themednet.org/does-it-matter-whether-one-uses-msi-pcr-testing-versus-ihc-for-mmr-deficiency-testing-in-order-to-determine-eligibility-for-immunotherapy weekly 0.8 https://www.themednet.org/would-you-treat-rectal-squamous-cell-carcinoma-the-same-as-rectal-adenocarcinoma-stage-for-stage weekly 0.8 https://www.themednet.org/how-do-you-approach-a-solitary-pelvic-nodal-recurrence-following-definitive-radiation-therapy-to-the-prostate-sv weekly 0.8 https://www.themednet.org/do-you-ever-start-immunotherapy-along-with-wbrt-in-patients-with-pdl1-50-metastatic-nsclc-with-significant-visceral-tumor-burden-in-addition-to-symptomatic-brain-mets weekly 0.8 https://www.themednet.org/how-do-you-acutely-manage-a-free-floating-thrombus-in-a-major-artery-in-a-patient-with-a-stroke-as-a-result-of-it weekly 0.8 https://www.themednet.org/how-do-you-approach-axillary-radiation-in-a-patient-with-breast-cancer-who-did-not-have-a-sentinel-node-biopsy weekly 0.8 https://www.themednet.org/when-treating-anal-cancer-with-vmat-or-imrt-do-you-use-bolus weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-treated-with-sbrt-1-year-ago-for-a-peripheral-lung-cancer-who-now-has-both-mediastinal-and-local-failure weekly 0.8 https://www.themednet.org/how-do-you-treat-localized-prostate-cancer-with-neuroendocrine-differentiation weekly 0.8 https://www.themednet.org/for-which-patients-with-resected-nsclc-will-you-offer-adjuvant-atezolizumab-after-completion-of-cisplatin-based-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/do-you-find-elevate-rr-data-and-study-design-compelling-to-start-preferentially-using-acalabrutinib-over-ibrutinib weekly 0.8 https://www.themednet.org/in-patients-with-breast-cancer-do-you-use-bolus-when-boosting-a-chest-wall-scar-or-flap-with-electrons weekly 0.8 https://www.themednet.org/how-do-you-manage-orthostatic-hypotension-in-patients-with-parkinsonian-syndromes weekly 0.8 https://www.themednet.org/in-what-situations-would-you-routinely-offer-25-gy-5-fx-for-glioblastoma weekly 0.8 https://www.themednet.org/when-do-you-offer-a-boost-for-patients-receiving-5-fraction-whole-breast-radiation-as-per-uk-fast-forward weekly 0.8 https://www.themednet.org/would-you-consider-adding-pembrolizumab-to-adjuvant-chemotherapy-in-a-patient-with-stage-3-tnbc-who-did-not-receive-neoadjuvant-treatment weekly 0.8 https://www.themednet.org/how-have-you-been-counseling-patients-with-sickle-cell-regarding-a-3rd-covid-vaccine weekly 0.8 https://www.themednet.org/how-do-you-treat-post-ivig-headache-that-is-not-responsive-to-tylenol-or-nsaids weekly 0.8 https://www.themednet.org/how-do-you-use-higher-photon-energies-in-your-treatment-of-breast-cancer-with-tangent-fields weekly 0.8 https://www.themednet.org/for-which-stroke-patients-if-any-do-you-recommend-implantable-loop-recorder-for-long-term-cardiac-monitoring-and-why weekly 0.8 https://www.themednet.org/what-factors-do-you-take-into-account-for-recommending-chemo-io-vs-io-io-vs-checkmate-9la-regimen-in-front-line-therapy-for-pd-l1-negative-advanced-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/what-plan-parameters-do-you-prioritize-in-3d-conformal-breast-treatment-planning weekly 0.8 https://www.themednet.org/would-you-offer-salvage-radiation-in-a-patient-s-p-radical-prostatectomy-with-imaging-showing-local-recurrence-as-well-as-oligometastatic-disease-in-the-pelvis weekly 0.8 https://www.themednet.org/how-do-you-address-and-mitigate-neutropenia-in-patients-with-tnbc-receiving-sacituzumab-govitecan-in-3rd-line-or-beyond weekly 0.8 https://www.themednet.org/how-would-use-of-adjuvant-pembrolizumab-after-nephrectomy-for-ccrcc-impact-your-treatment-choice-for-metastatic-recurrence weekly 0.8 https://www.themednet.org/do-you-recommend-a-workup-for-poems-and-or-amyloidosis-for-igm-monoclonal-gammopathies-associated-with-neuropathy weekly 0.8 https://www.themednet.org/in-which-scenarios-would-you-utilize-sacituzumab-govitecan-earlier-than-third-line-in-the-treatment-of-metastatic-tnbc weekly 0.8 https://www.themednet.org/how-to-you-sequence-hdr-brachytherapy-for-definitive-prostate-cancer-treatment weekly 0.8 https://www.themednet.org/do-you-recommend-adt-for-all-patients-who-are-unfavorable-intermediate-risk-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-view-the-use-of-adjuvant-cdk4-6-inhibitors-overall-given-discordant-results-between-monarche-and-pallas weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-patients-on-lamotrigine-who-develop-a-minor-rash weekly 0.8 https://www.themednet.org/will-you-offer-adjuvant-abemaciclib-to-breast-cancer-patients-with-high-ki-67-who-are-unable-to-receive-either-neoadjuvant-or-adjuvant-chemotherapy-due-to-comorbidities-or-who-decline-chemotherapy weekly 0.8 https://www.themednet.org/how-and-on-which-specimens-will-you-perform-ki-67-testing-in-newly-diagnosed-breast-cancer weekly 0.8 https://www.themednet.org/if-you-have-a-high-risk-hr-brca-breast-cancer-patient-who-qualifies-for-adjuvant-olaparib-and-abemaciclib-which-one-would-you-give-and-why weekly 0.8 https://www.themednet.org/when-do-you-recommend-neuropsychiatric-testing-in-patients-with-post-concussive-syndrome weekly 0.8 https://www.themednet.org/do-you-use-the-re-radiation-schedule-39gy-in-26-fx-bid-for-a-rectal-patient-who-initially-received-25-gy-in-5-fractions-and-then-has-pelvic-recurrence weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-gleason-8-or-9-prostate-cancer-pretreatment-psa-15-24-with-retroperitoneal-adenopathy weekly 0.8 https://www.themednet.org/do-you-apply-an-ipsilateral-lung-constraint-for-conventionally-fractionated-lung-rt weekly 0.8 https://www.themednet.org/how-do-you-manage-asymptomatic-radiation-necrosis-in-a-glioblastoma weekly 0.8 https://www.themednet.org/what-are-best-practices-for-engaging-with-multidisciplinary-colleagues-to-ensure-patients-with-earlier-stage-nsclc-are-being-appropriately-considered-for-novel-adjuvant-therapies weekly 0.8 https://www.themednet.org/do-you-recommend-emg-ncs-in-all-patients-with-clinical-findings-of-carpal-tunnel-syndrome weekly 0.8 https://www.themednet.org/when-do-you-use-plasmapheresis-after-ivig-in-patients-with-guillain-barre-syndrome weekly 0.8 https://www.themednet.org/what-do-you-view-as-reasonable-alternatives-to-cyclophosphamide-in-the-treatment-of-neuropsychiatric-lupus weekly 0.8 https://www.themednet.org/how-would-you-approach-protein-s-deficiency-found-on-hypercoagulability-work-up-in-a-patient-with-a-post-operative-central-retinal-vein-occlusion weekly 0.8 https://www.themednet.org/what-are-the-best-options-for-resistant-cases-of-et weekly 0.8 https://www.themednet.org/for-consideration-of-empiric-lung-sbrt-without-pathology-do-you-use-a-preferred-nomogram-to-guide-this-decision weekly 0.8 https://www.themednet.org/would-you-offer-brachytherapy-for-a-patient-with-metastatic-cervical-cancer-s-p-30gy-10-fx-to-the-pelvis-followed-by-chemotherapy-who-only-has-isolated-disease-in-the-cervix weekly 0.8 https://www.themednet.org/should-all-pediatric-cns-cases-be-referred-to-a-proton-center weekly 0.8 https://www.themednet.org/can-tamoxifen-be-safely-prescribed-for-breast-cancer-patients-with-cirrhosis weekly 0.8 https://www.themednet.org/how-do-you-approach-the-decision-to-boost-patients-diagnosed-with-dcis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-unresectable-node-negative-perihilar-cholangiocarcinoma-who-have-undergone-biliary-stenting-and-have-no-evidence-of-distant-disease weekly 0.8 https://www.themednet.org/what-is-the-role-of-x-ray-of-the-cervical-or-lumbar-spine-in-patients-presenting-with-radicular-symptoms weekly 0.8 https://www.themednet.org/what-adjuvant-systemic-therapy-would-you-recommend-for-a-woman-s-p-alnd-for-a-nodal-recurrence-of-er-her2-breast-cancer-1-year-after-completing-adjuvant-therapy-with-paclitaxel-trastuzumab-for-her-initial-disease weekly 0.8 https://www.themednet.org/what-is-the-most-effective-treatment-for-a-patient-with-persistent-post-stroke-headache weekly 0.8 https://www.themednet.org/is-active-rheumatoid-arthritis-ra-a-contraindication-to-hypofractionated-breast-irradiation weekly 0.8 https://www.themednet.org/what-are-the-best-treatment-options-for-persistent-post-traumatic-headaches-when-first-line-agents-like-tcas-have-failed weekly 0.8 https://www.themednet.org/what-adjuvant-chemotherapy-regimen-do-you-recommend-for-a-patient-with-t1cn0-tnbc weekly 0.8 https://www.themednet.org/would-you-offer-pmrt-to-an-er-pr-her-2-negative-ct3-tumor-treated-with-neoadjuvant-chemotherapy-but-with-a-minimal-treatment-response weekly 0.8 https://www.themednet.org/would-you-recommend-pmrt-for-stage-iia-pt1c-pn1a-er-her2-grade-2-idc-in-an-elderly-patient-with-a-single-positive-non-sentinel-lymph-node weekly 0.8 https://www.themednet.org/when-would-you-consider-rituximab-as-induction-therapy-in-igg4-related-disease weekly 0.8 https://www.themednet.org/in-what-situation-would-you-recommend-relatlimab-nivolumab-over-ipilimumab-nivolumab-in-the-treatment-of-metastatic-melanoma weekly 0.8 https://www.themednet.org/do-you-routinely-use-mannitol-to-prevent-cisplatin-induced-nephrotoxicity weekly 0.8 https://www.themednet.org/what-role-do-you-see-for-jak-inhibitors-in-ra-treatment-strategies-given-the-data-we-now-have-regarding-cv-and-cancer-outcomes weekly 0.8 https://www.themednet.org/would-you-give-chemotherapy-to-a-post-menopausal-woman-with-er-pr-positive-her2-negative-breast-cancer-t2n1-with-3-lymph-nodes-ki-67-30-and-oncotype-rs-of-10 weekly 0.8 https://www.themednet.org/what-are-your-recommendations-for-a-male-patient-who-was-recently-started-on-imatinib-and-wants-to-conceive weekly 0.8 https://www.themednet.org/what-is-the-soonest-you-can-start-adjuvant-whole-breast-radiation-after-surgery weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-borderline-resectable-pancreatic-cancer-with-ct-showing-no-change-in-tumor-size-after-4-cycles-of-neoadjuvant-folfirinox weekly 0.8 https://www.themednet.org/how-would-you-interpret-a-positive-dsdna-in-a-patient-with-a-negative-ana-performed-via-indirect-immunofluorescence weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-metastatic-nsclc-whose-initial-mutation-testing-was-limited-or-results-are-no-longer-available weekly 0.8 https://www.themednet.org/would-you-recommend-olaparib-for-a-patient-with-germline-brca1-mutation-and-her2-metastatic-breast-cancer-who-has-progressed-through-multiple-lines-of-her2-directed-therapy-including-trastuzumab-deruxtecan weekly 0.8 https://www.themednet.org/is-it-necessary-to-treat-the-entire-larynx-with-intermediate-or-elective-dose-in-a-t1-t2-squamous-cell-carcinoma-of-the-supraglottic-or-subglottic-larynx weekly 0.8 https://www.themednet.org/how-does-the-latency-from-the-original-melanoma-diagnosis-affect-your-approach-to-neoadjuvant-therapy-in-a-patient-with-clinically-detectable-stage-iii-nodal-recurrence weekly 0.8 https://www.themednet.org/do-you-have-safety-concerns-when-prescribing-glp-1-medications-in-patients-on-corticosteroids-or-immunosuppressive-therapy weekly 0.8 https://www.themednet.org/what-is-your-stepwise-approach-to-managing-no-re-flow-during-pci weekly 0.8 https://www.themednet.org/how-do-you-approach-the-discussion-about-the-potential-risks-of-radiation-therapy-exposure-and-the-development-of-secondary-malignancies-for-patients-with-germline-brca1-2-mutations weekly 0.8 https://www.themednet.org/do-you-adjust-the-hemodialysis-bicarbonate-bath-to-match-the-elevated-serum-bicarbonate-level-in-eskd-patients-with-hypercarbia-due-to-copd weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-gca-on-the-benefits-of-steroids-who-have-already-experienced-vision-loss weekly 0.8 https://www.themednet.org/how-do-you-talk-with-your-patients-regarding-radiographic-expectations-on-surveillance-ct-after-lung-sbrt weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-or-not-to-excise-a-pterygium-prior-to-cataract-surgery weekly 0.8 https://www.themednet.org/do-you-favor-a-certain-nrti-to-pair-with-dolutegravir-and-lamivudine-in-persons-with-hiv-to-minimize-the-risk-of-resistance-to-dolutegravir weekly 0.8 https://www.themednet.org/in-patients-with-glaucoma-who-are-not-ideal-candidates-for-goniotomy-angle-stenting-tubes-or-trabeculectomy-does-the-use-of-alloflo-provide-safe-and-predictable-iop-control-compared-to-other-surgical-options weekly 0.8 https://www.themednet.org/for-patients-with-xanthelasma-aside-from-a-lipid-panel-do-you-perform-any-additional-lab-workup-or-send-referrals weekly 0.8 https://www.themednet.org/what-are-your-preferred-second-line-medications-for-trigeminal-neuralgia weekly 0.8 https://www.themednet.org/would-you-include-the-supraclavicular-basin-in-adjuvant-radiation-treatment-fields-if-there-were-multiple-positive-axillary-sentinel-lymph-nodes-with-ece-discovered-at-the-time-of-resection-of-a-proximal-arm-cutaneous-scc weekly 0.8 https://www.themednet.org/are-there-instances-in-which-you-would-combine-belimumab-and-rituximab-for-management-of-difficult-to-control-sle weekly 0.8 https://www.themednet.org/how-many-days-prior-to-elective-major-surgery-do-you-recommend-holding-oral-glp-1-r-agonist-therapy weekly 0.8 https://www.themednet.org/what-maintenance-regimen-do-you-use-for-a-patient-with-lupus-cerebritis weekly 0.8 https://www.themednet.org/who-are-good-candidates-for-light-adjustable-lenses weekly 0.8 https://www.themednet.org/do-ttfields-work-synergistically-with-srs-for-patients-with-brain-metastases weekly 0.8 https://www.themednet.org/how-does-lal-compare-with-other-edof-lenses weekly 0.8 https://www.themednet.org/how-do-you-evaluate-and-manage-acute-alcohol-withdrawal-when-symptom-driven-protocols-are-confounded-unreliable weekly 0.8 https://www.themednet.org/what-is-your-preferred-intervention-for-diffuse-severe-isr-involving-two-layers-of-stent weekly 0.8 https://www.themednet.org/do-you-recommend-a-prolonged-duration-of-antibiotics-and-or-suppression-for-patients-without-pre-existing-hardware-who-have-placement-of-new-hardware-after-decompression-washout-of-staph-aureus-epidural-abscess weekly 0.8 https://www.themednet.org/what-is-your-radiation-approach-details-for-regionally-involved-prostate-cancer-n1 weekly 0.8 https://www.themednet.org/how-effective-have-you-found-acupuncture-for-treatment-of-chronic-migraine weekly 0.8 https://www.themednet.org/do-you-recommend-iv-sodium-bicarbonate-for-patients-with-rhabdomyolysis-and-aki-without-metabolic-alkalosis-or-hypocalcemia weekly 0.8 https://www.themednet.org/for-which-sle-manifestations-or-disease-activity-markers-do-you-generally-recommend-escalation-to-a-biologic-in-a-patient-who-does-not-have-apparent-renal-involvement weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-patient-with-sle-who-has-labs-suggesting-active-non-renal-disease-on-the-benefits-of-escalation-of-treatment-if-they-arent-experiencing-noticeable-symptoms weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-risks-and-benefits-of-antidepressant-use-during-pregnancy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-are-interested-in-using-kratom-for-chronic-pain-management weekly 0.8 https://www.themednet.org/how-do-you-balance-the-risks-and-benefits-of-stimulant-treatment-in-patients-with-poorly-controlled-hypertension weekly 0.8 https://www.themednet.org/when-would-you-consider-prescribing-a-wakefulness-promoting-agent-for-excessive-daytime-sleepiness-from-insufficient-sleep weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-families-whose-goals-of-care-are-clearly-aligned-with-a-comfort-focused-end-of-life-approach-but-who-are-hesitant-to-formally-enroll-in-hospice weekly 0.8 https://www.themednet.org/do-you-consider-holding-ppis-in-patients-hospitalized-with-infections-like-pneumonia-or-c-diff-colitis weekly 0.8 https://www.themednet.org/in-patients-with-f2-f3-fibrosis-would-you-start-resmetirom-if-they-had-normal-liver-enzymes weekly 0.8 https://www.themednet.org/if-an-ibd-patient-has-only-partial-clinical-response-to-a-new-biologic-and-or-small-molecule-do-you-extend-the-loading-phase-before-transitioning-to-the-maintenance-dose-interval-how-do-you-navigate-insurance-coverage weekly 0.8 https://www.themednet.org/when-would-you-obtain-optic-nerve-testing-in-patients-suspected-to-have-multiple-sclerosis-without-a-clinical-history-of-optic-neuritis weekly 0.8 https://www.themednet.org/what-is-a-reasonable-protocol-for-how-long-to-hold-warfarin-and-or-doacs-before-cardiac-catheterization weekly 0.8 https://www.themednet.org/how-do-you-interpret-isolated-psma-avid-sites-in-a-patient-with-prostate-cancer-with-no-pelvic-or-rp-ln-uptake weekly 0.8 https://www.themednet.org/in-patients-with-newly-diagnosed-her2-early-breast-cancer-what-do-you-anticipate-will-become-the-standard-sequencing-for-t-dxd-neoadjuvant-db11-or-adjuvant-db05-treatment weekly 0.8 https://www.themednet.org/what-pharmacologic-and-non-pharmacologic-strategies-have-you-found-helpful-in-managing-brain-fog-following-covid-19-infection weekly 0.8 https://www.themednet.org/how-long-would-you-continue-atezolizumab-bevacizumab-in-a-patient-with-hcc-who-is-having-a-prolonged-response-with-stable-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-who-are-inappropriately-worried-fixated-on-a-test-result-that-is-flagged-as-abnormal-but-not-clinically-significant weekly 0.8 https://www.themednet.org/if-adjuvant-radiation-is-indicated-for-a-merkel-cell-carcinoma-of-the-upper-extremity-and-hypofractionation-is-desired-what-dosing-regimens-are-recommended weekly 0.8 https://www.themednet.org/what-rt-dose-fractionation-would-you-use-to-treat-an-unresectable-grade-3-solitary-fibrous-tumor-abutting-the-optic-nerve-and-chiasm weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-normal-tension-glaucoma-and-how-do-you-discuss-this-with-patients weekly 0.8 https://www.themednet.org/does-the-recent-publication-of-epcore-fl-1-epcoritamab-r2-change-your-preferred-2l-soc-for-r-r-fl weekly 0.8 https://www.themednet.org/what-do-you-view-as-the-optimal-use-and-timing-of-cemiplimab-in-high-risk-cscc weekly 0.8 https://www.themednet.org/would-you-recommend-adjusting-the-hemodialysis-schedule-for-a-tts-dialysis-patient-who-is-scheduled-for-surgery-on-a-monday weekly 0.8 https://www.themednet.org/would-you-consider-using-transdermal-estrogen-in-a-patient-with-high-risk-apls-patient-on-warfarin weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-lymphoma-from-ash-2025 weekly 0.8 https://www.themednet.org/how-would-you-manage-the-side-effects-toxicities-e-g-pain-swelling-erythema-of-adjuvant-ebrt-to-the-ear-for-cutaneous-scc weekly 0.8 https://www.themednet.org/how-do-you-handle-requests-for-medication-refills-from-patients-who-were-formally-terminated-from-care-but-report-difficulty-accessing-a-new-psychiatrist weekly 0.8 https://www.themednet.org/how-do-you-approach-laboratory-evaluation-in-patients-with-fatigue weekly 0.8 https://www.themednet.org/are-there-patients-for-whom-cross-followed-by-surgery-and-adjuvant-nivolumab-should-still-be-considered-following-data-from-matterhorn-and-esopec weekly 0.8 https://www.themednet.org/do-you-favor-ticagrelor-or-prasugrel-first-line-for-the-treatment-of-acs-with-planned-pci-provided-no-contraindications-to-either-agent weekly 0.8 https://www.themednet.org/in-children-with-unknown-family-cardiac-history-do-you-require-a-routine-ekg-prior-to-starting-a-stimulant weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-want-to-understand-why-sublingual-cyclobenzaprine-works-to-relieve-their-fibromyalgia-pain-and-other-related-symptoms weekly 0.8 https://www.themednet.org/in-elderly-patients-with-advanced-melanoma-and-idiopathic-pulmonary-fibrosis-receiving-active-antifibrotic-therapy-would-neoadjuvant-or-adjuvant-immune-checkpoint-inhibition-be-preferred weekly 0.8 https://www.themednet.org/how-do-you-use-ivc-caliber-and-collapsibility-to-guide-decisions-about-diuresis weekly 0.8 https://www.themednet.org/have-you-found-that-migraine-prevention-treatments-help-non-specific-vestibular-symptoms-in-migraine-patients weekly 0.8 https://www.themednet.org/is-destiny-breast-09-data-sufficient-for-t-dxd-p-to-replace-thp-as-the-first-line-standard-of-care-for-her2-positive-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-clinical-approach-to-deprescribing-vs-continuing-low-dose-aspirin-used-for-primary-prevention-in-older-adults-who-are-already-taking-this-medication weekly 0.8 https://www.themednet.org/how-do-you-address-a-patient-who-may-be-getting-adderall-from-another-nonprescribed-source-while-youre-treating-them-with-adderall-for-adhd weekly 0.8 https://www.themednet.org/when-do-you-refer-patients-with-difficult-to-treat-depression-for-consideration-of-tms-or-esketamine weekly 0.8 https://www.themednet.org/have-you-utilized-denosumab-in-treatment-of-erosive-hand-osteoarthritis weekly 0.8 https://www.themednet.org/in-a-patient-who-has-been-receiving-1l-ibrutinib-for-tp53-cll-for-years-with-complete-hematologic-response-but-detectable-mrd-is-there-any-role-to-switch-to-the-novel-btki-agents-given-better-pfs weekly 0.8 https://www.themednet.org/what-is-your-approach-to-intralesional-steroid-injection-for-chalazia-in-terms-of-dosage-approach-timing weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-agent-for-type-1-von-willebrand-patients-needing-minor-procedures-if-they-have-a-history-of-severe-hyponatremia-with-ddavp weekly 0.8 https://www.themednet.org/when-do-you-order-brain-imaging-in-young-adults-presenting-with-first-episode-psychosis-in-the-absence-of-clear-neurologic-red-flags weekly 0.8 https://www.themednet.org/what-is-your-approach-for-managing-patients-with-recurrent-nephrolithiasis-who-have-elevated-urinary-cystine-levels-but-calcium-oxalate-stone-composition weekly 0.8 https://www.themednet.org/how-often-are-you-repeating-screening-pfts-in-patients-with-sards-who-have-3-or-more-years-of-normal-or-stable-pfts weekly 0.8 https://www.themednet.org/in-patients-with-end-stage-glaucoma-requiring-surgery-cataract-or-incisional-glaucoma-surgery-how-do-you-approach-discussion-of-possible-snuff-and-how-does-this-factor-in-your-decision-to-proceed-with-surgery weekly 0.8 https://www.themednet.org/what-is-your-radiotherapy-plan-for-stage-iva-ct4-cervical-scc-with-the-tumor-completely-obliterating-the-bladder-trigone weekly 0.8 https://www.themednet.org/how-do-you-counsel-b-cell-depleted-multiple-sclerosis-patients-on-the-benefits-of-regular-covid-19-vaccinations weekly 0.8 https://www.themednet.org/how-do-you-approach-consults-regarding-clearance-of-patients-with-chronic-kidney-disease-for-surgery weekly 0.8 https://www.themednet.org/how-do-you-counsel-newly-diagnosed-patients-with-als-on-dietary-recommendations weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-immunotherapy-in-an-elderly-patient-with-stage-iib-desmoplastic-melanoma-post-resection-with-underlying-autoimmune-disease weekly 0.8 https://www.themednet.org/how-would-you-manage-a-cvst-secondary-to-a-traumatic-brain-injury-with-the-presence-of-intracranial-hemorrhage weekly 0.8 https://www.themednet.org/in-what-situations-would-a-standard-fdg-pet-ct-be-useful-in-the-evaluation-of-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/if-using-26-fraction-moderate-hypofractionation-what-dose-do-you-use-for-the-intraprostatic-dominant-nodule-sib weekly 0.8 https://www.themednet.org/is-narrow-band-ultraviolet-b-nbuvb-phototherapy-contraindicated-or-recommended-with-caution-in-patients-with-a-personal-history-of-melanoma weekly 0.8 https://www.themednet.org/how-would-you-determine-the-safety-of-anticoagulation-in-patients-with-evidence-of-cerebral-microhemorrhages-who-present-with-acute-stroke-secondary-to-cardioembolism weekly 0.8 https://www.themednet.org/do-you-prefer-celecoxib-over-a-nonselective-nsaid-in-patients-with-chronic-kidney-disease weekly 0.8 https://www.themednet.org/do-you-utilize-ait-for-atopic-dermatitis-if-there-is-no-ar-present weekly 0.8 https://www.themednet.org/do-you-offer-prostate-rt-to-men-with-0-3-bone-metastases-on-conventional-imaging-when-psma-pet-shows-a-very-high-number-of-m1-lesions weekly 0.8 https://www.themednet.org/is-there-any-expanded-diagnostic-workup-that-you-pursue-for-a-young-female-patient-with-gout weekly 0.8 https://www.themednet.org/are-recurrent-utis-a-contraindication-to-sglt2i-use weekly 0.8 https://www.themednet.org/how-do-cll-patients-with-downstream-treatment-resistant-mutations-such-as-plcg2-respond-to-pirtobrutinib weekly 0.8 https://www.themednet.org/how-do-you-manage-nicotine-withdrawal-and-smoking-cessation-in-teens weekly 0.8 https://www.themednet.org/how-will-you-use-xanomeline-trospium-karxt-cobenfy-for-patients-with-schizophrenia weekly 0.8 https://www.themednet.org/is-adenocarcinoma-of-the-vulva-more-radioresistant-than-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/would-you-stop-denosumab-in-a-patient-with-chronic-kidney-disease-if-they-develop-asymptomatic-hypocalcemia-after-the-injection-2 weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiotherapy-to-a-recurrent-hpv-independent-vulvar-cancer-located-close-to-the-anus-which-was-resected-with-very-close-0-8-mm-margins weekly 0.8 https://www.themednet.org/how-do-you-determine-whether-to-add-abatacept-or-rituximab-to-the-treatment-regimen-in-patients-with-mild-ra-ild-on-methotrexate weekly 0.8 https://www.themednet.org/do-you-transcutaneously-pace-or-cardiovert-patients-with-dnr-status-who-have-not-lost-pulses weekly 0.8 https://www.themednet.org/which-biomarkers-or-diagnostic-tools-do-you-prioritize-to-support-the-decision-to-start-antifungal-treatment-in-septic-patients-with-no-clear-source-of-infection-but-at-high-risk-for-fungal-infections weekly 0.8 https://www.themednet.org/do-you-use-combination-therapy-for-persistent-mssa-bacteremia weekly 0.8 https://www.themednet.org/how-long-would-you-treat-an-upper-urinary-tract-infection-in-a-patient-with-acute-obstructive-pyelonephritis-due-to-a-kidney-stone-status-post-urinary-stenting-without-yet-removal-of-the-stone weekly 0.8 https://www.themednet.org/how-would-you-approach-an-in-field-recurrence-after-lung-sbrt-for-a-t1-nsclc-in-a-patient-with-poor-underlying-lung-function weekly 0.8 https://www.themednet.org/when-do-you-consider-starting-short-term-dapt-in-patients-who-present-more-than-24-hours-after-the-onset-of-a-high-risk-tia-or-minor-stroke-syndrome weekly 0.8 https://www.themednet.org/are-there-instances-when-you-recommend-initiation-of-dialysis-in-patients-with-advanced-chronic-kidney-disease-who-are-scheduled-for-a-major-surgery-but-do-not-currently-have-any-indications-for-renal-replacement-therapy weekly 0.8 https://www.themednet.org/would-you-consider-adding-an-sglt2i-for-a-patient-with-proteinuric-kidney-disease-who-is-already-on-maximal-dose-acei-arb-and-has-a-uacr-300-mg-g weekly 0.8 https://www.themednet.org/how-soon-after-an-elective-uncomplicated-coronary-intervention-would-you-feel-comfortable-having-a-patient-travel-by-air weekly 0.8 https://www.themednet.org/do-you-prefer-allopurinol-or-febuxostat-for-patients-with-chronic-kidney-disease-who-are-receiving-treatment-for-asymptomatic-hyperuricemia weekly 0.8 https://www.themednet.org/how-do-you-approach-a-young-patient-with-metastatic-poorly-differentiated-thyroid-cancer-with-rhabdoid-non-anaplastic-features weekly 0.8 https://www.themednet.org/how-would-you-manage-a-recurrent-cervical-cancer-previously-treated-with-vaginal-cuff-brachytherapy-and-has-had-a-complete-response-to-chemo-immunotherapy weekly 0.8 https://www.themednet.org/how-do-you-treat-stage-iiic-t4n3-nsclc weekly 0.8 https://www.themednet.org/do-you-find-the-updrs-useful-for-the-care-of-parkinsons-disease-patients-outside-of-research weekly 0.8 https://www.themednet.org/how-would-you-manage-a-cervical-cancer-patient-with-bulky-pa-lns-with-direct-extension-and-or-invasion-into-the-lumbar-vertebral-bodies weekly 0.8 https://www.themednet.org/how-do-you-sequence-targeted-therapy-and-immunotherapy-in-patients-with-metastatic-lung-adenocarcinoma-with-egfr-exon-20-insertion-mutations weekly 0.8 https://www.themednet.org/how-do-you-treat-extrapyramidal-symptoms-secondary-to-anti-psychotic-use-in-patients-who-have-not-benefited-from-cogentin-or-benadryl weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-cied-in-a-patient-with-community-acquired-staph-aureus-bacteremia-who-clears-blood-cultures-quickly-with-negative-follow-up-blood-cultures-within-72-hours-of-antimicrobial-therapy-and-negative-tee weekly 0.8 https://www.themednet.org/do-you-have-concerns-about-the-generalizability-of-mammaprint-oncotype-testing-in-making-chemotherapy-decisions-for-non-caucasian-women weekly 0.8 https://www.themednet.org/for-svg-graft-stenting-do-you-consider-routinely-embolic-protection-devices-epd-and-do-you-factor-lesion-location-prox-vs-distal-for-decision-making weekly 0.8 https://www.themednet.org/what-is-a-reasonable-inpatient-imaging-modality-alternative-to-evaluate-for-infective-endocarditis-in-a-morbidly-obese-patient-with-poor-acoustic-windows-on-tte-and-persistent-bacteremia-if-tee-is-not-feasible-or-contraindicated weekly 0.8 https://www.themednet.org/would-you-initiate-antifibrotic-therapy-in-a-patient-with-ctd-ild-experiencing-worsening-symptoms-and-declining-lung-function-despite-no-clear-evidence-of-fibrosis-on-ct-scans weekly 0.8 https://www.themednet.org/what-is-your-approach-to-radiographically-suspicious-lung-nodules-for-which-initial-biopsy-was-negative-for-malignancy weekly 0.8 https://www.themednet.org/do-you-use-any-thyroid-dose-constraints-for-head-neck-radiation-planning weekly 0.8 https://www.themednet.org/what-is-your-preferred-oral-regime-with-duration-for-treatment-of-onychomycosis weekly 0.8 https://www.themednet.org/what-radiation-treatments-would-you-offer-an-older-man-with-unfavorable-intermediate-risk-prostate-cancer-with-comorbid-conditions-if-you-dont-feel-he-is-a-good-candidate-for-full-course-radiation-therapy-with-adt weekly 0.8 https://www.themednet.org/can-patients-receive-adjuvant-radiation-therapy-after-keloid-excision-without-primary-closure-or-would-radiation-impede-healing-by-secondary-intention weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-patients-who-initially-present-with-symptomatic-intracranial-large-vessel-occlusion-but-subsequently-experience-resolution-of-symptoms-or-become-non-disabling-before-any-intervention weekly 0.8 https://www.themednet.org/what-is-your-recommended-long-term-management-of-extensive-dural-venous-sinus-thrombosis-in-an-otherwise-healthy-young-patient weekly 0.8 https://www.themednet.org/would-you-consider-re-irradiation-for-a-prostate-local-failure-for-a-patient-who-initially-received-standard-fractionation-with-a-focal-sib-to-95-gy-or-a-sbrt-boost-with-cyberknife-after-ebrt weekly 0.8 https://www.themednet.org/how-do-you-approach-elective-nodal-irradiation-in-muscle-invasive-bladder-cancer weekly 0.8 https://www.themednet.org/what-is-the-minimum-level-of-cognitive-symptoms-that-would-prompt-you-to-pursue-biomarker-testing-required-for-anti-amyloid-therapies-for-alzheimers weekly 0.8 https://www.themednet.org/what-would-prompt-discontinuing-treatment-versus-switching-or-sequencing-treatment-in-patients-treated-with-an-anti-amyloid-therapy-for-alzheimers weekly 0.8 https://www.themednet.org/for-patients-with-metabolic-syndrome-is-it-reasonable-to-wait-for-the-effect-of-tirzepatide-therapy-on-their-lipid-profile-prior-to-starting-statin-therapy weekly 0.8 https://www.themednet.org/how-do-you-differentiate-between-functional-neurologic-disorder-from-other-underlying-movement-disorders weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-latent-tb-for-patients-who-cannot-tolerate-rifamycins-or-isoniazid-due-to-allergy-intolerance-or-drug-drug-interactions weekly 0.8 https://www.themednet.org/how-would-you-approach-radiation-for-an-elderly-patient-with-pt2n1-tnbc-s-p-mrm-and-alnd-who-refused-chemo-immunotherapy weekly 0.8 https://www.themednet.org/how-would-you-manage-an-aortocaval-nodal-recurrence-of-prostate-cancer-in-a-patient-who-previously-received-salvage-radiation-to-the-fossa-and-pelvic-nodes weekly 0.8 https://www.themednet.org/how-does-one-approach-maintenance-treatment-in-transplant-ineligible-patients-with-newly-diagnosed-multiple-myeloma weekly 0.8 https://www.themednet.org/what-agent-and-for-how-long-would-you-treat-a-patient-with-asymptomatic-azole-resistant-c-auris-candiduria-who-is-planning-to-undergo-a-urological-procedure weekly 0.8 https://www.themednet.org/does-persistent-focal-slowing-without-epileptiform-discharges-indicate-increased-seizure-risk-in-patients-without-significant-structural-abnormalities weekly 0.8 https://www.themednet.org/do-you-still-consider-changing-atypical-antipsychotics-that-are-working-well-in-children-undergoing-puberty-if-the-prolactin-levels-are-high-but-there-are-no-symptoms-of-drug-induced-hyperprolactinemia weekly 0.8 https://www.themednet.org/would-you-start-an-sglt2-inhibitor-in-patients-with-diabetic-kidney-disease-who-also-have-a-history-of-prior-toe-amputation weekly 0.8 https://www.themednet.org/how-do-you-decide-between-oral-vs-nasal-route-of-entry-for-bronchoscopy-with-bal-with-moderate-sedation weekly 0.8 https://www.themednet.org/what-considerations-do-you-take-in-starting-stimulant-medications-for-the-management-of-adult-adhd weekly 0.8 https://www.themednet.org/how-do-you-decide-on-the-timing-and-number-of-blood-cultures-for-suspected-endocarditis-given-the-differences-in-recommendations-between-the-esc-guidelines-and-the-duke-criteria weekly 0.8 https://www.themednet.org/how-would-you-plan-sequencing-of-an-mri-directed-prostate-nodule-micro-boost-when-doing-a-sequential-plan weekly 0.8 https://www.themednet.org/what-varying-approaches-do-you-take-in-suicide-risk-assessments weekly 0.8 https://www.themednet.org/do-you-ever-favor-cefazolin-over-ceftriaxone-for-bacteremia-with-susceptible-e-coli weekly 0.8 https://www.themednet.org/do-you-recommend-self-breast-exams-to-your-patients-with-history-of-breast-cancer-in-addition-to-imaging-surveillance weekly 0.8 https://www.themednet.org/in-your-practice-or-during-fellowship-training-do-you-perform-curettage-of-cutaneous-carcinomas-to-define-subclinical-borders-prior-to-mohs weekly 0.8 https://www.themednet.org/how-would-you-approach-antithrombotic-therapy-in-patients-with-acute-ischemic-infarcts-and-a-non-occlusive-intracranial-thrombus weekly 0.8 https://www.themednet.org/would-you-start-potassium-citrate-for-a-patient-with-recurrent-calcium-oxalate-nephrolithiasis-who-has-normal-urinary-citrate-levels-but-persistent-acidic-urine weekly 0.8 https://www.themednet.org/when-do-you-consider-prescribing-memantine-for-migraine-treatment weekly 0.8 https://www.themednet.org/which-cognitive-screening-tools-do-you-use-when-evaluating-older-adults-with-suspected-dementia weekly 0.8 https://www.themednet.org/how-do-you-determine-the-timeline-for-healing-after-craniotomy-prior-to-starting-chemotherapy-and-radiation weekly 0.8 https://www.themednet.org/do-you-prefer-to-add-an-additional-phosphate-binder-or-increase-the-dose-of-an-existing-binder-in-patients-with-eskd-and-hyperphosphatemia weekly 0.8 https://www.themednet.org/how-do-you-handle-requests-for-disability-or-accommodations-in-clinical-settings-with-limited-administrative-support-or-documentation-time weekly 0.8 https://www.themednet.org/What-is-your-preferred-1L-treatment-for-newly-diagnosed-Del(17p)TP53-mutation-High-Risk-CLL weekly 0.8 https://www.themednet.org/if-calcium-phosphorus-and-pth-are-within-expected-range-for-an-esrd-patient-what-would-be-your-approach-to-an-elevated-alkaline-phosphatase-level weekly 0.8 https://www.themednet.org/have-you-changed-your-practice-in-treating-crao-with-iv-thrombolysis weekly 0.8 https://www.themednet.org/do-you-get-dexa-scans-routinely-before-starting-adt-for-prostate-cancer-or-endocrine-therapy-for-breast-cancer weekly 0.8 https://www.themednet.org/when-if-ever-do-you-consider-prescribing-clozapine-after-only-one-unsuccessful-antipsychotic-trial-in-schizophrenia weekly 0.8 https://www.themednet.org/how-do-you-choose-between-saci-and-other-systemic-therapies-in-the-first-line-setting-for-pd-l1-positive-metastatic-tnbc weekly 0.8 https://www.themednet.org/what-factors-falsely-cause-fibrosis-to-be-found-on-fibroscan-i-e-eating-sugar-prior-to-scan weekly 0.8 https://www.themednet.org/cost-and-access-aside-when-might-you-prefer-to-start-a-patient-on-a-triptan-instead-of-a-gepant-for-acute-migraine-therapy weekly 0.8 https://www.themednet.org/would-you-recommend-temporary-urinary-catheter-placement-for-a-patient-with-recurrent-nephrolithiasis-who-is-unable-to-adequately-complete-a-24-hour-urine-study-due-to-incontinence weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-hallucinations-in-dementia weekly 0.8 https://www.themednet.org/do-you-rely-on-urinalysis-testing-for-microscopic-hematuria-to-avoid-ct-radiation-exposure-in-patients-with-recurrent-nephrolithiasis-who-report-mild-potential-stone-related-pain weekly 0.8 https://www.themednet.org/in-an-older-man-on-tamsulosin-for-bph-who-is-presenting-with-recurrent-falls-how-do-you-manage-the-medication-in-light-of-urinary-symptom-control-and-and-fall-risk weekly 0.8 https://www.themednet.org/in-a-frail-older-adult-with-moderate-to-severe-lower-urinary-tract-symptoms-when-do-you-start-a-beta-3-agonist-like-vibegron-over-an-anticholinergic weekly 0.8 https://www.themednet.org/what-techniques-do-you-use-for-patients-with-tight-scrotums-during-in-office-vasectomies weekly 0.8 https://www.themednet.org/for-which-patients-with-type-2-diabetes-mellitus-would-you-consider-switching-to-once-weekly-basal-insulin-awiqli weekly 0.8 https://www.themednet.org/how-do-you-manage-persistent-hyperphosphatemia-in-a-hemodialysis-patient-who-is-adherent-to-phosphate-binders-and-has-already-been-counseled-extensively-on-dietary-restriction weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-a-patient-with-sarcoidosis-who-is-asymptomatic-but-demonstrates-progressively-enlarging-mediastinal-lymphadenopathy-and-rising-soluble-il-2-receptor-levels weekly 0.8 https://www.themednet.org/do-you-prefer-20mg-or-40mg-rosuvostatin-for-a-patient-s-p-stemi-and-pci weekly 0.8 https://www.themednet.org/would-you-add-tolvaptan-to-manage-difficult-to-treat-siadh-in-a-patient-who-is-already-on-high-doses-of-sodium-chloride-tablets-and-urea-but-fails-to-reach-adequate-serum-sodium-levels weekly 0.8 https://www.themednet.org/how-does-surgical-management-of-the-ipsilateral-cn0-pn0-neck-with-sln-vs-full-neck-dissection-impact-your-adjuvant-elective-neck-dose-in-oral-cavity-cancer weekly 0.8 https://www.themednet.org/do-you-initiate-a-high-intensity-statin-before-discharge-in-a-patient-hospitalized-with-a-first-stemi-who-has-an-ldl-below-70-mg-dl-on-no-prior-lipid-lowering-therapy weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-on-peritoneal-dialysis-who-develops-a-single-episode-of-cloudy-effluent-with-a-low-cell-count-and-no-organisms-on-gram-stain-while-remaining-clinically-well weekly 0.8 https://www.themednet.org/would-you-consider-combining-voclosporin-and-gazyva-for-pure-class-v-lupus-nephritis weekly 0.8 https://www.themednet.org/for-treatment-with-ebrt-for-h-n-cancers-for-ct-simulation-what-is-the-consensus-are-groups-planning-off-of-the-ct-sim-with-iv-contrast-or-the-non-contrast-scan weekly 0.8 https://www.themednet.org/would-you-initiate-a-sglt2-inhibitor-for-a-patient-on-chronic-lithium-with-the-goal-of-preserving-kidney-function weekly 0.8 https://www.themednet.org/should-kit-d816v-be-checked-in-all-patients-with-a-stinging-insect-allergy-even-with-a-normal-tryptase-so-that-mastocytosis-is-not-missed-in-patients-with-a-normal-tryptase weekly 0.8 https://www.themednet.org/Apart-from-the-side-effect-profile-what-is-making-faculty-choose-one-drug-over-the-other-in-the-first-line-if-we-have-a-PD-L1-negative-metastatic-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/When-do-you-opt-for-MRI-brain-in-addition-to-CTACTP-for-evaluating-eligibility-for-extended-window-thrombolysis weekly 0.8 https://www.themednet.org/how-often-do-you-disclose-a-diagnosis-with-a-personality-disorder-in-the-inpatient-setting weekly 0.8 https://www.themednet.org/r-old-male-with-bmi-33-dm2-htn-hlp-for-low-testosterone-levels-low-libido-and-decrease-erection-total-testosterone-by-immunoassay-at-10-am-273-repeat-by-lc-ms-296-4-free-testosterone-by-eq-dialysis-59-5-ref-47-244-with-normal-fsh-4-7-2-5-12-4-lh-5-5-ref-1 weekly 0.8 https://www.themednet.org/do-you-recommend-chemoradiation-following-neoadjuvant-folfirinox-for-resectable-pancreatic-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-a-stage-1-hr-her2-low-clinical-risk-pre-menopausal-patient-50-y-o-with-oncotype-dx-rs-of-24 weekly 0.8 https://www.themednet.org/when-do-you-consider-using-protons-for-breast-cancer weekly 0.8 https://www.themednet.org/what-would-be-your-next-line-of-therapy-for-a-postmenopausal-metastatic-er-her-2-bc-s-p-anastrazole-and-palbociclib-fulvestrant-who-has-progressive-disease-and-esr1-mutation-on-ctdna weekly 0.8 https://www.themednet.org/in-which-group-of-patients-you-would-send-for-rnaseq-for-translocations-fusions-that-might-be-missed-by-ngs-in-advanced-nsclc weekly 0.8 https://www.themednet.org/how-do-you-decide-between-a-parp-inhibitor-or-alpelisib-for-patients-with-metastatic-er-gbrca-pi3k-mutated-breast-ca-with-progression-on-cdk-4-6-inhibitor-fulvestrant weekly 0.8 https://www.themednet.org/do-you-offer-neo-adjuvant-therapy-to-a-post-menopausal-ct1cn0-her2-er-pr-idc-bc-or-recommend-surgery-first weekly 0.8 https://www.themednet.org/for-patients-with-p16-scc-of-a-cervical-lymph-node-subsequently-found-to-have-an-oropharyngeal-mass-on-imaging-is-it-necessary-to-biopsy-the-primary-site-prior-to-proceeding-with-definitive-rt weekly 0.8 https://www.themednet.org/in-patients-with-metastatic-lung-scc-who-are-on-pembrolizumab-maintenance-after-starting-pembrolizumab-carboplatin-nab-paclitaxel-what-is-your-treatment-strategy-if-they-progress-while-on-pembrolizumab-alone weekly 0.8 https://www.themednet.org/for-elderly-women-with-good-ps-when-would-you-omit-adjuvant-anthracycline-for-early-stage-hr-her2-breast-cancer-with-a-high-oncotype-dx-score weekly 0.8 https://www.themednet.org/are-there-guidlines-for-elective-coverage-of-nodal-basins-in-head-and-neck-for-skin-cancer-removed-in-the-area weekly 0.8 https://www.themednet.org/do-you-offer-induction-chemotherapy-for-patients-with-ct4n0-laryngeal-cancer-who-decline-surgery-and-are-not-candidates-for-high-dose-cisplatin-based-concurrent-rt weekly 0.8 https://www.themednet.org/how-would-you-treat-a-postmenopausal-woman-with-recurrent-localized-er-her2-breast-cancer-to-the-contralateral-breast-while-on-ai weekly 0.8 https://www.themednet.org/do-you-provide-prophylactic-radiotherapy-for-heterotopic-ossification-in-young-patients weekly 0.8 https://www.themednet.org/do-you-always-use-platinum-5-fu-as-the-chemo-backbone-with-pembrolizumab-for-recurrent-metastatic-h-n-cancer weekly 0.8 https://www.themednet.org/for-limited-stage-sclc-with-curative-intent-do-you-ever-substitute-carboplatin-for-cisplatin-in-concurrent-crt-setting weekly 0.8 https://www.themednet.org/how-do-you-decide-between-1st-line-parpi-or-immunotherapy-in-a-patient-with-metastatic-gbrca-mutated-tnbc weekly 0.8 https://www.themednet.org/what-is-the-role-of-consolidative-rt-to-initially-bulky-sites-8cm-in-a-patient-with-stage-iii-triple-hit-lymphoma-who-has-tolerated-only-4-cycles-of-da-epoch-r weekly 0.8 https://www.themednet.org/would-you-consider-off-label-use-of-olaparib-maintenance-in-patients-with-somatic-brca1-mutated-pancreatic-adenocarcinoma weekly 0.8 https://www.themednet.org/do-you-use-trastuzumab-for-patients-with-localized-her2-esophageal-cancer-after-definitive-chemort-who-are-not-surgical-candidates weekly 0.8 https://www.themednet.org/are-you-de-escalating-treatment-for-favorable-risk-stage-i-ii-dlbcl-patients-to-4-cycles-of-r-chop-with-2-additional-rituximab-cycles weekly 0.8 https://www.themednet.org/are-pd-l1-and-molecular-markers-from-pleural-fluid-specimens-reliable-enough-to-guide-decision-making-in-metastatic-nsclc weekly 0.8 https://www.themednet.org/what-are-the-common-side-effects-that-you-observe-with-ttfields weekly 0.8 https://www.themednet.org/how-do-you-improve-compliance-with-ttfields-for-patients-who-would-like-to-discontinue-therapy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-ttfields-if-they-have-reservations-about-the-aesthetics-and-inconvenience-of-the-treatment weekly 0.8 https://www.themednet.org/how-do-you-manage-insomnia-in-cancer-patients-that-is-refractory-to-traditional-sleep-aides weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-an-optic-nerve-sheath-meningioma weekly 0.8 https://www.themednet.org/what-dose-do-you-use-for-postoperative-rectum-boost weekly 0.8 https://www.themednet.org/how-would-you-approach-metastatic-adenocarcinoma-of-the-lung-with-ros1-rearrangement-by-fish-and-egfr-mutation-by-ngs weekly 0.8 https://www.themednet.org/would-you-consider-checkpoint-inhibitor-therapy-alone-in-a-patient-with-metastatic-nsclc-with-pdl-1-1-who-is-otherwise-refusing-chemotherapy weekly 0.8 https://www.themednet.org/do-you-use-a-custom-wax-tongue-immobilizer-for-oral-cavity-radiotherapy weekly 0.8 https://www.themednet.org/is-it-safe-to-offer-sbrt-for-a-secondary-nsclc-after-breast-or-chest-wall-irradiation-many-years-prior weekly 0.8 https://www.themednet.org/what-proton-dose-regimen-would-you-use-for-locally-recurrent-esophageal-cancer-previously-treated-with-chemort weekly 0.8 https://www.themednet.org/for-concurrent-chemoradiation-in-head-and-neck-cancers-how-important-is-the-timing-of-weekly-radiosensitizing-cisplatin-early-versus-late-in-the-week weekly 0.8 https://www.themednet.org/in-patients-receiving-concurrent-chemort-for-lung-cancer-do-you-have-thresholds-for-cytopenia-at-which-you-would-hold-rt weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-a-patient-with-metastatic-hepatocellular-carcinoma-with-childs-pugh-b-cirrhosis weekly 0.8 https://www.themednet.org/how-do-you-decide-the-right-time-to-transition-to-hospice weekly 0.8 https://www.themednet.org/what-would-be-your-chemotherapy-biologic-sequence-choice-in-a-ras-wildtype-metastatic-crc-for-which-folfox-and-bevacizumab-was-given-first-line weekly 0.8 https://www.themednet.org/are-there-any-recommendations-on-ways-to-reduce-capsulitis-in-patient-with-implants-receiving-adjuvant-whole-breast-radiation weekly 0.8 https://www.themednet.org/do-you-give-two-or-three-cycles-of-cisplatin-to-patients-with-h-n-squamous-cell-carcinoma-receiving-chemoradiation-with-q3-week-cisplatin weekly 0.8 https://www.themednet.org/what-are-best-practices-for-taking-care-of-lung-cancer-patients-during-the-covid-19-pandemic weekly 0.8 https://www.themednet.org/what-is-your-treatment-paradigm-for-rectal-cancer-in-the-setting-of-covid-19 weekly 0.8 https://www.themednet.org/how-do-you-manage-disease-progression-during-adjuvant-chemoradiotherapy-for-glioblastoma weekly 0.8 https://www.themednet.org/should-cisplatin-gemcitabine-and-veliparib-be-the-standard-of-care-in-treating-metastatic-unresectable-pancreatic-cancer-with-brca-or-palb2-mutation weekly 0.8 https://www.themednet.org/does-the-presence-of-dcis-in-conjunction-with-invasive-breast-cancer-require-consideration-of-adjuvant-rt-where-invasive-disease-alone-may-allow-for-omission weekly 0.8 https://www.themednet.org/is-it-reasonable-to-treat-with-rt-alone-for-limited-stage-sclc-if-unable-to-receive-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-treat-metastatic-adenocarcinoma-of-the-ampulla-of-vater weekly 0.8 https://www.themednet.org/which-early-stage-breast-cancer-patients-who-are-candidates-for-3-week-hypofractionated-whole-breast-ebrt-are-not-good-candidates-for-1-week-whole-breast-ebrt weekly 0.8 https://www.themednet.org/how-do-you-sequence-short-course-radiation-for-locally-advanced-rectal-cancer-when-using-the-total-neoadjuvant-approach weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-recommend-for-post-operative-radiation-therapy-for-an-excised-cutaneous-squamous-cell-carcinoma-of-the-foot-with-a-skin-graft weekly 0.8 https://www.themednet.org/how-would-you-approach-a-supraclavicular-high-grade-monophonic-synovial-sarcoma weekly 0.8 https://www.themednet.org/how-do-the-results-of-checkmate-9la-and-subsequent-fda-approval-of-nivo-ipi-chemo-impact-your-first-line-management-of-patients-with-non-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-conventionally-fractionated-radiotherapy-for-treatment-of-an-acoustic-neuroma weekly 0.8 https://www.themednet.org/are-there-any-data-to-guide-choice-of-immunotherapy-agent-in-first-line-treatment-for-extensive-stage-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/would-you-consider-prostate-sbrt-in-a-patient-with-focal-extracapsular-extension weekly 0.8 https://www.themednet.org/how-would-you-treat-a-bulky-axillary-squamous-cell-carcinoma-of-unknown-primary-in-an-elderly-person weekly 0.8 https://www.themednet.org/would-you-recommend-pre-op-radiation-for-an-operable-recurrent-well-differentiated-retroperitoneal-liposarcoma-with-abutment-of-the-right-kidney weekly 0.8 https://www.themednet.org/is-it-reasonable-to-delay-radiation-therapy-following-surgical-decompression-for-a-patient-with-spinal-cord-compression-if-systemic-therapy-must-be-started-as-soon-as-possible weekly 0.8 https://www.themednet.org/how-would-you-manage-adjuvant-treatment-of-a-patient-with-er-pr-her2-breast-cancer-and-a-small-amount-of-residual-disease-e-g-t1mi-following-neoadjuvant-tchp weekly 0.8 https://www.themednet.org/What-percentage-of-patients-outgrow-adhd-by-18urs-and-stop-the-medication weekly 0.8 https://www.themednet.org/how-is-the-cares-kappa-subgroup-data-changing-your-approach-to-newly-diagnosed-kappa-al-amyloidosis weekly 0.8 https://www.themednet.org/is-the-proteus-data-enough-to-change-your-practice-in-the-treatment-of-patients-with-high-risk-localized-or-locally-advanced-prostate-cancer weekly 0.8 https://www.themednet.org/What-factors-drive-your-selection-between-tafasitamab-and-epcoritamab-for-a-patient-with-relapsedrefractory-follicular-lymphoma weekly 0.8 https://www.themednet.org/how-aggressively-do-you-treat-the-ocular-surface-before-cataract-surgery-in-a-patient-with-inconsistent-k-readings-and-mild-dry-eye-who-is-otherwise-ready-for-surgery-and-does-this-differ-based-on-the-type-of-iol-offered weekly 0.8 https://www.themednet.org/In-a-patient-with-recurrent-SBOs-due-to-Crohn's-ileitis-despite-treatment-with-infliximab-do-you-consider-switching-to-a-different-biologic-versus-resection weekly 0.8 https://www.themednet.org/what-medications-do-you-consider-for-treatment-of-chronic-fatigue-syndrome weekly 0.8 https://www.themednet.org/do-you-include-a-specific-risk-assessment-in-your-outpatient-clinic-notes weekly 0.8 https://www.themednet.org/what-has-been-your-experience-with-cgrp-targeted-medications-for-vestibular-migraine weekly 0.8 https://www.themednet.org/how-do-the-results-of-the-phase-2-treasure-trial-for-consolidative-rt-for-es-sclc-impact-your-practice weekly 0.8 https://www.themednet.org/in-your-experience-when-do-antidepressants-begin-to-take-effect-for-depression-how-far-out-do-you-schedule-the-first-follow-up weekly 0.8 https://www.themednet.org/do-you-consider-testing-and-treating-ida-in-unexplained-thrombocytopenia weekly 0.8 https://www.themednet.org/do-you-pursue-genetic-testing-in-a-patient-with-unexplained-ckd-whose-kidney-biopsy-shows-nonspecific-tubulointerstitial-nephritis-without-an-identifiable-toxic-inflammatory-or-systemic-cause weekly 0.8 https://www.themednet.org/do-you-have-concerns-regarding-use-of-bactrim-in-lupus-and-risk-of-flare weekly 0.8 https://www.themednet.org/do-you-prefer-liquid-calcium-carbonate-over-other-calcium-carbonate-formulations-for-patients-with-recurrent-calcium-oxalate-nephrolithiasis-who-have-persistent-hyperoxaluria-on-24-hour-urine-studies weekly 0.8 https://www.themednet.org/What-do-you-prioritize-when-a-patient-has-discordant-clinicopathologic-features-and-genomic-risk-scores-to-estimate-melanoma-recurrence-risk weekly 0.8 https://www.themednet.org/How-do-gene-expression-profiling-results-influence-your-recommendations-for-surveillance-intensity-in-patients-with-early-stage-melanoma weekly 0.8 https://www.themednet.org/How-do-gene-expression-profiling-results-impact-your-decisions-regarding-adjuvant-therapy-in-node-negative-or-borderline-risk-melanoma-patients weekly 0.8 https://www.themednet.org/What-are-the-main-limitations-or-barriers-to-integrating-gene-expression-profiling-into-routine-melanoma-management-in-your-practice weekly 0.8 https://www.themednet.org/do-you-recommend-glp-1s-for-antispychotic-induced-weight-gain weekly 0.8 https://www.themednet.org/in-light-of-the-roads-data-how-are-you-choosing-between-intraoperative-tile-based-radiation-therapy-tbrt-and-postoperative-srt-for-newly-diagnosed-resectable-brain-metastases weekly 0.8 https://www.themednet.org/is-there-a-subset-of-patients-you-feel-benefit-from-gabapentin-for-migraine-prophylaxis weekly 0.8 https://www.themednet.org/In-patients-who-underwent-catheter-ablation-of-AFib-and-had-a-retroperitoneal-bleed-resulting-in-anemia-requiring-transfusions-when-would-you-restart-oral-anticoagulation-assuming-this-resolved-with-conservative-management-(holding-OAC-therapy) weekly 0.8 https://www.themednet.org/How-would-you-select-patients-for-epcoritamab-+-R-versus-R-or-other-regimens-at-second-line-relapsedrefractory-follicular-lymphoma weekly 0.8 https://www.themednet.org/has-the-recent-sbrt-vs-hdr-monotherapy-analysis-changed-your-use-of-hdr-monotherapy-for-intermediate-risk-prostate-cancer-1 weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-head-neck-cancers-from-asco-2026 weekly 0.8 https://www.themednet.org/do-you-stop-hemodialysis-and-monitor-the-patient-in-clinic-or-taper-dialysis-frequency-first-when-urine-output-and-lab-markers-suggest-kidney-recovery-in-a-hemodynamically-stable-outpatient-with-dialysis-requiring-aki weekly 0.8 https://www.themednet.org/in-an-als-patient-with-fvc-60-70-predicted-normal-daytime-abg-and-normal-nocturnal-oximetry-but-persistent-orthopnea-and-unrefreshing-sleep-do-you-initiate-nocturnal-niv-and-if-so-how-do-you-navigate-the-cms-coverage-gap weekly 0.8 https://www.themednet.org/do-you-offer-either-zoledronic-acid-or-denosumab-for-patients-with-mcspc-with-lytic-metastases-at-baseline-due-to-intraductal-histology-or-high-grade weekly 0.8 https://www.themednet.org/how-has-your-evaluation-of-irds-changed-with-advances-in-molecular-genetics weekly 0.8 https://www.themednet.org/if-a-ulcerative-colitis-patient-has-a-90-percent-response-to-a-biologic-or-small-molecule-after-over-12-months-would-you-consider-switching-medication-to-a-different-class-in-hopes-of-getting-a-complete-response-versus-trying-adjunctive-therapy weekly 0.8 https://www.themednet.org/has-the-fame-3-trial-showing-similar-5-year-mortality-between-ffr-guided-pci-and-cabg-changed-your-default-revascularization-recommendation-in-a-patient-with-three-vessel-coronary-artery-disease-who-is-eligible-for-both-procedures weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-a-symptomatic-bakers-cyst weekly 0.8 https://www.themednet.org/do-you-treat-45-mg-day-as-a-practical-ceiling-before-switching-strategies-in-a-child-with-adhd-and-incomplete-methylphenidate-response weekly 0.8 https://www.themednet.org/in-patients-with-newly-diagnosed-graves-disease-who-are-started-on-methimazole-therapy-when-do-you-recommend-repeating-thyroid-ultrasounds-to-monitor-incidental-thyroid-nodules-that-meet-fna-criteria weekly 0.8 https://www.themednet.org/what-advice-do-you-have-for-new-hospitalists-attending-on-teaching-services-for-the-first-time weekly 0.8 https://www.themednet.org/do-you-treat-persistent-microscopic-hematuria-as-a-clinically-meaningful-sign-of-ongoing-disease-activity-in-a-patient-with-iga-nephropathy-whose-proteinuria-is-well-controlled-on-current-therapy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-70-year-old-stage-iia-non-bulky-unfavorable-classic-hodgkin-lymphoma-patient-left-neck-subclav-mediastinum-hila-who-could-only-tolerate-2-cycles-of-chemotherapy-and-has-a-deauville-1-2-pet-ct-restaging-scan weekly 0.8 https://www.themednet.org/do-you-taper-glucocorticoids-less-aggressively-when-symptoms-improve-but-serologies-remain-active-in-a-patient-with-non-renal-sle weekly 0.8 https://www.themednet.org/what-medications-do-you-use-for-adjunct-treatment-of-conduct-disorder weekly 0.8 https://www.themednet.org/which-patients-are-good-candidates-for-transcranial-electrical-stimulation-for-the-treatment-of-chronic-insomnia weekly 0.8 https://www.themednet.org/in-patients-with-hormone-receptor-positive-her2-negative-early-stage-breast-cancer-whose-primary-tumor-appears-to-invade-the-pectoralis-muscle-on-imaging-but-without-involvement-of-other-chest-wall-structures-e-g-ribs-or-intercostal-muscles-what-is-the-pr weekly 0.8 https://www.themednet.org/how-do-you-approach-a-situation-where-you-disagree-with-a-consultants-recommendation-for-your-patient-particularly-when-the-consultant-has-more-disease-specific-expertise-but-you-have-a-fuller-picture-of-the-patients-overall-clinical-trajectory weekly 0.8 https://www.themednet.org/how-have-you-improved-your-serious-illness-conversation-skills-over-the-course-of-your-career-and-is-there-a-specific-framework-or-training-that-changed-your-approach weekly 0.8 https://www.themednet.org/How-do-you-integrate-rising-TCD-velocities-into-decisions-about-CTA-or-angiography-in-a-clinically-stable-patient-with-aneurysmal-subarachnoid-hemorrhage-How-do-concerning-TCD-trends-affect-your-management-of-a-clinically-stable-patient-with-aneurysmal-su weekly 0.8 https://www.themednet.org/what-nodal-volumes-should-be-covered-for-a-melanoma-of-the-posterior-scalp-with-poor-response-to-immunotherapy-s-p-wide-excision-and-occipital-nodal-dissection-with-multiple-nodes-present-with-ene weekly 0.8 https://www.themednet.org/what-clinical-features-of-a-patient-with-persistent-atrial-fibrillation-make-you-confident-enough-to-offer-pulsed-field-ablation-as-first-line-therapy-without-a-prior-trial-of-antiarrhythmic-drugs weekly 0.8 https://www.themednet.org/Which-PD-patients-will-you-be-implementing-tavapadon weekly 0.8 https://www.themednet.org/is-the-newly-approved-oral-pcsk9-inhibitor-lipfendra-as-clinically-efficacious-as-injectable-versions-of-the-drug-such-as-repatha weekly 0.8 https://www.themednet.org/has-the-hydra-study-of-hypofractionated-radiation-and-its-discussion-in-the-2026-nccn-guidelines-for-prostate-ca-changed-your-approach-to-moderate-hypofractionation-in-either-prostate-only-or-prostate-and-pelvic-node-radiation weekly 0.8 https://www.themednet.org/What-clinical-features-push-you-to-request-a-full-interprofessional-addiction-consult-rather-than-a-single-discipline-for-a-hospitalized-patient-with-substance-use-disorder weekly 0.8 https://www.themednet.org/for-a-marginal-dcd-kidney-on-perfusion-are-you-seeing-a-real-reconditioning-effect-or-is-the-perfusion-run-mostly-functioning-as-a-viability-test-that-tells-you-whether-to-use-the-organ-at-all weekly 0.8 https://www.themednet.org/do-you-recommend-scheduled-potassium-phosphate-dosing-during-pirrt-to-avoid-hypophosphatemia weekly 0.8 https://www.themednet.org/for-a-patient-with-a-locally-advanced-basal-cell-carcinoma-is-neoadjuvant-immunotherapy-followed-by-radiation-appropriate weekly 0.8 https://www.themednet.org/what-combination-of-clinical-and-pathologic-features-would-lead-you-to-be-comfortable-recommending-active-surveillance-in-a-gleason-7-prostate-cancer-patient weekly 0.8 https://www.themednet.org/can-sbrt-be-considered-for-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/what-do-you-use-for-igrt-for-definitive-h-n-imrt-treatments weekly 0.8 https://www.themednet.org/what-is-your-surveillance-strategy-for-locally-advanced-hpv-oropharynx-cancer-after-pet-cr weekly 0.8 https://www.themednet.org/what-target-volumes-do-you-use-for-cavity-srs-following-surgical-resection-of-brain-metastases weekly 0.8 https://www.themednet.org/when-if-ever-would-you-offer-radiotherapy-for-renal-cell-carcinoma-following-nephrectomy weekly 0.8 https://www.themednet.org/what-is-the-preferred-palliative-regimen-for-elderly-patients-with-rectal-cancer-who-elect-to-forego-surgery weekly 0.8 https://www.themednet.org/how-would-you-treat-a-premenopausal-patient-with-er-pr-her2-metastatic-breast-cancer-patient-who-progresses-on-tamoxifen weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-a-radiographically-proven-recurrence-in-the-prostate-bed-after-prostatectomy weekly 0.8 https://www.themednet.org/when-do-you-choose-to-give-cybord-over-rvd-in-a-newly-diagnosed-myeloma-patient weekly 0.8 https://www.themednet.org/how-do-you-decide-on-the-duration-of-endocrine-therapy-for-premenopausal-women-who-receive-chemotherapy-and-ai-ovarian-suppression-according-to-text-soft weekly 0.8 https://www.themednet.org/would-you-consider-use-of-parp-inhibitors-in-patients-with-metastatic-breast-cancer-with-moderate-penetrance-germline-mutations-such-as-chek2-atm-rad51 weekly 0.8 https://www.themednet.org/can-short-course-radiation-therapy-5-gy-x-5-fractions-be-given-for-low-lying-rectal-tumors-near-the-sphincter-but-not-involving-it weekly 0.8 https://www.themednet.org/do-you-consider-increased-tumor-thickness-alone-as-an-indication-for-postoperative-radiation-in-oral-cavity-cancers weekly 0.8 https://www.themednet.org/how-do-you-follow-patients-after-prostate-sbrt weekly 0.8 https://www.themednet.org/when-treating-a-patient-with-multiple-myeloma-with-bortezomib-how-do-you-decide-between-subcutaneous-vs-intravenous-dosing weekly 0.8 https://www.themednet.org/how-would-you-treat-a-diffuse-cns-myeloid-sarcoma-aka-chloroma-granulocytic-sarcoma-without-evidence-of-blood-or-bone-marrow-involvement weekly 0.8 https://www.themednet.org/what-is-your-threshold-for-transfusing-platelets-in-an-asymptomatic-patient-after-autologous-stem-cell-transplant weekly 0.8 https://www.themednet.org/do-you-have-a-preference-for-a-cdk4-6-inhibitor-for-first-line-metastatic-hr-positive-breast-cancer-in-combination-with-faslodex weekly 0.8 https://www.themednet.org/do-you-prefer-to-treat-patients-prone-on-a-belly-board-or-supine-when-treating-rectal-cancers weekly 0.8 https://www.themednet.org/how-does-a-prominent-component-of-intraductal-spread-affect-your-management-in-a-patient-with-otherwise-intermediate-risk-prostate-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-an-isolated-axumin-pet-positive-focus-in-the-prostate-bed-in-the-setting-of-rising-psa-after-prostatectomy-and-salvage-radiation weekly 0.8 https://www.themednet.org/how-would-you-treat-an-excised-t1n0m0-anal-canal-well-differentiated-squamous-cell-carcinoma-with-positive-microscopic-margin weekly 0.8 https://www.themednet.org/do-you-routinely-screen-for-pituitary-dysfunction-after-radiation-therapy-for-nasopharyngeal-cancer weekly 0.8 https://www.themednet.org/will-you-wait-to-simulate-or-resimulate-a-patient-after-teeth-extractions-in-preparation-for-hn-cancer-treatment weekly 0.8 https://www.themednet.org/for-what-patient-groups-if-any-do-you-routinely-recommend-screening-colonoscopy-prior-to-radiation-for-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-t1-2-scc-of-the-lip-postoperatively weekly 0.8 https://www.themednet.org/do-we-have-any-data-on-sequencing-of-up-front-therapies-for-patients-with-high-pd-l1-and-targeted-mutations weekly 0.8 https://www.themednet.org/would-you-consider-post-operative-boost-radiation-for-positive-margin-in-a-patient-with-rectal-cancer-who-underwent-short-course-rt-25-gy-in-5-fractions-prior-to-tme weekly 0.8 https://www.themednet.org/what-dose-fractionation-and-technique-do-you-use-when-treating-lentigo-maligna weekly 0.8 https://www.themednet.org/how-would-you-approach-definitive-prostate-radiation-in-a-patient-with-evidence-of-seminal-vesicle-invasion-on-mri-but-with-adjacent-small-bowel weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-prostatic-urethral-lift-urolift-seeking-definitive-radiation-for-prostate-cancer weekly 0.8 https://www.themednet.org/what-is-the-role-of-adjuvant-radiation-therapy-for-stage-iii-melanoma-in-the-era-of-adjuvant-opdivo weekly 0.8 https://www.themednet.org/would-you-consider-radiation-to-the-axillary-lymph-nodes-only-omitting-chest-wall-for-patients-with-1-3-axillary-lns-who-would-otherwise-not-receive-post-mastectomy-radiation-t1-2-clear-margins-etc-when-these-patients-have-or-will-undergo-breast-reconstru weekly 0.8 https://www.themednet.org/is-a-close-but-negative-for-margin-5-mm-an-indication-for-adjuvant-radiation-in-oral-cavity-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/is-it-possible-to-have-diffuse-bilateral-pulmonary-fibrosis-as-a-late-side-effect-of-unilateral-radiation-therapy-for-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-a-low-lying-rectal-cancer-wtih-para-aortic-lymphadenopathy weekly 0.8 https://www.themednet.org/what-are-your-dose-constraints-for-sbrt-pancreas-absolute-and-relative-when-treating-with-5-fractions weekly 0.8 https://www.themednet.org/how-do-you-explain-the-risks-and-benefits-of-palliative-radiation-therapy-to-patients-with-fungating-breast-masses weekly 0.8 https://www.themednet.org/how-do-you-counsel-an-early-stage-breast-cancer-patient-with-lupus-regarding-decisions-on-radiation weekly 0.8 https://www.themednet.org/would-you-ever-recommend-a-breast-boost-using-bid-fractionation-due-to-patient-scheduling weekly 0.8 https://www.themednet.org/when-do-you-hold-radiation-for-moist-desqumation-to-recover-when-treating-breast-cancer weekly 0.8 https://www.themednet.org/when-using-oral-contrast-for-simulation-how-much-prior-to-simulation-do-you-have-patients-drink-the-contrast weekly 0.8 https://www.themednet.org/is-there-any-benefit-to-adding-bevacizumab-to-chemo-immunotherapy-in-metastatic-nsclc weekly 0.8 https://www.themednet.org/would-you-recommend-axillary-dissection-for-a-patient-with-a-clinically-positive-scv-or-imn-node-who-has-a-clinical-cr-to-neoadjuvant-chemo-but-a-positive-slnb weekly 0.8 https://www.themednet.org/how-do-you-time-same-day-chemotherapy-and-radiation-for-patients-undergoing-concurrent-chemort weekly 0.8 https://www.themednet.org/in-which-prostate-cancer-patients-if-any-do-you-consider-adding-adt-to-adjuvant-radiation-therapy-following-prostatectomy weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-a-patient-with-igm-al-amyloidosis weekly 0.8 https://www.themednet.org/would-you-use-ar-v7-testing-to-decide-second-line-androgen-receptor-axis-targeted-therapy-vs-chemotherapy-for-patients-who-with-metastatic-castration-resistant-prostate-cancer weekly 0.8 https://www.themednet.org/what-is-the-drug-of-choice-in-order-of-preference-for-neuropathy-associated-with-different-agents-used-for-breast-cancer-treatment weekly 0.8 https://www.themednet.org/how-do-you-manage-fatigue-in-women-receiving-chemotherapy-hormonal-radiation-therapy-for-breast-cancer weekly 0.8 https://www.themednet.org/how-early-have-you-been-able-to-detect-a-response-with-car-t-in-patients-with-relapsed-dlbcl weekly 0.8 https://www.themednet.org/would-you-use-6-months-instead-of-12-months-of-herceptin-for-locally-advanced-her-2-positive-breast-cancer-patients weekly 0.8 https://www.themednet.org/do-you-offer-consolidation-chemotherapy-prior-to-durvalumab-in-locally-advanced-unresectable-nsclc weekly 0.8 https://www.themednet.org/should-women-with-adequately-debulked-ovarian-cancer-receive-bevacizumab-with-chemotherapy-in-the-adjuvant-setting weekly 0.8 https://www.themednet.org/how-do-you-manage-sexual-dysfunction-in-women-receiving-ovarian-suppression-for-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-for-arthralgias-from-ais weekly 0.8 https://www.themednet.org/for-patients-with-stage-i-nsclc-initially-treated-with-sbrt-how-do-you-best-manage-isolated-regional-nodal-failure weekly 0.8 https://www.themednet.org/how-would-you-approach-oligometastatic-solitary-recurrence-with-previously-resected-pancreatic-adenocarcinoma-and-adjuvant-chemotherapy-with-a-prolonged-disease-free-interval weekly 0.8 https://www.themednet.org/when-do-you-add-an-adjuvant-bone-modifying-agent-in-patients-with-history-of-localized-breast-cancer weekly 0.8 https://www.themednet.org/can-bicalutamide-be-used-instead-of-lhrh-agonist-in-intermediate-to-high-risk-prostate-patients-receiving-ebrt-who-want-to-preserve-erectile-function weekly 0.8 https://www.themednet.org/how-do-you-prevent-and-treat-lymphedema-following-head-and-neck-xrt weekly 0.8 https://www.themednet.org/would-you-recommend-alnd-or-sentinel-node-re-mapping-in-a-patient-with-recurrent-breast-cancer-of-the-areola-complex-who-had-previous-nipple-sparing-mastectomy-and-slnb-and-no-previous-radiation weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-resectable-nsclc-with-a-solitary-resectable-brain-metastasis-and-no-other-sites-of-metastasis weekly 0.8 https://www.themednet.org/would-you-consider-using-tamoxifen-in-er-negative-dcis weekly 0.8 https://www.themednet.org/are-there-specific-ros-1-fusions-mutations-that-confer-sensitivity-or-resistance-to-crizotinib-such-as-l1196m-for-alk-to-help-guide-selection-of-tki weekly 0.8 https://www.themednet.org/do-you-consider-folfirinox-dose-adjustments-for-elderly-patients-with-a-good-performance-status-in-the-neoadjuvant-setting-for-resectable-pancreatic-adenocarcinoma weekly 0.8 https://www.themednet.org/what-is-your-preferred-second-line-of-treatment-after-progression-on-cisplatin-gemcitabine-for-advanced-or-metastatic-cholangiocarcinoma weekly 0.8 https://www.themednet.org/would-you-consider-neoadjuvant-endocrine-therapy-in-a-postmenopausal-patient-with-er-locally-advanced-breast-cancer-with-nodal-disease-who-wants-to-avoid-chemotherapy weekly 0.8 https://www.themednet.org/do-you-use-a-chest-wall-constraint-when-treating-large-lung-cancers-with-8-or-10-fraction-sbrt weekly 0.8 https://www.themednet.org/is-it-safe-to-irradiate-a-patient-with-cowden-syndrome weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-prostate-cancer-with-suspicion-of-rectal-wall-invasion-but-otherwise-localized-disease weekly 0.8 https://www.themednet.org/how-long-after-initiation-of-steroids-do-you-typically-recommend-waiting-prior-to-delivering-radiation-therapy-for-spinal-cord-compression weekly 0.8 https://www.themednet.org/how-do-you-determine-the-choice-of-therapy-for-platinum-resistant-ovarian-cancer-in-healthy-good-performance-status-patients weekly 0.8 https://www.themednet.org/how-do-you-sequence-vaginal-cuff-brachytherapy-with-ebrt-for-post-op-endometrial-or-cervical-cases-that-require-both-modalities weekly 0.8 https://www.themednet.org/should-durvalumab-consolidation-still-be-offered-to-stage-iii-nsclc-patients-with-pd-l1-1 weekly 0.8 https://www.themednet.org/do-you-add-chemotherapy-to-pelvic-radiation-and-brachytherapy-for-an-isolated-vaginal-cuff-recurrence-of-endometrial-cancer weekly 0.8 https://www.themednet.org/do-you-deliver-prostate-sbrt-every-other-day-or-consecutively weekly 0.8 https://www.themednet.org/how-would-you-treat-an-early-stage-gastric-adenocarcinoma-in-a-patient-who-is-medically-inoperable-and-not-fit-enough-for-chemotherapy weekly 0.8 https://www.themednet.org/what-is-the-best-test-to-determine-hpv-status-for-scc weekly 0.8 https://www.themednet.org/how-do-you-approach-metastatic-colon-cancer-that-has-been-refractory-to-multiple-lines-of-systemic-therapy-though-maintaining-an-adequate-ps-for-additional-treatment weekly 0.8 https://www.themednet.org/do-you-routinely-use-any-type-of-motion-management-or-breathing-techniques-when-treating-a-lower-esophageal-cancer weekly 0.8 https://www.themednet.org/when-treating-a-patient-with-anal-cancer-with-a-vaginal-dilator-do-you-routinely-simulate-the-patient-with-and-without-the-dilator-in-place weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-radiation-therapy-to-a-t4n0-colon-cancer-with-invasion-into-other-organs-or-the-abdominal-wall-status-post-r1-resection weekly 0.8 https://www.themednet.org/is-it-safe-to-use-curcumin-during-cancer-treatment weekly 0.8 https://www.themednet.org/how-would-you-treat-an-elderly-fit-patient-with-stage-ie-dlbcl-single-skin-lesion weekly 0.8 https://www.themednet.org/how-do-you-choose-a-neoadjuvant-therapy-regimen-for-a-patient-with-a-triple-negative-breast-cancer-and-a-synchronous-er-her2-breast-cancer weekly 0.8 https://www.themednet.org/do-you-request-lumpectomy-cavity-markers-to-be-placed-at-time-of-surgery-to-guide-planning weekly 0.8 https://www.themednet.org/would-you-recommend-hypofractionated-treatment-for-early-stage-bilateral-breast-cancers weekly 0.8 https://www.themednet.org/what-dosing-regimen-of-carfilzomib-do-you-use-in-the-front-line-setting-for-high-risk-transplant-eligible-multiple-myeloma weekly 0.8 https://www.themednet.org/what-dose-constraints-do-you-use-for-60-gy-in-15-20-fraction-lung-treatments-that-are-adjacent-to-the-hilum weekly 0.8 https://www.themednet.org/do-you-routinely-offer-aspirin-as-an-adjunct-with-adjuvant-therapy-in-colorectal-cancer weekly 0.8 https://www.themednet.org/what-is-the-optimal-schedule-for-fractionated-srs-treatment-of-cns-tumors weekly 0.8 https://www.themednet.org/what-factors-do-you-use-to-determine-whether-to-add-brachytherapy-to-ebrt-for-iiic-endometrial-cancer weekly 0.8 https://www.themednet.org/can-a-lumpectomy-boost-be-omitted-in-a-cn0-triple-negative-breast-cancer-that-has-a-complete-response-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-modify-neoadjuvant-chemotherapy-for-a-stage-2-3-triple-negative-breast-cancer-who-has-baseline-grade-2-3-neuropathy weekly 0.8 https://www.themednet.org/would-you-recommend-starting-treatment-for-a-renal-cell-carcinoma-patient-with-new-low-burden-asymptomatic-sub-centimeter-bilateral-pulmonary-nodules-that-arise-after-a-short-disease-free-interval-6-months-after-nephrectomy-for-stage-i-disease weekly 0.8 https://www.themednet.org/what-is-your-surveillance-imaging-schedule-after-whole-brain-radiotherapy-for-brain-metastases weekly 0.8 https://www.themednet.org/how-would-you-treat-isolated-axillary-recurrence-of-a-previously-node-negative-er-pr-her2-breast-cancer-after-prior-neoadjuvant-chemotherapy-lumpectomy-adjuvant-rt-and-adjuvant-ai weekly 0.8 https://www.themednet.org/will-you-offer-adjuvant-t-dm1-for-patients-with-her2-breast-cancer-who-have-residual-invasive-disease-following-neoadjuvant-therapy weekly 0.8 https://www.themednet.org/do-you-consider-additional-chemotherapy-or-durvalumab-after-definitive-concurrent-chemo-rt-for-stage-ii-nsclc-for-patients-who-are-not-surgical-candidates weekly 0.8 https://www.themednet.org/what-is-your-approach-to-asymptomatic-patients-with-progressing-lung-metastatic-adenoid-cystic-carcinoma-originally-arising-from-the-trachea weekly 0.8 https://www.themednet.org/what-would-you-use-as-next-line-of-treatment-for-a-patient-with-ros1-metastatic-nsclc-progressing-on-first-line-tki weekly 0.8 https://www.themednet.org/how-would-you-manage-recurrent-laryngeal-cancer-after-previous-larynx-xrt-if-surgical-salvage-not-an-option weekly 0.8 https://www.themednet.org/what-is-your-general-approach-to-treating-bleeding-gastric-masses-with-palliative-rt weekly 0.8 https://www.themednet.org/what-adjuvant-treatment-would-you-use-in-a-pt1min0m0-er-her2-idc-of-the-breast-after-bilateral-mastectomies weekly 0.8 https://www.themednet.org/would-you-deliver-sbrt-to-the-adrenal-gland-if-a-patient-has-already-undergone-contralateral-adrenalectomy-for-oligometastatic-nsclc weekly 0.8 https://www.themednet.org/what-are-the-factors-that-convince-you-to-not-immediately-treat-mantle-cell-lymphoma-and-to-follow-a-course-of-active-surveillance weekly 0.8 https://www.themednet.org/how-long-do-you-give-maintenance-pemetrexed-pembrolizumab-in-metastatic-nsclc-treated-with-upfront-chemoimmunotherapy weekly 0.8 https://www.themednet.org/in-the-case-of-a-thoracic-esophageal-cancer-that-will-require-extensive-volume-coverage-2-3-of-the-esophagus-do-you-prophalactically-prescribe-a-feeding-tube-or-observe weekly 0.8 https://www.themednet.org/can-the-radiotherapy-dose-be-reduced-in-patients-with-head-and-neck-cancer-who-have-a-complete-response-to-induction-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/in-transplant-eligible-fit-patients-with-primary-refractory-myeloma-what-is-the-optimal-timing-for-stem-cell-collection weekly 0.8 https://www.themednet.org/would-you-ever-consider-srs-or-wbrt-in-an-asymptomatic-pregnant-patient-with-multiple-brain-metastases weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-a-posterior-fossa-metastasis-with-surrounding-vasogenic-edema-causing-mass-effect-on-the-4th-ventricle-in-an-asymptomatic-patient weekly 0.8 https://www.themednet.org/if-a-patient-is-unable-to-tolerate-one-cdk-4-6-inhibitor-do-you-switch-to-a-different-one weekly 0.8 https://www.themednet.org/in-what-scenario-if-any-would-you-treat-a-unilateral-neck-vs-bilateral-neck-for-post-operative-oral-cavity-in-historically-midline-structures-such-as-oral-tongue-fom-etc-scc-patients weekly 0.8 https://www.themednet.org/how-do-you-create-an-itv-for-liver-sbrt-metastatic-lesions-when-you-dont-have-a-4d-ct-or-fiducials weekly 0.8 https://www.themednet.org/what-image-guidance-do-you-use-when-treating-rectal-and-anal-cancers weekly 0.8 https://www.themednet.org/what-approach-do-you-take-to-determine-dose-constraints-for-conventionally-fractionated-reirradiation-of-the-head-and-neck weekly 0.8 https://www.themednet.org/do-you-place-any-constraint-on-dmax-when-developing-plans-for-linac-based-srs-or-sbrt weekly 0.8 https://www.themednet.org/are-you-categorically-using-lenvatinib-over-sorafenib-for-unresectable-hcc-in-the-absence-of-contraindications weekly 0.8 https://www.themednet.org/is-there-any-threshold-regarding-extraprostatic-extension-to-contraindicate-a-rectal-spacer weekly 0.8 https://www.themednet.org/would-you-resume-durvalumab-after-several-month-hiatus-due-to-io-unrelated-medical-comorbidities-that-has-since-resolved weekly 0.8 https://www.themednet.org/would-you-offer-nodal-rt-for-pt2n0-triple-negative-breast-cancer-s-p-bcs weekly 0.8 https://www.themednet.org/do-you-ever-consider-a-dose-constraint-to-the-spleen-when-treating-lung-tumors-with-stereotactic-radiotherapy weekly 0.8 https://www.themednet.org/how-do-you-typically-prescribe-dose-to-a-ptv-for-standard-imrt-plans weekly 0.8 https://www.themednet.org/would-you-go-back-and-do-an-axillary-lymph-node-dissection-if-a-sentinel-lymph-node-biopsy-showed-a-single-lymph-node-with-extracapsular-extension weekly 0.8 https://www.themednet.org/would-you-recommend-pmrt-using-a-hypofractionated-course-to-the-chest-wall-and-nodes weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-chemotherapy-for-high-grade-pleomorphic-dedifferentiated-liposarcoma weekly 0.8 https://www.themednet.org/what-is-your-preferred-neoadjuvant-chemotherapy-course-for-healthy-adult-patients-with-osteosarcoma weekly 0.8 https://www.themednet.org/do-the-results-of-s0226-change-your-endocrine-therapy-of-choice-in-denovo-metastatic-hormone-positive-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-image-when-using-dibh-with-breast-treatment weekly 0.8 https://www.themednet.org/what-is-the-role-of-liver-sbrt-in-the-setting-of-an-excellent-interventional-radiology-program weekly 0.8 https://www.themednet.org/do-you-recommend-adjustment-of-lung-dose-constraints-in-the-setting-of-stage-iii-lung-cancer-treated-with-definitive-concurrent-chemoradiation-followed-by-planned-consolidation-immunotherapy weekly 0.8 https://www.themednet.org/would-you-change-treatment-for-denovo-stage-iv-breast-cancer-her-2-positive-er-positive-in-remission-now-with-isolated-brain-metastasis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-severe-infusion-reaction-but-excellent-response-to-checkpoint-inhibitors weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-treatment-of-an-early-stage-hr-her2-cancer-if-the-patient-had-already-been-taking-an-aromatase-inhibitor-for-a-contra-lateral-hr-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/do-you-always-use-the-same-ctv-and-ptv-expansions-when-defining-fields-for-lumpectomy-bed-boost weekly 0.8 https://www.themednet.org/how-do-you-handle-risk-stratifying-and-radiation-treatment-in-a-patient-with-concurrent-mri-diagnosed-asymptomatic-prostatitis-and-prostate-cancer-diagnosis weekly 0.8 https://www.themednet.org/do-you-taper-memantine-after-completion-of-24-weeks-of-therapy weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-offer-a-patient-with-stage-ii-uterine-serous-carcinoma-without-lymph-node-sampling weekly 0.8 https://www.themednet.org/how-do-you-manage-a-bladder-cancer-patient-who-had-a-partial-cystectomy-with-a-positive-margin weekly 0.8 https://www.themednet.org/are-pre-menopausal-women-on-tamoxifen-at-risk-for-endometrial-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-a-nsclc-case-with-extensive-nodal-disease-that-results-in-a-radiation-plan-that-cannot-meet-normal-tissue-constraints weekly 0.8 https://www.themednet.org/how-would-you-manage-a-middle-aged-woman-with-history-of-severe-alcoholic-liver-cirrhosis-and-a-small-node-negative-er-pr-positive-her2-negative-breast-cancer weekly 0.8 https://www.themednet.org/would-you-offer-preoperative-radiation-therapy-when-treating-retroperitoneal-sarcomas weekly 0.8 https://www.themednet.org/when-do-you-recommend-preop-rt-for-retroperitoneal-sarcomas weekly 0.8 https://www.themednet.org/what-would-be-an-appropriate-age-cut-off-for-a-low-to-intermediate-prostate-cancer-to-receive-definitive-radiotherapy weekly 0.8 https://www.themednet.org/what-is-your-approach-for-a-pmrt-patient-that-cannot-tolerate-prone-or-supine-sim-with-necessary-arm-positioning weekly 0.8 https://www.themednet.org/in-a-patient-treated-with-chemoradiation-therapy-for-anal-cancer-10-years-ago-who-presents-again-with-localized-anal-squamous-cell-carcinoma-would-you-consider-repeat-chemoradiation-for-organ-preservation-instead-of-apr-since-so-much-time-has-passed-since weekly 0.8 https://www.themednet.org/what-dose-constraints-do-you-use-when-treating-ultra-central-lung-tumors-with-a-hypofractionated-ultra-hypofractionated-approach-using-8-10-fractions weekly 0.8 https://www.themednet.org/how-would-you-treat-an-older-patient-with-stage-iic-nonseminoma-who-is-unfit-for-platinum-chemotherapy-due-to-comorbidities weekly 0.8 https://www.themednet.org/how-do-you-manage-vte-in-the-setting-of-persistent-severe-thrombocytopenia weekly 0.8 https://www.themednet.org/when-do-you-include-the-mesorectum-for-definitive-cervical-cancer-patients-getting-concurrent-chemoradiation-followed-by-brachy weekly 0.8 https://www.themednet.org/do-you-incorporate-immunotherapy-in-your-multi-modality-treatment-after-chemoradiation-for-patients-with-potentially-resectable-stage-iii-superior-sulcus-nsclc weekly 0.8 https://www.themednet.org/would-you-use-upfront-atezo-bev-in-a-patient-with-hcc-and-untreated-hepatitis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-positive-antiphospholipid-antibodies-who-otherwise-do-not-meet-clinical-criteria-for-aps weekly 0.8 https://www.themednet.org/given-the-favorable-data-for-the-fast-and-fast-forward-trials-can-we-consider-those-ultra-hypofractionated-whole-breast-radiation-schemes-to-be-standard-of-care-for-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-control-of-glioma-related-seizures-following-radiation weekly 0.8 https://www.themednet.org/for-patients-with-hcc-receiving-atezo-bev-would-you-advise-any-other-clinical-investigations-scheduled-during-treatment-other-than-basic-lab-monitoring weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-systemic-therapy-for-a-pt3n0-i-hr-her2-negative-breast-cancer-with-an-intermediate-oncotype-in-a-post-menopausal-woman weekly 0.8 https://www.themednet.org/is-anticoagulation-a-relative-contraindication-to-atezolizumab-bevacizumab-for-advanced-hcc weekly 0.8 https://www.themednet.org/in-sickle-cell-patients-with-continued-pain-crises-despite-hydroxyurea-how-do-we-sequence-the-use-of-newer-agents weekly 0.8 https://www.themednet.org/are-there-any-special-considerations-when-evaluating-patients-with-non-malignant-hematologic-or-immunodeficiency-disorders-for-allogeneic-transplant weekly 0.8 https://www.themednet.org/why-is-pt3-not-a-port-indication-for-glottic-larynx-in-the-nccn-guidelines weekly 0.8 https://www.themednet.org/do-you-contour-and-constrain-cardiac-substructures-when-treating-locally-advanced-nsclc-with-chemoradiation weekly 0.8 https://www.themednet.org/would-you-consider-applying-the-principles-of-stampede-with-5-oligometastatic-non-regional-lymph-nodes-from-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-medically-inoperable-pleural-mesothelioma-confined-to-a-single-hemithorax-and-symptomatic-for-chest-wall-pain-not-responsive-to-first-line-systemic-therapy weekly 0.8 https://www.themednet.org/for-patients-with-dcis-on-biopsy-but-invasive-disease-in-lumpectomy-are-there-any-circumstances-in-which-you-would-not-recommend-returning-for-a-snb weekly 0.8 https://www.themednet.org/is-there-a-role-for-monitoring-serum-ancas-to-assess-anca-associated-vasculitis-disease-activity weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-regarding-adjuvant-therapy-for-stage-ia-uterine-serous-carcinoma-confined-to-a-polyp weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-recommend-using-for-a-locally-advanced-ulcerated-squamous-cell-carcinoma-resulting-in-a-non-healing-wound-in-the-setting-of-multiple-prior-surgeries-flap-reconstruction-and-baseline-immunosuppression weekly 0.8 https://www.themednet.org/how-would-you-council-a-woman-in-her-50s-with-stage-i-hr-her2-breast-cancer-with-a-high-risk-mammaprint-but-intermediate-oncotypedx-regarding-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/can-the-inguinal-and-pelvic-nodal-rt-be-omitted-for-figo-iva-unresectable-vulvar-cancer-with-a-negative-bilateral-inguinal-nodal-dissection weekly 0.8 https://www.themednet.org/how-do-you-choose-between-blinatumomab-and-car-t-cell-therapy-for-relapsed-or-refractory-pre-b-all weekly 0.8 https://www.themednet.org/would-you-offer-liver-sbrt-without-fiducial-placement weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-recommend-for-a-premenopausal-patient-with-er-pr-her2-negative-t2n0-breast-cancer-s-p-mastectomy-low-oncotypedx-score-and-in-first-trimester-of-pregnancy weekly 0.8 https://www.themednet.org/would-you-offer-definitive-rt-to-a-patient-with-metastatic-cervical-adenocarcinoma-s-p-carbo-taxol-avastin-with-a-partial-response-in-the-metastatic-sites weekly 0.8 https://www.themednet.org/would-you-place-an-ivc-filter-in-a-patient-with-an-acute-pe-and-an-absolute-contraindication-for-anticoagulation-but-negative-imaging-for-proximal-dvt weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-jak2-positive-pv-who-is-not-responding-to-hydroxyurea-or-ifn-alpha-for-cytoreduction weekly 0.8 https://www.themednet.org/has-covid-impacted-the-way-you-consider-using-subcutaneous-pertuzumab-trastuzumab-in-treatment-of-her2-breast-cancer weekly 0.8 https://www.themednet.org/what-additional-pathologic-or-clinical-features-might-sway-you-to-recommend-pmrt-specifically-for-a-very-young-patient-with-pt1-sentinel-node-negative-breast-cancer weekly 0.8 https://www.themednet.org/what-would-be-your-regimen-of-choice-for-a-healthy-80-year-old-with-localized-triple-negative-breast-cancer-2 weekly 0.8 https://www.themednet.org/what-dose-constraints-do-you-use-for-hypofractionated-radiotherapy-for-breast-cancer-undergoing-regional-nodal-irradiation weekly 0.8 https://www.themednet.org/given-the-long-half-life-of-dexamethasone-what-is-an-appropriate-dose-schedule weekly 0.8 https://www.themednet.org/how-are-you-considering-the-cost-impact-of-subcutaneous-pertuzumab-trastuzumab-in-your-treatment-planning weekly 0.8 https://www.themednet.org/would-you-feel-comfortable-changing-to-subcutaneous-pertuzumab-trastuzumab-in-a-patient-who-has-already-been-receiving-iv-formulation weekly 0.8 https://www.themednet.org/are-there-conditions-where-you-would-specifically-favor-using-the-subcutaneous-over-the-iv-formulation-of-pertuzumab-trastuzumab weekly 0.8 https://www.themednet.org/how-would-you-handle-recurring-toxicity-such-as-cytopenias-for-patients-receiving-subcutaneous-pertuzumab-trastuzumab weekly 0.8 https://www.themednet.org/based-on-the-results-of-monarche-would-you-offer-adjuvant-abemaciclib-for-hr-patients-who-do-not-achieve-pcr-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-stage-ivb-dlbcl-with-refractory-disease-in-the-retroperitoneum-and-spleen-after-6-cycles-of-rchop weekly 0.8 https://www.themednet.org/how-late-after-surgery-would-you-consider-prescribing-osimertinib-as-adjuvant-therapy-in-patients-with-resected-egfrm-nsclc weekly 0.8 https://www.themednet.org/when-would-you-recommend-postmastectomy-radiation-to-a-male-status-post-mastectomy-with-1-1-sentinel-nodes-with-itcs weekly 0.8 https://www.themednet.org/at-what-point-in-a-pediatric-patients-cancer-treatment-should-palliative-care-teams-become-involved-in-their-care weekly 0.8 https://www.themednet.org/when-do-you-evaluate-or-refer-for-a-cancer-predisposition-syndrome-in-a-young-child-diagnosed-with-a-sarcoma weekly 0.8 https://www.themednet.org/what-rt-fields-would-you-recommend-for-a-patient-with-early-stage-diffuse-large-b-cell-lymphoma-who-refuses-or-is-unfit-for-systemic-therapy weekly 0.8 https://www.themednet.org/what-brachial-plexus-dose-constraints-do-you-apply-when-treating-conventionally-fractionated-nsclc weekly 0.8 https://www.themednet.org/how-does-number-of-itc-influence-your-approach-to-adjuvant-rt-for-a-surgically-staged-1b-endometrial-cancer-meeting-hir-criteria weekly 0.8 https://www.themednet.org/when-would-you-use-parp-inhibitors-in-patients-with-refractory-metastatic-castrate-resistant-prostate-cancer-with-somatic-non-brca-hrd-mutations weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-a-patient-with-a-history-of-cutaneous-melanoma-and-only-overt-site-of-disease-being-a-bulky-level-iii-axillary-lymph-node weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-good-ps-and-no-treatment-contraindications-who-has-progressed-on-a-ret-inhibitor-for-nsclc weekly 0.8 https://www.themednet.org/how-do-you-manage-end-organ-toxicity-such-as-hepatotoxicity-or-pulmonary-toxicity-in-a-patient-receiving-ret-inhibitors-for-nsclc weekly 0.8 https://www.themednet.org/what-dose-constraints-do-you-use-for-a-young-female-patient-with-an-anterior-mediastinal-mass-being-treated-definitively-with-imrt weekly 0.8 https://www.themednet.org/do-you-stop-treatment-for-a-prostate-cancer-patient-diagnosed-with-acute-radiation-proctitis-with-significant-pain weekly 0.8 https://www.themednet.org/do-you-give-adjuvant-chemotherapy-trastuzumab-to-a-premenopausal-woman-with-a-pt1an0-hr-her2-breast-cancer weekly 0.8 https://www.themednet.org/what-is-the-utility-of-mri-for-identifying-disease-activity-in-myositis-patients-when-physical-exam-and-labs-are-inconclusive weekly 0.8 https://www.themednet.org/when-would-you-recommend-using-a-doac-in-a-pediatric-patient-with-vte weekly 0.8 https://www.themednet.org/assuming-an-absolute-contraindication-to-immunotherapy-and-good-ps-what-is-your-preferred-first-line-for-metastatic-squamous-cell-carcinoma-of-the-lung weekly 0.8 https://www.themednet.org/when-would-you-continue-bevacizumab-versus-using-parpi-alone-for-maintenance-therapy-in-brca-or-hrd-ovarian-cancer-after-response-to-primary-platinum-bevacizumab weekly 0.8 https://www.themednet.org/do-you-routinely-start-anticoagulation-for-a-patient-with-newly-diagnosed-hepatocellular-carcinoma-presenting-with-a-portal-venous-thrombosis weekly 0.8 https://www.themednet.org/which-parp-inhibitor-do-you-recommend-for-maintenance-therapy-in-brca-mutated-ovarian-cancer-after-primary-chemotherapy-and-why weekly 0.8 https://www.themednet.org/for-a-patient-with-h-n-squamous-cell-carcinoma-who-underwent-salvage-neck-dissection-for-residual-disease-following-primary-chemoradiation-with-weekly-cisplatin-do-you-offer-any-adjuvant-therapy-thereafter-if-extranodal-extension-is-found weekly 0.8 https://www.themednet.org/what-is-your-preferred-second-line-therapy-for-an-hcc-patient-who-progressed-after-first-line-checkpoint-inhibitor-monotherapy weekly 0.8 https://www.themednet.org/should-all-patients-with-suspected-giant-cell-arteritis-get-a-pet-scan-to-look-for-large-vessel-disease weekly 0.8 https://www.themednet.org/how-can-healthcare-providers-better-serve-as-allies-of-the-sickle-cell-community weekly 0.8 https://www.themednet.org/how-do-you-decide-on-the-timing-of-neoadjuvant-chemort-or-short-course-radiation-for-a-patient-with-mid-upper-rectal-cancer-with-resectable-liver-only-metastases weekly 0.8 https://www.themednet.org/how-would-you-manage-a-cervical-cancer-patient-who-develops-new-oligomet-to-the-spine-during-primary-cis-rt weekly 0.8 https://www.themednet.org/is-dexrazoxane-recommended-for-cardioprotection-in-aya-patients-with-hodgkin-lymphoma-who-are-receiving-anthracyclines-as-part-of-their-upfront-therapy weekly 0.8 https://www.themednet.org/what-third-line-treatment-do-you-consider-for-a-patient-with-metastatic-pancreatic-cancer-with-good-functional-status-and-no-targetable-mutations-after-progression-on-folfirinox-and-gemcitabine-nab-paclitaxel weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-for-stage-iia-seminoma-or-iib-seminoma-with-ln-3-cm-and-normal-tumor-markers-after-orchiectomy weekly 0.8 https://www.themednet.org/would-you-use-bevacizumab-in-a-patient-with-advanced-hcc-and-multiple-large-esophageal-varices-that-have-not-been-endosopically-intervened-upon weekly 0.8 https://www.themednet.org/would-you-extend-the-duration-of-anticoagulation-in-patients-with-a-provoked-dvt-but-evidence-of-residual-clot-at-3-months weekly 0.8 https://www.themednet.org/is-there-a-preferred-alk-targeting-agent-for-patients-with-alk-mnsclc-presenting-with-cns-metastases weekly 0.8 https://www.themednet.org/when-have-you-found-dual-energy-ct-most-useful-in-evaluating-for-gout weekly 0.8 https://www.themednet.org/how-do-you-approach-folate-supplementation-for-methotrexate-related-side-effects weekly 0.8 https://www.themednet.org/when-using-active-surveillance-for-rising-psa-after-prostatectomy-at-what-level-of-psa-would-you-start-adt weekly 0.8 https://www.themednet.org/do-you-consider-the-undissected-ipsilateral-level-iv-neck-a-high-or-low-risk-nodal-station-after-selective-neck-dissection-of-levels-i-iii-revealed-positive-node-s weekly 0.8 https://www.themednet.org/how-would-you-treat-superior-sulcus-nsclc-with-small-volume-n2-disease weekly 0.8 https://www.themednet.org/how-do-you-choose-your-systemic-treatment-for-primary-mediastinal-grey-zone-lymphomas weekly 0.8 https://www.themednet.org/would-you-consider-radiation-alone-or-chemoradiation-therapy-for-a-small-vulvar-cancer-near-the-urethra-or-clitoris weekly 0.8 https://www.themednet.org/for-a-patient-with-distal-esophageal-adenocarcinoma-with-residual-disease-after-folfox-x3-cycles-rt-followed-by-surgery-would-you-recommend-adjuvant-chemotherapy-or-adjuvant-nivolumab weekly 0.8 https://www.themednet.org/after-an-optimal-tertiary-cytoreduction-for-recurrent-granulosa-cell-tumor-previously-treated-with-bep-and-hormonal-therapy-would-you-recommend-systemic-chemotherapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-an-isolated-positive-rheumatoid-factor-negative-anti-ccp-antibody-and-no-clinical-or-imaging-evidence-of-rheumatoid-arthritis weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-risk-of-thromboembolic-complications-with-use-of-immunotherapy-in-nsclc weekly 0.8 https://www.themednet.org/when-if-ever-would-you-consider-hippocampal-avoidance-whole-brain-radiotherapy-in-the-setting-of-leptomeningeal-disease weekly 0.8 https://www.themednet.org/do-you-recommend-pre-emptive-anti-epileptic-treatment-for-patients-with-spontaneous-ich weekly 0.8 https://www.themednet.org/what-is-your-strategy-to-prevent-and-treat-constipation-in-patients-initiating-or-receiving-opioids weekly 0.8 https://www.themednet.org/for-ls-sclc-with-radiographic-cr-after-chemotherapy-is-there-a-time-point-beyond-which-you-do-not-offer-radiation-if-there-is-a-delay-in-initiation-of-radiation weekly 0.8 https://www.themednet.org/given-pop-rt-trial-do-you-cover-elective-nodes-in-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/what-chemotherapy-regimen-would-you-utilize-for-a-metastatic-poorly-differentiated-carcinoma-of-the-cervix-with-neuroendocrine-features weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-adjuvant-treatment-of-early-stage-mixed-histology-endometrial-cancer-with-a-significant-clear-cell-component weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-for-locally-advanced-poorly-differentiated-carcinoma-of-the-nasopharynx-with-bulky-neck-nodes-that-is-eber-negative-and-p16-negative weekly 0.8 https://www.themednet.org/would-you-offer-any-adjuvant-therapy-for-cervical-cancer-following-total-pelvic-exenteration-in-the-setting-of-a-positive-pelvic-lymph-node weekly 0.8 https://www.themednet.org/how-do-you-manage-testosterone-replacement-therapy-induced-erythrocytosis weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-metastatic-cholangiocarcinoma-after-progression-on-gemcitabine-cisplatin-folfox-and-pemigatinib weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-for-centrally-recurrent-cervical-scc-with-positive-margins-after-excision-that-was-not-exenteration weekly 0.8 https://www.themednet.org/what-clinical-factors-impact-your-upfront-treatment-decisions-in-transplant-ineligible-mm weekly 0.8 https://www.themednet.org/how-do-you-treat-anti-hmgcoa-myopathy weekly 0.8 https://www.themednet.org/is-there-a-role-for-the-use-of-transient-elastography-fibroscan-to-monitor-liver-fibrosis-in-patients-on-long-term-methotrexate weekly 0.8 https://www.themednet.org/how-would-your-elective-nodal-coverage-change-in-a-patient-with-anal-cancer-metastatic-to-a-high-external-iliac-node weekly 0.8 https://www.themednet.org/what-is-the-role-if-any-for-next-generation-sequencing-testing-in-patients-with-suspected-mpn-who-test-negative-for-commonly-identified-mutations-such-as-jak2-calr-mpl-and-bcr-abl weekly 0.8 https://www.themednet.org/is-it-ever-reasonable-to-offer-ebrt-alone-for-a-patient-with-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-the-timing-of-covid-19-vaccination-for-patients-with-multiple-sclerosis-on-b-cell-depleting-therapies weekly 0.8 https://www.themednet.org/would-you-consider-perioperative-chemotherapy-in-an-anastomotic-recurrence-of-gastric-cancer-after-partial-gastrectomy-who-did-not-receive-prior-chemotherapy-or-radiation weekly 0.8 https://www.themednet.org/do-you-treat-fibromyalgia-in-your-practice-or-do-you-refer-back-to-pcp-after-ruling-out-autoimmune-inflammatory-pathology weekly 0.8 https://www.themednet.org/when-using-io-therapy-for-front-line-treatment-of-metastatic-rcc-is-there-a-role-for-cytoreductive-nephrectomy weekly 0.8 https://www.themednet.org/what-factors-besides-disease-progression-would-lead-you-to-de-intensify-or-change-mm-therapy-for-a-patient-with-ongoing-response weekly 0.8 https://www.themednet.org/how-do-you-determine-when-to-use-a-maintenance-regimen-vs-continuous-3-drug-regimen-in-a-transplant-ineligible-mm-patient-after-response-to-first-line-therapy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-newly-diagnosed-transplant-ineligible-multiple-myeloma-on-the-expectations-of-treatment-in-terms-of-disease-control-duration-of-therapy-monitoring-and-follow-up weekly 0.8 https://www.themednet.org/when-giving-total-neoadjuvant-therapy-for-rectal-cancer-do-you-sequence-radiation-and-chemotherapy-differently-depending-on-the-tumor-distance-from-the-anal-verge weekly 0.8 https://www.themednet.org/would-you-consider-radical-prostatectomy-for-a-young-male-with-unfavorable-intermediate-risk-ct3a-prostate-cancer-and-psma-pet-concerning-for-regional-lymph-nodes-involvement-but-negative-conventional-imaging weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-patient-who-is-interested-in-using-supplements-such-as-fish-oil-or-turmeric-as-an-adjunct-to-treatment-of-inflammatory-arthritis weekly 0.8 https://www.themednet.org/is-inositol-just-as-effective-as-metformin-in-treating-insulin-resistance-associated-with-pcos weekly 0.8 https://www.themednet.org/how-do-you-best-incorporate-use-of-filgrastim-pegfilgrastim-in-capecitabine-based-regimens weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-sgo-2025 weekly 0.8 https://www.themednet.org/what-are-the-best-practices-for-preparing-blood-for-transfusion-in-a-patient-with-a-kidney-transplant-to-minimize-complications weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-a-patient-with-nonoliguric-eskd-massive-proteinuria-and-hypoalbuminemia-who-is-already-on-an-ace-inhibitor weekly 0.8 https://www.themednet.org/would-you-opt-to-start-iv-iron-load-maintenance-iron-therapy-or-no-iron-at-all-in-a-patient-with-eskd-on-hemodialysis-who-has-a-stable-hemoglobin-level-at-around-12-0-g-dl-but-also-has-low-iron-stores-as-evidenced-by-a-low-transferrin-saturation-and-ferri weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-that-are-positive-for-both-stimulatory-and-inhibitory-autoimmune-thyroid-markers-trab-tsi-and-tpo-ab-regarding-their-likelihood-of-flipping-from-hyperthyroidism-to-hypothyroidism weekly 0.8 https://www.themednet.org/what-do-you-recommend-for-a-commercial-drivers-license-holder-who-experiences-migraine-with-visual-aura weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-dermatomyositis-on-sun-protection weekly 0.8 https://www.themednet.org/do-you-avoid-progestin-only-contraceptives-and-iuds-in-patients-with-acne-due-to-their-androgenic-properties weekly 0.8 https://www.themednet.org/what-strategies-do-you-find-most-effective-at-managing-opioid-withdrawal-in-hospitalized-patients-who-are-not-interested-in-mat weekly 0.8 https://www.themednet.org/when-would-you-consider-intra-arterial-thrombolysis-for-acute-ischemic-stroke weekly 0.8 https://www.themednet.org/how-long-do-you-treat-staphylococcus-aureus-pyomyositis-with-antibiotics weekly 0.8 https://www.themednet.org/when-would-you-choose-to-measure-a-patients-spleen-stiffness weekly 0.8 https://www.themednet.org/do-you-recommend-avoiding-sglt2i-use-for-patients-with-proteinuria-from-diabetic-kidney-disease-if-they-have-urinary-retention-requiring-catheterization weekly 0.8 https://www.themednet.org/when-is-the-best-time-to-get-a-valproate-level-if-a-patient-is-taking-depakote-dr-once-daily weekly 0.8 https://www.themednet.org/does-the-presence-of-lcis-on-pathology-in-a-patient-with-idc-impact-your-decision-to-offer-apbi weekly 0.8 https://www.themednet.org/for-a-patient-with-metastatic-colon-cancer-which-is-msi-h-dmmr-and-braf-v600e-what-would-be-your-preferred-first-line-treatment weekly 0.8 https://www.themednet.org/how-do-checkmate-8hw-results-impact-your-sequencing-of-available-therapies-in-dmmr-msi-h-metastatic-colorectal-cancer weekly 0.8 https://www.themednet.org/would-you-offer-radiation-for-a-plasmacytoma-found-on-piecemeal-endoscopic-resection-of-an-initially-presumed-nasal-polyp-if-subsequent-pet-ct-was-negative-and-no-surgical-margin-status-was-known weekly 0.8 https://www.themednet.org/in-your-experience-how-does-the-dose-of-remeron-mirtazapine-influence-side-effects-like-hunger-and-weight-gain weekly 0.8 https://www.themednet.org/what-steps-do-you-take-to-ensure-that-partners-of-patients-diagnosed-with-chlamydia-receive-treatment weekly 0.8 https://www.themednet.org/should-an-ischemic-evaluation-be-considered-in-the-diagnostic-work-up-for-new-onset-diastolic-heart-failure-hfpef-in-patients-without-clear-anginal-symptoms weekly 0.8 https://www.themednet.org/should-ccta-be-considered-the-diagnostic-test-of-choice-in-the-outpatient-evaluation-of-chest-pain weekly 0.8 https://www.themednet.org/in-a-young-patient-who-was-vaccinated-to-chickenpox-as-a-child-no-previous-varicella-infection-should-the-patient-receive-a-shingles-vaccine-prior-to-starting-rinvoq weekly 0.8 https://www.themednet.org/how-do-you-distinguish-between-borderline-personality-disorder-and-complex-ptsd-in-patients-with-chronic-relational-trauma weekly 0.8 https://www.themednet.org/what-is-your-preferred-laboratory-test-to-assess-treatment-response-or-infection-resolution-in-patients-with-bacterial-pneumonia weekly 0.8 https://www.themednet.org/how-do-you-interpret-niagara-efficacy-given-that-adjuvant-nivolumab-was-not-administered-in-the-comparator-arm weekly 0.8 https://www.themednet.org/what-factors-should-be-considered-when-deciding-the-best-timing-for-choroidal-drainage-in-a-monocular-patient-with-a-suprachoroidal-hemorrhage-and-a-concurrent-retinal-detachment weekly 0.8 https://www.themednet.org/do-you-routinely-order-karius-in-evaluation-of-culture-negative-prosthetic-valve-endocarditis weekly 0.8 https://www.themednet.org/when-trying-to-increase-infliximab-for-active-disease-inflammatory-arthritis-or-sarcoidosis-do-you-prefer-to-increase-dosage-or-reduce-frequency-between-doses weekly 0.8 https://www.themednet.org/how-do-you-approach-dyspnea-in-a-patient-with-seropositive-rheumatoid-arthritis-with-normal-imaging-findings-but-abnormal-pft-findings-restriction-reduced-dlco weekly 0.8 https://www.themednet.org/for-patients-on-desiccated-bovine-thyroid-hormone-therapy-how-do-you-approach-transitioning-to-synthetic-thyroid-hormone-derivatives weekly 0.8 https://www.themednet.org/when-using-surface-image-guidance-for-breast-radiation-how-do-you-accommodate-for-changes-in-anatomy weekly 0.8 https://www.themednet.org/how-do-you-approach-questions-regarding-clearance-for-elective-surgery-in-patients-with-epilepsy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-offering-prk-for-1-diopter-of-myopia-in-patients-over-45-with-a-corneal-thickness-of-450-microns-and-no-keratoconus weekly 0.8 https://www.themednet.org/how-do-you-approach-recommending-ocular-exams-for-asymptomatic-candidemic-patients-considering-the-discordance-between-the-idsa-and-american-academy-of-ophthalmology-guidelines weekly 0.8 https://www.themednet.org/is-there-a-role-for-the-addition-of-radiation-to-preoperative-chemoimmunotherapy-in-nsclc-with-limited-n2-disease-planned-for-surgery weekly 0.8 https://www.themednet.org/how-do-you-evaluate-and-manage-patients-with-recurrent-multifocal-subcortical-ischemic-infarcts-of-unclear-etiology weekly 0.8 https://www.themednet.org/in-patients-who-relapse-during-a-treatment-free-period-after-achieving-remission-on-prior-1st-2nd-generation-tki-what-factors-should-be-taken-into-consideration-when-restarting-treatment weekly 0.8 https://www.themednet.org/do-you-avoid-peritoneal-dialysis-in-cirrhotic-patients-with-ascites weekly 0.8 https://www.themednet.org/how-do-you-manage-a-twice-recurrent-mucinous-adenocarcinoma-of-the-lower-eyelid-with-direct-involvement-of-the-lateral-rectus-muscle-and-lacrimal-duct weekly 0.8 https://www.themednet.org/what-is-the-current-role-of-ctdna-in-guiding-the-selection-of-adjuvant-treatment-for-stage-ii-iiia-melanoma weekly 0.8 https://www.themednet.org/would-you-consider-adding-encorafenib-cetuximab-to-adjuvant-mfolfox-for-a-patient-with-oligometastatic-colon-cancer-with-braf-v600e-mutation-s-p-metastasectomy-and-primary-resection-given-the-new-data-from-the-breakwater-trial weekly 0.8 https://www.themednet.org/what-is-the-appropriate-interval-before-safely-performing-cataract-surgery-after-plaque-radiation-therapy-for-iris-melanoma weekly 0.8 https://www.themednet.org/how-much-with-the-rule-astigmatism-would-you-intentionally-leave-in-patients-under-40-undergoing-cataract-surgery-considering-the-expected-age-related-shift-toward-against-the-rule-astigmatism weekly 0.8 https://www.themednet.org/do-you-temporarily-hold-esas-for-your-patients-with-kidney-disease-who-have-an-upcoming-surgical-procedure-with-the-goal-of-reducing-the-risk-for-dvts weekly 0.8 https://www.themednet.org/in-patients-with-indomethacin-responsive-hemicrania-continua-what-are-the-optimal-strategies-for-long-term-dosing-of-indomethacin-to-maintain-symptom-control-and-minimize-adverse-effects weekly 0.8 https://www.themednet.org/do-you-recommend-weekly-sq-immunoglobulin-replacement-for-an-asplenic-patient-who-only-responded-to-4-23-pneumococcal-serotypes-after-the-prevnar-20-vaccine weekly 0.8 https://www.themednet.org/if-youre-transitioning-laterally-between-biologic-classes-due-to-adverse-effects-do-you-repeat-the-loading-dose weekly 0.8 https://www.themednet.org/when-testing-for-patients-with-symptoms-of-mpn-do-you-prefer-to-do-jak2-cascade-testing-or-a-leukemia-ngs-testing-panel weekly 0.8 https://www.themednet.org/do-you-check-iga-levels-before-starting-ivig-for-other-autoimmune-conditions weekly 0.8 https://www.themednet.org/how-do-you-consider-and-approach-transition-to-hospice-in-a-patient-with-hfref-who-does-not-appear-to-tolerate-gdmt weekly 0.8 https://www.themednet.org/how-do-you-advise-your-patients-with-recurrent-nephrolithiasis-to-avoid-consuming-more-than-usual-fluid-volume-on-the-day-of-a-scheduled-24-hour-urine-stone-risk-study weekly 0.8 https://www.themednet.org/for-a-patient-s-p-tors-with-indications-for-adjuvant-radiation-how-does-your-management-change-with-persistently-elevated-cthpvdna weekly 0.8 https://www.themednet.org/for-biopsy-proven-extranodal-marginal-zone-lymphoma-involving-two-small-bilateral-lung-nodules-would-you-consider-definitive-treatment-to-both-nodules-with-radiation-therapy weekly 0.8 https://www.themednet.org/what-is-your-re-immunization-strategy-after-auto-sct-for-patients-with-myeloma-on-dara-len-maintenance weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-choosing-between-asciminib-vs-tki-in-a-newly-diagnosed-cml-patient weekly 0.8 https://www.themednet.org/how-do-you-assess-and-counsel-women-with-chronic-post-lumpectomy-or-mastectomy-pain weekly 0.8 https://www.themednet.org/given-the-results-of-plato-anal-cancer-study-is-4140-cgy-the-new-standard-for-early-stage-anal-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-stimulant-prescribing-for-adhd-when-a-patient-has-previously-reported-palpitations-with-stimulants-but-has-a-normal-ekg-off-medication weekly 0.8 https://www.themednet.org/would-you-consider-changing-a-non-diabetic-patient-with-obesity-and-a-history-of-cad-who-is-on-semaglutide-to-tirzepatide-if-they-have-not-achieved-their-weight-loss-goals weekly 0.8 https://www.themednet.org/after-confirming-the-patient-is-not-on-nsaids-how-do-you-approach-acute-ileitis-on-biopsies-in-a-patient-without-symptoms-or-with-only-mild-loose-stools weekly 0.8 https://www.themednet.org/how-do-you-treat-a-large-basal-cell-carcinoma-involving-the-dorsum-and-entire-tip-of-the-nose-when-brachytherapy-and-orthovoltage-are-not-feasible weekly 0.8 https://www.themednet.org/when-would-you-offer-neoadjuvant-immunotherapy-prior-to-mohs-surgery-in-a-locally-advanced-squamous-cell-carcinoma-for-which-clearance-may-require-enucleation weekly 0.8 https://www.themednet.org/would-you-consider-not-returning-the-blood-from-the-dialysis-circuit-as-a-strategy-for-managing-polycythemia-in-a-patient-with-eskd-on-hemodialysis-who-has-a-hemoglobin-level-greater-than-16-g-dl weekly 0.8 https://www.themednet.org/what-factors-should-be-considered-when-deciding-between-datopotamab-deruxtecan-and-sacituzumab-govitecan-for-a-patient-with-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/how-will-you-sequence-dato-dxd-among-available-therapies-for-hr-positive-her2-0-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/how-will-you-weigh-the-positive-pfs-but-negative-os-benefit-when-discussing-dato-dxd-with-patients weekly 0.8 https://www.themednet.org/how-would-you-manage-axial-stiffness-without-pain-in-an-elderly-gentleman-with-a-distant-history-of-hla-b27-axial-and-peripheral-spondyloarthritis-now-with-si-joint-fusion-no-peripheral-arthritis-normal-inflammatory-markers-and-no-response-to-tnf-inhibiti weekly 0.8 https://www.themednet.org/what-is-the-optimal-approach-to-managing-oral-toxicities-such-as-dysgeusia-caused-by-immune-checkpoint-inhibitors-icis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-bothersome-dyskinesias-in-parkinson-disease-patients weekly 0.8 https://www.themednet.org/how-might-meditation-be-helpful-for-a-patient-with-obsessive-compulsive-disorder weekly 0.8 https://www.themednet.org/would-you-use-argatroban-or-citrate-catheter-lock-in-a-patient-with-eskd-and-hitt weekly 0.8 https://www.themednet.org/do-you-routinely-integrate-telomere-length-testing-into-the-evaluation-of-patients-with-ild weekly 0.8 https://www.themednet.org/would-you-continue-sapt-beyond-12-months-after-left-main-stenting-in-an-elderly-patient-on-doac-for-paroxysmal-atrial-fibrillation weekly 0.8 https://www.themednet.org/do-you-recommend-using-intermediate-acting-insulin-over-long-acting-insulin-for-the-management-of-steroid-induced-hyperglycemia weekly 0.8 https://www.themednet.org/how-would-you-approach-post-op-radiation-recommendations-in-patients-who-had-neoadjuvant-chemoimmunotherapy-for-hpv-mediated-opscc-s-p-tors-who-have-a-complete-pathologic-response-pcr weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-incidental-hypertension-without-evidence-of-end-organ-damage-in-hospitalized-patients weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-active-axial-spondyloarthritis-refractory-to-nsaid-in-a-patient-with-concurrent-autoinflammatory-disease-on-long-term-anti-il-1-therapy weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-radiation-after-complete-resection-of-a-small-primary-cutaneous-follicular-lymphoma-of-the-scalp weekly 0.8 https://www.themednet.org/what-parameters-would-you-use-to-decide-whether-to-stop-hydroxychloroquine-in-a-patient-whose-lupus-is-well-controlled-but-is-found-to-have-a-prolonged-qt-interval-on-routine-ekg weekly 0.8 https://www.themednet.org/assuming-lab-accuracy-what-are-some-of-the-hallmarks-and-symptoms-that-would-lead-to-a-diagnosis-of-ana-negative-lupus-as-opposed-to-any-other-autoimmune-condition weekly 0.8 https://www.themednet.org/do-you-offer-low-dose-radiation-therapy-for-osteoarthritis-of-the-spine weekly 0.8 https://www.themednet.org/do-you-plan-to-initiate-combination-therapy-with-an-sglt-2-inhibitor-and-finerenone-instead-of-an-sglt-2-inhibitor-alone-when-treating-patients-with-proteinuric-chronic-kidney-disease-and-type-2-diabetes-in-light-of-the-confidence-trial-findings weekly 0.8 https://www.themednet.org/is-there-a-scenario-in-which-you-would-consider-observation-for-t4a-scc-involving-the-mandible weekly 0.8 https://www.themednet.org/would-you-continue-or-stop-anticoagulation-for-a-dvt-pe-in-a-patient-with-active-cancer-who-has-completed-6-months-of-therapy weekly 0.8 https://www.themednet.org/would-you-consider-proceeding-with-a-sentinel-lymph-node-biopsy-after-wide-excision-revealed-1-2-mm-residual-non-ulcerated-t2a-melanoma-on-the-upper-back weekly 0.8 https://www.themednet.org/how-do-you-taper-corticotropin-injections-acthar-in-patients-with-rheumatologic-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-to-checking-preoperative-cardiac-biomarkers-such-as-troponin-and-bnp weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-head-neck-cancers-from-asco-2025 weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-regarding-the-improvement-they-can-expect-when-starting-nemolizumab weekly 0.8 https://www.themednet.org/is-there-any-way-to-perform-a-baked-egg-challenge-in-an-infant-or-best-to-wait-until-developmentally-able-to-consume-baked-egg weekly 0.8 https://www.themednet.org/what-planning-and-dose-constraints-are-you-using-for-5-fraction-hypofractionated-frst-for-vestibular-schwannoma weekly 0.8 https://www.themednet.org/have-you-had-success-with-the-cala-trio-device-for-essential-tremor weekly 0.8 https://www.themednet.org/is-obinutuzumab-obligatory-with-av-combination-for-patients-with-unmutated-ighv weekly 0.8 https://www.themednet.org/do-you-temporarily-hold-diuretics-when-measuring-24-hour-urine-calcium-levels-in-the-evaluation-of-primary-hyperparathyroidism weekly 0.8 https://www.themednet.org/would-you-offer-re-irradiation-for-a-prostate-local-recurrence-after-i-125-seed-implant-10-years-ago-in-a-healthy-young-patient-with-life-expectancy-15-years weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-generalized-morphea-no-systemic-involvement-but-a-positive-rna-polymerase-iii weekly 0.8 https://www.themednet.org/would-you-add-immunotherapy-to-folfox-if-the-patient-is-not-a-flot-candidate-for-neoadjuvant-gastric-cancer-extrapolating-data-from-the-matterhorn-study weekly 0.8 https://www.themednet.org/for-a-patient-with-nsclc-harboring-an-egfr-or-alk-mutation-that-transforms-into-sclc-would-you-add-immunotherapy-to-chemotherapy-or-avoid-immunotherapy-given-the-tumors-egfr-alk-origin weekly 0.8 https://www.themednet.org/do-you-incorporate-the-results-of-24-hour-urine-chemistries-that-were-obtained-several-years-prior-when-evaluating-new-patients-for-kidney-stone-prevention weekly 0.8 https://www.themednet.org/what-is-the-maximum-dose-that-you-would-give-to-residual-unresectable-gross-disease-in-the-axilla-in-the-setting-of-recurrent-breast-cancer-s-p-alnd weekly 0.8 https://www.themednet.org/how-do-you-differentiate-between-erbb2-mutation-vs-her2-overexpression-testing-when-selecting-patients-for-tumor-agnostic-therapy weekly 0.8 https://www.themednet.org/when-do-you-recommend-hla-testing-prior-to-prescribing-lamotrigine-carbamazepine-or-oxcarbazepine-to-patients-of-asian-descent weekly 0.8 https://www.themednet.org/how-do-you-approach-surveillance-and-repeat-biopsies-in-a-patient-with-a-diagnosis-of-intestinal-metaplasia-aka-barretts-esophagus-on-pathology-who-appears-to-have-a-regular-z-line-or-1-cm-of-salmon-mucosa weekly 0.8 https://www.themednet.org/what-is-your-approach-to-bisphosphonate-use-in-patients-with-advanced-chronic-kidney-disease-and-osteoporosis weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-a-patient-with-strongly-positive-ssa-antibodies-and-an-extraglandular-feature-such-as-ild-or-peripheral-neuropathy-but-without-sicca-symptoms-or-parotid-abnormalities weekly 0.8 https://www.themednet.org/how-do-you-ensure-that-fibromyalgia-is-appropriately-recognized-in-patients-with-sjogrens weekly 0.8 https://www.themednet.org/for-patients-with-newly-diagnosed-unmutated-cll-how-will-you-decide-between-btki-alone-vs-ven-btki-vs-ven-obin-vs-ven-obin-acalabrutinib weekly 0.8 https://www.themednet.org/how-soon-after-a-fracture-would-it-be-safe-to-start-anti-resorptive-therapy weekly 0.8 https://www.themednet.org/what-adjuvant-treatment-approach-would-you-recommend-for-a-patient-with-early-stage-msi-high-gastric-cancer-who-received-neoadjuvant-ipilimumab-2-and-nivolumab-6-per-the-neonipiga-regimen-followed-by-r0-resection-with-no-pathologic-response weekly 0.8 https://www.themednet.org/what-is-your-approach-when-evaluating-a-child-brought-in-by-parents-who-suspect-pans-pandas-as-the-cause-of-the-childs-psychiatric-symptoms weekly 0.8 https://www.themednet.org/would-you-use-t-dxd-as-a-first-line-agent-for-a-patient-who-developed-early-metastatic-relapse-of-her2-urothelial-cancer-shortly-after-standard-perioperative-chemo-immunotherapy-over-other-standard-non-targeted-treatments weekly 0.8 https://www.themednet.org/under-what-circumstances-do-you-give-chemotherapy-for-a-nondiagnostic-pancreas-biopsy-that-is-suspicious-for-adenocarcinoma weekly 0.8 https://www.themednet.org/what-are-your-institutions-standard-liquid-intake-instructions-for-prostate-cancer-patients-going-through-definitive-external-beam-radiation weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-advising-a-patient-with-lupus-nephritis-on-the-safety-of-becoming-pregnant weekly 0.8 https://www.themednet.org/how-do-you-approach-firearm-safety-counseling-for-outpatients-with-elevated-suicide-risk-who-do-not-meet-the-criteria-for-involuntary-psychiatric-hospitalization weekly 0.8 https://www.themednet.org/how-would-you-manage-a-pt2n1a-invasive-ductal-carcinoma-s-p-lumpectomy-and-sentinel-lymph-node-biopsy-with-ece-and-two-mildly-avid-axillary-lymph-nodes-on-post-op-pet-ct weekly 0.8 https://www.themednet.org/what-biomarkers-best-predict-the-response-to-b-cell-depleting-therapies-in-ms weekly 0.8 https://www.themednet.org/what-would-be-your-approach-for-the-management-of-asymptomatic-severe-as-with-a-peak-velocity-of-5-m-s-in-an-otherwise-physically-active-patient-in-their-mid-90s-without-significant-co-morbidities weekly 0.8 https://www.themednet.org/what-is-your-next-step-in-management-for-patients-who-develop-sexual-side-effects-on-an-ssri-anorgasmia-low-libido-etc-but-are-responding-well-to-therapy weekly 0.8 https://www.themednet.org/what-is-your-hemoglobin-target-for-patients-with-nondialysis-chronic-kidney-disease-who-are-receiving-esa-therapy weekly 0.8 https://www.themednet.org/when-do-you-recommend-incorporating-her2-testing-into-the-diagnostic-pathway-for-tumor-types-where-her2-overexpression-is-not-commonly-assessed weekly 0.8 https://www.themednet.org/how-do-you-prioritize-treatment-in-a-lung-cancer-patient-who-has-her2-ihc3-along-with-other-actionable-mutations-that-have-tumor-specific-drugs-available weekly 0.8 https://www.themednet.org/how-would-you-apply-the-results-of-checkmate-204-in-an-asymptomatic-patient-with-10-20-metastatic-brain-lesions-on-dual-immunotherapy-for-melanoma weekly 0.8 https://www.themednet.org/how-would-you-advise-medical-oncologists-who-recommend-checkpoint-inhibitors-for-a-patient-with-baseline-type-1-diabetes weekly 0.8 https://www.themednet.org/what-strategies-do-you-find-helpful-in-advanced-care-planning-with-patients-families-who-are-very-miracle-centered weekly 0.8 https://www.themednet.org/is-there-a-general-consensus-on-margins-to-use-when-treating-sccis-or-bcc-with-ed-c weekly 0.8 https://www.themednet.org/what-has-been-your-impression-of-the-clinical-outcomes-for-photobiomodulation-for-dry-amd weekly 0.8 https://www.themednet.org/do-more-fractionated-regimens-reduce-severe-toxicity-over-sbrt-in-patients-with-ild-and-early-stage-nsclc weekly 0.8 https://www.themednet.org/would-you-pursue-temporary-dialysis-catheter-placement-followed-by-hemodialysis-in-a-hospitalized-patient-with-eskd-who-is-not-able-to-undergo-urgent-fistula-repair-for-a-non-functioning-fistula-and-receives-gadolinium-for-a-mri-study weekly 0.8 https://www.themednet.org/what-approach-do-you-use-for-monitoring-renal-response-to-ln-therapy weekly 0.8 https://www.themednet.org/how-would-you-manage-an-enlarging-brain-metastasis-that-has-progressed-in-size-three-months-after-radiosurgery weekly 0.8 https://www.themednet.org/how-have-you-gone-about-implementing-tms-in-your-practice-or-institution weekly 0.8 https://www.themednet.org/what-is-the-effectiveness-of-transmagnetic-stimulation-for-patients-with-chronic-pain-including-chronic-headaches weekly 0.8 https://www.themednet.org/would-you-favor-additional-work-up-for-abnormally-elevated-abis-that-suggest-noncompressible-vessels-to-confirm-the-presence-of-pad weekly 0.8 https://www.themednet.org/how-do-you-explain-a-very-high-positive-ds-dna-antibody-by-elisa-but-negative-by-ifa weekly 0.8 https://www.themednet.org/how-would-you-treat-an-early-stage-dmmr-rectal-squamous-cell-carcinoma-in-an-otherwise-healthy-elderly-patient weekly 0.8 https://www.themednet.org/how-would-you-manage-mrsa-and-enterococcus-faecalis-bacteriuria-in-a-patient-presenting-in-severe-heart-failure-without-urinary-symptoms-fever-or-chills-two-negative-blood-cultures-and-whose-transthoracic-echocardiogram-shows-no-new-valvular-abnormalities weekly 0.8 https://www.themednet.org/what-factors-do-you-use-when-considering-the-addition-of-celecoxib-to-adjuvant-chemotherapy-for-patients-with-stage-iii-colon-cancer-given-calgb-swog-80702-trial-results weekly 0.8 https://www.themednet.org/how-do-you-determine-whether-to-continue-anti-dementia-medications-such-as-cholinesterase-inhibitors-for-patients-with-dementia-when-enrolling-in-hospice weekly 0.8 https://www.themednet.org/how-can-we-approach-tapering-or-discontinuing-biologic-dmards-in-patient-in-their-80s-with-well-controlled-rheumatoid-arthritis weekly 0.8 https://www.themednet.org/what-are-the-best-practices-for-optimizing-transitions-from-hospital-to-skilled-nursing-facilities-for-older-adult-patients-with-specific-regard-to-adapting-hospital-medication-regimens-to-the-skilled-nursing-facility-setting weekly 0.8 https://www.themednet.org/in-outpatient-primary-care-settings-would-you-recommend-routinely-checking-cystatin-c-as-a-marker-of-renal-function-in-older-adults weekly 0.8 https://www.themednet.org/what-treatment-options-would-you-consider-for-an-anorectal-adenocarcinoma-following-long-course-chemort-mfolfirinox-and-apr-followed-by-an-incomplete-re-resection-of-a-local-recurrence weekly 0.8 https://www.themednet.org/how-have-you-incorporated-prescription-digital-therapeutic-treatments-for-chronic-insomnia-such-as-sleepiorx-or-somryst-into-your-practice weekly 0.8 https://www.themednet.org/how-has-your-use-of-slt-changed-given-the-6-year-results-of-the-light-trial weekly 0.8 https://www.themednet.org/in-cataract-surgery-following-penetrating-keratoplasty-do-you-think-the-use-of-scleral-tunnel-incisions-versus-clear-corneal-incisions-meaningfully-influence-graft-survival-or-astigmatic-stability weekly 0.8 https://www.themednet.org/how-do-you-discuss-the-role-if-there-is-any-of-frequently-weighing-yourself-at-home-for-patients-who-desire-weight-loss weekly 0.8 https://www.themednet.org/what-would-your-approach-be-in-a-man-currently-on-treatment-for-high-risk-prostate-cancer-with-adt-who-does-not-have-castrate-levels-of-testosterone weekly 0.8 https://www.themednet.org/would-you-increase-the-delivered-dose-to-more-than-25-ml-kg-hr-in-a-patient-on-ckrt-if-a-prolonged-interruption-for-a-procedure-is-planned-for-the-day weekly 0.8 https://www.themednet.org/based-upon-recently-published-information-in-the-journal-science-would-you-offer-zileuton-to-a-high-risk-food-allergy-patient-who-declines-oral-immunotherapy-and-omalizumab weekly 0.8 https://www.themednet.org/would-you-include-the-entire-op-bed-including-flap-within-the-radiation-field-in-a-patient-requiring-a-v-y-advancement-flap-for-closure-following-a-radical-vulvectomy weekly 0.8 https://www.themednet.org/in-a-patient-with-gastroesophageal-adenocarcinoma-treated-with-neoadjuvant-chemoimmunotherapy-who-had-a-good-response-but-is-unable-to-undergo-surgery-how-would-you-approach-radiation-therapy weekly 0.8 https://www.themednet.org/how-would-a-low-tumor-mutational-burden-10-influence-your-decision-to-offer-neoadjuvant-immunotherapy-for-cutaneous-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/when-do-you-start-anticoagulation-in-patients-with-endocarditis-and-evidence-of-mycotic-aneursym weekly 0.8 https://www.themednet.org/does-a-pathologic-complete-response-in-the-breast-and-axilla-change-your-radiation-recommendations weekly 0.8 https://www.themednet.org/is-history-of-radioactive-iodine-treatment-for-thyroid-cancer-a-contraindication-to-receive-xrt-for-prostate-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-who-present-with-unilateral-raynauds weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-immunotherapy-to-patients-with-stage-ii-iii-nsclc-who-achieved-a-pathologic-complete-response-from-3-cycles-of-neoadjuvant-nivolumab-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-workup-for-patients-with-suspected-muscular-dystrophy weekly 0.8 https://www.themednet.org/in-what-situations-if-any-would-you-recommend-nalirifox-over-folfirinox-for-first-line-treatment-of-patients-with-unresectable-pancreatic-cancer weekly 0.8 https://www.themednet.org/do-you-screen-for-vwd-in-all-women-with-menorrhagia-severe-enough-to-cause-iron-deficiency-anemia weekly 0.8 https://www.themednet.org/are-there-certain-patients-in-whom-you-would-avoid-initiation-of-ult-during-an-acute-gout-flare weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-restless-leg-syndrome-in-pregnancy weekly 0.8 https://www.themednet.org/would-you-recommend-switching-to-dapt-for-patients-on-anticoagulation-who-develop-symptoms-of-a-tia-secondary-to-icad weekly 0.8 https://www.themednet.org/can-guillain-barre-syndrome-present-with-intact-reflexes weekly 0.8 https://www.themednet.org/regarding-cvst-what-protocol-of-heparin-dosing-do-you-regularly-use-and-does-it-change-depending-on-clot-burden-ich-status weekly 0.8 https://www.themednet.org/based-on-recently-published-data-from-cog-anhl12p1-how-will-you-use-crizotinib-in-pediatric-and-aya-patients-with-alk-anaplastic-large-cell-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-a-patient-with-intermediate-risk-prostate-cancer-treated-upfront-with-hifu-and-intermittent-adt-who-is-later-found-to-have-rising-psa-and-biopsy-proven-prostate-confined-recurrence weekly 0.8 https://www.themednet.org/how-do-you-determine-which-patients-you-prescribe-5-fluorouracil-vs-5-fluorouracil-with-calcipotriene-for-actinic-field-disease weekly 0.8 https://www.themednet.org/do-you-favor-absorbable-or-non-absorbable-sutures-for-epidermal-closures weekly 0.8 https://www.themednet.org/what-is-the-role-of-gammatile-in-the-management-of-primary-brain-tumors-and-brain-metastases weekly 0.8 https://www.themednet.org/in-light-of-findings-from-gog-258-is-the-benefit-of-adjuvant-rt-in-iiic-endometrial-cancer-worth-the-potential-acute-and-late-risks-of-rt-in-the-setting-of-significant-autoimmune-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-mitral-valve-endocarditis-associated-with-a-large-vegetation-size-and-severe-mitral-regurgitation-but-without-any-heart-failure-hemodynamic-instability-or-valve-destruction weekly 0.8 https://www.themednet.org/do-you-change-treatment-for-confirmed-biochemical-progression-in-patients-with-otherwise-secretory-mm-even-if-the-m-spike-is-0-5-g-dl weekly 0.8 https://www.themednet.org/would-you-offer-re-irradiation-for-a-patient-with-a-left-sided-medial-diep-flap-recurrence-with-a-history-of-prior-whole-breast-radiation-25-years-ago weekly 0.8 https://www.themednet.org/how-can-hepatic-venous-pressure-gradients-in-patients-with-cirrhosis-be-used-to-differentiate-between-cardiac-cirrhosis-and-portopulmonary-hypertension weekly 0.8 https://www.themednet.org/is-morphea-cutaneous-scleroderma-with-no-organ-involvement-a-contraindication-for-radiation-in-early-stage-breast-cancer-as-part-of-breast-conservation-therapy weekly 0.8 https://www.themednet.org/what-is-the-normal-range-of-spinal-tap-opening-pressure weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-post-spinal-tap-headaches weekly 0.8 https://www.themednet.org/which-iv-medications-do-you-offer-for-outpatient-headache-infusions weekly 0.8 https://www.themednet.org/should-bed-or-eqd2-be-used-when-deciding-on-a-fractionation-scheme-for-breast-cancer-radiation-and-should-tumor-or-normal-tissue-be-prioritized-in-this-consideration weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-malignant-spindle-cell-neoplasm-of-the-scalp-excised-with-a-focally-positive-deep-margin weekly 0.8 https://www.themednet.org/how-would-you-manage-a-transplant-eligible-patient-with-dlbcl-who-relapsed-6-12-months-following-a-cr1-to-r-chop-and-then-attained-a-cr2-to-platinum-based-salvage-chemoimmunotherapy weekly 0.8 https://www.themednet.org/what-are-current-strategies-to-treat-severe-symptomatic-basilar-stenosis-failing-medical-therapy weekly 0.8 https://www.themednet.org/would-you-consider-sbrt-for-a-patient-with-a-solitary-hcc-lesion-with-sle-lupus-previously-on-immunosuppression weekly 0.8 https://www.themednet.org/in-clinically-metastatic-lung-cancer-with-bone-predominant-disease-do-you-routinely-biopsy-the-bone-to-prove-metastatic-involvement-knowing-that-bone-biopsies-are-generally-not-ideal-for-molecular-testing weekly 0.8 https://www.themednet.org/would-you-use-belimumab-in-a-breastfeeding-patient-with-sle-who-has-persistent-joint-pain-leukopenia-and-elevated-dsdna-despite-hcq-and-azathioprine weekly 0.8 https://www.themednet.org/do-you-ever-consider-hypo-fractionated-palliative-radiation-postoperatively-for-bone-metastases weekly 0.8 https://www.themednet.org/how-do-you-decide-between-rplnd-vs-chemotherapy-in-patients-with-stage-iia-mixed-germ-cell-tumor-as-primary-treatment weekly 0.8 https://www.themednet.org/what-level-of-exercise-do-you-recommend-in-patients-with-parkinsons-disease weekly 0.8 https://www.themednet.org/are-there-select-patients-with-rectal-cancer-where-radiation-field-size-reduction-might-be-feasible weekly 0.8 https://www.themednet.org/would-you-use-short-course-radiation-for-patients-with-rectal-cancer-and-ulcerative-colitis-or-crohns-disease weekly 0.8 https://www.themednet.org/how-long-do-you-wait-before-foley-or-iv-placement-in-patients-who-have-recieved-tnk-or-tpa weekly 0.8 https://www.themednet.org/has-use-of-psma-petct-revealed-increased-local-failures-than-previously-known-after-definitive-prostate-ebrt-with-biochemical-failure weekly 0.8 https://www.themednet.org/how-do-you-approach-an-itp-patient-who-responds-very-well-to-steroids-but-the-response-is-short-lived weekly 0.8 https://www.themednet.org/how-would-you-approach-neoadjuvant-radiation-therapy-for-an-adenocarcinoma-of-the-anus-involving-the-perirectal-skin-in-a-patient-with-a-history-of-total-proctocolectomy-with-an-ileoanal-j-pouch-anastomosis weekly 0.8 https://www.themednet.org/what-therapies-have-you-found-most-effective-for-managing-patients-with-darier-disease weekly 0.8 https://www.themednet.org/what-procedures-do-you-recommend-for-patients-interested-in-xanthelasma-removal weekly 0.8 https://www.themednet.org/is-there-any-role-for-rt-in-the-management-of-florid-lcis-after-mastectomy weekly 0.8 https://www.themednet.org/are-you-offering-chemotherapy-for-premenopausal-patients-with-hr-node-positive-breast-ca-with-oncotype-dx-scores-in-the-intermediate-range-of-11-25 weekly 0.8 https://www.themednet.org/do-you-recommend-adjuvant-radiation-for-a-recurrent-pt1bn0-vulvar-carcinoma weekly 0.8 https://www.themednet.org/do-you-recommend-an-additional-procedure-for-melanomas-if-there-is-tumor-within-1-2mm-of-the-margin weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-hydroxychloroquine-in-patients-with-a-history-of-visual-field-defect-from-another-cause-such-as-macular-degeneration-or-diabetic-retinopathy weekly 0.8 https://www.themednet.org/would-you-consider-radiation-therapy-before-chemotherapy-in-a-patient-with-stage-i-ii-high-grade-b-cell-lymphoma-presenting-with-a-large-necrotic-skin-lesion weekly 0.8 https://www.themednet.org/is-there-any-role-for-elacestrant-in-patient-who-have-received-prior-fulvestrant-if-they-have-esr1-mutation weekly 0.8 https://www.themednet.org/if-blood-counts-are-being-checked-during-concurrent-chemoradiation-is-there-a-number-at-which-point-you-would-recommend-a-radiation-treatment-break weekly 0.8 https://www.themednet.org/would-you-offer-definitive-chemort-for-nsclc-with-histologically-proven-contralateral-station-11-nodal-involvement weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-acc-2023 weekly 0.8 https://www.themednet.org/when-treating-stage-ivb-cervical-cancer-with-both-systemic-chemotherapy-and-local-pelvic-radiation-therapy-do-you-incorporate-the-use-of-bevacizumab-as-in-gog-240 weekly 0.8 https://www.themednet.org/do-you-consider-downstaging-neoadjuvant-cemiplimab-for-borderline-resectable-cscc-in-order-to-facilitate-surgical-resection weekly 0.8 https://www.themednet.org/what-role-if-any-do-biomarkers-play-in-selecting-appropriate-patients-for-neoadjuvant-cemiplimab-in-cutaneous-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-an-endocervical-cancer-indeterminate-for-endometrial-or-cervical-origin-status-post-tah-bso-and-sentinel-node-biopsy weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-prostate-cancer-with-sclerotic-lytic-lesions-found-on-a-ct-scan-but-not-seen-on-a-bone-scan-or-pet-psma weekly 0.8 https://www.themednet.org/would-you-start-fulvestrant-plus-cdk4-6-inhibitors-in-a-patient-with-esr1-mutation-with-metastatic-breast-cancer-on-liquid-biopsy-in-a-first-line-setting weekly 0.8 https://www.themednet.org/would-you-withhold-adjuvant-folfox-in-stage-iii-colon-cancer-if-signatera-circulating-tumor-dna-testing-is-negative weekly 0.8 https://www.themednet.org/in-which-scenario-would-you-prefer-use-of-passive-scatter-proton-therapy-over-intensity-modulated-proton-therapy weekly 0.8 https://www.themednet.org/does-phosphatidylserine-antibody-play-a-role-in-the-diagnosis-of-antiphospholipid-antibody-syndrome weekly 0.8 https://www.themednet.org/how-does-a-negative-psma-pet-change-your-management-when-completing-salvage-radiation-for-prostate-cancer weekly 0.8 https://www.themednet.org/in-light-of-the-improved-outcomes-seen-in-patients-receiving-io-olaparib-what-role-if-any-do-you-think-pelvic-radiation-still-plays-in-the-management-of-patients-with-advanced-endometrial-cancer weekly 0.8 https://www.themednet.org/how-are-you-managing-patients-with-h-n-cancers-meriting-definitive-concurrent-chemort-during-cisplatin-shortages weekly 0.8 https://www.themednet.org/in-what-clinical-scenarios-do-you-utilize-opioids-in-patients-with-restless-leg-syndrome weekly 0.8 https://www.themednet.org/do-you-routinely-screen-for-sleep-apnea-in-patients-with-acute-ischemic-stroke weekly 0.8 https://www.themednet.org/do-you-recommend-bedtime-administration-of-antihypertensives-in-patients-who-exhibit-nondipping-on-ambulatory-blood-pressure-monitoring weekly 0.8 https://www.themednet.org/how-do-you-define-an-adequate-ebus-when-staging-nsclc weekly 0.8 https://www.themednet.org/how-would-you-approach-therapy-for-a-patient-with-symptomatic-secondary-cns-marginal-zone-lymphoma-but-with-low-volume-systemic-disease-that-would-otherwise-not-warrant-therapy weekly 0.8 https://www.themednet.org/is-there-a-role-for-eculizumab-in-the-management-of-refractory-lupus-nephritis weekly 0.8 https://www.themednet.org/would-you-recommend-pmrt-for-t2n0-i-breast-cancer weekly 0.8 https://www.themednet.org/if-using-protons-instead-of-photons-does-the-use-of-protons-impact-your-recommendation-for-using-hypofractionation-in-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-referred-for-c1-2-pannus-erosions-without-clinical-findings-or-serologies-consistent-with-ra-or-cppd-arthropathy weekly 0.8 https://www.themednet.org/would-presence-of-diep-flap-reconstruction-impact-your-decision-to-proceed-with-a-bid-approach-to-pmrt-for-inflammatory-breast-cancer weekly 0.8 https://www.themednet.org/in-a-patient-with-her2-advanced-endometrial-cancer-do-you-include-io-olaparib-in-their-treatment-regimen-or-only-trastuzumab-in-addition-to-carboplatin-paclitaxel weekly 0.8 https://www.themednet.org/would-you-give-doxorubicin-and-cisplatin-for-localized-chondroblastic-osteosarcoma-in-a-patient-with-prior-childhood-anthracycline-exposure-and-resultant-cardiomyopathy-with-ef-50 weekly 0.8 https://www.themednet.org/do-you-recommend-retreatment-with-an-immune-checkpoint-inhibitor-in-a-patient-with-a-history-of-immune-checkpoint-inhibitor-related-aki-that-resolved-with-holding-the-immune-checkpoint-inhibitor-and-a-glucocorticoid-taper weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-an-icu-patient-with-brief-potentially-ictal-rhythmic-discharges-birds-on-eeg weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-osteoporosis-in-patients-post-bariatric-surgery weekly 0.8 https://www.themednet.org/would-you-consider-pbi-plus-covering-the-regional-lymph-nodes-for-a-ln-breast-cancer-in-the-remnant-of-the-axillary-tail weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-systemic-treatment-for-recurrent-metastatic-low-grade-er-pr-pmmr-endometrioid-endometrial-carcinoma weekly 0.8 https://www.themednet.org/what-would-be-your-next-step-in-treating-a-patient-with-osteoporosis-who-developed-aff-on-denosumab-and-who-then-completed-one-year-of-romosozumab weekly 0.8 https://www.themednet.org/how-do-you-manage-radiation-plexopathy weekly 0.8 https://www.themednet.org/what-indicators-do-you-use-to-determine-whether-a-patient-is-having-a-favorable-or-unfavorable-response-to-nintedanib weekly 0.8 https://www.themednet.org/is-it-time-to-re-evaluate-the-timing-of-radiation-and-chemotherapy-with-the-adoption-of-hypofractionated-courses-of-radiation-for-breast-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-initiating-an-ace-inhibitor-or-arb-in-a-patient-with-proteinuric-ckd-stage-5 weekly 0.8 https://www.themednet.org/would-you-alter-your-treatment-algorithm-for-uterus-mesonephric-like-adenocarcinoma weekly 0.8 https://www.themednet.org/when-prescribing-hydroxychloroquine-how-do-you-explain-the-mechanism-of-action-and-how-this-translates-into-clinical-benefit-for-the-patient weekly 0.8 https://www.themednet.org/how-do-you-interpret-the-ebctcg-meta-analysis-analyzing-the-magnitude-of-benefit-of-anthracyclines-in-early-stage-er-breast-cancer weekly 0.8 https://www.themednet.org/would-you-consider-pelvic-radiation-in-a-patient-with-prostate-cancer-and-myelofibrosis-with-mild-cytopenias weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-a-patient-with-idiopathic-pah-and-ana-but-no-other-current-symptoms-signs-of-active-rheumatologic-disease weekly 0.8 https://www.themednet.org/do-you-recommend-starting-aspirin-for-a-patient-with-eskd-secondary-to-lupus-nephritis-with-detected-antiphospholipid-antibodies-on-pretransplant-workup-but-no-history-of-a-thrombotic-event weekly 0.8 https://www.themednet.org/for-nsclc-patients-who-are-polymetastatic-who-then-become-and-remain-oligometastatic-is-there-a-role-for-local-ablative-rt-to-the-primary-and-metastatic-sites weekly 0.8 https://www.themednet.org/how-do-you-utilize-diamox-in-patients-with-cerebral-venous-sinus-thrombosis-and-vision-symptoms-who-do-not-undergo-thrombectomy-recanalization weekly 0.8 https://www.themednet.org/since-the-publication-of-destiny-breast-04-have-you-implemented-new-institutional-practices-for-characterization-of-her2-low-disease-given-known-limitations-in-pathologist-ihc-evaluation weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-ckd-who-are-on-a-ppi-given-a-prior-observational-study-showing-an-association-between-ppi-use-and-incident-ckd weekly 0.8 https://www.themednet.org/do-you-recommend-obtaining-one-or-two-24-hour-urine-stone-risk-profile-s-when-evaluating-patients-with-nephrolithiasis weekly 0.8 https://www.themednet.org/how-will-the-prospect-trial-presented-at-asco-2023-change-your-current-management-of-early-rectal-cancer weekly 0.8 https://www.themednet.org/is-it-reasonable-to-consider-the-use-of-doacs-for-lv-thrombus-management-instead-of-coumadin weekly 0.8 https://www.themednet.org/would-you-implement-car-t-therapy-earlier-in-practice-if-approved-in-earlier-lines-for-multiple-myeloma-based-on-the-karmma-3-and-cartitutude-4-studies weekly 0.8 https://www.themednet.org/would-you-treat-endometrioid-adenocarcinoma-arising-from-an-endometriosis-lesion-in-a-patient-with-prior-hyst-bso-like-an-ovarian-or-endometrial-primary weekly 0.8 https://www.themednet.org/do-you-recommend-patients-discontinue-spironolactone-after-a-certain-number-of-years weekly 0.8 https://www.themednet.org/how-long-can-you-treat-dermatomyositis-with-ivig weekly 0.8 https://www.themednet.org/when-is-mechlorethamine-better-than-more-common-treatments-like-light-therapy-and-topical-steroids-for-mycosis-fungoides weekly 0.8 https://www.themednet.org/with-the-current-cisplatin-and-carboplatin-shortages-for-hpv-h-n-patients-with-indications-for-concurrent-chemort-which-agent-do-you-recommend-next weekly 0.8 https://www.themednet.org/is-intermittent-fasting-effective-for-weight-loss weekly 0.8 https://www.themednet.org/would-you-start-anabolic-agents-for-osteoporotic-hip-fracture-healing weekly 0.8 https://www.themednet.org/how-will-you-sequence-therapies-in-dermatomyositis-given-the-results-of-the-proderm-trial weekly 0.8 https://www.themednet.org/how-are-you-utilizing-vibratory-devices-for-reducing-pain-associated-with-injection-or-procedures weekly 0.8 https://www.themednet.org/is-there-evidence-to-support-or-argue-against-intermittent-fasting-for-cancer-patients weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-patients-who-develop-psoriasis-while-on-dupixent weekly 0.8 https://www.themednet.org/how-long-would-you-wait-before-performing-a-kidney-biopsy-in-a-patient-with-possible-ain-whose-creatinine-has-plateaued-but-not-improved-after-discontinuing-the-suspected-offending-agent weekly 0.8 https://www.themednet.org/how-do-you-manage-a-recurrence-of-colon-cancer-within-3-4-months-of-completion-of-adjuvant-folfox weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-prefer-to-continue-tnfi-therapy-indefinitely-for-rheumatoid-arthritis-despite-long-standing-remission weekly 0.8 https://www.themednet.org/would-you-recommend-oral-or-intravenous-iron-in-a-chronic-kidney-disease-stage-4-patient-who-is-not-on-an-esa-and-has-a-hemoglobin-of-12-7-g-dl-and-an-iron-saturation-of-less-than-20 weekly 0.8 https://www.themednet.org/do-you-recommend-obtaining-a-spot-urine-or-24-hour-urine-magnesium-measurement-when-evaluating-patients-with-persistent-hypomagnesemia-of-unknown-etiology weekly 0.8 https://www.themednet.org/do-you-add-pelvic-rt-for-stage-ii-gr-2-endometrial-cancers-with-multiple-high-risk-features weekly 0.8 https://www.themednet.org/do-you-hold-rituximab-for-cataract-surgery weekly 0.8 https://www.themednet.org/what-is-your-approach-to-gdmt-uptitration-particularly-dosing-for-arbs-arnis-mra-if-there-is-further-evidence-of-renal-dysfunction-especially-in-situations-with-worsening-aki-on-ckd weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-a-prior-history-of-an-early-stage-breast-cancer-who-now-has-a-5-cm-tumor-in-this-ipsilateral-breast-with-nodal-involvement weekly 0.8 https://www.themednet.org/would-you-offer-pmrt-to-a-young-patient-with-a-remote-history-of-mantle-lung-rt-for-hodgkins-lymphoma-and-a-left-ct0n1-triple-positive-breast-cancer-with-a-complete-response-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-adjustments-do-you-make-to-a-hemodialysis-prescription-for-a-patient-with-a-recent-stroke weekly 0.8 https://www.themednet.org/given-the-cardioprotective-and-renoprotective-effects-of-sglt2-inhibitors-should-we-consider-administering-to-patients-with-well-controlled-type-1-diabetes-despite-the-risk-of-dka weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-ckd4-due-to-lupus-nephritis-of-unknown-class-who-develops-aki-requiring-hemodialysis-and-nephrotic-range-proteinuria-and-is-found-to-have-atrophic-kidneys-on-imaging weekly 0.8 https://www.themednet.org/do-you-dose-escalate-a-patient-with-high-risk-prostate-cancer-who-refuses-adt-due-to-potential-side-effects weekly 0.8 https://www.themednet.org/what-is-your-approach-for-treating-oligometastatic-head-and-neck-cancer-to-an-adjacent-nodal-site-ie-axilla-mediastinum-etc-with-radiation-therapy weekly 0.8 https://www.themednet.org/how-do-you-contour-a-resected-brain-metastases-for-fractionated-partial-brain-radiation weekly 0.8 https://www.themednet.org/in-patients-undergoing-mri-evaluation-for-inflammatory-back-pain-how-long-do-you-recommend-they-hold-nsaids-prior-to-imaging weekly 0.8 https://www.themednet.org/in-extremely-obese-patients-with-spontaneous-dvt-pe-who-have-been-anticoagulated-for-6-months-do-you-feel-comfortable-reducing-the-doac-to-prophylactic-dose-or-do-you-prefer-continuing-full-dose-indefinite-anticoagulation weekly 0.8 https://www.themednet.org/do-you-recommend-dietary-changes-to-your-patients-with-recurrent-kidney-stone-disease-who-consume-coffee-and-low-oxalate-teas-daily weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-high-risk-prostate-cancer-treated-with-rt-long-term-adt-who-want-to-allow-their-testosterone-level-to-rise-above-castration-before-receiving-their-next-lupron-injection weekly 0.8 https://www.themednet.org/how-do-you-choose-between-the-different-recently-approved-bispecifics-antibodies-for-relapsed-refractory-multiple-myeloma weekly 0.8 https://www.themednet.org/for-patients-on-commercial-teclistamab-who-achieve-a-response-are-there-patient-specific-or-response-specific-parameters-that-would-prompt-you-to-de-escalate-therapy-from-once-per-week weekly 0.8 https://www.themednet.org/do-you-recommend-continuing-sglt2-inhibitors-in-patients-with-diabetic-kidney-disease-and-congestive-heart-failure-who-have-been-taking-the-medication-for-several-years-and-later-develop-end-stage-kidney-disease weekly 0.8 https://www.themednet.org/how-do-you-choose-between-axicabtagene-ciloleucel-and-tisagenlecleucel-in-patients-with-follicular-lymphoma-for-whom-you-are-recommending-car-t-cell-therapy weekly 0.8 https://www.themednet.org/what-therapies-have-you-found-most-helpful-for-recalcitrant-non-infectious-cases-of-folliculitis weekly 0.8 https://www.themednet.org/are-scds-contraindicated-in-patients-with-acute-dvts weekly 0.8 https://www.themednet.org/when-do-you-expect-the-2023-figo-staging-for-endometrial-cancer-to-become-adopted-clinically-in-the-us weekly 0.8 https://www.themednet.org/following-completion-of-antiplatelet-monotherapy-i-e-plavix-plus-oral-anticoagulation-in-patients-with-afib-post-pci-would-you-favor-continuing-antiplatelet-therapy-oac-switching-from-plavix-to-aspirin-and-continuing-oac-or-stopping-antiplatelet-therapy-a weekly 0.8 https://www.themednet.org/do-you-typically-recommend-sleep-studies-for-patients-with-parkinsonism weekly 0.8 https://www.themednet.org/how-do-you-explain-the-clinical-benefit-of-lecanemab-or-donanemab-to-patients weekly 0.8 https://www.themednet.org/how-soon-after-car-t-cell-therapy-can-salvage-radiation-be-delivered weekly 0.8 https://www.themednet.org/would-you-start-anticoagulation-in-a-patient-with-provoked-blood-clot-in-the-past-now-with-labs-done-for-rheumatological-reasons-showing-triple-positive-apla weekly 0.8 https://www.themednet.org/what-percentage-of-your-breast-cancer-patients-do-you-plan-using-imrt-vs-3d weekly 0.8 https://www.themednet.org/when-treating-breast-cancer-patients-with-rni-how-often-do-you-include-internal-mammary-nodes weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-newly-diagnosed-high-grade-osteosarcoma-who-received-maximum-cumulative-dose-of-doxorubicin-for-a-soft-tissue-sarcoma-10-years-earlier weekly 0.8 https://www.themednet.org/when-attempting-peep-titration-how-long-do-you-wait-after-decrements-or-increments-to-assess-for-a-change-in-driving-pressure weekly 0.8 https://www.themednet.org/with-multiple-parpi-arsi-combinations-now-approved-how-are-you-selecting-which-combination-to-use-for-a-patient-with-brca-mutated-mcrpc weekly 0.8 https://www.themednet.org/what-role-does-radiation-plan-in-a-pt1a-endometrial-cancer-with-two-small-metastatic-foci-in-the-abdomen-found-during-surgery weekly 0.8 https://www.themednet.org/what-dose-constraints-do-you-use-when-treating-a-patient-with-bilateral-breast-cancer-with-rni weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-patients-with-lupus-and-transverse-myelitis-not-responding-to-pulse-dose-steroids weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-end-stage-kidney-disease-and-recurrent-ascites-who-do-not-have-any-evidence-of-cardiac-or-liver-disease weekly 0.8 https://www.themednet.org/how-have-you-adjusted-your-practice-for-treatment-of-syphilis-in-light-of-the-penicillin-g-benzathine-shortage weekly 0.8 https://www.themednet.org/do-you-add-gentamicin-when-treating-prosthetic-valve-endocarditis-secondary-to-viridans-group-streptococcus-with-a-penicillin-intermediate-isolate-mic-0-125-0-5 weekly 0.8 https://www.themednet.org/in-addition-to-ampicillin-is-there-any-benefit-to-the-addition-of-either-gentamicin-or-bactrim-when-treating-a-patient-with-listeria-meningitis-1 weekly 0.8 https://www.themednet.org/how-long-do-you-treat-an-isolated-bacterial-liver-abscess-which-has-either-undergone-percutaneous-drainage-or-for-which-an-indwelling-drain-is-placed weekly 0.8 https://www.themednet.org/do-you-treat-stenotrophomonas-maltophilia-bacteremia-with-combination-therapy-and-if-so-what-is-your-preferred-combination-of-antibacterials weekly 0.8 https://www.themednet.org/for-how-long-do-you-treat-an-early-spinal-hardware-infection-secondary-to-mssa-after-operative-washout-and-retention-of-hardware weekly 0.8 https://www.themednet.org/for-very-large-locally-advanced-head-and-neck-primary-malignancies-namely-scca-how-do-you-decide-between-adaptive-re-planning-of-a-vmat-imrt-plan-during-chemo-rt-as-option-instead-of-induction-chemotherapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-using-pegloticase-in-patients-with-congestive-heart-failure weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-t1c-hr-her2-breast-cancer-stage-iv-with-involvement-of-multiple-bilateral-axillary-nodes-and-no-evidence-of-distant-metastasis weekly 0.8 https://www.themednet.org/when-planning-concurrent-chemoradiation-for-locally-advanced-nsclc-do-you-consider-prescribing-primary-tumor-disease-to-a-lower-isodose-line-such-as-75-if-oar-constraints-for-standard-prescribing-are-met weekly 0.8 https://www.themednet.org/how-would-you-treat-an-endobronchial-nsclc-abutting-a-hiatal-hernia-in-a-patient-who-is-medically-inoperable weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-systemic-therapy-for-an-isolated-oligometastatic-cns-recurrence-of-rcc-that-was-treated-with-sbrt weekly 0.8 https://www.themednet.org/what-is-your-approach-to-maintenance-of-sotalol-in-terms-of-drug-monitoring-and-duration-of-therapy-for-outpatients-who-remain-in-normal-sinus-rhythm weekly 0.8 https://www.themednet.org/is-it-safe-to-combine-mycophenolate-and-adalimumab-for-management-of-pulmonary-sarcoidosis-in-a-patient-that-could-not-tolerate-methotrexate weekly 0.8 https://www.themednet.org/how-have-you-incorporated-new-psoriasis-therapies-such-as-deucravacitinib-and-bimekizumab-into-your-hierarchy-of-psoriasis-treatments weekly 0.8 https://www.themednet.org/do-patient-co-morbidities-impact-when-you-prescribe-oral-jak-inhibitors weekly 0.8 https://www.themednet.org/when-starting-hn-radiation-which-start-day-do-you-prefer-to-add-most-value-to-the-treatment-course weekly 0.8 https://www.themednet.org/how-do-you-approach-work-up-for-underlying-rheumatologic-disease-in-patients-referred-for-chronic-urticaria weekly 0.8 https://www.themednet.org/is-it-ever-acceptable-to-treat-low-pelvis-vs-whole-pelvis-for-an-early-vaginal-recurrence-of-endometrial-cancer weekly 0.8 https://www.themednet.org/is-there-a-good-rationale-for-using-vasopressors-induced-hypertension-in-a-patient-with-fluctuating-neurologic-deficits-from-symptomatic-intracranial-stenosis weekly 0.8 https://www.themednet.org/at-what-point-would-you-consider-anticoagulation-in-a-pregnant-patient-with-lupus-nephritis-and-non-nephrotic-range-proteinuria weekly 0.8 https://www.themednet.org/would-you-offer-focal-prostate-boost-per-flame-protocol-for-gtv-defined-by-pet-alone-without-mri weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-severe-ra-or-sle-that-worsens-after-stopping-immunosuppressants-due-to-having-chronic-foot-ulceration weekly 0.8 https://www.themednet.org/would-you-use-adagrasib-in-combination-with-cetuximab-based-on-recently-published-article-in-nejm-for-metastatic-colon-cancer-with-kras-g12c-mutation weekly 0.8 https://www.themednet.org/is-there-any-situation-where-hypofractionation-of-post-mastectomy-radiation-cw-and-regional-nodes-is-absolutely-contraindicated weekly 0.8 https://www.themednet.org/how-do-you-approach-the-timing-of-rituximab-during-pregnancy-in-a-patient-with-life-or-organ-threatening-autoimmune-disease weekly 0.8 https://www.themednet.org/how-do-you-differentiate-active-vasculitis-from-pregnancy-complications-such-as-pre-eclampsia-and-hellp-in-a-patient-with-aav weekly 0.8 https://www.themednet.org/for-hpv-negative-head-and-neck-cancer-of-unknown-primary-after-proper-work-up-and-biopsies-what-mucosal-surface-s-do-you-cover weekly 0.8 https://www.themednet.org/what-strategies-have-you-used-to-help-patients-with-advanced-kidney-disease-who-are-asymptomatic-understand-the-severity-of-their-condition weekly 0.8 https://www.themednet.org/do-you-ever-treat-a-recurrent-breast-cancer-with-rni-alone-rather-than-chest-wall-and-rni weekly 0.8 https://www.themednet.org/in-a-patient-with-severe-hyponatremia-and-acute-kidney-injury-in-the-setting-of-hypovolemic-shock-would-fluid-resuscitation-take-precedence-over-the-rate-at-which-sodium-is-corrected weekly 0.8 https://www.themednet.org/how-if-at-all-are-you-employing-ctdna-in-the-management-of-patients-with-colon-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-an-elderly-patient-80-years-with-stage-iic-melanoma-post-resection-with-oligometastatic-brain-lesion-post-intracranial-resection-which-developed-2-years-after-treatment weekly 0.8 https://www.themednet.org/what-is-your-preferred-choice-of-anticoagulant-vka-vs-doac-in-patients-with-an-lv-thrombus-and-apical-infarct weekly 0.8 https://www.themednet.org/which-chemotherapy-is-preferred-between-tc-and-ac-t-in-a-young-patient-with-er-pr-her2-node-negative-breast-cancer-intermediate-grade-with-high-oncotype-score weekly 0.8 https://www.themednet.org/how-do-you-address-incidental-small-cerebellar-infarcts-seen-on-mri weekly 0.8 https://www.themednet.org/what-is-your-treatment-algorithm-for-excoriation-disorder weekly 0.8 https://www.themednet.org/would-you-dose-escalate-for-prostate-cancer-extending-to-the-penile-bulb-towards-the-urethra-and-close-to-anorectal-junction weekly 0.8 https://www.themednet.org/should-patients-with-hypothyroidism-hold-their-morning-levothyroxine-dose-before-going-to-the-lab-to-check-free-t4-tsh weekly 0.8 https://www.themednet.org/do-you-offer-neoadjuvant-radiation-therapy-for-oral-cavity-sarcoma weekly 0.8 https://www.themednet.org/what-can-be-done-to-help-rehabilitate-trismus-secondary-to-radiation-and-surgery weekly 0.8 https://www.themednet.org/would-you-feel-comfortable-adding-benlysta-to-patient-already-taking-both-mycophenolate-and-tacrolimus-and-hydroxychloroquine-who-still-has-some-evidence-of-active-lupus-nephritis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-diagnosis-and-evaluation-of-nonbacterial-thrombotic-endocarditis-libman-sacks weekly 0.8 https://www.themednet.org/do-you-use-traditional-bony-landmarks-or-contoured-nodal-volumes-when-designing-breast-and-supraclavicular-treatment-fields weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-pembrolizumab-to-a-stage-ii-iii-adenocarcinoma-of-the-lung-who-had-a-complete-pathologic-response-to-4-cycles-of-cisplatin-pemetrexed-pembro-kn-671 weekly 0.8 https://www.themednet.org/how-will-you-approach-tapering-sarilumab-in-patients-with-pmr-in-remission weekly 0.8 https://www.themednet.org/will-you-be-changing-your-management-of-locally-advanced-cervical-cancer-based-on-the-results-of-the-recently-published-interlace-trial weekly 0.8 https://www.themednet.org/what-other-considerations-for-hyperlipidemia-management-would-you-have-for-a-patient-with-multiple-prior-pcis-whose-ldl-remains-above-goal-on-high-intensity-statin-ezetimibe-and-evolocumab-assuming-the-patient-is-compliant-with-medications weekly 0.8 https://www.themednet.org/how-do-you-manage-proteinuria-in-a-patient-with-type-1-diabetes-mellitus-who-has-orthostatic-hypotension-and-is-unable-to-tolerate-acei-arbs weekly 0.8 https://www.themednet.org/how-long-can-you-continue-chronic-low-dose-isotretinoin-for-refractory-acne-or-other-conditions weekly 0.8 https://www.themednet.org/do-you-take-the-primary-dissected-site-for-postoperative-oral-cavity-cancers-with-bony-invasion-to-66-gy weekly 0.8 https://www.themednet.org/what-is-your-strategy-for-managing-immunosuppression-in-patients-with-a-kidney-transplant-who-develop-metastatic-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-sglt2i-use-for-patients-with-chronic-kidney-disease-diabetes-mellitus-and-polycystic-kidney-disease weekly 0.8 https://www.themednet.org/do-you-administer-calcium-to-patients-with-k-6-5-without-ekg-changes weekly 0.8 https://www.themednet.org/is-there-a-subset-of-patients-with-pagets-disease-of-the-breast-in-whom-you-would-omit-radiation-after-a-central-lumpectomy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-vaccinations-and-titers-for-patients-with-myeloma-who-are-immunosuppressed-and-do-not-have-appropriate-antibody-responses-to-vaccines weekly 0.8 https://www.themednet.org/how-do-you-manage-recurrent-urticarial-lesions-in-a-patient-with-underlying-connective-tissue-disease-that-is-otherwise-well-controlled weekly 0.8 https://www.themednet.org/would-you-recommend-off-label-use-of-chemoimmunotherapy-for-metastatic-anal-squamous-cell-cancer weekly 0.8 https://www.themednet.org/for-which-patients-if-any-do-you-typically-order-additional-imaging-workup-for-staging-in-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-incorporate-dcisionrt-testing-in-the-setting-of-close-2-mm-or-positive-dcis-margins weekly 0.8 https://www.themednet.org/is-there-a-role-for-adjuvant-pembrolizumab-capecitabine-in-a-patient-with-tnbc-who-receives-neoadjuvant-ac-t-with-residual-disease-found-at-time-of-surgery weekly 0.8 https://www.themednet.org/is-there-an-sib-boost-regimen-for-a-dominant-prostate-lesion-for-60-gy-20-fx-to-the-whole-prostate weekly 0.8 https://www.themednet.org/do-you-prefer-to-taper-rituximab-by-extending-the-interval-between-doses-or-decreasing-the-actual-dose-administered-for-ra-patients-who-have-achieved-longstanding-remission weekly 0.8 https://www.themednet.org/how-do-you-approach-pre-operative-chemoradiation-for-vulvar-cancer weekly 0.8 https://www.themednet.org/what-disease-characteristics-will-guide-your-choice-of-alpelisib-plus-fulvestrant-per-solar-1-versus-capivasertib-plus-fulvestrant-per-capitello-291-in-pik3ca-mutated-advanced-er-her2-breast-cancer-after-progression-on-1l-et-regimen-given-both-are-now-app weekly 0.8 https://www.themednet.org/how-extensive-of-a-workup-do-you-do-for-systemic-al-amyloidosis-for-a-patient-with-a-resected-amyloidoma-localized-al-amyloid-deposition-in-their-airway-or-lungs-who-has-no-other-symptoms weekly 0.8 https://www.themednet.org/is-it-safe-to-use-quinacrine-in-sle-patients-with-a-history-of-hydroxychloroquine-associated-retinopathy weekly 0.8 https://www.themednet.org/how-do-you-calculate-qtc-intervals-in-patients-being-admitted-for-aad-drug-loading-who-remain-in-atrial-fibrillation-or-atrial-flutter weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-adult-onset-stills-disease-in-a-patient-with-ongoing-fatigue-and-inflammatory-joint-pain-despite-methotrexate-colchicine-canakinumab-and-tocilizumab weekly 0.8 https://www.themednet.org/is-there-a-particular-pvc-nsvt-burden-on-inpatient-telemetry-in-which-you-would-consider-discharging-a-patient-with-a-lifevest-post-stemi-with-newly-reduced-lvef-35-while-optimizing-gdmt weekly 0.8 https://www.themednet.org/when-treating-inguinal-lymph-nodes-in-the-setting-of-pelvic-rt-what-is-your-preferred-setup-in-order-to-minimize-dose-to-the-penis weekly 0.8 https://www.themednet.org/do-you-prescribe-fluocinolone-in-peanut-oil-in-patients-with-peanut-allergies weekly 0.8 https://www.themednet.org/is-history-of-radiation-an-absolute-contraindication-to-using-parathyroid-hormone-pth-analogues weekly 0.8 https://www.themednet.org/do-you-start-aspirin-for-patients-with-incidentally-found-intracranial-vertebral-stenosis weekly 0.8 https://www.themednet.org/do-you-offer-a-curative-surgery-whipple-procedure-to-patients-with-duodenal-adenocarcinoma-with-2-5-liver-metastases-and-with-near-cr-after-3-6-months-of-folfox-chemotherapy weekly 0.8 https://www.themednet.org/for-patients-undergoing-bladder-preservation-therapy-with-trimodal-therapy-how-do-you-manage-the-urinary-urgency-and-frequency-during-and-after-treatment weekly 0.8 https://www.themednet.org/in-patients-with-resected-pdac-treated-with-adjuvant-folfirinox-who-recur-from-1-3-years-post-completion-of-adjuvant-therapy-do-you-consider-retreatment-with-folfirinox-or-gemcitabine-nab-paclitaxel-in-the-absence-of-a-clinical-trial weekly 0.8 https://www.themednet.org/is-there-adequate-evidence-for-the-use-of-parpi-in-combination-with-arsi-for-brca-hrr-mutated-mcrpc-as-compared-to-sequential-therapy weekly 0.8 https://www.themednet.org/are-there-any-scenarios-in-which-you-would-consider-use-of-parpi-in-the-upfront-mcspc-setting-rather-than-reserving-for-crpc weekly 0.8 https://www.themednet.org/in-which-scenarios-do-you-stage-breast-cancer-using-ct-and-nuclear-bone-scans-versus-pet-ct weekly 0.8 https://www.themednet.org/in-clinically-node-positive-vulvar-cancer-are-you-recommending-bilateral-inguinal-lnd-or-nodal-debulking-followed-by-adjuvant-radiotherapy weekly 0.8 https://www.themednet.org/how-would-you-interpret-a-temporal-artery-biopsy-demonstrating-focal-chronic-inflammation-in-the-adventitia-associated-with-small-adventitial-vessels-and-nerves-without-inflammation-of-the-intima-and-media-and-without-giant-cells weekly 0.8 https://www.themednet.org/what-treatment-method-do-you-prefer-for-the-cosmetic-removal-of-benign-pigmented-moles weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-patients-with-hypertensive-crisis-and-avoiding-brisk-reductions-in-blood-pressure-and-subsequent-ischemic-acute-kidney-injury weekly 0.8 https://www.themednet.org/what-is-your-second-line-therapy-for-pdl1-negative-metastatic-squamous-esophageal-cancer-who-did-not-receive-a-checkpoint-inhibitor-in-first-line-setting weekly 0.8 https://www.themednet.org/would-you-recommend-additional-post-operative-chemoradiation-for-a-t2n1-proximal-rectal-cancer-having-received-adjuvant-capecitabine-oxaliplatin weekly 0.8 https://www.themednet.org/what-criteria-are-used-to-choose-a-specific-dose-of-aspirin-in-ischemic-stroke weekly 0.8 https://www.themednet.org/for-patients-on-crrt-with-worsening-hyperkalemia-despite-high-replacement-fluid-rate-using-a-0-meq-l-potassium-bath-do-recommend-using-an-additional-crrt-machine-with-separate-dialysis-access-for-improved-clearance weekly 0.8 https://www.themednet.org/have-you-seen-any-increased-dermatologic-toxicity-with-whole-breast-or-chest-wall-radiation-if-patients-have-received-recent-or-concurrent-pembrolizumab weekly 0.8 https://www.themednet.org/would-you-increase-the-hydroxychloroquine-dose-to-more-than-5-mg-kg-day-in-a-compliant-patient-with-active-non-organ-threatening-lupus-skin-joints-if-serum-hydroxychloroquine-is-not-at-goal-until-you-reach-an-acceptable-concentration weekly 0.8 https://www.themednet.org/do-you-recommend-using-vitamin-d-analogs-for-patients-with-ckd-and-a-high-pth-but-a-normal-25-hydroxy-vitamin-d-level weekly 0.8 https://www.themednet.org/how-long-do-you-wait-before-reassessing-a-24-hour-urine-calcium-level-in-patients-with-recurrent-nephrolithiasis-hypercalciuria-and-osteoporosis-who-are-initiated-on-bisphosphonate-therapy weekly 0.8 https://www.themednet.org/would-you-use-fezolinetant-for-hot-flashes-for-men-on-adt weekly 0.8 https://www.themednet.org/would-you-offer-capivasertib-fulvestrant-in-a-patient-with-metastatic-hr-her2-negative-breast-cancer-with-pten-mutation-who-has-progressed-on-fulvestrant-plus-ribociclib weekly 0.8 https://www.themednet.org/do-you-consider-post-nac-isolated-tumor-cells-in-lns-to-be-residual-disease-in-tnbc-to-justify-capecitabine weekly 0.8 https://www.themednet.org/do-you-routinely-use-3-sodium-chloride-and-desmopressin-to-correct-hypovolemic-hyponatremia-in-an-asymptomatic-patient-with-serum-sodium-of-less-than-120-meq-l weekly 0.8 https://www.themednet.org/how-do-you-use-boswellia-for-radiation-necrosis weekly 0.8 https://www.themednet.org/are-there-scenarios-where-you-would-consider-use-of-capivasertib-for-non-akt-pathway-altered-patients-given-the-efficacy-seen-in-the-overall-treatment-population-of-the-capitello-291-trial weekly 0.8 https://www.themednet.org/how-do-you-use-optical-coherence-tomography-in-the-diagnosis-and-management-of-patients-with-multiple-sclerosis-and-related-diseases weekly 0.8 https://www.themednet.org/in-which-patients-with-non-proteinuric-chronic-kidney-disease-would-you-initiate-a-sglt2i weekly 0.8 https://www.themednet.org/what-is-your-preferred-workup-for-a-patient-who-has-a-biopsy-consistent-with-dermal-hypersensitivity-reaction weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-at-intermediate-ascvd-risk-who-has-been-referred-to-you-because-of-an-abnormal-coronary-cta-obstructive-lesion-90-but-an-excellent-exercise-capacity-on-treadmill-without-angina-and-a-negative-mpi weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-aggressively-for-lupus-nephritis-if-they-have-persistent-proteinuria-over-1-gram-but-cannot-get-a-timely-kidney-biopsy weekly 0.8 https://www.themednet.org/do-you-recommend-preloading-with-iv-magnesium-to-decrease-the-risk-of-cisplatin-nephrotoxicity weekly 0.8 https://www.themednet.org/how-do-you-dose-gabapentin-in-patients-with-renal-failure weekly 0.8 https://www.themednet.org/how-do-you-treat-a-patient-with-tnbc-brca-wt-who-received-keynote-522-with-residual-disease-post-neoadjuvant-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-and-monitoring-sarcoidosis-manifested-by-maxillary-bone-teeth-loss-without-other-symptoms weekly 0.8 https://www.themednet.org/how-would-you-manage-the-contralateral-neck-and-adjacent-structures-for-a-glossotonsillar-or-glossopharyngeal-sulcus-primary-cancer-if-well-lateralized weekly 0.8 https://www.themednet.org/would-you-initiate-anti-arrhythmic-drug-therapy-in-patients-who-are-asymptomatic-and-have-normal-lv-function-but-with-a-pvc-burden-20-percent weekly 0.8 https://www.themednet.org/what-outpatient-therapies-do-you-recommend-for-continuous-or-severe-pain-from-migraine-that-is-refractory-to-acute-therapies weekly 0.8 https://www.themednet.org/when-do-you-consider-ambulatory-eeg-as-a-reasonable-alternative-to-inpatient-video-eeg weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-asymptomatic-intracranial-atherosclerosis-discovered-during-the-workup-of-an-acute-stroke weekly 0.8 https://www.themednet.org/how-do-you-workup-patients-with-neuropathy-suspected-to-be-secondary-to-sarcoid weekly 0.8 https://www.themednet.org/when-do-you-consider-the-use-of-steroids-in-the-management-of-acute-exacerbations-in-patients-with-cystic-fibrosis weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-presenting-with-recurrent-ct4-breast-cancer weekly 0.8 https://www.themednet.org/would-you-offer-whole-lung-radiation-therapy-in-a-head-neck-patient-who-relapsed-with-multiple-lung-only-mets weekly 0.8 https://www.themednet.org/when-do-you-discontinue-contact-precautions-in-patients-known-to-be-colonized-with-esbl-producing-enterobacterales weekly 0.8 https://www.themednet.org/are-there-any-circumstances-where-you-recommend-early-institution-of-systemic-therapy-for-patients-with-solitary-plasmacytoma weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-osteosarcoma-of-the-maxilla-for-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/do-you-send-csf-or-serum-ace-levels-in-the-workup-of-neurosarcoidosis weekly 0.8 https://www.themednet.org/how-do-you-initiate-steroids-in-ocular-myasthenia-gravis weekly 0.8 https://www.themednet.org/do-you-intensify-the-dialysis-prescription-for-patients-with-end-stage-kidney-disease-who-develop-uremic-pericarditis-despite-regular-dialysis-sessions weekly 0.8 https://www.themednet.org/what-is-your-approach-to-transitioning-an-sle-patient-from-a-pregnancy-incompatible-regimen-to-pregnancy-compatible-regimen weekly 0.8 https://www.themednet.org/how-do-you-approach-a-positive-quantiferon-ppd-test-result-in-a-patient-for-whom-testing-is-sent-without-a-clinical-indication-and-who-does-not-have-a-risk-factor-for-tb-exposure-nor-tb-reactivation weekly 0.8 https://www.themednet.org/what-is-your-treatment-algorithm-for-dissecting-cellulitis-of-scalp weekly 0.8 https://www.themednet.org/what-would-be-your-treatment-approach-in-a-premenopausal-brca2-patient-with-ct2n0-grade-2-3-er-negative-pr-variably-positive-30-staining-weak-to-high-her2-negative-breast-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-vitamin-d-and-omega-3-fatty-acid-supplementation-for-prevention-of-autoimmune-disease weekly 0.8 https://www.themednet.org/do-you-feel-comfortable-combining-mycophenolate-mofetil-with-azathioprine-in-patients-with-lupus weekly 0.8 https://www.themednet.org/do-you-use-the-homeostatic-model-assessment-homa-to-assess-for-insulin-resistance-and-change-your-clinical-management-of-patients weekly 0.8 https://www.themednet.org/how-would-you-manage-new-symptomatic-brain-metastases-10-15-in-a-young-woman-with-her2-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-treatment-of-idiopathic-intracranial-hypertension-with-transverse-sinus-stenosis weekly 0.8 https://www.themednet.org/do-you-assess-the-kidney-tissue-under-a-microscope-following-a-kidney-biopsy-to-determine-the-quality-of-the-specimen-obtained-and-if-additional-tissue-is-needed weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-patients-with-psoriatic-arthritis-who-have-significant-improvement-in-skin-disease-but-ongoing-inflammatory-arthritis-despite-multiple-dmards-and-or-biologics weekly 0.8 https://www.themednet.org/for-patients-with-a-jak2-positive-myeloproliferative-neoplasm-do-you-always-perform-a-bone-marrow-biopsy-at-diagnosis weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-recurrent-chest-wall-braf-mutated-melanoma-who-developed-multiple-metastatic-axillary-nodes-while-on-immunotherapy-now-post-axillary-dissection-for-adjuvant-radiation weekly 0.8 https://www.themednet.org/would-you-consider-omitting-pmrt-in-ct3n0-triple-negative-breast-cancer-with-a-pcr weekly 0.8 https://www.themednet.org/what-is-your-approach-to-utilizing-mrd-guided-therapy-in-previously-untreated-cll-particularly-in-choosing-between-continuous-versus-time-limited-treatment weekly 0.8 https://www.themednet.org/would-you-consider-using-finerenone-for-proteinuric-ckd-associated-with-type-1-diabetes-mellitus weekly 0.8 https://www.themednet.org/how-would-you-approach-the-work-up-of-sle-in-a-patient-over-80-years-old weekly 0.8 https://www.themednet.org/do-you-increase-the-frequency-of-hemodialysis-for-patients-with-calciphylaxis weekly 0.8 https://www.themednet.org/why-do-we-tend-to-boost-grade-3-dcis-but-not-grade-1-invasive-disease weekly 0.8 https://www.themednet.org/do-you-restrict-topical-diclofenac-use-in-your-patients-with-chronic-kidney-disease weekly 0.8 https://www.themednet.org/how-do-you-view-the-balance-between-opting-for-percutaneous-coronary-intervention-and-prioritizing-optimal-medical-therapy-as-the-initial-treatment-choice-for-patients-with-stable-angina weekly 0.8 https://www.themednet.org/is-there-a-role-for-levothyroxine-in-managing-the-symptoms-of-a-patient-with-euthyroid-hashimotos-thyroiditis weekly 0.8 https://www.themednet.org/is-there-any-value-to-getting-a-bone-marrow-biopsy-at-the-time-of-biochemical-relapse-in-multiple-myeloma-before-switching-to-a-new-line-of-therapy weekly 0.8 https://www.themednet.org/is-there-a-role-for-chronic-suppressive-oral-or-inhaled-therapy-for-recurrent-burkholderia-cepacia-pneumonia-causing-frequent-hospitalizations-in-a-patient-with-severe-bronchiectasis-with-or-without-underlying-cystic-fibrosis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-a-subtotally-resected-pineal-parenchymal-tumor-of-intermediate-differentiation-cns-who-grade-2 weekly 0.8 https://www.themednet.org/what-are-your-next-steps-for-managing-biopsy-proven-interstitial-nephritis-from-checkpoint-inhibitors-in-patients-who-do-not-have-a-response-to-prednisone weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-aan-2022 weekly 0.8 https://www.themednet.org/are-there-circumstances-where-you-would-use-hemibody-irradiation weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-a-diagnosis-of-aidp-who-do-not-respond-to-initial-ivig weekly 0.8 https://www.themednet.org/what-do-you-recommend-for-fertility-preservation-in-pediatric-patients-with-impending-cyclophosphamide-use-for-treatment-of-a-rheumatic-disease weekly 0.8 https://www.themednet.org/do-you-start-pap-in-patients-who-have-an-overall-ahi-of-less-than-5-but-demonstrate-significant-apneas-hypopneas-in-rem-sleep weekly 0.8 https://www.themednet.org/would-you-recommend-short-term-dual-antiplatelet-therapy-for-a-patient-who-received-tpa-and-is-otherwise-eligible-for-dual-antiplatelet-therapy-per-point-or-sammpris-trial weekly 0.8 https://www.themednet.org/are-there-concerns-in-use-or-dosing-of-immunotherapy-agents-in-extreme-obesity weekly 0.8 https://www.themednet.org/how-do-you-manage-acute-exacerbations-of-trigeminal-neuralgia weekly 0.8 https://www.themednet.org/do-you-routinely-obtain-an-eeg-in-patients-who-are-admitted-with-traumatic-intra-cerebral-hemorrhage weekly 0.8 https://www.themednet.org/what-therapies-do-you-recommend-for-preventing-keloid-recurrence-after-surgical-resection weekly 0.8 https://www.themednet.org/how-do-you-choose-between-neoadjuvant-and-adjuvant-chemo-immunotherapy-for-patients-with-resectable-stage-ii-iiia-nsclc weekly 0.8 https://www.themednet.org/where-in-the-sequence-of-biologics-would-you-consider-guselkumab-for-patients-with-active-psoriatic-arthritis-despite-standard-dmard-therapy weekly 0.8 https://www.themednet.org/do-you-consider-estrogen-patches-in-treatment-of-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-measure-testosterone-in-men-who-will-be-receiving-adt weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-rp-and-salvage-xrt-now-with-a-pet-psma-positive-node weekly 0.8 https://www.themednet.org/what-criteria-is-needed-in-relapsed-refractory-b-cell-all-to-choose-car-t-therapy-over-conventional-stem-cell-transplant-as-destination-therapy weekly 0.8 https://www.themednet.org/do-you-use-conventional-dmards-aside-from-methotrexate-to-prevent-anti-drug-antibody-development-for-patients-on-infliximab weekly 0.8 https://www.themednet.org/how-would-you-approach-a-young-patient-with-oligometastatic-inflammatory-triple-negative-breast-cancer-with-bone-only-metastases weekly 0.8 https://www.themednet.org/how-long-do-you-continue-surveillance-with-imaging-and-sputum-cultures-in-a-patient-with-ntm-with-no-indications-for-treatment weekly 0.8 https://www.themednet.org/when-if-ever-would-you-initiate-chemotherapy-for-recurrent-colorectal-cancer-based-on-a-positive-ctdna-assay-alone-such-as-signatera-in-the-absence-of-tumor-on-imaging-or-physical-exam weekly 0.8 https://www.themednet.org/how-do-you-interpret-treatment-response-in-the-discover-2-trial-when-patients-were-allowed-to-remain-on-up-to-10mg-of-prednisone-equivalent-for-disease-control-while-on-guselkumab weekly 0.8 https://www.themednet.org/what-treatments-would-you-recommend-for-rosacea-patients-with-persistent-soft-non-fibrotic-cysts-on-the-dorsal-nose-recalcitrant-to-chronic-doxycycline-and-topical-therapies weekly 0.8 https://www.themednet.org/do-you-recommend-antiplatelet-therapy-for-patients-who-have-suffered-stroke-due-to-cadasil weekly 0.8 https://www.themednet.org/when-do-you-prescribe-a-steroid-taper-after-the-high-dose-iv-course-for-a-multiple-sclerosis-exacerbation weekly 0.8 https://www.themednet.org/what-is-your-recommended-way-of-managing-a-locally-advanced-bulky-base-of-tongue-bot-p16-negative-squamous-cell-carcinoma-extending-into-multiple-structures-of-the-supraglottic-larynx weekly 0.8 https://www.themednet.org/do-you-recommend-genetic-testing-after-a-patient-on-clopidogrel-has-a-stroke-based-on-the-results-of-the-chance-2-trial weekly 0.8 https://www.themednet.org/what-is-your-surveillance-strategy-in-patients-with-brain-metastases-who-are-getting-systemic-therapy weekly 0.8 https://www.themednet.org/would-you-generalize-the-data-from-the-chance-2-trial-to-a-broader-clinic-population-given-that-the-study-was-specific-to-han-chinese-patients weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gu-cancers-from-asco-2022 weekly 0.8 https://www.themednet.org/in-patients-with-cml-on-imatinib-and-newly-diagnosed-breast-cancer-now-requiring-radiation-therapy-should-we-hold-imatinib weekly 0.8 https://www.themednet.org/what-is-trastuzumab-deruxtecans-activity-for-patients-with-cns-disease weekly 0.8 https://www.themednet.org/what-do-you-view-as-the-role-for-docetaxel-ramucirumab-for-patients-with-metastatic-nsclc-in-light-of-lung-map-s1800a-data weekly 0.8 https://www.themednet.org/would-you-include-a-seroma-in-an-adjuvant-radiation-field-for-post-op-endometrial-cancer weekly 0.8 https://www.themednet.org/for-patients-with-ms-on-natalizumab-at-what-jc-virus-antibody-titer-do-you-consider-switching-dmts weekly 0.8 https://www.themednet.org/is-there-a-risk-of-cyp2c19-gene-testing-only-being-adopted-by-wealthier-health-systems-thereby-creating-a-disparity-gap-in-treatment weekly 0.8 https://www.themednet.org/does-the-presence-and-location-of-cerebral-microbleeds-affect-your-decision-for-antithrombotic-treatment-in-patients-with-atrial-fibrillation weekly 0.8 https://www.themednet.org/are-there-differences-in-t-dxd-efficacy-along-the-spectrum-of-her2-ihc-expression-to-impact-treatment-decisions-or-sequencing weekly 0.8 https://www.themednet.org/how-do-you-evaluate-asymptomatic-patients-referred-for-benign-intracranial-hypertension weekly 0.8 https://www.themednet.org/how-do-you-fractionate-prostate-cancer-where-there-was-rectal-wall-infiltration-by-hydrogel-after-healing weekly 0.8 https://www.themednet.org/how-do-you-define-central-lung-cancers-when-considering-sbrt weekly 0.8 https://www.themednet.org/what-is-your-institutional-approach-to-a-restrictive-neutropenic-diet weekly 0.8 https://www.themednet.org/are-there-differences-in-efficacy-of-ramucirumab-pembrolizumab-based-on-extent-and-duration-of-response-to-first-line-chemo-pembro weekly 0.8 https://www.themednet.org/would-you-offer-a-palliative-or-more-aggressive-course-of-radiation-therapy-for-a-symptomatic-isolated-supraclavicular-recurrence-of-a-squamous-cell-carcinoma-of-the-esophagus weekly 0.8 https://www.themednet.org/among-non-hrrm-castrate-resistant-prostate-cancer-patients-are-there-features-predictive-of-response-to-propel-regimen-of-abiraterone-olaparib weekly 0.8 https://www.themednet.org/do-you-routinely-collect-debulking-specimens-for-paraffin-embedded-or-frozen-section-staining-prior-to-taking-a-mohs-layer-for-all-skin-cancers weekly 0.8 https://www.themednet.org/what-criteria-does-your-institution-use-to-indicate-patient-is-ready-for-peg-tube-removal weekly 0.8 https://www.themednet.org/how-would-you-manage-a-symptomatic-marginal-zone-lymphoma-of-the-base-of-tongue-causing-globus-sensation-also-incidentally-found-to-have-squamous-cell-carcinoma-in-situ weekly 0.8 https://www.themednet.org/do-you-ever-use-amantadine-or-modafinil-to-aid-in-the-rehabilitation-of-patients-with-ischemic-strokes weekly 0.8 https://www.themednet.org/how-would-you-manage-a-low-risk-patient-with-a-negative-fusion-prostate-lesion-by-biopsy-but-mri-shows-apparent-advanced-disease weekly 0.8 https://www.themednet.org/what-treatments-and-resources-have-you-found-helpful-for-ichthyosis-vulgaris-patients weekly 0.8 https://www.themednet.org/what-is-your-approach-to-using-medications-that-can-cause-bone-marrow-suppression-in-sle-patients-who-have-persistent-leukopenia weekly 0.8 https://www.themednet.org/in-a-patient-with-isolated-inguinal-nodal-recurrence-one-year-after-a-margin-negative-anal-excision-for-grade-1-t1-scca-of-the-anus-would-you-include-the-anal-canal-rectum-as-part-of-salvage-chemoradiation-therapy weekly 0.8 https://www.themednet.org/would-you-ever-switch-capmatinib-to-tepotinib-or-vice-versa-for-patients-with-nsclc-with-met-ex-14-skipping-mutation-who-are-responding-to-treatment-but-with-ongoing-edema-despite-dose-reductions weekly 0.8 https://www.themednet.org/how-would-you-treat-a-recurrent-endometrial-cancer-at-the-vaginal-cuff-that-was-initially-figo-1a-with-no-adj-treatment-in-a-patient-with-actively-treated-scleroderma weekly 0.8 https://www.themednet.org/would-you-recommend-upfront-radiosurgery-for-trigeminal-neuralgia-caused-by-avm-abutment-at-the-entry-root-zone weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-atrial-fibrillation-on-apixaban-who-has-a-new-cardioembolic-stroke weekly 0.8 https://www.themednet.org/is-500-cgy-x-5-an-appropriate-palliative-regimen-for-a-patient-with-a-low-lying-metastatic-rectal-cancer-with-ongoing-pain-and-bleeding-despite-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-manage-brain-mets-involving-the-cavernous-sinus weekly 0.8 https://www.themednet.org/how-do-you-prepare-patients-with-dlbcl-on-the-potential-need-for-cellular-therapies-after-progression-on-first-line-regimens weekly 0.8 https://www.themednet.org/how-would-you-manage-relapsed-dlbcl-in-a-patient-who-received-second-line-cd19-cart-treatment weekly 0.8 https://www.themednet.org/would-you-give-palliative-breast-rt-to-a-patient-receiving-weekly-paclitaxel-for-rapidly-progressing-metastatic-disease weekly 0.8 https://www.themednet.org/how-frequently-do-you-monitor-lfts-and-cbc-after-initiating-endothelin-receptor-antagonists weekly 0.8 https://www.themednet.org/would-you-consider-modifying-the-dose-for-focal-prostate-boost-to-other-fractionation-schedules weekly 0.8 https://www.themednet.org/to-obtain-insurance-approval-for-dibh-when-treating-left-breast-cancers-are-there-particular-dose-constraints-to-sites-that-you-employ weekly 0.8 https://www.themednet.org/what-topical-therapies-and-procedures-do-you-recommend-for-patients-with-atrophic-acne-scarring weekly 0.8 https://www.themednet.org/how-do-you-approach-nail-surgery-to-diagnose-nubs-neoplasms-of-uncertain-behavior weekly 0.8 https://www.themednet.org/what-lifestyle-modifications-do-you-recommend-for-patients-with-hidradenitis-suppurativa weekly 0.8 https://www.themednet.org/what-is-the-role-of-radiation-therapy-in-recurrent-rosai-dorfman-disease-after-surgical-resection-which-manifests-as-many-cutaneous-lesions-on-the-arms-and-buttocks weekly 0.8 https://www.themednet.org/is-there-a-preference-between-the-different-high-intensity-statins-for-high-risk-stroke-patients weekly 0.8 https://www.themednet.org/would-you-stop-belimumab-in-a-patient-with-sle-starting-ravulizumab-c5-inhibitor-for-myasthenia-gravis-due-to-concern-for-additive-immunosuppression weekly 0.8 https://www.themednet.org/how-does-prior-prostate-artery-embolization-impact-your-treatment-recommendations-for-prostate-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-dose-fractionation-for-ultra-central-lung-tumors weekly 0.8 https://www.themednet.org/when-do-you-recommend-mra-in-patients-with-spontaneous-ich-and-negative-cta weekly 0.8 https://www.themednet.org/how-do-you-utilize-skin-punch-biopsy-to-assess-for-alpha-synuclein-in-patients-with-parkinsonism weekly 0.8 https://www.themednet.org/how-would-you-treat-an-adenoid-cystic-carcinoma-well-diff-extensive-pni-of-the-vulva-s-p-excision-with-positive-margins weekly 0.8 https://www.themednet.org/do-you-electively-cover-any-nodal-volumes-for-superior-sulcus-tumors weekly 0.8 https://www.themednet.org/do-you-offer-patients-with-advanced-endometrial-cancer-lower-starting-doses-of-lenvatinib-when-used-in-combination-with-pembrolizumab-given-high-adverse-event-rates-with-20-mg-daily weekly 0.8 https://www.themednet.org/how-would-you-manage-a-bulky-locally-advanced-endometrial-cancer-with-extensive-parametrial-involvement-in-a-patient-inoperable-due-to-medical-comorbidities weekly 0.8 https://www.themednet.org/is-there-a-difference-in-the-incidence-of-serious-immune-related-adverse-events-with-the-lenvatinib-pembrolizumab-combination-vs-pembrolizumab-alone-in-endometrial-cancer weekly 0.8 https://www.themednet.org/are-there-known-biomarkers-predictive-of-iraes weekly 0.8 https://www.themednet.org/would-you-empirically-elective-to-anticoagulate-patients-with-a-remote-i-e-10-year-history-of-paroxysmal-atrial-fibrillation-presenting-with-newly-diagnosed-cva-presumed-cardioembolic-in-etiology-without-any-documented-recurrence-of-af weekly 0.8 https://www.themednet.org/would-you-consider-adding-voclosporin-to-belimumab-and-mmf-in-the-setting-of-active-proteinuria-rather-than-switching-agents weekly 0.8 https://www.themednet.org/when-should-you-discontinue-narrow-band-uvb-when-a-patient-is-in-clinical-remission-from-patch-stage-mycosis-fungoides weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-multiple-sclerosis-related-fatigue weekly 0.8 https://www.themednet.org/what-is-your-approach-to-using-nih-activity-and-chronicity-indices-from-renal-biopsy-in-tailoring-immunosuppression-to-a-patient-with-new-lupus-nephritis weekly 0.8 https://www.themednet.org/what-therapies-do-you-recommend-for-patients-with-recalcitrant-seborrheic-dermatitis weekly 0.8 https://www.themednet.org/what-scented-alternatives-do-you-recommend-patients-with-fragrance-allergies-try-to-replace-perfumes-colognes weekly 0.8 https://www.themednet.org/is-biopsy-of-the-nail-matrix-necessary-to-rule-out-atypia-associated-with-longitudinal-melanonychia weekly 0.8 https://www.themednet.org/what-volumetric-dose-constraints-if-any-do-you-use-for-the-mandible-in-the-definitive-setting-for-h-n-cancers weekly 0.8 https://www.themednet.org/what-are-the-perceived-implications-of-broader-genomic-sequencing-as-it-pertains-to-interpreting-variants-of-unknown-significance-and-germline-predisposition-mutations weekly 0.8 https://www.themednet.org/for-a-patient-requiring-adjuvant-endocrine-therapy-for-localized-breast-cancer-would-you-use-fulvestrant-if-they-were-intolerant-to-both-aromatase-inhibitor-and-tamoxifen weekly 0.8 https://www.themednet.org/what-treatment-would-you-offer-for-a-patient-with-prior-primary-prostate-radiation-with-a-biochemical-progression-to-psa-1-0-and-negative-psma-scan weekly 0.8 https://www.themednet.org/in-a-patient-with-type-i-von-willebrand-disease-with-history-of-vte-and-heavy-menses-would-tranexamic-acid-be-a-treatment-option weekly 0.8 https://www.themednet.org/how-do-you-monitor-patients-with-incidentally-found-high-titer-anti-smooth-muscle-antibodies-without-stigmata-of-liver-disease weekly 0.8 https://www.themednet.org/when-do-you-stop-trying-to-eradicate-an-acquired-factor-viii-inhibitor-2 weekly 0.8 https://www.themednet.org/what-diet-modifications-do-you-recommend-for-patients-with-acne-to-help-prevent-breakouts weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-two-concurrent-plasmacytomas-whose-bone-marrow-showed-no-evidence-of-multiple-myeloma-and-has-no-other-mm-defining-features weekly 0.8 https://www.themednet.org/do-you-use-oncotype-to-predict-chemo-benefit-on-all-localized-hr-patients-per-tailorx-criteria-or-do-you-use-your-judgement-and-skip-it-in-t1b-c-grade-1-or-grade-2-tumors weekly 0.8 https://www.themednet.org/do-you-offer-anticoagulation-to-patients-with-prior-antiphospholipid-antibodies-detected-in-pregnancy-without-a-history-of-pregnancy-loss-or-thrombosis weekly 0.8 https://www.themednet.org/do-you-recommend-continuous-antibiotic-prophylaxis-for-patients-on-complement-inhibitors-such-as-eculizumab weekly 0.8 https://www.themednet.org/when-do-you-consider-immunosuppression-in-patients-with-sjogrens-neuropathy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-ongoing-assessment-and-medication-tapering-in-well-controlled-discoid-lupus-without-systemic-features weekly 0.8 https://www.themednet.org/how-do-you-treat-non-melanomatous-skin-cancers-in-poorly-vascularized-tissue weekly 0.8 https://www.themednet.org/do-you-offer-finasteride-to-teenagers-with-androgenetic-alopecia weekly 0.8 https://www.themednet.org/for-a-rectal-cancer-with-questionable-t3-or-questionable-n-by-mri-can-short-course-radiation-be-given-followed-by-surgery-and-the-pathology-still-be-interpreted-to-guide-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-treat-episodes-of-profuse-sweating-in-parkinsons-patients weekly 0.8 https://www.themednet.org/how-do-you-account-for-a-normal-emg-ncs-in-the-setting-of-prolonged-clinical-symptoms-suggestive-of-a-radiculopathy weekly 0.8 https://www.themednet.org/what-recommendations-do-you-provide-to-patients-who-develop-ocular-side-effects-with-dupixent weekly 0.8 https://www.themednet.org/what-prescription-or-over-the-counter-therapies-have-you-found-effective-for-helping-vitiligo-patients-cover-active-areas weekly 0.8 https://www.themednet.org/what-treatments-would-you-recommend-for-patients-with-chronic-urticaria-who-have-minimal-improvement-with-anithistamines-and-xolair weekly 0.8 https://www.themednet.org/would-you-consider-using-sotorasib-first-line-in-patient-with-metastatic-kras-g12c-nsclc-who-declines-chemotherapy weekly 0.8 https://www.themednet.org/what-first-line-therapies-do-you-recommend-for-patients-with-folliculotropic-mycosis-fungoides weekly 0.8 https://www.themednet.org/when-do-you-consider-lymphadenectomy-vs-pelvic-lymph-node-rt-in-a-lymph-node-recurrence-after-prior-prostatectomy-or-prostate-only-rt weekly 0.8 https://www.themednet.org/how-do-you-approach-tapering-off-jak-inhibitors-in-patients-with-rheumatoid-arthritis-who-are-in-sustained-remission weekly 0.8 https://www.themednet.org/based-on-its-mechanism-of-action-do-you-think-sodium-phenylbutyrate-and-taurursodiol-could-have-benefit-in-other-neurodegenerative-disorders weekly 0.8 https://www.themednet.org/in-a-patient-with-otherwise-low-risk-prostate-cancer-does-presence-of-a-small-component-of-grade-group-3-disease-up-stage-to-unfavorable-intermediate weekly 0.8 https://www.themednet.org/do-you-feel-prp-is-effective-in-treating-androgenetic-alopecia weekly 0.8 https://www.themednet.org/how-do-you-consider-first-and-subsequent-lines-of-treatment-sequencing-in-metastatic-gastric-gej-cancer-that-is-both-her2-and-cps-5 weekly 0.8 https://www.themednet.org/would-you-consider-use-of-t-dxd-for-metastatic-gastric-gej-cancers-with-her2-low-given-emerging-data-in-the-breast-cancer-setting weekly 0.8 https://www.themednet.org/do-you-typically-assess-plasma-levels-of-the-phosphorylated-axonal-neurofilament-h-subunit-pnf-h-in-patients-with-als weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-side-effects-of-sodium-phenylbutyrate-and-taurursodiol weekly 0.8 https://www.themednet.org/would-the-concerns-about-respiratory-side-effects-from-sodium-phenylbutyrate-and-taurusodiol-change-your-management-of-patients-with-predominantly-bulbar-als weekly 0.8 https://www.themednet.org/would-you-treat-a-stage-i-er-pr-positive-her2-negative-breast-cancer-differently-if-it-is-associated-with-lynch-syndrome weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-utilize-for-a-large-solitary-liver-metastases-about-7-cm-abutting-colon weekly 0.8 https://www.themednet.org/in-patients-with-lupus-nephritis-on-maintenance-therapy-is-there-additional-benefit-in-utilizing-2-grams-vs-3-grams-of-mycophenolate-mofetil-mmf-daily weekly 0.8 https://www.themednet.org/would-you-offer-radiation-to-a-patient-with-extensive-vulvar-dysplasia-not-amenable-to-surgical-resection-and-previously-resected-micro-invasive-vulvar-cancer-in-the-setting-of-immunosuppression-for-solid-organ-transplant weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-for-a-fit-patient-with-unmutated-cll-who-has-progressed-after-btki-and-venetoclax-containing-regimens-in-the-first-and-second-line weekly 0.8 https://www.themednet.org/for-a-patient-with-pe-undergoing-procedures-like-port-placement-in-the-first-month-how-do-you-manage-anticoagulation weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-ebv-meningoencephalitis-csf-pleocytosis-and-csf-pcr-positive-for-ebv weekly 0.8 https://www.themednet.org/do-you-use-serum-or-urine-biomarkers-other-than-creatinine-when-evaluating-patients-with-acute-kidney-injury weekly 0.8 https://www.themednet.org/do-you-recommend-performing-surveillance-kidney-allograft-biopsies-in-your-asymptomatic-kidney-transplant-recipients weekly 0.8 https://www.themednet.org/what-is-your-preferred-method-for-confirming-the-diagnosis-of-primary-aldosteronism-in-a-patient-with-an-elevated-plasma-aldosterone-to-renin-ratio weekly 0.8 https://www.themednet.org/would-you-withhold-a-fluoropyrimidine-in-a-newly-diagnosed-patient-with-metastatic-colon-cancer-who-had-a-stemi-and-new-diagnosis-of-ischemic-cardiomyopathy-within-the-last-3-months weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-algorithm-for-a-patient-with-alopecia-universalis-who-has-failed-oral-and-intralesional-steroids weekly 0.8 https://www.themednet.org/do-you-repeat-molecular-testing-at-progression-in-gastric-gej-tumors-or-is-the-initial-pathology-sufficient-for-entire-treatment-course weekly 0.8 https://www.themednet.org/in-light-of-right-choice-trial-data-when-will-you-opt-for-a-cdk-4-6-inhibitor-plus-ai-instead-of-chemotherapy-in-patients-with-metastatic-hr-positive-her2-negative-breast-cancer-with-visceral-crisis weekly 0.8 https://www.themednet.org/what-are-outpatient-strategies-to-mitigate-taxane-induced-peripheral-neuropathy weekly 0.8 https://www.themednet.org/would-you-consider-hypofractionated-prostate-treatment-for-a-patient-with-well-controlled-ulcerative-colitis weekly 0.8 https://www.themednet.org/for-a-patient-who-would-benefit-from-an-anabolic-agent-for-osteoporosis-do-you-prefer-romosuzumab-over-teriparatide-in-the-absence-of-contraindications-to-either-agent weekly 0.8 https://www.themednet.org/what-alternate-neo-adjuvant-backbone-chemotherapy-would-you-recommend-in-a-patient-with-er-her2-clinical-stage-ii-breast-ca-with-severe-pan-colitis-following-a-cycle-of-tchp-with-docetaxel weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-myoclonic-status-epilepticus-from-anoxic-brain-injury weekly 0.8 https://www.themednet.org/would-you-consider-a-parpi-for-a-patient-with-palb2-mutated-metastatic-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/when-do-you-consider-stopping-anti-seizure-medications-in-seizure-free-pediatric-epilepsy-patients weekly 0.8 https://www.themednet.org/how-if-at-all-does-your-approach-to-adjuvant-chemoradiation-differ-with-proton-beam-radiation-vs-conventional-photon-radiation-for-h-n-cancers weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-sle-who-develop-a-rash-after-hydroxychloroquine-initiation weekly 0.8 https://www.themednet.org/what-is-the-optimal-adjuvant-vaginal-brachytherapy-schedule-when-a-patient-is-getting-concurrent-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-stimulants-in-patients-with-adhd-with-previous-or-current-substance-use-disorders weekly 0.8 https://www.themednet.org/would-you-consider-giving-thrombolytic-therapy-for-patients-with-acute-vision-loss-concerning-for-crao-based-on-history-and-within-the-window-before-any-ophthalmological-assessment-and-confirmation weekly 0.8 https://www.themednet.org/would-you-recommend-adding-a-daytime-dwell-over-an-additional-nighttime-exchange-to-achieve-volume-and-clearance-targets-for-an-eskd-patient-who-recently-stopped-making-urine-and-has-been-receiving-only-nighttime-automated-peritoneal-dialysis weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-durvalumab-for-stage-i-small-cell-lung-cancer-following-sbrt-or-surgery weekly 0.8 https://www.themednet.org/in-cases-of-intermediate-risk-pulmonary-embolism-what-factors-influence-your-decision-to-pursue-catheter-directed-thrombolysis weekly 0.8 https://www.themednet.org/are-there-any-contraindications-to-pluvicto-therapy-you-personally-use-given-that-there-are-none-directly-provided-by-the-manufacturer weekly 0.8 https://www.themednet.org/what-is-your-late-or-no-show-policy-for-patients weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-atrial-fibrillation-having-a-thromboembolic-infarct-despite-being-on-adequate-anticoagulation weekly 0.8 https://www.themednet.org/how-would-you-plan-a-post-op-distal-rectal-adenocarcinoma-s-p-neo-adjuvant-chemotherapy-and-apr-with-minimal-treatment-response weekly 0.8 https://www.themednet.org/do-you-routinely-treat-patients-with-neurosyphilis-with-im-penicillin-for-1-3-weeks-after-completing-a-full-treatment-course-of-iv-penicillin weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-diagnostic-endoscopy-for-patients-with-persistent-enterococcus-bacteremia-despite-receiving-adequate-antimicrobial-therapy-and-no-clear-nidus weekly 0.8 https://www.themednet.org/at-what-serum-bicarbonate-level-do-you-initiate-alkali-therapy-for-patients-with-chronic-kidney-disease weekly 0.8 https://www.themednet.org/what-treatment-options-would-you-consider-for-a-patient-with-stage-iv-nsclc-harboring-a-kras-g12a-mutation-who-has-progressed-after-chemoimmunotherapy-and-prefers-to-avoid-additional-chemotherapy weekly 0.8 https://www.themednet.org/are-there-instances-when-you-use-letermovir-without-the-addition-of-acyclovir-when-managing-a-kidney-transplant-recipient-for-cmv-prophylaxis weekly 0.8 https://www.themednet.org/how-would-you-manage-persistent-norovirus-diarrheal-infections-in-a-kidney-transplant-patient-that-are-not-responding-to-a-decrease-in-the-patients-maintenance-immunosuppressive-regimen weekly 0.8 https://www.themednet.org/what-specific-criteria-or-patient-conditions-would-make-you-hesitant-to-use-fluoroquinolones-early-in-the-treatment-course-for-managing-mssa-joint-infections-with-oral-antibiotics weekly 0.8 https://www.themednet.org/how-do-you-approach-tarlatamab-use-in-an-elderly-patient-with-relapsed-es-sclc weekly 0.8 https://www.themednet.org/in-which-breast-cancer-presentation-would-you-consider-earlier-treatment-with-t-dxd-given-the-similar-absolute-pfs-benefits-seen-with-t-dxd-in-the-destiny-breast06-trial-and-destiny-breast04-trials weekly 0.8 https://www.themednet.org/do-you-continue-antiplatelet-anticoagulant-therapy-in-patients-with-hemodynamically-stable-diverticular-bleeding-to-improve-localization-and-treatment-of-source-of-bleeding weekly 0.8 https://www.themednet.org/do-you-prefer-formal-testing-to-establish-a-diagnosis-of-sibo-imo-over-empiric-treatment weekly 0.8 https://www.themednet.org/is-there-a-particular-prokinetic-agent-that-you-recommend-if-a-patient-has-failed-both-ppi-and-tca-in-the-treatment-of-suspected-functional-dyspepsia weekly 0.8 https://www.themednet.org/what-do-you-do-for-patients-who-have-received-accidental-extra-dosages-of-long-acting-injectable-antipsychotics weekly 0.8 https://www.themednet.org/how-are-you-requesting-testing-for-her2-ultralow-status-in-light-of-db-06-trial-demonstrating-benefit-of-t-dxd-for-these-patients weekly 0.8 https://www.themednet.org/how-do-you-treat-a-patient-with-moderate-dementia-who-experiences-a-recurrence-of-depression weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-supportive-care-from-astro-2024 weekly 0.8 https://www.themednet.org/when-discontinuing-denosumab-after-more-than-2-3-years-of-therapy-when-do-you-recommend-giving-the-first-dose-of-zoledronic-acid weekly 0.8 https://www.themednet.org/do-you-recommend-routine-use-of-protamine-for-hemostasis-at-the-end-of-a-transfemoral-tavi weekly 0.8 https://www.themednet.org/what-is-your-approach-to-preventing-exercise-associated-hyponatremia weekly 0.8 https://www.themednet.org/what-factors-would-lead-you-to-extend-the-duration-of-antithyroid-drug-therapy-in-a-patient-with-graves-disease-who-is-clinically-euthyroid-at-12-months-but-has-risk-factors-for-recurrence weekly 0.8 https://www.themednet.org/when-prescribing-bevacizumab-for-high-risk-primary-ovarian-cancer-do-you-use-15-mg-m2-q-21-days-per-gog-0218-or-7-5-mg-m2-q-21-days-per-icon7 weekly 0.8 https://www.themednet.org/what-is-the-youngest-age-and-dose-that-you-would-consider-for-oral-minoxidil weekly 0.8 https://www.themednet.org/what-is-the-interpretation-of-two-igras-with-negative-mitogen-wells-in-the-absence-of-immunosuppression weekly 0.8 https://www.themednet.org/what-medications-have-you-had-success-with-for-patients-with-high-functioning-asd-and-co-morbid-adhd-and-anxiety weekly 0.8 https://www.themednet.org/what-considerations-do-you-take-regarding-using-valproic-acid-in-men-who-are-hoping-to-conceive-with-a-partner weekly 0.8 https://www.themednet.org/what-is-the-appropriate-approach-to-manage-a-patient-with-triple-negative-locally-advanced-breast-cancer-ln-who-progresses-on-neoadjuvant-chemo-immunotherapy-keynote-522-regimen weekly 0.8 https://www.themednet.org/when-would-you-consider-transdermal-treatments-for-adhd weekly 0.8 https://www.themednet.org/how-does-one-interpret-an-spep-showing-potentially-obscured-but-non-quantifiable-m-spike-however-an-ife-showing-monoclonal-protein weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-patient-with-longstanding-history-of-sle-but-having-active-psoriasis weekly 0.8 https://www.themednet.org/would-you-consider-endovascular-thrombectomy-for-acute-stroke-patients-with-large-vessel-occlusion-non-large-core-but-with-poor-functional-baseline-with-mrs-3-4 weekly 0.8 https://www.themednet.org/what-is-the-best-treatment-approach-to-a-patient-with-hgbcl-with-fish-translocation-of-bcl-6-and-c-myc-given-new-classification-of-this-entity weekly 0.8 https://www.themednet.org/how-do-you-reconcile-discordant-psma-and-mri-findings-in-patients-undergoing-definitive-radiotherapy-for-prostate-cancer weekly 0.8 https://www.themednet.org/what-adjuvant-treatment-would-you-recommend-for-a-patient-with-figo-2023-iiib2-endometrioid-endometrial-adenocarcinoma-grade-3-p53mut-mmr-proficient-metastatic-to-the-uterine-serosa-bilateral-ovaries-and-anterior-peritoneal-reflection weekly 0.8 https://www.themednet.org/in-patients-with-cholangiocarcinoma-who-qualify-for-haip-therapy-would-you-recommend-treating-with-chemotherapy-and-immunotherapy weekly 0.8 https://www.themednet.org/have-you-come-across-jak-treatment-failure-in-severe-alopecia-areata weekly 0.8 https://www.themednet.org/for-patients-with-ovarian-cancer-do-you-order-folate-receptor-alpha-testing-at-initial-diagnosis-first-recurrence-or-first-instance-of-platinum-resistance weekly 0.8 https://www.themednet.org/how-would-you-treat-severe-symptomatic-splenomegaly-in-a-patient-with-et-mf-who-has-progressed-through-all-approved-jak-inhibitors-and-is-not-a-candidate-for-allosct weekly 0.8 https://www.themednet.org/what-pharmacological-management-do-you-consider-in-patients-with-autism-spectrum-disorder-whose-primary-behavior-is-aggression weekly 0.8 https://www.themednet.org/what-is-a-reasonable-imaging-modality-for-older-patients-with-pafib-already-on-systemic-anticoagulation-outpatient-but-presenting-with-suspected-cardioembolic-stroke-and-tte-without-evidence-of-lv-thrombus weekly 0.8 https://www.themednet.org/what-strategies-or-initiatives-do-you-think-could-be-most-effective-in-addressing-the-rheumatology-workforce-shortage weekly 0.8 https://www.themednet.org/in-what-clinical-situations-do-you-switch-to-vyalev-in-patients-with-parkinsons-disease weekly 0.8 https://www.themednet.org/what-is-the-most-updated-consensus-regarding-the-use-of-pill-in-the-pocket-oral-anticoagulation-in-paroxysmal-atrial-fibrillation-and-populations-of-patients-who-are-most-likely-to-be-considered-for-enrollment-in-clinical-trials weekly 0.8 https://www.themednet.org/what-is-your-preferred-duration-for-triple-therapy-post-pci-in-patients-on-systemic-anticoagulation weekly 0.8 https://www.themednet.org/given-the-data-from-swog-1826-suggesting-that-nivo-avd-is-likely-the-preferred-regimen-for-advanced-hodgkin-lymphoma-patients-are-there-scenarios-where-alternative-regimens-may-still-be-preferred weekly 0.8 https://www.themednet.org/when-if-ever-would-you-select-a-three-drug-regimen-instead-of-four-drug-regimen-in-patients-with-newly-diagnosed-multiple-myeloma weekly 0.8 https://www.themednet.org/for-patients-on-medications-that-are-known-to-cause-photosensitivity-would-you-counsel-them-to-avoid-laser-hair-removal-or-laser-therapies weekly 0.8 https://www.themednet.org/what-is-the-recommended-fungal-workup-in-an-immunocompromised-patient-after-5-days-of-persistent-fever weekly 0.8 https://www.themednet.org/what-is-your-recommended-treatment-sequencing-strategy-in-patients-with-her2-breast-cancer-and-leptomeningeal-carcinomatosis weekly 0.8 https://www.themednet.org/do-you-recommend-procalcitonin-to-help-convince-other-providers-to-stop-antibiotics-in-patients-with-pneumonia-in-whom-a-non-infectious-diagnosis-is-strongly-suspected weekly 0.8 https://www.themednet.org/how-would-you-evaluate-the-role-for-adjuvant-radiation-in-a-very-young-female-20s-with-a-localized-vulvar-scc-hpv-independent-status-post-hemivulvectomy weekly 0.8 https://www.themednet.org/is-there-benefit-of-early-initiation-of-antiplatelet-therapy-or-dvt-prophylaxis-in-patients-who-present-with-large-mca-infarcts-and-are-being-considered-for-hemicraniectomy weekly 0.8 https://www.themednet.org/do-you-routinely-transition-patients-with-recurrent-calcium-based-kidney-stones-off-of-hydrochlorothiazide-and-onto-chlorthalidone-or-indapamide-for-optimal-control-of-hypercalciuria weekly 0.8 https://www.themednet.org/do-you-recommend-checking-1-25-hydroxy-vitamin-d-levels-in-patients-with-recurrent-nephrolithiasis-who-have-hypercalciuria-of-unknown-etiology weekly 0.8 https://www.themednet.org/how-would-you-manage-and-determine-the-duration-of-antibiotics-for-a-patient-with-suspected-chronic-postoperative-spinal-implant-infection-status-post-lumbar-fusion-now-presenting-with-loosened-hardware-on-imaging-normal-inflammatory-markers-and-no-system weekly 0.8 https://www.themednet.org/which-patient-characteristics-or-scenarios-drive-you-to-choose-tezepelumab-over-dupilumab-for-asthma weekly 0.8 https://www.themednet.org/what-is-a-reasonable-management-strategy-for-severely-symptomatic-atrial-fibrillation-with-persistent-laa-thrombus-in-spite-of-compliance-with-several-different-anticoagulation-agents weekly 0.8 https://www.themednet.org/would-you-consider-daratumumab-monotherapy-as-standard-of-care-for-smoldering-multiple-myeloma-based-on-the-aquila-trial weekly 0.8 https://www.themednet.org/how-do-you-manage-resistant-infections-that-persist-after-stopping-antibiotic-therapy-in-patients-with-non-cf-bronchiectasis weekly 0.8 https://www.themednet.org/would-you-start-treatment-for-mac-in-a-patient-with-nodular-bronchiectatic-disease-who-has-demonstrated-radiographic-progression-but-remains-asymptomatic-and-smear-negative weekly 0.8 https://www.themednet.org/are-there-data-to-support-full-dose-anticoagulation-added-to-an-antiplatelet-in-recurrent-peripheral-arterial-thrombosis-requiring-revascularization-and-stenting weekly 0.8 https://www.themednet.org/would-you-start-stone-preventative-medications-such-as-potassium-citrate-and-thiazide-diuretics-for-patients-with-recurrent-calcium-based-nephrolithiasis-and-abnormal-24-hour-urine-chemistries-if-they-no-longer-have-calculi-on-most-recent-imaging-testing weekly 0.8 https://www.themednet.org/how-do-the-results-of-insema-and-sound-impact-the-decision-of-omitting-slnd-in-young-women-with-breast-cancer-and-offering-adjuvant-rt-to-patients-who-would-otherwise-be-candidates-for-omission weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-parkinsons-disease-who-are-interested-in-starting-glp-1-agonists-for-neuroprotective-benefits weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-failures-with-squamous-cell-carcinoma-keratoacanthoma-type-lesions-that-did-not-respond-to-a-standard-srt-regimen-after-many-sessions weekly 0.8 https://www.themednet.org/what-factors-influence-your-decision-to-start-salt-tablets-urea-or-a-vaptan-first-in-the-management-of-a-patient-diagnosed-with-siadh weekly 0.8 https://www.themednet.org/what-adjuvant-treatment-would-you-offer-a-patient-who-underwent-cystoprostatectomy-for-a-muscle-invasive-bladder-cancer-and-discovered-to-also-have-prostate-cancer weekly 0.8 https://www.themednet.org/what-medications-have-you-found-to-be-effective-for-childhood-onset-speech-fluency-disorder weekly 0.8 https://www.themednet.org/when-do-you-attribute-tremors-to-lamotrigine weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-intradialytic-hypotension-and-autonomic-dysfunction-in-a-patient-with-eskd weekly 0.8 https://www.themednet.org/is-there-a-role-for-aspirin-81-mg-daily-in-patients-with-nonischemic-dilated-cardiomyopathy-with-reduced-ef weekly 0.8 https://www.themednet.org/should-glp-1-agonists-be-held-during-chemotherapy-1 weekly 0.8 https://www.themednet.org/do-all-patients-referred-for-acute-symptoms-of-tia-or-minor-stroke-require-additional-imaging-with-ct-mr-angiography-in-addition-to-admission-observation weekly 0.8 https://www.themednet.org/do-you-use-alcohol-to-trigger-seizures-in-patients-you-suspect-to-have-jme-to-confirm-diagnosis weekly 0.8 https://www.themednet.org/given-results-of-the-radicals-trials-is-lt-adt-standard-of-care-for-salvage-prostate-rt weekly 0.8 https://www.themednet.org/how-would-you-manage-long-segment-barretts-esophagus-with-both-lgd-and-hgd-that-has-failed-to-respond-to-rfa-cryoablation-or-even-nissen-fundoplication-for-large-hiatal-hernia weekly 0.8 https://www.themednet.org/how-do-you-approach-hematuria-in-a-patient-with-diabetic-nephropathy weekly 0.8 https://www.themednet.org/what-is-the-rationale-evidence-to-support-doing-4-puffs-of-albuterol-vs-2-puffs-for-a-reversibility-study weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-treatment-in-a-patient-with-completely-resected-undifferentiated-pleomorphic-sarcoma-of-the-chest-wall-that-recurred-after-2-years-initially-treated-with-neoadjuvant-radiation-and-resection weekly 0.8 https://www.themednet.org/when-utilizing-kn-a18-protocol-how-do-you-best-address-symptoms-of-colitis-cystitis weekly 0.8 https://www.themednet.org/for-neoadjuvant-treatment-of-muscle-invasive-bladder-cancer-are-you-utilizing-durvalumab-plus-gemcitabine-cisplatin-over-dose-dense-or-accelerated-mvac weekly 0.8 https://www.themednet.org/are-there-patient-populations-in-whom-you-would-consider-using-both-induction-chemotherapy-and-maintenance-pembrolizumab-for-a-patient-with-locally-advanced-cervical-cancer weekly 0.8 https://www.themednet.org/is-there-a-serum-ammonium-level-for-which-you-recommend-initiation-of-dialysis-in-a-patient-with-hepatic-encephalopathy weekly 0.8 https://www.themednet.org/when-should-delayed-removal-of-an-intraocular-foreign-body-be-considered weekly 0.8 https://www.themednet.org/how-do-you-manage-corneal-ectasia-after-refractive-surgery weekly 0.8 https://www.themednet.org/how-do-you-approach-the-timing-of-surgical-intervention-in-intermittent-exotropia weekly 0.8 https://www.themednet.org/when-do-you-use-glp-1-receptor-agonists-for-the-management-of-patients-with-idiopathic-intracranial-hypertension-iih weekly 0.8 https://www.themednet.org/when-would-you-consider-using-selective-laser-trabeculoplasty-slt-for-managing-uveitic-glaucoma weekly 0.8 https://www.themednet.org/what-factors-guide-the-decision-to-treat-with-rop-laser-treatment-versus-a-repeat-anti-vegf-injection-in-a-child-who-has-previously-received-anti-vegf-therapy-for-retinopathy-of-prematurity-rop weekly 0.8 https://www.themednet.org/do-you-restrict-the-dose-rate-during-treatment-delivery-to-a-pacemaker-in-addition-to-limiting-the-dmax weekly 0.8 https://www.themednet.org/how-do-you-transition-patients-between-different-long-acting-injectable-antipsychotics weekly 0.8 https://www.themednet.org/between-keynote-a-18-and-interlace-for-which-patients-would-you-recommend-using-one-protocol-over-another weekly 0.8 https://www.themednet.org/which-clinical-characteristics-would-prompt-you-to-consider-an-oral-factor-b-inhibitor-such-as-iptacopan-in-the-treatment-of-iga-nephropathy weekly 0.8 https://www.themednet.org/for-stroke-patients-with-ablated-paroxysmal-atrial-fibrillation-without-known-recurrence-and-icad-would-you-recommend-dual-antiplatelet-therapy-or-anticoagulation-with-or-without-an-antiplatelet-agent weekly 0.8 https://www.themednet.org/how-would-you-manage-jak2-polycythemia-vera-during-pregnancy-and-postpartum weekly 0.8 https://www.themednet.org/what-work-up-do-you-pursue-for-a-thorough-evaluation-in-patients-that-present-with-a-potential-diagnosis-of-dermatitis-artefacta weekly 0.8 https://www.themednet.org/what-is-the-role-of-hair-transplantation-for-scarring-alopecias-like-lichen-planopilaris weekly 0.8 https://www.themednet.org/what-treatment-combination-approach-would-you-recommend-for-mucous-membrane-pemphigoid weekly 0.8 https://www.themednet.org/is-there-any-evidence-that-ivermectin-suppresses-the-psa-level-in-prostate-cancer weekly 0.8 https://www.themednet.org/is-there-specific-data-on-using-luspatercept-for-sickle-beta-thalassemia-with-transfusion-dependent-anemia weekly 0.8 https://www.themednet.org/how-do-you-approach-chronic-t-cell-mediated-rejection-when-patient-is-intolerant-to-steroids weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-who-develops-a-rest-tremor-after-chemotherapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-agent-to-treat-anxiety-in-patients-with-parkinsons-disease weekly 0.8 https://www.themednet.org/would-you-consider-using-steroids-in-patients-with-respiratory-failure-caused-by-aspiration-pneumonitis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-newly-diagnosed-lbbb-in-individuals-70-years-old-who-are-free-of-any-signs-or-symptoms-of-heart-disease-and-without-other-significant-ascvd-risk-factors-besides-age weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-transition-to-dual-po-antibiotic-coverage-for-strep-species-and-mrsa-for-patients-with-purulent-cellulitis-and-in-the-absence-of-culture-data weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-in-treating-recurrent-bleeding-from-gave weekly 0.8 https://www.themednet.org/when-do-you-use-rozanolixizumab-for-musk-mg weekly 0.8 https://www.themednet.org/how-do-you-decide-on-the-timing-of-carotid-stenting-after-thrombectomy-for-an-intracranial-large-vessel-occlusion-with-ipsilateral-carotid-stenosis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-young-teenagers-with-acne-who-have-extremely-sensitive-skin-cannot-tolerate-typical-acne-regimens-cannot-tolerate-oral-antibiotics-and-refuse-accutane weekly 0.8 https://www.themednet.org/how-does-trimethoprim-sulfamethoxazoles-efficacy-against-s-pyogenes-influence-your-empirical-treatment-of-skin-infections-in-regions-with-high-resistance-rates weekly 0.8 https://www.themednet.org/do-you-offer-home-administration-of-esas-for-your-patients-with-anemia-of-chronic-kidney-disease weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-metabolic-syndrome-who-decline-statin-therapy-and-have-low-coronary-calcium-scores-regarding-their-long-term-cvd-risk weekly 0.8 https://www.themednet.org/would-you-offer-systemic-chemotherapy-to-a-patient-with-at-least-2023-figo-stage-ic-high-grade-serous-p53-mut-endometrial-cancer-with-extensive-lvi-for-whom-nodal-assessment-was-not-done weekly 0.8 https://www.themednet.org/is-it-safe-to-continue-azathioprine-in-a-patient-with-severe-bilateral-panuveitis-thought-to-be-related-to-sarcoidosis-and-benign-ethnic-neutropenia-given-worsening-neutropenia-since-starting-the-medication-or-should-an-alternative-immunosuppressive-agent weekly 0.8 https://www.themednet.org/in-what-circumstances-would-you-consider-use-of-idh-inhibitors-in-high-grade-astrocytomas weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-retroperitoneal-fibrosis-causing-ureteral-compression-that-has-already-caused-irreversible-loss-of-kidney-function weekly 0.8 https://www.themednet.org/are-there-any-successful-disease-modifying-therapy-for-diffuse-idiopathic-skeletal-hyperostosis-dish weekly 0.8 https://www.themednet.org/do-you-make-any-dose-adjustments-for-patients-with-eskd-who-are-on-apixaban-and-do-not-otherwise-meet-criteria-for-reduced-dosing weekly 0.8 https://www.themednet.org/what-is-your-preferred-method-for-latent-tuberculosis-screening-prior-to-outpatient-hemodialysis-initiation-for-a-patient-with-new-dialysis-requirements weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-isc-2025 weekly 0.8 https://www.themednet.org/how-do-you-determine-whether-to-limit-volume-removal-during-therapeutic-paracentesis-in-a-patient-without-acute-or-chronic-kidney-disease weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-use-lung-pocus-versus-ct-as-the-next-step-when-a-chest-x-ray-is-equivocal-for-pneumonia weekly 0.8 https://www.themednet.org/how-do-you-decide-on-switching-to-a-different-preventative-anti-cgrp-treatment-in-migraine-patients-who-are-experiencing-reduced-effectiveness-with-their-current-treatment weekly 0.8 https://www.themednet.org/would-you-switch-from-carboplatin-etoposide-to-cisplatin-etoposide-in-an-ls-sclc-patient-who-initially-declines-cisplatin-but-subsequently-agrees-to-it weekly 0.8 https://www.themednet.org/do-you-recommend-to-exchange-nephrostomy-tubes-when-a-patient-is-diagnosed-with-a-urinary-tract-infection-in-the-absence-of-any-overt-signs-of-infection-at-the-exit-site weekly 0.8 https://www.themednet.org/when-do-you-consider-attributing-isolated-psychosis-to-an-acute-ischemic-stroke weekly 0.8 https://www.themednet.org/would-you-consider-a-positive-dat-and-indirect-coombs-test-persistent-and-consistent-with-igg-warm-antibody-clinically-significant-in-absence-of-hemolysis weekly 0.8 https://www.themednet.org/have-you-had-patients-who-wish-to-take-ivermectin-and-or-fenbendazole-as-adjunct-treatments-for-gynecologic-cancers-and-if-so-how-have-you-handled-this weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-desiring-home-hospice-but-with-severe-thrombocytopenia-and-or-anemia-due-to-advanced-malignancy weekly 0.8 https://www.themednet.org/does-plasma-donation-cause-iron-deficiency weekly 0.8 https://www.themednet.org/what-second-line-therapy-would-you-offer-a-patient-with-metastatic-colon-cancer-with-her2-ihc-3-amplification-and-kras-g12d-mutation-whose-disease-progressed-on-folfox weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-deciding-what-type-of-glucagon-preparation-to-prescribe-for-rescue-hypoglycemia-in-patients-with-diabetes-on-insulin-therapy weekly 0.8 https://www.themednet.org/similar-to-the-hfa-icos-risk-stratification-tool-for-patients-on-chemotherapy-are-there-cardiac-risk-calculators-available-for-use-in-patients-starting-immunotherapy weekly 0.8 https://www.themednet.org/what-adverse-events-would-make-you-switch-off-nivo-avd-therapy-and-to-what-second-line-therapy-in-patients-with-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-approach-perioperative-steroids-for-a-quiescent-uveitis-patient-undergoing-cataract-surgery weekly 0.8 https://www.themednet.org/for-keloids-of-the-ear-that-require-a-skin-graft-for-surgical-closure-does-beginning-postoperative-radiation-within-24-hours-increase-the-risk-of-failure-of-the-graft weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-limited-stage-sclc-in-a-patient-with-idiopathic-pulmonary-fibrosis weekly 0.8 https://www.themednet.org/do-you-utilize-mammaprint-testing-to-determine-whether-or-not-to-offer-neoadjuvant-chemotherapy-for-high-risk-er-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-monitor-response-for-stage-iii-nsclc-patients-receiving-consolidation-immunotherapy weekly 0.8 https://www.themednet.org/would-you-use-neratinib-in-a-very-high-risk-her-2-positive-breast-cancer-patient-who-is-er weekly 0.8 https://www.themednet.org/would-you-electively-treat-the-neck-for-a-completely-resected-parotid-carcinoma-ex-pleomorphic-adenoma-with-negative-lymph-node-sampling weekly 0.8 https://www.themednet.org/do-you-routinely-use-bolus-for-treatment-of-early-stage-glottic-cancer weekly 0.8 https://www.themednet.org/do-you-offer-definitive-radiotherapy-for-recurrent-carcinoma-in-situ-of-oral-cavity-in-a-patient-who-is-not-a-surgical-candidate weekly 0.8 https://www.themednet.org/how-would-you-approach-a-locally-advanced-radioiodine-naive-papillary-thyroid-carcinoma-not-amenable-to-a-non-morbid-surgery weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-tnbc-who-developed-progressive-disease-during-neoadjuvant-chemotherapy-with-dose-dense-ac-and-weekly-paclitaxel weekly 0.8 https://www.themednet.org/for-large-avms-that-cannot-meet-the-v12-dose-constraint-how-low-are-you-willing-to-go-in-terms-of-single-fraction-dosing weekly 0.8 https://www.themednet.org/are-you-concerned-about-fiducials-shifting-within-the-prostate-during-prostate-imrt weekly 0.8 https://www.themednet.org/is-immunotherapy-the-next-best-option-for-a-patient-with-metastatic-translocation-associated-renal-cell-carcinoma-tfeb-rearrangement-after-progression-on-1st-line-sunitinib-and-2nd-line-everolimus-lenvatinib weekly 0.8 https://www.themednet.org/at-what-point-would-you-no-longer-offer-adjuvant-radiation-for-adenoid-cystic-ca-of-the-head-and-neck weekly 0.8 https://www.themednet.org/how-do-you-deliver-whole-breast-radiation-to-a-woman-with-pectus-excavatum weekly 0.8 https://www.themednet.org/for-er-breast-cancers-that-are-clinical-stage-iib-t2n1-nearing-locally-advanced-stages-what-criteria-do-you-use-to-determine-if-you-would-offer-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/for-apbi-do-you-prefer-a-brachytherapy-or-external-beam-technique weekly 0.8 https://www.themednet.org/would-you-offer-whole-abdominal-irradiation-to-a-pelvic-recurrence-of-rhabdomyosarcoma-with-tumor-rupture-spillage weekly 0.8 https://www.themednet.org/if-treating-a-patient-with-prior-breast-augmentation-with-whole-breast-radiation-would-you-alter-your-field-setup weekly 0.8 https://www.themednet.org/when-if-ever-do-you-consider-administering-weekly-paclitaxel-prior-to-dose-dense-ac-for-neoadjuvant-treatment-of-breast-cancer weekly 0.8 https://www.themednet.org/what-is-the-shortest-interval-you-would-consider-to-deliver-re-irradiation-for-a-recurrent-glioblastoma weekly 0.8 https://www.themednet.org/when-should-proton-beam-therapy-be-considered-for-uveal-melanoma weekly 0.8 https://www.themednet.org/do-you-offer-palliative-whole-liver-radiation-for-patients-with-diffuse-liver-metastases weekly 0.8 https://www.themednet.org/how-would-you-treat-a-isolated-high-grade-neuroendocrine-carcinoma-of-the-neck-with-no-obvious-primary-or-systemic-disease weekly 0.8 https://www.themednet.org/can-over-the-counter-mouth-guards-be-used-to-reduce-back-scatter-from-dental-fillings-during-head-and-neck-radiation weekly 0.8 https://www.themednet.org/when-completing-radiation-treatment-planning-on-a-4d-scan-do-you-prefer-the-average-or-free-breathing-scan-for-dose-calculation weekly 0.8 https://www.themednet.org/do-you-use-modified-folfirinox-preferentially-over-gem-nab-paclitaxel-for-first-line-metastatic-pancreatic-cancer-patients weekly 0.8 https://www.themednet.org/will-you-consider-additional-capecitabine-in-a-patient-with-tnbc-residual-disease-after-neo-adjuvant-chemo-before-getting-adjuvant-pembrolizumab-or-placebo-on-swog-1418-clinical-trial weekly 0.8 https://www.themednet.org/do-you-hold-immunotherapy-when-administering-lung-sbrt weekly 0.8 https://www.themednet.org/how-soon-after-chemort-for-a-head-and-neck-cancer-can-you-safely-initiate-esophageal-dilation weekly 0.8 https://www.themednet.org/how-long-do-you-continue-surveillance-imaging-for-nsclc-after-definitive-treatment weekly 0.8 https://www.themednet.org/what-dose-constraints-do-you-use-for-the-pulmonary-vein-pulmonary-artery-and-superior-vena-cava-for-thoracic-reirradiation-after-prior-conventional-fractionation-to-a-central-lung-tumor weekly 0.8 https://www.themednet.org/in-a-patient-with-intermediate-risk-metastatic-rcc-with-high-thrombotic-tumor-burden-in-the-ivc-extending-to-the-right-atrium-is-there-any-clinical-or-biologic-rationale-to-guide-choice-of-therapy-between-axitinib-pembrolizumab-vs-nivolumab-ipilimumab weekly 0.8 https://www.themednet.org/at-what-time-do-you-switch-to-olaparib-after-folfirinox-in-brca-mutated-metastatic-pancreatic-adenocarcinoma-patients weekly 0.8 https://www.themednet.org/when-would-you-consider-first-line-folfoxiri-bevacizumab-for-metastatic-colon-cancer weekly 0.8 https://www.themednet.org/for-patients-who-have-exceptionally-long-responses-to-hma-with-high-risk-mds-or-aml-and-not-candidate-for-more-aggressive-therapy-transplant-do-you-consider-treatment-holidays-or-spacing-out-doses-into-longer-intervals weekly 0.8 https://www.themednet.org/would-you-offer-salvage-radiation-for-biochemically-recurrent-prostate-cancer-with-a-transplanted-pelvic-kidney weekly 0.8 https://www.themednet.org/do-you-check-baseline-or-surveillance-audiometry-if-not-overtly-symptomatic-to-screen-for-hearing-loss-in-all-patients-getting-cisplatin weekly 0.8 https://www.themednet.org/how-would-you-manage-a-small-posterior-vaginal-defect-noted-at-the-time-of-cervical-brachytherapy weekly 0.8 https://www.themednet.org/does-the-final-report-and-approval-of-checkmate-227-ipi-nivo-regimen-change-your-first-line-recommendations-for-patients-with-pdl1-tps-1 weekly 0.8 https://www.themednet.org/what-itv-to-ptv-expansions-do-you-use-for-free-breathing-nsclc-sbrt-using-ct-sim-with-4dct weekly 0.8 https://www.themednet.org/what-is-the-optimal-duration-of-adt-for-cn1-disease-with-ebrt weekly 0.8 https://www.themednet.org/how-would-you-manage-a-resected-meningioma-found-to-harbor-a-small-focus-of-metastatic-disease-from-a-non-cns-primary-malignancy weekly 0.8 https://www.themednet.org/what-is-your-approach-in-a-transplant-eligible-patient-with-relapsed-classical-hodgkin-lymphoma-who-has-an-area-of-refractory-disease-after-salvage-chemotherapy weekly 0.8 https://www.themednet.org/when-giving-folfox-folfiri-and-skipping-5fu-bolus-do-you-still-give-leucovorin weekly 0.8 https://www.themednet.org/how-do-you-approach-a-post-menopausal-female-with-early-stage-er-her2-breast-cancer-s-p-lumpectomy-with-invasive-ductal-histology-and-lymph-node-involvement-with-invasive-lobular-histology weekly 0.8 https://www.themednet.org/what-is-the-role-for-rni-in-a-postmenopausal-female-with-clinically-n-hormone-receptor-positive-breast-cancer-s-p-lumpectomy-and-alnd-with-low-volume-nodal-disease-e-g-1-12-nodes-positive weekly 0.8 https://www.themednet.org/how-would-you-approach-frontline-treatment-of-a-patient-with-metastatic-non-squamous-nsclc-with-erbb2-amplification-and-pd-l1-50 weekly 0.8 https://www.themednet.org/how-do-you-manage-chronic-radiation-laryngeal-edema-for-patients-treated-with-rt-for-a-larynx-primary-in-the-past weekly 0.8 https://www.themednet.org/in-a-patient-with-m0crpc-with-psa-doubling-time-6-months-will-you-wait-until-the-absolute-psa-value-is-2-or-is-psadt-alone-sufficient-to-start-an-ar-targeted-agent weekly 0.8 https://www.themednet.org/how-do-you-determine-whether-to-choose-a-non-anthracycline-neoadjuvant-chemotherapy-regimen-in-a-fit-patient-with-tnbc weekly 0.8 https://www.themednet.org/if-a-patient-who-had-mastectomy-and-implant-reconstruction-for-t1n0-breast-cancer-developed-a-new-lesion-years-later-in-the-axillary-tail-should-the-implant-be-removed-and-the-chest-wall-treated-or-would-you-consider-apbi-to-spare-the-implant weekly 0.8 https://www.themednet.org/how-do-you-sequence-ttfields-into-your-salvage-therapy-plan-for-patients-with-recurrent-glioblastoma weekly 0.8 https://www.themednet.org/how-would-you-approach-an-isolated-supraclavicular-nodal-recurrence-of-breast-cancer-in-a-patient-who-was-treated-with-breast-conserving-surgery-and-whole-breast-radiation-without-rni weekly 0.8 https://www.themednet.org/is-it-reasonable-to-offer-3-days-bep-regimen-to-a-patient-with-high-risk-mixed-germ-cell-tumor-due-to-compliance-issues weekly 0.8 https://www.themednet.org/would-a-low-or-intermediate-oncotype-rs-affect-your-choice-of-adjuvant-endocrine-therapy-for-a-premenopausal-woman-with-high-clinical-risk-hr-early-stage-disease weekly 0.8 https://www.themednet.org/would-you-offer-consolidative-autologous-stem-cell-transplant-in-cr1-for-high-risk-diffuse-large-b-cell-lymphoma-dlbcl weekly 0.8 https://www.themednet.org/what-is-your-preferred-btk-inhibitor-for-patients-with-relapsed-refractory-mantle-cell-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-a-recurrent-low-grade-glioma-several-years-removed-from-prior-radiotherapy weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemort-for-node-positive-high-rectal-cancer-above-the-peritoneal-reflection weekly 0.8 https://www.themednet.org/in-a-patient-with-ypn-breast-cancer-with-an-adequately-dissected-axilla-do-you-omit-radiation-to-the-dissected-axilla-when-treating-the-regional-nodes weekly 0.8 https://www.themednet.org/would-you-consider-retrying-a-platinum-based-chemotherapy-agent-in-a-platinum-resistant-ovarian-cancer-patient weekly 0.8 https://www.themednet.org/would-you-treat-unfavorable-intermediate-risk-prostate-cancer-in-the-setting-of-recently-resected-nsclc weekly 0.8 https://www.themednet.org/would-you-include-the-regional-nodes-when-treating-with-pmrt-in-a-patient-with-a-high-grade-large-primary-tumor-but-low-burden-axillary-disease-with-a-complete-axillary-dissection-e-g-1-20-nodes-involved weekly 0.8 https://www.themednet.org/how-long-after-prostate-radiation-do-you-recommend-waiting-for-routine-screening-colonoscopy weekly 0.8 https://www.themednet.org/in-what-scenarios-would-you-incorporate-platinum-for-patients-with-localized-tnbc weekly 0.8 https://www.themednet.org/would-you-recommend-3-or-6-months-adjuvant-chemo-for-low-risk-stage-iii-sigmoid-cancer-t3-n1-but-with-positive-lvi-and-pni weekly 0.8 https://www.themednet.org/how-would-you-approach-a-postmenopausal-female-with-localized-er-breast-cancer-on-adjuvant-anastrozole-with-a-rising-estradiol-level weekly 0.8 https://www.themednet.org/what-cisplatin-regimen-do-you-prefer-with-adjuvant-radiation-in-oropharyngeal-scc-that-is-pt4n2-after-surgery-and-bilateral-neck-dissection weekly 0.8 https://www.themednet.org/which-patients-with-rectal-cancer-who-have-not-received-neoadjuvant-treatment-do-you-offer-adjuvant-radiation-to weekly 0.8 https://www.themednet.org/what-treatment-would-you-give-to-a-pediatric-patient-with-first-relapse-of-wilms-tumor weekly 0.8 https://www.themednet.org/what-systemic-therapy-would-you-offer-to-a-pediatric-patient-with-fibrolamellar-hepatocellular-carcinoma-after-an-initial-partial-surgical-resection weekly 0.8 https://www.themednet.org/would-you-offer-liver-transplant-to-a-pediatric-patient-with-unresectable-fibrolamellar-hepatocellular-carcinoma weekly 0.8 https://www.themednet.org/do-you-recommend-mri-pelvis-prostate-in-a-patient-with-biochemical-recurrence-after-xrt-and-negative-axumin-pet-scan weekly 0.8 https://www.themednet.org/how-would-you-treat-an-upper-extremity-high-grade-neuroendocrine-carcinoma-s-p-6-cycles-of-cisplatin-and-etoposide-followed-by-resection-ypt0-ypn1 weekly 0.8 https://www.themednet.org/how-do-you-manage-neurocognitive-decline-associated-with-chemotherapy-i-e-chemo-brain weekly 0.8 https://www.themednet.org/how-do-you-approach-a-women-with-localized-her2-breast-cancer-that-was-her2-by-fish-but-negative-0-by-ihc weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-recommend-to-elderly-patients-with-pt2n0-er-pr-her2-breast-cancer weekly 0.8 https://www.themednet.org/would-you-offer-trastuzumab-pertuzumab-alone-for-patients-with-early-stage-her2-breast-cancer-for-whom-tchp-is-clearly-indicated-but-who-adamantly-refuse-any-cytotoxic-therapy weekly 0.8 https://www.themednet.org/how-do-you-treat-plantar-fibromatosis-with-radiation weekly 0.8 https://www.themednet.org/how-should-radiation-oncology-departments-prepare-for-significant-resource-depletion-and-or-staff-shortages-with-the-covid-19-outbreak weekly 0.8 https://www.themednet.org/how-would-you-treat-an-elderly-female-with-metastatic-hr-her2-breast-cancer-on-endocrine-therapy-who-now-has-progressive-bone-only-disease weekly 0.8 https://www.themednet.org/does-your-recommendation-for-adt-change-in-an-elderly-patient-with-dementia-and-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/what-are-the-current-official-guidelines-regarding-managing-patients-during-covid-19 weekly 0.8 https://www.themednet.org/will-patients-who-receive-radiation-to-a-large-mediastinal-nodal-field-have-an-increased-susceptibility-to-covid-19 weekly 0.8 https://www.themednet.org/would-you-recommend-sentinel-lymph-node-biopsy-at-the-time-of-wide-excision-for-a-3-mm-merkel-cell-carcinoma-of-the-cheek-lateral-canthus weekly 0.8 https://www.themednet.org/what-is-your-preferred-next-line-of-therapy-for-a-fit-patient-with-unresectable-refractory-osteosarcoma-who-has-progressed-after-map-local-radiation-and-ie weekly 0.8 https://www.themednet.org/what-clinical-factors-would-lead-to-utilizing-a-tandem-and-cylinder-rather-than-tandem-and-ovoid-for-cervical-cancer-brachytherapy weekly 0.8 https://www.themednet.org/how-would-you-boost-a-high-risk-prostate-cancer-patient-who-received-standard-fractionation-treatment-and-is-not-able-to-get-ldr-boost-given-covid-19 weekly 0.8 https://www.themednet.org/for-a-patient-with-locally-advanced-lung-cancer-and-mediastinal-but-not-hilar-involvement-would-you-electively-treat-the-ipsilateral-hilum weekly 0.8 https://www.themednet.org/how-do-you-treat-a-high-grade-prostate-cancer-with-bulky-direct-bladder-invasion weekly 0.8 https://www.themednet.org/are-there-circumstances-where-you-would-recommend-every-6-week-dosing-schedule-for-pembrolizumab-monotherapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-metastatic-lung-cancer-with-her2-mutant-nsclc-who-is-not-a-trial-candidate weekly 0.8 https://www.themednet.org/are-there-any-indications-to-boost-the-axilla-for-women-with-locally-advanced-breast-cancer-who-do-not-have-clear-gross-residual-undissected-axillary-disease weekly 0.8 https://www.themednet.org/are-there-any-trials-currently-studying-low-dose-rt-for-confirmed-covid-19-infections-with-associated-pneumonia weekly 0.8 https://www.themednet.org/what-is-your-approach-to-systemic-treatment-of-a-rapidly-progressing-symptomatic-unresectable-mpnst-arising-from-a-plexiform-neurofibroma-in-a-patient-with-nf1 weekly 0.8 https://www.themednet.org/would-you-recommend-anticoagulation-prophylaxis-for-a-pediatric-patient-admitted-with-covid-19 weekly 0.8 https://www.themednet.org/in-what-scenario-would-you-prefer-weekly-vs-every-3-week-carboplatin-paclitaxel-for-high-grade-serous-ovarian-cancer weekly 0.8 https://www.themednet.org/would-you-recommend-pmrt-for-a-patient-with-a-right-breast-mastectomy-with-closest-margin-less-than-0-1cm weekly 0.8 https://www.themednet.org/for-a-patient-with-recurrent-endometrial-cancer-involving-the-vagina-with-a-good-response-to-ebrt-5mm-residual-how-would-you-prescribe-adjuvant-brachytherapy-with-a-cylinder-to-the-entire-vaginal-length weekly 0.8 https://www.themednet.org/how-do-you-treat-a-patient-with-a-history-of-clinical-stage-iib-cn2-mixed-germ-cell-embryonal-carcinoma-treated-with-bep-and-rplnd-five-years-ago-who-now-has-signet-ring-cell-adenocarcinoma-with-abdominal-carcinomatosis-with-an-unknown-primary weekly 0.8 https://www.themednet.org/how-long-should-breast-cancer-patients-whose-surgeries-are-delayed-due-to-covid-19-remain-on-neoadjuvant-endocrine-therapy weekly 0.8 https://www.themednet.org/how-do-you-manage-a-recurrent-craniopharyngioma weekly 0.8 https://www.themednet.org/would-you-consider-apbi-in-a-patient-who-received-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/does-er-status-impact-your-choice-of-neoadjuvant-systemic-therapy-in-premenopausal-women-with-ct2n0-her2-breast-cancer weekly 0.8 https://www.themednet.org/in-what-scenario-would-you-give-consolidation-chemotherapy-after-chemoradiation-for-stage-3-cervical-cancer-with-a-good-response weekly 0.8 https://www.themednet.org/how-would-you-treat-a-mixed-neuroendocrine-adenocarcinoma-appendiceal-tumor-with-metastasis-to-the-liver weekly 0.8 https://www.themednet.org/would-you-offer-hippocampal-sparing-whole-brain-radiation-for-patients-with-brain-metastases-due-to-es-sclc weekly 0.8 https://www.themednet.org/what-is-your-current-practice-for-obtaining-mutation-status-for-a-patient-with-newly-diagnosed-ovarian-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-treatment-option-for-a-fit-patient-with-non-squamous-nsclc-who-is-pdl1-positive-1-49-with-no-driver-mutations weekly 0.8 https://www.themednet.org/what-margins-do-you-use-for-hypofractionated-treatment-of-glioblastoma weekly 0.8 https://www.themednet.org/what-is-your-approach-for-endocrine-therapy-in-young-women-35-years-old-with-hr-her2-breast-ca-with-residual-disease-after-tchp-who-will-start-adjuvant-t-dm1 weekly 0.8 https://www.themednet.org/how-important-is-the-timing-of-weekly-cisplatin-in-concurrent-chemoradiation-for-definitive-treatment-of-cervical-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-a-high-intermediate-risk-stage-ia-grade-2-endometrial-ca weekly 0.8 https://www.themednet.org/would-you-give-full-post-operative-dose-radiation-for-an-undifferentiated-high-grade-pleomorphic-sarcoma-of-the-extremity-with-close-surgical-margins-if-the-patient-had-previously-received-20gy-preoperatively weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-breast-radiation-following-lumpectomy-for-a-well-differentiated-adenoid-cystic-carcinoma-that-appears-to-be-a-breast-primary weekly 0.8 https://www.themednet.org/which-myositis-patients-are-good-candidates-for-ivig weekly 0.8 https://www.themednet.org/what-baseline-work-up-or-staging-do-you-do-in-patients-with-a-new-diagnosis-of-sjogrens-i-e-pft-cryoglobulins-complement-rf-ua weekly 0.8 https://www.themednet.org/how-would-you-approach-a-locally-advanced-node-positive-oral-cavity-squamous-cell-carcinoma-of-the-h-n-with-ccr-after-induction-chemotherapy weekly 0.8 https://www.themednet.org/is-there-a-subset-of-patients-with-metastatic-breast-cancer-in-whom-you-would-consider-locoregional-therapy weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-pancreatic-adenocarcinoma-who-progress-during-neoadjuvant-folfirinox-such-that-borderline-resectable-disease-is-now-unresectable-but-still-localized weekly 0.8 https://www.themednet.org/will-you-recommend-abemaciclib-in-combination-with-standard-adjuvant-endocrine-therapy-in-patients-with-high-risk-hormone-receptor-positive-her2-early-breast-cancer weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-for-a-large-high-grade-radiation-induced-malignant-peripheral-nerve-sheath-tumor-following-r1-resection weekly 0.8 https://www.themednet.org/how-would-you-approach-a-postmenopausal-woman-with-stage-i-hr-her2-breast-cancer-who-had-a-cva-while-on-tamoxifen weekly 0.8 https://www.themednet.org/how-do-you-treat-primary-retroperitoneal-choriocarcinoma-with-liver-and-lung-metastases-and-markedly-elevated-b-hcg weekly 0.8 https://www.themednet.org/would-you-treat-a-localized-radiographic-prostate-failure-after-ebrt-with-hdr-brachytherapy weekly 0.8 https://www.themednet.org/how-would-you-manage-locally-advanced-head-and-neck-patients-getting-definitive-chemoradiation-who-show-progression-halfway-through-treatment weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-anal-squamous-cell-carcinoma-and-5-fu-induced-coronary-vasospasm-36-hours-after-starting-definitive-chemoradiation weekly 0.8 https://www.themednet.org/would-you-use-an-anti-il-17-over-an-anti-tnfa-as-your-first-line-biologic-in-psoriatic-arthritis weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-for-platinum-eligible-patients-with-pt2pn0-urothelial-carcinoma-of-bladder-or-utuc-who-did-not-receive-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-is-the-typical-work-up-completed-to-rule-out-other-conditions-prior-to-making-a-diagnosis-of-fibromyalgia-other-than-history-and-physical-exam weekly 0.8 https://www.themednet.org/how-do-you-manage-early-and-symptomatic-fibrosis-in-lung-cancer-patients-after-rt weekly 0.8 https://www.themednet.org/do-you-offer-partial-breast-irradiation-to-women-with-tumors-infiltrating-the-dermis-not-epidermis-who-otherwise-fall-in-the-suitable-astro-category weekly 0.8 https://www.themednet.org/would-you-add-whole-pelvis-radiation-as-mdt-metastasis-directed-therapy-in-a-patient-with-1-pelvic-node-and-2-osseous-metastatic-sites-for-castrate-resistant-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-ever-switch-to-vancomycin-after-clinical-improvement-and-blood-culture-clearance-in-a-patient-with-high-grade-vancomycin-susceptible-mrsa-bacteremia-in-whom-a-salvage-regimen-was-initiated weekly 0.8 https://www.themednet.org/how-do-you-navigate-requests-from-your-employers-to-see-patients-for-shorter-appointment-times-or-less-frequently-than-you-feel-is-clinically-indicated weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-use-pharmacologic-vte-prophylaxis-in-hospitalized-patients-with-decompensated-cirrhosis weekly 0.8 https://www.themednet.org/how-would-you-manage-a-frail-but-functioning-elderly-patient-with-extensive-thoracolumbar-spinal-fusions-4-5-years-ago-now-presenting-with-copious-purulent-drainage-from-l2-l4-whose-mri-shows-no-osteomyelitis-or-abscess-and-who-has-mild-pain-but-no-system weekly 0.8 https://www.themednet.org/what-is-your-approach-to-iron-supplementation-in-patients-with-an-active-infection weekly 0.8 https://www.themednet.org/when-do-you-decide-to-proceed-with-cataract-or-glaucoma-surgery-in-patients-with-non-quiescent-herpetic-stromal-keratitis weekly 0.8 https://www.themednet.org/how-would-the-updated-results-of-ecog-3311-influence-your-adjuvant-rt-recommendations-for-hpv-opscc weekly 0.8 https://www.themednet.org/do-you-still-recommend-consolidative-allogeneic-stem-cell-transplants-for-patients-with-richter-transformation-in-cr-after-frontline-treatment-in-the-modern-era-of-therapies weekly 0.8 https://www.themednet.org/how-do-you-manage-new-onset-vitiligo-in-a-patient-on-immune-checkpoint-inhibitors weekly 0.8 https://www.themednet.org/how-do-you-consider-sending-fungal-studies-in-a-patient-with-pneumonia weekly 0.8 https://www.themednet.org/what-is-your-antipsychotic-of-choice-and-general-titration-regimen-in-the-outpatient-setting-for-a-patient-with-dementia-and-behavioral-disturbances-assuming-reversible-causes-such-as-urinary-retention-constipation-etc-have-been-addressed weekly 0.8 https://www.themednet.org/do-you-recommend-vitamin-c-supplementation-with-po-iron-in-patients-with-iron-deficiency weekly 0.8 https://www.themednet.org/given-the-mixed-evidence-for-n-acetylcysteine-in-adolescent-cannabis-use-disorder-how-do-you-approach-discussing-this-with-families weekly 0.8 https://www.themednet.org/do-you-reduce-the-dose-of-hydroxychloroquine-in-patients-with-skin-graying-if-they-are-not-particularly-bothered-by-this-side-effect weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-patients-with-ehlers-danlos-hypermobile-type-with-chronic-muscle-spasms-with-minimal-exertion weekly 0.8 https://www.themednet.org/is-the-enhanced-liver-fibrosis-elf-test-superior-to-the-fib-4-test-in-the-diagnosis-of-masld weekly 0.8 https://www.themednet.org/are-you-comfortable-using-belimumab-in-patients-with-a-history-of-significant-depression weekly 0.8 https://www.themednet.org/what-is-your-go-to-multifocal-lens weekly 0.8 https://www.themednet.org/are-you-routinely-recommending-adjuvant-ribociclib-now-for-node-negative-hr-her2-breast-cancer-given-data-from-the-natalee-trial weekly 0.8 https://www.themednet.org/does-a-high-genomic-risk-score-impact-your-radiation-fields-for-patients-with-breast-cancer weekly 0.8 https://www.themednet.org/do-you-typically-recommend-placement-of-a-rectal-spacer-prior-to-definitive-radiotherapy-regardless-of-dose-fractionation weekly 0.8 https://www.themednet.org/would-patients-receiving-targeted-therapies-be-eligible-for-ttfields-for-brain-metastases weekly 0.8 https://www.themednet.org/in-patients-with-masld-and-f2-f3-fibrosis-would-you-initiate-resmetirom-even-if-they-are-not-making-active-lifestyle-changes weekly 0.8 https://www.themednet.org/what-strategies-have-you-found-most-effective-for-obtaining-prior-authorization-for-newer-antipsychotics-and-antidepressants weekly 0.8 https://www.themednet.org/for-ici-arthritis-how-soon-do-you-start-dmards weekly 0.8 https://www.themednet.org/do-you-recommend-placement-of-a-rectal-spacer-when-delivering-radiotherapy-to-the-prostate-in-patients-with-oligometastatic-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-adhd-treatment-in-patients-with-psychotic-disorders-who-are-now-psychiatrically-stable weekly 0.8 https://www.themednet.org/do-you-use-mrd-testing-to-guide-maintenance-therapy-discontinuation-in-newly-diagnosed-non-high-risk-myeloma-patients weekly 0.8 https://www.themednet.org/what-is-your-approach-when-a-patient-has-concomitant-acute-decompensated-heart-failure-and-rapid-atrial-fibrillation weekly 0.8 https://www.themednet.org/how-do-you-manage-symptomatic-ascites-in-a-patient-with-sbp weekly 0.8 https://www.themednet.org/how-do-you-plan-to-integrate-nerandomilast-into-the-treatment-algorithm-for-patients-with-ild weekly 0.8 https://www.themednet.org/which-eskd-patients-would-you-consider-transitioning-from-hemodialysis-to-hemodiafiltration-given-the-fda-approval-of-a-hemodiafiltration-system-in-the-us weekly 0.8 https://www.themednet.org/how-do-you-treat-metastatic-braf-mutated-small-bowel-adenocarcinoma-in-the-first-line-setting weekly 0.8 https://www.themednet.org/do-you-recommend-24-hour-urine-stone-risk-studies-for-patients-with-no-history-of-nephrolithiasis-who-are-undergoing-evaluation-as-potential-kidney-donors weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-necrotizing-pneumonia-due-to-a-susceptible-pseudomonas-aeruginosa-strain-who-continues-to-have-significant-purulent-secretions-and-worsening-imaging-while-receiving-cefepime weekly 0.8 https://www.themednet.org/what-has-been-your-experience-incorporating-the-port-delivery-system-pds-into-clinical-practice weekly 0.8 https://www.themednet.org/what-has-been-your-experience-adopting-office-based-surgery-and-has-it-meaningfully-improved-patient-access-or-practice-efficiency weekly 0.8 https://www.themednet.org/what-has-been-your-experience-using-sutureless-muellers-muscle-conjunctival-resection-mmcr-for-ptosis-repair weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-a-12-mm-recurrence-of-the-left-implant-based-breast-reconstruction-17-years-after-her-initial-diagnosis weekly 0.8 https://www.themednet.org/do-you-recommend-first-consulting-interventional-radiology-or-vascular-surgery-if-you-lack-access-to-interventional-nephrology-in-a-patient-with-eskd-who-is-suspected-of-having-a-clotted-fistula-and-is-unable-to-receive-hemodialysis weekly 0.8 https://www.themednet.org/in-the-current-era-of-adjuvant-cdk4-6-inhibitor-use-for-high-risk-hr-her2-negative-breast-cancer-what-is-the-preferred-adjuvant-chemotherapy-regimen-for-premenopausal-women-ac-t-or-tc weekly 0.8 https://www.themednet.org/what-is-your-approach-to-using-newer-atypical-antipsychotics-in-the-treatment-of-schizophrenia weekly 0.8 https://www.themednet.org/for-cirrhotic-patients-that-we-take-care-of-in-the-community-when-should-be-the-optimal-timing-of-referral-for-liver-transplantation-aside-from-the-meld-score weekly 0.8 https://www.themednet.org/do-you-perform-pap-smears-as-part-of-the-surveillance-of-patients-with-a-history-of-cervical-or-vaginal-cancers-who-had-radiation-as-part-of-their-treatment weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-who-presents-with-hair-loss-that-began-after-they-started-a-glp-1-inhibitor weekly 0.8 https://www.themednet.org/what-is-your-approach-to-selecting-and-adjusting-nippv-settings-in-the-management-of-patients-with-chronic-hypercapnic-respiratory-failure weekly 0.8 https://www.themednet.org/would-you-consider-neoadjuvant-immunotherapy-prior-to-radiation-for-a-locally-advanced-skin-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/would-you-start-a-mineralocorticoid-receptor-antagonist-in-patients-with-unilateral-primary-aldosteronism-while-they-are-awaiting-adrenalectomy weekly 0.8 https://www.themednet.org/what-is-your-pharmacological-approach-to-treating-depressive-disorders-in-patients-who-develop-serotonin-toxicity weekly 0.8 https://www.themednet.org/in-patients-on-long-term-proton-pump-inhibitors-for-gerd-with-stable-symptoms-do-you-routinely-attempt-discontinuation-or-continue-indefinitely-given-relapse-risk weekly 0.8 https://www.themednet.org/do-you-recommend-starting-a-statin-in-patients-above-75-years-old-with-diabetes-but-no-known-ascvd weekly 0.8 https://www.themednet.org/would-you-treat-scedosporium-growth-in-expectorated-sputum-in-a-patient-with-copd-pulmonary-hypertension-and-bronchiectasis-who-has-chronic-dyspnea-with-exertion-thick-sputum-production-negative-bacterial-cultures-and-no-signs-of-mold-infection-on-a-high- weekly 0.8 https://www.themednet.org/what-is-your-approach-when-the-child-refuses-to-separate-from-parents-during-psychiatric-evaluation weekly 0.8 https://www.themednet.org/how-do-you-approach-recommending-an-avf-for-a-patient-with-advanced-ckd-who-is-concerned-about-the-cosmetic-appearance-of-the-fistula weekly 0.8 https://www.themednet.org/for-patients-starting-pluvicto-do-you-have-patients-stop-their-arpi weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-idweek-2025 weekly 0.8 https://www.themednet.org/how-do-you-choose-between-liso-cel-and-axi-cel-in-patients-with-early-relapse-dlbcl-for-whom-you-are-recommending-car-t-cell-therapy weekly 0.8 https://www.themednet.org/how-do-you-treat-a-focal-pericardial-metastasis weekly 0.8 https://www.themednet.org/would-you-extend-pembrolizumab-for-over-2-years-in-a-patient-with-msi-h-pancreatic-ductal-adenocarcinoma-with-now-stable-disease weekly 0.8 https://www.themednet.org/do-you-continue-pjp-prophylaxis-indefinitely-in-patients-on-rituximab-maintenance-therapy weekly 0.8 https://www.themednet.org/which-patients-do-you-think-would-benefit-most-from-xanomeline-tropsium-cobenfy-monotherapy weekly 0.8 https://www.themednet.org/how-do-you-treat-an-isolated-in-transit-recurrence-of-melanoma-without-evidence-of-clinical-nodal-involvement-in-a-patient-with-a-history-of-previously-resected-primary-melanoma weekly 0.8 https://www.themednet.org/would-you-consider-leaving-fever-untreated-in-patients-with-sepsis-to-potentially-enhance-immune-responses-and-antimicrobial-efficacy weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gi-cancers-from-esmo-2025 weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-thoracic-cancers-from-esmo-2025 weekly 0.8 https://www.themednet.org/in-a-patient-with-de-novo-metastatic-rcc-s-p-ipi-nivo-with-partial-response-and-residual-viable-rcc-on-cytoreductive-nephrectomy-would-you-add-cabozantinib-or-other-tki-prior-to-disease-progression weekly 0.8 https://www.themednet.org/do-you-recommend-vasodilators-in-patients-with-raynauds-who-have-capillary-drop-out-but-are-otherwise-not-bothered-enough-by-their-symptoms-to-want-to-pursue-systemic-treatment weekly 0.8 https://www.themednet.org/in-which-patients-with-ssc-do-you-add-anti-platelet-therapy-and-or-statins-for-raynauds-phenomenon weekly 0.8 https://www.themednet.org/how-do-you-incorporate-hyperbaric-oxygen-therapy-into-the-care-of-patients-with-wounds-related-to-ischemic-ulcerations weekly 0.8 https://www.themednet.org/how-do-you-suggest-incorporating-pocus-into-the-evaluation-of-sstis-and-do-you-use-this-as-a-means-to-guide-initial-antibiotic-selection weekly 0.8 https://www.themednet.org/do-you-suggest-using-a-vascular-probe-to-assess-the-superficial-vasculature-prior-to-performing-a-bedside-procedure-such-as-paracentesis-thoracentesis-lumbar-puncture-etc weekly 0.8 https://www.themednet.org/how-do-you-recommend-mitigating-the-risks-of-using-beta-blocker-and-clonidine-therapy-in-combination-for-management-of-hypertension weekly 0.8 https://www.themednet.org/would-you-consider-pcsk9-inhibitors-for-patients-with-elevated-coronary-calcium-score-or-coronary-calcification-for-primary-prevention-in-lieu-of-statins-ezetimibe-and-or-bempedoic-acid weekly 0.8 https://www.themednet.org/when-would-you-consider-switching-to-or-adding-on-a-pcsk9-inhibitor-to-lipid-lowering-therapy-following-hospital-discharge-for-acute-coronary-syndrome-in-light-of-the-results-of-the-victorion-inception-trial-provided-ldl-is-still-not-at-goal weekly 0.8 https://www.themednet.org/when-do-you-think-physicians-should-seriously-consider-prescribing-pcsk9-inhibitors-for-the-prevention-of-heart-attack-and-stroke-in-people-with-ascvd-or-diabetes-based-on-the-results-of-the-vesalius-cv-trial weekly 0.8 https://www.themednet.org/when-should-patients-be-referred-for-advanced-mri-testing-to-assess-for-cvs-and-prl weekly 0.8 https://www.themednet.org/how-do-you-manage-sleep-disturbances-in-patients-with-alzheimers-disease-without-relying-heavily-on-deliriogenic-medications weekly 0.8 https://www.themednet.org/do-you-prefer-maximizing-fluid-removal-during-dialysis-or-starting-new-antihypertensive-medications-for-patients-with-eskd-on-intermittent-hemodialysis-who-are-chronically-hypertensive weekly 0.8 https://www.themednet.org/how-do-you-decide-the-best-way-to-treat-glaucoma-in-patients-with-ice-syndrome-given-their-higher-risk-of-surgical-failure-and-corneal-complications weekly 0.8 https://www.themednet.org/how-do-you-decide-if-patients-who-have-a-multifocal-demyelinating-polyneuropathy-would-benefit-from-surgical-treatment-of-carpal-tunnel-syndrome weekly 0.8 https://www.themednet.org/how-do-you-interpret-conflicting-findings-on-csf-immunoglobulin-tests-for-work-up-of-multiple-sclerosis-and-its-mimics weekly 0.8 https://www.themednet.org/what-class-es-of-antihypertensives-should-be-considered-next-for-refractory-hypertension-in-a-patient-compliant-with-high-doses-of-entresto-chlorthalidone-amlodipine-clonidine-and-spironolactone-if-they-previously-did-not-have-any-improvement-on-beta-bloc weekly 0.8 https://www.themednet.org/do-patients-with-hypogonadism-commonly-present-with-dizziness weekly 0.8 https://www.themednet.org/which-imaging-features-do-you-use-when-considering-normal-pressure-hydrocephalus-to-decide-whether-to-proceed-with-large-volume-lp-or-lumbar-drain-trial weekly 0.8 https://www.themednet.org/how-should-dato-dxd-be-managed-in-the-absence-of-necessary-resources-for-ocular-exams-and-referrals weekly 0.8 https://www.themednet.org/do-you-apply-manual-pressure-around-the-kidney-biopsy-site-immediately-post-procedure-and-prior-to-supine-positioning-to-help-prevent-perinephric-bleeding weekly 0.8 https://www.themednet.org/should-thunderstorm-asthma-be-incorporated-into-asthma-action-plans-2 weekly 0.8 https://www.themednet.org/how-do-you-introduce-patients-with-obsessive-compulsive-disorder-to-the-concept-of-exposure-and-response-prevention-erp-therapy-when-they-may-be-hesitant-to-engage-in-exposure-based-work weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-use-acid-suppressive-medications-for-gi-prophylaxis-when-patients-are-on-prolonged-corticosteroid-therapy weekly 0.8 https://www.themednet.org/would-you-avoid-starting-potassium-citrate-in-a-patient-with-recurrent-calcium-oxalate-nephrolithiasis-and-hypocitraturia-if-they-have-metabolic-alkalosis weekly 0.8 https://www.themednet.org/what-treatment-strategies-do-you-use-to-reduce-the-risk-of-post-herpetic-neuralgia-after-herpes-zoster-ophthalmicus weekly 0.8 https://www.themednet.org/where-in-the-current-treatment-algorithm-for-che-do-you-feel-delgocitinib-best-fits-1 weekly 0.8 https://www.themednet.org/do-you-cycle-through-topical-steroids-in-patients-with-che-and-should-the-approval-of-delgocitinib-change-our-approach-on-this-1 weekly 0.8 https://www.themednet.org/for-epidural-spinal-cord-compression-in-good-performance-prognosis-patients-who-are-otherwise-inoperable-do-you-still-aim-for-30-gy-in-10-fractions-or-are-you-fine-with-20-gy-in-5-fractions weekly 0.8 https://www.themednet.org/in-a-patient-with-an-r1-resection-of-a-chordoma-who-has-declined-proton-therapy-what-alternative-radiation-modality-would-you-recommend weekly 0.8 https://www.themednet.org/do-you-still-recommend-protons-for-grade-2-and-grade-3-glioma-following-the-soprano-study-results-showing-a-survival-detriment weekly 0.8 https://www.themednet.org/what-strategies-can-we-use-to-help-patients-receiving-dato-dxd-report-symptoms-earlier-with-the-goal-of-early-intervention-to-prevent-progression-to-higher-grade-side-effects weekly 0.8 https://www.themednet.org/how-would-you-treat-tophaceous-gout-after-a-course-of-pegloticase-infusions-if-the-patient-has-contraindications-or-intolerance-to-allopurinol-febuxostat-and-probenecid weekly 0.8 https://www.themednet.org/what-is-an-acceptable-upper-limit-for-ipsilateral-lung-v8-gy-when-using-the-fast-forward-regimen-with-high-tangents-to-cover-limited-axillary-disease weekly 0.8 https://www.themednet.org/for-an-upper-lip-near-midline-merkel-cell-carcinoma-s-p-wide-local-excision-with-negative-slnb-and-no-adjuvant-rt-with-the-recurrence-to-one-side-of-the-neck-a-year-later-should-the-contralateral-neck-be-included-in-the-radiation-field weekly 0.8 https://www.themednet.org/what-approach-is-suggested-for-extended-adjuvant-endocrine-therapy-in-a-hr-breast-cancer weekly 0.8 https://www.themednet.org/in-patients-receiving-adjuvant-cemiplimab-for-high-risk-cutaneous-scc-what-is-your-standard-surveillance-strategy-for-detecting-relapse weekly 0.8 https://www.themednet.org/how-does-your-management-of-stomatitis-from-dato-dxd-compare-to-your-approach-for-stomatitis-from-other-cancer-directed-treatments weekly 0.8 https://www.themednet.org/how-are-you-deciding-between-t-dxd-pertuzumab-and-thp-hp-tucatinib-in-patients-with-metastatic-her2-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-work-up-and-management-of-a-patient-with-advanced-hiv-and-poor-adherence-to-therapy-presenting-with-dysphagia-and-fever weekly 0.8 https://www.themednet.org/would-you-consider-empiric-anticoagulation-in-patients-with-an-acute-stroke-for-whom-you-have-high-suspicion-for-cardioembolic-source-but-have-not-yet-confirmed-lv-thrombus-atrial-fibrillation-etc weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-obsessive-behavior-in-patients-with-autism-spectrum-disorder weekly 0.8 https://www.themednet.org/for-patients-with-locally-advanced-gej-adenocarcinoma-with-low-pdl-1-score-will-you-still-incorporate-durvalumab-with-flot-therapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-strategy-for-young-adults-with-itp-complicated-by-recurrent-autoimmune-neutropenia weekly 0.8 https://www.themednet.org/what-clinical-and-pathological-features-are-you-using-when-selecting-patients-for-adjuvant-cemiplimab-in-high-risk-cscc-given-the-differences-between-trial-inclusion-criteria-and-nccn-guidelines-1 weekly 0.8 https://www.themednet.org/how-do-you-reconcile-the-differing-results-of-the-c-post-and-keynote-630-trials-when-discussing-treatment-options-with-high-risk-cscc-patients-1 weekly 0.8 https://www.themednet.org/what-are-best-practices-for-dermatologists-and-oncologists-to-collaborate-in-order-to-optimize-multidisciplinary-care-of-patients-with-high-risk-cscc-1 weekly 0.8 https://www.themednet.org/how-long-would-you-hold-antibiotics-before-performing-a-vertebral-biopsy-to-optimize-culture-yield-in-a-patient-who-has-been-on-empiric-antibiotics-for-a-week-for-suspected-vertebral-osteomyelitis weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-use-of-creatine-monohydrate-supplementation-during-a-hospitalization-for-acute-rhabdomyolysis-from-intense-physical-training weekly 0.8 https://www.themednet.org/in-cases-where-placing-an-iol-in-the-bag-sulcus-is-not-possible-how-do-you-decide-between-leaving-a-patient-aphakic-for-a-scleral-fixated-iol-assuming-this-cant-be-done-immediately-vs-placing-an-aciol weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-patients-with-decompensated-heart-failure-when-their-hypervolemia-is-refractory-to-oral-furosemide weekly 0.8 https://www.themednet.org/how-have-you-applied-the-findings-of-this-trial-to-your-current-approach-to-prescribing-rituximab-for-pemphigus-patients weekly 0.8 https://www.themednet.org/is-there-a-role-for-resection-of-the-cutaneous-primary-in-a-patient-on-dual-agent-immunotherapy-for-metastatic-melanoma weekly 0.8 https://www.themednet.org/when-do-you-consider-using-dual-orexin-receptor-antagonists-doras-for-the-treatment-of-insomnia weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-how-to-take-abortive-migraine-medications-during-the-prodrome-period weekly 0.8 https://www.themednet.org/would-you-transition-a-patient-with-recurrent-calcium-nephrolithiasis-and-hypercalciuria-from-chlorthalidone-to-indapamide-if-they-report-sexual-dysfunction-side-effects weekly 0.8 https://www.themednet.org/when-using-t-dxd-pertuzumab-regimen-in-frontline-treatment-of-her2-metastatic-breast-cancer-are-you-adapting-the-regimen-with-induction-and-then-de-escalation-to-maintenance weekly 0.8 https://www.themednet.org/how-do-you-approach-offering-multifocal-iols-to-patients-with-prior-retinal-pathology-and-surgery-i-e-mac-off-rd-who-have-had-relatively-good-recovery-of-vision weekly 0.8 https://www.themednet.org/where-in-your-treatment-approach-to-fibromyalgia-will-you-recommend-sublingual-cyclobenzaprine weekly 0.8 https://www.themednet.org/what-is-your-approach-to-titration-of-sublingual-cyclobenzaprine-in-your-patients-with-fibromyalgia weekly 0.8 https://www.themednet.org/what-dose-constraints-do-you-use-for-rcc-kidney-sbrt weekly 0.8 https://www.themednet.org/do-you-view-the-difference-between-oral-and-sublingual-cyclobenzaprine-as-clinically-significant weekly 0.8 https://www.themednet.org/how-long-do-you-continue-benzodiazepines-in-patients-who-have-recovered-from-catatonia weekly 0.8 https://www.themednet.org/what-are-the-recommended-prophylactic-measures-for-managing-or-mitigating-diarrhea-when-pertuzumab-is-combined-with-trastuzumab-deruxtecan-given-toxicity-risk-with-each-individually weekly 0.8 https://www.themednet.org/what-if-any-is-your-radiation-approach-to-treating-hepatic-metastases-abutting-invading-luminal-gi-structures weekly 0.8 https://www.themednet.org/how-do-you-approach-requests-from-patients-with-social-anxiety-disorder-or-agoraphobia-to-work-remotely-as-a-medical-accommodation weekly 0.8 https://www.themednet.org/do-you-withhold-performing-skin-testing-for-aeroallergens-foods-or-venoms-based-on-poor-lung-function weekly 0.8 https://www.themednet.org/how-do-you-determine-the-appropriateness-of-starting-iscgm-in-patients-aged-75-and-older-with-type-2-diabetes-on-multiple-daily-insulin-injections weekly 0.8 https://www.themednet.org/how-do-you-clinically-and-diagnostically-distinguish-stiff-skin-syndrome-from-scleroderma weekly 0.8 https://www.themednet.org/when-do-you-suspect-an-autoimmune-encephalitis-in-a-child-or-adolescent-with-new-onset-psychosis weekly 0.8 https://www.themednet.org/do-you-routinely-observe-inpatients-for-24-hours-after-transitioning-from-iv-empiric-antibiotics-to-an-oral-regimen-prior-to-discharge-when-the-source-of-infection-is-unclear weekly 0.8 https://www.themednet.org/how-do-you-go-about-assessing-a-patient-that-has-had-refractive-surprise-following-cataract-surgery-when-determining-the-cause-for-surprise-and-in-preparation-for-the-other-eye weekly 0.8 https://www.themednet.org/if-a-patient-has-persistent-ascites-requiring-diuretics-after-tips-at-what-point-do-you-consider-re-evaluation-of-tips weekly 0.8 https://www.themednet.org/how-would-you-manage-a-young-patient-with-sjogrens-disease-with-extranodal-marginal-zone-lymphoma-involving-bilateral-parotid-glands-with-bilateral-cervical-lymphadenopathy weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-suspected-cns-vasculitis-with-a-negative-work-up weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-who-present-repeatedly-to-the-ed-with-suicidal-ideation-but-no-clear-acute-change-in-risk weekly 0.8 https://www.themednet.org/do-you-recommend-maintaining-the-same-monitoring-interval-of-pfts-every-3-6-months-with-hrct-as-indicated-for-patients-with-anti-mda5-dermatomyositis-or-do-you-recommend-closer-surveillance-in-this-group weekly 0.8 https://www.themednet.org/how-do-you-counsel-breastfeeding-parents-with-postpartum-depression-when-sleep-deprivation-appears-to-be-worsening-mood-symptoms weekly 0.8 https://www.themednet.org/do-you-recommend-outpatient-dialysis-initiation-or-inpatient-admission-for-dialysis-initiation-in-a-ckd-stage-5-patient-with-stable-electrolytes-but-experiencing-nausea-and-vomiting-related-to-uremia weekly 0.8 https://www.themednet.org/with-a-head-and-neck-squamous-cell-of-of-unknown-primary-do-you-typically-treat-the-larynx weekly 0.8 https://www.themednet.org/what-is-the-maximum-v20-on-ipsilateral-lung-that-can-be-safely-accepted-for-3-or-4-field-breast-plans weekly 0.8 https://www.themednet.org/what-small-bowel-dose-constraints-do-you-use-in-gyn-brachytherapy weekly 0.8 https://www.themednet.org/do-you-decrease-the-duration-of-hormones-in-a-man-with-high-risk-prostate-cancer-and-cardiac-risk-factors weekly 0.8 https://www.themednet.org/do-you-attempt-to-spare-the-submandibular-glands-in-head-and-neck-imrt weekly 0.8 https://www.themednet.org/how-do-you-manage-small-oropharyngeal-cancers-with-n1-or-n2-disease weekly 0.8 https://www.themednet.org/is-it-feasible-to-treat-craniospinal-fields-with-new-generation-scanning-beam-only-proton-machines weekly 0.8 https://www.themednet.org/how-do-you-treat-synchronous-rectal-cancer-and-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-use-minimum-cutoff-values-for-any-pfts-below-which-you-would-not-offer-conventionally-fractionated-chemoradiation-or-sbrt-for-nsclc weekly 0.8 https://www.themednet.org/how-can-i-be-a-good-mentor weekly 0.8 https://www.themednet.org/is-social-media-useful-for-radiation-oncologists weekly 0.8 https://www.themednet.org/do-you-order-a-post-lumpectomy-mammogram-before-starting-rt weekly 0.8 https://www.themednet.org/should-a-formal-radiology-year-s-be-added-to-the-radiation-oncology-residency-training-program-given-the-number-and-increasing-modalities-used-for-target-delineation-and-treatment-planning weekly 0.8 https://www.themednet.org/do-you-require-a-biopsy-prior-to-sbrt-for-pulmonary-metastases-from-oligometastatic-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-early-stage-i-uterine-serous-carcinoma weekly 0.8 https://www.themednet.org/what-is-the-evidence-that-there-is-a-benefit-to-giving-doses-higher-than-3060-cgy-3600-cgy-in-the-elective-treatment-of-uninvolved-lymph-nodes-in-the-treatment-of-scc-of-anal-canal-with-chemoradiation weekly 0.8 https://www.themednet.org/how-do-you-approach-port-for-t3n0-nsclc-which-had-chest-wall-invasion-now-status-post-lobectomy-with-a-microscopically-positive-margin weekly 0.8 https://www.themednet.org/is-the-criteria-for-rt-pcv-for-low-grade-glioma-too-narrow weekly 0.8 https://www.themednet.org/is-it-necessary-to-treat-pelvic-lymph-nodes-for-muscle-invasive-bladder-cancer weekly 0.8 https://www.themednet.org/is-3d-non-coplanar-conformal-radiotherapy-preferable-over-arc-therapy-for-lung-sbrt weekly 0.8 https://www.themednet.org/when-re-irradiating-the-spinal-cord-what-do-you-use-as-a-guideline-for-the-interval-between-treatment-and-the-amount-of-tolerance-theoretically-regained weekly 0.8 https://www.themednet.org/do-you-treat-with-high-dose-radiation-alone-without-adt-for-favorable-intermediate-risk-prostate-cancer weekly 0.8 https://www.themednet.org/is-there-an-age-that-is-too-young-for-prostate-irradiation weekly 0.8 https://www.themednet.org/is-it-safe-to-offer-breast-chest-wall-radiotherapy-while-a-patient-is-receiving-perjeta weekly 0.8 https://www.themednet.org/how-do-you-manage-early-stage-uterine-carcinosarcoma weekly 0.8 https://www.themednet.org/when-treating-bladder-cancer-with-crt-in-the-bladder-preservation-paradigm-do-you-cone-down-to-partial-bladder-or-the-whole-bladder weekly 0.8 https://www.themednet.org/should-early-referral-to-palliative-care-be-standard-of-care-for-all-patients-with-metastatic-cancer weekly 0.8 https://www.themednet.org/for-a-pathologic-stage-i-squamous-cell-carcinoma-of-the-oral-tongue-with-negative-margins-and-adequate-neck-dissection-is-perineural-or-lymphovascuar-invasion-alone-an-indication-for-adjuvant-radiotherapy weekly 0.8 https://www.themednet.org/in-which-patients-with-early-stage-favorable-hodgkins-lymphoma-if-any-would-you-consider-omitting-consolidation-rt-after-abvd-chemotherapy weekly 0.8 https://www.themednet.org/what-total-dose-do-you-use-for-a-close-and-positive-breast-cancer-margin-that-cannot-be-re-excised weekly 0.8 https://www.themednet.org/can-a-second-course-of-srs-be-used-to-treat-a-brain-met-that-initially-responded-to-srs-and-then-progressed weekly 0.8 https://www.themednet.org/do-you-ever-start-patients-on-a-friday-if-non-emergent-and-youre-not-treating-over-the-weekend weekly 0.8 https://www.themednet.org/is-it-preferable-to-offer-hypofractionated-srt-over-single-fraction-srs-for-brain-metastases weekly 0.8 https://www.themednet.org/can-the-elective-target-volume-in-nasopharyngeal-cancer-as-specified-in-rtog-0615-be-reduced-if-oars-do-not-meet-constraints weekly 0.8 https://www.themednet.org/are-there-situations-where-you-would-use-hypofractionated-radiotherapy-for-stage-iii-breast-cancer weekly 0.8 https://www.themednet.org/when-treating-rectal-cancer-with-neoadjuvant-chemort-is-it-appropriate-to-employ-imrt-planning-rather-than-3d-conformal-for-all-cases-or-should-imrt-be-reserved-for-special-circumstances weekly 0.8 https://www.themednet.org/when-is-sbrt-or-hypofractionated-radiation-appropriate-as-adjuvant-treatment-for-pancreatic-cancer weekly 0.8 https://www.themednet.org/what-is-the-ideal-time-interval-to-wait-before-starting-radiation-for-postoperative-treatment-of-benign-brain-lesions weekly 0.8 https://www.themednet.org/in-which-patients-do-you-omit-a-boost-following-whole-breast-irradiation weekly 0.8 https://www.themednet.org/if-a-snb-is-positive-after-neoadjuvant-chemo-and-mastectomy-should-an-axillary-dissection-be-performed-or-xrt-given-to-all weekly 0.8 https://www.themednet.org/do-you-routinely-offer-pmrt-for-t3n0-breast-cancer weekly 0.8 https://www.themednet.org/would-you-use-sbrt-to-treat-a-5cm-nsclc-with-chest-wall-invasion-in-a-medically-inoperable-patient weekly 0.8 https://www.themednet.org/when-is-it-necessary-to-boost-the-chest-wall-scar-post-mastectomy weekly 0.8 https://www.themednet.org/how-do-you-treat-locally-advanced-operable-siewert-3-ge-junction-adenocarcinomas weekly 0.8 https://www.themednet.org/how-do-you-handle-post-op-pre-radiation-breast-seromas-and-hematomas weekly 0.8 https://www.themednet.org/is-it-acceptable-to-give-weekly-cisplatin-for-patients-with-locally-advanced-head-and-neck-scc-undergoing-chemoradiation weekly 0.8 https://www.themednet.org/how-do-you-taper-steroids-for-patients-with-symptomatic-edema-following-standard-chemoradiation-for-gbm weekly 0.8 https://www.themednet.org/when-should-sbrt-be-offered-to-oligometastatic-bone-disease-in-a-patient-with-prostate-cancer weekly 0.8 https://www.themednet.org/for-biochemical-failure-following-prostatectomy-is-there-a-psa-value-that-would-be-considered-too-high-to-offer-local-salvage-radiotherapy weekly 0.8 https://www.themednet.org/do-the-results-of-the-gepar-trials-indicate-that-pmrt-based-on-pre-neoadjuvant-chemo-risk-factors-irrelevant-of-pcr-should-be-the-standard-of-care-until-nsabp-b-51-is-completed weekly 0.8 https://www.themednet.org/do-you-counsel-young-patients-on-infertility-risks-following-ho-prophylaxis-with-rt weekly 0.8 https://www.themednet.org/is-systemic-sclerosis-an-absolute-contraindication-for-breast-conserving-therapy weekly 0.8 https://www.themednet.org/is-there-a-role-for-post-treatment-pet-ct-following-chemort-for-stage-iii-nsclc weekly 0.8 https://www.themednet.org/what-is-the-optimal-management-of-recurrent-seminoma-with-small-volume-retroperitoneal-disease-initially-managed-with-surveillance weekly 0.8 https://www.themednet.org/when-does-perineural-invasion-for-a-squamous-cell-carcinoma-of-the-skin-of-the-head-and-neck-merit-adjuvant-radiotherapy weekly 0.8 https://www.themednet.org/without-radiographic-evidence-for-metastatic-disease-is-there-a-psa-value-above-which-high-risk-localized-prostate-cancer-should-not-be-treated-definitively weekly 0.8 https://www.themednet.org/how-should-the-v10-or-v12-be-defined-when-evaluating-intracranial-srs-plans weekly 0.8 https://www.themednet.org/for-early-stage-nsclc-to-be-treated-with-sbrt-is-there-any-difference-in-the-technology-being-used-such-as-robotic-v-linac-based-vmat weekly 0.8 https://www.themednet.org/for-patient-with-primary-liver-carcinoma-is-prior-radioembolization-with-yttrium-90-microspheres-a-contra-indication-relative-or-absolute-to-external-beam-radiation-therapy-with-either-stereotactic-body-radiation-therapy-sbrt-or-proton-beam-therapy-3 weekly 0.8 https://www.themednet.org/is-pmrt-routinely-recommended-for-all-patients-with-positive-lymph-nodes-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/do-you-offer-vaginal-cuff-brachy-alone-vaginal-cuff-brachy-and-chemo-or-wprt-for-surgically-staged-ib-grade-3-endometrial-cancer weekly 0.8 https://www.themednet.org/when-do-you-start-steroids-for-radiation-pneumonitis weekly 0.8 https://www.themednet.org/is-there-evidence-to-support-routine-use-of-adjuvant-chemotherapy-for-resected-rectal-cancer-treated-with-pre-operative-chemoradiation weekly 0.8 https://www.themednet.org/what-is-the-age-cut-off-to-omit-radiation-therapy-after-breast-conserving-surgery-for-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/when-is-it-considered-inappropriate-to-omit-pathological-mediastinal-lymph-node-staging-for-non-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/when-do-you-use-a-vaginal-cuff-boost-with-pelvic-rt-for-stage-ii-endometrial-cancer weekly 0.8 https://www.themednet.org/in-what-situation-would-you-obtain-an-mri-before-adjuvant-or-salvage-rt-to-the-prostate-bed weekly 0.8 https://www.themednet.org/are-there-situations-where-its-appropriate-to-offer-postmastectomy-radiation-therapy-to-patients-with-biopsy-proven-m1-disease weekly 0.8 https://www.themednet.org/to-what-dose-do-you-treat-the-seminal-vesicles-in-intermediate-and-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-prophylactic-cranial-irradiation-for-stage-i-small-cell-lung-cancers-treated-with-lobectomy-and-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/do-you-offer-hypofractionated-courses-of-radiation-with-temozolomide-for-elderly-patients-with-gbm weekly 0.8 https://www.themednet.org/is-sbrt-an-appropriate-treatment-for-recurrent-and-unresectable-spinal-ependymoma weekly 0.8 https://www.themednet.org/are-there-situations-in-which-elective-nodal-volumes-may-be-reduced-for-t1-t2n0-anal-scc weekly 0.8 https://www.themednet.org/what-rt-fields-should-be-used-to-treat-a-triple-negative-breast-cancer-with-biopsy-positive-lymph-nodes-and-a-pcr-to-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/which-targeted-systemic-agents-should-be-held-while-delivering-palliative-radiation weekly 0.8 https://www.themednet.org/how-do-you-apply-hyperfractionated-rt-in-the-dose-painting-imrt-era-in-head-and-neck-cancers weekly 0.8 https://www.themednet.org/what-is-your-preferred-third-line-treatment-for-a-patient-with-metastatic-renal-cell-carcinoma-who-has-had-progression-of-disease-on-both-initial-vegfr-tki-therapy-and-second-line-nivolumab weekly 0.8 https://www.themednet.org/what-is-the-best-way-to-peer-review-radiation-therapy-treatment-plans-within-a-department-clinic weekly 0.8 https://www.themednet.org/is-there-a-time-frame-between-surgery-and-radiation-after-which-the-benefit-of-adjuvant-radiation-is-lost-and-no-longer-indicated-for-head-and-neck-cancers weekly 0.8 https://www.themednet.org/for-treatments-using-thermoplastic-mask-immobilaztion-when-supplemental-bolus-is-needed-what-is-your-method-for-ensuring-reproducibility-of-set-up-and-bolus-effect-efficacy weekly 0.8 https://www.themednet.org/what-is-the-role-of-surgery-in-patients-with-stage-iii-nsclc-and-n2-positive-lymph-nodes weekly 0.8 https://www.themednet.org/for-a-patient-treated-with-mohs-surgery-for-a-high-risk-skin-cancer-of-the-head-neck-do-you-post-operatively-treat-all-scars-to-full-dose-including-those-created-at-subsequent-closure weekly 0.8 https://www.themednet.org/how-common-is-hypothyroidism-in-postradiation-head-and-neck-cancer-patients weekly 0.8 https://www.themednet.org/at-what-psa-do-you-initiate-adt-for-a-biochemical-recurrence-after-prostate-radiotherapy-adjuvant-salvage-or-definitive weekly 0.8 https://www.themednet.org/what-are-the-advantages-and-disadvantages-of-concomitant-versus-sequential-boost-for-treating-cancers-of-the-head-and-neck-with-imrt weekly 0.8 https://www.themednet.org/for-women-with-metastatic-her2-breast-cancer-who-achieve-a-complete-response-how-long-do-you-continue-on-her2-directed-therapies weekly 0.8 https://www.themednet.org/if-a-patient-with-a-seminoma-fails-after-chemotherapy-in-the-paraaortic-nodes-what-is-the-best-salvage-therapy-different-chemotherapy-or-radiation weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-when-considering-treating-the-pelvic-nodes-in-a-salvage-prostatectomy-case-versus-covering-only-the-postoperative-bed weekly 0.8 https://www.themednet.org/what-treatment-fields-do-use-for-heterotopic-ossification-prophylaxis weekly 0.8 https://www.themednet.org/would-you-consider-sbrt-for-multiple-bilateral-lung-primaries-and-or-a-lung-primary-with-metastases-to-multiple-lobes weekly 0.8 https://www.themednet.org/how-would-you-treat-an-unresectable-scc-of-the-skin-local-recurrence-in-the-base-of-skull-with-clinical-and-radiographic-cn-involvement weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-stage-i-pure-seminoma-diagnosed-incidentally-after-transscrotal-orchiectomy weekly 0.8 https://www.themednet.org/how-do-you-manage-unresectable-esophageal-cancer-involving-both-the-thoracic-esophagus-and-ge-junction weekly 0.8 https://www.themednet.org/are-there-situations-for-which-you-consider-concurrent-chemoradiation-for-breast-cancer-patients weekly 0.8 https://www.themednet.org/what-radiation-dose-is-appropriate-for-patients-receiving-induction-chemoradiation-prior-to-surgery-for-superior-sulcus-tumors weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-treatment-to-the-tumor-bed-and-or-regional-lymph-nodes-for-an-early-stage-merkel-cell-carcinoma-status-post-wle-and-sentinel-lymph-node-biopsy weekly 0.8 https://www.themednet.org/do-you-see-a-role-for-adjuvant-sunitinib-after-resected-rcc weekly 0.8 https://www.themednet.org/given-the-secondary-analysis-of-rtog-0617-should-imrt-be-considered-standard-of-care-in-locally-advanced-non-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/do-you-base-liver-sbrt-dose-fractionation-on-size-volume-or-proximity-of-normal-tissue weekly 0.8 https://www.themednet.org/do-you-offer-radiation-in-the-setting-of-a-resected-desmoplastic-melanoma-with-negative-margins-given-that-several-retrospective-studies-show-a-local-control-benefit weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-patients-with-medically-inoperable-early-stage-endometrial-adenocarcinoma-who-also-cannot-tolerate-intracavitary-brachytherapy-rotte-y-etc-as-boost weekly 0.8 https://www.themednet.org/do-you-offer-memantine-for-patients-undergoing-pci weekly 0.8 https://www.themednet.org/does-the-presence-of-multifocal-disease-impact-your-decision-on-whether-or-not-to-recommend-post-mastectomy-radiation weekly 0.8 https://www.themednet.org/how-would-you-design-port-volumes-for-a-patient-with-nsclc-and-positive-chest-wall-margin weekly 0.8 https://www.themednet.org/who-discusses-and-prescribes-ttfs-at-your-facility weekly 0.8 https://www.themednet.org/is-it-appropriate-to-use-moderate-hypofractionation-for-the-treatment-of-patients-with-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/if-a-patient-has-a-mediport-within-the-radiation-field-will-you-insist-the-patient-have-it-removed-prior-to-radiation weekly 0.8 https://www.themednet.org/do-you-discontinue-anti-hormonal-therapy-if-a-high-risk-er-her2-localized-breast-cancer-patient-develops-blood-clots-on-anti-hormonal-therapy weekly 0.8 https://www.themednet.org/is-it-acceptable-to-do-ifrt-rather-than-whole-posterior-fossa-boost-for-high-risk-medulloblastoma weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-surgically-resected-t3n1-nsclc-who-is-found-to-have-one-small-brain-metastasis-on-staging-mri weekly 0.8 https://www.themednet.org/how-would-you-approach-definitive-nonsurgical-management-for-biopsy-proven-localized-small-cell-carcinoma-of-the-prostate weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-who-has-developed-a-symptomatic-pleural-effusion-while-on-dasatinib weekly 0.8 https://www.themednet.org/how-do-you-define-psa-progression-after-salvage-or-adjuvant-prostate-fossa-radiotherapy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-nsclc-50-pdl-1-positive-and-an-egfr-or-alk-gene-mutation-rearrangement-in-the-first-line-setting weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-with-hiv-or-hepatitis-c-with-an-anti-pd-1-agent weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-chemotherapy-in-patients-with-resected-pancreatic-adenocarcinoma weekly 0.8 https://www.themednet.org/what-dose-fractionation-regimen-do-you-prefer-when-treating-with-hypofractionated-whole-breast-radiation-therapy-without-a-boost-for-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-dose-fractionation-regimen-when-treating-high-risk-scc-of-the-skin-in-elderly-and-or-frail-patients weekly 0.8 https://www.themednet.org/can-a-nonbulky-t1-2-supraglottic-larynx-cancer-near-the-vocal-cords-be-treated-like-a-glottic-tumor weekly 0.8 https://www.themednet.org/how-do-you-approach-molecular-testing-in-patients-with-gastro-esophageal-cancers weekly 0.8 https://www.themednet.org/how-does-implant-breast-reconstruction-augmentation-at-the-time-of-lumpectomy-affect-your-adjuvant-radiotherapy-approach weekly 0.8 https://www.themednet.org/assuming-that-a-lipoma-is-causing-significant-morbidity-and-there-is-not-a-surgical-option-would-you-treat-it-with-radiation-therapy weekly 0.8 https://www.themednet.org/do-you-prescribe-steroids-prior-to-each-fraction-of-lung-sbrt weekly 0.8 https://www.themednet.org/have-you-encountered-somnolence-syndrome-after-whole-brain-radiotherapy weekly 0.8 https://www.themednet.org/would-you-offer-additional-radiation-therapy-in-a-medically-inoperable-patient-with-rectal-adenocarcinoma-who-has-a-persistently-palpable-tumor-after-definitive-chemoradiation-therapy weekly 0.8 https://www.themednet.org/how-would-you-manage-treatment-of-a-cervical-cancer-in-a-patient-unable-to-tolerate-chemotherapy-or-an-hdr-boost-due-to-medical-commodities weekly 0.8 https://www.themednet.org/how-do-you-manage-pt1-2n0-p16-tonsil-cancer-treated-with-tors-and-ipsilateral-negative-neck-dissection-but-with-positive-margin weekly 0.8 https://www.themednet.org/is-it-beneficial-to-use-fiducial-markers-if-you-are-using-daily-cone-beam-ct-for-prostate-localization weekly 0.8 https://www.themednet.org/what-gtv-to-ctv-margin-do-you-typically-use-for-the-primary-lesion-in-anal-cancer weekly 0.8 https://www.themednet.org/what-strategies-to-you-use-for-large-breasted-women-receiving-whole-breast-radiation weekly 0.8 https://www.themednet.org/how-do-you-sequence-abiraterone-and-enzalutamide-in-metastatic-castrate-resistant-prostate-cancer weekly 0.8 https://www.themednet.org/when-would-you-recommend-definitive-radiation-or-surgery-port-for-a-resectable-skin-cancer-metastatic-to-the-parotid weekly 0.8 https://www.themednet.org/what-is-the-role-of-radiotherapy-in-medically-inoperable-large-and-or-recurrent-aggressive-basal-cell-or-squamous-cell-cancer-of-the-skin-in-high-risk-areas weekly 0.8 https://www.themednet.org/how-long-after-wbrt-would-you-wait-to-give-srs-to-a-recurrent-brain-metastasis weekly 0.8 https://www.themednet.org/would-you-consider-pmrt-in-patients-with-clinically-node-negative-breast-cancer-found-to-have-micrometastatic-nodal-disease-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/for-multiple-myeloma-patients-with-vertebral-lesions-requiring-palliative-radiation-e-g-20-30-gy-in-10fx-do-you-treat-concurrently-with-modern-systemic-myeloma-agents-such-as-lenalidomide-and-bortezomib weekly 0.8 https://www.themednet.org/what-would-you-choose-as-second-line-therapy-in-patients-with-er-pr-positive-her2-negative-metastatic-breast-cancer-progressing-on-first-line-ckd-4-6-inhibitor-ai-combination weekly 0.8 https://www.themednet.org/for-patients-who-are-incidentally-found-to-have-pt1a-invasive-breast-cancer-on-excision-for-presumed-atypia-dcis-without-a-sentinel-lymph-node-biopsy-will-you-irradiate-without-the-slnb-being-performed weekly 0.8 https://www.themednet.org/how-do-you-define-low-volume-intermediate-risk-prostate-cancer-that-is-appropriate-for-brachytherapy-alone weekly 0.8 https://www.themednet.org/how-do-you-counsel-your-breast-cancer-survivors-about-weight-loss-dietary-modifications weekly 0.8 https://www.themednet.org/when-would-you-recommend-abiraterone-concurrently-with-rt-for-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/will-the-preliminary-results-of-portec-3-and-gog-258-change-your-approach-to-managing-patients-with-high-risk-or-node-positive-endometrial-cancer weekly 0.8 https://www.themednet.org/what-ptv-dose-heterogeneity-do-you-accept-for-head-and-neck-radiation-plans weekly 0.8 https://www.themednet.org/would-you-offer-whole-breast-rt-in-an-elderly-patient-with-early-stage-breast-cancer-with-eic weekly 0.8 https://www.themednet.org/do-you-consent-patients-about-diabetes-insipidus-following-srs-or-fractionated-radiation-for-pituitary-tumors weekly 0.8 https://www.themednet.org/should-density-overrides-for-vmat-lung-sbrt-planning-be-utilized-for-small-mobile-tumors weekly 0.8 https://www.themednet.org/is-it-safe-to-use-radioactive-iodine-therapy-for-patients-with-differentiated-thyroid-cancer-and-brain-metastases weekly 0.8 https://www.themednet.org/what-is-the-best-fractionation-for-head-and-neck-patients-who-cannot-receive-systemic-therapy-due-to-kps-or-medical-comorbidities weekly 0.8 https://www.themednet.org/what-volume-would-you-treat-for-an-isolated-axillary-recurrence-after-bcs-and-whole-breast-rt-who-have-resection-of-the-recurrent-disease weekly 0.8 https://www.themednet.org/what-rates-of-radiation-induced-secondary-malignancies-do-you-typically-quote-to-patients-in-their-30s-40s weekly 0.8 https://www.themednet.org/is-it-appropriate-to-use-a-hypofractionated-schedule-of-40-gy-in-15-fx-for-ls-sclc weekly 0.8 https://www.themednet.org/what-is-your-strategy-for-ovarian-suppression-if-unable-to-achieve-goal-estradiol-levels-with-leuprolide-3-75mg-monthly-dose weekly 0.8 https://www.themednet.org/if-a-patient-with-a-germ-cell-tumor-has-such-an-event-thrombotic-events-on-bep-is-it-safe-to-re-challenge-with-bep-therapy weekly 0.8 https://www.themednet.org/does-the-degree-of-er-pr-positivity-influence-your-treatment-option-in-the-patient-with-newly-diagnosed-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-assess-whether-a-patient-is-suitable-for-prostate-sbrt weekly 0.8 https://www.themednet.org/what-pulmonary-dose-constraints-do-you-use-for-patients-undergoing-lung-sbrt-for-metachronous-or-recurrent-disease-after-definitive-chemoradiation weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-basal-cell-carcinoma-with-single-lymph-node-involvement weekly 0.8 https://www.themednet.org/is-pectoralis-muscle-invasion-an-indication-for-post-mastectomy-radiation-pmrt-for-an-otherwise-early-stage-node-negative-breast-cancer-with-clear-margins weekly 0.8 https://www.themednet.org/do-you-use-nomograms-to-decide-whether-to-treat-pelvic-nodes-in-high-intermediate-to-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/when-should-single-fraction-sbrt-be-offered-for-peripheral-nsclc weekly 0.8 https://www.themednet.org/how-do-you-incorporate-naf-bone-scan-in-the-initial-workup-of-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-nsclc-and-3-oligometastatic-lesions-that-are-4-5-cm-in-muscles-of-the-extremities weekly 0.8 https://www.themednet.org/for-men-with-intermediate-or-high-risk-prostate-cancer-can-an-sbrt-boost-be-used-in-place-of-a-brachytherapy-boost-after-ebrt weekly 0.8 https://www.themednet.org/would-you-offer-sbrt-hypofractionation-for-stage-i-nsclc-with-positive-margins-after-resection weekly 0.8 https://www.themednet.org/for-nsclc-patients-with-limited-diagnostic-tissue-that-is-insufficient-for-genetic-testing-do-you-offer-repeat-biopsy-of-accessible-site-blood-based-testing-or-both-to-evaluate-for-actionable-driver-mutations weekly 0.8 https://www.themednet.org/would-you-continue-adjuvant-nivolumab-or-pembrolizumab-in-a-resected-stage-iii-melanoma-patient-that-developed-local-only-recurrence-at-the-site-of-previous-surgery weekly 0.8 https://www.themednet.org/how-are-you-incorporating-68-ga-dotatate-pet-scans-in-the-management-of-grade-i-ii-meningiomas weekly 0.8 https://www.themednet.org/how-would-you-treat-a-biopsy-proven-isolated-left-sided-internal-mammary-node-recurrence-20-years-after-mastectomy-and-chemotherapy-for-left-breast-cancer weekly 0.8 https://www.themednet.org/what-is-the-role-of-liver-transplant-in-net weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-newly-diagnosed-prostate-cancer-with-low-volume-bone-metastases-and-extensive-lung-metastases-with-a-very-low-psa-5-and-no-neuroendocrine-differentiation-on-pathology weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-de-novo-brain-only-metastatic-her2-positive-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-poorly-controlled-migraines-during-pregnancy weekly 0.8 https://www.themednet.org/what-bowel-constraints-do-you-use-when-treating-definitive-bladder weekly 0.8 https://www.themednet.org/would-you-consider-adding-her2-targeted-treatment-to-chemotherapy-for-a-patient-with-locally-advanced-her2-rectal-cancer-who-is-going-to-have-total-neoadjuvant-treatment weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-a-patient-with-extensive-small-cell-lung-cancer-who-has-progressed-on-third-line-therapy-with-borderline-functional-status-complicated-by-paraneoplastic-cns-syndrome weekly 0.8 https://www.themednet.org/do-you-have-a-preferred-systemic-agent-for-patients-with-metastatic-unresectable-functional-neuroendocrine-tumors-such-as-an-insulinoma-if-the-goal-is-to-get-a-quick-response weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-a-glioblastoma-in-pregnancy weekly 0.8 https://www.themednet.org/in-a-patient-with-an-n-anal-cancer-on-pre-treatment-pet-should-a-pet-scan-be-repeated-in-follow-up weekly 0.8 https://www.themednet.org/how-do-you-plan-for-excess-nonconforming-vaginal-tissue-with-a-hdr-cylinder weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-patients-with-one-clinical-demyelinating-event-and-mog-antibody-status weekly 0.8 https://www.themednet.org/is-it-ever-appropriate-to-omit-temozolomide-in-unmethylated-glioblastoma weekly 0.8 https://www.themednet.org/how-do-you-approach-breast-conserving-therapy-in-a-woman-who-has-formed-bothersome-keloids-after-prior-surgeries weekly 0.8 https://www.themednet.org/does-concurrent-brain-and-systemic-progression-alter-your-choice-of-systemic-therapy-for-patients-with-metastatic-sclc-with-early-progression-on-chemoimmunotherapy-and-wbrt weekly 0.8 https://www.themednet.org/would-you-consider-neoadjuvant-chemoradiation-with-oral-capecitabine-for-a-locally-advanced-sigmoid-adenocarcinoma-20-cm-from-the-anal-verge weekly 0.8 https://www.themednet.org/do-you-offer-chemoradiation-for-de-novo-oligometastatic-esophageal-cancer-after-chemotherapy-with-no-progression weekly 0.8 https://www.themednet.org/how-do-you-manage-a-supraclavicular-only-recurrence-in-nsclc-previously-treated-with-chemoradiation-for-stage-iii-disease weekly 0.8 https://www.themednet.org/given-results-of-the-elevate-rr-study-would-you-consider-use-of-acalabrutinib-in-all-patients-with-previously-treated-cll-or-restrict-it-to-certain-patient-populations weekly 0.8 https://www.themednet.org/what-is-your-approach-to-cll-in-patients-with-atrial-fibrillation-and-or-on-anticoagulation weekly 0.8 https://www.themednet.org/do-you-routinely-offer-fungal-prophylaxis-for-patients-on-btk-inhibitors weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-olaparib-in-a-patient-with-her2-high-risk-early-stage-breast-cancer-with-germline-brca-mutation weekly 0.8 https://www.themednet.org/how-would-you-manage-early-stage-low-rectal-cancer-in-a-patient-unable-or-unwilling-to-undergo-surgery weekly 0.8 https://www.themednet.org/what-neoadjuvant-therapy-will-you-give-to-a-premenopausal-woman-with-ct2n0-metaplastic-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-regimen-for-metastatic-clear-cell-rcc-following-progression-on-io-tki weekly 0.8 https://www.themednet.org/how-do-you-deal-with-an-interruption-in-definitive-ebrt-for-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-efficacy-of-breast-cancer-risk-reduction-strategies-such-as-breast-mri-surveillance-or-bilateral-mastectomy-for-those-considered-high-risk-by-polygenic-risk-score-pathogenic-variants-and-or-family-history weekly 0.8 https://www.themednet.org/how-would-you-approach-second-isolated-vaginal-cuff-recurrence-in-a-young-patient-with-figo-ia-grade-2-endometrioid-endometrial-adenocarcinoma-who-received-ebrt-interstitial-brachy-for-her-initial-recurrence weekly 0.8 https://www.themednet.org/would-you-extrapolate-results-from-elevate-rr-study-to-favor-use-of-acalabrutinib-as-first-line-therapy-in-treatment-naive-cll weekly 0.8 https://www.themednet.org/how-do-you-incorporate-radiation-therapy-in-patients-undergoing-car-t-cell-therapy-for-dlbcl weekly 0.8 https://www.themednet.org/given-results-of-sakk-09-10-in-which-dose-escalation-for-salvage-prostate-radiotherapy-to-70-gy-was-not-superior-to-64-gy-would-you-ever-consider-a-higher-dose weekly 0.8 https://www.themednet.org/how-would-you-treat-an-isolated-pancreatic-adenocarcinoma-recurrence-in-the-post-op-bed-with-progression-through-chemotherapy-and-no-prior-radiation-therapy weekly 0.8 https://www.themednet.org/what-is-your-experience-with-comparative-toxicities-of-the-available-1l-combination-regimens-in-metastatic-ccrcc weekly 0.8 https://www.themednet.org/what-data-do-you-view-as-most-impactful-to-treatment-decisions-in-1l-metastatic-ccrcc weekly 0.8 https://www.themednet.org/what-is-your-approach-to-prbc-transfusion-support-for-myeloma-related-anemia weekly 0.8 https://www.themednet.org/do-you-continue-bortezomib-past-8-cycles-for-transplant-ineligible-patients-with-multiple-myeloma-on-vrd-who-are-tolerating-therapy-well-with-no-neuropathy weekly 0.8 https://www.themednet.org/for-which-non-brca-pathogenic-germline-variants-if-any-might-you-consider-recommending-chemoprevention-with-serm-ai weekly 0.8 https://www.themednet.org/would-you-consider-a-treatment-holiday-in-a-patient-with-hr-oligometastatic-breast-cancer-who-is-in-a-prolonged-remission weekly 0.8 https://www.themednet.org/what-would-your-initial-treatment-be-for-an-elderly-patient-with-metastatic-her2-gej-cancer-with-pd-l1-5-who-cannot-tolerate-any-platinum-agents weekly 0.8 https://www.themednet.org/how-would-you-approach-a-small-node-negative-ct1-2n0-nasopharyngeal-cancer-in-a-patient-with-prior-h-n-cancer-treated-with-surgery-and-radiation weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-an-unresectable-sacral-chordoma weekly 0.8 https://www.themednet.org/is-either-esr-or-crp-more-sensitive-or-specific-for-the-diagnosis-of-gca weekly 0.8 https://www.themednet.org/what-is-your-strategy-to-help-prevent-paclitaxel-related-neuropathy weekly 0.8 https://www.themednet.org/do-you-routinely-cover-level-ia-lymph-nodes-for-advanced-bot-tumors-extending-into-floor-of-mouth-or-oral-tongue weekly 0.8 https://www.themednet.org/would-you-consider-salvage-rt-in-a-prostate-cancer-patient-with-controlled-crohns-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-newly-diagnosed-locally-advanced-nsclc-in-patients-who-are-intubated-for-respiratory-failure-due-to-their-disease-burden weekly 0.8 https://www.themednet.org/should-we-be-giving-adjuvant-nivolumab-to-all-eligible-esophageal-gej-cancer-irrespective-of-the-pd-l1-status-of-the-tumor weekly 0.8 https://www.themednet.org/can-the-results-of-checkmate-577-be-applied-to-patients-who-do-not-undergo-surgery-following-chemoradiation-because-of-a-clinical-complete-response weekly 0.8 https://www.themednet.org/what-is-optimal-therapy-for-a-5-year-delayed-recurrence-of-uterine-cancer-rendered-ned-by-solitary-pulmonary-metastasis-resection weekly 0.8 https://www.themednet.org/what-is-the-preferred-sequence-of-systemic-therapy-in-a-patient-with-endocrine-resistant-hr-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/what-is-the-best-method-for-ensuring-that-vaginal-cuff-cylinder-is-in-proper-position-at-each-fraction weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-metastatic-tnbc-on-their-various-treatment-options-after-progression-on-first-line-regimens weekly 0.8 https://www.themednet.org/how-has-the-ascent-trial-impacted-your-management-of-previously-treated-metastatic-tnbc weekly 0.8 https://www.themednet.org/how-do-you-approach-pain-management-in-patients-with-idiopathic-polyneuropathy weekly 0.8 https://www.themednet.org/how-would-you-approach-unresectable-cutaneous-angiosarcoma-of-the-scalp weekly 0.8 https://www.themednet.org/would-you-treat-the-contralateral-neck-in-post-op-parotid-salivary-gland-malignancy-with-multiple-positive-nodes-ipsilaterally weekly 0.8 https://www.themednet.org/what-impacts-your-decision-to-use-pet-vs-ct-for-radiographic-staging-of-clinically-locally-advanced-cervical-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-re-treatment-if-a-patient-still-has-pain-from-spine-metastasis-after-30-gy-in-10-fractions weekly 0.8 https://www.themednet.org/can-cm577-regimen-of-adjuvant-nivolumab-s-p-neoadjuvant-chemort-with-residual-disease-following-surgery-be-extrapolated-to-patients-with-r1-resection-unable-to-undergo-re-resection weekly 0.8 https://www.themednet.org/how-does-use-of-adjuvant-nivolumab-impact-your-subsequent-use-of-immunotherapy-chemo-in-a-pdl1-gej-cancer-with-metastatic-relapse weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-abemaciclib-an-aromatase-inhibitor-to-a-patient-with-a-local-hr-her-breast-cancer-reoccurrence-while-on-tamoxifen-that-meets-high-risk-criteria weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-olaparib-in-a-premenopausal-brca1-woman-with-stage-ia-pt1bn0-er-pr-her2-breast-cancer-and-a-high-oncotype-score weekly 0.8 https://www.themednet.org/when-is-brain-biopsy-useful-warranted-as-part-of-the-diagnostic-work-up-in-patients-with-suspected-primary-cns-angiitis weekly 0.8 https://www.themednet.org/how-frequently-do-you-observe-transient-enlargement-of-a-vestibular-schwannoma-after-srs weekly 0.8 https://www.themednet.org/do-you-find-data-from-phase-2-destiny-lung01-study-sufficient-to-change-practice-in-her2-mutant-nsclc-or-is-a-phase-3-study-still-needed weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-a-patient-with-metastatic-nsclc-with-pd-l1-1-and-her2-mutation weekly 0.8 https://www.themednet.org/for-head-and-neck-cancers-do-you-ever-reduce-ptv-coverage-in-the-post-op-setting-to-meet-an-oar-constraint weekly 0.8 https://www.themednet.org/how-would-you-approach-post-op-radiation-recommendations-in-patient-who-had-neoadjuvant-chemotherapy-for-locally-advanced-oral-cavity-cancers-oral-tongue-who-have-a-complete-pathologic-response-pcr-after-surgical-resection weekly 0.8 https://www.themednet.org/how-do-you-evaluate-and-treat-patients-with-cerebral-edema-secondary-to-hyperammonemia weekly 0.8 https://www.themednet.org/what-doses-and-volumes-do-you-use-in-treatment-of-rectal-cancer-post-operatively weekly 0.8 https://www.themednet.org/would-you-irradiate-the-prostate-in-a-patient-with-spaceoar-in-the-incorrect-location-but-not-invading-rectum-or-prostate weekly 0.8 https://www.themednet.org/what-is-your-preferred-radiation-therapy-technique-for-treating-resected-neurotropic-squamous-cell-carcinoma-of-the-facial-skin-situated-near-the-infraorbital-foramen weekly 0.8 https://www.themednet.org/what-treatment-would-you-recommend-for-a-patient-with-multi-focal-angiosarcoma-involving-the-gastrointestinal-tract weekly 0.8 https://www.themednet.org/how-do-you-decide-on-initiation-of-treatment-with-steroids-or-immunomodulatory-therapy-in-patients-with-statin-induced-myopathy-versus-statin-induced-autoimmune-necrotizing-myopathy weekly 0.8 https://www.themednet.org/would-you-treat-an-in-field-recurrence-marginal-recurrence-of-nsclc-following-previous-definitive-chemoradiation-with-salvage-sbrt weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-immunosuppression-in-patients-with-lupus-nephritis-that-go-on-to-dialysis weekly 0.8 https://www.themednet.org/how-would-you-approach-new-onset-large-vessel-vasculitis-in-a-young-patient-with-crohns-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-neuropathic-itch weekly 0.8 https://www.themednet.org/what-are-your-preferred-treatment-options-for-patients-with-cholestatic-pruritus-who-do-not-respond-to-light-therapy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-preventing-and-treating-maskne weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-offer-for-rectosigmoid-junction-adenocarcinoma-after-initial-lar weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-for-a-hr-her2-clinical-t1c-n0-male-breast-cancer weekly 0.8 https://www.themednet.org/do-you-plan-to-offer-adjuvant-olaparib-to-all-gbrca-breast-cancer-whether-tnbc-or-hr weekly 0.8 https://www.themednet.org/what-is-your-process-for-assessing-the-high-risk-clinical-features-in-gbrca-breast-cancer-in-order-to-offer-olaparib-given-varying-definitions-of-risk-and-recent-changes-in-staging-guidelines weekly 0.8 https://www.themednet.org/what-is-your-treatment-of-choice-for-triple-class-refractory-multiple-myeloma weekly 0.8 https://www.themednet.org/does-variable-allele-frequency-vaf-of-jak-mutation-affect-your-clinical-decision-making-in-mpn-in-any-scenario weekly 0.8 https://www.themednet.org/how-do-you-incorporate-oncotype-or-mammaprint-recurrence-score-when-planning-an-adjuvant-cdk4-6-inhibitor-for-high-risk-early-stage-hr-breast-cancer weekly 0.8 https://www.themednet.org/how-will-you-use-pola-r-chp-in-the-frontline-treatment-of-dlbcl weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-patients-with-metastatic-hr-breast-cancer-with-detection-of-esr1-mutation-after-initiation-of-an-ai-and-cdk4-6-inhibitor weekly 0.8 https://www.themednet.org/would-you-start-anticoagulation-in-a-patient-with-rcc-and-related-tumor-thrombus-with-extension-to-renal-vein-and-further weekly 0.8 https://www.themednet.org/is-angioedema-secondary-to-iv-tpa-considered-an-absolute-contraindication-for-tpa-in-future weekly 0.8 https://www.themednet.org/when-evaluating-margin-status-to-consider-apbi-for-early-stage-invasive-breast-cancer-given-the-specification-for-at-least-2-mm-margins-do-you-look-at-the-dcis-margin-or-only-the-invasive-margin weekly 0.8 https://www.themednet.org/do-you-send-oncotypedx-testing-in-breast-cancers-with-mucinous-histology weekly 0.8 https://www.themednet.org/would-you-consider-dual-anti-her2-therapy-for-a-perimenopausal-woman-found-to-have-multifocal-pt1mic-pn1mic-her2-hr-breast-cancer-following-a-bilateral-mastectomy-for-dcis weekly 0.8 https://www.themednet.org/what-is-your-strategy-for-breakthrough-chemotherapy-induced-n-v-in-patients-receiving-highly-emetogenic-chemotherapy-and-already-received-a-nk-1-antagonist-5-ht3-antagonist-dexamethasone-and-olanzapine weekly 0.8 https://www.themednet.org/what-is-your-approach-to-prescribing-gabapentin-for-oral-mucositis-prophylaxis-during-chemoradiation weekly 0.8 https://www.themednet.org/would-you-use-sbrt-to-a-localized-low-grade-neuroendocrine-carcinoma-in-the-head-of-pancreas-in-a-patient-with-high-surgical-risk weekly 0.8 https://www.themednet.org/how-would-you-treat-ct3n1-er-pr-her2-breast-cancer-who-had-mastectomy-alnd-with-a-pcr-in-the-nodes-but-ypt1-disease-in-the-breast weekly 0.8 https://www.themednet.org/what-could-explain-the-contradictory-results-between-checkmate-274-imvigor010-and-ambassador weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-renal-cell-cancer-with-crohns-disease-after-failing-available-tyrosine-kinase-inhibitor-therapies weekly 0.8 https://www.themednet.org/would-you-ever-consider-using-ibrutinib-in-cll-patients-who-have-received-first-line-acalabrutinib-and-then-progressed weekly 0.8 https://www.themednet.org/what-is-your-preferred-igrt-approach-when-treating-with-ultra-hypofractionation-for-breast-cancer weekly 0.8 https://www.themednet.org/for-a-cervical-cancer-patient-who-had-involved-para-aortic-lymph-nodes-how-much-higher-do-you-extend-the-superior-edge-of-your-field-if-there-are-nodes-close-to-the-renal-vessels-i-e-usual-superior-extend-of-field weekly 0.8 https://www.themednet.org/how-do-you-manage-osteonecrosis-and-pelvic-insufficiency-fractures-after-pelvic-radiotherapy weekly 0.8 https://www.themednet.org/is-there-any-outpatient-protocol-for-cisplatin-doxorubicin-neoadjuvant-chemotherapy-for-osteosarcoma weekly 0.8 https://www.themednet.org/would-you-offer-postmastectomy-re-irradiation-in-a-patient-with-locally-advanced-er-her2-disease-with-pathologic-complete-response-after-neoadjuvant-chemo weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-abemaciclib-to-node-positive-patients-with-low-er-expression weekly 0.8 https://www.themednet.org/what-would-be-your-next-line-of-treatment-for-disease-control-in-a-pediatric-patient-with-metastatic-hepatocellular-carcinoma-in-partial-response-after-multiple-therapies weekly 0.8 https://www.themednet.org/what-is-your-adjuvant-therapy-for-node-positive-low-grade-endometrioid-endometrial-adenocarcinoma weekly 0.8 https://www.themednet.org/how-does-the-updated-classification-system-of-gliomas-impact-your-recommendations-for-radiation weekly 0.8 https://www.themednet.org/would-you-offer-pmrt-to-er-pr-patients-with-synchronous-bone-metastasis weekly 0.8 https://www.themednet.org/what-initial-systemic-approach-will-you-recommend-for-metastatic-pmmr-her2-esophageal-gej-gastric-adenocarcinoma-with-cps-of-0-4 weekly 0.8 https://www.themednet.org/would-you-utilize-oncotypedx-to-guide-decision-making-for-a-male-with-er-her2-breast-cancer-and-1-3-positive-sentinel-lymph-nodes weekly 0.8 https://www.themednet.org/what-impacts-your-decisions-regarding-the-use-of-immunotherapy-in-metastatic-g-e-gej-cancers-overall-in-light-of-variations-in-fda-approval-guidelines-and-trial-data weekly 0.8 https://www.themednet.org/what-aeds-prevent-spikes-and-sharp-waves weekly 0.8 https://www.themednet.org/can-giant-cell-arteritis-present-with-a-partial-cranial-neuropathy weekly 0.8 https://www.themednet.org/do-you-take-into-account-alk-fusion-variants-in-your-practice-for-deciding-treatment-for-nsclc weekly 0.8 https://www.themednet.org/for-patients-with-prior-hr-her2-localized-breast-cancer-currently-receiving-adjuvant-endocrine-therapy-is-there-a-time-period-in-which-you-would-no-longer-recommend-adding-adjuvant-abemaciclib weekly 0.8 https://www.themednet.org/is-it-safe-to-give-radiation-for-early-stage-breast-cancer-in-a-kidney-transplant-patient-who-is-on-tacrolimus-cellcept weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiation-to-a-low-grade-myoepithelial-carcinoma-of-the-soft-palate-with-positive-margins-and-no-other-aggressive-features weekly 0.8 https://www.themednet.org/would-you-favor-restarting-anticoagulation-or-pursuing-left-atrial-appendage-closure-in-a-patient-with-hemorrhagic-stroke-on-anticoagulation-for-non-valvular-atrial-fibrillation weekly 0.8 https://www.themednet.org/in-what-clinical-scenarios-do-you-utilize-venetoclax-based-therapy-in-relapsed-refractory-multiple-myeloma weekly 0.8 https://www.themednet.org/when-is-it-appropriate-to-use-the-10mg-100mg-carbidopa-levodopa-formulation weekly 0.8 https://www.themednet.org/how-does-your-surveillance-for-dlbcl-change-given-the-new-role-of-car-t-in-2nd-line-treatment weekly 0.8 https://www.themednet.org/is-apbi-appropriate-in-post-menopausal-women-with-small-triple-negative-breast-cancers-excised-with-negative-margins weekly 0.8 https://www.themednet.org/do-you-recommend-a-deep-shave-biopsy-or-punch-biopsy-for-sampling-concerning-melanocytic-lesions weekly 0.8 https://www.themednet.org/how-does-the-potential-for-a-patient-to-accept-or-forego-adjuvant-tamoxifen-factor-into-your-recommendations-on-adjuvant-rt-for-dcis weekly 0.8 https://www.themednet.org/what-type-of-dvt-pe-prophylaxis-do-you-employ-for-an-outpatient-cervical-brachytherapy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-invasive-breast-cancer-and-dcis-s-p-mastectomy-and-immediate-reconstruction-with-a-negative-invasive-margin-but-a-close-dcis-margins weekly 0.8 https://www.themednet.org/when-contouring-pelvic-lymph-nodes-in-rectal-and-anal-carcinoma-do-you-exclude-bowel-from-your-ctv weekly 0.8 https://www.themednet.org/would-you-discontinue-anticoagulation-in-patients-with-antiphospholipid-antibody-syndrome-who-have-a-remote-history-of-thrombotic-events-and-are-now-negative-for-pathogenic-antiphospholipid-antibodies weekly 0.8 https://www.themednet.org/how-do-you-approach-the-work-up-for-patients-with-fibromyalgia-and-hypermobility weekly 0.8 https://www.themednet.org/based-on-the-stampede-trial-pooled-analysis-which-patients-with-high-risk-prostate-cancer-would-you-add-abiraterone-for-2-years weekly 0.8 https://www.themednet.org/based-on-the-topaz-1-study-do-you-now-routinely-include-durvalumab-in-first-line-treatment-of-advanced-bile-duct-cancer weekly 0.8 https://www.themednet.org/if-vertebral-body-pain-is-not-controlled-with-a-single-8-gy-fraction-what-non-sbrt-dose-scheme-would-you-consider-for-re-treatment weekly 0.8 https://www.themednet.org/are-there-best-practices-for-managing-or-mitigating-toxicity-from-sotorasib-such-as-hyperbilirubinemia-or-edema weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-sequencing-in-kras-g12c-nsclc weekly 0.8 https://www.themednet.org/what-adverse-features-would-prompt-you-to-give-post-tors-radiation-therapy-to-completely-resected-early-stage-t0-2-p16-tonsillar-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-psoriasis-in-pregnant-patients weekly 0.8 https://www.themednet.org/do-you-account-for-prostate-shrinkage-during-xrt-if-adt-is-started-concurrently weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-well-controlled-metastatic-lung-cancer-who-develops-a-new-primary-p16-positive-oropharyngeal-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/what-are-your-treatment-considerations-for-a-patient-with-stage-ivb-nsclc-who-is-kras-g12c-mutated-and-pd-l1-high-50 weekly 0.8 https://www.themednet.org/are-there-strategies-to-mitigate-the-risk-of-developing-ild-pneumonitis-while-using-trastuzumab-deruxtecan weekly 0.8 https://www.themednet.org/do-you-continue-methotrexate-while-starting-tnfi-therapy-in-patients-with-refractory-pulmonary-sarcoidosis weekly 0.8 https://www.themednet.org/how-do-you-treat-patients-with-sarcoid-who-have-persistent-symptoms-after-an-initial-6-week-course-of-corticosteroids weekly 0.8 https://www.themednet.org/do-you-consider-extensive-clot-burden-as-a-factor-in-determining-whether-patients-with-submassive-pe-may-be-appropriate-for-thrombolytic-therapy weekly 0.8 https://www.themednet.org/do-you-use-acetazolamide-to-aid-diuresis-in-patients-with-acute-on-chronic-respiratory-acidosis-with-significantly-elevated-serum-bicarbonate-levels weekly 0.8 https://www.themednet.org/how-would-you-approach-es-sclc-presenting-with-small-brain-metastases-that-resolve-after-chemotherapy weekly 0.8 https://www.themednet.org/what-is-the-maximum-electron-energy-you-would-consider-using-for-a-breast-lumpectomy-boost weekly 0.8 https://www.themednet.org/how-do-you-approach-a-thoracic-lymph-node-that-is-highly-suspicious-on-ct-and-pet-but-negative-on-ebus-in-patients-with-nsclc weekly 0.8 https://www.themednet.org/would-you-pursue-more-dedicated-stone-surveillance-imaging-testing-for-a-patient-with-recurrent-nephrolithiasis-who-has-pet-ct-scans-twice-yearly weekly 0.8 https://www.themednet.org/how-do-you-treat-non-spine-bone-oligometastases weekly 0.8 https://www.themednet.org/for-a-patient-with-ici-toxicity-who-is-resistant-to-the-use-of-high-dose-steroids-are-there-scenarios-where-you-would-consider-the-use-of-first-line-conventional-synthetic-dmard-in-place-of-steroids weekly 0.8 https://www.themednet.org/how-would-you-approach-anticoagulation-for-a-patient-with-acute-bilateral-pulmonary-emboli-related-to-malignancy-but-with-a-concomitant-cavitary-lung-mass-experiencing-episodic-small-volume-hemoptysis weekly 0.8 https://www.themednet.org/do-you-foresee-any-added-benefit-of-triple-agonist-therapy-glp-1-gip-and-glucagon-for-glycemic-control-in-patients-with-type-1-diabetes-mellitus weekly 0.8 https://www.themednet.org/what-are-some-of-benefits-of-the-newly-approved-lerochol-drug-over-traditional-pcsk9-inhibitors-for-the-treatment-of-familial-hyperlipidemia weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-pelvic-floor-physical-therapy-who-are-initially-very-hesitant-to-try-it weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-chronic-hypoxemic-respiratory-failure-who-have-apparent-higher-oxygen-needs-during-hospitalization-but-no-clear-acute-decompensated-respiratory-illness weekly 0.8 https://www.themednet.org/how-do-you-approach-screening-for-ild-in-patients-with-a-diagnosis-of-mctd-given-the-recommendation-discrepancies-between-the-most-recent-eular-and-acr-chest-guidelines weekly 0.8 https://www.themednet.org/do-you-offer-consolidative-radiation-for-oligometastatic-breast-cancer weekly 0.8 https://www.themednet.org/is-there-a-role-for-measuring-plasma-aldosterone-to-guide-the-treatment-of-heart-failure-in-specific-populations weekly 0.8 https://www.themednet.org/what-are-the-indications-if-any-for-trending-acth-and-cortisol-levels-in-patients-with-adrenal-insufficiency-on-steroid-replacement-therapy weekly 0.8 https://www.themednet.org/would-you-offer-pmrt-to-a-patient-with-ptisn1a-left-breast-dcis weekly 0.8 https://www.themednet.org/How-do-you-determine-the-optimal-duration-for-1L-doublet-treatment-in-newly-diagnosed-High-Risk-CLL weekly 0.8 https://www.themednet.org/Does-the-lack-of-long-term-data-influence-your-consideration-of-utilizing-zanubrutinib-and-venetoclax-1L-in-High-Risk-CLL weekly 0.8 https://www.themednet.org/After-prior-BTKi-+-venetoclax-and-subsequent-progression-how-do-you-then-choose-next-line-therapy weekly 0.8 https://www.themednet.org/can-a-16-year-old-patient-with-aplastic-anemia-shows-multiple-infiltrative-bone-lesion-in-the-spine-and-pelvis-by-imaging weekly 0.8 https://www.themednet.org/what-factors-would-lead-you-to-consider-revascularization-in-a-patient-with-bilateral-renal-artery-stenosis-between-50-70-who-has-persistently-uncontrolled-hypertension-despite-maximal-medical-therapy weekly 0.8 https://www.themednet.org/how-often-do-you-monitor-urine-protein-levels-for-patients-with-membranous-nephropathy-for-whom-you-initiate-obinutuzumab weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-rheumatoid-vasculitis-in-this-era weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-and-caregivers-about-the-trajectory-of-cognitive-decline-in-parkinsons-disease weekly 0.8 https://www.themednet.org/in-what-cases-do-you-consider-mannitol-for-cataract-surgery weekly 0.8 https://www.themednet.org/do-you-prescribe-hydroxychloroquine-to-patients-who-are-on-other-medications-that-can-prolong-the-qt-interval weekly 0.8 https://www.themednet.org/how-would-you-treat-a-very-young-male-with-egfr-19-mutation-with-locally-advanced-lung-mass-and-brain-met-that-has-been-resected weekly 0.8 https://www.themednet.org/what-techniques-do-you-use-to-help-reduce-procedural-pain-for-headache-injection-treatments weekly 0.8 https://www.themednet.org/how-are-you-using-cyp2c19-genotyping-for-determining-dual-antiplatelet-therapy-for-stroke weekly 0.8 https://www.themednet.org/what-are-the-current-recommendations-for-the-management-of-pediatric-non-infectious-uveitis weekly 0.8 https://www.themednet.org/what-incubation-times-do-you-use-for-pdt weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-who-send-hostile-messages-through-online-patient-portals-in-outpatient-psychiatry weekly 0.8 https://www.themednet.org/for-a-patient-with-stage-ivb-endometrioid-carcinoma-of-the-ovary-brca1-positive-s-p-surgical-debulking-adjuvant-carboplatin-paclitaxel-x6-and-3-years-of-maintenance-niraparib-with-ned-on-imaging-would-you-discontinue-niraparib-and-follow-on-active-surveil weekly 0.8 https://www.themednet.org/when-do-patients-presenting-with-self-harm-but-no-suicidal-ideation-in-an-outpatient-setting-require-a-higher-level-of-care weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-aaaai-2026 weekly 0.8 https://www.themednet.org/given-the-benefit-of-neoadjuvant-immune-checkpoint-inhibitors-in-select-patients-with-cutaneous-melanoma-when-would-you-consider-lymph-node-basin-us-or-imaging-ct-pet-prior-to-wle-slnb-in-those-with-clinically-negative-nodes-on-exam weekly 0.8 https://www.themednet.org/what-radiation-dose-and-dose-constraints-do-you-use-in-a-patient-treated-with-definitive-laryngeal-radiation-6300-cgy-28-fx-for-t2n0m-scca-presented-with-left-neck-nodal-recurrence-s-p-left-neck-node-excision-metastatic-squamous-cell-carcinoma-positive-fo weekly 0.8 https://www.themednet.org/do-you-routinely-check-infliximab-levels-on-d3-with-patients-admitted-with-acute-severe-ulcerative-colitis-are-there-any-patient-characteristics-that-support-this-strategy-how-do-you-intensify-the-dose-based-on-the-levels-if-you-check-it weekly 0.8 https://www.themednet.org/do-you-continue-daratumumab-beyond-24-months-in-first-line-treatment-of-amyloidosis weekly 0.8 https://www.themednet.org/do-you-prefer-starting-potassium-chloride-or-amiloride-for-those-with-recurrent-calcium-based-nephrolithiasis-and-hypercalciuria-who-do-not-have-hypocitraturia-and-develop-hypokalemia-following-thiazide-diuretic-initiation weekly 0.8 https://www.themednet.org/what-patient-characteristics-would-lead-you-to-undertake-the-complex-transition-to-gene-therapy-for-a-patient-with-hemophilia-b weekly 0.8 https://www.themednet.org/how-do-you-approach-the-evaluation-and-treatment-of-insomnia-in-children weekly 0.8 https://www.themednet.org/how-do-you-approach-pharmacologic-treatment-of-sleep-disturbances-in-perimenopausal-or-menopausal-patients-with-vasomotor-symptoms weekly 0.8 https://www.themednet.org/would-you-favor-the-use-of-denosumab-over-bisphosphonate-therapy-for-treatment-of-osteoporosis-in-patients-who-are-at-high-risk-for-osteoarthritis-given-recent-data-suggesting-reduced-risk-of-developing-knee-oa weekly 0.8 https://www.themednet.org/do-you-require-levothyroxine-to-be-taken-on-an-empty-stomach-in-patients-with-stable-hypothyroidism-or-is-dosing-with-breakfast-acceptable-with-dose-adjustment weekly 0.8 https://www.themednet.org/which-endometrial-cancers-do-you-choose-to-send-pole-testing-on-assuming-you-cannot-check-it-on-everyone weekly 0.8 https://www.themednet.org/what-do-you-recommend-for-patients-with-recurrent-nephrolithiasis-who-require-more-than-one-24-hour-collection-jug-due-to-polyuria-and-request-advice-for-adequately-mixing-the-specimens-prior-to-analysis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-iron-overload-in-children-with-transfusion-dependent-beta-thalassemia-who-have-adherence-challenges-or-toxicity-with-standard-chelation-regimens weekly 0.8 https://www.themednet.org/how-should-the-possibility-of-more-chronic-forms-of-autoimmune-encepahlitis-influence-our-neuronal-antibody-testing-thresholds-for-patients-with-slower-progressive-cognitive-decline weekly 0.8 https://www.themednet.org/after-remission-from-a-first-episode-of-psychosis-how-long-do-you-continue-antipsychotic-treatment-before-attempting-taper-or-discontinuation weekly 0.8 https://www.themednet.org/do-you-routinely-mention-the-risk-for-encapsulating-peritoneal-sclerosis-as-part-of-your-consent-process-for-dialysis-initiation-in-a-patient-with-advanced-ckd-who-is-considering-the-different-dialysis-options weekly 0.8 https://www.themednet.org/in-a-patient-with-decompensated-heart-failure-requiring-urgent-non-cardiac-surgery-how-much-volume-optimization-do-you-pursue-preoperatively-and-at-what-point-does-the-risk-of-further-surgical-delay-outweigh-the-benefit-of-continued-diuresis weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-refer-for-an-access-angiogram-in-a-patient-on-hemodialysis-with-a-drop-in-kt-v-but-no-other-signs-of-access-dysfunction weekly 0.8 https://www.themednet.org/what-follow-up-monitoring-would-you-recommend-for-a-patient-with-self-resolved-idiopathic-pupil-sparing-third-nerve-palsy weekly 0.8 https://www.themednet.org/how-do-you-approach-prescribing-stimulants-for-adhd-in-patients-who-are-concurrently-using-cannabis weekly 0.8 https://www.themednet.org/how-do-you-approach-the-psychiatric-evaluation-and-disposition-of-adolescents-presenting-after-an-overdose-that-was-not-a-suicide-attempt weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-aad-2026 weekly 0.8 https://www.themednet.org/what-is-your-first-line-therapy-for-acute-migraine-treatment-in-the-er weekly 0.8 https://www.themednet.org/in-a-patient-with-inflammatory-breast-cancer-er-pr-her2-who-receives-neoadjuvant-systemic-therapy-and-who-has-complete-response-in-the-nodes-on-dissection-and-who-has-no-evidence-of-high-grade-carcinoma-in-the-mastectomy-specimen-but-has-small-foci-of-int weekly 0.8 https://www.themednet.org/what-clinical-features-drive-your-decision-to-use-prophylactic-mechanical-circulatory-support-in-a-patient-with-severe-left-ventricular-dysfunction-undergoing-complex-pci-following-the-chip-bcis3-trial weekly 0.8 https://www.themednet.org/do-you-discontinue-sulfonylureas-and-transition-to-basal-insulin-when-initiating-glp-1-receptor-agonists-in-patients-with-longstanding-type-2-diabetes weekly 0.8 https://www.themednet.org/can-a-patient-with-mastocytosis-be-prescribed-scit weekly 0.8 https://www.themednet.org/how-have-flexible-and-navigable-suction-ureteral-access-sheaths-changed-how-you-decide-between-urs-vs-pcnl-for-larger-stones weekly 0.8 https://www.themednet.org/what-technique-or-tool-do-you-use-to-remove-mucinous-infection-stones weekly 0.8 https://www.themednet.org/do-you-need-to-perform-an-emergent-orchiopexy-on-a-patient-who-presents-with-acute-onset-testicular-pain-with-scrotal-ultrasound-showing-whirlpool-sign-and-flow-to-the-testicle weekly 0.8 https://www.themednet.org/would-you-perform-varicocelectomy-in-a-non-obstructive-azoospermic-patient-with-grade-3-varicocele-or-proceed-straight-to-sperm-retrieval weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-a-history-of-prostate-radiation-who-is-presenting-with-luts-and-elevated-pvr weekly 0.8 https://www.themednet.org/how-are-you-thinking-about-incorporating-mirtazapine-into-your-treatment-approach-for-patients-with-methamphetamine-use-disorder weekly 0.8 https://www.themednet.org/what-traditional-or-herbal-medications-do-you-regularly-screen-for-in-migraine-patients weekly 0.8 https://www.themednet.org/what-options-would-you-consider-for-removing-dense-fibrin-deposits-from-an-iol-in-a-patient-with-chronic-uveitis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-interpretation-of-24-hour-urine-stone-risk-studies-that-persistently-demonstrate-elevated-urinary-creatinine-excretion-despite-a-reliable-patient-who-denies-improper-collection weekly 0.8 https://www.themednet.org/what-is-your-approach-to-iron-deficiency-anemia-after-a-negative-egd-and-a-colonoscopy-do-you-routinely-order-a-vce-as-a-next-step-or-there-are-any-factors-you-consider-with-patient-characteristics-that-increase-or-decrease-the-pretest-probability-of-a-po weekly 0.8 https://www.themednet.org/what-is-your-approach-for-treating-allergic-conjunctivitis-in-a-patient-who-has-failed-ketotifen-and-olopatadine weekly 0.8 https://www.themednet.org/do-you-add-antiplatelet-medications-to-patients-already-on-anticoagulation-for-atrial-fibrillation-if-they-have-a-stroke-due-to-a-competing-etiology weekly 0.8 https://www.themednet.org/should-a-trial-of-cenobamate-xcopri-be-required-before-referring-a-patient-for-epilepsy-surgery weekly 0.8 https://www.themednet.org/would-you-recommend-discontinuing-testosterone-replacement-in-a-60-yo-male-with-newly-diagnosed-favorable-intermediate-risk-prostate-cancer-who-is-refusing-surgery-and-will-receive-definitive-radiation-if-so-when-would-you-restart-the-trt weekly 0.8 https://www.themednet.org/do-you-typically-excise-cellular-dermatofibromas weekly 0.8 https://www.themednet.org/what-is-your-radiotherapy-plan-for-an-elderly-woman-with-de-novo-metastatic-r-breast-cancer-diagnosis-around-5-years-ago-who-has-progressed-on-multiple-systemic-agents-now-with-overall-stable-disease-but-with-2-oligo-progressive-r-breast-and-chest-wall-le weekly 0.8 https://www.themednet.org/how-would-you-sequence-treatment-for-a-patient-with-a-very-symptomatic-locally-advanced-rectal-adenocarcinoma-mss-with-involved-pelvic-nodes-and-abuts-sphincter-complex-with-no-distant-disease-on-ct-but-marked-elevation-in-cea-above-300 weekly 0.8 https://www.themednet.org/have-you-used-prazosin-for-day-time-anxiety-in-ptsd-do-you-feel-comfortable-utilizing-low-dose-prn weekly 0.8 https://www.themednet.org/what-is-your-approach-to-terminal-ileal-structure-in-the-setting-of-new-diagnosis-of-crohns-disease-on-index-colonoscopy-what-are-the-factors-that-could-be-used-to-decide-on-dilation-on-the-index-colonoscopy-versus-addressing-the-inflammatory-component-fi weekly 0.8 https://www.themednet.org/when-do-you-use-olanzapine-for-acute-migraine-treatment weekly 0.8 https://www.themednet.org/how-do-you-counsel-post-menopausal-interested-in-hormone-replacement-therapy-as-a-treatment-for-multiple-sclerosis weekly 0.8 https://www.themednet.org/How-does-your-institution-incorporate-prophylactic-GCSF-for-sacituzumab-govotecan weekly 0.8 https://www.themednet.org/do-you-take-any-special-precautions-when-approaching-ptosis-repair-in-a-patient-with-a-prior-trabeculectomy weekly 0.8 https://www.themednet.org/Since-MIGS-has-been-commercially-available-for-over-a-decade-what-prospective-randomized-comparative-studies-have-been-done-to-assess-the-relative-benefits-and-risks-of-each-of-the-procedures-over-an-extended-period-of-at-least-5-years weekly 0.8 https://www.themednet.org/Aside-from-the-predefined-extended-window-thrombolysis-protocols-such-as-WAKE-UP-how-commonly-do-you-tend-to-use-other-extended-window-protocols-and-has-your-institution-started-using-newer-protocols-such-as-OPTION-for-non-LVO-stroke weekly 0.8 https://www.themednet.org/what-is-your-approach-to-differentiating-randall-plaques-from-actual-small-non-obstructing-stones-when-reviewing-imaging-testing-for-your-patients-with-recurrent-nephrolithiasis weekly 0.8 https://www.themednet.org/i-have-a-patient-with-nxp2-dermatomyositis-currently-on-cellcept-1500-bid-and-weaned-down-to-prednisone-5mg-ck-and-strength-exam-has-normalized-while-weaning-down-prednisone-worsening-of-rash-aggressive-gottron-sign-holster-shawl-rash-pruritic-planning-on weekly 0.8 https://www.themednet.org/how-soon-after-an-acute-upper-gi-bleed-do-you-restart-therapeutic-anticoagulation-in-a-patient-with-atrial-fibrillation-and-a-high-thromboembolic-risk-cha-ds-vasc-4 weekly 0.8 https://www.themednet.org/do-you-routinely-check-morning-cortisol-before-discharging-a-patient-who-received-more-than-3-days-of-high-dose-corticosteroids-during-a-hospitalization-for-an-acute-illness weekly 0.8 https://www.themednet.org/would-you-recommend-using-av-graft-fistula-for-cvvhd weekly 0.8 https://www.themednet.org/do-you-pursue-stress-testing-before-discharge-for-a-patient-admitted-with-chest-pain-who-has-negative-serial-high-sensitivity-troponins-and-a-low-heart-score weekly 0.8 https://www.themednet.org/how-would-you-treat-psychosis-if-a-hematologist-reports-possible-aripiprazole-induced-leukopenia-and-the-absolute-neutrophil-count-anc-is-0-5 weekly 0.8 https://www.themednet.org/do-you-recommend-lavender-oil-approved-as-silexan-in-eu-for-the-treatment-of-anxiety weekly 0.8 https://www.themednet.org/what-causes-erosions-of-bilateral-tarsometatarsal-joints-but-no-other-systemic-inflammatory-arthritis weekly 0.8 https://www.themednet.org/How-would-the-choice-of-second-line-therapy-change-if-there-was-a-lack-of-response-or-rapid-progression-from-first-line-sacituzumab-with-or-without-pembrolizumab weekly 0.8 https://www.themednet.org/do-you-recommend-a-washout-period-for-anti-cgrp-medications-before-conception weekly 0.8 https://www.themednet.org/Based-on-Together-PsA-would-you-favor-starting-all-patients-with-PsA-and-comorbid-obesity-on-combination-therapy-with-tirzepatide-+-bDMARD-or-will-you-pursue-initial-bDMARD-monotherapy-with-tirzepatide-rescue-in-the-event-of-bDMARD-non-response weekly 0.8 https://www.themednet.org/Will-you-give-a-trial-of-tirzepatide-in-patients-with-PsA-and-obesity-who-have-partial-response-to-bDMARD-rather-than-switching-their-immunosuppressive-regimen weekly 0.8 https://www.themednet.org/guanfacine-is-effective-though-off-label-for-treating-adhd-in-adults-so-why-dont-we-use-it-more-often-lessening-the-need-for-controlled-and-risky-stimulant-medications weekly 0.8 https://www.themednet.org/what-adjustments-do-you-make-for-patients-who-report-their-long-acting-stimulants-wear-off-too-quickly weekly 0.8 https://www.themednet.org/How-do-you-approach-ILD-monitoring-when-selecting-Dato-DXd-in-frontline-TNBC-treatment weekly 0.8 https://www.themednet.org/would-you-recommend-isrt-for-a-20-year-old-male-with-stage-iia-unfavorable-bulky-pelvic-node-nodular-lymphocyte-predominant-b-cell-lymphoma-with-a-deauville-2-response-to-4-cycles-of-r-chop weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-older-adult-patients-with-coronary-artery-disease-on-aspirin-who-have-developed-intermittent-diverticular-bleeds weekly 0.8 https://www.themednet.org/would-you-recommend-starting-finerenone-for-a-patient-with-diabetic-kidney-disease-who-has-marked-improvement-from-severely-increased-albuminuria-to-moderately-increased-albuminuria-following-arb-and-sglt2i-initiation weekly 0.8 https://www.themednet.org/how-do-you-choose-between-forteo-or-tymlos weekly 0.8 https://www.themednet.org/how-do-you-weigh-the-risks-of-antipsychotic-induced-metabolic-side-effects-when-treating-behavioral-symptoms-of-dementia-in-a-patient-with-diabetes weekly 0.8 https://www.themednet.org/how-do-you-choose-between-antithyroid-drugs-rai-and-surgery-for-hyperthyroidism-patients-with-existing-cardiovascular-disease-given-their-varying-effects-on-cardiovascular-outcomes weekly 0.8 https://www.themednet.org/would-you-consider-anthracycline-based-neoadjuvant-therapy-for-er-negative-her2-positive-inflammatory-breast-cancer-in-a-premenopausal-female-given-the-subset-not-adequately-represented-in-non-anthracycline-regimen-trials weekly 0.8 https://www.themednet.org/do-you-combine-methotrexate-and-leflunomide-for-the-treatment-of-ra weekly 0.8 https://www.themednet.org/how-would-you-manage-a-pole-mutated-p53-abnormal-ia-myoinvasive-carcinosarcoma-of-the-endometrium-with-no-lvsi weekly 0.8 https://www.themednet.org/what-do-you-recommend-to-patients-when-they-are-having-an-acute-flare-of-fibromyalgia-symptoms weekly 0.8 https://www.themednet.org/when-would-you-consider-neuro-stimulants-in-post-stroke-patients weekly 0.8 https://www.themednet.org/when-would-you-consider-initiating-patients-with-cad-and-aortic-stenosis-on-pcsk9-inhibitors-as-an-adjunct-to-statin-therapy-given-favorable-findings-in-the-fourier-trial weekly 0.8 https://www.themednet.org/how-would-you-treat-recurrent-endometrial-carcinoma-with-a-presentation-of-inguinal-and-external-iliac-adenopathy weekly 0.8 https://www.themednet.org/how-would-you-approach-local-therapy-surgery-or-rt-in-a-patient-with-radiographic-complete-response-after-chemoimmunotherapy-for-non-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/when-and-for-whom-should-we-consider-adding-bempedoic-acid-to-the-lipid-lowering-regimen weekly 0.8 https://www.themednet.org/what-treatments-options-may-be-considered-in-patients-with-pots-who-also-need-daily-diuretics-to-treat-heart-failure-and-are-already-wearing-compression-garments weekly 0.8 https://www.themednet.org/how-does-your-approach-to-subsegmental-pe-differ-from-segmental-pe-both-diagnostically-and-therapeutically weekly 0.8 https://www.themednet.org/how-do-you-manage-polymorphic-light-eruption-pmle weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-recurrent-nephrolithiasis-in-patients-with-mixed-composition-uric-acid-and-calcium-phosphate-stones weekly 0.8 https://www.themednet.org/what-second-line-therapy-do-you-use-for-metastatic-thymoma-that-recurs-following-cap weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-als-on-the-benefits-of-enteral-nutrition weekly 0.8 https://www.themednet.org/do-you-recommend-a-particular-antiresorptive-anabolic-agent-for-patients-who-are-at-high-risk-for-fractures-but-have-high-risk-of-osteonecrosis-of-the-jaw weekly 0.8 https://www.themednet.org/does-the-presence-of-psoriatic-arthritis-affect-your-decision-to-use-an-anti-il-17-or-il-23-drug-in-your-psoriasis-patients weekly 0.8 https://www.themednet.org/when-doing-a-tumor-bed-boost-following-whole-breast-irradiation-what-do-you-typically-use-for-ctv-and-ptv-margin-for-photon-and-electron-plans weekly 0.8 https://www.themednet.org/how-do-you-implement-antipsychotics-in-the-management-of-agitation-in-alzheimers-patients weekly 0.8 https://www.themednet.org/how-long-would-you-continue-trastuzumab-for-a-patient-with-metastatic-her2-esophageal-adenocarcinoma-whose-tumor-has-achieved-cr-with-folfox-trastuzumab-and-has-been-disease-free-for-nearly-3-years weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-acc-2024 weekly 0.8 https://www.themednet.org/how-do-you-sequence-hypofractionated-radiation-and-systemic-therapy-for-patients-with-unresectable-cholangiocarcinoma weekly 0.8 https://www.themednet.org/is-there-evidence-that-prostatectomy-improves-overall-survival-in-local-recurrence-of-prostate-cancer-post-definitive-radiation weekly 0.8 https://www.themednet.org/for-a-patient-with-iiic1-micromets-msi-high-grade-2-endometrial-adenocarcinoma-who-has-undergone-full-surgical-staging-do-you-recommend-adding-immunotherapy-to-adjuvant-chemotherapy-radiation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-use-of-paxlovid-for-patients-with-risk-factors-for-severe-covid-19-infection-but-who-have-received-sars-cov-2-vaccines-in-light-of-the-epic-sr-trial-findings weekly 0.8 https://www.themednet.org/what-evidence-supports-the-use-of-high-tangents-for-pn1mic-breast-cancer weekly 0.8 https://www.themednet.org/do-you-always-biopsy-suspicious-liver-lesions-if-you-have-a-biopsy-from-the-pancreatic-mass-showing-pdac weekly 0.8 https://www.themednet.org/how-do-you-manage-a-figo-stage-ib-dedifferentiated-endometrial-carcinoma-that-is-mmr-deficient-and-p53-wt weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-change-in-patients-with-psoriasis-who-have-been-stable-on-an-il-17-or-il-23-agent-but-then-begin-to-have-breakthrough-skin-disease weekly 0.8 https://www.themednet.org/do-you-choose-an-antibiotic-with-csf-penetration-such-as-nafcillin-over-cefazolin-in-the-setting-of-mssa-endocarditis-with-septic-emboli-to-the-brain-assuming-no-concomitant-meningitis-or-brain-abscess weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-insomnia-in-an-eskd-patient weekly 0.8 https://www.themednet.org/how-often-do-you-rely-on-using-the-c1-inhibitor-functional-assay-versus-the-quantitative-level-alone-to-diagnose-hae weekly 0.8 https://www.themednet.org/how-frequently-do-you-recommend-skin-cancer-screens-in-your-patients-with-kidney-transplants-who-are-on-immunosuppression weekly 0.8 https://www.themednet.org/would-you-consider-the-use-of-egfr-inhibition-cetuximab-panitumumab-in-first-line-in-metastatic-right-sided-ras-raf-wt-colon-cancer-if-bevacizumab-contraindicated weekly 0.8 https://www.themednet.org/should-ct-coronary-calcium-score-be-avoided-in-dialysis-patients-in-light-of-presumed-high-prevalence-of-cac-in-this-population weekly 0.8 https://www.themednet.org/when-treating-apbi-with-the-florence-regimen-are-you-using-daily-or-every-other-day-fractionation weekly 0.8 https://www.themednet.org/do-you-perform-routine-interval-lung-cancer-screening-in-non-smokers-who-are-1st-degree-relatives-of-patients-with-non-smoking-related-lung-cancers-with-known-egfr-mutations weekly 0.8 https://www.themednet.org/how-do-you-address-mental-health-and-online-presence-with-teenage-patients weekly 0.8 https://www.themednet.org/what-medications-do-you-prioritize-or-avoid-in-parkinsons-disease-related-psychosis-and-behavioral-disturbance weekly 0.8 https://www.themednet.org/in-what-cases-do-you-use-baclofen-for-alcohol-use-disorder weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-bipolar-disorder-who-want-to-breastfeed weekly 0.8 https://www.themednet.org/how-do-you-titrate-lithium-for-patients-with-bipolar-affective-disorder-during-pregnancy-and-immediately-after-delivery-in-the-context-of-fluid-shifts-and-changing-levels weekly 0.8 https://www.themednet.org/when-and-how-do-you-taper-antipsychotics-after-a-resolved-episode-of-bipolar-mania-with-psychotic-features weekly 0.8 https://www.themednet.org/what-post-protocol-therapies-did-patients-on-the-bruin-trial-in-cll-receive-and-how-did-these-therapies-impact-outcomes weekly 0.8 https://www.themednet.org/how-do-you-treat-benign-fasciculation-syndrome weekly 0.8 https://www.themednet.org/in-drawing-blood-cultures-from-a-central-line-to-evaluate-for-clabsi-do-you-advise-drawing-separate-blood-cultures-from-each-port-in-case-of-dual-or-triple-lumen-line weekly 0.8 https://www.themednet.org/how-do-you-approach-hypocomplementemia-in-sjogrens-without-features-of-lymphoma weekly 0.8 https://www.themednet.org/what-further-work-up-do-you-recommend-for-patients-with-a-chronic-high-anion-gap-metabolic-acidosis-with-normal-egfr-who-have-been-ruled-out-for-lactic-acidosis-ketosis-toxic-alcohols-and-other-usual-culprits-of-high-anion-gap-metabolic-acidosis weekly 0.8 https://www.themednet.org/would-a-low-genomic-mammaprint-score-deter-you-from-offering-adjuvant-chemotherapy-to-a-premenopausal-woman-with-hr-pt3n0-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-a-newly-diagnosed-hormone-sensitive-high-risk-prostate-cancer-with-one-small-lung-metastasis-and-no-other-evidence-of-metastatic-disease-per-psma-pet weekly 0.8 https://www.themednet.org/what-is-the-minimum-duration-of-weeks-on-anticoagulation-in-which-you-would-consider-performing-a-dccv-without-the-need-for-tee-provided-the-patient-is-an-excellent-historian-and-otherwise-reliable weekly 0.8 https://www.themednet.org/what-topicals-have-you-had-success-with-treating-body-acne weekly 0.8 https://www.themednet.org/how-do-you-approach-medication-management-in-patients-with-ra-when-transitioning-from-csdmard-triple-therapy-to-anti-tnf weekly 0.8 https://www.themednet.org/is-there-a-chest-wall-constraint-you-typically-use-for-60-gy-in-15-fraction-nsclc-treatment weekly 0.8 https://www.themednet.org/how-do-you-decide-between-il-4-il-13-blockade-dupixent-versus-il-13-blockade-only-adbry-as-treatments-for-atopic-dermatitis weekly 0.8 https://www.themednet.org/how-do-you-determine-duration-of-therapy-for-patients-who-have-responded-well-to-voclosporin-therapy weekly 0.8 https://www.themednet.org/do-you-ever-combine-voclosporin-and-belimumab-in-the-treatment-of-lupus-nephritis weekly 0.8 https://www.themednet.org/what-is-the-optimal-antithrombotic-management-if-at-all-in-patients-with-incidentally-identified-findings-of-multiple-silent-embolic-appearing-cerebral-infarcts weekly 0.8 https://www.themednet.org/would-you-consider-combining-tovorafenib-and-trametinib-as-dual-therapy weekly 0.8 https://www.themednet.org/would-you-offer-chemort-to-a-colon-cancer-case-with-a-resected-polyp-with-positive-margins-if-the-patient-wishes-to-avoid-surgery weekly 0.8 https://www.themednet.org/how-have-the-findings-from-danger-shock-rct-changed-your-perspective-on-which-patients-presenting-with-acute-mi-complicated-by-cardiogenic-shock-would-benefit-from-impella-for-additional-hemodynamic-support weekly 0.8 https://www.themednet.org/what-are-some-potential-etiologies-to-consider-for-isolated-mildly-elevated-bnp-levels-with-normal-tte-findings-in-an-asymptomatic-elderly-patient weekly 0.8 https://www.themednet.org/do-you-ever-consider-continuing-annual-ldct-chest-for-lung-cancer-screening-in-patients-who-quit-smoking-more-than-15-years-ago weekly 0.8 https://www.themednet.org/what-criteria-are-you-using-for-retreatment-with-pluvicto-lu-177-in-those-who-maintain-a-good-performance-status-and-appropriate-lab-work weekly 0.8 https://www.themednet.org/given-the-results-of-esopec-from-asco-2024-for-which-patients-with-resectable-esophageal-adenocarcinoma-would-you-favor-neoadjuvant-chemoradiation weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-stage-iiia-egfr-lung-cancer-regarding-treatment-intent-with-concurrent-chemort-consolidative-systemic-therapy weekly 0.8 https://www.themednet.org/what-is-a-reasonable-approach-to-coronary-calcification-that-is-incidentally-found-on-ct-in-a-patient-who-does-not-have-symptoms-suggestive-of-angina weekly 0.8 https://www.themednet.org/what-factors-aside-from-progression-do-you-consider-most-important-in-determining-whether-a-patient-with-metastatic-papillary-thyroid-carcinoma-is-radioactive-iodine-refractory weekly 0.8 https://www.themednet.org/how-do-you-approach-repeat-sbrt-in-the-abdomen-specifically-when-considering-constraints-for-bowel-and-mesenteric-vessels weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gyn-cancers-from-asco-2024 weekly 0.8 https://www.themednet.org/what-would-be-your-recommendation-for-treatment-of-worsening-lung-disease-in-a-patient-with-long-standing-scleroderma-after-long-term-mycophenolate-therapy-which-is-no-longer-an-option-due-to-side-effect-intolerance weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-head-neck-cancers-from-asco-2024 weekly 0.8 https://www.themednet.org/in-patients-with-her-2-positive-breast-cancer-on-pertuzumab-trastuzumab-with-newly-developed-asymptomatic-brain-metastases-only-do-you-wait-3-weeks-after-administration-of-the-targeted-therapy-to-deliver-srs weekly 0.8 https://www.themednet.org/is-there-a-bmi-cutoff-for-which-you-no-longer-recommend-kidney-transplantation-in-a-patient-with-end-stage-kidney-disease-and-obesity weekly 0.8 https://www.themednet.org/do-you-prefer-cinacalcet-or-etelcalcetide-for-patients-with-hyperparathyroidism-in-the-setting-of-kidney-disease weekly 0.8 https://www.themednet.org/for-hypothyroid-patients-on-dual-replacement-therapy-levothyroxine-liothyronine-do-you-recommend-monitoring-tsh-while-holding-off-on-the-morning-t3-dose weekly 0.8 https://www.themednet.org/would-you-recommend-initially-starting-twice-weekly-outpatient-hemodialysis-with-close-lab-monitoring-for-nonoliguric-aki-patients weekly 0.8 https://www.themednet.org/what-are-some-indications-that-might-lead-you-to-pursue-a-kidney-biopsy-in-a-patient-with-presumed-diabetic-kidney-disease weekly 0.8 https://www.themednet.org/are-you-comfortable-with-using-nsaids-in-a-patient-on-methotrexate-for-inflammatory-arthritis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-lab-and-imaging-monitoring-in-a-patient-with-an-elevated-creatinine-following-a-unilateral-nephrectomy weekly 0.8 https://www.themednet.org/do-you-have-any-specific-recommendations-to-prevent-large-fluctuations-in-sodium-levels-during-a-colonoscopy-prep-in-patients-with-central-diabetes-insipidus-on-ddavp weekly 0.8 https://www.themednet.org/what-is-your-experience-with-ritlecitinib-and-how-does-it-compare-to-baricitinib-for-alopecia-areata weekly 0.8 https://www.themednet.org/what-is-your-threshold-to-repeat-a-kidney-biopsy-in-a-patient-with-a-history-of-lupus-nephritis-who-is-on-maintenance-therapy-and-develops-subtle-changes-in-urinary-protein-excretion-or-microscopic-hematuria weekly 0.8 https://www.themednet.org/what-is-your-preferred-fractionation-scheme-for-spine-sbrt-for-radioresistant-histologies weekly 0.8 https://www.themednet.org/in-what-circumstance-if-any-would-you-consider-fulvestrant-capivasertib-over-cdk4-6-inhibitors-in-a-patient-who-has-hr-pik3ca-mutant-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/do-you-routinely-administer-desmopressin-to-patients-with-intracerebral-hemorrhage-who-are-also-on-anti-platelet-therapy weekly 0.8 https://www.themednet.org/how-would-you-manage-cardiac-sarcoid-with-intolerance-contraindications-to-methotrexate-azathioprine-and-mycophenolate-mycophenolic-acid-and-that-has-proven-refractory-to-adalimumab-and-infliximab-as-determined-by-pet weekly 0.8 https://www.themednet.org/do-you-routinely-check-digoxin-levels-and-if-so-when-would-you-consider-using-digibind-in-chronic-digoxin-use-patients weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-aortic-stenosis-in-an-elderly-frail-patient-with-multiple-comorbidities-who-is-symptomatic-but-considered-high-risk-for-surgical-aortic-valve-replacement weekly 0.8 https://www.themednet.org/how-do-you-counsel-eligible-patients-on-how-to-decide-between-lecanemab-vs-donanemab weekly 0.8 https://www.themednet.org/in-ct4an0-triple-negative-breast-cancer-would-you-still-recommend-pmrt-if-pcr-ypt0n0-sn-after-neoadj-chemo-is-achieved weekly 0.8 https://www.themednet.org/what-are-your-strategies-for-preventive-migraine-therapy-in-breastfeeding-patients weekly 0.8 https://www.themednet.org/would-you-consider-adding-or-switching-to-pirfenidone-for-a-patient-with-progressing-uip-based-on-imaging-and-pfts-who-is-currently-on-nintedanib weekly 0.8 https://www.themednet.org/what-post-treatment-surveillance-strategy-do-you-employ-for-patients-who-undergo-conservative-fertility-sparing-surgery-for-early-stage-cervical-cancer weekly 0.8 https://www.themednet.org/if-a-patient-meets-criteria-for-extrafascial-hysterectomy-for-early-stage-cervical-cancer-how-do-you-determine-your-surgical-approach-abdominal-vs-laparoscopic weekly 0.8 https://www.themednet.org/do-the-results-of-the-concerv-and-shape-trials-alter-how-you-might-counsel-a-patient-incidentally-found-to-have-ib1-after-simple-hysterectomy weekly 0.8 https://www.themednet.org/in-the-context-of-the-concerv-and-shape-trials-how-would-you-approach-a-patient-with-endometrioid-adenocarcinoma-within-an-excised-1-2-cm-cervical-polyp-negative-for-lvsi-who-has-no-suspicious-lymph-nodes-on-ct-scan weekly 0.8 https://www.themednet.org/what-is-your-approach-for-severe-scle-in-patients-unable-to-tolerate-hcq weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-glp1-r-agonist-therapy-in-patients-with-t1dm-for-weight-loss weekly 0.8 https://www.themednet.org/what-considerations-do-you-take-when-using-prednisone-in-patients-with-systemic-sclerosis weekly 0.8 https://www.themednet.org/what-treatment-approach-do-you-suggests-for-a-patient-with-nasal-polyp-disease-and-asthma-who-was-improved-on-dupilumab-but-over-last-2-years-has-begun-to-have-increased-nasal-symptoms-and-rising-eosinophil-counts weekly 0.8 https://www.themednet.org/when-a-patient-with-pancreatic-cancer-received-neoadjuvant-chemo-chemo-rt-how-do-you-manage-an-in-field-post-operative-positive-margin weekly 0.8 https://www.themednet.org/how-would-you-approach-an-isolated-supraclavicular-nodal-recurrence-involving-the-skin-in-a-patient-who-has-received-standard-chest-wall-and-nodal-radiation-therapy weekly 0.8 https://www.themednet.org/what-are-the-best-practices-for-centers-interested-in-providing-anti-amyloid-therapies-for-early-alzheimers-to-ensure-treatment-delivery-success weekly 0.8 https://www.themednet.org/what-is-your-approach-to-screening-for-malignancy-in-dermatomyositis-patients-who-do-not-have-a-high-risk-antibody-profile-and-whose-disease-responds-well-to-treatment weekly 0.8 https://www.themednet.org/for-recurrent-prostate-cancer-after-prostatectomy-with-soft-tissue-mass-in-the-prostate-fossa-is-hypofractionation-an-option-or-is-standard-fractionation-recommended weekly 0.8 https://www.themednet.org/how-would-you-manage-a-female-in-her-40s-with-stage-iii-cervical-cancer-with-hydronephrosis-and-crohns-disease weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-use-of-compounded-weight-loss-medications weekly 0.8 https://www.themednet.org/would-you-offer-inguinal-nodal-rt-to-a-patient-with-anal-scc-pt1n1a-inguinal-node-following-apr-in-the-setting-of-prior-prostate-pelvic-nodal-radiation weekly 0.8 https://www.themednet.org/when-treating-prostate-cancer-with-moderate-hypo-fractionation-what-urethral-dose-constraints-do-you-consider-when-boosting-the-dominate-intraprostatic-lesion weekly 0.8 https://www.themednet.org/do-you-recommend-or-have-any-clinical-experience-with-migraine-surgery weekly 0.8 https://www.themednet.org/what-have-you-found-to-be-effective-for-keratosis-pilaris weekly 0.8 https://www.themednet.org/in-patients-with-perihilar-cholangiocarcinoma-eligible-for-liver-transplant-what-is-the-protocol-for-neoadjuvant-chemo-rt-particularly-when-brachytherapy-is-not-available weekly 0.8 https://www.themednet.org/in-asymptomatic-patients-with-castrate-resistant-prostate-cancer-who-have-failed-chemotherapy-and-have-progressive-vertebral-body-metastases-when-do-you-prescribe-lutetium-177-vs-prophylactic-spinal-radiation weekly 0.8 https://www.themednet.org/do-you-perform-ebus-tbna-for-staging-in-patients-with-biopsy-proven-malignant-lung-nodules-with-no-lymphadenopathy-on-ct-chest-and-pet-scan weekly 0.8 https://www.themednet.org/how-would-you-treat-an-mmr-proficient-t2-n0-low-rectal-cancer-measuring-2-cm-extending-4-6-cm-from-the-anal-verge-in-a-patient-who-wishes-to-preserve-his-sphincter weekly 0.8 https://www.themednet.org/do-you-routinely-use-markers-or-tests-other-than-serum-creatinine-when-estimating-gfr-to-determine-if-patients-with-liver-failure-not-on-dialysis-meet-criteria-for-a-simultaneous-liver-kidney-transplant weekly 0.8 https://www.themednet.org/do-you-routinely-check-hormone-levels-to-confirm-postmenopausal-status-before-adding-aromatase-inhibitors-to-ofs-in-premenopausal-women-with-early-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-a-young-breast-cancer-patient-with-limited-nodal-involvement-and-an-isolated-sternal-oligometastasis-at-diagnosis weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-treat-prostate-cancer-without-a-biopsy weekly 0.8 https://www.themednet.org/would-you-ever-consider-using-durvalumab-tremelimumab-in-second-line-after-progression-on-atezolizumab-and-bevacizumab-in-advanced-hcc weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-when-they-ask-whether-the-ssri-or-snri-antidepressant-you-have-recommended-will-result-in-weight-gain weekly 0.8 https://www.themednet.org/when-should-the-dissected-axilla-levels-i-ii-be-included-when-delivering-rni weekly 0.8 https://www.themednet.org/what-unique-factors-do-you-take-into-consideration-for-geriatric-patients-with-a-first-lifetime-episode-depression weekly 0.8 https://www.themednet.org/in-the-post-mastectomy-setting-are-there-situations-where-only-the-regional-nodes-or-targeted-nodal-basis-are-covered weekly 0.8 https://www.themednet.org/is-there-a-benefit-to-having-a-transition-period-in-which-a-patient-continues-following-with-their-previous-pediatric-rheumatologist-while-establishing-care-with-a-new-adult-rheumatologist weekly 0.8 https://www.themednet.org/what-do-you-do-when-headache-appears-clinically-attributed-to-intracranial-hypotension-but-imaging-and-opening-pressure-are-normal-or-not-obtainable weekly 0.8 https://www.themednet.org/how-would-you-best-manage-c-spine-osteoradionecrosis weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-a-lumbar-puncture-for-patients-with-suspected-ocular-or-otic-syphilis-in-the-absence-of-additional-cns-symptoms weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-stage-iia-non-small-cell-lung-cancer-who-received-sbrt weekly 0.8 https://www.themednet.org/how-would-you-manage-a-pre-menopausal-woman-with-extranodal-marginal-zone-lymphoma-confined-to-the-bladder-wall weekly 0.8 https://www.themednet.org/what-is-your-target-or-goal-lipoprotein-a-level-for-patients-on-pcsk9-inhibitors-for-either-primary-or-secondary-prevention weekly 0.8 https://www.themednet.org/what-are-your-management-strategies-for-acute-kidney-injury-attributed-to-pembrolizumab-in-patients-with-a-kidney-biopsy-showing-predominately-acute-tubular-injury weekly 0.8 https://www.themednet.org/under-what-circumstances-do-you-recommend-targeting-a-systolic-blood-pressure-of-less-than-120-mmhg-in-a-patient-with-ckd weekly 0.8 https://www.themednet.org/how-soon-following-pacemaker-implantation-can-patients-safely-undergo-elective-cardioversion weekly 0.8 https://www.themednet.org/how-do-you-approach-interpreting-a-low-titer-dsdna-such-as-crithidia-1-40-to-1-80-in-the-setting-of-a-moderately-elevated-ana-without-other-specific-features-of-sle weekly 0.8 https://www.themednet.org/given-the-risk-of-hypocalcemia-in-dialysis-dependent-patients-treated-with-denosumab-what-is-the-best-method-of-treatment-for-osteoporosis-for-these-patients-and-should-we-be-transitioning-to-a-different-agent weekly 0.8 https://www.themednet.org/what-is-the-utility-of-an-oral-calcium-loading-test-to-differentiate-fhh-from-secondary-hyperparathyroidism-due-to-low-calcium-intake weekly 0.8 https://www.themednet.org/how-do-you-manage-atopic-dermatitis-in-patients-who-have-failed-dupilumab weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-sgo-2024 weekly 0.8 https://www.themednet.org/what-is-your-preferred-third-line-therapy-for-metastatic-colon-cancer-ras-wt-mss-low-tmb-with-no-targetable-alterations weekly 0.8 https://www.themednet.org/is-there-any-benefit-from-oral-vs-topical-steroids-in-herpes-zoster-opthalmicus weekly 0.8 https://www.themednet.org/how-do-you-do-a-levodopa-trial-in-the-outpatient-setting weekly 0.8 https://www.themednet.org/would-you-consider-deferring-chest-tube-placement-in-a-clinically-stable-patient-with-a-small-empyema-without-signs-of-systemic-infection weekly 0.8 https://www.themednet.org/would-you-refer-a-patient-for-parathyroidectomy-if-they-have-normal-calcium-levels-mild-hyperparathyroidism-and-evidence-of-osteopenia weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-for-managing-oligoprogressive-nsclc-during-second-line-or-later-systemic-therapy-if-patient-is-otherwise-responding-well-at-other-sites-of-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-to-anal-pap-screening-among-msm-with-hiv-and-if-routinely-recommend-starting-at-what-age-assuming-access-to-hra weekly 0.8 https://www.themednet.org/extrapolating-from-keynote-a18-would-you-consider-adding-pembrolizumab-to-chemoradiation-for-locally-advanced-vulvar-cancer weekly 0.8 https://www.themednet.org/how-has-the-introduction-of-lumasiran-affected-the-need-for-combined-liver-and-kidney-transplantation-in-patients-with-eskd-related-to-primary-hyperoxaluria-type-1 weekly 0.8 https://www.themednet.org/in-the-current-myeloma-landscape-do-you-make-treatment-decisions-based-on-mrd-results-either-for-mrd-negativity-or-mrd-resurgence weekly 0.8 https://www.themednet.org/should-low-intensity-statins-be-favored-to-minimize-the-risk-of-diabetes-onset-while-still-offering-cardiovascular-benefit-for-patients-with-prediabetes-where-a-statin-is-indicated weekly 0.8 https://www.themednet.org/do-you-make-adjustments-to-the-immunosuppressive-regimen-for-kidney-transplant-recipients-on-tacrolimus-who-develop-posterior-reversible-encephalopathy-syndrome-pres weekly 0.8 https://www.themednet.org/how-do-you-time-24-hour-urine-collections-when-calculating-creatinine-clearance-for-patients-receiving-thrice-weekly-hemodialysis weekly 0.8 https://www.themednet.org/do-you-avoid-esas-in-patients-with-end-stage-kidney-disease-who-also-have-heart-failure-due-to-increased-risk-of-stroke weekly 0.8 https://www.themednet.org/why-are-gout-flares-common-in-hospitalized-patients-undergoing-diuresis-but-not-commonly-observed-in-cancer-patients-with-hyperuricemia-resulting-from-tumor-lysis-syndrome weekly 0.8 https://www.themednet.org/do-you-extend-the-duration-of-maintenance-therapy-past-24-months-for-patients-with-anca-glomerulonephritis-who-have-multiple-organ-involvement weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-moderate-to-severe-atopic-dermatitis-in-pregnancy weekly 0.8 https://www.themednet.org/do-you-prefer-a-mycophenolate-or-tacrolimus-based-glucocorticoid-sparing-regimen-for-patients-with-minimal-change-disease weekly 0.8 https://www.themednet.org/in-cases-where-egfr-nsclc-has-transformed-into-small-cell-lung-cancer-after-treatment-with-osimertinib-and-with-no-cns-involvement-is-it-advisable-to-continue-osimertinib-alongside-chemotherapy weekly 0.8 https://www.themednet.org/what-is-your-intraprocedural-approach-to-reducing-time-to-reperfusion-in-stemi-cases-opting-for-culprit-lesion-pci-first-then-complete-angiography-or-complete-angiography-followed-by-culprit-lesion-pci weekly 0.8 https://www.themednet.org/how-frequently-do-you-opt-to-use-ivus-as-opposed-to-oct-or-invasive-hemodynamic-assessment-when-evaluating-coronary-lesions weekly 0.8 https://www.themednet.org/how-do-you-reconcile-the-benefits-of-high-glycemic-load-to-slow-als-disease-progression-with-previous-data-on-the-increased-risk-for-als-associated-with-diabetes-mellitus weekly 0.8 https://www.themednet.org/what-nutritional-supplements-do-you-recommend-for-patients-with-als weekly 0.8 https://www.themednet.org/what-are-your-next-steps-when-managing-patients-with-suspected-gitelman-syndrome-for-whom-genetic-testing-reveals-variants-of-uncertain-significance-or-novel-mutations-not-well-characterized weekly 0.8 https://www.themednet.org/why-are-patients-getting-enzalutamide-s-p-prostatectomy-not-candidates-for-salvage-radiation-therapy weekly 0.8 https://www.themednet.org/for-patients-with-hypertension-who-have-normal-filling-pressures-following-right-cardiac-catheterization-can-hypertension-still-be-attributed-to-volume-overload weekly 0.8 https://www.themednet.org/what-is-your-approach-to-dosing-rituximab-in-patients-with-multiple-sclerosis weekly 0.8 https://www.themednet.org/which-type-of-botulinum-toxin-do-you-use-for-the-initial-and-sequential-treatment-of-dystonia weekly 0.8 https://www.themednet.org/does-evidence-support-extending-the-duration-of-intravenous-iron-dextran-infed-infusion-in-pregnant-patients weekly 0.8 https://www.themednet.org/do-you-routinely-offer-spine-sbrt-for-vertebral-metastases-regardless-of-overall-patient-disease-burden-or-response weekly 0.8 https://www.themednet.org/are-there-patients-with-granulomatosis-with-polyangiitis-on-maintenance-rituximab-therapy-for-whom-you-do-not-co-administer-glucocorticoid-therapy weekly 0.8 https://www.themednet.org/do-you-ever-consider-close-clinical-monitoring-over-antifibrotic-therapy-in-patients-ascribed-an-mdd-diagnosis-of-ipf-who-have-normal-lung-function-and-are-asymptomatic weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-experience-diarrhea-from-mycophenolate-mofetil-cellcept weekly 0.8 https://www.themednet.org/do-you-discontinue-il-17a-il-17a-f-or-il-23-blockade-in-pregnant-patients-with-psoriasis weekly 0.8 https://www.themednet.org/should-all-thyroid-cancer-patients-have-thyroglobulin-levels-measured-pre-operatively weekly 0.8 https://www.themednet.org/what-is-your-approach-to-recurrent-asymptomatic-bacteriuria-in-pregnancy-for-patients-without-personal-history-of-recurrent-utis-or-pyelonephritis weekly 0.8 https://www.themednet.org/how-often-do-you-check-carnitine-levels-in-your-patients-with-end-stage-kidney-disease-on-hemodialysis weekly 0.8 https://www.themednet.org/what-is-the-practical-application-of-alpha-synuclein-seed-amplification-assay-csf-testing-for-the-diagnosis-and-management-of-parkinsons-disease weekly 0.8 https://www.themednet.org/do-you-ever-consider-tapering-off-steroid-sparing-agents-in-patients-with-stable-non-ipf-ild weekly 0.8 https://www.themednet.org/do-you-resume-zoledronic-acid-or-denosumab-at-relapse-in-multiple-myeloma weekly 0.8 https://www.themednet.org/would-you-stop-azathioprine-in-a-patient-with-anca-vasculitis-who-has-been-in-long-term-remission-on-azathioprine-but-has-a-new-diagnosis-of-lung-cancer-requiring-initiation-of-immunotherapy weekly 0.8 https://www.themednet.org/do-you-pursue-any-additional-testing-in-your-patients-with-chronic-kidney-disease-who-are-found-to-have-small-hypodensities-too-small-to-characterize-on-renal-ultrasound weekly 0.8 https://www.themednet.org/what-criteria-do-you-utilize-in-deciding-when-to-treat-or-not-treat-frequent-vpcs weekly 0.8 https://www.themednet.org/how-do-you-approach-medication-management-in-biopsy-proven-pulmonary-sarcoidosis-with-disease-stable-for-over-2-years-on-hydroxychloroquine-and-low-dose-prednisone weekly 0.8 https://www.themednet.org/would-you-consider-stopping-egfr-inhibitor-in-egfr-mutant-nsclc-on-a-patient-who-was-ned-for-5-years weekly 0.8 https://www.themednet.org/would-you-ever-re-treat-recurrent-ovarian-cancer-with-mirvetuximab-soravtansine-if-the-patient-responded-to-it-in-the-past-e-g-more-than-6-months-ago weekly 0.8 https://www.themednet.org/what-is-the-utility-of-checking-reverse-t3-in-clinical-practice weekly 0.8 https://www.themednet.org/are-there-clinical-scenarios-in-which-you-would-start-empiric-treatment-for-pulmonary-tb-without-microbiologic-confirmation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-using-beta-blockers-in-patients-with-acute-myocardial-infarction-with-preserved-lv-ejection-fraction-who-undergo-early-coronary-angiography-in-light-of-the-reduce-ami-trial-findings weekly 0.8 https://www.themednet.org/would-you-consider-pth-analog-therapy-in-a-woman-with-osteoporotic-vertebral-fractures-who-has-asymptomatic-non-obstructive-renal-stones-and-normal-24-hour-urine-calcium-level weekly 0.8 https://www.themednet.org/how-would-you-manage-sarcomatoid-carcinoma-of-the-prostate-with-poorly-differentiated-adenocarcinoma-that-is-not-amenable-to-surgery weekly 0.8 https://www.themednet.org/is-there-any-indication-for-hydroxyurea-in-patients-with-sickle-cell-trait weekly 0.8 https://www.themednet.org/how-do-you-choose-between-spironolactone-and-finerenone-for-patients-with-proteinuric-diabetic-kidney-disease-and-heart-failure weekly 0.8 https://www.themednet.org/do-you-utilize-phrenic-nerve-emg-in-patients-with-diaphragmatic-issues weekly 0.8 https://www.themednet.org/do-you-utilize-thrombolytic-therapy-in-patients-with-crao weekly 0.8 https://www.themednet.org/do-you-typically-load-dapt-in-patients-with-icad weekly 0.8 https://www.themednet.org/when-do-you-recommend-hyperacute-mri-for-patients-with-wake-up-stroke weekly 0.8 https://www.themednet.org/when-do-you-consider-stenting-in-patients-with-recurrent-stroke-with-icad weekly 0.8 https://www.themednet.org/should-we-be-using-a-cut-off-of-20-rather-than-the-traditional-10-hounsfield-units-to-distinguish-between-benign-and-malignant-adrenocortical-tumors-on-imaging weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-large-4-cm-node-negative-hr-her2-breast-cancer-in-an-elderly-woman-with-comorbidities-including-neuropathy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-risks-and-benefits-of-an-il-23-agent-versus-an-il-17a-or-il-17a-f-agent weekly 0.8 https://www.themednet.org/would-you-consider-omission-of-port-for-node-nsclc-with-a-positive-margin-in-the-setting-of-a-high-tumor-pd-l1-score-and-plans-for-immunotherapy weekly 0.8 https://www.themednet.org/how-do-you-decide-between-neoadjuvant-or-perioperative-chemoimmunotherapy-as-per-checkmate-816-or-keynote-671-for-early-stage-nsclc weekly 0.8 https://www.themednet.org/how-do-you-approaach-ischemic-stroke-from-suspected-symptomatic-ipsilateral-carotid-web-with-less-than-50-stenosis weekly 0.8 https://www.themednet.org/when-do-you-recommend-testing-for-apol1-variants-in-patients-with-proteinuric-chronic-kidney-disease weekly 0.8 https://www.themednet.org/would-you-perform-unilateral-or-bilateral-hippocampal-avoidant-whole-brain-rt-in-a-patient-with-a-prior-srs-to-a-small-hippocampal-metastasis weekly 0.8 https://www.themednet.org/what-are-some-considerations-to-make-when-managing-patients-with-recurrent-nephrolithiasis-who-are-found-to-have-nephrocalcinosis-on-imaging weekly 0.8 https://www.themednet.org/how-do-you-construct-your-target-volumes-for-superior-sulcus-tumors weekly 0.8 https://www.themednet.org/for-which-patients-could-you-consider-direct-oral-amoxicillin-challenge-as-opposed-to-skin-testing-for-penicillin-allergy-de-labeling weekly 0.8 https://www.themednet.org/do-you-recommend-obtaining-a-dexa-scan-for-patients-with-recurrent-nephrolithiasis-and-hypercalciuria-of-unknown-etiology weekly 0.8 https://www.themednet.org/for-how-long-would-you-treat-klebsiella-aerogenes-folliculitis-of-the-face-manifesting-as-a-cystic-lesion weekly 0.8 https://www.themednet.org/for-patients-with-essential-thrombocythemia-who-develop-venous-thrombosis-in-the-setting-of-elevated-platelet-counts-would-you-continue-lifelong-anticoagulation-even-after-cytoreduction-is-achieved weekly 0.8 https://www.themednet.org/what-is-your-preferred-vmat2-inhibitor-to-treat-tardive-dyskinesia-tetrabenazine-valbenazine-or-deutetrabenazine weekly 0.8 https://www.themednet.org/do-you-perform-genetic-testing-when-patients-have-persistent-hypogammaglobulinemia-after-rituximab-therapy weekly 0.8 https://www.themednet.org/how-do-you-reconcile-differences-between-spt-and-serum-ige-testing-for-aeroallergens-when-preparing-ait weekly 0.8 https://www.themednet.org/which-types-of-patients-do-you-treat-with-prolonged-antibiotics-before-obtaining-a-ct-sinus weekly 0.8 https://www.themednet.org/is-there-a-role-for-use-of-dupilumab-for-hypereosinophilic-gi-disorders-distal-to-the-esophagus weekly 0.8 https://www.themednet.org/what-vit-would-you-recommend-in-a-patient-who-had-grade-5-anaphylaxis-to-a-stinging-insect-but-negative-idt-and-serum-ige weekly 0.8 https://www.themednet.org/how-do-you-adjust-the-loading-and-maintenance-doses-for-keppra-when-treating-status-epilepticus-in-patients-with-esrd-patients-on-hd-or-patients-on-cvvh weekly 0.8 https://www.themednet.org/with-the-recent-approvals-of-car-t-for-second-line-therapy-in-myeloma-does-this-change-your-approach-to-use-of-consolidative-autologous-transplant-or-autologous-transplant-as-second-line-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-using-dmards-for-patients-with-cpp-arthritis-who-have-frequent-flares weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-chemotherapy-to-patients-with-rectal-cancer-who-were-on-watch-and-wait-had-local-recurrence-and-underwent-resection weekly 0.8 https://www.themednet.org/do-you-delay-pegloticase-in-a-patient-with-an-active-gout-flare weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-ra-stable-on-csdmards-on-whether-to-attempt-tapering-or-not weekly 0.8 https://www.themednet.org/do-you-avoid-tocilizumab-in-patients-with-prior-bariatric-surgery-given-the-risk-of-gi-perforation weekly 0.8 https://www.themednet.org/what-parameters-would-you-use-to-monitor-and-interpret-iron-levels-in-a-hemochromatosis-patient-where-ferritin-is-unreliable-due-to-underlying-chronic-inflammation weekly 0.8 https://www.themednet.org/will-you-use-vadadustat-in-place-of-an-esa-in-treating-anemia-of-chronic-kidney-disease weekly 0.8 https://www.themednet.org/would-you-re-irradiate-a-spleen-with-increasing-splenomegaly-for-a-patient-with-myelofibrosis weekly 0.8 https://www.themednet.org/do-you-recommend-antibiotic-prophylaxis-for-an-eskd-patient-with-a-tunneled-dialysis-catheter-who-is-planned-for-a-dental-procedure weekly 0.8 https://www.themednet.org/how-do-you-differentiate-demoralization-from-depression-during-cancer-treatment weekly 0.8 https://www.themednet.org/how-do-you-approach-managing-depression-symptoms-in-patients-who-have-had-repeated-high-risk-of-bleeding-2 weekly 0.8 https://www.themednet.org/how-do-you-manage-tacrolimus-related-psychosis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-assessing-traumatic-exposure-in-children weekly 0.8 https://www.themednet.org/how-do-you-counsel-elderly-patients-who-demonstrate-mild-cognitive-impairment-but-do-not-meet-the-criteria-for-a-neurocognitive-disorder weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-buprenorphine-naloxone-in-pregnant-and-breastfeeding-patients weekly 0.8 https://www.themednet.org/how-do-you-differentiate-postpartum-psychosis-from-postpartum-obsessive-compulsive-disorder weekly 0.8 https://www.themednet.org/is-keratosis-follicularis-darier-disease-a-contraindication-to-the-receipt-of-pmrt weekly 0.8 https://www.themednet.org/what-are-the-best-biologics-for-a-pediatric-patient-with-extensive-guttate-psoriasis-that-is-poorly-controlled-on-topicals weekly 0.8 https://www.themednet.org/are-there-additional-risks-associated-with-pmrt-for-a-patient-with-prior-lympho-venous-bypass-surgery weekly 0.8 https://www.themednet.org/what-prompts-you-to-consider-prescribing-different-formulations-of-benzodiazepines-for-a-seizure-rescue-medication weekly 0.8 https://www.themednet.org/is-there-a-role-for-radiation-in-palliating-malignant-small-bowel-obstruction weekly 0.8 https://www.themednet.org/what-is-your-approach-to-anticoagulation-in-a-patient-with-aki-and-cirrhosis-who-has-frequent-filter-clotting-on-crrt weekly 0.8 https://www.themednet.org/how-would-you-approach-a-young-patient-with-bilateral-lower-extremity-muscle-weakness-and-positive-anti-smith-dsdna-rnp-raynauds-and-pericardial-effusion-but-normal-muscle-enzymes weekly 0.8 https://www.themednet.org/do-you-recommend-automatically-starting-crrt-anticoagulation-when-initiating-crrt-if-there-are-no-medical-contraindications-to-anticoagulation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-sbrt-to-an-entire-kidney-infiltrated-with-rcc weekly 0.8 https://www.themednet.org/would-45-gy-to-the-pelvis-be-sufficient-for-a-locally-advanced-rectal-cancer-that-has-a-complete-metabolic-response-to-tnt weekly 0.8 https://www.themednet.org/what-is-your-planning-approach-for-sbrt-when-the-tumor-abuts-the-great-vessels-such-as-aortic-arch-or-svc weekly 0.8 https://www.themednet.org/what-typical-lab-tests-do-you-send-off-for-evaluation-of-neuropathy weekly 0.8 https://www.themednet.org/would-you-recommend-initiating-a-sglt2i-for-proteinuria-secondary-to-bevacizumab-in-a-patient-who-has-a-sub-optimal-response-to-an-acei-or-arb weekly 0.8 https://www.themednet.org/what-is-your-approach-to-prednisone-use-in-a-kidney-transplant-recipient-with-allograft-failure-residual-allograft-function-and-an-ongoing-dialysis-requirement-for-more-than-one-year weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-metformin-in-the-management-of-prediabetes-for-patients-who-are-neither-obese-nor-have-a-family-history-of-diabetes weekly 0.8 https://www.themednet.org/have-you-used-oral-vancomycin-as-prophylaxis-for-c-difficile-infection-in-patients-admitted-for-allogeneic-hematopoietic-cell-transplant weekly 0.8 https://www.themednet.org/how-do-you-read-a-pft-with-restrictive-type-spirometry-but-normal-lung-volumes weekly 0.8 https://www.themednet.org/how-are-you-counseling-your-patients-with-als-taking-sodium-phenylbutyrate-and-taurursodiol-on-continuing-treatment-in-light-of-the-negative-phase-3-trial-results weekly 0.8 https://www.themednet.org/what-leads-you-to-consider-a-non-oral-form-of-levodopa-for-the-treatment-of-parkinsons-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-a-pregnant-patient-with-lupus-who-develops-renal-disease-during-pregnancy-that-is-not-due-to-pre-eclampsia weekly 0.8 https://www.themednet.org/how-do-you-approach-discussing-the-pill-burden-of-voclosporin-with-patients-who-already-have-to-take-a-regimen-such-as-mmf-hcq-acei-and-possibly-more weekly 0.8 https://www.themednet.org/what-drives-you-to-choose-voclospsorin-over-tacrolimus-given-the-substantially-higher-cost weekly 0.8 https://www.themednet.org/do-you-have-a-higher-threshold-regarding-when-to-hold-bevacizumab-for-proteinuria-in-patients-who-had-known-baseline-proteinuria-from-diabetic-nephropathy weekly 0.8 https://www.themednet.org/do-you-consider-randalls-plaque-as-a-form-of-nephrocalcinosis-necessitating-genetic-testing-for-monogenic-kidney-stone-disorders weekly 0.8 https://www.themednet.org/which-fracture-sites-outside-of-the-classical-spine-and-hip-are-considered-to-be-osteoporotic-fractures-even-in-the-absence-of-a-bone-density-diagnosis weekly 0.8 https://www.themednet.org/would-you-treat-elderly-patients-with-early-stage-gastric-cancer-with-perioperative-folfox-or-flo-flot-without-t weekly 0.8 https://www.themednet.org/how-has-the-recent-fda-approval-of-tovorafenib-impacted-your-treatment-decisions-for-pediatric-patients-with-relapsed-refractory-low-grade-glioma weekly 0.8 https://www.themednet.org/what-is-the-earliest-you-would-start-postmastectomy-radiation-after-adjuvant-chemotherapy-for-a-patient-with-breast-cancer weekly 0.8 https://www.themednet.org/how-does-pirtobrutinib-compare-to-other-available-therapies-for-relapsed-refractory-cll-after-btk-inhibitor-treatment-particularly-in-terms-of-efficacy-and-tolerability weekly 0.8 https://www.themednet.org/does-tolerance-of-prior-btki-therapy-or-specific-agent-used-e-g-ibrutinib-acalabrutinib-influence-your-starting-dose-of-pirtobrutinib weekly 0.8 https://www.themednet.org/is-there-any-utility-to-trending-histoplasma-serology-titers-to-guide-duration-of-therapy-or-treatment-response-for-pulmonary-histoplasmosis-with-negative-urine-antigen weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiation-therapy-in-a-young-adult-with-nf1-who-has-a-craniopharyngioma-s-p-str weekly 0.8 https://www.themednet.org/do-you-counsel-isotretinoin-patients-to-use-otc-antihistamines-and-omega-3-to-decrease-purging-and-mucocutaneous-dryness weekly 0.8 https://www.themednet.org/in-which-patients-with-essential-thrombocythemia-would-you-use-ropeginterferon-alfa-2b weekly 0.8 https://www.themednet.org/what-would-be-your-advice-to-providers-who-are-wary-of-qtc-prolongation-after-starting-an-amiodarone-load-and-wish-to-discontinue-it weekly 0.8 https://www.themednet.org/would-you-omit-radiation-for-an-elderly-woman-with-bilateral-breast-cancers-both-early-stage-disease-and-er-pr-her2-negative-who-otherwise-meets-the-criteria-for-endocrine-therapy-alone weekly 0.8 https://www.themednet.org/would-you-use-bevacizumab-in-a-metastatic-ras-mutant-colon-cancer-if-the-patient-had-a-colon-perforation-that-was-resected weekly 0.8 https://www.themednet.org/do-you-recommend-careful-correction-of-serum-sodium-to-avoid-osmotic-demyelination-syndrome-in-patients-who-are-found-to-have-isoosmolar-hyponatremia-in-the-setting-of-an-elevated-bun-level weekly 0.8 https://www.themednet.org/what-was-the-rationale-behind-using-rano-hgg-criteria-instead-of-rapno-criteria-for-the-primary-endpoint-in-the-firefly-1-trial-for-plgg weekly 0.8 https://www.themednet.org/based-on-the-firefly-1-data-would-you-consider-using-tovorafenib-monotherapy-front-line-in-pediatric-patients-who-have-low-grade-gliomas-that-are-only-amenable-to-subtotal-resection-or-are-unresectable weekly 0.8 https://www.themednet.org/what-are-the-indications-for-postoperative-radiation-for-extramammary-pagets-disease weekly 0.8 https://www.themednet.org/how-do-you-decide-on-initial-and-sequential-anti-cd20-therapy-for-patients-with-multiple-sclerosis-given-the-availability-of-rituximab-ocrelizumab-ublituximab-and-ofatumumab weekly 0.8 https://www.themednet.org/what-advice-do-you-offer-to-patients-with-recurrent-nephrolithiasis-who-are-on-a-tube-feeding-diet-and-seeking-stone-prevention-guidance weekly 0.8 https://www.themednet.org/is-the-phosphorus-lowering-benefit-of-patiromer-compelling-enough-to-switch-a-patient-with-chronic-hyperkalemia-and-hyperphosphatemia-from-sodium-zirconium-cyclosilicate-to-patiromer weekly 0.8 https://www.themednet.org/what-instances-will-you-start-outpatient-steroids-in-patients-with-nephrotic-syndrome-of-unknown-etiology-prior-to-obtaining-a-kidney-biopsy weekly 0.8 https://www.themednet.org/what-is-your-pth-target-for-patients-with-eskd-and-brown-tumor weekly 0.8 https://www.themednet.org/what-is-your-blood-pressure-threshold-to-hold-an-esa-for-patients-with-eskd-anemia-and-hypertension weekly 0.8 https://www.themednet.org/do-you-routinely-continue-patients-on-anti-pd-l-1-beyond-2-years-of-treatment-while-on-io-tki-for-metastatic-ccrcc weekly 0.8 https://www.themednet.org/do-you-prefer-using-unfractionated-heparin-or-low-molecular-weight-heparin-in-stable-patients-presenting-with-nste-acs-awaiting-primary-pci-assuming-normal-renal-function weekly 0.8 https://www.themednet.org/do-you-consider-ablative-radiation-therapy-for-oligometastatic-colon-cancer-with-5-pulmonary-lesions-responding-to-chemotherapy weekly 0.8 https://www.themednet.org/do-you-prefer-a-loading-dose-of-300mg-or-600mg-plavix-for-patients-presenting-with-nstemi-or-unstable-angina-about-to-undergo-lhc weekly 0.8 https://www.themednet.org/for-ultracentral-lung-cancer-abutting-the-heart-what-dose-constraints-would-you-use-for-the-heart-and-bronchus-if-using-10-fraction-ultrahypofractionation weekly 0.8 https://www.themednet.org/what-recommendations-do-you-have-regarding-the-use-of-dronabinol-to-prevent-cannabis-withdrawal-in-an-inpatient-medical-or-psychiatric-setting weekly 0.8 https://www.themednet.org/what-cosmetic-treatments-have-you-had-success-with-in-treating-dermatofibromas weekly 0.8 https://www.themednet.org/in-pediatric-patients-with-low-grade-gliomas-showing-prolonged-response-or-stable-disease-on-tovorafenib-how-would-you-adjust-the-duration-of-therapy weekly 0.8 https://www.themednet.org/in-patients-with-multiple-basal-cell-carcinoma-lesions-on-vismodegib-would-you-hold-vismodegib-while-delivering-radiation-therapy-to-one-locally-advanced-bcc-lesion-that-was-not-amenable-to-surgery weekly 0.8 https://www.themednet.org/at-what-age-do-you-stop-ldct-chest-for-lung-cancer-screening weekly 0.8 https://www.themednet.org/how-would-you-sequence-parpi-vs-pembrolizumab-for-a-patient-who-has-progressed-on-arpi-to-mcrpc-that-has-somatic-palb2-mutation-and-msi-h weekly 0.8 https://www.themednet.org/do-you-recommend-lifelong-antibiotic-prophylaxis-or-do-you-prefer-a-more-selective-approach-based-on-risk-factors-in-asplenic-patients-without-a-history-of-severe-infections weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-recommend-early-fecal-microbiota-transplantation-over-antibiotic-treatment-or-bezlotoxumab-in-a-patient-with-recurrent-c-difficile-infection weekly 0.8 https://www.themednet.org/how-would-you-consolidate-a-patient-with-primary-refractory-double-hit-lymphoma-with-secondary-cns-involvement weekly 0.8 https://www.themednet.org/would-you-recommend-post-operative-radiation-in-an-adult-patient-with-a-thoracic-spine-osteosarcoma weekly 0.8 https://www.themednet.org/is-the-adage-if-gcs-8-intubate-still-relevant-for-non-tbi-patients weekly 0.8 https://www.themednet.org/do-you-administer-prophylactic-antibiotics-to-prevent-vap-following-intubation-in-patients-with-acute-brain-injury weekly 0.8 https://www.themednet.org/do-you-check-epo-levels-in-patients-with-anemia-of-chronic-kidney-disease weekly 0.8 https://www.themednet.org/is-there-a-role-for-24-hour-urine-stone-risk-profiles-in-your-patients-with-known-recurrent-struvite-kidney-stones weekly 0.8 https://www.themednet.org/how-would-you-manage-a-middle-aged-patient-with-pagets-disease-who-received-one-dose-of-zolendronic-acid-2-years-ago-currently-suppressed-ctx-normal-bone-specific-alkaline-phos-and-a-recent-hairline-fracture-in-the-thoracic-spine weekly 0.8 https://www.themednet.org/do-you-recommend-concurrent-cisplatin-and-gemcitabine-with-radiotherapy-for-unresectable-vulvar-cancer-as-described-in-gog-279 weekly 0.8 https://www.themednet.org/is-there-increased-risk-with-lung-sbrt-in-a-patient-who-has-a-mild-asymptomatic-pneumothorax-in-the-field-after-ct-guided-needle-biopsy weekly 0.8 https://www.themednet.org/would-you-uptitrate-methotrexate-dosing-when-a-patient-flares-on-a-tnfi-and-methotrexate-15-mg-weekly weekly 0.8 https://www.themednet.org/do-you-recommend-re-excision-of-a-unifocal-positive-anterior-margin-at-skin-after-lumpectomy-in-a-patient-with-otherwise-low-risk-breast-cancer-features weekly 0.8 https://www.themednet.org/based-on-the-dreamm-7-and-dreamm-8-data-if-approved-again-in-the-us-how-would-you-incorporate-belantamab-mafadotin-in-your-practice weekly 0.8 https://www.themednet.org/is-there-any-role-for-immunosuppressive-therapy-in-patients-with-primary-sjogrens-disease-with-severe-pulmonary-artery-hypertension-without-ild-findings weekly 0.8 https://www.themednet.org/what-changes-do-you-make-in-the-management-of-non-endemic-nasopharynx-cancer-compared-to-endemic weekly 0.8 https://www.themednet.org/is-there-any-role-for-25-oh-vitamin-d-testing-in-patients-older-than-75-years-old-in-the-general-population weekly 0.8 https://www.themednet.org/in-those-patients-who-are-initiated-on-omalizumab-for-multiple-food-allergies-once-baked-egg-and-baked-milk-are-introduced-into-the-diet-do-you-rely-upon-skin-prick-testing-and-or-immunocap-testing-in-order-to-make-the-decision-to-introduce-prepared-egg-o weekly 0.8 https://www.themednet.org/do-you-rule-out-active-urinary-tract-infections-prior-to-performing-a-kidney-biopsy weekly 0.8 https://www.themednet.org/how-do-you-decide-between-ceftolozane-tazobactam-and-ceftazidime-avibactam-for-empiric-treatment-of-an-infection-due-to-difficult-to-treat-pseudomonas-aeruginosa-while-awaiting-additional-susceptibilities weekly 0.8 https://www.themednet.org/what-are-the-clinical-indications-and-major-limitations-of-lipoprotein-apheresis weekly 0.8 https://www.themednet.org/what-is-the-therapeutic-role-and-blood-glucose-lowering-capability-of-bromocriptine-and-cholestyramine-for-the-treatment-of-type-2-diabetes weekly 0.8 https://www.themednet.org/do-you-perform-a-kidney-ultrasound-in-patients-following-a-kidney-biopsy-to-evaluate-for-post-procedural-complications weekly 0.8 https://www.themednet.org/would-you-consider-partial-breast-irradiation-in-patients-who-otherwise-meet-pbi-guidelines-who-have-a-pathogenic-variant-of-chek2-or-other-moderate-penetrance-gene weekly 0.8 https://www.themednet.org/do-you-treat-prosthetic-joint-infections-after-a-two-stage-revision-arthroplasty-with-oral-antibiotics-for-the-full-duration-of-therapy-assuming-a-susceptible-oral-option-is-available weekly 0.8 https://www.themednet.org/how-do-you-treat-depression-symptoms-in-patients-with-parkinsons-disease weekly 0.8 https://www.themednet.org/how-would-you-treat-iib-ovarian-carcinosarcoma-which-recurred-locally-at-1-month-post-initial-debulking-surgery-progressed-through-2-cycles-of-adjuvant-carbo-taxol-and-is-now-s-p-repeat-debulking weekly 0.8 https://www.themednet.org/do-you-prefer-performing-a-kidney-biopsy-on-the-left-or-right-kidney-if-both-kidneys-appear-similar-on-pre-biopsy-imaging weekly 0.8 https://www.themednet.org/is-it-safe-to-continue-administering-prolia-per-schedule-for-osteoporosis-treatment-shortly-after-a-patient-has-undergone-extensive-spinal-surgery weekly 0.8 https://www.themednet.org/should-one-perform-a-subsequent-screening-cta-or-mra-head-for-mycotic-aneurysm-after-cardio-embolic-strokes-in-a-setting-of-endocarditis-with-initial-unremarkable-cta-or-mra-head-neck weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-a-new-sle-patient-presenting-with-lupus-podocytopathy-with-fsgs-and-severe-proteinuria-pr-cr-18-without-immune-complex-deposition weekly 0.8 https://www.themednet.org/do-you-recommend-parathyroid-imaging-testing-for-patients-with-recurrent-nephrolithiasis-who-are-incidentally-found-to-have-an-elevated-pth-but-who-do-not-have-hypercalciuria-hypercalcemia-hypovitaminosis-d-or-chronic-kidney-disease weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-anti-scl70-ab-positive-sine-scleroderma-complicated-by-ild-who-also-has-seropositive-ra-with-active-arthritis weekly 0.8 https://www.themednet.org/when-do-you-recommend-plasmapheresis-plasma-exchange-for-management-of-severe-hypertriglyceridemia weekly 0.8 https://www.themednet.org/what-is-your-preferred-add-on-for-membranous-lupus-nephritis-2-2-grams-of-protein-normal-creatinine-in-a-young-woman-who-is-currently-on-hydroxychloroquine-and-mycophenolate-1500-mg-2x-daily weekly 0.8 https://www.themednet.org/what-immunosuppression-regimens-do-you-use-in-patients-with-progressive-rb-ild-despite-smoking-cessation-and-prednisone weekly 0.8 https://www.themednet.org/do-you-avoid-hyaluronic-acid-injections-in-patients-with-chondrocalcinosis-on-imaging weekly 0.8 https://www.themednet.org/do-you-prefer-telmisartan-over-other-arbs-given-its-longer-half-life-elimination weekly 0.8 https://www.themednet.org/what-are-the-advantages-disadvantages-of-using-static-imrt-vs-vmat-when-treating-breast-cancer weekly 0.8 https://www.themednet.org/are-there-situations-in-which-you-treat-calcinosis-cutis-that-is-not-symptomatic-for-the-patient weekly 0.8 https://www.themednet.org/what-is-your-preferred-fill-volume-dialysis-solution-and-dwell-time-for-patients-with-suspected-peritoneal-dialysis-associated-peritonitis-who-arrive-to-the-hospital-with-a-dry-abdomen weekly 0.8 https://www.themednet.org/when-do-you-start-cyclophosphamide-for-the-treatment-of-anti-nmda-receptor-encephalitis weekly 0.8 https://www.themednet.org/when-do-you-offer-tnk-for-ischemic-stroke-patients-with-a-large-vessel-occlusion-presenting-outside-the-4-5-hour-window weekly 0.8 https://www.themednet.org/would-you-add-cholecalciferol-or-ergocalciferol-to-calcitriol-therapy-in-patients-with-post-operative-hypoparathyroidism-who-have-low-25-oh-vitamin-d-levels weekly 0.8 https://www.themednet.org/are-there-instances-when-you-recommend-performing-a-kidney-biopsy-in-patients-with-presumed-acute-interstitial-nephritis-who-are-already-on-steroids-and-have-improving-renal-function weekly 0.8 https://www.themednet.org/what-experience-do-you-have-with-paralysis-or-myasthenia-like-symptoms-developing-on-temozolomide weekly 0.8 https://www.themednet.org/is-there-a-role-for-nitazoxanide-for-treatment-of-norovirus-gastroenteritis-in-immunocompromised-patients weekly 0.8 https://www.themednet.org/would-you-favor-stopping-low-dose-aspirin-and-continuing-oac-alone-in-a-patient-with-atrial-fibrillation-and-mild-coronary-artery-calcification-seen-on-routine-chest-imaging weekly 0.8 https://www.themednet.org/are-there-any-circumstances-in-which-you-would-consider-pci-for-cav-especially-for-focal-tubular-lesions-if-the-patient-is-a-candidate-for-re-transplantation weekly 0.8 https://www.themednet.org/what-treatment-do-you-use-for-stroke-prevention-in-cervical-artery-dissection weekly 0.8 https://www.themednet.org/what-dose-would-you-use-to-treat-unresectable-basal-cell-carcinoma-of-the-vulva weekly 0.8 https://www.themednet.org/in-a-patient-with-isolated-hla-b27-anterior-uveitis-how-long-would-you-continue-immunosuppressive-therapy weekly 0.8 https://www.themednet.org/when-do-you-consider-using-setmelanotide-for-treatment-of-hypothalamic-obesity weekly 0.8 https://www.themednet.org/in-which-cases-would-you-consider-early-transition-to-doac-within-72-hours-for-hospitalized-patients-with-intermediate-or-high-risk-pe weekly 0.8 https://www.themednet.org/when-considering-a-biologic-for-seropositive-ra-after-failure-of-methotrexate-or-triple-therapy-do-you-consider-using-abatacept-as-a-first-line-biologic-or-would-prefer-choosing-tnfi weekly 0.8 https://www.themednet.org/how-would-you-approach-pursuing-a-kidney-biopsy-in-a-patient-with-suspected-lupus-nephritis-who-is-on-warfarin-for-antiphospholipid-antibody-syndrome weekly 0.8 https://www.themednet.org/would-you-switch-azathioprine-to-a-different-immunosuppressant-if-a-controlled-patient-with-sle-develops-melanoma-and-or-non-melanoma-skin-cancer weekly 0.8 https://www.themednet.org/do-you-have-patients-with-recurrent-calcium-oxalate-kidney-stones-stop-taking-supplements-containing-vitamin-c-if-their-24-hour-urine-oxalate-excretion-is-normal weekly 0.8 https://www.themednet.org/would-you-consider-splenic-radiation-in-stage-iv-cd5-dlbcl-involving-the-bone-marrow-in-patients-who-initially-presented-with-symptomatic-splenomegaly-anemia-and-thrombocytopenia-but-achieved-complete-response-on-pet-after-6-cycles-of-r-minichop weekly 0.8 https://www.themednet.org/would-you-use-the-pneumococcal-conjugate-21-vaccine-capvaxive-instead-of-the-conjugate-20-prevnar-20-for-routine-vaccinations-in-immunosuppressed-patients weekly 0.8 https://www.themednet.org/what-is-the-clinical-importance-of-differentiating-between-impaired-glucose-tolerance-igt-and-impaired-fasting-glucose-ifg-states weekly 0.8 https://www.themednet.org/in-patients-with-sicca-symptoms-and-positive-ssa-ssb-how-often-do-you-perform-other-diagnostic-testing-such-as-salivary-gland-ultrasound-biopsy-shirmers-ocular-staining-stimulated-salivary-flow-etc weekly 0.8 https://www.themednet.org/what-are-the-indications-for-use-of-inclisiran-over-anti-pcsk9-monoclonal-antibody-therapies weekly 0.8 https://www.themednet.org/do-you-recommend-endovascular-therapy-in-patients-with-isolated-posterior-cerebral-artery-stroke weekly 0.8 https://www.themednet.org/for-patients-over-90-years-old-is-there-any-foreseeable-benefit-to-undergoing-left-atrial-appendage-occlusion-over-permanent-cessation-of-anticoagulation-particularly-for-those-at-high-risk-for-major-bleeding weekly 0.8 https://www.themednet.org/how-to-approach-reversal-of-tnk-in-hemorrhagic-conversion-of-ischemic-stroke weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-tdm-1-to-a-patient-with-her2-positive-breast-cancer-s-p-nac-with-tchp-found-to-have-no-residual-disease-in-the-breast-but-presence-of-itcs-ypn0-i-in-one-axillary-lymph-node weekly 0.8 https://www.themednet.org/what-are-your-management-strategies-for-patients-with-biopsy-proven-iga-nephropathy-with-rapidly-progressive-glomerulonephritis weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-family-history-of-protein-s-deficiency-now-with-provoked-vte-and-low-protein-s weekly 0.8 https://www.themednet.org/for-patients-with-sle-is-there-an-anc-level-for-which-you-would-hold-or-adjust-hydroxychloroquine-in-an-asymptomatic-patient weekly 0.8 https://www.themednet.org/for-srs-do-you-prefer-fixed-kv-imaging-e-g-exactrac-or-cone-beam-ct weekly 0.8 https://www.themednet.org/what-data-support-the-use-of-continuing-gnrh-therapy-backbone-in-metastatic-castration-resistant-prostate-cancer-mcrpc-receiving-additional-therapies weekly 0.8 https://www.themednet.org/for-patients-with-essential-thrombocythemia-already-on-prophylactic-dose-doacs-do-you-defer-starting-aspirin weekly 0.8 https://www.themednet.org/would-you-prescribe-tkis-for-stage-iv-differentiated-thyroid-cancer-patients-who-are-rai-naive-with-preserved-performance-status-and-are-not-eligible-for-surgery weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-duration-for-patients-with-persistent-candida-species-fungemia-with-a-history-of-a-prosthetic-heart-valve-but-negative-tee-ct-pet-and-no-other-identifiable-source-of-infection weekly 0.8 https://www.themednet.org/would-you-recommend-normal-saline-for-pre-and-post-lhc-hydration-in-patients-with-ckd-stage-iii-to-iv-with-reduced-lv-systolic-function-and-if-so-what-is-a-reasonable-amount-of-volume weekly 0.8 https://www.themednet.org/what-postural-change-in-fvc-is-suggestive-of-respiratory-muscle-weakness weekly 0.8 https://www.themednet.org/how-would-you-approach-dose-modifications-and-or-frequency-of-lenalidomide-in-patients-with-advanced-renal-impairment-egfr-30 weekly 0.8 https://www.themednet.org/how-do-you-decide-between-internal-versus-external-decompression-of-malignant-obstruction-of-the-ureter-muo weekly 0.8 https://www.themednet.org/what-techniques-do-you-use-in-the-lab-to-reduce-the-amount-of-contrast-that-needs-to-be-used-in-patients-with-ckd weekly 0.8 https://www.themednet.org/how-do-you-decide-between-administering-or-deferring-upstream-p2y12-inhibitor-treatment-until-patient-is-in-the-lab-for-nstemi-or-stemi-cases-with-unknown-coronary-anatomy weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-glp-1-r-agonist-therapy-for-obese-women-with-pcos-who-are-actively-trying-to-conceive weekly 0.8 https://www.themednet.org/do-you-recommend-daily-topical-exit-site-antibiotic-use-for-patients-with-a-peritoneal-dialysis-catheter-that-is-only-currently-being-accessed-for-once-weekly-flushes weekly 0.8 https://www.themednet.org/do-you-routinely-treat-chronic-sacral-osteomyelitis-when-there-is-no-plan-for-debridement-or-flap weekly 0.8 https://www.themednet.org/if-a-patient-who-has-tolerated-allopurinol-for-a-prolonged-period-of-time-is-subsequently-found-to-be-positive-for-the-hla-b-58-01-gene-how-would-you-manage-urate-lowering-therapy-thereafter weekly 0.8 https://www.themednet.org/should-presence-of-coronary-artery-calcifications-on-ct-cta-be-considered-as-presence-of-vascular-disease-on-cha2ds2-vasc-score weekly 0.8 https://www.themednet.org/which-patients-would-benefit-most-from-teplizumab-therapy-to-delay-the-onset-of-t1dm weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-well-controlled-hiv-on-biktarvy-who-is-interested-in-switching-to-injectable-haart-but-also-has-a-history-of-a-prior-hepatitis-b-infection weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-young-male-patient-with-discoid-lupus-who-has-had-minimal-response-to-hydroxychloroquine-and-subtherapeutic-whole-blood-levels-who-continues-to-use-tobacco-products weekly 0.8 https://www.themednet.org/how-do-you-treat-severe-vaginal-stenosis-after-radiation-in-a-patient-that-is-already-compliant-with-dilators weekly 0.8 https://www.themednet.org/do-you-routinely-perform-echocardiography-in-patients-with-staphylococcus-aureus-bacteremia-deemed-low-risk-for-metastatic-infection-or-do-you-selectively-omit-it-based-on-specific-clinical-criteria weekly 0.8 https://www.themednet.org/would-you-consider-prophylactic-metformin-as-an-anti-aging-treatment weekly 0.8 https://www.themednet.org/do-you-avoid-terlipressin-for-patients-with-hepatorenal-syndrome-who-have-a-serum-sodium-level-less-than-125-meq-l weekly 0.8 https://www.themednet.org/when-treating-a-high-rectal-cancer-does-your-coverage-of-the-caudal-mesorectum-depend-on-the-surgical-plan weekly 0.8 https://www.themednet.org/what-is-the-maximum-dose-of-leucovorin-that-you-use-with-methotrexate weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-who-develop-aria-e-or-aria-h-during-treatment-with-anti-amyloid-therapies weekly 0.8 https://www.themednet.org/how-do-you-medically-manage-acute-basilar-artery-occlusion-in-patients-with-low-nihss-who-are-not-candidates-for-evt-but-at-risk-for-deterioration weekly 0.8 https://www.themednet.org/is-there-any-data-to-use-pik3ca-directed-agents-in-mutated-metastatic-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/what-laboratory-workup-do-you-perform-in-patients-with-symptoms-consistent-with-erythromelalgia weekly 0.8 https://www.themednet.org/do-you-recommend-hyaluronic-acid-therapy-for-vaginal-dryness-in-female-patients-post-pelvic-rt weekly 0.8 https://www.themednet.org/under-what-circumstances-do-you-consider-valacyclovir-for-the-management-of-vzv-disease-of-the-cns weekly 0.8 https://www.themednet.org/how-does-comorbid-epilepsy-influence-your-decision-on-antipsychotic-medications weekly 0.8 https://www.themednet.org/would-you-recommend-surgery-or-stereotactic-radiation-therapy-for-a-young-woman-with-high-grade-serous-ovarian-cancer-presenting-with-a-pelvic-ln-oligometastasis-following-maintenance-therapy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-middle-thoracic-esophageal-squamous-cell-carcinoma-tumor-is-25-30-cm-from-carina-with-a-positive-supra-clavicular-lymph-node weekly 0.8 https://www.themednet.org/when-do-you-recommend-screening-patients-with-t2dm-for-heart-failure weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-her2-positive-cns-only-progression-on-fam-trastuzumab-which-had-previously-progressed-on-tucatinib-capecitabine-trastuzumab-and-has-failed-both-srs-and-wbrt weekly 0.8 https://www.themednet.org/what-radiation-dose-would-you-use-to-treat-a-symptomatic-osseous-lesion-secondary-to-al-amyloidosis weekly 0.8 https://www.themednet.org/would-you-consider-the-use-of-pembrolizumab-lenvatinib-after-progression-on-first-line-carboplatin-paclitaxel-immunotherapy-for-metastatic-endometrial-cancer weekly 0.8 https://www.themednet.org/can-cardioversion-be-safely-performed-for-recurrent-atrial-fibrillation-in-patients-who-have-undergone-left-atrial-appendage-clipping-during-cabg-if-they-are-not-on-chronic-anticoagulation-anymore weekly 0.8 https://www.themednet.org/what-is-the-recommended-approach-for-systemic-therapy-in-a-patient-with-metastatic-cutaneous-squamous-cell-carcinoma-with-active-autoimmune-disease-dermatomyositis weekly 0.8 https://www.themednet.org/is-there-a-correlation-with-severity-of-rash-as-an-adverse-event-and-response-rate-with-capivasertib weekly 0.8 https://www.themednet.org/when-treating-pancreatic-body-tail-lesions-that-result-in-significant-dose-spread-to-the-spleen-what-is-your-threshold-to-offer-pneumococcal-hemophilus-influenza-and-meningococcal-vaccines weekly 0.8 https://www.themednet.org/would-you-offer-12-16-gy-in-a-single-fraction-for-a-symptomatic-non-vertebral-bone-metastasis weekly 0.8 https://www.themednet.org/in-patients-with-possible-bartonella-henselae-infection-and-elevated-igg-titer-what-is-the-best-way-to-confirm-the-diagnosis-tissue-biopsy-with-warthin-starry-staining-tissue-sent-for-bartonella-henselae-pcr-or-tissue-sent-for-culture weekly 0.8 https://www.themednet.org/what-is-are-your-preferred-technique-s-for-obtaining-lv-ao-pressure-gradients-in-the-cath-lab weekly 0.8 https://www.themednet.org/what-prompts-you-to-procure-eeg-and-or-imaging-in-patients-presenting-with-multiple-simple-febrile-seizures weekly 0.8 https://www.themednet.org/how-would-you-approach-the-workup-of-unilateral-chorea-with-a-normal-mri weekly 0.8 https://www.themednet.org/which-interventions-have-you-found-effective-for-managing-sensory-sensitivities-in-children-with-autism-spectrum-disorder weekly 0.8 https://www.themednet.org/does-food-sensitivity-testing-for-igg-subclasses-help-guide-your-management-of-food-allergy weekly 0.8 https://www.themednet.org/how-do-you-approach-long-term-blood-pressure-parameters-in-ischemic-stroke-patients-with-severe-symptomatic-intracranial-stenosis weekly 0.8 https://www.themednet.org/do-you-still-offer-adjuvant-chemotherapy-and-chemoradiation-for-nsclc-after-neoadjuvant-chemoimmunotherapy weekly 0.8 https://www.themednet.org/is-adequate-bp-control-sufficient-enough-when-titrating-spironolactone-therapy-for-primary-hyperaldosteronism-treatment weekly 0.8 https://www.themednet.org/in-a-patient-with-anaphylaxis-and-loss-of-consciousness-from-stinging-insect-suspected-to-be-yellow-jacket-the-sige-was-significantly-positive-to-all-vespids-but-honeybee-and-paper-wasp-were-only-0-44-would-you-evaluate-further-with-skin-testing-to-wasp-a weekly 0.8 https://www.themednet.org/are-there-any-concerns-with-live-vaccine-innoculation-and-patients-who-are-on-denosumab weekly 0.8 https://www.themednet.org/is-there-data-to-support-worse-surgical-outcomes-in-short-course-rt-followed-by-surgery-vs-long-course-chemoradiation-followed-by-surgery-in-rectal-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-a-borderline-resectable-pancreatic-cancer-s-p-induction-chemo-chemo-rt-who-was-unable-to-go-to-surgery weekly 0.8 https://www.themednet.org/would-you-consider-using-ldrt-for-joint-pain-arthritis-caused-by-aromatase-inhibitors-as-a-means-to-keep-patients-on-therapy weekly 0.8 https://www.themednet.org/how-do-you-counsel-and-manage-patients-who-meet-criteria-for-sleep-apnea-based-on-3-but-not-4-desaturation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-acidic-urine-in-patients-with-recurrent-uric-acid-nephrolithiasis-who-have-normal-urinary-citrate-levels weekly 0.8 https://www.themednet.org/would-you-recommend-rai-ablation-therapy-to-patients-with-ptc-who-are-s-p-hemi-thyroidectomy-and-decline-completion-thyroidectomy-despite-meeting-criteria-based-on-pathology-results weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-request-to-decrease-hemodialysis-time-when-kt-v-values-are-above-target-but-serum-phosphorus-remains-poorly-controlled weekly 0.8 https://www.themednet.org/do-you-offer-hormonal-therapy-in-combination-with-an-anti-her2-t-dm1-or-t-dxd-in-metastatic-er-her2-breast-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-avoidance-of-vaginal-estrogen-in-patients-with-sle weekly 0.8 https://www.themednet.org/what-other-conditions-should-you-consider-in-someone-with-presumed-tolosa-hunt-but-without-significant-improvement-on-steroid-therapy weekly 0.8 https://www.themednet.org/what-are-your-first-line-treatment-choices-for-metastatic-combined-hcc-cholangiocarcinoma weekly 0.8 https://www.themednet.org/do-add-a-macrolide-for-immunomodulatory-effect-in-patients-with-macrolide-resistant-m-abscessus weekly 0.8 https://www.themednet.org/is-there-any-role-for-administering-another-course-of-recombinant-zoster-vaccine-shingrix-in-a-previously-vaccinated-patient-with-ra-who-is-in-clinical-remission-on-jak-inhibitor-but-has-had-a-breakthrough-shingles-infection weekly 0.8 https://www.themednet.org/what-dose-fractionation-do-you-use-for-salvage-hdr-brachytherapy-for-biopsy-proven-locally-recurrent-prostate-cancer-after-prior-external-beam-radiotherapy weekly 0.8 https://www.themednet.org/for-patients-with-central-hypothyroidism-and-a-clear-etiology-such-as-recent-head-irradiation-do-you-recommend-brain-imaging-prior-to-starting-thyroid-hormone-replacement-therapy weekly 0.8 https://www.themednet.org/when-would-you-treat-mild-anemia-from-low-testosterone-in-an-older-male weekly 0.8 https://www.themednet.org/when-would-you-consider-larynx-preservation-in-patients-with-t4n-scc-of-the-larynx weekly 0.8 https://www.themednet.org/what-are-your-favorite-strategies-in-fixing-post-surgical-depressions-from-facial-flaps weekly 0.8 https://www.themednet.org/what-is-the-longest-interval-that-you-have-been-able-to-stretch-a-biologic-before-losing-efficacy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-advanced-chronic-kidney-disease-who-are-taking-aluminum-containing-medications weekly 0.8 https://www.themednet.org/how-do-you-reassure-families-that-no-allergy-testing-is-needed-for-urticaria weekly 0.8 https://www.themednet.org/should-the-age-at-which-patients-transition-from-pediatric-to-adult-care-differ-depending-on-the-disease-diagnosis weekly 0.8 https://www.themednet.org/how-would-you-approach-post-chemoradiation-consolidation-in-a-patient-with-stage-iii-lung-adenocarcinoma-with-an-egfr-exon-18-g719a-mutation-and-highly-positive-pd-l1-level weekly 0.8 https://www.themednet.org/when-would-you-recommend-uric-acid-lowering-therapy-for-a-patient-with-asymptomatic-hyperuricemia-without-comorbidities-but-with-family-history-of-gout weekly 0.8 https://www.themednet.org/when-would-you-consider-genetic-screening-of-first-degree-relatives-in-patients-with-bicuspid-aortic-valves weekly 0.8 https://www.themednet.org/what-is-the-best-treatment-for-treatment-resistant-restless-leg-syndrome weekly 0.8 https://www.themednet.org/how-would-you-decide-between-conservative-management-vs-ilr-or-pacemaker-for-asymptomatic-nocturnal-bradycardia-pauses-as-an-example-rates-in-the-30s-pauses-ranging-4-12-seconds-in-the-absence-of-bradyarrhythmias-during-the-day-and-ecg-with-normal-interva weekly 0.8 https://www.themednet.org/would-you-consider-pth-analogue-in-a-patient-with-mildly-elevated-pth weekly 0.8 https://www.themednet.org/how-do-you-approach-patient-requests-for-medical-time-away-from-work-or-other-accommodations-such-as-disability-paperwork-when-the-patients-have-mild-moderate-symptoms-being-managed-in-the-outpatient-setting weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-patient-with-classic-gca-symptoms-elevated-esr-and-improvement-with-steroids-but-negative-temporal-artery-biopsy-and-cta-imaging-without-evidence-of-vasculitis weekly 0.8 https://www.themednet.org/in-which-clinical-scenarios-do-you-use-prolonged-intermittent-renal-replacement-therapy-pirrt weekly 0.8 https://www.themednet.org/how-do-you-choose-between-finerenone-and-traditional-steroidal-mras-for-patients-with-heart-failure-and-mildly-reduced-or-preserved-ef-considering-recent-results-showing-finerenones-efficacy-in-reducing-heart-failure-events weekly 0.8 https://www.themednet.org/how-do-you-integrate-next-generation-sequencing-with-traditional-culture-methods-to-improve-the-identification-of-fungal-pathogens-especially-in-cases-where-routine-cultures-are-negative-when-evaluating-suspected-prosthetic-joint-infections weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-to-a-post-menopausal-woman-with-t1-t3-primary-tumor-with-4-positive-axillary-lns-and-oncotypedx-score-less-than-15 weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-completely-resected-who-grade-ii-meningioma weekly 0.8 https://www.themednet.org/in-what-patients-would-you-consider-adjunctive-ivig-for-sjogrens-related-neuropathy weekly 0.8 https://www.themednet.org/what-is-your-preferred-adjuvant-therapy-for-a-patient-with-triple-negative-breast-cancer-and-has-a-brca-germline-mutation-who-had-minimal-to-no-response-to-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/would-you-offer-consolidation-rt-to-a-young-woman-with-bulky-mediastinal-dlbcl-who-achieved-early-and-persistent-cr-to-rchop-on-pet weekly 0.8 https://www.themednet.org/what-treatment-would-you-provide-for-a-patient-with-bilateral-synchronous-locally-advanced-ct4dn0-tnbc-and-ct1b-er-her2-breast-cancer weekly 0.8 https://www.themednet.org/for-patients-receiving-outpatient-venetoclax-azacitidine-who-develop-profound-neutropenia-with-anc-200-do-you-admit-for-monitoring-during-the-nadir-in-the-absence-of-fever weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-giant-cell-arteritis-treated-with-weekly-tocilizumab-and-low-dose-glucocorticoid-who-develops-sudden-vision-loss weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-chemotherapy-in-the-management-of-retroperitoneal-leiomyoscarcoma-who-did-not-respond-to-neoadjuvant-doxorubicin-dacarbazine weekly 0.8 https://www.themednet.org/do-you-recommend-routine-genetic-screening-i-e-periodic-fever-panel-in-a-pediatric-patient-where-you-strongly-suspect-a-periodic-fever-syndrome weekly 0.8 https://www.themednet.org/how-do-you-proceed-after-a-patient-has-a-partial-response-following-6-cycles-of-cisplatin-paclitaxel-bevacizumab-pembrolizumab-for-metastatic-scc-of-the-cervix weekly 0.8 https://www.themednet.org/do-you-adjust-immunosuppression-in-lung-transplant-recipients-diagnosed-with-covid-19 weekly 0.8 https://www.themednet.org/would-you-offer-pmrt-to-a-perimenopausal-female-with-a-single-positive-ln-with-microscopic-ene-who-has-otherwise-low-risk-features weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-dercums-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-patients-with-trigeminal-trophic-syndrome weekly 0.8 https://www.themednet.org/what-is-your-approach-to-aya-patients-with-b-cell-all-who-relapse-after-cd19-car-t weekly 0.8 https://www.themednet.org/for-primary-mzl-of-the-breast-do-you-do-whole-breast-to-24-gy-or-isrt weekly 0.8 https://www.themednet.org/do-you-feel-comfortable-using-azathioprine-for-dermatomyositis-in-patients-with-cirrhosis weekly 0.8 https://www.themednet.org/would-you-consider-patritumab-deruxtecan-on-clinical-trial-instead-of-chemotherapy-for-patients-with-egfr-lung-cancer-progressive-on-osimertinib weekly 0.8 https://www.themednet.org/in-what-n1-h-n-patients-if-any-would-you-consider-treating-the-gross-disease-primary-involved-node-only-without-elective-nodal-radiation-volume-with-definitive-intent-in-order-to-reduce-toxicity weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-sickle-cell-disease-during-pregnancy weekly 0.8 https://www.themednet.org/how-do-you-differentiate-erythrodermic-mycosis-fungoides-and-sezary-syndrome-is-it-primarily-based-on-the-burden-of-blood-involvement-of-malignant-cells weekly 0.8 https://www.themednet.org/in-light-of-the-recently-published-opra-trial-could-one-consider-organ-preservation-as-a-standard-treatment-option-for-appropriately-selected-patients-treated-with-total-neoadjuvant-therapy-for-locally-advanced-rectal-cancer weekly 0.8 https://www.themednet.org/how-do-you-incorporate-trastuzumab-pembrolizumab-and-folfox-as-per-keynote-811 weekly 0.8 https://www.themednet.org/how-long-do-you-wait-following-spinal-surgery-to-administer-srs weekly 0.8 https://www.themednet.org/how-would-you-manage-an-elderly-female-patient-with-a-remote-history-of-synchronous-bilateral-invasive-ductal-carcinoma-with-a-new-triple-negative-recurrence-in-the-left-breast-and-axilla-with-extension-to-the-contralateral-breast weekly 0.8 https://www.themednet.org/would-you-treat-the-entire-bladder-to-an-elective-dose-for-definitive-radiation-of-a-urethral-cancer weekly 0.8 https://www.themednet.org/with-the-approval-of-oral-jak-inhibitors-such-as-upadacitinib-for-atopic-dermatitis-how-are-you-considering-its-safety-profile-in-comparison-to-traditional-immunosuppressants-such-as-prednisone-methotrexate-azathioprine-and-mycophenolate weekly 0.8 https://www.themednet.org/for-a-refractory-gi-bleed-would-you-ever-consider-re-irradiation-of-an-unresectable-gastric-or-gej-tumor-in-a-patient-previously-treated-with-definitive-chemo-rt weekly 0.8 https://www.themednet.org/when-do-you-reach-for-tacrolimus-in-patients-with-myositis weekly 0.8 https://www.themednet.org/what-is-your-experience-with-using-extended-release-intra-articular-steroid-preparations-such-as-zilretta-in-patients-with-osteoarthritis weekly 0.8 https://www.themednet.org/is-there-evidence-that-radiotherapy-to-less-than-all-sites-of-oligometastatic-prostate-cancer-is-beneficial weekly 0.8 https://www.themednet.org/have-you-had-experience-using-the-new-echolight-technology-to-measure-bone-density weekly 0.8 https://www.themednet.org/how-would-you-manage-someone-with-antithrombin-deficiency-who-has-recurrent-vte-on-a-doac weekly 0.8 https://www.themednet.org/how-do-you-manage-inflammatory-back-pain-when-x-rays-and-mri-show-no-evidence-of-sacroiliitis weekly 0.8 https://www.themednet.org/do-you-recommend-holding-a-kras-inhibitor-during-palliative-radiotherapy weekly 0.8 https://www.themednet.org/at-what-psa-level-would-you-consider-restaging-a-patient-who-was-treated-with-adt-and-radiation-and-had-undetectable-psa weekly 0.8 https://www.themednet.org/do-you-scale-up-2nd-generation-anti-histamines-to-4x-daily-in-acute-urticaria-in-the-pediatric-population-as-you-do-in-adults weekly 0.8 https://www.themednet.org/what-if-any-role-does-systemic-therapy-have-in-the-treatment-of-hcc-amenable-to-definitive-locoregional-therapy weekly 0.8 https://www.themednet.org/what-neoadjuvant-regimen-would-you-give-a-patient-with-multicentric-idc-consisting-of-tnbc-and-concurrent-er-pr-her2-breast-cancer-with-er-pr-her2-axillary-ln-mets weekly 0.8 https://www.themednet.org/when-would-you-consider-additional-testing-for-nudt15-and-other-polymorphisms-related-to-6-mp-6-tg-metabolism-if-not-guided-by-a-study-protocol weekly 0.8 https://www.themednet.org/how-do-you-approach-adding-colchicine-to-a-patient-who-is-on-a-stable-statin-regimen weekly 0.8 https://www.themednet.org/when-do-you-consider-prescribing-medications-such-as-aricept-in-patients-with-down-syndrome-who-start-having-memory-issues weekly 0.8 https://www.themednet.org/how-would-you-approach-a-morbidly-obese-patient-with-early-stage-favorable-breast-cancer-who-is-premenopausal weekly 0.8 https://www.themednet.org/how-do-you-interpret-elevations-in-antiphospholipid-antibodies-that-are-lower-than-sapporo-criteria weekly 0.8 https://www.themednet.org/would-you-avoid-the-entire-class-of-bisphosphonates-if-a-patient-develops-an-allergic-reaction-or-would-you-consider-the-use-of-an-alternative-bisphosphonate weekly 0.8 https://www.themednet.org/would-you-recommend-an-allogenic-stem-cell-transplant-in-an-older-patient-50-with-ph-negative-acute-lymphoblastic-leukemia-who-is-mrd-negative-after-induction weekly 0.8 https://www.themednet.org/how-do-you-prescribe-a-steroid-taper-for-radiation-and-checkpoint-inhibitor-related-pneumonitis weekly 0.8 https://www.themednet.org/which-patients-with-cscc-could-you-omit-adjuvant-radiation-following-pathologic-complete-response-following-cemiplimab weekly 0.8 https://www.themednet.org/how-long-to-you-wait-after-laparoscopic-oophoropexy-to-deliver-pelvic-radiation weekly 0.8 https://www.themednet.org/what-is-the-negative-predictive-value-of-a-negative-extended-myositis-panel-in-dermatomyositis-patients weekly 0.8 https://www.themednet.org/do-you-advocate-for-dose-dense-ac-instead-of-every-3-week-dosing-in-neoadjuvant-tnbc-as-done-in-keynote-522 weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-anti-seizure-medication-necessity-or-lack-thereof-in-the-setting-of-pnes-without-comorbid-epilepsy weekly 0.8 https://www.themednet.org/how-do-you-manage-psoriatic-arthritis-in-patients-who-are-planning-to-start-treatment-with-checkpoint-inhibitors-for-underlying-malignancy weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-checkpoint-inhibitor-mediated-temporal-arteritis weekly 0.8 https://www.themednet.org/would-you-recommend-allogeneic-stem-cell-transplantation-for-consolidation-in-a-patient-with-follicular-lymphoma-who-relapsed-within-13-months-of-initial-chemo-immunotherapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-refractory-erosive-osteoarthritis weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-head-neck-cancers-from-asco-2022 weekly 0.8 https://www.themednet.org/do-you-recommend-maintenance-immunotherapy-after-cr-on-chemotherapy-for-patients-with-metastatic-tnbc weekly 0.8 https://www.themednet.org/what-adjuvant-radiation-modality-would-you-select-for-a-grade-2-endometrial-cancer-with-small-nodule-in-the-fallopian-tube weekly 0.8 https://www.themednet.org/what-protocols-or-safeguards-do-you-implement-if-bed-bugs-are-found-on-a-patient-or-their-belongings-while-on-the-treatment-table-or-near-equipment weekly 0.8 https://www.themednet.org/in-your-experience-what-has-been-the-most-effective-form-of-field-therapy-for-your-patients-with-higher-burdens-of-actinic-keratoses weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-immunotherapy-for-resected-pure-squamous-cell-carcinoma-t2-t4-or-n-of-the-renal-pelvis weekly 0.8 https://www.themednet.org/what-workup-do-you-do-for-patients-who-have-pl-7-elevation-when-screening-for-myopathy weekly 0.8 https://www.themednet.org/how-do-you-manage-rectal-or-bowel-perforation-from-interstitial-brachytherapy-needles-2 weekly 0.8 https://www.themednet.org/would-you-give-a-fit-40-year-old-with-t3n1b-low-risk-stage-iiib-colon-adenocarcinoma-6-months-of-adjuvant-chemo-or-feel-comfortable-limiting-to-3-months-of-capox weekly 0.8 https://www.themednet.org/how-do-you-select-the-concurrent-cisplatin-dose-and-schedule-when-treating-locally-advanced-endometrial-cancer-with-chemoradiation weekly 0.8 https://www.themednet.org/how-do-you-now-approach-treatment-sequencing-in-mm-in-light-of-the-determination-trial-data weekly 0.8 https://www.themednet.org/in-light-of-the-recent-reecur-trial-interim-analysis-would-you-offer-high-dose-ifosfamide-to-an-aya-patient-with-relapsed-ewings-sarcoma-who-initially-had-a-complete-response-to-up-front-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-an-elderly-patient-with-locally-advanced-breast-cancer-and-co-morbidities-who-strongly-refuses-surgery-but-is-willing-to-consider-radiation weekly 0.8 https://www.themednet.org/how-do-you-approach-the-continued-use-of-tnf-inhibitors-in-a-patient-with-inflammatory-arthritis-who-develops-a-positive-dsdna-without-clinical-evidence-of-drug-induced-lupus weekly 0.8 https://www.themednet.org/when-do-you-typically-check-vitamin-b5-levels-in-patients-with-peripheral-neuropathy weekly 0.8 https://www.themednet.org/how-do-you-treat-adrenal-metastases-with-sbrt weekly 0.8 https://www.themednet.org/what-dose-do-you-use-for-t2-anal-squamous-cell-carcinomas-measuring-greater-than-3cm weekly 0.8 https://www.themednet.org/is-rituximab-for-refractory-itp-contraindicated-in-the-setting-of-an-active-covid-infection-particularly-in-a-patient-with-asymptomatic-covid-8 weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gynecologic-cancers-from-asco-2022 weekly 0.8 https://www.themednet.org/despite-the-lack-of-evidence-do-you-utilize-glucosamine-and-chondroitin-sulfate-for-osteoarthritis weekly 0.8 https://www.themednet.org/would-you-consider-anifrolumab-in-the-management-of-hematologic-manifestations-in-sle weekly 0.8 https://www.themednet.org/in-a-patient-with-presumed-autoimmune-encephalitis-would-treating-them-with-ivig-before-getting-a-brain-biopsy-alter-the-pathological-changes-in-a-meaningful-way weekly 0.8 https://www.themednet.org/what-is-your-approach-to-diagnosing-and-managing-suspected-dental-amalgam-triggered-lichen-planus weekly 0.8 https://www.themednet.org/how-would-you-approach-therapy-for-a-patient-with-a-history-of-classical-hl-who-achieved-a-cr-to-6-cycles-of-brentuximab-plus-avd-who-now-presents-with-widespread-non-gc-dlbcl weekly 0.8 https://www.themednet.org/will-you-offer-olaparib-abiraterone-for-all-patients-with-metastatic-castrate-resistant-prostate-cancer-based-on-results-of-propel-trial weekly 0.8 https://www.themednet.org/for-a-patient-treated-with-abiraterone-for-first-line-metastatic-prostate-cancer-would-you-still-use-a-combination-of-abiraterone-olaparib-at-a-subsequent-progression weekly 0.8 https://www.themednet.org/what-is-your-preferred-ocp-protocol-when-the-aim-is-reduction-of-sebum-production-in-teenage-female-acne weekly 0.8 https://www.themednet.org/what-staging-procedures-do-you-include-for-clinically-apparent-stage-i-or-ii-ovarian-cancer weekly 0.8 https://www.themednet.org/is-il-6-inhibition-an-option-in-patients-who-are-going-to-be-rechallenged-with-checkpoint-inhibitors-after-previously-developing-ici-mediated-temporal-arteritis weekly 0.8 https://www.themednet.org/can-you-continue-checkpoint-inhibitor-therapy-in-the-setting-of-severe-cutaneous-irae-while-concurrently-treating-the-cutaneous-reaction weekly 0.8 https://www.themednet.org/what-dose-constraints-do-you-apply-to-the-lad-for-lung-sbrt weekly 0.8 https://www.themednet.org/for-unfavorable-intermediate-prostate-cancer-in-elderly-patients-would-you-consider-radiation-without-adt weekly 0.8 https://www.themednet.org/would-you-offer-endocrine-therapy-to-a-patient-who-developed-a-new-contralateral-pt1b-pn0-er-pr-her2-breast-idc-1-year-after-coming-off-10-years-of-anastrozole-for-prior-invasive-breast-cancer weekly 0.8 https://www.themednet.org/if-you-have-a-patient-with-isolated-cn-vii-palsy-bells-palsy-and-straightforward-symptoms-with-no-red-flags-such-as-concern-for-carcinomatous-meningitis-do-you-routinely-get-an-mri-brain-or-do-you-just-make-a-clinical-diagnosis weekly 0.8 https://www.themednet.org/do-you-offer-surgery-for-patients-with-early-stage-cervical-cancer-who-you-suspect-will-need-adjuvant-radiation-regardless-of-surgical-pathology-results weekly 0.8 https://www.themednet.org/what-is-the-role-of-egfr-inhibitors-in-patients-with-metastatic-transverse-colon-cancer weekly 0.8 https://www.themednet.org/would-you-offer-neoadjuvant-chemotherapy-to-ct1c-n0-triple-negative-breast-cancer-with-metaplastic-features-in-a-young-patient weekly 0.8 https://www.themednet.org/what-fractionation-would-you-offer-to-a-young-pre-menopausal-woman-with-early-stage-er-her2-breast-cancer-who-received-adjuvant-chemotherapy-and-is-highly-interested-in-maximizing-breast-cosmesis weekly 0.8 https://www.themednet.org/what-dose-fractionation-do-you-use-for-spine-schwannoma weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-oligometastatic-disease-to-the-lung-for-whom-sbrt-sabr-is-not-feasible weekly 0.8 https://www.themednet.org/if-using-durvalumab-tremelimumab-for-advanced-hcc-must-the-tremelimumab-be-given-with-the-first-cycle-of-durvalumab weekly 0.8 https://www.themednet.org/what-is-your-first-line-treatment-for-a-patient-with-epilepsy-who-is-homeless-and-has-a-history-of-poor-adherence weekly 0.8 https://www.themednet.org/given-several-parp-inhibitors-approved-or-with-emerging-positive-data-in-castrate-resistant-prostate-cancer-how-do-you-decide-which-one-and-when-to-use weekly 0.8 https://www.themednet.org/how-do-you-treat-a-rectoprostatic-fistula-after-prostate-sbrt weekly 0.8 https://www.themednet.org/are-there-any-unique-toxicity-concerns-with-combination-of-ramucirumab-pembrolizumab-as-compared-with-other-available-treatments-for-metastatic-nsclc weekly 0.8 https://www.themednet.org/how-would-you-treat-completed-resected-rectosigmoid-recurrence-of-endometrial-adenocarcinoma weekly 0.8 https://www.themednet.org/would-you-favor-stopping-hydralazine-in-a-patient-requiring-it-for-refractory-hypertension-if-they-also-have-a-high-titer-ana-in-the-absence-of-any-sle-symptoms weekly 0.8 https://www.themednet.org/in-which-clinical-settings-do-you-use-the-cerianna-fluoroestradiol-f18-pet-scan-for-breast-cancer weekly 0.8 https://www.themednet.org/do-you-often-see-clinical-improvement-that-is-significant-enough-to-de-list-patients-with-cf-for-transplant-after-the-initiation-of-cftr-modulator-therapy weekly 0.8 https://www.themednet.org/how-do-you-select-systemic-therapy-for-advanced-hcc-patients-with-portal-vein-thrombosis weekly 0.8 https://www.themednet.org/what-therapies-do-you-most-commonly-utilize-for-patients-with-scc-in-situ-on-the-head-and-neck weekly 0.8 https://www.themednet.org/how-do-you-manage-alopecia-areata-in-children-with-50-of-hair-loss-that-is-unresponsive-to-intralesional-or-topical-steroids weekly 0.8 https://www.themednet.org/for-patients-with-kras-g12c-mutated-nsclc-how-would-you-decide-between-using-targeted-therapy-with-sotorasib-vs-adagrasib weekly 0.8 https://www.themednet.org/would-you-offer-post-lumpectomy-rt-in-a-young-adult-with-dcis-who-received-bilateral-whole-lung-radiation-for-wilms-tumor-as-a-child weekly 0.8 https://www.themednet.org/would-you-offer-definitive-local-therapy-to-a-patient-with-er-pr-her2-neg-breast-cancer-with-oligometastatic-disease-that-responded-well-to-cdk-4-6-inhibitor-ai-despite-nrg-br002-results weekly 0.8 https://www.themednet.org/what-is-your-approach-to-monitoring-for-hepatic-fibrosis-in-chronic-methotrexate-use weekly 0.8 https://www.themednet.org/what-is-the-best-treatment-for-radiation-recall-skin-reaction-of-the-breast weekly 0.8 https://www.themednet.org/do-you-find-that-complete-interlobar-fissures-on-hrct-correlate-well-with-decreased-collateral-ventilation-on-endoscopic-balloon-occlusion-in-the-evaluation-and-placement-of-endobronchial-valves-for-bronchoscopic-lung-volume-reduction weekly 0.8 https://www.themednet.org/do-you-refer-all-patients-with-a-beighton-score-over-5-to-genetics-for-further-assessment weekly 0.8 https://www.themednet.org/do-you-favor-the-use-of-fick-or-thermodiluation-to-measure-cardiac-output-in-patients-with-interstitial-lung-disease-with-suspected-pulmonary-hypertension weekly 0.8 https://www.themednet.org/in-a-patient-with-both-stage-iii-nsclc-and-another-concurrent-high-risk-malignancy-how-do-you-sequence-consolidation-durvalumab-with-local-therapy-for-the-concurrent-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-systemic-polyarteritis-nodosa-with-orchitis-mononeuritis-and-glomerulonephritis-in-a-person-who-is-being-treated-for-hiv-with-low-level-viremia weekly 0.8 https://www.themednet.org/what-is-palliative-rt-technique-would-you-use-to-treat-a-secondary-lymphoma-of-the-scrotum-without-skin-involvement weekly 0.8 https://www.themednet.org/how-would-you-manage-polymyalgia-rheumatica-refractory-to-prednisone-methotrexate-and-tocilizumab weekly 0.8 https://www.themednet.org/would-you-treat-the-prostate-alone-or-prostate-and-mets-in-an-oligometastatic-prostate-cancer-patient weekly 0.8 https://www.themednet.org/what-is-your-preferred-steroid-sparing-therapy-in-a-patient-experiencing-a-severe-checkpoint-inhibitor-toxicity-and-not-responding-to-high-dose-iv-steroids weekly 0.8 https://www.themednet.org/would-you-consider-the-use-of-an-anabolic-agent-to-promote-fracture-healing weekly 0.8 https://www.themednet.org/how-would-you-manage-a-cll-patient-with-richters-transformation-that-is-resistant-to-r-chop-with-transfusion-dependent-cytopenias-and-a-marrow-demonstrating-significant-involvement-by-dlbcl-and-cll weekly 0.8 https://www.themednet.org/do-you-ever-stop-tobramycin-prophylaxis-in-a-patient-with-chronic-bronchiectasis-previously-colonized-with-pseudomonas weekly 0.8 https://www.themednet.org/what-is-your-psa-threshold-for-obtaining-psma-pet-for-biochemical-failure-after-rp weekly 0.8 https://www.themednet.org/do-you-recommend-adt-for-a-high-risk-prostate-cancer-patient-who-had-sbrt weekly 0.8 https://www.themednet.org/is-central-lumpectomy-always-required-for-pagets-disease-of-the-breast weekly 0.8 https://www.themednet.org/what-interventions-have-you-found-most-effective-for-reducing-ed-utilization-in-patients-with-pnes weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-abemaciclib-plus-endocrine-therapy-for-favorable-histology-er-pr-her2-negative-tumors-such-as-pure-tubular-mucinous-cribriform-or-papillary-that-otherwise-meet-monarche-trial-criteria weekly 0.8 https://www.themednet.org/do-you-perform-a-periodic-pet-ct-to-screen-for-extramedullary-disease-in-patients-with-mm-who-are-in-remission weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-recommend-for-a-cisplatin-and-io-ineligible-patient-with-node-positive-urothelial-carcinoma-with-mixed-histology weekly 0.8 https://www.themednet.org/do-you-typically-recommend-ct-angiogram-and-ct-venogram-to-assess-for-patients-with-lobar-spontaneous-ich weekly 0.8 https://www.themednet.org/do-you-typically-recommend-platelet-transfusions-in-patients-with-spontaneous-ich weekly 0.8 https://www.themednet.org/what-concurrent-dose-fractionation-regimen-do-you-prefer-when-treating-large-cell-neuroendocrine-tumor-of-the-lung weekly 0.8 https://www.themednet.org/would-you-administer-pelvic-radiation-therapy-to-a-post-menopausal-patient-with-locally-advanced-carcinosarcoma-with-high-risk-features-s-p-tah-bso-with-a-vesico-urethral-fistula-that-would-be-in-the-radiation-therapy-field weekly 0.8 https://www.themednet.org/provided-no-side-effects-to-what-dose-do-you-increase-propranolol-or-primidone-before-considering-them-ineffective-for-a-patient-with-essential-tremor weekly 0.8 https://www.themednet.org/do-you-offer-durvalumab-in-combination-with-gemcitabine-and-cisplatin-in-patients-with-metastatic-ampullary-adenocarcinoma-given-the-fact-that-abc-02-trial-included-patients-with-ampullary-adenocarcinoma-while-topaz-trial-excluded-those-patients weekly 0.8 https://www.themednet.org/how-do-you-approach-handling-the-many-page-disability-paperwork-of-neurological-disease-such-as-parkinsons-disease weekly 0.8 https://www.themednet.org/what-steroid-regimen-do-you-employ-prior-to-extubating-a-patient-who-does-not-have-a-suitable-cuff-leak weekly 0.8 https://www.themednet.org/what-are-real-world-exclusion-criteria-for-the-use-of-lenvatinib-pembrolizumab-for-advanced-endometrial-cancer weekly 0.8 https://www.themednet.org/what-is-the-role-of-uterine-artery-embolization-uae-in-patients-with-locally-advanced-cervical-cancer-with-emergent-bleeding-that-persists-through-vaginal-packing weekly 0.8 https://www.themednet.org/would-you-add-durvalumab-to-gem-cis-in-a-patient-with-recurrent-cholangiocarcinoma-after-liver-transplant weekly 0.8 https://www.themednet.org/would-you-consider-pd-l1-score-when-deciding-whether-to-incorporate-durvalumab-in-first-line-metastatic-biliary-cancer weekly 0.8 https://www.themednet.org/in-what-scenarios-do-you-consider-omitting-adjuvant-endocrine-therapy-after-lumpectomy-for-dcis weekly 0.8 https://www.themednet.org/what-is-your-approach-in-a-fit-patient-advanced-stage-bulky-classical-hodgkin-lymphoma-who-has-decreased-disease-burden-in-areas-but-a-persistent-hypermetabolic-deauville-5-anterior-mediastinal-mass-following-two-cycles-of-aavd weekly 0.8 https://www.themednet.org/what-references-do-you-use-for-multi-parametric-mri-delineation-of-the-gtv-in-prostate-cancer-for-prostate-nodule weekly 0.8 https://www.themednet.org/how-long-do-you-expect-gastrointestinal-side-effects-of-leflunomide-to-persist-after-stopping-treatment weekly 0.8 https://www.themednet.org/do-you-use-absolute-random-cortisol-levels-or-delta-cortisol-levels-after-acth-stimulation-to-diagnose-adrenal-insufficiency-in-the-critically-ill weekly 0.8 https://www.themednet.org/in-what-situations-if-any-is-it-appropriate-to-forego-surgery-for-nodal-recurrence-intraparotid-and-or-ipsilateral-neck-of-cutaneous-scc-and-definitively-treat-with-chemo-rt weekly 0.8 https://www.themednet.org/what-steroid-regimen-do-you-employ-in-the-treatment-of-patients-with-post-covid-19-pulmonary-fibrosis weekly 0.8 https://www.themednet.org/would-you-recommend-the-addition-of-radiation-to-neoadjuvant-chemotherapy-in-unresectable-ct4b-sigmoid-adenocarcinoma-at-or-above-the-peritoneal-reflection-adherent-to-the-bladder weekly 0.8 https://www.themednet.org/what-is-your-experience-with-using-dupilumab-for-alopecia-areata weekly 0.8 https://www.themednet.org/what-is-your-treatment-algorithm-for-patients-with-lichen-planus weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-biopsy-proven-abra-amyloid-beta-related-angiitis weekly 0.8 https://www.themednet.org/how-would-you-approach-a-cutaneous-squamous-cell-carcinoma-with-primary-tumor-completely-excised-but-multiple-foci-of-lvi-at-the-peripheral-specimen-margin-and-no-other-high-risk-features weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-to-patients-with-confluent-actinic-keratoses-on-lower-extremities weekly 0.8 https://www.themednet.org/when-would-you-hold-anticoagulation-medications-in-patients-undergoing-a-tandem-and-ovoid-ring weekly 0.8 https://www.themednet.org/would-you-consider-sbrt-for-node-negative-small-cell-carcinoma-of-the-prostate weekly 0.8 https://www.themednet.org/in-a-patient-identified-as-having-apls-because-of-recurrent-pregnancy-loss-without-history-of-thrombosis-but-now-has-a-new-dvt-pe-during-pregnancy-despite-use-of-enoxaparin-for-how-long-would-you-recommend-anticoagulation weekly 0.8 https://www.themednet.org/would-you-offer-rt-for-a-nodal-recurrence-of-nsclc-that-has-resolved-radiographically-after-chemotherapy weekly 0.8 https://www.themednet.org/are-triptans-contraindicated-in-patients-with-moya-moya-syndrome-who-have-never-had-an-ischemic-stroke weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-erosive-inflammatory-arthritis-ra-or-spa-in-a-patient-with-multiple-sclerosis-on-ocrelizumab-who-has-failed-csdmard-therapy weekly 0.8 https://www.themednet.org/how-would-you-escalate-therapy-beyond-mmf-in-a-patient-with-rapidly-progressive-ssc-ild weekly 0.8 https://www.themednet.org/would-you-treat-the-pelvis-electively-while-treating-the-prostate-in-a-setting-of-low-volume-metastatic-prostate-cancer weekly 0.8 https://www.themednet.org/where-do-oral-and-topical-jak-inhibitors-fit-into-your-treatment-algorithm-and-approach-to-atopic-dermatitis weekly 0.8 https://www.themednet.org/at-what-age-do-you-recommend-annual-skin-exams-in-a-patient-without-a-personal-or-family-history-of-skin-cancer weekly 0.8 https://www.themednet.org/do-you-perform-a-clamp-trial-before-removing-a-chest-tube-for-pneumothorax weekly 0.8 https://www.themednet.org/when-do-you-consider-referral-to-hand-surgery-for-management-of-joint-deformity-in-ra weekly 0.8 https://www.themednet.org/how-do-you-discern-whether-elevated-liver-enzymes-are-from-immunotherapy-versus-chemotherapy-when-a-patient-is-on-combination-chemo-immunotherapy weekly 0.8 https://www.themednet.org/when-would-you-consider-obtaining-a-cardiac-ct-in-lieu-of-standard-tee-for-the-detection-of-a-left-atrial-appendage-thrombus-in-atrial-fibrillation weekly 0.8 https://www.themednet.org/what-is-your-surveillance-approach-for-outpatient-monitoring-of-ici-myocarditis weekly 0.8 https://www.themednet.org/would-you-consider-starting-an-ace-inhibitor-on-a-patient-without-cvd-or-heart-failure-prior-to-initiation-of-anthracyclines-to-reduce-the-overall-risk-of-myocardial-toxicity weekly 0.8 https://www.themednet.org/would-you-start-an-amiodarone-load-for-new-onset-atrial-fibrillation-with-rvr-intermittently-in-normal-sinus-rhythm-to-further-suppress-af-recurrence-in-the-acute-setting weekly 0.8 https://www.themednet.org/when-would-you-consider-discharging-post-tavr-patients-on-outpatient-mobile-cardiac-telemetry-with-baseline-right-bundle-branch-block-without-further-signs-of-conduction-abnormalities-24-48-hours-after-the-procedure-given-risk-of-developing-later-onset-co weekly 0.8 https://www.themednet.org/how-are-pa-diastolic-goals-established-and-individualized-to-reduce-hf-readmission-risk-post-cardiomems-recognizing-the-overall-unclear-clinical-value-of-outpatient-pa-sensor-monitoring weekly 0.8 https://www.themednet.org/is-there-any-benefit-in-maintaining-statin-or-aspirin-therapy-in-patients-75-years-old-with-stable-multivessel-ischemic-heart-disease-in-light-of-challenges-encountered-with-polypharmacy weekly 0.8 https://www.themednet.org/in-a-pediatric-patient-diagnosed-with-orbital-sarcoidosis-dacryoadenitis-on-biopsy-would-you-recommend-completing-evaluation-for-pulmonary-sarcoidosis-and-neurosarcoidosis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-considering-geriatric-patients-for-complex-pci-given-their-overall-frailty-and-increased-risk-of-complications-such-as-bleeding-and-stroke-2 weekly 0.8 https://www.themednet.org/should-vasodilatory-therapies-be-considered-first-line-in-the-management-of-hypertension-in-patients-with-severe-aortic-regurgitation weekly 0.8 https://www.themednet.org/which-hemodynamic-parameters-can-be-used-to-titrate-positive-pressure-ventilation-in-preload-dependent-settings-such-as-rv-failure-cardiac-tamponade-hocm-or-hemodynamically-significant-pe weekly 0.8 https://www.themednet.org/when-is-an-appropriate-time-to-consider-genetic-testing-for-cardiomyopathies-for-athletes-as-part-of-risk-stratification-for-sudden-cardiac-death-in-light-of-heightened-prevalence-of-cardiac-remodeling-confounded-by-exercise-and-athletic-conditioning weekly 0.8 https://www.themednet.org/should-statin-initiation-be-considered-in-young-adult-patients-with-autoimmune-disease-or-chronic-inflammatory-conditions-without-an-elevated-ascvd-risk-score-given-risk-of-underestimation-of-underlying-cvd weekly 0.8 https://www.themednet.org/do-you-consider-younger-patients-with-nf2-to-have-a-relative-contraindication-to-radical-pelvic-rt-due-to-risk-of-secondary-malignancy weekly 0.8 https://www.themednet.org/is-cross-reactivity-low-enough-to-try-cisplatin-as-an-alternative-for-patients-who-experience-hypersensitivity-reaction-to-carboplatin weekly 0.8 https://www.themednet.org/how-would-you-work-up-a-patient-with-cutaneous-mastocytosis weekly 0.8 https://www.themednet.org/how-do-you-manage-metastatic-breast-cancer-to-the-uterus-ovaries-that-is-symptomatic weekly 0.8 https://www.themednet.org/do-you-avoid-intra-articular-and-bursa-tendon-sheath-corticosteroid-injections-in-patients-with-a-history-of-avascular-necrosis weekly 0.8 https://www.themednet.org/when-do-you-refer-patients-for-germline-testing-when-somatic-tumor-testing-is-negative-for-actionable-mutations weekly 0.8 https://www.themednet.org/how-do-you-approach-systemic-therapy-for-metastatic-prostate-cancer-in-geriatric-patient-when-progressed-to-mcrpc-on-adt-alone weekly 0.8 https://www.themednet.org/what-criteria-would-you-use-to-decide-between-trastuzumab-deruxtecan-and-sacituzumab-govitecan-in-her2-low-metastatic-tnbc-given-t-dxd-approval-in-her2-low-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-recurrent-inoperable-chest-wall-pleomorphic-liposarcoma-with-prior-radiation-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-symptomatic-spinal-cord-compression-who-is-a-poor-surgical-candidate-and-has-a-radio-resistant-primary-tumor weekly 0.8 https://www.themednet.org/would-you-recommend-biopsy-of-a-bone-met-noted-on-psma-pet-after-definitive-prostate-radiation weekly 0.8 https://www.themednet.org/how-do-you-manage-injection-site-reactions-in-patients-on-subcutaneous-biologics-such-as-tnf-inhibitors weekly 0.8 https://www.themednet.org/is-there-a-role-for-repeat-car-t-with-a-potentially-different-product-in-relapsed-and-refractory-multiple-myeloma weekly 0.8 https://www.themednet.org/what-maintenance-therapies-do-you-most-commonly-recommend-for-patients-with-improving-genital-lichen-sclerosis weekly 0.8 https://www.themednet.org/when-considering-the-use-of-doacs-in-apls-does-the-number-of-positive-apls-antibodies-influence-your-decision weekly 0.8 https://www.themednet.org/is-day-43-cisplatin-100mg-m2-needed-after-completion-of-rt-in-case-of-a-delay-related-to-neutropenia-for-locally-advanced-head-and-neck-cancer weekly 0.8 https://www.themednet.org/what-personnel-does-your-department-require-to-safely-deliver-vaginal-cylinder-brachytherapy-other-than-treating-radiation-oncologist-and-physicist weekly 0.8 https://www.themednet.org/do-you-get-routine-mri-brain-for-surveillance-on-patients-with-history-of-stage-iii-melanoma weekly 0.8 https://www.themednet.org/do-you-feel-that-more-frequent-genomic-sequencing-will-be-cost-effective-in-the-management-of-high-risk-pediatric-cancers weekly 0.8 https://www.themednet.org/how-do-you-envision-genomic-scoring-systems-for-pediatric-cancers-being-applied-in-a-real-world-setting weekly 0.8 https://www.themednet.org/how-would-you-manage-a-new-suspected-brain-metastasis-in-a-patient-with-a-distant-cancer-history weekly 0.8 https://www.themednet.org/when-would-you-consider-utilizing-bone-scintigraphy-in-the-assessment-of-inflammatory-arthritis weekly 0.8 https://www.themednet.org/would-you-continue-venetoclax-indefinitely-until-disease-progression-in-patients-treated-with-upfront-venetoclax-for-tp53-mutated-cll weekly 0.8 https://www.themednet.org/do-you-recommend-any-psma-pet-agent-over-another weekly 0.8 https://www.themednet.org/is-history-of-radiation-therapy-for-uterine-cancer-an-absolute-contraindication-to-parathyroid-hormone-parathyroid-hormone-related-protein-analogues-such-as-teriparatide-and-abaloparatide-in-a-patient-with-severe-osteoporosis-with-multiple-spine-fractures weekly 0.8 https://www.themednet.org/how-do-you-manage-hyponatremia-in-patients-with-renal-cell-carcinoma-on-cabozantinib-and-nivolumab weekly 0.8 https://www.themednet.org/how-do-you-approach-work-up-for-a-patient-suspected-for-monoclonal-gammopathy-of-renal-significance-for-whom-renal-biopsy-is-contraindicated weekly 0.8 https://www.themednet.org/would-you-consider-antiphospholipid-syndrome-to-be-a-contraindication-for-checkpoint-inhibitor-immunotherapy weekly 0.8 https://www.themednet.org/how-do-you-manage-headaches-in-stroke-patients weekly 0.8 https://www.themednet.org/what-would-your-radiation-volume-be-for-a-patient-with-scc-just-medial-to-the-infraorbital-foramen-with-positive-pni-who-presented-with-pain-s-p-regional-excision weekly 0.8 https://www.themednet.org/what-treatment-options-do-you-recommend-to-patients-with-microstomia-secondary-to-scleroderma weekly 0.8 https://www.themednet.org/what-dressings-do-you-recommend-for-patients-with-hidradenitis-suppurativa-to-help-prevent-friction-and-collect-drainage-from-open-areas weekly 0.8 https://www.themednet.org/what-steroid-regimen-do-you-use-in-patients-with-both-septic-shock-and-ards weekly 0.8 https://www.themednet.org/based-on-the-results-of-swog-s1801-neoadjuvant-vs-adjuvant-pembrolizumab-for-resected-stage-iiib-iv-melanoma-are-you-starting-to-recommend-neoadjuvant-pembro-for-your-patients weekly 0.8 https://www.themednet.org/would-you-offer-local-therapy-to-a-patient-with-gej-adenocarcinoma-with-fdg-avid-para-aortic-node-oligometastasis weekly 0.8 https://www.themednet.org/when-do-you-consider-the-insertion-of-nephrostomy-tubes-for-gynecologic-malignancies-without-fistulas weekly 0.8 https://www.themednet.org/what-would-be-the-main-indications-for-opting-for-biosimilars-over-an-original-biologic-outside-of-insurance-barriers weekly 0.8 https://www.themednet.org/how-do-you-approach-systemic-treatment-for-endometrial-endometrioid-adenocarcinoma-with-neuroendocrine-differentiation weekly 0.8 https://www.themednet.org/due-to-the-high-incidence-of-hyperlipidemia-secondary-to-lorlatinib-do-you-recommend-empiric-statin-therapy-to-all-patients-without-known-contraindications-upon-initiation-of-lorlatinib weekly 0.8 https://www.themednet.org/how-do-you-manage-grade-3-enterocolitis-from-5fu-mitomycin-and-pelvic-radiotherapy weekly 0.8 https://www.themednet.org/what-is-the-significance-of-grade-in-opscc weekly 0.8 https://www.themednet.org/how-do-you-approach-ra-management-in-a-patient-who-develops-a-new-solid-tumor-while-on-therapy weekly 0.8 https://www.themednet.org/how-do-you-manage-a-case-of-dermatomyositis-that-is-proven-on-skin-biopsy-and-clinically-has-proximal-muscle-weakness-but-normal-muscle-enzymes-including-ck-aldolase weekly 0.8 https://www.themednet.org/how-do-you-use-colchicine-for-gout-in-patients-with-chronic-kidney-disease-or-end-stage-renal-disease-on-hemodialysis weekly 0.8 https://www.themednet.org/what-is-your-preferred-dose-fractionation-for-who-grade-1-meningiomas weekly 0.8 https://www.themednet.org/what-is-your-second-line-therapy-for-patients-with-egpa-with-mainly-pulmonary-and-sinonasal-features-who-did-not-respond-to-mepolizumab-300-mg-month-and-still-require-high-doses-of-steroid weekly 0.8 https://www.themednet.org/how-long-do-you-wait-to-start-adjuvant-radiation-after-prostatectomy weekly 0.8 https://www.themednet.org/should-immune-checkpoint-inhibitor-be-held-for-palliative-rt-to-bladder-in-patient-with-metastatic-urothelial-carcinoma-who-has-stable-systemic-disease-on-immunotherapy weekly 0.8 https://www.themednet.org/how-would-you-evaluate-and-treat-an-older-teenage-patient-with-severe-perioral-dermatitis-with-histology-demonstrating-a-granulomatous-dermatitis-and-all-stains-have-come-back-negative weekly 0.8 https://www.themednet.org/should-post-transplant-cyclophosphamide-be-utilized-for-all-matched-unrelated-donor-peripheral-blood-stem-cell-transplants-for-hematologic-malignancy weekly 0.8 https://www.themednet.org/do-you-continue-to-utilize-esr-and-crp-in-patients-on-tocilizumab weekly 0.8 https://www.themednet.org/do-you-prefer-imrt-to-3d-for-partial-breast-treatment weekly 0.8 https://www.themednet.org/does-use-of-imaging-influence-diagnostic-accuracy-and-patient-outcome-in-patients-with-suspected-cidp weekly 0.8 https://www.themednet.org/among-the-metastatic-unresectable-melanoma-patients-you-would-historically-treat-with-anti-pd-1-monotherapy-are-you-now-recommending-nivolumab-relatlimab-instead weekly 0.8 https://www.themednet.org/what-is-your-approach-to-recurrent-metastatic-high-grade-uterine-carcinosarcoma-with-rhabdomyoblastic-differentiation weekly 0.8 https://www.themednet.org/what-antithrombotic-regimen-do-you-recommend-prior-to-and-in-anticipation-of-cea-for-patients-with-symptomatic-carotid-stenosis weekly 0.8 https://www.themednet.org/in-a-patient-with-solitary-metastasis-skin-subcutaneous-wrist-resected-with-graft-from-a-primary-breast-angiosarcoma-what-would-be-your-preferred-fields-and-dose weekly 0.8 https://www.themednet.org/do-you-routinely-start-full-dose-anticoagulation-in-new-onset-atrial-fibrillation-in-the-icu weekly 0.8 https://www.themednet.org/what-is-your-threshold-to-start-stress-dose-steroids-in-the-management-of-patients-with-septic-shock weekly 0.8 https://www.themednet.org/are-whole-blood-hydroxychloroquine-blood-levels-helpful-in-patients-taking-chloroquine weekly 0.8 https://www.themednet.org/what-are-the-indications-for-anticoagulation-in-splenic-infarctions weekly 0.8 https://www.themednet.org/in-light-of-the-recent-mskcc-phase-2-data-indicating-reduced-skeletal-events-with-treatment-how-will-you-approach-management-of-patients-with-asymptomatic-bone-mets weekly 0.8 https://www.themednet.org/what-recommendations-do-you-provide-to-isotretinoin-patients-about-delaying-cosmetic-procedures-lasers-fillers-botox-once-they-have-reached-their-goal-dose weekly 0.8 https://www.themednet.org/would-you-consider-using-capecitabine-in-a-patient-who-previously-had-encephalopathy-with-5-fu weekly 0.8 https://www.themednet.org/how-do-you-weigh-the-risks-of-re-treatment-with-infliximab-in-a-patient-who-has-been-off-it-for-over-a-year weekly 0.8 https://www.themednet.org/for-a-patient-with-localized-high-risk-prostate-cancer-with-high-risk-decipher-score-receiving-adt-and-abiraterone-is-there-any-value-of-continuing-adt-and-abiraterone-beyond-two-years weekly 0.8 https://www.themednet.org/do-you-routinely-use-a-bone-modifying-agent-in-patients-with-metastatic-rcc-with-bone-metastases-receiving-a-tki weekly 0.8 https://www.themednet.org/what-blood-pressure-goals-do-you-typically-target-for-patients-in-the-immediate-post-thrombectomy-period weekly 0.8 https://www.themednet.org/are-there-any-risk-factors-for-io-induced-rhabdomyolysis-and-how-do-you-approach-and-manage-it weekly 0.8 https://www.themednet.org/what-would-your-approach-be-for-a-patient-with-early-stage-gastric-cancer-who-declines-a-gastrectomy weekly 0.8 https://www.themednet.org/how-do-you-follow-up-a-patient-with-esophageal-adenocarcinoma-who-is-not-a-surgical-candidate-after-finishing-chemoradiation weekly 0.8 https://www.themednet.org/if-you-are-unable-to-meet-v50-dose-constraint-for-partial-breast-irradiation-do-you-revert-to-whole-breast-treatment weekly 0.8 https://www.themednet.org/would-you-offer-pmrt-to-a-pre-menopausal-patient-with-early-stage-breast-cancer-favorable-biology-and-an-axillary-dissection-showing-pn1a-disease weekly 0.8 https://www.themednet.org/how-would-you-approach-an-elderly-patient-with-tibial-plateau-insufficiency-fracture-and-normal-dexa weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-chest-2022 weekly 0.8 https://www.themednet.org/what-is-the-best-treatment-for-pt2-cn1-seminoma-with-mild-elevation-of-b-hcg-100 weekly 0.8 https://www.themednet.org/how-do-you-manage-inflammatory-post-filler-nodules weekly 0.8 https://www.themednet.org/would-you-require-biopsy-of-both-orbits-or-is-unilateral-biopsy-adequate-for-a-patient-with-suspected-bilateral-orbital-malt-lymphoma weekly 0.8 https://www.themednet.org/for-postmastectomy-patients-who-have-2-sentinel-nodes-involved-would-you-recommend-a-completion-axillary-dissection-or-proceed-with-pmrt weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-a-recurrent-brainstem-glioma weekly 0.8 https://www.themednet.org/what-is-the-significance-of-pni-in-cutaneous-bcc weekly 0.8 https://www.themednet.org/what-is-your-approach-to-discussing-risk-of-adverse-cardiovascular-events-in-patients-with-ra-whom-you-are-considering-starting-a-jak-inhibitor weekly 0.8 https://www.themednet.org/do-you-screen-for-paraneoplastic-antibodies-in-patients-with-suspected-als weekly 0.8 https://www.themednet.org/what-clinical-and-pathological-features-do-you-consider-when-deciding-which-androgen-receptor-targeted-agent-to-combine-with-adt-for-a-patient-with-newly-diagnosed-castrate-sensitive-metastatic-prostate-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-first-line-systemic-treatment-for-low-risk-gestational-trophoblastic-neoplasia weekly 0.8 https://www.themednet.org/what-is-your-approach-to-tapering-therapy-in-a-patient-with-recurrent-pericarditis-now-well-controlled-on-rilonacept weekly 0.8 https://www.themednet.org/how-would-you-treat-a-symptomatic-tongue-metastasis weekly 0.8 https://www.themednet.org/when-do-you-order-sseps-for-evaluation-of-multiple-sclerosis weekly 0.8 https://www.themednet.org/what-is-your-preferred-up-front-treatment-for-transplant-eligible-patients-with-primary-de-novo-plasma-cell-leukemia weekly 0.8 https://www.themednet.org/do-you-think-about-cdk4-6-inhibitor-selection-differently-in-a-patient-with-de-novo-rather-than-recurrent-metastatic-disease weekly 0.8 https://www.themednet.org/how-strict-are-you-about-adhering-to-the-eligibility-criteria-required-for-entry-onto-the-olympia-trial-in-considering-a-year-of-adjuvant-olaparib-as-adjuvant-therapy-for-brca-mutated-node-positive-er-positive-breast-cancer weekly 0.8 https://www.themednet.org/what-volumes-would-you-treat-and-what-dose-constraints-do-you-use-for-breast-and-lymphatic-re-irradiation weekly 0.8 https://www.themednet.org/how-would-you-approach-a-subcutaneous-oligometastatic-uterine-carcinosarcoma weekly 0.8 https://www.themednet.org/how-does-your-treatment-approach-vary-in-patients-with-hr-her2-breast-cancer-presenting-with-cns-metastases weekly 0.8 https://www.themednet.org/does-ivig-or-subcutaneous-ig-interfere-with-monoclonal-antibody-therapy-i-e-dupilumab-infliximab-rituximab-etc weekly 0.8 https://www.themednet.org/do-you-stop-hydroxyurea-or-switch-to-an-alternative-therapy-in-a-male-patient-with-controlled-hb-sc-disease-who-is-interested-in-having-children weekly 0.8 https://www.themednet.org/how-do-you-counsel-nsclc-patients-receiving-sbrt-on-fatigue weekly 0.8 https://www.themednet.org/have-you-had-success-using-resorcinol-15-topically-for-limited-hidradenitis weekly 0.8 https://www.themednet.org/would-you-consider-apbi-using-the-florence-regimen-in-patients-with-preexisting-breast-implants weekly 0.8 https://www.themednet.org/are-you-comfortable-combining-relugolix-with-enzalutamide-or-abiraterone weekly 0.8 https://www.themednet.org/what-is-the-significance-of-pni-in-oropharyngeal-cancer weekly 0.8 https://www.themednet.org/would-you-consider-regional-nodal-irradiation-for-a-patient-who-refused-initial-adjuvant-breast-rt-who-now-presents-with-locally-recurrent-multifocal-breast-cancer-s-p-lumpectomy-with-positive-margins-and-no-nodal-evaluation weekly 0.8 https://www.themednet.org/when-would-be-the-appropriate-time-to-refer-an-asymptomatic-young-adult-with-unicuspid-av-s-p-valvuloplasty-during-adolescence-for-avr-following-exercise-stress-tte-findings-demonstrating-increase-in-aortic-valve-mean-gradient-from-40mmhg-to-70mmhg-achiev weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-therapy-for-patients-with-advanced-ovarian-cancer-who-undergo-interval-debulking-surgery-following-six-cycles-of-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-is-the-role-of-a-simultaneous-integrated-boost-in-vulvar-cancer-to-the-primary-and-nodes weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-for-a-ct1n0m0-urothelial-carcinoma-of-the-ureter-high-grade-in-a-non-surgical-candidate-due-to-medical-comorbidities weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-acute-and-chronic-demodex-folliculitis weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-consider-in-patients-with-gallbladder-cancer-with-liver-metastases-that-are-resected-upfront weekly 0.8 https://www.themednet.org/how-would-you-approach-the-primary-treatment-of-a-rapidly-growing-uterine-carcinosarcoma-with-local-extension-through-the-anterior-abdominal-wall weekly 0.8 https://www.themednet.org/would-you-consider-using-a-jak-inhibitor-in-combination-with-an-il-23-inhibitor-in-cases-of-severe-psoriasis-psoriatic-arthritis-or-axial-spondyloarthritis-that-is-refractory-to-multiple-biologic-dmards weekly 0.8 https://www.themednet.org/should-testing-for-genetic-causes-of-hlh-be-performed-in-all-patients-with-mas-or-secondary-hlh-regardless-of-the-patients-age weekly 0.8 https://www.themednet.org/what-chemotherapy-regimen-would-you-use-for-a-testicular-cancer-patient-in-need-of-bepx3-but-unable-to-use-platinum-based-chemotherapy-regimen-due-to-cochlear-implants weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-active-lupus-nephritis-class-3-4-who-requires-pd-1-immunotherapy-for-refractory-metastatic-renal-cell-carcinoma weekly 0.8 https://www.themednet.org/what-treatment-would-you-recommend-for-a-patient-with-recurrent-oligometastatic-abdominal-leiomyosarcoma-with-two-liver-lesions weekly 0.8 https://www.themednet.org/what-is-your-approach-to-steroid-sparing-therapy-in-patients-with-suspected-ctd-ild weekly 0.8 https://www.themednet.org/how-would-you-approach-a-t3n1m0-mid-rectal-cancer-that-is-mmr-deficient weekly 0.8 https://www.themednet.org/how-much-decrease-in-egfr-do-you-tolerate-before-discontinuing-finerenone-started-in-patients-with-diabetic-kidney-disease weekly 0.8 https://www.themednet.org/do-you-obtain-periodic-kidney-ultrasounds-in-patients-with-stable-chronic-kidney-disease-to-evaluate-for-changes-in-kidney-size-that-might-reflect-progression-of-kidney-disease-not-detected-with-serum-studies weekly 0.8 https://www.themednet.org/how-do-you-approach-covid-19-vaccination-in-those-with-a-prior-history-of-glomerular-disease weekly 0.8 https://www.themednet.org/when-do-you-perform-a-kidney-biopsy-in-a-patient-with-aki-that-is-thought-to-be-related-to-an-immune-checkpoint-inhibitor weekly 0.8 https://www.themednet.org/are-there-preventative-measures-that-you-take-in-your-cancer-patients-with-chronic-kidney-disease-who-require-periodic-iodinated-contrast-ct-studies-for-monitoring-of-their-malignancy weekly 0.8 https://www.themednet.org/do-you-recommend-testing-for-g6pd-deficiency-in-those-with-whom-rasburicase-for-tumor-lysis-syndrome-is-indicated weekly 0.8 https://www.themednet.org/what-is-your-approach-to-thiazide-diuretic-use-in-those-with-uncontrolled-hypertension-and-advanced-chronic-kidney-disease weekly 0.8 https://www.themednet.org/what-is-your-daily-correction-goal-for-those-patients-being-treated-for-hypernatremia weekly 0.8 https://www.themednet.org/do-you-use-24-hour-urine-stone-risk-profiles-for-purposes-other-than-managing-nephrolithiasis weekly 0.8 https://www.themednet.org/what-therapies-have-you-found-most-effective-in-treating-teenagers-with-recurrent-carp weekly 0.8 https://www.themednet.org/what-nutritional-supplements-do-you-recommend-for-patients-with-hair-loss weekly 0.8 https://www.themednet.org/in-what-circumstances-would-you-stop-therapy-for-patients-with-metastatic-her2-breast-cancer-with-long-term-complete-response-to-her2-directed-therapy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-local-recurrence-of-a-spinal-hemangioblastoma-following-prior-surgical-resection-alone weekly 0.8 https://www.themednet.org/would-you-consider-thrombophilia-testing-in-a-pregnant-patient-with-vte weekly 0.8 https://www.themednet.org/do-you-repeat-images-in-patients-with-venous-thrombosis-to-inform-decision-about-duration-of-anticoagulation weekly 0.8 https://www.themednet.org/do-you-discontinue-or-adjust-azathioprine-when-a-patient-develops-elevated-mcv-after-starting-it weekly 0.8 https://www.themednet.org/how-do-you-manage-an-infection-that-occurs-in-the-treatment-field-while-under-treatment weekly 0.8 https://www.themednet.org/how-do-you-manage-surveillance-imaging-for-patients-with-metastatic-castration-naive-prostate-cancer-with-an-initial-low-psa weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-pmr-on-steroids-over-a-prolonged-initial-course-who-start-to-experience-weakness-concerning-for-steroid-myopathy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-considered-to-be-unfit-for-cystectomy-with-recurrent-nmibc-refractory-to-bcg-failed-pembrolizumab-and-unable-to-do-more-intravesical-rx weekly 0.8 https://www.themednet.org/what-goes-into-your-decision-making-when-deciding-between-superficial-radiation-and-mohs-surgery-for-cutaneous-squamous-cell-carcinoma-of-the-head-and-neck weekly 0.8 https://www.themednet.org/would-you-feel-comfortable-combining-mmf-and-an-il-17-blocker-in-a-patient-with-both-limited-scleroderma-and-psoriatic-arthritis weekly 0.8 https://www.themednet.org/what-is-the-role-of-adjuvant-radiation-for-gastric-cancer-found-to-be-locally-advanced-after-up-front-surgery-in-the-setting-of-d2-but-r0-resection weekly 0.8 https://www.themednet.org/do-you-anticipate-a-paradigm-shift-in-first-line-treatment-of-multiple-myeloma-from-rvd-to-immune-therapy-with-car-t-bispecifics weekly 0.8 https://www.themednet.org/what-is-your-approach-for-using-anticoagulation-aspirin-in-patients-with-multiple-myeloma weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-low-grade-follicular-lymphoma-stage-ie-of-the-breast-who-presents-with-local-recurrence-1-year-s-p-lumpectomy weekly 0.8 https://www.themednet.org/what-systemic-therapy-would-you-offer-a-patient-with-metastatic-melanoma-who-is-braf-wt-and-developed-metastases-while-on-adjuvant-nivolumab weekly 0.8 https://www.themednet.org/given-radicals-hd-are-you-completing-24-mo-vs-6-mo-of-adt-with-xrt-following-rp weekly 0.8 https://www.themednet.org/would-you-offer-radiation-therapy-post-lumpectomy-for-a-small-melanoma-oligometastasis-with-negative-margins weekly 0.8 https://www.themednet.org/would-you-substitute-carfilzomib-in-place-of-bortezomib-in-a-transplant-eligible-al-amyloidosis-patient-with-baseline-amyloid-neuropathy-and-worsening-neuropathy-on-bortezomib-despite-maximal-dose-reduction weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-diagnosis-and-management-of-lupus-cystitis weekly 0.8 https://www.themednet.org/which-group-of-stage-iii-msi-h-colon-cancer-patients-can-be-excluded-from-receiving-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/would-you-proceed-to-anthracycline-based-neoadjuvant-regimen-for-locally-advanced-triple-negative-breast-cancer-without-clinical-response-to-neoadjuvant-paclitaxel-or-proceed-to-surgery weekly 0.8 https://www.themednet.org/which-tumor-markers-if-any-would-you-use-to-follow-patients-with-high-grade-or-advanced-endometrial-cancers weekly 0.8 https://www.themednet.org/granted-adequate-target-coverage-do-you-constrain-dose-to-sub-volumes-of-the-heart-when-treating-locally-advanced-lung-cancer weekly 0.8 https://www.themednet.org/is-there-benefit-in-switching-between-sonedegib-to-vismodegib-or-vice-versa-for-patients-with-unresectable-basal-cell-carcinoma-of-the-face-that-progresses-on-first-line-hedgehog-inhibitor weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-brca-1-mutations-regarding-the-role-of-hysterectomy-as-a-part-of-risk-reducing-surgery weekly 0.8 https://www.themednet.org/do-you-offer-ovarian-transposition-to-premenopausal-cervical-cancer-patients-prior-to-chemoradiation-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-post-op-management-of-a-patient-s-p-bso-for-cystic-pelvic-mass-with-fallopian-stic-lesion-on-final-pathology weekly 0.8 https://www.themednet.org/has-anyone-used-radiation-to-treat-a-plantar-wart-not-responding-to-other-modalities weekly 0.8 https://www.themednet.org/would-you-introduce-ar-targeted-therapy-if-a-patient-has-already-been-successfully-treated-with-lhrh-for-low-risk-low-volume-metastatic-hormone-sensitive-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-newly-diagnosed-stage-iv-embryonal-rhabdomyosarcoma weekly 0.8 https://www.themednet.org/when-would-you-consider-transplant-for-a-patient-with-a-bone-marrow-failure-syndrome-fa-dc-etc weekly 0.8 https://www.themednet.org/what-is-your-dose-and-target-for-a-h3k27m-mutant-diffuse-midline-glioma-in-a-young-adult-following-maximal-safe-resection weekly 0.8 https://www.themednet.org/would-you-recommend-anticoagulation-for-patients-with-partial-false-lumen-thrombosis-in-type-b-aortic-dissection weekly 0.8 https://www.themednet.org/how-would-you-approach-metastatic-nsclc-adenocarcinoma-without-brain-mets-with-pd-l1-50-and-braf-v600e-driver-mutation weekly 0.8 https://www.themednet.org/for-a-breast-cancer-patient-who-previously-underwent-lumpectomy-sln-biopsy-and-pbi-with-brachytherapy-what-volume-would-you-treat-for-an-isolated-axillary-recurrence-s-p-alnd-and-chemo weekly 0.8 https://www.themednet.org/how-do-you-manage-severe-raynauds-phenomenon-with-ulceration-in-scleroderma-patients-that-is-refractory-to-oral-agents-ccbs-pdeis-arbs-and-eras weekly 0.8 https://www.themednet.org/is-there-a-role-for-post-operative-elective-nodal-irradiation-in-locally-advanced-sinonasal-clinically-n0-intestinal-type-adenocarcinoma-itac weekly 0.8 https://www.themednet.org/do-you-offer-surveillance-brain-imaging-for-patients-with-egfr-nsclc-stable-systemic-disease-on-tki-and-no-history-of-metastatic-brain-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-the-pharmacologic-management-of-cancer-related-fatigue weekly 0.8 https://www.themednet.org/do-you-use-precision-medicine-tools-such-as-rna-testing-prism-ra-in-clinical-practice-before-starting-a-tnf-inhibitor-for-ra weekly 0.8 https://www.themednet.org/does-serologic-activity-e-g-high-titer-dsdna-low-complements-without-clinical-disease-activity-in-a-pregnant-lupus-patient-affect-maternal-or-fetal-outcomes weekly 0.8 https://www.themednet.org/how-would-you-manage-a-stage-ib-endometrioid-endometrial-cancer-status-post-staging-surgery-with-a-rapid-vaginal-recurrence-1-month-post-operatively weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-systemic-therapy-for-a-patient-with-a-history-of-localized-triple-negative-breast-cancer-7-years-prior-for-which-she-received-adjuvant-ac-t-now-presenting-with-another-ipsilateral-t1cn0-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-a-young-post-menopausal-woman-with-a-grade-3-pt1a-5mm-node-negative-er-her2-invasive-ductal-carcinoma weekly 0.8 https://www.themednet.org/how-long-would-you-wait-after-palliative-short-course-radiation-i-e-30gy-10-fractions-in-metastatic-nsclc-before-initiation-of-chemo-immunotherapy weekly 0.8 https://www.themednet.org/what-systemic-therapy-would-you-recommend-for-metastatic-pleomorphic-dermal-sarcoma-with-a-large-inoperable-solitary-lung-metastasis-that-is-too-large-for-radiotherapy weekly 0.8 https://www.themednet.org/what-is-your-bladder-constraint-for-ldr-prostate-brachy weekly 0.8 https://www.themednet.org/in-a-patient-with-squamous-vulvar-cancer-previously-treated-with-cisplatin-and-radiotherapy-and-now-with-widely-metastatic-recurrence-would-you-initiate-treatment-with-chemotherapy-or-consider-immunotherapy weekly 0.8 https://www.themednet.org/what-small-bowel-dose-constraints-do-you-use-when-treating-with-short-course-radiation-for-rectal-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-on-demand-versus-fixed-schedule-dosing-for-rituximab-maintenance-in-anca-vasculitis weekly 0.8 https://www.themednet.org/how-would-you-manage-subsequent-treatment-for-a-patient-with-metastatic-er-her2-breast-cancer-that-develops-pneumonitis-on-a-cdk4-6-inhibitor-but-had-an-excellent-response-to-therapy weekly 0.8 https://www.themednet.org/is-radiation-therapy-a-treatment-option-for-refractory-pagets-disease-of-the-vulva-extending-onto-skin-of-buttocks-and-anal-margin weekly 0.8 https://www.themednet.org/do-you-utilize-consolidative-rt-for-oligometastatic-hpv-positive-head-neck-cancer-with-stable-disease-on-immunotherapy weekly 0.8 https://www.themednet.org/how-would-you-manage-rt-for-a-locally-advanced-squamous-cell-carcinoma-of-the-anal-canal-in-a-90-year-old-if-chemotherapy-is-not-recommended weekly 0.8 https://www.themednet.org/what-is-your-institutional-protocol-for-an-incidental-finding-of-an-adnexal-cyst-on-ct-simulation-for-cervical-cancer weekly 0.8 https://www.themednet.org/what-would-be-the-recommended-management-for-patients-with-rectal-adenocarcinoma-with-rectovaginal-fistula-at-presentation weekly 0.8 https://www.themednet.org/how-would-you-approach-therapy-in-a-young-adult-with-synovial-sarcoma-of-the-head-and-neck-who-is-not-amenable-to-surgery-due-to-location-on-the-face weekly 0.8 https://www.themednet.org/what-is-the-role-of-rt-for-a-patient-with-double-hit-dlbcl-and-a-single-site-of-relapse-who-can-no-longer-tolerate-chemotherapy weekly 0.8 https://www.themednet.org/are-there-any-special-radiotherapy-considerations-for-women-who-have-double-lumpectomy weekly 0.8 https://www.themednet.org/how-would-you-deliver-pelvic-radiation-as-cost-efficiently-as-possible-for-a-patient-with-endometrial-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-a-fit-older-70-years-with-grade-i-ii-bulky-follicular-lymphoma-causing-ureteral-obstruction-and-renal-failure weekly 0.8 https://www.themednet.org/in-the-setting-of-adjuvant-treatment-for-locally-advanced-oral-cavity-cancer-would-you-offer-altered-hypofractionated-courses-for-elderly-patients-with-lower-functional-status weekly 0.8 https://www.themednet.org/with-the-increased-use-of-gemtuzumab-in-induction-chemotherapy-for-children-with-acute-myeloid-leukemia-would-you-change-conditioning-regimens-to-help-prevent-sinusoidal-obstruction-syndrome-during-hematopoietic-stem-cell-transplant weekly 0.8 https://www.themednet.org/is-there-any-role-for-direct-oral-anticoagulants-in-the-treatment-of-antiphospholipid-syndrome weekly 0.8 https://www.themednet.org/do-you-extrapolate-from-uveitis-treatment-pathways-when-managing-other-inflammatory-eye-conditions-such-as-atypical-serpiginous-choroiditis weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-cn0-breast-cancer-who-has-high-risk-features-but-did-not-have-a-sentinel-node-biopsy weekly 0.8 https://www.themednet.org/would-you-consider-staging-lymph-node-dissection-for-a-patient-referred-for-stage-ia-endometrial-cancer-and-melf-pattern-on-final-pathology weekly 0.8 https://www.themednet.org/is-it-safe-to-treat-checkpoint-inhibitor-induced-arthritis-with-methotrexate-or-biologics weekly 0.8 https://www.themednet.org/would-you-consider-giving-flot-entirely-in-the-neoadjuvant-setting-for-resectable-gastric-cancer weekly 0.8 https://www.themednet.org/how-does-your-management-of-itp-change-when-related-to-cll weekly 0.8 https://www.themednet.org/under-what-circumstances-if-any-would-you-offer-hysterectomy-after-completion-of-primary-chemoradiation-for-locally-advanced-cervical-cancer weekly 0.8 https://www.themednet.org/do-you-follow-patients-with-elevated-esr-crp-if-their-work-up-for-rheumatologic-etiology-is-unrevealing-and-no-other-cause-is-identified weekly 0.8 https://www.themednet.org/are-there-certain-subsets-of-anca-vasculitis-patients-for-whom-you-would-consider-life-long-maintenance-therapy weekly 0.8 https://www.themednet.org/in-what-situations-if-any-would-you-recommend-eni-for-a-low-grade-parotid-mucoepidermoid-carcinoma weekly 0.8 https://www.themednet.org/how-would-you-approach-moderate-neutropenia-anc-1000-in-a-solid-organ-transplant-recipient weekly 0.8 https://www.themednet.org/when-are-increased-flank-doses-beneficial-in-stage-iii-wilms-tumor weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-proton-therapy-for-whole-ventricular-radiation-for-intracranial-germinoma-after-chemotherapy weekly 0.8 https://www.themednet.org/would-you-utilize-single-fraction-palliative-radiation-therapy-for-a-large-bone-metastasis weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-braf-v600e-mutated-dmmr-stage-ii-colon-cancer weekly 0.8 https://www.themednet.org/what-is-you-approach-for-first-line-treatment-in-an-elderly-patient-85-years-of-age-with-good-ps-and-a-hairy-cell-leukemia-variant weekly 0.8 https://www.themednet.org/how-would-you-treat-recurrent-unresectable-sarcoma-in-previously-irradiated-maxillary-region-with-no-distant-metastatic-disease weekly 0.8 https://www.themednet.org/is-it-ever-appropriate-to-initiate-a-higher-initial-dose-of-allopurinol-such-as-300mg-daily-than-is-typically-recommended-in-gout-patients-at-low-risk-of-allopurinol-hypersensitivity-syndrome-and-severe-hyperuricemia weekly 0.8 https://www.themednet.org/how-do-you-decide-between-systemic-vs-arterially-directed-therapies-in-the-first-line-setting-for-unresectable-hcc weekly 0.8 https://www.themednet.org/how-do-you-boost-a-positive-parametrial-margin-in-endometrial-cancer-after-tah-bso weekly 0.8 https://www.themednet.org/are-there-patients-who-can-forgo-anticoagulation-with-asymptomatic-incidentally-discovered-subsegmental-pulmonary-embolism weekly 0.8 https://www.themednet.org/would-you-consider-robotic-lymph-node-dissection-and-parametrectomy-for-a-patient-with-incidental-stage-1a2-cervical-cancer-after-simple-hysterectomy weekly 0.8 https://www.themednet.org/is-radiation-therapy-contraindicated-in-the-setting-of-an-active-abdominopelvic-infection weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-in-a-patient-with-a-solitary-plasmacytoma-with-minimal-marrow-involvement-10-clonal-plasma-cells weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-who-experience-widespread-progression-on-egfr-inhibitors-found-to-have-met-amplification-on-tumor-biopsy-in-addition-to-sensitizing-egfr-mutation weekly 0.8 https://www.themednet.org/what-bladder-constraints-do-you-use-for-prostate-cancer-patients-who-have-a-completely-empty-bladder weekly 0.8 https://www.themednet.org/how-would-you-sequence-chemotherapy-and-radiotherapy-for-a-patient-with-stage-iiic1-serous-endometrial-carcinoma weekly 0.8 https://www.themednet.org/do-you-think-there-is-a-role-for-belimumab-in-treating-lupus-nephritis-and-if-so-in-which-patients-would-you-considering-adding-it-on weekly 0.8 https://www.themednet.org/for-patients-with-hcc-that-have-stable-disease-on-immunotherapy-alone-would-you-consider-adding-bevacizumab-at-the-time-of-disease-progression-and-continue-immunotherapy weekly 0.8 https://www.themednet.org/are-there-any-biomarkers-that-might-indicate-who-might-be-responders-to-atezolizumab-bevacizumab-for-hcc weekly 0.8 https://www.themednet.org/when-would-you-continue-atezolizumab-bevacizumab-beyond-progression-in-advanced-hcc weekly 0.8 https://www.themednet.org/how-do-you-manage-intramedullary-spinal-cord-metastases-in-the-presence-of-previous-radiotherapy weekly 0.8 https://www.themednet.org/how-would-you-modify-adjuvant-radiation-for-oral-cavity-scc-based-on-the-presence-of-sarcomatoid-features weekly 0.8 https://www.themednet.org/what-radiation-dose-would-you-use-when-giving-definitive-chemoradiation-for-inoperable-rectal-cancer-with-extensive-invasion-into-gluteal-musculature weekly 0.8 https://www.themednet.org/how-do-you-approach-salvage-of-a-local-only-recrurrence-of-prostate-cancer-after-definitive-external-beam-radiation weekly 0.8 https://www.themednet.org/how-would-you-adjust-your-supraclavicular-field-if-at-all-for-a-patient-with-a-remote-history-of-receiving-radioactive-iodine-ablation-for-thyroid-disease weekly 0.8 https://www.themednet.org/how-do-you-treat-a-primary-pineal-neoplasm-of-intermediate-differentiation weekly 0.8 https://www.themednet.org/what-is-your-inflammatory-arthritis-differential-when-a-patient-presents-with-unilateral-tmj-synovitis weekly 0.8 https://www.themednet.org/what-adjuvant-treatment-would-you-recommend-for-stage-iii-vulvar-cancer-s-p-resection-with-a-history-of-prior-radiation-treatment-for-vaginal-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-getting-a-muscle-biopsy-in-a-patient-with-suspected-imnm-with-statin-exposure-weakness-elevated-ck-and-positive-hmgcr-antibody weekly 0.8 https://www.themednet.org/should-jak-inhibitors-and-anti-il6-medications-be-avoided-in-patients-with-known-diverticulosis weekly 0.8 https://www.themednet.org/how-do-you-approach-sbrt-liver-constraints-when-the-total-liver-volume-is-700-cc weekly 0.8 https://www.themednet.org/which-neoadjuvant-chemotherapy-regimen-would-you-use-in-a-young-premenopausal-woman-with-a-rapidly-growing-clinical-node-positive-poorly-differentiated-tnbc-with-a-germline-palb2-mutation weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-stage-iii-unresectable-combined-histology-nsclc-sclc weekly 0.8 https://www.themednet.org/are-there-any-special-considerations-for-treatment-of-metastatic-acral-melanoma weekly 0.8 https://www.themednet.org/would-you-offer-neoadjuvant-chemotherapy-to-a-patient-with-high-risk-non-muscle-invasive-urothelial-carcinoma-for-whom-cystectomy-is-planned weekly 0.8 https://www.themednet.org/what-is-your-approach-to-monitoring-lipids-in-patients-with-rheumatic-diseases-such-as-ra-and-sle-and-do-you-have-a-lower-threshold-to-start-lipid-lowering-agents-compared-to-the-general-population weekly 0.8 https://www.themednet.org/what-is-the-role-of-hydroxyurea-in-variant-sickle-cell-genotypes weekly 0.8 https://www.themednet.org/do-you-recommend-neoadjuvant-and-concurrent-adt-vs-concurrent-adt-for-salvage-post-prostatectomy-radiation weekly 0.8 https://www.themednet.org/what-bladder-filling-protocol-do-you-use-when-treating-children-with-bladder-neck-rhabdomyosarcoma-with-definitive-radiotherapy-vmat weekly 0.8 https://www.themednet.org/is-there-any-evidence-that-radiotherapy-can-worsen-balance-dizziness-or-vertigo-in-patients-treated-for-vestibular-schwannoma-due-to-transient-edema weekly 0.8 https://www.themednet.org/what-is-the-maximum-cumulative-anthracycline-dose-you-would-administer-in-a-patient-with-metastatic-soft-tissue-sarcoma-who-is-asymptomatic-with-good-disease-control weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiation-in-addition-to-chemotherapy-for-a-patient-with-stage-iiic-uterine-carcinosarcoma-with-cervical-involvement weekly 0.8 https://www.themednet.org/what-is-the-maximum-cumulative-anthracycline-dose-you-would-administer-in-a-patient-with-metastatic-breast-cancer-who-is-asymptomatic-with-good-disease-control-on-liposomal-doxorubicin weekly 0.8 https://www.themednet.org/which-patients-may-benefit-from-eculizumab-in-refractory-aps weekly 0.8 https://www.themednet.org/how-do-you-counsel-takayasu-patients-on-their-prognosis weekly 0.8 https://www.themednet.org/is-it-acceptable-to-use-tchp-instead-of-ac-t-trastuzumab-as-neoadjuvant-chemotherapy-for-her2-inflammatory-breast-cancer weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-for-1-3-node-positive-hr-her2-negative-breast-cancer-with-mammaprint-low-risk-to-a-young-pre-menopausal-patient weekly 0.8 https://www.themednet.org/do-you-have-a-preferred-therapy-for-patients-with-metastatic-gastroenteropancreatic-gep-neuroendocrine-tumors-that-progressed-through-octreotide-and-prrt weekly 0.8 https://www.themednet.org/when-is-a-bone-marrow-biopsy-indicated-in-the-up-front-evaluation-of-an-aya-patient-with-ewing-sarcoma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-ct3n0m0-mid-rectal-adenocarcinoma-with-clear-circumferential-resection-margins-on-mri weekly 0.8 https://www.themednet.org/are-there-any-situations-in-which-you-would-consider-starting-steroid-sparing-agents-at-the-outset-for-patients-with-scleritis-without-any-evidence-of-systemic-rheumatic-disease weekly 0.8 https://www.themednet.org/would-you-treat-regional-nodes-in-a-patient-with-complete-pathologic-response-on-axillary-dissection-after-neoadjuvant-chemo-for-isolated-axillary-recurrence weekly 0.8 https://www.themednet.org/in-gout-do-msu-crystals-form-only-in-tissue-or-are-there-circulating-microcrystals-of-msu-within-blood-vessels weekly 0.8 https://www.themednet.org/at-what-point-in-gca-management-do-you-typically-introduce-tocilizumab weekly 0.8 https://www.themednet.org/how-do-you-handle-hypogammaglobulinemia-detected-in-patients-prior-to-maintenance-rituximab-infusion weekly 0.8 https://www.themednet.org/would-you-offer-chemotherapy-to-a-postmenopausal-woman-with-microinvasive-er-pr-positive-her2-negative-invasive-ductal-carcinoma-with-a-single-lymph-node-metastasis-and-insufficient-tissue-for-oncotype-testing weekly 0.8 https://www.themednet.org/do-you-re-test-patients-who-test-positive-for-covid-19-during-or-prior-to-starting-cancer-treatment weekly 0.8 https://www.themednet.org/would-you-consider-hrt-after-bso-in-a-pre-menopausal-gbrca2-patient-who-has-no-intention-of-ever-having-prophylactic-bilateral-mastectomies-and-who-declines-chemoprophylaxis weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-regarding-initiation-of-total-parenteral-nutrition-tpn-with-malignant-small-bowel-obstruction weekly 0.8 https://www.themednet.org/what-would-be-your-choice-of-therapy-in-a-fit-patient-with-relapsed-cll-previously-treated-with-bendamustine-and-rituximab-who-does-not-want-btk-inhibitor-therapy weekly 0.8 https://www.themednet.org/outside-of-a-clinical-trial-do-you-currently-incorporate-the-tcga-molecular-classification-into-management-decisions-for-patients-with-endometrial-cancer weekly 0.8 https://www.themednet.org/is-extranodal-extension-of-pn1-nsclc-an-indication-to-offer-port weekly 0.8 https://www.themednet.org/is-a-patient-with-secondary-myeloid-sarcoma-a-candidate-for-hematopoietic-stem-cell-transplant weekly 0.8 https://www.themednet.org/do-you-constrain-dose-to-the-muscles-of-mastication-in-definitive-and-or-post-op-hn-rt-to-lower-the-risk-of-trismus weekly 0.8 https://www.themednet.org/how-do-you-risk-stratify-complex-karyotype-in-newly-diagnosed-multiple-myeloma-in-the-absence-of-specific-high-risk-cytogenetic-abnormalities weekly 0.8 https://www.themednet.org/how-would-you-manage-a-small-recurrent-melanoma-of-the-lower-eyelid-in-a-patient-deemed-inoperable weekly 0.8 https://www.themednet.org/would-you-offer-rituximab-maintenance-for-2-years-after-a-successful-response-to-induction-in-a-patient-with-splenic-marginal-zone-lymphoma weekly 0.8 https://www.themednet.org/should-platelet-transfusions-be-considered-for-anti-platelet-agent-reversal-in-patients-with-major-bleeding weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-localized-prostate-cancer-treated-with-radical-prostatectomy-and-found-to-have-a-single-involved-pelvic-lymph-node-on-final-pathology-and-a-detectable-postoperative-psa weekly 0.8 https://www.themednet.org/is-there-a-role-for-external-radiation-and-or-brachytherapy-in-stage-ivb-vaginal-cancer-aside-from-palliation weekly 0.8 https://www.themednet.org/in-gej-or-gastric-cancers-do-you-routinely-image-after-surgery-prior-to-resuming-systemic-therapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-refractory-thrombocytopenia-in-lupus weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-squamous-nsclc-with-nrg1-amplification-no-fusion-who-has-progressed-on-first-line-treatment weekly 0.8 https://www.themednet.org/what-do-you-use-for-treatment-induction-in-pure-class-v-lupus-nephritis-with-nephrotic-range-proteinuria-when-mmf-is-contraindicated weekly 0.8 https://www.themednet.org/what-kidney-constraints-would-you-use-for-a-patient-with-horseshoe-kidney weekly 0.8 https://www.themednet.org/what-is-your-preferred-adjuvant-systemic-treatment-for-resected-stage-iv-melanoma-with-a-braf-mutation weekly 0.8 https://www.themednet.org/do-you-repeat-somatic-tumor-testing-for-ovarian-cancer-patients-after-recurrence weekly 0.8 https://www.themednet.org/how-does-the-presence-of-myositis-alter-your-interpretation-of-cardiac-enzymes-when-evaluating-acute-chest-pain weekly 0.8 https://www.themednet.org/what-steroid-sparing-agent-do-you-use-for-treatment-of-cardiac-sarcoidosis weekly 0.8 https://www.themednet.org/how-do-you-incorporate-high-dose-chemotherapy-with-autologous-stem-cell-rescue-for-a-patient-with-relapsed-metastatic-ewing-sarcoma weekly 0.8 https://www.themednet.org/what-is-the-biologic-of-choice-in-a-patient-with-ra-and-history-of-non-melanoma-skin-cancer weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-patient-with-hr-her2-breast-cancer-with-an-oncotypedx-ror-score-of-0-who-is-refusing-endocrine-therapy weekly 0.8 https://www.themednet.org/when-would-you-offer-anthracycline-based-adjuvant-chemotherapy-for-a-t1cn0-tnbc weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-a-fully-resected-vulvar-carcinoma-with-a-single-positive-lymph-node weekly 0.8 https://www.themednet.org/what-are-the-benefits-of-sending-hla-b27-genotype-over-hla-b27-antigen-when-evaluating-for-spondyloarthritis weekly 0.8 https://www.themednet.org/when-do-you-discontinue-parp-inhibitor-maintenance-after-complete-response-to-first-line-chemotherapy-in-a-brca-patient weekly 0.8 https://www.themednet.org/do-you-recommend-testing-for-ugt1a1-prior-to-initiating-sacituzimab-govitecan-for-patients-with-metastatic-tnbc-to-mitigate-neutropenia-risk weekly 0.8 https://www.themednet.org/what-palliative-systemic-treatment-would-you-consider-for-a-patient-with-an-extensive-klatskin-tumor-with-associated-hyperbilirubinemia-bilirubin-20-not-amenable-to-local-intervention weekly 0.8 https://www.themednet.org/is-it-acceptable-to-treat-vulvar-cancers-with-split-course-radiation weekly 0.8 https://www.themednet.org/what-second-line-therapy-would-you-use-for-metastatic-clear-cell-rcc-after-a-6-12-month-response-to-ipilimumab-nivolumab-followed-by-development-of-multiple-bone-metastases-but-stable-soft-tissue-disease weekly 0.8 https://www.themednet.org/do-you-recommend-sentinel-node-biopsy-or-alnd-in-ct4-or-ct3-cn0-breast-cancer-patients weekly 0.8 https://www.themednet.org/do-you-correct-the-synovial-fluid-white-blood-cell-count-for-red-blood-cells-and-if-so-is-there-a-rough-approximation-equation-you-use weekly 0.8 https://www.themednet.org/in-locally-advanced-egfr-mutated-nsclc-with-initial-good-response-to-osimertinib-how-do-you-manage-local-progression-of-the-primary weekly 0.8 https://www.themednet.org/when-if-ever-would-you-cover-the-clinically-uninvolved-contralateral-oropharynx-when-treating-a-well-lateralized-oropharyngeal-cancer-of-the-head-and-neck weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-pv-or-et-who-is-experiencing-breakthrough-thrombosis weekly 0.8 https://www.themednet.org/would-the-presence-of-multifocal-lvsi-change-your-adjuvant-treatment-recommendation-for-a-surgically-staged-ia-dedifferentiated-endometrial-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-incorporate-denosumab-into-the-surgical-management-of-giant-cell-tumor-of-bone weekly 0.8 https://www.themednet.org/in-a-patient-with-metastatic-prostate-cancer-on-abiraterone-planning-to-start-radium-223-what-is-the-minimum-interval-between-the-last-dose-of-abiraterone-and-the-first-dose-of-radium weekly 0.8 https://www.themednet.org/when-would-you-recommend-radiation-therapy-for-an-asymptomatic-pathologic-fracture-in-a-vertebral-body weekly 0.8 https://www.themednet.org/would-you-consider-lymphovascular-invasion-at-the-margin-to-be-a-positive-margin-in-breast-cancer-surgery weekly 0.8 https://www.themednet.org/do-you-recommend-long-term-anticoagulation-for-all-patients-with-first-time-unprovoked-vte weekly 0.8 https://www.themednet.org/how-do-you-proceed-with-treatment-of-a-patient-with-stage-iiib-nsclc-who-progresses-during-treatment-with-concurrent-weekly-carboplatin-paclitaxel-and-radiation weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-uc-and-a-j-pouch-presenting-with-basaloid-carcinoma-of-the-prostate-who-is-not-a-surgical-candidate weekly 0.8 https://www.themednet.org/in-what-head-and-neck-subsites-if-any-would-you-recommend-adjuvant-radiation-s-p-high-quality-neck-dissection-if-pn1-disease-single-ipsilateral-ln-3cm-was-the-only-risk-factor weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-presenting-with-pancytopenia-and-splenomegaly-whose-bone-marrow-biopsy-is-morphologically-normal-but-has-a-positive-philadelphia-chromosome-in-bone-marrow-as-well-as-peripheral-blood weekly 0.8 https://www.themednet.org/how-do-you-approach-hotspots-heterogeneity-for-palliative-radiation-plans weekly 0.8 https://www.themednet.org/how-would-you-treat-a-sebaceous-carcinoma-of-the-orbit-definitively-with-radiation-if-they-refuse-exenteration weekly 0.8 https://www.themednet.org/would-you-use-a-parp-inhibitor-in-metastatic-er-pr-positive-breast-cancer-with-somatic-brca1-mutation-but-negative-for-germline-mutation weekly 0.8 https://www.themednet.org/when-would-you-include-the-superior-mediastinal-lymph-nodes-when-treating-head-neck-cancer-and-how-do-you-define-the-target-volume weekly 0.8 https://www.themednet.org/in-what-situations-do-you-utilize-motion-management-of-the-optic-structures weekly 0.8 https://www.themednet.org/what-is-the-target-ferritin-level-for-patients-with-hereditary-hemochromatosis-and-signs-of-end-organ-damage weekly 0.8 https://www.themednet.org/does-the-presence-of-cribiform-histology-at-biopsy-in-prostate-cancer-affect-your-management-in-an-otherwise-intermediate-risk-prostate-cancer weekly 0.8 https://www.themednet.org/would-you-offer-elective-rt-for-an-early-stage-high-grade-penile-cancer-sp-partial-penectomy-who-cannot-undergo-groin-sampling-sn-biopsy weekly 0.8 https://www.themednet.org/for-aya-patients-with-early-stage-hodgkins-lymphoma-being-treated-with-abvd-how-many-cycles-of-chemotherapy-do-you-administer-and-when-can-radiation-be-avoided weekly 0.8 https://www.themednet.org/in-which-patients-with-atypical-hus-would-you-consider-eculizumab-discontinuation weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-a-young-inflammatory-breast-cancer-patient-after-a-cr-to-neoadj-chemo-but-refuses-surgery weekly 0.8 https://www.themednet.org/what-is-your-threshold-for-pursuing-bone-marrow-biopsy-in-a-lupus-patient-with-cytopenias weekly 0.8 https://www.themednet.org/how-would-you-approach-localized-lymphadenopathy-in-a-patient-with-lupus-whose-symptoms-are-otherwise-well-controlled weekly 0.8 https://www.themednet.org/how-many-days-do-you-hold-osimertinib-during-or-around-sbrt-for-oligometastatic-egfr-mutated-advanced-lung-cancer weekly 0.8 https://www.themednet.org/do-you-avoid-adding-high-energy-photons-with-associated-neutrons-for-younger-breast-cancer-patients-out-of-concern-for-secondary-malignancy-risk weekly 0.8 https://www.themednet.org/how-would-you-approach-an-early-inguinal-recurrence-after-surgical-resection-of-merkel-cell-carcinoma-in-the-popliteal-region weekly 0.8 https://www.themednet.org/do-you-escalate-treatment-in-patients-with-myositis-who-achieve-clinical-remission-but-continue-to-have-elevated-cpk weekly 0.8 https://www.themednet.org/what-dose-fractionation-scheme-do-you-recommend-for-the-treatment-of-leukemia-cutis weekly 0.8 https://www.themednet.org/how-many-years-of-oral-antibiotics-prophylaxis-do-you-recommend-for-a-teenager-with-hereditary-spherocytosis-post-splenectomy weekly 0.8 https://www.themednet.org/what-is-your-criteria-for-undetectable-psa-value-after-prostatectomy weekly 0.8 https://www.themednet.org/how-do-you-workup-erythrocytosis-with-a-normal-or-elevated-serum-erythropoietin weekly 0.8 https://www.themednet.org/can-liquid-biopsy-be-substituted-for-tissue-biopsy-in-a-lung-mass-that-is-radiologically-suspicious-for-primary-lung-cancer-when-ct-guided-biopsy-cannot-be-done weekly 0.8 https://www.themednet.org/what-lung-constraints-do-you-use-for-early-stage-breast-hypofractionation weekly 0.8 https://www.themednet.org/is-there-any-benefit-in-continuing-vrd-instead-of-vr-as-maintenance-therapy-in-transplant-ineligible-multiple-myeloma weekly 0.8 https://www.themednet.org/would-you-ever-consider-srs-as-a-salvage-option-as-an-alternative-to-whole-brain-radiation-for-secondary-cns-lymphoma weekly 0.8 https://www.themednet.org/for-persistent-localized-muscle-invasive-bladder-cancer-following-chemoradiation-in-patients-who-are-not-surgical-candidates-what-is-an-appropriate-next-therapy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-are-candidates-for-a-clinical-trial-regarding-their-options weekly 0.8 https://www.themednet.org/how-would-you-manage-an-elderly-patient-with-clinical-stage-iiic-er-positive-breast-cancer-who-refuses-surgery-chemo-and-radiation-treatment-and-willing-to-take-only-oral-medications weekly 0.8 https://www.themednet.org/when-might-you-recommend-adjuvant-chemotherapy-for-fully-staged-resected-stage-ia-clear-cell-ovarian-carcinoma weekly 0.8 https://www.themednet.org/what-dose-constraints-do-you-use-for-the-stomach-in-conventionally-fractionated-definitive-chemoradiation-for-a-large-lll-primary-tumor weekly 0.8 https://www.themednet.org/what-are-your-recommendations-for-post-menopausal-patients-who-would-fit-into-rxponder-trial-criteria-hr-her2-breast-cancer-1-3-positive-lns-and-have-already-started-on-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/would-uterine-serosal-involvement-change-your-adjuvant-treatment-recommendation-for-a-patient-with-stage-ii-grade-2-endometrial-cancer weekly 0.8 https://www.themednet.org/how-do-you-treat-patients-with-newly-diagnosed-metastatic-mit-family-translocation-renal-cell-carcinoma weekly 0.8 https://www.themednet.org/how-would-you-treat-a-synchronous-oropharyngeal-cancer-and-proximal-esophageal-cancer weekly 0.8 https://www.themednet.org/what-treatment-regimen-would-you-choose-for-a-patient-with-gastric-adenocarcinoma-who-is-found-to-have-peritoneal-and-omental-implants-at-the-time-of-surgery-after-receiving-preoperative-flot weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-contrast-to-identify-sacroiliitis-on-mri weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-radiation-therapy-for-a-breast-cancer-patient-with-dermatomyositis weekly 0.8 https://www.themednet.org/does-the-presence-of-anaplasia-in-embryonal-rhabdomyosarcoma-change-your-treatment-approach weekly 0.8 https://www.themednet.org/how-do-you-advise-patients-on-duration-of-first-line-maintenance-parpi-and-the-potential-risk-of-mds-or-aml weekly 0.8 https://www.themednet.org/how-do-you-approach-immunosuppressive-therapy-in-lupus-associated-pulmonary-arterial-hypertension weekly 0.8 https://www.themednet.org/is-there-a-role-for-reassessing-somatic-mutation-status-at-relapse-in-patients-with-epithelial-ovarian-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-non-secretory-myeloma-in-an-inpatient-setting weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-rheumatoid-arthritis-in-a-patient-with-an-active-hematologic-malignancy-such-as-leukemia-or-lymphoma-after-methotrexate-failure weekly 0.8 https://www.themednet.org/can-radiation-to-the-breast-be-given-in-the-setting-of-prior-radiation-for-hodgkins-lymphoma weekly 0.8 https://www.themednet.org/is-there-any-role-for-parpi-maintenance-in-brca-hrd-patients-after-response-to-front-line-chemotherapy-bevacizumab weekly 0.8 https://www.themednet.org/what-is-your-preferred-3rd-line-therapy-for-patients-with-metastatic-sarcomatoid-rcc weekly 0.8 https://www.themednet.org/how-do-you-determine-when-to-give-a-second-car-t-cell-infusion-to-a-pediatric-or-young-adult-patient-with-relapsed-refractory-all weekly 0.8 https://www.themednet.org/what-is-your-regimen-of-choice-for-metastatic-papillary-renal-cell-carcinoma weekly 0.8 https://www.themednet.org/would-you-consider-stopping-maintenance-immunotherapy-for-es-sclc-after-2-years-for-exceptionally-responding-patients weekly 0.8 https://www.themednet.org/when-are-you-recommending-bone-marrow-transplant-recipients-receive-the-sars-cov-2-vaccine weekly 0.8 https://www.themednet.org/do-you-have-any-special-diagnostic-or-treatment-considerations-when-evaluating-never-smokers-with-metastatic-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/what-are-the-current-official-guidelines-regarding-covid-19-vaccination-for-patients-with-cancer-or-for-hematologic-conditions weekly 0.8 https://www.themednet.org/would-you-treat-the-prostate-per-stampede-in-a-patient-who-has-oligometastatic-disease-after-cryotherapy weekly 0.8 https://www.themednet.org/can-an-aya-patient-with-newly-diagnosed-aml-safely-sperm-bank-after-starting-cytoreduction-with-hydroxyurea-or-cytarabine weekly 0.8 https://www.themednet.org/would-you-offer-immunotherapy-for-recurrent-metastatic-ewing-sarcoma-if-the-tumor-is-msi-high-or-has-high-tmb weekly 0.8 https://www.themednet.org/do-you-include-bevacizumab-with-chemotherapy-in-patients-with-metastatic-colon-cancer-with-an-intact-primary-tumor-who-have-intermittent-obstructive-symptoms weekly 0.8 https://www.themednet.org/how-would-you-manage-a-p16-positive-small-cell-carcinoma-of-the-tonsil weekly 0.8 https://www.themednet.org/how-do-you-approach-dosage-changes-of-allopurinol-as-a-patients-gfr-decreases-over-time weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-regimen-for-a-patient-with-brca-metastatic-pancreatic-cancer-with-poor-performance-status weekly 0.8 https://www.themednet.org/with-the-rapido-trial-demonstrating-efficacy-of-short-course-xrt-as-part-of-tnt-for-locally-advanced-rectal-cancer-is-there-a-role-for-short-course-xrt-to-be-integrated-into-watch-and-wait-programs weekly 0.8 https://www.themednet.org/should-patients-receive-thrombophilia-testing-in-the-setting-of-a-provoked-vte-secondary-to-hormonal-therapy-ocps weekly 0.8 https://www.themednet.org/would-you-omit-rni-in-a-patient-with-locally-advanced-tnbc-with-n1-disease-who-has-an-alnd-and-is-found-to-have-a-pcr-in-the-nodes weekly 0.8 https://www.themednet.org/do-you-recommend-im-biopsy-in-the-initial-staging-of-breast-cancer-patients-with-suspicious-im-nodes-on-imaging weekly 0.8 https://www.themednet.org/how-would-your-follow-up-change-for-a-patient-non-surgical-candidate-with-endometrial-cancer-treated-with-definitive-radiation weekly 0.8 https://www.themednet.org/how-do-you-manage-acute-tenesmus-related-to-spaceoar weekly 0.8 https://www.themednet.org/do-you-recommend-irradiating-the-remaining-penis-and-pelvis-vs-pelvis-alone-in-a-patient-with-partial-penectomy-with-negative-margins-who-has-multiple-positive-groin-nodes-with-ece weekly 0.8 https://www.themednet.org/what-is-your-approach-to-tamoxifen-use-in-women-who-are-unable-to-discontinue-a-strong-cyp2d6-inhibitor-and-who-are-unable-to-use-or-tolerate-an-ai weekly 0.8 https://www.themednet.org/what-is-the-appropriate-dose-fractionation-when-treating-a-dermatofibrosarcoma-protuberans-of-the-spine-following-debulking-surgery-in-a-patient-with-a-good-performance-status weekly 0.8 https://www.themednet.org/for-persistent-psa-elevation-after-prostatectomy-would-you-recommend-salvage-radiation-if-pathologically-negative-nodes-but-regional-and-non-regional-lymphadenopathy-on-psma-pet weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-the-brain-in-a-patient-with-es-sclc-found-to-have-csf-cytology-positive-for-malignant-cells-but-negative-mri-of-the-brain weekly 0.8 https://www.themednet.org/what-planning-techniques-and-constraints-do-you-use-when-treating-h-n-cancer-with-vmat-as-it-relates-to-arcs-that-sweep-through-shoulders-that-ride-high weekly 0.8 https://www.themednet.org/would-you-ever-utilize-quad-shot-specifically-for-a-large-snuc weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-mpo-positive-isolated-peripheral-nerve-vasculitis weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-in-a-patient-with-well-controlled-ulcerative-colitis-planned-for-salvage-rt weekly 0.8 https://www.themednet.org/do-you-include-the-clinically-negative-contralateral-neck-in-your-field-for-a-lateralized-oral-cavity-who-has-n2b-disease-after-lnd weekly 0.8 https://www.themednet.org/in-what-circumstances-would-you-offer-adjuvant-radiation-after-resection-of-vulvar-mucosal-melanoma weekly 0.8 https://www.themednet.org/would-you-consider-177lu-dotatate-lutathera-in-patients-with-midgut-neuroendocrine-carcinoma-after-treatment-with-a-somatostatin-analog-but-with-ki67-20 weekly 0.8 https://www.themednet.org/for-esophageal-cancers-with-large-gaps-between-the-primary-and-pet-positive-lymph-nodes-do-you-treat-the-gaps-with-continuous-volumes-or-only-involved-areas weekly 0.8 https://www.themednet.org/how-do-you-treat-ctd-associated-organizing-pneumonia weekly 0.8 https://www.themednet.org/how-would-you-approach-therapy-for-a-nasal-high-grade-neuroendocrine-tumor-with-ipsilateral-local-cervical-adenopathy weekly 0.8 https://www.themednet.org/is-there-utility-in-metronomic-chemotherapy-in-adolescent-and-young-adult-patients-with-refractory-sarcoma weekly 0.8 https://www.themednet.org/when-do-you-refer-aya-patients-with-newly-diagnosed-severe-aplastic-anemia-for-transplant weekly 0.8 https://www.themednet.org/how-do-you-treat-refractory-cold-agglutinin-disease weekly 0.8 https://www.themednet.org/for-cases-of-foraminal-and-extraforaminal-monophasic-synovial-sarcoma-post-excision-with-note-of-residual-tumor-would-your-approach-be-a-second-look-surgery-with-re-excision-or-delivery-of-adjuvant-rt-with-boost-to-residual-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-systemic-treatment-for-isolated-cns-recurrence-of-er-her2-disease-with-local-treatment-completed-with-prior-treatment-with-chemotherapy-anti-her2-agents weekly 0.8 https://www.themednet.org/do-the-results-and-approval-based-on-adaura-trial-suggest-a-role-for-adjuvant-osimertinib-in-patients-with-stage-iiib-c-egfr-mutant-patients-treated-with-concurrent-chemoradiation weekly 0.8 https://www.themednet.org/what-normal-tissue-constraints-do-you-use-if-any-in-patients-receiving-vaginal-cuff-brachytherapy-alone weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-antiphospholipid-syndrome-in-the-setting-of-severe-steroid-refractory-thrombocytopenia weekly 0.8 https://www.themednet.org/would-you-consider-using-a-parp-inhibitor-in-a-patient-with-metastatic-pancreatic-cancer-with-a-germline-atm-mutation-after-progression-on-folfirinox-and-gemcitabine-based-chemotherapy weekly 0.8 https://www.themednet.org/when-would-you-consider-sequential-chemotherapy-and-radiation-rather-than-concurrent-for-early-stage-cervical-cancer-with-high-risk-pathologic-features weekly 0.8 https://www.themednet.org/how-do-you-approach-therapy-for-a-fit-adult-with-relapsed-aml-with-cns-involvement-after-allogeneic-stem-cell-transplantation weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiation-for-a-grade-1-osteosarcoma-of-the-mandilbe-with-close-margins-following-surgical-resection weekly 0.8 https://www.themednet.org/how-do-you-do-approach-treatment-of-a-recurrent-gliosarcoma weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-for-a-patient-with-uveal-melanoma-who-is-not-a-candidate-for-plaque-brachytherapy weekly 0.8 https://www.themednet.org/is-tumor-deposit-n1c-alone-an-indication-for-adjuvant-chemort-for-rectal-cancer-that-did-not-receive-neoadjuvant-therapy weekly 0.8 https://www.themednet.org/do-you-consider-high-para-aortic-nodes-above-the-renal-vessels-to-be-locally-advanced-or-metastatic-in-cervical-cancer weekly 0.8 https://www.themednet.org/is-it-appropriate-to-use-hypofractionation-to-treat-breast-cancer-when-the-patient-is-receiving-concurrent-tdm-1-kadcyla weekly 0.8 https://www.themednet.org/when-is-it-necessary-to-monitor-the-qtc-interval-in-patients-on-hydroxychloroquine weekly 0.8 https://www.themednet.org/should-high-dose-methotrexate-be-used-in-the-treatment-of-aya-patients-with-osteosarcoma weekly 0.8 https://www.themednet.org/how-do-positive-pelvic-washings-influence-your-decision-to-administer-adjuvant-therapy-to-early-stage-endometrial-cancer-who-otherwise-meets-no-criteria-for-adjuvant-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-inflammatory-polyarthritis-in-patients-with-myelodysplastic-syndromes weekly 0.8 https://www.themednet.org/would-you-treat-a-small-focus-of-pet-axumin-uptake-just-below-prior-field-of-salvage-prostate-bed-radiation-just-below-a-vesico-urethral-anastomoses weekly 0.8 https://www.themednet.org/would-a-finding-of-isolated-tumor-cells-on-snb-impact-your-decision-to-offer-omission-of-radiation-in-a-patient-with-breast-cancer-who-is-otherwise-a-candidate weekly 0.8 https://www.themednet.org/how-would-you-manage-an-incidental-catheter-related-thrombosis-in-a-functioning-dialysis-catheter weekly 0.8 https://www.themednet.org/do-you-ever-offer-minimally-invasive-surgery-for-treatment-of-early-stage-cervical-cancer weekly 0.8 https://www.themednet.org/how-do-you-treat-locally-advanced-ge-junction-adenocarcinoma-extending-to-the-esophagus-and-cardia-when-the-siewert-type-is-indistinguishable-between-2-and-3 weekly 0.8 https://www.themednet.org/what-is-the-preferred-dose-and-fractionation-regimen-for-cutaneous-squamous-cell-carcinoma-of-the-thumb weekly 0.8 https://www.themednet.org/how-would-you-non-surgically-approach-and-treat-two-synchronous-distinct-oropharynx-t1-t2n0-primaries-with-definitive-rt weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-a-bulky-stage-ii-dlbcl-in-a-patient-80-with-a-contraindication-to-anthracyclines-but-otherwise-good-performance-status weekly 0.8 https://www.themednet.org/do-you-check-pertussis-serologies-when-sending-labs-for-antiphospholipid-syndrome weekly 0.8 https://www.themednet.org/would-you-favor-an-adjuvant-anti-pd-1-inhibitor-or-dabrafenib-trametinib-for-stage-iiic-d-resected-braf-v600k-mutated-cutaneous-melanoma weekly 0.8 https://www.themednet.org/is-there-evidence-to-justify-the-recommended-anterior-margin-for-post-prostatectomy-radiation-to-the-pubic-bone weekly 0.8 https://www.themednet.org/what-treatment-would-you-offer-a-patient-who-underwent-surgery-for-an-extrahepatic-cholangiocarcinoma-and-subsequently-developed-an-isolated-malignant-biliary-stricture weekly 0.8 https://www.themednet.org/would-you-use-upfront-immunotherapy-in-a-patient-with-msi-high-metastatic-colon-cancer-in-the-setting-of-high-volume-disease weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-locally-advanced-rectal-cancer-with-an-ileal-conduit weekly 0.8 https://www.themednet.org/what-is-the-importance-of-finding-a-positive-titer-for-ts-hds-and-what-treatment-would-be-advised-for-these-patients weekly 0.8 https://www.themednet.org/at-what-point-do-you-refer-patients-with-medication-refractory-epilepsy-for-surgical-evaluation weekly 0.8 https://www.themednet.org/how-do-you-contour-the-pre-sacral-elective-nodes-for-prostate-cancer weekly 0.8 https://www.themednet.org/what-is-the-risk-of-ild-recurrence-in-mda5-ro52-positive-dermatomyositis-following-a-lung-transplantation weekly 0.8 https://www.themednet.org/when-treating-with-adjuvant-radiation-to-the-neck-after-dissection-for-a-nodal-recurrence-from-a-nonmelanoma-cutaneous-malignancy-would-you-include-the-primary-tumor-resection-bed-in-the-field-if-some-time-has-passed-since-the-primary-resection weekly 0.8 https://www.themednet.org/for-low-rectal-adenocarcinoma-that-extends-to-the-anus-through-the-internal-sphincter-muscle-would-you-recommend-neoadjuvant-therapy-in-a-patient-who-will-undergo-apr weekly 0.8 https://www.themednet.org/how-would-you-evaluate-a-patient-with-an-isolated-high-rbc-count-but-with-a-normal-hemoglobin-and-hematocrit weekly 0.8 https://www.themednet.org/when-would-you-recommend-adjuvant-therapy-for-a-patient-with-urethral-adenocarcinoma-after-partial-urethrectomy weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-therapy-for-a-premenopausal-patient-with-a-pathologic-brca1-mutation-whose-tnbc-had-a-complete-response-to-neoadjuvant-chemotherapy-except-for-an-itc-in-one-ln weekly 0.8 https://www.themednet.org/what-dose-and-volumes-do-you-use-for-incompletely-resected-who-grade-ii-meningiomas-with-brain-invasion weekly 0.8 https://www.themednet.org/what-surveillance-imaging-do-you-obtain-for-stage-iii-melanoma-patients-after-completing-systemic-adjuvant-therapy weekly 0.8 https://www.themednet.org/what-is-your-approach-for-a-symptomatic-inpatient-with-locally-advanced-nsclc-who-cannot-have-a-pet weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-history-of-locally-advanced-scc-of-the-cervix-treated-with-definitive-chemort-found-to-have-new-lung-lesions-6-months-post-treatment weekly 0.8 https://www.themednet.org/when-would-you-start-antiepileptic-drugs-in-a-critically-ill-patient-who-develops-myoclonic-jerks-but-has-not-yet-had-an-eeg weekly 0.8 https://www.themednet.org/how-do-you-approach-fertility-preservation-in-a-young-child-with-cancer weekly 0.8 https://www.themednet.org/when-do-you-consider-discontinuing-disease-modifying-therapies-for-multiple-sclerosis weekly 0.8 https://www.themednet.org/what-dose-regimen-would-you-use-to-treat-a-patient-with-locally-advanced-esophageal-scc-of-the-mid-esophagus-who-refuses-chemo-and-surgery-agreeing-only-to-radiation-alone weekly 0.8 https://www.themednet.org/how-can-you-adjust-neoadjuvant-or-adjuvant-platinum-based-chemotherapy-for-stage-stage-ii-iii-non-small-cell-lung-cancer-in-patients-with-significant-renal-insufficiency weekly 0.8 https://www.themednet.org/do-you-routinely-offer-a-bisphosphonate-or-denosumab-to-multiple-myeloma-patients-without-skeletal-lesions weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-incidental-radiographic-findings-of-sacroiliitis-without-clinical-inflammatory-back-pain weekly 0.8 https://www.themednet.org/would-you-recommend-surgery-or-radiation-for-newly-diagnosed-localized-prostate-cancer-diagnosed-on-a-urethral-lesion-biopsy weekly 0.8 https://www.themednet.org/in-cervical-cancer-is-the-presence-of-parametrial-lns-with-itcs-considered-parametrial-disease-requiring-adjuvant-chemo-rt weekly 0.8 https://www.themednet.org/do-you-add-chemotherapy-to-salvage-ebrt-brachytherapy-for-a-pt-with-small-vaginal-cuff-recurrence-of-cervical-ca-s-p-hysterectomy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-premenopausal-female-with-ct2cn0-hr-her2-negative-breast-cancer-who-received-neoadjuvant-tc-for-high-oncotype-had-no-pathologic-response-to-therapy-and-upstaged-to-pt2n1-on-surgery weekly 0.8 https://www.themednet.org/how-would-you-treat-an-ipsilateral-retropharyngeal-node-recurrence-in-a-patient-with-history-of-early-stage-oropharyngeal-cancer-managed-by-surgery-and-no-previous-adjuvant-radiation weekly 0.8 https://www.themednet.org/what-treatment-regimen-would-you-recommend-for-young-adults-with-platinum-refractory-relapsed-germ-cell-tumors weekly 0.8 https://www.themednet.org/do-you-consider-post-operative-radiation-therapy-for-pancreatic-neuroendocrine-carcinoma weekly 0.8 https://www.themednet.org/how-would-you-manage-adjuvant-therapy-for-a-premenopausal-female-with-a-t1cn1mi-breast-idc-that-is-hr-her2-positive-on-biopsy-but-hr-her2-negative-on-lumpectomy-surgical-specimen weekly 0.8 https://www.themednet.org/for-a-patient-with-metastatic-hr-positive-breast-cancer-presenting-with-spinal-cord-compression-but-no-visceral-metastases-what-is-your-recommended-first-line-systemic-therapy weekly 0.8 https://www.themednet.org/what-is-an-acceptable-maximum-bridging-dose-between-srs-srt-targeted-brain-metastases-in-close-proximity-to-one-another weekly 0.8 https://www.themednet.org/would-you-consider-ultra-hypofractionated-5-fraction-regional-nodal-radiation-in-a-node-breast-cancer-who-otherwise-wouldnt-tolerate-16-fractions-of-rt weekly 0.8 https://www.themednet.org/should-a-teenager-diagnosed-with-cml-in-blast-crisis-go-to-transplant-once-mrd-is-negative weekly 0.8 https://www.themednet.org/would-you-consider-using-a-tnfi-in-a-patient-with-a-family-history-of-demyelinating-disease-in-the-absence-of-a-personal-history weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-dexamethasone-and-anakinra-as-upfront-treatment-in-a-pediatric-patient-with-secondary-hlh-nonrheumatic-who-is-too-ill-to-tolerate-etoposide weekly 0.8 https://www.themednet.org/what-dose-of-peg-asparaginase-do-you-recommend-for-teens-with-high-bmi-treated-on-a-pediatric-all-regimen weekly 0.8 https://www.themednet.org/would-you-ever-discourage-salvage-prostate-xrt-given-a-patients-lower-urinary-tract-symptoms weekly 0.8 https://www.themednet.org/do-you-routinely-repeat-imaging-for-pe-after-anticoagulation-treatment-to-establish-a-new-baseline-2 weekly 0.8 https://www.themednet.org/for-a-cystic-lung-tumor-5cm-are-there-any-special-sbrt-planning-considerations-that-you-consider-as-compared-to-a-solid-lung-tumor weekly 0.8 https://www.themednet.org/are-there-any-bladder-constraints-for-preoperative-short-course-rectal-rt weekly 0.8 https://www.themednet.org/if-cbct-is-not-an-option-what-is-your-preferred-igrt-strategy-for-prone-breast-patients weekly 0.8 https://www.themednet.org/how-do-you-approach-relapsed-hepatocellular-malignant-neoplasm-nos-after-transplant-in-pediatric-or-aya-patients weekly 0.8 https://www.themednet.org/when-you-treat-postop-head-and-neck-cancer-do-you-typically-add-a-ctv-margin-to-the-delineated-postoperative-bed-or-just-treat-postop-bed-plus-ptv-margin weekly 0.8 https://www.themednet.org/how-would-you-treat-a-recurrent-seminoma-after-1st-line-bep-now-growing-during-salvage-tip-despite-initial-response weekly 0.8 https://www.themednet.org/how-do-you-manage-muscle-pain-and-irritation-due-to-radiation weekly 0.8 https://www.themednet.org/are-cold-spots-on-an-external-beam-plan-due-to-prostate-fiducials-concerning weekly 0.8 https://www.themednet.org/how-would-you-treat-patients-with-advanced-head-and-neck-cancer-with-involvement-of-upper-mediastinal-lymph-nodes weekly 0.8 https://www.themednet.org/what-is-the-preferred-number-of-cycles-of-capox-for-rectal-cancer-receiving-total-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-treat-an-unresectable-verrucous-carcinoma-invading-the-anal-sphincter weekly 0.8 https://www.themednet.org/what-is-your-methotrexate-initiation-strategy-in-dmard-naive-ra-patients weekly 0.8 https://www.themednet.org/how-would-you-treat-refractory-unresectable-pulmonary-metastases-in-high-grade-synovial-sarcoma weekly 0.8 https://www.themednet.org/when-do-you-restart-anticoagulation-in-patients-with-atrial-fibrillation-who-just-had-an-ischemic-stroke weekly 0.8 https://www.themednet.org/will-you-offer-adjuvant-olaparib-to-patients-with-somatic-brca-mutated-breast-cancer-given-that-olympia-only-enrolled-germline-brca weekly 0.8 https://www.themednet.org/how-would-you-sequence-177lu-psma-617-with-current-therapies-for-men-with-mcrpc weekly 0.8 https://www.themednet.org/do-you-recommend-menstrual-suppression-for-post-menarchal-adolescents-and-young-adults-receiving-myelosuppressive-chemotherapy weekly 0.8 https://www.themednet.org/in-which-type-of-patient-do-you-recommend-a-jak-inhibitor-as-first-line-systemic-therapy-biologic-naive-with-moderate-to-severe-atopic-dermatitis weekly 0.8 https://www.themednet.org/do-you-switch-to-a-different-jak-inhibitor-rather-than-escalating-dose-or-adding-adjunctive-therapy-in-patients-with-severe-alopecia-areata-who-have-had-a-partial-but-suboptimal-response-after-24-weeks-of-treatment weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-and-management-of-angiogram-negative-non-aneurysmal-subarachnoid-hemorrhage weekly 0.8 https://www.themednet.org/when-a-pathology-report-shows-scc-not-connected-to-the-epidermis-how-often-is-this-truly-metastatic-versus-a-sampling-artifact-and-do-you-routinely-pursue-full-metastatic-workup-or-referral-in-these-cases weekly 0.8 https://www.themednet.org/how-has-the-new-systematic-review-on-loss-of-muscle-mass-with-use-of-glp-1-agonists-changed-how-you-counsel-patients weekly 0.8 https://www.themednet.org/do-you-routinely-apply-the-2010-2011-acr-symptom-based-diagnostic-criteria-for-fibromyalgia-in-your-practice-or-do-you-continue-to-use-the-1990-tender-point-examination-to-make-the-diagnosis weekly 0.8 https://www.themednet.org/what-factors-lead-you-to-recommend-a-jak-inhibitor-as-second-line-therapy-in-a-patient-with-radiographic-axspa-who-has-had-a-primary-non-response-to-a-tnf-inhibitor-before-trying-an-il-17-inhibitor weekly 0.8 https://www.themednet.org/are-there-instances-when-you-offer-dialysis-to-patients-with-high-risk-hepatorenal-syndrome-who-are-not-transplant-candidates weekly 0.8 https://www.themednet.org/are-there-instances-when-you-use-diuretics-for-non-oliguric-patients-with-volume-overload-in-the-setting-of-hepatorenal-syndrome-who-have-normal-maps weekly 0.8 https://www.themednet.org/what-is-your-diagnostic-and-therapeutic-approach-to-hospitalized-patients-with-persistent-hypotension-map-65-of-uncertain-etiology-but-no-evidence-of-hypoperfusion-or-shock-physiology weekly 0.8 https://www.themednet.org/do-you-administer-empiric-ivermectin-simultaneously-with-urgent-high-dose-corticosteroids-in-a-patient-from-a-strongyloides-endemic-region-who-requires-immediate-immunosuppression-and-has-no-prior-screening weekly 0.8 https://www.themednet.org/do-you-list-a-patient-for-lung-transplantation-who-has-a-bmi-between-30-and-35-kg-m-and-is-otherwise-an-excellent-candidate-without-requiring-weight-loss-to-reach-a-bmi-below-30-first weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-a-patient-with-a-vns-device-that-is-having-impedance-challenges weekly 0.8 https://www.themednet.org/how-are-you-approaching-molecular-testing-in-patients-with-mpdac-who-may-be-eligible-for-daraxonrasib weekly 0.8 https://www.themednet.org/how-do-the-libretto-432-results-shape-the-potential-role-of-adjuvant-selpercatinib-in-patients-with-early-stage-ret-fusion-positive-nsclc weekly 0.8 https://www.themednet.org/how-would-you-approach-iron-supplementation-in-a-beta-thalassemia-trait-patient-with-restless-leg-syndrome weekly 0.8 https://www.themednet.org/how-do-you-manage-partial-response-following-6-cycles-of-carboplatin-taxol-immunotherapy-for-advanced-endometrial-cancer-with-persistent-peritoneal-disease-when-surgical-debulking-is-not-an-option weekly 0.8 https://www.themednet.org/with-the-latest-hepatitis-b-guidelines-pmid-41186418-and-recent-phase-3-trial-of-bepirovirsen-pmid-42206582-mentioning-the-utility-of-quantifying-hbsag-how-have-you-incorporated-hbsag-in-your-practice weekly 0.8 https://www.themednet.org/in-a-patient-with-locally-advanced-cervical-cancer-that-has-extensive-residual-disease-7-cm-in-greatest-dimension-after-chemoradiation-how-do-you-weigh-the-geometric-advantages-of-a-syed-neblett-template-against-the-superior-toxicity-profile-and-outpatien weekly 0.8 https://www.themednet.org/do-you-consider-adding-a-glp-1-receptor-agonist-to-insulin-therapy-in-a-patient-with-newly-diagnosed-lada-who-has-not-yet-progressed-to-insulin-dependence weekly 0.8 https://www.themednet.org/what-is-your-radiotherapy-plan-with-the-patient-with-a-history-of-localized-distal-esophageal-adenocarcinoma-s-p-neoadjuvant-chemoradiation-per-cross-then-ivor-lewis-robotic-esophagogastrectomy-ypt3n0-around-2-years-ago-and-then-1-year-of-adjuvant-opdivo- weekly 0.8 https://www.themednet.org/when-transitioning-a-patient-with-recurrent-calcium-based-nephrolithiasis-from-one-thiazide-diuretic-to-another-do-you-typically-recommend-a-washout-period weekly 0.8 https://www.themednet.org/how-long-after-a-dka-episode-do-you-anticipate-patients-with-ketosis-prone-diabetes-mellitus-to-be-able-to-discontinue-insulin-therapy weekly 0.8 https://www.themednet.org/management-of-ntm-prosthetic-joint-infection weekly 0.8 https://www.themednet.org/How-do-you-view-epcoritamab-+-R-in-an-older-or-frail-patient-with-follicular-lymphoma-who-would-otherwise-be-a-candidate-for-additional-treatment-after-progresion-on-first-line-therapy weekly 0.8 https://www.themednet.org/For-which-patients-with-relapsedrefractory-follicular-lymphoma-do-you-prefer-bispecific-antibody-based-therapy-at-2L-vs-reserving-it-for-later weekly 0.8 https://www.themednet.org/how-do-you-characterize-pleural-effusions-on-pocus-between-trace-small-moderate-and-large weekly 0.8 https://www.themednet.org/how-do-you-approach-an-acute-non-lvo-stroke-with-a-known-large-core-70-ml-0-5-aspects-or-other-metric-0-4-5-hours-and-4-5 weekly 0.8 https://www.themednet.org/do-you-still-give-premenopausal-women-with-high-clinical-and-low-genomic-risk-chemotherapy-after-presentation-of-the-optima-trial-at-asco-2026 weekly 0.8 https://www.themednet.org/what-are-the-main-confounding-variables-you-ask-about-and-monitor-in-patients-with-depression-and-anxiety weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-severe-hyponatremia-in-patients-with-alcohol-use-disorder-who-experience-seizures-that-could-be-secondary-to-the-electrolyte-derangement-or-withdrawal weekly 0.8 https://www.themednet.org/has-anyone-died-from-documented-anaphylaxis-due-to-alpha-gal-allergy weekly 0.8 https://www.themednet.org/what-is-your-preferred-prn-for-management-of-pediatric-agitation-in-the-emergency-department weekly 0.8 https://www.themednet.org/following-long-term-efficacy-and-safety-data-from-the-beti-cel-trials-up-to-10-years-of-follow-up-how-do-you-approach-gene-therapy-for-eligible-patients-with-transfusion-dependent-thalassemia-tdt weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-low-dose-radiation-therapy-for-osteoarthritis-in-an-older-adult-patient weekly 0.8 https://www.themednet.org/how-do-you-choose-between-titanium-and-cobalt-chromium-rods-in-a-patient-undergoing-multilevel-posterior-spinal-fusion weekly 0.8 https://www.themednet.org/if-approved-how-would-varegacestat-ringside-fit-into-your-treatment-approach-for-progressing-desmoid-tumors-compared-to-currently-available-systemic-options weekly 0.8 https://www.themednet.org/how-do-you-approach-doac-dose-reduction-for-secondary-prophylaxis-of-vte-in-cancer-associated-thrombosis weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-severe-mental-illness-whose-psychiatric-symptoms-worsen-significantly-during-inpatient-cancer-treatment weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-cgm-for-monitoring-of-postbariatric-hypoglycemia-given-recent-evidence-of-reduced-accuracy-in-dynamic-postprandial-conditions weekly 0.8 https://www.themednet.org/how-do-you-decide-between-repeat-resection-and-radiosurgery-when-mri-imaging-suggests-limited-residual-tumor-in-the-cavernous-sinus-in-patients-treated-for-acromegaly weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-cutaneous-malignancies-from-asco-2026 weekly 0.8 https://www.themednet.org/how-do-you-approach-the-decision-to-escalate-from-conservative-medical-therapy-to-surgical-intervention-in-a-patient-with-ebmd-related-recurrent-corneal-erosions-who-has-not-responded-to-several-months-of-nighttime-lubricating-ointment weekly 0.8 https://www.themednet.org/is-a-remote-history-of-seizures-a-contraindication-to-dalfampridine-for-patients-with-multiple-sclerosis weekly 0.8 https://www.themednet.org/what-role-if-any-do-you-see-for-functional-imaging-in-selecting-patients-with-hpv-associated-oropharyngeal-cancer-for-radiation-dose-de-escalation weekly 0.8 https://www.themednet.org/is-salvage-sbrt-an-option-for-focal-recurrence-of-pca-after-prior-proton-therapy-for-intermediate-risk-disease-what-volumes-would-you-treat-and-what-dose-do-you-recommend weekly 0.8 https://www.themednet.org/in-a-frail-older-adult-with-depression-unresponsive-to-two-ssri-trials-whats-your-next-step-in-management weekly 0.8 https://www.themednet.org/what-type-of-consolidation-therapy-if-any-would-you-offer-to-a-patient-with-thymoma-and-pleural-metastasis-with-complete-metabolic-response-after-chemotherapy-would-you-consider-lung-sparing-vmat-imrt-mediastinal-pleural-rt-if-dose-constraints-allow weekly 0.8 https://www.themednet.org/what-are-treatment-options-for-a-pediatric-patient-with-pretext-iv-hepatocellular-carcinoma-with-progressive-disease-following-plado-and-sorafenib-and-3-sessions-of-tace weekly 0.8 https://www.themednet.org/do-you-test-adults-for-food-allergies-if-they-have-non-ige-mediated-symptoms-to-provide-them-reassurance weekly 0.8 https://www.themednet.org/do-you-give-immunotherapy-to-partial-loss-of-msh6-but-pcr-stable-rectal-adenocarcinoma weekly 0.8 https://www.themednet.org/has-the-majesty-trial-changed-your-approach-to-the-rituximab-versus-obinutuzumab-choice-in-a-patient-with-newly-diagnosed-primary-membranous-nephropathy-and-nephrotic-syndrome weekly 0.8 https://www.themednet.org/do-you-measure-plasma-metanephrines-in-an-asymptomatic-normotensive-patient-with-an-adrenal-incidentaloma-below-10-hounsfield-units-on-non-contrast-ct-given-that-a-small-proportion-of-pheochromocytomas-can-appear-lipid-rich-on-imaging weekly 0.8 https://www.themednet.org/would-consider-giving-vaginal-estrogen-to-a-patient-with-a-history-of-low-grade-early-stage-endometrial-cancer-who-has-had-a-vaginal-cuff-recurrence-treated-with-radiation weekly 0.8 https://www.themednet.org/what-objective-measures-do-you-use-to-test-for-gait-improvement-after-large-volume-lp-for-nph-treatment weekly 0.8 https://www.themednet.org/how-do-you-incorporate-and-how-often-do-you-schedule-pelvic-mri-for-each-fraction-of-hdr-bt-to-the-cervix-with-or-without-an-mri-unit-in-the-department-vs-in-diagnostic-radiology-do-you-need-a-flat-table-and-what-imaging-sequences-and-parameters-slice-thi weekly 0.8 https://www.themednet.org/24-year-old-with-severe-atopic-dermatitis-failed-dupilumab-adequate-trial-history-of-embolism-so-avoiding-jak-inhibitors-would-appreciate-input-on-sequencing-particularly-experience-with-tralokinumab-after-dupilumab-failure-vs-using-a-cyclosporine-bridge weekly 0.8 https://www.themednet.org/do-you-routinely-use-oral-antibiotics-for-treatment-of-vertebral-osteomyelitis weekly 0.8 https://www.themednet.org/Is-it-appropriate-for-urologists-to-administer-and-oversee-the-toxicity-of-checkpoint-inhibitors-or-should-treatment-be-administered-by-a-medical-oncologist weekly 0.8 https://www.themednet.org/do-you-pursue-further-workup-for-a-coexisting-cause-of-true-hyperprolactinemia-or-attribute-the-elevation-to-macroprolactin-and-observe-when-peg-precipitation-confirms-macroprolactinemia-but-the-post-peg-monomeric-prolactin-remains-above-the-normal-range weekly 0.8 https://www.themednet.org/would-you-hold-off-using-enhertu-in-malignant-pleural-effusion weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-from-endemic-areas-who-have-positive-lyme-serology-with-ocular-abnormalities-that-are-rarely-reported-in-lyme-disease-optic-neuropathy-disc-edema-etc weekly 0.8 https://www.themednet.org/how-do-you-weigh-the-risks-of-overdose-with-medications-that-treat-severe-mental-illness weekly 0.8 https://www.themednet.org/how-to-you-treat-metastatic-bladder-cancer-with-extensive-squamous-differentiation-in-a-cisplatin-ineligible-patient weekly 0.8 https://www.themednet.org/with-talquetamab-based-combinations-tal-dp-and-tal-d-now-showing-efficacy-at-first-relapse-if-approved-how-will-you-position-gprc5d-targeted-bispecifics-relative-to-bcma-directed-therapy-in-your-treatment-algorithm weekly 0.8 https://www.themednet.org/does-ongoing-methimazole-requirement-post-radioactive-iodine-ablation-therapy-for-toxic-multinodular-goiter-suggest-failure-of-therapy-and-need-for-repeat-treatment-or-higher-dose-of-radioactive-iodine weekly 0.8 https://www.themednet.org/what-factors-guide-your-decision-to-test-for-or-start-empiric-treatment-for-acanthamoeba-keratitis-in-cases-of-corneal-ulcers weekly 0.8 https://www.themednet.org/would-you-treat-a-mastectomy-scar-that-went-into-the-high-axilla-with-a-radiation-boost weekly 0.8 https://www.themednet.org/Following-the-ECHO-trial-are-you-routinely-incorporating-acalabrutinib-plus-bendamustine-rituximab-into-your-frontline-treatment-approach-for-patients-with-MCL weekly 0.8 https://www.themednet.org/Is-the-PFS-benefit-sufficient-to-adopt-up-front-acalabrutinib-plus-BR-for-all-patients-with-MCL weekly 0.8 https://www.themednet.org/do-you-optimize-glycemic-control-in-diabetic-patients-undergoing-vasectomy weekly 0.8 https://www.themednet.org/how-do-you-select-patients-for-ustekinumab-optimization-instead-of-switching-therapy-after-secondary-loss-of-response-in-crohns-disease weekly 0.8 https://www.themednet.org/how-does-lv-non-compaction-on-tte-change-your-secondary-stroke-prevention-management weekly 0.8 https://www.themednet.org/what-scenarios-do-you-utilize-ct-venography-in-the-workup-of-suspected-dvt weekly 0.8 https://www.themednet.org/what-is-the-single-best-piece-of-advice-you-received-when-starting-out-as-a-hospitalist-for-the-first-time weekly 0.8 https://www.themednet.org/How-would-I-advise-patients-with-an-NNT-of-11-but-an-NNH-of-6 weekly 0.8 https://www.themednet.org/is-a-large-volume-stone-burden-still-an-indication-for-robotic-pyelolithotomy-in-the-modern-era-of-lasers-pcnls-and-flexible-and-navigable-suction-ureteral-access-sheathes weekly 0.8 https://www.themednet.org/do-you-feel-there-is-value-to-getting-endothelial-cell-counts-in-the-absence-of-frank-edema-visual-significance-in-your-management-endothelial-dystrophies weekly 0.8 https://www.themednet.org/what-strategies-have-you-found-most-helpful-to-improve-adherence-to-hydroxychloroquine-among-lupus-patients weekly 0.8 https://www.themednet.org/do-you-obtain-additional-studies-such-as-stool-elastase-or-oxalate-load-testing-in-patients-with-hyperoxaluria-for-whom-you-are-attempting-to-differentiate-enteric-from-primary-processes weekly 0.8 https://www.themednet.org/how-do-you-approach-exercise-recommendations-in-a-frail-patient-with-chronic-heart-failure-who-has-low-baseline-functional-capacity weekly 0.8 https://www.themednet.org/for-patients-with-myxoid-liposarcoma-who-needed-upfront-surgery-and-had-an-indication-for-port-would-you-consider-dose-reduction-of-adjuvant-radiation-in-light-of-doremy weekly 0.8 https://www.themednet.org/How-do-you-recommend-educating-patients-with-a-diagnosis-of-PCOS-with-the-new-name-change-to-PMOS weekly 0.8 https://www.themednet.org/when-should-patients-with-diabetes-mellitus-be-screened-for-osteoporosis weekly 0.8 https://www.themednet.org/in-a-patient-on-hydroxyurea-for-cytoreduction-would-you-also-consider-adding-esa-therapy-if-concurrent-anemia-from-ckd-and-need-to-continue-hydroxyurea-therapy weekly 0.8 https://www.themednet.org/for-patients-65-with-significant-intermittent-steroid-exposure-who-otherwise-do-not-have-risk-factors-for-osteoporosis-when-if-ever-do-you-recommend-considering-dexa-screening-if-you-do-consider-dexa-for-these-patients-does-insurance-coverage-play-a-role- weekly 0.8 https://www.themednet.org/what-advice-would-you-give-a-hospitalist-in-their-first-few-years-of-practice-who-wants-to-develop-a-focused-area-of-expertise-such-as-perioperative-medicine-quality-improvement-or-medical-education-while-maintaining-a-full-clinical-load weekly 0.8 https://www.themednet.org/how-has-the-publication-of-the-snap-trial-demonstrating-non-inferiority-of-cefazolin-for-mssa-bacteremia-influenced-your-practice weekly 0.8 https://www.themednet.org/are-you-offering-glp1s-to-women-at-high-risk-of-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-designing-the-boost-volumes-when-pmrt-is-recommended-for-the-indication-of-close-positive-margins-all-preop-imaging-had-intact-breast-and-postop-anatomy-is-either-with-or-without-reconstruction-how-do-think-about-ctv-boost-delineation- weekly 0.8 https://www.themednet.org/Do-you-start-inhaled-treprostinil-outside-a-pulmonary-hypertension-indication-in-a-patient-with-IPF-and-ongoing-FVC-decline-despite-antifibrotic-therapy weekly 0.8 https://www.themednet.org/in-patients-with-a-positive-centromere-antibody-and-history-of-raynaud-phenomenon-and-no-other-manifestations-how-long-do-you-check-yearly-pfts-and-echocardiograms-for weekly 0.8 https://www.themednet.org/what-institutional-recommendations-guide-the-choice-between-brachytherapy-and-mr-linac-guided-sbrt-for-locally-advanced-prostate-cancer-given-that-no-large-trials-have-directly-compared-the-two weekly 0.8 https://www.themednet.org/how-would-you-define-failure-of-anabolic-therapy-for-severe-osteoporosis-and-when-would-you-consider-ordering-a-second-round-of-evenity-or-pth-analogues weekly 0.8 https://www.themednet.org/for-patients-with-locally-advanced-ebv-associated-nasopharyngeal-carcinoma-treated-with-induction-gem-cis-per-the-zhang-protocol-nejm-2019-what-concurrent-chemo-regimen-do-you-typically-use-during-radiotherapy-zhang-et-al-used-q-3-week-cisplatin-but-nccn- weekly 0.8 https://www.themednet.org/have-you-found-clinical-differences-between-the-branded-and-generic-forms-of-medications weekly 0.8 https://www.themednet.org/in-your-opinion-when-does-a-psychiatric-medication-regiment-become-polypharmacy weekly 0.8 https://www.themednet.org/How-would-you-decide-between-Rituximab-and-Belimumab-in-class-4-lupus-nephritis-with-AKI-requiring-dialysis weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-in-a-patient-with-positive-ccp-ab-negative-rf-no-synovitis-on-exam-and-negative-inflammatory-markers-but-confirmed-and-progressive-nsip weekly 0.8 https://www.themednet.org/how-do-you-approach-anticoagulation-in-a-woman-with-sle-who-is-planning-pregnancy-has-persistently-positive-isolated-anticardiolipin-iga-and-anti-2-glycoprotein-i-iga-antibodies-and-a-prior-history-of-a-provoked-dvt-after-prolonged-air-travel weekly 0.8 https://www.themednet.org/how-do-you-try-to-encourage-interested-medical-students-and-residents-to-consider-a-career-in-rheumatology weekly 0.8 https://www.themednet.org/Do-you-favor-MRI-guided-adaptive-SBRT-over-conventional-SBRT-when-baseline-urinary-symptoms-raise-concern-for-toxicity-in-a-patient-with-localized-prostate-cancer weekly 0.8 https://www.themednet.org/management-of-vulvar-leiomyosarcoma-in-close-proximity-to-anus weekly 0.8 https://www.themednet.org/what-is-your-approach-to-foley-catheter-placement-and-duration-in-a-patient-with-a-prostatic-abscess-that-is-being-managed-with-either-aspiration-unroofing-or-antibiotics-alone weekly 0.8 https://www.themednet.org/do-you-prescribe-tebipenem-to-treat-an-outpatient-with-a-complicated-uti-caused-by-an-esbl-producing-organism-who-would-otherwise-require-hospitalization-for-iv-carbapenem-therapy-given-concerns-about-community-carbapenem-stewardship weekly 0.8 https://www.themednet.org/how-do-you-choose-vowst-versus-rebyota-after-an-antibiotic-course-for-recurrent-c-difficile weekly 0.8 https://www.themednet.org/what-is-your-approach-to-prescribing-off-label-oral-jak-inhibitors-for-children-under-12-years-of-age-with-severe-alopecia-areata-and-how-do-you-manage-dosing-and-monitoring weekly 0.8 https://www.themednet.org/what-early-clinical-findings-help-in-differentiating-cidp-vs-poems weekly 0.8 https://www.themednet.org/which-chronic-trigeminal-pain-patients-have-you-found-responded-best-to-peripheral-nerve-stimulation-implants weekly 0.8 https://www.themednet.org/do-you-have-a-preferred-sglt2-inhibitor-when-treating-your-patients-with-ckd weekly 0.8 https://www.themednet.org/does-decipher-metastatic-prostate-cancer-panel-add-any-value-on-determining-if-pt-needs-chemo-on-de-novo-met-hormone-sensitive-prostate-cancer-with-high-volume-disease weekly 0.8 https://www.themednet.org/would-you-start-potassium-citrate-for-a-patient-with-normal-urine-citrate-levels-but-recurrent-calcium-oxalate-nephrolithiasis-and-no-identifiable-risk-factors-of-24-hour-urine-studies-as-a-method-of-increasing-urine-citrate-levels-to-further-prevent-ston weekly 0.8 https://www.themednet.org/Is-it-recommended-to-hold-folic-acid-the-day-of-taking-methotrexate-or-not-necessary weekly 0.8 https://www.themednet.org/how-do-suggest-evaluating-infection-of-a-chronic-wound-in-patients-presenting-with-sepsis-of-unclear-etiology weekly 0.8 https://www.themednet.org/would-you-offer-break-wave-lithotripsy-as-a-first-line-option-in-a-patient-with-a-symptomatic-ureteral-or-renal-stone-who-is-a-candidate-for-ureteroscopy-given-s-o-u-n-d-trial-data-showing-noninferiority-to-shock-wave-lithotripsy-without-anesthesia weekly 0.8 https://www.themednet.org/have-you-noticed-tumor-flare-by-means-of-imaging-or-tumor-markers-when-adding-palbociclib-to-her2-er-pr-metastatic-breast-cancer-patients-as-per-the-patina-trial weekly 0.8 https://www.themednet.org/in-patients-with-delusions-of-parasitosis-given-recent-literature-would-you-attempt-to-trial-biologic-dupilumab-therapy-over-or-in-conjunction-with-standard-atypical-anti-psychotics-if-they-have-prominent-peripheral-eosinophilia-or-severe-secondary-excori weekly 0.8 https://www.themednet.org/do-you-recommend-peak-flow-meters-for-asthma-in-your-practice weekly 0.8 https://www.themednet.org/how-do-you-determine-which-patients-to-continue-vit-beyond-5-years weekly 0.8 https://www.themednet.org/how-do-you-treat-steroid-refractory-ms-flares-when-plex-is-unavailable weekly 0.8 https://www.themednet.org/Would-you-start-neoadjuvant-chemotherapy-or-upfront-surgery-or-deliver-the-baby-early-and-start-key-note-522-in-a-32-week-pregnant-woman-with-cT2N0-on-imaging-(-although-surgeon-thought-there-was-a-LN-palpable) weekly 0.8 https://www.themednet.org/how-do-decide-on-extending-an-ncs-for-a-suspected-cidp-patient-but-so-far-negative-testing weekly 0.8 https://www.themednet.org/do-you-routinely-offer-prophylactic-mid-urethral-sling-in-patients-undergoing-repair-of-significant-prolapse-without-preop-stress-incontinence weekly 0.8 https://www.themednet.org/do-you-add-liothyronine-or-switch-to-combination-therapy-in-an-athyreotic-patient-on-levothyroxine-with-persistent-hypothyroid-like-symptoms-a-normal-tsh-and-a-low-ft3-given-emerging-data-suggesting-reduced-peripheral-thyroid-hormone-action-in-this-subgro weekly 0.8 https://www.themednet.org/do-you-routinely-omit-a-ureteral-stent-after-uncomplicated-ureteroscopy-for-a-small-renal-or-ureteral-stone-given-randomized-multicenter-trial-data-showing-significantly-better-patient-reported-outcomes-without-a-stent weekly 0.8 https://www.themednet.org/in-hr-early-stage-breast-cancer-65-years-of-age-with-a-sentinel-lymph-node-biopsy-showing-isolated-tumor-cells-itc-only-is-there-a-role-for-high-tangent-fields-to-cover-the-low-axilla-given-the-absence-of-randomized-high-level-evidence-specifically-addres weekly 0.8 https://www.themednet.org/do-you-offer-intralesional-collagenase-xiaflex-for-peyronies-during-the-active-inflammatory-phase-instead-of-only-during-the-stable-phase-given-recent-data-of-comparable-safety-outcomes weekly 0.8 https://www.themednet.org/when-managing-an-adult-patient-with-moderate-to-severe-atopic-dermatitis-who-achieves-partial-response-on-dupixent-after-6-months-of-treatment-how-do-you-primarily-approach-escalation weekly 0.8 https://www.themednet.org/how-could-pocus-be-useful-in-the-initial-evaluation-of-a-severely-ill-patient-in-whom-infectious-endocarditis-is-suspected weekly 0.8 https://www.themednet.org/when-would-you-consider-offering-antiviral-treatment-to-an-immunocompetent-patient-with-acute-ebv-infection weekly 0.8 https://www.themednet.org/when-a-patient-presents-with-an-infected-ipp-do-you-go-straight-to-explant-salvage-reimplantation-or-explant-and-wait-for-completion-of-antibiotics-before-delayed-replacement weekly 0.8 https://www.themednet.org/if-small-cell-carcinoma-was-found-in-an-axillary-lymph-node-with-an-unknown-primary-would-you-recommend-axillary-lymph-node-dissection-prior-to-chemoradiation weekly 0.8 https://www.themednet.org/do-you-recommend-starting-sorafenib-at-a-reduced-dose-and-titrating-up-in-patients-with-advanced-hepatocellular-carcinoma weekly 0.8 https://www.themednet.org/would-you-consider-post-mastectomy-radiation-in-patient-with-a-triple-negative-tumor-pt2n0 weekly 0.8 https://www.themednet.org/what-are-your-considerations-in-choosing-partial-breast-irradiation-versus-external-beam-hypofractionated-whole-breast-rt-for-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/for-hodgkin-lymphoma-patients-with-initial-splenic-involvement-do-you-ever-include-the-pre-chemotherapy-involved-spleen-as-part-of-your-consolidative-isrt-treatment-after-a-cr weekly 0.8 https://www.themednet.org/how-do-you-manage-dry-eye-syndrome-due-to-lacrimal-or-meiobian-gland-dysfunction-after-external-beam-radiotherapy weekly 0.8 https://www.themednet.org/would-you-treat-a-uterine-carcinosarcoma-with-omental-spread-with-adjuvant-whole-abdominal-radiation weekly 0.8 https://www.themednet.org/what-are-the-best-strategies-to-obtain-good-simulation-ct-imaging-for-prostate-cancer-patients-who-have-had-hip-replacements weekly 0.8 https://www.themednet.org/when-do-you-consider-re-starting-treatment-for-a-patient-with-relapsed-myeloma weekly 0.8 https://www.themednet.org/what-target-volumes-do-you-use-for-rectosigmoid-very-superior-rectal-cancers weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-rt-in-an-elderly-patient-with-a-t1n0-er-breast-cancer-who-initially-proceeds-with-endocrine-therapy-alone-and-is-unable-to-tolerate-it weekly 0.8 https://www.themednet.org/what-is-the-maximum-dose-to-small-bowel-you-would-allow-in-a-single-fraction-with-gynecologic-brachytherapy weekly 0.8 https://www.themednet.org/how-do-you-delineate-target-volumes-for-patients-who-receive-induction-chemotherapy-prior-to-definitive-chemoradiation-for-locally-advanced-head-and-neck-cancers weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-or-not-to-cover-elective-lymphatics-when-treating-cutaneous-squamous-cell-carcinoma-of-the-head-and-neck-with-definitive-rt weekly 0.8 https://www.themednet.org/what-dose-regimen-do-you-use-when-a-women-with-inflammatory-breast-cancer-is-not-responding-to-chemotherapy-and-needs-radiation-prior-to-surgery weekly 0.8 https://www.themednet.org/how-do-you-simulate-and-treat-prostate-cancer-patients-on-dialysis-receiving-ebrt weekly 0.8 https://www.themednet.org/do-you-send-oncotype-in-patients-with-er-pr-breast-cancer-and-micrometastasis-in-one-sentinel-node weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-radiation-therapy-to-the-locoregional-lymph-node-basins-for-merkel-cell-carcinoma-mcc-with-a-solitary-macroscopically-positive-lymph-node-ln-without-ece-after-lymph-node-dissection weekly 0.8 https://www.themednet.org/what-is-the-preferred-second-line-agent-for-a-woman-with-metastatic-vulvar-cancer-who-has-progressed-on-carboplatin-paclitaxel weekly 0.8 https://www.themednet.org/would-you-treat-your-left-sided-breast-cancer-patients-with-dibh-deep-inspiration-breath-hold-and-imrt-when-the-target-includes-regional-lymph-nodes weekly 0.8 https://www.themednet.org/when-would-you-use-avd-brentuximab-instead-of-abvd-for-newly-diagnosed-stage-3-or-4-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/are-you-routinely-offering-spine-separation-surgery-followed-by-sbrt-srs-for-spine-oligometastatic-lesions-abutting-the-cord weekly 0.8 https://www.themednet.org/in-what-circumstances-would-you-repeat-bio-markers-er-pr-her2-in-a-patient-with-breast-cancer-who-has-residual-disease-after-neo-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/should-methotrexate-be-stopped-prior-to-radiation-therapy-if-a-patient-has-rheumatoid-arthritis weekly 0.8 https://www.themednet.org/when-would-you-treat-patients-with-esophageal-adenocarcinoma-with-neoadjuvant-chemotherapy-alone-such-as-detailed-in-the-uk-mrc-oe05-trial weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-patients-with-spine-metastases-wear-neck-collars-or-back-braces weekly 0.8 https://www.themednet.org/how-do-you-manage-the-timing-of-adjuvant-therapy-in-a-patient-with-a-glioblastoma-and-a-post-operative-surgical-site-infection weekly 0.8 https://www.themednet.org/do-you-routinely-hold-immunotherapy-during-whole-brain-radiation weekly 0.8 https://www.themednet.org/how-do-you-determine-dose-for-prostate-sbrt weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-patient-who-will-undergo-breast-irradiation-in-which-a-large-port-wine-stain-is-overlying-the-breast weekly 0.8 https://www.themednet.org/how-long-after-surgery-for-a-keloid-can-you-wait-to-treat-with-post-operative-radiation-before-the-treatment-becomes-ineffective weekly 0.8 https://www.themednet.org/would-you-recommend-rni-for-a-triple-negative-cancer-s-p-lumpectomy-and-alnd-with-low-ln-positivity-rate weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-er-pr-positive-breast-cancer-with-a-single-site-of-bone-metastasis weekly 0.8 https://www.themednet.org/would-you-consider-use-of-single-agent-lenvatinib-for-advanced-renal-cell-cancer-after-first-line-therapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-regimen-for-triple-positive-breast-cancer-with-visceral-metastasis-while-on-adjuvant-ai weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-approach-to-patients-with-good-ps-stage-iv-non-squamous-nsclc-that-is-egfr-ros1-alk-braf-wt-and-pdl-1-1 weekly 0.8 https://www.themednet.org/what-is-your-recommended-follow-up-schedule-for-a-meningioma-after-definitive-radiotherapy weekly 0.8 https://www.themednet.org/is-antiandrogen-monotherapy-a-reasonable-option-for-a-patient-with-high-risk-disease-getting-imrt-bt-boost-who-refuses-gnrh-modulators weekly 0.8 https://www.themednet.org/what-is-your-approach-to-young-healthy-women-with-locally-advanced-breast-cancer-and-biopsy-proven-low-cervical-lymph-nodes weekly 0.8 https://www.themednet.org/would-you-consider-upfront-chemoradiation-therapy-for-a-patient-with-metastatic-anal-squamous-cell-carcinoma-if-they-have-a-large-burden-of-disease-at-the-anus weekly 0.8 https://www.themednet.org/is-10-gy-x-5-an-acceptable-dose-to-use-for-lung-sbrt-in-tumors-with-favorable-location-eg-not-central-and-not-encroaching-on-the-chestwall weekly 0.8 https://www.themednet.org/would-you-treat-vaginal-intraepthelial-neoplasia-3-with-hdr-brachytherapy weekly 0.8 https://www.themednet.org/do-you-use-absolute-wbc-count-or-doubling-time-to-determine-whether-to-start-treatment-for-early-stage-cll weekly 0.8 https://www.themednet.org/how-do-you-approach-a-peripheral-t1-lung-cancer-with-a-positive-mediastinal-node-by-ebus weekly 0.8 https://www.themednet.org/do-you-use-a-metal-biliary-stent-as-a-fiducial-marker-for-cholangiocarcinoma weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-a-small-0-5-cm-node-negative-grade-3-brca1-mutated-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-concurrent-or-sequential-radiation-and-chemotherapy-for-margin-positive-node-negative-nsclc weekly 0.8 https://www.themednet.org/are-there-circumstances-when-you-would-consider-re-irradiation-of-the-esophagus-in-a-patient-who-is-not-a-surgical-candidate-or-declines-surgery weekly 0.8 https://www.themednet.org/how-do-you-approach-srs-reirradiation-for-brain-metastases-overlapping-previous-sites-of-srs weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-radiation-therapy-for-patients-with-hepatocellular-carcinoma-status-post-partial-hepatectomy-with-positive-parenchymal-margins weekly 0.8 https://www.themednet.org/when-would-you-recommend-hyperbaric-oxygen-treatments-for-skin-ulceration-non-healing-wounds-in-a-radiated-field weekly 0.8 https://www.themednet.org/what-is-your-adjuvant-treatment-approach-to-patients-with-strongly-hormone-receptor-positive-breast-cancer-who-have-minimal-response-to-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-chemotherapeutic-regimen-would-you-use-to-treat-locally-recurrent-tnbc weekly 0.8 https://www.themednet.org/is-is-okay-to-offer-sbrt-for-central-lung-tumors-in-direct-contact-with-the-esophagus weekly 0.8 https://www.themednet.org/does-external-iliac-coverage-such-as-in-a-t4-primary-justify-imrt-for-rectal-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-locally-advanced-anal-cancer-patients-with-pet-positive-para-aortic-lymph-nodes weekly 0.8 https://www.themednet.org/how-would-you-approach-a-follicular-grade-1-2-nhl-found-on-a-terminal-ileum-biopsy-with-otherwise-negative-egd-and-colonoscopy-and-contrast-enhanced-ct-scan weekly 0.8 https://www.themednet.org/how-do-you-manage-dysgeusia-from-head-and-neck-radiation weekly 0.8 https://www.themednet.org/how-would-you-manage-an-inguinal-only-recurrence-of-a-previously-treated-low-lying-rectal-cancer weekly 0.8 https://www.themednet.org/do-you-have-any-concerns-about-enhanced-radiation-toxicity-with-any-of-the-novel-agents-used-to-treat-multiple-myeloma weekly 0.8 https://www.themednet.org/do-you-routinely-modify-radiation-treatment-plans-for-patients-with-prostate-cancer-on-chronic-anticoagulation-or-with-bleeding-disorders weekly 0.8 https://www.themednet.org/for-patients-with-muscle-invasive-bladder-cancer-and-borderline-renal-function-would-you-consider-use-of-a-split-dose-cisplatin-gemcitabine-regimen-for-neoadjuvant-treatment weekly 0.8 https://www.themednet.org/how-would-you-approach-the-therapy-in-a-patient-with-metastatic-colon-cancer-hepatic-and-limited-non-hepatic-metastases-that-completely-responded-with-systemic-therapy-in-the-non-hepatic-sites-but-has-limited-hepatic-disease weekly 0.8 https://www.themednet.org/is-there-a-substitution-for-etoposide-you-would-recommend-for-testicular-cancer-patients-who-need-multiple-cycles-of-bep weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-who-has-an-inguinal-p16-scc-lymph-node-of-unknown-origin weekly 0.8 https://www.themednet.org/do-you-give-radiation-concurrently-with-adjuvant-pertuzumab-in-locally-advanced-her2-pos-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-a-stage-i-lll-medically-inoperable-lung-cancer-in-close-proximity-to-the-stomach weekly 0.8 https://www.themednet.org/how-would-you-manage-an-elderly-medically-inoperable-patient-with-high-grade-muscle-invasive-bladder-cancer-who-has-already-received-definitive-prostate-irradiation weekly 0.8 https://www.themednet.org/do-you-take-into-account-the-dose-calculation-algorithm-used-when-selecting-a-prescription-dose weekly 0.8 https://www.themednet.org/how-do-you-treat-radiation-myelopathy weekly 0.8 https://www.themednet.org/in-a-patient-with-metastatic-hr-breast-cancer-progressing-on-single-agent-ai-would-you-use-a-different-ai-with-cdk4-6-inhibitor weekly 0.8 https://www.themednet.org/how-do-you-manage-dry-mouth-after-head-and-neck-rt weekly 0.8 https://www.themednet.org/would-you-use-apalutamide-in-high-risk-non-metastatic-castrate-resistant-prostate-cancer weekly 0.8 https://www.themednet.org/what-is-your-experience-with-liposomal-encapsulated-daunorubicin-and-cytarabine-cpx-351-for-first-line-treatment-of-therapy-related-aml-or-aml-with-myelodysplasia-related-changes-in-elderly-patients weekly 0.8 https://www.themednet.org/given-the-biochemical-failure-definition-of-psa-nadir-2-ng-ml-how-do-you-approach-a-psa-bounce-of-magnitude-2-ng-ml-or-higher weekly 0.8 https://www.themednet.org/what-do-you-do-for-patients-with-hr-inflammatory-breast-cancer-who-do-not-achieve-a-pcr-with-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-approach-patients-with-alk-positive-metastatic-nsclc-who-progress-on-crizotinib-and-subsequently-alectinib weekly 0.8 https://www.themednet.org/for-inoperable-due-to-comorbidities-patients-with-stage-i-ii-high-risk-endometrial-carcinoma-for-which-the-recommendation-is-radiation-therapy-is-there-evidence-to-support-the-addition-of-concurrent-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-therapy-in-patients-who-have-a-poor-clinical-response-to-neoadjuvant-endocrine-therapy weekly 0.8 https://www.themednet.org/do-you-treat-early-stage-breast-cancer-patients-with-hypofractionation-in-the-prone-position weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-a-solitary-prostate-cancer-metastases-in-the-mandible weekly 0.8 https://www.themednet.org/would-you-re-irradiate-the-axilla-after-a-resection-for-an-isolated-axilla-recurrence-in-a-breast-cancer-patient-who-had-prior-radiation-to-the-breast-and-axilla weekly 0.8 https://www.themednet.org/how-would-you-manage-a-short-interval-0-3-months-failure-in-the-untreated-para-aortic-region-after-definitive-treatment-of-locally-advanced-cervical-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-a-subcentimeter-stage-i-vaginal-squamous-cell-carcinoma-after-a-positive-deep-margin-post-local-excision weekly 0.8 https://www.themednet.org/would-you-use-ibrutinib-plus-venetoclax-as-second-line-therapy-in-relapsed-refractory-mantle-cell-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-decide-to-choose-tc-vs-cmf-for-her2-negative-breast-cancer-patients-who-warrant-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-a-brca-mutated-premenopausal-woman-with-metastatic-er-her2-carcinoma-with-progression-on-thp weekly 0.8 https://www.themednet.org/is-there-any-role-for-additional-chemotherapy-for-a-pre-menopausal-woman-with-locally-advanced-er-her2-idc-with-residual-disease-after-neoadjuvant-ac weekly 0.8 https://www.themednet.org/how-would-you-treat-esthesioneuroblastoma-resected-with-focal-microscopically-positive-margins-in-difficult-to-resect-skull-base-regions weekly 0.8 https://www.themednet.org/do-you-use-oncotype-to-determine-the-benefit-of-adjuvant-chemotherapy-in-a-male-patient-with-breast-cancer weekly 0.8 https://www.themednet.org/would-you-consider-induction-chemotherapy-prior-to-starting-chemoradiation-therapy-in-squamous-cell-carcinoma-of-the-esophagus weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-large-retroperitoneal-mass-that-shows-seminoma-on-biopsy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-synchronous-locally-advanced-h-n-p16-and-locally-advanced-rectal-adenocarcinoma weekly 0.8 https://www.themednet.org/what-fractionation-regimen-do-you-use-for-combination-ebrt-and-hdr-for-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/would-you-electively-cover-any-nerves-for-adenoid-cystic-carcinoma-of-the-tonsil-with-positive-pni-on-pathology weekly 0.8 https://www.themednet.org/how-do-you-manage-chest-wall-pain-due-to-sbrt weekly 0.8 https://www.themednet.org/what-is-your-management-strategy-for-unresectable-endometrial-cancer-due-to-gross-cervical-involvement-with-parametrial-extension weekly 0.8 https://www.themednet.org/do-you-treat-early-stage-dupuytrens-disease-with-radiotherapy weekly 0.8 https://www.themednet.org/in-a-patient-diagnosed-with-prostate-cancer-based-on-a-biopsy-many-years-ago-placed-on-surveillance-now-with-rising-psa-do-you-require-repeat-biopsy-prior-to-definitive-radiation-treatment weekly 0.8 https://www.themednet.org/when-would-you-add-an-extra-radiation-dose-to-compensate-for-treatment-breaks weekly 0.8 https://www.themednet.org/is-there-a-role-for-retreatment-with-immunotherapy-in-patients-progressing-after-initial-treatment-with-immunotherapy-for-metastatic-non-small-cell-lung-cancer-and-who-achieve-complete-or-partial-response-at-two-years weekly 0.8 https://www.themednet.org/what-is-the-preferred-palliative-treatment-regimen-for-elderly-patients-with-advanced-cholangiocarcinoma weekly 0.8 https://www.themednet.org/is-chronic-methotrexate-for-rheumatoid-arthritis-a-contraindication-for-prostate-brachytherapy weekly 0.8 https://www.themednet.org/do-you-have-a-preferred-strategy-for-front-line-induction-therapy-in-dlbcl-patients-who-have-asymptomatic-depressed-ejection-fraction-and-thus-concern-about-anthracycline-dosing weekly 0.8 https://www.themednet.org/how-do-you-manage-a-recurrent-brain-metastasis-in-a-surgical-cavity-that-contains-mixed-radiation-necrosis-and-viable-tumor-in-the-setting-of-prior-srs weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-therapy-for-metastatic-sarcomatoid-renal-cell-carcinoma weekly 0.8 https://www.themednet.org/what-factors-influence-your-decision-regarding-whether-to-administer-a-dose-dense-chemotherapy-regimen-in-the-adjuvant-setting-to-patients-with-hormone-receptor-postive-disease weekly 0.8 https://www.themednet.org/are-you-offering-durvalumab-to-patients-with-stage-iii-nsclc-with-known-targeted-mutations-ie-alk-egfr-ros1-braf-after-completion-of-chemoradiation-per-pacific weekly 0.8 https://www.themednet.org/would-you-ever-not-recommend-adding-concurrent-chemotherapy-to-adjuvant-radiation-in-ece-oropharynx-scc-patients-who-can-tolerate-it weekly 0.8 https://www.themednet.org/would-you-ever-start-radiation-in-the-middle-of-cycle-1-of-chemotherapy-for-ls-sclc weekly 0.8 https://www.themednet.org/do-you-routinely-use-hippocampal-sparing-techniques-in-the-treatment-of-primary-brain-tumors weekly 0.8 https://www.themednet.org/in-a-medically-inoperable-elderly-frail-patient-with-muscle-invasive-node-negative-bladder-cancer-would-you-consider-combining-immunotherapy-with-radiotherapy-instead-of-chemotherapy weekly 0.8 https://www.themednet.org/would-you-ever-consider-definitive-thoracic-rt-with-concurrent-immunotherapy-in-stage-iii-nsclc weekly 0.8 https://www.themednet.org/would-you-offer-systemic-therapy-before-or-after-resection-of-an-axillary-only-recurrence-of-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/in-a-premenopausal-woman-with-low-risk-early-stage-hr-positive-breast-cancer-who-is-unable-to-discontinue-a-strong-cyp2d6-inhibitor-do-you-use-still-utilize-tamoxifen-versus-an-ai-with-ovarian-suppression weekly 0.8 https://www.themednet.org/is-there-a-degree-of-osteoporosis-based-on-t-score-that-would-prohibit-you-from-the-utilization-of-an-ai-in-a-strong-hr-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/how-do-i-convince-urologists-to-send-patients-for-a-discussion-of-adjuvant-radiation-after-prostatectomy weekly 0.8 https://www.themednet.org/what-bowel-dose-constraints-do-you-use-when-treating-bladder-cancer-with-moderate-hypofractionation weekly 0.8 https://www.themednet.org/is-it-safe-to-use-medroxyprogesterone-for-vasomotor-flushing weekly 0.8 https://www.themednet.org/do-you-use-gene-expression-profiling-for-premenopausal-women-with-hormone-receptor-positive-breast-cancer-with-1-3-positive-lymph-nodes-1 weekly 0.8 https://www.themednet.org/for-patients-with-distal-esophageal-adenocarcinoma-who-are-not-surgical-candidates-how-do-you-decide-between-the-preferred-chemotherapy-regimens-when-given-as-definitive-chemo-radiation weekly 0.8 https://www.themednet.org/would-you-recommend-stent-placement-upfront-in-a-patient-with-cervical-esophageal-cancer-and-a-te-fistula weekly 0.8 https://www.themednet.org/how-would-you-approach-a-biopsy-proven-nsclc-patient-with-mediastinum-negative-disease-and-contralateral-suspicious-spiculated-pet-avid-nodule-without-pathologic-diagnosis weekly 0.8 https://www.themednet.org/how-would-you-optimize-patient-set-up-and-planning-for-the-post-operative-treatment-of-a-distal-lower-extremity-sarcoma weekly 0.8 https://www.themednet.org/do-you-alter-definitive-treatment-recommendations-for-oropharynx-p16-cancers-based-on-the-new-staging weekly 0.8 https://www.themednet.org/how-would-you-treat-an-older-patient-with-newly-diagnosed-b-all-and-significant-cardiac-and-neurological-co-morbidities weekly 0.8 https://www.themednet.org/when-can-tamoxifen-be-safely-resumed-after-pregnancy weekly 0.8 https://www.themednet.org/how-long-after-surgery-would-you-no-longer-offer-adjuvant-postoperative-treatment-for-head-and-neck-cancer-when-a-patient-with-multiple-adverse-features-that-needs-adjuvant-treatment-keeps-postponing-the-start-of-radiation weekly 0.8 https://www.themednet.org/what-is-the-optimal-management-of-hot-flashes-for-women-receiving-hormonal-therapy weekly 0.8 https://www.themednet.org/what-recommendations-do-you-give-to-patients-who-ask-about-diet-during-breast-cancer-treatment weekly 0.8 https://www.themednet.org/when-would-you-recommend-surgical-debulking-of-pelvic-or-para-aortic-lymph-nodes-in-cervical-cancer-prior-to-definitive-chemoradiation-therapy weekly 0.8 https://www.themednet.org/what-dose-do-you-try-to-keep-the-contralateral-breast-when-treating-a-pmrt-inflammatory-breast-cancer-that-is-extending-across-midline weekly 0.8 https://www.themednet.org/how-do-you-treat-a-fit-patient-with-a-solitary-pulmonary-nodule-2cm-which-is-biopsy-proven-small-cell-lung-carcinoma weekly 0.8 https://www.themednet.org/can-you-skip-elective-inguinal-treatment-in-pet-negative-squamous-cell-carcinoma-of-anal-canal weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-multivitamin-use-during-therapy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-pregnant-woman-in-the-third-trimester-with-locally-advanced-hormone-receptor-positive-her2-positive-breast-cancer weekly 0.8 https://www.themednet.org/would-you-offer-definitive-radiotherapy-for-prostate-cancer-or-another-solid-organ-malignancy-to-a-patient-on-maintenance-rituximab-for-lymphoma weekly 0.8 https://www.themednet.org/what-do-you-consider-to-be-the-regional-nodal-bed-for-a-merkel-cell-carcinoma-of-the-thigh-with-a-positive-sentinel-node-in-the-inguinal-chain weekly 0.8 https://www.themednet.org/do-you-offer-pembrolizumab-monotherapy-or-carbo-pemetrexed-pembrolizumab-to-a-patient-with-stage-iv-large-cell-nsclc-with-pd-l1-of-80-and-kras-stk11-mutation weekly 0.8 https://www.themednet.org/how-would-you-treat-a-large-cell-neuroendocrine-carcinoma-of-the-breast-with-bulky-axillary-involvement-with-good-response-to-neoadjuvant-chemo-followed-by-mastectomy-alnd weekly 0.8 https://www.themednet.org/how-do-you-approach-an-er-negative-pr-positive-her2-negative-breast-cancer-in-terms-of-hormone-manipulation-based-on-pr-status-alone weekly 0.8 https://www.themednet.org/how-would-you-treat-metastatic-nsclc-in-a-non-smoker-with-bone-biopsy-showing-adenocarcinoma-of-lung-origin-but-inadequate-tissue-for-mutational-panel-or-pd-l1 weekly 0.8 https://www.themednet.org/do-you-use-platinum-therapy-in-brca1-mutated-patients-with-er-pr-positive-disease-receiving-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-treat-metastatic-colon-cancer-in-patients-on-dialysis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-decision-to-use-cpx-351-or-standard-7-3-for-de-novo-aml weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-who-had-a-previous-mastectomy-for-an-early-stage-breast-cancer-without-xrt-and-then-develops-an-isolated-axillary-recurrence-and-undergoes-alnd weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-aggressive-metastatic-cutaneous-squamous-cell-carcinoma-which-is-not-amenable-to-surgery-or-radiation weekly 0.8 https://www.themednet.org/in-a-patient-with-localized-prostate-cancer-with-rising-psa-would-you-consider-ebrt-if-the-patient-is-also-undergoing-chemotherapy-for-active-recurrent-colon-cancer weekly 0.8 https://www.themednet.org/what-are-your-criteria-for-inclusion-of-the-retropharyngeal-ln-in-node-negative-h-n-cancer-patients weekly 0.8 https://www.themednet.org/would-you-recommend-observation-in-an-elderly-patient-with-an-er-positive-early-stage-breast-cancer-who-has-a-high-risk-oncotype-dx-score weekly 0.8 https://www.themednet.org/is-there-data-supporting-the-omission-of-carboplatin-from-neoadjuvant-tchp-therapy-for-her2-positive-breast-cancer-to-reduce-toxicity-particularly-in-light-of-findings-from-the-katherine-study weekly 0.8 https://www.themednet.org/what-types-of-sexual-side-effects-do-you-discuss-with-men-undergoing-radiation-therapy-for-rectal-and-or-anal-cancer weekly 0.8 https://www.themednet.org/what-imaging-surveillance-do-you-do-after-sabr-of-oligo-lung-metastases weekly 0.8 https://www.themednet.org/how-often-do-you-believe-para-aortic-radiotherapy-in-addition-to-pelvic-radiotherapy-causes-additional-treatment-breaks-due-to-acute-toxicity weekly 0.8 https://www.themednet.org/when-do-you-consider-neoadjuvant-chemotherapy-prior-to-definitive-chemoradiation-for-cervical-cancer weekly 0.8 https://www.themednet.org/do-you-ever-recommend-port-or-chemort-rather-than-chemotherapy-alone-for-nsclc-with-adverse-features-other-than-positive-margins-or-n2-disease weekly 0.8 https://www.themednet.org/with-vaginal-cuff-brachytherapy-do-you-treat-to-active-or-treatment-length weekly 0.8 https://www.themednet.org/how-do-you-manage-the-severe-adverse-drug-reaction-of-central-serous-retinopathy-with-mek-inhibitors weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-decreased-but-residual-pet-activity-following-concurrent-chemort-and-pci-for-limited-stage-sclc weekly 0.8 https://www.themednet.org/would-you-offer-scrotal-radiation-to-a-patient-with-a-stage-iie-bilateral-testicular-dlbcl-treated-with-a-bilateral-orchiectomy-and-chemotherapy weekly 0.8 https://www.themednet.org/would-you-treat-the-supraclavicular-nodes-electively-for-a-patient-with-esophageal-adenocarcinoma-originating-in-the-mid-esophagus-but-extending-above-the-carina weekly 0.8 https://www.themednet.org/what-is-your-approach-for-pmrt-when-the-patient-has-a-diep-flap weekly 0.8 https://www.themednet.org/for-oligometastatic-nsclc-that-would-be-otherwise-considered-stage-3-would-you-consider-consolidative-immunotherapy-with-durvalumab-after-definitive-treatment-for-both-the-primary-and-oligometastatic-site weekly 0.8 https://www.themednet.org/how-are-you-treating-patients-who-progress-while-on-durvalumab-after-definitive-chemoradiation-for-stage-iii-nsclc weekly 0.8 https://www.themednet.org/do-you-treat-atypical-carcinoid-of-the-lung-with-n2-or-n3-nodal-involvement-with-definitive-concurrent-chemoradiation weekly 0.8 https://www.themednet.org/is-it-unusual-to-have-isolated-ldh-elevation-and-normal-hcg-and-afp-in-non-seminomatous-germ-cell-tumor-embryonal-carcinoma weekly 0.8 https://www.themednet.org/what-adjuvant-chemotherapy-is-preferred-in-primary-ovarian-mucinous-adenocarcinoma-of-intestinal-type weekly 0.8 https://www.themednet.org/how-would-you-treat-a-younger-patient-with-relapsed-mantle-cell-lymphoma-after-treatment-with-hypercvad weekly 0.8 https://www.themednet.org/do-you-offer-consolidative-thoracic-radiation-for-oligometastatic-nsclc-following-upfront-immunotherapy weekly 0.8 https://www.themednet.org/what-is-your-general-approach-to-post-allogeneic-hsct-maintenance-therapy-for-aml weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-history-of-multiple-perianal-condylomas-who-develop-focal-high-grade-squamous-intraepithelial-lesions-in-the-anal-margin weekly 0.8 https://www.themednet.org/is-there-any-clinical-benefit-in-giving-tamoxifen-in-a-pre-menopausal-woman-with-early-stage-breast-cancer-who-initially-refused-adjuvant-hormone-therapy-for-years weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-young-woman-carrying-a-brca-1-or-2-mutation-and-history-of-breast-cancer-who-desires-pregnancy weekly 0.8 https://www.themednet.org/would-you-consider-first-line-osimertinib-to-patients-with-an-egfr-exon-18-g719x-mutation weekly 0.8 https://www.themednet.org/in-castrate-resistant-metastatic-prostate-cancer-how-do-you-decide-whether-to-offer-radionuclide-therapy-versus-external-beam-radiation-therapy-to-select-sites weekly 0.8 https://www.themednet.org/how-would-you-approach-srs-for-a-multiply-hemorrhagic-unresectable-brainstem-cavernous-malformation weekly 0.8 https://www.themednet.org/how-do-you-best-manage-bulky-clinical-stage-iia-squamous-cell-cancer-of-the-cervical-stump-in-a-patient-with-a-previous-partial-supra-cervical-hysterectomy weekly 0.8 https://www.themednet.org/in-which-scenarios-would-you-consider-adjuvant-chemotherapy-for-a-patient-with-t1a-n0-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-mange-true-anal-margin-squamous-cell-carcinoma-with-no-involvement-of-anal-canal-if-wide-local-excision-cannot-be-done-and-chemoradiation-therapy-is-being-used-instead weekly 0.8 https://www.themednet.org/how-would-you-manage-a-male-with-a-prior-history-of-localized-prostate-cancer-s-p-radiation-to-prostate-only-two-years-ago-who-now-presents-with-a-t1n0-squamous-cell-carcinoma-of-the-anus weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-radiation-to-the-chest-wall-and-or-regional-lymphatics-after-a-resected-chest-wall-recurrence weekly 0.8 https://www.themednet.org/is-there-a-role-for-checkpoint-inhibition-in-patients-with-advanced-high-pd-l1-expressing-chemotherapy-refractory-thymoma weekly 0.8 https://www.themednet.org/would-you-recommend-radiation-for-an-unresectable-chest-wall-recurrence-after-two-prior-courses-of-radiation weekly 0.8 https://www.themednet.org/do-you-routinely-offer-neo-adjuvant-chemotherapy-for-patient-with-triple-negative-metaplastic-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-cervical-cancer-patient-s-p-definitive-chemort-who-is-not-sexually-active-and-refuses-to-use-vaginal-dilators-to-improve-compliance weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-egfr-oligo-metastatic-lung-adenocarcinoma-status-post-resection-of-the-primary-and-metastatic-sites weekly 0.8 https://www.themednet.org/how-does-lvi-affect-pmrt-decision-in-a-node-positive-patient weekly 0.8 https://www.themednet.org/is-there-any-upper-limit-of-volume-or-shape-of-a-prostate-gland-which-would-be-a-red-flag-to-cytoreduce-prior-to-treatment weekly 0.8 https://www.themednet.org/what-dose-constraint-do-you-use-for-the-spinal-cord-in-the-setting-of-re-irradiation weekly 0.8 https://www.themednet.org/are-there-data-for-treating-patients-with-metastatic-nsclc-with-braf-nonv600e-mutations-with-braf-and-mek-inhibitors weekly 0.8 https://www.themednet.org/in-a-thin-patient-with-anal-cancer-do-you-use-bolus-over-the-inguinal-nodal-volume-when-treating-with-an-imrt-technique weekly 0.8 https://www.themednet.org/would-you-still-offer-durvalumab-after-chemoradiation-in-patients-with-stage-iii-nsclc-whose-treatment-was-delayed-due-to-prolonged-recovery-from-chemoradiation weekly 0.8 https://www.themednet.org/should-atezolizumab-and-nab-paclitaxel-now-be-used-in-first-line-therapy-for-metastatic-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/does-the-presence-of-a-connective-tissue-disorder-such-as-lupus-or-scleroderma-modify-your-radiation-dose-or-technique-for-prostate-cancer weekly 0.8 https://www.themednet.org/what-adjuvant-systemic-therapy-do-you-recommend-for-a-pre-menopausal-patient-with-a-localized-recurrence-of-er-pr-her2-invasive-ductal-carcinoma-while-on-adjuvant-ovarian-suppression-with-an-aromatase-inhibitor weekly 0.8 https://www.themednet.org/when-treating-recurrent-rectal-cancer-with-re-irradiation-using-accelerated-hyperfractionation-39-45-gy-at-1-2-or-1-5-gy-bid-what-normal-tissue-constraints-would-you-recommend-for-the-bladder-and-bowel weekly 0.8 https://www.themednet.org/how-would-you-treat-a-p16-small-cell-neuroendocine-tumor-of-the-anal-canal-with-or-without-metastatic-inguinal-lymph-node-metastasis weekly 0.8 https://www.themednet.org/how-often-are-you-recommending-adjuvant-pembrolizumab-for-resected-stage-iib-c-melanoma-patients weekly 0.8 https://www.themednet.org/is-it-safe-to-start-immunotherapy-concurrently-with-radiation-to-a-bone-metastases weekly 0.8 https://www.themednet.org/how-would-you-manage-a-primary-dural-low-grade-lymphoma weekly 0.8 https://www.themednet.org/what-dose-constraint-do-you-use-for-the-proximal-bronchial-tree-for-when-treating-nsclc-to-60-gy-8-fx weekly 0.8 https://www.themednet.org/how-do-you-manage-leptomeningeal-carcinomatosis-from-a-metastatic-solid-tumor weekly 0.8 https://www.themednet.org/what-is-your-preferred-palliative-regimen-for-pancreatic-cancer-with-pain-related-to-celiac-plexus-involvement weekly 0.8 https://www.themednet.org/would-you-use-standard-neoadjuvant-chemoradiation-for-a-patient-with-advanced-rectal-cancer-and-a-history-of-previous-pelvic-rt-for-another-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-second-line-of-treatment-for-metastatic-gallbladder-carcinoma-after-progression-on-gemcitabine-cisplatin-in-a-young-fit-patient weekly 0.8 https://www.themednet.org/do-you-give-her2-targeted-therapy-in-patients-with-breast-cancer-with-her2-testing-showing-fish-ratio-equal-or-more-than-2-0-but-her2-copy-number-less-than-4-0-with-further-testing-showing-ihc-1 weekly 0.8 https://www.themednet.org/what-is-the-best-second-line-treatment-for-a-her2-metastatic-breast-cancer-treated-with-frontline-paclitaxel-and-anti-her2-therapy weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-chemoimmunotherapy-after-ifrt-for-stage-i-to-ii-low-grade-follicular-lymphoma weekly 0.8 https://www.themednet.org/would-you-offer-rt-to-a-large-infiltrative-renal-metastasis-in-a-patient-with-minimal-other-systemic-disease weekly 0.8 https://www.themednet.org/when-do-you-recommend-adjuvant-chemotherapy-for-an-incidentally-detected-low-grade-appendiceal-mucinous-neoplasm-s-p-appendectomy weekly 0.8 https://www.themednet.org/would-you-use-abiraterone-or-docetaxel-in-addition-to-adt-and-radiotherapy-for-patients-with-very-high-risk-node-negative-prostate-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-a-small-to-medium-sized-but-unresectable-nodal-recurrence-within-the-original-treatment-volume-for-a-head-and-neck-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-manage-sarcomas-of-the-hand-or-the-feet weekly 0.8 https://www.themednet.org/what-morphologic-criteria-do-you-use-to-call-prostate-cancer-n1-on-imaging weekly 0.8 https://www.themednet.org/for-postoperative-radiation-for-oral-cavity-cancer-should-the-entire-surgical-bed-including-grafts-and-plates-eg-reconstructed-mandible-receive-the-full-60-gy weekly 0.8 https://www.themednet.org/how-do-you-decide-between-abiraterone-or-docetaxel-for-first-line-treatment-of-newly-diagnosed-metastatic-prostate-cancer weekly 0.8 https://www.themednet.org/does-the-presence-of-perineural-invasion-on-a-prostate-biopsy-change-your-management-decision weekly 0.8 https://www.themednet.org/do-you-differ-your-pmrt-treatment-if-a-patient-had-a-nipple-sparing-mastectomy weekly 0.8 https://www.themednet.org/how-do-you-approach-adt-and-pelvic-lymph-node-radiation-in-the-salvage-setting-for-patients-with-a-psa-0-5-ng-ml weekly 0.8 https://www.themednet.org/is-it-appropriate-to-use-a-hypofractionated-regimen-to-treat-the-pelvic-nodes-in-prostate-cancer weekly 0.8 https://www.themednet.org/would-you-consider-hormonal-therapy-and-no-rt-in-an-elderly-pt-who-developed-a-contralateral-early-stage-er-breast-cancer-while-on-tamoxifen-for-previous-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-decide-for-which-high-risk-post-menopausal-women-to-extend-adjuvant-endocrine-therapy-after-completing-5-years weekly 0.8 https://www.themednet.org/would-you-offer-apbi-in-patients-with-a-high-oncotype-who-are-otherwise-considered-suitable-per-astro-guidelines weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-when-considering-treating-the-pelvic-nodes-in-a-salvage-prostatectomy-case weekly 0.8 https://www.themednet.org/is-multifocal-disease-an-indication-for-rt-in-an-elderly-patient-with-early-stage-and-otherwise-favorable-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-a-case-of-mixed-histology-nsclc-sclc-that-rapidly-progresses-following-chemoradiation-and-durvalumab weekly 0.8 https://www.themednet.org/what-cumulative-dose-would-you-allow-the-pharyngeal-carotid-to-receive-for-a-course-of-reirradiation-for-a-retropharyngeal-node weekly 0.8 https://www.themednet.org/what-radiation-regimen-do-you-use-to-palliate-bulky-melanoma-metastases-involving-the-oral-cavity weekly 0.8 https://www.themednet.org/how-do-you-manage-therapy-in-an-elderly-80-years-of-age-patient-with-triple-negative-breast-cancer-that-is-not-a-surgical-candidate weekly 0.8 https://www.themednet.org/how-do-you-treat-metastatic-urothelial-carcinoma-after-progression-on-immune-checkpoint-inhibitor weekly 0.8 https://www.themednet.org/how-do-you-choose-your-next-line-of-therapy-for-stage-4-gist-after-progression-on-imatinib weekly 0.8 https://www.themednet.org/in-patients-who-initially-received-chemo-hormonal-first-line-therapy-for-metastatic-prostate-cancer-followed-by-abiraterone-enzalutamide-for-castration-resistant-disease-would-you-re-challenge-with-docetaxel weekly 0.8 https://www.themednet.org/would-you-ever-choose-folfoxiri-over-folfox-for-high-risk-stage-iii-colon-adenocarcinoma-with-multiple-adverse-prognostic-features weekly 0.8 https://www.themednet.org/how-do-you-prevent-non-healing-ulcer-when-treating-patients-with-cutaneous-scc-of-the-distal-lower-extremity-who-have-peripheral-vascular-disease weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-recommend-for-a-large-brainstem-metastasis weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-braf-mutated-metastatic-melanoma-who-has-progressed-on-targeted-therapy-encorafenib-binimetinib-and-immuotherapy-nivolumab-ipilimumab-but-yet-maintain-an-excellent-performance-status weekly 0.8 https://www.themednet.org/is-there-a-psa-value-below-which-you-would-not-offer-salvage-radiation-post-prostatectomy weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-do-you-use-for-gynecomastia-prophylaxis weekly 0.8 https://www.themednet.org/how-would-you-approach-neoadjuvant-chemoradiation-in-a-patient-with-a-history-of-crohns-disease-diagnosed-with-regional-lymph-node-positive-esophageal-adenocarcinoma-of-the-ge-junction weekly 0.8 https://www.themednet.org/for-patients-who-received-neoadjuvant-imatinib-for-initially-unresectable-gist-tumours-do-you-routinely-prescribe-adjuvant-therapy-or-rely-on-preoperative-staging-and-preoperative-mitotic-index weekly 0.8 https://www.themednet.org/what-is-your-experience-with-directing-treatment-towards-the-androgen-receptor-in-metastatic-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/when-treating-rectal-cancer-with-conventional-neoadjuvant-chemoradiation-45-gy-to-pelvis-with-boost-to-50-4-gy-what-volume-do-you-use-for-the-boost weekly 0.8 https://www.themednet.org/how-do-you-manage-acute-esophagitis-that-persists-1-2-months-after-completing-chemoradiation-for-lung-cancer weekly 0.8 https://www.themednet.org/what-ptv-margins-do-you-use-for-definitive-prostate-radiation weekly 0.8 https://www.themednet.org/how-would-you-treat-a-young-female-with-a-recurrent-triple-negative-breast-cancer-to-the-contralateral-breast weekly 0.8 https://www.themednet.org/what-volume-and-dose-would-you-use-for-a-stage-i-malt-lymphoma-of-the-lung weekly 0.8 https://www.themednet.org/in-what-situations-would-you-consider-treating-metastases-to-the-spine-with-proton-sbrt weekly 0.8 https://www.themednet.org/how-would-you-treat-an-axillary-presentation-of-a-breast-cancer-in-the-absence-of-a-breast-primary weekly 0.8 https://www.themednet.org/for-a-r0-resected-large-inverted-papilloma-of-the-maxillary-sinus-with-invasion-into-multiple-surrounding-structures-but-only-a-small-malignant-portion-would-you-cover-the-entire-papilomma-extent-or-only-the-malignant-portion-post-op weekly 0.8 https://www.themednet.org/how-would-you-treat-a-stage-iii-lung-cancer-with-n2-disease-and-a-small-synchronous-contralateral-lung-primary weekly 0.8 https://www.themednet.org/should-definitive-concurrent-chemort-be-offered-to-patients-with-anal-canal-scca-with-common-iliac-nodal-involvement-by-definition-m1-disease-without-evidence-for-other-distant-disease weekly 0.8 https://www.themednet.org/is-it-safe-to-deliver-sbrt-to-progressive-lung-metastases-to-patients-with-metastatic-rcc-receiving-concurrent-pazopanib weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-radiotherapy-with-concurrent-ado-trastuzumab-emtansine-t-dm1-in-your-breast-cancer-patients weekly 0.8 https://www.themednet.org/how-do-you-approach-rectal-spacer-for-the-patient-with-renal-failure weekly 0.8 https://www.themednet.org/how-would-you-modify-therapy-for-a-metastatic-her2-breast-ca-who-develops-persistent-cardiomyopathy-after-dual-her2-blockade-with-trastuzumab-pertuzumab weekly 0.8 https://www.themednet.org/how-are-you-integrating-imrt-into-whole-brain-radiation-for-brain-metastases weekly 0.8 https://www.themednet.org/does-location-of-an-non-spinal-osseous-metastasis-affect-your-sbrt-dosing weekly 0.8 https://www.themednet.org/do-you-refer-patients-to-cardiology-if-they-have-no-history-of-cardiac-disease-but-will-be-receiving-xrt-with-high-mean-doses-to-the-heart weekly 0.8 https://www.themednet.org/how-do-you-decide-treatment-volumes-for-radiotherapy-for-bilateral-gynecomastia-secondary-to-bicalutamide-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-front-line-treatment-for-tp53-mutated-mantle-cell-lymphoma weekly 0.8 https://www.themednet.org/how-would-you-treat-someone-with-unknown-primary-metastatic-smarca4-deficient-tumor-high-grade-tumor-with-rhabdoid-morphology weekly 0.8 https://www.themednet.org/would-you-offer-a-mid-treatment-transition-from-transtuzumab-to-tdm-1-for-a-patient-already-on-1-year-of-adjuvant-trastuzumab-who-met-criteria-for-adjuvant-tdm-1-based-on-the-katherine-trial weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-an-unresectable-paraspinal-chondrosarcoma-causing-cord-compression weekly 0.8 https://www.themednet.org/how-do-you-decide-about-neoadjuvant-chemotherapy-in-a-women-with-both-idc-and-dcis-on-biopsy-when-the-tumor-is-ill-defined-on-imaging weekly 0.8 https://www.themednet.org/would-you-consider-nodal-irradiation-alone-not-irradiating-chest-wall-in-an-otherwise-early-stage-breast-cancer-cn0-patient-but-has-a-positive-node-from-a-sln-bx-who-is-status-post-mastectomy weekly 0.8 https://www.themednet.org/how-do-you-choose-between-regorafenib-or-tas-102-in-patients-with-metastatic-colorectal-carcinoma-that-has-progressed-on-all-prior-5-fu-based-regimens-and-anti-egfr-therapy weekly 0.8 https://www.themednet.org/in-a-patient-with-gastric-adenocarcinoma-with-peritoneal-cytology-status-post-an-r1-resection-would-you-consider-post-operative-chemoradiation weekly 0.8 https://www.themednet.org/in-patients-with-stage-ii-iii-her2-breast-cancer-who-were-not-treated-with-neoadjuvant-therapy-without-having-knowledge-of-response-to-neoadjuvant-therapy-i-e-pcr-or-not-after-chemotherapy-what-is-your-preferred-adjuvant-her2-directed-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-an-early-stage-breast-cancer-patient-s-p-bcs-in-which-ece-is-found-on-a-positive-sentinel-node weekly 0.8 https://www.themednet.org/given-the-superiority-of-adt-enzalutamide-over-adt-alone-demonstrated-in-the-arches-and-prosper-trials-would-you-recommend-it-in-the-definitive-setting-for-men-with-high-risk-castrate-sensitive-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-treat-patients-with-sensitizing-egfr-mutations-who-progress-on-osimertinib-with-small-cell-transformation-but-with-persistent-egfr-mutation-detected-in-the-peripheral-blood-or-tumor weekly 0.8 https://www.themednet.org/what-doses-would-you-treat-the-primary-and-lymph-nodes-in-node-positive-vulvar-cancer-patient-with-incidentally-found-focal-scc-in-a-field-of-vin3 weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-newly-diagnosed-metastatic-colon-cancer-in-a-patient-who-experienced-infusional-5fu-related-cardiotoxicity-with-initial-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-manage-significant-fatigue-caused-by-androgen-deprivation-therapy-in-prostate-cancer-patients weekly 0.8 https://www.themednet.org/what-dose-constraints-would-you-use-for-head-and-neck-sbrt-in-a-previously-untreated-field weekly 0.8 https://www.themednet.org/would-you-perform-an-oncotype-dx-in-a-patient-with-a-0-5cm-er-positive-breast-cancer-with-one-lymph-node-positive-for-macrometastatic-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-who-progress-on-maintenance-atezolizumab-after-platinum-based-chemotherapy-for-extensive-stage-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-initial-management-of-patient-with-clinically-palpable-axillary-disease-histologically-proven-breast-cancer-with-no-imaging-evidence-of-an-occult-primary-or-metastatic-disease weekly 0.8 https://www.themednet.org/what-is-your-igrt-strategy-for-prone-breast-radiation weekly 0.8 https://www.themednet.org/for-gross-supraclavicular-disease-in-lung-cancer-do-you-cover-full-dose-to-the-involved-lymph-node-with-margin-or-to-the-entire-supraclavicular-fossa weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-dpd-deficiency-that-experiences-severe-toxicity-on-5-fu-despite-dose-reduction-in-the-setting-of-metastatic-colorectal-cancer weekly 0.8 https://www.themednet.org/how-do-you-reason-the-risk-and-benefits-of-low-dose-vaginal-estrogen-to-a-patient-on-an-ai-for-postmenopausal-breast-cancer-that-is-suffering-from-symptomatic-vaginal-atrophy weekly 0.8 https://www.themednet.org/do-you-use-cabozantinib-preferentially-over-other-tkis-in-mrcc-patients-who-have-progressed-on-immunotherapy-with-primary-metastatic-burden-being-bony-disease weekly 0.8 https://www.themednet.org/do-you-routinely-treat-oligoprogressive-metastatic-sites-with-sbrt-in-patients-receiving-systemic-therapy-and-otherwise-stable-disease weekly 0.8 https://www.themednet.org/how-do-you-treat-intact-scc-of-the-subglottic-larynx weekly 0.8 https://www.themednet.org/would-you-consider-treating-the-regional-nodes-in-addition-to-the-breast-in-a-patient-with-skin-involvement-pt4b-after-a-lumpectomy-with-negative-margins-nodes-who-refuses-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-post-prostatectomy-pelvic-lymph-node-only-recurrence-found-on-advanced-imaging-in-a-patient-with-a-low-psa-0-5 weekly 0.8 https://www.themednet.org/do-you-prescribe-silvadene-cream-for-patients-with-a-sulfa-allergy weekly 0.8 https://www.themednet.org/how-to-you-account-for-motion-when-contouring-head-and-neck-primaries-in-more-mobile-areas-such-as-base-of-tongue-and-larynx weekly 0.8 https://www.themednet.org/when-do-you-consider-using-high-dose-il-2-in-patients-with-mrcc weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-offer-post-operative-adjuvant-treatment-for-a-stage-ic1-ovarian-granulosa-cell-tumor weekly 0.8 https://www.themednet.org/how-do-you-compensate-for-treatment-breaks-1-week-in-patients-with-nsclc-on-concurrent-chemoradiation weekly 0.8 https://www.themednet.org/would-you-consider-hrt-in-a-young-woman-35-years-old-with-gbrca-mutated-tnbc-who-underwent-bilateral-mastectomies-and-bso weekly 0.8 https://www.themednet.org/what-stage-is-bilateral-orbital-conjunctival-nhl-limited-only-to-the-bilateral-orbit-conjunctiva weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-chemotherapy-therapy-to-a-premenopausal-patient-with-er-lobular-breast-cancer-who-had-a-partial-response-to-neoadjuvant-endocrine-therapy weekly 0.8 https://www.themednet.org/at-what-point-during-first-line-treatment-with-mono-immunotherapy-for-oligometastatic-nsclc-is-the-ideal-time-to-consider-consolidative-radiation-sbrt-to-the-primary-and-oligometastatic-sites weekly 0.8 https://www.themednet.org/do-you-implement-an-age-cut-off-for-determining-use-of-adjuvant-chemotherapy-for-stage-iii-er-pr-breast-ca weekly 0.8 https://www.themednet.org/do-you-wait-a-certain-time-period-before-initiating-palliative-or-definitive-radiation-to-nsclc-after-airway-interventions-such-as-rigid-bronchoscopy-tumor-debulking-apc-etc weekly 0.8 https://www.themednet.org/how-do-you-approach-cns-prophylaxis-in-patients-with-dlbcl weekly 0.8 https://www.themednet.org/how-do-you-treat-metastatic-collecting-duct-carcinoma-of-the-kidney-in-the-first-line-setting weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-limited-dural-based-metastases weekly 0.8 https://www.themednet.org/when-using-quad-shot-regimen-for-palliation-of-unresectable-head-and-neck-cancers-would-you-treat-concurrently-with-chemotherapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-to-pmrt-with-inflammatory-breast-cancer-with-adverse-risk-features weekly 0.8 https://www.themednet.org/what-adjuvant-treatment-would-you-use-in-a-woman-with-triple-negative-ln-negative-metaplastic-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-dose-fractionation-for-cylinder-based-vaginal-cuff-hdr-brachytherapy-for-an-isolated-vaginal-cuff-recurrence-after-whole-pelvis-ebrt-with-residual-thickness-of-disease-5-mm weekly 0.8 https://www.themednet.org/for-small-peripherally-located-nsclc-when-do-consider-referral-for-mediastinal-evaluation-prior-to-curative-surgery-vs-proceeding-to-resection-with-mediastinal-eval-at-time-of-surgery weekly 0.8 https://www.themednet.org/when-offering-pci-for-sclc-patient-do-you-include-c1-in-the-treatment-field-or-do-you-stop-at-the-base-of-the-skull weekly 0.8 https://www.themednet.org/how-do-you-manage-maintenance-therapy-in-brca-wild-type-patients-who-have-undergone-primary-surgery-and-achieved-an-optimal-complete-gross-resection weekly 0.8 https://www.themednet.org/why-are-hypomethylating-agents-as-single-agents-not-approved-yet-by-fda-for-treatment-of-aml-technically-off-label weekly 0.8 https://www.themednet.org/would-you-recommend-covering-the-dissected-axilla-in-your-radiation-field-in-patients-with-cn2-n3-disease-who-had-complete-response-to-neoadjuvant-chemo-and-an-alnd weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-minimal-residual-disease-1-of-cd25-positive-cells-six-months-after-completing-therapy-with-2-cda-for-hairy-cell-leukemia weekly 0.8 https://www.themednet.org/do-you-recommend-adjuvant-radiotherapy-for-an-adult-patient-with-localized-myxopapillary-ependymoma-who-grade-2-status-post-gross-total-resection weekly 0.8 https://www.themednet.org/would-you-still-offer-trastuzumab-deruxtecan-in-a-patient-with-progressive-hr-her2-breast-cancer-who-has-prior-history-of-cell-cycle-inhibitor-related-pneumonitis weekly 0.8 https://www.themednet.org/how-do-you-treat-cervical-cancer-with-an-ovarian-metastasis weekly 0.8 https://www.themednet.org/can-jak-inhibitors-for-established-rheumatoid-arthritis-be-continued-when-starting-an-immune-checkpoint-inhibitor weekly 0.8 https://www.themednet.org/how-do-you-determine-if-pulmonary-hypertension-is-disproportionate-to-the-severity-of-lung-disease weekly 0.8 https://www.themednet.org/do-you-hold-crrt-for-a-period-of-time-before-performing-a-diuretic-challenge-in-a-patient-with-whom-you-are-assessing-for-the-ability-to-wean-off-of-continuous-dialysis weekly 0.8 https://www.themednet.org/do-you-recommend-adt-for-a-patient-with-hypogonadism-with-unfavorable-or-high-risk-prostate-cancer-whose-psa-dropped-to-1-after-cessation-of-supplementation weekly 0.8 https://www.themednet.org/can-you-safely-proceed-with-breast-irradiation-during-treatment-with-immunotherapy weekly 0.8 https://www.themednet.org/would-you-consider-a-patient-with-spina-bifida-and-end-stage-kidney-disease-secondary-to-reflux-nephritis-with-an-ileal-conduit-for-a-kidney-transplant weekly 0.8 https://www.themednet.org/following-the-bruin-data-in-mantle-cell-lymphoma-will-you-routinely-treat-with-pirtobrutinib-following-a-covalent-btki weekly 0.8 https://www.themednet.org/is-bilateral-hearing-loss-requiring-hearing-aids-an-absolute-or-relative-contraindication-for-neoadjuvant-cisplatin-in-mibc weekly 0.8 https://www.themednet.org/how-long-would-you-recommend-a-woman-with-hr-node-positive-breast-cancer-treated-with-surgery-and-chemotherapy-during-pregnancy-can-breastfeed-prior-to-starting-adjuvant-endocrine-therapy weekly 0.8 https://www.themednet.org/what-is-the-case-for-or-against-using-protons-for-lung-sbrt weekly 0.8 https://www.themednet.org/how-will-you-counsel-patients-regarding-aria weekly 0.8 https://www.themednet.org/what-makes-a-patient-a-good-candidate-for-treatments-targeting-amyloid-such-as-lecanemab-or-donanemab weekly 0.8 https://www.themednet.org/is-there-an-optimal-bridging-radiation-dose-for-aggressive-b-cell-nhl-undergoing-car-t-cell-therapy weekly 0.8 https://www.themednet.org/what-is-your-strategy-for-treating-headaches-in-patients-with-history-of-brain-tumor weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-metastatic-uveal-melanoma-not-a-candidate-for-tebentafusp-tebn weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-limited-stage-sclc-who-progressed-immediately-after-completing-chemoradiation-with-brain-metastasis weekly 0.8 https://www.themednet.org/would-you-consider-reserving-cdk4-6-inhibitors-as-second-line-treatment-in-patients-with-advanced-hr-her2-negative-breast-cancer-given-sonia-and-palmira-trial-results weekly 0.8 https://www.themednet.org/would-you-recommend-proceeding-with-a-kidney-biopsy-for-patients-with-waldenstroems-macroglobulinemia-who-have-hematuria-and-normal-kidney-function weekly 0.8 https://www.themednet.org/would-you-offer-postoperative-radiation-for-a-patient-who-initially-had-biopsy-proven-multistation-n2-nsclc-but-had-a-nodal-pcr-upon-surgical-resection-lnd-after-neoadjuvant-chemo-immunotherapy weekly 0.8 https://www.themednet.org/in-a-patient-with-recurrent-fibrolamellar-hcc-a-year-after-upfront-resection-previously-refused-adjuvant-therapy-with-a-solitary-abdominal-mass-would-you-offer-neoadjuvant-therapy-to-assess-response weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-tnbc-with-a-residual-strongly-pr-er-breast-mass-on-mastectomy-after-neoadjuvant-keynote-522-based-chemoimmunotherapy weekly 0.8 https://www.themednet.org/in-patients-with-medically-refractory-left-temporal-epilepsy-and-left-dominant-language-and-memory-how-should-you-approach-surgical-intervention weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-on-long-term-denosumab-who-now-requires-multiple-invasive-dental-procedures weekly 0.8 https://www.themednet.org/would-you-offer-definitive-crt-for-stage-iii-n3-nsclc-treated-with-neoadjuvant-immunotherapy-who-had-a-complete-radiographic-response weekly 0.8 https://www.themednet.org/do-you-recommend-sperm-banking-for-males-prior-to-undergoing-radiation weekly 0.8 https://www.themednet.org/are-there-instances-when-you-use-erythropoietin-stimulating-agents-in-patients-with-acute-kidney-injury-requiring-dialysis weekly 0.8 https://www.themednet.org/how-would-you-approach-new-dermal-mets-in-a-patient-who-recently-finished-chemoradiation-for-head-and-neck-scc weekly 0.8 https://www.themednet.org/for-a-patient-with-iiic-endometrial-adenocarcinoma-diagnosed-and-treated-with-6-cycles-of-carboplatin-paclitaxel-two-years-prior-would-you-consider-maintenance-therapy-with-pd-l1-inhibition-given-results-of-gy018-and-ruby weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-t4n1-duodenal-adenocarcinoma-by-eus-with-ampullary-invasion-that-is-dmmr weekly 0.8 https://www.themednet.org/when-treating-endometrial-cancer-patients-with-a-combination-of-chemotherapy-and-vaginal-cuff-brachytherapy-when-do-you-deliver-cuff-brachy weekly 0.8 https://www.themednet.org/when-do-you-offer-sbrt-for-a-small-slowly-growing-lung-lesion weekly 0.8 https://www.themednet.org/what-is-your-preferred-method-for-diagnosing-adenine-phosphoribosyltransferase-aprt-deficiency-in-a-patient-with-recurrent-kidney-stones-and-abnormal-crystalluria weekly 0.8 https://www.themednet.org/can-subclinical-hypothyroidism-cause-myxedema-coma weekly 0.8 https://www.themednet.org/in-which-patients-do-you-prefer-daily-standard-three-drug-therapy-for-non-cavitary-pulmonary-mac-as-opposed-to-three-times-a-week-dosing weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-of-macrolide-sensitive-localized-bone-joint-mac-disease weekly 0.8 https://www.themednet.org/is-there-any-role-for-additional-antiviral-therapy-during-rebound-from-covid-19-infection-after-a-course-of-paxlovid weekly 0.8 https://www.themednet.org/are-contact-precautions-effective-at-preventing-mrsa-transmission-in-healthcare-settings weekly 0.8 https://www.themednet.org/what-is-the-preferred-four-drug-regimen-for-initial-treatment-of-pan-susceptible-tuberculous-meningitis-given-the-need-to-achieve-optimal-cns-penetration weekly 0.8 https://www.themednet.org/what-duration-of-therapy-do-you-use-for-treatment-of-legionella-pneumonia-in-an-immunocompetent-host-without-associated-empyema-or-extrapulmonary-infection weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-capecitabine-and-radiation-in-addition-to-adjuvant-folfox-for-a-patient-with-resected-pt3n2-rectosigmoid-adenocarcinoma-with-other-high-risk-pathologic-features weekly 0.8 https://www.themednet.org/when-do-you-recommend-adjuvant-radiotherapy-for-a-resected-oncocytic-carcinoma-of-the-submandibular-gland weekly 0.8 https://www.themednet.org/do-you-prescribe-bronchodilators-to-patients-with-radiographic-emphysema-and-respiratory-symptoms-but-no-spirometric-obstruction weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-pembrolizumab-in-a-msi-h-oligometastatic-colorectal-cancer-status-post-resection-that-responded-to-neoadjuvant-ici weekly 0.8 https://www.themednet.org/do-you-have-cut-off-values-for-neutrophil-and-platelet-counts-when-doing-interstitial-brachytherapy-for-cervical-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-a-stage-iiib-recurrent-seminoma-with-early-recurrence-following-first-line-treatment-with-vip weekly 0.8 https://www.themednet.org/what-is-your-preferred-third-line-therapy-for-a-fit-patient-with-symptomatic-relapsed-follicular-lymphoma-who-has-failed-bendamustine-rituximab-and-lenalidomide-rituximab weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-living-kidney-donor-evaluation-for-a-patient-with-normal-kidney-function-who-wishes-to-donate-to-their-monozygotic-twin-who-has-eskd-due-to-an-autoimmune-disorder weekly 0.8 https://www.themednet.org/how-would-you-treat-a-post-menopausal-woman-with-recurrent-breast-cancer-t1bn0-hr-er-pr-90-her2-s-p-lumpectomy-and-adjuvant-rt-with-low-oncotype-of-6 weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-radiation-pneumonitis-who-remains-symptomatic-on-steroids weekly 0.8 https://www.themednet.org/what-else-do-you-consider-in-the-differential-diagnosis-for-pulmonary-renal-syndromes-if-there-is-low-clinical-and-serologic-evidence-of-aav-goodpastures-or-other-rheumatologic-disease-sle-ra-aps-scleroderma weekly 0.8 https://www.themednet.org/what-dose-constraints-and-technical-parameters-would-you-use-for-a-sib-fsrt-plan-for-a-large-brain-metastasis-resection-cavity-with-rapid-interval-tumor-growth-along-periphery-of-the-resection-cavity weekly 0.8 https://www.themednet.org/how-do-you-plan-to-use-canakinumab-for-the-treatment-of-gout weekly 0.8 https://www.themednet.org/is-there-a-role-for-a-kidney-biopsy-in-patients-diagnosed-with-fabry-disease-through-genetic-testing weekly 0.8 https://www.themednet.org/when-do-you-consider-starting-an-antiplatelet-in-a-patient-with-stoke-due-to-septic-emboli weekly 0.8 https://www.themednet.org/when-should-one-consider-obtaining-a-cardiac-mri-in-ischemic-stroke-patients weekly 0.8 https://www.themednet.org/does-receiving-ivig-confound-the-result-of-spep-and-or-upep weekly 0.8 https://www.themednet.org/how-would-you-treat-a-periungual-squamous-cell-carcinoma-of-the-thumb weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-systemic-therapy-in-a-hr-premenopausal-patient-over-the-age-of-50 weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiotherapy-to-a-young-patient-with-microinvasive-lobular-carcinoma-1-mm-in-a-background-of-lcis weekly 0.8 https://www.themednet.org/what-are-the-benefits-and-potential-risks-of-using-bisphosphonates-for-pseudoxanthoma-elasticum weekly 0.8 https://www.themednet.org/what-dose-constraint-do-you-use-for-the-spinal-cord-and-or-cauda-equina-for-a-spinal-meningioma weekly 0.8 https://www.themednet.org/how-do-you-time-pet-ct-surveillance-and-covid-boosters weekly 0.8 https://www.themednet.org/are-there-instances-when-you-would-pursue-a-kidney-biopsy-in-a-pregnant-patient-instead-of-waiting-to-perform-the-procedure-post-delivery weekly 0.8 https://www.themednet.org/in-a-patient-with-very-advanced-head-and-neck-cancer-treated-with-induction-chemotherapy-and-then-definitive-radiation-do-you-recommend-adding-concurrent-chemotherapy-with-the-radiation weekly 0.8 https://www.themednet.org/would-you-consider-reserving-enfortumab-pembrolizumab-combination-as-second-line-after-progression-post-platinum-based-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-incidentally-identified-unilateral-retinal-vasculitis-with-subsequent-labs-revealing-p-anca weekly 0.8 https://www.themednet.org/how-would-you-delineate-or-modify-target-volumes-for-stage-i-nsclc-abutting-the-chest-wall-in-a-thin-patient-for-whom-the-traditional-sbrt-ptv-margin-extends-to-the-skin weekly 0.8 https://www.themednet.org/can-bleeding-risk-when-switching-from-vka-treatment-to-a-noac-in-frail-elderly-patients-be-accurately-compared-if-individual-times-in-therapeutic-range-while-on-vka-treatment-are-not-captured weekly 0.8 https://www.themednet.org/how-long-do-you-anticoagulate-for-cirrhosis-patients-who-have-portal-vein-thrombosis-extending-to-the-mesenteric-veins weekly 0.8 https://www.themednet.org/for-patients-with-peritoneal-carcinomatosis-and-minimal-response-to-neoadjuvant-chemotherapy-is-there-a-benefit-to-palliative-cytoreductive-surgery-followed-by-whole-abdominal-radiotherapy weekly 0.8 https://www.themednet.org/would-you-offer-post-operative-radiation-for-a-glomus-tumor-of-the-spine-following-decompressive-laminectomy-and-incomplete-resection weekly 0.8 https://www.themednet.org/how-should-community-oncologists-practically-counsel-patients-with-aggressive-lymphomas-on-the-potential-treatment-course-as-they-move-into-2l-3l-therapies weekly 0.8 https://www.themednet.org/do-you-think-that-home-inr-monitoring-is-a-feasible-option-for-elderly-frail-patients-with-atrial-fibrillation-on-vka-treatment-given-variations-in-socioeconomic-status-and-access-to-care weekly 0.8 https://www.themednet.org/how-do-you-employ-focal-therapies-in-localized-hepatocellular-carcinoma weekly 0.8 https://www.themednet.org/would-atypical-fractures-of-the-hip-in-a-parent-treated-with-bisphosphonate-be-considered-when-calculating-the-frax-score-for-a-patient-with-osteopenia weekly 0.8 https://www.themednet.org/how-would-you-treat-surgically-inoperable-large-sarcomatoid-tumor-in-the-left-upper-lobe-causing-rib-erosion-and-pain weekly 0.8 https://www.themednet.org/do-you-routinely-obtain-baseline-vascular-imaging-cta-mra-pet-in-patients-with-suspected-gca-but-negative-temporal-artery-biopsy weekly 0.8 https://www.themednet.org/do-you-screen-for-cardiac-disease-in-patients-with-dermatomyositis-in-the-absence-of-symptoms weekly 0.8 https://www.themednet.org/do-you-delay-spinal-surgery-e-g-lumbar-decompression-for-stenosis-in-men-or-women-with-newly-diagnosed-osteoporosis-and-multiple-thoracic-compression-fractures-not-involving-site-of-potential-surgery-in-order-to-initiate-anabolic-or-anti-resorptive-therap weekly 0.8 https://www.themednet.org/would-you-offer-pelvic-radiation-in-a-patient-with-stage-iiic-endometrial-cancer-who-has-crohns-disease-and-a-permanent-ileostomy weekly 0.8 https://www.themednet.org/are-there-instances-when-you-would-recommend-obtaining-a-24-hour-urine-protein-measurement-in-place-of-spot-urine-protein-studies-in-patients-with-acute-kidney-injury-and-proteinuria weekly 0.8 https://www.themednet.org/what-patient-factors-prompt-you-to-consider-starting-dupilumab-in-patients-with-copd weekly 0.8 https://www.themednet.org/did-the-low-rate-of-copd-exacerbations-in-the-boreas-cohort-overall-confound-the-results-of-the-study weekly 0.8 https://www.themednet.org/are-the-results-of-the-boreas-trial-generalizable-to-non-white-populations weekly 0.8 https://www.themednet.org/will-you-use-feno-testing-in-all-copd-patients-to-determine-whether-they-are-candidates-for-therapy-with-dupilumab weekly 0.8 https://www.themednet.org/are-there-instances-when-you-recommend-obtaining-more-than-2-kidney-cores-when-performing-a-native-kidney-biopsy weekly 0.8 https://www.themednet.org/do-you-typically-check-vitamin-b6-levels-in-patients-on-sinemet weekly 0.8 https://www.themednet.org/when-do-you-consider-genetic-testing-in-patients-with-concern-for-hemiplegic-migraine weekly 0.8 https://www.themednet.org/how-do-you-treat-patients-with-hemiplegic-migraine weekly 0.8 https://www.themednet.org/what-is-the-practical-application-of-serological-ms-disease-activity-testing-offered-by-octave-bio-for-patients-with-ms weekly 0.8 https://www.themednet.org/should-we-be-shrinking-rectal-cancer-fields weekly 0.8 https://www.themednet.org/for-what-patients-are-you-adopting-the-prospect-approach-into-your-rectal-cancer-practice weekly 0.8 https://www.themednet.org/do-you-recommend-testing-for-hpv-in-patients-with-oral-lichen-planus weekly 0.8 https://www.themednet.org/what-is-your-approach-to-esa-use-in-patients-with-eskd-and-active-malignancy-on-treatment weekly 0.8 https://www.themednet.org/how-would-you-work-up-and-manage-an-isolated-cn3-deficit-with-anisocoria weekly 0.8 https://www.themednet.org/in-what-clinical-context-would-you-consider-offering-first-time-catheter-ablation-for-symptomatic-atrial-fibrillation-in-patients-with-advanced-heart-failure-as-opposed-to-a-trial-of-antiarrhythmics-and-or-cardioversion weekly 0.8 https://www.themednet.org/what-is-your-preferred-mechanism-for-venting-the-left-ventricle-in-patients-on-va-ecmo weekly 0.8 https://www.themednet.org/how-would-you-approach-an-msi-h-hpv-t2-n1-squamous-cell-carcinoma-of-the-anus weekly 0.8 https://www.themednet.org/what-is-your-preferred-pmrt-dose-fractionation-for-patients-with-implant-reconstruction weekly 0.8 https://www.themednet.org/would-you-consider-adding-dupilumab-to-adalimumab-or-other-monoclonal-antibodies-in-a-patient-who-has-ra-and-refractory-atopic-dermatitis-and-already-is-on-mtx-25-mg-weekly weekly 0.8 https://www.themednet.org/would-you-treat-a-nsclc-with-a-hypofractionated-course-daily-or-every-other-day weekly 0.8 https://www.themednet.org/how-would-you-manage-a-merkel-cell-carcinoma-that-spontaneously-regressed-clinically-in-a-patient-medically-high-risk-for-surgical-resection-anesthesia weekly 0.8 https://www.themednet.org/what-recommendations-do-you-offer-for-patients-who-have-a-peritoneal-dialysis-catheter-and-who-wish-to-swim weekly 0.8 https://www.themednet.org/what-pentoxifylline-and-vitamin-e-dose-do-you-typically-use-for-both-the-prevention-and-treatment-of-radiation-associated-fibrosis-after-breast-rt weekly 0.8 https://www.themednet.org/is-there-a-scenario-in-which-you-would-consider-neoadjuvant-radiation-for-rectal-cancer-after-previous-definitive-radiation-for-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-use-an-sib-schema-for-salvage-post-prostatectomy-rt-when-treating-the-fossa-in-33-39-fractions-and-including-the-pelvic-lymph-nodes weekly 0.8 https://www.themednet.org/how-do-you-approach-pre-conception-counseling-in-males-who-are-on-medications-for-which-there-is-limited-or-no-data-such-as-jak-inhibitors-apremilast-or-belimumab weekly 0.8 https://www.themednet.org/how-do-you-approach-evaluation-for-underlying-rheumatologic-disease-in-patients-with-chronic-asymptomatic-thrombocytopenia weekly 0.8 https://www.themednet.org/do-you-treat-hypercalciuria-in-post-menopausal-osteoporosis-with-normal-serum-calcium-and-pth weekly 0.8 https://www.themednet.org/does-the-risk-of-bowel-complications-change-in-a-case-where-there-is-bowel-invasion-in-a-non-functioning-portion-of-sigmoid-after-diversion-in-a-gynecologic-malignancy-getting-crt-brachy weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-suspected-cholangiocarcinoma-that-presents-with-biliary-obstruction-but-has-repeated-negative-brushings-biopsies weekly 0.8 https://www.themednet.org/what-hypofractionated-radiotherapy-dose-regimen-is-acceptable-for-plasmacytoma weekly 0.8 https://www.themednet.org/in-which-situations-do-you-omit-the-5fu-bolus-in-folfox-or-folfiri weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-patients-with-brachioradial-pruritus weekly 0.8 https://www.themednet.org/for-a-patient-with-triple-class-refractory-myeloma-and-cytopenias-who-has-been-collected-for-car-t-would-you-choose-aggressive-chemotherapy-or-a-bispecific-antibody-for-bridging weekly 0.8 https://www.themednet.org/in-patients-with-skin-squamous-cell-carcinoma-invading-the-skull-what-dose-do-you-limit-the-brain-when-treating-definitively-with-radiation weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-chest-2023 weekly 0.8 https://www.themednet.org/any-concern-for-lupus-flare-in-patients-undergoing-laser-hair-removal weekly 0.8 https://www.themednet.org/is-it-reasonable-to-extrapolate-data-from-glioblastoma-and-discuss-tumor-treating-fields-in-patients-with-grade-4-idh-mutant-astrocytomas weekly 0.8 https://www.themednet.org/are-there-special-recommendations-for-the-use-of-hydroxychloroquine-and-methotrexate-together weekly 0.8 https://www.themednet.org/in-what-clinical-scenario-if-any-would-you-consider-apbi-appropriate-treatment-for-a-patient-with-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-treatment-algorithm-for-managing-porokeratosis weekly 0.8 https://www.themednet.org/how-are-you-deciding-between-available-third-line-therapies-for-post-transplant-relapsed-dlbcl weekly 0.8 https://www.themednet.org/how-do-you-approach-prevention-of-kidney-stones-in-patients-with-an-ileal-diversion-and-recurrent-nephrolithiasis weekly 0.8 https://www.themednet.org/what-is-your-approach-between-choosing-lumasiran-or-nedosiran-for-patients-with-primary-hyperoxaluria-type-1 weekly 0.8 https://www.themednet.org/is-it-possible-to-have-undetectable-cortisol-levels-in-secondary-adrenal-insufficiency weekly 0.8 https://www.themednet.org/how-do-you-decide-on-an-outpatient-maintenance-diuretic-regimen-for-patients-approaching-discharge-for-adhf weekly 0.8 https://www.themednet.org/how-will-you-manage-a-patient-with-symptomatic-secondary-cns-involvement-from-dlbcl-not-eligible-for-hd-mtx weekly 0.8 https://www.themednet.org/is-history-of-gbs-a-contraindication-for-all-future-flu-vaccines weekly 0.8 https://www.themednet.org/what-is-your-approach-to-determining-which-patients-with-eskd-and-pruritis-should-be-started-on-difelikefalin weekly 0.8 https://www.themednet.org/how-do-you-treat-persistent-headache-after-rcvs weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-locally-advanced-nasopharyngeal-squamous-cell-carcinoma-post-induction-chemotherapy-with-gemcitabine-cisplatin-and-imaging-showing-mild-progression weekly 0.8 https://www.themednet.org/how-would-you-lead-a-goals-of-care-discussion-in-terms-of-prognosis-survival-likelihood-for-patients-with-inotropic-dependent-hfref-with-crt-d-on-maximally-tolerated-gdmt weekly 0.8 https://www.themednet.org/would-you-offer-empiric-radiation-for-a-growing-mediastinal-mass-radiographically-suspicious-for-thymoma-in-a-patient-who-declines-surgery weekly 0.8 https://www.themednet.org/what-is-your-approach-to-achieving-hypernatremia-in-a-patient-on-crrt-for-whom-increasing-the-rate-of-a-post-filter-3-sodium-chloride-infusion-is-insufficient weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-unresectable-pancreatic-cancer-on-gemcitabine-nab-paclitaxel-based-chemotherapy-q28-days-with-severe-neutropenia weekly 0.8 https://www.themednet.org/what-dose-and-target-volume-do-you-use-for-neoadjuvant-chemort-in-a-patient-with-a-locally-advanced-uterine-endometrial-cancer-involving-parametria-cervix-and-the-uterine-fundus-no-side-wall-involvement-requiring-downstage-to-be-eligible-for-surgery weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-to-low-volume-unresectable-metastatic-favorable-risk-rcc weekly 0.8 https://www.themednet.org/how-will-you-approach-drug-sequencing-in-patients-with-pmr-given-the-saphyr-data weekly 0.8 https://www.themednet.org/how-will-you-adjust-your-approach-to-steroid-taper-in-patients-with-pmr-also-on-sarilumab weekly 0.8 https://www.themednet.org/what-baseline-and-ongoing-testing-do-you-recommend-for-patients-with-pmr-who-are-going-to-be-on-a-prolonged-steroid-taper weekly 0.8 https://www.themednet.org/is-there-strong-evidence-to-use-tmb-found-in-circulating-tumor-dna-to-guide-the-use-of-ici-in-metastatic-colon-cancer weekly 0.8 https://www.themednet.org/do-you-perform-routine-interval-screening-for-pulmonary-fibrosis-in-individuals-who-have-been-identified-through-genetic-testing-as-being-at-risk-for-developing-pulmonary-fibrosis-but-dont-exhibit-any-signs-or-symptoms weekly 0.8 https://www.themednet.org/for-a-medically-inoperable-clinically-staged-figo-ia-endometrial-cancer-with-serous-clear-cell-or-other-non-endometrioid-high-risk-histology-treated-with-ebrt-alone-would-you-cover-elective-lymph-nodes-or-treat-the-uterus-alone weekly 0.8 https://www.themednet.org/how-often-would-you-repeat-testing-in-a-patient-suspected-of-cyclic-cushings weekly 0.8 https://www.themednet.org/how-would-you-manage-an-elderly-patient-with-mild-pancytopenia-who-refuses-bone-marrow-biopsy-and-whose-flow-cytometry-is-suggestive-of-cmml-mds weekly 0.8 https://www.themednet.org/is-reduction-in-proteinuria-with-sglt2i-dose-dependent weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-asn-2023 weekly 0.8 https://www.themednet.org/would-you-offer-treatment-according-to-the-prospect-trial-for-rectal-cancer-in-which-an-involved-lymph-node-approaches-the-circumferential-resection-margin-crm weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-al-amyloidosis-with-t-11-14-who-have-not-achieved-a-hematologic-complete-response-to-induction-therapy-with-6-cycles-of-dara-cybord weekly 0.8 https://www.themednet.org/would-you-offer-neoadjuvant-radiation-therapy-with-concurrent-chemotherapy-for-a-t4-rectal-carcinoma-with-an-associated-rectovesical-fistula weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-alopecia-on-the-timing-of-response-and-what-sort-of-outcomes-they-should-expect-with-jak-inhibitors weekly 0.8 https://www.themednet.org/do-you-use-steroids-in-the-management-of-pjp-pneumonia-with-severe-hypoxia-in-hiv-negative-patients weekly 0.8 https://www.themednet.org/how-would-you-approach-medication-de-escalation-in-a-patient-with-a-history-of-rapidly-progressive-ctd-ild-who-responded-to-and-is-currently-on-mycophenolate-3-grams-daily-and-ivig-2mg-kg-monthly-infusions-and-has-been-stable-for-two-years weekly 0.8 https://www.themednet.org/should-checking-a-urinalysis-with-reflex-to-culture-be-part-of-the-standard-work-up-for-fever-in-an-icu-patient-with-a-urinary-catheter weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-hodgkin-lymphoma-who-has-an-isolated-relapse-within-the-cns weekly 0.8 https://www.themednet.org/with-the-recent-trials-such-as-select-and-step-hfpef-demonstrating-benefits-of-glp1-agonists-in-terms-of-cv-risk-reduction-and-improved-exercise-function-have-you-begun-to-incorporate-this-class-of-medications-into-routine-cv-health-maintenance-for-patien weekly 0.8 https://www.themednet.org/what-is-your-approach-to-counseling-patients-who-require-definitive-radiation-therapy-to-the-head-and-neck-but-for-whatever-reason-cannot-will-not-undergo-recommended-extractions weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-metastatic-scc-of-the-larynx-pd-l1-1-unable-to-tolerate-5-fu-based-chemotherapy-due-to-grade-4-esophagitis-mucositis weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-a-negative-axillary-ultrasound-but-no-sentinel-lymph-node-evaluation-at-the-time-of-lumpectomy-for-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/for-patients-with-nephrolithiasis-and-hypercalciuria-attributed-to-a-parathyroid-adenoma-how-long-after-a-partial-parathyroidectomy-do-you-assess-for-improvement-in-24-hour-urine-calcium-levels weekly 0.8 https://www.themednet.org/what-dose-would-you-consider-for-a-patient-who-received-59-4-gy-18-years-ago-for-a-glioma-of-the-right-frontal-lobe-who-is-now-s-p-gross-total-resection-for-a-high-grade-glioma-in-the-same-area weekly 0.8 https://www.themednet.org/do-you-think-there-would-be-benefit-in-using-sparsentan-over-irbesartan-for-fsgs-given-a-higher-percentage-of-patients-with-partial-remission-of-proteinuria-on-sparsentan-despite-no-significant-difference-in-egfr-slope-in-the-duplex-trial weekly 0.8 https://www.themednet.org/for-a-young-patient-with-advanced-tnbc-with-a-single-lung-nodule-status-post-nac-not-amenable-to-biopsy-would-you-consider-sbrt-to-the-lesion weekly 0.8 https://www.themednet.org/are-there-instances-where-you-may-transiently-transition-a-perioperative-eskd-on-pd-inpatient-from-peritoneal-dialysis-to-hemodialysis-if-they-are-likely-to-receive-a-large-volume-of-fluid weekly 0.8 https://www.themednet.org/is-monitoring-for-fetal-heart-block-recommended-in-pregnant-patients-with-only-slightly-elevated-ssa weekly 0.8 https://www.themednet.org/for-a-patient-receiving-postmastectomy-imrt-to-chest-wall-with-expander-and-regional-nodes-including-imn-what-constraint-would-you-use-for-dose-to-the-contralateral-chest-wall-implant-if-the-patient-also-had-a-mastectomy-and-reconstruction-on-that-side weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-acr-convergence-2023 weekly 0.8 https://www.themednet.org/how-would-you-approach-peri-operative-immunosuppressive-management-of-a-patient-with-behcets-currently-controlled-on-azathioprine-who-needs-genital-surgery weekly 0.8 https://www.themednet.org/have-the-results-of-the-ancillary-study-of-the-vital-trial-demonstrating-that-vitamin-d3-supplementation-did-not-reduce-the-incident-rate-of-fractures-in-generally-healthy-midlife-and-older-adults-changed-how-you-prescribe-vitamin-d weekly 0.8 https://www.themednet.org/how-do-you-manage-osteoporosis-in-patients-with-anorexia-nervosa-who-often-are-young-women-40 weekly 0.8 https://www.themednet.org/for-an-asymptomatic-patient-discovered-during-workup-for-elevated-pt-ptt-to-have-mild-prothrombin-deficiency-would-you-suggest-any-preoperative-prophylaxis weekly 0.8 https://www.themednet.org/for-bone-metastases-requiring-surgical-stabilization-what-time-interval-from-the-date-of-surgery-do-you-use-for-post-op-radiation weekly 0.8 https://www.themednet.org/how-do-you-utilize-jak-inhibitors-for-alopecia-in-the-pediatric-population weekly 0.8 https://www.themednet.org/how-long-post-operatively-do-you-wait-before-transitioning-from-parenteral-anticoagulation-to-oral-anticoagulants-after-pulmonary-thromboendarterectomy-for-cteph weekly 0.8 https://www.themednet.org/what-additional-testing-is-recommended-with-heterozygous-hfe-c282y-mutation-whose-ferritin-is-elevated-and-transferrin-saturation-percentage-is-at-baseline weekly 0.8 https://www.themednet.org/in-oral-cavity-cancers-how-does-wpoi-worse-pattern-of-invasion-influence-your-decision-to-offer-adjuvant-therapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-therapy-in-well-differentiated-gi-net-with-ki67-55 weekly 0.8 https://www.themednet.org/how-would-you-manage-gout-with-hyperuricemia-10-mg-dl-despite-the-maximum-dose-of-allopurinol-plus-probenecid-and-a-prior-allergic-reaction-to-pegloticase weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-sle-undergoing-assisted-reproductive-therapy-with-estrogenic-effects weekly 0.8 https://www.themednet.org/what-is-the-clinical-utility-of-getting-repeat-antibody-testing-in-patients-with-recurrent-symptoms-and-a-history-of-miller-fischer-syndrome weekly 0.8 https://www.themednet.org/how-do-you-advise-a-patient-on-ozone-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-active-inflammatory-arthritis-in-a-patient-with-mctd-rnp-chromatin-and-stable-ild-who-has-failed-mmf-azathioprine-and-methotrexate weekly 0.8 https://www.themednet.org/what-abortive-and-preventative-treatments-have-you-found-to-be-helpful-for-a-vestibular-migraine weekly 0.8 https://www.themednet.org/in-a-patient-with-otherwise-favorable-dcis-and-a-focally-positive-margin-who-refuses-reexcision-is-apbi-an-appropriate-treatment-option weekly 0.8 https://www.themednet.org/when-do-you-consider-complement-inhibitors-or-fcrn-inhibitors-in-patients-with-myasthenia-gravis weekly 0.8 https://www.themednet.org/for-patients-with-kidney-stone-disease-and-chronic-kidney-disease-is-there-an-egfr-threshold-at-which-you-no-longer-recommend-pursing-24-hour-urine-stone-risk-studies weekly 0.8 https://www.themednet.org/in-which-patients-with-mgus-do-you-recommend-a-kidney-biopsy-to-evaluate-for-mgrs weekly 0.8 https://www.themednet.org/when-do-you-refer-patients-diagnosed-with-moyamoya-disease-to-neurosurgery weekly 0.8 https://www.themednet.org/do-you-adjust-the-dose-or-the-timing-of-levothyroxine-ingestion-in-patients-on-anti-acid-medications weekly 0.8 https://www.themednet.org/do-you-offer-ldrt-for-psoriatic-arthritis-rheumatoid-arthritis-or-polymyalgia-rheumatica-or-fibromyalgia weekly 0.8 https://www.themednet.org/do-you-adjust-chemotherapy-dose-if-10-change-in-calculated-dose-weight-bsa-or-if-any-of-these-three-parameters-are-met weekly 0.8 https://www.themednet.org/do-you-treat-patients-with-resected-adenocarcinoma-of-the-intrapancreatic-bile-duct-along-a-biliary-paradigm-or-pancreatic-paradigm weekly 0.8 https://www.themednet.org/would-you-give-a-second-round-of-therapeutic-rai-in-a-patient-with-ptc-s-p-total-thyroidectomy-and-i-131-ablation-who-is-found-to-have-recurrent-disease-in-cervical-lymph-nodes-s-p-repeat-neck-dissection weekly 0.8 https://www.themednet.org/aside-from-lifestyle-measures-such-as-calcium-intake-vitamin-d-repletion-and-weight-bearing-exercises-and-ruling-out-all-secondary-causes-what-is-the-preferred-approach-to-managing-osteoporosis-in-young-women-with-z-score-of-less-than-2-5-and-planning-to- weekly 0.8 https://www.themednet.org/should-oral-combined-contraceptives-be-held-prior-to-overnight-dexamethasone-suppression-test-to-rule-out-cushings weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiotherapy-for-a-gross-totally-resected-who-grade-2-hemangiopericytoma-mft-of-the-brain-in-a-patient-with-active-multiple-sclerosis weekly 0.8 https://www.themednet.org/for-patients-with-advanced-endometrial-cancer-are-the-improved-outcomes-in-pfs-from-duo-e-ruby-nrg-gy018-sufficient-to-move-immunotherapy-to-the-frontline-for-all-presuming-fda-approval weekly 0.8 https://www.themednet.org/what-is-the-optimal-sequence-of-available-therapies-in-patients-with-brca-hrr-mcrpc-after-progression-on-first-line-combinations weekly 0.8 https://www.themednet.org/would-you-favor-pci-or-cabg-for-younger-patients-with-radiation-associated-cardiac-disease-in-the-absence-of-any-significant-valvular-abnormalities weekly 0.8 https://www.themednet.org/what-is-your-typical-approach-to-the-use-of-beta-blockers-in-the-setting-of-recent-cocaine-use-amongst-patients-presenting-with-cocaine-related-mi-arrhythmias-or-new-onset-heart-failure weekly 0.8 https://www.themednet.org/should-systemic-anticoagulation-be-considered-for-patients-with-a-less-than-1-atrial-fibrillation-burden-on-outpatient-monitoring-with-an-elevated-chadsvasc-score-and-acceptable-bleeding-risk weekly 0.8 https://www.themednet.org/does-hepatitis-b-vaccination-reduce-the-risk-of-hbv-reactivation-associated-with-immunosuppressive-therapy weekly 0.8 https://www.themednet.org/can-combined-oral-contraceptive-use-cause-falsely-elevated-24-hour-urine-free-cortisol weekly 0.8 https://www.themednet.org/what-treatment-modalities-have-you-had-success-in-treating-perioral-or-periorbital-dermatitis-when-they-have-failed-topical-calcineurin-inhibitor-and-oral-antibiotics weekly 0.8 https://www.themednet.org/what-is-your-experience-with-using-5-alpha-reductase-inhibitors-in-females-of-childbearing-age-for-androgenetic-alopecia weekly 0.8 https://www.themednet.org/whats-your-treatment-algorithm-for-notalgia-paresthetica weekly 0.8 https://www.themednet.org/how-do-you-approach-an-older-male-with-a-chronic-and-persistent-granulomatous-cutaneous-medium-vessel-vasculitis-that-has-been-unresponsive-worsened-on-high-dose-steroids-cyclophosphamide-and-rituximab-immunosuppressive-agents-with-a-thorough-and-unremark weekly 0.8 https://www.themednet.org/what-is-your-approach-to-establishing-a-dry-weight-in-a-pregnant-patient-with-eskd-on-hemodialysis-given-the-expectation-of-weight-increase-and-pregnancy-related-edema weekly 0.8 https://www.themednet.org/in-light-of-the-shape-trial-results-how-would-you-manage-a-patient-with-an-incidentally-diagnosed-figo-ia1-cervical-cancer-after-simple-extrafascial-hysterectomy-bso weekly 0.8 https://www.themednet.org/would-you-consider-offering-immunotherapy-olaparib-to-a-patient-with-early-stage-endometrial-carcinoma-for-whom-you-are-recommending-adjuvant-chemotherapy-based-on-improved-outcomes-seen-in-ruby-duo-e-nrg-gy018 weekly 0.8 https://www.themednet.org/do-you-avoid-esa-use-in-patients-with-anemia-and-chronic-kidney-disease-who-also-have-apls-and-risk-for-thrombosis weekly 0.8 https://www.themednet.org/would-you-offer-additional-systemic-treatment-to-a-stage-ii-or-iii-resected-colon-cancer-that-received-3-months-of-adjuvant-capecitabine-oxaliplatin-and-now-is-presenting-with-a-solitary-lung-metastasis weekly 0.8 https://www.themednet.org/how-does-your-treatment-approach-differ-in-patients-with-acute-visual-loss-due-to-central-retinal-artery-occlusion-versus-retinal-vein-occlusion weekly 0.8 https://www.themednet.org/whats-your-approach-to-treating-multiple-facial-bccs-in-gorlin-syndrome weekly 0.8 https://www.themednet.org/how-do-you-manage-hemodialysis-for-an-eskd-patient-presenting-with-severe-hyponatremia-and-a-serum-sodium-more-than-10-meq-l-below-the-lowest-available-dialysate-sodium-concentration weekly 0.8 https://www.themednet.org/would-you-treat-an-isolated-elevated-total-cholesterol-in-a-post-menopausal-patient-who-is-otherwise-healthy-and-has-no-significant-cv-risk-factors weekly 0.8 https://www.themednet.org/how-would-you-treat-a-young-patient-who-presents-with-coronary-vasculitis-and-aortitis-with-persistently-positive-mpo-but-no-other-features-of-aav weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-in-patients-with-early-breast-cancer-with-axillary-soft-tissue-involvement-with-or-without-concurrent-lymph-node-involvement weekly 0.8 https://www.themednet.org/what-is-the-current-recommendation-for-air-travel-after-a-primary-spontaneous-pneumothorax weekly 0.8 https://www.themednet.org/how-do-you-define-pik3ca-akt-pten-alteration-for-capivasertib-use weekly 0.8 https://www.themednet.org/would-you-try-combination-ketorolac-and-cortisone-injections-in-a-patient-with-severe-knee-oa-who-refuses-surgery-and-had-partial-responses-to-injections-of-cortisone-and-ketorolac-separately weekly 0.8 https://www.themednet.org/how-would-you-approach-rheumatoid-arthritis-treatment-for-widespread-large-rheumatoid-nodules-but-no-active-synovitis-or-subjective-joint-pain weekly 0.8 https://www.themednet.org/what-blood-pressure-targets-do-you-enforce-in-the-first-24-48-hours-in-a-patient-who-develops-an-intracranial-hemorrhage-after-mechanical-thrombectomy weekly 0.8 https://www.themednet.org/are-there-any-scenarios-you-would-use-cdk-4-6i-to-treat-hr-positive-her2-positive-breast-cancer-in-combination-with-anti-her2-agents weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-bells-palsy-that-has-not-improved-after-six-months weekly 0.8 https://www.themednet.org/what-do-you-view-as-the-future-role-for-the-combination-of-durvalumab-olaparib-chemotherapy-in-the-management-of-patients-with-advanced-recurrent-endometrial-cancer-following-the-duo-e-trial-results weekly 0.8 https://www.themednet.org/what-is-your-practice-regarding-giving-g-csf-to-patients-with-all-during-initial-induction weekly 0.8 https://www.themednet.org/what-initial-therapy-do-you-offer-elderly-patients-with-metastatic-nsclc-with-met-amplification-and-pd-l1-50 weekly 0.8 https://www.themednet.org/how-would-you-manage-a-young-patient-with-hl-who-develops-hf-ef-30-after-4-cycles-of-a-avd-who-obtained-a-pet2-cr weekly 0.8 https://www.themednet.org/do-you-use-an-age-cutoff-for-prostate-brachytherapy weekly 0.8 https://www.themednet.org/for-otherwise-transplant-eligible-patients-with-myeloma-given-developments-of-bispecifics-and-car-t-what-is-your-age-cutoff-for-consolidative-autologous-transplant weekly 0.8 https://www.themednet.org/how-do-you-distinguish-between-primary-progressive-ms-versus-relapsing-remitting-ms-with-superimposed-relapses-in-a-newly-diagnosed-patient-that-is-naive-to-treatment weekly 0.8 https://www.themednet.org/do-you-see-a-current-or-future-clinical-role-of-neurofilament-light-chain-in-the-diagnosis-or-workup-of-multiple-sclerosis weekly 0.8 https://www.themednet.org/how-do-you-approach-cisplatin-ineligible-patients-with-bulky-eber-positive-nasopharyngeal-scc-for-induction-chemotherapy weekly 0.8 https://www.themednet.org/how-long-should-surgery-be-delayed-in-a-patient-with-localized-resectable-pancreatic-cancer-who-developed-acute-pancreatitis-following-eus-guided-biopsy weekly 0.8 https://www.themednet.org/in-what-situations-do-you-use-g-csf-for-patients-undergoing-allogeneic-hsct-to-facilitate-engraftment weekly 0.8 https://www.themednet.org/would-you-consider-enfortumab-vedotin-pembrolizumab-prior-to-surgery-for-a-patient-with-urothelial-carcinoma-with-regional-nodes-who-is-not-eligible-for-neoadjuvant-cisplatin weekly 0.8 https://www.themednet.org/how-often-do-you-check-urine-osmolality-and-urine-electrolytes-when-treating-hospitalized-patients-with-hyponatremia weekly 0.8 https://www.themednet.org/what-are-your-management-strategies-for-patients-with-recurrent-uric-acid-nephrolithiasis-and-chronic-kidney-disease-who-have-persistent-hypocitraturia-and-acidic-urine-ph weekly 0.8 https://www.themednet.org/do-you-include-the-prostate-when-treating-bladder-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-patients-with-primary-cardiac-sarcomas-for-adjuvant-systemic-treatment weekly 0.8 https://www.themednet.org/would-you-start-any-treatment-for-radiation-pneumonitis-if-there-is-a-large-area-of-consolidation-in-the-irradiated-lung-field-but-the-patient-is-asymptomatic weekly 0.8 https://www.themednet.org/is-80-gy-40-fx-adt-the-new-standard-of-care-for-definitive-radiation-of-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/do-patients-with-an-elevated-igf-1-level-and-features-of-acromegaly-need-to-have-confirmatory-growth-hormone-suppression-testing-with-ogtt weekly 0.8 https://www.themednet.org/would-you-include-the-entire-bladder-in-the-treatment-field-of-a-patient-with-a-history-of-t1-bladder-cancer-s-p-intravesical-therapy-who-is-now-being-planned-for-chemoradiation-for-a-t3n1-rectal-cancer weekly 0.8 https://www.themednet.org/do-you-consider-tracheostomy-for-the-management-of-continued-hypercapnea-despite-compliance-with-pap-in-patients-with-ohs-and-osa weekly 0.8 https://www.themednet.org/do-you-take-into-consideration-a-patients-serum-albumin-level-in-your-decision-to-use-ertapenem weekly 0.8 https://www.themednet.org/does-a-negative-staging-psma-pet-in-a-patient-with-biopsy-proven-recurrent-prostatic-adenocarcinoma-change-your-management weekly 0.8 https://www.themednet.org/what-is-the-next-step-in-management-of-a-thyroid-nodule-that-was-biopsied-and-classified-as-bethesda-iii-but-afirma-genetic-testing-reveals-parathyroid-signature weekly 0.8 https://www.themednet.org/in-which-situations-are-you-comfortable-with-alternative-dosing-of-ovarian-suppression-e-g-lupron-q3m-for-premenopausal-patients-during-adjuvant-breast-cancer-treatment weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-wearable-heart-monitor-devices-when-they-ask-about-specific-products-and-diagnostic-accuracy-of-these-devices-available-on-the-market weekly 0.8 https://www.themednet.org/do-you-obtain-an-echocardiogram-as-a-part-of-risk-stratification-in-all-patients-hospitalized-with-an-acute-pulmonary-embolism weekly 0.8 https://www.themednet.org/when-do-you-consider-the-use-of-ph-specific-therapies-in-patients-with-pre-capillary-pulmonary-hypertension-associated-with-sickle-cell-disease weekly 0.8 https://www.themednet.org/what-would-be-your-approach-to-a-patient-with-scleroderma-myositis-overlap-syndrome-anti-ku-and-active-inflammatory-eye-disease-despite-high-dose-mycophenolate weekly 0.8 https://www.themednet.org/how-do-you-approach-a-young-patient-with-undifferentiated-pleomorphic-sarcoma-of-the-upper-extremity-who-developed-ifosfamide-induced-nephrotoxicity-after-two-cycles-of-adjuvant-aim-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-determine-ipsilateral-vs-bilateral-neck-irradiation-for-early-stage-well-lateralized-nasal-cavity-scc weekly 0.8 https://www.themednet.org/what-would-be-your-approach-to-the-treatment-of-limited-stage-extrapulmonary-small-cell-carcinoma-of-the-nasopharynx-with-bilateral-cervical-lymphadenopathy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-prostate-cancer-with-psma-non-regional-lymph-nodes weekly 0.8 https://www.themednet.org/how-do-you-approach-driving-clearance-when-someone-has-an-rns-that-is-showing-seizure-activity-but-neither-the-patient-nor-the-patients-family-is-reporting-seizures weekly 0.8 https://www.themednet.org/are-there-any-patient-characteristics-that-make-you-change-fractionation-when-treating-per-stampede weekly 0.8 https://www.themednet.org/how-long-of-a-delay-are-you-willing-to-accept-for-vaginal-cuff-brachytherapy-either-as-primary-therapy-or-as-boost weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-highly-active-ankylosing-spondylitis-iritis-and-crohns-controlled-with-weekly-adalimumab-with-co-morbid-igg4rd-and-intolerance-of-azathioprine-due-to-elevated-lfts weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-in-a-patient-with-ct2-er-her2-breast-cancer-who-refuses-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-metastatic-hcc-on-atezolizumab-bevacizumab-who-requires-holding-bevacizumab-due-to-persistent-proteinuria-2g weekly 0.8 https://www.themednet.org/how-would-you-treat-grade-3-cauda-equina-meningioma-status-post-biopsy-only-with-a-history-of-prior-prostate-whole-pelvis-radiation weekly 0.8 https://www.themednet.org/for-vaginal-cylinder-hdr-in-the-setting-of-adjuvant-endometrial-cancer-radiation-do-you-routinely-alter-the-prescription-dose-based-on-the-diameter-of-the-cylinder weekly 0.8 https://www.themednet.org/what-is-your-approach-to-reporting-mandible-dose-received-to-the-dentist-oral-surgeon weekly 0.8 https://www.themednet.org/for-a-jehovahs-witness-patient-with-multiple-myeloma-could-you-safely-offer-a-bcma-directed-bispecific-antibody-or-car-t-therapy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-solitary-unresectable-liver-metastasis weekly 0.8 https://www.themednet.org/would-you-consider-opting-for-beta-blocker-withdrawal-to-improve-exercise-capacity-in-patients-with-heart-failure-with-preserved-ejection-fraction-and-chronotropic-incompetence weekly 0.8 https://www.themednet.org/would-you-offer-consolidative-full-dose-chemo-rt-for-local-residual-pancreatic-disease-in-a-patient-with-stage-iv-pancreatic-adenocarcinoma-with-excellent-response-after-induction-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-discuss-harms-of-mgus-screening-with-other-medical-providers weekly 0.8 https://www.themednet.org/what-is-the-maximum-dose-or-treatment-course-of-topical-steroids-that-you-generally-recommend-to-avoid-causing-systemic-adverse-effects weekly 0.8 https://www.themednet.org/do-you-consider-stopping-zonisamide-in-a-female-patient-with-epilepsy-who-becomes-pregnant weekly 0.8 https://www.themednet.org/what-type-of-visual-disturbance-qualifies-as-a-visual-aura weekly 0.8 https://www.themednet.org/how-do-you-counsel-hiv-patients-with-an-undetectable-viral-load-on-breastfeeding-2 weekly 0.8 https://www.themednet.org/what-would-be-your-approach-in-a-patient-who-presented-with-a-solitary-brain-metastasis-that-resolved-after-chemo-without-local-therapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-method-for-subclinical-cad-screening-prior-to-initiation-of-class-ic-antiarrhythmic-drugs-for-atrial-fibrillation weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-osimertinib-in-a-patient-with-complete-pathologic-response-to-neoadjuvant-platinum-doublet-for-a-stage-iiia-resected-egfr-mutant-lung-adenocarcinoma weekly 0.8 https://www.themednet.org/what-dose-fractionation-scheme-would-you-employ-for-treatment-of-a-bone-with-impending-fracture-prior-to-surgical-fixation weekly 0.8 https://www.themednet.org/what-is-your-approach-for-workup-and-management-of-prurigo-nodularis weekly 0.8 https://www.themednet.org/does-norethindrone-suppress-fsh-lh-completely weekly 0.8 https://www.themednet.org/does-your-treatment-strategy-differ-when-managing-patients-with-recurrent-calcium-oxalate-monohydrate-versus-calcium-oxalate-dihydrate-stones weekly 0.8 https://www.themednet.org/for-patients-presenting-with-acs-and-severe-aortic-stenosis-with-critical-left-main-disease-would-you-consider-bav-prior-to-pci-to-the-left-main weekly 0.8 https://www.themednet.org/is-there-a-role-for-biologics-to-improve-lung-function-in-patients-who-have-severe-asthma-with-daily-symptoms-and-reduced-lung-function-but-do-not-experience-frequent-exacerbations weekly 0.8 https://www.themednet.org/should-immunotherapy-be-added-to-standard-of-care-neoadjuvant-chemotherapy-in-borderline-resectable-msi-h-adenocarcinoma-of-pancreas weekly 0.8 https://www.themednet.org/what-is-the-approach-to-use-of-ace-inhibitors-for-suspected-scleroderma-renal-crisis-in-patients-with-only-mildly-elevated-bp-and-renal-artery-stenosis weekly 0.8 https://www.themednet.org/are-cgrp-antagonists-effective-at-aborting-intractable-headaches-in-hospitalized-patients-when-traditional-migraine-cocktails-have-failed weekly 0.8 https://www.themednet.org/does-pt-ptt-elevation-due-to-severe-vitamin-k-deficiency-protect-against-thrombosis weekly 0.8 https://www.themednet.org/what-if-any-cardioprotective-measures-beyond-dexrazoxane-may-be-used-to-minimize-cardiac-risk-during-or-after-chemo-or-radio-therapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-anticoagulation-antiplatelet-regimen-for-younger-patients-presenting-with-acs-found-to-have-an-acute-thrombotic-event-requiring-aspiration-thrombectomy-without-need-for-stent-deployment weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-who-has-anterior-uveitis-and-is-referred-for-evaluation-of-ocular-tb-with-a-positive-quantiferon-gold-as-part-of-their-workup-in-countries-with-low-tb-incidence weekly 0.8 https://www.themednet.org/do-you-recommend-progesterone-for-endometrial-protection-in-a-young-woman-on-estrogen-replacement-therapy-for-iatrogenic-menopause-after-definitive-radiation-therapy-for-locally-advanced-cervical-cancer weekly 0.8 https://www.themednet.org/would-re-excision-of-close-margins-1-mm-allow-a-patient-to-avoid-post-op-radiation-for-a-patient-with-metachronous-diagnosis-of-a-figo-stage-ib-vulvar-cancer-who-also-had-a-prior-contralateral-vulvar-cancer-resected-15-years-ago weekly 0.8 https://www.themednet.org/how-long-would-you-treat-a-patient-with-recent-history-of-tavr-presenting-with-e-faecalis-bacteremia-with-unclear-source-with-tee-showing-thickened-valves-but-no-obvious-vegetation weekly 0.8 https://www.themednet.org/how-would-you-manage-a-very-large-diffuse-skull-base-meningioma-involving-the-olfactory-groove-bilateral-cavernous-sinuses-and-abutting-optic-chiasm-that-is-not-amenable-to-surgical-resection weekly 0.8 https://www.themednet.org/what-is-the-optimal-number-of-days-to-hold-apixaban-prior-to-a-kidney-biopsy-or-tunneled-dialysis-catheter-placement weekly 0.8 https://www.themednet.org/would-you-recommend-starting-an-sglt2i-in-a-patient-with-a-kidney-transplant-and-moderately-increased-albuminuria weekly 0.8 https://www.themednet.org/does-your-institution-have-formal-policies-or-work-flows-to-reduce-unnecessary-igras-ordered-for-patients-on-biologics weekly 0.8 https://www.themednet.org/would-you-consider-radiation-omission-for-a-patient-with-a-stage-i-breast-cancer-with-an-elevated-oncotype-dx weekly 0.8 https://www.themednet.org/do-you-always-aspirate-effusions-in-patients-with-knee-osteoarthritis-prior-to-injecting-hyaluronic-acid weekly 0.8 https://www.themednet.org/in-patients-with-active-ibd-and-rectal-cancer-do-you-take-any-precautions-before-starting-tnt weekly 0.8 https://www.themednet.org/how-do-you-interpret-small-joint-effusions-seen-on-ultrasound-without-power-doppler-signal-in-the-setting-of-compatible-inflammatory-symptoms-i-e-morning-stiffness weekly 0.8 https://www.themednet.org/is-there-any-way-to-safely-treat-patients-with-mcrpc-with-177-lu-psma-who-are-on-hemodialysis weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-for-actinic-cheilitis weekly 0.8 https://www.themednet.org/would-you-consider-using-io-alone-for-lung-cancer-patients-with-pd-l1-1-but-who-have-high-tmb weekly 0.8 https://www.themednet.org/would-you-send-oncotype-for-pre-menopausal-women-with-hr-her2-breast-cancer-with-a-small-tumor-pt1b-and-micrometastatic-ln-involvement-or-recommend-adjuvant-chemotherapy-without-sending-oncotype weekly 0.8 https://www.themednet.org/do-you-pursue-a-skin-biopsy-or-kidney-biopsy-in-patients-whom-you-suspect-have-x-linked-alport-syndrome weekly 0.8 https://www.themednet.org/how-would-you-manage-bcr-abl-cml-that-is-resistant-to-imatinib-with-concurrent-jak2-mutation weekly 0.8 https://www.themednet.org/would-you-consider-replacing-ibrutinib-with-acalabrutinib-or-zanubrutinib-in-the-triangle-regimen-for-mcl-in-a-patient-with-atrial-fibrillation-or-high-risk-coronary-syndromes-who-is-otherwise-fit-for-aggressive-induction-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-advanced-resectable-basal-cell-carcinoma-for-possible-use-of-hedgehog-inhibitors weekly 0.8 https://www.themednet.org/what-is-your-approach-to-counseling-patients-regarding-re-initiation-of-anti-tnf-therapy-after-completion-of-treatment-for-non-disseminated-pulmonary-histoplasmosis weekly 0.8 https://www.themednet.org/in-an-adult-with-localized-spinal-myxopapillary-ependyoma-managed-with-subtotal-resection-and-54-gy-radiation-how-long-should-follow-up-mri-imaging-continue-with-what-frequency-and-for-what-volume weekly 0.8 https://www.themednet.org/how-do-you-determine-which-atrial-fibrillation-patients-with-a-high-thromboembolic-risk-and-a-contraindication-for-oral-anticoagulation-should-undergo-left-atrial-appendage-occlusion weekly 0.8 https://www.themednet.org/would-you-offer-reirradiation-for-a-patient-who-had-prior-mammosite-pbi weekly 0.8 https://www.themednet.org/for-a-patient-with-idiopathic-hypercalciuria-and-a-history-of-calcium-kidney-stones-who-has-not-normalized-24-hr-urine-calcium-level-on-thiazide-diuretic-is-there-evidence-for-targeting-a-certain-urine-calcium-level-for-decreased-future-risk-of-nephrolith weekly 0.8 https://www.themednet.org/what-approaches-can-we-take-to-initiate-therapy-and-improve-survival-rates-in-patients-with-hlh weekly 0.8 https://www.themednet.org/when-do-you-check-macroprolactin-in-the-evaluation-of-hyperprolactinemia weekly 0.8 https://www.themednet.org/would-you-offer-neoadjuvant-chemoimmunotherapy-per-keynote-522-for-a-patient-with-clinical-stage-iib-triple-negative-breast-cancer-with-apocrine-histology-or-recommend-surgery-first weekly 0.8 https://www.themednet.org/would-you-consider-a-treatment-break-for-a-patient-with-metastatic-urothelial-carcinoma-who-achieved-a-near-complete-response-to-enfortumab weekly 0.8 https://www.themednet.org/what-is-your-target-hgb-hct-for-women-who-are-pregnant-and-have-sickle-cell-disease-in-whom-you-are-doing-scheduled-transfusions weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-axial-spondyloarthritis-who-develops-new-onset-proteinuria weekly 0.8 https://www.themednet.org/is-there-a-bun-threshold-for-which-you-recommend-dialysis-prior-to-a-kidney-biopsy-to-avoid-risk-for-bleeding weekly 0.8 https://www.themednet.org/how-do-you-adjust-levothyroxine-dose-for-elderly-individuals-with-decompensated-heart-failure-on-low-dose-levothyroxine-therapy-presenting-with-tsh-10 weekly 0.8 https://www.themednet.org/in-patients-with-egjoo-on-esophageal-manometry-how-do-you-approach-subsequent-testing-for-further-evaluation weekly 0.8 https://www.themednet.org/what-therapies-would-be-considered-safe-and-effective-in-pregnant-patients-with-eoe weekly 0.8 https://www.themednet.org/in-what-scenario-would-you-stack-a-patient-on-multiple-laxatives-ex-linzess-prucalopride-if-they-have-an-incomplete-response-to-single-agent-therapies weekly 0.8 https://www.themednet.org/how-do-you-approach-selecting-a-dialysis-modality-for-a-patient-with-advanced-ckd-who-is-interested-in-home-therapy-but-has-a-history-of-medication-non-adherence-and-poor-attendance-at-clinic-appointments weekly 0.8 https://www.themednet.org/how-do-you-determine-your-next-line-of-therapy-in-alk-metastatic-nsclc-patients-who-have-widespread-progression-on-first-line-lorlatinib weekly 0.8 https://www.themednet.org/is-there-benefit-to-aggressively-treating-hemochromatosis-in-a-patient-who-has-already-progressed-to-cirrhosis-at-the-time-of-diagnosis weekly 0.8 https://www.themednet.org/how-do-you-approach-a-persistently-positive-mycoplasma-genitalium-cervical-swab-pcr-in-a-patient-who-has-undergone-multiple-courses-of-the-standard-cdc-recommended-therapy-but-continues-to-experience-pelvic-symptoms-and-vaginal-discharge weekly 0.8 https://www.themednet.org/are-there-specific-conventional-dmards-and-or-biologics-that-are-contraindicated-in-patients-with-alpha-gal-allergy weekly 0.8 https://www.themednet.org/how-do-you-design-pelvic-lymph-node-treatment-volumes-for-patients-with-tortuous-or-aberrant-vascular-anatomy weekly 0.8 https://www.themednet.org/under-what-circumstances-do-you-recommend-pocus-guidance-for-lumbar-puncture weekly 0.8 https://www.themednet.org/do-you-have-any-strategies-to-increase-yield-while-doing-a-bal weekly 0.8 https://www.themednet.org/would-you-rely-on-virtual-crossmatch-alone-to-proceed-with-a-kidney-transplant weekly 0.8 https://www.themednet.org/in-a-patient-who-underwent-cryoablation-for-early-nsclc-is-there-a-role-for-giving-preemptive-further-local-therapy weekly 0.8 https://www.themednet.org/would-you-offer-srs-to-a-hippocampal-metastasis-in-a-patient-with-es-sclc-treated-with-prior-wbrt weekly 0.8 https://www.themednet.org/when-do-you-recommend-genetic-testing-prior-to-kidney-transplantation-for-a-patient-with-eskd-secondary-to-fsgs weekly 0.8 https://www.themednet.org/who-would-be-the-right-candidate-in-which-tips-placement-would-reduce-portal-hypertension-to-allow-for-a-previously-unattainable-procedure weekly 0.8 https://www.themednet.org/how-do-you-determine-when-you-would-treat-an-identified-spleno-renal-shunt-and-how weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-discordant-fibroscan-and-serologic-testing-for-fibrosis weekly 0.8 https://www.themednet.org/how-does-a-patient-who-is-pnpla-3-positive-heterozygote-or-homozygote-impact-how-you-formulate-their-therapeutic-plan weekly 0.8 https://www.themednet.org/what-factors-into-your-choice-to-use-craving-related-medications-e-g-baclofen-naltrexone-acamprosate-etc-in-the-management-of-alcohol-use-disorder weekly 0.8 https://www.themednet.org/with-the-growth-of-non-alcoholic-beverages-e-g-na-beer-liquor-etc-how-do-you-approach-a-patients-consumption-of-these-products-in-the-setting-of-alcohol-related-liver-disease weekly 0.8 https://www.themednet.org/in-patients-with-confirmed-hypercortisolism-with-a-high-normal-unsuppressed-acth-who-have-both-a-pituitary-adenoma-and-adrenal-adenoma-identified-on-imaging-can-you-reliably-use-dhea-s-to-determine-the-source-of-cortisol-production weekly 0.8 https://www.themednet.org/when-do-you-consider-adding-an-antipsychotic-for-ssri-refractory-ocd-and-which-agent-do-you-typically-choose-first weekly 0.8 https://www.themednet.org/how-do-you-approach-induction-immunosuppression-in-patients-with-high-pra-undergoing-lung-transplantation weekly 0.8 https://www.themednet.org/what-is-your-preferred-rescue-inhaler-for-patients-with-asthma weekly 0.8 https://www.themednet.org/for-patients-with-hba1c-6-can-the-inavo-regimen-still-be-utilized-if-the-patient-is-otherwise-fit-and-has-a-strategy-for-ongoing-glycemic-control weekly 0.8 https://www.themednet.org/do-you-routinely-evaluate-for-pe-if-a-dvt-is-found weekly 0.8 https://www.themednet.org/whats-your-immediate-post-procedure-protocol-for-fractionated-laser-resurfacing-i-e-sciton-pro-fractional-laser weekly 0.8 https://www.themednet.org/how-would-you-approach-adjusting-nivo-avd-therapy-for-advanced-hodgkin-lymphoma-if-a-patient-develops-treatment-limited-immunotherapy-toxicity weekly 0.8 https://www.themednet.org/what-is-the-preferred-systemic-therapy-regimen-for-a-patient-in-their-40s-with-untreated-metastatic-sarcomatoid-carcinoma-of-unknown-primary-presenting-with-hepatic-lesions-abdominal-lymphadenopathy-and-a-lytic-bone-lesion weekly 0.8 https://www.themednet.org/how-do-you-manage-psa-progression-while-a-patient-is-on-xofigo-or-pluvicto weekly 0.8 https://www.themednet.org/would-you-start-allopurinol-for-a-patient-with-uric-acid-kidney-stones-who-does-not-have-hyperuricemia-or-hyperuricosuria weekly 0.8 https://www.themednet.org/would-you-consider-combination-belimumab-and-anakinra-for-a-patient-who-has-sle-and-mas weekly 0.8 https://www.themednet.org/do-you-recommend-delaying-spot-urine-protein-quantification-testing-until-after-nephrostomy-tube-removal-in-a-patient-with-obstructive-uropathy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-and-doctors-on-antibiotic-avoidance-in-myasthenia-gravis weekly 0.8 https://www.themednet.org/do-you-manage-antibacterials-for-enterococcal-bacteremia-differently-in-patients-with-severe-immunosuppression weekly 0.8 https://www.themednet.org/how-do-you-choose-between-initiating-long-term-therapy-with-mtor-inhibitors-versus-opting-for-interventional-treatments-such-as-embolization-or-surgery-in-a-patient-with-tuberous-sclerosis-experiencing-flank-pain-and-with-renal-angiomyolipomas-larger-than weekly 0.8 https://www.themednet.org/how-do-you-advise-a-patient-with-ckd-who-wants-to-take-an-herbal-medication-that-is-not-known-to-be-nephrotoxic-given-that-herbal-medications-are-not-regulated weekly 0.8 https://www.themednet.org/are-there-long-term-toxicity-and-qol-considerations-for-patients-receiving-nivo-ipi-compared-to-checkpoint-monotherapy-that-would-impact-your-treatment-decisions-for-first-line-metastatic-msi-h-dmmr-crc weekly 0.8 https://www.themednet.org/how-would-you-utilize-brachytherapy-boost-in-addition-to-ebrt-for-hpv-dependent-invasive-squamous-cell-carcinoma-present-as-a-large-pelvic-side-wall-mass-presumed-to-be-of-cervix-primary-albeit-the-negative-biopsies-of-the-cervix weekly 0.8 https://www.themednet.org/in-what-clinical-scenario-would-you-consider-liver-transplant-evaluation-for-a-patient-with-sickle-cell-hepatopathy weekly 0.8 https://www.themednet.org/when-would-you-consider-quantification-of-hepatitis-b-surface-antigen-as-part-of-the-treatment-decision-making-process weekly 0.8 https://www.themednet.org/what-are-your-clinical-considerations-to-pursue-an-automated-low-flow-ascites-alfa-pump-for-a-patient-with-refractory-ascites weekly 0.8 https://www.themednet.org/with-an-increase-in-the-prevalence-of-masld-in-the-united-states-population-what-recipient-and-donor-characteristics-do-you-find-favorable-for-acceptance-of-a-highly-steatotic-graft weekly 0.8 https://www.themednet.org/is-there-a-role-for-use-of-glp-1-gip-receptor-agonists-in-the-management-of-substance-use-disorders-whether-or-not-they-meet-other-inclusion-criteria-for-their-use weekly 0.8 https://www.themednet.org/when-would-you-consider-use-of-eus-guided-liver-biopsy-over-percutaneous-and-or-transjugular weekly 0.8 https://www.themednet.org/what-is-your-standard-diagnostic-workup-to-confirm-gvhd-in-a-patient-post-bmt-with-skin-rash-and-jaundice weekly 0.8 https://www.themednet.org/how-are-you-considering-use-of-inavolisib-palbociclib-fulvestrant-over-et-doublets-for-patients-with-high-risk-disease-features-such-as-visceral-metastases-visceral-crisis-high-tumor-burden weekly 0.8 https://www.themednet.org/do-you-recommend-plasmapheresis-prior-to-kidney-transplantation-for-patients-with-elevated-panel-reactive-antibody-percentages weekly 0.8 https://www.themednet.org/do-you-have-specific-waiting-periods-before-a-patient-can-be-listed-for-a-kidney-transplant-if-they-have-a-past-history-of-malignancy weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-idiopathic-anterior-uveitis-who-has-ongoing-disease-despite-adalimumab-every-two-weeks weekly 0.8 https://www.themednet.org/what-treatment-regimen-would-you-recommend-for-a-patient-with-biopsy-proven-giant-cell-arteritis-and-diffuse-cutaneous-systemic-sclerosis weekly 0.8 https://www.themednet.org/would-you-add-regional-citrate-anticoagulation-to-a-crrt-prescription-for-a-patient-on-systemic-heparin-but-who-experiences-recurrent-filter-clotting weekly 0.8 https://www.themednet.org/are-there-scenarios-where-you-would-still-prefer-adjuvant-nivolumab-based-on-known-pathologic-risk-over-using-perioperative-durvalumab-for-patients-with-muscle-invasive-bladder-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-a-patient-with-multiple-lung-nodules-and-low-titer-ccp-but-no-active-joint-symptoms-suggestive-of-ra weekly 0.8 https://www.themednet.org/is-evenity-appropriate-for-a-patient-with-severe-osteoporosis-t-score-3-1-unresponsive-to-bisphosphonates-and-persistent-primary-hyperparathyroidism-despite-two-surgeries weekly 0.8 https://www.themednet.org/in-treatment-naive-cll-without-del-17p-tp53-will-the-recent-interim-analysis-of-fixed-duration-acalabrutinib-plus-venetoclax-obinutuzumab-vs-chemoimmunotherapy-in-the-amplify-trial-change-your-practice weekly 0.8 https://www.themednet.org/what-are-your-preferred-non-benzodiazepine-therapies-for-the-hyperactive-agitated-phase-of-methamphetamine-withdrawal-both-in-the-hospital-and-in-the-office weekly 0.8 https://www.themednet.org/when-should-surgical-resection-be-considered-for-vasoproliferative-tumors weekly 0.8 https://www.themednet.org/are-you-dose-reducing-omitting-iv-dexamethasone-as-a-pre-medication-for-anti-emesis-in-patients-with-mibc-when-using-durvalumab-gemcitabine-cisplatin weekly 0.8 https://www.themednet.org/when-would-you-suspect-an-allergy-to-the-dialysis-membrane-in-patients-who-complain-of-pruritis-during-dialysis weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-patient-with-sjogrens-and-extremely-dry-mouth-who-is-losing-their-ability-to-taste-food weekly 0.8 https://www.themednet.org/do-you-prefer-vancomycin-or-daptomycin-for-gram-positive-coverage-in-culture-negative-prosthetic-valve-endocarditis-considering-both-corynebacterium-and-enterococcus-are-notable-possible-pathogens weekly 0.8 https://www.themednet.org/do-you-routinely-check-serum-phosphorus-levels-after-iv-iron-therapy weekly 0.8 https://www.themednet.org/when-screening-for-malignancy-do-you-order-ct-with-contrast-or-both-with-and-without-contrast weekly 0.8 https://www.themednet.org/how-do-you-approach-duration-of-immunotherapy-in-patients-with-metastatic-nsclc weekly 0.8 https://www.themednet.org/will-you-do-botox-or-use-injectable-cgrp-monoclonal-antibodies-in-patients-on-anticoagulation weekly 0.8 https://www.themednet.org/how-do-you-discuss-the-mechanism-and-potential-benefits-of-meditation-with-your-patients weekly 0.8 https://www.themednet.org/what-do-you-think-about-chronic-suppressive-therapy-for-hsv-2-in-a-patient-with-positive-antibodies-but-no-prior-clinical-outbreak weekly 0.8 https://www.themednet.org/would-you-favor-ct-av-calcium-score-or-dobutamine-stress-echo-for-a-patient-with-symptomatic-as-and-aortic-valve-with-normal-sv-sv-index-vmax-3-4m-s-ava-1-0cm2-and-mean-gradient-40mmhg weekly 0.8 https://www.themednet.org/is-it-possible-to-have-first-and-second-degree-av-block-either-type-1-or-2-on-the-same-ekg-strip weekly 0.8 https://www.themednet.org/how-would-you-manage-symptomatic-superficial-vein-thrombosis-during-pregnancy weekly 0.8 https://www.themednet.org/what-factors-guide-the-choice-between-early-versus-delayed-vitrectomy-after-an-open-globe-injury weekly 0.8 https://www.themednet.org/do-you-have-a-preferential-24-hour-urine-lab-test-between-urine-urea-nitrogen-urine-protein-catabolic-rate-and-urine-sulfate-when-evaluating-a-recurrent-calcium-based-stone-former-who-has-hypercalciuria-presumed-secondary-to-excess-animal-protein-intake weekly 0.8 https://www.themednet.org/given-the-new-asco-guidelines-on-snb-in-early-stage-breast-cancer-how-does-the-omission-of-snb-in-patients-aged-50-70-impact-your-adjuvant-radiation-recommendations weekly 0.8 https://www.themednet.org/how-often-do-you-monitor-pituitary-adenomas-once-established-as-non-functioning weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-risks-and-benefits-of-strontium-supplements-for-osteoporosis-management weekly 0.8 https://www.themednet.org/at-what-degree-of-lymphopenia-do-you-switch-discontinue-dimethyl-fumarate-in-patients-with-multiple-sclerosis weekly 0.8 https://www.themednet.org/in-patients-with-cml-who-are-receiving-1st-line-tki-with-good-molecular-response-are-you-continuing-therapy-or-switching-to-asciminib-based-on-the-asc4first-data weekly 0.8 https://www.themednet.org/would-you-consider-adding-metoprolol-succinate-to-a-medication-regimen-for-a-patient-with-paroxysmal-afib-on-sotalol-known-cad-hf-with-mildly-reduced-lvef-assuming-hemodynamics-could-tolerate-it weekly 0.8 https://www.themednet.org/how-do-you-guide-patients-who-seek-online-information-about-their-disease-to-ensure-it-is-accurate-supports-their-understanding-and-minimizes-unnecessary-anxiety weekly 0.8 https://www.themednet.org/how-do-you-counsel-someone-about-metformin-use-for-type-2-diabetes-mellitus-who-is-also-on-a-glp-1-agonist-and-achieved-goal-hba1c-but-prefers-not-to-be-on-metformin-anymore weekly 0.8 https://www.themednet.org/for-a-positive-anti-tpo-and-normal-tsh-in-the-workup-of-csu-are-you-referring-to-endocrinology weekly 0.8 https://www.themednet.org/do-you-recommend-avoiding-morphine-in-patients-with-eskd weekly 0.8 https://www.themednet.org/when-do-you-consider-testing-autoimmune-antibodies-for-axonal-polyneuropathies-without-clear-etiology weekly 0.8 https://www.themednet.org/what-brain-imaging-findings-do-you-find-reliable-to-help-support-a-diagnosis-of-idiopathic-intracranial-hypertension weekly 0.8 https://www.themednet.org/what-are-potential-pitfalls-in-the-use-of-oct-to-support-a-diagnosis-of-multiple-sclerosis weekly 0.8 https://www.themednet.org/do-you-start-a-statin-concurrently-with-icosapent-ethyl-for-patients-with-moderate-hypertriglyceridemia-and-high-ascvd-risk-or-do-you-prefer-to-start-a-statin-alone-and-monitor-triglyceride-levels weekly 0.8 https://www.themednet.org/how-do-you-approach-the-timing-of-vitrectomy-in-non-clearing-vitreous-hemorrhage-secondary-to-proliferative-diabetic-retinopathy weekly 0.8 https://www.themednet.org/how-do-you-decide-which-secondary-iol-to-place-in-an-aphakic-eye weekly 0.8 https://www.themednet.org/in-your-experience-what-factors-prompt-you-to-switch-a-patient-with-diabetic-macular-edema-to-eylea-hd weekly 0.8 https://www.themednet.org/what-is-your-approach-to-using-intraperitoneal-sodium-thiosulfate-for-a-patient-with-eskd-on-peritoneal-dialysis-who-develops-calciphylaxis weekly 0.8 https://www.themednet.org/whats-the-threshold-to-consider-a-psg-abnormal-enough-to-preclude-a-mslt-the-following-night weekly 0.8 https://www.themednet.org/in-what-circumstances-would-you-offer-axillary-re-irradiation-after-salvage-axillary-dissection weekly 0.8 https://www.themednet.org/how-would-you-structure-your-monitoring-for-a-low-risk-leukemic-tp53-negative-mantle-cell-lymphoma-with-5-mcl-cells-detected-in-both-peripheral-blood-and-bone-marrow-mild-splenomegaly-and-no-lymphadenopathy-or-b-symptoms weekly 0.8 https://www.themednet.org/do-you-recommend-air-purifier-in-bedrooms-and-office-workplaces-of-patients-with-chronic-lung-disease weekly 0.8 https://www.themednet.org/would-you-offer-live-vaccines-e-g-mmrv-measles-to-patients-on-bispecific-antibodies-for-multiple-myeloma weekly 0.8 https://www.themednet.org/how-do-you-predict-which-patients-are-most-likely-to-have-a-positive-response-to-oxervate-1 weekly 0.8 https://www.themednet.org/under-what-circumstances-would-cpc-be-considered-the-primary-intervention-for-severe-glaucoma-with-preserved-central-vision weekly 0.8 https://www.themednet.org/how-do-you-incorporate-intravitreal-methotrexate-injections-into-the-management-of-traumatic-retinal-detachment-repairs weekly 0.8 https://www.themednet.org/in-the-interest-of-brain-health-are-you-avoiding-tcas-in-migraine-treatment-due-to-increased-dementia-risk weekly 0.8 https://www.themednet.org/do-you-advise-your-patients-with-ckd-to-consume-a-set-amount-of-fluids-daily-in-an-attempt-to-prevent-disease-progression weekly 0.8 https://www.themednet.org/do-you-consider-dbs-for-essential-tremor-in-patients-who-already-underwent-focused-ultrasound-thalamotomy weekly 0.8 https://www.themednet.org/what-strategies-do-you-use-to-optimize-cataract-surgery-outcomes-in-patients-with-anterior-basement-membrane-dystrophy-abmd weekly 0.8 https://www.themednet.org/in-light-of-the-voluntary-recall-of-the-bausch-lomb-envista-iol-what-has-been-your-experience-regarding-patient-satisfaction-and-visual-outcomes-with-other-monofocal-iol-options weekly 0.8 https://www.themednet.org/how-would-you-manage-a-stage-iv-nlphl-that-has-residual-hypermetabolic-disease-involving-the-bilateral-neck-scv-following-rchop-x-4-cycles weekly 0.8 https://www.themednet.org/do-you-take-any-special-considerations-for-a-patient-with-eskd-who-has-an-ileostomy-colostomy-and-wishes-to-start-peritoneal-dialysis weekly 0.8 https://www.themednet.org/does-delay-to-the-time-of-lumpectomy-impact-your-decision-to-omit-radiation weekly 0.8 https://www.themednet.org/would-you-ever-consider-treatment-without-tissue-diagnosis-for-a-gastrointestinal-neuroendocrine-metastatic-tumor-based-on-a-positive-dotatate-scan-alone weekly 0.8 https://www.themednet.org/what-is-the-current-practice-regarding-the-use-of-glp-1-agonists-in-patients-listed-for-lung-transplant-and-in-the-post-transplant-period weekly 0.8 https://www.themednet.org/when-do-you-consider-ambulatory-eeg-to-assess-for-future-seizure-risk-in-someone-with-seemingly-resolved-acute-symptomatic-seizures weekly 0.8 https://www.themednet.org/what-has-been-your-experience-with-alternative-injection-sites-to-the-abdomen-for-improving-pain-tolerability-with-buprenorphine-extended-release weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-ffa-that-is-refractory-to-intralesional-steroids-dutasteride-hydroxychloroquine-systemic-retinoids-and-methotrexate weekly 0.8 https://www.themednet.org/are-there-situations-when-you-recommend-initiating-dialysis-in-patients-with-advanced-chronic-kidney-disease-even-if-their-symptoms-are-minimal-and-electrolytes-are-well-controlled-with-medical-management weekly 0.8 https://www.themednet.org/what-is-the-most-appropriate-next-step-for-a-patient-experiencing-prolonged-hypotony-following-ahmed-glaucoma-valve-implantation-and-unsuccessful-medical-management weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-to-managing-a-patient-with-tube-exposure weekly 0.8 https://www.themednet.org/do-you-recommend-temporarily-holding-sglt2-inhibitors-in-patients-with-ckd-who-are-undergoing-ct-imaging-with-intravenous-contrast weekly 0.8 https://www.themednet.org/how-do-you-work-psychodynamically-with-a-child-whose-somatic-complaints-increase-in-response-to-parental-marital-conflict weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-a-carotid-body-tumor-and-metastasis-to-the-cervical-lymph-node weekly 0.8 https://www.themednet.org/what-is-the-clinical-significance-of-a-paradoxical-decrease-in-hdl-cholesterol-after-starting-statin-therapy weekly 0.8 https://www.themednet.org/do-you-recommend-patients-with-hypertensive-kidney-disease-transition-from-wrist-to-upper-arm-home-blood-pressure-monitoring-prior-to-making-dose-adjustments-to-their-antihypertensive-regimen weekly 0.8 https://www.themednet.org/does-the-presence-of-thrombus-in-the-sinus-affect-your-decision-between-fractionated-radiation-and-srs-for-recurrent-grade-1-meningioma weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-recommend-for-a-prostate-patient-who-previously-received-1-of-5-planned-fractions-sbrt-in-2020 weekly 0.8 https://www.themednet.org/do-you-transition-to-non-tablet-formulations-of-potassium-citrate-in-patients-with-recurrent-calcium-oxalate-nephrolithiasis-and-hypocitraturia-who-are-noticing-intact-tablets-in-their-stool weekly 0.8 https://www.themednet.org/do-you-utilize-daily-enemas-for-patients-undergoing-prostate-sbrt weekly 0.8 https://www.themednet.org/do-you-recommend-treating-asymptomatic-proteus-urinary-infections-in-patients-with-alkaline-urine-and-recurrent-calcium-phosphate-nephrolithiasis weekly 0.8 https://www.themednet.org/do-you-use-sglt2-inhibitors-in-the-management-of-siadh weekly 0.8 https://www.themednet.org/how-do-you-manage-fatty-liver-disease-in-patients-on-olanzapine-who-are-reluctant-to-change-meds weekly 0.8 https://www.themednet.org/would-you-ever-consider-pelvic-exenteration-followed-by-sbrt-for-a-patient-with-recurrent-cervical-cancer-s-p-chemort-who-has-disease-only-in-the-central-pelvis-and-in-a-single-hilar-lymph-node weekly 0.8 https://www.themednet.org/what-are-your-vaccine-recommendations-while-patients-are-on-biologics weekly 0.8 https://www.themednet.org/are-there-different-strategies-you-would-utilize-to-monitor-and-manage-potential-resistance-in-patients-with-cml-receiving-asciminib weekly 0.8 https://www.themednet.org/have-the-10-year-results-from-uk-fast-forward-presented-at-estro-2025-impacted-your-practice-with-regard-to-patient-selection weekly 0.8 https://www.themednet.org/how-would-you-manage-a-frail-patient-with-gcb-dlbcl-who-is-unable-to-complete-r-chop-but-has-moderate-residual-disease weekly 0.8 https://www.themednet.org/do-you-recommend-bone-mineral-density-testing-in-your-patients-with-recurrent-nephrolithiasis-secondary-to-medullary-sponge-kidney weekly 0.8 https://www.themednet.org/what-is-your-approach-to-women-with-breast-cancer-who-opts-for-a-staged-approach-with-up-front-lumpectomy-and-sln-biopsy-pn-when-there-are-indications-for-adjuvant-radiation-therapy-but-she-plans-for-a-later-mastectomy-6-months weekly 0.8 https://www.themednet.org/how-would-you-approach-the-upfront-management-of-a-patient-with-acute-unilateral-vision-loss-with-strong-clinical-risk-factors-for-both-cardioembolic-stroke-and-gca-if-an-expedited-mri-is-not-possible-due-to-the-presence-of-an-aicd weekly 0.8 https://www.themednet.org/given-findings-from-the-life-trial-are-there-any-benefits-in-using-entresto-over-valsartan-alone-in-hfref-patients weekly 0.8 https://www.themednet.org/do-you-use-naltrexone-in-your-patients-with-fibromyalgia weekly 0.8 https://www.themednet.org/in-a-young-woman-with-large-invasive-breast-carcinoma-case-pt3-lobular-s-p-skin-sparing-mastectomy-with-positive-anterior-margin-what-is-the-practical-role-for-re-excision-with-or-without-pmrt weekly 0.8 https://www.themednet.org/if-you-do-not-have-easy-access-to-shear-wave-elastography-aka-fibroscan-what-do-you-recommend-for-non-invasive-tests-to-determine-if-a-masld-patient-has-clinically-significant-portal-hypertension-and-risk-stratify-them weekly 0.8 https://www.themednet.org/how-do-you-approach-the-titration-of-ambien-zolpidem-to-treat-catatonia weekly 0.8 https://www.themednet.org/how-would-you-manage-a-recurrent-meningioma-of-the-cervical-spine-after-resection-alone weekly 0.8 https://www.themednet.org/what-factors-influence-the-decision-between-anti-vegf-injections-and-surgical-displacement-with-tpa-for-treating-submacular-hemorrhage-in-amd-patients weekly 0.8 https://www.themednet.org/what-is-your-approach-regarding-adhd-drug-holidays-during-school-breaks weekly 0.8 https://www.themednet.org/would-you-add-immunotherapy-to-chemotherapy-for-a-patient-with-metastatic-nsclc-an-atypical-egfr-mutation-and-pd-l1-50-who-has-progressed-on-osimertinib weekly 0.8 https://www.themednet.org/how-do-you-manage-polyuria-and-polydipsia-from-lithium weekly 0.8 https://www.themednet.org/how-do-you-use-lithium-levels-to-adjust-treatment-during-mania weekly 0.8 https://www.themednet.org/do-you-avoid-low-dose-radiation-ct-stone-scans-in-obese-patients-with-recurrent-nephrolithiasis-given-concerns-for-inadequate-stone-detection weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-recurrent-nephrolithiasis-and-low-urine-volumes-who-struggle-with-increasing-fluid-intake-following-a-sleeve-gastrectomy-procedure weekly 0.8 https://www.themednet.org/how-do-you-most-effectively-dose-melatonin-for-children-with-insomnia-2 weekly 0.8 https://www.themednet.org/how-do-you-approach-checking-an-aldosterone-to-renin-ratio-in-an-outpatient-with-hypertension-and-hypokalemia-that-is-difficult-to-correct-with-oral-potassium-replacement weekly 0.8 https://www.themednet.org/would-you-consider-overdrive-pacing-for-recurrent-torsades-des-pointes-in-a-patient-without-an-obvious-drug-causing-qtc-prolongation-or-significant-electrolyte-abnormality weekly 0.8 https://www.themednet.org/what-is-your-stepwise-approach-to-treating-constipation-in-a-patient-with-symptoms-such-as-abdominal-pain-nausea-decreased-appetite-etc weekly 0.8 https://www.themednet.org/how-does-the-safety-profile-of-dato-dxd-influence-its-use-in-patients-with-comorbidities-or-frailty-compared-to-standard-chemotherapy weekly 0.8 https://www.themednet.org/for-a-patient-with-locally-current-endometrial-cancer-whose-disease-had-complete-radiographic-response-to-carboplatin-taxol-and-pembrolizumab-would-you-consider-adding-radiation-therapy weekly 0.8 https://www.themednet.org/have-you-seen-improvement-in-non-migraine-type-headaches-with-the-usage-of-drugs-targeting-cgrp weekly 0.8 https://www.themednet.org/do-you-utilize-cytokine-panels-to-guide-treatment-of-patients-with-egpa weekly 0.8 https://www.themednet.org/are-there-certain-clinical-features-that-help-you-choose-between-benralizumab-and-mepolizumab-for-egpa-in-clinical-practice weekly 0.8 https://www.themednet.org/when-do-you-decide-to-switch-stimulants-vs-continuing-to-maximize-dosage-in-adhd-treatment weekly 0.8 https://www.themednet.org/would-you-avoid-a-24-hour-urine-collection-for-creatinine-clearance-measurement-in-a-patient-who-is-on-fluid-restriction weekly 0.8 https://www.themednet.org/how-do-you-determine-whether-to-switch-to-a-different-anti-vegf-agent-or-to-ozurdex-after-a-patient-with-diabetic-macular-edema-fails-a-series-of-avastin weekly 0.8 https://www.themednet.org/do-you-favor-transthoracic-needle-biopsy-or-navigational-biopsy-for-diagnosis-of-intermediate-risk-pulmonary-nodules weekly 0.8 https://www.themednet.org/do-you-prescribe-lower-dose-ics-for-asthma-to-mitigate-the-risk-of-pneumonia-in-patients-with-a-history-of-respiratory-infections-or-compromised-immune-systems weekly 0.8 https://www.themednet.org/is-there-any-role-for-using-mandibular-advancement-splints-on-select-nights-in-place-of-cpap-in-the-management-of-patients-with-osa-who-have-difficulty-tolerating-cpap weekly 0.8 https://www.themednet.org/do-you-integrate-inhaled-colistimethate-sodium-into-existing-treatment-regimens-for-patients-with-bronchiectasis-and-psar-infection weekly 0.8 https://www.themednet.org/when-do-you-use-ambulatory-blood-pressure-monitoring-to-assess-hypertension-in-a-living-kidney-donor-candidate weekly 0.8 https://www.themednet.org/what-is-your-preferred-blood-flow-rate-for-a-patient-with-eskd-who-has-an-avf-but-is-only-undergoing-an-ultrafiltration-session weekly 0.8 https://www.themednet.org/how-do-you-handle-cases-where-patients-use-cannabis-to-self-manage-anxiety-but-are-hesitant-to-try-ssris weekly 0.8 https://www.themednet.org/is-it-safe-to-discontinue-prenatal-vitamins-that-contain-biotin-for-a-few-days-during-pregnancy-when-labs-in-particular-thyroid-tests-are-planned-for-treating-hypo-or-hyperthyroidism-in-pregnancy weekly 0.8 https://www.themednet.org/what-are-your-preferred-strategies-for-managing-sundowning-in-patients-with-moderate-alzheimers-disease weekly 0.8 https://www.themednet.org/what-markers-on-eeg-can-help-predict-detect-postoperative-or-icu-related-delirium weekly 0.8 https://www.themednet.org/how-should-one-manage-a-non-healing-wound-with-tunneling-at-the-site-of-a-cyst-excision-on-the-back-now-two-months-postoperatively-with-negative-wound-cultures-and-in-the-context-of-a-self-pay-patient weekly 0.8 https://www.themednet.org/which-type-of-patients-with-asymptomatic-peripheral-arterial-disease-with-an-abi-score-of-less-than-0-9-is-it-reasonable-to-offer-antiplatelet-and-statin-therapy-to weekly 0.8 https://www.themednet.org/how-would-you-resect-an-11mm-sessile-gastric-polyp weekly 0.8 https://www.themednet.org/does-being-on-maintenance-pembrolizumab-change-how-you-manage-patients-with-partial-metabolic-response-on-pet-ct-3-months-after-chemoradiation-for-cervical-cancer weekly 0.8 https://www.themednet.org/do-you-routinely-discontinue-atypical-coverage-in-community-acquired-pneumonia-when-pcr-testing-i-e-respiratory-pathogen-panel-is-negative-for-atypical-organisms weekly 0.8 https://www.themednet.org/how-do-24-hour-urine-creatinine-levels-affect-your-interpretation-of-24-hour-urinary-calcium-or-cortisol-studies weekly 0.8 https://www.themednet.org/would-you-stop-methotrexate-or-leflunomide-if-mcv-increases-after-starting-the-medication-with-no-other-parameters-of-anemia-or-leukopenia weekly 0.8 https://www.themednet.org/what-is-your-approach-to-optimizing-pre-operative-hemoglobin-in-patients-with-sickle-cell-disease weekly 0.8 https://www.themednet.org/what-are-your-preferred-alternative-biologic-agents-for-blau-syndrome-when-anti-tnf-therapies-are-contraindicated weekly 0.8 https://www.themednet.org/what-adjuvant-treatment-would-you-give-to-a-locally-advanced-esophageal-adenocarcinoma-status-post-neoadjuvant-flot-s-p-resection-with-positive-margins weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-who-developed-stage-iii-melanoma-while-receiving-cemiplimab-cycle-10-for-locally-advanced-cutaneous-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/do-you-use-bone-turnover-markers-to-assess-medical-adherence-in-patients-treated-for-osteoporosis weekly 0.8 https://www.themednet.org/is-it-a-good-practice-to-prescribe-clonidine-to-take-as-needed-for-occasional-severe-blood-pressure-elevations weekly 0.8 https://www.themednet.org/what-is-your-approach-to-follow-up-after-embolization-of-pulmonary-avm-in-patients-with-hht weekly 0.8 https://www.themednet.org/what-is-the-rationale-for-the-recent-change-in-the-nccn-criteria-for-very-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/would-you-consider-omitting-concurrent-chemoradiation-for-a-patient-with-stage-iii-egfr-mutant-nsclc-and-initiating-treatment-with-osimertinib-instead weekly 0.8 https://www.themednet.org/do-you-routinely-prescribe-linezolid-to-patients-who-are-concomitantly-on-methadone weekly 0.8 https://www.themednet.org/which-salt-substitutes-do-you-recommend-for-your-patients-with-recurrent-nephrolithiasis-who-have-hypercalciuria-from-excess-sodium-chloride-intake weekly 0.8 https://www.themednet.org/how-would-you-manage-t3n0m0-sarcomatoid-carcinoma-of-the-prostate-with-adenosquamous-differentiation-s-p-prostatectomy weekly 0.8 https://www.themednet.org/how-long-do-you-strictly-enforce-low-tidal-volume-ventilation-in-ards weekly 0.8 https://www.themednet.org/in-patients-with-early-fuchs-endothelial-dystrophy-how-do-you-determine-whether-to-proceed-with-cataract-surgery-alone-versus-a-combined-endothelial-keratoplasty weekly 0.8 https://www.themednet.org/how-do-you-do-risk-stratification-for-patients-with-light-chain-only-mgus weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-arthritis-mutilans-who-has-failed-tnfi-il-17i-and-jaki-and-now-on-bimekizumab-and-with-worsening-joint-disease weekly 0.8 https://www.themednet.org/what-systemic-therapy-would-you-use-in-patients-with-gastric-cancer-who-had-a-relapse-after-durva-flot-matterhorn-regimen weekly 0.8 https://www.themednet.org/how-do-you-assess-the-potential-role-of-obesity-in-driving-inflammatory-joint-symptoms weekly 0.8 https://www.themednet.org/at-what-point-would-you-recommend-initiating-psychotherapy-or-psychotropic-medications-to-manage-mood-and-anxiety-symptoms-following-a-new-oncology-diagnosis-in-pediatric-patients weekly 0.8 https://www.themednet.org/how-do-you-discuss-sexual-and-gender-identity-related-anxiety-with-teens-when-family-dynamics-are-rigid-or-culturally-conservative weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-initiate-medical-workup-e-g-thyroid-b12-infection-in-a-geriatric-patient-experiencing-new-onset-or-worsening-low-mood weekly 0.8 https://www.themednet.org/would-you-discontinue-tamoxifen-for-endometrial-hyperplasia-without-dysplasia-in-the-adjuvant-setting weekly 0.8 https://www.themednet.org/how-long-do-you-recommend-waiting-before-competitive-sports-athletes-resume-sports-activities-following-inpatient-management-for-an-nstemi weekly 0.8 https://www.themednet.org/how-do-you-approach-incidental-nxp-2-antibody-positivity-in-patients-without-current-clinical-evidence-of-myositis-or-systemic-autoimmune-disease weekly 0.8 https://www.themednet.org/what-additional-therapies-can-be-helpful-for-vaginal-dryness-causing-dyspareunia-in-premenopausal-woman-already-using-lubrication weekly 0.8 https://www.themednet.org/is-enteric-coated-aspirin-acceptable-to-use-in-polycythemia-vera-or-et weekly 0.8 https://www.themednet.org/what-is-your-approach-when-recommending-occipital-nerve-stimulation-for-refractory-cluster-headache weekly 0.8 https://www.themednet.org/how-do-you-decide-between-initiating-antidepressants-vs-hormone-replacement-therapy-for-post-menopausal-depression weekly 0.8 https://www.themednet.org/what-techniques-do-you-find-most-effective-for-visualization-of-rectal-disease-with-intestinal-ultrasound weekly 0.8 https://www.themednet.org/how-would-you-advise-a-ckd-patient-who-asks-about-oral-nsaids-for-management-of-chronic-pain-if-they-have-a-contraindication-to-taking-acetaminophen weekly 0.8 https://www.themednet.org/would-you-use-a-triptan-in-a-patient-with-a-vascular-malformation-such-as-an-arteriovenous-malformation-cavernous-malformation-or-developmental-venous-anomaly weekly 0.8 https://www.themednet.org/how-do-you-manage-b12-deficiency-refractory-to-subcutaneous-replacement weekly 0.8 https://www.themednet.org/do-you-recommend-patients-with-eskd-time-their-daily-b-complex-multivitamin-to-after-hemodialysis-on-hemodialysis-days weekly 0.8 https://www.themednet.org/how-do-you-approach-breast-hypofractionation-rni-with-the-results-of-the-skagen-trial-1 weekly 0.8 https://www.themednet.org/do-you-prefer-cta-or-mra-for-further-imaging-in-patients-with-ascending-aortic-dilatation-detected-on-tte weekly 0.8 https://www.themednet.org/how-do-you-adjust-your-glaucoma-management-strategy-for-pregnant-patients-who-require-iop-lowering weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gyn-cancers-from-asco-2025 weekly 0.8 https://www.themednet.org/how-does-nemolizumab-fit-into-your-current-treatment-approach-to-prurigo-nodularis-relative-to-other-biologics weekly 0.8 https://www.themednet.org/do-you-anticipate-trying-nemolizumab-in-patients-with-other-difficult-to-treat-pruritic-conditions weekly 0.8 https://www.themednet.org/how-will-you-counsel-patients-regarding-adverse-effects-of-nemolizumab weekly 0.8 https://www.themednet.org/how-often-do-you-draw-screening-anas-for-discoid-lupus weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-neuro-oncology-from-asco-2025 weekly 0.8 https://www.themednet.org/how-would-you-approach-the-timing-of-hemodialysis-for-an-eskd-patient-with-no-urgent-indications-who-has-nstemi-with-a-troponin-level-of-10-ng-dl-has-not-had-dialysis-in-2-days-and-is-planned-for-left-heart-catheterization-the-next-day weekly 0.8 https://www.themednet.org/would-you-recommend-urinary-glycolate-testing-prior-to-genetic-testing-in-a-patient-with-elevated-urinary-oxalate-and-suspicion-for-primary-hyperoxaluria-type-1 weekly 0.8 https://www.themednet.org/do-you-provide-empiric-doxycycline-for-lyme-disease-to-asymptomatic-patients-after-a-tick-bite-who-havent-developed-erythema-migrans-or-are-not-sure-it-was-an-ixodes-tick weekly 0.8 https://www.themednet.org/would-you-consider-prescribing-nac-for-a-patient-with-ocd-and-a-documented-sulfa-allergy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-express-concern-about-potentially-harmful-ingredients-in-sunscreens weekly 0.8 https://www.themednet.org/do-you-routinely-perform-ilm-peeling-in-all-epiretinal-membrane-erm-cases-or-do-you-selectively-peel-based-on-oct-features-and-membrane-characteristics weekly 0.8 https://www.themednet.org/would-you-start-a-vaptan-or-monitor-an-asymptomatic-patient-with-reset-osmostat-and-an-average-sodium-of-126-meq-l weekly 0.8 https://www.themednet.org/when-interpreting-pulmonary-function-tests-do-you-routinely-distinguish-between-hyperinflation-and-gas-trapping weekly 0.8 https://www.themednet.org/do-you-prefer-tte-cmr-or-cardiac-ct-for-the-evaluation-of-pfos weekly 0.8 https://www.themednet.org/would-you-offer-re-irradiation-ldrt-for-someone-with-osteoarthritis-or-tendinitis-if-symptoms-recur weekly 0.8 https://www.themednet.org/when-should-you-consider-adding-clonidine-to-an-antihypertensive-regimen-for-patients-with-advanced-ckd weekly 0.8 https://www.themednet.org/what-is-your-approach-to-persistently-low-inr-despite-escalating-doses-of-warfarin-in-a-patient-with-bioprosthetic-mitral-valve-replacement-who-is-unable-to-be-on-doacs weekly 0.8 https://www.themednet.org/how-do-you-approach-prescribing-analgesics-for-osteoarthritis-related-pain-in-patients-with-comorbidities-particularly-given-new-evidence-that-even-acetaminophen-is-associated-with-increased-risk-of-gi-complications-bleeding-peptic-ulcer-disease-heart-fai weekly 0.8 https://www.themednet.org/how-do-you-decide-between-a-combined-phacovitrectomy-approach-versus-a-staged-procedure-for-patients-with-a-retinal-detachment-and-dense-cataract weekly 0.8 https://www.themednet.org/which-method-provides-a-more-accurate-assessment-of-hypercalciuria-24-hour-urinary-calcium-excretion-or-the-spot-urine-calcium-to-creatinine-ratio weekly 0.8 https://www.themednet.org/would-you-offer-a-third-course-of-palliative-radiation-after-two-courses-of-8-gy-in-1-fx weekly 0.8 https://www.themednet.org/at-what-lab-values-ferritin-tsat-would-you-offer-iv-iron-therapy-to-patients-with-restless-leg-syndrome weekly 0.8 https://www.themednet.org/is-there-a-role-for-the-use-of-sglt2-inhibitors-for-the-treatment-of-reactive-hypoglycemia-not-responsive-to-dietary-modifications-or-acarbose weekly 0.8 https://www.themednet.org/would-you-recommend-the-1-hour-ogtt-over-the-2-hour-ogtt-for-postpartum-glucose-tolerance-testing-in-women-with-previous-gestational-diabetes weekly 0.8 https://www.themednet.org/how-do-you-modify-the-hemoglobin-goal-and-esa-dosing-for-patients-with-sickle-cell-anemia-and-eskd-on-hemodialysis weekly 0.8 https://www.themednet.org/how-do-you-plan-to-integrate-exercise-programs-after-adjuvant-chemotherapy-in-patients-with-colon-cancer-given-the-results-of-the-challenge-trial weekly 0.8 https://www.themednet.org/whats-your-threshold-for-initiating-treatment-in-patients-with-optic-nerve-cupping-but-normal-iop-normal-visual-fields-and-borderline-oct-findings weekly 0.8 https://www.themednet.org/how-do-you-determine-the-timing-and-necessity-of-surgical-removal-for-retained-subretinal-perfluorocarbon weekly 0.8 https://www.themednet.org/are-there-instances-when-you-use-a-3-sodium-chloride-infusion-for-patients-with-chronic-hyponatremia-secondary-to-siadh-but-who-are-asymptomatic-or-have-only-mild-symptoms weekly 0.8 https://www.themednet.org/do-you-recommend-starting-naltrexone-at-discharge-for-alcohol-use-disorder-in-patients-with-decompensated-cirrhosis-secondary-to-alcohol-use weekly 0.8 https://www.themednet.org/do-you-always-give-325mg-aspirin-if-not-already-loaded-with-antiplatelets-prior-to-the-start-of-every-lhc-even-just-for-diagnostics-in-the-absence-of-acs weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-isth-2025 weekly 0.8 https://www.themednet.org/how-do-you-evaluate-for-clinically-significant-ureteral-obstruction-in-a-pregnant-patient-with-aki-since-physiological-hydronephrosis-on-kidney-ultrasound-is-common weekly 0.8 https://www.themednet.org/would-the-presence-of-only-mature-teratoma-on-orchiectomy-specimen-lead-you-to-consider-upfront-rplnd-followed-by-adjuvant-chemotherapy-as-opposed-to-upfront-chemotherapy-in-a-patient-with-bulky-para-aortic-nodal-disease-cn3-and-afp-beta-hcg-elevation weekly 0.8 https://www.themednet.org/how-would-you-respond-to-a-patient-with-early-stage-resectable-nsclc-who-has-a-clinical-complete-response-to-neoadjuvant-chemo-io-but-subsequently-declines-surgery-not-feeling-its-necessary-anymore weekly 0.8 https://www.themednet.org/what-are-the-best-techniques-to-reduce-pocus-artifact-and-increase-the-diagnostic-accuracy-of-lung-ultrasound weekly 0.8 https://www.themednet.org/for-a-contact-allergy-do-you-need-to-test-for-the-metals-individually-or-does-it-suffice-to-just-test-with-a-piece-of-metal-from-the-device weekly 0.8 https://www.themednet.org/how-does-your-decision-to-use-high-efficacy-disease-modifying-treatments-het-differ-if-at-all-when-treating-late-onset-relapsing-remitting-multiple-sclerosis weekly 0.8 https://www.themednet.org/is-abnormally-elevated-estradiol-an-expected-finding-in-patients-with-pcos weekly 0.8 https://www.themednet.org/would-you-avoid-using-cephalosporins-in-a-patient-with-a-history-of-cephalosporin-neurotoxicity-in-the-setting-of-ckd weekly 0.8 https://www.themednet.org/would-you-refer-a-patient-for-kidney-only-or-kidney-and-liver-transplantation-if-they-develop-advanced-chronic-kidney-disease-secondary-to-primary-hyperoxaluria-type-2 weekly 0.8 https://www.themednet.org/which-patient-characteristics-or-clinical-factors-guide-the-decision-to-use-doxorubicin-and-trabectedin-as-first-line-treatment-for-metastatic-or-unresectable-leiomyosarcoma weekly 0.8 https://www.themednet.org/do-you-recommend-switching-from-a-glp-1-agonist-to-insulin-in-female-patients-with-type-2-diabetes-who-are-planning-to-become-pregnant weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-diffuse-patchy-paresthesias-affecting-the-head-face-lips-and-or-tongue weekly 0.8 https://www.themednet.org/in-a-patient-with-unresectable-hcc-who-developed-immune-related-colitis-with-the-first-dose-of-tremelimumab-durvalumab-would-you-consider-continuing-durvalumab-alone-after-resolution-of-the-colitis-with-steroid-treatment weekly 0.8 https://www.themednet.org/when-if-ever-would-you-consider-methotrexate-over-prednisone-for-first-line-therapy-in-patients-with-pulmonary-sarcoidosis weekly 0.8 https://www.themednet.org/when-interpreting-a-24-hour-urinary-calcium-which-is-more-accurate-24-hour-urine-calcium-mg-day-or-24-hour-calcium-to-creatinine-ratio-mg-g weekly 0.8 https://www.themednet.org/if-using-the-triplet-amplify-regimen-with-ven-acala-obin-upfront-what-do-you-then-plan-to-use-in-2nd-line-treatment-of-cll weekly 0.8 https://www.themednet.org/how-do-you-decide-between-performing-an-ecp-versus-a-migs-procedure-in-a-patient-undergoing-cataract-surgery weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-situation-where-dili-is-suspected-secondary-to-an-important-medication-e-g-anticoagulation-antibiotics-etc-but-the-diagnosis-is-uncertain-and-the-liver-injury-is-relatively-mild weekly 0.8 https://www.themednet.org/what-is-your-experience-with-transesophageal-lung-mass-biopsies weekly 0.8 https://www.themednet.org/in-an-obese-male-with-low-testosterone-would-you-initiate-testosterone-replacement-therapy-at-the-initial-visit-or-start-tirzepatide-first-and-monitor-for-improvement-in-testosterone-levels-and-erectile-function weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-risks-vs-benefits-of-naltrexone-for-alcohol-use-disorder-with-persistently-elevated-liver-enzymes weekly 0.8 https://www.themednet.org/what-is-your-approach-to-iv-fluid-resuscitation-during-a-sickle-cell-vaso-occlusive-crisis weekly 0.8 https://www.themednet.org/does-hyperprolactinemia-always-need-to-be-treated-if-the-patient-has-regular-menses-no-galactorrhea-no-desire-for-fertility-and-mri-of-the-pituitary-is-normal weekly 0.8 https://www.themednet.org/what-factors-do-you-weigh-most-heavily-in-the-selection-of-radiotherapy-versus-topical-treatments-for-lentigo-maligna-in-a-patient-who-is-not-a-surgical-candidate weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-aks-such-that-they-are-motivated-to-improve-or-optimize-sun-protection-behaviors weekly 0.8 https://www.themednet.org/do-you-rely-on-ct-hounsfield-units-to-determine-stone-composition-in-your-patients-with-recurrent-nephrolithiasis-who-have-yet-to-submit-a-stone-for-laboratory-based-composition-testing weekly 0.8 https://www.themednet.org/what-guides-your-choice-between-prophylactic-intermediate-and-full-therapeutic-dosing-of-enoxaparin-in-a-woman-with-apls-and-prior-fetal-loss-with-no-hx-of-thromboembolic-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-adjusting-insulin-pump-settings-in-patients-who-have-received-intra-articular-corticosteroid-injections weekly 0.8 https://www.themednet.org/in-patients-using-a-tandem-insulin-pump-on-auto-mode-control-iq-would-decreasing-the-basal-settings-on-the-profile-actually-reduce-the-delivered-hourly-insulin-dose-or-is-that-only-relevant-if-they-switch-to-manual-mode weekly 0.8 https://www.themednet.org/how-do-you-monitor-and-manage-visual-development-and-amblyopia-in-children-with-glaucoma-who-require-multiple-surgeries-during-critical-periods-of-visual-maturation weekly 0.8 https://www.themednet.org/how-has-using-a-chandelier-for-scleral-buckling-impacted-your-teaching-or-surgical-outcomes weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-option-after-tarlatamab-for-patients-with-es-sclc weekly 0.8 https://www.themednet.org/would-you-consider-using-a-combination-regimen-of-rituximab-low-dose-cyclophosphamide-and-steroids-to-improve-complete-remission-rates-in-patient-with-pla2r-positive-membranous-nephropathy weekly 0.8 https://www.themednet.org/do-you-recommend-buttonhole-cannulation-for-arteriovenous-fistulas weekly 0.8 https://www.themednet.org/how-do-you-approach-diagnosing-suspected-early-tardive-dyskinesia-with-minimal-positive-findings-on-aims-examination weekly 0.8 https://www.themednet.org/what-tsh-cut-off-do-you-use-to-determine-the-need-for-levothyroxine-supplementation-in-a-pregnant-patient-with-positive-tpo-antibodies weekly 0.8 https://www.themednet.org/how-do-you-counsel-breastfeeding-women-on-their-limitations-post-radioactive-iodine-ablation-for-thyroid-cancer-treatment weekly 0.8 https://www.themednet.org/in-patients-with-severe-osteoarthritis-can-elevated-alkaline-phosphatase-levels-be-attributed-to-increased-bone-turnover-from-advanced-joint-degeneration weekly 0.8 https://www.themednet.org/what-strategies-have-you-found-effective-in-reducing-intake-no-show-rates-among-patients-with-severe-and-persistent-mental-illness weekly 0.8 https://www.themednet.org/what-medications-do-you-consider-for-patients-with-premenstrual-dysphoric-disorder-who-do-not-respond-to-ssris weekly 0.8 https://www.themednet.org/what-are-some-considerations-for-planning-t-o-brachytherapy-in-a-patient-with-bilateral-hip-replacements-where-it-is-difficult-to-delineate-disease-on-mri-and-even-surrounding-structures-on-ct weekly 0.8 https://www.themednet.org/do-you-switch-to-an-alternative-agent-for-c-difficile-colitis-for-a-patient-with-suspected-infection-and-positive-testing-who-continues-to-have-3-watery-bowel-movements-daily-despite-multiple-days-of-oral-vancomycin-treatment weekly 0.8 https://www.themednet.org/for-patients-with-namd-who-are-developing-ga-in-the-same-eye-do-you-consider-adding-anti-complement-therapy weekly 0.8 https://www.themednet.org/for-patients-with-light-adjustable-lenses-what-has-been-your-approach-regarding-yag-capsulotomy-timing weekly 0.8 https://www.themednet.org/what-has-been-your-experience-with-durysta-bimatoprost-implant-for-glaucoma-management weekly 0.8 https://www.themednet.org/do-you-have-any-concerns-about-administering-a-vivitrol-injection-when-a-patient-has-severe-coagulopathy-and-or-thrombocytopenia-related-to-cirrhosis weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-for-refractory-warm-autoimmune-hemolytic-anemia-with-autoimmune-neutropenia weekly 0.8 https://www.themednet.org/how-would-you-manage-an-asymptomatic-patient-after-vce-showing-small-bowel-crohns-who-passes-the-patency-capsule-but-has-retained-the-video-capsule-in-the-distal-ileum-with-minimal-surrounding-inflammation weekly 0.8 https://www.themednet.org/how-would-you-manage-an-early-postoperative-spinal-implant-infection-when-intraoperative-cultures-while-on-antibiotics-are-negative-no-frank-purulence-or-other-evidence-of-infection-is-observed-during-washout-but-there-were-fascial-defects-and-fluid-track weekly 0.8 https://www.themednet.org/how-has-the-use-of-cgms-informed-or-improved-your-management-of-patients-with-pre-diabetes-or-diabetes-not-on-insulin weekly 0.8 https://www.themednet.org/how-have-you-incorporated-ctdna-into-the-clinical-management-of-patients-with-gynecologic-cancers weekly 0.8 https://www.themednet.org/under-what-clinical-circumstances-if-any-would-you-prescribe-fenofibrate-along-with-statin-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-requests-for-academic-accommodations-such-as-extended-test-time-in-college-students-with-adhd weekly 0.8 https://www.themednet.org/should-a-patient-on-medium-dose-ics-laba-with-normal-pfts-but-who-shows-a-greater-than-10-decrease-in-fev1-if-their-pfts-are-done-after-24-hours-off-their-inhaler-be-started-on-a-biologic weekly 0.8 https://www.themednet.org/are-there-instances-when-you-consider-rituximab-first-line-in-a-patient-with-class-v-ln weekly 0.8 https://www.themednet.org/what-factors-do-you-weigh-most-heavily-when-choosing-between-belimumab-and-voclosporin-as-part-of-a-triple-therapy-regimen-for-newly-diagnosed-class-iv-ln-1 weekly 0.8 https://www.themednet.org/what-intra-op-and-post-op-strategies-maximize-the-longevity-of-a-functional-bleb-in-younger-patients weekly 0.8 https://www.themednet.org/when-do-you-refer-patients-with-difficult-to-treat-depression-for-ect-rather-than-other-interventional-psychiatric-treatments-such-as-tms-or-esketamine weekly 0.8 https://www.themednet.org/what-is-your-preferred-potassium-binder-for-patients-with-ckd-and-hyperkalemia-that-persists-despite-dietary-potassium-restriction weekly 0.8 https://www.themednet.org/when-do-you-decide-to-initiate-potassium-binders-for-patients-with-hyperkalemia-in-the-setting-of-ckd weekly 0.8 https://www.themednet.org/how-do-you-manage-moya-moya-disease-medically-for-patients-that-are-unable-to-receive-ec-ic-bypass weekly 0.8 https://www.themednet.org/what-is-your-approach-to-using-intra-arterial-or-intrathecal-vasodilators-in-patients-with-vasospasm-in-subarachnoid-hemorrhage-despite-usage-of-oral-nimodipine weekly 0.8 https://www.themednet.org/what-has-been-your-experience-with-occluder-contact-lenses-for-intractable-diplopia weekly 0.8 https://www.themednet.org/when-do-you-consider-low-dose-buprenorphine-for-the-management-of-treatment-resistant-depression weekly 0.8 https://www.themednet.org/is-there-additional-concern-for-late-cardiac-toxicity-when-using-ultrahypofractionated-breast-radiation-protocols-given-that-the-bed-to-the-heart-is-higher weekly 0.8 https://www.themednet.org/what-is-your-response-when-child-adolescent-patients-who-are-already-seeing-a-therapist-tell-you-they-have-also-been-using-chatbots-as-additional-support weekly 0.8 https://www.themednet.org/how-do-you-manage-acting-out-behaviors-in-children-in-short-term-crisis-settings weekly 0.8 https://www.themednet.org/how-would-you-approach-managing-a-patient-with-well-controlled-ra-on-abatacept-who-develops-a-solid-malignancy weekly 0.8 https://www.themednet.org/how-effective-do-you-find-mao-b-inhibitors-for-the-treatment-of-parkinsons-disease weekly 0.8 https://www.themednet.org/how-do-you-evaluate-remission-in-acromegaly-when-postoperative-igf-1-and-gh-levels-are-discordant weekly 0.8 https://www.themednet.org/how-do-you-monitor-and-discuss-the-sexual-side-effects-of-ssris-with-adolescents weekly 0.8 https://www.themednet.org/in-which-sjogrens-patients-do-you-prioritize-systemic-treatment-strategies-at-time-of-diagnosis weekly 0.8 https://www.themednet.org/what-biomarkers-or-patient-characteristics-do-you-feel-best-predict-response-to-b-cell-depleting-therapies-in-a-patient-with-sjogrens weekly 0.8 https://www.themednet.org/what-tools-or-disease-activity-markers-do-you-find-most-useful-in-tracking-disease-activity-in-sjogrens-patients weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-a-patient-presenting-with-clinical-manifestations-of-systemic-sclerosis-cutaneous-involvement-raynauds-phenomenon-and-pulmonary-arterial-hypertension-but-negative-serologies weekly 0.8 https://www.themednet.org/how-would-you-approach-hormone-replacement-therapy-for-perimenopause-in-a-patient-with-increased-risk-factors-for-vte weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-decreasing-dietary-animal-protein-intake-in-patients-with-recurrent-calcium-oxalate-nephrolithiasis-who-are-found-to-have-hyperoxaluria-on-24-hour-urine-studies weekly 0.8 https://www.themednet.org/if-a-patient-requires-more-than-5-mg-per-day-of-methimazole-long-term-do-you-recommend-alternative-treatment-options-such-as-radio-iodine-ablation-or-surgery weekly 0.8 https://www.themednet.org/do-you-combine-anti-vegf-with-pdt-for-polypoidal-choroidal-vasculopathy-upfront-or-reserve-pdt-for-refractory-cases weekly 0.8 https://www.themednet.org/what-strategy-do-you-find-most-effective-for-outpatient-induction-of-buprenorphine-in-opioid-use-disorder weekly 0.8 https://www.themednet.org/is-it-safe-to-use-monthly-injectable-cgrp-antagonists-with-oral-gepants-in-the-same-patient weekly 0.8 https://www.themednet.org/how-would-you-treat-an-unresectable-epithelioid-angiosarcoma-invading-the-cavernous-sinus-wrapping-around-the-carotid-artery weekly 0.8 https://www.themednet.org/what-is-your-approach-to-determining-eligibility-for-hospice-in-persons-with-alzheimers-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-to-counseling-severely-frail-older-adults-regarding-their-planning-for-invasive-life-sustaining-therapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-counseling-older-patients-regarding-expected-functional-recovery-and-timeline-for-recovery-following-a-large-hemispheric-stroke-with-aphasia weekly 0.8 https://www.themednet.org/what-is-your-approach-to-initiation-of-mirtazapine-for-appetite-stimulation-and-depression-in-older-adults-both-in-terms-of-starting-dose-and-titration weekly 0.8 https://www.themednet.org/what-adjunctive-therapies-to-you-recommend-for-symptom-control-in-acute-opioid-withdrawal-beyond-full-partial-opioid-agonists weekly 0.8 https://www.themednet.org/what-is-your-approach-to-deprescribing-cholinesterase-inhibitors-and-or-memantine-in-advancing-stages-of-dementia weekly 0.8 https://www.themednet.org/how-do-you-approach-individualizing-a1c-goals-in-patients-with-dementia weekly 0.8 https://www.themednet.org/what-is-the-best-way-to-assess-exercise-capacity-in-kidney-transplantation-candidates-to-predict-post-transplant-outcomes weekly 0.8 https://www.themednet.org/how-do-you-counsel-older-adults-regarding-the-use-of-melatonin-dose-and-timing-for-sleep-related-problems weekly 0.8 https://www.themednet.org/how-do-you-counsel-older-adults-regarding-the-use-dosing-and-safety-of-cbd-containing-products-for-insomnia weekly 0.8 https://www.themednet.org/how-long-would-you-wait-before-repeating-a-kidney-biopsy-procedure-in-a-patient-with-inadequate-tissue-obtained-on-a-prior-attempt-which-was-also-complicated-by-a-small-perinephric-hematoma weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-selection-among-novel-bispecific-antibodies-and-adcs-for-patients-with-egfr-nsclc-previously-treated-with-3rd-generation-egfr-inhibitors weekly 0.8 https://www.themednet.org/when-will-you-select-dato-dxd-for-patients-with-egfr-mutated-non-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/would-you-advocate-for-sglt2-inhibitors-if-they-are-not-fully-covered-by-insurance-in-patients-with-moderately-increased-albuminuria-300-mg-g-who-are-on-maximal-dose-acei-arb weekly 0.8 https://www.themednet.org/how-do-you-approach-the-workup-for-a-patient-with-imaging-showing-features-suggestive-of-cirrhosis weekly 0.8 https://www.themednet.org/in-cases-of-failed-endothelial-keratoplasty-with-concurrent-cataract-do-you-favor-repeat-keratoplasty-plus-lens-extraction-in-the-same-setting-or-sequential-surgeries weekly 0.8 https://www.themednet.org/when-stopping-denosumab-and-transitioning-to-po-bisphosphonate-do-you-wait-for-6-months-after-the-last-denosumab-injection-to-start-po-bisphosphonate weekly 0.8 https://www.themednet.org/what-has-been-your-experience-both-intra-op-and-post-op-with-different-non-valved-implants-baerveldt-vs-clearpath weekly 0.8 https://www.themednet.org/do-you-recommend-immunomodulating-treatments-such-as-steroids-or-ivig-for-west-nile-virus-neuroinvasive-disease weekly 0.8 https://www.themednet.org/do-you-reflexively-test-for-tree-nut-allergies-when-you-diagnose-a-peanut-allergy weekly 0.8 https://www.themednet.org/how-do-you-decide-between-the-different-oral-longer-acting-levodopa-medications weekly 0.8 https://www.themednet.org/when-do-you-prefer-bariatric-surgery-such-as-sleeve-gastrectomy-or-gastric-bypass-over-an-initial-trial-of-a-glp-1-receptor-agonist-in-patients-with-severe-obesity-and-painful-knee-or-hip-osteoarthritis weekly 0.8 https://www.themednet.org/what-adjuvant-systemic-therapy-would-you-recommend-for-a-premenopausal-woman-with-a-germline-brca-mutation-who-initially-presented-with-locally-advanced-hr-her2-negative-fish-idc-but-was-later-found-on-surgical-pathology-to-have-hr-her2-disease-ihc-3-afte weekly 0.8 https://www.themednet.org/in-a-patient-with-high-ssa-antibodies-and-distal-renal-tubular-acidosis-rta-but-without-sicca-symptoms-or-other-systemic-features-of-sjogrens-should-immunomodulatory-therapy-with-hydroxychloroquine-or-azathioprine-be-considered-in-an-effort-to-reduce-subc weekly 0.8 https://www.themednet.org/if-pfts-are-done-on-different-machines-or-different-places-are-the-comparisons-valid weekly 0.8 https://www.themednet.org/are-there-instances-when-you-recommend-central-line-access-when-treating-a-patient-using-3-sodium-chloride-for-management-of-severe-hyponatremia weekly 0.8 https://www.themednet.org/given-concerns-about-cooperation-anesthesia-and-predictability-under-what-circumstances-do-you-use-adjustable-sutures-in-pediatric-strabismus-surgery weekly 0.8 https://www.themednet.org/in-asymptomatic-patients-with-unfavorable-intermediate-risk-prostate-cancer-and-a-psa-10-how-helpful-reliable-and-clinically-useful-is-bone-imaging weekly 0.8 https://www.themednet.org/do-you-screen-for-any-environmental-exposures-in-patients-with-newly-diagnosed-als weekly 0.8 https://www.themednet.org/how-would-you-continue-management-of-a-patient-with-clinical-stage-ii-cn-hr-her2-idc-with-grade-3-diarrhea-after-1-cycle-of-neoadjuvant-tchp weekly 0.8 https://www.themednet.org/what-is-the-role-of-local-control-whole-lung-irradiation-in-a-patient-with-relapsed-refractory-ewing-sarcoma-to-the-hilum-plus-multiple-lung-nodules weekly 0.8 https://www.themednet.org/for-what-duration-should-abiraterone-be-used-in-a-patient-with-biochemical-and-pelvic-node-recurrence-n1m0-who-had-prior-definitive-therapy-with-either-rp-or-rt weekly 0.8 https://www.themednet.org/how-do-you-approach-recurrent-costochondritis-in-an-sle-patient-with-nephritis-who-is-otherwise-controlled-on-mmf-and-hcq-but-cant-take-nsaids weekly 0.8 https://www.themednet.org/how-would-you-treat-a-synchronous-anal-canal-squamous-cell-carcinoma-and-localized-high-risk-prostate-adenocarcinoma weekly 0.8 https://www.themednet.org/what-group-of-early-pancreatic-cancer-patients-such-as-pt1a-can-be-excluded-from-adjuvant-chemotherapy-post-resection weekly 0.8 https://www.themednet.org/what-is-the-current-criteria-for-sentinel-node-biopsy-over-a-full-axillary-lymph-node-dissection-in-a-patient-with-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-myasthenia-gravis-in-patients-over-the-age-of-90 weekly 0.8 https://www.themednet.org/is-it-reasonable-to-use-hypofractionation-in-breast-cancer-patients-with-non-active-connective-tissue-disorders weekly 0.8 https://www.themednet.org/how-should-elevated-pt-of-unclear-etiology-and-significance-be-evaluated weekly 0.8 https://www.themednet.org/when-do-you-restart-antiplatelet-therapy-in-patients-with-hemorrhagic-conversion-of-stroke weekly 0.8 https://www.themednet.org/would-you-consider-omitting-platinum-from-neoadjuvant-chemotherapy-in-women-50-years-of-age-with-localized-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/do-you-routinely-isolate-and-test-for-tb-in-a-patient-incidentally-found-to-have-a-miliary-pattern-of-nodules-on-chest-ct weekly 0.8 https://www.themednet.org/what-is-the-highest-dose-to-which-you-treat-a-locally-advanced-esophageal-cancer-with-a-stent-in-place weekly 0.8 https://www.themednet.org/what-is-your-approach-to-tapering-treatments-for-patients-with-bullous-pemphigoid weekly 0.8 https://www.themednet.org/how-would-you-manage-p16-scc-of-the-oropharynx-with-bulky-lymph-nodes-that-are-not-responding-as-expected-to-standard-chemoradiation weekly 0.8 https://www.themednet.org/when-if-ever-would-you-consider-deep-venous-thrombosis-prophylaxis-for-patients-with-advanced-epithelial-ovarian-cancer-undergoing-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-taper-tocilizumab-in-a-patient-treated-with-the-giacta-26-week-steroid-and-tocilizumab-protocol weekly 0.8 https://www.themednet.org/how-do-you-approach-using-cd-19-20-levels-to-redose-rituximab-for-anca-associated-vasculitis weekly 0.8 https://www.themednet.org/how-would-you-manage-recurrent-laryngeal-papillomatosis-requiring-multiple-resections-of-lesions-with-pathology-never-revealing-any-degree-of-dysplasia weekly 0.8 https://www.themednet.org/what-are-the-current-timing-recommendations-for-initiating-radiation-after-lumpectomy weekly 0.8 https://www.themednet.org/would-you-consider-omission-of-radiotherapy-in-patients-70-years-and-older-with-invasive-ductal-carcinoma-who-had-initially-positive-lumpectomy-margins-but-had-no-residual-disease-upon-re-excision weekly 0.8 https://www.themednet.org/how-would-you-approach-a-low-to-moderate-titer-of-one-of-the-apls-antibodies-in-a-patient-with-a-strong-family-history-but-no-personal-history-of-thrombosis weekly 0.8 https://www.themednet.org/would-you-favor-post-op-radiation-therapy-for-soft-tissue-sarcoma-if-a-positive-margin-were-still-expected-despite-pre-op-radiation weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-patient-with-active-sle-on-treatment-low-to-moderate-level-of-one-of-the-apls-antibodies-and-remote-history-of-provoked-blood-clot-regarding-perioperative-anticoagulation weekly 0.8 https://www.themednet.org/how-do-you-incorporate-cell-phone-videos-when-diagnosing-seizures-vs-seizure-like-episodes weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-completion-hysterectomy-with-contralateral-salpingo-oophorectomy-for-patients-with-a-history-of-fertility-sparing-staging-for-borderline-tumor-of-the-ovary-who-have-since-completed-childbearing weekly 0.8 https://www.themednet.org/are-there-any-major-differences-in-clinical-manifestations-or-autoantibody-profiles-in-children-with-sle-based-on-ethnicity weekly 0.8 https://www.themednet.org/how-can-ethnic-representation-in-clinical-research-studies-in-childhood-and-adult-sle-be-improved weekly 0.8 https://www.themednet.org/what-are-some-explanations-for-the-persistent-renal-outcome-disparity-gaps-affecting-certain-minority-groups-of-patients-with-pediatric-sle-despite-improvement-in-overall-renal-outcomes weekly 0.8 https://www.themednet.org/what-dose-do-you-provide-of-folic-acid-in-pregnant-patients-with-epilepsy weekly 0.8 https://www.themednet.org/how-do-you-approach-a-prostate-cancer-patient-with-oligomet-disease-on-psma-pet weekly 0.8 https://www.themednet.org/do-you-discontinue-an-aromatase-inhibitor-in-a-patient-if-they-have-a-cardiac-event-while-on-the-drug weekly 0.8 https://www.themednet.org/how-do-you-define-impaired-distal-fusion-in-patients-with-icad weekly 0.8 https://www.themednet.org/is-prior-whole-brain-radiation-and-or-spinal-radiation-within-last-6-months-a-contraindication-for-intrathecal-methotrexate-treatment-in-with-leptomeningeal-disease weekly 0.8 https://www.themednet.org/do-you-routinely-use-vasopressin-in-the-management-of-rv-failure-leading-to-shock-state-in-the-absence-of-an-obvious-treatable-cause-such-as-infarction-or-pe weekly 0.8 https://www.themednet.org/do-you-typically-see-peripheral-neuropathy-in-patients-with-castleman-syndrome weekly 0.8 https://www.themednet.org/would-you-consider-re-irradiation-for-recurrence-of-dupuytrens-contracture weekly 0.8 https://www.themednet.org/how-would-you-approach-hdr-portion-of-cervical-scc-with-large-area-of-fistula-with-sigmoid-colon weekly 0.8 https://www.themednet.org/how-do-you-diagnose-and-manage-patients-with-hypnagogic-shooting-headache weekly 0.8 https://www.themednet.org/for-locally-advanced-rectal-cancer-will-the-recent-update-of-rapido-lead-you-to-change-your-practice-when-approaching-tnt weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-combined-pre-and-post-capillary-pulmonary-hypertension-after-successfully-optimizing-post-capillary-pressures-through-a-valvular-intervention weekly 0.8 https://www.themednet.org/do-you-ever-consider-discontinuing-hydroxychloroquine-in-patients-with-sle-in-longstanding-remission-except-in-cases-of-overt-toxicity weekly 0.8 https://www.themednet.org/would-you-offer-definitive-radiation-for-a-t1n0-glottic-larynx-scc-in-a-patient-with-a-history-of-rai-treatment weekly 0.8 https://www.themednet.org/what-is-your-approach-for-adjuvant-therapy-when-a-patient-has-discordant-oncotype-rs-e-g-20-and-mammaprint-e-g-high-risk-luminal-b-in-node-negative-hr-her2-breast-cancer weekly 0.8 https://www.themednet.org/should-we-be-using-heart-rate-variability-counts-to-gauge-disease-activity-in-persons-with-rheumatoid-arthritis weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-metastatic-signet-cell-carcinoma-of-likely-gastrointestinal-origin-with-no-primary-lesion-identified weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-a-patient-with-lower-extremity-ulcers-from-livedoid-vasculopathy-with-a-history-sjogrens-and-factor-v-leiden weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-use-for-cutaneous-head-and-neck-squamous-cell-carcinoma-status-post-resection-and-skin-grafting weekly 0.8 https://www.themednet.org/is-perfusion-imaging-reliable-in-determining-stroke-infarct-vs-area-at-risk weekly 0.8 https://www.themednet.org/do-you-contour-and-constrain-the-sublingual-glands weekly 0.8 https://www.themednet.org/based-on-the-asc4more-trial-would-you-add-asciminib-to-imatinib-if-patients-do-not-achieve-deep-molecular-remission-at-1-year weekly 0.8 https://www.themednet.org/do-you-switch-from-imatinib-to-another-tki-in-patients-with-chronic-phase-cml-who-develop-renal-insufficiency weekly 0.8 https://www.themednet.org/what-pharmacotherapeutic-strategy-do-you-use-in-catamenial-epilepsy-to-further-reduce-risk-of-breakthrough-seizures-around-the-time-of-menses weekly 0.8 https://www.themednet.org/would-you-consider-a-primary-prevention-icd-in-a-patient-with-hypertrophic-cardiomyopathy-and-non-sustained-ventricular-tachycardia-in-the-absence-of-any-other-high-risk-predictors-for-sudden-cardiac-death weekly 0.8 https://www.themednet.org/when-would-you-consider-tapering-glucocorticoids-in-a-patient-with-ici-associated-myocarditis weekly 0.8 https://www.themednet.org/what-lab-monitoring-do-you-perform-for-patients-taking-isotretinoin weekly 0.8 https://www.themednet.org/how-do-you-manage-anemia-in-a-patient-with-myelofibrosis-and-hemochromatosis weekly 0.8 https://www.themednet.org/what-is-the-best-way-to-prescribe-dhivy-carbidopa-levodopa-25-100mg-as-an-adjunct-medication-in-the-treatment-of-parkinsons-disease weekly 0.8 https://www.themednet.org/when-starting-a-patient-with-ms-on-a-dmt-how-frequently-should-mris-be-ordered-to-assess-whether-the-treatment-is-effective weekly 0.8 https://www.themednet.org/what-is-your-approach-to-leflunomide-and-statin-use-in-ra-patients weekly 0.8 https://www.themednet.org/would-you-consider-using-breast-cancer-index-to-make-decisions-about-extending-ai-therapy-in-patients-who-completed-5-years-of-ai-given-recent-data-presented-at-sabcs-2022-about-validation-of-bci-in-ideal-trial weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-regarding-contraception-use-while-taking-mycophenolate-mycophenolic-acid weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-worsening-dystonic-spasms-that-are-painful-and-refractory-to-standard-dystonia-medications weekly 0.8 https://www.themednet.org/what-are-some-commonly-missed-diagnoses-that-should-be-considered-in-cases-of-otherwise-seronegative-yet-steroid-responsive-autoimmune-encephalitis weekly 0.8 https://www.themednet.org/do-you-always-start-treatment-for-patients-who-meet-diagnostic-criteria-for-multiple-myeloma-by-slim-criteria-alone weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-jak2-et-without-history-of-thrombosis-during-pregnancy weekly 0.8 https://www.themednet.org/has-the-recent-presentation-of-radicals-hd-changed-your-adt-duration-recommendations-for-patients-receiving-post-operative-radiation-therapy-for-prostate-cancer-after-radical-prostatectomy weekly 0.8 https://www.themednet.org/how-do-you-approach-the-adjuvant-treatment-for-grade-1-endometrial-cancer-with-micrometastasis-in-a-sentinel-lymph-node-if-the-tumor-is-otherwise-low-risk weekly 0.8 https://www.themednet.org/when-treating-locally-advanced-cervical-cancer-with-concurrent-chemort-do-you-contour-the-presacral-lns-to-the-bottom-of-s3-or-you-stop-your-contour-at-s2-s3 weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-to-third-line-treatment-of-metastatic-her2-positive-esophageal-adenocarcinoma-after-progression-on-folfox-capox-trastuzumab-then-t-dxd weekly 0.8 https://www.themednet.org/is-there-any-role-of-sympathectomy-in-raynauds-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-new-onset-ild-in-a-patient-with-ra-who-is-otherwise-well-controlled-on-methotrexate-or-leflunomide weekly 0.8 https://www.themednet.org/how-would-you-manage-the-axilla-of-a-patient-with-a-recurrent-ipsilateral-breast-cancer-treated-with-lumpectomy-sentinel-node-biopsy-and-iort weekly 0.8 https://www.themednet.org/would-you-offer-curative-intent-therapy-to-a-patient-with-a-new-diagnosis-of-breast-cancer-with-multiple-small-lung-nodules-1cm-not-amenable-to-biopsy-as-the-only-possible-site-of-metastatic-disease weekly 0.8 https://www.themednet.org/would-you-prescribe-adt-or-ar-inhibitors-for-a-patient-with-moderate-to-severe-dementia-who-has-biochemical-recurrent-non-metastatic-prostate-cancer-but-otherwise-good-physical-performance-status-and-prognosis-5-years weekly 0.8 https://www.themednet.org/in-light-of-the-triangle-data-at-ash-how-should-we-now-approach-a-transplant-eligible-patient-with-a-new-diagnosis-of-aggressive-mantle-cell-lymphoma weekly 0.8 https://www.themednet.org/how-would-you-manage-scleritis-perforans-in-a-patient-with-seropositive-rheumatoid-arthritis-scleroderma-overlap weekly 0.8 https://www.themednet.org/what-are-the-best-labs-to-trend-improvement-in-hlh weekly 0.8 https://www.themednet.org/is-there-utility-in-obtaining-pericardial-fluid-autoimmune-labs-such-as-ana-or-rf-in-patients-with-recurrent-idiopathic-pericardial-effusions-but-no-other-clinical-or-serologic-evidence-of-rheumatic-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-stage-iii-resectable-nsclc-patients-treated-with-neoadjuvant-chemoimmunotherapy-per-checkmate-816-with-residual-disease-who-subsequently-refuse-surgery weekly 0.8 https://www.themednet.org/how-do-you-treat-clear-cell-renal-cell-carcinoma-with-metastatic-recurrence-while-on-adjuvant-pembrolizumab weekly 0.8 https://www.themednet.org/would-you-recommend-definitive-xrt-for-prostate-cancer-in-patients-with-prior-holmium-laser-enucleation-of-the-prostate-holep weekly 0.8 https://www.themednet.org/how-do-you-mitigate-6-mp-induced-gi-toxicity-in-pediatric-and-aya-patients-with-leukemia weekly 0.8 https://www.themednet.org/how-do-you-approach-balancing-the-potential-risk-of-worsening-actinic-damage-and-maintaining-ctcl-clearance-in-patients-treated-with-nb-uvb weekly 0.8 https://www.themednet.org/what-therapies-have-you-found-most-effective-in-providing-rapid-improvement-in-patients-with-erythrodermic-atopic-dermatitis weekly 0.8 https://www.themednet.org/what-treatments-have-you-found-helpful-in-treating-recurrent-aphthous-ulcers weekly 0.8 https://www.themednet.org/what-is-your-target-volume-when-treating-lymphoid-hyperplasia-of-the-lacrimal-gland-with-radiation-therapy weekly 0.8 https://www.themednet.org/what-gene-mutations-do-you-always-test-for-prior-to-starting-egfr-inhibitor-therapy-in-metastatic-colon-cancer-1 weekly 0.8 https://www.themednet.org/do-you-cover-the-sacral-foramen-when-treating-pelvic-lymph-nodes-for-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-use-il-1-inhibitors-to-prevent-flares-of-gout-or-cppd-in-patients-who-experience-flares-despite-prophylaxis-with-colchicine-nsaids-and-or-low-dose-prednisone weekly 0.8 https://www.themednet.org/do-you-check-for-egfr-and-other-mutations-in-patients-with-squamous-cell-lung-cancer-including-in-adjuvant-setting-before-considering-immunotherapy weekly 0.8 https://www.themednet.org/what-dose-constraints-do-you-use-when-treating-gastric-malt-or-dlbcl-with-radiation-therapy weekly 0.8 https://www.themednet.org/would-you-continue-warfarin-anticoagulation-in-patients-with-unprovoked-dvt-if-switching-to-low-dose-doac-is-cost-prohibitive weekly 0.8 https://www.themednet.org/does-aerobic-exercise-lead-to-any-change-in-ability-to-perform-adls-in-patients-with-parkinsons-disease weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-to-a-patient-with-myeloma-who-has-refractory-disease-to-dara-vrd-in-the-frontline-setting weekly 0.8 https://www.themednet.org/are-there-specific-sections-of-the-moca-which-showed-less-change-in-patients-in-the-exercise-group weekly 0.8 https://www.themednet.org/does-time-since-diagnosis-play-a-role-in-benefits-of-exercise-when-studying-patients-with-parkinsons-disease weekly 0.8 https://www.themednet.org/when-if-at-all-is-it-appropriate-to-re-challenge-a-patient-with-a-egfr-inhibitor-in-metastatic-ras-braf-wt-colon-cancer weekly 0.8 https://www.themednet.org/for-patients-with-locally-advanced-rectal-cancer-who-desire-organ-preservation-and-can-tolerate-fluoropyrimidine-but-not-oxaliplatin-what-is-the-appropriate-treatment-approach weekly 0.8 https://www.themednet.org/for-patients-with-ct1-t3-cn0-cm0-mid-low-rectal-cancer-seeking-organ-preservation-what-treatment-approach-do-you-recommend weekly 0.8 https://www.themednet.org/what-is-your-perspective-on-the-role-of-respiratory-therapists-in-managing-a-patient-who-is-dyssynchronous-on-their-current-mode-of-mechanical-ventilation weekly 0.8 https://www.themednet.org/would-you-consider-rni-in-a-patient-with-axillary-recurrence-after-lumpectomy-whole-breast-rt-and-cavity-boost-10-years-ago weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-metastatic-colon-cancer-with-biopsy-confirmed-bone-mets-who-has-a-significant-decrease-in-cea-on-folfox-but-develops-new-bone-lesions weekly 0.8 https://www.themednet.org/how-do-you-manage-orthostatic-symptoms-from-autonomic-neuropathy-due-to-diabetes weekly 0.8 https://www.themednet.org/do-you-recommend-any-dietary-modifications-for-patients-with-hsan1 weekly 0.8 https://www.themednet.org/what-is-your-preferred-workup-for-patients-who-present-with-concern-for-autonomic-neuropathy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-want-breast-augmentation-following-breast-conserving-surgery-and-whole-breast-radiation weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-ice-pick-headaches weekly 0.8 https://www.themednet.org/what-autonomic-symptoms-do-you-encounter-in-patients-with-als weekly 0.8 https://www.themednet.org/what-is-the-recommended-approach-for-extracranial-bleeding-after-tpa weekly 0.8 https://www.themednet.org/would-you-treat-primary-small-cell-cancer-of-the-trachea-with-spread-to-paratracheal-lymph-node-any-differently-than-a-limited-stage-sclc weekly 0.8 https://www.themednet.org/would-you-consider-using-anthracycline-for-treating-a-stage-i-triple-negative-breast-cancer-in-a-patient-with-a-baseline-mildly-reduced-lvef-50-55 weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiation-for-a-low-grade-cutaneous-leiomyosarcoma-after-r0-resection weekly 0.8 https://www.themednet.org/are-there-any-instances-when-you-would-not-perform-3-consecutive-daily-dialysis-sessions-when-initiating-a-patient-on-hemodialysis weekly 0.8 https://www.themednet.org/is-there-a-role-to-continue-aspirin-in-patients-with-myeloproliferative-disorders-who-have-never-had-a-thrombotic-event-that-are-starting-doac-for-stroke-prophylaxis-with-newly-diagnosed-atrial-fibrillation weekly 0.8 https://www.themednet.org/what-screening-recommendations-do-you-provide-for-patients-with-a-nevus-of-ota-with-ocular-involvement weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-cancer-with-a-lesion-invading-the-small-bowel-causing-bleeding-and-potential-obstruction weekly 0.8 https://www.themednet.org/would-you-compromise-target-coverage-to-meet-oar-constraints-for-prostate-radiation weekly 0.8 https://www.themednet.org/do-you-offer-local-consolidative-therapy-for-patients-with-polymetastatic-driver-mutation-positive-nsclc-who-respond-well-to-targeted-therapy weekly 0.8 https://www.themednet.org/do-your-radiation-treatment-recommendations-change-if-a-breast-cancer-patient-does-not-complete-a-full-course-of-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-nail-lichen-planus weekly 0.8 https://www.themednet.org/would-you-offer-a-patient-with-mmr-deficient-colon-cancer-who-underwent-surgical-resection-of-metachronous-liver-metastases-adjuvant-therapy weekly 0.8 https://www.themednet.org/what-is-the-role-of-cns-prophylaxis-in-a-healthy-patient-in-their-60s-with-a-large-dlbcl-of-the-cranium-dura-with-brain-parenchymal-invasion weekly 0.8 https://www.themednet.org/do-you-ever-treat-patients-with-phyllodes-tumor-of-the-breast-with-adjuvant-radiation weekly 0.8 https://www.themednet.org/what-dose-fractionation-scheme-and-esophageal-constraints-should-be-used-to-treat-an-ultra-central-medically-inoperable-stage-i-nsclc-abutting-the-esophagus weekly 0.8 https://www.themednet.org/do-you-offer-immunosuppression-to-patients-with-ctd-ild-with-concomitant-well-controlled-hiv weekly 0.8 https://www.themednet.org/what-is-a-reasonable-atrial-fibrillation-percentage-burden-that-would-benefit-from-systemic-anticoagulation-for-a-patient-with-an-elevated-cha-ds-vasc-score weekly 0.8 https://www.themednet.org/what-is-the-recommended-follow-up-surveillance-schedule-following-organ-preservation-treatment-approach-for-ct1-2n0-rectal-cancer weekly 0.8 https://www.themednet.org/what-initial-systemic-approach-will-you-recommend-for-metastatic-pmmr-her2-positive-esophageal-gej-gastric-adenocarcinoma-with-pdl1-of-0 weekly 0.8 https://www.themednet.org/would-you-offer-re-irradiation-for-recurrent-vaginal-bleeding weekly 0.8 https://www.themednet.org/in-a-patient-with-bisphosphonate-induced-bilateral-atypical-femur-fractures-how-would-you-approach-timing-of-alternative-osteoporosis-treatments-and-surgical-management weekly 0.8 https://www.themednet.org/can-a-patient-with-mds-have-ring-sideroblasts-in-the-absence-of-mutation-such-as-sf3b1 weekly 0.8 https://www.themednet.org/do-you-utilize-post-vaccination-igg-titers-to-detect-common-variable-immunodeficiency-in-patients-who-are-about-to-start-or-are-actively-on-b-cell-depleting-therapy weekly 0.8 https://www.themednet.org/do-you-perform-apnea-testing-prior-to-ancillary-tests-in-patients-with-suspected-brain-death-who-are-unable-to-undergo-complete-brainstem-testing weekly 0.8 https://www.themednet.org/do-you-recommend-treatment-of-worsening-skin-thickening-with-limited-scleroderma-ana-centromere-and-if-so-with-what-agent-would-you-use weekly 0.8 https://www.themednet.org/do-you-employ-the-use-of-noctournal-oximetry-to-assess-for-a-need-for-supplemental-o2-in-addition-to-auto-pap-in-patients-with-osa-who-have-not-had-an-in-lab-cpap-titration-study weekly 0.8 https://www.themednet.org/would-you-be-willing-to-give-definitive-chemo-radiation-and-chemotherapy-to-a-msi-stable-t2n0-low-lying-rectal-cancer-in-a-young-healthy-patient-who-wants-to-avoid-surgery weekly 0.8 https://www.themednet.org/when-if-ever-would-you-offer-adjuvant-radiation-to-a-patient-with-stage-ivb-endometrial-cancer-following-neoadjuvant-chemotherapy-and-cytoreductive-surgery weekly 0.8 https://www.themednet.org/would-you-offer-post-operative-srs-sbrt-in-the-case-of-a-resected-brain-metastasis-from-metastatic-nsclc-with-an-egfr-mutation weekly 0.8 https://www.themednet.org/do-you-consider-dual-biologic-therapy-in-patients-with-abpa-that-remain-steroid-dependent-despite-the-use-of-omalizumab weekly 0.8 https://www.themednet.org/for-patients-with-endometrial-cancer-should-tumor-size-be-included-as-a-risk-factor-for-recurrence weekly 0.8 https://www.themednet.org/how-do-you-manage-dry-eye-related-to-pluvicto-lu-177 weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-a-granular-cell-tumor-of-the-breast-with-positive-margins-following-excision weekly 0.8 https://www.themednet.org/how-do-you-address-the-axilla-in-an-incidentally-found-t1bnx-invasive-breast-cancer-with-extensive-dcis-on-bilateral-prophylactic-mastectomy-in-brca-2-mutated-woman weekly 0.8 https://www.themednet.org/what-treatments-have-you-found-to-be-most-effective-for-granulomatous-rosacea weekly 0.8 https://www.themednet.org/should-hippocampal-avoidance-wbrt-be-the-default-option-for-wbrt weekly 0.8 https://www.themednet.org/is-there-utility-of-modifying-dmard-treatment-in-a-seropositive-rheumatoid-arthritis-patient-with-recurrent-pleural-effusions-and-ra-nodules-without-other-signs-of-active-disease weekly 0.8 https://www.themednet.org/would-you-consider-re-challenging-a-patient-with-rituximab-after-they-experienced-delayed-neutropenia weekly 0.8 https://www.themednet.org/how-would-you-treat-a-woman-who-has-had-a-simple-extrafascial-hysterectomy-for-a-clinically-occult-pathologically-figo-stage-ib1-cervical-cancer weekly 0.8 https://www.themednet.org/what-neoadjuvant-regimen-would-you-consider-using-for-a-healthy-patient-with-node-positive-tnbc-who-is-refusing-anthracycline weekly 0.8 https://www.themednet.org/how-would-you-manage-primary-breast-osteosarcoma weekly 0.8 https://www.themednet.org/how-do-you-approach-cll-in-a-patient-not-currently-on-treatment-who-has-a-solid-tumor-that-requires-treatment weekly 0.8 https://www.themednet.org/is-there-a-role-for-radiation-therapy-in-the-management-of-unresectable-solid-papillary-cystic-tumor-of-the-pancreas weekly 0.8 https://www.themednet.org/what-is-your-approach-to-inpatient-immunosuppression-for-a-kidney-transplant-patient-on-home-tacrolimus-prednisone-and-mycophenolic-acid-who-cannot-tolerate-anything-by-mouth weekly 0.8 https://www.themednet.org/how-would-you-manage-de-novo-oligometastatic-nsclc-with-an-isolated-low-cervical-node-metastasis weekly 0.8 https://www.themednet.org/does-a-transperineal-approach-to-prostate-biopsy-change-your-treatment-plan-compared-to-transrectal weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-stable-axial-spondyloarthritis-who-develops-newly-active-iga-nephropathy weekly 0.8 https://www.themednet.org/what-dose-volume-constraints-do-you-use-for-apbi-using-the-livi-regimen-for-rib-contralateral-breast-and-lung weekly 0.8 https://www.themednet.org/what-are-your-recommendations-for-adult-sickle-cell-patients-who-end-up-being-admitted-several-times-a-year-for-pain-crises-despite-hydroxyurea-crizanlizumab-voxelotor-etc weekly 0.8 https://www.themednet.org/does-omission-of-pci-influence-your-decision-whether-to-offer-consolidative-thoracic-radiation-in-es-sclc-after-chemo-immunotherapy weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-osimertinib-to-egfr-exon-19-deleted-patients-with-t2n0-nsclc-treated-with-definitive-sbrt weekly 0.8 https://www.themednet.org/in-what-clinical-situation-would-you-consider-using-benzodiazepines-in-patients-with-dementia weekly 0.8 https://www.themednet.org/would-you-use-pcc-for-clotting-factor-repletion-in-acute-life-threatening-hemorrhage-in-a-patient-with-elevated-inr-from-coagulopathy-of-liver-disease weekly 0.8 https://www.themednet.org/what-biologic-e-g-porcine-xenografts-or-alternative-dressings-have-you-found-helpful-for-second-intention-wound-healing weekly 0.8 https://www.themednet.org/in-a-patient-hospitalized-for-several-days-with-a-refractory-pain-crisis-would-you-ever-consider-transfusion-either-simple-or-possibly-exchange-in-an-attempt-to-get-the-patient-over-the-crisis weekly 0.8 https://www.themednet.org/when-will-you-recommend-enfortumab-vedotin-plus-pembrolizumab-as-first-line-treatment-of-metastatic-urothelial-carcinoma-for-cisplatin-ineligible-patients weekly 0.8 https://www.themednet.org/how-do-you-manage-asymptomatic-patients-with-incidental-findings-of-the-carotid-web weekly 0.8 https://www.themednet.org/would-you-recommend-avoiding-picc-line-placement-in-a-kidney-transplant-patient-with-an-estimated-gfr-of-more-than-45-ml-min-1-73m2-and-no-functional-av-access weekly 0.8 https://www.themednet.org/do-you-consider-anti-viral-prophylaxis-in-patients-taking-jak-inhibitors-who-have-recurrent-uncomplicated-zoster-infection-but-would-prefer-not-changing-therapy weekly 0.8 https://www.themednet.org/what-is-your-approach-in-deciding-to-include-the-entire-tongue-or-a-smaller-volume-tumor-surgical-bed-margin-for-adjuvant-radiation-in-oral-tongue-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-a-vulvar-scc-with-extension-to-the-anal-sphincter-and-inguinal-nodes-10-years-after-definitive-chemort-brachy-for-a-cervical-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-a-prolonged-treatment-break-in-the-middle-of-lung-sbrt-for-early-stage-nsclc weekly 0.8 https://www.themednet.org/would-you-recommend-mycophenolate-mofetil-for-patients-with-progressive-iga-nephropathy-who-do-not-tolerate-corticosteroids weekly 0.8 https://www.themednet.org/what-is-your-approach-to-risk-stratification-of-asymptomatic-patients-with-pre-excitation-syndrome weekly 0.8 https://www.themednet.org/in-an-ra-patient-with-positive-rf-and-ccp-abs-who-is-stable-on-tnfi-biologic-how-would-you-approach-incidentally-found-low-titer-positive-dsdna-abs weekly 0.8 https://www.themednet.org/are-there-special-considerations-when-treating-a-patient-with-sarcomatoid-scc-of-the-head-and-neck weekly 0.8 https://www.themednet.org/do-you-combine-oral-and-topical-nsaids-for-pain-relief weekly 0.8 https://www.themednet.org/do-you-try-to-incorporate-mfolfirinox-in-total-neoadjuvant-therapy-for-rectal-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-decreasing-the-loop-diuretic-dose-when-starting-an-sglt2-inhibitor-in-a-ckd-patient-given-its-natriuretic-and-osmotic-diuretic-effects weekly 0.8 https://www.themednet.org/what-is-your-approach-to-initial-work-up-for-a-young-patient-with-bronchiectasis weekly 0.8 https://www.themednet.org/what-is-the-appropriate-dose-to-the-dissected-node-negative-neck-with-indication-for-radiation-due-to-advanced-primary weekly 0.8 https://www.themednet.org/do-you-use-apremilast-in-combination-with-biologic-dmards-for-psoriatic-arthritis-and-or-psoriasis weekly 0.8 https://www.themednet.org/do-you-have-any-concerns-about-using-checkpoint-inhibitors-in-a-patient-with-myeloma-who-has-a-second-malignancy weekly 0.8 https://www.themednet.org/what-is-your-cut-off-on-er-percent-positivity-to-treat-breast-cancer-as-functional-triple-negative-cancer weekly 0.8 https://www.themednet.org/would-you-use-tnf-inhibitors-in-patients-with-features-of-sle-but-active-peripheral-and-axial-spondylarthritis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-further-work-up-and-management-of-neutropenia-in-patients-with-sle-ra-overlap weekly 0.8 https://www.themednet.org/do-you-prefer-that-hospitalized-peritoneal-dialysis-patients-use-their-own-home-dialysis-equipment-during-the-admission weekly 0.8 https://www.themednet.org/what-is-your-blood-pressure-goal-for-the-first-three-months-after-kidney-transplantation weekly 0.8 https://www.themednet.org/how-would-you-approach-an-adult-patient-50-years-old-with-an-intermediate-risk-extremity-t2n0-fusion-neg-rhabdomyosarcoma-who-is-progressing-on-neoadjuvant-chemotherapy-with-vac weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-urothelial-carcinoma-with-early-progression-on-maintenance-immunotherapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-evaluation-and-management-of-a-patient-with-blau-syndrome-and-gi-manifestations weekly 0.8 https://www.themednet.org/do-you-modify-your-choice-of-systemic-therapy-for-localized-early-stage-er-pr-her2-breast-if-mammaprint-shows-basal-subtype weekly 0.8 https://www.themednet.org/how-do-you-approach-diagnosis-and-treatment-of-hlh-mas-following-car-t-cell-therapy weekly 0.8 https://www.themednet.org/what-is-the-expected-timeframe-one-would-expect-to-see-paroxysmal-sympathetic-hyperactivity-sympathetic-storming-persist-post-traumatic-brain-injury weekly 0.8 https://www.themednet.org/do-you-have-concerns-with-the-use-of-oral-contraceptives-in-patients-on-jak-inhibitors-given-the-black-box-warning-for-thromboembolic-events weekly 0.8 https://www.themednet.org/how-would-you-manage-hemodialysis-for-an-eskd-patient-who-presents-with-a-phosphorus-of-1-6-mg-dl-and-potassium-of-6-5-meq-l-without-ecg-changes weekly 0.8 https://www.themednet.org/when-do-you-feel-comfortable-adding-bevacizumab-to-a-braf-wt-kras-mutated-colon-cancer-patient-with-previously-hemorrhagic-brain-mets-that-responded-to-radiation weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-an-adenoma-malignum-of-the-cervix weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-of-infection-triggered-hlh-that-does-not-respond-to-treatment-of-the-underlying-infection weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-clinical-t3n1-anorectal-malignant-melanoma-referred-by-a-surgeon-for-neoadjuvant-therapy weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-abemaciclib-for-er-her2-neg-inflammatory-breast-cancer-who-do-not-achieve-pcr-with-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/do-you-recommend-ligation-of-a-functional-arteriovenous-fistula-after-kidney-transplantation weekly 0.8 https://www.themednet.org/how-have-the-results-of-the-phase-iii-rtog-0631-trial-impacted-your-use-of-spine-sbrt weekly 0.8 https://www.themednet.org/how-would-you-treat-a-kidney-transplant-patient-with-both-biopsy-proven-bk-nephropathy-and-recurrent-membranous-glomerulonephritis-with-nephrotic-range-proteinuria weekly 0.8 https://www.themednet.org/given-recent-studies-investigating-ici-myocarditis-biomarkers-such-as-temra-cd8-cells-is-there-now-a-growing-selection-of-clinical-biomarkers-besides-bnp-and-troponin-being-measured-routinely-in-ici-myocarditis-cases weekly 0.8 https://www.themednet.org/should-all-patients-with-a-remote-history-of-immunotherapy-chemotherapy-and-or-radiation-therapy-have-a-baseline-tte-regardless-of-ascvd-risk weekly 0.8 https://www.themednet.org/would-you-recommend-starting-an-sglt2-inhibitor-in-a-proteinuric-ckd-patient-with-chronic-asymptomatic-bacteriuria weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-obtain-genetic-testing-for-suspected-autoinflammatory-conditions-in-adults weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-a-new-primary-melanoma-not-an-in-transit-metastasis-while-on-adjuvant-immunotherapy-treatment-for-a-previous-melanoma-lesion weekly 0.8 https://www.themednet.org/would-you-offer-radiation-therapy-for-extramedullary-testicular-masses-in-the-setting-of-multiple-myeloma weekly 0.8 https://www.themednet.org/how-would-you-approach-a-recurrent-cutaneous-scc-of-the-face-with-high-risk-features-s-p-resection weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-radiotherapy-for-head-and-neck-cancer-after-resection-and-reconstruction-with-a-free-tissue-muscle-and-bone-flap weekly 0.8 https://www.themednet.org/when-would-you-consider-using-g-csf-in-patients-with-rheumatic-disease-who-have-received-cyclophosphamide weekly 0.8 https://www.themednet.org/for-patients-on-immune-checkpoint-inhibitors-presenting-with-chest-pain-dyspnea-fatigue-and-troponin-elevation-would-you-recommend-early-initiation-of-high-dose-steroids-for-empiric-treatment-of-ici-myocarditis-while-pursuing-workup-with-coronary-angiogra weekly 0.8 https://www.themednet.org/how-would-you-treat-pemphigus-foliaceous-in-an-elderly-patient-intolerant-to-oral-steroids weekly 0.8 https://www.themednet.org/would-you-recommend-av-fistula-placement-in-a-ckd-stage-5-patient-who-is-over-the-age-of-80 weekly 0.8 https://www.themednet.org/if-memantine-were-started-6-weeks-after-completion-of-radiation-to-base-of-skull-would-you-expect-any-potential-benefit weekly 0.8 https://www.themednet.org/how-would-you-approach-a-stage-iii-nsclc-that-is-a-biopsy-proven-new-primary-located-in-the-same-field-as-a-prior-stage-iii-nsclc-previously-treated-with-chemort weekly 0.8 https://www.themednet.org/what-is-your-approach-to-elevated-urine-uric-acid-levels-in-a-recurrent-calcium-based-stone-former weekly 0.8 https://www.themednet.org/for-an-atypical-meningioma-who-grade-2-s-p-gtr-do-molecular-findings-that-suggest-an-integrated-diagnosis-of-a-grade-3-tumor-change-adjuvant-radiation-treatment-recommendations weekly 0.8 https://www.themednet.org/is-there-any-clinical-benefit-in-referring-patients-with-sle-or-sjogrens-with-cognitive-impairment-for-neuropsychological-testing weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-solitary-plasmacytoma-with-an-flc-ratio-100-but-a-negative-bone-marrow-biopsy-and-negative-pet-ct weekly 0.8 https://www.themednet.org/what-would-be-your-approach-to-a-sle-patient-who-is-triple-aps-positive-has-no-prior-vte-obstetric-events-is-stable-on-hcq-and-low-dose-aspirin-and-wants-to-become-pregnant weekly 0.8 https://www.themednet.org/what-is-your-approach-to-monitoring-a-patient-with-sle-who-has-persistent-hypocomplementemia-on-hydroxychloroquine-but-clinically-has-resolution-of-cutaneous-symptoms-and-no-other-internal-organ-manifestations-of-disease weekly 0.8 https://www.themednet.org/how-would-you-manage-tubulointerstitial-nephritis-and-renal-tubular-acidosis-rta-in-a-patient-with-sjogrens-who-is-pregnant weekly 0.8 https://www.themednet.org/does-synovial-biopsy-provide-diagnostic-value-in-undifferentiated-inflammatory-arthritis weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-homologous-recombination-repair-proficient-tumors-already-on-niraparib-maintenance-therapy-prior-to-the-fda-restriction weekly 0.8 https://www.themednet.org/what-is-your-approach-towards-initial-regimen-and-tapering-of-mycophenolate-in-scleroderma weekly 0.8 https://www.themednet.org/do-you-start-steroid-therapy-in-a-patient-with-pure-ards-without-septic-shock-or-would-you-only-consider-steroids-only-in-those-with-severe-community-acquired-pneumonia weekly 0.8 https://www.themednet.org/do-you-perform-spontaneous-breathing-trials-on-higher-levels-of-peep-with-extubation-to-positive-pressure-ventilation-in-patients-intubated-for-obesity-hypoventilation-syndrome weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-active-bilateral-pan-uveitis-in-patients-who-have-a-history-of-prior-infectious-uveitis weekly 0.8 https://www.themednet.org/what-do-you-use-to-treat-cramping-in-kennedys-disease weekly 0.8 https://www.themednet.org/in-patient-s-p-definitive-chemort-for-vulvar-cancer-with-complete-response-how-do-you-manage-a-non-healing-vulvar-defect-if-biopsy-is-negative-for-residual-disease weekly 0.8 https://www.themednet.org/when-do-you-re-image-patients-with-a-diagnosis-of-venous-sinus-thrombosis weekly 0.8 https://www.themednet.org/is-there-a-reason-to-repeat-hmgcr-antibody-level-for-monitoring-disease-activity-once-documented-positive-in-patients-with-imnm weekly 0.8 https://www.themednet.org/would-you-recommend-transition-to-hemodialysis-for-a-patient-with-calciphylaxis-hyperphosphatemia-and-eskd-on-peritoneal-dialysis weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-blood-pressures-while-on-anti-angiogenic-tkis weekly 0.8 https://www.themednet.org/what-percentage-of-patients-with-non-sustained-focal-atrial-tachycardia-detected-on-an-outpatient-holter-develop-paroxysmal-atrial-fibrillation-and-how-should-we-identify-and-treat-patients-at-the-highest-risk-of-progressing-to-paf weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-ats-2023 weekly 0.8 https://www.themednet.org/which-biologics-are-you-comfortable-combining-with-vedolizumab-for-spondyloarthritis-or-psoriatic-arthritis-patients-in-the-setting-of-well-controlled-inflammatory-bowel-disease weekly 0.8 https://www.themednet.org/would-you-give-t-dxd-to-patients-with-resolved-drug-induced-ild-from-other-agents-such-as-prior-chemo-targeted-therapy-immunotherapy weekly 0.8 https://www.themednet.org/is-it-safe-to-deliver-palliative-spine-radiation-concurrently-with-sacituzumab-govitecan weekly 0.8 https://www.themednet.org/do-you-give-neoadjuvant-intralesional-5fu-mtx-prior-to-mohs-for-cscc-purely-to-reduce-scar-size-and-improve-cosmetic-outcome weekly 0.8 https://www.themednet.org/what-lifestyle-choices-are-helpful-in-reducing-the-risk-of-or-slowing-cognitive-decline weekly 0.8 https://www.themednet.org/how-do-you-approach-long-term-management-of-glucocorticoid-induced-osteoporosis-in-patients-who-develop-osteonecrosis-of-the-jaw-on-antiresorptive-agent weekly 0.8 https://www.themednet.org/would-you-offer-rt-for-a-low-grade-esophageal-gist-if-the-patient-was-not-a-surgical-candidate weekly 0.8 https://www.themednet.org/will-prior-novel-hormonal-therapy-affect-when-how-you-use-olaparib-plus-abiraterone-for-patients-with-brca-mutated-metastatic-castration-resistant-prostate-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-chronic-recurrent-parotitis-in-patients-with-sjogrens-syndrome weekly 0.8 https://www.themednet.org/is-a-completion-axillary-dissection-required-for-a-patient-with-clinical-n-disease-who-had-a-complete-clinical-response-in-the-axilla-to-neoadjuvant-systemic-therapy-but-is-found-to-ypn-disease-on-sentinel-node-biopsy weekly 0.8 https://www.themednet.org/do-you-ever-initiate-on-degarelix-and-then-switch-to-leuprolide-for-patients-with-prostate-cancer-and-cardiac-risk-factors-receiving-adt weekly 0.8 https://www.themednet.org/when-should-headache-treatment-be-escalated-to-inpatient-iv-lidocaine weekly 0.8 https://www.themednet.org/how-do-you-approach-post-transplant-maintenance-for-patients-with-high-risk-myeloma weekly 0.8 https://www.themednet.org/do-you-offer-semaglutide-for-weight-loss-management-in-patients-with-ckd weekly 0.8 https://www.themednet.org/how-have-you-incorporated-mirvetuximab-into-the-treatment-of-platinum-resistant-ovarian-cancer weekly 0.8 https://www.themednet.org/do-you-ever-extend-adjuvant-imatinib-for-patients-with-high-risk-localized-gist-beyond-3-years weekly 0.8 https://www.themednet.org/what-strategies-do-you-employ-to-minimize-the-risk-of-cardiovascular-collapse-when-intubating-a-patient-with-severe-pulmonary-hypertension weekly 0.8 https://www.themednet.org/would-you-consider-rituximab-in-a-patient-with-severe-gi-dysmotility-caused-by-scleroderma weekly 0.8 https://www.themednet.org/would-you-treat-the-prostate-in-a-patient-with-widely-metastatic-disease-who-has-cr-to-all-metastatic-sites-after-systemic-therapy-or-adt weekly 0.8 https://www.themednet.org/for-a-patient-with-a-lung-tumor-that-is-radiographically-consistent-with-early-stage-nsclc-but-pathology-with-characteristics-overlapping-with-upper-gi-origin-what-additional-diagnostic-procedures-would-you-consider-before-treating weekly 0.8 https://www.themednet.org/do-you-typically-categorize-keratoacanthomas-as-a-distinct-entity-from-squamous-cell-carcinomas-and-do-you-favor-medical-treatment-vs-surgery weekly 0.8 https://www.themednet.org/would-you-ever-offer-a-simultaneous-integrated-boost-to-the-lumpectomy-cavity-with-5-fraction-ultra-hypofractionated-whole-breast-radiotherapy-2600-cgy-in-5-fractions weekly 0.8 https://www.themednet.org/will-you-offer-single-fraction-sbrt-for-pulmonary-oligometastases weekly 0.8 https://www.themednet.org/what-is-your-approach-to-rheumatologic-disease-management-during-the-current-methotrexate-shortage weekly 0.8 https://www.themednet.org/would-you-consider-teriparatide-in-a-postmenopausal-woman-with-normal-dexa-who-had-a-traumatic-humerus-fracture-three-months-prior-with-surgical-intervention-and-plain-xrays-showing-only-partial-healing weekly 0.8 https://www.themednet.org/when-is-it-safe-for-a-rectal-biopsy-in-a-patient-with-prior-prostate-radiation weekly 0.8 https://www.themednet.org/how-do-you-dose-folfox-when-given-with-concurrent-chemoradiation-in-esophageal-adenocarcinoma weekly 0.8 https://www.themednet.org/should-fasting-c-peptide-levels-be-used-to-guide-t2dm-management weekly 0.8 https://www.themednet.org/should-insulin-be-started-early-prior-to-optimization-of-other-anti-hyperglycemic-medications-in-patients-with-mild-to-moderate-diabetes-and-hypertriglyceridemia-refractory-to-statin-and-fibrates weekly 0.8 https://www.themednet.org/should-lipid-lowering-therapy-be-started-in-patients-with-isolated-elevation-in-lipoprotein-a-and-minimal-cardiovascular-risk weekly 0.8 https://www.themednet.org/should-patients-with-mild-subclinical-hypothyroidism-tsh-10-miu-l-be-treated-with-thyroid-hormone-replacement-to-improve-their-lipid-profile weekly 0.8 https://www.themednet.org/would-you-transition-from-denosumab-to-anabolic-agents-in-patients-who-are-in-urgent-need-for-extensive-dental-work weekly 0.8 https://www.themednet.org/should-thyroxine-hormone-be-started-in-women-having-fertility-concerns-with-high-normal-tsh-and-negative-tpo-antibody weekly 0.8 https://www.themednet.org/how-long-should-t3-be-continued-in-hypothyroid-patients-who-received-no-symptomatic-benefit-after-starting-t3-t4-combination-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-polypoid-nodular-melanoma-for-adjuvant-therapy-when-breslow-depth-is-not-available-on-pathology weekly 0.8 https://www.themednet.org/for-unresectable-radiation-induced-angiosarcoma-what-dose-and-fractionation-would-you-use weekly 0.8 https://www.themednet.org/how-do-you-work-up-incidentally-found-papilledema-in-the-emergency-room weekly 0.8 https://www.themednet.org/would-you-avoid-the-use-of-keppra-in-patients-with-tbi-due-to-concerns-for-worsening-agitation weekly 0.8 https://www.themednet.org/what-is-your-preferred-adjuvant-treatment-for-surgically-staged-ib-dedifferentiated-endometrial-carcinoma-with-negative-slnbx-and-extensive-lvsi weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-persistent-painless-salivary-gland-swelling-sialadenitis-in-patients-with-sjogrens weekly 0.8 https://www.themednet.org/how-do-you-approach-contouring-of-the-itv-for-lung-sbrt weekly 0.8 https://www.themednet.org/what-is-your-workup-for-csf-studies-when-evaluating-for-possible-cns-lupus weekly 0.8 https://www.themednet.org/for-pediatric-patients-with-localized-diffuse-large-b-cell-lymphoma-being-treated-per-cog-anhl-1131-in-group-b-do-you-feel-it-is-necessary-to-complete-all-lumbar-punctures-with-it-therapy weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-olaparib-to-a-male-patient-with-hr-her2-t2n0-breast-cancer-with-a-brca2-germline-mutation-following-mastectomy-who-is-not-a-candidate-for-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/would-you-offer-prostate-sbrt-to-a-patient-on-a-tki weekly 0.8 https://www.themednet.org/how-do-you-address-logistic-barriers-related-to-blinatumomab-when-treating-relapsed-b-all weekly 0.8 https://www.themednet.org/what-is-your-preferred-steroid-sparing-agent-in-the-treatment-of-sjoegren-associated-lip weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-recommend-for-a-patient-with-high-grade-serous-ovarian-cancer-who-has-surgically-confirmed-unresectable-disease-after-a-partial-response-to-6-cycles-of-a-platinum-doublet weekly 0.8 https://www.themednet.org/how-would-you-manage-radiation-cystitis-in-a-vulvar-cancer-patient-still-receiving-ebrt-with-known-history-of-cystocele-and-who-is-otherwise-hemodynamically-stable weekly 0.8 https://www.themednet.org/how-long-do-you-continue-a-thiazide-diuretic-in-a-patient-with-nephrolithiasis-and-hypercalciuria-who-achieves-normalization-of-urinary-calcium-excretion-following-therapy-initiation weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-endocrine-therapy-to-a-premenopausal-woman-with-early-stage-node-positive-breast-cancer-that-was-er-negative-pr-positive-60-and-her2-positive weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-a-patient-with-tophaceous-gout-who-consistently-has-a-serum-uric-acid-under-5-on-allopurinol-but-continues-to-experience-gout-flares weekly 0.8 https://www.themednet.org/how-long-do-you-treat-with-immunotherapy-patients-with-msi-high-t4b-initially-unresectable-colon-adenocarcinoma weekly 0.8 https://www.themednet.org/do-you-avoid-the-use-of-hydroxychloroquine-in-patients-with-psoriasis-and-or-psoriatic-arthritis weekly 0.8 https://www.themednet.org/how-would-you-approach-bcma-directed-therapy-in-a-patient-with-myeloma-and-renal-failure-on-dialysis weekly 0.8 https://www.themednet.org/is-bone-marrow-biopsy-indicated-in-patients-with-primary-polycythemia-but-negative-for-jak2-mutation-including-exon-12 weekly 0.8 https://www.themednet.org/in-which-patients-do-you-recommend-craniectomy-watch-after-acute-stroke weekly 0.8 https://www.themednet.org/how-frequently-do-you-monitor-urine-protein-levels-in-a-patient-receiving-bevacizumab-who-develops-proteinuria-of-less-than-2-grams-per-day weekly 0.8 https://www.themednet.org/do-you-recommend-discontinuing-ivig-for-a-newly-diagnosed-hmgcr-statin-induced-necrotizing-myopathy-who-developed-a-recent-brachial-dvt weekly 0.8 https://www.themednet.org/would-you-alter-radiation-recommendations-for-a-patient-with-locally-advanced-rectal-cancer-and-a-history-of-abdominopelvic-lymphoma-radiation-40-years-ago weekly 0.8 https://www.themednet.org/would-you-offer-prostate-sbrt-to-a-patient-who-cannot-have-an-mri weekly 0.8 https://www.themednet.org/would-a-surgical-decompression-be-indicated-in-a-patient-with-amyloidosis-and-severe-median-neuropathy-at-the-wrist weekly 0.8 https://www.themednet.org/how-would-you-treat-synchronous-high-risk-prostate-and-rectal-adenocarcinomas-in-an-elderly-man-where-the-rectal-cancer-was-resected-secondary-to-obstruction-t3n0 weekly 0.8 https://www.themednet.org/what-is-your-outpatient-approach-to-patients-with-new-onset-paroxysmal-atrial-fibrillation-in-the-setting-of-acute-illness-but-who-are-otherwise-asymptomatic-with-normal-sinus-rhythm-post-hospital-discharge weekly 0.8 https://www.themednet.org/how-have-you-incorporated-biologics-targeting-the-il-36-pathway-e-g-spevigo-into-your-treatment-algorithm-for-psoriasis weekly 0.8 https://www.themednet.org/what-continuous-duration-of-device-defined-atrial-fibrillation-burden-warrants-initiation-of-anticoagulation-if-the-patient-qualifies-by-cha2ds2-vasc-score weekly 0.8 https://www.themednet.org/would-you-perform-plasmapheresis-for-an-abo-incompatible-kidney-transplant-recipient-who-has-titers-of-1-16-and-a-stable-creatinine-3-months-post-transplant weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-therapy-for-metastatic-cholangiocarcinoma-if-the-patient-is-cisplatin-ineligible-or-cisplatin-is-unavailable weekly 0.8 https://www.themednet.org/do-you-discontinue-proning-due-to-a-perceived-lack-of-response-to-intervention-in-a-patient-with-ards weekly 0.8 https://www.themednet.org/what-is-your-recommended-radiation-field-in-early-stage-vulvar-cancer-t1a-b-with-myelosuppression-inconclusive-slnbx-and-persistent-positive-margins weekly 0.8 https://www.themednet.org/do-you-increase-sedation-or-consider-the-use-of-neuromuscular-blockade-to-prevent-potential-self-induced-lung-injury-in-patients-with-high-respiratory-drive weekly 0.8 https://www.themednet.org/what-toxicities-related-to-mirvetuximab-have-you-seen-in-your-patients-and-how-have-you-managed-them weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-premenopausal-woman-with-oi-with-a-new-compression-fracture weekly 0.8 https://www.themednet.org/would-you-have-any-concerns-about-giving-pelvic-radiation-in-someone-with-a-previous-history-of-receipt-of-hipec weekly 0.8 https://www.themednet.org/how-do-you-instruct-patients-taking-sucralfate weekly 0.8 https://www.themednet.org/how-do-you-manage-igm-related-peripheral-neuropathy weekly 0.8 https://www.themednet.org/how-would-you-treat-stage-iii-unresectable-adenocarcinoma-of-the-lung-with-a-braf-v600e-mutation weekly 0.8 https://www.themednet.org/how-are-you-navigating-approval-of-cpap-for-patients-with-a-high-suspicion-for-osa-on-chronic-oxygen-who-are-unable-to-complete-an-in-lab-psg weekly 0.8 https://www.themednet.org/do-you-resume-rt-for-ls-sclc-after-a-prolonged-break weekly 0.8 https://www.themednet.org/would-you-consider-maintenance-immunotherapy-after-cisplatin-gemcitabine-chemotherapy-and-chemort-for-stage-3-bladder-cancer-in-a-patient-declining-cystectomy-or-who-is-a-poor-surgical-candidate weekly 0.8 https://www.themednet.org/are-there-biomarkers-or-other-factors-to-help-predict-which-patients-with-mcl-are-most-likely-to-benefit-or-not-from-pirtobrutinib-following-a-prior-covalent-btki weekly 0.8 https://www.themednet.org/what-subsequent-therapies-did-patients-receive-after-progressing-on-pirtobrutinib-in-the-mantle-cell-bruin-trial-population weekly 0.8 https://www.themednet.org/how-do-you-manage-immunotherapy-induced-myasthenia-gravis weekly 0.8 https://www.themednet.org/do-you-recommend-immediate-catheter-removal-or-anticoagulating-for-a-certain-amount-of-time-before-removing-the-tunneled-dialysis-catheter-of-a-patient-with-an-incidentally-found-asymptomatic-thrombus-at-the-end-of-the-catheter-that-does-not-interfere-wit weekly 0.8 https://www.themednet.org/would-you-consider-dual-antiplatelet-therapy-for-stroke-prevention-for-icad-in-patients-with-a-history-of-sah weekly 0.8 https://www.themednet.org/what-imaging-do-you-recommend-for-patients-with-suspected-csf-leak weekly 0.8 https://www.themednet.org/would-you-consider-lifelong-versus-short-term-i-e-several-months-course-of-anticoagulation-for-patients-with-elevated-chadsvasc-score-presenting-with-newly-diagnosed-paroxysmal-atrial-fibrillation-triggered-in-the-setting-of-acute-illness-i-e-tachyarrhyth weekly 0.8 https://www.themednet.org/what-is-the-appropriate-cardiac-work-up-and-management-for-an-otherwise-healthy-individual-who-has-experienced-immersion-pulmonary-edema-while-scuba-diving weekly 0.8 https://www.themednet.org/how-do-you-approach-hs-patients-with-persistent-hs-lesions-on-the-trunk weekly 0.8 https://www.themednet.org/which-patients-with-relapsed-refractory-nhl-are-appropriate-for-pre-car-t-bridging-radiation-therapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-crowned-dens-syndrome weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-intradialytic-cramping-that-recurs-despite-multiple-dry-weight-adjustments-in-a-patient-with-eskd weekly 0.8 https://www.themednet.org/what-laser-and-topical-therapies-have-you-found-to-be-most-effective-for-post-inflammatory-hyperpigmentation-from-acne weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-vaginal-cuff-radiation-in-patients-with-prior-definitive-pelvic-radiation-therapy weekly 0.8 https://www.themednet.org/can-you-give-pluvicto-with-concurrent-palliative-ebrt weekly 0.8 https://www.themednet.org/for-patients-who-require-aggressive-debulking-in-multiple-myeloma-what-is-your-preferred-chemotherapy-regimen-and-why weekly 0.8 https://www.themednet.org/will-you-recommend-pirtobrutinib-following-a-prior-covalent-btki-in-patients-with-cardiac-comorbidities weekly 0.8 https://www.themednet.org/how-do-you-treat-a-patient-with-warfarin-failure-with-therapeutic-inr-2-3-at-the-time-of-dvt-and-no-underlying-malignancy-or-hypercoagulable-state weekly 0.8 https://www.themednet.org/do-you-avoid-ssris-in-patients-with-a-history-of-rcvs weekly 0.8 https://www.themednet.org/how-do-you-manage-gi-side-effects-related-to-cftr-modulator-therapy weekly 0.8 https://www.themednet.org/what-are-the-next-steps-in-the-management-of-a-patient-admitted-with-an-ipf-exacerbation-resistant-to-steroid-therapy weekly 0.8 https://www.themednet.org/what-bed10-do-you-aim-for-when-prescribing-hypofractionated-treatment-for-ultra-central-tumors-of-the-lung weekly 0.8 https://www.themednet.org/what-treatments-do-you-recommend-and-how-do-you-counsel-patients-with-postpartum-hair-loss weekly 0.8 https://www.themednet.org/based-on-the-data-from-gy018-and-ruby-do-you-offer-immunotherapy-in-addition-to-carboplatin-paclitaxel-first-line-to-all-patients-with-advanced-endometrial-cancer-who-qualify-or-only-to-those-whose-tumors-are-mmr-protein-deficient weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-stage-iii-gastric-cancer-and-poor-performance-status-who-had-large-residual-disease-ypt4n1-after-neoadjuvant-capecitabine-and-was-later-found-to-be-msi-h weekly 0.8 https://www.themednet.org/what-would-your-next-line-of-treatment-be-for-a-patient-with-hb-sc-with-history-of-recurrent-voc-and-new-bone-infarct-who-is-already-on-hydroxyurea-and-phlebotomy weekly 0.8 https://www.themednet.org/are-there-reasons-to-not-use-prostate-sbrt-when-treating-the-prostate-proximal-sv weekly 0.8 https://www.themednet.org/how-would-you-approach-a-woman-with-apla-but-no-thrombosis-apls-a-history-of-itp-without-bleeding-who-is-now-pregnant weekly 0.8 https://www.themednet.org/do-you-recommend-pregnancy-testing-for-female-patients-with-recurrent-nephrolithiasis-for-whom-you-are-considering-a-ct-stone-scan-for-routine-stone-surveillance weekly 0.8 https://www.themednet.org/with-the-increasing-availability-of-biosimilars-and-their-adoption-onto-payer-formularies-how-do-you-approach-selection-among-available-biosimilars-in-clinical-practice weekly 0.8 https://www.themednet.org/for-a-patient-with-metastatic-melanoma-with-small-asymptomatic-brain-mets-what-is-your-preferred-systemic-therapy weekly 0.8 https://www.themednet.org/what-dose-and-treatment-area-of-radiation-should-be-given-when-p16-hpv-ish-negative-scc-is-found-in-the-scar-of-a-level-v-lymph-node-excisional-biopsy-with-all-other-workup-negative weekly 0.8 https://www.themednet.org/how-are-you-treating-msi-h-crc-in-a-liver-transplant-recipient-on-tacrolimus-sirolimus weekly 0.8 https://www.themednet.org/would-you-recommend-getting-a-pet-scan-or-iodine-whoe-body-scan-in-someone-with-recurrence-of-thyroid-cancer-in-the-neck-if-theyve-had-thyroidectomy-in-the-past-and-2-iodine-ablations-10-years-ago weekly 0.8 https://www.themednet.org/how-do-you-convert-between-tetrabenazine-deutetrabenazine-or-valbenazine-for-management-of-tardive-dyskinesia weekly 0.8 https://www.themednet.org/what-strategies-have-you-found-most-effective-in-improving-long-term-medication-adherence-in-patients-with-sle weekly 0.8 https://www.themednet.org/can-symptomatic-radiation-pneumonitis-ever-improve-spontaneously-without-corticosteroids weekly 0.8 https://www.themednet.org/do-you-offer-consolidation-durvalumab-in-a-patient-who-had-pneumonitis-requiring-steroids-following-chemoradiation-for-ls-sclc weekly 0.8 https://www.themednet.org/which-clinical-or-imaging-features-of-cerebral-amyloid-angiopathy-aid-in-predicting-future-risk-of-intracerebral-hemorrhage weekly 0.8 https://www.themednet.org/what-clinical-features-predict-visual-recovery-from-optic-neuritis-in-nmosd weekly 0.8 https://www.themednet.org/for-patients-with-evidence-of-prior-bilateral-uveitis-ps-pupillary-membranes-inactive-kp-no-view-posteriorly-who-reports-no-prior-symptoms-and-who-has-had-negative-lab-work-up-when-do-you-consider-repeat-work-up-and-which-labs-would-you-repeat weekly 0.8 https://www.themednet.org/what-is-the-evidence-if-any-for-the-use-of-low-dose-naltrexone-in-the-treatment-of-autoimmune-thyroiditis weekly 0.8 https://www.themednet.org/What-minimum-clinical-features-or-risk-factors-drive-you-to-obtain-a-baseline-HRCT-in-a-patient-with-RA-or-Sjogren's-disease weekly 0.8 https://www.themednet.org/What-findings-on-routine-monitoring-PFTs-prompt-you-to-pursue-HRCT-in-your-patients-with-SARDs weekly 0.8 https://www.themednet.org/in-an-older-adult-hospitalized-with-recurrent-falls-weight-loss-without-clear-injuries-but-with-an-inconsistent-or-difficult-to-reach-caregiver-what-findings-would-make-you-formally-report-suspected-elder-neglect-and-or-abuse weekly 0.8 https://www.themednet.org/in-what-scenarios-do-you-use-a-chromogenic-factor-x-assay-in-adjusting-inr-goals-for-patients-on-warfarin weekly 0.8 https://www.themednet.org/can-you-safely-use-a-cephalosporin-in-a-patient-who-previously-developed-acute-interstitial-nephritis-to-amoxicillin weekly 0.8 https://www.themednet.org/how-do-you-sequence-pluvicto-vs-docetaxel-in-a-fit-chemotherapy-naive-patient-with-high-volume-psma-avid-mcrpc-progressing-on-an-arpi weekly 0.8 https://www.themednet.org/does-the-possibility-of-future-lu-177-psma-therapy-change-your-current-threshold-to-offer-earlier-metastasis-directed-rt-in-oligometastatic-prostate-cancer weekly 0.8 https://www.themednet.org/in-mcrpc-patients-who-had-an-initial-response-to-pluvicto-but-progress-within-12-months-where-do-you-position-psma-radioligand-retreatment-relative-to-other-next-line-systemic-options-in-your-sequencing-strategy weekly 0.8 https://www.themednet.org/what-are-your-go-to-medical-management-options-for-high-ileostomy-output-in-patients-with-100-cm-of-remaining-small-bowel weekly 0.8 https://www.themednet.org/for-a-patient-s-p-laryngectomy-or-any-post-op-h-n-malignancy-requiring-post-operative-chemoradiotherapy-for-positive-margins-would-you-start-radiotherapy-6-weeks-s-p-surgery-if-there-is-a-delay-in-concurrent-chemotherapy-or-would-you-wait-for-chemotherapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-pregnant-patients-with-type-2b-von-willebrand-disease-particularly-when-thrombocytopenia-is-already-present weekly 0.8 https://www.themednet.org/what-is-your-approach-for-tapering-steroids-after-craniotomy-for-tumor-resection weekly 0.8 https://www.themednet.org/under-what-circumstances-do-you-utilize-an-evd-rather-than-a-lumbar-drain-for-management-of-csf-leak-after-a-transphenoidal-resection weekly 0.8 https://www.themednet.org/for-patients-with-hydrocephalus-secondary-to-leptomeningeal-disease-how-do-you-determine-what-type-of-shunt-device-to-place weekly 0.8 https://www.themednet.org/how-do-you-determine-when-to-transition-a-patient-with-a-shunt-placed-at-birth-to-an-adult-provider weekly 0.8 https://www.themednet.org/when-placing-a-shunt-at-birth-for-hydrocephalus-secondary-to-ivh-how-do-you-decide-between-a-programmable-and-non-programmable-shunt weekly 0.8 https://www.themednet.org/for-suspected-drug-induced-autoimmune-like-hepatitis-after-the-culprit-drug-is-stopped-and-there-is-no-advanced-fibrosis-how-do-you-decide-immunosuppression-duration-and-the-relapse-free-follow-up-interval-needed-to-confidently-label-it-di-alh-rather-than weekly 0.8 https://www.themednet.org/if-you-perform-skin-testing-for-a-penicillin-allergy-do-you-find-skin-prick-testing-necessary-or-do-you-only-perform-intradermal-testing weekly 0.8 https://www.themednet.org/how-do-you-decide-between-empiric-carvedilol-versus-obtaining-hvpg-to-confirm-csph-when-noninvasive-markers-suggest-csph-but-there-is-limited-hemodynamic-renal-reserve-borderline-map-and-or-ckd weekly 0.8 https://www.themednet.org/after-major-non-cardiac-surgery-in-high-risk-older-adults-do-you-routinely-check-post-operative-troponins-to-screen-for-myocardial-injury weekly 0.8 https://www.themednet.org/which-patients-with-mild-cognitive-impairment-do-you-consider-referring-for-amyloid-targeted-therapy weekly 0.8 https://www.themednet.org/how-do-you-determine-the-appropriate-level-of-care-for-an-adolescent-with-a-substance-use-disorder weekly 0.8 https://www.themednet.org/do-you-still-routinely-offer-post-op-radiation-after-bone-fixation weekly 0.8 https://www.themednet.org/how-do-you-decide-between-neoadjuvant-chemotherapy-vs-neoadjuvant-radiation-in-a-patient-with-endometrial-cancer-not-amenable-to-surgical-resection-due-to-cervical-involvement weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-alcoholic-cirrhosis-and-iga-nephropathy-with-high-risk-features-including-nephrotic-range-proteinuria-microscopic-hematuria-and-declining-egfr weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-chemotherapy-for-a-patient-with-serous-endometrial-cancer-initially-treated-with-neoadjuvant-radiation-due-to-cervical-involvement-precluding-surgical-resection-who-is-now-s-p-hysterectomy-bso-lnd-omentectomy-with-only-small-a weekly 0.8 https://www.themednet.org/i-have-a-patient-with-1-microhemorrhage-on-mri-at-baseline-and-i-started-her-on-kisunla-she-does-not-meet-criteria-for-caa-but-would-you-choose-kisunla-or-leqembi-for-her-care-she-is-apoe-3-3 weekly 0.8 https://www.themednet.org/what-minimum-inpatient-monitoring-and-discharge-criteria-should-be-required-after-single-high-dose-liposomal-amphotericin-b-induction-for-hiv-associated-cryptococcal-meningitis-when-the-patient-has-persistent-intracranial-hypertension-requiring-serial-lum weekly 0.8 https://www.themednet.org/patients-have-been-asking-me-more-frequently-about-the-risk-of-dementia-after-taking-a-statin-drug-long-term-i-am-unaware-of-any-data-that-supports-that-concern-is-there-any-objective-data-that-we-can-recite-to-relieve-patients-concerns-about-this-potenti weekly 0.8 https://www.themednet.org/would-you-offer-other-antibody-drug-conjugates-to-a-patient-who-had-a-history-of-g2-trastuzumab-deruxtecan-induced-pneumonitis-that-is-now-resolved weekly 0.8 https://www.themednet.org/how-do-you-choose-between-grenz-ray-in-a-short-course-e-g-5-7-fractions-versus-longer-course-superficial-megavoltage-external-beam-regimens-for-large-ill-defined-lentigo-maligna-on-the-cheek-when-surgery-is-not-feasible weekly 0.8 https://www.themednet.org/how-do-you-use-objective-sarcopenia-frailty-measures-during-liver-transplant-evaluation-to-decide-between-expedited-listing-versus-a-defined-period-of-prehabilitation-before-listing weekly 0.8 https://www.themednet.org/how-do-you-differentiate-major-depressive-disorder-from-baseline-functioning-in-adults-with-intellectual-disabilities weekly 0.8 https://www.themednet.org/how-do-you-approach-antidepressant-selection-in-patients-with-prolonged-qtc weekly 0.8 https://www.themednet.org/will-you-extrapolate-eortc-1333-peace-3-enzalutamide-rad223-to-any-other-non-abi-arpis-for-mcrpc weekly 0.8 https://www.themednet.org/in-alcohol-related-cirrhosis-with-social-barriers-i-e-lack-of-insurance-homelessness-limiting-follow-up-how-do-you-approach-management-of-esophageal-variceal-bleeding-after-the-inpatient-egd-with-banding weekly 0.8 https://www.themednet.org/when-pulmonary-vasodilator-therapy-lowers-pvr-to-transplant-targets-but-causes-systemic-hypotension-or-worsening-renal-perfusion-in-decompensated-cirrhosis-how-do-you-adjust-therapy-dose-reduction-agent-change-accepting-higher-pvr-while-preserving-both-he weekly 0.8 https://www.themednet.org/when-do-you-consider-changing-a-patients-levothyroxine-dose-during-hospitalization-due-to-abnormal-tfts-but-without-clinical-evidence-of-thyrotoxicosis-or-hypothyroidism weekly 0.8 https://www.themednet.org/in-advanced-parkinsons-disease-how-should-clinicians-assess-symptom-management-and-quality-of-life-when-patients-are-no-longer-able-to-communicate-themselves weekly 0.8 https://www.themednet.org/how-is-your-approach-to-a-patient-referred-for-radiotherapy-for-keloids-with-a-history-of-beals-syndrome weekly 0.8 https://www.themednet.org/how-do-you-approach-evaluation-of-a-patient-referred-for-mononeuritis-multiplex-and-ssb weekly 0.8 https://www.themednet.org/Would-you-treat-a-child-with-a-subtotally-resected-atypical-choroid-plexus-tumor weekly 0.8 https://www.themednet.org/how-do-you-determine-which-patient-may-be-a-good-candidate-for-the-aurora-ev-icd-and-its-smart-sense-algorithm weekly 0.8 https://www.themednet.org/would-you-consider-a-shorter-course-of-romosozumab-3-months-followed-by-maintenance-therapy-given-recent-evidence-that-it-is-noninferior-to-12-months-of-therapy-for-treatment-of-severe-osteoporosis weekly 0.8 https://www.themednet.org/are-there-specific-types-brands-of-drug-eluting-stent-you-prefer-that-perform-well-in-terms-of-lower-isr-rates-or-ones-that-are-better-for-patients-with-high-bleeding-risk weekly 0.8 https://www.themednet.org/do-you-see-glp-1-receptor-agonists-as-a-potential-adjunctive-therapy-in-patients-with-t2-low-asthma-and-obesity-who-remain-symptomatic-on-ics-laba-prior-to-escalation-to-tezepelumab weekly 0.8 https://www.themednet.org/how-do-you-approach-buprenorphine-dosing-and-titration-in-older-adults-with-opioid-use-disorder weekly 0.8 https://www.themednet.org/how-do-you-counsel-eligible-patients-on-lung-cancer-screening-who-are-hesitant-because-of-the-cancer-risk-from-ct-scans weekly 0.8 https://www.themednet.org/what-clinical-features-prompt-genetic-testing-for-patients-with-progressive-cerebellar-ataxia weekly 0.8 https://www.themednet.org/how-if-at-all-have-you-changed-your-approach-to-the-use-of-escitalopram-for-agitation-in-alzheimers-dementia-based-on-results-from-the-s-citad-rct weekly 0.8 https://www.themednet.org/what-1l-treatment-would-you-use-for-a-patient-with-newly-diagnosed-lung-adenocarcinoma-whose-cancer-has-both-an-egfr-exon-19-deletion-and-mutation-in-the-extracellular-portion-of-erbb2-that-is-predicted-to-be-activating-s310f weekly 0.8 https://www.themednet.org/do-the-poseidon-meta-analysis-results-influence-your-decision-on-which-patients-receive-hormone-therapy-with-post-operative-radiotherapy-for-recurrent-prostate-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-chemotherapy-backbone-when-combining-with-encorafenib-cetuximab-in-the-1l-setting-for-braf-v600e-mutant-mcrc weekly 0.8 https://www.themednet.org/what-is-the-comfort-level-with-transitioning-to-a-subcutaneous-maintainance-with-infliximab-in-a-patient-who-responded-to-inpatient-infliximab-in-the-background-of-prior-endoscopic-remission-to-entyvio-and-then-losing-response-requiring-hospitalization-fo weekly 0.8 https://www.themednet.org/would-you-use-ct-planning-to-treat-a-large-keloid-of-the-scalp-post-operatively-or-do-units-still-use-clinical-markups-for-keloids-even-in-case-where-the-keloid-is-near-sensitive-structure weekly 0.8 https://www.themednet.org/when-prescribing-smart-regimen-for-new-diagnosis-of-asthma-do-you-still-prescribe-rescue-inhaler-ie-saba-if-they-dont-have-it weekly 0.8 https://www.themednet.org/how-do-you-approach-disposition-planning-when-a-patient-makes-homicidal-threats-on-admission-but-later-recants weekly 0.8 https://www.themednet.org/what-workup-do-you-consider-necessary-for-medical-clearance-when-patients-present-with-altered-mental-status-and-possible-psychiatric-illness weekly 0.8 https://www.themednet.org/how-often-do-you-check-serum-glucose-and-lipid-levels-after-starting-a-thiazide-diuretic-for-patients-with-recurrent-calcium-based-nephrolithiasis weekly 0.8 https://www.themednet.org/do-you-routinely-supplement-folic-acid-in-patients-with-rheumatoid-arthritis-who-are-taking-sulfasalazine weekly 0.8 https://www.themednet.org/for-a-pediatric-patient-with-juvenile-spondyloarthropathy-with-partial-response-though-ongoing-axial-disease-on-a-jaki-would-you-increase-the-dose-of-jaki-add-methotrexate-or-switch-to-alternate-therapy-like-il-17-inhibition-they-previously-failed-tnfi weekly 0.8 https://www.themednet.org/do-you-give-additional-arv-agents-to-a-patient-with-low-level-viremia-to-400-on-cabenuva-injections-previously-undetectable-on-biktarvy-prior-to-switch-with-pan-sensitive-genotype-prior-to-switch-while-awaiting-repeat-genotype-testing-to-prevent-developme weekly 0.8 https://www.themednet.org/which-antidiabetic-agents-would-you-recommend-to-treat-hyperglycemia-secondary-to-pi3k-and-akt-inhibitor-therapy weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiation-to-a-large-solitary-fibrous-tumor-of-the-lung-s-p-wedge-resection-with-close-margins weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-to-a-patient-with-budesonide-refractory-microscopic-colitis-and-multiple-sclerosis weekly 0.8 https://www.themednet.org/how-do-you-approach-surveillance-for-gastric-intestinal-metaplasia-in-a-patient-with-no-risk-factors-for-gastric-cancer weekly 0.8 https://www.themednet.org/in-a-70-y-o-male-with-newly-diagnosed-good-risk-stage-iii-seminoma-with-grade-2-hearing-loss-what-would-recommend-for-chemotherapy-single-agent-carboplatin-auc-10-as-per-alfrangis-et-al weekly 0.8 https://www.themednet.org/how-do-you-determine-disposition-when-a-patient-presents-to-an-outpatient-psychiatry-visit-with-recent-self-injury-that-may-require-medical-attention weekly 0.8 https://www.themednet.org/whats-your-favorite-topical-otc-moisturizer-that-you-recommend-and-why weekly 0.8 https://www.themednet.org/in-your-clinical-practice-how-are-you-approaching-consideration-to-limbic-predominant-age-related-tdp-43-encephalopathy-late-in-the-differential-diagnosis-for-older-adults-previously-thought-to-have-alzheimers-disease weekly 0.8 https://www.themednet.org/do-you-aim-to-raise-potassium-to-the-high-normal-range-in-patients-with-icds-who-have-lower-baseline-potassium-to-reduce-ventricular-arrhythmia-risk weekly 0.8 https://www.themednet.org/do-you-still-use-fever-as-a-minor-criterion-when-applying-the-duke-iscvid-criteria-for-infective-endocarditis-given-data-suggesting-diagnostic-accuracy-may-improve-when-it-is-omitted weekly 0.8 https://www.themednet.org/what-is-your-approach-for-managing-patients-with-recurrent-nephrolithiasis-and-hypercalciuria-who-experience-significant-urinary-frequency-symptoms-after-starting-a-thiazide-diuretic weekly 0.8 https://www.themednet.org/do-you-routinely-prescribe-dry-powdered-inhalers-over-metered-dose-inhalers-for-the-purpose-of-addressing-carbon-emissions weekly 0.8 https://www.themednet.org/what-is-the-ideal-time-period-for-adjuvant-radiotherapy-on-merkel-cell-carcinoma-of-the-head-and-neck-region weekly 0.8 https://www.themednet.org/do-you-use-basal-bolus-insulin-rather-than-correctional-insulin-alone-to-manage-hyperglycemia-in-a-hospitalized-older-adult-with-type-2-diabetes-and-significant-frailty-or-dementia weekly 0.8 https://www.themednet.org/how-do-you-approach-cardiac-surveillance-in-an-asymptomatic-adult-who-received-anthracycline-based-chemotherapy-for-a-childhood-cancer-and-presents-to-you-without-an-active-survivorship-program weekly 0.8 https://www.themednet.org/what-is-your-approach-to-antibiotic-selection-for-bacterial-species-that-demonstrate-susceptibility-to-penicillin-cephalosporins-on-testing-but-are-known-to-harbor-inducible-ampc-resistance-e-g-citrobacter-freundii-uti-susceptible-to-piperacillin-tazobact weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-for-the-new-lipid-guidelines-released-today weekly 0.8 https://www.themednet.org/is-thyroglobulin-elevated-in-patients-with-hashimotos-on-full-thyroid-hormone-replacement weekly 0.8 https://www.themednet.org/have-you-stopped-given-pre-medications-prior-to-subcutaneous-darzalex weekly 0.8 https://www.themednet.org/when-do-you-consider-extended-steroid-tapers-for-acute-asthma-or-copd-exacerbations weekly 0.8 https://www.themednet.org/how-should-a-cac-score-of-350-influence-risk-stratification-in-an-asymptomatic-primary-prevention-patient-with-borderline-to-intermediate-ascvd-risk weekly 0.8 https://www.themednet.org/do-you-consider-use-of-antibiotics-in-patients-admitted-with-decompensated-cirrhosis-with-aki-with-creat-1-2-with-ascitic-fluid-protein-1-5-without-sbp-and-or-hyponatremia-bili-3-if-you-do-so-how-long-do-you-recommend-to-continue-that weekly 0.8 https://www.themednet.org/is-there-a-role-for-pursuing-hemochromatosis-genetic-studies-and-liver-biopsy-in-a-young-patient-who-has-persistent-elevation-in-tsat-and-ferritin-1000-after-cessation-of-alcohol-for-significant-amount-of-time-in-the-setting-of-decompensation-diuretic-res weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-patients-with-recurrent-nephrolithiasis-and-hypercalciuria-who-develop-sun-photosensitivity-following-thiazide-diuretic-initiation weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-therapy-for-transfusion-dependent-beta-thalassemia weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-risks-and-benefits-of-chemotherapy-or-radiation-offered-for-palliative-intent weekly 0.8 https://www.themednet.org/a-patient-with-stricturing-crohns-complicated-by-granulomatous-bronchiolitis-with-stenosis-reports-adverse-effect-of-hemoptysis-on-ustekinumab-which-was-therefore-discontinued-should-the-use-of-risankizumab-therefore-be-avoided-given-the-overlap-in-mechan weekly 0.8 https://www.themednet.org/if-there-is-trapped-lung-after-a-thoracentesis-in-an-outpatient-setting-in-a-patient-who-has-stable-vitals-no-dyspnea-is-there-role-of-overnight-observation weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-extend-rituximab-redosing-beyond-a-12-month-interval-for-replasing-multiple-sclerosis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-initiating-naltrexone-in-patients-with-alcohol-use-disorder-and-co-occurring-liver-disease weekly 0.8 https://www.themednet.org/in-the-treatment-of-osteoarthritis-with-low-dose-radiation-therapy-i-e-knee-oa-are-there-data-to-support-the-claim-that-ldrt-does-not-limit-or-preclude-later-orthopedic-surgery weekly 0.8 https://www.themednet.org/should-attr-mutation-with-bilateral-carpal-tunnel-alone-prompt-treatment-with-a-gene-silencing-drug weekly 0.8 https://www.themednet.org/do-you-discuss-fertility-preservation-options-with-all-pediatric-oncology-patients-at-the-time-of-diagnosis-and-if-not-what-determines-who-and-when-you-discuss-options weekly 0.8 https://www.themednet.org/What-is-the-best-way-to-support-a-pediatric-oncology-survivor-with-fears-about-2nd-neoplasm-or-relapse weekly 0.8 https://www.themednet.org/What-resourcesancillary-staff-do-you-utilize-for-school-re-entry-after-cancer-treatment-to-decrease-anxiety-improve-self-confidence-and-support-emotional-functioning weekly 0.8 https://www.themednet.org/What-are-effective-ways-to-improve-complianceinvolvement-in-long-term-survivorship-care-for-patients-particularly-AYA-patients weekly 0.8 https://www.themednet.org/what-data-exist-regarding-treatment-for-facial-erythema-from-dupilumab-in-children-5-years-of-age weekly 0.8 https://www.themednet.org/what-data-exist-regarding-treatment-for-conjunctivitis-from-dupilumab-in-children-5-years-of-age weekly 0.8 https://www.themednet.org/what-gdmt-do-you-recommend-for-patients-with-al-amyloid-systolic-cardiomyopathy weekly 0.8 https://www.themednet.org/how-do-you-approach-requests-from-facilities-requesting-prn-uas-for-changes-in-behavior-or-aggression weekly 0.8 https://www.themednet.org/how-can-being-on-dupixent-for-eczema-affect-food-allergy-skin-and-ige-testing weekly 0.8 https://www.themednet.org/how-do-you-differentiate-portal-hypertensive-ascites-from-multifactorial-volume-overload-when-imaging-shows-only-small-volume-ascites-in-cirrhosis-with-concomitant-cardiac-renal-dysfunction-and-which-findings-most-reliably-drive-your-management weekly 0.8 https://www.themednet.org/how-would-you-manage-sever-proteinuria-in-a-pregnant-lady-diagnosed-with-primary-fsgs-in-her-21st-weeks-of-gestation-other-than-starting-with-high-dose-pred-and-is-what-anti-proteinuric-options-can-be-used-in-pregnancy weekly 0.8 https://www.themednet.org/do-you-recommend-zinc-for-patients-with-advanced-ckd-who-have-dysgeusia weekly 0.8 https://www.themednet.org/what-hypofractionated-short-course-regimens-would-you-consider-for-postoperative-scca-of-the-hand-with-positive-margin-or-residual-small-volume-gross-residual-disease weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-evaluate-for-central-hypothyroidism-in-a-patient-with-low-normal-tsh-and-low-free-t4 weekly 0.8 https://www.themednet.org/in-your-clinical-practice-do-you-find-that-patients-with-moderate-dementia-due-to-alzheimers-see-much-benefit-from-increasing-donepezil-dosing-from-10-mg-day-to-a-higher-dose-such-as-23-mg-day weekly 0.8 https://www.themednet.org/with-appropriate-clinical-symptoms-and-a-hrm-both-in-line-with-the-diagnosis-of-diffuse-esophageal-spasm-or-iem-with-positive-ph-studies-suggesting-gerd-how-long-do-you-consider-treating-gerd-before-you-get-additional-testing-to-rule-out-underlying-achala weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-sgo-2026 weekly 0.8 https://www.themednet.org/do-you-recommend-completing-a-1-mg-dexamethasone-suppression-test-for-an-asymptomatic-incidental-pituitary-microadenoma weekly 0.8 https://www.themednet.org/what-features-would-push-you-towards-re-operation-for-completion-staging-vs-observation-for-a-premenopausal-woman-with-stage-ii-borderline-tumor-of-the-ovary-with-capsule-rupture-and-no-other-evidence-of-gross-residual-disease weekly 0.8 https://www.themednet.org/when-should-lumbar-puncture-be-prioritized-for-patients-with-suspected-guillain-barre-syndrome weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-do-you-not-experience-early-relief-of-hemifacial-spasm-after-microvascular-decompression-surgery weekly 0.8 https://www.themednet.org/is-optimal-timing-of-choroidal-drainage-in-the-case-of-kissing-choroidals-with-hypotony-after-glaucoma-surgery-different-in-a-vitrectomized-eye weekly 0.8 https://www.themednet.org/how-long-do-you-continue-empiric-anaerobic-coverage-for-brain-abscesses-originating-from-sinus-or-tooth-infection weekly 0.8 https://www.themednet.org/how-do-you-differentiate-chronic-membranous-nephropathy-vs-infection-related-gn-in-the-setting-of-borderline-low-complements weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-give-antibiotics-for-an-an-older-adult-receiving-comfort-focused-care-who-develops-signs-of-a-symptomatic-infection weekly 0.8 https://www.themednet.org/is-there-a-role-for-periodic-barium-esophagrams-or-endoscopic-reassessment-in-a-patient-with-a-remote-20-years-history-of-heller-myotomy-for-achalasia-if-they-remain-asymptotic weekly 0.8 https://www.themednet.org/is-the-presence-of-ubiquitin-specific-peptidase-8-usp8-genotype-helpful-in-determining-the-risk-of-cushing-disease-recurrence weekly 0.8 https://www.themednet.org/how-are-you-using-arteraai-in-2026-for-intermediate-risk-patients weekly 0.8 https://www.themednet.org/would-you-use-a-lumbar-drain-in-a-patient-with-spinal-stroke-from-fibrocartilagenous-embolism weekly 0.8 https://www.themednet.org/how-are-you-interpreting-early-results-of-studies-mayari-vita-investigating-a-1l-plex-free-strategy-for-ittp weekly 0.8 https://www.themednet.org/what-is-your-radiotherapy-plan-for-metastatic-pancreatic-tail-adenocarcinoma-biopsy-proven-liver-metastasis-s-p-gem-abraxane-and-folfiri-now-with-oligo-progressive-left-upper-lung-nodule weekly 0.8 https://www.themednet.org/what-is-your-approach-to-atropine-dosing-for-myopia-in-children weekly 0.8 https://www.themednet.org/would-you-provide-focal-therapy-for-a-patient-with-unfavorable-intermediate-risk-prostate-cancer-but-only-one-positive-core-from-a-targeted-lesion-biopsy weekly 0.8 https://www.themednet.org/what-are-treatment-options-for-elderly-patients-with-a-remote-history-of-cystoprostatectomy-with-neobladder-who-are-no-longer-able-to-empty-their-neobladder-fully-are-unable-to-cic-and-are-beginning-to-have-complications-such-as-infection-and-rising-creat weekly 0.8 https://www.themednet.org/how-do-you-bandage-the-penis-after-hypospadias-repair-and-how-long-do-you-leave-the-dressing-in-place weekly 0.8 https://www.themednet.org/until-what-age-do-you-monitor-asymptomatic-boys-with-a-history-of-posterior-urethral-valve-ablation weekly 0.8 https://www.themednet.org/what-pelvic-floor-physical-therapy-resources-do-you-offer-to-patients weekly 0.8 https://www.themednet.org/is-there-a-pvr-cutoff-over-which-you-worry-about-urinary-retention-when-giving-bladder-botox-to-spontaneously-voiding-patients-with-suprapontine-lesions weekly 0.8 https://www.themednet.org/what-medications-do-you-give-patients-prior-to-in-office-vasectomies weekly 0.8 https://www.themednet.org/what-is-your-management-for-persistent-bleeding-and-pain-at-the-donor-site-after-buccal-mucosa-graft weekly 0.8 https://www.themednet.org/do-you-routinely-use-hemostatic-agents-in-the-renal-defect-after-a-partial-nephrectomy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-potential-temporary-and-permanent-side-effects-of-finasteride weekly 0.8 https://www.themednet.org/how-do-you-treat-nocturia-refractory-to-desmopressin weekly 0.8 https://www.themednet.org/how-do-you-contour-the-cauda-equina-for-a-lumbar-spine-sbrt-case-below-the-spinal-cord-do-you-add-a-prv-on-this weekly 0.8 https://www.themednet.org/how-do-you-approach-management-for-recurrent-stone-formers-who-sleep-over-8-hours-per-day-and-fail-to-reach-2-5-liters-of-daily-urine-output-on-24-hour-urine-stone-risk-studies weekly 0.8 https://www.themednet.org/would-you-reload-hormone-therapy-for-prostate-cancer-with-gnrh-antagonist-if-a-patient-had-serum-testosterone-40-checked-several-weeks-after-initial-dose-of-gnrh-agonist weekly 0.8 https://www.themednet.org/how-do-you-feel-the-oral-il-23-icotyde-will-shape-psoriasis-management weekly 0.8 https://www.themednet.org/how-long-do-you-continue-lithium-after-a-singular-lifetime-manic-episode-before-considering-switching-to-a-medication-with-less-long-term-risks weekly 0.8 https://www.themednet.org/does-a-patients-ability-to-get-risk-factors-under-control-influence-your-recommendation-for-surgical-vs-medical-management-of-asymptomatic-carotid-disease weekly 0.8 https://www.themednet.org/what-resources-do-you-find-helpful-for-patients-with-msk-concerns-who-may-not-have-access-to-physical-therapy-or-who-cannot-afford-it weekly 0.8 https://www.themednet.org/what-monitoring-would-you-pursue-in-a-female-patient-with-repeatedly-very-high-titer-centromere-antibodies-but-no-clinical-symptoms-of-systemic-sclerosis-or-other-connective-tissue-disease weekly 0.8 https://www.themednet.org/do-you-discontinue-statin-therapy-when-patients-reach-ldl-levels-way-below-their-target-goal-with-pcsk9-inhibitor-therapy weekly 0.8 https://www.themednet.org/how-long-do-you-observe-for-spontaneous-remission-after-nsaid-discontinuation-before-initiating-corticosteroids-in-a-patient-with-biopsy-confirmed-minimal-change-disease weekly 0.8 https://www.themednet.org/do-you-continue-beta-blocker-therapy-beyond-1-year-after-myocardial-infarction-in-a-stable-patient-with-preserved-ejection-fraction-when-the-only-remaining-indication-is-mildly-elevated-blood-pressure-that-could-be-managed-with-an-alternative-agent weekly 0.8 https://www.themednet.org/do-you-still-recommend-adjunctive-corticosteroids-for-tuberculous-meningitis-in-light-of-more-recent-data-showing-heterogeneity-in-clinical-outcomes weekly 0.8 https://www.themednet.org/what-is-your-approach-to-timing-the-arterial-and-venous-urea-collections-in-a-patient-on-hemodialysis-for-whom-you-are-attempting-to-calculate-arteriovenous-fistula-recirculation weekly 0.8 https://www.themednet.org/do-you-offer-iv-iron-first-line-to-women-with-iron-deficiency-anemia-from-heavy-menstrual-bleeding weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-cannabis-use-for-ptsd weekly 0.8 https://www.themednet.org/how-would-you-treat-a-locally-advanced-rectal-squamous-cell-cancer-with-vaginal-invasion weekly 0.8 https://www.themednet.org/what-is-your-approach-for-testing-speech-in-bilingual-patients-undergoing-an-awake-craniotomy-for-glioma-resection weekly 0.8 https://www.themednet.org/are-there-any-biomarkers-imaging-or-other-clinical-information-that-can-be-used-to-better-choose-effective-therapies-for-super-refractory-status-epilepticus weekly 0.8 https://www.themednet.org/for-stage-0-cll-and-patient-clinically-doing-well-and-stable-and-does-not-need-treatment-do-you-still-obtain-ighv-cll-fish-and-p53-mutation-analysis-or-if-they-can-be-deferred-given-cost weekly 0.8 https://www.themednet.org/do-you-require-an-ecg-to-assess-the-qtc-interval-before-administering-ondansetron-to-a-hospitalized-patient-without-known-cardiac-history-or-qt-prolonging-medications weekly 0.8 https://www.themednet.org/for-microneedling-to-treat-boxcar-scars-how-should-the-needle-be-oriented weekly 0.8 https://www.themednet.org/do-you-routinely-consider-esophageal-biopsies-from-normal-appearing-esophagus-in-patients-with-gerd-without-transit-symptoms weekly 0.8 https://www.themednet.org/for-large-infantile-hemangiomas-treated-with-timolol-do-you-have-any-concerns-about-systemic-absorption weekly 0.8 https://www.themednet.org/when-to-cover-for-carbapenem-resistance-in-patient-with-acinetobacter-infection-when-choosing-initial-broad-spectrum-antibiotic weekly 0.8 https://www.themednet.org/for-relapsed-myeloma-patients-what-percentage-of-plasma-cells-in-the-marrow-under-which-below-do-you-feel-comfortable-giving-car-t-therapy weekly 0.8 https://www.themednet.org/are-there-any-serum-markers-that-can-be-used-to-measure-disease-response-to-multiple-sclerosis-therapies weekly 0.8 https://www.themednet.org/what-if-any-po-suppression-options-would-you-consider-for-a-patient-with-history-of-recurrent-esbl-e-coli-bacteremia-with-relapsed-esbl-e-coli-lumbar-spinal-hardware-infection-he-previously-underwent-lumbar-i-d-with-hardware-retention-and-is-not-a-candida weekly 0.8 https://www.themednet.org/is-there-a-greater-efficacy-of-doptelet-in-patients-who-have-undergone-a-splenectomy weekly 0.8 https://www.themednet.org/which-biologics-for-severe-ra-are-safe-in-ckd4 weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-initiate-semaglutide-for-mash-when-alcohol-intake-is-near-masld-metald-boundary-ranges-or-fluctuates-with-intermittently-positive-peth-specifically-do-you-require-a-documented-period-of-reduction-abstinence-before-treatment-or weekly 0.8 https://www.themednet.org/pancreatic-carcinoid-with-margins-adjuvant-therapy-surveillance weekly 0.8 https://www.themednet.org/do-you-hold-renin-angiotensin-system-blockade-at-the-time-of-kidney-transplant-and-restart-it-only-once-graft-function-is-established-or-do-you-continue-it-through-the-perioperative-period weekly 0.8 https://www.themednet.org/do-you-use-low-dose-clonidine-prn-for-anxiety-what-dose-do-you-use-and-what-do-you-tell-patients-re-fluctuating-use weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-requesting-prescription-sleep-aids-such-as-trazodone-quetiapine-or-olanzapine-at-discharge-after-they-have-found-them-beneficial-during-a-prolonged-hospitalization weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-diabetes-on-the-risks-of-cannabis-use weekly 0.8 https://www.themednet.org/when-to-suspect-nonconvulsive-antiepilepsy-in-patient-with-altered-mental-status weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-recommend-non-surgical-management-of-bowens-disease-in-light-of-long-term-data-showing-very-low-risk-of-invasive-cscc-after-treatment-with-5-fu-as-compared-to-surgical-excision weekly 0.8 https://www.themednet.org/when-do-you-check-thoracic-paraspinals-on-needle-emg-in-suspected-myopathy-or-myositis weekly 0.8 https://www.themednet.org/how-do-you-decide-who-to-rechallenge-clozapine-after-it-was-discontinued-for-a-neutropenic-episode weekly 0.8 https://www.themednet.org/would-you-recommend-a-diuretic-renogram-prior-to-planned-unilateral-nephrectomy-for-renal-cell-carcinoma-in-a-patient-with-normal-kidney-sizes-bilaterally weekly 0.8 https://www.themednet.org/How-do-you-manage-high-threshold-food-allergies-beyond-strict-avoidance weekly 0.8 https://www.themednet.org/What-is-the-consensus-on-the-size-of-the-expansion-from-the-gross-tumor-volume-(CTV)-to-the-clinical-target-volume-(PTV)-in-treating-intact-supraglottic-squamous-cell-carcinoma-with-radiotherapy weekly 0.8 https://www.themednet.org/what-guides-your-decision-whether-to-complete-a-full-course-of-intrapleural-alteplase-dornase-versus-proceeding-to-surgical-decortication-when-a-patient-continues-to-worsen-or-does-not-adequately-improve-with-intrapleural-therapy weekly 0.8 https://www.themednet.org/what-clinical-features-guide-your-choice-between-ketamine-and-etomidate-in-patients-with-septic-shock-who-require-rapid-sequence-intubation-given-recent-data-suggesting-no-difference-in-28-day-mortality weekly 0.8 https://www.themednet.org/how-does-the-extended-pfs-data-4-year-median-with-taletrectinib-impact-your-choice-of-frontline-therapy-and-subsequent-sequencing-approach-for-ros1-nsclc weekly 0.8 https://www.themednet.org/would-you-start-sodium-citrate-for-patients-with-advanced-chronic-kidney-disease-and-metabolic-acidosis-who-fail-to-reach-serum-bicarbonate-target-despite-high-doses-of-sodium-bicarbonate weekly 0.8 https://www.themednet.org/do-you-prefer-switching-to-a-biologic-with-a-different-mechanism-of-action-such-as-an-il-17-inhibitor-over-cycling-to-another-tnf-inhibitor-in-a-patient-with-moderate-to-severe-hs-who-has-experienced-secondary-failure-to-adalimumab-after-an-initial-good-r weekly 0.8 https://www.themednet.org/do-you-generally-switch-aspirin-to-another-antiplatelet-agent-if-a-patient-has-a-non-embolic-ischemic-stroke-and-isnt-a-candidate-for-dapt weekly 0.8 https://www.themednet.org/do-you-recommend-multisite-testing-for-gonorrhea-and-chlamydia-as-a-default-screening-strategy-in-sexually-active-women-regardless-of-reported-sexual-exposures weekly 0.8 https://www.themednet.org/if-i-have-a-patient-with-seropositive-high-titer-ccp-rf-rheumatoid-arthritis-that-was-previously-on-tnfi-with-high-titer-ana-and-dsdna-crithida-1-2560-chromatin-histone-should-i-assume-this-is-tnfi-drug-induced-lupus-apart-from-hcq-any-other-treatment-nee weekly 0.8 https://www.themednet.org/how-do-you-choose-between-a-ppar-agonist-obeticholic-acid-or-a-fibrate-as-second-line-therapy-in-pbc-with-optimized-ursodeoxycholic-acid-when-the-immediate-priority-is-clinically-significant-pruritus-but-you-also-want-to-optimize-long-term-biochemical-ris weekly 0.8 https://www.themednet.org/can-contrast-instilled-through-a-displaced-peg-tube-that-extravasates-into-the-abdomen-cause-acute-kidney-injury weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-decompression-alone-for-a-stable-grade-1-spondylolisthesis-at-l5-s1 weekly 0.8 https://www.themednet.org/what-is-your-approach-to-clearing-the-cervical-spine-in-intubated-patients-more-than-24-hours-after-their-initial-injury weekly 0.8 https://www.themednet.org/do-you-recommend-surveillance-mri-for-patients-with-mogad weekly 0.8 https://www.themednet.org/when-do-you-check-lp-a-in-patients-with-first-time-ischemic-stroke weekly 0.8 https://www.themednet.org/how-do-you-taper-dopamine-agonists-for-rls-in-patients-experiencing-augmentation weekly 0.8 https://www.themednet.org/what-is-the-minimum-headache-or-migraine-days-per-month-that-you-would-consider-starting-preventative-migraine-therapy weekly 0.8 https://www.themednet.org/How-do-you-if-you-do-stack-procedures-(combine-iStent-and-iDose-ect.)-in-one-sitting weekly 0.8 https://www.themednet.org/what-are-some-considerations-when-deciding-to-do-dropless-cataract-surgery-and-what-are-your-preferred-agents weekly 0.8 https://www.themednet.org/how-do-you-determine-the-duration-and-taper-of-systemic-corticosteroids-when-you-add-them-alongside-antibiotics-for-orbital-cellulitis weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-young-adult-patient-with-a-residual-hypermetabolic-mass-after-resection-of-a-solitary-jejunal-myeloblastic-sarcoma weekly 0.8 https://www.themednet.org/is-there-a-time-frame-in-which-you-would-no-longer-consider-a-prior-vein-mapping-study-reliable-and-thus-recommend-repeating-the-test-in-a-patient-with-advanced-chronic-kidney-disease-who-requires-evaluation-for-fistula-placement weekly 0.8 https://www.themednet.org/for-a-patient-with-advanced-serous-fallopian-tube-carcinoma-involving-the-uterus-cervix-and-vagina-who-is-now-s-p-interval-debulking-surgery-would-you-offer-adjuvant-radiation-if-the-upper-vaginectomy-margin-was-positive weekly 0.8 https://www.themednet.org/how-long-do-you-treat-uncomplicated-streptococcal-bacteremia weekly 0.8 https://www.themednet.org/Are-there-any-patients-that-you-would-not-give-Sacituzumab-and-Pembrolizumab-In-a-patient-who-has-had-an-excellent-response-would-you-ever-stop-the-Trodelvy-and-continue-the-Pembrolizumab weekly 0.8 https://www.themednet.org/do-you-add-empiric-anti-mrsa-coverage-to-the-initial-antibiotic-regimen-for-a-patient-admitted-with-community-acquired-pneumonia-who-has-risk-factors-for-mrsa-but-a-negative-mrsa-nasal-screen weekly 0.8 https://www.themednet.org/how-are-you-approaching-patient-selection-and-timing-of-rna-based-ngs-in-light-of-the-approval-of-zenocutuzumab-for-nrg1-fusion-positive-advanced-cholangiocarcinoma weekly 0.8 https://www.themednet.org/do-you-recommend-starting-a-statin-in-youth-greater-than-10-years-old-with-type-1-diabetes-mellitus-and-ldl-cholesterol-levels-greater-than-130 weekly 0.8 https://www.themednet.org/when-noninvasive-tests-are-discordant-e-g-low-fib-4-but-elevated-vcte-and-elf-what-is-your-decision-algorithm-for-initiating-a-glp-1-receptor-agonist-for-mash-and-what-specific-discordance-threshold-makes-you-revert-to-biopsy weekly 0.8 https://www.themednet.org/in-young-non-cirrhotic-hbv-hdv-coinfection-with-minimal-fibrosis-on-elastography-do-you-perform-lifelong-6-month-hcc-surveillance-based-on-hdv-status-alone-or-do-you-modulate-surveillance-intensity-based-on-fibrosis-trajectory-and-treatment-response weekly 0.8 https://www.themednet.org/Should-ASPECTS-be-used-to-determine-eligiblity-for-thrombolysis-beyond-4.5-hours weekly 0.8 https://www.themednet.org/how-often-if-at-all-do-you-monitor-a-cbc-with-differential-to-assess-peripheral-eosinophilia-in-patients-with-type-2-inflammatory-asthma-who-have-been-started-on-dupilumab weekly 0.8 https://www.themednet.org/in-patients-with-endometrial-hyperplasia-already-on-a-glp-1-ra-how-if-at-all-does-the-data-around-glp-1-ras-and-endometrial-cancer-risk-influence-your-management weekly 0.8 https://www.themednet.org/Do-you-think-we-can-extrapolate-the-results-of-TOGETHER-PsA-and-expect-similar-results-and-safety-when-adding-Tirzepatide-to-another-IL-17-inhibitor-or-to-a-bDMARD-with-different-mechanism-of-action weekly 0.8 https://www.themednet.org/How-will-you-approach-tapering-of-therapy-in-a-patient-with-PsA-who-has-responded-well-to-tirzepatide-and-ixekizumab-and-has-maintained-disease-remission-for-several-years weekly 0.8 https://www.themednet.org/for-those-of-you-with-cobenfy-prescribing-experience-whats-your-real-world-impression-of-it-where-does-it-fit-in-your-treatment-algorithm-what-fraction-of-starts-are-still-on-it-after-a-few-months-and-whats-the-main-reason-patients-discontinue-when-they-d weekly 0.8 https://www.themednet.org/for-a-patient-with-suspected-post-streptococcal-reactive-arthritis-who-does-not-meet-criteria-for-acute-rheumatic-fever-and-has-a-normal-echocardiogram-at-presentation-do-you-prescribe-1-year-of-antibiotic-prophylaxis weekly 0.8 https://www.themednet.org/if-zolbetuximab-was-not-given-first-line-and-on-progression-with-folfox-with-bone-lesions-in-gastric-cancer-can-you-give-it-with-second-line-with-what-chemo-backbone weekly 0.8 https://www.themednet.org/which-other-glp-1-r-agonist-if-any-would-you-consider-re-trialing-in-patients-who-had-severe-gastrointestinal-side-effects-with-ozempic weekly 0.8 https://www.themednet.org/Does-TROP2-expression-influence-clinical-decision-making-for-TNBC-today weekly 0.8 https://www.themednet.org/what-are-your-preferred-treatments-for-vasospasm-in-the-setting-of-rcvs weekly 0.8 https://www.themednet.org/n-patients-with-a-history-of-retinal-vein-occlusion-how-should-the-risk-of-recurrent-thromboembolic-events-influence-the-selection-of-osteoporosis-therapies weekly 0.8 https://www.themednet.org/do-you-use-any-strategies-to-minimize-loss-of-taste-from-radiation-for-oropharyngeal-cancer weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-isolated-rem-behavioral-sleep-disorder-secondary-to-antidepressant-on-the-risk-of-developing-a-neurodegenerative-disease weekly 0.8 https://www.themednet.org/Aortic-aneurysm-4.38-cmnew-when-to-repeat-ct-in-6-months-is-good weekly 0.8 https://www.themednet.org/in-an-elderly-patient-with-limited-transportation-issues-is-there-a-hypofractionated-regimen-you-have-found-acceptable-vis-a-vis-control-toxicity-for-a-localized-squamous-cell-carcinomas-of-the-eyelid-assuming-electrons-use-of-eye-shield-surface-collimati weekly 0.8 https://www.themednet.org/with-emerging-therapies-what-is-your-general-treatment-ladder-for-chronic-spontaneous-urticaria-csu weekly 0.8 https://www.themednet.org/if-approved-would-you-consider-adding-aglatimagene-besadenovec-can-2409-to-ebrt-as-an-adt-sparing-strategy-in-intermediate-risk-localized-prostate-cancer weekly 0.8 https://www.themednet.org/at-what-serum-sodium-level-do-you-stop-ddavp-when-using-a-clamp-strategy-to-prevent-overcorrection-in-hyponatremia weekly 0.8 https://www.themednet.org/what-is-your-opinion-about-use-of-doxy-pep-in-a-client-taking-isotretinoin-both-drugs-are-rarely-associated-with-pseudotumor-cerebri-but-in-almost-50-years-of-id-i-have-not-seen-a-single-case-with-either-i-have-several-clients-who-would-be-good-candidates weekly 0.8 https://www.themednet.org/how-would-you-recommend-using-pocus-to-evaluate-jugular-venous-pressure weekly 0.8 https://www.themednet.org/what-is-your-radiotherapy-plan-for-stage-iv-pdac-liver-metastases-s-p-12-cycles-of-folfirinox-and-then-maintenance-capecitabine-who-now-presents-with-disease-progression-increase-in-ca-19-9-and-size-of-pet-avid-pancreatic-head-mass weekly 0.8 https://www.themednet.org/how-has-the-new-data-regarding-long-term-follow-up-of-degenerative-meniscal-tears-vs-surgery-changed-your-management-approach-in-these-patients weekly 0.8 https://www.themednet.org/under-what-circumstances-do-you-consider-duraplasty-for-chiari-1-decompression weekly 0.8 https://www.themednet.org/what-testing-do-you-do-for-adjuvant-and-neoadjuvant-testing-for-gi-cancers-routinely-do-pole-1-and-tmb weekly 0.8 https://www.themednet.org/do-glp-1-agonists-have-measurable-anti-inflammatory-effects-in-diseases-like-ra-or-spondyloarthropathies-beyond-weight-loss weekly 0.8 https://www.themednet.org/how-do-you-decide-until-what-age-to-offer-ovarian-preservation-for-patients-with-biopsy-proven-grade-1-or-grade-2-endometrial-cancer-without-evidence-of-metastatic-disease-on-imaging-or-at-the-time-of-surgery weekly 0.8 https://www.themednet.org/does-baseline-facial-dermatitis-in-a-patient-with-ad-cause-hesitation-when-starting-dupixent-due-to-conjunctivitis-related-complications-especially-when-there-are-many-available-options weekly 0.8 https://www.themednet.org/what-is-your-recommendation-for-patients-who-are-on-weight-loss-medications-like-glp-1-based-therapies-while-receiving-chemoradiation-for-head-and-neck-cancer weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-stop-immunosuppression-in-a-patient-with-granulomatosis-with-polyangiitis-who-is-on-dialysis-has-not-yet-recovered-renal-function-but-has-shown-improvement-in-anca-levels weekly 0.8 https://www.themednet.org/what-factors-would-prompt-you-to-refer-a-patient-for-a-surgical-epilepsy-evaluation-who-has-not-yet-failed-two-anti-seizure-medications weekly 0.8 https://www.themednet.org/how-do-you-treat-a-mild-basilar-artery-occlusion-stroke weekly 0.8 https://www.themednet.org/would-you-offer-empiric-lung-sbrt-for-two-growing-fdg-avid-lung-lesions-in-a-patient-with-severe-copd-on-oxygen weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-capecitabine-for-a-patient-with-triple-negative-metaplastic-carcinoma-who-has-microinvasive-residual-disease-ypt1min0-following-neoadjuvant-therapy weekly 0.8 https://www.themednet.org/would-you-be-comfortable-combining-rituximab-with-voclosporin-in-patients-with-lupus-nephritis-not-responding-to-standard-therapy weekly 0.8 https://www.themednet.org/does-using-a-heads-up-display-for-surgery-improve-ergonomics-and-surgical-performance-compared-to-a-traditional-microscope-or-does-the-need-to-alternate-between-views-reduce-its-long-term-usability weekly 0.8 https://www.themednet.org/how-do-you-approach-surgical-repair-of-a-6-clock-hour-retinal-dialysis-with-posteriorly-folded-retina-and-what-strategies-do-you-use-to-minimize-retinal-slippage weekly 0.8 https://www.themednet.org/do-you-routinely-adjust-your-interpretation-of-slums-and-or-moca-tests-in-patients-depending-on-their-level-of-education weekly 0.8 https://www.themednet.org/when-using-hypofractionated-whole-breast-radiotherapy-with-a-simultaneous-integrated-boost-to-the-lumpectomy-cavity-what-igrt-strategy-do-you-use weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-a-patient-with-non-tophaceous-gout-who-relapses-upon-withdrawal-of-acute-gout-prophylaxis-despite-adequate-uric-acid-suppression-on-allopurinol weekly 0.8 https://www.themednet.org/have-you-completed-any-training-to-prepare-for-offering-psilocybin-treatment-in-the-event-that-it-eventually-becomes-fda-approved-for-difficult-to-treat-depression weekly 0.8 https://www.themednet.org/what-antidepressant-medications-do-you-usually-use-alongside-ketamine-or-esketamine-treatment-in-patients-with-difficult-to-treat-depression weekly 0.8 https://www.themednet.org/do-you-use-mrsa-nares-pcr-to-influence-antibiotic-selection-for-non-respiratory-infections weekly 0.8 https://www.themednet.org/for-those-who-dont-have-access-to-addiction-medicine-have-you-considered-using-naltrexone-for-the-treatment-of-stimulant-use-disorder-in-your-primary-care-clinic weekly 0.8 https://www.themednet.org/what-strategies-do-you-recommend-for-discussing-the-use-of-ocp-in-women-with-a-history-of-migraines-with-or-without-aura weekly 0.8 https://www.themednet.org/how-do-you-decide-which-commercially-available-pharmacogenetic-test-to-use-for-your-patients weekly 0.8 https://www.themednet.org/what-is-your-preferred-csi-dose-fractionation-for-leptomeningeal-disseminated-low-grade-glioma weekly 0.8 https://www.themednet.org/when-is-a-reasonable-amount-of-time-for-patients-to-be-on-90-mg-bid-of-ticagrelor-before-transitioning-to-60-mg-bid-following-pci weekly 0.8 https://www.themednet.org/how-do-you-decide-the-dose-of-aspirin-to-use-in-mpn-patients weekly 0.8 https://www.themednet.org/in-a-patient-with-zieves-syndrome-and-alcohol-related-cirrhosis-which-antibiotic-regimen-is-safe-to-treat-h-pylori weekly 0.8 https://www.themednet.org/what-do-you-do-for-a-patient-with-parkinsons-disease-and-orthostatic-hypotension-who-has-failed-midodrine-fludrocortisone-droxidopa-pyridostigmine-and-atomoxetine weekly 0.8 https://www.themednet.org/how-do-you-approach-balancing-the-risks-and-benefits-of-elective-surgery-with-patients-who-have-multiple-co-morbidities-e-g-frailty-chronic-kidney-disease-and-copd-when-standard-risk-calculators-do-not-capture-the-full-complexity-of-their-condition weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-a-patient-with-coexisting-psoriasis-and-systemic-sclerosis-particularly-when-both-active-psoriasis-and-skin-tightening-are-present weekly 0.8 https://www.themednet.org/what-therapies-do-you-recommend-for-patients-with-limited-life-expectancy-3-months-but-whose-depression-is-significantly-reducing-their-quality-of-life weekly 0.8 https://www.themednet.org/do-you-recommend-restarting-glp-1ra-after-bariatric-surgery-if-they-tolerated-it-before-the-surgery weekly 0.8 https://www.themednet.org/do-you-counsel-patients-to-take-antihypertensives-at-specific-times-of-day-to-maximize-efficacy-or-minimize-side-effects weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-include-a-basal-rate-when-initiating-a-pca weekly 0.8 https://www.themednet.org/are-there-patients-with-sle-associated-inflammatory-arthritis-in-whom-you-recommend-tnf-inhibitors-as-a-treatment-option weekly 0.8 https://www.themednet.org/for-what-sort-of-sle-clinical-profile-do-you-favor-anifrolumab-beyond-patients-with-prominent-skin-manifestations weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-initiate-hemodialysis-for-fetal-protection-in-a-pregnant-patient-with-ckd-stage-4-who-does-not-have-any-usual-indications-to-start-dialysis weekly 0.8 https://www.themednet.org/would-you-consider-apbi-in-a-patient-who-meets-all-criteria-but-has-high-risk-genomic-testing-and-is-not-receiving-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-assess-for-trauma-related-symptoms-in-children-and-adolescents-who-have-experienced-chronic-bullying weekly 0.8 https://www.themednet.org/for-patients-with-hashimotos-thyroiditis-is-there-a-commercially-available-blood-test-for-detecting-abnormalities-in-the-type-1-deiodinase-enzyme-in-order-to-identify-patients-who-would-potentially-benefit-from-t4-and-t3-combination-therapy weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-recommend-for-a-woman-in-her-90s-with-er-positive-her2-positive-breast-cancer-who-received-neoadjuvant-trastuzumab-pertuzumab-and-anastrozole-but-did-not-achieve-a-pathologic-complete-response weekly 0.8 https://www.themednet.org/do-you-recommend-cbd-cessation-prior-to-screening-of-liver-enzymes weekly 0.8 https://www.themednet.org/how-do-you-diagnose-and-manage-suspected-opioid-induced-esophageal-dysfunction weekly 0.8 https://www.themednet.org/how-are-you-using-slit-if-that-is-the-method-you-use-to-treat-allergic-rhinits weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-patients-with-recurrent-nephrolithiasis-who-consistently-fail-to-adhere-to-recommended-dietary-changes-including-animal-protein-and-sodium-restriction-and-remain-at-elevated-stone-risk-due-to-hypercalciuria-despite-thiazi weekly 0.8 https://www.themednet.org/how-do-you-approach-patient-requests-for-long-term-disability-for-major-depressive-disorder weekly 0.8 https://www.themednet.org/what-is-your-strategy-to-manage-the-complication-of-long-term-immunosuppression-in-liver-transplant-recipients-specifically-renal-dysfunction-and-onset-of-cardiometabolic-comorbidities weekly 0.8 https://www.themednet.org/would-you-continue-serial-psma-pet-scans-after-2-negative-scans-for-patients-with-a-persistently-rising-psa-post-rt weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-chemotherapy-in-an-adult-with-localized-osteosarcoma-who-demonstrates-50-90-tumor-necrosis-on-surgical-pathology-following-neoadjuvant-doxorubicin-and-cisplatin weekly 0.8 https://www.themednet.org/what-is-your-preferred-comprehensive-nodal-irradiation-approach-in-non-metastatic-breast-cancer-patients-with-underlying-respiratory-diseases-or-poor-baseline-respiratory-function-in-light-of-the-findings-from-the-radcomp-trial weekly 0.8 https://www.themednet.org/are-there-any-scenarios-in-which-you-would-offer-sbrt-as-your-preferred-treatment-approach-for-appropriate-candidates-with-intermediate-risk-prostate-cancer weekly 0.8 https://www.themednet.org/are-you-using-maintenance-lurbinectedin-with-immunotherapy-in-the-first-line-treatment-of-extensive-stage-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/when-is-the-ideal-time-in-the-disease-course-to-offer-radiotherapy-for-dupuytrens-disease-for-the-most-optimal-outcomes weekly 0.8 https://www.themednet.org/how-has-the-fluid-trial-which-showed-no-significant-difference-in-death-or-readmission-rates-between-lactated-ringers-solution-and-normal-saline-influenced-your-approach-to-iv-fluid-management weekly 0.8 https://www.themednet.org/do-you-have-a-strict-age-cut-off-for-not-referring-patients-for-cabg-evaluation weekly 0.8 https://www.themednet.org/how-would-you-workup-a-patient-who-develops-ascites-after-liver-transplantation weekly 0.8 https://www.themednet.org/how-do-you-decide-which-patient-and-with-which-device-to-pursue-machine-perfusion-for-the-organ-of-a-liver-transplant-recipient weekly 0.8 https://www.themednet.org/how-do-molecular-and-clinical-factors-guide-personalized-selection-of-hsrt-dose-fractionation-regimens-with-bevacizumab-in-recurrent-high-grade-gliomas weekly 0.8 https://www.themednet.org/how-have-you-incorporated-eye-movement-desensitization-and-reprocessing-emdr-into-your-outpatient-psychiatric-practice weekly 0.8 https://www.themednet.org/how-will-you-select-patients-with-brain-metastases-for-ttfields weekly 0.8 https://www.themednet.org/would-you-add-amiloride-for-patients-with-recurrent-calcium-nephrolithiasis-who-have-hypercalciuria-despite-adherence-to-maximum-dose-thiazide-low-sodium-dietary-intake-and-low-animal-protein-dietary-intake weekly 0.8 https://www.themednet.org/what-is-the-role-of-bilateral-same-day-cataract-surgery-in-your-practice weekly 0.8 https://www.themednet.org/how-have-you-used-hedgehog-pathway-inhibitors-as-neoadjuvant-adjuvant-therapies weekly 0.8 https://www.themednet.org/how-do-you-approach-prophylactic-antibiotics-in-patients-who-continue-to-have-recurrent-neutropenic-fever-following-chemotherapy-for-solid-tumors-despite-chemotherapy-dose-reduction-and-growth-factor-support weekly 0.8 https://www.themednet.org/what-recommendations-or-protocol-do-you-have-in-reducing-pain-when-using-levulan-with-blue-light-for-field-therapy-to-treat-aks weekly 0.8 https://www.themednet.org/how-do-you-weigh-the-risk-of-urinary-catheter-or-fecal-management-system-placement-with-that-of-soiling-sacral-wounds weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-who-develop-siadh-secondary-to-an-ssri-but-have-had-a-strong-positive-response-to-that-same-medication weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-woman-with-a-strong-family-history-of-thrombosis-about-oral-contraceptives weekly 0.8 https://www.themednet.org/in-managing-non-renal-sle-how-do-you-approach-choosing-between-belimumab-and-anifrolumab weekly 0.8 https://www.themednet.org/would-you-recommend-observation-or-laser-retinopexy-in-a-young-myope-with-asymptomatic-lattice-degeneration-with-retinal-holes-within-lattice-in-each-eye weekly 0.8 https://www.themednet.org/if-adjuvant-radiation-is-offered-to-an-elderly-patient-with-h-n-scc-s-p-mohs-surgery-who-is-planned-for-multi-stage-reconstruction-of-the-defect-with-plastic-surgery-when-should-adjuvant-radiation-be-started weekly 0.8 https://www.themednet.org/how-do-you-determine-when-ongoing-outpatient-treatment-is-no-longer-beneficial-and-it-may-be-appropriate-to-transition-a-patient-to-another-provider weekly 0.8 https://www.themednet.org/how-do-you-address-social-determinants-of-health-that-impact-patients-e-g-housing-instability-food-insecurity-but-for-which-there-are-no-immediate-resources-available weekly 0.8 https://www.themednet.org/how-do-you-choose-between-the-different-available-car-t-cell-therapy-products-for-the-treatment-of-relapsed-ph-negative-all weekly 0.8 https://www.themednet.org/would-you-recommend-anti-fungal-treatment-for-aspergillus-infection-for-a-patient-with-an-incidental-finding-of-worsening-ground-glass-opacities-and-enlarging-nodules-on-ct-chest-with-positive-bal-galactomannan-elevated-aspergillus-ige-and-igg-in-an-other weekly 0.8 https://www.themednet.org/what-target-expansions-do-you-use-when-treating-with-60-gy-in-15-fractions-for-the-lung weekly 0.8 https://www.themednet.org/when-do-you-consider-starting-an-antidepressant-without-a-mood-stabilizer-in-a-patient-with-a-historical-diagnosis-of-bipolar-ii-disorder-who-has-not-had-hypomanic-episodes-in-many-years weekly 0.8 https://www.themednet.org/would-you-obtain-an-abdominal-non-contrast-ct-study-for-further-routine-evaluation-of-stone-burden-in-a-patient-with-recurrent-nephrolithiasis-who-recently-completed-an-abdominal-iodinated-contrast-ct-study-for-non-stone-purposes weekly 0.8 https://www.themednet.org/what-is-your-approach-for-eskd-patients-on-peritoneal-dialysis-who-request-to-do-their-own-exchanges-during-a-hospitalization weekly 0.8 https://www.themednet.org/when-should-you-suspect-tr-related-to-pacemaker-lead-placement-as-a-cause-of-rv-dysfunction-rather-than-pulmonary-htn-or-other-etiologies-for-rv-failure-associated-with-tricuspid-regurgitation weekly 0.8 https://www.themednet.org/are-there-clinical-situations-where-you-would-advise-removal-of-the-lasik-flap-and-how-do-you-determine-if-it-is-clinically-necessary weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-unprovoked-distal-dvts weekly 0.8 https://www.themednet.org/what-are-your-thoughts-on-the-results-of-the-alone-af-trial-and-the-safety-profile-of-discontinuing-anticoagulation-post-ablation-provided-there-is-no-atrial-arrhythmia-recurrence weekly 0.8 https://www.themednet.org/does-lymphovascular-invasion-trump-pole-mutation-in-early-stage-uterine-cancer-adjuvant-therapy-decisions weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-concurrent-diagnoses-of-symptomatic-multiple-myeloma-and-a-newly-diagnosed-upper-extremity-undifferentiated-pleomorphic-sarcoma weekly 0.8 https://www.themednet.org/how-do-you-modify-the-management-of-an-sle-patient-with-active-systemic-lupus-for-a-gynecological-cancer-that-normally-requires-pelvic-radiation-and-brachytherapy weekly 0.8 https://www.themednet.org/do-you-have-to-extend-treatment-for-acute-lyme-disease-if-a-patient-is-on-high-dose-steroids-for-another-indication weekly 0.8 https://www.themednet.org/would-you-perform-screening-for-pulmonary-hypertension-in-a-patient-who-has-biopsy-proven-sjogrens-but-has-a-centromere-antibody weekly 0.8 https://www.themednet.org/is-it-appropriate-to-consider-ultra-hypofractionation-for-phyllodes-tumors-of-the-breast-when-adjuvant-radiotherapy-is-indicated weekly 0.8 https://www.themednet.org/in-patients-presenting-with-disabling-acute-ischemic-stroke-symptoms-early-in-the-therapeutic-window-would-you-consider-anticoagulation-reversal-to-enable-administration-of-intravenous-thrombolytics weekly 0.8 https://www.themednet.org/what-are-your-diagnostic-and-treatment-goals-for-a-patient-with-cirrhotic-cardiomyopathy weekly 0.8 https://www.themednet.org/how-do-you-evaluate-the-etiology-of-hyponatremia-in-a-patient-with-esrd-and-baseline-oliguria-anuria weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-a-patient-with-a-retroperitoneal-soft-tissue-mass-and-elevated-igg4-level-when-tissue-biopsy-is-not-feasible weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-initiate-or-restart-diuretics-in-a-cirrhotic-patient-with-ascites-if-they-are-receiving-a-therapeutic-paracentesis weekly 0.8 https://www.themednet.org/do-you-use-xoliar-as-add-on-treatment-for-hereditary-alpha-tryptasemia weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-glp-1-receptor-agonist-therapy-in-patients-who-develop-naion weekly 0.8 https://www.themednet.org/in-patients-with-retinitis-pigmentosa-associated-cystoid-macular-edema-that-is-refractory-to-medical-management-does-pars-plana-vitrectomy-have-a-therapeutic-role weekly 0.8 https://www.themednet.org/what-opportunities-do-you-see-for-combining-xanomeline-tropsium-cobenfy-with-other-anti-psychotic-agents weekly 0.8 https://www.themednet.org/would-you-recommend-early-empirical-anti-mold-therapy-for-patients-with-severe-influenza-pneumonia-admitted-to-the-icu-to-reduce-the-incidence-of-influenza-associated-pulmonary-aspergillosis weekly 0.8 https://www.themednet.org/how-do-you-approach-tapering-high-dose-continuous-infusions-for-status-epilepticus-in-patients-experiencing-serious-medication-related-toxicity weekly 0.8 https://www.themednet.org/how-often-and-for-how-long-do-you-monitor-pituitary-gland-function-in-a-patient-with-empty-sella-radiologic-finding-only weekly 0.8 https://www.themednet.org/what-is-your-approach-for-arranging-outpatient-antibiotics-on-discharge-for-a-hospitalized-patient-with-eskd-who-receives-in-center-hemodialysis-at-a-unit-you-do-not-round-at weekly 0.8 https://www.themednet.org/what-fractionation-would-you-use-for-a-young-patient-with-a-schwannoma-that-has-regrown-within-2-years-of-resection weekly 0.8 https://www.themednet.org/how-do-you-approach-managing-intolerable-vivid-dreams-as-a-side-effect-of-ssris weekly 0.8 https://www.themednet.org/do-you-recommend-glp-1-agonists-in-patients-with-mpn weekly 0.8 https://www.themednet.org/if-you-are-using-talquetamab-as-bridging-before-bcma-car-t-therapy-when-do-you-assess-for-response-and-or-stop-the-talquetamab weekly 0.8 https://www.themednet.org/in-patients-with-masld-would-you-consider-management-with-off-label-metformin-pioglitazone-despite-weight-gain-risk-glp-1-ra-or-simply-intensify-lifestyle-and-monitor weekly 0.8 https://www.themednet.org/among-patients-with-secured-subarachnoid-hemorrhage-who-are-receiving-daily-tcds-what-is-the-appropriate-frequency-of-post-operative-neurological-assessments weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-osteoarthritis-of-just-one-joint-of-the-hand weekly 0.8 https://www.themednet.org/when-do-you-use-tirofiban-for-acute-ischemic-stroke weekly 0.8 https://www.themednet.org/would-you-consider-levofloxacin-graded-challenge-extended-iv-aztreonam-or-an-alternative-treatment-in-a-patient-with-reported-anaphylaxis-to-penicillin-fluoroquinolones-and-cefuroxime-with-cavitary-pneumonia-secondary-to-klebsiella-and-pseudomonas weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-radiation-recommendations-for-low-risk-endometrial-cancer-in-which-the-patient-was-unable-to-undergo-pelvic-sentinel-node-mapping weekly 0.8 https://www.themednet.org/what-clinical-or-oct-based-parameters-guide-your-decision-to-perform-an-erm-peel-in-patients-with-dme-and-concurrent-erm weekly 0.8 https://www.themednet.org/at-what-egfr-do-you-typically-refer-for-vein-mapping-for-a-patient-with-advanced-ckd-who-prefers-hemodialysis-when-indicated weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-chemotherapy-for-a-postmenopausal-woman-with-pt1cn0-grade-2-er-breast-cancer-idc-and-oncotype-rs-of-25 weekly 0.8 https://www.themednet.org/what-would-be-your-treatment-approach-for-a-patient-with-concomitant-diagnoses-of-multiple-myeloma-and-axial-spondyloarthritis weekly 0.8 https://www.themednet.org/what-were-your-top-takeaways-in-sle-from-acr-convergence-2025 weekly 0.8 https://www.themednet.org/what-were-your-top-takeaways-in-myositis-from-acr-convergence-2025 weekly 0.8 https://www.themednet.org/would-you-perform-a-kidney-biopsy-to-rule-out-other-etiologies-before-diagnosing-loin-pain-hematuria-syndrome-in-a-patient-with-persistent-microscopic-hematuria-left-flank-pain-no-proteinuria-normal-renal-function-normal-cystoscopy-and-normal-imaging weekly 0.8 https://www.themednet.org/when-should-you-seek-hyperbaric-oxygen-therapy-for-patients-with-crao weekly 0.8 https://www.themednet.org/when-should-you-suspect-that-palatal-tremor-could-be-a-functional-neurologic-disorder weekly 0.8 https://www.themednet.org/would-you-offer-peritoneal-dialysis-to-a-patient-with-eskd-who-also-has-dementia-but-lives-with-family-who-can-assist-with-dialysis-treatments weekly 0.8 https://www.themednet.org/for-patients-with-high-volume-hormone-sensitive-prostate-cancer-would-you-consider-shortening-the-docetaxel-course-to-4-cycles-to-facilitate-better-tolerance weekly 0.8 https://www.themednet.org/would-you-recommend-large-field-radiation-therapy-to-treat-scc-of-the-skin-with-field-cancerization-e-g-entire-forearm-scalp-in-elderly-patients-with-cll-immune-compromise-who-have-had-mixed-responses-to-cemiplimab weekly 0.8 https://www.themednet.org/how-long-do-you-typically-treat-mixed-infections-involving-actinomyces-such-as-empyema-or-abdominal-abscesses-when-adequate-source-control-has-been-achieved weekly 0.8 https://www.themednet.org/what-is-your-pharmacologic-approach-to-treating-insomnia-comorbid-with-sleep-apnea weekly 0.8 https://www.themednet.org/would-you-consider-anti-il-5-therapy-mepolizumab-or-benralizumab-to-either-prevent-or-treat-the-more-severe-manifestations-of-eosinophilic-granulomatosis-with-polyangiitis-such-as-infiltrative-e-g-cardiomyopathy-pulmonary-infiltrates-or-gastroenteritis-or weekly 0.8 https://www.themednet.org/in-what-scenario-do-you-obtain-ammonia-levels-in-a-patient-with-cirrhosis weekly 0.8 https://www.themednet.org/do-you-find-trabecular-bone-score-tbs-useful-in-patients-with-a-history-of-ankylosing-spondylitis-when-screening-for-vertebral-fracture-risk weekly 0.8 https://www.themednet.org/how-does-an-incidental-finding-of-low-bone-density-on-imaging-done-for-another-reason-inform-your-screening-approach-for-osteoporosis weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-discordant-tbs-adjusted-t-score-and-traditional-t-score weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-recurrent-vte-who-develops-vte-again-after-reduction-of-apixaban-to-2-5-mg-bid weekly 0.8 https://www.themednet.org/what-would-be-your-approach-to-the-consideration-of-the-use-of-antiamyloid-monoclonal-antibodies-for-nonamnestic-alzheimers-disease-with-a-positive-biomarker-for-brain-amyloid-pathology weekly 0.8 https://www.themednet.org/in-pediatric-rrds-associated-with-high-myopia-or-stickler-syndrome-how-do-you-decide-between-scleral-buckle-alone-versus-combined-vitrectomy-and-buckle weekly 0.8 https://www.themednet.org/would-you-consider-transitioning-patients-older-than-75-years-of-age-with-coronary-disease-from-statins-and-or-other-lipid-lowering-agents-to-pcsk9-inhibitors-given-concerns-for-polypharmacy-provided-their-ldl-levels-remain-at-or-below-goal weekly 0.8 https://www.themednet.org/in-primary-angle-closure-suspects-without-cataracts-how-do-you-approach-the-discussion-about-lpis-given-the-relatively-low-risk-of-an-acute-angle-closure-attack weekly 0.8 https://www.themednet.org/do-you-dose-esas-via-an-intravenous-or-subcutaneous-route-for-hospitalized-patients-with-eskd-and-anemia weekly 0.8 https://www.themednet.org/should-a-patient-who-has-hereditary-alpha-tryptasemia-and-has-experienced-multiple-anaphylactoid-reactions-be-tested-for-a-venom-allergy-and-started-on-vit-if-positive weekly 0.8 https://www.themednet.org/when-do-you-start-pharmacotherapy-for-ptsd-in-children weekly 0.8 https://www.themednet.org/when-is-air-travel-safe-for-patients-who-have-developed-an-intracranial-bleed weekly 0.8 https://www.themednet.org/is-there-evidence-supporting-the-role-of-sbrt-in-the-management-of-oligometastatic-stage-iv-nsclc weekly 0.8 https://www.themednet.org/for-pediatric-patients-who-are-being-successfully-treated-for-migraines-with-a-tca-such-as-amitriptyline-would-you-consider-starting-an-additional-ssri-or-snri-for-mood-anxiety-symptoms-given-the-risk-of-serotonin-syndrome weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-ribociclib-to-a-postmenopausal-female-with-er-luminal-a-node-breast-cancer-pt1cn1a-grade-2-that-didnt-require-chemotherapy-per-oncotype-but-met-natalee-inclusion-criteria weekly 0.8 https://www.themednet.org/how-do-you-incorporate-smart-phone-microscopy-into-your-clinical-assessment-of-raynauds weekly 0.8 https://www.themednet.org/how-often-do-you-perform-nailfold-capillaroscopy-in-your-clinical-practice-in-patients-with-ctd weekly 0.8 https://www.themednet.org/what-are-your-favorite-topicals-when-treating-scarring-alopecia weekly 0.8 https://www.themednet.org/how-frequently-and-how-soon-after-starting-a-patient-on-flecainide-should-they-undergo-exercise-treadmill-testing-to-look-for-qrs-widening-due-to-use-dependence weekly 0.8 https://www.themednet.org/how-do-you-balance-empiric-therapy-and-diagnostic-testing-in-severe-pediatric-conjunctivitis-presentations weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-stop-anti-vegf-injections-for-patients-with-exudative-amd weekly 0.8 https://www.themednet.org/have-you-had-success-in-treating-extensive-lichen-nitidus-with-a-systemic-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-managing-patients-with-recurrent-nephrolithiasis-who-have-low-supersaturation-profiles-due-to-polyuria-and-stable-stone-disease-on-imaging-but-do-have-persistent-urinary-abnormalities-such-as-hyperoxaluria-hypercalciuria-and-hypocitrat weekly 0.8 https://www.themednet.org/what-adjuvant-treatment-would-you-offer-a-patient-with-adenocarcinoma-of-the-mid-esophagus-ct2n0m0-who-underwent-upfront-esophagectomy-which-showed-t2n1-disease-with-negative-margins weekly 0.8 https://www.themednet.org/how-do-you-approach-delivery-planning-in-patients-with-t1-vwd weekly 0.8 https://www.themednet.org/how-long-do-you-typically-treat-patients-with-phentermine-for-weight-loss-and-what-clinical-markers-do-you-follow weekly 0.8 https://www.themednet.org/how-would-you-advise-a-younger-patient-with-residual-recurrent-optic-nerve-meningioma-proceeding-with-radiotherapy-about-the-risks-of-malignant-transformation-or-induction-of-other-brain-malignancies-because-of-radiation weekly 0.8 https://www.themednet.org/what-patient-factors-do-you-consider-when-selecting-between-a-small-interfering-rna-like-inclisiran-and-pcsk9-inhibitors-in-patients-with-recent-acute-coronary-syndrome weekly 0.8 https://www.themednet.org/will-you-implement-the-conservative-dialysis-strategy-from-the-liberate-d-trial-for-patients-with-dialysis-requiring-acute-kidney-injury-or-will-you-continue-dialysis-on-a-schedule-until-recovery-based-on-creatinine-and-urine-output weekly 0.8 https://www.themednet.org/do-you-plan-to-incorporate-fish-oil-supplementation-into-the-care-of-hemodialysis-patients-to-reduce-cardiovascular-events-in-light-of-the-pisces-trial-results weekly 0.8 https://www.themednet.org/what-are-your-thoughts-on-telitacicept-use-in-sle-and-why-has-it-not-garnered-more-attention-in-us-news-cycle-in-rheumatology weekly 0.8 https://www.themednet.org/should-asymptomatic-esophageal-candidiasis-identified-incidentally-on-endoscopy-be-treated weekly 0.8 https://www.themednet.org/should-other-treatment-options-be-considered-for-malt-lymphoma-if-the-lacrimal-gland-will-be-included-in-the-radiation-field-in-a-patient-with-sjoegrens-disease weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-safety-and-toxicity-of-delgocitinib weekly 0.8 https://www.themednet.org/what-medication-management-strategies-exist-for-children-with-neurodevelopmental-disorders-who-respond-poorly-to-stimulants-and-have-intolerable-side-effects-on-antipsychotics weekly 0.8 https://www.themednet.org/do-you-postpone-hemodialysis-for-a-period-of-time-after-stem-cell-transplantation-in-a-hospitalized-patient-with-eskd weekly 0.8 https://www.themednet.org/how-have-you-integrated-the-new-hpv-self-swab-collection-into-your-routine-cervical-cancer-screening-particularly-in-those-with-prior-abnormal-results weekly 0.8 https://www.themednet.org/is-the-timing-of-childhood-eczema-onset-useful-as-a-prognostic-factor-in-predicting-food-allergy-tolerance weekly 0.8 https://www.themednet.org/how-do-stroke-risk-considerations-affect-your-use-of-atypical-antipsychotics-for-patients-with-dementia weekly 0.8 https://www.themednet.org/when-would-you-consider-glp-1-receptor-agonists-for-iih-in-patients-at-a-healthy-weight-and-bmi weekly 0.8 https://www.themednet.org/which-patients-will-have-earlier-diagnosis-of-multiple-sclerosis-via-the-new-2024-mcdonald-criteria weekly 0.8 https://www.themednet.org/what-are-best-practices-to-avoid-misdiagnosis-of-multiple-sclerosis-in-patients-over-50-years-old weekly 0.8 https://www.themednet.org/do-you-avoid-potassium-citrate-in-patients-with-recurrent-nephrolithiasis-and-hypocitraturia-if-they-also-take-antihistamine-medications weekly 0.8 https://www.themednet.org/when-would-you-pursue-a-kidney-biopsy-for-patients-with-inflammatory-bowel-disease-who-have-non-proteinuric-progressive-ckd-of-unknown-etiology weekly 0.8 https://www.themednet.org/how-do-you-use-transexamic-acid-txa-during-dermatologic-procedures weekly 0.8 https://www.themednet.org/what-is-the-preferred-second-line-therapy-for-her2-positive-patients-with-esophageal-squamous-cell-carcinoma-who-have-progressed-on-first-line-trastuzumab-and-immunotherapy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-interested-in-neuromodulation-tdcs-rtms-for-adhd weekly 0.8 https://www.themednet.org/for-non-functional-pituitary-macroadenomas-how-effective-has-cabergoline-been-in-reducing-tumor-size-or-preventing-the-need-for-surgery weekly 0.8 https://www.themednet.org/how-are-you-choosing-between-xolair-dupixent-or-rhapsido-for-patients-with-csu weekly 0.8 https://www.themednet.org/what-is-your-approach-to-iv-fluid-management-for-the-treatment-of-hypercalcemia-of-malignancy weekly 0.8 https://www.themednet.org/how-would-you-approach-rituximab-dosing-in-a-patient-with-sle-myositis-overlap-with-ln-class-iii-now-with-worsening-upcr-and-concern-for-worsening-ild-4-months-post-induction-and-incomplete-b-cell-depletion-on-recent-labs weekly 0.8 https://www.themednet.org/how-do-you-approach-the-initial-treatment-for-a-patient-presenting-with-mas-hlh-as-the-initial-manifestation-of-sle weekly 0.8 https://www.themednet.org/how-do-you-approach-cisplatin-dosing-for-locally-advanced-head-and-neck-scc-in-hpv-positive-and-hpv-negative-patients weekly 0.8 https://www.themednet.org/do-you-check-mycophenolate-levels-in-patients-prescribed-mycophenolate-who-present-with-a-lupus-nephritis-flare weekly 0.8 https://www.themednet.org/how-have-you-incorporated-sulopenem-etzadroxil-into-your-antibiotic-stewardship-protocols-particularly-for-managing-uncomplicated-utis-with-resistant-enterobacterales-organisms weekly 0.8 https://www.themednet.org/how-do-you-or-your-practice-manage-young-average-risk-patients-without-structural-lung-disease-referred-to-you-or-self-referred-for-concern-of-environmental-mold-exposure weekly 0.8 https://www.themednet.org/how-does-supremo-alter-your-recommendations-for-pmrt weekly 0.8 https://www.themednet.org/what-outcome-do-you-value-as-the-most-important-measure-of-success-when-treating-che-1 weekly 0.8 https://www.themednet.org/in-which-patients-with-che-will-you-prioritize-early-use-of-delgocitinib-1 weekly 0.8 https://www.themednet.org/how-do-you-choose-between-delgocitinib-ruxolitinib-for-patients-with-che weekly 0.8 https://www.themednet.org/how-do-the-results-of-crest-2-influence-your-recommendations-on-screening-for-asymptomatic-carotid-stenosis weekly 0.8 https://www.themednet.org/when-if-ever-do-you-incorporate-a-dental-evaluation-before-initiating-dato-dxd-to-offer-guidance-on-oral-care-and-help-limit-oral-toxicity weekly 0.8 https://www.themednet.org/what-patient-factors-influence-your-decision-between-prescribing-oral-pre-exposure-prophylaxis-and-long-acting-injectable-prep-for-hiv-prevention weekly 0.8 https://www.themednet.org/are-there-patients-in-whom-you-would-modify-the-course-of-adjuvant-durvalumab-in-resected-gastric-gej-adenocarcinoma-following-treatment-with-neoadjuvant-flot-durvalumab weekly 0.8 https://www.themednet.org/how-if-at-all-will-you-incorporate-durvalumab-flot-in-patients-with-her2-resectable-gastric-gej-adenocarcinoma weekly 0.8 https://www.themednet.org/how-do-you-reconcile-the-differing-outcomes-of-the-matterhorn-and-keynote-585-trials-when-determining-systemic-treatment-approach-for-gastric-gej-adenocarcinoma weekly 0.8 https://www.themednet.org/when-do-you-consider-csf-testing-for-patients-with-suspected-als weekly 0.8 https://www.themednet.org/can-you-clinically-distinguish-tias-from-transient-focal-neurologic-episodes-tfnes-of-cerebral-amyloid weekly 0.8 https://www.themednet.org/how-should-psychotherapy-techniques-for-patients-with-autism-spectrum-disorder-be-adjusted-if-at-all weekly 0.8 https://www.themednet.org/is-it-necessary-to-test-both-english-walnut-and-black-walnut-when-evaluating-for-a-walnut-allergy weekly 0.8 https://www.themednet.org/how-do-you-determine-when-to-discontinue-anti-complement-therapy-in-patients-with-geographic-atrophy-who-already-have-center-involving-disease-given-the-minimal-likelihood-of-central-vision-improvement-but-the-potential-for-more-rapid-scotoma-expansion-if weekly 0.8 https://www.themednet.org/do-you-routinely-give-prophylactic-antibiotics-prior-to-ercp-for-biliary-obstruction-in-light-of-recent-studies-suggesting-a-reduction-of-periprocedural-infection weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-with-an-n2-ipsilateral-recurrence-following-re-resection-of-bronchial-stump-recurrence weekly 0.8 https://www.themednet.org/how-would-you-approach-managing-a-patient-with-eskd-on-peritoneal-dialysis-who-has-a-milky-appearance-of-peritoneal-effluent-but-low-peritoneal-fluid-triglyceride-levels weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-strongly-suspected-lyme-arthritis-and-negative-bacterial-synovial-fluid-cultures-who-was-started-on-empiric-antibiotics-against-typical-bacterial-pathogens-arthritis-before-arthrocentesis-and-collection-of-cultures weekly 0.8 https://www.themednet.org/how-do-you-determine-the-timing-and-frequency-of-therapeutic-thoracentesis-in-patients-with-symptomatic-hepatic-hydrothorax weekly 0.8 https://www.themednet.org/what-treatment-strategies-are-effective-for-senile-gluteal-dermatosis-when-patients-do-not-improve-with-standard-lifestyle-modifications-and-emollients weekly 0.8 https://www.themednet.org/how-do-you-manage-microprolactinomas-in-women-who-are-resistant-to-dopamine-agonists-especially-considering-potential-tumor-growth-during-pregnancy weekly 0.8 https://www.themednet.org/would-you-start-patiromer-in-a-patient-with-ckd-who-has-persistent-hyperkalemia-despite-taking-sodium-zirconium-cyclosilicate-and-adherence-to-a-low-potassium-diet weekly 0.8 https://www.themednet.org/how-do-you-manage-a-symptomatic-primary-breast-tumor-in-a-patient-with-metastatic-disease weekly 0.8 https://www.themednet.org/does-anyone-have-experience-obtaining-sunvozertinib-in-the-second-line-setting-for-patients-with-egfr-exon-20-insertion-mutations weekly 0.8 https://www.themednet.org/would-you-recommend-immediately-exchanging-a-peritoneal-dialysis-catheter-or-waiting-until-the-completion-of-antibiotics-with-transition-to-hd-if-a-pd-patient-presents-with-peritonitis-and-a-nonfunctional-pd-catheter weekly 0.8 https://www.themednet.org/is-there-any-value-in-nonspecific-inflammation-seen-on-a-salivary-gland-biopsy-for-making-a-clinical-diagnosis-of-sjogrens-disease-in-a-seronegative-patient-with-sicca-symptoms-ie-chronic-sialoadenitis-with-focus-score-0 weekly 0.8 https://www.themednet.org/what-are-your-preferred-lipid-lowering-agents-and-target-ldl-reduction-goal-following-initiation-of-therapy-for-patients-with-familial-hyperlipidemia-without-underlying-cad weekly 0.8 https://www.themednet.org/do-you-recommend-prophylactically-adding-heparin-to-the-dialysate-in-patients-hospitalized-for-peritoneal-dialysis-associated-peritonitis-given-higher-incidence-of-fibrin-associated-catheter-issues weekly 0.8 https://www.themednet.org/how-do-you-balance-diagnostic-stewardship-and-high-value-cost-conscious-care-when-working-up-a-patient-with-newly-diagnosed-hiv-aids-admitted-to-the-icu-with-shortness-of-breath-who-most-likely-has-pjp-pneumonia-or-cryptococcal-infection-but-is-at-risk-of weekly 0.8 https://www.themednet.org/is-there-a-potential-role-that-hormonal-replacement-therapy-can-play-in-contributing-to-the-development-of-scad weekly 0.8 https://www.themednet.org/how-do-you-manage-pemphigus-patients-who-have-persistent-disease-and-circulating-autoantibodies-despite-two-full-courses-of-rituximab weekly 0.8 https://www.themednet.org/would-you-use-perioperative-durvalumab-in-patients-with-diffuse-type-gastric-adenocarcinoma-given-no-event-free-survival-benefit-was-seen-for-these-patients-in-matterhorn weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-cognitive-effects-of-dbs-for-parkinsons-disease weekly 0.8 https://www.themednet.org/does-theophylline-have-a-role-in-bradyarrhythmias-and-if-so-in-what-patient-population-s-can-this-be-considered weekly 0.8 https://www.themednet.org/for-marginal-recurrences-of-skin-cancers-after-prior-hypofractionated-radiation-therapy-i-e-30-gy-5-fx-55-gy-20-fx-where-there-is-concern-for-overlapping-fields-could-reirradiation-with-a-hypofractionated-course-be-considered weekly 0.8 https://www.themednet.org/how-should-cisplatin-be-used-in-head-and-neck-cancer-patients-with-sensorineural-hearing-loss weekly 0.8 https://www.themednet.org/how-have-the-results-of-the-sunmo-trial-with-mosunetuzumab-polatuzumab-vedotin-impacted-your-treatment-choices-for-transplant-ineligible-relapsed-refractory-dlbcl weekly 0.8 https://www.themednet.org/do-you-use-g-csf-for-a-patient-with-all-admitted-for-febrile-neutropenia-with-prolonged-count-recovery weekly 0.8 https://www.themednet.org/what-is-the-most-appropriate-next-step-in-management-for-a-patient-with-dermatomyositis-who-is-maintained-on-methotrexate-25-mg-weekly-but-develops-disease-flare-when-prednisone-is-tapered-below-10-mg-daily-and-is-unable-to-receive-ivig weekly 0.8 https://www.themednet.org/would-you-pursue-a-kidney-biopsy-in-a-patient-with-stable-stage-1-aki-bland-urine-sediment-and-a-positive-mpo-titer-without-systemic-signs-of-vasculitis weekly 0.8 https://www.themednet.org/how-do-you-approach-evaluating-the-hemorrhage-risk-of-restarting-anticoagulation-in-a-patient-with-ischemic-stroke-and-infective-endocarditis-without-access-to-dsa weekly 0.8 https://www.themednet.org/when-do-you-find-benefit-in-sequencing-different-dopamine-receptor-blockers-for-emergency-treatment-of-migraine weekly 0.8 https://www.themednet.org/what-treatment-options-are-there-for-uremic-pruritus-in-an-elderly-patient-with-risk-of-sundowning weekly 0.8 https://www.themednet.org/when-do-you-consider-the-use-of-an-maoi-in-treatment-resistant-major-depressive-disorder weekly 0.8 https://www.themednet.org/whats-the-role-of-contralateral-neck-re-irradiation-in-the-post-op-setting-for-someone-with-a-remote-history-of-head-and-neck-cancer-who-underwent-definitive-rt-with-elective-dose-to-the-bilateral-neck-now-with-a-new-primary-s-p-surgery-with-ipsilateral-n weekly 0.8 https://www.themednet.org/how-do-you-approach-selecting-optimal-muscle-biopsy-site-when-evaluating-a-patient-for-suspected-inflammatory-myopathy weekly 0.8 https://www.themednet.org/is-migraine-with-unilateral-motor-symptoms-mums-a-diagnostic-entity-worth-considering-in-patients-with-migraine-and-other-associated-symptoms weekly 0.8 https://www.themednet.org/what-is-your-approach-to-tapering-off-rituximab-in-a-patient-with-pemphigus-who-seems-to-be-remission weekly 0.8 https://www.themednet.org/is-it-necessary-to-test-for-all-tree-nuts-when-a-patient-presents-with-ige-mediated-symptoms-to-an-isolated-tree-nut weekly 0.8 https://www.themednet.org/when-do-you-use-greater-occipital-nerve-block-to-treat-acute-refractory-migraine weekly 0.8 https://www.themednet.org/how-would-you-manage-serum-sodium-monitoring-for-an-asymptomatic-outpatient-with-newly-diagnosed-siadh-and-a-serum-sodium-level-of-127-meq-l-for-whom-you-are-initiating-treatment-with-urea weekly 0.8 https://www.themednet.org/would-you-still-treat-with-course-for-osteomyelitis-if-proximal-bone-cultures-after-amputation-are-still-positive-but-pathology-does-not-demonstrate-osteomyelitis weekly 0.8 https://www.themednet.org/how-do-you-think-about-using-contraction-alkalosis-as-a-mark-of-achieving-goal-diuresis weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-older-adult-patients-with-dementia-who-repeatedly-aspirate-with-oral-intake-but-whose-family-hcp-may-be-unwilling-to-accept-the-aspiration-risk-associated-with-comfort-eating weekly 0.8 https://www.themednet.org/do-you-routinely-monitor-urine-toxicology-for-primary-care-patients-prescribed-tramadol-for-chronic-pain weekly 0.8 https://www.themednet.org/do-you-use-daptomycin-interchangeably-with-staphylococcal-beta-lactams-for-ease-of-dosing-on-discharge-for-patients-with-serious-mssa-infections-endocarditis-bacteremias-etc weekly 0.8 https://www.themednet.org/in-patients-with-masld-mash-do-you-perform-any-cardiac-testing-to-create-a-patients-risk-profile-given-that-cardiac-complications-are-the-top-cause-of-morbidity-and-mortality-in-this-patient-population-especially-those-with-advanced-fibrosis weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-request-a-welfare-check-police-or-mobile-crisis-when-a-typically-responsive-outpatient-becomes-suddenly-unreachable weekly 0.8 https://www.themednet.org/how-do-you-manage-arfid-in-children-encountered-in-your-practice weekly 0.8 https://www.themednet.org/how-do-you-address-parental-concern-about-children-becoming-addicted-to-stimulants-for-adhd-treatment weekly 0.8 https://www.themednet.org/which-patients-are-good-candidates-for-micropulse-cpc weekly 0.8 https://www.themednet.org/what-is-your-approach-to-augmenting-treatment-for-depressive-disorders-in-those-continuing-to-take-a-tricyclic-antidepressant-at-baseline-due-to-historical-effectiveness weekly 0.8 https://www.themednet.org/how-do-you-decide-when-and-how-often-to-reach-out-to-patients-with-serious-mental-illness-who-are-disengaging-from-care-due-to-psychosocial-stressors weekly 0.8 https://www.themednet.org/how-do-you-approach-mood-stabilizer-selection-for-older-adults-with-bipolar-ii-disorder weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-interested-in-primary-prevention-of-ms weekly 0.8 https://www.themednet.org/are-there-subgroups-of-patients-with-pemphigus-in-whom-you-prioritize-lower-dose-rituximab-regimens-1 weekly 0.8 https://www.themednet.org/how-do-you-tailor-rituximab-dosing-for-mucosal-predominant-vs-mucocutaneous-pemphigus-1 weekly 0.8 https://www.themednet.org/do-you-change-your-approach-to-prednisone-taper-based-on-rituximab-dosing-regimen-when-treating-patients-with-pemphigus-1 weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-pemhigus-on-the-main-safety-benefits-of-a-low-or-ultra-low-dose-rituximab-regimen-1 weekly 0.8 https://www.themednet.org/how-do-you-differentiate-cognitive-impairment-from-normal-age-related-cognitive-decline weekly 0.8 https://www.themednet.org/how-do-you-pragmatically-approach-a-conversation-about-liver-detox-liver-cleansers-when-patients-bring-up-this-topic weekly 0.8 https://www.themednet.org/in-what-kind-of-patient-scenario-would-you-consider-testing-for-inherited-disorders-of-lipid-metabolism-in-the-evaluation-of-a-patient-with-masld-what-are-you-looking-for-clinically-and-in-their-workup-and-how-do-you-proceed weekly 0.8 https://www.themednet.org/how-do-you-treat-gram-negative-folliculitis-in-a-transplant-patient-on-sirolimus-who-cannot-use-isotretinoin-due-to-drug-interactions weekly 0.8 https://www.themednet.org/how-would-you-manage-hht-with-ongoing-epistaxis-despite-iv-bevacizumab-with-a-history-of-superficial-thrombosis weekly 0.8 https://www.themednet.org/how-do-you-determine-when-patients-can-resume-their-previous-activities-after-a-subdural-hemorrhage weekly 0.8 https://www.themednet.org/is-there-any-role-for-topical-corticosteroids-in-the-treatment-of-photokeratitis weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-newly-discovered-prediabetes-in-adults-over-the-age-of-65 weekly 0.8 https://www.themednet.org/when-should-mog-ab-be-tested-in-patients-with-suspected-autoimmune-encephalitis-with-seizures-and-normal-mri weekly 0.8 https://www.themednet.org/do-you-use-an-antibiotic-with-antitoxin-activity-for-the-entire-duration-of-therapy-for-patients-with-necrotizing-mssa-or-mrsa-pneumonia-or-just-until-definitive-clinical-improvement weekly 0.8 https://www.themednet.org/is-there-benefit-for-anterior-chamber-washouts-for-the-treatment-of-infectious-keratitis-extending-into-the-anterior-chamber-and-when-do-you-consider-utilizing-it weekly 0.8 https://www.themednet.org/whats-is-the-best-thing-to-do-with-a-55-year-old-patient-with-ckd4-discovered-to-have-bilateral-complex-bosniak-2f-cysts weekly 0.8 https://www.themednet.org/any-new-well-tested-treatments-for-rapid-recurrence-of-fsgs-after-renal-transplant-besides-plasmapharesis-and-rituxan-also-who-are-the-experts-in-the-field weekly 0.8 https://www.themednet.org/do-you-change-your-pre-operative-insulin-dosing-when-patients-are-npo-for-surgery-but-also-just-recovering-from-newly-resolved-dka weekly 0.8 https://www.themednet.org/how-would-you-approach-counseling-an-older-patient-with-significant-hearing-loss-and-nonadherence-to-use-of-hearing-aids weekly 0.8 https://www.themednet.org/when-do-you-use-extended-release-buprenorphine-instead-of-daily-formulations-1 weekly 0.8 https://www.themednet.org/does-treatment-with-hydroxychloroquine-increase-the-risk-of-hypertension-or-exacerbate-pre-existing-hypertension weekly 0.8 https://www.themednet.org/what-safe-medications-can-we-use-for-anxiety-in-patients-with-myasthenic-crisis-who-got-recently-extubated weekly 0.8 https://www.themednet.org/what-drug-and-specific-dosing-would-you-use-for-secondary-pneumocystis-prophylaxis-in-a-patient-with-renal-transplant-documented-tmp-smx-allergy-and-normal-g6pd-testing-who-was-diagnosed-with-moderate-pjp-and-improved-on-clindamycin-primaquine-and-steroid weekly 0.8 https://www.themednet.org/when-do-you-write-notes-excusing-children-from-certain-school-activities-ex-gym-due-to-anxiety-disorder weekly 0.8 https://www.themednet.org/what-is-your-protocol-for-type-of-surveillance-imaging-ct-mri-pet-and-frequency-of-follow-up-after-sbrt-to-a-bone-metastasis weekly 0.8 https://www.themednet.org/how-does-lack-of-success-of-rituximab-treatment-affect-your-decision-to-trial-anti-cd19-therapies-like-inebilizumab weekly 0.8 https://www.themednet.org/what-is-your-diagnostic-approach-to-patients-presenting-for-adhd-concerns-when-you-suspect-untreated-sleep-apnea weekly 0.8 https://www.themednet.org/how-do-you-approach-incidental-image-findings-with-unclear-clinical-significance weekly 0.8 https://www.themednet.org/in-patients-with-concomitantly-diagnosed-stage-iv-dlbcl-and-gastric-malt-lymphoma-who-have-residual-gastric-malt-after-6-cycles-of-pola-r-chp-would-you-alter-the-standard-dose-fractionation-for-isrt-for-the-gastric-malt-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-young-man-receiving-ebrt-as-part-of-tnt-for-rectal-cancer-about-risk-of-infertility weekly 0.8 https://www.themednet.org/would-you-consider-using-acetazolamide-to-manage-glomerular-hyperfiltration-in-patients-with-type-1-diabetes-since-sglt2-inhibitors-are-contraindicated-in-this-population weekly 0.8 https://www.themednet.org/how-do-you-approach-the-decision-to-perform-preimplantation-biopsies-in-brain-dead-kidney-donors weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-management-of-alcohol-use-disorder-with-concomitant-depression weekly 0.8 https://www.themednet.org/do-you-use-lactulose-in-acute-liver-failure-particularly-in-patients-on-continuous-renal-replacement-therapy-crrt-for-ammonia-or-toxin-clearance weekly 0.8 https://www.themednet.org/would-you-avoid-potassium-citrate-initiation-in-a-pregnant-patient-with-hypocitraturia-and-recurrent-calcium-oxalate-nephrolithiasis weekly 0.8 https://www.themednet.org/how-would-you-approach-a-stable-3-cm-iatrogenic-pneumothorax-in-an-asymptomatic-patient weekly 0.8 https://www.themednet.org/would-you-perform-a-diagnostic-paracentesis-for-first-time-ascites-in-a-patient-with-established-chf-or-pulmonary-hypertension-but-without-apparent-liver-or-other-intra-abdominal-disease weekly 0.8 https://www.themednet.org/which-serologic-tests-are-most-helpful-when-evaluating-for-suspected-drug-induced-lupus weekly 0.8 https://www.themednet.org/how-do-you-work-with-patients-to-establish-reasonable-treatment-goals-for-the-management-of-fibromyalgia-related-pain-1 weekly 0.8 https://www.themednet.org/how-do-you-manage-withdrawal-symptoms-after-stimulant-discontinuation weekly 0.8 https://www.themednet.org/do-you-titrate-anti-seizure-medication-doses-in-the-setting-of-high-or-low-serum-drug-levels-if-patients-remain-seizure-free weekly 0.8 https://www.themednet.org/how-do-you-manage-maintenance-for-braf-v600e-mutated-metastatic-colon-cancer-responding-to-folfox-encorafenib-cetuximab-breakwater-in-the-first-line weekly 0.8 https://www.themednet.org/what-tools-do-you-use-to-evaluate-for-cognitive-deficits-in-young-patients weekly 0.8 https://www.themednet.org/what-is-the-role-for-checking-uric-acid-levels-in-evaluation-of-siadh-in-hospitalized-older-adults weekly 0.8 https://www.themednet.org/would-you-consider-recommending-parathyroidectomy-for-primary-hyperparathyroidism-patients-with-high-calcium-and-pth-levels-even-without-traditional-criteria-based-on-recent-studies-showing-reduced-anxiety-and-depression weekly 0.8 https://www.themednet.org/how-would-you-treat-a-small-cell-carcinoma-with-a-4-cm-right-bartholins-gland-primary-and-a-single-small-right-inguinal-adenopathy weekly 0.8 https://www.themednet.org/what-are-the-recommended-second-line-treatment-options-for-patients-with-metastatic-her2-breast-cancer-who-have-received-frontline-trastuzumab-deruxtecan-t-dxd weekly 0.8 https://www.themednet.org/for-hospitalized-patients-with-confirmed-viral-respiratory-infections-who-clinically-improve-but-remain-pcr-positive-how-long-do-you-maintain-isolation-precautions weekly 0.8 https://www.themednet.org/in-patients-with-persistent-borderline-hypotension-recovering-from-sepsis-or-critical-illness-do-you-use-midodrine-to-avoid-escalating-to-higher-levels-of-care weekly 0.8 https://www.themednet.org/in-older-adults-with-chronic-mild-hyponatremia-na-128-132-attributed-to-ssris-but-good-psychiatric-response-do-you-tolerate-persistent-hyponatremia-reduce-the-dose-or-switch-agents weekly 0.8 https://www.themednet.org/in-adults-80-years-with-tsh-6-10-miu-l-and-minimal-symptoms-do-you-initiate-levothyroxine-monitor-or-avoid-treatment-entirely weekly 0.8 https://www.themednet.org/how-do-you-approach-post-lumpectomy-surveillance-in-male-breast-cancer-patients-without-brca-or-other-mutations weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-start-steroids-for-a-patient-with-a-new-brain-tumor-prior-to-biopsy-or-resection weekly 0.8 https://www.themednet.org/when-would-you-consider-glucocorticoids-as-adjunctive-therapy-for-for-community-acquired-pneumonia-outside-of-the-icu-setting weekly 0.8 https://www.themednet.org/how-do-you-titrate-opioids-for-pain-and-breathlessness-in-patients-with-a-dnr-dni-code-status-but-who-otherwise-still-wish-to-pursue-life-prolonging-treatments weekly 0.8 https://www.themednet.org/what-is-the-appropriate-pediatric-dose-of-litfulo-for-a-preadolescent-with-refractory-alopecia-areata weekly 0.8 https://www.themednet.org/what-is-the-goal-oxygen-saturation-for-patients-with-copd-and-pulmonary-hypertension weekly 0.8 https://www.themednet.org/can-you-have-an-allergic-reaction-to-paprika-if-you-have-tree-nut-allergy weekly 0.8 https://www.themednet.org/for-high-risk-ulcer-bleeding-requiring-early-anticoagulant-resumption-what-endoscopic-clinical-threshold-prompts-you-to-add-adjunctive-prophylactic-hemostatic-powder-specifically-to-support-earlier-restart weekly 0.8 https://www.themednet.org/how-do-you-approach-continued-prescribing-of-benzodiazepines-when-a-patient-who-is-already-prescribed-benzodiazepines-reports-concurrent-illicit-benzodiazepine-use weekly 0.8 https://www.themednet.org/how-do-you-determine-personalized-blood-pressure-targets-after-ischemic-stroke weekly 0.8 https://www.themednet.org/do-you-counsel-patients-differently-about-the-risk-of-radiation-induced-malignancy-when-you-are-treating-a-proximal-joint-hip-vs-a-distal-joint-elbow-for-benign-conditions-such-as-oa weekly 0.8 https://www.themednet.org/what-is-the-preferred-osteoporosis-therapy-after-completing-teriparatide-in-a-young-woman-planning-pregnancy-within-the-next-year weekly 0.8 https://www.themednet.org/when-if-ever-do-you-consider-using-dronabinol-to-treat-agitation-in-dementia weekly 0.8 https://www.themednet.org/would-you-consider-anti-fibrinolytics-for-heavy-menses-in-patients-with-a-history-of-vte weekly 0.8 https://www.themednet.org/do-you-offer-antibiotic-therapy-for-patients-with-a-chronic-joint-infection-with-no-plans-for-surgery-and-with-an-open-draining-sinus-tract weekly 0.8 https://www.themednet.org/are-there-instances-when-you-recommend-initiation-of-hemodialysis-for-patients-with-severe-symptomatic-hypercalcemia weekly 0.8 https://www.themednet.org/how-do-you-approach-rising-psa-following-radical-prostatectomy-and-early-salvage-radiation-therapy weekly 0.8 https://www.themednet.org/is-there-any-evidence-that-spironolactone-or-finasteride-therapy-increase-blood-levels-of-testosterone weekly 0.8 https://www.themednet.org/beyond-fatigability-what-distinctive-features-of-diplopia-characterize-myasthenia-gravis weekly 0.8 https://www.themednet.org/what-clinical-parameters-or-cv-imaging-considerations-would-prompt-you-to-consider-av-nodal-ablation-for-patients-with-cardiac-amyloidosis-and-symptomatic-atrial-fibrillation weekly 0.8 https://www.themednet.org/how-do-you-determine-which-patients-with-icas-are-the-best-candidates-for-balloon-angioplasty-versus-those-who-should-continue-with-aggressive-medical-management-alone weekly 0.8 https://www.themednet.org/how-frequently-does-one-see-resting-tremor-in-drug-induced-parkinsonism weekly 0.8 https://www.themednet.org/should-hcq-be-continued-in-an-asymptomatic-sle-patient-who-has-received-renal-transplant weekly 0.8 https://www.themednet.org/given-some-of-the-theoretical-relationship-between-glutamate-and-ocd-do-you-ever-consider-the-use-of-nmda-or-ampa-antagonists-for-the-treatment-of-refractory-ocd weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-for-patients-with-limited-stage-small-cell-lung-cancer-who-after-initial-carboplatin-etoposide-develop-a-new-contralateral-lung-nodule-confirmed-as-sclc-while-their-primary-tumor-shows-a-partial-response weekly 0.8 https://www.themednet.org/when-do-you-consider-using-multiple-antipsychotic-medications-for-chronic-management-of-psychosis weekly 0.8 https://www.themednet.org/how-do-you-identify-which-patients-are-at-highest-risk-for-decompensation-and-most-likely-to-benefit-from-niv-for-pre-oxygenation-prior-to-intubation weekly 0.8 https://www.themednet.org/does-the-experience-level-of-the-intubation-operator-affect-outcomes-related-to-pre-oxygenation-with-niv-versus-an-oxygen-mask weekly 0.8 https://www.themednet.org/does-the-use-of-niv-for-pre-oxygenation-delay-the-time-to-intubation weekly 0.8 https://www.themednet.org/would-you-consider-over-the-counter-dextromethorphan-low-dose-slow-titration-as-augmentation-in-mdd weekly 0.8 https://www.themednet.org/would-you-consider-treating-empirically-for-avp-deficiency-in-a-patient-who-had-pituitary-surgery-6-months-earlier-and-complaints-of-polyuria-polydipsia-with-dilute-urine-without-performing-water-deprivation-studies weekly 0.8 https://www.themednet.org/do-you-taper-steroids-more-aggressively-to-decrease-the-risk-of-developing-new-onset-diabetes-after-transplantation-in-kidney-transplant-recipients-who-had-pretransplant-impaired-fasting-glucose weekly 0.8 https://www.themednet.org/how-would-you-approach-an-asymptomatic-older-female-patient-with-eosinophilia-to-17-000-present-for-years-and-normal-eosinophilia-workup-including-marrow-and-negative-flip1 weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-recommend-for-a-premenopausal-woman-with-low-er-pr-1-10-her2-pt1cn0-metaplastic-breast-cancer weekly 0.8 https://www.themednet.org/is-there-any-benefit-of-using-aspirin-to-mitigate-vte-risk-in-testosterone-induced-polycythemia weekly 0.8 https://www.themednet.org/what-is-your-preferred-sequencing-of-adjuvant-chemotherapy-and-pmrt-for-node-breast-cancer weekly 0.8 https://www.themednet.org/how-long-do-you-maintain-patients-with-anti-synthetase-syndrome-on-rituximab weekly 0.8 https://www.themednet.org/would-you-switch-to-a-tnfi-if-a-patient-developed-squamous-cell-skin-cancer-on-abatacept-after-failure-of-methotrexate-for-seropositive-ra weekly 0.8 https://www.themednet.org/as-partiqol-was-a-negative-study-what-is-the-current-role-for-proton-therapy-in-the-management-of-prostate-cancer-patients weekly 0.8 https://www.themednet.org/how-many-days-prior-to-surgery-do-you-recommend-stopping-sglt2-inhibitors-and-when-is-it-safe-to-resume-therapy weekly 0.8 https://www.themednet.org/is-your-decision-to-prescribe-empagliflozin-for-ckd-patients-without-albuminuria-influenced-by-a-recent-cost-utility-analysis-showing-that-empagliflozin-was-not-cost-effective-for-this-group weekly 0.8 https://www.themednet.org/do-you-recommend-moonstone-supplements-for-patients-with-recurrent-calcium-oxalate-nephrolithiasis-who-have-hypocitraturia-and-mild-hyperkalemia-for-which-potassium-citrate-is-contraindicated weekly 0.8 https://www.themednet.org/how-do-you-treat-patients-with-stroke-thought-to-be-secondary-to-lambl-excrescence weekly 0.8 https://www.themednet.org/how-do-you-approach-lu-177-use-in-taxane-naive-patients-with-metastatic-prostate-cancer weekly 0.8 https://www.themednet.org/when-would-you-consider-long-term-cardiac-monitoring-to-look-for-atrial-fibrillation-in-patients-with-mitral-stenosis-given-their-baseline-elevated-risk-for-atrial-fibrillation-and-thrombosis weekly 0.8 https://www.themednet.org/how-would-you-approach-surveillance-imaging-for-men-with-early-stage-hormone-receptor-positive-breast-cancer-after-unilateral-mastectomy weekly 0.8 https://www.themednet.org/do-you-prefer-using-losartan-in-your-patients-with-hypertension-and-gout-due-to-its-uricosuric-effects weekly 0.8 https://www.themednet.org/do-you-switch-from-0-15-mg-to-0-3-mg-epinephrine-at-55lbs-or-66lbs weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-patient-who-develops-squamous-cell-skin-cancer-while-on-abatacept weekly 0.8 https://www.themednet.org/do-you-avoid-performing-urine-microscopy-in-patients-with-aki-who-have-covid-19-given-concern-for-potential-aerosolization weekly 0.8 https://www.themednet.org/would-you-escalate-treatment-for-a-patient-with-crohn-disease-with-changes-suggestive-of-chronic-sacroiliitis-on-mri-but-without-bone-marrow-edema-or-effusion-that-suggests-active-inflammation weekly 0.8 https://www.themednet.org/do-you-ever-dose-escalate-radiotherapy-to-the-primary-in-low-volume-metastatic-prostate-cancer weekly 0.8 https://www.themednet.org/in-patients-with-resolved-lv-thrombus-post-mi-after-3-6-months-of-anticoagulation-would-you-consider-surveillance-imaging-for-thrombus-recurrence-if-there-is-persistent-apical-akinesis weekly 0.8 https://www.themednet.org/do-you-recommend-non-bypass-bariatric-surgeries-over-intestinal-bypass-procedures-for-kidney-transplant-eligible-candidates-to-prevent-oxalate-nephropathy-given-the-higher-risk-of-kidney-oxalate-deposition-with-intestinal-bypass weekly 0.8 https://www.themednet.org/for-patients-with-stage-iiib-or-iv-hd-flowing-bv-avepc-with-initial-large-mediastinal-adenopathy-how-can-we-avoid-isrt weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-pursue-completion-alnd-in-a-patient-with-multiple-positive-sentinel-nodes-after-breast-conserving-surgery weekly 0.8 https://www.themednet.org/what-approach-or-dosing-interval-do-you-find-is-most-effective-reducing-side-effects-of-hedgehog-inhibitors-i-e-vismodegib-for-patients-with-numerous-bcc weekly 0.8 https://www.themednet.org/have-you-used-itraconazole-as-a-primary-or-adjunct-therapy-for-individuals-with-numerous-bccs weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-would-you-deliver-to-the-sole-of-the-foot-in-a-patient-with-multifocal-cutaneous-dlbcl-that-is-resistant-to-systemic-therapy weekly 0.8 https://www.themednet.org/what-is-the-recommendation-for-women-with-migraine-with-aura-who-are-planning-to-undergo-ivf-hormone-therapy weekly 0.8 https://www.themednet.org/how-often-do-you-recommend-basic-metabolic-panel-checks-in-a-hospitalized-eskd-patient-on-thrice-weekly-hemodialysis-and-for-whom-hyperkalemia-is-not-of-major-concern weekly 0.8 https://www.themednet.org/have-you-considered-intralesional-cempilumab-for-locally-advanced-nmsc-kcs-prior-to-surgery weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-determining-whether-to-perform-a-biopsy-for-the-diagnosis-of-organizing-pneumonia weekly 0.8 https://www.themednet.org/how-do-you-approach-evaluation-and-management-of-a-patient-with-recurrent-monoarticular-inflammatory-arthritis-of-unclear-etiology weekly 0.8 https://www.themednet.org/would-you-consider-using-a-jak-inhibitor-for-a-patient-with-ra-associated-scleritis weekly 0.8 https://www.themednet.org/any-thoughts-on-whether-oral-immunotherapy-versus-xolair-would-provide-a-better-chance-of-outgrowing-a-food-allergy weekly 0.8 https://www.themednet.org/what-is-the-utility-of-near-infrared-autofluorescence-niraf-imaging-during-parathyroid-surgery weekly 0.8 https://www.themednet.org/which-type-of-colonic-polyps-or-mass-like-lesions-do-you-refer-to-an-advanced-endoscopist weekly 0.8 https://www.themednet.org/how-do-you-incorporate-intestinal-ultrasound-in-the-care-of-patients-with-inflammatory-bowel-disease weekly 0.8 https://www.themednet.org/does-pyloric-manometry-help-guide-your-choice-of-g-poem-vs-gastric-electrical-stimulation-in-the-treatment-of-gastroparesis weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-patients-who-require-nutritional-restoration-in-the-setting-of-a-presumed-functional-gi-disorder-recalcitrant-to-behavioral-medicine-and-pharmacologic-therapies weekly 0.8 https://www.themednet.org/when-do-you-send-for-genetic-testing-e-g-spink1-prss1-cftr-in-a-patient-with-recurrent-or-chronic-pancreatitis-without-an-obvious-etiology-and-how-does-it-impact-your-management weekly 0.8 https://www.themednet.org/how-do-you-cross-taper-when-switching-from-an-ssri-to-an-snri weekly 0.8 https://www.themednet.org/is-there-any-role-for-radiation-in-the-treatment-of-stage-ii-nasopharyngeal-dlbcl-involving-bilateral-nasopharynx-and-unilateral-cervical-nodal-involvement-but-without-bony-or-nerve-involvement weekly 0.8 https://www.themednet.org/for-patients-with-er-negative-her2-ultralow-breast-cancer-how-and-when-would-you-incorporate-t-dxd weekly 0.8 https://www.themednet.org/is-there-a-role-for-using-parenteral-anticoagulation-for-occlusive-extensive-ica-thrombus-with-acute-onset-of-symptoms-when-patients-are-not-candidates-for-endovascular-therapy-such-as-low-nihss weekly 0.8 https://www.themednet.org/how-often-do-you-monitor-for-pancreatitis-check-lipase-amylase-while-on-axitinib weekly 0.8 https://www.themednet.org/would-you-accept-the-diagnosis-of-sle-on-the-basis-of-an-avise-ctd-panel-where-the-results-just-showed-a-positive-ec4d-or-bc4d-positive-ana-1-80-one-clinical-criteria-such-as-multiple-tender-joints-but-did-otherwise-not-fulfill-criteria-for-sle weekly 0.8 https://www.themednet.org/would-you-recommend-avoiding-use-of-bimekizumab-in-patients-at-higher-risk-of-fungal-infections-such-as-patients-with-diabetes-who-are-on-sglt-2-inhibitors-which-also-increase-the-risk-of-fungal-infections weekly 0.8 https://www.themednet.org/are-there-any-special-treatment-considerations-when-treating-a-patient-with-laryngeal-cancer-with-significant-reinkes-edema-of-the-vocal-folds weekly 0.8 https://www.themednet.org/do-you-use-anticoagulants-in-the-management-of-patients-with-pulmonary-veno-occlusive-disease-pvod weekly 0.8 https://www.themednet.org/do-you-treat-non-albicans-strains-of-candida-on-sputum-culture-or-bal-in-patients-who-are-immunosuppressed weekly 0.8 https://www.themednet.org/do-you-routinely-perform-a-pre-extubation-bronchoscopy-for-secretion-clearance-during-the-index-hospitalization-in-patients-following-lung-transplantation weekly 0.8 https://www.themednet.org/would-you-switch-to-bimekizumab-if-a-patient-with-psoriatic-arthritis-who-is-already-on-an-il-17-inhibitor-has-breakthrough-skin-or-joint-disease weekly 0.8 https://www.themednet.org/would-you-choose-bimekizumab-over-other-il-17-inhibitors-in-patients-with-increased-levels-of-disease-related-pain-and-poor-functional-status weekly 0.8 https://www.themednet.org/should-ivig-dosing-in-patients-with-autoimmune-disease-i-e-dermatomyositis-who-become-pregnant-continue-to-be-based-on-actual-weight-at-the-time-of-each-infusion-or-should-it-be-limited-to-pre-pregnancy-weight weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-pediatric-patient-presenting-with-a-new-daily-persistent-headache weekly 0.8 https://www.themednet.org/what-workup-do-you-recommend-for-isolated-postural-and-action-tremors-in-a-developmentally-typical-toddler weekly 0.8 https://www.themednet.org/for-nsclc-patients-treated-with-neoadjuvant-chemoimmunotherapy-and-surgery-with-ypn2-disease-what-factors-would-cause-you-to-recommend-port weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gi-cancers-from-esmo-2024 weekly 0.8 https://www.themednet.org/what-additional-treatment-strategies-would-you-recommend-for-a-patient-with-a-mycobacterium-chelonae-and-mycobacterium-abscessus-infection-following-bilateral-prophylactic-mastectomies-and-implant-insertion-who-has-undergone-multiple-surgeries-and-an-exte weekly 0.8 https://www.themednet.org/what-is-the-recommended-approach-for-systemic-therapy-for-patients-with-locally-recurrent-p16-positive-scc-of-the-oral-cavity-who-are-not-candidates-for-resection-or-re-irradiation weekly 0.8 https://www.themednet.org/how-do-you-approach-pelvic-radiation-therapy-for-a-patient-with-multiple-myeloma-who-needs-more-intensive-therapy-e-g-dara-krd-or-impending-car-t-with-a-risk-of-cytopenias weekly 0.8 https://www.themednet.org/for-a-patient-with-enktl-nasal-type-nose-sinus-involvement-who-has-hepatic-toxicity-with-pegasparaginase-but-a-cr-after-2-cycles-of-chemotherapy-with-a-plan-for-sandwich-radiotherapy-what-if-any-chemotherapy-would-you-resume-after-completion-of-radiation weekly 0.8 https://www.themednet.org/how-do-you-interpret-the-presence-of-gad-antibody-in-a-middle-aged-patient-with-diabetes-when-all-other-type-1-diabetes-antibodies-are-absent weekly 0.8 https://www.themednet.org/what-alternative-medications-other-than-dapsone-would-you-consider-for-dermatitis-herpetiformis-in-a-sulfa-allergic-patient weekly 0.8 https://www.themednet.org/would-you-offer-pelvic-re-irradiation-in-the-setting-of-locally-recurrent-anal-cancer-in-the-presacral-region weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-rt-or-chemort-in-ls-sclc-s-p-lobectomy-with-n1-disease weekly 0.8 https://www.themednet.org/have-you-considered-priming-crrt-machines-with-renal-replacement-solutions-during-the-current-crystalloid-solution-shortage weekly 0.8 https://www.themednet.org/are-you-still-recommending-autologous-stem-cell-transplantation-asct-for-all-eligible-myeloma-patients-who-achieve-remission-after-induction-with-a-quadruplet-regimen weekly 0.8 https://www.themednet.org/how-do-you-talk-to-patients-with-intermediate-risk-prostate-cancer-deciding-between-ldr-brachytherapy-monotherapy-vs-hdr-mono-vs-sbrt-vs-ebrt-in-terms-of-the-comparative-side-effect-profile-of-each-approach weekly 0.8 https://www.themednet.org/are-the-laws-regarding-prescribing-c-2-medications-different-for-mail-order-pharmacies weekly 0.8 https://www.themednet.org/how-would-you-manage-an-intermediate-risk-segmental-pe-that-is-transiently-provoked-after-a-knee-surgery weekly 0.8 https://www.themednet.org/are-there-certain-disease-domains-in-a-patient-with-psoriatic-arthritis-that-will-make-bimekizumab-a-particularly-good-option weekly 0.8 https://www.themednet.org/where-do-you-anticipate-using-bimekizumab-in-your-sequence-of-treatment-options-for-a-patient-with-psoriatic-arthritis weekly 0.8 https://www.themednet.org/do-you-consider-jak-inhibitors-such-as-baricitinib-a-reasonable-option-for-ffa weekly 0.8 https://www.themednet.org/what-oral-treatment-options-would-you-offer-a-patient-with-severe-onychomycosis-who-is-also-on-methotrexate-for-another-condition weekly 0.8 https://www.themednet.org/when-do-you-consider-using-stimulants-in-patients-with-cognitive-impairments-secondary-to-traumatic-brain-injury weekly 0.8 https://www.themednet.org/would-you-offer-post-operative-radiation-for-a-patient-who-had-findings-of-lymphovascular-invasion-on-salvage-resection-of-a-recurrent-obturator-node-after-definitive-chemoradiation-for-cervical-cancer weekly 0.8 https://www.themednet.org/how-would-you-sequence-adjuvant-chemo-immunotherapy-paclitaxel-carbo-pembro-or-paclitaxel-carbo-dostarlimab-with-ebrt-and-vaginal-cuff-brachytherapy-in-advanced-uterine-cancer-that-meets-clinical-criteria-for-both-ebrt-and-chemo-io weekly 0.8 https://www.themednet.org/what-is-the-interpretation-of-an-igra-with-positive-tb-wells-and-negative-nil-and-negative-mitogen-wells weekly 0.8 https://www.themednet.org/would-you-start-potassium-citrate-in-a-patient-with-recurrent-nephrolithiasis-of-unknown-stone-composition-who-has-hypocitraturia-and-alkaline-urine-ph weekly 0.8 https://www.themednet.org/when-do-you-consider-testing-with-stroke-gene-panels-in-young-stroke-patients weekly 0.8 https://www.themednet.org/how-long-can-a-patient-with-newly-diagnosed-merkel-cell-carcinoma-wait-for-wide-local-excision-with-sentinel-node-biopsy weekly 0.8 https://www.themednet.org/how-would-you-treat-disseminated-flat-warts-in-an-immunosuppressed-patient-with-skin-of-color weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-positive-lrp4-antibodies-without-clinical-findings-of-myasthenia-gravis weekly 0.8 https://www.themednet.org/for-patients-between-40-49-years-old-who-undergo-lumpectomy-how-do-you-choose-between-offering-pbi-per-the-updated-pbi-guidelines-or-boosting-based-on-boost-guidelines weekly 0.8 https://www.themednet.org/what-are-your-preferred-anti-seizure-medications-for-doose-syndrome weekly 0.8 https://www.themednet.org/would-you-order-a-repeat-dexa-scan-1-year-later-for-a-kidney-transplant-patient-who-had-an-initial-dexa-scan-within-the-first-6-months-post-transplant-showing-osteopenia-but-no-history-of-fractures-and-who-has-been-stable-on-glucocorticoid-free-immunosupp weekly 0.8 https://www.themednet.org/would-you-offer-immunotherapy-to-a-patient-with-stage-ii-nsclc-with-an-egfr-exon-20-mutation weekly 0.8 https://www.themednet.org/do-you-feel-there-is-a-role-for-triple-phase-budesonide-in-the-management-of-patients-with-celiac-disease-who-refuse-to-follow-a-gluten-free-diet weekly 0.8 https://www.themednet.org/do-you-observe-worsening-irritability-mood-symptoms-or-increased-rates-of-suicidal-ideation-in-patients-with-bipolar-disorder-who-are-using-hormone-birth-control-including-hormone-releasing-iud weekly 0.8 https://www.themednet.org/is-there-a-role-for-reirradiation-for-scc-oral-tongue-with-high-risk-features-i-e-pni-close-margins-following-surgery weekly 0.8 https://www.themednet.org/when-will-you-choose-tarlatamab-over-an-alternative-systemic-therapy-e-g-lurbinectedin-topotecan-for-relapsed-es-sclc weekly 0.8 https://www.themednet.org/do-you-always-perform-salivary-gland-biopsy-to-confirm-the-diagnosis-in-patients-with-suspected-seronegative-sjogrens-syndrome weekly 0.8 https://www.themednet.org/would-you-consider-sbrt-to-a-single-nodal-recurrence-in-a-patient-with-previously-treated-metastatic-gej-adenocarcinoma-s-p-a-complete-response-to-systemic-therapy-followed-by-37-5-gy-to-the-primary-who-was-ned-for-12-months-up-until-this-recurrence weekly 0.8 https://www.themednet.org/do-you-recommend-a-patient-with-recurrent-nephrolithiasis-who-is-performing-a-24-hour-urine-collection-add-a-urine-preservative-or-keep-the-specimen-refrigerated weekly 0.8 https://www.themednet.org/how-well-does-a-negative-non-contrast-mri-of-the-brain-exclude-metastasis-in-a-patient-with-squamous-cell-carcinoma-of-the-lung weekly 0.8 https://www.themednet.org/do-you-interpret-failure-to-develop-hypernatremia-with-prolonged-water-deprivation-such-as-for-12-hours-as-evidence-against-diabetes-insipidus-even-if-the-urine-osmolality-is-just-below-normal weekly 0.8 https://www.themednet.org/what-is-your-approach-to-using-calcium-containing-medications-for-patients-with-recurrent-nephrolithiasis-and-hyperoxaluria weekly 0.8 https://www.themednet.org/would-you-recommend-waiting-for-a-low-vitamin-d-level-to-correct-to-goal-prior-to-giving-a-scheduled-prolia-injection-when-transitioning-a-patient-from-zolendronic-acid-to-prolia-therapy-for-worsening-osteoporosis weekly 0.8 https://www.themednet.org/how-do-you-approach-early-stage-breast-cancer-patients-who-are-asking-for-ctdna-or-tumor-marker-surveillance-or-previously-receiving-these-with-another-provider-when-these-are-not-part-of-the-nccn-or-asco-guidelines weekly 0.8 https://www.themednet.org/would-it-be-reasonable-to-begin-considering-glp1-ras-or-finerenone-for-patients-with-heart-failure-with-recovered-lvef-in-light-of-recent-trials-such-as-select-and-finearts-hf-showing-some-success-in-hfpef-and-hfmref-populations weekly 0.8 https://www.themednet.org/how-long-do-you-continue-rituximab-in-patients-with-anca-associated-vasculitis-who-have-achieved-remission weekly 0.8 https://www.themednet.org/do-you-continue-biologics-in-sjia-patients-who-develop-lung-disease-on-anti-il-1-or-anti-il-6-therapies weekly 0.8 https://www.themednet.org/do-you-use-elacestrant-for-all-patients-with-metastatic-er-her2-esr1-mutated-breast-cancer-regardless-of-duration-of-response-to-prior-et-cdk4-6i weekly 0.8 https://www.themednet.org/how-soon-after-starting-treatment-for-takayasu-arteritis-do-you-decide-on-the-need-for-any-vascular-interventions-to-manage-chronic-damage weekly 0.8 https://www.themednet.org/do-you-recommend-obtaining-both-a-parathyroid-ultrasound-and-a-parathyroid-nuclear-medicine-scan-when-evaluating-a-patient-with-recurrent-calcium-based-nephrolithiasis-who-is-found-to-have-an-elevated-pth-level-hypercalcemia-and-hypercalciuria weekly 0.8 https://www.themednet.org/how-do-you-manage-withdrawal-symptoms-of-snris-that-exist-even-after-slow-taper weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-of-airway-involvement-such-as-recurrent-bronchial-stenosis-in-relapsing-polychondritis weekly 0.8 https://www.themednet.org/how-do-you-manage-prostate-cancer-in-patients-that-cannot-swallow-pills weekly 0.8 https://www.themednet.org/do-you-ever-consider-a-third-course-of-cns-radiation-to-the-same-area-for-an-in-field-recurrence weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-a-kidney-transplant-recipient-who-develops-de-novo-donor-specific-antibodies-but-shows-no-clinical-signs-of-rejection-or-graft-dysfunction weekly 0.8 https://www.themednet.org/do-you-screen-for-mthfr-polymorphisms-in-your-patients-with-treatment-resistant-depression weekly 0.8 https://www.themednet.org/what-type-of-des-should-you-opt-for-if-a-patient-has-or-is-concerned-about-possible-nickel-allergy weekly 0.8 https://www.themednet.org/how-do-you-approach-managing-patients-with-diabetic-kidney-disease-and-proteinuria-who-develop-hypoglycemia-after-initiation-of-a-sglt2-inhibitor weekly 0.8 https://www.themednet.org/how-reliable-do-you-find-it-to-make-the-diagnosis-of-bipolar-disorder-based-on-a-patient-report-of-prior-symptoms-or-questionnaire-and-not-the-actual-observation-of-hypo-mania-on-the-exam weekly 0.8 https://www.themednet.org/under-what-circumstances-if-any-would-you-wait-on-initiating-a-tki-for-metastatic-recurrence-of-a-stage-iii-nsclc-which-occurred-while-on-consolidative-durvalumab-to-minimize-pneumonitis-risk weekly 0.8 https://www.themednet.org/what-is-your-approach-for-managing-persistent-psychotic-symptoms-of-a-hallucinogen-induced-persisting-psychotic-disorder weekly 0.8 https://www.themednet.org/would-you-treat-an-eskd-patient-with-renal-artery-stenosis-in-an-attempt-to-improve-blood-pressure-control-and-preserve-residual-renal-function weekly 0.8 https://www.themednet.org/would-you-recommend-dual-antiplatelet-therapy-or-anticoagulation-for-a-patient-previously-on-aspirin-who-has-a-breakthrough-stroke-with-history-of-cadasil weekly 0.8 https://www.themednet.org/what-is-the-recommended-treatment-approach-for-stage-iii-iva-nasopharyngeal-cancer-that-is-p16-negative-and-ebv-positive weekly 0.8 https://www.themednet.org/is-it-ever-safe-to-use-a-biologic-dmard-in-a-patient-with-ra-who-is-on-suppressive-antibiotics-due-to-a-history-of-septic-prosthetic-arthritis weekly 0.8 https://www.themednet.org/do-you-recommend-any-crrt-prescription-changes-for-optimal-clearance-for-patients-with-aki-who-are-on-a-reduced-blood-flow-rate-due-to-concurrent-regional-citrate-anticoagulation weekly 0.8 https://www.themednet.org/has-there-been-an-observed-interaction-between-ace-inhibitors-and-development-of-angioedema-in-a-block-demarcated-superficial-radiation-therapy-treatment-volume-ex-lip weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-omitting-radiation-in-patients-with-early-stage-unfavorable-bulky-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-to-decide-when-to-perform-a-bal-in-hypersensitivity-pneumonitis weekly 0.8 https://www.themednet.org/what-medications-are-preferred-and-contraindicated-for-insomnia-in-patients-with-a-recent-stroke-or-traumatic-brain-injury weekly 0.8 https://www.themednet.org/in-a-patient-with-history-of-recurrent-vte-despite-anticoagulation-would-you-consider-lenalidomide-as-part-of-your-initial-myeloma-regimen weekly 0.8 https://www.themednet.org/how-do-you-counsel-male-patients-with-androgenetic-alopecia-who-are-trying-to-conceive-about-using-oral-or-topical-minoxidil weekly 0.8 https://www.themednet.org/do-you-regularly-incorporate-oral-cryotherapy-in-your-practice-for-patients-receiving-oxaliplatin-to-decrease-the-risk-of-thermal-hyperalgesia weekly 0.8 https://www.themednet.org/should-patients-starting-cyclophosphamide-be-screened-routinely-for-latent-tuberculosis-tb weekly 0.8 https://www.themednet.org/for-plasmablastic-lymphoma-responsive-to-treatment-except-for-a-recurrent-lymph-node-eroding-into-a-vertebral-body-at-the-end-of-chemotherapy-would-you-cover-the-entire-vertebral-body-in-your-ctv-or-treat-only-the-involved-lymph-node-with-a-margin weekly 0.8 https://www.themednet.org/how-do-you-treat-tbi-associated-aggression weekly 0.8 https://www.themednet.org/how-do-you-treat-a-young-patient-with-desmoplastic-trichoepitheliomas weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-patients-with-cerebral-edema-in-the-setting-of-hypoxic-ischemic-injury weekly 0.8 https://www.themednet.org/in-what-situations-would-you-consider-doublet-chemotherapy-in-treatment-of-a-premenopausal-de-novo-metastatic-tnbc weekly 0.8 https://www.themednet.org/do-you-recommend-based-on-current-evidence-avoiding-antimotility-agents-in-patients-with-non-fulminant-c-difficile-infection-who-have-no-evidence-of-ileus weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-to-reduce-post-procedure-side-effects-with-onabotulinumtoxina-botox-for-chronic-migraine weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-marginal-zone-lymphoma-who-progress-after-treatment-on-a-bkti weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-patient-on-the-risk-benefit-profile-of-preventive-management-such-as-statin-initiation-if-they-have-an-elevated-lipoprotein-a-level-markedly-elevated-ldl-200-but-a-cac-score-of-0-without-other-cv-risk-factors weekly 0.8 https://www.themednet.org/what-patient-specific-factors-outside-of-health-insurance-coverage-do-you-use-to-decide-which-glp1-r-agonist-or-dual-agonist-therapy-to-start-in-patients-with-diabetes weekly 0.8 https://www.themednet.org/is-5fx-apbi-and-no-endocrine-therapy-a-new-standard-of-care-for-women-over-70-years-old-with-low-risk-breast-cancer-given-the-interim-analysis-of-the-europa-trial weekly 0.8 https://www.themednet.org/what-factors-would-encourage-you-to-choose-abatacept-vs-tocilizumab-in-a-patient-with-ra-ild-with-a-uip-pattern-of-pulmonary-fibrosis weekly 0.8 https://www.themednet.org/how-do-people-approach-non-hiv-patients-with-hepatitis-b-a-negative-hepatitis-b-e-antigen-normal-lfts-and-relatively-low-hbv-dna-between-2000-20000 weekly 0.8 https://www.themednet.org/in-a-patient-with-t2n0-breast-cancer-with-skin-involvement-s-p-lumpectomy-and-negative-margins-if-you-are-offering-whole-breast-radiation-would-you-bolus-your-tangent-fields weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-nonspecific-clinical-symptoms-and-pathology-consistent-with-spongiotic-and-psoriasiform-dermatitis-other-than-oral-jak-inhibitors weekly 0.8 https://www.themednet.org/what-concentration-of-tca-is-typically-used-to-treat-porokeratosis-on-the-arms-and-legs weekly 0.8 https://www.themednet.org/when-do-you-obtain-head-and-neck-vascular-imaging-in-patients-with-traumatic-brain-injury weekly 0.8 https://www.themednet.org/what-is-your-experience-with-using-anabolic-therapy-for-treatment-of-osteoporosis-in-patients-with-etoh-cirrhosis-and-is-one-agent-preferred-over-another-pth-analogue-vs-evenity weekly 0.8 https://www.themednet.org/where-does-dronedarone-fall-in-your-list-of-antiarrhythmics-drugs-to-use-in-terms-of-efficacy-and-patient-selection-in-contemporary-management-of-atrial-fibrillation weekly 0.8 https://www.themednet.org/should-we-be-aiming-for-normalization-of-both-late-night-salivary-cortisol-and-24hr-urinary-free-cortisol-levels-when-monitoring-response-to-cushings-disease-treatment weekly 0.8 https://www.themednet.org/what-circumstances-would-drive-you-to-consider-using-an-oral-il-23-inhibitor-over-parenteral-options-for-the-management-of-psoriasis-and-or-psoriatic-arthritis weekly 0.8 https://www.themednet.org/do-you-stop-acei-or-arb-medications-in-patients-with-eskd-who-are-on-hemodialysis-and-have-issues-with-chronic-hyperkalemia weekly 0.8 https://www.themednet.org/are-there-situations-when-you-a-1k-dialysis-bath-as-a-long-term-outpatient-prescription-for-patients-with-eskd weekly 0.8 https://www.themednet.org/how-do-you-approach-sequentially-tapering-combination-therapy-i-e-ivig-mycophenolate-rituximab-for-dermatomyositis-that-is-in-remission weekly 0.8 https://www.themednet.org/given-the-helen-006-trial-results-under-what-circumstances-if-any-would-you-consider-de-escalated-neoadjuvant-therapy-in-her2-positive-breast-cancer weekly 0.8 https://www.themednet.org/what-do-you-do-if-a-patient-with-adhd-on-dexamfetamine-for-many-years-develops-alzheimers-disease weekly 0.8 https://www.themednet.org/would-you-give-lung-sbrt-to-a-patient-with-bullous-pemphigoid-on-the-chest-and-torso weekly 0.8 https://www.themednet.org/would-you-consider-utilizing-transdermal-estrogen-for-hrt-to-treat-severe-hot-flashes-in-a-patient-with-sle-and-a-history-of-thrombosis-x2-and-positive-lupus-anticoagulant-but-negative-acl-b2gp1-abs weekly 0.8 https://www.themednet.org/in-a-young-male-patient-with-hypogonadotropic-hypogonadism-and-fertility-goals-would-starting-testosterone-replacement-therapy-affect-fertility-chances weekly 0.8 https://www.themednet.org/is-glp-1-therapy-a-viable-treatment-option-for-a-patient-with-type-2-diabetes-complicated-by-atherosclerotic-heart-disease-and-cholelithiasis weekly 0.8 https://www.themednet.org/after-what-time-frame-off-glp-1-ra-therapy-should-you-restart-at-the-lowest-starting-dose weekly 0.8 https://www.themednet.org/would-you-consider-using-long-acting-injectable-cabotegravir-rilpivirine-for-pregnant-women-with-hiv weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-uc-with-psc-and-how-do-you-position-oral-vancomycin-against-biologic-therapies weekly 0.8 https://www.themednet.org/what-is-the-role-of-radiation-in-intra-labyrinthine-cochlear-schwannoma weekly 0.8 https://www.themednet.org/when-do-you-consider-testing-for-anti-iglon5-disease-in-patients-with-parkinsonism weekly 0.8 https://www.themednet.org/how-do-you-manage-persistent-pseudomonas-positive-sputum-a-patient-with-non-cf-bronchiectasis-who-has-chronic-sputum-production-but-is-otherwise-asymptomatic weekly 0.8 https://www.themednet.org/what-are-the-most-effective-treatments-for-flat-warts-on-the-face weekly 0.8 https://www.themednet.org/what-would-be-your-approach-to-percutaneous-intervention-for-acute-plaque-rupture-and-cardiogenic-shock-for-a-patient-with-cirrhosis-and-severe-thrombocytopenia weekly 0.8 https://www.themednet.org/what-are-reasonable-alternatives-to-invasive-angiography-for-cav-surveillance-in-patients-who-are-a-few-years-out-from-cardiac-transplant-with-impaired-renal-function weekly 0.8 https://www.themednet.org/what-are-some-immunosuppression-regimens-to-consider-in-a-patient-with-refractory-cardiac-sarcoidosis weekly 0.8 https://www.themednet.org/do-you-make-any-changes-to-surveillance-imaging-frequency-24-hour-urine-stone-risk-collection-frequency-and-stone-preventative-medication-approaches-for-patients-with-recurrent-nephrolithiasis-who-become-pregnant weekly 0.8 https://www.themednet.org/is-there-a-role-for-calcitriol-in-dialysis-patients-regardless-of-pth-level weekly 0.8 https://www.themednet.org/how-do-your-pmrt-recommendations-change-with-itcs-after-neoadjuvant-chemotherapy-if-they-had-slnb-only-versus-alnd-in-light-of-b51 weekly 0.8 https://www.themednet.org/would-you-expect-cinacalcet-to-lower-calcium-levels-in-a-patient-with-familial-hypocalciuric-hypercalcemia-fhh weekly 0.8 https://www.themednet.org/what-is-your-approach-to-evaluating-amiodarone-induced-interstitial-pneumonitis weekly 0.8 https://www.themednet.org/how-effective-is-the-use-of-genomic-testing-methods-such-as-tape-strip-tests-for-assessing-suspicious-pigmented-lesions-in-clinical-practice weekly 0.8 https://www.themednet.org/how-do-you-manage-bladder-spasms-during-pelvic-radiotherapy weekly 0.8 https://www.themednet.org/how-do-you-decide-between-using-nuclear-medicine-scanning-versus-computed-tomographic-angiography-cta-for-ancillary-brain-death-testing weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-outcomes-of-endovascular-treatment-of-acute-basilar-artery-occlusion weekly 0.8 https://www.themednet.org/how-would-you-sequence-lifileucel-til-therapy-in-a-patient-with-metastatic-melanoma-who-is-braf-wild-type-braf-wt-and-progressed-on-adjuvant-nivolumab weekly 0.8 https://www.themednet.org/would-you-supplement-iron-for-low-iron-studies-in-absence-of-anemia weekly 0.8 https://www.themednet.org/what-is-your-goal-ferritin-level-in-pregnancy weekly 0.8 https://www.themednet.org/what-is-the-optimal-bp-target-for-patients-with-diabetes-and-hypertension-to-reduce-their-risk-of-mi-stroke weekly 0.8 https://www.themednet.org/is-there-a-role-for-bevacizimab-iv-or-ia-for-steroid-refractory-radionecrosis-for-avm weekly 0.8 https://www.themednet.org/would-you-still-consider-omalizumab-for-csu-with-angioedema-in-a-patient-with-factor-v-leiden-deficiency weekly 0.8 https://www.themednet.org/outside-of-teplizumab-what-therapies-do-you-recommend-for-preserving-beta-cell-function-in-patients-with-early-stage-type-1-diabetes-mellitus weekly 0.8 https://www.themednet.org/how-would-you-treat-newly-diagnosed-stage-iv-gej-adenocarcinoma-with-both-claudin-18-2-and-her2-3-via-ihc-overexpression weekly 0.8 https://www.themednet.org/would-you-consider-treating-hypercalcemia-with-crrt-and-regional-citrate-anticoagulation-for-a-dialysis-dependent-patient-who-does-not-respond-to-bisphosphonate-therapy-and-low-calcium-dialysate-bath weekly 0.8 https://www.themednet.org/how-do-you-factor-a-decreasing-but-persistently-elevated-ca-125-into-your-decision-regarding-whether-to-proceed-with-interval-cytoreductive-surgery-for-pax8-high-grade-serous-cancer-s-p-neoadjuvant-chemotherapy-with-minimal-disease-on-imaging weekly 0.8 https://www.themednet.org/how-do-you-adjust-the-management-of-epilepsy-in-patients-who-are-planning-to-fast weekly 0.8 https://www.themednet.org/when-do-you-consider-pacing-in-arrhythmogenic-epilepsy weekly 0.8 https://www.themednet.org/what-medications-have-you-found-helpful-in-the-treatment-of-stimulant-use-disorder weekly 0.8 https://www.themednet.org/do-you-recommend-routinely-monitoring-pancreatic-markers-such-as-amylase-and-lipase-while-receiving-glp1-r-agonist-or-dual-agonist-therapies-to-determine-their-risk-of-pancreatitis weekly 0.8 https://www.themednet.org/how-would-you-manage-active-severe-psoriasis-in-a-patient-planning-pregnancy-who-also-has-psoriatic-arthritis-with-well-controlled-joint-symptoms-on-certolizumab-pegol-anti-tnf-therapy weekly 0.8 https://www.themednet.org/when-treating-chestwall-rni-with-vmat-how-much-do-you-crop-the-ptv-into-lung-as-is-done-with-the-ptveval-in-3d-contouring-guides weekly 0.8 https://www.themednet.org/how-long-do-you-monitor-proteinuria-after-starting-an-sglt-2-inhibitor-before-considering-adding-another-medication-if-proteinuria-is-not-at-goal weekly 0.8 https://www.themednet.org/is-there-evidence-to-support-empiric-atrial-flutter-ablation-for-patients-undergoing-pvi-for-atrial-fibrillation-in-the-absence-of-clinical-evidence-of-atrial-flutter weekly 0.8 https://www.themednet.org/will-tryngolza-olezarsen-recently-approved-for-familial-chylomicronemia-syndrome-also-lower-triglycerides-due-to-other-genetic-causes-of-hypertriglyceridemia weekly 0.8 https://www.themednet.org/in-a-patient-with-sicca-symptoms-and-ss-b-antibodies-only-can-a-minor-salivary-gland-lip-biopsy-with-lymphoid-aggregates-but-also-scattered-areas-of-acute-neutrophilic-inflammation-be-consistent-with-sjogrens-disease weekly 0.8 https://www.themednet.org/do-you-recommend-routine-neurosyphilis-testing-in-patients-being-evaluated-for-dementia weekly 0.8 https://www.themednet.org/how-do-you-approach-radiotherapy-planning-when-there-is-no-identifiable-prostate-tissue-after-hifu-or-turp weekly 0.8 https://www.themednet.org/what-whole-brain-radiation-dose-would-you-recommend-for-primary-cns-lymphoma-with-partial-response-to-hd-mtx-r-and-r-ice-and-planned-for-concurrent-ibrutinib weekly 0.8 https://www.themednet.org/in-which-clinical-scenarios-do-you-find-medial-and-lateral-plantar-sensory-or-mixed-nerve-conduction-studies-to-be-valuable weekly 0.8 https://www.themednet.org/how-do-you-approach-postoperative-radiation-therapy-in-a-patient-with-head-and-neck-cancer-who-has-high-risk-of-recurrence-in-the-setting-of-active-epidermolysis-bullosa weekly 0.8 https://www.themednet.org/when-should-methotrexate-injections-be-initiated-for-proliferative-vitreoretinopathy weekly 0.8 https://www.themednet.org/how-do-you-manage-periocular-reconstructive-surgery-in-patients-with-advanced-orbital-fractures-and-concurrent-soft-tissue-injuries weekly 0.8 https://www.themednet.org/what-are-the-most-effective-strategies-for-managing-post-operative-complications-such-as-scarring-in-pediatric-oculoplastics-surgeries weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-amblyopia-in-children-with-developmental-delays-or-cognitive-impairments weekly 0.8 https://www.themednet.org/do-you-ever-utilize-a-steroid-pulse-in-patients-who-are-pregnant-with-status-migrainosus weekly 0.8 https://www.themednet.org/which-non-pharmacologic-treatments-for-neuropathic-pain-have-you-found-most-effective weekly 0.8 https://www.themednet.org/how-do-you-monitor-patients-who-are-symptomatically-well-managed-on-clozapine-with-supratherapeutic-drug-levels weekly 0.8 https://www.themednet.org/would-you-offer-zolbetuximab-chemotherapy-in-a-presumed-metastatic-duodenal-bulb-adenocarcinoma-with-80-claudin18-2-expression weekly 0.8 https://www.themednet.org/do-you-recommend-transitioning-elderly-patients-from-thiazide-diuretics-to-alternative-agents-when-managing-hypertension-given-the-increased-concern-for-hyponatremia-in-this-patient-population weekly 0.8 https://www.themednet.org/are-there-instances-when-you-obtain-an-abdominal-x-ray-over-an-ultrasound-or-ct-scan-for-kidney-stone-surveillance-in-a-patient-with-recurrent-calcium-based-nephrolithiasis weekly 0.8 https://www.themednet.org/do-you-use-delayed-release-budesonide-over-prednisone-or-methylprednisolone-for-the-treatment-of-iga-nephropathy-considering-the-available-safety-and-efficacy-data-1 weekly 0.8 https://www.themednet.org/how-do-you-address-patient-concerns-regarding-the-necessity-of-rems-monitoring-when-prescribing-sparsentan weekly 0.8 https://www.themednet.org/how-do-various-therapeutic-approaches-for-iga-nephropathy-target-the-different-stages-of-the-four-hit-hypothesis weekly 0.8 https://www.themednet.org/what-is-your-preferred-agent-for-fungal-prophylaxis-in-a-patient-post-lung-transplant-with-abnormal-lfts weekly 0.8 https://www.themednet.org/how-should-we-approach-the-recommendation-of-intermittent-fasting-for-weight-loss-in-patients-with-pre-existing-cardiovascular-conditions-given-the-observed-association-of-increased-cv-mortality-with-eating-durations-of-less-than-8-hrs weekly 0.8 https://www.themednet.org/would-you-recommend-pmrt-in-a-patient-with-a-triple-negative-ct2n0-ypt2n0-metaplastic-breast-cancer-s-p-nac-mastectomy-and-slnb weekly 0.8 https://www.themednet.org/do-you-perform-emg-and-repetitive-nerve-stimulation-in-patients-with-ocular-myasthenia-gravis-particularly-those-who-are-achr-positive-to-assess-for-electrophysiological-evidence-of-generalized-disease weekly 0.8 https://www.themednet.org/does-a-post-surgical-hematoma-in-the-breast-affect-your-recommendations-for-partial-breast-rt weekly 0.8 https://www.themednet.org/how-would-you-manage-an-eskd-patient-who-complains-of-severe-fatigue-after-hemodialysis-but-does-not-experience-intradialytic-or-post-dialysis-hypotension-and-has-not-responded-to-dry-weight-adjustments weekly 0.8 https://www.themednet.org/are-you-initiating-discussing-peanut-oit-in-most-children-less-than-age-2-due-to-the-benefits-of-desensitization-and-remission weekly 0.8 https://www.themednet.org/what-role-do-you-feel-there-is-for-antibiotics-in-the-management-of-severe-perianal-crohns-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-patients-with-mildly-elevated-mpap-21-24-mmhg-and-pvr-2-3-wu-who-may-be-at-risk-of-progression-given-the-recent-changes-in-the-hemodynamic-definition-of-pulmonary-hypertension weekly 0.8 https://www.themednet.org/how-do-you-counsel-migraine-patients-interested-in-implanted-neurostimulation-devices-for-migraine weekly 0.8 https://www.themednet.org/how-do-you-assess-whether-a-patient-will-be-a-good-dibh-candidate-for-lung-or-abdomen-treatments weekly 0.8 https://www.themednet.org/do-you-advise-your-patients-with-cystinuria-to-perform-home-urine-ph-testing weekly 0.8 https://www.themednet.org/for-optimal-gdmt-for-patients-with-hfref-and-co-existing-esrd-is-there-evidence-to-support-the-use-of-sglt2-inhibitors-and-or-arb-arni weekly 0.8 https://www.themednet.org/how-long-do-you-recommend-waiting-after-variceal-bleeding-and-banding-before-a-transesophageal-echocardiogram-can-be-performed-safely weekly 0.8 https://www.themednet.org/how-should-clinicians-balance-the-use-of-finerenone-with-other-heart-failure-treatments-like-sglt2-inhibitors-considering-their-glycemic-benefits weekly 0.8 https://www.themednet.org/at-what-point-should-aspirin-therapy-for-stable-cardiovascular-disease-be-discontinued-in-patients-with-a-diagnosis-of-chronic-cerebral-microbleeds-or-possible-cerebral-amyloid-angiopathy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-shrinking-lung-syndrome-in-sle weekly 0.8 https://www.themednet.org/would-you-recommend-radiation-or-chemoradiation-in-a-patient-with-cholangiocarcinoma-s-p-surgery-and-adjuvant-treatment-with-single-hepatic-metastasis-3-years-later weekly 0.8 https://www.themednet.org/how-do-you-counsel-younger-patients-regarding-long-term-radiologic-monitoring-of-non-functional-adrenal-adenomas weekly 0.8 https://www.themednet.org/when-do-you-consider-cheyne-stokes-respirations-noted-in-download-data-from-positive-pressure-machines-to-be-normal-vs-abnormal-requiring-intervention weekly 0.8 https://www.themednet.org/what-biologics-would-you-use-in-a-patient-with-rheumatoid-arthritis-who-developed-multiple-basal-cell-carcinomas-requiring-mohs-surgery-while-on-a-tnf-inhibitor-and-did-not-respond-to-rituximab weekly 0.8 https://www.themednet.org/how-do-you-adjust-dosing-of-rozanolixizumb-for-mg-patients-who-deteriorate-before-the-minimum-re-dosing-period weekly 0.8 https://www.themednet.org/how-do-you-treat-fatigue-symptoms-in-myasthenia-gravis weekly 0.8 https://www.themednet.org/which-methods-of-tracking-response-to-treatment-in-myasthenia-gravis-do-you-find-most-helpful weekly 0.8 https://www.themednet.org/what-is-your-approach-to-screening-a-cancer-survivor-for-iron-overload-and-what-is-your-treatment-of-choice weekly 0.8 https://www.themednet.org/when-do-you-evaluate-patients-with-parkinsons-disease-and-cognitive-decline-for-concurrent-alzheimers-disease weekly 0.8 https://www.themednet.org/what-do-you-feel-are-the-potential-barriers-to-widespread-use-of-obinutuzumab-in-proliferative-lupus-nephritis weekly 0.8 https://www.themednet.org/how-do-you-envision-incorporating-car-t-therapy-into-your-clinical-practice weekly 0.8 https://www.themednet.org/do-you-recommend-repeat-kidney-stone-composition-testing-for-a-patient-with-recurrent-nephrolithiasis-who-passed-an-additional-stone-but-previously-already-had-stone-composition-testing-performed weekly 0.8 https://www.themednet.org/do-you-routinely-check-an-allens-test-before-placing-a-radial-arterial-line weekly 0.8 https://www.themednet.org/what-factors-should-guide-the-choice-between-fosfomycin-and-nitrofurantoin-for-uncomplicated-cystitis-given-the-reduced-efficacy-of-fosfomycin weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-mild-to-moderate-tics-induced-by-stimulants-in-children weekly 0.8 https://www.themednet.org/what-alternative-adhd-medications-would-you-consider-in-a-child-with-a-complex-cardiac-history-unresponsive-to-guanfacine weekly 0.8 https://www.themednet.org/whats-your-follow-up-protocol-for-a-near-complete-response-ncr-in-rectal-patients-considering-non-operative-management-nom weekly 0.8 https://www.themednet.org/given-potential-long-term-cv-toxicity-concerns-with-lorlatinib-and-data-suggesting-that-dose-reduction-does-not-compromise-efficacy-do-you-ever-recommend-initiating-and-or-maintaining-lower-dose-lorlatinib-in-alk-nsclc weekly 0.8 https://www.themednet.org/would-you-give-immunotherapy-after-neoadjuvant-gem-cis-for-bladder-cancer-if-cystectomy-is-being-postponed-for-months-due-to-non-autoimmune-unrelated-comorbidities weekly 0.8 https://www.themednet.org/what-is-the-preferred-first-line-non-insulin-agent-in-patients-with-ketosis-prone-diabetes-during-remission-and-evidence-of-preserved-beta-cell-function weekly 0.8 https://www.themednet.org/do-you-routinely-use-pupillometry-for-serial-neurologic-examinations-in-the-icu-especially-for-patients-at-risk-for-transtentorial-herniation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-ild-associated-with-inflammatory-bowel-disease weekly 0.8 https://www.themednet.org/do-you-treat-patients-with-culture-positive-mycobacterium-abscessus-if-they-are-asymptomatic-and-do-not-have-progression-on-imaging weekly 0.8 https://www.themednet.org/how-do-you-approach-an-otherwise-healthy-patient-with-an-incidental-1-mm-gist-involving-the-serosal-surface-in-terms-of-staging-workup-egd-and-surveillance weekly 0.8 https://www.themednet.org/how-do-you-approach-agitation-management-especially-the-use-of-neuroleptics-in-hospitalized-patients-with-a-prolonged-qtc weekly 0.8 https://www.themednet.org/how-long-would-you-continue-chronic-transfusion-therapy-for-adult-sickle-cell-patients-who-have-had-a-stroke weekly 0.8 https://www.themednet.org/how-do-you-approach-radiation-treatment-of-extramammary-pagets-disease-of-vulva-diffusely-involving-the-urothelium-and-the-periurethral-glands weekly 0.8 https://www.themednet.org/how-do-you-approach-a-referral-for-findings-of-intestinal-metaplasia-on-a-biopsy-of-an-irregular-z-line weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-patients-with-recurrent-nephrolithiasis-who-continue-to-have-elevated-stone-risk-parameters-in-the-setting-of-dietary-factors-despite-receiving-education-from-a-dedicated-stone-clinic-dietician weekly 0.8 https://www.themednet.org/do-you-recommend-any-specific-testing-for-patients-with-recurrent-nephrolithiasis-and-suspected-absorptive-hypercalciuria weekly 0.8 https://www.themednet.org/how-do-you-optimally-set-a-patient-up-for-breast-radiation-therapy-if-you-dont-have-access-to-a-breast-board-or-wing-board weekly 0.8 https://www.themednet.org/what-is-your-approach-to-inpatient-work-up-for-suspected-long-qt-syndrome-in-a-young-adult-with-otherwise-normal-labs-and-no-medications-causing-prolonged-qtc weekly 0.8 https://www.themednet.org/do-you-obtain-liver-biopsy-to-confirm-the-diagnosis-of-cirrhosis-if-cirrhotic-liver-morphology-is-noted-on-imaging weekly 0.8 https://www.themednet.org/in-patients-treated-with-the-keynote-a-18-regimen-who-later-recur-would-you-rechallenge-with-immunotherapy-again weekly 0.8 https://www.themednet.org/do-you-use-prophylactic-defibrotide-in-pediatric-patients-undergoing-bmt-who-are-considered-to-be-at-high-risk-for-the-development-of-vod-sos weekly 0.8 https://www.themednet.org/when-do-you-consider-long-term-anti-seizure-medication-for-patients-who-have-an-acute-symptomatic-seizure-in-the-setting-of-a-cerebrovascular-event weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-hold-an-ace-inhibitor-or-arb-prior-to-surgery-in-a-patient-with-ckd weekly 0.8 https://www.themednet.org/what-dose-of-reirradiation-would-you-consider-for-locally-recurrent-breast-cancer-after-mastectomy-excised-with-positive-margins weekly 0.8 https://www.themednet.org/would-you-offer-neoadjuvant-pembrolizumab-to-a-tnbc-patient-with-multiple-pulmonary-nodules-and-bilateral-hilar-adenopathy-secondary-to-asymptomatic-sarcoidosis-biopsy-proven weekly 0.8 https://www.themednet.org/which-gi-cancer-patients-do-you-use-oral-contrast-in-staging-ct-scans weekly 0.8 https://www.themednet.org/what-is-your-approach-to-electrolyte-repletion-for-patients-hospitalized-with-cardiac-and-non-cardiac-conditions weekly 0.8 https://www.themednet.org/how-do-you-counsel-non-diabetic-patients-who-wish-to-start-metformin-to-reduce-the-risk-of-developing-dementia weekly 0.8 https://www.themednet.org/do-you-routinely-prescribe-naloxone-at-discharge-for-patients-with-a-known-history-of-opioid-use-disorder weekly 0.8 https://www.themednet.org/how-do-you-recommend-counseling-patients-on-the-prognosis-of-advanced-cancer-as-a-generalist-who-is-not-highly-specialized-in-cancer-literature-or-cancer-directed-therapies weekly 0.8 https://www.themednet.org/when-can-we-consider-deferring-an-insulin-drip-in-patients-with-hypertriglyceridemia-induced-pancreatitis weekly 0.8 https://www.themednet.org/how-do-you-decide-if-patients-without-contraindications-should-receive-iv-fluids-during-the-pre-operative-period-if-they-are-undergoing-surgery-during-their-hospitalization weekly 0.8 https://www.themednet.org/would-you-ever-consider-oral-doxycycline-for-treatment-of-either-gram-negative-or-gram-positive-uncomplicated-bacteremia weekly 0.8 https://www.themednet.org/how-do-you-mitigate-risk-when-performing-bronchoscopy-in-hypoxic-patients-requiring-high-levels-of-supplemental-oxygen weekly 0.8 https://www.themednet.org/do-you-routinely-genotype-adult-beta-thalassemia-patients weekly 0.8 https://www.themednet.org/how-long-do-you-wait-before-arranging-avf-placement-in-patients-with-aki-who-remain-dialysis-dependent weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-and-titration-of-cobenfy-in-patients-with-treatment-refractory-schizophrenia-not-responding-to-clozapine weekly 0.8 https://www.themednet.org/how-would-you-manage-active-non-stricturing-non-fistulizing-moderate-ileal-crohns-disease-in-patients-on-natalizumab-with-well-managed-multiple-sclerosis weekly 0.8 https://www.themednet.org/what-is-your-preferred-mode-of-vascular-access-for-testicular-cancer-regimens weekly 0.8 https://www.themednet.org/would-you-favor-oral-bisphosphonates-over-intravenous-formulations-for-patients-with-hormone-sensitive-prostate-cancer-and-androgen-deprivation-therapy-adt-related-osteopenia weekly 0.8 https://www.themednet.org/how-do-you-approach-new-onset-idiopathic-intracranial-hypertension-iih-with-someone-who-has-history-of-systemic-lupus-erythematosus weekly 0.8 https://www.themednet.org/how-would-you-approach-management-and-monitoring-of-al-amyloidosis-with-isolated-renal-involvement weekly 0.8 https://www.themednet.org/how-do-you-approach-diagnosing-adhd-in-patients-with-significant-trauma-histories weekly 0.8 https://www.themednet.org/which-factors-help-you-choose-between-intermittent-phenobarbital-dosing-versus-continuous-pentobarbital-infusion-for-pharmacological-burst-suppression-in-refractory-status-epilepticus weekly 0.8 https://www.themednet.org/how-would-you-treat-active-sle-with-high-level-crithidia-dsdna-abs-and-recurrent-pleuritis-with-effusions-still-requiring-corticosteroids-despite-combination-therapy-with-full-doses-of-mycophenolate-hydroxychloroquine-and-benlysta-for-over-6-months-after- weekly 0.8 https://www.themednet.org/how-would-you-manage-a-bulky-primary-exophytic-vulvar-sqcc-in-a-patient-with-uncontrolled-but-very-long-standing-hiv-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-titration-or-transitioning-to-cobenfy-in-patients-currently-on-an-antipsychotic weekly 0.8 https://www.themednet.org/how-would-you-treat-a-primary-angiosarcoma-arising-in-the-skull-excised-with-initial-excisional-biopsy weekly 0.8 https://www.themednet.org/would-you-offer-surgery-for-an-msi-h-pancreatic-adenocarcinoma-who-had-deep-response-to-pembrolizumab weekly 0.8 https://www.themednet.org/in-patients-getting-concurrent-chemo-immunotherapy-for-locally-advanced-cervix-cancer-would-you-hold-immunotherapy-during-the-2-5-3-weeks-of-brachytherapy weekly 0.8 https://www.themednet.org/what-neoadjuvant-chemotherapy-do-you-suggest-for-a-rapidly-growing-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/in-a-patient-with-well-controlled-ulcerative-colitis-on-tofacitinib-for-several-years-would-you-consider-switching-to-upadacitinib-for-a-more-favorable-side-effect-profile weekly 0.8 https://www.themednet.org/how-would-you-evaluate-the-right-inguinofemoral-lymph-nodes-in-a-female-patient-in-her-30s-with-a-4-mm-midline-scc-of-the-vulva-depth-of-invasion-1-45-mm-and-a-pet-positive-enlarged-left-inguinal-node-for-whom-you-plan-to-debulk-the-left-inguinofemoral-ly weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-deciding-between-dual-vs-single-agent-immunotherapy-for-patients-with-msi-h-or-dmmr-metastatic-crc weekly 0.8 https://www.themednet.org/of-the-two-ipilimumab-dosing-schedules-utilized-with-nivolumab-on-checkmate-8hw-do-you-have-a-preference-in-your-own-practice weekly 0.8 https://www.themednet.org/do-you-typically-adjust-pump-settings-for-patients-with-diabetes-who-are-on-automated-insulin-pumps-and-fasting-all-day-for-religious-reasons-such-as-ramadan weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-who-identify-so-strongly-with-being-sick-or-with-a-particular-diagnostic-label-that-it-makes-up-a-significant-portion-of-their-identity weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-anxiety-disorders-in-children-with-a-significantly-family-history-of-bipolar-disorder weekly 0.8 https://www.themednet.org/do-you-routinely-continue-dual-antibiotic-coverage-or-de-escalate-to-monotherapy-based-on-peritoneal-fluid-culture-sensitivities-in-patients-with-relapsing-pseudomonas-aeruginosa-peritoneal-dialysis-peritonitis-after-peritoneal-catheter-removal weekly 0.8 https://www.themednet.org/would-you-recommend-anticoagulation-in-subsequent-pregnancies-after-symptomatic-postpartum-r-ovarian-vein-thrombosis weekly 0.8 https://www.themednet.org/how-do-you-select-patients-with-spontaneous-intracerebral-hemorrhage-for-minimally-invasive-surgical-hematoma-evacuation-if-offered-at-your-institution weekly 0.8 https://www.themednet.org/how-do-you-approach-the-timing-of-skin-tightening-interventions-in-patients-who-experience-significant-weight-loss-to-optimize-both-intermediate-and-long-term-aesthetic-outcomes weekly 0.8 https://www.themednet.org/would-you-recommend-pharmacologic-treatment-with-levothyroxine-for-a-patient-with-subclinical-hypothyroidism-and-cad-s-p-stent-placement-even-if-the-tsh-is-less-than-10miu-l-given-a-described-association-with-reduced-risk-for-major-adverse-cardiovascular- weekly 0.8 https://www.themednet.org/what-is-your-approach-to-dosing-sodium-thiosulfate-for-a-patient-with-eskd-who-is-receiving-crrt weekly 0.8 https://www.themednet.org/do-you-consider-thrombocytopenia-a-contraindication-for-fibrinolytic-therapy-for-a-massive-pe weekly 0.8 https://www.themednet.org/would-you-administer-adjuvant-chemotherapy-for-extrahepatic-cholangiocarcinoma-that-has-received-neoadjuvant-therapy-and-achieved-near-cr weekly 0.8 https://www.themednet.org/do-you-avoid-terlipressin-for-patients-with-hepatorenal-syndrome-who-have-an-elevated-bilirubin-level weekly 0.8 https://www.themednet.org/how-do-you-approach-iol-exchange-in-a-patient-who-is-unhappy-after-cataract-surgery-with-a-premium-iol weekly 0.8 https://www.themednet.org/how-do-you-determine-the-timing-of-surgical-intervention-for-traumatic-cataracts-in-children weekly 0.8 https://www.themednet.org/what-is-your-surgical-approach-for-optic-disc-pit-retinal-detachments-if-laser-treatment-is-unsuccessful weekly 0.8 https://www.themednet.org/do-you-recommend-avoiding-combination-vancomycin-and-piperacillin-tazobactam-in-patients-with-acute-kidney-injury weekly 0.8 https://www.themednet.org/what-is-your-preferred-surgical-intervention-for-children-with-congenital-nystagmus weekly 0.8 https://www.themednet.org/how-do-you-decide-between-repeat-surgical-correction-vs-botulinum-toxin-injections-for-recurrent-intermittent-exotropia-after-previous-surgery weekly 0.8 https://www.themednet.org/how-often-do-you-monitor-asymptomatic-atrophic-holes-and-lattice-in-pediatric-patients weekly 0.8 https://www.themednet.org/what-is-your-preferred-regimen-for-metastatic-bladder-adenocarcinoma weekly 0.8 https://www.themednet.org/how-would-you-treat-a-seminoma-recurrence-to-para-aortic-ln-one-year-after-a-transscrotal-surgery weekly 0.8 https://www.themednet.org/should-breast-cancer-patients-with-never-treated-latent-tb-and-for-whom-chemotherapy-is-indicated-be-treated-for-latent-tb-during-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-manage-pneumonitis-in-patients-with-stage-iii-nsclc-receiving-durvalumab weekly 0.8 https://www.themednet.org/does-consolidation-durvalumab-increase-the-risk-of-pneumonitis-in-stage-iii-nsclc weekly 0.8 https://www.themednet.org/what-rt-dose-do-you-recommend-for-carcinoma-in-situ-of-the-glottic-larynx weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-gleason-9-prostate-cancer-and-regional-lymphadenopathy-as-well-as-inguinal-lymphadenopathy-m1a-but-no-bone-metastases weekly 0.8 https://www.themednet.org/how-would-you-approach-therapy-for-a-patient-with-newly-diagnosed-non-gc-dlbcl-with-previous-anthracycline-exposure weekly 0.8 https://www.themednet.org/for-triple-positive-metastatic-breast-cancer-is-there-a-role-for-aromatase-inhibitor-cdk-4-6-inhibitor-with-her2-directed-therapy-in-a-patient-that-refuses-chemotherapy weekly 0.8 https://www.themednet.org/would-you-recommend-parp-inhibitor-maintenance-for-a-brca-wild-type-hrd-advanced-ovarian-cancer weekly 0.8 https://www.themednet.org/what-is-the-threshold-for-negative-surgical-margins-in-multifocal-microinvasive-carcinoma-of-the-breast weekly 0.8 https://www.themednet.org/would-you-test-for-esr1-mutation-prior-to-deciding-on-ai-or-fulvestrant-for-metastatic-breast-cancer-2 weekly 0.8 https://www.themednet.org/what-changes-if-any-would-you-make-to-a-patients-endocrine-therapy-for-a-patient-with-dcis-on-tamoxifen-for-risk-reduction-who-develops-a-new-lesion-lcis-while-on-tamoxifen weekly 0.8 https://www.themednet.org/if-a-patient-on-ovarian-suppression-with-goserelin-for-er-her2-bc-achieves-post-menopausal-range-estradiol-levels-but-does-not-achieve-post-menopausal-fsh-levels-is-she-suppressed weekly 0.8 https://www.themednet.org/how-much-subglottic-extension-from-a-primary-glottic-tumor-would-you-make-you-treat-the-regional-lymph-nodes weekly 0.8 https://www.themednet.org/what-high-risk-features-for-stage-ib-nsclc-would-lead-you-to-consider-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/when-would-you-add-daratumumab-to-a-pi-imid-dex-backbone-for-first-line-treatment-of-transplant-eligible-multiple-myeloma weekly 0.8 https://www.themednet.org/how-long-would-a-vulvar-cancer-s-p-definitive-chemoradiotherapy-how-long-should-the-lesion-be-followed-for-regression-before-initiating-biopsy-or-salvage-surgery weekly 0.8 https://www.themednet.org/which-braf-mek-inhibitor-combination-have-you-found-most-tolerable-and-easiest-to-prescribe-in-good-performance-patients-with-mutated-metastatic-melanoma weekly 0.8 https://www.themednet.org/when-do-you-recommend-prone-breast-radiation weekly 0.8 https://www.themednet.org/when-do-you-consider-upfront-surgery-for-locally-advanced-t4-sinonasal-ca weekly 0.8 https://www.themednet.org/what-would-be-your-next-treatment-in-a-postmenopausal-woman-with-metastatic-er-lobular-cancer-with-progression-on-palbociclib-letrozole-with-multiple-liver-metastasis weekly 0.8 https://www.themednet.org/which-patients-with-metastatic-hormone-sensitive-prostate-cancer-would-you-treat-with-enzalutamide-or-apalutamide-instead-of-abiraterone-or-docetaxel weekly 0.8 https://www.themednet.org/how-do-you-approach-a-recurrence-of-grade-3-anaplastic-astrocytoma-after-initial-treatment-with-gross-total-resection-followed-by-rt-adjuvant-temozolomide weekly 0.8 https://www.themednet.org/given-the-results-of-keynote-062-presented-at-asco-2019-how-will-you-utilize-immunotherapy-in-gastric-cancer weekly 0.8 https://www.themednet.org/would-you-recommend-nodal-irradiation-in-a-patient-with-breast-cancer-with-a-single-positive-sentinel-node-and-a-low-oncotype-who-does-not-receive-chemotherapy weekly 0.8 https://www.themednet.org/would-you-give-additional-chemotherapy-with-taxane-for-a-patient-with-triple-negative-breast-cancer-who-has-achieved-pathologic-complete-response-with-adriamycin-and-cyclophosphamide weekly 0.8 https://www.themednet.org/how-would-you-interpret-a-negative-er-by-pcr-via-oncotype-but-positive-60-based-on-ihc-staining weekly 0.8 https://www.themednet.org/when-treating-a-low-lying-and-bulky-ct2n0-rectal-adenocarcinoma-invading-the-anal-sphincter-muscles-with-neoadjuvant-chemort-for-downstaging-would-you-electively-include-the-inguinal-lymph-nodes weekly 0.8 https://www.themednet.org/is-tamoxifen-absolutely-contraindicated-in-pre-menopausal-women-with-lynch-syndrome weekly 0.8 https://www.themednet.org/what-is-your-approach-for-locoregional-mediastinal-recurrence-of-nsclc-adenocarcinoma-in-fit-patients-5-years-from-definitive-treatment-chemoradiation-and-or-surgery weekly 0.8 https://www.themednet.org/in-the-case-of-a-high-upper-outer-quadrant-early-stage-breast-cancer-without-adverse-histological-factors-would-you-omit-boosting-the-breast-lumpectomy-cavity-if-the-treatment-area-would-involve-a-significant-portion-of-axilla-due-to-risk-of-lymphedema weekly 0.8 https://www.themednet.org/in-contemplating-neoadjuvant-rt-how-would-you-manage-a-large-non-rt-induced-angiosarcoma-of-the-right-breast-in-a-young-female weekly 0.8 https://www.themednet.org/in-what-situations-if-any-would-you-treat-locally-advanced-non-metastatic-anal-cancer-with-induction-chemotherapy-followed-by-chemort-rather-than-chemo-rt-by-itself weekly 0.8 https://www.themednet.org/are-ther-any-types-of-sarcomas-that-you-use-induction-and-or-concurrent-chemotherapy-with-radiation-prior-to-surgery weekly 0.8 https://www.themednet.org/when-treating-node-positive-anal-squamous-cell-carcinoma-dose-your-lymph-node-boost-include-only-gross-disease-with-margin-or-do-you-boost-the-entire-nodal-region weekly 0.8 https://www.themednet.org/would-you-recommend-consolidative-rt-for-a-mediastinal-germ-cell-tumor-with-partial-response-after-chemotherapy weekly 0.8 https://www.themednet.org/for-inpatient-treatment-of-lymphoma-and-all-can-rituximab-be-delayed weekly 0.8 https://www.themednet.org/do-you-recommend-prophylactic-hyperbaric-oxygen-for-patients-who-require-tooth-extraction-after-head-and-neck-radiation weekly 0.8 https://www.themednet.org/how-do-you-manage-painful-non-sbrt-bone-metastases-in-patients-receiving-nivolumab-or-other-immunotherapy weekly 0.8 https://www.themednet.org/are-there-specific-high-riks-features-for-which-you-would-offer-palliative-adjuvant-head-and-neck-radiation-in-the-setting-of-metastatic-disease-but-without-residual-gross-head-neck-disease weekly 0.8 https://www.themednet.org/for-metastatic-large-cell-neuroendocrine-carcinoma-of-lung-would-you-treat-as-small-cell-with-platinum-etoposide-atezolizumab-or-would-you-treat-as-nsclc-and-use-platinum-doublet-pembrolizumab weekly 0.8 https://www.themednet.org/when-would-you-consider-adjuvant-fulvestrant-for-er-breast-cancer-if-the-patient-does-not-tolerate-tamoxifen-or-any-of-the-ais weekly 0.8 https://www.themednet.org/can-total-neoadjuvant-therapy-be-considered-an-option-equivalent-to-standard-of-care-treatment-for-patients-with-t3n0-or-t3n1-rectal-adenocarcinoma weekly 0.8 https://www.themednet.org/for-patients-with-egfr-mutant-nsclc-who-progress-on-osimertinib-do-you-repeat-tumor-molecular-profiling-and-if-so-do-you-favor-repeat-tumor-biopsy-or-cfdna weekly 0.8 https://www.themednet.org/how-do-you-decide-between-high-tangents-or-regional-nodal-radiation-in-patients-with-small-er-breast-cancers-who-have-a-single-positive-sentinel-node weekly 0.8 https://www.themednet.org/what-non-taxane-chemotherapy-can-you-partner-with-trastuzumab-pertuzumab-for-her2-breast-ca-if-neuropathy-either-at-baseline-or-with-treatment-becomes-prohibitive weekly 0.8 https://www.themednet.org/what-is-your-approach-for-bulky-stage-i-primary-mediastinal-b-cell-lymphoma-in-a-patient-with-a-positive-post-chemotherapy-pet-ct-residual-mass-and-deauville-5 weekly 0.8 https://www.themednet.org/do-you-consider-neoadjuvant-pertuzumab-for-node-negative-multifocal-her2-er-idc-without-any-single-focus-2-cm weekly 0.8 https://www.themednet.org/what-second-line-therapy-do-you-use-for-metastatic-gastroenterohepatic-neuroendocrine-carcinoma-g3-nec-with-progression-after-platinum-based-therapy weekly 0.8 https://www.themednet.org/do-you-recommend-neoadjuvant-radiation-or-chemoradiation-for-patients-with-t1-2-n0-adenocarcinoma-of-the-anal-canal-prior-to-apr weekly 0.8 https://www.themednet.org/what-chemotherapy-regimen-do-you-recommend-with-radiation-therapy-for-cervical-esophageal-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/for-patients-with-metastatic-adenocarcinoma-of-the-lung-do-you-base-any-treatment-decisions-on-egfr-gene-amplification weekly 0.8 https://www.themednet.org/in-a-patient-with-lgl-leukemia-with-chronic-severe-neutropenia-who-has-had-treatment-failure-with-methotrexate-cytoxan-cyclosporine-and-danazol-but-who-has-not-experienced-significant-infectious-complications-would-you-offer-next-line-systemic-therapy-and weekly 0.8 https://www.themednet.org/how-would-you-manage-a-recurrent-mediastinal-node-2-years-after-45gy-bid-to-this-region-with-combined-chemotherapy-for-sclc-in-patient-no-longer-tolerating-systemic-therapy weekly 0.8 https://www.themednet.org/do-you-consider-omitting-adjuvant-radiation-therapy-in-an-older-patient-with-node-positive-tnbc-who-achieve-pcr-to-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/would-you-consider-an-axillary-dissection-in-a-young-patient-with-high-grade-breast-cancer-and-one-sentinel-ln-with-isolated-tumor-cells weekly 0.8 https://www.themednet.org/for-patients-with-her2-breast-ca-with-a-her2-local-relapse-within-12-months-of-completion-of-adjuvant-trastuzumab-who-are-still-candidates-for-repeat-surgery-what-adjuvant-therapy-would-you-recommend weekly 0.8 https://www.themednet.org/what-is-your-approach-for-perioperative-chemotherapy-in-msi-h-dmmr-localized-gastric-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-treatment-of-non-uterine-leiomyosarcoma weekly 0.8 https://www.themednet.org/how-might-you-alter-treatment-for-a-breast-cancer-patient-receiving-standard-taxane-based-adjuvant-therapy-who-develops-an-adverse-reaction-to-the-taxane-e-g-severe-pneumonitis-after-completion-of-ddac weekly 0.8 https://www.themednet.org/is-proximal-duodenal-adenocarcinoma-above-the-ampulla-of-vater-considered-biologically-similar-to-colon-adenocarcinoma-or-gastric-cancer weekly 0.8 https://www.themednet.org/would-you-prefer-fgfr-inhibitor-or-second-line-immunotherapy-in-a-patient-with-metastatic-urothelial-cancer-of-the-bladder-with-fgfr-mutation weekly 0.8 https://www.themednet.org/would-you-offer-radiotherapy-or-chemotherapy-a-patient-with-cervical-cancer-s-p-radical-hysterectomy-and-now-a-delayed-metastasis-to-the-ovary-that-was-completely-resected-without-tumor-spill weekly 0.8 https://www.themednet.org/in-patients-with-extensive-stage-small-cell-lung-cancer-with-brain-metastases-showing-improvement-of-brain-and-other-lesions-on-immunotherapy-would-you-offer-whole-brain-radiation-therapy weekly 0.8 https://www.themednet.org/what-is-optimal-timing-or-sequencing-of-therapy-for-patients-with-synchronous-locally-advanced-triple-negative-breast-cancer-and-ovarian-cancer-with-peritoneal-carcinomatosis weekly 0.8 https://www.themednet.org/does-the-presence-of-an-atm-mutation-impact-your-fractionation-regimen-for-a-woman-with-breast-cancer weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-chemotherapy-or-abiraterone-for-patients-with-high-and-very-high-risk-prostate-cancer-with-still-detectable-psa-after-rp-and-ln-dissection weekly 0.8 https://www.themednet.org/for-metastatic-small-cell-cervix-cancer-would-you-consider-adding-immunotherapy-up-front-per-a-small-cell-lung-cancer-paradigm weekly 0.8 https://www.themednet.org/do-you-recommend-definitive-chemoradiation-for-unresectable-gastric-adenocarcinoma-in-a-medically-unfit-patient weekly 0.8 https://www.themednet.org/has-the-role-of-radium-223-changed-in-the-treatment-of-prostate-cancer-given-the-availability-of-newer-anti-androgen-medications-to-treat-metastatic-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-androgen-deprivation-in-a-patient-with-oligometastatic-prostate-cancer-in-which-the-primary-and-all-known-metastatic-sites-have-been-treated-with-curative-intent-radiation-and-psa-remains-undetectable weekly 0.8 https://www.themednet.org/what-mri-sequences-do-you-utilize-for-spine-srs-treatment-planning weekly 0.8 https://www.themednet.org/are-there-any-histologic-subtypes-of-er-her2-breast-cancer-that-you-would-omit-adjuvant-endocrine-in weekly 0.8 https://www.themednet.org/is-there-a-lung-metastasis-size-cut-off-do-you-suggest-for-selecting-between-bep-and-vip-as-initial-chemotherapy-in-advanced-testicular-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-small-cell-ca-of-the-appendix-with-no-evidence-of-distant-mets weekly 0.8 https://www.themednet.org/is-it-feasible-to-give-pelvic-radiotherapy-in-patients-with-a-congenital-functioning-pelvic-kidney weekly 0.8 https://www.themednet.org/when-treating-dlbcl-with-induction-therapy-with-r-chop-if-after-2-cycles-you-have-a-mixed-response-on-pet-would-you-consider-that-treatment-failure-or-would-you-continue-r-chop weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-gbrca-mutated-er-her2-metastatic-breast-cancer-with-brain-mets-refractory-to-wbrt-and-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-deal-with-worsening-tinnitus-in-patients-on-concurrent-chemoradiation-with-weekly-cisplatin-for-head-and-neck-cancer weekly 0.8 https://www.themednet.org/for-an-non-operative-patient-with-ib1-cervical-cancer-would-you-recommend-rt-alone-or-concurrent-chemort-for-definitive-therapy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-lynch-syndrome-who-is-s-p-surgery-and-pelvic-rt-20-years-ago-for-endometrial-carcinoma-with-a-new-t3n0m0-squamous-cell-carcinoma-of-the-anus weekly 0.8 https://www.themednet.org/how-would-you-approach-a-small-mucinous-adenocarcinoma-of-the-anal-verge-without-anal-canal-involvement-with-positive-margins-after-resection weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-choose-for-resected-tail-of-pancreas-adeno-with-positive-margin-node-negative weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-extensive-stage-small-cell-carcinoma-and-severe-end-stage-copd-on-home-oxygen weekly 0.8 https://www.themednet.org/in-practice-do-you-discuss-the-role-of-oncotype-dx-before-ordering-the-test weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-newly-diagnosed-synchronous-triple-positive-and-metaplastic-triple-negative-breast-cancers weekly 0.8 https://www.themednet.org/would-you-resume-biologic-treatments-such-as-tnf-blockers-in-patients-with-symptomatic-autoimmune-conditions-who-are-in-remission-from-their-cancers weekly 0.8 https://www.themednet.org/should-neoadjuvant-chemotherapy-be-recommended-for-her2-clinically-ln-breast-cancer-measuring-2-3cm weekly 0.8 https://www.themednet.org/how-do-you-treat-patients-rendered-ned-after-resection-of-an-isolated-lung-recurrence-of-an-early-stage-triple-negative-breast-ca-years-after-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-are-the-current-recommendations-for-androgen-blockade-for-patients-undergoing-salvage-radiation-after-prostatectomy-with-psas-between-0-6-and-1-5 weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-metastatic-er-her2-who-has-progressed-on-trastuzumab-pertuzumab-tamoxifen-after-being-in-remission-for-4yrs weekly 0.8 https://www.themednet.org/how-often-do-women-develop-hpv-associated-oropharyngeal-cancers weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-poorly-differentiated-carcinoma-with-squamous-differentiation-of-the-kidney-following-nephrectomy-with-metastatic-retroperitoneal-adenopathy weekly 0.8 https://www.themednet.org/how-do-you-define-your-treatment-volumes-when-treating-a-patient-with-post-mastectomy-radiation-therapy weekly 0.8 https://www.themednet.org/in-women-with-locally-advanced-her2-breast-cancer-who-have-had-a-complete-response-to-neoadjuvant-chemotherapy-what-factors-impact-your-decision-to-offer-pmrt weekly 0.8 https://www.themednet.org/how-would-you-manage-a-local-recurrence-at-the-skull-base-after-concurrent-chemort-for-locally-advanced-nasopharyngeal-carcinoma weekly 0.8 https://www.themednet.org/would-the-findings-of-a-synchronous-t1a-ovarian-endometrioid-adenocarcinoma-affect-your-treatment-recommendation-for-a-ib-g2-uterine-endometrioid-adenocarcinoma-and-lvsi weekly 0.8 https://www.themednet.org/how-do-you-approach-early-stage-mixed-histology-lung-cancer-sclc-and-nsclc-components-in-patients-with-good-performance-status weekly 0.8 https://www.themednet.org/what-is-your-preferred-maintenance-therapy-in-young-fit-patients-with-de-novo-plasma-cell-leukemia-who-achieve-complete-response-after-autologous-stem-cell-transplantation weekly 0.8 https://www.themednet.org/is-there-a-preferred-sequence-of-therapy-in-renal-cell-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-manage-pelvic-pain-and-hematuria-due-to-recurrent-high-grade-transitional-cell-bladder-cancer-who-had-received-70-gy-to-bladder-and-is-not-a-chemotherapy-or-surgical-candidate weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-who-received-neoadjuvant-crt-per-the-cross-trial-for-esophageal-cancer-but-refuses-surgery-after-imaging-shows-a-good-radiographic-response weekly 0.8 https://www.themednet.org/would-you-retreat-a-patient-with-docetaxel-for-metastatic-castrate-resistant-prostate-cancer-if-treated-in-hormone-sensitive-setting-metastatic-disease-with-good-response-three-years-ago-but-now-has-crpc-and-has-progressed-on-abiraterone weekly 0.8 https://www.themednet.org/how-successful-is-ivf-after-definitive-radiation-therapy-to-the-pelvis-for-endometrial-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-non-surgical-patients-with-gist-who-are-intolerant-to-imatinib-400-mg-daily-and-unlikely-to-tolerate-other-tkis weekly 0.8 https://www.themednet.org/is-there-any-role-for-adjuvant-therapy-for-completely-resected-oligometastatic-rcc weekly 0.8 https://www.themednet.org/do-you-offer-adt-in-patients-with-intermediate-risk-prostate-cancer-who-receive-hypofractionated-ebrt weekly 0.8 https://www.themednet.org/if-tumor-is-stradling-the-peritoneal-reflection-how-do-you-decide-whether-to-treat-with-neoadjuvant-chemo-rt-vs-just-surgery weekly 0.8 https://www.themednet.org/how-do-you-account-for-tumor-growth-from-pre-operative-to-intra-operative-ultrasound-for-uveal-melanoma weekly 0.8 https://www.themednet.org/how-would-you-manage-a-postmenopausal-female-with-a-history-of-early-stage-invasive-ductal-er-her2-breast-cancer-s-p-mastectomy-who-has-a-local-recurrence-of-er-her2-lobular-carcinoma-while-on-letrozole weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-leydig-cell-tumor-of-the-testes-with-extensive-lung-and-abdominal-metastases-peritoneum-retroperitoneal-ln-and-soft-tissue-following-orchiectomy-and-maximal-surgical-resection-of-abdominal-disease weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-use-for-a-recurrent-basal-cell-carcinoma-of-the-right-ear-concha-close-to-the-tympanic-membrane-status-post-multiple-mohs-surgeries-with-close-positive-margins weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-a-premenopausal-female-with-hr-her2-breast-cancer-with-n1mic-disease weekly 0.8 https://www.themednet.org/would-you-re-introduce-bisphosphonate-or-denosumab-in-a-bone-only-metastatic-er-breast-cancer-patient-with-history-of-osteonecrosis-of-the-jaw weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-dlbcl-in-a-patient-on-hemodialysis weekly 0.8 https://www.themednet.org/what-high-dose-rectal-constraints-do-you-use-when-using-a-hypofractionated-prostate-regimen weekly 0.8 https://www.themednet.org/what-is-the-optimal-management-of-patients-with-stage-ii-lung-cancer-without-nodal-metastasis-but-unresectable-due-to-poor-pulmonary-reserve weekly 0.8 https://www.themednet.org/is-there-a-role-for-upfront-next-generation-sequencing-in-extensive-stage-small-cell-lung-carcinoma weekly 0.8 https://www.themednet.org/how-should-dose-homogeneity-across-bone-be-handled-in-pediatric-patients weekly 0.8 https://www.themednet.org/how-do-you-manage-pagets-disease-of-the-nipple weekly 0.8 https://www.themednet.org/can-you-omit-the-vulva-from-the-radiation-field-in-isolated-ln-recurrence-several-years-after-initial-vulvectomy-nodal-dissection-without-adjuvant-rt weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-for-definitive-chemoradiation-in-locally-advanced-nsclc-who-have-severe-neuropathy weekly 0.8 https://www.themednet.org/what-is-your-preferred-neoadjuvant-chemotherapy-regimen-for-muscle-invasive-bladder-cancer-adequate-performance-status-and-preserved-kidney-function weekly 0.8 https://www.themednet.org/would-you-continue-bleomycin-in-a-patient-with-intermediate-risk-stage-3b-nonseminona-who-had-a-pulmonary-embolism weekly 0.8 https://www.themednet.org/what-maximum-dose-would-you-allow-to-the-orbit-in-the-setting-of-adjuvant-radiation-therapy-for-an-excised-squamous-cell-carcinoma-of-the-cheek-with-orbital-bony-infiltration-and-positive-margin weekly 0.8 https://www.themednet.org/is-there-any-role-for-palliative-radiation-in-the-treatment-of-pericardial-metastases weekly 0.8 https://www.themednet.org/do-you-recommend-prophylactic-cranial-irradiation-for-es-sclc-patients-now-that-immunotherapy-is-included-in-the-treatment-schema weekly 0.8 https://www.themednet.org/how-would-you-approach-a-young-patient-with-a-locally-advanced-endometrial-cancer-with-cervical-involvement-and-a-solitary-bone-metastasis weekly 0.8 https://www.themednet.org/would-you-offer-pa-nodal-xrt-in-a-patient-with-rising-psa-and-multiple-pet-positive-nodes-after-previous-prostate-xrt-treatment-that-is-otherwise-locally-controlled weekly 0.8 https://www.themednet.org/what-is-the-role-for-ttfields-in-patients-who-cannot-undergo-complete-surgical-resection-for-glioblastoma weekly 0.8 https://www.themednet.org/for-a-patient-with-metastatic-colon-cancer-who-tested-positive-for-msi-i-e-mlh1-hypermethylation-etc-and-braf-mutation-what-would-be-your-preferred-choice-in-the-second-line-setting weekly 0.8 https://www.themednet.org/what-factors-affect-your-decision-to-offer-adjuvant-rt-for-thymoma-s-p-r0-resection weekly 0.8 https://www.themednet.org/would-you-offer-rt-to-a-patient-who-had-a-rp-showing-pt3b-pn1-gleason-9-prostate-cancer-with-elevated-post-op-psa weekly 0.8 https://www.themednet.org/how-would-you-approach-a-high-grade-neuroendocrine-carcinoma-found-in-a-mediastinal-lymph-node-with-unknown-primary weekly 0.8 https://www.themednet.org/do-you-routinely-prescribe-pcp-prophylaxis-for-patients-who-will-be-on-steroids-long-term weekly 0.8 https://www.themednet.org/for-a-patient-with-a-solitary-kidney-what-dose-constraints-would-you-use-for-sbrt-to-a-nearby-site weekly 0.8 https://www.themednet.org/can-a-rituxumab-biosimilar-be-used-for-a-high-grade-lymphoma weekly 0.8 https://www.themednet.org/what-is-the-best-management-for-a-patient-with-advanced-renal-medullary-carcinoma weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-dcis-er-pr-her2-negative-with-microinvasion-in-a-sln-that-is-her2-positive weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiation-to-a-patient-with-uterine-undifferentiated-sarcoma-s-p-resection-vaginal-cuff-recurrence-and-re-resection weekly 0.8 https://www.themednet.org/would-you-recommend-chemoradiation-to-the-pelvis-for-a-patient-with-squamous-cell-carcinoma-of-the-anus-metastatic-to-the-liver-who-has-had-a-complete-response-to-chemotherapy-in-the-pelvis-and-a-liver-resection weekly 0.8 https://www.themednet.org/when-treating-locally-advanced-breast-cancer-preoperatively-that-is-progressing-on-neoadjuvant-chemotherapy-to-what-doses-do-you-treat-the-gross-disease-breast-and-regional-nodes weekly 0.8 https://www.themednet.org/when-do-you-recommend-patients-get-vaccinations-with-respect-to-their-chemotherapy-course weekly 0.8 https://www.themednet.org/what-would-be-your-preferred-adjuvant-regimen-for-ampullary-carcinoma-pancreatic-histology-in-patient-with-pre-existing-neuropathy weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-igm-monoclonal-gammopathy-associated-with-severe-neuropathy-of-unclear-etiology weekly 0.8 https://www.themednet.org/can-post-lumpectomy-radiation-be-omitted-for-er-pr-low-volume-2-mm-low-int-dcis-with-2-mm-margins-in-a-post-menopausal-patient-who-will-be-taking-tamoxifen weekly 0.8 https://www.themednet.org/would-you-treat-t1a-glottic-cancer-with-single-vocal-cord-irradiation-using-igrt weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-a-her2-locoregional-recurrence-who-did-not-receive-prior-systemic-therapy weekly 0.8 https://www.themednet.org/do-you-give-bisphosphonates-after-completing-adjuvant-anti-her2-therapy-and-chemotherapy-for-her2-breast-cancer-to-reduce-the-risk-of-recurrence weekly 0.8 https://www.themednet.org/how-would-you-treat-an-endometrial-cancer-with-pelvic-sidewall-nodes-patient-s-p-tah-bso-but-nodes-were-fixed-and-unresectable weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-would-you-recommend-for-anal-melanoma-that-is-localized-but-refusing-surgery weekly 0.8 https://www.themednet.org/would-you-treat-pash-pseudoangiomatous-stromal-hyperplasia-with-focal-er-positivity-with-hormonal-agents weekly 0.8 https://www.themednet.org/how-would-you-treat-a-stage-ie-diffuse-large-b-cell-lymphoma-of-the-adrenal-gland-in-an-elderly-patient-who-is-not-a-candidate-for-systemic-therapy weekly 0.8 https://www.themednet.org/when-would-you-consider-radiation-for-a-sertoli-leydig-tumor-of-the-ovary-with-a-bulky-mass-and-peritoneal-metastases-after-surgery-and-bep-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-early-stage-rectal-adenocarcinoma-in-patients-with-confirmed-lynch-syndrome weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-no-driver-mutation-pd-l1-50-with-systemic-relapse-of-lung-adenocarcinoma-within-a-year-after-resection-and-completion-of-adjuvant-platinum-based-chemotherapy weekly 0.8 https://www.themednet.org/do-you-consider-discontinuing-brentuximab-in-stage-iii-iv-classical-hodgkin-lymphoma-patients-on-avd-brentuximab-who-have-a-good-response-to-2-cycles weekly 0.8 https://www.themednet.org/would-you-consider-elective-nodal-irradiation-when-treating-a-solitary-mediastinal-node-recurrence-after-chemo-rt-for-non-small-cell-adenocarcinoma weekly 0.8 https://www.themednet.org/in-a-patient-with-primary-mediastinal-seminoma-with-normalization-of-biomarkers-s-p-epx4-and-residual-non-fdg-avid-mass-would-you-consider-resection-of-residual-tumor-vs-surveillance weekly 0.8 https://www.themednet.org/is-there-any-evidence-that-demonstrates-an-increase-in-rectal-or-bladder-toxicity-with-protons-for-prostate-cancer-compared-to-imrt weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiotherapy-for-a-malignant-fibromyxoid-tumor-of-soft-tissue-with-margin-1-cm-on-re-excision weekly 0.8 https://www.themednet.org/what-is-the-preferred-approach-for-giving-high-dose-methotrexate-in-double-or-triple-hit-lymphomas-being-treated-with-da-epoch-r weekly 0.8 https://www.themednet.org/would-you-omit-postoperative-radiation-to-the-neck-for-a-patient-with-advanced-t-stage-hnscc-and-high-risk-features-and-bilateral-pn0-neck-dissection weekly 0.8 https://www.themednet.org/how-do-you-sequence-adt-relative-to-the-start-of-rt weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-endocrine-therapy-for-dcis-in-a-patient-who-received-bilateral-nipple-sparing-mastectomies weekly 0.8 https://www.themednet.org/what-is-your-preferred-initial-treatment-for-metastastic-primary-lung-liposarcoma-in-a-fit-patient weekly 0.8 https://www.themednet.org/what-dose-do-you-recommend-for-an-oligometastatic-bone-metastasis-involving-the-glenoid weekly 0.8 https://www.themednet.org/should-a-bowel-prep-be-considered-when-performing-an-ovarian-cancer-debulking-and-or-bowel-resection weekly 0.8 https://www.themednet.org/will-you-incorporate-immunotherapy-in-neoadjuvant-treatment-of-triple-negative-breast-cancer-based-off-keynote-522 weekly 0.8 https://www.themednet.org/how-do-you-manage-a-glioblastoma-of-the-brainstem-upper-cervical-spinal-cord weekly 0.8 https://www.themednet.org/would-you-recommend-radiation-for-micrometastasis-on-sentinel-lymph-node-biopsy-in-otherwise-low-risk-endometrial-cancer weekly 0.8 https://www.themednet.org/do-you-offer-systemic-therapy-for-nsclc-no-driver-mutation-after-resection-of-a-metachronous-solitary-brain-metastasis-occuring-after-definitive-therapy-for-limited-disease-with-no-evidence-of-active-extracranial-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-for-solitary-fibrous-tumor-with-a-multifocal-pleural-based-metastatic-recurrence-that-is-surgically-inoperable-in-a-patient-with-good-performance-status weekly 0.8 https://www.themednet.org/how-would-you-integrate-immunotherapy-into-the-treatment-of-a-patient-with-recurrent-widely-metastatic-gastric-adenocarcinoma-after-initial-treatment-with-perioperative-eox-and-subtotal-gastrectomy weekly 0.8 https://www.themednet.org/would-you-consider-ip-chemotherapy-in-a-brca-positive-advanced-ovarian-cancer-patient-after-upfront-ovarian-debulking-surgery-to-no-gross-residual weekly 0.8 https://www.themednet.org/would-you-offer-additional-therapy-for-a-patient-with-hr-breast-cancer-on-ai-os-who-is-found-to-have-a-focus-of-ovarian-metastasis-at-the-time-of-elective-bso weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-intact-prostate-cancer-with-metastases-to-a-para-aortic-node-and-single-bone weekly 0.8 https://www.themednet.org/what-bowel-dose-constraint-do-you-recommend-if-you-are-boosting-a-pelvic-lymph-node-for-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-obtain-approval-for-an-mri-prostate-for-radiation-planning weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-for-locally-advanced-gastric-adenosquamous-carcinoma-following-d2-resection weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-treatment-for-resected-colloid-pancreatic-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-manage-grade-2-3-chemotherapy-induced-peripheral-neuropathy-cipn-developing-during-adjuvant-paclitaxel-therapy-for-breast-cancer weekly 0.8 https://www.themednet.org/what-neoadjuvant-strategies-do-you-utilize-for-initially-unresectable-biliary-tract-cancer weekly 0.8 https://www.themednet.org/what-would-be-the-best-treatment-approach-for-bladder-cancer-patients-s-p-neoadjuvant-therapy-and-surgical-resection-who-develop-oligometastatic-recurrence-within-1-year-that-is-amenable-to-resection weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiation-to-the-surgical-bed-for-a-merkel-cell-carcinoma-of-the-upper-extremity-with-low-risk-features-as-per-the-nccn-guidelines weekly 0.8 https://www.themednet.org/do-you-treat-regional-nodes-for-node-negative-by-sln-patients-with-early-stage-breast-cancer-in-a-medial-location weekly 0.8 https://www.themednet.org/in-a-patient-with-early-stage-hr-breast-cancer-who-was-perimenopausal-at-diagnosis-but-intolerant-of-ai-would-you-consider-extending-tamoxifen-beyond-10-years weekly 0.8 https://www.themednet.org/how-would-you-manage-a-high-risk-scc-of-the-scalp-that-has-wound-healing-issues-after-mohs-surgery weekly 0.8 https://www.themednet.org/what-do-you-recommend-for-women-on-ai-therapy-who-experience-excessive-hair-loss weekly 0.8 https://www.themednet.org/in-a-patient-with-hr-her2-early-breast-cancer-who-is-receiving-adjuvant-t-dm1-for-residual-disease-do-you-overlap-endocrine-therapy-with-t-dm1 weekly 0.8 https://www.themednet.org/what-is-your-first-line-therapy-for-progressive-symptomatic-metastatic-adenoid-cystic-carcinoma weekly 0.8 https://www.themednet.org/do-you-do-a-ct-simulation-for-post-op-heterotopic-ossification-prophylaxis weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-offer-radiation-therapy-for-pleomorphic-lobular-carcinoma-in-situ-after-lumpectomy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-a-solitary-plasmacytoma-with-a-partial-response-to-rt weekly 0.8 https://www.themednet.org/in-what-situations-if-any-would-you-add-chemotherapy-to-adjuvant-radiotherapy-in-patients-with-resected-head-and-neck-cancer-without-ene-or-positive-magrin weekly 0.8 https://www.themednet.org/how-do-you-approach-itcs-in-sentinel-lymph-node-biopsy-in-a-vulvar-cancer-patient weekly 0.8 https://www.themednet.org/when-if-ever-would-you-recommend-hysterectomy-after-chemoradiation-for-patients-with-locally-advanced-cervical-cancer weekly 0.8 https://www.themednet.org/which-criteria-do-you-follow-to-recommend-low-dose-ct-screening-in-patients-at-high-risk-for-lung-cancer weekly 0.8 https://www.themednet.org/is-there-a-role-of-definitive-radiation-or-prostatectomy-in-a-patient-who-has-m0-castrate-resistant-prostate-cancer-and-whose-psa-is-undetectable-on-adt-and-enzulatamide weekly 0.8 https://www.themednet.org/are-there-specific-radiographic-features-that-would-alter-your-management-of-a-presumed-meningioma weekly 0.8 https://www.themednet.org/is-orchiectomy-necessary-for-a-patient-with-primary-retroperitoneal-seminoma-and-calcifications-seen-on-testicular-ultrasound-but-no-primary-testicular-mass weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-small-cell-of-the-prostate-who-is-progressing-on-cisplatin-etoposide-and-has-previous-ngs-without-actionable-mutations weekly 0.8 https://www.themednet.org/for-post-prostatectomy-radiation-what-rectum-sigmoid-and-bladder-constraints-do-you-use weekly 0.8 https://www.themednet.org/do-you-routinely-order-a-thoracic-or-brachial-plexus-mri-for-patients-with-apical-lung-cancers weekly 0.8 https://www.themednet.org/what-therapy-would-you-recommend-for-metastatic-myxoid-liposarcoma-in-a-young-patient-with-anthracycline-cardiomyopathy-with-ef-25-who-failed-eribulin weekly 0.8 https://www.themednet.org/how-would-you-approach-a-radiation-induced-angiosarcoma-of-the-breast-after-mastectomy-with-negative-margins weekly 0.8 https://www.themednet.org/how-would-you-manage-a-superior-sulcus-tumor-following-45gy-induction-chemoradiotherapy-then-resection-that-left-gross-residual-disease-in-the-bony-spine weekly 0.8 https://www.themednet.org/what-are-the-indications-for-radiation-after-cord-stripping-for-early-stage-glottic-cancers weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-isolated-lesions-within-the-spleen-for-a-patient-with-metastatic-small-cell-lung-cancer-and-well-controlled-disease-elsewhere-after-chemotherapy weekly 0.8 https://www.themednet.org/what-systemic-therapy-do-you-recommend-for-a-patient-with-a-local-relapse-of-ewing-sarcoma-who-previously-received-vdc-ie weekly 0.8 https://www.themednet.org/how-do-you-manage-a-pediatric-patient-less-than-3-years-old-with-first-relapse-of-medulloblastoma weekly 0.8 https://www.themednet.org/what-intracavitary-brachytherapy-regimen-would-you-use-after-ebrt-for-a-4cm-vaginal-leiomyosarcoma-the-mid-vagina-with-positive-margins weekly 0.8 https://www.themednet.org/how-do-cytopenias-factor-into-your-decision-of-whether-to-hold-radiotherapy-during-treatment-of-a-glioblastoma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-extremity-sts-g2-3-after-an-initial-unplanned-non-oncologic-surgery-who-is-planned-for-oncologic-re-excision weekly 0.8 https://www.themednet.org/in-patients-with-metastatic-colon-cancer-responding-to-treatment-with-folfox-folfiri-with-bevacizumab-who-develop-a-symptomatic-pe-do-you-continue-bevacizumab-after-treating-the-pe weekly 0.8 https://www.themednet.org/would-you-consider-repeat-lumpectomy-and-external-beam-partial-breast-reirradiation-for-in-breast-recurrent-cancers weekly 0.8 https://www.themednet.org/what-is-your-preferred-salvage-chemotherapy-regimen-for-bridge-to-auto-sct-for-patients-with-relapsed-classical-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/is-there-a-threshold-dose-to-the-mandible-above-which-you-consider-prophylactic-hbo-prior-to-dental-extractions-that-are-required-after-rt weekly 0.8 https://www.themednet.org/what-length-of-adt-do-you-recommend-in-a-patient-with-a-very-low-risk-prostate-cancer-who-otherwise-has-a-psa-20 weekly 0.8 https://www.themednet.org/would-you-offer-neoadjuvant-immunotherapy-in-addition-to-chemotherapy-for-locally-advanced-hr-breast-cancer-based-on-the-i-spy-2-data weekly 0.8 https://www.themednet.org/what-is-the-appropriate-concurrent-chemoradiation-regimen-to-treat-unresectable-stage-iib-lung-adenocarcinoma weekly 0.8 https://www.themednet.org/what-would-be-your-first-line-approach-to-a-patient-with-metastatic-hcc-with-significant-bleeding-risk weekly 0.8 https://www.themednet.org/how-do-you-approach-recurrent-localized-hr-her2-breast-cancer-in-a-patient-who-has-progressed-on-exemestane-and-previously-on-letrozole-and-tamoxifen weekly 0.8 https://www.themednet.org/would-you-offer-neoadjuvant-chemotherapy-to-premenopausal-women-with-ct1cn0-her2-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-t3-hr-her2-breast-cancer-who-had-no-clinical-improvement-after-ddac weekly 0.8 https://www.themednet.org/what-would-you-recommend-for-early-stage-vulvar-cancer-with-close-margins weekly 0.8 https://www.themednet.org/in-light-of-data-from-prodige7-for-patients-with-peritoneal-metastasis-from-colon-cancer-do-you-still-offer-hipec weekly 0.8 https://www.themednet.org/what-would-be-your-choice-of-adjuvant-chemotherapy-for-a-healthy-patient-with-localized-triple-negative-breast-cancer-who-is-not-a-candidate-for-anthracycline-and-has-severe-neuropathy weekly 0.8 https://www.themednet.org/would-you-consider-salvage-radiation-in-a-recurrent-prostate-cancer-with-a-positive-pelvic-node-and-high-inguinal-node-on-pet-axumin-but-negative-inguinal-biopsy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-hr-her2-metastatic-breast-cancer-with-a-gbrca-mutation-who-has-progressed-on-endocrine-therapy-with-a-new-pericardial-effusion weekly 0.8 https://www.themednet.org/what-measures-should-we-take-regarding-routine-follow-up-visits-for-well-patients-in-surveillance-during-the-coronavirus-pandemic weekly 0.8 https://www.themednet.org/have-your-treatment-recommendations-for-urothelial-cancer-patients-changed-given-the-ongoing-covid19-pandemic weekly 0.8 https://www.themednet.org/is-your-approach-to-managing-immune-related-adverse-events-altered-at-all-in-light-of-covid-19 weekly 0.8 https://www.themednet.org/are-you-altering-your-use-of-immune-checkpoint-inhibitors-given-the-risk-of-immune-related-pneumonitis-and-the-covid-19-outbreak weekly 0.8 https://www.themednet.org/should-we-be-utilizing-prophylactic-g-csf-in-our-patients-with-intermediate-risk-of-febrile-neutropenia-due-to-the-covid-19-pandemic weekly 0.8 https://www.themednet.org/what-are-best-practices-for-medical-oncology-clinics-during-the-covid-19-pandemic weekly 0.8 https://www.themednet.org/what-scenarios-if-any-are-you-delaying-adjuvant-chemotherapy-in-light-of-the-covid-19-outbreak weekly 0.8 https://www.themednet.org/how-should-you-manage-a-covid-19-infected-suspected-patient-who-is-receiving-chemotherapy-and-cannot-interrupt-or-delay-their-cancer-treatment weekly 0.8 https://www.themednet.org/how-should-our-selection-for-neoadjuvant-chemotherapy-for-breast-cancer-change-in-light-of-covid-19 weekly 0.8 https://www.themednet.org/should-extra-precautions-be-taken-for-pediatric-oncology-patients-in-light-of-the-recent-covid-19-outbreak weekly 0.8 https://www.themednet.org/what-is-the-longest-acceptable-interval-between-radical-orchiectomy-and-adjuvant-bep-for-stage-iib-iii-pure-seminoma-in-the-age-of-covid-19 weekly 0.8 https://www.themednet.org/how-does-avascular-necrosis-of-the-femoral-head-affect-definitive-radiation-to-the-prostate weekly 0.8 https://www.themednet.org/would-you-offer-immunotherapy-first-line-for-patients-with-adrenocortical-carcinoma-outside-of-a-clinical-trial weekly 0.8 https://www.themednet.org/how-has-covid-19-altered-your-recommendations-for-invasive-mediastinal-staging-for-nsclc weekly 0.8 https://www.themednet.org/are-maintenance-therapies-for-ovarian-cancer-being-held-at-your-institution-due-to-covid-19 weekly 0.8 https://www.themednet.org/what-is-the-longest-acceptable-interval-between-hysterectomy-and-vaginal-cuff-brachytherapy-for-high-intermediate-risk-endometrial-cancer-in-the-age-of-covid-19 weekly 0.8 https://www.themednet.org/how-do-you-manage-bladder-fullness-during-cervical-t-o-brachytherapy-to-minimize-oar-dose weekly 0.8 https://www.themednet.org/in-the-wake-of-the-covid-19-pandemic-are-there-any-hypofractionated-regimens-without-concurrent-chemotherapy-that-could-be-utilized-for-head-neck-cancer-in-a-post-operative-setting weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-in-a-patient-with-hr-breast-cancer-with-a-high-rs-25-given-the-current-covid-19-pandemic weekly 0.8 https://www.themednet.org/would-you-consider-modifying-t-o-fractionation-during-the-covid-19-pandemic weekly 0.8 https://www.themednet.org/would-you-offer-concurrent-chemoradiotherapy-and-or-adjuvant-systemic-therapy-chemo-or-immunotherapy-or-for-a-completely-resected-stage-iii-merkel-cell-after-wle-and-alnd weekly 0.8 https://www.themednet.org/in-light-of-the-covid-19-pandemic-would-you-consider-sbrt-for-appropriately-selected-early-stage-breast-cancer-patients weekly 0.8 https://www.themednet.org/given-covid-19-is-there-a-good-hypofractionated-regimen-for-postmastectomy-radiation-for-locally-advanced-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-for-a-patient-who-develops-a-nodal-recurrence-years-after-primary-resection-of-nsclc weekly 0.8 https://www.themednet.org/in-a-locoregionally-advanced-breast-cancer-with-multiple-positive-surgical-margins-how-safe-is-it-to-wait-for-a-re-excision-vs-treating-upfront-with-comprehensive-rt-if-surgery-cannot-be-done-the-short-term-due-to-the-covid-outbreak weekly 0.8 https://www.themednet.org/would-you-withhold-immunotherapy-for-es-sclc-during-the-covid-19-pandemic weekly 0.8 https://www.themednet.org/in-what-situations-do-you-utilize-g-csf-in-germ-cell-tumors-or-hodgkin-lymphoma-patients-receiving-bleomycin weekly 0.8 https://www.themednet.org/how-do-you-distinguish-between-radiation-necrosis-abscess-or-disease-recurrence-in-head-and-neck-cancer-patients weekly 0.8 https://www.themednet.org/how-would-you-prescribe-rt-dose-to-post-op-vulvar-cancer-with-margins-positive-for-severe-dysplasia weekly 0.8 https://www.themednet.org/are-there-any-alternative-hypofractionated-rt-courses-for-patients-with-dlbcl-that-can-be-used-during-the-covid-19-pandemic weekly 0.8 https://www.themednet.org/what-chemotherapy-would-you-recommend-for-a-patient-with-ewing-sarcoma-who-has-relapsed-after-being-initially-treated-with-vincristine-doxorubicin-ifosfamide weekly 0.8 https://www.themednet.org/how-do-you-manage-persistent-cytopenias-in-patients-with-aml-who-achieve-a-complete-remission-with-incomplete-count-recovery-after-venetoclax-and-hma weekly 0.8 https://www.themednet.org/how-do-you-determine-whether-to-treat-a-young-adult-with-stage-ia-hodgkin-lymphoma-with-the-adult-or-pediatric-treatment-paradigm weekly 0.8 https://www.themednet.org/would-you-stop-current-immunosuppressive-therapy-or-delay-starting-immunosuppressive-therapy-in-a-patient-with-aplastic-anemia-who-has-been-infected-with-covid-19 weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-chemotherapy-for-a-stage-iib-triple-negative-apocrine-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-balance-target-coverage-with-tolerances-of-the-ipsilateral-eye-structures-and-the-risk-of-vision-loss-in-advanced-head-and-neck-cancers weekly 0.8 https://www.themednet.org/is-there-a-valid-hypofractionated-regimen-for-postop-cervical-endometrial-cancers-given-covid-19 weekly 0.8 https://www.themednet.org/would-you-offer-partial-breast-irradiation-to-women-who-have-her2-disease weekly 0.8 https://www.themednet.org/are-you-offering-hypofractionated-comprehensive-nodal-irradiation-following-neoadjuvant-chemotherapy-for-patients-with-locally-advanced-breast-cancer-in-the-setting-of-covid-19 weekly 0.8 https://www.themednet.org/would-you-consider-short-course-rt-for-rectal-cancer-in-the-post-op-setting-given-covid-19 weekly 0.8 https://www.themednet.org/is-there-any-advantage-to-proton-beam-therapy-in-a-locally-recurrent-anal-carcinoma-which-has-already-been-treated-with-concurrent-chemo-rt-as-well-as-apr-for-relapse weekly 0.8 https://www.themednet.org/how-would-you-approach-a-resectable-and-isolated-in-field-local-recurrence-of-head-and-neck-cancer-detected-mid-way-through-adjuvant-radiation weekly 0.8 https://www.themednet.org/in-the-setting-of-covid-19-would-you-perform-a-slnb-for-a-patient-incidentally-found-to-have-microinvasive-er-ilc-in-contralateral-prophylactic-mastectomy-following-neoadjuvant-chemotherapy-for-a-locally-advanced-triple-positive-breast-cancer weekly 0.8 https://www.themednet.org/in-a-patient-with-early-stage-breast-cancer-previously-treated-with-lumpectomy-and-rt-how-would-you-manage-a-node-positive-recurrence-s-p-lumpectomy-and-snb weekly 0.8 https://www.themednet.org/how-are-you-counseling-hr-proficient-ovarian-cancer-patients-about-front-line-parp-inhibitor-maintenance weekly 0.8 https://www.themednet.org/would-you-consider-starting-immunotherapy-concurrently-with-whole-brain-radiation-for-newly-diagnosed-metastatic-braf-negative-melanoma-with-multifocal-symptomatic-brain-metastases weekly 0.8 https://www.themednet.org/would-you-consider-ofs-in-a-young-patient-35-with-er-breast-cancer-who-required-chemotherapy-and-menses-resumed-years-later-while-on-tamoxifen weekly 0.8 https://www.themednet.org/what-treatment-would-you-offer-a-young-pregnant-woman-with-a-symptomatic-midline-low-grade-glioma weekly 0.8 https://www.themednet.org/how-do-you-manage-a-recurrent-anaplastic-meningioma weekly 0.8 https://www.themednet.org/how-do-you-perform-surveillance-on-metastatic-well-differentiated-neuroendocrine-tumors weekly 0.8 https://www.themednet.org/how-would-you-approach-a-new-solitary-sternal-metastasis-for-a-triple-positive-breast-cancer-1-year-after-hypofractionated-breast-radiation weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-for-msi-h-stage-ii-colon-cancer-with-multiple-high-risk-features weekly 0.8 https://www.themednet.org/what-adjuvant-treatment-would-you-offer-after-repeat-surgery-for-a-locally-recurrent-lymph-node-positive-small-bowel-adenocarcinoma-with-residual-neuropathy-after-prior-folfox weekly 0.8 https://www.themednet.org/what-dose-constraints-do-you-use-for-15-25-fraction-hypofractionated-rt-for-cholangiocarcinoma weekly 0.8 https://www.themednet.org/would-you-consider-any-form-of-maintenance-therapy-for-a-patient-in-a-cr2-following-re-challenge-with-platinum-doublet-for-small-cell-lung-cancer-after-first-line-chemo-io weekly 0.8 https://www.themednet.org/would-a-high-decipher-score-affect-your-recommendation-regarding-the-addition-of-adt-to-xrt-in-a-favorable-intermediate-risk-prostate-patient weekly 0.8 https://www.themednet.org/what-is-your-approach-to-maintenance-therapy-post-autologous-stem-cell-transplant-for-patients-with-concurrent-multiple-myeloma-and-al-amyloidosis weekly 0.8 https://www.themednet.org/in-the-setting-of-recurrent-breast-cancer-after-breast-radiation-who-receives-a-mastectomy-and-is-found-to-have-positive-axillary-nodes-under-what-circumstances-would-you-give-radiation-to-the-chest-wall-and-nodes-vs-the-nodes-only weekly 0.8 https://www.themednet.org/what-dose-would-you-use-for-re-irradiation-of-metastatic-melanoma-to-an-inguinal-node weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-rt-for-a-small-merkel-cell-carcinoma-of-the-lateral-canthus-with-a-close-margin weekly 0.8 https://www.themednet.org/how-would-you-manage-a-treatment-interruption-during-sbrt-to-the-liver weekly 0.8 https://www.themednet.org/would-you-consider-using-bevacizumab-atezolizumab-in-hcc-patients-who-received-tki-in-the-first-line weekly 0.8 https://www.themednet.org/would-you-treat-the-whole-bladder-with-a-cervical-cancer-that-is-invading-the-bladder weekly 0.8 https://www.themednet.org/for-prostate-cancer-patients-with-n-disease-is-there-evidence-demonstrating-improved-outcomes-with-the-addition-of-nodal-rt-as-opposed-to-prostate-rt-alone-plus-adt weekly 0.8 https://www.themednet.org/would-you-anticoagulate-a-patient-with-an-isolated-arterial-thrombosis-in-the-setting-of-an-inherited-thrombophilia weekly 0.8 https://www.themednet.org/will-you-be-recommending-relugolix-due-to-rapid-suppression-of-testosterone-and-lower-risk-of-cardiovascular-events weekly 0.8 https://www.themednet.org/would-you-use-alpelisib-in-patients-with-biopsy-proven-hormone-negative-metastatic-breast-cancer-with-a-pik3ca-alteration weekly 0.8 https://www.themednet.org/for-muscle-invasive-bladder-cancer-after-neoadjuvant-chemotherapy-with-cis-gem-and-surgery-with-residual-tumor-and-lymph-node-involvement-would-you-consider-adjuvant-avelumab-as-an-extrapolation-base-on-the-javelin-100-results weekly 0.8 https://www.themednet.org/when-sending-patients-for-follow-up-chest-cts-after-sbrt-or-chemort-how-do-you-determine-whether-to-send-for-scans-with-or-without-iv-contrast weekly 0.8 https://www.themednet.org/do-you-offer-enasidenib-with-azacitadine-in-aml-with-an-idh2-mutation-for-patients-ineligible-for-intensive-induction-chemotherapy weekly 0.8 https://www.themednet.org/at-what-cumulative-anthracycline-dose-is-it-recommended-to-use-dexrazoxane-for-cardioprotection weekly 0.8 https://www.themednet.org/what-is-a-safe-dose-to-deliver-to-a-gastric-bed-recurrence-adjacent-to-the-duodenal-stump-post-total-gastrectomy-for-gastric-carcinoma weekly 0.8 https://www.themednet.org/in-rectal-cancer-patients-receiving-total-neoadjuvant-therapy-do-you-prefer-chemotherapy-followed-by-long-course-chemoradiation-or-short-course-rt-followed-by-chemotherapy weekly 0.8 https://www.themednet.org/do-you-ever-stop-pertuzumab-for-stable-disease-in-a-patient-with-metastatic-her2-positive-breast-with-stable-disease weekly 0.8 https://www.themednet.org/is-there-a-subset-of-anca-vasculitis-patients-for-which-you-would-try-plasma-exchange weekly 0.8 https://www.themednet.org/which-anca-vasculitis-patients-are-better-candidates-for-cyclophosphamide-rather-than-rituximab weekly 0.8 https://www.themednet.org/is-there-a-minimum-work-up-necessary-in-patients-with-an-ana-greater-than-1-160-and-no-clinical-symptoms-suggestive-of-lupus-i-e-specific-antibodies-ua weekly 0.8 https://www.themednet.org/when-is-it-appropriate-to-refer-a-systemic-sclerosis-patient-for-bone-marrow-transplant-evaluation weekly 0.8 https://www.themednet.org/how-do-you-manage-dental-extractions-in-a-patient-getting-reirradiation-to-the-mandibular-area weekly 0.8 https://www.themednet.org/would-you-radiate-a-multiply-recurrent-basal-cell-adenoma-of-the-parotid weekly 0.8 https://www.themednet.org/would-you-recommend-systemic-therapy-in-a-patient-with-a-history-of-stage-iii-high-grade-serous-endometrial-cancer-s-p-resection-of-a-solitary-pulmonary-metastasis-after-a-long-disease-free-interval weekly 0.8 https://www.themednet.org/what-is-the-best-sbrt-dose-fractionation-scheme-for-oligometastatic-disease-in-the-adrenal-gland weekly 0.8 https://www.themednet.org/how-would-you-manage-a-pediatric-patient-with-hypodiploid-acute-lymphoblastic-leukemia weekly 0.8 https://www.themednet.org/would-you-irradiate-the-breast-of-a-patient-with-an-unknown-primary-malignancy-manifesting-as-bulky-axillary-adenopathy-and-non-specific-poorly-differentiated-carcinoma-histology weekly 0.8 https://www.themednet.org/how-do-you-manage-oxaliplatin-induced-acute-peripheral-nerve-hyperexcitability weekly 0.8 https://www.themednet.org/what-rates-of-hemorrhage-do-you-quote-to-patients-receiving-srs-fsrt-to-intact-brain-metastases weekly 0.8 https://www.themednet.org/do-you-have-a-goal-isodose-line-coverage-for-skin-in-the-setting-of-post-mastectomy-rt-with-expanders-in-place weekly 0.8 https://www.themednet.org/what-dose-of-consolidative-ebrt-do-you-use-after-iort-for-breast weekly 0.8 https://www.themednet.org/would-you-add-bevacizumab-to-osimertinib-for-a-patient-with-nsclc-who-is-progressing-on-osimertinib-with-no-other-actionable-resistance-mutations weekly 0.8 https://www.themednet.org/for-a-patient-with-isolated-cns-recurrence-of-hr-her2-breast-cancer-after-completion-of-adjuvant-therapy-what-if-any-systemic-therapy-would-you-start-after-completion-of-local-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-symptomatic-anal-cancer-and-oligometastatic-lesion-to-the-lung weekly 0.8 https://www.themednet.org/do-you-recommend-that-children-with-sickle-cell-disease-refrain-from-returning-to-school-during-the-covid-19-pandemic weekly 0.8 https://www.themednet.org/do-children-with-intermediate-risk-burkitt-lymphoma-benefit-from-adding-rituximab weekly 0.8 https://www.themednet.org/what-is-the-management-of-residual-bulky-2cm-internal-mammary-lymph-node-metastasis-from-breast-cancer-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-ctv-margins-do-you-use-for-indolent-advanced-stage-lymphoma-treated-with-palliative-radiation-alone weekly 0.8 https://www.themednet.org/what-srs-dose-fraction-scheme-would-you-prescribe-to-a-pituitary-adenoma-for-a-patient-with-dry-type-macular-degeneration weekly 0.8 https://www.themednet.org/how-would-you-manage-a-young-patient-with-newly-recurrent-metastatic-triple-negative-breast-cancer-less-than-a-year-after-completing-adjuvant-chemotherapy-and-worsening-liver-function-due-to-intrahepatic-disease weekly 0.8 https://www.themednet.org/what-radiation-dose-constraints-should-be-used-for-the-spinal-cord-in-pediatrics weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-an-idh-wild-type-low-grade-astrocytoma-in-an-elderly-patient weekly 0.8 https://www.themednet.org/what-is-your-preferred-regimen-for-hdr-monotherapy-in-the-treatment-of-low-and-favorable-intermediate-prostate-cancers weekly 0.8 https://www.themednet.org/what-adjuvant-treatment-would-you-offer-a-young-woman-with-stage-ib-uterine-mullerian-adenosarcoma-with-sarcomatous-overgrowth weekly 0.8 https://www.themednet.org/in-the-treatment-of-lupus-nephritis-which-patients-may-benefit-from-the-use-of-rituximab-or-other-b-cell-depleting-agents-during-induction weekly 0.8 https://www.themednet.org/would-you-give-additional-radiation-for-a-positive-margin-after-salvage-hysterectomy-for-a-patient-with-cervical-cancer-who-had-initial-definitive-chemoradiation-with-ebrt-t-r weekly 0.8 https://www.themednet.org/how-would-you-manage-initially-unresectable-node-negative-pancreatic-adenocarcinoma-that-after-upfront-chemotherapy-achieves-a-complete-radiographic-response-on-interval-mri-and-ct weekly 0.8 https://www.themednet.org/when-should-you-use-caplacizumab-in-the-treatment-of-acute-ttp-patients weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-who-is-s-p-mastectomy-with-only-dcis-in-the-breast-and-a-large-positive-sentinel-node weekly 0.8 https://www.themednet.org/do-you-approach-the-treatment-of-post-lumpectomy-dcis-which-is-only-present-within-an-intraductal-papilloma-differently-if-it-does-not-involve-adjacent-breast-tissue weekly 0.8 https://www.themednet.org/should-gonadotropin-releasing-hormone-gnrh-agonists-be-offered-to-all-women-of-reproductive-age-about-to-undergo-treatment-with-cyclophosphamide weekly 0.8 https://www.themednet.org/would-you-offer-further-chemotherapy-in-the-adjuvant-setting-after-resection-of-an-isolated-liver-met-that-developed-shortly-after-completion-of-adjuvant-folfox-for-colon-cancer weekly 0.8 https://www.themednet.org/do-you-regularly-do-bone-density-testing-to-screen-for-osteoporosis-in-men-with-rheumatoid-arthritis-without-any-other-risk-factors weekly 0.8 https://www.themednet.org/what-is-the-role-of-nintedanib-in-the-treatment-of-ssc-ild weekly 0.8 https://www.themednet.org/would-you-recommend-completing-prostate-sbrt-without-fiducials weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-nsclc-with-repeated-episodes-of-cns-brain-metastases-but-otherwise-with-good-systemic-disease-control-on-maintenance-therapy weekly 0.8 https://www.themednet.org/what-agent-would-you-choose-for-a-patient-who-needs-osteoporosis-therapy-after-a-bisphosphonate-holiday weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-therapy-for-treatment-of-a-high-grade-astroblastoma weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-metastatic-merkel-cell-carcinoma-to-the-axillary-supraclavicular-lymph-nodes-of-unknown-primary weekly 0.8 https://www.themednet.org/are-there-any-preferred-chemotherapy-regimens-for-stage-iv-nut-carcinoma weekly 0.8 https://www.themednet.org/can-trental-vit-e-for-treatment-of-fibrosis-be-used-in-patients-taking-anticoagulants weekly 0.8 https://www.themednet.org/what-adjuvant-chemotherapy-would-you-recommend-in-a-premenopausal-patient-with-pt1cn1-hr-breast-cancer-who-previously-received-an-anthracycline-and-cyclophosphamide-30-years-prior weekly 0.8 https://www.themednet.org/in-a-patient-who-is-planned-for-wbrt-for-multiple-brain-metastases-but-also-needs-breast-palliation-do-you-favor-breast-radiation-over-palliative-mastectomy weekly 0.8 https://www.themednet.org/in-the-setting-of-single-or-multi-fraction-cranial-radiosurgery-do-you-have-different-constraints-for-the-dose-to-the-optic-tract-just-posterior-to-the-chiasm-compared-to-the-constraints-for-the-chiasm weekly 0.8 https://www.themednet.org/what-clinical-parameters-determine-when-you-treat-a-large-hcc-lesion-with-ablative-radiation-vs-y-90 weekly 0.8 https://www.themednet.org/would-you-consider-the-use-of-ctdna-as-part-of-surveillance-in-high-risk-tnbc-patients weekly 0.8 https://www.themednet.org/what-would-be-the-treatment-options-for-metastatic-clear-cell-carcinoma-of-kidney-who-develops-recurrent-thrombosis-despite-therapeutic-anticoagulant-on-cabozantinib-in-second-line-treatment-after-failing-immunotherapy weekly 0.8 https://www.themednet.org/how-do-you-manage-a-cervical-cancer-patient-on-anti-coagulation-for-pulmonary-embolism-requiring-interstitial-brachytherapy-boost weekly 0.8 https://www.themednet.org/how-would-you-proceed-for-a-patient-with-metastatic-gastric-type-adenocarcinoma-with-vaginal-and-inguinofemoral-disease-only-who-experiences-complete-response-to-her-vaginal-tumor-but-residual-inguinal-disease weekly 0.8 https://www.themednet.org/how-would-you-treat-a-postoperative-pt4a-nx-larynx-who-had-tl-without-node-dissection-and-no-suspicious-nodes-on-pre-surgical-imaging-specifying-nodal-volume-and-dose-levels weekly 0.8 https://www.themednet.org/how-would-you-approach-a-pt2-nonseminomatous-testicular-cancer-embryonal-caricnoma-with-lvi-with-persistent-b-hcg-20-post-operatively weekly 0.8 https://www.themednet.org/would-you-offer-neoadjuvant-chemotherapy-for-a-large-but-recurrent-grade-1-2-myxoid-chondrosarcoma-of-knee-which-is-no-longer-amenable-to-limb-salvage weekly 0.8 https://www.themednet.org/what-is-your-approach-to-long-covid-post-covid-syndrome-in-your-practice weekly 0.8 https://www.themednet.org/would-you-use-oncotype-in-a-postmenopausal-female-with-hr-her2-with-ln-involvement-who-clinically-meets-rxponder-criteria-of-1-3-ln-to-guide-the-use-of-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/in-patients-with-clinically-probable-als-what-other-mimicking-pathology-do-you-rule-out-before-establishing-the-diagnosis weekly 0.8 https://www.themednet.org/how-and-when-are-you-using-sipuleucel-t-in-metastatic-prostate-cancer-given-the-increase-in-available-treatment-options weekly 0.8 https://www.themednet.org/what-is-the-current-role-for-genetic-profile-testing-e-g-decisiondx-scc-in-the-treatment-paradigm-for-cutaneous-malignancies weekly 0.8 https://www.themednet.org/how-do-you-approach-monitoring-for-lymphoproliferative-disease-in-sjogrens-patients weekly 0.8 https://www.themednet.org/would-you-consider-boost-radiation-for-focally-positive-margins-after-50-gy-and-surgery-in-undifferentiated-pleomorphic-sarcoma-of-chest-wall weekly 0.8 https://www.themednet.org/with-advancing-and-new-therapies-emerging-for-metastatic-her2-breast-cancer-how-does-one-decide-between-options-for-third-line-therapy-at-time-of-progression weekly 0.8 https://www.themednet.org/how-do-you-manage-long-term-pain-associated-with-sensory-ganglionopathy weekly 0.8 https://www.themednet.org/how-would-you-manage-asymptomatic-brain-metastases-from-testicular-non-seminomatous-germ-cell-tumor-with-a-choriocarcinomatous-component weekly 0.8 https://www.themednet.org/how-does-age-factor-into-your-planning-whether-to-give-a-high-risk-pre-menopausal-patient-with-breast-cancer-ovarian-function-suppression weekly 0.8 https://www.themednet.org/is-there-a-role-for-starting-an-anabolic-agent-in-a-patient-that-developed-an-atypical-femoral-fracture-while-on-denosumab-sooner-than-6-months-after-the-last-denosumab-dose weekly 0.8 https://www.themednet.org/when-would-you-offer-post-op-radiation-for-the-treatment-of-sebaceous-carcinoma-of-the-eyelid weekly 0.8 https://www.themednet.org/for-breast-patients-that-are-clinically-node-negative-based-on-ultrasound-and-axial-imaging-is-axillary-radiation-an-acceptable-alternative-to-axillary-dissection-in-a-setting-where-a-sentinel-lymph-node-fails-to-map weekly 0.8 https://www.themednet.org/when-treating-luq-metastases-is-there-a-cutoff-dose-to-the-spleen-after-which-you-would-recommend-post-splenectomy-vaccinations-to-protect-against-overwhelming-post-splenectomy-infection weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-late-relapsed-metastatic-seminoma-with-only-large-10cm-pulmonary-metastases-and-ldh-nine-times-the-upper-limit-of-normal weekly 0.8 https://www.themednet.org/what-was-the-rationale-for-abrupt-discontinuation-of-etanercept-rather-than-gradual-tapering-in-the-seam-ra-trial weekly 0.8 https://www.themednet.org/how-do-you-approach-selection-of-dose-and-fractionation-for-definitive-treatment-of-localized-skin-cancers weekly 0.8 https://www.themednet.org/how-do-you-treat-behavioral-disturbances-in-patients-with-dementia-with-lewy-bodies weekly 0.8 https://www.themednet.org/which-patients-with-mcrpc-on-adt-advanced-anti-ar-do-you-treat-with-bisphosphonates-or-denosumab weekly 0.8 https://www.themednet.org/what-chemotherapy-backbone-will-you-use-with-pembrolizumab-in-the-neoadjuvant-setting-for-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-interpret-dxa-results-in-cases-where-there-is-discordance-between-normal-hip-and-spine-bmd-with-abnormal-one-third-radius-bmd weekly 0.8 https://www.themednet.org/how-do-you-utilize-anifrolumab-for-sle-in-your-practice weekly 0.8 https://www.themednet.org/would-you-consider-prrt-re-treatment-in-a-patient-with-a-well-differentiated-net-previously-treated-with-4-cycles-of-prrt weekly 0.8 https://www.themednet.org/what-first-line-treatment-would-you-consider-for-a-patient-with-stage-iv-gastric-cancer-that-is-her2-negative-and-msi-high weekly 0.8 https://www.themednet.org/what-would-you-offer-as-adjuvant-therapy-for-a-resected-stage-iiib-adeno-nsclc-in-a-patient-who-refuses-chemotherapy weekly 0.8 https://www.themednet.org/what-systemic-therapy-would-you-offer-for-a-local-unresectable-relapse-of-a-mixed-acinar-neuroendocrine-carcinoma-of-the-pancreas weekly 0.8 https://www.themednet.org/for-patients-with-triple-negative-breast-cancer-currently-undergoing-neoadjuvant-dd-ac-would-you-consider-adding-pembrolizumab-to-weekly-paclitaxel-based-on-recent-keynote-522-and-continue-as-adjuvant weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-treatment-for-metastatic-gastric-adenocarcinoma-that-is-pd-l1-cps-10-and-also-her2 weekly 0.8 https://www.themednet.org/what-is-your-preferred-systemic-treatment-for-patients-progressing-during-or-soon-after-completion-of-consolidation-durvalumab-for-unresectable-nsclc weekly 0.8 https://www.themednet.org/do-you-stop-tnf-inhibitors-during-the-third-trimester-of-pregnancy weekly 0.8 https://www.themednet.org/how-would-you-manage-symptomatic-iron-deficiency-in-patients-with-pv-on-frequent-phlebotomies weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-refractory-polymyositis-elevated-ck-weakness-despite-mmf-ivig-and-moderate-dose-prednisone weekly 0.8 https://www.themednet.org/are-there-circumstances-when-you-may-consider-imaging-enthesitis-in-patients-with-psoriatic-arthritis weekly 0.8 https://www.themednet.org/what-is-the-rationale-for-6-hours-between-ebrt-and-hdr-fractions-for-bid-treatment weekly 0.8 https://www.themednet.org/how-do-you-approach-a-mildly-positive-finding-on-an-autoimmune-encephalitis-panel-when-there-is-no-other-evidence-of-encephalitis-such-as-elevated-csf-protein-abnormal-imaging-or-eeg-findings weekly 0.8 https://www.themednet.org/at-what-stage-of-the-neuropathy-workup-do-you-screen-for-b6-toxicity weekly 0.8 https://www.themednet.org/would-you-consider-surgical-management-of-a-tnbc-primary-after-a-patient-has-had-radiographic-resolution-of-oligometastatic-disease weekly 0.8 https://www.themednet.org/in-patients-diagnosed-with-endometrial-cancer-who-do-not-undergo-slnb-or-lnd-at-the-time-of-hysterectomy-what-criteria-is-used-to-recommend-completion-surgery-for-ln-assessment weekly 0.8 https://www.themednet.org/how-would-you-manage-a-high-grade-acinic-cell-carcinoma-of-the-parotid-with-isolated-recurrence-in-the-ipsilateral-neck-s-p-salvage-resection weekly 0.8 https://www.themednet.org/for-patients-with-ischemic-stroke-status-post-decompressive-hemi-craniectomy-when-should-they-start-aspirin-for-secondary-stroke-prevention weekly 0.8 https://www.themednet.org/in-which-patients-with-oncologic-or-hematologic-disorders-are-you-recommending-a-3rd-dose-of-mrna-covid-vaccine weekly 0.8 https://www.themednet.org/in-which-patients-with-autoimmune-or-inflammatory-conditions-are-you-recommending-a-3rd-dose-of-the-mrna-covid-vaccine weekly 0.8 https://www.themednet.org/what-is-the-anticoagulation-recommendation-for-a-chronic-dvt weekly 0.8 https://www.themednet.org/does-multiple-myeloma-become-more-radioresistant-post-transplant weekly 0.8 https://www.themednet.org/how-exactly-would-you-utilize-adt-via-leuprolide-or-bicalutamide-with-salvage-rt-post-prostatectomy-with-psa-0-5 weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-hot-flashes-in-a-patient-who-wants-to-use-herbal-medicine weekly 0.8 https://www.themednet.org/how-do-you-approach-immunosuppression-in-patients-with-rheumatoid-arthritis-and-newly-diagnosed-bladder-cancer-who-willl-be-starting-intravesical-bcg-therapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-maintenance-strategy-for-high-risk-multiple-myeloma weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-stage-4-nsclc-with-egfr-r776h-mutation weekly 0.8 https://www.themednet.org/for-frail-patients-with-cardiac-co-morbidities-and-relapsed-cll-with-high-cytogenetic-risk-what-are-some-considerations-for-using-continuous-acalabrutinib-over-fixed-duration-therapies-such-as-venetoclax-rituximab weekly 0.8 https://www.themednet.org/in-a-patient-with-metastatic-tnbc-on-chemoimmunotherapy-for-several-years-and-a-near-complete-response-would-you-consider-an-immunotherapy-holiday weekly 0.8 https://www.themednet.org/how-will-you-use-regen-cov-casirivimab-imdevimab-monoclonal-antibody-treatment-recently-approved-under-eua-as-post-exposure-prophylaxis-for-covid-in-rheumatic-patients-on-immunosuppressive-therapy weekly 0.8 https://www.themednet.org/what-is-your-strategy-for-treatment-of-figo-iib-cervical-cancer-in-a-patient-who-poorly-tolerated-the-first-insertion-and-refuses-subsequent-insertions weekly 0.8 https://www.themednet.org/how-do-you-decide-between-tcar-vs-carotid-stenting-for-patients-unstable-for-cea weekly 0.8 https://www.themednet.org/what-regimen-would-you-offer-a-young-patient-with-t-cell-all-who-recurred-a-short-time-after-allo-transplant-and-was-initially-treated-with-calgb10403 weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-referred-for-abnormal-light-chain-ratio-when-individual-light-chains-are-in-normal-range weekly 0.8 https://www.themednet.org/should-we-recommend-the-covid-19-booster-vaccine-to-patients-who-had-a-dvt-or-any-other-complications-such-as-hemolytic-anemia-or-thrombocytopenia-from-prior-vaccine-doses weekly 0.8 https://www.themednet.org/what-are-indications-to-add-wprt-pa-field-to-chemotherapy-for-uterine-serous-carcinoma weekly 0.8 https://www.themednet.org/would-you-consider-switching-endocrine-therapies-for-a-peri-menopausal-woman-on-adjuvant-tamoxifen-solely-due-to-an-estradiol-level-if-this-was-checked-and-found-to-be-significantly-elevated weekly 0.8 https://www.themednet.org/do-you-frequently-encounter-asterixis-in-patients-with-uti-associated-encephalopathy weekly 0.8 https://www.themednet.org/is-there-a-role-for-immunosuppression-in-patients-with-triple-positive-antiphospholipid-antibodies-who-do-not-meet-the-clinical-criteria-for-aps weekly 0.8 https://www.themednet.org/how-do-you-approach-staging-and-treatment-for-a-p16-nasopharyngeal-scc weekly 0.8 https://www.themednet.org/would-you-offer-post-operative-radiation-therapy-for-a-pseudoendocrine-sarcoma-with-a-ctnnb-mutation-of-the-spine-that-has-been-resected-with-a-positive-margin weekly 0.8 https://www.themednet.org/what-hematologic-conditions-are-contraindications-for-a-covid-vaccine weekly 0.8 https://www.themednet.org/do-you-start-riluzole-on-all-patients-diagnosed-with-als weekly 0.8 https://www.themednet.org/when-if-ever-do-you-recommend-concurrent-chemotherapy-with-definitive-rt-for-early-stage-oral-cavity-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-sclerosing-mesenteritis-mesenteric-panniculitis weekly 0.8 https://www.themednet.org/how-would-you-manage-an-elderly-but-otherwise-healthy-patient-with-a-high-grade-endometrioid-uterine-cancer-with-micro-metastasis-to-a-sln-but-otherwise-confined-to-the-uterus-with-superficial-myometrial-invasion weekly 0.8 https://www.themednet.org/what-radiation-lung-dose-constraints-should-be-used-for-a-standard-fractionation-plan-in-patients-recovering-from-recent-immunotherapy-induced-pneumonitis weekly 0.8 https://www.themednet.org/how-do-you-approach-mds-patients-with-low-very-low-risk-ipss-r-but-high-risk-mutations-on-ngs weekly 0.8 https://www.themednet.org/for-a-young-patient-with-small-cell-bladder-cancer-what-would-you-recommend-following-cisplatin-etoposide-if-scans-show-no-evidence-of-distant-disease-and-repeat-turbt-shows-no-malignancy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-biopsy-proven-isolated-uterine-cervix-metastasis-of-adenocarcinoma-from-a-known-colon-cancer-primary-previously-stage-iiib-at-diagnosis-two-years-prior weekly 0.8 https://www.themednet.org/for-young-patients-with-smoldering-multiple-myeloma-who-wish-to-be-treated-with-lenalidomide-how-do-you-go-about-harvesting-their-cells-for-an-autologous-transplant weekly 0.8 https://www.themednet.org/how-do-you-dose-concurrent-chemotherapy-with-once-daily-radiation-for-bladder-preservation-in-urothelial-carcinoma weekly 0.8 https://www.themednet.org/how-are-you-choosing-between-ipilimumab-nivolumab-versus-platinum-pemetrexed-for-unresectable-epithelioid-mesotheliomas weekly 0.8 https://www.themednet.org/how-do-you-treat-metastatic-her2-positive-breast-cancer-in-a-patient-with-hepatic-visceral-crisis weekly 0.8 https://www.themednet.org/in-a-patient-with-progressive-thrombocytosis-but-negative-mpn-mutations-on-peripheral-blood-what-are-your-diagnostic-and-treatment-recommendations weekly 0.8 https://www.themednet.org/would-you-move-to-a-venetoclax-based-regimen-for-a-patient-with-pentarefractory-mm-and-t-11-14-translocation-previously-treated-with-bortezomib-and-carfilzomib weekly 0.8 https://www.themednet.org/in-a-patient-with-hr-b-all-and-severe-pancreatitis-due-to-peg-asparaginase-how-do-you-assess-the-impact-of-peg-discontinuation-on-risk-of-relapse weekly 0.8 https://www.themednet.org/would-you-use-pembrolizumab-to-treat-patients-with-bcg-refractory-ta-or-t1-nmibc-without-cis weekly 0.8 https://www.themednet.org/what-are-your-recommendations-regarding-methotrexate-usage-in-patients-with-persistent-chest-ct-changes-post-covid-pneumonia weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-unfavorable-stage-ii-hodgkins-lymphoma-who-achieved-ccr-after-6-cycles-of-systemic-therapy-but-developed-acute-pericarditis-with-non-malignant-effusion-after-2-fractions-of-consolidative-radiation-therapy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-pt1bn0-g1-endometrioid-carcinoma-with-significant-mmi-80-and-lvsi weekly 0.8 https://www.themednet.org/how-do-you-approach-the-initial-dosing-of-carfilzomib-for-patients-with-relapsed-multiple-myeloma weekly 0.8 https://www.themednet.org/what-volumes-do-you-cover-when-delivering-salvage-radiation-for-a-contralateral-neck-recurrence-after-upfront-ipsilateral-neck-radiation-for-tonsillar-cancer weekly 0.8 https://www.themednet.org/when-if-ever-would-you-recommend-risk-reducing-bso-in-patients-with-moderate-penetrance-breast-cancer-germline-mutations weekly 0.8 https://www.themednet.org/when-determining-frontline-treatment-for-nsclc-would-you-incorporate-molecular-predictors-of-resistance-to-immunotherapy-such-as-stk11-keap1-p53 weekly 0.8 https://www.themednet.org/do-you-send-an-antiphospholipid-antibody-panel-routinely-for-all-patients-with-an-unprovoked-thrombus weekly 0.8 https://www.themednet.org/would-you-consider-sbrt-for-an-intraocular-choroidal-metastasis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-hormone-therapy-for-hr-breast-cancer-in-post-menopausal-women-with-pre-existing-osteoporosis weekly 0.8 https://www.themednet.org/for-patients-with-rcc-or-other-radio-resistant-histology-with-metastasis-to-long-bones-requiring-surgical-stabilization-what-dose-and-volumes-do-you-use-for-post-op-rt weekly 0.8 https://www.themednet.org/what-factors-do-you-look-at-while-deciding-between-a-daratumumab-based-quadruplet-induction-versus-standard-triplet-induction-such-as-vrd-for-newly-diagnosed-mm weekly 0.8 https://www.themednet.org/what-gtv-to-ctv-expansion-do-you-use-for-limited-stage-small-cell-lung-cancer-with-imrt weekly 0.8 https://www.themednet.org/would-you-consider-hormone-replacement-therapy-in-young-women-with-germline-brca1-mutation-and-history-of-triple-negative-breast-cancer-who-underwent-bilateral-mastectomy-and-prophylactic-bilateral-salpingo-oophorectomy weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-recommend-for-a-t3n0-grade-3-undifferentiated-sarcoma-of-the-mandible-with-positive-margins-that-is-not-amenable-to-re-resection weekly 0.8 https://www.themednet.org/what-dose-constraints-for-lung-would-you-use-in-a-patient-with-breast-cancer-requiring-regional-nodal-irradiation-who-had-significant-pneumonitis-during-systemic-therapy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-poorly-controlled-seronegative-ra-patient-who-is-steroid-dependent-and-is-on-azathioprine-for-autoimmune-hepatitis weekly 0.8 https://www.themednet.org/how-do-you-manage-a-symptomatic-meningioma-and-associated-vasogenic-edema-in-a-poor-performance-status-patient weekly 0.8 https://www.themednet.org/how-do-you-treat-stage-i-head-of-pancreas-adenocarcinoma-in-an-older-patient-who-is-not-a-candidate-for-chemotherapy-or-surgery weekly 0.8 https://www.themednet.org/would-you-offer-cytoreductive-nephrectomy-to-a-young-healthy-patient-with-widely-metastatic-renal-medullary-carcinoma-with-partial-response-to-cisplatin-based-chemotherapy weekly 0.8 https://www.themednet.org/would-you-consider-pmrt-for-non-mass-like-enhancement-5cm-on-breast-mri-that-resolves-with-nac-and-has-a-pcr weekly 0.8 https://www.themednet.org/how-do-you-prescribe-perampanel-for-use-in-patients-with-refractory-status-epilepticus weekly 0.8 https://www.themednet.org/are-there-known-biomarkers-predictive-of-response-or-resistance-to-sacituzumab-govitecan-which-should-be-incorporated-into-treatment-decisions-for-metastatic-tnbc weekly 0.8 https://www.themednet.org/would-you-electively-cover-the-neck-for-intermediate-grade-mucoepidermoid-carcinoma-of-the-salivary-gland weekly 0.8 https://www.themednet.org/is-peritoneal-dialysis-a-contraindication-to-pelvic-radiotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-acute-attacks-of-mogad-associated-optic-neuritis weekly 0.8 https://www.themednet.org/how-would-you-approach-subtotal-resection-of-a-sarcoma-of-the-scrotum-groin-with-grossly-positive-margin-at-the-base-of-the-penis weekly 0.8 https://www.themednet.org/have-you-seen-rheumatoid-nodules-or-ra-ild-in-patients-with-seronegative-ra weekly 0.8 https://www.themednet.org/when-should-we-order-a-dat-scan-in-patients-suspected-of-parkinsonism-syndrome weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-offer-pci-in-patients-with-es-sclc-who-cannot-get-brain-mris weekly 0.8 https://www.themednet.org/how-do-you-sequence-hdr-brachytherapy-boost-and-external-beam-rt-for-prostate-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-definitive-rt-for-mid-esophageal-cancer-in-a-patient-who-declines-or-cannot-get-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-vitreoretinal-lymphoma-without-cns-or-systemic-involvement weekly 0.8 https://www.themednet.org/when-do-you-consider-re-irradiating-patients-with-recurrent-cervical-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-an-anaplastic-plasmacytoma-without-systemic-evidence-of-disease-in-the-bone-marrow weekly 0.8 https://www.themednet.org/do-you-always-perform-temporal-artery-biopsy-in-patients-with-positive-inflammatory-markers-and-high-clinical-suspicion-of-gca weekly 0.8 https://www.themednet.org/in-what-clinical-situations-do-you-treat-triphasic-waves-on-eeg weekly 0.8 https://www.themednet.org/what-is-your-fertility-sparing-management-of-a-stage-ia1-cervical-squamous-cell-carcinoma-following-a-leep-with-negative-margins-and-focal-lvsi weekly 0.8 https://www.themednet.org/what-is-your-treatment-of-choice-in-alk-positive-lung-adenocarcinomas-that-have-progressed-on-alectinib-with-resistance-mutations-that-are-not-g1202r weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-history-of-follicular-lymphoma-treated-with-bendamustine-rituximab-who-now-has-a-new-fdg-avid-lesion-that-is-biopsy-proven-cd30-positive-cd20-negative-dlbcl weekly 0.8 https://www.themednet.org/is-there-experience-reports-of-using-voxelotor-in-sickle-cell-patients-who-are-jehovah-witnesses-with-few-crises-but-who-have-fatigue-and-or-dyspnea weekly 0.8 https://www.themednet.org/would-you-offer-radiation-to-an-elderly-patient-with-ct2n1-triple-negative-breast-cancer-whose-lumpectomy-and-alnd-showed-a-complete-response-to-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/when-would-you-use-psma-pet-over-conventional-imaging-for-prostate-cancer weekly 0.8 https://www.themednet.org/what-would-you-recommend-as-first-line-therapy-for-metastatic-chromophobe-rcc weekly 0.8 https://www.themednet.org/do-your-radiation-treatment-margins-change-for-cutaneous-basal-cell-carcinoma-in-the-adjuvant-setting-compared-to-cutaneous-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/in-patients-with-thrombocytosis-with-negative-mpn-workup-from-peripheral-blood-and-bone-marrow-is-there-a-role-for-daily-81mg-aspirin-or-other-treatment weekly 0.8 https://www.themednet.org/how-would-you-treat-an-elderly-patient-with-borderline-cardiac-dysfunction-who-has-stage-3-hr-her2-breast-cancer weekly 0.8 https://www.themednet.org/what-are-the-indications-for-adjuvant-radiation-for-a-resected-intracapsular-carcinoma-ex-pleomorphic-adenoma-of-the-parotid weekly 0.8 https://www.themednet.org/what-strategies-can-be-employed-to-manage-interstitial-lung-disease-seen-with-trastuzumab-deruxtecan weekly 0.8 https://www.themednet.org/how-do-you-interpret-efficacy-of-trastuzumab-deruxtecan-based-on-her2-mutation-type-and-or-level-of-her2-overexpression weekly 0.8 https://www.themednet.org/what-is-your-recommended-adjuvant-approach-to-resected-nsclc-with-both-pd-l1-1-and-egfr-mutation weekly 0.8 https://www.themednet.org/would-you-recommend-the-addition-of-chemotherapy-in-a-patient-with-locally-recurrent-unresectable-squamous-cell-carcinoma-of-the-head-and-neck-for-whom-repeat-radiation-is-planned weekly 0.8 https://www.themednet.org/is-switching-to-carboplatin-gemcitabine-reasonable-for-a-patient-with-muscle-invasive-bladder-ca-who-proceeded-to-cystectomy-first-and-had-aki-with-cisplatin-gemcitabine-prohibiting-further-cisplatin weekly 0.8 https://www.themednet.org/would-you-offer-the-uk-fast-forward-regimen-to-a-patient-with-prior-breast-augmentation weekly 0.8 https://www.themednet.org/would-you-extrapolate-impower010-data-to-offer-adjuvant-atezolizumab-to-a-patient-with-n2-pdl1-high-50-nsclc-who-had-been-treated-with-induction-chemotherapy-followed-by-definitive-r0-resection-after-partial-response weekly 0.8 https://www.themednet.org/should-1-year-of-atezolizumab-be-the-standard-of-care-for-stage-ii-iiia-resected-pdl1-nsclc weekly 0.8 https://www.themednet.org/how-would-use-of-adjuvant-atezolizumab-for-pdl1-nsclc-potentially-impact-your-treatment-choice-at-recurrence weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-do-you-recommend-for-early-stage-poorly-differentiated-small-cell-neuroendocrine-carcinoma-of-the-cervix-after-surgical-resection weekly 0.8 https://www.themednet.org/do-you-escalate-the-dose-in-adjuvant-pancreatic-cancer-radiation-therapy-similar-to-how-many-are-treating-locally-advanced-disease-with-dose-escalation weekly 0.8 https://www.themednet.org/does-the-presence-of-an-atm-mutation-in-advanced-stage-ovarian-cancer-influence-the-decision-to-use-bev-vs-parp-inhibitor-for-maintenance weekly 0.8 https://www.themednet.org/would-you-consider-treating-an-adult-patient-with-severe-claustrophobia-with-daily-anesthesia-for-35-fractions-if-the-goal-is-larynx-preservation weekly 0.8 https://www.themednet.org/what-are-the-indications-for-pmrt-in-an-er-pr-her-2-patient-with-a-complete-pathologic-response-in-the-nodes-after-neoadjuvant-chemo-but-with-residual-disease-in-the-breast weekly 0.8 https://www.themednet.org/would-you-offer-definitive-xrt-for-muscle-invasive-bladder-cancer-arising-within-a-bladder-diverticulum weekly 0.8 https://www.themednet.org/will-the-recent-publication-of-the-krog-08-06-trial-change-your-practice-in-node-positive-breast-cancer-patients weekly 0.8 https://www.themednet.org/how-would-you-approach-unresectable-synovial-sarcoma-of-the-heart weekly 0.8 https://www.themednet.org/would-you-omit-radiation-in-er-pr-negative-dcis-patients-who-are-otherwise-low-risk weekly 0.8 https://www.themednet.org/how-does-the-presence-of-cabg-affect-your-radiotherapy-approach-for-definitive-management-of-locally-advanced-nsclc-with-mediastinal-involvement weekly 0.8 https://www.themednet.org/how-would-you-treat-unresectable-angiosarcoma-of-the-extremity-in-a-patient-who-is-inoperable-due-to-underlying-comorbidities weekly 0.8 https://www.themednet.org/would-you-consider-use-of-belimumab-in-a-patient-with-sle-with-recurrent-anterior-uveitis-who-failed-other-treatment-options weekly 0.8 https://www.themednet.org/what-is-your-approach-for-a-patient-with-an-acute-ischemic-stroke-caused-by-an-aortic-thrombus weekly 0.8 https://www.themednet.org/how-do-you-manage-anaplastic-thyroid-cancer-that-is-progressing-through-radiation-therapy weekly 0.8 https://www.themednet.org/what-is-the-optimal-age-at-which-a-patient-with-sickle-cell-disease-should-undergo-allogeneic-stem-cell-transplant weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-early-stage-invasive-ductal-carcinoma-with-associated-low-grade-dcis-who-was-found-to-have-adh-at-the-tumor-margin-on-post-op-pathology weekly 0.8 https://www.themednet.org/what-dose-can-you-give-the-axilla-after-5040-cgy-of-prior-radiation weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-inclusion-body-myositis weekly 0.8 https://www.themednet.org/what-dose-do-you-recommend-in-adjuvant-setting-following-r0-resection-of-sinonasal-undifferentiated-carcinoma-snuc-involving-paranasal-sinuses-nasal-cavity-and-close-proximity-to-eyes weekly 0.8 https://www.themednet.org/what-chemotherapy-would-you-consider-to-treat-platinum-resistant-high-grade-serous-ovarian-cancer-in-patients-with-a-low-grade-mds-from-prior-platinum-parpi weekly 0.8 https://www.themednet.org/how-do-you-evaluate-and-treat-patients-with-suspected-pots weekly 0.8 https://www.themednet.org/what-is-the-optimal-prophylaxis-regimen-to-use-prior-to-a-selinexor-based-regimen-in-the-treatment-of-multiple-myeloma-for-nausea-and-electrolyte-abnormalities weekly 0.8 https://www.themednet.org/what-is-the-preferred-radiation-delivery-technique-for-whole-abdominal-or-flank-rt-in-childhood-cancers weekly 0.8 https://www.themednet.org/would-you-use-bolus-in-patients-s-p-mastectomy-and-reconstruction-if-they-had-dermal-involvement weekly 0.8 https://www.themednet.org/how-do-you-manage-a-screening-pap-smear-result-of-hsil-and-hpv16-in-a-first-trimester-pregnancy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-gastric-malt-lymphoma-who-has-crest-syndrome weekly 0.8 https://www.themednet.org/how-would-one-alter-therapy-in-a-transplant-ineligible-al-amyloidosis-with-less-than-a-complete-response-to-six-cycles-of-dara-cybord weekly 0.8 https://www.themednet.org/which-patients-with-smoldering-myeloma-do-you-treat weekly 0.8 https://www.themednet.org/what-treatment-would-you-consider-for-small-cell-neuroendocrine-carcinoma-of-the-bladder-with-a-metastatic-recurrence-within-3-months-of-neoadjuvant-cisplatin-etoposide-followed-by-radical-cystectomy-ypt0n0 weekly 0.8 https://www.themednet.org/what-is-your-preferred-surgical-management-of-an-endometrial-cancer-with-clinically-apparent-extension-to-the-cervix weekly 0.8 https://www.themednet.org/how-soon-after-completion-of-salvage-rt-to-the-prostate-bed-do-you-allow-urethral-dilation weekly 0.8 https://www.themednet.org/are-there-any-breast-ca-patients-for-whom-you-would-offer-pmrt-if-they-were-cn0-and-ypn0 weekly 0.8 https://www.themednet.org/what-is-your-experience-managing-myelosuppression-from-busulfan-prescribed-for-pv weekly 0.8 https://www.themednet.org/how-do-you-manage-autonomic-symptoms-in-patients-with-myasthenia-gravis weekly 0.8 https://www.themednet.org/would-you-send-oncotype-dx-for-a-premenopausal-patient-with-a-pt2n0-er-pr-lobular-breast-cancer-that-was-diagnosed-during-the-first-trimester-of-pregnancy weekly 0.8 https://www.themednet.org/what-is-your-first-line-of-therapy-for-refractory-hodgkin-lymphoma-in-an-aya-patient weekly 0.8 https://www.themednet.org/how-does-one-interpret-persistently-positive-lambda-light-chains-on-serum-immunofixation-but-without-measurable-serum-monoclonal-protein-and-a-normal-light-chains-and-ratio weekly 0.8 https://www.themednet.org/should-we-be-performing-sentinel-lymph-node-biopsies-for-hr-patients-70-years-of-age weekly 0.8 https://www.themednet.org/in-a-patient-with-low-risk-t3n1-stage-iii-colon-cancer-unable-to-tolerate-capox-due-to-profound-gi-toxicity-would-you-switch-to-folfox-and-extend-to-6-months-of-adjuvant-therapy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-low-burden-metastatic-renal-cell-carcinoma-that-progressed-on-cabozantinib-who-is-not-a-candidate-for-immunotherapy weekly 0.8 https://www.themednet.org/how-would-you-treat-cervical-stump-scc-involving-bladder-pelvic-nodes-and-port-site-metastasis-in-a-patient-post-laparoscopic-hysterectomy weekly 0.8 https://www.themednet.org/what-is-the-optimal-duration-for-denosumab-use-in-the-setting-of-recurrent-un-resectable-giant-cell-tumor weekly 0.8 https://www.themednet.org/what-do-you-consider-to-be-the-minimum-technological-requirements-to-safely-deliver-spine-sbrt weekly 0.8 https://www.themednet.org/how-often-do-you-order-imaging-to-assess-for-possible-degenerative-joint-disease-in-the-spine-in-patients-with-neuropathic-itch weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-patients-with-dupilumab-induced-facial-redness weekly 0.8 https://www.themednet.org/what-are-your-preferred-treatment-options-for-patients-with-chronic-non-healing-leg-ulcers weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-patients-with-melasma-that-does-not-respond-to-hydroquinone-based-topical-therapies weekly 0.8 https://www.themednet.org/what-therapies-do-you-use-in-patients-with-cutaneous-lupus-recalcitrant-to-topical-steroids weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-onychomycosis-that-does-not-respond-to-terbinafine-and-prolonged-courses-of-fluconazole weekly 0.8 https://www.themednet.org/how-do-you-manage-eyebrow-and-eyelash-involvement-in-patients-with-alopecia-areata weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-patients-with-acne-keloidalis-nuchae-who-do-not-respond-to-a-potent-topical-steroid-or-retinoid weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-patients-with-chronically-brittle-nails weekly 0.8 https://www.themednet.org/how-do-you-manage-maintenance-therapy-in-metastatic-nsclc-adenocarcinoma-with-good-response-to-initial-chemo-carboplatin-pemetrexed-pembrolizumab-with-borderline-renal-function-that-has-worsened-during-initial-treatment weekly 0.8 https://www.themednet.org/when-treating-whole-breast-how-do-you-minimize-contralateral-breast-dose-without-sacrificing-coverage-and-lung-heart-dose weekly 0.8 https://www.themednet.org/would-you-recommend-pfo-closure-in-patients-60-years-old-with-presumed-paradoxical-embolism-as-their-mechanism-of-stroke weekly 0.8 https://www.themednet.org/what-dose-fractionation-scheme-would-you-use-for-a-bulky-15-cm-metastatic-renal-cell-carcinoma-deposit-with-brachial-plexus-encasement-and-spinal-canal-invasion weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-a-brainstem-avm-after-hemorrhage-in-a-patient-not-a-candidate-for-surgery-or-embolization weekly 0.8 https://www.themednet.org/when-tapering-moderate-to-high-doses-of-long-term-steroids-do-you-routinely-monitor-for-adrenal-insufficiency weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-non-resectable-periampullary-adenocarcinoma-in-an-elderly-patient-with-otherwise-good-ps weekly 0.8 https://www.themednet.org/do-you-recommend-adt-or-other-systemic-therapy-in-patients-with-rising-psa-after-prostatectomy-and-salvage-rt-and-psma-scan-negative-for-metastatic-disease weekly 0.8 https://www.themednet.org/what-are-contraindications-for-growth-factors-in-patients-with-hematologic-malignancies weekly 0.8 https://www.themednet.org/in-a-patient-s-p-lumpectomy-rt-for-an-early-stage-breast-cancer-who-later-has-recurrent-disease-requiring-mastectomy-and-pmrt-under-what-circumstances-would-you-recommend-a-boost weekly 0.8 https://www.themednet.org/how-would-you-proceed-when-a-cervical-cancer-undergoing-brachytherapy-has-exceeded-the-rectal-dose-but-not-met-the-target-dose weekly 0.8 https://www.themednet.org/in-what-subset-of-traumatic-brain-injury-concussion-patients-would-you-consider-use-of-n-acetyl-cysteine weekly 0.8 https://www.themednet.org/in-which-subset-of-patients-with-concussion-do-you-recommend-further-brain-imaging weekly 0.8 https://www.themednet.org/in-a-patient-with-favorable-risk-pt1n0-mic-i-breast-cancer-and-favorable-anatomy-would-you-use-import-low-style-pbi-while-incorporating-the-high-axilla weekly 0.8 https://www.themednet.org/what-conditions-do-you-screen-for-in-patients-with-hyperacusis weekly 0.8 https://www.themednet.org/would-you-change-chemotherapy-to-vip-in-a-young-patient-with-stage-iiib-intermediate-risk-non-seminomatous-germ-cell-tumor-with-borderline-dlco-after-one-cycle-of-bep weekly 0.8 https://www.themednet.org/is-reirradiation-in-the-setting-of-dcis-of-the-breast-ever-appropriate weekly 0.8 https://www.themednet.org/what-is-the-general-treatment-paradigm-for-resected-mucosal-melanoma-of-the-head-and-neck-with-respect-to-targeting-and-dosing weekly 0.8 https://www.themednet.org/how-do-you-approach-relapsed-idiopathic-hlh weekly 0.8 https://www.themednet.org/would-you-have-any-concerns-about-starting-an-anti-tnf-in-rf-and-anti-ccp-positive-ra-patients-who-also-have-high-titer-ana weekly 0.8 https://www.themednet.org/how-would-you-treat-a-recurrent-ovarian-malignant-mixed-mullerian-tumor-on-the-pelvic-side-wall weekly 0.8 https://www.themednet.org/what-strategy-do-you-use-to-determine-the-appropriate-timing-to-resume-osteoporosis-therapy-after-a-drug-holiday weekly 0.8 https://www.themednet.org/do-you-hold-adt-before-work-up-for-prostate-cancer-when-ordering-advanced-imaging-such-as-psma-pet weekly 0.8 https://www.themednet.org/how-do-you-think-about-biologic-use-in-patients-with-underlying-hiv-infection weekly 0.8 https://www.themednet.org/does-hpv-status-play-a-role-in-selection-of-immune-checkpoint-inhibitors-in-upfront-treatment-of-metastatic-head-and-neck-cancer weekly 0.8 https://www.themednet.org/what-risk-pathologic-factors-merit-pmrt-for-a-patient-with-recurrent-breast-cancer-and-a-prior-history-of-ipsilateral-breast-irradiation weekly 0.8 https://www.themednet.org/what-is-your-preferred-infliximab-dosing-strategy-for-hidradenitis-suppurativa weekly 0.8 https://www.themednet.org/when-would-you-consider-hyperbaric-oxygen-for-skull-base-necrosis-or-temporal-lobe-necrosis-following-cns-hn-rt weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-dermatomyositis-patients-with-pruritus-recalcitrant-to-oral-and-topical-steroids weekly 0.8 https://www.themednet.org/how-do-you-approach-screening-for-additional-malignancies-in-patients-with-a-history-of-ctcl weekly 0.8 https://www.themednet.org/what-are-non-clinical-trial-options-to-treat-high-risk-mds-in-a-transplant-ineligible-patient-after-progression-on-hypomethylating-agents weekly 0.8 https://www.themednet.org/what-is-the-negative-predictive-value-of-a-completely-unremarkable-emu-admission weekly 0.8 https://www.themednet.org/for-patients-with-triple-negative-breast-cancer-who-are-planned-to-receive-adjuvant-pembrolizumab-would-you-recommend-pembrolizumab-be-held-until-radiation-is-complete weekly 0.8 https://www.themednet.org/would-you-use-encorafenib-with-cetuximab-vs-encorafenib-alone-as-second-line-therapy-in-a-patient-with-metastatic-colon-cancer-with-concomitant-kras-g12v-and-braf-v600e-mutations-identified-on-liquid-biopsy weekly 0.8 https://www.themednet.org/do-you-ever-consider-treatment-outside-of-the-peripartum-period-in-a-patient-with-a-history-of-obstetric-aps weekly 0.8 https://www.themednet.org/do-you-recommend-the-hpv-vaccination-for-your-young-patients-with-hpv-associated-cancers-or-pre-cancers-who-have-not-yet-been-vaccinated weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-treatment-approach-for-a-patient-with-pdl-1-high-50-nsclc-presenting-with-cns-mets weekly 0.8 https://www.themednet.org/how-would-you-manage-an-in-field-small-volume-recurrence-of-early-stage-favorable-hodgkin-lymphoma-treated-previously-with-2-cycles-of-abvd-and-20gy weekly 0.8 https://www.themednet.org/how-do-you-differentiate-between-jak2-positive-et-and-pv-when-peripheral-blood-shows-erythrocytosis-and-thrombocytosis weekly 0.8 https://www.themednet.org/how-do-you-treat-multisystem-sarcoidosis-refractory-to-methotrexate-humira-and-remicade weekly 0.8 https://www.themednet.org/what-is-your-approach-to-first-line-systemic-therapy-in-metastatic-pd-l1-positive-cervical-cancer weekly 0.8 https://www.themednet.org/do-you-treat-an-endometrial-cancer-that-is-microsatellite-stable-but-has-a-high-tmb-after-progressing-on-platinum-based-therapy-with-pembrolizumab weekly 0.8 https://www.themednet.org/when-do-you-redose-ivig-in-gbs-patients-who-were-under-treated-and-are-worsening weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-in-premenopausal-patients-who-develop-a-contralateral-hr-breast-cancer-while-already-on-tamoxifen-and-ovarian-function-suppression weekly 0.8 https://www.themednet.org/in-what-circumstances-do-you-pursue-labial-salivary-gland-biopsy-in-an-asymptomatic-patient-with-high-titer-ana-and-positive-ssa weekly 0.8 https://www.themednet.org/which-medications-have-the-lowest-risk-of-tuberculosis-reactivation-in-patients-with-uncertain-tuberculosis-history-and-active-rheumatologic-disease weekly 0.8 https://www.themednet.org/in-the-absence-of-lung-disease-do-you-prefer-methotrexate-or-mycophenolate-mofetil-in-the-initial-treatment-of-cutaneous-only-manifestations-in-systemic-sclerosis weekly 0.8 https://www.themednet.org/do-you-recommend-the-hpv-vaccine-for-patients-with-recalcitrant-verruca-vulgaris weekly 0.8 https://www.themednet.org/when-is-the-ideal-time-to-start-adjuvant-nivolumab-after-radical-surgery-in-urothelial-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-approach-the-symptomatic-management-of-lhermittes-phenomenon-in-a-patient-with-ms weekly 0.8 https://www.themednet.org/how-would-you-manage-a-ct2-n0-poorly-differentiated-mucoepidermoid-carcinoma-with-sarcomatous-features-carcinosarcoma-affecting-the-soft-palate weekly 0.8 https://www.themednet.org/what-sbrt-dose-do-you-recommend-for-an-oligomet-of-the-lung-from-prostate-ca weekly 0.8 https://www.themednet.org/what-chemotherapy-do-you-use-with-radiation-for-urothelial-carcinoma-with-squamous-differentiation weekly 0.8 https://www.themednet.org/how-are-you-approaching-patients-with-stage-iv-egfr-nsclc-who-progress-on-first-line-tki-and-are-found-to-have-retained-egfr-mutation-as-well-as-met-amplification weekly 0.8 https://www.themednet.org/what-is-your-follow-up-schedule-after-completion-of-rt-for-pediatric-rhabdomyosarcoma weekly 0.8 https://www.themednet.org/is-lp-indicated-for-patients-with-recurrent-thunderclap-headaches-over-a-4-week-period-and-negative-head-imaging-for-sah weekly 0.8 https://www.themednet.org/what-is-the-significance-of-elevated-fractionated-catecholamines-in-pots weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-a-single-vertebral-body-involved-with-multiple-myeloma-mm weekly 0.8 https://www.themednet.org/how-many-missed-fractions-will-you-allow-for-a-definitive-lung-crt-before-recommending-treatment-on-the-weekend weekly 0.8 https://www.themednet.org/what-medication-do-you-consider-in-patients-who-cannot-take-indomethacin-or-triptans-with-a-diagnosis-of-hemicrania-continua weekly 0.8 https://www.themednet.org/given-the-updated-results-of-the-preopanc-study-how-can-gemcitabine-based-neoadjuvant-chemoradiation-be-best-incorporated-into-the-treatment-of-resectable-or-borderline-resectable-pancreatic-cancer weekly 0.8 https://www.themednet.org/how-do-you-use-hydroxychloroquine-in-patients-with-lupus-nephritis-on-hemodialysis-or-peritoneal-dialysis weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-early-stage-orbital-malt-lymphoma-with-high-proliferative-index weekly 0.8 https://www.themednet.org/would-you-consider-addition-of-docetaxel-to-abiraterone-and-adt-in-metastatic-hormone-senstive-prostate-cancer-patients-who-progress-on-adt-and-abiraterone weekly 0.8 https://www.themednet.org/do-you-avoid-pth-pthrp-analogs-in-patients-with-recurrent-severe-cppd weekly 0.8 https://www.themednet.org/what-is-the-differential-for-a-patient-with-unilateral-arm-swelling-mri-with-muscle-edema-and-markedly-elevated-cpk weekly 0.8 https://www.themednet.org/do-you-routinely-obtain-cps-assay-to-assess-candidacy-for-chemoimmunotherapy-in-newly-diagnosed-metastatic-esophageal-gej-gastric-adenocarcinoma weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-whose-stage-ii-tnbc-tumor-is-visibly-progressing-on-the-kn-522-neoadjuvant-regimen weekly 0.8 https://www.themednet.org/how-would-you-manage-an-osseous-lesion-that-received-palliative-sbrt-with-no-pain-relief weekly 0.8 https://www.themednet.org/would-you-change-treatment-in-a-patient-with-metastatic-crpc-on-parp-inhibitor-with-rising-psa-but-negative-axumin-pet-scan weekly 0.8 https://www.themednet.org/how-do-you-integrate-ophthalmic-exam-and-surveillance-into-routine-visits-for-cervical-cancer-patients-receiving-tisotumab-vedotin weekly 0.8 https://www.themednet.org/do-you-find-iga-isotypes-of-anti-beta2-glycoprotein-antibodies-and-anticardiolipin-antibodies-to-be-clinically-useful-in-the-evaluation-for-aps weekly 0.8 https://www.themednet.org/what-are-your-considerations-for-choice-of-immunotherapy-agent-with-patients-with-metastatic-pmmr-her2-esophageal-gej-gastric-adenocarcinoma-with-cps-10 weekly 0.8 https://www.themednet.org/do-you-consider-adt-intensification-with-enzalutamide-or-abiraterone-in-patients-receiving-adjuvant-radiation-with-adt weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-pt1b-t2-adenocarcinoma-of-mid-esophagus-with-residual-cancer-after-endoscopic-resection-and-who-is-a-poor-surgical-candidate weekly 0.8 https://www.themednet.org/how-many-vertebral-levels-do-you-choose-to-treat-with-post-op-rt weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-consider-for-sbrt-of-uveal-melanomas-too-large-for-plaque-brachytherapy weekly 0.8 https://www.themednet.org/is-adjuvant-rt-recommended-for-a-bartholins-gland-scc-s-p-piecemeal-resection-with-deep-invasion-and-negative-ipsilateral-ln-dissection weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-newly-diagnosed-hepatocellular-carcinoma-with-very-high-afp-100-000-but-no-clear-radiographic-evidence-of-metastatic-disease weekly 0.8 https://www.themednet.org/what-is-your-igrt-motion-management-approach-for-liver-sbrt weekly 0.8 https://www.themednet.org/how-would-you-treat-a-melanoma-of-the-penile-skin-in-a-medically-inoperable-patient weekly 0.8 https://www.themednet.org/what-is-the-role-of-splenectomy-versus-systemic-therapy-in-splenic-marginal-zone-lymphoma weekly 0.8 https://www.themednet.org/in-your-experience-is-there-an-association-between-interstitial-cystitis-and-systemic-lupus-erythematosus weekly 0.8 https://www.themednet.org/do-you-recommend-allopurinol-desensitization-in-gout-patients-who-develop-a-rash-on-allopurinol-therapy weekly 0.8 https://www.themednet.org/would-you-advise-a-patient-with-quiescent-vasculitis-who-flared-with-the-first-covid-mrna-vaccine-to-obtain-an-additional-dose weekly 0.8 https://www.themednet.org/how-do-you-decide-upon-a-preferred-dose-fractionation-scheme-for-breast-rt weekly 0.8 https://www.themednet.org/what-treatment-considerations-do-you-make-for-elderly-patients-with-relapsed-refractory-follicular-lymphoma weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-a-primary-splenic-dlbcl-who-has-residual-pet-avid-disease-after-6-cycles-of-r-chop weekly 0.8 https://www.themednet.org/how-do-you-sequence-i-131-and-external-beam-radiation-therapy-after-thyroidectomy-for-locally-advanced-thyroid-cancer weekly 0.8 https://www.themednet.org/how-do-you-account-for-only-a-partial-fraction-of-radiation-being-delivered-due-to-machine-malfunction weekly 0.8 https://www.themednet.org/what-is-the-longest-interval-to-proceed-with-brachytherapy-boost-for-cervical-ca-after-ebrt weekly 0.8 https://www.themednet.org/what-is-your-approach-to-chemoprevention-for-hr-dcis-in-the-ipsilateral-breast-in-a-patient-who-already-completed-7-years-of-an-ai-for-a-prior-hr-invasive-breast-cancer weekly 0.8 https://www.themednet.org/if-a-patient-with-her2-uterine-serous-carcinoma-recurs-while-on-maintenance-trastuzumab-would-you-continue-trastuzumab-with-second-line-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-differentiate-a-lupus-flare-versus-drug-induced-lupus-in-patients-with-sle-on-a-drug-associated-with-dile weekly 0.8 https://www.themednet.org/what-is-your-experience-with-using-frailty-index-or-other-geriatric-screening-in-making-decisions-for-elderly-patients-with-multiple-myeloma weekly 0.8 https://www.themednet.org/would-you-hold-abemaciclib-during-adjuvant-chest-wall-axillary-radiation-after-mastectomy weekly 0.8 https://www.themednet.org/what-adjuvant-treatment-would-you-recommend-for-a-patient-with-node-positive-tnbc-who-did-not-receive-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-to-a-woman-in-her-40s-s-p-tahbso-with-t2n1-er-pr-breast-cancer-with-oncotype-score-21-25 weekly 0.8 https://www.themednet.org/how-do-you-interpret-a-deauville-score-of-3-on-pet-when-performing-mid-treatment-assessments-in-patients-with-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-manage-new-brain-mets-in-a-patient-with-a-history-of-rt-necrosis-after-prior-srs weekly 0.8 https://www.themednet.org/how-would-you-treat-intermittent-hematuria-post-prostate-radiation weekly 0.8 https://www.themednet.org/does-r-chop-provide-durable-remission-in-low-risk-pediatric-burkitt-or-burkitt-like-lymphoma weekly 0.8 https://www.themednet.org/do-you-routinely-check-pulmonary-function-testing-prior-to-each-cycle-of-bep-for-young-patients-with-testicular-cancer-with-no-pulmonary-risk-factors weekly 0.8 https://www.themednet.org/when-do-you-consider-plasma-exchange-for-multiorgan-failure-in-a-patient-with-sickle-cell-disease weekly 0.8 https://www.themednet.org/how-often-do-you-monitor-cd-19-counts-and-immunoglobulin-levels-in-ms-patients-on-b-cell-depletion-therapy weekly 0.8 https://www.themednet.org/what-kinds-of-dental-work-do-you-particularly-worry-about-and-try-to-avoid-in-patients-on-bisphosphonates weekly 0.8 https://www.themednet.org/do-you-have-any-hesitations-for-combining-belimumab-with-any-of-the-dmards-in-patients-with-sle-ra-overlap weekly 0.8 https://www.themednet.org/how-do-you-time-concurrent-therapy-with-rituximab-and-ivig weekly 0.8 https://www.themednet.org/would-you-offer-reirradiation-after-resection-of-locally-recurrent-triple-negative-breast-cancer-only-6-months-after-completion-of-postmastectomy-radiation weekly 0.8 https://www.themednet.org/when-would-you-suspect-metabolic-myopathy-and-what-is-your-approach-to-initial-workup weekly 0.8 https://www.themednet.org/based-on-keynote-811-would-you-add-pembrolizumab-for-her2-distal-esophageal-adenocarcinoma-with-new-supraclavicular-lymph-nodes-if-treated-previously-with-concurrent-chemoradiation-and-pd-l1-cps-of-3 weekly 0.8 https://www.themednet.org/do-you-modify-your-treatment-for-a-patient-with-ulcerative-colitis-needing-vaginal-brachytherapy weekly 0.8 https://www.themednet.org/for-a-young-male-with-stage-iii-intermediate-risk-nsgct-with-active-1-ppd-smoking-history-but-normal-pfts-and-dlco-results-would-you-still-consider-use-of-bep-x-4 weekly 0.8 https://www.themednet.org/would-you-include-interconnecting-skin-in-the-radiation-volume-for-a-patient-with-lateral-forehead-squamous-cell-carcinoma-who-will-receive-radiation-to-the-surgical-bed-and-preauricular-lymph-nodes weekly 0.8 https://www.themednet.org/with-the-recent-fda-approval-of-neoadjuvant-chemotherapy-and-nivolumab-for-stage-ib-iiia-nsclc-does-the-fact-that-the-study-used-ajcc-7th-edition-staging-impact-your-patient-selection-at-all-since-we-currently-are-using-8th-edition-staging weekly 0.8 https://www.themednet.org/what-is-the-role-of-mri-in-target-delineation-of-radiation-therapy-for-non-npc-h-n-cancers weekly 0.8 https://www.themednet.org/are-there-best-practices-or-data-regarding-the-use-of-open-notes-among-oncology-patients weekly 0.8 https://www.themednet.org/how-would-you-manage-tucatinib-associated-grade-2-indirect-hyperbilirubinemia-in-a-patient-with-metastatic-her2-positive-breast-cancer-involving-the-cns-receiving-trastuzumab-capecitabine-tucatinib weekly 0.8 https://www.themednet.org/is-there-a-role-for-radiation-therapy-for-heterotopic-ossification-prophylaxis-of-the-ankle weekly 0.8 https://www.themednet.org/is-there-data-that-shows-that-late-side-effects-change-from-5-year-follow-up-to-10-year-follow-up-when-comparing-iso-effective-doses-of-conventional-and-hypofractionation-for-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-to-a-pregnant-patient-in-status-migrainosus-refractory-to-first-line-treatments weekly 0.8 https://www.themednet.org/how-do-psma-pet-positive-nodes-change-your-treatment-recommendations-after-rp weekly 0.8 https://www.themednet.org/how-do-you-approach-dmard-therapy-in-patients-with-rheumatoid-arthritis-and-chronic-hepatitis-b weekly 0.8 https://www.themednet.org/how-do-you-approach-cv-risk-assessment-in-ra-patients-when-ra-itself-is-associated-with-some-degree-of-increased-cv-risk-at-baseline weekly 0.8 https://www.themednet.org/would-you-recommend-that-a-patient-with-stable-coronary-artery-disease-and-well-controlled-ra-on-a-jak-inhibitor-continue-on-their-current-therapy weekly 0.8 https://www.themednet.org/would-you-recommend-medical-therapy-for-asymptomatic-idiopathic-intracranial-hypertension-with-completely-normal-visual-field-testing weekly 0.8 https://www.themednet.org/for-a-patient-with-metastatic-gastric-adenocarcinoma-with-ct-showing-ned-after-4-months-of-folfox-pembrolizumab-trastuzumab-would-you-consider-resection-of-the-primary-and-or-a-chemo-break weekly 0.8 https://www.themednet.org/would-you-consider-de-escalating-abiraterone-in-a-patient-treated-with-adt-abiraterone-prednisone-for-metastatic-hormone-sensitive-prostate-cancer-who-has-had-an-excellent-response-with-undetectable-psa-and-minimal-side-effects-for-over-2-years weekly 0.8 https://www.themednet.org/how-do-you-balance-target-coverage-vs-cord-constraints-with-spine-srs weekly 0.8 https://www.themednet.org/would-you-offer-rt-alone-to-an-elderly-woman-with-squamous-cell-carcinoma-in-situ-of-the-vulva-distal-vagina-and-periurethral-area weekly 0.8 https://www.themednet.org/do-you-generally-recommend-low-dose-aspirin-for-patients-with-giant-cell-arteritis weekly 0.8 https://www.themednet.org/would-you-consider-using-doacs-in-a-young-patient-with-sle-and-libman-sacks-endocarditis-who-is-negative-for-aps weekly 0.8 https://www.themednet.org/how-do-you-approach-borderline-non-regional-mediastinum-lymph-nodes-when-treating-locally-advanced-esophageal-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-a-previously-irradiated-localized-recurrence-of-an-adenoid-cystic-carcinoma-of-the-nasopharynx weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-regarding-the-cardiovascular-and-cancer-risks-associated-with-tofacitinib weekly 0.8 https://www.themednet.org/do-you-still-plan-to-offer-tofacitinib-to-ra-patients-over-65-if-they-have-one-or-more-additional-cv-risk-factors weekly 0.8 https://www.themednet.org/is-adjuvant-treatment-recommend-for-a-0-8cm-serous-endometrial-ca-confined-to-polyp-s-p-hysterectomy-surgical-staging weekly 0.8 https://www.themednet.org/would-you-give-adt-docetaxel-darolutamide-for-a-low-risk-castrate-sensitive-metastatic-prostate-cancer-patient-given-arasens-results weekly 0.8 https://www.themednet.org/would-you-offer-radiation-therapy-for-ovarian-remnant-syndrome weekly 0.8 https://www.themednet.org/how-would-you-manage-prostate-cancer-in-a-patient-who-received-prior-chemoradiation-followed-by-an-apr-for-rectal-cancer weekly 0.8 https://www.themednet.org/which-cisplatin-regimen-is-preferred-for-concurrent-chemoradiation-for-definitive-treatment-of-muscle-invasive-bladder-cancer weekly 0.8 https://www.themednet.org/do-you-routinely-continue-airway-clearance-therapies-in-the-setting-of-mild-to-moderate-hemoptysis-in-a-patient-with-cf weekly 0.8 https://www.themednet.org/is-there-a-role-for-biologic-therapies-in-asthma-copd-overlap-syndrome-with-evidence-of-type-2-inflammation weekly 0.8 https://www.themednet.org/do-you-routinely-use-donor-derived-cell-free-dna-levels-to-guide-surveillance-bronchoscopies-in-lung-transplant-recipients weekly 0.8 https://www.themednet.org/are-you-using-the-microbial-cell-free-dna-karius-test-to-aid-in-the-diagnosis-of-an-atypical-pulmonary-infection-such-as-pjp-or-ntm weekly 0.8 https://www.themednet.org/would-you-consider-spinal-cord-biopsy-for-an-intramedullary-cord-lesion-with-disabling-neurological-deficits-and-no-diagnosis-despite-a-comprehensive-workup weekly 0.8 https://www.themednet.org/when-do-you-send-achr-ocular-myasthenia-gravis-patients-for-thymectomy weekly 0.8 https://www.themednet.org/do-you-recommend-adjuvant-rt-for-positive-margins-of-dermatofibrosarcoma-protuberans weekly 0.8 https://www.themednet.org/for-a-patient-with-concurrent-diagnoses-of-hodgkin-lymphoma-and-light-chain-myeloma-complicated-by-myeloma-kidney-how-would-you-approach-treatment weekly 0.8 https://www.themednet.org/what-is-the-dose-conversion-formula-from-botulinum-toxin-type-b-myobloc-to-incobotulinum-toxin-type-a-xeomin-or-onabotulinum-toxin-type-a-botox weekly 0.8 https://www.themednet.org/how-would-you-palliate-a-metastatic-lesion-abutting-a-joint-with-an-associated-effusion weekly 0.8 https://www.themednet.org/is-oncotype-testing-useful-in-variant-histologies-such-as-micropapillary-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-therapy-for-a-patient-with-smoldering-multiple-myeloma-whose-light-chain-ratio-has-increased-to-greater-than-100-over-several-years-in-the-absence-of-any-other-myeloma-defining-events weekly 0.8 https://www.themednet.org/in-light-of-the-cosmesis-and-toxicity-outcomes-of-the-rapid-trial-should-external-beam-partial-breast-irradiation-be-avoided weekly 0.8 https://www.themednet.org/what-is-the-quickest-palliative-regimen-you-have-tried-for-obstructing-lesions-in-the-lung-in-patients-with-stage-iv-disease weekly 0.8 https://www.themednet.org/what-is-a-safe-and-efficacious-fractionation-to-use-when-re-irradiating-a-recurrent-gbm weekly 0.8 https://www.themednet.org/which-patients-with-intermediate-and-high-risk-prostate-cancer-should-not-receive-androgen-deprivation-therapy weekly 0.8 https://www.themednet.org/what-is-your-management-strategy-for-patients-with-positive-lymph-nodes-after-radical-prostatectomy weekly 0.8 https://www.themednet.org/what-indications-do-you-use-to-prophylactically-treat-para-aortic-lymph-nodes-in-cervical-cancer weekly 0.8 https://www.themednet.org/when-do-you-use-a-brachytherapy-vaginal-cuff-boost-in-postoperative-cervical-cancer-treatment weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-for-induction-chemotherapy-in-advanced-head-and-neck-cancers weekly 0.8 https://www.themednet.org/do-you-use-altered-fractionation-in-patients-with-locally-advanced-head-and-neck-cancers-who-are-not-candidates-for-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-justify-adjuvant-radiotherapy-in-pancreatic-cancer weekly 0.8 https://www.themednet.org/how-do-you-control-for-organ-motion-when-treating-pancreatic-cancer weekly 0.8 https://www.themednet.org/which-regimen-is-better-for-gastric-adenocarcinoma-neoadjuvant-chemotherapy-or-adjuvant-chemoradiation weekly 0.8 https://www.themednet.org/should-we-be-more-concerned-about-cardiac-toxicity-following-breast-radiotherapy weekly 0.8 https://www.themednet.org/does-current-data-support-use-of-intraoperative-breast-radiotherapy weekly 0.8 https://www.themednet.org/should-i-use-oncotype-to-determine-whether-to-offer-adjuvant-radiation-to-women-with-dcis weekly 0.8 https://www.themednet.org/do-you-ever-treat-the-contralateral-neck-for-high-grade-mucoepidermoid-salivary-gland-carcinomas weekly 0.8 https://www.themednet.org/for-nsclca-patients-who-are-found-to-have-n2-disease-at-time-of-surgery-what-treatment-volume-do-you-use-for-port weekly 0.8 https://www.themednet.org/how-often-do-you-order-follow-up-mammograms-after-breast-radiotherapy weekly 0.8 https://www.themednet.org/what-dose-would-you-give-for-unresectable-anaplastic-thyroid-carcinoma weekly 0.8 https://www.themednet.org/for-rectal-cancer-with-solitary-liver-metastasis-do-you-recommend-neoadjuvant-chemoradiation weekly 0.8 https://www.themednet.org/what-rt-dose-with-chemo-would-you-use-for-small-cell-of-the-bladder weekly 0.8 https://www.themednet.org/is-there-a-firm-rib-dose-constraint-when-treating-lung-tumors-abutting-the-visceral-pleura-chest-wall-with-sbrt weekly 0.8 https://www.themednet.org/when-do-you-transfuse-cervical-cancer-patients-undergoing-chemoradiation weekly 0.8 https://www.themednet.org/what-is-the-appropriate-rt-dose-for-an-advanced-stage-follicular-lymphoma weekly 0.8 https://www.themednet.org/how-should-total-radiation-dose-be-adjusted-in-head-and-neck-patients-who-have-had-extended-breaks-during-their-radiation-course weekly 0.8 https://www.themednet.org/for-a-patient-who-has-undergone-preoperative-chemoradiation-to-50gy-for-locally-advanced-rectal-cancer-followed-by-lar-or-apr-would-you-treat-a-positive-margin-with-radiation-therapy weekly 0.8 https://www.themednet.org/what-is-your-opinion-on-iort-for-breast-with-electron-brachytherapy weekly 0.8 https://www.themednet.org/is-there-solid-evidence-for-the-proper-sequencing-of-tamoxifen-serm-and-breast-radiation weekly 0.8 https://www.themednet.org/what-is-the-role-of-parametrial-and-pelvic-side-wall-boosts-in-the-setting-of-volumetric-brachytherapy-for-locally-advanced-cervical-cancer-treated-with-either-3dcrt-or-imrt weekly 0.8 https://www.themednet.org/what-clinical-and-pathological-factors-guide-your-decision-making-when-considering-whether-to-recommend-vaginal-cuff-brachytherapy-following-tah-bso-for-a-figo-stage-ia-or-ib-endometrial-carcinoma weekly 0.8 https://www.themednet.org/what-dose-fractionation-do-you-use-when-treating-primary-nsclc-with-oligometastatic-disease weekly 0.8 https://www.themednet.org/do-you-consider-treatment-of-the-supraclavicular-region-mandatory-for-breast-cancer-patients-with-a-chest-wall-recurrence weekly 0.8 https://www.themednet.org/for-intermediate-risk-prostate-cancer-do-you-recommend-short-term-complete-androgen-blockade-or-lhrh-agonist-alone weekly 0.8 https://www.themednet.org/can-srs-be-used-to-treat-an-atypical-meningioma weekly 0.8 https://www.themednet.org/do-you-feel-that-hdr-brachytherapy-alone-is-adequate-treatment-for-some-intermediate-risk-prostate-cancer-patients weekly 0.8 https://www.themednet.org/how-long-should-patients-wait-before-undergoing-reconstruction-following-pmrt weekly 0.8 https://www.themednet.org/can-pmrt-be-avoided-in-patients-with-1-3-nodes-if-they-achieve-a-pcr-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-is-the-optimal-management-of-a-pelvic-sidewall-recurrence-of-endometrial-cancer-in-a-patient-who-has-not-previously-received-radiation weekly 0.8 https://www.themednet.org/when-do-you-recommend-consolidative-xrt-for-patients-with-advanced-stage-iii-iv-dlbcl-who-achieve-cr-to-chemoimmunotherapy weekly 0.8 https://www.themednet.org/do-you-use-breath-hold-techniques-to-minimize-heart-dose-in-whole-breast-radiation weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-srs-to-the-surgical-bed-after-resection-of-a-single-brain-metastasis weekly 0.8 https://www.themednet.org/in-what-situations-do-you-recommend-adjuvant-radiotherapy-for-colon-cancer weekly 0.8 https://www.themednet.org/would-you-recommend-definitive-local-treatment-of-locally-recurrent-breast-cancer-with-a-positive-contralateral-axillary-lymph-node-and-no-signs-of-distant-metastasis weekly 0.8 https://www.themednet.org/in-a-patient-with-a-mediastinal-recurrence-following-lobectomy-for-early-stage-nsclc-what-would-be-your-treatment-volume weekly 0.8 https://www.themednet.org/do-you-recommend-breast-mri-for-patients-with-invasive-lobular-breast-cancer-considering-breast-conservation-therapy weekly 0.8 https://www.themednet.org/do-you-ever-consider-treating-the-axilla-in-patients-with-multiple-nodes-with-itcs weekly 0.8 https://www.themednet.org/whats-it-like-to-be-a-radiation-oncologist-at-a-veterans-affairs-hospital weekly 0.8 https://www.themednet.org/when-do-you-offer-pmrt-for-clinical-t3n0-breast-cancer-with-a-pcr-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-factors-do-you-typically-consider-when-deciding-whether-to-include-retropharyngeal-lymph-nodes-within-your-treatment-volumes-for-squamous-cell-carcinoma-of-the-oral-cavity-or-oropharynx weekly 0.8 https://www.themednet.org/when-using-short-course-fractionation-for-an-elderly-patient-with-glioblastoma-40-gy-in-15-fractions-what-are-appropriate-dose-constraints-for-chiasm-brainstem-optic-nerves weekly 0.8 https://www.themednet.org/is-there-a-benefit-to-adjuvant-chemotherapy-for-patients-with-a-solitary-liver-metastasis-from-previously-treated-colorectal-cancer weekly 0.8 https://www.themednet.org/in-patients-who-are-hpv-postive-and-non-smokers-who-have-a-complete-pet-response-to-induction-tpf-at-the-primary-site-would-you-still-treat-the-primary-site-to-full-dose weekly 0.8 https://www.themednet.org/what-factors-would-lead-you-to-consider-rt-for-men-with-stage-i-seminoma weekly 0.8 https://www.themednet.org/when-do-you-start-temozolomide-with-rt-for-high-grade-glioma weekly 0.8 https://www.themednet.org/would-you-offer-pmrt-for-an-axillary-only-recurrence-after-a-remote-mastectomy-and-alnd-in-a-patient-with-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/what-specific-dietary-changes-do-you-recommend-for-patients-undergoing-h-n-cns-or-gi-rt weekly 0.8 https://www.themednet.org/when-is-the-best-time-to-start-denosumab-in-men-with-metastatic-prostate-cancer weekly 0.8 https://www.themednet.org/would-you-treat-the-inguinal-nodes-in-a-patient-who-had-an-adenocarcinoma-excised-from-the-anal-canal weekly 0.8 https://www.themednet.org/what-dose-and-volume-would-be-recommended-for-a-medically-inoperable-patient-with-a-t4-rectal-adenocarcinoma weekly 0.8 https://www.themednet.org/should-one-perform-a-sentinel-node-biopsy-in-a-clinically-negative-axilla-prior-to-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/is-it-safe-and-appropriate-to-palliatively-treat-abdominal-or-thoracic-tumors-with-concurrent-chemotherapy-when-using-fractions-of-250-300-cgy weekly 0.8 https://www.themednet.org/do-you-add-a-margin-when-treating-brain-metastases-with-srs weekly 0.8 https://www.themednet.org/is-there-a-role-for-post-operative-chemoradiation-therapy-in-fully-resected-margin-negative-t3n1-nsclc weekly 0.8 https://www.themednet.org/when-would-you-use-concurrent-cetuximab-with-radiation-for-a-patient-with-h-n-cancer-who-is-not-a-good-candidate-for-concurrent-chemotherapy weekly 0.8 https://www.themednet.org/are-there-situations-in-which-hypofractionated-breast-rt-is-acceptable-after-neoadjuvant-chemotherapy-and-lumpectomy weekly 0.8 https://www.themednet.org/what-is-the-minimum-amount-of-time-you-should-wait-between-a-turp-and-the-start-of-definitive-prostate-radiation-therapy weekly 0.8 https://www.themednet.org/does-triple-negative-breast-cancer-influence-your-decision-to-boost-an-older-patient-post-lumpectomy weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiotherapy-to-a-small-low-grade-t1-adenoid-cystic-carcinoma-of-the-minor-salivary-gland-that-was-completely-resected weekly 0.8 https://www.themednet.org/should-the-incorporation-of-thoracic-rt-be-standard-in-patients-with-extensive-stage-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/what-are-your-target-volumes-and-dose-for-recurrent-atypical-meningiomas-that-have-been-initially-treated-with-definitive-surgery-alone weekly 0.8 https://www.themednet.org/whats-your-approach-to-adjuvant-therapy-for-neuroendocrine-small-cell-cancer-of-the-parotid-gland weekly 0.8 https://www.themednet.org/what-is-the-best-toxicity-data-to-quote-to-patients-for-prostate-imrt-vs-nerve-sparing-prostatectomy weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-with-small-cell-lung-cancer-limited-to-lung-and-mediastinum-but-also-with-a-malignant-pleural-effusion-with-upfront-definitive-thoracic-chemoradiation weekly 0.8 https://www.themednet.org/how-would-you-manage-asymptomatic-radiation-necrosis-seen-on-mri-after-srs-of-a-benign-tumor weekly 0.8 https://www.themednet.org/what-are-the-most-common-errors-that-can-be-made-when-performing-prostate-sbrt weekly 0.8 https://www.themednet.org/what-is-the-biggest-mistake-people-make-when-starting-a-linac-srs-program weekly 0.8 https://www.themednet.org/what-is-your-first-line-treatment-for-progressive-well-differentiated-metastatic-and-unresectable-pancreatic-neuroendocrine-tumors weekly 0.8 https://www.themednet.org/do-you-omit-anthracyclines-in-perioperative-chemotherapy-for-gastric-cancer weekly 0.8 https://www.themednet.org/when-do-you-give-treatment-breaks-for-patients-with-nsclc-undergoing-chemoradiation-with-serious-toxicity weekly 0.8 https://www.themednet.org/how-do-you-manage-high-risk-prostate-cancer-patients-with-well-controlled-crohns-disease weekly 0.8 https://www.themednet.org/is-there-an-age-cutoff-for-when-to-avoid-gem-nab-paclitaxel-in-older-patients-with-pancreatic-cancer weekly 0.8 https://www.themednet.org/how-long-should-the-duration-of-hormones-be-in-post-prostatectomy-patients-receiving-salvage-rt weekly 0.8 https://www.themednet.org/should-enzalutamide-be-given-concurrently-with-sip-t-in-castration-resistant-metastatic-prostate-cancer weekly 0.8 https://www.themednet.org/when-is-post-op-radiation-not-necessary-for-completely-resected-ipsilateral-neck-node-recurrence-in-a-previously-unirradiated-neck weekly 0.8 https://www.themednet.org/when-should-adjuvant-chemotherapy-be-offered-to-patients-with-soft-tissue-sarcoma-of-the-extremity weekly 0.8 https://www.themednet.org/what-imaging-workup-should-be-completed-in-patients-with-a-detectable-psa-following-prostatectomy weekly 0.8 https://www.themednet.org/how-do-you-define-involved-field-radiotherapy-for-lung-cancer weekly 0.8 https://www.themednet.org/what-should-be-the-first-line-treatment-for-metastatic-uveal-melanoma weekly 0.8 https://www.themednet.org/for-a-her2-positive-patient-who-has-undergone-neoadjuvant-her2-directed-therapy-do-you-offer-adjuvant-trastuzumab-if-the-surgical-specimen-is-her2-negative weekly 0.8 https://www.themednet.org/is-it-safe-to-treat-patients-who-have-thermal-burn-scars-in-the-field weekly 0.8 https://www.themednet.org/for-5-fraction-lung-sbrt-is-11-gy-per-fraction-superior-to-10-gy-per-fraction weekly 0.8 https://www.themednet.org/what-is-the-clinical-significance-of-r50-in-lung-sbrt weekly 0.8 https://www.themednet.org/for-patients-with-low-risk-prostate-cancer-and-with-very-large-prostates-80cc-with-significant-urinary-irritative-obstructive-symptoms-at-baseline-should-a-short-course-of-neoadjuvant-hormone-therapy-be-used-prior-to-ebrt-to-reduce-the-severity-of-urinary weekly 0.8 https://www.themednet.org/what-is-your-practice-regarding-axillary-isolated-recurrence-after-surgery-when-a-patient-received-previous-whole-breast-radiation weekly 0.8 https://www.themednet.org/is-there-a-role-for-prophylactic-cranial-irradiation-in-non-lung-neuroendocrine-carcinoma weekly 0.8 https://www.themednet.org/when-should-sbrt-be-preferred-in-operative-patients-who-cannot-undergo-a-lobectomy weekly 0.8 https://www.themednet.org/when-treating-pancreatic-cancer-with-adjuvant-chemoradiation-do-you-treat-the-initial-field-to-50-gy-as-per-rtog-0848-or-to-45-gy weekly 0.8 https://www.themednet.org/what-dose-do-you-use-for-definitive-treatment-of-squamous-cell-carcinoma-of-the-cervical-esophagus weekly 0.8 https://www.themednet.org/given-the-ma20-results-do-you-consider-cw-plus-scv-or-even-regional-nodal-radiation-postmastectomy-for-pt3n0-with-high-risk-features weekly 0.8 https://www.themednet.org/what-is-the-role-of-neoadjuvant-chemotherapy-in-the-treatment-of-locoregionally-advanced-nasopharyngeal-carcinoma weekly 0.8 https://www.themednet.org/when-is-postoperative-radiation-appropriate-for-a-typical-lung-carcinoid-tumor weekly 0.8 https://www.themednet.org/what-chemotherapy-regimen-is-best-suited-for-patients-with-platinum-refractory-metastatic-bladder-cancer-who-have-good-or-excellent-performance-status weekly 0.8 https://www.themednet.org/what-dose-is-most-appropriate-when-treating-a-post-prostatectomy-patient-with-positive-margins-in-the-adjuvant-setting weekly 0.8 https://www.themednet.org/do-you-administer-prophylactic-antibiotics-during-a-partial-breast-balloon-brachytherapy-treatment-course weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-treat-proximal-vs-entire-vaginal-cuff-with-intracavitary-brachytherapy-in-early-stage-endometrial-adenocarcinoma weekly 0.8 https://www.themednet.org/do-you-ever-recommend-concurrent-chemotherapy-for-high-risk-squamous-cell-skin-cancer-radiation weekly 0.8 https://www.themednet.org/what-is-the-role-of-radiation-treatment-of-stage-ia-alk-negative-anaplastic-large-cell-lymphoma weekly 0.8 https://www.themednet.org/does-a-negative-neck-dissection-adequately-cover-the-treatment-of-the-neck-for-a-patient-that-clearly-needs-port-for-an-oral-tongue-cancer weekly 0.8 https://www.themednet.org/what-are-the-current-thoughts-for-adt-and-prostate-sbrt-for-low-intermediate-risk-patients weekly 0.8 https://www.themednet.org/given-the-recent-pooled-analysis-of-stars-and-rosel-trials-can-we-say-sbrt-for-early-stage-nsclc-is-equivalent-to-lobectomy-based-on-level-1-evidence weekly 0.8 https://www.themednet.org/should-tnf-inhibitors-be-held-in-patients-undergoing-radiation-therapy weekly 0.8 https://www.themednet.org/for-t1b-or-t2a-nsclc-cancer-approached-with-sabr-should-chemotherapy-be-considered-in-the-adjuvant-setting weekly 0.8 https://www.themednet.org/are-there-certain-clinical-scenarios-that-make-you-favor-a-lower-whole-breast-total-dose-but-higher-lumpectomy-cavity-boost weekly 0.8 https://www.themednet.org/what-treatment-recommendations-for-a-low-or-intermediate-risk-prostate-cancer-do-you-consider-when-treating-patients-with-medical-commodities-such-as-ankylosing-spondylitis-and-ulcerative-colitis weekly 0.8 https://www.themednet.org/based-on-data-from-create-x-jbcrg-04-would-you-consider-adjuvant-capecitabine-in-breast-cancer-patients-treated-with-neoadjuvant-chemotherapy-who-do-not-achieve-a-pcr weekly 0.8 https://www.themednet.org/would-you-consider-whole-breast-irradiation-in-a-woman-who-develops-a-second-primary-breast-cancer-or-recurrence-after-lumpectomy-and-partial-breast-balloon-brachytherapy-and-declines-mastectomy weekly 0.8 https://www.themednet.org/how-do-you-use-a-4d-ct-to-account-for-hepatocellular-carcinoma-tumor-motion weekly 0.8 https://www.themednet.org/is-there-a-mednet-app weekly 0.8 https://www.themednet.org/is-sbrt-an-appropriate-first-line-treatment-for-oligometastatic-renal-cell-carcinoma weekly 0.8 https://www.themednet.org/should-a-lumpectomy-cavity-boost-be-given-to-cn0-patients-who-receive-neo-adjuvant-chemotherapy-and-have-a-path-cr-if-planning-to-complete-hypofractionated-whole-breast-radiation weekly 0.8 https://www.themednet.org/how-do-you-deal-with-the-brachial-plexus-in-head-and-neck-cancer-radiation-ie-suprglottic-larynx-when-there-is-a-positive-node-near-the-plexus-or-when-you-have-an-involved-nodal-level-that-you-want-to-take-to-a-higher-dose weekly 0.8 https://www.themednet.org/what-is-the-preferred-dose-and-fractionation-scheme-for-patients-with-pituitary-macroadenomas weekly 0.8 https://www.themednet.org/when-administering-breast-brachytherapy-10-fxs-bid-is-it-critical-that-treatment-start-on-a-monday-not-straddle-one-weekend weekly 0.8 https://www.themednet.org/when-giving-a-breast-boost-what-are-indications-for-a-photon-breast-boost weekly 0.8 https://www.themednet.org/what-do-you-consider-negative-or-close-margins-for-tonsillar-cancers weekly 0.8 https://www.themednet.org/when-treating-a-patient-with-a-high-grade-sarcoma-in-the-post-op-setting-do-i-need-to-get-full-dose-to-the-incision-and-drain-site-assuming-all-margins-negative weekly 0.8 https://www.themednet.org/in-what-situations-do-you-order-an-oncotype-dx-dcis-score-for-a-patient-with-dcis weekly 0.8 https://www.themednet.org/is-it-acceptable-for-a-medical-oncologist-to-use-xeloda-in-place-of-5fu-when-treating-gi-sites-other-than-rectal weekly 0.8 https://www.themednet.org/when-administering-adjuvant-rt-to-the-prostate-bed-with-concurrent-adt-do-you-start-concurrently-or-prefer-to-administer-the-adt-first weekly 0.8 https://www.themednet.org/is-there-a-standard-spinal-sbrt-dose-regimen-for-patients-with-oligometastatic-disease-being-treated-with-curative-intent weekly 0.8 https://www.themednet.org/do-you-transfuse-anemic-head-and-neck-cancer-patients-undergoing-chemoradiation weekly 0.8 https://www.themednet.org/is-there-evidence-to-support-the-use-of-definitive-crt-in-patients-with-nsclc-in-separate-ipsilateral-lobes-t4-old-m1-and-mediastinal-lymph-node-involvement-n2-3 weekly 0.8 https://www.themednet.org/how-do-you-incorporate-the-recent-proposed-guidelines-for-using-a-prostate-cancer-grade-grouping-system-i-e-scores-1-5-into-your-clinical-practice weekly 0.8 https://www.themednet.org/does-the-better-prognosis-associated-with-p16-h-n-cancers-relate-only-to-patients-who-are-treated-with-rt-chemo weekly 0.8 https://www.themednet.org/should-inoperable-squamous-cell-carcinoma-of-the-esophagus-be-treated-to-doses-60-gy weekly 0.8 https://www.themednet.org/what-is-appropriate-followup-duration-after-treatment-for-an-acoustic-neuroma weekly 0.8 https://www.themednet.org/what-healthcare-blogs-should-radiation-oncologists-be-reading weekly 0.8 https://www.themednet.org/what-surveillance-imaging-is-appropriate-after-spine-sbrt weekly 0.8 https://www.themednet.org/for-a-patient-with-inflammatory-breast-cancer-after-standard-initial-systemic-therapy-with-only-a-partial-response-do-you-recommend-more-systemic-therapy-pre-operative-radiation-or-proceed-to-modified-radical-mastectomy weekly 0.8 https://www.themednet.org/do-you-offer-hypofractionated-accelerated-whole-breast-radiation-therapy-for-women-receiving-trastuzumab-during-rt-particularly-those-with-left-sided-primaries weekly 0.8 https://www.themednet.org/what-marginal-srs-dose-do-you-prescribe-for-brain-metastases-2-cm-or-smaller weekly 0.8 https://www.themednet.org/for-brain-metastases-what-is-the-optimal-time-interval-between-surgery-and-post-operative-srs weekly 0.8 https://www.themednet.org/are-there-any-situations-in-which-you-would-offer-postoperative-rt-for-node-positive-prostate-cancer weekly 0.8 https://www.themednet.org/given-the-results-of-the-getug-14-randomized-trial-presented-at-asco-2016-should-all-men-with-intermediate-risk-prostate-cancer-receiving-dose-escalated-radiotherapy-receive-concurrent-adt weekly 0.8 https://www.themednet.org/when-do-you-recommend-a-breast-mri-for-breast-cancer-surveillance weekly 0.8 https://www.themednet.org/should-combined-brachytherapy-ebrt-adt-be-the-standard-of-care-for-men-with-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/what-is-your-typical-target-field-when-treating-a-patient-with-5-gy-x-5-fractions-pre-operatively-for-rectal-cancer weekly 0.8 https://www.themednet.org/in-what-situations-will-you-defer-srs-for-newly-detected-brain-metastases-in-a-patient-with-an-oncogene-driven-malignancy weekly 0.8 https://www.themednet.org/should-patients-receive-pmrt-if-they-just-have-a-positive-internal-mammary-lymph-node-on-imaging-and-a-negative-axillary-dissection weekly 0.8 https://www.themednet.org/when-starting-a-patient-on-a-tyrosine-kinase-inhibitor-for-chronic-phase-cml-which-drug-do-you-choose-upfront weekly 0.8 https://www.themednet.org/what-srs-dose-do-you-use-for-secreting-and-non-secreting-pituitary-adenomas-respectively weekly 0.8 https://www.themednet.org/do-you-routinely-offer-ar-v7-testing-to-determine-whether-to-treat-with-chemotherapy-versus-enzalutamide-or-abiraterone-in-metastatic-castration-resistant-prostate-cancer weekly 0.8 https://www.themednet.org/would-you-advocate-for-sphincter-preserving-chemoradiation-therapy-for-a-patient-with-a-diagnosis-of-anal-canal-carcinoma-who-has-previously-been-treated-with-pelvic-radiation-such-as-ebrt-or-brachytherapy weekly 0.8 https://www.themednet.org/for-patients-with-brain-metastases-do-molecular-subtypes-influence-your-decision-to-use-srs-versus-whole-brain-radiation weekly 0.8 https://www.themednet.org/in-what-situations-do-you-consider-adjuvant-radiation-for-ovarian-cancer weekly 0.8 https://www.themednet.org/when-do-you-use-a-rectal-spacer-in-combination-with-radiotherapy-for-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-use-immune-checkpoint-inhibitors-in-nsclc-patients-with-pre-existing-well-controlled-autoimmune-disease weekly 0.8 https://www.themednet.org/how-do-the-results-of-braf-testing-change-your-management-of-colon-cancer weekly 0.8 https://www.themednet.org/when-treating-locally-advanced-borderline-resectable-pancreatic-cancer-with-sbrt-what-are-the-typical-duodenal-dose-constraints-you-utilize weekly 0.8 https://www.themednet.org/when-should-multiparametric-mri-mpmri-be-utilized-in-prostate-cancer-workup weekly 0.8 https://www.themednet.org/what-is-your-approach-to-an-optimally-debulked-patient-with-stage-ia-figo-gr-3-serous-carcinoma-of-the-ovary weekly 0.8 https://www.themednet.org/under-what-circumstance-do-you-offer-a-definitive-approach-to-local-treatment-of-a-patient-with-oligomestastatic-cervical-cancer-found-on-initial-staging-pet-ct weekly 0.8 https://www.themednet.org/has-sbrt-shown-to-improve-os-or-pfs-in-patients-with-localized-pancreatic-cancer-who-are-not-a-eligible-for-surgery-due-to-other-comorbidities weekly 0.8 https://www.themednet.org/what-is-the-role-of-up-front-neck-dissection-in-locally-advanced-head-and-neck-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-counsel-women-with-a-history-of-breast-cancer-who-have-dense-breasts-with-regards-to-mammography-screening weekly 0.8 https://www.themednet.org/is-it-feasible-to-treat-central-liver-tumors-portal-vein-thrombus-with-sbrt-while-minding-central-hepatobiliary-tract-constraints weekly 0.8 https://www.themednet.org/for-an-unknown-primary-manifested-in-a-left-supraclavicular-node-what-area-would-you-treat-with-radiation-therapy weekly 0.8 https://www.themednet.org/does-finding-a-positive-surgical-margin-containing-pleomorphic-lcis-in-a-patient-with-early-stage-invasive-ductal-carcinoma-of-the-breast-affect-your-management-in-regards-to-breast-conservation-therapy weekly 0.8 https://www.themednet.org/what-dose-is-required-to-gross-disease-in-the-definitive-treatment-of-vulvar-cancer weekly 0.8 https://www.themednet.org/in-what-situation-would-you-check-receptor-status-er-pr-her2-on-more-than-one-lesion-in-a-multifocal-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-advise-patients-on-the-risk-for-permanent-alopecia-following-rt-to-the-scalp weekly 0.8 https://www.themednet.org/how-are-you-planning-to-use-mammaprint-for-the-management-of-locally-advanced-er-breast-cancer-at-clinical-high-risk-of-recurrence-based-on-size-and-up-to-3-lymph-nodes weekly 0.8 https://www.themednet.org/what-dose-do-you-recommend-for-salvage-radiotherapy-after-biochemical-recurrence-in-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-aromatase-inhibitor-associated-musculoskeletal-syndrome-aimss-symptoms-in-post-menopausal-breast-cancer-patients weekly 0.8 https://www.themednet.org/how-do-you-deal-with-wounds-in-or-around-the-radiation-fields weekly 0.8 https://www.themednet.org/how-are-you-using-liquid-biopsy-in-the-routine-management-of-your-patients-with-metastatic-nsclc weekly 0.8 https://www.themednet.org/can-any-non-sbrt-hypo-fractionation-regimen-for-prostate-cancer-be-regarded-as-the-new-standard-of-care-or-as-an-equal-alternative-standard-of-care weekly 0.8 https://www.themednet.org/in-patients-with-stage-i-seminoma-who-elect-surveillance-how-long-do-you-recommend-that-tumor-markers-be-followed weekly 0.8 https://www.themednet.org/for-patients-with-advanced-nsclc-who-have-radiographic-disease-progression-on-their-follow-up-scan-after-starting-a-pd-1-inhibitor-what-characteristics-either-clinical-or-radiographic-do-you-use-to-determine-whether-to-continue-with-therapy-or-switch-to-s weekly 0.8 https://www.themednet.org/aside-from-radiation-what-is-your-approach-to-patients-with-egfr-mutated-or-alk-translocated-metastatic-nsclc-who-have-systemic-disease-control-but-fail-in-the-cns weekly 0.8 https://www.themednet.org/do-you-routinely-use-tumor-lysis-prophylaxis-when-starting-chemotherapy-for-germ-cell-tumors weekly 0.8 https://www.themednet.org/what-is-the-minimum-number-of-hyperbaric-oxygen-treatments-you-would-prescribe-for-late-radiation-toxicities weekly 0.8 https://www.themednet.org/how-do-you-manage-excessive-or-difficult-to-control-secretions-in-patients-who-have-received-chemoradiation-for-head-and-neck-cancer weekly 0.8 https://www.themednet.org/what-dose-constraints-do-you-use-for-the-left-anterior-descending-artery-lad-for-breast-radiation weekly 0.8 https://www.themednet.org/what-duration-of-androgen-deprivation-therapy-do-you-use-for-patients-with-pn-prostate-cancer-undergoing-upfront-adjuvant-rt-after-a-radical-prostatectomy-and-pelvic-lymph-node-dissection weekly 0.8 https://www.themednet.org/what-is-the-best-management-of-early-stage-breast-cancer-in-patients-with-a-minimal-life-expectancy-10yrs weekly 0.8 https://www.themednet.org/for-the-first-line-treatment-of-metastatic-lung-adenocarcinoma-without-a-targetable-driver-mutation-do-you-routinely-add-bevacizumab-to-the-chemotherapy-backbone-in-the-absence-of-a-contraindication-to-the-drug weekly 0.8 https://www.themednet.org/how-aggressively-do-you-approach-pelvic-treatment-for-patients-with-low-volume-metastatic-cervical-cancer-but-bulky-local-disease weekly 0.8 https://www.themednet.org/what-dose-would-you-use-to-treat-an-unresectable-axillary-breast-cancer-recurrence-in-a-patient-who-has-not-previously-received-radiation-therapy weekly 0.8 https://www.themednet.org/what-adjuvant-chemotherapy-regimen-is-most-appropriate-for-a-patient-with-local-recurrence-several-years-after-surgery-and-ddac-t-for-localized-breast-cancer weekly 0.8 https://www.themednet.org/how-is-your-institution-incorporating-mri-planning-into-cervical-ebrt-brachy weekly 0.8 https://www.themednet.org/is-it-safe-to-hypofractionate-for-whole-breast-rt-in-patients-with-a-brca-1-2-or-chek2-mutation-to-chose-to-have-breast-conservation-for-early-stage-breast-cancer-or-dcis weekly 0.8 https://www.themednet.org/when-treating-resected-brain-metastases-with-post-op-srs-what-dose-fractionation-and-ptv-margin-do-you-use-for-large-3-cm-cavities weekly 0.8 https://www.themednet.org/how-do-you-approach-teeth-extractions-for-head-and-neck-cancer-patients-getting-radiation weekly 0.8 https://www.themednet.org/what-treatment-options-would-you-consider-for-a-patient-with-an-ecog-ps-of-0-with-metastatic-non-uterine-leiomyosarcoma-who-has-progressed-on-all-standard-systemic-therapies-including-anthracycline-gemcitabine-taxane-vinorelbine-pazopanib-temozolomide-and weekly 0.8 https://www.themednet.org/how-do-you-counsel-premenopausal-women-with-brca1-or-brca2-mutations-on-the-need-for-bilateral-oopherectomy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-cancer-of-undetermined-primary-site-presenting-as-peritoneal-carcinomatosis-with-pathology-suggesting-intestinal-or-pancreatobiliary-origin weekly 0.8 https://www.themednet.org/how-do-you-decide-which-dose-fractionation-to-use-for-consolidative-therapy-to-the-lung-in-patients-with-oligometastatic-nsclc-who-have-responded-well-to-first-line-systemic-therapy weekly 0.8 https://www.themednet.org/would-you-utilize-srs-sbrt-in-a-patient-with-oligometastatic-disease-from-adenocarcinoma-of-the-lung-who-is-unable-to-receive-standard-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-monitor-ovarian-function-in-high-risk-premenopausal-breast-cancer-patients-receiving-adjuvant-ovarian-suppression weekly 0.8 https://www.themednet.org/for-patients-with-metastatic-nsclc-with-sensitizing-egfr-mutations-who-progress-on-first-line-tki-therapy-who-do-not-have-evidence-of-t790m-mutation-do-you-add-cetuximab-with-afatinib-or-bevacizumab-with-erlotinib-at-progression weekly 0.8 https://www.themednet.org/what-volume-would-you-treat-with-radiation-in-the-setting-of-high-risk-oral-tongue-cancer-completely-resected-with-surgery-and-negative-bilateral-neck-dissections weekly 0.8 https://www.themednet.org/how-would-you-treat-a-braf-wt-metastatic-melanoma-patient-with-leptomeningeal-disease-in-the-frontline-setting weekly 0.8 https://www.themednet.org/for-patients-who-develop-oligometastatic-renal-cell-carcinoma-amenable-to-local-therapies-i-e-ablation-radiation-therapy-or-surgery-how-do-you-integrate-systemic-therapy-if-at-all weekly 0.8 https://www.themednet.org/do-you-electively-cover-the-celiac-axis-in-a-patient-with-node-negative-middle-third-to-distal-and-gej-esophageal-carcinoma weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-to-guide-your-decision-on-adjuvant-radiation-for-thymic-carcinoma weekly 0.8 https://www.themednet.org/in-a-patient-with-a-large-condyloma-adjacent-to-a-squamous-cell-carcinoma-of-the-anal-canal-being-treated-with-chemoradiation-how-would-you-incorporate-the-condyloma-in-the-target-volume-if-it-is-pet-negative-and-would-it-receive-a-different-dose weekly 0.8 https://www.themednet.org/how-do-you-assess-and-encourage-adherence-to-adjuvant-hormonal-therapy-in-early-stage-breast-cancer-patients weekly 0.8 https://www.themednet.org/what-radiation-dose-and-fractionation-schedule-do-you-use-to-treat-atypical-carcinoid-tumors-in-patients-who-are-medically-inoperable weekly 0.8 https://www.themednet.org/what-techniques-do-you-use-to-treat-patients-who-weigh-more-than-the-treatment-table-limit weekly 0.8 https://www.themednet.org/would-you-offer-sbrt-to-a-medically-inoperable-patient-with-systemic-lupus-erythematosus-or-other-connective-tissue-disorders-if-well-controlled weekly 0.8 https://www.themednet.org/how-do-you-manage-the-development-of-neuropathy-in-patients-receiving-bortezomib-for-multiple-myeloma weekly 0.8 https://www.themednet.org/when-treating-borderline-resectable-pancreatic-adenocarcinoma-patients-with-neoadjuvant-chemoradiation-do-you-treat-the-elective-nodal-regions-or-the-primary-alone weekly 0.8 https://www.themednet.org/what-is-the-role-of-platinum-agents-in-the-treatment-of-metastatic-breast-cancer-in-patients-with-brca-mutations weekly 0.8 https://www.themednet.org/how-old-was-the-most-elderly-patient-you-have-successfully-treated-with-definitive-radiation-or-chemoradiation-for-advanced-oropharyngeal-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-a-recurrent-brainstem-metastasis-following-prior-srs weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-patients-with-an-idh-wild-type-low-grade-glioma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-uterine-perforation-during-the-time-of-brachytherapy-implant-for-cervical-cancer weekly 0.8 https://www.themednet.org/is-it-safe-to-use-doses-of-3gy-in-a-bid-treatment-for-palliative-urgent-cases weekly 0.8 https://www.themednet.org/do-you-routinely-re-image-all-craniopharyngioma-patients-during-radiotherapy weekly 0.8 https://www.themednet.org/do-you-prefer-fulvestrant-over-an-ai-in-advanced-hormone-receptor-breast-cancer weekly 0.8 https://www.themednet.org/when-do-you-recommend-induction-chemotherapy-prior-to-concurrent-chemoradiotherapy-for-locally-advanced-nsclc weekly 0.8 https://www.themednet.org/at-what-point-do-you-prescribe-duloxetine-for-the-treatment-of-aims-aromatase-inhibitor-induced-musculoskeletal-syndrome weekly 0.8 https://www.themednet.org/what-dose-fractionation-do-you-utilize-when-treating-at-risk-and-elective-lymph-node-levels-in-patients-with-hpv-positive-oropharyngeal-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/do-you-advise-against-starting-tnf-alpha-modulating-agents-for-conditions-such-as-psoriasis-or-arthritis-while-actively-undergoing-radiation-treatment weekly 0.8 https://www.themednet.org/in-stage-iiic-endometrial-adenocarcinoma-does-the-finding-of-positive-pelvic-or-para-aortic-nodes-after-lymphadenectomy-influence-your-whole-pelvic-dose weekly 0.8 https://www.themednet.org/in-what-situations-if-any-do-you-offer-postoperative-radiation-or-chemoradiation-for-patients-with-squamous-cell-carcinoma-of-the-esophagus weekly 0.8 https://www.themednet.org/is-ca-27-29-helpful-in-surveillance-of-patients-with-stage-i-iii-breast-cancer-in-remission weekly 0.8 https://www.themednet.org/how-do-you-treat-synchronous-locally-advanced-lung-and-head-and-neck-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-the-elective-lymphatics-in-high-risk-squamous-cell-carcinoma-of-the-skin weekly 0.8 https://www.themednet.org/how-do-you-manage-intractable-hiccups-from-radiation weekly 0.8 https://www.themednet.org/how-do-you-approach-subsequent-treatment-in-patients-with-unresectable-hepatocellular-carcinoma-who-have-progressed-on-first-line-sorafenib weekly 0.8 https://www.themednet.org/is-ttf-treatment-an-appropriate-option-for-recurrent-gbm weekly 0.8 https://www.themednet.org/should-pituitary-suppressive-medications-be-stopped-prior-to-radiosurgery-for-patients-with-a-functioning-pituitary-adenoma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-brain-reirradiation-in-the-setting-of-recurrent-progressive-gliomas weekly 0.8 https://www.themednet.org/how-does-the-risk-of-urinary-obstruction-differ-between-hdr-and-ldr-brachytherapy-for-prostate-cancer weekly 0.8 https://www.themednet.org/are-your-criteria-for-pmrt-in-men-different-than-your-criteria-for-pmrt-in-women weekly 0.8 https://www.themednet.org/do-you-treat-elective-cervical-lymph-nodes-for-snuc-sinonasal-undifferentiated-carcinoma-of-the-ethmoid-sinus weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-stage-i-node-negative-er-invasive-ductal-carcinoma-s-p-lumpectomy-who-has-an-intermediate-oncotype weekly 0.8 https://www.themednet.org/what-chemotherapeutic-regimen-would-you-prefer-in-patients-with-t1n0-triple-negative-breast-cancer-assuming-no-contraindications-to-taxanes-and-anthracyclines weekly 0.8 https://www.themednet.org/would-you-use-mammaprint-in-patients-with-triple-negative-or-her2-positive-breast-cancer-based-on-the-results-from-the-mindact-trial weekly 0.8 https://www.themednet.org/how-do-you-decide-on-the-modality-of-consolidative-treatment-after-a-cr-in-primary-cns-lymphoma-patients-treated-with-a-high-dose-methotrexate-regimen weekly 0.8 https://www.themednet.org/in-which-patients-would-you-recommend-extending-adjuvant-ai-based-therapy-beyond-5-years weekly 0.8 https://www.themednet.org/do-you-routinely-send-oncotype-dx-on-er-positive-tumors-with-node-positive-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-who-need-radiation-for-synchronous-locally-advanced-head-and-neck-cancer-and-locally-advanced-breast-cancer weekly 0.8 https://www.themednet.org/when-do-you-consider-local-therapies-i-e-tace-in-patients-with-intrahepatic-cholangiocarcinoma-who-do-not-tolerate-or-respond-to-chemothearpy-or-who-are-not-surgical-candidates weekly 0.8 https://www.themednet.org/do-you-consider-idiopathic-pulmonary-fibrosis-a-contraindication-to-lung-sbrt weekly 0.8 https://www.themednet.org/would-you-use-a-hippocampal-sparing-technique-when-treating-with-pci-for-a-limited-stage-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/when-tpn-is-a-barrier-to-enrollment-in-hospice-for-an-eligible-cancer-patient-with-an-irreversible-malignant-bowel-obstruction-how-do-you-approach-the-conversation-about-discontinuation-of-tpn weekly 0.8 https://www.themednet.org/how-would-you-treat-anal-cancer-in-a-patient-with-non-dialysis-dependent-severe-chronic-kidney-disease-that-precludes-the-use-of-cisplatin weekly 0.8 https://www.themednet.org/are-there-any-special-considerations-when-treating-a-patient-with-anal-cancer-who-has-poorly-managed-hiv-aids weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-widely-metastatic-clear-cell-rcc-who-has-undergone-craniotomy-resection-of-a-single-brain-metastasis weekly 0.8 https://www.themednet.org/how-do-you-approach-and-counsel-women-with-high-risk-early-stage-breast-cancer-requiring-chemotherapy-for-whom-fertility-preservation-is-a-major-concern weekly 0.8 https://www.themednet.org/how-do-you-contour-and-dose-definitive-crt-target-volumes-for-an-unresectable-nsclc-invading-vertebral-bodies weekly 0.8 https://www.themednet.org/do-you-recommend-treatment-of-the-entire-extent-of-the-hardware-and-or-bone-when-treating-a-bone-metastasis-that-has-received-pre-irradiation-surgical-stabilization weekly 0.8 https://www.themednet.org/in-a-patient-with-stage-iii-iv-p16-oropharyngeal-cancer-undergoing-definitive-crt-who-is-unable-to-maintain-nutrition-would-you-rather-consider-stopping-treatment-early-to-an-investigational-de-escalated-dose-or-insert-a-feeding-tube-take-treatment-breaks weekly 0.8 https://www.themednet.org/how-do-you-account-for-artifact-due-to-hardware-or-what-measures-do-you-take-to-optimize-planning-in-the-setting-of-a-post-operative-spine-sbrt-treatment weekly 0.8 https://www.themednet.org/does-p16-status-influence-your-decision-when-choosing-between-surgery-and-definitive-chemo-rt-for-head-and-neck-patients weekly 0.8 https://www.themednet.org/in-what-situations-should-chemotherapy-be-added-to-adjuvant-radiation-therapy-in-a-resected-vuvlar-scc weekly 0.8 https://www.themednet.org/when-would-you-feel-comfortable-with-patients-who-have-a-history-of-hormone-receptor-positive-breast-cancer-using-hormonal-iuds-e-g-mirena weekly 0.8 https://www.themednet.org/how-would-you-manage-positive-surgical-margins-after-partial-nephrectomy-for-kidney-cancer weekly 0.8 https://www.themednet.org/what-is-your-technique-for-simulating-and-treating-patients-who-have-difficulty-lying-fully-supine-due-to-shortness-of-breath-pain-or-other-symptoms-despite-optimal-medical-management weekly 0.8 https://www.themednet.org/how-do-you-treat-multi-focal-diffuse-non-melanomatous-skin-cancers-of-the-face-and-scalp-for-which-you-would-also-want-to-cover-high-risk-elective-nodes weekly 0.8 https://www.themednet.org/do-you-counsel-patients-on-the-very-small-risk-of-permanent-hair-loss-with-docetaxel weekly 0.8 https://www.themednet.org/should-the-use-of-a-brachytherapy-boost-affect-the-duration-or-use-of-adt-in-intermediate-or-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/when-would-you-consider-initial-induction-chemotherapy-e-g-folfox-followed-by-neoadjuvant-chemoradiation-over-neoadjuvant-chemoradiation-alone-in-patients-with-locally-advanced-rectal-cancer weekly 0.8 https://www.themednet.org/are-there-instances-where-you-prefer-an-sbrt-boost-rather-than-a-brachytherapy-boost-when-treating-definitive-locally-advanced-cervical-cancer weekly 0.8 https://www.themednet.org/can-we-ever-observe-newly-diagnosed-chronic-phase-cml-patients-and-not-immediately-start-them-on-therapy weekly 0.8 https://www.themednet.org/would-you-offer-radiation-to-an-elderly-patient-with-dcis-who-would-otherwise-not-meet-criteria-for-rtog-9804 weekly 0.8 https://www.themednet.org/is-there-a-role-for-a-salvage-lymph-node-dissection-in-patients-who-present-with-a-biochemical-failure-after-prostatectomy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-endocrine-therapy-in-hormone-receptor-positive-male-breast-cancers weekly 0.8 https://www.themednet.org/is-acute-pancreatitis-a-contraindication-to-radiotherapy-for-patients-with-pancreatic-cancer weekly 0.8 https://www.themednet.org/how-to-you-manage-radiation-brachial-plexopathy-in-head-neck-patients weekly 0.8 https://www.themednet.org/is-your-decision-to-treat-with-hypofractionated-radiation-impacted-by-histology-ie-lobular-vs-ductal-cancers weekly 0.8 https://www.themednet.org/do-you-time-initiation-of-definitive-radiation-on-psa-response-to-neoadjuvant-adt weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-a-finding-of-carcinosarcoma-in-a-prostatectomy-specimen weekly 0.8 https://www.themednet.org/do-you-ever-consider-intermittent-adt-for-metastatic-prostate-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-an-endometrial-cancer-with-no-or-minimal-myometrial-invasion-and-only-a-very-small-focus-of-disease-in-a-pelvic-node weekly 0.8 https://www.themednet.org/when-would-you-consider-local-ablative-therapy-e-g-sbrt-surgery-for-patients-with-oligometastatic-non-small-cell-lung-cancer-on-immunotherapy weekly 0.8 https://www.themednet.org/what-do-you-do-for-patients-who-require-radiation-for-breast-cancer-either-post-lumpectomy-or-post-mastectomy-but-who-have-a-pacemaker-on-the-ipsilateral-side weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-locally-advanced-triple-negative-breast-cancer-with-residual-disease-at-the-time-of-surgery weekly 0.8 https://www.themednet.org/how-do-you-treat-a-gist-tumor-with-pdgfra-exon-18-d842v-mutation weekly 0.8 https://www.themednet.org/how-do-you-approach-non-metastatic-castration-resistant-prostate-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-for-a-brachytherapy-boost-in-prostate-cancer-patients-with-extracapsular-extension weekly 0.8 https://www.themednet.org/is-there-a-preferred-neoadjuvant-chemotherapy-regimen-for-a-marginally-resectable-dedifferentiated-mdm2-liposarcoma weekly 0.8 https://www.themednet.org/do-you-routinely-treat-postoperative-extremity-soft-tissue-sarcoma-with-imrt weekly 0.8 https://www.themednet.org/now-that-there-are-three-fda-approved-parp-inhibitors-for-use-in-ovarian-cancer-niraparib-rucaparib-olaparib-how-do-you-decide-which-one-to-use weekly 0.8 https://www.themednet.org/what-heart-dose-constraint-should-be-used-when-treating-locally-advanced-nsclc weekly 0.8 https://www.themednet.org/how-does-your-treatment-of-lymph-nodes-change-for-a-breast-cancer-with-limited-2mm-vs-more-extensive-ece weekly 0.8 https://www.themednet.org/do-you-utilize-a-v80gy-dose-constraint-for-the-rectum-for-definitive-dose-escalated-rt-of-the-prostate weekly 0.8 https://www.themednet.org/how-would-you-manage-a-well-differentiated-neuroendocrine-cancer-without-a-known-primary-that-is-not-clearly-resectable-but-not-overtly-metastatic weekly 0.8 https://www.themednet.org/would-you-use-sbrt-in-patients-with-medically-inoperable-renal-cell-carcinoma weekly 0.8 https://www.themednet.org/does-a-very-high-oncotype-score-influence-your-approach-to-adjuvant-treatment-in-a-patient-with-er-positive-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-best-communicate-sbrt-planning-directives-specifically-in-regard-to-how-hot-the-plan-should-be weekly 0.8 https://www.themednet.org/for-untreated-patients-with-minimal-complaints-and-good-ps-with-metastatic-adenocarcinoma-positive-for-exon-21-l858r-mutation-how-do-you-choose-among-the-available-first-line-egfr-directed-therapies weekly 0.8 https://www.themednet.org/how-do-you-approach-small-bowel-constraints-in-the-setting-of-reirradiation weekly 0.8 https://www.themednet.org/is-it-necessary-to-treat-one-vertebral-body-above-and-below-for-palliation-of-spinal-metastases weekly 0.8 https://www.themednet.org/do-you-recommend-ovarian-suppression-in-all-premenopausal-women-under-age-35-with-er-positive-breast-cancer-based-on-the-soft-text-data-regardless-of-other-risk-features weekly 0.8 https://www.themednet.org/when-do-you-recommend-involving-neurosurgery-in-the-planning-of-srs-cases weekly 0.8 https://www.themednet.org/do-you-try-to-cover-the-entire-mastectomy-scar-with-pmrt-even-if-it-crosses-over-midline-to-contralateral-side weekly 0.8 https://www.themednet.org/do-you-treat-pelvic-lymph-nodes-in-patients-with-high-risk-prostate-cancer-who-refuse-adt weekly 0.8 https://www.themednet.org/how-do-you-choose-among-the-available-pd-1-pdl-1-inhibitors-approved-for-metastatic-bladder-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-dental-care-oral-hygiene-and-nutrition-in-patients-with-trismus weekly 0.8 https://www.themednet.org/for-early-stage-hr-her2-breast-cancers-when-do-you-use-oncotypedx-v-mammaprint weekly 0.8 https://www.themednet.org/when-would-you-recommend-adjuvant-radiation-following-cystectomy-for-urothelial-bladder-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-a-head-and-neck-cancer-patient-with-the-presence-of-high-grade-dysplasia-at-a-margin weekly 0.8 https://www.themednet.org/for-alk-patients-rendered-ned-from-oligometastatic-nsclc-after-resection-of-both-lung-primary-and-isolated-cns-lesion-do-you-consider-offering-treatment-with-an-alk-inhibitor-after-adjuvant-chemotherapy-or-do-you-place-into-surveillance weekly 0.8 https://www.themednet.org/how-would-you-approach-a-chronic-phase-cml-patient-who-is-responding-to-second-generation-tki-but-not-yet-in-molecular-remission-and-is-now-pregnant weekly 0.8 https://www.themednet.org/does-your-treatment-approach-for-nk-t-cell-lymphoma-of-the-nasal-cavity-differ-with-a-small-volume-of-disease-versus-a-large-volume weekly 0.8 https://www.themednet.org/what-is-the-optimal-duration-of-therapy-in-patients-with-metastatic-colon-cancer-with-no-evidence-of-disease weekly 0.8 https://www.themednet.org/for-primary-cns-lymphoma-when-do-you-refer-for-whole-brain-radiation-therapy-wbrt weekly 0.8 https://www.themednet.org/if-a-patient-with-myeloma-develops-a-symptomatic-dvt-or-pe-while-on-an-immunomodulatory-drug-such-as-lenalidomide-would-you-stop-the-imid weekly 0.8 https://www.themednet.org/what-is-your-recommended-radiation-field-for-early-stage-vulvar-cancer-with-persistent-positive-margins-t1a-t1b weekly 0.8 https://www.themednet.org/mindful-of-the-coming-approval-of-abemaciclib-how-would-you-decide-between-a-cdk-4-6-inhibitor-in-either-the-first-or-second-line-setting-in-hr-positive-her2-negative-postmenopausal-metastatic-breast-ca weekly 0.8 https://www.themednet.org/when-will-you-prescribe-3-v-6-months-of-folfox-or-xelox-for-the-adjuvant-treatment-of-colon-cancer weekly 0.8 https://www.themednet.org/if-a-patient-with-non-metastatic-prostate-cancer-is-found-to-have-a-brca-mutation-should-this-influence-treatment-recommendations-for-local-therapy weekly 0.8 https://www.themednet.org/in-which-patients-will-you-consider-a-shorter-course-of-adjuvant-herceptin weekly 0.8 https://www.themednet.org/what-approach-have-you-found-works-best-in-treating-persistent-acute-radiation-proctitis-in-patients-undergoing-pelvic-ebrt weekly 0.8 https://www.themednet.org/how-do-you-approach-an-out-of-field-intracranial-recurrence-for-a-gbm weekly 0.8 https://www.themednet.org/what-is-your-regimen-for-treating-a-keloid-with-radiation-alone weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-low-volume-non-invasive-endometrioid-carcinoma-that-is-found-in-both-the-endometrium-and-ovary-pn0 weekly 0.8 https://www.themednet.org/in-light-of-the-recent-results-from-stampede-and-latitude-to-which-patients-with-newly-diagnosed-metastatic-prostate-cancer-are-you-offering-up-front-abiraterone-vs-up-front-docetaxel weekly 0.8 https://www.themednet.org/how-would-you-treat-a-widely-metastatic-poorly-differentiated-pancreatic-neuroendocrine-cancer weekly 0.8 https://www.themednet.org/would-you-consider-a-third-course-of-radiation-to-the-same-site-for-late-lung-cancer-in-field-recurrence weekly 0.8 https://www.themednet.org/how-do-you-decide-between-initial-radiotherapy-vs-systemic-therapy-in-patients-with-metastatic-melanoma-and-brain-metastases weekly 0.8 https://www.themednet.org/is-breast-conservation-therapy-appropriate-for-mutation-carriers weekly 0.8 https://www.themednet.org/is-there-a-role-for-re-irradiation-of-a-recurrent-keloid weekly 0.8 https://www.themednet.org/do-you-add-a-platinum-agent-to-neoadjuvant-chemotherapy-for-triple-negative-breast-cancer-in-brca-1-2-mutation-carriers weekly 0.8 https://www.themednet.org/when-would-you-include-uninvolved-nodal-stations-when-treating-patients-with-locally-advanced-nsclc-with-definitive-crt weekly 0.8 https://www.themednet.org/are-the-conformality-constraints-still-important-when-organ-at-risk-constraints-are-met-for-lung-sbrt weekly 0.8 https://www.themednet.org/how-do-you-approach-srs-for-a-brain-metastasis-in-an-eloquent-area-of-the-brain weekly 0.8 https://www.themednet.org/do-you-make-any-adjustments-when-treating-cavitary-lung-lesions-with-sbrt weekly 0.8 https://www.themednet.org/what-is-the-role-of-liquid-biopsy-in-patients-with-metastatic-castration-resistant-prostate-cancer-to-asses-brca1-2-or-other-mutations-and-consider-parp-inhibitors weekly 0.8 https://www.themednet.org/what-factors-would-push-you-to-consider-using-imrt-vs-opposed-lateral-fields-for-a-t2n0-glottic-scc weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-to-patients-with-extremity-sarcoma-with-multiple-positive-regional-nodes weekly 0.8 https://www.themednet.org/how-do-you-approach-local-therapy-for-oligoprogression-of-metastatic-nsclc weekly 0.8 https://www.themednet.org/is-it-necessary-to-use-double-contrast-mri-for-treatment-planning-of-brain-srs weekly 0.8 https://www.themednet.org/is-there-a-benefit-to-metastatic-primary-site-rt-in-rms-w-persistent-marrow-disease weekly 0.8 https://www.themednet.org/if-a-patient-has-a-history-of-lumpectomy-and-adjuvant-radiation-and-then-develops-an-in-breast-recurrence-s-p-mastectomy-with-breast-only-disease-and-no-nodal-disease-would-you-re-irradiate-the-chest-wall weekly 0.8 https://www.themednet.org/are-there-any-situations-in-which-you-would-offer-brachytherapy-alone-instead-of-whole-pelvis-rt-brachytherapy-for-an-endometrial-cancer-vaginal-cuff-recurrence weekly 0.8 https://www.themednet.org/what-is-the-appropriate-dose-and-volume-for-adjuvant-treatment-of-a-sigmoid-colon-adenocarcinoma-adherent-to-the-l5-vertebral-body-with-a-positive-radial-margin weekly 0.8 https://www.themednet.org/given-the-sensitivity-and-prognostic-value-of-the-serum-free-light-chain-ratio-for-light-chain-multiple-myeloma-do-you-continue-to-check-urine-studies weekly 0.8 https://www.themednet.org/is-it-appropriate-to-re-consider-bladder-preservation-in-patients-with-bladder-muscle-invasive-cancer-t2-who-were-initially-poor-candidates-for-bp-multifocal-disease-etc-but-had-complete-response-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/is-sentinel-lymph-node-biopsy-several-weeks-after-partial-mastectomy-as-reliable-as-sentinel-lymph-node-biopsy-done-at-the-time-of-partial-mastectomy weekly 0.8 https://www.themednet.org/do-you-consider-msi-testing-for-mcrpc weekly 0.8 https://www.themednet.org/how-would-you-approach-metastatic-hepatocellular-cancer-with-neuroendocrine-features weekly 0.8 https://www.themednet.org/in-the-high-risk-adjuvant-or-metastatic-setting-when-you-initiate-patients-on-ovarian-suppression-with-the-plan-to-start-an-ai-what-protocol-do-you-follow-in-terms-of-rechecking-estradiol weekly 0.8 https://www.themednet.org/for-a-recurrent-medulloblastoma-in-the-posterior-fossa-several-years-after-initial-standard-risk-therapy-23-4-gy-csi-and-in-which-the-patient-is-still-less-than-18-how-would-you-approach-re-irradiation weekly 0.8 https://www.themednet.org/for-which-patients-is-frameless-gamma-knife-radiosurgery-most-appropriate weekly 0.8 https://www.themednet.org/how-long-do-you-continue-trastuzumab-and-pertuzumab-after-lumpectomy-if-you-included-both-in-a-neoadjuvant-regimen-such-as-tch-p weekly 0.8 https://www.themednet.org/how-do-you-plan-urgent-radiation-therapy-for-vaginal-bleeding-caused-by-locally-advanced-cervical-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-svc-syndrome-in-a-patient-who-cant-get-or-refuses-chemotherapy weekly 0.8 https://www.themednet.org/would-you-recommend-repeat-radiation-therapy-for-a-painful-perineal-recurrence-in-a-patient-who-failed-definitive-crt-and-recurred-again-after-salvage-abdominoperineal-resection-apr weekly 0.8 https://www.themednet.org/would-you-give-post-operative-radiation-for-a-pt1n0-parotid-low-grade-mucoepidermoid-carcinoma-with-positive-margin-on-the-facial-nerve-to-an-adolescent weekly 0.8 https://www.themednet.org/when-is-it-appropriate-to-recommend-a-diverting-colostomy-for-treatment-of-anal-cancer-or-low-lying-rectal-cancer weekly 0.8 https://www.themednet.org/would-you-consider-neoadjuvant-chemotherapy-for-patients-with-muscle-invasive-bladder-cancer-who-are-cisplatin-ineligible weekly 0.8 https://www.themednet.org/do-you-leave-the-tracheostomy-tube-in-place-or-take-it-out-during-each-head-and-neck-cancer-radiation-treatment weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-patients-with-base-of-skull-glomus-jugalare-tumors-paraganglioma weekly 0.8 https://www.themednet.org/is-srs-or-3-5-fraction-srt-appropriate-for-cystic-brain-metastases weekly 0.8 https://www.themednet.org/would-you-offer-immunotherapy-after-chemoradiotherapy-for-stage-iii-lung-cancer-given-results-of-pacific-trial weekly 0.8 https://www.themednet.org/what-is-your-protocol-for-conscious-sedation-during-t-o-insertion weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-recurrent-brain-mets-from-small-cell-lung-cancer-who-has-already-received-previous-whole-brain-radiotherapy-30-gy-in-10fx weekly 0.8 https://www.themednet.org/what-treatment-fields-do-you-use-for-n1mi-breast-cancer-after-lumpectomy-slnb weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-small-mutli-focal-gastric-net weekly 0.8 https://www.themednet.org/do-you-offer-consolidative-thoracic-radiotherapy-to-patients-with-extensive-stage-sclc-who-have-a-complete-response-to-chemotherapy weekly 0.8 https://www.themednet.org/what-is-the-preferred-agent-for-metastatic-male-breast-cancer-patient-who-progresses-on-tamoxifen-and-is-not-a-candidate-for-chemotherapy weekly 0.8 https://www.themednet.org/which-normal-brain-dosimetric-constraints-are-most-important-when-treating-brain-mets-with-srs weekly 0.8 https://www.themednet.org/what-is-your-palliative-radiation-approach-to-larger-volume-locoregional-head-and-neck-scc-recurrences weekly 0.8 https://www.themednet.org/given-more-restrictions-on-later-line-parp-inhibitor-use-for-patients-by-brca-status-would-you-consider-repeat-biopsy-with-somatic-testing-to-identify-candidates-for-second-line-maintenance-therapy-following-platinum-treatment-for-a-patient-who-is-gbrcawt weekly 0.8 https://www.themednet.org/what-clinicopathologic-features-do-you-consider-when-deciding-whether-or-not-to-proceed-a-pmrt-scar-boost weekly 0.8 https://www.themednet.org/how-do-you-follow-patients-after-sbrt-for-nsclc weekly 0.8 https://www.themednet.org/would-you-give-pmrt-to-a-young-woman-with-a-t1-2-breast-cancer-with-a-micromet-on-slnb weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-cervical-scc-patient-in-which-youre-unable-to-properly-place-a-t-o-due-to-obliterated-cervical-os-after-completion-of-ebrt weekly 0.8 https://www.themednet.org/would-you-consider-a-trial-of-pembrolizumab-in-a-patient-with-metastatic-urothelial-carcinoma-progressing-on-atezolizumab weekly 0.8 https://www.themednet.org/what-sbrt-dose-and-constraints-would-you-use-for-a-primary-endobronchial-nsclc-that-is-too-thick-for-brachytherapy weekly 0.8 https://www.themednet.org/how-does-radiation-to-the-breast-in-a-lactating-woman-affect-milk-production weekly 0.8 https://www.themednet.org/what-is-your-strategy-and-evidence-to-use-hyperthermia-and-or-chemotherapy-with-radiation-for-recurrent-breast-cancer weekly 0.8 https://www.themednet.org/would-you-do-srs-for-a-patient-who-cannot-receive-gadolinium-contrast-and-has-a-single-brain-metastasis-on-non-contrast-mri weekly 0.8 https://www.themednet.org/when-a-patient-with-stage-iiia-nsclc-is-treated-with-induction-chemotherapy-alone-followed-by-surgery-and-has-a-pcr-do-you-offer-post-operative-rt-based-on-pre-chemo-findings-or-omit-due-to-complete-response weekly 0.8 https://www.themednet.org/do-you-prescribe-prophylactic-steroids-with-spine-sbrt weekly 0.8 https://www.themednet.org/how-do-you-approach-adaptive-planning-in-lung-cancer weekly 0.8 https://www.themednet.org/what-dose-and-fields-would-you-use-to-treat-a-low-grade-cns-lymphoma-that-presents-as-an-isolated-single-mass-in-the-brain weekly 0.8 https://www.themednet.org/would-you-offer-radiation-to-the-contralateral-breast-if-after-neo-adjuvant-chemo-and-prophylactic-contralateral-mastectomy-yielded-itc-only-in-a-single-lymph-node-and-no-breast-primary weekly 0.8 https://www.themednet.org/which-chemotherapy-regimen-do-you-prefer-for-concurrent-treatment-with-radiation-therapy-for-anal-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/what-data-is-there-for-using-srs-to-treat-more-than-3-lesions weekly 0.8 https://www.themednet.org/when-is-it-appropriate-to-use-adjuvant-whole-pelvis-radiotherapy-for-stage-i-endometrial-adenocarcinoma weekly 0.8 https://www.themednet.org/is-it-safe-to-give-localized-palliative-spinal-radiation-with-concurrent-intrathecal-cytarabine-if-so-do-doses-need-to-be-adjusted weekly 0.8 https://www.themednet.org/is-there-any-data-to-support-the-use-of-hormone-therapy-with-rt-in-the-adjuvant-post-prostatectomy-setting weekly 0.8 https://www.themednet.org/what-is-the-overall-goal-of-themednet weekly 0.8 https://www.themednet.org/whats-the-safest-way-to-hypofractionate-treatment-for-prostate-cancer weekly 0.8 https://www.themednet.org/for-patients-with-high-risk-prostate-cancer-is-there-data-to-support-prostatectomy-as-opposed-to-upfront-rt weekly 0.8 https://www.themednet.org/how-should-i-interpret-a-gleason-7-prostate-cancer-4-3-or-3-4-with-tertiary-grade-5 weekly 0.8 https://www.themednet.org/what-is-your-institutions-active-surveillance-protocol weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-who-failed-cryotherapy weekly 0.8 https://www.themednet.org/if-a-daily-conebeam-ct-is-done-for-prostate-cancer-treatments-do-you-subtract-any-treatment-fractions-to-compensate-for-the-daily-imaging-dose weekly 0.8 https://www.themednet.org/what-is-your-technique-for-ct-and-mri-fusion-for-external-beam-prostate-planning weekly 0.8 https://www.themednet.org/do-the-number-of-lymph-nodes-removed-in-a-non-stage-ia-figo-1-endometrial-cancer-case-affect-your-decision-for-wprt-v-vaginal-brachytherapy-alone weekly 0.8 https://www.themednet.org/with-vaginal-cuff-brachytherapy-do-you-treat-to-the-surface-or-a-depth-and-why weekly 0.8 https://www.themednet.org/how-is-my-home-page-generated weekly 0.8 https://www.themednet.org/how-do-i-follow-a-topic weekly 0.8 https://www.themednet.org/how-do-i-see-all-the-questions-posted-for-a-topic weekly 0.8 https://www.themednet.org/what-happens-when-i-specify-a-particular-expert-to-answer-my-question weekly 0.8 https://www.themednet.org/will-opinion-leaders-really-answer-my-questions weekly 0.8 https://www.themednet.org/who-moderates-themednet weekly 0.8 https://www.themednet.org/how-can-i-contact-the-editors weekly 0.8 https://www.themednet.org/how-does-themednet-make-money-to-support-itself weekly 0.8 https://www.themednet.org/why-did-you-decide-to-create-themednet weekly 0.8 https://www.themednet.org/how-do-i-edit-one-of-my-answers weekly 0.8 https://www.themednet.org/how-often-should-you-re-plan-interstitial-brachytherapy-for-gynecologic-malignancies weekly 0.8 https://www.themednet.org/what-instructions-do-you-give-patients-to-optimize-bladder-filling-and-rectal-emptying-for-gu-and-gyn-simulation-and-treatment weekly 0.8 https://www.themednet.org/what-is-your-strategy-to-deliver-ebrt-brachytherapy-and-a-parametria-lymph-node-boost-in-less-than-7-8-weeks-for-cervical-cancer weekly 0.8 https://www.themednet.org/is-there-a-role-for-pet-ct-in-pancreatic-cancer-staging-or-treatment-planning weekly 0.8 https://www.themednet.org/whats-the-worst-advice-you-received-as-a-young-attending weekly 0.8 https://www.themednet.org/do-you-ever-give-postoperative-chemoradiation-in-patients-who-underwent-preoperative-chemotherapy-for-gastric-adencocarcinoma weekly 0.8 https://www.themednet.org/do-you-stage-and-treat-ge-junction-tumors-like-gastric-or-esophageal-cancer weekly 0.8 https://www.themednet.org/should-i-use-pet-ct-for-ge-junction-treatment-planning weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-to-treat-the-supraclavicular-region-in-women-with-t1-2-disease-breast-cancer-and-1-3-positive-lymph-nodes weekly 0.8 https://www.themednet.org/is-irradiation-of-the-supraclavicular-and-internal-mammary-lymph-nodes-now-considered-the-standard-of-care-in-women-with-node-positive-breast-cancer weekly 0.8 https://www.themednet.org/is-post-mastectomy-radiation-required-in-patients-with-ct2n1-breast-cancer-who-undergo-neoadjuvant-chemotherapy-and-are-then-found-to-have-negative-lymph-nodes-at-the-time-of-mastectomy weekly 0.8 https://www.themednet.org/in-the-absence-of-other-risk-factors-do-you-treat-the-regional-lymph-nodes-in-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/which-patients-with-dcis-can-be-observed-following-lumpectomy weekly 0.8 https://www.themednet.org/if-a-pet-ct-scan-is-positive-for-mediastinal-lymph-node-involvement-is-a-mediastinoscopy-or-ebus-still-required-for-nsclc-staging weekly 0.8 https://www.themednet.org/what-kind-of-motion-control-do-you-use-when-treating-lung-cancer weekly 0.8 https://www.themednet.org/what-do-you-consider-is-an-acceptable-surgical-margin-for-invasive-breast-cancer weekly 0.8 https://www.themednet.org/how-much-do-you-deflate-a-tissue-expander-prior-to-beginning-post-mastectomy-irradiation weekly 0.8 https://www.themednet.org/what-is-the-best-imaging-study-to-differentiate-between-recurrent-glioblastoma-and-pseudoprogression weekly 0.8 https://www.themednet.org/do-you-include-the-dural-tail-when-treating-benign-meningioma-with-srs weekly 0.8 https://www.themednet.org/what-is-the-biggest-mistake-people-make-when-performing-lung-sbrt weekly 0.8 https://www.themednet.org/what-is-the-role-of-a-radiation-oncologist-in-a-nuclear-disaster weekly 0.8 https://www.themednet.org/what-dose-constraint-do-you-use-for-the-female-urethra-in-gynecologic-brachytherapy weekly 0.8 https://www.themednet.org/what-is-the-biggest-mistake-people-make-when-using-imrt-to-treat-cervical-cancer weekly 0.8 https://www.themednet.org/what-lessons-can-we-learn-from-rtog-0418-in-how-to-best-use-imrt-to-treat-endometrial-cancer weekly 0.8 https://www.themednet.org/do-radiation-oncology-missions-to-developing-countries-actually-provide-a-means-for-sustainable-cancer-care weekly 0.8 https://www.themednet.org/what-dose-do-you-use-in-the-adjuvant-treatment-of-desmoid-tumors weekly 0.8 https://www.themednet.org/is-it-acceptable-to-treat-pediatric-hodgkins-lymphoma-with-an-involved-nodal-field-outside-the-setting-of-a-clinical-trial weekly 0.8 https://www.themednet.org/is-it-preferable-to-simulate-pediatric-hodgkins-lymphoma-patients-with-arms-up-or-akimbo weekly 0.8 https://www.themednet.org/is-it-safe-to-re-irradiate-the-pelvis-after-definitive-prostate-brachytherapy weekly 0.8 https://www.themednet.org/what-is-the-likelihood-of-a-successful-pregnancy-following-pelvic-irradiation weekly 0.8 https://www.themednet.org/what-is-the-appropriate-dose-of-radiation-for-a-primary-osseous-non-hodgkins-lymphoma weekly 0.8 https://www.themednet.org/do-hiv-aids-patients-with-prostate-cancer-have-increased-radiation-toxicity weekly 0.8 https://www.themednet.org/is-it-safe-to-give-thoracic-irradiation-to-a-patient-with-lung-cancer-previously-treated-with-a-vegf-inhibitor weekly 0.8 https://www.themednet.org/what-happens-when-i-click-on-the-helpful-or-agree-button weekly 0.8 https://www.themednet.org/what-is-the-difference-between-involved-node-and-involved-site-irradiation weekly 0.8 https://www.themednet.org/is-it-time-to-start-incorporating-involved-site-irradiation-for-all-lymphomas weekly 0.8 https://www.themednet.org/after-pelvic-irradiation-how-often-do-you-recommend-that-female-patients-use-a-vaginal-dilator-and-for-how-long weekly 0.8 https://www.themednet.org/is-there-any-role-for-post-mastectomy-radiation-in-the-setting-of-n1mic-axillary-disease weekly 0.8 https://www.themednet.org/if-a-patient-with-locally-advanced-cervical-cancer-cannot-receive-brachytherapy-following-45gy-to-the-whole-pelvis-how-do-you-optimally-deliver-your-boost weekly 0.8 https://www.themednet.org/what-fractionation-and-dose-constraints-do-you-use-for-prostate-sbrt weekly 0.8 https://www.themednet.org/is-there-any-data-to-support-radiation-and-targeted-agents-braf-inhibitor-or-ipilimumab-combined-for-stage-iii-melanoma weekly 0.8 https://www.themednet.org/in-a-low-volume-prostate-cancer-2-of-12-cores-low-percentage-with-a-gs-4-4-8-how-long-does-adt-need-to-be-administered weekly 0.8 https://www.themednet.org/should-nodal-fields-be-added-to-post-mastectomy-radiation-treatment-after-neo-adjuvant-chemotherapy-if-there-is-a-cr-in-the-nodes weekly 0.8 https://www.themednet.org/can-you-observe-low-grade-follicular-lymphoma-if-the-involved-node-s-have-been-surgically-removed weekly 0.8 https://www.themednet.org/what-is-the-best-treatment-dose-and-fractionation-for-wbrt-in-a-patient-who-has-numerous-brain-mets-and-previously-received-pci-with-25gy-10fx-for-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/can-i-answer-my-own-question-on-themednet weekly 0.8 https://www.themednet.org/do-you-treat-neck-nodes-electively-in-transglottic-bulky-t2n0-laryngeal-cancers weekly 0.8 https://www.themednet.org/should-i-decline-to-treat-a-patient-with-a-first-site-of-metastasis-who-refuses-a-biopsy weekly 0.8 https://www.themednet.org/in-sbrt-for-lung-tumors-does-monte-carlo-dose-calculation-algorithm-versus-aaa-dose-calculation-give-a-better-representation-of-lung-target-dose-and-normal-tissue-dose weekly 0.8 https://www.themednet.org/how-do-you-best-palliate-metastatic-skin-and-subcutaneous-melanoma-lesions weekly 0.8 https://www.themednet.org/what-does-it-mean-when-i-follow-someone weekly 0.8 https://www.themednet.org/who-can-join-themednet weekly 0.8 https://www.themednet.org/has-pelvic-mri-replaced-eus-as-the-standard-of-care-for-rectal-cancer-staging weekly 0.8 https://www.themednet.org/is-imrt-preferred-over-3d-conformal-rt-for-lymphoma-of-the-head-and-neck weekly 0.8 https://www.themednet.org/what-is-the-best-treatment-for-a-medically-inoperable-endometrial-adenocarcinoma-of-the-uterus-figo-1-grade-1-type-1 weekly 0.8 https://www.themednet.org/how-do-you-treat-locally-advanced-medullary-thyroid-cancer-with-postoperative-rt weekly 0.8 https://www.themednet.org/is-svc-syndrome-a-medical-emergency weekly 0.8 https://www.themednet.org/once-endometrial-cancer-recurs-after-no-chemo-or-xrt-is-it-curative-or-palliative weekly 0.8 https://www.themednet.org/in-light-of-the-2-negative-bevacizumab-trials-for-up-front-gbm-how-do-you-feel-about-the-future-of-bevacizumab-in-gbm weekly 0.8 https://www.themednet.org/how-do-you-manage-grade-iii-oligodendroglioma weekly 0.8 https://www.themednet.org/how-many-ptvs-and-what-doses-do-you-utilize-for-a-ct3n0m0-squamous-cell-carcinoma-of-the-larynx-receiving-definitive-concurrent-chemoradiation weekly 0.8 https://www.themednet.org/how-were-decisions-made-about-what-dose-constraints-to-use-in-the-recent-rtog-protocols-for-lung-sbrt weekly 0.8 https://www.themednet.org/do-you-cover-vasogenic-edema-surrounding-the-gtv-when-treating-brain-metastasis-with-srs weekly 0.8 https://www.themednet.org/what-is-the-appropriate-dose-for-a-patient-with-recurrent-vulva-vin-iii weekly 0.8 https://www.themednet.org/in-treating-with-total-body-irradiation-how-should-the-lung-blocks-be-drawn-and-what-dose-should-the-lung-receive weekly 0.8 https://www.themednet.org/what-is-the-role-in-your-clinic-for-chest-imaging-in-head-and-neck-cancer-patients-who-are-free-of-local-disease-1-years-after-treatment weekly 0.8 https://www.themednet.org/how-do-you-contour-distal-esophageal-cancer-in-the-postop-setting-after-ivor-lewis-pt3n3-perigastric-and-periesophageal-ln weekly 0.8 https://www.themednet.org/when-is-it-appropriate-to-use-sbrt-in-treating-lung-metastases-oligomet-up-to-3-mets-etc weekly 0.8 https://www.themednet.org/if-one-decides-to-use-a-mpmri-to-stage-a-pt-with-low-risk-prostate-cancer-how-do-you-work-up-a-focal-lesion-suspicious-for-higher-grade-gs-7-10-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-for-a-locally-advanced-stage-iva-secondary-to-n2-disease-in-the-neck-hpv-negative-squamous-cell-carcinoma-of-the-base-of-tongue-in-a-patient-without-significant-comorbidities weekly 0.8 https://www.themednet.org/when-do-you-spare-constrictors-in-head-and-neck-treatment-planning weekly 0.8 https://www.themednet.org/what-clinical-factors-help-you-to-determine-whether-or-not-a-patient-is-an-appropriate-candidate-for-spine-srs-sbrt-in-the-setting-of-metastatic-disease weekly 0.8 https://www.themednet.org/how-do-you-stereotactically-treat-brain-metastases-greater-than-3-cm-additional-brain-mets weekly 0.8 https://www.themednet.org/how-do-you-manage-squamous-cell-carcinoma-in-situ-of-the-anus weekly 0.8 https://www.themednet.org/should-cn0-oral-cavity-cancers-that-are-completely-resected-but-have-indications-for-rt-ever-receive-elective-nodal-rt weekly 0.8 https://www.themednet.org/what-are-you-posterior-field-borders-for-endometrial-and-cervical-cancer-3dcrt-plans weekly 0.8 https://www.themednet.org/is-there-data-to-suggest-that-definitive-chemoradiation-to-70gy-vs-postoperative-chemoradiation-to-60-or-66gy-has-any-different-clinically-significant-effects-on-long-term-swallowing-function-and-other-side-effects-of-h-n-cancer-treatment weekly 0.8 https://www.themednet.org/what-is-the-best-management-for-a-local-recurrence-for-a-stage-i-nsclc-treated-previously-with-sbrt weekly 0.8 https://www.themednet.org/in-srs-treatment-planning-can-a-dosimetrist-take-the-place-of-a-medical-physicist weekly 0.8 https://www.themednet.org/what-volumes-do-you-treat-for-isrt-for-extranodal-dlbcl weekly 0.8 https://www.themednet.org/how-do-you-manage-parathyroid-carcinomas-with-positive-microscopic-margins weekly 0.8 https://www.themednet.org/to-what-dose-do-you-treat-enlarged-but-pet-negative-lymph-nodes-in-laryngeal-scc weekly 0.8 https://www.themednet.org/for-patients-with-laryngeal-cancer-about-to-start-chemort-who-have-a-narrow-airway-on-imaging-but-are-asymptomatic-without-any-stridor-or-shortness-of-breath-do-you-take-any-precautions-to-prevent-airway-obstruction-secondary-to-radiation-induced-edema weekly 0.8 https://www.themednet.org/should-prophylactic-breast-radiotherapy-still-be-practiced-for-patients-with-prostate-cancer-taking-bicalutamide weekly 0.8 https://www.themednet.org/what-is-the-best-management-of-an-unruptured-spetzler-martin-grade-3-arteriovenous-malformation-in-a-young-patient weekly 0.8 https://www.themednet.org/do-you-give-chemotherapy-for-focal-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/do-you-give-trastuzumab-to-women-with-small-lymph-node-negative-her2-positive-breast-cancer weekly 0.8 https://www.themednet.org/how-do-i-insert-a-link-into-my-answer weekly 0.8 https://www.themednet.org/do-you-offer-postoperative-radiotherapy-to-patients-with-stage-i-ii-small-cell-lung-cancer-after-complete-resection weekly 0.8 https://www.themednet.org/for-cutaneous-scc-of-the-cheek-with-microscopic-pni-which-nodal-levels-if-any-do-you-prophylactically-treat weekly 0.8 https://www.themednet.org/should-n1a-breast-cancer-patients-with-positive-intramammary-node-metastases-but-negative-axillary-sentinel-node-biopsy-receive-adjuvant-post-mastectomy-radiation weekly 0.8 https://www.themednet.org/is-local-failure-following-sabr-higher-then-previously-thought weekly 0.8 https://www.themednet.org/would-you-treat-radio-graphically-positive-pelvic-lymph-nodes-when-palliating-a-patient-with-metastatic-patient-prostate-cancer-and-obstructive-symptoms weekly 0.8 https://www.themednet.org/how-do-you-counsel-young-women-who-want-to-become-pregnant-after-breast-radiotherapy weekly 0.8 https://www.themednet.org/what-is-the-treatment-volume-for-primary-breast-lymphoma weekly 0.8 https://www.themednet.org/what-role-does-external-beam-radiotherapy-play-in-the-treatment-of-well-differentiated-papillary-thyroid-cancer-when-a-total-thyroidectomy-and-lymph-node-dissection-cannot-be-performed weekly 0.8 https://www.themednet.org/for-a-ge-junction-tumor-with-a-lymph-node-distant-from-the-primary-site-would-the-treatment-volume-be-contiguous weekly 0.8 https://www.themednet.org/what-is-your-advice-to-patients-who-ask-if-dental-x-rays-correlate-with-oral-oropharyngeal-cancer weekly 0.8 https://www.themednet.org/in-patients-with-early-stage-follicular-lymphoma-undergoing-definitive-rt-do-you-approach-grade-3a-disease-any-differently-than-grade-1-2-radiation-dose-fields-margins-systemic-therapy weekly 0.8 https://www.themednet.org/what-is-the-appropriate-treatment-for-marginal-zone-lymphoma-of-the-parotid-following-surgery weekly 0.8 https://www.themednet.org/would-you-use-sbrt-to-treat-a-lipoma-of-the-spine-that-recurred-twice-after-surgery weekly 0.8 https://www.themednet.org/what-field-and-dose-would-you-prescribe-for-a-an-extra-renal-rhabdoid-tumor-of-the-pelvis weekly 0.8 https://www.themednet.org/what-is-the-best-treatment-volume-and-dose-for-a-marginal-zone-orbital-lymphoma weekly 0.8 https://www.themednet.org/is-there-a-role-for-elective-para-aortic-nodal-irradiation-in-endometrial-cancer weekly 0.8 https://www.themednet.org/what-are-your-current-recommendations-for-treatment-of-symptomatic-splenomegaly-in-the-setting-of-myelofibrosis-when-splenectomy-is-not-an-option weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-inoperable-mucosal-melanoma-of-the-head-and-neck-region weekly 0.8 https://www.themednet.org/what-is-the-role-of-radiation-consolidation-after-chemotherapy-for-residual-splenic-involvement-in-follicular-lymphoma weekly 0.8 https://www.themednet.org/in-evaluating-v20-for-lung-rt-how-should-the-lung-volume-be-defined weekly 0.8 https://www.themednet.org/is-there-a-role-for-anti-pd-1-checkpoint-inhibitors-or-other-immunotherapies-with-radiation weekly 0.8 https://www.themednet.org/what-is-the-best-radiation-dose-to-treat-primary-cutaneous-b-cell-lymphoma weekly 0.8 https://www.themednet.org/for-t4a-bladder-cancer-only-involving-the-prostatic-stroma-and-no-bladder-involvement-what-is-your-final-cone-down-volume weekly 0.8 https://www.themednet.org/what-are-your-criteria-for-treating-a-patient-with-lung-sbrt-in-the-absence-of-a-biopsy weekly 0.8 https://www.themednet.org/what-is-the-evidence-that-we-should-do-anything-different-in-breast-cancer-patients-with-1-to-3-nodes-involved-versus-those-with-four-or-more-nodes-involved weekly 0.8 https://www.themednet.org/do-you-recommend-treating-the-chest-tube-site-or-pleural-biopsy-tract-in-patients-receiving-rt-for-malignant-pleural-mesothelioma weekly 0.8 https://www.themednet.org/for-which-patients-with-localized-prostate-cancer-is-sbrt-an-alternate-standard-of-care weekly 0.8 https://www.themednet.org/in-stage-i-ii-primary-mediastinal-b-cell-lymphoma-pmbl-bulky-or-non-bulky-is-post-chemotherapy-radiotherapy-still-standard-in-patients-with-a-complete-response-to-chop-r-chemotherapy weekly 0.8 https://www.themednet.org/should-all-gists-be-sequenced weekly 0.8 https://www.themednet.org/in-what-situations-would-you-consider-starting-zoledronic-acid-in-an-adjuvant-setting-for-a-woman-with-t2n0-hormone-positive-breast-cancer weekly 0.8 https://www.themednet.org/do-you-ever-offer-neoadjuvant-endocrine-therapy-to-pre-menopausal-women weekly 0.8 https://www.themednet.org/for-which-patients-with-stage-ia-nonsurgically-staged-endometriod-cancer-would-you-add-pelvic-rt weekly 0.8 https://www.themednet.org/is-post-mastectomy-radiation-therapy-indicated-based-only-on-pre-chemo-mri-and-pet-ct-positive-axillary-lymphadenopathy-if-surgery-following-neoadjuvant-chemo-showed-cr weekly 0.8 https://www.themednet.org/regarding-regional-nodal-irradiation-for-triple-positive-breast-cancers-how-much-do-you-weigh-in-the-availability-of-effective-adjuvant-systemic-therapies-i-e-hormonal-and-anti-her2-therapy-in-theory-being-able-to-control-subclinical-nodal-disease-without weekly 0.8 https://www.themednet.org/in-a-patient-with-history-of-early-stage-oral-cavity-cancer-and-a-new-ipsilateral-neck-failure-would-you-treat-the-initial-site-of-disease weekly 0.8 https://www.themednet.org/when-should-patients-with-metastatic-melanoma-be-referred-for-treatment-at-an-academic-center weekly 0.8 https://www.themednet.org/is-it-appropriate-to-treat-patients-with-limited-metastases-with-whole-brain-radiotherapy-and-a-concurrent-simultaneous-integrated-boost weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-egfr-mutant-adenocarcinoma-of-the-lung-on-erlotinib-with-a-single-site-of-disease-progression-but-otherwise-well-controlled-disease weekly 0.8 https://www.themednet.org/is-there-a-role-for-radiation-in-the-treatment-of-superficial-non-muscle-invasive-bladder-cancer weekly 0.8 https://www.themednet.org/what-is-the-optimal-dose-and-fractionation-of-rt-for-a-t2n0-laryngeal-scc weekly 0.8 https://www.themednet.org/how-do-you-effectively-spare-the-medial-rp-nodes-and-superior-constrictors-when-you-contour-the-bilateral-rp-nodes-and-place-a-3-5-mm-ctv-to-ptv-expansion weekly 0.8 https://www.themednet.org/what-size-cut-off-do-you-suggest-for-the-safe-administration-of-srs-in-the-setting-of-brain-metastases weekly 0.8 https://www.themednet.org/how-do-you-take-tumor-seeding-into-account-when-staging-nsclc weekly 0.8 https://www.themednet.org/do-you-treat-the-contralateral-rp-nodes-up-to-the-base-of-skull-in-a-node-negative-neck-if-the-primary-tumor-involves-any-hypopharyngeal-subsite weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-choice-for-gbm-that-crosses-the-corpus-callosum weekly 0.8 https://www.themednet.org/do-you-make-any-distinction-or-have-any-special-consideration-when-considering-a-patient-for-hypofractionation-for-left-versus-right-breast-cancer weekly 0.8 https://www.themednet.org/is-stage-n2a-alone-an-indication-for-port-in-oropharyngeal-squamous-cell-carcinoma-with-no-other-adverse-features weekly 0.8 https://www.themednet.org/is-it-possible-to-palliate-presacral-recurrences-of-rectal-cancer-in-patients-who-previously-received-neoadjuvant-chemoradiation-to-the-rectum weekly 0.8 https://www.themednet.org/in-post-op-rt-for-head-and-neck-cancer-with-a-close-or-positive-margin-is-there-data-suggesting-that-66-gy-at-2-gy-per-fraction-provides-better-local-control-than-63-gy-at-1-8-gy-per-fraction weekly 0.8 https://www.themednet.org/what-is-the-best-radiation-technique-for-treating-kaposi-sarcoma-involving-the-irregular-surfaces-of-the-toes-and-soles-of-the-feet weekly 0.8 https://www.themednet.org/what-mutational-testing-is-considered-the-standard-of-care-for-nsclc weekly 0.8 https://www.themednet.org/do-you-treat-pre-or-post-chemotherapy-nodal-volumes-on-a-patient-with-nsclc-following-induction-chemotherapy weekly 0.8 https://www.themednet.org/what-dose-and-expansion-of-gtv-is-recommended-for-a-low-grade-glioma weekly 0.8 https://www.themednet.org/how-do-you-approach-lung-tumors-with-vessel-encasement-especially-in-someone-with-active-hemoptysis weekly 0.8 https://www.themednet.org/how-are-the-long-term-results-of-rtog-9802-being-incorporated-into-practice-in-the-treatment-of-high-risk-low-grade-gliomas weekly 0.8 https://www.themednet.org/is-there-a-role-for-consolidation-radiation-in-a-patient-with-stage-i-low-grade-follicular-lymphoma-treated-with-chemotherapy weekly 0.8 https://www.themednet.org/for-meningiomas-causing-symptoms-such-as-headaches-what-percentage-of-patients-experience-improvement-of-symptoms-after-radiation-alone weekly 0.8 https://www.themednet.org/what-dose-do-you-feel-comfortable-treating-the-entire-circumference-of-an-extremity-to-before-you-are-concerned-about-chronic-toxicity weekly 0.8 https://www.themednet.org/how-do-you-manage-cranial-radiotherapy-in-the-setting-of-an-acute-cva weekly 0.8 https://www.themednet.org/for-patients-with-stage-1a-e-extra-nodal-marginal-zone-lymphoma-that-has-been-completely-excised-would-you-still-consider-radiation weekly 0.8 https://www.themednet.org/how-do-you-determine-whether-to-offer-whole-lung-radiation-to-children-with-favorable-histology-wilms-lung-metastases-and-a-cr-on-chemo-without-knowledge-of-1p16q-status-as-per-the-aren0533-protocol weekly 0.8 https://www.themednet.org/does-the-rta-proposed-legislation-that-would-remove-technical-payments-for-freestanding-radiation-oncology-centers-from-the-medicare-physician-fee-schedule-help-or-hurt-radiation-oncologists-in-a-freestanding-center weekly 0.8 https://www.themednet.org/does-the-presence-of-multiple-positive-intramammary-lymph-nodes-in-the-setting-of-negative-sentinel-lymph-nodes-cause-you-to-treat-regional-lymphatics weekly 0.8 https://www.themednet.org/what-rt-margins-do-you-use-when-treating-grade-iii-anaplastic-gliomas weekly 0.8 https://www.themednet.org/what-is-the-most-accurate-method-to-determine-initial-tumor-size-prior-to-neoadjuvant-chemotherapy-and-mastectomy weekly 0.8 https://www.themednet.org/should-patients-with-muscle-invasive-node-negative-bladder-cancer-wishing-to-have-bladder-preservation-receive-chemort-alone-or-neoadjuvant-chemotherapy-followed-by-chemort weekly 0.8 https://www.themednet.org/do-you-re-irradiate-for-heterotropic-ossification-in-patients-who-re-develop-ossifications weekly 0.8 https://www.themednet.org/in-what-situations-do-you-routinely-use-posterior-axillary-boost-pab-for-breast-cancer-radiotherapy weekly 0.8 https://www.themednet.org/can-the-addition-of-posterior-axillary-boost-pab-for-breast-cancer-increase-the-risk-of-brachial-plexopathy weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-early-stage-breast-cancer-with-autoimmune-disorders-such-as-rheumatoid-arthritis-and-collagen-vascular-disorders weekly 0.8 https://www.themednet.org/how-are-patients-on-anticoagulation-managed-in-the-context-of-intracranial-srs weekly 0.8 https://www.themednet.org/would-accelerated-hypofractionated-whole-breast-irradiation-therapy-be-contraindicated-in-a-patient-opting-for-breast-conservation-in-the-setting-of-breast-implants weekly 0.8 https://www.themednet.org/when-treating-with-chemo-rt-for-bladder-cancer-how-concerned-are-you-with-small-bowel-dose-constraints-when-boosting-the-bladder-to-60-gy weekly 0.8 https://www.themednet.org/do-you-omit-consolidative-rt-in-pediatric-patients-with-intermediate-risk-non-bulky-hodgkin-lymphoma-who-have-a-rapid-early-response-to-chemotherapy weekly 0.8 https://www.themednet.org/for-post-op-h-n-cancers-do-you-get-ct-neck-with-contrast-prior-to-sim weekly 0.8 https://www.themednet.org/how-do-you-manage-a-peripheral-nsclc-and-a-single-positive-contralateral-lymph-node weekly 0.8 https://www.themednet.org/is-weekly-cisplatin-considered-a-valid-alternative-to-cisplatin-cycles-every-3-weeks-as-part-of-definitive-chemo-radiation-for-muscle-invasive-bladder-cancer weekly 0.8 https://www.themednet.org/for-elderly-patients-with-locally-advanced-rectal-cancer-who-are-not-candidates-for-surgery-or-chemotherapy-what-would-be-an-appropriate-palliative-regimen weekly 0.8 https://www.themednet.org/what-is-the-best-approach-to-management-of-newly-diagnosed-intermediate-or-high-risk-prostate-cancer-in-a-patient-with-high-grade-non-muscle-invasive-bladder-cancer weekly 0.8 https://www.themednet.org/for-breast-cancer-patients-requiring-staging-should-one-order-a-ct-c-a-p-bone-scan-or-pet-scan weekly 0.8 https://www.themednet.org/what-dose-do-you-typically-use-when-retreating-locally-aggressive-and-recurrent-sccs-of-the-scalp-with-no-regional-or-distant-mets weekly 0.8 https://www.themednet.org/when-performing-imrt-treatment-planning-for-head-and-neck-cancer-how-do-you-instruct-your-dosimetrists-to-manage-the-optimization-process-for-targets-that-are-very-close-to-the-skin-surface-or-with-ptvs-that-extend-into-air-yet-the-skin-itself-is-not-at-r weekly 0.8 https://www.themednet.org/what-is-the-rate-of-dementia-following-whole-brain-radiotherapy-in-patients-with-brain-metastases-who-survive-for-over-a-year weekly 0.8 https://www.themednet.org/do-you-treat-the-surrounding-erythema-for-cutaneous-squamous-or-basal-cell-carcinoma weekly 0.8 https://www.themednet.org/for-patients-with-advanced-stage-nsclc-being-treated-with-concurrent-chemort-who-miss-treatment-days-secondary-to-acute-toxicities-do-you-add-on-fractions-at-the-end-of-treatment-to-compensate-for-repopulation-as-is-done-in-head-and-neck-cancers weekly 0.8 https://www.themednet.org/is-there-a-role-for-radiation-therapy-after-chemotherapy-for-localized-anaplastic-large-cell-lymphoma weekly 0.8 https://www.themednet.org/what-is-the-best-management-of-a-lacrimal-gland-maltoma weekly 0.8 https://www.themednet.org/would-you-give-breast-radiotherapy-to-a-patient-with-a-history-of-bilateral-retinoblastoma weekly 0.8 https://www.themednet.org/what-is-the-appropriate-treatment-for-a-low-lying-rectal-cancer-in-the-setting-of-prior-definitive-prostate-imrt weekly 0.8 https://www.themednet.org/is-post-mastectomy-rt-recommended-for-patients-who-have-a-local-failure-after-partial-breast-irradiation weekly 0.8 https://www.themednet.org/should-prostate-cancer-genomic-classifiers-such-as-decipher-be-used-in-all-high-risk-post-prostatectomy-patients-to-risk-stratify-patients-to-adjvant-rt-vs-psa-observation-and-possible-salvage-rt weekly 0.8 https://www.themednet.org/would-you-include-a-lymphocele-in-your-imrt-treatment-volumes-for-endometrial-carcinoma weekly 0.8 https://www.themednet.org/are-there-ever-indications-to-include-the-inguinal-nodes-in-the-rt-treatment-field-in-a-testicular-seminoma weekly 0.8 https://www.themednet.org/what-indicators-have-you-found-helpful-in-screening-cases-that-would-be-appropriate-for-possible-peer-review-in-radiation-oncology weekly 0.8 https://www.themednet.org/when-is-postoperative-radiation-indicated-after-enucleation-of-an-ocular-melanoma weekly 0.8 https://www.themednet.org/what-is-the-appropriate-management-of-stage-0-testicular-intratubular-neoplasia-of-the-testicle weekly 0.8 https://www.themednet.org/what-is-the-value-of-resection-in-high-risk-but-small-or-early-stage-skin-cancers-at-the-medial-canthus weekly 0.8 https://www.themednet.org/for-a-breast-cancer-patient-treated-with-a-mastectomy-who-has-clear-indications-for-post-mastectomy-radiation-therapy-what-do-you-consider-to-be-the-longest-acceptable-delay-prior-to-initiating-pmrt-following-surgery weekly 0.8 https://www.themednet.org/what-is-the-most-appropriate-adjuvant-treatment-for-a-gross-totally-resected-recurrent-spinal-meningioma-that-has-not-received-prior-radiation weekly 0.8 https://www.themednet.org/what-is-the-maximum-time-you-would-allow-between-simulation-treatment-planning-mri-and-delivered-treatment-for-stereotactic-radiosurgery-for-brain-metastases weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-do-you-use-when-you-want-an-abbreviated-course-for-incompletely-resected-squamous-cell-carcinoma-of-the-pre-auricular-area weekly 0.8 https://www.themednet.org/can-chemotherapy-be-used-instead-of-radiation-therapy-in-a-patient-with-extensive-stage-small-cell-lung-cancer-who-presents-with-epidural-spinal-cord-compression weekly 0.8 https://www.themednet.org/should-immunotherapy-be-standard-of-care-for-metastatic-msi-high-colorectal-cancer weekly 0.8 https://www.themednet.org/which-embolization-approach-is-preferred-for-liver-metastases-from-well-differentiated-neuroendocrine-tumors weekly 0.8 https://www.themednet.org/is-there-a-role-for-peritoneal-debulking-in-patients-with-peritoneal-metastases-from-colorectal-cancer weekly 0.8 https://www.themednet.org/what-is-the-best-adjuvant-treatment-for-resected-nsclc weekly 0.8 https://www.themednet.org/what-is-an-acceptable-sbrt-dose-for-a-central-lung-cancer-encasing-a-coronary-artery-bypass-graft weekly 0.8 https://www.themednet.org/does-the-literature-support-a-benefit-for-whole-lung-irradiation-for-high-risk-rhabdomyosarcoma-with-multiple-lung-metastases weekly 0.8 https://www.themednet.org/in-the-modern-imrt-sbrt-era-what-should-be-the-appropriate-definition-for-the-term-hot-spot-in-evaluating-a-plan weekly 0.8 https://www.themednet.org/which-older-patients-with-hormone-receptor-positive-her2-negative-breast-cancer-should-receive-chemotherapy weekly 0.8 https://www.themednet.org/do-you-use-a-tki-for-resected-egfr-non-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-without-a-pathologic-diagnosis-of-malignancy-referred-for-palliative-radiation weekly 0.8 https://www.themednet.org/what-are-your-dose-constraints-for-lung-v20-v5-mld-etc-in-patients-receiving-postoperative-radiation-therapy-after-lobectomy weekly 0.8 https://www.themednet.org/would-you-treat-the-whole-brain-for-brain-metastases-in-a-patient-with-active-systemic-scleroderma weekly 0.8 https://www.themednet.org/at-what-psa-do-you-start-calculating-doubling-time-post-prostatectomy weekly 0.8 https://www.themednet.org/when-do-you-perform-braf-testing-in-colon-cancer weekly 0.8 https://www.themednet.org/when-do-you-perform-her2-testing-in-patients-with-colorectal-cancer weekly 0.8 https://www.themednet.org/how-do-you-perform-geriatric-assessment-for-cancer-patients weekly 0.8 https://www.themednet.org/is-there-an-age-cutoff-for-when-to-avoid-folfirinox-in-older-patients-with-pancreatic-cancer weekly 0.8 https://www.themednet.org/what-dose-and-upper-field-border-would-you-use-following-transanal-excision-for-rectal-cancer-found-to-be-t2-by-final-pathology-but-without-lvsi-or-perineural-invasion weekly 0.8 https://www.themednet.org/in-determining-the-need-for-regional-nodal-irradiation-following-breast-cancer-surgery-do-you-consider-positive-intramammary-lymph-nodes-the-same-as-positive-axillary-lymph-nodes weekly 0.8 https://www.themednet.org/what-is-your-general-approach-to-treatment-sequencing-of-available-regimens-in-castration-resistant-metastatic-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-early-stage-tonsil-scc-treated-by-simple-tonsillectomy-alone-1 weekly 0.8 https://www.themednet.org/following-transanal-excision-with-positive-margins-for-for-t1-or-t2-rectal-cancer-is-it-more-appropriate-to-proceed-with-apr-or-attempt-sphincter-preservation-with-rt-chemo weekly 0.8 https://www.themednet.org/when-treating-a-high-risk-cutaneous-squamous-cell-carcinoma-post-operatively-to-the-tumor-bed-do-you-include-the-entire-pre-op-tumor-in-your-ptv-or-do-you-include-only-the-scar-with-margin weekly 0.8 https://www.themednet.org/how-do-you-manage-dabrafenib-fever weekly 0.8 https://www.themednet.org/do-you-consider-apbi-a-reasonable-alternative-to-mastectomy-for-women-with-early-stage-breast-cancer-and-collagen-vascular-diseases weekly 0.8 https://www.themednet.org/how-would-you-treat-a-pediatric-patient-with-stage-ivb-hodkin-lymphoma-who-still-has-persistent-pet-disease-after-dose-escalated-chemotherapy weekly 0.8 https://www.themednet.org/should-whole-brain-radiation-therapy-and-orbital-radiation-therapy-be-administered-in-situations-of-ocular-b-cell-lymphoma-recurrence-2-years-after-primary-cns-lymphoma-treated-with-intrathecal-methotrexate-and-no-prior-cranial-irradiation weekly 0.8 https://www.themednet.org/for-merkel-cell-carcinoma-of-the-lower-extremity-with-early-isolated-recurrence-in-the-ipsilateral-inguinal-nodes-would-you-include-pelvic-lymph-nodes-in-the-post-operative-field-following-inguinal-lymph-node-dissection weekly 0.8 https://www.themednet.org/in-what-setting-do-you-omit-adjuvant-radiation-therapy-in-a-t3n0-rectal-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-muscle-invasive-bladder-cancer-in-an-elderly-patient-who-cannot-tolerate-chemotherapy weekly 0.8 https://www.themednet.org/would-you-treat-a-muscle-invasive-urethral-recurrence-of-bladder-cancer-with-definitive-chemoradiation weekly 0.8 https://www.themednet.org/how-do-you-manage-postoperative-residual-disease-after-neoadjuvant-chemoradiotherapy-and-surgery-for-a-patient-with-locally-advanced-esophageal-or-ge-junction-adenocarcinoma weekly 0.8 https://www.themednet.org/what-are-your-preferred-dose-fractionation-options-for-treatment-of-hemoptysis-related-to-central-lung-metastasis weekly 0.8 https://www.themednet.org/do-you-recommend-adjuvant-pelvic-rt-for-stage-1-cervical-adenocarcinoma weekly 0.8 https://www.themednet.org/for-patients-with-brain-tumors-without-a-history-of-seizure-what-is-your-policy-on-driving weekly 0.8 https://www.themednet.org/do-you-recommend-adjuvant-chemoradiation-for-t2n0-gastric-adenocarcinoma-2 weekly 0.8 https://www.themednet.org/other-than-part-of-a-clinical-trial-or-for-its-fda-approved-indication-second-line-therapy-for-metastatic-squamous-cell-nsclc-when-do-you-offer-nivolumab-to-your-patients-with-nsclc weekly 0.8 https://www.themednet.org/how-long-do-you-continue-maintenance-chemotherapy-for-metastatic-non-small-cell-lung-cancer-in-patients-who-have-achieved-a-radiographic-cr weekly 0.8 https://www.themednet.org/what-factors-would-make-you-strongly-consider-re-irradiation-of-the-chest-wall-in-a-patient-who-has-previously-undergone-whole-breast-irradiation weekly 0.8 https://www.themednet.org/in-light-of-chaarted-and-stampede-should-all-men-with-newly-diagnosed-treatment-naive-metastatic-prostate-cancer-be-treated-with-chemohormonal-therapy weekly 0.8 https://www.themednet.org/should-bone-directed-agents-such-as-denosumab-or-zoledronic-acid-be-given-when-patients-are-being-treated-with-radium-223 weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-muscle-invasive-bladder-cancer-who-are-ineligible-for-neoadjuvant-cisplatin-based-chemotherapy weekly 0.8 https://www.themednet.org/what-would-you-include-in-the-radiation-field-for-a-patient-with-t2-n0-m0-adenocarcinoma-of-the-distal-1-3-of-the-esophagus weekly 0.8 https://www.themednet.org/when-using-conventionally-fractionated-breast-rt-does-one-need-to-treat-the-whole-breast-to-50gy-or-is-45gy-followed-by-a-boost-satisfactory weekly 0.8 https://www.themednet.org/what-pelvic-fields-do-you-treat-for-patients-with-figo-ia2-ib-cervical-cancer-patients-who-inadvertently-get-a-simple-hysterectomy-but-with-lymph-node-sampling-for-presumed-endometrial-carcinoma weekly 0.8 https://www.themednet.org/what-is-an-appropriate-dose-for-nodular-lymphocyte-predominant-stage-1-hodgkin-lymphoma-following-nodal-excision weekly 0.8 https://www.themednet.org/how-frequently-should-you-order-brain-imaging-after-whole-brain-rt-in-patients-not-undergoing-a-planned-srs-boost weekly 0.8 https://www.themednet.org/at-what-point-would-radium-223-dicholoride-treatment-be-the-best-management-for-a-patient-with-established-metastatic-prostate-cancer-with-an-elevated-psa-and-symptomatic-bone-pain-with-corresponding-bone-lesions-on-imaging weekly 0.8 https://www.themednet.org/do-you-routinely-include-imns-for-left-sided-inflammatory-breast-cancer weekly 0.8 https://www.themednet.org/is-there-an-ideal-method-for-abdominal-motion-control-when-treating-upper-abdomen-malignancies weekly 0.8 https://www.themednet.org/when-would-you-consider-testicular-rt-prior-to-tbi-for-bmt weekly 0.8 https://www.themednet.org/do-you-use-the-pet-scan-hypermetabolic-lesion-to-help-contour-the-gtv-for-lung-sbrt-especially-in-setting-of-peripheral-atelectasis weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-ut1n0m0-gastric-cancer-if-the-eus-is-consistent-with-linitis-plastica weekly 0.8 https://www.themednet.org/do-you-treat-fully-resected-squamous-cell-carcinoma-of-the-ear-with-cartilage-invasion-with-adjuvant-radiation weekly 0.8 https://www.themednet.org/who-is-a-good-candidate-for-pre-operative-srs-for-resectable-brain-metastases weekly 0.8 https://www.themednet.org/is-post-operative-radiotherapy-indicated-in-hpv-associated-10-pack-year-smoking-low-volume-i-e-t1n1-squamous-cell-carcinomas-of-the-head-and-neck-when-the-only-adverse-risk-feature-present-on-pathology-is-lvsi weekly 0.8 https://www.themednet.org/when-do-you-prescribe-steroids-prior-to-palliative-radiotherapy-of-bone-metastases-to-prevent-pain-flare weekly 0.8 https://www.themednet.org/in-light-of-the-2015-astro-plenary-session-presentation-about-involved-field-radiation-vs-elective-nodal-radiation-therapy-are-you-including-elective-nodal-fields-celiac-mediastinal-supraclavicular-in-the-treatment-of-locally-advanced-esophageal-cancer weekly 0.8 https://www.themednet.org/what-ctv-margins-should-be-used-with-early-stage-favorable-hodgkins-lymphoma-in-the-illiac-chain-if-they-had-a-complete-response-on-pet-after-2-cycles-of-abvd weekly 0.8 https://www.themednet.org/how-would-you-treat-classic-hodgkins-lymphoma-when-the-nodal-sites-are-non-contiguous weekly 0.8 https://www.themednet.org/since-chemotherapy-is-omitted-in-stage-iia-nodular-lymphocyte-predominant-hodgkins-lymphoma-should-all-borderline-suspicious-lymph-node-regions-on-pet-ct-receive-radiation-therapy weekly 0.8 https://www.themednet.org/how-does-positive-peritoneal-washings-factor-into-your-treatment-decisions-regarding-pelvic-radiation-and-or-chemotherapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-stage-iii-melanoma-now-that-the-fda-has-approved-adjuvant-ipilimumab-for-high-risk-stage-iii-melanoma-patients weekly 0.8 https://www.themednet.org/what-are-the-indications-for-adjuvant-rt-following-resection-for-intracranial-hemangiocytomas weekly 0.8 https://www.themednet.org/do-you-treat-supraclavicular-metastasis-with-sbrt weekly 0.8 https://www.themednet.org/is-there-an-effective-therapy-for-radiation-myelitis weekly 0.8 https://www.themednet.org/would-you-recommend-prophylactic-retro-peritoneal-rt-in-an-adolescent-with-paratesticular-rhabdomyosarcoma-s-p-radical-inguinal-orchiectomy-without-a-lymph-node-dissection weekly 0.8 https://www.themednet.org/should-post-op-rt-be-delayed-for-children-3yo-after-a-gtr-resection-for-a-posterior-fossa-or-supratentorial-ependymoma weekly 0.8 https://www.themednet.org/what-is-the-value-and-potential-morbidity-of-second-look-surgery-in-patients-with-sub-totally-resected-ependymoma weekly 0.8 https://www.themednet.org/do-you-consider-1-8gy-and-2gy-fraction-sizes-completely-equivalent-when-performing-whole-breast-radiation-therapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-dose-for-definitive-radiation-of-squamous-cell-cancer-of-the-thoracic-esophagus-that-will-be-combined-with-chemothererapy weekly 0.8 https://www.themednet.org/in-which-patients-receiving-regional-nodal-irradiation-do-you-include-the-internal-mammary-nodes weekly 0.8 https://www.themednet.org/what-prostate-size-or-baseline-urinary-symptoms-are-relative-contraindications-for-prostate-hdr weekly 0.8 https://www.themednet.org/in-the-imrt-era-what-role-does-brachytherapy-play-in-the-treatment-of-squamous-cell-carcinoma-of-the-vulva weekly 0.8 https://www.themednet.org/should-we-be-integrating-tumor-treating-fields-into-standard-glioblastoma-treatment weekly 0.8 https://www.themednet.org/based-on-the-recent-disease-free-survival-results-from-abcsg-18-presented-at-san-antonio-do-you-favor-the-use-of-denosumab-in-the-adjuvant-setting weekly 0.8 https://www.themednet.org/given-the-improved-ability-to-spare-heart-kidney-and-liver-should-imrt-be-the-standard-of-care-for-gastric-malt-lymphoma-despite-the-low-dose-needed-to-effectively-treat-these-patients weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-low-lying-rectal-adenocarcinoma-who-refuse-surgery weekly 0.8 https://www.themednet.org/how-does-a-close-dcis-margin-factor-into-surgical-and-radiation-decision-making-for-stage-i-invasive-ductal-carcinoma-after-breast-conserving-surgery weekly 0.8 https://www.themednet.org/are-special-precautions-necessary-for-esophageal-cancer-with-tracheal-invasion-prior-to-chemoradiation weekly 0.8 https://www.themednet.org/are-there-consensus-target-volume-definitions-for-craniospinal-irradiation-following-resection-for-adult-medulloblastoma weekly 0.8 https://www.themednet.org/when-does-a-rising-psa-after-prostatectomy-indicate-growth-just-of-normal-prostate weekly 0.8 https://www.themednet.org/when-treating-a-soft-tissue-sarcoma-close-to-humeral-head-what-humeral-head-dose-constraint-should-be-used weekly 0.8 https://www.themednet.org/do-you-boost-residual-lung-disease-after-chemotherapy-after-whole-lung-irradiation-for-patients-with-ewings-rhabdomyosarcoma-or-wilms weekly 0.8 https://www.themednet.org/for-extremity-rhabdomyosarcomas-hand-with-positive-epitrochlear-and-axillary-lymph-nodes-do-you-treat-the-lymph-nodes-or-just-the-primary weekly 0.8 https://www.themednet.org/in-light-of-the-dbcg-imn-study-are-you-treating-internal-mammary-nodes-in-women-with-positive-axillary-ln-who-have-path-cr-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/when-do-you-employ-post-op-external-beam-radiotherapy-in-papillary-thyroid-carcinoma weekly 0.8 https://www.themednet.org/what-is-the-appropriate-dose-for-palliation-of-bulky-prostate-cancer weekly 0.8 https://www.themednet.org/is-chemoradiation-the-preferred-treatment-for-t2-scc-of-the-anal-canal-in-a-patient-with-ibd weekly 0.8 https://www.themednet.org/is-there-a-role-for-partial-breast-rt-in-dcis weekly 0.8 https://www.themednet.org/how-do-you-treat-limited-stage-small-cell-carcinoma-of-the-lung-after-a-complete-response-or-near-complete-response-to-chemotherapy-prior-to-radiation weekly 0.8 https://www.themednet.org/what-is-the-appropriate-nodal-coverage-a-invasive-ductal-carcinoma-status-post-lumpectomy-with-50-or-more-of-the-sln-biopsied-for-example-2-of-4-sln-showing-micrometastases weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-for-late-recurrence-at-a-primary-site-only-of-a-limited-stage-small-cell-lung-cancer-initially-treated-with-chemoradiaton weekly 0.8 https://www.themednet.org/when-do-you-consider-boosting-the-the-tracheostomy-site-in-post-operative-head-and-neck-cancer-patients weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-recommendations-would-you-make-for-a-patient-with-pt3n0m0-duodenal-cancer weekly 0.8 https://www.themednet.org/is-it-appropriate-to-use-sbrt-on-unresectable-pancreatic-tumors-invading-the-duodenum weekly 0.8 https://www.themednet.org/is-there-a-way-to-predict-clinically-or-from-ct-which-patients-with-left-sided-breast-tumors-would-benefit-more-from-the-prone-v-supine-position weekly 0.8 https://www.themednet.org/is-there-data-or-even-anecdotal-reports-of-cosmesis-or-capsular-contracture-of-a-previously-augmented-breast-after-lumpectomy-and-hypofractionated-whole-breast-radiation weekly 0.8 https://www.themednet.org/is-it-feasible-to-use-mv-fluoroscopy-to-monitor-the-treatment-port-for-left-sided-breast-cancer-with-dibh weekly 0.8 https://www.themednet.org/in-laryngeal-cancer-assuming-no-pharyngeal-extension-with-level-ii-iii-involvement-should-rps-and-level-ib-on-the-involved-side-be-covered weekly 0.8 https://www.themednet.org/should-patients-with-anal-canal-scc-undergo-an-fna-biopsy-of-any-palpable-inguinal-ln-that-is-also-fdg-avid-on-pet-ct-or-should-these-nodes-be-assumed-to-be-positive-and-treated-to-a-higher-dose weekly 0.8 https://www.themednet.org/how-do-i-report-problems-or-errors-with-the-website weekly 0.8 https://www.themednet.org/does-the-dose-rate-of-an-external-beam-linear-accelerator-matter-in-terms-of-radiobiology weekly 0.8 https://www.themednet.org/how-do-you-boost-patients-with-squamous-cell-carcinoma-of-the-cervix-or-upper-vagina-with-invasion-of-the-posterior-bladder weekly 0.8 https://www.themednet.org/per-2016-nccn-guidelines-is-the-addition-of-6-cycles-docetaxel-now-the-standard-of-care-for-all-nccn-high-and-very-high-risk-prostate-cancer-patients-receiving-definitive-xrt-adt weekly 0.8 https://www.themednet.org/is-there-any-data-on-an-effective-rt-regimen-dose-fractionation-for-inducing-an-abscopal-effect-using-a-pd-1-inhibitor-in-refractory-hodgkins-lymphoma weekly 0.8 https://www.themednet.org/when-treating-a-patient-with-classic-early-stage-diffuse-large-b-cell-lymphoma-stage-i-ii-when-is-it-appropriate-for-patients-to-receive-3-versus-6-cycles-of-r-chop-chemotherapy-when-the-treatment-is-followed-by-isrt weekly 0.8 https://www.themednet.org/how-should-masticator-space-involvement-be-defined-with-regards-to-nasopharynx-cancer-should-we-use-the-ajccs-vague-definition-or-anatomical-definitions-of-the-masticator-space weekly 0.8 https://www.themednet.org/does-a-rare-histology-prostate-cancer-such-as-ductal-or-mucinous-change-your-typical-management-recommendations weekly 0.8 https://www.themednet.org/do-you-routinely-offer-consolidation-rt-to-sites-of-previous-bulky-disease-in-stage-iii-and-iv-hodgkins-lymphoma-who-have-a-complete-metabolic-response-on-restaging-pet-ct-following-6-cycles-of-abvd weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-tki-to-patients-with-stage-iii-egfr-mutant-nsclc-after-standard-chemoradiation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-gliomatosis-cerebri weekly 0.8 https://www.themednet.org/do-you-recommend-delayed-versus-immediate-breast-reconstruction-in-patients-who-will-require-post-mastectomy-radiation-therapy weekly 0.8 https://www.themednet.org/in-patients-with-vertebral-bone-metastases-what-criteria-do-you-use-to-select-patients-for-kyphoplasty-referral-prior-to-palliative-radiotherapy weekly 0.8 https://www.themednet.org/is-there-any-role-for-radium-223-early-in-the-course-of-castration-resistant-prostate-cancer-with-bone-metastases weekly 0.8 https://www.themednet.org/should-high-risk-prostate-cancer-patients-be-placed-on-more-potent-adt-abiraterone-or-enzalutamide-in-the-upfront-setting-with-definitive-rt-instead-of-the-standard-lhrh-agonist weekly 0.8 https://www.themednet.org/is-there-evidence-to-support-bladder-preservation-therapy-in-node-positive-bladder-cancer weekly 0.8 https://www.themednet.org/when-treating-a-high-grade-neuroendocrine-tumor-of-the-rectum-with-involved-pelvic-lymph-nodes-do-you-use-the-same-approach-dose-fractionation-concurrent-chemotherapies-as-you-would-for-a-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/for-high-risk-stage-i-non-seminomatous-testicular-germ-cell-tumors-are-there-particular-circumstances-under-which-rplnd-is-clearly-preferred-over-chemotherapy-or-surveillance weekly 0.8 https://www.themednet.org/are-there-any-situations-where-you-would-specifically-not-use-imrt-vmat-to-treat-post-operative-gynecologic-malignancies weekly 0.8 https://www.themednet.org/given-the-results-of-the-recently-published-getug-16-randomized-trial-should-all-men-undergoing-salvage-prostate-radiotherapy-receive-concurrent-hormone-therapy weekly 0.8 https://www.themednet.org/when-pre-operatively-treating-high-grade-soft-tissue-sarcomas-involving-the-chest-abdomen-or-pelvis-what-margins-do-you-use-for-ctv-and-ptv weekly 0.8 https://www.themednet.org/what-dose-would-be-appropriate-for-large-intra-abdominal-or-retroperitoneal-sarcomas-that-are-unresectable weekly 0.8 https://www.themednet.org/what-is-the-absolute-maximum-lung-v20-that-you-will-accept-for-patients-undergoing-chemoradiation-for-locally-advanced-lung-cancer weekly 0.8 https://www.themednet.org/is-there-a-role-for-neoadjuvant-chemotherapy-in-upper-tract-urothelial-carcinoma weekly 0.8 https://www.themednet.org/should-fish-studies-be-repeated-when-cll-patients-under-active-surveillance-have-progressive-disease-warranting-treatment weekly 0.8 https://www.themednet.org/when-should-intermittent-androgen-deprivation-vs-continuous-androgen-deprivation-be-used-for-the-treatment-of-prostate-cancer weekly 0.8 https://www.themednet.org/should-capecitabine-be-administered-at-a-specific-time-prior-to-rt-in-pre-op-chemoradiation-treatment-for-rectal-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-refractory-radiation-cystitis-status-post-pelvic-ebrt-bt weekly 0.8 https://www.themednet.org/in-patients-who-are-medically-poor-surgical-candidates-what-are-the-treatment-options-available-for-bulbomembranous-urethral-cancer weekly 0.8 https://www.themednet.org/do-you-routinely-boost-focally-positive-margins-after-preoperative-50-gy-and-surgery-in-patients-with-extremity-sarcomas weekly 0.8 https://www.themednet.org/how-do-you-minimize-skin-toxicity-in-patients-who-have-a-significant-amount-of-breast-tissue-contacting-the-couch-during-prone-breast-radiotherapy weekly 0.8 https://www.themednet.org/in-patients-with-low-grade-gliomas-that-are-older-than-40-y-o-or-have-subtotal-resections-do-you-ever-withhold-upfront-rt-off-protocol weekly 0.8 https://www.themednet.org/what-dose-fractionation-regimen-do-you-use-for-the-moderately-accelerated-hypofractionated-treatment-of-localized-prostate-cancer weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-when-choosing-an-applicator-system-for-cervical-brachytherapy-patients weekly 0.8 https://www.themednet.org/should-adjuvant-crt-be-considered-in-gastric-cancer-pts-who-received-pre-op-chemo-based-on-the-recent-results-of-the-critics-trial weekly 0.8 https://www.themednet.org/what-dose-should-be-used-for-a-g3-retroperitoneal-sarcoma-with-r1-resection weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-with-prostate-biopsy-and-or-mri-suspicious-for-extraprostatic-extension-as-high-risk-if-they-otherwise-have-ir-disease-factors weekly 0.8 https://www.themednet.org/is-there-a-role-for-adjuvant-radiation-in-phyllodes-tumors-of-the-breast weekly 0.8 https://www.themednet.org/is-there-a-role-for-adjuvant-docetaxel-in-patients-with-high-risk-localized-prostate-cancer-who-elect-for-prostatectomy weekly 0.8 https://www.themednet.org/how-do-you-treat-primary-refractory-diffuse-large-b-cell-lymphoma-in-elderly-patients-with-good-performance-status weekly 0.8 https://www.themednet.org/how-would-you-follow-patients-with-differentiated-thyroid-cancer-that-no-longer-picks-up-iodine-after-thyroidectomy-and-rai-and-have-thyroglobulin-antibodies weekly 0.8 https://www.themednet.org/following-presentation-of-the-prince-at-asco-2016-should-we-be-offering-intermittent-docetaxel-to-patients-with-metastatic-castration-resistant-prostate-cancer weekly 0.8 https://www.themednet.org/when-should-post-op-rt-be-offered-in-patients-with-recurrent-papillary-thyroid-carcinoma-that-no-longer-takes-up-iodine weekly 0.8 https://www.themednet.org/is-there-a-role-for-veristrat-testing-in-determining-when-to-use-an-egfr-tki-in-previously-treated-squamous-cell-nsclc weekly 0.8 https://www.themednet.org/for-what-stages-of-primary-vaginal-cancer-do-you-typically-recommend-concurrent-chemotherapy-with-external-beam-radiation-therapy weekly 0.8 https://www.themednet.org/how-should-rt-be-combined-with-immunotherapy-to-generate-an-abscopal-response weekly 0.8 https://www.themednet.org/when-giving-concurrent-chemoradiation-therapy-is-it-important-that-the-infusion-be-prior-to-rt-as-opposed-to-after-rt weekly 0.8 https://www.themednet.org/what-is-the-best-way-to-discuss-an-early-palliative-care-referral-with-a-patient weekly 0.8 https://www.themednet.org/based-on-the-data-from-the-ma-17r-trial-would-you-re-start-an-ai-in-post-menopausal-women-who-stopped-therapy-after-5-years weekly 0.8 https://www.themednet.org/for-male-patients-with-invasive-ductal-carcinoma-s-p-unilateral-mastectomy-subsequently-found-to-have-a-brca-mutation-should-a-prophylactic-contralateral-mastectomy-be-performed weekly 0.8 https://www.themednet.org/do-you-choose-to-include-or-omit-growth-factor-support-in-the-treatment-of-hodgkins-lymphoma weekly 0.8 https://www.themednet.org/in-what-situation-if-any-should-a-proton-boost-be-used-to-boost-gross-disease-in-head-and-neck-cases-how-can-this-be-done-logistically-to-coordinate-the-proton-boost-off-site weekly 0.8 https://www.themednet.org/for-castration-naive-metastatic-prostate-cancer-patients-who-you-plan-to-treat-with-lhrh-agonist-monotherapy-how-long-do-you-treat-with-an-anti-androgen-therapy-prior-to-and-after-initiating-the-lhrh-agonist weekly 0.8 https://www.themednet.org/is-there-any-role-for-adjuvant-radiation-for-a-low-grade-intraductal-papillary-mucinous-neoplasm-ipmn-of-the-pancreas-after-resection-with-a-positive-pancreatic-margin weekly 0.8 https://www.themednet.org/how-often-should-a-patients-patients-pacemaker-icd-be-interrogated-while-they-are-undergoing-a-course-of-radiotherapy weekly 0.8 https://www.themednet.org/when-using-chemort-for-bladder-preservation-in-muscle-invasive-bladder-cancer-after-maximal-turbt-how-should-the-mid-point-40-45-gy-cystoscopy-be-utilized weekly 0.8 https://www.themednet.org/should-ovarian-suppression-be-recommended-to-premenopausal-er-pr-positive-patients weekly 0.8 https://www.themednet.org/what-adjuvant-treatment-would-you-recommend-for-stage-iii-colon-cancer-in-a-patient-75yo-but-with-a-good-performance-status weekly 0.8 https://www.themednet.org/is-there-a-role-for-any-of-the-cdk4-6-inhibitors-in-er-her2-or-er-her2-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/is-there-a-field-size-in-which-you-would-consider-single-fraction-palliative-radiation-unsafe weekly 0.8 https://www.themednet.org/do-you-offer-somatostatin-analogues-eg-lanreotide-octreotide-to-asymptomatic-patients-with-metastatic-nonfunctioning-well-differentiated-enteropancreatic-neuroendrocrine-tumors weekly 0.8 https://www.themednet.org/for-a-patient-with-metastatic-urothelial-cancer-who-has-progressed-on-platinum-based-chemotherapy-do-you-test-for-tumor-pd-l1-expression-prior-to-choosing-atezolizumab-as-second-line-treatment weekly 0.8 https://www.themednet.org/what-are-the-appropriate-dose-fractionation-schedules-for-patients-being-treated-with-ebrt-as-opposed-to-srs-for-an-acoustic-neuroma weekly 0.8 https://www.themednet.org/do-you-ever-offer-adjuvant-chemotherapy-to-patients-with-resected-stage-ib-non-small-cell-lung-cancer-when-the-tumor-is-less-than-4cm-in-size weekly 0.8 https://www.themednet.org/how-would-you-treat-a-young-man-with-refractory-aml-after-hidac-induction-who-developed-cerebellar-toxicity-to-hidac-and-previously-received-doxorubicin-300-mg-m2-for-lymphoma weekly 0.8 https://www.themednet.org/how-should-a-contralateral-breast-cancer-be-treated-when-found-during-a-prophylactic-mastectomy weekly 0.8 https://www.themednet.org/do-you-routinely-include-sipuleucel-t-as-one-of-your-lines-of-systemic-therapy-for-metastatic-castration-resistant-prostate-cancer weekly 0.8 https://www.themednet.org/can-close-surveillance-be-used-to-manage-an-intracystic-papillary-carcinoma-that-is-associated-with-a-small-amount-of-low-grade-dcis weekly 0.8 https://www.themednet.org/for-definitive-fractionated-rt-of-meningioma-presumed-without-biopsy-is-it-always-necessary-to-treat-edema-evident-on-mri-flair-sequence weekly 0.8 https://www.themednet.org/which-pet-imaging-modality-if-any-is-preferred-to-work-up-possible-nodal-involvement-or-local-recurrence-in-prostate-cancer weekly 0.8 https://www.themednet.org/for-early-stage-breast-cancer-patients-should-lumpectomy-rt-be-recommended-over-mastectomy weekly 0.8 https://www.themednet.org/how-should-verrucous-carcinomas-of-the-head-and-neck-be-managed weekly 0.8 https://www.themednet.org/what-is-your-approach-for-an-inoperable-patient-with-epidural-spinal-cord-compression-who-has-previously-received-maximum-spinal-cord-dose-during-a-previous-course-of-radiation-therapy weekly 0.8 https://www.themednet.org/do-you-ever-alter-dose-fractionation-for-early-stage-endometrial-cancer-patients-receiving-vaginal-brachytherapy-alone weekly 0.8 https://www.themednet.org/what-third-and-fourth-line-options-do-you-consider-for-patients-with-pleomorphic-sarcoma-and-a-good-performance-status-who-have-progressed-on-standard-anthracycline-and-gemcitabine-docetaxel weekly 0.8 https://www.themednet.org/for-patients-eligible-for-and-considering-active-surveillance-for-low-risk-prostate-cancer-do-you-routinely-use-tests-for-molecular-risk-stratification weekly 0.8 https://www.themednet.org/how-should-bolus-be-utilized-with-different-types-of-surgical-reconstruction weekly 0.8 https://www.themednet.org/is-there-any-role-for-the-use-of-cytochrome-p450-2d6-cyp2d6-testing-for-tamoxifen-resistance-in-routine-practice weekly 0.8 https://www.themednet.org/in-newly-diagnosed-metastatic-non-squamous-nsclc-patients-which-if-any-genomic-targets-are-you-routinely-testing-for-besides-egfr-and-alk weekly 0.8 https://www.themednet.org/would-you-consider-accelerated-radiotherapy-in-a-patient-with-locally-advanced-nsclc-who-is-not-a-candidate-for-chemotherapy weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-for-recommending-palliative-radiation-in-patients-who-are-asymptomatic-but-have-good-performance-status weekly 0.8 https://www.themednet.org/is-there-a-role-for-radium-223-in-patients-that-have-a-non-prostate-malignancy-who-otherwise-would-be-a-reasonable-candidate weekly 0.8 https://www.themednet.org/do-you-have-any-advice-when-utilizing-palliative-radiation-therapy-in-patients-currently-being-treated-with-a-parp-inhibitor weekly 0.8 https://www.themednet.org/are-there-any-unique-considerations-for-treating-pediatric-high-grade-glioma weekly 0.8 https://www.themednet.org/what-would-your-management-approach-be-for-a-patient-with-high-grade-large-cell-neuroendocrine-of-the-lung-status-post-resection-with-negative-margins-but-visceral-pleura-invasion-noted-on-path weekly 0.8 https://www.themednet.org/are-you-routinely-offering-nivolumab-for-second-line-treatment-of-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-esophageal-adenocarcinoma-that-is-locally-recurrent-after-neoadjuvant-chemoradiotherapy-and-ivor-lewis-esophagectomy weekly 0.8 https://www.themednet.org/is-there-any-role-for-srs-wbrt-for-patients-with-a-limited-number-of-small-brain-metastases weekly 0.8 https://www.themednet.org/when-do-you-consider-consolidation-chest-radiation-in-a-patient-with-stage-iv-non-small-cell-carcinoma-of-the-lung-who-has-had-good-response-to-systemic-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-systemic-therapy-for-locoregional-recurrence-in-a-patient-with-triple-negative-breast-cancer-who-has-previously-received-anthracycline-and-taxane-based-chemotherapy weekly 0.8 https://www.themednet.org/are-there-any-circumstances-in-which-you-would-treat-only-the-lymph-nodes-and-omit-the-chest-wall-for-pmrt weekly 0.8 https://www.themednet.org/for-breast-cancer-with-occult-primary-do-you-favor-radiation-therapy-or-mastectomy-for-local-management weekly 0.8 https://www.themednet.org/when-do-you-refer-patients-for-turp-prior-to-prostate-radiotherapy weekly 0.8 https://www.themednet.org/after-cryoablation-for-early-breast-cancer-are-there-any-particular-considerations-to-take-when-planning-adjuvant-rt weekly 0.8 https://www.themednet.org/how-long-should-one-wait-before-biopsying-a-persistently-palpable-mass-of-early-stage-nodular-lymphocte-predominant-hodgkin-lymphoma-nlphl-after-radiation weekly 0.8 https://www.themednet.org/when-treating-patients-with-immune-checkpoint-inhibitors-do-you-routinely-check-markers-of-endocrinopathies-such-as-tsh-acth-or-only-when-a-patient-has-symptoms weekly 0.8 https://www.themednet.org/do-you-routinely-offer-a-stereotactic-boost-to-patients-with-bulky-3cm-residual-brain-metastasis-after-whole-brain-radiation-for-multiple-brain-metastases weekly 0.8 https://www.themednet.org/what-options-would-you-present-to-an-otherwise-healthy-patient-with-early-stage-breast-cancer-who-absolutely-refuses-surgery weekly 0.8 https://www.themednet.org/how-does-a-finding-of-low-level-microsatellite-instability-msi-low-in-colorectal-cancer-change-your-management weekly 0.8 https://www.themednet.org/for-a-recurrent-grade-1-meningioma-after-resection-do-you-favor-srs-or-fractionated-rt weekly 0.8 https://www.themednet.org/do-you-routinely-use-pet-ct-to-monitor-response-to-systemic-therapies-in-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/for-a-patient-with-stage-iii-nsclc-who-is-treated-with-chemoradiation-followed-by-surgery-when-do-you-offer-additional-adjuvant-chemotherapy-after-surgery weekly 0.8 https://www.themednet.org/do-you-offer-the-addition-of-necitumumab-to-first-line-chemotherapy-for-patients-with-advanced-metastatic-squamous-cell-nsclc weekly 0.8 https://www.themednet.org/in-what-situations-do-you-consider-radiation-to-the-pelvic-and-inguinal-lymph-nodes-without-treatment-of-the-primary-in-vulvar-cancer weekly 0.8 https://www.themednet.org/how-do-you-address-the-risks-of-radiation-induced-carcinogenesis-when-counseling-younger-adult-patients-40-60-years-old-on-definitive-radiation-therapy-for-non-melanomatous-skin-cancer-of-the-head-neck weekly 0.8 https://www.themednet.org/how-do-you-sequence-systemic-therapies-for-recurrent-metastatic-head-neck-cancer-following-the-recent-approval-of-pembrolizumab weekly 0.8 https://www.themednet.org/is-there-an-age-cutoff-at-which-you-would-recommend-against-radiosurgery-for-a-schwannoma-or-trigeminal-neuralgia-in-someone-who-is-a-good-surgical-candidate-with-no-comorbidities weekly 0.8 https://www.themednet.org/do-you-repeat-the-comprehensive-brca-analysis-like-myriad-in-at-risk-patients-with-a-positive-family-history-who-tested-negative-for-brca1-and-brca2-deleterious-mutations-10-years-ago weekly 0.8 https://www.themednet.org/how-do-you-treat-patients-with-early-stage-er-her2-breast-cancer-who-recur-years-later-after-definitive-therapy-and-hormonal-therapy weekly 0.8 https://www.themednet.org/what-is-the-recommended-initial-treatment-for-spinal-cord-compression-due-to-non-hodgkin-lymphoma-e-g-diffuse-large-b-cell-lymphoma weekly 0.8 https://www.themednet.org/is-hypofractionation-ever-appropriate-in-women-with-early-stage-breast-cancer-and-latent-lupus-who-have-never-experienced-skin-symptoms-in-their-lifetime weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-initial-treatment-of-metastatic-melanoma-patients-with-nras-mutations weekly 0.8 https://www.themednet.org/for-metastatic-nsclc-patients-who-are-started-on-first-line-platinum-doublet-chemotherapy-and-are-subsequently-found-to-have-an-egfr-exon-19-or-21-driver-mutation-do-you-switch-to-an-egfr-tki-immediately-once-the-mutation-is-detected-or-do-you-wait-until- weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-refer-a-patient-with-metastatic-renal-cell-carcinoma-for-cytoreductive-nephrectomy weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-for-isolated-vaginal-cuff-recurrence-of-endometrial-cancer-in-a-patient-previously-treated-with-adjuvant-vaginal-cuff-brachytherapy weekly 0.8 https://www.themednet.org/when-giving-palliative-lung-radiation-to-a-patient-on-immune-checkpoint-blockade-for-nsclc-do-you-hold-immunotherapy weekly 0.8 https://www.themednet.org/which-if-any-aspects-of-your-management-of-prostate-cancer-differ-in-your-african-american-patients-versus-those-of-other-racial-ethnic-backgrounds weekly 0.8 https://www.themednet.org/should-4-gy-x-5-be-the-standard-of-care-for-spinal-cord-compression-in-patients-with-poor-prognosis weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-node-positive-triple-negative-breast-cancer-during-her-first-trimester-of-pregnancy weekly 0.8 https://www.themednet.org/how-do-you-manage-an-open-wound-that-is-not-healing-after-radiation-treatment-for-an-ulcerated-scc-of-the-scalp weekly 0.8 https://www.themednet.org/does-infra-versus-supra-tentorial-tumor-location-change-your-management-strategy-for-the-treatment-of-single-brain-metastases weekly 0.8 https://www.themednet.org/how-do-you-decide-on-a-fractionation-scheme-for-retreatment-of-a-progressive-painful-spine-metastasis weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-for-replanning-with-a-new-ct-simulation-for-patients-being-treated-definitively-for-head-and-neck-cancer weekly 0.8 https://www.themednet.org/in-what-settings-would-you-offer-adjuvant-radiation-for-a-r1-resected-desmoid-tumor weekly 0.8 https://www.themednet.org/would-you-ever-boost-the-lumpectomy-cavity-and-the-scar-after-whole-breast-rt weekly 0.8 https://www.themednet.org/can-apbi-be-integrated-with-oncoplastics weekly 0.8 https://www.themednet.org/for-recurrent-prostate-cancer-after-definitive-radiation-how-do-you-guide-patients-between-the-various-salvage-options-vs-adt weekly 0.8 https://www.themednet.org/would-you-recommend-lung-cancer-screening-in-someone-who-is-not-a-surgical-candidate weekly 0.8 https://www.themednet.org/in-a-patient-with-er-her2-breast-cancer-do-you-ever-use-oncotype-testing-to-assist-in-decision-making-regarding-adjuvant-chemotherapy-when-the-tumor-size-is-less-than-0-5-cm-or-when-there-are-positive-lymph-nodes weekly 0.8 https://www.themednet.org/in-women-with-cn0-breast-cancer-who-receive-neoadjuvant-chemotherapy-due-to-other-high-risk-features-how-does-the-finding-of-treatment-effect-in-a-post-chemo-sentinel-lymph-node-affect-your-radiation-recommendations weekly 0.8 https://www.themednet.org/is-there-a-role-for-adjuvant-nodal-irradiation-for-early-stage-squamous-cell-carcinoma-of-the-penis weekly 0.8 https://www.themednet.org/do-you-ever-use-bevacizumab-in-combination-with-standard-radiation-and-temozolomide-in-the-first-line-setting-for-patients-with-glioblastoma weekly 0.8 https://www.themednet.org/what-is-the-best-approach-in-a-patient-with-a-single-brain-metastasis-in-the-setting-of-progressing-systemic-disease weekly 0.8 https://www.themednet.org/what-is-the-best-management-for-recurrent-basal-cell-carcinoma-after-prior-radiation-and-vismodegib weekly 0.8 https://www.themednet.org/when-would-you-offer-pmrt-to-a-patient-after-prior-tni-for-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-manage-moist-desquamation-when-treating-vulvar-cancer weekly 0.8 https://www.themednet.org/when-if-ever-do-you-add-platinum-to-neoadjuvant-chemotherapy-in-patients-with-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/after-chemotherapy-for-early-and-locally-advanced-breast-cancer-how-long-do-you-advise-women-to-wait-before-attempting-to-conceive weekly 0.8 https://www.themednet.org/what-is-the-duration-of-ai-that-you-use-in-men-with-hormone-receptor-positive-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-the-nodal-treatment-of-vaginal-cancer-using-imrt-or-more-specifically-in-what-situations-do-you-modify-elective-nodal-coverage weekly 0.8 https://www.themednet.org/what-is-the-best-treatment-management-of-low-grade-early-stage-follicular-lymphoma-of-the-mesentery weekly 0.8 https://www.themednet.org/are-there-any-subgroups-of-patients-with-advanced-metastatic-nsclc-for-whom-you-are-using-pd-1-inhibitors-in-the-first-line-setting-either-alone-or-in-combination-with-platinum-based-chemotherapy weekly 0.8 https://www.themednet.org/what-adverse-pathological-features-would-be-an-indication-for-wbi-whole-breast-irradiation-after-a-patient-receives-iort-for-early-breast-cancer weekly 0.8 https://www.themednet.org/is-there-a-role-for-atezolizumab-as-a-first-line-agent-for-metastatic-urothelial-carcinomas weekly 0.8 https://www.themednet.org/is-it-appropriate-to-treat-a-stage-ie-dlbcl-of-the-cervix-with-close-followup-if-a-cr-is-achieved-after-4-cycles-of-r-chop-followed-by-a-hysterectomy-omitting-rt weekly 0.8 https://www.themednet.org/is-it-necessary-to-cover-the-drain-sites-during-post-mastectomy-radiation weekly 0.8 https://www.themednet.org/what-scans-do-you-order-for-follow-up-in-locally-advanced-non-small-cell-lung-cancer-patients-who-have-completed-definitive-radiation-with-concurrent-chemotherapy weekly 0.8 https://www.themednet.org/for-lung-cancer-patients-who-experience-grade-3-4-toxicity-from-a-pd-1-inhibitor-necessitating-cessation-of-therapy-but-whose-tumor-has-responded-to-the-treatment-do-you-consider-restarting-pd-1-inhibitor-therapy-at-the-time-when-they-progress-again weekly 0.8 https://www.themednet.org/is-atm-a-contraindication-to-radiation-therapy weekly 0.8 https://www.themednet.org/for-a-localized-hidradenocarcinoma-of-the-extremity-managed-with-resection-what-adjuvant-dose-to-the-surgical-bed-would-you-recommend weekly 0.8 https://www.themednet.org/how-do-you-treat-patients-with-small-cell-lung-cancer-that-is-primarily-refractory-to-platinum-etoposide-i-e-disease-that-continues-to-progress-despite-first-line-chemotherapy weekly 0.8 https://www.themednet.org/do-you-offer-post-mastectomy-radiation-for-invasive-lobular-carcinomas weekly 0.8 https://www.themednet.org/when-patients-with-egfr-mutant-or-alk-translocated-advanced-nsclc-progress-after-all-available-targeted-therapies-do-you-use-chemotherapy-or-pd-1-pd-l1-inhibitor-therapy-as-the-next-line weekly 0.8 https://www.themednet.org/how-do-you-approach-first-line-therapy-for-metastatic-hormone-receptor-positive-her2-negative-breast-cancer-in-post-menopausal-women weekly 0.8 https://www.themednet.org/do-you-consider-use-of-tip-as-first-line-therapy-for-poor-risk-advanced-germ-cell-tumors weekly 0.8 https://www.themednet.org/what-maximum-volume-in-ccs-of-small-bowel-would-you-allow-to-receive-45-gy-in-a-patient-with-node-positive-squamous-cell-carcinoma-of-the-anal-canal-receiving-concurrent-chemoradiation-with-5-fu-mmc-being-treated-with-imrt weekly 0.8 https://www.themednet.org/how-do-you-treat-fit-patients-with-metastatic-adenocarcinoma-of-colon-who-have-progressed-on-at-least-2-prior-lines-of-standard-chemotherapy weekly 0.8 https://www.themednet.org/would-you-wait-to-treat-a-ground-glass-opacity-lesion-minimally-invasive-adenocarcinoma-or-adenocarcnioma-in-situ-with-sbrt-until-there-is-more-of-a-solid-component weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-options-for-men-with-germ-cell-tumors-that-relapse-within-2-years-of-initial-chemotherapy weekly 0.8 https://www.themednet.org/could-a-non-cirrhotic-patient-with-a-single-hcc-lesion-measuring-5cm-who-is-ineligible-for-liver-transplant-by-milan-size-criteria-alone-become-a-candidate-if-the-tumor-shrinks-after-tace weekly 0.8 https://www.themednet.org/what-is-the-appropriate-volume-to-re-irradiate-in-a-recurrent-gbm weekly 0.8 https://www.themednet.org/how-to-you-treat-patients-with-germ-cell-tumors-that-progress-during-treatment-with-first-line-platinum-based-chemotherapy-i-e-platinum-refractory-disease weekly 0.8 https://www.themednet.org/in-a-patient-with-brain-metastasis-confined-to-the-cerebellum-would-it-be-reasonable-to-treat-the-posterior-fossa-only-vs-wbrt weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-msi-high-small-bowel-adenocarcinoma-in-the-frontline-setting-and-after-first-progression weekly 0.8 https://www.themednet.org/how-do-you-manage-an-acute-herpes-zoster-infection-shingles-in-a-radiation-therapy-treatment-field-where-the-skin-is-getting-a-significant-dose-of-rt weekly 0.8 https://www.themednet.org/what-dose-fractionation-schedule-should-be-used-for-adjuvant-rt-after-surgical-decompression-of-a-spinal-cord-compression-from-multiple-myeloma-osseous-lesions weekly 0.8 https://www.themednet.org/do-you-recommend-holding-a-tki-when-treating-brain-metastases-with-srs-wbrt weekly 0.8 https://www.themednet.org/how-would-you-manage-a-localized-low-grade-follicular-lymphoma-diagnosed-shortly-after-a-patient-had-a-cr-to-an-aggressive-treatment-regimen-for-dlbcl weekly 0.8 https://www.themednet.org/do-you-adjust-your-lung-dvh-constraints-when-treating-a-patient-that-has-lobar-atelectasis-due-to-tumor-obstruction weekly 0.8 https://www.themednet.org/is-there-a-threshold-absolute-neutrophil-count-for-which-you-would-consider-holding-radiation weekly 0.8 https://www.themednet.org/what-is-the-best-treatment-management-for-a-metaplastic-carcinoma-of-the-breast-such-as-adenosquamous weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-colon-adenocarcinoma-with-a-her2-tumor-who-has-progressed-despite-standard-5-fu-containing-regimens weekly 0.8 https://www.themednet.org/do-you-ever-consider-referring-fit-patients-with-nsclc-and-oligometastatic-disease-isolated-to-the-pleura-for-extrapleural-pneumonectomy weekly 0.8 https://www.themednet.org/is-the-presence-of-carcinoma-in-situ-at-the-staple-line-after-lobectomy-completed-for-invasive-disease-an-indication-for-port weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-low-er-positive-1-9-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-biopsy-proven-extrapulmonary-small-cell-carcinoma-ct-chest-negative-characterized-only-by-inguinal-lymphadenopathy-who-is-otherwise-asymptomatic weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-borderline-resectable-pancreatic-cancer-in-patients-with-superior-mesenteric-artery-vs-vein-abutment weekly 0.8 https://www.themednet.org/how-do-you-counsel-men-with-prostate-cancer-on-the-cardiovascular-risks-of-androgen-deprivation-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-metastatic-breast-cancer-with-extensive-skin-involvement weekly 0.8 https://www.themednet.org/do-you-recommend-using-altered-fractionation-for-a-patient-with-squamous-cell-carcinoma-of-the-skin-in-the-head-and-neck-region-who-cannot-receive-concurrent-chemotherapy weekly 0.8 https://www.themednet.org/when-do-you-initiate-vaginal-cuff-brachytherapy-treatment-after-hysterectomy-for-early-stage-endometrial-cancer weekly 0.8 https://www.themednet.org/do-you-routinely-perform-molecular-profiling-for-potentially-actionable-targets-in-patients-with-advanced-pancreatic-cancer weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-a-mss-metastatic-colorectal-cancer-patient-who-has-progressed-on-folfox-and-folfiri weekly 0.8 https://www.themednet.org/how-do-you-manage-musculoskeletal-pain-in-men-receiving-androgen-deprivation-therapy-for-non-metastatic-prostate-cancer weekly 0.8 https://www.themednet.org/when-do-you-consider-using-alk-targeted-systemic-therapy-in-lieu-of-wbrt-or-srs-for-patients-with-metastatic-alk-positive-nsclc weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-to-young-adults-with-cns-pure-germinoma-markers-negative-single-nodule-csf-negative weekly 0.8 https://www.themednet.org/which-chemotherapy-regimen-would-you-choose-for-a-female-adolescent-with-favorable-prognosis-stage-i-ii-classical-hodgkin-lymphoma-assuming-the-patient-prefers-not-to-do-ifrt-if-the-initial-pet-response-is-good weekly 0.8 https://www.themednet.org/should-the-hemorrhage-be-included-in-the-volume-when-treating-brain-mets-with-srs weekly 0.8 https://www.themednet.org/does-radiation-improve-bone-health-and-allow-for-healing-of-a-pathological-fracture-in-a-patient-with-multiple-myeloma-refusing-surgery weekly 0.8 https://www.themednet.org/do-you-use-anti-pd-1-anti-pd-l1-therapies-in-lung-cancer-patients-with-a-prior-history-of-radiation-pneumonitis weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-regimen-for-metastatic-head-and-neck-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-braf-v600e-mutated-metastatic-melanoma-who-have-a-mixed-radiographic-response-after-several-months-of-therapy-with-dabrafenib-trametinib weekly 0.8 https://www.themednet.org/what-dose-schedule-do-you-prescribe-to-the-hrctv-when-using-interstitial-technique-for-treating-cervical-cancer-with-hdr-brachytherapy weekly 0.8 https://www.themednet.org/how-do-approach-palliation-of-local-symptoms-in-the-setting-of-metastatic-vulvar-cancer weekly 0.8 https://www.themednet.org/what-treatment-fields-and-dose-do-you-use-in-the-treatment-of-postoperative-angiosarcoma-of-the-scalp weekly 0.8 https://www.themednet.org/should-a-glioma-patient-on-phenytoin-be-completely-tapered-off-prior-to-starting-radiation weekly 0.8 https://www.themednet.org/what-is-the-best-radiation-therapy-treatment-for-vertebral-body-metastasis-with-epidural-extension-adjacent-to-the-spinal-cord-for-radio-resistant-tumors-melanoma-renal-cell-etc weekly 0.8 https://www.themednet.org/how-would-you-define-your-radiation-treatment-volume-for-a-primary-diffuse-large-b-cell-lymphoma-of-the-l4-vertebral-body-that-had-a-complete-response-to-chemotherapy weekly 0.8 https://www.themednet.org/when-do-you-use-high-dose-il-2-for-metastatic-renal-cell-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-manage-hematologic-toxicities-in-solid-tumor-patients-treated-with-immune-checkpoint-inhibitors weekly 0.8 https://www.themednet.org/what-do-your-treatment-volumes-include-when-treating-a-resected-mucoepidermoid-carcinoma-of-the-parotid-gland-with-close-but-negative-margins-where-recurrence-would-require-sacrifice-of-branches-of-the-facial-nerve weekly 0.8 https://www.themednet.org/how-do-you-treat-leptomeningeal-carcinomatosis-in-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/in-patients-with-3-or-more-positive-sentinel-lymph-nodes-who-get-a-slnb-only-do-you-advocate-for-an-alnd-even-if-you-are-planning-to-treat-their-regional-nodes-regardless weekly 0.8 https://www.themednet.org/should-presacral-lymph-nodes-be-included-in-a-locally-advanced-endometrial-cancer-without-cervical-involvement-with-incomplete-surgical-staging-i-e-no-lymph-node-dissection weekly 0.8 https://www.themednet.org/how-does-tissue-subtype-ie-hepatobiliary-or-intestinal-of-ampullary-carcinoma-affect-your-treatment-recommendations weekly 0.8 https://www.themednet.org/do-you-preferentially-use-10mv-over-6mv-in-cns-imrt-treatments-to-prevent-alopecia weekly 0.8 https://www.themednet.org/in-your-practice-what-is-your-goal-dose-for-boosting-positive-pa-nodes-in-either-the-adjuvant-or-definitive-treatment-for-cervical-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-to-a-patient-with-newly-diagnosed-primary-mediastinal-b-cell-lymphoma-in-the-upfront-setting weekly 0.8 https://www.themednet.org/when-treating-patients-with-whole-breast-rt-with-a-sequential-boost-what-technique-to-you-use-for-the-boost-when-treating-patients-prone-for-whole-breast-irradiation weekly 0.8 https://www.themednet.org/when-treating-patients-with-hypofractionated-radiation-to-the-breast-in-16-fractions-do-you-typically-treat-4-or-5-days-a-week weekly 0.8 https://www.themednet.org/in-a-patient-with-a-small-cell-of-the-esophagus-in-which-trimodality-therapy-is-planned-what-dose-of-preoperative-radiation-would-you-use-and-would-you-utilize-bid-fractionation weekly 0.8 https://www.themednet.org/which-chemotherapy-should-be-held-while-delivering-palliative-radiation weekly 0.8 https://www.themednet.org/for-newly-diagnosed-braf-mutated-melanoma-with-brain-metastases-do-you-prefer-to-start-with-targeted-therapy-or-with-immunotherapy weekly 0.8 https://www.themednet.org/would-you-offer-prostate-radiotherapy-to-a-patient-with-lymphocytic-colitis-which-is-being-managed-with-budesonide weekly 0.8 https://www.themednet.org/would-you-offer-salvage-rt-to-a-patient-with-adverse-features-after-prostatectomy-if-his-post-operative-psa-was-highly-elevated-for-example-10-ng-ml-but-his-metastatic-work-up-was-negative weekly 0.8 https://www.themednet.org/what-is-the-role-of-radiation-in-a-patient-with-limited-stage-small-cell-lung-cancer-initially-treated-with-chemotherapy-alone-and-received-a-complete-response-based-on-ct-and-pet-ct weekly 0.8 https://www.themednet.org/is-there-evidence-to-limit-a-patients-intake-of-antioxidants-such-as-vitamin-c-during-radiation-to-prevent-detrimental-outcomes weekly 0.8 https://www.themednet.org/for-patients-with-malignant-mesothelioma-who-achieve-macroscopic-complete-resection-what-factors-would-lead-you-to-consider-adjuvant-chemotherapy-or-radiation weekly 0.8 https://www.themednet.org/would-you-recommend-the-soft-text-adjuvant-approach-of-ovarian-suppression-ai-in-a-premenopausal-woman-with-high-risk-disease-who-still-desires-to-have-a-pregnancy weekly 0.8 https://www.themednet.org/should-pre-pectoral-implants-be-avoided-for-reconstruction-in-breast-cancer-patients-out-of-concern-that-it-may-mask-local-recurrences weekly 0.8 https://www.themednet.org/what-is-your-approach-for-and-in-which-situations-would-you-use-an-external-boost-in-the-management-of-gynecologic-cancers weekly 0.8 https://www.themednet.org/when-would-you-offer-adjuvant-rt-after-r0-resection-for-a-distal-esophageal-adenocarcinoma weekly 0.8 https://www.themednet.org/is-there-a-role-for-hyperbaric-oxygen-treatment-concurrent-with-radiotherapy-in-the-treatment-of-pediatric-glioblastoma weekly 0.8 https://www.themednet.org/what-margin-do-you-give-around-the-internal-mammary-vessels-when-treating-imn-nodes-for-breast-cancer weekly 0.8 https://www.themednet.org/would-you-use-immune-checkpoint-inhibitors-in-patients-with-well-compensated-liver-cirrhosis weekly 0.8 https://www.themednet.org/how-do-you-approach-disease-monitoring-in-patients-with-localized-rectal-cancer-who-have-received-treatment-with-chemoradiation weekly 0.8 https://www.themednet.org/how-do-you-handle-pregnancy-testing-for-women-of-childbearing-age weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-chemotherapy-radiation-do-you-recommend-for-incidentally-found-focus-of-small-cell-prostate-cancer-at-time-of-radical-prostatectomy weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-to-decide-between-1-fraction-vs-multi-fraction-e-g-5-fractions-for-who-1-meningiomas weekly 0.8 https://www.themednet.org/how-do-you-manage-severe-cytarabine-syndrome-in-aml-patients-manifesting-as-severe-hypotension-fevers-rash-and-myalgias weekly 0.8 https://www.themednet.org/do-you-routinely-obtain-surveillance-brain-mri-studies-after-pci weekly 0.8 https://www.themednet.org/how-do-you-manage-radiation-induced-serous-otitis-media weekly 0.8 https://www.themednet.org/do-you-consider-consolidating-the-chest-for-patients-with-extensive-stage-sclc-with-brain-metastases-with-a-pr-cr-after-whole-brain-rt-and-systemic-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-decide-what-to-use-for-2nd-line-treatment-of-liver-predominant-metastatic-neuroendocrine-tumor-that-has-progressed-on-a-somatostatin-analog weekly 0.8 https://www.themednet.org/when-if-ever-would-you-consider-adjuvant-pelvic-radiation-after-chemotherapy-for-a-completely-resected-localized-stage-i-ii-clear-cell-carcinoma-of-the-ovary weekly 0.8 https://www.themednet.org/do-you-offer-memantine-for-cognitive-preservation-to-glioma-patients weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-a-patient-with-oligometastatic-nsclc-characterized-by-a-lul-mass-and-a-solitary-adrenal-metastasis-assuming-a-good-performance-status weekly 0.8 https://www.themednet.org/how-do-you-manage-moist-desquamation-when-treating-breast-cancer weekly 0.8 https://www.themednet.org/do-you-routinely-perform-an-axillary-ultrasound-in-women-with-newly-diagnosed-breast-cancer-without-palpable-axillary-nodes weekly 0.8 https://www.themednet.org/do-you-offer-srs-to-patients-with-sclc-who-have-intracranial-relapses-after-prior-wbrt weekly 0.8 https://www.themednet.org/what-is-an-appropriate-target-volume-for-a-chordoma-or-chondrosarcoma-after-a-gross-total-resection weekly 0.8 https://www.themednet.org/for-the-rare-nsclc-patient-who-achieves-a-cr-on-anti-pd-1-or-pd-l1-therapy-do-you-consider-either-spacing-out-dosing-intervals-or-offering-treatment-breaks weekly 0.8 https://www.themednet.org/how-do-you-interpret-the-results-of-the-act-ii-trial-in-terms-of-the-choice-between-cisplatin-and-mitomycin-in-the-treatment-of-anal-cancers weekly 0.8 https://www.themednet.org/what-strategies-do-you-use-for-dose-escalation-when-irradiating-patients-with-inflammatory-breast-cancer weekly 0.8 https://www.themednet.org/which-pathologic-features-do-you-use-to-determine-vcb-vs-pelvic-rt-in-stage-ia-ib-endometrial-patients-in-the-era-of-sentinal-lymph-node-biopsy weekly 0.8 https://www.themednet.org/how-do-you-factor-environmental-or-occupational-radiation-exposure-in-counseling-or-planning-for-radiation-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-further-management-in-patients-with-initially-unresectable-hepatocellular-carcinoma-who-are-downstaged-after-transarterial-chemoembolization weekly 0.8 https://www.themednet.org/while-we-await-the-completion-of-rtog-1008-what-instances-do-you-offer-chemotherapy-for-salivary-gland-tumors weekly 0.8 https://www.themednet.org/how-does-your-department-manage-scheduling-surrounding-holidays weekly 0.8 https://www.themednet.org/what-do-you-recommend-if-you-find-persistent-lymphadenopathy-during-ct-simulation-for-adjuvant-head-neck-radiation-therapy weekly 0.8 https://www.themednet.org/when-determining-treatment-approach-to-newly-diagnosed-follicular-lymphoma-e-g-watchful-waiting-vs-chemotherapy-do-you-take-the-intensity-of-the-suv-measurements-on-pet-into-account weekly 0.8 https://www.themednet.org/what-do-you-consider-a-radiation-oncology-emergency weekly 0.8 https://www.themednet.org/would-you-routinely-offer-imrt-to-the-entire-pleural-cavity-in-patients-who-undergo-pleurectomy-local-resection-for-mesothelioma-without-epp weekly 0.8 https://www.themednet.org/how-do-you-approach-prostate-cancer-patients-with-persistent-obstructive-lower-urinary-tract-symptoms-after-primary-radiation-therapy weekly 0.8 https://www.themednet.org/is-there-evidence-that-radiation-therapy-can-cause-a-flare-in-cancer-antigens-or-other-biomarkers weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-locally-advanced-unresectable-but-non-metastatic-bladder-cancer weekly 0.8 https://www.themednet.org/when-do-you-use-neoadjuvant-endocrine-therapy-for-postmenopausal-women-with-er-positive-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/for-retroperitoneal-sarcomas-do-you-consider-neoadjuvantly-boosting-the-posterior-rind-or-area-at-high-risk-of-positive-margin weekly 0.8 https://www.themednet.org/what-dose-fractionation-do-you-use-when-treating-scc-of-the-vagina-with-vaginal-cylinder-brachytherapy-after-ebrt weekly 0.8 https://www.themednet.org/do-you-use-brachytherapy-for-treating-primary-tumors-of-the-lip-with-definitive-radiation weekly 0.8 https://www.themednet.org/should-we-continue-to-offer-consolidative-radiation-for-early-stage-non-bulky-hodgkins-disease-for-individuals-who-have-had-a-complete-response-deauville-1-or-2-after-chemotherapy-by-pet weekly 0.8 https://www.themednet.org/for-patients-with-widespread-bony-metastases-from-prostate-cancer-do-you-ever-consider-treating-with-beta-emitters-such-as-samarium-153-or-strontium-89-over-radium-223 weekly 0.8 https://www.themednet.org/after-induction-therapy-for-acute-promyelocytic-leukemia-with-arsenic-trioxide-and-atra-at-what-point-do-you-start-consolidation weekly 0.8 https://www.themednet.org/is-there-any-role-for-re-challenge-with-enzalutamide-or-abiraterone-after-prior-failure-in-metastatic-castrate-resistant-prostate-cancer weekly 0.8 https://www.themednet.org/is-there-an-advantage-in-treating-with-a-sib-simultaneous-integrated-boost-over-sequential-boost-for-anal-cancer weekly 0.8 https://www.themednet.org/do-you-offer-optune-of-ttf-for-patients-with-newly-diagnosed-gbm weekly 0.8 https://www.themednet.org/for-postoperative-gastric-patients-status-post-total-gastrectomy-how-do-you-approach-anastamotic-coverage weekly 0.8 https://www.themednet.org/in-a-patient-with-a-history-of-treated-stage-ii-seminoma-with-rising-bhcg-while-on-surveillance-do-you-routinely-recheck-the-bhcg-with-a-different-assay weekly 0.8 https://www.themednet.org/at-your-institution-how-are-cervical-cancer-patients-managed-who-are-intraoperatively-found-by-frozen-section-to-have-positive-pelvic-lymph-nodes weekly 0.8 https://www.themednet.org/do-you-have-a-tolerance-dose-for-a-skin-graft-when-treating-a-high-risk-skin-cancer weekly 0.8 https://www.themednet.org/for-clinically-node-negative-large-squamous-cell-carcinomas-of-the-scalp-vertex-would-you-electively-treat-the-nodes weekly 0.8 https://www.themednet.org/what-is-the-optimal-dosing-schedule-and-duration-of-zoledronic-acid-in-breast-cancer-patients-with-bone-metastases weekly 0.8 https://www.themednet.org/is-there-a-volume-or-size-criteria-where-you-feel-that-standard-doses-for-palliative-radiation-8gy-1fx-30gy-10fx-are-not-effective weekly 0.8 https://www.themednet.org/how-do-you-manage-immune-related-toxicity-from-checkpoint-inhibitors-that-is-refractory-to-initial-steroid-therapy weekly 0.8 https://www.themednet.org/would-you-continue-immune-checkpoint-inhibitor-therapy-in-a-metastatic-nsclc-patient-with-cns-failure-if-the-systemic-disease-is-otherwise-controlled weekly 0.8 https://www.themednet.org/do-you-routinely-add-anti-hormonal-therapy-to-her2-directed-therapy-in-a-patient-with-er-her2-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-metastatic-prostate-cancer-with-primary-resistance-to-gnrh-analogues-or-early-crpc weekly 0.8 https://www.themednet.org/how-do-you-treat-patients-with-single-solitary-brain-metastases-who-undergo-resection-after-failing-srs weekly 0.8 https://www.themednet.org/do-you-ever-use-molecular-assays-such-as-oncotype-to-modify-your-recommendations-for-withholding-rt-after-lumpectomy-in-invasive-breast-cancer weekly 0.8 https://www.themednet.org/how-does-genomic-profiling-next-generation-sequencing-assays-influence-your-treatment-recommendations-in-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-a-rapidly-growing-clinically-localized-breast-cancer-who-is-medically-inoperable weekly 0.8 https://www.themednet.org/should-adjuvant-radiation-be-given-for-an-atypical-who-ii-meningioma-of-the-thoracic-spine-after-gross-total-resection weekly 0.8 https://www.themednet.org/would-it-be-appropriate-to-treat-an-adult-with-a-pure-germinoma-at-1-8-gy-fraction-instead-of-the-pediatric-dose-of-1-5-gy-fx-when-treating-with-radiation-alone-to-the-whole-ventricle-with-cone-down-to-primary weekly 0.8 https://www.themednet.org/is-there-any-data-to-support-to-use-of-brentuximab-in-the-up-front-setting-in-the-treatment-of-hodgkin-lymphomas weekly 0.8 https://www.themednet.org/when-do-you-offer-consolidation-chemotherapy-for-patients-receiving-chemoradiation-for-locally-advanced-nsclc weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-prostate-cancer-who-has-a-history-of-total-colectomy-with-primary-anastomosis-and-is-not-a-surgical-candidate weekly 0.8 https://www.themednet.org/in-patients-with-metastatic-nsclc-would-you-consider-atezolizumab-after-failure-of-nivolumab-or-pembrolizumab weekly 0.8 https://www.themednet.org/do-you-have-a-methodical-procedure-for-checking-treatment-plans-before-approving weekly 0.8 https://www.themednet.org/do-you-ever-withhold-adjuvant-rt-after-bcs-in-older-women-with-stage-i-triple-positive-luminal-her2-subtype-breast-cancers weekly 0.8 https://www.themednet.org/for-patients-with-seminoma-testicular-cancer-who-are-stage-ii-positive-retroperitoneal-lymph-nodes-what-factors-do-you-consider-when-choosing-between-radiation-versus-chemotherapy weekly 0.8 https://www.themednet.org/how-should-a-patient-be-treated-when-they-have-an-isolated-para-aortic-recurrence-after-upfront-chemotherapy-and-vaginal-cuff-brachytherapy-for-intermediate-risk-endometrioid-endometrial-adenocarcinoma weekly 0.8 https://www.themednet.org/what-is-the-role-of-sbrt-in-recurrent-oligometastatic-ovarian-cancer weekly 0.8 https://www.themednet.org/how-do-you-treat-anal-margin-tumors weekly 0.8 https://www.themednet.org/what-is-the-optimal-dose-fractionation-for-treating-liver-metastases-in-the-central-liver-causing-obstruction-of-biliary-flow weekly 0.8 https://www.themednet.org/how-do-you-logistically-give-sandwich-chemotherapy-and-whole-pelvis-radiation-treatment-in-advanced-endometrial-cancer weekly 0.8 https://www.themednet.org/what-is-the-best-treatment-for-a-head-and-neck-cancer-in-a-patient-with-parkinsons-disease-with-nuerostimulators-located-in-the-clavicular-region weekly 0.8 https://www.themednet.org/will-you-continue-anti-estrogen-therapy-in-the-setting-of-initiation-of-tdm-1-for-patients-with-metastatic-er-her2-breast-cancer weekly 0.8 https://www.themednet.org/would-you-consider-srs-of-non-progressive-stable-intracranial-lesions-while-treating-with-srs-for-a-single-progressive-brain-metastasis-after-previous-wbrt-for-multiple-brain-metastases weekly 0.8 https://www.themednet.org/would-you-recommend-prophylactic-mastectomy-if-a-patients-estimated-lifetime-risk-of-breast-cancer-using-the-gail-or-clause-models-approaches-that-of-a-person-with-a-germline-brca1-mutation-eg-65-85-in-the-absence-of-high-risk-mutations weekly 0.8 https://www.themednet.org/would-you-consider-first-line-cabozantinib-in-patients-with-intermediate-or-poor-risk-mrcc weekly 0.8 https://www.themednet.org/given-the-significant-risk-of-recurrence-after-chemoradiation-for-locally-advanced-anal-carcinoma-should-resection-be-considered-with-or-without-neoadjuvant-treatment-in-select-cases weekly 0.8 https://www.themednet.org/how-do-you-counsel-your-palb2-mutation-positive-breast-cancer-patients-with-regards-to-risk-reducing-surgery weekly 0.8 https://www.themednet.org/how-would-you-treat-small-cell-cancer-of-the-cervix weekly 0.8 https://www.themednet.org/what-is-the-best-igrt-strategy-in-treating-the-prostate-bed-adjuvant-or-salvage-daily-anatomy-kv-images-vs-fiducial-seed-kv-images-vs-cbcts weekly 0.8 https://www.themednet.org/how-do-you-approach-maintenance-therapy-for-relapsed-follicular-lymphoma weekly 0.8 https://www.themednet.org/are-there-technical-alternatives-to-srs-for-a-radiation-center-without-the-requisite-micrcollimator-or-cones-for-patients-with-early-crainal-merastases weekly 0.8 https://www.themednet.org/do-you-use-anti-microbial-prophylaxis-when-you-prescribe-ibrutinib weekly 0.8 https://www.themednet.org/what-is-the-risk-of-breast-cancer-that-you-quote-to-young-women-with-early-stage-hodgkins-lymphoma-receiving-involved-field-site-radiation-therapy weekly 0.8 https://www.themednet.org/how-do-you-treat-hiccups-in-cancer-patients weekly 0.8 https://www.themednet.org/is-there-ever-a-situation-where-you-would-recommend-radiation-after-gross-total-resection-of-a-craniopharyngioma weekly 0.8 https://www.themednet.org/would-you-consider-treatment-of-advanced-hcc-with-checkpoint-blockade-after-progression-on-sorafenib weekly 0.8 https://www.themednet.org/do-you-treat-pre-or-post-operatively-for-ho-prophylaxis weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-regarding-antioxidant-use-during-their-course-of-rt weekly 0.8 https://www.themednet.org/have-we-established-standard-doses-for-radiation-therapy-for-h-n-cancers weekly 0.8 https://www.themednet.org/how-do-you-treat-gist-with-de-differentiation-to-pleomorphic-sarcoma-on-chronic-therapy-with-imatinib weekly 0.8 https://www.themednet.org/what-dose-fractionation-and-ctv-margins-do-you-typically-employ-for-a-cns-hemangiopericytoma weekly 0.8 https://www.themednet.org/what-challenges-and-adverse-effects-have-you-encountered-with-spaceoar-injection weekly 0.8 https://www.themednet.org/should-we-be-using-comprehensive-panels-when-testing-for-hereditary-cancer-syndromes weekly 0.8 https://www.themednet.org/are-certain-pd-l1-assays-considered-more-accurate-or-reliable-than-others-for-nsclc weekly 0.8 https://www.themednet.org/has-the-combination-of-daratumumab-bortezomib-and-dexamethasone-been-tried-for-the-treatment-of-plasma-cell-leukemia weekly 0.8 https://www.themednet.org/how-do-you-treat-a-radioresistant-e-g-rcc-or-melanoma-oligometastases-in-a-weight-bearing-bone-after-surgical-resection-and-stabilization weekly 0.8 https://www.themednet.org/what-treatment-volume-should-be-included-for-a-resected-glioma-with-a-large-hygroma-adjacent-to-the-resection-cavity weekly 0.8 https://www.themednet.org/in-cll-patients-who-have-had-a-very-good-response-to-ibrutinib-e-g-resolution-of-lymphadenopathy-and-normalization-of-counts-should-therapy-be-discontinued-until-resurgence-of-indications-for-therapy-or-should-treatment-be-continued-indefinitely weekly 0.8 https://www.themednet.org/how-would-you-treat-a-t1b-n0-metaplastic-myoepithelial-breast-cancer-regarding-role-of-adjuvant-therapy weekly 0.8 https://www.themednet.org/would-you-ever-consider-stopping-immunotherapy-in-a-patient-with-metastatic-melanoma-after-achieving-a-good-response weekly 0.8 https://www.themednet.org/do-you-offer-bladder-sparing-approaches-as-an-alternative-to-cystectomy-for-surgery-eligible-patients-with-muscle-invasive-bladder-cancer weekly 0.8 https://www.themednet.org/which-chemotherapy-regimen-if-any-do-you-recommend-for-palliative-concurrent-chemoradiation-for-a-symptomatic-patient-with-metastatic-cervical-carcinoma-and-ckd-stage-4-gfr-15-29 weekly 0.8 https://www.themednet.org/how-many-cycles-of-post-operative-adjuvant-chemotherapy-do-you-typically-plan-for-a-patient-with-resected-mesothelioma weekly 0.8 https://www.themednet.org/when-do-you-use-imrt-in-breast-radiotherapy weekly 0.8 https://www.themednet.org/for-early-stage-indolent-nhl-low-grade-follicular-malt-involving-midline-structures-of-the-head-and-neck-ie-base-of-tongue-soft-palate-how-do-you-apply-the-concepts-of-isrt weekly 0.8 https://www.themednet.org/what-igrt-strategy-do-you-use-when-treating-intact-prostate weekly 0.8 https://www.themednet.org/what-is-the-most-appropriate-management-for-a-patient-with-a-primary-brain-sarcoma weekly 0.8 https://www.themednet.org/when-do-you-initiate-androgen-deprivation-therapy-for-biochemical-relapse-of-prostate-cancer-following-primary-therapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-locally-advanced-metaplastic-breast-cancer-with-squamous-features weekly 0.8 https://www.themednet.org/will-you-start-using-ribociclib-instead-of-palbocicib-in-advanced-hr-positive-her2-negative-breast-cancer weekly 0.8 https://www.themednet.org/in-which-patients-do-you-offer-adjuvant-radiation-for-porocarcinoma weekly 0.8 https://www.themednet.org/does-rituximab-lenalidomide-have-a-role-in-advanced-follicular-lymphoma weekly 0.8 https://www.themednet.org/do-you-use-anticonvulsant-prophylaxis-in-patients-with-multiple-cns-metastases-absent-a-history-of-seizures weekly 0.8 https://www.themednet.org/for-esophageal-and-gastroesophageal-junction-cancers-which-lymph-nodes-are-metastatic-versus-regional weekly 0.8 https://www.themednet.org/what-is-your-preferred-second-line-agent-for-treatment-of-metastatic-urothelial-carcinoma weekly 0.8 https://www.themednet.org/do-you-routinely-use-chemo-cold-caps weekly 0.8 https://www.themednet.org/how-do-you-choose-between-single-agent-versus-combination-checkpoint-inhibitors-for-braf-wildtype-metastatic-melanoma weekly 0.8 https://www.themednet.org/what-treatment-technique-do-you-recommend-for-maximum-hearing-preservation-when-treating-a-vestibular-schwannoma-fractionated-radiosurgery-25-gy-in-5-fractions-or-single-fraction-radiosurgery weekly 0.8 https://www.themednet.org/is-it-ever-acceptable-for-high-risk-prostate-cancer-patients-to-be-treated-with-upfront-radical-prostatectomy weekly 0.8 https://www.themednet.org/would-you-recommend-sorafenib-as-an-adjunct-to-liver-targeted-therapy-in-patients-with-hepatocellular-carcinoma-who-are-awaiting-liver-transplant weekly 0.8 https://www.themednet.org/is-there-any-role-for-post-chemotherapy-r-chop-x-6-radiation-therapy-after-a-splenectomy-for-a-stage-ie-diffuse-large-b-cell-lymphoma-involving-only-the-spleen weekly 0.8 https://www.themednet.org/what-is-your-approach-to-pre-menopausal-or-male-breast-cancer-patients-on-adjuvant-tamoxifen-who-develop-a-dvt-in-the-absence-of-other-risk-factors-for-thromboembolic-disease weekly 0.8 https://www.themednet.org/is-there-evidence-of-clinical-benefit-to-proceeding-with-partial-pleurectomy-decortication-over-palliative-chemotherapy-with-bsc-pleurex-catheter-pleurodesis-in-a-patient-with-mesothelioma-who-is-not-a-candidate-for-extra-pleural-pneumectomy weekly 0.8 https://www.themednet.org/what-dose-and-planning-techniques-would-you-use-for-linac-based-srs-of-a-craniopharyngioma-with-reasonable-distance-from-critical-optics-and-brainstem-oars weekly 0.8 https://www.themednet.org/do-you-recommend-pmrt-and-if-so-do-you-treat-the-regional-nodes-in-patients-who-are-ct4n0-non-inflammatory-treated-with-neoadjuvant-chemotherapy-who-have-a-pcr-at-the-time-of-mastectomy weekly 0.8 https://www.themednet.org/what-is-your-preferred-palliative-radiation-regimen-for-patients-with-painful-bone-metastasis weekly 0.8 https://www.themednet.org/is-turp-a-contraindication-for-prostate-cancer-sbrt weekly 0.8 https://www.themednet.org/what-would-you-recommend-for-a-stage-i-diffuse-large-b-cell-lymphoma-ipi-0-1-involving-a-single-lymph-node-that-is-completely-removed-with-an-excisional-biopsy weekly 0.8 https://www.themednet.org/do-you-do-urethrogram-at-time-of-prostate-simulation weekly 0.8 https://www.themednet.org/in-what-settings-do-you-routinely-image-the-spine-for-work-up-of-an-intracranial-glioma weekly 0.8 https://www.themednet.org/how-would-you-treat-locoregionally-recurrent-anal-ca weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-do-you-use-to-palliate-mycosis-fungoides-lesions weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-inoperable-urothelial-carcinoma-of-the-bladder-with-persistent-non-muscle-invasive-disease-despite-intravesical-bcg-ifn-and-intravesical-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-isolated-recurrence-in-a-para-aortic-lymph-node-following-definitive-radiation-for-localized-prostate-cancer weekly 0.8 https://www.themednet.org/would-obtaining-a-breast-mri-for-patients-going-to-be-treated-with-apbi-be-beneficial weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-use-of-denosumab-in-patients-with-metastatic-breast-cancer-with-bony-involvement weekly 0.8 https://www.themednet.org/how-do-you-manage-an-adult-primary-rhabdomyosarcoma-of-the-lung-mediastinum weekly 0.8 https://www.themednet.org/is-a-fluciclovine-axumin-pet-scan-an-adequate-imaging-modality-for-prostate-cancer-re-staging-after-a-biochemical-failure weekly 0.8 https://www.themednet.org/how-would-you-treat-a-stage-ii-gastric-adenocarcinoma-with-de-differentiation-to-high-grade-neuroendocrine-tumor-post-resection weekly 0.8 https://www.themednet.org/would-you-treat-the-supraclavicular-field-and-imns-for-a-patient-with-ct3n0-breast-cancer-who-has-a-complete-response-following-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/would-you-consider-a-trial-of-anti-pd-1-therapy-following-disease-progression-through-anti-pd-l1-therapy-for-advanced-urothelial-carcinoma weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-radiation-for-a-completely-resected-large-well-differentiated-sarcoma-i-e-liposarcoma-involving-the-retropharyngeal-area-and-mediastinum weekly 0.8 https://www.themednet.org/what-is-the-optimal-regimen-for-advanced-stage-nodular-lymphocyte-predominant-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-solitary-node-positive-bladder-cancer-e-g-n1-in-a-patient-who-is-otherwise-a-candidate-for-either-bladder-preservation-or-radical-cystectomy weekly 0.8 https://www.themednet.org/are-there-contraindications-to-giving-radium-223-concurrently-with-palliative-radiotherapy-or-systemic-chemotherapy-for-mcrpc weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-patients-with-ampullary-carcinoma-who-are-poor-surgical-candidates-but-otherwise-eligible-for-curative-intent-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-surgically-resected-conjunctival-melanoma-that-has-recurred-locally weekly 0.8 https://www.themednet.org/what-is-the-preferred-regimen-for-testicular-lymphoma-with-de-novo-symptomatic-cns-involvement-and-systemic-disease-at-the-time-of-presentation weekly 0.8 https://www.themednet.org/is-there-an-effective-treatment-for-multiple-appearances-of-cutaneous-kaposis-lesions-besides-radiation weekly 0.8 https://www.themednet.org/how-do-you-manage-a-rib-fracture-caused-by-sbrt weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-re-irradiation-of-a-pituitary-adenoma weekly 0.8 https://www.themednet.org/what-treatment-volume-is-appropriate-when-treating-postoperatively-for-esophageal-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-optimize-nutrition-for-patients-experiencing-dysphagia-while-undergoing-chemoradiation-therapy-for-esophageal-cancer weekly 0.8 https://www.themednet.org/what-surveillance-strategy-do-you-use-for-patients-after-resection-of-localized-renal-cell-cancer weekly 0.8 https://www.themednet.org/do-you-ever-recommend-pci-for-large-cell-neuroendocrine-cancer-of-the-lung weekly 0.8 https://www.themednet.org/with-the-accelerated-approval-of-brigatinib-and-now-three-approved-alk-inhibitors-in-the-2nd-line-setting-how-do-you-decide-between-these-agents weekly 0.8 https://www.themednet.org/what-volumes-would-you-use-for-salvage-radiation-in-a-patient-with-a-pelvic-lymph-node-recurrence-of-cervical-cancer-initially-treated-with-surgery-alone weekly 0.8 https://www.themednet.org/how-do-you-manage-adjuvant-therapy-for-patients-with-locally-advanced-er-positive-breast-cancer-with-no-response-to-neoadjuvant-endocrine-therapy weekly 0.8 https://www.themednet.org/how-do-you-choose-which-lhrh-agonist-or-antagonist-to-prescribe-for-adt-in-patients-with-prostate-cancer weekly 0.8 https://www.themednet.org/when-treating-the-regional-nodes-what-factors-cause-you-to-treat-the-lower-axilla weekly 0.8 https://www.themednet.org/does-the-upstaging-of-breast-cancer-based-on-grade-and-hormone-receptor-status-in-ajcc-8-change-your-treatment-recommendations weekly 0.8 https://www.themednet.org/when-do-you-offer-radioembolization-y90-in-the-treatment-of-unresectable-hcc weekly 0.8 https://www.themednet.org/should-lymph-nodes-be-treated-with-postop-rt-of-undifferentiated-pleomorphic-sarcoma-of-the-head-and-neck weekly 0.8 https://www.themednet.org/is-there-any-benefit-to-changing-a-monoclonal-egfr-inhibitor-therapy-when-one-had-to-be-stopped-for-cutaneous-toxicity weekly 0.8 https://www.themednet.org/how-do-you-treat-her2-equivocal-breast-cancer-in-the-neoadjuvant-setting weekly 0.8 https://www.themednet.org/how-do-you-treat-a-locally-invasive-keratin-positive-gastrointestinal-spindle-cell-neoplasm weekly 0.8 https://www.themednet.org/is-there-a-preferential-approach-for-systemic-therapy-for-triple-negative-breast-cancer-patients-with-leptomeningeal-disease weekly 0.8 https://www.themednet.org/how-would-you-manage-her2-gej-adenocarcinoma-that-recurs-as-a-single-1-6cm-lung-nodule-a-year-after-completing-primary-chemoradiation-and-esophagectomy weekly 0.8 https://www.themednet.org/in-a-male-patient-with-a-single-inguinal-node-containing-scc-with-no-identifiable-anal-or-penile-lesions-what-areas-would-you-cover-and-to-what-dose weekly 0.8 https://www.themednet.org/would-you-start-immunotherapy-in-a-patient-with-metastatic-melanoma-who-is-on-steroids-e-g-dexamethasone-for-cerebral-edema weekly 0.8 https://www.themednet.org/do-you-prefer-rhtsh-for-tsh-stimulation-instead-of-thyroid-hormone-withdrawal-when-treating-patients-with-radioactive-iodine-for-papillary-thyroid-carcinoma weekly 0.8 https://www.themednet.org/in-the-absence-of-an-available-clinical-trial-would-you-favor-regorafenib-immediately-post-sorafenib-or-nivolumab-in-patients-with-hcc weekly 0.8 https://www.themednet.org/in-patients-with-newly-diagnosed-cervical-esophageal-cancer-with-limited-metastatic-disease-do-you-treat-the-primary-with-chemoradiation weekly 0.8 https://www.themednet.org/when-do-you-consider-for-first-line-atezolizumab-for-metastatic-bladder-cancer weekly 0.8 https://www.themednet.org/what-do-you-recommend-to-a-patient-who-has-biopsy-positive-dcis-or-invasive-carcinoma-and-at-time-of-lumpectomy-the-pathology-is-benign-assuming-biopsy-pathology-and-post-surgical-tumor-needle-localization-verified weekly 0.8 https://www.themednet.org/does-a-transitional-zone-vs-peripheral-zone-location-of-low-risk-prostate-cancer-affect-your-recommendation-for-active-surveillance weekly 0.8 https://www.themednet.org/what-role-does-laser-interstitial-thermal-therapy-litt-play-in-the-treatment-of-primary-and-metastatic-brain-neoplasms weekly 0.8 https://www.themednet.org/do-you-intentionally-modify-your-breast-cancer-treatment-plans-for-those-on-chronic-immunosuppression-to-avoid-secondary-cancers weekly 0.8 https://www.themednet.org/what-is-the-upper-limits-of-anthracycline-dose-you-are-willing-to-give-in-a-treatment-refractory-metastatic-breast-cancer-patient-if-the-patient-is-responding-to-salvage-weekly-adriamycin-after-progression-on-multiple-prior-regimens weekly 0.8 https://www.themednet.org/do-you-resume-immunotherapy-such-as-nivolumab-for-metastatic-melanoma-after-therapy-induced-grade-4-hyperglycemia-that-has-resolved weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-a-history-of-non-seminomatous-germ-cell-tumor-who-has-a-rising-afp-after-primary-chemotherapy-without-any-imaging-evidence-of-recurrence weekly 0.8 https://www.themednet.org/what-normal-tissue-constraints-do-you-use-when-treating-a-palliative-head-and-neck-patient-with-the-quad-shot weekly 0.8 https://www.themednet.org/for-male-patients-in-chronic-phase-cml-on-a-tki-and-not-yet-in-a-mmr-is-there-a-preferred-amount-of-time-spent-in-a-mmr-before-discontinuing-tki-therapy-to-conceive-or-bank-sperm weekly 0.8 https://www.themednet.org/what-strategies-have-you-found-to-be-most-helpful-in-improving-patient-compliance-with-vaginal-dilator-use-after-pelvic-radiotherapy weekly 0.8 https://www.themednet.org/when-do-you-suggest-ovarian-suppression-for-fertility-preservation-in-premenopausal-women-receiving-neo-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/would-you-ever-omit-adjuvant-therapy-for-rectal-cancer-in-patients-who-underwent-primary-resection-tme-without-any-neoadjuvant-therapy weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-do-you-use-for-palliative-radiotherapy-of-gi-carcinoid-tumor-metastatic-to-spine-bone weekly 0.8 https://www.themednet.org/how-do-you-manage-the-neck-in-patients-with-cutaneous-scc-who-are-at-high-risk-of-nodal-disease-but-had-a-negative-neck-dissection weekly 0.8 https://www.themednet.org/can-you-treat-the-regional-lymphatics-when-using-a-prone-technique-for-treating-the-whole-breast weekly 0.8 https://www.themednet.org/when-treating-prostate-or-other-pelvic-malignancies-what-dose-constraints-do-you-use-for-the-sigmoid-colon weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-upfront-treatment-of-anaplastic-large-cell-lymphoma-alk-positive-with-low-ipi-score-in-a-young-person weekly 0.8 https://www.themednet.org/would-you-use-ado-trastuzumab-as-first-line-therapy-for-metastatic-her2-breast-cancer-in-a-post-menopausal-woman-who-developed-metastatic-disease-years-after-finishing-dual-her2-directed-therapy weekly 0.8 https://www.themednet.org/do-you-rely-on-ki67-as-an-estimate-of-proliferation-to-guide-the-decision-for-chemotherapy-in-premenopausal-women-with-hormonally-driven-breast-tumors weekly 0.8 https://www.themednet.org/do-you-recommend-msi-testing-to-any-tumor-that-is-not-already-eligible-for-immunotherapy weekly 0.8 https://www.themednet.org/do-you-recommend-adjuvant-or-indefinite-systemic-therapy-after-surgery-radiation-for-patients-with-synchronous-bilateral-breast-cancers-that-are-of-the-same-histology-and-receptor-status weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-to-help-guide-treatment-for-patients-with-high-grade-large-cell-neuroendocrine-cancers-of-the-lung weekly 0.8 https://www.themednet.org/would-you-recommend-an-inguinal-node-dissection-as-part-of-definitive-treatment-for-adenocarcinoma-of-the-anus-with-suspicious-inguinal-nodes weekly 0.8 https://www.themednet.org/how-do-you-manage-rituximab-induced-neutropenia weekly 0.8 https://www.themednet.org/would-you-use-a-platinum-containing-regimen-in-the-adjuvant-setting-for-a-triple-negative-breast-cancer-patient-with-contraindications-to-anthracycline-based-therapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-locally-recurrent-prostate-cancer-following-cryotherapy-or-hifu weekly 0.8 https://www.themednet.org/what-is-the-appropriate-timing-of-crt-after-turbt-for-bladder-preservation-in-the-treatment-of-bladder-cancer weekly 0.8 https://www.themednet.org/how-often-do-you-monitor-aml-patients-after-transplant-for-recurrence weekly 0.8 https://www.themednet.org/were-there-any-practice-changing-studies-for-pancreatic-cancer-presented-at-the-asco-2017-annual-meeting weekly 0.8 https://www.themednet.org/is-venetoclax-expected-to-be-useful-in-patients-with-refractory-cll-sll-who-do-not-have-del-17p weekly 0.8 https://www.themednet.org/for-patients-who-have-completed-up-front-docetaxel-for-metastatic-castration-sensitive-prostate-cancer-should-they-proceed-to-abiraterone-before-the-development-of-castration-resistance weekly 0.8 https://www.themednet.org/given-results-of-the-idea-study-presented-at-asco-would-you-consider-truncating-adjuvant-therapy-with-stage-ii-colon-cancer weekly 0.8 https://www.themednet.org/how-would-you-deliver-salvage-prostate-bed-radiation-in-a-patient-with-a-neobladder weekly 0.8 https://www.themednet.org/should-axillary-imaging-be-routinely-performed-in-all-patients-with-a-new-diagnosis-of-breast-cancer weekly 0.8 https://www.themednet.org/would-you-treat-an-unresectable-papillary-thyroid-carcinoma-metastasis-to-the-nasopharynx-with-skull-base-and-perineurial-invasion-with-radioactive-iodine-radiation-therapy-or-chemo-radiation weekly 0.8 https://www.themednet.org/given-the-results-from-the-bilcap-trial-presented-at-asco-would-you-change-to-or-initiate-therapy-with-capecitabine-for-patients-with-biliary-tract-cancer-in-the-post-operative-setting weekly 0.8 https://www.themednet.org/what-would-be-your-frontline-therapeutic-choice-for-a-patient-with-stage-iv-pancreatic-adenocarcinoma-with-good-ps-but-elevated-bilirubin-4-5-due-to-tumor-volume weekly 0.8 https://www.themednet.org/have-the-results-of-lap07-caused-your-institution-to-pursue-more-aggressive-systemic-therapy-before-radiotherapy-in-the-treatment-of-pancreatic-cancer weekly 0.8 https://www.themednet.org/in-which-patients-will-you-consider-the-use-of-adjuvant-pertuzumab-for-her2-positive-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/when-would-a-completion-inguinofemoral-node-dissection-followed-by-adjuvant-rt-chemo-be-favored-over-definitive-rt-chemo-for-sln-vulvar-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-radiation-for-anorectal-mucosal-melanoma-s-p-wide-local-excision weekly 0.8 https://www.themednet.org/for-patients-receiving-concurrent-chemoradiation-for-anal-cancer-what-is-your-anc-threshold-for-holding-radiation-or-switching-to-a-boost-plan-to-limit-myelotoxicity weekly 0.8 https://www.themednet.org/for-a-young-patient-with-stage-4-endometrial-cancer-with-an-excellent-response-to-anthracyclines-would-you-continue-to-give-anthracyclines-beyond-the-standard-dosage-cap-if-cardiac-function-remains-normal-by-echocardiogram weekly 0.8 https://www.themednet.org/how-would-you-approach-an-adjuvant-prostate-cancer-case-if-small-bowel-falls-into-the-prostate-bed weekly 0.8 https://www.themednet.org/based-on-the-findings-of-the-calor-trial-among-which-group-of-patients-with-locoregional-recurrence-of-hormone-receptor-positive-breast-cancer-would-you-treat-with-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-thoracic-treatment-volumes-for-limited-stage-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/are-there-any-indications-on-advanced-stage-hodgkins-disease-that-one-might-consider-stopping-the-bleomycin-after-first-two-cycles weekly 0.8 https://www.themednet.org/do-you-routinely-use-imrt-to-spare-the-carotids-for-early-stage-glottic-cancer weekly 0.8 https://www.themednet.org/in-women-in-whom-you-suspect-chemotherapy-induced-amenorrhea-and-are-required-to-start-an-ai-what-is-your-strategy-with-regard-to-ovarian-suppression weekly 0.8 https://www.themednet.org/for-linac-based-fractionated-radiosurgery-5-fx-to-a-brainstem-metastasis-is-there-a-dose-constraint-for-normal-brainstem-outside-of-the-target-volume weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-adjuvant-radiation-for-r1-resected-paragangliomas weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-a-patient-with-locally-advanced-cervical-cancer-as-well-as-synchronous-endometrial-adenocarcinoma weekly 0.8 https://www.themednet.org/would-you-consider-omitting-breast-radiation-in-a-male-with-early-stage-breast-cancer-who-has-undergone-bct weekly 0.8 https://www.themednet.org/for-elderly-patients-who-cannot-tolerate-chemotherapy-is-radiation-alone-an-option-for-a-stage-ia-favorable-classical-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-when-deciding-whether-to-offer-radiation-for-thyroid-associated-ophthalmopathy weekly 0.8 https://www.themednet.org/do-you-consider-local-therapy-in-a-patient-with-de-novo-metastatic-triple-negative-breast-cancer-who-has-a-complete-response-to-first-line-chemotherapy weekly 0.8 https://www.themednet.org/what-is-the-recommended-treatment-volume-for-residual-or-recurrent-pituitary-adenoma-after-resection weekly 0.8 https://www.themednet.org/in-patients-with-good-performance-status-metastatic-clear-cell-kidney-cancer-and-minimal-metastatic-disease-would-you-consider-nephrectomy-or-partial-nephrectomy-if-there-are-mets-to-brain weekly 0.8 https://www.themednet.org/how-would-you-approach-therapy-for-a-localized-adenoid-cystic-carcinoma-of-the-breast weekly 0.8 https://www.themednet.org/can-sib-technique-be-used-for-gbm-treatment weekly 0.8 https://www.themednet.org/should-additional-molecular-testing-be-performed-on-triple-negative-breast-cancers-up-front-to-identify-potentially-targetable-mutations-e-g-activating-her2-mutations-homologous-recombination-repair-deficiency-assays-etc weekly 0.8 https://www.themednet.org/how-do-you-manage-endocrine-therapy-for-premenopausal-women-with-breast-cancer-who-are-heterozygous-for-factor-v-leiden-but-have-no-history-of-thrombosis weekly 0.8 https://www.themednet.org/are-there-any-cases-for-which-you-would-limit-the-dose-to-the-scapula-or-ribs-when-treating-the-breast-chest-wall-and-regional-nodes weekly 0.8 https://www.themednet.org/would-you-consider-pembrolizumab-treatment-in-metastatic-gastric-cancer-with-absence-expression-of-a-single-mismatch-repair-enzyme weekly 0.8 https://www.themednet.org/what-dose-fractionation-schedule-do-you-utilize-to-treat-a-locally-advanced-symptomatic-breast-mass-in-a-patient-with-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/knowing-that-spread-of-lobular-carcinoma-is-often-more-insidious-than-ductal-carcinoma-do-you-order-different-staging-studies-for-lobular-cancer weekly 0.8 https://www.themednet.org/in-the-modern-era-what-volume-of-involvement-is-considered-limited-stage-sclc weekly 0.8 https://www.themednet.org/do-you-ever-use-altered-fractionation-in-the-postoperative-setting-for-patients-with-head-and-neck-scc weekly 0.8 https://www.themednet.org/how-soon-after-pelvic-rt-can-a-routine-colonoscopy-be-completed weekly 0.8 https://www.themednet.org/aside-from-the-number-and-volume-of-brain-metastases-what-factors-do-you-consider-when-choosing-between-repeat-wbrt-or-srs-in-a-patient-who-has-received-prior-wbrt weekly 0.8 https://www.themednet.org/how-would-you-treat-stage-3-lymphocyte-predominant-hodgkin-lymphoma-that-is-cd20-negative weekly 0.8 https://www.themednet.org/does-anaphylactoid-reaction-to-one-immunotherapy-agent-exclude-the-possibility-of-using-other-immunotherapy-agents weekly 0.8 https://www.themednet.org/under-what-circumstances-do-you-offer-post-operative-spine-srs-over-standard-ebrt weekly 0.8 https://www.themednet.org/do-you-use-off-label-olaparib-in-metastatic-her2-negative-brca2-positive-breast-cancer-based-on-the-olympiad-data-presented-at-asco weekly 0.8 https://www.themednet.org/when-do-you-offer-observation-for-resected-stage-ii-endometrial-cancer weekly 0.8 https://www.themednet.org/does-neurosurgery-need-to-be-consulted-for-assessment-of-spinal-stability-in-patients-with-cervical-spine-mets-prior-to-starting-rt weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-for-patients-with-painful-gynecomastia-on-anti-androgen-therapy-for-prostate-cancer weekly 0.8 https://www.themednet.org/in-which-her2-breast-cancer-patients-would-you-recommend-extended-adjuvant-therapy-with-neratinib weekly 0.8 https://www.themednet.org/would-you-consider-local-therapy-e-g-xrt-in-patients-with-mrcc-with-oligometastatic-disease-progression-1 weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-for-metastatic-cutaneous-squamous-cell-carcinoma-after-standard-chemotherapy-failure weekly 0.8 https://www.themednet.org/in-a-patient-with-resected-er-her2-breast-cancer-how-do-you-decide-between-tc-vs-ddac-t-for-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/would-you-consider-exemestane-instead-of-fulvestrant-in-post-menopausal-patients-with-hormone-receptor-pos-her2-breast-cancer-who-progress-on-letrozole-or-anastrozole weekly 0.8 https://www.themednet.org/how-do-you-simulate-a-patient-with-a-large-beard-who-needs-a-thermoplastic-mask weekly 0.8 https://www.themednet.org/what-systemic-therapies-would-you-consider-for-a-patient-with-her2-positive-breast-cancer-with-progressive-brain-metastases-despite-whole-brain-radiation-but-no-systemic-disease weekly 0.8 https://www.themednet.org/what-systemic-therapy-would-you-offer-a-colon-cancer-patient-after-resection-of-oligometastatic-disease-that-developed-while-on-adjuvant-therapy weekly 0.8 https://www.themednet.org/would-you-continue-her-2-neu-directed-therapy-for-a-patient-with-breast-cancer-if-a-biopsy-on-progression-confirms-her-2-neu-negative-disease weekly 0.8 https://www.themednet.org/would-you-offer-breast-conservation-or-pmrt-if-clinically-warranted-to-someone-with-breast-cancer-in-the-context-of-li-fraumeni-syndrome weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-for-isolated-lung-recurrences-in-patients-that-did-not-tolerate-chemotherapy-after-lobectomy weekly 0.8 https://www.themednet.org/can-radium-223-be-given-to-patients-who-have-osseous-metastases-with-a-history-of-visceral-metastatic-disease weekly 0.8 https://www.themednet.org/when-treating-with-high-tangents-do-you-use-conventional-fractionation-or-hypofractionation weekly 0.8 https://www.themednet.org/would-you-consider-localized-therapies-such-as-radiofrequency-ablation-to-a-lung-metastasis-or-yttrium-90-for-liver-metastases-for-disease-control-for-er-her2-breast-cancer-patients-with-visceral-oligometastatic-disease-who-have-progressed-on-all-hormonal weekly 0.8 https://www.themednet.org/how-do-you-sequence-therapy-for-metastatic-nsclc-patient-with-a-braf-v600e-mutation weekly 0.8 https://www.themednet.org/would-you-send-a-gene-assay-like-mammoprint-or-oncotype-on-a-small-1-cm-lymph-node-negative-lobular-infiltrating-carcinoma weekly 0.8 https://www.themednet.org/would-you-use-lapatinib-to-prevent-recurrence-of-brain-mets-in-a-patient-with-recurrent-brain-only-mets-from-her2-breast-cancer-now-rendered-ned-after-radiation weekly 0.8 https://www.themednet.org/what-is-the-appropriate-target-volume-for-sbrt-to-a-non-vertebral-osseous-metastasis weekly 0.8 https://www.themednet.org/is-there-a-volume-limit-above-which-you-might-not-offer-standard-chemoradiation-for-a-patient-with-a-gbm weekly 0.8 https://www.themednet.org/how-do-you-treat-the-seminal-vesicles-when-using-moderate-hypofractionation-for-prostate-cancer weekly 0.8 https://www.themednet.org/in-a-patient-with-er-pr-positive-metastatic-breast-cancer-with-cns-disease-progression-on-tamoxifen-would-you-consider-ai-palbo-or-capecitabine weekly 0.8 https://www.themednet.org/for-a-patient-with-metastatic-colon-cancer-kras-wt-when-would-you-consider-using-egfr-cetuximab-panitumumab-over-vegf-bevacizumab-antagonists-as-inital-therapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-an-advanced-stage-diffuse-large-b-cell-lymphoma-treated-with-chemotherapy-alone-with-a-pet-cr-who-then-develops-an-isolated-cns-relapse weekly 0.8 https://www.themednet.org/do-you-ever-offer-repeat-radiation-for-hepatobiliary-cancers-in-cases-of-local-recurrence-after-definitive-external-beam-or-sbrt weekly 0.8 https://www.themednet.org/what-chemotherapy-regimen-would-you-recommend-for-a-patient-with-symptomatic-cutaneous-b-cell-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-biochemical-relapse-of-high-risk-prostate-cancer-with-psa-doubling-time-less-than-6-months weekly 0.8 https://www.themednet.org/how-would-you-utilize-adjuvant-radiation-therapy-in-a-patient-with-a-cutaneous-spindle-cell-neoplasm-of-the-scalp-metastatic-to-the-parotid-gland weekly 0.8 https://www.themednet.org/what-is-your-next-step-in-management-for-a-patient-with-immunotherapy-induced-pneumonitis-that-does-not-improve-on-high-dose-steroids-for-48-hours weekly 0.8 https://www.themednet.org/what-factors-would-make-you-consider-adding-adjuvant-radiation-to-the-neck-of-h-n-cancer-after-a-negative-dissection-pn0 weekly 0.8 https://www.themednet.org/how-do-you-decide-between-re-irradiation-chemotherapy-and-alternating-electric-field-therapy-in-patients-with-relapsed-gbm-post-chemoradiation-with-tmz weekly 0.8 https://www.themednet.org/do-you-offer-consolidative-rt-for-patients-with-oligometastatic-nsclc-who-initially-presented-with-a-malignant-pleural-effusion weekly 0.8 https://www.themednet.org/how-do-you-approach-the-workup-of-subcentimeter-contralateral-nodules-in-cases-of-locally-advanced-nsclc weekly 0.8 https://www.themednet.org/is-there-utility-in-molecular-or-proteomic-testing-e-g-foundation-or-caris-for-metastatic-clear-cell-renal-cell-carcinoma-when-several-lines-have-failed weekly 0.8 https://www.themednet.org/in-multiple-myeloma-patients-on-bortezomib-and-dexamethasone-who-develop-hzv-reactivation-while-on-hzv-prophylaxis-do-you-stop-bortezomib-dexamethasone-permanently weekly 0.8 https://www.themednet.org/what-is-your-preferred-dosing-and-schedule-for-interferon-in-pregnant-cml-patients weekly 0.8 https://www.themednet.org/how-do-you-manage-recurrent-cns-ependymoma weekly 0.8 https://www.themednet.org/do-you-evaluate-patients-for-low-health-literacy-prior-to-discussing-treatment-options weekly 0.8 https://www.themednet.org/what-is-the-role-of-radiation-in-regionally-recurrent-gastric-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-volumes-and-dosing-around-post-operative-neck-dissection-scars-in-patients-with-head-and-neck-sccs weekly 0.8 https://www.themednet.org/how-would-you-use-oncotype-for-adjuvant-colon-cancer-treatment-decisions weekly 0.8 https://www.themednet.org/how-do-you-approach-the-development-of-an-lgl-clone-in-a-nhl-patient-actively-getting-therapy weekly 0.8 https://www.themednet.org/what-systemic-therapy-if-any-would-you-recommend-for-a-patient-with-oligometastatic-melanoma-who-is-rendered-ned-after-resection weekly 0.8 https://www.themednet.org/what-factors-do-you-use-to-determine-whether-an-enlarging-lesion-after-srs-is-radionecrosis-versus-progression weekly 0.8 https://www.themednet.org/what-is-the-appropriate-role-for-radiation-therapy-in-patients-with-hcc-or-intrahepatic-cholangiocarcinoma-who-are-transplant-candidates weekly 0.8 https://www.themednet.org/would-you-recommend-anti-hormonal-therapy-in-a-patient-with-dcis-that-is-er-pr-positive-between-1-9 weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-radiotherapy-for-pancreatic-adenocarcinoma-following-surgical-resection weekly 0.8 https://www.themednet.org/what-is-your-approach-for-post-implant-dosimetry-when-utilizing-a-focal-ldr-prostate-implant-for-salvage-after-a-localized-primary-ldr-brachytherapy-failure weekly 0.8 https://www.themednet.org/how-do-you-approach-choice-of-systemic-chemotherapy-for-a-young-and-otherwise-healthy-patient-with-her2-negative-esophogeal-adenocarcinoma weekly 0.8 https://www.themednet.org/do-you-recommend-imaging-surveillance-vs-adjuvant-rt-for-a-large-low-grade-sarcoma-of-the-lower-extremity-with-multiple-positive-margins weekly 0.8 https://www.themednet.org/when-treating-high-grade-gliomas-abutting-critical-structures-how-do-you-balance-tumor-dose-with-critical-structure-constraints weekly 0.8 https://www.themednet.org/what-dose-constraint-do-you-use-for-the-brainstem-for-repeat-cranial-irradiation weekly 0.8 https://www.themednet.org/what-would-be-your-choice-and-duration-of-adjuvant-therapy-for-a-perforated-msi-h-stage-ii-t4n0-colon-cancer weekly 0.8 https://www.themednet.org/is-a-cll-fish-panel-sufficient-to-aid-in-treatment-decisions-in-cll-or-is-p53-sequence-analysis-also-needed weekly 0.8 https://www.themednet.org/how-would-you-treat-metastatic-squamous-esophageal-carcinoma-that-is-her2-negative weekly 0.8 https://www.themednet.org/would-you-recommend-any-adjuvant-therapy-for-a-premenopausal-woman-with-er-microinvasive-breast-cancer-who-cannot-tolerate-tamoxifen weekly 0.8 https://www.themednet.org/is-there-evidence-to-suggest-that-srs-sbrt-for-spine-or-bone-metastases-provides-faster-and-more-durable-palliative-relief-or-soft-tissue-decompression-than-a-fractionated-course weekly 0.8 https://www.themednet.org/how-do-you-interpret-and-utilize-psa-values-in-patients-on-dialysis weekly 0.8 https://www.themednet.org/would-you-recommend-post-operative-radiation-to-an-oligometastatic-subcutaneous-lesion-resected-with-positive-microscopic-margins weekly 0.8 https://www.themednet.org/do-you-recommend-using-oncotype-dx-prior-to-hormonal-or-cytotoxic-neoadjuvant-therapy-in-ln-negative-er-positive-her2-negative-breast-cancer weekly 0.8 https://www.themednet.org/when-do-you-consider-is-too-late-after-resection-to-offer-adjuvant-therapy-for-high-grade-osteosarcoma weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-for-the-management-of-choroidal-oligometastases weekly 0.8 https://www.themednet.org/how-do-you-monitor-for-cardiac-toxicity-in-patients-taking-osimertinib weekly 0.8 https://www.themednet.org/do-you-use-endocrine-therapy-concurrently-or-sequentially-with-radiation-therapy-in-hormone-receptor-positive-breast-cancer-patients weekly 0.8 https://www.themednet.org/can-rt-to-non-bulky-sites-be-omitted-in-an-early-stage-stage-i-or-ii-classical-hodgkins-lymphoma-case-with-a-cr-by-pet-ct weekly 0.8 https://www.themednet.org/is-superficial-underdosing-of-hypofractionated-breast-rt-acceptable-in-patients-with-a-large-breast-separation weekly 0.8 https://www.themednet.org/what-imaging-schedule-do-you-use-for-patients-with-sclc-who-choose-surveillance-over-immediate-pci weekly 0.8 https://www.themednet.org/do-you-omit-anthracyclines-in-triple-positive-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-front-line-regimen-for-metastatic-squamous-cell-nsclc-that-is-pd-l1-and-driver-mutation-negative weekly 0.8 https://www.themednet.org/do-you-consider-alternate-therapy-with-a-different-anti-pd1-agent-after-a-patient-responds-to-an-anti-ctla4-anti-pd1-agent-but-develops-serious-side-effects weekly 0.8 https://www.themednet.org/in-the-setting-of-head-and-neck-cancer-if-the-pathology-report-shows-extranodal-extension-ece-but-the-location-of-the-node-is-uncertain-how-do-you-define-your-boost-volume weekly 0.8 https://www.themednet.org/how-would-you-qualify-and-treat-a-patient-with-neutropenia-anemia-and-abnormal-nk-cell-population-with-normal-trilineage-marrow-maturation weekly 0.8 https://www.themednet.org/for-patients-demonstrating-ypn1-disease-on-slnb-following-neoadjuvant-chemotherapy-is-it-reasonable-to-proceed-with-regional-rt-in-lieu-of-axlnd-outside-of-the-alliance-a011202-trial weekly 0.8 https://www.themednet.org/what-dose-would-you-use-for-multifocal-recurrent-subtotally-resected-pleomorphic-adenoma-of-the-left-neck-salivary-glands weekly 0.8 https://www.themednet.org/in-patients-with-t790m-mutation-and-progression-of-disease-on-osimertinib-is-there-any-utility-in-checking-peripheral-blood-cdna-for-continued-presence-or-absence-of-the-t790m-mutation weekly 0.8 https://www.themednet.org/are-mammaprint-and-oncotypedx-as-useful-in-stratifying-risk-in-patients-with-early-stage-hr-her2-negative-lobular-carcinomas-as-in-those-with-ductal-carcinomas weekly 0.8 https://www.themednet.org/how-do-you-treat-a-parotid-warthins-tumor-in-a-medically-inoperable-patient weekly 0.8 https://www.themednet.org/do-you-treat-bilateral-trigeminal-neuralgia-with-srs weekly 0.8 https://www.themednet.org/for-a-malt-of-the-eyelid-do-you-treat-the-entire-conjunctiva-reflection-as-well-or-just-the-eyelid weekly 0.8 https://www.themednet.org/how-do-you-choose-between-azacitidine-and-decitabine-when-deciding-to-treat-a-patient-with-mds-with-a-hypomethylating-agent weekly 0.8 https://www.themednet.org/for-unresectable-typical-carcinoid-what-is-the-appropriate-radiation-regimen weekly 0.8 https://www.themednet.org/would-you-prescribe-an-aromatase-inhibitor-prophylactically-for-a-post-menopausal-woman-with-a-deleterious-brca2-mutation-and-a-history-of-dcis-who-declines-prophylactic-mastectomy weekly 0.8 https://www.themednet.org/when-giving-hypofractionated-ablative-doses-of-radiation-for-cholangiocarcinoma-do-you-give-concurrent-xeloda-or-hold-chemo-during-radiation weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-you-are-deciding-whether-to-recommend-endocrine-therapy-for-a-woman-who-has-had-a-mastectomy-for-dcis-for-contralateral-breast-cancer-risk-reduction weekly 0.8 https://www.themednet.org/what-would-you-recommend-as-adjuvant-treatment-for-a-patient-with-stage-iii-melanoma weekly 0.8 https://www.themednet.org/when-treating-a-patient-with-colon-cancer-with-adjuvant-folfox-in-what-situation-if-any-would-you-consider-removing-the-5-fu-bolus-empirically weekly 0.8 https://www.themednet.org/for-localized-esophageal-cancer-in-patients-with-preexisting-neuropathy-what-do-you-use-concurrently-with-radiation-therapy weekly 0.8 https://www.themednet.org/would-you-consider-using-tamoxifen-instead-of-an-ai-in-a-post-menopausal-women-with-er-and-or-pr-breast-cancer-who-cant-wont-discontinue-hormone-replacement-therapy weekly 0.8 https://www.themednet.org/how-do-you-treat-vaginal-dryness-associated-with-estrogen-deprivation-therapy-for-er-and-or-pr-breast-cancer weekly 0.8 https://www.themednet.org/how-long-after-intrathecal-chemotherapy-do-you-typically-wait-before-giving-whole-brain-radiation weekly 0.8 https://www.themednet.org/how-long-to-do-you-wait-after-resection-of-gbm-to-start-radiation weekly 0.8 https://www.themednet.org/how-does-your-approach-to-contouring-change-when-treating-pancreatic-body-tail-lesions-vs-head-tumors-in-the-postop-setting weekly 0.8 https://www.themednet.org/do-you-use-avastin-in-patients-with-history-of-vte-dvt-pe-who-are-stable-on-anticoagulation weekly 0.8 https://www.themednet.org/how-do-you-manage-recurrent-atypical-meningiomas-in-patients-who-have-previously-received-radiotherapy weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-gastric-ge-junction-carcinoma-who-has-positive-lymph-nodes-at-resection-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/in-patients-with-recurrent-advanced-ovarian-carcinoma-and-a-hypersensitivity-reaction-to-platinum-do-you-prefer-a-desensitization-protocol-to-maximize-response-or-switching-to-a-non-platinum-regimen weekly 0.8 https://www.themednet.org/what-is-the-maximum-acceptable-hot-spot-for-hypofractionation-breast weekly 0.8 https://www.themednet.org/what-is-your-preferred-non-taxane-chemotherapy-regimen-for-early-stage-her2-negative-breast-cancer-patients-who-develop-grade-3-4-neuropathy-before-completion-of-taxane-based-therapy weekly 0.8 https://www.themednet.org/do-you-take-patients-off-anticoagulation-for-tandem-and-ovoid-or-tandem-and-ring-procedures weekly 0.8 https://www.themednet.org/what-dosimetric-or-physics-considerations-would-you-take-for-the-treatment-of-the-prostate-and-pelvic-lns-in-patients-with-a-penile-pump-prosthesis-implant weekly 0.8 https://www.themednet.org/how-are-you-incorporating-abscopal-radiation-into-your-practice-for-metastatic-nsclc weekly 0.8 https://www.themednet.org/how-do-you-do-immobilization-for-liver-sbrt weekly 0.8 https://www.themednet.org/do-you-routinely-use-imaging-us-whole-body-iodine-scans-etc-to-follow-papillary-or-follicular-thyroid-cancer-after-thyroidectomy-and-rai-therapy weekly 0.8 https://www.themednet.org/what-features-would-make-you-consider-covering-elective-nodes-in-a-locally-advanced-node-negative-paranasal-sinus-scc weekly 0.8 https://www.themednet.org/how-do-you-decide-on-the-optimal-neoadjuvant-regimen-for-locally-advanced-gej-cancer weekly 0.8 https://www.themednet.org/is-there-a-role-for-herceptin-in-the-preoperative-chemoradiation-regimen-for-her2-esophageal-adenocarcinoma-ct3n0 weekly 0.8 https://www.themednet.org/is-there-a-role-for-induction-chemotherapy-for-locally-advanced-head-and-neck-squamous-cell-carcinoma-prior-to-definitive-chemoradiation weekly 0.8 https://www.themednet.org/is-there-a-role-for-port-in-a-n1-nsclc-patient-who-refuses-chemotherapy-after-lobectomy weekly 0.8 https://www.themednet.org/what-is-the-appropriate-treatment-approach-for-a-primary-squamous-cell-carcinoma-of-the-trachea weekly 0.8 https://www.themednet.org/in-a-patient-with-resected-nsclc-whose-only-site-of-relapse-is-cns-treated-with-wbrt-or-sbrt-would-you-also-start-systemic-therapy-with-erlotinib-afatinib-if-the-patient-was-found-to-be-egfr-positive weekly 0.8 https://www.themednet.org/what-do-you-use-for-post-treatment-follow-up-for-prostate-cancer-patients-whose-cancers-make-little-to-no-psa-such-as-very-high-gleason-grade-neuroendocrine-tumors weekly 0.8 https://www.themednet.org/based-on-the-flaura-trial-would-you-consider-using-osimertinib-firstline-in-egfr-mutated-nsclc weekly 0.8 https://www.themednet.org/how-do-you-manage-multifocal-glioblastoma-or-high-grade-gliomas weekly 0.8 https://www.themednet.org/would-you-consider-concurrent-chemort-for-unresectable-bladder-adenocarcinoma weekly 0.8 https://www.themednet.org/how-do-you-choose-among-regimens-for-relapsed-refractory-myeloma weekly 0.8 https://www.themednet.org/would-you-consider-a-distal-esophageal-adenocarcinoma-as-a-gej-cancer-to-be-able-to-use-immune-check-point-inhibitor-therapy weekly 0.8 https://www.themednet.org/how-do-you-treat-elective-neck-regions-in-a-patient-with-a-second-primary-hn-cancer-and-prior-neck-dissection-and-radiation weekly 0.8 https://www.themednet.org/how-do-you-handle-the-situation-where-a-curative-intent-patient-unexpectedly-passes-away-while-under-treatment weekly 0.8 https://www.themednet.org/when-is-radiation-indicated-in-the-treatment-of-perianal-pagets-disease weekly 0.8 https://www.themednet.org/is-sbrt-appropriate-for-a-small-endobronchial-tumor-distal-to-the-proximal-bronchial-tree weekly 0.8 https://www.themednet.org/does-p16-status-hpv-influence-your-decision-on-whether-to-offer-adjuvant-chemoradiation-or-radiation-in-node-positive-h-n-cancers weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-locally-advanced-cervical-cancer-who-presents-with-a-fistula-rectal-or-bladder weekly 0.8 https://www.themednet.org/how-would-you-approach-patients-with-egfr-mutation-positive-exon-19-nsclc-who-rapidly-progress-on-front-line-egfr-inhibition-with-first-generation-tki-at-first-imaging weekly 0.8 https://www.themednet.org/would-you-treat-the-chest-wall-alone-in-a-patient-that-had-a-previous-prophylactic-mastectomy-and-later-developed-an-early-stage-breast-cancer-pt1-2n0-after-a-lumpectomy weekly 0.8 https://www.themednet.org/are-there-any-situations-where-you-would-you-add-docetaxel-to-gemcitabine-capecitabine-for-locally-advanced-unresectable-pancreatic-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-adjuvant-chemotherapy-for-local-relapse-of-invasive-lobular-carcinoma-after-surgical-resection weekly 0.8 https://www.themednet.org/what-palliative-radiation-dose-would-you-give-to-a-patient-with-vulvar-cancer-who-has-an-inguinal-recurrence-in-a-field-previously-irradiated-with-45-gy weekly 0.8 https://www.themednet.org/how-do-you-determine-the-most-appropriate-intraocular-lens-choice-for-children-teens-based-on-age-and-developmental-stage weekly 0.8 https://www.themednet.org/do-you-routinely-check-csf-cell-counts-and-cultures-on-patients-with-external-ventricular-drains-to-monitor-for-infection weekly 0.8 https://www.themednet.org/do-you-incorporate-laser-hair-removal-into-your-treatment-plan-for-patients-with-hs weekly 0.8 https://www.themednet.org/what-factors-influence-your-decision-to-recommend-surgical-versus-non-surgical-options-for-patients-with-severe-skin-laxity-post-weight-loss weekly 0.8 https://www.themednet.org/would-you-consider-a-secondary-prevention-icd-in-a-patient-who-had-a-cardiac-arrest-deemed-attributable-to-a-spontaneous-coronary-artery-dissection-scad-with-no-intervention-performed weekly 0.8 https://www.themednet.org/what-cochlear-dose-constraint-if-any-would-you-use-when-treating-an-acoustic-neuroma-without-serviceable-hearing-on-that-side weekly 0.8 https://www.themednet.org/how-do-you-approach-boost-to-the-lumpectomy-cavity-and-4-lymph-nodes-with-extra-nodal-extension-when-treating-breast-cancer-with-hypofractionation weekly 0.8 https://www.themednet.org/what-barretts-esophagus-screening-protocol-do-you-follow-for-patients-with-scleroderma-given-the-increased-risk-of-reflux-and-esophageal-stasis weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-primary-cns-lymphoma-who-received-r-mtx-followed-by-autologous-transplant-with-systemic-relapse-5-years-later-for-which-r-pola-chp-was-given-now-followed-by-cns-relapse weekly 0.8 https://www.themednet.org/when-do-you-obtain-nerve-biopsy-to-evaluate-for-vasculitic-neuropathy-in-patients-with-distal-symmetric-polyneuropathies weekly 0.8 https://www.themednet.org/do-you-recommend-using-a-24-hour-urinary-cortisol-urinary-creatinine-ratio-over-a-24-hour-urine-cortisol-to-screen-patients-for-cushings-syndrome weekly 0.8 https://www.themednet.org/what-dietary-modifications-do-you-recommend-for-the-management-of-type-2-diabetes-considering-the-benefits-of-mediterranean-plant-based-low-carbohydrate-and-ketogenic-diets weekly 0.8 https://www.themednet.org/how-would-you-treat-a-t2n1-er-90-pr-10-her-2-negative-breast-cancer-in-premenopausal-women-with-a-tumor-abutting-the-pectoralis-fascia-with-loss-of-fat-plane-with-a-concern-for-a-positive-surgical-margin weekly 0.8 https://www.themednet.org/what-is-your-risk-benefit-analysis-when-deciding-on-the-appropriateness-and-timing-for-discontinuation-of-systemic-anticoagulation-in-patients-who-underwent-ablation-for-paroxysmal-atrial-fibrillation-with-chads2vasc-score-2 weekly 0.8 https://www.themednet.org/do-you-take-any-special-considerations-when-working-up-a-pregnant-patient-for-secondary-causes-of-hypertension weekly 0.8 https://www.themednet.org/how-would-you-manage-a-solitary-painful-lytic-bony-lesion-in-a-patient-with-negative-pet-ct-but-bone-marrow-biopsy-confirmation-of-multiple-myeloma weekly 0.8 https://www.themednet.org/what-is-your-typical-steroid-taper-regimen-for-managing-ra-flares weekly 0.8 https://www.themednet.org/do-you-routinely-perform-muscle-biopsies-in-patients-presenting-with-the-classic-symptoms-of-inclusion-body-myositis-along-with-positive-cn1a-antibody weekly 0.8 https://www.themednet.org/in-an-adult-patient-with-asymptomatic-isolated-neutropenia-in-whom-you-suspect-a-duffy-null-phenotype-at-what-anc-or-in-what-situations-would-you-do-a-bone-marrow-to-look-for-other-etiologies-of-neutropenia weekly 0.8 https://www.themednet.org/how-have-the-results-of-the-balance-trial-which-demonstrated-the-noninferiority-of-7-days-of-antibiotics-compared-to-14-days-for-non-s-aureus-bloodstream-infections-influenced-your-practice weekly 0.8 https://www.themednet.org/what-is-your-approach-for-patients-who-have-marked-inter-arm-blood-pressure-differences-on-home-and-in-office-measurements weekly 0.8 https://www.themednet.org/do-you-recommend-initiating-treatment-with-an-sglt2-inhibitor-or-semaglutide-first-for-a-patient-with-obesity-and-heart-failure-with-preserved-ejection-fraction weekly 0.8 https://www.themednet.org/would-you-start-glycopyrrolate-in-elderly-population-and-how-do-you-counsel-the-patient weekly 0.8 https://www.themednet.org/how-do-you-approach-extensive-recurrent-genital-warts-that-have-failed-liquid-nitrogen-imiquimod-5-fluorouracil-and-electrodessication weekly 0.8 https://www.themednet.org/what-are-your-recommendations-for-perioperative-management-of-dmards-and-biologics-in-patients-undergoing-bariatric-surgery weekly 0.8 https://www.themednet.org/do-you-check-the-duffy-null-phenotype-before-starting-azathioprine-and-in-which-patients weekly 0.8 https://www.themednet.org/in-a-patient-with-type-i-von-willebrand-disease-who-is-pregnant-and-at-increased-risk-for-preeclampsia-would-you-recommend-treatment-with-aspirin weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-locally-excise-vs-deroof-a-persistent-draining-tunnel-in-a-patient-with-otherwise-medically-optimized-hs weekly 0.8 https://www.themednet.org/how-do-you-recommend-incorporating-b-lines-on-lung-pocus-as-part-of-evaluating-a-patients-volume-status weekly 0.8 https://www.themednet.org/how-will-you-treat-an-uterine-embryonal-rhabdomyosarcoma-with-regional-node-involvement-resected-to-involved-parametrial-margins weekly 0.8 https://www.themednet.org/is-the-combination-of-sglt2i-and-glp-1-r-agonist-therapy-contraindicated-in-patients-who-develop-an-episode-of-euglycemic-dka weekly 0.8 https://www.themednet.org/do-you-typically-excise-clear-cell-acanthomas weekly 0.8 https://www.themednet.org/how-often-do-you-recommend-eye-examinations-in-your-patients-with-primary-hyperoxaluria weekly 0.8 https://www.themednet.org/what-are-your-recommendations-for-stone-prevention-for-patients-with-recurrent-calcium-based-nephrolithiasis-who-consume-well-water-with-a-high-calcium-concentration weekly 0.8 https://www.themednet.org/when-would-you-consider-referring-a-patient-with-resistant-hypertension-for-renal-denervation weekly 0.8 https://www.themednet.org/is-there-a-role-for-early-glp-1-therapy-for-weight-loss-in-patients-with-early-stage-adpkd-and-obesity-given-the-association-between-obesity-and-the-risk-of-progression-to-eskd weekly 0.8 https://www.themednet.org/what-is-the-risk-of-radiation-therapy-to-an-abdominal-aortic-aneurysm-infiltrated-by-lymphoma weekly 0.8 https://www.themednet.org/do-you-recommend-a-metabolic-evaluation-in-a-kidney-transplant-patient-with-no-prior-history-of-nephrolithiasis-who-is-found-to-have-donor-derived-kidney-stones weekly 0.8 https://www.themednet.org/what-variables-do-you-weigh-most-heavily-when-choosing-which-copper-chelation-therapy-youll-recommend-for-a-patient weekly 0.8 https://www.themednet.org/how-would-you-approach-a-referral-for-concern-for-hemochromatosis-with-ferritin-elevation-but-otherwise-normal-iron-studies weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-to-a-patient-with-incidentally-found-low-ceruloplasmin weekly 0.8 https://www.themednet.org/how-do-you-manage-liver-enzyme-elevations-in-patients-with-pbc-after-starting-elanifibranor weekly 0.8 https://www.themednet.org/what-patient-factors-guide-your-selection-of-maintenance-therapies-for-a-patient-with-autoimmune-hepatitis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-anti-pruritic-therapies-in-patients-with-cholestatic-liver-disease weekly 0.8 https://www.themednet.org/what-kind-of-monitoring-do-you-choose-in-patients-at-risk-for-reactivation-of-hepatitis-b-who-are-on-immunosuppression weekly 0.8 https://www.themednet.org/all-things-being-equal-what-patient-factors-are-you-looking-at-in-the-selection-of-taf-or-tdf-in-the-management-of-hepatitis-b weekly 0.8 https://www.themednet.org/in-what-scenarios-do-you-defer-treatment-of-a-patients-hepatitis-c-if-they-are-undergoing-liver-transplant-evaluation weekly 0.8 https://www.themednet.org/how-do-you-explain-the-additional-risks-that-a-transplant-recipient-may-carry-by-pursuing-a-hepatitis-c-positive-organ-if-they-are-negative weekly 0.8 https://www.themednet.org/what-is-your-endoscopic-approach-to-the-management-of-refractory-gave-in-persistently-anemic-patients weekly 0.8 https://www.themednet.org/what-role-do-you-see-for-albumin-infusions-in-patients-with-hypoalbuminemia-to-help-assist-in-volume-status-outside-of-its-use-in-replenishment-after-a-large-volume-paracentesis-or-renal-dysfunction weekly 0.8 https://www.themednet.org/how-does-the-use-of-checkpoint-inhibitors-for-treatment-of-hcc-impact-timing-of-liver-transplant-and-subsequent-immunosuppression weekly 0.8 https://www.themednet.org/what-is-your-evaluation-approach-for-a-new-patient-referral-for-an-incidentally-found-liver-lesion weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-options-for-patients-with-fibrolamellar-hcc-compared-to-normal-hcc weekly 0.8 https://www.themednet.org/how-does-the-identification-of-a-hepatic-adenoma-in-a-male-patient-affect-your-management-and-evaluation weekly 0.8 https://www.themednet.org/how-much-do-you-factor-in-a-patients-frailty-in-selection-for-transplant-if-the-underlying-driver-for-their-debility-is-their-underlying-liver-disease-itself weekly 0.8 https://www.themednet.org/what-would-be-the-right-patient-profile-and-experience-for-someone-who-may-have-operational-tolerance-and-how-do-you-approach-immunosuppresison-management-or-withdrawal-in-this-patient weekly 0.8 https://www.themednet.org/how-do-you-determine-which-patients-are-good-candidates-to-have-their-organ-receive-machine-perfusion-therapy-before-implantation weekly 0.8 https://www.themednet.org/for-how-long-would-you-treat-a-patient-with-latent-tb-before-allowing-them-to-proceed-with-a-liver-transplant weekly 0.8 https://www.themednet.org/do-you-find-there-is-any-benefit-to-giving-n-acetyl-cysteine-in-non-acetaminophen-related-acute-liver-failure weekly 0.8 https://www.themednet.org/when-would-you-decide-to-pursue-plasma-exchange-in-a-patient-in-acute-liver-failure-due-to-sinusoidal-obstruction-syndrome weekly 0.8 https://www.themednet.org/how-do-you-utilize-liver-assistive-devices-in-the-management-algorithm-of-patients-with-acute-liver-failure weekly 0.8 https://www.themednet.org/when-do-you-pursue-liver-biopsy-for-assessment-of-dili weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-drug-induced-autoimmune-hepatitis-compared-to-non-drug-induced-autoimmune-hepatitis weekly 0.8 https://www.themednet.org/how-do-you-approach-fertility-family-planning-and-counseling-in-patients-with-end-stage-liver-disease weekly 0.8 https://www.themednet.org/what-management-considerations-do-you-keep-in-mind-in-the-management-of-pregnant-patients-with-autoimmune-liver-disease weekly 0.8 https://www.themednet.org/how-has-the-move-away-from-a-strict-6-month-period-of-sobriety-impacted-your-patient-selection-criteria-for-transplant-of-patients-with-alcohol-associated-liver-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-a-conversation-with-a-patient-with-a-markedly-positive-peth-200-ug-l-who-is-insistent-that-they-do-not-consume-any-alcohol weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-who-has-incidentally-found-liver-and-renal-cysts weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-an-elevated-alkaline-phosphatase-level-but-negative-pbc-serologies-and-normal-biliary-imaging weekly 0.8 https://www.themednet.org/how-do-you-utilize-cystatin-c-as-a-marker-of-renal-dysfunction-in-patients-with-chronic-liver-disease weekly 0.8 https://www.themednet.org/what-is-your-diagnostic-and-treatment-approach-for-patients-hospitalized-with-erythroderma weekly 0.8 https://www.themednet.org/what-would-be-a-reasonable-threshold-to-recommend-epicardial-crt-d-intra-op-in-a-patient-post-acs-with-lvef-35-qrs-duration-120-and-breakthrough-vt-undergoing-emergent-cabg weekly 0.8 https://www.themednet.org/for-a-patient-with-a-metastatic-solid-tumor-in-remission-on-a-checkpoint-inhibitor-who-also-has-r-r-multiple-myeloma-would-you-feel-comfortable-with-a-bispecific-t-cell-engager-antibody weekly 0.8 https://www.themednet.org/if-using-gcsf-with-mfolfirinox-would-you-ever-use-it-during-day-1 weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-nsclc-adenocarcinoma-subtype-with-braf-v600k-mutation-pd-l1-50-with-progression-on-1st-line-chemo-immunotherapy weekly 0.8 https://www.themednet.org/how-would-you-evaluate-and-manage-someone-with-leukoaraiosis-and-an-acute-ischemic-stroke weekly 0.8 https://www.themednet.org/what-radiation-treatment-volume-would-you-include-in-chemoradiation-given-for-perihilar-lymph-node-recurrence-after-surgical-resection-and-mediastinal-lymph-node-dissection-for-nsclc weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-low-grade-stage-ia-triple-negative-apocrine-adenocarcinoma-of-the-breast-in-a-female-patient-in-her-70s weekly 0.8 https://www.themednet.org/does-cinacalcet-reduce-hypercalciuria-in-primary-hyperparathyroidism weekly 0.8 https://www.themednet.org/can-fhh-present-with-marked-hypercalcemia-e-g-12-mg-dl weekly 0.8 https://www.themednet.org/are-there-any-special-considerations-to-take-into-account-when-managing-patients-with-recurrent-nephrolithiasis-who-are-found-to-have-a-horseshoe-kidney weekly 0.8 https://www.themednet.org/when-do-you-use-wearable-eeg-or-epilepsy-detection-devices-for-epilepsy-management weekly 0.8 https://www.themednet.org/would-you-start-once-weekly-tirzepatide-over-once-daily-basal-insulin-in-a-patient-with-type-2-diabetes-with-inadequate-control-on-oral-antihyperglycemia-drugs weekly 0.8 https://www.themednet.org/when-would-you-consider-switching-a-patient-with-insulin-requiring-type-2-dm-to-an-automated-insulin-delivery-system weekly 0.8 https://www.themednet.org/what-has-been-your-approach-to-minimizing-the-risk-of-vascular-complications-when-placing-impella-support-devices weekly 0.8 https://www.themednet.org/how-do-you-adjust-antipsychotic-treatment-during-pregnancy weekly 0.8 https://www.themednet.org/do-you-use-more-stringent-liver-constraints-when-treating-hcc-with-sbrt-in-patients-who-are-cp-b8-9-or-c weekly 0.8 https://www.themednet.org/would-you-recommend-off-label-use-of-nedosiran-for-patients-with-primary-hyperoxaluria-type-2 weekly 0.8 https://www.themednet.org/would-you-refer-an-eskd-patient-with-an-identified-living-donor-for-av-access-placement-if-kidney-transplantation-is-anticipated-in-4-months weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-prioritize-injectable-semaglutide-over-oral-semaglutide-in-patients-with-type-2-diabetes-with-atherosclerotic-cardiovascular-disease-or-chronic-kidney-disease weekly 0.8 https://www.themednet.org/what-is-a-reasonable-stepwise-approach-to-diagnostic-imaging-when-there-is-ongoing-concern-for-cardiac-amyloidosis weekly 0.8 https://www.themednet.org/is-there-any-evidence-to-support-further-uptitration-of-dobutamine-beyond-5mcg-kg-min-for-patients-with-advanced-hf-and-or-cardiogenic-shock-or-should-further-investigation-into-potential-mcs-be-considered-at-that-point weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-acc-2025 weekly 0.8 https://www.themednet.org/do-you-consider-immunosuppression-in-patients-with-a-history-of-sjogrens-disease-and-clinical-features-of-inclusion-body-myositis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-concurrent-severe-siadh-and-large-volume-malignant-ascites-when-aggressive-volume-removal-appears-to-exacerbate-both-symptoms-and-hyponatremia weekly 0.8 https://www.themednet.org/what-is-your-institutional-practice-for-neoadjuvant-therapy-prior-to-transplanting-cholangiocarcinoma weekly 0.8 https://www.themednet.org/in-fontan-associated-liver-disease-fald-what-clinical-scenario-would-lead-you-to-pursue-an-evaluation-for-simultaneous-liver-heart-transplant-as-opposed-to-heart-alone-if-there-is-evidence-of-fibrosis-on-a-liver-biopsy weekly 0.8 https://www.themednet.org/how-would-you-differentiate-neurologic-manifestations-of-a-patient-with-wilsons-disease-versus-manifestations-of-hepatic-encephalopathy-due-to-end-stage-liver-disease weekly 0.8 https://www.themednet.org/how-do-you-differentiate-primary-from-secondary-iron-overload weekly 0.8 https://www.themednet.org/how-do-you-balance-infection-risk-in-patients-with-immune-mediated-liver-disease-on-chronic-immunosuppression-ex-prednisone-aza-mmf-etc weekly 0.8 https://www.themednet.org/in-what-clinical-scenario-would-you-consider-the-use-of-budesonide-over-prednisone-as-part-of-the-pharmacologic-management-of-autoimmune-hepatitis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-induction-therapy-and-maintenance-therapy-for-patients-with-autoimmune-hepatitis weekly 0.8 https://www.themednet.org/how-do-you-approach-the-surveillance-and-serologic-evaluation-of-a-patient-in-whom-you-suspect-has-a-hepatitis-b-pre-core-mutant weekly 0.8 https://www.themednet.org/what-role-is-there-for-the-assessment-of-hepatitis-b-virus-genotype-as-it-pertains-to-pharmacologic-therapy-and-hcc-screening weekly 0.8 https://www.themednet.org/what-clinical-scenario-do-you-consider-screening-for-hepatitis-delta weekly 0.8 https://www.themednet.org/when-would-you-consider-quantification-of-hepatitis-b-surface-antigen-as-part-of-the-treatment-decision-making-process-2 weekly 0.8 https://www.themednet.org/in-what-scenario-do-you-screen-patients-with-hepatitis-b-for-hepatitis-d-co-infection weekly 0.8 https://www.themednet.org/what-clinical-evidence-do-you-find-most-favorable-of-a-positive-response-post-liver-transplant-for-patients-with-portopulmonary-hypertension weekly 0.8 https://www.themednet.org/what-clinical-scenario-would-you-favor-not-using-terlipressin-for-the-management-of-hrs-if-there-were-no-notable-contraindications-for-its-initiation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-post-tips-hepatic-encephalopathy weekly 0.8 https://www.themednet.org/what-patient-clinical-factors-do-you-find-most-impact-a-patients-beta-blocker-window-and-their-ability-to-maintain-and-tolerate-beta-blocker-therapy weekly 0.8 https://www.themednet.org/how-do-you-foresee-the-integration-of-artificial-intelligence-in-the-management-and-evaluation-of-patients-with-liver-lesions-tumors weekly 0.8 https://www.themednet.org/when-would-you-plan-to-biopsy-a-hepatic-adenoma-to-see-if-it-has-high-risk-features-mutations weekly 0.8 https://www.themednet.org/what-pre-transplant-patient-factors-impact-surveillance-intervals-and-methods-after-liver-transplant-for-hcc weekly 0.8 https://www.themednet.org/what-patient-factors-impact-your-selection-of-initial-therapies-in-patients-with-localized-cholangiocarcinoma weekly 0.8 https://www.themednet.org/how-do-you-approach-the-evaluation-of-a-living-donor-liver-transplant-candidate weekly 0.8 https://www.themednet.org/how-do-you-approach-risk-of-development-of-ptld-in-liver-transplant-recipients-with-positive-ebv-antibodies-and-or-viral-loads weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-use-of-marginal-organs-and-or-high-risk-donors-who-are-on-the-liver-transplant-wait-list weekly 0.8 https://www.themednet.org/what-patient-features-would-favor-the-creation-of-a-hutson-loop-intra-operatively weekly 0.8 https://www.themednet.org/how-do-you-incorporate-other-pharmacologic-bariatric-appetite-suppressants-in-the-context-of-their-clinical-care-plan-for-masld weekly 0.8 https://www.themednet.org/what-is-your-approach-on-the-pursuit-of-bariatric-surgery-in-a-patient-with-advanced-fibrosis weekly 0.8 https://www.themednet.org/how-does-presence-of-clinically-significant-portal-hypertension-change-patient-prognosis-in-masld weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patients-candidacy-for-simultaneous-liver-transplant-and-bariatric-surgery-if-masld-is-the-etiology-of-their-end-stage-liver-disease weekly 0.8 https://www.themednet.org/how-do-you-utilize-the-sustained-alcohol-use-post-liver-transplant-salt-score-on-surveillance-for-alcohol-use-for-patients-after-liver-transplant weekly 0.8 https://www.themednet.org/in-what-clinical-scenario-would-larsucosterol-be-considered-as-therapy-in-alcohol-related-hepatitis weekly 0.8 https://www.themednet.org/how-do-you-balance-infection-risk-versus-therapeutic-benefit-of-steroid-tapers-when-treating-patients-with-alcohol-related-hepatitis weekly 0.8 https://www.themednet.org/what-role-is-there-for-use-of-elf-in-patients-with-active-alcohol-use-disorder-for-which-fibroscan-is-not-able-to-give-a-reliable-assessment-of-fibrosis-due-to-ongoing-active-alcohol-use weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-ordering-a-5-nucleotidase-or-a-ggt-is-the-most-appropriate-option-in-the-evaluation-of-an-elevated-alkaline-phosphatase weekly 0.8 https://www.themednet.org/what-is-your-clinical-approach-to-the-evaluation-of-cytopenias-in-patients-with-end-stage-liver-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-viscoelastic-assays-ex-teg-rotem-in-patients-with-identified-coagulopathy-in-the-peri-procedural-period weekly 0.8 https://www.themednet.org/do-you-use-an-lad-constraint-in-the-setting-of-bid-thoracic-radiation-for-sclc weekly 0.8 https://www.themednet.org/what-is-your-standard-for-monitoring-triglyceride-level-during-therapy-for-all-particularly-in-regards-to-receiving-pegaspargase weekly 0.8 https://www.themednet.org/how-do-you-differentiate-cognitive-inflexibility-due-to-autism-from-similar-patterns-in-anxiety-or-ocd weekly 0.8 https://www.themednet.org/whats-your-approach-when-a-parent-declines-mental-health-services-for-their-child-due-to-cultural-stigma-or-fear-of-cps-involvement weekly 0.8 https://www.themednet.org/would-you-consider-changing-management-for-a-patient-with-bipolar-disorder-stable-on-an-antipsychotic-who-is-on-anticoagulation-after-a-recent-pe-or-vte weekly 0.8 https://www.themednet.org/is-there-a-specific-criteria-that-you-use-to-determine-if-a-patient-with-respiratory-symptoms-should-have-a-multiplex-respiratory-test-performed weekly 0.8 https://www.themednet.org/do-you-target-specific-kt-v-values-or-specific-duration-of-hemodialysis-sessions-for-hospitalized-patients-who-you-are-planning-several-consecutive-and-progressive-hemodialysis-initiation-sessions weekly 0.8 https://www.themednet.org/would-you-recommend-temporary-transition-to-hemodialysis-in-a-peritoneal-dialysis-patient-who-has-risk-factors-such-as-recurrent-peritonitis-for-the-development-of-encapsulating-peritoneal-sclerosis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-intensifying-the-hemodialysis-prescription-for-patients-found-to-have-dialysis-related-amyloidosis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-dose-adjusting-mycophenolate-in-a-kidney-transplant-recipient-who-is-transitioned-from-tacrolimus-to-cyclosporine weekly 0.8 https://www.themednet.org/when-do-you-consider-placing-an-amniotic-membrane-when-performing-prk weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-patient-with-sjia-that-was-previously-well-controlled-on-tocilizumab-but-is-now-having-ongoing-joint-disease-activity weekly 0.8 https://www.themednet.org/how-would-you-treat-progressive-rosai-dorfman-destombes-disease-after-initial-limited-radiation-therapy weekly 0.8 https://www.themednet.org/how-does-triple-negative-status-influence-your-management-of-et weekly 0.8 https://www.themednet.org/how-would-you-approach-the-radiation-treatment-of-multiple-recurrent-lentigo-maligna-on-the-sole-of-the-foot-in-an-active-patient-not-desiring-further-surgery weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-use-of-berberine-to-prevent-the-progression-of-prediabetes-to-type-2-diabetes-mellitus weekly 0.8 https://www.themednet.org/what-alternatives-do-you-recommend-for-oral-dexamethasone-solution-for-hn-cancer weekly 0.8 https://www.themednet.org/based-on-niagara-data-do-you-now-feel-more-comfortable-offering-cisplatin-based-chemotherapy-to-patients-with-impaired-renal-function weekly 0.8 https://www.themednet.org/how-do-you-treat-a-patient-with-new-class-v-lupus-nephritis-and-recent-hx-of-breast-cancer-on-tamoxifen weekly 0.8 https://www.themednet.org/how-do-you-manage-copper-deficiency weekly 0.8 https://www.themednet.org/in-a-patient-with-hae-and-on-prophylaxis-for-hiv-who-has-failed-tazhyro-and-orladeyo-and-breakthrough-on-cinryze-what-do-you-recommend-for-prophylaxis weekly 0.8 https://www.themednet.org/do-you-wait-until-serum-anti-gbm-antibody-titers-are-undetectable-before-hospital-discharge-in-a-patient-with-anti-gbm-antibody-disease-with-renal-involvement-who-is-receiving-daily-plasmapheresis-cyclophosphamide-and-steroids weekly 0.8 https://www.themednet.org/what-is-your-approach-to-long-term-lab-monitoring-for-sjogrens-disease-activity weekly 0.8 https://www.themednet.org/would-you-offer-prone-apbi-with-imrt-vmat weekly 0.8 https://www.themednet.org/do-you-test-for-genetic-ataxias-prior-to-making-a-diagnosis-of-cerebellar-type-multiple-system-atrophy weekly 0.8 https://www.themednet.org/what-is-your-preferred-next-therapeutic-step-in-managing-a-patient-with-type-2-diabetes-on-a-glp-1-ra-with-a-hemoglobin-a1c-of-8-9 weekly 0.8 https://www.themednet.org/do-you-recommend-hydrochlorothiazide-to-manage-polyuria-in-patients-with-adpkd-who-are-on-tolvaptan weekly 0.8 https://www.themednet.org/what-long-term-complications-have-you-observed-in-previously-stable-preterm-infants-with-incomplete-peripheral-retinal-vascularization-who-did-not-undergo-rop-laser-treatment weekly 0.8 https://www.themednet.org/what-strategies-do-you-find-helpful-to-stop-zolpidem-in-patients-who-have-been-taking-the-medicine-for-months-or-years weekly 0.8 https://www.themednet.org/what-adjunctive-therapies-beyond-an-antisecretory-agent-e-g-ppi-h2ra-etc-do-you-find-most-helpful-in-managing-the-acute-symptoms-of-pud weekly 0.8 https://www.themednet.org/what-would-be-your-next-diagnostic-test-of-choice-for-a-patient-with-findings-concerning-for-silent-ischemia-on-noninvasive-functional-testing-in-the-absence-of-chest-pain weekly 0.8 https://www.themednet.org/how-would-you-approach-warfarin-management-in-patients-with-mechanical-aortic-valve-and-atrial-fibrillation-if-they-develop-chemotherapy-related-severe-thrombocytopenia weekly 0.8 https://www.themednet.org/what-criteria-do-you-prioritize-when-trying-to-select-the-most-effective-exosome-products-for-your-patients weekly 0.8 https://www.themednet.org/in-addition-to-a-therapist-what-are-your-favorite-resources-for-tackling-perfectionism weekly 0.8 https://www.themednet.org/in-a-hospitalized-patient-who-undergoes-a-mri-with-gadolinium-contrast-study-would-you-perform-hemodialysis-if-they-have-aki-with-prior-dialysis-requirements-but-do-not-currently-otherwise-meet-criteria-for-dialysis weekly 0.8 https://www.themednet.org/how-do-you-decide-the-maximum-amount-of-volume-to-remove-during-a-therapeutic-thoracentesis weekly 0.8 https://www.themednet.org/what-are-some-practical-ways-to-incorporate-cardiac-pocus-in-the-primary-care-setting weekly 0.8 https://www.themednet.org/how-do-you-approach-pre-operative-risk-assessment-and-optimization-in-a-patient-with-interstitial-lung-disease weekly 0.8 https://www.themednet.org/are-there-any-heightened-risks-for-cardioversion-following-a-recent-pci-from-a-stent-patency-standpoint-or-hemodynamic-concerns weekly 0.8 https://www.themednet.org/what-is-the-recommended-duration-of-therapy-for-enterococcal-bacteremia-from-a-urinary-source-in-patients-with-prosthetic-valves-assuming-negative-tee-and-clearance-of-bacteremia weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-benefits-of-immunotherapy-for-anti-mag-neuropathy weekly 0.8 https://www.themednet.org/what-examination-findings-are-indicative-of-bilateral-optic-neuritis-or-optic-neuropathy-as-the-underlying-cause-of-bilateral-vision-loss weekly 0.8 https://www.themednet.org/whats-your-approach-to-managing-postoperative-inflammation-and-cme-in-high-risk-patients-after-cataract-surgery weekly 0.8 https://www.themednet.org/what-advice-do-you-typically-offer-competitive-athletes-with-recently-diagnosed-myocarditis-on-when-to-resume-competitive-sports-and-how-do-often-should-outpatient-imaging-and-mobile-cardiac-telemetry-monitoring-be-performed-to-aid-in-this-decision weekly 0.8 https://www.themednet.org/can-the-desmopressin-stimulation-test-be-used-to-assess-for-central-adrenal-insufficiency weekly 0.8 https://www.themednet.org/what-are-the-main-barriers-you-encounter-in-enrolling-pediatric-oncology-patients-on-clinical-trials weekly 0.8 https://www.themednet.org/do-you-always-get-a-baseline-chest-xray-in-patients-who-will-be-starting-methotrexate weekly 0.8 https://www.themednet.org/when-would-you-consider-aspirin-for-long-term-management-of-unprovoked-vte-after-initial-therapeutic-anticoagulation weekly 0.8 https://www.themednet.org/would-it-be-reasonable-to-refer-an-otherwise-healthy-patient-in-their-40s-for-lhc-after-ccta-findings-note-significant-proximal-rca-stenosis-which-was-obtained-following-a-transient-episode-of-resting-substernal-chest-pain-but-without-subsequent-reproduci weekly 0.8 https://www.themednet.org/would-having-mucinous-rectal-adenocarcinoma-impact-your-recommendation-for-short-vs-long-course-rt-as-part-of-a-tnt-regimen weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-posterior-uveitis-caused-by-toxoplasma-gondii-in-immunocompromised-patients-considering-the-potential-for-atypical-presentations-and-treatment-resistance weekly 0.8 https://www.themednet.org/what-treatment-do-you-recommend-for-painful-large-plaques-of-leiomyomas-on-the-back-of-a-patient-with-hlrcc-syndrome-when-lesions-are-too-large-for-excision weekly 0.8 https://www.themednet.org/for-vaginal-cuff-recurrence-of-an-endometrial-cancer-when-do-you-utilize-a-multichannel-cylinder-versus-single-channel-cylinder-if-a-patient-has-5-mm-residual-disease-after-ebrt weekly 0.8 https://www.themednet.org/in-light-of-recent-measles-outbreaks-have-you-adjusted-your-vaccination-counseling-or-preventive-strategies-for-adult-immunocompromised-patients weekly 0.8 https://www.themednet.org/is-it-safe-to-re-irradiate-non-spine-bone-metastases-with-sbrt-if-they-received-previous-sbrt weekly 0.8 https://www.themednet.org/should-a-different-weight-based-dosing-algorithm-for-levothyroxine-therapy-be-considered-in-women-versus-men-given-higher-incidence-of-iatrogenic-thyrotoxicosis-in-women weekly 0.8 https://www.themednet.org/is-there-a-maximum-duration-for-raloxifene-use weekly 0.8 https://www.themednet.org/would-you-consider-long-term-avatrombopag-use-in-patients-with-cirrhosis-requiring-higher-platelet-counts-for-medical-therapy weekly 0.8 https://www.themednet.org/what-stroke-symptoms-would-lead-you-to-avoid-using-oxaliplatin-in-a-patient-with-metastatic-colon-cancer-and-a-recent-stroke weekly 0.8 https://www.themednet.org/for-patients-with-recent-post-delivery-symptomatic-ovarian-vein-thrombosis-on-anticoagulation-how-would-you-approach-periop-ac-management-for-upcoming-procedures-like-d-c weekly 0.8 https://www.themednet.org/does-injectable-semaglutide-have-a-higher-glucose-lowering-efficiency-than-oral-semaglutide weekly 0.8 https://www.themednet.org/what-is-your-approach-to-determining-if-a-patient-treated-with-vancomycin-has-atn-related-to-vancomycin-or-the-underlying-infection weekly 0.8 https://www.themednet.org/how-do-you-decide-between-using-an-intracranial-pressure-monitor-bolt-versus-an-extraventricular-drain-evd-for-intracranial-pressure-monitoring-in-cases-of-diffuse-cerebral-injury weekly 0.8 https://www.themednet.org/how-do-you-support-recovery-in-patients-with-mdd-and-aud-experiencing-anhedonia-and-social-isolation-after-losing-alcohol-based-social-networks weekly 0.8 https://www.themednet.org/do-you-pursue-additional-cardiac-evaluation-for-patients-diagnosed-with-sheehan-syndrome-considering-their-elevated-risk-for-atherosclerotic-cardiovascular-diseases weekly 0.8 https://www.themednet.org/how-often-and-why-do-you-complete-disability-forms-for-dermatologic-patients weekly 0.8 https://www.themednet.org/should-we-be-recommending-a-specific-daily-protein-intake-to-prevent-sarcopenia-in-geriatric-patients-or-do-you-find-it-more-beneficial-to-focus-on-encouraging-activity-within-their-mobility-limitations-to-preserve-muscle-mass weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-scalp-psoriasis-who-initially-responds-well-to-tildrakizumab-but-experiences-a-plateau-in-improvement-or-partial-relapse-after-about-1-year weekly 0.8 https://www.themednet.org/for-patients-with-pi3k-mutated-metastatic-breast-cancer-who-progress-on-a-pi3k-inhibitor-will-you-use-an-alternative-pi3k-inhibitor-subsequently weekly 0.8 https://www.themednet.org/how-do-you-approach-an-isolated-metastasis-to-left-supraclavicular-node-in-rectal-cancer-treated-with-tnt-with-folfox-regimen-followed-by-long-course-radiation weekly 0.8 https://www.themednet.org/do-you-have-your-patients-with-recurrent-calcium-phosphate-nephrolithiasis-and-hypocitraturia-avoid-high-citrate-containing-foods-if-they-have-alkaline-urine weekly 0.8 https://www.themednet.org/in-what-situations-would-you-recommend-adjuvant-radiation-therapy-for-patients-with-locally-advanced-and-or-recurrent-basal-cell-carcinoma-that-receive-vismodegib-followed-by-surgery weekly 0.8 https://www.themednet.org/how-likely-is-late-radiation-induced-lumbosacral-plexopathy-from-treatment-of-anal-cancer-with-chemo-rt-20-years-ago-and-how-would-you-manage-it weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-deciding-between-monotherapy-with-an-antipseudomonal-cephalosporin-and-combination-therapy-in-icu-patients-with-pseudomonas-aeruginosa-bloodstream-infection-who-are-not-in-septic-shock weekly 0.8 https://www.themednet.org/is-there-therapeutic-relevance-for-flt3-itd-mutation-in-relapsed-apml weekly 0.8 https://www.themednet.org/is-there-any-indication-benefit-for-heparin-in-a-patient-with-suspected-type-2-myocardial-infarction weekly 0.8 https://www.themednet.org/what-is-your-preferred-regimen-for-treating-recalcitrant-and-recurrent-macula-threatening-ocular-toxoplasmosis weekly 0.8 https://www.themednet.org/what-factors-would-make-you-choose-ipi3-nivo1-frontline-for-advanced-unresectable-and-metastatic-hcc-based-on-checkmate-9dw weekly 0.8 https://www.themednet.org/what-is-the-best-course-of-treatment-for-limbal-stem-cell-deficiency-with-a-perforated-corneal-ulcer weekly 0.8 https://www.themednet.org/what-are-your-best-strategies-for-managing-intraoperative-floppy-iris-syndrome-during-cataract-surgery-when-the-iris-becomes-incarcerated-in-the-paracentesis-immediately-after-anterior-wound-construction weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-epithelial-ingrowth-in-a-patient-who-underwent-lasik-20-years-ago-and-developed-epithelial-ingrowth-following-recent-cataract-surgery weekly 0.8 https://www.themednet.org/what-alternative-treatments-are-available-for-refractory-filamentary-keratitis-in-a-patient-for-whom-bandage-contact-lenses-provide-the-only-relief-and-who-has-failed-cyclosporine-and-n-acetylcysteine-drops weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-seronegative-myasthenia-gravis-in-patients-who-have-not-responded-to-immunotherapy weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-would-you-use-for-a-non-operable-solitary-fibrous-tumor-in-the-lumbar-vertebra-with-definitive-intent weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-substance-use-disorders-who-require-chemotherapy-for-their-cancer weekly 0.8 https://www.themednet.org/for-patients-on-t4-t3-combination-therapy-for-management-of-hypothyroidism-is-there-an-indication-for-monitoring-t3-levels-and-if-so-what-is-the-appropriate-timing-trough-versus-peak-given-the-pharmacokinetics-of-liothyronine weekly 0.8 https://www.themednet.org/what-would-your-approach-be-for-a-locally-advanced-head-and-neck-cancer-diagnosed-concurrently-with-a-mid-esophageal-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-a-kidney-ultrasound-to-evaluate-for-microcystic-changes-when-caring-for-a-patient-with-chronic-kidney-disease-suspected-secondary-to-chronic-lithium-use weekly 0.8 https://www.themednet.org/what-factors-influence-your-evaluation-of-surgical-candidacy-for-persistent-fetal-vasculature-and-how-do-you-approach-operative-management weekly 0.8 https://www.themednet.org/how-do-you-approach-diagnosis-and-management-of-orbital-myositis weekly 0.8 https://www.themednet.org/do-you-consider-the-efficacy-of-different-nasal-sprays-when-prescribing-for-allergic-rhinitis-or-conjunctivitis weekly 0.8 https://www.themednet.org/are-you-managing-chronic-urticaria-angioedema-any-differently-if-the-patient-is-only-predominantly-presenting-with-urticaria-or-angioedema weekly 0.8 https://www.themednet.org/what-is-your-process-for-considering-alternative-imaging-modalities-for-cardiac-imaging-when-pocus-is-limited-by-patient-conditions-such-as-emphysema-or-body-habitus weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-patient-with-ankylosing-spondylitis-who-was-doing-well-on-tofacitinib-but-experienced-a-stemi-while-on-therapy weekly 0.8 https://www.themednet.org/do-you-check-a-fractional-excretion-of-sodium-in-nonoliguric-patients-with-aki weekly 0.8 https://www.themednet.org/what-is-your-approach-to-pancreatic-adenocarcinoma-s-p-surgery-with-n0-r0-disease-and-intermediate-risk-factors-with-regard-to-adjuvant-chemo-radiation weekly 0.8 https://www.themednet.org/how-do-you-approach-perioperative-antimicrobial-prophylaxis-in-patients-undergoing-reconstructive-surgery-with-myocutaneous-flaps-whom-have-recently-been-treated-for-active-infection weekly 0.8 https://www.themednet.org/in-your-outpatient-practice-which-antidepressants-do-you-most-prefer-for-treating-depression-in-older-adults weekly 0.8 https://www.themednet.org/what-clinical-outcomes-or-measures-of-success-do-you-prioritize-in-your-patients-with-ichthyosis weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-a-patient-with-an-ileostomy-who-has-recurrent-prerenal-aki-episodes-that-improve-with-iv-fluids-but-worsen-with-each-attempt-to-transition-to-oral-fluids-alone weekly 0.8 https://www.themednet.org/how-do-you-differentiate-between-allergic-and-irritant-contact-dermatitis-in-patients-using-topical-minoxidil weekly 0.8 https://www.themednet.org/how-often-do-you-re-screen-with-autoantibody-testing-for-type-1-diabetes-if-the-initial-test-is-negative-in-a-patient-with-primary-adrenal-insufficiency weekly 0.8 https://www.themednet.org/how-do-you-approach-insulin-adjustments-for-a-patient-with-type-1-diabetes-who-is-not-on-an-insulin-pump-and-who-has-higher-blood-glucose-levels-in-the-late-luteal-phase-of-the-menstrual-cycle-when-glucose-levels-are-expected-to-rise weekly 0.8 https://www.themednet.org/what-is-typical-presentation-and-time-course-for-belimumab-infusion-related-depression-and-or-hallucinations-and-how-do-you-approach-management weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-a-patient-presenting-with-bilateral-central-corneal-perforations-following-treatment-with-ipilimumab-nivolumab weekly 0.8 https://www.themednet.org/what-factors-guide-the-decision-to-proceed-with-trabeculectomy-in-a-patient-with-advanced-glaucoma-who-retains-good-central-vision weekly 0.8 https://www.themednet.org/for-patients-with-a-history-of-pregnancy-loss-do-you-evaluate-for-pai-1-polymorphisms-as-part-of-a-thrombophilia-workup weekly 0.8 https://www.themednet.org/when-interpreting-pulmonary-function-tests-pfts-do-you-include-diagnostic-language-such-as-findings-are-suggestive-of-copd-or-do-you-limit-your-report-to-a-descriptive-interpretation-of-the-data weekly 0.8 https://www.themednet.org/are-there-instances-when-you-recommend-kidney-stone-disorder-gene-testing-in-patients-suspected-of-having-cystinuria weekly 0.8 https://www.themednet.org/for-essential-thrombocythemia-with-an-indication-for-aspirin-would-you-defer-therapy-if-they-are-on-celecoxib weekly 0.8 https://www.themednet.org/how-would-you-manage-new-onset-amenorrhea-diabetes-insipidus-and-growth-hormone-deficiency-without-other-pituitary-deficiencies-or-excess-in-young-females-with-mri-findings-of-pituitary-mass-and-hypothalamic-edema weekly 0.8 https://www.themednet.org/what-is-your-step-wise-approach-to-differentiating-svt-with-aberrancy-versus-vt weekly 0.8 https://www.themednet.org/what-would-be-a-reasonable-next-step-approach-to-the-evaluation-of-mild-lv-systolic-dysfunction-with-regional-wall-motion-abnormalities-on-tte-in-a-patient-receiving-carboplatin-paclitaxel-for-ovarian-cancer-without-any-cardiac-symptoms weekly 0.8 https://www.themednet.org/in-what-situations-do-you-recommend-secondary-prophylaxis-for-nocardia-after-completion-of-treatment weekly 0.8 https://www.themednet.org/would-you-consider-long-course-pelvic-crt-after-neoadjuvant-chemotherapy-in-a-patient-with-low-lying-locally-advanced-rectal-adenocarcinoma-when-youre-unable-to-meet-small-bowel-constraints weekly 0.8 https://www.themednet.org/what-is-your-preferred-forceps-size-for-transbronchial-biopsies-considering-options-ranging-from-1-8-to-2-8mm weekly 0.8 https://www.themednet.org/how-do-you-remove-and-code-for-the-following-polyps weekly 0.8 https://www.themednet.org/how-might-the-introduction-of-brensocatib-as-a-treatment-option-impact-the-use-of-other-anti-inflammatory-or-antibiotic-therapies-currently-employed-in-bronchiectasis-management weekly 0.8 https://www.themednet.org/do-you-consider-metformin-as-a-disease-modifying-adjunct-in-the-management-of-patients-with-oa-particularly-in-those-with-comorbid-metabolic-syndrome-or-type-2-diabetes weekly 0.8 https://www.themednet.org/do-you-tend-to-avoid-the-use-of-oral-weight-loss-stimulant-medications-such-as-phentermine-in-obese-patients-on-ssri-or-adhd-treatments weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-a-patient-who-develops-an-accelerated-junctional-rhythm-who-exhibits-no-symptoms-and-has-no-prior-history-of-cardiac-issues-aside-from-consulting-a-cardiologist weekly 0.8 https://www.themednet.org/would-you-pursue-a-colonoscopy-for-a-patient-in-their-20s-with-constipation-and-rectal-bleeding-if-they-had-a-first-degree-relative-who-died-young-from-a-carcinoid-tumor weekly 0.8 https://www.themednet.org/what-has-been-your-experience-with-netarsudil-in-the-management-of-corneal-edema-particularly-concerning-its-clinical-effectiveness-and-insurance-coverage weekly 0.8 https://www.themednet.org/does-anyone-have-concern-with-giving-oral-antiseizure-medications-to-patients-receiving-tpn-because-of-suspected-malabsorption-syndrome weekly 0.8 https://www.themednet.org/how-do-you-manage-or-monitor-hypogonadal-men-on-clomiphene-citrate weekly 0.8 https://www.themednet.org/in-patients-with-unresectable-liver-limited-neuroendocrine-tumors-nets-what-clinical-or-radiographic-criteria-guide-your-decision-to-prioritize-systemic-therapy-over-locoregional-approaches weekly 0.8 https://www.themednet.org/what-is-your-approach-for-adjuvant-chemotherapy-for-a-patient-with-colon-adenocarcinoma-pmmr-t2-with-3-positive-lymph-nodes-and-2-pericolic-adipose-tumor-deposits weekly 0.8 https://www.themednet.org/do-you-treat-complicated-pneumonia-with-a-drained-empyema-longer-if-streptococcus-anginosus-is-cultured-either-in-isolation-or-with-other-organisms-compared-to-cases-in-which-it-is-not weekly 0.8 https://www.themednet.org/how-would-you-approach-failure-of-maintenance-therapy-azathioprine-for-pr3-positive-c-anca-positive-pulmonary-renal-vasculitis-previously-induced-with-cyclophosphamide-with-a-history-of-anaphylaxis-to-rituximab weekly 0.8 https://www.themednet.org/would-you-pursue-imaging-to-clear-the-left-atrial-appendage-or-have-a-risk-benefit-discussion-with-a-patient-prior-to-semi-urgent-cardioversion-if-there-was-concern-for-delayed-administration-or-a-single-missed-dose-of-anticoagulation weekly 0.8 https://www.themednet.org/how-have-you-incorporated-donor-derived-cell-free-dna-to-help-with-the-diagnosis-of-rejection-or-monitoring-of-the-treatment-response-to-rejection weekly 0.8 https://www.themednet.org/do-you-favor-peritoneal-dialysis-over-hemodialysis-in-patients-with-an-lvad-who-have-eskd weekly 0.8 https://www.themednet.org/how-would-you-manage-bcc-to-the-left-cheek-after-only-half-of-a-radiation-course-was-completed-three-months-ago-and-non-operative-management-is-preferred weekly 0.8 https://www.themednet.org/how-do-you-balance-the-risk-of-unnecessary-treatment-with-acyclovir-against-the-risk-of-delaying-treatment-in-encephalitis-cases-where-csf-pleocytosis-is-absent weekly 0.8 https://www.themednet.org/what-is-your-preferred-management-for-renal-artery-thrombosis-causing-renal-infarct-of-unclear-etiology weekly 0.8 https://www.themednet.org/other-than-oxybutynin-or-mirabegron-what-pharmacological-and-non-pharmacological-treatments-would-you-consider-for-increased-urinary-frequency-not-caused-by-infection-medications-or-resulting-in-incontinence weekly 0.8 https://www.themednet.org/what-is-the-role-of-inebilizumab-in-the-maintenance-treatment-of-igg4-related-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-therapy-cases-where-cbt-techniques-seem-to-increase-distress-or-exacerbate-underlying-rigidity weekly 0.8 https://www.themednet.org/do-you-recommend-chronic-oral-suppressive-antibiotics-after-initial-intensive-treatment-of-6-8-weeks-in-patients-with-culture-negative-prosthetic-joint-or-bone-infections-with-retained-hardware weekly 0.8 https://www.themednet.org/what-is-your-preferred-method-for-suprachoroidal-drainage weekly 0.8 https://www.themednet.org/in-patients-with-preexisting-vitreous-prolapse-undergoing-glaucoma-drainage-implant-surgery-what-is-the-optimal-surgical-timing-for-performing-an-anterior-vitrectomy-to-minimize-complications-and-ensure-successful-tube-placement weekly 0.8 https://www.themednet.org/what-alternative-treatment-strategies-can-be-considered-for-pediatric-patients-with-idiopathic-choroidal-neovascularization-cnvm-who-require-q4-week-intravitreal-anti-vegf-injections weekly 0.8 https://www.themednet.org/what-is-the-recommended-workup-for-pth-independent-hypercalcemia-secondary-to-an-elevated-1-25-dihydroxyvitamin-d-level weekly 0.8 https://www.themednet.org/what-is-your-approach-to-distinguishing-a-jarisch-herxheimer-reaction-from-a-delayed-anaphylactoid-reaction weekly 0.8 https://www.themednet.org/would-you-recommend-sglt2-inhibitors-for-patients-with-sickle-cell-nephropathy-and-severely-increased-albuminuria-despite-the-potential-medication-associated-risk-for-vaso-occlusive-crises weekly 0.8 https://www.themednet.org/what-is-your-approach-to-bone-imaging-in-mgus weekly 0.8 https://www.themednet.org/how-do-you-address-the-discrepancy-between-traditional-allergy-skin-testing-and-the-rinkel-skin-test-results weekly 0.8 https://www.themednet.org/how-do-you-counsel-women-on-anti-cd20-therapy-for-ms-who-are-planning-for-pregnancy weekly 0.8 https://www.themednet.org/how-do-you-counsel-women-post-natural-menopause-who-are-interested-in-hrt-for-reducing-dementia-risk weekly 0.8 https://www.themednet.org/when-do-you-consider-antipsychotic-augmentation-of-antidepressants-for-ptsd weekly 0.8 https://www.themednet.org/would-you-offer-postoperative-rt-for-pt2pn0-rectal-cancer-with-close-distal-margin-within-2-mm-and-only-6-lymph-nodes-obtained-from-surgery weekly 0.8 https://www.themednet.org/would-you-forgo-lumpectomy-cavity-boost-for-grade-1-papillary-carcinoma-with-associated-grade-1-dcis-that-has-been-resected-with-good-margins weekly 0.8 https://www.themednet.org/how-do-you-manage-oxaliplatin-induced-splenomegaly weekly 0.8 https://www.themednet.org/what-is-a-reasonable-timeline-for-a-left-heart-catheterization-in-a-patient-with-newly-diagnosed-severe-lv-systolic-dysfunction-of-unclear-etiology-and-without-an-acs-presentation weekly 0.8 https://www.themednet.org/is-there-a-role-for-pdt-in-a-young-patient-with-pxe-and-bilateral-cnvm-who-requires-intravitreal-anti-vegf-injections-every-4-weeks-and-is-beginning-to-develop-atrophy weekly 0.8 https://www.themednet.org/are-there-benefits-to-adding-il5-il5-receptor-blockade-in-patients-with-vasculitic-manifestations-of-egpa weekly 0.8 https://www.themednet.org/how-does-your-hospital-approach-the-use-of-insulin-pumps-for-admitted-patients weekly 0.8 https://www.themednet.org/how-much-proteinuria-would-warrant-consideration-of-native-kidney-nephrectomies-at-the-time-of-a-kidney-transplant weekly 0.8 https://www.themednet.org/how-do-you-rule-out-spontaneous-bacterial-peritonitis-in-a-patient-with-minimal-ascites-that-is-not-amenable-to-paracentesis weekly 0.8 https://www.themednet.org/how-do-you-rule-out-empyema-in-a-small-pleural-effusion-that-is-not-amenable-to-thoracentesis weekly 0.8 https://www.themednet.org/what-patient-factors-do-you-feel-are-most-important-when-considering-reduced-dosing-regimens-of-il17a-inhibitors-such-as-secukinumab-and-ixekizumab-for-psoriasis weekly 0.8 https://www.themednet.org/what-precautions-need-to-be-taken-to-ensure-the-successful-maturation-and-long-term-functionality-of-an-endovascular-arteriovenous-fistula weekly 0.8 https://www.themednet.org/how-do-you-approach-dosing-beta-blockers-for-variceal-prophylaxis-when-the-standard-dose-doesnt-achieve-the-target-heart-rate weekly 0.8 https://www.themednet.org/would-you-recommend-treating-asymptomatic-bacteriuria-in-a-kidney-transplant-patient-who-has-a-ureteral-stent-in-place weekly 0.8 https://www.themednet.org/in-patients-with-post-pv-myelofibrosis-who-are-ineligible-for-allogeneic-stem-cell-transplant-how-do-you-approach-symptomatic-splenomegaly-refractory-to-splenic-radiation-and-ruxolitinib weekly 0.8 https://www.themednet.org/how-would-you-manage-presumed-gestational-thrombocytopenia-with-moderate-thrombocytopenia-for-delivery-planning weekly 0.8 https://www.themednet.org/how-do-you-bill-cosmetic-follow-up-appointments weekly 0.8 https://www.themednet.org/would-you-consider-simulating-a-patient-with-brain-metastases-in-the-prone-position-if-they-are-unable-to-tolerate-lying-supine-for-srs-treatment weekly 0.8 https://www.themednet.org/for-a-cutaneous-malignancy-near-the-eyelid-how-do-you-decide-whether-to-use-an-internal-eye-shield-or-an-external-eye-shield-during-treatment weekly 0.8 https://www.themednet.org/how-do-you-approach-choosing-between-subcutaneous-and-iv-actemra-for-ra weekly 0.8 https://www.themednet.org/what-imaging-features-can-help-distinguish-between-an-acute-versus-chronic-cervical-internal-carotid-occlusion weekly 0.8 https://www.themednet.org/what-is-the-role-of-mechanical-circulatory-support-in-mixed-cardiogenic-vasodilatory-shock weekly 0.8 https://www.themednet.org/would-you-start-romosozumab-in-an-active-smoker weekly 0.8 https://www.themednet.org/how-do-you-think-about-using-ropeginterferon-alfa-2b-for-polycythemia-vera-in-patients-with-active-autoimmune-disease weekly 0.8 https://www.themednet.org/would-you-treat-a-brain-abscess-due-to-s-anginosus-longer-than-one-caused-by-another-organism weekly 0.8 https://www.themednet.org/how-long-would-you-anticoagulate-for-a-catheter-associated-dvt-in-pregnancy weekly 0.8 https://www.themednet.org/how-do-you-approach-weaning-treatments-for-cidp-in-remission weekly 0.8 https://www.themednet.org/is-there-evidence-supporting-the-use-of-nab-paclitaxel-in-place-of-paclitaxel-in-the-keynote-522-neoadjuvant-regimen-for-triple-negative-breast-cancer-in-cases-of-paclitaxel-hypersensitivity weekly 0.8 https://www.themednet.org/would-a-longstanding-diagnosis-of-multiple-sclerosis-impact-your-radiation-recommendations-for-a-patient-with-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-a-patient-with-bilateral-adrenal-gland-thickening-biochemical-evidence-of-acth-independent-hypercortisolism weekly 0.8 https://www.themednet.org/do-you-routinely-use-antifibrinolytics-for-patients-with-heavy-menstrual-bleeding-who-are-already-on-hormonal-therapy weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-radiation-for-a-patient-with-head-neck-merkel-cell-carcinoma-following-a-pathologic-complete-response-to-neoadjuvant-immunotherapy weekly 0.8 https://www.themednet.org/how-do-you-advise-your-patients-to-optimally-store-a-recently-passed-kidney-stone-to-ensure-it-can-later-undergo-composition-testing weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-administer-subcutaneous-hydrocortisone-instead-of-iv-hydrocortisone-to-a-patient-with-adrenal-insufficiency weekly 0.8 https://www.themednet.org/do-you-recommend-prescribing-methimazole-to-prevent-iodinated-contrast-media-induced-exacerbation-of-thyrotoxicosis-in-patients-with-pre-existing-hyperthyroidism weekly 0.8 https://www.themednet.org/how-long-do-you-wait-for-a-reduction-in-ebv-viral-load-after-reducing-immunosuppression-before-deciding-to-start-rituximab-in-a-kidney-transplant-patient-with-ebv-viremia weekly 0.8 https://www.themednet.org/what-factors-influence-your-decision-to-initiate-antifungal-treatment-in-asymptomatic-lung-transplant-recipients-colonized-with-aspergillus weekly 0.8 https://www.themednet.org/how-do-you-consider-sbrt-relative-to-other-emerging-therapies-for-pediatric-sarcomas-such-as-proton-therapy-or-immunotherapy-in-terms-of-efficacy-and-safety weekly 0.8 https://www.themednet.org/should-ertapenem-use-in-refractory-hs-be-managed-by-id-and-how-many-times-would-you-consider-using-it-in-a-patient weekly 0.8 https://www.themednet.org/how-many-doses-of-im-penicillin-would-you-recommend-for-a-patient-with-biopsy-confirmed-syphilis-proctitis weekly 0.8 https://www.themednet.org/do-you-have-any-tips-for-effectively-performing-ebus-with-biopsy-at-the-4l-lymph-node-station weekly 0.8 https://www.themednet.org/would-you-evaluate-for-an-ectopic-source-in-a-patient-with-persistently-elevated-igf-1-level-but-no-clinical-features-of-acromegaly-or-evidence-of-pituitary-abnormalities weekly 0.8 https://www.themednet.org/how-do-you-approach-recurrent-migratory-superficial-thrombophlebitis-in-a-patient-with-a-negative-malignancy-workup-and-low-titer-anticardiolipin-antibodies weekly 0.8 https://www.themednet.org/how-do-you-approach-diagnosis-in-a-patient-with-inflammatory-joint-symptoms-and-isolated-bilateral-cmc-joint-erosions-on-x-ray-imaging weekly 0.8 https://www.themednet.org/how-would-you-manage-aplastic-anemia-refractory-to-multiple-agents weekly 0.8 https://www.themednet.org/what-is-the-preferred-duration-of-adjuvant-aromatase-inhibitor-therapy-in-patients-with-triple-positive-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-severe-refractory-schizophrenia-or-schizoaffective-disorder-who-need-complex-pharmacologic-regimens-but-consistently-refuse-labs-and-ecg-monitoring weekly 0.8 https://www.themednet.org/what-medications-would-you-consider-for-severe-delusional-disorder-in-a-patient-with-rls-worsened-by-aripiprazole-and-quetiapine-who-refuses-clozapine weekly 0.8 https://www.themednet.org/would-you-start-a-biologic-without-a-tissue-diagnosis-in-a-young-male-presenting-with-recurrent-small-bowel-obstruction-and-mre-showing-distal-ileitis-which-was-unable-to-be-reached-despite-repeat-colonoscopy weekly 0.8 https://www.themednet.org/how-effective-do-you-find-lifestyle-modifications-in-management-of-migraine weekly 0.8 https://www.themednet.org/in-patients-using-nuvaring-for-contraception-is-the-1mg-dexamethasone-suppression-test-reliable-to-screen-for-cortisol-excess weekly 0.8 https://www.themednet.org/is-there-a-role-for-quad-shot-or-similar-regimen-in-a-patient-with-a-technically-resectable-but-medically-inoperable-colon-cancer-that-is-both-bleeding-and-causing-a-partial-obstruction weekly 0.8 https://www.themednet.org/are-there-specific-findings-that-would-make-you-suspicious-of-igd-or-ige-monoclonal-gammopathies weekly 0.8 https://www.themednet.org/what-is-your-approach-to-initial-management-of-patients-with-suspected-or-confirmed-primary-cutaneous-cd8-positive-aggressive-epidermotropic-t-cell-lymphoma-pcaectcl weekly 0.8 https://www.themednet.org/are-there-instances-where-you-can-defer-on-mass-spectrometry-testing-for-amyloid-typing-in-congo-red-positive-tissue weekly 0.8 https://www.themednet.org/how-do-you-decide-on-supportive-care-vs-empiric-antibiotics-in-a-patient-with-suspected-aspiration-pneumonitis-i-e-witnessed-macroaspiration-event-within-the-past-24-hours-but-with-features-that-could-suggest-pneumonia-e-g-acute-respiratory-distress-fever weekly 0.8 https://www.themednet.org/what-is-your-approach-to-anticoagulation-in-cirrhotic-patients-with-platelet-count-loss-than-50-in-the-setting-of-atrial-fibrillation-and-elevated-chadsvasc weekly 0.8 https://www.themednet.org/what-strategies-have-you-found-effective-in-overcoming-socioeconomic-and-cultural-barriers-to-amblyopia-treatment-adherence weekly 0.8 https://www.themednet.org/what-is-your-perspective-on-the-role-of-digital-binocular-therapies-in-amblyopia-management weekly 0.8 https://www.themednet.org/what-surgical-strategies-do-you-recommend-for-managing-isolated-skew-deviation-after-stroke weekly 0.8 https://www.themednet.org/does-micropapillary-subtype-for-a-g1-2-dcis-affect-your-radiation-treatment-recommendations weekly 0.8 https://www.themednet.org/how-do-you-approach-diagnosis-and-management-in-patients-with-persistent-hypercalcemia-and-elevated-but-improved-pth-six-months-after-parathyroidectomy-for-primary-hyperparathyroidism weekly 0.8 https://www.themednet.org/do-you-have-a-preference-between-rai-therapy-and-antithyroid-medication-for-patients-with-graves-hyperthyroidism-and-moderate-to-severe-graves-orbitopathy-who-are-on-glucocorticoid-treatment weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-obtain-mr-imaging-of-the-kidneys-in-a-patient-with-adpkd-who-was-recently-diagnosed-following-ct-imaging weekly 0.8 https://www.themednet.org/what-treatments-have-you-found-to-be-effective-for-mal-de-debarquement-after-trialing-benzodiazepines-such-as-clonazepam weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-or-not-to-pursue-inpatient-workup-of-an-incidental-liver-mass weekly 0.8 https://www.themednet.org/do-you-favor-eti-trikafta-or-vtd-alyftrek-for-patients-with-cf-eligible-for-either-drug weekly 0.8 https://www.themednet.org/what-factors-prompt-you-to-consider-revision-vs-removal-of-endobronchial-valves-in-patients-who-do-not-develop-atelectasis-after-blvr weekly 0.8 https://www.themednet.org/do-you-consider-early-belatacept-based-immunosuppression-in-lung-transplant-recipients weekly 0.8 https://www.themednet.org/do-you-plan-to-use-benralizumab-to-treat-acute-exacerbations-of-asthma-or-copd-associated-with-eosinophilia weekly 0.8 https://www.themednet.org/how-do-you-mitigate-the-risk-of-inadverdent-under-or-over-diagnosis-of-copd-in-certain-populations-with-transition-to-race-neutral-spirometry-reference-equations weekly 0.8 https://www.themednet.org/do-you-consider-indwelling-pleural-catheters-in-patients-with-refractory-transudative-pleural-effusions weekly 0.8 https://www.themednet.org/how-do-you-plan-to-integrate-sotatercept-into-the-current-treatment-algorithm-for-pah-particularly-in-patients-who-are-stable-on-existing-therapies weekly 0.8 https://www.themednet.org/would-you-use-tnf-inhibitor-therapy-in-a-patient-with-seropositive-ra-who-had-optic-neuritis-as-a-child-without-relapse-as-an-adult weekly 0.8 https://www.themednet.org/when-would-you-consider-long-term-suppressive-antibiotic-therapy-in-patients-with-chronic-or-recurrent-bacterial-prostatitis-who-continue-to-experience-symptoms-despite-multiple-courses-of-antibiotics weekly 0.8 https://www.themednet.org/how-can-you-differentiate-vessel-wall-enhancement-related-to-cns-vasculitis-versus-atherosclerotic-changes-on-mra-brain-vessel-wall-imaging weekly 0.8 https://www.themednet.org/how-do-you-approach-the-decision-of-when-to-perform-left-heart-catheterization-in-a-patient-with-an-nstemi-who-recently-had-an-acute-ischemic-stroke weekly 0.8 https://www.themednet.org/what-strategies-do-you-recommend-to-address-the-negative-self-talk-internalized-bias-that-patients-carry-about-their-own-weight weekly 0.8 https://www.themednet.org/would-you-consider-5-fraction-whole-breast-rt-for-a-patient-with-multiple-positive-margins-following-lumpectomy-for-whom-reexcision-is-not-possible weekly 0.8 https://www.themednet.org/can-carbamazepine-make-thyroid-function-test-results-look-spuriously-abnormal weekly 0.8 https://www.themednet.org/in-patients-with-secondary-adrenal-insufficiency-when-would-you-consider-adding-fludrocortisone-to-their-steroid-regimen weekly 0.8 https://www.themednet.org/would-you-recommend-the-use-of-an-ace-inhibitor-to-patients-with-type-1-diabetes-mellitus-who-are-normotensive-but-have-persistent-moderate-proteinuria weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-who-are-positive-for-the-21-hydroxylase-antibody-but-have-no-clinical-or-laboratory-evidence-of-adrenal-insufficiency weekly 0.8 https://www.themednet.org/what-guides-reoperation-versus-observation-in-managing-macular-folds-after-retinal-detachment-surgery weekly 0.8 https://www.themednet.org/how-would-you-tailor-immunosuppression-in-an-elderly-patient-presenting-with-primary-fsgs weekly 0.8 https://www.themednet.org/do-you-always-stop-dexamethasone-at-discharge-for-patients-admitted-with-covid-requiring-respiratory-support-as-done-in-the-recovery-trial-or-are-there-situations-in-which-you-will-prescribe-it-to-complete-a-10-day-course weekly 0.8 https://www.themednet.org/how-does-the-mechanism-of-trauma-in-post-traumatic-headache-influence-counseling-of-patients-and-their-families weekly 0.8 https://www.themednet.org/would-you-test-treat-a-middle-aged-adult-male-who-was-stung-in-his-30s-and-developed-immediate-lip-swelling-that-resolved-with-antihistamines-in-15-minutes weekly 0.8 https://www.themednet.org/do-you-use-first-generation-cephalosporins-to-treat-non-endovascular-streptococcus-mitis-infections weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-cequa-in-eyes-with-severe-corneal-thinning-from-a-prior-healed-corneal-ulcer weekly 0.8 https://www.themednet.org/in-a-patient-with-strong-serologic-evidence-of-sle-presenting-with-isolated-bilateral-lower-limb-sensorimotor-neuropathy-normal-neuroimaging-and-csf-would-you-initiate-cyclophosphamide-with-pulse-dose-steroids-upfront-or-reserve-escalation-e-g-plasma-exch weekly 0.8 https://www.themednet.org/how-do-you-use-nt-probnp-in-patients-with-chronic-kidney-disease-or-end-stage-kidney-disease-given-that-these-conditions-can-affect-nt-probnp-levels weekly 0.8 https://www.themednet.org/would-you-ever-recommend-radiofrequency-ablation-over-surgery-or-radioiodine-for-a-patient-with-an-autonomously-functioning-thyroid-nodule weekly 0.8 https://www.themednet.org/are-there-clinical-laboratory-or-imaging-features-that-can-help-distinguish-primary-sjoegrens-syndrome-from-secondary-sjoegrens-in-patients-with-overlapping-inflammatory-arthritis-or-positive-rheumatoid-factor weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-who-developed-an-intraprostatic-abscess-after-spaceoar-injection-prior-to-starting-radiation weekly 0.8 https://www.themednet.org/do-you-maintain-a-strict-platelet-threshold-of-50k-when-performing-a-lumbar-puncture-or-are-there-situations-in-which-you-feel-comfortable-with-a-lower-threshold weekly 0.8 https://www.themednet.org/is-it-clinically-necessary-to-provide-supplemental-oxygen-to-patients-with-mild-asymptomatic-hypoxemia-only-during-activity-while-they-are-recovering-from-an-acute-respiratory-illness weekly 0.8 https://www.themednet.org/what-are-some-practical-tips-for-tacrolimus-management-monitoring-in-sle-nephritis weekly 0.8 https://www.themednet.org/do-you-always-pursue-testing-for-nod2-mutations-when-you-are-suspecting-a-diagnosis-of-blau-syndrome weekly 0.8 https://www.themednet.org/in-an-asymptomatic-patient-who-has-had-a-routine-tte-for-non-cardiac-reasons-would-you-order-further-work-up-if-there-are-any-wma-or-mild-lvef-reduction weekly 0.8 https://www.themednet.org/what-are-red-flags-in-an-evaluation-for-possible-multiple-sclerosis-that-should-prompt-workup-for-genetic-inherited-conditions weekly 0.8 https://www.themednet.org/what-techniques-do-you-find-most-helpful-to-optimize-image-acquisition-for-cardiac-pocus-in-patients-with-poor-acoustic-windows weekly 0.8 https://www.themednet.org/do-you-recommend-low-or-intermediate-dosing-of-tmp-smx-over-high-dosing-for-the-initial-treatment-of-non-disseminated-pulmonary-nocardiosis weekly 0.8 https://www.themednet.org/statistically-speaking-approximately-what-percentage-of-thyroid-nodule-fna-biopsies-are-bethesda-category-1-nondiagnostic-or-unsatisfactory-and-what-percentage-are-indeterminate-bethesda-category-3-and-4 weekly 0.8 https://www.themednet.org/how-do-you-approach-surveillance-of-gastric-hyperplastic-polyps-of-various-sizes weekly 0.8 https://www.themednet.org/how-will-the-findings-from-the-recent-boss-study-affect-your-management-of-barretts-esophagus-without-dysplasia weekly 0.8 https://www.themednet.org/in-asymptomatic-patients-with-mild-ckd-pth-independent-hypercalcemia-and-hypercalciuria-after-excluding-common-causes-such-as-hyperparathyroidism-vitamin-d-abnormalities-multiple-myeloma-thyroid-disease-vitamin-a-excess-and-antacid-use-what-is-the-next-be weekly 0.8 https://www.themednet.org/can-fatty-liver-disease-present-with-elevations-in-alkaline-phosphatase-without-other-liver-enzyme-elevations-ast-and-alt weekly 0.8 https://www.themednet.org/if-a-patient-is-legally-blind-and-on-hydroxychloroquine-do-you-still-recommend-follow-up-with-ophthalmology-to-monitor-for-hydroxychloroquine-retinal-toxicity weekly 0.8 https://www.themednet.org/how-frequently-do-you-monitor-ct-scans-pfts-and-ttes-in-patients-with-ila-or-mild-ild weekly 0.8 https://www.themednet.org/how-do-you-integrate-dd-cfdna-into-the-evaluation-and-management-of-acr-in-lung-transplant-recipients weekly 0.8 https://www.themednet.org/how-do-you-treat-molluscum-on-the-eyelid-in-a-child-or-an-adult weekly 0.8 https://www.themednet.org/do-you-routinely-transition-to-po-antibiotics-for-patients-with-native-joint-septic-arthritis-whom-have-undergone-washout-and-the-organism-is-not-s-aureus weekly 0.8 https://www.themednet.org/would-you-give-go-and-or-a-flt3-inhibitor-for-patients-with-aml-with-t-8-21-and-flt3-itd-low-in-addition-to-7-3 weekly 0.8 https://www.themednet.org/how-do-you-evaluate-and-manage-patients-with-lupus-who-are-having-issues-with-decreased-libido weekly 0.8 https://www.themednet.org/what-factors-influence-your-decision-to-use-femtosecond-laser-assisted-cataract-surgery-in-complex-cases weekly 0.8 https://www.themednet.org/for-patients-with-progessive-ckd-with-comorbid-conditions-do-you-adjust-ivig-or-switch-to-scig-to-prevent-further-progession-in-gfr-reduction weekly 0.8 https://www.themednet.org/with-the-difficulty-in-access-to-ppsv23-as-the-new-pneumonia-vaccine-is-now-standard-non-polysaccharide-vaccine-have-you-used-mpsv4-meningococcal-vaccine-for-evaluation-of-response-to-polysaccharide-vaccine weekly 0.8 https://www.themednet.org/how-do-you-decide-which-iv-opioid-to-use-for-symptom-relief-at-the-end-of-life weekly 0.8 https://www.themednet.org/when-do-you-consider-using-a-paramedian-approach-for-a-lumbar-puncture weekly 0.8 https://www.themednet.org/what-would-be-your-recommended-regimen-for-an-aya-patient-with-relapsed-mediastinal-pure-seminoma-with-relapse-20-months-after-completion-of-bep weekly 0.8 https://www.themednet.org/how-would-you-approach-endoscopic-diagnosis-and-treatment-of-an-area-of-visible-nodularity-concerning-for-cancer-within-long-segment-barretts-esophagus weekly 0.8 https://www.themednet.org/what-is-your-endoscopic-approach-towards-laterally-spreading-colonic-lesions-that-are-over-2-cm-in-size weekly 0.8 https://www.themednet.org/for-those-treating-osteoarthritis-with-ldrt-is-there-any-concern-of-adverse-effects-or-decreased-efficacy-in-patients-with-osteoporosis weekly 0.8 https://www.themednet.org/how-do-you-distinguish-tma-caused-by-cni-toxicity-versus-antibody-mediated-rejection-in-a-kidney-transplant-patient weekly 0.8 https://www.themednet.org/do-you-recommend-initiating-zoledronic-acid-for-osteoporosis-at-the-time-of-hospitalization-for-a-fracture weekly 0.8 https://www.themednet.org/how-do-you-approach-hcc-screening-in-patients-with-advanced-fibrosis-e-g-f3-on-fibroscan weekly 0.8 https://www.themednet.org/how-do-you-approach-reirradiation-in-a-patient-who-underwent-breast-conserving-surgery-for-recurrent-breast-cancer-after-initial-lumpectomy-and-apbi weekly 0.8 https://www.themednet.org/do-you-routinely-screen-and-replace-vitamin-d-in-patients-with-itp weekly 0.8 https://www.themednet.org/what-is-your-approach-to-isolated-alkaline-phosphatase-without-other-laboratory-abnormalities weekly 0.8 https://www.themednet.org/what-medications-do-you-use-to-treat-encapsulating-peritoneal-sclerosis weekly 0.8 https://www.themednet.org/what-considerations-should-you-discuss-with-patients-prior-to-genetic-testing-for-suspected-huntington-disease weekly 0.8 https://www.themednet.org/is-there-evidence-to-support-the-use-of-automated-blood-pressure-checks-during-exercise-stress-testing-or-does-manual-bp-remain-superior-in-terms-of-accuracy-and-consistency weekly 0.8 https://www.themednet.org/how-safe-and-effective-is-carotid-stenting-in-carotid-dissection weekly 0.8 https://www.themednet.org/what-is-your-preferred-diagnostic-approach-to-suspected-immune-checkpoint-inhibitor-cardiotoxicity-in-patients-who-are-otherwise-not-clinically-stable-enough-for-cmri weekly 0.8 https://www.themednet.org/do-you-recommend-treatment-of-male-partners-for-patients-with-recurrent-bacterial-vaginosis weekly 0.8 https://www.themednet.org/how-long-do-you-recommend-waiting-before-repeating-a-serum-electrolyte-panel-after-the-conclusion-of-an-intermittent-hemodialysis-session-to-ensure-accurate-results-are-obtained weekly 0.8 https://www.themednet.org/when-would-you-consider-use-of-emapalumab-for-hlh-mas weekly 0.8 https://www.themednet.org/how-would-you-treat-an-isolated-urothelial-cancer-local-recurrence-abutting-the-duodenum weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-who-develop-eczema-flare-after-food-exposure weekly 0.8 https://www.themednet.org/what-techniques-do-you-use-to-minimize-the-risk-of-buckle-extrusion-or-infection-especially-in-younger-or-highly-myopic-patients weekly 0.8 https://www.themednet.org/how-do-you-determine-whether-to-proceed-with-topography-guided-prk-lamellar-keratoplasty-or-a-full-thickness-transplant-in-patients-with-irregular-astigmatism-and-corneal-scarring weekly 0.8 https://www.themednet.org/do-you-target-a-lower-goal-driving-pressure-in-older-patients-with-ards weekly 0.8 https://www.themednet.org/when-do-you-consider-switching-from-another-biologic-to-benralizumab-in-patients-with-severe-eosinophilic-asthma-with-a-history-of-suboptimal-response-to-previous-biologic-agents weekly 0.8 https://www.themednet.org/how-do-you-utilize-fdg-pet-in-the-evaluation-of-dementias weekly 0.8 https://www.themednet.org/is-there-a-role-for-cinacalcet-in-the-management-of-pthrp-mediated-hypercalcemia weekly 0.8 https://www.themednet.org/do-you-prefer-automated-peritoneal-dialysis-during-the-day-or-night-for-a-hospitalized-patient-with-eskd-on-pd weekly 0.8 https://www.themednet.org/how-do-you-manage-a-prostate-cancer-patient-with-pelvic-lymphadenopathy-and-a-single-enlarged-psma-pet-gastrohepatic-node weekly 0.8 https://www.themednet.org/do-you-always-pursue-biopsy-confirmation-before-diagnosing-iga-vasculitis weekly 0.8 https://www.themednet.org/how-do-you-approach-prescribing-oxcarbazepine-when-the-patient-is-on-an-oral-contraceptive weekly 0.8 https://www.themednet.org/do-you-avoid-high-potency-p2y12-inhibitors-in-favor-of-clopidogrel-in-patients-with-atrial-fibrillation-on-a-doac-who-undergo-pci weekly 0.8 https://www.themednet.org/is-there-evidence-supporting-the-adjuvant-use-of-neratinib-in-patients-with-high-risk-hormone-receptor-positive-her2-negative-breast-cancer-that-harbors-an-activating-her2-mutation weekly 0.8 https://www.themednet.org/are-there-scenarios-in-which-pericardiocentesis-should-be-considered-for-large-pericardial-effusions-without-tamponade-physiology weekly 0.8 https://www.themednet.org/how-do-you-manage-expectations-around-response-time-and-durability-of-benefit-in-patients-starting-tms weekly 0.8 https://www.themednet.org/would-you-favor-culprit-only-pci-complete-revascularization-via-percutaneous-approach-or-urgent-cabg-evaluation-for-a-young-diabetic-patient-with-newly-reduced-lvef-35-presenting-with-an-anterior-stemi-and-multivessel-disease weekly 0.8 https://www.themednet.org/how-do-you-explain-and-manage-transient-post-ect-symptoms-like-irritability-tearfulness-or-panic-attacks-that-resolve-within-a-day weekly 0.8 https://www.themednet.org/how-do-you-define-treatment-resistant-depression-in-your-practice weekly 0.8 https://www.themednet.org/is-there-an-age-cutoff-where-you-consider-the-risks-of-monoclonal-antibody-therapy-outweigh-any-potential-benefit-s-in-early-onset-dementia weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-polycythemia-and-mpn-symptoms-aquagenic-pruritus-fatigue-that-is-jak2-calr-mpl-negative-but-peripheral-blood-ngs-positive-for-idh2 weekly 0.8 https://www.themednet.org/how-do-you-manage-symptomatic-fat-necrosis-following-adjuvant-breast-radiotherapy weekly 0.8 https://www.themednet.org/how-do-you-monitor-glaucoma-progression-in-highly-myopic-patients-with-unreliable-visual-fields-and-atypical-rnfl-scans weekly 0.8 https://www.themednet.org/how-do-you-approach-vitamin-d-supplementation-in-patients-with-chronic-kidney-disease-given-the-findings-that-vitamin-d2-supplementation-may-lead-to-decreased-conversion-of-25-hydroxyvitamin-d3-to-1-25-dihydroxyvitamin-d3 weekly 0.8 https://www.themednet.org/what-are-your-preferred-treatments-for-disrupted-nighttime-sleep-in-elderly-patients-with-narcolepsy-already-taking-sodium-oxybate weekly 0.8 https://www.themednet.org/in-patients-who-have-failed-5-asa-and-have-moderate-to-severe-uc-do-you-utilize-5-asa-as-an-adjunct-especially-rectal-therapy weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-patient-with-ckd-stage-5-and-prediabetes-who-is-concerned-about-their-risk-of-developing-diabetes-if-they-start-peritoneal-dialysis weekly 0.8 https://www.themednet.org/would-you-recommend-switching-from-an-integrase-strand-transfer-inhibitor-based-regimen-to-a-different-antiretroviral-regimen-or-would-you-instead-add-weight-loss-medications-for-a-person-with-hiv-experiencing-weight-gain-that-has-not-improved-with-lifest weekly 0.8 https://www.themednet.org/are-you-incorporating-ttfields-into-treatment-protocols-for-locally-advanced-pancreatic-cancer-based-on-the-panova-3-study weekly 0.8 https://www.themednet.org/what-are-your-first-line-vasopressors-of-choice-for-the-management-of-acute-severe-aortic-regurgitation-and-persistent-hypotension-shock weekly 0.8 https://www.themednet.org/which-anticoagulant-doac-or-warfarin-would-you-recommend-in-the-case-of-a-70-year-old-male-with-persistent-atrial-fibrillation-and-history-of-rheumatic-mitral-stenosis-now-status-post-bioprosthetic-mvr weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-antipsychotics-such-as-seroquel-zyprexa-for-insomnia-in-patients-unresponsive-to-standard-treatments weekly 0.8 https://www.themednet.org/what-factors-influence-your-decision-to-continue-or-taper-antipsychotics-for-behavioral-symptoms-of-dementia-after-the-acute-phase-resolves weekly 0.8 https://www.themednet.org/in-a-patient-with-severe-tr-when-is-the-best-time-to-start-thinking-about-t-teer weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-ra-on-abatacept-now-experiencing-recurrent-pericarditis-not-responsive-to-colchicine weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-continue-hydroxychloroquine-in-a-young-patient-who-develops-subretinal-neovascularization-with-no-other-risk-factors weekly 0.8 https://www.themednet.org/does-pre-chemotherapy-extent-of-nodal-involvement-impact-your-decision-to-offer-adjuvant-radiation-in-cn1-ypn0-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/when-would-you-consider-using-amiloride-over-spironolactone-for-treatment-resistant-hypertension-not-reaching-goal-bp-on-3-agents-including-a-diuretic weekly 0.8 https://www.themednet.org/which-patient-subgroups-do-you-plan-to-omit-regional-nodal-irradiation-for-given-the-publication-of-nsabp-b-51 weekly 0.8 https://www.themednet.org/do-you-recommend-chanca-piedra-supplements-for-patients-with-recurrent-calcium-oxalate-nephrolithiasis weekly 0.8 https://www.themednet.org/which-patient-factors-drive-you-to-pursue-patch-testing-in-the-workup-of-chronic-hand-eczema weekly 0.8 https://www.themednet.org/do-you-obtain-a-urinalysis-for-glucose-testing-for-your-patients-on-sglt2-inhibitors-to-assess-for-medication-adherence weekly 0.8 https://www.themednet.org/how-do-you-manage-high-risk-mds-ib2-patients-on-hma-and-venetoclax-who-develop-an-acute-stroke-requiring-antiplatelet-therapy weekly 0.8 https://www.themednet.org/how-do-you-manage-newly-diagnosed-multiple-myeloma-patients-who-have-a-contraindication-to-steroids weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-indeterminate-orbital-lesions-in-asymptomatic-patients-with-inconclusive-imaging-findings weekly 0.8 https://www.themednet.org/how-do-you-approach-the-workup-of-a-patient-with-a-large-focal-wedge-shaped-cortical-swelling-on-ct-concerning-for-renal-infarct-but-with-a-normal-echocardiogram-showing-no-thrombus-or-vegetation weekly 0.8 https://www.themednet.org/are-there-specific-populations-with-hypothyroidism-for-whom-you-would-consider-adding-liothyronine-to-levothyroxine-therapy-given-observational-data-linking-levothyroxine-therapy-alone-to-higher-risks-of-dementia-and-mortality weekly 0.8 https://www.themednet.org/in-a-patient-with-pancreatic-cancer-who-is-heterozygous-for-the-atm-c-875c-t-pro292leu-mutation-with-functional-impairment-in-the-gene-product-is-there-any-data-or-recommendation-to-support-using-sbrt-vs-chemo-rt weekly 0.8 https://www.themednet.org/how-do-you-make-decisions-about-decolonization-for-a-chronic-asymptomatic-mrsa-carrier weekly 0.8 https://www.themednet.org/is-there-any-emerging-data-demonstrating-the-utility-of-performing-gene-expression-assays-in-tnbc-to-understand-potential-chemotherapy-sensitivity weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-isolated-cns-relapse-of-seminoma weekly 0.8 https://www.themednet.org/other-than-clozapine-what-antipsychotics-do-you-use-in-a-manic-or-psychotic-patient-with-td weekly 0.8 https://www.themednet.org/when-giving-albumin-challenge-for-acute-kidney-injury-with-suspected-hepatorenal-syndrome-do-you-administer-a-single-dose-daily-or-split-the-dose-of-albumin weekly 0.8 https://www.themednet.org/when-would-you-consider-ppm-implantation-for-intermittent-episodes-of-high-degree-avb-that-persist-following-a-successful-pci-in-a-patient-presenting-with-an-inferior-stemi weekly 0.8 https://www.themednet.org/what-are-your-preferred-femoral-vascular-closure-devices-for-severely-calcified-femoral-artery-vessels-following-pci-especially-with-higher-sticks-and-why weekly 0.8 https://www.themednet.org/when-do-you-consider-repeating-csf-studies-in-a-patient-with-suspected-viral-encephalitis-but-overall-initially-unrevealing-csf weekly 0.8 https://www.themednet.org/would-you-use-a-parathyroid-hormone-analog-for-treatment-of-osteoporosis-in-a-patient-with-mildly-elevated-alkphos-of-unclear-etiology weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-regarding-alcohol-consumption-following-treatment-of-head-and-neck-cancer weekly 0.8 https://www.themednet.org/what-patient-factors-are-most-important-when-considering-who-needs-a-broader-workup-for-osteoporosis-prior-to-starting-therapy weekly 0.8 https://www.themednet.org/would-you-ever-consider-switching-a-patient-with-an-lvad-from-warfarin-to-eliquis-such-as-in-the-setting-of-recurrent-gi-bleeds weekly 0.8 https://www.themednet.org/is-there-any-data-to-support-the-use-of-bivalirudin-over-heparin-in-patients-on-va-ecmo-without-ongoing-concerns-for-hit weekly 0.8 https://www.themednet.org/when-treating-with-sbrt-and-immunotherapy-for-unresectable-hcc-how-do-you-sequence-the-treatment weekly 0.8 https://www.themednet.org/would-you-continue-to-monitor-urinary-protein-levels-and-dose-adjust-axitinib-in-a-patient-with-metastatic-malignancy-who-is-now-dialysis-dependent-but-has-residual-renal-function weekly 0.8 https://www.themednet.org/how-do-you-tailor-protein-intake-recommendations-for-older-patients-with-stages-3-5-non-dialysis-dependent-ckd-considering-the-unique-metabolic-and-physiologic-factors-that-influence-protein-metabolism-in-this-population weekly 0.8 https://www.themednet.org/what-time-frame-number-of-psas-and-calculator-do-you-use-for-calculating-psa-doubling-times weekly 0.8 https://www.themednet.org/will-you-offer-lurbinectedin-with-atezolizumab-for-patients-with-es-sclc-during-maintenance-if-they-had-brain-metastases-at-baseline weekly 0.8 https://www.themednet.org/how-do-you-anticipate-rusfertide-will-be-used-in-the-management-of-polycythemia-vera weekly 0.8 https://www.themednet.org/in-light-of-data-from-triangle-echo-and-enrich-what-is-the-best-strategy-to-treat-newly-diagnosed-patients-with-the-blastoid-variant-mcl weekly 0.8 https://www.themednet.org/is-it-safe-to-use-acarbose-in-patients-with-advanced-chronic-kidney-disease weekly 0.8 https://www.themednet.org/when-if-ever-is-it-appropriate-to-switch-from-generic-levothyroxine-to-brand-name-synthroid weekly 0.8 https://www.themednet.org/how-do-you-manage-oral-prednisone-when-initiating-nefecon-in-a-patient-with-iga-nephropathy weekly 0.8 https://www.themednet.org/how-do-you-titrate-the-dose-of-an-ace-inhibitor-in-a-patient-with-type-1-diabetes-mellitus-who-is-normotensive-but-has-moderately-increased-albuminuria weekly 0.8 https://www.themednet.org/in-a-patient-with-cardiac-light-chain-amyloid-who-has-significant-heart-failure-symptoms-including-inotrope-dependence-at-presentation-how-much-clinical-benefit-does-treatment-provide weekly 0.8 https://www.themednet.org/in-hospitalized-patients-with-significant-lower-extremity-edema-how-can-you-integrate-bedside-pocus-findings-with-clinical-assessment-to-guide-the-decision-to-start-empiric-anticoagulation-for-suspected-dvt-before-formal-imaging weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-sle-and-stage-4-ln-who-presents-with-persistent-significant-elevation-in-esr-crp-and-dsdna-despite-improvement-of-symptoms-and-resolution-of-proteinuria-on-mmf-and-hcq weekly 0.8 https://www.themednet.org/would-you-recommend-holding-anticoagulation-in-a-patient-with-persistent-atrial-fibrillation-presenting-with-a-mechanical-fall-and-found-to-have-a-scalp-hematoma-in-the-absence-of-intracranial-bleeding weekly 0.8 https://www.themednet.org/would-you-give-durvalumab-consolidation-to-a-patient-with-stage-iii-nsclc-with-an-stk11-mutation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-failed-trabeculectomies-with-scarring-but-controlled-iop weekly 0.8 https://www.themednet.org/when-might-you-soften-the-post-thrombolysis-monitoring-requirements-for-patients-receiving-tpa-for-acute-stroke weekly 0.8 https://www.themednet.org/when-do-you-consider-pharmacogenetic-testing-to-assist-in-the-selection-of-antipsychotic-medications weekly 0.8 https://www.themednet.org/how-do-you-recommend-adjusting-insulin-pump-settings-when-transitioning-from-u-100-to-u-200-humalog-insulin weekly 0.8 https://www.themednet.org/do-you-prefer-the-routine-use-of-bivalirudin-over-ufh-during-pci-cases-in-patients-presenting-with-acs weekly 0.8 https://www.themednet.org/is-it-reasonable-to-tell-patients-that-evenity-lowers-fracture-risk-by-about-70-while-prolia-reduces-it-by-around-50 weekly 0.8 https://www.themednet.org/what-do-you-recommend-to-your-patients-to-prevent-muscle-loss-when-prescribing-a-glp-1-agonist-for-weight-loss weekly 0.8 https://www.themednet.org/what-resources-do-you-provide-patients-with-alopecia-areata weekly 0.8 https://www.themednet.org/is-there-a-role-for-patients-who-have-a-strong-familial-history-of-hs-to-receive-a-genetics-evaluation-or-referral-to-clinical-trials weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-inquire-about-microplastics-in-their-cosmetics-or-physician-dispensed-products-given-emerging-associations-with-conditions-such-as-psoriasis-eczema-lupus-and-hormonal-disruption weekly 0.8 https://www.themednet.org/what-is-your-approach-to-bronchiolocentric-interstitial-pneumonia-patterns-observed-on-histology weekly 0.8 https://www.themednet.org/do-you-prescribe-empiric-antibiotics-to-patients-with-cap-who-test-positive-for-a-respiratory-virus weekly 0.8 https://www.themednet.org/how-do-pediatric-functional-neurologic-disorders-differ-from-adult-disorders-in-their-presentation-and-diagnosis weekly 0.8 https://www.themednet.org/what-factors-do-you-take-into-account-when-deciding-which-gene-expression-assay-to-utilize-when-making-adjuvant-treatment-decisions-in-patients-with-non-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-incorporating-ipl-therapy-for-meibomian-gland-dysfunction weekly 0.8 https://www.themednet.org/after-diagnosing-genital-warts-condyloma-accuminatum-do-you-order-an-sti-panel weekly 0.8 https://www.themednet.org/in-what-clinical-scenarios-do-you-incorporate-topical-insulin-drops-to-treat-persistent-epithelial-defects weekly 0.8 https://www.themednet.org/what-is-your-perspective-on-using-ai-with-octa-to-assess-optic-nerve-blood-flow-in-glaucoma-management weekly 0.8 https://www.themednet.org/what-maintenance-therapy-do-you-recommend-for-metastatic-gastric-adenocarcinoma-with-continued-response-to-folfox-with-zolbetuximab-after-oxaliplatin-removal weekly 0.8 https://www.themednet.org/do-you-have-any-concerns-about-lower-extremity-compression-e-g-compression-stockings-intermittent-pneumatic-compression-etc-worsening-ascites-in-a-patient-with-portal-hypertension weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-place-an-ngt-or-peg-tube-in-patients-with-dysphagia-precluding-adequate-po-nutritional-intake weekly 0.8 https://www.themednet.org/when-and-should-you-consider-watchmans-for-patients-with-high-bleed-risk-recurrent-gi-bleeds-and-valvular-atrial-fibrillation-with-moderate-severe-mitral-stenosis weekly 0.8 https://www.themednet.org/would-you-consider-a-short-duration-of-dual-antiplatelet-therapy-following-plain-old-balloon-angioplasty-poba-to-a-femoropopliteal-bypass-graft weekly 0.8 https://www.themednet.org/for-patients-admitted-with-acute-decompensated-heart-failure-do-you-wait-until-the-patient-is-euvolemic-before-ordering-a-tte weekly 0.8 https://www.themednet.org/do-you-modify-the-albumin-level-below-which-you-would-prophylactically-anticoagulate-a-pregnant-patient-with-nephrotic-range-proteinuria-given-that-hypoalbuminemia-is-expected-in-pregnancy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-waiting-period-for-an-eskd-patient-getting-a-kidney-transplant-after-just-being-treated-for-bacteremia weekly 0.8 https://www.themednet.org/how-do-you-manage-levodopa-in-a-patient-with-parkinsons-and-rls-with-augmentation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-vte-prophylaxis-in-hospitalized-patients-who-are-already-on-dapt weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-chemotherapy-for-a-stage-ii-colon-cancer-patient-who-has-negative-ctdna-but-presented-with-obstruction weekly 0.8 https://www.themednet.org/how-should-pcos-be-addressed-after-menopause weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-iga-nephropathy-in-patients-who-also-have-iga-vasculitis weekly 0.8 https://www.themednet.org/do-you-routinely-obtain-a-tee-or-vascular-imaging-in-a-patient-with-non-typhoid-salmonella-bacteremia-without-persistent-bacteremia weekly 0.8 https://www.themednet.org/is-there-utility-for-endovascular-stenting-of-severe-symptomatic-vertebral-artery-stenosis weekly 0.8 https://www.themednet.org/what-additional-workup-do-you-pursue-in-a-patient-in-whom-you-suspect-yellow-nail-syndrome weekly 0.8 https://www.themednet.org/how-frequently-do-you-recommend-skin-exams-in-patients-with-multiple-aks weekly 0.8 https://www.themednet.org/how-do-you-educate-patients-about-the-risks-of-actinic-keratosis-progressing-to-skin-cancer weekly 0.8 https://www.themednet.org/do-you-routinely-pursue-cardiac-evaluation-in-children-presenting-with-post-streptococcal-reactive-arthritis-given-the-diagnostic-overlap-with-acute-rheumatic-fever weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-hae-to-best-ensure-timely-administration-of-on-demand-treatments-for-attacks weekly 0.8 https://www.themednet.org/do-you-check-amh-levels-to-decide-on-adjuvant-chemotherapy-in-premenopausal-patients-with-node-positive-er-breast-cancer weekly 0.8 https://www.themednet.org/when-following-current-cog-all-protocols-with-the-addition-of-two-courses-of-blinatumomab-to-treatment-for-sr-and-hr-patients-how-frequently-should-surveillance-bone-marrow-and-mrd-evaluations-be-performed weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-post-operative-dysphagia-following-c-spine-surgery weekly 0.8 https://www.themednet.org/what-are-your-thoughts-on-trending-beta-hydroxybutyrate-once-a-diagnosis-of-dka-is-already-established weekly 0.8 https://www.themednet.org/what-is-your-preferred-stain-for-melanocytic-lesions weekly 0.8 https://www.themednet.org/how-do-you-work-with-your-patients-to-ensure-good-coordination-of-care-if-they-are-seeing-multiple-providers-within-your-specialty weekly 0.8 https://www.themednet.org/is-azilsartan-superior-to-other-angiotension-receptor-blockers-in-regard-to-cardiorenal-outcome-data weekly 0.8 https://www.themednet.org/how-soon-after-stopping-oral-steroids-can-patch-testing-be-performed weekly 0.8 https://www.themednet.org/would-you-consider-intravenous-thrombolytics-for-an-acute-spinal-ischemic-stroke weekly 0.8 https://www.themednet.org/what-doses-of-methimazole-do-you-consider-low-dose-when-treating-graves-disease-long-term weekly 0.8 https://www.themednet.org/in-a-patient-with-known-chronic-lv-thrombus-and-atrial-fibrillation-is-rhythm-control-still-an-option weekly 0.8 https://www.themednet.org/what-should-be-done-for-a-patient-with-biopsy-proven-seborrheic-dermatitis-on-the-scalp-and-central-forehead-presenting-as-a-large-annular-scaly-thin-plaque-who-has-failed-treatment-with-fluconazole-antifungal-creams-and-zoryve-which-is-too-expensive weekly 0.8 https://www.themednet.org/how-long-do-you-continue-aspirin-and-clopidogrel-after-and-uncomplicated-transfemoral-carotid-stent weekly 0.8 https://www.themednet.org/how-do-you-manage-gram-negative-bacteremia-in-a-patient-with-an-aortic-bypass-graft-for-whom-there-is-low-clinical-suspicion-for-active-graft-infection weekly 0.8 https://www.themednet.org/can-cinacalcet-be-used-short-term-to-manage-hypercalcemia-from-tertiary-hyperparathyroidism-in-advanced-ckd-while-awaiting-parathyroidectomy weekly 0.8 https://www.themednet.org/would-you-consider-bevacizumab-for-a-patient-with-sclc-who-has-asymptomatic-brain-metastasis-progression-after-cns-radiation-while-on-maintenance-immunotherapy weekly 0.8 https://www.themednet.org/what-is-the-risk-of-giving-dupixent-for-eczema-in-a-patient-with-asymptomatic-cll-on-observation weekly 0.8 https://www.themednet.org/would-you-consider-the-use-of-ruxolitinib-for-tumor-fevers-and-leukocytosis weekly 0.8 https://www.themednet.org/do-you-prefer-kidney-ultrasound-or-a-non-contrast-ct-scan-to-evaluate-for-nephrolithiasis-in-an-asymptomatic-patient-with-primary-hyperparathyroidism weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-deciding-between-rfa-and-surgery-for-a-patient-with-a-benign-thyroid-nodule-causing-dysphagia weekly 0.8 https://www.themednet.org/how-do-you-determine-when-it-is-appropriate-to-transition-a-patient-back-to-peritoneal-dialysis-after-they-were-switched-to-hemodialysis-due-to-pd-catheter-removal-for-refractory-peritonitis-once-the-infection-has-been-treated weekly 0.8 https://www.themednet.org/when-a-patient-has-cvid-and-is-then-diagnosed-with-lymphoma-receiving-ongoing-chemotherapy-how-do-you-manage-the-trough-levels weekly 0.8 https://www.themednet.org/for-a-patient-on-appropriate-treatment-for-invasive-aspergillosis-how-do-you-determine-if-and-when-it-is-acceptable-to-reintroduce-a-tnf-inhibitor-that-likely-contributed-to-their-acquisition-of-the-infection-but-is-considered-essential-for-control-of-the weekly 0.8 https://www.themednet.org/when-do-you-consider-using-valproate-to-manage-behavioral-disturbances-in-patients-with-delirium weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-high-crp-rising-liver-enzymes-and-new-biopsy-proven-liver-granulomas-6-months-after-starting-methotrexate-and-rituximab-therapy-for-anca-vasculitis weekly 0.8 https://www.themednet.org/how-do-you-utilize-tools-such-as-mmt8-in-clinical-practice-when-evaluating-myositis weekly 0.8 https://www.themednet.org/what-are-the-advantages-of-oral-octreotide-acetate-over-its-long-acting-injectable-formulation-for-treatment-of-acromegaly weekly 0.8 https://www.themednet.org/how-will-the-newer-jcem-guidelines-on-primary-aldosteronism-pa-impact-your-management-and-screening-of-pa weekly 0.8 https://www.themednet.org/is-there-a-target-alkaline-phosphatase-level-for-hypophosphatasia-patients-on-asfotase-alfa-therapy-2 weekly 0.8 https://www.themednet.org/is-a-baseline-cortisol-at-0-minutes-necessary-to-do-as-part-of-an-acth-stimulation-test-when-performing-the-test-in-late-morning-or-in-the-afternoon weekly 0.8 https://www.themednet.org/for-patients-with-adrenal-insufficiency-who-are-on-hydrocortisone-replacement-would-you-recommend-stress-doses-to-cover-for-minor-procedures-such-as-dental-work-or-thyroid-fine-needle-aspiration-biopsies weekly 0.8 https://www.themednet.org/what-treatment-would-you-recommend-for-a-patient-with-early-stage-tnbc-treated-per-keynote-522-pd-l1-cps-10-with-metastatic-recurrence-within-12-months-of-treatment-completion weekly 0.8 https://www.themednet.org/in-a-patient-with-selective-igm-deficiency-who-is-completely-asymptomatic-in-terms-of-infections-what-is-your-typical-laboratory-work-up weekly 0.8 https://www.themednet.org/what-degree-of-prolactin-elevation-is-typically-seen-in-patients-with-end-stage-kidney-disease-on-hemodialysis weekly 0.8 https://www.themednet.org/is-re-excision-of-residual-disease-ever-itself-an-indication-for-pmrt weekly 0.8 https://www.themednet.org/given-the-10-year-outcomes-of-uk-fast-forward-presented-at-estro-how-have-you-expanded-the-use-of-ultra-hypofractionation-in-your-practice weekly 0.8 https://www.themednet.org/what-are-some-methods-you-use-to-limit-or-decrease-the-development-of-post-icu-ptsd-in-patients weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-evaluation-of-minipolymyoclonus weekly 0.8 https://www.themednet.org/how-do-you-facilitate-access-to-interventional-treatments-such-as-tms-for-patients-with-difficult-to-treat-depression-who-are-on-medicaid weekly 0.8 https://www.themednet.org/how-do-you-approach-cases-of-transient-monocular-vision-loss-when-initial-carotid-imaging-and-cardiac-workup-are-unrevealing weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-are-concerned-that-discontinuation-of-certain-chronic-medications-may-actually-perpetuate-suffering-at-the-end-of-life weekly 0.8 https://www.themednet.org/what-are-some-helpful-tips-to-identify-and-optimize-visualization-of-the-common-bile-duct-on-abdominal-pocus weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-newly-diagnosed-lupus-lupus-nephritis-receiving-cyclophosphamide-euro-lupus-protocol-with-active-hemolysis-not-responding-to-steroids-or-ivig weekly 0.8 https://www.themednet.org/how-would-you-approach-using-the-new-vagus-nerve-stimulator-for-patients-with-ra weekly 0.8 https://www.themednet.org/what-is-your-strategy-in-the-management-of-patients-with-autoimmune-hepatitis-who-failed-azathioprine-therapy-and-what-parameters-do-you-monitor-with-what-frequency weekly 0.8 https://www.themednet.org/will-you-offer-durva-flot-perioperatively-for-adenocarcinoma-of-the-esophagus weekly 0.8 https://www.themednet.org/is-there-a-specific-group-of-children-that-you-start-on-ait-for-prevention-of-asthma weekly 0.8 https://www.themednet.org/what-hormonal-workup-is-recommended-for-a-male-with-abnormally-high-serum-testosterone-not-on-supplements-or-hormone-replacement-therapy weekly 0.8 https://www.themednet.org/what-specific-precautions-or-restrictions-do-you-recommend-when-prescribing-home-hemodialysis-for-a-patient-with-eskd-who-lives-alone weekly 0.8 https://www.themednet.org/do-you-have-any-concerns-about-using-long-acting-cabotegravir-rilpivirine-in-obese-patients-with-hiv weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-who-insist-on-testosterone-replacement-therapy-despite-normal-testosterone-levels-on-repeated-labs weekly 0.8 https://www.themednet.org/do-you-believe-the-collective-data-support-neoadjuvant-chemotherapy-or-primary-debulking-surgery-for-patients-with-advanced-ovarian-cancer weekly 0.8 https://www.themednet.org/whats-your-approach-to-an-asymptomatic-hemodynamically-stable-patient-with-moderate-spontaneous-pneumomediastinum-without-pneumothorax-and-normal-esophagogram weekly 0.8 https://www.themednet.org/what-is-your-preferred-management-approach-for-scleroderma-renal-crisis-in-a-patient-with-a-history-of-anaphylaxis-to-ace-inhibitors weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-who-report-complex-sleep-behaviors-while-taking-zolpidem-or-another-z-hypnotic weekly 0.8 https://www.themednet.org/how-often-do-you-check-weight-and-adjust-anticoagulation-dosing-in-pregnancy weekly 0.8 https://www.themednet.org/when-do-you-consider-the-use-of-zuranolone-to-treat-postpartum-depression weekly 0.8 https://www.themednet.org/do-you-incorporate-diurnal-or-nocturnal-iop-measurements-in-your-management-of-progression-despite-seemingly-adequate-daytime-control weekly 0.8 https://www.themednet.org/what-initial-systemic-therapy-would-you-offer-a-patient-with-metastatic-colon-cancer-with-braf-v600e-mutation-mss-who-is-not-an-oxaliplatin-candidate weekly 0.8 https://www.themednet.org/if-a-pregnant-patient-with-a-mechanical-heart-valve-takes-warfarin-throughout-her-pregnancy-what-are-the-chances-that-the-fetus-will-be-harmed weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-aki-secondary-to-intravenous-acyclovir weekly 0.8 https://www.themednet.org/how-do-you-decide-between-radioligand-therapy-or-cytotoxic-chemotherapy-in-patients-with-metastatic-castration-resistant-prostate-cancer-with-prior-arpi-exposure-who-have-cancer-related-anemia weekly 0.8 https://www.themednet.org/how-would-you-approach-first-line-treatment-for-a-patient-with-metastatic-colon-cancer-who-develops-an-anaphylactic-reaction-to-cetuximab-with-folfox-cetuximab-encorafenib weekly 0.8 https://www.themednet.org/what-strategies-have-you-used-to-facilitate-insurance-approval-of-off-label-psychiatric-medications-for-children-and-adolescents weekly 0.8 https://www.themednet.org/for-patients-presenting-with-suspected-type-1-nstemi-and-atrial-fibrillation-on-anticoagulation-do-you-favor-triple-therapy-or-sapt-with-systemic-anticoagulation-instead-while-awaiting-lhc weekly 0.8 https://www.themednet.org/how-do-you-assess-periprocedural-risk-for-patients-with-incidental-silent-ischemic-infarcts-scheduled-for-elective-surgeries-major-or-intravascular-procedures weekly 0.8 https://www.themednet.org/what-would-prompt-you-to-consider-a-sleep-study-for-narcolepsy-in-a-child-or-adolescent-with-new-onset-hallucinations weekly 0.8 https://www.themednet.org/when-do-you-consider-cardiac-ct-to-evaluate-for-etiology-of-acute-ischemic-stroke weekly 0.8 https://www.themednet.org/how-do-you-decide-between-the-gene-silencing-drugs-for-familial-amyloidosis-with-polyneuropathy weekly 0.8 https://www.themednet.org/have-you-found-sphenopalatine-blocks-to-be-an-effective-treatment-for-headaches-secondary-to-subarachnoid-hemorrhage weekly 0.8 https://www.themednet.org/how-do-you-determine-whether-medical-or-surgical-intervention-is-more-appropriate-for-managing-abdominal-discomfort-due-to-hepatic-cysts-in-patients-with-adpkd weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-a-newly-acquired-pseudomonas-aeruginosa-infection-that-was-not-eradicated-with-initial-treatment-in-a-patient-with-cf weekly 0.8 https://www.themednet.org/are-there-instances-where-tracheostomy-alone-without-mechanical-ventilation-can-be-sufficient-to-manage-neuromuscular-respiratory-failure weekly 0.8 https://www.themednet.org/given-that-esopec-did-not-mandate-pet-staging-are-the-conclusions-of-the-study-still-applicable-for-patients-who-are-staged-with-pet weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-parents-seeking-alternative-or-complementary-treatment-in-pediatric-oncology-patients weekly 0.8 https://www.themednet.org/what-is-the-role-of-adjuvant-rt-for-metastatic-rcc-to-the-thyroid-resected-with-high-risk-features weekly 0.8 https://www.themednet.org/do-you-routinely-obtain-a-biopsy-of-a-presumed-meningioma-prior-to-srs-to-confirm-grade-1 weekly 0.8 https://www.themednet.org/how-do-you-counsel-an-otherwise-healthy-patient-on-how-soon-they-can-go-back-to-moderate-exercise-after-a-bilateral-pulmonary-embolism weekly 0.8 https://www.themednet.org/for-patients-on-peritoneal-dialysis-with-type-2-diabetes-mellitus-do-you-have-a-preferred-long-acting-insulin-and-time-of-insulin-administration weekly 0.8 https://www.themednet.org/how-do-you-treat-patients-with-t-cell-all-t-cell-lymphoblastic-lymphoma-who-have-pre-existing-ckd-with-a-crcl-of-30-ml-min-or-less weekly 0.8 https://www.themednet.org/is-there-an-available-ascvd-risk-calculator-that-does-not-exclude-patients-on-statin-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-psychopharmacologic-treatment-of-adhd-in-correctional-settings weekly 0.8 https://www.themednet.org/when-do-you-consider-using-uzedy-the-subcutaneous-long-acting-injectable-version-of-risperidone weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-postural-orthostatic-tachycardia-syndrome-pots-regarding-safe-and-effective-exercise-regimens weekly 0.8 https://www.themednet.org/what-cosmetic-options-can-you-provide-to-patients-with-facial-discoid-lupus-that-seems-stable weekly 0.8 https://www.themednet.org/what-is-your-workup-for-patients-presenting-with-hypopigmented-macules weekly 0.8 https://www.themednet.org/is-dll3-expression-necessary-for-tarlatamab-efficacy-in-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/what-new-or-emerging-therapies-for-autoimmune-gastritis-are-available-beyond-iron-and-vitamin-b12-replacement weekly 0.8 https://www.themednet.org/how-do-you-approach-management-in-patients-with-adult-onset-stills-disease-presenting-with-active-polyarthritis-without-macrophage-activation-syndrome-who-remain-symptomatic-despite-prednisone-15-mg-day-and-methotrexate-25-mg-week weekly 0.8 https://www.themednet.org/how-do-you-treat-agitation-in-progressive-supranuclear-palsy weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-autonomic-neuropathy-in-a-patient-with-sjogrens weekly 0.8 https://www.themednet.org/would-you-offer-any-adjuvant-therapy-for-a-young-patient-with-anal-cancer-s-p-definitive-chemoradiation-and-r0-resection-with-significant-residual-disease weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-want-to-use-vaping-to-quit-smoking-cigarettes weekly 0.8 https://www.themednet.org/would-you-consider-iv-thrombolytics-in-patients-with-acute-ischemic-stroke-with-or-without-a-large-vessel-occlusion-if-they-have-a-history-of-von-willebrand-disease-vwd-regardless-of-its-type weekly 0.8 https://www.themednet.org/how-do-you-reconcile-the-risk-of-contrast-induced-nephropathy-cin-with-the-diagnostic-benefit-of-contrasted-ct-in-patients-with-aki-ckd weekly 0.8 https://www.themednet.org/what-is-your-approach-to-perioperative-risk-stratification-and-optimization-in-patients-with-cirrhosis weekly 0.8 https://www.themednet.org/how-does-the-presence-of-gallbladder-sludge-vs-stones-on-pocus-impact-your-suspicion-for-gallbladder-disease-as-a-cause-of-abdominal-pain weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-tpa-in-patients-undergoing-ppv-for-endophthalmitis-when-dense-fibrin-or-membranes-are-present-preoperatively weekly 0.8 https://www.themednet.org/what-is-your-strategy-for-counseling-patients-who-dont-qualify-for-colorectal-cancer-crc-screening-under-the-current-guidelines-but-are-concerned-with-its-increasing-incidence-at-a-younger-age weekly 0.8 https://www.themednet.org/what-intervention-would-you-choose-for-a-patient-with-a-post-bulbar-nsaid-related-diaphragm-or-stricture-with-a-luminal-diameter-of-5-6-mm weekly 0.8 https://www.themednet.org/how-long-would-you-stop-standard-gbm-radiotherapy-if-the-patient-had-a-fall-with-minor-head-trauma weekly 0.8 https://www.themednet.org/is-the-6-month-post-operative-calcium-level-a-good-indicator-of-patients-risk-of-recurrence-of-primary-hyperparathyroidism weekly 0.8 https://www.themednet.org/how-do-you-adjust-chronic-outpatient-steroid-therapy-when-myasthenia-gravis-patients-are-admitted-for-crisis weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-to-obtaining-an-objective-measure-of-frailty-on-physical-exam-in-a-primary-care-practice-setting weekly 0.8 https://www.themednet.org/how-do-you-select-an-ssri-and-dosing-strategy-for-older-adults-newly-being-treated-for-depression weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-depressive-symptoms-in-an-older-adult-already-taking-an-ssri weekly 0.8 https://www.themednet.org/what-is-your-approach-to-deprescribing-gabapentinoids-so-as-to-prevent-withdrawal-effects weekly 0.8 https://www.themednet.org/would-you-recommend-pre-dialysis-exercise-for-an-eskd-patient-as-a-means-of-cardioprotection weekly 0.8 https://www.themednet.org/how-do-you-choose-among-ssris-and-dosing-strategies-for-the-management-of-behavioral-and-psychological-symptoms-of-dementia weekly 0.8 https://www.themednet.org/how-do-you-approach-balancing-the-treatment-of-urinary-incontinence-with-anticholinergic-medications-with-the-use-of-cholinesterase-inhibitors-in-dementia weekly 0.8 https://www.themednet.org/are-there-scenarios-in-which-you-would-advise-using-benzodiazepines-for-the-treatment-of-hyperactive-delirium weekly 0.8 https://www.themednet.org/how-do-you-approach-vitamin-d-testing-and-supplementation-in-older-adults-following-a-fragility-fracture weekly 0.8 https://www.themednet.org/how-would-you-approach-the-decision-to-biopsy-a-kidney-transplant-recipient-who-previously-experienced-a-page-kidney-following-a-kidney-biopsy weekly 0.8 https://www.themednet.org/if-a-child-4-years-of-age-or-younger-has-respiratory-symptoms-consistent-with-asthma-are-you-diagnosing-asthma-or-using-different-terminology-such-as-bronchiolitis-or-reactive-airway-disease weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-a-recent-diagnosis-of-advanced-dlbcl-non-gcb-subtype-who-has-baseline-grade-3-neuropathy weekly 0.8 https://www.themednet.org/are-there-instances-when-you-would-prescribe-a-phosphate-binder-to-an-eskd-patient-on-hemodialysis-who-has-a-phosphorus-level-in-the-target-range-of-less-than-5-5-mg-dl weekly 0.8 https://www.themednet.org/how-if-at-all-are-you-modifying-your-practice-and-clinical-workflow-for-patients-receiving-checkpoint-inhibitors-with-data-showing-improved-outcomes-for-patients-receiving-infusions-earlier-in-the-day weekly 0.8 https://www.themednet.org/what-are-the-target-distensibility-index-and-egj-diameter-values-on-endoflip-following-peroral-endoscopic-myotomy-poem weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-selection-for-patients-with-non-small-cell-lung-cancer-who-have-uncommon-egfr-mutations-compared-to-those-with-common-mutations weekly 0.8 https://www.themednet.org/how-far-in-advance-of-a-nuclear-medicine-thyroid-update-and-scan-should-thionamides-be-discontinued-and-does-this-duration-vary-based-on-radio-isotope-used-i-e-technetium-versus-rai-123 weekly 0.8 https://www.themednet.org/if-a-patient-with-initially-borderline-resectable-pancreatic-cancer-receives-neoadjuvant-cht-followed-by-crt-and-is-ultimately-deemed-unresectable-do-you-consider-an-rt-boost weekly 0.8 https://www.themednet.org/do-you-recommend-surveillance-lumbar-punctures-for-patients-with-mollarets-meningitis-after-diagnosis-or-in-between-clinical-episodes weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-are-interested-in-dietary-approaches-for-managing-major-depressive-disorder weekly 0.8 https://www.themednet.org/is-there-a-potential-role-for-glp-1-receptor-agonists-in-the-management-of-premenstrual-dysphoric-disorder weekly 0.8 https://www.themednet.org/is-there-a-role-for-leucovorin-in-improving-verbal-communication-in-children-with-autism-spectrum-disorder weekly 0.8 https://www.themednet.org/is-there-data-supporting-the-extension-of-adjuvant-olaparib-beyond-one-year-in-patients-with-early-stage-her2-negative-breast-cancer-and-germline-brca1-2-mutations weekly 0.8 https://www.themednet.org/what-is-your-approach-to-delayed-or-inhibited-ejaculation-related-to-ssri-sexual-dysfunction weekly 0.8 https://www.themednet.org/in-an-infant-whose-mother-resumes-tnf-inhibitor-therapy-e-g-adalimumab-infliximab-certolizumab-after-delivery-and-is-breastfeeding-do-you-recommend-delaying-live-vaccinations weekly 0.8 https://www.themednet.org/is-it-safe-to-continue-teriparatide-beyond-3-years-in-a-patient-with-severe-osteoporosis-and-atypical-fracture-of-the-femur weekly 0.8 https://www.themednet.org/what-is-your-approach-to-discharge-planning-for-a-patient-with-chronic-siadh-who-is-admitted-with-asymptomatic-acute-on-chronic-hyponatremia weekly 0.8 https://www.themednet.org/at-what-bmi-or-waist-circumference-threshold-do-you-opt-to-move-from-fibroscan-to-other-nilda-for-fibrosis-assessment weekly 0.8 https://www.themednet.org/how-do-you-determine-the-time-window-for-which-to-monitor-for-cerebral-edema-development-in-patients-with-brain-injury weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-a-bone-biopsy-in-the-workup-of-renal-osteodystrophy weekly 0.8 https://www.themednet.org/when-transitioning-from-romosozumab-to-alendronate-or-teriparatide-to-alendronate-is-there-a-minimum-amount-of-time-that-alendronate-needs-to-be-continued-to-prevent-loss-of-bmd-gains weekly 0.8 https://www.themednet.org/is-there-a-role-for-leucovorin-in-a-patient-who-is-3-days-post-her-most-recent-treatment-dose-of-methotrexate-for-gtn-who-is-experiencing-grade-3-mucositis weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-add-steroid-sparing-immunotherapy-for-myasthenia-gravis-after-starting-prednisone-and-mestinon weekly 0.8 https://www.themednet.org/are-there-any-indications-for-valve-intervention-in-asymptomatic-patients-with-moderate-as weekly 0.8 https://www.themednet.org/is-the-accuracy-of-continuous-glucose-monitors-dexcom-or-libre-lower-in-patients-undergoing-dialysis weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-bilateral-adrenal-metastases-if-sbrt-is-not-an-option weekly 0.8 https://www.themednet.org/do-you-generally-favor-nebulizers-hfas-or-other-devices-in-children-aged-5-and-younger-with-asthma weekly 0.8 https://www.themednet.org/how-long-would-you-wait-before-performing-a-kidney-biopsy-in-a-patient-with-nephrotic-range-proteinuria-a-negative-pla2r-antibody-a-negative-anti-thsd7a-antibody-and-stable-renal-function-who-recently-started-treatment-a-week-ago-with-a-doac-for-a-pulmona weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-a-kidney-biopsy-in-an-hiv-patient-with-subnephrotic-range-proteinuria-microscopic-hematuria-and-stable-renal-function-who-has-been-on-a-tenofovir-based-regimen weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-both-a-resting-and-action-tremor-suggestive-of-pd-and-essential-tremor-together weekly 0.8 https://www.themednet.org/how-do-you-handle-medication-management-for-patients-on-immunosuppressive-therapy-who-are-lost-to-follow-up weekly 0.8 https://www.themednet.org/how-do-you-talk-to-patients-about-psychedelic-clinical-trials-for-the-treatment-of-major-depressive-disorder-or-ptsd weekly 0.8 https://www.themednet.org/how-would-you-approach-choosing-a-migs-procedure-for-a-patient-with-mild-glaucoma-with-progressively-worsening-pas-undergoing-cataract-surgery weekly 0.8 https://www.themednet.org/when-do-you-consider-referring-adolescents-with-major-depressive-disorder-for-tms weekly 0.8 https://www.themednet.org/when-you-interpret-a-pft-officially-do-you-include-a-comparison-to-an-older-pft-on-your-report weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-asymptomatic-severe-hyponatremia-secondary-to-impaired-free-water-clearance-in-a-patient-with-oliguric-acute-kidney-injury-who-is-not-on-renal-replacement-therapy weekly 0.8 https://www.themednet.org/what-mri-findings-would-you-consider-compatible-with-an-acute-seizure-or-seizures weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-chronic-cough-in-patients-with-ild weekly 0.8 https://www.themednet.org/what-questions-are-important-to-ask-before-performing-pdl-laser weekly 0.8 https://www.themednet.org/when-do-you-consider-using-olanzapine-samidorphan weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-to-determine-if-a-change-is-clinically-significant-while-evaluating-pfts weekly 0.8 https://www.themednet.org/how-do-you-approach-the-outpatient-management-of-bispecific-antibody-therapy-for-hematologic-malignancies weekly 0.8 https://www.themednet.org/what-is-the-best-approach-to-determine-whether-antiviral-post-exposure-prophylaxis-for-influenza-is-appropriate-in-an-elderly-immunocompromised-patient-who-has-been-vaccinated weekly 0.8 https://www.themednet.org/are-the-results-of-conko-007-changing-practice-for-the-management-of-pancreatic-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-bilateral-groin-recurrence-of-vulvar-small-cell-neuroendocrine-carcinoma-in-a-patient-who-has-previously-had-pelvic-and-groin-radiation weekly 0.8 https://www.themednet.org/in-general-how-do-you-manage-patients-with-early-stage-endometrioid-endometrial-cancer-who-have-concomitant-pole-and-tp53-mutations weekly 0.8 https://www.themednet.org/how-do-you-individualize-treatment-choices-for-progressive-myopia-in-children weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-treatment-of-a-locally-advanced-metaplastic-breast-cancer-with-squamous-differentiation weekly 0.8 https://www.themednet.org/how-would-you-change-the-regimen-for-a-patient-receiving-neoadjuvant-tchp-or-node-positive-hr-her2-breast-cancer-who-develops-a-severe-allergic-reaction-to-docetaxel weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-borderline-resectable-pancreatic-adenocarcinoma-in-an-elderly-patient-80-years-old-with-a-poor-performance-status-who-is-not-a-surgical-candidate weekly 0.8 https://www.themednet.org/when-do-you-add-chemotherapy-to-post-operative-rt-for-thymomas-after-a-r2-resection weekly 0.8 https://www.themednet.org/in-patients-with-knee-osteoarthritis-do-you-recommend-the-use-of-hyaluronate-injections-if-it-is-available-and-affordable-for-the-patient weekly 0.8 https://www.themednet.org/how-do-you-differentiate-between-axial-psoriatic-arthritis-and-axial-spondylitis-with-psoriasis-and-is-it-important-to-distinguish-between-these-two-conditions-from-a-prognostic-and-treatment-perspective weekly 0.8 https://www.themednet.org/do-you-choose-rituximab-or-calcineurin-inhibitors-for-patients-with-class-iv-v-lupus-nephritis-who-are-refractory-to-standard-of-care-therapies weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-therapy-following-successful-resection-of-a-solitary-lung-recurrence-of-leiomyosarcoma-if-no-other-evidence-of-recurrent-disease-on-pet-ct weekly 0.8 https://www.themednet.org/given-risks-to-adt-do-you-use-it-for-cytoreduction-in-low-risk-and-favorable-intermediate-risk-patients-prior-to-brachytherapy-or-sbrt weekly 0.8 https://www.themednet.org/how-do-you-treat-pediatric-aml-that-has-relapsed-after-transplant weekly 0.8 https://www.themednet.org/do-you-use-hydroxychloroquine-for-prevention-of-neonatal-lupus-in-patients-with-a-positive-ssa-who-are-planning-on-becoming-pregnant weekly 0.8 https://www.themednet.org/is-chronic-major-salivary-gland-enlargement-in-a-patient-with-sjogrens-an-indication-for-immune-modulating-therapy-such-as-hydroxychloroquine-or-methotrexate weekly 0.8 https://www.themednet.org/how-would-you-approach-the-post-operative-radiation-treatment-volumes-for-a-merkel-cell-carcinoma-of-the-hand weekly 0.8 https://www.themednet.org/would-you-consider-using-a-parp-inhibitor-as-maintenance-therapy-after-initial-platinum-chemotherapy-in-a-patient-with-metastatic-pancreatic-cancer-who-has-a-somatic-non-brca-dna-damage-repair-gene-alteration weekly 0.8 https://www.themednet.org/is-the-skin-dose-adequate-when-treating-a-patient-prone-for-breast-cancer weekly 0.8 https://www.themednet.org/in-patients-with-metastatic-persistant-recurrent-cervical-cancer-who-have-completed-platinum-based-chemotherapy-with-bevacizumab-do-you-offer-maintenance-bevacizumab weekly 0.8 https://www.themednet.org/would-you-consider-hipec-in-patients-with-advanced-ovarian-cancer-undergoing-primary-cytoreductive-surgery weekly 0.8 https://www.themednet.org/do-you-recommend-sentinel-lymph-node-dissection-or-full-lymphadenectomy-for-high-grade-and-type-ii-uterine-cancers weekly 0.8 https://www.themednet.org/what-starting-dose-of-lenvatinib-are-you-ultilizing-in-recurrent-endometrial-cancer-patients-initiating-lenvatinib-pembro weekly 0.8 https://www.themednet.org/how-do-you-treat-small-fiber-neuropathy-associated-with-rheumatic-conditions-like-sjogrens-syndrome weekly 0.8 https://www.themednet.org/how-do-you-handle-bladder-filling-for-treatment-planning-mris-for-prostate-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-triple-negative-breast-cancer-involving-a-pericardial-effusion weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-ask-you-about-trying-oral-or-topical-formulations-of-medical-marijuana-for-pain-related-to-arthritis-or-fibromyalgia weekly 0.8 https://www.themednet.org/when-is-it-too-late-to-start-parp-manitenance-after-adjuvant-chemotherapy-in-brca-mutated-ovarian-cancer-who-had-a-delay-in-completing-genetic-testing weekly 0.8 https://www.themednet.org/what-is-the-risk-of-secondary-malignancy-and-or-conversion-to-mpnst-for-patients-with-nf-1-who-undergo-radiation weekly 0.8 https://www.themednet.org/do-you-routinely-offer-chemotherapy-after-resection-of-solitary-or-oligometastatic-pulmonary-nodule-s-in-young-patients-with-previously-treated-soft-tissue-sarcoma-who-are-otherwise-without-any-evidence-of-disease weekly 0.8 https://www.themednet.org/for-a-post-menopausal-patient-with-a-pt2n0-hr-her2-breast-cancer-at-surgery-after-4-months-of-neoadjuvant-anastrozole-with-minimal-clinical-or-pathologic-response-would-you-utilize-genomic-testing-to-guide-decision-about-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-chemotherapy-in-a-young-patient-with-stage-ic1-sertoli-leydig-cell-tumor-moderately-differentiated-with-heterologous-rhabdosarcomatous-component-and-retiform-elements weekly 0.8 https://www.themednet.org/what-baseline-work-up-do-you-do-for-patients-with-suspected-palindromic-rheumatism weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-utilize-to-treat-an-oligometastatic-rib-lesion-for-durable-local-control weekly 0.8 https://www.themednet.org/how-would-you-treat-oligometastatic-nsclc-brain-and-bone-with-non-v600e-braf-mutations weekly 0.8 https://www.themednet.org/would-you-treat-a-seminal-vesicle-only-recurrence-with-xrt-in-a-patient-who-recieved-prior-xrt-to-the-prostate-but-not-the-sv weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-offer-for-an-incidental-endometrioid-adenocarcinoma-of-the-ovary-noted-on-lso-who-has-only-a-3mm-residual-disease-on-peritoneal-biopsy-from-completion-staging weekly 0.8 https://www.themednet.org/how-do-you-transition-to-an-anabolic-agent-in-a-patient-who-develops-an-atypical-fracture-while-on-denosumab weekly 0.8 https://www.themednet.org/are-there-any-special-considerations-for-treating-cml-in-the-very-elderly-greater-than-85-years-old weekly 0.8 https://www.themednet.org/what-systemic-therapy-would-you-consider-if-any-for-an-isolated-but-multifocal-cns-recurrence-of-her2-hr-negative-breast-cancer-treated-with-local-therapy-4-lesions-treated-with-resection-and-srs weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-chemotherapy-for-concurrent-early-stage-nsclc-in-ipsilateral-separate-lobes-or-do-you-consider-them-as-separate-primaries weekly 0.8 https://www.themednet.org/how-would-you-treat-metastatic-squamous-cell-carcinoma-of-the-gall-bladder weekly 0.8 https://www.themednet.org/are-there-any-clinical-situations-in-which-checking-for-anti-chromatin-antibodies-is-helpful weekly 0.8 https://www.themednet.org/what-is-the-optimal-work-up-for-patient-with-repeatedly-negative-biopsies-of-a-mid-rectal-lesion-with-signs-of-malignant-etiology weekly 0.8 https://www.themednet.org/would-you-start-neoadjuvant-treatment-with-immunotherapy-or-braf-mek-inhibitors-in-a-patient-with-a-large-regional-inoperable-braf-v600e-positive-melanoma-iiic weekly 0.8 https://www.themednet.org/do-you-routinely-check-tumor-genomics-including-pole-status-for-new-endometrial-cancers weekly 0.8 https://www.themednet.org/do-you-include-the-anterior-fibromuscular-stroma-in-your-prostate-ctv-volume-when-using-mri-fusion weekly 0.8 https://www.themednet.org/what-is-the-role-of-srs-in-the-treatment-of-malignant-gliomas weekly 0.8 https://www.themednet.org/does-diffuse-high-grade-pin-in-a-low-risk-prostate-cancer-patient-affect-your-recommendation-for-surveillance weekly 0.8 https://www.themednet.org/how-do-you-manage-severe-vaginal-dryness-and-vulvodynia-refractory-to-topical-lubricants-in-patients-with-sjogrens-syndrome weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-to-radiation-induced-meningiomas weekly 0.8 https://www.themednet.org/how-would-you-treat-a-oligometastatic-para-aortic-recurrence-1-year-after-definitive-chemo-radiation-for-anal-cancer weekly 0.8 https://www.themednet.org/do-you-sample-radiologically-negative-paraaortic-nodes-in-cervical-cancer-patients-with-clinically-positive-pelvic-nodes-prior-to-initiating-primary-chemoradiation weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-history-of-clear-cell-rcc-4-years-ago-who-has-a-solitary-oligometastatic-brain-lesion-that-is-asymptomatic-and-too-small-for-stereotactic-radiation weekly 0.8 https://www.themednet.org/when-would-you-add-a-vaginal-cuff-brachy-boost-to-external-beam-radiation-for-uterine-carcinosarcoma weekly 0.8 https://www.themednet.org/would-you-offer-a-male-patient-adjuvant-radiation-for-treatment-of-his-breast-cancer-if-his-axillary-dissection-specimen-shows-a-single-node-with-isolated-tumor-cell-s-itc weekly 0.8 https://www.themednet.org/how-would-you-manage-newly-diagnosed-spinal-cord-compression-presenting-with-paraplegia-without-tissue-confirmation weekly 0.8 https://www.themednet.org/are-there-any-features-that-help-differentiate-sjogrens-related-cns-demyelinating-plaques-from-multiple-sclerosis-in-a-patient-with-primary-sjogrens-syndrome weekly 0.8 https://www.themednet.org/when-treating-the-whole-brain-with-hippocampal-avoidance-do-you-ever-deliver-sib-to-gross-disease weekly 0.8 https://www.themednet.org/do-you-constrain-the-dose-to-the-oropharynx-parotids-or-oral-cavity-when-planning-ha-wbrt weekly 0.8 https://www.themednet.org/is-a-stereotactic-thin-slice-mri-of-the-brain-absolutely-necessary-to-determine-eligibility-for-hippocampal-sparing-whole-brain-radiation-therapy weekly 0.8 https://www.themednet.org/do-you-treat-muscle-invasive-urothelial-bladder-cancer-with-plasmacytoid-features-any-differently-in-terms-of-the-recommendation-for-neoadjuvant-cisplatin-based-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-manage-recurrent-endometrial-cancer-limited-to-pelvic-and-inguinal-nodes-in-a-patient-with-no-previous-radiation weekly 0.8 https://www.themednet.org/how-would-you-approach-unresectable-pelvic-side-wall-recurrence-in-cervical-cancer-with-previous-definitive-chemoradiation weekly 0.8 https://www.themednet.org/is-there-a-role-for-tocilizumab-in-treatment-of-polymyalgia-rheumatica-in-patients-who-do-not-have-features-of-giant-cell-arteritis-or-rheumatoid-arthritis weekly 0.8 https://www.themednet.org/what-maintenance-treatment-would-you-recommend-for-ph-positive-all-following-hyper-cvad-transplant-eligible-or-ineligible weekly 0.8 https://www.themednet.org/how-do-you-approach-b-cell-lymphoblastic-lymphoma-without-bone-marrow-involvement-in-older-adults-65-70-years weekly 0.8 https://www.themednet.org/how-would-you-treat-a-skull-based-chordoma-in-a-pediatric-patient weekly 0.8 https://www.themednet.org/in-a-patient-treated-with-peri-operative-chemotherapy-via-the-magic-regimen-for-gastric-cancer-who-has-a-locoregional-relapse-in-unresectable-celiac-node-how-would-you-approach-radiation-treatment weekly 0.8 https://www.themednet.org/how-does-sarcomatous-overgrowth-in-a-uterine-carcinosarcoma-change-your-management-of-adjuvant-therapies weekly 0.8 https://www.themednet.org/how-do-you-interpret-granulomatous-features-on-a-muscle-biopsy weekly 0.8 https://www.themednet.org/are-subcutaneous-ra-therapies-less-effective-in-obese-patients weekly 0.8 https://www.themednet.org/would-you-avoid-the-use-of-a-tnf-inhibitors-in-patients-with-a-remote-history-of-melanoma-including-those-with-ocular-melanoma weekly 0.8 https://www.themednet.org/how-do-you-incorporate-diagnostic-laparoscopy-for-interval-debulking-surgery weekly 0.8 https://www.themednet.org/should-methotrexate-be-categorically-avoided-in-ra-patients-with-copd-or-ra-ild weekly 0.8 https://www.themednet.org/should-adjuvant-maintenance-chemotherapy-be-provided-to-children-with-anaplastic-ependymoma-following-radiation-therapy weekly 0.8 https://www.themednet.org/would-you-consider-an-osteoporosis-medication-in-a-pre-menopausal-young-patient-with-a-low-z-score-and-an-ongoing-risk-factor-for-secondary-osteoporosis-such-as-chronic-antiepileptic-treatment weekly 0.8 https://www.themednet.org/do-you-use-bite-block-during-radiation-treatment-for-base-of-tongue-bot-cancer weekly 0.8 https://www.themednet.org/would-you-add-tucatinib-to-systemic-therapy-for-er-her2-metastatic-breast-cancer-where-there-is-systemic-control-but-new-brain-metastasis weekly 0.8 https://www.themednet.org/how-would-you-approach-definitive-chemoradiation-for-node-positive-anal-cancer-with-a-history-of-ulcerative-colitis-status-post-total-proctocolectomy weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-a-high-risk-stage-iii-colon-cancer-which-is-msi-high-in-a-patient-70-years-of-age weekly 0.8 https://www.themednet.org/do-you-have-any-suggestions-about-how-to-improve-rheumatology-training-in-internal-medicine-residency-programs weekly 0.8 https://www.themednet.org/when-treating-anal-squamous-cell-carcinoma-how-does-your-radiotherapy-regimen-change-when-there-is-a-bleeding-anal-fissure weekly 0.8 https://www.themednet.org/what-second-line-treatment-would-you-choose-for-a-post-menopausal-woman-with-hr-her2-metastatic-breast-cancer-with-low-burden-disease-treated-with-first-line-aromatase-inhibitor-and-trastuzumab weekly 0.8 https://www.themednet.org/would-you-consider-starting-ivig-as-initial-steroid-sparing-agent-instead-of-azathioprine-methotrexate-in-a-patient-with-inflammatory-myopathy-high-jo-1-weakness-with-severe-dysphagia-and-without-skin-involvement-or-ild weekly 0.8 https://www.themednet.org/what-is-your-work-up-and-management-for-patients-who-develop-neuropathy-on-a-tnf-inhibitor weekly 0.8 https://www.themednet.org/how-do-steroids-and-or-dmards-affect-biopsy-results-if-a-renal-biopsy-for-suspected-lupus-nephritis-is-delayed weekly 0.8 https://www.themednet.org/how-do-you-manage-calcium-and-vitamin-d-supplementation-in-patients-with-sarcoidosis-on-chronic-steroids weekly 0.8 https://www.themednet.org/would-you-give-omit-regional-nodal-irradiation-in-low-nodal-burden-er-her2-disease-s-p-bcs-with-slnb weekly 0.8 https://www.themednet.org/do-you-recommend-salvage-radiation-therapy-to-limited-recurrent-ewings-sarcoma-bony-lesions weekly 0.8 https://www.themednet.org/would-development-of-a-rectovaginal-fistula-mid-treatment-with-second-line-pembrolizumab-lenvatinib-for-endometrial-cancer-cause-you-to-change-regimens-eliminate-lenvatinib-or-continue-current-therapy weekly 0.8 https://www.themednet.org/would-you-start-a-patient-with-sickle-cell-disease-and-covid-19-on-prophylactic-anticoagulation weekly 0.8 https://www.themednet.org/for-a-patient-with-oligometastatic-breast-cancer-that-has-completed-adequate-local-therapy-would-you-consider-ablating-synchronous-oligometastatic-disease weekly 0.8 https://www.themednet.org/is-there-any-role-for-differential-cardiac-substructure-dose-tolerances-when-treating-with-radiation-for-breast-cancer weekly 0.8 https://www.themednet.org/in-the-treatment-of-recurrent-trigeminal-neuralgia-what-local-therapy-would-you-recommend-after-failure-of-medical-therapy weekly 0.8 https://www.themednet.org/how-should-early-stage-well-differentiated-neuroendocrine-neoplasms-of-the-breast-with-intermediate-proliferative-index-ki-67-approximately-20-30-be-managed-in-the-adjuvant-setting weekly 0.8 https://www.themednet.org/would-you-offer-radiation-alone-to-localized-recurrence-of-extensive-stage-small-cell-lung-cancer-while-on-maintenance-immunotherapy-or-would-you-start-alternative-systemic-therapy weekly 0.8 https://www.themednet.org/are-there-any-special-considerations-when-giving-breast-radiation-to-a-patient-with-sjogrens-syndrome weekly 0.8 https://www.themednet.org/what-do-you-tell-men-with-low-but-detectable-psa-who-have-completed-adt-and-rt weekly 0.8 https://www.themednet.org/what-fgfr-inhibitor-would-you-use-for-a-patient-with-cholangiocarcinoma-and-a-fgfr3-mutation weekly 0.8 https://www.themednet.org/what-is-the-role-of-radiation-in-a-patient-with-stage-iv-dlbcl-with-bilateral-testicular-involvement weekly 0.8 https://www.themednet.org/how-would-you-approach-a-t1n1-nsclc-with-a-small-peripheral-primary-tumor-and-single-hilar-node-in-a-patient-not-fit-for-concurrent-chemo-or-surgery weekly 0.8 https://www.themednet.org/what-clinical-factors-do-you-use-to-determine-timing-of-on-demand-dosing-of-rituximab-in-anca-vasculitis-maintenance-therapy weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-therapy-for-a-1a-grade-2-endometrial-adenocarcinoma-with-melf-pattern-and-itcs-in-one-pelvic-lymph-node weekly 0.8 https://www.themednet.org/at-what-level-of-bone-marrow-disease-would-you-agree-to-proceed-with-transplant-for-a-patient-with-refractory-aml weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-a-low-grade-adnexal-carcinoma-of-the-scalp-in-a-patient-with-prior-history-of-wbrt-as-a-child weekly 0.8 https://www.themednet.org/is-romosozumab-an-option-in-a-patient-who-has-completed-2-years-of-teriparatide-therapy-and-has-a-fracture-while-on-denosumab weekly 0.8 https://www.themednet.org/what-is-the-utility-and-recommendation-for-adding-troponin-and-or-bnp-to-echocardiograms-to-screen-for-cardiac-dysfunction-in-breast-cancer-patients-receiving-anthracycline-based-regimens weekly 0.8 https://www.themednet.org/how-would-you-manage-the-cavity-of-a-resected-anaplastic-meningioma-with-pulmonary-metastases weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-unresectable-nsclc-planned-for-concurrent-chemoradiation-who-develop-a-serious-infusion-reaction-to-paclitaxel weekly 0.8 https://www.themednet.org/would-itcs-in-a-single-axillary-node-push-you-towards-recommending-adjuvant-chemotherapy-for-a-young-woman-with-a-t1a-2mm-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-using-non-anthracycline-based-neoadjuvant-treatment-for-triple-negative-breast-cancer-especially-in-older-patients-with-node-negative-disease weekly 0.8 https://www.themednet.org/what-are-some-strategies-for-radiographically-differentiating-between-erosions-secondary-to-erosive-osteoarthritis-versus-psoriatic-arthritis-involving-the-dip-joints weekly 0.8 https://www.themednet.org/how-long-do-you-continue-ivig-for-myositis-patients-in-remission-on-that-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-vulvar-cancer-with-bulky-lymph-node-metastasis weekly 0.8 https://www.themednet.org/what-steroid-sparing-agent-would-you-use-for-treatment-of-neurosarcoidosis-with-leptomeningeal-and-parenchymal-involvement weekly 0.8 https://www.themednet.org/would-the-diagnosis-of-skin-only-morphea-localized-scleroderma-alter-treatment-recommendations-for-localized-anal-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-palliation-of-a-symptomatic-cervical-cancer-involving-the-supraclavicular-lymph-nodes weekly 0.8 https://www.themednet.org/are-you-offering-parp-inhibitor-alone-or-both-parp-inhibitor-and-bevacizumab-maintenance-for-hrd-ovarian-cancer-patients-after-upfront-treatment weekly 0.8 https://www.themednet.org/whats-the-best-treatment-for-calcinosis-universalis-in-a-scleroderma-patient weekly 0.8 https://www.themednet.org/what-do-you-use-to-treat-a-gca-patient-refractory-to-methotrexate-who-responded-but-had-adverse-effects-with-both-tocilizumab-and-sarilumab weekly 0.8 https://www.themednet.org/what-is-the-optimal-vte-prophylaxis-for-hospitalized-patients-with-covid-19 weekly 0.8 https://www.themednet.org/how-would-you-manage-a-pediatric-patient-with-immune-thrombocytopenia-who-has-severe-thrombocytopenia-without-bleeding-symptoms weekly 0.8 https://www.themednet.org/when-would-you-offer-post-operative-concurrent-chemoradiation-in-anaplastic-thyroid-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-for-treating-transplant-ineligible-patients-with-relapsed-blastic-plasmacytoid-dendritic-cell-neoplasm-bpdcn-who-have-progressed-on-tagraxofusp weekly 0.8 https://www.themednet.org/what-is-the-preferred-immunosuppressive-modality-for-patients-with-an-acquired-factor-8-inhibitor weekly 0.8 https://www.themednet.org/when-would-you-consider-radiation-therapy-for-an-optic-pathway-glioma-in-a-pediatric-patient weekly 0.8 https://www.themednet.org/would-you-continue-tnfi-for-inflammatory-arthritis-if-the-patient-develops-a-solid-organ-malignancy-while-on-that-therapy weekly 0.8 https://www.themednet.org/how-would-you-manage-gastrointestinal-bleeding-after-radiation-therapy-for-pancreas-cancer weekly 0.8 https://www.themednet.org/when-do-you-recommend-prophylactic-treatment-of-spinal-metastasis-es-after-initial-identification-on-staging-imaging-for-a-metastatic-solid-tumor weekly 0.8 https://www.themednet.org/how-do-you-choose-chemotherapy-for-a-pediatric-patient-with-mixed-phenotype-acute-leukemia weekly 0.8 https://www.themednet.org/what-is-the-preferred-dmard-in-active-spondyloarthropathy-with-psoriasis-and-sacroiliitis-features-in-the-setting-of-treated-hepatitis-c-with-negative-viral-load weekly 0.8 https://www.themednet.org/how-would-you-approach-a-new-pelvic-mass-in-a-patient-with-history-of-mixed-germ-cell-tumor-but-normalized-tumor-markers weekly 0.8 https://www.themednet.org/can-hydrogel-spacer-be-placed-in-a-previously-irradiated-pelvis-if-considering-prostate-radiation-by-brachytherapy-or-sbrt weekly 0.8 https://www.themednet.org/in-what-situations-do-you-check-for-hiv-status-in-your-workup-for-inflammatory-arthritis weekly 0.8 https://www.themednet.org/what-is-your-starting-dose-of-ponatinib-for-cml weekly 0.8 https://www.themednet.org/what-is-your-approach-to-dental-prophylaxis-for-patients-on-biologics weekly 0.8 https://www.themednet.org/would-you-consider-fertility-sparing-management-of-stage-ib1-cervical-cancer-using-nact-followed-by-conization weekly 0.8 https://www.themednet.org/how-do-you-evaluate-an-isolated-prolonged-aptt-in-patients weekly 0.8 https://www.themednet.org/do-you-have-a-preferred-systemic-therapy-for-unresectable-epithelioid-hemangioendothelioma weekly 0.8 https://www.themednet.org/what-would-be-your-differential-for-a-wrist-monoarthritis-in-an-elderly-female-with-erosions-on-mri-after-less-than-3-months-of-symptoms weekly 0.8 https://www.themednet.org/when-is-a-biopsy-necessary-to-diagnose-relapsing-polychondritis weekly 0.8 https://www.themednet.org/what-would-you-use-to-treat-polymyositis-refractory-to-high-dose-steroids-methotrexate-mycophenolate-ivig-and-cyclophosphamide weekly 0.8 https://www.themednet.org/for-a-relapsed-aml-patient-who-has-previously-received-7-3-followed-by-hidac-consolidation-how-do-you-choose-between-flag-ida-or-mec-re-induction weekly 0.8 https://www.themednet.org/how-should-young-patients-with-rhabdomyosarcoma-be-managed-in-the-absence-of-a-clinical-trial weekly 0.8 https://www.themednet.org/how-would-you-manage-a-premenopausal-female-with-stage-i-triple-positive-breast-cancer-who-is-asymptomatic-and-tests-positive-for-covid-mid-way-through-radiation-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-an-hpv-retroperitoneal-mass-s-p-resection-involving-the-psoas-ureter-with-uterus-cervix-negative-for-any-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-bladder-cancer-surveillance-in-patients-who-have-received-cyclophosphamide weekly 0.8 https://www.themednet.org/which-of-the-androgen-blocking-agents-have-the-best-cns-penetration-for-someone-with-metastatic-crpc-with-brain-metastases weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-therapy-for-a-patient-with-stage-i-high-risk-invasive-mole-after-hysterectomy weekly 0.8 https://www.themednet.org/how-would-you-approach-timing-of-adjuvant-chemotherapy-in-a-stage-1-tnbc-lost-to-follow-up-for-1-month-since-surgery weekly 0.8 https://www.themednet.org/how-would-you-manage-a-locally-advanced-prostate-cancer-with-positive-pelvic-nodes-incidentally-found-at-the-time-of-radical-cystectomy-for-bladder-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-patient-with-a-recurrent-thymic-carcinoma-after-prior-surgery-and-concurrent-chemoradiation weekly 0.8 https://www.themednet.org/how-do-you-balance-short-course-adt-in-unfavorable-intermediate-risk-prostate-cancer-patients-with-cardiac-comorbidities weekly 0.8 https://www.themednet.org/how-would-you-treat-a-pt-with-ct2n0m0-scc-of-the-supraglottic-larynx-good-ps-swallowing-function-with-a-bulky-primary-tumor weekly 0.8 https://www.themednet.org/how-do-you-approach-interval-cytoreductive-surgery-in-patients-with-epithelial-ovarian-cancer-requiring-6-or-more-cycles-of-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-to-a-young-woman-with-widely-metastatic-low-grade-endometrial-stromal-sarcoma-not-amenable-to-complete-cytoreduction weekly 0.8 https://www.themednet.org/what-pre-treatment-findings-on-ct-scan-if-any-influence-your-concern-for-gi-perforation-risk-with-bevacizumab-use-in-ovarian-cancer-patients weekly 0.8 https://www.themednet.org/how-do-you-screen-dermatomyositis-patients-for-malignancy-if-they-have-a-high-risk-antibody-profile-nxp-2-tif1gamma-positive-and-their-initial-screen-is-negative weekly 0.8 https://www.themednet.org/what-are-the-most-effective-therapies-for-cppd-with-a-pseudo-ra-pattern weekly 0.8 https://www.themednet.org/are-tkis-safe-for-a-patient-with-metastatic-renal-cell-carcinoma-and-a-transplanted-kidney weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-treatment-of-gamma-heavy-chain-disease-franklins-disease weekly 0.8 https://www.themednet.org/how-do-you-treat-a-positive-margin-of-vulvar-pagets-after-radical-vulvectomy weekly 0.8 https://www.themednet.org/how-would-you-manage-prostate-cancer-in-a-patient-who-received-prior-chemoradiation-followed-by-lar-for-rectal-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-endocrine-therapy-after-excision-of-a-hormone-positive-recurrence-after-mastectomy-who-finished-5-years-of-aromatase-inhibitor-for-the-same-primary-tumor-in-the-context-of-natalee-and-monarche-trials weekly 0.8 https://www.themednet.org/are-there-any-situations-you-would-recommend-prophylactic-anticoagulation-for-a-patient-with-factor-v-heterozygosity weekly 0.8 https://www.themednet.org/what-is-your-approach-to-elective-radiation-of-the-neck-with-primary-cutaneous-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/what-is-the-safest-approach-to-treating-refractory-ra-in-the-setting-of-an-active-solid-organ-malignancy weekly 0.8 https://www.themednet.org/how-often-do-you-utilize-soluble-transferrin-receptor-or-hepcidin-testing-in-the-diagnosis-of-ambiguous-iron-deficiency-such-as-with-concomitant-anemia-of-chronic-disease weekly 0.8 https://www.themednet.org/what-is-your-local-therapy-paradigm-for-unresectable-pelvic-ews-cases weekly 0.8 https://www.themednet.org/what-chemotherapy-would-you-offer-if-any-in-a-young-patient-after-resection-and-radiation-of-a-single-site-of-metastatic-pdl1-positive-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/for-patients-with-metastatic-thymic-carcinoma-what-would-you-offer-patients-who-progress-after-platinum-doublet-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-assess-transaminitis-in-a-patient-with-sarcoidosis-with-known-liver-involvement-being-treated-with-methotrexate weekly 0.8 https://www.themednet.org/what-is-your-approach-to-gynecologic-examinations-surveillance-in-a-standard-risk-patient-on-adjuvant-tamoxifen weekly 0.8 https://www.themednet.org/is-it-okay-to-use-belimumab-to-treat-sle-in-a-patient-who-has-a-history-of-lymphoma-and-is-on-a-brutons-tyrosine-kinase-inhibitor-such-as-ibrutinib weekly 0.8 https://www.themednet.org/for-alk-positive-nsclc-where-in-treatment-sequencing-do-you-utilize-lorlatinib weekly 0.8 https://www.themednet.org/should-tuberculosis-screening-be-performed-before-beginning-methotrexate-for-treatment-of-rheumatoid-arthritis weekly 0.8 https://www.themednet.org/how-do-you-manage-post-menopausal-osteoporosis-in-a-patient-with-stable-bone-density-and-no-fractures-after-three-years-of-holiday-after-giving-zoledronic-acid weekly 0.8 https://www.themednet.org/what-are-examples-of-rheumatology-quality-measures-that-are-both-clinically-meaningful-and-can-be-captured-accurately-and-efficiently weekly 0.8 https://www.themednet.org/what-are-the-current-frontline-treatment-options-for-newly-diagnosed-pediatric-aml-patients-with-high-flt3-itd-allelic-ratio-and-idh2-mutation weekly 0.8 https://www.themednet.org/would-you-include-carboplatin-with-an-anthracycline-and-taxane-for-neoadjuvant-treatment-for-triple-negative-inflammatory-breast-cancer weekly 0.8 https://www.themednet.org/is-there-a-role-for-the-vectra-or-other-multi-biomarker-tests-in-evaluating-rheumatoid-arthritis-disease-activity weekly 0.8 https://www.themednet.org/for-which-subset-s-of-aps-patients-do-you-recommend-an-inr-of-3-or-higher weekly 0.8 https://www.themednet.org/when-contouring-presacral-space-for-gynecological-tumors-for-imrt-plans-how-far-inferiorly-do-you-take-your-contour weekly 0.8 https://www.themednet.org/is-placing-a-vp-shunt-a-major-risk-to-spread-medulloblastoma-or-other-malignant-brain-tumors-into-the-gut weekly 0.8 https://www.themednet.org/would-you-use-a-myeloablative-or-reduced-intensity-conditioning-regiment-for-a-pediatric-or-aya-patient-who-does-not-recover-their-counts-after-treatment-for-aml-but-remains-disease-free weekly 0.8 https://www.themednet.org/which-steroid-sparing-agent-do-you-prefer-to-treat-multi-organ-sweets-syndrome weekly 0.8 https://www.themednet.org/do-you-avoid-any-specific-biologic-therapies-in-hiv-positive-patients weekly 0.8 https://www.themednet.org/does-your-approach-to-first-line-treatment-of-metastatic-colon-cancer-change-for-a-mucinous-adenocarcinoma weekly 0.8 https://www.themednet.org/is-there-a-role-for-radiation-therapy-after-neoadjuvant-systemic-therapy-and-irreversible-electroporation-in-patients-with-locally-advanced-pancreas-cancer weekly 0.8 https://www.themednet.org/are-there-any-therapeutic-options-for-cauda-equina-syndrome-secondary-to-dural-ectasia-in-end-stage-ankylosing-spondylitis weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-with-refractory-metastatic-castrate-resistant-prostate-cancer-who-has-somatic-atm-mutation-with-a-parp-inhibitor weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-locally-advanced-triple-negative-breast-cancer-s-p-mrm-who-refuses-adjuvant-chemo weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-radiation-for-perihilar-cholangiocarinoma weekly 0.8 https://www.themednet.org/do-you-recommend-a-dose-constraint-for-breast-implants-when-treating-a-patient-for-nsclc-with-radiotherapy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-gliosarcoma-s-p-gtr-with-leptomeningeal-spread weekly 0.8 https://www.themednet.org/how-would-you-manage-a-young-woman-with-vulvar-langerhans-cell-histiocytosis-and-positive-margins-after-wide-local-excision weekly 0.8 https://www.themednet.org/how-do-you-treat-ra-in-patients-with-pulmonary-mycobacterium-avium-complex-mac-infections weekly 0.8 https://www.themednet.org/what-rt-dose-would-you-use-to-treat-a-single-site-relapse-of-high-risk-multiple-myeloma weekly 0.8 https://www.themednet.org/what-is-the-transfusion-management-of-a-sickle-cell-patient-during-pregnancy weekly 0.8 https://www.themednet.org/how-would-you-approach-oligoprogression-of-metastatic-prostate-cancer-with-a-large-met-in-the-humeral-head weekly 0.8 https://www.themednet.org/how-would-you-manage-an-unresectable-central-meningioma-in-a-young-patient-with-evidence-of-mild-compression-on-the-optic-nerve-and-4th-ventricle-involvement weekly 0.8 https://www.themednet.org/how-would-manage-a-patient-with-stage-iii-anal-cancer-and-history-of-child-pugh-b-liver-cirrhosis-with-platelets-count-of-less-than-100-000 weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-patients-with-von-willebrand-disease-or-hemophilia-a-previously-managed-with-intranasal-ddavp-during-the-recall weekly 0.8 https://www.themednet.org/how-would-you-approach-therapy-for-a-solitary-fibrous-tumor-of-the-orbit-with-residual-disease-10-after-surgery weekly 0.8 https://www.themednet.org/does-invasive-pleomorphic-lobular-breast-carcinoma-broaden-your-indications-for-adjuvant-rt weekly 0.8 https://www.themednet.org/how-would-you-approach-bone-only-metastases-in-a-postmenopausal-woman-with-hr-her2-breast-cancer-currently-on-anti-her2-ai-maintenance weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-renal-cell-and-esrd-on-dialysis weekly 0.8 https://www.themednet.org/what-treatment-options-would-you-consider-for-a-metastatic-low-grade-serous-ovarian-carcinoma-that-transforms-to-high-grade weekly 0.8 https://www.themednet.org/what-is-the-radiation-volume-for-unresected-gross-paraaortic-lymph-node-in-a-wilms-patient weekly 0.8 https://www.themednet.org/for-a-patient-with-previously-relapsed-ttp-but-in-clinical-remission-what-is-the-role-of-rituximab-in-treating-asymptomatic-adamts13-deficiency-to-prevent-relapse weekly 0.8 https://www.themednet.org/how-does-the-presence-of-nonalcoholic-fatty-liver-disease-nafld-impact-your-choice-of-csdmard-for-ra weekly 0.8 https://www.themednet.org/would-you-use-a-psma-test-obtained-as-part-of-a-clinical-trial-to-alter-your-treatment-management weekly 0.8 https://www.themednet.org/how-do-you-approach-image-guidance-and-creation-of-itv-ptv-margins-for-rib-sbrt weekly 0.8 https://www.themednet.org/what-agents-can-you-use-for-treatment-induction-besides-rituximab-in-cryoglobulinemic-vasculitis-without-hepatitis weekly 0.8 https://www.themednet.org/would-you-consider-maintenance-immunotherapy-following-chemoradiation-for-a-patient-with-an-isolated-mediastinal-recurrence-of-nsclc weekly 0.8 https://www.themednet.org/how-would-you-treat-an-elderly-frail-patient-with-a-bulky-penile-scc-with-bilateral-inguinal-nodes weekly 0.8 https://www.themednet.org/how-would-you-approach-maintenance-for-high-risk-b-all-off-study weekly 0.8 https://www.themednet.org/what-areas-do-you-treat-with-rt-for-an-intermediate-or-high-risk-pediatric-hodgkin-lymphoma-with-a-slow-early-response weekly 0.8 https://www.themednet.org/how-strongly-you-would-recommend-surgery-in-case-of-distal-squamous-cell-esophageal-cancer-who-completed-chemo-rt-and-achieved-cr weekly 0.8 https://www.themednet.org/how-would-you-treat-an-adult-patient-with-t-cell-lymphoblastic-lymphoma-with-fgfr1-rearrangement-and-co-exisiting-myeloproliferative-neoplasm weekly 0.8 https://www.themednet.org/when-is-a-bilateral-bone-marrow-aspirate-biopsy-indicated-in-the-initial-diagnosis-of-pediatric-nhl-patients weekly 0.8 https://www.themednet.org/what-is-the-role-of-anticoagulation-in-patients-with-septic-thrombophlebitis weekly 0.8 https://www.themednet.org/is-there-a-role-for-surgical-resection-in-parameningeal-rhabdomyosarcoma-either-at-diagnosis-or-following-initial-therapy-w-vac-at-week-12 weekly 0.8 https://www.themednet.org/how-would-you-manage-adjuvant-therapy-in-a-gross-totally-resected-favorable-site-embryonal-rms-with-resected-positive-lymph-nodes weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiation-to-a-patient-with-a-vaginal-spindle-cell-sarcoma-s-p-modified-radical-hysterectomy-with-bilateral-sapingoopherectomy-with-negative-margins weekly 0.8 https://www.themednet.org/what-is-your-preferred-technique-and-dose-fractionation-for-treatment-of-a-metastasis-involving-the-retina-or-optic-nerve weekly 0.8 https://www.themednet.org/what-dose-constraints-would-you-use-for-the-heart-pericardium-when-treating-a-sternal-metastasis-with-five-fraction-sbrt weekly 0.8 https://www.themednet.org/do-you-routinely-prophylactically-anticoagulate-patients-undergoing-systemic-chemotherapy-outside-of-the-perioperative-period weekly 0.8 https://www.themednet.org/when-would-you-perform-a-thrombophilia-workup-in-a-pediatric-patient-presenting-with-vte weekly 0.8 https://www.themednet.org/what-is-the-utility-of-granulocyte-infusions-in-patients-with-neutropenia-and-severe-infection weekly 0.8 https://www.themednet.org/would-you-consider-using-immunotherapy-in-mismatch-repair-proficient-metastatic-colorectal-cancer-with-pdl1-pdl2-gene-amplification weekly 0.8 https://www.themednet.org/how-would-you-approach-multiply-recurrent-prostate-cancer-in-a-patient-who-has-had-both-ldr-and-salvage-hdr weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-to-select-which-patients-with-thoracic-mesothelioma-to-send-for-an-extrapleural-pneumonectomy-or-pleurectomy-decortication weekly 0.8 https://www.themednet.org/what-is-your-approach-to-screening-for-cardiac-involvement-in-patients-with-myositis-and-how-does-the-finding-of-cardiac-involvement-change-your-management weekly 0.8 https://www.themednet.org/would-you-consider-repeat-sbrt-for-a-hilar-in-field-recurrence-previously-treated-with-sbrt weekly 0.8 https://www.themednet.org/is-there-a-role-for-mrd-monitoring-in-the-decision-to-switch-from-a-triplet-regimen-to-maintenance-therapy-in-transplant-ineligible-myeloma-patients weekly 0.8 https://www.themednet.org/how-do-you-manage-incidentally-identified-chemotherapy-associated-aortitis-large-vessel-vasculitis weekly 0.8 https://www.themednet.org/for-patients-with-nsclc-with-non-classical-driver-mutation-alterations-atypical-egfr-braf-nonv600e-etc-what-resources-do-you-utilize-to-determine-likelihood-that-tumor-will-be-sensitive-to-targeted-therapies weekly 0.8 https://www.themednet.org/how-do-you-define-bulky-mediastinal-disease-in-hodgkins-lymphoma weekly 0.8 https://www.themednet.org/how-does-your-treatment-algorithm-differ-for-drug-induced-anca-vasculitis-compared-to-non-drug-induced-anca-vasculitis-in-cases-with-severe-organ-threatening-manifestations weekly 0.8 https://www.themednet.org/would-you-consider-using-adjuvant-chemotherapy-for-a-patient-with-anal-squamous-cell-carcinoma-with-a-positive-surgical-margin-after-apr-done-for-persistent-progressive-disease-after-chemoradiotherapy weekly 0.8 https://www.themednet.org/is-guillain-barre-syndrome-a-contraindication-for-radiation-therapy weekly 0.8 https://www.themednet.org/how-do-you-decide-between-blinatumomab-or-traditional-chemotherapy-in-combination-with-tki-for-upfront-treatment-of-adult-patients-with-ph-all weekly 0.8 https://www.themednet.org/how-do-you-decide-what-induction-chemotherapy-regimen-to-use-for-a-patient-with-locally-advanced-rectal-cancer-ct4n1-receiving-total-neoadjuvant-therapy weekly 0.8 https://www.themednet.org/would-you-treat-a-locally-advanced-head-and-neck-cutaneous-squamous-cell-carcinoma-with-axillary-only-mets-definitively weekly 0.8 https://www.themednet.org/would-you-recommend-adt-in-a-patient-receiving-salvage-post-prostatectomy-radiation-with-psa-0-5-and-a-high-decipher-score weekly 0.8 https://www.themednet.org/how-does-presence-of-mmr-deficiency-lynch-syndrome-affect-your-recommendation-on-peri-operative-chemotherapy-for-high-grade-upper-tract-urothelial-cancer weekly 0.8 https://www.themednet.org/should-a-young-adult-male-patient-with-philadelphia-like-all-being-treated-on-the-alliance-a041501-protocol-and-in-remission-undergo-transplant weekly 0.8 https://www.themednet.org/is-there-a-role-for-phlebotomy-in-secondary-polycythemia weekly 0.8 https://www.themednet.org/how-do-you-treat-locally-advanced-choriocarcinoma-of-the-urinary-bladder weekly 0.8 https://www.themednet.org/is-there-a-role-for-endocrine-therapy-alone-in-patients-with-metastatic-hr-her2-breast-cancer-after-all-her2-directed-therapies-have-been-used weekly 0.8 https://www.themednet.org/how-do-you-treat-a-low-grade-b-cell-lymphoma-with-plasmacytic-differentiation-waldenstroms-confined-to-the-cns weekly 0.8 https://www.themednet.org/how-would-you-approach-therapy-for-a-smarca4-deficient-undifferentiated-sarcoma-with-isolated-involvement-of-a-mediastinal-lymph-node weekly 0.8 https://www.themednet.org/would-you-consider-holding-treatment-with-hypomethylating-agents-and-venetoclax-in-elderly-patients-diagnosed-with-aml-who-achieve-cr-and-are-mrd-negative weekly 0.8 https://www.themednet.org/how-long-do-you-continue-steroid-sparing-agents-such-as-tocilizumab-for-gca-once-the-disease-is-in-remission-off-steroids weekly 0.8 https://www.themednet.org/would-you-dose-escalate-the-radiation-prescription-for-patients-with-radioresistance-snps-in-ercc1-or-ercc2 weekly 0.8 https://www.themednet.org/how-would-you-manage-a-recurrent-uterine-leiomyosarcoma-now-status-post-secondary-cytoreduction-with-no-gross-residual-disease weekly 0.8 https://www.themednet.org/how-do-you-interpret-a-high-positive-rnp-in-the-setting-of-a-negative-ana-and-negative-sm-rnp weekly 0.8 https://www.themednet.org/can-venetoclax-and-radiation-be-safely-given-concurrently weekly 0.8 https://www.themednet.org/how-would-you-treat-a-relatively-focal-but-multinodular-staple-line-recurrence-of-non-mutated-lung-adenocarcinoma-s-p-margin-negative-lobectomy weekly 0.8 https://www.themednet.org/how-do-you-incorporate-next-gen-sequencing-results-into-your-management-of-pediatric-patients-with-b-all-who-have-not-been-transplanted weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-metastatic-urothelial-carcinoma-who-has-progressed-on-maintenance-avelumab weekly 0.8 https://www.themednet.org/do-you-offer-iron-supplementation-to-a-non-anemic-adolescent-athlete-with-a-low-ferritin weekly 0.8 https://www.themednet.org/how-would-the-presence-of-micro-metastatic-disease-in-multiple-sentinel-pelvic-lymph-nodes-change-your-recommendation-for-adjuvant-therapy-in-a-patient-with-otherwise-stage-i-endometrioid-adenocarcinoma weekly 0.8 https://www.themednet.org/for-a-recurrent-msi-h-endometrial-cancer-do-you-usually-treat-with-pembrolizumab-alone-or-in-combination-with-lenvatinib weekly 0.8 https://www.themednet.org/what-indications-do-you-use-to-consider-adjuvant-radiation-therapy-for-vaginal-cancer-s-p-resection weekly 0.8 https://www.themednet.org/how-do-you-approach-post-operative-srs-for-resected-brain-metastases-in-the-presence-of-residual-disease weekly 0.8 https://www.themednet.org/would-you-recommend-stem-cell-transplant-or-gene-therapy-for-a-patient-with-cml-and-sickle-cell-disease-currently-on-imatinib-with-worsening-anemia weekly 0.8 https://www.themednet.org/how-would-you-attempt-to-determine-the-etiology-of-intracranial-hemorrhage-in-a-patient-with-newly-diagnosed-lupus-and-an-active-viral-infection weekly 0.8 https://www.themednet.org/do-you-monitor-rs3pe-patients-for-gca-with-the-same-vigilance-that-you-do-in-pmr-patients weekly 0.8 https://www.themednet.org/what-is-your-approach-to-definitive-rt-for-nasal-vestibule-squamous-cell-carcinomas weekly 0.8 https://www.themednet.org/how-does-the-loss-of-heterozygosity-loh-of-1p-or-16q-affect-the-treatment-options-of-stage-ii-or-iii-newly-diagnosed-wilms-tumor weekly 0.8 https://www.themednet.org/is-xeroderma-pigmentosum-a-contraindication-for-adjuvant-radiation-therapy-to-the-breast-in-the-breast-conservation-setting weekly 0.8 https://www.themednet.org/do-you-use-leflunomide-in-rheumatoid-arthritis-patients-on-hemodialysis weekly 0.8 https://www.themednet.org/what-is-your-first-choice-contraceptive-agent-for-women-with-sle weekly 0.8 https://www.themednet.org/what-fractionation-do-you-use-for-prostate-cancer-after-turp weekly 0.8 https://www.themednet.org/what-treatment-would-you-initiate-post-operatively-for-patients-with-de-novo-metastatic-follicular-thyroid-ca-requiring-laminectomy-for-cord-compression weekly 0.8 https://www.themednet.org/would-you-offer-and-what-data-would-support-the-use-of-an-fgfr-inhibitor-in-fgfr3-mutated-anaplastic-thyroid-cancer weekly 0.8 https://www.themednet.org/would-you-use-a-platinum-containing-regimen-such-as-docetaxel-carboplatin-for-an-aggressive-er-breast-cancer-in-a-patient-with-a-deleterious-mutation-in-atm weekly 0.8 https://www.themednet.org/are-stress-dose-steroids-indicated-in-patients-with-adrenal-insufficiency-receiving-radiation-therapy weekly 0.8 https://www.themednet.org/how-do-you-manage-a-young-patient-with-mediastinal-nonseminomatous-germ-cell-tumor-that-has-relapsed-after-primary-treatment-with-four-cycles-of-vip weekly 0.8 https://www.themednet.org/how-do-you-manage-mek-inhibitor-induced-ocular-adverse-events weekly 0.8 https://www.themednet.org/when-if-ever-would-you-consider-using-encorafenib-binimetinib-or-vemurafenib-cobimetinib-instead-of-dabrafenib-trametinib-for-adjuvant-treatment-of-braf-mutated-melanoma weekly 0.8 https://www.themednet.org/what-are-the-treatment-options-available-for-isolated-extramedullary-relapse-of-an-aya-patient-with-aml-following-hsct weekly 0.8 https://www.themednet.org/would-you-recommend-post-op-rt-for-an-ulcerated-clarks-level-iv-melanoma-of-the-zygomatic-preauricular-region-following-a-wle-with-diffuse-melanoma-in-situ-at-the-margins weekly 0.8 https://www.themednet.org/would-you-consider-using-checkpoint-inhibitor-therapy-as-an-alternative-to-adjuvant-mfolfirinox-in-a-patient-with-a-very-high-risk-resected-pancreatic-adenocarcinoma-poorly-differentiated-n2-disease-and-lynch-syndrome weekly 0.8 https://www.themednet.org/is-it-appropriate-to-consider-biologic-therapy-for-treatment-of-ra-in-a-patient-with-non-small-cell-lung-carcinoma-treated-with-radiation-therapy-who-has-ongoing-active-synovitis-uncontrolled-by-conventional-dmards weekly 0.8 https://www.themednet.org/how-long-do-you-wait-for-response-to-corticosteroids-and-conventional-synthetic-dmards-before-considering-ivig-in-patients-with-hmgcr-antibody-positive-imnm weekly 0.8 https://www.themednet.org/are-there-any-new-treatments-for-erosive-osteoarthritis-of-the-hands weekly 0.8 https://www.themednet.org/are-docetaxel-and-paclitaxel-interchangeable-for-stage-ii-iii-her2-breast-cancer-patients-receiving-neoadjuvant-chemotherapy-with-ac-thp weekly 0.8 https://www.themednet.org/is-it-ever-appropriate-to-use-hydroxychloroquine-temporarily-in-higher-doses-more-than-5mg-kg-to-control-lupus-activity-such-as-skin-manifestations weekly 0.8 https://www.themednet.org/how-would-you-treat-a-de-novo-cll-with-wbc-of-1-000-000-and-no-overt-signs-of-leukostasis weekly 0.8 https://www.themednet.org/what-radiation-dose-fractionation-would-you-consider-for-palliation-of-an-unresectable-vulvar-cancer-that-received-previous-definitive-radiation-therapy weekly 0.8 https://www.themednet.org/is-there-an-increased-risk-of-covid-19-in-patients-on-immunosuppressants weekly 0.8 https://www.themednet.org/what-chemotherapy-would-you-recommend-for-a-stage-ic3-large-cell-neuroendocrine-tumor-of-the-ovary weekly 0.8 https://www.themednet.org/what-is-the-optimal-management-of-a-patient-with-refractory-ttp-who-has-had-poor-response-to-plasma-exchange-steroids-rituximab-especially-when-caplacizumab-is-unavailable weekly 0.8 https://www.themednet.org/what-is-the-best-way-to-compensate-for-hypofractionated-radiation-interruptions-due-to-covid weekly 0.8 https://www.themednet.org/what-is-the-optimal-neoadjuvant-systemic-therapy-dosing-and-schedule-in-a-patient-with-undifferentiated-pleomorphic-sarcoma-of-the-extremity-for-whom-up-front-surgery-would-portend-significant-morbidity weekly 0.8 https://www.themednet.org/would-you-hold-all-immunosuppressive-medications-for-the-first-month-of-ltbi-treatment-or-just-biologics weekly 0.8 https://www.themednet.org/how-would-you-manage-acquired-von-willebrand-syndrome-secondary-to-a-myeloproliferative-neoplasm-in-a-patient-who-is-already-on-anticoagulation weekly 0.8 https://www.themednet.org/would-you-continue-durvalumab-beyond-12-months-in-an-oligometastatic-nsclc-patient-treated-with-concurrent-crt-followed-by-consolidation-durvalumab-after-treating-a-single-metastatic-site weekly 0.8 https://www.themednet.org/would-you-give-rt-to-an-ulcerated-resected-t2-bcc-of-the-perianal-margin-with-close-margins-and-no-anal-canal-involvement weekly 0.8 https://www.themednet.org/what-would-be-your-choice-for-re-induction-in-a-young-patient-with-flt3-refractory-aml-after-7-3-induction-therapy-with-no-flt3-mutation-on-the-day-14-marrow weekly 0.8 https://www.themednet.org/for-a-malt-lymphoma-involving-the-preseptal-orbit-only-woud-you-treat-the-entire-orbit-or-limit-the-ctv-to-the-preseptal-orbit weekly 0.8 https://www.themednet.org/how-do-you-manage-hand-foot-syndrome-associated-with-capecitabine-and-other-conventional-chemotherapy-agents weekly 0.8 https://www.themednet.org/for-pdl1-testing-in-triple-negative-breast-cancer-is-cps-by-22c3-equivalent-to-sp142-ventana weekly 0.8 https://www.themednet.org/what-dose-and-volume-s-would-you-consider-for-a-young-woman-with-an-axillary-nodal-recurrence-from-breast-cancer-s-p-tbi-as-well-as-chest-wall-only-radiation weekly 0.8 https://www.themednet.org/what-is-your-preferred-choice-and-timing-of-systemic-therapy-in-a-patient-with-high-risk-oligometastatic-prostate-cancer-undergoing-metastasis-directed-therapy-to-all-sites-of-disease-including-the-prostate weekly 0.8 https://www.themednet.org/do-you-consider-cystic-fibrosis-a-contraindication-to-lung-sbrt-for-primary-nsclc-or-oligometastases weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-metastatic-colon-cancer-with-pathologic-features-indeterminate-between-adenocarcinoma-and-small-cell-carcinoma weekly 0.8 https://www.themednet.org/do-you-recommend-medical-therapy-for-extensive-atraumatic-osteonecrosis-of-the-femoral-head-to-mitigate-pain-or-prevent-femoral-head-collapse weekly 0.8 https://www.themednet.org/how-do-you-manage-early-rectal-symptoms-such-as-tenesmus-in-a-patient-undergoing-pelvic-radiation-for-prostate-cancer weekly 0.8 https://www.themednet.org/which-immunosuppressed-patients-with-sle-would-benefit-from-antibiotic-prophylaxis-to-prevent-pneumocystis-pneumonia weekly 0.8 https://www.themednet.org/in-what-situations-do-you-consider-platelet-rich-plasma-injections-in-patients-with-osteoarthritis weekly 0.8 https://www.themednet.org/are-there-any-known-bone-marrow-constraints-that-should-be-utilized-for-prostate-imrt weekly 0.8 https://www.themednet.org/how-would-you-manage-a-woman-with-recurrent-pagets-disease-of-the-vulva-s-p-resection-with-most-recent-pathology-showing-multiple-foci-of-early-invasion weekly 0.8 https://www.themednet.org/do-you-recommend-using-il-1-il-6-inhibitors-in-covid-19-multisystem-inflammatory-syndrome-in-adults-mis-a weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-young-patient-regarding-hrt-after-bso-for-stage-iiia1-serous-borderline-tumor weekly 0.8 https://www.themednet.org/do-you-recommend-adjuvant-xrt-for-adrenal-cortical-carcinoma-s-p-resection-with-a-positive-margin weekly 0.8 https://www.themednet.org/how-would-a-focus-of-anaplastic-carcinoma-change-your-approach-to-adjuvant-therapy-for-a-premenopausal-patient-with-stage-ic-mucinous-borderline-tumor-of-the-ovary weekly 0.8 https://www.themednet.org/should-venous-thrombosis-in-a-patient-with-behcet-syndrome-be-treated-with-both-immunosuppression-and-anticoagulation weekly 0.8 https://www.themednet.org/do-you-consider-adjuvant-chemotherapy-for-older-women-75-years-of-age-with-hr-invasive-ductal-carcinoma-and-3-positive-ln-however-intermediate-risk-recurrence-scores weekly 0.8 https://www.themednet.org/for-a-metastatic-neuroendocrine-tumor-patient-who-has-experienced-prolonged-progression-free-survival-how-would-you-approach-surgical-debulking weekly 0.8 https://www.themednet.org/have-you-ever-used-a-quad-shot-regimen-or-other-fractionation-for-patients-with-uncontrolled-inguinal-nodal-disease weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-to-a-premenopausal-patient-with-er-pr-breast-cancer-nodal-micrometastasis-low-oncotypedx-score-but-also-brca2-carrier weekly 0.8 https://www.themednet.org/is-it-safe-to-use-statins-in-iim-patients-if-hmgcr-antibodies-are-negative weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-systemic-therapy-for-radiation-induced-epithelioid-angiosarcoma-of-the-chest-wall-after-successful-margin-negative-resection weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-rt-for-porocarcinoma-of-the-face weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-newly-diagnosed-locally-advanced-nsclc-and-concurrent-active-tuberculosis-on-anti-tb-therapy weekly 0.8 https://www.themednet.org/how-would-you-set-up-and-treat-a-mycoses-fungoides-patient-with-symptomatic-bilateral-inner-thigh-groin-and-scrotal-plaques weekly 0.8 https://www.themednet.org/what-neoadjuvant-treatment-strategy-would-you-use-for-an-unresectable-intrahepatic-cholangiocarcinoma-with-dmmr-with-the-goal-of-downstaging-to-achieve-surgical-resectability weekly 0.8 https://www.themednet.org/do-you-modify-your-target-volume-for-treatment-of-trigeminal-neuralgia-confined-to-a-single-branch-of-cn-v weekly 0.8 https://www.themednet.org/do-you-recommend-post-mastectomy-rt-for-a-premenopausal-woman-with-er-pr-her2-negative-breast-cancer-and-li-fraumeni-syndrome-with-rcbii-and-residual-disease-in-multiple-lns-following-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-therapy-would-you-give-to-an-aml-patient-with-induction-failure-while-awaiting-hsct weekly 0.8 https://www.themednet.org/how-would-you-manage-a-premenopausal-woman-with-a-poorly-differentiated-pt2-hr-her2-breast-cancer-and-3-3-slns-with-itcs weekly 0.8 https://www.themednet.org/how-do-you-approach-radiation-for-a-locally-advanced-prostate-cancer-with-caudal-extension-into-the-penis-in-a-patient weekly 0.8 https://www.themednet.org/is-there-a-role-for-pcsk9-inhibitors-in-patients-with-statin-associated-immune-mediated-necrotizing-myopathy weekly 0.8 https://www.themednet.org/is-celiac-lymph-node-involvement-a-contraindication-for-chemoradiaton-in-esophageal-adenocarcinoma weekly 0.8 https://www.themednet.org/for-an-optimally-cytoreduced-stage-iii-ovarian-carcinosarcoma-would-you-offer-bevacizumab-maintenance-after-completion-of-adjuvant-carboplatin-taxol weekly 0.8 https://www.themednet.org/what-is-your-preferred-formulation-of-parenteral-iron weekly 0.8 https://www.themednet.org/how-would-you-approach-a-braf-negative-metastatic-melanoma-patient-on-immune-checkpoint-inhibitor-therapy-with-enlarging-symptomatic-brain-lesions-that-had-previously-been-treated-with-srs weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-mediastinal-only-recurrence-of-small-cell-lung-cancer-6-months-after-primary-surgical-resection-and-adjuvant-platinum-etoposide-for-stage-i-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-ovarian-suppression-for-premenopausal-patients-with-hr-her2-positive-breast-cancer weekly 0.8 https://www.themednet.org/would-you-give-immunotherapy-to-patient-with-metastatic-nsclc-who-had-liver-transplant-for-hepatocellular-carcinoma-and-now-is-progressing-on-chemotherapy weekly 0.8 https://www.themednet.org/would-you-offer-definitive-radiation-therapy-for-a-merkel-cell-carcinoma-in-which-surgical-resection-would-be-disfiguring-or-result-in-significant-dysfunction weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-recurrent-malignant-perivascular-epithelioid-cell-neoplasm-pecoma-arising-from-the-kidney-and-metastatic-to-lungs weekly 0.8 https://www.themednet.org/how-do-you-decide-timing-of-adjuvant-radiation-with-respect-to-chemotherapy-for-a-patient-with-resected-pancreatic-adenocarcinoma-with-microscopic-positive-margins weekly 0.8 https://www.themednet.org/when-can-brachytherapy-be-used-alone-in-the-definitive-treatment-of-figo-ia1-ia2-medically-inoperable-cervical-cancer weekly 0.8 https://www.themednet.org/when-would-you-consider-adjuvant-chemoradiation-in-a-patient-with-esthesioneuroblastoma weekly 0.8 https://www.themednet.org/would-you-offer-treatment-for-asymptomatic-cll-with-wbc-of-300k-or-greater-high-risk-cytogenetics-or-doubling-time-of-6-12-months weekly 0.8 https://www.themednet.org/are-there-any-reasons-to-consider-a-prolonged-course-of-steroids-with-taper-over-a-shorter-course-of-pulsed-steroids-in-the-treatment-of-itp weekly 0.8 https://www.themednet.org/how-do-you-approach-very-treatment-refractory-itp weekly 0.8 https://www.themednet.org/would-you-consider-atezolizumab-bevacizumab-combination-in-a-patient-with-metastatic-hepatocellular-carcinoma-who-presented-with-paraneoplastic-myasthenia-gravis weekly 0.8 https://www.themednet.org/what-is-the-appropriate-radiation-volume-for-a-stage-iii-group-iii-unresectable-embryonal-rhabdomyosarcoma-originating-from-the-bladder weekly 0.8 https://www.themednet.org/what-is-the-utility-and-optimal-timing-of-histologic-conformation-of-nggct weekly 0.8 https://www.themednet.org/what-is-the-anterior-expansion-for-the-paraaortic-ctv-in-endometrial-and-cerivcal-cancer weekly 0.8 https://www.themednet.org/what-is-a-safe-and-effective-ablative-dose-and-fractionation-for-oligometastasis-to-humeral-head-or-femoral-neck-from-lung-cancer-with-controlled-disease-elsewhere weekly 0.8 https://www.themednet.org/are-there-particular-concerns-related-to-the-use-of-b-cell-depletion-therapies-such-as-rituximab-for-rheumatic-disease-during-the-covid-19-pandemic weekly 0.8 https://www.themednet.org/what-is-your-approach-to-vte-prophylaxis-following-hematopoietic-stem-cell-transplant weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-patient-with-extragenital-lichens-sclerosis-on-the-acute-and-long-term-risks-of-post-lumpectomy-radiotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-diagnosing-a-patient-with-iron-refractory-iron-deficiency-anemia-irida weekly 0.8 https://www.themednet.org/how-would-you-consider-use-of-high-dose-il-2-for-metastatic-renal-cell-carcinoma-in-light-of-novel-checkpoint-therapy-combinations-now-available weekly 0.8 https://www.themednet.org/would-you-treat-an-er-pr-inflammatory-breast-cancer-that-is-her2-2-by-ihc-but-5-positive-by-fish-as-her2-positive weekly 0.8 https://www.themednet.org/what-is-your-simulation-setup-when-treating-bladder-with-concurrent-chemoradiation weekly 0.8 https://www.themednet.org/is-there-a-role-for-radiation-in-a-patient-with-supraclavicular-and-cervical-node-recurrence-of-breast-cancer-after-prior-whole-breast-rt-no-eni weekly 0.8 https://www.themednet.org/what-is-the-longest-treatment-break-you-would-accept-when-treating-a-patient-for-breast-cancer weekly 0.8 https://www.themednet.org/can-retrograde-ejaculation-be-caused-by-prostate-radiation weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-a-t3-spindle-cell-metaplastic-breast-cancer weekly 0.8 https://www.themednet.org/would-you-treat-a-postmenopausal-women-with-high-grade-t2n0-er-pr-her2-invasive-ductal-carcinoma-with-upfront-surgery-or-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-diagnostic-excisional-procedure-for-a-pregnant-patient-with-exam-concerning-for-carcinoma-and-cervical-biopsies-x-2-suspicious-for-foci-of-invasive-disease weekly 0.8 https://www.themednet.org/is-there-a-role-for-anti-neutrophil-antibody-testing-in-the-workup-of-neutropenia weekly 0.8 https://www.themednet.org/would-you-treat-with-post-mastectomy-radiotherapy-in-patients-with-early-stage-t1-t2-node-negative-hormone-positive-disease-if-the-only-risk-factor-for-recurrence-was-a-focally-positive-anterior-margin weekly 0.8 https://www.themednet.org/how-would-you-approach-nodal-assessment-in-a-pregnant-patient-with-new-diagnosis-of-at-least-stage-ib1-cervical-scc weekly 0.8 https://www.themednet.org/what-is-your-preferred-adjuvant-regimen-for-an-optimally-cytoreduced-stage-iii-low-grade-serous-ovarian-carcinoma weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-if-any-would-you-offer-for-a-high-grade-perivascular-epithelioid-cell-pecoma-tumor-of-the-endometrium-after-r0-resection weekly 0.8 https://www.themednet.org/how-would-you-incorporate-whole-abdomen-radiation-therapy-after-cytoreduction-in-an-aya-patient-with-desmoplastic-small-round-cell-tumor weekly 0.8 https://www.themednet.org/would-you-use-maintenance-avelumab-for-a-patient-with-metastatic-urothelial-carcinoma-who-progressed-on-first-line-pembrolizumab-then-had-stable-disease-after-at-least-four-cycles-of-second-line-carboplatin-plus-gemcitabine weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-approach-for-a-patient-who-has-prostate-cancer-with-disease-only-in-retroperitoneal-nodes-experiencing-rapid-biochemical-progression-on-abiraterone-and-who-was-previously-treated-with-an-androgen-receptor-inhibitor-while-n weekly 0.8 https://www.themednet.org/what-modality-urine-catecholamines-pet-mibg-is-the-most-sensitive-for-evaluation-of-treatment-response-in-a-patient-with-high-risk-neuroblastoma weekly 0.8 https://www.themednet.org/what-is-your-preferred-dose-and-fractionation-for-verrucous-carcinoma-of-the-larynx weekly 0.8 https://www.themednet.org/is-there-any-role-for-alpelisib-in-a-patient-who-has-triple-positive-breast-cancer-and-an-activating-pik3ca-mutation weekly 0.8 https://www.themednet.org/for-patients-with-cancer-receiving-a-bone-modifying-agent-bisphosphonate-or-denosumab-who-suffer-a-fracture-requiring-stabilization-or-reconstruction-how-do-you-manage-the-bone-modifying-agent-peri-operatively weekly 0.8 https://www.themednet.org/what-disease-activity-measures-do-you-find-helpful-in-clinical-practice-for-psoriatic-arthritis-peripheral-spondyloarthritis weekly 0.8 https://www.themednet.org/how-would-you-manage-ocps-in-a-patient-who-develops-a-vte-while-on-treatment weekly 0.8 https://www.themednet.org/how-do-you-screen-for-colon-cancer-in-patients-with-behcet-syndrome-with-colonic-involvement weekly 0.8 https://www.themednet.org/would-you-offer-partial-breast-radiation-to-a-women-who-otherwise-meets-suitability-criteria-but-is-not-going-to-receive-endocrine-therapy weekly 0.8 https://www.themednet.org/what-are-your-thoughts-on-adding-mycophenolate-to-steroids-in-the-first-line-treatment-of-itp-based-on-the-results-of-the-flight-trial weekly 0.8 https://www.themednet.org/in-a-patient-with-high-risk-gestational-trophoblastic-neoplasia-how-would-you-approach-treatment-of-recurrence-at-6-months-post-ema-co weekly 0.8 https://www.themednet.org/how-do-you-incorporate-surveillance-imaging-for-patients-with-ovarian-cancer-on-maintenance-therapy weekly 0.8 https://www.themednet.org/would-you-use-first-line-combination-immunotherapy-with-chemotherapy-in-patients-with-metastatic-low-er-pr-10-her2-negative-breast-cancer weekly 0.8 https://www.themednet.org/when-would-you-offer-ovarian-suppression-in-addition-to-endocrine-therapy-for-premenopausal-women-who-omit-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/would-a-history-of-definitive-chemort-for-anal-scc-change-the-workup-for-an-ascus-hpv-negative-pap-smear-in-a-patient-who-has-never-had-an-abnormal-pap-smear-in-the-past weekly 0.8 https://www.themednet.org/how-do-you-counsel-male-to-female-transgender-patients-on-the-vte-risk-of-hormonal-therapy weekly 0.8 https://www.themednet.org/would-you-recommend-a-right-hemicolectomy-for-a-1-cm-low-grade-appendiceal-goblet-cell-adenocarcinoma-found-incidentally-during-appendectomy-without-high-risk-features-on-pathology weekly 0.8 https://www.themednet.org/when-would-you-consider-adjuvant-chemotherapy-for-resected-intermediate-grade-lung-neuroendocrine-tumors weekly 0.8 https://www.themednet.org/what-non-taxane-chemotherapy-if-any-would-you-give-with-trastuzumab-in-adjuvant-setting-of-a-pt1cn0-her2-breast-ca-in-patients-with-hyperbilirubinemia-3-due-to-cirrhosis weekly 0.8 https://www.themednet.org/how-will-you-counsel-patients-with-breast-cancer-receiving-adjuvant-chemotherapy-regarding-covid-19-vaccine-administration weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-overlapping-features-of-pmr-and-seronegative-ra weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-for-patient-with-a-large-high-grade-leiomyosarcoma-of-the-colon-who-underwent-an-r0-resection-with-no-lymph-node-involvement weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-radiotherapy-of-laryngeal-cancer-after-laryngectomy-and-flap-reconstruction weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-do-you-recommend-for-comprehensively-staged-stage-ii-figo-grade-3-deeply-invasive-endometrial-cancer weekly 0.8 https://www.themednet.org/in-the-era-of-mek-inhibitors-and-braf-v600e-targeted-therapy-what-is-the-role-of-traditional-vinorelbine-prednisone-in-the-management-of-langerhans-cell-histiocytosis weekly 0.8 https://www.themednet.org/will-you-use-ovarian-function-suppression-in-lieu-of-chemotherapy-in-premenopausal-patients-with-pn1-er-her2-breast-ca-with-oncotype-rs-25 weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-type-1-cryoglobulinemia-secondary-to-mgus weekly 0.8 https://www.themednet.org/how-soon-after-a-vte-would-you-feel-comfortable-with-a-patient-undergoing-an-elective-surgery weekly 0.8 https://www.themednet.org/what-is-your-strategy-for-having-covid-positive-patients-resume-infusions-after-they-have-recovered-from-the-infection weekly 0.8 https://www.themednet.org/would-you-recommend-hypofractionated-salvage-or-adjuvant-prostate-xrt-in-the-covid-setting weekly 0.8 https://www.themednet.org/how-do-you-define-lvsi-in-breast-cancer weekly 0.8 https://www.themednet.org/do-you-still-consider-isolated-skin-involvement-by-primary-breast-cancer-without-inflammatory-change-to-be-locally-advanced-stage-iii-disease weekly 0.8 https://www.themednet.org/what-are-specific-treatment-considerations-for-dactylitis-or-enthesitis-predominant-axspa-psa weekly 0.8 https://www.themednet.org/would-you-continue-or-switch-therapy-for-someone-who-progressed-through-ar-directed-therapy-and-has-a-rapid-rise-in-psa-while-receiving-ra-223-for-bone-dominant-castrate-resistant-prostate-cancer weekly 0.8 https://www.themednet.org/would-you-add-chemotherapy-to-a-tki-in-treating-an-elderly-patient-with-de-novo-cml-blast-crisis weekly 0.8 https://www.themednet.org/for-which-rituximab-infusion-reaction-symptoms-do-you-consider-it-safe-to-re-challenge-in-the-office-with-adjusted-rates-and-pre-medications weekly 0.8 https://www.themednet.org/do-you-recommend-shingles-vaccine-to-all-immunosuppressed-patients-under-the-age-of-50-y-o weekly 0.8 https://www.themednet.org/when-would-you-consider-splenectomy-or-other-immunosuppressive-cytotoxic-therapy-for-steroid-refractory-warm-autoimmune-hemolytic-anemia weekly 0.8 https://www.themednet.org/what-are-your-indications-for-pursuing-a-rheumatologic-workup-in-a-pediatric-patient-with-itp weekly 0.8 https://www.themednet.org/is-it-safe-to-treat-a-recurrent-esophageal-scc-with-definitive-chemoradiation-after-a-prior-endoscopic-mucosal-resection weekly 0.8 https://www.themednet.org/when-is-pelvic-lymph-node-dissection-indicated-in-vulvar-cancers weekly 0.8 https://www.themednet.org/do-you-contour-the-abdominal-para-aortic-nodes-in-your-elective-ctvnodes-for-t3n1-adenocarcinoma-of-the-gej-getting-preop-chemort weekly 0.8 https://www.themednet.org/do-you-assess-baseline-salivary-gland-function-before-starting-treatment-in-patients-with-sjogrens-syndrome weekly 0.8 https://www.themednet.org/do-you-include-subcarinal-ap-window-and-mediastinal-paraaortic-nodes-in-your-ctv-for-esophageal-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-elective-nodal-irradiation-when-treating-unresectable-pancreatic-adenocarcinoma weekly 0.8 https://www.themednet.org/how-useful-are-anti-ribosomal-p-antibodies-in-the-evaluation-for-sle-psychosis weekly 0.8 https://www.themednet.org/when-do-you-refer-patients-receiving-cns-directed-radiotherapy-to-endocrinology weekly 0.8 https://www.themednet.org/how-would-you-treat-lung-adenocarcinoma-patients-progressing-on-osimertinib-who-are-not-candidates-for-chemotherapy weekly 0.8 https://www.themednet.org/would-you-consider-just-treating-radiographic-residual-disease-as-opposed-to-all-original-sites-of-disease-involvement-per-ilrog-guidelines-in-a-patient-with-bulky-early-stage-hodgkins-lymphoma-of-the-mediastinum weekly 0.8 https://www.themednet.org/should-mtx-be-avoided-in-ra-patients-with-asymptomatic-lung-nodules weekly 0.8 https://www.themednet.org/when-should-a-gallium-dotatate-scan-be-incorporated-into-the-initial-evaluation-of-a-patient-with-a-carcinoid-tumor-of-the-appendix weekly 0.8 https://www.themednet.org/how-does-positive-p53-staining-influence-your-recommendation-for-adjuvant-therapy-in-comprehensively-staged-early-stage-ia-or-ib-grade-2-endometrioid-endometrial-cancers weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-patient-regarding-possibility-of-ovarian-preservation-at-time-of-surgery-for-malignant-mesothelioma-initially-discovered-in-a-myomectomy-specimen-and-involving-peritoneal-surfaces weekly 0.8 https://www.themednet.org/how-would-you-treat-an-adolescent-or-young-adult-with-newly-diagnosed-hepatosplenic-t-cell-lymphoma weekly 0.8 https://www.themednet.org/what-is-the-flank-radiation-dose-for-recurrent-wilms weekly 0.8 https://www.themednet.org/do-you-block-kidney-to-meet-kidney-constraint-when-treating-wilms-with-diffuse-unresectable-peritoneal-implants weekly 0.8 https://www.themednet.org/what-are-the-indications-for-rt-for-an-alveolar-fox01-fusion-positive-paratesticular-rhabdomyosarcoma-s-p-radical-inguinal-orchiectomy-and-plnd-showing-pn0-group-1-stage-1-disease weekly 0.8 https://www.themednet.org/how-would-you-treat-laryngeal-neuroendocrine-carcinoma weekly 0.8 https://www.themednet.org/do-you-treat-hiv-aids-associated-cns-vasculitis-with-antiretrovirals-alone-or-in-combination-with-steroids weekly 0.8 https://www.themednet.org/is-there-evidence-that-either-asdas-or-basdai-is-superior-for-measuring-clinical-outcomes-in-axial-spondyloarthritis weekly 0.8 https://www.themednet.org/is-a-comprehensive-physical-exam-with-vital-signs-warranted-for-routine-follow-up-visits-in-well-controlled-uncomplicated-ra-patients weekly 0.8 https://www.themednet.org/is-there-a-role-for-measuring-hydroxychloroquine-blood-levels-in-clinical-practice weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-multiply-relapsed-germ-cell-tumor-with-rising-tumor-markers-but-no-obvious-site-of-disease weekly 0.8 https://www.themednet.org/is-there-a-utility-to-initiating-maintenance-azacitidine-therapy-for-a-patient-with-a-history-of-refractory-aml-who-is-now-post-transplant weekly 0.8 https://www.themednet.org/are-you-more-inclined-to-offer-adjuvant-chemotherapy-for-a-post-menopausal-woman-after-lumpectomy-for-a-small-tnbc-who-has-a-concurrent-metastatic-er-breast-ca weekly 0.8 https://www.themednet.org/would-you-use-an-il-17-inhibitor-for-a-psoriatic-arthritis-patient-with-inactive-inflammatory-bowel-disease weekly 0.8 https://www.themednet.org/how-does-a-history-of-splenectomy-alter-how-you-counsel-patients-on-the-infection-risk-of-tnf-inhibitors-or-other-biologics weekly 0.8 https://www.themednet.org/is-nailfold-capillaroscopy-useful-for-prognostication-and-evaluation-of-disease-progression-in-scleroderma-patients weekly 0.8 https://www.themednet.org/is-nailfold-capillaroscopy-useful-for-prognostication-and-evaluation-of-disease-progression-in-mctd-myositis-patients weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-found-to-have-a-coronary-lesion-suggestive-of-vasculitis-on-coronary-ct weekly 0.8 https://www.themednet.org/is-there-a-maximum-ifosfamide-cumulative-dose-in-patients-with-normal-kidney-function weekly 0.8 https://www.themednet.org/when-do-you-utilize-lenalidomide-in-patients-with-mds-without-del-5q weekly 0.8 https://www.themednet.org/what-type-of-surveillance-would-you-recommend-following-resection-of-primary-mucinous-carcinoma-of-the-skin weekly 0.8 https://www.themednet.org/how-would-you-approach-diagnosis-of-residual-ovarian-tissue-in-a-patient-with-er-positive-breast-cancer-history-of-bso-and-a-rising-estradiol-level-on-tamoxifen weekly 0.8 https://www.themednet.org/how-would-you-modify-ewing-sarcoma-chemotherapy-and-timing-of-dialysis-for-a-dialysis-dependent-patient weekly 0.8 https://www.themednet.org/for-a-completely-resected-high-risk-adrenal-cortical-carcinoma-with-a-high-mitotic-rate-what-is-your-approach-to-adjuvant-therapy weekly 0.8 https://www.themednet.org/for-premenopausal-patients-with-er-pr-her2-negative-breast-cancer-and-lymph-node-micrometastases-would-recurrence-score-be-most-appropriately-interpreted-based-on-tailorx-data-given-such-patients-were-excluded-from-rxponder weekly 0.8 https://www.themednet.org/what-group-of-patients-is-suitable-for-breast-radiation-using-high-tangents weekly 0.8 https://www.themednet.org/what-is-the-biologic-of-choice-in-a-patient-with-ra-and-myasthenia-gravis weekly 0.8 https://www.themednet.org/how-do-you-approach-anticoagulation-in-patients-with-catastrophic-antiphospholipid-syndrome-and-thrombocytopenia weekly 0.8 https://www.themednet.org/how-do-you-approach-the-evaluation-of-patients-referred-for-chronic-lyme-disease-and-counsel-patients-regarding-this-entity weekly 0.8 https://www.themednet.org/would-you-use-adjuvant-hypofractionation-15-20-fractions-after-bct-with-negative-margins-for-a-patient-with-malignant-phyllodes-tumor weekly 0.8 https://www.themednet.org/is-it-safe-to-deliver-definitive-radiation-for-a-solid-tumor-malignancy-ie-h-n-concurrently-with-maintenance-lenalidomide-revlimid-for-multiple-myeloma weekly 0.8 https://www.themednet.org/which-egpa-patients-are-most-likely-to-benefit-from-treatment-with-anti-il-5-agents-such-as-mepolizumab weekly 0.8 https://www.themednet.org/what-is-considered-an-adequate-treatment-period-to-assess-response-of-aav-induction-therapy-with-rituximab-or-cyclophosphamide weekly 0.8 https://www.themednet.org/do-you-recommend-adjuvant-therapy-for-early-stage-ib-high-grade-endometrial-stromal-sarcoma weekly 0.8 https://www.themednet.org/what-dose-constraints-do-you-recommend-for-the-heart-when-treating-an-intrahepatic-cholagiocarcionma-with-ablative-15-fx-techniques-when-the-tumor-is-adjacent-to-the-right-atrium weekly 0.8 https://www.themednet.org/for-a-patient-otherwise-suitable-for-apbi-would-neoadjuvant-endocrine-therapy-administered-for-extemporizing-reasons-e-g-covid-diagnosis-and-recovery-rather-than-downstaging-preclude-consideration-of-apbi weekly 0.8 https://www.themednet.org/do-you-approach-the-diagnosis-and-treatment-of-hit-patients-differently-in-the-outpatient-setting-or-in-a-resource-limited-community-setting weekly 0.8 https://www.themednet.org/how-would-you-treat-an-elderly-patient-with-cd30-negative-ptcl-nos-involving-base-of-tongue-vallecula-and-bilateral-cervical-lymph-nodes weekly 0.8 https://www.themednet.org/how-do-you-approach-h-n-radiation-in-a-patient-who-recently-had-carotid-endarterectomy-cancer-incidentally-found-during-surgery weekly 0.8 https://www.themednet.org/are-there-aav-patients-for-whom-you-would-consider-combination-therapy-with-cyclophosphamide-and-rituximab weekly 0.8 https://www.themednet.org/is-there-risk-for-local-recurrence-if-thymoma-received-ct-guided-biopsy-transgressing-the-capsule-prior-to-surgery weekly 0.8 https://www.themednet.org/would-you-treat-a-prostate-cancer-patient-with-a-positive-peri-aortic-node weekly 0.8 https://www.themednet.org/would-you-consider-definitive-rt-in-a-patient-with-oligometastatic-bladder-cancer-who-is-not-a-surgical-or-chemotherapy-candidate weekly 0.8 https://www.themednet.org/how-would-you-treat-uveitis-in-a-patient-with-a-history-of-cutaneous-t-cell-lymphoma weekly 0.8 https://www.themednet.org/when-do-you-recommend-prophylactic-orthopaedic-stablization-of-a-long-bone-metastasis-perceived-to-have-high-risk-of-pathologic-fracture weekly 0.8 https://www.themednet.org/for-incidentally-found-stage-i-indolent-non-hodgkins-lymphoma-in-young-patients-which-subtypes-would-more-strongly-warrant-a-consideration-for-curative-intent-radiation weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-endocrine-therapy-in-a-pre-menopausal-patient-with-node-negative-hr-her2-breast-cancer-with-a-high-oncotype-rs-who-received-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/would-you-recommend-gastrectomy-for-a-patient-who-has-poorly-differentiated-adenocarcinoma-in-a-resected-gastric-polyp weekly 0.8 https://www.themednet.org/do-you-consider-tertiary-grade-pattern-lvi-or-pni-on-prostatectomy-specimens-as-adverse-features-to-recommend-ebrt-and-adt-for-patients-with-unfavorable-intermediate-prostate-ca-after-prostatectomy-with-undetectable-psa weekly 0.8 https://www.themednet.org/would-you-offer-sbrt-for-intraprostatic-recurrence-after-definitive-rt-in-a-patient-with-contraindications-to-ablation-and-brachytherapy weekly 0.8 https://www.themednet.org/do-you-switch-to-certolizumab-in-ra-patients-who-are-doing-well-on-other-tnfis-and-planning-to-become-pregnant weekly 0.8 https://www.themednet.org/would-you-give-a-her2-targeted-agent-to-a-patient-whose-initial-cancer-was-er-pr-positive-her2-negative-but-now-with-metastatic-disease-that-is-er-positive-pr-negative-her2-2-fish-equivocal weekly 0.8 https://www.themednet.org/how-will-you-counsel-patients-receiving-radiation-therapy-regarding-covid-19-vaccine-administration weekly 0.8 https://www.themednet.org/is-there-a-role-for-rt-in-localized-nodal-relapse-of-stage-iv-follicular-lymphoma-with-the-goal-of-delaying-the-need-for-additional-systemic-therapy weekly 0.8 https://www.themednet.org/how-do-the-new-rxponder-results-affect-your-choice-of-adjuvant-therapy-for-postmenopausal-women-with-hr-her2-negative-breast-cancer-and-1-3-positive-lymph-nodes weekly 0.8 https://www.themednet.org/how-do-you-manage-a-delayed-hemolytic-transfusion-reaction-in-a-patient-with-sickle-cell-disease weekly 0.8 https://www.themednet.org/how-would-you-treat-and-delineate-target-volume-for-a-pt1n2-nsclc-after-wedge-resection-with-clear-margins weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-therapy-for-stage-ic-low-grade-serous-ovarian-cancer-s-p-full-staging-with-r0-resection weekly 0.8 https://www.themednet.org/how-would-you-approach-patient-with-metastatic-anaplastic-thyroid-cancer-with-ngs-revealing-only-arid1a-mutation weekly 0.8 https://www.themednet.org/would-you-electively-treat-any-lymph-node-regions-for-small-cell-carcinoma-of-the-pancreas weekly 0.8 https://www.themednet.org/are-you-recommending-tocilizumab-for-any-covid-19-patients weekly 0.8 https://www.themednet.org/how-do-recent-rxponder-results-affect-your-adjuvant-therapy-choice-for-premenopausal-women-with-hr-her2-negative-breast-cancer-with-1-3-positive-lns weekly 0.8 https://www.themednet.org/what-is-your-hemoglobin-transfusion-threshold-for-asymptomatic-pediatric-solid-tumor-patients-during-radiation weekly 0.8 https://www.themednet.org/do-you-find-addition-of-quinacrine-to-methotrexate-or-mycophenolate-helpful-in-treatment-of-refractory-cadm weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-of-lupus-peritonitis weekly 0.8 https://www.themednet.org/how-do-you-monitor-response-to-treatment-in-patients-with-mononeuritis-multiplex-secondary-to-vasculitis weekly 0.8 https://www.themednet.org/if-a-patient-with-recurrent-endometrial-cancer-experiences-minimal-or-slow-disease-progression-on-pembrolizumab-or-pembro-lenvatinib-would-you-consider-continuing-or-would-you-change-agents weekly 0.8 https://www.themednet.org/in-a-patient-with-newly-diagnosed-anal-squamous-cell-carcinoma-who-has-an-extensive-history-of-active-autoimmune-disease-including-crohns-lupus-and-arthropathies-on-multiple-therapies-would-you-forgo-radiation-therapy-and-proceed-to-apr-upfront weekly 0.8 https://www.themednet.org/for-patients-on-a-bone-modifying-agent-for-osteoporosis-severe-osteopenia-in-the-context-of-adjuvant-ai-therapy-how-do-you-manage-the-bone-modifying-agent-once-their-ai-course-is-complete weekly 0.8 https://www.themednet.org/is-it-safe-to-continue-capmatinib-during-palliative-radiation-to-a-bone-lesion-in-patients-with-metastatic-lung-cancer weekly 0.8 https://www.themednet.org/what-treatment-options-are-available-for-patients-with-spondyloarthritis-who-develop-biologic-induced-psoriasis weekly 0.8 https://www.themednet.org/do-you-generally-reduce-doac-dosing-for-extended-anticoagulation-in-patients-with-first-unprovoked-vte weekly 0.8 https://www.themednet.org/how-do-you-approach-multiply-recurrent-early-stage-oral-tongue-scc-despite-multiple-resections weekly 0.8 https://www.themednet.org/would-you-consider-xrt-for-relapsed-seminoma-in-the-retroperitoneum-pelvis-and-mediastinum-with-good-response-after-chemo-but-with-poor-kidney-function weekly 0.8 https://www.themednet.org/how-do-you-manage-arthralgias-with-subclinical-synovitis-seen-on-us-or-mri weekly 0.8 https://www.themednet.org/in-patients-with-autoimmune-cytopenias-is-there-any-reservation-for-covid-vaccination weekly 0.8 https://www.themednet.org/how-would-you-manage-a-clinically-inoperable-stage-iiib-mmr-deficient-uterine-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-recurrent-granulosa-tumor-following-secondary-r0-cytoreduction-and-negative-inhibins-postoperatively weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-regimen-for-locally-advanced-iib-iva-high-grade-neuroendocrine-carcinoma-of-the-cervix-small-cell-type weekly 0.8 https://www.themednet.org/what-is-the-evidence-rationale-for-not-treating-neuroblastoma-metastatic-sites-which-are-mibg-negative-after-induction-chemo weekly 0.8 https://www.themednet.org/what-is-the-volume-and-dose-for-a-rhabdo-bone-met-showing-complete-response-to-chemo weekly 0.8 https://www.themednet.org/what-is-your-typical-approach-for-soft-tissue-sarcomas-of-the-buttock weekly 0.8 https://www.themednet.org/what-dose-do-you-treat-the-involved-lymph-node-chain-to-in-definitive-radiation-for-rhabdomyosarcoma weekly 0.8 https://www.themednet.org/how-does-the-presence-of-mmr-deficiency-affect-your-decision-to-treat-with-3-versus-6-months-of-adjuvant-chemotherapy-in-high-risk-stage-iii-colon-cancer weekly 0.8 https://www.themednet.org/is-there-a-role-for-g-csf-treatment-for-sle-patients-with-persistent-neutropenia weekly 0.8 https://www.themednet.org/what-is-the-anticipated-recovery-of-bone-marrow-hematopoiesis-after-palliative-radiation-therapy weekly 0.8 https://www.themednet.org/when-would-you-ever-choose-cisplatin-over-carboplatin-in-extensive-stage-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/can-hydrogel-spaceoar-placed-interstitially-for-prostate-cancer-embolize-to-the-lung weekly 0.8 https://www.themednet.org/what-is-the-utility-of-immunotherapy-in-management-of-malignant-peripheral-nerve-sheath-tumors weekly 0.8 https://www.themednet.org/would-you-recommend-radiation-to-oligometastatic-boney-site-for-an-otherwise-pure-seminoma-who-had-a-cr-to-bep-x4 weekly 0.8 https://www.themednet.org/how-do-you-approach-unresectable-or-borderline-resectable-symptomatic-nasal-paranasal-rosai-dorfman-disease weekly 0.8 https://www.themednet.org/would-you-recommend-axillary-dissection-for-a-patient-with-ct1n1-triple-negative-metaplastic-breast-cancer weekly 0.8 https://www.themednet.org/what-radiation-dose-should-be-used-for-definitive-chemoradiation-for-an-unresectable-pancoast-tumor weekly 0.8 https://www.themednet.org/do-you-routinely-refer-young-patients-with-iron-deficiency-anemia-for-gi-evaluation weekly 0.8 https://www.themednet.org/for-a-patient-on-dialysis-with-metastatic-clear-cell-renal-cancer-what-regimen-would-you-use-after-front-line-immunotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-peri-operative-management-of-anti-resorptive-therapies-such-as-denosumab-in-patients-undergoing-joint-replacement weekly 0.8 https://www.themednet.org/when-would-you-offer-adjuvant-chemotherapy-after-axillary-dissection-and-rt-for-an-isolated-squamous-cell-carcinoma-of-an-axillary-node-with-unknown-primary weekly 0.8 https://www.themednet.org/what-are-your-volumes-for-a-patient-undergoing-total-neoadjuvant-chemotherapy-for-rectal-cancer-who-has-initially-bulky-disease-and-is-node-positive-and-has-a-complete-response-on-restaging-mri-after-neoadjuvant-chemotherapy-and-before-chemoradiation weekly 0.8 https://www.themednet.org/when-treating-definitive-bladder-cancer-would-you-ever-utilize-a-bladder-boost-first-prior-to-the-larger-bladder-pelvic-field weekly 0.8 https://www.themednet.org/do-you-consider-low-dose-aspirin-for-primary-thromboprophylaxis-in-patients-with-high-risk-antiphospholipid-antibody-profiles weekly 0.8 https://www.themednet.org/in-what-situations-would-you-offer-systemic-therapy-for-her2-microinvasive-invasive-ductal-carcinoma weekly 0.8 https://www.themednet.org/is-there-a-role-for-anti-il6-therapy-in-ssc-associated-ild weekly 0.8 https://www.themednet.org/for-a-young-patient-with-high-grade-pt1n0-medially-located-breast-cancer-under-what-circumstances-would-you-include-the-imn-in-your-treatment-fields weekly 0.8 https://www.themednet.org/for-palliation-of-gastric-bleeding-due-to-malignancy-is-a-g-tube-a-contraindication-for-rt weekly 0.8 https://www.themednet.org/do-you-image-the-spine-in-addition-to-the-sacroiliac-joints-when-you-suspect-axial-spondyloarthritis weekly 0.8 https://www.themednet.org/what-is-your-preferred-oral-iron-formulation-and-dosing-for-treatment-of-iron-deficiency-anemia weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-for-mda5-dermatomyositis-patients-with-rapidly-progressive-ild weekly 0.8 https://www.themednet.org/why-are-autoantibodies-not-often-detected-on-monoclonal-gammopathy-assays-spep-ife-quantitiative-immunoglobulins weekly 0.8 https://www.themednet.org/is-there-an-equivalent-test-for-serum-viscosity-in-sickle-cell-disease weekly 0.8 https://www.themednet.org/how-do-you-utilize-serum-viscosity-in-the-clinical-management-of-plasma-cell-disorders weekly 0.8 https://www.themednet.org/if-patient-had-a-significant-treatment-break-during-breast-chest-wall-radiation-would-you-consider-boosting weekly 0.8 https://www.themednet.org/should-hydroxychloroquine-be-stopped-prior-to-standard-or-hypofractionated-breast-treatment weekly 0.8 https://www.themednet.org/how-does-clinical-intramammary-lymph-node-involvement-in-her2-breast-cancer-affect-your-neoadjuvant-chemotherapy-choice weekly 0.8 https://www.themednet.org/for-a-patient-who-is-cisplatin-eligible-with-localized-high-grade-upper-tract-urothelial-carcinoma-but-no-muscularis-propria-seen-on-biopsy-what-is-your-approach weekly 0.8 https://www.themednet.org/is-there-a-role-for-orchiectomy-in-a-patient-with-stage-iv-dlbcl-who-presents-with-a-testicular-mass weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-a-small-type-a-thymoma-who-is-not-a-candidate-for-resection-due-to-medical-co-morbidities weekly 0.8 https://www.themednet.org/what-is-your-neoadjuvant-chemotherapy-of-choice-in-patients-with-er-breast-ca-who-are-receiving-neoadjuvant-therapy-with-goal-to-convert-to-bcs-from-mastectomy weekly 0.8 https://www.themednet.org/how-do-you-manage-a-hr-her2-breast-cancer-patient-with-local-progression-during-neoadjuvant-tchp weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-therapy-for-a-fully-resected-contained-morcellation-and-laparoscopic-removal-isolated-retroperitoneal-leiomyosarcoma-in-a-patient-with-a-remote-history-of-a-hysterectomy weekly 0.8 https://www.themednet.org/is-concurrent-administration-of-intraocular-avastin-for-macular-degeneration-a-concern-when-planning-sbrt-for-lung-cancer weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-androgen-deprivation-therapy-for-ar-salivary-ductal-carcinomas-treated-with-curative-intent weekly 0.8 https://www.themednet.org/how-do-you-approach-delivery-of-wbrt-in-the-setting-of-srs-induced-radionecrosis weekly 0.8 https://www.themednet.org/how-do-you-manage-endocrine-therapy-in-patients-on-tamoxifen-who-develop-thrombophlebitis-but-not-dvt weekly 0.8 https://www.themednet.org/do-you-recommend-anticoagulation-for-a-splenic-infarct-in-patients-with-myelofibrosis-and-splenomegaly weekly 0.8 https://www.themednet.org/do-you-routinely-check-egfr-mutational-status-in-all-resected-nsclc-regardless-of-histology weekly 0.8 https://www.themednet.org/how-would-you-treat-a-stage-i-peripheral-3cm-extranodal-marginal-zone-lymphoma-of-the-lung-is-sbrt-appropriate-if-so-what-dose-would-you-use weekly 0.8 https://www.themednet.org/how-do-you-predict-the-likelihood-of-radiotherapy-causing-lung-re-expansion-in-a-patient-with-advanced-or-metastatic-nsclc-and-complete-lung-collapse-due-to-obstructive-tumor weekly 0.8 https://www.themednet.org/what-is-the-best-treatment-approach-for-fit-young-patients-with-extraskeletal-ewing-sarcoma-in-the-lung weekly 0.8 https://www.themednet.org/is-it-okay-to-use-medications-associated-with-drug-induced-lupus-in-patients-with-sle weekly 0.8 https://www.themednet.org/how-do-you-manage-a-large-surgical-cavity-following-resection-of-a-melanoma-brain-metastasis weekly 0.8 https://www.themednet.org/how-would-you-treat-a-stage-ia-mixed-carcinosarcoma-neuroendocrine-tumor-of-the-endometrium-negative-lns weekly 0.8 https://www.themednet.org/what-systemic-therapy-would-you-choose-for-elderly-patients-with-her2-breast-ca-who-have-early-metastatic-relapse-within-months-of-completing-adjuvant-trastuzumab-paclitaxel weekly 0.8 https://www.themednet.org/how-would-you-manage-an-active-rheumatoid-arthritis-patient-on-suppressive-antibiotic-therapy-for-ocular-hsv-who-has-abnormal-liver-function-tests weekly 0.8 https://www.themednet.org/would-you-change-systemic-therapy-for-metastatic-melanoma-on-braf-mek-targeted-therapy-with-excellent-extracranial-response-but-with-cns-only-progression weekly 0.8 https://www.themednet.org/do-you-routinely-add-endocrine-therapy-to-anti-her2-maintenance-therapy-after-6-cycles-of-thp-for-metastatic-er-her2-breast-ca weekly 0.8 https://www.themednet.org/how-would-you-time-covid-19-vaccination-with-someone-on-r-chop-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-manage-methotrexate-therapy-in-an-active-rheumatoid-arthritis-patient-undergoing-treatment-for-latent-tb-with-rifampin weekly 0.8 https://www.themednet.org/when-would-you-recommended-restarting-biologic-medications-in-an-active-ra-patient-after-treatment-with-monoclonal-antibodies-convalescent-plasma-or-antiviral-medications-for-a-covid-19-infection weekly 0.8 https://www.themednet.org/in-patients-who-have-received-neoadjuvant-endocrine-therapy-for-localized-er-pr-her2-negative-breast-cancer-how-do-you-decide-which-patients-to-offer-adjuvant-chemotherapy-to weekly 0.8 https://www.themednet.org/how-do-you-clinically-distinguish-between-cutaneous-lupus-with-photosensitivity-and-polymorphic-light-eruption-like-reactions weekly 0.8 https://www.themednet.org/how-would-you-approach-older-patients-who-are-not-fit-or-frail-with-stage-1-favorable-classical-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/how-would-you-manage-progressive-diffuse-both-cords-and-arytenoid-high-grade-dysplasia-of-the-larynx-with-no-in-situ-or-invasive-disease-on-biopsies weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-recurrent-stage-iiic-granulosa-tumor-following-secondary-r0-cytoreduction weekly 0.8 https://www.themednet.org/in-a-patient-with-ectopic-splenic-tissue-causing-symptomatic-mass-effect-in-the-pelvis-would-you-approach-radiation-differently-than-you-would-splenomagaly-due-to-a-hematologic-malignancy weekly 0.8 https://www.themednet.org/what-is-the-best-way-to-monitor-intraoperative-heparin-use-in-a-patient-with-factor-xii-deficiency weekly 0.8 https://www.themednet.org/do-you-account-for-the-effect-of-coffee-on-platelet-aggregation-studies weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-an-early-stage-er-cancer-of-the-accessory-breast-tissue-in-the-axilla-with-clear-margins-and-negative-sentinel-lymph-nodes weekly 0.8 https://www.themednet.org/can-therapy-safely-be-reduced-to-2-years-for-males-with-pediatric-t-cell-leukemia weekly 0.8 https://www.themednet.org/would-you-use-neoadjuvant-chemotherapy-to-treat-a-patient-with-nmibc-on-turbt-pathology-but-with-ct-imaging-suggestive-of-ct3-disease weekly 0.8 https://www.themednet.org/when-do-you-stop-dantrolene-in-a-patient-with-neuroleptic-malignant-syndrome weekly 0.8 https://www.themednet.org/what-are-your-thoughts-on-use-of-14-3-3-serum-levels-in-rheumatoid-arthritis-in-conjunction-with-rf-and-acpa weekly 0.8 https://www.themednet.org/given-improved-bfs-from-the-phase-iii-flame-trial-do-you-recommend-focal-sib-up-to-95-gy-for-unfavorable-and-high-risk-prostate-patients weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-a-history-of-lymphoma-in-remission-who-are-in-need-of-immunosuppressive-e-g-tnf-blockers-6mp-or-other-therapies-e-g-jak-inhibitors-for-autoimmune-disease-that-have-been-linked-with-the-development-of-lymphoma weekly 0.8 https://www.themednet.org/would-you-consider-pembrolizumab-for-a-patient-with-microsatellite-stable-stage-iv-colon-cancer-with-high-tmb-on-liquid-biopsy-who-has-progressed-on-all-standard-therapies weekly 0.8 https://www.themednet.org/how-do-you-decide-between-cpx-351-and-hma-venetoclax-in-treating-transplant-eligible-aml-mrc weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-malignant-breast-adenomyoepithelioma weekly 0.8 https://www.themednet.org/what-is-your-platelet-cutoff-for-atezolizumab-bevacizumab-in-hcc-in-the-absence-of-bleeding-variceal-or-otherwise weekly 0.8 https://www.themednet.org/are-there-any-clinical-scenarios-where-you-would-recommend-adjuvant-docetaxel-for-localized-prostate-cancer weekly 0.8 https://www.themednet.org/would-you-modify-your-initial-treatment-for-a-patient-with-de-novo-metastatic-hr-her2-breast-ca-who-has-cardiomyopathy-at-baseline-ef-35 weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-young-female-patient-who-refuses-to-use-contraception-during-radiotherapy weekly 0.8 https://www.themednet.org/is-pre-treatment-nodal-ultrasound-evaluation-necessary-if-a-patient-undergoes-upfront-pet-ct-for-staging weekly 0.8 https://www.themednet.org/how-would-you-approach-radiation-in-a-patient-with-iiic2-scc-of-the-cervix-with-a-history-of-ileoanal-reanastomosis-and-j-pouch weekly 0.8 https://www.themednet.org/is-there-a-role-for-regular-hepatitis-and-tb-screening-in-patients-on-chronic-immunosuppressive-therapy-in-the-absence-of-new-risk-factors-or-exposures weekly 0.8 https://www.themednet.org/is-there-a-role-for-adjuvant-systemic-therapy-in-addition-to-adjuvant-radiation-in-an-early-stage-resected-cutaneous-angiosarcoma-of-the-head-neck weekly 0.8 https://www.themednet.org/would-you-give-post-mastectomy-radiation-for-a-t2n1-triple-negative-brca-2-patient-who-had-a-complete-response-from-neoadjuvant-chemo weekly 0.8 https://www.themednet.org/how-is-esr-used-in-the-clinical-staging-risk-classification-of-classical-hodgkin-lymphoma-in-pediatric-and-adult-patients weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-a-patient-with-asymptomatic-oligometastatic-basal-cell-carcinoma weekly 0.8 https://www.themednet.org/do-you-consider-an-ovarian-cancer-patient-who-progresses-on-parp-inhibitor-either-for-treatment-or-maintenance-to-be-platinum-resistant-regardless-of-time-since-last-platinum-based-chemotherapy weekly 0.8 https://www.themednet.org/what-is-an-appropriate-steroid-regimen-for-a-patient-treated-with-rt-for-spinal-cord-compression weekly 0.8 https://www.themednet.org/in-a-healthy-patient-65-years-of-age-with-glioblastoma-multiforme-what-is-the-recommendation-for-temozolomide-when-given-concurrently-with-adjuvant-radiation-therapy weekly 0.8 https://www.themednet.org/is-it-safe-to-deliver-sbrt-with-concurrent-immunotherapy-to-head-and-neck-sites-of-progressive-metastatic-disease weekly 0.8 https://www.themednet.org/for-early-stage-tnbc-without-nodal-disease-is-a-prone-breast-setup-contraindicated-due-to-concerns-of-suboptimal-chest-wall-coverage weekly 0.8 https://www.themednet.org/how-do-you-modify-therapy-for-patients-with-severe-intolerance-to-imatinib-in-the-adjuvant-setting-for-gist weekly 0.8 https://www.themednet.org/how-would-you-approach-patients-who-have-undergone-nipple-sparing-mastectomies-with-close-or-positive-margins-at-the-nipple-areola-complex weekly 0.8 https://www.themednet.org/what-ratio-of-lumpectomy-cavity-volume-to-normal-breast-tissue-do-you-consider-reasonable-for-treating-a-patient-with-apbi weekly 0.8 https://www.themednet.org/how-long-would-you-keep-a-patient-on-endocrine-dual-anti-her-2-therapy-after-resection-of-a-late-5-years-oligometastatic-recurrence-of-er-her2-breast-ca weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-an-keratoacanthoma-of-the-right-nasal-ala weekly 0.8 https://www.themednet.org/how-would-you-recommend-dosing-the-mmr-or-other-live-vaccines-for-patients-with-rheumatoid-arthritis-on-immunosuppressive-medications-such-as-dmards-and-anti-tnf-alpha-therapy weekly 0.8 https://www.themednet.org/what-is-your-approach-for-salvage-therapy-in-a-patient-with-relapsed-refractory-primary-mediastinal-b-cell-lymphoma-that-has-received-a-rituximab-containing-upfront-regimen weekly 0.8 https://www.themednet.org/how-would-you-treat-oligometastatic-kidney-cancer-in-a-young-fit-patient-with-recurrence-6-months-after-nephrectomy weekly 0.8 https://www.themednet.org/do-you-offer-consolidative-rt-to-the-pancreas-for-patients-who-initially-present-with-metastatic-disease-and-have-radiographic-cr-after-chemotherapy weekly 0.8 https://www.themednet.org/which-systemic-therapy-if-any-do-you-offer-premenopausal-women-with-a-second-tnbc-local-resectable-recurrence-and-an-extensive-chemotherapy-history weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-pelvic-rtto-a-patient-with-distal-sigmoid-colon-adenocarcinoma-following-lar-with-pt4a-pn1-with-radial-margins-and-no-room-for-further-resection weekly 0.8 https://www.themednet.org/would-you-offer-definitive-chemort-for-bladder-cancer-in-a-patient-who-had-previously-received-prostate-radiation weekly 0.8 https://www.themednet.org/how-do-you-treat-raynauds-in-patients-with-baseline-low-blood-pressure weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-itp-in-a-pregnant-patient-who-did-not-respond-to-prednisone weekly 0.8 https://www.themednet.org/what-could-explain-discordant-iron-studies weekly 0.8 https://www.themednet.org/how-would-you-approach-refractory-gangrenous-raynauds-secondary-to-type-one-cryoglobulins weekly 0.8 https://www.themednet.org/would-you-consider-using-teriparatide-beyond-a-cumulative-maximum-of-two-years-now-that-the-black-box-warning-regarding-osteosarcoma-has-been-removed weekly 0.8 https://www.themednet.org/for-anatomic-stage-iii-er-pr-breast-cancer-treated-upfront-with-surgery-how-do-you-decide-which-adjuvant-chemotherapy-to-offer weekly 0.8 https://www.themednet.org/would-you-omit-imn-coverage-in-cn1-tnbc-with-a-cr-after-neoadjuvant-chemo weekly 0.8 https://www.themednet.org/how-would-you-define-the-primary-site-gtv-and-ctv-volumes-in-a-high-risk-neuroblastoma-patient-who-obtained-a-complete-response-to-induction-chemo weekly 0.8 https://www.themednet.org/is-there-a-role-for-anti-fibrinolytic-agents-in-patients-with-hyperfibrinolytic-disseminated-intravascular-coagulation weekly 0.8 https://www.themednet.org/if-neoadjuvant-therapy-is-indicated-for-luminal-a-breast-cancer-when-do-you-decide-to-use-chemotherapy-versus-endocrine-therapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-consolidation-for-localized-small-cell-bladder-cancer-after-neoadjuvant-cisplatin-and-etoposide weekly 0.8 https://www.themednet.org/when-if-ever-would-you-offer-adjuvant-sunitinib-to-a-patient-with-chromophobe-renal-cell-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-manage-prophylactic-antimicrobial-medications-in-patients-who-undergo-atg-cyclosporine-eltrombopag-induction-for-severe-aplastic-anemia weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-stage-1-seminoma-on-surveillance-without-prior-radiation-or-chemotherapy-who-develops-para-aortic-lymphadenopathy-without-increase-in-tumor-markers weekly 0.8 https://www.themednet.org/what-is-the-radiation-volume-for-m-pure-germinoma-with-brain-only-extra-ventricular-mets-and-negative-csf-spine-imaging weekly 0.8 https://www.themednet.org/how-will-you-use-tocilizumab-in-the-treatment-algorithm-for-ssc-ild-given-its-recent-fda-approval weekly 0.8 https://www.themednet.org/how-do-you-manage-adjuvant-endocrine-therapy-for-pre-menopausal-women-with-locally-advanced-weakly-positive-er-pr-her2-negative-breast-cancer weekly 0.8 https://www.themednet.org/is-there-a-role-for-prophylactic-tranexamic-acid-in-patients-with-hematologic-malignancy-with-chemotherapy-induced-thrombocytopenia weekly 0.8 https://www.themednet.org/how-would-you-approach-a-triple-negative-carcinoma-of-the-axilla-with-unknown-primary-and-a-cr-after-neoadj-chemo-followed-by-alnd weekly 0.8 https://www.themednet.org/when-do-you-consider-including-rituximab-into-the-treatment-regimen-for-a-pediatric-or-aya-patient-with-intermediate-and-advanced-stage-nodular-lymphocyte-predominant-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-regimen-and-duration-would-you-use-for-t2n1-ampullary-adenocarcinoma-intestinal-type weekly 0.8 https://www.themednet.org/how-would-you-treat-a-pediatric-or-aya-patient-with-ph-like-all-with-induction-failure weekly 0.8 https://www.themednet.org/what-aspects-on-history-and-physical-exam-could-help-differentiate-genetic-muscular-dystrophy-from-immune-mediated-myopathy weekly 0.8 https://www.themednet.org/how-do-you-counsel-peri-or-post-menopausal-women-diagnosed-with-hr-breast-ca-who-wish-to-continue-receiving-testosterone-supplementation weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiation-therapy-for-a-merkel-cell-carcinoma-limited-to-the-epidermis-with-close-margins weekly 0.8 https://www.themednet.org/how-should-the-results-of-the-advocate-trial-be-applied-in-aav-patients-who-receive-rituximab-induction-and-maintenance-therapy weekly 0.8 https://www.themednet.org/are-there-particular-subsets-of-aav-patients-in-which-avacopan-is-more-effective weekly 0.8 https://www.themednet.org/should-the-use-of-avacopan-be-limited-to-those-patients-at-increased-risk-of-steroid-toxicity-given-the-anticipated-high-cost-of-this-medication weekly 0.8 https://www.themednet.org/would-you-consider-adding-midostaurin-to-azacitadine-in-elderly-patients-with-newly-diagnosed-aml-with-flt3-itd-mutations-in-the-frontline-setting weekly 0.8 https://www.themednet.org/would-you-pursue-adjuvant-immunotherapy-for-a-resected-stage-iiic-or-iiid-braf-wild-type-melanoma-patient-with-pre-existing-ulcerative-colitis-that-is-well-managed-on-maintenance-infliximab weekly 0.8 https://www.themednet.org/should-end-of-therapy-echocardiograms-be-obtained-for-aya-patients-with-sarcomas-who-have-received-high-dose-anthracyclines weekly 0.8 https://www.themednet.org/how-would-you-manage-recurrent-popliteal-and-inguinal-lns-from-melanoma weekly 0.8 https://www.themednet.org/how-would-you-define-bulky-involvement-of-the-tonsil-in-a-patient-with-dlbcl weekly 0.8 https://www.themednet.org/would-you-consider-tamoxifen-to-be-contraindicated-for-chemoprevention-in-patients-with-a-history-of-ocp-induced-vte weekly 0.8 https://www.themednet.org/how-would-you-manage-a-stage-ie-dlbcl-of-the-stomach-non-germinal-center-type-by-ihc-and-ki-67-of-70-but-negative-for-double-triple-hit-by-fish weekly 0.8 https://www.themednet.org/when-do-you-consider-iron-chelation-in-elderly-patients-with-transfusion-dependent-mds weekly 0.8 https://www.themednet.org/would-you-initiate-chemoimmunotherapy-e-g-rchop-in-a-symptomatic-patient-with-dlbcl-who-tested-positive-for-covid19 weekly 0.8 https://www.themednet.org/what-are-the-current-appropriate-planning-margins-for-wilms-tumor-in-lymph-node-negative-cases weekly 0.8 https://www.themednet.org/how-would-you-manage-an-incidentally-identified-1-0-mm-anal-squamous-cell-carcinoma-5-5-mm-margin-in-a-background-of-severe-dysplasia-cis-involving-the-peripheral-excision-margins-found-on-a-hemorrhoidectomy-specimen weekly 0.8 https://www.themednet.org/how-would-you-manage-adjuvant-endocrine-therapy-for-a-postmenopausal-patient-with-early-stage-hr-breast-ca-who-develops-an-ischemic-cva-on-an-ai weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-early-stage-er-her2-breast-ca-who-cannot-receive-definitive-local-therapy-due-to-severe-cardiopulmonary-co-morbidities weekly 0.8 https://www.themednet.org/how-would-you-manage-a-recurrent-endometrial-cancer-confined-to-the-vaginal-cuff-that-is-completely-resected weekly 0.8 https://www.themednet.org/how-would-you-treat-counsel-a-patient-with-stage-ib3-scc-of-the-cervix-who-is-18-weeks-pregnant-and-desires-to-maintain-pregnancy weekly 0.8 https://www.themednet.org/would-you-ever-consider-prophylactic-anticoagulation-in-patients-with-ckd-requiring-esa-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-immunosuppression-targeting-skin-thickening-in-scleroderma-after-the-initial-three-years-of-onset weekly 0.8 https://www.themednet.org/would-you-recommend-isrt-after-salvage-auto-transplant-for-relapsed-classical-hodgkin-lymphoma-if-the-patient-had-deauville-2-after-icex2-prior-to-beam-auto-transplant-and-now-has-deauville-1-imaging weekly 0.8 https://www.themednet.org/do-you-alter-your-surveillance-plan-after-achieving-local-control-for-patients-with-breast-ca-with-locoregional-recurrence-given-the-higher-risk-of-distant-recurrence weekly 0.8 https://www.themednet.org/what-studies-do-you-find-helpful-to-determine-if-an-axial-spondyloarthritis-patient-presenting-late-in-the-disease-course-with-significant-irreversible-joint-damage-may-benefit-from-immunosuppression weekly 0.8 https://www.themednet.org/what-image-guidance-do-you-utilize-for-photon-breast-boost weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiation-to-a-woman-with-a-history-of-mastectomy-and-reconstruction-for-dcis-no-prior-rt-who-develops-a-ct1cn0-new-primary-idc-in-the-chest-wall weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-cutaneous-scc-of-the-lower-extremity-with-isolated-inguinal-nodal-involvement weekly 0.8 https://www.themednet.org/do-you-offer-whole-lung-radiation-with-metastatic-recurrence-of-wilms-tumor-fh-no-loh-1p16q weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-radiation-therapy-for-sacral-chordoma-s-p-gross-total-resection-with-close-margins-0-5-cm weekly 0.8 https://www.themednet.org/how-would-you-optimally-manage-a-patient-with-a-mds-mpn-overlap-syndrome-who-has-both-transfusion-dependent-anemia-and-marked-thrombocytosis weekly 0.8 https://www.themednet.org/what-gemtuzumab-regimen-and-schedule-with-standard-7-plus-3-would-you-use-for-a-newly-diagnosed-aml-patient-with-favorable-genetics weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-outpatient-induction-for-aml weekly 0.8 https://www.themednet.org/how-do-you-manage-a-cervical-cancer-that-needs-interstitial-brachytherapy-with-prolonged-thrombocytopenia-after-concurrent-chemort weekly 0.8 https://www.themednet.org/do-you-continue-methotrexate-in-patients-with-inflammatory-arthritis-who-develop-non-melanomatous-skin-cancer-while-on-therapy weekly 0.8 https://www.themednet.org/is-it-essential-to-wait-one-week-after-loading-dose-of-erbitux-to-start-rt-for-head-and-neck-cancer weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-jak-inhibitors-about-the-risk-of-venous-thromboembolism-mace-and-cancer weekly 0.8 https://www.themednet.org/what-adjuvant-treatment-if-any-would-you-recommend-for-a-post-menopausal-patient-with-a-borderline-t1b-0-5-cm-grade-2-er-pr-her2-negative-invasive-lobular-breast-ca-after-bilateral-mastectomies weekly 0.8 https://www.themednet.org/does-microscopic-ene-warrant-post-mastectomy-radiotherapy-if-all-other-factors-are-low-risk weekly 0.8 https://www.themednet.org/what-chemotherapy-if-any-would-you-offer-for-an-elderly-patient-with-congestive-heart-failure-with-completely-excised-stage-i-classical-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/do-you-recommend-prophylactic-ureteral-stenting-in-patients-who-have-recently-completed-sbrt-to-a-region-in-close-proximity-to-the-ureter-prior-to-the-potential-development-of-fibrosis weekly 0.8 https://www.themednet.org/how-do-you-approach-staging-for-a-patient-with-adult-granulosa-cell-tumor-grossly-confined-to-one-ovary-and-desiring-a-fertility-sparing-procedure weekly 0.8 https://www.themednet.org/what-would-be-your-next-step-in-management-of-a-dermatomyositis-patient-on-hydroxychloroquine-and-methotrexate-whose-skin-is-still-active weekly 0.8 https://www.themednet.org/what-therapies-have-you-had-the-most-success-with-for-calcinosis-cutis-in-dermatomyositis-patients weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-systemic-therapy-for-metastatic-chordoma weekly 0.8 https://www.themednet.org/what-is-the-optimal-management-for-a-patient-with-tourette-syndrome-with-severe-tics-that-preclude-the-patient-from-lying-still-for-radiation weekly 0.8 https://www.themednet.org/are-there-any-concerns-about-using-nintedanib-in-a-patient-with-progressive-fibrosing-ild-on-background-mycophenolate weekly 0.8 https://www.themednet.org/do-you-avoid-immunotherapy-in-patients-with-stage-iv-nsclc-with-atypical-egfr-mutations-such-as-g719s-or-s768i weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-therapy-for-a-non-invasive-grade-3-endometrioid-endometrial-cancer-that-is-p53-wild-type-and-mmr-deficient-due-to-methylation weekly 0.8 https://www.themednet.org/would-you-avoid-capecitabine-in-favor-of-fluorouracil-in-the-adjuvant-treatment-of-colon-cancer-for-a-patient-with-history-of-a-gastric-bypass weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-history-of-stage-iiic-hgsoc-after-secondary-cytoreduction-of-isolated-inguinal-node-recurrence-12-years-after-primary-treatment weekly 0.8 https://www.themednet.org/would-you-recommend-aspirin-600-mg-daily-for-two-years-to-a-patient-with-lynch-syndrome-and-a-history-of-colon-cancer-based-on-the-results-of-the-capp2-study-for-cancer-prevention weekly 0.8 https://www.themednet.org/what-would-be-the-ideal-patient-to-receive-selinexor-based-therapy-over-other-options-for-penta-refractory-multiple-myeloma weekly 0.8 https://www.themednet.org/is-positive-pleural-fluid-cytology-from-pleural-mesothelioma-considered-m weekly 0.8 https://www.themednet.org/in-a-patient-with-breakthrough-vte-on-rivaroxaban-would-you-switch-to-apixaban-or-an-agent-with-a-different-mechanism-of-action weekly 0.8 https://www.themednet.org/would-you-add-concurrent-chemotherapy-to-definitive-radiation-based-on-suspicion-for-extranodal-extension-ece-ene-on-imaging-adjacent-fat-stranding-for-a-clinical-t1-2n1-single-node-3cm-oropharyngeal-cancer weekly 0.8 https://www.themednet.org/what-is-the-preferred-treatment-approach-for-an-aya-patient-with-intermediate-to-high-risk-hodgkin-lymphoma-the-pediatric-approach-abve-pc-radiation-or-the-adult-approach-abvd-with-possible-escalation-to-beacopp weekly 0.8 https://www.themednet.org/are-there-features-of-a-nerve-biopsy-that-help-distinguish-late-nerve-damage-from-vasculitis-versus-from-a-demyelinating-disease weekly 0.8 https://www.themednet.org/what-workup-do-you-perform-to-evaluate-for-underlying-triggers-associated-conditions-in-a-pediatric-patient-with-autoimmune-hemolytic-anemia weekly 0.8 https://www.themednet.org/given-favorable-uk-fast-forward-data-for-whole-breast-would-you-consider-this-daily-1-week-fractionation-scheme-when-treating-with-partial-breast-approach weekly 0.8 https://www.themednet.org/how-do-you-approach-therapy-for-severe-osteoporosis-after-an-initial-12-months-of-romosozumab weekly 0.8 https://www.themednet.org/is-there-a-contraindication-to-orthodonture-in-an-aya-after-high-dose-head-and-neck-radiation-where-the-mandible-got-close-to-full-dose-e-g-60-gy-for-nasopharyngeal-carcinoma weekly 0.8 https://www.themednet.org/would-you-ever-include-the-proximal-seminal-vesicles-in-your-prostate-sbrt-volume weekly 0.8 https://www.themednet.org/would-you-consider-use-of-upfront-bv-plus-nivolumab-to-treat-hodgkin-lymphoma-in-elderly-patients-unable-to-receive-standard-chemotherapy weekly 0.8 https://www.themednet.org/for-a-breast-plan-utilizing-a-medial-electron-patch-for-comprehensive-nodal-coverage-do-you-have-a-limit-for-hot-spot-at-the-electron-photon-match weekly 0.8 https://www.themednet.org/after-completing-6-cycles-of-docetaxel-plus-adt-for-metastatic-hormone-sensitive-prostate-cancer-per-chaarted-are-there-clinical-scenarios-in-which-you-would-add-an-additional-ar-targeted-agent-ex-enzalutamide-abiraterone-or-apalutamide-to-adt weekly 0.8 https://www.themednet.org/would-you-ever-offer-adjuvant-immunotherapy-after-definitive-chemoradiation-for-esophageal-cancer weekly 0.8 https://www.themednet.org/at-what-lower-end-of-recurrence-risk-do-you-offer-adjuvant-imatinib-for-patients-with-resected-gist weekly 0.8 https://www.themednet.org/do-you-screen-adults-in-your-practice-with-sickle-cell-disease-for-silent-cerebral-infarcts weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-muscle-invasive-urothelial-carcinoma-with-squamous-differentiation weekly 0.8 https://www.themednet.org/in-patients-with-a-history-of-hit-how-do-you-counsel-them-on-the-use-of-the-astrazeneca-vaccine-given-reports-of-unusual-thrombosis-and-association-with-pf4-heparin-antibodies weekly 0.8 https://www.themednet.org/what-are-your-next-steps-in-workup-for-a-pediatric-patient-with-microcytic-anemia-with-normal-iron-levels-normal-hemoglobin-analysis-and-normal-alpha-thal-trait-testing weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-a-history-of-severe-ifosfamide-neurotoxicity-who-need-additional-ifosfamide weekly 0.8 https://www.themednet.org/is-there-data-to-support-holding-the-5th-cycle-of-intensification-for-an-aml-patient-with-good-prognosis-and-a-history-of-significant-infections-and-or-prolonged-count-recovery weekly 0.8 https://www.themednet.org/when-can-defibrotide-be-discontinued-before-the-21-day-treatment-course-is-completed-in-a-pediatric-patient-with-sos weekly 0.8 https://www.themednet.org/how-do-you-advise-patients-who-had-autoimmune-diseases-triggered-by-covid-infections-on-getting-covid-vaccination weekly 0.8 https://www.themednet.org/when-would-you-use-tocilizumab-to-treat-takayasus weekly 0.8 https://www.themednet.org/do-you-offer-iron-supplementation-to-a-patient-with-iron-studies-that-are-normal-including-normal-ferritin-except-for-low-iron-saturation weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-treatment-of-pt1cn0-metaplastic-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-abnormal-lipids-in-a-patient-on-tocilizumab weekly 0.8 https://www.themednet.org/for-a-patient-with-metastatic-nsclc-who-had-progression-x2-at-a-single-site-treated-w-rt-would-you-switch-systemic-treatment weekly 0.8 https://www.themednet.org/do-you-offer-maintenance-rituximab-in-transplant-ineligible-patients-with-mantle-cell-lymphoma weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-a-growing-central-liver-metastasis-previously-treated-with-sbrt-who-is-ineligible-for-chemotherapy weekly 0.8 https://www.themednet.org/what-additional-testing-if-any-should-be-performed-for-an-adolescent-patient-with-heavy-menstrual-bleeding-and-a-negative-von-willebrand-disease-evaluation weekly 0.8 https://www.themednet.org/how-do-you-use-daratumumab-in-the-treatment-of-systemic-al-amyloidosis weekly 0.8 https://www.themednet.org/do-you-approach-therapy-differently-for-patients-with-a-diagnosis-of-osteoporosis-based-on-a-fragility-fracture-rather-than-based-on-bone-mineral-density-on-dxa-assuming-no-secondary-causes-of-osteoporosis weekly 0.8 https://www.themednet.org/do-you-eventually-stop-urate-lowering-therapy-in-gout-patients-with-ckd-who-start-hemodialysis weekly 0.8 https://www.themednet.org/how-would-you-modify-adjuvant-therapy-for-a-patient-with-er-her2-breast-ca-with-no-response-to-neoadjuvant-tchp-and-develops-pneumonitis-on-adjuvant-tdm-1 weekly 0.8 https://www.themednet.org/what-is-the-importance-of-finding-a-positive-titer-for-fgfr3-and-what-treatment-would-be-advised-for-these-patients weekly 0.8 https://www.themednet.org/what-abortive-migraine-treatment-is-preferred-in-pregnant-patients weekly 0.8 https://www.themednet.org/would-you-recommend-a-cgrp-inhibitor-for-migraine-prevention-in-pregnant-patients weekly 0.8 https://www.themednet.org/what-treatments-would-you-recommend-in-patients-with-adult-onset-rasmussens-encephalitis-after-the-patient-is-on-two-or-more-aeds weekly 0.8 https://www.themednet.org/at-what-point-could-starting-aeds-be-considered-for-patients-with-recurrent-simple-febrile-seizures weekly 0.8 https://www.themednet.org/how-do-you-determine-the-timing-of-anticoagulation-for-patients-with-large-mca-strokes-secondary-to-atrial-fibrillation weekly 0.8 https://www.themednet.org/how-do-you-limit-the-onset-of-new-strokes-in-patients-with-moya-moya-syndrome weekly 0.8 https://www.themednet.org/should-patients-with-clinically-isolated-syndrome-be-started-on-medication weekly 0.8 https://www.themednet.org/when-do-you-recommend-electrical-stimulation-cefaly-device-in-patients-with-chronic-migraine-if-at-all weekly 0.8 https://www.themednet.org/is-an-emg-ncs-required-to-clinically-diagnose-guillain-barre-syndrome weekly 0.8 https://www.themednet.org/when-is-a-paraneoplastic-panel-indicated-when-working-up-patients-with-neuromuscular-conditions weekly 0.8 https://www.themednet.org/what-is-the-preferred-management-plan-for-patients-diagnosed-with-a-concussion-in-the-acute-setting weekly 0.8 https://www.themednet.org/at-what-point-is-it-warranted-to-send-an-autoimmune-epilepsy-panel-in-patients weekly 0.8 https://www.themednet.org/at-what-point-is-a-skin-biopsy-indicated-in-patients-with-neuropathy weekly 0.8 https://www.themednet.org/when-do-you-refer-a-patient-with-recurrent-glioma-for-reoperation weekly 0.8 https://www.themednet.org/when-should-surgical-tumor-resection-be-considered-in-patients-with-a-low-grade-glioma weekly 0.8 https://www.themednet.org/in-what-clinical-settings-is-acute-ich-clot-removal-recommended weekly 0.8 https://www.themednet.org/what-workup-and-management-plan-is-indicated-for-patients-with-orthostatic-tremor weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-a-sleep-study-in-patients-with-clinical-history-of-rem-sleep-behavior-disorder weekly 0.8 https://www.themednet.org/should-patients-with-cerebral-amyloid-angiopathy-have-any-statin-medications-discontinued weekly 0.8 https://www.themednet.org/are-there-scenarios-where-you-send-additional-antibodies-beyond-anti-centromere-scl-70-and-rna-polymerase-iii-in-suspected-scleroderma-patients weekly 0.8 https://www.themednet.org/would-you-start-tki-therapy-in-a-patient-with-new-diagnosis-of-t-all-without-bcr-abl-gene-rearrangement-on-fish-but-found-to-have-very-low-level-p190-transcript-on-rt-pcr weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-a-2-cm-forehead-subcutaneous-lesion-s-p-excision-found-to-be-a-diffuse-large-b-cell-lymphoma-germinal-center weekly 0.8 https://www.themednet.org/would-you-consider-a-focal-prostate-boost-per-flame-trial-with-treatment-of-the-pelvis weekly 0.8 https://www.themednet.org/how-would-you-treat-hr-positive-her2-positive-metastatic-breast-cancer-in-patients-with-a-borderline-or-poor-performance-status weekly 0.8 https://www.themednet.org/would-you-recommend-hematopoietic-stem-cell-transplant-for-ayas-with-ph-like-all weekly 0.8 https://www.themednet.org/how-do-you-approach-missed-doses-of-durvalumab-consolidation-in-patients-with-stage-iii-nsclc weekly 0.8 https://www.themednet.org/can-radiation-therapy-alone-for-localized-recurrence-of-high-grade-b-cell-lymphoma-be-considered-for-those-that-previously-received-rituximab-based-chemotherapy weekly 0.8 https://www.themednet.org/what-is-your-threshold-for-number-of-alcoholic-drinks-per-week-before-reconsidering-prescribing-methotrexate-leflunomide weekly 0.8 https://www.themednet.org/how-do-you-approach-imaging-in-the-treatment-planning-of-resected-high-grade-gliomas-glioblastoma weekly 0.8 https://www.themednet.org/when-if-ever-do-you-check-for-anti-platelet-antibodies-for-workup-of-thrombocytopenia weekly 0.8 https://www.themednet.org/what-neoadjuvant-regimen-would-use-you-for-a-patient-over-70-years-old-with-resectable-gastric-cancer weekly 0.8 https://www.themednet.org/how-do-you-account-for-hot-cold-spots-generated-by-a-metallic-port-used-to-inflate-tissue-expander-in-breast-reconstruction weekly 0.8 https://www.themednet.org/how-do-you-treat-an-aav-patient-with-recurrent-bronchial-stenosis-that-has-not-responded-to-rituximab-induction-therapy-and-dilatations weekly 0.8 https://www.themednet.org/when-would-you-consider-upfront-eculizumab-for-sickle-cell-hyperhemolysis weekly 0.8 https://www.themednet.org/would-you-consider-irradiating-the-prostate-and-a-positive-node-noted-on-pet-auxumin-while-omitting-elective-pelvic-nodal-coverage weekly 0.8 https://www.themednet.org/how-do-you-approach-chemotherapy-dosing-in-extremely-obese-patients weekly 0.8 https://www.themednet.org/how-would-you-approach-radiation-treatment-of-recurrent-braf-negative-melanoma-with-left-distal-leg-metastases-and-two-isolated-pet-avid-inguinal-nodes weekly 0.8 https://www.themednet.org/how-would-you-sequence-therapies-for-a-patient-with-chemotherapy-naive-metastatic-castration-resistant-prostate-cancer-who-is-msi-h-on-tissue-based-ngs weekly 0.8 https://www.themednet.org/what-is-the-role-of-consolidative-radiotherapy-in-a-stage-iv-triple-hit-lymphoma-with-partial-response-above-and-below-diaphragm-s-p-8-cycles-of-rchop weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-capmatinib-induced-edema weekly 0.8 https://www.themednet.org/should-targeted-therapies-such-as-brentuximab-or-crizotinib-be-used-in-the-upfront-management-of-anaplastic-large-cell-lymphoma-in-a-pediatric-or-aya-patient weekly 0.8 https://www.themednet.org/how-do-you-approach-contraception-and-pregnancy-counseling-in-women-of-childbearing-age-with-desmoid-tumors-who-may-be-contemplating-future-pregnancy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-widely-metastatic-penile-squamous-cell-carcinoma-with-mixed-response-to-4-cycles-of-tip-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-biologics-in-patients-with-a-history-of-guillain-barre-syndrome weekly 0.8 https://www.themednet.org/in-breast-cancer-patients-with-a-positive-margin-on-permanent-tissue-but-not-on-frozen-do-you-recommend-re-excision-or-just-proceed-with-radiation weekly 0.8 https://www.themednet.org/would-you-start-tocilizumab-in-a-patient-with-temporal-arteritis-and-cirrhosis weekly 0.8 https://www.themednet.org/do-you-routinely-check-platelet-counts-after-covid-19-vaccines-in-patients-with-chronic-itp weekly 0.8 https://www.themednet.org/how-do-you-approach-srs-for-brain-metastases-in-the-setting-of-a-connective-tissue-disorder-such-as-lupus-or-scleroderma weekly 0.8 https://www.themednet.org/what-are-your-indications-for-starting-emicizumab-in-pediatric-patients-with-hemophilia-a weekly 0.8 https://www.themednet.org/what-is-your-approach-for-gout-flare-prophylaxis-in-patients-with-diabetes-and-advanced-ckd weekly 0.8 https://www.themednet.org/is-there-a-role-for-sbrt-with-vaginal-melanoma weekly 0.8 https://www.themednet.org/how-would-you-treat-an-advanced-stage-small-cell-carcinoma-of-the-ovary-hypercalcemic-type-sccoht weekly 0.8 https://www.themednet.org/when-do-you-consider-lesion-therapy-such-as-pallidotomy-or-subthalamotomy-instead-of-dbs-in-patients-with-parkinsons-disease weekly 0.8 https://www.themednet.org/would-you-include-ipsilateral-nodes-in-adjuvant-rt-for-bulky-mammary-analogue-secretory-carcinoma-of-salivary-gland weekly 0.8 https://www.themednet.org/for-a-chest-wall-scar-boost-with-a-very-long-scar-that-requires-2-electron-fields-how-do-you-do-that-clinical-setup weekly 0.8 https://www.themednet.org/how-would-you-manage-the-primary-site-of-a-metastatic-nasopharyngeal-cancer-showing-ccr-after-systemic-therapy weekly 0.8 https://www.themednet.org/is-there-a-role-for-prednisolone-over-prednisone-in-rheumatic-patients-with-hepatic-impairment weekly 0.8 https://www.themednet.org/how-would-you-advise-patients-with-known-stable-autoimmune-thrombocytopenia-regarding-the-ad26-cov2-s-johnson-johnson-janssen-vaccine weekly 0.8 https://www.themednet.org/do-the-results-of-checkmate-451-nivo-ipi-or-nivo-maintenance-after-chemotherapy-in-patients-with-sclc-raise-any-questions-for-you-about-the-role-of-immunotherapy-in-sclc-as-established-by-the-caspian-and-impower-133-trials weekly 0.8 https://www.themednet.org/what-is-your-approach-following-r1-resection-in-a-patient-who-has-received-total-neoadjuvant-therapy-for-rectal-cancer weekly 0.8 https://www.themednet.org/what-is-the-optimal-time-to-wait-prior-to-surgery-following-radiation-therapy-for-rectal-cancer-to-maximize-the-pathologic-complete-response-rate weekly 0.8 https://www.themednet.org/for-patients-that-fail-initial-srs-for-trigeminal-neuralgia-what-factors-do-you-consider-when-considering-re-irradiation weekly 0.8 https://www.themednet.org/when-should-upfront-molecular-sequencing-be-performed-in-a-pediatric-or-aya-patient-with-sarcoma weekly 0.8 https://www.themednet.org/would-you-recommend-use-of-esa-for-anemia-of-kidney-disease-in-the-setting-of-metastatic-solid-tumor-malignancy weekly 0.8 https://www.themednet.org/in-what-situations-would-you-consider-memantine-when-treating-multiple-brain-metastases-with-srs weekly 0.8 https://www.themednet.org/how-do-you-manage-a-t1n0-well-differentiated-anal-margin-squamous-cell-carcinoma-with-low-grade-dysplasia-at-the-surgical-margin-who-has-already-undergone-re-excision-and-is-not-eligible-for-further-excision-without-an-apr weekly 0.8 https://www.themednet.org/do-you-offer-partial-breast-irradiation-to-woman-with-a-germline-variant-of-unknown-significance-vus-who-otherwise-fall-into-the-suitable-astro-category weekly 0.8 https://www.themednet.org/is-there-a-role-for-frontline-combination-therapy-with-a-hypomethylating-agent-plus-venetoclax-for-high-risk-mds weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-an-egfr-exon-19-mutated-nsclc-who-develops-progression-on-osimertinib-and-repeat-biopsy-demonstrates-the-egfr-exon-19-mutation-and-a-new-braf-v600e-mutation weekly 0.8 https://www.themednet.org/how-would-you-design-chest-wall-boost-in-a-patient-who-underwent-mastectomy-with-a-wise-pattern-incision weekly 0.8 https://www.themednet.org/would-you-treat-a-vulvar-scc-with-definitive-chemort-with-50-4-gy-imrt-then-boost-the-gtv-with-en-face-with-electrons-to-6400 weekly 0.8 https://www.themednet.org/is-sbrt-an-option-for-a-paravertebral-lung-cancer-with-vertebral-body-and-rib-invasion-for-patients-who-are-not-chemo-candidates weekly 0.8 https://www.themednet.org/what-risk-if-any-do-you-quote-for-erectile-dysfunction-in-a-young-male-being-treated-for-a-lumbosacral-ependymoma weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-immunotherapy-for-a-melanoma-patient-with-lymphocytic-colitis weekly 0.8 https://www.themednet.org/what-is-the-optimal-sequence-of-systemic-therapy-for-a-patient-with-hr-gbrca-mutated-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-deliver-time-radiation-for-a-patient-with-iiic1-serous-endometrial-cancer-who-is-her2 weekly 0.8 https://www.themednet.org/how-do-you-approach-less-common-cutaneous-mucosal-toxicities-from-egfr-tki-and-monoclonal-antibody-therapies-such-as-ocular-keratitis-and-conjunctivitis-and-genital-mucositis-vulvovaginitis-and-balanitis weekly 0.8 https://www.themednet.org/for-a-patient-with-cardiac-sarcoma-is-there-a-minimum-ejection-fraction-to-proceed-with-adjuvant-radiation-therapy weekly 0.8 https://www.themednet.org/how-would-you-manage-multiple-myeloma-with-a-suboptimal-response-to-frontline-quadruplet-therapy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-imaging-suspicious-undissected-ipsilateral-lymph-node-in-the-setting-of-post-op-rt-for-an-oral-cavity-cancer-with-extensive-nodal-disease-and-ece weekly 0.8 https://www.themednet.org/do-you-routinely-prescribe-vaginal-estrogen-therapy-post-chemo-xrt-for-female-patients-finishing-anal-cancer-treatment weekly 0.8 https://www.themednet.org/do-you-think-there-is-any-compelling-data-to-support-giving-brentuximab-as-frontline-therapy-for-pediatric-patients-with-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/when-is-a-tips-procedure-indicated-for-a-pediatric-patient-with-sinusoidal-obstructive-syndrome weekly 0.8 https://www.themednet.org/would-you-alter-neoadjuvant-chemotherapy-regimen-for-a-high-grade-small-cell-neuroendocrine-carcinoma-of-the-ovary-if-she-has-already-received-cycle-1-of-carbo-taxol weekly 0.8 https://www.themednet.org/in-a-patient-with-metastatic-clear-cell-rcc-who-achieved-a-prolonged-pr-with-first-line-nivolumab-ipilimumab-discontinued-due-to-iraes-would-you-consider-a-tki-checkpoint-inhibitor-combination-regimen weekly 0.8 https://www.themednet.org/would-you-consider-allogeneic-stem-cell-transplant-for-a-newly-diagnosed-patient-with-favorable-risk-aml-who-had-residual-disease-after-initial-therapy-that-included-the-need-for-re-induction weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-low-dose-aspirin-for-primary-prevention-in-non-pregnant-patients-with-sle-and-positive-apl-antibodies-without-clinical-criteria-for-aps weekly 0.8 https://www.themednet.org/when-do-you-trial-pyridostigmine-in-a-patient-with-suspected-myasthenia-gravis weekly 0.8 https://www.themednet.org/how-would-you-approach-a-young-person-with-jak2-v617f-positive-essential-thrombocytosis-with-otherwise-low-risk-features weekly 0.8 https://www.themednet.org/do-you-routinely-perform-next-generation-sequencing-on-otherwise-low-risk-gist-to-guide-adjuvant-therapy weekly 0.8 https://www.themednet.org/how-would-you-adjust-therapy-for-a-patient-with-high-risk-stage-iii-choriocarcinoma-lung-mets-in-the-context-of-renal-insufficiency-cr-3-8 weekly 0.8 https://www.themednet.org/would-you-add-dose-fractions-to-a-post-mastectomy-patient-who-had-a-two-week-break-due-to-being-covid-19-positive weekly 0.8 https://www.themednet.org/would-you-use-inhaled-steroids-with-or-without-oral-steroids-for-the-treatment-of-radiation-pneumonitis weekly 0.8 https://www.themednet.org/do-you-treat-the-elective-pelvic-lymph-nodes-up-to-the-common-iliac-bifurcation-per-the-nrg-oncology-updated-international-consensus-atlas weekly 0.8 https://www.themednet.org/is-it-ever-appropriate-to-de-escalate-regional-nodal-coverage-in-pmrt-for-patients-with-localized-inflammatory-breast-cancer-ibc weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-igg4-related-disease-who-has-failed-rituximab-and-mycophenolate-and-continues-to-rely-on-high-dose-steroids weekly 0.8 https://www.themednet.org/when-planning-a-moderately-hypofractionationed-treatment-for-prostate-cancer-do-you-recommend-using-a-bladder-volume-dose-constraint weekly 0.8 https://www.themednet.org/how-do-you-manage-hr-her2-negative-ilc-metastatic-recurrence-in-a-post-menopausal-woman-with-extensive-gi-involvement-complicated-by-a-small-bowel-obstruction weekly 0.8 https://www.themednet.org/what-is-your-approach-to-platelet-transfusion-in-heparin-induced-thrombocytopenia weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-patients-with-inflammatory-arthritis-who-are-asymptomatic-but-develop-radiographic-progression weekly 0.8 https://www.themednet.org/would-you-use-autologous-hematopoietic-stem-cells-collected-from-a-hr-neuroblastoma-patient-found-to-be-covid-positive-after-harvest weekly 0.8 https://www.themednet.org/in-patients-with-recurrent-ischemic-infarcts-on-the-same-side-as-an-internal-carotid-artery-lesion-is-intervention-warranted-even-if-there-is-less-than-50-obstruction weekly 0.8 https://www.themednet.org/at-what-psa-value-do-you-obtain-molecular-imaging-in-a-post-rp-patient-with-previous-salvage-prostate-bed-radiotherapy weekly 0.8 https://www.themednet.org/what-dose-constraints-would-you-use-if-reirradiating-the-prostate-using-sbrt weekly 0.8 https://www.themednet.org/how-would-you-treat-a-seminoma-if-orchiectomy-showed-a-burned-out-primary-with-positive-pelvic-and-paraaortic-lymph-nodes weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-clear-cell-renal-cancer-who-has-progressed-on-immunotherapy-and-developed-bleeding-on-cabozantinib weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-an-optic-glioma-in-an-adult weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-to-a-young-adult-with-undifferentiated-embryonal-sarcoma-of-the-liver weekly 0.8 https://www.themednet.org/is-there-an-absolute-igm-level-in-an-asymptomatic-patient-on-surveillance-that-initiation-of-therapy-would-be-considered-for-waldenstroms-macroglobulinemia weekly 0.8 https://www.themednet.org/how-do-you-determine-when-to-transition-off-pegloticase-to-other-uric-acid-lowering-therapies weekly 0.8 https://www.themednet.org/how-do-you-approach-transaminase-elevations-with-use-of-allopurinol-in-gout weekly 0.8 https://www.themednet.org/do-you-recommend-trilaciclib-as-primary-prophylaxis-for-myelosuppression-in-certain-patients-with-es-sclc-treated-with-first-line-chemo-immunotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-for-arthritis-associated-with-multicentric-reticulohistiocytosis weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-tamoxifen-in-premenopausal-woman-with-high-grade-dcis-and-familial-chek2-mutation-who-had-bilateral-mastectomies weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-drug-induced-thrombotic-microangiopathy weekly 0.8 https://www.themednet.org/what-is-the-current-opinion-on-g-csf-usage-for-aml-patients-during-induction-and-consolidation-phases-of-treatment weekly 0.8 https://www.themednet.org/what-would-be-your-treatment-approach-for-a-patient-with-a-new-pet-positive-para-aortic-node-3-months-following-completion-of-definitive-chemoradiation-for-locally-advanced-cervical-cancer weekly 0.8 https://www.themednet.org/when-do-you-consider-starting-hypertonic-saline-solution-in-patients-with-an-acute-ischemic-stroke weekly 0.8 https://www.themednet.org/how-do-you-treat-paroxysmal-phenomena-such-as-paroxysmal-dysarthria-or-dyskinesia-in-multiple-sclerosis weekly 0.8 https://www.themednet.org/how-often-do-you-monitor-thiamine-levels-in-a-myelofibrosis-patient-taking-fedratinib weekly 0.8 https://www.themednet.org/do-you-consider-splenic-response-as-adequate-to-judge-efficacy-of-jak2-inhibitors-in-myeloproliferative-disorders weekly 0.8 https://www.themednet.org/how-would-you-approach-chronic-isolated-severe-non-cyclic-neutropenia-with-negative-bone-marrow-and-rheumatologic-work-up weekly 0.8 https://www.themednet.org/do-you-routinely-monitor-cea-in-addition-to-ca-19-9-in-patients-with-pancreatic-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-radiation-in-scc-of-oral-cavity-with-exposed-bone-following-mandibulectomy-and-reconstruction weekly 0.8 https://www.themednet.org/what-immunosuppressive-agents-aside-from-steroids-would-you-use-to-treat-bronchiolitis-obliterans-in-a-patient-with-long-standing-seropositive-ra weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-a-iiic2-figo-grade-2-endometrial-cancer-with-1-7-positive-para-aortic-lymph-nodes weekly 0.8 https://www.themednet.org/how-do-you-manage-cancer-treatment-related-cognitive-change-or-chemo-brain weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-for-enlarging-bilateral-acoustic-schwannomas weekly 0.8 https://www.themednet.org/what-surveillance-plan-would-you-recommend-for-stage-iv-melanoma-patients-who-achieve-a-cr-or-stable-pr-response-with-immunotherapy weekly 0.8 https://www.themednet.org/does-apocrine-differentiation-ar-positivity-alter-your-radiation-recommendations-for-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-isolated-metastatic-high-grade-sarcoma-to-inguinal-and-external-nodes-in-a-patient-with-brca-mutation weekly 0.8 https://www.themednet.org/what-are-the-benefits-and-risks-of-using-medical-marijuana-for-cancer-related-symptoms weekly 0.8 https://www.themednet.org/what-chemotherapy-would-you-utilize-for-a-metastatic-dysgerminoma-diagnosed-in-the-second-trimester-of-pregnancy weekly 0.8 https://www.themednet.org/what-further-genetic-testing-would-you-perform-on-a-pediatric-patient-with-cyclic-neutropenia-who-is-negative-for-the-most-common-associated-mutations weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-ssc-ild-in-a-patient-on-immune-checkpoint-therapy weekly 0.8 https://www.themednet.org/how-do-you-decide-on-first-line-treatment-for-a-patient-with-metastatic-colon-cancer-with-dmmr-a-her2-mutation-and-no-mutations-in-kras-or-braf weekly 0.8 https://www.themednet.org/how-do-you-approach-screening-for-inflammatory-bowel-disease-prior-to-starting-il-17-inhibitors weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-isolated-local-recurrence-of-head-and-neck-cancer-with-a-pharyngocutaneous-fistula-within-previously-irradiated-field weekly 0.8 https://www.themednet.org/in-cases-in-which-oncotype-dx-test-is-not-available-how-do-you-decide-which-patients-with-hr-and-her2-breast-cancer-are-candidates-for-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-is-the-preferred-regimen-for-aya-patients-with-t-cell-lymphoblastic-lymphoma weekly 0.8 https://www.themednet.org/with-new-data-showing-similar-outcomes-of-mismatched-unrelated-donor-and-haploidentical-related-donor-allogeneic-transplants-using-post-transplant-cyclophosphamide-how-does-one-decide-which-donor-is-optimal weekly 0.8 https://www.themednet.org/what-is-your-preferred-second-line-therapy-for-patients-with-metastatic-large-cell-neuroendocrine-carcinoma-of-the-lung-after-progression-on-first-line-chemo-immunotherapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-bone-modifying-agent-and-frequency-of-dosing-in-patients-with-breast-cancer-and-bony-metastases weekly 0.8 https://www.themednet.org/is-there-evidence-that-oral-contraceptive-pills-are-less-effective-in-pre-menopausal-women-on-tamoxifen-chemoprevention weekly 0.8 https://www.themednet.org/how-is-pediatric-and-young-adult-primary-bone-lymphoma-risk-stratified weekly 0.8 https://www.themednet.org/is-there-a-role-for-antibody-testing-to-confirm-vaccine-response-for-patients-on-rituximab-after-covid-19-vaccination weekly 0.8 https://www.themednet.org/when-giving-single-agent-docetaxel-for-patients-with-metastatic-nsclc-who-have-progressed-on-platinum-and-immunotherapy-do-you-stop-after-6-cycles-or-do-you-continue-as-long-as-tolerated-and-disease-is-stable weekly 0.8 https://www.themednet.org/how-do-you-approach-evaluation-of-pulmonary-vein-thrombosis weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-cerebral-venous-sinus-thrombosis-in-a-patient-with-severe-thrombocytopenia weekly 0.8 https://www.themednet.org/how-should-a-patient-with-perforated-h-pylori-negative-gastric-malt-be-managed weekly 0.8 https://www.themednet.org/would-you-consider-bone-marrow-transplant-in-a-pediatric-patient-with-recurrent-hlh-with-no-identified-exogenous-trigger-or-hlh-associated-mutation weekly 0.8 https://www.themednet.org/what-is-your-decision-process-on-decreasing-the-sodium-goal-for-patients-with-cerebral-edema weekly 0.8 https://www.themednet.org/when-do-you-initiate-immunosuppressant-drugs-for-patients-with-a-diagnosis-of-myasthenia-gravis weekly 0.8 https://www.themednet.org/what-is-your-approach-for-adjuvant-endocrine-therapy-in-a-female-with-hr-breast-cancer-with-history-of-provoked-dvt-while-on-ocps weekly 0.8 https://www.themednet.org/when-do-you-consider-re-treatment-with-lenalidomide-in-later-line-therapy-for-relapsed-multiple-myeloma weekly 0.8 https://www.themednet.org/how-would-you-proceed-after-complete-response-to-carboplatin-paclitaxel-bevacizumab-in-a-patient-who-presented-with-distantly-recurrent-scc-of-the-cervix weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-cover-the-upper-cord-when-treating-a-high-grade-glioma-involving-the-posterior-fossa weekly 0.8 https://www.themednet.org/do-you-routinely-obtain-bone-marrow-biopsy-in-newly-diagnosed-autoimmune-hemolytic-anemia-when-working-up-potential-underlying-etiologies weekly 0.8 https://www.themednet.org/how-do-you-approach-gi-prophylaxis-e-g-ppis-h2-blockers-in-patients-on-long-term-nsaids weekly 0.8 https://www.themednet.org/what-is-your-approach-for-treating-mononeuritis-multiplex-in-patients-with-anca-vasculitis weekly 0.8 https://www.themednet.org/does-calcinosis-appear-differently-in-patients-with-dermatomyositis-compared-to-systemic-sclerosis weekly 0.8 https://www.themednet.org/what-is-your-preferred-adjuvant-treatment-option-for-a-patient-with-stage-iii-braf-mutated-melanoma-and-a-history-of-a-solid-organ-transplantation-on-immunosuppressants weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-patient-with-incidental-diagnosis-of-at-least-high-intermediate-risk-endometrial-cancer-found-on-robotic-hysterectomy-with-non-contained-uterine-morcellation-and-no-node-sampling weekly 0.8 https://www.themednet.org/would-sbrt-be-recommended-for-a-non-surgical-isolated-para-aortic-recurrence-in-the-setting-of-metastatic-papillary-serous-ovarian-cancer-residual-disease-after-systemic-therapy weekly 0.8 https://www.themednet.org/how-does-evidence-of-cerebral-amyloid-angiopathy-microbleeds-affect-choices-for-secondary-stroke-prevention-in-patients-with-a-history-of-ischemic-stroke-and-atrial-fibrillation weekly 0.8 https://www.themednet.org/how-do-you-advise-a-patient-with-vte-on-indefinite-anticoagulants-regarding-the-ad26-cov2-s-johnson-johnson-janssen-covid-vaccine weekly 0.8 https://www.themednet.org/would-you-treat-the-pelvis-in-a-high-risk-prostate-cancer-patient-who-is-anticipating-pelvic-kidney-transplantation weekly 0.8 https://www.themednet.org/do-you-recommend-adjuvant-treatment-for-nodal-isolated-tumor-cells-in-an-otherwise-low-risk-endometrial-cancer weekly 0.8 https://www.themednet.org/in-a-patient-with-localized-tnbc-how-would-you-decide-in-whom-to-perform-breast-mri-prior-to-starting-neoadjuvant-systemic-therapy weekly 0.8 https://www.themednet.org/in-patients-with-ret-fusion-positive-nsclc-with-symptomatic-brain-metastases-would-you-consider-starting-selpercatinib-pralsetinib-upfront-or-would-you-proceed-with-whole-brain-radiation-with-tki-to-follow weekly 0.8 https://www.themednet.org/what-recommendations-are-you-giving-when-patients-ask-about-the-best-cancer-diet-to-be-on weekly 0.8 https://www.themednet.org/what-is-your-approach-to-immunotherapy-related-pancreatitis weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-immunotherapy-after-nephrectomy weekly 0.8 https://www.themednet.org/are-there-any-data-for-second-line-nivolumab-ipilimumab-in-patients-with-metastatic-nsclc-treated-with-either-single-agent-pembrolizumab-or-chemotherapy-ici-as-first-line-therapy weekly 0.8 https://www.themednet.org/would-you-consider-de-escalating-treatment-to-endocrine-therapy-alone-in-a-patient-with-prolonged-ned-on-cdk-4-6-inhibitor-endocrine-therapy weekly 0.8 https://www.themednet.org/how-will-you-decide-among-the-options-of-either-carbo-gem-avelumab-or-checkpoint-monotherapy-for-cisplatin-ineligible-pd-l1-expressing-urothelial-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-approach-an-isolated-cns-relapse-of-aml-in-a-young-child-under-the-age-of-5 weekly 0.8 https://www.themednet.org/what-strategies-have-you-found-to-be-most-effective-in-engaging-pcps-in-a-primary-care-or-shared-care-model-of-survivorship-for-pediatric-and-aya-patients-who-will-receive-ongoing-care-in-their-communities-away-from-their-primary-oncology-treatment-site weekly 0.8 https://www.themednet.org/how-do-you-manage-random-off-periods-in-patients-with-parkinsons-disease-who-are-otherwise-having-good-control-of-their-motor-symptoms weekly 0.8 https://www.themednet.org/what-target-volume-and-dose-would-you-boost-for-inflammatory-breast-cancer-with-prepectoral-saline-implant weekly 0.8 https://www.themednet.org/what-is-the-role-of-inpatient-psychiatric-or-psychological-evaluation-in-patients-who-have-had-acute-function-change-as-an-inpatient weekly 0.8 https://www.themednet.org/how-do-you-approach-monitoring-of-patients-found-to-have-a-positive-anti-dsdna-antibody-without-other-clinical-evidence-of-sle weekly 0.8 https://www.themednet.org/for-which-head-and-neck-cancer-patients-do-you-or-your-dental-colleagues-recommend-fluoride weekly 0.8 https://www.themednet.org/how-would-you-manage-leptomeningeal-disease-of-the-spine-in-the-setting-of-prior-wbrt weekly 0.8 https://www.themednet.org/do-you-have-a-size-cutoff-for-liver-sbrt weekly 0.8 https://www.themednet.org/what-neoadjuvant-chemotherapy-would-you-consider-for-squamous-cell-carcinoma-arising-from-a-ruptured-tailgut-cyst weekly 0.8 https://www.themednet.org/how-do-you-incorporate-integrative-medicine-into-the-field-of-pediatric-hematology-oncology weekly 0.8 https://www.themednet.org/how-do-you-modify-tnbc-neoadjuvant-chemotherapy-in-patients-with-multiple-sclerosis weekly 0.8 https://www.themednet.org/are-there-any-clinical-scenarios-in-which-you-would-treat-brca-mutated-her2-negative-metastatic-breast-cancer-with-a-parp-inhibitor-in-combination-with-carboplatin weekly 0.8 https://www.themednet.org/how-would-you-manage-anastomotic-site-recurrence-of-colon-cancer-3-years-after-resection-of-a-t3n0-tumor-without-high-risk-features weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-eosinophilic-fasciitis-refractory-to-glucocorticoids-and-methotrexate weekly 0.8 https://www.themednet.org/how-often-do-you-follow-ferritin-and-organ-iron-deposition-in-a-patient-who-has-known-hereditary-hemochromatosis-but-no-current-evidence-of-iron-overload weekly 0.8 https://www.themednet.org/what-is-the-optimal-initial-therapy-and-management-of-erdheim-chester-disease-without-actionable-mutations-such-as-braf-or-mapk-erk-pathway-alterations weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-blepharospasm-regarding-driving weekly 0.8 https://www.themednet.org/when-do-you-consider-a-levodopa-trial-in-patients-with-new-onset-dystonia weekly 0.8 https://www.themednet.org/do-you-use-the-highest-or-most-recent-psa-for-risk-stratification-for-newly-diagnosed-prostate-cancer weekly 0.8 https://www.themednet.org/in-a-patient-with-hr-breast-cancer-who-is-not-able-to-tolerate-adjuvant-ai-or-standard-dose-tamoxifen-due-to-side-effects-would-you-consider-a-lower-dose-of-tamoxifen weekly 0.8 https://www.themednet.org/how-do-you-utilize-immunoglobulin-testing-to-affect-treatment-decisions-in-patients-with-myeloma weekly 0.8 https://www.themednet.org/what-is-the-indication-for-phlebotomy-in-compound-heterozygous-hemochromatosis weekly 0.8 https://www.themednet.org/what-are-your-preferred-strategies-to-manage-mild-to-moderate-rectal-ulceration-causing-tenesmus-and-discomfort-after-chemoradiation-for-rectal-adenocarcinoma weekly 0.8 https://www.themednet.org/how-do-you-decide-the-right-time-for-mitraclip-intervention-in-patients-with-symptomatic-heart-failure-and-severe-mitral-regurgitation-who-are-on-maximally-tolerated-gdmt weekly 0.8 https://www.themednet.org/do-you-recommend-giving-iv-albumin-with-furosemide-to-augment-diuresis-in-a-patient-with-hypoalbuminemia-and-volume-overload weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-immunotherapy-in-a-patient-with-high-risk-rcc-with-new-worsening-post-op-renal-dysfunction-and-crcl-30 weekly 0.8 https://www.themednet.org/do-you-routinely-prescribe-acetazolamide-for-patients-with-cystinuria-who-do-not-have-significant-urinary-alkalinization-or-are-intolerant-to-citrate-therapy weekly 0.8 https://www.themednet.org/how-long-do-you-continue-antibiotics-after-cholecystostomy-tube-placement-for-acute-cholecystitis weekly 0.8 https://www.themednet.org/would-you-omit-post-lumpectomy-radiotherapy-for-high-clinical-risk-but-low-molecular-risk-dcis weekly 0.8 https://www.themednet.org/do-you-recommend-a-kidney-biopsy-for-patients-who-develop-acute-kidney-injury-after-starting-sacituzumab weekly 0.8 https://www.themednet.org/is-there-a-role-for-chemotherapy-for-asymptomatic-well-differentiated-papillary-mesothelioma-or-multicystic-mesothelioma weekly 0.8 https://www.themednet.org/how-do-you-manage-an-intramedullary-benign-nerve-sheath-tumor-post-sub-total-resection-seen-on-post-operative-mri weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-psa-persistence-after-ralp-demonstrating-metastasis-in-regional-lymph-nodes-without-further-evidence-of-disease-on-bone-or-ct-scans weekly 0.8 https://www.themednet.org/when-do-you-use-mri-to-further-evaluate-patients-with-non-traumatic-subdural-hemorrhage weekly 0.8 https://www.themednet.org/what-are-your-management-strategies-for-patients-with-nephrolithiasis-and-hypercalciuria-who-have-a-severe-sulfa-drug-allergy-and-are-unable-to-tolerate-thiazide-diuretics weekly 0.8 https://www.themednet.org/how-have-you-incorporated-led-light-therapies-in-your-practice weekly 0.8 https://www.themednet.org/what-topical-regimens-do-you-recommend-for-redness-related-to-rosacea-in-patients-who-defer-laser-treatments weekly 0.8 https://www.themednet.org/are-there-other-therapies-such-as-sglt2-inhibitors-or-alpha-lipoic-acid-that-you-are-offering-your-patients-with-cystinuria-who-continue-to-have-active-stone-disease-despite-conservative-therapy-and-thiol-based-agents weekly 0.8 https://www.themednet.org/would-you-hold-cgrp-calcitonin-gene-related-peptide-monoclonal-antibodies-such-as-eptinezumab-jjmr-vyepti-before-during-or-after-lung-sbrt weekly 0.8 https://www.themednet.org/are-there-concerns-with-combining-anti-il5-biologics-mepolizumab-or-benralizumab-for-severe-asthma-with-other-biologics-for-ra weekly 0.8 https://www.themednet.org/would-you-offer-pmrt-when-the-only-indication-is-a-focally-positive-margin weekly 0.8 https://www.themednet.org/would-you-ever-considering-de-escalating-therapy-in-any-way-for-women-with-inflammatory-breast-cancer-who-had-a-complete-pathologic-response-after-surgery weekly 0.8 https://www.themednet.org/when-do-you-consider-spinal-cord-stimulator-for-patients-with-neuropathic-pain weekly 0.8 https://www.themednet.org/would-you-consider-exploratory-surgery-in-a-young-patient-with-normocalcemic-hyperparathyroidism-that-meets-one-or-more-criteria-for-parathyroidectomy-but-has-no-localized-pathology-on-advanced-neck-imaging weekly 0.8 https://www.themednet.org/what-specific-clinical-factors-would-drive-you-to-recommend-surgical-intervention-for-patients-with-small-nonfunctional-pituitary-adenomas-who-exhibit-no-neurological-symptoms weekly 0.8 https://www.themednet.org/do-you-give-adjuvant-chemotherapy-for-an-incidental-cholangiocarcinoma-found-at-time-of-liver-transplant-done-for-hcc-or-other-reason-in-the-explanted-liver weekly 0.8 https://www.themednet.org/have-you-incorporated-the-use-of-steroids-for-patients-with-severe-community-acquired-pneumonia weekly 0.8 https://www.themednet.org/what-serologic-biomarkers-do-you-send-to-assess-for-sarcoidosis-at-baseline-and-or-during-flares-in-patients-where-it-may-correlate-with-disease-activity weekly 0.8 https://www.themednet.org/how-do-you-sequence-treatment-for-a-patient-following-r2-resection-of-a-large-extremity-leiomyosarcoma-who-has-small-lung-nodules-concerning-for-metastatic-disease-but-not-yet-biopsy-proven weekly 0.8 https://www.themednet.org/how-do-you-approach-monitoring-when-using-combination-jak-inhibitors-and-methotrexate-in-ra weekly 0.8 https://www.themednet.org/should-glp1-r-agonists-be-used-as-first-line-glucose-lowering-agents-in-patients-with-eskd-and-dm2 weekly 0.8 https://www.themednet.org/would-you-consider-glp1-r-agonist-therapy-in-a-patient-with-a-history-of-severe-gallstone-pancreatitis-that-is-now-post-cholecystectomy weekly 0.8 https://www.themednet.org/would-you-avoid-chemotherapy-in-a-postmenopausal-woman-age-65-with-t3-hr-her2-negative-with-oncotype-dx-25 weekly 0.8 https://www.themednet.org/in-what-clinical-scenarios-should-we-use-the-2-day-2mg-dst-instead-of-the-1mg-overnight-dst-for-screening-of-cushing-syndrome weekly 0.8 https://www.themednet.org/what-clinical-sign-or-symptom-do-you-consider-to-be-the-most-specific-for-cushing-syndrome weekly 0.8 https://www.themednet.org/what-is-a-reasonable-way-to-treat-statin-induced-myalgia-and-what-statin-substitute-would-you-consider-using-in-the-event-the-myalgia-is-not-resolved weekly 0.8 https://www.themednet.org/how-do-you-approach-the-decision-to-use-terlipressin-in-a-patient-with-hepatorenal-syndrome-type-1-aki-and-a-history-of-heart-failure-given-its-potential-cardiovascular-effects weekly 0.8 https://www.themednet.org/how-are-you-dosing-ivig-following-bcma-car-t-or-bispecific-antibodies-in-multiple-myeloma weekly 0.8 https://www.themednet.org/does-a-low-serofast-rpr-titer-such-as-1-1-or-1-2-in-the-setting-of-a-remote-history-of-appropriately-treated-latent-syphilis-in-a-patient-with-now-uveitis-of-yet-unknown-etiology-referred-from-ophthalmology-for-possible-ocular-syphilis-make-a-diagnosis-of weekly 0.8 https://www.themednet.org/given-the-new-2022-who-classification-of-pituitary-tumors-should-we-be-regularly-counseling-our-patients-about-the-risk-of-malignancy-for-what-we-previously-referred-to-as-pituitary-adenomas-but-now-classified-as-pituitary-neuroendocrine-tumors-pitnets weekly 0.8 https://www.themednet.org/do-you-treat-a0b1-rejection-noted-on-surveillance-bronchoscopy-in-a-patient-less-than-one-year-post-lung-transplant weekly 0.8 https://www.themednet.org/do-you-recommend-avoiding-esas-in-pregnant-patients-with-anemia-of-chronic-kidney-disease-who-also-have-preeclampsia weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-for-a-patient-with-t2n0-er-pr-her2-negative-breast-cancer-with-planned-tc-treatment-following-a-hypersensitivity-reaction weekly 0.8 https://www.themednet.org/does-your-evaluation-of-a-young-person-with-spontaneous-upper-extremity-dvt-vary-as-compared-to-lower-extremity-dvt weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-adult-patients-with-cvid-and-sarcoid-like-syndrome weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-use-for-a-multiply-recurrent-and-now-unresectable-ameloblastoma-involving-the-masticator-space-pterygopalatine-fossa-and-right-maxillary-sinus weekly 0.8 https://www.themednet.org/in-patients-with-concurrent-cad-and-atrial-fibrillation-more-than-1-year-post-pci-the-most-recent-aha-acc-guidelines-state-that-oral-anticoagulation-monotherapy-is-recommended-over-the-continuation-of-oral-anticoagulant-therapy-and-a-single-antiplatelet-t weekly 0.8 https://www.themednet.org/what-is-your-preferred-topical-retinoid-for-acne weekly 0.8 https://www.themednet.org/how-do-you-counsel-nccn-low-and-very-low-risk-prostate-cancer-patients-who-receive-a-high-risk-decipher-score weekly 0.8 https://www.themednet.org/how-do-you-manage-desmoplastic-trichilemmoma weekly 0.8 https://www.themednet.org/do-you-screen-children-with-sickle-cell-disease-for-silent-cerebral-infarcts weekly 0.8 https://www.themednet.org/is-there-still-a-role-for-mtor-inhibitors-in-metastatic-rcc-in-the-immunotherapy-tki-era weekly 0.8 https://www.themednet.org/how-do-you-manage-concurrent-non-life-threatening-hemoptysis-and-acute-pulmonary-embolism weekly 0.8 https://www.themednet.org/how-do-you-adjust-your-hba1c-goal-for-managing-diabetes-in-elderly-patients-with-multiple-chronic-illnesses-but-no-limitations-in-performing-self-care-tasks weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-immunotherapy-after-salvage-neck-dissection-for-persistent-nodal-disease-after-definitive-chemort-for-a-patient-with-p16-oropharyngeal-scc weekly 0.8 https://www.themednet.org/how-would-you-approach-first-line-treatment-in-metastatic-nsclc-for-a-patient-with-alk-eml4-v3a-b-variant-and-msi-high-status weekly 0.8 https://www.themednet.org/would-you-prescribe-a-thiazide-diuretic-for-patients-with-recurrent-nephrolithiasis-attributed-to-hypercalciuria-in-the-setting-of-excess-dietary-sodium-or-animal-protein-intake-who-fail-or-are-unwilling-to-adhere-to-recommended-dietary-changes weekly 0.8 https://www.themednet.org/what-is-your-approach-to-determining-recurrent-versus-rai-refractory-differentiated-thyroid-cancer-in-patients-presenting-with-metastatic-disease-several-years-after-surgery weekly 0.8 https://www.themednet.org/when-and-how-do-you-taper-off-cabergoline-therapy-for-treatment-of-microprolactinoma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-tumor-bed-boost-in-early-stage-breast-cancer-patients-with-micrometastasis weekly 0.8 https://www.themednet.org/following-cardiac-mri-what-imaging-modality-would-you-consider-to-further-evaluate-mild-aortic-regurgitation-regurgitant-fraction-on-cardiac-mri-of-26-and-mild-to-moderate-mitral-regurgitation-secondary-to-mild-bi-leaflet-mitral-valve-prolapse-rf-30-with- weekly 0.8 https://www.themednet.org/when-do-you-consider-patients-with-acute-stroke-with-large-vessel-occlusion-with-very-low-aspects-scores-less-than-3-for-endovascular-thrombectomy weekly 0.8 https://www.themednet.org/do-you-utilize-robotic-bronchoscopy-to-biopsy-a-lung-cavity-wall weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-undifferentiated-pleomorphic-sarcoma-encasing-the-spinal-cord-post-radiation-for-neurological-deficits-for-further-management weekly 0.8 https://www.themednet.org/how-do-you-approach-ovarian-function-suppression-in-premenopausal-women-with-hr-her2-node-negative-breast-cancer-and-intermediate-oncotype-dx-scores-11-25-who-received-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-no-history-of-miscarriage-but-who-is-unable-to-conceive-who-has-a-positive-lupus-anticoagulant-without-diagnosis-of-antiphospholipid-syndrome weekly 0.8 https://www.themednet.org/what-subset-of-sickle-cell-disease-patients-are-you-offering-sickle-cell-disease-gene-therapy weekly 0.8 https://www.themednet.org/are-you-including-bortezomib-as-standard-of-care-in-the-upfront-treatment-of-t-lymphoblastic-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-treat-metastatic-breast-cancer-which-is-hr-positive-her2-negative-with-pik3ca-and-high-tumor-mutational-burden-10-who-progressed-after-prior-et-cdk-4-6-and-pik3ca-inhibitor-therapy weekly 0.8 https://www.themednet.org/given-that-high-coronary-calcium-scores-portend-significantly-increased-cardiac-mortality-rates-over-5-6-years-is-there-any-data-to-support-performing-coronary-angiography-when-the-score-is-very-high-e-g-over-1000-even-in-asymptomatic-patients-with-no-obj weekly 0.8 https://www.themednet.org/how-would-you-manage-a-radiation-induced-sarcoma-of-the-spinal-cord-following-r1-resection weekly 0.8 https://www.themednet.org/what-do-you-advise-regarding-the-timing-and-safety-of-major-surgery-in-patients-with-moderate-to-severe-intracranial-atherosclerosis weekly 0.8 https://www.themednet.org/how-do-you-approach-weakly-positive-pl-7-antibody-in-a-patient-who-initially-presented-with-muscle-weakness-rhabdomyolysis-and-non-specific-muscular-edema-on-mri-that-resolved-with-iv-fluids weekly 0.8 https://www.themednet.org/how-small-of-a-nodule-would-you-attempt-to-biopsy-with-robotic-bronchoscopy weekly 0.8 https://www.themednet.org/is-methacholine-challenge-on-its-way-out weekly 0.8 https://www.themednet.org/what-is-your-preferred-beta-blocker-for-management-of-arrhythmias-and-or-htn-during-pregnancy weekly 0.8 https://www.themednet.org/in-male-patients-in-their-60s-who-had-a-single-episode-of-paf-24-hours-terminated-spontaneously-or-with-beta-blockers-without-recurrence-on-30-day-monitoring-and-without-reversible-triggers-such-as-osa-should-lifelong-anticoagulation-be-started-when-they- weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-undetectable-mmr-titers-checked-prior-to-or-during-immunosuppression-and-a-history-of-mmr-vaccination-in-childhood weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-retroperitoneal-lymphadenopathy-that-has-been-biopsy-proven-metastatic-seminoma-who-is-not-a-candidate-for-orchiectomy-rplnd-or-systemic-therapy weekly 0.8 https://www.themednet.org/how-do-you-treat-a-patient-with-a-gram-negative-infection-with-resistance-to-imipenem-but-sensitivity-to-meropenem-and-negative-for-carbapenem-resistant-organism-by-xpert-carba-r-assay weekly 0.8 https://www.themednet.org/in-a-clinically-node-negative-early-stage-breast-cancer-patient-who-underwent-neoadjuvant-systemic-therapy-would-surgical-finding-of-fibrosis-suspicious-for-treatment-effect-in-sentinel-nodes-impact-your-rt-decision weekly 0.8 https://www.themednet.org/how-do-you-apply-the-cdc-prep-guidelines-for-cisgender-women-particularly-when-faced-with-underreported-risk-behaviors-or-uncertain-partner-hiv-status weekly 0.8 https://www.themednet.org/would-you-recommend-vip-x-4-cycles-over-ep-x-4-cycles-in-a-patient-with-good-risk-stage-iiib-seminoma-but-an-elevated-ldh-over-5x-upper-limit-of-normal-with-a-20-pack-year-smoking-history weekly 0.8 https://www.themednet.org/what-is-your-approach-to-differentiating-and-managing-dmard-induced-nodulosis-induced-by-methotrexate-or-leflunomide-for-example-from-de-novo-ra-nodules-in-seropositive-ra-patients weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-p53-mutated-mcl-who-has-progressed-after-a-btki-and-car-t-with-a-cd20-negative-clone weekly 0.8 https://www.themednet.org/do-you-have-your-patients-with-recurrent-nephrolithiasis-stop-supplements-such-as-turmeric weekly 0.8 https://www.themednet.org/what-is-the-current-paradigm-for-breast-cancer-diagnosed-with-isolated-metastases-prior-to-initial-treatment weekly 0.8 https://www.themednet.org/what-is-your-approach-to-recurrent-uric-acid-stone-formers-who-have-a-persistently-acidic-urine-ph-and-are-unable-to-tolerate-potassium-citrate weekly 0.8 https://www.themednet.org/do-you-consider-administration-of-nintedanib-or-pirfenidone-via-enteral-tube-in-patients-unable-to-take-po-due-to-recurrent-aspiration weekly 0.8 https://www.themednet.org/what-approach-do-you-use-when-treating-adult-diffuse-gliomas-with-h3-g34-mutations-now-classified-into-their-own-category-under-the-2021-glioma-guidelines weekly 0.8 https://www.themednet.org/how-would-you-approach-scc-of-unknown-primary-p16-ebv-metastatic-to-a-large-5-5-cm-level-2-neck-node-if-you-suspect-a-cutaneous-origin-after-clinical-workup weekly 0.8 https://www.themednet.org/in-people-who-have-had-a-single-detected-episode-of-atrial-fibrillation-but-none-documented-subsequently-is-there-any-consideration-for-increased-thrombolembolic-risk-just-from-altered-atrial-architecture-impaired-contractility weekly 0.8 https://www.themednet.org/would-you-add-abatacept-to-treat-active-inflammatory-arthritis-in-a-patient-with-history-of-ra-ild-who-is-already-taking-mycophenolate weekly 0.8 https://www.themednet.org/what-is-your-preferred-protocol-for-squaric-acid-sadbe-treatments-for-alopecia-areata-totalis weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-ishlt-2024 weekly 0.8 https://www.themednet.org/does-growth-hormone-gh-replacement-therapy-reduce-the-risk-of-fractures-in-patients-with-gh-deficiency weekly 0.8 https://www.themednet.org/do-you-routinely-check-a-tsh-level-in-patients-with-recurrent-kidney-stones-who-have-hypercalciuria-of-unknown-cause weekly 0.8 https://www.themednet.org/how-long-should-we-treat-patients-with-newly-diagnosed-myeloma-with-bisphosphonates-or-rankl-inhibitors-for-their-myeloma-bone-disease-given-recent-data weekly 0.8 https://www.themednet.org/how-would-you-post-operatively-manage-a-peripheral-stage-i-small-cell-lung-carcinoma-s-p-upfront-wedge-resection-with-an-r1-microscopic-positive-margin-along-the-staple-line-and-visceral-pleural-invasion weekly 0.8 https://www.themednet.org/what-is-your-approach-to-duration-of-systemic-antibiotics-for-treatment-of-isolated-bacterial-endophthalmitis-in-the-absence-of-bacteremia-or-other-deep-seated-metastatic-foci-of-infection weekly 0.8 https://www.themednet.org/do-you-utilize-gcsf-during-pelvic-chemoradiation-therapy-for-cervical-cancer-or-avoid-it-due-to-concern-for-paradoxical-neutropenia-from-concomitant-radiation-gcsf weekly 0.8 https://www.themednet.org/how-would-you-approach-choosing-a-regimen-for-a-patient-with-multiple-myeloma-refractory-to-daratumumab-and-lenalidomide-with-severe-neuropathy-from-bortezomib weekly 0.8 https://www.themednet.org/what-is-your-approach-to-differentiating-diabetes-insipidus-from-primary-polydipsia-in-the-outpatient-setting weekly 0.8 https://www.themednet.org/what-is-your-strategy-for-optimizing-hydroxyurea-dosage-in-patients-with-symptomatic-sickle-cell-disease-particularly-for-genotypes-hbss-and-hbs-beta-thal weekly 0.8 https://www.themednet.org/how-often-is-a-contrast-enhanced-brain-mri-truly-normal-in-the-setting-of-spontaneous-intracranial-hypotension weekly 0.8 https://www.themednet.org/what-volumes-would-you-cover-in-a-young-patient-with-otherwise-low-risk-breast-cancer-in-whom-the-sentinel-node-failed-to-map-and-alnd-was-not-performed weekly 0.8 https://www.themednet.org/when-do-you-consider-nerve-blocks-for-headache-management-in-patients-admitted-to-the-neuro-intensive-care-unit-with-subarachnoid-hemorrhage weekly 0.8 https://www.themednet.org/do-you-get-volumetric-mri-in-all-patients-with-cognitive-difficulties weekly 0.8 https://www.themednet.org/would-you-consider-starting-dual-antiplatelet-therapy-in-a-patient-with-evidence-of-petechial-hemorrhage-post-stroke-secondary-to-icad weekly 0.8 https://www.themednet.org/how-do-you-wean-off-of-primidone-in-patients-with-essential-tremors weekly 0.8 https://www.themednet.org/would-you-avoid-triptans-in-patients-with-cadasil weekly 0.8 https://www.themednet.org/when-do-you-initiate-migalastat-in-female-patients-with-genetic-evidence-of-heterozygous-fabry-disease weekly 0.8 https://www.themednet.org/what-workup-do-you-recommend-for-patients-with-symptoms-suggestive-of-saphenous-neuropathy weekly 0.8 https://www.themednet.org/do-you-recommend-thiamine-for-patients-presenting-with-acute-symptoms-of-tga weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patient-selection-for-cardioneuroablation-for-vasovagal-syncope weekly 0.8 https://www.themednet.org/what-are-your-management-strategies-for-malignant-pericardial-effusion-with-a-high-risk-of-spontaneous-hemorrhage-particularly-in-patients-requiring-anticoagulation-for-chronic-atrial-fibrillation weekly 0.8 https://www.themednet.org/in-a-patient-with-serous-ovarian-adenocarcinoma-who-presents-with-sbo-due-to-focal-involvement-of-the-small-bowel-but-who-has-other-extensive-metastases-and-cannot-get-chemotherapy-due-to-bone-marrow-compromise-would-you-recommend-palliative-rt-in-additio weekly 0.8 https://www.themednet.org/what-endocrine-therapy-would-you-recommend-to-a-premenopausal-female-with-early-stage-hr-breast-cancer-who-is-transitioning-from-female-to-male-and-currently-on-testosterone weekly 0.8 https://www.themednet.org/is-abi-ankle-brachial-index-lower-limb-arterial-doppler-not-recommended-if-patient-already-has-arterial-stents-in-the-legs-and-if-so-what-other-imaging-modality-would-you-consider-as-first-line weekly 0.8 https://www.themednet.org/in-a-patient-with-node-positive-limited-stage-small-cell-lung-cancer-how-do-you-approach-radiation-in-a-patient-whose-small-primary-tumor-resolves-after-one-cycle-of-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-adjust-your-management-strategy-to-address-the-unique-needs-of-anuric-end-stage-kidney-disease-patients-when-treating-diabetic-ketoacidosis weekly 0.8 https://www.themednet.org/did-nrg-lu004-demonstrate-safety-with-hypofractionated-lung-radiation-and-concurrent-ici weekly 0.8 https://www.themednet.org/how-do-you-determine-the-feasibility-of-doing-a-valve-in-valve-for-patients-requiring-avr-with-index-surgical-aortic-valve-replacement weekly 0.8 https://www.themednet.org/how-does-the-location-or-type-of-psoriasis-affect-your-initial-biologic-choice weekly 0.8 https://www.themednet.org/what-target-volumes-and-expansions-would-you-use-for-neoadjuvant-chemoradiotherapy-to-a-large-thymoma-with-the-goal-of-shrinking-the-tumor-to-aid-resectability weekly 0.8 https://www.themednet.org/what-constraints-do-you-use-for-the-bid-small-cell-lung-cancer-regimen weekly 0.8 https://www.themednet.org/how-often-and-in-what-way-do-you-monitor-patients-who-are-receiving-teprotumumab-tepezza-for-thyroid-eye-disease weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-recommend-the-maternal-rsv-vaccine-for-a-pregnant-patient-if-nirsevimab-will-also-be-available-for-the-infant-after-birth weekly 0.8 https://www.themednet.org/what-agents-do-you-utilize-for-mucociliary-clearance-during-the-index-hospitalization-of-patients-post-lung-transplant weekly 0.8 https://www.themednet.org/what-is-the-role-of-apol1-genotyping-in-the-evaluation-of-a-living-kidney-donor weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-of-patients-with-fulminant-c-difficile-infection-who-required-ileostomy-creation-or-colectomy weekly 0.8 https://www.themednet.org/have-you-incorporated-the-use-of-linezolid-in-lieu-of-vancomycin-plus-clindamycin-for-empiric-treatment-of-necrotizing-fasciitis weekly 0.8 https://www.themednet.org/how-long-do-you-treat-uncomplicated-gram-negative-rod-bacteremia-in-solid-organ-transplant-recipients weekly 0.8 https://www.themednet.org/what-adjuvant-systemic-therapy-would-you-give-a-patient-with-pn2-nodal-relapse-of-er-her2-breast-cancer-now-s-p-alnd-after-initial-mastectomy-adjuvant-tc-and-5-years-of-endocrine-therapy weekly 0.8 https://www.themednet.org/should-we-recommend-sglt2i-initiation-at-discharge-to-all-patients-hospitalized-with-acute-myocardial-infarction weekly 0.8 https://www.themednet.org/in-2024-do-you-consider-isolated-gain-1q-not-amp-1q-to-be-a-high-risk-cytogenetic-abnormality-in-multiple-myeloma weekly 0.8 https://www.themednet.org/what-are-the-implications-of-immunosuppressive-therapy-in-a-chronic-asymptomatic-t-cell-lymphopenic-adult-undergoing-lung-transplant-evaluation weekly 0.8 https://www.themednet.org/how-do-you-recommend-spacing-dosing-between-immunoglobulin-replacement-and-eculizmab-administration weekly 0.8 https://www.themednet.org/what-treatments-do-you-consider-for-cholinergic-urticaria-refractory-to-high-dose-h1-blockers-and-omalizumab weekly 0.8 https://www.themednet.org/would-you-favor-treating-hes-manifesting-with-eoe-with-dupilumab-or-anti-il5-therapy weekly 0.8 https://www.themednet.org/how-often-do-you-monitor-the-eosinophil-count-after-initiating-anti-il5-therapy-for-hes weekly 0.8 https://www.themednet.org/what-parasites-do-you-screen-for-in-your-workup-of-hes weekly 0.8 https://www.themednet.org/do-you-utilize-urinary-leukotrienes-as-a-marker-for-initiation-of-montelukast weekly 0.8 https://www.themednet.org/how-do-you-factor-smoking-history-into-biologic-selection-for-asthma-since-the-clinical-trials-generally-excluded-these-patients weekly 0.8 https://www.themednet.org/what-methods-have-you-found-successful-in-getting-young-children-to-use-nasal-sprays weekly 0.8 https://www.themednet.org/do-you-look-for-local-ige-production-in-the-nares-with-negative-spt-and-ige-testing-if-the-clinical-history-suggests-ar-and-the-patient-desires-ait weekly 0.8 https://www.themednet.org/is-addition-of-slit-likely-to-provide-additional-benefit-for-isolated-dust-mite-allergy-that-is-not-completely-treated-with-scit weekly 0.8 https://www.themednet.org/is-ait-safe-to-use-with-an-active-malignancy-such-as-ctcl weekly 0.8 https://www.themednet.org/is-asymptomatic-long-qt-syndrome-a-contraindication-for-starting-ait weekly 0.8 https://www.themednet.org/how-do-you-manage-introduction-of-other-seeds-when-the-patient-has-never-been-exposed-and-has-a-sesame-allergy weekly 0.8 https://www.themednet.org/do-you-avoid-use-of-inhalers-with-milk-protein-in-patients-with-a-milk-allergy weekly 0.8 https://www.themednet.org/does-gastric-bypass-increase-the-risk-of-developing-food-allergies weekly 0.8 https://www.themednet.org/do-you-recommend-im-kenalog-injection-for-refractory-crswnp-in-a-patient-already-on-maximal-therapy weekly 0.8 https://www.themednet.org/when-would-you-consider-initiating-antibiotic-sinus-rinses-for-recurrent-sinus-infections-assuming-no-other-underlying-pathology-and-normal-infunction weekly 0.8 https://www.themednet.org/are-systemic-effects-from-corticosteroid-use-greater-with-budesonide-rinses-compared-to-nasal-sprays weekly 0.8 https://www.themednet.org/do-you-recommend-food-elimination-diets-for-gi-eosinophilic-disorder-not-affecting-the-esophagus weekly 0.8 https://www.themednet.org/is-there-a-role-for-anti-il5-therapy-in-the-treatment-of-eoe weekly 0.8 https://www.themednet.org/is-there-a-role-for-omalizumab-in-a-patient-who-is-on-vit-but-still-experiences-anaphylaxis-to-stinging-insects weekly 0.8 https://www.themednet.org/are-drug-challenges-after-serum-sickness-like-reactions-useful-in-delabeling-the-allergy weekly 0.8 https://www.themednet.org/do-you-favor-24-hour-urinary-metabolites-over-random-urine-collection-when-screening-for-mcas weekly 0.8 https://www.themednet.org/do-you-diagnose-mcas-if-a-patient-is-concurrently-on-drugs-known-to-cause-non-specific-mast-cell-degranulation weekly 0.8 https://www.themednet.org/are-you-requiring-markers-other-than-lte4-to-be-elevated-to-diagnose-mcas weekly 0.8 https://www.themednet.org/do-patients-with-a-peg-allergy-have-a-contraindication-to-receiving-mrna-vaccines weekly 0.8 https://www.themednet.org/what-functional-assays-do-you-recommend-to-determine-if-mgrprx2-receptor-activation-has-led-to-a-non-ige-mediated-anaphylaxis weekly 0.8 https://www.themednet.org/do-you-continue-to-check-tryptase-levels-in-your-patients-with-idiopathic-anaphylaxis-despite-normal-levels-5-on-repeated-checks weekly 0.8 https://www.themednet.org/how-would-you-treat-a-sarcoid-patient-whose-only-manifestations-are-b-symptoms-and-generalized-lymphadenopathy weekly 0.8 https://www.themednet.org/would-you-treat-a-completely-resected-stage-ia-nsclc-egfr-exon-19-with-adjuvant-osimertinib-alone-omitting-chemotherapy weekly 0.8 https://www.themednet.org/do-you-avoid-esas-in-patients-with-anemia-and-chronic-kidney-disease-who-also-have-factor-v-leiden weekly 0.8 https://www.themednet.org/which-genomic-test-do-you-choose-for-a-patient-with-favorable-intermediate-prostate-cancer-trying-to-decide-between-active-surveillance-and-treatment weekly 0.8 https://www.themednet.org/do-you-recommend-hypofractionated-radiotherapy-for-elderly-and-or-poor-kps-patients-with-diffuse-idh-mutant-grade-2-glioma-by-extrapolation-from-high-grade-glioma-trials weekly 0.8 https://www.themednet.org/how-long-after-surgical-repair-of-a-pleuroperitoneal-leak-do-you-resume-peritoneal-dialysis weekly 0.8 https://www.themednet.org/should-there-be-a-role-for-sacubitril-valsartan-in-the-management-of-patients-with-heart-failure-with-preserved-ejection-fraction weekly 0.8 https://www.themednet.org/do-you-start-patients-on-a-b-complex-multivitamin-if-they-are-on-crrt-and-have-not-previous-been-on-renal-replacement-therapy weekly 0.8 https://www.themednet.org/what-is-the-consensus-on-giving-pemivibart-for-pre-exposure-covid-prophylaxis-in-immunocompromised-patients weekly 0.8 https://www.themednet.org/would-you-give-treatment-to-a-male-patient-with-subjective-dysuria-but-no-objective-pyuria-with-ureaplasma-urealyticum-detected-by-pcr-from-urine weekly 0.8 https://www.themednet.org/do-you-consider-late-latent-syphilis-adequately-treated-if-a-patient-receives-a-10-14-day-course-of-iv-ceftriaxone-for-another-indication weekly 0.8 https://www.themednet.org/under-which-circumstances-would-you-prefer-ropeginterferon-over-hydroxyurea-for-patients-with-polycythemia-vera weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-patients-with-new-laboratory-evidence-of-hypopituitarism-e-g-very-low-plasma-acth-level-and-low-morning-serum-cortisol-and-a-remote-history-of-trans-sphenoidal-surgery-for-nfpa weekly 0.8 https://www.themednet.org/what-is-your-approach-to-safely-performing-hemodialysis-in-a-patient-with-a-fistula-who-is-hospitalized-for-altered-mental-status-and-unable-to-remain-still weekly 0.8 https://www.themednet.org/what-is-the-management-strategy-for-patients-who-develop-aki-and-nephrotic-range-proteinuria-secondary-to-biopsy-proven-fsgs-during-immune-checkpoint-inhibitor-therapy weekly 0.8 https://www.themednet.org/would-you-consider-teriparatide-use-in-a-patient-with-prior-radiation-therapy-given-that-the-black-box-warning-regarding-osteosarcoma-risk-has-been-removed-by-the-fda weekly 0.8 https://www.themednet.org/what-is-your-experience-with-gelclair-for-oral-mucositis-during-head-neck-radiotherapy weekly 0.8 https://www.themednet.org/when-do-you-decide-to-use-liothyronine-t3-for-augmentation-in-treatment-for-treatment-resistant-depression-and-how-do-you-implement-it weekly 0.8 https://www.themednet.org/how-do-you-approach-managing-clozapine-in-patients-who-are-critically-ill weekly 0.8 https://www.themednet.org/what-policies-do-you-take-regarding-legalized-recreational-marijuana-or-medical-marijuana-use-in-transplant-patients weekly 0.8 https://www.themednet.org/what-is-your-approach-to-using-ketamine-for-agitation-in-the-ed-setting weekly 0.8 https://www.themednet.org/what-do-you-consider-when-selecting-an-antipsychotic-medication-for-acute-agitation weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-vaping-cessation-as-compared-to-smoking-cessation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-a-patient-with-egodystonic-pedophilia-thoughts weekly 0.8 https://www.themednet.org/when-do-you-select-cholinesterase-inhibitors-vs-nmda-antagonist-medications-in-patients-with-moderate-alzheimers-dementia weekly 0.8 https://www.themednet.org/how-do-you-manage-stroke-related-abulia weekly 0.8 https://www.themednet.org/how-do-you-differentiate-down-syndrome-disintegrative-disorder-from-alzheimers-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-the-psychiatric-symptom-management-of-huntingtons-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-pain-management-needs-for-patients-well-established-on-buprenorphine-naloxone weekly 0.8 https://www.themednet.org/how-do-you-manage-antipsychotic-induced-prolactinemia weekly 0.8 https://www.themednet.org/how-do-you-approach-neuromodulation-in-postpartum-depression weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-regarding-using-stimulants-for-attention-deficit-hyperactivity-disorder-during-pregnancy weekly 0.8 https://www.themednet.org/how-do-you-approach-tapering-electroconvulsive-therapy-after-an-acute-treatment-course-leading-to-successful-resolution-of-symptoms-for-treatment-resistant-depression weekly 0.8 https://www.themednet.org/what-is-your-approach-to-antiviral-treatment-of-hsv-acute-retinal-necrosis weekly 0.8 https://www.themednet.org/does-the-degree-of-elevation-in-free-light-chains-ratio-correlate-with-a-probability-of-al-amyloidosis weekly 0.8 https://www.themednet.org/how-do-you-choose-between-eculizumab-and-ravulizumab-for-patients-with-acute-kidney-injury-from-complement-mediated-thrombotic-microangiopathy weekly 0.8 https://www.themednet.org/is-there-any-evidence-regarding-bone-density-gains-fracture-reduction-in-the-setting-of-treatment-with-romosozumab-after-a-two-year-course-of-teriparatide weekly 0.8 https://www.themednet.org/what-are-some-practical-tips-for-caring-for-resource-limited-patients-with-severe-hurley-stage-iii-hidradenitis-suppurativa weekly 0.8 https://www.themednet.org/is-there-any-indication-for-monitoring-for-renal-medullary-carcinoma-in-patients-with-sickle-cell-trait weekly 0.8 https://www.themednet.org/what-range-of-musculoskeletal-complaints-have-you-seen-with-romosozumab-use weekly 0.8 https://www.themednet.org/do-you-routinely-perform-in-office-urine-microscopy-for-your-patients-with-recurrent-nephrolithiasis weekly 0.8 https://www.themednet.org/how-do-you-track-objective-clinical-response-to-treatment-in-cidp weekly 0.8 https://www.themednet.org/would-you-offer-neoadjuvant-chemotherapy-prior-to-trimodality-therapy-in-a-fit-patient-who-refuses-surgery-for-muscle-invasive-bladder-cancer weekly 0.8 https://www.themednet.org/when-would-you-phlebotomize-patients-with-secondary-hemochromatosis-such-as-due-to-nafld-cirrhosis weekly 0.8 https://www.themednet.org/which-screening-method-for-diabetes-do-you-consider-to-be-the-most-sensitive weekly 0.8 https://www.themednet.org/would-you-consider-skipping-intravenous-thrombolysis-in-patients-with-tandem-occlusions-who-qualify-for-endovascular-thrombectomy weekly 0.8 https://www.themednet.org/are-patients-with-mibc-and-bladder-neck-involvement-good-candidates-for-bladder-preservation-with-chemoradiation-after-maximal-but-not-complete-turbt weekly 0.8 https://www.themednet.org/what-is-your-approach-to-withdrawal-of-ventilatory-support-at-the-end-of-life weekly 0.8 https://www.themednet.org/how-do-you-factor-in-a-negative-tilt-table-test-in-the-workup-for-patients-with-suspected-autonomic-dysfunction weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-chemotherapy-for-a-patient-with-hr-her2-breast-cancer-luminal-type-a-on-mammaprint-after-knowing-that-the-patient-had-a-poor-response-to-neoadjuvant-endocrine-therapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-asymptomatic-orn-of-the-mandible weekly 0.8 https://www.themednet.org/do-you-usually-recommend-a-modified-diet-for-clostridioides-difficile-infection-cdi weekly 0.8 https://www.themednet.org/do-you-periodically-check-a-urine-culture-for-patients-without-dysuria-but-who-have-a-history-of-struvite-kidney-stones-and-urinary-tract-infections-with-urease-producing-organisms weekly 0.8 https://www.themednet.org/do-you-use-oral-fosfomycin-as-a-treatment-option-for-uncomplicated-cystitis-due-to-esbl-producing-e-coli weekly 0.8 https://www.themednet.org/do-you-give-additional-pneumococcal-vaccines-after-a-dose-of-pcv20-in-patients-with-asplenia weekly 0.8 https://www.themednet.org/would-you-recommend-lymph-node-biopsy-in-a-patient-with-scc-of-the-right-ventral-tongue-1-cm-post-excision-with-close-margins-and-no-noted-adenopathy-on-imaging weekly 0.8 https://www.themednet.org/do-you-recommend-sending-an-autoimmune-work-up-for-patients-with-recurrent-nephrolithiasis-and-24-hour-urine-chemistries-consistent-with-distal-renal-tubular-acidosis weekly 0.8 https://www.themednet.org/is-dosimetry-more-important-than-preparation-ie-rhtsh-versus-thw-when-treating-thyroid-cancer-with-radioactive-iodine-therapy weekly 0.8 https://www.themednet.org/what-specific-markers-or-symptoms-guide-your-decision-to-adjust-or-stop-prophylactic-calcium-supplementation-and-calcitriol-in-managing-postoperative-hypoparathyroidism-following-thyroidectomy weekly 0.8 https://www.themednet.org/how-do-you-decide-between-ct-and-ultrasound-imaging-tests-for-surveillance-imaging-for-patients-with-recurrent-nephrolithiasis weekly 0.8 https://www.themednet.org/do-you-recommend-parathyroid-adenoma-resection-or-ablation-for-patients-with-primary-hyperparathyroidism-and-recurrent-nephrolithiasis-who-are-found-to-have-a-single-gland-adenoma-on-parathyroid-ultrasound-and-nuclear-medicine-imaging weekly 0.8 https://www.themednet.org/do-you-recommend-neuromodulation-treatments-with-an-implantable-device-for-patients-with-chronic-painful-diabetic-neuropathy-who-have-not-responded-to-common-oral-therapies-such-as-gabapentin-and-amitriptyline weekly 0.8 https://www.themednet.org/what-is-your-preferred-initial-imaging-choice-for-a-patient-suspected-of-having-renal-artery-stenosis-who-does-not-have-any-contraindications-to-imaging-contrast-media weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-pulmonary-fibrosis-in-patients-with-a-history-of-microscopic-polyangiitis-who-do-not-have-other-active-organ-involvement weekly 0.8 https://www.themednet.org/do-you-adhere-to-the-standard-5-day-minimum-treatment-duration-for-community-acquired-pneumonia-or-have-you-used-shorter-courses-for-certain-low-risk-patients weekly 0.8 https://www.themednet.org/do-you-caution-against-starting-biologics-for-psoriasis-if-patient-has-hepatitis-a-antibodies weekly 0.8 https://www.themednet.org/what-is-your-approach-to-anticoagulation-in-patients-with-hypertrophic-cardiomyopathy-and-an-apical-aneurysm weekly 0.8 https://www.themednet.org/do-you-wait-on-initiating-biologic-therapy-for-guttate-psoriasis weekly 0.8 https://www.themednet.org/how-would-you-treat-an-elderly-male-with-history-of-mantle-cell-lymphoma-who-relapsed-after-chemoimmunotherapy-and-cbtki-w-multiple-co-morbidities-including-ckd-and-chf-w-low-ef weekly 0.8 https://www.themednet.org/are-there-instances-where-you-would-use-c5-complement-inhibitors-for-isolated-elevation-of-sc5b-9-in-the-absence-of-other-ta-tma-features weekly 0.8 https://www.themednet.org/what-dose-and-duration-of-steroid-therapy-do-you-employ-while-starting-mycophenolate-in-an-outpatient-with-relatively-stable-ctd-ild weekly 0.8 https://www.themednet.org/what-is-a-reasonable-class-of-antihypertensive-to-start-in-patients-with-hcm-who-remain-hypertensive-and-symptomatic-in-spite-of-maximal-doses-of-beta-blockade-or-calcium-channel-blockers weekly 0.8 https://www.themednet.org/is-there-a-need-to-bridge-a-patient-with-a-history-of-factor-v-leiden-on-systemic-anticoagulation-such-as-a-doac-prior-to-elective-low-rise-procedures-such-as-colonoscopy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-recurrent-nephrolithiasis-and-hypercalciuria-who-are-unable-to-tolerate-thiazide-diuretics-due-to-hyperglycemia weekly 0.8 https://www.themednet.org/can-milwaukee-shoulder-present-with-a-large-subacromial-bursitis-or-does-it-predominantly-cause-joint-effusion-destruction weekly 0.8 https://www.themednet.org/what-is-your-approach-to-use-of-d-mannose-for-prevention-of-recurrent-uncomplicated-cystitis weekly 0.8 https://www.themednet.org/what-factors-would-you-consider-when-deciding-between-tamoxifen-vs-ofs-ai-in-premenopausal-women-with-early-stage-hr-breast-cancer weekly 0.8 https://www.themednet.org/do-you-preferentially-avoid-use-of-piperacillin-tazobactam-for-empiric-anti-pseudomonal-coverage-in-hospitalized-patients-due-to-risk-of-nephrotoxicity weekly 0.8 https://www.themednet.org/for-patients-with-metastatic-cancer-on-a-systemic-therapy-regimen-that-includes-bevacizumab-are-you-comfortable-treating-brain-metastases-srs-or-wbrt-without-holding-bevacizumab weekly 0.8 https://www.themednet.org/what-is-the-optimal-treatment-for-adenocarcinoma-of-the-vulva weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-a-prior-intracerebral-hemorrhage-from-probable-cerebral-amyloid-angiopathy-who-develop-new-small-vessel-ischemic-infarcts weekly 0.8 https://www.themednet.org/would-you-offer-local-therapy-with-either-sbrt-or-y-90-in-a-patient-with-metastatic-er-her2-low-breast-cancer-with-two-oligometastatic-liver-lesions-currently-on-ai-cdk4-6-inhibitor weekly 0.8 https://www.themednet.org/do-you-take-any-special-approaches-with-patients-with-recurrent-nephrolithiasis-who-first-developed-stones-prior-to-adulthood-but-have-negative-kidney-stone-disorder-genetic-test-findings weekly 0.8 https://www.themednet.org/what-is-your-radiation-dose-volume-for-adjuvant-treatment-of-a-clear-cell-odontogenic-carcinoma-of-the-mandible-after-segmental-resection weekly 0.8 https://www.themednet.org/do-you-always-comment-on-va-and-kco-when-reading-pfts-when-gas-transfer-is-ordered weekly 0.8 https://www.themednet.org/is-there-a-risk-of-hepatitis-c-activation-with-rituximab-in-a-patient-who-has-a-history-of-hcv-treated-with-antivirals-and-who-is-in-sustained-viral-response weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-offer-pmrt-in-a-patient-with-dcis weekly 0.8 https://www.themednet.org/what-is-your-approach-for-de-escalation-of-antiarrhythmics-for-patients-with-a-history-of-ventricular-arrhythmias weekly 0.8 https://www.themednet.org/is-there-a-role-of-maximizing-gdmt-medications-for-patients-with-durable-vads weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-systemic-therapy-for-recurrent-fallopian-tube-leiomyosarcoma-after-resection-of-an-isolated-liver-metastasis-that-presented-within-1-year-from-primary-surgery weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-persistent-hyperphosphatemia-in-eskd-patients-who-are-non-adherent-to-phosphate-binders weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-ild-in-the-presence-of-weakly-positive-rf-and-ana-but-no-other-objective-systemic-findings-of-connective-tissue-disease weekly 0.8 https://www.themednet.org/do-you-routinely-ask-for-removal-of-a-indwelling-central-line-picc-or-tunneled-catheter-in-a-patient-with-pseudomonal-bacteremia-from-known-source-with-otherwise-appropriate-clinical-improvement-on-anti-pseudomonal-antibiotic-therapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-duration-of-fidaxomicin-in-a-patient-receiving-treatment-for-first-c-difficile-infection-while-also-receiving-concurrent-antibiotics-for-an-infection weekly 0.8 https://www.themednet.org/do-you-use-combination-antibiotic-therapy-for-treatment-of-bacterial-endocarditis-due-to-gram-negative-bacilli weekly 0.8 https://www.themednet.org/how-do-you-approach-restarting-cdmards-bdmards-in-a-patient-with-active-ra-after-incidence-of-disseminated-cns-vzv-infection-while-on-tofacitinib weekly 0.8 https://www.themednet.org/when-would-you-use-proximal-complement-inhibitors-like-pegcetacoplan-over-terminal-complement-inhibitors-for-initial-treatment-of-paroxysmal-nocturnal-hemoglobinuria weekly 0.8 https://www.themednet.org/if-a-patient-diagnosed-with-seminoma-after-orchiectomy-has-margin-positive-disease-noted-in-the-spermatic-cord-and-no-overt-metastasis-on-imaging-and-normal-tumor-markers-how-should-this-patient-be-staged weekly 0.8 https://www.themednet.org/when-would-you-administer-the-next-maintenance-dose-of-rituximab-in-a-patient-with-anca-glomerulonephritis-who-last-received-an-infusion-six-months-ago-and-has-low-immunoglobulin-levels-and-an-undetectable-cd-19-cell-count weekly 0.8 https://www.themednet.org/does-your-decision-to-start-or-continue-ozempic-therapy-in-patients-with-diabetic-retinopathy-depend-on-the-severity-of-the-retinopathy weekly 0.8 https://www.themednet.org/how-do-you-approach-symptom-control-in-a-patient-with-diffuse-cutaneous-systemic-sclerosis-dcssc-and-rapidly-progressive-skin-disease weekly 0.8 https://www.themednet.org/do-you-hold-anticoagulation-prior-to-performing-bronchoalveolar-lavage weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-recurrent-nephrolithiasis-and-hypercalciuria-who-take-daily-calcium-supplements weekly 0.8 https://www.themednet.org/what-would-be-your-threshold-to-recommend-tee-guided-dccv-in-a-patient-who-has-remained-in-atrial-fibrillation-in-the-post-operative-period-following-cabg-who-has-achieved-adequate-amiodarone-loading-dose weekly 0.8 https://www.themednet.org/would-you-consider-a-d2-gastrectomy-in-young-fit-patients-with-gastric-adenocarcinoma-and-positive-peritoneal-cytology-without-macroscopic-disease-if-cytology-turned-negative-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-way-of-administering-nivolumab-ipilimumab-in-gi-cancers weekly 0.8 https://www.themednet.org/for-isolated-and-very-high-lipoprotein-a-levels-ldl-of-140-has-an-lp-a-100-in-a-patient-with-no-cardiac-symptoms-or-risk-factors-would-you-start-lipid-lowering-treatment-such-as-with-a-pcsk9i-if-they-develop-statin-intolerance weekly 0.8 https://www.themednet.org/do-you-routinely-take-a-cancer-history-from-patients-being-evaluated-for-atopy weekly 0.8 https://www.themednet.org/how-do-you-reconcile-the-lack-of-os-benefit-in-the-clear-trial-comparing-lenvatinib-pembrolizumab-to-sunitinib-to-the-very-impressive-orr-and-mpfs-benefit-seen weekly 0.8 https://www.themednet.org/would-you-consider-palliative-rt-in-the-setting-of-tumor-causing-osteonecrosis-in-an-elderly-patient weekly 0.8 https://www.themednet.org/are-you-using-vaginal-dilators-during-treatment-of-rectal-cancer-to-spare-anterior-vaginal-wall-or-are-you-reserving-this-for-anal-cancers weekly 0.8 https://www.themednet.org/when-and-how-do-you-deviate-from-efgartigimod-vyvgart-dosing-from-the-drug-label-recommendation-of-weekly-infusions-for-four-weeks-in-patients-with-myasthenia-gravis weekly 0.8 https://www.themednet.org/what-antibiotics-would-you-use-for-empiric-treatment-of-a-brain-abscess-in-patients-allergic-to-penicillin-metronidazole-and-vancomycin weekly 0.8 https://www.themednet.org/do-you-perform-routine-pelvic-exams-on-patients-undergoing-active-treatment-for-gynecologic-cancer-without-gyn-symptoms weekly 0.8 https://www.themednet.org/how-would-you-best-evaluate-and-manage-a-patient-with-hemiplegic-migraine-and-a-history-of-ischemic-stroke weekly 0.8 https://www.themednet.org/would-you-recommend-a-neck-soft-collar-after-a-cervical-internal-carotid-artery-dissection weekly 0.8 https://www.themednet.org/do-you-avoid-empagliflozin-in-patients-with-history-of-amputation weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-a-patient-with-active-ra-and-a-history-of-lynch-syndrome weekly 0.8 https://www.themednet.org/would-history-of-breast-cancer-deter-you-from-using-ospemifene-for-severe-vaginal-dryness-dyspareunia weekly 0.8 https://www.themednet.org/do-you-use-the-peri-operative-management-of-biologics-and-dmards-guidelines-which-were-mainly-based-on-total-hip-and-knee-replacement-surgeries-for-all-peri-operative-surgical-management weekly 0.8 https://www.themednet.org/how-soon-after-radioactive-iodine-therapy-for-hyperthyroidism-should-methimazole-be-resumed weekly 0.8 https://www.themednet.org/how-would-you-treat-a-late-local-recurrence-of-extramammary-pagets-disease-of-the-vulva-not-amenable-to-resection weekly 0.8 https://www.themednet.org/why-do-the-most-recent-nccn-guidelines-version-4-2024-05-17-24-omit-the-duration-of-adt-for-high-risk-prostate-cancer-patients weekly 0.8 https://www.themednet.org/how-often-do-you-monitor-plasma-oxalate-levels-for-patients-with-eskd-secondary-to-primary-hyperoxaluria-who-are-on-hemodialysis-and-receiving-lumasiran weekly 0.8 https://www.themednet.org/how-do-you-approach-the-workup-of-clinically-diagnosed-cutaneous-vasculitis-in-healthy-young-individuals-without-systemic-symptoms weekly 0.8 https://www.themednet.org/how-do-you-utilize-corticosteroids-in-the-management-of-cidp weekly 0.8 https://www.themednet.org/when-do-you-recommend-the-use-of-oral-testosterone-replacement-over-injectable-testosterone weekly 0.8 https://www.themednet.org/would-you-consider-once-weekly-radiation-with-a-simultaneous-integrated-boost-for-a-patient-with-node-negative-breast-cancer-with-a-positive-margin-for-whom-reexcision-is-not-an-option weekly 0.8 https://www.themednet.org/do-you-obtain-spot-urine-protein-or-24-hour-urine-protein-quantification-studies-in-pregnant-patients-who-are-found-to-have-proteinuria-on-a-standard-urinalysis-test weekly 0.8 https://www.themednet.org/do-you-use-spo2-to-define-ards-in-patients-with-darker-skin-pigmentation weekly 0.8 https://www.themednet.org/do-you-consider-use-of-convalescent-plasma-early-in-disease-course-in-covid-19-induced-ards-in-mechanically-ventilated-patients weekly 0.8 https://www.themednet.org/do-you-use-bronchodilator-response-to-distinguish-between-asthma-copd-or-asthma-copd-overlap weekly 0.8 https://www.themednet.org/are-there-instances-when-you-recommend-femoral-vein-dialysis-catheter-placement-in-patients-newly-started-on-hemodialysis-in-an-effort-to-preserve-upper-extremity-future-fistula-options weekly 0.8 https://www.themednet.org/would-you-use-olaparib-after-progression-on-an-arpi-for-a-patient-with-somatic-palb2-mutated-mcrpc weekly 0.8 https://www.themednet.org/how-do-you-decide-between-treating-with-neoadjuvant-nivolumab-ipilimumab-versus-neoadjuvant-pembrolizumab-for-patients-with-resectable-clinical-node-stage-iii-melanoma-given-the-nadina-trial-results weekly 0.8 https://www.themednet.org/how-does-omalizumab-play-a-role-in-the-armamentarium-of-atopic-dermatitis weekly 0.8 https://www.themednet.org/will-you-incorporate-ensifentrine-in-the-treatment-regimen-of-patients-with-copd-on-baseline-dual-or-triple-inhaler-therapy weekly 0.8 https://www.themednet.org/do-you-favor-aggressive-airway-clearance-regimens-or-bronchoscopy-for-clearing-occluding-mucous-plugs-in-patients-who-are-not-in-respiratory-distress weekly 0.8 https://www.themednet.org/is-there-still-a-role-for-direct-laryngoscopy-in-the-intubation-of-patients-in-the-icu weekly 0.8 https://www.themednet.org/what-is-your-recommended-rheumatic-disease-evaluation-for-a-pediatric-patient-presenting-with-interstitial-keratitis-and-a-negative-infectious-disease-workup-e-g-hsv-syphilis-lyme weekly 0.8 https://www.themednet.org/do-you-recommend-routine-ophthalmologic-exam-for-all-patients-with-hypervirulent-klebsiella-pneumoniae-bacteremia weekly 0.8 https://www.themednet.org/would-you-offer-consolidative-radiotherapy-for-oligometastatic-nsclc weekly 0.8 https://www.themednet.org/how-often-do-you-pursue-malignant-transformation-screening-in-patients-with-lymphomatoid-papulosis-or-pityriasis-lichenoides weekly 0.8 https://www.themednet.org/how-do-you-dose-oral-tranexamic-acid-for-melasma weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-use-andexanet-andexxa-for-intracranial-hemorrhage-associated-with-factor-xa-inhibitors weekly 0.8 https://www.themednet.org/is-the-p-tau217-plasma-test-used-as-a-surrogate-for-amyloid-pet-scan-or-csf-testing-when-considering-starting-leqembi-in-patients-with-alzheimers-disease weekly 0.8 https://www.themednet.org/do-you-prefer-sodium-bicarbonate-or-sodium-citrate-in-your-chronic-kidney-disease-patients-with-metabolic-acidosis weekly 0.8 https://www.themednet.org/what-therapies-have-you-had-success-with-in-treating-carp-when-they-have-failed-minocycline weekly 0.8 https://www.themednet.org/based-on-the-imroz-and-benefit-data-would-you-recommend-quadruplet-therapy-for-non-transplant-eligible-newly-diagnosed-multiple-myeloma weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-test-for-hypercortisolism-in-a-patient-with-insulin-resistance weekly 0.8 https://www.themednet.org/how-long-do-you-wait-to-repeat-a-24-hour-urine-stone-risk-study-after-stopping-topiramate-in-patient-with-recurrent-calcium-based-kidney-stones-attributed-to-the-medication weekly 0.8 https://www.themednet.org/have-you-noticed-poor-response-to-tyvaso-dpi-compared-to-the-nebulized-form-in-ph-ild weekly 0.8 https://www.themednet.org/what-clinical-and-pathologic-features-do-you-use-to-discern-whether-2-synchronous-lung-nodules-biopsy-proven-lung-adenocarcinoma-are-different-primaries-versus-metastatic-disease weekly 0.8 https://www.themednet.org/how-would-you-treat-a-young-premenopausal-female-with-triple-negative-inflammatory-breast-cancer-who-progressed-on-carboplatin-paclitaxel-pembrolizumab-keynote-522-but-didnt-receive-anthracycline-portion-and-has-a-positive-brca2-mutation weekly 0.8 https://www.themednet.org/does-the-degree-of-hormone-receptor-positivity-influence-your-decision-to-perform-oncotype-testing weekly 0.8 https://www.themednet.org/does-biotin-interfere-with-the-measurement-of-other-metabolites-of-the-vitamin-d-pathway-outside-of-the-25-hydroxy-vitamin-d-assay weekly 0.8 https://www.themednet.org/what-hemoglobin-level-do-you-target-for-adult-beta-thalassemia-intermedia-patients-with-a-pre-transfusion-hb-7-g-dl weekly 0.8 https://www.themednet.org/have-you-used-karius-to-aid-in-the-diagnosis-of-a-non-resolving-pneumonia-with-negative-bronchoscopy-biopsy-and-other-infectious-work-up-in-an-immunocompetent-patient weekly 0.8 https://www.themednet.org/how-do-you-identify-the-subset-of-heart-failure-patients-who-are-likely-to-benefit-from-cardiac-resynchronization-therapy-in-the-setting-of-an-rbbb-pattern weekly 0.8 https://www.themednet.org/under-which-circumstances-is-there-a-role-for-reduction-in-immunosuppression-post-sot-in-a-patient-with-recurrent-cmv-viremia-and-or-disease weekly 0.8 https://www.themednet.org/in-those-patients-who-are-initiated-on-omalizumab-for-multiple-food-allergies-how-long-should-you-wait-before-performing-baked-egg-and-baked-milk-challenges weekly 0.8 https://www.themednet.org/what-is-your-approach-to-work-up-for-patients-referred-for-early-onset-osteoarthritis weekly 0.8 https://www.themednet.org/how-do-you-treat-triple-positive-essential-thrombocythemia-with-evidence-of-fibrosis-on-bone-marrow-biopsy-but-does-not-meet-diagnostic-criteria-for-myelofibrosis weekly 0.8 https://www.themednet.org/do-you-feel-comfortable-using-jak-inhibitors-in-patients-with-a-strong-family-history-of-cad-but-no-other-risk-factors weekly 0.8 https://www.themednet.org/how-often-should-lupus-anticoagulant-be-checked-in-patients-with-sle-if-prior-was-negative-or-if-prior-was-positive weekly 0.8 https://www.themednet.org/how-do-you-manage-fanconis-syndrome-and-polyuria-related-to-ifosfamide weekly 0.8 https://www.themednet.org/how-reliable-is-the-frax-score-for-assessing-risk-of-osteoporotic-fractures weekly 0.8 https://www.themednet.org/would-a-metal-endobronchial-stent-within-the-treatment-field-change-your-radiation-treatment-plan-for-a-thoracic-malignancy weekly 0.8 https://www.themednet.org/what-treatment-would-you-recommend-for-a-patient-with-non-mutated-stage-iii-lung-squamous-cell-carcinoma-with-relapse-following-neoadjuvant-chemoimmunotherapy-surgery-and-during-adjuvant-immunotherapy weekly 0.8 https://www.themednet.org/in-those-patients-who-are-initiated-on-omalizumab-for-multiple-food-allergies-once-baked-egg-and-baked-milk-are-introduced-into-the-diet-how-long-should-you-wait-until-a-prepared-egg-and-whole-milk-challenge-is-conducted weekly 0.8 https://www.themednet.org/are-there-any-varying-treatment-considerations-to-make-when-managing-patients-with-carbonate-apatite-versus-hydroxyapatite-kidney-stones weekly 0.8 https://www.themednet.org/how-do-you-approach-cosmetic-removals-of-labial-melanocytic-macules weekly 0.8 https://www.themednet.org/do-5ht4-agonists-such-as-metoclopramide-actually-lead-to-improvement-in-symptoms-for-patients-with-diabetes-related-gastroparesis weekly 0.8 https://www.themednet.org/how-do-you-treat-metastatic-large-cell-neuroendocrine-carcinoma-of-prostate-with-undetectable-psa-who-had-the-treatment-related-transformation-while-on-adt-monotherapy weekly 0.8 https://www.themednet.org/in-patients-presenting-with-classical-findings-of-primary-hyperparathyroidism-i-e-mild-hypercalcemia-high-24hr-urine-calcium-elevated-1-25-vit-d-but-normal-pth-can-spontaneous-normalization-of-calcium-be-explained-by-episodic-hypersecretion-of-pth weekly 0.8 https://www.themednet.org/what-is-your-approach-for-patients-with-recurrent-nephrolithiasis-who-require-daily-use-of-acetazolamide-for-management-of-an-unrelated-chronic-condition weekly 0.8 https://www.themednet.org/how-do-you-manage-intradural-extramedullary-metastases-of-the-spinal-cord-from-non-cns-malignancies weekly 0.8 https://www.themednet.org/do-shorter-door-to-balloon-d2b-times-impact-outcomes-in-stemi-if-its-already-less-than-90-minutes-and-to-what-degree-i-e-30-vs-60-minutes-would-have-a-more-significant-impact weekly 0.8 https://www.themednet.org/do-you-treat-tumefactive-multiple-sclerosis-differently-than-other-forms-of-ms-both-in-the-acute-and-maintenance-phase weekly 0.8 https://www.themednet.org/what-features-on-cta-mra-are-most-helpful-for-differentiating-large-vessel-vasculitis-from-atherosclerosis weekly 0.8 https://www.themednet.org/how-do-you-decide-on-the-treatment-target-of-burst-suppression-pattern-vs-seizure-cessation-for-patients-with-status-epilepticus weekly 0.8 https://www.themednet.org/when-do-you-consider-ketamine-to-treat-nonconvulsive-status-epilepticus weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-treatment-of-visual-snow-syndrome weekly 0.8 https://www.themednet.org/do-you-recommend-stopping-triamterene-in-patients-with-recurrent-kidney-stones-who-have-stone-composition-results-consistent-with-calcium-based-stone-disease weekly 0.8 https://www.themednet.org/are-there-instances-when-you-recommend-against-a-kidney-biopsy-in-a-patient-with-a-single-kidney-who-otherwise-has-indications-for-a-biopsy-consents-and-has-no-medical-contraindications-for-the-procedure weekly 0.8 https://www.themednet.org/would-you-modify-your-treatment-approach-for-treating-an-hpv-positive-head-and-neck-cancer-in-a-patient-with-symptomatic-sjogrens weekly 0.8 https://www.themednet.org/would-you-recommend-genetic-testing-to-determine-if-there-is-a-potential-underlying-primary-process-in-a-patient-with-congenital-solitary-kidney-who-is-presumed-to-have-secondary-fsgs weekly 0.8 https://www.themednet.org/for-patients-diagnosed-with-t-cell-lymphoblastic-lymphoma-with-cns-involvement-csf-what-is-your-approach-to-the-typical-schedule-for-it-chemotherapy weekly 0.8 https://www.themednet.org/in-a-patient-with-acute-stroke-ich-sdh-hyperammonemia-at-risk-for-rebound-edema-with-new-onset-renal-failure-do-you-prefer-crrt-versus-low-and-slow-hd weekly 0.8 https://www.themednet.org/what-treatments-are-most-effective-for-muscle-cramps-and-stiffness-in-isaacs-syndrome-and-other-peripheral-nerve-hyperexcitability-disorders weekly 0.8 https://www.themednet.org/do-you-prefer-assessing-cystatin-c-or-creatinine-when-monitoring-a-patients-egfr-who-is-receiving-chemotherapy-for-malignancy weekly 0.8 https://www.themednet.org/would-you-escalate-therapy-in-a-patient-with-rheumatoid-arthritis-without-synovitis-but-a-new-rheumatoid-nodule weekly 0.8 https://www.themednet.org/do-you-prescribe-prophylactic-steroids-to-patients-receiving-radiosurgery-for-avms weekly 0.8 https://www.themednet.org/do-you-routinely-use-anti-resorptive-medications-in-patients-who-have-osteoporosis-and-longstanding-hypoparathyroidism weekly 0.8 https://www.themednet.org/how-do-you-treat-factor-xi-deficient-patients-with-surgery-or-trauma-related-bleeding-1 weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-if-any-is-best-for-mucinous-tubular-and-spindle-cell-carcinoma-of-the-kidney weekly 0.8 https://www.themednet.org/is-active-smoking-a-contraindication-to-starting-menopausal-hormone-therapy-hrt-in-a-post-menopausal-woman-with-severe-vasomotor-symptoms-and-no-other-cardiovascular-risk-factors weekly 0.8 https://www.themednet.org/for-patients-with-primary-cns-lymphoma-and-less-than-a-cr-to-chemotherapy-in-what-situation-would-you-consider-partial-or-focal-radiation weekly 0.8 https://www.themednet.org/does-cytotoxic-chemotherapy-affect-the-yield-of-germline-testing weekly 0.8 https://www.themednet.org/would-you-offer-hypofractionation-for-a-larger-avm weekly 0.8 https://www.themednet.org/how-would-you-manage-a-gastric-malt-patient-with-anemia-and-peri-gastric-and-abdominal-retrocaval-nodal-involvement weekly 0.8 https://www.themednet.org/do-you-recommend-adjusting-the-duration-of-a-drug-holiday-based-on-the-specific-bisphosphonate-used-when-treating-osteoporosis weekly 0.8 https://www.themednet.org/would-you-consider-reducing-the-dialysate-sodium-concentration-to-135-meq-l-as-a-strategy-to-decrease-interdialytic-weight-gain-in-a-hypervolemic-eskd-patient weekly 0.8 https://www.themednet.org/what-evaluation-do-you-do-in-patients-with-hypertension-and-persistently-elevated-aldosterone-renin-ratio-over-20-but-without-an-elevated-aldosterone-level-under-10-ng-dl weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-to-a-premenopausal-woman-with-hr-her2-negative-idc-t1cn0-with-isolated-tumor-cells-oncotype-rs-20-grade-2-with-multifocal-lvi weekly 0.8 https://www.themednet.org/when-performing-adrenal-vein-sampling-is-calculating-selectivity-index-using-androstenedione-superior-to-using-cortisol-alone-for-determining-successful-catheterization weekly 0.8 https://www.themednet.org/how-do-you-manage-arthritis-resulting-from-deferiprone-in-transfusion-dependent-thalassemia weekly 0.8 https://www.themednet.org/is-there-a-preferred-chemotherapy-regimen-for-chemo-mobilization-prior-to-hdct-for-a-patient-with-nsgct-with-prior-bep-and-tip weekly 0.8 https://www.themednet.org/what-is-your-approach-to-differentiating-tender-spots-as-in-fibromyalgia-and-enthesitis-as-in-axspa weekly 0.8 https://www.themednet.org/can-transudative-pleural-effusions-lead-to-trapped-lung weekly 0.8 https://www.themednet.org/for-a-patient-with-t3n1m0-esophageal-adenocarcinoma-who-suffered-esophageal-perforation-necessitating-metallic-stent-placement-would-you-favor-a-neoadjuvant-chemoradiation-or-perioperative-chemotherapy-approach weekly 0.8 https://www.themednet.org/what-has-been-your-approach-to-using-contrast-enhancement-agent-in-the-echo-lab-in-pregnant-patients-if-there-is-concern-for-lv-thrombus-or-poor-imaging-windows-for-lvef-valvular-disease-assessment weekly 0.8 https://www.themednet.org/do-you-recommend-dietary-protein-restriction-in-your-patients-with-chronic-kidney-disease weekly 0.8 https://www.themednet.org/when-using-fast-forward-how-important-is-it-for-the-treatment-to-be-delivered-monday-through-friday-in-one-week-as-opposed-to-spanning-a-weekend weekly 0.8 https://www.themednet.org/for-patients-who-have-previously-undergone-maze-ligation-presenting-with-paroxysmal-atrial-fibrillation-how-would-you-counsel-them-on-the-risk-of-stroke-long-term-when-deciding-whether-or-not-to-start-or-continue-anticoagulation weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-patient-with-checkpoint-inhibitor-induced-psoriatic-arthritis weekly 0.8 https://www.themednet.org/what-is-your-approach-for-cancer-screening-for-elderly-onset-ra weekly 0.8 https://www.themednet.org/what-is-your-approach-to-monitoring-blood-parasite-smears-in-an-immunocompetent-patient-with-babesiosis weekly 0.8 https://www.themednet.org/do-you-require-lupus-patients-with-eskd-or-advanced-ckd-to-be-on-minimal-immunosuppression-around-the-time-of-kidney-transplantation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-prescribing-ripe-for-6-month-vs-rifapentine-moxifloxacin-for-4-months-in-the-treatment-of-drug-sensitive-tb-in-the-us weekly 0.8 https://www.themednet.org/is-a-history-of-provoked-dvt-a-contraindication-to-starting-testosterone-replacement-therapy-in-a-middle-aged-man-with-symptomatic-hypogonadism-who-is-on-anti-coagulation weekly 0.8 https://www.themednet.org/do-you-prioritize-dietary-modifications-and-exercise-over-early-pharmacologic-interventions-such-as-metformin-or-insulin-for-women-diagnosed-with-gestational-diabetes weekly 0.8 https://www.themednet.org/is-there-a-role-for-routine-lp-in-hiv-patients-with-disseminated-histoplasmosis-even-in-the-absence-of-cns-signs-symptoms weekly 0.8 https://www.themednet.org/how-long-do-you-recommend-patients-hold-aspirin-for-prior-to-and-after-undergoing-a-native-kidney-biopsy weekly 0.8 https://www.themednet.org/in-a-patient-with-amyloidosis-and-abnormal-liver-function-but-child-pugh-a-would-you-still-proceed-with-sabr-for-a-liver-metastasis weekly 0.8 https://www.themednet.org/what-work-up-do-you-recommend-for-persistent-subclinical-hyperthyroidism-with-decreased-rai-uptake-and-negative-thyroid-antibody-tests weekly 0.8 https://www.themednet.org/what-are-your-recommendations-for-the-long-term-management-of-patients-who-have-experienced-takotsubo-cardiomyopathy-particularly-regarding-ongoing-medication-management-and-follow-up-imaging weekly 0.8 https://www.themednet.org/what-patient-population-is-most-likely-to-benefit-from-pill-in-pocket-strategy-for-management-of-paroxysmal-atrial-fibrillation-in-an-unmonitored-setting weekly 0.8 https://www.themednet.org/would-you-consider-ppm-implantation-for-patients-during-their-hospital-stay-following-tavr-if-they-were-to-develop-lengthening-pr-intervals-and-widening-lbbb-qrs-duration-exceeding-150ms-afterwards weekly 0.8 https://www.themednet.org/do-you-recommend-stopping-a-sglt2i-indefinitely-if-a-patient-with-chronic-kidney-disease-and-diabetes-develops-euglycemic-diabetic-ketoacidosis weekly 0.8 https://www.themednet.org/what-hotspot-and-heterogeneity-metrics-do-you-utilize-when-delivering-pmrt-to-a-patient-who-has-had-breast-reconstruction weekly 0.8 https://www.themednet.org/do-you-find-hzv-titers-useful-in-diagnosing-shingles-sine-herpete weekly 0.8 https://www.themednet.org/how-do-you-manage-osteoporosis-treatment-following-parathyroidectomy-for-primary-hyperparathyroidism weekly 0.8 https://www.themednet.org/do-you-recommend-initiating-a-potassium-sparing-diuretic-in-patients-with-recurrent-nephrolithiasis-who-have-hypercalciuria-but-do-not-tolerate-thiazide-diuretics weekly 0.8 https://www.themednet.org/would-you-consider-offering-adjuvant-olaparib-to-a-patient-with-early-stage-triple-negative-breast-cancer-ct3n0-ypt1an0-with-brca-vus-who-has-residual-disease-after-neoadjuvant-keynote-522-regimen weekly 0.8 https://www.themednet.org/in-a-patient-with-cardiac-comorbidities-who-meets-astro-apbi-criteria-other-than-a-positive-margin-would-you-offer-apbi-in-an-attempt-to-reduce-cardiac-dose weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-stoma-bag-adhesive-allergic-contact-dermatitis weekly 0.8 https://www.themednet.org/in-post-prostatectomy-patients-where-urinary-continence-is-never-achieved-how-and-when-would-you-plan-rt-when-it-is-clinically-indicated weekly 0.8 https://www.themednet.org/when-treating-a-bulky-squamous-cell-carcinoma-of-the-anal-canal-do-you-try-to-limit-the-dose-to-the-external-anal-sphincter-to-any-particular-number-to-reduce-the-risk-of-chronic-fecal-incontinence weekly 0.8 https://www.themednet.org/do-you-consider-prophylactically-increasing-eculizumab-frequency-for-pregnant-or-postpartum-pnh-patients weekly 0.8 https://www.themednet.org/are-you-comfortable-combining-palliative-radiotherapy-with-capivasertib-fulvestrant weekly 0.8 https://www.themednet.org/can-intra-abdominal-pressure-serve-as-a-surrogate-for-pleural-pressure-to-titrate-peep-in-obese-patients-or-those-with-intra-abdominal-hypertension weekly 0.8 https://www.themednet.org/how-do-you-decide-between-using-a-self-expanding-supraannular-valve-and-a-balloon-expandable-valve-for-tavr-in-patients-with-severe-aortic-stenosis-and-a-small-aortic-annulus weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-embolic-stroke-of-an-undetermined-source-and-a-papillary-fibroelastoma-found-on-an-echocardiogram weekly 0.8 https://www.themednet.org/how-would-you-treat-an-older-patient-with-multiple-co-morbidities-and-borderline-performance-status-with-resectable-esophageal-cancer-in-light-of-esopec-trial weekly 0.8 https://www.themednet.org/how-would-you-manage-a-cardiac-metastasis-from-merkel-cell-carcinoma weekly 0.8 https://www.themednet.org/is-there-a-role-for-cefpodoxime-for-treatment-of-acute-cystitis-caused-by-an-enterobacterales-isolate-with-resistance-to-cefazolin-but-susceptibility-to-ceftriaxone weekly 0.8 https://www.themednet.org/do-you-use-terlipressin-for-patients-with-hepatorenal-syndrome-who-also-have-elevated-blood-pressures weekly 0.8 https://www.themednet.org/what-cardiac-surveillance-would-you-do-for-an-asymptomatic-male-patient-with-a-remote-history-of-mantle-field-radiation-for-hodgkins-lymphoma weekly 0.8 https://www.themednet.org/will-you-incorporate-the-use-of-tirzepatide-in-the-management-of-patients-with-osa weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-subacute-thyroiditis-in-a-patient-presenting-with-recurrent-fevers weekly 0.8 https://www.themednet.org/what-treatment-approach-is-best-for-management-of-neutrophilic-dermatosis-in-a-patient-with-acute-myeloid-leukemia-any-suggestions-for-long-term-management weekly 0.8 https://www.themednet.org/do-you-prefer-monitoring-creatinine-over-cystatin-c-levels-in-patients-with-lymphoma-and-chronic-kidney-disease-given-the-potential-for-cystatin-c-levels-to-be-increased-with-certain-malignancies weekly 0.8 https://www.themednet.org/which-patients-with-stage-ii-iii-lung-adenocarcinoma-in-whom-you-are-considering-neoadjuvant-chemoimmunotherapy-can-you-rely-on-liquid-ngs-to-exclude-driver-mutations-in-lieu-of-repeat-tissue-biopsy weekly 0.8 https://www.themednet.org/would-you-consider-continuing-or-re-trialing-hydroxyurea-for-sickle-cell-patients-after-development-of-a-leg-ulcer weekly 0.8 https://www.themednet.org/do-you-use-direct-oral-anticoagulants-to-treat-port-a-cath-related-vte-in-patients-with-an-active-malignancy weekly 0.8 https://www.themednet.org/would-you-use-triplet-chemotherapy-flot-in-lieu-of-chemort-for-patients-with-localized-esophageal-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/which-patients-with-localized-esophageal-adenocarcinoma-if-any-would-you-offer-nivolumab-after-lack-of-pcr-to-neoadjuvant-flot weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-patients-with-recurrent-nephrolithiasis-and-nephrocalcinosis-in-the-setting-of-hypoparathyroidism weekly 0.8 https://www.themednet.org/is-there-a-role-for-radiation-in-biphenotypic-sinonasal-sarcoma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-de-escalation-of-asthma-therapy-if-patients-have-remained-clinically-stable-on-triple-inhaler-therapy-and-a-biologic-agent weekly 0.8 https://www.themednet.org/what-is-your-approach-to-tapering-therapy-in-patients-with-pulmonary-sarcoidosis-who-are-asymptomatic-with-stable-pulmonary-function-and-imaging weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-hidradenitis-suppurativa weekly 0.8 https://www.themednet.org/what-recommendations-would-you-make-for-a-patient-on-long-term-phenytoin-due-to-epilepsy-with-a-newly-diagnosed-breast-cancer-requiring-doxorubicin-as-part-of-her-chemotherapy weekly 0.8 https://www.themednet.org/what-chemotherapy-regimen-would-you-offer-to-a-patient-with-dlbcl-who-was-originally-diagnosed-and-treated-r-chop-15-years-ago-now-with-a-2nd-primary-late-recurrence-of-dlbcl weekly 0.8 https://www.themednet.org/in-obese-men-presenting-with-gynecomastia-elevated-estrogens-and-hypogonadism-what-clinical-factors-would-push-you-to-obtain-testicular-and-or-adrenal-imaging-to-rule-out-an-estrogen-producing-tumor weekly 0.8 https://www.themednet.org/do-you-hospitalize-patients-with-newly-diagnosed-lupus-nephritis-and-nephrotic-syndrome-if-you-are-able-to-provide-pulse-steroids-outpatient-and-follow-them-closely weekly 0.8 https://www.themednet.org/in-patients-with-differentiated-thyroid-cancer-do-you-consider-pathology-characteristics-not-found-in-the-ata-risk-stratification-guidelines-ie-microscopic-margins-or-multifocal-cancer-when-determining-recurrence-risk-and-management weekly 0.8 https://www.themednet.org/would-you-ever-omit-or-reduce-prostate-bed-radiation-in-a-post-prostatectomy-patient-who-develops-recurrence-in-pelvic-lns weekly 0.8 https://www.themednet.org/do-you-recommend-using-anastrazole-in-men-developing-gynecomastia-while-on-testosterone-replacement-treatment-for-hypogonadism-depending-on-pre-treatment-estradiol-level weekly 0.8 https://www.themednet.org/would-you-continue-forteo-treatment-past-the-recommended-2-years-if-t-scores-remain-low-and-procollagen-p1np-is-elevated-and-if-so-how-would-you-monitor-response weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-a-high-risk-asymptomatic-bone-metastasis-with-a-driver-mutation weekly 0.8 https://www.themednet.org/do-you-use-breast-mri-or-ultrasound-to-assess-tumor-size-prior-to-neoadjuvant-chemotherapy-in-breast-cancer weekly 0.8 https://www.themednet.org/what-are-your-favorite-billing-tips-for-em-and-cpt-codes-that-you-wish-you-knew-earlier-in-your-career weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-desmoplastic-melanoma-pt3n0m0-post-resection-for-adjuvant-treatment weekly 0.8 https://www.themednet.org/how-do-you-determine-the-severity-of-restrictive-lung-disease weekly 0.8 https://www.themednet.org/do-you-administer-immunosuppression-to-patients-with-idiopathic-nsip-who-have-normal-lung-function-and-mild-to-moderate-respiratory-symptoms weekly 0.8 https://www.themednet.org/do-you-avoid-potassium-citrate-due-to-concerns-with-increasing-the-urine-ph-in-patients-with-recurrent-struvite-nephrolithiasis-who-also-have-hypocitraturia weekly 0.8 https://www.themednet.org/do-you-recommend-radioactive-iodine-for-huerthle-cell-thyroid-carcinoma weekly 0.8 https://www.themednet.org/is-there-a-role-of-adjuvant-or-systemic-therapy-for-patients-with-resected-stage-i-colon-cancer-with-subsequent-local-recurrence-s-p-a-second-resection-and-now-has-ned weekly 0.8 https://www.themednet.org/would-an-mpl-variant-mutation-of-unknown-clinical-significance-be-considered-diagnostic-of-essential-thrombocytosis-in-a-patient-with-longstanding-elevation-in-the-platelet-count-and-for-whom-all-secondary-causes-have-been-excluded weekly 0.8 https://www.themednet.org/would-you-offer-apbi-to-a-patient-with-very-large-breast-anatomy-and-a-small-lumpectomy-cavity-after-an-oncoplastic-closure weekly 0.8 https://www.themednet.org/is-there-any-contraindication-for-use-of-invisalign-teeth-aligners-in-patients-undergoing-treatment-for-osteoporosis weekly 0.8 https://www.themednet.org/what-workup-do-you-perform-for-elevated-b12-levels-in-an-adult-who-is-not-taking-supplements weekly 0.8 https://www.themednet.org/how-would-you-manage-anticoagulation-in-a-patient-with-acute-mi-or-pe-with-prolonged-aptt-due-to-congenital-factor-xii-deficiency weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-female-to-male-transgender-patient-regarding-vte-risk-with-testosterone-therapy-who-has-additional-mild-moderate-risk-factors-for-thrombosis weekly 0.8 https://www.themednet.org/what-patient-specific-factors-would-influence-your-decision-to-initiate-semaglutide-therapy-in-patients-with-hiv-associated-lipohypertrophy weekly 0.8 https://www.themednet.org/would-you-offer-palliative-radiation-to-a-patient-with-hematuria-from-squamous-metaplasia-of-the-bladder-that-is-not-responding-to-endoscopic-therapy weekly 0.8 https://www.themednet.org/what-recommendations-do-you-have-for-treatment-resistant-dariers-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-neurocognitive-and-memory-deficits-in-post-concussive-syndrome weekly 0.8 https://www.themednet.org/do-you-monitor-cbcs-to-assess-for-drug-toxicity-in-patients-on-nintedanib weekly 0.8 https://www.themednet.org/what-is-your-workup-and-treatment-approach-for-cranial-neuropathies-in-patients-with-lupus weekly 0.8 https://www.themednet.org/is-there-a-role-for-intravenous-temozolomide-in-place-of-oral-for-the-5-day-dosing-q-28-days-after-surgery-xrt-temozolomide-for-glioblastoma-multiforme weekly 0.8 https://www.themednet.org/when-would-you-consider-using-ibutilide-for-rapid-pharmacologic-cardioversion-of-atrial-fibrillation weekly 0.8 https://www.themednet.org/for-patients-with-vexas-syndrome-and-good-response-to-azacitidine-what-duration-of-therapy-do-you-consider weekly 0.8 https://www.themednet.org/do-you-reduce-the-potassium-citrate-dose-for-patients-with-recurrent-calcium-oxalate-nephrolithiasis-who-are-started-on-the-medication-but-experience-persistently-elevated-urinary-ph-levels-above-7-0 weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-hypokalemia-in-patients-with-bartter-syndrome-who-are-on-high-doses-of-potassium-chloride-but-cannot-tolerate-amiloride-or-acei-arbs-due-to-low-blood-pressures weekly 0.8 https://www.themednet.org/what-are-your-management-strategies-for-patients-with-bradycardia-post-kidney-biopsy-who-received-lidocaine-for-local-anesthesia weekly 0.8 https://www.themednet.org/would-you-recommend-against-starting-sglt2-inhibitors-in-patients-with-a-history-of-struvite-nephrolithiasis-who-also-have-proteinuria-and-chronic-kidney-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-hemophilia-a-carriers-with-no-history-of-bleeding-complications-but-with-mildly-low-factor-viii-activity-6-40 weekly 0.8 https://www.themednet.org/in-the-post-covid-era-could-the-ilrog-hypofractionated-regimens-published-as-emergency-guidelines-for-lymphoma-be-considered-as-standard-of-care-for-isrt weekly 0.8 https://www.themednet.org/what-immunosuppressant-will-you-choose-in-a-patient-with-necrotizing-myopathy-partially-responding-to-iv-steroids-and-ivig-with-a-history-of-non-hodgkins-lymphoma weekly 0.8 https://www.themednet.org/what-role-does-oral-roflumilast-play-in-dermatology weekly 0.8 https://www.themednet.org/do-you-recommend-any-particular-type-of-contraceptive-use-in-young-patients-with-strokes-of-unclear-etiology weekly 0.8 https://www.themednet.org/do-you-recommend-encephaloduroateriosynangiosis-in-pediatric-patients-with-moyamoya-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-elevated-bone-specific-alp-2x-the-normal-limit-but-no-other-evidence-of-pagets-disease weekly 0.8 https://www.themednet.org/when-would-you-opt-to-manage-anal-squamous-cell-carcinoma-hpv-with-surveillance-vs-adjuvant-treatment-following-a-trans-anal-excision weekly 0.8 https://www.themednet.org/have-the-breast-surgeons-at-your-institution-adopted-the-sound-trial-into-their-clinical-practice weekly 0.8 https://www.themednet.org/what-is-the-typical-timeline-for-remission-of-autoimmune-hypoglycemia weekly 0.8 https://www.themednet.org/would-you-offer-sbrt-for-a-lung-lesion-adjacent-to-the-heart-in-a-patient-receiving-bevacizumab weekly 0.8 https://www.themednet.org/what-is-your-experience-with-pylarify-vs-posluma-psma-pet-for-prostate-cancer-and-is-one-preferred-over-the-other weekly 0.8 https://www.themednet.org/would-you-recommend-changing-a-patient-from-the-pill-form-of-levothyroxine-to-tirosint-sol-if-they-are-started-on-a-proton-pump-inhibitor weekly 0.8 https://www.themednet.org/would-you-transition-from-iv-to-oral-antibiotics-in-a-solid-organ-transplant-recipient-with-uncomplicated-gram-negative-bacteremia weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-diagnosis-and-management-of-optic-chiasmitis-in-systemic-lupus-erythematosus weekly 0.8 https://www.themednet.org/how-would-you-approach-post-operative-vte-prophylaxis-for-renal-transplant-in-patients-with-a-prior-history-of-provoked-vte weekly 0.8 https://www.themednet.org/what-chemoprophylaxis-if-any-would-you-consider-in-a-transplant-patient-with-numerous-kc-nmscs weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-neck-radiation-for-metastatic-chordoma-to-cervical-lymph-node-s-p-neck-dissection-with-1-10-positive-nodes-and-no-residual-on-post-op-imaging weekly 0.8 https://www.themednet.org/is-metformin-contraindicated-in-patients-using-long-term-oxygen-therapy-at-home weekly 0.8 https://www.themednet.org/how-would-you-approach-the-workup-and-management-of-isolated-inflammatory-subglottic-stenosis-in-a-young-previously-healthy-patient-that-is-steroid-responsive-with-a-completely-negative-serologic-autoimmune-workup weekly 0.8 https://www.themednet.org/what-if-any-resources-exist-with-recommendations-regarding-the-timing-and-toxicity-of-radiation-in-patients-who-have-received-or-are-currently-on-immunotherapy weekly 0.8 https://www.themednet.org/would-you-consider-belimumab-for-an-sle-patient-who-has-generalized-hair-thinning-leukopenia-wbc-3-low-c3-and-markedly-positive-anti-dsdna-who-is-otherwise-asymptomatic weekly 0.8 https://www.themednet.org/when-would-you-consider-av-nodal-ablation-in-crt-non-responders-with-persistent-atrial-fibrillation weekly 0.8 https://www.themednet.org/are-there-instances-when-you-recommend-using-sevelamer-for-patients-with-recurrent-calcium-phosphate-nephrolithiasis weekly 0.8 https://www.themednet.org/do-you-recommend-using-methionine-to-acidify-the-urine-in-patients-with-alkaline-urine-and-recurrent-calcium-phosphate-nephrolithiasis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-of-relapsed-high-risk-mds-with-tp53-mutation-in-a-patient-that-is-not-considered-a-transplant-candidate weekly 0.8 https://www.themednet.org/how-do-you-approach-the-wearing-off-phenomenon-for-patients-with-multiple-sclerosis-on-b-cell-depleting-therapies weekly 0.8 https://www.themednet.org/how-would-you-treat-suspected-secondary-hlh-in-patients-whom-etoposide-is-contraindicated weekly 0.8 https://www.themednet.org/how-do-you-advise-families-about-the-risks-and-benefits-of-long-term-ssri-use-for-children-who-being-treated-at-a-very-early-age-e-g-early-elementary-school weekly 0.8 https://www.themednet.org/do-you-routinely-consider-fdg-pet-ct-imaging-for-workup-of-fever-of-unknown-origin weekly 0.8 https://www.themednet.org/what-patient-characteristics-prompt-you-to-prescribe-vericiguat-for-patients-with-heart-failure-with-reduced-ejection-fraction-who-are-already-on-standard-therapy weekly 0.8 https://www.themednet.org/what-are-first-line-choices-for-vasopressors-inotropes-to-use-in-hypotensive-patients-with-eisenmenger-syndrome weekly 0.8 https://www.themednet.org/do-you-recommend-a-ketogenic-diet-for-patients-with-autosomal-dominant-polycystic-kidney-disease weekly 0.8 https://www.themednet.org/how-is-your-experience-with-point-of-care-inr-systems-for-home-monitoring-of-vitamin-k-antagonists weekly 0.8 https://www.themednet.org/how-would-you-treat-an-elderly-patient-with-stage-iia-chl-with-3-nodal-sites-of-involvement-who-has-a-contraindication-to-bleomycin weekly 0.8 https://www.themednet.org/how-would-you-approach-ct3n0m0-squamous-cell-carcinoma-of-the-supraglottic-larynx-in-a-patient-with-a-history-of-breast-cancer-and-prior-radiation-to-the-supraclavicular-fossa weekly 0.8 https://www.themednet.org/is-there-data-to-support-the-substitution-of-docetaxel-with-nab-paclitaxel-in-the-tchp-neoadjuvant-regimen-in-the-event-of-hypersensitivity weekly 0.8 https://www.themednet.org/how-was-treatment-response-assessed-on-the-prospect-trial weekly 0.8 https://www.themednet.org/would-you-recommend-cinacalcet-for-patients-with-recurrent-nephrolithiasis-who-have-hypercalciuria-despite-thiazide-diuretic-use-and-who-also-have-an-elevated-pth-level-without-localizing-parathyroid-adenoma-on-imaging weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-for-a-glioblastoma-from-a-radiation-standpoint-that-was-initially-thought-to-be-a-metastases-and-therefore-treated-with-multiple-courses-of-srs-over-the-past-few-years weekly 0.8 https://www.themednet.org/what-are-the-treatment-options-for-severe-recurrent-hypoglycemia-in-a-patient-with-malignant-insulinoma weekly 0.8 https://www.themednet.org/how-do-you-manage-anemia-associated-with-belzutifan-therapy weekly 0.8 https://www.themednet.org/how-do-you-decide-between-manual-pressure-versus-opting-for-a-specific-vascular-closure-device-at-the-conclusion-of-a-femoral-access-case weekly 0.8 https://www.themednet.org/how-significant-are-the-cardiovascular-side-effects-such-as-hypertension-associated-with-valproate weekly 0.8 https://www.themednet.org/would-you-recommend-pmrt-for-multifocal-idc-with-extensive-lvi-and-1-sln-with-itcs weekly 0.8 https://www.themednet.org/would-you-change-therapy-for-a-cml-patient-in-hematologic-remission-on-imatinib-found-with-positive-qualitative-bcr-abl1-for-the-p230-protein weekly 0.8 https://www.themednet.org/do-you-prefer-still-over-carbonated-water-for-your-patients-with-recurrent-nephrolithiasis-who-have-chronically-low-urine-volumes weekly 0.8 https://www.themednet.org/can-defibrotide-be-given-safely-for-vod-in-patients-with-refractory-thrombocytopenia-to-platelet-transfusions weekly 0.8 https://www.themednet.org/what-are-your-preferred-treatment-options-for-recalcitrant-pemphigus-vulgaris weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-radiation-induced-bullous-pemphigoid weekly 0.8 https://www.themednet.org/can-tpo-agonists-like-avatrombopag-or-lusutrombopag-be-used-for-patients-with-chronic-thrombocytopenia-and-new-acute-portal-vein-thrombosis weekly 0.8 https://www.themednet.org/how-would-you-manage-incidentally-found-prostate-cancer-on-turp weekly 0.8 https://www.themednet.org/how-do-you-counsel-male-patients-with-androgenetic-alopecia-who-are-trying-to-conceive-about-using-dutasteride-or-finasteride weekly 0.8 https://www.themednet.org/do-you-recommend-starting-anti-fungal-prophylaxis-for-patients-on-systemic-antibiotics-who-have-a-peritoneal-dialysis-catheter-that-is-only-currently-being-accessed-for-once-weekly-flushes weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-patient-with-a-medium-to-large-vessel-vasculitis-who-developed-perforation-of-the-stomach-and-colon-on-steroids-and-cyclophosphamide weekly 0.8 https://www.themednet.org/what-is-the-role-of-adrenalectomy-in-managing-isolated-recurrence-of-stage-iiic-melanoma-occurring-2-years-after-the-original-diagnosis-in-a-patient-who-declined-adjuvant-therapy weekly 0.8 https://www.themednet.org/would-you-consider-50-gy-in-20-fractions-for-a-primary-head-and-neck-malignancy-in-an-elderly-patient-with-poor-kps weekly 0.8 https://www.themednet.org/is-there-safety-data-regarding-the-use-of-hormonal-iuds-in-patients-with-atypical-ductal-hyperplasia-and-other-high-risk-non-malignant-breast-lesions weekly 0.8 https://www.themednet.org/what-treatments-have-you-found-most-effective-for-cholestatic-pruritus weekly 0.8 https://www.themednet.org/would-you-use-bupropion-for-mood-disorder-or-substance-use-in-an-adult-patient-with-previous-childhood-seizures-that-resolved weekly 0.8 https://www.themednet.org/how-do-you-monitor-multiple-myeloma-in-patients-receiving-dialysis weekly 0.8 https://www.themednet.org/do-you-use-potassium-phosphate-for-patients-with-recurrent-nephrolithiasis-to-acidify-the-urine-and-prevent-certain-types-of-stones weekly 0.8 https://www.themednet.org/what-would-you-use-for-cytoreduction-in-a-pregnant-patient-with-high-risk-et-and-apls weekly 0.8 https://www.themednet.org/do-you-routinely-check-cefepime-levels-in-patients-with-suspected-cefepime-induced-neurotoxicity weekly 0.8 https://www.themednet.org/would-you-transition-a-patient-with-axial-spondyloarthritis-to-a-biologic-if-their-axial-symptoms-were-controlled-with-an-nsaid-but-they-also-required-a-ppi-to-control-dyspepsia-gerd-caused-by-the-nsaid weekly 0.8 https://www.themednet.org/would-you-use-neoadjuvant-tki-or-neoadjuvant-radiation-for-a-large-chest-wall-sarcoma-with-an-ntrk-fusion-on-ngs weekly 0.8 https://www.themednet.org/what-is-your-approach-to-high-grade-neuroendocrine-tumor-of-the-stomach weekly 0.8 https://www.themednet.org/how-do-you-approach-palliative-conversations-about-what-patients-can-expect-when-deciding-to-stop-maintenance-dialysis weekly 0.8 https://www.themednet.org/when-managing-patients-with-suspected-masld-what-specific-criteria-or-findings-would-prompt-you-to-refer-them-to-hepatology weekly 0.8 https://www.themednet.org/do-you-utilize-serial-mri-imaging-in-patients-with-axial-spondyloarthritis-to-ensure-good-disease-control-or-do-you-rely-on-symptoms-and-physical-exam-to-assess-treatment-response weekly 0.8 https://www.themednet.org/how-do-you-advise-patients-on-cardiotoxicity-when-they-are-expected-to-receive-a-low-mean-heart-dose-and-low-cardiac-substructure-doses-with-their-radiation-plan weekly 0.8 https://www.themednet.org/do-you-consider-chest-wall-constraints-when-treating-with-5-fraction-apbi weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-immunotherapy-pembrolizumab-for-chromophobe-rcc-with-r1-resection weekly 0.8 https://www.themednet.org/how-do-you-decide-between-using-ropeginterferon-alfa-2b-and-peginterferon-alfa-2a-in-mpn weekly 0.8 https://www.themednet.org/how-do-you-manage-asymptomatic-non-sustained-atrial-arrhythmia-in-patients-with-single-ventricle-and-fontan-physiology weekly 0.8 https://www.themednet.org/how-do-you-approach-cognitive-impairment-in-the-assessment-of-transplant-candidacy weekly 0.8 https://www.themednet.org/what-is-your-experience-managing-patients-with-chronic-spontaneous-urticaria-occurring-only-at-night weekly 0.8 https://www.themednet.org/how-do-you-approach-use-of-dmards-and-or-biologics-for-inflammatory-arthritis-in-patients-with-a-history-of-seizure-disorder-on-anti-epileptic-medications weekly 0.8 https://www.themednet.org/in-difficult-cases-what-is-your-approach-to-find-a-causative-agent-of-fixed-drug-or-fixed-food-eruption weekly 0.8 https://www.themednet.org/how-do-you-determine-the-treatment-course-of-esketamine-or-iv-ketamine-when-used-for-treatment-resistant-major-depressive-disorder weekly 0.8 https://www.themednet.org/do-you-have-different-hotspot-and-heterogeneity-goals-for-sbrt-of-ground-glass-lesions-vs-more-solid-adenocarcinoma-nsclc-lesions weekly 0.8 https://www.themednet.org/would-you-continue-belimumab-in-high-risk-lupus-patients-with-overlapping-scleroderma-features-with-ild-who-become-pregnant-and-who-are-already-on-hcq-and-azathioprine weekly 0.8 https://www.themednet.org/do-you-alternate-ct-stone-scans-and-renal-ultrasounds-for-stone-monitoring-in-your-patients-with-recurrent-nephrolithiasis-with-the-goal-of-limiting-radiation-exposure weekly 0.8 https://www.themednet.org/what-steps-do-you-recommend-to-ensure-continued-viral-suppression-and-prevent-drug-resistance-in-an-hiv-patient-on-injectable-cabotegravir-and-rilpivirine-who-misses-their-scheduled-injection-appointment-by-two-weeks weekly 0.8 https://www.themednet.org/how-does-contralateral-suppression-of-more-than-50-with-cosyntropin-during-adrenal-venous-sampling-influence-your-decision-to-recommend-adrenalectomy-in-patients-with-primary-aldosteronism weekly 0.8 https://www.themednet.org/how-are-you-integrating-prostox-into-your-practice-for-prostate-patients-deciding-between-sbrt-and-hypofractionation weekly 0.8 https://www.themednet.org/is-the-combination-of-a-negative-bal-pjp-pcr-and-normal-fungitell-enough-to-rule-out-pjp-pneumonia-in-an-at-risk-non-hiv-patient weekly 0.8 https://www.themednet.org/how-do-you-time-csf-analysis-for-suspected-cns-lymphoma-in-patients-who-are-on-steroids weekly 0.8 https://www.themednet.org/when-do-you-consider-the-use-of-clonidine-in-gabaergic-withdrawal-and-how-do-you-approach-the-risk-of-masking-the-autonomic-signs-of-withdrawal-when-it-is-used weekly 0.8 https://www.themednet.org/in-what-scenarios-if-ever-would-you-check-peripheral-blood-flow-cytometry-in-a-patient-with-known-multiple-myeloma-to-evaluate-for-circulating-plasma-cells-cpcs-in-the-absence-of-an-abnormal-smear weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-iv-systemic-antibiotic-therapy-in-additional-to-intravitreal-antibiotic-therapy-for-exogenous-bacterial-endophthalmitis weekly 0.8 https://www.themednet.org/do-you-use-hydroxychloroquine-for-patients-with-asymptomatic-primary-sjogren-syndrome-to-treat-hypergammaglobulinemia-without-other-concerning-features weekly 0.8 https://www.themednet.org/what-dose-and-regimen-would-you-treat-a-stage-i-laryngeal-cancer-s-p-r1-resection weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-to-determine-when-to-start-a-steroid-sparing-agent-for-hypersensitivity-pneumonitis weekly 0.8 https://www.themednet.org/what-is-your-preferred-method-of-surveillance-after-mastectomy weekly 0.8 https://www.themednet.org/would-you-offer-consolidative-durvalumab-after-chemort-for-an-isolated-mediastinal-recurrence-of-nsclc-that-occurred-during-adjuvant-pembrolizumab-given-for-the-initial-lung-cancer weekly 0.8 https://www.themednet.org/what-factors-influence-your-choice-between-low-dose-doac-therapy-and-dual-antiplatelet-therapy-for-the-first-3-months-after-percutaneous-left-atrial-appendage-occlusion weekly 0.8 https://www.themednet.org/what-is-your-approach-to-determining-fitness-for-patients-to-undergo-car-t-therapy-for-relapsed-refractory-multiple-myeloma-and-any-absolute-perceived-contraindications-for-car-t weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-hyperlipidemia-in-patients-taking-jak-inhibitors weekly 0.8 https://www.themednet.org/would-you-utilize-splenic-radiation-for-patients-with-non-myeloid-malignancy-and-splenomegaly-in-the-setting-of-platelet-sequestration-which-is-limiting-cytotoxic-systemic-therapy-options weekly 0.8 https://www.themednet.org/do-progesterone-only-oral-contraceptive-pills-affect-cortisol-binding-globulin weekly 0.8 https://www.themednet.org/for-a-platelet-transfusion-dependent-elderly-patient-with-recurrent-bacteremia-and-a-dual-chamber-pacemaker-and-tee-with-fibrin-vs-possible-vegetation-would-you-consider-device-removal-or-favoring-treatment-with-suppressive-antibiotics weekly 0.8 https://www.themednet.org/how-do-you-manage-hypoxia-induced-by-belzutifan weekly 0.8 https://www.themednet.org/how-do-you-start-and-manage-therapeutic-sc-heparin-for-acute-thrombosis-in-pregnancy-as-the-patient-approaches-delivery weekly 0.8 https://www.themednet.org/is-rezum-water-vapor-thermotherapy-for-bph-safe-after-ebrt weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-micrometastatic-node-positive-tumor-post-mastectomy-no-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/do-you-use-amyloid-lowering-therapy-in-patients-on-chronic-anticoagulation weekly 0.8 https://www.themednet.org/would-you-consider-antifungal-prophylaxis-for-immunocompromised-patients-with-covid-19-requiring-mechanical-ventilation-considering-the-high-risk-of-invasive-pulmonary-aspergillosis-in-patients-with-severe-covid-19 weekly 0.8 https://www.themednet.org/would-you-consider-using-evenity-in-an-elderly-patient-with-rate-controlled-atrial-fibrillation-without-history-of-mi-or-cva weekly 0.8 https://www.themednet.org/how-do-you-use-cardiac-biomarkers-if-at-all-in-prognostication-for-patients-with-ischemic-stroke weekly 0.8 https://www.themednet.org/what-considerations-guide-your-decision-to-perform-endovascular-therapy-in-stroke-involving-acute-m2-or-m3-occlusions weekly 0.8 https://www.themednet.org/is-a-history-of-coronary-artery-disease-and-afib-a-contraindication-to-using-donepezil weekly 0.8 https://www.themednet.org/how-do-you-mitigate-the-risk-of-rebound-disease-activity-when-discontinuing-s1p-inhibitors-or-tysabri-in-patients-with-multiple-sclerosis weekly 0.8 https://www.themednet.org/are-there-any-precautions-you-would-take-when-radiating-the-pelvis-in-an-obese-patient-with-recent-extensive-ventral-hernia-repair-to-minimize-dehiscence-risk weekly 0.8 https://www.themednet.org/do-you-modify-dosing-or-use-of-bupropion-to-mitigate-seizure-risk-in-patients-without-eating-disorder-who-are-restricting-calories-to-lose-weight weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-an-incidental-finding-of-1-mm-focus-of-high-grade-serous-carcinoma-in-the-fallopian-tube-after-tahbso-was-done-for-a-benign-broad-ligament-fibroid-with-negative-pelvic-washings weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-newer-anti-seizure-medications-for-epilepsy-patients-on-doacs weekly 0.8 https://www.themednet.org/do-you-have-a-preferred-oral-magnesium-formulation-for-patients-with-hypomagnesemia-secondary-to-gitleman-syndrome-and-who-also-have-chronic-diarrhea weekly 0.8 https://www.themednet.org/when-following-active-surveillance-paradigm-what-psa-increase-will-trigger-prostate-biopsy weekly 0.8 https://www.themednet.org/when-do-you-recommend-initiation-of-targeted-therapies-in-active-ra-with-history-of-malignancy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-anca-associated-vasculitis-who-has-recurrent-flare-including-pulmonary-hemorrhage-persistent-mpo-antibody-positivity-while-on-maintenance-rituximab-and-avacopan-regimen-even-after-induction-rituximab-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-stereotactic-radiosurgery-for-acoustic-neuroma-in-patients-who-are-awaiting-cochlear-implant weekly 0.8 https://www.themednet.org/is-there-a-role-for-suppressive-antibiotic-therapy-when-it-comes-to-chronic-femoral-tibial-osteomyelitis weekly 0.8 https://www.themednet.org/what-is-the-recommended-adjuvant-dose-for-neuroendocrine-cancer-in-the-head-and-neck weekly 0.8 https://www.themednet.org/when-would-be-your-threshold-to-consider-obtaining-an-exercise-rhc-for-undifferentiated-dyspnea-to-help-diagnose-hfpef weekly 0.8 https://www.themednet.org/how-would-you-approach-secondary-stroke-prevention-in-an-adult-with-hemoglobin-sc-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-anti-seizure-medication-management-when-it-was-started-by-another-team-for-a-seizure-naive-patient-before-after-craniotomy-for-a-tumor weekly 0.8 https://www.themednet.org/what-is-your-diagnostic-approach-to-patients-referred-for-central-sleep-apnea-on-psg-but-normal-overnight-eeg-and-mri weekly 0.8 https://www.themednet.org/what-is-your-approach-to-immune-management-in-opsoclonus-myoclonus-ataxia-syndrome weekly 0.8 https://www.themednet.org/how-do-you-determine-candidacy-for-selective-dorsal-rhizotomy-in-spastic-cerebral-palsy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-and-caregivers-on-dietary-interventions-for-autism weekly 0.8 https://www.themednet.org/when-do-you-consider-lumbar-spinal-fluid-drainage-after-acute-spinal-cord-injury weekly 0.8 https://www.themednet.org/how-do-you-use-muscle-mri-in-the-diagnosis-and-management-of-muscular-dystrophies weekly 0.8 https://www.themednet.org/what-workup-do-you-recommend-for-otherwise-healthy-migraine-patients-that-develop-dizziness-with-episodes weekly 0.8 https://www.themednet.org/what-is-your-approach-to-helping-parents-manage-sleep-disturbances-in-patients-with-autism-spectrum-disorder weekly 0.8 https://www.themednet.org/would-you-recommend-a-specific-workup-or-change-in-management-for-patients-with-severe-persistent-deficits-from-methotrexate-leukoencephalopathy weekly 0.8 https://www.themednet.org/how-do-you-utilize-at-home-seizure-monitoring-devices-for-your-patients-with-epilepsy weekly 0.8 https://www.themednet.org/would-you-recommend-anticoagulation-in-a-pediatric-patient-with-metastases-in-a-dural-venous-sinus weekly 0.8 https://www.themednet.org/what-is-the-value-of-sending-placental-pathology-in-neonatal-patients-who-have-suffered-an-in-utero-arterial-ischemic-stroke weekly 0.8 https://www.themednet.org/what-baseline-visual-testing-if-any-do-you-recommend-at-diagnosis-for-patients-with-multiple-sclerosis-who-deny-visual-complaints weekly 0.8 https://www.themednet.org/what-is-your-approach-to-light-sedation-in-pediatric-emg weekly 0.8 https://www.themednet.org/when-do-you-consider-discontinuation-of-treatment-in-pediatric-patients-who-have-responded-well-to-preventive-migraine-medications weekly 0.8 https://www.themednet.org/how-do-different-inflammatory-markers-like-crp-and-ferritin-contribute-differently-if-at-all-to-the-monitoring-of-cart-neurotoxicity weekly 0.8 https://www.themednet.org/what-is-your-preferred-agent-and-duration-to-treat-an-epidural-abscess-due-to-azole-resistant-candida-species weekly 0.8 https://www.themednet.org/how-would-you-treat-autologous-gvhd-after-a-thymic-transplant-but-with-no-thymopoeisis weekly 0.8 https://www.themednet.org/when-would-you-pursue-genetic-testing-for-severe-recalcitrant-atopic-dermatitis weekly 0.8 https://www.themednet.org/what-are-the-implications-of-checking-post-vaccine-titers-after-administration-of-prevnar-20-compared-to-ppsv23 weekly 0.8 https://www.themednet.org/should-in-office-oscillometry-for-lung-function-measurements-be-utilized-in-pediatric-patients-who-are-unable-to-reliably-perform-spirometry weekly 0.8 https://www.themednet.org/what-is-your-preferred-biologic-in-children-and-adolescents-with-t2-high-asthma weekly 0.8 https://www.themednet.org/do-you-feel-high-dose-symbicort-or-dulera-is-appropriate-to-use-for-smart-despite-these-doses-not-being-studied-in-clinical-trials weekly 0.8 https://www.themednet.org/is-there-any-non-invasive-validated-testing-for-annatto-e-160b-also-known-as-norbixin weekly 0.8 https://www.themednet.org/is-there-utility-in-doing-a-baked-egg-versus-lightly-cooked-egg-challenge-for-fpies weekly 0.8 https://www.themednet.org/do-you-counsel-a-mother-to-avoid-certain-food-in-her-diet-if-she-is-still-breast-feeding-and-her-child-has-confirmed-ige-mediated-food-allergies weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-neonatal-intrapericardial-germ-cell-tumor-as-compared-to-other-patients-with-mediastinal-germ-cell-tumors weekly 0.8 https://www.themednet.org/do-you-transition-patients-with-recurrent-nephrolithiasis-and-hypercalciuria-off-of-hydrochlorothiazide-in-favor-of-an-alternative-thiazide-diuretic weekly 0.8 https://www.themednet.org/in-asymptomatic-patients-with-castrate-resistant-prostate-cancer-who-have-failed-chemotherapy-and-have-progressive-psma-avid-vertebral-body-metastases-when-do-you-prescribe-lutetium-177-pluvicto-vs-prophylactic-spinal-radiation weekly 0.8 https://www.themednet.org/do-you-use-a-comprehensive-volumetric-rather-than-numeric-cutoff-in-consideration-of-srs-vs-wbrt-for-brain-metastases weekly 0.8 https://www.themednet.org/how-would-you-manage-a-young-healthy-patient-s-p-open-radical-hysterectomy-bilateral-salpingectomy-ovarian-transposition-bilateral-slnd-with-now-stage-ib3-hpv-dependent-adenosquamous-cervical-carcinoma weekly 0.8 https://www.themednet.org/do-you-have-patients-with-recurrent-nephrolithiasis-target-a-certain-urine-volume-or-rather-consume-fluids-as-needed-for-goal-of-having-consistent-clear-urine weekly 0.8 https://www.themednet.org/what-is-your-approach-to-genetic-counseling-prior-to-obtaining-genetic-testing-in-young-asymptomatic-patients-suspected-of-having-autosomal-dominant-polycystic-kidney-disease weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-a-patient-with-adenocarcinoma-of-unknown-primary-only-found-in-a-left-supraclavicular-lymph-node weekly 0.8 https://www.themednet.org/how-do-you-manage-significant-asymptomatic-indirect-hyperbilirubinemia-in-patients-with-hemolytic-diseases-scd-hs-etc weekly 0.8 https://www.themednet.org/how-do-you-optimize-a-beta-thalassemia-patient-on-luspatercept-who-is-interested-in-becoming-pregnant weekly 0.8 https://www.themednet.org/how-do-you-decide-between-hsct-and-immunosuppressive-therapy-for-treating-hepatitis-associated-aplastic-anemia weekly 0.8 https://www.themednet.org/for-how-long-would-you-hold-anticoagulation-before-percutaneous-left-atrial-appendage-closure-with-watchman-or-amulet-devices weekly 0.8 https://www.themednet.org/do-you-start-immunosuppression-for-enlarging-pulmonary-nodules-without-symptoms-impaired-pulmonary-function-or-extra-pulmonary-disease-in-a-patient-with-sarcoidosis weekly 0.8 https://www.themednet.org/do-you-routinely-prescribe-memantine-for-patients-who-will-be-receiving-hippocampal-sparing-whole-brain-rt-if-they-are-already-on-donepezil-or-is-donepezil-alone-sufficient weekly 0.8 https://www.themednet.org/do-you-recommend-genetic-testing-for-patients-incidentally-found-to-have-nephrocalcinosis-on-imaging weekly 0.8 https://www.themednet.org/what-are-your-recommendations-in-managing-pudendal-neuralgia-red-scrotum-syndrome weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-endocrine-therapy-in-combination-with-immunotherapy-for-triple-negative-metaplastic-breast-cancer-with-residual-disease-that-is-er-strongly-positive weekly 0.8 https://www.themednet.org/when-transitioning-from-anabolic-agent-to-denosumab-do-you-stop-teriparatide-1-day-prior-to-transition-and-romosozumab-1-month-prior-to-transition weekly 0.8 https://www.themednet.org/how-do-you-approach-initial-treatment-for-al-amyloidosis-with-excess-plasmacytosis-in-the-bone-marrow-that-has-cardiac-involvement-and-is-not-a-transplant-candidate weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-for-patients-with-proliferative-glomerulonephritis-with-monoclonal-igg-deposits-pgnmid-with-end-stage-renal-disease-who-are-considering-kidney-transplant weekly 0.8 https://www.themednet.org/what-is-your-preferred-imaging-modality-cmr-vs-tte-to-evaluate-for-myocardial-strain-if-concerned-for-chemotherapy-induced-cardiomyopathies weekly 0.8 https://www.themednet.org/what-is-the-optimal-anti-androgen-dose-of-spironolactone-when-treating-female-hirsutism weekly 0.8 https://www.themednet.org/in-small-intracanalicular-acoustic-neuromas-with-facial-nerve-dysfunction-is-there-benefit-for-hypofractionation-5-gy-by-5-fractions-as-opposed-to-single-fraction-srs weekly 0.8 https://www.themednet.org/what-infections-should-we-rule-out-in-patients-who-develop-diarrhea-on-immunotherapy weekly 0.8 https://www.themednet.org/in-a-patient-with-low-titer-anti-sae-antibody-and-known-ild-but-no-other-clinical-features-of-dermatomyositis-how-would-you-approach-further-testing-or-would-you-treat-the-patient-as-dermatomyositis-associated-ild weekly 0.8 https://www.themednet.org/what-is-your-approach-to-de-escalation-of-asthma-inhaler-therapy-in-the-setting-of-negative-bronchoprovocation-testing-when-patients-are-averse-to-deprescribing weekly 0.8 https://www.themednet.org/what-is-a-reasonable-length-of-time-to-pass-before-considering-tee-guided-dccv-for-atrial-fibrillation-in-a-patient-with-a-suspected-acute-cardioembolic-stroke-and-concerns-for-tachycardia-mediated-cardiomyopathy weekly 0.8 https://www.themednet.org/if-a-patient-has-multiple-pet-avid-level-3-supraclavicular-or-imn-nodes-that-are-small-and-would-have-been-considered-negative-by-size-criteria-with-traditional-imaging-that-are-no-longer-positive-on-pet-after-chemotherapy-would-you-try-to-boost-these-nod weekly 0.8 https://www.themednet.org/do-you-assess-for-podocyte-detachment-in-addition-to-effacement-when-considering-the-degree-of-glomerular-injury-and-potential-treatment-options-following-a-native-kidney-biopsy-in-a-patient-with-proteinuria weekly 0.8 https://www.themednet.org/do-you-follow-lfts-in-patients-on-tamoxifen-as-suggested-in-the-prescribing-guidelines weekly 0.8 https://www.themednet.org/what-are-your-management-strategies-for-patients-with-recurrent-nephrolithiasis-and-hypercalciuria-who-develop-hypercalcemia-after-thiazide-initiation weekly 0.8 https://www.themednet.org/how-would-you-approach-the-workup-and-management-of-a-young-patient-with-recurrent-biannual-non-scarring-oral-ulcers-and-new-onset-neurologic-symptoms-with-associated-cns-white-matter-lesions-concerning-for-behcets weekly 0.8 https://www.themednet.org/what-are-your-top-5-reasons-to-choose-between-a-tavi-valve-edwards-sapien-3-edwards-lifesciences-vs-an-evolut-fx-medtronic-and-what-favors-one-over-the-other weekly 0.8 https://www.themednet.org/what-is-your-approach-to-immunosuppression-in-patients-with-preserved-kidney-function-who-are-found-to-have-nephrotic-syndrome-of-unknown-etiology-and-cannot-safely-undergo-a-kidney-biopsy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-end-stage-kidney-disease-on-peritoneal-dialysis-who-has-an-adequate-kt-v-but-persistent-azotemia weekly 0.8 https://www.themednet.org/how-would-you-treat-a-perineural-igg4-rd-with-persistent-paresthesia weekly 0.8 https://www.themednet.org/do-you-routinely-obtain-serum-anti-thsd7a-and-anti-nell1-tests-in-your-patients-with-nephrotic-syndrome-suspected-secondary-to-membraneous-nephropathy weekly 0.8 https://www.themednet.org/what-strategies-do-you-employ-for-adjusting-the-dosage-of-levothyroxine-in-hypothyroid-patients-who-experience-significant-weight-loss-or-are-initiated-on-glp-1-receptor-agonists weekly 0.8 https://www.themednet.org/would-you-anticoagulate-an-smv-thrombosis-caused-by-malignant-obstruction-in-the-setting-of-metastatic-colorectal-cancer-1 weekly 0.8 https://www.themednet.org/how-long-are-cholinergic-agonists-such-as-pilocarpine-required-to-be-held-before-doing-tear-assessments-ocular-scoring-and-schirmers-and-sialography-salivary-collection weekly 0.8 https://www.themednet.org/is-there-any-benefit-to-using-desmopressin-over-vwf-replacement-therapy-for-vwd weekly 0.8 https://www.themednet.org/how-do-you-discuss-sexual-health-with-pediatric-patients-transitioning-to-adult-rheumatology-care-when-the-patient-is-accompanied-by-parents-or-caregiver weekly 0.8 https://www.themednet.org/how-often-do-you-see-bony-erosions-in-patients-with-lyme-arthritis weekly 0.8 https://www.themednet.org/to-what-extent-do-you-incorporate-electrodiagnostic-testing-and-ultrasonography-in-your-clinical-practice-for-evaluating-suspected-cases-of-meralgia-paresthetica weekly 0.8 https://www.themednet.org/how-frequently-do-you-recommend-ordering-labs-to-monitor-for-side-effects-of-disease-modifying-therapies-for-multiple-sclerosis weekly 0.8 https://www.themednet.org/do-you-prefer-starting-a-sglt2i-before-steroids-in-patients-with-iga-nephropathy-and-proteinuria-1-0-gram-day-who-are-unable-to-tolerate-acei-arb-due-to-hypotension weekly 0.8 https://www.themednet.org/how-do-you-evaluate-a-patient-with-mgus-and-peripheral-neuropathy weekly 0.8 https://www.themednet.org/is-there-any-role-for-adjuvant-radiotherapy-for-resected-multistation-n2-atypical-carcinoid-tumor-of-the-lung weekly 0.8 https://www.themednet.org/what-work-up-do-you-pursue-for-splinter-hemorrhages-in-an-otherwise-healthy-patient weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-follicular-lymphoma-with-central-nervous-system-involvement weekly 0.8 https://www.themednet.org/for-a-patient-with-stage-iib-pure-seminoma-s-p-orchiectomy-who-has-bilateral-rp-adenopathy-do-you-also-cover-the-contralateral-iliac-nodes-in-the-dog-leg-field weekly 0.8 https://www.themednet.org/do-you-recommend-a-daily-b-complex-multivitamin-for-patients-with-end-stage-kidney-disease-who-are-receiving-peritoneal-dialysis weekly 0.8 https://www.themednet.org/how-do-you-approach-revascularization-in-patients-over-75-years-with-nstemi-given-recent-evidence-from-the-senior-rita-trial-that-an-invasive-strategy-does-not-significantly-reduce-cardiovascular-events-compared-to-a-conservative-strategy weekly 0.8 https://www.themednet.org/is-separating-dust-mite-and-molds-still-necessary-in-light-of-increased-addition-of-glycerol-to-it-mixtures weekly 0.8 https://www.themednet.org/how-do-you-approach-performing-a-food-challenge-in-a-patient-with-csu-who-is-dependent-on-their-h1-blockers weekly 0.8 https://www.themednet.org/how-often-do-you-monitor-the-eosinophil-count-after-initiating-anti-il5-therapy-for-hae weekly 0.8 https://www.themednet.org/would-you-ever-consider-foregoing-surveillance-ct-scans-for-resected-stage-ii-or-iii-colon-cancer-in-favor-of-circulating-ctdna-assays weekly 0.8 https://www.themednet.org/how-do-you-approach-frontline-treatment-for-an-elderly-patient-with-adult-t-cell-leukemia-lymphoma-atl weekly 0.8 https://www.themednet.org/would-you-offer-sbrt-as-an-alternative-to-surgery-for-an-atypical-carcinoid-lung-tumor weekly 0.8 https://www.themednet.org/what-is-your-approach-to-interpreting-urine-studies-in-patients-hospitalized-for-hyponatremia-who-have-recently-received-intravenous-fluids-containing-sodium-chloride weekly 0.8 https://www.themednet.org/how-would-you-manage-superficial-thrombophlebitis-of-the-great-saphenous-vein-involving-the-knee-and-calf weekly 0.8 https://www.themednet.org/what-are-some-of-the-biggest-challenges-you-run-into-when-patients-transition-from-pediatric-to-adult-care weekly 0.8 https://www.themednet.org/do-you-recommend-adjusted-adult-cancer-screening-for-patients-who-have-been-on-long-term-biologics-and-or-tsdmards-since-childhood weekly 0.8 https://www.themednet.org/what-are-some-strategies-to-help-teach-patients-transitioning-from-pediatric-to-adult-care-to-become-more-independent-with-respect-to-their-care-and-less-dependent-on-their-caregivers weekly 0.8 https://www.themednet.org/is-there-evidence-to-suggest-there-is-a-withdrawal-syndrome-from-muscle-relaxants-such-as-tizanidine weekly 0.8 https://www.themednet.org/how-do-you-determine-osteoporosis-treatment-response-when-patients-have-discrepant-dexa-scan-results-during-monitoring-eg-improved-bmd-of-the-hip-and-spine-but-worsening-bmd-of-the-femoral-neck weekly 0.8 https://www.themednet.org/when-do-you-recommend-using-trabecular-bone-score-tbs-for-managing-osteoporosis weekly 0.8 https://www.themednet.org/would-bag-mask-ventilation-with-a-peep-valve-be-a-reasonable-alternative-to-niv-for-pre-oxygenation-prior-to-intubation-in-settings-where-niv-is-not-easily-accessible weekly 0.8 https://www.themednet.org/what-duration-of-antibiotics-do-you-use-in-patients-with-actinomyces-osteomyelitis-i-e-do-you-stop-after-6-weeks-or-do-you-give-a-longer-oral-antibiotic-course weekly 0.8 https://www.themednet.org/how-do-the-results-of-the-esprit-trial-which-evaluated-the-impact-of-an-sbp-target-of-120-mmhg-on-preventing-major-cardiovascular-events-influence-your-blood-pressure-management-goals-for-hypertensive-patients-with-diabetes-or-a-history-of-stroke weekly 0.8 https://www.themednet.org/which-brand-preparation-of-levothyroxine-do-you-recommend-to-treat-hypothyroid-patients-with-alpha-gal-allergy weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-patient-with-systemic-sclerosis-who-wants-to-consider-microneedling-on-the-face-or-other-skin-which-is-not-clearly-involved-with-scleroderma weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-glp-1-receptor-agonists-for-the-management-of-patients-with-metabolically-healthy-obesity weekly 0.8 https://www.themednet.org/is-omalizumab-an-option-for-a-patient-needing-a-specific-antibiotic-with-an-ige-mediated-reaction-who-continues-to-have-reactions-during-a-desensitization weekly 0.8 https://www.themednet.org/how-long-would-you-anticoagulate-for-pe-developed-after-air-travel-in-a-woman-on-an-estrogen-containing-vaginal-ring-for-contraception weekly 0.8 https://www.themednet.org/do-you-use-asthma-or-eoe-dosing-if-initiating-dupilumab-in-a-patient-who-meets-criteria-for-treatment-for-both-disorders weekly 0.8 https://www.themednet.org/would-you-consider-caplacizumab-in-a-pregnant-patient-with-ittp weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-to-non-uremic-calciphylaxis weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-a-young-female-who-has-an-idiopathic-small-right-elbow-effusion-with-synovial-thickening-that-has-resulted-in-limitation-in-her-range-of-motion weekly 0.8 https://www.themednet.org/do-you-recommend-prophylactic-post-operative-use-of-an-intravenous-calcium-infusion-for-patients-with-eskd-who-undergo-subtotal-parathyroidectomy-for-secondary-hyperparathyroidism weekly 0.8 https://www.themednet.org/in-what-clinical-scenarios-do-you-consider-pre-or-post-treatment-with-imiquimod-for-cutaneous-melanoma weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-progressive-refractory-molluscum-contagiosum-who-is-well-controlled-on-methotrexate-for-seropositive-rheumatoid-arthritis weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-patient-with-esrd-on-the-transplant-list-who-is-found-to-have-high-titer-aps-labs-acl-b2gp1-lac weekly 0.8 https://www.themednet.org/how-would-you-approach-potentially-tapering-maintenance-mycophenolate-mofetil-in-a-patient-with-a-history-of-class-iv-ln-that-has-been-in-remission-for-5-years weekly 0.8 https://www.themednet.org/what-work-up-do-you-recommend-in-post-bariatric-surgery-patients-who-are-slowly-gaining-back-the-weight-despite-no-changes-in-diet weekly 0.8 https://www.themednet.org/what-factors-influence-your-decision-between-guidewire-exchange-versus-removal-and-replacement-through-a-new-tunnel-tract-for-patients-with-tunneled-hemodialysis-catheter-mechanical-failure weekly 0.8 https://www.themednet.org/what-are-your-criteria-for-starting-tolvaptan-in-adult-patients-diagnosed-with-autosomal-dominant-polycystic-kidney-disease weekly 0.8 https://www.themednet.org/do-you-recommend-dosing-potassium-citrate-three-times-or-two-times-daily-for-patients-with-recurrent-calcium-oxalate-nephrolithiasis-and-hypocitraturia weekly 0.8 https://www.themednet.org/what-are-the-treatment-options-for-relapsed-t-all-in-a-patient-who-was-nonadherent-with-aall-and-hyper-cvad-regimens weekly 0.8 https://www.themednet.org/with-the-presentation-of-hypog-01-phase-iii-unicancer-trial-at-esmo-2024-should-hypofractionated-radiotherapy-be-the-standard-across-the-board-for-breast-cancer weekly 0.8 https://www.themednet.org/would-you-order-a-fibroscan-to-screen-for-masld-in-patients-with-insulin-resistance-but-normal-lfts weekly 0.8 https://www.themednet.org/how-do-you-determine-the-need-to-biopsy-subcutaneous-nodules-in-infants-to-rule-out-infantile-myofibromatosis weekly 0.8 https://www.themednet.org/is-there-a-role-for-prophylactic-trental-and-vitamin-e-in-a-patient-at-high-risk-for-osteoradionecrosis weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-severe-hurley-stage-3-active-draining-hs-who-is-also-currently-requiring-rituxan-for-management-of-vasculitis weekly 0.8 https://www.themednet.org/do-you-recommend-plasmapheresis-for-treatment-of-patients-with-osmotic-demyelination weekly 0.8 https://www.themednet.org/how-would-you-manage-active-psoriasis-and-psoriatic-arthritis-in-patient-on-rituximab-and-prednisone-for-mpo-positive-vasculitis weekly 0.8 https://www.themednet.org/how-would-you-balance-the-risk-of-intracranial-hemorrhage-with-thrombosis-of-mechanical-valves-in-patients-with-infective-endocarditis weekly 0.8 https://www.themednet.org/would-you-add-immunosuppression-in-ocular-myasthenia-gravis-patients-who-are-symptomatically-well-controlled-on-pyridostigmine weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-korlym-mifepristone-for-patients-with-difficult-to-control-diabetes-and-evidence-of-mild-endogenous-hypercortisolism-of-unknown-source weekly 0.8 https://www.themednet.org/what-are-your-typical-recommendations-for-when-a-patient-can-return-to-work-following-a-cardiac-arrest-considering-the-variation-in-neurological-recovery-and-the-potential-ramifications-based-on-the-type-of-job weekly 0.8 https://www.themednet.org/do-you-prefer-using-end-expiratory-or-mean-pulmonary-artery-wedge-pressure-obtained-during-diagnostic-right-heart-catheterization-for-the-classification-of-precapillary-vs-postcapillary-ph weekly 0.8 https://www.themednet.org/do-you-consider-the-use-of-antifibrotics-at-presentation-in-patients-with-a-radiographic-uip-pattern-of-pulmonary-fibrosis-in-the-presence-of-positive-serologies-without-any-symptoms-of-ctd-who-have-not-yet-demonstrated-evidence-of-a-progressive-phenotype weekly 0.8 https://www.themednet.org/would-you-include-midostaurin-in-induction-and-consolidation-for-patients-with-good-risk-aml-with-npm1-mutation-and-flt3-itd-0-5 weekly 0.8 https://www.themednet.org/is-there-a-role-for-the-use-of-biologics-as-steroid-sparing-agents-in-treating-patients-with-abpa-who-are-intolerant-to-prednisone weekly 0.8 https://www.themednet.org/what-is-the-preferred-approach-to-treating-poorly-controlled-ra-in-the-setting-of-active-hepatitis-b-undergoing-anti-viral-therapy weekly 0.8 https://www.themednet.org/would-you-be-comfortable-starting-tamoxifen-for-a-hr-breast-cancer-patient-with-a-history-of-early-stage-endometrial-cancer-treated-via-hysterectomy weekly 0.8 https://www.themednet.org/would-you-consider-a-parp-inhibitor-in-the-treatment-of-a-parp-inhibitor-naive-platinum-resistant-recurrent-ovarian-cancer-with-loh-hrd weekly 0.8 https://www.themednet.org/how-do-you-approach-preventing-and-treating-bruising-after-filler-injections weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-offer-for-a-cisplatin-eligible-patient-with-upper-tract-urothelial-carcinoma-and-lynch-syndrome weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-t4n1m0-gej-adenocarcinoma-with-local-progression-after-concurrent-chemort-who-still-has-resectable-disease weekly 0.8 https://www.themednet.org/how-would-you-adjust-therapy-for-a-her2-breast-cancer-patient-found-to-have-elevated-lfts-while-on-tchp weekly 0.8 https://www.themednet.org/how-would-you-manage-mild-suv-uptake-at-a-3-month-pet-ct-scan-post-chemort-scan-for-a-scc-of-the-cervix weekly 0.8 https://www.themednet.org/is-post-operative-radiation-therapy-indicated-for-a-sigmoid-colon-cancer-above-the-peritoneal-reflection-status-post-resection-with-operative-pathology-findings-of-positive-lymph-nodes-below-the-peritoneal-reflection weekly 0.8 https://www.themednet.org/do-you-escalate-treatment-for-reactive-lymphadenopathy-in-an-otherwise-stable-and-asymptomatic-patient-with-lupus weekly 0.8 https://www.themednet.org/how-long-do-you-continue-hydroxychloroquine-in-pediatric-patients-with-quiescent-lupus weekly 0.8 https://www.themednet.org/is-there-a-role-for-medications-beyond-treatment-for-concomitant-psychiatric-disorders-in-the-management-of-pediatric-amplified-musculoskeletal-pain-syndrome weekly 0.8 https://www.themednet.org/what-is-your-approach-to-seronegative-presumed-pediatric-autoimmune-encephalitis weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-progressive-muscular-dystrophy-affecting-the-pharyngeal-muscles-who-needs-treatment-for-a-p16-positive-base-of-tongue-cancer-with-bilateral-neck-disease weekly 0.8 https://www.themednet.org/would-you-consider-car-t-therapy-without-autologous-transplant-in-a-patient-with-multiple-myeloma-whose-best-response-to-induction-therapy-is-a-partial-response weekly 0.8 https://www.themednet.org/is-there-a-role-for-biologics-to-help-patients-with-abpa-who-are-steroid-responsive-and-have-removed-their-allergen-insult-but-continue-to-have-an-elevated-serum-ige-and-incomplete-resolution-of-symptoms-return-to-their-baseline-functional-status weekly 0.8 https://www.themednet.org/do-you-prefer-using-an-anthracycline-or-non-anthracycline-adjuvant-regimen-in-brca-premenopausal-patients-with-localized-hr-breast-cancer weekly 0.8 https://www.themednet.org/how-does-your-approach-to-the-primary-treatment-of-glassy-cell-carcinoma-of-the-cervix-differ-from-the-primary-treatment-of-squamous-cell-or-adenocarcinoma-of-the-cervix weekly 0.8 https://www.themednet.org/how-would-you-treat-low-grade-primary-breast-leiomyosarcoma-following-lumpectomy weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-capecitabine-in-a-patient-with-nasopharyngeal-carcinoma-who-has-had-cisplatin-gemcitabine-induction-followed-by-chemoradiotherapy-with-cisplatin weekly 0.8 https://www.themednet.org/how-do-you-clinically-distinguish-between-group-i-and-group-iii-ph-in-patients-with-ctd-ild weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-recommend-surgical-stabilization-prior-to-rt-for-a-femoral-neck-metastasis weekly 0.8 https://www.themednet.org/would-you-provide-the-keynote-522-regimen-for-a-patient-with-er-low-pr-her2-stage-iiib-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-taper-off-clonazepam-in-women-with-epilepsy-who-are-family-planning weekly 0.8 https://www.themednet.org/how-do-you-manage-anti-mi-2-positive-dermatomyositis-with-predominantly-cutaneous-manifestations weekly 0.8 https://www.themednet.org/how-do-you-determine-duration-of-anticoagulation-for-an-ovarian-vein-thrombosis-following-a-provoking-event weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-recurrent-periorificial-dermatitis weekly 0.8 https://www.themednet.org/what-ihc-stains-do-you-routinely-use-for-identifying-invasive-squamous-cell-carcinomas weekly 0.8 https://www.themednet.org/what-is-the-role-of-radiotherapy-in-cutaneous-pseudolymphoma weekly 0.8 https://www.themednet.org/what-is-your-preferred-adjuvant-chemotherapy-regimen-after-a-completely-resected-stage-iiib-granulosa-cell-tumor-of-the-ovary weekly 0.8 https://www.themednet.org/at-what-heart-dose-would-you-prospectively-refer-a-patient-to-cardiology-due-to-anticipated-long-term-risks weekly 0.8 https://www.themednet.org/how-do-you-approach-urate-lowering-therapy-in-patients-with-advanced-chronic-kidney-disease weekly 0.8 https://www.themednet.org/what-is-the-optimal-treatment-strategy-for-patients-with-stage-iv-nsclc-who-have-an-actionable-molecular-target-identified-after-initiation-of-first-line-systemic-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-for-a-patient-with-hypoplastic-mds-who-is-not-eligible-for-transplant weekly 0.8 https://www.themednet.org/what-elective-areas-are-you-comfortable-omitting-in-the-n0-neck-for-npc weekly 0.8 https://www.themednet.org/how-do-you-typically-screen-for-lymphedema-in-breast-cancer-patients-following-rt weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-bisphosphonates-in-reproductive-aged-women weekly 0.8 https://www.themednet.org/is-there-a-role-for-immunosuppression-in-addition-to-standard-pah-therapy-in-the-management-of-pulmonary-hypertension-associated-with-primary-sjogrens-syndrome weekly 0.8 https://www.themednet.org/at-this-time-how-are-you-using-mrd-testing-for-clinical-management-of-patients-with-multiple-myeloma weekly 0.8 https://www.themednet.org/when-planning-to-give-adjuvant-nivolumab-for-esophageal-cancer-would-you-be-comfortable-with-nivolumab-with-q4-weekly-dosing-as-opposed-to-q2-weekly-dosing weekly 0.8 https://www.themednet.org/what-precautions-or-modifications-if-any-would-you-employ-when-considering-lung-sbrt-for-early-nsclc-in-a-patient-recovering-from-acute-lung-injury weekly 0.8 https://www.themednet.org/do-you-avoid-using-tafasitamab-in-germinal-center-subtype-diffuse-large-b-cell-lymphoma weekly 0.8 https://www.themednet.org/can-abiraterone-or-enzalutamide-be-substituted-for-bicalutamide-to-prevent-a-flare-when-initiating-adt-with-a-gnrh-agonist-for-metastatic-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-treat-de-novo-metastatic-hormone-sensitive-prostate-cancer-presenting-with-a-paraneoplastic-syndrome-more-aggressively weekly 0.8 https://www.themednet.org/when-would-you-add-acyclovir-for-treatment-of-bells-palsy-in-addition-to-steroids-and-symptomatic-care weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-glossopharyngeal-neuralgia weekly 0.8 https://www.themednet.org/do-you-discourage-patients-from-skydiving-roller-coasters-with-a-chiari-malformation weekly 0.8 https://www.themednet.org/at-what-point-do-you-recommend-muscle-biopsy-in-the-workup-for-myositis weekly 0.8 https://www.themednet.org/do-you-counsel-patients-against-driving-who-presents-with-transient-global-amnesia weekly 0.8 https://www.themednet.org/what-workup-do-you-recommend-for-patients-with-low-back-pain-and-imaging-concerning-for-spina-bifida-occulta weekly 0.8 https://www.themednet.org/to-what-extent-does-the-degree-of-thrombocytopenia-correlate-with-the-severity-of-cirrhosis weekly 0.8 https://www.themednet.org/what-is-the-appropriate-timeline-to-start-post-mastectomy-chest-wall-regional-nodal-xrt-reconstruction-after-surgery weekly 0.8 https://www.themednet.org/would-you-consider-head-and-neck-rt-for-a-patient-with-pre-existing-carotid-blowout-due-to-tumor-involvement weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-tophaceous-gout-in-patients-whose-uric-acid-is-below-5-prior-to-initiating-uric-acid-lowering-therapy weekly 0.8 https://www.themednet.org/would-you-consider-using-avacopan-in-pr3-mononeuritis-multiplex-without-other-systemic-involvement weekly 0.8 https://www.themednet.org/would-you-have-concerns-starting-an-anti-tnf-in-ra-patients-with-history-of-itp-chronic-idiopathic-thrombocytopenia weekly 0.8 https://www.themednet.org/how-do-you-approach-relapsing-anca-associated-vasculitis-in-a-patient-who-has-already-undergone-kidney-transplant weekly 0.8 https://www.themednet.org/would-you-offer-ofs-ai-alone-or-with-the-addition-of-chemotherapy-in-a-premenopausal-female-with-er-pr-breast-cancer-with-microscopic-ln-involvement-and-an-oncotypedx-score-11 weekly 0.8 https://www.themednet.org/in-a-patient-with-multiple-myeloma-on-lenalidomide-who-develops-covid-19-and-is-going-to-receive-paxlovid-treatment-would-you-stop-lenalidomide-for-the-duration-of-paxlovid-treatment weekly 0.8 https://www.themednet.org/how-long-after-starting-anticoagulation-would-you-remove-an-ivc-filter-in-a-patient-with-a-dvt-presenting-with-stroke-and-pfo-which-is-now-closed weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-to-consider-pleurodesis-vs-indwelling-tunneled-catheters-in-patients-with-malignant-pleural-effusion weekly 0.8 https://www.themednet.org/when-do-you-consider-balloon-pulmonary-angioplasty-in-patients-with-inoperable-cteph weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-regarding-prognosis-following-a-diagnosis-of-ipf weekly 0.8 https://www.themednet.org/what-advantages-does-sbrt-for-rcc-have-compared-to-other-ablative-techniques weekly 0.8 https://www.themednet.org/how-will-you-decide-between-neoadjuvant-checkmate-816-approach-vs-adjuvant-impower010-approach-in-a-fit-patient-with-egfr-negative-resectable-stage-ii-iii-nsclc-patient-with-pd-l1-high-expression-tumor weekly 0.8 https://www.themednet.org/how-long-do-you-delay-post-op-radiation-for-cord-compression-if-there-is-superficial-proximal-scar-dehiscence weekly 0.8 https://www.themednet.org/is-your-decision-to-hypofractionate-or-boost-altered-by-surgeons-plans-for-diep-reconstruction-after-radiotherapy weekly 0.8 https://www.themednet.org/are-you-using-nac-in-lieu-of-hypertonic-saline-amidst-the-current-shortage-of-hypertonic-saline-in-patients-with-either-cf-or-non-cf-bronchiectasis weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-who-develop-minor-antigen-antibodies-and-require-multiple-blood-transfusions weekly 0.8 https://www.themednet.org/how-do-you-manage-high-grade-dysplasia-of-true-vocal-cord-a-yr-after-radiation-to-the-larynx-for-t1-lesion weekly 0.8 https://www.themednet.org/what-is-the-role-of-non-prednisone-oral-glucocorticoids-in-the-management-of-systemic-rheumatologic-disease weekly 0.8 https://www.themednet.org/is-it-safe-to-give-large-fraction-stereotactic-irradiation-for-brain-metastases-concurrently-with-vegf-inhibitors weekly 0.8 https://www.themednet.org/when-do-you-consider-dmard-therapy-in-patients-with-persistent-oligoarticular-jia-who-continue-to-flare-in-adulthood weekly 0.8 https://www.themednet.org/how-do-you-manage-an-implanted-insulin-pump-or-continuous-glucose-monitoring-device-during-radiation weekly 0.8 https://www.themednet.org/do-you-recommend-hydroxyurea-in-patients-with-sickle-cell-disease-with-hereditary-persistence-of-fetal-hemoglobin-who-have-recurrent-vaso-occlusive-crises-requiring-hospital-admission weekly 0.8 https://www.themednet.org/is-there-any-benefit-to-transplant-patients-with-ph-all-who-have-achieved-mrd-negativity weekly 0.8 https://www.themednet.org/with-the-increasing-reports-of-correlation-of-frontal-fibrosing-alopecia-and-titanium-dioxide-sunscreens-do-you-advise-patients-against-the-use-of-micronized-sunscreens-on-the-face weekly 0.8 https://www.themednet.org/would-you-give-antithrombin-concentrate-for-surgical-vte-prophylaxis-in-case-of-congenital-at-deficiency weekly 0.8 https://www.themednet.org/in-a-patient-who-has-poor-pulmonary-function-test-results-do-you-treat-esophageal-cancer-with-concurrent-chemoradiation-therapy weekly 0.8 https://www.themednet.org/are-btk-inhibitors-safe-to-use-in-patients-with-severe-renal-failure weekly 0.8 https://www.themednet.org/how-has-the-virtual-aspect-of-tumor-boards-impacted-their-educational-quality-in-the-covid-19-era weekly 0.8 https://www.themednet.org/what-is-the-optimal-treatment-for-a-fit-elderly-patient-with-ngc-diffuse-large-b-cell-lymphoma-that-recurred-about-1-year-after-dose-attenuated-r-chop weekly 0.8 https://www.themednet.org/when-would-you-recommend-standard-of-care-over-hypofractionated-treatment-in-an-elderly-patient-diagnosed-with-glioblastoma weekly 0.8 https://www.themednet.org/what-would-be-your-preferred-dosage-and-schedule-for-leuprolide-for-ovarian-suppression-alongside-endocrine-therapy-for-the-treatment-of-breast-cancer weekly 0.8 https://www.themednet.org/when-would-you-use-adjuvant-abemaciclib-in-patients-with-clinically-high-risk-er-her2-negative-breast-cancer-but-pcr-following-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-discuss-curative-vs-palliative-treatment-intent-for-patients-with-favorable-risk-1p-19q-co-deleted-oligodendrogliomas weekly 0.8 https://www.themednet.org/how-would-you-approach-radiation-for-a-patient-with-limited-stage-small-cell-lung-cancer-who-refuses-chemotherapy weekly 0.8 https://www.themednet.org/how-does-tumor-stage-affect-your-choice-of-adjuvant-chemotherapy-in-pancreatic-cancer weekly 0.8 https://www.themednet.org/how-do-you-treat-medically-refractory-sleep-related-movement-disorders weekly 0.8 https://www.themednet.org/how-would-you-treat-a-fit-patient-with-a-history-of-relapsed-cll-who-now-presents-with-richter-transformation-s-p-autologous-anti-cd19-chimeric-antigen-receptor-car-t-cells weekly 0.8 https://www.themednet.org/how-do-you-manage-unresectable-granular-cell-tumors-of-the-orbit weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-a-history-of-high-risk-leukemia-who-has-increasing-loss-of-donor-chimerism-in-the-post-transplant-setting-in-the-absence-of-disease-relapse weekly 0.8 https://www.themednet.org/how-important-do-you-feel-hlab51-testing-is-in-diagnosing-behcets-disease weekly 0.8 https://www.themednet.org/would-you-consider-prophylactic-antifungal-treatment-prior-to-immunosuppressive-therapies-in-a-patient-with-previously-treated-pulmonary-coccidiomycosis-and-residual-parenchymal-changes weekly 0.8 https://www.themednet.org/for-a-t1-true-vocal-cord-cancer-that-is-p16-would-you-use-standard-dose-63-gy-in-28-fx-or-use-a-lower-dose-of-radiation weekly 0.8 https://www.themednet.org/what-is-optimal-endocrine-therapy-in-a-young-premenopausal-women-with-er-pr-positive-oligometastic-breast-cancer-successfully-treated-with-curative-intent-neoadjuvant-chemo-followed-by-surgery-rt-to-skeletal-oligomet weekly 0.8 https://www.themednet.org/how-do-you-approach-dmt-choice-in-a-patient-with-ms-with-a-history-of-cancer weekly 0.8 https://www.themednet.org/would-it-be-reasonable-to-offer-a-patient-with-cll-a-treatment-break-from-acalabrutinib-or-any-btk-inihibitor-after-a-period-of-time-assuming-good-response weekly 0.8 https://www.themednet.org/what-treatment-regimen-do-you-start-for-patients-who-present-with-mucous-membrane-pemphigoid weekly 0.8 https://www.themednet.org/would-you-include-the-entire-hardware-as-part-of-isrt-for-a-patient-with-stage-ie-dlbcl-of-the-distal-femur-treated-with-upfront-prophylactic-nailing-for-impending-fracture-who-had-a-cr-to-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-manage-the-developmental-and-behavioral-regression-seen-in-down-syndrome-disintegrative-disorder-dsdd weekly 0.8 https://www.themednet.org/are-adults-with-idd-at-increased-risk-for-adverse-events-like-nms-or-central-anticholinergic-syndrome weekly 0.8 https://www.themednet.org/how-would-you-approach-a-locally-recurrent-her2-positive-breast-cancer-patient-previously-treated-with-tchp-lumpectomy-and-a-year-of-adjuvant-tdm-1 weekly 0.8 https://www.themednet.org/do-you-recommend-giving-anti-complement-therapy-to-a-patient-with-approximately-20-pnh-clones-who-has-severe-aplastic-anemia-but-no-other-risks-for-thrombosis-or-hemolysis weekly 0.8 https://www.themednet.org/can-the-tracheostomy-be-reversed-after-completion-of-chemoradiation-for-laryngeal-cancers weekly 0.8 https://www.themednet.org/do-you-recommend-probiotics-to-patients-receiving-pelvic-radiotherapy weekly 0.8 https://www.themednet.org/how-do-you-define-cisplatin-ineligibility-for-muscle-invasive-bladder-cancer weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiation-for-a-sebaceous-carcinoma-of-head-and-neck-after-wide-local-excision weekly 0.8 https://www.themednet.org/do-you-often-encounter-compressive-neuropathies-such-as-carpal-tunnel-syndrome-in-patients-with-spastic-cerebral-palsy weekly 0.8 https://www.themednet.org/at-what-point-do-you-consider-implantation-of-a-baclofen-pump-in-patients-with-cerebral-palsy weekly 0.8 https://www.themednet.org/what-are-your-recommendations-for-screening-for-sleep-disorders-in-patients-with-idd weekly 0.8 https://www.themednet.org/what-monitoring-do-you-routinely-perform-on-lifelong-eds-for-epilepsy-syndromes weekly 0.8 https://www.themednet.org/how-do-you-dose-apixaban-in-patients-with-crcl-30-ml-minute weekly 0.8 https://www.themednet.org/for-patients-with-multiple-myeloma-when-using-lenalidomide-or-pomalidomide-how-do-you-approach-dose-adjustment-based-on-patient-tolerance weekly 0.8 https://www.themednet.org/in-which-circumstances-would-you-offer-adjuvant-brachytherapy-to-a-surgically-staged-patient-with-endometrial-cancer-if-they-have-received-prior-pelvic-external-beam-radiation-therapy-for-a-non-gynecologic-pelvic-tumor weekly 0.8 https://www.themednet.org/is-there-a-role-for-ivig-in-the-treatment-of-active-morphea-refractory-to-immunosuppressive-agents weekly 0.8 https://www.themednet.org/if-you-have-clinical-suspicion-for-a-paraneoplastic-process-e-g-dermatomyositis-or-pemphigus-what-work-up-do-you-pursue weekly 0.8 https://www.themednet.org/what-is-the-incidence-of-melanoma-arising-from-vitiliginous-patches-and-do-they-develop-from-different-mechanisms-than-melanomas-arising-from-normal-skin weekly 0.8 https://www.themednet.org/what-is-the-most-efficient-way-to-contour-small-and-large-bowel weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-to-a-patient-with-high-grade-pt1-bladder-cancer-with-concurrent-pt2-prostatic-urethral-stroma-involvement weekly 0.8 https://www.themednet.org/do-you-obtain-biopsies-to-confirm-positive-dotatate-pet-scans-during-surveillance-or-treatment weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-who-is-hiv-with-a-p16-scc-obturator-node-presumed-to-be-t0n1-anal-cancer weekly 0.8 https://www.themednet.org/what-holistic-treatments-do-you-recommend-for-patients-with-migraine-without-aura weekly 0.8 https://www.themednet.org/how-would-you-treat-gray-zone-lymphoma-which-initially-achieved-a-cr-after-2-cycles-of-da-r-epoch-but-end-of-treatment-pet-demonstrates-progression-with-new-sites-of-biopsy-proven-disease weekly 0.8 https://www.themednet.org/would-you-treat-with-aza-venetoclax-to-achieve-cr2-before-proceeding-to-allogeneic-stem-cell-transplant-in-a-young-fit-patient-with-favorable-risk-aml-who-relapsed-within-a-year-after-7-3-and-hidac-consolidation weekly 0.8 https://www.themednet.org/when-would-you-consider-a-workup-for-c-diff-in-a-patient-with-diarrhea-under-going-concurrent-chemoradiotherapy-for-rectal-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-workup-for-an-underlying-disorder-in-a-patient-with-bilateral-hip-avascular-necrosis weekly 0.8 https://www.themednet.org/does-romosozumab-need-to-be-followed-immediately-by-an-anti-resorptive-agent-to-preserve-bmd-gains-or-could-you-consider-a-drug-holiday weekly 0.8 https://www.themednet.org/would-the-presence-of-a-close-but-negative-pleomorphic-lcis-surgical-margin-impact-your-decision-for-apbi-in-a-patient-who-is-otherwise-a-favorable-candidate weekly 0.8 https://www.themednet.org/how-does-the-presence-of-concurrent-infections-or-wound-issues-affect-your-choice-and-timing-of-induction-in-patients-with-aml-or-mds-with-excess-blasts weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-elevated-factor-viii-levels-for-their-thrombosis-risk weekly 0.8 https://www.themednet.org/would-you-offer-anti-her2-therapy-to-a-patient-found-to-have-heterogenous-her2-residual-disease-after-original-treatment-for-tnbc-using-the-keynote-522-regimen weekly 0.8 https://www.themednet.org/what-is-the-role-of-stem-cell-transplant-as-a-consolidation-therapy-in-relapsed-wilms-tumor weekly 0.8 https://www.themednet.org/how-does-your-approach-to-low-risk-gestational-trophoblastic-neoplasia-differ-for-patients-whose-hcg-levels-plateau-following-initial-single-agent-systemic-therapy-vs-those-who-have-a-good-initial-response-and-then-plateau weekly 0.8 https://www.themednet.org/how-do-you-boost-patients-with-iva-cervical-cancer-who-present-with-a-large-fistula-that-worsens-during-chemoradiation weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-necrobiosis-lipoidica-especially-cases-that-have-ulcerated weekly 0.8 https://www.themednet.org/when-do-you-prescribe-clascoterone-cream-for-your-acne-patients weekly 0.8 https://www.themednet.org/what-is-your-approach-to-an-incidental-diagnosis-of-low-risk-endometrial-cancer-in-a-patient-who-underwent-minimally-invasive-hysterectomy-with-uterine-morcellation-with-gross-intra-operative-tumor-spillage weekly 0.8 https://www.themednet.org/do-you-give-adjuvant-rt-to-vulva-in-a-patients-with-node-positive-vulvar-cancer-and-no-high-risk-features-for-vulvar-recurrence weekly 0.8 https://www.themednet.org/how-would-you-approach-a-vulvar-cancer-with-para-aortic-and-pelvic-nodes weekly 0.8 https://www.themednet.org/how-do-you-manage-recurrent-inflammatory-pleural-effusions-in-lupus-pleuritis weekly 0.8 https://www.themednet.org/what-patient-characteristics-would-lead-you-to-opt-for-triple-therapy-versus-double-therapy-in-newly-diagnosed-pah weekly 0.8 https://www.themednet.org/how-do-you-approach-the-workup-of-pauci-immune-glomerulonephritis weekly 0.8 https://www.themednet.org/what-is-the-benefit-of-cytoreduction-with-hydroxyurea-for-patients-with-newly-diagnosed-chronic-phase-cml-with-a-wbc-count-100-prior-to-the-initiation-of-a-tki weekly 0.8 https://www.themednet.org/is-there-a-role-for-cyclophosphamide-in-refractory-digital-ischemia-in-patients-with-scleroderma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-toddler-aged-patient-with-speech-apraxia-without-other-autistic-features weekly 0.8 https://www.themednet.org/for-adjuvant-radiation-decision-making-purposes-how-is-the-lower-uterine-segment-lus-defined weekly 0.8 https://www.themednet.org/do-you-routinely-provide-gi-protection-in-the-form-of-a-ppi-or-histamine-blocker-for-patients-with-immunobullous-disease-initiated-on-high-doses-of-oral-corticosteroids weekly 0.8 https://www.themednet.org/do-you-have-particular-recommendations-for-management-of-a-nipple-piercing-during-adjuvant-breast-radiation weekly 0.8 https://www.themednet.org/what-platelet-threshold-if-any-is-your-goal-for-cytoreduction-in-essential-thrombocythemia weekly 0.8 https://www.themednet.org/would-you-target-the-same-hydroxychloroquine-blood-level-for-discoid-lupus-compared-to-systemic-lupus weekly 0.8 https://www.themednet.org/are-there-patients-you-currently-utilize-neoadjuvant-tkis-for-stage-ii-iii-nsclc weekly 0.8 https://www.themednet.org/how-would-you-approach-radiation-to-a-thoracic-tumor-adjacent-to-an-aortic-dissection weekly 0.8 https://www.themednet.org/how-do-you-choose-which-btk-inhibitor-to-use-in-nhl weekly 0.8 https://www.themednet.org/in-what-scenario-would-you-consider-dual-io-and-tki-therapy-in-advanced-stage-melanoma weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-blastoid-mantle-cell-lymphoma-with-hepatic-involvement-causing-significantly-elevated-bilirubin weekly 0.8 https://www.themednet.org/in-a-patient-with-sickle-cell-disease-on-hydroxyurea-who-is-planning-to-have-a-family-for-how-long-should-they-be-off-the-drug-before-trying-to-conceive weekly 0.8 https://www.themednet.org/in-metastatic-recurrent-clear-cell-carcinoma-with-a-solitary-site-of-metastasis-to-the-bone-when-if-ever-do-you-consider-local-therapy-adequate-and-hold-systemic-therapy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-sun-exposure-during-radiation weekly 0.8 https://www.themednet.org/what-is-your-experience-with-iontophoresis-for-hyperhidrosis weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-with-metastatic-castration-resistant-prostate-cancer-and-prior-treatment-with-ra-223-with-lu-117-psma-617-therapy weekly 0.8 https://www.themednet.org/how-do-you-switch-cross-titrate-regular-levodopa-to-rytary-in-a-patient-with-parkinsons-disease weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-radiation-for-low-grade-spindle-cell-neoplasm-of-the-breast-after-lumpectomy weekly 0.8 https://www.themednet.org/do-you-ever-use-ivig-in-patients-with-parsonage-turner-syndrome weekly 0.8 https://www.themednet.org/how-do-you-interpret-a-mildly-positive-nt5c1a-lab-test-in-patients-with-hyperckemia weekly 0.8 https://www.themednet.org/are-there-situations-where-you-would-start-treatment-for-cardiac-amyloid-in-a-patient-with-amyloid-seen-on-biopsy-but-still-pending-mass-spectrometry-results weekly 0.8 https://www.themednet.org/how-do-you-mitigate-the-risk-of-renal-crisis-from-corticosteroids-in-a-patient-with-uctd weekly 0.8 https://www.themednet.org/in-a-patient-with-history-of-pneumonectomy-would-you-consider-sbrt-for-treatment-of-a-new-tumor-in-the-remaining-lung weekly 0.8 https://www.themednet.org/how-do-you-define-bulky-disease-for-hodgkins-lymphoma-which-is-outside-the-mediastinum weekly 0.8 https://www.themednet.org/do-you-routinely-perform-genetic-testing-in-patients-presenting-with-pulmonary-fibrosis-who-endorse-a-family-history-of-fibrotic-lung-disease weekly 0.8 https://www.themednet.org/do-you-consider-the-use-of-bevacizumab-in-patients-with-hht-who-have-high-output-cardiac-failure-related-to-liver-avms-who-also-have-cerebral-avms weekly 0.8 https://www.themednet.org/how-do-you-approach-continuation-versus-cessation-of-systemic-therapy-for-patients-with-stage-iv-triple-negative-breast-cancer-with-a-prolonged-complete-response-to-therapy-and-who-are-tolerating-therapy-well weekly 0.8 https://www.themednet.org/do-you-hold-or-avoid-pemetrexed-in-patients-with-nsclc-and-pleural-effusions weekly 0.8 https://www.themednet.org/what-would-be-your-adjuvant-treatment-approach-for-patients-with-hormone-receptor-positive-breast-cancer-who-have-not-responded-to-neoadjuvant-aromatase-inhibitor-endocrine-therapy weekly 0.8 https://www.themednet.org/in-a-patient-with-a-bleeding-disorder-how-would-one-approach-anticoagulation-during-active-covid-infection weekly 0.8 https://www.themednet.org/in-someone-with-an-asymptomatic-jak2-v617-mutated-and-bcr-abl-negative-mpn-with-a-steadily-rising-wbc-when-do-you-decide-to-start-cytoreductive-therapy-and-which-agent-s-do-you-recommend weekly 0.8 https://www.themednet.org/how-will-you-treat-a-young-man-with-recurrent-cryptogenic-strokes-with-no-identifiable-cause-with-mthfr-a1298c-homozygous-mutation-and-normal-homocysteine-level weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-of-severe-intestinal-vasculopathy-in-patients-with-myositis-such-as-nxp2 weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-younger-patients-with-early-female-pattern-hair-loss weekly 0.8 https://www.themednet.org/would-you-consider-anticoagulation-for-a-young-patient-with-a-recent-embolic-stroke-and-newly-diagnosed-global-cardiac-hypokinesis-with-ejection-fraction-of-less-than-25 weekly 0.8 https://www.themednet.org/when-do-you-recommend-driving-tests-in-patients-who-have-memory-loss weekly 0.8 https://www.themednet.org/when-do-you-order-an-emg-for-evaluation-of-patients-with-movement-disorders weekly 0.8 https://www.themednet.org/how-do-you-work-up-patients-who-present-with-elevated-myoglobin-in-the-setting-of-normal-creatinine-kinase-and-exercise-intolerance weekly 0.8 https://www.themednet.org/when-do-you-pursue-mr-imaging-in-patients-who-present-for-migraine-evaluation weekly 0.8 https://www.themednet.org/do-you-maintain-an-age-cutoff-for-the-use-of-triptans-in-healthy-older-patients-without-cardiovascular-risk-factors weekly 0.8 https://www.themednet.org/outside-of-a-clinical-trial-what-is-your-preferred-third-line-systemic-therapy-option-for-a-patient-with-relapsed-refractory-es-sclc weekly 0.8 https://www.themednet.org/would-you-recommend-xrt-treatment-fields-of-a-locally-recurrent-prostate-cancer-s-p-rp-similar-to-salvage-vs-intact-prostate-treatment weekly 0.8 https://www.themednet.org/does-aspirin-dose-81-mg-vs-325-mg-matter-for-secondary-stroke-prevention weekly 0.8 https://www.themednet.org/when-do-you-consider-plasmapheresis-instead-of-or-in-addition-to-iv-steroids-for-patients-with-acute-ms-exacerbation weekly 0.8 https://www.themednet.org/when-do-you-consider-vascular-imaging-in-patients-with-raynauds-and-what-type-of-imaging-modalities-do-you-utilize weekly 0.8 https://www.themednet.org/for-patients-with-resected-pancreatic-cancer-who-received-neoadjuvant-gemcitabine-abraxane-would-you-switch-to-gemcitabine-capecitabine-to-complete-6-months-of-peri-operative-therapy weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-melanoma-from-asco-2022 weekly 0.8 https://www.themednet.org/how-would-you-manage-a-medically-inoperable-patient-with-an-invasive-squamous-cell-carcinoma-of-the-oropharynx-and-extensive-adjacent-leukoplakia-harboring-pathologically-proven-in-situ-disease weekly 0.8 https://www.themednet.org/what-is-the-appropriate-time-interval-to-assess-treatment-response-in-primary-vaginal-scc weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-stage-i-gastric-malt-who-achieved-a-complete-response-to-chemoimmunotherapy-after-only-2-cycles weekly 0.8 https://www.themednet.org/do-you-consider-bronchoscopic-lung-volume-reduction-in-patients-with-homogenous-emphysema weekly 0.8 https://www.themednet.org/how-would-you-manage-endocrine-therapy-in-a-male-patient-with-gbrca2-with-a-metachronous-contralateral-er-breast-ca-that-occurred-while-on-adjuvant-tamoxifen-for-a-different-er-breast-ca weekly 0.8 https://www.themednet.org/how-do-you-decide-on-a-steroid-sparing-agent-for-idiopathic-orbital-inflammation-partially-responsive-to-steroids weekly 0.8 https://www.themednet.org/what-topical-therapies-have-you-found-most-effective-for-managing-scarring-alopecias weekly 0.8 https://www.themednet.org/what-could-explain-the-discordant-results-between-parp-abiraterone-combinations-in-magnitude-and-propel-in-non-hrrm-prostate-cancer weekly 0.8 https://www.themednet.org/in-the-setting-of-platinum-resistant-ovarian-cancer-do-you-consider-repeat-use-of-bevacizumab-with-subsequent-lines-of-chemotherapy-following-prior-treatment-with-chemotherapy-bevacizumab-with-bevacizumab-maintenance weekly 0.8 https://www.themednet.org/are-there-any-situations-where-you-would-consider-neoadjuvant-chemoradiation-as-opposed-to-chemoimmunotherapy-for-patients-with-resectable-nsclc-prior-to-surgical-resection weekly 0.8 https://www.themednet.org/what-are-various-positioning-and-treatment-techniques-you-use-to-help-reduce-bowel-dose weekly 0.8 https://www.themednet.org/what-is-your-work-up-for-acquired-keratoderma weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-regimen-for-myeloma-with-severe-renal-impairment-either-on-or-off-dialysis weekly 0.8 https://www.themednet.org/how-do-you-evaluate-livedo-reticularis-not-livideo-racemosa weekly 0.8 https://www.themednet.org/in-a-patient-with-extensive-stage-small-cell-lung-cancer-and-a-neurologic-paraneoplastic-syndrome-do-you-feel-comfortable-using-an-ici-along-with-the-chemotherapy weekly 0.8 https://www.themednet.org/are-smooth-muscle-hamartomas-associated-with-hypoplasia-of-underlying-structures weekly 0.8 https://www.themednet.org/what-are-your-preferred-ihc-stain-s-for-desmoplastic-melanoma weekly 0.8 https://www.themednet.org/when-do-you-use-levocarnitine-in-patients-on-depakote-therapy-for-seizures weekly 0.8 https://www.themednet.org/do-you-treat-patients-with-riluzole-who-have-als-and-a-valosin-containing-protein-mutation weekly 0.8 https://www.themednet.org/do-you-ever-do-surveillance-mr-imaging-in-patients-with-stable-exam-and-history-of-cardioembolic-stroke weekly 0.8 https://www.themednet.org/how-do-you-approach-hippocampal-sparing-rt-in-the-setting-of-peri-hippocampal-metastases weekly 0.8 https://www.themednet.org/do-you-utilize-surgical-and-medical-treatments-when-treating-patients-with-erythroplasia-of-queyrat-bowenoid-papulosis-or-giant-condyloma-acuminatum weekly 0.8 https://www.themednet.org/which-if-any-young-fit-intermediate-risk-aml-patients-would-you-not-offer-allogeneic-transplant-to-in-mrd-cr1 weekly 0.8 https://www.themednet.org/do-normal-methylmalonic-acid-levels-absolutely-rule-out-vitamin-b12-deficiency weekly 0.8 https://www.themednet.org/are-there-any-differences-in-your-approach-to-therapy-for-secondary-versus-primary-myelofibrosis weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-synchronous-primary-pancreatic-and-base-of-tongue-cancers weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-new-renal-failure-and-mild-anemia-in-the-setting-of-a-moderate-m-spike-and-low-kappa-lambda-ratio-but-with-negative-pet-and-bone-marrow-with-10-plasma-cells weekly 0.8 https://www.themednet.org/how-soon-do-you-anticipate-response-to-cyclosporine-in-red-cell-aplasia-and-what-cyclosporine-trough-levels-do-you-target weekly 0.8 https://www.themednet.org/do-you-routinely-use-milrinone-to-augment-rv-function-in-patients-with-massive-pulmonary-emboli-on-vasoactive-support weekly 0.8 https://www.themednet.org/in-postmenopausal-osteoporosis-would-you-switch-to-romosozumab-rather-than-a-pth-pthrp-analog-if-a-patient-fractures-while-on-denosumab weekly 0.8 https://www.themednet.org/do-you-require-both-biopsy-of-the-primary-in-addition-to-nodes-in-your-practice-for-hnc weekly 0.8 https://www.themednet.org/would-you-offer-radiation-for-suspected-retroperitoneal-nodal-metastases-in-patient-with-metastatic-colorectal-cancer-with-a-single-liver-metastasis-who-had-an-excellent-response-to-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/would-the-recent-use-of-high-dose-glucocorticoids-impact-your-selection-of-first-line-therapy-for-patients-with-intermediate-poor-risk-metastatic-rcc weekly 0.8 https://www.themednet.org/how-do-you-approach-anticoagulation-in-the-setting-of-hit-and-thrombocytopenia weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-for-a-patient-with-a-biochemical-relapse-while-on-maintenance-lenalidomide-after-autologous-stem-cell-transplant-for-multiple-myeloma weekly 0.8 https://www.themednet.org/which-triptans-do-you-use-in-stroke-induced-migraines weekly 0.8 https://www.themednet.org/do-you-use-any-particular-dose-constraints-in-patients-receiving-whole-brain-radiation-in-the-setting-of-prior-srs weekly 0.8 https://www.themednet.org/what-is-the-earliest-time-to-check-psa-after-prostatectomy weekly 0.8 https://www.themednet.org/when-do-you-use-clinical-decision-tools-like-herdoo2-or-dash-to-determine-duration-of-anticoagulation-in-venous-thromboembolism weekly 0.8 https://www.themednet.org/what-is-your-approach-to-postoperative-radiation-for-intraductal-carcinoma-of-the-parotid weekly 0.8 https://www.themednet.org/how-long-do-you-continue-temozolomide-in-a-patient-receiving-capecitabine-temozolomide-for-well-differentiated-neuroendocrine-tumor weekly 0.8 https://www.themednet.org/in-what-cases-if-any-do-you-find-the-use-of-naltrexone-to-augment-lifestyle-interventions-i-e-cognitive-behavioral-therapy-graded-exercise-therapy-for-chronic-fatigue-to-be-helpful weekly 0.8 https://www.themednet.org/if-a-patient-had-a-grade-2-infusion-reaction-to-initial-dose-of-iv-rituximab-can-you-give-subcutaneous-rituximab-for-cycle-2-or-continue-with-iv-rituximab weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-on-biologics-peri-operatively weekly 0.8 https://www.themednet.org/what-chemical-peels-or-alternative-treatment-modalities-have-you-found-most-effective-for-hyperpigmentation weekly 0.8 https://www.themednet.org/how-do-you-approach-screening-for-occult-cardiac-or-tracheal-involvement-in-a-patient-with-relapsing-polychondritis weekly 0.8 https://www.themednet.org/what-have-you-found-effective-for-the-chronic-fatigue-that-is-often-seen-in-patients-with-sle-or-sjogrens-despite-overall-good-disease-control weekly 0.8 https://www.themednet.org/how-much-weight-would-you-place-on-a-low-titer-ku-antibody-in-a-patient-with-mild-cpk-elevation-but-no-weakness-on-exam-and-no-other-features-of-ctd-overlap-syndrome weekly 0.8 https://www.themednet.org/how-do-you-approach-differentiating-segmental-arterial-mediolysis-from-abdominal-vasculitis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-of-benign-fasciculation-syndrome weekly 0.8 https://www.themednet.org/for-hrrm-prostate-cancer-will-you-use-olaparib-alone-or-in-combination-with-abiraterone weekly 0.8 https://www.themednet.org/can-you-re-treat-vertebral-metastases-with-sbrt weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-ai-abemaciclib-to-a-post-menopausal-node-luminal-a-breast-cancer-that-did-not-require-chemotherapy-per-oncotype-yet-still-met-criteria-per-monarche weekly 0.8 https://www.themednet.org/do-you-continue-endocrine-therapy-for-women-with-her2-hr-metastatic-breast-cancer-when-starting-a-her2-directed-antibody-drug-conjugate weekly 0.8 https://www.themednet.org/do-you-give-iv-fluids-to-avoid-renal-compromise-in-patients-with-inflammatory-myositis-with-a-ck-over-a-certain-threshold weekly 0.8 https://www.themednet.org/in-patients-with-breast-cancer-and-concern-for-bone-only-metastases-on-imaging-but-with-non-diagnostic-ir-biopsies-do-you-pursue-surgical-bone-resection-for-diagnosis-or-treat-empirically-for-metastatic-disease-based-on-pathology-from-breast-lesion weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-high-grade-gastric-lymphoma-who-achieved-a-cr-following-chemotherapy weekly 0.8 https://www.themednet.org/is-there-any-scenario-where-you-would-consider-treating-a-relapsed-aya-patient-with-hodgkin-lymphoma-without-consolidative-auto-transplant weekly 0.8 https://www.themednet.org/do-you-account-for-prior-ebrt-when-treating-with-177lu-psma-617 weekly 0.8 https://www.themednet.org/would-you-offer-ebrt-for-an-unresectable-and-growing-substernal-goiter-compressing-the-trachea-esophagus-and-aorta-that-has-been-refractory-to-rai weekly 0.8 https://www.themednet.org/in-a-breast-cancer-patient-treated-with-neoadjuvant-endocrine-therapy-how-would-the-presence-of-a-lymph-node-micrometastasis-influence-your-recommendations-regarding-radiation-therapy weekly 0.8 https://www.themednet.org/what-drug-class-would-you-use-to-treat-active-psoriasis-and-psoriatic-arthritis-with-axial-involvement-in-patients-on-immunosuppression-for-other-indications-e-g-tacrolimus-for-a-liver-transplant weekly 0.8 https://www.themednet.org/what-protocol-do-you-follow-when-performing-staged-excision-with-paraffin-sections-for-the-treatment-of-cutaneous-melanoma weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-capecitabine-in-a-patient-with-resected-stage-ia-cholangiocarcinoma-with-msi-high-status weekly 0.8 https://www.themednet.org/would-you-add-daratumumab-to-upfront-treatment-of-multiple-myeloma-in-a-patient-with-tetraploidy-on-fish weekly 0.8 https://www.themednet.org/would-you-treat-comprehensive-nodes-in-an-er-pr-her2-breast-cancer-with-an-initial-biopsied-node-showing-atypia-and-then-pcr-0-2-sln-on-lumpectomy weekly 0.8 https://www.themednet.org/what-topical-and-oral-therapies-do-you-prescribe-for-patients-with-recalcitrant-melasma weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-bullous-cutaneous-lupus weekly 0.8 https://www.themednet.org/how-often-do-you-perform-surveillance-brain-mris-in-patients-with-ms-on-highly-effective-dmts weekly 0.8 https://www.themednet.org/how-would-you-reconcile-eqd2-calculation-for-organs-at-risk-in-patients-receiving-bid-fractionation-to-the-chest-after-an-initial-course-of-daily-conventional-fractionation weekly 0.8 https://www.themednet.org/how-do-you-manage-dyschezia-and-tenesmus-following-tnt-with-short-course-rt weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-for-patients-with-microscopic-polyangiitis-who-have-sustained-remission-at-6-months-after-induction-rituximab weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-secondary-progressive-multiple-sclerosis-manifesting-with-increased-neuropsychiatric-manifestations-ex-psychosis-with-no-recent-changes-on-brain-mri weekly 0.8 https://www.themednet.org/is-an-elevated-crp-an-expected-finding-in-an-otherwise-healthy-patient-with-hemoglobin-s-alpha-thalassemia weekly 0.8 https://www.themednet.org/do-you-ever-initiate-pirfenidone-in-patients-with-ctd-ild weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-offer-to-a-young-patient-with-resected-margin-negative-stage-iii-extrahepatic-cholangiocarcinoma weekly 0.8 https://www.themednet.org/should-all-patients-diagnosed-with-b12-deficiency-get-a-baseline-egd weekly 0.8 https://www.themednet.org/in-your-experience-is-a-bra-worn-during-radiation-treatment-for-large-breasted-patients-ever-beneficial weekly 0.8 https://www.themednet.org/are-there-any-contraindications-to-bcs-and-adjuvant-radiotherapy-in-patients-with-bard1-mutation weekly 0.8 https://www.themednet.org/how-do-you-assess-potential-fetal-harm-in-patients-who-have-unplanned-pregnancy-while-taking-teratogenic-medications weekly 0.8 https://www.themednet.org/which-regimen-would-you-recommend-for-a-young-patient-with-node-positive-triple-negative-breast-cancer-with-significant-anthracycline-induced-cardiomyopathy weekly 0.8 https://www.themednet.org/do-you-recommend-starting-an-antiplatelet-for-primary-prophylaxis-in-post-splenectomy-thrombocytosis-given-there-is-some-increased-risk-of-venous-thrombosis weekly 0.8 https://www.themednet.org/how-do-you-evaluate-patients-who-have-panuveitis-without-any-systemic-symptoms weekly 0.8 https://www.themednet.org/do-you-initiate-management-of-new-onset-diabetes-in-a-patient-on-immunotherapy-or-refer-immediately-to-endocrinology-given-the-risk-of-rapid-worsening weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-oligometastatic-crc-who-have-completed-6-months-of-chemotherapy-with-favorable-response-followed-by-partial-hepatectomy-while-awaiting-resection-of-the-primary-tumor weekly 0.8 https://www.themednet.org/would-you-ever-initiate-steroids-during-conventional-lung-radiotherapy-in-a-patient-who-develops-dry-cough-during-treatment weekly 0.8 https://www.themednet.org/do-you-counsel-your-ra-patients-to-hold-their-methotrexate-dose-for-simple-infections-such-as-utis weekly 0.8 https://www.themednet.org/would-you-consider-plex-for-patients-with-dah-from-sle-associated-capillaritis weekly 0.8 https://www.themednet.org/do-you-give-intrapleural-lytics-for-complicated-effusion-empyema-in-patients-on-systemic-anticoagulation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-work-up-and-management-of-interstitial-lung-abnormalities weekly 0.8 https://www.themednet.org/what-is-your-approach-to-further-workup-and-treatment-of-abdominal-aortitis-found-on-imaging-in-asymptomatic-individuals-with-elevated-inflammatory-markers weekly 0.8 https://www.themednet.org/for-a-patient-with-high-suspicion-for-nmda-receptor-encephalitis-is-there-a-role-for-giving-rituximab-along-with-methylprednisolone-ivig-all-three-together-while-the-csf-anti-nmdar-antibodies-are-still-pending weekly 0.8 https://www.themednet.org/do-you-consider-travel-as-a-risk-factor-for-dvts-in-the-absence-of-any-other-underlying-predisposing-factors weekly 0.8 https://www.themednet.org/what-is-your-preferred-regimen-for-palliative-treatment-of-unresectable-retroperitoneal-sarcoma weekly 0.8 https://www.themednet.org/would-you-give-iv-iron-for-low-tsat-in-patients-with-mds-anemia-who-are-transfusion-independent-but-on-an-esa weekly 0.8 https://www.themednet.org/do-you-change-management-in-patients-that-are-taking-bisphosphonates-and-develop-atrial-fibrillation weekly 0.8 https://www.themednet.org/how-would-you-work-up-and-manage-persistent-lymphopenia-in-an-asymptomatic-patient weekly 0.8 https://www.themednet.org/what-are-your-triggers-for-bm-biopsy-in-polycythemia-vera weekly 0.8 https://www.themednet.org/is-ultra-hypofractionation-to-the-whole-breast-an-appropriate-adjuvant-radiation-treatment-for-pagets-localized-to-the-nipple-status-post-central-lumpectomy weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-for-ovarian-carcinosarcoma-that-has-progressed-during-adjuvant-carboplatin-paclitaxel-and-bevacizumab-following-optimal-tumor-reductive-surgery weekly 0.8 https://www.themednet.org/what-workup-and-initial-treatment-should-be-considered-for-suspected-autoimmune-myelofibrosis weekly 0.8 https://www.themednet.org/how-should-one-monitor-for-and-manage-cmv-reactivation-in-patients-receiving-alemtuzumab weekly 0.8 https://www.themednet.org/what-topical-and-oral-therapies-do-you-prescribe-for-patients-with-papulopustular-rosacea weekly 0.8 https://www.themednet.org/when-do-you-order-genetic-studies-such-as-comparative-genomic-hybridization-for-melanocytic-lesions weekly 0.8 https://www.themednet.org/how-would-you-approach-a-rising-pr3-in-a-patient-with-limited-gpa-who-is-currently-asymptomatic-on-methotrexate weekly 0.8 https://www.themednet.org/what-is-your-approach-in-a-patient-who-develops-interstitial-lung-disease-while-on-anti-tnf-therapy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-t2n0-anal-squamous-cell-carcinoma-in-a-patient-with-a-history-of-fap-s-p-remote-proctocolectomy-with-j-pouch-creation weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-on-pegloticase-and-immunomodulation-in-whom-the-uric-acid-has-never-dropped-below-6 weekly 0.8 https://www.themednet.org/when-would-you-recommend-observation-and-withhold-adjuvant-rt-in-resected-esthesioneuroblastoma weekly 0.8 https://www.themednet.org/do-you-utilize-the-same-radiosurgery-constraints-for-each-substructure-of-the-brainstem weekly 0.8 https://www.themednet.org/in-terms-of-contraception-what-do-you-recommend-for-patients-with-a-history-of-hormone-receptor-negative-compared-to-hormone-receptor-positive-breast-cancer weekly 0.8 https://www.themednet.org/where-does-elotuzumab-based-combination-therapy-specifically-epd-fit-in-your-treatment-paradigm-for-relapsed-mm weekly 0.8 https://www.themednet.org/do-you-counsel-patients-with-an-ileostomy-about-significant-diarrhea-when-treating-the-pelvis-with-radiotherapy weekly 0.8 https://www.themednet.org/do-you-ever-employ-the-use-of-prolonged-periods-of-pressure-support-ventilation-as-means-of-weaning-in-the-management-of-patients-with-acute-respiratory-failure weekly 0.8 https://www.themednet.org/how-long-do-you-hold-pyridostigmine-prior-to-emg-nerve-conduction-study-in-patients-with-suspected-myasthenia weekly 0.8 https://www.themednet.org/how-long-after-starting-an-antiepileptic-drug-do-you-check-levels weekly 0.8 https://www.themednet.org/do-you-typically-pursue-emg-nerve-conduction-study-in-patients-who-already-have-a-clinical-diagnosis-of-myasthenia-gravis weekly 0.8 https://www.themednet.org/how-do-you-approach-the-workup-for-patients-with-hyperckemia-and-positive-nxp2-with-no-clinical-symptoms weekly 0.8 https://www.themednet.org/when-performing-salivary-gland-ultrasound-for-sjogrens-what-else-do-you-include-in-the-differential-diagnosis weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-a-patient-with-duodenal-adenocarcinoma-with-ypt3-pn2-disease-on-whipple-resection-after-neoadjuvant-folfox-x6 weekly 0.8 https://www.themednet.org/what-is-the-diagnostic-utility-of-ordering-an-early-sjogrens-syndrome-profile-which-tests-novel-autoantibodies-to-support-a-diagnosis-of-sjogrens-syndrome-in-patients-who-test-negative-for-ssa-ssb weekly 0.8 https://www.themednet.org/do-you-add-trastuzumab-to-adjuvant-chemotherapy-for-patients-with-her2-stage-i-ii-high-grade-serous-uterine-cancer-following-surgical-staging weekly 0.8 https://www.themednet.org/what-dose-fractionation-and-clinical-target-volume-do-you-use-when-treating-tenosynovial-giant-cell-tumor-tgct-historically-known-as-pigmented-villonodular-synovitis-pvns-of-the-knee weekly 0.8 https://www.themednet.org/what-is-your-preferred-second-line-treatment-for-high-grade-neuroendocrine-carcinoma-of-gi-origin-after-progression-on-carboplatin-etoposide weekly 0.8 https://www.themednet.org/do-you-hold-adt-prior-to-biopsy-of-possible-prostate-cancer-metastatic-disease weekly 0.8 https://www.themednet.org/do-you-provide-prophylactic-anticoagulation-with-abemaciclib-in-the-adjuvant-setting-given-known-thrombosis-risk weekly 0.8 https://www.themednet.org/is-axitinib-with-concurrent-spinal-rt-safe weekly 0.8 https://www.themednet.org/how-would-you-manage-subclinical-ild-associated-with-mda-5-dermatomyositis weekly 0.8 https://www.themednet.org/when-using-daratumumab-in-the-setting-of-post-transplant-red-cell-aplasia-or-post-transplant-immune-mediated-cytopenias-do-you-hold-the-drug-for-certain-anc-parameters weekly 0.8 https://www.themednet.org/in-a-patient-who-completed-5-years-of-oral-bisphosphonate-and-has-a-t-score-persistently-in-osteoporotic-range-what-factors-help-you-decide-whether-it-is-appropriate-to-start-a-drug-holiday-vs-switch-to-an-alternative-agent weekly 0.8 https://www.themednet.org/how-do-you-approach-steroid-refractory-gvhd-in-patients-who-either-cannot-receive-ruxolitinib-or-do-not-respond-to-ruxolitinib weekly 0.8 https://www.themednet.org/what-is-the-role-of-kyphoplasty-or-vertebroplasty-in-patients-with-osteoporotic-spinal-fractures weekly 0.8 https://www.themednet.org/how-do-you-approach-managing-perioperative-anxiety-in-mohs-patients weekly 0.8 https://www.themednet.org/how-do-you-manage-nausea-in-the-setting-of-hydroxychloroquine-use weekly 0.8 https://www.themednet.org/what-is-your-approach-to-further-workup-monitoring-and-treatment-of-sjogrens-syndrome-patients-with-positive-cryoglobulins-but-no-clear-signs-of-vasculitis weekly 0.8 https://www.themednet.org/what-is-the-utility-and-yield-of-csf-studies-for-orbital-apex-syndrome weekly 0.8 https://www.themednet.org/how-would-you-approach-a-young-patient-with-stage-i-follicular-lymphoma-of-the-mesenteric-lymph-nodes weekly 0.8 https://www.themednet.org/is-there-a-difference-in-survival-or-disease-response-between-patients-with-recurrence-free-interval-1-vs-1-year-from-platinum-based-cytotoxic-therapy-who-are-treated-with-pembrolizumab-lenvatinib weekly 0.8 https://www.themednet.org/how-do-you-approach-the-initiation-and-or-continuation-of-antiseizure-medication-in-a-patient-who-has-experienced-one-lifetime-seizure-with-a-normal-eeg-and-mri-with-a-comorbid-health-condition-that-is-associated-with-an-increased-risk-of-epilepsy weekly 0.8 https://www.themednet.org/how-long-would-you-consider-the-use-of-low-dose-aspirin-in-a-patient-with-sle-and-high-risk-apl-profile-without-a-clinical-event weekly 0.8 https://www.themednet.org/what-is-your-treatment-algorithm-for-treating-patients-with-lichen-planopilaris weekly 0.8 https://www.themednet.org/what-are-your-treatment-options-for-her2-over-expressing-metastatic-breast-cancer-in-a-patient-whose-lvef-decreased-to-50-from-normal-baseline-on-her2-directed-therapy-and-ef-fails-to-improve-after-holding-therapy-for-2-months weekly 0.8 https://www.themednet.org/what-patient-related-factors-and-hemodynamic-parameters-would-lead-you-to-avoid-transbronchial-biopsies-in-patients-with-pulmonary-hypertension weekly 0.8 https://www.themednet.org/how-would-you-treat-a-locally-recurrent-extraosseous-pulmonary-ewing-sarcoma weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-chemotherapy-for-high-risk-advanced-endometrial-cancer-patients weekly 0.8 https://www.themednet.org/what-is-the-recommended-management-approach-in-regard-to-diagnostic-evaluation-and-treatment-for-patients-with-homocystinuria-and-cerebral-thrombosis weekly 0.8 https://www.themednet.org/how-do-you-approach-a-breast-cancer-with-noninflammatory-skin-invasion-t4b weekly 0.8 https://www.themednet.org/how-would-you-approach-residual-ipsilateral-diaphragmatic-disease-for-m1a-thymic-cancer-after-induction-chemotherapy-and-otherwise-complete-resection-of-primary-and-pleural-disease weekly 0.8 https://www.themednet.org/would-you-offer-upfront-radiation-for-a-large-painful-keloid-of-the-chest-that-has-arisen-from-an-irritated-pyoderma-gangrenosum-lesion weekly 0.8 https://www.themednet.org/do-you-ever-offer-scalp-cooling-therapy-to-metastatic-breast-cancer-patients-wishing-to-avoid-alopecia weekly 0.8 https://www.themednet.org/do-you-consider-clinically-node-negative-patients-who-have-been-on-neoadjuvant-endocrine-therapy-eligible-for-omission-of-axillary-dissection-if-their-sentinel-node-is-positive weekly 0.8 https://www.themednet.org/do-you-hold-nivolumab-and-ipilimumab-when-giving-palliative-radiation-to-abdominal-targets weekly 0.8 https://www.themednet.org/what-are-high-risk-clinical-and-echocardiographic-features-in-pregnant-patients-with-congenital-heart-disease weekly 0.8 https://www.themednet.org/is-extramural-venous-invasion-emvi-alone-an-indication-to-treat-rectal-cancer-patients-with-total-neoadjuvant-therapy-as-opposed-to-neoadjuvant-chemoradiation-therapy-or-short-course-radiation-therapy-alone weekly 0.8 https://www.themednet.org/what-is-the-best-way-to-approach-adjuvant-therapy-for-a-figo-stage-iiib-clear-cell-carcinoma-of-uterus-s-p-tah-bso-with-pathology-showing-extensive-involvement-of-lus-the-cervix-and-bilateral-parametria-with-positive-parametrial-margins weekly 0.8 https://www.themednet.org/would-an-stk11-mutation-influence-your-choice-of-single-vs-combination-immunotherapy-in-a-patient-with-msi-h-metastatic-crc weekly 0.8 https://www.themednet.org/when-if-ever-do-you-use-capecitabine-temozolomide-in-metastatic-high-grade-neuroendocrine-carcinoma weekly 0.8 https://www.themednet.org/how-does-avidity-on-dotatate-pet-impact-your-choice-of-whether-to-start-somatostatin-analogues-in-metastatic-neuroendocrine-tumors weekly 0.8 https://www.themednet.org/what-if-any-adjuvant-therapy-would-you-offer-a-high-risk-based-on-size-location-mitotic-rate-gist-patient-who-is-wild-type-or-pdgfra-d842v-mutated weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-psa-relapse-10-years-after-salvage-radiotherapy-with-psa-doubling-time-6-months weekly 0.8 https://www.themednet.org/what-dose-constraints-if-any-would-you-use-when-administering-tbi weekly 0.8 https://www.themednet.org/in-patients-with-severe-hemophilia-a-on-emicizumab-for-prophylaxis-in-case-of-noncompliance-leading-to-a-lapse-of-more-than-2-3-months-off-therapy-do-you-reload-with-emicizumab weekly 0.8 https://www.themednet.org/for-patients-receiving-tnt-for-locally-advanced-rectal-cancer-who-have-received-chemotherapy-prior-to-chemoradiotherapy-do-you-treat-the-pre-or-post-chemotherapy-volume-for-the-boost-especially-in-patients-who-have-had-a-near-complete-response weekly 0.8 https://www.themednet.org/how-do-you-monitor-a-patient-with-scleroderma-during-pregnancy weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-immune-checkpoint-inhibitor-therapy-for-non-small-cell-lung-cancer-patients-with-residual-disease-after-neoadjuvant-chemoradiation-and-surgical-resection weekly 0.8 https://www.themednet.org/is-there-a-role-for-progestin-therapy-to-temporize-bleeding-from-endometrial-cancer-in-a-patient-with-an-active-venous-thromboembolism weekly 0.8 https://www.themednet.org/how-do-you-counsel-high-risk-women-with-congenital-heart-disease-who-are-looking-to-conceive weekly 0.8 https://www.themednet.org/when-should-we-integrate-ct-calcium-scoring-into-routine-outpatient-practice-to-arbitrate-severity-of-aortic-stenosis weekly 0.8 https://www.themednet.org/when-should-we-consider-screening-patients-with-systemic-sarcoidosis-for-cardiac-involvement-using-cardiac-mri-or-pet-given-their-high-risk-for-sudden-cardiac-death-and-discrepancies-between-reported-cardiac-symptoms-2-5-and-evidence-of-cardiac-inflammati weekly 0.8 https://www.themednet.org/when-should-cardiac-mri-be-obtained-alongside-standard-echocardiography-for-outpatient-monitoring-of-the-progression-of-chronic-aortic-regurgitation weekly 0.8 https://www.themednet.org/which-molecular-biomarkers-do-you-favor-to-risk-stratify-patients-without-cv-risk-factors-before-and-after-undergoing-treatment-with-cardiotoxic-cancer-treatments weekly 0.8 https://www.themednet.org/is-there-a-validated-risk-prediction-model-you-favor-to-risk-stratify-patients-for-cardiotoxicity-prior-to-initiation-of-chemotherapy weekly 0.8 https://www.themednet.org/among-asymptomatic-patients-with-structurally-normal-tte-undergoing-treatment-with-anthracyclines-or-alkylating-agents-that-develop-mildly-elevated-bnp-and-or-troponin-levels-would-you-consider-referring-them-for-cardiac-mri-to-evaluate-for-subclinical-ca weekly 0.8 https://www.themednet.org/what-is-your-preferred-pharmacologic-agent-for-recurrent-vt-suppression-in-arrhythmogenic-right-ventricular-cardiomyopathy weekly 0.8 https://www.themednet.org/what-is-your-stepwise-approach-to-initiating-gdmt-in-the-inpatient-setting-for-newly-diagnosed-hfref weekly 0.8 https://www.themednet.org/should-we-routinely-incorporate-iron-studies-into-admissions-for-acute-decompensated-heart-failure weekly 0.8 https://www.themednet.org/when-is-an-appropriate-time-to-consider-endomyocardial-biopsy-for-non-ischemic-cardiomyopathy weekly 0.8 https://www.themednet.org/should-we-refer-patients-with-nonischemic-cardiomyopathy-without-a-reversible-cause-for-genetic-screening-in-the-absence-of-any-family-history-of-heart-failure-or-sudden-cardiac-death weekly 0.8 https://www.themednet.org/what-is-a-reasonable-blood-pressure-goal-for-refractory-htn-in-the-geriatric-population weekly 0.8 https://www.themednet.org/when-would-you-consider-initiating-gdmt-for-new-onset-hf-in-the-geriatric-population weekly 0.8 https://www.themednet.org/should-we-routinely-include-geriatric-functional-assessments-to-determine-candidacy-for-tavr weekly 0.8 https://www.themednet.org/which-clinical-and-echocardiographic-parameters-i-e-lvef-ava-do-you-use-when-determining-patient-candidacy-for-lv-device-assisted-percutaneous-balloon-aortic-valvuloplasty-in-patients-with-cardiogenic-shock-and-severe-as weekly 0.8 https://www.themednet.org/is-there-a-preferred-heart-rate-range-for-patients-with-moderate-to-severe-paravalvular-leak-post-tavr weekly 0.8 https://www.themednet.org/what-would-be-a-reasonable-means-of-mechanical-circulatory-support-as-a-bridge-to-avr-for-patients-with-severe-aortic-regurgitation-complicated-by-cardiogenic-shock weekly 0.8 https://www.themednet.org/among-asymptomatic-patients-with-chronic-severe-primary-mr-can-serial-global-longitudinal-strain-measurements-assist-with-determining-timing-for-repeat-surveillance-tees-and-or-facilitate-timing-for-mvr weekly 0.8 https://www.themednet.org/what-is-a-reasonable-surveillance-strategy-and-length-of-time-to-maintain-patients-with-thrombosed-bioprosthetic-valves-on-systemic-anticoagulation weekly 0.8 https://www.themednet.org/when-should-we-consider-using-acarbose-for-postprandial-hypotension-2 weekly 0.8 https://www.themednet.org/what-is-your-approach-to-initiating-and-titrating-midodrine-for-both-inpatient-and-ambulatory-settings weekly 0.8 https://www.themednet.org/which-class-es-of-antihypertensives-do-you-recommend-for-first-line-therapy-for-hypertension-in-severe-aortic-stenosis weekly 0.8 https://www.themednet.org/is-there-any-benefit-to-supervised-pad-exercise-programs-in-the-presence-of-collaterals-seen-on-angiography-for-patients-with-severe-claudication-and-significant-lesions weekly 0.8 https://www.themednet.org/should-a-toe-brachial-index-be-obtained-in-lieu-of-resting-abi-as-an-initial-screen-for-pad-in-high-risk-patients-such-as-those-with-longstanding-diabetes-or-advanced-age-with-stiffened-vessels weekly 0.8 https://www.themednet.org/is-it-sufficient-to-maintain-patients-with-atrial-fibrillation-and-established-pad-on-a-doac-or-vka-alone-or-is-there-an-additional-benefit-to-adding-an-antiplatelet-agent-for-cvd-benefit weekly 0.8 https://www.themednet.org/should-bare-metal-stents-be-favored-over-drug-eluting-stents-for-pregnant-patients-presenting-with-acute-coronary-syndrome weekly 0.8 https://www.themednet.org/should-we-begin-using-bromocriptine-for-cvd-management-during-pregnancy-per-esc-guidelines-in-patients-with-peripartum-cardiomyopathy weekly 0.8 https://www.themednet.org/should-all-pregnant-patients-with-newly-reduced-lvef-45-be-referred-as-soon-as-possible-to-advanced-heart-failure-given-high-risk-for-maternal-morbidity-mortality-in-setting-of-suspected-peripartum-cardiomyopathy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-medical-management-and-echocardiographic-surveillance-for-pregnant-patients-with-severe-aortic-stenosis-during-the-first-second-and-third-trimesters weekly 0.8 https://www.themednet.org/what-is-your-approach-to-weaning-iabps weekly 0.8 https://www.themednet.org/what-are-your-preferred-ventilatory-settings-mode-s-for-patients-with-acute-hypoxic-respiratory-failure-presenting-with-severe-biventricular-dysfunction-in-cardiogenic-shock weekly 0.8 https://www.themednet.org/would-you-consider-coronary-artery-calcium-scoring-or-coronary-cta-for-asymptomatic-elite-competitive-sports-athletes-undergoing-routine-screening-visits-without-a-family-history-significant-for-coronary-artery-disease weekly 0.8 https://www.themednet.org/should-we-have-a-lower-threshold-to-consider-revascularization-of-coronary-lesions-in-athletes-compared-to-non-athletes weekly 0.8 https://www.themednet.org/when-would-you-consider-implantable-loop-recorders-for-athletes-with-nonspecific-complaints-of-palpitations-dizziness-without-known-history-of-arrhythmias weekly 0.8 https://www.themednet.org/what-is-your-preferred-rate-control-agent-for-atrial-fibrillation-with-rapid-ventricular-rate-and-why weekly 0.8 https://www.themednet.org/for-young-adults-20-39-years-of-age-with-moderate-hypercholesterolemia-should-we-aim-to-reduce-ldl-c-levels-by-or-equal-to-50-and-maintain-them-on-long-term-statin-therapy weekly 0.8 https://www.themednet.org/can-doacs-be-a-reasonable-alternative-instead-of-vka-for-management-of-lv-thrombus-post-mi-and-what-is-a-reasonable-follow-up-time-for-surveillance-outpatient-imaging-and-subsequent-duration-of-therapy-outpatient weekly 0.8 https://www.themednet.org/do-you-recommend-inguinal-hernia-repair-before-or-after-chemort-for-inguinal-node-positive-anal-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-young-adult-patient-with-significant-nail-psoriasis-and-not-much-cutaneous-disease weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-epithelioid-hemangioendothelioma weekly 0.8 https://www.themednet.org/how-would-you-differentiate-new-onset-inflammatory-myositis-from-paraneoplastic-phenomena-in-a-patient-with-recurrent-uterine-cancer-who-is-taking-aromatase-inhibitor weekly 0.8 https://www.themednet.org/how-do-you-manage-anti-seizure-medications-at-follow-up-in-patients-who-had-acute-symptomatic-seizures-due-to-pres weekly 0.8 https://www.themednet.org/how-would-you-approach-an-early-stage-ii-unfavorable-hodgkins-lymphoma-following-6-cycles-abvd-with-persistent-deauville-5-with-negative-biopsy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-bulky-9-cm-dlbcl-of-the-axilla-following-an-excisional-biopsy-to-negative-margins weekly 0.8 https://www.themednet.org/would-you-recommend-definitive-xrt-with-extensive-lymph-node-involvement-of-prostate-cancer weekly 0.8 https://www.themednet.org/for-male-patients-who-strongly-prefer-to-stop-anticoagulation-for-unprovoked-vte-are-there-any-tools-or-labs-that-you-would-use-to-guide-your-decision-making weekly 0.8 https://www.themednet.org/when-if-ever-would-you-consider-lenvatinib-pembrolizumab-as-first-line-therapy-for-patients-with-stage-iv-microsatellite-stable-endometrial-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-adjuvant-radiation-in-patients-with-intrahepatic-cholangiocarcinoma-ihcc-resected-with-a-positive-margin-r1-resection weekly 0.8 https://www.themednet.org/does-multi-level-facet-joint-ankylosis-without-vertebral-body-ankylosis-heighten-your-suspicion-for-axial-spondyloarthritis-or-can-isolated-facet-joint-ankylosis-be-explained-by-degenerative-disease-of-the-spine-alone weekly 0.8 https://www.themednet.org/in-which-clinical-scenarios-would-you-prefer-to-sequence-chemotherapy-prior-to-radiation-therapy-in-total-neoadjuvant-therapy-for-locally-advanced-rectal-cancer weekly 0.8 https://www.themednet.org/in-massive-transfusion-protocol-from-suspected-hemorrhage-is-it-worth-obtaining-a-teg-to-guide-transfusion weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-ongoing-scleritis-in-sle-despite-mycophenolate weekly 0.8 https://www.themednet.org/how-would-you-manage-a-premenopausal-woman-with-dcis-who-has-a-contraindication-to-tamoxifen weekly 0.8 https://www.themednet.org/are-there-instances-where-you-would-offer-erdafitinib-instead-of-avelumab-for-maintenance-therapy-for-fgfr3-mutated-metastatic-bladder-cancer-after-stable-disease-on-cisplatin-gemcitabine weekly 0.8 https://www.themednet.org/for-a-patient-with-psma-mcrpc-but-relatively-low-suv-values-does-that-influence-your-decision-to-use-177lu-psma-or-discussion-with-patient-regarding-potential-benefit weekly 0.8 https://www.themednet.org/what-is-the-appropriate-management-of-arthralgias-associated-with-bosutinib weekly 0.8 https://www.themednet.org/do-you-hold-iv-iron-in-the-setting-of-active-infection weekly 0.8 https://www.themednet.org/what-recommendations-do-you-have-for-a-transgender-female-patient-with-history-of-prothrombin-gene-mutation-who-is-interested-in-starting-gender-affirming-hormone-therapy weekly 0.8 https://www.themednet.org/are-there-any-data-that-suggest-superiority-of-lenvatinib-pembrolizumab-vs-platinum-based-cytotoxic-chemotherapy-for-advanced-or-recurrent-endometrial-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-antiepileptic-medication-for-a-patient-with-treatment-refractory-epilepsy-who-also-has-alcohol-use-disorder weekly 0.8 https://www.themednet.org/do-you-utilize-ethyl-chloride-spray-prior-to-steroid-injections weekly 0.8 https://www.themednet.org/how-would-you-treat-a-young-patient-with-a-resected-stage-iii-chromophobe-rcc weekly 0.8 https://www.themednet.org/do-you-consider-discontinuing-maintenance-therapy-in-transplant-ineligible-patients-with-multiple-myeloma weekly 0.8 https://www.themednet.org/do-you-routinely-send-ngs-testing-from-bone-marrow-samples-in-patients-with-unexplained-cytopenia-or-cytoses weekly 0.8 https://www.themednet.org/do-you-recommend-ivig-and-or-cytoreduction-for-patients-with-igm-mgus-with-reciprocal-depression-in-igg-and-recurrent-infections weekly 0.8 https://www.themednet.org/what-is-the-appropriate-time-to-initiate-adjuvant-chemo-endocrine-therapy-for-premenopausal-er-pr-her2-negative-early-stage-breast-cancer-with-moderate-oncotype-following-breast-conserving-surgery weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiation-in-a-woman-with-solitary-plasmacytoma-of-the-breast-who-underwent-lumpectomy-with-clear-surgical-margins weekly 0.8 https://www.themednet.org/if-you-treat-a-patient-with-high-risk-smoldering-myeloma-on-trial-and-they-develop-biochemical-progression-by-m-spike-but-still-no-crab-slim-criteria-what-would-you-do-next weekly 0.8 https://www.themednet.org/what-is-your-simulation-setup-and-dose-fractionation-for-dlbcl-of-the-hand-with-deauville-4-residual-disease-following-r-chop weekly 0.8 https://www.themednet.org/do-you-continue-to-routinely-screen-for-renal-involvement-in-a-patient-with-established-sjogrens-syndrome-who-otherwise-has-only-sicca-symptoms weekly 0.8 https://www.themednet.org/do-you-employ-a-phrenic-nerve-dose-constraint-with-conventional-fractionation weekly 0.8 https://www.themednet.org/is-there-any-role-for-re-biopsy-and-ngs-for-patients-with-nsclc-and-kras-g12c-at-time-of-progression-after-first-line-therapy-before-starting-sotorasib-or-after-progression-on-sotorasib weekly 0.8 https://www.themednet.org/what-topical-or-oral-treatments-do-you-recommend-for-patients-with-recurrent-mrsa-infections weekly 0.8 https://www.themednet.org/what-biologics-have-you-found-to-be-most-effective-in-treating-hidradenitis-suppurativa weekly 0.8 https://www.themednet.org/how-do-you-approach-malignant-plexopathy weekly 0.8 https://www.themednet.org/when-planning-prostate-brachytherapy-do-you-use-a-bladder-neck-constraint weekly 0.8 https://www.themednet.org/how-do-you-manage-and-or-prevent-ruxolitinib-withdrawal-syndrome weekly 0.8 https://www.themednet.org/do-you-need-to-hold-humira-adalimumab-during-radiation-for-breast-cancer-in-a-patient-with-psoriatic-arthritis weekly 0.8 https://www.themednet.org/is-there-a-role-for-il2-receptor-antagonists-and-tnf-alpha-inhibitors-in-cytokine-release-syndrome-as-a-complication-of-car-t-or-immunotherapy weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-recommend-using-the-2helps2b-score-to-decide-whether-or-not-to-pursue-long-term-ceeg weekly 0.8 https://www.themednet.org/does-your-practice-currently-use-low-dose-radiation-in-the-treatment-of-osteoarthritis weekly 0.8 https://www.themednet.org/how-would-you-manage-an-isolated-port-site-recurrence-of-grade-1-endometrioid-endometrial-cancer weekly 0.8 https://www.themednet.org/at-what-ferritin-threshold-would-a-patient-with-anemia-of-inflammation-or-malignancy-no-longer-benefit-from-iron-supplementation-for-functional-iron-deficiency weekly 0.8 https://www.themednet.org/when-considering-omission-of-elective-nodal-irradiation-in-the-post-op-head-and-neck-bilateral-dissected-pn0-setting-what-is-considered-an-adequately-dissected-neck weekly 0.8 https://www.themednet.org/would-you-continue-ruxolitinib-in-combination-with-hma-plus-venetoclax-in-myelofibrosis-at-the-time-of-transformation-to-aml weekly 0.8 https://www.themednet.org/how-do-you-manage-calcium-and-vitamin-d-replacement-in-scleroderma-and-myositis-patients-with-dysphagia-and-malabsorption weekly 0.8 https://www.themednet.org/what-additional-immunomodulation-would-you-consider-in-a-patient-with-severe-nxp-2-jdm-who-has-already-received-cyclophosphamide-and-rituximab-but-has-persistent-gastrointestinal-vasculopathy weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-idiopathic-aortitis weekly 0.8 https://www.themednet.org/would-you-consider-adding-immune-checkpoint-blockade-to-platinum-etoposide-for-metastatic-high-grade-large-cell-neuroendocrine-tumor-of-the-gi-tract weekly 0.8 https://www.themednet.org/in-uterine-cancer-how-does-positive-peritoneum-biopsy-influence-your-recommendation-for-adjuvant-rt weekly 0.8 https://www.themednet.org/will-you-use-or-have-you-been-using-the-ipss-m-as-the-primary-way-to-risk-stratify-patients-with-mds-to-determine-use-of-hypomethylating-agents weekly 0.8 https://www.themednet.org/would-you-consider-trastuzumab-deruxtecan-for-a-patient-with-metastatic-her2-colorectal-cancer-even-if-the-cancer-is-ras-mutated weekly 0.8 https://www.themednet.org/would-you-recommend-that-hematologists-test-for-clonal-hematopoiesis-of-indeterminate-potential-chip-in-patients-with-an-intermediate-10-year-risk-of-ascvd weekly 0.8 https://www.themednet.org/how-would-you-treat-a-bladder-cancer-with-rectal-invasion-with-radiation weekly 0.8 https://www.themednet.org/what-is-your-current-practice-around-genomic-sequencing-for-pediatric-cancers weekly 0.8 https://www.themednet.org/how-do-you-manage-refractory-hyponatremia-in-patients-on-active-therapy-in-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/do-you-utilize-oncotype-dx-dcis-score-to-decide-on-the-need-and-duration-of-endocrine-therapy-in-patients-with-dcis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-nodal-coverage-in-a-patient-with-lateralized-adenoid-cystic-carcinoma-ie-buccal-mucosa-with-positive-lymph-node-s weekly 0.8 https://www.themednet.org/how-do-you-approach-performing-ebus-tbna-in-patients-with-latex-allergy weekly 0.8 https://www.themednet.org/would-you-consider-definitive-radiation-to-a-medically-inoperable-patient-with-left-sided-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/do-you-include-the-entire-seroma-in-your-lumpectomy-cavity-volume-for-pbi-when-it-extends-far-beyond-surgical-clips weekly 0.8 https://www.themednet.org/what-would-your-radiation-field-be-for-a-7-5-cm-dlbcl-involving-the-tibia-with-pretibial-soft-tissue-involvement-after-cr-to-r-chop-x6 weekly 0.8 https://www.themednet.org/how-would-you-approach-radiation-treatment-for-a-grade-3a-follicular-lymphoma-that-has-recurred-multiple-times-with-one-site-of-active-disease weekly 0.8 https://www.themednet.org/how-do-you-plan-to-use-adjuvant-denosumab-in-patients-with-hormone-positive-breast-cancer-given-the-survival-advantage-seen-in-the-abcsg-18-trial weekly 0.8 https://www.themednet.org/would-you-prefer-nivolumab-ipilimumab-combination-over-single-agent-pembrolizumab-for-a-metachronous-low-volume-msi-h-metastatic-colon-cancer-with-kras-mutation weekly 0.8 https://www.themednet.org/is-there-a-difference-in-treatment-of-status-epilepticus-from-alcohol-withdrawal-vs-other-causes weekly 0.8 https://www.themednet.org/how-do-you-initially-treat-patients-with-cn3-cm0-esophageal-cancer weekly 0.8 https://www.themednet.org/would-you-consider-trastuzumab-deruxtecan-as-next-line-of-therapy-for-patients-with-erbb2-mutation-positive-stage-iiib-nsclc-who-progress-within-6-months-of-chemo-radiation weekly 0.8 https://www.themednet.org/for-patients-with-nsclc-on-osimertinib-who-progress-would-you-continue-osimertinib-when-moving-onto-chemotherapy-for-2nd-line-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-a-local-failure-with-a-rising-psa-following-prostate-sbrt weekly 0.8 https://www.themednet.org/what-systemic-therapy-would-you-recommend-for-a-patient-with-metastatic-triple-negative-breast-cancer-her2-1-who-has-progression-of-brain-mets-after-wbrt-and-while-receiving-first-line-chemotherapy weekly 0.8 https://www.themednet.org/what-patient-factors-if-any-would-lead-you-to-extubate-a-patient-at-high-risk-of-extubation-failure-to-avaps-rather-than-bipap weekly 0.8 https://www.themednet.org/other-than-b12-repletion-is-there-any-further-treatment-or-work-up-indicated-in-pernicious-anemia-with-positive-parietal-cell-antibodies weekly 0.8 https://www.themednet.org/how-do-you-explain-ttp-to-patients weekly 0.8 https://www.themednet.org/what-aspirin-dose-do-you-favor-for-thrombotic-prophylaxis-in-myeloproliferative-neoplasms weekly 0.8 https://www.themednet.org/how-do-you-manage-mpn-patients-with-acquired-vwd-in-the-perioperative-setting weekly 0.8 https://www.themednet.org/what-recommendations-do-you-have-for-patients-with-post-vaccination-neurologic-amyotrophy-parsonage-turner-syndrome-regarding-their-future-vaccinations weekly 0.8 https://www.themednet.org/what-is-your-approach-to-using-apremilast-for-psoriatic-arthritis-in-patients-with-history-of-depression weekly 0.8 https://www.themednet.org/how-do-you-manage-early-stage-breast-cancer-patients-with-suspicious-internal-mammary-nodes-on-imaging weekly 0.8 https://www.themednet.org/what-prescription-or-over-the-counter-therapies-do-you-recommend-for-patients-with-side-effects-from-vismodegib weekly 0.8 https://www.themednet.org/what-is-your-treatment-algorithm-for-management-of-retroperitoneal-fibrosis-that-does-not-respond-to-high-dose-glucocorticoids weekly 0.8 https://www.themednet.org/how-do-you-approach-radiotherapy-after-the-patient-has-a-facial-nerve-graft-as-result-of-tumor-resection weekly 0.8 https://www.themednet.org/in-what-situations-would-you-place-a-prophylactic-trach-prior-to-radiation-for-head-and-neck-cancers weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-recurrent-dlbcl-15-years-after-definitive-treatment-of-initial-de-novo-disease-with-r-chop weekly 0.8 https://www.themednet.org/how-would-you-approach-an-adolescent-patient-with-stage-iiic-serous-borderline-tumor-s-p-fertility-sparing-surgical-staging-with-unilateral-salpingo-oophorectromy-who-presents-with-an-enlarging-contralateral-ovarian-mass-and-additional-pelvic-disease-on-i weekly 0.8 https://www.themednet.org/when-would-you-consider-neoadjuvant-rt-for-dermatofibrosacroma-protuberans weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-steroid-refractory-necrobiosis-lipoidica weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-offer-following-adjuvant-chemotherapy-for-a-patient-with-stage-iii-lung-adenocarcinoma-with-an-atypical-egfr-mutation-such-as-egfr-l861r weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-stage-iiia-non-seminoma-with-an-anaphylactoid-reaction-to-etoposide-during-first-cycle weekly 0.8 https://www.themednet.org/do-you-continue-androgen-receptor-pathway-inhibitors-in-patients-receiving-lu177-psma-for-metastatic-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-hold-histone-deacetylase-hdac-inhibitors-for-patients-receiving-palliative-radiation-therapy-for-cutaneous-lymphomas weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-incidentally-found-to-have-pet-avid-large-vessel-vasculitis-on-ct-angiogram-during-pre-cabg-workup weekly 0.8 https://www.themednet.org/what-duration-of-adt-abiraterone-do-you-recommend-prior-to-initiation-of-hdr-brachytherapy-followed-by-ebrt-for-very-high-risk-localized-ct3bn0-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-ever-refer-patients-for-surgery-with-significant-peripheral-neuropathy-and-lumbosacral-radiculopathy weekly 0.8 https://www.themednet.org/how-do-you-approach-covid-vaccine-counseling-in-patients-with-rheumatic-disease-and-history-of-pericarditis-serositis weekly 0.8 https://www.themednet.org/do-you-consider-a-solitary-ihc-sentinel-inguinal-node-lymph-node-to-have-the-same-implication-for-treatment-as-a-single-positive-node-or-multiple-positive-nodes weekly 0.8 https://www.themednet.org/does-preoperative-rupture-always-necessitate-whole-abdomen-rt-for-wilms-tumor weekly 0.8 https://www.themednet.org/do-you-commonly-recommend-oral-minoxidil-dutasteride-or-a-combination-of-both-for-patients-with-androgenic-alopecia weekly 0.8 https://www.themednet.org/what-is-the-role-of-pd-1-inhibitors-in-relapsed-b-cell-all weekly 0.8 https://www.themednet.org/how-would-you-treat-an-elderly-patient-with-t1-glottic-laryngeal-cancer-who-refuses-28-fractions weekly 0.8 https://www.themednet.org/what-were-the-historical-radiation-fields-and-dose-for-treatment-of-benign-tonsillitis weekly 0.8 https://www.themednet.org/how-does-a-diffusely-positive-psma-in-the-prostate-affect-treatment-planning-in-a-patient-with-mri-and-biopsy-showing-only-one-area-of-disease weekly 0.8 https://www.themednet.org/how-would-you-manage-a-non-surgical-poorly-differentiated-neuroendocrine-tumor-of-unknown-primary-with-a-bulky-nodal-conglomerate-causing-pain weekly 0.8 https://www.themednet.org/how-would-you-approach-cytopenias-5-weeks-after-initial-dosing-in-a-young-patient-with-mds-treated-with-azacitadine-as-a-bridge-to-transplant weekly 0.8 https://www.themednet.org/what-factors-influence-whether-you-treat-a-suspected-flare-of-nmosd-neuromyelitis-optica-spectrum-disorder-with-pulse-dose-steroids-versus-plasmaphereis weekly 0.8 https://www.themednet.org/when-if-ever-would-you-consider-ovarian-preservation-in-a-premenopausal-patient-with-high-grade-endometrial-carcinoma weekly 0.8 https://www.themednet.org/do-you-recommend-adjuvant-chemotherapy-in-a-patient-with-node-positive-gastric-adenocarcinoma-with-mixed-dmmr-msi-histology weekly 0.8 https://www.themednet.org/what-is-your-preferred-medical-treatment-of-carpal-tunnel-syndrome-that-recurs-after-carpal-tunnel-release weekly 0.8 https://www.themednet.org/when-do-you-investigate-for-genetic-causes-in-a-young-patient-presenting-with-new-onset-parkinsonism weekly 0.8 https://www.themednet.org/would-you-restart-prophylactic-anticoagulation-in-a-patient-with-a-history-of-unprovoked-pe-who-received-short-term-anticoagulation-with-a-prior-physician weekly 0.8 https://www.themednet.org/does-ctdna-play-a-surveillance-role-in-advanced-biliary-tract-cancers-during-active-therapy-assessing-response-and-or-defining-relapsing-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-dermatomyositis-related-to-underlying-malignancy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-recurrent-anaplastic-supratentorial-ependymoma-in-an-adult weekly 0.8 https://www.themednet.org/how-would-you-approach-second-line-treatment-for-prostate-adenocarcinoma-with-diffuse-neuroendocrine-features weekly 0.8 https://www.themednet.org/what-dose-and-setup-would-be-recommended-for-isolated-penile-shaft-metastasis-from-bladder-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-a-locally-advanced-anorectal-melanoma-with-local-progression-after-4-cycles-of-nivolumab-and-ipilimumab-who-is-not-a-surgical-candidate weekly 0.8 https://www.themednet.org/would-you-offer-post-op-adjuvant-radiation-following-keloid-resection-if-it-would-result-in-a-significant-dose-being-delivered-to-the-patients-thyroid-gland weekly 0.8 https://www.themednet.org/how-do-you-choose-between-azithromycin-and-roflumilast-in-the-management-of-a-patient-with-severe-copd-who-remains-symptomatic-with-frequent-exacerbations-despite-maximal-dose-laba-lama-ics-with-demonstrated-compliance-and-proper-inhaler-technique weekly 0.8 https://www.themednet.org/how-would-you-manage-eber-positive-non-keratinizing-scca-of-unknown-primary-in-the-head-and-neck weekly 0.8 https://www.themednet.org/what-are-your-takeaways-from-the-gprc5d-targeted-car-t-trial-mailankody-et-al-nejm-sept-2022-and-any-key-differences-compared-to-the-bcma-directed-products weekly 0.8 https://www.themednet.org/how-do-you-manage-a-ta-pure-squamous-cell-carcinoma-of-the-urinary-bladder weekly 0.8 https://www.themednet.org/should-sbrt-for-bone-metastasis-be-delivered-daily-or-every-other-day weekly 0.8 https://www.themednet.org/what-radiation-fractionation-scheme-would-you-use-to-palliate-a-patient-with-metastatic-paratesticular-leiomyosarcoma-limited-mainly-to-soft-tissue-sites-as-well-as-the-scrotum weekly 0.8 https://www.themednet.org/what-dose-fractionation-scheme-would-you-employ-to-palliate-a-metastatic-colon-cancer-patient-with-several-large-painful-anterior-abdominal-wall-lesions weekly 0.8 https://www.themednet.org/what-features-on-pft-or-flow-volume-loops-do-you-look-at-to-suspect-small-airway-dysfunction weekly 0.8 https://www.themednet.org/what-is-your-approach-and-preferred-first-line-treatment-regimen-for-advanced-metastatic-adenosquamous-nsclc weekly 0.8 https://www.themednet.org/how-would-you-treat-active-rheumatoid-arthritis-in-a-patient-in-complete-response-on-loralatinib-for-stage-iv-alk-positive-nsclc weekly 0.8 https://www.themednet.org/what-are-your-recommendations-regarding-sexual-activity-for-a-couple-when-one-of-them-is-diagnosed-with-a-hpv-positive-oropharyngeal-cancer weekly 0.8 https://www.themednet.org/how-do-you-create-the-boost-fields-for-a-definitive-bladder-cancer-treatment weekly 0.8 https://www.themednet.org/for-a-patient-who-has-core-binding-factor-aml-but-also-a-small-flt3-itd-mutation-detected-do-you-proceed-with-allo-transplant-or-only-hidac-consolidation-after-achieving-cr-from-induction-chemotherapy weekly 0.8 https://www.themednet.org/how-would-treat-a-patient-with-good-performance-status-with-ptcl-nos-found-to-have-leptomeningeal-disease-during-treatment-course-with-choep weekly 0.8 https://www.themednet.org/when-do-you-recommend-post-operative-radiation-therapy-for-extracranial-chondrosarcoma weekly 0.8 https://www.themednet.org/what-would-your-next-line-treatment-be-for-a-patient-previously-treated-with-repeat-resection-craniospinal-irradiation-and-initial-cisplatin-vincristine-ccnu-with-medulloblastoma weekly 0.8 https://www.themednet.org/would-you-still-offer-adjuvant-osimertinib-to-patients-who-elect-not-to-receive-chemotherapy-in-resected-egfr-mutated-lung-cancer weekly 0.8 https://www.themednet.org/do-you-recheck-screening-labs-esr-bun-cr-urinalysis-ana-etc-for-patients-with-recurrent-small-vessel-vasculitis-of-unknown-origin-with-each-flare weekly 0.8 https://www.themednet.org/for-siewert-3-locally-advanced-gej-adenocarcinoma-when-do-you-offer-preop-chemoradiation-cross-regimen-vs-periop-chemotherapy-magic-or-flot weekly 0.8 https://www.themednet.org/how-would-you-manage-an-older-frail-ecog-2-patient-with-stage-ii-muscle-invasive-bladder-cancer-with-other-competing-risk-of-death weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-small-fiber-neuropathy-and-elevated-fgfr3-titers-of-6000 weekly 0.8 https://www.themednet.org/how-do-you-incorporate-ctdna-in-the-management-of-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-anti-platelet-therapy-in-patients-presenting-with-ischemic-stroke-and-have-a-history-of-von-willebrand-disease weekly 0.8 https://www.themednet.org/would-a-patient-receiving-intravitreal-avastin-have-a-contraindication-to-prostate-radiation weekly 0.8 https://www.themednet.org/any-role-for-adjuvant-systemic-therapy-for-resected-sebaceous-skin-carcinoma weekly 0.8 https://www.themednet.org/how-would-you-treat-de-novo-met-amplified-ras-wt-metastatic-crc-after-progression-on-standard-first-line-therapy weekly 0.8 https://www.themednet.org/do-you-treat-secondary-erythrocytosis-caused-by-sglt2-inhibitor weekly 0.8 https://www.themednet.org/would-you-consider-upfront-immunotherapy-in-a-patient-with-msi-strongly-positive-locally-advanced-adenocarcinoma-of-the-anus-versus-standard-of-care weekly 0.8 https://www.themednet.org/how-do-you-choose-bridging-therapy-prior-to-car-t-leukapheresis weekly 0.8 https://www.themednet.org/do-you-use-gcsf-for-a-patient-with-mds-with-excess-blasts-and-neutropenia weekly 0.8 https://www.themednet.org/would-you-ever-hold-off-consolidation-durvalumab-in-nsclc-stage-iii-after-chemoradiation-if-kras-g12c-mutation-positive-given-recent-concerns-for-toxicity-with-io-sotorasib weekly 0.8 https://www.themednet.org/for-pediatric-ewing-sarcoma-what-is-the-role-of-metastatic-site-consolidation weekly 0.8 https://www.themednet.org/how-do-you-select-systemic-therapy-for-recurrent-hr-her2-negative-breast-cancer-in-the-bones-in-a-premenopausal-woman-within-a-year-of-starting-adjuvant-ai-with-ofs-plus-abemaciclib-and-zoledronic-acid weekly 0.8 https://www.themednet.org/when-the-initial-diagnosis-of-stage-i-uterine-leiomyosarcoma-is-made-via-a-non-intact-resection-such-as-a-myomectomy-or-supracervical-hysterectomy-what-factors-if-any-might-push-you-to-consider-adjuvant-chemotherapy-after-completion-surgery weekly 0.8 https://www.themednet.org/how-do-you-monitor-risk-of-erythrocytosis-from-testosterone-use-for-female-to-male-transgender-patients weekly 0.8 https://www.themednet.org/do-you-rule-out-tb-in-patients-with-aids-and-lobar-pneumonia weekly 0.8 https://www.themednet.org/is-there-any-data-for-prophylactic-use-of-lymphedema-sleeves-during-breast-radiation weekly 0.8 https://www.themednet.org/do-you-utilize-a-constraint-for-skin-dermatitis-in-setting-of-thoracic-chemoradiation weekly 0.8 https://www.themednet.org/how-do-you-workup-splenomegaly-related-to-possible-hematologic-etiology-in-the-absence-of-abnormal-blood-counts-adenopathy-or-severe-constitutional-symptoms weekly 0.8 https://www.themednet.org/how-would-you-confirm-the-diagnosis-of-splenic-marginal-zone-lymphoma-without-utilizing-splenic-biopsy-or-splenectomy weekly 0.8 https://www.themednet.org/how-do-you-work-up-a-young-patient-with-increasing-ferritin-and-normal-tsat-without-infectious-inflammatory-or-liver-disorders weekly 0.8 https://www.themednet.org/do-you-consider-induction-immunotherapy-or-chemoio-prior-to-chemoradiation-for-locally-advanced-pdl-1-50-nsclc-if-normal-tissue-constraints-are-not-met weekly 0.8 https://www.themednet.org/is-there-value-to-oncotype-dx-and-or-ngs-testing-for-mutations-such-as-esr1-in-patients-who-have-ipsilateral-isolated-resectable-skin-recurrence-in-er-positive-low-oncotype-breast-cancer-10-years-after-mastectomy-and-adjuvant-ai-for-5-years weekly 0.8 https://www.themednet.org/on-a-field-in-field-breast-tangent-plan-do-you-have-a-minimum-mu-you-accept-for-a-subfield weekly 0.8 https://www.themednet.org/what-is-the-choice-of-treatment-for-a-teenager-with-low-risk-neuroblastoma-s-p-resection weekly 0.8 https://www.themednet.org/when-you-use-selinexor-for-relapsed-refractory-myeloma-with-what-total-weekly-dose-do-you-practically-start weekly 0.8 https://www.themednet.org/how-do-you-treat-colorectal-cancer-with-heterogeneous-loss-of-mismatch-repair-protein-expression weekly 0.8 https://www.themednet.org/how-do-you-integrate-surgery-in-treatment-of-recurrent-tenosynovial-giant-cell-tumors-tgct-when-using-pexidartinib weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-chemotherapy-in-resected-t4n0-colon-cancer weekly 0.8 https://www.themednet.org/when-and-how-would-you-consider-utilizing-checkpoint-inhibitor-immunotherapy-in-egfr-mutated-metastatic-lung-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-initiating-belimumab-in-a-patient-with-serologic-evidence-of-prior-hepatitis-b-infection weekly 0.8 https://www.themednet.org/why-is-it-recommended-that-patients-not-apply-moisturizer-in-the-radiation-field-immediately-prior-to-daily-treatment weekly 0.8 https://www.themednet.org/when-do-you-recommend-treating-stimulus-induced-generalized-periodic-discharges-gpds weekly 0.8 https://www.themednet.org/what-elective-nodal-areas-do-you-cover-in-medically-inoperable-endometrial-cancer weekly 0.8 https://www.themednet.org/how-do-you-modify-your-dose-constraints-when-giving-lung-sbrt-to-a-new-lesion-in-a-patient-previously-treated-with-lung-sbrt weekly 0.8 https://www.themednet.org/how-do-you-approach-methotrexate-management-in-patients-with-rheumatoid-arthritis-and-moderate-nash-but-no-fibrosis-per-fibrosure weekly 0.8 https://www.themednet.org/is-there-any-role-for-prophylactic-bronchial-artery-embolization-in-immunocompromised-patients-with-invasive-pulmonary-aspergillosis weekly 0.8 https://www.themednet.org/how-should-you-work-up-calvarium-or-other-osseous-lesions-when-found-during-the-initial-staging-of-a-patient-with-a-new-diagnosis-of-nsclc-otherwise-non-metastatic weekly 0.8 https://www.themednet.org/which-chemo-regimen-if-any-would-you-use-as-adjuvant-treatment-in-a-young-patient-with-primary-malignant-thyroid-teratoma weekly 0.8 https://www.themednet.org/when-can-abdominal-surgery-be-safely-performed-for-presumptive-ovarian-cancer-in-a-patient-with-recent-pulmonary-emboli weekly 0.8 https://www.themednet.org/what-is-the-ideal-interval-to-wait-after-surgery-before-starting-external-beam-pbi-treatment weekly 0.8 https://www.themednet.org/what-is-the-treatment-strategy-for-a-resected-atypical-endometriosis-mass-in-the-parametrium-that-has-grade-1-endometrioid-adenocarcinoma-in-patient-who-had-prior-elective-hysterectomy-bso weekly 0.8 https://www.themednet.org/is-there-any-role-for-ascertaining-somatostatin-receptor-status-with-a-dotatate-pet-scan-in-prostatic-adenocarcinoma-with-neuroendocrine-features-to-consider-lanreotide-along-with-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-manage-a-diabetic-patient-with-generalized-myasthenia-gravis-post-thymectomy-previously-treated-with-imuran weekly 0.8 https://www.themednet.org/is-it-safe-to-give-radiation-to-a-breast-cancer-patient-with-discoid-lupus weekly 0.8 https://www.themednet.org/what-is-the-treatment-of-choice-for-mixed-phenotype-all weekly 0.8 https://www.themednet.org/what-are-some-techniques-youve-used-in-the-past-to-manage-medial-canthal-webbing-after-surgery weekly 0.8 https://www.themednet.org/what-timeframe-do-you-recommend-for-performing-imaging-in-pediatric-patients-with-moderate-to-high-risk-congenital-melanocytic-nevi weekly 0.8 https://www.themednet.org/how-do-you-determine-if-a-positive-thimerosal-patch-test-isnt-a-false-positive weekly 0.8 https://www.themednet.org/is-there-a-role-of-everolimus-or-capecitabine-and-temozolomide-in-diffuse-idiopathic-pulmonary-neuroendocrine-cell-hyperplasia-in-patients-already-on-octreotide weekly 0.8 https://www.themednet.org/is-there-any-pft-criteria-that-you-use-in-guiding-decision-making-to-offer-transbronchial-lung-cryobiopsy-to-patients-with-interstitial-lung-disease weekly 0.8 https://www.themednet.org/how-do-you-utilize-p53-ngs-testing-in-your-treatment-planning-for-patients-with-cll weekly 0.8 https://www.themednet.org/after-definitive-prostate-rt-when-do-you-prescribe-adt-for-local-salvage-ebrt-hdr-ldr weekly 0.8 https://www.themednet.org/what-are-the-current-treatment-options-for-progressive-multifocal-leukoencephalopathy-in-patients-without-hiv-aids weekly 0.8 https://www.themednet.org/can-apls-cause-a-false-positive-hit-elisa weekly 0.8 https://www.themednet.org/what-is-your-approach-in-differentiating-ipaf-interstitial-pneumonia-with-autoimmune-features-versus-ctd-ild-in-patients-with-serologic-abnormalities-but-do-not-fulfill-criteria-for-autoimmune-disease weekly 0.8 https://www.themednet.org/is-there-a-role-for-low-dose-aspirin-in-a-patient-with-avn-in-four-large-joints-who-has-underlying-well-controlled-sle-and-positive-apls-but-no-history-of-clots weekly 0.8 https://www.themednet.org/what-is-the-optimal-management-of-a-patient-needing-surgical-clearance-for-a-knee-replacement-with-vwf-ag-and-factor-viii-between-40-50-and-no-bleeding-history weekly 0.8 https://www.themednet.org/how-would-you-treat-an-elderly-patient-with-biopsy-proven-extensive-non-resectable-metastatic-pseudopapillary-pancreatic-tumor weekly 0.8 https://www.themednet.org/how-does-failure-to-recover-clinically-after-2-years-in-a-patient-with-suspected-diabetic-amytrophy-shift-diagnostic-and-therpeutic-approach weekly 0.8 https://www.themednet.org/do-you-routinely-obtain-next-generation-sequencing-for-patients-with-metastatic-renal-cell-carcinoma-and-if-so-what-is-your-approach-to-incorporating-these-results-into-treatment-decision-making weekly 0.8 https://www.themednet.org/how-do-you-manage-triple-negative-primary-squamous-cell-carcinoma-of-the-breast weekly 0.8 https://www.themednet.org/would-you-consider-post-operative-sbrt-following-long-bone-stabilization-i-e-femoral-intramedullary-nail-for-radioresistant-tumors weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-do-you-recommend-for-an-unresectable-epithelioid-hemangioendothelioma-of-the-rib weekly 0.8 https://www.themednet.org/is-oral-lichen-planus-a-contraindication-for-immunotherapy-in-a-patient-with-recurrent-oral-scc weekly 0.8 https://www.themednet.org/are-there-any-concerns-utilizing-apremilast-for-psoriatic-arthritis-in-patients-who-are-also-taking-roflumilast-for-copd weekly 0.8 https://www.themednet.org/do-you-prescribe-antifibrotics-to-patients-with-combined-pulmonary-fibrosis-and-emphysema-cpfe weekly 0.8 https://www.themednet.org/how-would-you-manage-an-adult-patient-status-post-subtotal-resection-of-spinal-osteoblastoma weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-rectal-cancer-with-a-solitary-lung-metastasis-who-now-has-no-evidence-of-disease-after-total-neoadjuvant-therapy-followed-by-rectal-surgery-and-resection-of-the-solitary-metastasis weekly 0.8 https://www.themednet.org/do-you-recommend-a-waiting-period-to-conceive-after-prostate-radiation weekly 0.8 https://www.themednet.org/how-would-you-manage-young-female-patients-with-a-phyllodes-tumor-of-the-breast-s-p-excision-with-a-positive-margin-at-the-posterior-fascia weekly 0.8 https://www.themednet.org/do-you-see-any-role-for-parp-inhibitors-in-nsclc-given-the-recent-pin-trial-of-maintenance-olaparib-did-not-show-significant-improvement-in-pfs weekly 0.8 https://www.themednet.org/how-would-you-treat-a-newly-metastatic-er-pr-her2-triple-positive-breast-cancer-with-diffuse-symptomatic-disease-and-severe-neuropathy-from-prior-adjuvant-paclitaxel weekly 0.8 https://www.themednet.org/would-you-consider-radiotherapy-for-unresectable-malignant-pleural-mesothelioma-in-an-asymptomatic-patient weekly 0.8 https://www.themednet.org/does-the-magnitude-of-oncotype-recurrence-score-above-26-inform-decision-between-tc-and-ac-t-in-er-her2-1-3-node-positive-postmenopausal-patients-with-breast-cancer weekly 0.8 https://www.themednet.org/are-there-any-contraindications-to-starting-a-patient-on-dupixent-for-prurigo-nodularis-if-the-patient-is-already-on-xolair-for-asthma weekly 0.8 https://www.themednet.org/how-do-you-select-your-first-line-endocrine-therapy-to-accompany-cdk4-6-inhibitor-in-metastatic-hr-breast-cancer weekly 0.8 https://www.themednet.org/when-do-you-pursue-interventional-treatments-in-a-lung-transplant-patient-with-anastomotic-dehiscence-complicated-by-a-bronchopleural-fistula weekly 0.8 https://www.themednet.org/how-often-should-you-screen-for-lymphoma-in-patients-with-primary-sjogrens-syndrome weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-metastatic-testicular-cancer-nsgct-who-has-multiple-cns-only-recurrences-after-prior-systemic-bep-and-tip weekly 0.8 https://www.themednet.org/how-have-the-results-of-rtog-1112-influenced-your-opinion-of-y90-and-other-ir-ablative-strategies-vs-sbrt-for-hcc-not-amenable-to-surgery weekly 0.8 https://www.themednet.org/based-on-results-from-adaura-in-clinical-practice-how-likely-are-you-to-recommend-adjuvant-chemotherapy-prior-to-adjuvant-osimertinib-for-stage-iia-t2bn0-egfr-mutant-nsclc weekly 0.8 https://www.themednet.org/do-you-routinely-use-sweat-tests-if-you-are-going-to-titrate-a-cf-patient-onto-a-lower-dose-of-eti-for-any-reason-allergy-mental-health-etc-to-assess-the-severity-of-their-response-to-the-lower-dose weekly 0.8 https://www.themednet.org/how-do-you-utilize-cytokine-panels-in-your-clinical-practice weekly 0.8 https://www.themednet.org/how-do-you-choose-between-tpo-ra-for-itp weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-use-for-a-patient-with-unresectable-er-pr-her2-negative-breast-cancer-who-declines-chemotherapy-and-progresses-locally-after-receiving-endocrine-therapy-with-abemaciclib weekly 0.8 https://www.themednet.org/how-would-you-treat-newly-diagnosed-metastatic-her2-positive-breast-cancer-with-liquid-ngs-revealed-erbb2-l755s-mutation-a-marker-for-resistance-against-trastuzumab weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-recurrent-metastatic-hcc-6-years-after-liver-transplant-for-hcc weekly 0.8 https://www.themednet.org/do-you-routinely-screen-for-pulmonary-artery-aneurysm-in-patients-with-behcets weekly 0.8 https://www.themednet.org/what-is-the-significance-of-isolated-increase-of-asialo-gm1-antibodies-with-nerve-conduction-suggestive-of-sensory-motor-axonal-polyneuropathy weekly 0.8 https://www.themednet.org/should-osimertinib-be-held-prior-to-yttrium-90-liver-directed-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-the-use-of-jak-inhibitors-in-a-patient-with-stable-ra-who-is-now-starting-treatment-for-pulmonary-mac-infection weekly 0.8 https://www.themednet.org/does-recent-covid-19-infection-result-in-elevated-psa weekly 0.8 https://www.themednet.org/how-long-do-you-wait-after-fiducial-marker-placement-to-simulate-patients-undergoing-liver-sbrt weekly 0.8 https://www.themednet.org/what-is-the-recommended-length-for-adt-in-the-setting-of-n1-disease-receiving-definitive-radiation weekly 0.8 https://www.themednet.org/do-you-typically-recommend-a-wash-out-period-when-switching-patients-with-myasthenia-gravis-from-soliris-to-vyvgart weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-ra-with-methotrexate-in-a-patient-with-treated-hepatitis-c-and-normal-liver-function weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-a-patient-with-pah-who-is-resistant-to-contraception-and-planning-a-pregnancy weekly 0.8 https://www.themednet.org/in-what-situations-would-you-omit-craniospinal-irradiation-in-a-patient-with-a-pineoblastoma weekly 0.8 https://www.themednet.org/what-is-the-recommended-radiation-treatment-volume-for-a-patient-with-orbital-dlbcl-who-achieved-a-cr-to-chemotherapy weekly 0.8 https://www.themednet.org/for-cisplatin-ineligible-patients-with-locally-advanced-head-and-neck-cancer-would-you-consider-rt-immunotherapy-rather-than-rt-cetuximab weekly 0.8 https://www.themednet.org/how-do-you-manage-long-term-xerosis-and-xerophthalmia-in-patients-who-have-completed-a-course-of-isotretinoin weekly 0.8 https://www.themednet.org/do-you-ever-consider-using-a-higher-dose-of-upadacitinib-30-mg-daily-for-rheumatoid-arthritis-in-patients-who-fail-to-respond-partially-respond-to-established-dosing-of-15-mg-daily weekly 0.8 https://www.themednet.org/what-treatment-would-you-recommend-to-a-patient-with-a-locally-recurrent-sarcoma-of-the-retrohepatic-ivc-reconstruction-of-ivc-with-ptfe-graft-resected-over-2-years-ago weekly 0.8 https://www.themednet.org/when-are-steroids-indicated-in-the-treatment-of-strep-pneumo-meningitis weekly 0.8 https://www.themednet.org/do-you-find-mri-helpful-to-differentiate-early-erosive-oa-from-psoriatic-arthritis-when-early-x-ray-changes-in-both-conditions-may-be-hard-to-distinguish weekly 0.8 https://www.themednet.org/what-is-your-approach-to-bk-hemorrhagic-cystitis-not-responding-to-cidofovir weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-bilateral-synchronous-breast-cancers-and-evidence-of-metastatic-disease-on-imaging-when-one-breast-has-a-triple-negative-cancer-and-the-other-breast-has-a-er-pr-negative-her2-cancer weekly 0.8 https://www.themednet.org/in-patients-with-secondary-sjogrens-how-do-you-approach-screening-for-lymphoproliferative-malignancy weekly 0.8 https://www.themednet.org/is-it-preferred-to-use-vmat-or-dynamic-conformal-arcs-for-coplanar-lung-sbrt weekly 0.8 https://www.themednet.org/does-covid-19-infection-and-use-of-paxlovid-or-other-antivirals-affect-your-decision-on-timing-of-maintenance-anti-cd20-mab-therapy-eg-rituxan-ocrevus-in-patients-with-multiple-sclerosis weekly 0.8 https://www.themednet.org/what-constraints-do-you-use-for-a-non-weight-bearing-bone-when-treating-a-patient-with-sarcoma weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-a-grade-4-idh-mutant-astrocytoma-a-diagnosis-now-distinct-from-glioblastoma-according-to-the-2021-who-classification-for-cns-tumors weekly 0.8 https://www.themednet.org/which-patients-with-acute-promyelocytic-leukemia-do-you-consider-maintenance-after-completing-consolidation weekly 0.8 https://www.themednet.org/for-a-postmenopausal-patient-with-a-pt2n0-breast-cancer-s-p-bcs-snb-who-qualifies-for-ma20-how-do-you-decide-between-rni-high-tangents-and-standard-whole-breast-rt weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-stage-ie-gastric-malt-lymphoma-with-negative-testing-for-h-pylori weekly 0.8 https://www.themednet.org/would-you-consider-adding-durvalumab-to-second-line-chemotherapy-for-cholangiocarcinoma-which-progressed-on-gem-cis-alone weekly 0.8 https://www.themednet.org/in-stage-4-hilar-cholangiocarcinoma-after-stenting-the-biliary-tree-is-there-value-in-radiating-the-hilar-area-in-addition-to-systemic-therapy-so-as-to-maintain-patency-of-the-biliary-system-for-a-longer-period-of-time-or-do-you-depend-on-the-systemic-the weekly 0.8 https://www.themednet.org/how-do-you-define-bone-disease-progression-in-mcrpc-while-on-docetaxel weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-therapy-of-any-kind-to-a-patient-with-synchronous-primary-lung-cancers-if-all-early-stage-and-curatively-treated weekly 0.8 https://www.themednet.org/are-there-instances-when-you-do-not-perform-urine-microscopy-and-rely-solely-on-laboratory-performed-urinalysis-when-evaluating-a-patient-for-acute-kidney-injury weekly 0.8 https://www.themednet.org/do-you-use-any-urinary-staining-techniques-when-performing-urine-microscopy-for-patients-with-acute-kidney-injury weekly 0.8 https://www.themednet.org/what-is-your-blood-pressure-or-mean-arterial-pressure-goal-in-a-critically-ill-patient-with-acute-kidney-injury weekly 0.8 https://www.themednet.org/when-do-you-restart-acei-arb-medications-for-patients-whom-these-medications-were-previously-discontinued-due-to-acute-kidney-injury weekly 0.8 https://www.themednet.org/do-you-recommend-uric-acid-lowering-therapies-for-asymptomatic-hyperuricemia-in-chronic-kidney-disease weekly 0.8 https://www.themednet.org/do-you-use-alkali-therapy-in-those-with-stable-chronic-kidney-disease-and-a-normal-serum-bicarbonate-level-who-have-a-low-urine-ph weekly 0.8 https://www.themednet.org/how-much-decrease-in-egfr-do-you-tolerate-before-discontinuing-a-sglt2i-started-in-patients-with-diabetic-kidney-disease weekly 0.8 https://www.themednet.org/when-do-you-avoid-or-stop-erythropoietin-stimulating-agents-in-patients-with-anemia-and-end-stage-kidney-disease weekly 0.8 https://www.themednet.org/when-do-you-avoid-or-stop-iron-agents-in-patients-with-anemia-and-end-stage-kidney-disease weekly 0.8 https://www.themednet.org/do-you-treat-low-25-oh-vitamin-d-levels-in-those-with-end-stage-kidney-disease weekly 0.8 https://www.themednet.org/what-is-the-antifungal-prophylaxis-regimen-that-you-use-in-patients-on-peritoneal-dialysis-who-are-receiving-antibiotics weekly 0.8 https://www.themednet.org/are-there-cases-of-glomerulonephritis-where-you-do-not-perform-a-kidney-biopsy-in-a-patient-deemed-safe-to-undergo-the-procedure weekly 0.8 https://www.themednet.org/how-frequently-do-you-monitor-anti-pla2r-antibody-titers-in-patients-with-stable-renal-function-proteinuria-and-a-past-diagnosis-of-pla2r-associated-membranous-nephropathy weekly 0.8 https://www.themednet.org/what-changes-to-immunosuppressant-medications-do-you-adopt-for-kidney-transplant-patients-who-contract-covid-19 weekly 0.8 https://www.themednet.org/how-do-you-approach-covid-19-vaccination-in-those-who-underwent-kidney-transplantation-for-native-kidney-glomerular-disease weekly 0.8 https://www.themednet.org/do-you-routinely-advise-patients-waiting-for-a-kidney-transplant-to-seek-referrals-at-multiple-institutions-to-decrease-waiting-time weekly 0.8 https://www.themednet.org/which-medications-do-you-deem-necessary-to-stop-prior-to-measuring-plasma-renin-and-plasma-aldosterone-when-evaluating-a-patient-for-possible-primary-aldosteronism weekly 0.8 https://www.themednet.org/for-which-patients-do-you-prioritize-ambulatory-blood-pressure-monitoring-over-self-measured-blood-pressure weekly 0.8 https://www.themednet.org/how-do-you-estimate-daily-dietary-sodium-intake-in-your-patients-with-hypertension weekly 0.8 https://www.themednet.org/do-you-prefer-transtubular-potassium-gradient-ttkg-or-urine-potassium-to-urine-creatinine-ratio-when-evaluating-patients-with-abnormal-potassium-levels weekly 0.8 https://www.themednet.org/what-degree-of-hyperkalemia-do-you-tolerate-for-those-with-proteinuric-chronic-kidney-disease-and-persistently-elevated-serum-potassium-levels weekly 0.8 https://www.themednet.org/what-is-your-approach-to-using-bisphosphonates-in-those-with-severe-hypercalcemia-and-chronic-kidney-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-hypocalcemia-following-a-parathyroidectomy-in-patients-with-end-stage-kidney-disease weekly 0.8 https://www.themednet.org/what-is-your-daily-correction-goal-for-those-patients-being-treated-for-hyponatremia weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-use-of-desmopressin-prior-to-performing-a-kidney-biopsy-to-potentially-prevent-procedural-associated-bleeding weekly 0.8 https://www.themednet.org/is-there-a-platelet-count-threshold-when-you-would-avoid-performing-a-kidney-biopsy-in-patients-with-thrombocytopenia weekly 0.8 https://www.themednet.org/are-there-instances-when-you-perform-a-repeat-kidney-biopsy-in-patients-whom-tolerated-the-first-procedure-but-are-still-without-a-definitive-diagnosis weekly 0.8 https://www.themednet.org/what-is-your-mmhg-threshold-to-cancel-a-kidney-biopsy-for-patients-with-pre-procedural-elevated-blood-pressures weekly 0.8 https://www.themednet.org/do-you-require-patients-who-undergo-a-kidney-biopsy-to-be-admitted-to-the-hospital-for-observation weekly 0.8 https://www.themednet.org/under-what-conditions-do-you-perform-a-post-procedural-kidney-ultrasound-in-patients-who-recently-underwent-a-kidney-biopsy weekly 0.8 https://www.themednet.org/do-you-advise-patients-to-limit-physical-exertion-including-lifting-heavy-objects-following-a-kidney-biopsy weekly 0.8 https://www.themednet.org/which-patients-do-you-recommend-referral-to-interventional-radiology-to-perform-a-kidney-biopsy weekly 0.8 https://www.themednet.org/how-frequently-do-you-obtain-24-hour-urine-stone-risk-profiles-in-your-patients-with-kidney-stone-disease-who-pass-less-than-one-stone-per-year weekly 0.8 https://www.themednet.org/in-which-patients-do-you-obtain-genetic-testing-for-further-evaluation-of-kidney-stone-disease weekly 0.8 https://www.themednet.org/how-do-you-advise-your-kidney-stone-patients-about-optimal-daily-fluid-intake weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-medical-management-of-struvite-kidney-stones weekly 0.8 https://www.themednet.org/what-dietary-advice-do-you-provide-your-patients-with-calcium-oxalate-nephrolithiasis weekly 0.8 https://www.themednet.org/how-would-you-work-up-a-mildly-neutropenic-patient-anc-800-with-family-history-of-neutropenia-and-personal-history-of-occasional-mouth-sore weekly 0.8 https://www.themednet.org/would-you-drop-the-duration-of-palbociclib-from-1-21-days-to-1-14-days-if-still-neutropenic-with-75-mg-dose-in-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-treat-patients-with-linear-iga-that-are-deficient-in-g6pd weekly 0.8 https://www.themednet.org/how-do-you-advise-patients-with-sickle-cell-disease-on-contraception weekly 0.8 https://www.themednet.org/what-is-the-appropriate-management-of-severe-myalgia-during-atezolizumab-infusion weekly 0.8 https://www.themednet.org/how-do-you-typically-treat-aortitis-associated-with-spondyloarthritis weekly 0.8 https://www.themednet.org/do-you-ever-offer-spine-sbrt-for-patients-with-multiple-adjacent-involved-vertebrae weekly 0.8 https://www.themednet.org/when-do-you-consider-cenobamate-for-focal-epilepsy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-muscle-invasive-bladder-carcinoma-with-multifocal-cis-who-refuses-cystectomy weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-consider-for-salvage-re-irradiation-of-a-vestibular-schwannoma-after-fractionated-stereotactic-radiation-4-years-later weekly 0.8 https://www.themednet.org/what-is-your-approach-to-cmml-mds-in-an-older-patient-with-low-risk-disease-who-is-becoming-transfusion-dependent weekly 0.8 https://www.themednet.org/in-patients-chronically-treated-for-wilsons-disease-with-trientine-hydrochloride-syprine-would-you-expect-development-of-neurologic-symptoms weekly 0.8 https://www.themednet.org/how-do-you-approach-ictal-interictal-continuum-in-patients-with-presumed-toxic-metabolic-etiology weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-gvhd-prophylaxis-in-the-setting-of-severe-infection weekly 0.8 https://www.themednet.org/would-you-consider-partial-breast-reirradiation-in-an-otherwise-healthy-elderly-patient-with-a-distant-history-of-bcs-rt-now-with-a-clinical-stage-i-triple-negative-idc weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-persistent-recurrent-disease-in-the-neck-6-months-after-receiving-definitive-chemo-rt-for-p16-negative-oropharyngeal-scc weekly 0.8 https://www.themednet.org/in-light-of-the-challenges-with-non-adherence-to-oral-therapies-in-breast-cancer-how-do-you-monitor-patient-adherence-in-your-practice weekly 0.8 https://www.themednet.org/what-would-you-recommend-in-the-adjuvant-settings-for-an-elderly-patient-status-post-hysterectomy-without-nodal-staging-and-was-found-with-figo-1a-g3-endometrial-cancer-with-no-lvsi-and-no-myometrial-involvement-without-nodal-staging weekly 0.8 https://www.themednet.org/in-light-of-recent-who-classification-update-for-glioma-how-would-your-treatment-volumes-and-dose-prescription-change-for-a-non-enhancing-molecular-glioblastoma weekly 0.8 https://www.themednet.org/how-do-you-manage-polymorphous-eruption-of-pregnancy-formerly-puppp weekly 0.8 https://www.themednet.org/how-do-you-titrate-hydroxyurea-in-the-management-of-myeloproliferative-neoplasms weekly 0.8 https://www.themednet.org/how-would-you-manage-ivf-using-ovarian-stimulation-in-a-woman-with-a-prior-estrogen-related-thrombotic-event weekly 0.8 https://www.themednet.org/what-is-your-go-to-steroid-regimen-for-post-srs-headache weekly 0.8 https://www.themednet.org/how-are-you-managing-patients-with-recurrent-nmibc-with-cis-who-decline-cystectomy-with-the-recent-bcg-shortage weekly 0.8 https://www.themednet.org/do-you-routinely-obtain-a-sural-nerve-biopsy-in-patients-with-emg-evidence-of-mononeuritis-multiplex-and-clinically-suspected-polyarteritis-nodosa weekly 0.8 https://www.themednet.org/how-would-you-treat-margin-positive-node-positive-pn-prostate-cancer-with-detectable-post-op-psa-but-negative-psma-pet-after-radical-perineal-prostatectomy weekly 0.8 https://www.themednet.org/when-if-ever-would-you-perform-her2-testing-in-serous-intraepithelial-neoplasia-of-the-endometrium weekly 0.8 https://www.themednet.org/what-is-your-adjuvant-therapy-approach-for-stage-ii-endometrioid-endometrial-cancer weekly 0.8 https://www.themednet.org/would-you-consider-clearing-a-patient-with-essential-thrombocytosis-for-a-kidney-donation weekly 0.8 https://www.themednet.org/how-would-you-approach-a-young-patient-with-a-history-of-apls-and-vte-desiring-hormone-replacement-therapy-after-oophorectomy weekly 0.8 https://www.themednet.org/if-metastatic-disease-is-found-at-the-time-of-minimally-invasive-hysterectomy-for-uterine-cancer-when-would-you-decide-to-convert-to-open-versus-minimally-invasive-debulking weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-bleeding-risk-and-factor-viii-replacement-in-a-patient-with-severe-hemophilia-a-undergoing-stem-cell-transplant weekly 0.8 https://www.themednet.org/what-work-up-do-you-recommend-in-patients-with-early-onset-dementia weekly 0.8 https://www.themednet.org/would-you-consider-bone-antiresorptive-therapy-in-mcrpc-with-only-1-lesion-per-psma-scan weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-incidentally-noted-infrarenal-periaortitis-with-positive-c-anca-normal-inflammatory-markers-and-no-systemic-symptoms weekly 0.8 https://www.themednet.org/do-you-do-prophylactic-lp-it-chemotherapy-in-high-risk-apml-prior-to-starting-consolidation weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-chronic-phase-cml-who-could-not-tolerate-nilotinib-due-to-g4-thrombocytopenia-despite-sequential-dose-reductions weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-patient-with-early-stage-breast-cancer-planned-for-breast-conserving-surgery-who-wants-implants-at-the-time-of-surgery-or-soon-thereafter weekly 0.8 https://www.themednet.org/would-you-offer-neoadjuvant-chemoimmunotherapy-to-a-woman-with-clinical-t3-n0-m0-triple-negative-metaplastic-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-sicca-symptoms-in-patients-not-responding-or-not-tolerating-conservative-measures-pilocarpine-and-cevimeline weekly 0.8 https://www.themednet.org/how-do-you-manage-cases-of-levodopa-intolerance-due-to-nausea-or-drowsiness weekly 0.8 https://www.themednet.org/is-there-any-role-in-continuing-apixaban-in-a-patient-with-occlusion-of-the-right-internal-jugular-vein-with-chronic-postthrombotic-change-to-prevent-a-recurrent-dvt weekly 0.8 https://www.themednet.org/would-you-offer-consolidative-rt-for-nec-of-the-esophagus-with-good-response-to-systemic-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-imrt-vmat-boost-for-grossly-involved-internal-mammary-nodes-in-breast-cancer-patients weekly 0.8 https://www.themednet.org/how-long-after-initiating-adt-androgen-blockade-is-it-acceptable-to-start-docetaxel-in-a-patient-with-high-burden-de-novo-metastatic-hspc-where-you-are-recommending-triplet-therapy weekly 0.8 https://www.themednet.org/how-do-you-use-baby-tam-low-dose-tamoxifen-in-your-practice weekly 0.8 https://www.themednet.org/how-would-you-manage-a-premenopausal-patient-with-her-2-positive-dcis-in-the-setting-of-a-prior-her-2-positive-contralateral-breast-cancer weekly 0.8 https://www.themednet.org/when-and-how-do-we-do-cytoreduction-in-cll weekly 0.8 https://www.themednet.org/do-you-hold-anticoagulation-prior-to-prostate-brachytherapy weekly 0.8 https://www.themednet.org/do-you-hold-anticoagulation-prior-to-ldr-or-hdr-prostate-brachytherapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-management-for-diffuse-idiopathic-pulmonary-neuroendocrine-cell-hyperplasia-dipnech weekly 0.8 https://www.themednet.org/does-stopping-anagrelide-affect-fibrosis-in-patients-with-et-who-develop-post-et-myelofibrosis weekly 0.8 https://www.themednet.org/are-there-any-possible-scenarios-where-you-would-do-phlebotomies-for-heterozygous-hemochromatosis weekly 0.8 https://www.themednet.org/how-would-you-manage-immune-check-point-inhibitor-induced-capillary-leak-syndrome-refractory-to-ivig-monotherapy weekly 0.8 https://www.themednet.org/what-first-line-therapy-would-you-give-a-premenopausal-patient-with-her-2-positive-and-er-positive-metastatic-breast-cancer-with-visceral-organ-involvement weekly 0.8 https://www.themednet.org/does-acute-radiation-cystitis-cause-microscopic-hematuria-and-pyuria weekly 0.8 https://www.themednet.org/for-patients-with-igg-kappa-multiple-myeloma-receiving-an-igg-kappa-mab-i-e-daratumumab-how-important-is-it-clinically-to-use-an-interference-assay-if-theyre-in-a-vgpr-to-see-if-their-m-spike-might-actually-be-0 weekly 0.8 https://www.themednet.org/would-repeat-mmr-her-2-or-ngs-testing-be-beneficial-during-progression-of-gastric-cancer-in-patients-who-have-already-received-first-line-chemotherapy weekly 0.8 https://www.themednet.org/what-are-indications-for-adjuvant-radiation-for-well-differentiated-non-intestinal-adenocarcinoma-of-the-nasal-cavity weekly 0.8 https://www.themednet.org/how-do-you-approach-a-urethral-carcinoma-s-p-non-oncologic-resection weekly 0.8 https://www.themednet.org/would-you-recommend-imatinib-400-mg-bid-or-stay-with-the-usual-dose-of-400-mg-day-for-adjuvant-therapy-for-a-patient-with-intermediate-high-risk-exon-9-mutated-gist weekly 0.8 https://www.themednet.org/when-do-you-consider-discontinuing-pegloticase-in-a-patient-with-tophaceous-gout-who-has-had-excellent-response-to-therapy weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-to-determine-the-resectability-of-mucosal-melanoma-of-the-h-n-region weekly 0.8 https://www.themednet.org/what-dosing-range-of-doxycycline-do-you-recommend-for-short-term-and-long-term-management-of-ocular-rosacea weekly 0.8 https://www.themednet.org/what-initial-workup-do-you-perform-when-there-is-a-concern-for-porphyria weekly 0.8 https://www.themednet.org/in-light-of-the-recently-published-alliance-a021501-trial-what-is-your-approach-to-incorporating-sbrt-for-the-treatment-of-borderline-resectable-pancreatic-cancer weekly 0.8 https://www.themednet.org/what-is-the-treatment-approach-if-an-aml-patient-receiving-azacitidine-venetoclax-is-later-found-to-have-flt3-and-idh2-mutations weekly 0.8 https://www.themednet.org/are-there-any-situations-in-which-you-would-treat-a-cutaneous-in-situ-squamous-cell-carcinoma-of-the-head-and-neck-with-radiation weekly 0.8 https://www.themednet.org/do-you-have-any-precautions-to-your-injury-to-the-uterine-artery-when-placing-interstitial-needles-as-ovoid-extenders-to-cover-parametrial-disease-in-cervical-t-o-procedures weekly 0.8 https://www.themednet.org/what-labs-do-you-order-to-monitor-patients-on-jak1-inhibitiors-abrocitinib-or-upadacitinib weekly 0.8 https://www.themednet.org/how-do-you-approach-hormone-replacement-therapy-for-premenopausal-patients-following-pelvic-radiation-therapy weekly 0.8 https://www.themednet.org/would-you-have-a-patient-temporarily-discontinue-methotrexate-while-receiving-a-fast-or-fast-forward-regimen-for-breast-irradiation weekly 0.8 https://www.themednet.org/do-you-recommend-using-dextrose-based-solutions-to-induce-osmotic-diuresis-for-euvolemic-patients-with-acute-kidney-injury-in-the-setting-of-a-hemolytic-condition weekly 0.8 https://www.themednet.org/for-patients-with-suspected-complement-mediated-tma-are-there-specific-clinical-or-laboratory-parameters-that-can-help-guide-the-decision-for-starting-empirical-treatment-e-g-eculizumab-while-awaiting-the-results-of-complement-testing weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-after-sbrt-for-biopsy-proven-sub-centimeter-metastatic-pulmonary-nodule-from-rectal-cancer weekly 0.8 https://www.themednet.org/would-you-offer-a-different-alk-inhibitor-to-a-patient-receiving-alectinib-who-had-decompensation-of-liver-function-in-the-setting-of-preexisting-cirrhosis weekly 0.8 https://www.themednet.org/would-you-perform-dialysis-on-a-patient-with-altered-mental-status-in-the-setting-of-an-elevated-blood-urea-nitrogen-level-attributed-to-a-tube-feeding-diet weekly 0.8 https://www.themednet.org/how-do-you-evaluate-and-diagnose-patients-with-persistent-postural-perceptual-dizziness weekly 0.8 https://www.themednet.org/when-would-you-consider-initiation-of-bempedoic-acid-for-statin-intolerant-patients-i-e-ldl-threshold-comorbidities weekly 0.8 https://www.themednet.org/when-would-you-consider-initiation-of-low-dose-aspirin-for-primary-prevention-and-or-statin-therapy-in-patients-with-acceptable-bleeding-risk-and-evidence-of-coronary-artery-calcification-on-prior-ct-chest-imaging weekly 0.8 https://www.themednet.org/is-there-a-role-for-vascular-intervention-in-patients-with-renal-artery-stenosis-found-during-work-up-of-resistant-hypertension weekly 0.8 https://www.themednet.org/in-a-patient-with-local-recurrence-of-breast-cancer-after-mastectomy-how-would-you-sequence-adjuvant-treatment-after-wide-local-resection weekly 0.8 https://www.themednet.org/how-do-you-follow-patients-with-bronchus-associated-lymphoid-tissue-lymphoma-treated-with-2-gy-x-2-fractions weekly 0.8 https://www.themednet.org/do-you-recommend-using-doses-of-acei-or-arbs-that-is-above-the-usual-dosing-with-the-goal-of-reducing-a-patients-proteinuria-further weekly 0.8 https://www.themednet.org/how-do-you-sequence-everolimus-endocrine-therapy-versus-fam-trastuzumab-deruxtecan-after-progression-on-cdk4-6i-in-metastatic-er-her2-low-breast-cancer weekly 0.8 https://www.themednet.org/when-should-vaccines-be-given-if-not-received-prior-to-the-start-of-high-dose-radiation-40-50-gy-to-the-spleen weekly 0.8 https://www.themednet.org/would-you-consider-adding-an-sglt2-inhibitor-to-augment-diuresis-in-patients-with-worsening-renal-function-presenting-with-acute-decompensated-heart-failure-and-aki-on-ckd weekly 0.8 https://www.themednet.org/when-would-you-consider-offering-pvc-ablation-for-otherwise-healthy-patients-with-preserved-lv-systolic-function weekly 0.8 https://www.themednet.org/what-is-your-approach-to-correlating-stenotic-lesions-on-coronary-angiography-to-magnitude-of-decline-in-lv-systolic-function-or-cardiomyopathy-severity-when-deciding-to-intervene-or-medically-manage-stable-ischemic-heart-disease-as-an-outpatient weekly 0.8 https://www.themednet.org/is-it-reasonable-to-offer-apbi-in-an-obese-patients-with-large-breasts-and-n1mi-disease weekly 0.8 https://www.themednet.org/for-patients-with-microscopic-hematuria-do-you-prefer-a-lab-submitted-urinalysis-sample-undergoes-automated-urine-analysis-or-microscopic-analysis-by-laboratory-staff-for-quantification-of-red-blood-cells weekly 0.8 https://www.themednet.org/would-you-consider-a-biologic-or-jak-inhibitor-to-manage-active-psa-in-a-patient-on-chronic-antibiotic-therapy-if-they-had-previously-failed-all-conventional-dmards-including-apremilast weekly 0.8 https://www.themednet.org/what-is-your-approach-to-mrd-testing-in-the-frontline-treatment-of-multiple-myeloma weekly 0.8 https://www.themednet.org/is-there-a-correlation-between-spleen-size-and-degree-of-thrombocytopenia weekly 0.8 https://www.themednet.org/how-would-you-approach-a-clinical-stage-3-sigmoid-colon-cancer-dmmr-msi-h-with-comorbidities-and-increased-risk-of-surgical-complications weekly 0.8 https://www.themednet.org/how-would-you-manage-a-treatment-naive-patient-who-has-painful-vertebral-lesions-from-es-sclc weekly 0.8 https://www.themednet.org/would-you-consider-post-bmt-maintenance-therapy-for-patients-with-ph-like-all-with-a-jak2-mutation weekly 0.8 https://www.themednet.org/can-you-use-apixaban-or-rivaroxaban-in-case-of-dabigatran-failure weekly 0.8 https://www.themednet.org/do-you-personally-review-all-imaging-you-order-or-rely-judiciously-on-radiologist-interpretation weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-to-decide-whether-to-start-anticonvulsants-in-patients-with-brain-metastases weekly 0.8 https://www.themednet.org/how-would-you-manage-patients-with-exposed-bone-due-to-injured-gingiva-after-recent-chemoradiation weekly 0.8 https://www.themednet.org/how-do-you-manage-grade-1-3a-follicle-center-lymphoma-of-the-lower-female-genital-tract-presenting-with-a-cervical-mass weekly 0.8 https://www.themednet.org/what-vertebral-body-dose-constraint-do-you-use-in-sbrt-to-limit-compression-fracture weekly 0.8 https://www.themednet.org/what-is-your-general-approach-to-parpi-usage-in-the-front-line-and-recurrent-ovarian-cancer-setting-in-light-of-fda-label-changes-over-the-years weekly 0.8 https://www.themednet.org/when-planning-spine-sbrt-do-you-use-volume-dose-limits-to-the-spinal-cord-prv-such-as-d0-35cc-in-addition-to-maximum-point-dose weekly 0.8 https://www.themednet.org/when-would-you-consider-proceeding-with-antiarrhythmic-drug-load-concurrently-with-dccv-as-opposed-to-dccv-alone-in-patients-with-new-onset-atrial-fibrillation weekly 0.8 https://www.themednet.org/what-burden-of-pvcs-nsvt-in-an-inpatient-post-mi-cardiomyopathy-patient-would-prompt-an-ep-study-guided-icd-implantation-prior-to-discharge-1 weekly 0.8 https://www.themednet.org/in-what-situations-patient-population-would-you-consider-placing-an-implantable-cardiac-monitor-in-favor-of-external-monitors-for-long-term-dynamic-monitoring-of-atrial-fibrillation weekly 0.8 https://www.themednet.org/what-hemoglobin-level-prompts-you-to-start-erythropoietin-in-a-patient-with-low-risk-mds weekly 0.8 https://www.themednet.org/when-do-you-recommend-genetic-testing-in-patients-with-parkinsonism weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-if-any-to-recommend-statin-therapy-for-patients-with-polycystic-kidney-disease weekly 0.8 https://www.themednet.org/would-you-offer-bridging-radiation-before-or-after-leukapheresis weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-gca-who-develops-necrotizing-fasciitis-and-then-flares-because-they-are-off-of-tocilizumab weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-patients-with-isolated-cervical-adenopathy-related-to-sarcoidosis weekly 0.8 https://www.themednet.org/how-if-at-all-would-adenosquamous-histology-affect-your-coverage-volume-compared-to-squamous-cell-carcinoma-of-the-head-and-neck weekly 0.8 https://www.themednet.org/when-do-you-include-the-primary-site-in-the-radiation-field-for-a-penile-cancer-with-negative-margins weekly 0.8 https://www.themednet.org/does-management-of-nmda-receptor-encephalitis-change-in-a-patient-with-hiv-aids weekly 0.8 https://www.themednet.org/do-you-attempt-more-aggressive-peep-titration-to-improve-the-p-f-ratio-prior-to-proceeding-with-proning-in-patients-with-ards-and-p-f-150 weekly 0.8 https://www.themednet.org/for-patient-with-polycystic-kidney-disease-and-proteinuria-who-are-on-maximum-dose-of-acei-arb-what-are-other-anti-proteinuric-medications-that-should-be-considered weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-to-determine-the-utility-of-dibh-for-breast-cancer-patients weekly 0.8 https://www.themednet.org/do-you-take-any-different-approaches-for-patients-with-end-stage-kidney-disease-who-are-about-to-be-initiated-on-intermittent-hemodialysis-and-have-residual-renal-function weekly 0.8 https://www.themednet.org/is-there-an-optimal-salvage-radiation-dose-for-relapsed-post-cart-disease weekly 0.8 https://www.themednet.org/how-do-you-choose-between-peginterferon-and-anagrelide-for-et-patients-if-hydroxyurea-intolerant weekly 0.8 https://www.themednet.org/how-do-you-approach-clearing-a-patient-with-sle-and-esrd-for-renal-transplant weekly 0.8 https://www.themednet.org/would-one-year-of-steroids-for-jra-during-teen-years-with-subsequently-well-controlled-autoimmune-disease-be-sufficient-to-explain-a-vertebral-t-score-of-4-4-of-a-woman-in-her-early-50s-without-any-other-risk-factors weekly 0.8 https://www.themednet.org/what-is-your-approach-to-continuing-or-altering-therapy-when-inheriting-a-patient-with-combined-biologic-immunosuppression-that-is-in-excess-of-guidelines weekly 0.8 https://www.themednet.org/do-you-reduce-the-steroid-regimen-for-patients-with-acute-interstitial-nephritis-who-have-a-high-risk-for-developing-side-effects-from-glucocorticoid-therapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-intravenous-fluid-type-for-matching-volume-loss-in-a-patient-with-persistent-surgical-drain-output-and-pre-renal-acute-kidney-injury weekly 0.8 https://www.themednet.org/would-you-re-challenge-a-cll-patient-who-had-good-response-to-zanubrutinib-but-contracted-cryptococcal-pneumonia-with-another-btk-inhibitor weekly 0.8 https://www.themednet.org/what-is-the-optimal-approach-to-treat-isolated-diastolic-hypertension weekly 0.8 https://www.themednet.org/if-a-patient-with-relapsing-remitting-ms-has-comorbid-sjogrens-syndrome-and-is-on-hydroxychloroquine-plaquenil-how-does-that-impact-choice-of-dmt-for-ms weekly 0.8 https://www.themednet.org/would-you-consider-giving-hormone-replacement-therapy-to-a-patient-with-atypical-ductal-hyperplasia-with-no-alternative-options-to-manage-postmenopausal-symptoms weekly 0.8 https://www.themednet.org/do-you-consider-starting-hydroxyurea-in-a-patient-with-hemoglobin-s-beta-thalassemia-with-chronic-kidney-disease-secondary-to-fsgs weekly 0.8 https://www.themednet.org/would-you-offer-xrt-as-bridging-for-all-patients-with-limited-pre-car-t-disease-or-as-consolidation-for-only-those-with-residual-pet-avidity-on-day-30-post-car-t weekly 0.8 https://www.themednet.org/do-you-ever-repeat-screening-for-acquired-von-willebrand-in-patients-with-essential-thrombocythemia-who-have-high-platelet-counts-and-very-low-risk-disease-not-on-cytoreductive-therapy weekly 0.8 https://www.themednet.org/do-you-modify-the-external-beam-plan-that-follows-if-a-patient-develops-prolonged-urinary-retention-after-ldr weekly 0.8 https://www.themednet.org/do-you-recommend-starting-sglt2-inhibitors-for-patients-with-a-normal-creatinine-but-who-have-microalbuminuria-and-are-unable-to-tolerate-acei-or-arbs weekly 0.8 https://www.themednet.org/do-you-recommend-obtaining-24-hour-urine-ammonium-levels-in-patients-with-recurrent-uric-acid-nephrolithiasis weekly 0.8 https://www.themednet.org/how-do-you-treat-a-stage-ie-dlbcl-of-the-breast weekly 0.8 https://www.themednet.org/how-long-after-a-motor-vehicle-accident-would-you-expect-symptoms-including-memory-loss-hypersomnia-and-mood-changes-to-be-attributable-to-the-accident weekly 0.8 https://www.themednet.org/can-droxidopa-be-used-for-augmenting-orthostatic-hypotension-treatment-in-patients-who-are-already-on-midodrine-and-or-fludrocortisone weekly 0.8 https://www.themednet.org/how-would-you-treat-high-risk-prostate-cancer-in-a-patient-with-autonomic-bladder-dysfunction weekly 0.8 https://www.themednet.org/what-additional-studies-would-you-obtain-for-a-patient-with-end-stage-kidney-disease-on-hemodialysis-who-has-persistent-hypercalcemia-and-low-pth weekly 0.8 https://www.themednet.org/are-there-mechanisms-in-place-to-distinguish-svt-with-aberrant-conduction-from-vt-on-external-cardiac-monitoring-devices weekly 0.8 https://www.themednet.org/do-you-recommend-taking-any-unique-approaches-to-managing-patients-with-persistent-hypertension-following-bilateral-renal-artery-stenting weekly 0.8 https://www.themednet.org/how-do-you-approach-a-persistently-elevated-mean-platelet-volume-and-immature-platelet-fraction-in-an-otherwise-healthy-patient-with-a-normal-platelet-count weekly 0.8 https://www.themednet.org/how-would-you-counsel-about-dmt-options-for-disease-modifying-therapy-for-a-patient-with-multiple-sclerosis-and-positive-hepatitis-b-surface-antigen-with-negative-hbv-dna-pcr weekly 0.8 https://www.themednet.org/what-do-you-do-when-the-dose-constraints-for-heart-and-or-lung-do-not-pass-at-all-in-a-whole-breast-treatment-planning weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-node-positive-sebaceous-cell-carcinoma-of-the-eyelid-for-adjuvant-chemotherapy-and-radiation weekly 0.8 https://www.themednet.org/what-would-be-your-approach-to-first-line-therapy-for-patient-with-metastatic-her2-positive-breast-cancer-with-chf-lvef-50 weekly 0.8 https://www.themednet.org/do-you-use-mannitol-when-initiating-patients-on-intermittent-hemodialysis weekly 0.8 https://www.themednet.org/for-patients-undergoing-tnt-for-rectal-cancer-with-planned-operative-management-what-is-the-optimal-sequencing-and-timing-of-workup-imaging-and-procedures weekly 0.8 https://www.themednet.org/do-you-use-lenalidomide-for-patients-with-mds-with-5q-without-other-cytogenetic-abnormalities-but-with-one-or-more-mutations-on-ngs weekly 0.8 https://www.themednet.org/are-there-preferred-home-exercise-programs-for-patients-without-access-to-pulmonary-rehabilitation weekly 0.8 https://www.themednet.org/does-your-approach-to-extubating-obese-patients-differ-from-your-approach-in-non-obese-patients weekly 0.8 https://www.themednet.org/is-there-a-kidney-length-for-which-you-would-no-longer-recommend-attempting-a-kidney-biopsy-due-to-safety-concerns-and-lack-of-diagnostic-yield weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-with-a-pancreatic-head-mass-based-on-common-bile-duct-brushings-suggestive-of-malignancy-with-repeated-negative-eus-biopsy weekly 0.8 https://www.themednet.org/if-a-patient-is-noted-to-have-multiple-pirads-4-and-pirad-5-lesions-of-the-prostate-on-mri-do-you-offer-simultaneous-integrated-boost-via-flame weekly 0.8 https://www.themednet.org/in-patients-with-recurrent-endometrial-carcinoma-how-do-you-decide-when-to-offer-carboplatin-paclitaxel-pembrolizumab-or-dostarlimab-nrg-gy018-ruby-versus-lenvatinib-pembrolizumab-keynote-775 weekly 0.8 https://www.themednet.org/how-do-you-navigate-pap-approval-for-patients-with-tracheobronchomalacia-or-excessive-dynamic-airway-collapse-who-do-not-have-osa weekly 0.8 https://www.themednet.org/for-women-with-non-autologous-breast-reconstruction-who-require-pmrt-is-it-better-to-radiate-an-implant-or-an-expander weekly 0.8 https://www.themednet.org/what-is-your-approach-to-pacemaker-lead-thromboses-in-terms-of-threshold-for-lead-extraction-and-initiation-of-systemic-anticoagulation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-counseling-an-octogenarian-on-the-risks-and-benefits-of-lhc-in-the-context-of-nstemi-complicated-by-new-onset-heart-failure-and-aki-on-ckd weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-evaluation-and-management-of-a-suspected-intrapulmonary-hematoma weekly 0.8 https://www.themednet.org/in-clinical-practice-are-you-using-single-dose-liposomal-amphotericin-b-for-treatment-of-cryptococcal-meningitis-for-patients-living-with-hiv weekly 0.8 https://www.themednet.org/when-would-you-add-a-third-antibacterial-agent-in-addition-to-macrolide-and-ethambutol-for-treatment-of-a-patient-with-hiv-and-disseminated-mac weekly 0.8 https://www.themednet.org/given-recent-data-from-the-reprieve-trial-how-will-you-adapt-your-practice-with-regards-to-prescribing-statins-to-patients-living-with-hiv weekly 0.8 https://www.themednet.org/what-is-your-approach-to-starting-antiretroviral-therapy-in-a-patient-living-with-hiv-who-is-diagnosed-with-cryptococcal-meningitis-1 weekly 0.8 https://www.themednet.org/for-patients-on-prep-is-there-a-role-for-hiv-rna-pcr-screening-in-addition-to-4th-generation-antigen-antibody-testing weekly 0.8 https://www.themednet.org/what-is-your-approach-to-antimicrobial-prophylaxis-in-adult-patients-undergoing-treatment-for-hlh weekly 0.8 https://www.themednet.org/what-is-your-approach-to-secondary-prophylaxis-for-c-difficile-infection-during-concomitant-antibiotic-use-in-a-patient-with-a-history-of-c-difficile-infection weekly 0.8 https://www.themednet.org/are-there-clinical-circumstances-in-which-there-is-a-role-for-steroids-in-treatment-of-calcified-neurocysticercosis-associated-with-perilesional-edema-and-seizures weekly 0.8 https://www.themednet.org/do-you-routinely-refer-all-patients-with-cutaneous-leishmaniasis-with-a-species-associated-with-mucocutaneous-leishmaniasis-to-ent-for-comprehensive-nasal-oropharyngeal-evaluation-or-do-you-refer-only-if-mucocutaneous-involvement-is-suspected-based-on-car weekly 0.8 https://www.themednet.org/do-you-treat-subarachnoid-neurocysticercosis-with-albendazole-alone-or-with-the-addition-of-praziquantel weekly 0.8 https://www.themednet.org/what-is-your-approach-to-monitoring-patients-with-the-indeterminate-form-of-chagas-disease weekly 0.8 https://www.themednet.org/for-which-patients-or-under-which-circumstances-do-you-recommend-a-9-month-over-a-6-month-course-of-isoniazid-for-treatment-of-ltbi weekly 0.8 https://www.themednet.org/what-is-current-best-practice-with-regards-to-antibacterial-prophylaxis-in-patients-with-hematologic-malignancy-and-resolved-neutropenic-fever-72-hours weekly 0.8 https://www.themednet.org/do-you-use-letermovir-as-cmv-prophylaxis-in-solid-organ-transplant-patients weekly 0.8 https://www.themednet.org/is-there-a-role-for-secondary-cmv-prophylaxis-in-solid-organ-transplant-patients weekly 0.8 https://www.themednet.org/is-there-ever-a-role-for-the-use-of-cmv-immune-globulin-for-treatment-of-cmv-viremia-and-or-disease weekly 0.8 https://www.themednet.org/is-there-a-role-for-repeat-surveillance-blood-cultures-in-patients-with-prosthetic-valve-endocarditis-without-associated-cardiac-abscess-after-a-6-week-course-of-antibiotic-treatment-without-surgical-intervention weekly 0.8 https://www.themednet.org/what-is-the-preferred-antibiotic-treatment-regimen-for-vancomycin-resistant-enterococcus-faecium-endocarditis-assuming-susceptibility-to-both-daptomycin-and-linezolid weekly 0.8 https://www.themednet.org/would-you-consider-stepping-down-from-an-echinocandin-to-azole-therapy-prior-to-the-end-of-an-initial-six-week-course-for-fluconazole-susceptible-candida-albicans-endocarditis-in-the-absence-of-valve-surgery weekly 0.8 https://www.themednet.org/for-how-long-do-you-treat-uncomplicated-cre-bacteremia-in-an-immunocompetent-patient weekly 0.8 https://www.themednet.org/have-you-applied-the-poet-trial-to-clinical-practice weekly 0.8 https://www.themednet.org/after-a-course-of-treatment-for-neurosyphilis-do-you-administer-an-additional-im-dose-of-penicillin-g-one-week-after-finishing-the-course-of-iv-penicillin-therapy weekly 0.8 https://www.themednet.org/are-there-any-non-beta-lactam-antibiotic-options-for-treatment-of-neurosyphilis-in-non-pregnant-adults weekly 0.8 https://www.themednet.org/what-is-the-recommended-treatment-regimen-for-mycoplasma-genitalium-in-a-pregnant-woman weekly 0.8 https://www.themednet.org/do-you-repeat-a-lumbar-puncture-in-a-patient-living-with-hiv-diagnosed-with-and-treated-for-neurosyphilis-and-if-so-when weekly 0.8 https://www.themednet.org/are-you-now-using-luspatercept-as-your-first-choice-for-anemia-management-in-patients-with-low-risk-mds-otherwise-appropriate-for-epo-initiation-regardless-of-presence-of-sf3b1-or-ringed-sideroblasts weekly 0.8 https://www.themednet.org/would-you-recommend-post-op-radiation-therapy-for-a-primary-pulmonary-synovial-sarcoma-which-underwent-lobectomy weekly 0.8 https://www.themednet.org/what-immunotherapy-backbone-do-you-utilize-for-patients-with-resectable-stage-iii-melanoma-when-you-offer-neoadjuvant-therapy weekly 0.8 https://www.themednet.org/how-do-you-dose-steroids-in-neurosarcoidosis-patients-with-a-worsening-clinical-symptoms-or-mri-findings weekly 0.8 https://www.themednet.org/how-do-you-typically-sequence-chemotherapy-and-palliative-radiation-for-metastatic-endometrial-and-cervical-cancers weekly 0.8 https://www.themednet.org/which-novel-immunomodulatory-treatment-s-do-you-consider-in-refractory-seronegative-bulbar-predominant-myasthenia-1 weekly 0.8 https://www.themednet.org/would-you-offer-pmrt-for-a-small-focus-of-invasive-disease-in-a-background-of-extensive-dcis weekly 0.8 https://www.themednet.org/what-is-the-minimum-duration-to-be-on-bicalutamide-prior-to-starting-gnrh-agonist-in-de-novo-metastatic-prostate-cancer-with-significant-bone-disease weekly 0.8 https://www.themednet.org/is-there-a-role-for-prostate-cancer-lesion-boost-with-ebrt-in-the-setting-of-combination-ebrt-brachytherapy weekly 0.8 https://www.themednet.org/what-techniques-and-dose-constraints-do-you-utilize-to-limit-lower-extremity-neuropathy-when-providing-post-op-radiation-following-soft-tissue-sarcoma-resection weekly 0.8 https://www.themednet.org/in-a-patient-with-active-spondylarthritis-and-uveitis-who-cannot-take-tnf-inhibitors-what-is-your-next-agent-of-choice weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-recurrent-papillary-thyroid-cancer-following-thyroidectomy-who-now-has-palpable-cervical-nodes-and-underwent-neck-dissection-and-rai weekly 0.8 https://www.themednet.org/do-you-have-a-preference-between-quantiferon-gold-and-t-spot-tb-for-screening-in-patients-starting-immunosuppressive-agents weekly 0.8 https://www.themednet.org/what-is-your-approach-in-treatment-of-oligometastatic-triple-negative-inflammatory-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-skin-surface-maximum-dose-constraint-for-skin-brachytherapy weekly 0.8 https://www.themednet.org/does-the-presence-of-facet-joint-effusions-on-lumbar-spine-mri-increase-your-suspicion-for-axial-spondyloarthritis weekly 0.8 https://www.themednet.org/is-there-a-utility-in-getting-repeat-antibody-testing-on-gbs-patients-after-plex weekly 0.8 https://www.themednet.org/does-the-presence-of-asparaginase-antibodies-on-granger-genetics-testing-indicate-need-to-switch-asparaginase-formulations weekly 0.8 https://www.themednet.org/do-you-utilize-the-bronchiectasis-severity-index-bsi-in-your-approach-to-managing-non-cf-bronchiectasis weekly 0.8 https://www.themednet.org/do-you-modify-the-whole-brain-radiation-dose-if-a-patient-has-previously-been-treated-with-srs-for-brain-metastases weekly 0.8 https://www.themednet.org/are-there-instances-when-you-would-recommend-against-pursuing-adrenal-vein-sampling-in-a-patient-with-primary-hyperaldosteronism-and-normal-adrenal-imaging weekly 0.8 https://www.themednet.org/when-would-you-ever-consider-lifelong-imatinib-in-adjuvant-therapy-for-gist weekly 0.8 https://www.themednet.org/would-you-ever-use-a-pet-dotatate-ct-to-monitor-response-of-a-gep-nen-that-is-sstr-positive weekly 0.8 https://www.themednet.org/how-would-you-approach-a-postmenopausal-patient-on-letrozole-who-developed-cataracts-within-the-first-six-months-of-treatment weekly 0.8 https://www.themednet.org/what-additional-therapies-would-you-consider-in-a-pregnant-woman-with-bechets-on-an-antitnf-and-azathioprine-who-has-uncontrolled-non-pulmonary-large-vessel-vasculitis weekly 0.8 https://www.themednet.org/how-long-after-surgery-would-you-no-longer-offer-pmrt-for-a-patient-who-had-pcr-after-neoadjuvant-chemotherapy-for-stage-iib-her2-breast-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-elacestrant-after-prior-fulvestrant-in-metastatic-hormone-positive-breast-cancer weekly 0.8 https://www.themednet.org/when-do-you-entertain-a-diagnosis-of-hla-negative-antibody-mediated-rejection-in-lung-transplant-recipients weekly 0.8 https://www.themednet.org/how-has-the-recently-fda-approved-topical-cantharidin-altered-your-molluscum-treatment-algorithm weekly 0.8 https://www.themednet.org/is-there-a-role-for-further-her2-directed-therapies-after-progression-on-fam-trastuzumab-deruxtecan-after-a-sustained-initial-response-in-patients-with-metastatic-her2-colorectal-cancer weekly 0.8 https://www.themednet.org/do-you-consider-hyperuricemia-as-a-potential-etiology-of-an-anion-gap-metabolic-acidosis-in-patients-with-elevated-uric-acid-levels-and-no-other-readily-explainable-causes-of-acidosis weekly 0.8 https://www.themednet.org/when-do-you-consider-the-use-of-jak-inhibitors-for-cutaneous-manifestations-of-myositis weekly 0.8 https://www.themednet.org/what-are-best-practices-in-management-of-severe-acute-infusion-reaction-from-infliximab weekly 0.8 https://www.themednet.org/would-you-consider-alk-directed-tki-for-a-alk-l1198f-point-mutation-in-a-patient-with-metastatic-lung-adenocarcinoma-after-progressing-through-first-line-chemoimmunotherapy weekly 0.8 https://www.themednet.org/when-do-you-consider-the-use-of-corticosteroids-in-patients-diagnosed-with-evali weekly 0.8 https://www.themednet.org/what-is-your-preferred-method-of-lesion-interrogation-for-intermediate-left-main-coronary-artery-stenosis weekly 0.8 https://www.themednet.org/what-therapies-do-you-most-commonly-recommend-for-prevention-of-nmsc-in-organ-transplant-patients weekly 0.8 https://www.themednet.org/how-reliable-is-an-exercise-stress-echo-in-the-diagnosis-of-exercise-induced-heart-failure-with-preserved-ejection-fraction weekly 0.8 https://www.themednet.org/what-approach-do-you-take-to-determine-dose-constraints-for-sbrt-reirradiation-of-the-head-and-neck weekly 0.8 https://www.themednet.org/what-is-the-role-for-molecular-agents-alone-for-medically-inoperable-nsclc-who-is-not-a-good-candidate-for-chemort weekly 0.8 https://www.themednet.org/how-do-you-define-the-suprapubic-volume-for-adjuvant-penile-cancer-treatment weekly 0.8 https://www.themednet.org/in-which-situations-do-you-preferentially-use-an-mcot-in-lieu-of-a-standard-event-monitor weekly 0.8 https://www.themednet.org/have-you-seen-drug-induced-scle-from-il-17-inhibitors weekly 0.8 https://www.themednet.org/would-you-consider-chemoimmunotherapy-cp-pembro-ac-in-triple-negative-breast-cancer-if-tumor-is-not-palpable-on-physical-exam weekly 0.8 https://www.themednet.org/what-therapies-do-you-routinely-use-to-prevent-mucus-plug-formation-after-endobronchial-stent-placement weekly 0.8 https://www.themednet.org/would-you-order-a-dexa-scan-for-a-cervical-cancer-patient-with-osteoporosis weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-while-selecting-high-risk-patients-for-prophylactic-niv-after-planned-extubation weekly 0.8 https://www.themednet.org/do-you-routinely-use-prophylactic-anticoagulation-when-treating-ovarian-cancer-patients-with-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-progressive-calvarial-hyperostosis-found-in-an-elderly-adult-not-caused-by-pagets-acromegaly-or-hypercalcemia weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-who-has-a-cardiac-pet-scan-suggestive-of-sarcoid-but-no-other-supporting-evidence-of-a-diagnosis-of-sarcoid weekly 0.8 https://www.themednet.org/for-patients-with-high-risk-stress-test-features-with-ischemic-ekg-changes-and-mild-to-no-symptoms-what-would-be-your-threshold-to-directly-admit-them-for-coronary-angiography-or-pursue-outpatient-elective-coronary-angiogram weekly 0.8 https://www.themednet.org/how-do-the-results-of-tropion-lung01-phase-iii-trial-change-your-practice-in-the-management-of-locally-advanced-or-metastatic-nsclc weekly 0.8 https://www.themednet.org/which-patients-presenting-with-spontaneous-ich-should-be-considered-for-a-diagnostic-cerebral-angiogram-dsa weekly 0.8 https://www.themednet.org/with-the-canova-results-in-mind-would-you-continue-using-venetoclax-in-patients-with-multiple-myeloma-with-t-11-14 weekly 0.8 https://www.themednet.org/what-is-your-approach-to-bridging-anticoagulation-in-patients-with-history-of-recent-hit weekly 0.8 https://www.themednet.org/do-you-avoid-losartan-in-patients-with-hypertension-and-uric-acid-nephrolithiasis-due-to-the-drugs-uricosuric-effects weekly 0.8 https://www.themednet.org/how-do-you-approach-sbrt-and-constraining-healthy-liver-for-a-small-liver weekly 0.8 https://www.themednet.org/how-do-you-approach-evaluation-and-management-of-arthralgia-in-a-patient-after-car-t-cell-therapy weekly 0.8 https://www.themednet.org/do-you-consider-pulmonary-hypertension-related-to-sarcoidosis-to-be-an-indication-to-start-steroids weekly 0.8 https://www.themednet.org/would-you-combine-sutimlimab-with-bendamustine-rituximab-for-cold-agglutinin-disease-if-patient-continues-to-hemolyze-during-treatment weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-therapy-for-metastatic-hr-inflammatory-breast-cancer weekly 0.8 https://www.themednet.org/is-it-safe-to-administer-lu-177-therapies-in-patients-with-epidural-disease-in-the-spinal-canal weekly 0.8 https://www.themednet.org/how-would-manage-a-patient-with-primary-mediastinal-nsgct-who-has-radiographic-response-but-rising-afp-while-receiving-vip weekly 0.8 https://www.themednet.org/how-would-approach-the-management-of-a-patient-with-significantly-positive-anticardiolopin-and-beta-2-glycoprotein-antibodies-in-the-absence-of-any-clotting-including-obstetric-history-but-with-significant-thrombocytopenia-but-no-other-features-of-active- weekly 0.8 https://www.themednet.org/do-you-avoid-triptans-in-patients-with-migraine-with-motor-aura weekly 0.8 https://www.themednet.org/when-do-you-consider-use-of-ketamine-in-patients-with-migraine-with-aura weekly 0.8 https://www.themednet.org/when-do-you-order-genetic-testing-in-patients-with-dystonia weekly 0.8 https://www.themednet.org/do-you-recommend-any-diagnostic-testing-for-patients-with-blepharospasm weekly 0.8 https://www.themednet.org/how-do-you-treat-patients-with-blepharospasm weekly 0.8 https://www.themednet.org/what-is-a-reasonable-amount-of-ventricular-arrhythmia-burden-on-outpatient-remote-monitoring-that-would-prompt-consideration-for-vt-ablation-in-patients-with-normal-lv-function-and-mild-symptoms weekly 0.8 https://www.themednet.org/do-you-recommend-postoperative-radiation-for-spinal-cord-compression-dlbcl weekly 0.8 https://www.themednet.org/in-the-era-of-hypofractionation-for-breast-cancer-how-would-you-re-irradiate-for-these-cases-if-recurrence-develops-years-later weekly 0.8 https://www.themednet.org/how-do-you-balance-the-need-for-wound-healing-and-time-to-treatment-initiation-in-head-and-neck-cancer-patients-who-require-a-second-operation weekly 0.8 https://www.themednet.org/what-is-the-rationale-behind-the-anesthesiology-recommendation-to-hold-one-dose-of-weekly-glp-ra-prior-to-general-anesthesia weekly 0.8 https://www.themednet.org/despite-low-t-scores-2-5-or-worse-what-is-the-actual-fracture-risk-in-relatively-younger-patients-early-50s-to-mid-60s-with-low-bmd weekly 0.8 https://www.themednet.org/what-is-the-differential-for-elevated-t3-with-suppressed-t4-and-normal-tsh-in-a-patient-not-taking-any-thyroid-hormones weekly 0.8 https://www.themednet.org/would-you-wait-a-period-of-time-before-collecting-a-24-hour-urine-stone-risk-study-in-a-patient-with-nephrolithiasis-who-recently-underwent-a-urologic-stone-removal-procedure weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-to-decide-the-duration-of-iv-steroids-in-patients-with-optic-neuritis weekly 0.8 https://www.themednet.org/which-patients-with-primary-early-stage-nsclc-would-you-utilize-immunotherapy-in-conjunction-with-sbrt weekly 0.8 https://www.themednet.org/for-a-tsh-producing-microadenoma-would-you-recommend-surgery-vs-methimazole-if-the-patient-is-elderly-and-the-tumor-is-relatively-small weekly 0.8 https://www.themednet.org/how-long-do-you-normally-wait-before-considering-any-bronchoscopic-procedure-ebus-tbna-transbronchial-biopsy-after-an-episode-of-acute-pe-in-a-patient-needing-these-procedures weekly 0.8 https://www.themednet.org/do-you-typically-adjust-or-hold-immunosuppression-in-a-well-controlled-ra-patient-who-is-being-treated-for-mycobacterium-avium-intracellulare-mai weekly 0.8 https://www.themednet.org/what-lab-levels-would-lead-you-to-consider-switching-dmts-for-patients-with-ms-on-fingolimod weekly 0.8 https://www.themednet.org/what-is-your-approach-to-tapering-chronic-steroids-in-patients-who-are-at-high-risk-of-hpa-suppression weekly 0.8 https://www.themednet.org/would-you-add-voclosporin-to-mycophenolate-for-refractory-proteinuria-in-a-patient-with-low-ef weekly 0.8 https://www.themednet.org/what-is-your-current-approach-to-maintenance-therapy-in-flt3-mutant-aml-post-allogeneic-hct weekly 0.8 https://www.themednet.org/when-would-you-consider-ct-aortic-valve-calcium-score-over-tee-to-further-delineate-the-severity-of-lflg-aortic-stenosis weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-very-low-risk-stage-iiia-cutaneous-melanoma-for-adjuvant-immunotherapy weekly 0.8 https://www.themednet.org/what-workup-do-you-suggest-for-patients-with-concern-for-opsoclonus-myoclonus-syndrome weekly 0.8 https://www.themednet.org/what-is-your-approach-to-re-challenging-btk-inhibitors-for-a-patient-who-has-had-intolerance-to-several-different-agents weekly 0.8 https://www.themednet.org/what-is-the-preferred-treatment-for-a-patient-with-an-ebv-monomorphic-ptld-dlbcl-not-currently-on-immunosuppressive-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-immunomodulatory-treatment-for-systemic-lupus-associated-protein-losing-enteropathy-ple-in-a-patient-whose-clinical-course-has-been-complicated-by-significant-infection weekly 0.8 https://www.themednet.org/what-is-the-best-treatment-of-isolated-elevated-dhea-s-in-a-woman-with-clinical-androgen-excess-without-pcos-neoplasm-etc weekly 0.8 https://www.themednet.org/how-would-you-approach-treating-a-patient-with-rheumatoid-arthritis-psoriatic-arthritis-and-alcoholic-cirrhosis weekly 0.8 https://www.themednet.org/would-you-treat-an-unresectable-msi-h-colon-cancer-patient-with-persistent-hepatitis-c-with-immunotherapy weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-in-a-patient-with-mss-colon-cancer-who-only-has-residual-mucin-left-without-viable-cancer-cells-despite-no-pre-operative-chemotherapy-in-the-colon-and-lymph-nodes weekly 0.8 https://www.themednet.org/what-radiation-dose-fractionation-regimen-would-you-choose-for-squamous-cell-carcinoma-of-the-great-toe-in-a-patient-who-declines-surgery weekly 0.8 https://www.themednet.org/how-do-you-interpret-a-low-vwf-activity-antigen-ratio-when-both-activity-and-antigen-levels-are-above-50 weekly 0.8 https://www.themednet.org/is-there-an-indication-for-adrenalectomy-in-patients-with-subclinical-cushing-syndrome-and-adrenal-nodule weekly 0.8 https://www.themednet.org/in-a-young-patient-with-relapsing-polychondritis-and-aortitis-which-has-led-to-severe-aortic-valve-regurgitation-is-there-any-preference-for-a-mechanical-versus-bioprosthetic-valve-replacement weekly 0.8 https://www.themednet.org/what-is-the-risk-of-local-recurrence-in-a-high-grade-muscle-invasive-bladder-cancer-mibc-s-p-incomplete-turbt-treated-with-concurrent-chemoradiation-compared-to-a-complete-turbt weekly 0.8 https://www.themednet.org/do-you-usually-recommend-pfo-closure-for-patients-with-frequent-migraines-with-aura weekly 0.8 https://www.themednet.org/what-is-your-approach-to-maintenance-treatment-in-a-patient-with-sjogrens-who-received-rituximab-for-mononeuritis-multiplex weekly 0.8 https://www.themednet.org/what-further-work-up-if-any-should-be-considered-in-patients-with-pituitary-microadenoma-and-stigmata-of-cushings-disease-but-low-acth-and-repeatedly-normal-plasma-urinary-and-salivary-cortisol-levels weekly 0.8 https://www.themednet.org/in-patients-taking-biologics-who-are-planning-joint-replacement-and-are-known-mrsa-carriers-do-you-perform-decolonization-prior-to-surgery weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-who-develops-acute-stroke-during-neoadjuvant-chemotherapy-with-keynote-522-for-stage-iii-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/do-you-consider-surgical-thrombectomy-in-patients-with-a-large-obstructive-pulmonary-venous-thrombosis-after-lung-transplant weekly 0.8 https://www.themednet.org/in-light-of-de-escalation-data-for-patients-undergoing-standard-dose-radiation-for-favorable-hpv-oropharynx-cancer-do-you-accept-lower-coverage-of-the-low-dose-rt-field-to-better-spare-oars weekly 0.8 https://www.themednet.org/how-would-you-manage-a-hr-her2-breast-cancer-patient-with-no-response-during-neoadjuvant-tchp weekly 0.8 https://www.themednet.org/is-it-possible-for-certain-individuals-with-osteoporosis-to-be-a-denosumab-non-responder weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-severe-sicca-symptoms-and-history-of-b-cell-lymphoma weekly 0.8 https://www.themednet.org/how-would-you-manage-autoimmune-pancreatitis-in-a-patient-after-whipples-procedure weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-p16-neck-lymph-node-metastasis-of-an-unknown-primary-considering-their-history-of-prior-supraclavicular-and-chest-wall-irradiation weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-mcrpc-with-a-good-clinical-and-50-reduction-in-psa-to-lu-psma-but-evidence-of-radiographic-progression-on-psma-pet-ct weekly 0.8 https://www.themednet.org/would-you-anticoagulate-a-patient-with-splenic-infarctions-in-the-setting-of-cmv-viremia weekly 0.8 https://www.themednet.org/would-you-offer-radiation-for-stage-iii-nsclc-in-a-non-surgical-candidate-with-prior-post-mastectomy-chest-wall-rt weekly 0.8 https://www.themednet.org/can-joint-replacement-surgery-be-performed-in-someone-with-active-pagets-disease-elsewhere weekly 0.8 https://www.themednet.org/based-on-results-from-the-voyager-pad-trial-when-would-you-consider-the-primary-use-of-rivaroxaban-with-aspirin-clopidogrel-as-opposed-to-conventional-aspirin-clopidogrel-in-patients-undergoing-lower-extremity-revascularization weekly 0.8 https://www.themednet.org/when-would-you-consider-using-acetazolamide-to-augment-diuresis-in-patients-with-adhf weekly 0.8 https://www.themednet.org/how-do-you-approach-a-well-controlled-hiv-patient-with-diffuse-cutaneous-kaposi-sarcoma-who-failed-to-respond-to-radiation-paclitaxel-and-monthly-liposomal-doxorubicin weekly 0.8 https://www.themednet.org/what-workup-do-you-initiate-for-thoracic-outlet-syndrome weekly 0.8 https://www.themednet.org/do-you-typically-recommend-emg-nerve-conduction-study-for-patients-with-stinger-syndrome-as-a-result-of-an-athletic-injury weekly 0.8 https://www.themednet.org/what-management-do-you-recommend-in-patients-with-backpack-palsy weekly 0.8 https://www.themednet.org/when-do-you-consider-genetic-testing-in-patients-with-suspected-hereditary-brachial-plexopathy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-postmedian-sternotomy-plexopathy weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-a-solitary-brain-metastasis-from-small-cell-lung-cancer-s-p-resection-with-otherwise-limited-thoracic-disease weekly 0.8 https://www.themednet.org/does-an-egfr-mutation-in-a-never-smoker-change-your-radiation-treatment-recommendations-for-es-sclc weekly 0.8 https://www.themednet.org/do-you-switch-therapy-to-sacituzumab-in-a-patient-with-metastatic-hr-her2-breast-cancer-who-has-stable-systemic-disease-but-new-1cm-brain-metastasis weekly 0.8 https://www.themednet.org/for-insurance-how-do-you-justify-medical-necessity-for-imrt-to-the-pancreas-in-the-preoperative-unresectable-and-post-operative-settings weekly 0.8 https://www.themednet.org/how-do-you-perform-patch-testing-in-patients-who-are-allergic-to-adhesives weekly 0.8 https://www.themednet.org/does-dupixent-interfere-with-patch-testing weekly 0.8 https://www.themednet.org/how-do-you-manage-acne-relapses-after-isotretinoin weekly 0.8 https://www.themednet.org/what-protective-post-op-measures-do-you-recommend-for-a-patient-with-scleroderma-and-a-history-of-ild-ph-raynauds-and-digital-ischemia-undergoing-cardiothoracic-surgery weekly 0.8 https://www.themednet.org/what-is-the-preferred-imaging-modality-to-evaluate-subaortic-membranes-in-patients-with-aortic-valve-disease weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-that-did-not-have-preoperative-axillary-imaging-and-was-found-to-have-macromets-on-sentinel-node-biopsy-and-on-radiation-planning-scan-has-abnormal-appearing-nodes weekly 0.8 https://www.themednet.org/what-are-some-considerations-to-make-when-managing-a-patient-on-peritoneal-dialysis-who-develops-acute-pancreatitis weekly 0.8 https://www.themednet.org/what-is-the-appropriate-timing-for-adjuvant-radiation-for-vulvar-cancer weekly 0.8 https://www.themednet.org/how-would-you-interpret-a-positive-single-specific-markers-like-ssa-or-ssb-in-setting-of-working-up-an-connective-tissue-disease-especially-when-ana-is-negative weekly 0.8 https://www.themednet.org/would-you-still-recommend-bone-marrow-biopsy-in-an-elderly-non-transplant-eligible-patient-with-mild-cytopenias-if-ngs-from-peripheral-blood-indicates-mds-mutations weekly 0.8 https://www.themednet.org/would-you-prescribe-vaginal-estrogen-cream-for-vaginal-dryness-to-a-patient-in-her-40s-with-a-history-of-stage-ia-granulosa-cell-tumor weekly 0.8 https://www.themednet.org/is-there-a-limit-to-the-size-of-a-prostate-cancer-oligometastasis-for-sbrt weekly 0.8 https://www.themednet.org/how-does-the-recently-published-sound-trial-affect-your-approach-to-breast-rt weekly 0.8 https://www.themednet.org/how-do-you-manage-drug-drug-interactions-between-oral-anticoagulants-and-the-arsi-agents-such-as-apalutamide-and-enzalutamide weekly 0.8 https://www.themednet.org/what-would-be-your-approach-to-a-patient-with-new-diagnosis-of-seropositive-rheumatoid-arthritis-manifesting-as-a-constrictive-pericarditis-with-no-joint-pain-complaints weekly 0.8 https://www.themednet.org/is-there-a-concern-for-the-potential-of-future-congenital-malformations-in-offspring-when-preservation-of-eggs-and-sperm-is-done-after-cyclophosphamide-treatment-given-that-it-is-an-alkylating-agent weekly 0.8 https://www.themednet.org/do-you-consider-immunosuppressive-agents-in-progressive-interstitial-pneumonias-or-pneumonitis-without-a-clear-driving-etiology weekly 0.8 https://www.themednet.org/in-a-patient-with-previous-cervix-cancer-treated-with-surgery-and-adjuvant-ebrt-who-presents-with-recurrent-hgsil-status-post-vaginectomy-would-you-consider-brachytherapy weekly 0.8 https://www.themednet.org/will-you-now-recommend-enfortumab-and-pembrolizumab-for-most-patients-with-metastatic-urothelial-carcinoma-regardless-of-platinum-eligibility-based-on-the-ev-302-presentation-at-esmo-2023 weekly 0.8 https://www.themednet.org/what-special-considerations-do-you-take-when-treating-cancer-patients-with-severe-intellectual-disabilities weekly 0.8 https://www.themednet.org/for-a-pediatric-patient-with-b-all-who-requires-surgery-during-maintenance-what-therapy-modifications-do-you-recommend-to-allow-for-optimal-healing-and-minimal-treatment-disruption weekly 0.8 https://www.themednet.org/what-are-your-thoughts-on-the-relevance-of-sentinel-lymph-node-biopsy-before-the-onset-of-neoadjuvant-chemotherapy-for-her2-or-triple-negative-ct2-n0m0-breast-cancer-patients weekly 0.8 https://www.themednet.org/how-is-monoclonal-gammopathy-of-renal-significance-mgrs-different-from-myeloma-kidney weekly 0.8 https://www.themednet.org/for-patients-with-recurrence-or-second-primary-in-the-head-and-neck-after-prior-radiation-what-would-be-the-postoperative-indications-for-adjuvant-radiation weekly 0.8 https://www.themednet.org/for-a-localized-vaginal-cuff-recurrence-of-uterine-leiomyosarcoma-what-is-the-preferred-management-strategy weekly 0.8 https://www.themednet.org/how-do-you-taper-phenobarbital-in-a-patient-with-epilepsy weekly 0.8 https://www.themednet.org/in-patients-with-secondary-osteoporosis-due-to-primary-hyperparathyroidism-should-parathyroidectomy-be-recommended-in-the-setting-of-recent-prior-bisphosphonate-use weekly 0.8 https://www.themednet.org/would-you-start-asa-and-or-statin-therapy-on-an-asymptomatic-patient-noted-to-have-incidental-pathologic-q-waves-on-ekg-assuming-no-prior-history-of-ischemic-heart-disease weekly 0.8 https://www.themednet.org/is-it-okay-to-send-an-oncotype-solely-for-prognostic-purposes-to-a-patient-who-doesnt-want-chemotherapy-or-an-elderly-patient-with-poor-ps weekly 0.8 https://www.themednet.org/would-you-attempt-a-brain-mri-in-patients-who-present-to-the-er-with-subacute-presentation-of-obstructive-hydrocephalus weekly 0.8 https://www.themednet.org/how-frequently-do-you-check-ck-in-patients-with-beckers-muscular-dystrophy weekly 0.8 https://www.themednet.org/is-there-a-role-for-inpatient-emg-ncs-in-patients-who-present-with-rhabdomyolysis-with-unclear-etiology weekly 0.8 https://www.themednet.org/would-you-recommend-a-ct-venogram-or-mr-venogram-in-patients-with-concern-for-venous-sinus-thrombosis weekly 0.8 https://www.themednet.org/how-do-you-manage-vitamin-d-dosing-in-patients-with-nephrolithiasis-and-hypercalciuria-who-require-supplemental-vitamin-d-for-treating-other-medical-conditions weekly 0.8 https://www.themednet.org/would-you-offer-dose-reduction-to-36-gy-pre-op-to-a-lower-extremity-low-grade-myxoid-liposarcoma-based-on-results-of-the-doremy-non-randomized-data weekly 0.8 https://www.themednet.org/what-is-the-goal-of-estradiol-levels-on-ovarian-suppression-and-ai-for-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-an-elderly-patient-with-multiple-myeloma-and-calr-myelofibrosis-with-elevated-platelets weekly 0.8 https://www.themednet.org/how-soon-after-an-intervention-is-done-for-peritoneal-catheter-inflow-or-outflow-obstruction-is-it-advisable-to-repeat-the-kt-v weekly 0.8 https://www.themednet.org/how-do-you-approach-an-obese-patient-on-long-term-methotrexate-with-normal-liver-tests-in-terms-of-workup-for-underlying-fatty-liver weekly 0.8 https://www.themednet.org/what-is-your-approach-to-evaluation-in-patients-who-present-with-erythromelalgia weekly 0.8 https://www.themednet.org/what-are-the-current-indications-for-proton-beam-therapy-in-the-treatment-of-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-evaluate-and-treat-a-disabling-tongue-tremor weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-and-partners-of-patients-with-hpv-cancers-regarding-the-hpv-vaccine weekly 0.8 https://www.themednet.org/what-treatment-options-do-you-recommend-in-a-patient-with-idiopathic-granulomatous-mastitis-that-has-not-improved-on-steroids-and-methotrexate weekly 0.8 https://www.themednet.org/in-light-of-the-flaura2-data-which-patients-would-you-recommend-upfront-treatment-with-chemotherapy-osimertinib-rather-than-osimertinib-monotherapy weekly 0.8 https://www.themednet.org/would-you-consider-a-fast-forward-fractionation-for-a-ct1a-idc-with-dcis-that-was-found-to-be-ptis-on-lumpectomy-specimen weekly 0.8 https://www.themednet.org/do-you-recommend-monitoring-igg-level-in-patients-with-aav-receiving-rituximab weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-risks-versus-benefits-of-jak-inhibitors-for-the-treatment-of-alopecia weekly 0.8 https://www.themednet.org/would-you-offer-consolidative-scrotal-rt-for-patients-with-bilateral-testicular-lymphoma-involvement-s-p-bilateral-orchiectomy-and-chemotherapy weekly 0.8 https://www.themednet.org/what-is-a-reasonable-hemoglobin-goal-for-patients-with-chronic-anemia-presenting-with-acute-mi weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-class-of-anti-anginals-for-minoca-with-proven-epicardial-coronary-vasospasm weekly 0.8 https://www.themednet.org/how-do-you-define-treatment-volumes-for-patients-treated-with-neoadjuvant-chemoimmunotherapy-for-resectable-nsclc-who-are-no-longer-surgical-candidates-or-decline-surgery weekly 0.8 https://www.themednet.org/what-are-the-factors-that-you-would-consider-for-the-use-of-esa-in-patients-with-anemia-of-ckd-with-a-history-of-stroke-or-tia weekly 0.8 https://www.themednet.org/what-are-your-outpatient-surveillance-strategies-biomarkers-imaging-symptoms-to-monitor-response-to-treatment-for-attr-amyloidosis-with-cardiac-involvement weekly 0.8 https://www.themednet.org/how-do-you-manage-immunosuppressive-medications-in-patients-who-develop-a-pneumonia weekly 0.8 https://www.themednet.org/when-considering-re-irradiation-of-a-critical-organ-should-eqd2-or-bed-be-utilized weekly 0.8 https://www.themednet.org/would-you-offer-salvage-radiation-for-prostate-bed-recurrence-on-psma-pet-in-a-patient-with-limited-bone-mets weekly 0.8 https://www.themednet.org/would-you-treat-a-sputum-culture-positive-for-aspergillus-niger-despite-an-atypical-ct-chest-and-a-negative-serum-galactomannan-in-an-immunosuppressed-patient-who-is-too-high-risk-for-bronchoscopy weekly 0.8 https://www.themednet.org/is-there-enough-evidence-now-to-use-injectable-semaglutide-as-a-foundational-therapy-for-symptomatic-heart-failure-with-preserved-ejection-fraction-in-the-setting-of-overweight-or-obesity weekly 0.8 https://www.themednet.org/is-it-appropriate-to-offer-definitive-trimodality-therapy-as-an-equivalent-option-to-neoadjuvant-chemotherapy-followed-by-radical-cystectomy-in-patients-with-muscle-invasive-bladder-cancer-regardless-of-fitness-or-platinum-eligibility weekly 0.8 https://www.themednet.org/how-long-would-you-wait-for-outflow-to-improve-before-consulting-surgery-in-a-peritoneal-dialysis-patient-with-an-outflow-obstruction-who-is-prescribed-laxatives-for-catheter-migration weekly 0.8 https://www.themednet.org/how-do-you-determine-the-fill-volume-of-icodextrin-for-a-volume-overloaded-eskd-on-pd-patient-considering-that-the-dwell-may-last-throughout-the-day weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-chemo-for-a-mucinous-stage-ii-adenocarcinoma-of-the-colon-in-the-lack-of-other-high-risk-clinical-pathological-features weekly 0.8 https://www.themednet.org/is-it-acceptable-to-give-hypofractionated-breast-radiation-in-a-patient-who-is-being-treated-for-rheumatoid-arthritis-with-actemra-methotrexate-and-leucovorin weekly 0.8 https://www.themednet.org/is-macrilen-macimorelin-dx-still-available-in-the-us-for-diagnosis-of-adult-growth-hormone-deficiency-aghd weekly 0.8 https://www.themednet.org/how-do-you-reconcile-the-differences-between-2022-abs-apbi-recommendations-and-2023-astro-apbi-recommendations weekly 0.8 https://www.themednet.org/do-you-add-fludrocortisone-to-hydrocortisone-when-starting-stress-dose-steroids-in-a-patient-with-septic-shock weekly 0.8 https://www.themednet.org/how-should-we-think-about-endocrine-resistance-in-patients-with-inherited-germline-mutations-such-as-brca-chek2-etc weekly 0.8 https://www.themednet.org/for-recurrent-glioblastoma-treated-with-combined-re-irradiation-and-bevacizumab-how-long-do-you-continue-bevacizumab weekly 0.8 https://www.themednet.org/how-should-one-approach-an-incidentally-found-t-cell-gene-arrangement weekly 0.8 https://www.themednet.org/would-you-offer-ofs-5-years-out-from-diagnosis-in-a-young-patient-whose-menses-have-returned-with-previously-treated-idc weekly 0.8 https://www.themednet.org/how-do-you-screen-alopecia-patients-to-determine-whether-they-are-appropriate-candidates-for-jak-inhibitors weekly 0.8 https://www.themednet.org/how-do-you-utilize-jak-inhibitors-in-combination-with-other-therapies-to-manage-alopecia weekly 0.8 https://www.themednet.org/how-do-you-approach-a-breast-cancer-patient-with-outside-pathology-returning-as-her2-positive-on-fish-but-internal-pathology-review-showing-conflicting-results-and-her2-negative-on-fish-on-same-sample weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-a-patient-with-lumbar-spinal-metastasis-with-neurologic-symptoms-but-without-evidence-of-spinal-cord-compression weekly 0.8 https://www.themednet.org/how-do-you-approach-immunosuppression-in-patients-with-a-positive-interferon-gamma-release-assay-and-prior-intravesicular-bcg-treatment-for-bladder-cancer weekly 0.8 https://www.themednet.org/would-you-treat-a-hemochromatosis-carrier-with-iv-iron-if-they-have-iron-deficiency-anemia-in-conjunction-with-elevated-ferritin weekly 0.8 https://www.themednet.org/what-is-your-approach-for-steroid-dosing-for-patients-with-anca-vasculitis-on-induction-treatment-with-rituximab-avacopan-and-glucocorticoid-therapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-monitoring-patients-with-cardiac-sarcoid-while-tapering-immunosuppression weekly 0.8 https://www.themednet.org/what-risk-factors-would-favor-the-addition-of-ovarian-function-suppression-to-endocrine-therapy-in-triple-positive-breast-cancer weekly 0.8 https://www.themednet.org/what-eni-lymph-node-stations-would-you-treat-for-a-locally-advanced-scc-of-the-thumb weekly 0.8 https://www.themednet.org/in-a-patient-with-a-factor-v-leiden-heterozygous-mutation-but-no-prior-thrombosis-would-you-consider-using-a-jak-inhibitor-for-the-treatment-of-spondyloarthritis-or-rheumatoid-arthritis-if-other-options-have-been-ineffective weekly 0.8 https://www.themednet.org/how-do-you-sequence-ra-223-and-lu-177-in-patients-with-mcrpc-with-predominantly-bony-disease weekly 0.8 https://www.themednet.org/how-would-you-treat-an-msi-h-metastatic-cholangiocarcinoma-found-on-liquid-biopsy weekly 0.8 https://www.themednet.org/how-would-you-approach-patient-with-known-lynch-syndrome-who-developed-a-gall-bladder-cancer-which-on-pathologic-testing-of-the-tumor-by-pcr-and-immunohistochemistry-is-pmmr-and-mss weekly 0.8 https://www.themednet.org/what-are-some-measures-to-prevent-flares-of-loin-pain-hematuria-syndrome weekly 0.8 https://www.themednet.org/what-is-your-protocol-to-starting-stopping-glucocorticoid-replacement-in-cushing-disease-patients-after-their-transsphenoidal-resection-surgery weekly 0.8 https://www.themednet.org/do-you-perform-peep-titration-while-patients-are-proned weekly 0.8 https://www.themednet.org/when-would-you-consider-a-kidney-biopsy-in-a-patient-with-longstanding-diabetes-and-hypertension-baseline-creatinine-4-5-4-proteinuria-who-was-recently-found-to-have-dsdna-positivity weekly 0.8 https://www.themednet.org/does-the-extent-of-ene-affect-your-recommendation-for-concurrent-chemotherapy-in-hpv-opscc-patients-planned-for-adjuvant-rt weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-symptomatic-cystic-fibrosis-carriers weekly 0.8 https://www.themednet.org/how-frequently-should-outpatient-mobile-cardiac-telemetry-be-ordered-following-resolution-of-post-cabg-related-atrial-fibrillation-for-patients-off-anticoagulation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-genital-lichen-sclerosus-that-is-not-responding-to-super-potent-topical-steroids weekly 0.8 https://www.themednet.org/if-prompted-as-an-outpatient-how-do-you-counsel-patients-on-the-rare-cardiac-complications-of-vaccinations-including-myocarditis weekly 0.8 https://www.themednet.org/do-you-stop-activated-vitamin-d-ie-paricalcitol-in-your-dialysis-patients-who-have-hyperphosphatemia-despite-low-phosphate-diet-and-phosphorus-binder-adherence weekly 0.8 https://www.themednet.org/how-would-you-approach-additional-workup-and-management-of-a-patient-with-active-crohns-disease-who-has-multiple-lung-and-brain-nodules-with-lung-pathology-demonstrating-necrotizing-granulomatous-inflammation-and-brain-biopsy-with-granulomatous-inflammati weekly 0.8 https://www.themednet.org/what-treatment-modalities-have-you-had-success-with-for-treating-extensive-molluscum-in-the-pediatric-population weekly 0.8 https://www.themednet.org/is-there-a-role-for-voclosporin-in-non-renal-lupus weekly 0.8 https://www.themednet.org/how-do-you-optimize-definitive-external-beam-pelvic-radiation-in-a-patient-with-cervical-cancer-that-is-unable-to-fill-her-bladder-due-to-bilateral-percutaneous-nephrostomy-tubes weekly 0.8 https://www.themednet.org/is-there-a-role-for-systemic-therapy-for-a-patient-with-scleroderma-sine-sclerosis-with-esophageal-strictures-and-raynauds-syndrome-but-no-pulmonary-involvement weekly 0.8 https://www.themednet.org/in-patients-with-intrinsic-acute-kidney-injury-of-unknown-etiology-and-with-pending-kidney-biopsy-results-are-there-instances-when-you-would-recommend-a-trial-of-glucocorticoids weekly 0.8 https://www.themednet.org/which-adjuvant-chemotherapy-would-you-offer-to-a-msi-high-pancreatic-cancer-patient-after-whipple weekly 0.8 https://www.themednet.org/does-a-genetic-predisposition-to-cancer-affect-your-recommendations-regarding-breast-conservation-and-radiation weekly 0.8 https://www.themednet.org/how-do-you-treat-rotational-vertebral-artery-syndrome weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-status-dystonicus weekly 0.8 https://www.themednet.org/after-seeing-results-from-gog238-is-there-a-subset-of-patients-that-might-still-benefit-from-chemoradiation-for-centrally-recurrent-endometrial-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-biopsy-proven-dlbcl-in-a-patient-who-was-treated-with-6-cycles-of-r-chop-15-years-ago-for-dlbcl weekly 0.8 https://www.themednet.org/how-would-you-manage-worsening-severe-macroglossia-affecting-function-in-a-patient-after-definitive-chemoradiation-in-the-subacute-setting-for-p16-scc-of-the-base-of-tongue weekly 0.8 https://www.themednet.org/how-do-you-prescribe-ketamine-for-treatment-of-refractory-status-epilepticus-and-what-is-its-efficacy weekly 0.8 https://www.themednet.org/what-treatment-volume-and-dose-would-you-recommend-for-locally-advanced-nsclc-with-cr-after-induction-chemotherapy weekly 0.8 https://www.themednet.org/would-you-do-apbi-for-encapsulated-papillary-carcinoma-with-negative-margins-and-no-surgical-axillary-assessment weekly 0.8 https://www.themednet.org/do-you-have-to-remove-gold-dental-crowns-if-patch-testing-reveals-a-gold-allergy weekly 0.8 https://www.themednet.org/among-patients-with-recovered-lvef-on-gdmt-with-a-reversible-cause-for-heart-failure-i-e-tachycardia-mediated-or-alcohol-mediated-cardiomyopathy-would-you-consider-de-escalation-of-gdmt weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-a-patient-with-sjogrens-disease-and-lung-mass-biopsy-revealing-amyloidosis weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-nlphl-and-ckd-who-relapsed-after-a-long-disease-free-interval-i-e-7-years-following-bendamustine weekly 0.8 https://www.themednet.org/which-medications-do-you-recommend-for-lactating-mothers-with-kidney-disease-and-proteinuria-that-persists-post-delivery weekly 0.8 https://www.themednet.org/how-do-you-dose-or-sequence-therapy-to-overcome-radioresistance-from-oligometastatic-disease-from-rcc weekly 0.8 https://www.themednet.org/what-are-some-device-parameters-and-clinical-scenarios-in-which-recommendations-should-be-made-to-deactivate-the-lv-lead-in-patients-with-an-existing-crt-d-device-following-lvad-implantation weekly 0.8 https://www.themednet.org/what-considerations-do-you-take-when-evaluating-a-patient-for-kidney-transplantation-who-has-a-history-of-kidney-disease-and-an-abdominal-aortic-aneurysm-treated-with-past-stenting weekly 0.8 https://www.themednet.org/whats-your-approach-to-recurrent-idiopathic-erythema-nodosum-that-failed-nsaids weekly 0.8 https://www.themednet.org/for-patients-with-rectal-cancer-being-treated-along-prospect-paradigm-would-you-extrapolate-from-the-idea-literature-and-offer-3-months-of-capox-neoadjuvantly-without-adjuvant-therapy weekly 0.8 https://www.themednet.org/is-there-a-role-for-elacestrant-in-er-metastatic-breast-cancer-with-esr1-yap1-fusion-on-ngs weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-patients-with-labile-blood-pressures-secondary-to-baroreflex-failure weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-radiation-for-a-patient-with-recurrent-pelvic-node-melanoma-s-p-immunotherapy-and-pelvic-lymph-node-dissection-with-complete-pathological-response-only-necrotic-tissue-no-viable-melanoma weekly 0.8 https://www.themednet.org/how-do-you-reduce-the-risk-of-contralateral-fracture-in-a-patient-with-atypical-femur-fracture-from-prolonged-bisphosphonate-use weekly 0.8 https://www.themednet.org/what-factors-do-you-use-when-selecting-which-ngs-platform-to-use-for-sequencing-solid-tumors weekly 0.8 https://www.themednet.org/would-you-continue-rituximab-infusions-in-a-patient-with-gpa-and-renal-involvement-who-has-been-in-remission-on-avacopan-and-rituximab-but-had-pres-post-rituximab-infusion weekly 0.8 https://www.themednet.org/would-you-ever-start-adjuvant-pelvic-radiation-with-a-drain-in-place weekly 0.8 https://www.themednet.org/what-is-your-approach-to-inhaler-therapy-in-a-patient-with-asthma-who-cannot-be-on-an-inhaled-corticosteroid-due-to-ocular-disease weekly 0.8 https://www.themednet.org/what-are-the-potential-causes-for-significant-discrepancies-between-predicted-a1c-by-dexcom-cgm-and-standard-serum-a1c-by-lab-draw weekly 0.8 https://www.themednet.org/do-you-offer-apbi-to-patients-with-close-margins weekly 0.8 https://www.themednet.org/how-do-you-handle-grade-3-4-standard-infusion-reactions-with-amivantamab weekly 0.8 https://www.themednet.org/is-it-possible-to-give-inotuzumab-ozogamicin-in-the-front-line-setting-for-an-older-patient-with-ph-pre-b-all weekly 0.8 https://www.themednet.org/which-other-agent-would-you-consider-for-a-patient-with-vexas-who-has-failed-methotrexate-multiple-tnf-inhibitors-tocilizumab-and-ruxolitinib weekly 0.8 https://www.themednet.org/do-distant-lymph-nodes-from-metastatic-prostate-cancer-retroperitoneal-and-scv-count-as-oligometastatic-disease weekly 0.8 https://www.themednet.org/do-you-typically-do-genetic-testing-in-patients-with-progressive-supranuclear-palsy weekly 0.8 https://www.themednet.org/do-you-recommend-csf-analysis-in-young-patients-with-imaging-findings-consistent-with-progressive-supranuclear-palsy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-patients-with-suspected-osmotic-nephrosis-from-monthly-ivig-infusions weekly 0.8 https://www.themednet.org/in-what-situations-would-you-consider-esas-in-hospitalized-patients-with-severe-anemia-for-indications-other-than-ckd-or-myelosuppressive-chemotherapy-e-g-acd-hemorrhage weekly 0.8 https://www.themednet.org/how-would-you-address-squamous-cell-carcinoma-in-situ-focally-present-at-the-bronchial-margin-after-lobectomy weekly 0.8 https://www.themednet.org/do-you-treat-patients-with-hiv-aids-and-positive-cryptococcal-antigenemia-but-negative-csf-cryptococcal-antigen-with-standard-meningitis-treatment-given-the-potential-for-the-postzone-effect weekly 0.8 https://www.themednet.org/for-a-pedunculated-rectal-polyp-found-to-be-adenocarcinoma-after-endoscopic-removal-with-pni-as-the-only-adverse-feature-would-you-recommend-additional-treatment-such-as-surgery-or-chemoradiation weekly 0.8 https://www.themednet.org/is-thyrotropin-receptor-antibody-a-good-biomarker-to-predict-development-of-thyroid-eye-disease weekly 0.8 https://www.themednet.org/when-would-you-offer-definitive-or-adjuvant-rt-for-solitary-fibrous-tumor-or-hemangiopericytoma-in-the-head-and-neck weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-patients-with-recurrent-ammonium-urate-kidney-stones weekly 0.8 https://www.themednet.org/what-systemic-therapy-would-you-recommend-for-axillary-recurrence-of-triple-negative-secretory-breast-cancer-previously-treated-with-mastectomy-alone weekly 0.8 https://www.themednet.org/in-a-patient-with-early-stage-her2-breast-cancer-s-p-surgery-would-you-consider-a-noncytotoxic-chemotherapy-approach-with-anti-her2-therapy-alone-if-the-ps-is-borderline-and-or-patient-declines-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-a-patient-with-persistent-ebv-infection-and-mas-despite-treatment-with-rituximab-anakinra-and-canakinumab weekly 0.8 https://www.themednet.org/how-long-do-oscillopsia-and-ataxia-secondary-to-thiamine-deficiency-last-after-completing-repletion weekly 0.8 https://www.themednet.org/how-many-times-one-can-use-ivig-in-gbs weekly 0.8 https://www.themednet.org/how-do-you-apply-the-2helps2b-score-into-clinical-decision-making-for-determining-duration-of-ceeg-testing weekly 0.8 https://www.themednet.org/when-do-you-add-chemotherapy-to-post-operative-rt-for-vulvar-carcinoma weekly 0.8 https://www.themednet.org/do-you-advise-kegels-pelvic-floor-physical-therapy-to-minimize-urinary-incontinence-when-irradiating-the-prostatic-fossa weekly 0.8 https://www.themednet.org/what-treatment-regime-would-you-recommend-for-localized-hyperhidrosis-affecting-the-scalp-that-has-failed-topical-aluminum-chloride-and-oral-glycopyrrolate weekly 0.8 https://www.themednet.org/what-is-your-approach-to-determining-the-need-for-continued-isolation-in-the-dialysis-unit-for-an-eskd-patient-who-had-a-positive-hepatitis-b-surface-antigen-one-year-ago-but-who-now-has-a-negative-hbsag-in-the-absence-of-treatment weekly 0.8 https://www.themednet.org/does-the-presence-of-osteoporosis-change-the-extent-of-workup-that-should-be-performed-for-an-older-patient-with-otherwise-serologically-low-risk-mgus weekly 0.8 https://www.themednet.org/would-you-recommend-parp-inhibitor-maintenance-for-a-patient-with-hr-proficient-ovarian-cancer-with-no-targetable-mutation-but-with-a-favorable-kelim-score-and-a-significant-clinical-radiographic-and-serological-response-to-platinum-based-chemotherapy weekly 0.8 https://www.themednet.org/what-is-your-approach-for-an-ra-patient-with-lung-cancer-who-is-starting-immunotherapy weekly 0.8 https://www.themednet.org/should-colchicine-be-considered-in-patients-with-ischemic-heart-disease-and-persistently-elevated-hscrp-despite-statin-and-aspirin-therapy-and-appropriate-physical-activity weekly 0.8 https://www.themednet.org/can-the-sib-regimen-from-rtog-1005-be-extrapolated-to-all-patients-requiring-whole-breast-irradiation weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-presenting-with-de-novo-metastatic-prostate-cancer-and-baseline-low-testosterone weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-over-the-age-of-40-with-a-sub-totally-resected-frontal-oligodendroglioma-who-grade-ii-1p-19q-co-deleted-idh-mutant-with-imaging-concerning-for-second-site-in-the-pontomedullary-junction weekly 0.8 https://www.themednet.org/how-would-you-manage-out-of-field-nodal-recurrence-of-nsclc-post-definitive-crt-and-adjuvant-immunotherapy weekly 0.8 https://www.themednet.org/for-an-otherwise-resectable-esophageal-cancer-with-involved-celiac-lymph-nodes-would-you-ever-consider-an-sib-beyond-50-4-gy weekly 0.8 https://www.themednet.org/would-concurrent-crlf2-igh-rearrangement-affect-your-treatment-recommendations-for-an-adult-patient-with-ph-p190-high-risk-age-35-wbc-30-b-cell-all-that-was-started-on-induction-therapy-with-ponatinib-blinatumomab weekly 0.8 https://www.themednet.org/how-do-you-medically-manage-uncontrolled-graves-disease-in-a-patient-awaiting-surgery-who-is-intolerant-to-methimazole-and-ptu-and-refusing-rai weekly 0.8 https://www.themednet.org/can-anabolic-agents-be-used-in-a-patient-with-history-of-radioactive-iodine-treatment-for-hyperthyroidism weekly 0.8 https://www.themednet.org/in-the-setting-of-recurrent-breast-cancer-localized-to-the-chest-wall-no-prior-rt-do-you-allow-concurrent-abemaciclib-or-enhertu-with-post-operative-comprehensive-chest-wall-irradiation weekly 0.8 https://www.themednet.org/for-aml-patients-when-do-you-stop-antiinfective-agents weekly 0.8 https://www.themednet.org/how-do-you-manage-mild-type-1-von-willebrand-disease-undergoing-wisdom-teeth-removal weekly 0.8 https://www.themednet.org/what-would-be-your-next-step-in-management-for-a-patient-with-oligometastatic-colon-nec-who-only-achieved-stable-disease-after-4-cycles-of-carboplatin-etoposide weekly 0.8 https://www.themednet.org/when-evaluating-for-pmrt-in-patients-who-did-not-receive-neoadjuvant-chemotherapy-and-are-found-to-be-pn0-do-you-utilize-clinical-t-staging-or-pathologic-t-staging weekly 0.8 https://www.themednet.org/do-you-recommend-holding-tyrosine-kinase-inhibitors-for-extracranial-metastases-being-treated-with-sbrt weekly 0.8 https://www.themednet.org/how-exhaustive-especially-considering-cost-should-an-immunological-workup-be-for-patients-with-extensive-recurrent-or-deep-seated-staph-aureus-infections-without-obvious-immunocompromise-e-g-cancer-diabetes-steroids-or-recurrent-breaks-in-skin-integrity weekly 0.8 https://www.themednet.org/would-you-recommend-indefinite-or-extended-anticoagulation-in-any-scenario-of-a-provoked-clot weekly 0.8 https://www.themednet.org/is-there-an-age-at-which-you-consider-not-starting-antifibrotic-therapy-in-a-patient-with-ipf weekly 0.8 https://www.themednet.org/in-patients-with-htlv-1-associated-acute-t-cell-leukemia-is-there-any-clear-benefit-of-adding-antivirals weekly 0.8 https://www.themednet.org/how-do-you-manage-acute-keratoconjunctivitis-following-total-skin-electron-therapy-tset weekly 0.8 https://www.themednet.org/following-abaloparatide-use-for-osteoporosis-treatment-how-long-do-you-consolidate-with-bisphosphonates-before-considering-a-drug-holiday weekly 0.8 https://www.themednet.org/how-do-you-approach-melanoma-patients-with-a-positive-sentinel-node-with-extra-nodal-extension-for-definitive-surgical-management weekly 0.8 https://www.themednet.org/which-multiple-sclerosis-dmts-would-you-consider-in-patients-with-concurrent-crohns-disease-and-elevated-jcv-ab-titers weekly 0.8 https://www.themednet.org/will-you-consider-definitive-concurrent-chemoradiation-for-stage-iv-lung-adenocarcinoma-with-metastasis-limited-to-an-internal-mammary-lymph-node weekly 0.8 https://www.themednet.org/given-that-there-are-a-fair-number-of-myocarditis-cases-without-a-troponin-elevation-how-do-you-clinically-approach-the-diagnosis-of-myocarditis weekly 0.8 https://www.themednet.org/what-would-be-your-threshold-to-offer-coronary-angiography-for-patients-presenting-with-atypical-chest-pain-features-and-wellens-syndrome-on-ekg-without-a-troponin-elevation-or-dynamic-ekg-changes weekly 0.8 https://www.themednet.org/are-there-any-instances-when-you-use-vitamin-b6-to-prevent-kidney-stones-in-patients-with-recurrent-calcium-oxalate-nephrolithiasis-who-do-not-have-primary-hyperoxaluria weekly 0.8 https://www.themednet.org/for-a-patient-who-has-t4-squamous-cell-esophageal-carcinoma-on-imaging-and-who-has-biopsy-confirmed-disease-in-an-involved-local-lymph-node-are-eus-or-egd-still-indicated-to-complete-workup weekly 0.8 https://www.themednet.org/can-sotalol-initiation-for-atrial-fibrillation-be-performed-safely-outpatient-and-if-so-what-would-be-a-reasonable-protocol-for-implementing-this weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-patient-with-rapidly-progressive-systemic-sclerosis-with-worsening-skin-disease-myositis-arthritis-dysphagia-and-failure-to-thrive-developing-within-6-months weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-indeterminate-uip-on-hrct-with-grossly-positive-mpo-antibody-and-no-other-features-consistent-with-aav weekly 0.8 https://www.themednet.org/when-do-you-refer-a-patient-with-mody3-to-gi-hepatology-for-monitoring-management-of-hepatic-adenomas weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-the-initial-acne-purge-while-on-isotretinoin weekly 0.8 https://www.themednet.org/in-light-of-new-nccn-guidelines-that-state-combination-chemotherapy-pelvic-rt-should-be-reserved-for-endometrial-cancer-of-at-least-stage-iiib-will-you-recommend-ebrt-in-addition-to-chemotherapy-for-stage-iiia-endometrial-cancers weekly 0.8 https://www.themednet.org/what-are-your-management-strategies-for-patients-with-chronic-kidney-disease-attributed-to-deferasirox-use-who-require-frequent-blood-products-for-a-hematologic-disorder weekly 0.8 https://www.themednet.org/how-would-you-treat-an-lgl-leukemia-patient-who-has-been-refractory-to-treatments-with-cyclosporine-mtx-and-cyclophosphamide weekly 0.8 https://www.themednet.org/for-those-rare-patients-now-out-5-years-post-gbm-treatment-and-continuous-optune-is-there-a-point-one-would-stop-optune weekly 0.8 https://www.themednet.org/is-there-a-role-for-radiation-therapy-for-florid-lcis-managed-with-lumpectomy weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-xrt-to-the-prostate-fossa-in-a-patient-with-lynch-syndrome weekly 0.8 https://www.themednet.org/would-you-offer-partial-breast-radiation-for-bilateral-dcis weekly 0.8 https://www.themednet.org/what-do-you-consider-when-deciding-to-use-a-high-efficacy-dmt-as-an-initial-treatment-in-multiple-sclerosis weekly 0.8 https://www.themednet.org/do-you-warn-patients-about-suicidal-ideation-when-starting-anti-seizure-medications weekly 0.8 https://www.themednet.org/when-would-you-consider-using-hypertonic-saline-for-patients-with-refractory-acute-decompensated-heart-failure-and-diuretic-resistance weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-smarcb1-deficient-sinonasal-carcinoma-for-immunotherapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-patients-with-recurrent-nephrolithiasis-who-have-24-hour-urine-chemistry-results-that-demonstrate-low-risk-for-stone-formation-but-continue-to-experience-stone-events weekly 0.8 https://www.themednet.org/do-you-prefer-to-use-7-3-or-cpx-351-as-standard-induction-therapy-in-younger-patients-with-aml-mrc-or-t-aml weekly 0.8 https://www.themednet.org/given-the-results-of-keynote-a18-do-you-plan-to-recommend-adding-pembrolizumab-to-primary-chemoradiotherapy-for-advanced-stage-cervical-cancer weekly 0.8 https://www.themednet.org/in-which-scenarios-do-you-use-vaginal-estrogen-in-patients-with-history-of-hr-positive-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-method-for-subclinical-cad-screening-prior-to-initiation-of-class-ia-antiarrhythmic-drugs-for-atrial-fibrillation weekly 0.8 https://www.themednet.org/in-a-patient-with-low-risk-papillary-thyroid-carcinoma-in-1-thyroid-lobe-s-p-hemithyroidectomy-how-would-a-diagnosis-of-graves-orbitopathy-euthyroid-biochemically-affect-your-classification-and-tsh-target-for-thyroid-cancer-treatment weekly 0.8 https://www.themednet.org/when-do-you-consider-hemispherectomy-for-patients-with-rasmussen-encephalitis-with-stable-epilepsy-and-preserved-function-of-the-affected-half-of-body weekly 0.8 https://www.themednet.org/how-do-you-approach-tapering-immunosuppression-in-a-patient-with-a-history-of-susac-syndrome-who-has-stabilized-on-mmf-and-ivig weekly 0.8 https://www.themednet.org/in-a-patient-with-bilateral-neck-level-ii-small-cell-carcinoma-with-no-apparent-primary-after-workup-with-plans-to-receive-concurrent-cisplatin-etoposide-what-would-be-your-treatment-volumes weekly 0.8 https://www.themednet.org/what-is-the-preferred-approach-for-an-aya-patient-with-vhr-b-all-with-iamp21-mutation-with-an-isolated-early-cns-relapse weekly 0.8 https://www.themednet.org/how-do-you-approach-the-work-up-of-pulmonary-artery-aneurysm-in-the-absence-of-other-clinical-features-of-behcets weekly 0.8 https://www.themednet.org/how-do-you-risk-stratify-patients-with-different-who-groups-of-pulmonary-hypertension-prior-to-non-cardiac-surgeries weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-sle-that-has-a-remote-history-of-positive-anti-phospholipid-antibodies-with-a-current-dvt-and-now-completely-negative-apls weekly 0.8 https://www.themednet.org/how-do-you-manage-unintended-hypercalciuria-that-results-from-an-increase-in-dietary-calcium-intake-as-recommended-to-patients-with-recurrent-calcium-oxalate-nephrolithiasis-attributed-to-enteric-hyperoxaluria weekly 0.8 https://www.themednet.org/do-you-counsel-your-patients-on-the-potential-decreased-effectiveness-of-oral-contraceptives-while-on-sarilumab weekly 0.8 https://www.themednet.org/in-patients-who-have-residual-bladder-tumors-after-maximal-turbt-would-you-boost-the-gtv-above-typical-doses-55-gy-20-fractions-or-64-gy-32-fractions-assuming-you-can-meet-constraint weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-essential-thrombocytosis-in-a-woman-planning-to-start-a-family weekly 0.8 https://www.themednet.org/what-is-the-preferred-approach-to-managing-non-occlusive-or-partially-occlusive-venous-sinus-thrombosis weekly 0.8 https://www.themednet.org/when-do-you-consider-treating-intracerebral-hemorrhage-associated-with-cerebral-amyloid-angiopathy-as-an-inflammatory-caa weekly 0.8 https://www.themednet.org/is-whole-body-pet-scan-sufficient-to-rule-out-cardiac-involvement-in-sarcoidosis weekly 0.8 https://www.themednet.org/what-would-be-your-second-pressor-of-choice-if-patients-with-lvot-obstruction-remain-persistently-hypotensive-on-phenylephrine weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-refer-patients-with-obstructive-hypertrophic-cardiomyopathy-for-alcohol-septal-ablation-versus-septal-myectomy weekly 0.8 https://www.themednet.org/how-would-you-treat-rapidly-growing-inflammatory-breast-cancer-invasive-lobular-triple-negative-subtype-after-two-cycles-of-neoadjuvant-keynote-522 weekly 0.8 https://www.themednet.org/what-dose-and-fields-would-you-use-for-basosquamous-carcinoma-basal-cell-carcinoma-of-the-vulva-s-p-wle-but-not-fully-excised-due-to-adhesion-to-the-rectum-with-no-further-surgery-offered weekly 0.8 https://www.themednet.org/how-do-you-manage-de-novo-high-volume-mcspc-with-both-brca2-mutation-and-msi-h-on-somatic-testing weekly 0.8 https://www.themednet.org/would-you-consider-anabolic-osteoporosis-therapy-in-a-young-adult-male-with-multiple-non-traumatic-vertebral-compression-fractures-and-low-bone-density-for-age-z-score-2-6 weekly 0.8 https://www.themednet.org/in-light-of-the-recital-study-would-rituximab-be-a-reasonable-choice-in-a-patient-with-pl-12-antibodies-rapidly-progressive-pulmonary-disease-with-organizing-pneumonia-on-biopsy weekly 0.8 https://www.themednet.org/would-you-continue-jak-inhibitor-therapy-in-a-patient-with-long-standing-previously-refractory-ra-in-their-60s-who-was-found-to-have-stenosis-of-the-left-common-femoral-artery-and-no-other-history-of-arteriosclerotic-disease weekly 0.8 https://www.themednet.org/would-you-treat-the-mandible-if-the-patients-has-osteonecrosis-from-zoledronic-acid-but-also-multiple-myeloma-in-this-region-biopsy-proven weekly 0.8 https://www.themednet.org/are-there-patients-with-recurrent-nephrolithiasis-for-who-you-recommend-magnesium-supplementation-to-reduce-stone-risk weekly 0.8 https://www.themednet.org/how-would-you-approach-a-locally-advanced-ampullary-carcinoma-with-brca1-mutation-whose-whipple-showed-complete-pathologic-response-after-5-cycles-of-neoadjuvant-mfolfirinox weekly 0.8 https://www.themednet.org/how-would-you-approach-grade-2-3-rash-due-to-erlotinib-for-a-patient-with-metastatic-egfr-mutated-lung-adenocarcinoma-that-is-well-controlled-for-5-years-and-ned-by-pet weekly 0.8 https://www.themednet.org/what-is-your-approach-for-female-patients-with-severe-atopic-dermatitis-well-controlled-on-dupixent-planning-to-conceive-or-already-pregnant weekly 0.8 https://www.themednet.org/how-would-you-approach-treating-a-patient-who-refuses-surgery-but-has-significant-residual-disease-after-chemoradiotherapy-for-squamous-cell-carcinoma-of-the-esophagus weekly 0.8 https://www.themednet.org/would-you-restart-sirolimus-for-a-decline-in-lung-function-or-pneumothoraces-in-a-pregnant-patient-with-lam weekly 0.8 https://www.themednet.org/would-you-consider-re-irradiation-in-the-setting-of-prior-salvage-prostatectomy-after-prostate-brachytherapy weekly 0.8 https://www.themednet.org/are-there-any-special-considerations-when-treating-patients-with-recurrent-nephrolithiasis-who-also-have-medullary-sponge-kidney weekly 0.8 https://www.themednet.org/what-would-be-the-preferred-treatment-option-for-pmr-if-patient-develops-gastric-perforation-soon-after-initiation-of-steroids weekly 0.8 https://www.themednet.org/is-there-a-role-for-nocturnal-supplemental-oxygen-as-opposed-to-no-therapy-in-patients-with-osa-who-are-unable-to-tolerate-pap-therapy weekly 0.8 https://www.themednet.org/can-non-16-18-hpv-types-cause-ascus-and-squamous-cervical-metaplasia-on-biopsy-within-3-months-of-acquisition-or-would-it-take-longer weekly 0.8 https://www.themednet.org/would-you-consider-dhe-for-patients-with-status-migrainous-with-elevated-blood-pressure-at-the-time-of-presentation weekly 0.8 https://www.themednet.org/would-you-use-sumatriptan-in-a-patient-with-a-history-of-cerebral-aneurysm-rupture weekly 0.8 https://www.themednet.org/would-you-consider-aeds-in-patients-with-recurrent-tga weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-recurrent-tga-in-the-emergency-room weekly 0.8 https://www.themednet.org/do-you-ever-use-ocular-ultrasound-in-evaluation-of-papilledema weekly 0.8 https://www.themednet.org/what-is-your-approach-to-monitoring-the-neurologic-status-of-a-patient-with-a-traumatic-brain-injury-requiring-burst-suppression-for-status-epilepticus weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-refer-a-patient-with-mild-autonomous-cortisol-secretion-without-features-of-cushing-syndrome-for-adrenalectomy weekly 0.8 https://www.themednet.org/is-there-benefit-to-performing-cvvh-instead-of-intermittent-hemodialysis-for-a-patient-with-aki-secondary-to-rhabdomyolysis-who-requires-renal-replacement-therapy weekly 0.8 https://www.themednet.org/should-patients-who-develop-primary-hyperparathyroidism-after-5-years-of-prolia-treatment-for-osteoporosis-be-referred-for-parathyroidectomy weekly 0.8 https://www.themednet.org/in-patients-with-high-risk-prostate-cancer-and-involved-common-iliac-lymph-nodes-would-you-recommend-radiation weekly 0.8 https://www.themednet.org/do-you-consider-it-safe-to-continue-adalimumab-for-spondyloarthritis-in-a-patient-who-develops-localized-melanoma-if-the-adalimumab-has-worked-well weekly 0.8 https://www.themednet.org/do-you-recommend-avoidance-of-occupational-environmental-exposures-in-patients-with-pulmonary-sarcoidosis weekly 0.8 https://www.themednet.org/in-what-situations-would-immunotherapy-alone-be-appropriate-for-non-metastatic-nsclc weekly 0.8 https://www.themednet.org/how-would-you-manage-cognitive-changes-in-a-patient-with-memory-impairment-and-significant-brain-atrophy-with-no-diagnostic-testing-consistent-with-alzheimers-disease weekly 0.8 https://www.themednet.org/would-you-consider-switching-choice-of-p2y12-inhibitor-for-patients-with-isr-non-acs-presentation-with-acceptable-bleeding-risk weekly 0.8 https://www.themednet.org/how-do-you-manage-internal-vaginal-burning-during-pelvic-radiation weekly 0.8 https://www.themednet.org/how-would-one-approach-concomitant-diffuse-large-b-cell-lymphoma-and-fibrotic-phase-myelofibrosis weekly 0.8 https://www.themednet.org/what-alternative-therapies-do-you-recommend-for-botox-non-responders weekly 0.8 https://www.themednet.org/in-which-patients-with-nephrocalcinosis-and-an-incomplete-distal-rta-would-you-consider-further-testing-for-medullary-sponge-kidney weekly 0.8 https://www.themednet.org/would-you-recommend-switching-a-diabetic-ckd-patient-on-oral-semaglutide-to-the-subcutaneous-form-since-the-benefits-in-ckd-have-primarily-been-reported-in-studies-using-subcutaneous-glp-1-receptor-agonists weekly 0.8 https://www.themednet.org/for-patients-who-progress-to-mcrpc-on-adt-arsi-started-in-mcspc-setting-do-you-continue-the-arsi-if-patients-have-had-a-mixed-response weekly 0.8 https://www.themednet.org/how-do-you-manage-a-cytology-negative-pleural-effusion-that-develops-after-lung-rt weekly 0.8 https://www.themednet.org/what-is-your-preferred-management-for-eruptive-vellus-hair-cysts weekly 0.8 https://www.themednet.org/how-early-do-you-involve-palliative-care-in-the-management-of-a-ckd-stage-5-patient-who-does-not-wish-to-pursue-renal-replacement-therapy weekly 0.8 https://www.themednet.org/do-you-recommend-increasing-dietary-potassium-intake-for-blood-pressure-management-in-non-ckd-patients-with-hypertension weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-sub-total-resected-zfta-fusion-ependymoma-after-radiation-therapy-in-a-young-adult weekly 0.8 https://www.themednet.org/what-is-your-approach-to-practical-monitoring-of-lupus-disease-activity-in-clinical-practice weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-benefits-of-diet-and-exercise-in-oa-in-a-way-that-motivates-them-to-comply weekly 0.8 https://www.themednet.org/are-there-patients-with-gout-in-whom-you-would-choose-febuxostat-first-line-over-allopurinol-for-urate-lowering-therapy weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-automated-insulin-delivery-systems-such-as-control-iq-with-tandem-insulin-pumps-for-managing-gestational-diabetes weekly 0.8 https://www.themednet.org/how-do-you-follow-pulmonary-embolism-patients-who-have-completed-anticoagulation weekly 0.8 https://www.themednet.org/how-do-you-distinguish-between-primary-and-tertiary-hyperparathyroidism-in-a-patient-with-esrd weekly 0.8 https://www.themednet.org/how-do-you-decide-the-length-of-a-routine-eeg weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-lymph-node-positive-osteosarcoma-of-the-extremities-for-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-fields-would-you-treat-for-a-postmastectomy-patient-with-a-single-suspected-small-imn-node-on-mri-but-no-other-criteria-for-pmrt-and-a-negative-snb weekly 0.8 https://www.themednet.org/is-vocal-cord-paralysis-a-complication-of-thoracic-rt weekly 0.8 https://www.themednet.org/do-you-offer-apbi-to-patients-who-do-not-have-surgical-clips-but-a-visible-seroma weekly 0.8 https://www.themednet.org/do-you-use-hypercapnia-as-an-exclusion-criteria-in-all-patients-that-are-being-assessed-for-bronchoscopic-lung-volume-reduction weekly 0.8 https://www.themednet.org/how-should-patients-time-the-ingestion-of-their-alendronate-and-levothyroxine-given-issues-with-food-drug-interactions weekly 0.8 https://www.themednet.org/is-there-utility-in-monitoring-ige-levels-in-patients-with-igg4-rd weekly 0.8 https://www.themednet.org/in-light-of-the-noah-afnet6-and-artesia-trials-how-would-you-approach-the-decision-regarding-anticoagulation-for-patients-with-incidentally-detected-af-24-hrs-on-pacemakers-defibrillators weekly 0.8 https://www.themednet.org/what-is-the-optimal-choice-of-therapy-for-a-patient-with-hodgkin-variant-of-richters-transformation-from-underlying-cll-sll weekly 0.8 https://www.themednet.org/do-you-consider-new-onset-autoimmune-disease-e-g-seronegative-rheumatoid-arthritis-a-few-months-after-completing-immunotherapy-for-cancer-to-be-an-immune-related-adverse-effect-to-the-immunotherapy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-new-temporal-headache-temporal-artery-tenderness-and-ta-biopsy-with-mild-thickening-but-normal-inflammatory-markers weekly 0.8 https://www.themednet.org/how-would-you-treat-an-older-patient-with-b-symptoms-and-biopsy-consistent-with-grade-3-follicular-lymphoma-but-noted-to-have-a-pet-scan-with-suv-readings-of-20 weekly 0.8 https://www.themednet.org/when-do-you-start-to-cross-titrate-from-steroids-to-cellcept-in-patients-with-myasthenia-gravis weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-ra-and-severe-bronchiectasis-with-associated-findings-of-uip weekly 0.8 https://www.themednet.org/how-do-you-approach-the-timing-of-dmard-initiation-in-patients-with-active-ra-who-are-on-treatment-for-latent-tb weekly 0.8 https://www.themednet.org/what-duration-do-you-feel-comfortable-maintaining-for-the-pediatric-population-on-topical-calcineurin-inhibitors weekly 0.8 https://www.themednet.org/what-is-your-preferred-salvage-therapy-for-patients-with-follicular-lymphoma-who-relapsed-within-24-months-of-completing-front-line-chemoimmunotherapy-pod24-and-will-proceed-to-high-dose-therapy-with-auto-sct weekly 0.8 https://www.themednet.org/how-do-you-advise-patients-with-recurrent-nephrolithiasis-who-also-have-chronic-mild-hyponatremia-for-which-they-limit-daily-fluid-intake weekly 0.8 https://www.themednet.org/would-you-offer-a-patient-with-good-risk-dcis-and-an-elevated-dcisionrt-score-apbi-or-wbi weekly 0.8 https://www.themednet.org/how-do-you-approach-ongoing-screening-for-tb-in-patients-with-a-history-of-treated-latent-tb-but-who-have-ongoing-use-of-dmards-and-or-biologics-given-quantiferon-testing-and-ppd-can-remain-positive weekly 0.8 https://www.themednet.org/can-romosozumab-be-used-in-patients-on-dialysis weekly 0.8 https://www.themednet.org/what-sort-of-telehealth-approaches-do-you-pursue-for-a-newly-diagnosed-end-stage-kidney-disease-patient-starting-peritoneal-dialysis-or-home-hemodialysis weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-stage-iv-egfr-l858r-mutation-but-with-a-debilitating-drug-rash-from-osimertinib weekly 0.8 https://www.themednet.org/how-would-you-manage-a-case-of-subcutaneous-panniculitis-like-t-cell-lymphoma-a-b-who-is-already-on-steroids-and-methotrexate-for-autoimmune-disease weekly 0.8 https://www.themednet.org/in-which-patients-with-suspected-iga-nephropathy-and-microalbuminuria-would-you-recommend-a-kidney-biopsy weekly 0.8 https://www.themednet.org/would-you-extrapolate-from-embark-to-use-an-arpi-other-than-enzalutamide-in-high-risk-biochemically-recurrent-prostate-cancer-for-a-patient-with-contraindications-to-enzalutamide weekly 0.8 https://www.themednet.org/what-are-the-recommendations-for-considering-deep-brain-stimulation-in-a-patient-with-tremors-and-dementia-or-mild-cognitive-impairment weekly 0.8 https://www.themednet.org/how-do-you-approach-autologous-stem-cell-transplant-in-t-cell-lymphomas-ptcl-after-induction-chemotherapy-with-achievement-of-cr1 weekly 0.8 https://www.themednet.org/how-do-you-counsel-and-manage-joint-pain-after-isotretinoin-treatment weekly 0.8 https://www.themednet.org/how-would-you-optimally-manage-a-small-solitary-plasmacytoma-of-the-alveolar-ridge-including-minimizing-the-risk-of-dental-toxicity weekly 0.8 https://www.themednet.org/are-there-instances-when-you-prefer-serum-creatinine-over-cystatin-c-when-estimating-gfr-in-a-patient-with-ckd weekly 0.8 https://www.themednet.org/do-you-continue-to-prone-patients-with-severe-ards-after-initiation-of-vv-ecmo weekly 0.8 https://www.themednet.org/how-do-you-treat-metastatic-adenoid-cystic-carcinoma-of-breast-primary-er-3-pr-her-2-negative-with-liver-only-metastasis weekly 0.8 https://www.themednet.org/how-long-do-you-continue-pjp-prophylaxis-in-a-patient-with-gpa-who-is-able-to-wean-steroids-and-remains-only-on-rituximab-for-maintenance-therapy weekly 0.8 https://www.themednet.org/what-is-the-preferred-treatment-regimen-for-cardiovascular-syphilis-specifically-syphilitic-ostial-coronary-artery-disease weekly 0.8 https://www.themednet.org/what-are-the-important-aspects-that-you-mention-when-consenting-patients-for-hemodialysis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-dosing-and-duration-of-rituximab-for-refractory-lupus-nephritis-not-responsive-to-cyclophosphamide-or-mycophenolate weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-osteoporosis-in-patients-with-end-stage-kidney-disease weekly 0.8 https://www.themednet.org/how-do-you-classify-extensive-lvsi-in-endometrial-cancer weekly 0.8 https://www.themednet.org/between-mean-arterial-pressure-map-and-blood-pressure-bp-which-do-you-use-when-prescribing-hemodialysis-to-instruct-a-hold-on-additional-ultrafiltration-should-the-value-become-too-low weekly 0.8 https://www.themednet.org/is-there-a-risk-of-increased-skin-toxicity-with-combined-radiation-and-doxycycline weekly 0.8 https://www.themednet.org/would-you-recommend-hospitalization-for-surgery-for-a-large-papillary-fibroelastoma-or-atrial-myxoma-discovered-on-an-outpatient-echocardiogram weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-a-patient-with-ra-and-cirrhosis-who-did-not-respond-to-csdmards weekly 0.8 https://www.themednet.org/is-it-safe-to-give-spine-sbrt-after-recent-cryoablation weekly 0.8 https://www.themednet.org/after-completing-12-months-romosozumab-what-is-the-next-best-treatment-option-for-patients-with-severe-osteoporosis-high-risk-for-fracture-and-normal-kidney-function weekly 0.8 https://www.themednet.org/what-is-your-approach-to-differentiating-primary-from-secondary-hyperparathyroidism-in-recurrent-kidney-stone-formers-who-also-have-chronic-kidney-disease-an-elevated-pth-and-hypercalcemia weekly 0.8 https://www.themednet.org/what-ctv-margin-do-you-use-for-idh-mutant-who-grade-3-or-4-astrocytoma weekly 0.8 https://www.themednet.org/do-you-see-secondary-emg-ncs-abnormalities-in-patients-with-chronic-upper-motor-neuron-dysfunction-such-as-cerebral-palsy-myelopathy-or-remote-stroke weekly 0.8 https://www.themednet.org/do-you-still-consider-hepatorenal-syndrome-in-patients-with-renal-impairment-and-liver-disease-who-are-found-to-have-rare-muddy-brown-casts-on-urine-microscopy weekly 0.8 https://www.themednet.org/is-a-bone-marrow-necessary-in-patient-with-splenomegaly-and-polycythemia-vera weekly 0.8 https://www.themednet.org/how-would-you-manage-a-ct4n0-her2-distal-esophageal-adenocarcinoma-cps-score-30-with-good-response-to-neoadjuvant-chemo-rt-on-pet-and-residual-disease-on-egd-in-a-patient-who-declines-surgery weekly 0.8 https://www.themednet.org/what-is-your-plasma-oxalate-target-when-treating-patients-with-lumasiran-for-end-stage-kidney-disease-secondary-to-primary-hyperoxaluria-type-1 weekly 0.8 https://www.themednet.org/have-you-utilized-a-dose-reduced-approach-for-elderly-patients-receiving-frontline-pola-r-chp-similar-to-r-minichop weekly 0.8 https://www.themednet.org/when-should-paclitaxel-or-other-chemo-be-discontinued-in-de-novo-metastatic-triple-negative-breast-cancer-with-high-pdl1-in-favor-of-continuing-pembrolizumab-alone-with-good-treatment-response weekly 0.8 https://www.themednet.org/what-is-your-preferred-subsequent-treatment-in-patients-with-metastatic-bladder-cancer-with-progression-on-pembrolizumab-enfortumab weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-patient-with-hypothyroidism-who-complains-of-persistent-hypothyroid-symptoms-despite-achieving-normal-tsh-values-with-levothyroxine weekly 0.8 https://www.themednet.org/do-you-or-your-institution-use-a-creatinine-clearance-value-calculated-by-actual-ideal-or-adjusted-body-weight-for-chemotherapeutics-dosed-by-creatinine-clearance weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-muscle-invasive-bladder-cancer-getting-neoadjuvant-gemcitabine-cisplatin-who-develops-significant-ototoxicity-due-to-cisplatin-after-two-cycles weekly 0.8 https://www.themednet.org/in-patients-being-evaluated-for-brain-death-which-abnormal-movements-are-definitively-known-to-still-be-consistent-with-brain-death-and-which-are-possibly-consistent-with-brain-death-but-lack-definitive-evidence weekly 0.8 https://www.themednet.org/should-serum-calcitonin-for-surveillance-of-medullary-thyroid-cancer-be-done-fasting weekly 0.8 https://www.themednet.org/is-it-safe-to-administer-cabazitaxel-to-a-patient-with-mcrpc-who-developed-grade-3-pneumonitis-from-docetaxel weekly 0.8 https://www.themednet.org/do-you-consider-anti-carbamylated-protein-antibodies-anti-carp-as-having-any-significance-in-evaluation-of-patients-if-rf-and-acpa-negative-and-clinically-no-active-synovitis-yet-widespread-arthralgias-and-generalized-osteoarthritis weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-prior-to-offering-a-trial-of-ics-laba-therapy-versus-a-methacholine-challenge-test-in-patients-with-suspected-asthma-but-normal-pulmonary-function-testing weekly 0.8 https://www.themednet.org/how-do-you-evaluate-exercise-induced-hematuria-that-persists-after-one-week-of-cessation-of-exercise weekly 0.8 https://www.themednet.org/in-patients-with-tetralogy-of-fallot-and-an-indication-for-primary-prevention-icd-nsvt-induced-vt-during-eps-or-low-lvef-should-pulmonary-valve-interventions-be-offered-prior-to-icd-to-assess-if-improvement-in-vt-burden-ef weekly 0.8 https://www.themednet.org/how-would-you-approach-the-work-up-of-a-patient-with-nasal-septal-perforation-a-negative-infectious-workup-and-negative-anca-titers weekly 0.8 https://www.themednet.org/how-long-do-you-wait-for-a-patient-to-be-seizure-free-before-you-clear-them-with-regard-to-operating-heavy-machinery-i-e-for-work weekly 0.8 https://www.themednet.org/does-the-use-of-a-avd-versus-abvd-affect-your-decision-for-consolidation-rt-for-bulky-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-interpret-negative-hmgcr-antibody-test-results-in-a-patient-with-necrotizing-myopathy-who-has-already-been-on-treatment-with-steroids-and-whose-ck-has-normalized weekly 0.8 https://www.themednet.org/do-you-consider-skin-involvement-associated-with-tattoos-to-be-a-marker-of-disease-activity-and-an-indication-to-start-treatment-in-a-patient-with-sarcoidosis weekly 0.8 https://www.themednet.org/how-would-you-manage-axial-spondyloarthritis-in-a-patient-who-was-doing-well-on-tnf-inhibitor-therapy-then-developed-a-new-solid-organ-malignancy-while-on-treatment weekly 0.8 https://www.themednet.org/how-do-you-modify-daratumumab-rvd-relative-to-the-protocols-used-in-trials-when-used-as-a-first-line-agent-to-transplant-eligible-patients-with-myeloma weekly 0.8 https://www.themednet.org/in-your-practice-when-do-you-opt-to-treat-unilateral-primary-hyperaldosteronism-medically-rather-than-surgically weekly 0.8 https://www.themednet.org/for-anal-radiation-dermatitis-does-anyone-have-experience-with-3m-cavilon-protectant weekly 0.8 https://www.themednet.org/would-you-recommend-radiation-therapy-for-an-adult-patient-with-rhabdomyosarcoma-embryonal-of-the-upper-extremity-s-p-amputation-with-multiple-lymph-node-involvement-and-ene-on-pathology weekly 0.8 https://www.themednet.org/would-you-use-elacestrant-in-a-patient-with-an-esr1-akap12-fusion weekly 0.8 https://www.themednet.org/what-is-your-outpatient-approach-to-monitoring-paroxysmal-atrial-fibrillation-i-e-mobile-cardiac-telemetry-decision-to-anticoagulate-if-high-likelihood-of-recurrence-in-young-adults-with-chadsvasc-score-of-0-in-light-of-potential-remodeling-and-increased- weekly 0.8 https://www.themednet.org/do-you-recommend-patients-temporarily-hold-cilostazol-prior-to-and-after-a-kidney-biopsy weekly 0.8 https://www.themednet.org/do-you-recommend-osteoporosis-medication-in-postmenopausal-females-on-anastrozole-with-very-low-vitamin-d-4-5 weekly 0.8 https://www.themednet.org/is-there-a-specific-inr-cut-off-value-that-would-prompt-you-to-consider-administering-vitamin-k-for-patients-with-mechanical-valves-requiring-urgent-non-cardiac-surgery-and-if-so-what-would-be-your-starting-dose weekly 0.8 https://www.themednet.org/how-would-you-treat-a-stage-iia-ns-hd-patient-with-bulky-disease-who-refuses-chemotherapy weekly 0.8 https://www.themednet.org/would-you-recommend-starting-a-moderate-intensity-statin-in-a-patient-under-the-age-of-40-years-old-with-hiv-and-a-10-year-ascvd-risk-estimate-below-5 weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-pre-operatively-with-a-prolonged-ptt-that-does-not-correct-on-mixing-with-lupus-anticoagulant-testing-that-is-abnormal-by-la-ptt-only weekly 0.8 https://www.themednet.org/what-combinational-therapies-do-you-recommend-for-skin-tightening-that-can-be-completed-on-the-same-day weekly 0.8 https://www.themednet.org/what-recommendations-do-you-offer-for-patients-who-have-nail-longitudinal-ridging weekly 0.8 https://www.themednet.org/what-workup-do-you-recommend-for-pediatric-patients-with-telogen-effluvium weekly 0.8 https://www.themednet.org/is-there-evidence-to-suggest-that-whole-pelvic-radiation-is-immunosuppressive-and-may-lead-to-worse-outcomes-in-the-setting-of-chemoio-treatment-for-stage-iii-endometrial-cancer weekly 0.8 https://www.themednet.org/would-you-do-active-surveillance-or-completion-thyroidectomy-in-a-patient-with-1-6-cm-tall-cell-ptc-with-posterior-margins-indeterminate-and-7-mm-isoechoic-solid-nodule-on-other-side weekly 0.8 https://www.themednet.org/is-there-a-role-for-vitamin-d-supplementation-in-the-treatment-of-hashimotos-thyroiditis weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-migraine-triggers weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-diffuse-systemic-sclerosis-who-develops-severe-rapidly-progressive-calcinosis weekly 0.8 https://www.themednet.org/what-isolation-policies-are-rheumatology-offices-employing-for-both-staff-and-patients-diagnosed-with-covid-19-given-the-new-cdc-guidelines weekly 0.8 https://www.themednet.org/what-are-the-principal-clinical-and-laboratory-findings-that-lead-a-community-rheumatologist-to-refer-patients-with-scleroderma-and-lupus-to-a-tertiary-care-center weekly 0.8 https://www.themednet.org/is-there-a-role-for-sglt-2-inhibitors-in-the-treatment-of-chronic-hypomagnesemia weekly 0.8 https://www.themednet.org/how-do-you-approach-delivering-isrt-to-nodular-lymphocyte-predominant-hodgkin-lymphoma-that-has-responded-on-fdg-pet-ct-after-chemotherapy weekly 0.8 https://www.themednet.org/how-often-do-you-screen-for-cerebral-aneurysms-in-patients-with-autosomal-dominant-polycystic-kidney-disease-who-do-not-have-a-family-history-of-intracranial-aneurysms-or-for-whom-the-family-history-is-unknown weekly 0.8 https://www.themednet.org/do-you-routinely-check-n-telopeptide-levels-in-patients-who-you-suspect-might-have-immobilization-induced-hypercalcemia weekly 0.8 https://www.themednet.org/would-you-offer-intensive-cns-prophylaxis-to-ph-negative-b-all-patients-who-have-possible-mandibular-nerve-involvement-on-mri-face weekly 0.8 https://www.themednet.org/for-a-small-5-mm-hard-soft-palate-junctional-primary-with-doi-2-mm-status-post-limited-excision-with-negative-but-close-deep-margin-how-would-you-approach-neck-management-in-the-adjuvant-rt-setting weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-non-statin-associated-inflammatory-myopathies-about-statin-use weekly 0.8 https://www.themednet.org/what-approaches-do-you-take-for-your-patients-with-nephrolithiasis-who-undergo-intermittent-fasting-for-cultural-religious-or-personal-reasons weekly 0.8 https://www.themednet.org/how-do-you-consider-the-role-of-probiotics-for-mucositis-mitigation-in-patients-receiving-head-and-neck-radiotherapy weekly 0.8 https://www.themednet.org/is-there-a-limit-on-the-number-of-brain-metastases-that-can-be-safely-treated-with-single-isocenter-multitarget-linac-based-srs-using-hyperarc weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-would-you-use-for-kaposis-sarcoma-of-the-tonsil-post-op weekly 0.8 https://www.themednet.org/what-ipsilateral-lung-constraints-if-any-do-you-utilize-for-sbrt-and-or-hypofractionated-rt-in-the-lungs weekly 0.8 https://www.themednet.org/in-well-controlled-epilepsy-patients-who-suffer-an-unprovoked-seizure-with-medication-compliance-what-would-prompt-you-to-increase-their-anti-seizure-medication weekly 0.8 https://www.themednet.org/for-locally-advanced-adenocarcinoma-of-the-maxillary-sinus-how-should-the-neck-be-managed weekly 0.8 https://www.themednet.org/would-you-offer-salvage-radiation-for-a-local-recurrence-of-prostate-cancer-that-was-initially-treated-with-sbrt weekly 0.8 https://www.themednet.org/what-considerations-do-you-take-when-managing-a-patient-with-end-stage-kidney-disease-on-peritoneal-dialysis-who-is-planning-on-undergoing-peg-tube-placement weekly 0.8 https://www.themednet.org/what-is-the-best-approach-in-management-of-device-related-thrombus-seen-immediately-after-watchman-deployment weekly 0.8 https://www.themednet.org/what-is-your-approach-to-deciding-when-to-stop-therapy-for-cutaneous-mycobacterium-chelonae-infections weekly 0.8 https://www.themednet.org/how-would-you-approach-a-finding-of-osteoporosis-z-score-4-5-in-a-recently-postpartum-patient-who-had-dexa-sent-for-long-term-low-dose-glucocorticoid-use weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-with-ct2-er-her2-breast-cancer-with-neoadjuvant-her2-directed-therapy-if-her2-positivity-is-group-3 weekly 0.8 https://www.themednet.org/in-patients-with-hypertension-and-suspected-primary-aldosteronism-who-have-undergone-negative-confirmatory-testing-what-follow-up-and-monitoring-strategies-would-you-recommend-to-ensure-early-detection-of-potential-aldosteronism weekly 0.8 https://www.themednet.org/do-you-pursue-a-malignancy-workup-beyond-age-appropriate-malignancy-screening-in-patients-with-antibody-negative-necrotizing-myopathy weekly 0.8 https://www.themednet.org/what-are-your-management-strategies-for-patients-with-end-stage-kidney-disease-on-hemodialysis-who-develop-hypercalcemia-of-immobility weekly 0.8 https://www.themednet.org/what-criteria-do-you-utilize-in-deciding-between-different-jak-inhibitors-for-atopic-dermatitis weekly 0.8 https://www.themednet.org/do-you-routinely-check-echocardiograms-on-all-patients-who-are-starting-tdm1 weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-sdh-deficient-advanced-gist-tumor-for-systemic-treatment weekly 0.8 https://www.themednet.org/do-you-send-only-serum-paraneoplastic-panels-or-also-include-csf-evaluation-in-patients-with-concern-for-paraneoplastic-neuropathy weekly 0.8 https://www.themednet.org/what-is-the-role-of-radiation-therapy-for-an-elderly-patient-with-medullary-thyroid-cancer-who-is-not-a-surgical-candidate weekly 0.8 https://www.themednet.org/how-would-you-approach-an-early-stage-p16-scc-of-the-tonsil-s-p-tors-and-neck-dissection-with-initial-positive-margins-but-then-negative-on-re-resection weekly 0.8 https://www.themednet.org/for-pregnant-patients-in-their-first-trimester-presenting-with-acute-mi-with-plan-for-emergent-angiogram-who-then-subsequently-have-resolution-of-chest-pain-and-ekg-changes-following-initiation-of-heparin-gtt-dapt-would-you-still-consider-proceeding-with- weekly 0.8 https://www.themednet.org/would-you-drop-carboplatin-paclitaxel-weeks-or-considering-shortening-duration-of-treatment-in-a-brca1-patient-with-synchronous-tnbc-left-2-4-cm-tumor-right-9-mm-tumor-who-has-complete-response-on-interim-breast-ultrasound weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-asco-gi-2024 weekly 0.8 https://www.themednet.org/what-are-your-criteria-for-deciding-if-a-patient-who-had-vf-arrest-in-the-setting-of-subacute-myocarditis-requires-icd-or-long-term-wcd weekly 0.8 https://www.themednet.org/do-you-use-any-drugs-prophylactically-to-reduce-the-risk-of-radiation-pneumonitis-in-lung-sbrt weekly 0.8 https://www.themednet.org/are-durva-cis-gem-or-pembro-cis-gem-less-efficacious-in-cholangiocarcinomas-with-fgfr2-fusions weekly 0.8 https://www.themednet.org/do-you-routinely-perform-mammograms-for-women-that-underwent-nipple-sparing-mastectomy-with-reconstruction-after-a-breast-cancer-diagnosis weekly 0.8 https://www.themednet.org/what-antibiotic-antifungal-and-antiviral-prophylaxis-you-give-post-car-t-therapy-and-what-is-the-duration weekly 0.8 https://www.themednet.org/what-systemic-therapy-would-you-offer-to-a-patient-with-metastatic-egfr-exon-19-deleted-nsclc-to-the-brain-with-isolated-cns-progression-while-on-osimertinib-80-mg-and-progressed-through-wbrt weekly 0.8 https://www.themednet.org/how-would-you-manage-an-early-stage-hpv-mediated-pure-adenocarcinoma-of-the-tonsil-with-a-large-but-resectable-primary-and-multiple-ipsilateral-nodes-without-clear-ece-on-imaging weekly 0.8 https://www.themednet.org/how-will-you-decide-between-using-paclitaxel-coated-balloons-versus-conventional-uncoated-balloons-for-managing-in-stent-restenosis weekly 0.8 https://www.themednet.org/how-do-you-advise-patients-with-paroxysmal-atrial-fibrillation-regarding-their-caffeine-consumption-given-that-a-randomized-clinical-trial-found-no-association-between-caffeine-intake-and-the-triggering-of-af-episodes weekly 0.8 https://www.themednet.org/in-siadh-due-to-malignancy-do-you-prefer-to-use-free-water-restriction-or-salt-tablets weekly 0.8 https://www.themednet.org/what-would-you-offer-a-patient-with-msi-high-metastatic-endometrial-cancer-after-disease-progression-on-pembrolizumab weekly 0.8 https://www.themednet.org/what-is-your-stepwise-approach-to-a-patient-with-erosive-gingivitis weekly 0.8 https://www.themednet.org/how-do-you-determine-if-a-pyoderma-gangrenosum-lesion-is-burned-out weekly 0.8 https://www.themednet.org/is-there-a-role-for-nintedanib-in-the-management-of-patients-with-radiation-induced-pulmonary-fibrosis weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-to-neurological-sjogrens-disease-with-both-peripheral-neuropathy-and-transverse-myelitis weekly 0.8 https://www.themednet.org/what-is-the-right-approach-in-terms-of-gdmt-and-device-consideration-for-patients-with-intermittent-lbbb-qrs-duration-exceeding-150ms-and-hfref weekly 0.8 https://www.themednet.org/would-you-consider-using-tucatinib-in-a-patient-with-de-novo-metastatic-her2-hr-breast-cancer-patient-with-extensive-intraparenchymal-and-leptomeningeal-carcinomatosis weekly 0.8 https://www.themednet.org/how-do-you-interpret-the-results-of-oligoclonal-bands-ordered-to-evaluate-for-demyelinating-disease-in-patients-with-brain-mri-lesions-of-unclear-etiology weekly 0.8 https://www.themednet.org/with-the-recent-odac-review-of-the-commerically-available-car-t-therapies-in-relapsed-refractory-myeloma-post-1-3-lines-of-therapy-what-is-your-preferred-regimen-therapy-for-first-relapse-and-which-are-the-situations-where-you-would-absolutely-consider-ca weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-central-sleep-apnea-due-to-heart-failure-with-reduced-ejection-fraction weekly 0.8 https://www.themednet.org/how-do-you-incorporate-blinatumomab-into-therapy-for-a-pediatric-or-aya-patient-with-isolated-cns-relapse-of-b-all-if-at-all weekly 0.8 https://www.themednet.org/do-young-early-stage-breast-cancer-patients-with-pcr-to-chemoimmunotherapy-still-benefit-from-pmrt weekly 0.8 https://www.themednet.org/if-a-patient-develops-itching-with-their-first-dose-of-tysabri-despite-pre-treatment-does-this-indicate-that-further-cycles-of-tysabri-are-contraindicated-or-do-you-continue-tysabri-at-the-next-cycle weekly 0.8 https://www.themednet.org/is-there-a-role-for-cinacalcet-suppression-testing-when-evaluating-patients-for-suspected-primary-hyperparathyroidism-who-also-have-recurrent-calcium-containing-kidney-stone-disease weekly 0.8 https://www.themednet.org/do-you-routinely-screen-for-cardiovascular-risk-factors-in-a-patient-with-moderate-to-severe-psoriasis weekly 0.8 https://www.themednet.org/do-you-attempt-to-taper-or-discontinue-a-jak-inhibitor-in-a-patient-with-severe-alopecia-areata-who-has-maintained-complete-scalp-hair-regrowth-for-at-least-one-year weekly 0.8 https://www.themednet.org/Will-achieving-bone-marrow-MRD-negativity-at-1-yr-justify-stopping-daratumumab-at-1-year-instead-of-the-recommended-3-years-of-therapy-per-AQUILA-trial-for-high-risk-smoldering-myeloma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-return-to-play-of-a-contact-sport-after-mild-concussion-in-children weekly 0.8 https://www.themednet.org/do-you-add-elafibranor-or-seladelpar-to-udca-within-the-first-year-of-treatment-in-a-patient-with-primary-biliary-cholangitis-who-has-an-inadequate-alkaline-phosphatase-response-but-no-symptoms-of-pruritus weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-utilize-a-radial-approach-versus-a-femoral-approach-for-vascular-access-during-an-angiogram weekly 0.8 https://www.themednet.org/is-there-any-utility-in-starting-quinidine-for-non-ischemic-vt-storm-refractory-to-amiodarone-lidocaine weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-utilizing-deep-brain-stimulation-for-treatment-of-obesity weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-perform-bilateral-focused-ultrasound-thalamotomy-for-severe-bilateral-essential-tremor weekly 0.8 https://www.themednet.org/have-you-treated-the-thoracic-duct-for-bilateral-chylothorax-in-the-case-of-a-hematologic-malignancy-with-no-discrete-adenopathy weekly 0.8 https://www.themednet.org/do-you-use-topical-corticosteroids-to-manage-severe-inflammatory-reactions-after-5-fu-treatment-or-do-you-allow-the-reaction-to-run-its-course weekly 0.8 https://www.themednet.org/do-you-routinely-test-corneal-sensation-as-part-of-your-initial-evaluation-of-a-patient-presenting-with-a-chronic-or-recurrent-epithelial-defect-of-uncertain-etiology weekly 0.8 https://www.themednet.org/which-patients-do-you-routinely-prescribe-ketorolac-for-after-cataract-surgery weekly 0.8 https://www.themednet.org/what-is-your-approach-to-discontinuing-immunotherapy-in-stable-mogad weekly 0.8 https://www.themednet.org/do-you-continue-calcium-channel-blocker-monotherapy-in-a-patient-with-idiopathic-pah-who-had-an-acute-vasoreactive-response-at-diagnosis-and-achieved-who-functional-class-i-or-ii-at-12-months-or-would-you-still-add-disease-modifying-therapy-with-sotaterce weekly 0.8 https://www.themednet.org/What-radiation-dose-would-you-use-for-t4-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-persistent-fatigue-in-a-patient-after-thyroidectomy-whose-tsh-is-within-the-target-range-given-that-fatigue-affects-the-majority-of-thyroidectomy-patients-yet-its-underlying-mechanisms-remain-poorly-understood weekly 0.8 https://www.themednet.org/what-is-your-preferred-hemodialysis-regimen-for-patients-with-acute-lithium-toxicity weekly 0.8 https://www.themednet.org/have-you-had-success-using-lumateperone-for-behavioral-symptoms-in-autism-spectrum-disorder weekly 0.8 https://www.themednet.org/what-is-your-preferred-next-step-when-you-do-not-achieve-daily-diuresis-goals-with-spot-doses-of-iv-furosemide-in-patients-with-decompensated-heart-failure weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-pressure-ulcers-in-bedbound-older-adults-who-are-community-dwelling weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-sequencing-for-patients-with-her2-mutant-metastatic-non-squamous-nsclc weekly 0.8 https://www.themednet.org/should-ocps-be-held-before-measuring-amh-to-assess-menopausal-status-and-if-so-for-how-long weekly 0.8 https://www.themednet.org/what-therapies-do-you-offer-to-patients-with-hypophosphatasia-and-low-bone-density-who-do-not-qualify-for-enzyme-replacement-therapy weekly 0.8 https://www.themednet.org/do-you-continue-trikafta-throughout-pregnancy-in-a-woman-with-cystic-fibrosis-who-has-adequate-lung-function-and-is-in-a-stable-clinical-state-rather-than-discontinuing-therapy-out-of-concern-for-unknown-fetal-risk weekly 0.8 https://www.themednet.org/do-you-prefer-awake-ecmo-as-a-bridge-to-lung-transplantation-in-a-spontaneously-breathing-patient-with-end-stage-lung-disease-who-is-deteriorating-on-the-waitlist-rather-than-proceeding-to-intubation-and-mechanical-ventilation weekly 0.8 https://www.themednet.org/has-the-frostbite-2-trial-changed-how-you-choose-between-cryoprobe-and-forceps-for-transbronchial-biopsy-in-your-practice weekly 0.8 https://www.themednet.org/how-do-you-manage-toxicities-in-patients-with-mpdac-receiving-daraxonrasib weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-a-child-with-a-new-brain-tumor-who-is-unable-tolerate-an-mri weekly 0.8 https://www.themednet.org/how-do-you-approach-utilization-of-focused-ultrasound-thalamotomy-in-elderly-patients weekly 0.8 https://www.themednet.org/how-do-you-decide-which-patients-would-benefit-from-ecap-closed-loop-spinal-cord-stimulation weekly 0.8 https://www.themednet.org/if-approved-does-peak-bezuclastinib-sunitinib-change-your-second-line-approach-for-advanced-kit-mutant-gist-after-imatinib-failure weekly 0.8 https://www.themednet.org/with-multiple-step-up-therapies-for-urticaria-which-are-you-finding-most-successful-the-first-time-for-remission-of-symptoms weekly 0.8 https://www.themednet.org/would-you-support-a-modified-chlorthalidone-treatment-regimen-involving-a-drug-holiday-two-days-per-week-for-patients-with-recurrent-calcium-based-nephrolithiasis-who-have-less-erectile-dysfunction-side-effects-when-temporarily-off-of-the-thiazide-diureti weekly 0.8 https://www.themednet.org/do-you-routinely-switch-an-eskd-patient-from-a-noac-to-warfarin-to-allow-for-deceased-donor-kidney-transplant-listing weekly 0.8 https://www.themednet.org/how-does-the-tobas-srs-registry-change-your-approach-to-small-avms-in-deep-eloquent-areas-with-prior-rupture weekly 0.8 https://www.themednet.org/has-mr-spectroscopy-ever-led-you-to-forego-a-planned-stereotactic-biopsy-in-a-patient-with-a-suspected-intracranial-neoplasm weekly 0.8 https://www.themednet.org/when-do-you-consider-treatment-with-temporal-bone-windows-to-decrease-intracranial-pressure-for-patients-with-idiopathic-intracranial-hypertension weekly 0.8 https://www.themednet.org/are-triptans-contraindicated-for-migraine-treatment-in-patients-with-sickle-cell-disease weekly 0.8 https://www.themednet.org/how-do-you-interpret-and-manage-sputum-afb-cx-with-one-growing-mac-and-other-nocardia-in-an-otherwise-immunocompetent-patient-with-imaging-showing-bronchiectasis-and-patient-with-mild-respiratory-symptoms weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-recurrent-organizing-pneumonia-in-patients-with-side-effects-from-steroids weekly 0.8 https://www.themednet.org/For-patients-with-eosinophilic-esophagitis-in-remission-on-stable-maintenance-therapy-at-what-intervals-should-you-consider-repeat-endoscopic-evaluation-Does-the-severity-or-history-of-complications-influence-these-intervals weekly 0.8 https://www.themednet.org/what-does-do-you-use-for-palliation-of-a-Large-lung-mass-invading-ribs-and-causing-pain weekly 0.8 https://www.themednet.org/how-do-you-approach-deprescribing-or-continuing-statin-therapy-in-older-adults-with-end-stage-kidney-disease-who-are-initiating-dialysis weekly 0.8 https://www.themednet.org/do-you-have-any-tips-for-best-practices-or-resources-for-interacting-with-adult-protective-services-when-reporting-elder-mistreatment weekly 0.8 https://www.themednet.org/what-resources-or-interventions-do-you-provide-to-older-adults-who-are-experiencing-financial-mistreatment-scams weekly 0.8 https://www.themednet.org/how-do-you-approach-mood-stabilizer-initiation-in-an-older-adult-with-a-new-diagnosis-of-bipolar-disorder weekly 0.8 https://www.themednet.org/do-you-proactively-convert-stable-kidney-transplant-recipients-from-twice-daily-immediate-release-tacrolimus-to-once-daily-extended-release-tacrolimus-to-improve-long-term-adherence weekly 0.8 https://www.themednet.org/is-there-an-optimal-number-of-aeroallergens-to-test-for-that-captures-cross-reactivity-without-having-an-extensive-panel weekly 0.8 https://www.themednet.org/do-you-routinely-check-a-psa-before-starting-finasteride weekly 0.8 https://www.themednet.org/how-do-you-address-sleep-disturbance-related-to-cessation-of-daily-cannabis-use weekly 0.8 https://www.themednet.org/what-hemodynamic-parameters-or-rhc-numbers-do-you-use-to-prompt-venting-the-lv-emergently-with-an-impella-overnight-for-patients-on-va-ecmo weekly 0.8 https://www.themednet.org/how-does-the-presence-of-va-ecmo-influence-your-interpretation-of-rhc-numbers-like-mixed-venous-sat weekly 0.8 https://www.themednet.org/are-there-instances-when-you-continue-phosphate-binders-for-patients-receiving-crrt weekly 0.8 https://www.themednet.org/what-is-your-approach-to-intracatheter-alteplase-use-for-hospitalized-eskd-patients-who-are-experiencing-tunneled-dialysis-catheter-issues weekly 0.8 https://www.themednet.org/does-your-ldl-goal-change-in-elderly-patients-with-diabetes-and-hyperlipidemia-who-are-on-statin-therapy weekly 0.8 https://www.themednet.org/What-infectious-prophylaxis-would-you-recommend-in-a-infant-with-Wiskott-Aldrich-syndrome-during-donor-search-and-pre-transplant-especially-if-not-planning-transplant-for-a-year weekly 0.8 https://www.themednet.org/if-a-cscc-requires-multiple-mohs-stages-and-the-final-defect-exceeds-2-cm-does-this-warrant-additional-staging-workup-such-as-imaging-or-referral-for-radiation weekly 0.8 https://www.themednet.org/does-severe-genital-hidradenitis-suppurativa-warrant-screening-for-crohns-disease-and-what-diagnostic-evaluation-do-you-perform weekly 0.8 https://www.themednet.org/do-you-recommend-an-overall-decrease-in-daily-dietary-animal-protein-or-focus-more-on-decreasing-the-actual-portion-size-of-animal-protein-per-meal-in-your-patients-with-recurrent-calcium-based-nephrolithiasis-who-have-hypercalciuria weekly 0.8 https://www.themednet.org/how-do-you-decide-on-the-timing-and-urgency-of-transplant-evaluation-when-a-patient-recovering-from-alcohol-associated-hepatitis-has-rapid-biochemical-improvement-meld-falls-into-the-low-teens-but-persistent-portal-hypertension-features-and-frailty-sarcop weekly 0.8 https://www.themednet.org/after-endoscopic-control-of-variceal-hemorrhage-what-minimum-safety-bundle-timing-tube-type-size-monitoring-and-contraindications-do-you-require-to-place-a-small-bore-nasoenteric-tube-within-24-hours-for-nutrition-and-hepatic-encephalopathy-therapy weekly 0.8 https://www.themednet.org/in-compensated-mash-cirrhosis-with-frailty-sarcopenia-how-do-you-use-glp-1-receptor-agonists-safely-what-lean-mass-or-functional-monitoring-strategy-and-stopping-adjustment-thresholds-do-you-use-to-prevent-harmful-weight-loss-associated-muscle-loss-while- weekly 0.8 https://www.themednet.org/for-patients-with-mixed-metabolic-and-alcohol-associated-liver-disease-or-ongoing-moderate-alcohol-use-who-otherwise-meet-presumed-f2-f3-criteria-by-nits-how-do-you-operationalize-initiation-and-monitoring-of-a-glp-1-receptor-agonist-particularly-how-you- weekly 0.8 https://www.themednet.org/in-masld-patients-with-high-cardiometabolic-risk-who-already-meet-a-clear-metabolic-indication-for-a-glp-1-receptor-agonist-how-much-fibrosis-stage-certainty-do-you-require-before-treating-it-as-liver-directed-mash-therapy-and-documenting-monitoring-it-as weekly 0.8 https://www.themednet.org/in-biopsy-confirmed-f2-mash-with-a-lean-bmi-what-phenotype-features-e-g-visceral-adiposity-worsening-glycemia-prediabetes-atherogenic-dyslipidemia-most-strongly-push-you-toward-a-glp-1-receptor-agonist-first-versus-a-thyroid-hormone-receptor-beta-agonist- weekly 0.8 https://www.themednet.org/when-considering-liver-transplantation-after-downstaging-beyond-milan-criteria-what-minimum-downstaging-endpoints-afp-response-radiographic-response-necrosis-and-required-duration-of-stability-do-you-use-to-justify-proceeding-to-transplant-to-optimize-lon weekly 0.8 https://www.themednet.org/when-using-vasoconstrictors-for-hrs-aki-what-map-target-do-you-use-in-practice-absolute-map-vs-map-and-how-do-you-adjust-that-target-in-patients-with-chronic-hypertension-cirrhotic-cardiomyopathy-or-very-low-baseline-map weekly 0.8 https://www.themednet.org/is-there-an-association-between-treatment-with-anti-il-5-agents-for-eosinophilic-asthma-and-the-development-of-ra-is-treatment-any-different-than-traditional-course-of-treatment-for-ra weekly 0.8 https://www.themednet.org/have-you-used-lithium-for-agitation-in-dementia weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-nodular-regenerative-hyperplasia-of-the-liver-in-patients-with-sle weekly 0.8 https://www.themednet.org/how-do-you-incorporate-oct-and-oct-a-in-conjunction-with-fa-in-your-evaluation-of-retinal-diseases weekly 0.8 https://www.themednet.org/how-do-you-manage-uncontrolled-glaucoma-in-patients-in-their-mid-90s-and-beyond weekly 0.8 https://www.themednet.org/in-extensive-basal-cell-carcinoma-involving-both-upper-and-lower-eyelids-and-the-lacrimal-gland-is-radiotherapy-poorly-tolerated-especially-to-doses-up-to-50-60-gy-and-or-is-orbital-exenteration-preferred weekly 0.8 https://www.themednet.org/what-is-your-approach-to-outpatient-antihypertensive-therapy-after-ich-for-secondary-prevention weekly 0.8 https://www.themednet.org/what-is-your-approach-to-determining-the-ideal-starting-dose-of-sodium-chloride-tablets-when-transitioning-a-patient-with-hyponatremia-from-a-3-sodium-chloride-infusion weekly 0.8 https://www.themednet.org/how-does-osteoporosis-or-fracture-risk-affect-your-use-of-cgrp-monoclonal-antibodies weekly 0.8 https://www.themednet.org/during-staged-excision-slow-mohs-for-mmis-at-what-point-do-you-stop-due-to-patient-morbidity-and-consider-alternative-or-adjuvant-treatments weekly 0.8 https://www.themednet.org/does-mast-cell-activation-cause-early-closure-of-growth-plates weekly 0.8 https://www.themednet.org/in-what-scenarios-do-you-find-trending-beta-d-glucan-helpful weekly 0.8 https://www.themednet.org/how-do-you-approach-systemic-therapy-for-a-patient-with-hpv-unrelated-recurrent-metastatic-head-and-neck-squamous-cell-carcinoma-who-has-progressed-on-both-a-platinum-based-regimen-and-immune-checkpoint-inhibitor-therapy weekly 0.8 https://www.themednet.org/Any-recommendations-for-how-to-eliminate-chronicrecurrent-fungal-stent-colonization-in-a-patient-with-chronic-hydronephrosis-who-is-not-eligible-for-reconstructive-surgery-due-to-medical-comorbidity weekly 0.8 https://www.themednet.org/which-patients-with-locally-advanced-cervical-cancer-do-you-consider-most-appropriate-candidates-for-moderately-hypofractionated-pelvic-chemoradiation-before-brachytherapy weekly 0.8 https://www.themednet.org/how-long-can-demyelinating-findings-persist-on-nerve-conduction-studies-ncs-after-aidp-illness weekly 0.8 https://www.themednet.org/what-is-your-approach-to-perioperative-risk-stratification-and-optimization-of-patients-with-esrd weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-ada-2026 weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-hold-chronic-medications-with-sedation-potential-in-patients-presenting-with-acute-encephalopathy weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-act-upon-tft-derangements-in-hospitalized-patients-e-g-start-adjust-thyroid-replacement-therapy-vs-attribute-to-ntis-formerly-euthyroid-sick-syndrome-and-advise-repeat-tfts-as-an-outpatient weekly 0.8 https://www.themednet.org/what-strategies-have-you-found-more-effective-for-those-attempting-vaping-cessation weekly 0.8 https://www.themednet.org/when-have-you-used-suzetrogene-for-acute-migraine-treatment weekly 0.8 https://www.themednet.org/how-have-the-new-usda-dietary-guidelines-which-seem-to-promote-several-sources-of-saturated-fat-i-e-full-fat-dairy-products-butter-red-meat-changed-how-you-approach-dietary-advice-with-your-patients weekly 0.8 https://www.themednet.org/do-patients-with-low-c4-and-known-hereditary-angioedema-need-an-immunodeficiency-complement-deficiency-evaluation-even-if-there-is-no-infection-history weekly 0.8 https://www.themednet.org/how-do-you-factor-in-pain-castrophizing-in-your-decision-to-pursue-surgery-for-degenerative-lumbar-spondylolisthesis weekly 0.8 https://www.themednet.org/when-do-you-consider-evd-in-pediatric-severe-tbi-when-initial-imaging-is-unremarkable weekly 0.8 https://www.themednet.org/do-you-initiate-daptomycin-plus-an-anti-mrsa-cephalosporin-as-upfront-combination-therapy-rather-than-waiting-for-persistent-bacteremia-before-escalating-in-a-patient-with-mrsa-bacteremia-and-an-endovascular-source weekly 0.8 https://www.themednet.org/when-do-you-refer-for-peritoneal-dialysis-catheter-placement-in-a-patient-with-advanced-chronic-kidney-disease-who-does-not-currently-have-dialysis-needs-but-does-have-a-progressive-decline-in-egfr weekly 0.8 https://www.themednet.org/how-long-do-you-try-an-inhaler-before-increasing-the-dose-because-it-was-inadequate-failed-to-control-the-patients-asthma weekly 0.8 https://www.themednet.org/in-symptomatic-women-with-an-overall-ahi-of-5-but-rem-ahi-30-and-meaningful-rem-related-hypoxic-burden-do-you-treat-and-how-do-you-handle-payer-denials-that-key-on-overall-ahi weekly 0.8 https://www.themednet.org/in-a-patient-on-chronic-stable-methadone-or-buprenorphine-for-oud-who-develops-symptomatic-central-sleep-apnea-do-you-prioritize-treating-the-csa-cpap-asv-if-lvef-45-adjunct-acetazolamide-o-or-pushing-the-opioid-team-toward-dose-reduction-where-does-loop- weekly 0.8 https://www.themednet.org/do-you-anticipate-added-benefit-of-triple-agonist-therapy-for-patients-with-early-type-2-diabetes-mellitus-and-masld-given-evidence-of-glucagon-resistance weekly 0.8 https://www.themednet.org/how-many-statins-do-you-try-before-considering-alternative-therapies-like-pcsk9-inhibitors-or-inclisiran-to-lower-ldl-levels weekly 0.8 https://www.themednet.org/how-do-you-decide-between-immediate-liver-transplant-referral-versus-a-time-limited-recompensation-observation-period-in-patients-with-alcohol-related-cirrhosis-who-present-with-a-first-decompensation-and-achieve-early-verified-abstinence weekly 0.8 https://www.themednet.org/do-you-routinely-condition-the-implantation-of-a-microaxial-flow-pump-upon-echocardiographic-exclusion-of-left-ventricular-thrombus weekly 0.8 https://www.themednet.org/would-you-recommend-delaying-a-24-hour-urine-stone-risk-study-until-a-patient-is-off-of-antibiotics-if-they-are-on-a-short-course-for-an-upper-respiratory-infection-but-are-experiencing-no-medication-side-effects weekly 0.8 https://www.themednet.org/how-do-you-decide-when-dangerous-or-illegal-behaviors-in-youth-with-conduct-disorder-require-legal-involvement weekly 0.8 https://www.themednet.org/what-literature-do-you-recommend-for-reviewing-lymphocyte-panels-for-the-workup-of-immunodeficiency weekly 0.8 https://www.themednet.org/do-you-prefer-your-patients-with-recurrent-nephrolithiasis-who-have-completed-a-24-hour-urine-stone-risk-study-drop-off-the-entire-collection-to-the-respective-lab-for-processing-or-personally-mix-and-aliquot-a-representative-sample-prior-to-dropping-off- weekly 0.8 https://www.themednet.org/what-is-your-approach-to-counseling-families-whos-loved-one-has-a-worsening-malignant-brain-tumor-but-is-not-a-surgical-candidate weekly 0.8 https://www.themednet.org/when-would-you-consider-a-posterior-approach-for-patients-with-a-cervical-radiculopathy-and-foraminal-stenosis-without-central-stenosis weekly 0.8 https://www.themednet.org/when-do-you-order-an-mra-to-better-evaluate-results-from-a-cta weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gyn-cancers-from-asco-2026 weekly 0.8 https://www.themednet.org/does-a-history-of-ipsilateral-breast-atypia-preclude-apbi-when-otherwise-suitable weekly 0.8 https://www.themednet.org/when-do-you-add-corticosteroids-to-treatment-of-hsv-encephalitis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-concomitant-hypernatremia-and-hyperglycemia-in-patients-with-encephalopathy weekly 0.8 https://www.themednet.org/when-do-you-pursue-additional-workup-for-incidental-thrombocytosis-in-hospitalized-patients weekly 0.8 https://www.themednet.org/is-there-an-egfr-or-urine-output-rate-for-which-you-would-recommend-against-pre-and-post-hydration-for-a-patient-with-aki-who-requires-liposomal-amphotericin-b weekly 0.8 https://www.themednet.org/in-a-patient-with-persistent-symptoms-of-lyme-arthritis-do-you-prefer-a-second-course-of-oral-antibiotics-or-do-you-frequently-offer-a-course-of-iv-ceftriaxone weekly 0.8 https://www.themednet.org/how-are-you-approaching-the-option-to-transition-to-an-all-oral-treatment-ascertain-v-in-your-practice-for-newly-diagnosed-unfit-aml weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-neuro-oncology-from-asco-2026 weekly 0.8 https://www.themednet.org/What-is-your-preferred-treatment-in-patients-with-Hairy-cell-leukemia-requiring-treatment-(pancytopenia-from-bone-marrow-involvement)-and-CKD-stage-3 weekly 0.8 https://www.themednet.org/what-is-your-preferred-way-to-manage-anxiety-pain-in-bone-marrow-examinations-in-a-very-anxious-patient weekly 0.8 https://www.themednet.org/how-do-you-approach-chemotherapy-induced-thrombocytopenia-in-patients-who-do-not-respond-adequately-to-romiplostim weekly 0.8 https://www.themednet.org/what-dose-fractionation-regimen-would-you-recommend-when-re-irradiating-intramedullary-local-recurrence-of-pilocytic-astrocytoma-of-the-spinal-cord weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-sarcoma-from-asco-2026 weekly 0.8 https://www.themednet.org/what-is-your-first-step-non-invasive-test-for-the-evaluation-of-angina-in-the-outpatient-primary-care-setting weekly 0.8 https://www.themednet.org/do-you-routinely-prescribe-oral-anti-fungals-for-seborrhoeic-dermatitis weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-do-you-recommend-if-any-for-a-vaginal-margin-that-is-positive-for-hsil-vain3-following-radical-hysterectomy-but-negative-for-invasive-cancer-and-otherwise-does-not-meet-sedlis-criteria-for-adjuvant-radiation weekly 0.8 https://www.themednet.org/In-a-patient-with-chronic-intestinal-pseudo-obstruction-who-develops-refractory-postoperative-ileus-what-is-your-pharmacologic-escalation-strategy-and-when-do-you-move-beyond-medications-to-endoscopic-or-procedural-interventions weekly 0.8 https://www.themednet.org/in-hospitalized-patients-with-end-stage-renal-disease-esrd-who-develop-mechanical-hemolysis-from-high-velocity-dialysis-what-is-your-approach-to-balancing-lower-ultrafiltration-rates-ufr-to-mitigate-hemolysis-while-also-optimizing-inpatient-length-of-stay weekly 0.8 https://www.themednet.org/what-alternative-low-effort-airway-clearance-strategies-do-you-use-in-frail-neuromuscular-patients-who-are-unable-to-tolerate-or-fail-manual-chest-physiotherapy-e-g-oscillating-pep-devices-high-frequency-chest-wall-oscillation-vests-or-mechanical-insuffla weekly 0.8 https://www.themednet.org/when-do-you-recommend-using-nicotinic-acid-or-chlorpromazine-for-patients-with-neobladder-acidosis weekly 0.8 https://www.themednet.org/what-minimum-workflow-repeat-testing-interval-escalation-thresholds-and-referral-triggers-do-you-recommend-for-implementing-nit-based-prognostic-stratification-for-masld-in-primary-care-endocrinology-so-that-a-high-risk-result-reliably-leads-to-an-actiona weekly 0.8 https://www.themednet.org/in-patients-with-ascites-how-do-you-operationally-define-when-carvedilol-nsbbs-are-still-within-a-safe-and-effective-window-using-bedside-markers-without-routine-hvpg-and-which-specific-thresholds-make-you-hold-or-discontinue-therapy weekly 0.8 https://www.themednet.org/how-do-you-utilize-oct-for-the-diagnosis-and-management-of-iih weekly 0.8 https://www.themednet.org/in-the-absence-of-fiducial-marker-do-you-insert-a-vaginal-marker-for-planning-a-cervical-cancer-post-op-recurrence-for-ct-simulation-and-then-do-you-treat-with-the-marker-in-place-can-you-avoid-a-vaginal-marker-by-using-a-pelvic-mri-obtained-in-diagnostic weekly 0.8 https://www.themednet.org/can-needle-emg-or-nerve-conduction-studies-cause-transient-mri-abnormalities-such-as-apparent-inflammation-edema-or-enhancement-of-a-nerve-that-could-be-mistaken-for-neuritis-on-subsequent-imaging weekly 0.8 https://www.themednet.org/when-do-you-consider-genetic-testing-for-autoinflammatory-diseases-in-patients-with-recurrent-pericarditis-and-fever-particularly-when-symptoms-are-highly-responsive-to-il-1-blockade weekly 0.8 https://www.themednet.org/how-has-the-embolise-trial-changed-your-practice-regarding-concurrent-subdural-hematoma-evacuation-and-mma-embolization weekly 0.8 https://www.themednet.org/what-is-your-timing-for-angiogram-and-treatment-for-patients-with-sentinel-bleeds-from-recently-discovered-aneurysm weekly 0.8 https://www.themednet.org/what-patient-factor-lead-to-performing-a-direct-bypass-rather-than-an-indirect-bypass-for-treatment-of-moyamoya weekly 0.8 https://www.themednet.org/after-lumbar-laminectomy-and-fusion-how-long-do-you-keep-a-subfascial-drain-in-place weekly 0.8 https://www.themednet.org/how-do-you-change-the-shunt-setting-after-adding-an-antisiphon-device weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-place-a-drain-after-a-subdural-hematoma-evacuation weekly 0.8 https://www.themednet.org/in-the-case-of-concomitant-tethered-cord-and-chiari-malformation-with-syringomyelia-how-do-you-determine-priority-of-treatment weekly 0.8 https://www.themednet.org/do-you-find-that-framing-refractive-surgery-success-around-functional-goals-rather-than-visual-acuity-targets-improves-patient-satisfaction-in-your-practice weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-capecitabine-plus-trastuzumab-in-a-premenopausal-patient-with-unifocal-microinvasive-0-7mm-er-pr-her-2-positive-invasive-ductal-carcinoma-pt1min0-with-the-recent-iris-a-trial-asco-2026 weekly 0.8 https://www.themednet.org/Despite-good-compliance-to-oral-iron-I-find-it-very-hard-to-bring-up-the-ferritin-more-than-30-in-children.-Especially-when-the-sleep-medicine-folks-want-it-close-to-50.-How-do-you-approach-this. weekly 0.8 https://www.themednet.org/in-a-patient-with-multiple-organ-abscesses-no-known-predisposing-factors-and-negative-genetic-panel-testing-for-cgd-and-normal-oxidative-burst-what-other-testing-modalities-should-be-considered-ex-autoantibody-testing-functional-assays-etc weekly 0.8 https://www.themednet.org/does-stage-of-transformed-dlbcl-from-indolent-lymphoma-matter-in-decision-making-of-the-treatment-cycles-of-rchop weekly 0.8 https://www.themednet.org/what-does-elevated-complement-c3-c4-in-a-patient-with-inflammatory-arthritis-inflammatory-rheumatic-conditions-signify weekly 0.8 https://www.themednet.org/do-you-routinely-opt-for-continuing-a-doac-post-cardiac-transplant-in-a-patient-with-a-history-of-atrial-fibrillation-pre-transplant weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-and-surveillance-of-mixed-aortic-valvular-disease-with-moderate-as-and-ar-and-threshold-to-refer-for-surgical-intervention weekly 0.8 https://www.themednet.org/based-on-results-of-the-pines-trial-have-you-shifted-your-practice-to-start-treatment-for-newly-diagnosed-pediatric-itp-with-eltrombopag weekly 0.8 https://www.themednet.org/how-has-propensity-matched-data-showing-lower-mortality-and-fewer-cardiovascular-events-with-parathyroidectomy-versus-cinacalcet-affected-your-pth-threshold-for-surgical-referral-in-a-patient-with-ckd-related-secondary-hyperparathyroidism weekly 0.8 https://www.themednet.org/do-you-tailor-your-choice-of-beta-blocker-to-the-specific-arrhythmia-mechanism-or-do-you-default-to-a-cardioselective-agent-regardless-of-clinical-context weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-epinephrine-auto-injectors-for-patients-with-isolated-oral-allergy-syndrome-or-only-when-there-are-risk-factors-for-progression-to-systemic-reactions weekly 0.8 https://www.themednet.org/is-dog-immunotherapy-effective-in-patients-monosensitized-to-can-f-5 weekly 0.8 https://www.themednet.org/do-you-recommend-or-require-patients-to-undergo-immunization-boosters-prior-to-rituximab-treatment weekly 0.8 https://www.themednet.org/when-managing-a-patient-with-overlapping-seborrheic-dermatitis-and-a-heavy-actinic-keratosis-ak-burden-on-the-face-and-scalp-i-debated-between-using-topical-roflumilast-versus-a-traditional-corticosteroid-according-to-its-fda-approved-labeling-and-clinica weekly 0.8 https://www.themednet.org/what-is-your-approach-to-intractable-hiccups-of-uncertain-etiology-in-hospitalized-patients weekly 0.8 https://www.themednet.org/What-medications-are-indicated-for-the-treatment-of-hypersomnolence-in-dementia weekly 0.8 https://www.themednet.org/for-patients-with-patellofemoral-pain-syndrome-whose-sx-continue-despite-an-adequate-course-of-physical-therapy-what-adjunctive-treatments-bracing-taping-injections-orthotics-or-imaging-do-you-consider-most-helpful-and-in-what-order weekly 0.8 https://www.themednet.org/what-findings-help-you-differentiate-between-catatonia-and-nms weekly 0.8 https://www.themednet.org/with-pan-genotypic-treatment-options-available-when-do-you-consider-checking-the-genotype-in-hepatitis-c-what-would-be-the-factors-that-would-guide-in-testing-it weekly 0.8 https://www.themednet.org/in-a-t2n0-60f-with-tnbc-low-ki67-and-androgen-receptor-100-s-p-resection-would-you-add-enzaluatmide-or-bicalutamide-adjuvantly weekly 0.8 https://www.themednet.org/what-factors-push-you-toward-upfront-necrosectomy-rather-than-step-up-drainage-in-a-patient-with-symptomatic-walled-off-necrosis-after-four-weeks weekly 0.8 https://www.themednet.org/what-is-your-treatment-strategy-for-pregnant-patients-with-newly-discovered-prolactinomas weekly 0.8 https://www.themednet.org/would-you-consider-a-stagged-approach-using-gamma-knife-radiation-for-brain-tumors-larger-than-3cm-in-diameter weekly 0.8 https://www.themednet.org/in-patients-with-low-alkaline-phosphatase-and-high-vitamin-b6-levels-does-negative-genetic-testing-for-alpl-mutation-rule-out-hypophosphatasia weekly 0.8 https://www.themednet.org/when-do-you-consider-starting-medications-such-as-metformin-or-a-glp-1-ra-for-the-purpose-of-dm-prevention-in-patients-whose-a1c-in-not-in-diagnostic-range-but-demonstrates-progressive-weight-gain-metabolic-dysfunction weekly 0.8 https://www.themednet.org/in-non-visually-significant-hypotony-maculopathy-after-trabeculectomy-how-do-you-approach-timing-and-decision-to-revise-the-trab weekly 0.8 https://www.themednet.org/how-do-you-decide-timing-of-repair-of-a-chronic-macula-threatening-tractional-retinal-detachment weekly 0.8 https://www.themednet.org/adjuvant-chemotherapy-in-stage-1b-lung-squamous-cell weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-ahs-2026-scientific-session weekly 0.8 https://www.themednet.org/when-do-you-consider-pharmacologic-therapies-such-a-sodium-tablets-urea-vaptans-etc-vs-conservative-management-for-persistent-asymptomatic-hyponatremia-in-hospitalized-patients weekly 0.8 https://www.themednet.org/do-you-have-any-specific-concerns-regarding-chemotherapy-and-or-radiation-tolerance-in-a-patient-with-fshd-type-1-who-now-presents-with-ct4an2cm0-scc-of-the-mandibular-alveolar-ridge-curious-whether-anyone-has-prior-experience-with weekly 0.8 https://www.themednet.org/what-is-your-threshold-for-offering-nucleos-t-ide-analogue-cessation-in-an-hbeag-negative-non-cirrhotic-patient-with-low-eot-qhbsag-e-g-80-iu-ml-and-which-clinical-factors-would-make-you-advise-against-stopping-even-with-reliable-follow-up weekly 0.8 https://www.themednet.org/what-minimum-cardiometabolic-evaluation-and-treatment-workflow-do-you-recommend-at-the-time-of-masld-diagnosis-in-hepatology-clinic weekly 0.8 https://www.themednet.org/when-do-you-consider-platelet-transfusion-in-thrombocytopenic-patients-who-are-undergoing-holep weekly 0.8 https://www.themednet.org/what-key-principles-of-consultative-peri-operative-medicine-would-you-emphasize-for-early-career-hospitalists-serving-in-this-role-without-much-prior-experience weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-selection-between-adjuvant-pembrolizumab-alone-and-pembrolizumab-plus-belzutifan-in-patients-with-resected-clear-cell-rcc weekly 0.8 https://www.themednet.org/how-do-you-manage-prostate-cancer-with-adenocarcinoma-histology-at-the-primary-site-but-neuroendocrine-differentiation-in-visceral-metastases weekly 0.8 https://www.themednet.org/do-you-still-recommend-daily-fluid-restriction-to-ambulatory-patients-with-mild-to-moderate-heart-failure-symptoms-given-rct-data-showing-no-improvement-in-health-status-compared-to-liberal-fluid-intake weekly 0.8 https://www.themednet.org/in-budd-chiari-presenting-with-acute-liver-failure-ascites-encephalopathy-but-a-technically-amenable-short-segment-hepatic-vein-lesion-how-do-you-decide-between-urgent-decompression-tips-dips-or-recanalization-versus-prioritizing-expedited-transplant-list weekly 0.8 https://www.themednet.org/after-liver-transplantation-for-budd-chiari-in-patients-with-persistent-high-risk-thrombophilia-e-g-mpn-aps-pnh-and-prior-splanchnic-thrombosis-extension-what-is-your-standard-long-term-anticoagulation-strategy-and-what-objective-findings-prompt-you-to-in weekly 0.8 https://www.themednet.org/are-there-clinical-contexts-where-you-would-not-use-spleen-stiffness-to-drive-endoscopy-nsbb-decisions-because-you-suspect-the-ssm-signal-is-dominated-by-splenic-congestion-hyperdynamic-circulation-rather-than-portal-pressure-and-how-do-you-identify-those weekly 0.8 https://www.themednet.org/would-you-start-potassium-citrate-in-a-patient-with-recurrent-nephrolithiasis-and-only-minimal-uric-acid-composition-who-persistently-has-acidic-urine weekly 0.8 https://www.themednet.org/looking-for-colleagues-experience-using-cannabinoid-based-products-thc-included-for-non-psychotic-primary-insomnia-in-depressed-patients-whose-mood-symptoms-are-well-treated-but-whose-insomnia-has-remained-refractory-to-standard-options-cbt-i-orexin-inhib weekly 0.8 https://www.themednet.org/for-which-patients-with-type-1-diabetes-on-insulin-pump-therapy-do-you-consider-transitioning-from-rapid-acting-to-ultra-rapid-acting-insulin weekly 0.8 https://www.themednet.org/what-medications-do-you-add-if-any-to-reduce-further-gfr-decline-ckd-progression-after-nephrectomy-in-an-adult weekly 0.8 https://www.themednet.org/what-are-your-thoughts-about-becoming-active-with-national-societies-in-your-clinical-specialty weekly 0.8 https://www.themednet.org/what-are-your-thoughts-about-becoming-active-with-national-societies-in-your-clinical-specialty-1 weekly 0.8 https://www.themednet.org/how-long-after-stopping-prednisone-do-esr-and-crp-become-clinically-reliable-for-reassessing-disease-activity weekly 0.8 https://www.themednet.org/how-do-you-interpret-significant-eosinophilia-in-a-patient-with-suspected-granulomatosis-with-polyangiitis-gpa weekly 0.8 https://www.themednet.org/how-have-you-implemented-digital-data-into-your-evaluations-of-parkinsons-patients weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-in-his-90s-with-achalasia-type-1-and-an-eckardt-symptom-score-of-6-who-is-not-a-peroral-endoscopic-myotomy-poem-candidate weekly 0.8 https://www.themednet.org/when-do-you-if-ever-use-plasma-exchange-for-multiple-sclerosis-flares weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-premature-babies-with-ivh weekly 0.8 https://www.themednet.org/how-do-you-work-up-and-manage-patients-with-persistent-cloudy-and-mucus-like-urine-but-no-obvious-cause-on-imaging-or-urinalysis weekly 0.8 https://www.themednet.org/would-you-offer-uk-fast-forward-type-5-fraction-breast-radiation-for-a-patient-with-a-4-5cm-idc-with-good-margins-er-pos-pr-pos-her2-negative-and-negative-slnb weekly 0.8 https://www.themednet.org/in-what-scenario-could-brachytherapy-be-favored-over-cabg-for-isr-lesions-with-two-layers-of-stent-provided-the-patient-is-a-good-surgical-candidate weekly 0.8 https://www.themednet.org/do-you-change-your-approach-with-medications-for-cannabis-induced-psychosis-or-mania weekly 0.8 https://www.themednet.org/what-strategies-do-you-recommend-for-new-primary-care-providers-to-help-create-boundaries-with-patient-on-their-virtual-portals-ie-mychart weekly 0.8 https://www.themednet.org/when-a-patient-with-a-known-venom-allergy-reports-a-sting-during-immunotherapy-but-before-reaching-maintenance-dose-do-you-accelerate-the-build-up-schedule-or-restart-from-the-beginning weekly 0.8 https://www.themednet.org/how-has-your-approach-to-dry-eye-management-evolved-with-the-advent-of-several-prescription-medications-and-neutriceuticals weekly 0.8 https://www.themednet.org/do-you-feel-there-is-value-to-schirmer-testing-in-clinic-prior-to-starting-dry-eye-treatment weekly 0.8 https://www.themednet.org/do-you-still-obtain-tensilon-edrophonium-testing-for-myasthenia-gravis-and-what-do-you-feel-is-the-added-value-over-serum-testing weekly 0.8 https://www.themednet.org/what-is-your-radiotherapy-plan-in-a-pt-with-hx-of-metastatic-thymic-neuroendocrine-tumor-now-s-p-resection-of-a-posterior-inferior-chest-wall-subcutaneous-mass weekly 0.8 https://www.themednet.org/do-you-need-to-do-spinal-mris-when-chiari-1-is-diagnosed-on-brain-mri-in-an-asymptomatic-25-year-old weekly 0.8 https://www.themednet.org/what-is-your-approach-to-preventing-significant-hematoma-and-postoperative-swelling-following-penile-implant-surgery weekly 0.8 https://www.themednet.org/how-do-you-decide-which-children-need-early-steroid-sparing-therapy-rather-than-hydroxychloroquine-plus-a-short-steroid-course-in-pediatric-non-renal-sle weekly 0.8 https://www.themednet.org/how-has-this-guideline-changed-your-threshold-to-start-systemic-therapy-rather-than-rotating-topicals-in-a-child-with-persistent-atopic-dermatitis-despite-good-adherence weekly 0.8 https://www.themednet.org/how-do-you-approach-comorbidity-screening-beyond-food-allergy-in-a-child-with-moderate-to-severe-atopic-dermatitis weekly 0.8 https://www.themednet.org/do-you-counsel-patients-with-in-moderate-to-severe-psoriasis-and-obesity-or-type-2-diabetes-on-the-potential-role-of-adjunctive-glp-1-therapy-in-reduction-of-psoriasis-burden weekly 0.8 https://www.themednet.org/what-is-your-approach-to-counseling-patients-on-the-safety-and-side-effect-profile-of-a-biosimilar-compared-to-its-reference-biologic weekly 0.8 https://www.themednet.org/what-is-your-initial-management-approach-to-suspected-coagulase-negative-staphylococcus-endocarditis weekly 0.8 https://www.themednet.org/which-type-of-pancreatic-cancer-patients-should-we-consider-sending-to-a-center-that-offers-eus-guided-radiofrequency-ablation-rfa-therapy weekly 0.8 https://www.themednet.org/is-there-any-guidance-on-resuming-successful-abatacept-therapy-in-a-refractory-ra-patient-undergoing-resection-of-stage-1-adenocarcinoma-of-the-lung weekly 0.8 https://www.themednet.org/for-those-who-treat-chronic-migraine-with-onabotulinumtoxina-do-you-routinely-perform-peripheral-nerve-blocks-greater-occipital-auriculotemporal-or-supraorbital-at-the-same-visit-a-few-specific-questions-timing-and-sequencing-do-you-perform-the-nerve-bloc weekly 0.8 https://www.themednet.org/what-specific-strategies-have-you-found-most-effective-in-your-academic-program-for-inspiring-internal-medicine-residents-to-consider-nephrology-as-a-career weekly 0.8 https://www.themednet.org/how-would-you-approach-the-consideration-of-levodopa-trial-in-an-older-adult-with-a-history-of-schizophrenia-stable-on-antipsychotic-who-has-changes-consistent-with-drug-induced-parkinsonism-vs-parkinsons-disease weekly 0.8 https://www.themednet.org/would-you-consider-maintenance-capecitabine-for-a-patient-with-pt1cn0-triple-negative-breast-cancer-following-completion-of-adjuvant-dose-dense-ac-t weekly 0.8 https://www.themednet.org/do-you-continue-voriconazole-beyond-the-minimum-recommended-duration-in-a-patient-with-invasive-pulmonary-aspergillosis-who-is-clinically-improved-but-has-persistent-radiographic-abnormalities-on-ct weekly 0.8 https://www.themednet.org/How-do-you-determine-whether-a-patient-who-repeatedly-tests-positive-for-strep-when-ill-is-infected-v.-a-carrier-When-do-you-give-antibiotics-v.-Observe weekly 0.8 https://www.themednet.org/what-is-your-strategy-for-discontinuing-benzodiazepines-in-patients-with-ptsd weekly 0.8 https://www.themednet.org/how-do-you-advocate-for-geriatric-focused-care-models-such-as-age-friendly-health-systems-ace-units-or-inpatient-delirium-programs-in-institutions-that-dont-have-a-strong-geriatrics-infrastructure weekly 0.8 https://www.themednet.org/i-have-encountered-several-patients-with-atrial-fibrillation-or-low-cardiac-output-who-presented-with-basilar-artery-occlusion-and-underwent-successful-mechanical-thrombectomy-only-to-reocclude-within-24-to-48-hours-in-these-cases-there-was-no-evidence-of weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-metastatic-castrate-sensitive-prostate-cancer-who-have-discrepant-psa-and-radiographic-response-to-upfront-triplet-therapy weekly 0.8 https://www.themednet.org/has-adopting-a-3d-heads-up-digital-visualization-system-changed-your-approach-to-teaching-residents-or-fellows-during-complex-cataract-cases weekly 0.8 https://www.themednet.org/in-bilateral-sequential-naion-do-you-expect-any-progressive-worsening-of-oct-vf-years-from-the-ischemic-event-and-when-would-you-have-these-patients-evaluated-for-another-progressive-optic-neuropathy weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-decompressing-the-cystic-part-of-a-cystic-brain-mass-prior-to-resecting-the-nodule weekly 0.8 https://www.themednet.org/in-a-patient-with-low-risk-mds-who-is-anemic-and-has-only-symptomatic-anemia-has-an-sf3b1-mutation-vaf-40-no-ringed-sideroblasts-identified-and-an-epo-level-200-do-you-have-a-first-line-preference-between-esa-and-luspatercept weekly 0.8 https://www.themednet.org/how-do-you-chose-which-patients-are-eligible-for-a-percutaneous-spinal-cord-stimulator-trial weekly 0.8 https://www.themednet.org/what-is-your-timeline-for-restarting-anticoagulants-for-patients-with-a-recent-craniotomy-for-hematoma-evacuation-who-are-also-on-an-lvad weekly 0.8 https://www.themednet.org/Has-this-trial-regarding-long-term-outcomes-changed-your-default-salvage-therapy-after-failed-Heller-myotomy-in-a-patient-with-recurrent-achalasia weekly 0.8 https://www.themednet.org/How-do-you-counsel-and-manage-cough-as-a-side-effect-when-initiating-inhaled-treprostinil-in-a-patient-with-IPF weekly 0.8 https://www.themednet.org/How-do-you-decide-which-patients-should-pursue-add-on-bepirovirsen-rather-than-continue-indefinite-nucleos(t)ide-analogue-monotherapy-for-noncirrhotic-chronic-HBV weekly 0.8 https://www.themednet.org/What-toxicity-threshold-would-make-you-stop-bepirovirsen-while-pursuing-functional-cure-in-a-noncirrhotic-patient-with-chronic-HBV-on-suppressive-nucleos(t)ide-analogue-therapy weekly 0.8 https://www.themednet.org/in-patients-with-connective-tissue-disease-associated-interstitial-lung-disease-ctd-ild-who-have-achieved-clinical-and-physiologic-stability-after-successful-discontinuation-of-prednisone-while-on-mycophenolate-mofetil-how-do-you-typically-approach-taperi weekly 0.8 https://www.themednet.org/when-diuretics-or-lactulose-are-newly-started-or-uptitrated-at-discharge-what-clinical-factors-make-you-schedule-follow-up-within-72-96-hours-rather-than-the-usual-7-14-days weekly 0.8 https://www.themednet.org/would-you-consider-whole-liver-radiation-for-diffuse-liver-metastases-to-lower-bilirubin-so-a-patient-with-metastatic-pancreatic-cancer-is-eligible-for-daraxonrasib weekly 0.8 https://www.themednet.org/how-has-your-approach-to-de-escalating-a-conversation-with-a-distressed-or-angry-family-member-evolved-over-your-career-and-is-there-a-specific-technique-that-became-a-turning-point-for-you weekly 0.8 https://www.themednet.org/how-have-you-developed-your-approach-to-delivering-a-new-serious-diagnosis-such-as-cancer-diabetes-or-a-chronic-progressive-condition-in-the-primary-care-setting-where-the-relationship-is-longitudinal-and-the-follow-up-is-yours-to-carry weekly 0.8 https://www.themednet.org/how-have-you-refined-your-approach-to-disclosing-a-new-diagnosis-of-dementia-to-a-patient-and-their-family-and-is-there-a-specific-conversation-structure-or-lesson-from-experience-that-shaped-how-you-do-it-now weekly 0.8 https://www.themednet.org/how-should-the-hydra-trial-change-the-diagnostic-workup-of-suspected-pe-in-patients-with-active-cancer-and-which-cancer-patients-should-still-go-directly-to-ctpa-despite-meeting-years-rule-out-criteria weekly 0.8 https://www.themednet.org/what-is-the-best-immediate-and-long-term-management-of-an-iatrogenic-mid-ureteral-injury weekly 0.8 https://www.themednet.org/does-screening-for-sleep-apnea-in-asymptomatic-patients-reduce-long-term-dementia-risk weekly 0.8 https://www.themednet.org/do-you-recommend-gradual-initiation-of-dialysis-or-conventional-initiation-of-dialysis-for-pregnant-patients-with-worsening-renal-function-who-require-dialysis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-use-of-erythropoiesis-stimulating-agents-in-pregnant-patients-with-anemia-and-advanced-chronic-kidney-disease weekly 0.8 https://www.themednet.org/do-you-raise-your-tsh-target-in-a-postmenopausal-woman-on-long-term-levothyroxine-who-develops-osteoporosis-to-minimize-the-bone-effects-of-even-mild-over-replacement weekly 0.8 https://www.themednet.org/for-a-patient-with-clinically-node-positive-pancreatic-cancer-do-you-simply-boost-the-involved-nodes-to-full-dose-or-treat-additional-adjacent-nodal-regions-electively weekly 0.8 https://www.themednet.org/what-dose-would-you-use-to-treat-amyloidosis-involving-sciatic-nerve-for-symptom-relief-no-oncologic-involvement weekly 0.8 https://www.themednet.org/what-is-your-radiotherapy-approach-for-a-patient-presenting-with-simultaneous-stage-iia-limited-stage-sclc-and-stage-iiic-cervical-scc-who-is-receiving-standard-treatment-for-both weekly 0.8 https://www.themednet.org/how-would-you-treat-a-hepatic-dome-hcc-lesion-in-a-patient-with-a-history-of-ild weekly 0.8 https://www.themednet.org/do-you-perform-routine-cystoscopy-after-hysterectomy-for-gynecologic-cancer-staging weekly 0.8 https://www.themednet.org/what-is-your-approach-to-initiating-jak-inhibitor-therapy-in-patients-for-refractory-inflammatory-disease-with-a-history-of-venous-thromboembolism-who-are-currently-on-anticoagulation-does-the-type-of-anticoagulation-change-your-management weekly 0.8 https://www.themednet.org/how-do-you-approach-the-decision-to-proceed-with-staged-second-side-mrgfus-thalamotomy-in-a-patient-with-a-good-unilateral-response-who-later-develops-disabling-contralateral-tremor weekly 0.8 https://www.themednet.org/how-do-you-decide-between-mrgfus-thalamotomy-litt-and-stereotactic-radiosurgery-for-an-older-patient-with-medication-refractory-essential-tremor-who-is-not-a-dbs-candidate weekly 0.8 https://www.themednet.org/for-which-patients-would-you-consider-offering-a-spinal-cord-stimulator-for-management-of-autonomic-dysfunction weekly 0.8 https://www.themednet.org/how-would-you-approach-patient-selection-for-dbs-after-chronic-post-stroke-for-motor-rehabilitation-in-light-of-the-recent-phase-1-clinical-trial weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-for-surgical-timing-for-management-of-a-large-pituitary-mass-with-suprasellar-extension weekly 0.8 https://www.themednet.org/how-has-the-utilization-of-of-mobile-stroke-units-changed-the-landscape-of-in-hospital-stroke-management weekly 0.8 https://www.themednet.org/renal-transplant-recipient-on-chronic-immunosuppression-underwent-egd-for-epigastric-pain-and-intermittent-dysphagia-the-patient-had-no-dysphagia-at-the-time-of-endoscopy-and-currently-denies-any-dysphagia-or-odynophagia-esophageal-biopsies-were-equivocal weekly 0.8 https://www.themednet.org/how-can-hospitalists-most-effectively-advocate-for-funding-to-support-pocus-initiatives-e-g-curriculum-faculty-development-equipment-etc-at-their-institutions weekly 0.8 https://www.themednet.org/when-a-patient-with-ici-induced-inflammatory-arthritis-requires-biologic-dmard-therapy-how-do-you-balance-need-to-treat-with-concern-for-faster-cancer-progression weekly 0.8 https://www.themednet.org/do-you-manage-a-patient-presenting-with-ici-induced-pmr-like-syndrome-using-the-same-glucocorticoid-dosing-and-tapering-schedule-you-would-apply-to-primary-pmr-or-do-you-treat-it-as-a-distinct-entity-requiring-a-lower-steroid-dose-given-evidence-suggestin weekly 0.8 https://www.themednet.org/how-do-you-approach-tapering-decisions-for-disease-modifying-therapy-for-ici-induced-inflammatory-arthritis-after-the-patients-cancer-treatment-has-been-completed-or-the-ici-has-been-discontinued weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-ultrafiltration-during-dialysis-sessions-in-a-pregnant-patient-who-recently-started-on-hemodialysis weekly 0.8 https://www.themednet.org/which-osteoporosis-medications-are-safe-to-offer-a-patient-with-severe-osteoporosis-who-is-strictly-vegan weekly 0.8 https://www.themednet.org/which-blood-pressure-medications-do-you-favor-using-to-manage-ongoing-hypertension-post-adrenalectomy-for-hyperaldosteronism weekly 0.8 https://www.themednet.org/for-presumed-posner-schlossman-syndrome-how-useful-is-viral-pcr-on-aqueous-and-is-there-value-in-treating-empirically-with-antivirals weekly 0.8 https://www.themednet.org/what-is-your-go-to-intravesical-therapy-for-recurrent-high-grade-non-muscle-invasive-bladder-cancer-when-bcg-is-unavailable weekly 0.8 https://www.themednet.org/how-is-your-office-streamlining-the-process-of-signing-up-medicare-patients-on-glp-1-agonists-under-the-new-program-that-started-july-1st weekly 0.8 https://www.themednet.org/how-do-you-manage-restarting-isotretinoin-for-patients-that-have-to-abruptly-stop-treament-for-a-few-months-due-to-side-effects-e-g-cheilitis-xerosis-does-your-cumulative-end-goal-change weekly 0.8 https://www.themednet.org/how-if-at-all-has-the-fda-approval-of-zidesamtinib-changed-your-treatment-approach-for-patients-with-locally-advanced-or-metastatic-ros1-nsclc-who-have-previously-received-a-ros1-kinase-inhibitor weekly 0.8 https://www.themednet.org/what-is-your-threshold-to-use-nitazoxanide-for-treatment-of-cryptosporidium-in-an-immunocompetent-patient weekly 0.8 https://www.themednet.org/has-anyone-used-fostamatinib-tavalisse-for-persistent-thrombocytopenia-after-temozolomide-in-a-patient-with-recurrent-gbm weekly 0.8 https://www.themednet.org/How-do-you-counsel-patients-with-newly-diagnosed-advanced-cancer-on-smoking-cessation-Although-responses-to-treatment-are-better-with-smoking-cessation-I've-found-it-difficult-to-have-the-conversation-especially-with-patients-with-metastatic-disease-who-f weekly 0.8 https://www.themednet.org/do-the-emg-of-patients-with-aidp-gbs-normalize-overtime-when-months-years weekly 0.8 https://www.themednet.org/what-is-your-clinical-pathway-when-a-transplant-candidate-reports-abstinence-but-has-a-positive-phosphatidylethanol-peth-including-how-you-confirm-results-and-decide-on-addiction-medicine-involvement-and-listing-implications weekly 0.8 https://www.themednet.org/how-do-you-approach-a-microscopic-colitis-patient-whose-diarrhea-is-not-improving-despite-budesonide weekly 0.8 https://www.themednet.org/in-patients-with-suspected-che-and-major-confounders-e-g-osa-alcohol-related-cognitive-impairment-early-dementia-what-is-your-practical-stopping-rule-for-escalating-he-directed-therapy-before-pivoting-to-a-primary-non-he-evaluation-sleep-medication-neuroc weekly 0.8 https://www.themednet.org/which-patients-with-oligodendrogliomas-are-good-candidates-for-vorasidenib-to-delay-radiation-therapy weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-is-recommended-for-a-patient-treated-for-a-who-grade-3-meningioma-s-p-gtr-and-adjuvant-radiation-one-year-ago-with-negative-brain-mri-who-now-presents-s-p-selective-neck-dissection-of-a-enlarged-lymph-node-with-pathology-confirming-w weekly 0.8 https://www.themednet.org/how-do-you-treat-postherpetic-neuralgia-not-adequately-responding-to-oral-neuropathic-pain-medications-lidocaine-and-capsaicin weekly 0.8 https://www.themednet.org/How-would-you-treat-a-66-yo-with-a-modular-basal-cell-carcinoma-of-medial-canthus-invaded-"to-bone"-with-ultimate-negative-margins-after-4-stage-Moh's-surgery-where-tipumor-was-peeled-off-bone weekly 0.8 https://www.themednet.org/what-is-your-threshold-to-offer-trimethoprim-sulfamethoxazole-for-treatment-of-cyclosporiasis-to-an-immunocompetent-patient weekly 0.8 https://www.themednet.org/when-treating-a-patient-with-her2-3-stage-iv-colorectal-cancer-with-fam-trastuzumab-deruxtecan-and-they-have-a-complete-radiographic-response-and-negative-ctdna-testing-is-there-any-data-or-anecdotal-evidence-to-support-giving-a-treatment-break-and-monito weekly 0.8 https://www.themednet.org/where-can-we-obtain-anti-iga-igg weekly 0.8 https://www.themednet.org/would-you-offer-varicocele-repair-to-a-man-with-elevated-dna-fragmentation-but-otherwise-normal-semen-parameters weekly 0.8 https://www.themednet.org/do-you-routinely-check-lipid-panels-for-transgender-men-on-testosterone-replacement-therapy weekly 0.8 https://www.themednet.org/in-routine-cirrhosis-practice-what-are-the-main-practical-barriers-to-embedding-evidence-based-alcohol-use-disorder-treatment-within-hepatology-care weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-initiate-buprenorphine-for-chronic-pain weekly 0.8 https://www.themednet.org/would-you-offer-more-external-beam-radiation-in-a-young-patient-with-t4n1-rectal-cancer-who-already-completed-tnt-and-had-a-pelvic-exenteration-with-a-positive-deep-margin-without-gross-disease-seen-on-post-operative-imaging weekly 0.8 https://www.themednet.org/would-you-consider-weekly-low-dose-decitabine-and-weekly-venetoclax-metronomic-dosing-in-frail-patients-with-high-risk-mds weekly 0.8 https://www.themednet.org/how-does-pseudoexfoliation-change-expected-long-term-success-of-trabecular-migs weekly 0.8 https://www.themednet.org/would-you-consider-reducing-physiological-replacement-doses-of-steroids-for-secondary-adrenal-insufficiency-in-patients-who-develop-steroid-induced-complications-such-as-avascular-necrosis-of-the-joints weekly 0.8 https://www.themednet.org/what-have-you-been-using-in-place-of-tensilon-test-as-a-pharmacologic-challenge-for-myasthenia-gravis-diagnosis weekly 0.8 https://www.themednet.org/how-do-you-decide-between-second-line-immunotherapy-for-multifocal-motor-neuropathy weekly 0.8 https://www.themednet.org/How-do-you-incorporate-a-positive-viral-NAAT-into-antibiotic-de-escalation-when-chest-imaging-still-suggests-pneumonia-in-a-hospitalized-patient weekly 0.8 https://www.themednet.org/what-non-medication-interventions-or-resources-do-you-provide-parents-of-children-with-oppositional-behaviors weekly 0.8 https://www.themednet.org/which-calculators-nomograms-or-other-resources-if-any-do-you-use-to-help-advise-and-prognosticate-patients-with-newly-diagnosed-glioblastoma-or-other-gliomas weekly 0.8 https://www.themednet.org/do-you-add-an-sglt2-inhibitor-to-mineralocorticoid-receptor-antagonist-therapy-in-a-patient-with-primary-aldosteronism-who-is-not-a-surgical-candidate-given-retrospective-data-showing-significantly-lower-mortality-and-cardiorenal-events-with-the-combinati weekly 0.8 https://www.themednet.org/Do-you-consider-off-label-dupilumab-rather-than-dietary-therapy-in-a-patient-with-eosinophilic-gastritis-needing-long-term-disease-control weekly 0.8 https://www.themednet.org/Do-you-escalate-therapy-based-on-persistent-gastric-eosinophilia-in-a-patient-with-eosinophilic-gastritis-improving-symptomatically-on-corticosteroids weekly 0.8 https://www.themednet.org/How-do-you-counsel-women-with-cystic-fibrosis-on-when-pregnancy-is-reasonably-safe-after-lung-transplant weekly 0.8 https://www.themednet.org/How-do-you-decide-if-a-patient-should-get-follow-up-perfusion-imaging-after-acute-PE-when-they-are-minimally-symptomatic-but-with-prior-VTE weekly 0.8 https://www.themednet.org/Do-you-still-favor-skin-testing-over-direct-oral-challenge-when-the-penicillin-reaction-history-is-remote-but-poorly-characterized-in-a-hospitalized-adult weekly 0.8 https://www.themednet.org/how-do-you-distinguish-between-antidepressants-losing-effectiveness-vs-not-being-effective-in-the-first-place weekly 0.8 https://www.themednet.org/do-you-routinely-check-an-ecg-in-the-ambulatory-setting-in-patients-without-a-cardiac-history-when-starting-a-medical-that-can-potentially-prolong-qtc weekly 0.8 https://www.themednet.org/when-managing-severe-treatment-refractory-hidradenitis-suppurativa-exhibiting-incomplete-response-to-single-biologic-agents-what-safety-parameters-diagnostic-biomarkers-and-or-monitoring-protocols-govern-your-decision-to-utilize-off-label-dual-targeted-th weekly 0.8 https://www.themednet.org/for-cavitary-lung-disease-with-mycobacterium-malmoense-do-you-substitute-inhaled-amikacin-for-intravenous-amikacin-in-addition-to-the-triple-regimen-of-macrolide-ethambutol-rifampin weekly 0.8 https://www.themednet.org/what-are-your-thoughts-on-patients-with-hyponatremia-receiving-iv-fluids-before-urine-studies-are-collected-and-etiology-is-fully-characterized weekly 0.8 https://www.themednet.org/how-do-you-weigh-the-risks-and-benefits-of-ongoing-hospitalization-in-elderly-patients-with-protracted-delirium-but-without-clear-acutely-reversible-cause weekly 0.8 https://www.themednet.org/how-do-you-distinguish-normal-post-operative-pain-and-swelling-in-an-extremity-from-a-post-operative-complication-such-as-hemorrhage-surgical-site-infection-etc weekly 0.8 https://www.themednet.org/do-you-monitor-magnesium-levels-in-patients-on-patiromer weekly 0.8 https://www.themednet.org/In-which-clinical-situations-if-any-would-you-still-consider-carboplatin-paclitaxel-alone-rather-than-chemoimmunotherapy-for-first-line-treatment-of-metastatic-squamous-anal-cancer-after-POD1UM-303InterAACT-2 weekly 0.8 https://www.themednet.org/do-you-typically-start-pth-analogue-therapy-for-osteoporosis-at-lower-doses-and-gradually-titrate-up-to-improve-tolerance-and-longer-term-use weekly 0.8 https://www.themednet.org/what-normal-brain-ptv-dose-constraint-would-you-recommend-for-a-large-solitary-cerebellar-metastasis-planning-3-or-5-fraction-srt-is-your-constraint-different-for-cerebellar-vs-cerebral-metastasis weekly 0.8 https://www.themednet.org/for-lals-after-lock-in-when-does-a-residual-refractive-shift-justify-corneal-enhancement-rather-than-continued-observation weekly 0.8 https://www.themednet.org/what-type-of-drain-do-you-place-after-burr-holes-for-subdural weekly 0.8 https://www.themednet.org/how-do-you-determine-timing-between-stage-1-anterior-fusion-and-stage-2-posterior-fusion-for-deformity-correction weekly 0.8 https://www.themednet.org/has-the-tolerance-induction-program-been-beneficial-in-allowing-patients-with-multiple-food-allergies-to-freely-eat-all-their-food-allergens weekly 0.8 https://www.themednet.org/Would-you-biopsy-a-39-year-female-with-8-g-proteinuria-but-normal-albumin-and-negative-serologic-workup-The-patient-is-obese-with-BMI-35-and-a-history-of-preeclampsia. weekly 0.8 https://www.themednet.org/how-do-you-manage-paraspinal-extramedullary-hematopoietic-masses-in-patients-with-transfusion-dependent-thalassemia weekly 0.8 https://www.themednet.org/do-you-continue-calcineurin-inhibitor-based-immunosuppression-after-a-failed-kidney-transplant-that-remains-in-situ-to-reduce-hla-sensitization-and-preserve-retransplantation-options weekly 0.8 https://www.themednet.org/would-you-consider-starting-with-12-mg-of-adenosine-rather-than-6-mg-in-a-hemodynamically-stable-patient-with-svt weekly 0.8 https://www.themednet.org/do-you-favor-switching-a-virologically-suppressed-patient-with-hiv-and-significant-weight-gain-to-dolutegravir-lamivudine-over-bictegravir-emtricitabine-tenofovir-alafenamide-given-paso-doble-trial-data-showing-noninferior-virologic-efficacy-with-less-wei weekly 0.8 https://www.themednet.org/what-is-the-treatment-strategy-and-priority-in-a-patient-with-newly-diagnosed-hodgkin-lymphoma-but-hlh-at-presentation weekly 0.8 https://www.themednet.org/how-do-you-change-your-approach-for-treatment-of-depression-in-adolescents-with-cannabis-use-disorder weekly 0.8 https://www.themednet.org/what-types-of-hemorrhage-would-you-consider-the-adjunctive-use-of-octreotide weekly 0.8 https://www.themednet.org/how-do-you-track-improvement-in-overall-functioning-with-treatment-of-depression weekly 0.8 https://www.themednet.org/i-have-observed-both-p155-140-and-tif1g-being-at-the-myositis-panel-from-arup-lab-is-there-any-difference-between-2-tests-i-have-observed-only-tif1g-being-positive-in-some-patients-without-a-confirmed-diagnosis-but-positive-for-both-in-true-dermatomyositi weekly 0.8 https://www.themednet.org/after-starting-high-dose-smart-what-maximum-total-daily-inhalations-are-appropriate weekly 0.8 https://www.themednet.org/when-would-you-consider-switching-from-standard-calcium-replacement-therapy-to-the-newly-approved-encaleret-therapy-for-treatment-of-hypocalcemia-secondary-to-hypoparathyroidism weekly 0.8 https://www.themednet.org/for-patients-with-graves-disease-managed-on-methimazole-therapy-who-are-seeking-pregnancy-how-long-before-trying-to-conceive-do-you-typically-recommend-switching-to-propylthiouracil weekly 0.8 https://www.themednet.org/can-spaceoar-be-inserted-a-second-time weekly 0.8 https://www.themednet.org/how-has-the-elvis-trial-changed-your-approach-for-management-of-post-hemorrhagic-ivh weekly 0.8 https://www.themednet.org/for-which-patients-do-you-consider-stereotactic-radiosurgery-rather-than-focused-ultrasound-for-treatment-of-essential-tremor weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-perform-selective-stereotactic-radiosurgery-to-patients-with-multiple-sub-centimeter-brain-metastases-and-1-2-slightly-larger-brain-metastases weekly 0.8 https://www.themednet.org/Do-you-set-mTICI-specific-systolic-blood-pressure-targets-after-successful-endovascular-therapy-for-acute-ischemic-stroke weekly 0.8 https://www.themednet.org/what-is-first-intervention-you-reach-for-when-a-caregiver-shows-signs-of-burnout weekly 0.8 https://www.themednet.org/for-breakthrough-psychosis-on-a-maximized-lai-do-you-add-oral-supplementation-or-shorten-the-injection-interval-first weekly 0.8 https://www.themednet.org/what-is-your-approach-to-long-term-suppressive-therapy-of-valganciclovir-for-a-patient-with-hx-of-cmv-anterior-uveitis weekly 0.8 https://www.themednet.org/if-acanthamoeba-testing-is-unavailable-locally-what-immediate-management-is-reasonable-while-arranging-urgent-referral weekly 0.8 https://www.themednet.org/what-is-your-approach-to-dosing-scig-for-cidp-in-patients-stable-on-ivig weekly 0.8 https://www.themednet.org/how-aggressively-do-you-screen-the-menopausal-patient-presenting-with-new-or-worsening-insomnia-for-osa-and-what-is-your-threshold-for-in-lab-psg-after-a-negative-hsat-in-this-population weekly 0.8 https://www.themednet.org/for-antenatal-hydronephrosis-thats-improving-on-serial-ultrasound-when-do-you-stop-getting-ultrasounds-and-does-that-differ-if-its-unilateral-versus-bilateral weekly 0.8 https://www.themednet.org/how-long-do-you-prescribe-an-alpha-blocker-after-ureteroscopy-in-a-patient-with-residual-stone-fragments-on-postoperative-imaging weekly 0.8 https://www.themednet.org/should-chemoradiotherapy-to-primary-and-neck-be-offered-to-patients-with-stage-ivc-nasopharyngeal-carcinoma-with-limited-osseous-disease weekly 0.8 https://www.themednet.org/do-you-consider-adding-a-brachytherapy-boost-to-imrt-in-patients-with-ct3b-and-or-cn1-prostate-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-a-pediatric-embryonal-rhabdomyosarcoma-of-the-kidney-with-preoperative-rupture-s-p-nephrectomy-and-getting-vac-vi-chemotherapy weekly 0.8 https://www.themednet.org/do-you-recommend-elective-lymph-node-irradiation-for-a-basal-cell-carcinoma-of-the-skin-that-is-deeply-invading-muscle weekly 0.8 https://www.themednet.org/would-you-recommend-bcs-and-adjuvant-radiation-for-early-stage-multicentric-breast-cancer weekly 0.8 https://www.themednet.org/when-do-you-consider-it-too-late-after-surgery-to-offer-adjuvant-chemotherapy-for-colon-adenocarcinoma weekly 0.8 https://www.themednet.org/how-would-you-advise-your-patient-about-starting-adjuvant-breast-radiation-who-has-a-planned-vacation weekly 0.8 https://www.themednet.org/what-techniques-do-you-use-to-minimize-gas-artifacts-on-cone-beam-ct-when-treating-upper-abdominal-lesions weekly 0.8 https://www.themednet.org/how-do-you-treat-recurrent-tracheal-carcinoma weekly 0.8 https://www.themednet.org/should-nsclc-with-positive-cervical-nodes-be-managed-with-definitive-chemoradiation weekly 0.8 https://www.themednet.org/what-igrt-strategy-do-you-use-when-treating-intact-prostate-and-lymph-nodes weekly 0.8 https://www.themednet.org/do-you-offer-postoperative-radiation-for-adrenocortical-carcinoma weekly 0.8 https://www.themednet.org/how-long-do-you-give-adjuvant-hormonal-therapy-for-women-over-70-with-breast-cancer-treated-with-lumpectomy-only weekly 0.8 https://www.themednet.org/can-ctdna-be-used-to-evaluate-response-to-checkpoint-inhibitors-in-nsclc-when-pseudoprogression-is-suspected-on-ct-imaging weekly 0.8 https://www.themednet.org/is-there-any-role-for-ctdna-testing-after-surgery-or-sbrt-for-stage-ib-nsclc-to-determine-the-need-for-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/is-there-a-role-in-sending-liquid-biopsy-for-patients-progressing-on-alk-inhibitors weekly 0.8 https://www.themednet.org/how-are-you-approaching-head-and-neck-re-irradiation-cases-if-the-recurrent-cancer-has-been-resected-but-with-high-risk-features-such-as-ece-etc weekly 0.8 https://www.themednet.org/can-patients-on-steroids-receive-immunotherapy weekly 0.8 https://www.themednet.org/have-you-ever-used-sodium-alginate-to-treat-radiation-induced-mucositis-of-the-upper-digestive-tract weekly 0.8 https://www.themednet.org/how-would-your-management-change-for-high-risk-prostate-cancer-in-a-patient-who-is-not-a-surgical-candidate-due-to-age-or-medical-comorbidities-and-had-prior-pelvic-irradiation weekly 0.8 https://www.themednet.org/what-surrogate-s-do-you-use-to-determine-toxicity-safety-for-a-srs-plan-with-numerous-metastases weekly 0.8 https://www.themednet.org/would-you-add-a-brachytheray-boost-to-a-locally-advanced-cervical-cancer-after-surgical-resection-and-pelvic-rt weekly 0.8 https://www.themednet.org/would-you-feel-comfortable-giving-a-her2-breast-cancer-patient-her-next-cycle-of-tchp-taxotere-carboplatin-herceptin-perjeta-on-day-17-of-the-previous-cycle weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-with-an-early-stage-favorable-breast-cancer-who-has-synchronous-advanced-or-metastatic-nsclc weekly 0.8 https://www.themednet.org/would-you-offer-a-patient-over-70-years-old-with-early-stage-favorable-breast-cancer-adjuvant-whole-breast-radiation-if-her-sentinel-node-biopsy-shows-a-single-node-with-isolated-tumor-cell-itc weekly 0.8 https://www.themednet.org/how-would-you-approach-isolated-inguinal-lymph-node-squamous-cell-carcinoma-of-occult-primary weekly 0.8 https://www.themednet.org/would-you-recommend-partial-breast-irradiation-using-ldr-seeds-after-lumpectomy-for-a-suitable-candidate-with-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/would-you-consider-bid-treatment-for-a-patient-with-a-pelvic-scc-e-g-cervix-or-anal-if-a-significant-amount-of-treatment-days-have-been-missed weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-low-risk-prostate-cancer-on-active-surveillance-who-develops-high-risk-features-but-absolutely-refuses-a-repeat-biopsy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-cn0-penile-cancer-with-a-moderate-risk-of-nodal-metastasis weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-be-recommended-for-node-positive-gastric-adenocarcinoma-s-p-gastrectomy-who-did-not-receive-neoadjuvant-therapy weekly 0.8 https://www.themednet.org/for-women-receiving-breast-rt-who-develop-a-severe-skin-reaction-during-treatment-what-is-your-threshold-for-giving-a-treatment-break weekly 0.8 https://www.themednet.org/how-would-you-manage-palliation-in-a-patient-with-postobstructive-pneumonia-caused-by-a-mediastinal-mass weekly 0.8 https://www.themednet.org/do-you-routinely-offer-adjuvant-chemotherapy-to-patients-with-extrahepatic-cholangiocarcinoma-after-r0-resection weekly 0.8 https://www.themednet.org/do-you-think-it-makes-a-difference-to-fractionate-at-2-gy-versus-1-8-gy-per-fraction weekly 0.8 https://www.themednet.org/do-you-have-a-cut-off-for-bilirubin-for-treatment-of-patients-with-poorly-differentiated-nsclc-with-good-ps-and-liver-dysfunction-due-to-mets weekly 0.8 https://www.themednet.org/has-precision-medicine-changed-how-you-consent-patients-for-treatment weekly 0.8 https://www.themednet.org/how-do-you-present-the-trade-off-between-a-small-chance-of-a-sustained-response-for-a-new-drug-at-the-expense-of-potential-worsening-quality-of-life weekly 0.8 https://www.themednet.org/when-discussing-immunotherapy-with-patients-how-do-you-frame-the-conversation-in-a-way-that-acknowledges-the-fact-that-many-patients-do-not-respond-but-allows-for-hope-for-a-durable-response weekly 0.8 https://www.themednet.org/when-do-you-recommend-pmrt-for-individuals-with-spindle-cell-carcinoma-of-the-breast weekly 0.8 https://www.themednet.org/how-would-you-manage-treatment-of-keloid-that-is-so-large-it-requests-a-graft weekly 0.8 https://www.themednet.org/what-cumulative-dose-constraints-would-you-use-for-the-normal-liver-when-repeating-sbrt-for-liver-metastases-with-a-longer-time-interval-i-e-2-3-years weekly 0.8 https://www.themednet.org/when-would-you-consider-using-radiation-for-cardiac-metastases weekly 0.8 https://www.themednet.org/do-you-send-oncotype-or-mammaprint-as-a-predictive-tool-for-patients-with-high-grade-3-3-lymph-node-negative-er-breast-cancers weekly 0.8 https://www.themednet.org/what-is-a-standard-field-for-ln-paratesticular-rhabdomyosarcoma-ie-aorta-ivc-ipsi-common-iliac weekly 0.8 https://www.themednet.org/what-is-your-method-for-delineation-of-the-hippocampal-avoidance-structure-in-patients-who-are-unable-to-undergo-mri weekly 0.8 https://www.themednet.org/how-do-you-choose-a-dose-of-5-fu-during-chemo-radiation-for-a-patient-with-rectal-cancer-who-is-dialysis-dependent weekly 0.8 https://www.themednet.org/for-triple-positive-metastatic-breast-cancer-do-you-sequence-or-simultaneously-use-hormonal-therapy-along-with-chemotherapy weekly 0.8 https://www.themednet.org/how-does-your-prescribed-srs-dose-vary-with-cavity-size-for-treatment-of-resected-brain-metastases weekly 0.8 https://www.themednet.org/do-you-offer-patients-bid-treatment-days-during-holiday-weeks-with-only-3-business-days weekly 0.8 https://www.themednet.org/do-you-consider-multiple-sclerosis-a-contraindication-for-srs weekly 0.8 https://www.themednet.org/would-you-offer-pmrt-after-nac-in-a-boderline-patient-with-a-pcr-based-on-suspicious-pre-chemotherapy-im-nodes weekly 0.8 https://www.themednet.org/what-is-your-approach-when-it-comes-to-reirradiation-for-dipg-patients-who-have-already-received-54gy-upfront weekly 0.8 https://www.themednet.org/what-are-your-indications-for-treating-a-pelvic-desmoid-tumor-in-a-young-woman-concerned-with-fertility weekly 0.8 https://www.themednet.org/what-is-the-maximum-interval-you-would-consider-delivering-adjuvant-radiation-therapy-for-endometrial-cancer weekly 0.8 https://www.themednet.org/what-is-the-sensitivity-of-slnb-after-neoadjuvant-chemotherapy-for-cn0-patients weekly 0.8 https://www.themednet.org/do-you-prefer-a-chemo-radiation-combination-or-chemotherapy-followed-by-sequential-radiation-approach-for-early-stage-nk-t-cell-lymphoma weekly 0.8 https://www.themednet.org/what-alternative-therapies-would-you-consider-for-a-patient-with-metastatic-castration-sensitive-prostate-cancer-who-declines-gnrh-analogues weekly 0.8 https://www.themednet.org/what-is-your-preferred-regimen-for-triple-positive-breast-cancer-with-bone-only-recurrence weekly 0.8 https://www.themednet.org/how-would-you-treat-a-solitary-intracranial-oligometastasis-from-ewings-sarcoma-that-has-been-resected weekly 0.8 https://www.themednet.org/would-you-recommend-apbi-in-an-otherwise-suitable-patient-who-has-had-a-previous-history-of-estrogen-replacement-therapy-prior-to-early-stage-breast-cancer-diagnosis weekly 0.8 https://www.themednet.org/what-treatment-would-you-offer-for-patients-with-metastatic-nsclc-adenocarcinoma-who-are-egfr-positive-and-pd-l1-50-who-fail-first-line-egfr-therapy-and-are-negative-for-t790m-mutation weekly 0.8 https://www.themednet.org/what-regimen-would-you-choose-for-patients-with-breast-cancer-requiring-adjuvant-chemotherapy-whose-livelihoods-depend-on-fine-dexterity-such-as-a-professional-musician weekly 0.8 https://www.themednet.org/would-you-boost-a-resected-axilla-if-extra-nodal-extension-is-found-in-a-patient-with-breast-cancer weekly 0.8 https://www.themednet.org/would-you-consider-maintenance-therapy-for-patients-who-achieve-complete-response-after-palliative-chemoradiation-for-metastatic-distal-esophageal-adenocarcinoma weekly 0.8 https://www.themednet.org/how-do-you-evaluate-a-suspicious-but-negative-pleural-effusion-when-working-up-nsclc-and-sclc weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-low-grade-appendiceal-mucinous-neoplasm-found-incidentally-at-appendectomy weekly 0.8 https://www.themednet.org/how-do-you-approach-rising-gastrin-and-chromogranin-levels-without-radiographic-evidence-of-disease-in-patients-with-gastrinoma-that-has-been-fully-resected weekly 0.8 https://www.themednet.org/would-you-recommend-cardiac-radiotherapy-for-malignant-pericardial-effusion-refractory-to-pericardial-fenestration weekly 0.8 https://www.themednet.org/do-you-find-the-measurement-of-ultra-sensitive-psa-provides-clinical-benefit-in-a-patient-with-biochemical-recurrence-after-radical-prostatectomy-compared-to-non-ultra-sensitive-psa-measurement weekly 0.8 https://www.themednet.org/how-do-i-search-themednet weekly 0.8 https://www.themednet.org/how-do-i-get-an-answer-to-my-question weekly 0.8 https://www.themednet.org/why-wasnt-my-question-approved weekly 0.8 https://www.themednet.org/how-would-you-treat-a-biopsy-proven-isolated-internal-mammary-node-recurrence-one-year-after-a-mastectomy-and-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-simultaneously-diagnosed-stage-iva-scc-of-the-head-and-neck-and-limited-stage-small-cell-lung-cancer-neither-is-symptomatic weekly 0.8 https://www.themednet.org/for-liver-metastases-what-criteria-do-you-use-to-decide-between-sbrt-vs-y90 weekly 0.8 https://www.themednet.org/how-does-treatment-management-change-with-a-positive-intramammary-lymph-node-in-the-setting-of-a-negative-axilla-with-the-inclusion-of-these-as-n1-node-in-the-ajcc-8th-edition weekly 0.8 https://www.themednet.org/what-is-your-approach-to-re-irradiation-of-the-brachial-plexus weekly 0.8 https://www.themednet.org/what-sites-for-sbrt-are-thought-to-be-more-immunogenic-for-antigen-presentation-when-combined-with-immunotherapy weekly 0.8 https://www.themednet.org/would-irreversible-elctroporation-ire-performed-at-the-time-of-whipple-affect-your-plans-or-dose-for-radiation-in-the-setting-of-adjuvant-treatment-for-pancreatic-adenocarcinoma weekly 0.8 https://www.themednet.org/what-treatment-would-you-offer-to-a-patient-after-resection-of-a-solitary-metastatic-melanoma-from-the-brain-without-evidence-of-other-sites-of-disease weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-for-a-patient-with-er-pr-her2-breast-cancer-less-than-5mm-in-size-with-a-high-oncotype-score weekly 0.8 https://www.themednet.org/among-patients-with-anal-scc-is-it-reasonable-to-replace-5-fu-with-capecitabine-when-delivering-definitive-chemoradiotherapy-with-concurrent-mitomycin-c weekly 0.8 https://www.themednet.org/when-do-you-refer-patients-for-acupuncture-for-ai-associated-joint-pain weekly 0.8 https://www.themednet.org/are-there-any-situations-where-you-would-not-offer-sbrt-for-an-oligometastatic-bone-lesion-from-breast-cancer weekly 0.8 https://www.themednet.org/would-you-use-single-agent-adjuvant-her2-directed-therapy-for-patients-with-low-risk-her2-breast-cancer-who-are-not-candidates-for-chemotherapy weekly 0.8 https://www.themednet.org/what-sbrt-dose-and-tissue-constraints-would-you-choose-for-a-presacral-rectal-recurrence-status-post-preoperative-chemoradiation-to-50-4-gy-followed-by-surgical-resection-in-a-patient-who-is-not-a-candidate-for-surgical-re-resection weekly 0.8 https://www.themednet.org/have-the-presented-results-of-gog-249-at-astro-2017-changed-management-of-early-stage-uterine-papillary-serous-cancers-from-chemo-vc-ebrt-to-pelvic-rt-only weekly 0.8 https://www.themednet.org/do-you-treat-radiation-induced-sarcomas-similarly-to-de-novo-sarcomas weekly 0.8 https://www.themednet.org/for-patients-with-a-history-of-seizures-secondary-to-brain-metastases-what-are-your-criteria-for-discontinuing-antiepileptic-medications-if-the-seizures-have-been-controlled-since-srs-or-surgery weekly 0.8 https://www.themednet.org/do-you-treat-the-ipsilateral-neck-and-primary-site-for-a-resected-skin-cancer-with-parotid-mets weekly 0.8 https://www.themednet.org/what-is-the-appropriate-follow-up-after-chemoradiotherapy-for-patients-with-anal-scc weekly 0.8 https://www.themednet.org/would-you-ever-consider-giving-treatment-break-to-patients-with-triple-negative-metastatic-breast-cancer-who-responded-to-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-manage-adult-brainstem-lesions-in-the-absence-of-a-tissue-diagnosis weekly 0.8 https://www.themednet.org/what-post-treatment-imaging-do-you-recommend-for-glomus-jugulare-tumors-paragangliomas-following-definitive-radiation-therapy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-fit-newly-diagnosed-high-risk-multiple-myeloma-patient-with-multiple-poor-risk-factors-and-circulating-plasma-cells weekly 0.8 https://www.themednet.org/how-do-you-manage-scc-metastasis-to-the-parotid-with-unknown-primary weekly 0.8 https://www.themednet.org/can-post-op-rt-be-omitted-in-a-surgically-repaired-pathological-fracture-site-in-multiple-myeloma-if-the-patient-will-receive-systemic-therapy weekly 0.8 https://www.themednet.org/would-you-use-alternative-management-in-a-chronic-phase-cml-with-a-3-way-translocation-between-chromosome-9-22-and-7 weekly 0.8 https://www.themednet.org/in-what-situations-do-you-obtain-both-a-pelvic-mri-and-eus-for-rectal-cancer-staging-and-treatment-planning weekly 0.8 https://www.themednet.org/what-is-the-optimal-management-of-krukenberg-tumor-in-a-pre-menopausal-woman-with-hr-pos-metastatic-breast-cancer-progressed-on-tamoxifen-and-second-line-gemcitabine-with-the-rest-of-the-disease-sites-well-controlled weekly 0.8 https://www.themednet.org/how-do-you-treat-locally-recurrent-papillary-thyroid-carcinoma-following-multiple-surgeries-rai weekly 0.8 https://www.themednet.org/would-you-recommend-concurrent-chemotherapy-for-a-t1n1-oropharynx-cancer-if-the-patient-underwent-excisional-biopsy-of-the-node-and-was-found-to-have-ece weekly 0.8 https://www.themednet.org/when-do-you-offer-salvage-prostate-bed-rt-to-patients-who-have-a-biochemical-recurrence-5-years-after-rp weekly 0.8 https://www.themednet.org/how-do-you-treat-anal-adenocarcinoma weekly 0.8 https://www.themednet.org/would-you-treat-a-t2n0-high-grade-neuroendocrine-carcinoma-of-the-nasal-cavity-after-a-r1-resection weekly 0.8 https://www.themednet.org/would-you-take-any-precautions-of-plan-radiation-therapy-differently-for-a-patient-with-head-and-neck-cancer-who-has-active-bullous-pemphigoid-in-the-mucosal-area-that-will-be-radiated weekly 0.8 https://www.themednet.org/is-it-appropriate-to-substitute-vincristine-for-vinblastine-in-abvd-for-systemic-therapy-of-hodgkins-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-treat-an-early-stage-breast-cancer-with-cn0-but-could-not-undergo-a-slnb weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-a-myxopapillary-ependymoma-of-the-conus-with-drop-metastases-to-the-cauda-equina weekly 0.8 https://www.themednet.org/do-you-have-indications-for-adjuvant-radiation-in-h-n-cancers-oropharynx-oral-cavity-etc-other-than-listed-in-the-nccn-guidelines-ece-positive-margins-pt3-4-n2-3-or-lv-iv-v-pni-lvsi weekly 0.8 https://www.themednet.org/does-the-ebctcg-meta-analysis-showing-higher-lrr-in-nac-group-sway-you-from-giving-neo-adjuvant-chemotherapy-to-patients-with-localized-breast-cancer weekly 0.8 https://www.themednet.org/why-was-my-question-rejected weekly 0.8 https://www.themednet.org/why-was-my-question-modified weekly 0.8 https://www.themednet.org/what-kind-of-questions-are-on-themednet weekly 0.8 https://www.themednet.org/who-is-on-themednet weekly 0.8 https://www.themednet.org/how-is-themednet-different-from-other-online-communities weekly 0.8 https://www.themednet.org/how-would-you-treat-an-isolated-lung-recurrence-from-colon-adenocarcinoma-that-was-initially-resected-without-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/in-what-instances-would-you-use-bolus-for-locally-advanced-vulvar-cancer-using-imrt weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiation-for-a-1-cm-preauricular-sebaceous-carcinoma-after-wide-local-excision weekly 0.8 https://www.themednet.org/would-you-give-post-operative-radiation-therapy-and-or-chemotherapy-after-an-apr-for-anal-cancer-if-inguinal-lymph-nodes-were-involved-but-margins-were-negative weekly 0.8 https://www.themednet.org/would-you-recommend-post-lumpectomy-rt-in-an-elderly-woman-with-a-t1n0m0-stage-breast-cancer-er-pr-her2-positive weekly 0.8 https://www.themednet.org/at-what-dose-would-you-recommend-future-audiogram-screening-for-pediatric-patients-treated-with-radiotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-locally-advanced-head-and-neck-cancer-requiring-chemoradiation-that-needs-extensive-dental-work-from-an-oral-surgeon-but-because-of-insurance-and-social-issues-cannot-feasibly-get-the-teeth-removed weekly 0.8 https://www.themednet.org/would-you-consider-substituting-infusional-5fu-for-capecitabine-in-the-flot-regimen-for-localized-gastric-adenocarcinoma weekly 0.8 https://www.themednet.org/what-volumes-and-prescription-doses-do-you-use-when-treating-patients-with-unresectable-cholangiocarcinoma weekly 0.8 https://www.themednet.org/should-regional-nodes-be-included-in-whole-breast-rt-for-a-favorable-pt3n0-breast-cancer-after-lumpectomy-and-slnb weekly 0.8 https://www.themednet.org/what-is-your-superior-field-or-ctv-border-when-treating-para-aortic-lymph-nodes-with-extended-field-radiation-therapy-for-endometrial-cancer-in-the-post-operative-setting weekly 0.8 https://www.themednet.org/among-the-many-assays-tests-available-for-liquid-biopsies-in-metastatic-nsclc-are-there-any-situations-where-you-would-want-to-use-one-specific-assay-over-the-others weekly 0.8 https://www.themednet.org/how-would-you-treat-the-axilla-if-a-breast-cancer-patient-had-cn1-disease-in-the-axilla-but-after-neoadjuvant-chemo-the-slnb-revealed-no-positive-nodes-and-the-clip-placed-in-the-axilla-was-not-found weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-an-early-stage-lung-cancer-adjacent-to-a-prior-lung-cancer-previously-treated-with-sbrt weekly 0.8 https://www.themednet.org/in-what-situation-would-you-cover-the-scar-of-a-temporary-tracheostomy-post-operatively-for-oral-cavity-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-colon-cancer-chemotherapy-in-a-patient-who-has-had-documented-coronary-vasospasm-with-folfox weekly 0.8 https://www.themednet.org/how-do-you-approach-small-lymphocytic-lymphoma-that-does-not-have-a-leukemic-phase weekly 0.8 https://www.themednet.org/what-would-you-choose-as-a-first-line-therapy-for-a-patient-with-cll-who-is-asymptomatic-with-rai-stage-4-with-bulky-adenopathy-and-organomegaly weekly 0.8 https://www.themednet.org/for-metastatic-and-bulky-locally-recurrent-carcinosarcoma-what-palliative-dose-would-you-deliver-to-the-pelvis-for-symptomatic-control weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-recommend-hypofractionated-radiation-for-bladder-cancer weekly 0.8 https://www.themednet.org/would-you-boost-a-positive-margin-r1-resection-or-r2-resection-in-a-gej-esophageal-carcinoma-that-completed-neoadjuvant-chemoradiation weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-woman-regarding-her-previous-hormonal-contraception-and-the-risks-with-her-newly-diagnosed-invasive-breast-cancer weekly 0.8 https://www.themednet.org/do-you-modify-the-duration-of-adjuvant-therapy-for-patients-with-colon-cancer-who-have-undergone-metastectomy-and-primary-tumor-resection weekly 0.8 https://www.themednet.org/beyond-pd-l1-when-would-you-consider-additional-molecular-testing-egfr-alk1-ros1-for-patients-with-squamous-cell-lung-cancers weekly 0.8 https://www.themednet.org/what-evidence-is-there-for-the-benefit-of-adjuvant-radiation-therapy-for-a-large-primary-thoracic-synovial-sarcoma-that-was-completely-resected weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-early-stage-ebv-positive-diffuse-large-b-cell-lymphoma-of-the-elderly-after-a-cr-to-systemic-therapy weekly 0.8 https://www.themednet.org/does-your-institution-omit-prophylactic-cranial-irradiation-in-high-risk-all-patients-greater-than-3-years-of-age weekly 0.8 https://www.themednet.org/how-would-you-treat-hgil-in-a-woman-with-a-history-of-early-stage-endometrial-cancer weekly 0.8 https://www.themednet.org/do-you-treat-adenocarcinoma-in-situ-ais-or-minimally-invasive-adenocarcinoma-mia-of-the-lung-with-sbrt-in-medically-inoperable-patients weekly 0.8 https://www.themednet.org/how-do-you-define-your-post-operative-treatment-volumes-for-a-patient-with-a-resected-high-grade-soft-tissue-sarcoma-of-the-soft-tissues-of-the-upper-back weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-a-locally-advanced-primary-tongue-scc-lesion-spanning-oral-cavity-and-base-of-tongue weekly 0.8 https://www.themednet.org/how-do-you-follow-patients-after-radiation-treatment-for-orbital-malt-lymphoma weekly 0.8 https://www.themednet.org/do-you-use-an-alternative-dosing-regimen-for-cdk4-6-inhibitor-in-patient-with-benign-ethnic-leukopenia weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-when-selecting-a-multi-fraction-vs-single-fraction-approach-for-treatment-of-spine-metastases-with-radiosurgery weekly 0.8 https://www.themednet.org/what-are-the-recommended-treatment-fields-for-desmoid-tumors weekly 0.8 https://www.themednet.org/do-you-pursue-testing-for-erbb2-mutations-in-patients-with-metastatic-breast-cancer-who-are-clinically-her2-negative-by-ihc-and-fish weekly 0.8 https://www.themednet.org/would-you-recommend-pmrt-in-a-patient-with-early-stage-breast-cancer-who-has-multicentric-disease-and-close-margins weekly 0.8 https://www.themednet.org/do-you-change-dose-and-fractionation-when-repeating-rt-for-heterotopic-ossification-prophylaxis weekly 0.8 https://www.themednet.org/how-are-you-using-the-data-on-cardiac-morbidity-in-regards-to-the-lv-v5-in-breast-cancer-patients weekly 0.8 https://www.themednet.org/how-would-you-treat-a-post-menopausal-woman-with-newly-diagnosed-pr-positive-er-negative-and-her-2-negative-metastatic-breast-cancer-with-germ-line-brca2-mutation weekly 0.8 https://www.themednet.org/how-do-you-manage-hpv-positive-squamous-cell-carcinoma-in-situ-of-the-oropharynx weekly 0.8 https://www.themednet.org/in-what-situations-do-you-recommend-preoperative-chemoradiation-for-gastric-cancer weekly 0.8 https://www.themednet.org/would-you-consider-aggressive-presentation-of-multiple-squamous-cell-carcinomas-of-the-skin-an-indication-for-treatment-of-cll weekly 0.8 https://www.themednet.org/is-there-any-mature-data-about-cognitive-outcomes-in-12-gy-vs-18-gy-in-the-setting-of-prophylactic-cranial-irradiation-for-all-in-children weekly 0.8 https://www.themednet.org/is-there-a-role-or-data-to-support-the-use-of-capecitabine-with-radiation-to-the-breast-axilla-in-a-metastatic-er-positive-breast-cancer-in-the-palliative-setting weekly 0.8 https://www.themednet.org/would-you-recommend-a-cycle-of-chemotherapy-prior-to-concurrent-chemoradiation-for-a-stage-iii-nsclc-patient-who-needs-to-start-treatment-sooner-than-allowed-by-the-imrt-planning-process weekly 0.8 https://www.themednet.org/how-do-you-decide-which-tyrosine-kinase-inhibitor-sunitinib-pazopanib-cabozantinib-to-use-in-the-first-line-setting-for-newly-diagnosed-metastatic-rcc weekly 0.8 https://www.themednet.org/what-is-the-best-strategy-after-initial-treatment-with-hypomethylating-agents-for-high-grade-myelodysplatic-syndromes-mainly-for-responders-who-became-transfusion-independent weekly 0.8 https://www.themednet.org/how-does-pelvic-radiation-impact-a-patient-with-a-known-iiliac-aneurysm weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-patient-with-breast-cancer-and-a-rad50-mutation-when-deciding-between-lumpectomy-and-radiation-vs-mastectomy weekly 0.8 https://www.themednet.org/would-you-recommend-apbi-in-a-suitable-candidate-if-they-have-pre-existing-breast-implants weekly 0.8 https://www.themednet.org/is-there-any-form-of-liquid-biopsy-that-can-detect-er-and-her-2-expression-for-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-adjuvant-capecitabine-for-a-very-small-amount-2-mm-ypt1a-of-residual-invasive-disease-in-tnbc-patients-following-neoadjuvant-chemotherapy-and-lumpectomy weekly 0.8 https://www.themednet.org/do-you-use-oral-etoposide-in-combination-with-carboplatin-for-small-cell-lung-cancer-in-light-of-the-national-shortage-of-iv-etoposide weekly 0.8 https://www.themednet.org/do-you-take-any-precautions-in-planning-pmrt-for-patients-who-had-taxane-induced-pneumonitis weekly 0.8 https://www.themednet.org/what-factors-other-than-resection-status-r1-2-do-you-consider-when-offering-adjuvant-chemotherapy-for-patients-with-thymic-carcinoma-and-how-do-you-coordinate-with-post-op-radiation weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-resected-stage-iia-adenocarcinoma-of-the-colon-in-an-elderly-but-highly-functional-patient weekly 0.8 https://www.themednet.org/how-does-a-sentinel-lymph-node-biopsy-versus-nodal-dissection-affect-your-treatment-decision-for-stage-ii-endometrial-cancer weekly 0.8 https://www.themednet.org/what-anal-squamous-cell-carcinoma-patients-if-any-do-you-take-to-59-4-gy weekly 0.8 https://www.themednet.org/what-is-the-role-of-upfront-pembrolizumab-in-metastatic-pd-l1-positive-nsclc-presenting-with-svc-syndrome weekly 0.8 https://www.themednet.org/what-dose-would-you-treat-a-patient-to-for-a-positive-deep-skeletal-muscle-margin-after-mastectomy-who-is-not-a-candidate-for-re-resection weekly 0.8 https://www.themednet.org/does-hiv-aids-change-your-management-of-locally-advanced-nsclc weekly 0.8 https://www.themednet.org/what-growth-factor-would-you-use-with-a-avd-if-any-at-all weekly 0.8 https://www.themednet.org/do-you-ever-consider-the-use-of-weekly-as-opposed-to-bi-weekly-bortezomib-for-newly-diagnosed-multiple-myeloma-patients-who-are-transplant-eligible weekly 0.8 https://www.themednet.org/is-it-necessary-to-hold-immunotherapy-during-a-4-6wk-steroid-taper-after-resolution-of-immunotherapy-related-toxicity weekly 0.8 https://www.themednet.org/how-do-you-decide-which-lab-to-use-for-multi-gene-hereditary-testing weekly 0.8 https://www.themednet.org/is-radiation-an-appropriate-alternative-for-a-patient-with-multiply-recurrent-cin-3-being-considered-for-hysterectomy-but-unable-to-be-medically-optimized-for-surgery weekly 0.8 https://www.themednet.org/how-do-you-approach-the-subsequent-management-of-a-patient-with-appendiceal-adenocarcinoma-t4bn2m1a-with-completely-resected-single-peritoneal-and-omental-deposits weekly 0.8 https://www.themednet.org/what-is-your-approach-to-genetic-testing-for-high-risk-patients-2 weekly 0.8 https://www.themednet.org/what-is-the-complication-profile-of-subpectoral-versus-sublgandular-implants-after-pmrt weekly 0.8 https://www.themednet.org/would-you-consider-observation-instead-of-a-whipple-in-a-borderline-resectable-pancreatic-cancer-patient-treated-with-neoadj-crt-who-has-a-radiographic-cr weekly 0.8 https://www.themednet.org/how-do-you-treat-a-young-woman-of-child-bearing-age-group-diagnosed-with-primary-cns-lymphoma weekly 0.8 https://www.themednet.org/do-you-ever-change-your-cns-radiation-recommendations-for-patients-with-multiple-sclerosis-ms weekly 0.8 https://www.themednet.org/do-somatostatin-based-therapies-have-any-role-in-treating-neuroendocrine-tumors-that-are-silent-on-octreotide-scanning weekly 0.8 https://www.themednet.org/is-there-a-role-for-pd-1-inhibitors-for-metastatic-or-locally-recurrent-cutaneous-squamous-cell-carcinomas-after-failure-of-first-line-therapy-egfr-inhibitors weekly 0.8 https://www.themednet.org/would-you-do-alnd-for-low-er-pos-1-10-her2-patient-with-positive-sentinel-lymph-nodes weekly 0.8 https://www.themednet.org/what-role-if-any-should-ki-67-play-in-decision-making-about-the-role-of-adjuvant-radiotherapy-in-patients-who-meet-calgb-9343-entry-criteria weekly 0.8 https://www.themednet.org/what-risk-factors-prompt-you-to-treat-an-early-stage-nasal-squamous-cell-carcinoma-of-the-skin-with-post-operative-radiation-to-the-primary-and-or-elective-nodal-radiation weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-scheme-do-you-prefer-for-retreatment-of-meningiomas-in-close-proximity-to-the-optic-structures weekly 0.8 https://www.themednet.org/how-do-you-decide-on-the-sequence-of-systemic-and-local-therapy-for-patients-with-oligometastatic-nsclc weekly 0.8 https://www.themednet.org/how-long-after-the-presentation-of-graves-ophthalmopathy-is-orbital-radiotherapy-helpful weekly 0.8 https://www.themednet.org/is-further-workup-and-management-required-for-an-incidentally-found-small-focus-of-neuroendocrine-tumor-of-the-endometrium weekly 0.8 https://www.themednet.org/how-do-you-approach-cns-prophylaxis-in-double-hit-lymphoma-patients weekly 0.8 https://www.themednet.org/what-dose-of-radiotherapy-do-you-use-for-low-volume-castlemans-disease weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-who-had-bilateral-mastectomies-for-a-bilateral-squamous-cell-carcinoma-of-the-breast-with-a-positive-lymph-node weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-primary-refractory-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-approach-boosting-a-distal-vaginal-tumor-residual-thickness-5mm-abutting-the-rectum weekly 0.8 https://www.themednet.org/when-do-you-combine-hypomethylating-agents-with-venetoclax-or-gemtuzumab-ozogamicin-in-elderly-patients-with-aml-who-are-ineligible-for-intensive-chemotherapy weekly 0.8 https://www.themednet.org/what-are-the-indications-for-adjuvant-radiation-for-a-resected-acinic-carcinoma-of-the-parotid weekly 0.8 https://www.themednet.org/if-a-man-has-been-on-a-5-alpha-reductase-inhibitor-for-urinary-symptoms-prior-to-prostate-radiation-therapy-is-there-value-in-continuing-it-after-radiation-therapy weekly 0.8 https://www.themednet.org/do-you-hold-maintenance-lenalidomide-or-bortezomib-for-a-patient-who-needs-a-surgery weekly 0.8 https://www.themednet.org/what-has-been-your-institutional-or-personal-experience-with-the-venezia-or-other-hybrid-interstitial-brachytherapy-applicators weekly 0.8 https://www.themednet.org/how-are-you-making-the-diagnosis-of-chronic-lymphocytic-leukemia-transforming-to-prolymphocytic-leukemia weekly 0.8 https://www.themednet.org/do-you-think-there-will-be-a-role-for-duvelisib-in-the-treatment-of-relapsed-refractory-chronic-lymphocytic-leukemia weekly 0.8 https://www.themednet.org/what-is-the-optimal-timing-of-adjuvant-chemotherapy-and-radiation-for-a-young-adult-with-a-grade-ii-oliogodendroglioma weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-chemotherapy-for-adenoid-cystic-carcinoma-of-breast-that-is-low-er-positive-early-stage-node-negative weekly 0.8 https://www.themednet.org/is-there-a-threshold-platelet-count-for-which-you-would-consider-holding-rt weekly 0.8 https://www.themednet.org/how-do-you-approach-breast-cancer-treatment-planning-for-patients-with-tissue-expanders-that-have-magnetic-valves-or-metal-ports weekly 0.8 https://www.themednet.org/how-would-you-manage-an-axillary-lymph-node-only-recurrence-after-prior-mastectomy-chemotherapy-and-hormone-therapy weekly 0.8 https://www.themednet.org/would-you-consider-stopping-chemotherapy-and-continuing-herceptin-alone-in-a-patient-with-metastatic-her2-positive-gej-cancer-who-had-a-complete-response-to-chemotherapy-and-herceptin weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-patient-with-a-history-of-breast-cancer-regarding-use-of-breast-mri-for-screening weekly 0.8 https://www.themednet.org/how-do-you-treat-pleomorphic-rhabdomyosarcoma-in-an-adult weekly 0.8 https://www.themednet.org/would-you-consolidate-marginal-zone-lymphoma-transformed-to-a-high-grade-b-cell-lymphoma-with-a-stem-cell-transplant weekly 0.8 https://www.themednet.org/for-multiple-myeloma-is-8-gy-in-1-fraction-an-appropriate-palliative-dose-although-this-histology-was-excluded-from-trials-examining-a-single-fraction weekly 0.8 https://www.themednet.org/how-do-you-minimize-the-risk-of-cardiotoxicity-in-metastatic-her2-breast-cancer-patients-who-are-receiving-trastuzumab-and-have-a-history-of-pre-existing-cardiac-disease weekly 0.8 https://www.themednet.org/what-volumes-do-you-treat-for-unresectable-tracheobronchial-cancer weekly 0.8 https://www.themednet.org/do-you-have-a-preferred-regimen-for-patients-with-her-2-positive-metastatic-breast-cancer-who-have-progressed-through-thp-followed-by-t-dm1 weekly 0.8 https://www.themednet.org/how-do-you-treat-diffuse-large-b-cell-lymphoma-in-a-patient-with-liver-cirrhosis-and-severe-thrombocytopenia-secondary-to-cirrhosis weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-for-high-risk-prostate-cancer-in-patients-who-need-clearance-for-organ-transplant-listing weekly 0.8 https://www.themednet.org/how-do-you-approach-radiation-treatment-planning-for-prostate-cancer-in-a-patient-with-microscopic-colitis weekly 0.8 https://www.themednet.org/how-do-you-balance-aspiration-risks-with-encouraging-po-intake-for-hn-cancer-patients-during-and-after-chemoradiation weekly 0.8 https://www.themednet.org/would-you-recommend-hypofractionation-in-breast-cancer-patients-who-had-partial-mastectomy-with-significant-oncoplasty weekly 0.8 https://www.themednet.org/in-a-patient-with-prostate-cancer-who-developed-prostatits-after-placement-of-fiducials-how-long-does-one-wait-before-initiating-radiation-treatments weekly 0.8 https://www.themednet.org/what-is-the-rate-of-a-cardiac-events-that-you-quote-to-a-patient-with-preexisting-heart-disease-going-on-trastuzumab-for-metastatic-her2-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-the-adjuvant-management-of-locally-advanced-pancreatic-neuroendocrine-tumor-s-p-resection-with-positive-margins-and-positive-lymph-nodes-high-lymph-node-ratio-lvi-low-grade-and-well-differentiated weekly 0.8 https://www.themednet.org/would-you-consider-primary-tumor-resection-in-a-patient-with-oligometastatic-colon-cancer-with-complete-metabolic-response-after-6-months-of-initial-chemotherapy weekly 0.8 https://www.themednet.org/do-you-give-3-or-4-cycles-of-hidac-during-consolidation-for-good-intermediate-risk-aml-without-an-available-allotransplant-donor weekly 0.8 https://www.themednet.org/how-do-you-manage-urgency-and-frequency-of-bowel-movements-secondary-to-radiation-proctitis weekly 0.8 https://www.themednet.org/how-do-you-optimize-hdr-brachytherapy-for-intracavitary-treatment-of-cervical-cancer weekly 0.8 https://www.themednet.org/what-is-the-recommended-management-for-a-large-unresectable-intracranial-hemangiopericytoma weekly 0.8 https://www.themednet.org/how-do-you-approach-a-lung-malignancy-with-a-single-pleural-nodule-near-a-primary weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-high-volume-metastatic-prostate-cancer-who-has-asymptomatic-biochemical-relapse-after-having-a-good-response-to-upfront-docetaxel weekly 0.8 https://www.themednet.org/would-you-de-escalate-therapy-for-a-prostate-cancer-that-is-barely-high-risk-and-has-only-1-of-12-cores-positive weekly 0.8 https://www.themednet.org/how-do-you-manage-early-stage-breast-cancer-in-patients-who-can-not-have-a-surgery weekly 0.8 https://www.themednet.org/which-of-the-many-possible-adjuvant-chemotherapy-regimens-do-you-prefer-for-a-fully-resected-extraskeletal-osteosarcoma weekly 0.8 https://www.themednet.org/what-would-your-rt-volumes-be-for-a-high-grade-sarcoma-of-a-joint-such-as-the-knee-after-a-gross-total-resection weekly 0.8 https://www.themednet.org/do-you-recommend-post-operative-radiation-therapy-for-gastric-cancer-after-pre-operative-chemotherapy-when-there-is-no-pathologic-response-to-chemotherapy weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-for-choosing-or-pointedly-not-choosing-parotid-sparing-with-imrt-in-patients-with-bilateral-neck-nodal-disease-from-a-mucosal-head-and-neck-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-smoldering-myeloma-that-has-a-quickly-rising-and-very-high-m-spike-6-g-dl-range weekly 0.8 https://www.themednet.org/how-if-at-all-has-the-new-dahanca-h-n-contouring-guidelines-changed-how-you-delineate-low-dose-ctv-ctv-p2-for-head-and-neck-cancer-primaries weekly 0.8 https://www.themednet.org/would-you-ever-recommend-resection-only-no-chemorads-for-a-t1n0-anal-canal-cancer weekly 0.8 https://www.themednet.org/would-you-add-elective-nodal-radiation-for-high-grade-myoepithelial-carcinoma-of-the-hard-palate-in-addition-to-adjuvant-radiation-of-the-post-operative-bed weekly 0.8 https://www.themednet.org/how-would-you-approach-a-completely-resected-dlbcl-of-the-appendix-if-pet-scan-and-bone-marrow-biopsy-suggest-no-other-disease weekly 0.8 https://www.themednet.org/would-you-avoid-radiation-in-a-patient-with-breast-cancer-with-active-skin-lupus weekly 0.8 https://www.themednet.org/what-dose-objectives-and-constraints-do-you-use-for-hypofractionateed-whole-breast-irradiation weekly 0.8 https://www.themednet.org/would-you-recommend-pmrt-in-a-male-patient-with-a-t2n0-breast-cancer weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-with-definitive-local-xrt-without-systemic-therapy-if-he-she-presents-with-pathology-showing-a-ptcl-nos-from-a-small-1-5-cm-lesion-of-the-skin-of-the-chin weekly 0.8 https://www.themednet.org/what-treatment-do-you-recommend-for-patients-with-siewert-iii-gastroesophageal-junction-cancer-with-periesophageal-or-mediastinal-lymph-node-involvement-beyond-what-is-considered-regional-for-gastric-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-resection-for-positive-anterior-or-posterior-margins-in-a-patient-s-p-mastectomy-if-the-surgeon-says-they-took-all-the-breast-tissue-anteriorly-to-the-skin-or-posteriorly-to-the-fascia weekly 0.8 https://www.themednet.org/what-are-your-radiotherapy-recommendations-for-a-unilateral-primary-intraocular-large-b-cell-lymphoma-following-high-dose-methotrexate-and-rituximab weekly 0.8 https://www.themednet.org/how-do-you-approach-previously-treated-grade-1-follicular-lymphoma-now-with-transformation-to-a-large-cell-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-locoregional-lymph-node-recurrence-after-radical-cystectomy-for-muscle-invasive-bladder-cancer weekly 0.8 https://www.themednet.org/what-would-you-recommend-for-pta-stage-0a-papillary-urothelial-carcinoma-of-the-distal-ureter weekly 0.8 https://www.themednet.org/how-would-you-treat-epithelial-myoepithelial-carcinoma-of-the-parotid-following-resection-with-clear-but-close-surgical-margins weekly 0.8 https://www.themednet.org/would-you-offer-preoperative-radiotherapy-for-muscle-invasive-scc-of-the-bladder-catheter-associated weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-patients-with-unresectable-paransasal-sinus-cancers-in-close-proximity-to-the-critical-structures-of-the-base-of-skull weekly 0.8 https://www.themednet.org/how-long-after-definitive-treatment-is-it-reasonable-to-consider-reconstruction-for-a-woman-with-inflammatory-breast-cancer weekly 0.8 https://www.themednet.org/have-you-used-immunotherapy-for-nsclc-in-a-patient-with-multiple-sclerosis weekly 0.8 https://www.themednet.org/which-systemic-therapy-would-you-use-to-treat-a-poorly-differentiated-round-cell-sarcoma-with-cic-dux4-gene-fusion weekly 0.8 https://www.themednet.org/would-you-consider-offering-adjuvant-chemotherapy-to-a-patient-with-hr-her2-t1c-disease-with-negative-axillary-lymph-nodes-but-with-a-positive-intramammary-node weekly 0.8 https://www.themednet.org/would-you-continue-consolidation-temozolomide-for-more-than-1-year-for-a-patient-with-grade-3-anaplastic-astrocytoma-after-gross-total-resection-and-daily-temozolomide-ebrt weekly 0.8 https://www.themednet.org/would-you-use-enzalutamide-concurrently-in-combination-with-radium-223 weekly 0.8 https://www.themednet.org/do-you-have-any-recommended-techniques-or-tips-for-palliative-radiation-to-a-digit-e-g-thumb weekly 0.8 https://www.themednet.org/do-you-ever-consider-alternate-dosing-strategies-for-hormone-directed-therapy-in-breast-cancer-patients-who-cannot-tolerate-these-drugs-despite-other-supportive-care-strategies weekly 0.8 https://www.themednet.org/what-is-your-preferred-dose-fractionation-regimen-for-ct1-t2n0-oropharynx-treated-with-radiation-alone weekly 0.8 https://www.themednet.org/do-you-treat-patients-with-metastatic-renal-cell-carcinoma-who-progress-on-first-line-tki-with-single-agent-nivolumab-or-the-combination-of-nivolumab-plus-ipilimumab weekly 0.8 https://www.themednet.org/how-would-you-treat-a-high-grade-sarcoma-of-the-breast weekly 0.8 https://www.themednet.org/are-there-subsets-of-patient-in-which-you-would-choose-chemotherapy-pembrolizumab-vs-pembrolizumab-monotherapy-in-metastatic-nsclc weekly 0.8 https://www.themednet.org/what-methods-do-you-use-to-decrease-genital-skin-reaction-when-delivering-pelvic-radiation-to-patients-in-the-prone-position weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-reirradiation-for-a-patient-with-recurrent-previously-irradiated-early-stage-laryngeal-cancer-now-s-p-salvage-laryngectomy weekly 0.8 https://www.themednet.org/is-there-a-situation-where-you-would-use-a-purine-analogue-in-combination-with-rituximab-for-the-frontline-line-treatment-of-normal-variant-hairy-cell-leukemia weekly 0.8 https://www.themednet.org/when-would-you-consider-treating-a-testicular-relapse-with-definitive-radiation-in-a-child-with-all weekly 0.8 https://www.themednet.org/is-eni-necessary-for-postoperative-treatment-of-clinically-n0-adenoid-cystic-carcinoma-of-the-head-and-neck weekly 0.8 https://www.themednet.org/would-you-consider-sbrt-for-a-retroperitoneal-sarcoma-with-an-r2-resection-near-critical-structures-precluding-re-resection weekly 0.8 https://www.themednet.org/what-dose-constraints-do-you-use-for-pituitary-in-a-young-woman-with-completely-resected-esthesioneuroblastoma weekly 0.8 https://www.themednet.org/for-pre-menopausal-patients-with-high-risk-er-disease-and-who-desire-pregnancy-what-is-the-best-time-frame-to-pause-endocrine-therapy-to-allow-for-pregnancy weekly 0.8 https://www.themednet.org/is-extensive-abutment-of-the-duodenum-without-invasion-a-contraindication-to-sbrt-for-pancreatic-tumors weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-electively-cover-ipsilateral-level-ib-or-v-in-a-node-positive-neck weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-in-a-patient-with-small-cell-lung-cancer-and-a-pericardial-effusion weekly 0.8 https://www.themednet.org/what-margins-ctv-and-ptv-do-you-use-for-boosting-breast-lumpectomy-cavity weekly 0.8 https://www.themednet.org/would-you-recommend-reirradiation-in-a-patient-who-has-extensive-subcutaneous-chest-wall-nodules-and-axillary-recurrence-after-previous-pmrt weekly 0.8 https://www.themednet.org/what-would-be-your-choice-of-endocrine-therapy-if-any-for-a-premenopausal-woman-with-an-er-positive-2nd-dcis-in-ipsilateral-breast-who-has-completed-5-years-of-tamoxifen-after-lumpectomy-of-1st-dcis weekly 0.8 https://www.themednet.org/can-the-cdk-4-6-inhibitors-be-used-in-patients-with-metastatic-breast-cancer-to-the-bone-marrow weekly 0.8 https://www.themednet.org/what-anatomical-sites-would-you-electively-cover-to-intermediate-dose-for-an-oropharyngeal-primary-with-clear-extension-into-the-nasopharynx weekly 0.8 https://www.themednet.org/what-is-your-recommended-dose-fractionation-when-treating-with-sbrt-for-a-non-spine-bone-metastasis weekly 0.8 https://www.themednet.org/what-postop-volume-would-you-treat-for-for-cutaneous-squamous-cell-carcinoma-of-the-upper-neck-with-perineural-invasion-of-multiple-nerves weekly 0.8 https://www.themednet.org/what-dose-constraint-s-would-you-use-for-a-patient-with-a-pelvic-kidney-transplant-getting-pelvic-rt weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-use-to-treat-a-single-large-melanoma-lung-metastasis weekly 0.8 https://www.themednet.org/how-would-you-treat-metastatic-malignant-peripheral-nerve-sheath-tumor-in-a-patient-who-received-adjuvant-adriamycin-240-mg-m2-10-years-ago-for-breast-cancer weekly 0.8 https://www.themednet.org/is-there-any-evidence-for-efficacy-of-using-a-parp-inhibitor-in-metastatic-triple-negative-breast-cancer-who-progressed-on-platinum-therapy-with-brca-2-variant-of-unknown-clinical-significance-on-molecular-testing weekly 0.8 https://www.themednet.org/is-adt-alone-appropriate-for-high-risk-prostate-cancer-patients-without-evidence-of-metastasis-and-limited-life-expectancy weekly 0.8 https://www.themednet.org/is-there-a-role-for-any-non-cisplatin-based-adjuvant-therapy-or-radiotherapy-in-absence-of-platinum-sensitizer-for-muscle-invasive-node-negative-bladder-cancer-after-radical-cystectomy weekly 0.8 https://www.themednet.org/what-palliative-systemic-treatment-options-if-any-may-be-considered-for-metastatic-adenocarcinoma-of-the-rete-testis weekly 0.8 https://www.themednet.org/what-are-the-anesthesia-risks-for-pediatric-patients-undergoing-radiation-treatments-given-its-repetitive-use-throughout-the-treatment-course weekly 0.8 https://www.themednet.org/how-can-i-be-an-editor-on-themednet weekly 0.8 https://www.themednet.org/in-the-setting-of-unresectable-ewings-sarcoma-in-an-adult-would-you-consider-boosting-to-a-higher-dose weekly 0.8 https://www.themednet.org/how-do-you-assess-the-risk-of-cardiotoxicity-from-her2-agents weekly 0.8 https://www.themednet.org/what-is-your-approach-to-women-with-early-stage-hormone-responsive-breast-cancer-intolerant-of-ais-who-want-to-remain-on-endocrine-therapy-but-have-contraindications-to-tamoxifen weekly 0.8 https://www.themednet.org/when-would-you-recommend-delaying-pmrt-until-after-breast-reconstruction-is-completed weekly 0.8 https://www.themednet.org/for-patients-with-her2-positive-breast-cancer-s-p-neoadjuvant-chemotherapy-with-tc-hp-who-did-not-have-a-complete-pathological-response-at-surgery-is-there-any-evidence-to-use-an-anthracycline-based-chemotherapy-after-the-surgery weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-recommend-for-large-5-cm-perianal-bowens-disease-squamous-cell-cis weekly 0.8 https://www.themednet.org/does-proximity-to-or-involvement-of-the-aorta-effect-the-dose-and-fractionation-you-use-for-an-early-stage-nsclc weekly 0.8 https://www.themednet.org/what-is-the-best-dose-to-treat-splenomegaly-with-pancytonenia-in-the-setting-of-myelofibrosis weekly 0.8 https://www.themednet.org/is-there-a-difference-in-the-durability-of-cr-based-on-the-dosage-of-pembrolizumab-used-in-metastatic-melanoma weekly 0.8 https://www.themednet.org/would-you-consider-catheter-based-apbi-in-the-setting-of-a-recurrent-stage-i-breast-cancer-in-a-patient-who-has-received-whole-breast-radiotherapy-and-is-refusing-mastectomy weekly 0.8 https://www.themednet.org/how-do-you-chose-the-starting-dose-of-capecitabine weekly 0.8 https://www.themednet.org/are-you-considering-the-use-of-circulating-tumor-dna-or-circulating-tumor-cell-count-to-make-clinical-decisions-in-the-adjuvant-setting-after-colon-cancer-resection weekly 0.8 https://www.themednet.org/is-nf1-an-absolute-contraindication-to-intracranial-radiation-in-pediatric-gliomas weekly 0.8 https://www.themednet.org/can-denosumab-be-given-every-3-months weekly 0.8 https://www.themednet.org/how-do-you-manage-systemic-therapy-with-srs-for-brain-or-spine-metastases weekly 0.8 https://www.themednet.org/when-do-you-recommend-postoperative-radiation-therapy-for-a-ureter-carcinoma weekly 0.8 https://www.themednet.org/what-are-the-indications-for-adjuvant-radiotherapy-for-basal-cell-carcinoma-of-the-skin-of-the-head-and-neck weekly 0.8 https://www.themednet.org/what-factors-might-influence-your-initial-treatment-decision-of-oligometastatic-nsclc-assuming-good-performance-status-lack-of-actionable-mutation-and-pd-l1-status-50 weekly 0.8 https://www.themednet.org/how-do-you-manage-a-soft-tissue-sarcoma-arising-from-neurofibromas-nf1 weekly 0.8 https://www.themednet.org/when-do-you-use-immunotherapy-with-msi-high-advanced-colorectal-cancer weekly 0.8 https://www.themednet.org/is-there-a-role-for-radiation-therapy-if-squamous-cell-carcinoma-scc-is-incidentally-found-in-an-excised-epidermoid-cyst weekly 0.8 https://www.themednet.org/how-would-you-manage-a-recurrent-chest-wall-desmoid-tumor weekly 0.8 https://www.themednet.org/is-there-any-data-to-support-the-combination-of-a-cdk-4-6-inhibitor-with-tamoxifen weekly 0.8 https://www.themednet.org/how-does-your-management-of-locally-advanced-nsclc-change-in-a-patient-with-a-previous-contralateral-pneumonectomy weekly 0.8 https://www.themednet.org/in-what-scenario-would-you-prefer-to-use-every-two-weeks-paclitaxel-over-weekly-paclitaxel-in-the-adjuvant-treatment-of-breast-cancer weekly 0.8 https://www.themednet.org/what-is-the-role-of-neoadjuvant-breast-radiation-in-patients-with-triple-negative-breast-cancer-progressing-on-ac-t weekly 0.8 https://www.themednet.org/how-long-after-achieving-a-cr-would-you-consider-stopping-pembrolizumab-in-metastatic-melanoma weekly 0.8 https://www.themednet.org/would-you-consider-stopping-nivo-ipi-combination-after-a-cr-in-a-patient-with-metastatic-melanoma weekly 0.8 https://www.themednet.org/would-you-hold-immunotherapy-if-a-patient-with-metastatic-melanoma-has-stable-disease-for-6-months weekly 0.8 https://www.themednet.org/what-is-the-your-choice-of-treatment-after-progression-or-ae-following-pembrolizumab-in-metastatic-melanoma weekly 0.8 https://www.themednet.org/do-you-routinely-offer-adjuvant-whole-pelvis-and-or-extended-field-radiation-therapy-for-lymph-node-positive-undifferentiated-uterine-sarcoma-with-positive-pelvic-and-para-aortic-lymph-nodes-respectively-after-complete-surgical-staging weekly 0.8 https://www.themednet.org/how-would-you-manage-papillary-variant-squamous-cell-carcinoma-of-the-oropharynx weekly 0.8 https://www.themednet.org/how-do-you-treat-localized-esophageal-carcinoma-in-patients-who-are-unwilling-or-unable-to-undergo-chemotherapy-or-surgery weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-to-the-treatment-of-transplant-ineligible-multiple-myeloma-that-has-been-treated-with-a-triplet-regimen-and-reached-a-plateau-phase weekly 0.8 https://www.themednet.org/what-brain-surveillance-imaging-frequency-do-you-recommend-for-srs-patients-as-they-reach-beyond-a-year-of-disease-control weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-whole-brain-radiotherapy-in-a-patient-who-has-previously-received-2-or-more-courses-of-srs-to-overlapping-sites weekly 0.8 https://www.themednet.org/would-you-use-herceptin-with-chemotherapy-in-a-patient-with-metastatic-gastric-cancer-that-is-her2-negative-but-erbb3-positive weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-will-undergo-external-beam-radiation-regarding-complications-with-breast-implants-from-previous-breast-augmentation weekly 0.8 https://www.themednet.org/what-is-the-role-of-ebrt-brachytherapy-as-an-addition-to-chemotherapy-in-the-adjuvant-management-of-optimally-debulked-stage-iv-uterine-serous-carcinoma weekly 0.8 https://www.themednet.org/what-is-your-target-volume-for-a-recurrent-low-grade-meningioma-previously-treated-with-surgical-resection-alone weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-newly-diagnosed-plasma-cell-leukemia weekly 0.8 https://www.themednet.org/when-do-you-use-amifostine-in-head-and-neck-cancers weekly 0.8 https://www.themednet.org/would-you-recommend-apbi-in-an-otherwise-suitable-candidate-who-is-undergoing-chemotherapy weekly 0.8 https://www.themednet.org/what-do-you-advise-young-low-risk-pre-menopausal-patients-requiring-adjuvant-hormonal-therapy-who-have-endometriosis-and-are-worried-about-the-effects-of-tamoxifen weekly 0.8 https://www.themednet.org/do-you-offer-pci-for-resected-mixed-histology-lung-cancers-with-a-minor-component-of-small-cell weekly 0.8 https://www.themednet.org/do-you-routinely-do-imaging-on-patients-to-look-for-intrathoracic-or-abdominal-lymphadenopathy-in-newly-diagnosed-patients-with-cll weekly 0.8 https://www.themednet.org/what-is-your-treatment-algorithm-for-solitary-hepatocellular-carcinoma-3-5-cm-non-operative-candidate-but-child-turcotte-pugh-a-b weekly 0.8 https://www.themednet.org/what-are-your-treatment-volumes-for-patients-with-gastric-cancer-receiving-adjuvant-chemort-for-a-positive-margin-following-gastrectomy-and-d2-nodal-dissection weekly 0.8 https://www.themednet.org/how-would-you-approach-systemic-therapy-in-a-postmenopausal-female-with-previous-early-stage-er-pr-positive-idc-on-anastrozole-with-new-isolated-metastatic-disease-that-remains-strongly-er-pr-positive weekly 0.8 https://www.themednet.org/would-you-consider-pci-for-a-patient-with-neuroendocrine-carcinoma-of-the-esophagus weekly 0.8 https://www.themednet.org/what-level-of-24h-urine-m-protein-do-you-consider-to-define-active-myeloma-in-a-patient-with-renal-insufficiency-proteinuria-and-monoclonal-gammopathy weekly 0.8 https://www.themednet.org/in-the-setting-of-an-atypical-lipoma-well-differentiated-liposarcoma-of-the-extremity-with-a-small-component-of-dedifferentiated-liposarcoma-is-it-necessary-to-treat-the-entire-mass-with-neoadjuvant-radiotherapy-or-just-the-dedifferentiated-component-that weekly 0.8 https://www.themednet.org/what-is-the-maximum-number-of-metastatic-sites-you-would-treat-with-consolidative-radiation-for-a-patient-with-high-risk-neuroblastoma weekly 0.8 https://www.themednet.org/given-the-criticism-of-gog-88-and-in-light-of-various-other-recent-data-would-you-deliver-definitive-xrt-in-place-of-inguinal-lymph-node-dissection weekly 0.8 https://www.themednet.org/how-do-you-approach-endometrial-cancer-in-the-setting-of-multiple-pelvic-lymph-nodes-with-itcs-and-or-micromets-but-no-macrometastasis weekly 0.8 https://www.themednet.org/what-treatment-do-you-recommend-for-marginal-zone-lymphoma-in-a-patient-who-previously-received-bendamustine-and-rituximab-for-malt weekly 0.8 https://www.themednet.org/would-you-ever-recommend-radiation-alone-for-a-t1n0-anal-cancer weekly 0.8 https://www.themednet.org/would-you-ever-treat-the-internal-mammary-lymph-nodes-in-a-high-risk-patient-who-is-axillary-sentinel-lymph-node-negative weekly 0.8 https://www.themednet.org/what-are-some-preferred-steroid-sparing-regimens-for-untreated-multiple-myeloma-patients-who-have-type-1-diabetes-mellitus weekly 0.8 https://www.themednet.org/does-the-location-of-tissue-expander-and-implant-pre-pectoral-vs-post-pectoral-have-any-impact-on-outcomes-in-patients-treated-with-postmastectomy-radiation weekly 0.8 https://www.themednet.org/how-do-you-manage-non-mucinous-metastatic-appendiceal-adenocarcinoma weekly 0.8 https://www.themednet.org/how-will-you-decide-between-mfolfirinox-vs-gemcitabine-capecitabine-for-resected-pancreatic-cancer-patients weekly 0.8 https://www.themednet.org/would-you-consider-breast-radiation-in-patients-with-atypical-ductal-hyperplasia-bordering-on-low-grade-dcis weekly 0.8 https://www.themednet.org/how-do-you-counsel-treat-a-locally-advanced-stage-iib-cervix-cancer-while-patient-is-12-weeks-pregnant weekly 0.8 https://www.themednet.org/would-you-consider-apbi-in-an-otherwise-suitable-patient-who-has-itc-in-a-sentinel-lymph-node weekly 0.8 https://www.themednet.org/how-would-you-approach-locally-advanced-bladder-cancer-in-a-patient-on-hemodialysis weekly 0.8 https://www.themednet.org/would-you-consider-first-line-therapy-with-pd-1-inhibitors-ctla4-for-patients-with-metastatic-nsclc-with-high-tumor-mutational-burden-despite-negative-pd-l1 weekly 0.8 https://www.themednet.org/what-is-your-strategy-for-assessment-of-mutations-from-a-liquid-biopsy-in-metastatic-breast-cancer-that-has-progressed-on-multiple-therapies weekly 0.8 https://www.themednet.org/are-total-abdominal-radical-hysterectomies-preferred-over-laparoscopic-hysterectomies-in-early-cervical-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-emergence-of-egfr-c797s-mutation-at-the-time-of-progression-on-osimertinib-given-for-egfr-t790m-mutation weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-who-presented-with-synchronous-squamous-cell-carcinoma-of-the-anus-ct2n0-and-adenocarcinoma-of-the-rectum-ct3n0-at-7cm-from-the-anal-verge weekly 0.8 https://www.themednet.org/what-is-the-role-of-adjuvant-systemic-chemotherapy-in-patients-previously-resected-nsclc-now-with-isolated-solitary-relapsed-brain-lesion-treated-with-resection-and-sbrt weekly 0.8 https://www.themednet.org/how-do-you-approach-an-avl-atypical-vascular-lesion-of-the-breast weekly 0.8 https://www.themednet.org/what-is-your-recommended-dose-and-treatment-volume-for-multifocal-glioblastoma-involving-the-bilateral-cerebral-hemispheres weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-relapsed-subcutaneous-panniculitis-like-t-cell-lymphoma weekly 0.8 https://www.themednet.org/for-patients-at-high-risk-of-breast-cancer-do-you-recommend-tomosynthesis-over-traditional-two-view-screening-mammogram-2 weekly 0.8 https://www.themednet.org/for-a-patient-with-metastatic-castration-resistant-prostate-cancer-to-the-bones-with-rising-psa-but-no-evidence-of-radiographic-or-symptomatic-progression-would-you-continue-with-the-same-treatment-or-change-therapy-based-on-biochemical-progression weekly 0.8 https://www.themednet.org/how-do-you-manage-adjuvant-hormonal-therapy-in-a-patient-with-high-risk-prostate-cancer-who-already-received-prolonged-neoadjuvant-adt-prior-to-being-referred-for-radiation weekly 0.8 https://www.themednet.org/how-do-you-determine-which-her-2-positive-patients-should-receive-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/do-you-have-a-size-limitation-e-g-3cm-for-offering-srs-for-pituitary-adenomas-if-oar-tolerances-can-otherwise-be-respected weekly 0.8 https://www.themednet.org/how-do-you-approach-local-control-in-intermediate-risk-bladder-rhabdomyosarcoma-in-very-young-24-months-children weekly 0.8 https://www.themednet.org/what-neoadjuvant-chemotherapy-regimen-would-you-choose-for-a-young-patient-with-her2-positive-breast-cancer-with-reduced-ejection-fraction weekly 0.8 https://www.themednet.org/how-do-you-manage-a-locally-advanced-hormone-receptor-positive-invasive-ductal-carcinoma-with-neuroendocrine-small-cell-features weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-a-very-large-adenocarcinoma-of-the-rectum-10-cm-that-extends-to-the-anal-verge-with-positive-peri-rectal-and-inguinal-lymph-nodes-but-no-distant-organ-involvement weekly 0.8 https://www.themednet.org/is-alnd-required-in-all-patient-with-clinically-positive-axillary-nodes weekly 0.8 https://www.themednet.org/is-there-a-role-for-prophylactic-cranial-irradiation-in-patients-with-nsclc weekly 0.8 https://www.themednet.org/what-approach-would-you-take-for-patients-with-metastatic-castration-resistant-prostate-cancer-with-marked-psa-response-undetectable-on-docetaxel-but-radiographic-progression-in-bone-metastases weekly 0.8 https://www.themednet.org/how-would-you-advise-a-woman-who-had-a-full-axillary-lymph-node-dissection-on-the-risk-of-lymphedema-with-mountain-climbing weekly 0.8 https://www.themednet.org/in-light-of-portec-3-and-gog-249-data-do-you-use-adjuvant-radiation-therapy-alone-in-stage-ib-serous-endometrial-carcinoma weekly 0.8 https://www.themednet.org/do-you-wait-until-a-ureteral-stent-is-placed-to-plan-a-locally-advanced-cervical-cancer-with-hydronephrosis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-use-of-carmustine-wafers-for-glioma-patients weekly 0.8 https://www.themednet.org/how-do-you-fractionate-sbrt-for-nsclc-abutting-the-chest-wall-or-in-which-the-ptv-encompasses-part-of-the-chest-wall weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-a-3-5-cm-squamous-cell-carcinoma-of-the-perianus-with-no-involvement-of-the-anal-canal-with-a-positive-inguinal-node weekly 0.8 https://www.themednet.org/what-kidney-dose-constraints-do-you-use-for-extended-field-radiation-for-cervical-cancer-using-vmat-or-imrt weekly 0.8 https://www.themednet.org/if-you-decide-to-discontinue-tki-after-prolonged-molecular-remission-in-cml-how-often-would-you-follow-the-bcr-abl-after-discontinuation weekly 0.8 https://www.themednet.org/how-would-you-treat-a-synchronous-anal-and-oropharyngeal-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-a-h-o-hsil-vain3-and-recent-colposcopic-vaginal-biopsies-highly-concerning-for-exophytic-pattern-squamous-cell-carcinoma-refusing-vaginectomy weekly 0.8 https://www.themednet.org/what-factors-do-you-use-to-decide-between-phase-based-vs-amplitude-based-gating-for-lung-sbrt weekly 0.8 https://www.themednet.org/in-light-of-the-recently-published-carmena-trial-is-there-still-a-role-for-cytoreductive-nephrectomy-in-metastatic-rcc-patients weekly 0.8 https://www.themednet.org/does-keynote-189-establish-combination-chemotherapy-immunotherapy-as-the-standard-of-care-for-stage-iv-lung-adenocarcinoma weekly 0.8 https://www.themednet.org/what-is-your-current-preferred-approach-in-the-management-of-metasatic-sarcomatoid-nsclc weekly 0.8 https://www.themednet.org/when-treating-younger-men-with-anal-cancer-do-you-consider-dose-to-the-prostate weekly 0.8 https://www.themednet.org/how-do-you-manage-vaginal-dehiscence-discovered-during-vaginal-brachytherapy weekly 0.8 https://www.themednet.org/would-you-recommend-modification-of-radiation-dose-or-fields-in-a-breast-cancer-patient-in-which-radiation-is-recommended-who-has-had-prior-total-body-irradation weekly 0.8 https://www.themednet.org/in-which-patients-with-stage-iv-nsclc-and-pd-l1-tps-50-plus-concomitant-autoimmune-disease-is-it-consider-safe-to-give-immune-checkpoint-blockers weekly 0.8 https://www.themednet.org/aside-from-ece-or-positive-surgical-margins-when-if-ever-would-you-offer-post-operative-chemoradiation-in-patients-with-squamous-cell-cancer-of-the-head-and-neck weekly 0.8 https://www.themednet.org/do-you-utilize-urethral-catheterization-at-the-time-of-simulation-for-prostate-sbrt-planning weekly 0.8 https://www.themednet.org/in-what-situations-would-you-treat-elective-regional-lymph-nodes-for-a-squamous-cell-carcinoma-of-the-skin-on-the-extremity-trunk-that-was-clinically-node-negative weekly 0.8 https://www.themednet.org/what-is-an-appropriate-dose-for-definitive-radiation-of-a-stage-ie-ebv-polymorphic-b-cell-lymphoproliferative-disorder weekly 0.8 https://www.themednet.org/how-are-you-using-the-decipher-score-in-the-definitive-setting-for-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-incorporate-carboplatin-into-the-treatment-for-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-treat-non-resectable-carcinoid-of-the-thymus weekly 0.8 https://www.themednet.org/if-a-patient-develops-intermittent-painless-hematuria-during-standard-prostate-rt-do-you-attribute-this-to-cystitis-or-would-you-work-it-up-further weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-is-safe-to-use-for-palliation-of-a-large-pelvic-mass-several-years-after-definitive-prostate-brachytherapy weekly 0.8 https://www.themednet.org/would-you-offer-imatinib-to-a-patient-with-a-high-risk-gist-10-cm-low-ki-67-s-p-complete-resection-who-initially-declined-adjuvant-therapy-but-is-now-interested-14-months-post-surgery weekly 0.8 https://www.themednet.org/how-do-you-advise-women-who-are-at-high-risk-for-breast-cancer-and-for-whom-annual-screening-breast-mris-are-recommended-regarding-the-long-term-risks-of-gadolinium-contrast weekly 0.8 https://www.themednet.org/how-long-do-you-continue-low-dose-ct-screening-for-lung-cancer weekly 0.8 https://www.themednet.org/how-do-you-decide-between-nivolumab-ipilimumab-and-pembrolizumab-or-nivolumab-monotherapy-in-later-lines-of-msi-h-colorectal-cancer weekly 0.8 https://www.themednet.org/does-cd5-positivity-by-itself-in-dlbcl-pose-a-high-risk-of-cns-recurrence-and-necessitate-cns-prophylaxis weekly 0.8 https://www.themednet.org/how-do-you-manage-vaginal-necrosis-after-pelvic-radiation weekly 0.8 https://www.themednet.org/does-size-influence-your-decision-making-for-women-with-low-or-low-intermediate-risk-endometrial-cancer-after-hysterectomy weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-a-non-castrate-testosterone-level-and-rising-psa-despite-receiving-lhrh-agonist-therapy weekly 0.8 https://www.themednet.org/when-is-adjuvant-radiotherapy-recommended-for-a-high-risk-squamous-cell-carcinoma-of-the-skin-non-h-n-if-the-tumor-is-resected-with-widely-negative-margins-and-there-is-no-perineural-invasion weekly 0.8 https://www.themednet.org/is-there-a-role-for-ddr-gene-mutation-or-tumor-mutation-burden-load-in-predicting-response-to-immunotherapy-in-urothelial-cancer weekly 0.8 https://www.themednet.org/is-there-any-data-on-the-use-of-parp-inhibitors-in-patients-with-metastatic-urothelial-carcinoma-with-deleterious-ddr-mutations weekly 0.8 https://www.themednet.org/does-anything-need-to-be-done-if-hyperlymphocytosis-i-e-alc-300k-develops-in-a-cll-patient-just-starting-ibrutinib weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-to-therapy-in-transplant-ineligible-multiple-myeloma-initially-treated-with-cybord-owing-to-acute-renal-failure-after-achieving-a-vgpr-ife-alone-with-continued-mild-moderate-renal-impairment weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-biopsy-proven-recurrent-urothelial-bladder-cancer-with-m1a-disease-limited-to-retroperitoneal-nodal-disease weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-therapy-for-advanced-nsclc-with-an-egfr-activating-mutation weekly 0.8 https://www.themednet.org/what-is-your-systemic-therapy-approach-to-women-with-isolated-local-recurrences-of-hormone-receptor-positive-breast-cancer weekly 0.8 https://www.themednet.org/is-it-safe-and-or-necessary-to-combine-osimertinib-and-carboplatin-paclixel-for-a-patient-with-stage-iv-egfr-mutated-nsclc-and-advanced-ovarian-carcinoma weekly 0.8 https://www.themednet.org/do-you-recommend-sending-oncotype-for-bilateral-synchronous-primary-er-breast-cancers weekly 0.8 https://www.themednet.org/is-there-anything-you-use-for-patients-with-anticipatory-nausea-who-has-failed-ativan-and-zyprexa weekly 0.8 https://www.themednet.org/what-fractionation-would-you-recommend-in-a-patient-with-recurrent-early-stage-breast-cancer-who-has-had-prior-lumpectomy-and-iort-and-refuses-mastectomy weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-electing-to-observe-small-brain-metastases-vs-treating-with-srs weekly 0.8 https://www.themednet.org/how-do-you-treat-duodenal-adenocarcinoma-when-using-primary-chemoradiation-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-young-patient-with-a-prior-er-her2-breast-ca-now-local-recurrence-that-now-has-her2-positive-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-for-treating-oligometastatic-head-and-neck-cancer-in-patients-with-a-good-performance-status weekly 0.8 https://www.themednet.org/would-you-offer-radiation-therapy-to-a-nf-1-patient-with-a-painful-and-unresectable-neurofibroma-of-the-head-and-neck weekly 0.8 https://www.themednet.org/at-what-field-size-would-you-consider-splitting-a-palliative-spine-treatment-into-two-different-courses weekly 0.8 https://www.themednet.org/do-you-routinely-add-eight-extra-rituximab-doses-to-six-cycles-of-r-chop-in-elderly-patients-with-dlbcl-treated-with-minir-chop-as-done-in-smarte-r-chop-14-trial weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-a-history-of-er-breast-cancer-over-10-years-ago-now-presenting-with-an-er-loco-regional-recurrence-while-still-on-tamoxifen weekly 0.8 https://www.themednet.org/what-is-your-strategy-for-image-surveillance-for-occult-breast-cancer-after-treatment weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-for-a-patient-with-locally-advanced-nsclc-and-systemic-scleroderma-if-chemoradiation-is-their-only-curative-option weekly 0.8 https://www.themednet.org/how-do-you-interpret-and-manage-discordant-her2-in-idc-breast-cancer-between-primary-tumor-and-lymph-nodes weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-in-recurrent-localized-rectal-mucinous-adenocarcinoma weekly 0.8 https://www.themednet.org/would-you-recommend-10-years-instead-of-5-years-of-tamoxifen-in-a-premenopausal-woman-with-early-stage-node-negative-er-pr-her2-positive-breast-cancer weekly 0.8 https://www.themednet.org/do-you-routinely-offer-ovarian-suppression-in-addition-to-aromatase-inhibitor-in-premenopausal-patients-under-50-with-an-intermediate-oncotype-score-11-25 weekly 0.8 https://www.themednet.org/when-do-you-recommend-endocrine-therapy-for-chemoprevention-in-women-with-high-risk-benign-breast-lesions weekly 0.8 https://www.themednet.org/do-you-recommend-routine-dental-evaluation-for-all-patients-before-starting-bisphosponates-in-patients-with-bone-metastases weekly 0.8 https://www.themednet.org/is-carboplatin-pemetrexed-as-effective-as-cisplatin-pem-in-treatment-of-unresectable-malignant-pleural-mesothelioma-in-a-patient-with-contraindication-to-cisplatin weekly 0.8 https://www.themednet.org/what-is-your-preferred-induction-regimen-prior-to-allo-hct-for-mantle-cell-lymphoma weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-treatment-for-patients-with-high-risk-mds-who-are-not-candidates-for-transplant weekly 0.8 https://www.themednet.org/when-in-the-treatment-algorithm-for-pancreatic-gi-net-do-you-recommend-interferon weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-metastatic-prostate-cancer-who-does-not-acheive-a-psa-response-to-upfront-adt weekly 0.8 https://www.themednet.org/is-concurrent-intrathecal-therapy-necessary-with-hd-mtx-for-cns-lymphoma weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-head-and-neck-squamous-cell-carcinoma-and-adverse-features-with-borderline-renal-function-in-the-adjuvant-setting weekly 0.8 https://www.themednet.org/is-there-any-evidence-to-treat-the-primary-breast-tumor-with-local-therapy-after-a-radiographic-cr-with-systemic-therapy-for-stage-iv-disease weekly 0.8 https://www.themednet.org/is-there-any-reason-to-switch-endocrine-therapy-after-a-patient-undergoes-bilateral-oophorectomy weekly 0.8 https://www.themednet.org/would-you-consider-using-a-pd-l1-inhibitor-after-progression-on-a-pd-1-inhibitor-for-metastatic-nsclc weekly 0.8 https://www.themednet.org/is-it-routine-to-check-imaging-during-or-after-neoadjuvant-chemotherapy-for-breast-cancer-to-assess-for-a-radiographic-response weekly 0.8 https://www.themednet.org/what-volume-would-you-cover-for-hpv-positive-scc-of-level-ib-node-with-ece weekly 0.8 https://www.themednet.org/how-do-you-manage-focal-dcis-in-mammoplasty-specimen weekly 0.8 https://www.themednet.org/what-is-the-standard-of-care-if-any-for-pediatric-desmoplastic-round-cell-tumor weekly 0.8 https://www.themednet.org/regarding-adjuvant-therapy-for-resected-gist-how-do-you-select-patients-for-adjuvant-therapy-or-not-when-the-risk-is-intermediate-by-the-nih-criteria-and-low-by-the-nccn-cap-criteria weekly 0.8 https://www.themednet.org/for-patients-doing-well-on-targeted-therapies-alectinib-osimertinib-for-metastatic-nsclc-what-data-guidelines-do-you-use-to-decide-about-holding-treatment-before-after-surgical-procedures weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-would-you-recommend-for-treating-the-primary-site-of-a-patient-with-metastatic-anal-melanoma weekly 0.8 https://www.themednet.org/how-do-you-monitor-patients-with-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/would-you-use-paclitaxel-and-trastuzumab-in-er-negative-her2neu-breast-cancer-with-micrometastases-in-a-single-node weekly 0.8 https://www.themednet.org/how-would-you-treat-a-woman-with-an-isolated-vaginal-cuff-recurrence-from-endometrial-cancer-who-has-received-salvage-resection weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-metastatic-disease-involving-the-brainstem-or-cervical-spinal-cord-in-the-setting-of-prior-xrt weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-to-ameliorate-bone-pain-from-g-csf weekly 0.8 https://www.themednet.org/can-olaparib-be-given-with-endocrine-therapy-in-a-metastatic-brca-mutated-er-breast-cancer-patient weekly 0.8 https://www.themednet.org/for-a-patient-with-diffuse-large-b-cell-lymphoma-of-the-testicle-do-you-irradiate-the-contralateral-testicle-alone-or-do-you-recommend-radiation-to-the-lymphatics-and-remaining-testicle weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-bilateral-renal-cell-carcinomas weekly 0.8 https://www.themednet.org/what-types-of-supportive-care-do-you-offer-patients-undergoing-definitive-therapy-for-their-head-and-neck-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-anejaculation-following-definitive-radiation-for-prostate-cancer weekly 0.8 https://www.themednet.org/what-would-be-your-second-line-approach-for-a-patient-with-msi-h-metastatic-colon-cancer-who-progressed-on-first-line-chemotherapy weekly 0.8 https://www.themednet.org/should-a-patient-be-given-extended-endocrine-therapy-if-she-was-on-a-lower-dose-than-recommended-for-part-of-her-treatment weekly 0.8 https://www.themednet.org/for-women-who-have-had-either-embryo-or-oocyte-cryopreservation-do-you-also-recommend-administering-gnrh-analogs weekly 0.8 https://www.themednet.org/is-there-a-subset-of-breast-cancer-patients-who-may-benefit-more-from-gnrh-analogs-for-fertility-preservation-compared-to-others weekly 0.8 https://www.themednet.org/how-do-you-determine-the-optimal-duration-of-bevacizumab-therapy-for-treatment-of-brain-radionecrosis-following-srs weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-limited-stage-dlbcl-of-the-colon weekly 0.8 https://www.themednet.org/how-would-you-treat-indeterminate-non-pet-avid-sub-cm-common-iliac-nodes-in-a-patient-with-locally-advanced-cervical-cancer weekly 0.8 https://www.themednet.org/would-you-recommend-pmrt-in-a-patient-with-dermal-invasion-as-the-sole-adverse-feature-after-a-skin-sparing-mastectomy-for-an-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/what-would-you-recommend-as-a-subsequent-therapy-for-patients-with-ros-1-gene-re-arrangement-after-progression-on-crizotinib weekly 0.8 https://www.themednet.org/when-would-you-consider-neoadjuvant-immunotherapy-for-advanced-melanoma weekly 0.8 https://www.themednet.org/when-do-you-consider-preoperative-chemort-v-chemotherapy-in-unresectable-thymoma-or-thymic-carcinoma weekly 0.8 https://www.themednet.org/what-are-your-recommendation-for-vaccines-in-patients-while-on-immunotherapy weekly 0.8 https://www.themednet.org/how-would-you-treat-an-elderly-transplant-ineligible-patient-with-recurrent-dlbcl weekly 0.8 https://www.themednet.org/what-is-the-role-for-maintenance-lenalidomide-in-elderly-patients-with-dlbcl weekly 0.8 https://www.themednet.org/does-isolated-del-5q-have-the-same-prognostic-implications-for-post-pv-secondary-myelofibrosis-as-it-does-in-mds weekly 0.8 https://www.themednet.org/how-do-you-manage-a-breast-cancer-patient-with-discordance-in-hormone-receptor-status-with-ihc-and-oncotype weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-stage-iii-colon-cancer-t2n1-in-an-elderly-patient-with-a-good-ps weekly 0.8 https://www.themednet.org/how-would-you-approach-a-locally-recurrent-unresectable-due-to-copd-nsclc-that-is-ros1-positive weekly 0.8 https://www.themednet.org/would-you-consider-160-mg-of-osimertinib-as-opposed-to-80-mg-for-adenocarcinoma-lung-with-leptomeningeal-metastasis weekly 0.8 https://www.themednet.org/what-would-be-your-next-line-of-treatment-for-nsclc-adenocarcinoma-that-has-recurred-after-chemoradiation-with-cis-etoposide weekly 0.8 https://www.themednet.org/how-would-you-approach-risk-stratification-staging-of-a-extra-gonadal-germ-cell-tumor-with-both-mediastinal-and-retroperitoneal-lymphadenopathy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-in-regards-to-the-options-and-risks-for-salvage-lobectomy-wedge-after-sbrt weekly 0.8 https://www.themednet.org/what-is-the-role-of-braftovi-encorafenib-and-mektovi-binimetinib-in-combination-for-unresectable-or-metastatic-melanoma weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-multiple-similar-appearing-ground-glass-opacities-8-9-on-chest-ct-where-one-has-been-surgically-removed-and-confirmed-to-be-adenocarcinoma-in-situ weekly 0.8 https://www.themednet.org/how-do-you-approach-the-adjuvant-treatment-of-glioblastoma-following-up-front-laser-interstitial-thermal-therapy-litt weekly 0.8 https://www.themednet.org/how-do-you-apply-bolus-and-confirm-daily-air-gaps-setup-for-vulvar-cancer-especially-for-larger-fungating-lesions weekly 0.8 https://www.themednet.org/any-data-available-regarding-the-benefit-of-adjuvant-chemotherapy-in-patients-with-early-stage-lymph-node-negative-triple-negative-adenosquamous-breast-cancers weekly 0.8 https://www.themednet.org/is-there-concern-for-hemorrhage-after-sbrt-to-a-lung-metastasis-that-directly-involves-a-branch-of-the-pulmonary-artery weekly 0.8 https://www.themednet.org/would-you-offer-pmrt-to-an-er-pr-positive-her2-amplified-early-stage-node-negative-breast-cancer-patient-found-to-have-less-than-pcr-to-neoadjuvant-tchp weekly 0.8 https://www.themednet.org/how-does-the-finding-of-synchronous-bladder-cancer-affect-your-treatment-recommendations-for-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/is-it-appropriate-to-offer-low-dose-radiation-for-hidradenitis-suppurativa-that-have-failed-conservative-interventions weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-her2-positive-breast-cancer-who-have-progressive-cns-metastases-after-prior-exposure-to-pertuzumab-trastuzumab-tdm1-and-lapatinib weekly 0.8 https://www.themednet.org/are-there-any-treatment-related-considerations-in-a-patient-with-hiv-who-is-on-antiretroviral-therapy-and-receiving-adjuvant-radiation-for-breast-cancer-treatment weekly 0.8 https://www.themednet.org/what-naming-convention-do-you-use-when-treating-multiple-brain-mets-with-srs weekly 0.8 https://www.themednet.org/how-do-you-approach-definitive-radiation-in-a-patient-with-an-indwelling-catheter-due-to-obstruction-from-locally-advanced-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-post-prostatectomy-radiotherapy-to-patients-with-inflammatory-bowel-disease weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-for-spinal-drop-metastases-from-a-glioblastoma weekly 0.8 https://www.themednet.org/how-if-at-all-does-the-presence-of-hemorrhoidal-bleeding-affect-your-radiation-recommendations-for-prostate-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-metastatic-choroidal-melanoma-with-systemic-metastases-outside-of-a-clinical-trial weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-m0-castrate-resistant-prostate-cancer-started-on-enzalutamide-who-continues-to-have-increasing-psa-levels-without-metastases-seen-on-imaging weekly 0.8 https://www.themednet.org/what-is-your-routine-workup-and-treatment-approach-to-patients-with-nsclc-nos-discovered-in-mediastinal-nodes-but-without-obvious-primary-lung-lesions-or-metastatic-disease weekly 0.8 https://www.themednet.org/in-locally-advanced-rectal-cancer-treated-with-total-neoadjuvant-therapy-do-you-adjust-boost-volumes-to-only-include-post-chemo-gross-disease-nodes-plus-a-margin weekly 0.8 https://www.themednet.org/when-do-you-refer-a-patient-with-metastatic-ovarian-cancer-for-upfront-debulking-v-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/is-there-an-age-cutoff-over-which-you-would-not-recommend-definitive-radiation-for-intermediate-risk-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-srs-for-brain-metastases-in-the-presence-of-cranial-hardware weekly 0.8 https://www.themednet.org/is-there-a-role-for-extended-treatment-volumes-elective-nodal-in-the-definitive-treatment-of-parameningeal-rhabdomyosarcoma-in-a-young-adult weekly 0.8 https://www.themednet.org/do-you-perform-biomarker-based-screening-for-al-amyloidosis-in-patients-with-newly-diagnosed-mgus weekly 0.8 https://www.themednet.org/can-paclitaxel-and-trastuzumab-be-given-neoadjuvantly-in-her2-positive-breast-cancer weekly 0.8 https://www.themednet.org/would-you-consider-the-use-of-intrathecal-chemotherapy-in-patients-with-diffuse-spinal-metastasis-due-to-squamous-cell-lung-cancer weekly 0.8 https://www.themednet.org/should-gnrh-agonist-therapy-be-continued-beyond-5-years-along-with-an-aromatase-inhibitor-in-young-pre-menopausal-women-with-high-risk-breast-cancer-who-continue-to-have-ovarian-function-at-5-years-of-endocrine-treatment weekly 0.8 https://www.themednet.org/do-you-recommend-bevacizumab-in-platinum-sensitive-recurrences-of-epithelial-ovarian-cancer weekly 0.8 https://www.themednet.org/what-is-your-alternative-first-line-approach-to-follicular-lymphoma-that-requires-treatment-if-initial-treatment-with-br-leads-to-significant-neutropenia-despite-g-csf weekly 0.8 https://www.themednet.org/in-patients-undergoing-pre-operative-chemoradiation-for-rectal-adenocarcinoma-with-clinically-positive-pelvic-sidewall-nodes-that-may-not-be-surgically-accessible-do-you-boost-these-nodes-above-50-4-gy weekly 0.8 https://www.themednet.org/what-margins-do-you-use-for-glioblastoma-in-close-proximity-to-critical-structures weekly 0.8 https://www.themednet.org/how-do-you-treat-a-female-with-a-diagnosis-of-invasive-apocrine-carcinoma-of-the-breast weekly 0.8 https://www.themednet.org/how-do-you-discuss-avoiding-pregnancy-in-the-premenopausal-patient-while-on-chemotherapy-and-or-endocrine-therapy weekly 0.8 https://www.themednet.org/what-are-your-treatment-recommendations-in-a-patient-with-de-novo-metastatic-prostate-adenocarcinoma-with-neuroendocrine-differentiation weekly 0.8 https://www.themednet.org/how-would-you-manage-an-osteosarcoma-patient-with-local-disease-only-and-an-r0-resection-who-could-not-tolerate-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-metastatic-non-clear-cell-rcc weekly 0.8 https://www.themednet.org/what-potential-risks-of-sbrt-do-you-counsel-patients-on-when-treating-early-stage-lung-cancer-with-an-underlying-chronic-lung-infection weekly 0.8 https://www.themednet.org/would-you-use-cetuximab-or-panitumumab-to-treat-a-patient-with-stage-iv-colon-cancer-who-is-kras-nras-wild-type-but-has-a-pik3ca-mutation-in-tumor-tissue weekly 0.8 https://www.themednet.org/would-you-give-additional-chemotherapy-to-women-with-stage-iii-her2-breast-cancer-who-have-a-grossly-suboptimal-response-to-neoadjuvant-tchp-x6 weekly 0.8 https://www.themednet.org/what-are-your-preferred-target-doses-for-bulky-t4-rectal-adenocarcinomas-with-extensive-gu-and-anal-sphincter-involvement-as-well-as-common-illiac-and-inguinal-adenopathy-as-part-of-total-neoadjuvant-therapy-when-future-apr-is-planned weekly 0.8 https://www.themednet.org/what-chemotherapy-regimen-would-you-recommend-for-high-risk-er-her2-ln-negative-breast-cancer-with-high-genomic-risk-disease weekly 0.8 https://www.themednet.org/would-you-consider-age-of-70-years-as-a-contraindication-without-any-other-cardiac-risks-to-use-anthracycline-in-a-triple-negative-breast-cancer-patient weekly 0.8 https://www.themednet.org/does-the-presence-of-interstitial-lung-disease-excluding-ipf-affect-your-decision-to-offer-conventional-fractionated-rt-for-stage-iii-nsclc weekly 0.8 https://www.themednet.org/why-do-we-give-four-cycles-of-tc-as-adjuvant-therapy-when-some-of-the-clinical-trials-administered-six-cycles weekly 0.8 https://www.themednet.org/would-you-recommend-observation-for-an-early-stage-low-grade-er-pure-tubular-carcinoma-of-the-breast-after-lumpectomy-with-negative-margins-for-women-younger-than-65 weekly 0.8 https://www.themednet.org/is-a-tumor-ever-too-small-to-send-off-a-genomic-assay-like-oncotype-or-mammoprint-in-hr-positive-her2-negative-stage-1-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-who-progressed-on-immunotherapy-for-merkel-cell-carcinoma weekly 0.8 https://www.themednet.org/would-you-continue-treatment-of-a-rectal-metastasis-in-a-patient-who-is-found-to-have-radiographic-evidence-of-contained-rectal-perforation-during-the-treatment weekly 0.8 https://www.themednet.org/is-there-a-role-for-temozolomide-in-patients-with-stage-iv-nsclc-with-leptomeningeal-disease-who-have-progressed-on-first-line-chemo-immunotherapy weekly 0.8 https://www.themednet.org/what-factors-determine-the-choice-of-treatment-in-the-management-of-intermediate-bclc-stage-b-hepatocellular-carcinoma weekly 0.8 https://www.themednet.org/would-you-alter-your-treatment-plan-of-the-neck-for-oropharynx-cancer-after-an-excisional-biopsy-violation-of-the-neck weekly 0.8 https://www.themednet.org/how-would-you-treat-recurrent-parotid-gland-carcinoma-with-unresectable-metastatic-disease weekly 0.8 https://www.themednet.org/would-you-add-her2-targeted-therapy-to-adjuvant-chemotherapy-for-a-patient-with-initial-breast-biopsy-showing-a-er-pr-positive-her2-negative-invasive-ductal-carcinoma-but-mastectomy-sample-showing-equivocal-her2-by-fish-on-initial-assay-with-an-alternativ weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-radiation-to-the-breast-for-low-grade-adenosquamous-carcinoma-after-lumpectomy weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-to-a-patient-with-t3n0m0-nsclc-if-the-reason-for-the-t3-stage-was-due-to-multiple-tumor-nodules-in-the-same-lobe weekly 0.8 https://www.themednet.org/when-would-you-consider-neratinib-in-a-patient-with-locally-advanced-hr-positive-her2-positive-breast-cancer-who-received-one-year-of-trastuzumab-and-pertuzumab weekly 0.8 https://www.themednet.org/do-you-ever-consider-hormone-replacement-therapy-in-a-woman-who-is-suffering-from-early-menopause-that-has-been-likely-cured-of-her-breast-cancer-and-undergone-bilateral-mastectomies weekly 0.8 https://www.themednet.org/would-you-offer-durvalumab-as-consolidation-therapy-to-a-patient-with-stage-iii-nsclc-but-had-local-recurrence-treated-with-definitive-sbrt weekly 0.8 https://www.themednet.org/what-is-your-approach-to-cmv-prophylaxis-in-the-post-allogeneic-stem-cell-transplant-setting weekly 0.8 https://www.themednet.org/how-do-you-utilize-lenalidomide-maintenance-in-non-transplant-eligible-myeloma weekly 0.8 https://www.themednet.org/for-pre-menopausal-female-patients-who-present-with-acute-leukemia-in-need-urgent-anti-neoplastic-therapy-what-is-your-preferred-approach-in-effort-to-preserve-fertility weekly 0.8 https://www.themednet.org/what-other-chemotherapy-would-you-consider-in-a-patient-with-high-risk-er-positive-her2-negative-disease-that-developed-pulmonary-toxicity-to-paclitaxel-and-refuses-any-more-taxanes weekly 0.8 https://www.themednet.org/how-would-you-approach-distant-oligometastatic-hpv-positive-oropharyngeal-cancer-previously-treated-with-definitive-local-therapy weekly 0.8 https://www.themednet.org/what-chemotherapy-regimen-do-you-prefer-for-postmenopausal-women-with-t1-er-positive-tumors-with-1-positive-ln weekly 0.8 https://www.themednet.org/when-do-you-feel-it-is-safe-to-initiate-palliative-radiation-therapy-to-the-bone-spine-femur-humerus-etc-following-surgical-fixation-with-hardware-with-or-without-cement-without-compromising-the-stability-of-the-hardware weekly 0.8 https://www.themednet.org/how-do-you-match-a-para-aortic-field-to-a-previously-irradiated-whole-pelvis-field-in-a-woman-with-pa-nodal-failure-after-definitive-chemort-for-cervical-cancer weekly 0.8 https://www.themednet.org/is-cardiac-sparing-whole-lung-imrt-acceptable-for-wilms-tumor weekly 0.8 https://www.themednet.org/what-is-the-longest-treatment-break-you-would-allow-during-definitive-hn-rt-chemo weekly 0.8 https://www.themednet.org/what-is-the-role-of-targeted-therapy-in-relapsed-refractory-alk-anaplastic-large-cell-lymphoma weekly 0.8 https://www.themednet.org/should-atezolizumab-be-used-with-chemotherapy-in-the-first-line-treatment-of-es-sclc weekly 0.8 https://www.themednet.org/what-is-the-role-of-salvage-radiation-therapy-in-patients-with-locally-recurrent-hodgkin-lymphoma-after-an-autologous-stem-cell-transplant weekly 0.8 https://www.themednet.org/is-there-any-data-to-quote-possible-benefit-of-endocrine-therapy-in-an-elderly-woman-with-low-risk-breast-cancer-who-is-refusing-primary-surgical-treatment weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-radiation-therapy-for-a-merkel-cell-carcinoma-of-the-cheek-in-an-immunocompromised-patient weekly 0.8 https://www.themednet.org/is-it-acceptable-defer-or-forgo-biopsy-and-to-start-androgen-deprivation-therapy-in-an-elderly-fragile-patient-with-psa-in-the-900s-and-evidence-of-bone-metastases weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-a-glioblastoma-who-cannot-have-an-mri weekly 0.8 https://www.themednet.org/what-lung-constraint-do-you-use-when-delivering-sbrt-for-local-failure-of-early-stage-nsclc-following-surgery weekly 0.8 https://www.themednet.org/are-there-any-circumstances-you-would-not-recommend-sentinel-lymph-node-biopsy-in-a-breast-cancer-patient weekly 0.8 https://www.themednet.org/how-would-you-treat-an-scc-of-the-helix-of-the-ear-with-posterior-auricular-nerve-involvement-s-p-surgical-resection weekly 0.8 https://www.themednet.org/when-do-you-treat-oligometastatic-triple-negative-breast-cancer-aggressively weekly 0.8 https://www.themednet.org/is-there-a-risk-of-severe-radiation-toxicity-for-a-patient-with-paraneoplastic-dermatomyositis-due-to-lung-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-a-newly-diagnosed-locally-advanced-er-her2-breast-cancer-with-synchronous-diagnosis-of-metastatic-melanoma weekly 0.8 https://www.themednet.org/how-do-you-approach-need-for-adjuvant-therapy-after-r0-resection-of-breast-angiosarcoma weekly 0.8 https://www.themednet.org/how-do-you-manage-elderly-women-with-high-risk-her2-positive-disease-with-baseline-low-ejection-fraction weekly 0.8 https://www.themednet.org/what-dose-constraint-if-any-do-you-use-for-the-ureters-during-prostate-radiation weekly 0.8 https://www.themednet.org/what-systemic-chemotherapy-do-you-prefer-with-concurrent-radiation-therapy-in-the-neoadjuvant-setting-for-early-stage-rectal-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-systemic-therapy-in-newly-diagnosed-colon-cancer-with-synchronous-solitary-liver-metastases weekly 0.8 https://www.themednet.org/do-you-ever-change-treatment-for-metastatic-breast-cancer-with-rising-tumor-markers-but-no-evidence-of-progression-on-imaging weekly 0.8 https://www.themednet.org/how-would-you-sequence-srs-for-brain-metastases-for-a-patient-receiving-dual-immunotherapies weekly 0.8 https://www.themednet.org/would-you-include-any-elective-nodal-stations-for-cases-of-t3-t4-node-negative-nsclc-staged-by-pet-ct-in-which-a-patient-cannot-undergo-nodal-sampling weekly 0.8 https://www.themednet.org/in-view-of-possible-equivalent-efficacy-of-low-dose-abiraterone-with-food-has-anyone-had-clinical-experience-offering-low-dose-abiraterone-to-spare-patients-from-financial-toxicity-of-abiraterone weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-treatment-for-a-premenopausal-woman-with-a-large-lymph-node-positive-hr-her2-negative-lobular-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-an-isolated-port-recurrence-of-an-early-stage-cervical-patient-s-p-wle weekly 0.8 https://www.themednet.org/what-are-your-constraints-when-treating-an-abdominal-site-with-sbrt weekly 0.8 https://www.themednet.org/would-you-use-immunotherapy-in-a-patient-with-metastatic-lung-adencoarcinoma-high-pdl1-but-had-polymyositis-as-a-presenting-paraneoplastic-syndrome weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-nivolumab-for-iiia-melanoma weekly 0.8 https://www.themednet.org/what-would-you-choose-as-the-second-line-treatment-option-for-a-stage-iv-egfr-mutant-lung-adenocarcinoma-that-has-progressed-on-osimertinib weekly 0.8 https://www.themednet.org/are-the-cardiac-risks-of-lhrh-agonists-also-seen-in-patients-undergoing-bilateral-orchiectomy-for-adt-in-hormone-sensitive-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-a-metastatic-intermediate-grade-net-of-gi-origin-with-clinically-significant-tumor-burden weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-hairy-cell-leukemia-with-inadequate-response-to-front-line-therapy weekly 0.8 https://www.themednet.org/how-do-you-explain-the-benefit-of-endocrine-therapy-after-bilateral-mastectomies-in-early-stage-breast-cancer-for-a-postmenopausal-woman weekly 0.8 https://www.themednet.org/how-does-your-approach-differ-when-managing-a-triple-hit-versus-a-double-hit-or-double-expressor-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-define-close-and-negative-margins-for-soft-tissue-sarcoma weekly 0.8 https://www.themednet.org/how-do-you-manage-unresctable-thoracic-esophageal-cancer-invading-the-trachea weekly 0.8 https://www.themednet.org/how-do-you-chose-between-4-or-6-cycles-of-chemotherapy-in-patients-with-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/what-dose-fractionation-schedule-do-you-use-to-treat-head-and-neck-cancer-in-a-patient-with-fanconis-anemia weekly 0.8 https://www.themednet.org/when-do-you-choose-motion-management-over-free-breathing-techniques-for-lung-sbrt weekly 0.8 https://www.themednet.org/how-do-you-approach-elective-cranial-nerve-target-volumes-for-head-and-neck-cancers-to-account-for-potential-retrograde-or-anterograde-spread-along-cranial-nerves weekly 0.8 https://www.themednet.org/what-constraints-do-you-use-for-the-normal-brain-when-treating-large-cns-tumors-with-standard-fractionation weekly 0.8 https://www.themednet.org/how-do-you-approach-fit-patients-with-quickly-relapsed-hodgkin-lymphoma-disease-free-interval-less-than-or-equal-to-one-year-after-6-cycles-of-avbd-and-radiation-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-incidentally-diagnosed-mantle-cell-lymphoma-found-on-a-routine-screening-colonoscopy weekly 0.8 https://www.themednet.org/do-you-routinely-use-prvs-for-cns-planning weekly 0.8 https://www.themednet.org/should-radiotherapy-be-utilized-in-stage-iva-nsclc-with-a-malignant-pericardial-effusion weekly 0.8 https://www.themednet.org/what-positioning-and-immobilization-technqiues-do-you-use-for-anal-canal-carcinoma-radiotherapy-in-the-era-of-imrt weekly 0.8 https://www.themednet.org/how-would-you-manage-an-elderly-patient-with-metastatic-breast-cancer-with-locally-advanced-bilateral-primaries weekly 0.8 https://www.themednet.org/how-do-you-manage-new-brain-metastases-in-patients-on-trastuzumab-emtansine-tdm-1-who-has-controlled-extracranial-disease weekly 0.8 https://www.themednet.org/do-you-ever-treat-patients-with-rectal-or-anal-cancer-with-imrt-in-the-prone-position weekly 0.8 https://www.themednet.org/do-you-have-any-normal-tissue-constraints-for-endometrial-cancer-patients-receiving-ebrt-and-vaginal-cuff-brachytherapy weekly 0.8 https://www.themednet.org/how-would-you-re-irradiate-a-breast-recurrence-in-a-patient-treated-with-prior-whole-breast-radiotherapy weekly 0.8 https://www.themednet.org/what-front-line-therapy-would-you-recommend-for-a-patient-with-cll-on-chronic-dual-antiplatelet-therapy weekly 0.8 https://www.themednet.org/what-systemic-therapy-option-do-you-use-for-metastatic-anal-squamous-cancer-with-progression-following-folfox-and-subsequent-nivolumab weekly 0.8 https://www.themednet.org/should-olaparib-maintenance-therapy-be-recommended-in-patients-with-brca-positive-advanced-ovarian-cancer-after-first-line-platinum-based-chemotherapy weekly 0.8 https://www.themednet.org/would-you-offer-upfront-osimertinib-rather-than-whole-brain-irradiation-for-a-patient-with-stage-iv-egfr-exon-19-mutated-lung-adenocarcinoma-who-presents-with-leptomeningeal-metastases weekly 0.8 https://www.themednet.org/are-there-any-volumetric-constraints-associated-with-toxicity-in-the-dose-range-that-is-moderately-above-prescription-i-e-30-35-gy-range-when-planning-hippocampal-sparing-whole-brain-radiation weekly 0.8 https://www.themednet.org/how-will-the-final-overal-survival-results-of-paloma-3-affect-your-practice weekly 0.8 https://www.themednet.org/at-what-point-do-you-refer-patients-to-see-a-pain-specialist weekly 0.8 https://www.themednet.org/with-the-intent-for-cure-what-neoadjuvant-therapy-would-you-give-a-patient-with-only-chest-wall-recurrence-10-years-after-an-advanced-breast-cancer-was-managed-with-mastectomy-ddac-and-t-and-5-years-of-adjuvant-endocrine-therapy weekly 0.8 https://www.themednet.org/do-you-offer-nivolumab-for-metastatic-hcc-in-the-second-line-or-if-sorafenib-is-intolerable weekly 0.8 https://www.themednet.org/should-patients-who-received-pelvic-radiation-get-colonoscopy-screenings-more-often-than-what-is-recommended-for-the-general-population weekly 0.8 https://www.themednet.org/how-do-you-discern-between-pseudo-progression-or-hyper-progression-in-patients-with-nsclc-or-cancers-treated-with-immune-checkpoint-inhibitors weekly 0.8 https://www.themednet.org/what-is-the-next-step-in-management-following-surgical-resection-of-a-primary-adenoid-cystic-carcinoma-of-the-lung weekly 0.8 https://www.themednet.org/what-is-your-approach-to-choosing-a-conditioning-regimen-for-allogeneic-transplant-in-aml weekly 0.8 https://www.themednet.org/would-you-consider-apbi-in-a-patient-50-years-of-age weekly 0.8 https://www.themednet.org/why-is-it-more-preferable-to-perform-slnb-after-neoadjuvant-systemic-chemotherapy-versus-before-therapy weekly 0.8 https://www.themednet.org/do-you-ever-consider-debulking-abdominal-pelvic-metastatic-breast-cancer-with-hr-positive-disease weekly 0.8 https://www.themednet.org/would-you-consider-neoadjuvant-endocrine-therapy-instead-of-chemotherapy-for-a-pre-menopausal-patient-with-a-node-positive-er-pr-lobular-breast-cancer weekly 0.8 https://www.themednet.org/when-treating-an-inoperable-patient-with-squamous-cell-carcinoma-of-the-thoracic-esophagus-do-you-ever-dose-escalate-beyond-50-4gy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-neuroendocrine-carcinoma-of-the-gallbladder-with-early-relapse-after-platinum-doublet weekly 0.8 https://www.themednet.org/would-you-consider-treating-elective-cervical-nodal-volumes-for-a-highly-invasive-pituitary-adenoma-with-high-risk-features weekly 0.8 https://www.themednet.org/what-would-you-recommend-for-treatment-of-figo-stage-ic2-mucinous-tumor-of-the-ovary weekly 0.8 https://www.themednet.org/do-you-consider-multifocal-disease-an-indication-for-chemotherapy-with-trastuzumab-in-patients-with-microinvasive-her2-hr-breast-cancer weekly 0.8 https://www.themednet.org/what-first-line-treatment-would-you-choose-for-stage-iv-adenocarcinoma-of-lung-with-alk-gene-rearrangement-and-pd-l1-tps-95 weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-newly-diagnosed-stage-iia-triple-negative-breast-cancer-with-a-history-of-renal-transplantation-on-immunosuppressive-therapy weekly 0.8 https://www.themednet.org/would-you-offer-chemotherapy-to-a-patient-with-an-in-breast-recurrence-less-than-2-years-after-a-history-of-lymph-node-positive-er-pr-her2-breast-cancer-treated-with-mastectomy-and-adjuvant-hormonal-blockade weekly 0.8 https://www.themednet.org/how-would-you-treat-patients-with-muscle-invasive-urothelial-carcinoma-of-the-bladder-with-small-cell-and-sarcomatoid-differentiation weekly 0.8 https://www.themednet.org/do-you-still-consider-surgery-for-n2-nsclc-the-era-of-consolidative-immunotherapy weekly 0.8 https://www.themednet.org/in-which-patients-do-you-prescribe-marinol weekly 0.8 https://www.themednet.org/how-long-after-high-dose-iv-methothrexate-for-chemo-refractory-cns-lymphoma-do-you-wait-before-giving-brain-radiation weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-locally-recurrent-esophageal-carcinoma-who-is-s-p-previous-chemort-and-refuses-salvage-surgery weekly 0.8 https://www.themednet.org/when-treating-adenocarinoma-of-the-pancreas-to-75-gy-in-25-fractions-what-dose-constraints-do-you-use-for-small-bowel-large-bowel-and-stomach weekly 0.8 https://www.themednet.org/would-you-recommend-decreasing-dose-to-the-whole-breast-and-nodes-if-constraints-cannot-be-met weekly 0.8 https://www.themednet.org/how-would-the-presence-of-active-rheumatoid-arthritis-on-methotrexate-impact-your-choice-of-fractionation-for-a-patient-with-prostate-cancer weekly 0.8 https://www.themednet.org/when-would-you-omit-rt-for-pleomorphic-lcis weekly 0.8 https://www.themednet.org/would-you-offer-rt-to-a-patient-with-a-stage-i-low-grade-follicular-lymphoma-in-the-groin-upper-thigh-7-cm-s-p-complete-excision-with-negative-margins weekly 0.8 https://www.themednet.org/would-you-treat-bilateral-synchronous-breast-cancers-in-prone-position weekly 0.8 https://www.themednet.org/in-a-patient-who-requires-prostate-cytoreduction-prior-to-ebrt-or-brachytherapy-do-you-include-a-5-alpha-reductase-inhibitor-in-your-adt-regimen weekly 0.8 https://www.themednet.org/how-do-you-treat-newly-diagnosed-low-volume-metastatic-hormone-sensitive-prostate-cancer-in-light-of-new-data-from-stampede-presented-at-esmo-2018 weekly 0.8 https://www.themednet.org/how-do-you-choose-between-neoadjuvant-chemotherapy-alone-vs-neoadjuvant-chemoradiation-in-patients-with-potentially-resectable-stage-iii-nsclc-who-are-not-upfront-surgical-candidates weekly 0.8 https://www.themednet.org/would-you-consider-ivosidenib-for-a-patient-with-metastatic-cholangiocarcinoma-and-an-idh1-mutation-following-progression-on-gem-cis-and-folfox weekly 0.8 https://www.themednet.org/what-alternative-adjuvant-therapy-do-you-recommend-to-an-imatinib-intolerant-patient-with-high-risk-gist weekly 0.8 https://www.themednet.org/in-patients-who-develop-a-vte-on-palbociclib-do-you-discontinue-therapy-or-continue-as-long-as-the-patient-is-receiving-adequate-anticoagulation-therapy weekly 0.8 https://www.themednet.org/how-much-variability-can-you-see-in-levels-of-er-pr-expression-between-the-primary-tumor-and-a-metastasis-to-make-you-reconsider-if-its-a-second-primary weekly 0.8 https://www.themednet.org/do-you-use-any-dose-constraints-ovaries-uterus-in-premenopausal-women-receiving-pelvic-rt-and-hoping-to-preserve-fertility weekly 0.8 https://www.themednet.org/what-is-your-cochlear-dose-constraint-when-treating-acoustic-neuromas-with-srs-in-a-patient-with-intact-hearing weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-chemoradiation-for-t1n0-gastric-adenocarcinoma-status-post-r0-resection-but-no-d2-lymph-node-dissection weekly 0.8 https://www.themednet.org/is-treating-high-risk-prostate-cancer-with-trimodality-therapy-safe-for-a-patient-who-remains-on-anti-pd1-therapy-for-metastatic-melanoma weekly 0.8 https://www.themednet.org/would-you-consider-using-an-anthracycline-based-regimen-again-for-a-breast-cancer-patient-who-previously-received-doxorubicin-10-years-prior weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-therapy-for-poorly-differentiated-adenocarcinoma-of-the-galbladder-s-p-r0-resection-with-negative-nodes weekly 0.8 https://www.themednet.org/what-is-your-standard-dose-for-total-skin-irradiation-in-a-mycosis-fungoides-patient weekly 0.8 https://www.themednet.org/do-you-do-recommend-further-mediastinal-staging-for-patients-with-sclc-or-inoperable-nsclc-with-n1-disease-on-pet weekly 0.8 https://www.themednet.org/how-do-you-manage-gastroesophageal-junction-cancer-after-resection-with-a-positive-circumferential-surgical-margin-when-no-neoadjuvant-treatment-has-been-given weekly 0.8 https://www.themednet.org/would-you-re-challenge-patients-with-an-egfr-tki-beyond-progression-if-repeated-biopsies-show-redemostration-of-a-sensitizing-mutation-exon-19-deletion-and-no-other-resistance-mechanisms weekly 0.8 https://www.themednet.org/what-is-your-preferred-imaging-modality-for-evaluating-brain-necrosis-versus-tumor-progression-after-srs weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-chemotherapy-and-or-radiotherapy-for-patients-with-resected-atypical-carcinoid-of-the-lung-with-positive-mediastinal-lymph-nodes-t3n2m0 weekly 0.8 https://www.themednet.org/do-you-skip-sentinel-lymph-node-biopsy-for-women-70-years-old-with-small-2cm-hr-node-negative-breast-cancer weekly 0.8 https://www.themednet.org/would-you-treat-a-patients-with-metastatic-squamous-cell-lung-cancer-with-50-pdl-1-expression-with-first-line-pembrolizumab-carboplatin-paclitaxel-combination-or-with-pembrolizumab-alone weekly 0.8 https://www.themednet.org/are-there-any-contraindications-to-treating-early-stage-breast-cancer-with-radiation-in-patients-on-rituximab weekly 0.8 https://www.themednet.org/with-the-recent-fda-approvals-of-venetoclax-and-glasdegib-in-aml-is-one-generally-preferred-over-the-other-for-elderly-and-or-unfit-patients-in-combination-with-a-hypomethylating-agent-low-dose-cytarabine weekly 0.8 https://www.themednet.org/do-you-treat-facial-and-peri-parotid-nodes-in-locally-advanced-nasal-cavity-nasal-vestibule-cancer weekly 0.8 https://www.themednet.org/when-would-you-cover-the-pre-and-or-post-auricular-nodal-basins-electively-in-the-post-op-setting-for-tumor-involving-the-parotid-gland weekly 0.8 https://www.themednet.org/which-regimen-do-you-prefer-for-patients-with-newly-diagnosed-dlbcl-that-are-not-candidates-for-doxorubicin-secondary-to-low-ejection-fraction weekly 0.8 https://www.themednet.org/what-is-the-optimal-intrathecal-chemotherapy-regimen-for-leptomeningeal-carcinomatosis-from-breast-cancer weekly 0.8 https://www.themednet.org/do-you-use-docetaxel-interchangeably-with-paclitaxel-in-breast-cancer weekly 0.8 https://www.themednet.org/can-you-spare-radiation-to-the-neck-on-a-lateralized-supraglottic-cancer-with-cn0-neck-clinically-and-neg-nodes-on-pet weekly 0.8 https://www.themednet.org/do-you-recommend-using-dibh-for-young-adults-with-hodgkin-lymphoma-who-require-mediastinal-rt weekly 0.8 https://www.themednet.org/do-you-omit-the-breast-boost-in-patients-with-lumpectomy-bed-near-the-nipple-areolar-complex weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-in-patients-with-stage-iii-non-small-cell-lung-cancer-invading-the-atrium-of-the-heart weekly 0.8 https://www.themednet.org/how-do-you-manage-cavernous-sinus-meningiomas weekly 0.8 https://www.themednet.org/is-there-a-role-for-assessing-measurable-minimal-residual-disease-mrd-in-multiple-myeloma-at-this-time weekly 0.8 https://www.themednet.org/how-do-you-prevent-treat-nasal-synechiae-after-radiation-for-scc-of-nasal-vestibule weekly 0.8 https://www.themednet.org/would-you-switch-from-weekly-cetuximab-to-cisplatin-during-definitive-chemort-for-locally-advanced-oropharyngeal-scc weekly 0.8 https://www.themednet.org/is-there-a-role-for-incorporating-local-therapy-into-the-management-of-oligometastatic-egfr-mutant-nsclc-with-curative-intent weekly 0.8 https://www.themednet.org/how-important-is-a-severely-diminished-diffusion-capacity-in-determining-whether-to-offer-a-lung-cancer-patient-radiotherapy weekly 0.8 https://www.themednet.org/with-new-data-now-available-for-use-of-brentuximab-in-alk-positive-cd30-anaplastic-large-cell-lymphoma-what-is-your-first-line-regimen weekly 0.8 https://www.themednet.org/do-you-recommend-elective-mediastinal-nodal-irradiation-for-an-inoperable-nsclc-patient-with-n1-disease-who-is-unable-to-undergo-mediastinal-staging weekly 0.8 https://www.themednet.org/would-you-recommend-removal-of-pec-muscle-for-a-positive-microscopic-deep-margin-post-mastectomy weekly 0.8 https://www.themednet.org/do-you-recommend-matchline-shifts-when-treating-abutting-photon-and-electron-fields-when-treating-the-chestwall weekly 0.8 https://www.themednet.org/how-do-you-decide-between-enrolling-an-oligometastatic-nsclc-patient-on-lu-002-versus-treating-them-with-sbrt-off-trial weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-capecitabine-as-well-as-trastuzumab-in-a-patient-with-er-pr-negative-her2-positive-breast-cancer-treated-with-neoadjuvant-chemotherapy-trastuzumab-pertuzumab-who-has-residual-disease-on-path weekly 0.8 https://www.themednet.org/will-you-offer-ibrutinib-and-rituximab-for-untreated-patients-with-cll-without-a-17p-deletion weekly 0.8 https://www.themednet.org/how-will-the-findings-from-the-study-of-adjuvant-capecitabine-in-tnbc-presented-at-sabcs-2018-ciboma-2004-01-geicam-2003-11-affect-standard-of-care weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-therapy-for-a-patient-with-standard-risk-multiple-myeloma weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-an-inflammatory-triple-negative-breast-cancer-with-contraindications-to-an-anthracycline weekly 0.8 https://www.themednet.org/do-you-offer-durvalumab-to-patients-with-stage-iiib-nsclc-after-chemoradiation-if-they-are-also-on-long-term-dialysis-for-esrd weekly 0.8 https://www.themednet.org/how-do-you-treat-endometrial-cancer-in-the-setting-of-a-pcr-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-definitive-radiation-for-prostate-cancer-in-a-patient-with-perineal-urethrostomy weekly 0.8 https://www.themednet.org/how-do-you-sequence-follow-up-mammograms-in-patients-undergoing-breast-cancer-treatment weekly 0.8 https://www.themednet.org/how-would-you-manage-adjuvant-therapy-in-a-brca1-mutated-woman-with-er-her2-negative-breast-cancer-with-residual-disease-at-surgery-after-neoadjuvant-therapy-with-a-taxane-based-regimen weekly 0.8 https://www.themednet.org/what-are-your-indications-for-radiotherapy-in-children-with-pleomorphic-xanthoastrocytoma weekly 0.8 https://www.themednet.org/what-is-the-best-treatment-approach-for-locally-advanced-t3-and-or-n-rectal-cancer-status-post-low-anterior-resection-in-a-patient-who-has-a-remote-history-of-seed-implant-for-low-risk-prostate-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-third-line-approach-for-a-patient-with-refractory-small-cell-lung-cancer-who-has-failed-second-line-therapy-with-nivolumab-after-recieving-first-line-platinum-based-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-therapy-of-serous-intraepithelial-carcinoma-of-the-endometrium weekly 0.8 https://www.themednet.org/how-do-results-from-nsabp-b-39-influence-your-practice-for-apbi-compared-to-wbi-in-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/do-you-make-any-modifications-to-your-treatment-plan-for-older-patients-undergoing-prostate-sbrt weekly 0.8 https://www.themednet.org/is-there-a-role-for-xrt-in-the-treatment-of-epistaxis-from-hereditary-hemorrhagic-telangiectasia weekly 0.8 https://www.themednet.org/what-chemotherapy-regimen-would-you-give-for-metastatic-adenocarcinoma-that-arose-from-teratoma-germ-cell-tumor weekly 0.8 https://www.themednet.org/how-would-you-treat-very-locally-aggressive-rectal-cancer-extending-into-muscle-and-causing-internal-iliac-tumor-thrombus-in-a-patient-who-is-not-a-surgical-candidate weekly 0.8 https://www.themednet.org/do-you-routinely-add-a-platinum-to-systemic-chemotherapy-in-the-adjuvant-setting-for-patients-with-brca-mutated-er-breast-ca weekly 0.8 https://www.themednet.org/what-is-the-maximum-time-you-would-wait-after-hysterectomy-to-start-rt-for-a-figo-ii-endometriod-adenocarcinoma-before-cancelling-treatment-and-saving-for-salvage weekly 0.8 https://www.themednet.org/how-do-you-manage-surveillance-imaging-for-patients-with-metastatic-castration-resistant-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-chemotherapy-use-in-patients-with-locally-advanced-er-her2-negative-patients-with-cirrhosis-and-platelets-100k weekly 0.8 https://www.themednet.org/what-is-the-role-of-neo-adjuvant-chemotherapy-in-triple-positive-ct1c-n0-breast-cancer-especially-after-recent-data-from-katherine-trial weekly 0.8 https://www.themednet.org/would-you-switch-to-tdm-1-in-the-adjuvant-setting-in-her-2-positive-breast-cancer-patients-with-residual-disease-after-neoadjuvant-chemotherapy-if-neoadjuvant-chemotherapy-did-not-include-anthracyclines weekly 0.8 https://www.themednet.org/what-are-the-preferred-treatment-options-for-platinum-resistant-clear-cell-ovarian-carcinoma weekly 0.8 https://www.themednet.org/is-port-recommended-for-incidentally-found-n2-nsclc-after-lobectomy-for-oligoprogressive-metastatic-nsclc weekly 0.8 https://www.themednet.org/when-do-you-consider-neoadjuvant-radiation-for-inflammatory-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-a-young-patient-with-metastatic-rectal-cancer-and-a-painful-local-recurrence-who-underwent-chemort-to-50-4-gy-two-years-ago-and-declined-surgery weekly 0.8 https://www.themednet.org/in-a-patient-with-high-risk-acute-promyelocytic-leukemia-when-do-you-consider-atra-ato-with-go-vs-atra-ato-with-idarubicin weekly 0.8 https://www.themednet.org/does-the-presence-of-interstitial-lung-disease-affect-your-recommendation-for-bct-vs-mastectomy-for-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/do-you-regularly-utilize-antiemetic-or-gi-prophylaxis-when-treating-abdominal-sites-with-sbrt weekly 0.8 https://www.themednet.org/how-do-you-manage-an-unresectable-high-grade-glioma-of-the-distal-cord-cauda-equina weekly 0.8 https://www.themednet.org/would-you-add-atezolizumab-to-carboplatin-etoposide-for-small-cell-neuroendocrine-prostate-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-suspicious-node-positive-bladder-cancer-that-did-not-respond-to-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/in-patients-with-oligometastatic-disease-would-you-offer-sbrt-to-a-metastatic-lymph-node-abutting-the-trachea-and-or-esophagus weekly 0.8 https://www.themednet.org/when-if-ever-do-you-consider-radiation-therapy-as-adjuvant-treatment-for-gist weekly 0.8 https://www.themednet.org/when-do-you-consider-it-too-late-after-breast-surgery-to-offer-adjuvant-chemotherapy-to-a-patient-with-high-risk-non-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/what-would-be-your-recommended-target-volume-for-a-high-risk-head-and-neck-cutaneous-squamous-cell-carcinoma-with-microscopic-not-clinical-perineural-invasion-and-negative-sentinel-node-biopsy weekly 0.8 https://www.themednet.org/would-you-recommend-local-therapy-for-a-residual-breast-tumor-after-chemotherapy-following-cr-of-distant-disease-in-a-patient-with-metastatic-disease weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-a-refractory-primary-splenic-marginal-zone-lymphoma-with-symptomatic-splenomegaly-20-cm-and-a-mild-pancytopenia weekly 0.8 https://www.themednet.org/are-there-local-control-and-or-toxicity-differences-between-multi-catheter-interstitial-versus-balloon-catheter-techniques-for-apbi weekly 0.8 https://www.themednet.org/how-do-you-utilize-cdk-4-6-inhibitors-in-metastatic-er-her2-breast-cancer weekly 0.8 https://www.themednet.org/is-it-acceptable-to-omit-post-lumpectomy-radiation-in-an-elderly-patient-with-recurrent-ipsilateral-breast-cancer-but-low-risk-features weekly 0.8 https://www.themednet.org/would-you-recommend-a-simultaneous-integrated-boost-with-hypofractionated-whole-breast-radiation weekly 0.8 https://www.themednet.org/what-is-your-recommended-surveillance-imaging-routine-for-a-patient-with-an-esthesioneuroblastoma-following-adjuvant-radiation weekly 0.8 https://www.themednet.org/how-would-you-manage-a-localized-stage-iv-squamous-cell-carcinoma-of-vagina-involving-the-posterior-vaginal-wall-and-full-thickness-of-the-anterior-rectal-wall weekly 0.8 https://www.themednet.org/how-would-you-recommend-treating-locally-recurrent-pancreatic-cancer weekly 0.8 https://www.themednet.org/would-you-offer-regional-nodal-irradiation-for-cn1-breast-cancer-patients-who-undergo-neoadjuvant-chemotherapy-and-experience-a-complete-nodal-response weekly 0.8 https://www.themednet.org/how-do-you-treat-de-novo-metastatic-hepatocellular-carcinoma-in-a-non-cirrhotic-patient-with-a-prior-orthotopic-liver-transplant-for-hepatitis-b-now-on-chronic-immunosuppression weekly 0.8 https://www.themednet.org/what-is-the-role-of-adjuvant-radiation-therapy-for-isolated-melanoma-lymph-node-metastases-status-post-resection-and-found-to-have-extranodal-extension weekly 0.8 https://www.themednet.org/do-you-utilize-oncotype-dx-or-other-multigene-assays-to-guide-adjuvant-chemotherapy-for-er-her2-breast-cancers-that-are-pt3n0 weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-planning-for-preoperative-radiation-therapy-in-gastric-cancer weekly 0.8 https://www.themednet.org/what-adjuvant-treatment-would-you-use-for-a-cisplatin-ineligible-node-positive-upper-tract-urothelial-cancer-patient-after-radical-nephroureterectomy weekly 0.8 https://www.themednet.org/how-would-you-treat-oligoprogressive-metastatic-gist-to-the-liver-with-a-single-enlarging-liver-lesion-while-on-imatinib-and-no-other-evidence-of-active-disease-where-surgery-and-rfa-are-not-possible weekly 0.8 https://www.themednet.org/how-do-you-manage-elderly-patients-with-borderline-ps-and-er-inflammatory-breast-cancer-without-metastasis weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-utilize-when-treating-an-elderly-patient-with-local-only-pancreatic-cancer-who-is-not-eligible-for-systemic-therapy-or-surgery weekly 0.8 https://www.themednet.org/are-you-using-prostate-pet-imaging-for-any-newly-diagnosed-prostate-cancers weekly 0.8 https://www.themednet.org/in-a-patient-with-liver-metastases-from-a-pancreatic-net-that-have-been-successfully-treated-with-ablation-by-interventional-radiology-would-you-resect-the-primary-pancreas-lesion weekly 0.8 https://www.themednet.org/what-would-be-your-recommended-adjuvant-treatment-approach-for-a-completely-excised-lymphoepithelial-carcinoma-of-the-right-nose-recurrent-in-a-left-level-ib-lymph-node-status-post-excisional-biopsy weekly 0.8 https://www.themednet.org/how-would-you-treat-dlbcl-of-the-terminal-ileum-in-an-otherwise-healthy-patient weekly 0.8 https://www.themednet.org/would-a-history-of-receiving-green-light-laser-therapy-for-bph-change-your-management-of-newly-diagnosed-prostate-cancer weekly 0.8 https://www.themednet.org/would-you-consider-initiation-of-bevacizumab-maintenance-in-a-patient-with-primary-ovarian-cancer-after-optimal-debulking-surgery-and-standard-carbo-taxol-if-they-did-not-receive-bevacizumab-beginning-with-the-carbo-taxol weekly 0.8 https://www.themednet.org/do-you-treat-prostate-cancer-with-hormone-sensitive-metastatic-recurrence-the-same-as-de-novo-metastatic-hormone-sensitive-disease-i-e-with-adt-abiraterone-docetaxel weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-p16-oropharyngeal-carcinoma-with-one-positive-node-on-neck-dissection weekly 0.8 https://www.themednet.org/would-you-consider-rt-to-lns-in-a-gr-2-3-adenocarcinoma-of-the-lacrimal-gland-if-there-are-high-risk-features weekly 0.8 https://www.themednet.org/would-you-rather-start-radiation-for-stage-iii-nsclc-in-the-middle-of-a-chemotherapy-cycle-or-wait-for-the-2nd-cycle-if-it-could-not-be-started-on-cycle-1-day-1 weekly 0.8 https://www.themednet.org/how-would-you-manage-a-slowly-progressive-benign-brain-tumor-located-near-critical-structures-such-as-the-optic-chiasm-brainstem weekly 0.8 https://www.themednet.org/when-do-you-give-exogenous-albumin-in-an-attempt-to-reduce-risk-of-ifosfamide-induced-encephalopathy weekly 0.8 https://www.themednet.org/how-do-you-reconcile-the-difference-with-regard-to-adjuvant-treatment-recommendations-when-a-breast-biopsy-reveals-10-er-but-a-subsequent-lumpectomy-of-the-same-lesion-is-er-negative weekly 0.8 https://www.themednet.org/is-it-reasonable-to-only-treat-the-inguinal-nodes-and-not-the-pelvic-nodes-in-an-unresectable-ct1cn0-vulvar-scc-at-the-clitoris weekly 0.8 https://www.themednet.org/how-do-you-define-and-ir-ctv-for-cervical-brachytherapy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-metastatic-lung-adenocarcinoma-with-met-exon-14-skip-mutation-on-ctdna-negative-tissue-ngs-and-pd-l1-of-50 weekly 0.8 https://www.themednet.org/how-should-we-address-the-questions-about-the-use-of-hormone-replacement-therapy-in-post-menopausal-women-who-have-concerns-about-its-relation-to-breast-cancer weekly 0.8 https://www.themednet.org/in-what-situation-if-any-would-you-combine-immunotherapy-concurrently-with-radiation-for-patients-with-head-and-neck-cancer weekly 0.8 https://www.themednet.org/can-invasive-lobular-cancer-be-triple-negative weekly 0.8 https://www.themednet.org/how-do-you-approach-isolated-cns-recurrence-in-previously-treated-neuroblastoma weekly 0.8 https://www.themednet.org/what-would-you-recommend-for-a-patient-with-a-new-or-locally-recurrent-anal-cancer-s-p-chemort-for-anal-cancer-15-years-ago weekly 0.8 https://www.themednet.org/what-treatment-would-you-recommend-for-a-3-cm-basal-cell-carcinoma-of-the-perianal-skin-with-anal-canal-involvement weekly 0.8 https://www.themednet.org/what-is-the-preferred-treatment-approach-for-patients-with-metastatic-phyllodes-tumor weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-chemoradiation-for-a-resected-ampullary-adenocarcinoma weekly 0.8 https://www.themednet.org/what-would-you-offer-as-systemic-therapy-to-an-elderly-woman-age-75-years-with-hr-negative-her2-positive-lymph-node-negative-breast-cancer-whose-tumor-is-2-cm-or-less weekly 0.8 https://www.themednet.org/in-light-of-the-ongoing-gog-263-trial-do-you-consider-adding-concurrent-chemo-with-rt-for-early-stage-cervical-cancer-as-adjuvant-after-rad-hyst-off-trial weekly 0.8 https://www.themednet.org/has-the-recently-published-select-trial-of-adjuvant-erlotinib-in-early-stage-egfr-mutant-nsclc-impacted-your-management-of-these-patients weekly 0.8 https://www.themednet.org/how-do-you-choose-between-atezolizumab-bevacizumab-carboplatin-paclitaxel-impower-150-vs-pembrolizumab-plus-chemotherapy-keynote-189-in-patients-with-metastatic-nsclc weekly 0.8 https://www.themednet.org/do-you-consider-a-dose-constraint-to-the-phrenic-nerve-during-lung-and-liver-sbrt weekly 0.8 https://www.themednet.org/would-you-give-cns-prophylaxis-to-a-patient-with-waldeyers-ring-diffuse-large-b-cell-lymphoma-if-it-is-not-triple-or-double-hit weekly 0.8 https://www.themednet.org/how-do-you-treat-metastatic-renal-cell-carcinoma-with-unclassified-histology-without-sarcomatoid-features weekly 0.8 https://www.themednet.org/do-you-recommend-homogenous-or-inhomogenous-dose-distribution-for-postoperative-srs-fsrt-for-a-resected-brain-metastasis weekly 0.8 https://www.themednet.org/for-a-patient-with-carcinosarcoma-of-the-uterus-and-an-allergic-reaction-to-paclitaxel-would-you-have-any-reservations-about-using-docetaxel-instead weekly 0.8 https://www.themednet.org/what-ln-stations-would-you-advise-covering-for-lung-adeno-with-ln-at-level-9-s-p-lobectomy-lnd weekly 0.8 https://www.themednet.org/would-you-trial-a-different-tki-vs-chemotherapy-if-a-patient-with-metastatic-egfrm-lung-adenocarcinoma-developed-grade-4-pneumonitis-on-first-line-osimertinib weekly 0.8 https://www.themednet.org/what-is-the-general-practice-for-patients-that-have-spaceoar-placed-and-then-have-a-delay-to-treatment-start weekly 0.8 https://www.themednet.org/what-is-a-preferred-regimen-for-metastatic-leiomyosarcoma-after-failure-of-doxorubicin-olaratumab-and-gemcitabine-docetaxel weekly 0.8 https://www.themednet.org/for-patients-with-metastatic-poorly-differentiated-large-cell-neuroendocrine-carcinoma-of-the-lung-do-you-typically-use-nsclc-or-sclc-regimens weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-who-develops-lhermittes-sign weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-esophageal-scc-that-completed-concurrent-chemoradiation-without-definitive-surgery-with-imaging-evidence-of-local-progression-but-biopsies-only-show-focal-dysplasia weekly 0.8 https://www.themednet.org/in-prostate-cancer-patients-receiving-ebrt-when-if-ever-do-you-use-mri-to-change-your-seminal-vesicle-coverage weekly 0.8 https://www.themednet.org/what-chemotherapy-regimen-would-you-recommend-to-a-patient-with-local-regional-recurrent-er-negative-her2-positive-breast-cancer-who-received-tch-more-than-5-years-ago weekly 0.8 https://www.themednet.org/in-transplant-eligible-fit-patients-with-multiple-myeloma-who-have-an-inadequate-response-to-front-line-therapy-what-regimen-would-you-choose-for-second-line weekly 0.8 https://www.themednet.org/what-is-your-preferred-radiation-sensitizing-regimen-for-cisplatin-ineligible-patients-with-locally-advanced-unresectable-p16-tonsil-scca weekly 0.8 https://www.themednet.org/should-patients-with-idiopathic-pulmonary-fibrosis-be-placed-on-nintedanib-or-pirfenidone-before-starting-radiotherapy-for-lung-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-a-premenopausal-woman-with-triple-positive-breast-cancer-that-has-not-had-any-therapy-with-a-bilirubin-of-10mg-dl-due-to-intrahepatic-disease weekly 0.8 https://www.themednet.org/would-you-consider-using-a-targeted-agent-as-induction-therapy-outside-of-clinical-trial-for-a-patient-with-stage-iiib-n2-who-may-be-a-candidate-for-surgical-resection-and-has-a-targetable-mutation weekly 0.8 https://www.themednet.org/what-brainstem-constraints-do-you-use-when-giving-single-fraction-srs-for-trigeminal-neuralgia-vs-brain-metastases weekly 0.8 https://www.themednet.org/in-staging-hodgkins-lymphoma-would-you-identify-a-pet-bony-focus-as-disease-when-there-are-no-associated-bone-changes-on-ct-and-a-biopsy-was-not-obtained weekly 0.8 https://www.themednet.org/do-you-ever-pause-or-delay-radiation-for-an-infection weekly 0.8 https://www.themednet.org/do-you-recommend-stopping-olaratumab-in-patients-receiving-doxorubicin-olaratumab-for-treatment-of-advanced-sarcoma weekly 0.8 https://www.themednet.org/how-do-you-decide-between-continuing-5fu-chemo-oxaliplatin-or-irinotecan-bevacizumab-versus-switching-to-maintenance-5fu-bevacizumab-in-the-first-line-setting-for-metastatic-colon-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-postoperative-radiation-therapy-for-pathologic-t1-2n1-small-cell-carcinoma-of-the-lung weekly 0.8 https://www.themednet.org/what-neoadjuvant-approach-is-best-for-an-adenocarcinoma-of-the-ge-junction-arising-in-barretts-with-a-large-hiatal-hernia weekly 0.8 https://www.themednet.org/do-you-treat-bulky-pelvic-retroperitoneal-lymph-nodes-for-prostate-cancer-to-palliate-lower-extremity-lymphedema weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-simultaneously-diagnosed-with-t2n1m0-triple-negative-breast-cancer-and-t3n2m0-rectal-adenocarcinoma weekly 0.8 https://www.themednet.org/would-you-consider-adding-io-therapy-to-1st-line-platinum-etoposide-in-a-patient-with-metastatic-extrapulmonary-small-cell-carcinoma weekly 0.8 https://www.themednet.org/in-a-patient-with-waldenstroms-macroglobulinemia-doing-well-and-feeling-better-on-ibrutinib-rituximab-but-with-a-rising-igm-do-you-switch-treatment-or-continue weekly 0.8 https://www.themednet.org/when-considering-post-mastectomy-radiation-do-your-recommendations-change-for-a-biopsy-proven-positive-intramammary-node-in-the-axillary-tail-prior-to-neoadjuvant-chemotherapy-vs-positive-axillary-node weekly 0.8 https://www.themednet.org/is-it-safe-to-continue-re-challenge-oxaliplatin-in-patients-with-oxaliplatin-induced-hepatic-sinusoidal-injury-and-splenomegaly weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-locally-and-distant-recurrent-rectal-cancer-who-has-previously-received-chemoradiation-but-now-presents-with-pain-and-bleeding-from-the-site-of-local-recurrence weekly 0.8 https://www.themednet.org/when-using-concurrent-hyperthermia-with-reirradiation-is-there-any-benefit-to-delivering-hyperthermia-on-non-rt-days weekly 0.8 https://www.themednet.org/do-you-routinely-order-double-hit-assessment-in-cutaneous-dlbcl weekly 0.8 https://www.themednet.org/would-you-recommended-adjuvant-endocrine-therapy-for-a-high-grade-dcis-er-negative-but-pr-positive-that-has-underwent-lumpectomy-and-adjuvant-radiation weekly 0.8 https://www.themednet.org/how-does-breast-cancer-histology-affect-your-decision-whether-to-omit-radiation weekly 0.8 https://www.themednet.org/are-connective-tissue-disorders-a-contraindication-to-breast-radiation weekly 0.8 https://www.themednet.org/would-you-offer-local-radiotherapy-to-prostate-in-a-patient-with-small-cell-neuroendocrine-carcinoma-who-had-a-complete-response-to-chemotherapy weekly 0.8 https://www.themednet.org/would-you-recommend-re-excision-in-a-breast-cancer-patient-who-received-neo-adjuvant-chemotherapy-with-no-residual-tumor-on-pathology-but-sterile-mucin-at-the-edges-was-present weekly 0.8 https://www.themednet.org/do-you-change-your-definitive-therapy-approach-for-a-patient-with-locally-advanced-central-nsclc-with-obstruction-of-a-mainstream-bronchus-and-subsequent-collapse-of-the-lung weekly 0.8 https://www.themednet.org/when-chemotherapy-is-indicated-in-early-stage-soft-tissue-sarcoma-would-you-prefer-to-use-ad-or-ai weekly 0.8 https://www.themednet.org/how-would-you-manage-simultaneous-muscle-invasive-bladder-cancer-and-intermediate-or-high-risk-prostate-cancer-in-a-patient-who-refuses-surgery weekly 0.8 https://www.themednet.org/would-detection-of-an-adverse-cytogenetic-marker-such-as-dup-1q-alone-in-the-setting-of-mgus-satisfy-criteria-for-a-diagnosis-of-multiple-myeloma weekly 0.8 https://www.themednet.org/how-do-you-decide-on-adjuvant-therapy-in-a-patient-with-a-stage-ia-uterine-carcinosarcoma-without-any-myometrial-invasion weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-patient-on-treatment-with-sbrt-sabr-vs-thermal-ablation-in-the-setting-of-early-stage-nsclc-or-lung-metastases weekly 0.8 https://www.themednet.org/what-is-your-preferred-chemotherapy-regimen-for-a-fit-younger-patient-with-mantle-cell-lymphoma weekly 0.8 https://www.themednet.org/for-patients-receiving-adjuvant-trastuzumab-for-her2-positive-breast-cancer-if-a-patient-misses-a-dose-do-you-make-up-that-dose-or-stop-at-1-year-mark-without-making-the-dose-up weekly 0.8 https://www.themednet.org/how-would-you-manage-a-hemangioendothelioma-with-brain-invasion-s-p-partial-resection weekly 0.8 https://www.themednet.org/how-would-you-advise-a-pre-menopausal-hr-her2-bc-with-treated-brain-metastases-and-ned-while-on-trastuzumab-pertuzumab-who-wants-to-conceive weekly 0.8 https://www.themednet.org/would-you-consider-adding-atezolizumab-to-a-different-chemotherapy-platinum-doublet-backbone-from-the-impower-133-trial-for-a-new-es-sclc-patient weekly 0.8 https://www.themednet.org/what-recommendations-do-you-make-regarding-the-use-of-biologics-for-uncontrolled-crohns-disease-in-patients-who-have-a-history-of-dlbcl-that-developed-while-on-infliximab-and-azathioprine-and-whose-lymphoma-is-essentially-cured weekly 0.8 https://www.themednet.org/is-there-a-role-for-radiation-in-the-treatment-of-bulky-axillary-adenopathy-in-patients-with-newly-diagnosed-oligometastatic-melanoma weekly 0.8 https://www.themednet.org/how-do-you-define-your-partial-breast-volumes-when-doing-partial-breast-irradiation weekly 0.8 https://www.themednet.org/when-do-you-recommend-broader-molecular-testing-for-clinical-trials-in-stage-iv-nsclc-patients-who-have-negative-initial-molecular-testing-for-fda-approved-targetable-mutations weekly 0.8 https://www.themednet.org/would-you-recommend-maintenance-therapy-with-a-parp-inhibitor-for-brca-patients-with-advanced-uterine-serous-cancer weekly 0.8 https://www.themednet.org/do-you-ever-consider-small-vessel-doses-when-determining-your-dose-for-sbrt weekly 0.8 https://www.themednet.org/how-do-you-decide-on-the-type-of-ovarian-suppression-gnrh-agonist-vs-gnrh-antagonist-in-premenopausal-patients-treated-wtih-an-ai weekly 0.8 https://www.themednet.org/do-you-consider-adjuvant-radiation-for-low-grade-t1bn0-gallbladder-adenocarcinoma-with-negative-margins-after-oncologic-resection weekly 0.8 https://www.themednet.org/how-would-you-manage-cml-first-line-second-generation-tki-with-a-best-response-of-mmr-4-but-now-with-a-loss-of-mmr-with-more-than-one-log-response-loss-but-still-in-complete-cytogenetic-remission-and-mutation-panel-negative weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-a-figo-g1-pt1bn0-endometrial-adenoca-involving-the-lower-uterine-segment-with-50-invasion-and-a-separate-focus-of-disease-found-involving-the-endocervical-mucosa-with-no-cervical-stromal-invasion weekly 0.8 https://www.themednet.org/what-is-your-preferred-induction-chemotherapy-for-stage-iiia-nsclc-squamous-and-adenocarcinoma weekly 0.8 https://www.themednet.org/can-you-use-mammaprint-to-decide-on-chemotherapy-in-a-young-patient-with-positive-sentinel-nodes-if-no-further-axillary-dissection-is-planned-to-see-if-there-is-more-nodal-involvement weekly 0.8 https://www.themednet.org/would-you-ever-consider-chemoradiation-for-bladder-preservation-in-someone-who-has-had-prior-ldr-prostate-brachytherapy weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-choosing-adjuvant-treatment-for-resected-r0-gallbladder-carcinoma-with-positive-nodes weekly 0.8 https://www.themednet.org/what-factors-affect-your-decisions-in-in-the-initial-management-of-a-stage-iiib-bladder-cancer weekly 0.8 https://www.themednet.org/do-you-use-any-dose-constraints-for-the-spleen-while-delivering-abdominal-radiation-therapy weekly 0.8 https://www.themednet.org/is-there-a-benefit-to-ebrt-for-recurrent-solitary-fibrous-tumor-hemangiopericytoma-in-patient-with-multiple-sites-of-intrapelvic-recurrence weekly 0.8 https://www.themednet.org/do-you-do-neurocognitive-testing-before-giving-pci-or-any-time-thereafter weekly 0.8 https://www.themednet.org/would-you-use-different-ebrt-field-edge-for-an-hiv-positive-patient-with-figo-iiic1-2018-cervical-cancer-with-positive-bilateral-external-iliac-nodes weekly 0.8 https://www.themednet.org/would-you-recommend-surgery-adjuvant-xrt-or-definitive-xrt-in-elderly-patients-with-recurrent-squamous-cell-carcinoma-of-the-ear-with-direct-invasion-through-the-cartilage-of-the-helix weekly 0.8 https://www.themednet.org/how-would-you-treat-a-braf-mutated-and-kras-wt-metastatic-colon-cancer-who-has-progressed-after-folfox-and-now-irinotecan-cetuximab-vemurafenib weekly 0.8 https://www.themednet.org/for-metastatic-nsclc-patients-with-mixed-response-to-pembrolizumab-would-you-radiate-focal-progressing-lesions-and-continue-pembrolizumab-add-in-chemotherapy-to-pembrolizumab-or-discontinue-pembrolizumab-and-move-to-second-line weekly 0.8 https://www.themednet.org/how-would-you-approach-first-line-treatment-in-a-young-patient-with-vhl-with-intermediate-poor-risk-metastatic-clear-cell-rcc weekly 0.8 https://www.themednet.org/is-there-currently-a-role-for-adding-venetoclax-to-a-hypomethylating-agent-hma-after-failure-of-single-agent-hma-therapy-in-mds weekly 0.8 https://www.themednet.org/would-you-offer-pmrt-for-ct2n0-triple-negative-breast-cancer-s-p-nac-and-mastectomy-with-residual-disease-and-no-positive-lymph-nodes weekly 0.8 https://www.themednet.org/how-do-you-manage-venous-thromboembolic-events-or-bleeding-events-in-rcc-or-hcc-patients-on-anti-angiogenic-tkis weekly 0.8 https://www.themednet.org/for-ct2n0-bladder-cancer-receiving-definitive-chemort-do-you-cover-the-prostate-if-you-are-not-treating-pelvic-nodes weekly 0.8 https://www.themednet.org/how-would-you-manage-dcis-diagnosed-in-the-first-trimester-of-pregnancy weekly 0.8 https://www.themednet.org/is-obesity-a-risk-factor-for-recurrence-after-definitive-treatment-for-endometrial-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-primary-cns-lymphoma-who-is-not-a-candidate-for-high-dose-methotrexate weekly 0.8 https://www.themednet.org/how-do-you-manage-classical-early-stage-hodgkin-lymphoma-patients-when-an-esr-is-not-checked-as-part-of-their-workup weekly 0.8 https://www.themednet.org/what-would-you-recommend-as-a-first-line-systemic-therapy-for-metastatic-sarcomatoid-carcinoma-of-the-lung-without-driver-mutations weekly 0.8 https://www.themednet.org/how-do-you-approach-er-pr-weakly-positive-her2-negative-breast-cancer-in-the-metastatic-setting weekly 0.8 https://www.themednet.org/when-using-ebrt-to-deliver-apbi-what-dose-do-you-prescribe-and-to-what-volume weekly 0.8 https://www.themednet.org/what-is-the-best-first-line-treatment-for-stage-iv-pancreatic-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/for-stage-ib1-cervical-cancer-s-p-surgery-with-only-1-sedlis-criteria-should-adjuvant-pelvic-ebrt-or-vaginal-cuff-brachytherapy-be-recommended-in-the-presence-of-other-adverse-pathologic-features-such-as-high-tumor-grade-or-very-close-but-negative-margins weekly 0.8 https://www.themednet.org/is-ki-67-expression-routinely-performed-on-er-breast-cancer-patients-and-do-you-find-that-information-useful-for-making-treatment-decisions weekly 0.8 https://www.themednet.org/what-would-be-your-choice-of-endocrine-therapy-for-a-patient-with-hr-early-stage-second-breast-primary-after-completing-5-years-of-adjuvant-ai weekly 0.8 https://www.themednet.org/how-would-you-treat-a-limited-stage-small-cell-carcinoma-of-the-larynx weekly 0.8 https://www.themednet.org/how-do-you-approach-your-choice-of-systemic-therapy-for-relapsed-metastatic-h-n-cancer-failed-definitive-concurrent-chemort-not-amenable-to-further-locoregional-therapies weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-do-you-use-for-definitive-radiation-for-scc-in-situ-of-glottic-larynx weekly 0.8 https://www.themednet.org/in-which-clinical-situations-if-any-would-you-use-imiquimod-for-treatment-of-breast-cancer-skin-metastases weekly 0.8 https://www.themednet.org/how-would-you-treat-frontline-metastatic-er-her2-breast-cancer-with-activating-pi3k-mutations weekly 0.8 https://www.themednet.org/how-do-you-manage-imaging-artifacts-from-surgical-staples-when-planning-post-operative-radiotherapy-for-resected-brain-tumors weekly 0.8 https://www.themednet.org/is-there-any-data-comparing-neoadjuvant-pancreatic-sbrt-vs-standard-fractionation-in-terms-of-its-ability-to-convert-unresectable-tumors-to-resectable-tumors weekly 0.8 https://www.themednet.org/how-long-after-pancreatic-sbrt-do-you-wait-to-re-image weekly 0.8 https://www.themednet.org/what-rate-of-second-malignancies-do-you-quote-for-patients-receiving-radiosurgery-for-benign-cns-tumors weekly 0.8 https://www.themednet.org/do-you-send-multiple-oncotype-testing-for-each-sample-in-a-multifocal-or-multicentric-breast-cancer weekly 0.8 https://www.themednet.org/would-you-consider-pmrt-in-a-patient-with-n0-i-luminal-a-disease weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-utilize-to-treat-a-multiply-recurrent-high-grade-urothelial-carcinoma-of-the-bladder-in-a-patient-who-is-not-a-surgical-nor-chemotherapy-candidate weekly 0.8 https://www.themednet.org/do-you-routinely-treat-the-anterior-oblique-breast-suprclav-field-with-6mv-photons-or-do-you-use-a-higher-dose-such-as-10-mv weekly 0.8 https://www.themednet.org/do-you-treat-retroperitoneal-sarcomas-with-a-boost-to-the-rind-or-suspected-close-surgical-margin weekly 0.8 https://www.themednet.org/what-adjuvant-endocrine-therapy-would-you-recommend-for-a-male-patient-with-hr-positive-breast-cancer-and-history-of-dvt-pe weekly 0.8 https://www.themednet.org/do-you-utilize-consolidative-radiation-for-metastatic-nsclc-lung-cancer-patients-on-maintenance-immunotherapy weekly 0.8 https://www.themednet.org/how-do-you-best-utilize-f-18-fluciclovine-axumin-pet-ct-in-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-treat-metastatic-mesenchymal-chondrosarcoma weekly 0.8 https://www.themednet.org/how-do-you-manage-metal-dental-fillings-prosthetics-and-hot-spot-concerns-for-head-neck-radiation weekly 0.8 https://www.themednet.org/do-you-perform-a-bone-health-assessment-in-men-who-will-be-receiving-short-term-androgen-deprivation-for-localized-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-decide-between-adjuvant-tdm-1-and-trastuzumab-in-breast-cancer-patients-who-have-residual-disease-at-time-of-surgery-but-were-unable-to-complete-the-recommended-neoadjuvant-course weekly 0.8 https://www.themednet.org/is-there-a-role-for-treating-actinic-keratosis-with-superficial-radiation-therapy-to-widespread-areas-on-scalp weekly 0.8 https://www.themednet.org/would-you-recommend-pmrt-in-a-patient-with-a-microinvasive-component-but-a-large-dcis-component-who-had-a-mastectomy-with-negative-margins weekly 0.8 https://www.themednet.org/what-is-your-approach-for-a-primary-tracheal-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/would-you-recommend-sbrt-for-locally-advanced-pancreatic-adenocarcinoma-invading-the-stomach-s-p-multiple-rounds-of-chemotherapy weekly 0.8 https://www.themednet.org/for-patients-with-nsclc-with-large-primary-tumors-ie-t4-but-no-mediastinal-nodal-involvement-who-are-found-to-have-isolated-oligometastatic-disease-in-the-brain-do-you-still-consider-definitive-management-of-the-primary-lung-tumor weekly 0.8 https://www.themednet.org/how-do-you-manage-endocrine-therapy-for-a-perimenopausal-woman weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-if-any-do-you-consider-for-high-grade-extraskeletal-osteosarcomas-after-r0-resection weekly 0.8 https://www.themednet.org/would-you-recommend-pre-operative-chemo-radiotherapy-for-a-patient-with-a-t3-n0-low-rectal-cancer-in-a-patient-with-active-crohns-disease weekly 0.8 https://www.themednet.org/for-a-patient-with-unresectable-egfr-positive-lung-adenocarcinoma-treated-with-chemoradiation-and-a-single-site-of-oligometastasis-treated-definitively-would-you-consider-durvalumab-as-per-pacific-study-or-egfr-directed-therapy weekly 0.8 https://www.themednet.org/do-you-treat-elective-nodes-in-unresectable-pancreas-when-treating-with-15fx weekly 0.8 https://www.themednet.org/is-postoperative-radiotherapy-indicated-for-a-5-cm-grade-2-synovial-sarcoma-of-the-knee-joint weekly 0.8 https://www.themednet.org/are-there-any-contraindications-to-or-concerns-with-radiating-a-rectal-cancer-patient-receiving-bevacuzimab weekly 0.8 https://www.themednet.org/how-many-cycles-of-docetaxel-do-you-give-to-patients-with-metastatic-castration-resistant-prostate-cancer weekly 0.8 https://www.themednet.org/in-patients-who-have-pneumonitis-related-to-alk-inhibitor-therapy-is-it-possible-to-rechallenge-patients-with-the-same-drug-or-a-different-alk-inhibitor weekly 0.8 https://www.themednet.org/with-recent-measles-outbreaks-occurring-in-the-us-would-you-consider-offering-multiple-myeloma-patients-s-p-asct-on-maintenance-treatment-vaccination-or-an-alternate-means-of-immunity weekly 0.8 https://www.themednet.org/which-patients-with-metastatic-breast-cancer-should-have-mastectomy weekly 0.8 https://www.themednet.org/is-it-safe-to-offer-head-and-neck-radiotherapy-to-a-patient-with-a-diagnosis-of-porphyria-such-as-erythropoietic-protoporphyria-or-porphyria-cutanea-tarda weekly 0.8 https://www.themednet.org/what-considerations-do-you-take-when-performing-functional-srs-for-tremor weekly 0.8 https://www.themednet.org/do-you-recommend-additional-nodal-boost-in-patients-with-suspicious-internal-mammary-nodes-that-respond-completely-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-spindle-cell-carcinoma-of-the-glottic-t1-t2n0-compartment-and-what-fractionation-would-you-use weekly 0.8 https://www.themednet.org/after-progression-on-osimertinib-do-you-recommend-overlapping-tki-with-2nd-line-chemotherapy-or-chemo-io-to-avoid-accelerated-disease-progression weekly 0.8 https://www.themednet.org/how-would-you-manage-an-elderly-patient-with-a-history-of-stage-i-cll-and-newly-diagnosed-metastatic-er-her2-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-a-triple-negative-large-6-cm-cancer-in-a-woman-in-her-second-trimester-of-pregnancy weekly 0.8 https://www.themednet.org/do-you-offer-radiation-to-hcc-with-a-single-positive-celiac-node weekly 0.8 https://www.themednet.org/in-the-absence-of-specific-driver-mutations-are-you-routinely-offering-combination-chemotherapy-immunotherapy-first-line-for-metastatic-squamous-cell-carcinoma-of-the-lung-in-patients-with-autoimmune-disease-but-not-currently-on-immunosuppression weekly 0.8 https://www.themednet.org/are-there-any-factors-which-would-lead-you-away-from-recommending-active-surveillance-in-low-risk-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-consider-met-amplification-in-your-first-line-treatment-decisions-for-patients-with-metastatic-nsclc weekly 0.8 https://www.themednet.org/in-a-patient-with-end-stage-renal-disease-and-chronic-oliguria-what-strategies-do-you-use-to-avoid-excessive-bladder-irradiation-when-treating-prostate-cancer-with-external-beam-radiotherapy weekly 0.8 https://www.themednet.org/with-the-approval-of-frontline-pembrolizumab-monotherapy-for-advanced-nsclc-with-pd-l1-of-1-or-above-how-do-you-select-who-gets-chemo-io-versus-pembro-monotherapy-if-pd-l1-between-1-49 weekly 0.8 https://www.themednet.org/what-radiation-dose-fractionation-and-volume-would-you-use-in-an-elderly-patient-with-localized-extensive-anorectal-malignant-melanoma-status-post-laparoscopic-apr weekly 0.8 https://www.themednet.org/what-would-be-your-approach-in-a-patient-with-met-amplification-and-pdl-1-80-expression weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemort-to-a-patient-with-pancreatic-adenocarcinoma-who-underwent-neoadjuvant-therapy-with-folfirinox-and-sbrt-but-had-a-positive-neck-margin-on-resection-and-is-now-s-p-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-treat-encapsulated-papillary-carcinoma-of-the-breast-after-lumpectomy-with-negative-margins weekly 0.8 https://www.themednet.org/what-systemic-therapy-would-you-offer-a-postmenopausal-women-with-oligometastatic-sternal-disease-which-developed-while-on-tamoxifen weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-anti-hormonal-therapy-after-bilateral-mastectomies-for-multifocal-multicentric-high-grade-dcis weekly 0.8 https://www.themednet.org/do-you-attempt-to-spare-a-strip-of-skin-for-palliative-8-gy-x-1-fraction-radiation-treatments weekly 0.8 https://www.themednet.org/are-there-any-specific-high-risk-features-or-situations-for-which-you-would-offer-adjuvant-radiation-to-a-newly-diagnosed-benign-pleomorphic-adenomas-following-resection weekly 0.8 https://www.themednet.org/if-a-patient-achieves-excellent-clinical-radiographic-response-to-neoadjuvant-thp-would-you-omit-ac-and-proceed-with-surgery weekly 0.8 https://www.themednet.org/for-patients-undergoing-breast-conservation-therapy-how-do-you-ensure-dose-to-the-skin-during-treatment-planning weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-a-malt-lymphoma-h-pylori-negative-found-incidentally-in-the-surgical-specimen-at-the-time-of-sleeve-gastrectomy weekly 0.8 https://www.themednet.org/how-do-you-mitigate-the-risk-of-hearing-loss-for-patients-requiring-cisplatin weekly 0.8 https://www.themednet.org/would-uterine-perforation-at-the-time-of-hysterectomy-push-you-to-recommend-pelvic-rt-in-a-patient-who-would-otherwise-receive-cuff-brachytherapy weekly 0.8 https://www.themednet.org/would-you-offer-radiation-therapy-for-pleural-or-peritoneal-based-pseudomyxoma-peritonei weekly 0.8 https://www.themednet.org/how-do-you-manage-soft-tissue-necrosis-in-a-patient-who-underwent-tors-followed-by-rt weekly 0.8 https://www.themednet.org/how-do-you-manage-brca-wild-type-patients-with-an-incidental-stic-found-at-the-time-of-an-opportunistic-salpingectomy weekly 0.8 https://www.themednet.org/what-is-your-preferred-workflow-when-treating-avms-with-srs weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-in-a-patient-with-extensive-lcis-dcis-s-p-mastectomy-and-multiple-positive-lymph-nodes-due-to-surgical-seeding weekly 0.8 https://www.themednet.org/in-a-pre-menopausal-female-with-cervical-cancer-would-you-boost-a-hypermetabolic-ovary-on-pet weekly 0.8 https://www.themednet.org/how-would-you-approach-systemic-management-of-a-patient-with-an-early-aggressive-metastatic-relapse-of-previously-early-stage-triple-negative-disease-in-breast-only-but-now-with-multiple-distant-metastatic-sites-including-contralateral-breast-which-is-now weekly 0.8 https://www.themednet.org/how-do-you-approach-positioning-and-irradiation-of-breast-cancer-in-accessory-breast-tissue-in-the-axilla-if-the-accessory-breast-tissue-extends-into-the-arm-how-would-you-position-immobilize-the-arm weekly 0.8 https://www.themednet.org/what-is-the-best-supportive-care-for-lacrimation-rhinorrhea-with-pemetrexed-for-lung-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-tnbc-breast-cancer-with-local-recurrence-at-mastectomy-site-within-3-months-of-surgery weekly 0.8 https://www.themednet.org/for-stage-iii-nsclc-treated-with-definitive-intent-chemort-how-do-you-decide-to-proceed-with-surgery-vs-consolidation-immunotherapy weekly 0.8 https://www.themednet.org/what-dosimetric-concerns-do-you-have-regarding-pmrt-in-patients-with-magnetic-valve-tissue-expanders weekly 0.8 https://www.themednet.org/can-5-fu-be-substituted-for-adjuvant-capecitabine-for-a-dialysis-dependent-patient-with-triple-negative-breast-cancer-s-p-neoadjuvant-chemotherapy-followed-by-mastectomy-showing-small-residual-disease weekly 0.8 https://www.themednet.org/how-would-you-manage-contralateral-neck-recurrence-6-mos-following-resection-and-adjuvant-ccrt-for-node-positive-tongue-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-in-an-older-65-but-fit-patient-with-intermediate-risk-aml-but-with-mrd-persistence-after-induction-with-7-3 weekly 0.8 https://www.themednet.org/what-are-the-clear-criteria-for-unresectability-in-locally-advanced-nsclc-patients-other-than-medical-or-anatomic weekly 0.8 https://www.themednet.org/how-do-you-identify-immunotherapy-related-pneumonitis-vs-radiation-pneumonitis-in-a-patient-status-post-chemoradiation-receiving-consolidation-immunotherapy weekly 0.8 https://www.themednet.org/for-newly-diagnosed-alk-or-egfr-nsclc-with-oligometastases-to-brain-only-and-otherwise-cn0-1-thoracic-disease-would-you-offer-targeted-therapy-alone-or-srs-to-brain-concurrent-chemoradiation-surgery-to-chest weekly 0.8 https://www.themednet.org/in-otherwise-stage-iii-nsclc-patients-with-a-single-metastatic-site-that-is-treated-definitively-radiation-or-resection-followed-by-standard-of-care-chemoradiation-would-you-still-consider-consolidation-immunotherapy weekly 0.8 https://www.themednet.org/how-would-you-manage-an-elderly-patient-with-ge-junction-adenocarcinoma-who-is-not-interested-in-surgery-and-who-has-ulcerative-colitis-not-currently-on-medication-or-symptomatic weekly 0.8 https://www.themednet.org/in-patients-witih-locally-advanced-pancreatic-cancer-how-long-would-you-wait-after-1st-line-induction-chemotherapy-with-folfirinox-before-you-image-for-assessment-of-response-and-deciding-about-2nd-line-therapy weekly 0.8 https://www.themednet.org/how-would-your-treat-a-pregnant-woman-2nd-trimester-with-multifocal-her2-er-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-treat-metastatic-small-cell-carcinoma-of-the-bladder-cancer-refractory-to-first-line-therapy-cisplatin-etoposide weekly 0.8 https://www.themednet.org/how-do-you-time-re-staging-studies-and-adjuvant-durvalumab-for-stage-iii-nsclc-treated-with-definitive-ccrt weekly 0.8 https://www.themednet.org/do-you-stop-consolidative-durvalumab-after-one-year-as-per-the-pacific-trial-or-continue-if-the-patient-is-otherwise-tolerating-well weekly 0.8 https://www.themednet.org/is-there-a-role-for-the-neoadjuvant-use-of-cdk-4-6-inhibitors-with-endocrine-therapy-in-patients-with-well-differentiated-and-or-invasive-lobular-histology-who-desire-breast-conservation weekly 0.8 https://www.themednet.org/can-you-use-oncotype-for-determining-adjuvant-therapy-in-a-young-postmenopausal-woman-with-multifocal-hr-breast-cancer-s-p-mastectomy-with-2-positive-lymph-nodes weekly 0.8 https://www.themednet.org/what-is-your-approach-to-mediastinal-only-failure-outside-of-the-previous-chemo-radiation-field-for-sclc weekly 0.8 https://www.themednet.org/do-you-offer-apbi-to-patients-with-palb2-mutation-who-is-a-suitable-candidate weekly 0.8 https://www.themednet.org/how-do-you-manage-an-anal-scc-status-post-a-non-oncologic-excision-of-a-2-3-cm-primary-and-positive-excisional-biopsy-of-an-inguinal-node-with-pathology-revealing-lvsi-positive-surgical-margins-and-more-regional-lymph-nodes-on-pet weekly 0.8 https://www.themednet.org/what-are-the-roles-of-whole-brain-radiotherapy-and-stereotactic-radiosurgery-for-hemorrhagic-brain-metastases weekly 0.8 https://www.themednet.org/how-do-you-decide-what-elective-lymph-node-stations-to-include-in-your-treatment-volume-for-cervical-and-upper-and-middle-thoracic-esophagus-cancer weekly 0.8 https://www.themednet.org/would-you-recommend-hypofractionated-pmrt-with-a-positive-deep-margin weekly 0.8 https://www.themednet.org/what-dosing-schedule-of-cladribine-do-you-use-for-newly-diagnosed-hairy-cell-leukemia-in-need-of-treatment weekly 0.8 https://www.themednet.org/how-do-you-approach-elderly-patients-with-stage-iii-nsclc-who-have-a-reasonable-performance-status weekly 0.8 https://www.themednet.org/how-do-you-approach-prostate-cancer-patients-who-present-with-retroperitoneal-lymphadenopathy-stage-m1a weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-nsclc-on-pembrolizumab-with-a-sustained-complete-response-now-with-2-isolated-small-liver-lesions weekly 0.8 https://www.themednet.org/do-you-use-the-nm-lymphoscintigram-during-sentinel-node-identification-to-decide-whether-to-treat-the-internal-mammary-nodes weekly 0.8 https://www.themednet.org/at-what-anc-do-you-hold-weekly-taxol-for-adjuvant-therapy-of-her2-positive-breast-cancer weekly 0.8 https://www.themednet.org/do-you-continue-ovarian-suppression-for-pre-menopausal-women-with-hr-breast-cancer-after-progression-on-ovarian-suppression-ai-cdk4-6-inhibitor-i-e-when-fulvestrant-is-the-appropriate-next-line-of-therapy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-a-known-history-of-er-pr-90-and-her2-negative-who-develops-skeletal-metastatic-disease-on-adjuvant-endocrine-therapy-but-now-er-is-only-2-and-is-pr-and-her2-negative weekly 0.8 https://www.themednet.org/have-you-changed-your-steroid-pre-medication-regimens-when-treating-with-chemo-immunotherapy-combinations-for-metastatic-nsclc-vs-chemotherapy-alone weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-therapy-for-localized-medullary-carcinoma-of-the-ascending-colon-that-is-msi-h weekly 0.8 https://www.themednet.org/what-is-the-clinical-utility-of-the-combined-positive-score-cps-for-pdl-1-expression-when-considering-pembrolizumab-for-gastric-cancer weekly 0.8 https://www.themednet.org/would-you-consider-definitive-radiotherapy-for-ipmn-in-a-patient-who-is-not-a-surgical-candidate weekly 0.8 https://www.themednet.org/in-fully-resected-oral-scc-pts-with-high-risk-factors-that-does-not-cross-midline-would-you-radiate-the-contralateral-neck-if-it-is-pn0 weekly 0.8 https://www.themednet.org/how-would-you-treat-stage-ii-pediatric-type-follicular-lymphoma-that-is-not-amenable-to-surgical-resection-in-an-adolescent-and-young-adult-patient weekly 0.8 https://www.themednet.org/what-is-your-preferred-igrt-strategy-when-treating-breast-cancer-using-imrt weekly 0.8 https://www.themednet.org/how-long-do-you-continue-caplacizumab-in-relapsed-refractory-ttp weekly 0.8 https://www.themednet.org/what-is-your-perioperative-approach-for-a-patient-with-severe-hemophilia weekly 0.8 https://www.themednet.org/would-you-offer-a-ret-inhibitor-for-a-ret-mutated-medullary-thyroid-carcinoma-after-r1-resection-in-a-patient-with-elevated-calcitonin weekly 0.8 https://www.themednet.org/what-endocrine-therapy-would-you-recommend-for-a-perimenopausal-female-with-a-low-risk-oncotype-hr-her2-negative-slnb-negative-breast-cancer-who-is-clinically-postmenopausal-but-with-fsh-lh-and-estradiol-that-are-not-in-the-postmenopausal-range weekly 0.8 https://www.themednet.org/will-you-offer-adjuvant-bep-after-orchiectomy-to-a-patient-with-embryonal-carcinoma-solely-based-on-the-size-at-presentation-such-as-a-6-cm-testicular-mass weekly 0.8 https://www.themednet.org/are-there-any-specific-circumstances-when-you-would-consider-the-use-of-immunosuppression-for-dish weekly 0.8 https://www.themednet.org/what-is-your-approach-to-neoadjuvant-chemotherapy-for-a-t3n0-mid-rectal-cancer weekly 0.8 https://www.themednet.org/how-would-you-design-your-post-op-radiation-field-for-pt4a-laryngeal-scc-with-subglottic-extension-s-p-tl-who-has-a-te-fistula weekly 0.8 https://www.themednet.org/in-which-clinical-scenarios-is-relying-on-the-urine-protein-to-creatinine-ratio-as-a-measure-of-proteinuria-unreliable-and-interpretations-should-be-made-looking-at-urine-protein-and-urine-creatinine-separately weekly 0.8 https://www.themednet.org/in-women-of-childbearing-age-with-nmda-encephalitis-and-normal-pelvic-imaging-is-there-a-role-for-oophorectomy-for-possible-microteratoma weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-a-large-vessel-stroke-if-you-anticipate-the-development-of-malignant-cerebral-edema weekly 0.8 https://www.themednet.org/how-would-you-approach-a-primary-small-cell-carcinoma-of-the-vagina-in-a-patient-with-an-intact-uterus-and-cervix weekly 0.8 https://www.themednet.org/how-do-you-choose-between-oral-and-iv-cyclophosphamide-for-the-treatment-of-anca-associated-vasculitis weekly 0.8 https://www.themednet.org/how-do-you-help-your-patients-with-relapsed-refractory-terminal-osteosarcoma-who-want-to-donate-their-tumor-for-research weekly 0.8 https://www.themednet.org/is-there-any-role-for-iron-chelation-in-a-patient-with-iatrogenic-transfusion-induced-iron-overload-such-as-in-patients-with-end-stage-kidney-or-liver-disease weekly 0.8 https://www.themednet.org/when-do-you-prefer-pre-operative-srs-over-post-operative-srs-for-brain-metastases weekly 0.8 https://www.themednet.org/what-is-the-role-of-upfront-addition-of-an-alk-inhibitor-in-an-alk-positive-mature-b-cell-lymphoma-in-an-aya-patient weekly 0.8 https://www.themednet.org/would-diagnosis-of-a-low-grade-non-invasive-papillary-bladder-cancer-alter-your-recommendations-for-salvage-prostate-radiotherapy-after-rising-psa weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-mss-kras-mutated-locally-advanced-rectal-adenocarcinoma-with-a-mixed-response-to-neoadjuvant-folfox weekly 0.8 https://www.themednet.org/how-would-you-treat-single-celiac-focus-of-adenocarcinoma-of-unknown-primary weekly 0.8 https://www.themednet.org/how-do-you-determine-timing-and-frequency-of-stability-scans-for-a-patient-with-spontaneous-non-aneurysmal-intracerebral-hemorrhage weekly 0.8 https://www.themednet.org/in-a-patient-who-experienced-less-than-90-necrosis-after-neoadjuvant-chemotherapy-for-localized-high-grade-osteosarcoma-do-you-recommend-adjuvant-ifosfamide weekly 0.8 https://www.themednet.org/is-there-an-age-beyond-which-you-will-not-perform-salvage-prostate-brachytherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-at-risk-draining-nodes-and-the-bronchial-stump-in-port-volumes-for-margin-positive-pn0-nsclc weekly 0.8 https://www.themednet.org/what-is-the-best-way-to-approach-elevated-liver-enzymes-in-patients-treated-with-combination-tki-and-immunotherapy weekly 0.8 https://www.themednet.org/how-would-you-mange-a-completely-excised-true-anal-margin-squamous-cell-carcinoma-with-anal-canal-uninvolved-with-positive-inguinal-nodes-that-were-not-managed-surgically weekly 0.8 https://www.themednet.org/how-would-you-treat-a-stage-i-dlbcl-invading-the-mandible weekly 0.8 https://www.themednet.org/are-there-clinical-features-that-would-lead-you-to-consider-combining-sbrt-immunotherapy-in-a-high-risk-early-stage-nsclc weekly 0.8 https://www.themednet.org/how-would-you-treat-high-risk-prostate-adenocarcinoma-who-relapsed-after-rt-and-adt-with-a-very-low-psa-widespread-mets-to-bone-and-soft-tissue-who-is-progressing-on-adt-docetaxel-and-carboplatin weekly 0.8 https://www.themednet.org/in-light-of-rxponder-results-for-postmenopausal-women-with-early-stage-node-positive-hr-her2-breast-cancer-when-is-there-a-role-for-full-axillary-ln-dissection-to-confirm-degree-of-nodal-involvement-and-when-would-sentinel-ln-evaluation-be-sufficient weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-1b2-adenocarcinoma-of-the-endocervix-s-p-tah-bso-who-was-found-to-have-bilateral-metastasis-to-fallopian-tube-a-1-cm-pelvic-side-wall-metastasis-and-no-ln-metastasis weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-anca-vasculitis-who-had-partial-response-but-continue-to-have-disease-activity-on-q-6-month-maintenance-rituximab-and-remain-on-steroids weekly 0.8 https://www.themednet.org/when-if-ever-would-you-trace-the-facial-nerve-back-to-the-base-of-skull-for-a-pleomorphic-adenoma-of-the-parotid weekly 0.8 https://www.themednet.org/what-is-your-preferred-regimen-for-remission-induction-and-maintenance-in-egpa-with-cardiac-involvement weekly 0.8 https://www.themednet.org/how-soon-after-ebrt-would-you-consider-salvage-brachytherapy-for-biopsy-confirmed-local-recurrence-of-prostate-cancer weekly 0.8 https://www.themednet.org/can-you-use-other-iron-formulations-if-a-patient-develops-stevens-johnson-syndrome-with-ferumoxytol weekly 0.8 https://www.themednet.org/do-you-typically-incorporate-radiotherapy-into-the-management-of-extraskeletal-myxoid-chondrosarcoma weekly 0.8 https://www.themednet.org/what-is-the-role-of-preoperative-radiation-in-patients-with-bone-metastases-needing-surgical-stabilization-ie-orif-but-without-tumor-resection weekly 0.8 https://www.themednet.org/when-is-the-best-time-to-consider-left-atrial-appendage-closure-for-secondary-stroke-prevention-in-patients-with-atrial-fibrillation weekly 0.8 https://www.themednet.org/how-do-you-approach-the-diagnosis-of-ms-subtypes-like-balos-concentric-sclerosis weekly 0.8 https://www.themednet.org/do-you-use-pimavanserin-to-treat-psychotic-symptoms-in-lewy-body-dementia weekly 0.8 https://www.themednet.org/what-is-the-appropriate-workup-and-treatment-for-patients-with-smart-syndrome-following-radiation-for-brain-tumors weekly 0.8 https://www.themednet.org/what-is-the-preferred-adjuvant-therapy-for-high-risk-non-clear-cell-rcc weekly 0.8 https://www.themednet.org/how-would-you-approach-therapy-for-a-patient-with-high-grade-sarcoma-who-is-unable-to-tolerate-systemic-cytotoxic-chemotherapy-but-whose-tumor-revealed-nras-g12a-brca1-and-met-amplification weekly 0.8 https://www.themednet.org/does-the-presence-of-anca-antibodies-in-patients-with-newly-diagnosed-lupus-nephritis-alter-your-approach-to-management weekly 0.8 https://www.themednet.org/how-would-you-approach-immunosuppression-for-patients-with-severe-aplastic-anemia-who-are-not-transplant-or-atg-candidates weekly 0.8 https://www.themednet.org/for-patients-with-generalized-tonic-clonic-seizures-lasting-2-minutes-without-iv-access-what-alternative-medications-can-be-used weekly 0.8 https://www.themednet.org/how-do-you-approach-a-tumor-bed-recurrence-after-previous-neoadjuvant-chemo-and-cystectomy-for-bladder-cancer weekly 0.8 https://www.themednet.org/in-patients-with-duchenne-muscular-dystrophy-who-have-an-exon-51-mutation-do-you-treat-with-both-prednisone-and-eteplirsen weekly 0.8 https://www.themednet.org/what-data-is-used-to-show-cystectomy-is-superior-to-concurrent-chemoradiation-for-muscle-invasive-bladder-cancer weekly 0.8 https://www.themednet.org/is-there-role-for-partial-breast-radiation-in-a-small-1cm-low-to-intermediate-grade-dcis-with-widely-negative-margins weekly 0.8 https://www.themednet.org/which-chemotherapy-regimen-would-you-recommend-for-locally-recurrent-tnbc-several-years-after-therapy-with-docetaxel-cyclophosphamide-for-four-cycles weekly 0.8 https://www.themednet.org/what-is-your-perioperative-approach-to-holding-and-restarting-hydroxyurea-in-patients-with-essential-thrombocythemia weekly 0.8 https://www.themednet.org/do-you-routinely-perform-bilateral-oophorectomy-at-the-time-of-hysterectomy-for-a-premenopausal-woman-with-a-uterine-leiomyosarcoma-that-appears-to-be-limited-to-the-uterus weekly 0.8 https://www.themednet.org/would-one-expect-any-significant-response-of-pulmonary-metastases-with-usual-dosage-of-weekly-cisplatin-during-definitive-chemort-for-cervical-cancer weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-use-on-a-large-retroperitoneal-recurrence-of-cervical-cancer-that-is-extending-to-previously-treated-5040cgy-pelvis weekly 0.8 https://www.themednet.org/how-late-after-completion-of-adjuvant-capecitabine-and-radiation-would-you-consider-adjuvant-olaparib-for-a-patient-with-gbrca-mutated-tnbc weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-therapy-after-diagnosis-of-presumed-stage-ia-5cm-er-pr-uterine-adenosarcoma-on-a-total-hysterectomy-with-bilateral-salpingoopheretomy-without-staging weekly 0.8 https://www.themednet.org/should-assessing-for-a-mthfr-mutation-be-part-of-the-thrombophilia-evaluation-in-a-patient-presenting-with-a-thrombus weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-severe-manifestations-of-neuropsychiatric-sle-in-the-setting-of-concomitant-infection weekly 0.8 https://www.themednet.org/is-there-a-role-for-measuring-serum-mycophenolate-mofetil-levels-or-its-active-metabolite-in-the-management-of-lupus-nephritis weekly 0.8 https://www.themednet.org/what-regimen-would-you-recommend-for-a-younger-fit-transplant-eligible-patient-with-relapsed-idh1-positive-aml weekly 0.8 https://www.themednet.org/do-you-prefer-carboplatin-or-cisplatin-with-etoposide-for-stage-iv-extra-pulmonary-neuroendocrine-carcinomas-with-a-ki-67-55 weekly 0.8 https://www.themednet.org/would-you-offer-sbrt-for-a-functional-adrenal-adenoma weekly 0.8 https://www.themednet.org/would-you-consider-single-agent-tki-for-patient-with-metastatic-renal-cell-carcinoma-who-developed-biopsy-proven-giant-cell-arteritis-days-after-starting-immunotherapy weekly 0.8 https://www.themednet.org/would-you-modify-the-dose-of-aromatase-inhibitors-or-selective-estrogen-receptor-modulators-in-patients-who-have-a-history-of-gastric-bypass-or-other-malabsorptive-conditions-surgeries weekly 0.8 https://www.themednet.org/how-would-you-manage-metastatic-alveolar-soft-part-sarcoma-in-an-young-patient-failing-tki weekly 0.8 https://www.themednet.org/is-it-necessary-to-hold-azathioprine-in-a-crohns-patient-receiving-breast-radiation weekly 0.8 https://www.themednet.org/would-you-recommend-rt-for-dlbcl-of-a-pre-isthmus-node-incidentally-found-during-thyroidectomy-for-papillary-thyroid-cancer weekly 0.8 https://www.themednet.org/with-what-agents-can-you-replace-ppis-if-they-cause-thrombocytopenia weekly 0.8 https://www.themednet.org/what-would-be-your-preferred-second-line-treatment-for-a-frail-elderly-patient-progressing-on-rd weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-who-has-developed-neutropenia-with-the-combination-of-trastuzumab-pertuzumab-in-the-adjuvant-setting weekly 0.8 https://www.themednet.org/would-you-offer-a-complement-inhibitor-to-a-minimally-symptomatic-pnh-patient-with-mild-non-transfusion-dependent-hemolytic-anemia weekly 0.8 https://www.themednet.org/how-do-you-approach-infused-prostacyclin-therapy-for-critical-digital-ischemia weekly 0.8 https://www.themednet.org/do-you-ever-treat-regional-lymph-nodes-for-malignant-phyllodes-tumor-of-the-breast weekly 0.8 https://www.themednet.org/what-indications-would-lead-you-to-recommending-adjuvant-rt-for-adenoid-cystic-carcinoma-of-the-bartholins-gland weekly 0.8 https://www.themednet.org/how-do-you-approach-an-isolated-t-cell-gene-arrangement-found-in-the-setting-of-persistent-hypereosinophilia weekly 0.8 https://www.themednet.org/is-there-a-strong-rationale-for-contouring-small-and-large-bowel-structures-for-gi-cases-of-imrt-vmat-3d-crt-separately weekly 0.8 https://www.themednet.org/what-adjustments-if-any-do-you-make-to-chemotherapy-regimens-for-patients-with-chromosomal-breakage-disorders-who-develop-malignancy weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-1p19q-non-codeleted-high-grade-gliomas weekly 0.8 https://www.themednet.org/were-the-patients-enrolled-in-the-seam-ra-trial-prior-methotrexate-monotherapy-non-responders weekly 0.8 https://www.themednet.org/are-the-results-of-the-seam-ra-trial-generalizable-to-other-tnf-inhibitors-given-the-differences-in-immunogenicity weekly 0.8 https://www.themednet.org/was-the-methotrexate-dose-reduced-over-time-in-the-combination-therapy-or-methotrexate-monotherapy-groups-in-the-seam-ra-trial weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-driver-mutation-positive-stage-iv-nsclc-who-dont-benefit-from-upfront-first-line-tki weekly 0.8 https://www.themednet.org/in-which-platelet-function-disorders-would-you-consider-use-of-novoseven-as-opposed-to-platelet-transfusion weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-metastatic-hepatocellular-carcinoma-in-an-adolescent weekly 0.8 https://www.themednet.org/what-is-the-optimal-systemic-therapy-for-dedifferentiated-chondrosarcoma weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-anticoagulation-in-a-young-female-patient-with-persistently-elevated-factor-xi-activity weekly 0.8 https://www.themednet.org/how-would-you-treat-newly-diagnosed-advanced-stage-hodgkins-lymphoma-in-a-patient-with-significant-cardiac-systolic-dysfunction weekly 0.8 https://www.themednet.org/what-is-your-differential-for-a-patient-presenting-with-multiple-digits-affected-by-flexor-tenosynovitis-dupuytrens-and-no-evidence-of-peripheral-inflammatory-arthritis weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-holmes-tremor weekly 0.8 https://www.themednet.org/do-you-use-premedications-acetaminophen-diphenhydramine-before-prbc-and-plt-transfusions-to-prevent-febrile-nonhemolytic-transfusion-reactions-and-allergic-reactions weekly 0.8 https://www.themednet.org/when-would-you-initiate-chronic-therapeutic-phlebotomy-in-a-patient-with-erythrocytosis-secondary-to-a-high-hemoglobin-oxygen-affinity-hemoglobinopathy weekly 0.8 https://www.themednet.org/in-addition-to-adt-how-would-you-treat-gleason-8-pure-ductal-prostate-adenocarcinoma-with-oligometastatic-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-for-disease-activity-monitoring-in-patients-with-sarcoidosis weekly 0.8 https://www.themednet.org/how-do-you-manage-autonomic-storming-in-patients-with-increased-intracranial-pressure weekly 0.8 https://www.themednet.org/what-treatment-strategies-do-you-employ-in-patients-with-huntingtons-disease-who-have-parkinsonian-features weekly 0.8 https://www.themednet.org/what-indicators-do-you-use-to-identify-patients-with-ctd-ild-who-do-not-have-potential-to-improve-from-continued-immunosuppressive-therapy weekly 0.8 https://www.themednet.org/would-you-offer-consolidative-radiation-for-oligometastatic-uterine-serous-ca-s-p-surgery-and-chemotherapy-with-complete-response weekly 0.8 https://www.themednet.org/would-you-consider-using-oncotype-dx-testing-in-a-patient-with-breast-cancer-if-nodal-evaluation-is-not-performed weekly 0.8 https://www.themednet.org/would-you-consider-orbit-sparing-treatment-for-a-lacrimal-gland-carcinoma weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-therapy-for-a-urothelial-carcinoma-t2-on-turbt-but-ptis-at-margins-on-cystectomy weekly 0.8 https://www.themednet.org/should-patients-with-active-multiple-myeloma-and-other-gammopathies-be-routinely-vaccinated-against-herpes-zoster weekly 0.8 https://www.themednet.org/would-you-treat-pelvic-lymph-nodes-in-your-salvage-prostate-patient-after-rp-without-adverse-features-due-to-a-limited-no-pelvic-lymph-node-sampling weekly 0.8 https://www.themednet.org/how-often-should-you-repeat-iron-testing-in-patients-with-hemochromatosis-not-on-phlebotomy weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-vasculitis-in-a-sickle-cell-disease-patient weekly 0.8 https://www.themednet.org/in-patients-in-the-icu-who-are-on-the-inter-ictal-continuum-how-do-you-decide-whether-or-not-to-treat-for-potential-non-convulsive-status-epilepticus weekly 0.8 https://www.themednet.org/is-there-any-evidence-that-sotorasib-is-effective-in-kras-driven-tumors-beyond-kras-g12c weekly 0.8 https://www.themednet.org/would-you-routinely-use-g-csf-prophylaxis-in-a-cmml-patient-for-decitabine-related-neutropenia weekly 0.8 https://www.themednet.org/what-palliative-regimen-do-you-use-for-intra-pelvic-recurrence-of-cervical-cancer-after-definitive-chemort-with-t-o-brachytherapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-therapy-for-metastatic-extraskeletal-osteosarcoma-in-a-young-fit-patient weekly 0.8 https://www.themednet.org/is-it-ever-reasonable-to-switch-to-a-different-tnfi-as-opposed-to-switching-to-an-agent-in-a-different-class-in-a-case-of-tnfi-induced-lupus-or-psoriasis weekly 0.8 https://www.themednet.org/is-there-utility-in-administering-adjuvant-chemotherapy-to-a-patient-with-relapsed-osteosarcoma-for-whom-cr2-is-achieved-after-surgical-resection-alone weekly 0.8 https://www.themednet.org/when-would-you-consider-a-diagnosis-of-peritonitis-in-a-patient-with-sle weekly 0.8 https://www.themednet.org/what-is-the-maximum-prbc-volume-you-can-transfuse-when-performing-a-manual-exchange-transfusion-in-an-adult-sized-patient-with-sickle-cell-disease weekly 0.8 https://www.themednet.org/when-contouring-the-prostate-bed-for-salvage-xrt-do-you-include-the-mesorectal-fat-anterior-to-the-rectum-or-just-the-mesorectal-fat-at-or-below-the-levator-ani weekly 0.8 https://www.themednet.org/for-locally-recurrent-nsclc-after-surgical-resection-but-with-subcentimeter-ipsilateral-nodules-of-indeterminate-etiology-would-you-consider-local-therapy-such-as-chemoradiation-durvalumab weekly 0.8 https://www.themednet.org/how-do-you-approach-nsaid-use-in-patients-on-ssris weekly 0.8 https://www.themednet.org/how-do-you-approach-a-metastatic-juvenile-granulosa-cell-tumor-of-the-ovary-in-a-premenopausal-patient-following-a-hysterectomy-and-uso-with-the-remaining-ovary-in-situ weekly 0.8 https://www.themednet.org/how-long-would-you-treat-with-antimycobacterials-before-starting-biologic-dmard-in-a-patient-with-latent-tb-and-active-rheumatoid-arthritis weekly 0.8 https://www.themednet.org/do-you-recommend-sbrt-for-an-unresectable-unembolizable-10cm-chest-wall-avm-with-a-diffuse-nidus weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-on-echocardiogram-and-pft-to-determine-who-needs-further-evaluation-for-ctd-associated-pulmonary-hypertension weekly 0.8 https://www.themednet.org/how-would-you-approach-systemic-therapy-for-a-pre-menopausal-woman-with-er-pr-her2-positive-breast-cancer-who-had-a-local-recurrence-6-months-after-completing-adjuvant-tch-and-a-year-of-trastuzumab-tamoxifen weekly 0.8 https://www.themednet.org/is-prior-prostate-sbrt-a-contraindication-to-hemorrhoidal-banding weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-sickle-cell-patients-who-mistrust-western-medicine-and-prefer-naturopathic-therapies weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-idiopathic-myorhythmia weekly 0.8 https://www.themednet.org/would-you-consider-short-course-radiation-therapy-for-rectal-cancer-following-apr weekly 0.8 https://www.themednet.org/outside-of-a-clinical-trial-what-is-your-treatment-of-choice-for-metastatic-melanoma-of-soft-parts-or-clear-cell-sarcoma weekly 0.8 https://www.themednet.org/how-do-you-tailor-seizure-medications-in-patients-who-become-pregnant-or-are-family-planning weekly 0.8 https://www.themednet.org/how-do-you-manage-incidentally-identified-pituitary-lesions-on-brain-imaging weekly 0.8 https://www.themednet.org/in-what-situation-do-you-use-nerve-blocks-in-patients-with-headache weekly 0.8 https://www.themednet.org/for-patients-with-post-stroke-headaches-what-treatment-do-you-typically-recommend weekly 0.8 https://www.themednet.org/what-workup-do-you-start-in-patients-with-evidence-of-demyelination-on-emg-ncs weekly 0.8 https://www.themednet.org/how-do-you-differentiate-motor-neuron-disease-from-limb-girdle-muscular-dystrophy-on-electrodiagnostic-testing weekly 0.8 https://www.themednet.org/how-long-would-you-continue-chemotherapy-for-resectable-pancreatic-cancer-not-amenable-to-surgery-due-to-functional-status-or-comorbidity weekly 0.8 https://www.themednet.org/would-you-have-concerns-using-azathioprine-in-nxp-2-or-tif-1-gamma-positive-dermatomyositis-patients-due-to-higher-risk-of-malignancy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-differentiating-sle-flare-in-pregnancy-vs-pre-eclampsia weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-cervical-cancer-in-a-patient-with-a-previous-supra-cervical-hysterectomy weekly 0.8 https://www.themednet.org/do-you-recommend-that-patients-undergoing-radiation-treatment-get-a-covid-vaccine-booster weekly 0.8 https://www.themednet.org/will-you-consider-adding-an-ar-targeted-agent-to-adt-for-a-patient-thought-to-have-isolated-pelvic-nodal-recurrence-of-prostate-ca-if-next-generation-imaging-reveals-additional-non-regional-disease-not-seen-on-conventional-imaging weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-for-a-locally-advanced-cervical-cancer-in-the-context-of-a-completely-prolapsed-uterus-in-a-non-surgical-candidate weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-olaparib-in-a-premenopausal-female-with-tnbc-with-high-risk-features-and-germline-brca1-mutation-who-achieved-pcr-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/in-the-rare-setting-of-enoxaparin-injection-induced-abdominal-wall-hematoma-in-patients-requiring-long-term-anticoagulation-what-is-your-timeline-for-restarting-anticoagulation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-rheumatoid-arthritis-and-moderate-disease-activity-on-25-mg-of-po-methotrexate weekly 0.8 https://www.themednet.org/would-you-recommend-induction-chemotherapy-such-as-tpf-to-a-patient-with-locally-advanced-sarcomatoid-carcinoma-of-the-nasal-cavity weekly 0.8 https://www.themednet.org/how-do-you-recommend-differentiating-between-localized-cutaneous-melanoma-of-the-perianal-skin-versus-mucosal-melanoma-of-anal-canal weekly 0.8 https://www.themednet.org/in-the-era-of-neoadjuvant-chemotherapy-how-reliable-is-biopsy-for-assessment-of-lvi-to-make-decisions-about-pmrt weekly 0.8 https://www.themednet.org/how-would-you-manage-a-cll-patient-who-experienced-severe-infusion-reactions-with-rituximab-and-has-exhausted-all-other-options weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-osteoporosis-in-patients-with-ckd-who-develop-a-fragility-fracture-while-on-denosumab weekly 0.8 https://www.themednet.org/what-dhe-migraine-protocol-works-best-for-acute-treatment-both-in-terms-of-dosage-and-timeframe weekly 0.8 https://www.themednet.org/how-are-you-timing-the-third-dose-of-the-covid-19-mrna-vaccine-in-patients-on-rituximab weekly 0.8 https://www.themednet.org/would-you-use-aspirin-81-mg-for-vte-prophylaxis-in-patients-on-adjuvant-tamoxifen-serms weekly 0.8 https://www.themednet.org/what-is-the-preferred-treatment-regimen-for-an-adolescent-or-young-adult-patient-with-treatment-related-aml weekly 0.8 https://www.themednet.org/would-you-pursue-temporal-artery-biopsy-in-patients-with-pmr-who-develop-cranial-gca-symptoms-and-have-been-on-pmr-dose-steroids-for-one-year weekly 0.8 https://www.themednet.org/what-is-your-approach-to-checking-serum-vwf-antigen-levels-in-adult-patients-with-cns-vasculitis-for-monitoring-disease-activity weekly 0.8 https://www.themednet.org/how-do-you-approach-prophylaxis-against-glucocorticoid-induced-osteoporosis-in-patients-with-end-stage-renal-disease-on-dialysis weekly 0.8 https://www.themednet.org/how-long-should-patients-treated-with-frontline-therapy-for-hodgkin-lymphoma-wait-before-attempting-to-conceive-a-child weekly 0.8 https://www.themednet.org/how-would-you-approach-patients-with-resected-node-positive-n1-n2-large-cell-neuroendocrine-carcinoma-of-the-lung-who-have-esrd-on-dialysis weekly 0.8 https://www.themednet.org/how-would-you-approach-definitive-treatment-of-intermediate-risk-prostate-cancer-with-baseline-severe-aua-25-urinary-dysfunction-and-severe-rheumatoid-arthritis weekly 0.8 https://www.themednet.org/how-do-you-approach-radiation-volumes-and-dose-for-unknown-primary-presumed-minor-salivary-gland-carcinoma weekly 0.8 https://www.themednet.org/how-would-you-manage-a-nodal-recurrence-of-cutaneous-scc-if-the-patient-is-unable-to-receive-surgery-for-6-8-weeks weekly 0.8 https://www.themednet.org/would-you-consider-radiation-therapy-for-prostate-cancer-in-a-patient-with-osteogenesis-imperfecta weekly 0.8 https://www.themednet.org/how-do-you-approach-liver-sbrt-in-patients-with-hepatocellular-carcinoma-who-arent-candidates-for-surgery-or-other-interventional-procedures-when-the-overall-liver-volume-is-small-making-it-difficult-to-achieve-liver-constraints weekly 0.8 https://www.themednet.org/are-there-extra-precautions-required-for-sbrt-to-a-lesion-that-is-proximal-to-an-aortic-aneurysm weekly 0.8 https://www.themednet.org/how-do-you-determine-if-a-patient-is-safe-to-drive-after-having-a-pca-infarct weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-favorable-intermediate-prostate-cancer-patient-who-obtains-a-high-decipher-test-score-at-the-end-of-their-rt-course weekly 0.8 https://www.themednet.org/would-you-add-a-parp-inhibitor-to-bevacizumab-maintenance-for-a-patient-with-a-high-grade-serous-ovarian-cancer-with-a-germline-brca2-variant-of-unknown-significance-and-negative-somatic-testing weekly 0.8 https://www.themednet.org/for-colorectal-cancer-would-you-consider-using-capecitabine-5-days-on-2-days-off-instead-of-the-usual-2-weeks-on-1-week-off-or-1-week-on-1-week-off-schedules weekly 0.8 https://www.themednet.org/how-do-you-manage-adhd-in-patients-with-tourette-syndrome weekly 0.8 https://www.themednet.org/what-treatment-options-would-you-provide-a-her2-hr-patient-with-significant-residual-disease-s-p-tchp-if-they-go-on-to-develop-severe-neuropathy-following-adjuvant-t-dm1-therapy weekly 0.8 https://www.themednet.org/would-you-consider-maintenance-therapy-in-a-recurrent-endometrial-cancer-that-is-msi-h-and-er-pr-that-achieved-a-complete-response-after-pelvic-rtx-and-4-cycles-of-carbo-taxol weekly 0.8 https://www.themednet.org/how-do-you-manage-tinnitus-in-patients-with-intracranial-hypotension weekly 0.8 https://www.themednet.org/how-would-you-approach-low-grade-non-invasive-urothelial-carcinoma-arising-from-seminal-vesicle-and-ejaculatory-ducts-with-invasion-into-prostate weekly 0.8 https://www.themednet.org/for-esophageal-cancer-treated-with-primary-chemoradiotherapy-with-residual-disease-on-3-months-pet-would-you-repeat-a-pet-at-6-months weekly 0.8 https://www.themednet.org/would-you-modify-standard-wprt-brachy-radiation-for-cervical-scc-s-p-negative-nodal-staging-but-aborted-hysterectomy-due-to-previously-undetected-superficial-vaginal-disease weekly 0.8 https://www.themednet.org/for-patients-with-metastatic-triple-negative-breast-cancer-on-nab-paclitaxel-atezolizumab-who-have-an-ongoing-response-are-you-continuing-immunotherapy-after-the-fda-withdrawal-of-atezolizumab weekly 0.8 https://www.themednet.org/when-do-you-start-anticoagulation-for-secondary-prevention-in-patients-with-hfref-and-history-of-embolic-strokes weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-treatment-of-metastatic-renal-cell-carcinoma-with-unclassified-histology weekly 0.8 https://www.themednet.org/how-do-you-approach-egfr-mutated-nsclc-with-isolated-progression-in-the-chest-who-is-planned-for-a-course-of-radiation-at-least-3-4-weeks weekly 0.8 https://www.themednet.org/how-would-you-treat-high-grade-urothelial-carcinoma-of-the-prostate-with-only-hguc-with-cis-in-bladder weekly 0.8 https://www.themednet.org/which-method-do-you-prefer-to-assess-for-stigmata-of-old-optic-neuropathy weekly 0.8 https://www.themednet.org/would-differentiating-between-embryonal-vs-alveolar-rhabdomyosarcoma-of-the-nasal-cavity-change-your-neoadjuvant-chemotherapy-regimen-or-make-you-consider-neoadjuvant-radiation-in-a-locally-advanced-pleomorphic-rms weekly 0.8 https://www.themednet.org/would-concurrent-endocrine-therapy-and-parpi-maintenance-be-safe-and-appropriate-after-surgical-treatment-adjuvant-chemotherapy-for-a-patient-with-brca1-mutated-synchronous-early-stage-hr-breast-ca-and-stage-iia-fallopian-tube-carcinoma weekly 0.8 https://www.themednet.org/do-you-screen-for-hla-b-5801-prior-to-starting-allopurinol-in-patients-of-backgrounds-other-than-asian-or-african-american weekly 0.8 https://www.themednet.org/how-do-you-treat-patients-with-symptoms-of-acute-ischemic-stroke-who-have-an-allergic-reaction-to-alteplase weekly 0.8 https://www.themednet.org/how-would-you-treat-a-recurrent-metastatic-invasive-pagets-disease-of-the-vulva weekly 0.8 https://www.themednet.org/how-do-you-diagnose-and-treat-patients-who-develop-uveitis-while-on-bisphosphonate-therapy-for-osteoporosis weekly 0.8 https://www.themednet.org/when-do-you-check-for-epor-gene-mutations-in-your-workup-for-erythrocytosis-and-if-found-how-do-you-manage-it weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-workup-for-an-underlying-systemic-condition-in-a-patient-presenting-with-retinal-vasculitis weekly 0.8 https://www.themednet.org/what-is-your-steroid-sparing-agent-of-choice-to-treat-gca-given-the-current-tocilizumab-shortage weekly 0.8 https://www.themednet.org/how-do-you-approach-a-medically-inoperable-patient-with-clinically-stage-2-grade-1-endometrioid-endometrial-carcinoma-with-heavy-vaginal-bleeding-that-is-refractory-to-ebrt-and-requiring-inpatient-management-with-transfusions weekly 0.8 https://www.themednet.org/for-an-otherwise-healthy-post-menopausal-woman-with-early-stage-hr-bc-and-persistent-ai-intolerance-is-there-an-age-cutoff-above-which-you-would-consider-avoiding-adjuvant-tamoxifen-therapy weekly 0.8 https://www.themednet.org/what-is-the-best-approach-to-organ-confined-squamous-cell-cancer-of-the-prostate weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-well-controlled-seropositive-ra-on-abatacept-who-develops-melanoma weekly 0.8 https://www.themednet.org/for-patients-with-well-differentiated-net-whose-carcinoid-symptoms-are-controlled-on-ssas-but-have-persistently-elevated-5hiaa-would-you-consider-adding-telotristat-for-prevention-of-carcinoid-heart-disease weekly 0.8 https://www.themednet.org/does-your-adjuvant-radiation-approach-differ-for-ependymomas-with-rela-fusion weekly 0.8 https://www.themednet.org/would-use-of-proton-radiation-versus-photon-radiation-in-neuroblastoma-patients-post-autologous-stem-cell-transplant-reduce-the-risk-of-transplant-associated-tma weekly 0.8 https://www.themednet.org/how-would-you-manage-t4n0-nsclc-with-two-separate-nodules-in-different-ipsilateral-lobes weekly 0.8 https://www.themednet.org/how-many-cycles-of-bep-would-you-treat-an-immature-teratoma-of-the-ovary weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-to-adjuvant-therapy-for-a-masaoka-stage-iii-thymic-carcinoma-after-r1-resection weekly 0.8 https://www.themednet.org/would-you-add-neoadjuvant-pembrolizumab-to-chemotherapy-in-a-premenopausal-female-with-t2n1-breast-cancer-that-is-weakly-er-or-pr-positive weekly 0.8 https://www.themednet.org/how-do-you-treat-muscle-invasive-bladder-cancer-with-neuroendocrine-differentiation weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-acquired-von-willebrand-disease-who-requires-dapt-for-arterial-disease weekly 0.8 https://www.themednet.org/in-the-absence-of-symptoms-would-you-still-treat-high-risk-myelofibrosis-if-transplant-ineligible weekly 0.8 https://www.themednet.org/would-you-treat-iron-deficiency-in-post-pv-myelofibrosis-if-anemia-is-the-predominant-concern weekly 0.8 https://www.themednet.org/is-there-a-role-for-liver-transplantation-in-an-initially-unresectable-hcc-with-a-complete-response-after-bevacizumab-atezolizumab weekly 0.8 https://www.themednet.org/would-you-continue-pembrolizumab-in-a-patient-with-bcg-refractory-nmibc-with-cis-who-has-a-negative-surveillance-cystoscopy-including-random-biopsies-but-positive-urine-cytology weekly 0.8 https://www.themednet.org/how-do-you-manage-botox-injections-in-patients-with-cervical-dystonia-after-getting-implanted-with-dbs weekly 0.8 https://www.themednet.org/would-you-prioritize-tace-or-systemic-therapy-in-bclc-b-multifocal-hcc-with-tumor-bulk-higher-than-up-to-7 weekly 0.8 https://www.themednet.org/would-you-give-whole-abdomen-rt-for-preoperative-rupture-of-favorable-histology-wilms-tumor-treated-with-induction-chemotherapy-followed-by-gtr weekly 0.8 https://www.themednet.org/do-you-offer-consolidation-durvalumab-in-stage-iii-patients-with-nsclc-who-developed-grade-2-radiation-pneumonitis-during-chemoradiation weekly 0.8 https://www.themednet.org/how-do-you-approach-conversations-regarding-discontinuation-of-transfusions-in-patients-with-advanced-hematologic-malignancies-who-are-otherwise-appropriate-for-hospice weekly 0.8 https://www.themednet.org/is-vaginal-delivery-safe-in-patients-diagnosed-with-pseudotumor-cerebri-iih weekly 0.8 https://www.themednet.org/do-you-need-to-wait-for-estradiol-and-fsh-levels-to-normalize-before-you-can-switch-from-tamoxifen-to-an-ai-for-a-pre-menopausal-woman-with-er-breast-cancer weekly 0.8 https://www.themednet.org/what-is-the-optimal-sequencing-of-systemic-therapy-and-consolidative-thoracic-rt-for-oligometastatic-nsclc weekly 0.8 https://www.themednet.org/what-particular-pre-operative-considerations-should-we-consider-for-sle-patients-undergoing-elective-surgery weekly 0.8 https://www.themednet.org/how-do-you-treat-leptomeningeal-disease-in-metastatic-hr-her2-breast-cancer weekly 0.8 https://www.themednet.org/does-anticoagulation-alter-your-decision-for-elective-nodal-radiation-in-a-prostate-cancer-patient weekly 0.8 https://www.themednet.org/does-the-presence-of-a-brca-1-2-mutation-affect-your-recommendation-for-post-mastectomy-rt-in-patients-with-pt1-2-n0-disease weekly 0.8 https://www.themednet.org/do-you-recommend-covid-vaccination-in-patients-with-antiphospholipid-antibody-positivity-or-other-prothrombotic-states-not-on-anti-coagulation weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-underlying-psychiatric-disorders-who-refuse-cml-treatment-due-to-not-believing-their-diagnosis weekly 0.8 https://www.themednet.org/would-you-offer-additional-adjuvant-folfox-for-patients-with-rectal-ca-undergoing-tnt-who-transition-to-cape-rt-and-subsequent-surgery-early-due-to-absence-of-clinical-response-to-folfox weekly 0.8 https://www.themednet.org/how-would-you-manage-vte-in-a-patient-with-bleeding-disorder-such-as-hemophilia weekly 0.8 https://www.themednet.org/do-you-always-initiate-hypercoagulable-work-up-in-a-patient-with-recurrent-stroke weekly 0.8 https://www.themednet.org/how-would-you-treat-a-metastatic-small-cell-carcinoma-of-the-larynx-that-is-locally-progressing-on-cisplatin-etoposide weekly 0.8 https://www.themednet.org/how-do-you-manage-trastuzumab-emtansine-peri-operarively weekly 0.8 https://www.themednet.org/how-would-you-approach-an-early-stage-node-negative-breast-cancer-s-p-bcs-with-a-history-of-severe-chest-wall-burns weekly 0.8 https://www.themednet.org/how-do-you-account-for-previous-dose-from-i-131-when-delivering-external-beam-radiation-therapy-near-the-thyroid-bed weekly 0.8 https://www.themednet.org/in-your-practice-do-you-usually-check-mma-and-b12-simultaneously-or-start-with-b12-levels-and-check-mma-only-if-indeterminate weekly 0.8 https://www.themednet.org/how-would-you-treat-a-bone-oligometastasis-that-required-surgical-fixation-for-pathologic-fracture weekly 0.8 https://www.themednet.org/when-do-you-consider-starting-an-anticholinergic-in-patients-with-tremor-predominant-parkinsons-disease weekly 0.8 https://www.themednet.org/when-is-a-lumbar-puncture-indicated-in-a-lymphoma-staging-work-up-for-a-pediatric-or-aya-patient weekly 0.8 https://www.themednet.org/in-what-circumstances-would-you-give-g-csf-to-a-patient-with-severe-neutropenia-and-hlh weekly 0.8 https://www.themednet.org/in-a-patient-with-suspected-miller-fisher-syndrome-would-you-wait-until-antibody-testing-results-to-start-ivig-or-treat-empirically weekly 0.8 https://www.themednet.org/how-would-you-approach-synchronous-early-stage-nsclc-adenocarcinoma-and-locally-advanced-symptomatic-squamous-head-and-neck-cancer-that-is-deemed-nonresectable-upfront weekly 0.8 https://www.themednet.org/is-there-a-role-for-extended-adjuvant-neratinib-with-pcr-after-neoadjuvant-chemotherapy-in-triple-positive-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-regarding-the-cardiovascular-risk-of-febuxostat weekly 0.8 https://www.themednet.org/how-you-approach-treatment-of-a-glioblastoma-in-the-setting-of-prior-wbrt-for-a-metastatic-non-cns-malignancy weekly 0.8 https://www.themednet.org/what-dose-should-you-treat-the-anal-canal-after-excision-of-a-t1-anal-cancer-with-positive-margins weekly 0.8 https://www.themednet.org/what-is-the-best-treatment-for-a-squamous-cell-carcinoma-of-the-palpebral-conjunctiva-with-persistently-positive-margins-after-resection weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-steroids-for-active-muscle-disease-in-patients-with-scleroderma-myositis-overlap-syndromes weekly 0.8 https://www.themednet.org/how-would-you-approach-early-stage-unfavorable-classical-hodgkin-lymphoma-with-metabolic-cr-apart-from-a-single-residual-positive-node-after-6-cycles-of-abvd weekly 0.8 https://www.themednet.org/in-what-setting-would-you-omit-neoadjuvant-radiation-in-favor-of-neoadjuvant-chemotherapy-alone-for-a-t3n0-upper-rectal-adenocarcinoma weekly 0.8 https://www.themednet.org/do-you-consider-adjuvant-chemoradiation-for-resected-pancreatic-cancer-with-anterior-surface-margin-positivity weekly 0.8 https://www.themednet.org/for-hypogammaglobulinemia-as-a-complication-of-successful-treatment-do-you-empirically-start-prophylaxis-with-either-400-mg-kg-monthly-for-ivig-or-100-mg-kg-weekly-for-subcutaneous-immune-globulin weekly 0.8 https://www.themednet.org/in-what-circumstances-would-you-recommend-using-dibh-in-patients-with-breast-cancer-during-an-electron-boost weekly 0.8 https://www.themednet.org/how-do-you-diagnose-sickle-hepatopathy weekly 0.8 https://www.themednet.org/how-would-you-proceed-with-the-management-of-a-healthy-patient-with-stage-iv-grade-3-endometrioid-uterine-cancer-metastatic-to-the-right-diaphragm-and-other-peritoneal-surfaces weekly 0.8 https://www.themednet.org/what-treatment-approach-would-you-use-for-patients-with-localized-wilms-tumor-which-is-unilateral-favorable-histology-negative-loh-who-develop-a-new-lung-nodule-at-the-end-of-therapy weekly 0.8 https://www.themednet.org/when-would-you-use-acalabrutinib-in-combination-with-obinutuzumab-vs-acalabrutinib-alone-in-upfront-cll-treatment weekly 0.8 https://www.themednet.org/would-you-irradiate-elective-lymph-nodes-for-a-t1-merkel-cell-carcinoma-of-the-head-and-neck-with-a-negative-sentinel-lymph-node weekly 0.8 https://www.themednet.org/how-do-you-manage-severe-fibrosis-contracture-and-breast-axilla-pain-in-a-patient-with-a-history-of-breast-radiation-who-cannot-tolerate-trental weekly 0.8 https://www.themednet.org/how-would-you-treat-a-locally-advanced-breast-cancer-who-had-prior-radiation-to-the-contralateral-breast-over-10-years-ago weekly 0.8 https://www.themednet.org/how-would-you-manage-a-localized-small-cell-carcinoma-of-the-anal-canal-without-nodal-or-distant-disease weekly 0.8 https://www.themednet.org/what-is-your-experience-and-practice-patterns-when-treating-midline-nut-carcinoma-of-the-head-and-neck weekly 0.8 https://www.themednet.org/what-hdr-dosing-would-you-use-in-the-neoadjuvant-setting-of-endometrial-cancer weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemort-to-a-patient-who-underwent-neck-dissection-for-a-t0n1m0-p16-head-and-neck-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/at-what-platelet-count-would-you-feel-comfortable-dosing-aspirin-81-mg-for-coronary-artery-disease-in-a-patient-with-itp weekly 0.8 https://www.themednet.org/what-is-your-preferred-anticoagulant-for-acute-portal-vein-thrombosis weekly 0.8 https://www.themednet.org/how-do-you-counsel-young-adults-with-antibody-negative-necrotizing-myopathy-on-prognosis-and-long-term-monitoring-treatment weekly 0.8 https://www.themednet.org/would-you-consider-a-cdk-4-6-inhibitor-in-combination-with-endocrine-therapy-for-a-patient-with-er-low-1-9-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/what-is-the-role-for-angiography-in-the-workup-of-digital-ischemia weekly 0.8 https://www.themednet.org/when-treating-early-stage-rectal-cancer-t1-2n0-with-neoadjuvant-long-course-crt-with-the-goal-of-downstaging-for-sphincter-preserving-surgery-do-you-reduce-your-radiation-volumes-to-spare-toxicity weekly 0.8 https://www.themednet.org/what-suspected-myositis-manifestations-drive-you-to-start-empiric-therapy-before-the-work-up-is-complete weekly 0.8 https://www.themednet.org/what-is-your-standard-workup-and-treatment-for-an-incidentally-noted-splanchnic-vein-thrombosis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-post-operative-prophylactic-anticoagulation-for-patients-undergoing-minimally-invasive-surgery-for-gynecologic-malignancies weekly 0.8 https://www.themednet.org/would-you-provide-treatment-dosing-anti-coagulation-for-a-pediatric-patient-who-had-an-ischemic-stroke-and-was-found-to-have-a-heterozygous-prothrombin-gene-mutation weekly 0.8 https://www.themednet.org/how-do-you-approach-salvage-for-a-local-marginal-failure-after-ir-ablation-for-medically-inoperable-stage-i-nsclc weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-who-had-salvage-prostatectomy-after-cryotherapy-failure-and-now-has-a-rising-psa weekly 0.8 https://www.themednet.org/how-do-you-manage-hit-in-a-patient-with-high-bleeding-risk weekly 0.8 https://www.themednet.org/do-you-recommend-treatment-for-cll-patients-with-biopsy-proven-infiltrative-lesions-in-the-liver-without-hepatic-dysfunction-or-hepatomegaly weekly 0.8 https://www.themednet.org/how-do-you-approach-post-operative-srs-for-melanoma-metastases-in-the-setting-of-immunotherapy weekly 0.8 https://www.themednet.org/do-you-offer-partial-breast-radiation-in-the-absence-of-surgical-clips weekly 0.8 https://www.themednet.org/is-there-any-reason-to-stop-mesalamine-in-a-patient-with-uc-undergoing-breast-regional-nodal-radiation weekly 0.8 https://www.themednet.org/how-do-you-manage-multiple-cavernous-malformations-that-have-bled-and-enlarged-over-time weekly 0.8 https://www.themednet.org/how-has-advanced-imaging-especially-pet-ct-changed-your-treatment-volumes-and-approach-for-a-head-and-neck-cancer-of-unknown-primary weekly 0.8 https://www.themednet.org/how-would-you-manage-liver-metastatic-pancreatic-neuroendocrine-tumor-after-progression-on-a-somatostatin-analogue-chemotherapy-immune-checkpoint-blockade-and-embolization weekly 0.8 https://www.themednet.org/for-a-young-patient-who-had-a-prior-pcr-to-neoadjuvant-therapy-would-you-consider-systemic-therapy-after-local-resection-and-radiation-of-an-isolated-brain-metastatic-recurrence-of-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/at-what-timepoint-do-you-do-an-emg-ncs-in-patients-with-suspected-gbs weekly 0.8 https://www.themednet.org/is-there-an-absolute-psa-level-above-which-you-would-not-recommend-a-radical-prostatectomy-for-newly-diagnosed-prostate-cancer-despite-the-absence-of-metastatic-disease-with-advanced-imaging weekly 0.8 https://www.themednet.org/what-is-your-escalation-strategy-for-chronic-gvhd weekly 0.8 https://www.themednet.org/how-would-you-approach-an-intrathoracic-solitary-fibrous-tumor-in-a-patient-who-is-not-a-surgical-candidate weekly 0.8 https://www.themednet.org/when-if-at-all-would-you-consider-sequential-chemotherapy-and-radiation-for-locally-advanced-lung-cancer-instead-of-concurrent weekly 0.8 https://www.themednet.org/is-prophylactic-anticoagulation-indicated-in-patients-with-frequent-ulcerative-colitis-flares weekly 0.8 https://www.themednet.org/what-is-your-management-approach-for-patients-with-adult-onset-stills-who-are-planning-pregnancy weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-or-osimertinib-if-egfr-to-patients-with-two-synchronous-stage-1a-lung-cancers-that-appear-to-be-distinct-and-have-both-been-resected weekly 0.8 https://www.themednet.org/how-do-you-approach-dmard-therapy-in-a-patient-with-lupus-and-recurrent-pericarditis weekly 0.8 https://www.themednet.org/how-to-you-treat-pregnant-women-who-develop-bells-palsy weekly 0.8 https://www.themednet.org/would-you-consider-parp-inhibition-in-a-patient-with-metastatic-prostate-cancer-and-a-germline-brca2-variant-of-unknown-significance weekly 0.8 https://www.themednet.org/would-you-re-challenge-a-patient-with-refractory-multiple-myeloma-with-carfilzomib-who-responded-well-but-developed-grade-3-heart-failure-and-subsequently-recovered-the-ef-upon-holding-carfilzomib weekly 0.8 https://www.themednet.org/is-a-close-1mm-posterior-margin-an-indication-for-lumpectomy-cavity-boost-in-a-patient-with-early-stage-breast-cancer-when-dissection-was-carried-down-to-the-pectoral-fascia weekly 0.8 https://www.themednet.org/do-you-routinely-obtain-a-chest-x-ray-prior-to-initiating-anti-tnf-or-other-biologic-therapy weekly 0.8 https://www.themednet.org/how-does-the-presence-of-ascites-affect-your-treatment-planning-for-sbrt-for-hcc weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-metastatic-alveolar-rhabdomyosarcoma-with-progression-on-first-line-therapy weekly 0.8 https://www.themednet.org/should-radiation-oncologists-advocate-for-changes-in-the-uspstf-guideline-that-recommends-lung-cancer-screening-for-patients-as-long-as-they-can-undergo-curative-lung-surgery-but-currently-omits-the-concept-of-curative-radiation-therapy weekly 0.8 https://www.themednet.org/what-features-or-presentations-would-prompt-you-to-offer-radiotherapy-for-paraganglioma-vs-continued-surveillance weekly 0.8 https://www.themednet.org/are-you-comfortable-using-doacs-in-obese-patients-with-vte weekly 0.8 https://www.themednet.org/what-is-your-approach-to-post-operative-radiation-when-to-offer-volume-dose-fractionation-for-a-primary-intraosseous-squamous-cell-carcinoma-piocc-of-the-head-neck weekly 0.8 https://www.themednet.org/how-would-you-manage-a-localized-melanoma-of-the-anal-canal-with-sphincter-involvement-but-without-nodal-or-distant-disease weekly 0.8 https://www.themednet.org/for-patients-with-a-new-diagnosis-of-active-secondary-progressive-multiple-sclerosis-spms-without-prior-trials-of-disease-modifying-therapy-do-you-treat-with-siponimod-or-do-you-start-with-a-different-dmt weekly 0.8 https://www.themednet.org/whats-the-optimal-management-of-stage-ia-nodal-atll-in-a-young-fit-patient weekly 0.8 https://www.themednet.org/how-would-you-manage-adjuvant-treatment-of-a-premenopausal-woman-with-her2-positive-er-pr-negative-multifocal-micro-invasive-node-negative-breast-cancer weekly 0.8 https://www.themednet.org/assuming-a-clinical-trial-is-unavailable-would-you-consider-tazemetostat-in-a-patient-with-metastatic-ini1-smarcb1-deficient-sinonasal-carcinoma weekly 0.8 https://www.themednet.org/when-would-you-consider-treatment-with-steroids-in-patients-with-diabetic-radiculoplexus-neuropathy weekly 0.8 https://www.themednet.org/does-discovery-of-clonal-hematopoiesis-on-liquid-biopsy-for-solid-tumors-change-your-treatment-approach-in-terms-of-which-chemotherapy-to-offer-for-the-solid-tumor weekly 0.8 https://www.themednet.org/how-would-you-treat-an-elderly-female-with-residual-tnbc-following-surgery-and-neoadjuvant-carboplatin-and-paclitaxel weekly 0.8 https://www.themednet.org/does-cytoreductive-therapy-in-high-risk-pv-reduce-thrombotic-events-because-of-better-normalization-of-blood-counts-as-compared-to-phlebotomy-or-through-some-other-mechanism weekly 0.8 https://www.themednet.org/what-treatment-would-you-consider-for-metastatic-urachal-carcinoma-following-progression-on-folfox-and-folfiri weekly 0.8 https://www.themednet.org/for-a-patient-with-cervical-cancer-s-p-chemort-would-you-consider-brachytherapy-to-downstage-tumor-to-allow-for-hysterectomy-rather-than-pelvic-exenteration weekly 0.8 https://www.themednet.org/in-what-clinical-circumstances-would-you-consider-re-irradiation-for-skin-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-systemic-therapy-for-a-young-post-menopausal-woman-with-locoregional-tnbc-chest-wall-recurrence-treated-with-definitive-radiation weekly 0.8 https://www.themednet.org/what-is-the-typical-time-course-of-cytopenias-after-car-t-therapy-and-how-do-you-treat-them weekly 0.8 https://www.themednet.org/how-young-is-too-young-to-treat-a-childs-keloid-with-radiation weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-for-patients-with-anti-phospholipid-syndrome-with-recurrent-thrombosis-on-coumadin-and-lmwh weekly 0.8 https://www.themednet.org/when-do-you-offer-adjuvant-radiation-therapy-for-high-grade-non-rhabdomyosarcoma-soft-tissue-sarcoma-nrsts-in-a-skeletally-mature-teenager-or-young-adult weekly 0.8 https://www.themednet.org/is-there-a-maximum-period-of-elapsed-time-after-which-you-would-no-longer-consider-radiation-to-a-positive-margin-following-surgery-for-nsclc weekly 0.8 https://www.themednet.org/how-would-you-manage-metastatic-small-cell-neuroendocrine-bladder-cancer-after-response-to-6-cycles-of-platinum-etoposide weekly 0.8 https://www.themednet.org/when-do-you-consider-deep-brain-stimulation-in-patients-with-huntingtons-disease weekly 0.8 https://www.themednet.org/what-treatment-modalities-do-you-offer-patients-who-have-ataxia weekly 0.8 https://www.themednet.org/when-would-you-consider-checking-jc-virus-prior-to-initiating-biologic-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-for-fulminant-ra-associated-ild weekly 0.8 https://www.themednet.org/when-do-you-consider-middle-meningeal-artery-embolization-in-patients-with-recurrent-subdural-hemorrhages weekly 0.8 https://www.themednet.org/what-immunosuppressive-agents-would-be-available-to-patients-with-a-history-of-melanoma weekly 0.8 https://www.themednet.org/do-you-routinely-check-for-copper-deficiency-as-part-of-workup-for-bicytopenia-with-leukopenia-anemia-or-pancytopenia weekly 0.8 https://www.themednet.org/at-what-intervals-do-you-obtain-dexa-scans-for-patients-on-antiseizure-medications weekly 0.8 https://www.themednet.org/do-you-look-at-or-constrain-v10-lung-dose-for-your-imrt-esophagus-patients weekly 0.8 https://www.themednet.org/would-you-provide-tdm1-or-capecitabine-for-residual-disease-in-hr-negative-patients-with-her2-positivity-based-on-copy-number-alone weekly 0.8 https://www.themednet.org/in-what-situations-would-you-offer-salvage-radiotherapy-for-relapsed-refractory-dlbcl weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-treatment-for-stage-ia-small-cell-carcinoma-of-the-ovary-hypercalcemic-type-after-fertility-sparing-surgical-staging weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-rectal-cancer-with-a-positive-margin-on-resection-after-receiving-tnt weekly 0.8 https://www.themednet.org/which-fgfr-inhibitor-do-you-prefer-for-patients-with-cholangiocarcinoma-and-an-fgfr2-gene-rearrangement weekly 0.8 https://www.themednet.org/how-would-you-manage-a-resectable-satellite-in-transit-melanoma-recurrence-that-developed-during-adjuvant-immunotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-commercial-testing-such-as-avise-ctd-in-clinical-practice weekly 0.8 https://www.themednet.org/when-would-you-consider-stopping-chronic-transfusion-therapy-in-a-sickle-cell-patient-with-history-of-abnormal-tcds-but-no-stroke weekly 0.8 https://www.themednet.org/in-stage-ii-iii-node-positive-patients-with-driver-mutations-positive-nsclc-who-are-not-surgical-candidates-and-are-unlikely-to-tolerate-concurrent-chemotherapy-and-radiation-would-you-consider-radiation-alone-tki-alone-or-would-you-ever-consider-tki-rt weekly 0.8 https://www.themednet.org/what-guidance-do-you-give-to-patients-and-families-regarding-resuming-vaccination-after-completion-of-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-lower-risk-stage-iii-colon-cancer-who-is-unable-to-tolerate-the-planned-3-months-of-oxaliplatin-based-therapy-due-to-neuropathy weekly 0.8 https://www.themednet.org/in-patients-who-develop-a-vte-what-conditions-do-you-consider-as-persistent-provoking-risk-factors-and-at-what-point-are-they-controlled-enough-to-stop-anticoagulation weekly 0.8 https://www.themednet.org/how-do-you-plan-prostate-radiation-in-a-patient-with-a-sacral-nerve-stimulator weekly 0.8 https://www.themednet.org/what-radiation-dose-and-fractionation-is-appropriate-for-hairy-cell-leukemia-presenting-as-an-isolated-skeletal-lesion-where-systemic-treatment-is-not-recommended weekly 0.8 https://www.themednet.org/what-are-your-indications-for-including-the-contralateral-neck-when-planning-postoperative-primary-and-ipsilateral-elective-neck-radiotherapy-for-a-well-lateralized-buccal-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/would-you-omit-a-boost-in-a-patient-with-an-indication-if-a-very-large-200cc-post-op-seroma-obscures-the-actual-tumor-bed weekly 0.8 https://www.themednet.org/in-patients-with-high-risk-polycythemia-vera-with-a-history-of-thrombosis-should-aspirin-be-used-in-addition-to-indefinite-anticoagulation-and-cytoreduction-for-prevention-of-recurrent-thrombosis weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-a-patient-with-resected-t4n1-high-grade-large-cell-neuroendocrine-tumor-of-the-cecum-with-adenocarcinoma-component weekly 0.8 https://www.themednet.org/how-would-you-approach-osteoporosis-management-in-a-patient-who-fractures-while-on-denosumab-therapy weekly 0.8 https://www.themednet.org/what-induction-combination-s-would-be-appropriate-for-newly-diagnosed-standard-cytogenetic-risk-multiple-myeloma-who-have-a-transplanted-kidney weekly 0.8 https://www.themednet.org/in-young-patients-with-essential-thrombocythemia-and-early-significant-atherosclerotic-disease-but-no-thrombotic-history-would-you-consider-the-addition-of-cytoreductive-therapy weekly 0.8 https://www.themednet.org/in-what-situations-would-you-consider-focal-irradiation-for-nodular-leptomeningeal-disease weekly 0.8 https://www.themednet.org/would-you-use-oncotype-dx-to-guide-adjuvant-therapy-recommendations-in-the-context-of-locally-recurrent-node-negative-er-breast-cancer-previously-treated-with-endocrine-therapy-alone weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-transfusion-dependent-mds-with-concurrent-hemochromatosis-requiring-phlebotomy weekly 0.8 https://www.themednet.org/how-would-you-manage-an-asymptomatic-elderly-frail-patient-with-newly-diagnosed-mantle-cell-lymphoma-with-tp53-mutation weekly 0.8 https://www.themednet.org/how-would-you-manage-asymptomatic-radiographic-progression-from-m0-crpc-to-m1-crpc-to-bone weekly 0.8 https://www.themednet.org/when-do-you-include-the-presacral-nodes-in-post-operative-xrt-of-endometrial-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-an-immunosuppressed-patient-with-high-risk-cutaneous-scc-of-the-axilla-with-node-positivity-on-axillary-node-dissection weekly 0.8 https://www.themednet.org/would-you-continue-io-monotherapy-in-a-patient-with-metastatic-rcc-started-on-first-line-io-tki-combination-but-with-poor-tolerance-to-tki weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-superficial-venous-thrombosis-with-close-proximity-3-cm-to-deep-veins-and-an-inherited-thrombophilia weekly 0.8 https://www.themednet.org/how-do-you-approach-hemorrhagic-brain-metastases-in-melanoma weekly 0.8 https://www.themednet.org/how-do-you-approach-decision-making-in-terms-to-adjuvant-chemotherapy-after-csi-in-adult-medulloblastoma weekly 0.8 https://www.themednet.org/given-the-ldl-paradox-in-which-ra-patients-with-the-highest-levels-of-inflammation-can-have-ultra-low-levels-of-ldl-70-how-do-you-approach-initiation-of-statin-therapy-in-these-patients weekly 0.8 https://www.themednet.org/how-would-you-manage-a-large-grade-2-endometrial-adenocarcinoma-with-invasion-into-the-parametria-and-upper-vagina-without-nodal-or-metastatic-disease weekly 0.8 https://www.themednet.org/what-dose-constraints-are-appropriate-for-sbrt-treatment-to-a-5-cm-neck-metastasis-from-renal-cell-carcinoma weekly 0.8 https://www.themednet.org/do-you-ever-attribute-oscillopsia-to-a-cortical-lesion weekly 0.8 https://www.themednet.org/do-you-consider-10mv-beams-safe-in-a-patient-with-an-implantable-cardiac-device weekly 0.8 https://www.themednet.org/for-muscle-invasive-bladder-cancer-with-predominant-90-squamous-differentiation-would-you-consider-cisplatin-based-neoadjuvant-chemotherapy-prior-to-radical-cystectomy-or-upfront-surgery weekly 0.8 https://www.themednet.org/do-you-use-breast-cancer-index-bci-in-patients-with-1-3-node-positive-er-her2-idc weekly 0.8 https://www.themednet.org/would-you-give-ep-chemotherapy-to-a-patient-with-stage-iia-nonseminoma-with-negative-markers-who-underwent-rplnd-and-had-pn2-disease-with-predominant-teratoma weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-rcc-and-significant-baseline-proteinuria-after-progression-on-immunotherapy weekly 0.8 https://www.themednet.org/would-you-consider-use-of-an-oral-bisphosphonate-such-as-alendronate-liquid-in-a-patient-with-eosinophilic-esophagitis weekly 0.8 https://www.themednet.org/what-is-your-typical-workup-for-a-patient-with-a-spontaneous-renal-infarct weekly 0.8 https://www.themednet.org/how-would-you-treat-a-head-and-neck-patient-who-had-definitive-chemoradiation-who-develops-an-isolated-mediastinal-lymph-node-recurrence weekly 0.8 https://www.themednet.org/how-do-you-decide-between-whole-brain-radiotherapy-vs-partial-brain-irradiation-vs-srs-for-treatment-of-cns-metastases weekly 0.8 https://www.themednet.org/do-you-measure-drug-levels-particularly-hydroxychloroquine-or-mycophenolate-in-your-lupus-patients weekly 0.8 https://www.themednet.org/is-whole-body-phototherapy-for-skin-disorders-a-contraindication-to-chest-wall-or-breast-radiation weekly 0.8 https://www.themednet.org/how-would-you-manage-eccrine-porocarcinoma-of-the-great-toe-with-positive-superficial-groin-and-pelvic-lymph-nodes-s-p-toe-amputation-and-pelvic-lymph-node-dissection weekly 0.8 https://www.themednet.org/how-do-you-approach-transplant-eligible-myeloma-patients-with-a-partial-or-minimal-response-to-treatment-with-3-4-cycles-of-rvd weekly 0.8 https://www.themednet.org/would-you-offer-gemcitabine-based-chemoradiation-for-a-resected-node-positive-cholangiocarcinoma-with-negative-margins-that-has-tolerated-adjuvant-capecitabine weekly 0.8 https://www.themednet.org/what-workup-do-you-recommend-for-patients-with-stabbing-headaches weekly 0.8 https://www.themednet.org/when-is-follow-up-imaging-warranted-in-patients-with-anoxic-brain-injury weekly 0.8 https://www.themednet.org/what-symptomatic-management-do-you-recommend-in-patients-with-post-lp-headaches weekly 0.8 https://www.themednet.org/is-it-necessary-to-include-entire-lymphocele-in-ctv-while-treating-post-operative-nodal-sites-of-pelvic-malignancy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-normal-lfts-and-high-titer-auto-antibodies-suggestive-of-autoimmune-hepatitis weekly 0.8 https://www.themednet.org/are-cavitary-lung-lesions-a-contraindication-to-tkis-vegf-inhibitor-use-in-renal-cell-carcinoma weekly 0.8 https://www.themednet.org/is-there-any-experience-of-using-sarilumab-instead-of-tocilizumab-for-steroid-sparing-effect-in-gca-during-national-tocilizumab-shortage weekly 0.8 https://www.themednet.org/what-are-the-risks-of-treating-locally-advanced-pancreatic-cancer-with-chemoradiation-with-duodenal-stent-in-place-due-to-malignant-obstruction weekly 0.8 https://www.themednet.org/are-you-using-the-commercially-available-naveris-assay-for-hpv-opx-cancers-in-your-practice weekly 0.8 https://www.themednet.org/now-that-ropeginterferon-is-approved-for-pv-how-do-you-select-patients-for-this-therapy weekly 0.8 https://www.themednet.org/do-you-find-14-3-3-eta-or-vectra-da-helpful-in-clinical-practice weekly 0.8 https://www.themednet.org/would-you-give-ep-to-a-patient-with-stage-i-testicular-nonseminoma-with-risk-factors-lvi-and-90-embryonal-who-is-not-a-candidate-for-bleomycin weekly 0.8 https://www.themednet.org/how-would-you-treat-an-isolated-ipsilateral-axillary-recurrence-in-a-brca-hr-her2-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-an-elderly-patient-with-dementia-with-multifocal-pt1b-idc-s-p-lumpectomy-with-extensive-dcis-and-medial-margin-positive-for-dcis weekly 0.8 https://www.themednet.org/in-patients-with-hcc-and-asymptomatic-but-endoscopically-visible-varices-how-long-do-you-wait-to-start-bevacizumab-after-banding weekly 0.8 https://www.themednet.org/when-a-patient-with-a-preexisting-rheumatic-disease-and-on-immunotherapy-begins-to-flare-how-do-you-decide-if-this-is-an-underlying-rheumatic-disease-activity-versus-an-immunotherapy-related-adverse-event weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-new-isolated-enlarged-lymph-node-6-months-after-rplnd-with-prior-pt2nx-non-seminoma-treated-with-orchiectomy-then-rplnd-within-1-year-due-to-nodal-metastases weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-suspected-cns-lymphoma-who-have-been-treated-with-steroids weekly 0.8 https://www.themednet.org/how-do-you-interpret-nccn-chemort-dose-recommendations-for-sclc-which-start-higher-than-nsclc weekly 0.8 https://www.themednet.org/when-do-you-use-a-bite-block-for-h-n-cases weekly 0.8 https://www.themednet.org/when-do-you-include-the-neck-in-the-rt-field-for-resected-thyroid-cancer weekly 0.8 https://www.themednet.org/what-is-the-best-course-of-action-for-a-patient-with-isolated-carcinomatous-meningitis-who-is-responding-well-to-intrathecal-methotrexate-but-now-has-mri-findings-suspicious-for-methotrexate-leukoencephalopathy weekly 0.8 https://www.themednet.org/would-you-consider-sbrt-and-adjuvant-therapy-for-a-4cm-node-negative-non-oncogene-driven-nsclc-not-amenable-to-surgical-resection weekly 0.8 https://www.themednet.org/how-has-your-use-of-b-cell-depleting-therapy-for-ms-changed-during-the-covid-19-pandemic weekly 0.8 https://www.themednet.org/in-a-patient-with-inflammatory-orbital-disease-without-a-discrete-mass-to-biopsy-and-recent-bisphosphonate-use-how-much-additional-workup-would-you-do-if-basic-labs-urine-studies-anca-serologies-thyroid-studies-chest-imaging-to-r-out-sarcoid-are-normal-be weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-early-stage-small-cell-carcinoma-of-the-breast weekly 0.8 https://www.themednet.org/is-it-reasonable-to-omit-nodal-rt-in-an-elderly-patient-with-t3n0-scc-of-the-glottic-larynx weekly 0.8 https://www.themednet.org/do-you-give-adjuvant-chemotherapy-to-a-patient-with-a-completely-resected-mediastinal-pure-seminoma weekly 0.8 https://www.themednet.org/would-you-consider-definitive-chemoradiation-followed-by-surgery-for-esophageal-adenocarcinoma-with-a-single-distant-metastatic-site weekly 0.8 https://www.themednet.org/how-would-you-approach-local-control-in-a-patient-with-extra-osseous-metastatic-ewing-sarcoma-of-the-kidney weekly 0.8 https://www.themednet.org/when-mgus-is-suspected-in-a-patient-with-one-risk-factor-and-no-evidence-of-end-organ-damage-what-additional-workup-should-be-done-if-any weekly 0.8 https://www.themednet.org/in-a-patient-with-stage-iii-nsclc-who-was-treated-with-neoadjuvant-systemic-therapy-and-had-a-pr-would-you-deliver-rt-to-all-sites-of-initially-involved-disease-or-only-residual-sites-of-disease weekly 0.8 https://www.themednet.org/what-is-the-role-for-consolidative-isrt-for-patients-with-stage-iii-follicular-lymphoma-following-a-good-response-to-systemic-therapy weekly 0.8 https://www.themednet.org/are-there-effective-adjunct-therapies-to-relieve-tumor-flare-pain-from-tamoxifen-in-the-metastatic-setting weekly 0.8 https://www.themednet.org/how-long-do-you-continue-immunotherapy-ie-rituximab-in-patients-with-nmdar-encephalitis-with-initially-severe-disease-but-a-good-trajectory-of-recovery weekly 0.8 https://www.themednet.org/what-is-the-role-of-radiation-therapy-in-a-patient-with-diffuse-cutaneous-melanoma-metastases-who-cannot-tolerate-systemic-therapy weekly 0.8 https://www.themednet.org/do-you-use-adjuvant-radiation-therapy-for-low-grade-biliary-neuroendocrine-cancer-with-positive-margin weekly 0.8 https://www.themednet.org/is-it-ever-appropriate-to-reduce-urate-lowering-therapy-dose-due-to-very-low-urate-levels weekly 0.8 https://www.themednet.org/how-would-you-approach-asymptomatic-hepatic-sarcoid weekly 0.8 https://www.themednet.org/how-would-you-treat-a-young-patient-with-classical-intermediate-risk-hodgkin-lymphoma-who-has-an-underlying-dna-repair-deficiency-disorder-such-as-congenital-mismatch-repair-disorder-or-ataxia-telangiectasia weekly 0.8 https://www.themednet.org/would-you-consider-continuing-a-biologic-for-difficult-to-control-autoimmune-disease-in-a-patient-with-a-recent-diagnosis-of-a-surgically-curable-solid-malignancy weekly 0.8 https://www.themednet.org/in-a-patient-with-a-remote-history-of-mantle-field-radiation-is-there-any-contraindication-to-whole-breast-irradiation-for-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-management-for-a-patient-who-was-treated-with-definitive-chemoradiation-for-locally-advanced-cervical-cancer-who-now-has-a-biopsy-proven-isolated-brain-metastasis-5-years-later weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-oligometastatic-renal-cell-carcinoma-after-nephrectomy-and-metastatectomy weekly 0.8 https://www.themednet.org/how-long-do-you-wait-before-performing-liver-directed-therapy-on-a-colon-cancer-patient-with-liver-only-disease-and-prior-radiation-induced-liver-injury weekly 0.8 https://www.themednet.org/how-long-after-completion-of-radiation-therapy-should-patients-continue-fluoride-treatment-for-dental-health weekly 0.8 https://www.themednet.org/what-radiation-strategy-do-you-use-in-clinically-node-positive-pancreas-cancer-responding-to-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-sequencing-of-systemic-therapy-and-radiation-in-nsclc-with-epidural-invasion weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-hormonal-therapy-to-elderly-men-with-strongly-hr-dcis-after-mastectomy weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-patients-with-delusions-of-parasitosis-who-can-not-tolerate-an-antipsychotic weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-patients-with-chronic-pruritus-of-unclear-etiology weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-rapidly-progressing-vitiligo weekly 0.8 https://www.themednet.org/how-do-you-approach-restarting-biologics-for-psoriasis-patients-who-have-discontinued-therapy-for-3-6-months weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-bullous-pemphigoid-who-have-ige-autoantibodies-to-bp180 weekly 0.8 https://www.themednet.org/what-are-some-of-your-preferred-treatment-options-for-managing-facial-papules-that-occur-in-the-setting-of-lichen-planopilaris weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-twenty-nail-dystrophy-of-unclear-etiology weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-yellow-nail-syndrome weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-patients-with-central-centrifugal-cicatricial-alopecia-ccca-who-do-not-respond-to-ilk-or-doxycycline weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-patients-with-lichen-planopilaris-who-do-not-respond-to-hydroxychloroquine weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-alopecia-totalis-who-are-not-candidates-for-jak-inhibitors weekly 0.8 https://www.themednet.org/what-is-your-approach-to-starting-and-monitoring-methotrexate-in-elderly-patients weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-chronic-flushing-that-do-not-respond-to-beta-blockers weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-chronic-telogen-effluvium weekly 0.8 https://www.themednet.org/how-do-you-manage-eruptive-squamous-atypia-that-does-not-respond-to-intralesional-5-fluorouracil-or-intralesional-methotrexate weekly 0.8 https://www.themednet.org/for-someone-with-asymmetric-graves-ophthalmopathy-do-you-still-treat-both-eyes-or-target-the-single-affected-orbit weekly 0.8 https://www.themednet.org/how-do-you-approach-transitioning-ms-patients-from-ocrevus-to-tysabri-or-vice-versa weekly 0.8 https://www.themednet.org/would-you-consider-definitive-radiation-therapy-ebrt-interstitial-hdr-in-lieu-of-pelvic-exenteration-for-a-vaginal-spindle-cell-sarcoma weekly 0.8 https://www.themednet.org/how-do-you-manage-residual-hyperpigmentation-after-breast-irradiation weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-parkinsons-disease-when-dopaminergic-therapy-worsens-the-freezing-phenomenon weekly 0.8 https://www.themednet.org/if-technically-feasible-would-you-consider-sbrt-for-locally-recurrent-ampullary-carcinoma-in-an-inoperable-radiation-naive-patient weekly 0.8 https://www.themednet.org/when-if-ever-would-you-use-aflibercept-instead-of-bevacizumab-in-the-treatment-of-colorectal-cancer weekly 0.8 https://www.themednet.org/what-is-the-utility-in-repeating-a-temporal-ultrasound-us-in-a-previously-us-diagnosed-positive-gca-patient-who-has-received-treatment-and-is-presenting-with-recurrent-gca-symptoms weekly 0.8 https://www.themednet.org/what-options-are-available-for-patients-with-relapsed-refractory-al-amyloidosis-after-dara-cybord-other-than-clinical-trial weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-use-to-treat-a-papillary-thyroid-cancer-with-bulky-cervical-adenopathy-and-laryngeal-invasion-with-impending-airway-obstruction-that-is-refusing-laryngectomy-and-surgical-management weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-cn1-mibc-treated-with-neoadjuvant-cisplatin-based-chemotherapy-with-outstanding-clinical-response-who-is-no-longer-a-cystectomy-candidate weekly 0.8 https://www.themednet.org/how-you-do-approach-adjuvant-radiation-recommendations-rai-and-ebrt-for-papillary-thyroid-carcinoma-tall-cell-variant-status-post-total-thyroidectomy weekly 0.8 https://www.themednet.org/how-would-you-treat-corneal-melt-in-the-absence-of-peripheral-arthritis-in-rheumatoid-arthritis weekly 0.8 https://www.themednet.org/do-you-omit-apbi-for-lobular-histology weekly 0.8 https://www.themednet.org/how-do-you-treat-celiac-disease-associated-inflammatory-arthritis-refractory-to-gluten-free-diet weekly 0.8 https://www.themednet.org/for-lymphoma-how-long-after-chemotherapy-can-you-wait-to-start-consolidative-radiation-therapy weekly 0.8 https://www.themednet.org/what-are-your-considerations-for-peri-operative-anticoagulation-in-patients-with-a-mechanical-heart-valve-undergoing-a-major-noncardiac-surgery weekly 0.8 https://www.themednet.org/would-you-use-radiotherapy-including-sbrt-in-a-patient-with-locally-advanced-pancreatic-cancer-who-has-multiple-cystic-structures-in-the-pancreatic-head-on-imaging-possibly-due-to-pancreatic-leak-but-is-asymptomatic weekly 0.8 https://www.themednet.org/would-you-give-postop-rt-for-a-patient-with-pvns-pigmented-villonodular-synovitis-of-the-knee-after-a-total-knee-replacement-with-total-synovectomy weekly 0.8 https://www.themednet.org/for-women-who-have-difficulty-healing-after-a-mastectomy-but-need-adjuvant-radiation-therapy-is-there-an-amount-of-time-for-which-you-would-abandon-plans-for-radiation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-evaluation-of-underlying-autoimmune-disease-in-patients-with-bilateral-scleromalacia weekly 0.8 https://www.themednet.org/do-you-recommend-routine-use-of-evusheld-for-pre-exposure-prophylaxis-for-patients-on-immunosuppression weekly 0.8 https://www.themednet.org/does-testing-for-elevated-serum-homocysteine-have-any-relevance-in-thrombophilia-management weekly 0.8 https://www.themednet.org/what-additional-treatments-do-you-offer-to-patients-with-progressive-supranuclear-palsy-other-than-a-levodopa-carbidopa-challenge weekly 0.8 https://www.themednet.org/how-do-you-counsel-post-menopausal-patients-with-hr-breast-cancer-who-are-interested-in-taking-medroxyprogesterone weekly 0.8 https://www.themednet.org/would-you-consider-using-ensartinib-in-patients-with-alk-positive-nsclc-who-have-progressed-on-alectinib-and-lorlatinib weekly 0.8 https://www.themednet.org/do-you-adjust-the-dose-of-ruxolitinib-in-primary-myelofibrosis-based-on-hemoglobin weekly 0.8 https://www.themednet.org/when-discussing-prostate-cancer-treatment-options-how-do-you-address-that-surgery-side-effects-are-considered-acute-and-radiation-side-effects-are-long-lasting weekly 0.8 https://www.themednet.org/in-a-premenopausal-hr-patient-with-pt2-pn0-i-disease-and-rs-16-does-the-presence-of-isolated-lymph-node-tumor-cells-affect-your-decision-to-avoid-chemotherapy weekly 0.8 https://www.themednet.org/is-there-any-adjunct-therapy-to-help-with-tamoxifen-induced-leg-cramps weekly 0.8 https://www.themednet.org/would-you-consider-adding-adjuvant-vaginal-cuff-brachytherapy-for-a-figo-1a-endometrial-cancer-g1-no-lvsi-based-on-the-presence-of-extensive-lower-uterine-segment-involvement weekly 0.8 https://www.themednet.org/how-do-you-treat-refractory-focal-status-epilepticus-in-patients-with-traumatic-bilateral-subdural-hematomas weekly 0.8 https://www.themednet.org/how-have-you-been-incorporating-abemaciclib-into-the-adjuvant-management-of-high-risk-node-positive-hr-breast-cancer weekly 0.8 https://www.themednet.org/would-you-hold-cabozantinib-for-radiation-therapy-or-is-concurrent-use-safe weekly 0.8 https://www.themednet.org/do-you-account-for-dose-from-previous-lu-177-treatment-for-definitive-prostate-cancer-treatment weekly 0.8 https://www.themednet.org/for-patients-with-scleroderma-at-high-risk-of-renal-crisis-would-you-feel-comfortable-giving-corticosteroids-as-pre-medication-for-rituximab weekly 0.8 https://www.themednet.org/what-would-be-your-approach-for-a-patient-with-triple-negative-metastatic-breast-cancer-with-oligo-progressive-disease-in-the-axilla-alone weekly 0.8 https://www.themednet.org/with-the-recent-published-results-of-desktop-iii-do-you-intend-to-change-your-practice-of-performing-secondary-cytoreductive-surgery-for-recurrent-platinum-sensitive-ovarian-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-a-resected-solitary-osseous-plasmacytoma weekly 0.8 https://www.themednet.org/how-do-you-manage-and-treat-post-stroke-alien-hand-syndrome weekly 0.8 https://www.themednet.org/how-would-you-manage-a-dehiscent-vaginal-cuff-2-months-after-vaginal-cuff-brachytherapy weekly 0.8 https://www.themednet.org/would-you-use-belzutifan-in-metastatic-renal-cell-carcinoma-with-somatic-mutation-in-vhl-vhl-p-q73-without-having-germline-vhl-and-or-other-manifestations-of-vhl-syndrome weekly 0.8 https://www.themednet.org/how-do-you-approach-the-workup-of-a-patient-with-incidentally-found-pachymeningitis weekly 0.8 https://www.themednet.org/how-do-you-approach-the-workup-and-management-of-patients-with-suspected-functional-neurologic-disorders weekly 0.8 https://www.themednet.org/would-it-be-prudent-to-complete-long-term-cardiac-monitoring-ie-30-day-in-a-patient-with-a-new-typical-appearing-lacunar-type-thalamic-infarct-and-history-of-hypertension weekly 0.8 https://www.themednet.org/is-there-any-role-for-neoadjuvant-chemotherapy-for-low-grade-adenosquamous-metaplastic-tnbc weekly 0.8 https://www.themednet.org/is-there-a-clinically-significant-increased-risk-of-venous-thromboembolism-with-the-use-of-fulvestrant-for-metastatic-hr-breast-cancer weekly 0.8 https://www.themednet.org/for-women-with-hr-breast-cancer-and-low-libido-due-to-endocrine-therapy-would-you-consider-flibanserin-therapy weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-immunotherapy-to-a-patient-with-esophageal-cancer-who-completed-neoadjuvant-chemo-rt-followed-by-surgery-a-year-ago weekly 0.8 https://www.themednet.org/how-should-one-manage-a-patient-with-leukocytosis-and-borderline-detectable-bcr-abl-without-other-clinical-features-of-cml-such-as-basophilia-or-splenomegaly weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-stage-i-non-muscle-invasive-urothelial-bladder-cancer-with-small-cell-neuroendocrine-features-ki67-90 weekly 0.8 https://www.themednet.org/would-you-use-imrt-to-treat-stage-ii-seminoma weekly 0.8 https://www.themednet.org/is-a-biopsy-of-either-skin-or-muscle-always-indicated-in-the-diagnosis-of-dermatomyositis weekly 0.8 https://www.themednet.org/for-newly-diagnosed-advanced-cervical-cancer-how-soon-after-periaortic-lymph-node-evaluation-do-you-start-definitive-chemoradiation-treatment weekly 0.8 https://www.themednet.org/what-is-the-best-approach-to-treat-a-triple-negative-inflammatory-breast-cancer-with-pcr-following-preoperative-chemotherapy-and-a-prior-history-of-ipsilateral-breast-irradiation weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-recurrent-endometrial-cancer-within-the-field-of-prior-primary-radiation-who-is-not-a-surgical-or-cytotoxic-chemotherapy-candidate weekly 0.8 https://www.themednet.org/have-you-seen-patients-who-develop-neuromuscular-disorders-following-covid-19-vaccination weekly 0.8 https://www.themednet.org/when-do-you-start-anticoagulation-in-a-patient-with-cardioembolic-cva-secondary-to-new-onset-atrial-fibrillation-with-hemorrhagic-conversion weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-an-optic-nerve-sheath-meningioma-presenting-with-complete-ipsilateral-visual-loss weekly 0.8 https://www.themednet.org/how-do-you-manage-severe-thrombocytopenia-due-to-splenomegaly-and-bone-marrow-involvement-in-cll-when-starting-obinituzumab-and-venetoclax weekly 0.8 https://www.themednet.org/have-you-utilized-silicone-based-film-forming-dressings-to-prevent-minimize-or-treat-radiation-dermatitis weekly 0.8 https://www.themednet.org/do-you-recommend-a-specific-xrt-fractionation-for-young-men-with-prostate-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-for-a-post-menopausal-woman-with-hr-her2-stage-3-papillary-carcinoma-of-the-breast weekly 0.8 https://www.themednet.org/what-is-the-appropriate-management-of-breast-cancer-patients-with-axillary-nodal-involvement-based-on-imaging-mri-or-ultrasound-but-negative-axillary-nodal-involvement-based-on-physical-exam weekly 0.8 https://www.themednet.org/does-the-presence-of-signet-ring-or-mucinous-pathology-alter-your-management-of-stage-2-colon-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-a-post-menopausal-women-with-ct2-cn0-tnbc-on-biopsy-s-p-neoadjuvant-chemotherapy-and-mastectomy-who-is-later-found-to-have-rcb2-hr-breast-cancer-on-surgical-pathology weekly 0.8 https://www.themednet.org/what-tumor-related-factors-help-in-deciding-between-braf-meki-vs-ici-in-stage-iv-braf-mutant-melanoma-patients weekly 0.8 https://www.themednet.org/do-you-start-anticoagulation-in-a-patient-with-infective-endocarditis-who-also-has-atrial-fibrillation-and-stroke weekly 0.8 https://www.themednet.org/how-do-you-manage-the-wide-array-of-emotions-like-anger-and-disappointment-patients-may-have-when-they-first-learn-of-an-incurable-relapse-of-an-early-stage-cancer weekly 0.8 https://www.themednet.org/would-you-treat-a-male-breast-cancer-patient-with-post-mastectomy-radiotherapy-for-a-single-positive-sentinel-lymph-node-and-a-low-oncotype weekly 0.8 https://www.themednet.org/how-would-you-approach-evaluation-and-treatment-of-a-patient-on-pembrolizumab-therapy-who-presents-with-symmetric-proximal-upper-extremity-and-lower-extremity-painful-weakness-without-an-elevated-ck weekly 0.8 https://www.themednet.org/how-do-you-decide-between-maintenance-avelumab-vs-crt-for-patients-with-n2-3-bladder-cancer-who-have-sd-or-pr-after-platinum-induction weekly 0.8 https://www.themednet.org/would-oncotypedx-impact-your-decision-to-provide-adjuvant-chemotherapy-for-node-negative-hr-breast-cancer-with-dermis-or-chest-wall-involvement weekly 0.8 https://www.themednet.org/would-you-hold-osimertinib-in-a-patient-with-a-stemi-and-for-how-long weekly 0.8 https://www.themednet.org/how-would-you-treat-a-high-risk-merkel-cell-carcinoma-of-the-lower-leg-after-r1-re-resection-who-failed-sentinel-mapping weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-osimertinib-or-both-to-a-patient-with-stage-ib-egfr-mutated-lung-adenocarcinoma-found-in-the-lung-explant-pathology-after-bilateral-lung-transplant weekly 0.8 https://www.themednet.org/in-a-patient-who-had-a-prior-cabg-with-internal-mammary-grafting-who-now-requires-comprehensive-rni-what-landmarks-would-you-use-to-contour-the-imn-volume weekly 0.8 https://www.themednet.org/would-you-consider-pmrt-in-a-patient-40-y-o-with-a-with-an-er-pr-her-2-pt1-cn0-breast-cancer-patient-lvsi-positive-who-did-not-have-sentinel-lymph-node-biopsy weekly 0.8 https://www.themednet.org/do-you-hold-tocilizumab-for-patients-who-are-diagnosed-with-covid-and-are-with-mild-to-moderate-symptoms-or-non-hospitalized weekly 0.8 https://www.themednet.org/would-you-give-chemotherapy-to-a-fit-patient-with-myxoid-liposarcoma-of-the-knee-that-is-resectable-with-adverse-functional-outcomes-who-will-be-undergoing-neoadjuvant-radiation-and-resection weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-endothelin-receptor-antagonists-in-patients-with-scleroderma-renal-crisis-and-hypertension-refractory-to-maximum-ace-inhibition-and-calcium-channel-blockers weekly 0.8 https://www.themednet.org/do-you-give-an-etoposide-based-regimen-more-aggressive-therapy-for-lymphoma-associated-hlh-such-as-da-epoch-r-over-r-chop weekly 0.8 https://www.themednet.org/how-do-you-manage-her2-metastatic-esophageal-cancer-in-frail-and-elderly-patients weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-would-you-give-for-gastric-cancer-patient-with-solitary-fdg-avid-metastasis-to-gluteal-muscle weekly 0.8 https://www.themednet.org/how-do-you-approach-the-decision-to-pursue-early-versus-delayed-autologous-stem-cell-transplantation-in-newly-diagnosed-multiple-myeloma weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-offer-a-post-menopausal-chek2-patient-with-hr-her2-t1bn1-breast-cancer-and-concurrent-hr-her2-t1n0-disease weekly 0.8 https://www.themednet.org/would-you-recommend-post-operative-chemort-for-a-young-female-patient-with-ct2n0-rectal-adenocarcinoma-who-had-pt2n1-disease-with-1-21-lymph-nodes-positive weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-rcc-who-developed-posterior-reversible-encephalopathy-syndrome-pres-on-a-tki-containing-regimen weekly 0.8 https://www.themednet.org/how-do-you-approach-a-potential-drug-holiday-in-a-patient-with-osteoporosis-who-has-had-improvement-in-bmd-after-several-years-of-denosumab-therapy weekly 0.8 https://www.themednet.org/what-is-your-practice-for-work-up-and-treatment-of-incidental-splenic-infarcts-with-or-without-splenomegaly-in-patients-without-sickle-cell-disease weekly 0.8 https://www.themednet.org/how-would-you-treat-a-young-patient-with-metastatic-colorectal-cancer-who-initially-tolerated-12-cycles-of-folfox-bev-with-disease-progression-after-cycle-3-of-maintenance-5-fu-bev weekly 0.8 https://www.themednet.org/would-you-use-de-escalated-radiation-or-chemoradiation-therapy-for-an-incidental-finding-of-invasive-squamous-cell-carcinoma-but-with-clear-margins-in-a-hemorrhoidecotomy-specimen weekly 0.8 https://www.themednet.org/under-what-conditions-would-you-offer-observation-for-asymptomatic-low-volume-brain-metastases weekly 0.8 https://www.themednet.org/how-would-you-manage-a-metastatic-lesion-abutting-the-optic-structures-globe-optic-nerve-etc weekly 0.8 https://www.themednet.org/what-features-help-distinguish-thyroid-myopathy-from-immune-checkpoint-inhibitor-associated-myopathy weekly 0.8 https://www.themednet.org/for-treatment-of-itp-what-would-you-add-to-dexamethasone-to-achieve-the-fastest-recovery-in-a-patient-waiting-for-a-procedure weekly 0.8 https://www.themednet.org/what-infectious-prophylaxis-do-you-use-for-patients-with-newly-diagnosed-multiple-myeloma weekly 0.8 https://www.themednet.org/do-you-treat-cerebral-vein-thrombosis-with-parenchymal-hemorrhage-using-full-dose-heparin-protocol-rather-than-the-high-risk-protocol weekly 0.8 https://www.themednet.org/do-you-take-any-special-precautions-when-treating-cervical-spine-metastases weekly 0.8 https://www.themednet.org/how-do-you-approach-the-symptomatic-management-of-central-vertigo-in-a-patient-with-minimal-improvement-on-or-contraindication-to-meclizine weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-recurrent-grade-3-neutropenia-on-imid-containing-regimens-e-g-vrd-or-krd-beyond-dose-reductions weekly 0.8 https://www.themednet.org/how-do-you-treat-lupus-associated-small-fiber-neuropathy weekly 0.8 https://www.themednet.org/for-patients-with-small-early-stage-breast-cancers-that-undergo-cryoablation-do-you-ever-offer-adjuvant-radiation weekly 0.8 https://www.themednet.org/how-would-you-treat-metastatic-pure-tubulocystic-renal-cell-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-therapy-for-br-refractory-waldenstrom-macroglobulinemia-when-there-is-a-mixed-response-to-zanabrutinib weekly 0.8 https://www.themednet.org/do-you-use-a-combination-of-anticoagulant-and-antiplatelet-therapy-for-treating-intraluminal-internal-cerebral-artery-thrombus-causing-stroke weekly 0.8 https://www.themednet.org/what-would-you-offer-postoperatively-for-a-pt-with-resected-3-separate-hpv-scc-primaries-with-pn1-disease-with-ece-who-is-cisplatin-ineligible weekly 0.8 https://www.themednet.org/are-there-any-known-contraindications-for-il-23-use-in-patients-with-psoriatic-arthritis-and-ckd-or-esrd weekly 0.8 https://www.themednet.org/what-are-your-recommendations-for-a-patient-with-metastatic-non-mutated-lung-adenocarcinoma-who-previously-had-headaches-responsive-to-prednisone-but-with-negative-temporal-artery-biopsy-for-gca weekly 0.8 https://www.themednet.org/how-long-do-you-maintain-a-patient-with-seropositive-neuromyelitis-optica-spectrum-disorder-on-disease-modifying-therapy weekly 0.8 https://www.themednet.org/what-is-the-role-of-synovectomy-in-the-diagnosis-and-management-of-patients-with-inflammatory-arthritis weekly 0.8 https://www.themednet.org/would-you-use-new-doac-loading-dose-or-start-with-maintenance-dosing-for-a-stable-patient-on-existing-doac-who-needs-to-switch-brand-due-to-insurance-formulary-reasons weekly 0.8 https://www.themednet.org/how-do-you-sequence-therapy-in-an-older-patient-with-newly-diagnosed-blastoid-mantle-cell-lymphoma-with-a-17p-deletion weekly 0.8 https://www.themednet.org/would-you-ever-consider-sbrt-for-de-novo-cutaneous-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/do-you-offer-neoadjuvant-folfox-for-elderly-patients-with-locally-advanced-rectal-cancer-receiving-short-course-radiation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-postoperative-radiation-therapy-in-a-patient-with-intermediate-grade-early-stage-i-ii-mucoepidermoid-carcinoma-of-the-parotid-and-no-other-risk-features weekly 0.8 https://www.themednet.org/is-it-reasonable-to-treat-a-solitary-plasmacytoma-of-the-lung-parenchyma-with-sbrt weekly 0.8 https://www.themednet.org/what-consolidative-radiation-volumes-and-dose-would-you-use-for-plasmablastic-lymphoma-of-the-l-maxilla-s-p-incisional-biopsy-and-6-cycles-of-epoch-r weekly 0.8 https://www.themednet.org/in-which-cases-would-you-use-adjuvant-abemaciclib-for-a-patient-with-extensive-residual-disease-that-is-triple-positive-er-pr-her2-following-neoadjuvant-tchp weekly 0.8 https://www.themednet.org/what-lab-markers-are-helpful-for-monitoring-polymyalgia-rheumatica-patients-on-tocilizumab weekly 0.8 https://www.themednet.org/how-do-you-approach-ivig-replacement-for-pediatric-patients-with-low-igg-during-treatment-for-hematologic-malignancies weekly 0.8 https://www.themednet.org/would-you-treat-regional-lymph-nodes-in-an-elderly-patient-with-a-triple-negative-pt2-idc-of-the-uoq-of-the-left-breast-s-p-lumpectomy-with-n0-sentinel-node-biopsy-but-was-clinically-node-negative weekly 0.8 https://www.themednet.org/what-radiation-approach-do-you-prefer-when-using-total-neoadjuvant-therapy-for-rectal-cancer-with-extensive-anal-sphincter-or-pelvic-floor-involvement weekly 0.8 https://www.themednet.org/would-you-still-obtain-ki-67-prior-to-use-of-adjuvant-abemaciclib-in-a-patient-who-has-otherwise-met-monarche-treatment-criteria-such-as-1-3-positive-lns-grade-3-and-or-tumor-5-cm weekly 0.8 https://www.themednet.org/how-do-you-treat-a-stage-ii-grade-3-endometrioid-endometrial-adenocarcinoma weekly 0.8 https://www.themednet.org/is-there-a-role-for-adjuvant-capecitabine-in-sequence-with-abemaciclib-for-high-risk-hr-breast-cancer-with-residual-disease weekly 0.8 https://www.themednet.org/what-is-your-preferred-therapy-for-cdk12-altered-advanced-prostate-cancer-outside-clinical-trial weekly 0.8 https://www.themednet.org/how-do-you-approach-therapy-for-a-patient-with-stage-iiia-nsgct-who-received-4-cycles-of-ep-followed-by-rplnd-which-revealed-residual-mixed-teratoma-and-embryonal-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-manage-ttfields-for-a-patient-with-glioblastoma-in-the-setting-of-disease-progression weekly 0.8 https://www.themednet.org/how-would-you-work-up-focal-periventricular-leukomalacia-presenting-in-adulthood weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-who-got-three-months-of-adjuvant-capox-for-t4n0-stage-ii-colon-cancer-but-had-a-solitary-pulmonary-metastasis-a-year-later-which-was-resected weekly 0.8 https://www.themednet.org/is-there-any-role-for-neoadjuvant-chemotherapy-in-renal-leiomyosarcoma weekly 0.8 https://www.themednet.org/for-patients-with-myeloma-on-an-imid-how-do-you-decide-on-the-dosages-of-aspirin-or-anticoagulants-in-vte-prophylaxis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-initial-assessment-of-disease-extent-in-patients-with-behcets-disease weekly 0.8 https://www.themednet.org/what-has-been-your-experience-using-apremilast-to-treat-mild-to-moderate-psoriatic-arthritis-not-controlled-with-nsaids weekly 0.8 https://www.themednet.org/how-do-you-account-for-treatment-breaks-longer-than-one-week-for-patients-with-anal-cancer-receiving-definitive-chemoradiation weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-with-non-clear-cell-renal-cell-carcinoma-with-nivolumab-and-ipilimumab weekly 0.8 https://www.themednet.org/do-you-ever-check-antibodies-against-ebv-as-part-of-a-workup-for-ms-in-a-patient-with-white-matter-lesions-of-unclear-etiology-on-mri weekly 0.8 https://www.themednet.org/how-are-you-using-circulating-tumor-dna-in-your-clinical-decisions-for-hpv-associated-opscc weekly 0.8 https://www.themednet.org/would-you-consider-moderate-hypofractionation-for-men-with-large-prostate-100cc-and-poor-aua-ipss-score weekly 0.8 https://www.themednet.org/which-mr-simulation-sequences-do-you-prefer-for-head-and-neck-rt weekly 0.8 https://www.themednet.org/what-daily-weekly-imaging-mv-kv-cbct-do-you-use-when-treating-regional-nodes-in-breast-cancer weekly 0.8 https://www.themednet.org/for-metastatic-prostate-cancer-when-would-you-add-carboplatin-to-docetaxel-or-cabazitaxel weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-about-the-risk-of-osteonecrosis-of-the-jaw-with-anabolic-agents-such-as-teriparatide-or-romosozumab weekly 0.8 https://www.themednet.org/for-patients-with-mild-ckd-how-do-you-decide-between-zoledronic-acid-and-denosumab-for-bone-protection-in-patients-with-multiple-myeloma weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-comprehensive-breast-or-chest-wall-rt-for-locally-advanced-breast-cancer-on-a-cdk-4-6-inhibitor weekly 0.8 https://www.themednet.org/how-do-you-manage-drug-induced-thrombocytopenia-when-the-implicated-drug-is-essential weekly 0.8 https://www.themednet.org/in-the-modern-era-what-is-the-role-of-beta-emitting-bone-targeted-radiopharmaceutical-therapy weekly 0.8 https://www.themednet.org/in-those-with-a-history-of-anti-nmda-encephalitis-with-identified-teratoma-s-p-resection-and-clinical-symptom-improvement-is-there-a-role-for-monitoring-anti-nmda-antibody-titer-as-a-marker-of-disease-recurrence weekly 0.8 https://www.themednet.org/do-you-recommend-esophagectomy-vs-adjuvant-chemoradiation-vs-surveillance-for-an-otherwise-healthy-patient-with-a-pt1b-cn0-cm0-lower-thoracic-esophagus-scc-status-post-endoscopic-submucosal-dissection weekly 0.8 https://www.themednet.org/would-you-recommend-nivo-ipi-instead-of-chemotherapy-nivo-or-chemotherapy-alone-in-advanced-squamous-esophageal-cancer-based-on-checkmate-648 weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-offer-a-tnbc-patient-with-residual-disease-after-receiving-the-neoadjuvant-keynote-522-regimen weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-offer-an-elderly-but-healthy-patient-with-t2n1-hr-her2-breast-cancer-who-is-not-willing-to-receive-cytotoxic-chemotherapy weekly 0.8 https://www.themednet.org/would-you-consider-using-luspatercept-for-a-patient-with-mds-with-anemia-refractory-to-esa-hma-that-has-a-sf3b1-mutation-but-without-ringed-sideroblasts weekly 0.8 https://www.themednet.org/in-a-patient-with-a-heterozygous-prothrombin-gene-mutation-who-has-covid-with-minimal-symptoms-do-you-recommend-prophylactic-and-or-therapeutic-anticoagulation weekly 0.8 https://www.themednet.org/is-unilateral-intracranial-eeg-monitoring-ever-appropriate-in-the-pre-surgical-workup-for-presumed-non-lesional-epilepsy weekly 0.8 https://www.themednet.org/how-does-the-fda-safety-warning-on-the-cardiac-effects-of-lamotrigine-based-on-in-vitro-data-inform-your-clinical-practice weekly 0.8 https://www.themednet.org/how-would-treat-recurrent-unresectable-thymoma-in-patients-treated-previously-with-cap-and-radiation-therapy-with-long-interval-to-recurrence-2-years weekly 0.8 https://www.themednet.org/how-do-you-adjust-tamoxifen-use-in-hr-patients-with-a-history-of-gastric-bypass weekly 0.8 https://www.themednet.org/would-you-treat-the-prostate-in-a-case-of-oligometastatic-disease-with-well-controlled-uc weekly 0.8 https://www.themednet.org/when-treating-keloids-with-electrons-post-operatively-what-margin-do-you-use-when-making-your-electron-field-cut-out weekly 0.8 https://www.themednet.org/how-would-you-treat-an-early-stage-er-pr-her-2-negative-breast-cancer-s-p-lumpectomy-in-an-elderly-patient-who-had-sentinel-node-biopsy-omission weekly 0.8 https://www.themednet.org/when-would-you-utilize-hypofractionated-partial-breast-irradiation-40-gy-15-fxs weekly 0.8 https://www.themednet.org/what-is-the-first-line-therapy-for-demyelinating-neuropathy-with-positive-nf-155-antibodies weekly 0.8 https://www.themednet.org/would-you-consider-using-hma-in-management-of-polycythemia-vera weekly 0.8 https://www.themednet.org/in-a-patient-with-metastatic-her2-positive-breast-cancer-who-has-received-prior-tdm1-in-the-adjuvant-setting-for-residual-disease-would-you-consider-reintroduction-of-tdm1 weekly 0.8 https://www.themednet.org/does-irradiation-of-a-patient-with-pyoderma-gangrenosum-carry-risk-of-morbidity-similar-to-necrosis-caused-by-minor-surgery weekly 0.8 https://www.themednet.org/is-there-any-role-for-adjuvant-atezolizumab-or-adjuvant-osimertinib-in-patients-who-received-neoadjuvant-chemotherapy-for-resectable-nsclc weekly 0.8 https://www.themednet.org/in-what-situations-do-you-recommend-upfront-haploidentical-transplant-in-a-pediatric-patient-with-newly-diagnosed-idiopathic-severe-aplastic-anemia-who-does-not-have-a-msd-mud-donor weekly 0.8 https://www.themednet.org/are-there-scenarios-in-which-you-would-add-nimotuzumab-to-cisplatin-based-concurrent-chemort-to-treat-locally-advanced-head-and-neck-cancer weekly 0.8 https://www.themednet.org/would-you-recommend-adding-debio-1143-to-high-dose-cisplatin-chemoradiotherapy-in-high-risk-locoregionally-advanced-squamous-cell-carcinoma-of-the-head-and-neck weekly 0.8 https://www.themednet.org/would-you-offer-immunotherapy-in-addition-to-chemotherapy-and-trastuzumab-for-patients-with-metastatic-her2-positive-gastroesophageal-cancer-with-low-pdl1 weekly 0.8 https://www.themednet.org/in-thymoma-with-r0-resection-showing-pure-thymoma-how-would-the-presence-of-slightly-elevated-preoperative-afp-and-bhcg-influence-your-approach-to-adjuvant-radiation-if-at-all weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-rt-to-a-figo-iv-endometrial-ca-with-pulm-mets-s-p-hysterectomy-with-residual-disease-then-ccr-to-both-sites-after-chemotherapy weekly 0.8 https://www.themednet.org/how-long-do-you-give-systemic-therapies-or-skin-directed-therapies-to-work-before-changing-treatments-in-patients-with-diffuse-skin-limited-mycoses-fungoides weekly 0.8 https://www.themednet.org/what-bdmard-would-you-choose-for-a-patient-with-ra-with-high-infection-risk-and-inadequate-response-to-cdmards weekly 0.8 https://www.themednet.org/would-you-avoid-cisplatin-with-etoposide-in-a-patient-getting-chemoradiotherapy-for-stage-iii-non-squamous-nsclc-who-has-a-history-of-cabg-4-years-ago-and-echocardiogram-showing-left-atrial-dilatation weekly 0.8 https://www.themednet.org/do-you-routinely-offer-doxycycline-or-minocycline-prophylaxis-for-cutaneous-reactions-to-egfr-inhibitors-such-as-cetuximab weekly 0.8 https://www.themednet.org/would-you-offer-pmrt-to-a-young-woman-with-high-grade-neuroendocrine-carcinoma-of-the-breast weekly 0.8 https://www.themednet.org/if-a-premenopausal-woman-underwent-a-hysterectomy-with-unilateral-so-with-final-pathology-demonstrating-an-intact-mucinous-borderline-tumor-with-negative-washings-would-you-take-her-back-for-surgical-staging weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-bisphosphonates-to-high-risk-premenopausal-women-on-ovarian-suppression-for-early-stage-breast-cancer-who-would-want-to-consider-pregnancy-in-the-future weekly 0.8 https://www.themednet.org/what-is-the-role-of-adjuvant-chemotherapy-in-a-desmoid-tumor-after-r2-resection weekly 0.8 https://www.themednet.org/how-do-you-manage-a-ct3bn0-endometrial-cancer-with-large-vaginal-drop-met-s-p-nac-and-tah-bso-with-pcr weekly 0.8 https://www.themednet.org/would-you-restart-endocrine-therapy-for-a-patient-with-new-contralateral-lcis-diagnosed-2-years-following-completion-of-ai-therapy-for-stage-1a-hr-idc weekly 0.8 https://www.themednet.org/would-you-consider-giving-neoadjuvant-therapy-using-a-keynote-522-regimen-to-someone-with-ct1c-cn0-tnbc weekly 0.8 https://www.themednet.org/in-what-scenario-would-you-add-systemic-therapy-with-adjuvant-radiation-therapy-in-resected-locally-advanced-cutaneous-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-radiotherapy-for-recurrent-paraganglioma-with-lymph-node-involvement-treated-with-salvage-neck-dissection-with-no-residual-disease weekly 0.8 https://www.themednet.org/in-light-of-arasens-presented-at-gu-asco-2022-how-do-you-approach-treatment-of-de-novo-metastatic-hormone-sensitive-prostate-cancer weekly 0.8 https://www.themednet.org/why-do-we-use-dexamethasone-for-cns-edema-and-prednisone-for-pneumonitis weekly 0.8 https://www.themednet.org/would-you-consider-sbrt-or-more-conventionally-fractionated-radiation-for-an-in-field-mediastinal-recurrence-of-esophageal-adenocarcinoma-s-p-preoperative-crt-esophagectomy-and-now-progressing-on-immunotherapy weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-nivolumab-for-patients-with-upper-tract-urothelial-cancer weekly 0.8 https://www.themednet.org/in-patient-with-upper-esophageal-scc-who-had-partial-response-to-neoadjuvant-chemoradiation-but-deemed-not-to-be-a-surgical-candidate-would-you-recommend-chemotherapy-or-nivolumab weekly 0.8 https://www.themednet.org/for-locally-advanced-nsclc-with-additional-synchronous-nsclc-primaries-in-the-same-lung-or-lobe-what-is-your-approach-to-definitive-therapy weekly 0.8 https://www.themednet.org/is-it-reasonable-to-use-hypofractionation-in-early-stage-male-breast-cancer-s-p-lumpectomy weekly 0.8 https://www.themednet.org/for-patients-with-significant-side-effects-to-a-cholinesterase-inhibitor-do-you-try-another-medication-in-the-class-or-avoid-it-altogether weekly 0.8 https://www.themednet.org/how-do-you-utilize-methotrexate-and-or-hydroxychloroquine-in-the-setting-of-limited-scleroderma-crest weekly 0.8 https://www.themednet.org/what-would-be-the-workup-and-the-treatment-of-choice-for-isometric-tremor weekly 0.8 https://www.themednet.org/do-you-apply-a-tracheal-dose-constraint-during-thoracic-radiation-and-or-reirradiation weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-treatment-for-metastatic-follicular-dendritic-cell-sarcoma weekly 0.8 https://www.themednet.org/do-you-avoid-dupilumab-il-4-inhibition-for-severe-asthma-in-patients-already-taking-a-biologic-agent-for-ra weekly 0.8 https://www.themednet.org/when-would-you-consider-an-umbilical-cord-blood-transplant-over-a-haploidentical-transplant-with-post-transplant-cyclophosphamide-or-using-a-desensitization-protocol-for-high-donor-specific-antibodies weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-imaging-and-labs-suggestive-of-potentially-resectable-cholangiocarcinoma-when-several-core-biopsies-reveal-bridging-fibrosis-with-no-malignant-cells weekly 0.8 https://www.themednet.org/how-do-you-manage-neuropathic-chemotherapy-agents-in-patients-with-underlying-multiple-sclerosis weekly 0.8 https://www.themednet.org/how-would-you-treat-a-prostate-cancer-with-malignant-priapism-due-to-direct-tumor-extension weekly 0.8 https://www.themednet.org/should-a-pregnant-woman-who-is-heterozygous-for-factor-v-leiden-who-has-never-had-a-thrombotic-event-receive-prophylactic-anticoagulation weekly 0.8 https://www.themednet.org/would-you-consider-lymph-node-basin-radiation-in-a-patient-with-upper-extremity-merkel-cell-carcinoma-with-one-positive-sln-but-with-no-other-positive-lymph-nodes-found-on-axillary-dissection weekly 0.8 https://www.themednet.org/how-would-you-approach-therapy-for-a-patient-with-non-seminomatous-germ-cell-tumor-ct3n3mx-and-symptomatic-lower-extremity-thrombus-extending-to-the-ivc-when-it-is-unclear-if-bland-or-tumor-thrombus weekly 0.8 https://www.themednet.org/how-would-you-approach-breast-cancer-screening-in-an-adolescent-patient-with-a-cdh1-mutation weekly 0.8 https://www.themednet.org/what-would-be-a-reasonable-radiation-approach-and-dose-for-a-patient-with-multiple-myeloma-with-brain-involvement weekly 0.8 https://www.themednet.org/is-there-any-utility-in-checking-hla-b-5801-in-our-black-and-asian-patients-who-are-already-tolerating-allopurinol weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-for-a-patient-with-progressive-ild-uip-pattern-with-high-titer-rf-but-no-articular-symptoms weekly 0.8 https://www.themednet.org/how-do-you-approach-heparin-management-in-patients-who-have-suprathetherapeutic-xa-levels-on-minimal-heparin weekly 0.8 https://www.themednet.org/how-do-you-treat-a-low-grade-mucoepidermoid-carcinoma-with-unkown-primary-site weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-erosive-pustular-dermatosis weekly 0.8 https://www.themednet.org/have-you-found-success-in-managing-refractory-hidradenitis-suppurativa-with-ertapenem weekly 0.8 https://www.themednet.org/how-do-you-manage-lengthy-unplanned-breaks-during-radiation-therapy-for-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-t4-nsclc-due-to-several-ipsilateral-lung-nodules-in-different-lobes weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-sreat-steroid-responsive-encephalopathy-with-autoimmune-thyroiditis-after-initial-pulse-dose-steroids weekly 0.8 https://www.themednet.org/how-do-you-manage-recurrent-portal-vein-thromboses-in-a-patient-with-jak2-pv-on-therapeutic-anticoagulation-and-appropriate-cytoreduction weekly 0.8 https://www.themednet.org/does-potential-longterm-risk-for-leukemia-influence-your-decision-for-using-hydroxyurea-in-young-patients-with-myeloproliferative-neoplasms weekly 0.8 https://www.themednet.org/would-you-start-a-tnf-i-for-seronegative-non-erosive-ra-in-a-patient-with-positive-ana-and-sun-sensitivity-without-other-sle-features weekly 0.8 https://www.themednet.org/how-do-you-manage-near-field-recurrence-of-a-soft-tissue-sarcoma-that-was-previously-treated-with-pre-op-rt weekly 0.8 https://www.themednet.org/how-would-you-treat-a-post-menopausal-woman-found-to-have-a-node-negative-ipsilateral-hr-breast-cancer-recurrence-with-pectoral-muscle-invasion-following-a-prior-mastectomy-radiation-and-ai-therapy-completed-5-years-ago weekly 0.8 https://www.themednet.org/does-4g-5g-polymorphism-in-the-plasminogen-activator-inhibitor-pai-1-gene-increase-the-risk-of-thrombosis weekly 0.8 https://www.themednet.org/would-you-intensify-therapy-in-igg4-related-disease-based-solely-on-a-persistently-significantly-elevated-igg4-level-when-all-disease-manifestations-and-inflammatory-markers-have-normalized weekly 0.8 https://www.themednet.org/how-do-you-approach-the-diagnosis-and-treatment-of-recurrent-neurosyphilis-in-a-previously-treated-patient weekly 0.8 https://www.themednet.org/what-is-your-approach-to-long-term-immunosuppression-in-patients-with-adult-onset-stills-disease weekly 0.8 https://www.themednet.org/what-maintenance-therapy-if-any-do-you-offer-patients-with-metastatic-her2-esophageal-or-gastric-cancer weekly 0.8 https://www.themednet.org/how-has-wilms-tumor-therapy-evolved-over-the-years weekly 0.8 https://www.themednet.org/when-is-postmastectomy-radiation-therapy-indicated-for-a-de-novo-occurrence-of-cancer-in-the-chest-wall-after-mastectomy-without-prior-malignancy-such-as-in-a-patient-who-had-prophylactic-mastectomy weekly 0.8 https://www.themednet.org/how-do-you-manage-real-time-release-of-pathology-and-radiology-results-to-oncology-patients-following-enaction-of-the-cures-act weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-parathyroid-hormone-related-protein-analog-drugs-in-the-setting-of-prior-external-beam-radiation weekly 0.8 https://www.themednet.org/what-additional-benefit-does-radiation-offer-for-a-patient-65-years-old-with-t1an0-er-invasive-carcinoma-tubular-histology-of-the-breast weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-hormonal-therapy-for-premenopausal-woman-with-positive-margin-hr-dcis-after-a-bilateral-mastectomy weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-to-adjuvant-treatment-for-stage-ic-grade-1-endometrioid-ovarian-adenocarcinoma weekly 0.8 https://www.themednet.org/would-you-still-consider-durvalumab-consolidation-after-definitive-chemoradiation-for-patients-with-stage-iii-nsclc-who-are-on-stable-weekly-methotrexate-dosing-for-psoriasis-psoriatic-arthritis weekly 0.8 https://www.themednet.org/are-pancreatic-fiducials-necessary-when-delivering-dose-escalated-radiation-therapy-for-inoperable-pancreatic-cancer-and-using-cone-beam-ct-for-igrt weekly 0.8 https://www.themednet.org/how-would-you-sequence-treatment-for-hpv-concurrent-advanced-oropharynx-and-anal-scc-1 weekly 0.8 https://www.themednet.org/would-you-recommend-xrt-to-post-cystectomy-bladder-cancer-patient-with-metastatic-pa-and-mesenteric-nodes weekly 0.8 https://www.themednet.org/for-post-operative-radiation-of-resected-high-grade-soft-tissue-sarcoma-how-long-of-a-delay-do-you-tolerate-before-starting-radiation weekly 0.8 https://www.themednet.org/what-is-the-significance-of-entrapped-nerves-present-on-pathology-for-oral-cavity-cancers weekly 0.8 https://www.themednet.org/what-is-the-clinical-benefit-of-primary-site-postoperative-radiation-after-neoadjuvant-chemotherapy-and-oncologic-surgery-for-an-extremity-soft-tissue-synovial-sarcoma-in-an-oligometastatic-patient-with-pulmonary-metastases weekly 0.8 https://www.themednet.org/for-relapsed-refractory-myeloma-how-long-of-a-disease-free-interval-from-first-autologous-transplant-do-you-recommend-before-considering-a-second-autologous-transplant weekly 0.8 https://www.themednet.org/would-you-check-vitamin-b6-routinely-in-the-work-up-of-anemia weekly 0.8 https://www.themednet.org/what-would-be-your-approach-to-initial-treatment-of-a-patient-with-standard-risk-myeloma-unwilling-to-undergo-autologous-stem-cell-transplant-if-practicing-in-a-resource-limited-setting weekly 0.8 https://www.themednet.org/would-you-offer-rt-for-a-patient-with-early-stage-breast-cancer-with-a-focally-positive-margin-who-was-lost-to-follow-up-for-over-a-year-after-surgery weekly 0.8 https://www.themednet.org/in-which-situations-do-you-offer-neoadjuvant-chemotherapy-for-a-nodal-recurrence-alone-of-er-pr-positive-her2-negative-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-recommended-management-algorithm-for-bleeding-associated-with-an-acquired-factor-viii-inhibitor weekly 0.8 https://www.themednet.org/can-docetaxel-be-safely-given-to-patients-with-hyperbilirubinemia-from-gilberts-syndrome weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-recurrent-histiocytic-sarcoma-in-a-young-healthy-patient-after-surgical-resection weekly 0.8 https://www.themednet.org/would-you-recommend-tamoxifen-x-5-years-following-mastectomy-in-a-male-with-pure-dcis weekly 0.8 https://www.themednet.org/in-what-conditions-can-you-see-roving-eye-movements weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-cytopenia-related-to-nk-cell-lgl-leukemia weekly 0.8 https://www.themednet.org/do-you-divide-interpolation-flaps-2-or-3-weeks-after-the-initial-surgery weekly 0.8 https://www.themednet.org/would-you-administer-postoperative-adjuvant-atezolizumab-or-chemotherapy-for-patients-with-locally-advanced-nsclc-and-pathological-residual-disease-following-neoadjuvant-nivolumab-chemotherapy-and-surgical-resection weekly 0.8 https://www.themednet.org/when-would-you-opt-for-a-chemotherapy-free-approach-in-the-first-line-treatment-for-hairy-cell-leukemia weekly 0.8 https://www.themednet.org/would-you-consider-palliative-radiation-for-a-bone-metastasis-while-patient-is-on-pembrolizumab-and-axinitib weekly 0.8 https://www.themednet.org/is-there-an-indication-for-bolus-in-whole-breast-rt-for-early-stage-invasive-ductal-carcinoma-with-micropapillary-features weekly 0.8 https://www.themednet.org/do-you-repeat-antiphospholipid-antibody-testing-in-a-patient-that-previously-met-criteria-for-apls weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-a-patient-with-pt2n2-lung-adenocarcinoma-who-underwent-an-r1-resection-and-is-not-amenable-to-further-surgical-intervention weekly 0.8 https://www.themednet.org/do-you-treat-stage-1-non-seminoma-differently-if-there-is-a-component-of-embryonal-carcinoma weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-resected-renal-cell-carcinoma-collecting-duct-type-with-sarcomatoid-and-rhabdoid-features weekly 0.8 https://www.themednet.org/how-would-you-treat-prostate-cancer-that-recurs-after-radical-prostatectomy-with-invasion-into-bladder-rectum-and-musculature weekly 0.8 https://www.themednet.org/would-you-have-any-hesitation-to-use-belimumab-in-a-patient-with-iga-deficiency weekly 0.8 https://www.themednet.org/how-would-you-approach-therapy-for-relapsed-refractory-mantle-cell-lymphoma-restricted-to-the-cns weekly 0.8 https://www.themednet.org/would-you-give-a-tpo-agonist-for-thrombocytopenia-in-alcoholic-cirrhosis weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-prostate-cancer-with-de-novo-bone-and-bone-marrow-metastases-with-cytopenias weekly 0.8 https://www.themednet.org/for-a-patient-with-breast-cancer-s-p-lumpectomy-found-to-have-a-heterozygous-rad50-mutation-is-adjuvant-radiation-appropriate-therapy-or-would-you-recommend-completion-mastectomy weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-therapy-for-rectal-intramucosal-carcinoma-within-a-large-rectal-adenoma weekly 0.8 https://www.themednet.org/how-do-you-manage-a-duodenal-somatostatinoma-metastatic-to-liver weekly 0.8 https://www.themednet.org/how-do-you-approach-radiation-therapy-for-a-target-volume-adjacent-to-a-watchman-atrial-appendage-closure-device weekly 0.8 https://www.themednet.org/what-are-your-skull-constraints-when-administering-cranial-srs-fsrs weekly 0.8 https://www.themednet.org/what-is-the-role-of-radiotherapy-in-a-newly-diagnosed-patient-with-parameningeal-rhabdomyosarcoma-w-intracranial-extension-a-positive-csf-but-no-extra-cns-metastases weekly 0.8 https://www.themednet.org/what-is-your-practice-for-the-timing-of-resumption-of-oral-anticoagulation-after-ich weekly 0.8 https://www.themednet.org/if-patient-has-multicentric-triple-negative-breast-cancer-with-complete-radiographic-response-post-chemo-is-bcs-feasible weekly 0.8 https://www.themednet.org/what-treatment-would-you-recommend-in-an-older-patient-with-multiply-relapsed-double-hit-lymphoma-with-recurrence-following-asct-pola-br-and-car-t-therapy weekly 0.8 https://www.themednet.org/what-is-the-optimal-management-of-patients-with-gastroesophageal-cancer-who-progress-to-metastatic-disease-during-preoperative-flot weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-suspected-chronic-contact-dermatitis-and-negative-patch-testing weekly 0.8 https://www.themednet.org/how-do-you-differentiate-atopic-dermatitis-from-mycosis-fungoides-histologically weekly 0.8 https://www.themednet.org/when-consolidating-dlbcl-with-radiotherapy-do-you-treat-all-originally-involved-sites-or-just-initially-bulky-and-partial-responder-sites weekly 0.8 https://www.themednet.org/given-recent-os-data-from-the-olympia-trial-would-you-offer-adjuvant-olaparib-to-a-brca-patient-with-pt1bn0-tnbc weekly 0.8 https://www.themednet.org/how-would-you-treat-an-elderly-patient-with-a-well-lateralized-large-ie-ct3-node-negative-oral-tongue-cancer-who-is-not-felt-to-be-a-surgical-candidate weekly 0.8 https://www.themednet.org/would-you-consider-eliminating-post-lumpectomy-rt-in-a-premenopausal-patient-with-pcr-after-chemotherapy-for-a-ct1cn0-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/would-you-give-liposomal-doxorubicin-to-a-patient-with-recurrent-left-thigh-atypical-spindle-cell-lipomatous-tumor-low-to-intermediate-grade-that-is-not-a-surgical-or-radiation-candidate weekly 0.8 https://www.themednet.org/how-would-you-manage-recurrent-anal-scc-after-chemoradiation-with-positive-margins-after-resection weekly 0.8 https://www.themednet.org/for-patients-who-received-neoadjuvant-chemotherapy-and-found-to-have-an-egfr-sensitizing-mutation-at-time-of-r0-surgical-resection-would-you-offer-still-offer-adjuvant-osimertinib weekly 0.8 https://www.themednet.org/how-would-you-treat-an-early-stage-rectal-adenocarcinoma-in-a-patient-that-had-previously-received-ebrt-prostate-radiation weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-would-you-recommend-for-palliative-intent-radiation-therapy-for-cutaneous-angiosarcoma-in-a-patient-with-distant-metastases weekly 0.8 https://www.themednet.org/in-a-life-time-non-smoker-with-stage-iv-lung-adenocarcinoma-presenting-in-visceral-crisis-what-therapy-would-you-recommend-to-avoid-organ-failure-while-awaiting-mutational-status weekly 0.8 https://www.themednet.org/how-would-you-approach-treating-patients-with-ra-refractory-to-cdmards-and-a-prior-history-of-malt-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-cutaneous-pan weekly 0.8 https://www.themednet.org/for-external-beam-partial-breast-irradiation-if-the-ctv-lies-close-to-the-skin-surface-do-you-apply-bolus weekly 0.8 https://www.themednet.org/what-radiation-dose-do-you-typically-use-for-relapsed-dlbcl-following-6-cycles-of-r-chop weekly 0.8 https://www.themednet.org/how-would-you-approach-therapy-for-newly-diagnosed-germinal-center-dlbcl-who-previously-received-an-unknown-systemic-regimen-with-radiation-for-history-of-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-decide-on-the-elective-radiation-volume-when-treating-a-lateralized-node-negative-non-tongue-oral-cavity-cancer-with-definitive-chemort weekly 0.8 https://www.themednet.org/did-the-approval-of-lutetium-lu-177-vipivotide-tetraxetan-pluvicto-change-how-you-image-and-manage-patients-with-metastatic-castrate-resistant-prostate-cancer weekly 0.8 https://www.themednet.org/would-you-be-comfortable-with-patients-taking-juven-protein-powder-during-head-and-neck-radiation weekly 0.8 https://www.themednet.org/do-you-recommend-patients-wait-to-have-a-total-hip-sx-after-salvage-radiation-for-rp weekly 0.8 https://www.themednet.org/would-you-give-chemotherapy-and-trastuzumab-to-a-patient-with-multifocal-high-grade-microscopic-5-mm-hr-her2-idc-embedded-in-extensive-dcis-staged-as-ptis-pt1a-m-n0 weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-patients-with-erythema-nodosum-recalcitrant-to-nsaids weekly 0.8 https://www.themednet.org/when-and-how-do-you-initiate-therapeutic-phlebotomy-for-patients-with-hereditary-hemochromatosis-without-evidence-of-end-organ-injury weekly 0.8 https://www.themednet.org/do-you-routinely-monitor-the-qtc-when-adding-voclosporin-to-hydroxychloroquine-in-a-patient-with-lupus-nephritis weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiotherapy-to-an-elderly-patient-with-t4-scc-of-the-scalp-and-positive-margins-6-months-after-mohs-surgery weekly 0.8 https://www.themednet.org/why-do-we-not-typically-see-features-of-rhabdomyolysis-or-acute-kidney-injury-with-idiopathic-inflammatory-myopathies weekly 0.8 https://www.themednet.org/for-patients-with-early-stage-t1-t2-n0-low-rectal-cancers-who-are-not-candidates-for-transanal-surgery-and-decline-apr-due-to-ostomy-would-you-offer-chemort-followed-by-surveillance-or-chemort-then-a-course-of-chemotherapy-followed-by-surveillance weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-young-female-regarding-fertility-risks-from-cranial-radiation weekly 0.8 https://www.themednet.org/would-you-offer-palliative-radiation-for-painful-bone-metastases-in-a-patient-with-scleroderma weekly 0.8 https://www.themednet.org/how-would-you-treat-localized-cutaneous-pan-recalcitrant-to-high-dose-steroids weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-pembrolizumab-post-metachronous-oligometastatic-resection-of-rcc-beyond-the-first-year-of-diagnosis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-treatment-of-pml-iris-in-patients-with-hiv-who-have-progressed-to-aids weekly 0.8 https://www.themednet.org/would-you-consider-avoidance-of-ac-and-proceeding-to-surgery-in-a-ct2n0-tnbc-patient-who-achieves-a-significant-clinical-response-to-carboplatin-paclitaxel-and-pembrolizumab-as-part-of-the-keynote-522-regimen weekly 0.8 https://www.themednet.org/what-schedule-and-type-of-antiemetics-do-you-provide-for-patients-receiving-pcv-for-co-deleted-oligodendrogliomas weekly 0.8 https://www.themednet.org/would-you-recommend-consolidative-radiation-therapy-for-advanced-stage-bulky-hodgkins-lymphoma-with-a-delayed-complete-response-after-6-cycles-of-a-avd-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-for-a-pre-menopausal-patient-with-pr-positive-er-negative-her2-negative-ct1c-n1-breast-cancer weekly 0.8 https://www.themednet.org/what-are-the-alternatives-to-anticoagulation-in-an-individual-with-an-atrial-thrombus-and-absolute-contraindications-to-anticoagulation weekly 0.8 https://www.themednet.org/which-patients-with-resectable-stage-ib-iiia-nsclc-would-most-benefit-from-using-neoadjuvant-chemoimmunotherapy-as-per-checkmate-816 weekly 0.8 https://www.themednet.org/in-patients-with-recurrent-msi-h-endometrial-cancer-on-immunotherapy-with-pembrolizumab-when-do-you-discontinue-therapy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-essential-thrombocythemia-and-persistent-pruritus-despite-adequate-control-of-cbc-with-hydroxyurea-and-aspirin weekly 0.8 https://www.themednet.org/do-you-perform-routine-interval-screening-for-renal-angiomyolipomas-in-patients-with-sporadic-lam weekly 0.8 https://www.themednet.org/is-there-a-role-for-antifibrotic-therapy-in-post-covid-19-pulmonary-fibrosis weekly 0.8 https://www.themednet.org/which-images-do-you-routinely-request-when-ordering-a-hrct-chest weekly 0.8 https://www.themednet.org/do-you-de-escalate-airway-clearance-therapies-in-patients-with-cf-who-experience-an-improvement-in-mucus-production-and-clearance-after-cftr-modulator-therapy-is-started weekly 0.8 https://www.themednet.org/is-there-a-role-for-the-use-of-inhaled-corticosteroids-in-patients-with-pulmonary-sarcoidosis-who-have-stage-ii-or-iii-disease-with-abnormal-lung-function-but-only-mild-respiratory-symptoms weekly 0.8 https://www.themednet.org/do-you-utilize-soluble-il-2-receptor-or-ace-levels-as-serum-biomarkers-to-monitor-disease-activity-in-pulmonary-sarcoidosis weekly 0.8 https://www.themednet.org/based-on-findings-of-the-increase-trial-are-you-routinely-prescribing-inhaled-treprostinil-to-patients-with-group-3-pulmonary-hypertension-secondary-to-interstitial-lung-disease weekly 0.8 https://www.themednet.org/which-class-of-biologic-agent-do-you-use-first-in-a-patient-with-asthma-who-may-qualify-for-multiple-drugs weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-portable-high-efficiency-particulate-absolute-air-cleaners-to-former-smokers-with-moderate-to-severe-copd weekly 0.8 https://www.themednet.org/do-you-consider-ebus-tbna-in-the-diagnostic-evaluation-of-patients-with-mediastinal-lymphadenopathy-with-concern-for-lymphoma weekly 0.8 https://www.themednet.org/when-would-you-consider-biopsy-for-an-incidentally-noted-pet-negative-solid-solitary-pulmonary-nodule-that-is-8mm-in-size weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-indwelling-pleural-catheters-in-the-management-of-patients-with-hepatic-hydrothorax-requiring-frequent-drainage weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-endobronchial-valves-in-the-management-of-patients-with-spontaneous-pneumothorax-with-persistent-air-leak weekly 0.8 https://www.themednet.org/do-you-employ-the-use-of-extracorporeal-photopheresis-in-the-management-of-patients-with-progressive-bos-following-lung-transplantation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-therapy-in-patients-with-progressive-scedosporium-pulmonary-infection-who-are-not-candidates-for-surgical-debridement weekly 0.8 https://www.themednet.org/do-you-treat-candida-spp-isolated-from-a-bronchoalveolar-lavage weekly 0.8 https://www.themednet.org/do-you-employ-the-use-of-external-chest-compression-with-sandbags-in-the-management-of-patients-with-severe-ards-who-are-not-candidates-for-proning weekly 0.8 https://www.themednet.org/do-you-routinely-use-inhaled-pulmonary-vasodilators-in-the-management-of-patients-with-ards-with-refractory-hypoxemia weekly 0.8 https://www.themednet.org/what-is-your-approach-to-counseling-and-management-of-patients-with-severe-symptomatic-osa-whose-pap-devices-have-been-recalled weekly 0.8 https://www.themednet.org/how-do-you-approach-determining-appropriateness-for-extubation-in-a-patient-with-acute-respiratory-failure-in-the-setting-of-known-chronic-neuromuscular-disease weekly 0.8 https://www.themednet.org/do-you-favor-the-use-of-maximal-inspiratory-expiratory-pressure-measurement-or-supine-spirometry-in-the-evaluation-of-a-patient-with-suspected-respiratory-muscle-weakness weekly 0.8 https://www.themednet.org/what-is-your-approach-to-counseling-a-patient-with-exertional-hypoxia-but-normal-resting-oxygen-saturation-who-is-hesitant-to-use-supplemental-oxygen-therapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-monitoring-and-management-of-a-never-smoker-with-respiratory-symptoms-and-a-nonspecific-ventilatory-pattern-on-pulmonary-function-testing weekly 0.8 https://www.themednet.org/would-you-consider-hipec-in-a-known-brca-iiic-ovarian-cancer-patient-undergoing-interval-debulking-surgery-if-the-patient-is-known-to-desire-parpi-maintenance-following-completion-of-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-manage-a-stenotic-airway-following-sbrt-or-hypofractionated-radiation-to-a-central-lung-tumor weekly 0.8 https://www.themednet.org/for-invasive-ductal-carcinoma-with-micropapillary-features-s-p-lumpectomy-is-bolus-needed-when-treated-with-adjuvant-whole-breast-rt weekly 0.8 https://www.themednet.org/what-dose-constraints-do-you-use-for-oars-when-treating-with-breast-imrt weekly 0.8 https://www.themednet.org/what-would-be-your-post-operative-therapy-approach-for-a-high-grade-neuroendocrine-carcinoma-of-the-thymus weekly 0.8 https://www.themednet.org/do-you-stop-ppi-when-starting-patients-on-immunotherapy weekly 0.8 https://www.themednet.org/would-you-offer-preoperative-radiation-for-an-intrathoracic-leiomyosarcoma-in-the-posterior-mediastinum weekly 0.8 https://www.themednet.org/in-a-patient-with-stage-1-mixed-germ-cell-tumor-who-cleared-tumor-markers-post-orchiectomy-but-with-subsequent-rise-to-borderline-abnormal-within-6-weeks-would-you-treat-with-3-cycles-bep-as-for-s1-disease weekly 0.8 https://www.themednet.org/what-is-your-institutions-practice-guidelines-for-considering-a-reduced-intensity-ric-over-a-myeloablative-mac-conditioning-regimen weekly 0.8 https://www.themednet.org/what-systemic-therapy-if-any-would-you-offer-a-patient-after-wbrt-for-an-isolated-cns-relapse-of-initially-limited-stage-sclc-that-received-chemort-without-pci weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-small-asymptomatic-well-differentiated-pnets weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-stage-iv-non-small-cell-lung-cancer-with-concomitant-atypical-egfr-mutation-such-as-g719d-and-atypical-ros1-fusion weekly 0.8 https://www.themednet.org/do-you-routinely-perform-a-breast-boost-after-whole-breast-radiation weekly 0.8 https://www.themednet.org/what-is-the-difference-between-multisystem-inflammatory-syndrome-in-adults-mis-a-and-mas-hlh weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-chemotherapy-for-a-patient-who-achieved-a-cr-after-tnt-for-stage-iii-rectal-adenocarcinoma-but-underwent-no-initial-surgery-and-now-has-a-local-recurrence-12-months-later-with-plans-to-undergo-low-anterior-resection weekly 0.8 https://www.themednet.org/how-soon-after-valve-replacement-would-you-start-thoracic-radiation-for-nsclc weekly 0.8 https://www.themednet.org/how-does-urinary-obstruction-impact-your-choice-of-therapy-for-metastatic-or-locally-advanced-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-use-intrapleural-tpa-dornase-in-loculated-effusions-that-are-not-due-to-infection weekly 0.8 https://www.themednet.org/would-you-retry-rituximab-in-steroid-refractory-warm-autoimmune-hemolytic-anemia-which-responded-to-rituximab-before weekly 0.8 https://www.themednet.org/are-there-any-whole-breast-rt-techniques-or-modifications-to-optimize-cosmesis-for-patients-who-had-prior-breast-augmentation weekly 0.8 https://www.themednet.org/how-do-you-position-patients-in-a-prone-belly-board-for-reproducibility-and-optimal-small-bowel-sparing-for-rectal-cancer-treatment weekly 0.8 https://www.themednet.org/how-do-you-address-extended-break-from-ebrt-during-cervical-cancer-treatment weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-chemotherapy-induced-paronychia weekly 0.8 https://www.themednet.org/do-you-routinely-offer-antiviral-prophylaxis-for-patients-receiving-chemoimmunotherapy weekly 0.8 https://www.themednet.org/would-you-provide-abemaciclib-to-a-premenopausal-women-with-ct2-cn1-er-breast-cancer-and-ki67-of-80-who-achieves-pcr-following-neoadjuvant-ac-t weekly 0.8 https://www.themednet.org/in-light-of-alk-directed-therapy-what-is-the-role-of-chemotherapy-for-patients-with-newly-diagnosed-alk-dlbcl weekly 0.8 https://www.themednet.org/would-you-continue-adjuvant-folfox-for-a-patient-with-stage-iii-colon-cancer-and-triple-vessel-coronary-artery-disease-who-developed-nstemi-after-the-first-cycle weekly 0.8 https://www.themednet.org/are-there-situations-in-which-neoadjuvant-chemoimmunotherapy-surgery-would-be-preferred-over-chemoradiation-consolidative-immunotherapy-for-stage-iii-lung-cancer weekly 0.8 https://www.themednet.org/would-you-anticoagulate-recurrent-venous-thromboembolism-in-a-patient-with-ehlers-danlos-syndrome weekly 0.8 https://www.themednet.org/should-impower010-results-be-extrapolated-to-superior-sulcus-tumors-treated-with-chemoradiation-and-surgery weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-cicatricial-pemphigoid-refractory-to-doxycycline-and-dapsone weekly 0.8 https://www.themednet.org/what-margin-do-you-use-when-treating-the-prostate-bed-fossa weekly 0.8 https://www.themednet.org/what-are-your-recommendations-for-management-of-patients-with-familial-polycythemia-due-to-epor-mutation-during-pregnancy weekly 0.8 https://www.themednet.org/what-dose-constraints-do-you-use-when-palliating-pelvic-structures-in-5-10-fractions weekly 0.8 https://www.themednet.org/in-a-patient-diagnosed-with-multiple-myeloma-is-there-a-role-for-24-hour-upep-prior-to-treatment weekly 0.8 https://www.themednet.org/based-on-recent-data-would-you-consider-adding-atra-to-low-dose-rituximab-for-steroid-refractory-itp weekly 0.8 https://www.themednet.org/how-do-you-treat-metastatic-wild-type-gist weekly 0.8 https://www.themednet.org/what-is-your-approach-to-cns-surveillance-in-resected-superior-sulcus-tumors-given-high-rates-of-intracranial-metastasis-in-this-population weekly 0.8 https://www.themednet.org/how-would-you-treat-a-recurrent-chylothorax-in-a-patient-with-metastatic-cholangiocarcinoma weekly 0.8 https://www.themednet.org/how-do-you-prefer-to-repair-skin-cancer-excisions-done-on-lower-extremities weekly 0.8 https://www.themednet.org/what-is-your-approach-when-counseling-patients-interested-in-bio-identical-hormones-for-management-of-menopause-versus-traditional-hormone-replacement-therapy weekly 0.8 https://www.themednet.org/in-what-situations-would-you-recommend-metformin-in-addition-to-aggressive-lifestyle-interventions-for-patients-with-prediabetes-and-obesity weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-recurrent-grade-3-oligodendroglioma-mgmt-methylated-idh-mutant-1p-19q-co-deleted-1-year-after-gross-total-resection-and-adjuvant-chemotherapy-and-radiation weekly 0.8 https://www.themednet.org/would-you-ever-re-irradiate-the-groin-inguinal-region weekly 0.8 https://www.themednet.org/what-is-the-role-for-chemo-immunotherapy-in-the-up-front-setting-in-non-metastatic-head-neck-cancer-outside-of-clinical-trials weekly 0.8 https://www.themednet.org/how-would-you-approach-the-prevention-of-irinotecan-induced-diarrhea-in-a-patient-who-previously-experienced-a-diffuse-rash-with-cefixime weekly 0.8 https://www.themednet.org/what-is-your-stepwise-approach-to-supporting-the-rv-in-the-setting-of-rv-failure-from-unrevascularized-rca-disease-in-an-unstable-patient-in-the-absence-of-rp-impella-availability weekly 0.8 https://www.themednet.org/do-you-recommend-treating-a-macroprolactinoma-that-is-acutely-undergoing-spontaneous-apoplexy-with-dopaminergic-agents weekly 0.8 https://www.themednet.org/how-do-you-decide-the-duration-of-dapt-following-tavr-especially-for-patients-already-on-a-doac weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-hold-acalabrutinib-or-zanubrutinib-in-patients-with-indolent-b-cell-lymphoma-leukemias-in-a-perioperative-periprocedural-setting weekly 0.8 https://www.themednet.org/do-you-prefer-cantharidin-plus-or-y-canth-for-management-of-pediatric-molluscum weekly 0.8 https://www.themednet.org/does-the-degree-of-tsh-suppression-significantly-impact-the-risk-of-differentiated-thyroid-carcinoma-recurrence weekly 0.8 https://www.themednet.org/do-you-use-biomarkers-to-improve-risk-prediction-in-patients-with-adpkd-during-early-disease-stages weekly 0.8 https://www.themednet.org/would-you-consider-starting-short-term-metformin-in-an-otherwise-healthy-patient-who-is-beginning-high-dose-glucocorticoids-to-prevent-glucocorticoid-induced-insulin-resistance weekly 0.8 https://www.themednet.org/do-you-recommend-checking-plasma-metanephrine-levels-during-adrenal-venous-sampling-to-assist-in-assessing-lateralization-in-primary-aldosteronism weekly 0.8 https://www.themednet.org/when-would-you-consider-testing-for-lgi1-antibodies-in-patients-with-unexplained-neuropathic-pain weekly 0.8 https://www.themednet.org/how-do-you-approach-the-risk-benefit-ratio-of-pericardiocentesis-as-opposed-to-close-observation-with-serial-ttes-in-a-hemodynamically-stable-elderly-patient-on-anticoagulation-with-a-large-circumferential-pericardial-effusion weekly 0.8 https://www.themednet.org/would-you-make-any-dialysis-prescription-modifications-for-an-eskd-patient-who-develops-tachycardia-during-a-hemodialysis-session weekly 0.8 https://www.themednet.org/how-do-you-weigh-the-risks-and-benefits-of-glp-1-ras-in-patients-over-age-65-specifically-in-regards-to-loss-of-muscle-mass-and-osteoporosis weekly 0.8 https://www.themednet.org/do-you-continue-ovarian-suppression-for-metastatic-hormone-positive-breast-cancer-patients-who-are-premenopausal-regardless-of-line-of-therapy weekly 0.8 https://www.themednet.org/is-there-a-role-for-functional-medicine-approaches-in-psychiatric-treatment weekly 0.8 https://www.themednet.org/how-do-you-monitor-and-manage-minimal-residual-disease-mrd-in-patients-with-core-binding-factor-cbf-aml-who-are-in-remission-post-induction-and-consolidation-therapy weekly 0.8 https://www.themednet.org/would-involved-site-radiation-therapy-be-recommended-in-a-patient-with-poems-syndrome-whose-myelopathy-symptoms-worsened-after-one-cycle-of-cybord weekly 0.8 https://www.themednet.org/would-you-consider-the-use-of-romosozumab-in-men-who-have-failed-therapy-with-teriparatide-and-sustained-multiple-vertebral-fractures weekly 0.8 https://www.themednet.org/how-do-you-approach-adt-in-patients-with-high-risk-prostate-cancer-who-have-risk-factors-for-vte-such-as-factor-v-leiden weekly 0.8 https://www.themednet.org/do-you-routinely-hold-anticoagulation-including-pharmacologic-vte-prophylaxis-for-bedside-procedures-such-as-paracentesis-thoracentesis-and-central-venous-catheter-placement weekly 0.8 https://www.themednet.org/when-do-you-switch-to-a-different-dmt-in-multiple-sclerosis-patients-planning-for-pregnancy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-interested-in-carotid-endarterectomy-for-asymptomatic-carotid-disease-as-a-means-to-reduce-dementia-risk weekly 0.8 https://www.themednet.org/how-do-structural-and-functional-findings-on-echocardiogram-influence-your-decision-to-anticogulate-esus-cases weekly 0.8 https://www.themednet.org/for-patients-with-neovascular-glaucoma-and-uncontrolled-iop-do-you-ever-consider-a-glaucoma-drainage-device-gdd-combined-with-ecp-as-opposed-to-just-a-standalone-gdd weekly 0.8 https://www.themednet.org/how-does-ctak-compare-to-conventional-keratoplasty-techniques-pk-alk-in-patients-with-corneal-ectasia weekly 0.8 https://www.themednet.org/how-does-a-history-of-malignant-glaucoma-in-one-eye-influence-your-surgical-approach-to-the-fellow-eye-particularly-regarding-prophylactic-intra-operative-measures-i-e-iridotomy-izh weekly 0.8 https://www.themednet.org/would-you-recommend-antifungal-treatment-or-observation-without-therapy-in-an-immunocompetent-patient-with-a-pulmonary-nodule-who-underwent-malignancy-workup-and-was-found-to-have-yeast-forms-consistent-with-histoplasma-on-gms-stain weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-for-a-postmenopausal-patient-who-was-treated-more-than-5-years-ago-with-ac-t-for-tnbc-and-who-now-presents-with-ipsilateral-locally-advanced-node-positive-tnbc-but-has-severe-residual-neuropathy-from-prior-taxane-exposure weekly 0.8 https://www.themednet.org/in-resected-n2-nsclc-what-nodal-pathologic-characteristics-prompt-you-to-recommend-port weekly 0.8 https://www.themednet.org/what-is-the-role-of-botox-for-pelvic-floor-dyssynergia weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-panic-attacks-disorder-with-psychotic-features weekly 0.8 https://www.themednet.org/do-you-incorporate-the-alascca-trial-into-your-clinical-practice-and-perform-ngs-on-all-early-stage-colon-cancer-patients-to-determine-if-adjuvant-aspirin-would-be-beneficial weekly 0.8 https://www.themednet.org/can-estradiol-patches-be-prescribed-once-weekly-instead-of-twice-weekly-for-the-treatment-of-postmenopausal-symptoms weekly 0.8 https://www.themednet.org/do-you-avoid-the-use-of-glp-1-r-agonist-therapy-for-treatment-of-obesity-in-patients-with-known-gastroparesis weekly 0.8 https://www.themednet.org/how-would-you-manage-an-elderly-patient-with-a-de-novo-tnbc-in-the-setting-of-a-remote-prior-ipsilateral-breast-cancer-s-p-mastectomy-and-implant weekly 0.8 https://www.themednet.org/how-would-you-approach-anticoagulation-for-a-newly-recurrent-vte-on-progestin-only-therapy weekly 0.8 https://www.themednet.org/how-do-you-weigh-the-benefit-of-urinary-catheter-placement-for-strict-i-o-measurement-with-the-risk-of-avoidable-cauti weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-antibody-mediated-rejection-in-a-pregnant-patient-with-a-kidney-transplant weekly 0.8 https://www.themednet.org/how-do-you-clinically-distinguish-between-pericardial-effusion-from-volume-overload-versus-uremic-pericarditis-in-advanced-ckd weekly 0.8 https://www.themednet.org/what-is-your-preferred-method-of-wound-closure-after-wide-excision-for-hidradenitis-suppurativa weekly 0.8 https://www.themednet.org/are-there-patients-with-pemphigus-whom-you-plan-to-give-additional-doses-of-rituximab-even-if-they-are-in-complete-remission-at-six-months-from-their-initial-dose weekly 0.8 https://www.themednet.org/do-you-still-skin-test-for-a-penicillin-allergy-if-the-symptoms-are-consistent-with-an-ige-mediated-reaction-grade-2-or-less-even-if-the-reaction-was-30-years-ago weekly 0.8 https://www.themednet.org/have-you-incorporated-national-acupuncture-detoxification-association-nada-ear-acupuncture-into-the-treatment-of-substance-use-disorders weekly 0.8 https://www.themednet.org/what-is-your-approach-to-use-of-il-17-inhibitors-in-patients-with-axial-spondyloarthritis-and-a-family-history-of-inflammatory-bowel-disease weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-for-cml-that-presents-with-thrombocytosis weekly 0.8 https://www.themednet.org/for-an-elderly-woman-with-a-platinum-resistant-recurrence-of-a-high-grade-serous-ovarian-cancer-who-has-been-rendered-ned-surgically-is-observation-a-reasonable-approach weekly 0.8 https://www.themednet.org/how-do-you-integrate-hiv-serostatus-into-a-patients-ascvd-if-they-would-not-otherwise-qualify-for-a-statin-either-for-primary-or-secondary-prophylaxis weekly 0.8 https://www.themednet.org/would-the-presence-of-an-svc-stent-affect-your-decision-to-offer-bid-vs-once-daily-chemoradiation-for-sclc weekly 0.8 https://www.themednet.org/do-you-routinely-integrate-the-use-of-a-multiplex-pcr-panel-in-the-evaluation-and-diagnosis-of-patients-suspected-of-having-vap weekly 0.8 https://www.themednet.org/how-has-intraoperative-oct-influenced-your-surgical-decision-making-during-complex-macular-cases weekly 0.8 https://www.themednet.org/in-eyes-with-lamellar-macular-holes-what-clinical-or-oct-features-push-you-toward-recommending-surgery-versus-continued-observation weekly 0.8 https://www.themednet.org/in-what-clinical-situations-do-you-consider-azathioprine-for-treatment-of-inflammatory-arthritis weekly 0.8 https://www.themednet.org/what-vitamins-and-minerals-do-you-check-yearly-for-patients-post-gastric-bypass-surgery weekly 0.8 https://www.themednet.org/how-do-you-decide-between-vyalev-and-onapgo-for-patients-who-would-benefit-from-continuous-dopaminergic-stimulation weekly 0.8 https://www.themednet.org/when-do-you-find-ultrasound-guidance-to-be-most-helpful-for-botulinum-toxin-injection weekly 0.8 https://www.themednet.org/what-factors-will-most-influence-your-decision-to-offer-encelto-to-patients-with-macular-telangiectasia-type-2 weekly 0.8 https://www.themednet.org/is-there-a-role-for-definitive-radiotherapy-in-patients-with-de-novo-metastatic-cervical-cancer-after-achieving-complete-response-with-chemo-immunotherapy-per-keynote-826 weekly 0.8 https://www.themednet.org/would-you-consider-perioperative-antifibrinolytics-for-mild-factor-7-deficiency-undergoing-surgery weekly 0.8 https://www.themednet.org/what-recommendations-do-you-provide-to-patients-on-isotretinoin-about-timing-of-tattoos weekly 0.8 https://www.themednet.org/how-do-you-approach-transplant-psychiatric-evaluations-when-ongoing-mental-illness-raises-concerns-about-adherence-to-post-transplant-treatment weekly 0.8 https://www.themednet.org/do-you-always-send-for-sdhb-by-ihc-for-workup-of-gist-or-is-ngs-fish-that-includes-sdhb-sufficient weekly 0.8 https://www.themednet.org/in-what-patients-is-it-inappropriate-to-offer-dcisionrt-testing weekly 0.8 https://www.themednet.org/how-do-you-incorporate-psychological-care-into-the-surveillance-and-treatment-of-a-pediatric-patient-found-to-have-a-cancer-predisposition-syndrome weekly 0.8 https://www.themednet.org/how-long-would-you-anticoagulate-a-patient-with-recurrent-vte-who-has-ongoing-risk-factors-for-intracranial-bleeding weekly 0.8 https://www.themednet.org/do-you-routinely-treat-pregnant-patients-for-latent-tuberculosis-or-delay-treatment-until-2-3-months-post-partum weekly 0.8 https://www.themednet.org/what-patient-characteristics-guide-the-selection-of-a-step-up-versus-a-step-down-elimination-diet-strategy-in-the-management-of-eosinophilic-esophagitis weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-ldl-apheresis-in-a-kidney-transplant-patient-with-fsgs-recurrence-within-three-months-of-transplantation weekly 0.8 https://www.themednet.org/do-you-recommend-repeat-tsh-testing-after-a-patient-switches-from-brand-name-to-generic-levothyroxine weekly 0.8 https://www.themednet.org/in-patients-with-philadelphia-negative-all-who-are-transplant-ineligible-is-there-any-data-to-guide-the-duration-of-maintenance-pomp-therapy weekly 0.8 https://www.themednet.org/when-do-you-start-a-vaginal-dilator-after-ebrt-to-the-vaginal-canal weekly 0.8 https://www.themednet.org/how-do-you-manage-catheter-associated-upper-extremity-superficial-venous-thrombosis weekly 0.8 https://www.themednet.org/what-could-explain-failure-to-luspatercept-in-patients-with-transfusion-dependent-beta-thalassemia weekly 0.8 https://www.themednet.org/are-you-comfortable-using-durvalumab-tremelimumab-in-advanced-hcc-with-portal-vein-thrombus-when-these-patients-were-not-included-in-the-himalaya-trial weekly 0.8 https://www.themednet.org/do-you-favor-obinutuzumab-over-voclosporin-for-patients-with-lupus-nephritis-and-significant-proteinuria-and-a-history-of-non-adherence-to-medications weekly 0.8 https://www.themednet.org/should-a-patient-who-requires-definitive-treatment-for-prostate-cancer-as-a-pre-transplant-requirement-be-strictly-required-to-complete-their-course-prior-to-transplant-initiation-of-immunosuppression weekly 0.8 https://www.themednet.org/are-there-cirrhotic-patients-in-whom-you-might-withhold-or-shorten-duration-of-prophylactic-antibiotics-after-ugib weekly 0.8 https://www.themednet.org/how-would-you-approach-chronic-achilles-tendonitis-that-persists-despite-rest-and-physical-therapy weekly 0.8 https://www.themednet.org/would-you-consider-rni-alone-without-cw-for-an-isolated-nodal-recurrence-after-treatment-with-mastectomy-and-snb-for-an-early-stage-breast-cancer-with-no-prior-rt weekly 0.8 https://www.themednet.org/what-are-your-institutions-preferences-on-sbrt-vs-histotripsy-for-treatment-of-liver-metastases weekly 0.8 https://www.themednet.org/if-an-anatomical-defect-forms-due-to-rapid-disease-response-from-pelvic-radiation-for-large-gynecological-tumors-is-it-safe-to-proceed-with-a-further-radiotherapy-boost weekly 0.8 https://www.themednet.org/how-can-you-manage-a-patient-with-bilateral-pcns-who-requires-pluvicto-administration weekly 0.8 https://www.themednet.org/in-cases-of-severe-ocular-trauma-with-nlp-vision-under-what-circumstances-do-you-consider-proceeding-with-pars-plana-vitrectomy weekly 0.8 https://www.themednet.org/what-criteria-would-you-consider-to-select-patients-for-20-gy-consolidative-rt-in-dlbcl-hgbl weekly 0.8 https://www.themednet.org/does-the-choice-of-radiation-modality-3d-imrt-vmat-protons-impact-the-effectiveness-of-the-reduced-dose-of-20-gy-in-dlbcl weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-interested-in-lal-monovision-about-the-possibility-of-reduced-glasses-dependence weekly 0.8 https://www.themednet.org/what-laboratory-biomarkers-are-most-helpful-for-predicting-tbi-severity weekly 0.8 https://www.themednet.org/do-you-recommend-temporarily-holding-hydroxyurea-prior-to-and-after-a-native-kidney-biopsy-to-prevent-procedure-related-bleeding-complications weekly 0.8 https://www.themednet.org/when-in-the-treatment-of-oa-do-you-think-it-is-optimal-to-offer-ldrt weekly 0.8 https://www.themednet.org/do-you-use-a-profile-with-high-ultrafiltration-rates-interrupted-by-uf-pauses-to-manage-eskd-patients-prone-to-intradialytic-hypotension weekly 0.8 https://www.themednet.org/what-dose-duration-of-corticosteroids-do-you-use-for-patients-with-intractable-episodic-cluster-headaches weekly 0.8 https://www.themednet.org/what-is-a-reasonable-mcs-option-for-patients-in-cardiogenic-shock-and-the-presence-of-a-vsd-as-a-bridge-to-cardiac-surgery weekly 0.8 https://www.themednet.org/would-you-recommend-11c-methionine-pet-ct-imaging-for-patients-with-persistent-or-recurrent-cushings-disease-after-transsphenoidal-surgery weekly 0.8 https://www.themednet.org/how-do-you-logistically-incorporate-a-scope-and-score-of-a-patient-with-newly-diagnosed-advanced-ovarian-cancer-into-a-busy-or-schedule weekly 0.8 https://www.themednet.org/what-is-your-approach-to-medication-selection-and-titration-for-post-operative-pain weekly 0.8 https://www.themednet.org/how-will-the-recent-withdrawal-of-ocaliva-for-the-treatment-of-pbc-impact-your-therapeutic-and-management-plan-for-these-patients weekly 0.8 https://www.themednet.org/how-does-the-presence-of-porto-mesenteric-vein-thrombosis-impact-a-patients-transplant-candidacy weekly 0.8 https://www.themednet.org/what-is-your-strategy-to-manage-peri-procedural-bleeding-risk-in-patients-with-cirrhosis weekly 0.8 https://www.themednet.org/how-do-you-account-for-dosimetric-contributions-from-177lu-pnt2002-when-planning-sbrt weekly 0.8 https://www.themednet.org/do-you-recommend-neoadjuvant-177lu-pnt2002-followed-by-mdt-per-the-lunar-trial-as-your-preferred-treatment-approach-for-oligorecurrent-prostate-cancer-as-opposed-to-mdt-and-psma-radioligand-therapy-used-as-temporally-separate-treatments weekly 0.8 https://www.themednet.org/in-a-patient-undergoing-neoadjuvant-177lu-pnt2002-mdt-for-oligorecurrent-prostate-cancer-as-per-the-lunar-trial-what-are-the-implications-for-other-escalated-systemic-therapies-with-arpis-chemotherapy-which-may-otherwise-be-used-concurrent-with-adt-in-thi weekly 0.8 https://www.themednet.org/how-do-you-balance-short-term-efficacy-against-increased-low-grade-toxicity-and-quality-of-life-considerations-for-higher-single-fraction-regimens-in-recurrent-glioma-patients weekly 0.8 https://www.themednet.org/what-is-the-recommended-treatment-for-locally-advanced-gej-adenocarcinoma-with-metastases-to-the-subcarinal-nodes weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-eskd-on-hd-who-denies-a-history-of-abdominal-hernias-but-lifts-heavy-objects-daily-as-part-of-work-requirements-and-is-desiring-to-transition-to-pd weekly 0.8 https://www.themednet.org/what-strategies-do-you-have-for-obtaining-collateral-information-about-adhd-symptoms-when-a-child-is-homeschooled-or-in-virtual-school weekly 0.8 https://www.themednet.org/how-will-the-results-of-nrg-gu006-and-the-use-of-the-pam50-genomic-classifier-impact-treatment-for-recurrent-prostate-cancer weekly 0.8 https://www.themednet.org/is-there-a-difference-in-efficacy-between-steroid-sparing-agents-like-methotrexate-mycophenolate-and-azathioprine-in-the-treatment-of-immune-mediated-myopathies weekly 0.8 https://www.themednet.org/would-you-use-immunotherapy-in-patients-with-hiv-and-a-positive-viral-load weekly 0.8 https://www.themednet.org/how-do-you-approach-tube-shunt-placement-in-very-high-myopes-with-thin-sclera weekly 0.8 https://www.themednet.org/what-is-your-algorithm-for-transitioning-a-patient-with-chronic-noninfectious-posterior-uveitis-from-corticosteroids-to-immunosuppressive-therapy weekly 0.8 https://www.themednet.org/what-strategies-do-you-use-to-manage-refractory-cystoid-macular-edema-in-uveitis-patients-who-have-already-received-ocular-steroids-and-systemic-immunosuppression weekly 0.8 https://www.themednet.org/how-do-you-approach-the-role-of-professional-home-organizers-in-the-treatment-of-patients-with-hoarding-disorder weekly 0.8 https://www.themednet.org/how-do-you-approach-early-interventions-to-reduce-the-risk-of-developing-post-traumatic-stress-disorder-following-a-traumatic-event weekly 0.8 https://www.themednet.org/would-you-include-the-tract-in-your-treatment-field-in-a-patient-with-squamous-cell-carcinoma-of-the-anal-canal-presenting-with-an-ano-cutaneous-fistula weekly 0.8 https://www.themednet.org/how-should-immunotherapy-be-incorporated-into-the-treatment-strategy-for-patients-with-resectable-stage-iii-microsatellite-instability-high-msi-h-or-mismatch-repair-deficient-dmmr-extrahepatic-cholangiocarcinoma weekly 0.8 https://www.themednet.org/in-patients-with-suspected-relapsing-polychondritis-can-pain-redness-and-swelling-occur-only-with-sustained-pressure-on-the-ears-or-nose-rather-than-presenting-spontaneously weekly 0.8 https://www.themednet.org/how-often-are-you-performing-ct-screening-in-cvid-patients-to-screen-for-ild weekly 0.8 https://www.themednet.org/would-you-offer-sbrt-for-primary-pulmonary-adenoid-cystic-carcinoma-in-a-patient-who-was-medically-not-a-surgical-candidate weekly 0.8 https://www.themednet.org/what-clinical-and-diagnostic-factors-best-predict-who-will-benefit-from-intervention-versus-observation-for-patients-with-visually-significant-floaters weekly 0.8 https://www.themednet.org/what-are-the-advantages-of-using-plexitome-for-treating-recurrent-corneal-erosions-compared-with-traditional-methods weekly 0.8 https://www.themednet.org/do-you-start-bisphosphonates-after-tapering-off-menopausal-hormone-therapy-to-prevent-the-rapid-decline-of-bone-mineral-density weekly 0.8 https://www.themednet.org/do-certain-subtypes-of-bcc-respond-better-to-hedgehog-pathway-inhibitors weekly 0.8 https://www.themednet.org/what-high-risk-features-for-stage-i-nsclc-would-lead-you-to-consider-adjuvant-osimertinib weekly 0.8 https://www.themednet.org/what-induction-regimen-would-you-consider-for-kmt2a-rearranged-aml-in-a-young-patient-with-multiple-medical-co-morbidities-who-is-ineligible-for-clinical-trials weekly 0.8 https://www.themednet.org/when-considering-cytoreductive-nephrectomy-in-metastatic-kidney-cancer-in-which-situations-would-you-consider-nephron-sparing-approaches-such-as-partial-nephrectomy-or-sbrt weekly 0.8 https://www.themednet.org/for-those-using-5-betadine-as-a-single-use-prep-how-are-you-handling-the-associated-costs-or-aliquoting weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-doing-a-furosemide-stress-test-in-the-workup-of-aki weekly 0.8 https://www.themednet.org/how-do-you-approach-using-fecal-microbiota-therapy-for-recurrent-clostridioides-difficile-infection-in-immunocompromised-patients weekly 0.8 https://www.themednet.org/would-you-use-oral-cefixime-as-an-alternative-treatment-for-early-syphilis-in-cases-of-benzathine-penicillin-g-shortages weekly 0.8 https://www.themednet.org/when-evaluating-a-patient-with-igg4-related-disease-are-there-particular-exposures-or-risk-factors-you-routinely-ask-about-during-the-history-to-help-identify-potential-contributors weekly 0.8 https://www.themednet.org/what-would-be-the-minimum-duration-of-il-1-therapy-you-would-recommend-for-chronic-pericarditis weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-de-novo-oligometastatic-anal-cancer-with-a-single-metastasis-in-the-pubic-bone weekly 0.8 https://www.themednet.org/what-is-the-role-of-metformin-in-treating-hashimotos-disease weekly 0.8 https://www.themednet.org/what-is-the-role-of-cognitive-training-exercises-in-older-patients-with-short-term-memory-problems-and-or-are-diagnosed-with-mild-cognitive-impairment weekly 0.8 https://www.themednet.org/have-any-studies-shown-that-testosterone-replacement-therapy-lowers-the-incidence-of-prostate-cancer-in-hypogonadal-men-or-is-the-evidence-still-largely-neutral weekly 0.8 https://www.themednet.org/would-you-offer-tpo-ras-to-a-steroid-refractory-chronic-itp-patient-with-history-of-stroke weekly 0.8 https://www.themednet.org/what-would-be-your-radiotherapy-plan-for-an-overall-stage-iia-low-lying-mmrd-rectal-adenocarcinoma-to-try-to-avoid-apr weekly 0.8 https://www.themednet.org/do-you-recommend-cholestyramine-for-your-patients-with-recurrent-nephrolithiasis-secondary-to-enteric-hyperoxaluria weekly 0.8 https://www.themednet.org/would-you-treat-an-enlarging-metastasis-of-the-brainstem-upper-cervical-spinal-cord-with-srs-in-the-setting-of-widespread-disease-and-prior-wbrt weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-sle-and-class-ii-ln-who-has-persistent-lupus-activity-and-incomplete-b-cell-depletion-on-rituximab-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-male-in-his-60s-with-bilateral-optic-perineuritis-neuritis-on-mri-steroid-responsive-bilateral-jaw-pain-normal-esr-crp-negative-temporal-artery-biopsy-and-elevated-igg4 weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-poems-syndrome-with-severe-debilitating-neuropathy weekly 0.8 https://www.themednet.org/what-is-your-general-approach-to-an-immunocompetent-patient-with-chronic-non-infectious-diarrhea weekly 0.8 https://www.themednet.org/what-is-your-systolic-blood-pressure-target-for-patients-over-80-with-frailty-and-multiple-comorbidities weekly 0.8 https://www.themednet.org/what-is-your-go-to-strategy-for-non-opioid-management-of-chronic-low-back-pain-in-patients-with-limited-access-to-physical-therapy-or-behavioral-health weekly 0.8 https://www.themednet.org/what-signs-and-symptoms-in-a-patient-are-you-having-gi-evaluate-for-an-egid weekly 0.8 https://www.themednet.org/would-you-continue-spironolactone-in-a-patient-who-has-recently-progressed-to-eskd-on-hd-with-oliguria-and-was-diagnosed-with-primary-hyperaldosteronism-years-ago weekly 0.8 https://www.themednet.org/what-has-been-your-experience-with-the-travoprost-intracameral-implant-idose weekly 0.8 https://www.themednet.org/what-is-the-best-way-to-prepare-children-with-von-willebrand-disease-for-tonsillectomy-to-reduce-the-risk-of-post-operative-hemorrhage weekly 0.8 https://www.themednet.org/how-do-you-manage-a-spinal-intramedullary-metastasis-following-resection weekly 0.8 https://www.themednet.org/would-you-recommend-adding-a-novel-agent-such-as-lumasiran-or-nedosiran-to-treat-a-newly-diagnosed-patient-with-primary-hyperoxaluria-type-1-who-has-preserved-kidney-function-and-persistent-but-significantly-improved-urinary-oxalate-levels-following-pyrid weekly 0.8 https://www.themednet.org/in-patients-with-nccn-defined-very-high-risk-localized-prostate-adenocarcinoma-who-have-a-contraindication-to-abiraterone-plus-prednisone-do-you-consider-starting-arpi-such-as-enzalutamide-instead-in-addition-to-adt weekly 0.8 https://www.themednet.org/could-plasmapheresis-be-reasonably-considered-in-pregnant-patients-for-primary-prevention-in-asymptomatic-familial-hypercholesterolemia-and-if-so-is-there-an-ldl-cutoff-that-would-prompt-consideration-to-proceed weekly 0.8 https://www.themednet.org/what-neurologic-and-hemodynamic-parameters-do-you-use-to-determine-candidacy-for-emergent-cath-lab-activation-following-out-of-hospital-cardiac-arrest-from-vt-vf-in-patients-with-nstemi-after-rosc-has-been-achieved weekly 0.8 https://www.themednet.org/do-you-offer-prophylactic-antibiotics-or-valacyclovir-prior-to-ablative-laser-therapy weekly 0.8 https://www.themednet.org/should-atezolimab-and-chemotherapy-be-considered-for-stage-iii-dmmr-colon-cancer-with-braf-mutation weekly 0.8 https://www.themednet.org/what-are-some-practical-tips-in-distinguishing-between-metabolic-bone-disease-due-to-chronic-kidney-disease-and-osteoporosis weekly 0.8 https://www.themednet.org/outside-of-their-use-in-performance-anxiety-have-you-tried-or-found-benefit-with-a-daily-beta-blocker-for-generalized-anxiety weekly 0.8 https://www.themednet.org/do-you-advise-patients-with-a-personal-or-family-history-of-germ-cell-tumors-to-avoid-endocrine-disruptors-such-as-marijuana-cbd-lavender-oils-or-tea-tree-oils weekly 0.8 https://www.themednet.org/when-do-you-consider-scheduled-antiemetics-in-hospitalized-patients-experiencing-severe-nausea weekly 0.8 https://www.themednet.org/would-you-consider-prescribing-a-jak-inhibitor-for-a-patient-with-a-history-of-dvt-who-is-on-chronic-anticoagulation-or-would-the-thrombotic-risk-deter-you weekly 0.8 https://www.themednet.org/do-you-see-mr-linac-having-a-role-in-the-treatment-of-cns-disease weekly 0.8 https://www.themednet.org/should-an-ischemic-evaluation-be-pursued-in-cases-of-unexplained-complete-heart-block-or-high-degree-av-block weekly 0.8 https://www.themednet.org/do-you-utilize-ctdna-based-mrd-testing-after-frontline-chemotherapy-for-dlbcl weekly 0.8 https://www.themednet.org/what-additional-workup-would-you-perform-to-evaluate-a-new-onset-of-spontaneous-hemarthrosis weekly 0.8 https://www.themednet.org/what-is-your-experience-in-the-efficacy-of-vortioxetine-for-treating-anxiety-disorders weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-who-develops-a-1-mm-abscess-at-the-internal-os-of-the-paracentesis-tract-following-an-ac-tap-after-an-izervay-injection-with-eye-pain-but-no-vitreous-cell-or-retinal-involvement weekly 0.8 https://www.themednet.org/what-strategies-do-you-use-to-improve-jones-tube-tolerability-in-patients-who-require-cpap-therapy weekly 0.8 https://www.themednet.org/in-what-scenarios-do-you-consider-using-an-amniotic-membrane-graft-for-macular-hole-closure weekly 0.8 https://www.themednet.org/what-has-been-your-experience-using-dextenza-for-postoperative-inflammation-and-pain-control weekly 0.8 https://www.themednet.org/would-you-consider-whole-breast-re-irradiation-in-a-patient-with-a-second-recurrent-breast-cancer-and-prior-history-of-breast-radiation-therapy-many-years-ago-if-the-tumor-characteristics-are-not-amenable-to-partial-breast-re-irradiation weekly 0.8 https://www.themednet.org/how-do-you-approach-evaluating-sudden-mental-status-changes-in-telepsychiatry-patients-particularly-older-adults-when-medical-causes-such-as-infection-or-metabolic-disturbance-may-be-contributing-factors weekly 0.8 https://www.themednet.org/what-factors-do-you-take-into-account-when-deciding-the-length-of-adjuvant-temozolamide-in-gbm weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-hypercalcemia-secondary-to-immobilization weekly 0.8 https://www.themednet.org/are-you-comfortable-using-low-molecular-weight-heparin-as-an-alternative-to-unfractionated-heparin-for-eskd-patients-on-nocturnal-home-hemodialysis weekly 0.8 https://www.themednet.org/which-patients-with-nnrti-resistance-mutations-who-wish-to-simplify-their-hiv-antiretroviral-regimens-do-you-consider-switching-to-cabotegravir-rilpivirine weekly 0.8 https://www.themednet.org/is-there-sufficient-evidence-yet-to-support-the-use-of-lithium-supplementation-or-prescription-in-the-management-of-neurodegenerative-diseases weekly 0.8 https://www.themednet.org/would-you-recommend-avoiding-intravesical-bladder-tobramycin-administration-in-a-patient-with-advanced-chronic-kidney-disease weekly 0.8 https://www.themednet.org/how-would-you-treat-a-young-man-with-a-history-of-stage-ia-testicular-pure-seminoma-s-p-radical-orchiectomy-who-has-a-solitary-left-inguinal-lymph-node-recurrence-and-normal-tumor-markers weekly 0.8 https://www.themednet.org/does-non-urothelial-histology-impact-your-approach-to-chemoradiotherapy-for-muscle-invasive-bladder-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-perioperative-management-of-anabolic-therapies-such-as-romosozumab-and-pth-analogues-in-patients-undergoing-joint-replacement weekly 0.8 https://www.themednet.org/in-a-bedridden-medically-fragile-patient-with-a-symptomatic-conjunctival-cyst-superior-to-the-limbus-what-is-the-optimal-management-approach weekly 0.8 https://www.themednet.org/how-do-you-manage-episodes-of-raynauds-that-are-frequent-and-bothersome-in-the-winter-months weekly 0.8 https://www.themednet.org/what-cardiac-testing-do-you-perform-for-patients-undergoing-liver-transplant-evaluation weekly 0.8 https://www.themednet.org/having-gone-through-multiple-iterations-what-meld-updates-considerations-should-we-anticipate-in-the-future weekly 0.8 https://www.themednet.org/are-there-any-specific-guidelines-for-the-transplantation-of-metastatic-disease-to-the-liver-or-are-these-institution-specific weekly 0.8 https://www.themednet.org/what-graft-and-patient-factors-would-increase-the-risk-of-early-graft-failure weekly 0.8 https://www.themednet.org/would-you-avoid-fistula-placement-in-patients-with-eskd-secondary-to-scleroderma weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-radiation-for-a-large-dedifferentiated-anterior-abdominal-wall-liposarcoma weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-imaging-findings-after-liver-sbrt-for-hcc-particularly-with-regard-to-expectations-on-timing-to-tumor-resolution weekly 0.8 https://www.themednet.org/do-you-routinely-use-cefdinir-for-the-treatment-of-common-infections-diagnosed-in-the-outpatient-setting-such-as-cap-uncomplicated-utis weekly 0.8 https://www.themednet.org/can-patients-age-out-of-screening-colonoscopies-if-on-their-last-colonoscopy-prior-to-turning-76-they-had-tubular-adenomas weekly 0.8 https://www.themednet.org/what-treatment-management-strategies-do-you-find-helpful-for-cannabis-use-disorder weekly 0.8 https://www.themednet.org/what-is-the-role-of-femtosecond-laser-assisted-techniques-in-pediatric-cataracts weekly 0.8 https://www.themednet.org/what-are-your-thoughts-on-the-results-from-the-aquatic-trial-which-showed-that-the-addition-of-aspirin-daily-oral-anticoagulation-in-patients-6-months-from-pci-and-with-high-atherothrombotic-risk-was-associated-with-a-higher-risk-of-death-mi-stroke-corona weekly 0.8 https://www.themednet.org/who-is-your-ideal-candidate-for-a-xen-over-other-filtering-procedures-such-as-trabs-or-tubes weekly 0.8 https://www.themednet.org/how-are-you-selecting-between-oral-therapies-and-parenteral-treatments-for-managing-hereditary-angioedema-attacks weekly 0.8 https://www.themednet.org/what-do-you-consider-an-appropriate-observation-period-following-resolution-of-anaphylaxis-signs-and-symptoms-given-the-risk-of-biphasic-reactions weekly 0.8 https://www.themednet.org/do-you-recommend-that-your-patients-with-copd-avoid-gabapentin-or-pregabalin-entirely-given-the-increased-rate-of-exacerbations-noted-in-patients-on-these-medications weekly 0.8 https://www.themednet.org/what-factors-influence-your-decision-between-dexmedetomidine-and-propofol-for-sedation-in-mechanically-ventilated-patients weekly 0.8 https://www.themednet.org/what-is-your-preferred-therapy-for-mds-mpn-with-significant-leukocytosis-and-neutrophilia weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-an-incidentally-detected-subcentimeter-nodule-located-just-below-adjacent-to-the-ge-junction-in-a-patient-without-barretts-that-is-found-to-harbor-high-grade-dysplasia-hgd-on-pathology-following-emr weekly 0.8 https://www.themednet.org/what-is-your-typical-duration-and-route-of-treatment-for-a-lytic-lesion-in-the-metaphysis-of-a-long-bone-secondary-to-mssa-i-e-a-brodie-abscess-following-debridement-in-an-immunocompetent-patient weekly 0.8 https://www.themednet.org/how-do-you-manage-rheumatoid-arthritis-that-flares-when-an-adjunctive-nsaid-is-withdrawn-despite-otherwise-stable-dmard-therapy weekly 0.8 https://www.themednet.org/what-are-the-best-treatment-options-for-adults-with-widespread-molluscum-and-on-immunosuppressive-medication weekly 0.8 https://www.themednet.org/how-can-i-incorporate-neuromuscular-ultrasound-into-my-practice-with-limited-prior-experience weekly 0.8 https://www.themednet.org/for-a-patient-with-large-volume-glioblastoma-what-do-you-do-if-they-are-found-to-have-a-subdural-infection-in-the-middle-of-chemort-requiring-repeat-surgery weekly 0.8 https://www.themednet.org/whats-your-therapeutic-approach-for-patients-with-severe-cystic-acne-who-have-a-history-of-inflammatory-bowel-diseases weekly 0.8 https://www.themednet.org/would-oral-roflumilast-be-a-reasonable-and-tolerable-option-for-severe-psoriasis-in-an-elderly-patient-with-a-history-of-pulmonary-aspergillosis-who-has-failed-other-systemic-therapies weekly 0.8 https://www.themednet.org/how-would-you-approach-managing-an-asymptomatic-patient-with-normal-kidney-function-who-has-elevated-p-anca-and-mpo-titers-along-with-evidence-for-pauci-immune-glomerulonephritis-on-kidney-biopsy weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-therapy-to-a-patient-with-a-high-grade-mucinous-appendiceal-neoplasm-that-is-pt3-pn0-m0-12-lymph-nodes-removed-with-ileocecectomy weekly 0.8 https://www.themednet.org/for-patients-over-70-with-elevated-ascvd-risk-but-no-prior-cardiovascular-events-do-you-ever-recommend-continuing-or-initiating-low-dose-aspirin weekly 0.8 https://www.themednet.org/in-middle-aged-adults-with-tsh-5-10-miu-l-and-no-symptoms-would-you-start-levothyroxine-or-monitor-and-does-your-threshold-change-with-cardiovascular-risk-factors weekly 0.8 https://www.themednet.org/would-you-biopsy-calcified-lung-nodules-and-or-lymphadenopathy-that-have-shown-stability-over-a-2-year-period-in-a-bid-to-rule-out-sarcoidosis-2 weekly 0.8 https://www.themednet.org/would-you-recommend-enfortumab-vedotin-plus-pembrolizumab-for-localized-advanced-non-invasive-urothelial-carcinoma-of-the-renal-pelvis weekly 0.8 https://www.themednet.org/how-do-you-adjust-postoperative-refraction-targets-for-lal-in-patients-with-altered-corneal-anatomy weekly 0.8 https://www.themednet.org/do-you-still-prescribe-a-statin-for-patients-with-diabetes-on-glp-1s-for-cardiovascular-risk-reduction-if-their-ldl-is-at-goal weekly 0.8 https://www.themednet.org/for-the-neoadjuvant-treatment-for-thymoma-when-do-you-favor-cap-with-prednisone-over-cap weekly 0.8 https://www.themednet.org/would-you-prescribe-testosterone-to-a-post-menopausal-woman-for-low-libido-and-or-fatigue-symptoms-assuming-all-other-work-up-is-unremarkable weekly 0.8 https://www.themednet.org/how-would-you-treat-a-schwannoma-of-the-breast-with-a-positive-margin-that-is-not-amenable-to-re-excision weekly 0.8 https://www.themednet.org/in-pediatric-patients-with-hodgkin-lymphoma-who-have-a-partial-response-after-chemotherapy-and-multiple-disease-sites-above-and-below-the-diaphragm-how-do-you-approach-radiotherapy-planning-considering-cumulative-dose-and-toxicity weekly 0.8 https://www.themednet.org/has-the-data-for-the-enrich-study-changed-your-practice-for-the-initial-treatment-of-mantle-cell-lymphoma weekly 0.8 https://www.themednet.org/how-would-you-recommend-approaching-screening-for-elder-abuse-in-the-primary-care-setting-for-older-adults weekly 0.8 https://www.themednet.org/in-cases-of-congenital-ptosis-with-poor-levator-function-how-do-outcomes-of-frontalis-flap-suspension-compare-to-silicone-rod-frontalis-sling weekly 0.8 https://www.themednet.org/during-a-coronary-intervention-if-the-activated-clotting-time-act-is-not-within-the-therapeutic-range-despite-administering-weight-based-unfractionated-heparin-what-alternative-options-do-you-consider weekly 0.8 https://www.themednet.org/how-do-you-manage-dyshidrotic-eczema-in-children-during-the-winter-months weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-recurrent-kikuchi-fujimoto-disease weekly 0.8 https://www.themednet.org/are-you-using-tarlatamab-for-neuroendocrine-carcinomas-necs-and-poorly-differentiated-neuroencocrine-tumors-of-gi-non-lung-origins weekly 0.8 https://www.themednet.org/what-is-your-approach-when-a-female-patient-does-not-want-a-male-ma-scribe-present-in-the-exam-room-but-other-staff-are-unavailable weekly 0.8 https://www.themednet.org/how-do-you-modify-your-adjuvant-therapy-course-in-a-patient-experiencing-liver-dysfunction-within-the-first-few-months-of-starting-cdk4-6i weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patients-chronic-methadone-when-they-are-admitted-to-the-hospital-for-acute-toxic-metabolic-encephalopathy-due-to-another-cause-e-g-alcohol-intoxication-withdrawal-hepatic-encephalopathy-etc weekly 0.8 https://www.themednet.org/are-you-more-permissive-of-perioperative-interruption-of-anticoagulation-for-vte-depending-on-the-location-and-relative-chronicity-of-the-thrombus weekly 0.8 https://www.themednet.org/what-clinical-criteria-do-you-use-to-decide-between-antivirals-rituximab-plasmapheresis-or-a-combination-therapy-for-treating-hepatitis-c-virus-associated-cryoglobulinemic-membranoproliferative-glomerulonephritis weekly 0.8 https://www.themednet.org/how-do-you-balance-the-need-for-diuretics-from-a-volume-perspective-ex-ascites-edema-in-decompensated-cirrhotic-patients-and-progressive-renal-dysfunction weekly 0.8 https://www.themednet.org/when-if-ever-do-you-recommend-taping-a-patient-off-of-buprenorphine-after-sustained-remission weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-chest-2025 weekly 0.8 https://www.themednet.org/would-you-consider-pharmacotherapy-i-e-glp1-agonist-or-behavioral-nutrition-interventions-alone-in-a-patient-with-a-remote-history-of-a-restrictive-eating-disorder-now-presenting-with-obesity-and-metabolic-complications weekly 0.8 https://www.themednet.org/given-that-cardiovascular-disease-is-the-top-cause-of-morbidity-mortality-in-patients-with-masld-do-you-perform-any-additional-screening-and-or-testing-for-these-patients-to-minimize-this-impact weekly 0.8 https://www.themednet.org/in-patients-with-met-ald-how-do-you-approach-their-treatment-plan weekly 0.8 https://www.themednet.org/in-patients-with-met-ald-would-you-still-offer-the-same-therapeutic-pharmacologic-treatments-ex-gip-glp-1-agonists-resmetirom-ex-for-management-of-their-disease-as-in-a-pure-masld-patient weekly 0.8 https://www.themednet.org/what-risk-factors-in-a-cirrhotic-patient-would-predispose-them-to-the-development-of-sarcopenia-and-how-do-you-address-these-risk-factors weekly 0.8 https://www.themednet.org/what-alternative-treatments-do-you-recommend-trying-for-patients-struggling-with-persistent-chronic-ocular-surface-pain-following-refractive-surgery-unresponsive-to-traditional-methods-i-e-lubrication-topical-cyclosporine-punctal-plugs weekly 0.8 https://www.themednet.org/how-do-you-approach-the-diagnostic-evaluation-of-osteoporosis-in-ckd-when-renal-dysfunction-limits-use-of-certain-tests-or-biomarkers weekly 0.8 https://www.themednet.org/when-should-bone-biopsy-be-considered-to-guide-management-in-patients-in-whom-youre-differentiating-osteoporosis-and-renal-osteodystrophy weekly 0.8 https://www.themednet.org/how-do-you-approach-liver-function-testing-and-monitoring-when-using-xanomeline-tropsium-cobenfy weekly 0.8 https://www.themednet.org/how-does-a-pathological-cr-to-neoadjuvant-chemotherapy-influence-your-practice-for-the-use-of-bolus-with-adjuvant-pmrt-patients-without-inflammatory-breast-cancer-but-who-would-meet-traditional-risk-factors-for-skin-involvement weekly 0.8 https://www.themednet.org/what-strategies-have-you-found-effective-for-obtaining-insurance-approval-for-xanomeline-tropsium-cobenfy weekly 0.8 https://www.themednet.org/would-you-include-the-internal-mammary-nodes-unilateral-or-bilateral-in-the-adjuvant-radiation-field-for-a-small-merkel-cell-carcinoma-located-along-the-sternum-on-the-medial-chest-wall-s-p-r0-resection-but-no-sentinel-lymph-node-biopsy weekly 0.8 https://www.themednet.org/what-would-you-offer-for-a-very-young-patient-with-metastatic-renal-medullary-carcinoma-who-has-progressed-on-cisplatin-based-chemotherapy weekly 0.8 https://www.themednet.org/do-you-recommend-sglt2-inhibitors-for-patients-with-fabry-disease-and-proteinuria-despite-acei-arb-use weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-radiation-therapy-in-a-patient-with-recurrent-skin-scc-of-the-gluteus-s-p-multiple-resections-with-positive-margins-and-adjacent-osteomyelitis-to-the-ischium-and-pubic-ramus weekly 0.8 https://www.themednet.org/for-suspected-igg4-rd-what-imaging-modality-do-you-use-in-your-practice-for-initial-diagnostic-evaluation weekly 0.8 https://www.themednet.org/what-is-the-appropriate-monitoring-for-an-incidental-low-grade-rectal-neuroendocrine-tumor-resected-endoscopically-with-positive-margins weekly 0.8 https://www.themednet.org/what-dietary-advice-do-you-give-patients-with-hyperlipidemia-who-want-to-try-and-manage-it-with-lifestyle-changes-first weekly 0.8 https://www.themednet.org/would-you-consider-adding-a-loop-diuretic-for-patients-with-hrs-type-1-who-are-on-a-stable-dose-of-vasoconstrictors-to-enhance-diuresis weekly 0.8 https://www.themednet.org/how-would-you-treat-an-isolated-para-aortic-recurrence-while-receiving-adjuvant-pembrolizumab-after-definitive-chemoradiation-for-cervical-cancer weekly 0.8 https://www.themednet.org/would-you-start-a-mineralocorticoid-receptor-antagonist-or-aprocitentan-first-in-a-patient-with-resistant-hypertension-and-advanced-ckd weekly 0.8 https://www.themednet.org/which-patients-do-you-find-respond-best-to-dhe-nasal-powder-for-acute-migraine weekly 0.8 https://www.themednet.org/when-should-ct-guided-blood-patch-be-considered-for-patients-with-spontaneous-intracranial-hypotension-headache weekly 0.8 https://www.themednet.org/how-do-you-weigh-risks-benefits-when-referring-child-and-adolescent-patients-for-ect weekly 0.8 https://www.themednet.org/when-is-it-useful-to-test-for-multiple-amyloid-related-biomarkers-for-patients-undergoing-work-up-for-cognitive-impairment weekly 0.8 https://www.themednet.org/with-openbiome-no-longer-in-operation-what-is-your-current-approach-for-obtaining-fmt-for-inpatients-with-acute-severe-fulminant-c-difficile-infection-unresponsive-to-antibiotics weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gyn-cancers-from-esmo-2025 weekly 0.8 https://www.themednet.org/are-there-dosimetric-scenarios-where-using-a-fff-beam-would-be-beneficial-in-a-non-modulated-beam-like-ap-pa-or-3d-conformal weekly 0.8 https://www.themednet.org/how-would-you-approach-radiation-for-node-positive-prostate-cancer-in-a-patient-with-an-aortic-and-or-common-iliac-arterial-aneurysm-not-meeting-criteria-for-surgical-repair weekly 0.8 https://www.themednet.org/in-patients-with-anti-pl7-antibody-associated-antisynthetase-syndrome-can-sacroiliitis-occur-as-part-of-the-inflammatory-arthritis-spectrum-or-should-alternative-causes-be-considered weekly 0.8 https://www.themednet.org/do-you-generally-recommend-device-exchange-removal-in-patients-with-gram-positive-bacteremia-in-the-setting-of-intra-aortic-balloon-bump-or-other-mechanical-circulatory-devices weekly 0.8 https://www.themednet.org/is-there-evidence-that-certain-ppis-provide-superior-clinical-efficacy-compared-to-others-in-real-world-practice weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-patient-with-relapsing-polychondritis-who-is-considering-a-turbinectomy-for-nasal-obstruction-regarding-potential-risks-and-disease-related-complications weekly 0.8 https://www.themednet.org/how-does-the-presence-of-indeterminate-lymphadenopathy-on-psma-pet-scan-alter-your-management-of-unfavorable-intermediate-risk-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-we-decide-between-gallium-dotatate-pet-ct-and-mibg-scans-when-evaluating-a-patient-for-suspected-pheochromocytoma weekly 0.8 https://www.themednet.org/what-is-a-reasonable-length-of-time-to-wait-before-performing-a-cardiac-ablation-for-atrial-fibrillation-in-a-patient-with-an-embolic-stroke weekly 0.8 https://www.themednet.org/how-do-you-approach-inflammatory-arthralgias-without-synovitis-in-a-patient-with-psoriasis weekly 0.8 https://www.themednet.org/what-patient-profiles-or-clinical-contexts-would-justify-the-initiation-of-elinzanetant-lynkuet-for-postmenopausal-vasomotor-symptoms-considering-its-mechanism-and-current-evidence-base weekly 0.8 https://www.themednet.org/do-you-offer-hypofractionation-or-rni-for-a-pt1n0-high-grade-primary-neuroendocrine-carcinoma-of-the-breast weekly 0.8 https://www.themednet.org/have-the-growing-reports-about-doxycycline-resistance-in-gonorrhea-isolates-from-patients-prescribed-doxy-pep-for-prevention-of-bacterial-stis-influenced-your-use-of-doxycycline-for-this-indication weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-asn-kidney-week-2025 weekly 0.8 https://www.themednet.org/for-pregnant-nontransfusion-dependent-beta-thalassemia-patients-when-would-you-consider-esas-for-worsening-anemia weekly 0.8 https://www.themednet.org/how-to-you-approach-the-risk-benefit-discussion-for-hormone-replacement-therapy-in-perimenopausal-women-with-significant-vasomotor-symptoms-and-borderline-ascvd-risk weekly 0.8 https://www.themednet.org/do-you-use-buprenorphine-in-patients-with-chronic-pain-and-prior-history-of-opioid-use-disorder weekly 0.8 https://www.themednet.org/how-do-visual-outcomes-differ-among-scleral-lenses-refractive-surgery-and-phakic-iols-in-keratoconus-patients-with-irregular-astigmatism-following-cross-linking weekly 0.8 https://www.themednet.org/how-does-a-mildly-elevated-cbg-cortisol-binding-globulin-level-affect-the-interpretation-of-the-1mg-overnight-dexamethasone-suppression-test-results weekly 0.8 https://www.themednet.org/in-addition-to-monitoring-hemoglobin-and-supplementing-folic-acid-what-is-your-approach-to-hereditary-spherocytosis-in-pregnancy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-relapsing-babesiosis-in-immunosuppressed-patients weekly 0.8 https://www.themednet.org/would-you-offer-pmrt-to-a-patient-with-potential-metastatic-disease weekly 0.8 https://www.themednet.org/would-you-consider-adding-metformin-to-the-regimen-of-a-diabetic-patient-with-a-benign-thyroid-nodule-to-decrease-its-volume weekly 0.8 https://www.themednet.org/is-ultrahypofractionation-appropriate-for-a-b51-candidate-receiving-breast-only-radiation weekly 0.8 https://www.themednet.org/how-do-you-approach-the-decision-to-repeat-small-bowel-biopsies-in-a-patient-with-persistent-gastrointestinal-symptoms-like-abdominal-pain-and-diarrhea-when-prior-biopsies-performed-years-earlier-were-normal weekly 0.8 https://www.themednet.org/what-were-your-top-takeaways-from-acaai-2025 weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-aha-2025 weekly 0.8 https://www.themednet.org/how-do-you-modify-hma-treatments-for-a-patient-with-high-risk-mds-experiencing-prolonged-cytopenias-after-each-cycle weekly 0.8 https://www.themednet.org/how-has-your-approach-to-managing-asymptomatic-bacteriuria-in-kidney-transplant-patients-changed-in-light-of-a-recent-meta-analysis-showing-no-significant-differences-in-pyelonephritis-symptomatic-uti-or-graft-loss-between-patients-treated-with-antibiotic weekly 0.8 https://www.themednet.org/is-there-a-role-for-stents-for-patients-with-a-new-diagnosis-of-metastatic-upper-rectal-cancer-with-a-near-obstructing-primary weekly 0.8 https://www.themednet.org/how-would-you-approach-escalation-of-therapy-in-an-adult-patient-with-refractory-stills-disease-and-associated-mas-hlh-ferritin-100-000-transaminitis-dic-despite-high-dose-steroids-high-dose-anakinra-tocilizumab-and-ruxolitinib weekly 0.8 https://www.themednet.org/when-do-you-consider-using-ketamine-to-treat-depressive-symptoms-in-patients-with-borderline-personality-disorder weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-aasld-2025 weekly 0.8 https://www.themednet.org/how-do-you-decide-between-anticoagulation-or-portal-vein-recanalization-in-a-patient-with-portal-vein-thrombosis weekly 0.8 https://www.themednet.org/for-remote-liver-transplant-recipients-back-under-the-care-of-a-community-gastroenterologist-or-pcp-what-should-be-the-approach-to-new-liver-enzyme-elevations weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-offer-a-postmenopausal-woman-with-a-new-pt2n0-hr-her2-breast-cancer-primary-who-is-concurrently-being-treated-with-anastrozole-ribociclib-for-well-controlled-oligometastatic-hr-her2-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-incidentally-elevated-hdl-levels-in-isolation-and-is-there-any-utility-for-further-ascvd-risk-stratification-and-or-genetic-testing-for-lipid-disorders weekly 0.8 https://www.themednet.org/in-a-pregnant-patient-with-pnh-without-aplastic-anemia-who-has-residual-hemolysis-while-on-ravulizumab-and-on-prophylactic-lmwh-what-else-can-be-done-to-reduce-thrombotic-risk-and-improve-maternofetal-outcomes weekly 0.8 https://www.themednet.org/have-you-seen-synovitis-even-if-subtle-with-aromatase-inhibitor-musculoskeletal-syndrome weekly 0.8 https://www.themednet.org/would-you-offer-tarlatamab-to-patients-with-metastatic-egfr-nsclc-that-transformed-into-sclc weekly 0.8 https://www.themednet.org/what-would-be-your-radiotherapy-plan-for-a-patient-with-recurrent-gbm-who-grade-4-idh-wild-type-s-p-2-prior-resections-with-no-prior-radiation weekly 0.8 https://www.themednet.org/after-wide-local-excision-of-a-decisiondx-scc-class-2a-cutaneous-scc-of-the-posterior-inferior-scalp-would-you-irradiate-nodal-basins weekly 0.8 https://www.themednet.org/how-do-you-handle-child-adolescent-patients-on-the-inpatient-unit-who-have-developed-medication-seeking-behaviors-as-a-primary-way-of-coping-with-distress weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-in-patients-with-pachychoroid-disease-who-show-fluctuating-subretinal-fluid-without-visual-decline weekly 0.8 https://www.themednet.org/how-do-you-balance-the-risks-versus-benefits-of-starting-a-statin-in-a-patient-with-masld-and-a-persistent-but-mild-elevation-in-their-ast-alt weekly 0.8 https://www.themednet.org/in-clinical-practice-how-can-amd-imaging-biomarkers-guide-risk-stratification-and-shape-discussions-with-patients-regarding-prognosis-and-monitoring weekly 0.8 https://www.themednet.org/for-a-patient-who-previously-underwent-pbi-and-then-developed-a-second-ipsilateral-primary-would-you-offer-repeat-pbi weekly 0.8 https://www.themednet.org/when-and-how-do-you-perform-genetic-testing-for-congenital-myasthenia-gravis-in-seronegative-cases weekly 0.8 https://www.themednet.org/are-there-any-special-considerations-you-take-with-esa-use-in-hospitalized-patients-with-eskd-who-undergo-stem-cell-transplantation weekly 0.8 https://www.themednet.org/how-do-you-evaluate-for-an-ascending-uti-in-a-patient-with-a-urostomy weekly 0.8 https://www.themednet.org/how-will-you-utilize-the-paradigm-study-results-from-ash-2025-comparing-azacitidine-venetoclax-to-intensive-induction-chemotherapy-for-fit-patients-with-newly-diagnosed-aml weekly 0.8 https://www.themednet.org/when-should-we-suspect-climate-amplified-rhinitis-asthma-versus-poor-control-from-other-causes weekly 0.8 https://www.themednet.org/are-there-best-practices-for-integrating-pollen-wildfire-smoke-and-aqi-data-into-asthma-allergic-rhinitis-action-plans weekly 0.8 https://www.themednet.org/does-solid-trabecular-type-papillary-thyroid-carcinoma-pathology-confer-a-higher-risk-of-recurrence-and-warrant-radioactive-iodine-ablation-therapy weekly 0.8 https://www.themednet.org/what-is-the-clinical-significance-of-newly-appreciated-left-atrial-enlargement-following-atrial-fibrillation-ablation-and-approach-to-monitoring-for-atrial-fibrillation-recurrence-post-ablation-in-that-setting weekly 0.8 https://www.themednet.org/would-you-recommend-post-mastectomy-radiation-for-a-low-grade-adenoid-cystic-carcinoma-of-the-breast-resected-with-negative-margins weekly 0.8 https://www.themednet.org/would-you-consider-making-a-diagnosis-of-hepatorenal-syndrome-associated-acute-kidney-injury-with-a-one-day-diagnostic-fluid-challenge-instead-of-a-two-day-challenge-to-expedite-vasoconstrictor-therapy-if-needed weekly 0.8 https://www.themednet.org/in-phacomorphic-glaucoma-with-limited-view-how-do-you-approach-surgical-management-i-e-staged-or-combined-surgery-temporize-with-lpi weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-metastatic-nsclc-and-high-level-met-amplification-who-achieved-a-near-cr-on-tepotinib-but-is-unable-to-tolerate-dose-reduced-tepotinib weekly 0.8 https://www.themednet.org/do-you-think-the-benefits-of-performing-a-repeat-kidney-biopsy-to-assess-histologic-evidence-of-disease-activity-or-chronic-damage-outweigh-the-risks-in-a-patient-with-recently-treated-lupus-nephritis-and-improving-creatinine-levels weekly 0.8 https://www.themednet.org/how-should-the-timing-of-rsv-vaccination-be-managed-for-patients-who-undergo-stem-cell-transplant-during-periods-of-high-community-transmission weekly 0.8 https://www.themednet.org/would-you-consider-utilizing-pembrolizumab-enfortumab-as-a-bladder-preservation-approach-in-patients-with-mibc weekly 0.8 https://www.themednet.org/do-the-results-of-imvigor011-influence-you-to-utilize-ctdna-to-guide-all-adjuvant-io-in-mibc weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-treat-hypocalcemia-in-hospitalized-patients weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-of-mantle-cell-lymphoma-in-someone-with-a-mutated-gene-downstream-of-the-btk-receptor-such-as-mutated-card11 weekly 0.8 https://www.themednet.org/what-approximate-portion-of-men-develop-infertility-following-a-mumps-infection weekly 0.8 https://www.themednet.org/do-you-boost-a-breast-cavity-for-a-high-ki-67-index-in-the-absence-of-other-risk-factors weekly 0.8 https://www.themednet.org/what-clinical-factors-guide-your-decision-about-if-and-when-to-restart-antipsychotic-medications-in-patients-with-primary-psychotic-disorders-recovering-from-catatonia-after-stabilization-with-benzodiazepines-or-ect weekly 0.8 https://www.themednet.org/what-role-do-you-think-ai-based-clinical-decision-making-aids-should-play-in-psychiatric-practice-today weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-body-dysmorphic-disorder-who-pursue-repeated-dermatologic-or-other-cosmetic-procedures-despite-reassurance-or-prior-interventions weekly 0.8 https://www.themednet.org/how-do-you-approach-laboratory-assessment-for-anticoagulation-adherence-when-working-up-anticoagulation-failure weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-asymptomatic-alt-and-ggt-elevation-in-an-older-adult-patient-with-depression-with-psychosis-and-without-history-of-hepatitis-who-recently-had-dose-of-quetiapine-increased-and-new-initiation-of-snri weekly 0.8 https://www.themednet.org/how-do-you-approach-the-frequency-of-dexa-scan-monitoring-for-older-adults-on-bisphosphonate-therapy-during-the-course-of-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-extremely-low-ldl-levels-in-older-adult-patients-receiving-statin-therapy-for-primary-prevention-of-cardiovascular-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-sle-with-acute-bilateral-sensorineural-hearing-loss-refractory-to-high-dose-systemic-and-intratympanic-steroids-normal-mri-brain-and-apl-labs weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-hyperkalemia-secondary-to-respiratory-acidosis weekly 0.8 https://www.themednet.org/would-rhapsido-be-beneficial-in-patients-with-mcas-who-experience-anaphylaxis weekly 0.8 https://www.themednet.org/how-are-you-addressing-accurate-dissemination-of-information-to-patients-with-the-increase-in-inaccurate-information-in-the-digital-era weekly 0.8 https://www.themednet.org/in-a-patient-with-recurrent-episodes-of-gca-that-flare-shortly-after-steroid-tapering-how-do-you-differentiate-between-steroid-dependent-inflammatory-relapse-an-alternative-autoimmune-vasculitic-process-and-a-paraneoplastic-phenomenon weekly 0.8 https://www.themednet.org/would-you-expect-a-reduced-neutrophil-count-in-individuals-with-a-partial-duffy-null-phenotype weekly 0.8 https://www.themednet.org/are-there-circumstances-in-which-you-would-check-a-serum-copeptin-level-when-evaluating-patients-for-possible-siadh weekly 0.8 https://www.themednet.org/in-patients-with-progressive-azoor-who-demonstrate-enlarging-zones-of-outer-retinal-loss-despite-corticosteroid-therapy-how-do-you-determine-when-to-escalate-to-steroid-sparing-immunomodulatory-agents weekly 0.8 https://www.themednet.org/what-specific-exam-findings-or-test-changes-prompt-escalation-of-care-when-evaluating-pediatric-patients-with-optic-disc-drusen-for-possible-increased-intracranial-pressure weekly 0.8 https://www.themednet.org/is-there-an-upper-threshold-of-pco-that-can-cause-symptomatic-hypercapnia-e-g-ams-despite-metabolic-compensation-and-normal-ph weekly 0.8 https://www.themednet.org/do-you-commonly-observe-acute-erythrocytosis-in-patients-with-ild-flares-being-treated-with-supplemental-oxygen-and-high-dose-corticosteroids weekly 0.8 https://www.themednet.org/what-clinical-features-would-raise-your-suspicion-for-igg-4-related-disease weekly 0.8 https://www.themednet.org/how-have-you-used-glp1s-in-dermatology weekly 0.8 https://www.themednet.org/what-clinical-scenarios-warrant-the-use-of-a-skin-substitute weekly 0.8 https://www.themednet.org/how-do-you-choose-between-various-jak-inhibitors-in-the-management-of-alopecia-areata weekly 0.8 https://www.themednet.org/is-there-any-antiresorptive-therapy-that-you-would-be-comfortable-prescribing-if-the-patient-refuses-to-see-a-dentist-for-clearance-and-is-at-risk-of-skeletal-related-events weekly 0.8 https://www.themednet.org/what-is-your-approach-to-evaluating-post-operative-hypotension weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-post-concussion-syndrome-with-symptoms-including-vertigo-headaches-persistent-fatigue-and-or-mood-symptoms weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-sle-who-is-planning-pregnancy-and-has-serologically-active-disease-elevated-dsdna-low-c3-c4-mild-arthritis-and-is-otherwise-asymptomatic-on-hydroxychloroquine-200-mg-bid-and-methotrexate-15-mg-weekly weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-do-you-utilize-for-node-positive-hcc weekly 0.8 https://www.themednet.org/what-treatment-strategies-would-you-utilize-in-a-patient-with-newly-diagnosed-hla-b27-axial-spondyloarthritis-with-active-and-chronic-sacroiliitis-on-mri-and-recent-diagnosis-of-ms-that-is-well-controlled-ms-ocrelizumab-given-the-need-to-avoid-tnf-inhibit weekly 0.8 https://www.themednet.org/do-you-consider-use-of-oral-antibiotics-for-complicated-polymicrobial-intra-abdominal-infections weekly 0.8 https://www.themednet.org/what-therapeutic-approaches-have-you-found-effective-for-athletes-with-anorexia-nervosa-whose-eating-disorder-symptoms-are-intertwined-with-sport-driven-weight-pressures weekly 0.8 https://www.themednet.org/how-do-you-decide-the-threshold-and-duration-of-subretinal-fluid-that-can-be-safely-tolerated-in-exudative-amd-when-adjusting-treat-and-extend-intervals weekly 0.8 https://www.themednet.org/what-is-the-frequency-in-which-patients-should-be-taking-pill-in-the-pocket-medication-for-paroxysmal-atrial-fibrillation-before-you-begin-to-consider-maintenance-dosing-medications-instead weekly 0.8 https://www.themednet.org/which-patients-are-you-utilizing-subcutaneous-pd-1-l1-inhibitors-instead-of-the-intravenous-formulation weekly 0.8 https://www.themednet.org/what-is-the-preferred-neoadjuvant-adjuvant-chemotherapy-regimen-for-hpv-associated-nasopharyngeal-cancer weekly 0.8 https://www.themednet.org/at-what-initial-sodium-level-do-you-recommend-strict-avoidance-of-overcorrection-e-g-no-more-than-6-meq-l-in-24-hours-in-patients-with-hyponatremia weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-to-determine-if-a-patient-with-chronic-asymptomatic-hyponatremia-is-safe-to-proceed-with-surgery weekly 0.8 https://www.themednet.org/how-do-you-approach-imetelstat-therapy-in-mds-patients-with-baseline-neutropenia-or-thrombocytopenia weekly 0.8 https://www.themednet.org/how-if-at-all-does-your-practice-differ-between-male-and-female-breast-cancer-patients-with-respect-to-the-use-of-bolus weekly 0.8 https://www.themednet.org/how-do-you-manage-obsessive-compulsive-symptoms-secondary-to-clozapine weekly 0.8 https://www.themednet.org/would-you-add-a-dmard-such-as-methotrexate-for-a-patient-with-gca-and-partial-response-to-tocilizumab-but-inability-to-taper-prednisone-below-10mg-daily weekly 0.8 https://www.themednet.org/is-a-larger-prostate-size-or-volume-associated-with-a-higher-absolute-psa-bounce-after-radiation weekly 0.8 https://www.themednet.org/how-do-you-interpret-nodes-with-minimal-increased-uptake-on-psma-pet-in-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-prefer-using-the-delta-ratio-or-corrected-bicarbonate-formula-when-further-evaluating-a-patient-with-high-anion-gap-metabolic-acidosis weekly 0.8 https://www.themednet.org/what-role-do-you-feel-topical-steroids-play-in-the-management-of-atopic-dermatitis-with-the-growing-availability-of-non-steroid-topicals weekly 0.8 https://www.themednet.org/in-a-patient-with-class-iv-lupus-nephritis-and-cardiomyopathy-who-has-received-cyclophosphamide-how-do-you-approach-the-use-of-biologics-such-as-belimumab-or-voclosporin-in-the-setting-of-ongoing-proteinuria weekly 0.8 https://www.themednet.org/should-an-individual-who-received-the-purified-protein-hepatitis-b-vaccine-in-1985-receive-a-booster-or-have-antibody-titers-checked weekly 0.8 https://www.themednet.org/would-you-give-long-term-antistreptococcal-antibiotic-prophylaxis-to-a-patient-who-presents-with-features-of-poststreptococcal-reactive-arthritis-but-who-also-meets-criteria-for-acute-rheumatic-fever weekly 0.8 https://www.themednet.org/is-there-any-benefit-to-trend-testosterone-and-dhea-s-levels-in-patients-with-pcos-to-determine-response-to-therapy weekly 0.8 https://www.themednet.org/how-should-medical-oncologists-and-dermatologists-communicate-about-patients-with-at-least-stage-iib-iii-cutaneous-melanoma-regarding-neoadjuvant-immunotherapy weekly 0.8 https://www.themednet.org/does-the-presence-of-paraneoplastic-pemphigus-influence-your-treatment-options-in-cll weekly 0.8 https://www.themednet.org/what-patient-factors-most-strongly-influence-your-decision-to-start-biologic-agents-in-mild-cognitive-impairment weekly 0.8 https://www.themednet.org/in-extremely-premature-infants-born-at-25-weeks-gestational-age-how-do-you-individualize-the-timing-and-frequency-of-rop-screening weekly 0.8 https://www.themednet.org/what-are-some-practical-steps-physicians-can-take-to-optimize-mobility-and-reduce-falls-in-hospitalized-patients weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-chronic-urticaria-on-the-role-of-stress-management-strategies-in-their-treatment-plan weekly 0.8 https://www.themednet.org/would-you-offer-partial-breast-irradiation-for-a-patient-who-otherwise-meets-pbi-guidelines-but-has-a-pten-mutation weekly 0.8 https://www.themednet.org/how-do-you-manage-severe-chronic-scalp-pruritus-in-older-women-when-biopsies-and-exams-show-no-primary-skin-disease-and-standard-therapies-fail weekly 0.8 https://www.themednet.org/what-gtv-to-ctv-expansion-do-you-utilize-for-npc weekly 0.8 https://www.themednet.org/under-what-circumstances-do-you-order-ambulatory-blood-pressure-monitoring-in-a-patient-receiving-maintenance-hemodialysis weekly 0.8 https://www.themednet.org/is-there-a-role-for-checking-calprotectin-or-other-markers-of-inflammation-in-decision-making-or-monitoring-in-patients-undergoing-abdominopelvic-radiotherapy-with-history-of-ibd weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-rash-associated-with-pirfenidone weekly 0.8 https://www.themednet.org/how-does-the-cll17-trial-presented-at-ash-2025-change-current-practice-guidelines weekly 0.8 https://www.themednet.org/when-do-you-consider-de-escalating-therapy-such-as-dupilumab-in-eosinophilic-esophagitis weekly 0.8 https://www.themednet.org/how-would-you-treat-a-stage-i-fully-resected-double-hit-dlbcl weekly 0.8 https://www.themednet.org/do-you-check-carnitine-levels-for-your-patients-on-crrt weekly 0.8 https://www.themednet.org/which-patients-if-any-do-you-revert-back-to-ultrasound-screening-for-hcc-after-prior-diagnosis-definitive-treatment-of-hcc weekly 0.8 https://www.themednet.org/would-you-ever-consider-adjuvant-chemotherapy-for-a-patient-with-rectal-cancer-treated-with-rapido-total-neoadjuvant-therapy-after-positive-pni-was-found-on-the-surgery weekly 0.8 https://www.themednet.org/when-using-iv-tnf-inhibitors-do-you-follow-levels-to-determine-if-the-current-dose-is-adequately-treating-the-patient weekly 0.8 https://www.themednet.org/in-light-of-the-pending-overall-survival-data-and-reported-declines-in-quality-of-life-associated-with-the-psmaddition-trial-how-do-you-envision-incorporating-pluvicto-into-the-management-of-mhspc weekly 0.8 https://www.themednet.org/what-is-your-approach-to-scheduling-and-then-weaning-nebulizers-in-patients-admitted-with-acutely-exacerbated-asthma-or-copd weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-implement-a-renal-diet-i-e-restricting-electrolyte-and-or-fluid-intake-in-hospitalized-patients-with-renal-impairment weekly 0.8 https://www.themednet.org/how-are-you-approaching-endocrine-therapy-for-patients-with-metastatic-hr-her2-breast-cancer-in-light-of-enhanced-her2-directed-treatment-with-either-t-dxd-pertuzumab-or-hp-tucatinib weekly 0.8 https://www.themednet.org/how-do-you-manage-erythrocytosis-secondary-to-sotatercept-for-patients-with-pah weekly 0.8 https://www.themednet.org/in-patients-with-myopic-traction-maculopathy-what-clinical-and-imaging-thresholds-prompt-you-to-intervene-surgically-rather-than-continue-observation weekly 0.8 https://www.themednet.org/how-do-you-balance-medical-management-versus-additional-glaucoma-surgery-in-patients-with-advanced-glaucoma-who-develop-iop-elevation-after-healing-from-a-trabeculectomy-revision-for-bleb-leak-complicated-by-prior-suprachoroidal-hemorrhage weekly 0.8 https://www.themednet.org/in-a-patient-with-low-or-normal-bmi-but-findings-of-steatosis-on-imaging-no-cardiometabolic-comorbidities-and-very-elevated-cap-scores-what-are-your-next-diagnostic-and-therapeutic-steps-to-identify-the-cause-of-their-steatosis-and-subsequent-management weekly 0.8 https://www.themednet.org/how-do-you-approach-decision-making-around-initiation-of-osteoporosis-therapy-in-patients-with-advanced-dementia weekly 0.8 https://www.themednet.org/what-radiation-dose-and-margins-would-you-recommend-for-treatment-of-a-progressive-cerebellar-glioma-with-bcor-bcor1-fusion-after-initial-subtotal-resection-with-residual-disease-adjacent-to-the-posterior-brainstem weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-treatment-of-surgically-staged-deeply-invasive-grade-3-endometrioid-endometrial-cancer-with-no-lymph-node-involvement weekly 0.8 https://www.themednet.org/how-do-you-manage-hypercalcemia-in-an-osteoporosis-patient-on-a-pth-analogue weekly 0.8 https://www.themednet.org/would-you-offer-cisplatin-concurrent-with-radiation-to-a-patient-with-p53-mutated-stage-iii-endometrial-cancer-if-she-has-adult-onset-hearing-loss-and-uses-a-cochlear-implant weekly 0.8 https://www.themednet.org/when-do-you-consider-extended-courses-of-oseltamivir-in-immunocompromised-patients-2 weekly 0.8 https://www.themednet.org/in-what-clinical-scenarios-if-any-would-you-consider-using-sacituzumab-govitecan-prior-to-trastuzumab-deruxtecan-for-hr-her2-metastatic-breast-cancer-treatment weekly 0.8 https://www.themednet.org/should-nivolumab-be-discontinued-in-a-patient-who-develops-bullous-pemphigoid-but-is-otherwise-responding-well-to-therapy-if-bp-is-being-managed-with-dupilumab weekly 0.8 https://www.themednet.org/what-is-your-view-on-the-potential-role-of-immune-targeted-therapies-in-parkinsons-disease weekly 0.8 https://www.themednet.org/would-you-start-low-dose-methimazole-therapy-in-patients-with-positive-trab-normal-ft4-and-ft3-levels-but-ongoing-tsh-suppression-in-a-completely-asymptomatic-young-patient weekly 0.8 https://www.themednet.org/how-would-you-approach-systemic-treatment-of-oligometastatic-recurrence-following-surgical-removal-of-the-single-area-of-metastasis-in-a-patient-with-er-20-30-pr-negative-her2-negative-breast-cancer weekly 0.8 https://www.themednet.org/in-what-circumstances-would-you-recommend-adjuvant-radiation-for-a-keratocanthoma-with-scc-after-resection weekly 0.8 https://www.themednet.org/is-there-data-to-support-treating-postoperative-endometrial-pelvic-ebrt-with-a-daily-dilator-in-the-vaginal-canal weekly 0.8 https://www.themednet.org/what-are-your-thoughts-about-lions-mane-supplementation-to-slow-the-decline-or-improve-cognitive-capacity-for-those-at-risk-of-dementia weekly 0.8 https://www.themednet.org/do-you-ever-recommend-the-use-of-a-creatine-monohydrate-supplementation-to-your-patients-looking-to-improve-physical-fitness weekly 0.8 https://www.themednet.org/what-is-your-approach-to-volume-resuscitation-in-patients-who-are-third-spacing-fluids weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-radiation-oncology-from-sabcs-2025 weekly 0.8 https://www.themednet.org/do-you-recommend-3-months-of-chemotherapy-6-months-of-chemotherapy-or-no-chemotherapy-along-atezolizumab-in-patients-with-low-risk-t1-3-n1-stage-iii-dmmr-colon-cancer weekly 0.8 https://www.themednet.org/why-how-do-patients-report-seeing-flashes-of-light-when-receiving-pulsed-dye-light-pdl-treatments-on-the-face weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-discontinue-immunotherapy-for-primary-angiitis-of-the-central-nervous-system-pacns weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-treat-transient-global-amnesia-with-antithrombotic-therapy weekly 0.8 https://www.themednet.org/how-do-you-select-between-imlunestrant-abemaciclib-and-elacestrant-for-those-with-an-esr1-mutation-and-progressed-on-ai-and-cdk4-6-inhibitor-for-patients-with-metastatic-er-her2-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-a-healthcare-provider-with-major-depressive-disorder-when-their-condition-is-suspected-to-impact-their-job-performance weekly 0.8 https://www.themednet.org/how-do-you-approach-continuation-of-benzodiazepines-in-elderly-patients-with-anxiety-who-have-had-poor-response-to-other-medications weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-a-patient-with-psoriasis-and-chronic-anterior-uveitis-who-is-unable-to-take-dmards-and-has-tried-tnf-inhibitors-and-il-17-inhibitors-but-has-ongoing-bilateral-anterior-uveitis weekly 0.8 https://www.themednet.org/what-is-the-maximum-dose-mg-kg-you-will-push-an-iv-tnfi-to-for-a-patient-with-takayasu-arteritis-who-is-adherent-and-does-not-have-evidence-of-anti-drug-antibodies-before-switching-to-an-alternate-class-of-therapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-surgical-approach-for-revision-of-an-over-filtering-bleb weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-selection-for-an-elderly-woman-with-de-novo-metastatic-her2-breast-cancer-with-lung-and-brain-mets weekly 0.8 https://www.themednet.org/what-are-your-favorite-sutures-to-use-in-dermatologic-surgery weekly 0.8 https://www.themednet.org/how-do-the-altto-trial-findings-influence-your-choice-of-adjuvant-endocrine-therapy-ai-with-or-without-ovarian-function-suppression-versus-serm-based-therapy-for-patients-with-hr-her2-early-breast-cancer weekly 0.8 https://www.themednet.org/for-a-patient-with-a-large-pheochromocytoma-how-would-you-evaluate-for-possible-autonomous-cortisol-co-secretion-prior-to-adrenalectomy-to-assess-need-for-risk-of-glucocorticoid-withdrawal-postoperatively weekly 0.8 https://www.themednet.org/when-would-you-consider-treating-growth-hormone-deficiency-in-surgically-treated-acromegaly-with-longstanding-low-igf-1-levels weekly 0.8 https://www.themednet.org/when-can-emg-be-deferred-in-cases-of-distal-sensory-polyneuropathy weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-initiate-antibiotics-for-superimposed-bacterial-pneumonia-in-patients-with-influenza weekly 0.8 https://www.themednet.org/in-light-of-recent-updates-on-neoadjuvant-enfortumab-vedotin-plus-pembrolizumab-for-muscle-invasive-bladder-cancer-showing-benefit-how-should-a-trimodality-bladder-preservation-strategy-be-contextualized weekly 0.8 https://www.themednet.org/when-interpreting-bone-density-reports-are-t-scores-adjusted-for-different-age-brackets weekly 0.8 https://www.themednet.org/can-estrogen-be-given-as-hormone-replacement-therapy-after-surgical-menopause-to-a-patient-with-history-of-endometriosis weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-mucinous-cysts-associated-with-hand-osteoarthritis weekly 0.8 https://www.themednet.org/would-you-consider-antithrombotic-therapy-in-a-patient-with-refractory-migraines-and-antiphospholipid-syndrome weekly 0.8 https://www.themednet.org/what-level-of-relief-do-you-target-with-acute-migraine-treatments-before-you-think-there-is-diminishing-returns-on-trialing-a-different-agent weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-ivig-for-viral-myocarditis weekly 0.8 https://www.themednet.org/in-patients-with-hepatitis-b-and-co-infection-with-hepatitis-d-given-their-increased-risk-of-development-of-hcc-how-do-you-approach-screening-for-this weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-experiencing-symptoms-complications-of-menopause-who-desire-use-of-hrt-if-they-have-a-history-of-known-hepatic-adenomas weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-inclusion-of-simultaneous-bariatric-surgery-at-time-of-liver-transplant-especially-in-masld-mash-cirrhotics weekly 0.8 https://www.themednet.org/how-do-you-approach-the-optimization-and-risk-stratification-of-a-cirrhotic-patient-who-is-undergoing-extra-hepatic-abdominal-or-other-surgery weekly 0.8 https://www.themednet.org/pending-final-results-but-in-what-scenario-would-you-select-bepirovirsen-as-opposed-to-established-therapy-for-hepatitis-b-patients-ex-taf-or-tdf weekly 0.8 https://www.themednet.org/how-are-you-incorporating-the-newer-rct-data-suggesting-no-mortality-benefit-to-indefinite-beta-blocker-therapy-for-patients-who-are-several-years-out-from-an-mi-with-preserved-lvef-and-no-angina-or-arrhythmia weekly 0.8 https://www.themednet.org/how-do-you-modify-your-peritonitis-prevention-strategy-for-a-patient-starting-peritoneal-dialysis-who-has-a-history-of-recurrent-staphylococcal-skin-infections weekly 0.8 https://www.themednet.org/how-would-you-decide-whether-to-change-acromegaly-therapy-or-intensify-diabetes-management-in-patients-with-acromegaly-and-prediabetes-or-diabetes-starting-an-oral-sstr2-selective-therapy-if-they-experience-worsening-glycemic-control weekly 0.8 https://www.themednet.org/what-clinical-criteria-do-you-use-to-decide-whether-to-continue-intravenous-gentamicin-or-fluoroquinolone-for-the-full-duration-of-treatment-or-to-step-down-to-oral-therapy-in-hospitalized-patients-with-tularemia weekly 0.8 https://www.themednet.org/how-do-you-decide-when-a-patient-with-dementia-needs-additional-support-at-home-versus-a-transition-to-a-more-structured-living-environment weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-mag-antibody-associated-polyneuropathy weekly 0.8 https://www.themednet.org/what-volumes-and-dose-would-you-use-for-a-chest-wall-recurrence-in-a-patient-who-had-previous-mastectomy-and-completed-only-a-partial-prior-course-of-pmrt weekly 0.8 https://www.themednet.org/do-you-omit-pmrt-for-patients-who-would-have-been-eligible-for-nsabp-b-51-but-are-found-to-have-significant-pure-lvsi-only-without-stromal-carcinoma-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-interventions-do-you-recommend-for-preschool-aged-children-exposed-to-severe-trauma-ex-sexual-assault-but-not-displaying-any-observable-signs-of-ptsd weekly 0.8 https://www.themednet.org/how-soon-do-you-consider-repeating-external-diode-cpc-for-a-patient-whos-iop-remains-relatively-unchanged-and-uncontrolled-post-op-after-initial-cpc weekly 0.8 https://www.themednet.org/is-there-an-evidence-based-consensus-on-ct-derived-hounsfield-unit-thresholds-for-opportunistic-assessment-of-osteoporosis-and-how-should-such-measurements-be-applied-when-dxa-results-are-inconclusive-or-do-not-meet-diagnostic-criteria weekly 0.8 https://www.themednet.org/are-there-robust-clinical-data-on-the-safety-of-iv-amiodarone-for-atrial-fibrillation-of-unclear-duration-and-very-difficult-to-control-hr-in-the-current-era-of-widespread-doac-use-as-opposed-to-older-data-with-warfarin weekly 0.8 https://www.themednet.org/would-you-consider-prophylactic-anticoagulation-for-may-thurner-syndrome-in-pregnancy-if-prior-endovascular-intervention-has-been-completed weekly 0.8 https://www.themednet.org/how-do-you-treat-a-patient-with-early-stage-breast-cancer-s-p-lumpectomy-and-oncoplastic-reconstruction-with-a-positive-margin-when-re-excision-is-not-feasible weekly 0.8 https://www.themednet.org/knowing-that-there-is-going-to-be-significant-pr-prolongation-with-ra-pacing-should-a-lbba-pacing-lead-be-recommended-in-patients-with-a-ppm-indication-and-a-significant-first-degree-av-block-250msecs-especially-if-the-patient-has-a-borderline-lvef-45-55- weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-extra-hepatic-manifestations-complications-of-pbc weekly 0.8 https://www.themednet.org/how-would-you-approach-glp-1-gip-agonist-use-for-masld-management-in-a-patient-who-had-a-prior-episode-of-pancreatitis weekly 0.8 https://www.themednet.org/in-a-psc-patient-who-has-received-liver-transplant-what-graft-and-or-patient-factors-predispose-to-a-more-rapid-return-of-their-disease-and-how-do-you-manage-these-peri-operatively-and-post-transplant weekly 0.8 https://www.themednet.org/is-it-reasonable-to-start-de-escalating-gdmt-for-patients-with-recovered-lvef-following-pci-for-anterior-stemi-and-if-so-what-class-of-medication-would-you-consider-stopping-first weekly 0.8 https://www.themednet.org/in-patients-with-livedoid-vasculitis-and-chronic-venous-insufficiency-on-rivaroxaban-what-therapeutic-strategies-beyond-compression-and-topical-care-are-safe-and-effective-for-controlling-pain-ulceration-and-edema weekly 0.8 https://www.themednet.org/what-is-your-approach-to-prescribing-jak-inhibitors-in-patients-with-alopecia-areata-who-have-a-prior-history-of-cutaneous-malignancy-such-as-dfsp weekly 0.8 https://www.themednet.org/what-practical-next-steps-would-you-recommend-once-identifying-loneliness-in-an-older-adult-patient weekly 0.8 https://www.themednet.org/what-would-you-offer-to-a-patient-with-musculoskeletal-pain-from-tarlatamab-requiring-hospitalization-and-opioid-use weekly 0.8 https://www.themednet.org/what-is-your-preferred-initial-treatment-strategy-for-patient-with-new-diagnosis-of-seropositive-ra-who-has-end-stage-renal-disease weekly 0.8 https://www.themednet.org/have-you-seen-microscopic-polyangiitis-associated-with-temporal-artery-involvement weekly 0.8 https://www.themednet.org/what-is-your-approach-to-explaining-the-role-of-the-microbiome-to-patients-with-inflammatory-arthritis weekly 0.8 https://www.themednet.org/how-do-you-advise-using-mycoplasma-antibody-testing-to-guide-antibiotic-selection-in-patients-with-pneumonia weekly 0.8 https://www.themednet.org/do-you-perform-food-challenges-after-starting-xolair-for-ige-mediated-food-allergy-to-ensure-efficacy weekly 0.8 https://www.themednet.org/how-do-you-determine-when-patients-can-resume-massage-therapy-weight-lifting-or-sports-after-a-spontaneous-csf-leak weekly 0.8 https://www.themednet.org/if-a-patient-has-a-low-ceruloplasmin-with-normal-24-hours-urine-copper-excretion-how-would-you-go-about-an-approach-to-evaluation-of-other-disorders-of-copper-metabolism-as-a-cause-of-liver-disease weekly 0.8 https://www.themednet.org/how-have-the-results-of-the-u-s-pointer-study-involving-multidomain-lifestyle-interventions-to-protect-cognitive-function-influenced-your-practice weekly 0.8 https://www.themednet.org/what-has-been-your-experience-in-using-topical-hydroquinone-prior-to-a-chemical-peel-for-melasma-to-reduce-post-inflammatory-hyperpigmentation weekly 0.8 https://www.themednet.org/how-if-at-all-does-the-spectrum-of-her2-positivity-impact-efficacy-of-t-dxd-in-the-frontline-setting weekly 0.8 https://www.themednet.org/what-has-been-your-experience-using-gene-expression-profiles-geps-to-predict-treatment-response-in-atopic-dermatitis weekly 0.8 https://www.themednet.org/how-would-you-approach-de-intensifying-antihypertensives-in-frail-older-adults-with-sbp-130-mmhg-who-have-nephrotic-range-proteinuria-given-the-results-of-the-retreat-frail-trial weekly 0.8 https://www.themednet.org/what-empiric-dose-change-if-any-do-you-make-for-patients-already-taking-liquid-or-softgel-levothyroxine-preconception-upon-confirmation-of-a-positive-pregnancy-test weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-treating-uncomplicated-gonorrhea-with-zoliflodacin-instead-of-the-standard-treatment-regimen-with-ceftriaxone-and-azithromycin weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-use-tenapanor-over-more-frequently-prescribed-phosphorus-binders-for-managing-hyperphosphatemia-in-ckd-patients weekly 0.8 https://www.themednet.org/what-aspects-of-hf-management-do-you-think-hospitalists-should-prioritize-before-discharge-in-order-to-optimize-hf-admission-care-if-there-are-limited-resources-available-for-specialized-hf-care-both-inpatient-and-outpatient weekly 0.8 https://www.themednet.org/for-opiate-related-ileus-in-the-post-operative-setting-at-what-point-do-you-consider-trialing-methylnaltrexone weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-aud-about-non-alcoholic-na-beverage-consumption weekly 0.8 https://www.themednet.org/do-you-have-any-pearls-for-how-to-manage-osa-with-cpap-in-older-adults-with-cognitive-impairment weekly 0.8 https://www.themednet.org/how-do-you-approach-discussing-possible-dementia-with-an-older-adult-who-is-presenting-with-depression-when-you-are-concerned-that-raising-this-possibility-could-worsen-their-depressive-symptoms weekly 0.8 https://www.themednet.org/how-do-you-handle-requests-from-patients-to-complete-medical-paperwork-that-falls-outside-your-scope-of-practice-when-they-cannot-access-their-other-clinicians weekly 0.8 https://www.themednet.org/how-do-you-manage-increasing-ebv-viremia-of-15-000-copies-in-a-seropositive-heart-transplant-recipient-with-transplant-performed-15-years-ago-in-a-patient-who-is-otherwise-asymptomatic weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-about-the-potential-malignancy-risk-associated-with-traditional-dmards weekly 0.8 https://www.themednet.org/what-is-the-recommended-timing-for-starting-denosumab-after-completing-zoledronic-acid weekly 0.8 https://www.themednet.org/for-unresectable-appearing-braf-v600e-papillary-thyroid-cancer-involving-the-trachea-and-carotid-artery-is-neoadjuvant-targeted-therapy-a-viable-path-to-surgery-or-is-definitive-radiation-the-better-option weekly 0.8 https://www.themednet.org/what-diagnostic-workup-is-recommended-when-immune-thrombocytopenia-is-present-in-multiple-family-members weekly 0.8 https://www.themednet.org/for-a-patient-with-glioblastoma-also-found-to-have-a-distant-presumed-meningioma-with-a-location-size-such-that-you-would-have-otherwise-recommended-rt-would-you-offer-concurrent-treatment weekly 0.8 https://www.themednet.org/could-patients-with-smipi-1-and-poor-tolerability-to-rchop-be-offered-isrt-after-3-cycles-of-rchop-if-interim-pet-showed-5-ps-1-3-response weekly 0.8 https://www.themednet.org/in-a-patient-with-iabp-set-on-1-1-do-you-always-maintain-them-on-systemic-heparin-and-if-so-is-there-a-goal-act-range weekly 0.8 https://www.themednet.org/what-is-your-approach-to-long-term-radiographic-monitoring-for-patients-with-isolated-single-segment-transverse-myelitis-with-an-initial-negative-workup-i weekly 0.8 https://www.themednet.org/has-your-approach-to-direct-from-blood-bacterial-testing-changed-after-a-pragmatic-rct-showed-no-reduction-in-antibiotic-duration-compared-to-blood-cultures-alone weekly 0.8 https://www.themednet.org/what-is-your-approach-to-discussions-with-patients-about-the-meld-score-its-use-for-prognostication-of-outcomes-and-decompensation weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-the-quantification-of-hbsag-titers-in-chronic-hepatitis-b-infection-who-are-eag-negative-with-viral-suppression-on-treatment weekly 0.8 https://www.themednet.org/have-you-changed-your-approach-to-delaying-hip-surgery-in-the-context-of-decompensated-chf-given-the-findings-of-the-hip-attack-study weekly 0.8 https://www.themednet.org/have-you-started-using-novel-non-opioid-pain-medications-like-suzetrigine-in-the-post-operative-setting weekly 0.8 https://www.themednet.org/when-do-you-consider-a-trial-of-steroids-for-acute-hypoxemic-respiratory-failure-when-there-are-no-other-clear-indications-for-its-use-i-e-covid-copd-organizing-pneumonia-etc weekly 0.8 https://www.themednet.org/how-do-you-approach-prescribing-statins-in-patients-with-an-ascvd-7-5-but-have-a-strong-family-history-and-or-elevated-ldl-but-190 weekly 0.8 https://www.themednet.org/when-considering-deprescribing-antihypertensives-in-older-patients-how-do-you-approach-prioritization-of-which-antihypertensives-to-target-first weekly 0.8 https://www.themednet.org/what-are-fractionation-options-for-a-patient-with-progressive-jugular-foramen-paraganglioma-now-causing-multiple-cranial-nerve-deficits weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-a-patient-with-elevated-iron-saturation-60-and-ferritin-500s-with-negative-genetic-testing-for-hemochromatosis weekly 0.8 https://www.themednet.org/do-you-check-for-jcv-before-starting-belimumab weekly 0.8 https://www.themednet.org/in-patients-with-hypogonadism-when-do-you-recommend-subcutaneous-over-intramuscular-testosterone-injections weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-patient-diagnosed-with-htlv-2-after-an-abnormal-blood-donor-screening weekly 0.8 https://www.themednet.org/what-radiation-fields-would-you-recommend-in-a-young-patient-with-luminal-b-histology-and-itcs-in-a-single-sentinel-node weekly 0.8 https://www.themednet.org/what-concentration-dose-of-mitomycin-c-do-you-use-for-trabeculectomies-and-xens-and-how-do-you-titrate-based-on-patient-factors weekly 0.8 https://www.themednet.org/how-important-are-retinal-fluid-fluctuations-for-long-term-vision-and-how-do-you-factor-them-in-when-making-treatment-decisions-for-conditions-like-namd-and-dme weekly 0.8 https://www.themednet.org/in-patients-with-t1dm-when-would-you-consider-the-use-of-amylin-analogues-for-control-of-post-prandial-hyperglycemia weekly 0.8 https://www.themednet.org/what-laboratory-studies-do-you-routinely-order-when-evaluating-a-patient-with-interface-dermatitis-on-biopsy weekly 0.8 https://www.themednet.org/should-jak-inhibitors-be-avoided-in-patients-with-a-recent-history-of-melanoma weekly 0.8 https://www.themednet.org/how-do-you-manage-recurrent-scabies-in-both-a-patient-and-their-partner-when-standard-therapy-fails-3 weekly 0.8 https://www.themednet.org/do-you-generally-treat-family-members-of-patients-with-scabies weekly 0.8 https://www.themednet.org/do-you-start-more-than-one-medication-for-alcohol-use-disorder-simultaneously-e-g-disulfram-with-gabapentin-acamprosate-or-naltrexone-or-do-you-start-one-agent-at-a-time weekly 0.8 https://www.themednet.org/what-is-your-approach-to-empiric-treatment-of-achromobacter-infections weekly 0.8 https://www.themednet.org/how-do-you-transition-severely-agitated-icu-patients-off-a-dexmedetomidine-infusion-when-it-is-being-used-primarily-for-psychiatric-agitation weekly 0.8 https://www.themednet.org/do-allergy-shots-play-a-role-in-preventing-recurrence-of-nasal-polyps weekly 0.8 https://www.themednet.org/would-you-offer-peritoneal-dialysis-to-a-patient-with-eskd-who-also-has-a-ventriculoperitoneal-shunt weekly 0.8 https://www.themednet.org/how-do-you-approach-initiating-esketamine-treatment-in-older-adults-with-difficult-to-treat-depression weekly 0.8 https://www.themednet.org/in-p16-positive-oropharyngeal-squamous-cell-carcinoma-when-induction-therapy-is-considered-before-definitive-chemoradiation-how-do-you-choose-between-a-traditional-tpf-regimen-and-carboplatin-paclitaxel-pembrolizumab weekly 0.8 https://www.themednet.org/for-pediatric-patients-with-iron-overload-high-ferritin-and-transferrin-saturation-do-you-perform-hfe-screening-first-or-proceed-to-non-hfe-gene-sequencing-upfront-to-evaluate-for-hjv-mutation-as-well weekly 0.8 https://www.themednet.org/what-is-your-approach-to-chronic-non-immune-mediated-thrombocytopenia-management-in-children weekly 0.8 https://www.themednet.org/how-do-you-approach-biopsy-and-management-decisions-for-a-rapidly-enlarging-periocular-tumor-in-an-elderly-patient-with-dementia-who-is-unable-to-communicate-and-whose-family-prefers-to-avoid-aggressive-treatment weekly 0.8 https://www.themednet.org/which-anti-hypertensives-do-you-hold-and-for-how-long-when-screening-for-hyperaldosteronism-in-a-patient-with-resistant-hypertension-and-initial-screening-with-unsuppressed-renin-but-elevated-aldosterone-20-while-on-anti-hypertensive-therapy weekly 0.8 https://www.themednet.org/would-you-consider-topical-estrogen-for-facial-anti-aging weekly 0.8 https://www.themednet.org/for-low-intermediate-essential-thrombocythemia-not-on-cytoreduction-would-you-temporarily-cytoreduce-in-anticipation-of-surgery weekly 0.8 https://www.themednet.org/how-routinely-do-you-use-pocus-to-assess-fluid-responsiveness-in-patients-with-sepsis weekly 0.8 https://www.themednet.org/how-would-you-approach-the-consideration-of-continuing-or-ceasing-colonoscopy-for-colon-cancer-screening-in-a-relatively-fit-man-in-his-80s-without-a-history-of-polyps-on-prior-colonoscopies weekly 0.8 https://www.themednet.org/how-do-you-approach-the-choice-of-pharmacological-therapy-when-treating-insomnia-in-older-adults-in-the-outpatient-setting-with-a-high-falling-risk weekly 0.8 https://www.themednet.org/what-oral-contraceptives-pills-do-you-favor-for-treatment-of-pcos weekly 0.8 https://www.themednet.org/how-do-you-manage-early-patient-reported-polyuria-after-starting-an-sglt2-inhibitor-to-prevent-premature-discontinuation weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-choose-the-1-month-1hp-treatment-over-a-3-4-month-regimen-for-latent-tb weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-ls-sclc-after-sbrt-for-a-prior-nsclc-in-the-ipsilateral-lung weekly 0.8 https://www.themednet.org/would-you-stop-bimekizumab-in-a-patient-who-has-severe-psoriasis-and-has-responded-well-to-this-therapy-but-is-found-to-have-newly-diagnosed-cirrhosis weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-place-an-evd-for-hunt-hess-1-or-2-patients-with-subarachnoid-hemorrhage-secondary-to-ruptured-cerebral-aneurysm weekly 0.8 https://www.themednet.org/how-do-you-manage-perioperative-anticoagulation-for-a-patient-with-a-history-of-recent-surgically-provoked-vte weekly 0.8 https://www.themednet.org/in-patients-without-raynauds-how-frequently-do-you-perform-nailfold-examination-during-the-initial-clinical-assessment weekly 0.8 https://www.themednet.org/what-steroid-durations-do-you-use-for-the-treatment-of-acute-chronic-and-drug-induced-eosinophilic-pneumonia weekly 0.8 https://www.themednet.org/has-andromeda-shock-2-changed-how-you-use-capillary-refill-time-crt-versus-lactate-to-guide-fluid-resuscitation-and-vasopressor-therapy-in-septic-shock weekly 0.8 https://www.themednet.org/how-do-you-approach-escalating-anti-seizure-medication-treatment-of-patients-with-atypical-seizure-semiologies weekly 0.8 https://www.themednet.org/are-you-increasing-the-dose-and-or-frequency-of-xolair-administration-if-patients-have-failed-standard-dosing-for-csu weekly 0.8 https://www.themednet.org/for-septic-patients-with-borderline-heart-failure-how-do-you-individualize-the-decision-about-additional-fluid-boluses-after-the-initial-resuscitation weekly 0.8 https://www.themednet.org/how-many-total-days-of-antibiotics-do-you-prescribe-for-uncomplicated-non-purulent-cellulitis-in-hospitalized-patients-who-show-clear-clinical-improvement-within-48-72-hours weekly 0.8 https://www.themednet.org/when-home-bp-readings-are-consistently-lower-than-office-measurements-how-do-you-decide-whether-to-intensify-maintain-or-de-escalate-antihypertensive-therapy weekly 0.8 https://www.themednet.org/when-incidental-microscopic-hematuria-is-found-on-routine-urinalysis-how-do-you-decide-on-further-workup-versus-repeat-testing weekly 0.8 https://www.themednet.org/do-you-recommend-vitamin-k2-supplements-in-patients-with-osteoporosis weekly 0.8 https://www.themednet.org/how-do-you-evaluate-and-manage-incidental-urinary-retention-in-hospitalized-patients weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-struggling-to-decide-if-they-wish-to-pursue-an-invasive-diagnostic-procedure-to-confirm-a-severe-illness-with-poor-prognosis-and-or-limited-treatment-options weekly 0.8 https://www.themednet.org/under-what-circumstances-would-brachytherapy-be-preferred-over-electron-therapy-for-treating-skin-cancers weekly 0.8 https://www.themednet.org/how-do-you-conduct-follow-up-on-patients-with-brain-mets-who-have-undergone-gammatile-placement weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-non-mutated-oligometastatic-nsclc-with-a-brain-met-who-underwent-resection-of-the-brain-met-had-4-cycles-chemoio-and-had-resection-of-the-primary-lung-ca-with-pcr-and-now-is-ned weekly 0.8 https://www.themednet.org/would-you-give-consolidation-durvalumab-to-a-patient-who-underwent-chemoradiation-for-his-stage-iii-nsclc-and-is-being-started-on-antifibrotic-therapy-by-pulmonology-for-his-ild weekly 0.8 https://www.themednet.org/do-you-avoid-prescribing-thiazide-diuretics-for-hypertension-management-in-adpkd-patients-given-concerns-about-vasopressin-release weekly 0.8 https://www.themednet.org/which-biologics-for-asthma-have-data-regarding-mucus-plugging weekly 0.8 https://www.themednet.org/what-factors-determine-whether-a-patient-in-their-20s-with-a-new-oncologic-diagnosis-is-better-served-by-an-adult-or-pediatric-center weekly 0.8 https://www.themednet.org/when-do-you-treat-suspected-autoimmune-encephalitis-before-antibody-results weekly 0.8 https://www.themednet.org/would-you-treat-the-axilla-and-supraclav-in-a-recurrent-breast-cancer-that-presented-in-the-breast-and-imns-that-had-comprehensive-breast-node-radiation-many-years-ago weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-risk-of-hypothyroidism-after-radioactive-ablation-for-hot-nodules weekly 0.8 https://www.themednet.org/what-would-be-your-radiation-boost-technique-and-dose-levels-for-adjuvant-treatment-of-endometrial-cancer-with-high-grade-disease-or-aggressive-histology-if-there-was-a-positive-margin-at-the-parametrium-after-tah-bso weekly 0.8 https://www.themednet.org/for-locally-advanced-nsclc-does-endobronchial-tumor-debulking-just-prior-to-treatment-influence-your-decision-making-regarding-bronchial-tissue-constraints-expected-toxicity weekly 0.8 https://www.themednet.org/how-do-you-decide-in-older-adults-with-newly-diagnosed-stage-2-hypertension-when-to-start-with-two-antihypertensive-agents-versus-taking-a-more-cautious-approach-due-to-concerns-about-potential-orthostasis-frailty-or-polypharmacy weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-initiate-antibiotics-in-adults-hospitalized-with-rsv-and-a-suspected-bacterial-co-infection weekly 0.8 https://www.themednet.org/do-you-feel-there-is-a-role-for-capsulectomy-for-failed-ahmed-implants-and-what-is-your-preferred-surgical-approach weekly 0.8 https://www.themednet.org/would-you-recommend-phlebotomy-for-a-patient-with-previously-treated-all-and-hbv-reactivation-both-now-in-remission-but-with-elevated-liver-enzymes-and-ferritin-and-liver-biopsy-with-widespread-peri-canalicular-moderate-iron-deposition-and-perisinusoidal- weekly 0.8 https://www.themednet.org/how-do-you-manage-a-delayed-cutaneous-reaction-to-docetaxel-after-the-first-cycle-of-adjuvant-tc-in-early-stage-hr-positive-her2-negative-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-tapering-anesthetic-drips-for-refractory-status-epilepticus-after-achieving-burst-suppression weekly 0.8 https://www.themednet.org/how-do-you-determine-if-generic-vs-brand-formulation-of-a-dmt-is-the-probable-cause-of-worsening-multiple-sclerosis-disease-activity weekly 0.8 https://www.themednet.org/how-do-you-treat-dermal-metastases-in-the-setting-of-prior-breast-irradiation weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-regimen-to-treat-a-severe-or-fulminant-c-difficile-infection weekly 0.8 https://www.themednet.org/how-do-you-decide-which-glp-1s-to-prescribe-for-obesity weekly 0.8 https://www.themednet.org/is-there-a-preferred-jak-inhibitor-for-the-treatment-of-alopecia-associated-with-childhood-onset-systemic-lupus-erythematosus weekly 0.8 https://www.themednet.org/would-you-consider-radiating-an-unresectable-intimal-sarcoma-if-it-involved-the-valves-of-the-great-vessels weekly 0.8 https://www.themednet.org/what-are-your-favorite-modalities-for-preventing-hypergranulation-tissue weekly 0.8 https://www.themednet.org/do-you-frequently-recommend-the-hpv-vaccination-series-to-patients-above-26-years-old weekly 0.8 https://www.themednet.org/have-treatment-recommendations-changed-for-stage-i-endometrial-cancer-based-upon-portec-4-results weekly 0.8 https://www.themednet.org/would-you-use-consolidation-immunotherapy-after-chemoradiation-for-patients-with-stage-iii-nsclc-and-egfr-amplification weekly 0.8 https://www.themednet.org/what-do-you-prescribe-for-hiv-post-exposure-prophylaxis-in-patients-who-cannot-swallow-tablets-and-have-no-enteral-tube weekly 0.8 https://www.themednet.org/in-a-patient-with-borderline-resectable-pancreatic-adenocarcinoma-s-p-10-cycles-folfox-and-aborted-whipple-due-to-locally-advanced-disease-do-you-recommend-dose-escalation-beyond-54-gy weekly 0.8 https://www.themednet.org/for-transplant-ineligible-aplastic-anemia-planned-for-immunosuppression-how-do-you-approach-duration-and-tapering-of-cyclosporine-and-eltrombopag weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-withdrawing-aspirin-and-continuing-with-potent-p2y12-inhibitor-monotherapy-after-successful-pci-in-patients-with-acute-coronary-syndromes-based-on-the-findings-of-the-neo-mindset-trial weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-of-fibrillary-gn-coexistent-with-monoclonal-gammopathy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-rare-presentation-of-an-older-adult-after-gross-total-resection-of-an-infant-type-hemispheric-glioma-of-the-left-frontal-lobe-idh1-negative-and-negative-for-myb-fusions weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-elevated-liver-enzymes-in-patients-who-recently-started-treatment-with-tocilizumab weekly 0.8 https://www.themednet.org/in-older-male-patients-with-a-history-of-underlying-autoimmune-disease-what-clinical-manifestations-would-prompt-you-to-evaluate-for-vexas-syndrome weekly 0.8 https://www.themednet.org/do-you-treat-early-stage-multifocal-breast-cancer-similarly-to-single-site-lesion weekly 0.8 https://www.themednet.org/do-you-use-steroids-in-patients-with-respiratory-failure-who-are-infected-with-both-influenza-and-covid-19 weekly 0.8 https://www.themednet.org/does-your-approach-to-the-management-of-a-patient-with-an-acute-exacerbation-of-cpfe-where-the-ild-is-attributed-to-ipf-differ-from-the-management-of-a-patient-with-an-exacerbation-of-ipf-alone weekly 0.8 https://www.themednet.org/if-using-hyperthermia-in-breast-reirradiation-what-type-of-protocol-do-you-follow weekly 0.8 https://www.themednet.org/is-there-any-reason-to-hold-fulvestrant-during-sbrt-to-an-oligoprogressive-nodule weekly 0.8 https://www.themednet.org/for-cervical-cancer-intracavitary-brachytherapy-do-you-use-contrast-when-using-ct-based-planning-to-better-visualize-the-ureters weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-use-of-nsaids-in-patients-with-a-history-of-gastric-sleeve-bypass weekly 0.8 https://www.themednet.org/do-you-offer-ivig-to-myeloma-patients-with-recurrent-infections weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-to-persistent-chillblains-lesions-in-the-absence-of-systemic-lupus weekly 0.8 https://www.themednet.org/what-treatment-would-you-use-in-a-patient-with-osteoporosis-on-denosumab-for-10-years-who-develops-onj-at-a-site-of-an-old-implant weekly 0.8 https://www.themednet.org/how-would-you-approach-the-adjuvant-management-of-thoracic-smarca4-deficient-undifferentiated-tumor-of-the-lung-following-lobectomy weekly 0.8 https://www.themednet.org/when-do-you-refer-pediatric-patients-with-eczema-to-an-allergist weekly 0.8 https://www.themednet.org/how-do-you-prefer-to-manage-multiple-or-numerous-symptomatic-skull-metastases-in-a-patient-without-brain-metastases weekly 0.8 https://www.themednet.org/for-a-patient-obtaining-significant-benefit-and-no-side-effects-from-pentoxifylline-vitamin-e-for-radiation-induced-vulvovaginal-fibrosis-do-you-continue-treatment-longer-than-6-7-months-or-discontinue weekly 0.8 https://www.themednet.org/what-are-your-shift-tolerances-for-fractionated-sbrt-and-srs-treatments weekly 0.8 https://www.themednet.org/do-you-routinely-boost-the-lumpectomy-cavity-for-her2-positive-breast-cancer-in-the-absence-of-other-risk-factors weekly 0.8 https://www.themednet.org/for-patients-with-newly-diagnosed-brain-metastases-without-a-history-of-seizure-activity-do-you-routinely-start-anti-seizure-medication weekly 0.8 https://www.themednet.org/how-would-you-treat-lymphoplasmacytic-lymphoma-lpl-with-a-non-igm-paraprotein weekly 0.8 https://www.themednet.org/when-is-the-index-of-suspicion-high-for-paraneoplastic-systemic-sclerosis-in-terms-of-clinical-and-serological-presentation-and-how-will-you-work-it-up weekly 0.8 https://www.themednet.org/do-you-typically-use-noacs-or-lovenox-in-patients-with-stroke-due-to-hypercoagulability-from-malignancy weekly 0.8 https://www.themednet.org/when-do-you-recommend-genetic-testing-in-patients-with-neuropathy weekly 0.8 https://www.themednet.org/do-you-typically-encounter-phrenic-involvement-in-patients-with-cidp weekly 0.8 https://www.themednet.org/do-you-ever-start-a-ketogenic-diet-in-patients-who-present-with-status-epilepticus-admitted-to-the-icu weekly 0.8 https://www.themednet.org/do-you-use-isosorbide-dinitrate-spray-for-the-treatment-of-neuropathic-pain weekly 0.8 https://www.themednet.org/how-would-you-treat-a-locally-recurrent-nsclc-abutting-the-heart-that-was-previously-treated-with-conventional-chemort weekly 0.8 https://www.themednet.org/would-you-cover-presacral-lymph-nodes-in-endometrial-cancer-patients-with-locally-advanced-disease-iiic2-disease-who-received-neo-adjuvant-chemotherapy-prior-to-resection-with-no-residual-disease-on-pathology weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-purposeless-groaning-involuntary-humming-in-psp weekly 0.8 https://www.themednet.org/what-is-your-threshold-to-start-triple-therapy-in-mild-to-moderate-asthma-copd-overlap-with-minimal-functional-limitation weekly 0.8 https://www.themednet.org/for-a-lymph-node-negative-nasopharyngeal-ebv-ct3n0-what-lymph-node-levels-would-you-electively-cover-after-a-good-response-to-induction-chemotherapy weekly 0.8 https://www.themednet.org/do-all-patients-initiating-omalizumab-need-to-have-it-administered-in-a-healthcare-setting weekly 0.8 https://www.themednet.org/what-is-your-approach-to-maintenance-rituximab-in-patients-with-igg4-rd weekly 0.8 https://www.themednet.org/how-would-you-approach-treating-a-patient-with-active-rheumatoid-arthritis-and-a-history-of-treated-lymphoma-that-is-currently-in-remission weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-to-prevent-progression-of-phymatous-rosacea weekly 0.8 https://www.themednet.org/how-does-pathological-skin-involvement-i-e-nipple-epidermis-but-not-clinical-skin-involvement-change-your-recommendations-regarding-pmrt-in-the-absence-of-other-risk-factors weekly 0.8 https://www.themednet.org/whats-the-role-of-ibrutinib-and-venetoclax-in-cll-in-light-of-data-emerging-from-ash-2022 weekly 0.8 https://www.themednet.org/would-you-give-iv-thrombolysis-to-a-patient-presenting-with-acute-disabling-stroke-symptoms-after-a-tavi-procedure weekly 0.8 https://www.themednet.org/whats-your-choice-of-next-line-therapy-for-a-metastatic-papillary-rcc-who-has-progressed-on-cabozantinib weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-treatment-for-node-positive-high-grade-gastric-type-endocervical-adenocarcinoma-following-radical-hysterectomy weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-breast-cancer-with-enlarged-but-indeterminate-breast-nodes weekly 0.8 https://www.themednet.org/assuming-all-options-for-bcma-directed-therapy-are-available-how-would-you-approach-treatment-for-a-patient-with-4-prior-lines-of-myeloma-directed-therapy-who-is-eligible-for-a-bcma-directed-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-oral-dmard-and-or-biologic-selection-in-patients-with-ra-and-a-history-of-gastric-bypass-or-whom-are-planning-bariatric-surgery weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-erythrocytosis-of-unknown-cause-in-pregnancy weekly 0.8 https://www.themednet.org/for-patients-with-metachronous-isolated-oligometastatic-cancer-of-gynecologic-origin-to-the-supraclavicular-fossa-do-you-prefer-standard-fractionation-therapy-to-cover-the-entire-supraclav-or-sbrt-to-the-involved-nodes weekly 0.8 https://www.themednet.org/when-future-immunotherapy-is-anticipated-do-you-alter-brain-metastasis-srs-dose-margin-fractionation-or-other-factors-in-an-attempt-to-decrease-the-risk-of-symptomatic-radionecrosis weekly 0.8 https://www.themednet.org/what-would-you-use-for-a-maintenance-regimen-after-high-dose-chemotherapy-and-autologous-stem-cell-transplant-for-a-patient-with-17p-deleted-multiple-myeloma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-biopsy-proven-giant-cell-arteritis-that-continue-to-have-symptoms-after-initiation-of-high-dose-glucocorticoid-therapy weekly 0.8 https://www.themednet.org/what-would-be-your-next-step-in-workup-for-a-patient-with-igg-kappa-monoclonal-protein-detected-on-spep-and-free-lambda-light-chains-found-in-the-urine-with-chronic-diarrhea-for-3-years-and-concern-for-gi-amyloidosis weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-immune-checkpoint-therapy-for-a-patient-with-resected-mucosal-melanoma-with-a-tumor-thickness-4-0-mm-with-negative-ln-involvement weekly 0.8 https://www.themednet.org/how-would-you-treat-an-isolated-para-aortic-lymph-node-endometrial-cancer-recurrence-following-a-prolonged-disease-free-interval-previously-treated-with-surgery-chemotherapy-and-radiation-therapy-if-it-is-located-outside-of-the-previously-irradiated-field weekly 0.8 https://www.themednet.org/would-you-offer-whole-breast-rt-to-a-brca-positive-patient-who-has-multifocal-recurrent-disease-after-apbi weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-chemotherapy-for-a-patient-with-subcentimeter-pancreatic-adenocarcinoma-incidentally-found-during-a-whipple-resection-for-high-risk-ipmn weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-a-nonspecific-platelet-function-disorder-and-heterozygous-protein-c-deficiency-during-pregnancy weekly 0.8 https://www.themednet.org/do-you-continue-cftr-modulator-therapy-in-patients-with-extra-pulmonary-manifestations-of-cf-after-lung-transplant weekly 0.8 https://www.themednet.org/do-you-recommend-adjuvant-radiation-therapy-for-resected-spine-metastases-in-nsclc-with-targetable-mutations weekly 0.8 https://www.themednet.org/how-would-you-treat-bilateral-synchronous-breast-cancer-with-single-bony-metastatic-disease-on-imaging-when-one-is-er-her2-neg-and-other-is-tnbc weekly 0.8 https://www.themednet.org/how-would-you-approach-therapy-for-a-transplant-eligible-patient-with-peripheral-t-cell-lymphoma-nos-who-experiences-early-relapse-after-choep-but-achieves-remission-to-salvage-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-incorporating-immunotherapy-in-neoadjuvant-treatment-for-ge-junction-and-gastric-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-prophylactic-anticoagulation-to-pregnant-women-undergoing-chemotherapy-for-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-systemic-therapy-of-choice-for-patients-with-metastatic-small-cell-carcinoma-of-breast-origin weekly 0.8 https://www.themednet.org/what-is-your-first-line-strategy-for-tp53-mutant-aml weekly 0.8 https://www.themednet.org/what-is-the-risk-of-uveitis-flare-in-patients-with-jia-and-uveitis-who-are-in-remission-when-tapering-medications weekly 0.8 https://www.themednet.org/are-there-any-data-regarding-safety-or-efficacy-of-osimertinib-and-concurrent-chemotherapy-in-patients-with-metastatic-nsclc-harboring-sensitizing-egfr-mutation weekly 0.8 https://www.themednet.org/what-target-do-you-utilize-in-clinical-practice-for-defining-disease-remission-in-ra weekly 0.8 https://www.themednet.org/when-would-you-offer-nivolumab-relatlimab-to-a-metastatic-melanoma-patient-following-progression-on-braf-mek-targeted-therapy weekly 0.8 https://www.themednet.org/does-the-lack-of-survival-data-with-palbociclib-in-metastatic-breast-cancer-make-you-lean-towards-using-abemaciclib-or-ribociclib-in-various-combinations weekly 0.8 https://www.themednet.org/is-it-safe-to-deliver-palliative-radiation-to-the-spine-with-a-spinal-stimulator-device-in-place weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-chemotherapy-to-a-patient-who-has-stage-ib-grade-1-endometrioid-endometrial-cancer-with-isolated-tumor-cells-in-two-pelvic-lymph-nodes-and-extensive-lvsi weekly 0.8 https://www.themednet.org/how-can-you-differentiate-perforator-disease-vs-artery-to-artery-embolus-as-a-stroke-etiology weekly 0.8 https://www.themednet.org/would-you-consider-radiation-omission-in-an-elderly-patient-with-a-2-mm-focus-of-invasive-ductal-carcinoma-in-a-background-of-high-grade-dcis weekly 0.8 https://www.themednet.org/how-do-you-wean-patients-off-cenobamate-in-the-emu-and-how-long-can-these-patients-be-off-of-it-before-having-to-restart-the-two-month-uptitration weekly 0.8 https://www.themednet.org/how-long-do-you-continue-treatment-with-imatinib-in-a-patient-with-chronic-eosinophilic-leukemia-who-achieves-remission weekly 0.8 https://www.themednet.org/do-you-hold-mtor-inhibitors-during-radiation weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-progressive-cerebellar-ataxia-and-positive-cardiolipin-antibodies weekly 0.8 https://www.themednet.org/is-a-fast-regimen-reasonable-for-re-treating-a-patient-with-pbi-after-prior-whole-breast-radiation-ten-years-ago weekly 0.8 https://www.themednet.org/what-is-your-approach-to-pulmonary-vasodilator-therapy-in-patients-with-copd-and-severe-group-3-pulmonary-hypertension weekly 0.8 https://www.themednet.org/how-would-the-development-of-pneumonitis-from-pembrolizumab-after-treatment-as-per-keynote-522-alter-your-pmrt-recommendations weekly 0.8 https://www.themednet.org/when-would-you-consider-adjuvant-radiation-therapy-for-tenosynovial-giant-cell-tumors-of-the-extremity weekly 0.8 https://www.themednet.org/for-a-small-focally-positive-dcis-margin-in-the-setting-of-invasive-disease-and-negative-invasive-margins-not-undergoing-re-excision-what-boost-dose-would-you-use weekly 0.8 https://www.themednet.org/what-therapies-have-you-found-most-effective-for-treating-lower-extremity-dsap weekly 0.8 https://www.themednet.org/is-febuxostat-a-safe-alternative-for-patients-who-are-hla-b-58-01-positive-and-of-han-chinese-descent weekly 0.8 https://www.themednet.org/at-what-absolute-lymphocyte-count-do-you-consider-alternative-discontinuing-dmt-in-a-patient-with-ms-on-fingolimod-or-other-s1p-modulator weekly 0.8 https://www.themednet.org/what-recommendations-do-you-make-for-patients-with-lower-abdomen-eczema-from-nickel-in-their-belt-buckle weekly 0.8 https://www.themednet.org/what-is-your-approach-to-rectal-cancer-staging-in-patients-who-cannot-undergo-an-mri weekly 0.8 https://www.themednet.org/how-would-you-choose-between-left-bundle-pacing-and-crt-p-in-a-patient-with-a-new-high-degree-av-block-and-pre-existing-reduced-lvef-who-does-not-otherwise-meet-the-criteria-for-crt-d weekly 0.8 https://www.themednet.org/what-is-your-preferred-po-afterload-reducing-agent-immediately-after-being-weaned-off-inotropic-support-in-cardiogenic-shock weekly 0.8 https://www.themednet.org/are-there-single-fraction-regimens-for-postoperative-treatment-for-keloids weekly 0.8 https://www.themednet.org/is-prior-turp-a-contraindication-to-spaceoar-placement weekly 0.8 https://www.themednet.org/in-a-patient-who-fractures-after-several-years-of-denosumab-therapy-would-you-wait-6-months-after-the-last-denosumab-injection-to-start-an-anabolic-agent-or-could-start-an-anabolic-agent-sooner weekly 0.8 https://www.themednet.org/in-small-cell-lung-cancer-with-effusion-that-is-negative-on-thoracentesis-twice-do-you-assume-limited-stage-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-to-screening-for-complete-heart-block-in-an-asymptomatic-pregnant-patient-with-negative-ssa-and-positive-ssb-antibodies weekly 0.8 https://www.themednet.org/are-there-specific-recreational-activities-or-exercises-you-recommend-patients-with-ankylosing-spondylitis-avoid weekly 0.8 https://www.themednet.org/do-you-use-anticoagulation-in-cancer-patients-who-develop-an-unprovoked-superficial-vein-thrombosis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-curative-intent-therapy-for-a-young-fit-patient-with-newly-diagnosed-monomorphic-epitheliotropic-intestinal-t-cell-lymphoma-meitl weekly 0.8 https://www.themednet.org/is-there-still-a-role-for-plasma-exchange-plex-for-confirmed-or-suspected-cast-nephropathy-in-multiple-myeloma-to-rapidly-reduce-light-chain-burden weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-mild-hypercalcemia-in-patients-with-sarcoidosis weekly 0.8 https://www.themednet.org/in-the-nebraska-mayo-transplant-protocol-for-perihilar-cholangiocarcinoma-do-you-ever-offer-prophylactic-biliary-drainage-stenting-to-prevent-obstruction-post-chemoradiation weekly 0.8 https://www.themednet.org/do-you-check-beta-2-microglobulin-in-patients-with-mgus weekly 0.8 https://www.themednet.org/how-do-you-approach-the-concept-of-spondyloarthritis-disease-activity-burning-out-and-no-longer-requiring-immunosuppression weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiation-for-a-patient-who-is-incidentally-found-to-have-a-pt2b-nx-adenocarcinoma-of-the-gallbladder-after-a-simple-cholecystectomy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-persistent-encephalopathy-following-ischemic-injury-to-bilateral-thalami weekly 0.8 https://www.themednet.org/when-patients-develop-headaches-from-luspatercept-do-they-tend-to-improve-over-time weekly 0.8 https://www.themednet.org/what-precautions-do-you-take-prior-to-cabg-in-a-patient-with-sickle-cell-trait weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-a-pediatric-patient-with-uterine-embryonal-rhabdomyosarcoma-found-after-removal-of-a-prolapsing-uterine-mass-with-no-evidence-of-distant-metastasis-on-imaging weekly 0.8 https://www.themednet.org/what-clinical-or-pathologic-features-would-make-you-more-concerned-that-a-new-skin-scc-is-from-metastatic-disease-or-a-new-cutaneous-primary weekly 0.8 https://www.themednet.org/what-chemotherapy-backbone-would-you-use-with-trastuzumab-in-patients-with-her2-esophagogastric-cancer-that-relapse-after-perioperative-flot4 weekly 0.8 https://www.themednet.org/can-tacrolimus-in-a-transplant-patient-be-used-during-radiation-and-concurrent-chemoradiation weekly 0.8 https://www.themednet.org/how-would-you-approach-a-sarcoma-that-was-initially-diagnosed-as-ups-of-the-distal-femur-with-groin-lymph-node-spread-resected-and-found-to-have-an-ewsr1-fli1-fusion-diagnostic-of-ewings-on-ngs weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-lymph-node-only-recurrences-in-the-setting-of-previously-resected-colon-cancer-that-are-not-amenable-to-biopsy weekly 0.8 https://www.themednet.org/how-would-you-approach-the-staging-and-treatment-of-extranodal-marginal-zone-lymphoma-of-left-and-right-lacrimal-gland weekly 0.8 https://www.themednet.org/do-you-typically-get-muscle-mri-in-patients-with-symptoms-of-myopathy weekly 0.8 https://www.themednet.org/in-what-clinical-scenarios-do-you-utilize-neuromuscular-ultrasound weekly 0.8 https://www.themednet.org/how-do-you-manage-cramps-in-patients-with-als weekly 0.8 https://www.themednet.org/how-do-you-approach-the-diagnostic-workup-for-patients-with-suspected-fabrys-disease weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-about-the-malignancy-risk-associated-with-azathioprine weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-adjuvant-treatment-for-stage-ia-grade-2-endometrioid-adenocarcinoma-without-lvsi-whose-molecular-classification-is-p53-abnormal-mmr-intact-pole-wild-type weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-radiation-treatment-planning-for-r1-r2-node-negative-nsclc weekly 0.8 https://www.themednet.org/for-t-cell-all-treated-in-cr-without-transplant-how-often-do-you-do-bm-biopsies-as-part-of-surveillance-and-for-how-long weekly 0.8 https://www.themednet.org/what-is-your-approach-to-therapy-for-pulmonary-sarcoidosis-resistant-to-methotrexate weekly 0.8 https://www.themednet.org/how-do-you-approach-evaluation-of-hypocomplementemia-in-a-patient-with-arthralgias-and-a-history-of-hodgkins-lymphoma-treated-in-the-past weekly 0.8 https://www.themednet.org/how-do-you-approach-differentiating-infectious-vs-inflammatory-tenosynovitis weekly 0.8 https://www.themednet.org/how-would-you-approach-an-atypical-teratoid-rhabdoid-tumor-at-rt-in-an-adult-patient weekly 0.8 https://www.themednet.org/how-would-you-treat-a-late-hilar-recurrence-of-biopsy-proven-small-cell-lung-cancer-within-the-previously-irradiated-volume weekly 0.8 https://www.themednet.org/should-follow-up-imaging-for-unruptured-intracranial-aneurysms-include-mra-head-and-mri-brain-to-evaluate-for-arterial-wall-enhancement weekly 0.8 https://www.themednet.org/how-would-you-manage-stable-slightly-enlarged-pulmonary-metastasis-from-non-seminoma-testicular-cancer-after-receiving-3-cycles-of-bep-which-resulted-in-a-mixed-responses-on-chest-ct-but-normalized-afp weekly 0.8 https://www.themednet.org/in-mismatch-repair-deficient-recurrent-endometrial-cancer-eligible-for-single-agent-pd-1-inhibitor-do-you-prefer-pembrolizumab-or-dostarlimab-and-why weekly 0.8 https://www.themednet.org/what-is-your-approach-to-determining-if-an-spep-abnormality-is-causal-or-coincidental-in-peripheral-neuropathy-work-up weekly 0.8 https://www.themednet.org/what-strategies-do-you-employ-to-prevent-post-intubation-hypotension-in-a-profoundly-hypoxic-patient-given-a-paralytic-for-intubation weekly 0.8 https://www.themednet.org/would-you-consider-177lu-psma-617-for-a-patient-with-mcrpc-that-has-neuroendocrine-features-on-biopsy-but-psma-positive-disease-on-pet weekly 0.8 https://www.themednet.org/for-primary-angiosarcoma-of-the-breast-following-mastectomy-what-would-your-targets-be-for-adjuvant-radiation-therapy weekly 0.8 https://www.themednet.org/do-you-recommend-surveillance-for-secondary-malignancies-of-the-rectum-and-bladder-after-prostate-xrt weekly 0.8 https://www.themednet.org/in-a-patient-with-neurosarcoidosis-who-required-infliximab-for-initially-refractory-symptoms-but-is-now-stable-how-do-you-decide-on-the-optimal-time-to-de-escalate-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-a-cervical-node-biopsy-proven-follicular-lymphoma-in-situ-in-a-symptomatic-patient-with-night-sweats-and-pet-findings-of-low-suv-uptake-throughout-the-body weekly 0.8 https://www.themednet.org/would-you-switch-a-patient-with-glucocorticoid-induced-osteoporosis-to-romosozumab-if-a-patient-sustained-a-fragility-fracture-1-year-into-treatment-with-teriparatide weekly 0.8 https://www.themednet.org/how-would-you-approach-the-adjuvant-treatment-of-a-stage-iva-adenosarcoma-of-the-ovary weekly 0.8 https://www.themednet.org/what-is-the-preferred-timing-for-removal-of-a-peritoneal-dialysis-catheter-in-a-patient-who-has-transitioned-to-hemodialysis weekly 0.8 https://www.themednet.org/how-do-you-perform-fertility-counseling-for-a-patient-with-a-duplication-of-one-of-the-alpha-genes-and-their-partner-who-has-a-beta-chain-point-mutation weekly 0.8 https://www.themednet.org/would-you-recommend-adding-a-tki-to-a-pediatric-regimen-for-a-aya-b-all-patient-with-ikzf1-mutation weekly 0.8 https://www.themednet.org/does-oncotype-score-affect-your-decision-to-do-regional-nodal-irradiation-in-a-patient-with-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/what-advice-do-you-have-for-the-management-of-nail-toxicity-associated-with-pemigatinib-and-other-fgfr-inhibitors weekly 0.8 https://www.themednet.org/is-a-larger-bore-percutaneous-chest-tube-sufficient-to-adequately-drain-a-hemothorax-or-is-a-surgical-chest-tube-required weekly 0.8 https://www.themednet.org/do-you-consider-the-duration-of-lung-lobar-atelectasis-in-your-decision-making-while-offering-airway-stents-for-malignant-central-airway-obstruction weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-preventing-nail-damage-with-constant-pedicures-manicures-and-nail-polish weekly 0.8 https://www.themednet.org/would-you-consider-immunotherapy-in-high-risk-resectable-msi-h-colorectal-cancer weekly 0.8 https://www.themednet.org/what-is-your-recommended-management-for-a-pt1n0-perianal-moderately-differentiated-scc-s-p-wide-local-excision-with-close-1-mm-deep-margin weekly 0.8 https://www.themednet.org/how-does-the-performance-of-a-lympha-procedure-affect-the-timing-and-planning-of-post-mastectomy-radiation weekly 0.8 https://www.themednet.org/for-a-stable-avm-after-srs-would-you-consider-repeat-srs weekly 0.8 https://www.themednet.org/would-you-add-immunotherapy-to-chemotherapy-in-the-adjuvant-treatment-of-resected-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/would-you-give-pentoxiphylline-and-vitamin-e-during-hbo-for-vaginal-necrosis weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-synchronous-locally-advanced-cervical-and-ovarian-cancers weekly 0.8 https://www.themednet.org/what-is-your-experience-with-using-oral-deucravacitinib-off-label-for-conditions-such-as-recalcitrant-facial-discoid-lupus-or-recalcitrant-lichen-planus weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-radiation-in-a-patient-with-stage-1-1-cm-merkel-cell-carcinoma-of-the-lateral-upper-arm-status-post-resection-to-negative-wide-margins weekly 0.8 https://www.themednet.org/would-you-deliver-post-operative-axillary-radiation-for-breast-cancer-patients-who-have-contralateral-axillary-disease-s-p-alnd weekly 0.8 https://www.themednet.org/how-can-oncologists-be-more-collaborative-with-palliative-care-physicians weekly 0.8 https://www.themednet.org/do-you-consider-using-160-mg-osimertinib-in-patients-with-egfr-positive-metastatic-nsclc-to-the-brain weekly 0.8 https://www.themednet.org/do-you-use-anti-dfs70-ab-to-help-reduce-the-posttest-probability-of-ana-positive-patients-having-a-systemic-autoimmune-disease-if-other-autoantibodies-are-negative weekly 0.8 https://www.themednet.org/how-does-depth-of-invasion-factor-into-your-decision-making-when-considering-postoperative-radiotherapy-for-vulvar-cancer weekly 0.8 https://www.themednet.org/would-you-consider-complement-inhibitor-therapy-or-immunosuppressive-therapy-e-g-cyclosporine-corticosteroids-for-a-patient-with-a-pnh-clone-and-early-mds-who-presents-with-pancytopenia weekly 0.8 https://www.themednet.org/how-do-you-manage-post-radiation-chronic-vaginitis-with-bleeding weekly 0.8 https://www.themednet.org/how-do-you-counsel-pregnant-patients-with-myasthenia-gravis weekly 0.8 https://www.themednet.org/when-would-you-consider-percutaneous-mechanical-aspiration-of-vegetation-in-right-sided-endocarditis weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-recurrent-braf-negative-melanoma-and-resected-oligo-metastasis-after-completing-one-year-of-adjuvant-nivolumab weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-cml-in-chronic-phase-with-a-significant-cardiac-history-such-as-heart-failure-with-reduced-ejection-fraction-or-arrhythmia weekly 0.8 https://www.themednet.org/how-do-you-approach-imaging-in-patients-with-m0-castration-resistant-prostate-cancer-with-rising-psa-on-an-arsi weekly 0.8 https://www.themednet.org/how-would-you-treat-a-potentially-resectable-stage-iii-lung-adenocarcinoma-with-an-egfr-mutation weekly 0.8 https://www.themednet.org/how-do-you-specifically-counsel-patients-on-conservative-measures-such-as-hand-warming-in-the-treatment-of-ssc-associated-digital-ulceration weekly 0.8 https://www.themednet.org/would-you-offer-sbrt-to-an-oligometastatic-non-vertebral-bony-site-that-already-has-a-pathologic-fracture weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-who-underwent-a-right-colectomy-for-a-polyp-with-high-risk-dysplasia-with-pathology-showing-no-primary-but-one-of-the-ln-showing-adenocarcinoma-suggestive-of-gi-primary weekly 0.8 https://www.themednet.org/should-the-schedule-of-disease-modifying-therapy-medication-administration-be-changed-if-patient-has-received-high-dose-steroids-for-an-ms-exacerbation weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-treatment-for-patients-with-early-stage-cervical-cancer-and-isolated-tumor-cells-identified-in-sentinel-lymph-nodes-if-they-would-otherwise-not-meet-criteria-for-adjuvant-radiation-therapy weekly 0.8 https://www.themednet.org/do-you-consider-a-severe-ica-stenosis-70-99-narrowing-per-nascet-criteria-symptomatic-if-a-lacunar-stroke-attributable-to-small-vessel-disease-occurs-in-the-perforating-arteries-e-g-lenticulostriate-downstream-from-the-stenosis weekly 0.8 https://www.themednet.org/for-what-opx-subsites-would-you-consider-not-treating-the-high-retropx-drainage-in-the-node-positive-neck weekly 0.8 https://www.themednet.org/how-do-you-approach-adt-in-a-post-prostatectomy-patient-who-had-higher-gleason-score-on-biopsy-but-a-lower-gleason-score-on-final-pathology weekly 0.8 https://www.themednet.org/what-pre-operative-work-up-do-you-follow-in-your-institution-prior-to-ec-ic-bypass-in-patients-with-a-focal-intracranial-stenosis-and-patients-with-mmd weekly 0.8 https://www.themednet.org/what-dose-and-formulation-of-gnrh-agonist-do-you-use-for-ovarian-suppression-in-young-breast-cancer-patients weekly 0.8 https://www.themednet.org/what-therapies-have-you-most-effective-in-managing-the-pruritus-associated-with-lichen-amyloid weekly 0.8 https://www.themednet.org/what-is-the-timing-of-onset-of-alectinib-induced-ild-and-is-there-any-correlation-between-dose-and-the-occurrence-of-ild weekly 0.8 https://www.themednet.org/for-patients-with-endometrial-recurrence-of-vaginal-vault-pelvis-who-are-not-candidates-for-brachytherapy-boost-what-external-beam-boost-dose-have-you-used-following-pelvic-ebrt weekly 0.8 https://www.themednet.org/would-you-consider-administration-of-neoadjuvant-anthracycline-for-ct2n1-er-pr-her2-patients-given-that-this-may-be-excessive-for-n1-disease-or-do-you-wait-until-nodal-status-is-confirmed-on-surgical-pathology weekly 0.8 https://www.themednet.org/how-do-you-treat-significant-keloidal-acne-scarring-on-the-back-of-a-teenager weekly 0.8 https://www.themednet.org/what-is-your-ferritin-threshold-to-prescribe-iron-to-female-adolescent-athletes-who-have-symptomatic-iron-deficiency-without-anemia weekly 0.8 https://www.themednet.org/how-do-you-approach-systemic-treatment-for-intracranial-only-brain-metastases-for-er-positive-pr-negative-her2-negative-breast-cancer-after-stereotactic-radiosurgery-for-brain-metastases-with-negative-pet-imaging weekly 0.8 https://www.themednet.org/what-do-you-quote-as-the-recurrence-risk-without-radiation-for-patients-that-undergo-neoadjuvant-systemic-therapy-followed-by-lumpectomy-and-are-found-to-have-a-complete-pathologic-response weekly 0.8 https://www.themednet.org/do-you-use-both-rituximab-and-plasmapheresis-in-patients-with-recurrent-primary-fsgs-within-three-months-of-kidney-transplantation weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-chemotherapy-to-a-distal-esophageal-adenocarcinoma-t3nxm0-who-s-p-chemo-radiation-and-esophagectomy-had-a-complete-pathologic-response-ypt0n0 weekly 0.8 https://www.themednet.org/would-you-anticoagulate-a-patient-with-an-asymptomatic-gonadal-vein-thrombosis-on-ct-scan-found-on-surveillance-imaging-for-colorectal-cancer weekly 0.8 https://www.themednet.org/what-is-the-optimal-frequency-and-duration-of-post-operative-radiological-surveillance-following-resection-of-a-solitary-fibrous-tumor weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-who-received-pelvic-radiation-15-years-ago-and-now-has-a-5-cm-colon-adenocarcinoma-and-squamous-cell-carcinoma-of-the-anorectum weekly 0.8 https://www.themednet.org/what-is-your-approach-to-checking-igg-levels-post-vaccination-to-detect-common-variable-immunodeficiency-in-patients-with-systemic-lupus weekly 0.8 https://www.themednet.org/is-there-still-a-role-of-brachytherapy-in-uterine-cancer-if-intensity-modulated-radiation-therapy-is-available weekly 0.8 https://www.themednet.org/how-would-you-treat-an-essential-like-tremor-secondary-to-tumor-e-g-glioma weekly 0.8 https://www.themednet.org/in-which-situations-do-you-consider-post-mastectomy-radiation-therapy-when-the-patient-has-a-localized-node-positive-breast-cancer-with-a-complete-nodal-response-and-minimal-residual-disease-in-the-breast-post-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/are-apocrine-type-tnbc-breast-cancers-less-sensitive-to-radiation weekly 0.8 https://www.themednet.org/what-topical-therapies-do-you-most-commonly-prescribe-for-rashes-near-the-eyes weekly 0.8 https://www.themednet.org/how-do-you-approach-the-usage-of-hydroxychloroquine-in-patients-with-rheumatologic-conditions-and-baseline-cardiomyopathy-or-heart-failure weekly 0.8 https://www.themednet.org/is-there-a-role-for-rituximab-in-refractory-hit weekly 0.8 https://www.themednet.org/in-a-patient-on-asms-in-the-emu-thats-diagnosed-with-a-non-epileptic-event-i-e-functional-seizures-and-has-a-normal-eeg-how-do-you-approach-coming-off-meds weekly 0.8 https://www.themednet.org/when-do-you-check-neurofilament-light-chain-in-patients-with-neurodegenerative-illnesses weekly 0.8 https://www.themednet.org/would-you-change-ar-signaling-inhibitor-in-a-patient-with-high-volume-metastatic-castration-sensitive-prostate-cancer-who-started-darolutamide-with-initial-plan-for-docetaxel-but-in-whom-chemotherapy-was-eventually-deferred weekly 0.8 https://www.themednet.org/in-a-patient-with-aps-and-obesity-during-pregnancy-when-switched-to-lmwh-do-you-cap-the-dose-of-dalteparin-as-per-manufacturers-labeling-at-18-000u-per-day-or-do-you-use-weight-based-dosing weekly 0.8 https://www.themednet.org/do-you-ever-go-above-200-mg-daily-dose-of-carbidopa-and-if-yes-what-is-your-maximum-dose-daily-dose-of-carbidopa weekly 0.8 https://www.themednet.org/is-there-a-role-for-hydroxychloroquine-for-secondary-prevention-in-patients-with-aps-without-sle weekly 0.8 https://www.themednet.org/do-the-level-of-positive-lupus-anticoagulant-titers-correlate-with-the-risk-of-vte weekly 0.8 https://www.themednet.org/do-you-use-bladder-scans-to-assess-fill-prior-to-simulation-and-during-treatment-for-patients-receiving-prostate-radiation weekly 0.8 https://www.themednet.org/if-a-patient-with-msi-h-endometrial-cancer-slowly-progresses-on-single-agent-pembrolizumab-would-you-add-lenvatinib weekly 0.8 https://www.themednet.org/does-low-decipher-score-alter-your-duration-of-adt-for-a-high-risk-prostate-cancer-patient weekly 0.8 https://www.themednet.org/when-do-you-recommend-checking-blink-reflex-in-patients-with-bells-palsy weekly 0.8 https://www.themednet.org/do-you-always-excise-down-to-the-fascia-when-treating-invasive-melanomas-and-does-body-site-location-influence-the-depth-of-excision weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-brca1-mutation-with-stage-iva-high-grade-serous-ovarian-carcinoma-following-complete-cytoreduction-and-adjuvant-chemotherapy-currently-on-parp-inhibitor-maintenance-found-to-have-residual-suprafascial-disease-on-pathology- weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-offer-tamoxifen-or-ofs-ai-in-premenopausal-patients-with-metastatic-er-her2-breast-cancer-as-your-endocrine-therapy weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-would-you-use-for-metastasis-to-the-rectus-muscle-of-the-eye weekly 0.8 https://www.themednet.org/what-is-your-approach-for-induction-therapy-in-dual-positive-anti-gbm-pr3-disease-with-esrd-presenting-with-recurrent-dah-previously-treated-with-cyclophosphamide weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-discordant-breast-cancer-risk-prediction-scores-for-prevention weekly 0.8 https://www.themednet.org/would-you-consider-tpo-mimetics-for-chemotherapy-induced-thrombocytopenia-that-persists-despite-dose-reductions weekly 0.8 https://www.themednet.org/how-do-you-manage-an-inoperable-t1b1-n1-m0-cervix-adenocarcinoma-which-developed-6-years-after-treatment-of-a-rectal-adenocarcinoma-s-p-lar-with-adjuvant-posterior-pelvic-radiation-and-chemotherapy weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-offer-a-non-operable-patient-with-a-low-lying-t2n0-rectal-cancer-in-the-setting-of-prior-pelvic-radiation-10-years-ago weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-of-skin-limited-cryoglobulinemic-vasculitis-in-patients-with-sjogrens-syndrome-who-lack-evidence-of-neurological-or-renal-involvement weekly 0.8 https://www.themednet.org/for-patients-who-have-undergone-ablation-for-atrial-fibrillation-with-elevated-bleeding-risk-what-is-your-risk-benefit-approach-when-deciding-to-continue-oral-anticoagulation-long-term weekly 0.8 https://www.themednet.org/is-there-a-correlation-between-rectal-cancer-stage-and-dose-response-to-radiotherapy weekly 0.8 https://www.themednet.org/do-you-use-acetylcholinesterase-inhibitors-in-patients-with-cognitive-changes-in-the-setting-of-cerebral-amyloid-angiopathy weekly 0.8 https://www.themednet.org/would-you-give-transdermal-hormone-replacement-therapy-to-a-woman-with-remote-history-of-provoked-pulmonary-embolism weekly 0.8 https://www.themednet.org/do-you-recommend-patients-continue-folic-acid-for-a-few-weeks-after-methotrexate-discontinuation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-urate-lowering-therapy-in-patient-with-gout-who-is-on-azathioprine-for-example-for-transplant-where-allopurinol-and-febuxostat-are-both-contraindicated weekly 0.8 https://www.themednet.org/do-you-hold-osimertinib-when-delivering-partial-or-whole-brain-3d-radiation weekly 0.8 https://www.themednet.org/how-would-you-approach-radiation-therapy-for-indolent-t-cell-lymphoproliferative-disorder-of-the-gastrointestinal-tract weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-use-of-topical-nitroglycerin-for-raynauds weekly 0.8 https://www.themednet.org/do-you-feel-comfortable-using-ribociclib-in-a-patient-with-metastatic-er-her2-breast-cancer-who-has-borderline-systolic-heart-failure-from-previous-her2-based-treatment weekly 0.8 https://www.themednet.org/what-scenario-would-prophylactic-tocilizumab-be-considered-to-prevent-ipilimumab-nivolumab-immunotherapy-induced-toxicity-in-malignant-melanoma weekly 0.8 https://www.themednet.org/what-scenario-would-flipped-dosing-versus-standard-dosing-of-ipilimumab-nivolumab-be-beneficial-in-metastatic-melanoma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-positive-anti-ccp-negative-rf-and-tobacco-use-but-no-current-signs-of-active-rheumatoid-arthritis weekly 0.8 https://www.themednet.org/are-there-concerns-with-using-sulfasalazine-in-sle weekly 0.8 https://www.themednet.org/do-you-have-recommendations-after-prostate-rt-for-patients-who-want-to-conceive weekly 0.8 https://www.themednet.org/does-the-presence-of-perineural-invasion-in-early-stage-breast-cancer-post-lumpectomy-affect-the-decision-regarding-partial-breast-vs-whole-breast-radiation weekly 0.8 https://www.themednet.org/how-do-you-define-severe-hypoxic-burden-on-home-sleep-testing weekly 0.8 https://www.themednet.org/would-you-offer-a-2nd-generation-anti-ar-or-abiraterone-after-progression-on-adt-in-patients-with-metastatic-ar-her2-expressing-salivary-gland-carcinoma weekly 0.8 https://www.themednet.org/would-you-consider-a-somatostatin-analog-for-a-patient-with-carcinoid-involving-ileum-and-appendix-with-positive-mesenteric-margin-after-right-hemicolectomy-and-liver-metastases-that-have-been-resected weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-chronic-low-adamts13-activity-and-low-level-of-inhibitor-without-signs-of-thrombocytopenia-or-hemolysis weekly 0.8 https://www.themednet.org/do-you-ever-taper-or-stop-urate-lowering-therapy-in-patients-who-have-had-no-gout-flares-and-serum-urate-persistently-below-6-mg-dl weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-septated-parapneumonic-pleural-effusions-that-do-not-satisfy-traditional-criteria-for-complicated-effusion-after-diagnostic-thoracentesis weekly 0.8 https://www.themednet.org/how-do-you-manage-anticoagulation-bridging-for-outpatient-eskd-patients-given-concerns-for-bleeding-risk-with-enoxaparin-in-this-population weekly 0.8 https://www.themednet.org/do-you-treat-the-optional-radcomp-posterior-lymph-node-field-for-patients-with-breast-cancer weekly 0.8 https://www.themednet.org/in-patients-with-vod-post-hsct-what-would-be-the-role-of-tpo-agonists-instead-of-platelet-transfusions-given-their-platelet-refractoriness-and-concerns-for-fluid-overload weekly 0.8 https://www.themednet.org/can-trastuzumab-deruxtecan-be-continued-during-radiation weekly 0.8 https://www.themednet.org/how-do-you-target-therapy-before-the-eeg-is-connected-in-a-patient-who-comes-to-the-ed-in-super-refractory-generalized-convulsive-status-epilepticus-once-the-convulsions-resolve weekly 0.8 https://www.themednet.org/what-would-be-the-utility-of-calcium-scoring-for-the-evaluation-of-low-flow-low-gradient-aortic-stenosis-and-what-cut-off-values-typically-fall-within-the-severe-range weekly 0.8 https://www.themednet.org/what-structural-features-preclude-a-transcatheter-edge-to-edge-repair-in-a-patient-with-severe-symptomatic-tricuspid-regurgitation weekly 0.8 https://www.themednet.org/how-would-you-approach-grade-2-neurologic-toxicity-in-a-patient-on-daratumumab-dexamethasone-and-lenalidomide-for-relapsed-multiple-myeloma weekly 0.8 https://www.themednet.org/how-would-you-treat-esrd-patients-on-hd-with-locoregional-squamous-cell-carcinoma-of-the-anus weekly 0.8 https://www.themednet.org/would-you-offer-partial-breast-irradiation-for-women-with-g2-4cm-dcis-with-close-margins-of-1mm-but-a-very-large-breast-size weekly 0.8 https://www.themednet.org/in-which-situations-do-you-offer-ovarian-suppression-with-chemotherapy-to-prevent-the-development-of-premature-menopause-in-premenopausal-women-with-er-negative-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-utilize-prame-for-melanocytic-biopsies weekly 0.8 https://www.themednet.org/when-do-you-prescribe-topical-jak-inhibitors-for-adult-patients-with-atopic-dermatitis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-therapy-for-an-r0-alk-resected-lung-adenocarcinoma-with-n2-disease weekly 0.8 https://www.themednet.org/do-you-recommend-chlorhexidine-mouth-rinse-for-prophylaxis-against-oral-complications-in-patients-undergoing-dental-work-who-are-immunosuppressed weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-aad-2023 weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-cp-cml-who-has-a-history-of-inadequate-response-and-severe-myelotoxicity-to-multiple-tkis-such-as-imatinib-nilotinib-and-dasatinib weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-a-patient-with-recurrent-choroid-plexus-papilloma-with-intraventricular-dissemination weekly 0.8 https://www.themednet.org/what-is-the-most-convenient-and-reproducible-setup-for-simulation-and-treatment-of-the-contralateral-testis-in-a-primary-testicular-lymphoma weekly 0.8 https://www.themednet.org/are-there-any-concerns-regarding-side-effects-in-changing-from-denosumab-to-zolendronic-acid-or-vice-versa weekly 0.8 https://www.themednet.org/how-do-you-differentiate-the-normal-feeding-vessel-to-the-lunate-from-an-erosion-or-power-doppler-signal-on-ultrasound weekly 0.8 https://www.themednet.org/what-changes-in-av-access-flows-measured-during-hemodialysis-would-prompt-you-to-refer-for-an-angiogram weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-a-patient-with-a-single-lymph-node-positive-in-the-peri-prostatic-fat-without-pelvic-lymph-node-dissection weekly 0.8 https://www.themednet.org/how-would-you-manage-pleomorphic-adenoma-of-minor-salivary-glands-involving-hypopharynx-larynx-with-positive-surgical-margin weekly 0.8 https://www.themednet.org/how-do-you-interpret-discrepancies-between-mmr-testing-and-msi-testing weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-use-to-treat-an-oligometastatic-ap-window-lymph-node weekly 0.8 https://www.themednet.org/how-long-would-you-wait-to-start-another-biologic-agent-after-rituximab-administration-in-patients-with-dermatomyositis-and-refractory-inflammatory-arthritis-intolerant-to-traditional-dmards weekly 0.8 https://www.themednet.org/how-do-you-treat-congenital-paramyotonia-symptoms weekly 0.8 https://www.themednet.org/how-do-you-approach-further-treatment-in-patients-with-anti-hmg-coa-myopathy-who-have-residual-disease-activity-ongoing-weakness-elevated-ck-after-1-year-of-combination-therapy-e-g-ivig-and-methotrexate weekly 0.8 https://www.themednet.org/do-you-routinely-incorporate-g-csf-with-chemo-if-you-experience-neutropenia-after-the-first-cycle-of-chemotherapy weekly 0.8 https://www.themednet.org/what-dose-and-duration-of-steroid-therapy-do-you-use-in-steroid-responsive-ild weekly 0.8 https://www.themednet.org/when-should-i-consider-anticoagulation-in-an-unprovoked-upper-extremity-deep-venous-thrombosis weekly 0.8 https://www.themednet.org/when-should-i-consider-anticoagulation-in-an-unprovoked-upper-extremity-superficial-venous-thrombosis weekly 0.8 https://www.themednet.org/how-would-you-approach-a-non-healing-wound-following-lumpectomy-for-recurrent-disease-in-a-patient-who-underwent-breast-conservation-therapy-with-radiation-10-years-prior weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-colon-cancer-that-is-dmmr-msi-high-with-a-solitary-liver-lesion-that-is-deemed-resectable weekly 0.8 https://www.themednet.org/do-you-consider-resuming-venetoclax-for-patients-with-cll-upon-progression-recurrence-in-whom-venetoclax-rituximab-achieved-cr-and-venetoclax-was-previously-well-tolerated-but-stopped-after-completing-2-years-of-therapy weekly 0.8 https://www.themednet.org/what-is-your-adjuvant-treatment-approach-to-patients-with-stage-ic1-clear-cell-carcinoma-of-the-ovary-intraoperative-rupture weekly 0.8 https://www.themednet.org/what-is-your-approach-to-discordant-dsdna-testing-such-as-positivity-to-dsdna-by-crithidia-but-negativity-to-dsdna-by-other-modalities weekly 0.8 https://www.themednet.org/would-you-favor-starting-with-pembrolizumab-or-chemotherapy-for-a-metastatic-msi-high-pancreatic-ductal-adenocarcinoma weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-plasmablastic-lymphoma-of-the-nasal-cavity-s-p-excisional-biopsy-to-positive-margins-who-is-not-a-candidate-for-systemic-therapy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-provoked-blood-clot-for-a-patient-who-had-been-placed-on-low-dose-doac-for-history-of-unprovoked-blood-clot weekly 0.8 https://www.themednet.org/do-you-routinely-prescribe-ppi-prophylaxis-for-myeloma-patients-who-will-be-on-low-dose-aspirin-and-weekly-dexamethasone weekly 0.8 https://www.themednet.org/how-would-you-approach-a-pre-viable-pregnant-patient-in-the-second-trimester-with-metastatic-ovarian-cancer-who-wants-to-keep-the-pregnancy weekly 0.8 https://www.themednet.org/at-what-point-if-at-all-do-you-decrease-the-frequency-of-or-discontinue-pegloticase-infusions-after-achieving-persistently-low-serum-urate-levels weekly 0.8 https://www.themednet.org/do-you-routinely-do-restaging-imaging-before-surgery-for-a-patient-who-completed-neoadjuvant-treatment-for-mibc weekly 0.8 https://www.themednet.org/is-close-observation-a-reasonable-option-for-elderly-patients-with-a-small-basal-cell-carcinoma-of-the-face weekly 0.8 https://www.themednet.org/what-is-your-approach-towards-continuing-cancer-screening-in-a-young-adult-with-tif-1-dermatomyositis-and-negative-initial-ct-chest-abd-pelvis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-abbreviated-dapt-in-post-pci-patients-acs-and-non-acs-with-high-bleeding-risk weekly 0.8 https://www.themednet.org/when-do-you-recommend-lumbar-puncture-in-patients-with-concern-for-memory-loss weekly 0.8 https://www.themednet.org/how-frequently-do-you-check-lab-work-in-patients-with-stable-myasthenia-gravis weekly 0.8 https://www.themednet.org/how-would-you-treat-a-woman-with-iron-deficiency-anemia-unresponsive-to-iron-sulfate-and-with-allergic-reaction-to-iron-sucrose weekly 0.8 https://www.themednet.org/when-is-a-kidney-biopsy-warranted-in-a-patient-with-possible-scleroderma-renal-crisis weekly 0.8 https://www.themednet.org/what-oral-therapies-do-you-most-commonly-recommend-for-skin-cancer-prevention weekly 0.8 https://www.themednet.org/under-which-clinical-scenarios-do-you-consider-an-inpatient-emg weekly 0.8 https://www.themednet.org/would-you-offer-gemcitabine-cisplatin-or-other-platinum-based-regimens-for-metastatic-pancreatic-cancer-harboring-somatic-atm-mutations weekly 0.8 https://www.themednet.org/what-is-your-approach-to-peep-titration-in-the-management-of-a-morbidly-obese-patient-with-ards weekly 0.8 https://www.themednet.org/what-systemic-therapy-do-you-recommend-for-prostate-cancer-pelvic-nodal-recurrence-on-psma-pet-ct-after-prostatectomy-and-salvage-radiation weekly 0.8 https://www.themednet.org/do-patients-on-eculizumab-or-ravulizumab-require-repeat-vaccination-against-meningococcal-infection-after-a-certain-interval weekly 0.8 https://www.themednet.org/how-would-you-approach-a-2-cm-malignant-primary-cutaneous-adnexal-adenocarcinoma-of-the-axilla-s-p-resection-with-positive-margin-who-is-unable-to-undergo-additional-surgery weekly 0.8 https://www.themednet.org/what-is-your-local-control-approach-to-localized-relapse-of-ewing-sarcoma-in-a-site-that-was-previously-unresectable-and-received-definitive-radiation weekly 0.8 https://www.themednet.org/do-you-include-a-dural-ctv-margin-for-intact-brain-metastases-touching-the-dura-when-treating-with-srs-or-fsrt weekly 0.8 https://www.themednet.org/what-is-a-reasonable-approach-to-monitoring-mechanical-valve-function-if-systemic-anticoagulation-needs-to-be-held-in-the-setting-of-an-acute-intracranial-hemorrhage weekly 0.8 https://www.themednet.org/what-guidance-do-you-provide-for-anesthesia-in-patients-with-incidentally-found-carotid-web weekly 0.8 https://www.themednet.org/do-you-use-a-liver-dose-constraint-for-right-sided-breast-cancer weekly 0.8 https://www.themednet.org/what-additional-testing-besides-lac-apls-factor-v-leiden-prothrombin-gene-mutation-jak-2-do-you-draw-for-unprovoked-cerebral-venous-sinus-thrombosis weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-capecitabine-to-a-patient-with-resected-intrahepatic-cholangiocarcinoma-after-being-treated-with-neoadjuvant-gap-chemotherapy weekly 0.8 https://www.themednet.org/would-you-consider-chemoimmunotherapy-in-a-patient-with-hormone-positive-breast-cancer-treated-with-chemotherapy-who-has-progressed-to-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/would-you-use-a-matched-sibling-donor-with-a-germline-heterozygous-brca1-mutation-for-stem-cell-transplant weekly 0.8 https://www.themednet.org/what-constraints-do-you-use-for-sbrt-near-the-renal-vessels weekly 0.8 https://www.themednet.org/what-is-your-pth-threshold-for-referring-an-eskd-patient-with-secondary-hyperparathyroidism-on-maximum-medical-therapy-for-parathyroidectomy weekly 0.8 https://www.themednet.org/do-you-routinely-continue-using-tpa-dornase-for-treatment-of-empyema-if-there-is-accumulation-of-new-sero-sanguinous-output-from-the-chest-tube-after-the-initial-treatment weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-patients-with-mda5-positive-amyopathic-dermatomyositis-who-also-have-anti-ccp-positive-rheumatoid-arthritis-but-no-clinical-lung-involvement weekly 0.8 https://www.themednet.org/what-is-your-surveillance-protocol-for-patients-with-common-variable-immunodeficiency-receiving-chronic-ivig-therapy weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-give-to-a-patient-with-resected-pt4bn2m0-msi-h-colon-cancer-and-post-op-markedly-elevated-cea-but-no-metastatic-disease-seen-on-imaging weekly 0.8 https://www.themednet.org/what-is-the-preferred-initial-therapy-for-t-cell-lymphoblastic-lymphoma-in-non-aya-non-elderly-adults weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-offer-partial-breast-radiation-to-t2-tumors-that-are-2-3cm-in-size weekly 0.8 https://www.themednet.org/do-you-use-tolvaptan-for-management-of-hyponatremia-related-to-heart-failure-given-the-side-effect-profile-and-lack-of-mortality-benefit-seen-in-a-previous-trial weekly 0.8 https://www.themednet.org/would-you-be-comfortable-using-a-jak-inhibitor-in-a-patient-with-baseline-thrombocytosis weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-a-prior-history-of-an-er-pr-breast-cancer-s-p-mastectomy-who-develops-nodal-recurrence-2-years-after-surgery weekly 0.8 https://www.themednet.org/what-is-your-adjuvant-radiation-approach-for-a-patient-that-declines-chemotherapy-for-an-occult-primary-tnbc-after-alnd-only-with-1-2-non-bulky-nodes-positive-no-ene weekly 0.8 https://www.themednet.org/how-do-you-manage-pityriasis-lichenoides-chronica-plc weekly 0.8 https://www.themednet.org/do-you-routinely-monitor-imaging-or-pulmonary-function-in-patients-with-pulmonary-tb-after-the-completion-of-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-low-risk-patient-60-yo-with-platelets-600-k-jak2-positivity-and-heterozygosity-for-factor-5-leiden-mutation-with-no-previous-thrombosis weekly 0.8 https://www.themednet.org/when-would-you-offer-extra-fascial-hysterectomy-to-patients-with-low-risk-early-stage-cervical-cancer-in-light-of-data-from-the-concerv-trial weekly 0.8 https://www.themednet.org/do-you-proceed-with-outpatient-hemodialysis-for-an-asymptomatic-eskd-patient-who-has-missed-the-last-three-hemodialysis-sessions weekly 0.8 https://www.themednet.org/how-do-you-discuss-use-of-tamoxifen-in-your-stage-i-breast-cancer-patients-who-are-80-years-old-weighing-in-risk-of-vte-with-benefit-from-adjuvant-treatment weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-in-metastatic-breast-cancer-with-osseous-metastases-resulting-in-significant-cytopenias weekly 0.8 https://www.themednet.org/how-do-you-treat-cidp-patients-unresponsive-to-ivig-and-steroids weekly 0.8 https://www.themednet.org/what-do-you-use-to-treat-a-kidney-transplant-patient-with-progressive-bk-nephropathy-despite-a-maximal-decrease-in-immunosuppression-for-months weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-osteoporosis-on-denosumab-who-develops-significant-renal-insufficiency-where-it-is-difficult-to-continue-denosumab-due-to-increased-risk-of-hypocalcemia-i-e-egfr-in-the-low-20s weekly 0.8 https://www.themednet.org/do-you-prefer-cisplatin-or-carboplatin-in-combination-with-nivolumab-per-checkmate-816-for-patients-with-resectable-nsclc weekly 0.8 https://www.themednet.org/what-alternative-regimens-would-you-consider-to-neoadjuvant-tchp-in-setting-of-national-carboplatin-shortage-for-locally-advanced-her2-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-assessing-whether-oral-nasal-ulcerations-are-features-of-systemic-lupus-erythematosus-versus-from-another-etiology weekly 0.8 https://www.themednet.org/do-you-give-a-short-acting-antihypertensive-before-starting-outpatient-hemodialysis-on-an-asymptomatic-eskd-patient-with-a-predialysis-blood-pressure-of-more-than-200-100 weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-a-low-grade-follicular-lymphoma-and-gleason-6-adenocarcinoma-of-the-prostate weekly 0.8 https://www.themednet.org/in-which-patients-with-chronic-kidney-disease-and-low-25-oh-vitamin-d-levels-do-you-prefer-weekly-ergocalciferol-to-daily-cholecalciferol-supplementation weekly 0.8 https://www.themednet.org/does-the-presence-of-ductal-adenocarcinoma-change-how-you-risk-stratify-or-treat-patients-with-localized-prostate-cancer weekly 0.8 https://www.themednet.org/when-offering-apbi-if-a-patient-has-invasive-ductal-carcinoma-and-dcis-do-they-need-to-fill-suitability-criteria-for-both-or-does-the-dcis-criteria-only-apply-to-pure-dcis weekly 0.8 https://www.themednet.org/would-you-consider-tki-discontinuation-in-a-patient-who-has-negative-bcr-transcripts-on-bosutinib weekly 0.8 https://www.themednet.org/when-you-send-for-molecular-studies-for-polycythemia-vera-what-are-the-mutations-that-predict-increased-cardiovascular-risk weekly 0.8 https://www.themednet.org/what-chemotherapy-regimen-would-you-offer-a-stage-iii-pmmr-rectal-adenocarcinoma-agreeable-to-tnt-but-with-significant-underlying-neuropathy weekly 0.8 https://www.themednet.org/are-you-treating-with-the-superoxide-dismutase-mimetic-avasopasem-gc4419-for-patients-receiving-chemoradiation-for-head-neck-cancers weekly 0.8 https://www.themednet.org/do-you-continue-adt-lupron-in-all-patients-with-castrate-resistance-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-have-a-preference-between-using-2-dose-levels-5940-6996-versus-3-dose-levels-5700-6300-6996-for-npc-ebv-and-why weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-recommend-for-a-patient-with-a-sarcomatoid-carcinoma-of-the-submandibular-gland-after-r1-resection weekly 0.8 https://www.themednet.org/if-the-patient-has-had-prior-partial-nephrectomy-for-rcc-would-you-consider-sbrt-for-a-contralateral-rcc weekly 0.8 https://www.themednet.org/when-do-you-consider-performing-a-diagnostic-laparoscopy-before-neoadjuvant-chemotherapy-in-pancreatic-adenocarcinoma-patients weekly 0.8 https://www.themednet.org/is-there-a-role-for-radiotherapy-to-the-primary-in-high-volume-metastatic-prostate-cancer-with-well-controlled-disease-on-adt weekly 0.8 https://www.themednet.org/what-is-the-diagnostic-yield-of-working-up-suspected-autoimmune-encephalitis-in-patients-with-new-onset-behavioral-disturbance-without-overt-neurological-deficits weekly 0.8 https://www.themednet.org/for-a-patient-with-adenosarcoma-of-the-ovary-with-high-grade-sarcomatous-overgrowth-removed-intact-with-appropriate-oncologic-surgery-is-there-any-role-for-radiation weekly 0.8 https://www.themednet.org/what-is-the-best-approach-to-manage-iron-overload-secondary-to-both-heterozygous-hfe-gene-mutation-and-two-heterozygous-aceruloplasminemia-gene-mutations weekly 0.8 https://www.themednet.org/in-light-of-the-fda-approval-of-tofersen-for-sod1-related-als-what-is-your-approach-to-counseling-people-who-are-presymptomatic-genetic-carriers-of-one-of-the-monogenic-als-genes weekly 0.8 https://www.themednet.org/what-are-your-diagnostic-and-management-approaches-beyond-statin-therapy-for-hyperlipidemia-in-young-adults-with-significantly-elevated-ldl-levels-in-isolation-i-e-reasonable-calcium-score-normal-lipoprotein-a-levels weekly 0.8 https://www.themednet.org/do-you-find-consumer-grade-wrist-actigraphy-useful-in-measuring-sleep-quality-and-duration weekly 0.8 https://www.themednet.org/in-what-clinical-circumstances-do-you-use-repository-corticotropin-injections-in-the-management-of-a-glomerulonephritis weekly 0.8 https://www.themednet.org/how-do-you-re-stratify-patients-with-a-primary-prevention-icd-in-need-of-a-generator-change-if-their-lvef-has-improved-to-40-and-they-have-not-previously-required-any-device-therapies weekly 0.8 https://www.themednet.org/would-you-recommend-temporary-evd-or-more-permanently-vps-to-lower-icp weekly 0.8 https://www.themednet.org/in-the-setting-of-secondary-hlh-associated-with-initial-diagnosis-of-lymphoma-would-you-adjust-steroid-dose-and-type-to-account-for-differences-in-hlh-and-lymphoma-treatment-protocols weekly 0.8 https://www.themednet.org/for-a-glioblastoma-patient-who-had-an-mri-immediately-postoperatively-and-you-are-able-to-repeat-one-closer-to-the-time-of-ct-simulation-do-you-use-the-more-recent-scan-or-the-immediate-postoperative-scan-for-contouring-t2-flair-and-t1-post weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-use-of-intravenous-sodium-thiosulfate-for-the-management-of-calciphylaxis-in-a-patient-with-end-stage-kidney-disease-and-on-hemodialysis weekly 0.8 https://www.themednet.org/which-factors-favor-extended-dual-antiplatelet-therapy-beyond-one-year-in-acs-patients-with-low-bleeding-risk weekly 0.8 https://www.themednet.org/how-do-you-treat-sarcoidosis-associated-hypercalcemia-in-a-patient-with-adenopathy-and-no-other-signs-of-systemic-involvement weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-a-young-adult-with-severe-aplastic-anemia-unresponsive-to-steroids-and-tpo-mimetics weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-early-stage-resected-melanoma-stage-iia-for-adjuvant-treatment weekly 0.8 https://www.themednet.org/how-would-you-treat-the-primary-site-of-an-adenoid-cystic-carcinoma-of-the-floor-of-mouth-s-p-resection-with-positive-margins-with-oligometastatic-disease weekly 0.8 https://www.themednet.org/is-there-a-role-for-using-an-external-ventricular-drain-evd-trial-in-the-workup-of-normal-pressure-hydrocephalus weekly 0.8 https://www.themednet.org/how-do-you-approach-dosing-of-anakinra-in-mas weekly 0.8 https://www.themednet.org/in-which-scenarios-would-you-consider-a-planned-neck-dissection-following-definitive-radiation-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-interictal-discharge-burden-in-patients-with-generalized-epilepsy-syndromes-i-e-genetic weekly 0.8 https://www.themednet.org/what-is-your-preferred-strategy-for-controlling-bleeding-after-transbronchial-or-endobronchial-biopsies weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-elderly-patients-with-cardiopulmonary-comorbidities-and-severe-pulmonary-hypertension weekly 0.8 https://www.themednet.org/what-is-your-approach-to-systemic-treatment-of-de-novo-metastatic-hormone-sensitive-prostate-ductal-adenocarcinoma-with-lung-only-metastases weekly 0.8 https://www.themednet.org/would-you-ever-consider-managing-hr-dcis-non-surgically weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-regimen-would-you-use-for-a-patient-with-dcis-with-multiple-close-margins-unable-to-undergo-re-excision-who-has-a-history-of-photosensitivity-polymorphous-light-eruption weekly 0.8 https://www.themednet.org/can-car-t-cell-therapy-be-considered-for-heart-transplant-recipients-with-concurrent-lymphoproliferative-disorders weekly 0.8 https://www.themednet.org/are-there-any-accruing-trials-in-the-u-s-evaluating-selective-use-of-radiation-after-mastectomy-in-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/is-a-bone-marrow-biopsy-necessary-in-a-patient-with-a-previous-tissue-diagnosis-of-plasmacytoma-or-smoldering-multiple-myeloma-who-now-meets-criteria-for-active-myeloma weekly 0.8 https://www.themednet.org/do-patients-with-nph-communicating-hydrocephalus-always-require-vps weekly 0.8 https://www.themednet.org/would-you-include-her2-directed-therapy-in-the-treatment-of-her2-small-bowel-adenocarcinoma weekly 0.8 https://www.themednet.org/do-you-stop-tolvaptan-below-a-certain-egfr-in-a-patient-with-autosomal-dominant-polycystic-kidney-disease weekly 0.8 https://www.themednet.org/how-would-you-approach-evaluation-of-a-patient-with-persistent-elevated-ace-angiotensin-converting-enzyme-level-without-evidence-of-cutaneous-ocular-or-pulmonary-granulomatous-disease weekly 0.8 https://www.themednet.org/would-you-use-adjuvant-pembrolizumab-for-bilateral-ccrcc-with-r1-resection weekly 0.8 https://www.themednet.org/what-intracavitary-brachytherapy-dose-and-fractionation-would-you-recommend-for-stage-i-vaginal-cancer-post-resection-with-positive-r1-margins weekly 0.8 https://www.themednet.org/is-it-possible-to-develop-worsening-motor-features-of-parkinsons-disease-pd-when-using-clozapine-for-treatment-of-pd-psychosis-above-a-certain-dose weekly 0.8 https://www.themednet.org/do-you-recommend-switching-to-a-non-dihydropyridine-calcium-channel-blocker-with-the-goal-of-decreasing-proteinuria-in-a-proteinuric-hypertensive-ckd-patient-already-on-a-dihydropyridine-calcium-channel-blocker weekly 0.8 https://www.themednet.org/what-exfoliative-regimen-do-you-recommend-for-patients-with-recurrent-plantar-keratoderma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-in-hormone-receptor-positive-her2-negative-0-ihc-metastatic-breast-cancer-with-erbb2-gene-amplification-after-progression-on-ai-and-fulvestrant-cdk4-6i-with-visceral-crisis weekly 0.8 https://www.themednet.org/what-would-be-your-index-of-suspicion-for-al-amyloidosis-with-cardiac-involvement-in-a-patient-with-mgus-to-prompt-further-imaging-and-which-modality-would-be-preferred weekly 0.8 https://www.themednet.org/per-the-latest-asco-and-esmo-guidelines-which-stage-ii-npc-patients-would-you-omit-concurrent-cisplatin weekly 0.8 https://www.themednet.org/how-soon-after-an-end-stage-kidney-disease-patient-receives-a-mri-study-with-gadolinium-contrast-do-you-perform-their-next-hemodialysis-session weekly 0.8 https://www.themednet.org/what-is-your-blood-pressure-goal-for-a-pregnant-patient-on-hemodialysis weekly 0.8 https://www.themednet.org/in-what-situations-if-any-would-you-recommend-adjuvant-concurrent-chemoradiation-rather-than-rt-alone weekly 0.8 https://www.themednet.org/when-using-sbrt-to-treat-unresectable-pancreatic-cancer-after-induction-chemotherapy-do-you-treat-elective-lymph-nodes weekly 0.8 https://www.themednet.org/should-patients-with-co-existing-moderate-severe-valvular-disease-particularly-as-and-ms-and-malignancy-requiring-radiation-therapy-undergo-more-frequent-surveillance-surface-echocardiograms weekly 0.8 https://www.themednet.org/how-does-rtog-0815-change-your-recommendation-for-st-adt-for-men-getting-xrt-for-favorable-intermediate-risk-prostate-ca weekly 0.8 https://www.themednet.org/should-we-repeat-a-dose-escalation-trial-for-stage-iii-nsclc-in-the-era-of-modern-radiotherapy-techniques-and-dose-constraints weekly 0.8 https://www.themednet.org/how-long-would-you-continue-prednisone-in-an-eskd-patient-with-a-failed-kidney-transplant-who-develops-mild-graft-pain-when-steroids-are-tapered weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-abemciclib-to-er-positive-her2-negative-with-1-ln-positive-ki-67-20-and-low-oncotype weekly 0.8 https://www.themednet.org/how-would-you-treat-a-metastatic-pure-urethral-adenocarinoma weekly 0.8 https://www.themednet.org/do-you-recommend-performing-cognitive-testing-in-the-clinic-to-determine-the-blood-pressure-target-in-patients-80-years-or-older weekly 0.8 https://www.themednet.org/do-you-check-asparaginase-levels-for-all-patients-receiving-receiving-e-coli-derived-products-or-only-in-certain-clinical-situations weekly 0.8 https://www.themednet.org/what-is-your-preferred-radiation-technique-for-treatment-of-skin-cancer-of-the-eyelid weekly 0.8 https://www.themednet.org/what-radiation-would-you-offer-for-isolated-nodal-recurrence-in-a-patient-who-received-apbi-for-breast-cancer-about-2-years-ago-after-alnd weekly 0.8 https://www.themednet.org/in-what-clinical-scenarios-do-you-utilize-post-cardiac-arrest-targeted-temperature-management-ttm weekly 0.8 https://www.themednet.org/for-patients-maintained-on-antiplatelet-monotherapy-post-dapt-following-pci-what-is-your-recommendation-for-holding-antiplatelet-therapy-prior-to-non-cardiac-surgery weekly 0.8 https://www.themednet.org/would-you-add-an-sglt2-inhibitor-to-augment-diuresis-during-a-hospitalization-in-a-patient-with-nephrotic-syndrome-an-egfr-above-30-ml-min-1-73m2-and-refractory-hypervolemia-on-an-intravenous-loop-diuretic weekly 0.8 https://www.themednet.org/how-would-you-adjust-your-ctv-for-a-locally-advanced-rectal-cancer-case-with-invasion-of-the-prostate weekly 0.8 https://www.themednet.org/given-the-platinum-drug-shortage-and-the-recently-presented-now-trial-would-you-consider-parp-inhibitor-use-in-place-of-platinum-based-chemotherapy-for-advanced-ovarian-cancer weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-regarding-alcohol-intake-when-prescribing-dmards-other-than-methotrexate weekly 0.8 https://www.themednet.org/are-there-cases-that-should-be-referred-to-a-center-with-a-mr-linac-for-rt weekly 0.8 https://www.themednet.org/how-would-you-treat-inflammatory-arthritis-in-a-patient-with-sjogrens-syndrome-and-ild-on-mycophenolate-that-is-not-responsive-to-hydroxychloroquine weekly 0.8 https://www.themednet.org/how-do-you-approach-the-diagnosis-of-erythronychia weekly 0.8 https://www.themednet.org/how-do-you-approach-longitudinal-melanonychia-of-one-fingernail-in-a-pediatric-patient weekly 0.8 https://www.themednet.org/what-is-your-approach-to-elevated-ck-in-patients-without-clinical-or-serologic-evidence-of-immune-mediated-myopathy weekly 0.8 https://www.themednet.org/how-do-you-handle-the-obturator-prosthesis-during-radiation-delivery-for-scc-of-hard-palate weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-approach-to-patients-with-stage-iv-non-squamous-nsclc-with-good-performance-status-no-driver-mutations-pd-l1-low-positive-and-ckd-iiib-or-worse-crcl-45-ml-min weekly 0.8 https://www.themednet.org/how-would-you-manage-a-grade-ii-idh-mutant-astrocytoma-with-otherwise-low-risk-features-but-gemistocytic-histology weekly 0.8 https://www.themednet.org/in-a-fit-young-patient-how-do-you-manage-endometrial-cancer-with-inguinal-node-involvement-that-has-had-favorable-response-after-upfront-systemic-therapy weekly 0.8 https://www.themednet.org/should-car-t-therapy-be-considered-for-a-kidney-transplant-patient-with-refractory-ptld weekly 0.8 https://www.themednet.org/would-you-offer-any-additional-adjuvant-therapy-after-platinum-based-chemotherapy-for-patients-with-resected-pd-l1-positive-stage-ii-iii-lung-adenocarcinoma-with-egfr-exon-20-insertions weekly 0.8 https://www.themednet.org/do-you-recommend-continued-pcr-testing-in-a-cml-patient-who-underwent-allogeneic-stem-cell-transplantation-with-an-identical-match-about-20-years-ago weekly 0.8 https://www.themednet.org/are-there-contraindications-to-growth-hormone-therapy-in-patients-who-have-completed-treatment-for-pediatric-cancer weekly 0.8 https://www.themednet.org/how-does-residual-dcis-after-neoadjuvant-chemotherapy-impact-prognosis-if-there-is-a-cr-of-the-invasive-disease weekly 0.8 https://www.themednet.org/what-considerations-do-you-make-to-the-dialysis-prescription-for-a-pregnant-patient-on-peritoneal-dialysis weekly 0.8 https://www.themednet.org/below-what-egfr-would-you-consider-discontinuing-lithium-in-a-bipolar-disorder-patient-with-chronic-kidney-disease weekly 0.8 https://www.themednet.org/have-you-used-jak-inhibitors-with-tnf-blockade-at-the-same-time weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-patients-with-active-ra-and-recurrent-non-severe-c-diff weekly 0.8 https://www.themednet.org/is-the-efficacy-and-dose-same-for-subcutaneous-vs-intravenous-ivigs-being-used-for-dermatomyositis weekly 0.8 https://www.themednet.org/do-you-recommend-checking-urine-sodium-2-hours-after-loop-diuretic-administration-to-determine-the-need-for-dose-adjustment-in-a-patient-with-acute-decompensated-heart-failure weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-patient-who-is-status-post-resection-of-a-who-grade-1-planum-sphenoidale-meningioma-which-was-adherent-to-the-optic-nerve weekly 0.8 https://www.themednet.org/for-patients-presenting-with-spontaneous-coronary-artery-dissection-what-other-non-cardiac-vascular-work-up-can-be-considered-to-further-risk-stratify-them-as-a-predictor-for-any-future-cardiovascular-events weekly 0.8 https://www.themednet.org/would-you-consider-adding-abiraterone-in-addition-to-adt-for-patients-with-less-than-very-high-risk-localized-prostate-cancer-but-high-clinical-genomic-metastasis-risk-after-ebrt weekly 0.8 https://www.themednet.org/what-are-the-main-reasons-that-exercise-trials-have-collectively-failed-to-demonstrate-sufficient-evidence-for-disease-modification-in-parkinsons-disease weekly 0.8 https://www.themednet.org/how-do-you-evaluate-patients-with-suspected-pseudo-dementia weekly 0.8 https://www.themednet.org/do-you-typically-recommend-anti-epileptic-medication-in-patients-with-acute-multi-compartmental-intracranial-hemorrhage weekly 0.8 https://www.themednet.org/what-chemotherapy-regimen-would-you-use-for-a-woman-with-pre-existing-neuropathy-causing-imbalance-who-now-has-a-t1n0-er-and-her2-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-assess-the-use-of-heimlich-valves-for-patients-who-present-with-persistent-air-leaks weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-a-locally-recurrent-myxofibrosarcoma-fnclcc-grade-2-that-has-recurred-after-multiple-resections-and-radiotherapy weekly 0.8 https://www.themednet.org/what-is-the-appropriate-amount-of-time-to-allow-for-wound-healing-prior-to-post-operative-radiation-for-metastatic-disease weekly 0.8 https://www.themednet.org/do-you-recommend-stopping-vitamin-d-supplementation-in-a-patient-with-hypercalcemia-and-a-low-25-oh-d-level weekly 0.8 https://www.themednet.org/what-adjuvant-treatment-approach-would-you-choose-for-a-premenopausal-woman-with-lymph-node-positive-poorly-differentiated-metaplastic-breast-cancer-that-is-er-low-pr-her2-negative weekly 0.8 https://www.themednet.org/has-your-preferred-adjuvant-treatment-for-ic-mucinous-ovarian-cancer-changed-in-response-to-the-platinum-chemotherapy-shortage weekly 0.8 https://www.themednet.org/are-there-any-particular-considerations-to-take-when-external-beam-radiation-is-recommended-in-a-patient-who-has-received-rai-before weekly 0.8 https://www.themednet.org/when-can-you-utilize-external-ventricular-drains-evds-in-the-management-of-posterior-fossa-strokes weekly 0.8 https://www.themednet.org/what-is-your-approach-to-pharmacologic-treatment-options-in-a-patient-with-both-sle-and-crohns-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-a-distal-vaginal-recurrence-of-endometrial-adenocarcinoma-in-a-patient-who-had-adjuvant-external-beam-and-cylinder-brachytherapy-boost-to-the-top-4-cm-of-the-vaginal-cuff weekly 0.8 https://www.themednet.org/for-inoperable-cholangiocarcinoma-do-you-recommend-up-front-chemotherapy-prior-to-offering-sbrt-or-combination-chemoradiation weekly 0.8 https://www.themednet.org/what-outcome-data-do-you-view-as-most-impactful-to-make-treatment-decisions-regarding-the-use-of-parp-inhibitors-in-later-line-or-recurrent-ovarian-cancer weekly 0.8 https://www.themednet.org/is-an-early-chest-tube-and-tpa-dornase-therapy-for-a-loculated-and-complex-pleural-effusion-that-is-not-an-empyema-or-hemothorax-helpful-in-reducing-the-rate-of-developing-trapped-lung weekly 0.8 https://www.themednet.org/can-hodgkin-like-ptld-be-treated-with-rituximab-and-weaning-of-immunosuppression-or-is-hodgkin-directed-chemotherapy-necessary-for-cure weekly 0.8 https://www.themednet.org/which-targeted-therapies-should-we-be-more-cautious-of-giving-after-recent-immunotherapy-in-nsclc weekly 0.8 https://www.themednet.org/is-there-emerging-and-compelling-enough-evidence-to-maintain-patients-on-p2y12i-monotherapy-in-lieu-of-aspirin-following-completion-of-dapt weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-use-of-acetazolamide-in-patients-with-osa weekly 0.8 https://www.themednet.org/would-you-offer-palliative-rt-for-a-patient-with-a-pelvic-mass-fistulizing-to-large-bowel weekly 0.8 https://www.themednet.org/would-you-recommend-initiating-rrt-in-a-patient-with-tumor-lysis-syndrome-and-a-phosphorus-of-9-mg-dl-or-more-who-does-not-have-symptomatic-hypocalcemia-or-other-indications-for-dialysis weekly 0.8 https://www.themednet.org/when-would-you-recommend-adding-peritoneal-dialysis-to-a-patient-with-oxalosis-who-is-already-receiving-hemodialysis weekly 0.8 https://www.themednet.org/when-would-you-include-treatment-of-the-entire-staple-line-for-an-nsclc-staple-line-recurrence weekly 0.8 https://www.themednet.org/what-are-your-options-for-refractory-itp-after-steroids-and-tpo-for-elderly-patients weekly 0.8 https://www.themednet.org/how-long-would-you-continue-trastuzumab-and-pertuzumab-in-a-patient-with-er-her2-breast-cancer-with-initially-osseous-involvement-treated-with-act-hp-and-is-now-in-cr-by-pet-for-2-years weekly 0.8 https://www.themednet.org/do-complex-cytogenetics-have-any-therapeutic-or-prognostic-relevance-in-cll weekly 0.8 https://www.themednet.org/below-what-ejection-fraction-would-you-avoid-referral-for-av-access-creation-in-a-patient-with-advanced-ckd-and-heart-failure-with-reduced-ejection-fraction weekly 0.8 https://www.themednet.org/is-there-a-high-risk-ctv-volume-for-epiglottis-primary weekly 0.8 https://www.themednet.org/based-on-the-vesper-trial-data-do-you-recommend-the-full-6-cycles-or-3-4-cycles-of-ddmvac-for-neoadjuvant-muscle-invasive-bladder-cancer-treatment weekly 0.8 https://www.themednet.org/is-there-a-role-for-routine-eeg-in-the-diagnostic-evaluation-of-critically-ill-comatose-patients-or-should-these-patients-always-receive-long-term-continuous-video-eeg-monitoring weekly 0.8 https://www.themednet.org/would-you-use-the-mipss-pv-risk-scoring-to-decide-in-decision-making-for-cytoreductive-therapy-in-pv weekly 0.8 https://www.themednet.org/does-pregabalin-contribute-to-esophagitis-or-gastroparesis weekly 0.8 https://www.themednet.org/do-you-routinely-use-hypertonic-saline-for-pulmonary-toileting-in-patients-with-non-cf-bronchiectasis weekly 0.8 https://www.themednet.org/how-often-and-when-do-you-consider-trending-nt-probnp-levels-for-patients-with-hfref-admitted-for-acute-decompensated-heart-failure weekly 0.8 https://www.themednet.org/would-you-consider-a-cycle-of-ep-in-a-patient-with-good-risk-stage-iiib-seminoma-on-bep-but-with-bleomycin-omitted-for-cycle-3 weekly 0.8 https://www.themednet.org/in-patients-with-embolic-stroke-and-a-pfo-how-often-do-you-go-beyond-venous-doppler-of-the-lower-extremities-to-screen-for-dvt-e-g-mrv-or-ctv-abdomen-and-pelvis weekly 0.8 https://www.themednet.org/have-you-encountered-acute-kidney-injury-after-starting-eltrombopag-for-aplastic-anemia-as-part-of-triple-immunosuppressive-regimen-with-atg-and-cyclosporine weekly 0.8 https://www.themednet.org/would-you-recommend-radiation-to-the-prostate-after-prior-transurethral-ultrasound-ablation-tulsa-pro weekly 0.8 https://www.themednet.org/what-is-the-optimal-timing-for-zoster-vaccine-administration-for-a-patient-who-recently-recovered-from-herpes-zoster-infection-and-is-now-planning-to-start-b-cell-depletion-therapy weekly 0.8 https://www.themednet.org/in-what-instances-might-you-recommend-twice-daily-7-5-icodextrin-to-patients-on-peritoneal-dialysis weekly 0.8 https://www.themednet.org/how-would-you-manage-asymptomatic-osseous-sarcoidosis-of-the-lumbar-spine-without-any-other-systemic-involvement weekly 0.8 https://www.themednet.org/do-you-offer-ultra-hypofractionated-5-fraction-whole-breast-rt-after-oncoplastic-rearrangement weekly 0.8 https://www.themednet.org/do-you-assess-telomere-length-in-all-patients-with-ipf-prior-to-lung-transplant weekly 0.8 https://www.themednet.org/would-you-recommend-a-tips-procedure-in-the-management-of-hepatorenal-syndrome-for-a-patient-with-no-history-of-hepatic-encephalopathy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-working-up-diarrhea-in-an-immunocompromised-patient weekly 0.8 https://www.themednet.org/how-would-you-approach-persistent-episcleritis-uveitis-due-to-pr3-gpa-which-needs-low-dose-prednisone-to-control-despite-induction-with-rituximab weekly 0.8 https://www.themednet.org/when-using-hyperfractionation-with-a-bid-regimen-what-are-typical-dose-constraints-for-the-head-and-neck weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-patients-with-lupus-profundus weekly 0.8 https://www.themednet.org/do-you-use-sitting-vs-supine-spirometry-to-consider-tracheostomy-in-a-patient-with-amyotrophic-lateral-sclerosis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-a-patient-with-a-history-of-tardive-dyskinesia-on-a-vmat2-inhibitor-presenting-with-parkinsonism-and-found-to-have-an-abnormal-dat-scan weekly 0.8 https://www.themednet.org/how-do-you-sequence-her2-therapy-in-her2-biliary-tract-cancer-with-the-positive-results-of-tucatinib-trastuzumab-and-zanidatamab-in-phase-2-studies weekly 0.8 https://www.themednet.org/are-there-any-indications-to-close-a-pfo-during-pregnancy-if-a-woman-had-a-cryptogenic-stroke-in-her-first-trimester weekly 0.8 https://www.themednet.org/in-a-young-female-with-severe-osteoporosis-due-to-congenital-estrogen-deficiency-can-estrogen-be-prescribed-if-genetic-testing-for-congenital-disorders-reveals-a-heterozygous-factor-v-leiden-mutation weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-radiotherapy-for-completely-resected-breast-fibromatosis-after-lumpectomy weekly 0.8 https://www.themednet.org/how-frequently-and-when-should-lipoprotein-a-levels-be-monitored weekly 0.8 https://www.themednet.org/are-there-studies-looking-at-ra-223-and-sbrt-for-oligometastatic-disease-in-the-setting-of-mcrpc weekly 0.8 https://www.themednet.org/would-you-manage-a-subtotally-resected-pilocytic-astrocytoma-with-deleted-cdkn2a-differently-than-one-with-intact-cdkn2a weekly 0.8 https://www.themednet.org/would-you-offer-ultrahypofractionated-5-fraction-breast-radiation-to-a-patient-with-lupus weekly 0.8 https://www.themednet.org/what-is-the-minimum-egfr-at-which-we-should-avoid-initiating-sglt2i-therapy weekly 0.8 https://www.themednet.org/how-do-you-interpret-the-finding-of-identical-bands-in-csf-and-serum-in-patients-being-evaluated-for-ms weekly 0.8 https://www.themednet.org/when-if-ever-would-you-re-challenge-with-immunotherapy-for-patients-with-metastatic-rcc weekly 0.8 https://www.themednet.org/how-does-the-extent-of-dcis-influence-eligibility-for-apbi-for-invasive-breast-cancer weekly 0.8 https://www.themednet.org/do-you-transfuse-platelets-prior-to-central-line-placement-in-patients-with-platelet-counts-less-than-50-000 weekly 0.8 https://www.themednet.org/in-patients-with-afib-on-anticoagulation-and-concurrent-intracranial-atherosclerotic-disease-would-you-consider-adding-an-anti-platelet-to-anticoagulation-if-there-are-recurrent-events-that-could-be-related-to-the-icad weekly 0.8 https://www.themednet.org/do-you-recommend-prescribing-pneumocystis-jiroveci-pneumonia-pjp-prophylaxis-for-a-patient-with-membranous-glomerulonephritis-on-rituximab weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-for-a-r-r-mantle-cell-lymphoma-patient-with-a-history-of-autoimmune-hepatitis-who-has-progressed-on-both-a-covalent-and-non-covalent-btki weekly 0.8 https://www.themednet.org/in-what-clinical-situation-do-you-use-botox-in-patients-with-increased-salivation weekly 0.8 https://www.themednet.org/for-patients-with-incidental-findings-of-venous-thromboembolism-during-workup-of-a-treatable-malignancy-how-do-you-approach-discontinuation-after-the-treatment-is-complete weekly 0.8 https://www.themednet.org/how-would-you-approach-post-operative-radiation-in-a-patient-with-er-pr-negative-her2-positive-t1c-n0-breast-cancer-originating-in-the-ectopic-mammary-tissue-close-to-the-axilla-treated-wide-excision-followed-by-apt-regimen-weekly-paclitaxel-plus-trastuzu weekly 0.8 https://www.themednet.org/how-do-you-manage-severe-intra-dialytic-hypertension-that-is-not-responsive-to-dry-weight-challenge-in-an-asymptomatic-patient-with-eskd weekly 0.8 https://www.themednet.org/do-you-routinely-use-g-csf-post-allogeneic-transplant-for-non-haploidentical-transplants weekly 0.8 https://www.themednet.org/would-you-place-an-ivc-filter-in-a-patient-with-an-acute-intermediate-risk-pe-and-a-proximal-dvt-who-is-on-anticoagulation weekly 0.8 https://www.themednet.org/do-you-recommend-transfer-to-an-institution-with-a-pe-response-team-for-a-patient-with-an-intermediate-risk-pe weekly 0.8 https://www.themednet.org/after-presentation-of-the-shape-trial-at-asco-would-you-consider-offering-a-simple-hysterectomy-with-pelvic-ln-dissection-for-early-stage-cervical-cancer-2cm weekly 0.8 https://www.themednet.org/below-what-platelet-count-would-you-avoid-using-an-av-fistula-in-a-patient-with-eskd-and-thrombocytopenia weekly 0.8 https://www.themednet.org/what-is-your-approach-to-evaluating-a-patient-with-known-rheumatologic-disease-and-elevated-free-kappa-lambda-ratio-but-no-evidence-of-monoclonal-immunoglobulins weekly 0.8 https://www.themednet.org/can-a-patient-still-have-primary-hlh-even-in-the-absence-of-any-hlh-associated-genetic-mutations weekly 0.8 https://www.themednet.org/is-there-a-dose-to-the-lens-that-would-be-a-contraindication-for-future-cataract-surgery weekly 0.8 https://www.themednet.org/do-you-recommend-performing-a-kidney-biopsy-in-patients-with-suspected-ifosfamide-nephrotoxicity weekly 0.8 https://www.themednet.org/what-are-the-preferred-inotropes-vasopressors-agents-for-cardiogenic-shock-in-situations-with-and-without-lvot-obstruction weekly 0.8 https://www.themednet.org/do-you-recommend-obtaining-a-vasculitis-work-up-for-all-patients-seen-for-chronic-kidney-disease-who-are-without-a-kidney-biopsy weekly 0.8 https://www.themednet.org/would-you-offer-a-bone-marrow-biopsy-to-the-patient-with-normal-cbc-and-low-mds-associated-mutation-burden-found-on-ngs weekly 0.8 https://www.themednet.org/do-you-recommend-holding-cinacalcet-after-kidney-transplantation-and-monitoring-pth-levels-before-restarting-it weekly 0.8 https://www.themednet.org/how-would-you-approach-a-localized-but-unresectable-adenoid-cystic-carcinoma-of-the-distal-trachea weekly 0.8 https://www.themednet.org/how-long-do-you-continue-immunosuppression-in-patients-with-behcets-who-have-a-history-of-mucocutaneous-and-ocular-disease-but-are-now-in-remission weekly 0.8 https://www.themednet.org/how-common-are-nasal-telangiectasia-in-patients-with-systemic-sclerosis weekly 0.8 https://www.themednet.org/how-do-you-schedule-iv-po-dexamethasone-if-giving-immunotherapy-concurrently-with-chemotherapy-in-patients-with-nsclc weekly 0.8 https://www.themednet.org/how-would-you-approach-choosing-osteoporosis-treatment-in-a-patient-with-a-t-score-3-3-in-lumbar-spine-and-no-prior-fracture-history-who-has-squamous-cell-cancer-and-received-radiation-therapy weekly 0.8 https://www.themednet.org/do-you-include-trastuzumab-in-the-treatment-regimen-of-patients-with-advanced-stage-her2-endometrial-cancer-that-is-not-serous-or-carcinosarcoma weekly 0.8 https://www.themednet.org/would-you-consider-restarting-a-sglt2i-at-a-reduced-dose-in-a-patient-who-you-previously-discontinued-the-medication-because-of-an-associated-significant-decline-in-egfr weekly 0.8 https://www.themednet.org/would-you-recommend-giving-n-acetylcysteine-in-addition-to-holding-diuretics-in-a-patient-with-chronic-kidney-disease-and-mild-hypervolemia-who-is-planned-to-have-a-contrast-study weekly 0.8 https://www.themednet.org/how-do-you-manage-me-anticoagulation-in-a-patient-with-may-thurner-syndrome-who-does-not-have-history-of-thrombosis-and-becomes-pregnant weekly 0.8 https://www.themednet.org/does-your-approach-to-treating-latent-tuberculosis-differ-in-a-patient-on-anti-fibrotic-therapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-therapy-to-raise-urinary-citrate-in-a-patient-with-recurrent-calcium-based-stone-disease-and-hypocitraturia weekly 0.8 https://www.themednet.org/should-consideration-be-taken-to-defer-using-pw-to-calculate-aortic-valve-area-if-lvot-pulsed-wave-is-greater-than-1-7-m-s-aliasing-velocity weekly 0.8 https://www.themednet.org/what-work-up-should-be-considered-in-patients-with-significantly-worsening-a1c-despite-steady-diet-lifestyle-and-medication-adherence weekly 0.8 https://www.themednet.org/which-patient-population-would-most-benefit-from-inhaled-insulin-afrezza weekly 0.8 https://www.themednet.org/should-glp-1-agonists-be-weaned-in-patients-who-have-achieved-goal-weight-loss-and-glycemic-control weekly 0.8 https://www.themednet.org/should-orlistat-be-considered-in-the-management-of-hypertriglyceridemia weekly 0.8 https://www.themednet.org/should-weight-loss-medications-be-used-in-women-who-are-gaining-excessive-weight-during-pregnancy weekly 0.8 https://www.themednet.org/which-patient-population-would-benefit-most-from-cellulose-and-citric-acid-plenity-therapy-for-weight-loss weekly 0.8 https://www.themednet.org/should-metformin-be-used-in-women-with-pcos-for-weight-loss weekly 0.8 https://www.themednet.org/would-you-start-osteoporosis-treatment-in-patients-with-low-frax-scores-but-have-t-scores-lower-than-2-5 weekly 0.8 https://www.themednet.org/how-should-very-low-t-scores-worse-than-3-be-interpreted-in-very-thin-patients-bmi-18 weekly 0.8 https://www.themednet.org/should-thyroid-hormone-replacement-be-initiated-in-patients-with-very-prolonged-critical-illness-with-associated-low-thyroid-hormone-levels weekly 0.8 https://www.themednet.org/should-dopamine-agonist-treatment-stop-in-pregnant-patients-with-recurrent-prolactinoma-despite-prior-surgery weekly 0.8 https://www.themednet.org/should-patients-with-non-functional-pituitary-macroadenomas-with-persistent-but-tolerable-headaches-be-recommended-for-surgery weekly 0.8 https://www.themednet.org/should-patients-with-asymptomatic-gh-deficiency-be-treated-with-gh-replacement-therapy-if-they-have-prior-known-severe-cad weekly 0.8 https://www.themednet.org/does-caution-have-to-be-used-in-gh-replacement-therapy-in-any-and-all-types-of-cancer-history weekly 0.8 https://www.themednet.org/does-preoperative-use-of-somatostatin-receptor-ligand-improve-remission-rates-after-surgery-for-acromegaly weekly 0.8 https://www.themednet.org/is-a-significant-rise-in-cortisol-post-cosyntropin-stimulation-sufficient-to-rule-out-adrenal-insufficiency-in-patients-with-low-albumin weekly 0.8 https://www.themednet.org/should-a-short-trial-of-androgen-therapy-be-used-in-patients-with-primary-adrenal-insufficiency-suffering-from-persistent-fatigue-and-hypoactive-sexual-desire-despite-sufficient-glucocorticoid-and-mineralocorticoid-replacement weekly 0.8 https://www.themednet.org/can-osilodrostat-be-used-indefinitely-in-poor-surgical-candidates-with-cushing-syndrome-from-adrenal-adenoma weekly 0.8 https://www.themednet.org/what-is-the-next-best-anti-hypertensive-medication-to-start-after-mineralocorticoid-receptor-antagonists-in-patients-with-primary-aldosteronism weekly 0.8 https://www.themednet.org/in-adult-women-with-nccah-is-there-a-benefit-in-using-supratherapeutic-doses-of-prednisone-in-addition-to-clomiphene-to-improve-fertility-rates weekly 0.8 https://www.themednet.org/how-long-does-it-take-the-hypothalamic-pituitary-gonadal-axis-to-recover-from-secondary-amenorrhea-in-the-setting-early-onset-and-chronic-use-of-oral-combined-contraceptive-pills weekly 0.8 https://www.themednet.org/should-testosterone-replacement-be-stopped-in-elderly-men-who-suffered-acute-stroke-even-when-testosterone-levels-have-been-stably-in-the-low-to-mid-normal-range weekly 0.8 https://www.themednet.org/would-you-recommend-prescribing-testosterone-replacement-therapy-to-reduce-osteoporosis-fracture-rates-in-men-with-hypogonadism weekly 0.8 https://www.themednet.org/how-do-you-time-evenity-after-completion-of-forteo weekly 0.8 https://www.themednet.org/what-workup-do-you-recommend-on-patients-with-suspected-ischemic-cranial-nerve-six-palsy weekly 0.8 https://www.themednet.org/how-frequently-do-you-monitor-ekgs-for-patients-newly-initiated-on-lacosimide weekly 0.8 https://www.themednet.org/do-you-ever-utilize-lacosimide-in-patients-with-atrial-fibrillation weekly 0.8 https://www.themednet.org/is-intracranial-hemorrhage-a-contraindication-for-valproic-acid weekly 0.8 https://www.themednet.org/do-you-utilize-muscle-mri-to-track-disease-progression-in-myopathies weekly 0.8 https://www.themednet.org/is-there-any-utility-in-using-lytics-for-loculated-malignant-pleural-effusion weekly 0.8 https://www.themednet.org/how-do-you-proceed-with-radiation-planning-for-preliminary-suspected-high-grade-gliomas-after-surgery-when-there-is-a-delay-in-final-molecular-diagnosis weekly 0.8 https://www.themednet.org/would-you-use-a-parp-inhibitor-as-treatment-for-recurrent-platinum-sensitive-ovarian-cancer-with-a-rad51-or-other-moderate-penetration-hrd-germline-mutation weekly 0.8 https://www.themednet.org/can-you-use-ngs-panels-or-ctdna-to-help-you-find-organ-of-origin-in-the-workup-of-carcinoma-of-unknown-origin weekly 0.8 https://www.themednet.org/what-are-common-indications-for-ordering-ngs-of-peripheral-blood weekly 0.8 https://www.themednet.org/what-is-the-significance-of-lvsi-in-determining-post-op-management-for-oropharyngeal-cancer weekly 0.8 https://www.themednet.org/how-would-you-work-up-an-elevated-copper-level-without-cytopenias-in-a-patient-with-history-of-bariatric-surgery-not-on-supplements-or-using-copper-utensils weekly 0.8 https://www.themednet.org/would-you-offer-definitive-radiation-therapy-for-extracranial-schwannoma-located-in-the-neck weekly 0.8 https://www.themednet.org/when-do-you-start-bisphosphonates-empirically-irrespective-of-dexa-results-in-patients-going-on-chronic-glucocorticoids weekly 0.8 https://www.themednet.org/what-systemic-treatment-do-you-utilize-for-patients-with-metastatic-fibrosarcomatous-dfsp-that-have-progressed-on-imatinib weekly 0.8 https://www.themednet.org/what-is-a-reasonable-duration-of-time-for-dual-anti-platelet-therapy-in-patients-who-have-undergone-placement-of-a-covered-coronary-stent weekly 0.8 https://www.themednet.org/what-post-auto-maintenance-therapy-do-you-recommend-for-patients-with-high-risk-multiple-myeloma weekly 0.8 https://www.themednet.org/what-is-your-approach-towards-management-of-symptomatic-broncholithiasis weekly 0.8 https://www.themednet.org/for-esophageal-adenocarcinoma-with-extensive-associated-barretts-would-you-extend-your-ctv-coverage-beyond-the-usual-expansions-to-cover-the-areas-of-known-barretts weekly 0.8 https://www.themednet.org/how-often-do-you-monitor-labs-such-as-complete-blood-count-liver-function-panel-and-urine-protein-in-a-patient-with-cystinuria-receiving-tiopronin weekly 0.8 https://www.themednet.org/how-do-you-manage-hyperalgesia-in-patients-with-sickle-cell-disease weekly 0.8 https://www.themednet.org/what-is-your-frontline-treatment-of-choice-for-patients-with-systemic-and-secondary-cns-involvement-by-dlbcl weekly 0.8 https://www.themednet.org/would-testing-for-attr-cardiac-amyloidosis-be-considered-in-an-older-patient-with-bilateral-carpal-tunnel-surgeries-and-multiple-spinal-stenosis-surgeries-but-no-obvious-cardiac-symptoms weekly 0.8 https://www.themednet.org/would-you-recommend-neoadjuvant-chemotherapy-for-a-3-5-cm-low-grade-utuc-in-a-cisplatin-eligible-patient weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-therapy-to-minimize-cardiotoxicity-in-early-stage-node-negative-her2-hr-breast-cancer-with-history-of-chest-wall-radiation-and-previous-cardiotoxic-agents-for-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-manage-recurrent-hemodialysis-filter-clotting-in-an-in-center-eskd-patient-with-heparin-induced-thrombocytopenia weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-semaglutide-or-tirzepatide-in-light-of-potential-cancer-risks weekly 0.8 https://www.themednet.org/how-do-you-interpret-psma-pet-with-focal-prostate-activity-after-xrt-currently-on-adt-with-stable-psa weekly 0.8 https://www.themednet.org/with-immunotherapy-now-often-being-used-in-the-first-line-setting-for-advanced-endometrial-cancer-what-is-the-role-of-immunotherapy-in-the-second-line weekly 0.8 https://www.themednet.org/in-patients-with-confirmed-medically-refractory-bitemporal-epilepsy-how-do-you-decide-on-dbs-vs-rns-for-treatment weekly 0.8 https://www.themednet.org/do-you-use-continuous-or-intermittent-bronchodilator-therapy-in-severe-airway-obstruction weekly 0.8 https://www.themednet.org/do-you-recommend-targeting-a-higher-kt-v-in-an-eskd-patient-on-hemodialysis-with-pruritis-and-a-kt-v-of-1-4 weekly 0.8 https://www.themednet.org/how-do-you-manage-severe-hypertriglyceridemia-in-the-adolescent-young-adult-population-receiving-chemotherapy-for-all-in-the-absence-of-complications-related-to-hypertriglyceridemia weekly 0.8 https://www.themednet.org/should-patients-of-advanced-maternal-age-35-years-of-age-undergo-routine-cardiovascular-risk-stratification-with-echocardiogram-during-pregnancy weekly 0.8 https://www.themednet.org/do-you-recommend-continuing-peritoneal-dialysis-in-an-eskd-patient-on-peritoneal-dialysis-who-is-diagnosed-with-encapsulating-peritoneal-sclerosis-since-abdominal-symptoms-may-worsen-when-peritoneal-dialysis-is-stopped weekly 0.8 https://www.themednet.org/in-a-patient-with-er-her2-breast-cancer-with-significant-residual-disease-post-neoadjuvant-tchp-is-there-a-role-of-using-cdk4-6i-in-the-adjuvant-setting-with-t-dm1 weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-osimertinib-for-patients-with-non-classical-but-sensitizing-egfr-mutation-positive-nsclc-s-p-surgical-resection weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-systemic-sclerosis-and-chronic-thrombotic-microangiopathy-on-renal-biopsy-but-no-other-evidence-of-scleroderma-renal-crisis weekly 0.8 https://www.themednet.org/what-is-your-approach-for-a-kidney-transplant-patient-who-develops-proteinuria-after-everolimus-initiation weekly 0.8 https://www.themednet.org/for-path-cr-after-neoadjuvant-chemotherapy-in-breast-cancer-with-sentinel-node-2-3-nodes-negative-but-4-nodes-positive-on-initial-pet-do-you-boost-the-nodes-not-assessed-by-sentinel-node weekly 0.8 https://www.themednet.org/do-you-have-experience-using-photobiomodulation-low-level-laser-therapy-to-prevent-and-or-treat-patients-with-oral-mucositis-or-other-side-effects-from-chemo-and-radiation weekly 0.8 https://www.themednet.org/what-histologic-findings-most-commonly-lead-you-to-order-additional-staining-for-potential-desmoplastic-melanoma weekly 0.8 https://www.themednet.org/when-do-you-screen-for-pulmonary-hypertension-in-ild-patients weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-elevated-cpk-in-the-500-1000-range-with-no-weakness-on-exam-or-myositis-on-mri-but-with-positive-hmgcoa-ab weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-that-develop-atopic-dermatitis-while-on-biologics-for-psoriasis weekly 0.8 https://www.themednet.org/how-do-you-counsel-parents-of-children-with-atopic-dermatitis-about-preventing-recurrent-staph-infections weekly 0.8 https://www.themednet.org/when-offering-palliative-radiation-for-spinal-cord-compression-do-you-ever-open-up-the-field-if-there-is-evidence-of-leptomeningeal-disease-on-mri weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-who-received-2-cycles-of-r-chop-for-dlbcl-who-was-subsequently-diagnosed-with-follicular-lymphoma weekly 0.8 https://www.themednet.org/in-a-patient-with-a-history-of-hit-how-would-you-reintroduce-heparin weekly 0.8 https://www.themednet.org/would-you-offer-bm-biopsy-as-the-next-step-for-progressive-thrombocytosis-when-peripheral-blood-is-negative-for-jak2-calr-and-mpl-mutations-for-mpn-diagnosis weekly 0.8 https://www.themednet.org/would-you-offer-capecitabine-re-challenge-for-a-patient-with-metastatic-breast-cancer-and-a-history-of-coronary-vasospasm weekly 0.8 https://www.themednet.org/how-do-you-approach-methotrexate-management-around-vaccines-other-than-covid-and-influenza weekly 0.8 https://www.themednet.org/what-are-alternative-myeloma-therapies-for-patients-who-are-unable-to-afford-lenalidomide-or-oral-cyclophosphamide-due-to-gaps-in-prescription-drug-coverage weekly 0.8 https://www.themednet.org/how-do-you-approach-spine-sbrt-to-2-separate-noncontiguous-vertebral-bodies weekly 0.8 https://www.themednet.org/in-which-patients-do-you-offer-adjuvant-bisphosphates-in-breast-cancer-treatment weekly 0.8 https://www.themednet.org/do-you-consider-prior-use-of-cisplatin-for-a-previously-diagnosed-cancer-a-contraindication-for-its-use-as-radiosensitizer-in-a-new-head-neck-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-deciding-how-long-to-use-avacopan-for-anca-associated-vasculitis weekly 0.8 https://www.themednet.org/do-you-continue-to-obtain-dedicated-imaging-of-the-spine-after-palliative-radiation-for-epidural-disease-or-cord-compression weekly 0.8 https://www.themednet.org/which-factors-would-prompt-empirical-lead-extraction-in-bacteremic-patients-without-tee-evidence-of-lead-vegetation weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-symptomatic-and-rapidly-progressing-metastatic-hr-her2-low-breast-cancer-with-pik3ca-wt-esr1-mutated-tmb-high-after-progression-on-cdk-4-6-inhibitor-a-taxane-and-t-dxd weekly 0.8 https://www.themednet.org/in-which-patients-awaiting-a-kidney-transplant-do-you-evaluate-for-primary-hyperoxaluria-given-the-high-risk-of-allograft-dysfunction-following-transplantation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-membranous-glomerulonephritis-who-have-persistently-elevated-pla2r-titers-but-largely-improved-proteinuria-and-creatinine weekly 0.8 https://www.themednet.org/would-you-recommend-anti-platelet-or-anticoagulation-in-a-patient-with-recurrent-strokes-cadasil-and-antiphospholipid-syndrome weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-abemaciclib-to-young-premenopausal-women-desiring-more-children-who-meet-criteria-for-the-same-based-on-monarche-trial weekly 0.8 https://www.themednet.org/for-patients-with-metastatic-thymic-carcinoma-is-there-a-role-for-local-treatment-options-such-as-sbrt-for-oligoprogressive-or-oligopersistent-disease-after-systemic-therapy weekly 0.8 https://www.themednet.org/would-you-recommend-prostate-re-irradiation-using-sbrt weekly 0.8 https://www.themednet.org/would-you-offer-post-operative-radiation-for-a-t2n0-rectal-cancer-with-less-than-12-lymph-nodes-found-in-the-specimen-after-lar weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-considering-leqembi-therapy-for-alzheimers-disease-who-cannot-get-mris weekly 0.8 https://www.themednet.org/what-definitive-dose-would-you-use-to-treat-a-recurrent-basal-cell-carcinoma-in-the-oral-cavity weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-chronic-azithromycin-in-patients-with-cf-who-may-require-therapy-with-iv-tobramycin-in-the-future weekly 0.8 https://www.themednet.org/for-a-patient-interested-in-home-dialysis-modalities-what-are-some-key-points-that-you-discuss-with-them-to-help-them-make-a-decision-on-peritoneal-dialysis-versus-home-hemodialysis weekly 0.8 https://www.themednet.org/do-you-recommend-genetic-testing-for-patients-with-a-family-history-of-polycystic-kidney-disease-and-who-meet-the-imaging-criteria-but-the-specific-genetic-variant-in-the-family-is-unknown weekly 0.8 https://www.themednet.org/is-there-practical-utility-from-obtaining-csf-autoantibodies-in-patients-with-suspected-neuropsychiatric-systemic-lupus-erythematosus weekly 0.8 https://www.themednet.org/what-is-your-preferred-adjuvant-chemotherapy-regimen-for-a-patient-with-local-recurrence-of-tnbc-two-years-after-completing-neoadjuvant-ddac-t-who-declined-prior-adjuvant-capecitabine weekly 0.8 https://www.themednet.org/how-would-you-manage-a-er-pr-positive-her2-negative-grade-2-t3n0-invasive-breast-cancer-s-p-adjuvant-chemotherapy-who-had-post-operative-complications-with-reconstruction weekly 0.8 https://www.themednet.org/is-there-any-indication-for-obtaining-adrenal-imaging-in-patients-with-men2-who-have-normal-plasma-or-urinary-metanephrines weekly 0.8 https://www.themednet.org/how-accurate-of-an-indicator-is-reticulocyte-hemoglobin-equivalent-for-iron-deficiency weekly 0.8 https://www.themednet.org/what-would-you-recommend-for-a-patient-with-ms-on-dimethyl-fumarate-with-recent-exacerbations-including-optic-neuritis-and-new-enhancing-brain-lesions-who-wishes-to-go-on-more-intensive-therapy-such-as-a-b-cell-depletion-but-recently-required-treatment-fo weekly 0.8 https://www.themednet.org/are-there-standardized-discrete-cut-off-values-in-t1-t2-mapping-and-extracellular-volume-fraction-to-aid-in-the-diagnosis-of-various-cardiomyopathies-or-are-these-values-largely-scanner-institution-specific weekly 0.8 https://www.themednet.org/how-would-you-manage-adjuvant-therapy-for-a-patient-with-pulmonary-adenoid-cystic-carcinoma-s-p-resection-with-positive-bronchial-and-vascular-margins-and-nodal-involvement weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-malignant-melanoma-who-are-disease-free-on-immunotherapy-for-over-3-years weekly 0.8 https://www.themednet.org/can-an-acid-loading-test-be-used-to-assist-with-the-diagnosis-of-rtas-other-than-an-incomplete-distal-rta weekly 0.8 https://www.themednet.org/how-do-you-approach-workup-and-management-of-hyperhidrosis weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-stage-iii-melanoma-for-adjuvant-treatment weekly 0.8 https://www.themednet.org/how-would-you-approach-consolidative-rectal-irradiation-for-a-patient-with-liver-confined-metastatic-rectal-adenocarcinoma-who-has-sustained-a-near-cr-after-capeox-capecitabine-and-ongoing-bevacizumab weekly 0.8 https://www.themednet.org/what-staff-members-would-you-recommend-to-start-a-lu-177-psma-therapy-program weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-try-stopping-hydroxychloroquine-in-patients-with-erosive-osteoarthritis weekly 0.8 https://www.themednet.org/do-you-recommend-noninvasive-testing-or-coronary-angiography-as-the-initial-test-for-pre-kidney-transplant-evaluation-of-an-asymptomatic-patient-older-than-50-years-of-age-with-eskd-secondary-to-diabetic-nephropathy-and-no-known-history-of-cad weekly 0.8 https://www.themednet.org/what-is-your-approach-to-postpartum-screening-and-cardiovascular-risk-assessment-in-patients-with-a-prior-history-of-preeclampsia weekly 0.8 https://www.themednet.org/is-it-true-that-a-ferritin-above-200-essentially-rules-out-iron-deficiency weekly 0.8 https://www.themednet.org/what-are-the-most-common-pain-regimens-that-you-use-in-cancer-care weekly 0.8 https://www.themednet.org/how-would-you-alter-your-treatment-volumes-in-a-patient-with-distal-esophageal-cancer-who-has-had-prior-gastric-bypass-surgery weekly 0.8 https://www.themednet.org/would-you-recommend-complement-testing-in-a-kidney-transplant-recipient-with-chronic-antibody-mediated-rejection-and-biopsy-proven-thrombotic-microangiopathy-to-determine-the-need-for-eculizumab weekly 0.8 https://www.themednet.org/in-g1-metastatic-gep-net-with-small-lesions-visible-on-pet-dotatate-very-low-burden-of-disease-on-ct-and-no-clinical-symptoms-are-there-any-data-to-suggest-early-lanreotide-changes-natural-history-of-disease-and-prolongs-os-vs-observation-until-symptoms weekly 0.8 https://www.themednet.org/what-electron-beam-dose-fractionation-would-you-use-for-a-recurrence-basal-cell-carcinoma-of-the-scalp-adjacent-to-a-split-thickness-skin-graft weekly 0.8 https://www.themednet.org/do-you-try-to-treat-the-acidosis-resulting-from-acetazolamide-in-patients-with-iih weekly 0.8 https://www.themednet.org/when-treating-sinonasal-undifferentiated-carcinoma-snuc-with-induction-chemotherapy-followed-by-definitive-chemoradiation-do-you-include-the-entire-pre-chemo-volume-in-your-high-dose-ctv weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-report-a-history-of-a-lidocaine-allergy weekly 0.8 https://www.themednet.org/how-do-you-monitor-patients-with-cutaneous-lupus-for-progression-to-sle weekly 0.8 https://www.themednet.org/what-topical-therapies-have-you-found-most-effective-for-managing-scalp-psoriasis weekly 0.8 https://www.themednet.org/is-there-a-role-for-systemic-therapy-in-recurrent-oligometastatic-triple-negative-breast-cancer-with-brain-only-disease weekly 0.8 https://www.themednet.org/how-are-you-approaching-patients-who-receive-neoadjuvant-chemo-immunotherapy-for-resectable-nsclc-who-after-completion-of-neoadjuvant-treatment-are-no-longer-surgical-candidates-due-to-factors-such-as-toxicity-decline-in-ps-or-patient-preference weekly 0.8 https://www.themednet.org/what-factors-would-prompt-you-to-offer-post-operative-rt-in-early-stage-t1-2n0-nasal-cavity-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/how-would-you-approach-microcytosis-without-anemia-with-high-tsat-and-ferritin weekly 0.8 https://www.themednet.org/what-is-your-treatment-algorithm-for-actinic-cheilitis weekly 0.8 https://www.themednet.org/are-there-any-potential-benefits-to-irradiating-the-partial-breast-with-an-mr-linac-over-conventional-linac weekly 0.8 https://www.themednet.org/what-factors-should-prompt-a-kidney-biopsy-to-evaluate-for-monoclonal-gammopathy-of-renal-significance-in-a-patient-with-mgus-and-suspected-chronic-diabetic-nephropathy weekly 0.8 https://www.themednet.org/how-would-you-adjust-the-steroid-dose-for-steroid-induced-psychosis-in-a-patient-being-treated-for-secondary-hlh-with-the-hlh-94-protocol weekly 0.8 https://www.themednet.org/how-do-you-choose-between-atezolizumab-bevacizumab-imbrave-150-versus-durvalumab-tremelimumab-himalaya-in-first-line-metastatic-hepatocellular-cancer weekly 0.8 https://www.themednet.org/how-is-transferrin-saturation-a-reliable-indicator-for-any-parameter-if-serum-iron-is-not-reliable weekly 0.8 https://www.themednet.org/when-would-you-initiate-exchange-transfusion-in-babesiosis-and-significant-hemolysis weekly 0.8 https://www.themednet.org/what-is-the-next-best-osteoporosis-treatment-option-for-patients-who-completed-2-years-of-teriparatide-but-has-contraindication-to-bisphosphosnate-therapy-e-g-history-of-atypical-femur-fracture weekly 0.8 https://www.themednet.org/do-you-think-repeated-routine-eeg-is-sufficient-for-cardiac-arrest-patients-or-should-we-be-always-using-continuous-eeg weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-pmr-in-a-patient-who-has-had-avascular-necrosis-of-the-hip-after-starting-steroids weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-rcc-with-high-grade-neuroendocrine-and-sarcomatoid-features-after-progression-on-io-tki weekly 0.8 https://www.themednet.org/how-would-you-manage-warfarin-in-a-patient-with-apls-and-alcoholic-cirrhosis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-counseling-a-patient-with-stable-but-severe-multivessel-coronary-disease-if-the-patient-does-not-wish-to-undergo-bypass-surgery weekly 0.8 https://www.themednet.org/how-would-you-approach-patients-receiving-neoadjuvant-pembrolizumab-swog-1801-for-melanoma-with-no-response-to-systemic-treatment weekly 0.8 https://www.themednet.org/in-a-patient-with-rectal-adenocarcinoma-and-involved-gluteal-lymph-nodes-what-would-your-elective-lymph-node-volume-include weekly 0.8 https://www.themednet.org/how-would-you-sequence-treatment-of-a-synchronous-ic1-high-grade-serous-ovarian-cancer-and-ct3n1-rectal-cancer weekly 0.8 https://www.themednet.org/what-brachytherapy-regimen-would-you-use-for-a-patient-who-completed-only-the-ebrt-portion-of-their-planned-definitive-chemoradiation-course-for-locally-advanced-cervical-cancer-who-is-now-presenting-with-persistent-recurrent-local-disease weekly 0.8 https://www.themednet.org/for-a-patient-with-osteopenia-or-osteoporosis-how-long-can-intravenous-zoledronic-acid-be-maintained-if-there-are-not-adverse-events weekly 0.8 https://www.themednet.org/when-utilizing-isrt-for-hodgkin-lymphoma-what-volumetric-expansions-itv-and-ptv-are-appropriate-on-top-of-the-ctv-that-includes-the-original-pre-systemic-therapy-disease weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-recurrent-calcium-phosphate-nephrolithiasis-who-has-hypercalciuria-hypocitraturia-and-a-urine-ph-greater-than-6-3 weekly 0.8 https://www.themednet.org/do-you-use-mtx-along-with-rituximab-in-patients-with-early-nsip-on-hrct-in-patient-with-active-ra-and-polymyositis-pl7 weekly 0.8 https://www.themednet.org/how-would-you-treat-esrd-patients-on-hemodialysis-with-recurrent-av-fistula-thrombosis-found-with-low-protein-c-activity weekly 0.8 https://www.themednet.org/is-there-data-to-support-a-3-weeks-regimen-of-panitumumab-with-maintenance-capecitabine-in-colon-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-a-patient-with-idiopathic-pneumonia-syndrome-following-stem-cell-transplant-who-does-not-demonstrate-clinical-improvement-with-steroid-therapy weekly 0.8 https://www.themednet.org/is-there-evidence-for-development-of-more-severe-autoimmune-toxicities-for-young-patients-vs-older-patients-on-immune-checkpoint-inhibitors weekly 0.8 https://www.themednet.org/what-is-the-ideal-period-to-wait-until-curative-surgery-for-patients-with-acute-pulmonary-embolism-and-solid-malignancy weekly 0.8 https://www.themednet.org/do-you-ever-perform-adaptive-replanning-for-interfraction-tumor-volume-changes-appreciated-during-a-fractionated-srs-5-fx-treatment-for-cns-metastases weekly 0.8 https://www.themednet.org/is-polymyalgia-rheumatica-associated-with-increased-toxicity-for-lung-sbrt weekly 0.8 https://www.themednet.org/would-you-consider-adding-abiraterone-to-adt-and-salvage-rt-in-a-prostate-cancer-patient-with-pn1-disease-at-radical-prostatectomy weekly 0.8 https://www.themednet.org/would-you-hesitate-to-give-breast-radiation-to-a-patient-with-prior-near-fatal-stevens-johnson-medication-reaction weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-persistent-hydropneumothorax-due-to-a-non-expandable-lung weekly 0.8 https://www.themednet.org/would-you-recommend-axillary-lymph-node-dissection-in-a-pre-menopausal-woman-with-er-pr-her2-idc-s-p-lumpectomy-and-sln-with-pt1c-pn1-cm0-disease-where-2-sentinel-nodes-are-positive-for-macrometastasis-and-1-sn-is-positive-for-micrometastasis weekly 0.8 https://www.themednet.org/is-there-a-time-interval-after-which-you-would-not-offer-adjuvant-radiotherapy-for-a-malignant-grade-3-meningioma weekly 0.8 https://www.themednet.org/for-merkel-cell-carcinoma-of-the-eyelid-how-do-you-approach-post-operative-management-and-what-are-the-recommended-radiation-treatment-volumes weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-chronic-neutropenia-in-a-patient-with-sjogrens-who-was-recently-diagnosed-with-metastatic-endometrial-cancer-and-plans-to-start-chemotherapy weekly 0.8 https://www.themednet.org/in-a-patient-with-history-of-scleroderma-renal-crisis-resulting-in-esrd-would-you-recommend-using-steroids-for-when-needed weekly 0.8 https://www.themednet.org/when-if-at-all-do-you-use-nasolacrimal-duct-stents-to-prevent-stenosis-obstruction-when-treating-skin-sinonasal-or-other-mid-facial-h-n-cancers-with-radiation-therapy weekly 0.8 https://www.themednet.org/how-do-you-manage-adjuvant-endocrine-therapy-for-microinvasive-hr-positive-disease-measuring-1-mm-in-extension weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-necrotizing-myopathy-with-positive-anti-hmhcor-ab-unresponsive-to-standard-therapies weekly 0.8 https://www.themednet.org/would-you-offer-neoadjuvant-chemotherapy-to-high-grade-t1-urothelial-carcinoma-in-a-bladder-diverticulum weekly 0.8 https://www.themednet.org/do-you-recommend-a-kidney-biopsy-in-a-patient-with-myelodysplastic-syndrome-diagnosed-two-years-prior-who-develops-new-onset-proteinuria weekly 0.8 https://www.themednet.org/how-would-you-treat-a-carcinoma-in-situ-of-the-larynx-with-involvement-of-the-false-cord-and-arytenoid-mucosal-surface weekly 0.8 https://www.themednet.org/how-would-you-treat-a-btki-naive-p53-mutated-mcl-in-1st-relapse-with-disease-noted-both-systemically-and-in-the-cns weekly 0.8 https://www.themednet.org/what-is-the-risk-of-serious-bacterial-infection-in-a-febrile-solid-tumor-patient-who-has-not-yet-started-cancer-directed-therapy-and-has-normal-cell-counts-with-no-central-line weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treat-metastatic-poorly-differentiated-thyroid-cancer-with-papillary-features weekly 0.8 https://www.themednet.org/how-does-the-presence-of-psma-negative-lesions-in-a-patient-with-mcrpc-affect-your-decision-to-treat-with-lutetium-177lu-vipivotide-tetraxetan weekly 0.8 https://www.themednet.org/where-do-sibo-testing-and-or-empiric-antibiotics-fit-into-the-management-of-patients-with-bloating-abdominal-pain-diarrhea-constipation-or-distention weekly 0.8 https://www.themednet.org/in-patients-with-sever-asthma-who-are-candidates-for-biologics-do-you-put-them-on-an-ics-laba-lama-rather-than-high-dose-ics-laba weekly 0.8 https://www.themednet.org/in-nsclc-would-you-manage-other-met-alterations-such-as-a-met-t618t-mutation-in-the-same-way-as-a-met-exon-14-skipping-mutation weekly 0.8 https://www.themednet.org/at-what-point-do-you-stop-monitoring-nonfunctional-pituitary-adenomas-given-recent-evidence-showing-no-long-term-benefit-1 weekly 0.8 https://www.themednet.org/what-is-your-preferred-method-of-secondary-iol-placement-yamane-vs-scleral-sutured-and-why weekly 0.8 https://www.themednet.org/what-is-your-approach-to-audiometric-monitoring-for-patients-on-teprotumumab-and-how-do-you-discuss-the-possibility-of-irreversible-hearing-loss-with-your-patients weekly 0.8 https://www.themednet.org/what-is-the-optimal-duration-of-biologic-therapy-before-assessing-for-non-response-and-initiating-a-switch-in-patients-with-uncontrolled-asthma weekly 0.8 https://www.themednet.org/what-workup-would-you-perform-for-a-patient-with-chronic-kidney-disease-and-kidney-biopsy-showing-hypersensitivity-type-interstitial-nephritis weekly 0.8 https://www.themednet.org/what-is-an-effective-technique-for-obtaining-tissue-for-pathological-analysis-from-a-broad-based-luminal-punctal-canalicular-mass weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-sexually-inappropriate-behaviors-in-hospitalized-patients-with-psychotic-symptoms weekly 0.8 https://www.themednet.org/what-are-the-clinical-prompts-that-lead-you-to-consider-deprescribing-bisphosphonate-therapy-in-older-adults-with-osteoporosis weekly 0.8 https://www.themednet.org/does-si-joint-erosion-on-mri-pelvis-push-you-to-use-tnf-inhibitors-over-nsaids-as-first-line-for-axial-spondyloarthritis weekly 0.8 https://www.themednet.org/in-patients-with-sle-and-coexisting-knee-osteoarthritis-how-useful-is-musculoskeletal-ultrasound-particularly-power-doppler-in-distinguishing-an-sle-inflammatory-arthritis-flare-from-an-oa-flare-when-serologies-and-inflammatory-markers-may-not-be-helpful weekly 0.8 https://www.themednet.org/do-you-routinely-give-combination-antifungal-therapy-for-invasive-mold-infections-2 weekly 0.8 https://www.themednet.org/in-a-patient-with-biochemical-recurrence-after-radical-prostatectomy-for-pt2-disease-and-a-high-risk-decipher-genomic-classifier-with-a-psa-of-0-7-ng-ml-is-there-a-rationale-for-administering-salvage-radiation-therapy-to-the-prostate-fossa weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-timing-of-their-medications-when-they-are-taking-both-oral-semaglutide-and-levothyroxine weekly 0.8 https://www.themednet.org/for-afib-patients-with-high-risk-of-cva-who-cannot-tolerate-full-dose-ac-due-to-bleeding-do-you-consider-low-dose-extended-dosing-anticoagulation-even-if-they-do-not-meet-age-gfr-criteria-for-a-dose-reduction-if-watchman-is-not-readily-available-as-an-opt weekly 0.8 https://www.themednet.org/what-is-the-utility-of-remibrutinib-or-other-tyrosine-kinase-inhibitors-in-mcas weekly 0.8 https://www.themednet.org/how-do-you-discuss-the-importance-of-ongoing-lifestyle-based-interventions-when-starting-a-glp-1-agonist-for-medically-relevant-obesity-i-e-with-comorbid-conditions weekly 0.8 https://www.themednet.org/for-a-patient-with-intracranial-mets-for-es-sclc-who-undergoes-resection-do-you-routinely-offer-post-op-srs-to-the-cavity-or-do-you-proceed-with-wbrt weekly 0.8 https://www.themednet.org/how-do-you-differentiate-between-hiv-associated-neurocognitive-disease-hand-and-other-causes-of-neurocognitive-impairment weekly 0.8 https://www.themednet.org/do-you-routinely-hold-sglt2-inhibitors-prescribed-for-chf-or-ckd-in-acutely-ill-patients-upon-admission-to-the-hospital weekly 0.8 https://www.themednet.org/for-older-adults-undergoing-intermediate-risk-non-cardiac-surgery-do-you-routinely-check-pre-operative-pro-bnp-levels-for-risk-stratification-based-on-emerging-data-and-updated-canadian-guidelines weekly 0.8 https://www.themednet.org/for-patients-with-acute-renal-failure-and-possible-urinary-retention-do-you-obtain-a-bedside-bladder-pocus-exam-before-ordering-renal-imaging-or-placing-a-foley-catheter weekly 0.8 https://www.themednet.org/is-there-any-role-for-adjusting-how-long-to-hold-anticoagulation-perioperatively-based-on-doac-dose weekly 0.8 https://www.themednet.org/in-patients-with-an-acute-gout-flare-who-have-stage-3-4-ckd-or-are-on-anticoagulation-what-is-your-preferred-first-line-treatment weekly 0.8 https://www.themednet.org/do-you-modify-dosing-and-monitoring-of-lu-177-psma-therapy-for-patients-with-prior-large-field-rt-involving-substantial-active-marrow-compared-with-patients-who-only-had-focal-bone-sbrt weekly 0.8 https://www.themednet.org/when-selecting-mcrpc-patients-for-pluvicto-which-baseline-variables-do-you-find-most-useful-or-predictive-of-potential-hematologic-toxicity weekly 0.8 https://www.themednet.org/what-triggers-you-to-choose-urgent-thyroidectomy-versus-therapeutic-plasma-exchange-versus-continued-medical-management-for-refractory-thyroid-storm-despite-12-24-hours-of-guideline-concordant-therapy weekly 0.8 https://www.themednet.org/when-proceeding-with-neoadjuvant-crt-what-is-your-radiotherapy-plan-in-a-patient-with-distal-esophageal-adenocarcinoma-and-an-avid-ap-window-lymph-node weekly 0.8 https://www.themednet.org/how-should-ppis-or-h2-blockers-be-managed-in-peritoneal-dialysis-patients-with-a-history-of-peritonitis-and-peptic-ulcer-disease-considering-the-potential-infection-risk weekly 0.8 https://www.themednet.org/do-you-initiate-anticoagulation-for-patients-with-vascular-compression-secondary-to-solid-tumor-lymphoma weekly 0.8 https://www.themednet.org/how-long-do-you-apply-patch-testing-before-interpreting-the-results weekly 0.8 https://www.themednet.org/do-you-typically-excise-spitz-nevus-nevi weekly 0.8 https://www.themednet.org/when-would-you-consider-endomyocardial-biopsy-for-newly-noted-lvh-with-genetic-testing-significant-for-myh7-mutation-but-also-a-ttr-vus-also-present weekly 0.8 https://www.themednet.org/what-radiation-doses-and-subsequent-treatment-monitoring-would-you-recommend-for-multiple-myeloma-patients-with-multifocal-bony-lesions-and-decline-chemotherapy weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-give-nimodipine-to-patients-with-non-traumatic-non-anuerysmal-subarchnoid-hemorrhage weekly 0.8 https://www.themednet.org/what-is-your-approach-for-surveillance-of-coiled-unruptured-aneurysm weekly 0.8 https://www.themednet.org/what-is-your-antiplatelet-strategy-after-aneurysm-coiling weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-awake-mapping-for-dbs-placement weekly 0.8 https://www.themednet.org/how-do-you-determine-which-targeting-modality-to-utilize-for-dbs-placement weekly 0.8 https://www.themednet.org/do-you-include-pembrolizumab-for-metastatic-recurrent-cervical-cancer-per-keynote-826-regardless-of-pdl1-status weekly 0.8 https://www.themednet.org/what-is-your-approach-for-an-intact-patient-who-is-found-to-have-new-concurrent-superficial-cortical-brain-and-lumbar-spine-tumors weekly 0.8 https://www.themednet.org/how-do-you-determine-which-site-to-utilize-for-ventricular-peritoneal-shunt-placement weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-a-patient-with-traumatic-unilateral-perched-facets weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-reherniated-lumbar-disc-that-was-initially-treated-with-a-minimally-invasive-hemilaminectomy-and-discectomy weekly 0.8 https://www.themednet.org/how-do-you-determine-when-to-change-an-evd-in-a-trauma-patient-that-may-not-need-a-shunt weekly 0.8 https://www.themednet.org/for-patients-who-have-4-levels-of-ventral-cervical-compression-how-do-you-determine-whether-to-do-an-anterior-or-posterior-approach weekly 0.8 https://www.themednet.org/how-do-you-decide-between-an-alif-vs-a-tlif-for-l5-s1-spondylolisthesis weekly 0.8 https://www.themednet.org/how-do-you-determine-when-to-use-a-standalone-cage-during-an-extension-of-an-anterior-cervical-fusion weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-using-the-robot-rather-than-stealth-for-image-guided-screw-placement weekly 0.8 https://www.themednet.org/under-what-circumstances-do-you-perform-an-mma-embolization-prior-to-chronic-subdural-hematoma-evacuation weekly 0.8 https://www.themednet.org/for-sellar-tumors-with-suprasellar-extension-how-do-you-decide-between-an-endoscopic-approach-versus-a-craniotomy weekly 0.8 https://www.themednet.org/how-do-you-determine-timing-for-surveillance-imaging-for-an-asymptomatic-patient-who-was-incidentally-found-to-have-a-meningioma weekly 0.8 https://www.themednet.org/would-you-recommend-empiric-coverage-for-vancomycin-resistance-enterococcus-in-an-unstable-patient-with-sepsis-multiple-comorbidities-and-a-recent-icu-stay-in-a-high-vre-prevalence-unit-despite-recent-cultures-without-growth-of-vre weekly 0.8 https://www.themednet.org/under-what-circumstances-do-you-consider-mayfield-pinning-for-fixation-during-a-translabyrinthine-approach-for-vestibular-schwannoma-resection weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-a-post-natal-myelomeningocele-repair-rather-than-a-fetal-myelomeningocele-repair weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-transitioning-back-to-a-ventricular-peritoneal-shunt-from-a-ventricular-pleural-shunt weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-a-selective-dorsal-rhizotomy-for-treatment-of-lower-extremity-spasticity weekly 0.8 https://www.themednet.org/how-do-you-decide-what-type-of-spinal-cord-stimulator-to-utilize-for-pain-control weekly 0.8 https://www.themednet.org/what-is-the-best-alternative-oral-therapy-for-treatment-of-non-severe-pulmonary-nocardiosis-in-an-immunocompetent-patient-with-sulfa-allergy weekly 0.8 https://www.themednet.org/would-you-consider-restarting-imid-therapy-in-a-patient-with-recent-stroke-while-on-imid weekly 0.8 https://www.themednet.org/what-would-you-your-approach-to-evaluation-and-monitoring-of-a-patient-with-elevated-ama-and-increased-immunoglobulins-with-a-low-alkaline-phosphatase weekly 0.8 https://www.themednet.org/in-a-patient-with-known-aps-triple-positive-and-interstitial-lung-disease-nsip-how-do-you-distinguish-aps-associated-lung-involvement-from-connective-tissue-disease-related-ild weekly 0.8 https://www.themednet.org/what-is-the-best-time-frame-to-intervene-surgically-for-the-management-of-traumatic-macular-hole-and-what-techniques-should-one-consider weekly 0.8 https://www.themednet.org/for-very-low-cylinder-that-does-not-qualify-for-a-toric-lens-and-no-access-to-femto-do-you-ever-consider-lris-or-slightly-adjusting-your-main-wound-placement-if-possible weekly 0.8 https://www.themednet.org/what-is-your-approach-to-stone-prevention-for-patients-with-recurrent-nephrolithiasis-who-are-started-on-glp-1-agonist-therapy-and-subsequently-consume-less-daily-water-intake weekly 0.8 https://www.themednet.org/what-is-your-approach-in-deciding-when-to-start-or-briefly-defer-anticoagulation-in-newly-diagnosed-budd-chiari-syndrome-with-large-esophageal-varices-and-very-recent-banding weekly 0.8 https://www.themednet.org/what-early-response-criteria-and-timeframe-do-you-use-to-declare-corticosteroid-non-response-and-move-to-expedited-transplant-listing-in-patient-with-acute-severe-aih-without-encephalopathy weekly 0.8 https://www.themednet.org/in-aih-pbc-overlap-with-both-hepatitis-and-cholestasis-how-do-you-determine-whether-incomplete-biochemical-response-at-6-12-months-reflects-undertreated-aih-versus-inadequately-controlled-cholestasis weekly 0.8 https://www.themednet.org/what-adjustments-to-total-parenteral-nutrition-tpn-do-you-recommend-for-hospitalized-patients-with-hyponatremia weekly 0.8 https://www.themednet.org/do-you-have-different-24-hour-serum-sodium-correction-targets-for-patients-with-severe-moderate-and-mild-hyponatremia weekly 0.8 https://www.themednet.org/in-patients-who-meet-baveno-vii-nit-criteria-for-csph-and-are-candidates-for-nsbb-to-prevent-decompensation-when-if-ever-do-you-still-perform-screening-endoscopy-before-starting-nsbb-and-what-specific-findings-would-change-your-management weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-patients-with-recurrent-orolabial-herpes weekly 0.8 https://www.themednet.org/how-do-you-approach-management-and-monitoring-of-a-patient-with-features-suggestive-of-early-or-incomplete-antisynthetase-syndrome-mechanics-hands-and-positive-antisynthetase-antibody-but-no-objective-evidence-of-myositis-arthritis-or-ild-at-presentation weekly 0.8 https://www.themednet.org/how-do-you-manage-hypercalcemia-in-sarcoidosis-despite-being-on-immunosuppressive-therapy weekly 0.8 https://www.themednet.org/do-you-ever-use-pocus-to-evaluate-for-fecal-impaction-or-stool-burden-in-a-patient-with-abdominal-pain weekly 0.8 https://www.themednet.org/how-did-the-sprint-mind-study-influence-your-approach-to-blood-pressure-management-in-older-patients-at-risk-of-dementia weekly 0.8 https://www.themednet.org/in-patients-with-type-2-diabetes-and-albuminuric-ckd-already-on-acei-arb-are-you-initiating-finerenone-over-spironolactone-in-the-primary-care-setting weekly 0.8 https://www.themednet.org/in-an-older-adults-with-dementia-related-behavioral-symptoms-refractory-to-nonpharmacological-management-in-whom-you-are-starting-ssri-do-you-ever-consider-a-short-course-of-antipsychotic-medication-to-overlap-with-the-initiation-of-ssri-while-waiting-for weekly 0.8 https://www.themednet.org/does-postpartum-status-impact-your-choice-of-chemotherapy-regimen-for-young-women-with-a-hr-her2-invasive-ductal-carcinoma-with-1-3-positive-lymph-nodes weekly 0.8 https://www.themednet.org/what-has-your-experience-been-with-using-ssris-to-treat-negative-symptoms-of-schizophrenia weekly 0.8 https://www.themednet.org/would-you-recommend-hrt-to-treat-hypogonadism-in-an-80-year-old-male-patient weekly 0.8 https://www.themednet.org/would-you-start-a-glp-1-receptor-agonist-for-treatment-of-type-2-diabetes-in-patients-with-remote-family-history-of-medullary-thyroid-cancer-without-genetic-testing weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-young-woman-referred-for-isolated-anterior-uveitis-now-resolved-in-the-absence-of-systemic-manifestations-or-end-organ-involvement-but-with-serologies-notable-for-strongly-positive-pr3-negative-c-anca weekly 0.8 https://www.themednet.org/how-do-you-counsel-your-patients-with-diabetes-that-tighter-glycemic-control-could-be-harmful-as-they-age-when-theyve-been-committed-to-a-goal-a1c-7-0-7-5-for-many-years weekly 0.8 https://www.themednet.org/in-a-patient-with-gout-previously-treated-with-pegloticase-and-then-discontinued-therapy-can-pegloticase-be-safely-and-effectively-restarted weekly 0.8 https://www.themednet.org/do-you-integrate-firearm-violence-prevention-into-your-annual-wellness-visits weekly 0.8 https://www.themednet.org/how-do-you-manage-the-side-effects-of-ropeginterferon-alfa-2b-for-polycythemia-vera-patients weekly 0.8 https://www.themednet.org/Can-a-breast-cancer-patient-who-received-chemotherapy-with-AC-during-her-3rd-trimester-breastfeed-before-resuming-chemotherapy-postpartum weekly 0.8 https://www.themednet.org/for-patients-hospitalized-with-volume-overload-who-improve-after-iv-diuresis-but-have-no-prior-outpatient-diuretic-regimen-do-you-routinely-start-a-scheduled-oral-diuretic-at-discharge weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-hsct-associated-thrombotic-microangiopathy weekly 0.8 https://www.themednet.org/what-factors-prompt-you-to-treat-enterococcus-when-isolated-in-polymicrobial-culture-from-patients-with-urinary-tract-infection weekly 0.8 https://www.themednet.org/do-you-use-skin-prick-testing-wheal-size-grade-or-serum-ige-levels-when-deciding-what-dose-of-allergen-immunotherapy-to-start-a-patient-on weekly 0.8 https://www.themednet.org/do-you-recommend-that-patients-with-type-2-diabetes-who-regularly-drink-artificially-sweetened-beverages-continue-their-current-consumption-gradually-reduce-their-intake-or-switch-entirely-to-water-in-light-of-the-sodas-trial weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-anticholinergic-medications-in-patients-at-risk-for-sudden-cardiac-death-given-evidence-that-increased-anticholinergic-burden-may-elevate-the-risk-of-out-of-hospital-cardiac-arrest weekly 0.8 https://www.themednet.org/in-current-practice-after-dcd-transplantation-what-early-clinical-or-laboratory-signals-push-you-to-escalate-beyond-mrcp-first-toward-earlier-ercp-or-targeted-hepatic-arterial-assessment-for-suspected-ischemic-cholangiopathy weekly 0.8 https://www.themednet.org/in-dcd-liver-offers-where-nrp-or-hypothermic-oxygenated-perfusion-is-available-what-donor-recipient-factors-are-still-absolute-or-near-absolute-reasons-to-decline-because-of-ischemic-cholangiopathy-risk weekly 0.8 https://www.themednet.org/how-do-you-decide-between-urgent-early-liver-transplant-listing-versus-a-time-limited-watchful-waiting-strategy-in-critically-ill-severe-alcohol-associated-hepatitis-with-some-signs-of-potential-hepatic-recovery weekly 0.8 https://www.themednet.org/under-what-circumstances-do-you-recommend-use-of-antibiotics-during-end-of-life-care weekly 0.8 https://www.themednet.org/in-what-circumstances-would-you-consider-monotherapy-for-empiric-treatment-of-unresectable-nontuberculous-mycobacterial-lymphadenitis weekly 0.8 https://www.themednet.org/what-are-the-treatment-options-for-a-patient-with-unfavorable-intermediate-risk-pca-who-desires-future-child-bearing weekly 0.8 https://www.themednet.org/in-patients-with-anoxic-brain-injury-who-have-a-tracheostomy-but-liberated-from-the-ventilator-and-appear-to-be-able-to-protect-their-airway-but-have-no-meaningful-neurological-function-is-there-a-role-for-decannulation weekly 0.8 https://www.themednet.org/would-you-treat-patient-with-early-stage-unfavorable-classic-hodgkin-lymphoma-with-6-cycles-instead-of-4-cycles-of-nivo-avd-to-avoid-mediastinal-radiation-in-young-female weekly 0.8 https://www.themednet.org/do-you-routinely-perform-serologic-testing-for-systemic-sclerosis-when-absent-contractility-is-identified-on-high-resolution-manometry weekly 0.8 https://www.themednet.org/in-a-patient-with-anorectal-scc-t2n0-with-a-history-of-bladder-prolapse-managed-with-pessary-would-the-pessary-need-to-be-removed-prior-to-radiation weekly 0.8 https://www.themednet.org/would-you-offer-apbi-in-a-patient-with-pagets-disease weekly 0.8 https://www.themednet.org/when-telemetry-or-ecg-shows-a-newly-prolonged-qtc-e-g-500-ms-in-an-otherwise-stable-hospitalized-patient-how-aggressively-do-you-modify-medications-electrolytes-or-monitoring weekly 0.8 https://www.themednet.org/emerging-data-from-the-nejm-clinician-2025-year-in-review-highlight-the-high-stroke-risk-associated-with-transient-hospital-onset-atrial-fibrillation-when-you-identify-new-af-in-a-hospitalized-patient-that-cardioverts-spontaneously-within-24-48-hours-and- weekly 0.8 https://www.themednet.org/for-a-55-year-old-patient-who-has-been-on-low-dose-lorazepam-0-5-mg-nightly-for-insomnia-for-six-years-prescribed-by-a-psychiatrist-who-is-no-longer-involved-in-their-care-they-are-cognitively-intact-works-full-time-and-has-no-history-of-substance-misuse- weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-rsv-vaccination-in-adults-60-74-years-old-who-have-risk-factors-for-several-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-chronic-pain-in-older-adults-who-are-poor-candidates-for-both-opioids-and-nsaids weekly 0.8 https://www.themednet.org/have-results-from-recent-quasi-experimental-trials-around-herpes-zoster-vaccination-and-dementia-risk-progression-affected-your-clinical-practice weekly 0.8 https://www.themednet.org/when-an-older-patient-with-mild-cognitive-impairment-asks-you-directly-whether-they-should-still-be-driving-how-do-you-handle-that-conversation-and-what-clinical-tools-or-thresholds-if-any-guide-your-recommendation weekly 0.8 https://www.themednet.org/how-do-you-decide-when-a-geriatric-patients-weight-loss-warrants-an-extensive-workup-versus-a-more-focused-or-watchful-approach weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-diazoxide-for-the-management-of-reactive-hypoglycemia-in-patients-who-have-not-responded-to-acarbose-or-dietary-modifications weekly 0.8 https://www.themednet.org/what-is-the-clinical-significance-of-a-low-c-peptide-and-insulin-level-when-glucose-levels-are-normal weekly 0.8 https://www.themednet.org/what-have-you-found-more-effective-blue-light-or-red-light-photodynamic-therapy-pdt weekly 0.8 https://www.themednet.org/how-does-progression-independent-of-relapse-activity-pirma-influence-your-decision-to-change-treatment-in-relapsing-remitting-multiple-sclerosis weekly 0.8 https://www.themednet.org/what-would-prompt-you-to-obtain-igra-in-a-patient-starting-an-il-17-inhibitor-for-psoriasis-who-is-also-on-concomitant-immunosuppression-despite-the-no-routine-testing-recommendations-before-initiating-this-class-of-biologic weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-biopsy-a-patient-with-overlapping-signs-of-female-pattern-hair-loss-and-possible-early-central-centrifugal-cicatricial-alopecia weekly 0.8 https://www.themednet.org/how-would-you-treat-pattern-hair-loss-in-a-woman-on-aromatase-inhibitors-for-breast-cancer weekly 0.8 https://www.themednet.org/do-you-stop-netarsudil-or-brimonidine-for-patients-with-very-injected-conjunctiva-prior-to-trabeculectomy-and-what-do-you-feel-is-the-benefit weekly 0.8 https://www.themednet.org/would-you-pursue-cholestyramine-washout-in-a-patient-on-leflunomide-for-ra-who-is-experiencing-worsening-necrotic-dental-infection-secondary-to-pseudomonas weekly 0.8 https://www.themednet.org/what-threshold-do-you-use-to-escalate-to-a-multidisciplinary-child-sexual-abuse-evaluation-when-a-child-with-newly-diagnosed-lichen-sclerosus-also-has-persistent-recurrent-vulvovaginal-symptoms-despite-appropriate-lichen-sclerosus-therapy weekly 0.8 https://www.themednet.org/when-utilizing-hypofractionation-for-postmastectomy-radiation-what-is-your-strategy-for-boosting-an-enlarged-internal-mammary-lymph-node weekly 0.8 https://www.themednet.org/for-patients-with-mssa-bacteremia-and-planned-oxacillin-at-home-via-opat-due-to-start-the-day-after-discharge-would-you-consider-discharging-after-one-time-dose-of-ceftriaxone-or-daptomycin weekly 0.8 https://www.themednet.org/in-a-patient-with-rectal-cancer-when-would-you-consider-brachytherapy-monotherapy-or-brachytherapy-boost-after-crt weekly 0.8 https://www.themednet.org/do-you-read-contact-patch-tests-on-removal-and-do-those-results-matter-if-negative-at-72-or-96-hours weekly 0.8 https://www.themednet.org/how-would-you-approach-lung-sbrt-for-an-early-stage-nsclc-in-a-patient-who-is-not-an-ideal-surgical-candidate-and-has-pulmonary-avms weekly 0.8 https://www.themednet.org/do-you-always-check-an-ldh-for-surveillance-of-cll-patients-when-they-are-asymptomatic-and-not-on-treatment weekly 0.8 https://www.themednet.org/is-there-any-value-in-checking-igvh-mutation-status-in-cll-patients weekly 0.8 https://www.themednet.org/would-you-use-routine-pet-scans-after-two-cycles-of-r-chop-to-guide-first-line-treatment-de-escalation-in-low-risk-aaipi-0-dlbcl-patients weekly 0.8 https://www.themednet.org/when-do-you-consider-benzodiazepine-sparing-treatment-protocols-for-acute-alcohol-withdrawal weekly 0.8 https://www.themednet.org/when-do-you-consider-giving-iv-albumin-for-severe-hypoalbuminemia-with-third-spacing-of-fluid-outside-of-standard-indications-i-e-large-volume-paracentesis-hrs-sbp-shock-etc weekly 0.8 https://www.themednet.org/what-clinical-criteria-do-you-use-to-start-oral-nicotinamide-for-chemoprevention weekly 0.8 https://www.themednet.org/what-has-been-your-experience-with-tecovirimat-for-monkeypox weekly 0.8 https://www.themednet.org/for-mcrpc-patients-who-are-elibible-for-both-would-you-recommend-enzalutamide-rad223-eortc-1333-peace-3-or-enzalutamide-lu-psma-617-enza-p weekly 0.8 https://www.themednet.org/do-you-stop-esa-when-starting-myelofibrosis-patients-on-jak-inhibitor-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-abdominal-pain-and-increased-stool-frequency-found-to-have-endoscopic-ileitis-but-histology-without-typical-features-of-chronicity-with-worsening-symptoms-after-starting-budesonide weekly 0.8 https://www.themednet.org/prior-to-gender-affirming-surgery-do-you-hold-estrogen-or-convert-to-transdermal-to-minimize-postop-vte-risk-is-10-days-of-postop-prophylactic-dose-lmwh-a-reasonable-strategy-for-these-patients-if-their-caprini-score-is-5 weekly 0.8 https://www.themednet.org/if-a-young-patient-with-biopsy-proven-eoe-is-doing-well-on-bid-ppi-when-would-you-consider-switching-to-dupixent-in-order-to-precent-long-term-complications-such-as-strictures weekly 0.8 https://www.themednet.org/when-alt-is-persistently-normal-and-hbv-dna-is-high-but-noninvasive-markers-suggest-more-advanced-disease-how-do-you-triage-between-biopsy-immediate-antiviral-therapy-or-close-observation-and-which-discordance-patterns-most-strongly-suggest-silent-progres weekly 0.8 https://www.themednet.org/have-you-found-a-successful-treatment-option-for-fixed-descemets-folds-following-prolonged-hypotony-after-hypotony-has-been-treated-resolved-or-descemets-striae-from-a-surgical-incision weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-genetic-testing-in-patients-older-than-30-years-with-resistant-hypertension-and-hypokalemia-but-with-a-normal-aldosterone-to-renin-ratio-and-no-known-family-history-of-hypertension weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-fidaxomicin-versus-vancomycin-for-initial-clostridioides-difficile-infection-in-immunocompromised-patients-considering-the-lower-recurrence-rates-but-higher-cost-of-fidaxomicin weekly 0.8 https://www.themednet.org/how-do-the-results-of-keynote-b15-ev-304-influence-your-preferred-treatment-for-cisplatin-eligible-mibc weekly 0.8 https://www.themednet.org/how-do-you-treat-behavioral-changes-in-patients-with-temporal-lobe-epilepsy weekly 0.8 https://www.themednet.org/is-there-a-standard-or-standard-recommendation-for-secondary-our-primary-stroke-prevention-in-a-patient-with-pulmonary-shunt weekly 0.8 https://www.themednet.org/when-do-you-consider-pet-ct-to-evaluate-for-an-occult-source-of-infection-in-patients-with-persistent-bacteremia-if-tte-tee-do-not-show-evidence-of-endocarditis weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-type-1-diabetic-patient-or-a-type-2-diabetic-patient-with-hpref-on-implementing-sglt-2-inhibitors-as-part-of-heart-failure-treatment weekly 0.8 https://www.themednet.org/what-is-your-preferred-analgesic-in-patients-with-small-bowel-obstructions-or-ileus weekly 0.8 https://www.themednet.org/what-is-your-approach-to-minimizing-volume-intake-for-patients-on-dialysis-who-are-receiving-total-parenteral-nutrition-tpn weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-dysphagia-whose-egd-shows-mild-esophageal-rings-and-furrows-but-histology-was-negative-for-interepithelial-eosinophils weekly 0.8 https://www.themednet.org/in-cirrhosis-with-suspected-hrs-aki-and-baseline-ckd-or-chronically-elevated-creatinine-how-do-you-define-a-clinically-meaningful-improvement-during-an-albumin-trial-over-24-48-hours-to-distinguish-hrs-aki-from-volume-responsive-aki weekly 0.8 https://www.themednet.org/how-do-you-decide-between-proceeding-with-elective-tips-versus-delaying-for-right-heart-catheterization-and-possible-pulmonary-hypertension-therapy-when-pre-tips-tte-is-borderline-e-g-mildly-elevated-tr-velocity-with-preserved-rv-function-but-portal-decom weekly 0.8 https://www.themednet.org/how-do-you-distinguish-portopulmonary-hypertension-from-group-3-or-mixed-etiology-ph-in-liver-transplant-candidates-with-copd-ild-and-elevated-mpap-what-additional-testing-pfts-dlco-ct-v-q-abg-repeat-rhc-maneuvers-or-hemodynamic-interpretation-do-you-rely weekly 0.8 https://www.themednet.org/how-do-you-consider-the-clinical-relevance-of-elevated-serum-b12-levels-as-a-marker-of-underlying-hepatic-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-to-symptom-management-in-patients-with-infectious-diarrhea weekly 0.8 https://www.themednet.org/have-you-used-pocus-with-color-power-doppler-to-assess-blood-pressure-in-a-patient-whose-cuff-readings-are-in-doubt weekly 0.8 https://www.themednet.org/how-do-the-five-year-ublituximab-ole-results-influence-your-treatment-paradigm-with-anti-cd20-drugs-for-multiple-sclerosis weekly 0.8 https://www.themednet.org/assuming-approval-in-which-patients-would-you-choose-belzutifan-lenvatinib-litespark-011-for-advanced-rcc-with-progression-after-io-therapy weekly 0.8 https://www.themednet.org/what-were-your-actrims-2026-top-takeaways weekly 0.8 https://www.themednet.org/how-would-you-approach-the-evaluation-and-management-of-a-patient-with-rheumatoid-arthritis-receiving-leflunomide-who-presents-with-progressive-peripheral-pulmonary-cavitary-nodules-with-biopsy-revealing-necrotizing-granulomatous-inflammation weekly 0.8 https://www.themednet.org/what-are-your-isc-2026-top-takeaways weekly 0.8 https://www.themednet.org/are-you-performing-genetic-testing-on-all-patient-that-you-suspect-to-have-hereditary-angioedema-with-normal-c1-inhibitor weekly 0.8 https://www.themednet.org/would-you-consider-a-history-of-pancreatitis-an-indication-for-parathyroidectomy-in-patients-with-mild-hypercalcemia-secondary-to-primary-hyperparathyroidism weekly 0.8 https://www.themednet.org/in-patients-with-sarcoidosis-and-persistently-elevated-liver-function-tests-when-do-you-consider-initiating-ursodeoxycholic-acid-udca weekly 0.8 https://www.themednet.org/does-pleural-tenting-adjacent-to-tumor-impact-your-target-volume-for-early-stage-nsclc-planned-for-sbrt weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-lithium-about-nsaid-use weekly 0.8 https://www.themednet.org/for-a-patient-with-sclc-who-presented-with-limited-asymptomatic-brain-metastases-and-was-treated-with-systemic-therapy-alone-carbo-etop-atezo-with-partial-response-in-the-brain-after-2-cycles-how-would-you-treat-the-brain-srs-vs-wbrt-vs-continue-with-more weekly 0.8 https://www.themednet.org/are-there-any-special-considerations-for-cataract-surgery-in-a-patient-with-ice-syndrome-chandler-with-a-relatively-clear-cornea weekly 0.8 https://www.themednet.org/how-do-you-mitigate-maternal-cardiovascular-risk-in-pregnant-patients-with-known-coronary-artery-disease-who-have-discontinued-statin-therapy weekly 0.8 https://www.themednet.org/in-patients-with-moderate-persistent-asthma-and-elevated-feno-despite-adequate-symptom-control-on-omalizumab-and-ics-laba-would-you-consider-switching-to-another-biologic-such-as-dupilumab-or-tezepelumab weekly 0.8 https://www.themednet.org/in-suspected-portopulmonary-hypertension-with-high-cardiac-output-where-mpap-is-elevated-but-pvr-is-acceptable-do-you-base-liver-transplant-candidacy-primarily-on-pvr-and-rv-function-rather-than-mpap-and-how-do-you-operationalize-that-in-your-listing-deci weekly 0.8 https://www.themednet.org/do-you-avoid-using-immunotherapy-if-there-is-concomitant-keap1-mutation-in-adjuvant-therapy-of-stage-ii-or-iii-malignant-melanoma weekly 0.8 https://www.themednet.org/what-is-the-appropriate-surveillance-strategy-for-a-columnar-metaplasia-seen-in-a-c1m3-segment-of-salmon-colored-mucosa-in-the-tubular-esophagus-with-repeated-biopsies-without-goblet-cells-intestinal-metaplasia-performed-by-different-gastroenterologists weekly 0.8 https://www.themednet.org/what-is-your-approach-to-performing-outpatient-hemodialysis-in-patients-with-lvads-particularly-regarding-blood-pressure-assessment-and-ultrafiltration-management-when-doppler-measurements-are-required-due-to-low-pulsatility weekly 0.8 https://www.themednet.org/how-does-a-strong-family-history-of-breast-cancer-influence-your-decision-between-rai-and-thyroidectomy-for-definitive-treatment-of-hyperthyroidism-in-light-of-emerging-observational-data-suggesting-a-possible-association-between-rai-and-increased-breast- weekly 0.8 https://www.themednet.org/are-you-more-likely-to-initiate-a-calcium-channel-blocker-rather-than-a-beta-blocker-as-first-line-therapy-in-patients-with-symptomatic-nonobstructive-hypertrophic-cardiomyopathy-in-light-of-emerging-randomized-data-suggesting-potential-physiologic-advant weekly 0.8 https://www.themednet.org/brca-1-pos-p-t1c-pn0-triple-neg-breast-cancer-s-p-mastectomy-ckd-stage-5-cr-6-0-do-you-recommend-adjuvant-chemo weekly 0.8 https://www.themednet.org/do-you-routinely-evaluate-patients-with-collagen-disorders-or-ehlers-danlos-for-platelet-defects weekly 0.8 https://www.themednet.org/what-are-your-next-steps-for-a-patient-with-gastritis-on-histology-without-nsaid-use-and-h-pylori-negative weekly 0.8 https://www.themednet.org/how-do-you-approach-the-decision-to-initiate-or-continue-bisphosphonate-therapy-in-an-older-patient-with-significant-esophageal-disease-or-swallowing-dysfunction weekly 0.8 https://www.themednet.org/as-direct-to-consumer-continuous-glucose-monitoring-becomes-more-common-patients-without-diabetes-are-bringing-their-glucose-data-and-asking-for-interpretation-and-action-how-do-you-decide-when-this-information-is-clinically-useful-and-has-it-changed-any- weekly 0.8 https://www.themednet.org/what-framework-or-risk-assessment-tool-is-most-effective-in-determining-surgical-or-palliative-management-of-acute-hip-fracture-after-a-fall-in-an-elderly-patient-with-co-morbidities-and-poor-functional-status weekly 0.8 https://www.themednet.org/how-do-you-manage-acute-agitation-or-psychosis-in-patients-who-are-already-taking-aripiprazole-oral-or-long-acting-injectable weekly 0.8 https://www.themednet.org/do-you-recommend-captopril-for-patients-with-cystine-nephrolithiasis-given-mixed-data-on-its-effectiveness weekly 0.8 https://www.themednet.org/what-clinical-or-imaging-features-help-distinguish-intracranial-atherosclerotic-disease-from-intracranial-dissection-in-the-setting-of-an-lvo weekly 0.8 https://www.themednet.org/for-a-patient-with-acute-stroke-who-cannot-tolerate-statins-what-is-your-preferred-second-line-agent-for-secondary-prevention weekly 0.8 https://www.themednet.org/how-do-you-approach-a-child-with-recurrent-parotitis-who-has-had-negative-serum-testing-for-sjogrens-and-igg4-related-disease-would-a-minor-salivary-gland-biopsy-be-sufficient-to-rule-out-inflammatory-diagnoses-or-do-you-prefer-a-core-parotid-gland-biopsy weekly 0.8 https://www.themednet.org/how-do-you-distinguish-cannabinoid-hyperemesis-syndrome-from-cyclic-vomiting-syndrome weekly 0.8 https://www.themednet.org/how-do-you-approach-osteoporosis-screening-in-men weekly 0.8 https://www.themednet.org/for-patients-with-chronic-spontaneous-urticaria-who-remain-symptomatic-despite-maximally-dosed-second-generation-h1-antihistamines-do-you-notice-any-meaningful-difference-in-symptom-response-with-add-on-montelukast-versus-famotidine weekly 0.8 https://www.themednet.org/do-you-routinely-test-for-toxoplasmosis-during-work-up-of-fever-of-unknown-origin-in-an-immunocompetent-patient-with-significant-cat-exposure weekly 0.8 https://www.themednet.org/when-would-you-consider-using-transvaginal-cabergoline-in-the-treatment-of-prolactinoma weekly 0.8 https://www.themednet.org/in-patients-with-severe-osteoporosis-history-of-retinal-artery-occlusion-and-hypercalciuria-would-you-favor-pth-analogue-therapy-or-evenity weekly 0.8 https://www.themednet.org/do-you-switch-patients-off-of-boosted-protease-inhibitor-based-regimens-for-hiv-treatment-if-you-are-able-given-the-increased-cardiovascular-risk-associated-with-them weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-w-dlbcl-that-progressed-on-after-epoch-and-subsequently-treated-with-a-cd19-allo-car-t-product-within-90-days-of-receiving-the-aphaeresis-product weekly 0.8 https://www.themednet.org/would-you-still-restrict-live-viral-vaccines-in-a-pediatric-patient-with-cd4-count-500-even-though-they-had-previously-tolerated-them-before-cd4-testing-was-obtained weekly 0.8 https://www.themednet.org/how-reliable-are-the-expiration-dates-of-patch-test-allergens weekly 0.8 https://www.themednet.org/how-do-you-treat-83-year-old-woman-with-merkel-cell-carcinoma-of-the-right-thigh-s-p-wle-slnb-her-pathology-shows-negative-margins-of-the-primary-site-excision-of-the-right-thigh-but-1-3-right-inguinal-sentinel-lymph-nodes-positive-for-isolated-tumor-cell weekly 0.8 https://www.themednet.org/in-the-community-setting-with-limited-neuropsychiatry-availability-how-would-you-decide-if-it-is-appropriate-to-start-achei-in-those-with-mci-with-moca-showing-stm-deficits-but-also-executive-dysfunction-do-all-these-pts-need-formal-testing-before-startin weekly 0.8 https://www.themednet.org/do-you-recommend-any-specific-tools-or-processes-references-to-help-with-determination-of-capacity-for-decision-making-for-hospitalized-older-adults weekly 0.8 https://www.themednet.org/are-there-any-lab-tests-that-can-help-determine-if-systemic-inflammation-could-interfere-with-novel-amyloid-blood-based-biomarkers-for-the-detection-of-brain-amyloid weekly 0.8 https://www.themednet.org/for-relapses-of-relapsing-polychondritis-with-suboptimal-response-to-nsaids-and-prednisone-what-are-strategies-you-use-for-flare-treatment weekly 0.8 https://www.themednet.org/Should-methotrexate-and-anti-tnf-agent-be-stopped-in-RA-patient-diagnosed-with-PJP-and-for-how-long weekly 0.8 https://www.themednet.org/Do-Mednet-experts-prefer-lower-lithium-targets-in-bipolar-II-maintenance weekly 0.8 https://www.themednet.org/do-you-accept-a-decline-in-egfr-during-aggressive-diuresis-for-heart-failure-if-the-patient-is-successfully-decongesting-given-data-suggesting-modest-egfr-decline-with-improved-congestion-may-still-be-associated-with-lower-mortality weekly 0.8 https://www.themednet.org/is-anyone-currently-willing-to-use-single-dose-bicillin-for-latent-syphilis-of-unknown-duration-to-mitigate-the-supply-issues-at-pfizer weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-bipolar-i-disorder-who-report-emotional-blunting-or-numbness-while-taking-lithium weekly 0.8 https://www.themednet.org/how-do-you-manage-spinal-cord-compression-in-a-new-neuroblastoma-diagnosis weekly 0.8 https://www.themednet.org/how-long-to-wait-after-superficial-keratectomy-for-cataract-measurements weekly 0.8 https://www.themednet.org/do-you-initiate-hormone-replacement-therapy-in-a-young-woman-with-treatment-induced-primary-ovarian-insufficiency-after-childhood-cancer weekly 0.8 https://www.themednet.org/how-do-approach-a-patient-with-indolent-small-volume-but-slowly-progressive-lung-mets-from-sarcoma weekly 0.8 https://www.themednet.org/what-has-been-your-experience-with-dslt weekly 0.8 https://www.themednet.org/what-are-the-toxic-effects-of-a-small-amount-of-intraocular-perfluoron-on-the-retina-and-cornea weekly 0.8 https://www.themednet.org/how-do-you-suggest-using-pocus-to-detect-or-confirm-a-pneumothorax weekly 0.8 https://www.themednet.org/do-you-have-a-standard-approach-to-using-pocus-to-evaluate-acute-abdominal-pain weekly 0.8 https://www.themednet.org/do-you-consider-resmetirom-for-someone-with-diabetes-with-alt-ast-consistently-in-the-100s-despite-attempted-lifestyle-changes-after-a-comprehensive-work-up-ruling-out-medications-hepatotrophic-and-non-hepatotrophic-viruses-inherited-liver-diseases-autoim weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-to-large-esophageal-varices-with-redwale-marks-found-on-the-egd-done-for-screening-for-varices-in-the-setting-of-decompensated-liver-disease-who-has-never-had-gi-bleeding-and-is-adherent-to-recommendations weekly 0.8 https://www.themednet.org/what-is-the-specificity-of-dynamic-air-bronchograms-for-bacterial-pneumonia weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-offering-a-re-do-microvascular-decompression weekly 0.8 https://www.themednet.org/do-you-modify-your-cataract-surgery-i-e-biometry-phaco-parameters-post-operative-regimen-in-any-way-for-patients-with-prior-glaucoma-surgeries-and-or-severe-glaucoma weekly 0.8 https://www.themednet.org/what-psychiatric-medications-do-you-feel-comfortable-prescribing-as-a-dermatologist weekly 0.8 https://www.themednet.org/what-type-of-air-sf6-fill-following-dseak-in-scleral-fixated-iol-patients-only-ac-fill-vs-full-eye-fluid-gas-exchange weekly 0.8 https://www.themednet.org/is-there-any-role-for-prophylactic-dmard-therapy-to-prevent-immune-related-adverse-events-iraes-in-patients-receiving-immune-checkpoint-inhibitors weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-multidrug-resistant-strep-mitis-bacteremia-in-a-patient-with-prolonged-neutropenia-and-prior-severe-allergic-reaction-to-vancomycin weekly 0.8 https://www.themednet.org/when-do-you-consider-using-dextromethorphan-bupropion-for-the-treatment-of-depression weekly 0.8 https://www.themednet.org/how-do-you-identify-and-respond-to-possible-elder-abuse-in-patients-with-dementia weekly 0.8 https://www.themednet.org/when-do-you-consider-using-modafinil-as-an-adjunctive-treatment-for-depression weekly 0.8 https://www.themednet.org/which-cardiac-comorbidities-prompt-you-to-obtain-cardiology-evaluation-before-starting-stimulant-treatment-in-adults-with-newly-diagnosed-adhd weekly 0.8 https://www.themednet.org/when-do-you-consider-using-benzodiazepines-to-treat-insomnia-in-patients-with-acute-mania weekly 0.8 https://www.themednet.org/can-any-superficial-chemical-peels-be-safely-used-for-patients-with-preadolescent-comedonal-acne-which-is-not-responding-to-typical-topical-therapies weekly 0.8 https://www.themednet.org/in-patients-with-pd-l1-negative-metastatic-cervical-squamous-cell-carcinoma-at-primary-diagnosis-do-you-add-pembrolizumab-atezolizumab-or-no-immunotherapy-to-combination-platinum-taxane-bevacizumab-therapy weekly 0.8 https://www.themednet.org/what-is-your-radiotherapy-plan-for-a-large-sellar-suprasellar-mass-with-encasement-of-the-right-cavernous-and-terminal-internal-carotid-arteries weekly 0.8 https://www.themednet.org/which-neoadjuvant-adjuvant-chemotherapy-regimen-would-you-select-in-a-patient-with-resectable-stage-ib-pancreatic-head-adenocarcinoma-and-mds-sf3b1-on-reblozyl-baseline-hgb-of-8-9-g-dl weekly 0.8 https://www.themednet.org/when-do-patients-with-descending-paralysis-and-suspected-botulism-require-inpatient-emg weekly 0.8 https://www.themednet.org/what-serum-biomarkers-are-most-helpful-in-cardiac-arrest-prognostication weekly 0.8 https://www.themednet.org/are-you-using-tamoxifen-for-primary-prevention-in-your-practice weekly 0.8 https://www.themednet.org/with-2026-predictions-highlighting-menopause-as-a-major-cardiovascular-bone-and-brain-health-turning-point-and-emerging-clinical-guidelines-e-g-finlands-first-national-menopause-guideline-what-changes-should-internal-medicine-clinicians-make-in-risk-asses weekly 0.8 https://www.themednet.org/new-ed-and-primary-care-based-studies-suggest-7-day-injectable-buprenorphine-performs-similarly-to-daily-oral-buprenorphine-for-early-treatment-engagement-how-are-you-deciding-between-injectable-and-oral-formulations-when-initiating-moud-in-outpatient-gen weekly 0.8 https://www.themednet.org/what-art-regimen-would-you-switch-my-adherent-patient-to-with-low-level-viremia-to-the-300s-400s-on-symtuza-with-some-pi-resistance-however-sensitive-to-darunavir-and-insti-resistance-to-elvitegravir-raltegravir-bictegravir-cabotegravir-sensitive weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-ct2cn0-brca1-pre-menopausal-patient-with-er-pr-her2-disease-and-high-oncotype weekly 0.8 https://www.themednet.org/when-evaluating-an-older-adult-patient-for-cognitive-concerns-what-is-your-process-for-deciding-whether-or-not-to-refer-them-for-neuropsychological-testing weekly 0.8 https://www.themednet.org/at-what-point-would-you-consider-stopping-antidepressant-treatment-of-late-life-depression-after-remission weekly 0.8 https://www.themednet.org/how-would-you-approach-the-counseling-and-management-of-a-76-year-old-man-presenting-to-clinic-having-purchased-a-direct-to-consumer-ptau181-elecsys-test-rule-out-that-is-positive-for-amyloid-with-moca-29-30 weekly 0.8 https://www.themednet.org/what-is-your-approach-to-picking-a-dose-formulation-of-vitamin-d-for-a-community-dwelling-older-adult-found-to-have-vitamin-d-deficiency weekly 0.8 https://www.themednet.org/is-there-a-role-for-selective-arterial-embolization-of-rcc-before-primary-sbrt-if-so-what-criteria-size-vascular-invasion-etc-suggest-it-would-be-beneficial weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-empirically-cover-pseudomonas-for-pneumonia-in-hospitalized-patients weekly 0.8 https://www.themednet.org/as-bolus-for-pmrt-is-now-limited-to-select-cases-how-do-you-check-surface-dose-and-if-you-do-measure-and-it-is-low-what-modifications-do-you-make weekly 0.8 https://www.themednet.org/how-do-you-approach-an-isolated-positive-anti-scl-70-antibody-in-a-patient-with-no-symptoms-or-exam-findings-suggestive-of-systemic-sclerosis weekly 0.8 https://www.themednet.org/when-adding-infliximab-for-sarcoidosis-what-dose-of-methotrexate-do-you-typically-continue-to-prevent-antibody-formation weekly 0.8 https://www.themednet.org/does-global-brain-atrophy-increase-risk-for-intracranial-bleed-after-fall-in-older-adults weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-stop-routine-laboratory-monitoring-in-a-patient-with-ckd-stage-5-who-has-chosen-conservative-management weekly 0.8 https://www.themednet.org/do-you-still-recommend-a-low-sodium-diet-in-a-patient-with-heart-failure-given-recent-data-and-guideline-changes-supporting-more-liberal-intake weekly 0.8 https://www.themednet.org/do-any-subgroups-of-headache-patients-benefit-more-from-neuromodulation-devices-compared-to-pharmacologic-treatment weekly 0.8 https://www.themednet.org/how-would-you-sequence-prioritize-therapy-for-patient-with-newly-diagnosed-large-but-relatively-asymptomatic-limited-small-cell-lung-carcinoma-of-the-lung-with-newly-diagnosed-partially-obstructing-ascending-colon-cancer-with-multiple-large-liver-mets-liv weekly 0.8 https://www.themednet.org/in-patients-with-inflammatory-arthritis-ra-psoriatic-arthritis-and-a-history-of-mgus-are-there-any-concerns-regarding-use-of-biologics weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-diagnostic-workup-of-small-fiber-neuropathy-in-patients-with-known-rheumatic-disease weekly 0.8 https://www.themednet.org/what-are-the-patient-characteristics-that-increase-the-yield-of-the-test-a1at-levels-in-a-newly-diagnosed-cirrhosis-when-should-phenotype-be-requested-in-addition-to-the-levels weekly 0.8 https://www.themednet.org/how-do-you-adjust-transplant-benefit-based-decision-making-for-hcc-patients-with-prior-immune-checkpoint-inhibitor-exposure-given-the-potential-for-increased-peri-transplant-rejection-or-graft-loss weekly 0.8 https://www.themednet.org/i-have-a-74yo-female-who-suddenly-developed-malar-rash-fatigue-arthralgias-ana-1-160-smith-rnp-extremely-elevated-at-707-histone-ab-1-5-low-titer-rf-she-was-on-hctz-a-year-ago-but-it-was-discontinued-now-on-verapamil-is-this-drug-induced-lupus-or-elderly- weekly 0.8 https://www.themednet.org/would-you-consider-anti-pd1-for-treatment-of-recurrent-multifocal-cutaneous-scca-not-amenable-to-further-surgical-resection-or-radiotherapy-in-a-patient-with-t-lgl-with-baseline-moderate-pancytopenia weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-a-pediatric-patient-with-h3k27m-mutant-diffuse-midline-glioma-following-progression-after-radiation-therapy weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-ici-following-adjuvant-platinum-based-chemo-for-a-patient-with-resected-pt2a-pn1-nsclc-with-pd-l1-0-negative-egfr-alk-and-a-pathogenic-her2-exon-20-duplication weekly 0.8 https://www.themednet.org/how-do-you-schedule-follow-up-visits-for-patients-with-a-history-of-depression-who-are-pregnant-both-during-pregnancy-and-in-the-postpartum-period weekly 0.8 https://www.themednet.org/what-preoperative-printed-materials-would-you-provide-to-a-patient-if-any-to-prepare-them-to-have-mohs-surgery weekly 0.8 https://www.themednet.org/should-a-patient-with-breakthrough-urticaria-on-maximal-dosing-of-second-generation-h1-antihistamines-with-elevated-crp-and-anti-tpo-antibodies-be-treated-with-xolair-to-protect-the-thryroid-from-autoantibodies-and-improve-urticaria-control weekly 0.8 https://www.themednet.org/how-would-you-treat-aml-in-a-pregnant-patient-at-12-weeks-gestation weekly 0.8 https://www.themednet.org/how-do-you-approach-re-treatment-in-a-patient-with-chronic-central-serous-chorioretinopathy-who-has-residual-subretinal-fluid-after-their-first-half-dose weekly 0.8 https://www.themednet.org/how-should-ectasia-risk-be-triaged-using-rsb-pta-and-tomography weekly 0.8 https://www.themednet.org/How-do-you-counsel-families-of-prepubertal-girls-with-an-oncologic-diagnosis-about-cryopreservation-of-ovarian-tissue weekly 0.8 https://www.themednet.org/When-do-you-refer-patients-back-to-their-PCP-for-the-predominant-management-of-their-medical-care weekly 0.8 https://www.themednet.org/What-screening-measure-on-an-echocardiogram-is-most-helpful-for-identifying-anthracycline-induced-cardiomyopathy weekly 0.8 https://www.themednet.org/How-do-you-screen-(imaging-modality)-for-bone-density-changes-following-oncologic-treatment weekly 0.8 https://www.themednet.org/what-is-your-stepwise-approach-to-the-management-of-culprit-stemi-lesions-with-very-high-thrombotic-burden-in-spite-of-multiple-runs-of-mechanical-thrombectomy weekly 0.8 https://www.themednet.org/can-venom-immunotherapy-cause-ocular-complications weekly 0.8 https://www.themednet.org/how-do-you-weigh-in-the-risk-and-benefit-on-using-the-combination-of-anti-tnf-and-azathioprine-upfront-in-a-young-male-with-crohns-disease-with-risk-of-aggressive-lymphoma-in-the-era-of-several-novel-agents weekly 0.8 https://www.themednet.org/what-anti-proteinuria-medications-do-you-recommend-beyond-acei-arb-for-patients-with-bevacizumab-induced-proteinuria weekly 0.8 https://www.themednet.org/how-do-you-manage-pregnancy-associated-osteoporosis-in-post-partum-patients-with-vertebral-fractures weekly 0.8 https://www.themednet.org/do-you-order-the-fda-cleared-plasma-ptau181-blood-test-for-alzheimers-disease-in-a-community-dwelling-older-adult-with-subjective-cognitive-complaints-and-a-normal-cognitive-screen-and-how-do-you-handle-a-positive-result-when-the-patient-is-not-yet-eligib weekly 0.8 https://www.themednet.org/what-weight-neutral-language-do-you-recommend-be-used-for-charting-patients-with-obesity-to-avoid-stigmatizing-those-who-live-in-a-larger-body-even-more weekly 0.8 https://www.themednet.org/how-would-you-approach-the-diagnosis-and-management-of-a-patient-with-features-of-portal-hypertension-but-normal-hvpg-and-no-cirrhosis-on-biopsy-in-the-setting-of-possible-but-atypical-primary-biliary-cholangitis-and-how-would-you-evaluate-for-alternative weekly 0.8 https://www.themednet.org/do-you-expect-postoperative-single-fraction-s-pbi-to-become-the-new-soc-over-5-fraction-pbi-for-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/how-often-do-you-require-patients-seen-via-telehealth-to-have-in-person-visits-in-outpatient-psychiatry weekly 0.8 https://www.themednet.org/for-an-hbsag-positive-healthcare-worker-performing-exposure-prone-procedures-with-low-level-viremia-and-no-fibrosis-what-hbv-dna-target-complete-suppression-vs-a-specific-cutoff-do-you-use-to-justify-antiviral-therapy-solely-to-reduce-occupational-transmi weekly 0.8 https://www.themednet.org/has-the-recent-large-observational-data-suggesting-that-continuing-metformin-during-hospitalization-is-associated-with-lower-post-discharge-mortality-and-hypoglycemia-changed-your-approach-to-holding-it-on-admission-in-stable-non-critically-ill-patients-w weekly 0.8 https://www.themednet.org/in-a-hospitalized-patient-with-compensated-cirrhosis-or-heavy-alcohol-use-requiring-analgesia-do-you-use-acetaminophen-and-if-so-how-do-you-approach-dosing weekly 0.8 https://www.themednet.org/has-the-closure-af-trial-changed-your-threshold-for-referring-a-patient-with-atrial-fibrillation-for-left-atrial-appendage-closure weekly 0.8 https://www.themednet.org/would-you-use-low-dose-infliximab-as-adjunctive-therapy-in-a-patient-with-severe-central-nervous-system-tuberculosis weekly 0.8 https://www.themednet.org/when-do-you-consider-adding-baclofen-or-alginate-based-formulation-in-patients-with-gerd-what-are-the-patient-characteristics-that-you-exercise-caution-with-these weekly 0.8 https://www.themednet.org/The-Mojarro-easy-trial-why-was-there-more-hypoglycemia-in-the-Mojarro-with-metformin-as-opposed-to-the-intensive-conventional-care-that-include-included-insulin weekly 0.8 https://www.themednet.org/what-go-to-resources-or-apps-do-you-recommend-for-cbt-i-for-older-adults-with-insomnia weekly 0.8 https://www.themednet.org/for-a-patient-who-is-male-sex-but-female-gender-and-wishing-to-appear-more-feminine-and-requesting-tracheal-shave-and-vocal-feminization-surgery-should-ent-or-speech-language-pathology-be-involved-first-to-consider-behavioral-speech-therapy-is-there-evide weekly 0.8 https://www.themednet.org/in-a-patient-who-had-cataract-surgery-in-one-eye-several-years-ago-with-a-monofocal-iol-and-for-whom-there-is-no-way-to-determine-what-model-iol-was-placed-what-monofocal-iol-would-you-choose-for-the-second-eye weekly 0.8 https://www.themednet.org/in-the-era-of-nsabp-b51-would-you-consider-omission-of-rni-and-whole-breast-rt-alone-in-a-patient-with-an-axillary-nodal-presentation-and-an-occult-primary-of-triple-negative-idc-status-post-neoadjuvant-chemotherapy-and-immunotherapy-with-a-pcr-in-her-nod weekly 0.8 https://www.themednet.org/how-do-you-decide-between-stereotactic-arrhythmia-radiation-therapy-and-repeat-catheter-ablation-in-patients-with-refractory-ventricular-tachycardia-who-have-already-failed-one-prior-ablation weekly 0.8 https://www.themednet.org/for-hemodynamically-stable-patients-with-acute-pulmonary-embolism-the-recent-aha-acc-guideline-updates-favor-low-molecular-weight-heparin-over-unfractionated-heparin-for-initial-parenteral-anticoagulation-have-you-noticed-shifts-in-your-approach-as-newer- weekly 0.8 https://www.themednet.org/what-assay-do-you-use-in-instances-where-you-want-to-assess-adequate-levels-of-pradaxa-ie-dilute-thrombin-time-vs-pradaxa-level weekly 0.8 https://www.themednet.org/do-you-consider-an-eus-prior-to-the-diagnosis-of-type-1-sod-before-embarking-on-an-ercp-in-the-setting-of-appropriate-biliary-symptoms-dilatation-of-ducts-with-no-stones-on-mrcp-and-liver-related-tests-suggestive-of-cholestasis-and-how-does-the-history-of weekly 0.8 https://www.themednet.org/what-is-a-reasonable-minimal-duration-of-dapt-following-drug-coated-balloon-angioplasty-for-isr-lesions weekly 0.8 https://www.themednet.org/how-do-you-manage-moderately-severe-rls-in-a-patient-with-advanced-ckd-egfr-15-30-who-has-developed-dopaminergic-augmentation-on-a-dopamine-agonist-given-that-standard-gabapentinoid-replacement-agents-carry-significant-accumulation-risk-at-this-level-of-r weekly 0.8 https://www.themednet.org/what-is-your-step-wise-approach-to-treating-worsening-ocular-myasthenia-gravis-symptoms weekly 0.8 https://www.themednet.org/what-is-the-best-next-surgical-approach-to-manage-severe-inferior-oblique-overaction-and-superior-oblique-underaction-after-inferior-oblique-myectomy weekly 0.8 https://www.themednet.org/how-do-you-assess-the-pros-and-cons-of-discontinuing-a-slective-alpha-blocker-such-as-tamsulosin-or-alfuzosin-in-an-older-adult-male-with-orthostatic-hypotension-and-established-urinary-retention weekly 0.8 https://www.themednet.org/how-would-you-approach-adding-adt-to-salvage-radiation-therapy-for-a-biochemically-recurrent-prostate-cancer-patient-with-very-high-decipher-but-non-luminal-b-on-pam50 weekly 0.8 https://www.themednet.org/has-the-pulmcrit-analysis-challenging-the-routine-use-of-beta-blockers-in-thyroid-storm-with-sinus-tachycardia-changed-your-practice-or-do-you-still-reach-for-propranolol-as-first-line weekly 0.8 https://www.themednet.org/do-you-counsel-patients-who-are-considering-stopping-a-glp-1-agonist-after-achieving-their-weight-loss-goal-differently-now-that-long-term-maintenance-data-suggest-most-will-regain-a-substantial-portion-of-their-weight-within-a-year-of-discontinuation weekly 0.8 https://www.themednet.org/has-the-traverse-trial-which-showed-testosterone-therapy-was-noninferior-to-placebo-for-mace-but-raised-signals-for-pulmonary-embolism-and-atrial-fibrillation-changed-how-you-counsel-middle-aged-men-who-specifically-cite-cardiovascular-safety-when-request weekly 0.8 https://www.themednet.org/when-a-patient-returns-after-her-annual-mammogram-with-a-report-noting-heterogeneously-or-extremely-dense-breast-tissue-how-do-you-counsel-her-about-supplemental-screening-and-does-your-approach-change-based-on-her-other-risk-factors weekly 0.8 https://www.themednet.org/in-a-patient-with-a-long-and-complicated-history-of-metastatic-breast-cancer-who-has-progressed-on-multiple-medications-and-has-now-developed-multiple-brain-metastases-what-is-your-radiotherapy-plan-if-the-patient-is-taking-sacituzumab-govitecan weekly 0.8 https://www.themednet.org/what-strategies-have-you-found-effective-in-improving-acceptance-of-long-acting-injectable-antipsychotics-in-patients-with-serious-mental-illness-who-are-ambivalent-about-treatment weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-a-patient-with-metastatic-non-small-cell-lung-cancer-who-previously-received-whole-brain-radiation-therapy-three-years-ago-and-now-presents-with-20-new-brain-metastases-on-mri-the-patient-currently-has-good-perform weekly 0.8 https://www.themednet.org/do-elevated-neutrophils-in-the-bronchoalveolar-lavage-of-patients-with-sarcoidosis-have-any-prognostic-value weekly 0.8 https://www.themednet.org/when-an-older-adult-with-multiple-comorbidities-develops-a-new-significant-functional-decline-after-a-hospitalization-how-do-you-decide-whether-to-pursue-further-diagnostic-workup-versus-accept-it-as-post-hospitalization-deconditioning-and-focus-on-rehabi weekly 0.8 https://www.themednet.org/what-is-your-radiotherapy-plan-for-recurrent-midline-epidermoid-cyst-after-resection-around-10-months-ago weekly 0.8 https://www.themednet.org/when-is-the-earliest-you-escalate-prolonged-migraine-attacks-parenteral-or-emergency-level-care weekly 0.8 https://www.themednet.org/in-2l-itp-management-following-glucocorticoid-failure-or-relapse-is-the-clinical-benefit-of-adding-ianalumab-to-eltrombopag-meaningful-enough-to-accept-the-increased-risk-of-hematologic-complications-compared-to-eltrombopag-monotherapy-or-other-2l-options weekly 0.8 https://www.themednet.org/do-you-recommend-doxycycline-over-azithromycin-as-first-line-treatment-for-outpatient-community-acquired-pneumonia-in-otherwise-healthy-adults-given-rising-macrolide-resistance-rates weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-acc-2026 weekly 0.8 https://www.themednet.org/would-you-use-sq-unfractionated-heparin-and-at-what-dose-in-a-patient-with-recurrent-dvt-pe-with-doac-failure-who-is-also-100kg-and-on-hemodialysis-and-is-unable-to-take-warfarin-due-to-concurrent-calciphylaxis weekly 0.8 https://www.themednet.org/what-further-endocrine-work-up-do-you-recommend-for-chronically-elevated-bone-specific-alkaline-phosphatase-levels-in-young-asymptomatic-patients-with-normal-nuclear-bone-scans weekly 0.8 https://www.themednet.org/in-a-patient-with-an-egfr-exon-20-insertion-mutation-with-stage-iiia-lung-adenocarcinoma-is-there-any-experience-using-amivantamab-carboplatin-pemetrexed-in-a-neoadjuvant-fashion weekly 0.8 https://www.themednet.org/how-do-you-contextualize-the-stage-1-results-from-the-preserve-003-trial-within-the-current-treatment-landscape-for-patients-with-squamous-nsclc-who-have-progressed-on-pdl-1-therapy weekly 0.8 https://www.themednet.org/would-you-pursue-cystoscopy-and-ct-urogram-in-a-young-patient-with-one-episode-of-gross-hematuria-and-no-other-risk-factors-for-bladder-cancer weekly 0.8 https://www.themednet.org/is-psa-reliable-in-a-patient-who-has-a-foley-catheter-or-has-undergone-recent-dre weekly 0.8 https://www.themednet.org/would-you-take-back-an-asymptomatic-patient-for-stent-exchange-or-adjustment-if-imaging-revealed-that-the-stent-was-intraparenchymal weekly 0.8 https://www.themednet.org/how-many-days-of-preoperative-antibiotics-do-you-give-a-patient-if-they-have-a-positive-urine-culture-and-are-scheduled-for-ureteroscopy-and-laser-lithotripsy weekly 0.8 https://www.themednet.org/do-you-use-a-larger-or-smaller-diameter-ureteral-stent-in-a-patient-with-hydronephrosis-due-to-malignant-obstruction weekly 0.8 https://www.themednet.org/how-do-you-differentiate-between-asymptomatic-bacteruria-and-a-true-urinary-tract-infection-in-pediatric-patients-with-urinary-diversions-who-have-a-positive-urine-culture weekly 0.8 https://www.themednet.org/would-you-repeat-a-midurethral-sling-in-a-patient-with-recent-failure-of-a-mesh-midurethral-sling-placed-10-years-ago weekly 0.8 https://www.themednet.org/what-is-your-technique-for-denuding-vaginal-epithelium-during-a-colpocleisis weekly 0.8 https://www.themednet.org/how-do-you-proceed-if-you-cannot-get-a-bellows-reflex-during-stage-1-sacral-neuromodulation weekly 0.8 https://www.themednet.org/do-you-send-urine-cultures-and-treat-positive-results-prior-to-bladder-botox-injections weekly 0.8 https://www.themednet.org/what-interventions-do-you-recommend-for-patients-with-chronic-catheter-blockage-due-to-sediment weekly 0.8 https://www.themednet.org/what-treatment-do-you-offer-for-patients-with-florid-incontinence-due-to-a-patulous-urethra-secondary-to-chronic-catheterization weekly 0.8 https://www.themednet.org/how-do-you-differentiate-between-asymptomatic-bacteriuria-and-a-true-urinary-tract-infection-in-a-neuro-urology-patient weekly 0.8 https://www.themednet.org/what-are-the-indications-and-contraindications-for-starting-testosterone-replacement-therapy-in-someone-with-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-place-patients-on-a-blood-thinner-after-a-distal-shunt-for-priapism weekly 0.8 https://www.themednet.org/if-a-patient-has-abdominal-tubing-erosion-within-a-few-months-of-aus-placement-and-does-not-appear-infected-do-you-need-to-replace-the-whole-device weekly 0.8 https://www.themednet.org/what-treatments-do-you-use-for-persistent-pain-at-split-thickness-skin-graft-donor-sites weekly 0.8 https://www.themednet.org/if-a-patient-has-urinary-retention-and-a-history-of-metoidioplasty-would-you-try-cathing-with-a-coude-or-would-you-proceed-directly-to-cystoscopy-assisted-catheter-placement weekly 0.8 https://www.themednet.org/how-long-do-you-leave-a-ureteral-stent-if-placed-at-the-time-of-transplant weekly 0.8 https://www.themednet.org/do-you-perform-a-running-or-interrupted-anastomosis-for-the-ureteroneocystotomy weekly 0.8 https://www.themednet.org/if-a-patient-has-hydronephrosis-in-the-immediate-postoperative-period-following-renal-transplant-would-you-place-a-stent-or-nephrostomy-tube weekly 0.8 https://www.themednet.org/how-do-you-decide-between-an-endoscopic-and-open-approach-for-a-patient-with-a-1-5-cm-distal-ureteral-stricture-6-months-postoperatively-following-renal-transplant weekly 0.8 https://www.themednet.org/how-and-with-what-urgency-do-you-work-up-hematuria-in-a-patient-with-eskd-who-is-pending-renal-transplant weekly 0.8 https://www.themednet.org/what-steps-would-you-take-if-the-conduit-doesnt-reach-the-abdominal-wall-during-a-robotic-radical-cystectomy-and-ileal-conduit weekly 0.8 https://www.themednet.org/how-would-you-treat-a-monopolar-injury-to-the-bowel-if-there-is-no-obvious-defect-in-the-intestinal-wall weekly 0.8 https://www.themednet.org/how-do-you-perform-the-renorrhaphy-during-a-partial-nephrectomy weekly 0.8 https://www.themednet.org/how-much-and-for-how-long-does-the-average-patient-leak-after-holep weekly 0.8 https://www.themednet.org/is-there-a-pvr-cutoff-or-percent-empty-cutoff-you-use-to-determine-if-an-asymptomatic-patient-needs-a-foley-catheter weekly 0.8 https://www.themednet.org/would-you-recommend-a-bladder-outlet-procedure-in-a-patient-with-a-large-prostate-but-no-bladder-function-on-urodynamics weekly 0.8 https://www.themednet.org/how-do-you-counsel-and-manage-patients-with-chronic-pain-conditions-such-as-fibromyalgia-or-osteoarthritis-who-are-taking-centrally-acting-agents-gabapentin-duloxetine-and-are-planning-to-use-or-self-administer-psychedelics-for-symptom-management weekly 0.8 https://www.themednet.org/how-do-you-diagnose-and-manage-iron-deficiency-in-heart-failure weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-check-a-peth-level-in-patients-hospitalized-with-alcohol-associated-disease weekly 0.8 https://www.themednet.org/is-anifrolumab-safe-and-to-use-in-patients-with-a-history-of-malignancy weekly 0.8 https://www.themednet.org/how-would-you-approach-alnd-decision-in-a-patient-with-breast-cancer-who-had-sentinel-nodes-which-were-negative-but-had-a-non-sentinel-node-that-was-positive weekly 0.8 https://www.themednet.org/are-there-any-specific-scenarios-in-which-you-refer-to-estimated-creatinine-clearance-over-egfr-in-an-older-adult-patient weekly 0.8 https://www.themednet.org/in-a-hospitalized-older-adult-with-significant-pain-and-delirium-in-which-delirium-may-be-due-either-to-underlying-pain-or-use-of-pain-medications-such-as-narcotics-how-do-you-approach-clinical-management-of-delirium weekly 0.8 https://www.themednet.org/do-you-generally-pursue-a-temporal-artery-biopsy-in-a-patient-who-has-a-halo-sign-on-ultrasound-but-has-an-atypical-clinical-presentation-of-gca-with-normal-inflammatory-markers-in-the-setting-of-persistent-temporal-headache weekly 0.8 https://www.themednet.org/in-patients-with-muscle-invasive-bladder-cancer-in-what-clinical-scenarios-would-you-consider-neoadjuvant-cisplatin-based-therapy-in-light-of-emerging-data-on-enfortumab-vedotin-plus-pembrolizumab weekly 0.8 https://www.themednet.org/does-cea-still-have-a-role-for-surgical-asymptomatic-carotid-disease-management weekly 0.8 https://www.themednet.org/would-you-perform-a-bone-marrow-biopsy-in-a-patient-who-had-systemic-anaphylaxis-with-hypotension-to-a-stinging-insect weekly 0.8 https://www.themednet.org/in-patients-with-stickler-syndrome-would-you-recommend-prophylactic-laser-to-areas-of-lattice weekly 0.8 https://www.themednet.org/what-are-some-special-considerations-for-treatment-of-glaucoma-and-iop-lowering-in-patients-with-optic-disc-drusen weekly 0.8 https://www.themednet.org/how-do-you-manage-monitoring-menopausal-status-for-a-premenopausal-patient-with-dcis-on-tamoxifen-who-would-likely-become-post-menopausal-during-therapy weekly 0.8 https://www.themednet.org/with-the-advent-of-glp-1-receptor-agonist-therapy-when-if-ever-do-you-consider-adding-pioglitazone-to-patients-diabetes-regimen weekly 0.8 https://www.themednet.org/is-lithium-induced-hypothyroidism-typically-due-to-the-production-of-autoimmune-hashimotos-antibodies-or-to-the-disruption-of-thyroid-hormone-production weekly 0.8 https://www.themednet.org/in-severe-alcohol-associated-hepatitis-complicated-by-renal-dysfunction-or-prolonged-hospitalization-do-you-start-medications-for-alcohol-use-disorder-during-the-admission-or-defer-until-medical-stabilization weekly 0.8 https://www.themednet.org/how-would-you-escalate-treatment-for-a-pediatric-patient-with-cno-with-mandibular-involvement-and-only-partial-response-to-biweekly-tnfi weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-depression-who-ask-about-the-role-of-the-gut-brain-axis-e-g-diet-probiotics-microbiome-targeted-interventions-in-their-symptoms weekly 0.8 https://www.themednet.org/do-you-still-use-itraconazole-for-aspergillus-prophylaxis-in-heart-transplant-recipients-or-have-you-transitioned-exclusively-to-posaconazole weekly 0.8 https://www.themednet.org/at-what-egfr-would-you-begin-recommending-leukoreduced-blood-products-given-the-potential-future-need-for-kidney-transplantation-in-patients-with-ckd-who-are-not-currently-listed weekly 0.8 https://www.themednet.org/under-what-situation-do-you-consider-empiric-dilatation-in-a-patient-with-dysphasia-in-the-absence-of-any-overt-endoscopic-features-in-the-esophagus-do-you-find-the-balloon-in-the-endoflip-system-to-give-an-idea-of-the-esophageal-lumen-to-make-that-decisi weekly 0.8 https://www.themednet.org/are-there-any-radiation-dosimetric-considerations-for-patients-with-lung-cancer-that-have-had-a-tavr weekly 0.8 https://www.themednet.org/what-specific-clinical-and-echocardiographic-thresholds-lead-you-to-taper-de-escalate-pulmonary-hypertension-therapy-before-liver-transplant weekly 0.8 https://www.themednet.org/how-are-you-approaching-patient-selection-for-relacorilant-nab-paclitaxel-rosella-in-platinum-resistant-ovarian-cancer-given-the-consistent-benefit-across-all-subgroups weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-crinecerfont-in-patients-with-congenital-adrenal-hyperplasia-to-reduce-corticosteroid-requirements weekly 0.8 https://www.themednet.org/what-is-the-standard-of-care-for-timing-of-a-mac-off-retinal-detachment-repair weekly 0.8 https://www.themednet.org/do-you-use-frax-score-or-bmd-scores-to-determine-whether-patients-with-primary-hyperparathyroidism-would-benefit-from-parathyroidectomy-to-reduce-fracture-risk weekly 0.8 https://www.themednet.org/when-do-you-use-anticoagulation-over-antiplatelet-therapy-for-secondary-stroke-prevention-in-patients-with-lv-injury-or-dysfunction weekly 0.8 https://www.themednet.org/do-you-add-echinocandins-adjunctively-in-patients-with-pneumocystis weekly 0.8 https://www.themednet.org/under-what-circumstances-do-you-consider-an-enbloc-resection-versus-biopsy-for-a-lower-lumbar-spinal-column-tumor weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-completing-a-decompressive-hemicraniectomy-and-a-frontal-sinus-cranialization-at-the-same-time-for-penetrating-cranial-trauma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-4th-ventricular-tumors-in-order-to-reduce-the-risk-of-cerebellar-mutism weekly 0.8 https://www.themednet.org/what-is-you-approach-to-management-of-a-traumatic-pseudoaneurysm-for-a-patient-who-has-a-concurrent-traumatic-ich weekly 0.8 https://www.themednet.org/under-what-circumstances-do-you-consider-a-biopsy-for-a-patient-with-a-new-brain-lesion-who-is-undergoing-active-systemic-cancer-treatment weekly 0.8 https://www.themednet.org/how-would-you-approach-small-cell-lung-cancer-that-would-otherwise-be-limited-stage-except-for-a-solitary-brain-metastasis-would-it-be-reasonable-to-treat-with-definitive-chemoradiation-to-the-primary-and-srs-to-the-brain-metastasis weekly 0.8 https://www.themednet.org/how-do-you-deal-with-conflicting-results-about-her2-expression-via-ihc-fish-and-oncotype-her2-expression-levels weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-osteoporosis-and-cervical-spine-osteoarthritis-who-are-considering-chiropractic-cervical-manipulation-or-traction weekly 0.8 https://www.themednet.org/in-patients-treated-with-infliximab-do-rates-of-immunogenicity-vary-based-on-underlying-disease-ra-ibd-sarcoidosis-etc-and-or-baseline-disease-activity weekly 0.8 https://www.themednet.org/what-interventions-do-you-find-helpful-for-the-initial-management-of-functional-gi-disorders weekly 0.8 https://www.themednet.org/how-if-at-all-do-you-incorporate-techniques-such-as-mindfulness-into-your-discussions-with-patients-who-have-chronic-pain-particularly-if-you-are-hoping-to-taper-their-opioids weekly 0.8 https://www.themednet.org/in-suspected-antibiotic-associated-cholestatic-dili-with-jaundice-and-no-obstructing-lesion-on-mrcp-what-specific-clinical-or-laboratory-trajectory-triggers-you-to-proceed-to-early-liver-biopsy-to-evaluate-for-evolving-vanishing-bile-duct-syndrome-rather- weekly 0.8 https://www.themednet.org/do-you-empirically-administer-high-dose-iv-thiamine-to-all-patients-admitted-with-sepsis-and-a-history-of-alcohol-use-disorder-even-without-clinical-signs-of-wernicke-encephalopathy weekly 0.8 https://www.themednet.org/when-would-you-consider-starting-pharmacologic-therapy-anti-ldl-apob-to-young-adults-30-years-of-age-who-have-markedly-elevated-lp-a-and-family-history-of-elevated-lp-a-and-ischemic-heart-disease weekly 0.8 https://www.themednet.org/do-you-stop-oral-antihistamines-before-checking-a-serum-tryptase weekly 0.8 https://www.themednet.org/what-is-your-radiotherapy-plan-for-a-50-year-old-man-with-who-grade-3-astrocytoma-s-p-resection-and-ebrt-20-years-ago-recurrence-2-years-ago-s-p-fractionated-srs-33-gray-in-3-fractions-followed-by-adjuvant-bevacizumab-and-temozolomide-who-now-has-recurren weekly 0.8 https://www.themednet.org/what-role-if-any-does-ultra-low-dose-io-have-for-us-based-patients-with-r-r-solid-tumors weekly 0.8 https://www.themednet.org/how-would-you-approach-an-interval-worsening-of-pancreatic-fluid-collection-with-development-of-extensive-pancreatitis-in-the-absence-of-elevated-lipase-or-any-abdominal-pain-nausea-or-vomiting weekly 0.8 https://www.themednet.org/what-degree-of-aortic-valve-insufficiency-is-reasonable-to-tolerate-for-impella-supported-pci-provided-that-the-impella-will-be-removed-at-conclusion-of-case weekly 0.8 https://www.themednet.org/do-you-prefer-isotonic-sodium-bicarbonate-over-other-isotonic-iv-fluids-in-those-with-light-chain-cast-nephropathy weekly 0.8 https://www.themednet.org/What-antibiotic-prophylaxis-do-you-recommend-for-patients-with-GI-bleeds-with-cirrhosis-if-at-all-in-light-of-the-recent-meta-analysis-published-in-JAMA-internal-medicine weekly 0.8 https://www.themednet.org/how-do-you-manage-extreme-leukocytosis-of-170k-in-a-patient-with-myelofibrosis-on-pacritinib-failed-momelotinib-and-platelets-50k-and-procrit-for-anemia-bone-marrow-showed-persistent-myelofibrosis-no-transformation-no-blasts-differential-on-peripheral-blo weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-high-volume-thick-tracheal-secretions-in-a-patient-with-a-tracheostomy-when-there-is-no-clear-evidence-of-pulmonary-infection weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-therapy-for-patients-with-resected-nsclc-3-cm-with-visceral-pleural-involvement-and-no-lymph-node-involvement weekly 0.8 https://www.themednet.org/for-patients-with-definite-uip-and-mpo-anca-associated-vasculitis-limited-to-the-lungs-without-systemic-manifestations-what-is-the-role-of-immunosuppression weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-eskd-who-request-intravenous-diphenhydramine-during-hemodialysis-sessions-for-various-perceived-dialysis-related-complaints weekly 0.8 https://www.themednet.org/in-patients-with-disorders-of-gut-brain-interaction-how-far-down-in-the-treatment-algorithm-do-you-consider-evaluating-for-carbohydrate-malabsorption-syndromes-and-how-do-you-go-about-doing-that weekly 0.8 https://www.themednet.org/in-pregnant-liver-transplant-recipients-which-transplant-specific-modifiable-targets-do-you-prioritize-to-reduce-prematurity-and-fetal-growth-restriction weekly 0.8 https://www.themednet.org/in-patients-with-ild-who-are-started-on-nerandomilast-on-top-of-background-nintedanib-what-monitoring-is-most-important-early-in-therapy weekly 0.8 https://www.themednet.org/how-often-do-you-have-worsening-hypoxia-with-patients-started-on-sotatercept weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-cdk-4-6-inhibitors-in-microscopically-involved-lymph-node-idc-breast-t2n1mi-grade-3-er-pr-her2-neg-ki67-50 weekly 0.8 https://www.themednet.org/Do-you-ever-use-Joyrnavx-in-a-patient-with-end-stage-liver-disease-What-do-you-look-for-in-terms-of-safety weekly 0.8 https://www.themednet.org/in-a-patient-with-intermittent-pouchitis-who-has-up-to-3-acute-pouchitis-episodes-that-respond-well-to-antibiotics-how-do-you-manage-leakage-of-stool-especially-at-night weekly 0.8 https://www.themednet.org/are-there-any-important-considerations-when-initiating-orbital-radiation-therapy-for-ted-in-a-patient-with-diabetic-retinopathy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-for-recalcitrant-mgd weekly 0.8 https://www.themednet.org/how-do-you-modify-cpc-i-e-parameters-location-of-probe-in-high-myopes-that-may-have-thin-sclera-or-more-posterior-ciliary-bodies weekly 0.8 https://www.themednet.org/what-factors-affect-correlate-with-viral-pcr-yield-in-aqueous-in-a-patient-with-recurrent-episodes-of-uveitis-associated-with-high-iop weekly 0.8 https://www.themednet.org/do-you-perform-genetic-testing-in-all-patients-with-cvid weekly 0.8 https://www.themednet.org/how-do-you-set-practical-referral-and-discharge-criteria-for-a-masld-multidisciplinary-clinic-to-capture-high-risk-phenotypes-without-being-overwhelmed weekly 0.8 https://www.themednet.org/in-lean-masld-with-visceral-adiposity-and-or-high-risk-metabolic-genetic-features-in-an-already-physically-active-patient-when-do-you-recommend-additional-weight-loss-versus-focusing-on-diet-quality-and-central-adiposity-reduction-and-how-do-you-monitor-t weekly 0.8 https://www.themednet.org/in-routine-practice-where-repeat-biopsy-and-outcomes-data-are-not-available-what-longitudinal-nit-pattern-e-g-vcte-elf-mri-pdff-alt-trajectory-do-you-consider-sufficient-to-continue-semaglutide-specifically-for-mash-and-what-trajectory-would-trigger-a-fut weekly 0.8 https://www.themednet.org/given-the-results-of-portec-4a-what-adjuvant-therapy-if-any-would-you-offer-a-patient-with-a-pole-mutant-endometrial-cancer-who-also-has-a-p53-mutation-and-substantial-5-foci-of-lvsi weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-reflux-hypersensitivity-in-patients-on-ppi-therapy weekly 0.8 https://www.themednet.org/what-are-the-best-antidepressants-for-trauma-survivors-with-treatment-resistant-depression-who-have-not-responded-to-ssris-snris-and-multiple-novel-agents weekly 0.8 https://www.themednet.org/what-is-your-approach-to-screening-for-cognitive-impairment-in-hospitalized-older-adults weekly 0.8 https://www.themednet.org/how-do-you-approach-a-metastatic-mixed-non-seminoma-germ-cell-tumor-s-p-orchiectomy-and-chemotherapy-with-normalization-of-tumor-markers-and-persistent-multiple-lung-metastasis-1-cm-that-cannot-be-fully-resected weekly 0.8 https://www.themednet.org/if-a-patient-had-an-ige-mediated-reaction-to-augmentin-non-anaphylactic-but-can-tolerate-amoxicillin-would-you-directly-proceed-with-an-oral-challenge-to-augmentin weekly 0.8 https://www.themednet.org/when-do-you-consider-certolizumab-for-pregnant-women-with-antiphospholipid-syndrome-with-positive-lupus-anticoagulant weekly 0.8 https://www.themednet.org/do-you-still-perform-routine-defibrillation-testing-at-the-time-of-subcutaneous-icd-implantation weekly 0.8 https://www.themednet.org/do-you-obtain-routine-blood-cultures-in-a-non-immunocompromised-patient-with-community-acquired-pneumonia-who-does-not-meet-criteria-for-severe-cap weekly 0.8 https://www.themednet.org/what-would-be-an-appropriate-de-escalation-strategy-for-ecog-0-patient-with-mtnbc-on-1st-line-gem-carbo-pembro-was-intolerant-to-taxanes-and-has-excellent-disease-response-and-now-negative-ctdna-currently-on-q14d-regimen-gem-carbo-with-pembro-q6w-of-note- weekly 0.8 https://www.themednet.org/do-you-recommend-adjuvant-chemotherapy-to-a-low-risk-t3n0-stage-ii-colon-cancer-if-there-was-bowel-perforation-upstream-from-the-tumor-ie-the-tumor-itself-was-not-perforated-but-the-bowel-proximally-was weekly 0.8 https://www.themednet.org/when-treating-osteoporosis-does-your-duration-of-maintenance-bisphosphonate-therapy-post-anabolic-therapy-with-pth-analogue-change-based-on-c-telopeptide-levels weekly 0.8 https://www.themednet.org/what-is-your-preferred-frontline-regimen-for-metastatic-unresectable-fibrolamellar-carcinoma-in-an-aya-patient weekly 0.8 https://www.themednet.org/does-switching-arms-enhance-the-efficacy-of-subcutaneous-allergen-immunotherapy weekly 0.8 https://www.themednet.org/how-frequently-do-you-check-lfts-for-patients-doing-ongoing-ketamine-treatments-to-treat-severe-recurrent-depression-i-ask-as-i-had-a-patient-develop-cholangitis-as-a-result-of-ongoing-ketamine-use weekly 0.8 https://www.themednet.org/in-a-non-operable-patient-with-primary-ascending-colon-mass-and-poor-ecog-for-chemotherapy-would-you-offer-radiation-therapy-as-an-option weekly 0.8 https://www.themednet.org/when-starting-glp-1-ra-therapy-for-weight-loss-purposes-how-do-you-counsel-patients-on-duration-of-treatment-therapy weekly 0.8 https://www.themednet.org/how-does-vexus-evaluation-differ-in-a-patient-with-a-transjugular-intrahepatic-portosystemic-shunt-tips weekly 0.8 https://www.themednet.org/when-reviewing-right-heart-catheterization-numbers-in-obese-individuals-what-adjustments-or-caveats-do-you-routinely-apply-to-your-interpretation weekly 0.8 https://www.themednet.org/what-are-some-advantages-of-veligrotug-over-tepezza-for-the-treatment-of-thyroid-eye-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-selection-of-systemic-treatment-in-a-patient-with-atopic-dermatitis-with-severe-itch weekly 0.8 https://www.themednet.org/what-factors-do-you-weigh-most-heavily-when-deciding-on-the-duration-of-treatment-with-dupilumab-in-a-patient-with-atopic-dermatitis-who-is-responding-well-and-tolerating-therapy weekly 0.8 https://www.themednet.org/do-you-typically-recommend-initial-therapy-with-a-jak-inhibitor-or-systemic-corticosteroids-in-acute-extensive-alopecia-areata weekly 0.8 https://www.themednet.org/can-cinacalcet-be-used-in-primary-hyperparathyroidism-to-determine-if-mild-moderate-hypercalcemia-is-responsible-for-non-specific-complaints-in-other-words-can-a-trial-of-normalizing-calcium-with-the-drug-help-determine-which-patients-are-likely-to-have-s weekly 0.8 https://www.themednet.org/is-neuropsychological-testing-required-in-all-patients-with-alzheimers-disease-before-starting-monoclonal-antibody-treatment weekly 0.8 https://www.themednet.org/how-can-we-make-the-diagnosis-of-insulin-allergy weekly 0.8 https://www.themednet.org/how-early-do-you-implement-pcsk9-inhibitor-therapy-for-stroke-patients-with-very-high-risk-ascvd weekly 0.8 https://www.themednet.org/when-do-you-consider-using-general-anesthesia-for-endovascular-thrombectomy weekly 0.8 https://www.themednet.org/how-do-you-decide-on-next-therapy-for-post-ici-triple-m-syndrome-myositis-myocarditis-myasthenia-after-steroids-plex-and-ivig weekly 0.8 https://www.themednet.org/when-do-you-find-fdg-pet-ct-helpful-in-the-workup-for-autoimmune-encephalitis weekly 0.8 https://www.themednet.org/how-do-you-manage-atomoxetine-related-fatigue weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-about-the-likelihood-of-improvement-in-kidney-disease-after-anti-cancer-treatment-is-initiated-in-a-patient-with-malignancy-associated-membranous-nephropathy weekly 0.8 https://www.themednet.org/what-has-been-your-experience-with-edof-lenses-in-patients-with-glaucoma weekly 0.8 https://www.themednet.org/do-you-feel-there-is-benefit-to-subconjunctival-steroid-or-mmc-injection-at-the-time-of-valved-tube-placement weekly 0.8 https://www.themednet.org/why-are-total-ige-levels-often-less-than-the-summation-of-food-allergy-component-testing weekly 0.8 https://www.themednet.org/what-objective-tools-do-you-use-to-determine-if-a-patient-is-too-high-risk-for-anticoagulation-to-prevent-stroke-or-dvt weekly 0.8 https://www.themednet.org/Is-there-a-role-for-extended-window-TNK-in-patients-with-no-demonstrable-vessel-occlusion-but-a-favorable-perfusion-mismatch-profile-given-that-~32percent-of-OPTION-patients-had-no-identifiable-occlusion weekly 0.8 https://www.themednet.org/thoughts-saw-a-27-year-old-female-with-h-o-adhd-on-adderrall-for-a-long-time-she-was-experiencing-intermittent-episodes-of-anxiety-palpitations-dizziness-diarrhea-for-1-year-her-initial-labs-showed-elevated-free-t4-of-1-84h-ref-0-80-1-80-with-normal-tsh-o weekly 0.8 https://www.themednet.org/is-anyone-doing-nemluvio-q3-weeks-is-there-any-contraindication-for-this weekly 0.8 https://www.themednet.org/how-do-you-manage-persistent-menstrual-bleeding-following-insertion-of-an-iud-assuming-no-structural-abnormalities-or-coagulation-disorders weekly 0.8 https://www.themednet.org/what-is-you-approach-with-c-diff-treatment-in-patients-admitted-and-being-treated-for-acute-severe-ulcerative-colitis-with-a-positive-gdh-and-pcr-for-toxins-with-a-negative-eia-for-toxins weekly 0.8 https://www.themednet.org/in-hospitalized-individuals-with-diabetes-do-you-universally-performed-point-of-care-poc-blood-glucose-monitoring-before-meals-or-every-4-6-h-for-those-who-are-not-eating weekly 0.8 https://www.themednet.org/Is-fetal-monitoring-recommended-when-administrating-IV-iron-to-a-pregnant-patient weekly 0.8 https://www.themednet.org/where-do-you-anticipate-positioning-mim8-denecimig-alongside-existing-options-within-your-hemophilia-a-prophylaxis-approach-assuming-regulatory-approval-frontier2 weekly 0.8 https://www.themednet.org/do-you-typically-narrow-to-penicillin-or-first-generation-cephalosporin-or-continue-anaerobic-coverage-for-patients-with-bacterial-lymphadenitis-requiring-surgical-drainage-whose-cultures-grow-only-group-a-strep-and-gram-stain-only-gram-positive-cocci weekly 0.8 https://www.themednet.org/when-showing-lab-results-with-patients-who-have-chronic-kidney-disease-do-you-prefer-to-use-the-absolute-creatinine-value-or-egfr weekly 0.8 https://www.themednet.org/when-have-you-found-hypnosis-helpful-for-parasomnia weekly 0.8 https://www.themednet.org/what-do-you-do-as-part-of-a-baseline-neurologic-exam-pre-car-t-therapy-in-addition-to-the-ice-score weekly 0.8 https://www.themednet.org/how-do-you-decide-which-patients-with-asymptomatic-hyperkalemia-and-ckd-warrant-inpatient-admission-versus-expedited-outpatient-management weekly 0.8 https://www.themednet.org/do-you-initiate-a-glp-1-receptor-agonist-as-first-line-pharmacotherapy-ahead-of-metformin-in-a-patient-with-newly-diagnosed-type-2-diabetes-and-a-bmi-above-35 weekly 0.8 https://www.themednet.org/what-is-your-radiotherapy-plan-for-the-patient-with-a-history-of-stage-iiia-ct2-cn2-and-a-high-scc-s-p-neoadjuvant-chemoimmunotherapy-and-then-l-pneumonectomy-pt1b-pn2-4-12-lns-positive-with-ene-8-months-ago-currently-on-adjuvant-durvalumab-who-is-found-t weekly 0.8 https://www.themednet.org/has-the-april-2026-cochrane-review-on-anti-amyloid-antibodies-changed-how-you-counsel-older-adults-with-early-alzheimers-disease-about-whether-to-pursue-treatment-with-lecanemab-or-donanemab weekly 0.8 https://www.themednet.org/how-do-you-approach-initiating-a-deprescribing-conversation-about-a-long-standing-benzodiazepine-in-an-older-adult-who-has-been-on-a-stable-dose-for-years-and-reports-no-side-effects weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-recommend-conservative-kidney-management-over-dialysis-initiation-in-a-frail-older-adult-with-stage-5-ckd weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-give-data-on-long-term-use-of-second-generation-antipsychotics-and-risk-of-involuntary-movement-disorders weekly 0.8 https://www.themednet.org/in-lean-masld-with-sarcopenia-or-visceral-adiposity-despite-normal-bmi-how-do-you-prioritize-resistance-training-nutrition-versus-pharmacologic-cardiometabolic-prevention-and-what-metrics-do-you-track-to-decide-if-the-plan-is-working weekly 0.8 https://www.themednet.org/in-hospitalized-patients-treated-for-presumed-overt-hepatic-encephalopathy-who-show-no-meaningful-improvement-after-48-72-hours-of-adequate-therapy-and-precipitant-management-what-is-your-highest-yield-next-diagnostic-step-and-what-clinical-features-drive weekly 0.8 https://www.themednet.org/in-patients-with-pbc-and-possible-autoimmune-hepatitis-overlap-on-immunosuppression-how-do-you-decide-whether-improvement-in-alt-igg-after-starting-a-ppar-agonist-reflects-adequate-control-of-hepatitic-activity-versus-nonspecific-biochemical-improvement-a weekly 0.8 https://www.themednet.org/what-is-your-practical-approach-to-monitoring-pruritus-severity-over-time-in-pbc-to-guide-treatment-adjustments-e-g-daily-vs-interval-numeric-rating-scales-especially-when-follow-up-intervals-are-long-and-symptom-scores-can-be-variable weekly 0.8 https://www.themednet.org/in-patients-entering-aud-treatment-who-also-have-obesity-diabetes-a-metald-phenotype-how-do-you-modify-your-thresholds-for-fibrosis-assessment-and-for-initiating-aud-pharmacotherapy-and-metabolic-therapy-e-g-glp-1-receptor-agonists-with-the-explicit-goal- weekly 0.8 https://www.themednet.org/in-psvd-what-specific-clinical-imaging-or-thrombophilia-features-would-make-you-start-pre-emptive-anticoagulation-before-any-documented-pvt-and-how-do-you-monitor-for-net-benefit-thrombosis-prevention-versus-harm-bleeding-in-this-population weekly 0.8 https://www.themednet.org/what-treatment-strategies-reduce-the-risk-of-post-concussion-syndrome-after-an-acute-injury weekly 0.8 https://www.themednet.org/is-it-appropriate-safe-to-utilize-bolus-with-ultra-hypofractionated-breast-radiation-ie-dermal-involvement-invasion-on-path weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-use-onyx-rather-than-coils-to-treat-a-ruptured-aneurysm weekly 0.8 https://www.themednet.org/how-would-you-approach-a-focally-positive-anterior-margin-after-salvage-exenteration-for-a-recurrent-high-grade-leiomyosarcoma-of-the-uterus-who-had-received-prior-adjuvant-pelvic-radiation-50-4gy-28fx-2-years-prior weekly 0.8 https://www.themednet.org/for-patients-who-would-otherwise-meet-criteria-for-a-simple-hysterectomy-based-off-shape-or-gog-278-do-you-require-negative-margins-on-the-excisional-biopsy-specimen weekly 0.8 https://www.themednet.org/in-a-patient-with-sle-and-high-ds-dna-on-hydroxychloroquine-who-is-now-planning-pregnancy-whose-only-symptom-is-arthralgia-now-controlled-unable-to-tolerate-azathioprine-however-if-they-have-significantly-high-ds-dna-level-would-you-add-on-another-agent-o weekly 0.8 https://www.themednet.org/is-maternal-asthma-control-associated-with-the-baby-developing-atopic-disease weekly 0.8 https://www.themednet.org/do-you-regularly-check-switched-memory-b-cells-in-cvid weekly 0.8 https://www.themednet.org/for-patients-with-endoscopic-appearance-of-celiac-disease-do-you-routinely-repeat-an-egd-to-document-healing-after-a-couple-of-years-vs-just-follow-up-with-serial-serologies-and-repeat-egd-only-based-on-absence-of-clinical-response weekly 0.8 https://www.themednet.org/other-than-firearms-what-dangerous-items-do-you-recommend-removing-or-securing-as-a-part-of-safety-planning weekly 0.8 https://www.themednet.org/in-quiescent-patients-with-history-of-herpetic-keratouveitis-with-uncontrolled-iop-on-topicals-do-you-prescribe-pgas weekly 0.8 https://www.themednet.org/has-the-condor-trial-changed-your-first-line-approach-to-treatment-naive-proliferative-diabetic-retinopathy-in-a-patient-with-good-visual-acuity-who-is-able-to-attend-regular-follow-up-visits weekly 0.8 https://www.themednet.org/would-you-treat-with-prolonged-abx-6-weeks-for-sacral-osteomyelitis-if-pt-underwent-debridement-but-no-plans-for-flap-coverage-only-wound-vac weekly 0.8 https://www.themednet.org/can-autoimmune-thyroiditis-present-with-recurrent-angioedema-and-bronchospasm weekly 0.8 https://www.themednet.org/how-effective-is-weight-loss-in-improving-visual-function-in-iih-and-how-much-weight-loss-what-strategies-i-e-formal-exercise-program-weight-loss-medications-do-you-recommend-counsel-patients-on weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-ways-to-boost-their-hdl-cholesterol-levels-while-on-lipid-lowering-therapy weekly 0.8 https://www.themednet.org/what-would-be-your-next-treatment-of-choice-after-full-dose-mtx-for-biopsy-proven-statin-induced-myositis-in-a-75-yo-female-original-dx-was-made-in-2019-and-she-has-done-well-until-this-past-month-with-a-spike-in-her-cpk-aldolase-and-noticeable-leg-weakne weekly 0.8 https://www.themednet.org/do-you-see-any-reason-to-consider-use-of-brexpiprazole-over-older-atypical-antipsychotics-that-may-be-less-expensive-for-the-management-of-agitation-refractory-to-nonpharmacological-management-in-older-adults-with-dementia weekly 0.8 https://www.themednet.org/what-are-some-tips-for-visual-estimation-of-ejection-fraction-when-trying-to-difference-between-low-normal-50-55-and-mildly-reduced-45-50 weekly 0.8 https://www.themednet.org/can-beta-blockers-be-used-safely-in-a-myasthenic-patient weekly 0.8 https://www.themednet.org/do-you-prescribe-a-low-dose-tricyclic-antidepressant-as-a-gut-brain-neuromodulator-for-a-patient-with-ibs-that-has-not-responded-to-dietary-modification-and-first-line-pharmacotherapy-1 weekly 0.8 https://www.themednet.org/when-do-you-add-a-thiazide-type-diuretic-to-iv-furosemide-for-a-patient-with-acute-decompensated-heart-failure-who-has-had-an-inadequate-diuretic-response-after-48-hours weekly 0.8 https://www.themednet.org/what-is-your-approach-to-acute-pain-management-in-hospitalized-patients-who-receive-long-acting-injectable-naltrexone-for-alcohol-use-disorder weekly 0.8 https://www.themednet.org/a-patient-with-pcn-susceptible-pve-endocarditis-on-ceftriaxone-needs-to-undergo-a-dental-procedure-would-you-give-additional-antibiotic-coverage-if-so-which-antibiotic weekly 0.8 https://www.themednet.org/would-you-pursue-renal-artery-revascularization-in-a-patient-with-bilateral-renal-artery-stenosis-stable-ckd-stage-3a-blood-pressure-well-controlled-on-2-medications-no-episodes-of-acute-pulmonary-edema-but-with-decreasing-kidney-size-by-1-cm-over-2-years weekly 0.8 https://www.themednet.org/why-do-foods-seem-to-not-have-a-refractory-period-when-performing-testing-as-is-often-the-case-with-venom-testing weekly 0.8 https://www.themednet.org/given-the-various-trials-in-the-literature-studying-different-target-maintenance-doses-particularly-as-it-pertains-to-peanut-allergy-how-do-you-determine-your-target-maintenance-dose-for-each-patient-undergoing-oral-immunotherapy weekly 0.8 https://www.themednet.org/can-immune-checkpoint-inhibitors-be-considered-in-a-patient-with-chronic-graft-vs-host-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-suspected-mgrs-in-a-patient-refusing-kidney-biopsy weekly 0.8 https://www.themednet.org/is-anabolic-therapy-for-treatment-of-severe-osteoporosis-less-effective-when-not-taken-continuously-for-the-12-to-24-month-duration-of-therapy weekly 0.8 https://www.themednet.org/should-i-give-iv-iron-to-a-male-with-severe-iron-deficiency-but-who-takes-supraphysiologic-testosterone-cypionate-for-body-building-and-has-a-hct-51-5 weekly 0.8 https://www.themednet.org/do-you-ever-consider-steroid-treatment-for-grade-1-icans-without-crs weekly 0.8 https://www.themednet.org/when-do-you-consider-sciatic-nerve-imaging-in-cases-of-foot-drop-without-clinical-or-emg-involvement-beyond-the-peroneal-nerve-without-clearly-indentified-compression-site weekly 0.8 https://www.themednet.org/do-you-order-screening-echocardiograms-for-patients-with-migraine-with-aura weekly 0.8 https://www.themednet.org/how-do-you-sequence-omidubicel-for-severe-aplastic-anemia weekly 0.8 https://www.themednet.org/what-volumes-do-you-use-for-postoperative-soft-tissue-sarcoma-of-the-scalp-with-negative-margins weekly 0.8 https://www.themednet.org/how-do-you-explain-recurrent-elevated-pmn-on-wet-prep-in-an-asymptomatic-patient-that-has-negative-sti-testing-and-negative-wet-prep-what-further-workup-would-you-pursue-in-an-asymptomatic-patient weekly 0.8 https://www.themednet.org/are-there-any-situations-in-which-you-consider-initiation-of-dronabinol-for-sleep-related-problems-in-older-adult-patients weekly 0.8 https://www.themednet.org/how-do-you-choose-between-various-nonpharmacological-strategies-for-prevention-of-behavioral-and-psychological-symptoms-of-dementia-such-as-bright-light-therapy-pet-therapy-robot-therapy-exercise-massage weekly 0.8 https://www.themednet.org/how-do-you-discuss-the-benefits-and-potential-risks-of-anticoagulation-for-a-strong-indication-e-g-atrial-fibrillation-with-high-cha2ds2-vasc-score-with-older-adult-patients-with-frequent-falls weekly 0.8 https://www.themednet.org/at-follow-up-around-72-weeks-what-degree-of-noninvasive-test-nonresponse-would-prompt-you-to-stop-a-glp-1-receptor-agonist-prescribed-specifically-for-mash-even-if-weight-and-aminotransferases-improve-and-what-objective-criteria-do-you-use-in-the-absence- weekly 0.8 https://www.themednet.org/when-patients-meet-criteria-for-more-than-one-mash-directed-agent-class-how-do-you-sequence-versus-combine-therapies-in-someone-with-high-cardiovascular-risk-but-borderline-hepatic-severity-and-what-surrogate-response-threshold-would-make-you-comfortable- weekly 0.8 https://www.themednet.org/do-you-continue-semiannual-hcc-surveillance-after-hbsag-loss-in-a-non-cirrhotic-patient-with-additional-risk-factors-e-g-first-degree-family-history-of-hcc-and-ongoing-alcohol-use-and-what-criteria-drive-that-decision weekly 0.8 https://www.themednet.org/what-is-your-management-of-a-central-pelvic-8-cm-recurrent-leiomyosarcoma-not-involving-any-vital-structures-associated-with-fdg-avid-1-cm-external-iliac-ln weekly 0.8 https://www.themednet.org/what-is-the-role-of-topical-aqueous-suppressants-as-an-adjunct-to-intravitreal-anti-vegf-therapy-in-patients-with-persistent-macular-edema-despite-optimized-injection-frequency-depending-on-etiology-of-me weekly 0.8 https://www.themednet.org/how-do-you-approach-the-diagnosis-of-hepatorenal-syndrome-in-a-patient-with-cirrhosis-and-aki-who-has-not-responded-to-albumin-resuscitation-but-has-a-recent-nephrotoxic-exposure-that-could-explain-the-renal-dysfunction weekly 0.8 https://www.themednet.org/in-a-patient-with-occupational-coal-mine-dust-exposure-how-do-you-interpret-the-presence-of-non-necrotizing-granulomas-in-a-lung-biopsy-specimen-with-respect-to-a-possible-diagnosis-of-coal-workers-pneumoconiosis-cwp-does-this-finding-favor-cwp-make-it-le weekly 0.8 https://www.themednet.org/How-do-you-minimize-skin-toxicity-when-targeting-neck-nodes-in-a-patient-with-HNSCC-and-skin-folds-in-the-neck weekly 0.8 https://www.themednet.org/what-is-your-approach-to-escalating-therapies-for-stiff-person-syndrome-that-is-refractory-to-ivig-and-steroids weekly 0.8 https://www.themednet.org/how-do-you-treat-persistent-headache-after-cvst-diagnosis weekly 0.8 https://www.themednet.org/do-you-recommend-delaying-dental-extractions-in-patients-who-have-recently-received-intravenous-bisphosphonate-therapy-for-osteoporosis-treatment weekly 0.8 https://www.themednet.org/Do-I-cover-laminectomy-site-with-SBRT weekly 0.8 https://www.themednet.org/how-would-you-approach-medical-therapy-of-scad-dapt-in-a-patient-with-atrial-fibrillation-with-high-stroke-risk-who-is-also-on-therapeutic-anticoagulation weekly 0.8 https://www.themednet.org/how-do-you-evaluate-persistent-resting-sinus-tachycardia-heart-rate-100-bpm-in-a-hospitalized-patient-whose-acute-illness-has-otherwise-stabilized weekly 0.8 https://www.themednet.org/what-is-the-shortest-amount-of-time-scit-buildup-for-aeroallergens-can-be-performed-if-you-are-not-using-a-cluster-or-rush-protocol weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-hiv-re-infection-of-hepatitis-c-that-has-not-yet-been-treated-chronic-hepatitis-b-infection-on-bic-ftc-taf-with-undetectable-hiv-viral-load-but-hbv-viral-load-consistently-100-000-with-normal-alt weekly 0.8 https://www.themednet.org/for-a-pediatric-patient-with-takayasu-arteritis-with-persistent-enhancement-and-mild-progression-on-imaging-after-recent-transition-to-tocilizumab-2-months-would-you-continue-tocilizumab-therapy-increase-to-q2-week-dosing-or-transition-to-cyclophosphamide weekly 0.8 https://www.themednet.org/would-you-consider-upfront-time-limited-anti-il-5-therapy-for-i-hes-or-l-hes-to-avoid-steroid-side-effects weekly 0.8 https://www.themednet.org/what-is-the-optimal-therapy-for-laryngeal-candidiasis-in-pregnancy weekly 0.8 https://www.themednet.org/do-you-escalate-to-7-2-mg-semaglutide-in-a-patient-with-obesity-who-has-not-achieved-their-weight-loss-goal-on-the-2-4-mg-dose-despite-the-increased-risk-of-dysesthesia-at-the-higher-dose weekly 0.8 https://www.themednet.org/do-you-still-offer-nirmatrelvir-ritonavir-to-a-vaccinated-older-adult-with-comorbidities-and-mild-covid-19-illness-given-recent-trial-data-showing-no-reduction-in-hospitalization-or-mortality weekly 0.8 https://www.themednet.org/how-would-you-manage-the-following-scenario-50yr-old-female-who-received-her-first-cycle-of-carboplatin-paclitaxel-and-bevacizumab-and-developed-a-whole-body-rash-with-lip-swelling-at-day-7-after-her-first-infusion-assuming-this-was-a-delayed-reaction-to- weekly 0.8 https://www.themednet.org/how-would-you-approach-organ-harvesting-in-an-ambulatory-patient-with-als-who-wishes-to-transition-to-comfort-measures-and-to-be-an-organ-donor weekly 0.8 https://www.themednet.org/In-light-of-the-recent-results-of-FAST-FORWARD-particularly-the-5-years-results-of-the-nodal-substudy-would-you-consider-offering-26Gy-5fr-for-WBI-+-RNI-Would-you-consider-it-when-including-the-IMN weekly 0.8 https://www.themednet.org/how-do-you-distinguish-low-testosterone-due-to-aging-andropause-and-low-levels-due-to-hypogonadism weekly 0.8 https://www.themednet.org/besides-anticoagulation-how-would-you-approach-the-management-of-a-large-lv-thrombus-newly-seen-on-tte-in-patients-on-va-ecmo weekly 0.8 https://www.themednet.org/how-do-you-decide-between-tcas-ssris-snris-pregabalin-atypical-antipsychotics-for-neuromodulation-in-ibs-patients weekly 0.8 https://www.themednet.org/how-do-you-advise-a-patient-with-a-history-of-hr-breast-cancer-who-would-like-to-go-on-hrt-for-post-menopausal-symptoms weekly 0.8 https://www.themednet.org/would-you-consider-combination-mycophenolate-and-jaki-in-a-patient-with-ra-ild weekly 0.8 https://www.themednet.org/given-that-micronized-progesterone-has-a-better-side-effect-profile-and-a-lower-risk-of-dvt-pe-compared-to-mpa-is-there-a-scenario-would-mpa-be-preferred weekly 0.8 https://www.themednet.org/when-have-you-found-the-nidra-tomac-device-to-be-helpful-for-refractory-restless-leg-syndrome weekly 0.8 https://www.themednet.org/how-do-you-counsel-cluster-headache-patients-interested-in-treatment-via-n-n-dimethyltryptamine-dmt-and-psychadelics weekly 0.8 https://www.themednet.org/in-severe-alcohol-associated-liver-disease-with-limited-documented-abstinence-what-prospectively-measurable-psychosocial-signals-are-sufficient-for-you-to-support-expedited-listing-treatment-engagement-insight-caregiver-reliability-objective-toxicology-st weekly 0.8 https://www.themednet.org/in-contemporary-lt-evaluation-when-do-you-move-away-from-functional-stress-testing-as-the-default-cad-screen-in-cirrhosis-and-instead-choose-coronary-ct-angiography-or-upfront-invasive-angiography-and-which-clinical-features-most-reliably-drive-that-choic weekly 0.8 https://www.themednet.org/when-severe-hepatopulmonary-syndrome-pao-50-mmhg-coexists-with-borderline-portopulmonary-hemodynamics-on-therapy-e-g-mpap-high-30s-with-pvr-3-wu-how-do-you-sequence-optimization-and-listing-strategy-and-what-physiologic-thresholds-make-you-proceed-to-tran weekly 0.8 https://www.themednet.org/how-do-you-triage-psc-patients-with-multifocal-predominantly-intrahepatic-dominant-strictures-and-recurrent-cholangitis-without-advanced-cirrhosis-between-ercp-targeted-minimal-contrast-drainage-percutaneous-drainage-and-early-transplant-center-evaluation weekly 0.8 https://www.themednet.org/in-healthy-living-liver-donors-with-a-persistent-postoperative-bile-leak-what-leak-and-patient-specific-thresholds-e-g-drain-output-trend-biloma-size-systemic-inflammatory-signs-duct-anatomy-push-you-to-early-ercp-rather-than-continued-percutaneous-draina weekly 0.8 https://www.themednet.org/in-a-living-donor-with-persistent-abdominal-pain-and-new-ascites-on-pod6-despite-a-normal-doppler-ultrasound-what-discordant-imaging-findings-or-lab-patterns-prompt-you-to-escalate-to-ct-venography-angiography-or-invasive-venography-to-rule-out-hepatic-ve weekly 0.8 https://www.themednet.org/in-cirrhosis-patients-with-borderline-pre-transplant-pvr-2-3-wu-what-additional-findings-e-g-mpap-tpg-pulmonary-artery-compliance-rv-strain-on-echo-dlco-prompt-you-to-treat-this-as-higher-risk-and-arrange-closer-follow-up-or-ph-center-referral-rather-than weekly 0.8 https://www.themednet.org/in-patients-who-develop-severe-precapillary-ph-within-6-12-weeks-after-lt-which-potentially-reversible-post-transplant-contributors-do-you-prioritize-ruling-out-before-escalating-pah-therapy-because-they-are-most-actionable-and-most-plausibly-causal-in-yo weekly 0.8 https://www.themednet.org/for-post-lt-patients-who-improve-on-pah-therapy-what-objective-criteria-do-you-require-before-attempting-medication-withdrawal-and-how-do-you-structure-a-safe-de-escalation-plan weekly 0.8 https://www.themednet.org/does-your-working-phenotype-for-new-pah-after-lt-occult-poph-vs-pah-unmasked-after-hps-resolution-vs-distinct-post-lt-vasculopathy-change-what-you-actually-do-specifically-who-you-screen-more-aggressively-and-when-you-initiate-pah-therapy weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-ats-2026 weekly 0.8 https://www.themednet.org/how-do-you-educate-patient-or-family-about-overflow-diarrhea-and-address-the-concern-about-laxative-induced-diarrhea weekly 0.8 https://www.themednet.org/whats-your-trick-to-convince-a-stubborn-patient-to-go-to-skill-nursing-facility-or-inpatient-rehab-to-the-best-of-the-patient weekly 0.8 https://www.themednet.org/how-do-you-approach-cases-of-zonular-dehisence-weakness-noticed-intra-op-i-e-regarding-use-of-ctrs-3-piece-iols-vs-1-piece-iols-placement-in-the-bag-vs-sulcus weekly 0.8 https://www.themednet.org/in-patients-with-treated-endophthalmitis-secondary-to-a-bleb-leak-how-do-you-determine-timing-of-revision weekly 0.8 https://www.themednet.org/do-you-re-load-with-monthly-doses-when-switching-a-patient-with-dme-from-aflibercept-to-faricimab-or-do-you-transition-directly-to-a-treat-and-extend-schedule weekly 0.8 https://www.themednet.org/in-patients-with-history-of-embolic-strokes-from-atrial-fibrillation-and-cerebral-amyloid-angiopathy-who-are-felt-to-be-poor-candidates-for-long-term-anticoagulation-left-atrial-appendage-occlusion-with-the-watchman-device-is-often-considered-as-an-altern weekly 0.8 https://www.themednet.org/are-there-clinical-scenarios-in-which-you-might-use-buspirone-on-an-as-needed-basis weekly 0.8 https://www.themednet.org/in-a-patient-with-eosinophilic-asthma-that-is-controlled-daily-in-between-exacerbations-but-has-very-symptomatic-exacerbations-which-lead-to-er-visits-and-steroid-bursts-about-2-to-3-times-per-year-would-you-consider-starting-a-biologic-agent-for-preventi weekly 0.8 https://www.themednet.org/should-a-biologic-be-started-for-prevention-of-asthma-related-exacerbations-and-hospitalizations-if-these-are-infrequent-and-patient-is-well-controlled-outside-of-flares-but-is-also-on-prednisone-that-they-cannot-get-off-indefinitely-due-to-adrenal-insuff weekly 0.8 https://www.themednet.org/when-patient-does-not-have-comorbid-atopic-dermatitis-or-nasal-polyposis-how-do-you-determine-when-to-use-the-200-mg-vs-300-mg-maintenance-dosing-for-dupixent-for-asthma weekly 0.8 https://www.themednet.org/how-do-you-taper-steroids-for-caa-ri weekly 0.8 https://www.themednet.org/what-ways-can-pocus-assist-in-volume-status-assessments-in-the-clinic-for-patients-who-are-unable-to-lay-at-an-incline-or-get-to-the-exam-table weekly 0.8 https://www.themednet.org/what-is-the-dose-of-daptomycin-for-discitis-have-you-given-10-mg-kg weekly 0.8 https://www.themednet.org/in-pediatric-patients-with-newly-diagnosed-b-cell-all-and-underlying-lynch-syndrome-how-does-the-mmr-deficiency-inform-your-treatment-planning-and-survivorship-surveillance weekly 0.8 https://www.themednet.org/how-long-do-you-continue-a-first-line-somatostatin-receptor-ligand-before-concluding-inadequate-biochemical-response-and-escalating-therapy-in-a-patient-with-persistent-acromegaly-after-transsphenoidal-surgery weekly 0.8 https://www.themednet.org/if-history-of-ckd3-dmii-hyperuricemia-9-5-with-only-one-gout-flare-in-the-past-and-sjs-with-allopurinol-drug-rash-to-febuxostat-what-would-you-try-next-for-hyperuricemia-does-sglt2-have-modest-urate-lowering-effect weekly 0.8 https://www.themednet.org/would-you-treat-with-post-operative-cisplatin-and-radiation-therapy-or-radiation-therapy-alone-in-a-patient-with-pt3pn2-adenoid-cystic-carcinoma-of-the-base-of-tongue-grade-2-with-1-24-lns-with-extranodal-extension-and-perineural-invasion weekly 0.8 https://www.themednet.org/how-do-you-a-approach-a-patient-maintained-on-chronic-methadone-incidentally-found-to-have-a-prolonged-qtc weekly 0.8 https://www.themednet.org/when-do-you-consider-initiating-zoster-prophylaxis-in-patients-what-about-for-planned-procedures weekly 0.8 https://www.themednet.org/in-patients-with-peptic-esophageal-structure-in-the-setting-of-la-grade-d-esophagitis-do-you-consider-cooling-it-off-with-ppi-first-vs-esophageal-dilatation-on-index-egd weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-treat-intractable-drug-resistant-epilepsy-with-focused-ultrasound-rather-than-other-surgical-approaches weekly 0.8 https://www.themednet.org/at-what-point-do-you-refer-patients-to-neurology-for-evaluation-of-tics weekly 0.8 https://www.themednet.org/are-there-instances-when-you-recommend-48-hour-ambulatory-blood-pressure-monitoring-over-typical-24-hour-studies-for-evaluation-of-patients-with-hypertensive-kidney-disease weekly 0.8 https://www.themednet.org/would-you-avoid-use-of-jak-inhibitors-in-patients-with-dermatomyositis-with-autoantibody-subtypes-with-increased-risk-of-malignancy-tif1y-nxp2 weekly 0.8 https://www.themednet.org/how-long-after-initiation-of-steroids-and-immunosuppressive-therapy-does-muscle-biopsy-remain-reliably-informative-in-the-setting-of-suspected-inflammatory-myopathy weekly 0.8 https://www.themednet.org/do-you-use-isavuconazole-for-treatment-of-moderate-to-severe-histoplasmosis-in-patients-with-co-morbidities-acute-or-chronic-renal-failure-or-other-features-that-increase-the-risk-of-side-effects-of-itraconazole weekly 0.8 https://www.themednet.org/how-would-you-treat-low-grade-follicular-lymphoma-with-diffuse-epidural-involvement-would-you-give-intratheracal-or-high-dose-systemic-methotrexate-in-addition-to-systemic-chemoimmunotherapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-induction-regimen-for-primary-cns-lymphoma-in-a-young-patient-matrix-mtr-etc weekly 0.8 https://www.themednet.org/what-is-the-role-for-adjuvant-chemotherapy-and-or-radiation-in-ampullary-carcinoma weekly 0.8 https://www.themednet.org/how-long-after-a-tracheostomy-would-you-wait-before-initiating-rt weekly 0.8 https://www.themednet.org/for-borderline-resectable-pancreas-treated-with-induction-chemo-therapy-and-minimal-radiographic-response-if-unable-to-do-sbrt-do-you-prefer-36-15-or-50-4-28-given-that-is-where-we-have-more-data weekly 0.8 https://www.themednet.org/would-you-offer-the-pacific-protocol-to-a-patient-with-stage-iii-lung-cancer-with-performance-status-2-3 weekly 0.8 https://www.themednet.org/what-cumulative-dose-constraints-to-you-utilize-when-treating-high-risk-prostate-cancer-with-combined-external-beam-and-brachytherapy-boost weekly 0.8 https://www.themednet.org/how-would-you-approach-an-elderly-patient-with-early-stage-breast-cancer-with-micropapillary-histology weekly 0.8 https://www.themednet.org/what-are-your-dose-constraints-for-treating-axillary-nodal-basin-in-melanoma-with-30gy-5fx weekly 0.8 https://www.themednet.org/should-upfront-neck-dissection-in-head-and-neck-squamous-cell-carcinoma-obviate-the-need-for-chemo-in-a-t1n2-oropharyngeal-cancer-with-no-ece weekly 0.8 https://www.themednet.org/how-would-you-treat-a-young-patient-with-good-performance-status-who-has-de-novo-metastatic-hr-her2-inflammatory-breast-cancer-with-asymptomatic-leptomeningeal-and-cns-parenchymal-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-in-field-perineural-recurrences-in-the-skull-base weekly 0.8 https://www.themednet.org/do-you-routinely-offer-post-operative-radiotherapy-for-resected-retroperitoneal-sarcomas weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-inquire-about-response-rates-in-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-advise-patients-looking-for-2nd-opinions-while-on-standard-of-care-first-line-treatment-for-metastatic-er-her2-bc-i-e-a-cdk4-6-inhibitor-aromatase-inhibitor-to-bolster-requests-for-chemotherapy-when-non-indicated weekly 0.8 https://www.themednet.org/do-you-make-diagnostic-lumbar-puncture-part-of-routine-work-up-for-newly-diagnosed-aml-if-patient-is-asymptomatic weekly 0.8 https://www.themednet.org/what-is-the-best-treatment-regimen-for-a-fungating-scca-of-the-scrotum-arising-from-untreated-genital-warts-invading-the-groin-and-base-of-the-penis-with-bilateral-inguinal-nodes weekly 0.8 https://www.themednet.org/when-do-you-consider-total-neoadjuvant-therapy-chemotherapy-and-chemoradiation-for-rectal-cancer weekly 0.8 https://www.themednet.org/in-what-circumstances-if-any-do-you-administer-concurrent-capecitabine-with-radiation-therapy-in-the-treatment-of-breast-cancer weekly 0.8 https://www.themednet.org/how-does-the-presence-of-lymphangitic-spread-in-a-single-lobe-impact-your-management-strategy-for-locally-advanced-nsclc weekly 0.8 https://www.themednet.org/for-gastric-cancer-receiving-flot-perioperatively-with-negative-margins-but-multiple-positive-nodes-do-you-offer-postoperative-chemort weekly 0.8 https://www.themednet.org/would-you-treat-a-young-patient-with-de-novo-triple-negative-breast-cancer-metastasis-to-the-superior-mediastinum-as-locally-advanced-with-chemotherapy-followed-by-radiation-or-palliative-chemo-immunotherapy-if-pd-l1-positive weekly 0.8 https://www.themednet.org/what-is-your-preferred-third-line-treatment-option-for-metastatic-nsclc-after-first-line-chemo-immunotherapy-and-second-line-single-agent-chemo-assuming-no-actionable-mutations weekly 0.8 https://www.themednet.org/do-you-offer-bevacizumab-to-patients-more-than-65-years-old-with-metastatic-colon-cancer-that-are-kras-mutant weekly 0.8 https://www.themednet.org/how-much-later-after-starting-a-hypomethylating-agent-in-an-elderly-patient-with-aml-being-treated-in-the-upfront-setting-can-venetoclax-be-started weekly 0.8 https://www.themednet.org/would-mild-hemophilia-a-that-does-not-require-frequent-factor-replacement-be-an-absolute-contraindication-to-anti-vegf-medications-when-indicated weekly 0.8 https://www.themednet.org/how-do-you-approach-gastric-cancer-with-oligometastatic-disease weekly 0.8 https://www.themednet.org/how-would-you-manage-prostate-cancer-with-isolated-presacral-nodal-metastasis weekly 0.8 https://www.themednet.org/do-you-have-any-specific-bowel-constraints-when-treating-patients-with-palliative-radiation-3000-10 weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-er-her-2-metastatic-disease-on-t-dm1-with-ned-for-over-2-years-now-with-an-isolated-recurrence-that-is-er-but-her-2-negative weekly 0.8 https://www.themednet.org/is-there-a-role-for-adjuvant-chemotherapy-in-a-young-healthy-patient-with-a-large-malignant-phyllodes-tumor-of-the-breast weekly 0.8 https://www.themednet.org/can-you-use-immunotherapy-in-patients-with-liver-transplants weekly 0.8 https://www.themednet.org/how-would-you-manage-a-locally-advanced-tnbc-and-a-malignant-appearing-renal-mass-suspicious-for-a-synchronous-renal-cell-carcinoma weekly 0.8 https://www.themednet.org/what-is-the-role-if-any-for-rituximab-in-a-patient-with-cd20-philadelphia-chromosome-positive-all weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-for-a-primary-carcinosarcoma-of-the-cervix-with-pelvic-and-para-aortic-nodal-involvement weekly 0.8 https://www.themednet.org/in-a-germline-brca2-positive-pt-with-nsclc-after-chemoio-frontline-and-taxotere-as-a-second-line-would-you-consider-parp-inhibitors weekly 0.8 https://www.themednet.org/when-do-you-recommend-pd-l1-testing-for-patients-with-recurrent-cervical-cancer weekly 0.8 https://www.themednet.org/how-do-you-choose-1st-line-therapy-for-recurrent-cervical-cancer weekly 0.8 https://www.themednet.org/would-you-recommend-1st-line-pembrolizumab-for-pd-l1-positive-recurrent-metastatic-cervical-cancer-patient-who-is-not-a-candidate-for-or-refuses-chemotherapy weekly 0.8 https://www.themednet.org/is-pembrolizumab-considered-standard-of-care-in-the-2nd-line-treatment-of-recurrent-cervical-cancer weekly 0.8 https://www.themednet.org/how-do-you-determine-which-systemic-therapy-to-recommend-in-the-2nd-line-setting-for-metastatic-pd-l1-negative-cervical-cancer weekly 0.8 https://www.themednet.org/do-you-consider-using-capecitabine-and-irinotecan-xeliri-instead-of-folfiri-for-first-line-metastatic-colorectal-cancer weekly 0.8 https://www.themednet.org/do-you-consider-tumor-mutation-burden-as-a-possible-biomarker-for-response-to-immune-checkpoint-therapy-in-the-second-line-setting-for-cervical-cancer weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-endocrine-therapy-for-a-patient-with-t1a-luminal-a-breast-cancer weekly 0.8 https://www.themednet.org/what-is-a-safe-time-interval-from-completion-of-hormones-and-external-beam-radiation-to-turp-in-patients-who-develop-refractory-obstruction weekly 0.8 https://www.themednet.org/how-do-you-approach-nodal-coverage-in-port-for-nsclc-with-involved-station-8 weekly 0.8 https://www.themednet.org/would-you-ever-consider-offering-more-than-4-cycles-of-adjuvant-chemotherapy-in-early-stage-nsclc weekly 0.8 https://www.themednet.org/how-do-you-approach-a-case-of-nasopharyngeal-adenoid-cystic-carcinoma-with-neck-node-unilaeral-involvement weekly 0.8 https://www.themednet.org/do-you-avoid-teriparatide-in-previously-irradiated-breast-cancer-patients-with-osteoporosis-given-the-black-box-warning-for-potential-risk-of-osteosarcoma weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-interpreting-post-treatment-pet-deauville-scores-for-patients-treated-with-chemotherapy-for-classical-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-radiation-for-an-atypical-fibroxanthoma-of-the-scalp-that-is-completed-resected-with-pni-and-lvi weekly 0.8 https://www.themednet.org/how-do-you-dose-midostaurin-in-patients-with-aml-who-need-azole-antifungal-prophylaxis weekly 0.8 https://www.themednet.org/since-the-approval-of-carbo-vp-16-atezolizumab-impower133-for-extensive-stage-small-cell-lung-cancer-how-are-you-treating-those-patients-who-progress-6-months-after-chemotherapy-alone-who-were-treated-prior-to-the-approval-of-impower133 weekly 0.8 https://www.themednet.org/should-special-precautions-be-taken-when-treating-oligometastatic-disease-in-the-sacrum-or-pelvis-with-sbrt-in-a-patient-with-a-long-life-expectancy weekly 0.8 https://www.themednet.org/for-localized-prostate-cancer-patients-do-you-routinely-give-antiandrogen-therapy-for-patients-receiving-lhrh-agonist-therapy weekly 0.8 https://www.themednet.org/in-light-of-recent-data-from-asco-2019-and-the-nejm-would-you-recommend-induction-chemotherapy-or-an-adjuvant-approach-in-combination-with-chemoradiation-for-locally-advanced-nasopharyngeal-carcinoma weekly 0.8 https://www.themednet.org/should-consolidation-autologous-stem-cell-transplant-be-considered-for-de-novo-follicular-lymphoma-transformation-to-dlbcl-after-achieving-a-pr-with-r-chop-x-6-cycles-if-residual-disease-showed-original-indolent-follicular-lymphoma weekly 0.8 https://www.themednet.org/for-an-otherwise-healthy-individual-what-would-be-your-front-line-choice-for-de-novo-richters-transformation weekly 0.8 https://www.themednet.org/in-light-of-recent-data-suggesting-limited-activity-of-atezolizumab-monotherapy-in-the-2nd-line-treatment-of-es-sclc-would-you-still-offer-atezolizumab-maintenance-following-combination-chemo-io-in-the-first-line-setting weekly 0.8 https://www.themednet.org/what-dose-and-oar-constraints-do-you-use-for-boost-with-imrt-or-sbrt-when-a-patient-with-cancer-of-the-cervix-is-not-a-candidate-for-brachytherapy weekly 0.8 https://www.themednet.org/based-on-the-select-d-trial-would-you-favor-rivaroxaban-over-lmwh-for-treating-cancer-associated-vte-in-patients-with-low-risk-of-bleeding weekly 0.8 https://www.themednet.org/would-using-obinutuzumab-and-venetoclax-second-line-after-bendamutine-and-rituximab-be-a-reasonable-option-for-a-patient-with-ighv-unmutated-cll weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-brainstem-metastases-in-the-setting-of-prior-wbrt weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-who-has-a-large-dcis-status-post-mastectomy-and-implant-with-extensive-positive-margins weekly 0.8 https://www.themednet.org/for-patients-with-metastatic-nsclc-with-met-amplification-who-respond-well-to-first-line-crizotinib-but-develop-hepatotoxicity-how-do-you-decided-whether-to-consider-re-challenge-or-change-therapy-altogether weekly 0.8 https://www.themednet.org/what-is-your-approach-to-imaging-for-localization-of-biochemical-relapse-of-prostate-cancer-after-radical-prostatectomy weekly 0.8 https://www.themednet.org/would-you-consider-prone-sbrt-with-solid-image-guidance-techniques-if-bowel-is-lying-on-a-target-for-instance-bowel-surrounding-an-oligometastatic-lymph-node-or-next-to-a-kidney-tumor weekly 0.8 https://www.themednet.org/what-is-your-first-line-treatment-of-choice-for-advanced-stage-iiia-follicular-lymphoma-histologic-grade-1-2-in-an-otherwise-young-healthy-patient-in-2019 weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-avascular-necrosis-and-symptomatic-bone-met-in-the-region weekly 0.8 https://www.themednet.org/when-do-you-offer-consolidative-tandem-autologous-stem-cell-transplantation-for-high-risk-multiple-myeloma weekly 0.8 https://www.themednet.org/is-there-a-role-for-jakafi-in-essential-thrombocythemia weekly 0.8 https://www.themednet.org/what-elective-areas-do-you-cover-for-a-primary-oropharynx-scc-isolated-to-the-pharyngeal-wall weekly 0.8 https://www.themednet.org/do-you-offer-pelvic-radiation-for-endometrial-cancer-with-itcs-in-the-node-s-and-no-other-high-or-intermediate-risk-factors weekly 0.8 https://www.themednet.org/when-treating-a-patient-definitively-for-high-risk-prostate-cancer-how-would-you-interpret-the-interval-development-of-sclerotic-bone-lesions-that-appeared-during-neoadjuvant-adt weekly 0.8 https://www.themednet.org/how-do-you-choose-between-adjuvant-pcv-vs-temozolomide-in-high-risk-oligodendroglioma-with-idh-mutation-and-1p-19q-co-deletion weekly 0.8 https://www.themednet.org/would-you-recommend-ebrt-brachythrapy-for-any-patients-with-stage-iii-iv-uterine-ca-in-light-of-gog-258-data weekly 0.8 https://www.themednet.org/do-you-continue-megestrol-in-a-patient-with-inoperable-endometrial-cancer-during-definitive-radiation-therapy weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiation-therapy-for-high-grade-t1-nasal-vestibule-squamous-cell-carcinoma-with-negative-margin-5mm-but-positive-focal-perineural-invasion weekly 0.8 https://www.themednet.org/which-patients-age-50-with-oncotype-score-11-do-you-offer-ovarian-suppression weekly 0.8 https://www.themednet.org/how-would-you-manage-the-axilla-in-a-patient-with-merkel-cell-carcinoma-of-the-left-forearm-with-clinically-negative-axillary-sentinel-node-positive-disease weekly 0.8 https://www.themednet.org/what-dose-fractionation-do-you-like-to-use-for-palliation-of-bulky-lad-from-cll-sll weekly 0.8 https://www.themednet.org/in-vulvar-cancer-patients-with-a-well-lateralized-primary-s-p-vulvectomy-and-ipsilateral-lnd-meeting-nodal-based-criteria-for-adjuvant-rt-would-you-consider-rt-to-the-ipsilateral-groin-and-pelvis weekly 0.8 https://www.themednet.org/for-a-woman-with-baseline-neuropathy-is-there-any-evidence-to-use-a-different-chemotherapy-with-atezolizumab-in-metastatic-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/in-patients-with-high-risk-or-very-high-risk-prostate-cancer-who-undergo-radical-prostatectomy-and-adjuvant-rt-for-adverse-features-who-also-opt-to-receive-adjuvant-docetaxel-what-duration-of-adt-would-consider-giving weekly 0.8 https://www.themednet.org/in-refractory-germ-cell-tumor-in-the-absence-of-results-of-the-randomized-tiger-trial-how-do-you-determine-if-patients-should-be-treated-with-conventional-dose-chemotherapy-versus-high-dose-chemotherapy weekly 0.8 https://www.themednet.org/how-long-after-biopsy-is-it-safe-to-place-rectal-spacer-when-treating-a-patient-definitively-for-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-treat-a-stage-i-endometrial-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-approach-rectal-cancer-with-a-solitary-bone-metastasis-that-is-biopsy-proven weekly 0.8 https://www.themednet.org/how-if-at-all-do-you-use-biozorb-to-help-guide-your-external-beam-partial-breast-irradiation-volumes weekly 0.8 https://www.themednet.org/would-you-finish-neoadjuvant-tc-in-a-postmenopausal-stage-i-tnbc-patient-who-transferred-care-to-your-practice-after-1-cycle-or-you-would-proceed-with-surgery-and-finish-chemo-adjuvantly weekly 0.8 https://www.themednet.org/what-is-the-preferred-clinical-management-of-hyperglycemia-related-to-alpelisib weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-radiation-for-r1-resection-for-thymoma-with-solitary-pleural-deposit-along-diaphram weekly 0.8 https://www.themednet.org/in-patients-with-inflammatory-bowel-disease-with-low-rectal-cancer-with-planned-proctocolectomy-would-you-consider-creation-of-a-pouch weekly 0.8 https://www.themednet.org/after-partial-mastectomy-would-you-consider-oncotype-for-an-older-male-with-hr-her-2-idc-t1cn0-grade-2-disease weekly 0.8 https://www.themednet.org/is-it-appropriate-to-treat-unresectable-secretory-insulinoma-of-tail-of-the-pancreas-with-radiation-therapy weekly 0.8 https://www.themednet.org/do-you-use-same-criteria-for-offering-neoadjuvant-chemotherapy-in-a-lobular-breast-cancer-as-you-would-ductal weekly 0.8 https://www.themednet.org/how-if-at-all-would-you-consider-incorporating-alpelisib-in-metastatic-hr-pik3ca-mutated-breast-cancer-in-a-patient-who-previously-progressed-on-fulvestrant weekly 0.8 https://www.themednet.org/how-do-you-treat-a-patient-who-develops-metastatic-prostate-ca-while-on-enzalutamide-or-apalutamide-for-originally-m0-crpc weekly 0.8 https://www.themednet.org/would-you-consider-delaying-radiation-to-wait-for-oncotype-results-to-guide-adjuvant-chemotherapy-for-early-stage-hr-node-negative-breast-cancer weekly 0.8 https://www.themednet.org/what-systemic-therapy-would-you-suggest-for-metastatic-odontogenic-clear-cell-carcinoma-with-no-actionable-mutations-on-ngs weekly 0.8 https://www.themednet.org/with-the-fda-approval-of-third-line-pembrolizumab-for-patients-with-sclc-how-would-you-select-a-candidate-for-pembrolizumab-or-nivolumab-in-the-third-line-management-of-sclc weekly 0.8 https://www.themednet.org/would-you-offer-chestwall-rt-after-capsultectomy-explant-for-an-implant-related-alcl weekly 0.8 https://www.themednet.org/how-do-you-approach-prostate-cancer-patients-who-have-hypertestosteronism-on-pre-treatment-labs weekly 0.8 https://www.themednet.org/for-a-patient-with-vaginal-adhesions-stenosis-do-you-recommend-any-other-therapy-besides-a-dilator weekly 0.8 https://www.themednet.org/would-you-consider-lenvatinib-plus-everolimus-as-first-line-treatment-for-a-patient-with-tuberous-sclerosis-and-metastatic-renal-cell-carcinoma weekly 0.8 https://www.themednet.org/how-long-do-you-give-neoadjuvant-therapy-in-resectable-borderline-resectable-pancreatic-cancer-when-you-are-considering-chemoradiotherapy-as-part-of-your-neoadjuvant-strategy weekly 0.8 https://www.themednet.org/what-would-be-the-preferred-chemotherapy-regimen-in-elderly-patients-with-advanced-stage-classical-hodgkin-lymphoma-and-contraindication-to-adriamycin-and-bleomycin weekly 0.8 https://www.themednet.org/what-therapy-would-you-offer-a-young-braf-wild-type-patient-with-metastatic-melanoma-who-progressed-on-single-agent-pembrolizumab weekly 0.8 https://www.themednet.org/would-you-consider-her2-directed-therapy-in-a-patient-with-pretreated-metastatic-right-sided-colon-adenocarcinoma-progressed-on-folfox-bevacizumab-if-they-are-both-her2-neu-amplified-and-have-a-her2-neu-exon-19-mutation weekly 0.8 https://www.themednet.org/would-you-use-cts5-to-help-you-decide-whether-to-offer-prolonged-adjuvant-et-to-hr-breast-cancer weekly 0.8 https://www.themednet.org/would-you-recommend-radium-223-for-extensive-bone-disease-in-a-prostate-cancer-patient-with-adenopathy-3cm weekly 0.8 https://www.themednet.org/how-do-you-approach-cranial-radiotherapy-in-a-patient-with-a-cochlear-implant weekly 0.8 https://www.themednet.org/how-would-you-manage-lung-adenocarcinoma-in-a-patient-with-an-index-lesion-requiring-treatment-who-has-additional-slowly-evolving-ggos-subsolid-nodules weekly 0.8 https://www.themednet.org/would-you-consider-a-parp-inhibitor-in-a-patient-who-harbors-a-germline-brca-mutation-who-has-metastatic-her2-negative-gastric-cancer weekly 0.8 https://www.themednet.org/would-you-consider-cystectomy-in-a-patient-who-acheived-radiologic-and-cystoscopic-cr-from-chemo-radiation-for-oligometastatic-urothelial-carcinoma-originating-in-the-bladder-if-remains-disease-free-6-months weekly 0.8 https://www.themednet.org/if-you-saw-a-medically-inoperable-patient-for-chemort-for-muscle-invasive-bladder-cancer-who-had-a-congenital-recto-urethral-fistula-would-you-deliberately-exclude-the-prostate-prostatic-urethra-from-the-target-volume weekly 0.8 https://www.themednet.org/when-do-you-have-a-patient-proceed-to-surgery-for-breast-ca-after-completion-of-neoadjuvant-chemotherapy-if-they-developed-a-line-associated-upper-extremity-dvt-vte-after-completing-chemo weekly 0.8 https://www.themednet.org/do-you-consider-sabr-for-oligometastatic-disease-in-patients-with-tp53-germline-mutation weekly 0.8 https://www.themednet.org/in-patients-with-metastatic-nsclc-with-egfr-mutation-currently-being-treated-with-osimertinib-would-you-consider-increasing-dose-from-80mg-to-160mg-at-the-time-of-progression weekly 0.8 https://www.themednet.org/what-is-your-preferred-sequence-of-chemotherapy-regimens-after-patients-with-metastatic-endometrial-cancer-develop-resistance-to-carboplatin-paclitaxel weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-oligometastatic-disease-in-the-femoral-head weekly 0.8 https://www.themednet.org/would-you-still-offer-adjuvant-chemoradiation-therapy-to-a-patient-with-pt3-pn1a-rectal-cancer-who-did-not-receive-any-neoadjuvant-treatment-and-whose-adjuvant-treatment-is-delayed-by-4-months-due-to-post-operative-complications weekly 0.8 https://www.themednet.org/how-long-do-you-treat-recurrent-classical-hodgkin-lymphoma-with-brentuximab-nivolumab-if-the-patient-does-not-want-to-proceed-to-bmt weekly 0.8 https://www.themednet.org/are-there-any-anatomical-locations-that-you-would-consider-omiting-preoperative-radiation-for-sarcoma-due-to-toxicity-concerns weekly 0.8 https://www.themednet.org/would-you-consider-giving-tamoxifen-prophylaxis-to-young-women-with-pathogenic-brca2-muations-who-are-35-years-old weekly 0.8 https://www.themednet.org/how-do-you-define-ptv-margins-for-lung-sbrt-using-breath-hold-technique weekly 0.8 https://www.themednet.org/what-systemic-therapy-would-you-offer-to-a-postmenopausal-patient-with-an-unresectable-local-recurrence-of-her2-er-weakly-idc weekly 0.8 https://www.themednet.org/would-you-consider-perioperative-immunotherapy-for-a-patient-with-locally-advanced-resectable-gastric-cancer-but-not-a-candidate-for-chemotherapy weekly 0.8 https://www.themednet.org/in-a-patient-with-newly-diagnosed-high-risk-prostate-cancer-how-do-you-work-up-a-bone-scan-showing-suspicious-areas-of-radiotracer-uptake weekly 0.8 https://www.themednet.org/how-do-you-treat-recurrent-dedifferentiated-liposarcoma-after-initial-complete-resection-if-the-recurrence-is-multifocal-but-surgically-resectable weekly 0.8 https://www.themednet.org/in-light-of-gog-252-are-there-any-situations-where-ip-chemotherapy-would-be-preferable-following-debulking-of-advanced-epithelial-ovarian-cancer weekly 0.8 https://www.themednet.org/when-do-you-choose-dose-dense-chemotherapy-v-q3-week-therapy-in-advanced-epithelial-ovarian-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-frontline-bevacizumab-with-carbo-taxol-in-patients-with-advanced-epithelial-ovarian-and-brca-mutation-who-will-be-receiving-olaparib-maintenance weekly 0.8 https://www.themednet.org/how-would-your-recommendations-for-post-mastectomy-radiation-change-for-a-patient-with-scleroderma weekly 0.8 https://www.themednet.org/how-do-you-use-neratinib-in-hr-her2-patients-in-the-adjuvant-setting-if-patients-got-adjuvant-t-dm1-for-residual-disease-after-neoadjuvant-therapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-tki-and-dosing-for-ayas-or-adult-patients-with-ph-all weekly 0.8 https://www.themednet.org/aside-from-adrenal-insufficiency-and-thyroid-toxicities-how-do-you-approach-other-hormonal-imbalances-during-treatment-with-immune-checkpoint-inhibitors weekly 0.8 https://www.themednet.org/if-a-patient-develops-a-radiation-recall-reaction-do-you-typically-recommend-avoiding-the-causative-chemotherapy-in-the-future weekly 0.8 https://www.themednet.org/is-there-a-role-for-a-pdl-1-inhibitor-in-patients-with-chemo-refractory-metastatic-esophageal-adenocarcinoma-with-pdl-negative-msi-stable-disease weekly 0.8 https://www.themednet.org/does-the-presence-of-interstitial-cystitis-disease-affect-your-decision-to-offer-post-prostatectomy-salvage-radiation-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-primary-cns-lymphoma-in-elderly-patients-over-80-years-old weekly 0.8 https://www.themednet.org/for-patients-with-metastatic-radioctive-iodine-refractory-papillary-thyroid-carcinoma-that-is-braf-v600e-mutant-and-rapidly-progressive-would-you-consider-dabrafenib-trametinib-combo-instead-of-lenvantinib-or-sorafenib-first-line weekly 0.8 https://www.themednet.org/which-imaging-modalities-and-schedule-do-you-use-to-follow-stage-i-ii-follicular-lymphoma-that-was-treated-with-radiotherapy-alone weekly 0.8 https://www.themednet.org/what-is-the-most-appropriate-adjuvant-chemotherapy-regimen-for-pre-menopausal-pt1bn0-tnbc weekly 0.8 https://www.themednet.org/in-a-newly-diagnosed-elderly-patient-with-aml-who-harbors-an-idh1-mutation-would-you-treat-with-upfront-with-ivosidenib-hma-or-would-you-proceed-with-venetoclax-and-hma-as-your-first-line-treatment weekly 0.8 https://www.themednet.org/aside-from-met-exon-14-skip-mutations-are-there-other-targetable-met-mutations-or-fusions-that-you-would-consider-for-tki-therapy weekly 0.8 https://www.themednet.org/following-mastectomy-with-a-snb-and-single-positive-axillary-lymph-node-would-you-refer-a-patient-back-for-an-axillary-dissection-if-she-has-borderline-indications-for-pmrt weekly 0.8 https://www.themednet.org/do-you-offer-concomitant-chemotherapy-and-radiation-to-patients-with-locally-advanced-ulcerated-breast-masses-that-have-good-performance-status-and-are-potentially-curable weekly 0.8 https://www.themednet.org/would-you-offer-sbrt-to-small-but-growing-level-ii-lymph-nodes-in-a-kadish-d-multiply-recurrent-multifocal-esthesioneuroblastoma weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-radiation-for-well-differentiated-gastric-type-adenocarcinoma-of-the-cervix-stage-1b-without-lvi weekly 0.8 https://www.themednet.org/for-metastatic-pancreatic-cancer-is-there-a-role-for-maintenance-chemotherapy-if-patient-has-stable-disease-at-the-end-of-12-cycles-of-dose-reduced-modified-folfirinox weekly 0.8 https://www.themednet.org/is-a-very-rapidly-rising-wbc-count-ever-an-indication-for-the-upfront-treatment-of-cll weekly 0.8 https://www.themednet.org/in-a-patient-with-ild-and-metastatic-nsclc-with-positive-pd-l1-would-you-give-chemo-pembrolizumab-chemotherapy-alone-or-pembrolizumab-alone weekly 0.8 https://www.themednet.org/is-the-presence-of-stump-stromal-tumor-of-uncertain-malignant-potential-after-prostatectomy-an-indication-for-adjuvant-radiation weekly 0.8 https://www.themednet.org/how-would-you-approach-a-metastatic-erbb2-amplified-gallbladder-carcinoma weekly 0.8 https://www.themednet.org/what-is-the-appropriate-radiation-dose-volume-for-perianal-basal-cell-carcinoma weekly 0.8 https://www.themednet.org/do-you-consider-initiating-systemic-therapy-for-patients-with-nsclc-who-develop-oligometastatic-disease-and-have-all-known-sites-of-disease-treated-with-sbrt weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-chemotherapy-for-high-grade-large-cell-neuroendocrine-lung-cancers weekly 0.8 https://www.themednet.org/how-much-emphasis-do-you-place-on-anti-ar-therapy-in-a-patient-with-metastatic-castration-resistant-prostate-adenocarcinoma-with-progressive-neuroendocrine-differentiation weekly 0.8 https://www.themednet.org/does-radiation-offer-a-benefit-for-knuckle-pads-due-to-dupuytrens weekly 0.8 https://www.themednet.org/what-would-be-your-choice-for-treatment-for-an-hiv-positive-patient-with-no-detectable-viral-load-with-cd20-negative-and-cd30-positive-dlbcl weekly 0.8 https://www.themednet.org/what-role-if-any-is-there-for-y90-in-metastatic-gallbladder-cancer-to-the-liver weekly 0.8 https://www.themednet.org/would-you-offer-maintenance-lenalidomide-or-rituximab-in-a-patient-with-dlbcl-transformed-from-a-marginal-zone-lymphoma-in-a-young-fit-patient weekly 0.8 https://www.themednet.org/how-do-you-diagnose-mds-in-a-patient-with-equivocal-morphological-findings weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-s-p-neoadjuvant-chemotherapy-pcr-and-surgery-for-a-right-bc-er-5-pr-her2-found-to-have-a-rp-node-invaded-by-a-carcinoma-with-er-70-deemed-from-ovarian-origin-by-pathology-found-during-tah-bso weekly 0.8 https://www.themednet.org/would-you-approach-a-salvage-case-post-prostatectomy-differently-in-a-patient-with-a-piece-of-broken-metallic-surgical-tool-located-in-the-prostate-bed weekly 0.8 https://www.themednet.org/how-do-you-approach-deciding-between-srs-and-fractionated-radiation-for-an-acoustic-neuroma weekly 0.8 https://www.themednet.org/would-focal-clear-cell-features-change-your-management-for-a-grade-2-endometrial-adenocarcinoma weekly 0.8 https://www.themednet.org/is-there-any-role-for-neoadjuvant-therapy-in-urothelial-tis-refractory-to-bcg-therapy weekly 0.8 https://www.themednet.org/do-you-consider-regional-nodal-irradiation-for-women-with-er-breast-cancer-with-a-single-micrometastasis-after-lumpectomy-and-sentinel-lymph-node-sampling weekly 0.8 https://www.themednet.org/if-a-patient-has-distal-esophageal-adenocarcinoma-and-a-pet-left-supraclavicular-lymph-node-and-nothing-in-between-would-you-cover-the-entire-esophagus-both-supraclavicular-fields weekly 0.8 https://www.themednet.org/do-you-recommend-treating-the-entire-extent-of-hardware-for-a-femoral-neck-plasmacytoma-with-pathologic-fracture-requiring-internal-fixation weekly 0.8 https://www.themednet.org/would-you-offer-liver-sbrt-to-a-patient-with-a-history-of-a-liver-transplant weekly 0.8 https://www.themednet.org/what-is-your-preferred-systemic-therapy-for-metastatic-malignant-peripheral-nerve-sheath-tumor-with-early-relapse-after-adjuvant-aim weekly 0.8 https://www.themednet.org/what-dose-would-you-offer-a-person-with-symptomatic-lymphoid-hyperplasia-of-the-orbit-with-mass-on-imaging weekly 0.8 https://www.themednet.org/for-a-pt-with-relapse-acute-myeloid-leukemia-flt3-positive-on-azacytidine-and-venetoclax-is-there-any-role-for-the-addition-of-midostaurin-to-the-treatment-regimen-to-improve-complete-remission-rate weekly 0.8 https://www.themednet.org/would-you-deliver-srs-xrt-for-isolated-asymptomatic-cns-metastasis-before-start-of-immunotherapy-for-stage-iv-lung-cancer-negative-for-driver-mutation-with-high-positive-pdl1 weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-brain-metastases-in-a-patient-with-behcets-disease weekly 0.8 https://www.themednet.org/for-retreatment-of-lung-cancer-mediastinal-lymph-node-failure-what-tissue-tolerance-do-you-use-for-esophagus-spinal-cord-and-heart-published-limits-would-likely-be-exceeded weekly 0.8 https://www.themednet.org/would-you-recommend-radiation-therapy-for-a-pathologic-vertebral-compression-fracture-already-treated-with-kyphoplasty-and-rfa-osteocool weekly 0.8 https://www.themednet.org/would-you-risk-offering-alpelisib-or-everolimus-to-a-patient-with-metastatic-er-her2-breast-ca-with-type-1-dm weekly 0.8 https://www.themednet.org/how-do-you-decide-between-carboplatin-vs-not-recommending-adjuvant-chemotherapy-entirely-for-patients-with-resected-nsclc-with-relative-or-absolute-contraindications-to-cisplatin weekly 0.8 https://www.themednet.org/how-do-you-incorporate-advanced-imaging-into-cranial-radiosurgery weekly 0.8 https://www.themednet.org/what-constraints-do-you-use-for-the-gallbladder-when-giving-liver-sbrt-to-lesions-close-to-the-gallbladder weekly 0.8 https://www.themednet.org/how-do-you-treat-a-gastric-plasmacytoma-which-is-not-amenable-to-radiation weekly 0.8 https://www.themednet.org/do-you-include-gemtuzumab-ozogamicin-for-any-of-your-newly-diagnosed-aml-patients-who-are-candidates-for-7-3-induction-chemotherapy weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-radiation-therapy-for-a-patient-with-a-5-cm-resected-malignant-peripheral-nerve-sheath-tumor-with-1-cm-negative-margin weekly 0.8 https://www.themednet.org/would-you-offer-radiation-therapy-to-a-patient-with-unresectable-intracranial-rosai-dorfman-disease weekly 0.8 https://www.themednet.org/how-would-you-manage-a-recurrent-pineoblastoma-following-prior-csi weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-would-you-recommend-for-adjuvant-radiation-treatment-of-a-giant-cell-tumor-of-the-tendon-sheath-in-the-hand weekly 0.8 https://www.themednet.org/how-do-you-manage-steroid-refractory-acute-gvhd-following-allogeneic-transplant weekly 0.8 https://www.themednet.org/what-would-be-your-approach-to-a-patient-with-a-pik3ca-mutation-after-progressing-on-multiple-lines-of-chemotherapy-immunotherapy-and-parpi-for-gbrca-mutated-metastatic-tnbc weekly 0.8 https://www.themednet.org/do-you-offer-definitive-chemoradiation-for-a-primary-duodenal-adenocarcinoma weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-therapy-for-ros-1-rearranged-metastatic-nsclc-for-patients-presenting-with-cns-metastases weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-ge-junction-or-esophageal-cancer-with-oligomestatic-disease-at-presentation weekly 0.8 https://www.themednet.org/what-treatment-planning-challenges-do-you-consider-when-treating-a-woman-with-synchronous-bilateral-breast-cancers weekly 0.8 https://www.themednet.org/when-would-you-consider-adding-adjuvant-parp-inhibitor-in-a-young-gbrca-mutated-patient-with-hr-her2-early-breast-cancer weekly 0.8 https://www.themednet.org/what-positions-and-immobilization-strategies-do-you-use-to-minimize-breast-and-heart-dose-when-treating-axillary-and-mediastinal-nodes-in-young-women-with-large-breasts-who-require-consolidative-radiation-isrt-for-hodgkins-lympoma weekly 0.8 https://www.themednet.org/for-head-and-neck-cancer-patients-who-are-already-edentulous-do-you-have-them-leave-dentures-in-for-treatment-to-avoid-changes-in-jaw-position weekly 0.8 https://www.themednet.org/would-you-recommend-consolidative-radiation-therapy-to-an-isolated-frontal-dural-malt-lymphoma-after-complete-response-to-chemotherapy weekly 0.8 https://www.themednet.org/would-you-recommend-re-irradiation-to-the-pelvis-for-palliation-of-bone-metastases-in-a-patient-who-previously-had-prostate-brachytherapy weekly 0.8 https://www.themednet.org/what-is-a-reasonable-dose-to-treat-the-entire-bladder-for-an-muscle-invasive-multi-focal-bladder-cancer-in-a-non-surgical-patient weekly 0.8 https://www.themednet.org/is-there-any-role-for-regional-lymph-node-dissection-with-radical-nephrectomy-for-patients-with-early-stage-rcc weekly 0.8 https://www.themednet.org/how-do-you-treat-unresectable-pancreatic-adenocarcinoma-invading-into-the-duodenum weekly 0.8 https://www.themednet.org/in-deciding-between-3-versus-6-months-of-adjuvant-therapy-for-colon-cancer-how-would-you-factor-in-the-presence-of-isolated-tumor-deposits-staged-as-n1c-but-negative-lymph-nodes weekly 0.8 https://www.themednet.org/in-patients-with-metastatic-rcc-who-have-had-a-complete-response-to-pembrolizumab-and-axitinib-and-undergone-a-nephrectomy-how-long-would-you-continue-therapy-post-operatively weekly 0.8 https://www.themednet.org/is-there-a-role-for-pre-operative-rt-chemo-for-a-borderline-resectable-klatskin-tumor-as-an-attempt-to-try-to-get-them-to-surgery weekly 0.8 https://www.themednet.org/how-does-the-presence-of-active-rheumatoid-arthritis-on-rituxan-impact-your-decision-to-proceed-with-prostate-radiation weekly 0.8 https://www.themednet.org/how-would-you-manage-a-cml-patient-with-a-t315i-mutation-that-developed-severe-abdominal-pain-requiring-hospitalization-after-starting-ponatinib-45-mg weekly 0.8 https://www.themednet.org/when-considering-adjuvant-chemotherapy-for-resected-lung-cancer-do-you-treat-rarer-histologic-patterns-such-as-acinar-or-lepidic-the-same-as-you-would-a-more-typical-nsclc weekly 0.8 https://www.themednet.org/how-do-you-decide-between-adjuvant-trastuzumab-vs-trastuzumab-pertuzumab-in-a-patient-with-localized-her2-breast-cancer-post-neoadjuvant-tchp-who-has-achieved-a-pcr weekly 0.8 https://www.themednet.org/how-would-you-approach-a-mucinous-adenocarcinoma-of-the-anal-verge-without-anal-canal-involvement-status-post-excision-with-positive-margins-but-without-the-possibility-of-additional-surgery weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-chemotherapy-and-radiation-options-in-a-patient-with-locally-advanced-tnbc-and-diamond-blackfan-anemia-s-p-lumpectomy weekly 0.8 https://www.themednet.org/is-there-any-role-for-using-oncotype-dx-to-decide-between-neoadjuvant-chemotherapy-vs-endocrine-therapy-in-a-postmenopausal-woman-with-t2n0-er-her2-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-treat-unresectable-combined-hepatocellular-cholangiocarcinoma weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-neurocognitive-effects-of-whole-brain-radiation-therapy weekly 0.8 https://www.themednet.org/would-you-offer-modest-hypofractionation-e-g-70-gy-28-fractions-to-a-patient-with-intermediate-risk-prostate-cancer-and-celiac-disease weekly 0.8 https://www.themednet.org/should-anal-cancer-patients-undergoing-definitive-chemoradiation-be-put-on-a-treatment-break-for-neutropenic-status weekly 0.8 https://www.themednet.org/would-you-consider-a-single-insertion-hdr-scheme-for-t-o-brachytherapy-bid-fractionation-over-3-days weekly 0.8 https://www.themednet.org/would-you-consider-chemoradiation-to-the-primary-in-a-patient-with-resectable-pancreatic-cancer-s-p-neoadjuvant-chemotherapy-found-to-have-single-liver-metastasis-on-re-staging weekly 0.8 https://www.themednet.org/would-you-offer-a-patient-with-pt4-renal-urothelial-cancer-adjuvant-rt-for-a-positive-margin-if-re-excision-is-not-possible weekly 0.8 https://www.themednet.org/how-do-you-choose-the-appropriate-first-line-treatment-between-everolimus-somatostatin-analogues-or-cytotoxic-chemotherapy-in-patients-with-good-ecog-ps-and-widely-metastatic-atypical-carcinoid-of-the-lung weekly 0.8 https://www.themednet.org/how-do-you-approach-palliative-treatment-of-a-metastasis-to-the-skull-with-involvement-of-the-overlying-skin weekly 0.8 https://www.themednet.org/what-dose-fractionation-do-you-use-for-recurrent-scc-face-that-was-previously-multiply-resected-and-radiated-but-has-a-persistently-positive-margin-after-re-resection weekly 0.8 https://www.themednet.org/for-a-patient-with-terminal-ileal-crohns-disease-who-requires-chemort-for-distal-rectal-cancer-can-mercaptopurine-6mp-be-continued-during-that-phase-of-treatment weekly 0.8 https://www.themednet.org/in-a-patient-with-distal-esophageal-cancer-with-a-single-non-regional-neck-lymph-node-would-you-offer-chemoradiation-therapy-or-surgery-to-the-primary-site-if-the-lymph-node-has-a-complete-radiographic-response-after-chemotherapy weekly 0.8 https://www.themednet.org/what-small-bowel-constraint-do-you-use-when-planning-standard-moderately-hypofx-ebrt-for-prostate-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-oligometastatic-her2-positive-breast-cancer-particularly-after-excellent-clinical-response-in-all-sites-of-disease-to-trastuzumab-pertuzumab-and-a-taxane weekly 0.8 https://www.themednet.org/what-dose-constraints-if-any-do-you-use-for-the-thyroid-gland-when-treating-with-regional-nodal-irradiation-for-breast-cancer weekly 0.8 https://www.themednet.org/should-neoadjuvant-chemoradiation-ever-be-considered-in-the-a-patient-with-high-risk-rectal-cancer-in-the-setting-of-active-ulcerative-colitis weekly 0.8 https://www.themednet.org/do-you-routinely-offer-parp-inhibitor-maintenance-therapy-to-germline-brca1-2-figo-stage-ii-serous-ovarian-carcinoma-patients-after-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-post-operative-radiation-therapy-to-someone-with-head-and-neck-cancer-who-has-high-risk-of-local-recurrence-who-also-has-scleroderma weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-stage-iii-egfr-nsclc-who-develops-oligometastatic-disease-while-on-consolidation-durvalumab weekly 0.8 https://www.themednet.org/what-is-the-preferred-chemotherapy-regimen-for-a-patient-with-bladder-adenocarcinoma-with-signet-ring-features weekly 0.8 https://www.themednet.org/should-systemic-therapies-be-added-to-adt-and-salvage-rt-in-patients-with-psas-2-ng-ml-after-rp weekly 0.8 https://www.themednet.org/would-there-be-any-contraindication-to-whole-pelvic-rt-for-a-patient-with-an-ax-bifem-bypass-the-graft-crosses-the-lower-abdomen-within-the-rt-field weekly 0.8 https://www.themednet.org/in-very-rapidly-progressive-poorly-differentiated-hepatocellular-cancer-would-you-use-the-targeted-options-sorafenib-lenvatinib-or-would-you-try-a-traditional-cytotoxic-regimen weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-with-esrd-on-hemodialysis-and-penile-cancer-with-neoadjuvant-ifosfamide weekly 0.8 https://www.themednet.org/for-a-solitary-liver-met-of-pancreatobiliary-origin-with-neoadjuvant-chemotherapy-required-for-preoperative-downstaging-would-you-recommend-mfolfirinox-or-gem-cis weekly 0.8 https://www.themednet.org/should-radiation-therapy-be-offered-to-the-prostate-pelvic-nodes-in-a-patient-who-had-psma-pet-ct-positive-pelvic-ln-and-prostate-disease-that-resolved-after-a-year-of-adt weekly 0.8 https://www.themednet.org/would-you-offer-post-operative-radiation-to-a-patient-with-a-parotid-basal-cell-adenocarcinoma-after-a-negative-margin-resection weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-an-elderly-patient-with-recurrent-atypical-fibroxanthoma-malignant-spindle-cell-neoplasm-after-mohs-surgery weekly 0.8 https://www.themednet.org/when-is-the-earliest-you-would-consider-starting-radiation-after-total-laryngectomy weekly 0.8 https://www.themednet.org/at-what-doses-of-steroids-would-you-feel-its-acceptable-to-either-initiate-or-resume-checkpoint-inhibitors weekly 0.8 https://www.themednet.org/how-do-your-adjuvant-treatment-recommendations-change-if-at-all-for-clinically-node-positive-stage-iii-desmoplastic-melanoma weekly 0.8 https://www.themednet.org/would-you-consider-offering-neoadjuvant-concurrent-chemoradiation-to-a-young-50-patient-with-adenocarcinoma-of-the-ge-junction-with-a-site-of-solitary-metastasis-bone weekly 0.8 https://www.themednet.org/would-you-omit-a-lumpectomy-boost-in-a-patient-with-a-single-positive-sentinel-lymph-node-with-a-primary-tumor-that-is-otherwise-favorable weekly 0.8 https://www.themednet.org/in-a-patient-with-intermediate-risk-castration-sensitive-prostate-cancer-s-p-prostectomy-and-now-with-biochemical-recurrence-regional-lymph-node-involvement-8-months-post-rp-would-you-do-hormonal-therapy-adt-or-adt-abiraterone-with-or-without-ebrt weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-metastatic-her2-breast-cancer-on-tdm-1-with-progression-in-the-breast-and-stable-systemic-disease weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-localized-breast-cancer-who-had-a-low-oncotype-dx-recurrence-score-but-a-20-risk-of-distant-recurrence-without-chemotherapy weekly 0.8 https://www.themednet.org/in-patients-with-rectal-cancer-receiving-neoadjuvant-chemoradiation-how-does-possible-seminal-vesicle-involvement-on-mri-affect-the-contours-of-your-target weekly 0.8 https://www.themednet.org/how-do-you-treat-a-composite-nhl-of-various-subtypes weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-would-you-recommend-for-a-localized-primary-bone-marginal-zone-lymphoma weekly 0.8 https://www.themednet.org/for-a-very-high-risk-prostate-cancer-with-relatively-no-elevation-in-psa-but-no-distant-or-nodal-metastasis-would-you-consider-neoadjuvant-adt-and-chemotherapy-prior-to-ebrt weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-oligometastatic-colon-cancer-status-post-resection-of-the-primary-whose-single-unresectable-liver-lesion-has-had-a-complete-response-to-folfox-chemotherapy-by-pet weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-li-fraumeni-syndrome-and-a-mucinous-anal-adenocarcinoma-with-inguinal-node-metastases weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-do-you-recommend-for-stage-iii-colon-cancer-patients-unable-to-tolerate-5fu-regardless-of-modality-dose-reduction weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-who-responded-to-first-line-osimertinib-but-develop-an-isolated-progressing-lesion-that-retains-sensitizing-egfr-mutation-but-develops-met-amplification weekly 0.8 https://www.themednet.org/how-would-you-approach-a-post-menopausal-woman-who-now-wishes-to-start-adjuvant-endocrine-therapy-more-than-3-years-since-surgery weekly 0.8 https://www.themednet.org/how-do-you-approach-the-work-up-and-surgery-for-h-n-scc-of-unknown-primary weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-stage-iiib-c-nsclc-with-ipsilateral-supraclavicular-n3-disease weekly 0.8 https://www.themednet.org/do-patients-with-stage-iii-unresectable-nsclc-with-lepidic-features-require-a-different-approach-to-chemo-radiation weekly 0.8 https://www.themednet.org/would-you-recommend-salvage-rt-in-a-patient-who-previously-had-prostatectomy-for-high-risk-prostate-cancer-who-is-no-longer-tolerating-his-intermittent-hormonal-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-young-patient-with-er-her2-bilateral-breast-cancer-with-a-solitary-bone-metastasis weekly 0.8 https://www.themednet.org/is-there-a-role-at-this-time-for-chemo-immunotherapy-in-the-upfront-treatment-of-classic-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/how-would-you-manage-a-high-grade-primary-mediastinal-leiomyosarcoma-status-post-excision-with-negative-margins weekly 0.8 https://www.themednet.org/how-would-you-treat-a-residual-mediastinal-mass-in-patients-with-a-mediastinal-germ-cell-tumor-with-an-incomplete-response-to-primary-chemotherapy-with-bepx4 weekly 0.8 https://www.themednet.org/how-would-you-approach-potential-sbrt-to-liver-metastases-in-a-patient-on-a-vegf-inhibitor weekly 0.8 https://www.themednet.org/would-you-require-pre-rt-dental-evaluation-and-clearance-for-a-patient-who-is-being-treated-with-isrt-to-waldeyers-ring-bot-area-to-30-36gy weekly 0.8 https://www.themednet.org/is-there-a-role-for-consolidative-definitive-radiation-therapy-for-metastatic-rectal-adenocarcinoma-with-good-response-to-systemic-therapy-patient-is-not-symptomatic weekly 0.8 https://www.themednet.org/how-would-you-approach-a-post-menopausal-female-with-both-a-previously-hr-her2-breast-cancer-and-hr-her2-breast-cancer-with-new-brain-metastasis weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-er-her2-t4n0-breast-cancer-with-chest-wall-involvement weekly 0.8 https://www.themednet.org/should-indications-for-postmastectomy-radiation-be-different-after-a-goldilocks-mastectomy weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-or-not-to-give-immunotherapy-in-patients-with-a-history-of-an-isolated-severe-autoimmune-event weekly 0.8 https://www.themednet.org/is-there-a-role-for-adjuvant-radiotherapy-for-a-symptomatic-vertebral-body-hemangioma-following-debulking-surgery weekly 0.8 https://www.themednet.org/should-you-offer-radiation-therapy-to-a-low-risk-prostate-cancer-patient-on-active-surveillance-so-that-he-may-receive-testosterone-supplementation weekly 0.8 https://www.themednet.org/is-there-a-maximum-time-delay-in-offering-adjuvant-radiation-to-patients-with-wound-healing-issues-for-sarcoma-and-skin-cancer-patients-with-aggressive-histology-and-positive-margins weekly 0.8 https://www.themednet.org/how-do-you-decide-to-transition-a-patient-with-stable-pnh-on-eculizumab-to-extended-half-life-ravulizumab weekly 0.8 https://www.themednet.org/in-patients-with-low-metastatic-burden-receiving-prostate-directed-therapy-with-mri-confirmed-invasion-of-the-seminal-vesicles-would-you-include-the-sv-in-your-field weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-t3n0-rectal-cancer-status-post-transanal-excision-who-is-not-a-surgical-candidate-and-who-received-pelvic-radiation-for-prostate-cancer-20-years-ago weekly 0.8 https://www.themednet.org/how-would-you-approach-maintenance-therapy-following-chemo-immunotherapy-for-extensive-stage-small-cell-lung-cancer-per-the-impower133-trial-if-there-is-a-mixed-response-post-treatment-but-clearly-some-clinical-benefit weekly 0.8 https://www.themednet.org/what-itv-to-ptv-expansions-do-you-use-for-free-breathing-definitive-imrt-for-locally-advanced-nsclc-using-ct-sim-with-4dct weekly 0.8 https://www.themednet.org/would-you-offer-contralateral-prophylactic-mastectomy-in-an-older-brca1-woman-who-is-getting-treated-for-newly-diagnosed-bc-with-mastectomy-and-slnb weekly 0.8 https://www.themednet.org/how-do-you-approach-a-scc-of-unknown-primary-that-is-metastatic-to-a-submental-level-ia-lymph-node weekly 0.8 https://www.themednet.org/when-if-ever-do-you-use-gemcitabine-erlotinib-in-patients-with-metastatic-pancreatic-cancer weekly 0.8 https://www.themednet.org/are-you-testing-for-pd-l1-ihc-expression-in-extensive-stage-small-cell-lung-cancer-who-are-planned-to-be-treated-with-chemotherapy-plus-immunotherapy weekly 0.8 https://www.themednet.org/would-you-omit-radiation-to-the-r0-tonsil-tumor-bed-after-tors-for-p16-tonsillar-scc-when-delivering-adjuvant-radiation-to-the-neck-due-to-lymph-nodes-found-intraoperatively weekly 0.8 https://www.themednet.org/how-would-you-approach-local-recurrence-of-scalp-angiosarcoma-during-the-course-of-adjuvant-radiotherapy-after-a-widely-r0-resection weekly 0.8 https://www.themednet.org/what-are-the-options-of-induction-treatment-of-young-aml-patients-who-are-on-crrt-continuous-renal-replacement-therapy weekly 0.8 https://www.themednet.org/what-are-indications-for-rt-coverage-of-pleural-cavity-for-margin-positive-resected-askin-tumor-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/are-egfr-exon-20-insertion-mutations-in-lung-cancer-predictive-of-a-poor-response-to-immunotherapy weekly 0.8 https://www.themednet.org/would-you-consider-using-immunotherapy-off-label-in-metastatic-pancreatic-cancer-with-high-pd-l1-expression weekly 0.8 https://www.themednet.org/given-in-rtog-9601-that-patients-who-had-a-pre-rt-psa-0-7-did-not-derive-a-survival-benefit-with-adt-why-was-other-cause-mortality-evaluated-in-patients-with-psa-0-6-as-noted-in-this-years-plenary weekly 0.8 https://www.themednet.org/how-do-you-treat-patients-with-stage-iii-squamous-cell-carcinoma-of-the-lung-with-persistent-progressive-disease-despite-concurrent-chemoradiation weekly 0.8 https://www.themednet.org/is-rad51d-heterozygous-mutation-a-contraindication-to-postmastectomy-radiation weekly 0.8 https://www.themednet.org/how-do-you-choose-between-moderate-hypofractionation-vs-sbrt-for-intact-low-or-intermediate-risk-prostate-cancer-patients weekly 0.8 https://www.themednet.org/what-adjuvant-endocrine-therapy-would-you-recommend-for-patients-who-have-undergone-prior-gastrectomy-1 weekly 0.8 https://www.themednet.org/do-you-prefer-hyper-cvad-or-the-calgb-9111-protocol-for-high-intensity-remission-induction-treatment-in-ph-negative-all-patients weekly 0.8 https://www.themednet.org/how-do-you-manage-persistent-tumors-at-the-primary-and-or-nodal-site-for-p16-tonsilar-scc-after-definitive-chemo-rt weekly 0.8 https://www.themednet.org/in-rectal-cancer-in-patients-receiving-total-neoadjuvant-therapy-of-folfox-followed-by-5fu-radiation-is-there-a-role-for-additional-adjuvant-chemotherapy-based-on-significant-residual-disease-at-time-of-surgery weekly 0.8 https://www.themednet.org/is-it-common-to-have-atypical-squamous-cells-on-pap-smear-s-p-chemoradiation-for-anal-cancer-in-a-female weekly 0.8 https://www.themednet.org/would-you-offer-palliative-radiation-therapy-for-bleeding-risk-reduction-in-a-patient-with-large-vessel-invasion-from-an-intrathoracic-tumor-who-requires-anticoagulation weekly 0.8 https://www.themednet.org/what-alternative-boost-methods-techniques-dose-do-you-recommend-for-a-vaginal-cuff-boost-after-whole-pelvis-when-imaging-shows-bowel-adherent-to-the-vaginal-cuff weekly 0.8 https://www.themednet.org/would-you-consider-radiation-therapy-for-ovarian-dysgerminoma-with-residual-lymphadenopathy-after-chemotherapy weekly 0.8 https://www.themednet.org/are-you-checking-for-any-specific-mutations-in-nsclc-that-suggest-resistance-to-checkpoint-inhibitors weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-to-metastatic-pdl1-negative-tnbc weekly 0.8 https://www.themednet.org/would-the-need-for-infliximab-mtx-nonsteroidals-to-control-initial-irae-affect-your-decision-to-rechallenge-these-patients-with-ici weekly 0.8 https://www.themednet.org/is-there-a-period-of-time-after-which-you-would-not-resume-ici-after-a-patient-has-had-an-irae-and-required-a-prolonged-steroid-taper weekly 0.8 https://www.themednet.org/before-re-challenging-a-patient-with-ici-after-grade-1-2-pneumonitis-do-you-re-image-to-confirm-resolution-of-pneumonitis weekly 0.8 https://www.themednet.org/for-prostate-cancer-when-do-you-pursue-a-biopsy-for-metastatic-disease-to-the-bone-found-on-imaging-study weekly 0.8 https://www.themednet.org/would-you-consider-using-nab-paclitaxel-gemcitabine-cisplatin-in-first-line-setting-for-metastatic-pancreatic-adenocarcinoma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-systemic-al-amyloidosis-who-has-achieved-a-hematologic-response-but-not-an-organ-response-with-cybord weekly 0.8 https://www.themednet.org/when-do-you-recommend-adjuvant-chemotherapy-for-adenocarcinoma-ex-goblet-carcinoid-with-signet-ring-features-status-post-right-hemicolectomy weekly 0.8 https://www.themednet.org/what-type-of-surveillance-plan-should-one-use-to-follow-a-young-person-after-orchiectomy-for-a-3cm-pure-mature-teratoma-of-the-testicle weekly 0.8 https://www.themednet.org/how-do-you-decide-on-dose-modification-interruption-or-discontinuation-of-temozolomide-in-the-concurrent-and-sequential-settings weekly 0.8 https://www.themednet.org/following-oral-cavity-radiotherapy-how-do-you-advise-patients-on-ongoing-bisphosphonate-therapy-and-the-risk-for-osteonecrosis weekly 0.8 https://www.themednet.org/what-regimen-would-you-offer-a-young-fit-patient-with-low-grade-mucinous-adenocarcinoma-of-the-appendix-with-pseudomyxoma-peritonei-to-attempt-to-get-him-to-cytoreductive-surgery-with-hipec weekly 0.8 https://www.themednet.org/how-would-you-approach-a-symptomatic-patient-with-with-a-history-of-whole-brain-rt-with-new-bilateral-mri-enhancing-lesions-within-the-optic-nerves weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-newly-diagnosed-advanced-urothelial-cancer weekly 0.8 https://www.themednet.org/what-is-your-surveillance-imaging-schedule-following-treatment-of-a-pituitary-adenoma weekly 0.8 https://www.themednet.org/do-you-recommend-lenalidomide-for-high-risk-smoldering-multiple-myeloma weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-localized-ewings-sarcoma-who-wish-to-stop-or-cannot-complete-the-full-course-of-14-cycles-of-perioperative-chemotherapy weekly 0.8 https://www.themednet.org/does-the-presence-of-a-pole-mutation-in-endometrial-cancer-guide-your-recommendations-regarding-adjuvant-radiation weekly 0.8 https://www.themednet.org/when-would-you-consider-metastastectomy-of-liver-lesions-in-metastatic-pancreatic-cancer-who-achieve-a-favorable-response-to-mfolfirinox weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-early-stage-breast-cancer-on-adjuvant-docetaxel-that-developed-lacrimal-duct-obstruction-after-2-cycles weekly 0.8 https://www.themednet.org/how-do-you-sequence-antiviral-therapy-and-cancer-directed-therapy-in-a-newly-diagnosed-patient-with-hepatocellular-carcinoma-and-incidentally-found-hepatitis-c weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-chemotherapy-to-patients-with-urachal-adenocarcinoma-and-at-least-one-high-risk-feature weekly 0.8 https://www.themednet.org/how-would-you-manage-locoregionally-advanced-nsclc-with-extensive-tracheal-mucosal-malignant-skip-lesions-covering-almost-the-entire-trachea weekly 0.8 https://www.themednet.org/do-you-hold-pelvic-radiation-for-patient-with-clostridium-difficile-associated-diarrhea weekly 0.8 https://www.themednet.org/how-do-i-get-started-on-my-job-search weekly 0.8 https://www.themednet.org/what-are-the-differences-between-academic-and-community-jobs weekly 0.8 https://www.themednet.org/what-resources-are-available-for-my-job-search weekly 0.8 https://www.themednet.org/how-do-i-use-the-institution-directory weekly 0.8 https://www.themednet.org/what-are-verified-and-unverified-hiring-contacts weekly 0.8 https://www.themednet.org/what-are-good-questions-to-ask-during-my-interviews weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-grade-1-2-pancreatic-neuroendocrine-tumor-after-progressing-on-octreotide weekly 0.8 https://www.themednet.org/how-do-you-treat-unresectable-localized-desmoid-tumor weekly 0.8 https://www.themednet.org/do-you-ever-start-with-lower-than-standard-doses-of-tkis-when-initiating-treatment-for-chronic-phase-cml weekly 0.8 https://www.themednet.org/is-there-any-data-to-support-slnb-instead-of-alnd-in-patients-with-clinically-n2-3-breast-cancer-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-incorporate-prognostic-mutations-into-your-management-of-primary-myelofibrosis weekly 0.8 https://www.themednet.org/would-you-recommend-radiotherapy-for-a-para-aortic-recurrence-of-endometrial-cancer-in-a-patient-who-previous-completed-surgery-chemotherapy-and-wprt weekly 0.8 https://www.themednet.org/would-you-recommend-scrotal-rt-in-a-patient-with-stage-iv-primary-testicular-lymphoma-with-cns-involvement-after-cr-to-rchop-and-mtx weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-metastatic-inflammatory-tnbc-at-diagnosis-with-a-good-ps weekly 0.8 https://www.themednet.org/when-would-you-consider-active-surveillance-for-a-patient-with-metastatic-rcc weekly 0.8 https://www.themednet.org/what-is-your-recommendations-for-vaccines-to-prevent-shingles-in-cll-patients weekly 0.8 https://www.themednet.org/do-you-alter-your-management-of-stage-i-ii-dlbcl-if-its-double-or-triple-hit weekly 0.8 https://www.themednet.org/how-do-you-evaluate-psa-decline-after-ebrt-for-low-and-intermediate-risk-prostate-cancer-not-treated-with-adt weekly 0.8 https://www.themednet.org/is-there-evidence-for-dose-escalation-of-large-bony-metastases-secondary-to-hepatocellular-carcinoma weekly 0.8 https://www.themednet.org/would-you-consider-pembrolizumab-plus-lenvatinib-for-stage-iv-uterine-carcinosarcoma-after-progression-on-chemotherapy-as-per-keynote-146-and-now-with-keynote-775 weekly 0.8 https://www.themednet.org/why-do-we-immediately-perform-cns-staging-with-a-lp-at-diagnosis-of-all-when-the-risk-of-seeding-is-highest-with-a-high-lymphoblast-count weekly 0.8 https://www.themednet.org/when-treating-prone-breast-how-do-you-recommend-contouring-the-breast weekly 0.8 https://www.themednet.org/how-do-you-approach-further-treatment-of-patients-who-develop-grade-2-3-immune-colitis-from-nivolumab-ipilimumab-prior-to-completion-of-the-4-ipilimumab-doses weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-high-risk-prostate-cancer-with-rising-psa-after-rp-who-has-oligometastatic-bone-disease-in-the-pelvis weekly 0.8 https://www.themednet.org/what-is-your-preferred-graft-source-and-conditioning-regimen-in-a-patient-with-fanconi-anemia-and-aml-undergoing-stem-cell-transplant weekly 0.8 https://www.themednet.org/which-radiation-modality-for-definitive-prostate-cancer-has-the-lowest-risk-of-erectile-dysfunction weekly 0.8 https://www.themednet.org/when-do-you-consider-cytoreduction-in-patients-with-essential-thrombocytosis weekly 0.8 https://www.themednet.org/what-dose-and-volume-would-you-treat-in-a-patient-with-diffuse-large-b-cell-lymphoma-confined-to-the-stomach-after-complete-response-to-r-chop weekly 0.8 https://www.themednet.org/for-es-sclc-with-a-distant-ccr-and-local-cpr-after-systemic-therapy-sustained-for-at-least-1-year-how-would-you-approach-consolidative-thoracic-rt weekly 0.8 https://www.themednet.org/is-there-a-role-for-adjuvant-rt-in-a-pleomorphic-dermal-sarcoma-after-wle weekly 0.8 https://www.themednet.org/if-a-patient-with-low-metastatic-burden-has-bulky-retroperitoneal-adenopathy-without-osseous-metastasis-would-you-recommend-prostatic-radiation weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-metastatic-er-pr-her2-breast-cancer-with-linear-leptomeningeal-enhancement-on-mri-but-negative-csf-protein-and-cytology weekly 0.8 https://www.themednet.org/what-would-be-your-first-line-treatment-option-for-a-symptomatic-patient-with-grade-3-well-differentiated-gi-neuroendocrine-tumor weekly 0.8 https://www.themednet.org/would-you-offer-consolidative-rt-to-a-patient-with-early-stage-non-bulky-high-grade-non-hodgkins-lymphoma-of-the-orbit-after-6-cycles-of-rchop-it-chemotherapy weekly 0.8 https://www.themednet.org/how-does-the-management-of-nasopharyngeal-cancer-in-kids-young-adults-differ-from-adult-patients weekly 0.8 https://www.themednet.org/in-patients-who-had-a-lumpectomy-alone-without-nodal-evaluation-for-early-stage-breast-cancer-how-do-you-determine-whether-additional-surgical-ln-evaluation-is-necessary weekly 0.8 https://www.themednet.org/how-would-you-approach-a-postmenopausal-female-with-tnbc-with-ln-involvement-and-ckd-stage-5 weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-a-non-seminoma-brain-metastasis-with-a-partial-response-to-chemotherapy weekly 0.8 https://www.themednet.org/for-a-patient-with-stage-4-lung-cancer-pdl1-tps-50-and-long-term-history-of-myasthenia-gravis-stable-on-mycophenolate-would-you-ever-consider-pembrolizumab-or-would-this-be-absolute-contraindication weekly 0.8 https://www.themednet.org/do-you-use-hippocampal-avoidance-techniques-when-delivering-pci-for-high-risk-leukemia weekly 0.8 https://www.themednet.org/would-you-offer-sbrt-to-a-biopsy-proven-t1-renal-cell-carcinoma-on-a-transplanted-kidney weekly 0.8 https://www.themednet.org/in-a-patient-with-pn1-penile-squamous-cell-carcinoma-s-p-inguinal-lymph-node-dissection-would-you-offer-adjuvant-tip-vs-adjuvant-chemort-vs-surveillance weekly 0.8 https://www.themednet.org/do-you-take-any-special-precautions-when-radiating-the-mediastinum-of-a-patient-with-moderate-or-severe-aortic-valve-stenosis weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-dose-and-schedule-for-capecitabine-for-patients-with-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/for-patients-with-breast-cancer-who-are-otherwise-excellent-candidates-for-omitting-radiation-based-on-their-age-and-pathology-does-a-strong-family-history-of-breast-or-ovarian-cancer-influence-your-recommendation weekly 0.8 https://www.themednet.org/do-you-consider-adjuvant-chemotherapy-in-a-patient-who-has-received-ddmvac-preoperatively-and-had-pt3pn2-disease-at-time-of-surgery weekly 0.8 https://www.themednet.org/how-do-you-proceed-if-a-breast-cancer-patient-has-imaging-concerning-for-pulmonary-lymphangitic-carcinomatosis-but-no-other-evidence-of-metastatic-disease weekly 0.8 https://www.themednet.org/would-you-offer-lung-sbrt-for-an-individual-with-rheumatoid-arthritis weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-nf1-diagnosed-with-breast-cancer-regarding-breast-radiation weekly 0.8 https://www.themednet.org/do-you-recommend-a-washout-period-for-a-patient-receiving-intrathecal-chemotherapies-prior-to-after-receiving-intracranial-srs weekly 0.8 https://www.themednet.org/does-a-complete-pathologic-response-to-neoadjuvant-chemotherapy-affect-the-duration-of-endocrine-therapy-ofs-that-you-recommend-for-a-premenopausal-patient-with-hr-her2-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-g-csf-use-when-offering-neoadjuvant-chemort-for-lower-extremity-soft-tissue-sarcoma weekly 0.8 https://www.themednet.org/what-would-you-recommend-for-a-patient-with-bilateral-conjunctival-malt-without-systemic-disease weekly 0.8 https://www.themednet.org/how-do-you-minimize-urethral-dose-when-doing-ldr-prostate-seed-brachytherapy-with-small-glands-20-cc weekly 0.8 https://www.themednet.org/how-do-you-decide-which-local-consolidative-therapy-to-offer-for-a-single-lung-metastasis-in-a-patient-with-metastatic-colorectal-cancer weekly 0.8 https://www.themednet.org/how-much-volume-reduction-do-you-typically-observe-following-radiotherapy-for-a-meningioma weekly 0.8 https://www.themednet.org/what-factors-influence-whether-you-order-oncotypedx-in-hr-node-negative-ilc weekly 0.8 https://www.themednet.org/what-constraints-do-you-use-for-the-external-beam-portion-of-radiation-when-combined-with-brachytherapy-boost weekly 0.8 https://www.themednet.org/is-there-a-role-for-dose-escalation-beyond-50-4-gy-in-neoadjuvant-chemoradiation-therapy-for-rectal-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-chemotherapy-regimen-for-patients-with-peripheral-neuropathy-and-high-risk-hr-her2-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-a-recent-mi-s-p-des-who-is-being-considered-for-neoadjuvant-chemotherapy-for-tnbc weekly 0.8 https://www.themednet.org/how-would-you-approach-an-inoperable-elderly-frail-patient-with-high-risk-endometrial-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-a-young-adult-with-an-intracranial-anaplastic-ependymoma-and-a-single-intradural-cervical-spine-metastasis weekly 0.8 https://www.themednet.org/what-is-the-protocol-for-stopping-tki-used-in-rcc-prior-to-a-surgery weekly 0.8 https://www.themednet.org/for-metastatic-thymic-carcinoma-or-thymoma-after-6-cycles-of-chemotherapy-ie-cisplatin-cyclophosphamide-doxorubicin-with-good-a-response-what-if-any-maintenance-regimen-would-you-consider weekly 0.8 https://www.themednet.org/how-do-you-sequence-chemoradiation-and-chemotherapy-for-patients-with-locally-advanced-rectal-cancer-undergoing-tnt-based-upon-data-from-cao-aro-aio-12 weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-who-develop-de-novo-or-recurrent-skin-cancers-scc-or-bcc-while-on-lenalidomide weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-her-2-directed-therapy-for-er-pr-her2-pt1-t2-n0-papillary-carcinoma-of-the-breast weekly 0.8 https://www.themednet.org/in-what-situations-would-you-treat-with-adjuvant-radiation-for-resected-gallbladder-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-frontline-treatment-for-a-metastatic-non-squamous-nsclc-patient-with-met-amplification-and-a-concurrent-kras-mutation weekly 0.8 https://www.themednet.org/do-you-typically-recommend-re-resection-for-secretory-carcinoma-of-the-parotid-with-focal-positive-margins weekly 0.8 https://www.themednet.org/how-does-the-presence-of-microcystic-elongated-and-fragmented-melf-invasion-impact-post-operative-treatment-of-stage-ia-figo-grade-1-endometrial-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-pathologic-review-and-genomic-testing-if-indicated-of-a-spindle-cell-neoplasm weekly 0.8 https://www.themednet.org/for-adult-intracranial-posterior-fossa-ependymoma-how-do-you-approach-spinal-cord-constraints-with-planning-to-54-59-4-gy weekly 0.8 https://www.themednet.org/for-post-prostatectomy-radiation-are-there-any-special-considerations-if-there-is-a-bladder-sling-or-artificial-urinary-sphincter weekly 0.8 https://www.themednet.org/how-do-you-manage-local-recurrence-of-a-resected-stage-iii-braf-wt-melanoma-occurring-during-or-shortly-after-completion-of-adjuvant-nivolumab weekly 0.8 https://www.themednet.org/how-do-you-decide-on-a-salvage-regimen-for-relapsed-refractory-dlbcl-assuming-a-patient-is-transplant-eligible weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-dementia-who-require-but-cannot-tolerate-an-aquaplast-mask-for-radiation-therapy weekly 0.8 https://www.themednet.org/how-would-you-treat-metastatic-colon-ca-with-braf-non-v600e-mutation weekly 0.8 https://www.themednet.org/would-you-treat-with-consolidative-sbrt-for-oligometastatic-liver-mets-from-her2-breast-cancer-if-these-lesions-demonstrated-radiographic-cr-near-cr-following-neoadjuvant-tchp-chemotherapy-and-patient-is-receiving-ongoing-adjuvant-hp-therapy weekly 0.8 https://www.themednet.org/does-germline-brca-1-2-mutation-status-impact-your-use-of-oncotype-dx-for-early-stage-er-positive-breast-cancers-in-post-menopausal-women weekly 0.8 https://www.themednet.org/in-what-situations-would-you-perform-a-sentinel-lymph-node-biopsy-for-cervical-cancer weekly 0.8 https://www.themednet.org/how-would-you-decide-on-vrd-vs-drd-for-initial-management-of-transplant-ineligible-multiple-myeloma weekly 0.8 https://www.themednet.org/for-unresectable-metastatic-cholangiocarcinoma-would-you-continue-gemcitabine-cisplatin-beyond-24-weeks-if-the-patient-continues-to-have-a-response-to-therapy weekly 0.8 https://www.themednet.org/do-you-insist-on-biopsy-confirmation-of-invasive-disease-in-the-setting-of-in-situ-pathology-findings-but-otherwise-clinical-radiographic-evidence-of-invasive-cancer weekly 0.8 https://www.themednet.org/are-you-routinely-using-thrombopoietin-agonists-in-patients-with-hep-c-and-hcc weekly 0.8 https://www.themednet.org/how-do-you-approach-the-workup-and-initial-treatment-of-systemic-al-amyloidosis weekly 0.8 https://www.themednet.org/how-do-you-treat-elderly-or-frail-patients-with-metastatic-rcc weekly 0.8 https://www.themednet.org/what-are-your-target-volumes-for-treatment-of-a-hemorrhagic-brain-metastasis-with-srs weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-offer-adjuvant-rt-following-breast-conserving-surgery-for-borderline-phyllodes-tumors weekly 0.8 https://www.themednet.org/how-do-you-manage-docetaxel-or-other-taxane-induced-nail-toxicity weekly 0.8 https://www.themednet.org/would-you-consider-using-single-agent-oxaliplatin-for-adjuvant-treatment-for-colon-cancer-in-elderly-patients-who-did-not-tolerate-single-agent-5-fu weekly 0.8 https://www.themednet.org/how-does-your-management-change-for-patients-with-bone-marrow-failure-due-to-a-metastatic-solid-tumor-to-the-marrow weekly 0.8 https://www.themednet.org/when-consolidating-de-novo-oligometastatic-nsclc-with-initial-hilar-nodal-involvement-would-you-still-include-the-hilum-if-that-disease-completely-responded-to-induction-chemotherapy weekly 0.8 https://www.themednet.org/what-would-you-recommend-for-a-stage-i-follicular-lymphoma-of-the-bone weekly 0.8 https://www.themednet.org/do-you-administer-prophylactic-antibiotics-for-gu-procedures weekly 0.8 https://www.themednet.org/does-the-use-of-slow-release-hormone-replacement-therapy-impact-your-adjuvant-treatment-recommendations-for-a-perimenopausal-patient-with-an-intermediate-oncotype-score weekly 0.8 https://www.themednet.org/would-you-offer-sbrt-in-a-patient-with-history-of-crc-subsequently-found-to-have-a-solitary-liver-metastasis-treated-with-chemotherapy-followed-metastasectomy-with-positive-margins weekly 0.8 https://www.themednet.org/when-treating-nsclc-with-sabr-if-the-preceding-lung-biopsy-resulted-in-post-biopsy-hemorrhage-how-would-you-modify-your-target-volumes-if-at-all weekly 0.8 https://www.themednet.org/would-you-forgo-consolidation-radiotherapy-for-a-patient-with-stage-1ea-diffuse-large-b-cell-lymphoma-of-the-stomach-who-presented-with-a-perforated-ulcer weekly 0.8 https://www.themednet.org/how-do-you-manage-radiotherapy-for-a-glioblastoma-when-there-is-a-delay-in-starting-systemic-therapy weekly 0.8 https://www.themednet.org/in-the-setting-of-a-recurrent-grade-1-liposarcoma-of-the-spermatic-cord-that-extended-to-the-scrotum-and-was-previously-treated-with-surgery-alone-what-volume-and-dose-would-you-use-in-following-re-resection weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-a-superior-sulcus-tumor-of-the-lung-treated-with-upfront-surgery-who-achieves-negative-margins-and-has-negative-mediastinal-nodes weekly 0.8 https://www.themednet.org/what-is-your-approach-to-localized-pancreatic-cancer-that-would-otherwise-be-resectable-except-for-poor-patient-characteristics weekly 0.8 https://www.themednet.org/how-would-you-treat-stage-iv-dlbcl-with-severe-liver-involvement weekly 0.8 https://www.themednet.org/would-you-recommend-salvage-xrt-in-a-pt-who-had-rp-for-high-risk-prostate-cancer-who-then-had-recurrence-in-the-bladder-s-p-cystectomy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-adenocarcinoma-of-the-ge-junction-in-the-setting-of-interstitial-lung-disease weekly 0.8 https://www.themednet.org/how-do-you-treat-metastatic-testicular-cancer-with-the-primary-orchiectomy-pathology-showing-non-seminoma-with-components-of-teratoma-and-primitive-neuroectodermal-tumor weekly 0.8 https://www.themednet.org/would-you-consider-consolidative-rt-in-patients-with-metastatic-bladder-cancer-after-near-complete-response-after-keytruda weekly 0.8 https://www.themednet.org/for-premenopausal-patients-with-early-stage-hr-breast-cancer-for-whom-you-are-recommending-tamoxifen-how-do-you-select-patients-for-extended-endocrine-therapy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-contralateral-mastectomy-scar-recurrence-of-inflammatory-breast-cancer weekly 0.8 https://www.themednet.org/would-you-clear-a-patient-who-completed-treatment-for-breast-dcis-to-donate-her-kidney-to-her-husband weekly 0.8 https://www.themednet.org/do-you-routinely-discuss-hrt-with-patients-that-have-undergone-surgical-menopause-due-to-treatment-of-cervical-cancer weekly 0.8 https://www.themednet.org/are-there-any-subsets-of-patients-where-you-would-consider-first-line-dacomitinib-for-egfr-mutations-positive-nsclc weekly 0.8 https://www.themednet.org/how-do-you-approach-cns-directed-therapy-in-a-patient-with-parkinsons-disease weekly 0.8 https://www.themednet.org/do-you-have-preferred-regimens-for-young-patients-30-y-o-with-early-stage-dlbcl weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-metastatic-squamous-nsclc-that-progressed-on-carbo-paclitaxel-pembro-and-has-a-fgfr3-s249c-mutation weekly 0.8 https://www.themednet.org/what-is-the-largest-non-spine-bone-metastasis-you-would-be-willing-to-treat-with-sbrt weekly 0.8 https://www.themednet.org/for-breast-cancer-patients-s-p-iort-with-pathologic-features-indicating-that-follow-up-whole-breast-radiation-is-needed-is-the-current-standard-of-care-to-use-conventional-fractionation-or-are-there-data-to-support-hypofractionation weekly 0.8 https://www.themednet.org/is-there-a-role-for-definitive-radiation-in-a-patient-with-vaginal-melanoma-who-is-not-a-surgical-candidate weekly 0.8 https://www.themednet.org/would-you-substitute-vinblastine-for-vincristine-in-rchop weekly 0.8 https://www.themednet.org/how-would-you-treat-a-t4-rectal-cancer-invading-the-uterus-that-is-causing-rectal-and-vaginal-bleeding weekly 0.8 https://www.themednet.org/when-do-you-offer-adjuvant-chemotherapy-after-wide-local-excision-for-soft-tissue-extremity-sarcomas weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-with-testicular-cancer-stage-i-pure-seminoma-on-orchiectomy-but-with-high-bhcg-in-1000s-as-seminoma-or-as-non-seminoma weekly 0.8 https://www.themednet.org/how-do-you-sequence-adt-relative-to-radiation-for-a-low-volume-m1-prostate-cancer weekly 0.8 https://www.themednet.org/what-radiation-approach-would-you-use-for-a-young-patient-with-locally-advanced-her2-breast-cancer-with-complete-metabolic-response-after-neoadjuvant-chemotherapy-who-refuses-surgery weekly 0.8 https://www.themednet.org/would-you-offer-systemic-therapy-for-bclc-stage-c-hcc-portal-vein-invasion-following-local-therapy-with-y90 weekly 0.8 https://www.themednet.org/for-locally-recurrent-disease-after-surgical-resection-of-egfr-alk-positive-nsclc-that-appears-suitable-for-chemoradiation-would-you-proceed-directly-to-chemoradiation-or-consider-tki-first weekly 0.8 https://www.themednet.org/would-you-consider-splenectomy-for-an-early-stage-l-ll-primary-splenic-diffuse-large-b-cell-lymphoma-followed-by-r-chop weekly 0.8 https://www.themednet.org/is-there-a-role-for-ip-chemotherapy-in-advanced-mucinous-ovarian-cancers-following-complete-cytoreductive-surgery weekly 0.8 https://www.themednet.org/how-do-you-evaluate-and-constrain-the-cumulative-lung-dvh-for-inoperable-patients-who-have-received-multiple-courses-of-lung-sbrt-and-now-require-fractionated-mediastinal-rt weekly 0.8 https://www.themednet.org/when-would-you-consider-gemcitabine-cisplatin-with-y90-for-patients-with-unresectable-intrahepatic-cholangiocarcinoma weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-progesterone-therapy-to-a-young-woman-with-low-grade-endometrial-stromal-sarcoma-who-had-elected-ovarian-conservation weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-a-new-axillary-skin-lesion-with-pathology-suspecting-a-metastatic-breast-cancer-and-no-other-sites-of-disease-noted-on-pet-imaging weekly 0.8 https://www.themednet.org/how-do-you-diagnose-acute-leukemia-mixed-phenotype weekly 0.8 https://www.themednet.org/how-do-you-treat-metastatic-rcc-with-fumarate-hydratase-mutation-hereditary-leiomyomatosis-and-rcc-hlrcc weekly 0.8 https://www.themednet.org/for-a-post-menopausal-woman-with-a-pt1c-node-negative-her2-positive-breast-cancer-does-er-status-influence-your-choice-of-adjuvant-paclitaxel-trastuzumab-versus-docetaxel-carboplatin-trastuzumab weekly 0.8 https://www.themednet.org/how-do-you-manage-limited-intracranial-disease-from-a-metastatic-large-cell-neuroendocrine-tumor weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-recommend-for-a-stage-iiic-low-grade-serous-ovarian-cancer-following-following-fertility-sparing-surgery weekly 0.8 https://www.themednet.org/would-you-offer-neoadjuvant-chemotherapy-for-a-patient-with-low-grade-upper-tract-renal-pelvis-urothelial-carcinoma-with-concurrent-bladder-drop-metastasis weekly 0.8 https://www.themednet.org/does-mucinous-histology-impact-your-recommendations-for-neoadjuvant-therapy-in-a-postmenopausal-patient-with-hr-her2-breast-cancer-with-multiple-positive-lymph-nodes weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-needing-pmrt-with-a-history-of-severe-burn-to-the-chest weekly 0.8 https://www.themednet.org/does-high-risk-cytogenetics-as-a-sole-abnormality-influence-your-treatment-decision-for-smoldering-multiple-myeloma weekly 0.8 https://www.themednet.org/what-is-the-effect-of-iv-contrast-on-dosimetry-for-thoracic-rt-planning weekly 0.8 https://www.themednet.org/what-dose-constraint-do-you-use-for-the-ostomy-site-when-treating-a-patient-with-close-adjacent-disease weekly 0.8 https://www.themednet.org/how-long-do-you-treat-with-imid-in-a-case-of-smoldering-multiple-myeloma weekly 0.8 https://www.themednet.org/what-rectal-dose-constraints-do-you-use-for-definitive-chemoradiation-for-vulvar-vaginal-cancer weekly 0.8 https://www.themednet.org/do-you-modify-your-neoadjuvant-considerations-for-patients-with-micropapillary-histology-and-pt2-urothelial-carcinoma-and-no-distant-neoplastic-disease weekly 0.8 https://www.themednet.org/when-a-patient-presents-with-2-lung-lesions-do-you-routinely-recommend-a-biopsy-of-both-lung-lesions weekly 0.8 https://www.themednet.org/would-you-consider-giving-esa-for-anemia-secondary-to-chronic-kidney-disease-in-a-patient-with-follicular-lymphoma-in-remission-and-on-rituximab-maintenance weekly 0.8 https://www.themednet.org/is-there-a-role-for-adjuvant-therapy-either-radiation-chemo-or-systemic-therapies-immunotherapy-targeted-agents-or-chemotherapy-after-resection-of-anorectal-mucosal-melanoma weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-for-a-resected-composite-hemangioendothelioma-of-the-skin-arising-from-a-childhood-hemangioma weekly 0.8 https://www.themednet.org/what-radiation-dose-is-appropriate-for-unresectable-spindle-cell-sarcoma-of-the-spine weekly 0.8 https://www.themednet.org/in-a-patient-metastatic-recurrent-endometrioid-endometrial-cancer-who-has-a-mixed-response-to-carboplatin-and-paclitaxel-what-is-your-next-choice-of-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-the-re-challenge-with-trastuzumab-in-metastatic-her2-patients-who-develop-cardiomyopathy-on-trastuzumab-pertuzumab-with-subsequent-improvement-with-discontinuation weekly 0.8 https://www.themednet.org/how-do-you-think-through-the-various-treatment-options-for-patients-with-unfavorable-intermediate-risk-prostate-cancer weekly 0.8 https://www.themednet.org/is-there-a-role-for-a-post-operative-boost-in-a-patient-with-rectal-cancer-who-has-a-positive-margin-after-total-neoadjuvant-chemo-and-chemoradiation-therapy weekly 0.8 https://www.themednet.org/for-a-patient-with-remote-history-of-mantle-field-radiation-for-early-stage-hodgkins-lymphoma-now-with-oligometastatic-breast-cancer-would-you-offer-sbrt-to-chest-wall-metastasis weekly 0.8 https://www.themednet.org/in-a-patient-with-a-vaginal-cuff-recurrence-from-endometrial-cancer-not-amenable-to-interstitial-brachytherapy-how-would-you-boost-after-45gy weekly 0.8 https://www.themednet.org/would-you-use-neoadjuvant-cdk4-6-inhibitor-and-ai-in-hr-breast-cancer-based-upon-the-randomized-phase-ii-coralleen-trial weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-obtain-dental-evaluation-to-reduce-the-risk-of-medication-related-osteonecrosis-of-the-jaw-prior-to-initiating-non-urgent-bone-modifying-agent-therapy weekly 0.8 https://www.themednet.org/what-treatment-do-you-offer-to-a-pediatric-patient-with-metastatic-ewing-sarcoma-who-has-completed-vdc-ie-chemotherapy weekly 0.8 https://www.themednet.org/what-treatment-do-you-offer-to-a-pediatric-patient-with-aml-in-first-relapse-who-was-previously-treated-with-chemotherapy-only-not-transplanted weekly 0.8 https://www.themednet.org/what-treatment-would-you-give-to-a-pediatric-patient-with-rhabdomyosarcoma-in-first-relapse weekly 0.8 https://www.themednet.org/what-would-be-your-next-line-of-therapy-for-a-pediatric-patient-with-t-all-in-first-relapse-who-has-not-received-a-transplant weekly 0.8 https://www.themednet.org/what-treatment-would-you-recommend-to-effectively-treat-a-pediatric-patient-newly-diagnosed-with-low-risk-hodgkins-lymphoma-while-minimizing-the-risk-of-late-toxicity weekly 0.8 https://www.themednet.org/what-do-you-counsel-the-families-of-pediatric-cancer-patients-who-want-to-take-probiotics-while-receiving-chemotherapy weekly 0.8 https://www.themednet.org/can-acupuncture-be-safely-used-in-a-pediatric-oncology-patient-with-severe-thrombocytopenia-or-neutropenia weekly 0.8 https://www.themednet.org/what-treatment-would-you-recommend-to-a-pediatric-patient-newly-diagnosed-with-unresectable-symptomatic-desmoid-tumor weekly 0.8 https://www.themednet.org/do-you-recommend-using-brafv600e-mutation-status-to-risk-stratify-treatment-for-a-pediatric-patient-with-langerhans-cell-histiocytosis weekly 0.8 https://www.themednet.org/do-you-recommend-using-cell-free-brafv600e-to-track-response-to-therapy-in-pediatric-patients-with-langerhans-cell-histiocytosis weekly 0.8 https://www.themednet.org/what-is-your-preferred-radiotherapy-regimen-for-palliative-treatment-of-cutaneous-t-cell-lymphoma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-incidentally-found-dcis-or-invasive-disease-after-a-breast-reduction weekly 0.8 https://www.themednet.org/what-neoadjuvant-adjuvant-chemotherapy-regimen-or-targeted-therapy-can-be-used-in-paediatric-patients-with-pelvic-peripheral-medulloepithelioma weekly 0.8 https://www.themednet.org/would-you-consider-low-dose-lenvatinib-or-dabrafenib-trametinib-for-rapidly-progressive-rai-refractory-thyroid-cancer-with-braf-v600e-mutation-in-a-patient-in-whom-you-are-concerned-about-tolerance-of-full-dose-lenvatinib weekly 0.8 https://www.themednet.org/what-is-your-process-for-obtaining-and-using-next-generation-sequencing-on-patients-with-advanced-endometrial-cancer weekly 0.8 https://www.themednet.org/do-we-need-to-continue-dose-escalations-wtih-da-repoch-after-a-negative-interim-pet-scan-for-pmbcl weekly 0.8 https://www.themednet.org/how-long-after-lumpectomy-for-dcis-in-a-premenopausal-patient-can-tamoxifen-be-started-and-still-retain-the-benefit weekly 0.8 https://www.themednet.org/how-do-you-choose-between-sbrt-and-rfa-for-crc-metastases-to-the-liver weekly 0.8 https://www.themednet.org/would-you-discontinue-dabrafenib-trametinib-in-a-patient-with-braf-mutant-metastatic-lung-cancer-if-you-see-mild-cardiomyopathy-which-could-be-related-to-the-drugs weekly 0.8 https://www.themednet.org/when-do-you-consider-and-how-do-you-implement-spatially-fractionated-grid-radiation-therapy weekly 0.8 https://www.themednet.org/do-you-electively-treat-the-ipsilateral-hilum-in-patients-with-peripheral-limited-stage-small-cell-lung-cancer-who-have-negative-pathological-sampling-of-mediastinal-and-hilar-nodes-by-ebus-and-no-fdg-avid-nodes-on-pet weekly 0.8 https://www.themednet.org/would-an-unfavorable-molecular-subtype-cause-you-to-proceed-with-alndx-after-a-positive-slnbx weekly 0.8 https://www.themednet.org/how-do-you-think-about-management-options-in-a-patient-with-a-minute-focus-of-gleason-grade-4-4-4-on-1-core-from-needle-biopsy-along-with-only-gleason-3-3-disease-in-other-biopsy-cores-and-psa-10 weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-radiation-after-wedge-resection-for-a-1-0-cm-non-small-cell-lung-cancer-with-close-margins-of-2mm weekly 0.8 https://www.themednet.org/for-rectal-adenocarcinoma-initially-staged-as-t2n0-and-treated-with-upfront-surgical-resection-but-pathologically-upstaged-to-pt3n0-without-high-risk-features-how-do-you-approach-adjuvant-therapy weekly 0.8 https://www.themednet.org/for-a-patient-with-limited-resectable-metastatic-melanoma-and-no-evidence-of-disease-after-resection-when-would-you-consider-doublet-immunotherapy-rather-than-nivolumab-or-pembrolizumab-monotherapy weekly 0.8 https://www.themednet.org/how-do-you-treat-metastatic-squamous-cell-carcinoma-of-the-bladder weekly 0.8 https://www.themednet.org/would-you-consider-the-use-of-parp-inhibitors-in-patients-with-bard-1-mutation-and-refractory-pancreatic-cancer weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-tki-to-patients-with-locally-recurrent-multifocal-adenoid-cystic-carcinoma weekly 0.8 https://www.themednet.org/for-a-patient-with-her2-breast-cancer-with-progressive-but-asymptomatic-disease-in-the-brain-would-you-hold-off-on-wbrt-to-do-a-trial-of-tucatinib-or-proceed-with-wbrt-then-tucatinib weekly 0.8 https://www.themednet.org/in-patients-with-cancer-of-unknown-primary-do-you-routinely-send-molecular-testing-to-help-determine-primary-tumor-origin weekly 0.8 https://www.themednet.org/how-would-you-plan-adjuvant-radiation-for-a-n-breast-cancer-in-a-patient-who-had-received-prior-lung-sbrt-near-the-treatment-field weekly 0.8 https://www.themednet.org/how-do-you-manage-a-supratentorial-anaplastic-ependymoma-in-an-adult weekly 0.8 https://www.themednet.org/would-you-offer-salvage-chemotherapy-to-a-patient-with-stage-iiic-poor-risk-nsgct-in-whom-afp-fail-to-normalize-even-after-2-months-of-completion-of-4-cycles-bep weekly 0.8 https://www.themednet.org/what-small-bowel-dose-constraints-do-you-utilize-when-treating-resected-pancreatic-cancer weekly 0.8 https://www.themednet.org/is-there-a-role-for-maintenance-lenalidomide-after-non-anthracycline-regimens-in-elderly-patients-with-dlbcl weekly 0.8 https://www.themednet.org/would-you-use-a-ntrk-tki-for-a-patient-with-metastatic-hr-her2-breast-cancer-with-a-complex-ntrk3-gene-re-arrangement-on-foundation-testing weekly 0.8 https://www.themednet.org/do-you-change-systemic-endocrine-therapy-for-a-patient-who-progresses-only-in-the-brain-after-srs-for-metastatic-hr-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-tki-induced-secondary-polycythemia-in-a-patient-with-rcc weekly 0.8 https://www.themednet.org/do-you-alter-treatment-in-high-grade-serous-ovarian-cancer-patients-receiving-neoadjuvant-chemotherapy-with-stable-disease-after-3-cycles weekly 0.8 https://www.themednet.org/what-pathologic-response-criteria-do-you-use-to-determine-the-need-for-further-adjuvant-therapy-in-patients-with-breast-cancer weekly 0.8 https://www.themednet.org/what-treatment-would-you-offer-a-patient-with-metastatic-cervical-cancer-to-the-supraclavicular-nodes-with-a-complete-clinical-response-in-her-nodes-but-a-3-cm-residual-in-the-cervix weekly 0.8 https://www.themednet.org/what-is-your-preferred-adjuvant-chemotherapy-for-a-pediatric-patient-less-than-1-year-old-who-had-a-gross-total-resection-of-a-localized-intracranial-ependymoma-and-will-not-be-receiving-radiation-therapy-due-to-his-her-young-age weekly 0.8 https://www.themednet.org/how-do-we-know-expert-opinions-are-not-biased-sponsored weekly 0.8 https://www.themednet.org/what-treatment-do-you-offer-to-a-pediatric-patient-with-an-optic-pathway-glioma-with-a-brafv600e-mutation-who-progressed-despite-receiving-conventional-chemotherapy-braf-mek-inhibitors-and-radiation-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-a-pre-menopausal-female-with-hr-breast-cancer-with-discordant-ihc-and-oncotypedx-er-expression weekly 0.8 https://www.themednet.org/do-you-alter-your-management-of-adt-in-a-patient-with-high-risk-prostate-cancer-who-is-a-transwoman-receiving-estradiol-hormone-therapy weekly 0.8 https://www.themednet.org/how-would-you-incorporate-ctdna-to-follow-up-a-patient-status-post-surgical-resection-of-the-primary-colon-adenocarcinoma-and-omental-deposits-after-6-months-of-folfox weekly 0.8 https://www.themednet.org/what-is-your-preferred-second-line-therapy-for-metastatic-follicular-dendritic-cell-sarcoma-after-progression-on-anthracycline-based-chemotherapy weekly 0.8 https://www.themednet.org/in-what-clinical-scenarios-would-you-cover-the-optic-nerves-when-treating-with-whole-brain-radiotherapy weekly 0.8 https://www.themednet.org/what-adjuvant-chemotherapy-would-you-offer-for-completely-resected-carcinosarcoma-of-the-pancreas weekly 0.8 https://www.themednet.org/what-are-your-next-steps-in-management-for-a-patient-with-endocervical-adenocarcinoma-s-p-radical-trachelectomy-with-a-positive-pelvic-lymph-node-noted-on-final-pathology weekly 0.8 https://www.themednet.org/is-it-safe-for-a-patient-to-breastfeed-during-their-course-of-ebrt weekly 0.8 https://www.themednet.org/do-you-consider-msi-testing-for-nonserous-ovarian-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-further-systemic-treatment-after-definitive-local-treatment-for-patients-with-locally-advanced-tnbc-that-had-early-local-progression-through-neoadjuvant-ac-t-adjuvant-cape-and-adjuvant-rt weekly 0.8 https://www.themednet.org/what-is-the-preferred-approach-for-gastric-malt-lymphoma-with-histologic-and-radiographic-partial-response-after-radiation weekly 0.8 https://www.themednet.org/do-you-consider-the-presence-of-multifocality-to-decide-whether-to-offer-adjuvant-therapy-for-patients-with-node-negative-multiple-pt1a-triple-negative-breast-cancers weekly 0.8 https://www.themednet.org/do-you-offer-liver-sbrt-for-metastatic-colorectal-cancer-after-local-recurrence-following-previous-treatments-such-as-radiofrequency-ablation-rfa-radioembolization-and-chemoembolization weekly 0.8 https://www.themednet.org/should-i-wear-gloves-during-a-routine-physical-exam-on-an-asymptomatic-patient-with-no-risk-factors-for-covid-19 weekly 0.8 https://www.themednet.org/what-frontline-therapy-would-you-offer-for-a-patient-who-is-elderly-or-unfit-for-standard-induction-therapy-with-both-idh-2-and-flt-3-itd-mutations weekly 0.8 https://www.themednet.org/would-you-give-abiraterone-in-the-post-prostatectomy-setting-to-patients-with-positive-nodes-detected-at-surgery weekly 0.8 https://www.themednet.org/how-do-you-deal-with-a-discordant-mri-prostate-after-a-systematic-biopsy weekly 0.8 https://www.themednet.org/do-you-routinely-use-risk-assessment-scores-e-g-the-khorana-score-to-assess-the-risk-of-venous-thromboembolism-and-consideration-of-prophylactic-anticoagulation-in-ambulatory-cancer-patients-undergoing-about-to-undergo-treatment weekly 0.8 https://www.themednet.org/how-would-differing-breast-cancer-receptors-between-biopsy-and-surgery-affect-your-treatment-recommendations weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-locally-advanced-hr-breast-cancer-with-contralateral-axillary-lymph-node-involvement weekly 0.8 https://www.themednet.org/how-would-you-approach-a-premenopausal-woman-with-hr-her2-metastatic-breast-and-a-pik3ca-mutation weekly 0.8 https://www.themednet.org/is-there-a-role-for-high-dose-chemotherapy-in-a-patient-with-metastatic-choriocarcinoma-with-brain-only-recurrence-within-two-years-of-diagnosis-after-prior-treatment-with-first-and-second-line-chemotherapy-bep-x4-and-vip-x3 weekly 0.8 https://www.themednet.org/how-would-you-approach-missed-doses-of-fulvestrant-due-to-covid-19 weekly 0.8 https://www.themednet.org/would-you-offer-egfr-inhibitors-to-a-patient-with-metastatic-lung-adenocarcinoma-egfr-l858r-mutation-and-concomitant-nras-mutation-both-on-blood-based-testing weekly 0.8 https://www.themednet.org/how-do-you-measure-the-skin-dose-when-you-are-concerned-about-dosing-to-the-skin weekly 0.8 https://www.themednet.org/how-should-you-manage-a-pediatric-oncology-patient-who-has-an-anc-500-and-a-normal-chest-x-ray-but-is-confirmed-to-be-infected-with-covid-19-and-is-immunosuppressed-from-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-treat-anaplastic-multiple-myeloma weekly 0.8 https://www.themednet.org/how-do-you-assess-whether-an-early-stage-hodgkins-patient-is-unfavorable weekly 0.8 https://www.themednet.org/is-there-any-consensus-or-guidance-on-how-to-manage-germ-cell-tumor-patients-in-the-covid-19-era weekly 0.8 https://www.themednet.org/is-apbi-appropriate-for-patients-with-rare-tumor-histology-mucinous-medullary-or-tubular-if-they-meet-all-other-suitability-criteria weekly 0.8 https://www.themednet.org/in-what-scenarios-would-you-include-the-ventricles-in-your-ctv-for-treatment-of-high-grade-gliomas weekly 0.8 https://www.themednet.org/are-you-more-inclined-to-use-neoadjuvant-endocrine-therapy-over-neoadjuvant-chemotherapy-or-upfront-surgery-for-your-er-her2-breast-cancer-patients-during-the-covid19-pandemic weekly 0.8 https://www.themednet.org/how-long-can-you-delay-the-start-of-radiation-in-a-patient-who-has-received-adjuvant-chemotherapy-after-lumpectomy-mastectomy weekly 0.8 https://www.themednet.org/what-is-your-preferred-neoadjuvant-chemotherapy-folfirinox-vs-gemcitabine-nab-paclitaxel-and-duration-for-a-resectable-t2n1-pancreatic-adenocarcinoma-in-a-fit-patient-whose-surgery-has-been-cancelled-due-to-covid-19-risk-in-the-hospital weekly 0.8 https://www.themednet.org/is-there-a-reliable-way-to-distinguish-a-metastasis-from-a-secondary-primary-tumor-if-the-histology-is-the-same weekly 0.8 https://www.themednet.org/when-do-you-change-treatment-for-an-asymptomatic-metastatic-melanoma-with-a-mixed-response-after-at-least-3-months-of-treatment-with-a-pd-l1-inhibitor weekly 0.8 https://www.themednet.org/in-light-of-promising-results-of-hydroxychloroquine-in-covid-19-should-we-consider-using-it-prophylactically-in-cancer-patients-especially-if-immunocompromised weekly 0.8 https://www.themednet.org/how-do-you-work-up-and-manage-a-patient-with-prostate-cancer-and-a-borderline-enlarged-pelvic-lymph-node weekly 0.8 https://www.themednet.org/should-we-consider-deferring-adjuvant-chemotherapy-for-resected-early-stage-nsclc-in-light-of-covid-19 weekly 0.8 https://www.themednet.org/should-our-selection-for-neoadjuvant-chemotherapy-in-ovarian-cancer-patients-change-in-light-of-covid-19 weekly 0.8 https://www.themednet.org/for-prostate-cancer-patients-undergoing-an-hdr-boost-what-constraints-do-you-use-for-hypofractionationated-ebrt weekly 0.8 https://www.themednet.org/how-do-you-deliver-appropriate-bilateral-post-mastectomy-radiation-therapy-for-a-young-woman-with-a-bilateral-clinically-node-positive-lobular-breast-cancer-with-a-pacemaker-in-place weekly 0.8 https://www.themednet.org/when-do-you-consider-testing-for-dihydropyrimidine-dehydrogenase-dpd-for-patients-prior-to-treatment-with-5-fu-capecitabine weekly 0.8 https://www.themednet.org/in-the-setting-of-vulvar-cancer-do-you-perform-complete-inguinal-lymphadnectomy-when-inguinal-sentinel-nodes-demonstrate-micrometastatic-2mm-disease weekly 0.8 https://www.themednet.org/how-do-you-factor-time-from-past-cytotoxic-chemotherapy-exposure-into-diagnosing-therapy-related-aml weekly 0.8 https://www.themednet.org/if-colostomy-is-indicated-prior-to-nigro-for-locally-advanced-anal-scc-would-you-wait-to-simulate-after-this-procedure-or-do-you-feel-pelvic-anatomy-will-not-be-distorted weekly 0.8 https://www.themednet.org/do-you-crop-the-mediastinal-nodal-ctv-out-of-normal-lung-parenchyma-when-treating-locally-advanced-nsclc weekly 0.8 https://www.themednet.org/with-covid-19-worries-are-you-more-likely-to-offer-women-with-endometrial-cancer-vaginal-cuff-brachytherapy-over-ebrt weekly 0.8 https://www.themednet.org/are-you-altering-your-use-of-active-breathing-coordination-for-breath-hold-technique-patients-in-light-of-the-covid-19-pandemic weekly 0.8 https://www.themednet.org/how-are-you-modifying-your-current-sarcoma-directed-therapy-in-the-setting-of-the-covid-19-pandemic weekly 0.8 https://www.themednet.org/what-upfront-maintenance-therapy-would-you-recommend-for-a-brca-negative-advanced-epithelial-ovarian-cancer-patient-after-completing-adjuvant-carboplatin-paclitaxel-bevacizumab weekly 0.8 https://www.themednet.org/are-you-routinely-considering-treating-p16-positive-nonsmokers-occult-primary-with-pharyngeal-sparing-technique-in-patients-who-have-undergone-extensive-tors-workup weekly 0.8 https://www.themednet.org/for-patients-who-meet-criteria-to-be-treated-with-3-months-of-capeox-based-on-idea-study-is-it-reasonable-to-use-capecitabine-alone-for-3-months-and-drop-oxaliplatin-during-the-covid-pandemic weekly 0.8 https://www.themednet.org/would-you-choose-neoadjuvant-endocrine-therapy-for-a-low-grade-node-negative-er-pr-positive-breast-cancer-given-delays-in-definitive-surgery-due-to-the-covid-19-pandemic weekly 0.8 https://www.themednet.org/given-the-current-covid-19-pandemic-how-long-would-you-delay-mastectomy-post-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-treat-late-medullary-relapsed-b-all-in-a-patient-with-down-syndrome weekly 0.8 https://www.themednet.org/is-it-appropriate-to-offer-combination-lung-sbrt-and-immunotherapy-for-oligometastatic-melanoma-outside-of-a-clinical-trial weekly 0.8 https://www.themednet.org/do-you-recommend-salvage-xrt-to-the-prostate-bed-in-the-setting-of-oligometastatic-prostate-cancer-after-rp weekly 0.8 https://www.themednet.org/what-is-your-bilirubin-threshold-to-treat-a-metastatic-pancreaticobiliary-tumor-with-folfox weekly 0.8 https://www.themednet.org/how-would-you-approach-a-poorly-differentiated-neuroendocrine-carcinoma-of-the-stomach-with-small-cell-morphology-without-any-evidence-of-peritoneal-or-distant-spread weekly 0.8 https://www.themednet.org/would-you-give-a-parp-inhibitor-and-at-what-dose-to-a-patient-with-end-stage-renal-disease-on-hemodialysis-after-completion-of-6-cycles-of-carboplatin-and-paclitaxel-for-advanced-ovarian-cancer weekly 0.8 https://www.themednet.org/what-systemic-treatment-would-you-offer-for-metastatic-her2-breast-cancer-that-has-progressed-through-thp-and-tdm-1-with-predominant-cns-progression-and-without-localized-treatment-options weekly 0.8 https://www.themednet.org/is-the-covid-19-pandemic-affecting-your-choice-of-high-dose-versus-weekly-cisplatin-for-definitive-concurrent-chemoradiation-for-hpv-negative-head-and-neck-cancer weekly 0.8 https://www.themednet.org/should-maintenance-rituximab-be-held-due-to-covid-19-in-patients-with-advanced-bulky-follicular-lymphoma-who-attain-a-pr-cr-to-weekly-rituximab weekly 0.8 https://www.themednet.org/are-you-covering-the-tracheostomy-site-with-a-surgical-mask-due-to-covid-19-to-protect-the-therapist weekly 0.8 https://www.themednet.org/is-there-any-contraindication-to-concurrent-administration-of-radioactive-iodine-in-a-patient-on-immunotherapy weekly 0.8 https://www.themednet.org/what-are-your-policies-practices-for-physician-role-of-sbrt-sabr-treatment-delivery weekly 0.8 https://www.themednet.org/do-your-post-operative-rectal-fields-differ-from-pre-operative-fields weekly 0.8 https://www.themednet.org/is-sbrt-feasible-to-a-renal-cell-carcinoma-at-the-renal-hilum weekly 0.8 https://www.themednet.org/do-you-continue-somatostatin-analogs-beyond-progression-to-maintain-disease-control-in-low-intermediate-grade-neuroendocrine-tumors weekly 0.8 https://www.themednet.org/what-oral-alternatives-would-you-recommend-as-opposed-to-injectable-gnrh-agonists-for-those-who-do-not-wish-to-come-to-clinic-due-to-covid-19 weekly 0.8 https://www.themednet.org/how-do-you-apply-brain-metastasis-velocity-in-the-clinic weekly 0.8 https://www.themednet.org/would-you-offer-consolidative-radiation-for-metastatic-small-cell-bladder-cancer-with-good-response-to-immunotherapy weekly 0.8 https://www.themednet.org/would-you-consider-a-cisplatin-based-regimen-with-hypofractionated-radiation-for-bladder-cancer weekly 0.8 https://www.themednet.org/outside-of-a-clinical-trial-what-is-your-preferred-first-line-therapy-for-a-fit-patient-with-de-novo-metastatic-spindle-cell-sarcoma weekly 0.8 https://www.themednet.org/when-treating-bladder-cancer-with-55-gy-in-20-fractions-what-small-bowel-dose-constraints-do-people-use weekly 0.8 https://www.themednet.org/what-form-of-surveillance-do-you-recommend-for-esophageal-adenocarcinoma-s-p-nacrt-and-resection-at-what-frequency weekly 0.8 https://www.themednet.org/how-would-you-treat-metastatic-squamous-cell-carcinoma-arising-from-a-mature-cystic-ovarian-teratoma weekly 0.8 https://www.themednet.org/what-is-your-preferred-et-treatment-for-patients-intolerant-resistant-to-hydroxyurea weekly 0.8 https://www.themednet.org/is-there-an-increased-risk-of-pneumonitis-in-covid-19-patients-receiving-lung-irradiation weekly 0.8 https://www.themednet.org/what-chemotherapy-options-are-there-for-clear-cell-carcinoma-of-uterus-with-progression-of-disease-on-carboplatin-and-paclitaxel weekly 0.8 https://www.themednet.org/what-would-you-recommend-for-an-elderly-patient-80-year-old-with-resectable-pancreatic-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-sickle-cell-disease-who-is-infected-with-covid-19 weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-in-addition-to-pelvic-rt-in-a-patient-with-fully-resected-pelvic-recurrence-of-endometrial-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-manage-intracranial-metastases-from-gestational-trophoblastic-neoplasia weekly 0.8 https://www.themednet.org/how-would-you-treat-an-sclc-patient-who-manifests-a-bona-fide-etoposide-allergy-on-cycle-two-day-one weekly 0.8 https://www.themednet.org/for-metastatic-colorectal-cancer-is-it-possible-for-the-tumor-to-be-mismatch-repair-proficient-at-primary-site-but-mismatch-repair-deficient-at-metastatic-site weekly 0.8 https://www.themednet.org/what-factors-if-any-such-as-microscopic-ene-2-mm-or-larger-nodal-size-e-g-4-cm-would-prompt-you-to-treat-the-contralateral-neck-for-oropharyngeal-cancers-otherwise-eligible-for-unilateral-radiotherapy weekly 0.8 https://www.themednet.org/due-to-the-thrombotic-nature-of-covid-19-should-we-be-discontinuing-tamoxifen-temporarily-in-patients-with-an-active-infection weekly 0.8 https://www.themednet.org/for-t2-t3-n-rectal-patients-with-large-2-cm-bilateral-sidewall-nodes-outside-the-tme-volume-should-you-extend-elective-nodal-volumes-anteriorly-to-include-external-iliacs weekly 0.8 https://www.themednet.org/would-you-offer-radiation-therapy-to-the-prostate-in-addition-to-up-to-1-3-osseous-metastases-in-a-patient-with-newly-castrate-resistant-oligometastatic-prostate-cancer-with-no-prior-treatment-to-the-prostate weekly 0.8 https://www.themednet.org/what-is-your-tki-preference-in-patients-with-chronic-phase-cml-on-hemodialysis weekly 0.8 https://www.themednet.org/how-would-you-approach-an-elderly-patient-with-early-stage-tnbc-with-node-negative-disease weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-t1an1-breast-cancer-when-the-er-pr-her2-status-cannot-be-determined-by-ihc weekly 0.8 https://www.themednet.org/do-you-routinely-contour-spinal-nerves-as-avoidance-structures-for-spine-sbrt-srs-cases-other-than-those-for-the-brachial-and-lumbosacral-plexuses weekly 0.8 https://www.themednet.org/how-would-you-approach-giving-concurrent-chemoradiation-for-stage-iiib-lung-adenocarcinoma-in-the-setting-of-concurrent-int-2-myelofibrosis-which-has-been-stable-without-cytopenias-on-ruxolitinib weekly 0.8 https://www.themednet.org/would-you-offer-immunotherapy-for-a-patient-with-a-history-of-kidney-transplant-on-immunosuppression-who-has-clear-cell-rcc-in-the-native-kidney weekly 0.8 https://www.themednet.org/should-patients-about-to-start-radiation-be-required-to-have-covid-19-testing-if-resources-are-available weekly 0.8 https://www.themednet.org/do-you-obtain-somatic-genomic-testing-for-ovarian-cancer-patients-that-test-negative-for-gbrca-mutation weekly 0.8 https://www.themednet.org/how-would-you-treat-burkitt-lymphoma-during-an-uncomplicated-pregnancy weekly 0.8 https://www.themednet.org/would-you-continue-pembrolizumab-in-an-asymptomatic-metastatic-nsclc-patient-with-high-pd-l1-who-develops-granulomatous-mediastinal-lymphadenopathy-biopsy-proven-as-sarcoid weekly 0.8 https://www.themednet.org/should-patients-with-bleeding-disorders-increase-their-home-supplies-of-clotting-factors-foreseeing-a-possible-shortage-of-product-availability-due-to-covid-19 weekly 0.8 https://www.themednet.org/are-patients-with-bleeding-disorders-receiving-plasma-derived-products-at-increased-risk-of-acquiring-covid-19 weekly 0.8 https://www.themednet.org/do-you-contour-the-renal-hilum-vascular-trunk-and-renal-cortex-as-separate-structures-when-doing-sbrt-near-the-kidney weekly 0.8 https://www.themednet.org/what-are-the-first-line-treatment-options-in-hcc-patients-with-significant-baseline-proteinuria weekly 0.8 https://www.themednet.org/would-you-consider-adding-neoadjuvant-endocrine-therapy-in-a-patient-with-hr-her2-breast-cancer-who-has-not-clinically-responded-to-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-a-craniopharyngioma-in-an-older-adult-patient weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-for-non-contiguous-stage-iia-nodular-lymphocyte-predominant-hodgkins-lymphoma-nlphl weekly 0.8 https://www.themednet.org/which-adjuvant-chemotherapy-regimen-would-you-recommend-for-a-peri-menopausal-woman-with-synchronous-stage-ia-primary-breast-tumors-one-that-is-er-her2-and-the-second-er-her2 weekly 0.8 https://www.themednet.org/do-you-offer-fertility-preservation-to-patients-prior-to-car-t-therapy weekly 0.8 https://www.themednet.org/would-you-consider-definitive-concurrent-chemoradiation-to-a-patient-with-muscle-invasive-bladder-cancer-and-a-history-of-distal-sigmoid-ulcerative-colitis weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-a-locoregional-recurrence-tnbc-who-requires-neoadjuvant-treatment weekly 0.8 https://www.themednet.org/is-there-any-role-for-bisphosphonate-or-alternative-bone-modifying-agents-use-in-smm-in-the-absence-of-other-indications-for-its-use weekly 0.8 https://www.themednet.org/is-there-any-role-for-early-stem-cell-mobilization-and-collection-during-the-smm-phase weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-metastatic-squamous-carcinoma-of-the-prostate weekly 0.8 https://www.themednet.org/are-there-any-hypofractionated-rt-regimens-that-could-be-considered-in-a-post-op-setting-for-extremity-soft-tissue-sarcoma weekly 0.8 https://www.themednet.org/what-lifestyle-changes-if-any-do-you-recommend-to-patients-and-caregivers-regarding-the-bodily-fluids-of-patients-receiving-systemic-therapy weekly 0.8 https://www.themednet.org/what-is-the-optimal-sequencing-for-sbrt-boosts-in-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-routinely-prescribe-anticoagulation-for-patients-on-active-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-centrally-located-new-primary-squamous-nsclc-after-prior-definitive-chemoradiation-to-45-gy-30-fractions-for-small-cell-lung-carcinoma weekly 0.8 https://www.themednet.org/should-new-patients-requiring-chemotherapy-be-tested-for-covid-19-prior-to-starting-treatment weekly 0.8 https://www.themednet.org/would-you-offer-systemic-therapy-after-rendered-ned-from-srs-to-isolated-cns-metastases-in-a-patient-with-prior-curative-intent-treatment-of-lung-adenocarcinoma-and-clear-cell-rcc weekly 0.8 https://www.themednet.org/would-you-offer-radiation-therapy-to-a-patient-with-sigmoid-colon-cancer-that-is-medically-inoperable weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-who-responded-to-cdk4-6-inhibitor-endocrine-therapy-combination-for-metastatic-hr-her2-breast-cancer-who-now-has-disease-progression-which-is-biopsy-proven-tnbc weekly 0.8 https://www.themednet.org/would-you-treat-a-pleomorphic-sarcoma-of-the-pelvis-post-operatively weekly 0.8 https://www.themednet.org/what-regimen-constraints-do-you-use-for-moderately-hypofractionated-salvage-post-prostatectomy-radiation weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-atm-mutation-with-prostate-cancer weekly 0.8 https://www.themednet.org/can-prrt-be-used-in-a-patient-with-a-gi-neuroendocrine-tumor-and-estimated-gfr-of-less-than-30 weekly 0.8 https://www.themednet.org/do-you-ever-boost-equivocal-pelvic-lymph-nodes-in-a-patient-with-low-psa-who-will-get-salvage-xrt weekly 0.8 https://www.themednet.org/do-you-use-an-age-limit-cutoff-for-sbrt-in-lung-cancer weekly 0.8 https://www.themednet.org/what-fractionation-would-you-recommend-in-a-patient-with-prostate-cancer-and-a-bulbar-urethral-stricture weekly 0.8 https://www.themednet.org/how-do-you-manage-taxane-acute-pain-syndrome-taps weekly 0.8 https://www.themednet.org/would-you-consider-telomeropathies-as-an-absolute-contraindication-to-radiation-therapy weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-choosing-between-a-1st-and-2nd-generation-tki-in-a-newly-diagnosed-cml-patient weekly 0.8 https://www.themednet.org/when-during-all-induction-therapy-are-you-checking-for-mrd weekly 0.8 https://www.themednet.org/how-do-you-treat-a-pediatric-patient-with-t-17-19-acute-lymphoblastic-leukemia weekly 0.8 https://www.themednet.org/would-you-hold-rituximab-for-newly-diagnosed-b-cell-lymphoma-if-the-patient-is-covid-19-positive weekly 0.8 https://www.themednet.org/when-do-you-stop-immunosuppressants-in-patients-with-gpa weekly 0.8 https://www.themednet.org/what-is-your-approach-to-unresectable-metastatic-rhabdomyosarcoma-transformed-from-an-embryonal-cell-germ-cell-tumor weekly 0.8 https://www.themednet.org/how-do-you-counsel-families-of-pediatric-patients-regarding-risk-of-secondary-malignancy-or-iq-changes-with-cranial-radiation-using-photons weekly 0.8 https://www.themednet.org/is-it-acceptable-to-deliver-ablative-hypofractionated-radiation-therapy-for-unresectable-intrahepatic-cholangiocarcoma-in-conjunction-with-concurrent-checkpoint-inhibitor weekly 0.8 https://www.themednet.org/how-long-would-you-wait-after-a-cycle-of-it-mtx-to-treat-a-spinal-lesion-causing-cord-compression-in-a-patient-with-stage-iv-dlbcl weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-resected-spindle-cell-rhabdosarcoma-of-the-tongue weekly 0.8 https://www.themednet.org/what-frontline-treatment-would-you-offer-a-patient-with-aitl-who-is-not-a-candidate-for-an-anthracycline-due-to-baseline-cardiomyopathy weekly 0.8 https://www.themednet.org/do-you-recommend-routine-surveillance-mri-brain-for-asymptomatic-patients-with-metastatic-her2-breast-cancer weekly 0.8 https://www.themednet.org/what-are-best-practices-for-pediatric-hematology-oncology-patient-and-staff-precautions-with-the-covid-19-pandemic weekly 0.8 https://www.themednet.org/how-would-you-approach-therapy-for-an-elderly-patient-with-nf1-associated-metastatic-mpnst-who-remains-asymptomatic weekly 0.8 https://www.themednet.org/how-do-you-manage-symptomatic-brain-metastases-from-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/what-radiation-sensitizer-do-you-recommend-for-early-stage-poorly-differentiated-squamous-cell-carcinoma-of-the-anus-in-a-patient-with-stage-iv-chronic-kidney-disease weekly 0.8 https://www.themednet.org/how-would-you-treat-maxillary-ameloblastic-carcinoma-s-p-r1-resection-and-perineural-invasion weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-would-you-use-for-definitive-intent-radiation-therapy-for-a-metastatic-melanoma-of-the-maxillary-sinus weekly 0.8 https://www.themednet.org/does-themednet-offer-cme weekly 0.8 https://www.themednet.org/would-you-stop-hydroxyurea-for-thrombocytosis-in-a-prostate-patient-receiving-radiation weekly 0.8 https://www.themednet.org/with-the-approval-of-capmatinib-how-would-you-approach-a-newly-diagnosed-metastatic-nsclc-with-met-exon-14-skipping-mutation weekly 0.8 https://www.themednet.org/how-would-you-approach-an-unresectable-locally-advanced-lung-cancer-invading-the-chest-wall-25-years-after-whole-breast-radiotherapy-to-the-same-side weekly 0.8 https://www.themednet.org/what-dose-of-radiation-would-you-give-for-an-orbital-psuedotumor weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-with-radium-223-for-prostate-cancer-with-mainly-bone-metastasis-if-he-has-a-history-of-osteonecrosis-of-the-jaw-bone-from-bisphosphonate-denosumab weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-utilize-for-an-unresectable-localized-cutaneous-melanoma-that-has-progressed-on-immunotherapy weekly 0.8 https://www.themednet.org/what-is-the-risk-that-primary-prostate-radiotherapy-will-exacerbate-levator-syndrome-or-other-chronic-pelvic-pain-syndromes weekly 0.8 https://www.themednet.org/how-do-you-manage-severe-lenalidomide-associated-drug-rash-in-a-transplant-eligible-patient-with-multiple-myeloma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-advanced-hodgkin-lymphoma-when-bleomycin-is-contraindicated-and-infectious-complications-arise-with-a-avd weekly 0.8 https://www.themednet.org/how-do-you-clearly-communicate-to-parents-that-the-main-purpose-of-a-phase-i-trial-is-to-find-the-best-dose-of-a-new-drug-with-the-fewest-side-effects-rather-than-treating-the-patients-cancer weekly 0.8 https://www.themednet.org/what-is-your-first-choice-tki-for-pediatric-patients-with-ph-all-who-are-not-on-a-study weekly 0.8 https://www.themednet.org/which-modality-of-rt-is-most-appropriate-for-a-patient-with-pt3n0-sn-endometrial-cancer weekly 0.8 https://www.themednet.org/how-do-you-treat-metastatic-epithelioid-sarcoma-in-pediatric-patients weekly 0.8 https://www.themednet.org/what-would-you-recommend-as-the-next-line-treatment-in-a-post-menopausal-woman-with-hormone-receptor-positive-her2-positive-breast-cancer-with-progression-on-t-dm1-in-combination-with-aromatase-inhibitor weekly 0.8 https://www.themednet.org/in-which-clinical-situations-is-there-a-good-rationale-for-the-use-of-proton-therapy-for-gi-cancers weekly 0.8 https://www.themednet.org/would-you-choose-a-different-anti-cd20-antibody-in-early-relapsed-6-months-dlbcl-treated-with-rituximab weekly 0.8 https://www.themednet.org/in-a-patient-with-multiple-myeloma-who-cannot-tolerate-lenalidomide-or-bortezomib-due-to-gi-toxicity-what-regimen-would-you-choose-for-next-line-therapy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-and-caregivers-regarding-management-of-cancer-associated-cachexia weekly 0.8 https://www.themednet.org/for-patients-with-early-stage-resected-giant-cell-lung-cancer-and-other-less-common-histologies-are-there-any-specific-considerations-for-adjuvant-therapy weekly 0.8 https://www.themednet.org/what-prostate-cancer-patient-population-would-benefit-from-a-brachytherapy-boost-after-ebrt-without-the-use-of-adt weekly 0.8 https://www.themednet.org/what-is-the-role-for-adjuvant-monoclonal-antibody-therapy-with-radiation-for-diffuse-intrinsic-pontine-glioma weekly 0.8 https://www.themednet.org/would-you-recommend-prophylactic-cranial-irradiation-pci-for-a-teenager-with-a-t-cell-acute-lymphoblastic-leukemia-in-remission weekly 0.8 https://www.themednet.org/for-patients-with-braf-v600e-positive-lung-cancer-and-recent-pe-dvt-is-there-any-contraindication-to-braf-mek-inhibitor-therapy weekly 0.8 https://www.themednet.org/what-are-the-alternatives-to-gonioscopy-gel-to-protect-the-cornea-when-using-internal-eye-shielding weekly 0.8 https://www.themednet.org/would-you-offer-neoadjuvant-chemotherapy-to-a-patient-with-muscle-invasive-enteric-adenocarcinoma-of-the-bladder weekly 0.8 https://www.themednet.org/what-is-your-preferred-conditioning-regimen-for-fit-patients-with-high-risk-mds-undergoing-mud-allogeneic-stem-cell-transplantation weekly 0.8 https://www.themednet.org/what-is-your-strategy-for-a-patient-who-develops-an-enlarging-ipsilateral-axillary-lymph-node-shortly-after-undergoing-mastectomy-and-alnd-for-a-pt2n3-er-her2-right-breast-cancer weekly 0.8 https://www.themednet.org/do-you-give-post-operative-radiation-to-ewing-sarcoma-if-there-is-poor-histologic-response-to-neoadjuvant-therapy-in-a-completely-resected-tumor weekly 0.8 https://www.themednet.org/do-you-adjust-psa-for-finasteride-use-when-determining-prostate-cancer-stage-and-risk-category weekly 0.8 https://www.themednet.org/do-you-offer-radiation-therapy-for-locally-advanced-node-positive-rectal-adenocarcinoma-in-patients-with-li-fraumeni-syndrome weekly 0.8 https://www.themednet.org/how-would-you-treat-a-stage-1a-sertoli-leydig-cell-tumor-with-heterologous-elements weekly 0.8 https://www.themednet.org/what-prostate-size-if-any-is-a-relative-contraindication-for-external-beam-rt weekly 0.8 https://www.themednet.org/how-do-you-treat-extensive-stage-small-cell-lung-cancer-in-the-very-elderly-more-than-80-yrs weekly 0.8 https://www.themednet.org/how-do-you-stage-patients-with-testicular-cancer-who-may-have-csis-disease weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-metastatic-colon-cancer-and-brca2-mutation-in-next-generation-sequencing weekly 0.8 https://www.themednet.org/would-you-use-tucatinib-in-a-patient-with-recurrent-her2-breast-cancer-with-isolated-brain-metastasis-with-leptomeningeal-disease weekly 0.8 https://www.themednet.org/will-you-offer-capecitabine-for-1-year-to-all-localized-tnbc-patients weekly 0.8 https://www.themednet.org/in-a-patient-who-had-childhood-sarcoma-treated-with-surgery-and-chemotherapy-but-without-radiation-would-this-history-impact-their-risk-of-second-malignancy-from-radiation-to-a-new-cancer-given-as-an-adult weekly 0.8 https://www.themednet.org/which-patients-would-you-treat-with-relugolix-instead-of-injectable-gnrh-agonist-therapy weekly 0.8 https://www.themednet.org/what-brachytherapy-dose-fractionation-should-be-used-for-small-cell-carinoma-of-the-cervix weekly 0.8 https://www.themednet.org/do-you-apply-pet-adapted-therapy-flyer-trial-and-omit-radiation-therapy-for-older-patients-60-years-with-early-stage-non-bulky-dlbcl weekly 0.8 https://www.themednet.org/what-is-your-therapy-of-choice-for-relapsed-metastatic-alveolar-rhabdomyosarcoma weekly 0.8 https://www.themednet.org/how-long-after-discontinuation-of-tki-for-complete-remission-would-you-feel-it-is-safe-for-a-patient-with-cml-to-consider-pregnancy weekly 0.8 https://www.themednet.org/whats-your-preferred-management-for-a-newly-diagnosed-chronic-phase-cml-with-concurrent-thrombocytopenia weekly 0.8 https://www.themednet.org/when-do-you-get-a-bone-marrow-biopsy-for-likely-essential-thrombocytosis weekly 0.8 https://www.themednet.org/in-light-of-desktop-iii-how-will-you-approach-secondary-debulking-for-platinum-sensitive-epithelial-ovarian-cancer-patients weekly 0.8 https://www.themednet.org/how-do-you-treat-newly-diagnosed-multiple-myeloma-with-1q-gain weekly 0.8 https://www.themednet.org/under-what-circumstances-you-would-consider-treating-stage-ii-colon-cancer-with-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/in-the-management-of-the-primary-site-in-high-risk-neuroblastoma-is-there-a-role-for-a-cone-down-to-residual-disease-boost-following-treatment-of-the-post-chemo-pre-surgical-extent-to-21-6-gy weekly 0.8 https://www.themednet.org/what-sabr-dose-fractionation-would-you-use-when-treating-an-oligometastatic-site-in-the-femur-or-weight-bearing-acetabulum weekly 0.8 https://www.themednet.org/how-do-you-approach-use-of-tamoxifen-for-chemo-prevention-in-post-menopausal-women-with-non-brca-germline-mutations weekly 0.8 https://www.themednet.org/when-would-you-consider-obtaining-tumor-tissue-in-nf-1-associated-pediatric-low-grade-glioma weekly 0.8 https://www.themednet.org/how-do-you-approach-myeloablative-chemotherapy-for-high-risk-ewing-sarcoma-patients weekly 0.8 https://www.themednet.org/would-you-consider-using-cdk-4-6-inhibitors-in-a-patient-with-end-stage-renal-disease-esrd-along-with-an-aromatase-inhibitor weekly 0.8 https://www.themednet.org/does-liver-directed-therapy-sbrt-y-90-tace-rfa-microwave-ablation-etc-improve-overall-survival weekly 0.8 https://www.themednet.org/how-should-patients-be-selected-for-metastatic-site-directed-radiotherapy-in-rhabdomyosarcoma weekly 0.8 https://www.themednet.org/what-is-your-initial-treatment-strategy-for-patients-with-tnbc-who-present-with-isolated-bulky-axillary-and-cervical-adenopathy weekly 0.8 https://www.themednet.org/would-weak-pr-positivity-make-you-consider-adjuvant-endocrine-therapy-for-a-young-pre-menopausal-woman-with-a-her2-positive-er-negative-breast-cancer weekly 0.8 https://www.themednet.org/when-treating-an-intact-whole-breast-using-breath-hold-technique-with-a-planned-electron-boost-do-you-generate-a-separate-plan-for-the-boost-with-a-free-breathing-scan-or-plan-the-electron-boost-on-the-breath-hold-scan-but-treat-free-breathing weekly 0.8 https://www.themednet.org/how-do-you-approach-discussion-of-adjuvant-chemotherapy-for-a-t1b-0-5-cm-hormone-positive-breast-cancer-with-high-risk-features-and-an-oncotype-score-of-31 weekly 0.8 https://www.themednet.org/how-do-you-treat-muscle-invasive-and-metastatic-sarcomatoid-bladder-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-high-risk-triple-negative-breast-cancer-with-metastatic-disease-after-recent-adjuvant-ac-t weekly 0.8 https://www.themednet.org/what-do-you-try-in-patients-with-ibd-related-spondyloarthritis-with-predominantly-axial-symptoms-who-are-refractory-to-tnf-inhibitors weekly 0.8 https://www.themednet.org/what-is-your-first-treatment-of-choice-in-patients-with-dermatomyositis-sine-myositis weekly 0.8 https://www.themednet.org/what-is-your-next-step-in-patients-with-polymyositis-without-interstitial-lung-disease-who-are-refractory-to-methotrexate weekly 0.8 https://www.themednet.org/what-agent-do-you-try-next-in-patients-with-myositis-related-interstitial-lung-disease-who-are-refractory-to-mycophenolate-mofetil-and-azathioprine weekly 0.8 https://www.themednet.org/when-do-you-use-tacrolimus-in-patients-with-myositis-related-interstitial-lung-disease weekly 0.8 https://www.themednet.org/what-is-your-initial-treatment-of-choice-in-patients-with-ra-and-associated-interstitial-lung-disease weekly 0.8 https://www.themednet.org/do-you-continue-hydroxychloroquine-in-lupus-patients-who-develop-cardiomyopathy weekly 0.8 https://www.themednet.org/would-you-consider-post-operative-radiation-therapy-for-resected-malignant-melanoma-with-in-transit-metastasis weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-a-spinal-meningioma weekly 0.8 https://www.themednet.org/would-you-consider-preoperative-radiation-for-a-retroperitoneal-sarcoma-in-a-patient-with-li-fraumeni-syndrome-where-upfront-surgery-is-likely-to-yield-a-positive-margin weekly 0.8 https://www.themednet.org/how-would-you-approach-a-postmenopausal-patient-with-hr-her2-breast-cancer-who-has-oligometastatic-disease-and-is-s-p-complete-resection-of-brain-met-with-no-other-evidence-of-systemic-disease weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-consolidative-radiation-to-bulky-site-s-in-the-setting-of-advanced-stage-dlbcl weekly 0.8 https://www.themednet.org/would-you-consider-neoadjuvant-ifosfamide-based-chemotherapy-for-a-large-10cm-high-grade-soft-tissue-extremity-sarcoma-in-an-attempt-to-achieve-limb-sparing-surgery-in-an-otherwise-healthy-young-patient weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-capecitabine-in-a-premenopausal-patient-with-hr-positive-inflammatory-breast-cancer-who-had-residual-disease-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-srs-to-a-thalamic-metastasis weekly 0.8 https://www.themednet.org/would-you-consider-sbrt-to-a-perirectal-node-after-previous-external-beam-and-prostate-brachytherapy weekly 0.8 https://www.themednet.org/how-would-you-evaluate-a-pediatric-patient-referred-to-rule-out-cancer-due-to-an-isolated-significantly-elevated-vitamin-b12-level weekly 0.8 https://www.themednet.org/are-there-any-specific-planning-techniques-that-are-used-to-avoid-underdosing-the-match-line-in-a-single-isocenter-breast-plan-treating-the-chest-wall-and-supraclavicular-region weekly 0.8 https://www.themednet.org/would-you-consider-adding-enasidinib-to-frontline-combination-therapy-with-hma-and-venetoclax-in-a-patient-with-newly-diagnosed-aml-with-idh2-mutation-that-is-75-or-unfit-for-standard-induction-therapy weekly 0.8 https://www.themednet.org/how-do-you-manage-immunotherapy-associated-pruritis-that-is-persistent-despite-steroid-use weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-tdm-1-for-a-patient-with-hr-her2-breast-cancer-with-pcr-in-the-breast-but-n1mic-disease-post-neoaduvant-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-locoregional-squamous-cell-carcinoma-of-the-stomach-extending-to-ge-junction weekly 0.8 https://www.themednet.org/are-there-any-safety-or-efficacy-data-regarding-the-use-of-egfr-inhibitors-in-patients-on-hemodialysis-for-esrd weekly 0.8 https://www.themednet.org/what-ctv-expansion-volumes-would-you-recommend-for-a-large-unresectable-symptomatic-desmoid-tumor-of-the-neck weekly 0.8 https://www.themednet.org/how-do-you-choose-first-or-second-line-systemic-therapy-for-fibrolamellar-hepatocellular-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-in-an-infant-with-metastatic-atypical-teratoid-rhabdoid-tumor-atrt-of-the-brain weekly 0.8 https://www.themednet.org/how-do-you-approach-subsequent-wbrt-following-prior-brainstem-srs-fsrt weekly 0.8 https://www.themednet.org/after-wbrt-what-systemic-therapy-would-you-favor-for-maximal-cns-penetrance-in-a-patient-with-triple-negative-metastatic-breast-cancer-and-multifocal-cns-disease weekly 0.8 https://www.themednet.org/is-postoperative-radiotherapy-indicated-for-a-primary-parotid-gland-melanoma weekly 0.8 https://www.themednet.org/what-would-you-use-as-adjuvant-endocrine-therapy-for-a-patient-who-developed-an-invasive-hormone-receptor-positive-breast-cancer-while-on-raloxifene-for-almost-a-decade-prior weekly 0.8 https://www.themednet.org/do-you-utilize-eus-to-determine-the-nodal-radiation-fields-in-esophageal-adenocarcinoma weekly 0.8 https://www.themednet.org/how-do-you-approach-use-of-tamoxifen-in-premenopausal-patients-who-developed-ovarian-cysts-while-on-therapy weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-recommend-for-pt2-pn1-cholangiocarcinoma weekly 0.8 https://www.themednet.org/does-p16-negative-status-of-anal-squamous-cell-carcinomas-affect-your-treatment-approach weekly 0.8 https://www.themednet.org/is-there-any-benefit-to-giving-pelvic-radiation-prior-to-systemic-chemotherapy-or-vice-versa-for-a-patient-with-stage-iiia-uterine-serous-carcinoma weekly 0.8 https://www.themednet.org/when-do-you-offer-hyperbaric-oxygen-therapy-to-a-pediatric-brain-tumor-patient-with-radiation-injury-necrosis weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-advanced-stage-dlbcl-with-a-single-site-of-residual-fdg-avid-disease-after-completion-of-r-chop-in-the-frontline-setting weekly 0.8 https://www.themednet.org/what-surveillance-do-you-recommend-for-a-patient-with-locally-advanced-rectal-adenocarcinoma-who-had-a-complete-clinical-response-to-total-neoadjuvant-therapy-and-declines-to-undergo-surgery weekly 0.8 https://www.themednet.org/how-soon-after-surgery-do-you-start-chemotherapy-for-extensive-stage-sclc-following-resection-of-a-brain-metastasis weekly 0.8 https://www.themednet.org/how-would-you-approach-therapy-for-a-young-fit-patient-with-alveolar-rhabdomyosarcoma-involving-the-anterior-nasal-vault-sinuses-in-the-absence-of-available-clinical-trials weekly 0.8 https://www.themednet.org/would-you-assume-a-diagnosis-of-metastatic-recurrence-and-initiate-therapy-for-a-patient-with-history-of-locally-advanced-nsclc-treated-with-definitive-chemoradiation-who-develops-multiple-enlarging-lung-nodules-that-are-too-small-to-biopsy weekly 0.8 https://www.themednet.org/are-you-recommending-aspirin-in-breast-cancer-survivors weekly 0.8 https://www.themednet.org/would-you-recommend-bone-scan-or-pet-ct-for-detecting-metastatic-bony-lesions-in-a-patient-with-osteosarcoma weekly 0.8 https://www.themednet.org/would-you-consider-nivolumab-and-ipilimumab-as-first-line-for-pleural-mesothelioma weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-patients-with-an-e14a3-b3a3-bcr-abl-fusion-in-chronic-phase-cml weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-severe-aplastic-anemia-and-a-large-pnh-clone weekly 0.8 https://www.themednet.org/how-do-you-manage-palliative-pelvic-radiotherapy-in-a-patient-receiving-avastin weekly 0.8 https://www.themednet.org/would-you-consider-apbi-in-a-primary-breast-adenoid-cystic-carcinoma weekly 0.8 https://www.themednet.org/in-high-risk-prostate-cancer-treated-with-rt-with-neoadjuvant-concurrent-adt-is-adjuvant-intermittent-adt-reasonable-instead-of-continuous-adt weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-in-a-patient-with-fanconi-anemia-and-glioblastoma weekly 0.8 https://www.themednet.org/are-there-particular-adjuvant-therapy-considerations-for-locally-advanced-hnscc-patients-who-are-found-to-have-metastatic-involvement-of-cystic-lymph-nodes-during-surgery weekly 0.8 https://www.themednet.org/how-would-you-manage-a-positive-deep-margin-in-the-setting-of-mastectomy-and-expander-placement weekly 0.8 https://www.themednet.org/would-you-change-tkis-in-a-patient-with-ph-like-or-ph-positive-b-cell-all-who-relapses-on-therapy-along-with-giving-relapse-chemotherapy weekly 0.8 https://www.themednet.org/can-fulvestrant-cause-a-tumor-flare-reaction-in-hormone-receptor-positive-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-systemic-therapy-for-a-postmenopausal-female-with-metastatic-er-her2-breast-cancer-liver-bone-who-achieved-a-cr-for-5-years-on-trastuzumab-pertuzumab-and-exemestane-with-continued-asymptomatic-brain-progression weekly 0.8 https://www.themednet.org/what-chest-wall-boost-volume-do-you-use-for-patients-with-inflammatory-breast-cancer weekly 0.8 https://www.themednet.org/is-there-a-role-for-minimally-invasive-surgery-in-patients-undergoing-an-interval-cytoreductive-surgery weekly 0.8 https://www.themednet.org/for-pregnant-patients-progressing-on-anthracycline-based-chemotherapy-ex-fac-would-you-consider-other-chemotherapeutics-such-as-taxanes-or-proceed-to-locoregional-treatment weekly 0.8 https://www.themednet.org/what-elective-lymph-node-areas-do-you-cover-for-t4a-rectal-adenocarcinoma weekly 0.8 https://www.themednet.org/would-the-presence-of-diverticulosis-change-your-dose-constraint-for-large-bowel weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-therapy-to-a-patient-who-underwent-bilateral-mastectomies-for-dcis-and-was-found-to-have-isolated-tumor-cells-on-sentinel-node-biopsy weekly 0.8 https://www.themednet.org/do-you-offer-consolidation-rt-to-the-prostate-in-patients-with-extensive-stage-small-cell-carcinoma-of-the-prostate-after-pr-to-chemotherapy weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-offer-a-fully-resected-isolated-pelvic-peritoneal-recurrence-of-a-uterine-serous-carcinoma weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-relapsed-ph-all-and-mrd-positive-after-blinatumomab weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-utilize-to-palliate-a-symptomatic-distal-rectal-cancer-in-an-inoperable-elderly-gentleman-with-previous-prostate-bed-radiation-therapy-30-years-prior weekly 0.8 https://www.themednet.org/would-you-consider-adding-atezolizumab-to-chemotherapy-for-metastatic-esophageal-small-cell-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-discrepancies-between-mri-and-mammogram-results-for-staging-for-breast-cancer weekly 0.8 https://www.themednet.org/what-dose-is-needed-for-salvage-rt-for-recurrent-endometrial-cancer-in-untreated-pa-region-who-has-received-pelvic-rt-after-good-pet-response-to-systemic-therapy weekly 0.8 https://www.themednet.org/do-you-omit-seminal-vesicle-radiation-if-mri-is-negative-for-svi weekly 0.8 https://www.themednet.org/how-do-you-dose-chemotherapy-r-epoch-or-r-chop-in-patients-with-aggressive-lymphoma-involving-liver-leading-to-elevated-bilirubin-and-liver-enzymes weekly 0.8 https://www.themednet.org/during-induction-therapy-for-acute-leukemia-when-do-you-decide-to-discontinue-the-antimicrobial-prophylaxis weekly 0.8 https://www.themednet.org/how-would-you-approach-re-irradiation-to-a-localized-dlbcl-of-the-lower-extremity weekly 0.8 https://www.themednet.org/how-would-you-manage-relapsed-desmoplastic-small-round-cell-tumor weekly 0.8 https://www.themednet.org/does-pathologic-complete-response-impact-your-selection-criteria-for-tumor-bed-boost-of-breast-cancer-patients-status-post-neoadjuvant-chemotherapy-and-breast-conserving-surgery weekly 0.8 https://www.themednet.org/what-is-the-preferred-steroid-regimen-for-metastatic-prostate-cancer-patients-on-docetaxel weekly 0.8 https://www.themednet.org/what-treatment-approach-do-you-take-in-a-pediatric-patient-less-than-3-years-old-with-malignant-papillary-epithelioid-tumor-within-the-pineal-region weekly 0.8 https://www.themednet.org/when-would-you-consider-omitting-breast-radiation-in-a-65-yo-woman-who-is-s-p-bcs weekly 0.8 https://www.themednet.org/for-patients-with-locally-unresectable-metastatic-head-and-neck-cancer-who-achieve-complete-response-to-chemoimmunotherapy-how-do-you-manage-their-subsequent-care-in-terms-of-continuing-therapy-vs-close-monitoring weekly 0.8 https://www.themednet.org/how-would-you-treat-a-metastatic-pancreatic-cancer-patient-who-develops-symptomatic-leptomeningeal-disease-on-first-line-folfirinox weekly 0.8 https://www.themednet.org/do-you-offer-sbrt-liver-for-patients-with-low-platelets weekly 0.8 https://www.themednet.org/are-you-considering-sbrt-in-your-prostate-cancer-patients-who-had-a-rp-and-now-have-a-rising-psa-and-oligometastatic-bone-disease weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-residual-melanoma-in-situ-of-the-perianal-skin weekly 0.8 https://www.themednet.org/would-you-give-preop-chemoradiation-to-a-rectal-cancer-just-above-the-peritoneal-reflection-with-pelvic-nodes-seen-on-imaging weekly 0.8 https://www.themednet.org/would-you-offer-postop-chemort-to-a-patient-with-pt3n2bm0-rectal-cancer-and-ulcerative-colitis-s-p-prococolectomy-with-j-pouch-creation weekly 0.8 https://www.themednet.org/when-do-you-offer-adjuvant-radiation-in-addition-to-chemotherapy-for-patients-with-high-risk-localized-gastric-adenocarcinoma-who-did-not-receive-pre-operative-therapy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-newly-diagnosed-male-with-metastatic-hr-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-and-surveillance-of-breast-cancers-in-patients-carrying-germline-mutyh-mutation weekly 0.8 https://www.themednet.org/which-genomic-test-do-you-use-when-considering-active-surveillance-in-prostate-cancer weekly 0.8 https://www.themednet.org/would-you-change-chemotherapy-in-metastatic-tnbc-with-impending-cord-compression-but-other-visceral-disease-stable weekly 0.8 https://www.themednet.org/would-you-consider-salvage-srs-in-a-young-patient-with-locally-recurrent-atrt weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-in-an-otherwise-young-fit-patient-with-transformed-aml-currently-in-remission-with-a-plan-for-transplant-and-was-found-to-have-an-invasive-fungal-infection-not-amenable-to-resection-upon-recovery-from-induction weekly 0.8 https://www.themednet.org/for-ablative-treatment-of-intrahepatic-cholangiocarcinoma-what-dose-constraints-do-you-recommend-for-the-ivc-when-the-tumor-is-adjacent-to-it weekly 0.8 https://www.themednet.org/would-you-re-challenge-patients-who-have-had-a-tnf-associated-paradoxical-adverse-event-such-as-inflammatory-bowel-disease-with-a-different-tnf-inhibitor weekly 0.8 https://www.themednet.org/would-you-hold-pertuzumab-around-the-time-of-surgery weekly 0.8 https://www.themednet.org/how-would-you-treat-an-unresectable-eccrine-carcinoma-of-the-skin-of-the-face weekly 0.8 https://www.themednet.org/is-it-okay-to-use-cox-2-selective-nsaids-in-patients-with-ibd-associated-arthritis-when-the-ibd-is-in-remission weekly 0.8 https://www.themednet.org/should-regular-screening-brain-mris-be-done-for-children-with-germline-rb1-mutation-in-addition-to-eye-exams weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-pembrolizumab-for-a-patient-with-muscle-invasive-bladder-cancer-who-is-cisplatin-ineligible-and-found-at-surgery-to-have-t4an2m0-disease weekly 0.8 https://www.themednet.org/what-are-the-implications-of-a-vp-shunt-located-in-the-radiation-field-in-a-patient-receiving-treatment-for-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-her2-directed-therapy-with-discrepant-results-between-fish-and-oncotype weekly 0.8 https://www.themednet.org/should-patients-be-screened-for-hepatitis-b-c-prior-to-starting-a-conventional-synthetic-dmard-such-as-methotrexate weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-who-are-hepatitis-b-core-antibody-positive-surface-antigen-negative-and-starting-a-biologic-dmard-other-than-rituximab weekly 0.8 https://www.themednet.org/for-lung-sbrt-do-you-constrain-dose-to-small-bronchioles-small-airways weekly 0.8 https://www.themednet.org/in-which-osteoporosis-patients-would-you-consider-starting-with-anabolic-therapy-over-antiresorptive-therapy weekly 0.8 https://www.themednet.org/what-would-you-advise-a-breastfeeding-woman-with-localized-hr-breast-cancer-in-terms-of-risk-of-progression-with-breastfeeding-prior-to-local-therapy-with-surgery weekly 0.8 https://www.themednet.org/how-do-you-manage-a-hemorrhage-from-a-cavernous-malformation-following-srs weekly 0.8 https://www.themednet.org/how-would-you-treat-refractory-diarrhea-in-a-patient-with-low-grade-serous-ovarian-cancer-treated-with-trametinib weekly 0.8 https://www.themednet.org/do-you-recommend-cdk4-6-inhibitor-radiotherapy-or-both-following-surgery-for-a-pathologic-fracture-from-hr-breast-cancer weekly 0.8 https://www.themednet.org/would-you-recommend-consolidative-rt-for-an-hiv-positive-patient-with-stage-i-bulky-dlbcl-of-the-mediastinum-s-p-r-epoch weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-for-a-patient-with-a-high-grade-ipmn-who-was-found-to-have-a-small-focus-of-invasive-adenocarcinoma-pt1an0-after-whipple weekly 0.8 https://www.themednet.org/how-do-you-approach-recommending-tamoxifen-in-a-premenopausal-woman-with-li-fraumeni-syndrome-and-early-stage-low-risk-er-breast-cancer weekly 0.8 https://www.themednet.org/is-there-still-any-role-for-afatinib-or-first-generation-tkis-in-the-management-of-egfr-mutated-metastatic-lung-adenocarcinoma weekly 0.8 https://www.themednet.org/what-region-would-you-treat-in-a-patient-with-high-grade-leiomyosarcoma-localized-to-the-spermatic-cord-with-close-margins-1mm-s-p-inguinal-orchiectomy weekly 0.8 https://www.themednet.org/when-treating-patients-with-low-bone-mineral-density-when-how-do-you-monitor-bone-turnover-markers-ntx-ctx-etc weekly 0.8 https://www.themednet.org/does-histology-e-g-lobular-vs-ductal-impact-your-decision-to-offer-omission-of-rt-to-women-with-breast-cancer-who-are-otherwise-candidates weekly 0.8 https://www.themednet.org/what-is-your-treatment-algorithm-for-rs3pe weekly 0.8 https://www.themednet.org/how-do-you-manage-osteopenia-osteoporosis-and-calcium-vit-d-supplementation-in-a-patient-with-calcinosis weekly 0.8 https://www.themednet.org/in-a-patient-with-a-pt3n0-rectal-adenocarcinoma-would-you-consider-omitting-nodal-rt-and-treating-only-the-rectal-bed-with-adjuvant-chemoradiation-therapy-when-a-large-number-of-nodes-have-been-removed-and-all-found-to-be-negative weekly 0.8 https://www.themednet.org/how-do-you-approach-continuing-vs-discontinuing-ovarian-suppression-for-high-risk-hr-breast-cancer-when-a-patient-becomes-post-menopausal weekly 0.8 https://www.themednet.org/when-would-you-use-oral-cedazuridine-decitabine-as-opposed-to-parenteral-hmas-to-treat-intermediate-or-high-risk-mds weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-metastatic-rhabdomyosarcoma-complicated-by-sinusoidal-obstruction-syndrome-sos-after-neoadjuvant-chemotherapy-and-radiation-therapy weekly 0.8 https://www.themednet.org/how-do-you-adjust-the-dose-of-ibrutinib-in-hepatic-dysfunction-particularly-if-disease-related weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-localized-small-cell-bladder-cancer weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-a-diagnosis-of-ein-regarding-sentinel-lymph-node-dissection weekly 0.8 https://www.themednet.org/how-do-you-manage-thrombocytopenia-when-radiating-the-spleen weekly 0.8 https://www.themednet.org/what-is-your-preferred-setup-immobilization-for-patients-with-cutaneous-malignancy-of-the-toe-involving-the-medial-aspect-of-the-digit weekly 0.8 https://www.themednet.org/is-there-a-role-for-ultrasound-in-assessing-for-clinically-silent-inflammatory-arthritis-prior-to-tapering-dmard-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-vulvar-scc-with-inguinal-nodes-9-months-after-completion-of-surgery-adjuvant-ebrt-for-cervical-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-langerhans-cell-histiocytosis-involving-a-single-bone-site-after-resection weekly 0.8 https://www.themednet.org/how-do-you-manage-leptomeningeal-disease-in-relapsed-rhabdomyosarcoma weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-selecting-dose-fractionation-for-whole-brain-radiotherapy weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-avapritinib-or-imatinib-for-a-high-risk-pdgfr-d842v-mutated-gist-after-resection weekly 0.8 https://www.themednet.org/would-you-treat-extranodal-extension-within-a-matted-nodal-mass-differently-than-at-the-surface-in-the-postoperative-setting-for-h-n-cancer weekly 0.8 https://www.themednet.org/any-differences-in-the-parp-inhibitors-with-respect-to-development-of-anemia weekly 0.8 https://www.themednet.org/when-would-you-consider-fulvestrant-alpelisib-in-a-postmenopausal-patient-who-has-hr-pik3ca-mutant-metastatic-breast-cancer-instead-of-initial-cdk4-6-inhibitor-therapy weekly 0.8 https://www.themednet.org/when-suspecting-a-diagnosis-of-complex-regional-pain-syndrome-or-reflex-sympathetic-dystrophy-what-workup-should-be-done-to-confirm-or-exclude-it weekly 0.8 https://www.themednet.org/do-you-offer-local-treatment-to-the-breast-primary-in-patients-with-de-novo-oligometastatic-hormone-positive-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-a-young-patient-with-symptomatic-rosai-dorfman-disease-who-has-recurrent-life-threatening-pericardial-and-pleural-effusions weekly 0.8 https://www.themednet.org/what-if-any-adjuvant-treatment-do-you-offer-a-a-patient-with-stage-i-clear-cell-endometrial-carcinoma weekly 0.8 https://www.themednet.org/would-you-offer-re-irradiation-after-prostate-sbrt-for-recurrence-in-prostate-and-lymph-node weekly 0.8 https://www.themednet.org/would-you-give-dasatinib-to-a-standard-risk-pre-b-all-patient-with-an-abl1-mutation weekly 0.8 https://www.themednet.org/do-you-rebiopsy-grade-1-2-follicular-lymphoma-if-suv-is-high-by-pet weekly 0.8 https://www.themednet.org/how-would-you-treat-a-locally-recurrent-triple-negative-breast-cancer-after-achieving-cr-a-year-earlier-to-neoadjuvant-ddac-t-bcs-and-wbrt weekly 0.8 https://www.themednet.org/in-what-cases-do-you-rely-on-fiducials-for-alignment-prior-to-sbrt weekly 0.8 https://www.themednet.org/is-there-any-evidence-for-amyloid-amyloidosis-causing-a-spurious-false-psa-reading weekly 0.8 https://www.themednet.org/would-you-offer-lung-sbrt-in-a-patient-with-pulmonary-langerhans-cell-histiocytosis-plch weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiation-for-a-dfsp-with-fibrosarcomatous-transformation-s-p-wide-local-excision weekly 0.8 https://www.themednet.org/do-you-use-or-recommend-clinical-severity-scores-or-other-parameters-in-helping-prognostication-in-patients-with-refractory-status-epilepticus weekly 0.8 https://www.themednet.org/would-you-consider-proton-therapy-as-part-of-tnt-for-rectal-cancer weekly 0.8 https://www.themednet.org/are-there-situations-where-you-would-consider-treating-e-faecalis-or-e-faecium-that-grows-from-a-respiratory-culture weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-bempedoic-acid-nexletol-for-treatment-of-hyperlipidemia-in-patients-with-elevated-baseline-uric-acid-levels weekly 0.8 https://www.themednet.org/is-there-a-benefit-to-augmenting-treatment-for-schizophrenia-by-adding-aripiprazole-a-partial-d2-agonist-to-a-full-d2-antagonist-such-as-haloperidol weekly 0.8 https://www.themednet.org/what-is-your-approach-to-evaluating-a-patient-with-a-suspected-myocardial-contusion weekly 0.8 https://www.themednet.org/how-would-you-approach-the-decision-to-escalate-dmt-in-a-patient-with-relapsing-multiple-sclerosis-who-has-two-to-three-new-t2-lesion-but-no-clinical-symptoms weekly 0.8 https://www.themednet.org/how-would-you-prioritize-physiotherapy-and-cognitive-behavioral-therapy-for-functional-movement-disorders-in-a-resource-limited-setting-where-access-to-both-might-be-constrained weekly 0.8 https://www.themednet.org/what-factors-would-influence-your-decision-to-use-or-avoid-heparin-bridging-in-patients-with-mechanical-heart-valves-resuming-anticoagulation-after-intracerebral-hemorrhage weekly 0.8 https://www.themednet.org/given-the-findings-of-sunset-demonstrating-60-gy-in-8-fractions-to-be-a-safe-and-effective-regimen-for-ultracentral-lesions-in-what-situations-would-you-elect-to-use-a-10-fraction-hypofractionated-regimen weekly 0.8 https://www.themednet.org/what-is-your-approach-to-using-stimulants-in-treating-children-with-both-adhd-and-autism weekly 0.8 https://www.themednet.org/how-do-you-treat-postpartum-obsessive-compulsive-disorder weekly 0.8 https://www.themednet.org/based-on-most-current-research-regarding-the-more-widespread-use-of-class-ic-antiarrhythmic-drugs-what-are-your-prescribing-practices-in-patients-with-coronary-artery-disease weekly 0.8 https://www.themednet.org/is-there-a-subset-of-patients-in-whom-pre-oxygenation-with-nrb-or-bvm-could-be-safely-pursued weekly 0.8 https://www.themednet.org/what-are-the-logistical-challenges-and-time-constraints-of-implementing-niv-for-pre-oxygenation-in-emergency-settings-compared-to-oxygen-masks weekly 0.8 https://www.themednet.org/what-is-your-preferred-initial-systemic-therapy-approach-to-metastatic-clear-cell-adenocarcinoma-of-the-urethra-ccau weekly 0.8 https://www.themednet.org/can-you-explain-the-block-and-replace-approach-in-the-treatment-of-thyrotoxicosis-including-when-it-is-most-appropriate-to-use-and-how-it-compares-to-other-treatment-options weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-for-patients-on-an-individual-basis-when-establishing-a-post-cardiac-arrest-map-goal-after-rosc-is-achieved-considering-some-may-benefit-from-higher-map-goals-for-optimal-cerebral-perfusion weekly 0.8 https://www.themednet.org/should-pmrt-be-offered-for-ypn0-i-disease-if-only-1-2-nodes-were-removed-in-the-post-chemotherapy-slnb-and-there-is-no-plan-for-a-completion-axlnd weekly 0.8 https://www.themednet.org/does-vitamin-d-supplementation-in-primary-hyperparathyroidism-increase-the-risk-of-kidney-stones weekly 0.8 https://www.themednet.org/would-you-consider-tpo-agonists-for-thrombocytopenia-from-low-risk-mds weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-newly-diagnosed-alk-stage-iiib-non-small-cell-lung-cancer-nsclc weekly 0.8 https://www.themednet.org/how-do-you-decide-between-systemic-antiangiogenic-therapies-for-hht weekly 0.8 https://www.themednet.org/in-patients-with-lupus-nephritis-and-maha-with-positive-anti-phospholipid-autoantibodies-what-are-the-considerations-to-use-or-not-use-anti-coagulation-therapy weekly 0.8 https://www.themednet.org/how-long-do-you-treat-retroperitoneal-fibrosis-with-immunosuppression weekly 0.8 https://www.themednet.org/would-you-evaluate-for-thrombophilia-in-patients-with-incidental-splenic-infarcts-in-the-setting-of-known-cirrhosis-portal-hypertension-and-splenomegaly weekly 0.8 https://www.themednet.org/when-should-metformin-be-stopped-before-surgery-and-when-is-it-considered-safe-to-resume weekly 0.8 https://www.themednet.org/what-is-the-minimum-daily-duration-of-supplemental-oxygen-therapy-you-recommend-to-patients-with-chronic-hypoxic-respiratory-failure weekly 0.8 https://www.themednet.org/what-is-your-approach-to-weaning-dialysis-in-a-patient-with-aki-on-ckd-and-chf-who-now-has-resolved-aki-but-a-history-of-recurrent-episodes-of-decompensated-heart-failure weekly 0.8 https://www.themednet.org/what-is-the-upper-limit-of-blood-glucose-target-in-hyperglycemic-critically-ill-patients weekly 0.8 https://www.themednet.org/how-do-you-recommend-discussing-family-member-genetic-testing-with-a-patient-recently-diagnosed-with-adpkd weekly 0.8 https://www.themednet.org/what-factors-guide-you-in-adjusting-the-dose-of-fludrocortisone-in-a-patient-with-primary-adrenal-insufficiency weekly 0.8 https://www.themednet.org/would-you-still-offer-adjuvant-chemo-at-24-weeks-post-whipple-for-a-pt1c-pn2-cm0-neg-margins-ampullary-adenocarcinoma weekly 0.8 https://www.themednet.org/what-is-your-approach-for-choosing-between-imetelstat-and-luspatercept-in-managing-mds-related-anemia weekly 0.8 https://www.themednet.org/how-do-you-counsel-sickle-cell-patients-on-the-use-of-g-csf-to-treat-neutropenia-from-other-causes-like-malignancy weekly 0.8 https://www.themednet.org/do-you-recommend-starting-pyridoxine-in-a-patient-with-eskd-secondary-to-primary-hyperoxaluria-type-1-who-is-also-on-lumasiran-for-plasma-oxalate-reduction weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-patients-with-locally-advanced-unresectable-mucosal-melanoma-in-the-head-and-neck-region weekly 0.8 https://www.themednet.org/when-will-you-consider-doing-a-biopsy-of-a-potential-metastatic-site-lymph-node-lung-visceral-for-testicular-cancer-after-orchiectomy weekly 0.8 https://www.themednet.org/do-you-recommend-adding-low-dose-aspirin-for-primary-prevention-in-patients-with-type-2-diabetes-on-eliquis-for-another-indication weekly 0.8 https://www.themednet.org/have-you-been-able-to-safely-use-other-bisphosphonates-in-patients-who-developed-an-allergic-reaction-angioedema-to-fosamax weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-nodular-scleritis-in-the-setting-of-suspected-gca weekly 0.8 https://www.themednet.org/how-do-you-contour-your-elective-obturator-lymph-node-volume weekly 0.8 https://www.themednet.org/what-is-your-approach-to-evaluation-and-diagnosis-following-a-non-diagnostic-mslt-in-a-patient-with-suspected-narcolepsy-type-2 weekly 0.8 https://www.themednet.org/how-would-you-treat-an-isolated-recurrence-in-the-pelvic-muscle-after-prior-definitive-chemoradiation-with-brachytherapy-boost-for-vaginal-adenocarcinoma weekly 0.8 https://www.themednet.org/if-a-patient-who-has-previously-been-taking-lamotrigine-stops-taking-it-for-between-two-weeks-and-a-month-do-you-have-to-uptitrate-it-all-over-again-or-do-you-have-another-way-to-resume-it weekly 0.8 https://www.themednet.org/can-dupixent-dupliumab-be-safely-used-in-patients-who-are-taking-other-biologics-for-rheumatic-disease weekly 0.8 https://www.themednet.org/what-is-your-preferred-choice-of-therapy-for-first-line-treatment-of-a-patient-with-good-intermediate-or-poor-risk-stage-iii-nonseminomatous-germ-cell-tumor-if-the-patient-is-truly-cisplatin-ineligible weekly 0.8 https://www.themednet.org/how-do-you-approach-the-bronchoscopic-evaluation-of-a-cavitary-lesion-of-the-lung weekly 0.8 https://www.themednet.org/in-patients-with-diffuse-scleroderma-and-symptomatic-lower-extremity-venous-insufficiency-would-you-recommend-treatment-with-endovenous-laser-ablation weekly 0.8 https://www.themednet.org/in-patients-with-history-of-prior-axillary-surgery-subsequently-with-breast-cancer-recurrence-and-sentinel-lymph-nodes-mapped-to-internal-mammary-area-but-were-not-biopsied-do-you-offer-post-mastectomy-radiation-to-cover-the-imns weekly 0.8 https://www.themednet.org/how-do-you-choose-between-alnd-and-rni-in-the-setting-of-lympha-or-s-lympha-surgery weekly 0.8 https://www.themednet.org/would-you-consider-a-patient-with-dlbcl-to-have-cns-involvement-if-no-brain-lesion-is-seen-on-imaging-csf-flow-cytometry-is-negative-but-pcr-is-positive-for-myd88-and-kmt2d-mutations weekly 0.8 https://www.themednet.org/how-would-you-treat-locally-advanced-melanoma-of-the-scalp-with-several-in-transit-lesions-and-a-metastatic-lesion-to-the-parotid-if-the-patient-is-progressing-on-immunotherapy-such-as-pembrolizumab weekly 0.8 https://www.themednet.org/what-is-the-recommended-frequency-and-duration-of-exercise-sessions-in-order-to-sustain-the-beneficial-effects-of-exercise-on-insulin-sensitivity weekly 0.8 https://www.themednet.org/do-you-recommend-boric-acid-for-patients-with-recurrent-candida-vulvovaginitis weekly 0.8 https://www.themednet.org/how-do-you-manage-perineural-inflammation-when-encountered-on-mohs weekly 0.8 https://www.themednet.org/how-soon-after-starting-treatment-would-you-repeat-imaging-in-patients-with-takayasu-to-monitor-response-and-ensure-you-have-the-correct-diagnosis weekly 0.8 https://www.themednet.org/what-urethral-dose-constraints-would-you-use-off-trial-for-reirradiating-the-prostate-using-sbrt weekly 0.8 https://www.themednet.org/what-is-your-approach-to-evaluating-tardive-dyskinesia-in-nonverbal-patients weekly 0.8 https://www.themednet.org/do-you-avoid-sodium-zirconium-cyclosilicate-use-in-your-patients-with-eskd-and-hyperkalemia-who-also-have-peripheral-edema weekly 0.8 https://www.themednet.org/given-the-negative-results-of-gog-0238-but-the-positive-results-of-the-ruby-trial-how-do-you-manage-isolated-vaginal-cuff-recurrence-of-endometrial-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-symptomatic-superficial-thrombosis-of-the-pelvic-veins-occurring-in-the-immediate-postpartum-period weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-persistent-low-libido-despite-normal-testosterone-levels-after-use-of-exogenous-testosterone-replacement-therapy weekly 0.8 https://www.themednet.org/how-quickly-do-you-expect-iron-stores-to-decrease-after-starting-iron-chelators weekly 0.8 https://www.themednet.org/are-you-comfortable-utilizing-stelara-ustekinumab-as-biologic-treatment-of-psoriasis-for-patients-with-a-history-of-severe-latex-allergy weekly 0.8 https://www.themednet.org/have-you-adopted-the-use-of-low-dose-morphine-for-treatment-of-cough-in-patients-with-ipf weekly 0.8 https://www.themednet.org/what-is-the-best-way-to-manage-low-systolic-blood-pressures-on-clozapine-when-the-patient-has-failed-multiple-other-antipsychotic-trials weekly 0.8 https://www.themednet.org/how-do-you-approach-increasing-urinary-citrate-levels-in-a-patient-with-recurrent-calcium-nephrolithiasis-who-has-hypocitraturia-non-acidic-urine-and-normal-serum-bicarbonate-levels weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-chest-2024 weekly 0.8 https://www.themednet.org/how-do-you-approach-the-work-up-for-a-patient-with-iron-deficiency-anemia-who-is-not-responding-to-oral-iron-therapy weekly 0.8 https://www.themednet.org/should-all-kidney-transplant-patients-be-started-on-statin-therapy-post-operatively-given-their-increased-risk-of-cvd weekly 0.8 https://www.themednet.org/what-is-your-preferred-prophylactic-agent-in-idiopathic-angioedema weekly 0.8 https://www.themednet.org/what-treatment-options-do-you-consider-if-eosinophilia-with-end-organ-dysfunction-persists-with-q8-week-dosing-of-benralizumab-and-you-cant-obtain-approval-for-q4-week-dosing weekly 0.8 https://www.themednet.org/would-you-ever-use-dupilumab-for-atopic-dermatitis-in-a-patient-who-also-has-egpa weekly 0.8 https://www.themednet.org/when-do-you-consider-extending-the-dosing-interval-for-patients-on-biologics-with-crswnp weekly 0.8 https://www.themednet.org/what-patients-with-food-allergies-do-you-screen-for-eoe weekly 0.8 https://www.themednet.org/do-you-perform-a-bone-marrow-biopsy-in-all-patients-with-grade-5-anaphylaxis-to-stinging-insects-and-negative-workup-for-hat-mcas-c-kit weekly 0.8 https://www.themednet.org/is-there-any-role-for-immunosuppressive-immunomodulatory-therapy-used-off-label-for-mast-cell-activation-syndrome-besides-omalizumab weekly 0.8 https://www.themednet.org/do-you-recommend-patients-try-antihistamines-such-as-oral-ketotifen-that-are-not-approved-in-the-us-but-are-approved-in-the-eu-for-mcas-if-currently-available-formulations-have-not-been-effective weekly 0.8 https://www.themednet.org/how-do-you-decide-between-obtaining-routine-outpatient-ett-versus-stress-tte-when-screening-for-cad-especially-given-insurance-company-preference-on-etts weekly 0.8 https://www.themednet.org/with-the-data-from-aall1731-how-is-blinatumomab-being-implemented-for-sr-and-hr-leukemia-patients-not-previously-planned-randomized-to-receive-blinatumomab weekly 0.8 https://www.themednet.org/is-there-a-stroke-volume-threshold-you-use-for-giving-or-not-giving-dapt-for-an-acute-ischemic-stroke weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-crohns-disease-on-a-biologic-and-presents-with-non-bloody-diarrhea-normal-appearing-mucosa-on-sigmoidoscopy-but-severe-colitis-on-biopsy-with-a-positive-cmv-stain weekly 0.8 https://www.themednet.org/what-additional-workup-would-you-recommend-for-a-patient-with-a-liver-abscess-caused-by-fusobacterium-and-aggregatibacter-who-has-had-unrevealing-endoscopies-and-no-other-abdominal-masses-on-a-ct-scan weekly 0.8 https://www.themednet.org/what-is-your-approach-to-differentiating-ra-ild-from-medication-toxicity-i-e-from-methotrexate weekly 0.8 https://www.themednet.org/is-arbovirus-testing-available-in-your-state-outside-the-traditional-summer-season weekly 0.8 https://www.themednet.org/do-you-recommend-patients-with-chronic-kidney-disease-avoid-supplements-containing-creatine weekly 0.8 https://www.themednet.org/do-you-routinely-perform-de-fatting-for-full-thickness-skin-grafts weekly 0.8 https://www.themednet.org/how-do-you-incorporate-absolute-percent-pattern-4-app4-into-your-risk-stratification-specifically-your-recommendation-for-adt-for-intermediate-prostate-cancer weekly 0.8 https://www.themednet.org/is-there-a-role-for-using-continuous-glucose-monitors-for-perioperative-glucose-monitoring-in-patients-with-diabetes weekly 0.8 https://www.themednet.org/would-you-recommend-muscle-or-nerve-biopsy-in-a-patient-with-amyoplasia-congenita weekly 0.8 https://www.themednet.org/what-is-the-clinical-significance-of-positive-anti-thyroid-antibodies-in-a-patient-that-is-post-thyroidectomy weekly 0.8 https://www.themednet.org/how-do-you-transition-from-levetiracetam-to-brivaracetam-particularly-at-doses-of-1500-mg-bid-or-higher weekly 0.8 https://www.themednet.org/what-antidepressants-are-recommended-for-management-of-depression-or-anxiety-in-patients-with-spinal-cord-injuries weekly 0.8 https://www.themednet.org/if-you-have-a-patient-with-eoe-on-dupixent-300-mg-weekly-and-they-have-severe-tree-nut-allergies-would-it-be-safe-to-add-xolair-for-severe-food-allergy weekly 0.8 https://www.themednet.org/how-often-do-you-find-a-food-allergy-on-a-skin-test-in-an-eoe-patient-that-when-avoided-will-result-in-significant-resolution-of-eoe weekly 0.8 https://www.themednet.org/now-that-the-interlace-trial-is-published-do-you-plan-to-do-induction-chemotherapy-prior-to-chemort-or-chemort-with-immunotherapy-per-keynote-a18-for-locally-advanced-cervical-cancer weekly 0.8 https://www.themednet.org/are-there-certain-patient-characteristics-that-drive-you-to-recommend-intralesional-5-fu-or-mtx-for-a-large-scc-on-the-back weekly 0.8 https://www.themednet.org/do-you-routinely-use-single-use-duodenoscopes-for-ercps-in-patients-with-a-history-of-infections-secondary-to-mdr-organisms weekly 0.8 https://www.themednet.org/do-you-feel-there-is-any-difference-between-performing-an-ercp-with-an-edge-together-in-a-single-session-or-separately-in-two-sessions-in-a-patient-with-roux-en-y-anatomy weekly 0.8 https://www.themednet.org/do-you-discharge-patients-on-preventative-therapies-like-octreotide-or-bevacizumab-after-a-patients-first-admission-for-symptomatic-anemia-secondary-to-bleeding-from-a-small-bowel-avm-that-was-treated-with-apc weekly 0.8 https://www.themednet.org/how-do-you-practically-approach-a-tailored-elimination-diet-in-young-patients-with-numerous-food-impactions-and-esophageal-strictures-who-are-intermittently-compliant-with-ppi-or-topical-steroids weekly 0.8 https://www.themednet.org/how-would-you-manage-an-elderly-patient-with-type-3-achalasia-who-previously-underwent-poem-and-has-recurrent-dysphagia-high-eckardt-score-and-dilated-esophagus-concerning-for-blown-out-myotomy-on-esophagram weekly 0.8 https://www.themednet.org/how-often-would-you-perform-an-upper-endoscopy-on-an-individual-with-chronic-gastritis-and-previously-eradicated-h-pylori-with-respect-to-risk-of-gastric-malignancy weekly 0.8 https://www.themednet.org/how-do-you-choose-between-resmetirom-and-semaglutide-in-the-treatment-of-mash weekly 0.8 https://www.themednet.org/which-patients-with-cirrhosis-and-portal-hypertension-are-ideal-candidates-to-undergo-tips-to-reduce-perioperative-risk-in-anticipation-of-an-elective-surgery weekly 0.8 https://www.themednet.org/when-and-how-should-we-use-biomarkers-i-e-crp-stool-calprotectin-mab-levels-to-guide-or-optimize-medical-management-of-crohns-disease-or-ulcerative-colitis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-choosing-a-particular-advanced-therapy-based-on-patient-or-disease-factors-when-initiating-treatment-for-moderate-severe-ibd weekly 0.8 https://www.themednet.org/how-do-you-approach-mild-prolactin-elevations-20-80-in-women-with-galactorrhea-on-nipple-stimulation-but-regular-menses-and-no-plans-for-pregnancy weekly 0.8 https://www.themednet.org/how-do-you-treat-a-patient-with-shared-delusional-disorder-aka-folie-a-deux weekly 0.8 https://www.themednet.org/with-regard-to-cat-immunotherapy-if-testing-is-positive-for-cat-pelt-and-cat-hair-do-you-include-include-50-pelt-and-50-hair-if-doing-immunotherapy weekly 0.8 https://www.themednet.org/what-do-you-use-for-treatment-refractory-anxiety-where-trials-of-antidepressants-have-not-worked-either-from-ability-to-tolerate-or-inadequate-effect weekly 0.8 https://www.themednet.org/how-do-you-engage-and-approach-a-patient-presenting-with-psychotic-symptoms-who-has-demonstrated-a-pattern-of-malingering-and-also-has-polysubstance-use-disorder weekly 0.8 https://www.themednet.org/during-treatment-of-severe-osteoporosis-with-pth-analogs-abaloparatide-would-a-rise-in-alkaline-phosphatase-level-200-in-the-setting-of-normal-ggt-warrant-discontinuation-of-medication weekly 0.8 https://www.themednet.org/how-do-you-treat-withdrawal-symptoms-from-kratom-addiction weekly 0.8 https://www.themednet.org/what-strategies-do-you-use-to-prevent-overcorrection-of-serum-sodium-in-patients-with-severe-hyponatremia-and-adrenal-insufficiency-when-initiating-glucocorticoid-therapy weekly 0.8 https://www.themednet.org/is-there-a-maximum-dose-of-potassium-citrate-you-would-use-for-patients-with-recurrent-calcium-oxalate-nephrolithiasis-and-hypocitraturia weekly 0.8 https://www.themednet.org/what-activity-restrictions-do-you-counsel-patients-on-after-radiosurgery-for-arteriovenous-malformations-given-the-continued-risk-of-hemorrhage-until-nidus-obliteration weekly 0.8 https://www.themednet.org/for-mild-to-moderate-hemophilia-b-do-you-routinely-screen-for-inhibitors weekly 0.8 https://www.themednet.org/does-oral-semaglutide-provide-similar-cardiovascular-risk-reduction-benefits-as-injectable-semaglutide weekly 0.8 https://www.themednet.org/for-von-willebrand-type-2b-do-you-expect-a-decline-in-platelet-count-over-time-as-vwf-increases-with-age weekly 0.8 https://www.themednet.org/do-you-consider-the-use-of-tocilizumab-in-patients-with-covid-pneumonia-who-have-had-an-improvement-in-supplemental-o2-requirements-but-have-significantly-elevated-inflammatory-markers-after-day-two-of-remdesivir-and-dexamethasone weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-child-with-toe-walking-with-a-reassuring-exam-but-a-family-history-of-difficulty-walking weekly 0.8 https://www.themednet.org/what-workup-do-you-consider-for-a-developmentally-typical-child-with-multiple-large-cafe-au-lait-macules-but-no-other-signs-of-neurofibromatosis weekly 0.8 https://www.themednet.org/do-you-recommend-early-oral-nutrition-when-managing-diabetic-ketoacidosis weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-elevated-thyroglobulin-peroxidase-antibody-levels-diffuse-thyroiditis-features-on-ultrasound-non-specific-symptoms-of-fatigue-but-normal-biochemical-thyroid-function-labs weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-irradiation-for-brain-metastases-with-active-or-recent-bleeding weekly 0.8 https://www.themednet.org/does-tpa-or-tnk-cause-acute-post-infusion-severe-headache-with-no-intracranial-bleed weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-id-week-2024 weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-gyn-cancers-from-esmo-2024 weekly 0.8 https://www.themednet.org/do-you-recommend-checking-a-serum-phosphorus-level-in-patients-with-recurrent-nephrolithiasis weekly 0.8 https://www.themednet.org/how-do-you-approach-management-for-patients-with-hiv-on-art-with-persistent-low-level-viremia-but-no-new-resistance-mutations-identified weekly 0.8 https://www.themednet.org/would-you-recommend-imaging-of-the-brain-and-lungs-to-investigate-potential-disseminated-disease-in-a-recent-heart-transplant-patient-with-a-skin-nodule-that-grew-rhizopus weekly 0.8 https://www.themednet.org/how-do-you-factor-cerebrospinal-fluid-csf-antibody-results-when-deciding-on-the-diagnosis-and-treatment-of-racemose-neurocysticercosis-given-the-uncertainties-associated-with-csf-antibody-testing weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-thoracic-cancers-from-astro-2024 weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-head-neck-cancers-from-astro-2024 weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-in-neuro-oncology-from-astro-2024 weekly 0.8 https://www.themednet.org/how-often-do-you-assess-for-frailty-in-your-clinical-practice-for-patients-with-multiple-myeloma-and-what-tool-do-you-use weekly 0.8 https://www.themednet.org/how-do-you-determine-the-optimal-time-to-restart-a-diuretic-in-a-patient-with-cirrhosis-ascites-and-lower-extremity-edema-who-presented-with-acute-kidney-injury-that-resolved-with-iv-albumin-and-holding-diuretics weekly 0.8 https://www.themednet.org/what-is-your-hemoglobin-target-for-prbc-transfusion-in-cases-of-acute-brain-injury weekly 0.8 https://www.themednet.org/when-would-you-refer-patients-with-parsonage-turner-syndrome-for-surgical-treatment weekly 0.8 https://www.themednet.org/would-you-add-olaparib-to-maintenance-immunotherapy-for-a-patient-with-recurrent-mmr-proficient-her2-negative-serous-endometrial-carcinoma weekly 0.8 https://www.themednet.org/is-elevated-bone-specific-alkaline-phosphatase-an-absolute-contraindication-to-teriparatide weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-microscopic-colitis weekly 0.8 https://www.themednet.org/what-are-the-best-initial-treatments-for-unprescribed-stimulant-use-in-patients-who-are-using-stimulants-periodically-to-improve-occupational-or-academic-functioning weekly 0.8 https://www.themednet.org/how-do-you-address-manage-the-recreational-use-of-dextromethorphan-sometimes-called-robo-tripping-that-has-risen-to-the-level-of-use-disorder weekly 0.8 https://www.themednet.org/how-do-you-manage-persistent-rectal-bleeding-in-the-setting-of-rectal-adenocarcinoma-in-a-treatment-naive-patient weekly 0.8 https://www.themednet.org/has-anyone-incidentally-diagnosed-iga-deficiency-in-a-patient-who-does-not-present-with-any-recurrent-infections weekly 0.8 https://www.themednet.org/is-there-a-serum-potassium-level-for-when-you-would-recommend-discontinuing-potassium-citrate-in-a-patient-with-recurrent-nephrolithiasis-hypocitraturia-and-hyperkalemia weekly 0.8 https://www.themednet.org/would-you-consider-treating-a-patient-with-prostate-cancer-and-biopsy-proven-involved-inguinal-nodes-with-radiation-to-the-prostate-pelvis-groin weekly 0.8 https://www.themednet.org/in-addition-to-supportive-transfusions-do-you-consider-other-interventions-for-symptomatic-anemia-and-thrombocytopenia-associated-with-chronic-neutrophilic-leukemia weekly 0.8 https://www.themednet.org/do-you-recommend-ct-or-ultrasound-imaging-testing-when-monitoring-a-patient-with-nephrocalcinosis weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-asn-2024 weekly 0.8 https://www.themednet.org/what-workup-is-sufficient-to-determine-if-an-aortic-aneurysm-is-mycotic-infectious-or-not-in-that-you-would-not-prescribe-empiric-antibiotic-therapy weekly 0.8 https://www.themednet.org/is-there-utility-to-ordering-biochemical-screening-labs-for-global-developmental-delay weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-mild-congenital-myopathy-about-exercise-limitations weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-lgi-1-encephalitis-with-faciobracial-dystonic-seizures-who-has-not-improved-with-3-days-of-intravenous-steroids weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-peritoneal-dialysis-regarding-the-safety-of-engaging-in-aerobic-and-resistance-exercises-considering-the-risk-of-developing-abdominal-wall-complications weekly 0.8 https://www.themednet.org/would-you-favor-giving-mirvetuximab-before-paclitaxel-bevacizumab weekly 0.8 https://www.themednet.org/what-therapy-would-you-consider-for-refractory-pediatric-hr-aml-with-kmt2ar-to-try-to-induce-remission-for-transplant weekly 0.8 https://www.themednet.org/is-there-a-role-for-crs-prophylaxis-with-tocilizumab-during-bispecific-t-cell-engager-initiation-for-myeloma weekly 0.8 https://www.themednet.org/do-you-recommend-up-titrating-the-metformin-dose-of-patients-with-t2dm-who-are-at-goal-a1c-in-order-to-decrease-their-risk-of-diabetes-related-delirium weekly 0.8 https://www.themednet.org/are-there-instances-when-you-dose-sodium-zirconium-cyclosilicate-more-than-once-daily-for-long-term-therapy-for-patients-with-end-stage-kidney-disease-and-hyperkalemia weekly 0.8 https://www.themednet.org/how-do-you-manage-clozapine-related-sedation-for-patients-who-have-treatment-resistant-schizophrenia-and-otherwise-had-good-response-to-clozapine weekly 0.8 https://www.themednet.org/what-genetic-testing-would-you-consider-for-recurrent-arterial-events-cryptogenic-strokes-mi-in-patients-with-limited-risk-factors weekly 0.8 https://www.themednet.org/what-is-your-approach-when-cryptococcus-serum-or-csf-antigen-titers-do-not-change-despite-treatment-in-hiv-positive-patients-with-cryptococcal-meningitis-or-invasive-disease-but-there-is-clinical-improvement-and-cultures-remain-negative weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-patients-with-suspected-membranous-lupus-nephritis-who-are-found-to-have-positive-pla2r-antibodies weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-osimertinib-for-nsclc-with-an-egfr-e746-s752delinsv-exon-19-mutation weekly 0.8 https://www.themednet.org/can-anti-cardiolipin-or-anti-beta-2-glycoprotein-antibodies-cause-prolonged-ptt-in-the-absence-of-a-lupus-anticoagulant weekly 0.8 https://www.themednet.org/what-are-some-important-considerations-for-use-of-ace-inhibition-in-scleroderma-renal-crisis-patients-who-require-dialysis weekly 0.8 https://www.themednet.org/does-your-choice-of-dose-and-fractionation-for-bone-metastasis-depend-on-the-location-of-the-metastasis-in-question weekly 0.8 https://www.themednet.org/what-further-evaluation-do-you-pursue-for-patients-who-present-with-vague-symptoms-such-as-subjective-fevers-or-intermittent-night-sweats-who-have-no-pulmonary-symptoms-but-have-a-positive-igra weekly 0.8 https://www.themednet.org/would-you-recommend-mri-post-surgery-and-pre-irradiation-for-patients-with-extensive-dcis-and-close-margins-and-how-would-it-impact-your-management weekly 0.8 https://www.themednet.org/what-is-your-approach-to-evaluation-and-management-of-gerd-in-a-patient-with-ipf weekly 0.8 https://www.themednet.org/do-you-recommend-checking-both-tsi-and-tbii-antibodies-for-graves-disease-diagnosis-and-monitoring weekly 0.8 https://www.themednet.org/how-often-should-tsh-levels-be-monitored-in-patients-with-a-history-of-graves-disease-who-are-in-remission-with-negative-tsi-tbii-antibodies-and-off-medical-therapy weekly 0.8 https://www.themednet.org/how-does-the-management-of-pole-mutated-colorectal-cancer-differ-from-that-of-dmmr-msi-high-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-patients-with-recurrent-calcium-oxalate-nephrolithiasis-since-childhood-who-are-found-to-be-gene-carriers-for-mutations-in-genes-associated-with-primary-hyperoxaluria weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-takayasu-arteritis-controlled-on-tnfi-who-develops-erythema-nodosum-that-is-only-partially-responsive-to-nsaids weekly 0.8 https://www.themednet.org/would-you-recommend-desmopressin-for-a-patient-with-eskd-receiving-thrice-weekly-hemodialysis-who-is-hospitalized-for-a-persistent-gastrointestinal-bleed-not-amenable-to-usual-interventional-treatment-strategies weekly 0.8 https://www.themednet.org/what-do-you-recommend-to-reduce-treat-skin-reactions-for-those-taking-anti-cgrp-monoclonal-antibodies-to-treat-migraine weekly 0.8 https://www.themednet.org/would-you-recommend-pmrt-to-a-clinically-node-positive-biopsy-proven-axillary-node-and-indeterminate-single-imn-node-brca-positive-patient-with-multiple-medical-co-morbidities-including-scleroderma-and-ild-who-is-treated-with-neoadjuvant-chemotherapy-nac- weekly 0.8 https://www.themednet.org/what-treatment-options-would-you-consider-for-a-young-patient-with-limited-mobility-low-bone-mass-and-multiple-vertebral-compression-fractures-who-is-on-dialysis-for-advanced-kidney-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-management-for-ccus-with-severe-cytopenias weekly 0.8 https://www.themednet.org/would-you-recommend-administering-iv-amino-acids-prior-to-cardiac-surgery-with-cardiopulmonary-bypass-given-recent-trial-findings-of-improved-aki-rates-but-no-significant-difference-in-kidney-replacement-therapy-with-iv-amino-acids weekly 0.8 https://www.themednet.org/how-do-you-manage-a-3-cm-solitary-pulmonary-cryptococcoma-in-an-asymptomatic-immunocompetent-hiv-negative-host weekly 0.8 https://www.themednet.org/do-oral-contraceptives-lower-bone-mineral-density-in-women-with-hypothalamic-amenorrhea-by-lowering-igf-1 weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-hyperkalemia-in-pregnant-patients-with-chronic-kidney-disease weekly 0.8 https://www.themednet.org/does-the-presence-of-diastolic-dysfunction-guide-subsequent-pharmacological-pacing-and-ablative-therapies-for-atrial-fibrillation weekly 0.8 https://www.themednet.org/do-you-typically-include-exercise-restrictions-and-or-alcohol-intake-restrictions-in-routine-counseling-for-patients-with-atrial-fibrillation weekly 0.8 https://www.themednet.org/what-are-your-preferred-methods-for-qtc-calculation-for-normal-tachycardic-and-bradycardic-heart-rates weekly 0.8 https://www.themednet.org/what-is-the-role-of-consolidative-durvalumab-and-prophylactic-cranial-irradiation-in-patients-with-stage-i-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/what-is-the-clinical-significance-of-a-low-titer-rnp-negative-sm-but-sm-rnp-that-is-very-high-titer weekly 0.8 https://www.themednet.org/is-there-any-difference-in-the-cardiovascular-risk-reduction-profile-of-brand-name-vascepa-versus-generic-icosapent-ethyl-for-patients-with-hypertriglyceridemia weekly 0.8 https://www.themednet.org/do-patients-with-central-adrenal-insufficiency-on-maintenance-hydrocortisone-therapy-require-doubling-of-their-corticosteroid-during-chemotherapy-cycles weekly 0.8 https://www.themednet.org/would-you-recommend-slnbx-in-a-patient-with-moderately-differentiated-scc-on-the-scalp weekly 0.8 https://www.themednet.org/how-do-you-weigh-the-risks-of-intraocular-eye-shields-when-performing-co2-laser-to-the-eyelids-and-periocular-area weekly 0.8 https://www.themednet.org/would-you-recommend-continuing-accutane-in-a-teenage-female-who-has-experienced-a-drop-in-calcium-to-8-8-and-reductions-in-albumin-and-protein-levels-one-month-into-therapy weekly 0.8 https://www.themednet.org/are-thyroid-molecular-tests-such-as-afirma-thyroseq-validated-for-use-on-fna-thyroid-nodule-samples-that-are-not-bethesda-class-3-4 weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-who-is-unable-to-undergo-the-recommended-ophthalmologic-examinations-during-treatment-with-mirvetuximab-soravtansine weekly 0.8 https://www.themednet.org/after-corticosteroids-what-second-line-agent-do-you-select-to-treat-drug-induced-hypersensitivity-syndrome-also-known-as-dress-syndrome weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-low-risk-mds-who-achieves-transfusion-independence-with-luspatercept-but-continues-to-have-fatigue weekly 0.8 https://www.themednet.org/how-do-you-identify-patients-with-false-positive-achr-antibodies weekly 0.8 https://www.themednet.org/when-is-the-best-time-to-try-targeted-therapy-in-adult-type-diffuse-non-idh-glioma weekly 0.8 https://www.themednet.org/would-you-avoid-sglt2-inhibitors-in-patients-with-nephrostomy-tubes weekly 0.8 https://www.themednet.org/when-and-how-should-we-be-stopping-glp-1-receptor-agonist-dual-agonist-therapy weekly 0.8 https://www.themednet.org/in-es-sclc-presenting-with-extensive-brain-metastases-how-do-you-time-whole-brain-radiation-after-the-first-cycle-of-chemotherapy-has-already-been-delivered weekly 0.8 https://www.themednet.org/how-do-you-manage-critically-ill-poor-risk-mixed-germ-cell-tumor-patients-presenting-de-novo-with-extensive-lung-metastases-and-severe-respiratory-failure weekly 0.8 https://www.themednet.org/how-would-one-approach-treating-a-patient-with-primary-immunodeficiency-on-ivig-treatment-who-develops-myasthenia-gravis weekly 0.8 https://www.themednet.org/do-you-find-ivig-to-be-an-effective-maintenance-therapy-for-myasthenia-gravis weekly 0.8 https://www.themednet.org/when-can-you-get-a-false-negative-result-from-rt-quic-testing weekly 0.8 https://www.themednet.org/do-you-hold-or-dose-modify-chemotherapy-with-bep-or-ep-for-severe-cytopenia-or-renal-injury-when-treating-testicular-cancer-in-the-curative-setting weekly 0.8 https://www.themednet.org/how-do-you-treat-idiopathic-acute-anterior-uveitis-that-recurs-immediately-after-a-course-of-topical-corticosteroids weekly 0.8 https://www.themednet.org/when-performing-a-closure-with-deeps-then-applying-dermabond-or-glue-do-you-bill-for-a-simple-or-intermediate-closure weekly 0.8 https://www.themednet.org/how-frequently-do-you-monitor-for-hypocalcemia-in-patients-on-romosozumab weekly 0.8 https://www.themednet.org/how-often-do-you-check-renal-function-panels-for-patients-with-recurrent-nephrolithiasis weekly 0.8 https://www.themednet.org/how-soon-would-you-repeat-pet-ct-in-a-patient-with-cardiac-sarcoid-after-starting-treatment-with-infliximab weekly 0.8 https://www.themednet.org/what-has-been-your-stepwise-approach-to-oxygenation-including-when-to-consider-the-use-of-inhaled-nitric-oxide-or-epoprostenol-in-refractory-hypoxemia-due-to-cardiogenic-pulmonary-edema-in-patients-who-are-otherwise-not-ecmo-candidates weekly 0.8 https://www.themednet.org/how-long-do-you-wait-before-starting-a-non-selective-beta-blocker-in-patients-with-newly-reduced-lvef-and-recent-cocaine-use weekly 0.8 https://www.themednet.org/what-is-your-approach-to-biologic-selection-in-a-patient-with-resistant-persistent-abpa weekly 0.8 https://www.themednet.org/how-would-you-manage-distal-dvt-in-first-trimester-of-pregnancy weekly 0.8 https://www.themednet.org/when-would-you-repeat-a-kidney-ultrasound-with-post-void-residual-measurement-for-a-patient-with-chronic-kidney-disease-from-bladder-outlet-obstruction-who-is-started-on-tamsulosin weekly 0.8 https://www.themednet.org/what-is-your-recommended-dosing-regimen-for-propranolol-in-treating-an-infantile-hemangioma-after-the-proliferative-phase weekly 0.8 https://www.themednet.org/do-you-counsel-patients-to-acutely-treat-migraine-with-aura-at-the-onset-of-aura-or-headache weekly 0.8 https://www.themednet.org/how-would-you-treat-an-asymptomatic-patient-with-a-positive-blastomyces-antibody-evidence-of-prior-granulomatous-lung-disease-on-imaging-and-who-may-require-immunosuppression-in-the-future weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-a-patient-with-mast-cell-leukemia weekly 0.8 https://www.themednet.org/with-the-rise-in-home-monitoring-devices-how-should-we-approach-asymptomatic-nsvt-detected-in-healthy-individuals-with-no-prior-cardiac-history-and-with-low-risk-cardiac-profile weekly 0.8 https://www.themednet.org/in-a-pregnant-patient-with-scarring-alopecia-lpp-or-ccca-what-treatment-options-are-available weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-vasospasm-after-avm-rupture weekly 0.8 https://www.themednet.org/given-the-patriot-trial-and-hypo-flame-2-0-do-you-consider-once-a-week-prostate-sbrt-instead-of-every-other-day weekly 0.8 https://www.themednet.org/what-is-the-duration-of-steroids-that-you-prescribe-for-organizing-pneumonia weekly 0.8 https://www.themednet.org/do-you-use-different-dose-constraints-for-large-bowel-vs-small-bowel weekly 0.8 https://www.themednet.org/given-the-different-rates-of-testosterone-recovery-do-you-alter-the-duration-of-adt-when-using-leuprorelin-gnrh-agonist-vs-relugolix-gnrh-antagonist-in-patients-with-intermediate-or-high-risk-prostate-cancer-who-received-definitive-radiation weekly 0.8 https://www.themednet.org/how-do-you-determine-which-patients-with-anca-associated-vasculitis-may-be-good-candidates-for-reduced-dose-glucocorticoid-tapering weekly 0.8 https://www.themednet.org/what-is-your-approach-to-screening-patients-with-sjia-for-associated-lung-disease weekly 0.8 https://www.themednet.org/what-is-the-optimal-anti-platelet-anticoagulant-strategy-and-duration-following-a-left-atrial-appendage-occlusion-with-a-watchmen-device-and-is-a-cta-good-enough-to-assess-if-the-device-is-well-seated-and-without-any-peri-device-leaks weekly 0.8 https://www.themednet.org/what-approach-to-antipsychotics-do-you-take-with-patients-with-primary-thought-disorder-who-are-now-geriatric weekly 0.8 https://www.themednet.org/what-or-where-is-the-best-reference-guide-for-managing-patients-with-bipolar-disorder-who-are-on-meds-and-want-to-become-pregnant weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-aha-2024 weekly 0.8 https://www.themednet.org/how-do-you-decide-among-ai-full-dose-tamoxifen-and-low-dose-tamoxifen-in-a-postmenopausal-woman-with-dcis-without-contraindications-to-either-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-the-medical-evaluation-of-new-onset-psychosis-in-elderly-patients weekly 0.8 https://www.themednet.org/what-parameters-do-you-follow-to-avoid-rebound-effects-when-using-clonidine-only-for-nightly-or-daily-as-needed-indications weekly 0.8 https://www.themednet.org/how-do-you-manage-nausea-side-effects-in-patients-on-cariprazine weekly 0.8 https://www.themednet.org/how-do-you-differentiate-between-hyperactive-delirium-and-excited-catatonia weekly 0.8 https://www.themednet.org/what-is-your-treatment-algorithm-for-managing-scalp-vitiligo weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-in-a-patient-with-refractory-coccidioidal-meningitis-who-has-previously-been-treated-with-iv-amphotericin-b weekly 0.8 https://www.themednet.org/what-are-some-tte-findings-that-suggest-worsening-function-of-a-bioprosthetic-avr-that-would-require-further-surveillance-or-diagnostic-imaging weekly 0.8 https://www.themednet.org/is-there-any-evidence-for-combining-surgery-and-xrt-adt-for-treatment-of-localized-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/what-are-the-realistic-modern-10-year-survival-curves-for-localized-prostate-cancer-given-the-improvements-we-have-made-in-diagnostics-and-treatment weekly 0.8 https://www.themednet.org/would-you-consider-chemo-rt-for-duodenal-adenocarcinoma-s-p-resection-with-at-least-1-cm-positive-margin-in-a-patient-with-a-history-of-crohns-disease weekly 0.8 https://www.themednet.org/what-is-the-best-way-to-proceed-in-anal-cancer-surveillance-if-pet-avidity-of-the-primary-is-reduced-but-still-avid-at-time-point-6-months-s-p-chemo-rt weekly 0.8 https://www.themednet.org/what-medications-are-safe-to-use-to-treat-major-depression-and-or-anxiety-in-a-patient-with-closed-angle-glaucoma weekly 0.8 https://www.themednet.org/how-do-you-use-total-igg-levels-if-at-all-to-guide-plasma-exchange-for-myasthenia-gravis-exacerbations weekly 0.8 https://www.themednet.org/how-do-you-approach-severe-anemia-and-thrombocytopenia-in-an-elderly-patient-whose-bone-marrow-biopsy-shows-hypercellular-marrow-with-mild-dysplasia-in-erythroid-and-megakaryocytic-lineage-but-normal-cytogenetics-and-a-negative-ngs-panel weekly 0.8 https://www.themednet.org/for-a-patient-with-a-rising-psa-after-prostatectomy-with-seminal-vesicles-being-negative-for-disease-at-surgery-do-you-ever-treat-the-prostate-bed-and-seminal-vesicle-bed-with-different-doses-in-an-sib-plan weekly 0.8 https://www.themednet.org/how-do-you-interpret-csf-pleocytosis-in-the-context-of-significant-leukocytosis-on-cbc weekly 0.8 https://www.themednet.org/what-is-the-likelihood-of-recovery-of-parathyroid-gland-function-for-patients-who-underwent-total-thyroidectomy-found-to-have-embedded-parathyroid-glands-intra-operatively-and-then-subsequently-had-them-re-implanted-into-neck-muscle weekly 0.8 https://www.themednet.org/is-there-a-role-for-use-of-glp1-r-agonist-or-dual-agonist-therapy-for-management-of-post-bariatric-hypoglycemia-and-dumping-syndrome weekly 0.8 https://www.themednet.org/what-is-your-approach-to-liver-transplantation-candidacy-in-those-with-decompensated-cirrhosis-who-have-been-treated-for-a-solid-organ-malignancy-such-as-oral-scc weekly 0.8 https://www.themednet.org/what-is-your-advice-to-patients-with-ibd-who-are-on-biologic-therapies-and-planning-for-pregnancy-1 weekly 0.8 https://www.themednet.org/do-you-recommend-adjuvant-rt-to-patients-with-non-atm-genetic-mutations-e-g-brca-nf-who-elect-to-have-lumpectomy-and-are-otherwise-prime-ii-calgb-candidates-for-rt-omission-i-e-low-risk-disease-characteristics-strongly-er-1cm-grade-1-2-no-lvi-widely-negat weekly 0.8 https://www.themednet.org/how-would-you-manage-lpl-with-associated-al-amyloidosis weekly 0.8 https://www.themednet.org/do-you-recommend-genetic-screening-for-fmf-in-asymptomatic-first-degree-relatives-with-a-strong-family-history-multiple-family-members-severe-refractory-disease weekly 0.8 https://www.themednet.org/is-it-possible-to-use-radiation-to-treat-mortons-neuroma-in-a-patient-who-continues-to-have-symptoms-after-steroid-injections-and-alcohol-ablation weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-who-exhibits-classic-bipolar-symptomatology-including-cycling-sleep-changes-behavioral-changes-and-mood-changes-but-has-never-responded-to-any-form-of-adequate-trials-of-mood-stabilizer-treatment weekly 0.8 https://www.themednet.org/can-xolair-omalizumab-be-safely-used-in-combination-with-biologics-for-patients-with-rheumatic-disease weekly 0.8 https://www.themednet.org/how-would-you-manage-superficial-vein-thrombosis-that-persists-on-imaging-after-treatment-with-full-dose-anticoagulation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-determining-the-safety-appropriateness-and-timing-of-spect-or-pet-mpi-in-patients-admitted-with-nstemi-and-who-remain-chest-pain-free-and-hemodynamically-stable weekly 0.8 https://www.themednet.org/for-metastatic-cholangiocarcinoma-that-has-progressed-on-first-line-chemotherapy-and-immunotherapy-that-is-her2-3-which-her2-regimen-is-preferred-tdxd-zanidatamab-or-tucatinib-trastuzumab weekly 0.8 https://www.themednet.org/how-do-you-manage-rem-sleep-disorder-in-geriatric-patients-with-dementia-associated-with-periods-of-catatonia weekly 0.8 https://www.themednet.org/would-you-prefer-sbrt-or-fractionated-radiation-for-a-sacral-peripheral-nerve-sheath-tumor weekly 0.8 https://www.themednet.org/would-elevated-bone-mineral-density-t-score-be-enough-to-make-a-diagnosis-of-osteopetrosis weekly 0.8 https://www.themednet.org/do-you-pursue-a-cardiac-evaluation-in-all-patients-with-an-excised-cutaneous-myxoma weekly 0.8 https://www.themednet.org/what-treatment-would-you-offer-a-patient-with-extensive-lymphangioma-circumscriptum-intermittently-covering-the-entire-abdomen weekly 0.8 https://www.themednet.org/have-you-seen-cd30-lymphoproliferative-skin-lesions-with-upadacitinib-treatment-of-atopic-dermatitis weekly 0.8 https://www.themednet.org/what-are-your-practice-recommendations-regarding-live-vaccinations-in-infants-children-of-women-who-are-currently-on-dmards-and-are-breastfeeding weekly 0.8 https://www.themednet.org/what-duration-of-therapy-do-you-recommend-for-patients-with-a-vascular-graft-infection-in-which-the-graft-has-been-removed-and-another-graft-placed-in-the-infected-space weekly 0.8 https://www.themednet.org/for-how-long-would-you-treat-a-patient-with-dematiaceous-fungi-growing-on-a-native-heart-valve-discovered-at-the-time-of-valve-replacement weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-for-patients-with-renal-limited-anca-vasculitis-who-have-persistent-proteinuria-hematuria-and-anca-titers-and-have-completed-a-steroid-taper-and-received-three-doses-of-rituximab weekly 0.8 https://www.themednet.org/what-normal-tissue-dose-constraints-do-you-use-when-delivering-up-to-3-cycles-of-the-palliative-quad-shot-regimen-for-gynecologic-pelvic-malignancies weekly 0.8 https://www.themednet.org/does-radiation-therapy-ex-to-the-breast-in-patients-with-cdk4-mutations-increase-the-risk-of-developing-melanoma weekly 0.8 https://www.themednet.org/what-factors-drive-you-to-prioritize-treatments-that-inhibit-t-cells-vs-b-cell-depletion-when-choosing-therapies-for-patients-with-refractory-sle weekly 0.8 https://www.themednet.org/would-you-dose-escalate-neoadjuvant-radiotherapy-for-t3-and-or-n-rectal-cancer-in-patients-who-are-unwilling-or-unable-to-get-chemotherapy weekly 0.8 https://www.themednet.org/is-there-a-role-for-doac-use-for-patients-with-unprovoked-pe-that-have-had-recent-sleeve-gastrectomy-with-duodenal-bypass weekly 0.8 https://www.themednet.org/is-tall-cell-variant-papillary-thyroid-cancer-automatically-categorized-as-intermediate-risk-regardless-of-other-histopathological-features-and-should-consequently-be-treated-with-rai weekly 0.8 https://www.themednet.org/when-do-you-recommend-preoperative-chemotherapy-or-hormonal-therapy-for-er-breast-cancer weekly 0.8 https://www.themednet.org/what-24-hr-urine-calcium-cut-off-value-do-you-use-for-recommending-parathyroidectomy-in-patients-with-asymptomatic-hyperparathyroidism weekly 0.8 https://www.themednet.org/how-do-you-distinguish-between-episodes-of-vascular-steal-and-seizures-in-patients-with-an-avm weekly 0.8 https://www.themednet.org/what-is-your-approach-to-diagnosis-and-treatment-to-intermittent-cheilitis-that-does-not-respond-to-anti-fungal-therapy weekly 0.8 https://www.themednet.org/should-we-be-more-cautious-with-the-use-of-glp-1-r-agonist-therapy-in-patients-with-type-1-diabetes-mellitus-and-obesity-given-the-increased-risk-of-cardiovascular-disease-with-high-body-weight-variability weekly 0.8 https://www.themednet.org/is-there-any-role-for-ivig-or-steroids-in-viral-myositis-complicated-by-severe-rhabdomyolysis-diffuse-compartment-syndrome-dic-and-aki weekly 0.8 https://www.themednet.org/what-is-your-current-practice-for-de-escalation-of-frequency-of-administration-of-bispecific-antibodies-among-responders-in-patients-with-relapsed-refractory-multiple-myeloma weekly 0.8 https://www.themednet.org/what-are-the-treatment-options-for-patients-with-duodenal-cancer-who-have-progressed-on-folfirinox weekly 0.8 https://www.themednet.org/would-you-increase-or-maintain-the-same-initial-dose-of-methimazole-for-treatment-of-hyperthyroidism-if-symptoms-and-thyroid-tests-improve-but-are-not-normalized weekly 0.8 https://www.themednet.org/how-do-you-manage-and-adjust-parkinsons-medication-if-a-patient-has-worsening-orthostatic-hypotension-while-being-treated-with-carbidopa-levodopa weekly 0.8 https://www.themednet.org/is-there-any-difference-between-colchicine-0-5mg-vs-0-6-mg-for-high-risk-coronary-artery-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-recurrent-episcleritis-in-a-patient-with-ra-that-is-otherwise-well-controlled weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-depression-in-graves-disease weekly 0.8 https://www.themednet.org/do-you-routinely-check-vitamin-k-levels-in-post-bariatric-surgery-patients weekly 0.8 https://www.themednet.org/how-long-do-you-typically-wait-before-starting-anticoagulation-after-holding-leqembi-kisunla-in-patients-with-cognitive-impairment weekly 0.8 https://www.themednet.org/what-are-reasonable-next-steps-in-the-work-up-of-suspected-attr-amyloidosis-if-the-pyp-scan-is-equivocal-in-light-of-the-potential-risks-of-endomyocardial-biopsy weekly 0.8 https://www.themednet.org/are-there-other-scenarios-besides-prior-history-of-tia-or-stroke-or-lv-dysfunction-in-which-systemic-anticoagulation-for-lv-non-compaction-would-be-considered weekly 0.8 https://www.themednet.org/what-is-a-reasonable-surveillance-strategy-in-terms-of-preferred-imaging-modality-and-frequency-of-monitoring-for-suspected-av-bioprosthetic-stenosis-in-patients-status-post-savr weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-teen-patients-with-recurrent-mediastinal-germ-cell-tumor-who-have-failed-standard-therapy-radiation-and-hd-therapy-stem-cell-rescue weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-recommend-for-primary-aneurysmal-bone-cyst-of-spine-after-a-subtotal-resection weekly 0.8 https://www.themednet.org/can-the-presence-of-elevated-ring-sideroblasts-20-on-a-bone-marrow-biopsy-without-dysplastic-changes-or-suspicious-molecular-mutations-still-be-indicative-of-an-underlying-mds-in-a-patient-with-unexplained-anemia weekly 0.8 https://www.themednet.org/does-a-patient-with-known-systemic-mastocytosis-need-a-bone-biopsy-of-lytic-vertebral-lesions-to-rule-out-other-etiologies weekly 0.8 https://www.themednet.org/what-is-your-disease-modifying-treatment-of-choice-for-a-patient-with-relapsing-remitting-multiple-sclerosis-with-treated-well-controlled-hiv weekly 0.8 https://www.themednet.org/what-dose-would-you-use-for-a-plaque-brachytherapy-for-a-melanoma-involving-the-iris weekly 0.8 https://www.themednet.org/could-you-describe-the-variables-that-influence-your-decision-against-or-advocating-for-performing-atrial-fibrillation-flutter-ablations-in-morbidly-obese-patients-versus-opting-for-medical-therapy-and-if-so-choice-of-antiarrhythmic-agent weekly 0.8 https://www.themednet.org/would-you-consider-sotalol-to-be-a-suitable-non-selective-beta-blocker-for-primary-prevention-of-variceal-bleeding-in-a-patient-who-requires-sotalol-for-treatment-of-arrhythmia-in-the-setting-of-fontan-associated-liver-disease-and-clinically-significant-p weekly 0.8 https://www.themednet.org/how-would-you-approach-radiotherapy-planning-for-a-pediatric-patient-with-ewing-sarcoma-of-the-spine-vertebral-body-primary weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-obinutuzumab-instead-of-rituximab-when-treating-primary-membranous-nephropathy weekly 0.8 https://www.themednet.org/how-do-you-manage-persistent-insomnia-despite-asv-titration-in-patients-with-complex-sleep-apnea weekly 0.8 https://www.themednet.org/do-you-routinely-obtain-a-cxr-or-ct-after-identifying-an-etiology-for-dyspnea-on-pocus weekly 0.8 https://www.themednet.org/how-often-do-you-monitor-pulmonary-function-tests-in-patients-with-fibrotic-lung-disease weekly 0.8 https://www.themednet.org/how-do-you-monitor-safety-effectiveness-and-adherence-to-therapy-when-using-sedative-hypnotics-in-patients-with-insomnia weekly 0.8 https://www.themednet.org/when-do-you-consider-de-escalation-from-combination-therapy-with-anti-tnfs-and-thiopurines-to-monotherapy-with-anti-tnfs-in-patients-with-ibd weekly 0.8 https://www.themednet.org/would-you-recommend-statin-initiation-in-a-young-adult-patient-age-40-with-type-1-diabetes-mellitus-and-ldl-cholesterol-levels-greater-than-100-without-any-cardiovascular-risk-factors weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-endocrine-therapy-for-a-postmenopausal-female-with-stage-iii-triple-positive-multicentric-breast-cancer-dcis-and-invasive-ductal-carcinoma-s-p-neoadjuvant-tchp-followed-by-bilateral-mastectomy-with-no-residual-disease weekly 0.8 https://www.themednet.org/how-would-you-manage-elevated-vwf-and-fviii-levels-in-a-patient-with-a-family-history-of-coagulopathy weekly 0.8 https://www.themednet.org/would-you-change-treatment-approach-for-rectal-cancer-with-an-associated-intussusception weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-pregnant-patients-with-iga-nephropathy-who-have-worsening-proteinuria-during-the-first-trimester weekly 0.8 https://www.themednet.org/what-is-your-approach-for-patients-with-recurrent-nephrolithiasis-who-you-have-a-strong-suspicion-for-primary-hyperoxaluria-though-genetic-testing-returns-without-any-abnormalities weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-endocrine-therapy-to-a-patient-with-a-history-of-er-positive-dcis-s-p-bilateral-mastectomy-now-with-chest-wall-recurrence-of-dcis-four-years-later weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-likelihood-of-resolution-of-their-hypertension-post-adrenalectomy-for-primary-hyperaldosteronism weekly 0.8 https://www.themednet.org/is-it-appropriate-to-use-electrons-to-treat-a-fibrosarcomatous-dfsp-of-the-face-s-p-r1-wle weekly 0.8 https://www.themednet.org/how-would-you-approach-unexpected-chemo-breaks-during-planned-neoadjuvant-chemoradiation-for-esophageal-adenocarcinoma weekly 0.8 https://www.themednet.org/do-you-recommend-restricting-alcohol-use-in-patients-with-recurrent-nephrolithiasis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-in-a-patient-with-radiographic-uip-but-pathologic-evidence-of-both-fibrotic-nsip-and-uip weekly 0.8 https://www.themednet.org/would-you-feel-comfortable-doing-high-tangents-with-ultra-hypofractionation weekly 0.8 https://www.themednet.org/what-is-your-approach-for-patients-with-a-history-of-nephrolithiasis-who-are-being-evaluated-for-living-kidney-donation weekly 0.8 https://www.themednet.org/do-you-recommend-periodically-testing-for-anti-gbm-antibody-in-patients-with-eskd-secondary-to-alports-syndrome-who-are-status-post-kidney-transplantation weekly 0.8 https://www.themednet.org/when-treating-early-stage-breast-cancer-with-adjuvant-rt-what-risk-factors-would-lead-you-to-include-the-level-1-and-2-axilla-in-patients-with-pn0-i-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-the-chemotherapy-portion-of-chemoradiation-in-a-patient-with-stage-iiib-hydronephrosis-cervical-cancer-on-hemodialysis weekly 0.8 https://www.themednet.org/in-a-woman-with-bipolar-disorder-with-a-menstrual-component-would-lamotrigine-itself-worsen-the-condition-given-that-it-interacts-with-prescribed-estrogen weekly 0.8 https://www.themednet.org/is-dcisionrt-appropriate-for-multifocal-dcis weekly 0.8 https://www.themednet.org/which-patients-if-any-treated-according-to-prospect-for-an-early-stage-rectal-cancer-would-you-offer-surveillance-if-they-achieved-ccr-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/would-you-treat-with-extended-field-pelvic-radiation-for-a-patient-with-figo-iiic1-endometrial-cancer-who-was-found-with-isolated-tumor-cells-itcs-on-a-single-paraaortic-sentinel-lymph-node weekly 0.8 https://www.themednet.org/when-do-you-consider-revascularizing-chronic-total-occlusions-after-failing-medical-management weekly 0.8 https://www.themednet.org/can-mavacamten-be-considered-for-patients-with-hcm-and-ongoing-dyspnea-in-setting-of-an-elevated-lvedp-but-without-significant-lv-outflow-obstruction-on-imaging weekly 0.8 https://www.themednet.org/for-asymptomatic-incidentally-found-lambls-excrescence-should-long-term-surveillance-imaging-be-considered-and-if-so-how-often-should-repeat-imaging-be-ordered weekly 0.8 https://www.themednet.org/how-long-should-patients-with-atrial-fibrillation-who-are-already-on-systemic-anticoagulation-and-are-status-post-tavr-and-pci-6-months-ago-remain-on-plavix weekly 0.8 https://www.themednet.org/how-do-you-approach-an-asymptomatic-patient-with-evidence-of-intense-radiotracer-activity-at-the-left-sternoclavicular-joint-on-bone-scan-with-a-history-of-sapho-syndrome-on-humira weekly 0.8 https://www.themednet.org/in-patients-with-t1-anal-squamous-cell-cancer-status-post-local-excision-with-a-close-margin-would-you-recommend-close-observation-or-adjuvant-concurrent-chemoradiation weekly 0.8 https://www.themednet.org/is-there-any-benefit-to-the-use-of-low-dose-radiation-in-patients-with-osteoarthritis-who-have-already-undergone-joint-replacement weekly 0.8 https://www.themednet.org/what-hydroxyurea-dose-do-you-target-for-hbsc-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-osteoporosis-in-patients-post-lung-transplant weekly 0.8 https://www.themednet.org/what-is-the-recommended-approach-for-a-7-cm-x-5-cm-paraspinal-subcutaneous-desmoid-tumor-t6-to-t9-incidentally-detected-on-pet-ct-during-nsclc-monitoring-with-confirmed-growth-over-18-months weekly 0.8 https://www.themednet.org/can-lupus-anticoagulant-be-positive-despite-a-normal-aptt weekly 0.8 https://www.themednet.org/what-are-the-best-radiation-therapy-options-for-a-young-adult-with-3-brain-metastases-from-myeloid-sarcoma-that-hasnt-responded-well-to-intrathecal-therapy weekly 0.8 https://www.themednet.org/does-papillary-thyroid-cancer-with-extensive-squamous-differentiation-require-specialized-treatment-beyond-rai-and-tsh-suppression weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-a-kidney-transplant-patient-who-develops-bk-viremia-after-treatment-for-rejection weekly 0.8 https://www.themednet.org/which-patients-if-any-do-you-offer-transdermal-estradiol-as-a-method-of-adt-instead-of-lhrh-agonists weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-chronic-kidney-disease-who-are-found-to-have-pelviectasis-without-hydronephrosis-on-renal-ultrasound-imaging weekly 0.8 https://www.themednet.org/what-is-the-optimal-management-of-pain-and-loss-of-function-due-to-pathologic-compression-fractures weekly 0.8 https://www.themednet.org/how-do-you-manage-prostatic-adenocarcinoma-after-a-subtotal-resection weekly 0.8 https://www.themednet.org/how-often-do-you-utilize-intrafraction-motion-tracking-when-treating-prostate-cancer-1 weekly 0.8 https://www.themednet.org/how-long-would-you-hold-clomiphene-before-checking-baseline-morning-testosterone-levels-to-evaluate-the-need-for-testosterone-replacement-therapy-initiation weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-patient-with-seropositive-ra-and-uip-ild-with-concern-for-active-lung-disease weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-a-patient-with-stage-iiia-lung-adenocarcinoma-and-multifocal-hepatocellular-carcinoma-with-child-pugh-a-cirrhosis weekly 0.8 https://www.themednet.org/how-do-you-manage-nephrotic-range-proteinuria-in-a-pregnant-patient-with-a-known-history-of-diabetic-nephropathy-prior-to-pregnancy weekly 0.8 https://www.themednet.org/when-and-how-do-you-do-testing-for-disaccharidases-on-gi-biopsies weekly 0.8 https://www.themednet.org/would-you-use-sutimlimab-for-cold-agglutinin-disease-syndrome-in-patients-with-a-concurrent-hematologic-malignancy weekly 0.8 https://www.themednet.org/do-you-recommend-patients-consume-dairy-products-over-taking-calcium-carbonate-with-meals-if-they-have-recurrent-calcium-based-nephrolithiasis-and-persistent-hyperoxaluria weekly 0.8 https://www.themednet.org/how-would-you-treat-patient-with-a-stage-iv-lung-adenocarcinoma-an-exon-21-p-h835l-mutation-high-tmb-and-negative-pd-l1 weekly 0.8 https://www.themednet.org/how-do-you-approach-inpatient-dvt-prophylaxis-in-patients-already-on-low-dose-rivaroxaban-2-5-mg-bid-for-pad weekly 0.8 https://www.themednet.org/what-is-your-preferred-site-for-central-venous-access-in-patients-with-concern-for-raised-intracranial-pressures weekly 0.8 https://www.themednet.org/in-an-elderly-transplant-ineligible-idh1-mutated-patient-with-aml-who-is-in-remission-after-6-cycles-of-azacitidine-and-ivosidenib-would-you-discontinue-azacitidine-after-cycle-6-and-continue-maintenance-ivosidenib-until-progression-toxicity-or-continue-b weekly 0.8 https://www.themednet.org/is-stage-i-b-l-breast-er-cancer-a-contraindication-to-breast-radiation-omission-after-breast-conservation-surgery weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-tamoxifen-to-a-premenopausal-with-er-pr-her2-stage-ia-pt1a-pn0-i-1-breast-cancer-s-p-bilateral-mastectomies weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-tremors-in-a-kidney-transplant-recipient-who-is-taking-a-cni-for-immunosuppression weekly 0.8 https://www.themednet.org/for-patients-with-spinal-hardware-infections-in-what-circumstances-do-you-recommend-12-weeks-over-6-weeks-of-antimicrobial-therapy weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-suppressive-antibiotic-therapy-for-patients-with-spinal-hardware-infections-who-have-undergone-surgical-debridement-with-retention-of-hardware weekly 0.8 https://www.themednet.org/does-long-term-use-of-5-alpha-reductase-inhibitors-change-the-way-you-evaluate-a-psma-pet weekly 0.8 https://www.themednet.org/how-would-you-manage-a-scalp-squamous-cell-carcinoma-s-p-mohs-with-high-risk-features-who-underwent-placental-grafting-to-expedite-the-healing-process weekly 0.8 https://www.themednet.org/how-do-you-assess-and-adjust-treatment-in-patients-who-develops-hypothyroidism-after-being-on-lithium-for-several-years weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-for-a-pt1c-triple-negative-invasive-papillary-carcinoma-of-breast weekly 0.8 https://www.themednet.org/at-what-age-are-you-comfortable-to-start-prescribing-spironolactone-for-acne-in-adolescent-females weekly 0.8 https://www.themednet.org/what-is-your-preferred-dosing-of-iv-ganciclovir-for-cmv-disease-in-immunocompromised-patients weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-who-has-history-consistent-with-juvenille-myoclonic-epilepsy-jme-but-does-not-have-the-classic-polyspike-pattern-on-eeg weekly 0.8 https://www.themednet.org/is-it-better-to-give-dose-2-of-the-mrna-2024-2025-covid-19-vaccine-at-month-2-or-month-6-after-dose-1-in-moderately-immunocompromised-patients weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-crohns-colitis-in-the-setting-of-immunosuppression-for-liver-transplant weekly 0.8 https://www.themednet.org/how-do-you-further-workup-and-treat-a-patient-with-nausea-and-weight-loss-found-to-have-granulomatous-gastritis-on-endoscopic-biopsies-with-a-negative-workup-for-sarcoidosis-or-crohns-disease weekly 0.8 https://www.themednet.org/how-do-you-handle-elevated-blood-calcium-levels-from-lithium weekly 0.8 https://www.themednet.org/what-has-been-your-approach-to-percutaneous-intervention-for-calcified-nodules-and-threshold-for-intervention weekly 0.8 https://www.themednet.org/what-are-standard-selection-criteria-for-patients-who-are-eligible-for-heart-transplantation weekly 0.8 https://www.themednet.org/when-would-you-consider-referring-a-patient-with-suspected-cardiac-sarcoidosis-based-on-pet-and-mri-for-endomyocardial-biopsy-given-degree-of-patchy-involvement-as-opposed-to-initiating-empiric-immunosuppressive-therapies weekly 0.8 https://www.themednet.org/what-is-your-fluid-intake-target-for-patients-with-nephrocalcinosis-and-no-history-of-kidney-stones weekly 0.8 https://www.themednet.org/should-we-be-considering-transsphenoidal-surgical-resection-as-first-line-therapy-for-prolactinomas weekly 0.8 https://www.themednet.org/how-do-you-manage-reactive-thrombocytosis-and-potentially-symptomatic-fatigue-from-jak2-p-vera-with-iron-deficiency weekly 0.8 https://www.themednet.org/with-the-fda-recently-approving-acoramidis-for-attr-cardiac-amyloidosis-how-should-we-decide-on-optimal-drug-therapy-and-options-for-our-patients weekly 0.8 https://www.themednet.org/how-often-do-you-consider-lamotrigine-in-patients-with-myoclonic-epilepsy weekly 0.8 https://www.themednet.org/would-you-consider-an-icd-for-secondary-prevention-in-an-otherwise-previously-healthy-adult-found-to-have-severe-lv-systolic-dysfunction-admitted-s-p-vf-vt-arrest-due-to-profound-hypokalemia-and-hypomagnesemia-or-defer-implantation-given-resolution-of-arr weekly 0.8 https://www.themednet.org/how-would-you-treat-a-basal-cell-carcinoma-on-the-temporal-skin-and-zygomatic-area-s-p-excision-with-pni-and-significant-flaps-for-closure weekly 0.8 https://www.themednet.org/what-therapies-have-you-found-most-effective-for-jak-induced-associated-acne-jakcne weekly 0.8 https://www.themednet.org/what-if-any-radiation-regimen-would-you-use-for-knee-arthrofibrosis-in-a-patient-undergoing-repeat-arthroscopy-with-lysis-of-adhesions weekly 0.8 https://www.themednet.org/what-treatment-options-would-you-recommend-for-a-patient-with-severe-generalized-pustular-psoriasis-who-has-a-history-of-colon-cancer-s-p-chemotherapy-and-well-controlled-hiv weekly 0.8 https://www.themednet.org/how-do-you-treat-restless-leg-syndrome-in-patients-with-end-stage-renal-disease weekly 0.8 https://www.themednet.org/when-would-you-consider-elective-hospitalization-for-parenteral-treatment-for-new-daily-persistent-headache weekly 0.8 https://www.themednet.org/how-would-you-manage-bulky-cervical-adenocarcinoma-that-incompletely-responded-to-primary-chemoradiation weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-germline-brca-mutations-who-have-stic-lesions-found-at-the-time-of-risk-reducing-bso weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-partially-occlusive-thrombus-in-the-splenic-vein-posterior-to-the-pancreatic-cancer-lesion weekly 0.8 https://www.themednet.org/when-do-you-consider-diaphragmatic-pacing-in-patients-with-diaphragmatic-paresis weekly 0.8 https://www.themednet.org/are-there-factors-that-would-prompt-you-to-consider-the-use-of-methylene-blue-in-refractory-septic-shock weekly 0.8 https://www.themednet.org/what-is-the-likelihood-of-recovery-of-the-hypothalamic-pituitary-adrenal-hpa-axis-in-patients-who-develop-immunotherapy-induced-adrenal-insufficiency weekly 0.8 https://www.themednet.org/is-there-any-circumstance-where-you-would-consider-bevacizumab-in-patients-with-locally-advanced-colorectal-cancer-with-rectouterine-fistula weekly 0.8 https://www.themednet.org/is-there-a-concern-for-using-fff-beams-in-single-isocenter-multi-target-lung-sbrt weekly 0.8 https://www.themednet.org/what-is-your-approach-to-statin-and-or-pcsk9i-initiation-and-counseling-in-a-patient-who-has-an-hdl-above-100-ldl-within-normal-range-but-markedly-elevated-calcium-score-exceeding-1000 weekly 0.8 https://www.themednet.org/if-a-patient-has-potential-arrhythmic-sounding-syncope-and-a-noninducible-type-2-or-3-brugada-ecg-pattern-have-we-excluded-brugada-syndrome-as-the-etiology-for-their-syncope weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-and-surveillance-in-low-grade-traumatic-blunt-ica-injury weekly 0.8 https://www.themednet.org/do-you-recommend-any-alternative-schedule-for-cabozantinib-to-make-treatment-compliance-easier-for-patients-with-metastatic-renal-cell-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-manage-raynauds-symptoms-that-develop-in-patient-on-cgrp-inhibitors weekly 0.8 https://www.themednet.org/how-does-metaplastic-thymoma-histology-impact-your-decision-regarding-adjuvant-radiation weekly 0.8 https://www.themednet.org/how-do-you-choose-between-therapies-for-newly-diagnosed-itp-that-is-refractory-to-steroids-and-ivig weekly 0.8 https://www.themednet.org/for-trigeminal-neuralgia-in-patients-with-multiple-sclerosis-do-you-consider-microvascular-decompression-or-stereotactic-radiosurgery-as-treatment-options weekly 0.8 https://www.themednet.org/what-treatments-have-you-found-to-be-most-effective-in-patients-with-a-schizo-obsessive-disorder weekly 0.8 https://www.themednet.org/is-there-a-bmi-cutoff-for-which-you-would-refer-a-patient-needing-a-native-kidney-biopsy-to-interventional-radiology weekly 0.8 https://www.themednet.org/do-you-recommend-initiating-immunosuppression-and-plasmapheresis-in-patients-with-dialysis-dependent-aki-in-the-setting-of-anti-gbm-disease-who-do-not-have-pulmonary-involvement weekly 0.8 https://www.themednet.org/how-would-you-manage-a-presumed-radiation-induced-sarcoma-of-the-head-and-neck weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-for-heterotopic-ossification-prophylaxis-if-72-hours-after-surgery weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-minimally-symptomatic-factor-vii-deficiency-about-procedures-and-periprocedural-management weekly 0.8 https://www.themednet.org/when-do-you-consider-intramuscular-indomethacin-for-the-assessment-of-trigeminal-autonomic-cephalalgias weekly 0.8 https://www.themednet.org/would-you-recommend-initiation-of-cinacalcet-in-a-patient-with-hypercalcemia-and-recurrent-nephrolithiasis-attributed-to-an-atypical-presentation-of-familial-hypocalciuric-hypercalcemia weekly 0.8 https://www.themednet.org/what-is-your-approach-to-exit-site-prophylaxis-in-patients-receiving-peritoneal-dialysis-who-are-unable-to-tolerate-gentamicin-or-mupirocin-due-to-allergic-reactions weekly 0.8 https://www.themednet.org/do-you-continue-tnf-inhibitors-in-patients-with-a-new-diagnosis-of-cll weekly 0.8 https://www.themednet.org/would-you-still-consider-adding-clindamycin-for-streptococcal-toxic-shock-syndrome-in-situations-where-the-isolate-is-considered-to-be-resistant weekly 0.8 https://www.themednet.org/does-your-dosimetrist-use-skin-flash-for-vmat-whole-breast-or-rni-plans weekly 0.8 https://www.themednet.org/in-patients-with-longstanding-uc-or-crohns-colitis-would-you-extend-the-interval-of-surveillance-colonoscopy-to-longer-than-3-years-if-they-have-had-little-inflammatory-disease-over-the-years-and-no-other-factors-to-increase-their-risk-ie-history-of-polyp weekly 0.8 https://www.themednet.org/do-you-recommend-combined-baseline-cortisol-and-dhea-s-testing-to-improve-the-efficiency-and-accuracy-of-adrenal-insufficiency-diagnosis weekly 0.8 https://www.themednet.org/how-do-you-decide-between-using-immediate-release-versus-long-acting-lithium weekly 0.8 https://www.themednet.org/are-there-any-contraindications-using-nurtec-in-patients-with-headaches-in-the-setting-of-recent-rcvs weekly 0.8 https://www.themednet.org/when-is-air-travel-safe-for-patients-with-recent-diagnosis-of-ischemic-stroke weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-wish-to-travel-to-high-altitudes-with-myasthenia-gravis weekly 0.8 https://www.themednet.org/how-do-you-counsel-advise-patients-when-asked-to-compare-ultrahypofractionated-radiotherapy-with-the-tulsa-procedure weekly 0.8 https://www.themednet.org/would-you-offer-ultrahypofractionated-5-fraction-whole-breast-only-for-a-women-with-er-her2-cn-disease-with-pcr-following-neoadjuvant-systemic-therapy weekly 0.8 https://www.themednet.org/do-you-generally-utilize-calcium-channel-blockers-on-an-as-needed-basis-for-patients-with-raynauds-phenomenon weekly 0.8 https://www.themednet.org/in-pure-red-cell-aplasia-does-peripheral-blood-positive-igg-for-parvovirus-have-significance-if-persistently-positive-on-retesting-but-igm-and-pcr-are-negative weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-dry-corneal-melt-in-a-patient-requiring-high-dose-systemic-steroids-and-no-apparent-underlying-systemic-autoimmune-disease weekly 0.8 https://www.themednet.org/is-there-any-increased-risk-with-adjuvant-breast-radiation-for-a-patient-with-muscular-dystrophy weekly 0.8 https://www.themednet.org/are-you-offering-lutathera-for-multiple-recurrent-meningiomas weekly 0.8 https://www.themednet.org/besides-treadmill-what-other-exercises-may-be-considered-for-post-exercise-abis-and-are-their-diagnostic-parameters-identical-to-standard-post-exercise-abis weekly 0.8 https://www.themednet.org/when-cinacalcet-is-used-to-treat-hypercalcemia-in-primary-hyperparathyroidism-does-it-also-normalize-low-serum-phosphorus-levels weekly 0.8 https://www.themednet.org/how-would-you-work-up-an-older-male-patient-with-elevated-testosterone-level-for-age weekly 0.8 https://www.themednet.org/how-are-you-sequencing-immunotherapy-with-zolbetuximab-in-locally-advanced-metastatic-gej-cancer-when-cps-5-and-claudin-18-2-75 weekly 0.8 https://www.themednet.org/how-do-you-manage-pregnant-individuals-with-newly-diagnosed-idiopathic-intracranial-hypertension weekly 0.8 https://www.themednet.org/how-would-you-approach-transfusion-dependent-anemia-in-an-intermediate-risk-mds-patient-refractory-to-azacitidine weekly 0.8 https://www.themednet.org/what-is-your-protocol-for-transitioning-to-oral-anticoagulation-post-thrombolysis-for-pulmonary-embolism weekly 0.8 https://www.themednet.org/in-light-of-the-2024-shkreli-awards-how-do-you-address-patient-concerns-regarding-the-240-mg-versus-960-mg-dose-of-sotorasib weekly 0.8 https://www.themednet.org/should-you-consider-thromboprophylaxis-even-for-low-dose-lenalidomide-maintenance-post-autologous-transplantation weekly 0.8 https://www.themednet.org/under-what-circumstances-is-it-okay-to-initiate-treatment-for-suspected-multiple-myeloma-without-a-bone-marrow-biopsy weekly 0.8 https://www.themednet.org/how-do-you-approach-initial-steroid-dosing-in-patients-with-eosinophilic-fasciitis weekly 0.8 https://www.themednet.org/what-medications-would-you-have-a-patient-avoid-with-an-ige-mediated-reaction-to-cyclobenzaprine weekly 0.8 https://www.themednet.org/is-a-target-tsh-closer-to-the-mid-normal-range-justified-in-older-individuals-age-70-or-above-without-any-known-cardiac-ischemia-or-dysrhythmia-or-osteoporosis weekly 0.8 https://www.themednet.org/what-is-your-experience-with-the-modified-ramp-up-of-tarlatamab-where-an-extra-5-mg-is-given-in-the-ramp-up-phase-before-increasing-to-the-full-dose weekly 0.8 https://www.themednet.org/can-rapid-weight-loss-following-glp1-r-agonist-therapy-lead-to-postprandial-hypoglycemia-and-if-so-what-are-the-treatment-options-outside-of-dietary-modifications weekly 0.8 https://www.themednet.org/excluding-cll-in-which-patients-would-you-screen-for-hypogammaglobulinemia weekly 0.8 https://www.themednet.org/what-is-your-calcium-level-threshold-for-initiating-targeted-calcium-lowering-therapies-for-patients-with-an-acute-kidney-injury-believed-secondary-to-renal-vasoconstriction-and-volume-depletion weekly 0.8 https://www.themednet.org/how-frequently-do-you-check-serum-electrolytes-for-patients-on-crrt weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-patients-with-recurrent-nephrolithiasis-and-osteoporosis-who-are-receiving-teriparatide weekly 0.8 https://www.themednet.org/what-is-the-appropriate-interval-to-obtain-a-hydroxychloroquine-level-after-making-a-dosage-adjustment weekly 0.8 https://www.themednet.org/are-there-specific-indications-where-you-would-use-thalidomide-over-lenalidomide-for-treatment-of-newly-diagnosed-multiple-myeloma weekly 0.8 https://www.themednet.org/how-do-you-manage-cystoid-macular-edema-cme-unresponsive-to-topical-treatments-in-steroid-responders weekly 0.8 https://www.themednet.org/how-should-diabetic-retinopathy-surveillance-be-adjusted-for-patients-starting-glp-1-agonists weekly 0.8 https://www.themednet.org/what-factors-should-be-considered-when-deciding-whether-to-perform-corneal-crosslinking-cxl-in-mild-cases-of-keratoconus weekly 0.8 https://www.themednet.org/how-do-you-manage-a-situation-where-the-lens-optic-shifts-in-front-of-the-iris-after-a-yamane-technique weekly 0.8 https://www.themednet.org/what-factors-influence-your-decision-to-pursue-surgical-management-in-cases-of-infectious-keratitis-caused-by-multidrug-resistant-pathogens weekly 0.8 https://www.themednet.org/when-do-you-consider-performing-laser-refractive-surgery-on-corneal-transplants weekly 0.8 https://www.themednet.org/can-someone-get-sensitized-to-an-allergen-if-they-receive-it-in-an-ait-mix-but-they-are-not-initially-allergic-to-it weekly 0.8 https://www.themednet.org/what-strategies-have-you-found-helpful-for-balancing-telehealth-and-in-person-appointments-to-reduce-bottlenecks weekly 0.8 https://www.themednet.org/how-do-you-manage-macular-threatening-toxoplasma-chorioretinitis-in-pregnancy weekly 0.8 https://www.themednet.org/how-do-you-manage-cancer-associated-retinopathy-car-in-a-patient-who-doesnt-have-a-known-cancer-diagnosis-given-the-difficulty-in-finding-the-underlying-cancer-and-the-risks-of-using-immunosuppressive-treatments-to-preserve-vision weekly 0.8 https://www.themednet.org/when-should-amblyopia-treatment-be-initiated-in-patients-being-treated-for-retinoblastoma weekly 0.8 https://www.themednet.org/what-work-up-do-you-recommend-for-optic-nerve-edema-in-a-patient-who-is-immunocompromised weekly 0.8 https://www.themednet.org/what-operative-techniques-do-you-use-to-minimize-the-risk-of-postoperative-ectropion-in-a-patient-with-pre-existing-lower-eyelid-laxity-undergoing-lower-eyelid-blepharoplasty weekly 0.8 https://www.themednet.org/how-do-you-decide-on-treatment-modality-for-ocular-surface-squamous-neoplasia weekly 0.8 https://www.themednet.org/what-factors-influence-the-decision-to-initiate-anti-vegf-injections-to-prevent-radiation-retinopathy-after-plaque-brachytherapy weekly 0.8 https://www.themednet.org/how-do-you-decide-on-when-to-start-or-continue-anti-vegf-injections-during-pregnancy weekly 0.8 https://www.themednet.org/how-do-you-manage-checkpoint-inhibitor-associated-vogt-koyanagi-harada-vkh-disease-in-patients-who-have-poorly-controlled-diabetes weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-a-patient-with-a-small-indeterminate-choroidal-mass-with-no-obvious-primary-malignancy weekly 0.8 https://www.themednet.org/how-do-you-decide-between-escalating-treatment-with-additional-iop-lowering-medications-versus-surgical-options-for-patients-with-normal-tension-glaucoma-and-progressive-visual-field-loss-despite-well-controlled-iop weekly 0.8 https://www.themednet.org/how-do-you-decide-between-initiating-systemic-immunotherapy-versus-local-treatment-for-uveitis-with-associated-hla-b27-and-spondyloarthropathy weekly 0.8 https://www.themednet.org/how-do-you-differentiate-between-ocular-involvement-due-to-active-tuberculosis-versus-latent-infection-in-a-patient-with-uveitis-and-suspected-tuberculosis weekly 0.8 https://www.themednet.org/how-do-you-approach-re-operations-for-vertical-strabismus-in-cases-where-prior-horizontal-muscle-surgery-has-affected-vertical-alignment weekly 0.8 https://www.themednet.org/for-an-older-patient-with-hormone-sensitive-high-volume-high-risk-prostate-cancer-with-metastases-to-bone-who-developed-toxicity-with-enzalutamide-what-other-oral-ar-blocker-would-you-offer weekly 0.8 https://www.themednet.org/do-you-use-triptan-medications-in-patients-with-asymptomatic-critical-intracranial-artery-stenosis weekly 0.8 https://www.themednet.org/for-which-pediatric-oncology-patients-do-you-start-bacterial-prophylaxis-inpatient-or-outpatient-and-what-is-your-antibiotic-of-choice weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-adpkd-in-pregnancy-considering-the-need-to-stop-tolvaptan-therapy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-symptomatic-pagets-disease-and-osteoporosis-who-developed-new-fragility-fractures-while-on-fosamax weekly 0.8 https://www.themednet.org/would-you-proceed-with-anti-cd20-treatment-in-an-ms-patient-who-is-vzv-igg-negative-in-spite-of-vaccination-in-the-last-year weekly 0.8 https://www.themednet.org/how-do-you-manage-anticoagulation-in-a-patient-with-dvt-from-likely-malignant-mechanical-obstruction weekly 0.8 https://www.themednet.org/what-is-your-approach-for-linac-based-radiosurgery-when-dealing-with-benign-perioptic-lesions-very-close-to-the-optics-apparatus weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-about-prognosis-with-figo-2018-iiic-cervix-cancer-managed-in-the-new-era-of-chemoradiation-plus-immunotherapy weekly 0.8 https://www.themednet.org/can-you-use-bisphosphonates-in-a-patient-with-osteoporosis-who-has-had-prior-avascular-necrosis-of-tmj-due-to-steroid-use weekly 0.8 https://www.themednet.org/for-patients-with-candida-species-osteomyelitis-who-have-undergone-extensive-surgical-debridement-do-you-routinely-still-recommend-6-12-months-of-antifungal-therapy-or-opt-for-a-shorter-duration weekly 0.8 https://www.themednet.org/do-you-utilize-tumor-treating-fields-in-patients-with-anaplastic-pleomorphic-xanthoastrocytoma-pxa-iii weekly 0.8 https://www.themednet.org/how-frequently-do-you-re-evaluate-achr-and-musk-antibodies-in-patients-with-clinical-and-electrodiagnostic-evidence-of-seronegative-myasthenia-gravis weekly 0.8 https://www.themednet.org/do-you-recommend-using-a-ctdna-assay-for-a-patient-with-her2-metastatic-breast-cancer-in-a-continued-cr-to-guide-decision-about-whether-to-stop-anti-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-for-a-patient-with-an-isolated-perineal-pubic-recurrence-of-penile-scc-s-p-definitive-surgery weekly 0.8 https://www.themednet.org/how-do-you-treat-adhd-with-short-periods-of-benefit-from-stimulant-medications weekly 0.8 https://www.themednet.org/are-you-using-any-molecular-allergen-diagnostics-for-predicting-the-long-term-outcomes-of-venom-specific-immunotherapy-and-as-guidance-to-stop-vit weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-sglt2-inhibitors-to-reduce-the-risk-of-liver-cirrhosis-in-patients-with-type-2-diabetes-mellitus weekly 0.8 https://www.themednet.org/in-an-n-rectal-adenocarcinoma-treated-via-prospect-with-neoadjuvant-folfox-with-omission-of-crt-and-no-treatment-response-in-the-primary-on-pathology-ypn-would-you-offer-adjuvant-chemotherapy-or-chemo-radiation weekly 0.8 https://www.themednet.org/do-you-typically-counsel-patients-to-avoid-intranasal-triptan-administration-on-same-side-of-pain-in-cluster-headaches weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-diagnosis-of-acute-kidney-injury-suspected-secondary-to-renal-infarction-from-thromboembolic-disease weekly 0.8 https://www.themednet.org/is-there-a-role-for-vadadustat-in-addition-to-an-esa-in-eskd-patients-who-are-hyporesponsive-to-esas-alone weekly 0.8 https://www.themednet.org/in-a-patient-with-metastatic-colorectal-cancer-to-the-lung-and-liver-is-there-a-role-for-liver-directed-therapy-if-the-lung-is-not-amenable-to-local-therapy weekly 0.8 https://www.themednet.org/what-are-your-thoughts-on-using-abatacept-for-ra-associated-ild-in-a-patient-undergoing-treatment-for-cll-with-zanubrutinib-and-how-would-you-assess-the-potential-increased-risk-of-infection-in-this-context weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-ac-pembrolizumab-for-a-triple-negative-breast-cancer-patient-whose-tumor-progressed-on-carboplatin-paclitaxel-pembrolizumab-on-keynote-522-and-required-urgent-surgery-ypt3-ypn0 weekly 0.8 https://www.themednet.org/would-you-consider-elective-neck-nodal-irradiation-for-a-large-5-cm-head-and-neck-extramedullary-solitary-plasmacytoma-arising-from-the-nasal-cavity weekly 0.8 https://www.themednet.org/what-are-the-potential-implications-of-re-introduction-of-long-term-responders-to-calcium-channel-blockers-in-the-classification-of-pulmonary-hypertension-and-how-should-clinicians-approach-the-identification-and-management-of-these-patients weekly 0.8 https://www.themednet.org/with-the-addition-of-pembrolizumab-following-chemoradiation-per-keynote-a18-would-you-be-less-likely-to-treat-the-paraaortic-chain-prophylactically weekly 0.8 https://www.themednet.org/when-do-you-usually-introduce-conversations-regarding-tracheostomy-placement-in-patients-with-refractory-status-epilepticus-or-other-conditions-where-one-may-anticipate-delayed-awakening weekly 0.8 https://www.themednet.org/would-you-consider-starting-immunotherapy-in-a-patient-with-stage-iv-nsclc-a-high-pdl1-level-and-active-untreated-hepatitis-c weekly 0.8 https://www.themednet.org/is-there-any-benefit-of-anastrozole-in-addition-to-fulvestrant-and-palbociclib-in-a-patient-with-hr-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/do-you-use-dual-anti-platelet-therapy-inpatients-with-low-nihss-who-have-had-bilateral-brainstem-strokes weekly 0.8 https://www.themednet.org/how-do-you-approach-chronic-active-amr-concurrent-with-changes-of-cni-toxicity weekly 0.8 https://www.themednet.org/how-do-you-decide-between-opting-for-semi-elective-outpatient-versus-inpatient-tavr-for-patients-with-severe-critical-as weekly 0.8 https://www.themednet.org/what-is-your-experience-with-metformin-for-improving-cognitive-impairment-in-schizophrenia weekly 0.8 https://www.themednet.org/what-is-your-experience-with-transcutaneous-vagal-nerve-stimulation-for-the-treatment-of-anxiety-disorders-and-major-depressive-disorder weekly 0.8 https://www.themednet.org/what-further-testing-do-you-recommend-for-incidentally-found-ependymitis-granularis-as-part-of-headache-workup weekly 0.8 https://www.themednet.org/when-do-you-prefer-to-use-bolus-for-treating-superficial-tumors-adjacent-to-or-involving-the-skin-surface-especially-for-complex-surface-anatomy-in-the-pelvis-head-neck-and-extremity-regions weekly 0.8 https://www.themednet.org/would-you-add-an-additional-alkali-medication-for-patients-with-recurrent-uric-acid-nephrolithiasis-who-are-on-high-doses-of-potassium-citrate-and-continue-to-have-acidic-urine weekly 0.8 https://www.themednet.org/how-do-you-choose-roflumilast-vs-ensifentrine-in-copd-patients-with-dyspnea-despite-adequate-laba-lama-ics-therapy-where-indicated weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-acute-intermittent-porphyria-when-it-comes-to-fasting-for-religious-reasons weekly 0.8 https://www.themednet.org/in-a-patient-with-sjia-who-has-been-stable-on-anakinra-however-is-now-planning-to-conceive-or-becomes-pregnant-would-you-consider-switching-to-cimzia weekly 0.8 https://www.themednet.org/would-you-offer-partial-breast-radiation-to-a-young-breast-cancer-patient-with-brca-1-if-all-other-criteria-are-met weekly 0.8 https://www.themednet.org/would-you-offer-zolbetuximab-in-a-non-asian-population weekly 0.8 https://www.themednet.org/would-you-change-systemic-therapy-in-a-patient-with-sclc-with-stable-systemic-disease-but-cns-progression weekly 0.8 https://www.themednet.org/for-patients-with-intermediate-or-lower-risk-essential-thrombocythemia-with-plt-1000-but-no-symptoms-do-you-favor-aspirin-only-therapy-or-aspirin-and-cytoreduction weekly 0.8 https://www.themednet.org/would-you-stop-romosozumab-if-a-patient-developed-mild-asymptomatic-hypocalcemia-while-on-treatment weekly 0.8 https://www.themednet.org/what-criteria-are-used-to-select-patients-who-have-locally-advanced-bcc-patients-for-treatment-with-sonidegib weekly 0.8 https://www.themednet.org/would-you-recommend-a-sglt2i-for-a-non-diabetic-patient-with-recurrent-uric-acid-or-calcium-phosphate-nephrolithiasis weekly 0.8 https://www.themednet.org/how-do-you-approach-interval-monitoring-of-cavernous-carotid-aneurysms weekly 0.8 https://www.themednet.org/how-many-proctored-robotic-assisted-bronchoscopies-does-it-take-to-become-proficient-at-it weekly 0.8 https://www.themednet.org/in-patients-presenting-to-the-hospital-with-atrial-fibrillation-of-48-hours-and-are-started-on-anticoagulation-provided-they-spontaneously-convert-with-av-nodal-blocking-agents-but-then-revert-back-into-af-would-you-need-laa-imaging-before-a-rhythm-contro weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-doxycycline-for-pregnant-individuals-with-rickettsial-diseases-despite-the-historical-concern-for-side-effects-in-pregnancy weekly 0.8 https://www.themednet.org/what-is-the-role-of-surveillance-imaging-after-first-line-therapy-in-patients-with-aggressive-lymphomas weekly 0.8 https://www.themednet.org/how-do-you-manage-persistent-cytopenias-after-fcr-chemotherapy-for-treatment-of-cll weekly 0.8 https://www.themednet.org/in-the-absence-of-clear-guidelines-when-would-be-a-reasonable-threshold-to-refer-patients-with-resistant-hypertension-for-renal-denervation weekly 0.8 https://www.themednet.org/how-often-do-you-check-fibrinogen-levels-and-when-do-you-administer-ffp-for-patients-with-aki-requiring-plasma-exchange weekly 0.8 https://www.themednet.org/what-are-your-perspectives-on-using-glp-1-agonists-as-a-primary-or-adjunctive-treatment-in-psychiatric-care weekly 0.8 https://www.themednet.org/what-does-bevacizumab-contribute-in-metastatic-cervical-cancer-when-used-in-combination-with-a-platinum-doublet-pembrolizumab weekly 0.8 https://www.themednet.org/how-do-you-manage-mat-for-opioid-use-disorder-in-lung-transplant-patients-during-the-peri-postoperative-period weekly 0.8 https://www.themednet.org/what-is-your-clinical-threshold-for-treating-a-potential-monoclonal-gammopathy-of-thrombotic-significance weekly 0.8 https://www.themednet.org/for-what-patients-diagnoses-do-you-currently-use-sodium-thiosulfate-to-reduce-the-risk-of-cisplatin-associated-ototoxicity weekly 0.8 https://www.themednet.org/do-you-have-a-preferred-iv-iron-formulation-for-pregnant-women weekly 0.8 https://www.themednet.org/in-a-patient-with-cryptogenic-stroke-while-on-antecedent-aspirin-81-mg-how-do-you-decide-between-single-antiplatelet-therapy-dual-antiplatelet-therapy-or-antiplatelet-agent-combined-with-anticoagulation-such-as-rivaroxaban-2-5-mg-bid weekly 0.8 https://www.themednet.org/do-you-still-consider-the-use-of-pegloticase-in-someone-with-substantial-tophaceous-burden-despite-optimal-uric-acid-levels weekly 0.8 https://www.themednet.org/what-radiation-treatment-volume-and-dose-would-you-deliver-to-an-isolated-dlbcl-relapse-in-the-left-eye-s-p-vitrectomy-and-intraocular-methotrexate weekly 0.8 https://www.themednet.org/what-pharmacologic-treatments-have-you-found-helpful-in-treating-comorbid-schizophrenia-and-ocd weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-choosing-between-vimseltinib-and-pexidartinib-for-tenosynovial-giant-cell-tumor-tgct-patients weekly 0.8 https://www.themednet.org/would-you-consider-omitting-adjuvant-radiation-in-a-very-elderly-patient-with-a-small-triple-negative-breast-cancer weekly 0.8 https://www.themednet.org/how-should-we-approach-the-management-of-pcos-in-transgender-men-seeking-virilization weekly 0.8 https://www.themednet.org/do-you-recommend-low-dose-rai-ablation-for-low-risk-papillary-thyroid-cancer-with-lymphatic-invasion-alone-no-angio-invasion-or-known-nodal-involvement weekly 0.8 https://www.themednet.org/would-you-discontinue-or-dose-reduce-tamoxifen-in-a-patient-who-developed-hepatic-steatosis weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-ogilvies-syndrome-presenting-with-a-cecal-diameter-above-12-cm-unresponsive-to-conservative-management-with-electrolyte-correction-decompression-by-flexible-sigmoidoscopy-and-rectal-tube-placement weekly 0.8 https://www.themednet.org/do-you-have-concerns-about-the-validity-of-the-interlace-data-considering-the-long-study-recruitment-period-10-years-and-evolution-of-radiation-techniques-that-have-occurred-during-that-time-frame weekly 0.8 https://www.themednet.org/do-you-ever-delay-starting-levodopa-in-patients-with-parkinsons-disease weekly 0.8 https://www.themednet.org/how-frequently-do-you-recommend-ekgs-in-pediatric-patients-on-antipsychotics-especially-in-patients-taking-antipsychotics-with-more-qtc-risk weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-synchronous-node-positive-prostate-cancer-t3bn1m0-and-oligometastatic-rectosigmoid-cancer-t4an1m1-with-a-solitary-liver-metastasis weekly 0.8 https://www.themednet.org/how-soon-after-initiating-oral-anticoagulation-therapy-for-atrial-fibrillation-can-it-be-interrupted-for-surgery-or-procedures weekly 0.8 https://www.themednet.org/would-you-offer-ultra-hypofractionated-accelerated-partial-breast-re-irradiation-using-5-fractions weekly 0.8 https://www.themednet.org/would-you-provide-vitamin-b12-supplementation-to-a-patient-on-pemetrexed-therapy-if-their-b12-levels-are-normal-or-high weekly 0.8 https://www.themednet.org/when-do-you-consider-pembrolizumab-for-the-treatment-of-progressive-multifocal-leukoencephalopathy weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-albumin-adjusted-calcium-measurement-formulas-to-accurately-assess-calcium-levels weekly 0.8 https://www.themednet.org/how-do-you-counsel-approach-antidepressant-use-in-patients-planning-to-utilize-or-self-administer-psychedelics-for-chronic-ptsd-or-depression weekly 0.8 https://www.themednet.org/would-you-consider-spine-re-irradiation-after-pluvicto-1 weekly 0.8 https://www.themednet.org/what-experience-have-you-had-with-familial-clustering-of-polycythemia-vera weekly 0.8 https://www.themednet.org/how-long-after-initiating-mycophenolate-do-you-wait-before-tapering-prednisone-off-in-patients-with-myositis-associated-ild weekly 0.8 https://www.themednet.org/do-you-recommend-holding-ace-inhibitors-arbs-and-sglt2-inhibitors-for-patients-with-chronic-kidney-disease-and-malignancy-who-are-about-to-start-high-dose-intravenous-methotrexate weekly 0.8 https://www.themednet.org/what-would-be-your-approach-to-managing-severe-anca-associated-vasculitis-in-a-patient-who-is-also-septic-from-a-bacterial-infection weekly 0.8 https://www.themednet.org/for-patients-who-do-not-have-access-to-biologic-therapies-what-are-some-csdmard-combination-pearls-or-tips-that-you-have-that-have-particular-efficacy-in-different-rheumatologic-diseases weekly 0.8 https://www.themednet.org/what-factors-should-be-prioritized-when-deciding-the-timing-of-cied-extraction-in-patients-with-high-surgical-risk-or-multiple-comorbidities weekly 0.8 https://www.themednet.org/in-patients-with-advanced-hr-her2-breast-cancer-who-have-progressed-on-first-line-cdk-4-6i-and-et-and-found-to-have-esr1-mutation-are-you-offering-combination-of-abemaciclib-and-elacestrant-in-the-2nd-line-or-serd-monotherapy weekly 0.8 https://www.themednet.org/how-do-you-adjust-medications-for-patients-with-eosinophilic-esophagitis-who-responded-to-budesonide-or-ppi-and-when-do-you-repeat-egd weekly 0.8 https://www.themednet.org/how-do-you-treat-mas-in-patients-with-systemic-jia-or-aosd-with-hla-drb1-15-alleles-given-risk-for-dress-hypersensitivity-to-il1-or-il6-inhibitor-therapy weekly 0.8 https://www.themednet.org/in-a-patient-with-stage-ivb-her2-3-high-grade-serous-endometrial-cancer-who-had-disease-confined-to-a-polyp-and-microscopic-omental-metastases-how-long-would-you-continue-maintenance-trastuzumab-after-chemotherapy weekly 0.8 https://www.themednet.org/is-concurrent-immuno-radiation-therapy-a-viable-treatment-option-for-patients-with-unresectable-non-metastatic-locally-advanced-lung-cancer-who-have-high-pd-l1-expression-and-no-oncogenic-mutations weekly 0.8 https://www.themednet.org/what-stomach-constraint-would-you-accept-in-abdominal-reirradiation weekly 0.8 https://www.themednet.org/what-work-up-and-treatment-do-you-recommend-for-exertional-headaches weekly 0.8 https://www.themednet.org/is-there-a-kidney-stone-size-for-which-you-refer-your-patients-with-recurrent-nephrolithiasis-to-urology weekly 0.8 https://www.themednet.org/when-should-a-biopsy-be-obtained-to-rule-out-small-cell-transformation-in-a-patient-with-stage-iv-nsclc-and-an-egfr-mutation weekly 0.8 https://www.themednet.org/how-do-you-decide-when-if-ever-to-defer-pharmacologic-venous-thromboembolism-prophylaxis-for-hospitalized-patients weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-agent-for-vte-prophylaxis-in-hospitalized-medical-patients-with-adequate-renal-function weekly 0.8 https://www.themednet.org/how-do-you-decide-which-patients-with-upper-gi-bleeds-should-be-monitored-on-telemetry weekly 0.8 https://www.themednet.org/when-do-you-consider-using-aspirin-81-mg-po-bid-for-vte-prophylaxis-over-other-agents-in-patients-with-a-fracture-considering-recent-trial-data weekly 0.8 https://www.themednet.org/how-do-you-use-cardiac-pocus-to-potentially-defer-formal-echocardiogram-in-patients-presenting-with-an-acute-pulmonary-embolism weekly 0.8 https://www.themednet.org/how-do-you-use-ivc-collapsibility-on-pocus-to-inform-decisions-for-managing-hypotension weekly 0.8 https://www.themednet.org/how-would-you-manage-an-epidural-spinal-metastasis-causing-cord-compression-from-rhabdomyosarcoma weekly 0.8 https://www.themednet.org/in-patients-with-moderate-calcific-mitral-stenosis-possible-hfpef-and-dyspnea-on-exertion-how-would-you-differentiate-the-etiology-of-the-symptoms weekly 0.8 https://www.themednet.org/what-is-your-preferred-screening-tool-for-colon-cancer-in-an-average-risk-patient weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-express-concerns-about-receiving-multiple-vaccinations-at-once-versus-spacing-them-out-over-time weekly 0.8 https://www.themednet.org/would-you-recommend-a-glp-1-agonist-as-an-option-to-reduce-the-risk-of-dementia-in-patients-with-a-strong-family-history weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-start-mat-for-opioid-use-disorder-during-hospitalization weekly 0.8 https://www.themednet.org/when-do-you-consider-using-phenobarbital-over-symptom-driven-alcohol-withdrawal-protocols-for-patients-at-low-to-moderate-risk-of-withdrawal-complications weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-reinitiate-a-glp-1-agonist-after-a-patient-has-experienced-acute-pancreatitis-while-on-this-therapy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-glp-1-agonists-for-weight-loss-who-wish-to-space-out-their-medication-or-take-a-drug-holiday-to-temporarily-increase-their-appetite weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-ask-if-they-should-take-a-daily-multivitamin weekly 0.8 https://www.themednet.org/do-you-recommend-starting-with-oral-or-intramuscular-b12-supplementation-in-patients-with-newly-diagnosed-deficiency weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-average-risk-patients-should-undergo-annual-or-biennial-breast-cancer-screening weekly 0.8 https://www.themednet.org/when-do-you-recommend-starting-a-continuous-opioid-infusion-for-symptom-control-at-the-end-of-life weekly 0.8 https://www.themednet.org/do-you-prefer-scopolamine-patches-glycopyrrolate-or-other-treatment-regimens-to-manage-oropharyngeal-secretions-at-the-end-of-life weekly 0.8 https://www.themednet.org/at-what-point-should-you-consider-deactivating-icds-or-implanted-pacemakers-in-patients-nearing-the-end-of-life-but-not-imminently-dying weekly 0.8 https://www.themednet.org/what-suggestions-for-environmental-modifications-do-you-find-most-helpful-to-reduce-the-risk-of-falls-in-the-geriatric-population weekly 0.8 https://www.themednet.org/do-you-routinely-prescribe-vitamin-d-to-reduce-the-risk-of-fall-related-fractures-in-elderly-patients-regardless-of-their-serum-levels weekly 0.8 https://www.themednet.org/would-you-start-octreotide-in-a-patient-with-suspected-sulfonyurea-overdose-but-without-frank-hypoglycemia weekly 0.8 https://www.themednet.org/do-you-routinely-use-higher-dose-vte-prophylaxis-in-patients-admitted-with-traumatic-orthopedic-injuries-undergoing-surgery weekly 0.8 https://www.themednet.org/when-do-you-consider-switching-a-generic-formulation-antiseizure-medication-to-the-brand-formulation weekly 0.8 https://www.themednet.org/would-you-use-febuxostat-for-an-african-american-patient-with-gout-and-previous-cardiovascular-events-stroke-mi-who-tested-positive-for-hla-b-5801 weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-severe-deforming-seronegative-ra-who-has-failed-or-been-intolerant-to-dmards-tnfi-abatacept-jak-inhibitors-il-6-and-il-1-agents-in-addition-to-rituxan-and-moderate-dose-prednisone weekly 0.8 https://www.themednet.org/do-you-seek-pathologic-confirmation-before-proceeding-with-empiric-immunosuppressive-therapy-in-symptomatic-patients-with-radiographic-nsip weekly 0.8 https://www.themednet.org/would-the-diagnostic-yield-for-abis-or-peripheral-arterial-duplex-doppler-in-a-patient-with-metal-rods-in-both-legs-be-similar-or-acceptable-in-comparison-to-those-tests-in-a-patient-without-metal-rods weekly 0.8 https://www.themednet.org/is-it-reasonable-to-extrapolate-the-findings-of-rt-charm-and-alliance-to-intact-breast-patients-and-offer-hypofractionated-rni-to-all-patients-who-are-eligible-for-rni weekly 0.8 https://www.themednet.org/how-do-you-think-about-deferring-vte-prophylaxis-versus-implementing-non-pharmacologic-methods-when-chemical-prophylaxis-is-contraindicated weekly 0.8 https://www.themednet.org/how-do-you-approach-the-significance-of-rnp-iii-antibody-in-a-patient-with-positive-ana-but-no-other-signs-or-symptoms-of-systemic-sclerosis weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-recurrent-idiopathic-pleuropericarditis weekly 0.8 https://www.themednet.org/what-chemotherapy-regimen-do-you-use-for-de-novo-metastatic-squamous-cell-carcinoma-of-penile-urethra weekly 0.8 https://www.themednet.org/how-do-you-counsel-glioblastoma-multiforme-patients-on-which-types-of-clinical-trials-to-pursue weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-behavioral-disturbance-aggression-in-patients-with-a-recent-traumatic-brain-injury weekly 0.8 https://www.themednet.org/what-factors-should-be-considered-when-deciding-whether-to-omit-radiation-in-pediatric-aya-patients-receiving-n-avd-particularly-regarding-long-term-outcomes-and-second-malignancy-risks weekly 0.8 https://www.themednet.org/are-there-instances-when-you-recommend-oral-phosphate-for-patients-with-recurrent-nephrolithiasis weekly 0.8 https://www.themednet.org/is-it-appropriate-to-use-bolus-with-hypofractionated-pmrt weekly 0.8 https://www.themednet.org/do-you-favor-sotagliflozin-over-sglt2i-alone-for-cardiovascular-risk-reduction-in-patients-with-type-2-diabetes-and-chronic-kidney-disease weekly 0.8 https://www.themednet.org/do-you-regularly-recommend-an-immunological-workup-for-patients-with-suspected-immunodeficiency-or-defer-to-immunology weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-radiation-therapy-for-a-grade-1-meningioma-with-an-elevated-ki67 weekly 0.8 https://www.themednet.org/how-would-you-manage-recurrent-migratory-lower-extremity-thrombophlebitis-that-occurs-despite-being-on-therapeutic-apixaban weekly 0.8 https://www.themednet.org/is-there-any-benefit-to-checking-serum-viscosity-in-patients-with-autoimmune-disease-and-headaches-migraines-to-see-if-aspirin-or-clopidogrel-may-be-beneficial weekly 0.8 https://www.themednet.org/what-is-your-approach-to-weight-loss-interventions-for-patients-with-recurrent-nephrolithiasis-and-obesity weekly 0.8 https://www.themednet.org/do-you-recommend-to-continue-acyclovir-to-prevent-hsv-infection-in-an-hiv-patient-with-cd4-count-more-than-200-and-with-high-viral-load weekly 0.8 https://www.themednet.org/do-you-constrain-heterogeneity-or-hotspots-when-delivering-spine-sbrt-for-bone-metastases weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patients-pain-from-the-skin-tattoos-placed-at-the-ct-simulation weekly 0.8 https://www.themednet.org/for-patients-with-low-risk-differentiated-thyroid-cancer-how-do-you-navigate-the-decision-between-less-aggressive-treatments-such-as-lobectomy-alone-without-radioactive-iodine-and-more-aggressive-strategies weekly 0.8 https://www.themednet.org/what-is-the-role-for-inpatient-limited-montage-eeg-recording weekly 0.8 https://www.themednet.org/what-is-your-approach-to-an-infant-12-mo-with-new-onset-petechiae-and-thrombocytopenia-with-labs-consistent-with-itp weekly 0.8 https://www.themednet.org/would-you-rechallenge-with-cabozantinib-in-a-patient-with-hcc-after-the-development-of-a-6-mm-gastrohepatic-fistula-without-perforation-or-communication-with-the-peritoneal-cavity weekly 0.8 https://www.themednet.org/when-do-you-offer-adjuvant-radiation-therapy-for-a-glomus-tumor-of-uncertain-malignant-potential-of-the-extremity-resected-with-negative-margins weekly 0.8 https://www.themednet.org/is-fast-forward-ultra-hypofractionation-suitable-for-an-early-stage-breast-patient-after-a-lumpectomy-with-oncoplastic-reduction weekly 0.8 https://www.themednet.org/are-sglt2-inhibitors-contraindicated-in-patients-with-osteoporosis-and-history-of-vertebral-and-hip-fractures weekly 0.8 https://www.themednet.org/would-you-re-rt-for-heterotopic-ossification-if-the-first-course-of-postoperative-radiation-failed-to-prevent-ho-formation weekly 0.8 https://www.themednet.org/would-you-offer-a-ret-inhibitor-to-a-patient-with-de-novo-metastatic-ret-v706m-mutant-squamous-cell-lung-cancer weekly 0.8 https://www.themednet.org/what-is-the-recommended-approach-to-treating-severe-constipation-in-patients-on-glp1-r-agonist-therapy weekly 0.8 https://www.themednet.org/do-you-recommend-malic-acid-supplementation-for-patients-with-recurrent-calcium-oxalate-nephrolithiasis-and-hypocitraturia weekly 0.8 https://www.themednet.org/do-you-recommend-avoiding-esas-in-eskd-patients-with-heart-failure-who-require-a-left-ventricular-assist-device weekly 0.8 https://www.themednet.org/how-do-you-approach-deprescribing-psychiatric-medications-in-elderly-patients-with-polypharmacy-concerns weekly 0.8 https://www.themednet.org/what-behavioral-interventions-have-you-found-most-effective-for-managing-self-injurious-behavior-in-autism weekly 0.8 https://www.themednet.org/do-you-prescribe-respiratory-muscle-training-rmt-devices-to-patients-with-dysphagia weekly 0.8 https://www.themednet.org/when-starting-stress-dose-steroids-for-patient-with-primary-adrenal-insufficiency-how-do-you-decide-whether-to-start-hydrocortisone-100-mg-every-8-hours-versus-50-mg-every-6-hours weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-metastatic-high-grade-neuroendocrine-carcinoma-of-the-breast-which-is-hr-her2-negative weekly 0.8 https://www.themednet.org/is-there-any-genetic-testing-available-for-the-cdhr3-receptor weekly 0.8 https://www.themednet.org/should-the-rsv-vaccine-be-administered-to-pregnant-mothers-even-if-it-is-not-seasonally-circulating-but-they-are-32-36-weeks-pregnant weekly 0.8 https://www.themednet.org/are-your-performing-food-challenges-prior-to-starting-oit-or-omalizumab-to-determine-if-these-patients-have-a-threshold-dose-that-would-actually-benefit-from-the-intervention weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-resistant-depression-and-anxiety-related-to-menopause-refractory-to-ssri-snris-and-hormone-replacement-therapy weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-radiotherapy-in-addition-to-chemotherapy-in-gastric-adenocarcinoma-s-p-gastrectomy-with-a-distal-positive-resection-margin weekly 0.8 https://www.themednet.org/how-are-you-diagnosing-chronic-fpies-in-adults weekly 0.8 https://www.themednet.org/how-do-you-weigh-upfront-nodal-burden-when-deciding-to-omit-pmrt-in-a-patient-with-cn1-ypn0-disease-after-neoadjuvant-chemo-mastectomy-and-alnd weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-a-patient-with-stage-iv-nsclc-harboring-both-a-classical-and-non-classical-compound-egfr-mutations weekly 0.8 https://www.themednet.org/would-you-consider-sentinel-lymph-nodes-in-a-patient-with-a-history-of-radiation-for-rectal-cancer-no-surgery-now-with-newly-diagnosed-endometrial-cancer weekly 0.8 https://www.themednet.org/for-stage-iii-iv-hodgkins-lymphoma-would-you-consider-consolidative-radiation-for-bulky-disease-after-a-complete-response-was-seen-using-n-avd-per-the-s1826-trial weekly 0.8 https://www.themednet.org/in-a-patient-with-prior-rt-to-the-prostate-and-svs-and-newly-diagnosed-locally-advanced-rectal-cancer-at-10-15-cm-would-you-offer-preoperative-chemoradiation weekly 0.8 https://www.themednet.org/do-you-prioritize-adding-a-glp-1-receptor-agonist-over-an-sglt-2-inhibitor-in-patients-with-ckd-related-to-type-2-diabetes-uncontrolled-proteinuria-despite-being-on-an-acei-and-obesity weekly 0.8 https://www.themednet.org/do-you-add-adt-to-rt-for-a-patient-with-intermediate-risk-prostate-cancer-with-discordant-decipher-and-arteraai-results weekly 0.8 https://www.themednet.org/do-you-use-the-same-hemoglobin-target-as-an-eskd-patient-for-an-outpatient-with-aki-d-who-has-been-receiving-dialysis-for-more-than-30-days-and-is-prescribed-an-esa weekly 0.8 https://www.themednet.org/how-do-you-discontinue-ketogenic-diets-previously-used-as-a-treatment-for-epilepsy weekly 0.8 https://www.themednet.org/how-does-the-presence-of-signs-of-cerebral-edema-influence-your-decision-for-thrombolysis-and-endovascular-thrombectomy weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-pursue-genetic-testing-for-cerebral-palsy weekly 0.8 https://www.themednet.org/can-palliative-radiation-be-used-to-treat-recurrent-malignant-pleural-effusion-in-nsclc weekly 0.8 https://www.themednet.org/what-biologic-or-conventional-synthetic-dmard-would-you-use-as-a-steroid-sparing-agent-in-a-patient-with-gca-and-a-history-of-diverticulitis weekly 0.8 https://www.themednet.org/is-it-safe-to-use-one-tnf-inhibitor-e-g-infliximab-in-a-patient-who-has-had-a-severe-allergic-reaction-to-a-different-tnf-inhibitor-e-g-adalimumab weekly 0.8 https://www.themednet.org/do-you-always-biopsy-patients-who-present-with-classic-skin-findings-of-dermatomyositis weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-inquire-about-benzene-exposure-and-carcinogenic-risk-from-bpo-containing-acne-and-rosacea-products weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-adjunctive-rifampin-therapy-for-the-management-of-staphylococcus-aureus-native-vertebral-osteomyelitis weekly 0.8 https://www.themednet.org/when-should-you-consider-performing-an-ac-tap-in-patients-with-suspected-herpetic-uveitis weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-treatment-for-patients-with-chronic-osteomyelitis-of-long-bones-based-on-radiographic-findings-alone-in-the-absence-of-superficial-infection-or-recommend-bone-biopsy-to-evaluate-for-therapy weekly 0.8 https://www.themednet.org/how-do-you-manage-peep-in-a-morbidly-patient-with-severe-hypoxia-who-is-already-proned-with-no-access-to-esophageal-ballon weekly 0.8 https://www.themednet.org/how-do-you-titrate-midodrine-in-your-patients-with-eskd-who-suffer-from-intradialytic-hypotension weekly 0.8 https://www.themednet.org/how-frequently-would-you-consider-iv-iron-treatment-for-ongoing-iron-loss-and-severe-iron-deficiency-anemia weekly 0.8 https://www.themednet.org/what-orals-or-biologics-do-you-reach-for-in-a-child-with-recalcitrant-inverse-psoriasis-in-the-groin-who-has-tried-and-failed-topical-including-steroids-pimecrolimus-zoryve-ketoconazole-and-tacrolimus weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-bilateral-non-infectious-uveitis-in-the-pediatric-population weekly 0.8 https://www.themednet.org/how-do-you-approach-patient-selection-for-starting-intravitreal-complement-inhibitors weekly 0.8 https://www.themednet.org/when-would-you-consider-discontinuing-immunosuppressive-treatment-in-a-quiescent-uveitis-patient-without-systemic-manifestations-of-inflammation weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-using-off-label-glp-1-agonists-for-alcohol-or-opioid-cravings weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-about-the-risks-and-benefits-of-mood-stabilizers-e-g-lithium-lamotrigine-during-pregnancy weekly 0.8 https://www.themednet.org/what-is-the-optimal-vitamin-d-level-for-pregnant-women-for-maternal-and-fetal-health-and-how-should-this-be-supplemented-in-pregnancy weekly 0.8 https://www.themednet.org/what-ecg-features-for-st-depression-would-prompt-you-to-report-these-st-changes-if-a-patient-exercised-well-and-did-not-have-any-questions-during-their-stress-test weekly 0.8 https://www.themednet.org/are-there-instances-where-tavr-should-be-considered-for-patients-with-moderate-as-and-hfref weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-hbss-and-severe-pulmonary-hypertension-on-home-oxygen weekly 0.8 https://www.themednet.org/how-do-you-approach-the-planning-of-oculoplastic-surgery-for-pediatric-patients-with-craniofacial-syndromes weekly 0.8 https://www.themednet.org/what-is-your-approach-to-eyelid-reconstruction-in-children-with-severe-congenital-or-acquired-eyelid-defects weekly 0.8 https://www.themednet.org/how-do-you-evaluate-treat-a-patient-with-minimal-papillary-thyroid-cancer-foci-in-ovarian-mature-teratoma-tissue-after-an-oophorectomy-that-does-not-meet-criteria-for-struma-ovarii-diagnosis weekly 0.8 https://www.themednet.org/would-you-offer-definitive-radiation-therapy-for-an-extracranial-schwannoma-located-in-the-pelvis weekly 0.8 https://www.themednet.org/do-you-utilize-temporal-artery-ultrasound-in-your-practice weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-seronegative-ra-and-ild weekly 0.8 https://www.themednet.org/what-is-your-approach-to-medical-management-for-cocaine-induced-acute-mi-and-threshold-to-consider-referral-for-coronary-angiography-in-the-setting-of-a-markedly-elevated-troponin-and-lv-systolic-dysfunction weekly 0.8 https://www.themednet.org/when-should-you-consider-prescribing-dexarazoxane-for-patients-on-anthracyclines weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-osteoporosis-who-remains-at-risk-for-osteoporotic-fracture-and-who-had-an-atypical-femur-fracture-on-denosumab weekly 0.8 https://www.themednet.org/do-you-see-a-role-for-early-aggressive-treatment-for-mctd-to-prevent-progression-of-disease-even-though-there-has-not-been-end-organ-manifestations weekly 0.8 https://www.themednet.org/how-do-you-manage-luts-in-the-post-prostatectomy-setting weekly 0.8 https://www.themednet.org/can-24-hour-urine-aldosterone-levels-be-used-to-screen-for-primary-aldosteronism-in-a-patient-taking-finerenone weekly 0.8 https://www.themednet.org/do-you-use-antifibrotics-in-patients-with-restrictive-allograft-syndrome-post-lung-transplant weekly 0.8 https://www.themednet.org/do-you-recommend-a-trial-of-testosterone-replacement-therapy-in-male-patients-with-symptoms-consistent-with-hypogonadism-low-total-testosterone-but-normal-free-androgen-index-fai weekly 0.8 https://www.themednet.org/are-you-aware-of-drug-induced-anca-vasculitis-associated-with-new-wt-loss-medications-ex-tirzepatide-or-semaglutide weekly 0.8 https://www.themednet.org/do-you-routinely-offer-suppressive-antibiotics-to-patients-with-a-prosthetic-joint-infection-when-surgery-is-delayed-for-months weekly 0.8 https://www.themednet.org/can-a-biopsy-finding-of-eosinophilia-in-the-gut-esophagus-stomach-duodenum-be-reactive-in-the-setting-of-crohns-disease-or-due-to-anti-tnf-blockade weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-profound-hyperpigmentation-of-the-face-and-neck-which-is-attributed-to-a-post-covid-vaccine-reaction weekly 0.8 https://www.themednet.org/how-would-you-approach-egpa-with-renal-involvement-that-was-on-maintenance-rituximab-last-infusion-two-months-ago-and-develops-new-onset-liver-involvement weekly 0.8 https://www.themednet.org/what-are-reasonable-induction-and-paralytic-agents-to-use-during-intubation-for-patients-with-acute-mi-and-newly-reduced-lvef-with-biventricular-failure weekly 0.8 https://www.themednet.org/what-is-your-experience-and-treatment-efficacy-of-tucatinib-if-used-after-enhertu-in-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/can-clomiphene-therapy-cause-low-libido-while-increasing-the-testosterone-level-in-men-with-low-testosterone weekly 0.8 https://www.themednet.org/how-are-small-to-medium-sized-clinics-1-2-machines-maximizing-efficiency-of-scheduling-patients-on-the-machine weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-patients-who-develop-arthritis-following-asymptomatic-or-mild-chikungunya-infection weekly 0.8 https://www.themednet.org/what-would-be-an-ideal-time-to-place-a-vp-shunt-in-a-patient-with-candida-meningitis-ventriculitis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-use-of-tms-for-treatment-refractory-schizophrenia weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-to-biopsy-confirmed-chronic-lichen-nitidus-in-an-adult-recalcitrant-to-topical-steroids-topical-calcineurin-inhibitors-and-topical-ruxolitinib weekly 0.8 https://www.themednet.org/do-you-recommend-using-topical-metronidazole-for-managing-odor-related-to-pressure-ulcers weekly 0.8 https://www.themednet.org/do-you-recommend-starting-testosterone-replacement-therapy-in-male-patients-with-hypogonadism-symptoms-total-testosterone-levels-at-the-higher-end-of-normal-above-500-but-low-free-testosterone weekly 0.8 https://www.themednet.org/do-you-routinely-monitor-inr-when-starting-glp1-r-agonist-therapy-on-patients-taking-warfarin weekly 0.8 https://www.themednet.org/would-you-give-ivig-for-rituximab-induced-immunodeficiency-in-patients-with-reduced-kidney-function-from-renal-gpa weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-chemotherapy-for-high-grade-node-positive-medullary-renal-cell-cancer-after-complete-resection-with-negative-margins weekly 0.8 https://www.themednet.org/how-long-would-you-wait-to-place-a-new-bone-flap-for-a-patient-with-c-auris-skull-osteomyelitis-associated-with-cranioplasty-s-p-bone-flap-removal-who-is-currently-on-anti-fungal-therapy weekly 0.8 https://www.themednet.org/what-second-line-therapy-would-you-recommend-for-a-patient-with-a-pathogenic-brca-1-mutation-and-stage-iiia-fallopian-tube-high-grade-serous-carcinoma-who-underwent-r0-cytoreduction-followed-by-6-cycles-of-carboplatin-paclitaxel-with-complete-response-who weekly 0.8 https://www.themednet.org/is-there-a-role-for-genetic-testing-after-diagnosing-hae weekly 0.8 https://www.themednet.org/how-do-you-manage-recurrent-epistaxis-from-nasal-steroids weekly 0.8 https://www.themednet.org/when-would-you-favor-initiation-of-mepolizumab-versus-dupilumab-for-crswnp weekly 0.8 https://www.themednet.org/are-you-using-any-ai-models-to-de-label-penicillin-allergy weekly 0.8 https://www.themednet.org/how-do-you-discuss-the-overlap-of-pots-ehlers-danlos-and-mcas-with-patients weekly 0.8 https://www.themednet.org/do-you-consider-immunoglobulin-replacement-in-a-patient-who-has-rapidly-waning-vaccine-titers-but-does-appropriately-respond-to-revaccination weekly 0.8 https://www.themednet.org/how-have-you-employed-ai-based-tools-in-your-practice-and-what-do-you-foresee-its-role-becoming weekly 0.8 https://www.themednet.org/how-do-you-define-sepsis-in-2024 weekly 0.8 https://www.themednet.org/how-would-you-manage-ib-vulvar-small-cell-neuroendocrine-carcinoma-after-surgical-treatment-revealing-a-5cm-tumor-with-closest-margin-2-3mm-and-negative-sentinel-lymph-nodes weekly 0.8 https://www.themednet.org/when-should-antibiotics-be-discontinued-for-an-immunocompetent-patient-with-signs-of-meningoencephalitis-who-undergoes-an-lp-without-prior-administration-of-antibiotics-and-the-csf-shows-a-neutrophilic-pleocytosis-negative-gram-stain-negative-pcr-panel-an weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-on-tocilizumab-for-recently-diagnosed-severe-gca-who-developed-a-bowel-obstruction-several-weeks-after-the-first-dose-of-tocilizumab weekly 0.8 https://www.themednet.org/how-do-you-distinguish-between-senile-hypertensive-sigmoid-septal-hypertrophy-versus-sigmoid-septal-hypertrophy-seen-in-hypertrophic-cardiomyopathy weekly 0.8 https://www.themednet.org/would-you-ever-consider-retreatment-with-an-antiresorptive-medication-in-a-patient-with-a-remote-history-of-atypical-fracture-attributed-to-an-oral-bisphosphonate weekly 0.8 https://www.themednet.org/would-you-offer-radiotherapy-for-a-symptomatic-large-intraorbital-venous-lymphatic-malformation-that-is-non-operable weekly 0.8 https://www.themednet.org/what-would-be-the-recommended-sequencing-of-adjuvant-chemotherapy-osimertinib-and-postoperative-radiation-for-a-patient-with-nsclc-who-was-upstaged-to-stage-iii-following-resection-with-negative-margins weekly 0.8 https://www.themednet.org/when-differentiating-and-treating-patients-with-shock-distributive-cardiogenic-how-reliable-would-you-consider-the-noninvasive-clinical-platform-ev1000-when-derived-from-peripheral-arterial-lines weekly 0.8 https://www.themednet.org/with-regards-to-cat-allergy-and-immunotherapy-do-you-test-both-cat-pelt-and-cat-hair-separately weekly 0.8 https://www.themednet.org/what-factors-influence-your-choice-of-emr-vs-esd-vs-ftr-for-gastric-neoplastic-lesions weekly 0.8 https://www.themednet.org/what-do-you-consider-an-optimal-interval-of-time-to-repeat-necrosectomies-for-treatment-of-won weekly 0.8 https://www.themednet.org/which-patients-would-benefit-from-pancreatic-duct-stents-in-combination-with-rectal-indomethacin-for-prophylaxis-against-post-ercp-pancreatitis weekly 0.8 https://www.themednet.org/what-prompts-you-to-seek-an-alternative-ppi-versus-escalating-to-pcab-therapy-in-patients-with-symptoms-and-sequelae-of-gerd-who-have-clinically-failed-one-ppi-trial-despite-appropriate-pre-prandial-use weekly 0.8 https://www.themednet.org/what-inpatient-diagnostic-workup-do-you-pursue-in-a-patient-with-an-unspecified-vomiting-disorder-who-cannot-be-discharged-due-to-poor-po-tolerance weekly 0.8 https://www.themednet.org/what-recommendations-do-you-provide-to-advance-an-inpatients-oral-tolerance-in-the-setting-of-an-unspecified-vomiting-disorder weekly 0.8 https://www.themednet.org/what-factors-guide-your-choice-of-hot-snare-polypectomy-vs-cold-snare-polypectomy-for-non-pedunculated-colonic-polyps-between-10-20-mm-in-size-and-those-greater-than-20-mm-in-size weekly 0.8 https://www.themednet.org/what-sampling-techniques-do-you-use-to-improve-the-diagnostic-yield-of-biopsies-in-a-patient-with-suspected-vasculitis-and-extensive-scattered-ulceration-throughout-the-gi-tract weekly 0.8 https://www.themednet.org/how-would-you-treat-blue-rubber-bleb-nevus-syndrome weekly 0.8 https://www.themednet.org/what-pharmacologic-therapies-do-you-use-to-treat-alcohol-use-disorder-in-a-patient-with-cirrhosis weekly 0.8 https://www.themednet.org/in-which-patients-do-you-recommend-endoscopic-bariatric-procedures-such-as-endoscopic-sleeve-gastroplasty-instead-of-laparoscopic-bariatric-surgery weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-who-is-reliant-on-nsaids-for-arthritis-but-has-developed-pud weekly 0.8 https://www.themednet.org/how-do-you-treat-refractory-bipolar-disorder-ii-depression weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-hidradenitis-suppurativa-and-inflammatory-arthritis-ra-vs-psa weekly 0.8 https://www.themednet.org/how-do-you-use-tms-for-tinnitus-where-do-you-target-and-what-settings-on-the-magnet-do-you-use-is-anyone-using-either-itbs-or-ctbs-for-this weekly 0.8 https://www.themednet.org/how-does-outflow-tract-vt-differ-in-management-between-structurally-normal-and-structurally-abnormal-hearts weekly 0.8 https://www.themednet.org/do-you-utilize-scheduled-acetaminophen-in-patients-with-sepsis-and-respiratory-or-circulatory-organ-failure weekly 0.8 https://www.themednet.org/how-would-you-approach-a-case-of-enteroblastic-cholangiocarcinoma weekly 0.8 https://www.themednet.org/how-are-you-incorporating-tumor-treating-fields-for-locally-progressive-metastatic-nsclc-if-at-all weekly 0.8 https://www.themednet.org/what-is-your-preferred-regimen-for-a-patient-with-clear-cell-rcc-progression-after-an-io-io-regimen-with-a-chronic-non-healing-wound weekly 0.8 https://www.themednet.org/in-a-neonate-with-cerebral-sinus-venous-thrombosis-who-is-fluid-limited-by-renal-or-cardiac-disease-do-you-recommend-hyperhydration-before-anticoagulation weekly 0.8 https://www.themednet.org/how-do-you-use-bridge-therapies-such-as-prednisone-or-naproxen-for-chronic-pediatric-migraine weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-to-diagnose-ataxic-cerebral-palsy weekly 0.8 https://www.themednet.org/can-you-see-false-positive-autoimmune-serologies-in-patients-with-a-history-of-stem-cell-transplant-and-chronic-graft-vs-host-disease weekly 0.8 https://www.themednet.org/is-there-a-role-for-checking-hormone-receptor-status-on-lcis-before-offering-chemoprevention weekly 0.8 https://www.themednet.org/in-what-situations-would-you-use-direct-to-inject-art-such-as-cabenuva-without-an-oral-lead-in weekly 0.8 https://www.themednet.org/how-do-you-manage-enfortumab-vedotin-related-dka-that-is-refractory-to-standard-therapy-insulin-fluids-etc weekly 0.8 https://www.themednet.org/do-you-recommend-prescribing-one-or-two-parenteral-antibiotics-in-addition-to-oral-therapy-in-the-management-of-mycobacterium-abscesses-peritonitis-related-to-peritoneal-dialysis weekly 0.8 https://www.themednet.org/what-alternative-treatment-regimen-do-you-recommend-for-patients-with-mycobacterium-kansasii-lung-infection-who-can-no-longer-tolerate-ethambutol-due-to-drug-toxicities weekly 0.8 https://www.themednet.org/do-you-prolong-iv-therapy-or-reduce-the-number-of-antibiotic-agents-for-patients-with-pulmonary-ntm-infections-who-have-completed-induction-iv-therapy-and-cannot-access-oral-antibiotic-therapy-due-to-cost weekly 0.8 https://www.themednet.org/what-is-your-recommendation-for-timing-of-urgent-chemotherapy-in-patients-with-s-aureus-bacteremia-or-endocarditis-who-require-prolonged-durations weekly 0.8 https://www.themednet.org/is-there-any-definitive-contraindication-to-use-tamoxifen-in-patients-with-a-brain-aneurysm-that-is-being-monitored weekly 0.8 https://www.themednet.org/can-blood-pressure-measurements-be-reliably-interpreted-and-obtained-using-forearm-cuff-pressures-especially-for-patients-in-certain-situations-such-as-obesity weekly 0.8 https://www.themednet.org/do-you-have-concerns-about-the-use-of-red-light-therapy-in-a-patient-with-lupus weekly 0.8 https://www.themednet.org/is-there-an-increased-risk-of-dementia-in-patients-with-adhd-since-both-conditions-affect-executive-function weekly 0.8 https://www.themednet.org/do-you-routinely-consider-evaluation-for-edac-in-patients-with-asthma-or-copd-on-maximal-inhaler-therapy-who-have-refractory-symptoms weekly 0.8 https://www.themednet.org/have-you-found-radiation-to-be-helpful-in-the-management-of-xanthogranuloma weekly 0.8 https://www.themednet.org/does-entresto-interfere-with-the-measurement-of-arr-aldosterone-to-renin-ratio-when-working-up-a-patient-for-hyperaldosteronism weekly 0.8 https://www.themednet.org/what-features-on-history-or-physical-drive-you-to-order-an-extended-workup-in-patients-with-hirsutism-or-acne weekly 0.8 https://www.themednet.org/how-do-you-help-patients-understand-the-difference-between-prolonged-morning-stiffness-and-pain weekly 0.8 https://www.themednet.org/what-is-your-threshold-for-initiating-tocilizumab-in-patients-with-norse weekly 0.8 https://www.themednet.org/have-you-ever-seen-a-case-of-c-difficile-from-topical-mupiricin weekly 0.8 https://www.themednet.org/how-do-you-approach-psychotropic-demonstrated-ssris-and-antipsychotics-induced-urinary-retention-when-a-patient-is-otherwise-having-good-response-to-treatment weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-therapy-for-resected-gb-cancer-6-months-of-surgery-time-if-there-are-high-risk-features-pt3n0-positive-margins-pni-and-therapy-was-delayed-due-to-hepatic-abscess-post-operative weekly 0.8 https://www.themednet.org/when-if-ever-would-you-pursue-genetic-testing-in-an-asymptomatic-child-with-multiple-first-degree-relatives-with-epilepsy weekly 0.8 https://www.themednet.org/how-would-you-manage-concurrent-immunotherapy-related-colitis-and-c-difficile-infection weekly 0.8 https://www.themednet.org/if-a-patient-has-progression-of-scleroderma-ild-on-mmf-alone-and-you-are-planning-to-start-tocilizumab-would-you-continue-mmf-at-a-lower-dose-to-maintain-skin-softening weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-constipation-in-patients-with-chronic-kidney-disease weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-when-deciding-whether-to-start-esketamine-treatment-for-patients-with-treatment-resistant-mdd-who-are-concomitant-cns-depressants weekly 0.8 https://www.themednet.org/would-you-consider-the-addition-of-trabectedin-to-adjuvant-doxorubicin-in-a-patient-with-ivb-leiomyosarcoma-with-completely-resected-disease-hysterectomy-and-thigh-mass-with-negative-margins weekly 0.8 https://www.themednet.org/how-do-you-counsel-parents-of-patients-with-autism-spectrum-disorder-regarding-the-limitations-of-medications-without-engaging-in-behavioral-or-family-interventions weekly 0.8 https://www.themednet.org/what-infectious-differentials-should-be-considered-for-a-patient-with-intractable-erythema-nodosum-that-is-non-responsive-to-acyclovir-and-steroids weekly 0.8 https://www.themednet.org/how-long-of-a-drug-holiday-can-you-offer-to-patients-being-treated-with-exemestane-who-develop-severe-and-disabling-side-effects-tenosinovitis-joint-arthritis-and-repeatedly-test-negative-to-ctdna weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-proximal-lower-limb-asymmetrical-weakness-and-pain-of-thighs-mri-findings-of-muscle-enhancement-of-bilateral-thighs-but-muscle-biopsy-with-vasculitis-changes-only-without-findings-of-myositis weekly 0.8 https://www.themednet.org/in-a-patient-with-psoriatic-arthritis-and-recurrent-pericarditis-would-you-combine-abatacept-or-other-biologics-with-rilonacept weekly 0.8 https://www.themednet.org/how-would-you-interpret-the-presence-of-both-high-titer-anti-pr3-and-anti-mpo-antibodies-in-a-panca-positive-patient-with-evidence-of-small-vessel-vasculitis weekly 0.8 https://www.themednet.org/have-you-utilized-jak-inhibitors-in-patients-on-dialysis weekly 0.8 https://www.themednet.org/have-you-had-experience-performing-punch-mini-grafts-for-vitiligo weekly 0.8 https://www.themednet.org/would-you-recommend-using-a-rectal-swab-for-c-difficile-testing-in-an-inpatient-with-diarrhea-if-nurses-have-been-unable-to-collect-a-stool-sample-for-24-hours-due-to-the-patient-not-cooperating-with-collection weekly 0.8 https://www.themednet.org/would-you-use-anabolic-agents-romosozumab-or-pth-analogues-for-osteoporosis-treatment-in-patients-with-ckd weekly 0.8 https://www.themednet.org/how-do-you-manage-psychosis-in-a-patient-with-tardive-dyskinesia-where-clozapine-is-not-an-option weekly 0.8 https://www.themednet.org/do-you-consider-immunosuppression-in-a-patient-with-cocaine-induced-midline-lesions-who-is-anca-positive-but-has-no-other-evidence-of-vasculitis weekly 0.8 https://www.themednet.org/have-you-noticed-granulomatous-reactions-becoming-more-common-with-the-rise-in-peptide-based-and-nano-technology-topical-formulations-along-with-increased-use-of-resurfacing-devices-outside-of-physician-oversight weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-steroid-refractory-dress weekly 0.8 https://www.themednet.org/what-behavioral-or-medication-strategies-do-you-recommend-for-the-rigid-thought-processes-of-youth-with-asd weekly 0.8 https://www.themednet.org/do-you-routinely-use-oral-vancomycin-prophylaxis-in-patients-with-a-history-of-cdi-who-are-receiving-antibiotics weekly 0.8 https://www.themednet.org/how-do-you-advise-women-already-at-higher-risk-for-breast-cancer-about-the-potential-relationship-between-antidepressants-and-increased-incidence-of-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-refractory-psoriatic-arthritis-now-well-controlled-on-upadacitinib-in-a-current-smoker-with-a-history-of-melanoma-and-who-recently-developed-an-unprovoked-pulmonary-embolism-now-on-apixaban weekly 0.8 https://www.themednet.org/what-is-the-optimal-salvage-therapy-for-a-patient-with-a-relapsed-primary-mediastinal-yolk-sac-tumor-with-brain-metastases weekly 0.8 https://www.themednet.org/how-do-you-treat-an-adult-with-diamond-blackfan-anemia-that-is-steroid-refractory-transfusion-dependent-and-not-a-candidate-for-transplant weekly 0.8 https://www.themednet.org/when-do-you-need-to-keep-patients-on-anti-seizure-medications-when-they-had-an-acute-symptomatic-seizure-in-the-setting-of-eclampsia-particularly-if-mgso4-was-given-and-there-was-no-seizure-recurrence weekly 0.8 https://www.themednet.org/what-templates-or-scales-do-you-use-as-part-of-the-psychosocial-recipient-evaluation-for-solid-organ-transplant weekly 0.8 https://www.themednet.org/for-patients-on-anti-cd20-therapy-for-ms-without-frequent-opportunistic-infections-are-there-serum-igg-levels-or-alc-levels-in-which-you-pause-or-change-therapy-due-to-low-levels weekly 0.8 https://www.themednet.org/for-patients-with-newly-diagnosed-aml-who-are-induction-chemotherapy-eligible-do-you-dose-reduce-cytarabine-for-any-mild-elevation-in-ast-alt weekly 0.8 https://www.themednet.org/how-do-you-manage-malignancies-in-patients-with-birt-hogg-dube-syndrome-bhd-is-there-concern-for-increased-radiosensitivity weekly 0.8 https://www.themednet.org/how-do-you-work-with-patients-with-somatic-symptom-disorder-who-do-not-have-a-stable-medical-team weekly 0.8 https://www.themednet.org/do-you-pursue-coronary-artery-calcium-scoring-in-patients-with-metabolic-risk-factors-and-autoimmune-disease-in-order-to-guide-decisions-regarding-glp-1-medications weekly 0.8 https://www.themednet.org/where-do-you-introduce-sglt2-and-glp1-medications-in-the-sequence-of-treatments-for-patients-with-lupus-nephritis weekly 0.8 https://www.themednet.org/does-the-pattern-on-chest-ct-help-determine-which-patients-with-ra-ild-will-respond-to-immunosuppression weekly 0.8 https://www.themednet.org/in-patients-with-possible-early-sle-or-undifferentiated-disease-can-multiomics-be-used-to-help-predict-what-disease-phenotype-they-will-develop weekly 0.8 https://www.themednet.org/how-and-when-is-primary-refractory-al-amyloidosis-defined-following-d-cybord-treatment-is-there-a-threshold-of-biomarker-reduction-following-1-2-cycles-that-if-not-met-should-prompt-early-consideration-of-treatment-change weekly 0.8 https://www.themednet.org/is-there-any-contraindication-in-using-tremfya-in-a-patient-with-traumatic-iph weekly 0.8 https://www.themednet.org/would-you-start-antiseizure-medications-in-tuberous-sclerosis-before-seizure-onset weekly 0.8 https://www.themednet.org/what-has-been-your-experience-with-coronary-cta-with-ffr-results-and-its-ability-to-accurately-predict-epicardial-cad-on-diagnostic-lhc weekly 0.8 https://www.themednet.org/how-do-you-manage-a-subchorionic-hematoma-in-type-1-von-willebrand-disease-with-borderline-normal-levels-of-vwf weekly 0.8 https://www.themednet.org/how-would-you-approach-jak-inhibitors-in-pregnancy weekly 0.8 https://www.themednet.org/what-do-you-make-of-the-results-of-the-recent-phase-2-rct-on-zerlasiran-in-terms-of-effectiveness-at-reducing-lipoprotein-a-levels-and-the-timing-for-when-this-will-become-readily-available-for-patients-who-may-benefit-the-most-from-it weekly 0.8 https://www.themednet.org/what-treatment-options-are-there-for-fanconi-syndrome-induced-osteoporosis-in-young-female-patients-outside-of-electrolyte-and-mineral-replacement weekly 0.8 https://www.themednet.org/how-would-you-approach-the-workup-of-a-patient-with-a-history-of-hcc-post-tare-with-a-recent-non-viable-mri-but-a-new-portal-vein-thrombosis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-acne-induced-by-psychiatric-medications-in-patients-who-cannot-discontinue-the-offending-medication weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-igg-kappa-smoldering-myeloma-who-develops-progressive-vision-loss-from-optic-neuropathy weekly 0.8 https://www.themednet.org/would-you-add-immunosuppression-for-recurrent-calcium-kidney-stones-in-a-patient-with-sarcoidosis weekly 0.8 https://www.themednet.org/does-a-positive-lupus-anticoagulant-alone-confer-high-enough-risk-that-warfarin-is-preferred-over-doacs-in-antiphospholipid-syndrome weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-metastatic-renal-cell-carcinoma-who-developed-a-stemi-while-on-tki-lenvatinib-and-immunotherapy-combination weekly 0.8 https://www.themednet.org/in-which-settings-would-you-use-external-beam-radiotherapy-for-retinoblastoma-in-the-upfront-new-diagnosis-setting weekly 0.8 https://www.themednet.org/what-suggestions-do-you-have-to-help-patients-tolerate-patch-delivery-stimulants-without-reverting-back-to-oral-medications weekly 0.8 https://www.themednet.org/how-do-you-counsel-parents-about-the-anticipated-abdominal-pain-associated-with-oral-desensitization-in-peanut-allergic-children weekly 0.8 https://www.themednet.org/what-is-your-diagnostic-and-treatment-approach-to-pediatric-patients-with-erythrocytosis weekly 0.8 https://www.themednet.org/how-do-you-manage-atypical-adenomatous-hyperplasia-aah-at-the-margin-for-2-sites-of-the-same-lobe-in-a-patient-with-multiple-ggos-s-p-wedge-resection weekly 0.8 https://www.themednet.org/how-do-you-integrate-immunotherapy-as-a-part-of-neoadjuvant-treatment-for-msi-high-stage-iii-gastric-carcinoma weekly 0.8 https://www.themednet.org/in-the-era-of-targeted-therapies-are-there-any-specific-cytokines-that-help-guide-therapy weekly 0.8 https://www.themednet.org/can-hypogammaglobulinemia-cause-a-false-negative-dif-in-bullous-disease weekly 0.8 https://www.themednet.org/what-dose-contraints-do-use-for-the-pulmonary-artery-and-vein-when-treating-with-a-lung-lesion-with-sbrt weekly 0.8 https://www.themednet.org/which-patients-with-metastatic-her2-negative-pd-l1-1-esophageal-cancer-patients-would-you-utilize-paclitaxel-ramucirumab-maintenance weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiation-therapy-for-a-completely-resected-node-positive-mucoepidermoid-carcinoma-of-the-lung weekly 0.8 https://www.themednet.org/what-sheath-s-is-preferred-for-crossing-a-bioprosthetic-aortic-valve-during-vt-ablation weekly 0.8 https://www.themednet.org/how-if-at-all-do-you-incorporate-the-new-2023-acr-eular-criteria-for-diagnosing-antiphospholipid-syndrome weekly 0.8 https://www.themednet.org/how-would-you-workup-an-elevated-igg-level-in-which-there-is-no-evidence-of-cirrhosis-or-autoimmune-hepatitis-on-liver-biopsy weekly 0.8 https://www.themednet.org/are-there-data-to-support-the-use-of-herbal-supplements-prebiotics-or-probiotics-in-the-management-of-sibo weekly 0.8 https://www.themednet.org/how-do-you-interpret-a-negative-anca-and-a-low-positive-pr3 weekly 0.8 https://www.themednet.org/how-do-you-manage-recurrent-c-diff-which-occurs-shortly-after-fmt-when-alternate-etiologies-of-diarrhea-have-been-excluded-and-patient-is-responding-to-c-diff-directed-therapies weekly 0.8 https://www.themednet.org/what-is-the-role-of-combination-antimicrobial-antiviral-and-immunomodulatory-therapies-in-managing-recurrent-erythema-multiforme-with-suspected-infectious-triggers weekly 0.8 https://www.themednet.org/would-you-use-a-gi-regimen-folfox-or-a-gyn-regimen-carboplatin-paclitaxel-immuno-for-a-71yo-women-with-ascites-a-large-pelvic-mass-arising-from-the-uterus-on-ct-and-peritoneal-implants-that-are-cdx2-positive-pax-8-wt-1-negative-p53-wild-type-intestinal-ty weekly 0.8 https://www.themednet.org/is-it-safe-to-combine-prolia-with-other-immunosuppressants weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-figo-stage-iiib-endometrial-carcinoma-who-developed-significant-back-pain-with-carboplatin-paclitaxel-cycle-1-which-worsened-during-cycle-2 weekly 0.8 https://www.themednet.org/in-light-of-wsg-adapt-hr-her2-trial-at-sabcs-2024-showing-a-5-year-idfs-benefit-with-neoadjuvant-nab-paclitaxel-over-paclitaxel-will-you-change-your-practice weekly 0.8 https://www.themednet.org/when-treating-esophageal-cancer-with-post-operative-radiation-what-if-any-are-some-strategies-to-minimize-the-risk-of-complications-at-the-site-of-surgical-anastomosis weekly 0.8 https://www.themednet.org/have-you-encountered-idiopathic-aseptic-facial-granuloma-in-areas-other-than-the-face weekly 0.8 https://www.themednet.org/when-would-you-consider-lacosamide-for-treatment-of-status-epilepticus-in-patients-with-prolonged-pr-interval-or-first-degree-av-block weekly 0.8 https://www.themednet.org/do-you-recommend-consolidation-immunotherapy-after-sbrt-or-surgery-and-chemo-for-t1-t2n0-sclc weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-severe-tricuspid-regurgitation-secondary-to-endocarditis-with-the-presence-of-an-rv-pacemaker-lead-in-place weekly 0.8 https://www.themednet.org/is-there-a-role-for-thiotepa-based-auto-transplant-for-consolidation-in-pcnsl-if-the-patient-had-progression-on-both-mtx-and-ara-c weekly 0.8 https://www.themednet.org/what-specific-clinical-signs-or-epidemiological-indicators-do-you-prioritize-for-early-identification-of-bartonella-quintana-infection weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-egpa-with-main-manifestations-of-asthma-nasal-polyposis-and-mononeuritis-multiplex-who-has-clinically-responded-to-rituximab-yet-has-persistently-high-eosinophilia-40 weekly 0.8 https://www.themednet.org/how-would-you-approach-patients-with-high-risk-localized-prostate-cancer-per-stampede-criteria-receiving-rt-and-concurrent-adt-but-are-unable-to-tolerate-abiraterone-secondary-to-toxicities weekly 0.8 https://www.themednet.org/how-would-you-approach-the-evaluation-and-management-of-isolated-vasculitis-with-aneurysms-involving-the-segmental-hepatic-arteries-causing-hepatic-hemorrhage-in-an-otherwise-healthy-patient-in-his-80s weekly 0.8 https://www.themednet.org/what-is-the-data-to-guide-salvage-radiation-to-a-patient-with-recurrence-anal-cancer-to-the-lymph-node-after-an-initial-definitive-chemoradiation weekly 0.8 https://www.themednet.org/how-do-you-manage-hepatotoxicity-thought-to-be-related-to-romosozumab-use weekly 0.8 https://www.themednet.org/how-long-should-a-patient-be-treated-with-a-bisphosphonate-after-a-course-of-an-anabolic-medication-has-been-completed weekly 0.8 https://www.themednet.org/are-there-any-known-contraindications-or-scenarios-in-which-using-antifibrinolytics-would-cause-worsening-of-bleeding-symptoms weekly 0.8 https://www.themednet.org/how-would-you-approach-a-young-fit-patient-with-suspected-cns-involvement-with-high-circulating-blasts weekly 0.8 https://www.themednet.org/how-should-we-interpret-dxa-scans-in-patients-with-ankylosing-spondylitis-who-have-ankylosis-of-the-spine weekly 0.8 https://www.themednet.org/what-could-potentially-account-for-new-increases-in-ntprobnp-or-bnp-levels-in-patients-immediately-post-teer-of-mitral-and-or-tricuspid-valves-without-clinical-signs-of-heart-failure-and-or-volume-overload weekly 0.8 https://www.themednet.org/after-achieving-clinical-response-to-bexarotene-for-cutaneous-lymphoma-e-g-mf-stage-ib-or-fmf-do-you-wean-to-the-lowest-dose-for-sustained-remission-and-if-so-when weekly 0.8 https://www.themednet.org/what-do-you-do-when-a-patient-with-postpartum-depression-at-risk-for-harming-their-children-stops-treatment-against-medical-advice weekly 0.8 https://www.themednet.org/is-it-safe-to-prescribe-invokana-or-metformin-for-patients-taking-biktarvy weekly 0.8 https://www.themednet.org/do-you-accelerate-your-withdrawal-time-with-the-utilization-of-add-on-devices-to-the-colonoscope-such-as-endocuff-that-enhance-mucosal-inspection-and-polyp-detection weekly 0.8 https://www.themednet.org/how-do-you-use-coronary-cta-qualitative-plaque-analysis-low-attenuation-versus-calcified-plaque-for-example-in-routine-clinical-practice weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-antimicrobial-therapy-for-intra-abdominal-infections-to-avoid-unnecessary-double-anaerobic-coverage-in-light-of-associated-risks-and-guidelines weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-chemotherapy-for-older-patients-75-years-of-age-with-t4b-grade-2-hr-her2-mucinous-carcinoma-of-the-breast weekly 0.8 https://www.themednet.org/is-there-benefit-of-cold-cap-use-while-patient-is-on-sacituzumab-govitecan weekly 0.8 https://www.themednet.org/can-inflammatory-arthritis-develop-in-patients-with-a-history-of-chronic-hepatitis-b weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-a-patient-with-ra-on-methotrexate-who-has-gingivitis-or-or-frequent-cavities weekly 0.8 https://www.themednet.org/would-you-consider-use-of-doxycycline-for-deep-seated-pasteurella-multicoda-infection-in-a-patient-with-contraindications-to-first-line-antimicrobial-agents weekly 0.8 https://www.themednet.org/when-do-you-recommend-adjuvant-trastuzumab-for-completely-resected-uterine-cancer-and-for-how-long-do-you-give-it weekly 0.8 https://www.themednet.org/would-you-consider-the-combination-of-amivantamab-and-lazertinib-in-a-patient-with-nsclc-harboring-an-egfr-exon-19-deletion-that-transformed-to-small-cell-carcinoma-on-osimertinib-if-resistance-profiling-still-detects-the-egfr-mutation weekly 0.8 https://www.themednet.org/how-do-you-manage-follow-up-for-patient-who-was-diagnosed-with-pineal-gland-germinomas-with-drop-metastases-to-the-spinal-cord weekly 0.8 https://www.themednet.org/would-you-be-more-inclined-to-offer-adjuvant-therapy-to-a-patient-who-is-age-60-with-stage-1b-seminoma weekly 0.8 https://www.themednet.org/how-would-you-approach-a-toddler-with-alternating-head-tilt-episodes-lasting-for-weeks weekly 0.8 https://www.themednet.org/are-there-specific-tools-that-you-request-for-an-iep-of-a-child-with-dyslexia weekly 0.8 https://www.themednet.org/when-is-the-most-appropriate-time-to-initiate-evaluation-for-learning-disorders-following-traumatic-brain-injury-in-an-adolescent weekly 0.8 https://www.themednet.org/do-you-use-metronidazole-twice-daily-dosing-for-routine-anaerobic-coverage-such-as-non-cns-h-pylori-c-diff-or-parasitic-infections weekly 0.8 https://www.themednet.org/how-would-you-approach-the-risk-benefit-ratio-of-systemic-anticoagulation-in-certain-clinical-scenarios-such-as-atrial-fibrillation-or-lv-thrombus-when-a-patients-history-is-also-notable-for-type-b-aortic-dissection-or-other-aortic-pathology-such-as-aorti weekly 0.8 https://www.themednet.org/what-is-the-clinical-significance-of-intracardiac-vacuum-s-noted-during-diastole-especially-in-terms-of-the-diagnosis-and-management-of-diastolic-dysfunction weekly 0.8 https://www.themednet.org/what-is-your-diagnostic-approach-to-mild-chronic-eosinophilia-with-aec-1500 weekly 0.8 https://www.themednet.org/how-do-you-transition-between-tkis-for-stage-iv-nsclc-with-actionable-mutations weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-co-occurring-adhd-and-cardiac-concerns weekly 0.8 https://www.themednet.org/should-there-be-age-cut-off-considerations-when-ordering-ttes-with-bubble-routinely-as-part-of-stroke-work-up weekly 0.8 https://www.themednet.org/do-you-have-any-experience-with-compounded-iguratimod-either-as-adjunctive-therapy-or-monotherapy-for-rheumatoid-arthritis-sjogrens-or-axial-spondyloarthropathy weekly 0.8 https://www.themednet.org/would-a-patient-with-a-resected-nsclc-mass-under-3-cm-without-lymph-node-involvement-or-distant-metastases-but-with-visceral-invasion-identified-on-pathology-benefit-from-adjuvant-therapy weekly 0.8 https://www.themednet.org/do-routinely-recommend-antifungal-prophylaxis-for-non-transplant-patients-who-have-been-diagnosed-and-completed-treatment-for-possible-probable-pulmonary-aspergillosis-and-who-will-need-varying-degrees-of-ongoing-immunosuppression weekly 0.8 https://www.themednet.org/would-you-have-concerns-with-continuing-denosumab-for-much-longer-than-the-available-ten-year-clinical-safety-trial-data-for-an-individual-with-renal-insufficiency-with-persistent-osteoporosis-history-of-compression-fractures weekly 0.8 https://www.themednet.org/based-on-the-results-of-the-bladderpath-trial-are-you-considering-multiparametric-bladder-mri-for-all-patients-with-suspected-bladder-cancer-diagnosis-prior-to-turbt-or-for-select-patients-only weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-choose-palopegteriparatide-over-teriparatide-in-patients-with-chronic-hypoparathyroidism weekly 0.8 https://www.themednet.org/how-do-you-select-patients-for-placement-of-minimally-invasive-bedside-subdural-drain weekly 0.8 https://www.themednet.org/what-is-a-reasonable-duration-of-therapy-post-operatively-for-ccb-or-nitrate-use-in-patients-who-have-undergone-cabg-with-radial-artery-bypass-graft weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-patient-with-mixed-cryoglobulinemic-vasculitis-with-predominant-skin-involvement-and-no-major-organ-involvement weekly 0.8 https://www.themednet.org/how-do-you-manage-prevent-recurrent-hordeolum weekly 0.8 https://www.themednet.org/what-is-your-preferred-p2y12-inhibitor-to-use-upstream-of-stemi-cases-if-you-decide-to-administer-an-agent-before-proceeding-to-the-cath-lab weekly 0.8 https://www.themednet.org/when-should-mitomycin-intravascular-chemoembolization-be-considered-as-a-treatment-for-corneal-neovascularization weekly 0.8 https://www.themednet.org/what-factors-influence-the-choice-of-reconstructive-technique-considering-both-oncological-control-and-cosmetic-outcomes-when-performing-surgery-for-periocular-melanoma weekly 0.8 https://www.themednet.org/how-do-you-determine-the-role-of-adjunctive-therapies-for-a-patient-with-conjunctival-squamous-cell-carcinoma-scc-that-has-recurred-after-initial-surgical-excision weekly 0.8 https://www.themednet.org/in-stage-iv-oligometastatic-nsclc-when-considering-local-consolidative-therapies-to-the-primary-tumor-do-providers-typically-stage-the-mediastinum-at-diagnosis-or-after-initial-systemic-therapy-assuming-no-progression weekly 0.8 https://www.themednet.org/is-there-any-data-supporting-the-use-of-osimertinib-in-patients-with-l858r-mutated-lung-cancer-who-had-a-durable-response-to-prior-egfr-tki-therapy-and-who-progressed-1-2-years-after-discontinuation-of-other-egfr-inhibitors weekly 0.8 https://www.themednet.org/how-do-you-treat-adhd-with-comorbid-menieres-disease weekly 0.8 https://www.themednet.org/in-a-patient-with-cied-lead-infection-and-bacteremia-who-had-blood-cultures-cleared-before-cied-extraction-do-we-still-need-72-hrs-of-documented-negative-blood-cultures-obtained-post-extraction-to-consider-reimplantation-and-can-we-do-same-time-extraction weekly 0.8 https://www.themednet.org/what-is-the-diagnostic-approach-and-management-for-suspected-hashimoto-encephalitis weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-hand-oa weekly 0.8 https://www.themednet.org/how-would-you-manage-a-healthy-young-adult-patient-with-nodular-lymphocyte-predominant-hodgkin-lymphoma-with-steroid-responsive-severe-hemolytic-anemia-and-no-other-symptoms weekly 0.8 https://www.themednet.org/would-you-prescribe-a-glp-1-receptor-agonist-for-an-obese-patient-with-low-to-moderate-cardiovascular-risk-but-a-high-cac-score weekly 0.8 https://www.themednet.org/what-are-the-treatment-options-for-refractory-dysthyroid-optic-neuropathy-in-a-patient-with-extensive-gastrointestinal-history-including-gastric-ulcers-and-colitis weekly 0.8 https://www.themednet.org/can-dupixent-and-durvalumab-be-used-at-the-same-time-in-a-patient-with-extensive-stage-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-ra-with-newly-diagnosed-t-lgll-who-was-previously-treated-with-enbrel-and-is-now-flaring-off-enbrel-while-on-low-dose-methotrexate weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-intensification-in-patients-with-ra-and-low-disease-activity-but-not-in-remission-considering-the-potential-risks-of-increased-immunosuppression weekly 0.8 https://www.themednet.org/does-valproic-acid-or-lithium-use-in-the-egg-donor-pose-a-risk-to-the-fetus-in-a-surrogate-pregnancy weekly 0.8 https://www.themednet.org/does-mbd4-associated-neoplasia-syndrome-predispose-a-patient-to-increased-risk-of-side-effects-or-secondary-malignancy-with-radiation weekly 0.8 https://www.themednet.org/should-a-patient-with-resected-stage-iiia-lung-adenocarcinoma-harboring-an-stk11-mutation-receive-adjuvant-immune-checkpoint-inhibitor-therapy-following-the-completion-of-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/do-you-consider-steroid-sparing-agents-for-treatment-of-patients-with-steroid-responsive-relapsed-hashimoto-encephalopathy weekly 0.8 https://www.themednet.org/would-you-use-methotrexate-to-treat-a-small-t-lgl-clone-650-cells-m3-with-mild-pancytopenia-and-associated-autoimmune-disease-such-as-systemic-sclerosis weekly 0.8 https://www.themednet.org/what-therapy-do-you-recommend-in-situations-where-iv-steroids-and-ivig-do-not-help-patients-with-gaba-a-encephalitis weekly 0.8 https://www.themednet.org/when-measuring-lv-volumes-on-echo-using-ultrasound-enhancing-agents-are-you-using-different-volume-cut-offs weekly 0.8 https://www.themednet.org/would-you-consider-using-elahere-for-patients-with-folr1-positive-metastatic-lung-adenocarcinoma weekly 0.8 https://www.themednet.org/what-is-the-recommended-duration-of-burosumab-therapy-for-treating-x-linked-hypophosphatemia-and-how-is-response-to-therapy-monitored weekly 0.8 https://www.themednet.org/would-you-offer-liver-re-irradiation-in-a-child-pugh-a-patient-with-oligo-metastatic-colon-cancer-to-the-liver-diagnosed-10-years-prior-with-previous-tace-sbrt-to-same-liver-metastasis-5-years-ago weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-early-stage-her2-breast-cancer-patient-who-progressed-on-mastectomy-after-completing-neoadjuvant-tchp weekly 0.8 https://www.themednet.org/do-you-recommend-completion-thyroidectomy-and-rait-in-patients-found-to-have-unifocal-minimally-invasive-follicular-variant-of-papillary-carcinoma-on-pathology-after-thyroid-lobectomy weekly 0.8 https://www.themednet.org/is-it-safe-to-treat-the-stomach-to-a-definitive-dose-if-the-patient-has-a-g-tube-peg-in-place weekly 0.8 https://www.themednet.org/should-we-aim-to-reduce-or-stop-thiazides-in-patients-with-thiazide-induced-hypercalcemia-given-its-similar-risk-profile-to-untreated-primary-hyperparathyroidism weekly 0.8 https://www.themednet.org/what-pharmacologic-and-non-pharmacologic-interventions-have-you-found-helpful-in-the-treatment-of-misophonia weekly 0.8 https://www.themednet.org/in-a-patient-with-potentially-resectable-lung-cancer-experiencing-severe-pain-due-to-chest-wall-invasion-would-you-consider-palliative-radiation-therapy-prior-to-neoadjuvant-perioperative-chemoimmunotherapy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-stage-ie-burkitt-lymphoma-with-stable-disease-after-three-cycle-of-da-r-epoch weekly 0.8 https://www.themednet.org/what-is-the-role-of-mri-in-assessing-the-risk-of-embolism-in-patients-with-persistent-left-ventricular-thrombus-following-myocardial-infarction weekly 0.8 https://www.themednet.org/in-your-experience-do-any-of-the-new-treatments-for-amyloidosis-help-amyloid-arthropathy weekly 0.8 https://www.themednet.org/how-can-the-integration-of-mrd-assessments-into-treatment-protocols-be-optimized-to-improve-risk-stratification-and-therapy-decisions-in-t-all weekly 0.8 https://www.themednet.org/do-patients-with-25-oh-vitamin-d-levels-under-20-ng-ml-and-normal-pth-levels-relative-hypoparathyroidism-still-carry-a-risk-for-bone-and-calcium-metabolism-disorders-such-as-osteomalacia weekly 0.8 https://www.themednet.org/if-a-patient-with-limited-scleroderma-presents-with-the-three-active-domains-including-skin-thickening-inflammatory-joint-pain-and-ild-would-you-consider-starting-actemra weekly 0.8 https://www.themednet.org/as-part-of-work-up-for-hyperparathyroidism-what-form-of-calcium-replacement-dietary-or-supplements-would-you-recommend-in-a-patient-with-a-history-of-gastric-bypass-and-multiple-calcium-containing-kidney-stones weekly 0.8 https://www.themednet.org/what-is-your-approach-to-methotrexate-use-or-avoidance-in-patients-with-varying-mthfr-mutations weekly 0.8 https://www.themednet.org/what-are-some-situations-where-a-non-prednisone-steroid-would-be-more-appropriate-than-prednisone weekly 0.8 https://www.themednet.org/how-might-the-integration-of-pet-ct-with-traditional-imaging-modalities-alter-the-clinical-decision-making-process-for-suspected-cied-infections-without-clear-generator-pocket-involvement weekly 0.8 https://www.themednet.org/what-role-could-emerging-technologies-such-as-antimicrobial-coatings-or-biofilm-disrupting-agents-play-in-reducing-the-incidence-of-cied-infections weekly 0.8 https://www.themednet.org/how-do-you-manage-transaminitis-in-a-patient-receiving-tnf-alpha-inhibitors weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-selective-igm-deficiency-on-ivig-infusions-with-a-new-diagnosis-of-cll weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-a-post-prostatectomy-biochemical-and-pelvic-nodal-recurrence-with-a-blm-mutation weekly 0.8 https://www.themednet.org/in-patients-with-atm-heterozygous-mutation-do-you-prefer-aromatase-inhibitor-over-tamoxifen-for-adjuvant-endocrine-therapy weekly 0.8 https://www.themednet.org/what-symptom-or-constellation-of-symptoms-are-most-specific-for-endometriosis-that-should-prompt-further-workup weekly 0.8 https://www.themednet.org/what-do-you-consider-when-there-is-incidentally-found-patchy-peripheral-nerve-enlargement-on-imaging-with-otherwise-unremarkable-clinical-and-electrophysiological-findings weekly 0.8 https://www.themednet.org/how-do-you-typically-approach-adjuvant-therapy-for-a-masaoka-stage-iva-thymoma-post-r0-resection weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-sle-and-catastrophic-antiphospholipid-antibody-system-that-has-not-responded-to-heparin-steroids-and-plex weekly 0.8 https://www.themednet.org/how-do-you-manage-pleuroparenchymal-fibroelastosis-in-a-patient-with-seronegative-ra-that-is-progressing-on-rituxan-and-dmard-therapy weekly 0.8 https://www.themednet.org/when-do-you-target-the-thalamus-for-seeg-exploration-or-neuromodulation-in-patients-with-drug-resistant-epilepsy weekly 0.8 https://www.themednet.org/would-you-recommend-patients-with-newly-diagnosed-bladder-cancer-to-discontinue-sglt2-inhibitors weekly 0.8 https://www.themednet.org/when-do-you-consider-systemic-therapy-for-patients-with-progressive-fibrosing-mediastinitis weekly 0.8 https://www.themednet.org/how-are-you-utilizing-subcutaneous-nivolumab-in-genitourinary-cancers weekly 0.8 https://www.themednet.org/would-you-offer-bisphosphonate-therapy-for-infants-with-osteogenesis-imperfecta-type-11 weekly 0.8 https://www.themednet.org/do-you-recommend-a-trial-of-tamoxifen-to-treat-young-men-with-painful-unilateral-gynecomastia-with-normal-testosterone-levels weekly 0.8 https://www.themednet.org/when-do-you-consider-altering-treatment-for-a-patient-with-metastatic-osteosarcoma-who-showed-poor-response-to-upfront-therapy-with-map-doxorubicin-cisplatin-methotrexate-chemotherapy weekly 0.8 https://www.themednet.org/what-would-be-an-appropriate-frontline-aml-regimen-for-transplant-ineligible-patients-with-chronic-kidney-disease-creatinine-2-5-or-higher weekly 0.8 https://www.themednet.org/when-managing-bronchial-fistulas-what-factors-determine-if-patching-is-an-appropriate-treatment-option weekly 0.8 https://www.themednet.org/what-estradiol-patch-dose-do-you-recommend-for-transgender-adult-patients-with-prior-history-of-stroke-or-myocardial-infarction weekly 0.8 https://www.themednet.org/have-you-incorporated-the-use-of-mycotox-profiles-into-your-clinical-practice-and-if-so-in-what-capacity weekly 0.8 https://www.themednet.org/how-do-you-approach-hypogammaglobulinemia-in-a-patient-with-sarcoidosis weekly 0.8 https://www.themednet.org/in-patients-with-aml-who-achieve-a-cr-with-hma-ven-what-is-the-optimal-dose-and-schedule-for-venetoclax-for-further-cycles weekly 0.8 https://www.themednet.org/would-you-recommend-starting-an-sglt-2-inhibitors-in-patients-with-non-severe-aortic-stenosis-based-on-recent-evidence-suggesting-it-may-slow-progression-of-disease weekly 0.8 https://www.themednet.org/would-you-consider-re-dosing-rituximab-in-a-patient-with-anca-vasculitis-early-glomerulonephritis-pulmonary-nodules-sinus-symptoms-who-experiences-a-flare-of-the-disease-and-return-of-cd19-cells-3-months-after-initial-rituximab-administration weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-treat-a-patient-with-an-aortic-graft-infection-for-greater-than-6-weeks-of-antibiotic-therapy-whom-has-undergone-total-graft-explanation-and-replacement weekly 0.8 https://www.themednet.org/how-do-you-manage-oral-ulcers-as-a-side-effect-from-leflunomide weekly 0.8 https://www.themednet.org/in-a-patient-with-severe-osteoporosis-t-score-3-9-and-multiple-vertebral-fractures-in-the-setting-of-multiple-myeloma-with-bone-involvement-would-you-consider-adding-an-anabolic-agent-such-as-romosozumab-or-teriparatide-despite-concerns-about-osteosarcoma weekly 0.8 https://www.themednet.org/have-you-experienced-any-issues-with-alvesco-inhalers-getting-clogged-repeatedly weekly 0.8 https://www.themednet.org/what-are-your-top-takeaways-from-the-updated-acs-guidelines-that-will-inform-changes-in-clinical-practice weekly 0.8 https://www.themednet.org/what-is-the-process-for-purchasing-and-billing-medicare-for-biologics-used-in-the-treatment-of-psoriasis weekly 0.8 https://www.themednet.org/in-a-patient-with-a-history-of-parathyroidectomy-due-to-primary-hyperparathyroidism-with-low-t-scores-and-high-risk-of-fractures-is-there-any-contraindication-to-give-teriparatide-forteo-if-pth-is-in-normal-range-after-surgery weekly 0.8 https://www.themednet.org/what-is-your-approach-in-managing-patients-with-suspected-super-infected-pancreatic-pseudocysts-that-are-not-yet-mature-enough-for-drainage weekly 0.8 https://www.themednet.org/how-do-you-work-up-and-manage-an-eskd-patient-with-controlled-blood-pressure-who-complains-of-recurrent-headaches-while-on-hemodialysis weekly 0.8 https://www.themednet.org/how-do-you-approach-tapering-of-anifrolumab-in-patients-with-cutaneous-lupus-who-have-responded-well-to-it weekly 0.8 https://www.themednet.org/what-is-your-experience-using-sucrosomial-iron-for-symptomatic-iron-deficient-patients-who-are-intolerant-of-ferrous-sulfate-and-prefer-an-oral-regimen weekly 0.8 https://www.themednet.org/in-patients-with-contraindications-to-tee-and-poor-windows-for-tte-what-is-the-next-best-test-to-look-for-pfo weekly 0.8 https://www.themednet.org/do-you-treat-with-antibiotics-active-against-methicillin-resistant-staphylococci-when-a-patients-culture-grows-non-lugdunensis-coagulase-negative-staphylococci-that-tests-susceptible-to-oxacillin-by-phenotypic-testing-given-the-low-constitutive-pbp2a-prod weekly 0.8 https://www.themednet.org/what-is-the-best-approach-to-asymptomatic-severe-primary-tricuspid-regurgitation-when-imaging-begins-to-show-rv-enlargement weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-gardasil-after-they-complete-definitive-therapy-for-an-hpv-induced-head-neck-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-locally-advanced-rectal-adenocarcinoma-with-anal-canal-involvement-and-an-involved-unilateral-inguinal-lymph-node weekly 0.8 https://www.themednet.org/would-you-offer-radiation-for-an-atypical-hidraadenoma weekly 0.8 https://www.themednet.org/do-you-manage-gca-with-intracranial-involvement-stroke-any-differently-than-gca-without-intracranial-involvement weekly 0.8 https://www.themednet.org/do-you-discontinue-an-oral-jak-inhibitor-if-a-patient-develops-eczema-herpeticum-while-on-the-drug weekly 0.8 https://www.themednet.org/when-if-ever-would-you-consider-performing-pelvic-sentinel-lymph-node-dissection-for-patients-with-vulvar-cancer-with-positive-inguinal-lymph-nodes weekly 0.8 https://www.themednet.org/how-do-you-treat-hodgkin-lymphoma-relapsed-after-frontline-a-avd weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-therapy-for-a-patient-with-stage-iia1-cervical-adenocarcinoma-with-equivocal-lvsi-following-radical-hysterectomy weekly 0.8 https://www.themednet.org/given-recent-data-would-you-offer-cdk4-6-inhibitor-in-addition-to-ai-or-fulvestrant-to-metastatic-hr-her2-and-brca weekly 0.8 https://www.themednet.org/what-are-your-preferred-additional-therapies-for-cutaneous-leishmaniasis-ie-intralesional-topical-or-thermal weekly 0.8 https://www.themednet.org/would-you-approach-a-previously-strongly-er-and-pr-positive-and-her2-1-breast-ductal-carcinoma-as-a-triple-negative-breast-cancer-if-its-histology-now-shows-er-5-pr-0-her2-0-and-it-is-behaving-like-a-triple-negative weekly 0.8 https://www.themednet.org/whats-your-approach-to-diagnosis-and-management-of-vulvovaginitis-in-patient-with-history-of-lupus-nephritis-in-remission-off-meds-now-for-few-years weekly 0.8 https://www.themednet.org/is-anyone-using-iv-cetirizine-as-an-alternative-to-iv-diphenhydramine-at-their-institution-in-the-outpatient-setting-as-pre-medication-to-prevent-chemotherapy-induced-infusion-reactions weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-for-pediatric-lichen-sclerosus-recalcitrant-to-initial-high-potency-topical-steroids weekly 0.8 https://www.themednet.org/for-a-high-grade-glioma-with-strong-pd-l1-expression-that-has-recurred-progressed-after-standard-of-care-chemoradiation-which-pd-l1-inhibitor-would-you-consider-starting-and-at-what-point weekly 0.8 https://www.themednet.org/how-do-you-approach-initial-treatment-of-unresectable-locally-advanced-er-her2-negative-male-breast-cancer weekly 0.8 https://www.themednet.org/are-there-clinical-features-that-can-help-differentiate-fungal-onycholysis-from-psoriatic-nail-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-referred-for-autoimmune-inner-ear-disease weekly 0.8 https://www.themednet.org/would-a-past-history-of-duodenal-ulcer-be-a-consideration-in-whether-to-use-actemra-in-a-patient-with-giant-cell-arteritis weekly 0.8 https://www.themednet.org/do-you-recommend-a-waiting-period-after-water-vapor-therapy-for-bph-to-start-prostate-xrt weekly 0.8 https://www.themednet.org/is-there-a-role-for-adjuvant-immunotherapy-after-adjuvant-chemotherapy-for-patients-with-stage-ii-iii-nsclc-that-is-pdl1-negative-but-tmb-high-and-without-driver-mutation weekly 0.8 https://www.themednet.org/what-dose-volume-constraints-do-you-use-with-repeat-stereotactic-radiosurgery-for-targets-adjacent-to-brainstem weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-glioblastoma-planned-for-concurrent-radiation-and-chemotherapy-but-unable-to-start-temozolomide-due-to-underlying-comorbities weekly 0.8 https://www.themednet.org/if-a-patient-has-a-positive-lupus-anticoagulant-and-then-the-repeat-is-negative-is-there-utility-in-checking-again-in-the-future-without-a-new-vte-event weekly 0.8 https://www.themednet.org/how-do-you-manage-adamantinoma-like-ewing-sarcoma-ales weekly 0.8 https://www.themednet.org/what-instructions-do-you-normally-give-to-a-male-patient-for-topical-5-fu-usage-for-penile-intraepithelial-lesion weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-osteoporosis-in-patients-on-dialysis weekly 0.8 https://www.themednet.org/are-you-incorporating-arteraai-for-risk-stratification-and-treatment-for-prostate-cancer weekly 0.8 https://www.themednet.org/would-you-advise-an-immunocompromised-patient-that-developed-a-dermatomal-rash-after-the-first-recombinant-zoster-vaccine-to-receive-the-second-dose weekly 0.8 https://www.themednet.org/would-you-consider-any-form-of-hypercoagulable-workup-in-patients-with-acute-coronary-stent-thrombosis weekly 0.8 https://www.themednet.org/what-therapies-have-you-found-most-effective-for-immunocompromised-patients-who-develop-recurrent-thrush weekly 0.8 https://www.themednet.org/for-pediatric-alcl-alk-involving-multiple-bone-sites-what-is-your-preferred-upfront-management weekly 0.8 https://www.themednet.org/what-adjuvant-treatment-would-you-recommend-for-a-microinvasive-er-breast-cancer-with-a-high-ki67 weekly 0.8 https://www.themednet.org/how-do-you-treat-metastatic-tnbc-breast-cancer-with-predominantly-squamous-cell-differentiation-in-a-patient-who-previously-received-ac-t-for-neoadjuvant-therapy weekly 0.8 https://www.themednet.org/what-is-the-role-of-intraoperative-radiation-for-rectal-cancer-with-clinically-close-circumferential-margin-despite-optimal-tnt weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-for-palliation-of-gynecologic-malignancies weekly 0.8 https://www.themednet.org/what-dose-constraints-do-you-use-when-palliating-pelvic-malignancies-with-quad-shot-regimen weekly 0.8 https://www.themednet.org/how-do-you-approach-leflunomide-use-in-patients-with-rheumatoid-arthritis-and-advanced-ckd weekly 0.8 https://www.themednet.org/would-r-chop-x-3-followed-by-isrt-be-considered-suboptimal-treatment-for-stage-ie-high-grade-lymphoma-nos-involving-the-breast-in-a-young-patient weekly 0.8 https://www.themednet.org/how-do-you-mange-stage-iv-rcc-with-high-tumor-burden-responding-to-salvage-io-cabozantinib-but-with-significant-drug-associated-rise-in-serum-creatinine weekly 0.8 https://www.themednet.org/in-a-critically-ill-patient-with-tma-intermediate-risk-plasmic-score-and-severe-vitamin-b12-deficiency-would-you-perform-plasma-exchange-while-awaiting-adamts13-testing weekly 0.8 https://www.themednet.org/is-there-any-role-for-immunotherapy-after-concurrent-chemoradiation-in-patients-with-mediastinal-recurrence-of-early-stage-small-cell-lung-cancer-treated-initially-with-surgery-and-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-lichen-planus-pigmentosus-that-does-not-respond-to-topical-steroids weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-pityriasis-rubra-pilaris-recalcitrant-to-oral-retinoids weekly 0.8 https://www.themednet.org/how-do-you-approach-the-evaluation-and-management-of-granulomatous-myositis weekly 0.8 https://www.themednet.org/what-is-the-optimal-surgical-timing-and-duration-of-perioperative-interruption-of-front-line-parp-inhibitor-maintenance-therapy-for-patients-with-high-grade-serous-ovarian-cancer-who-need-surgical-closure-reanastomosis-of-a-diverting-ostomy weekly 0.8 https://www.themednet.org/what-systemic-option-would-you-use-for-squamous-cell-carcinoma-of-the-kidney-parenchyma-not-renal-pelvis-with-ln-and-lung-mets weekly 0.8 https://www.themednet.org/how-would-you-approach-the-frontline-treatment-of-advanced-stage-t-cell-histiocyte-rich-large-b-cell-lymphoma weekly 0.8 https://www.themednet.org/do-you-hold-or-dose-modify-folfox-for-new-hepatomegaly-seen-on-a-scan-after-starting-treatment weekly 0.8 https://www.themednet.org/what-are-indications-for-adjuvant-radiation-therapy-for-cutaneous-adnexal-tumors-of-the-head-and-neck weekly 0.8 https://www.themednet.org/when-if-ever-would-you-consider-using-docetaxel-cisplatin-5-fu-for-first-line-metastatic-anal-cancer weekly 0.8 https://www.themednet.org/how-do-you-differentiate-between-isaac-syndrome-and-cramp-fasciulation-syndrome weekly 0.8 https://www.themednet.org/is-it-safe-to-give-anti-vegf-treatment-in-a-patient-with-hemorrhagic-brain-metastases weekly 0.8 https://www.themednet.org/how-would-you-evaluate-a-cold-agglutinin-disease-patient-on-observation-developing-recent-drenching-night-sweats weekly 0.8 https://www.themednet.org/in-patients-with-ugt1a1-heterozygous-1-28-status-what-dose-of-irinotecan-do-you-use weekly 0.8 https://www.themednet.org/how-would-you-manage-itp-with-platelet-less-than-5k-in-a-septic-patient-with-renal-failure weekly 0.8 https://www.themednet.org/how-would-you-treat-metastatic-small-cell-neuroendocrine-carcinoma-of-unknown-primary-that-fails-to-respond-to-4-cycles-of-first-line-platinum-etoposide-atezolizumab weekly 0.8 https://www.themednet.org/is-there-a-size-cut-off-for-er-dcis-to-safely-omit-endocrine-therapy weekly 0.8 https://www.themednet.org/how-do-you-manage-therapeutic-anticoagulation-needs-in-patients-with-prostate-cancer-on-enzalutamide weekly 0.8 https://www.themednet.org/how-do-you-approach-lymph-node-evaluation-in-vulvar-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-geriatric-assessment-in-the-oncologic-setting weekly 0.8 https://www.themednet.org/how-do-you-distinguish-between-steroid-induced-and-ici-induced-pancreatitis-in-patients-treated-with-chemo-immunotherapy weekly 0.8 https://www.themednet.org/do-you-place-a-pediatric-patient-with-hgbss-on-chronic-transfusion-therapy-based-on-a-single-clinical-presentation-concerning-for-tia-but-with-a-normal-mra-brain-tcd weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-hpv-vaccine-to-all-patients-who-undergo-excisional-procedure-for-cervical-dysplasia weekly 0.8 https://www.themednet.org/in-a-patient-with-cold-agglutinin-disease-on-observation-when-do-you-suspect-waldenstrom-macroglobulinemia weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-chemotherapy-for-peri-anal-adenocarcinoma-t1n0m0-mss-s-p-chemoradiation-with-pathologic-complete-response-on-apr weekly 0.8 https://www.themednet.org/when-would-you-use-multi-detector-ct-in-the-evaluation-of-mechanical-valve-thrombosis-versus-pannus weekly 0.8 https://www.themednet.org/how-would-you-choose-between-surgery-and-fibrinolysis-in-a-hemodynamically-stable-patient-with-mechanical-valve-thrombosis weekly 0.8 https://www.themednet.org/would-you-consider-giving-adalimumab-to-a-patient-with-psoriatic-arthritis-who-is-4-years-post-melanoma-skin-excision-with-no-sequalae weekly 0.8 https://www.themednet.org/how-do-you-choose-between-gap-or-gp-for-patients-with-borderline-resectable-cholangiocarcinoma weekly 0.8 https://www.themednet.org/when-performing-tavr-for-aortic-insufficiency-what-is-your-approach-to-valvular-sizing weekly 0.8 https://www.themednet.org/to-calculate-the-depth-of-invasion-in-vulvar-cancer-does-your-institution-use-ajcc-nccn-guidelines-most-superficial-dermal-papilla-to-the-deepest-point-of-invasion-or-the-updated-figo-2021-guidelines-basement-membrane-of-the-deepest-adjacent-tumor-free-re weekly 0.8 https://www.themednet.org/what-do-you-recommend-to-manage-autonomic-dysfunction-as-a-result-of-guillian-barre-syndrome weekly 0.8 https://www.themednet.org/when-do-you-recommend-testing-for-hsan3-in-patients-with-autonomic-dysfunction weekly 0.8 https://www.themednet.org/what-recommendations-do-you-provide-to-anesthesiologists-in-regards-to-intra-operative-management-of-patients-with-central-core-myopathy weekly 0.8 https://www.themednet.org/would-you-continue-tocilizumab-for-gca-in-patient-who-developed-an-extensive-dvt-while-on-treatment weekly 0.8 https://www.themednet.org/how-would-you-manage-a-newly-diagnosed-aml-in-a-patient-with-concurrent-metastatic-castrate-resistant-prostate-cancer-that-has-progressed-on-enzalutamide-with-a-doubling-time-of-two-months weekly 0.8 https://www.themednet.org/when-do-you-consider-offering-cytoreductive-surgery-hipec-for-peritoneal-metastases-from-colon-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-hypercalcemia-in-a-patient-with-metastatic-prostate-cancer-with-extensive-bone-metastasis weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-therapy-for-low-grade-endometrioid-ovarian-cancer-s-p-optimal-secondary-cytoreduction-for-pelvic-confined-recurrence weekly 0.8 https://www.themednet.org/how-would-you-manage-cancer-associated-hypoalbuminemia-causing-significant-anasarca weekly 0.8 https://www.themednet.org/are-there-enough-data-to-consider-temozolomide-plus-parp-inhibitor-in-es-sclc-after-progression-on-chemo-immunotherapy-and-lurbinectedin-in-the-absence-of-a-clinical-trial weekly 0.8 https://www.themednet.org/can-romiplostim-be-used-for-chemotherapy-induced-thrombocytopenia-in-a-patient-who-already-had-a-vte weekly 0.8 https://www.themednet.org/what-femoral-head-constraint-do-you-recommend-with-pelvic-reirradiation weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-offer-chemotherapy-or-consider-a-circulating-tumor-dna-test-to-decide-upon-adjuvant-chemotherapy-for-stage-ia-grade-2-endometrioid-ovarian-carcinoma-following-comprehensive-surgical-staging weekly 0.8 https://www.themednet.org/when-does-a-branchial-cleft-cyst-require-removal weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-nivolumab-for-patients-with-gej-adenocarcinoma-who-achieve-a-pcr-to-neoadjuvant-concurrent-chemo-rt weekly 0.8 https://www.themednet.org/what-would-be-your-regimen-of-choice-for-a-young-aya-with-new-diagnosis-of-hodgkin-lymphoma-and-a-history-of-undiagnosed-chronic-kidney-disease-calculated-crcl-30 weekly 0.8 https://www.themednet.org/what-preoperative-considerations-do-you-have-for-a-patient-with-t1-2-breast-cancer-with-an-intramammary-node-and-an-otherwise-negative-clinical-axilla weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-therapy-to-stage-iiib-cecal-medullary-carcinoma-that-is-mmr-proficient weekly 0.8 https://www.themednet.org/in-which-patients-with-metastatic-tnbc-would-you-use-metronomic-chemotherapy weekly 0.8 https://www.themednet.org/would-you-consider-neoadjuvant-endocrine-therapy-for-er-positive-dcis-that-cannot-undergo-negative-margin-mastectomy weekly 0.8 https://www.themednet.org/how-would-you-manage-radiation-induced-organizing-pneumonia-in-a-patient-who-completed-3-field-breast-radiation-5-months-ago weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-an-atypical-carcinoid-of-the-thymus-with-positive-surgical-margins weekly 0.8 https://www.themednet.org/would-you-consider-re-challenging-trastuzumab-after-resolved-grade-2-pneumonitis weekly 0.8 https://www.themednet.org/are-there-any-special-considerations-to-take-into-account-in-workup-and-management-when-treating-a-50-year-old-male-patient-with-idiopathic-osteoporosis-with-strong-family-history weekly 0.8 https://www.themednet.org/what-oral-therapies-do-you-recommend-for-skin-cancer-prevention-in-patients-with-a-history-of-multiple-nmscs weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-if-his-insurance-denies-sbrt-but-he-has-oligometastatic-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-abatacept-and-methotrexate-in-a-patient-with-rheumatoid-arthritis-and-newly-diagnosed-cml-who-is-starting-imatinib-mesylate-gleevec weekly 0.8 https://www.themednet.org/what-treatment-would-you-consider-for-rapid-local-recurrence-of-anal-scc-following-radiation-alone-in-an-elderly-patient-with-borderline-performance-status weekly 0.8 https://www.themednet.org/would-you-consider-itraconazole-or-steroids-in-a-case-of-acute-histoplasma-pneumonia-complicated-by-symptomatic-pleural-effusion-that-does-not-improve-after-tube-thoracostomy-and-tpa-dornase-in-an-immunocompetent-patient weekly 0.8 https://www.themednet.org/do-you-stop-hydroxyurea-or-switch-to-an-alternative-therapy-in-a-female-with-hgbss-disease-who-is-interested-in-having-children weekly 0.8 https://www.themednet.org/how-do-you-manage-cytopenias-in-an-adult-patient-with-osteopetrosis weekly 0.8 https://www.themednet.org/would-it-be-reasonable-to-consider-anticoagulation-for-an-incidental-mural-thrombus-in-the-context-of-apical-akinesia-reduced-ef-in-the-absence-of-acs weekly 0.8 https://www.themednet.org/what-is-the-maximum-dose-you-would-give-to-the-cervical-spinal-cord-with-conventional-fractionation-in-the-setting-of-definitive-treatment weekly 0.8 https://www.themednet.org/how-would-you-approach-anticoagulation-in-a-patient-with-vte-and-history-of-retinal-bleeding weekly 0.8 https://www.themednet.org/in-patients-with-a-history-of-several-allergic-reactions-to-biologics-do-you-pursue-any-form-of-skin-testing-before-starting-the-next-agent weekly 0.8 https://www.themednet.org/would-you-consider-induction-egfr-tki-therapy-or-chemotherapy-for-locally-advanced-egfr-nsclc-to-reduce-radiation-field-if-planning-for-definitive-chemoradiation weekly 0.8 https://www.themednet.org/what-ancillary-or-supportive-therapies-do-you-provide-patients-with-gbs weekly 0.8 https://www.themednet.org/when-contouring-gliomas-how-do-you-distinguish-true-tumor-related-flair-from-ischemic-changes-from-prior-strokes weekly 0.8 https://www.themednet.org/in-a-patient-with-aortic-thrombus-what-is-your-preferred-anticoagulant weekly 0.8 https://www.themednet.org/is-there-a-scenario-where-you-would-consider-multiple-nsclc-lesions-in-the-same-lobe-as-multifocal-synchronous-malignancies-rather-than-intrapulmonary-metastases-ie-mpt1-rather-than-t3 weekly 0.8 https://www.themednet.org/can-avacopan-be-used-in-patients-with-anca-vasculitis-who-are-dialysis-dependent weekly 0.8 https://www.themednet.org/how-do-you-approach-renal-cell-carcinoma-with-ipsilateral-vs-contralateral-adrenal-metastasis-is-there-a-role-of-surgery weekly 0.8 https://www.themednet.org/is-there-any-scoring-system-that-predicts-immunotherapy-associated-pneumonitis weekly 0.8 https://www.themednet.org/how-do-you-choose-between-darolutamide-and-abiraterone-when-adding-to-docetaxel-plus-adt-in-management-of-castrate-sensitive-high-burden-metastatic-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-treat-a-patient-with-chronic-phase-cml-who-developed-severe-prolonged-thrombocytopenia-with-reduced-dose-nilotinib-and-then-imatinib weekly 0.8 https://www.themednet.org/how-will-the-results-of-the-sandstorm-pooled-analysis-affect-your-adt-prescription-patterns weekly 0.8 https://www.themednet.org/would-you-recommend-endocrine-therapy-in-dcis-with-a-low-burden-of-er-expression-eg-10-15-positive weekly 0.8 https://www.themednet.org/with-the-approval-of-pembrolizumab-per-pearls-study-do-you-recommend-any-patients-to-receive-adjuvant-immunotherapy-in-resected-nsclc-and-negative-pd-l1 weekly 0.8 https://www.themednet.org/is-there-a-role-for-caval-valve-implantation-in-patients-with-severe-tricuspid-regurgitation-who-have-already-developed-cardiac-cirrhosis weekly 0.8 https://www.themednet.org/how-do-you-choose-between-ct-ffr-and-conventional-stress-testing-for-the-evaluation-of-patients-with-stable-angina weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-telangiectatic-matting-after-sclerotherapy weekly 0.8 https://www.themednet.org/how-long-do-you-wait-to-start-adjuvant-ebrt-after-rai-in-a-patient-receiving-both-adjuvant-rai-and-ebrt-following-total-thyroidectomy weekly 0.8 https://www.themednet.org/how-do-you-manage-a-uterine-tumor-resembling-an-ovarian-sex-cord-stromal-tumor weekly 0.8 https://www.themednet.org/for-patients-undergoing-adt-who-do-you-recommend-dexa-scan weekly 0.8 https://www.themednet.org/would-you-consider-adding-a-cdk-4-6-inhibitor-to-elacestrant-after-progression-on-ai-with-presence-of-esr1-mutation weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-would-you-use-for-isolated-intradural-extramedullary-drop-metastases-to-the-cervical-and-thoracic-cord-from-solitary-fibrous-tumor-hemangiopericytoma weekly 0.8 https://www.themednet.org/how-do-you-counsel-pre-menopausal-breast-cancer-patients-about-birth-control weekly 0.8 https://www.themednet.org/why-do-you-think-smaller-ptv-margins-reduced-gu-toxicity-in-the-mirage-trial weekly 0.8 https://www.themednet.org/how-do-you-approach-biopsy-proven-endobronchial-squamous-metaplasia-without-parenchymal-lung-lesions-in-a-non-smoker weekly 0.8 https://www.themednet.org/what-is-the-optimal-chemotherapy-regimen-for-unresectable-pancoast-tumor-cisplatin-and-etoposide-or-weekly-carboplatin-paclitaxel-with-radiation-followed-by-durvalumab weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-recurrent-podagra-but-a-normal-serum-urate-and-no-evidence-of-dactylitis-or-prior-trauma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-infectious-purpura-fulminans weekly 0.8 https://www.themednet.org/how-do-you-approach-post-chemoradiation-therapy-in-patients-with-stage-iii-nsclc-harboring-targetable-mutations-other-than-egfr-or-alk weekly 0.8 https://www.themednet.org/how-would-you-treat-an-intraductal-oncocytic-papillary-neoplasm-iopn-of-the-pancreas-that-has-metastasized weekly 0.8 https://www.themednet.org/is-there-any-role-for-ruxolitinib-in-the-management-of-secondary-autoimmune-myelofibrosis-in-patients-with-sle weekly 0.8 https://www.themednet.org/does-having-mgus-change-your-management-of-refractory-itp-that-is-not-responsive-to-first-line-therapies-like-tpo-agonists-rituximab-or-steroids weekly 0.8 https://www.themednet.org/for-patients-who-undergo-sublobar-resection-for-early-stage-nsclc-with-ln-sampling-found-to-have-unexpected-n2-positive-disease-would-you-consider-neoadjuvant-chemoimmunotherapy-followed-by-completion-lobectomy-or-proceed-directly-to-adjuvant-therapy weekly 0.8 https://www.themednet.org/how-does-your-pathologist-aggregate-tumor-characteristics-when-a-conization-has-been-done-prior-to-a-radical-hysterectomy-for-cervical-cancer weekly 0.8 https://www.themednet.org/what-systemic-therapy-regimen-would-you-use-for-msi-high-resectable-pdac-of-the-tail-of-the-pancreas weekly 0.8 https://www.themednet.org/when-do-you-recommend-plasmapheresis-in-the-treatment-of-primary-and-secondary-cold-agglutinin-disorders weekly 0.8 https://www.themednet.org/how-do-you-use-cold-agglutinin-titers-to-guide-your-management-of-cold-agglutinin-disorders weekly 0.8 https://www.themednet.org/what-safety-precautions-do-you-maintain-when-doing-a-lumbar-puncture-in-a-patient-with-suspected-crutzfeld-jacob-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-pregnant-patients-with-newly-identified-glioblastoma weekly 0.8 https://www.themednet.org/how-do-you-manage-incidental-discovery-of-a-gleason-5-4-prostate-cancer-in-a-turp-specimen weekly 0.8 https://www.themednet.org/under-what-circumstances-if-any-do-you-offer-treatment-holidays-when-treating-patients-with-metastatic-her2-breast-cancer weekly 0.8 https://www.themednet.org/for-a-catheter-associated-dvt-on-d1-of-aml-induction-chemotherapy-would-you-remove-the-catheter weekly 0.8 https://www.themednet.org/would-you-consider-dose-modified-adagrasib-in-a-patient-with-nsclc-with-kras-g12c-mutation-previously-treated-with-sotorasib-with-excellent-response-but-significant-hepatic-toxicity-necessitating-discontinuation weekly 0.8 https://www.themednet.org/what-is-your-treatment-algorithm-for-pemphigus-foliaceous-1 weekly 0.8 https://www.themednet.org/what-is-the-utility-of-follow-up-mri-to-assess-response-to-steroids-when-treating-edema weekly 0.8 https://www.themednet.org/what-treatment-would-you-recommend-for-a-high-risk-prostate-patient-who-had-testicular-seminoma-and-who-many-years-ago-had-radiation-using-dog-leg-fields weekly 0.8 https://www.themednet.org/would-you-offer-radiation-therapy-to-a-patient-with-early-stage-breast-cancer-following-chemotherapy-in-the-setting-of-systemic-bullous-mastocytosis weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-hgb-ss-disease-who-does-not-have-an-increase-in-fetal-hgb-while-being-compliant-with-hydroxyurea weekly 0.8 https://www.themednet.org/do-you-continue-denosumab-indefinitely-in-a-patient-with-osteoporosis-who-is-tolerating-therapy-without-issues weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-for-management-of-symptomatic-lower-extremity-edema-from-retroperitoneal-lymphadenopathy-compressing-ivc weekly 0.8 https://www.themednet.org/are-there-specific-considerations-to-take-into-account-when-managing-a-patient-with-ra-on-conventional-dmards-who-is-receiving-gender-affirming-hormone-therapy weekly 0.8 https://www.themednet.org/in-what-circumstance-if-any-would-you-consider-parp-inhibition-in-metastatic-brca-wild-type-tnbc-who-has-exhausted-all-other-treatment-options weekly 0.8 https://www.themednet.org/how-do-you-approach-using-anti-tnf-agents-in-seropositive-ra-patients-with-sjogrens-overlap-positive-ssa-antibodies weekly 0.8 https://www.themednet.org/would-you-consider-giving-weekly-carboplatin-and-paclitaxel-with-pembrolizumab-for-patients-with-squamous-nsclc-with-pd-l1-50-if-there-were-concerns-over-tolerability-with-standard-q3w-chemotherapy-dosing weekly 0.8 https://www.themednet.org/how-do-you-draw-your-treatment-volumes-when-treating-meningiomas-with-fractionated-srs-1 weekly 0.8 https://www.themednet.org/in-older-or-frail-adults-65-years-of-age-with-cns-lymphoma-who-completed-high-dose-methotrexate-containing-regimens-would-you-consider-maintenance-therapy-with-monthly-temozolomide-rituximab-or-ibrutinib weekly 0.8 https://www.themednet.org/what-are-your-indications-for-obtaining-beta-globin-gene-sequencing-in-a-patient-with-sickle-cell-disease weekly 0.8 https://www.themednet.org/can-you-use-ultrasound-therapy-for-capsular-fibrosis-after-radiation-therapy-for-postmastectomy-patients weekly 0.8 https://www.themednet.org/how-do-you-dose-arsenic-in-a-super-morbid-person-500-lbs-with-apml weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-metastatic-chordoma-with-leptomeningeal-spread-involving-multiple-nodules-and-a-dominant-cervical-spine-lesion-causing-motor-weakness weekly 0.8 https://www.themednet.org/when-if-ever-would-you-consider-consolidation-treatment-with-an-immune-checkpoint-inhibitor-for-the-treatment-of-small-cell-carcinoma-of-the-cervix-following-neoadjuvant-platinum-resection-and-radiation-currently-without-any-evidence-of-disease weekly 0.8 https://www.themednet.org/how-would-you-medically-manage-a-patient-with-chronic-gi-bleed-from-avms-who-needs-weekly-transfusion-and-iv-iron-with-otherwise-repeatedly-negative-gi-work-up weekly 0.8 https://www.themednet.org/how-do-you-administer-chemotherapy-with-y90-for-a-triple-negative-breast-cancer-patient-with-brca1-and-liver-only-metastases-who-is-not-a-candidate-for-repeat-sbrt weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-rheumatoid-vasculitis-of-skin-of-lower-extremities-in-the-setting-of-osteomyelitis-due-to-sacral-pressure-ulcer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-of-warm-hemolytic-anemia-in-patients-with-lupus-who-have-not-responded-to-rituximab-and-or-cyclophosphamide weekly 0.8 https://www.themednet.org/what-are-your-diagnostic-and-treatment-practices-for-epidermodysplasia-verruciformis weekly 0.8 https://www.themednet.org/with-the-ongoing-platinum-shortage-are-there-any-non-platinum-front-line-alternative-small-cell-regimens-supported-by-data-with-or-without-immunotherapy weekly 0.8 https://www.themednet.org/how-do-you-see-the-sleep-proteome-being-incorporated-into-practice weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-cervical-and-vulvar-cancer-meriting-definitive-chemort-during-platinum-drug-shortages weekly 0.8 https://www.themednet.org/how-do-you-approach-the-timing-feasibility-of-cd38-re-treatment-daratumumab-or-isatuximab-in-a-previously-cd38-refractory-patient-with-myeloma weekly 0.8 https://www.themednet.org/how-do-you-manage-bowel-associated-dermatosis-arthritis-syndrome weekly 0.8 https://www.themednet.org/what-hormonal-therapy-if-any-would-you-offer-for-adjuvant-treatment-of-stage-ic-er-pr-low-grade-serous-ovarian-cancer weekly 0.8 https://www.themednet.org/when-is-it-safe-to-resume-dmards-in-a-patient-who-was-diagnosed-with-active-tb-and-started-on-treatment weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-a-symptomatic-mature-intracranial-teratoma-who-is-a-not-a-surgical-candidate weekly 0.8 https://www.themednet.org/are-there-any-solutions-that-allow-for-expensive-dressings-e-g-mepitel-to-be-billed-to-insurance-rather-than-having-to-pass-the-cost-on-to-patients weekly 0.8 https://www.themednet.org/do-you-use-doacs-for-patients-with-class-iii-obesity-with-weight-120-kg-bmi-40-kg-m2-who-have-arterial-events weekly 0.8 https://www.themednet.org/what-is-your-management-approach-in-patients-with-severe-factor-xi-deficiency-being-considered-for-deep-brain-stimulation weekly 0.8 https://www.themednet.org/are-there-any-reliable-imaging-findings-to-differentiate-benign-asbestos-pleural-effusion-bape-from-malignant-mesothelioma weekly 0.8 https://www.themednet.org/does-serum-calcium-need-to-be-checked-prior-to-each-monthly-dose-of-romosozumab weekly 0.8 https://www.themednet.org/is-hyper-ige-syndrome-a-contraindication-for-radiation-therapy weekly 0.8 https://www.themednet.org/how-would-you-manage-oligometastatic-progression-of-prostate-adenocarcinoma-after-initial-cryotherapy-without-any-upfront-xrt weekly 0.8 https://www.themednet.org/how-would-you-counsel-patients-with-type-2-diabetes-on-short-term-nsaid-use-in-light-of-a-recent-observational-study-demonstrating-an-association-between-nsaid-use-and-first-time-heart-failure-hospitalization-risk-in-diabetic-patients weekly 0.8 https://www.themednet.org/would-you-recommend-different-fiducial-markers-for-the-right-left-of-a-prostate-for-sbrt weekly 0.8 https://www.themednet.org/what-therapies-have-you-found-most-effective-for-managing-pustular-psoriasis weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-urticaria-multiforme weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-hypertrophic-lichen-planus weekly 0.8 https://www.themednet.org/how-would-you-incorporate-results-from-the-presto-trial-into-your-practice-in-light-of-greater-use-of-psma-pet-scans-for-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-eosinophilic-cellulitis-uncontrolled-on-systemic-steroids weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-diagnosis-of-lgl-leukemia-or-feltys-syndrome-in-a-patient-with-rheumatoid-arthritis weekly 0.8 https://www.themednet.org/in-metastatic-hormone-receptor-positive-breast-cancer-would-you-consider-combination-exemestane-and-cdk4-6-inhibitor-if-letrozole-and-anastrazole-are-not-tolerated weekly 0.8 https://www.themednet.org/do-you-have-a-preference-of-denosumab-over-zoledronic-acid-in-patients-with-metastatic-breast-cancer-with-osseous-involvement-with-normal-renal-function weekly 0.8 https://www.themednet.org/how-do-you-manage-late-rib-fractures-with-soft-tissue-breakdown-after-two-courses-of-radiotherapy weekly 0.8 https://www.themednet.org/how-do-you-manage-moderate-chest-wall-pain-after-breast-radiation-if-imaging-studies-are-normal weekly 0.8 https://www.themednet.org/how-often-do-you-see-pseudoprogession-in-pancreatic-cancer-after-sbrt-and-how-do-you-manage-it-if-the-patient-is-planed-for-surgical-exploration weekly 0.8 https://www.themednet.org/would-you-consider-a-parp-inhibitor-in-metastatic-tnbc-with-high-loh-on-ngs weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-inflammatory-arthritis-ra-in-a-patient-with-multiple-sclerosis-on-natalizumab weekly 0.8 https://www.themednet.org/how-do-you-manage-steroid-refractory-pneumonitis-due-to-docetaxel-or-trastuzumab weekly 0.8 https://www.themednet.org/what-treatments-have-you-found-most-effective-for-managing-acquired-perforating-collagenosis weekly 0.8 https://www.themednet.org/whats-your-experience-in-injection-prp-enhanced-with-xenograft-extracellular-matrix-such-as-matristem-in-scalp-for-hair-loss weekly 0.8 https://www.themednet.org/do-you-offer-resection-of-oligometastatic-disease-for-patients-with-recurrent-uterine-serous-carcinoma-within-the-pelvis-following-initial-treatment-with-adjuvant-chemotherapy-and-vaginal-cuff-brachytherapy weekly 0.8 https://www.themednet.org/do-you-routinely-obtain-urine-pregnancy-tests-in-patients-on-immunosuppression-who-use-only-a-single-method-of-contraception weekly 0.8 https://www.themednet.org/is-there-a-role-of-adding-hormonal-therapy-to-fam-trastuzumab-deruxtecan-in-patients-with-metastatic-er-pr-her2-low-breast-cancer-after-progressing-on-aromatase-inhibitor-and-cdk4-6i weekly 0.8 https://www.themednet.org/would-you-use-neoadjuvant-immunotherapy-to-spare-renal-cortex-prior-to-sbrt weekly 0.8 https://www.themednet.org/how-do-you-decide-between-treatment-with-abvd-vs-a-avd-in-a-patient-in-their-70s-with-advanced-stage-4-classical-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-brain-metastases-treated-with-fsrt-that-inadvertently-continued-alectinib-during-treatment weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-cause-of-epidermal-inclusion-cysts weekly 0.8 https://www.themednet.org/is-whole-brain-radiation-contraindicated-for-adults-with-dandy-walker-syndrome weekly 0.8 https://www.themednet.org/how-do-you-risk-stratify-patients-for-surgical-procedures-who-are-on-anticoagulation-due-to-history-of-stroke weekly 0.8 https://www.themednet.org/when-do-you-repeat-imaging-in-patients-who-have-already-demonstrated-ct-stability-with-multicompartmental-hemorrhage weekly 0.8 https://www.themednet.org/what-is-your-approach-to-switching-from-one-biologic-agent-to-another-in-allergic-asthma-type-ii-inflammation weekly 0.8 https://www.themednet.org/how-would-you-choose-between-leuprorelin-gnrh-agonist-vs-relugolix-gnrh-antagonist-in-patients-with-intermediate-or-high-risk-prostate-cancer-who-received-definitive-radiation weekly 0.8 https://www.themednet.org/do-you-treat-an-arteriovenous-fistula-with-the-same-principles-as-an-arteriovenous-malformation weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-in-localized-rcc-with-vhl-mutation-after-progression-on-belzutifan weekly 0.8 https://www.themednet.org/what-is-your-approach-to-leflunomide-counseling-and-use-in-patients-with-diabetic-or-other-neuropathy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-drug-induced-oral-and-cutaneous-lichen-planus-associated-with-tnf-inhibitors weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-in-a-male-with-er-her2-metastatic-breast-cancer-who-received-tchp-but-developed-irreversible-cardiomyopathy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-evaluation-of-a-patient-with-persistent-costochondritis weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-esrd-on-hemodialysis-with-good-risk-metastatic-seminoma-with-bulky-retroperitoneal-adenopathy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-isolated-thoracic-recurrence-of-nsclc-in-an-otherwise-asymptomatic-patient-with-prior-chemoradiation-and-immunotherapy weekly 0.8 https://www.themednet.org/for-patients-with-biphasic-mesothelioma-who-complete-pleurectomy-decortication-would-you-consider-offering-adjuvant-combination-immune-checkpoint-inhibitor-therapy-vs-platinum-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-non-surgical-t1-high-grade-urothelial-carcinoma-of-the-bladder-with-a-remote-history-of-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-acutely-manage-bleeding-sites-of-extramedullary-hematopoiesis-in-a-patient-with-transfusion-dependent-beta-thalassemia weekly 0.8 https://www.themednet.org/what-are-the-scenarios-where-peripheral-blood-ngs-testing-may-substitute-for-bm-biopsy weekly 0.8 https://www.themednet.org/have-you-used-radiation-to-treat-systemic-therapy-resistant-problematic-lesion-of-granulomatosis-with-polyangitis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-evaluation-and-management-of-symptomatic-nodular-episcleritis weekly 0.8 https://www.themednet.org/how-do-you-approach-dosing-of-benzodiazepines-or-other-muscle-relaxers-in-stiff-person-syndrome weekly 0.8 https://www.themednet.org/what-treatment-algorithm-do-you-most-commonly-use-for-children-with-diffuse-moderately-severe-atopic-dermatitis weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-microcystic-lymphatic-malformations weekly 0.8 https://www.themednet.org/based-on-the-results-of-the-norpact-1-trial-presented-at-asco-2023-would-you-offer-upfront-surgery-or-neoadjuvant-chemotherapy-to-early-stage-pancreatic-ductal-adenocarcinoma weekly 0.8 https://www.themednet.org/how-would-you-elect-to-treat-a-patient-with-asymptomatic-vertebral-metastasis-after-vertebral-augmentation weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-about-hormonal-contraception-in-patients-with-high-risk-benign-breast-pathology-i-e-lcis-adh-alh-who-would-quality-for-chemoprevention weekly 0.8 https://www.themednet.org/how-do-you-manage-persistently-high-triglycerides-following-a-course-of-isotretinoin weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-transfusion-dependent-beta-thalassemia-about-luspatercept weekly 0.8 https://www.themednet.org/what-induction-would-you-choose-for-a-healthy-65-year-old-with-prior-chemo-rt-for-h-n-cancer-2-years-ago-now-with-flt3-itd-0-25-and-inv-16-aml weekly 0.8 https://www.themednet.org/would-you-treat-a-multifocal-clear-cell-rcc-in-a-solitary-kidney-with-sbrt weekly 0.8 https://www.themednet.org/would-you-offer-radiation-therapy-for-a-59-year-old-female-patient-with-orbital-sarcoidosis-and-no-other-site-of-disease-who-can-no-longer-tolerate-systemic-therapy weekly 0.8 https://www.themednet.org/what-patient-population-would-you-target-for-phergain-trial-enrollment-from-asco2023-in-clinical-practice weekly 0.8 https://www.themednet.org/how-would-you-weight-parental-atypical-femoral-fracture-that-occurred-after-15-years-of-bisphosphonate-use-when-deciding-on-osteoporosis-therapy weekly 0.8 https://www.themednet.org/how-would-you-manage-metastatic-small-cell-bladder-cancer-in-a-patient-who-is-platinum-ineligible weekly 0.8 https://www.themednet.org/what-dose-of-prednisone-do-you-prefer-when-treating-crpc-vs-cspc-with-abiraterone weekly 0.8 https://www.themednet.org/what-is-the-role-of-ivig-in-treating-post-covid-vaccine-related-vestibular-injury-symptoms weekly 0.8 https://www.themednet.org/what-is-your-approach-to-lymph-node-evaluation-in-patients-undergoing-radical-hysterectomy-for-early-cervical-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-an-early-isolated-cns-relapse-in-a-pediatric-patient-with-ph-positive-all weekly 0.8 https://www.themednet.org/in-a-patient-with-tp53-mutated-aml-which-has-been-refractory-to-van-aza-and-flag-and-in-a-center-with-limited-clinical-trial-options-what-treatment-would-you-offer-this-patient weekly 0.8 https://www.themednet.org/in-what-specific-situations-do-you-consider-utilizing-vein-of-marshall-ethanol-infusion-for-atrial-tachyarrhythmias-do-you-ever-use-them-in-conjunction-with-rf-ablation-for-first-time-ablations-or-reserve-ethanol-infusion-use-for-repeat-ablations weekly 0.8 https://www.themednet.org/how-do-you-approach-the-decision-for-adjuvant-chemotherapy-in-perimenopausal-patients-with-er-breast-cancer weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-5-fu-based-therapy-for-a-patient-with-adenocarcinoma-involving-the-ischiorectal-fossa-thought-to-be-tailgut-cyst-adenocarcinoma-who-achieved-a-pcr-to-5-fu-rt-followed-by-surgery weekly 0.8 https://www.themednet.org/how-would-you-sequence-therapy-for-patient-with-metastatic-rcc-who-was-not-able-to-tolerate-tki-but-now-have-progress-on-single-agent-io weekly 0.8 https://www.themednet.org/would-you-consider-dose-or-margin-alterations-when-treating-a-multifocal-squamous-cell-carcinoma-of-the-lower-esophagus-gej-and-stomach-in-the-neoadjuvant-setting weekly 0.8 https://www.themednet.org/do-you-measure-pleural-pressure-during-right-heart-catheterization-to-obtain-a-wedge-pressure-in-obese-patients weekly 0.8 https://www.themednet.org/for-a-diabetic-patient-with-presumed-stage-i-grade-1-endometrial-cancer-what-hemoglobin-a1c-level-would-prompt-you-to-recommend-medical-management-instead-of-surgery weekly 0.8 https://www.themednet.org/in-a-patient-with-prior-leep-and-no-residual-cervix-found-to-have-hsil-on-ecc-what-type-of-hysterectomy-would-you-offer weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-nsaids-in-patients-on-antiplatelets-and-or-anticoagulants weekly 0.8 https://www.themednet.org/what-consolidative-therapy-if-any-would-you-use-for-an-older-transplant-ineligible-patient-with-secondary-cns-lymphoma-who-is-in-a-cr-after-hd-mtx-cytarabine weekly 0.8 https://www.themednet.org/would-you-incorporate-a-parp-inhibitor-into-the-management-of-a-patient-with-endometrial-cancer-with-a-germline-or-somatic-brca-mutation weekly 0.8 https://www.themednet.org/should-short-courses-of-insulin-be-considered-for-steroid-induced-hyperglycemia-in-patients-with-pre-diabetes-or-mild-diabetes-well-controlled-on-oral-therapy weekly 0.8 https://www.themednet.org/should-biomarkers-of-insulin-resistance-homa-ir-be-used-to-guide-medical-therapy-in-healthy-patients-at-higher-risk-for-diabetes-based-on-ethnicity-and-family-history weekly 0.8 https://www.themednet.org/when-is-it-safe-to-start-or-resume-bisphosphonate-therapy-in-patients-with-a-history-of-osteonecrosis-of-the-jaw-that-is-unrelated-to-osteoporosis-treatment weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-low-bone-density-in-very-young-women-with-longstanding-functional-hypothalamic-amenorrhea weekly 0.8 https://www.themednet.org/is-it-appropriate-to-treat-mild-thyroid-eye-disease-with-selenium-200-mcg-daily-versus-100-mcg-twice-daily-to-increase-medication-adherence-rates weekly 0.8 https://www.themednet.org/given-the-better-safety-profile-of-transdermal-estrogen-is-there-a-specific-clinical-advantage-to-using-oral-estrogen-to-treat-menopausal-symptoms weekly 0.8 https://www.themednet.org/should-estrogen-therapy-be-initiated-in-patients-with-refractory-functional-hypothalamic-amenorrhea-to-improve-bone-health weekly 0.8 https://www.themednet.org/how-do-you-adjust-enfortumab-vedotin-dosing-due-to-side-effects weekly 0.8 https://www.themednet.org/do-you-approach-systemic-therapy-any-differently-for-patients-with-locally-advanced-relapses-of-tnbc-with-metaplastic-squamous-differentiation-as-opposed-to-patients-with-tnbc weekly 0.8 https://www.themednet.org/what-jak-inhibitors-oral-or-topical-have-you-found-most-helpful-in-treating-bullous-pemphigoid weekly 0.8 https://www.themednet.org/what-dosing-range-for-mtx-do-you-typically-use-for-treating-scc-in-situ-on-the-trunk-and-extremities weekly 0.8 https://www.themednet.org/what-therapies-do-you-most-commonly-recommend-for-patients-with-bromohidrosis weekly 0.8 https://www.themednet.org/what-is-your-preferred-chemotherapy-regimen-in-concurrent-chemo-radiation-in-esophageal-adenocarcinoma-either-pre-op-or-definitive weekly 0.8 https://www.themednet.org/how-would-you-manage-a-post-menopausal-patient-who-has-simple-mastectomy-for-dcis-but-was-found-to-have-invasive-ductal-carcinoma-on-post-operative-pathology weekly 0.8 https://www.themednet.org/what-systemic-therapy-options-are-preferred-in-a-patient-with-recurrent-glioblastoma-with-leptomeningeal-dissemination weekly 0.8 https://www.themednet.org/how-do-you-approach-an-elderly-patient-with-thymoma-related-pure-red-cell-aplasia-who-has-failed-multiple-lines-of-treatment weekly 0.8 https://www.themednet.org/how-would-you-manage-persistent-chest-wall-disease-after-adjuvant-chemort-s-p-lobectomy-for-t3n0-nsclc-with-an-involved-margin weekly 0.8 https://www.themednet.org/how-do-you-approach-the-logistical-challenges-when-using-mannitol-as-an-agent-for-bronchoprovocation-testing weekly 0.8 https://www.themednet.org/what-is-your-approach-to-peri-operative-stress-dose-steroids-in-patients-on-chronic-prednisone weekly 0.8 https://www.themednet.org/for-a-patient-with-history-of-sleeve-gastrectomy-now-diagnosed-with-ge-junction-adenocarcinoma-would-you-alter-standard-radiation-volumes-or-change-your-treatment-strategy weekly 0.8 https://www.themednet.org/would-you-offer-palliative-radiation-for-a-patient-with-symptomatic-mediastinal-metastases-from-rectal-cancer-currently-on-bevacizumab weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-myocarditis-in-systemic-sclerosis weekly 0.8 https://www.themednet.org/how-do-you-approach-lung-entrapment-vs-trapped-lung-in-a-patient-with-a-new-onset-hydro-pneumothorax weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-new-dvt-while-on-dabigatran-for-atrial-fibrillation-who-may-have-missed-some-doses-of-dabigatran-around-time-of-dvt weekly 0.8 https://www.themednet.org/for-early-stage-resectable-un-mutated-nsclc-patients-who-received-neoadjuvant-chemoimmunotherapy-and-did-not-attain-a-pcr-do-you-adjust-adjuvant-therapy-strategies weekly 0.8 https://www.themednet.org/what-therapies-have-you-found-most-effective-in-treating-post-inflammatory-hyperpigmentation-due-to-rashes-such-as-a-fixed-drug-eruption weekly 0.8 https://www.themednet.org/how-would-you-approach-workup-and-management-of-a-patient-who-has-signs-and-symptoms-consistent-with-gpa-found-to-have-a-cavitary-lung-lesion-however-is-anca-negative-and-has-no-kidney-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-hypo-or-dysfibrinogenemia-during-pregnancy weekly 0.8 https://www.themednet.org/do-you-consider-any-favorable-subset-of-patients-with-stage-iv-pancreatic-cancer-to-be-candidates-for-local-pre-operative-crt-and-surgical-resection weekly 0.8 https://www.themednet.org/is-there-a-benefit-to-sound-wave-therapy-for-erectile-dysfunction-that-is-due-to-prostate-radiation weekly 0.8 https://www.themednet.org/what-are-the-most-important-factors-that-you-use-to-decide-between-r-chop-vs-r-minichop-in-elderly-or-frail-patients-with-dlbcl weekly 0.8 https://www.themednet.org/are-there-discernible-alterations-in-sleep-patterns-following-local-treatment-for-pineal-gland-tumors weekly 0.8 https://www.themednet.org/would-you-typically-offer-adjuvant-folfox-or-xelox-to-a-pt4b-pn0-colon-cancer weekly 0.8 https://www.themednet.org/as-a-clinician-what-are-the-management-differences-between-lobular-and-ductal-carcinoma-of-the-breast weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-htlv1-myelopathy weekly 0.8 https://www.themednet.org/how-do-you-mitigate-severe-radiation-skin-fibrosis-from-concurrent-pembrolizumab-and-radiation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-a-young-male-with-vascular-eds-with-z-score-3-3-in-ap-spine-and-previous-fragility-fracture-in-the-distal-radius weekly 0.8 https://www.themednet.org/what-is-the-role-of-vagus-nerve-stimulation-in-post-stroke-rehabilitation weekly 0.8 https://www.themednet.org/how-long-would-you-wait-to-start-next-line-chemotherapy-in-a-patient-recovering-from-grade-3-immune-mediated-hepatitis-secondary-to-lenvatinib-pembrolizumab-for-endometrial-cancer weekly 0.8 https://www.themednet.org/what-treatment-helps-itch-and-prevent-new-lesions-in-patients-with-erythema-dyschromicum-perstans weekly 0.8 https://www.themednet.org/do-you-consider-igm-or-iga-levels-in-addition-to-igg-levels-when-planning-further-doses-of-rituximab weekly 0.8 https://www.themednet.org/do-you-routinely-give-prophylactic-antibiotics-steroids-for-patients-on-mek-inhibitors-e-g-trametinib-to-prevent-rash-dermatitis weekly 0.8 https://www.themednet.org/would-you-consider-using-trastuzumab-deruxtecan-in-her2-low-expressing-nsclc-based-on-data-from-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-the-manifestations-of-creutzfeldt-jakob-disease weekly 0.8 https://www.themednet.org/how-you-treat-large-b-cell-lymphoma-with-irf4-rearrangement weekly 0.8 https://www.themednet.org/what-factors-into-your-decision-about-whether-to-use-hipec-for-advanced-ovarian-cancer weekly 0.8 https://www.themednet.org/how-do-you-treat-an-mds-patient-who-presents-with-significant-cytopenias-who-is-not-a-candidate-for-lenalidomide-or-luspatercept-how-do-you-initiate-an-hma-when-they-are-severely-neutropenic weekly 0.8 https://www.themednet.org/in-patients-with-driver-mutation-positive-nsclc-who-have-progressed-on-targeted-therapy-and-are-planned-for-chemotherapy-as-the-next-line-of-treatment-for-which-driver-alterations-do-you-add-in-io-and-which-do-you-omit-io weekly 0.8 https://www.themednet.org/whats-your-approach-to-treatment-of-low-to-intermediate-low-risk-category-precapillary-ph-in-esrd-patients weekly 0.8 https://www.themednet.org/when-should-we-utilize-mri-for-neuromuscular-disorders weekly 0.8 https://www.themednet.org/how-do-you-navigate-drug-interactions-in-patients-with-moderate-to-severe-asthma-and-hiv-on-antiretroviral-therapy weekly 0.8 https://www.themednet.org/is-there-any-data-for-treating-single-fraction-immediately-after-a-v-fistula-creation-for-dialysis-access-in-human-to-prevent-future-occlusions weekly 0.8 https://www.themednet.org/how-do-you-treat-r-r-t-cell-histiocyte-rich-large-b-cell-lymphoma weekly 0.8 https://www.themednet.org/patient-with-known-itp-now-having-a-relapse-in-the-setting-of-a-mitral-valve-vegetation-and-responding-to-steroids-and-ivig-would-you-consider-a-tpo-agonist-and-wean-steroids weekly 0.8 https://www.themednet.org/are-there-any-circumstances-where-you-would-consider-bridging-for-patients-on-doacs weekly 0.8 https://www.themednet.org/what-chemotherapy-regimens-would-be-appropriate-for-cisplatin-ineligible-patients-to-receive-concurrently-with-definitive-radiotherapy-for-locally-advanced-inoperable-thymic-carcinoma weekly 0.8 https://www.themednet.org/what-is-your-standard-approach-to-treatment-of-plasmablastic-lymphoma-in-hiv-negative-patients weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-iv-iron-to-treat-hair-loss-in-an-adolescent-patient-with-iron-deficiency-without-anemia weekly 0.8 https://www.themednet.org/how-do-you-approach-contraception-counseling-with-transgender-patients-taking-gender-affirming-hormone-therapy-prior-to-starting-teratogenic-medications weekly 0.8 https://www.themednet.org/how-do-you-approach-use-of-immunosuppressants-in-patients-with-rheumatologic-disease-and-active-intravenous-drug-use weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-a-patient-who-was-diagnosed-with-surgically-staged-and-completely-resected-stage-ii-high-grade-serous-ovarian-cancer-while-she-prepared-for-neoadjuvant-chemoradiation-for-rectal-cancer weekly 0.8 https://www.themednet.org/a-patient-has-unresectable-node-positive-oligometastatic-gallbladder-cancer-when-would-you-offer-radiation weekly 0.8 https://www.themednet.org/is-there-an-increaed-risk-of-cancer-when-using-spironolactone-in-patients-with-hormone-positive-breast-cancer weekly 0.8 https://www.themednet.org/which-regimen-do-you-recommend-for-chemoradiation-for-a-patient-with-locally-advanced-inoperable-thymic-tumor-in-the-setting-of-ckd-stage-iii weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-a-locally-advanced-bladder-cancer-s-p-turbt-who-had-prior-radiation weekly 0.8 https://www.themednet.org/is-there-a-contraindication-to-spine-radiation-in-patient-with-an-atm-mutation weekly 0.8 https://www.themednet.org/in-patients-with-von-willebrand-disease-who-are-presenting-with-ct1n0-scc-of-the-skin-what-dose-fractionation-is-recommended weekly 0.8 https://www.themednet.org/what-is-your-approach-to-rsv-vaccination-in-immunocompromised-patients weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-a-women-who-was-incidentally-found-to-have-a-deeply-invasive-low-grade-endometrial-carcinoma-after-she-underwent-a-supracervical-hysterectomy-with-placement-of-mesh-for-uterine-prolapse weekly 0.8 https://www.themednet.org/in-a-premenopausal-receptor-positive-node-positive-woman-with-breast-cancer-who-has-regular-menses-prior-to-initiation-of-chemotherapy-and-then-stops-during-chemotherapy-how-do-you-determine-the-timing-of-ovarian-suppression-or-treatment-with-medication-o weekly 0.8 https://www.themednet.org/how-do-you-sequence-treatment-in-a-patient-with-widespread-mets-with-testicular-mixed-germ-cell-tumor-and-1-3-brain-mets weekly 0.8 https://www.themednet.org/do-you-prefer-daily-or-every-other-day-fractionation-for-fsrs-of-brain-metastases weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-recurrent-cervical-cancer-in-a-young-patient-with-esrd-on-dialysis weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-use-for-a-young-patient-with-stage-iiib-high-grade-ess-s-p-optimal-debulking weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-recurrent-endometrial-cancer-lung-with-areas-of-squamous-differentiation-er-pr-and-ms-stable weekly 0.8 https://www.themednet.org/is-there-any-role-for-combination-checkpoint-blockade-such-as-nivolumab-ipilimumab-in-a-patient-with-stage-iv-tonsillar-squamous-cell-carcinoma-who-has-progressed-on-single-agent-pembrolizumab weekly 0.8 https://www.themednet.org/would-you-offer-myomectomy-to-a-patient-with-history-of-pelvic-mesonephric-adenocarcinoma-s-p-resection-and-a-hyper-metabolic-myometrial-mass-on-pet-ct weekly 0.8 https://www.themednet.org/how-do-you-manage-burkitt-type-post-transplant-lymphoproliferative-disorder-bl-ptld weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-the-finding-of-a-5mm-well-differentiated-neuroendocrine-tumor-arising-from-within-a-dermoid-cyst-after-ovarian-cystectomy-with-an-apparent-contralateral-ovarian-cyst weekly 0.8 https://www.themednet.org/what-is-the-best-approach-for-lung-cancer-with-compound-egfr-mutations-exon18-and-exon-20ins-co-mutations weekly 0.8 https://www.themednet.org/what-would-be-the-optimal-adjuvant-strategy-in-addition-to-post-op-rt-for-someone-with-hpv-g2-squamous-carcinoma-of-the-bladder-after-radical-cystectomy-with-node-negative-locally-advanced-disease-ulcerating-through-the-vagina-and-involving-the-cervix weekly 0.8 https://www.themednet.org/what-is-the-preferred-modality-for-breast-cancer-surveillance-during-pregnancy-and-lactation weekly 0.8 https://www.themednet.org/would-you-omit-rt-as-part-of-tnt-for-a-rectal-cancer-with-a-good-response-by-mri weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-systemic-treatment-for-a-resected-stage-iii-melanoma-with-microscopic-satellites-but-negative-sln-evaluation weekly 0.8 https://www.themednet.org/do-you-recommend-using-ivig-and-or-rituximab-to-treat-a-mild-delayed-hemolytic-transfusion-reaction-in-a-pediatric-patient weekly 0.8 https://www.themednet.org/how-would-you-manage-persistent-severe-neutropenia-from-obinutuzumab-in-a-1st-line-cll-patient-prior-to-venetoclax-initiation weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-for-recurrent-pediatric-tenosynovial-giant-cell-tumor weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-high-risk-apl-with-wbc-100k weekly 0.8 https://www.themednet.org/how-would-you-treat-cml-and-cll-that-occurred-together weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-postoperatively-for-spinal-cord-compression-due-to-stage-iv-dlbcl weekly 0.8 https://www.themednet.org/in-a-patient-with-her2-metastatic-breast-cancer-who-is-on-the-her2climb-regimen-for-several-months-with-stable-disease-would-you-consider-discontinuation-of-capecitabine weekly 0.8 https://www.themednet.org/would-you-consider-surgical-resection-after-crt-for-an-initially-unresectable-anaplastic-thyroid-cancer-with-a-good-response weekly 0.8 https://www.themednet.org/what-work-up-would-you-consider-for-a-pediatric-patient-with-sensorineural-hearing-loss-and-a-hypoplastic-bone-marrow weekly 0.8 https://www.themednet.org/how-would-you-treat-a-locally-recurrent-melanoma-after-excision-adjuvant-rt-and-immunotherapy weekly 0.8 https://www.themednet.org/would-you-consider-radiotherapy-for-a-pediatric-patient-with-chemorefractory-localized-histiocytic-sarcoma-in-the-absence-of-the-potential-for-surgical-clearance weekly 0.8 https://www.themednet.org/what-anti-epileptic-drugs-do-you-use-in-pregnant-patients-or-those-planning-on-becoming-pregnant weekly 0.8 https://www.themednet.org/what-would-be-your-therapeutic-approach-for-an-aya-patient-with-an-unresectable-thymic-carcinoma weekly 0.8 https://www.themednet.org/how-long-should-a-patient-with-covid-19-vaccine-induced-thrombotic-thrombocytopenia-be-treated-with-anticoagulation weekly 0.8 https://www.themednet.org/can-pseudogout-ever-lead-to-joint-erosion-or-should-an-erosion-always-make-you-consider-an-alternative-process weekly 0.8 https://www.themednet.org/is-there-an-increased-risk-of-spinal-cord-myelopathy-in-patients-who-have-heterozygous-atm-mutations weekly 0.8 https://www.themednet.org/how-would-you-manage-a-burkitt-lymphoma-recurrence-in-the-neck weekly 0.8 https://www.themednet.org/how-do-you-adjust-status-epilepticus-treatment-protocols-for-medication-limiting-comorbidities-such-as-esrd-and-cardiac-arrhythmia weekly 0.8 https://www.themednet.org/how-do-you-manage-a-serous-borderline-tumor-of-the-ovary-with-microinvasion-and-positive-peritoneal-washings weekly 0.8 https://www.themednet.org/now-that-we-are-using-cbct-regularly-have-there-been-any-updates-on-dosimetry-or-second-cancer-risk weekly 0.8 https://www.themednet.org/how-do-you-incorporate-circulating-tumor-dna-in-the-management-of-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-a-subglottic-high-grade-chondrosarcoma-after-laryngectomy-with-positive-margins weekly 0.8 https://www.themednet.org/how-would-you-treat-gastric-adenocarcinoma-with-choriocarcinoma-features weekly 0.8 https://www.themednet.org/do-you-constrain-an-implantable-loop-recorder-cardiac-device-in-patients-getting-radiation weekly 0.8 https://www.themednet.org/how-would-you-evaluate-a-pediatric-patient-with-persistent-elevation-of-d-dimer weekly 0.8 https://www.themednet.org/should-ncs-emg-be-always-performed-in-patients-with-clinically-suspected-critical-illness-neuropathy-and-myopathy-cip-cim-to-confirm-the-diagnosis weekly 0.8 https://www.themednet.org/how-would-you-manage-an-incidental-diagnosis-of-a-primary-mesenteric-carcinoid-tumor-abutting-bowel-in-a-patient-with-an-otherwise-guarded-prognosis weekly 0.8 https://www.themednet.org/is-there-an-increased-risk-of-toxicity-in-patients-undergoing-prostate-radiation-who-recently-completed-immunotherapy weekly 0.8 https://www.themednet.org/do-you-usually-use-prednisone-as-prevention-for-differentiation-syndrome-in-apl weekly 0.8 https://www.themednet.org/how-would-you-manage-stage-ie-dlbcl-of-the-breast weekly 0.8 https://www.themednet.org/in-light-of-zuma-7-results-would-you-consider-use-of-car-t-off-label-for-a-pediatric-or-aya-patient-with-relapsed-or-refractory-large-b-cell-lymphoma weekly 0.8 https://www.themednet.org/what-should-oncologists-know-when-considering-use-of-pd-1-pd-l1-immunotherapy-in-patients-on-interleukin-antagonists weekly 0.8 https://www.themednet.org/how-do-you-manage-selpercatinib-induced-hypersensitivity weekly 0.8 https://www.themednet.org/what-is-your-approach-to-screening-and-follow-up-for-lung-involvement-in-systemic-diseases-associated-with-ild weekly 0.8 https://www.themednet.org/how-do-you-approach-patient-with-metastatic-pancreatic-acinar-cell-carcinoma weekly 0.8 https://www.themednet.org/what-is-the-role-of-rfa-for-symptomatic-bone-metastasis weekly 0.8 https://www.themednet.org/how-would-you-treat-a-primary-breast-carcinoma-of-the-vulva weekly 0.8 https://www.themednet.org/what-would-be-your-preferred-chemotherapy-regimen-for-a-patient-with-recurrent-metastatic-mesonephric-cervical-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-treat-patients-with-pediatric-autoimmune-neuropsychiatric-disorders-associated-with-streptococcus-infections-long-term weekly 0.8 https://www.themednet.org/do-you-offer-parp-inhibitor-maintenance-therapy-to-stage-ic-high-grade-serous-ovarian-cancer-patients weekly 0.8 https://www.themednet.org/what-is-the-best-liver-directed-therapy-for-extensive-unresectable-hepatic-metastases-in-colorectal-cancer-patients-with-liver-only-disease-after-a-response-to-systemic-therapy weekly 0.8 https://www.themednet.org/would-you-recommend-elective-pelvic-node-xrt-in-a-high-risk-prostate-patient-who-has-vascular-disease weekly 0.8 https://www.themednet.org/do-you-alter-the-remaining-fractions-of-a-whole-brain-course-if-the-patient-has-a-prolonged-break-during-the-course weekly 0.8 https://www.themednet.org/do-current-recommendations-still-advocate-for-the-avoidance-of-ipsilateral-blood-draws-iv-catheterizations-and-blood-pressure-readings-in-those-who-undergo-breast-surgery-without-axillary-lymph-node-dissection weekly 0.8 https://www.themednet.org/would-you-consider-a-definitive-or-only-palliative-approach-to-an-oligometastatic-prostate-patient-after-prostatectomy-with-persistent-psa-elevation-in-the-4-5-range-residual-involved-pelvic-nodes-and-residual-tumor-in-the-prostate-bed weekly 0.8 https://www.themednet.org/for-scc-of-the-oral-tongue-s-p-resection-and-slnb-with-planned-port-could-you-forego-a-completion-neck-dissection weekly 0.8 https://www.themednet.org/what-brainstem-constraint-do-you-use-for-h-n-reirradiation-with-sbrt weekly 0.8 https://www.themednet.org/do-you-take-any-additional-precautions-when-treating-skull-base-tumors-in-patients-with-charcot-marie-tooth-disease weekly 0.8 https://www.themednet.org/would-you-include-the-surgical-bed-in-your-volume-when-treating-resected-seminoma-with-positive-margin-at-spermatic-cord weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-colon-cancer-with-erbb2-amplification weekly 0.8 https://www.themednet.org/how-do-you-define-induction-failure-in-all-for-an-adult-patient-on-hypercvad-if-goal-is-to-proceed-to-transplant weekly 0.8 https://www.themednet.org/for-high-volume-metastatic-crpc-to-bone-what-dosing-schedule-of-zoledronic-acid-or-denosumab-do-you-use weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-cirrhosis-splenomegaly-associated-cytopenias-who-is-requiring-adjuvant-chemo-for-a-solid-malignancy-with-curative-intent weekly 0.8 https://www.themednet.org/when-would-you-consider-using-fostamatinib-monotherapy-vs-fostamatinib-combined-with-tpo-ra-for-treatment-refractory-itp weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-young-patient-with-an-initially-presumed-primary-cns-lymphoma-involving-the-brainstem-that-responded-to-steroids-but-showed-no-regression-with-hd-mtx weekly 0.8 https://www.themednet.org/would-you-consider-a-peripheral-arm-mediport-for-patients-receiving-infusional-5-fu-via-ambulatory-pump weekly 0.8 https://www.themednet.org/would-you-ever-consider-depleting-alloantibodies-using-plasma-exchange-to-allow-for-partially-matched-rbc-exchange-in-sickle-cell-patients-with-critically-severe-acute-chest weekly 0.8 https://www.themednet.org/given-recent-data-on-similar-outcomes-for-isolated-distal-and-proximal-dvts-improved-with-doac-therapy-will-your-decision-to-anticoagulate-all-provoked-isolated-distal-dvts-change weekly 0.8 https://www.themednet.org/would-you-consider-definitive-xrt-for-high-grade-sarcomatoid-bladder-ca-s-p-turbt-in-an-inoperable-patient weekly 0.8 https://www.themednet.org/what-kidney-dose-constraints-would-you-use-in-a-patient-s-p-nephrectomy-requiring-total-body-irradiation weekly 0.8 https://www.themednet.org/do-you-perform-sentinel-lymph-node-mapping-in-early-stage-cervical-cancer-of-tumors-2cm weekly 0.8 https://www.themednet.org/how-do-you-monitor-for-therapeutic-efficacy-and-disease-progression-for-patients-with-wilsons-disease-on-chelation-therapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-maintenance-regimen-for-standard-risk-myeloma-patients-who-received-daratumumab-bortezomib-dex-induction-followed-by-an-autologous-transplant weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-symptoms-of-arachnoiditis weekly 0.8 https://www.themednet.org/what-parameters-do-you-use-for-extra-operative-cortical-stimulation-mapping-of-motor-sensory-and-language-cortices-in-the-context-of-surgical-evaluation-for-drug-resistant-epilepsy weekly 0.8 https://www.themednet.org/do-you-recommend-autologous-transplant-in-patients-with-al-amyloidosis-who-have-a-complete-hematologic-response-to-daratumumab-cybord weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-treatment-related-mds weekly 0.8 https://www.themednet.org/how-do-you-manage-thrombocytopenia-50k-in-a-patient-requiring-dual-antiplatelet-therapy weekly 0.8 https://www.themednet.org/is-there-data-for-the-ideal-number-of-consolidation-cycles-in-patients-older-than-60-with-favorable-risk-aml weekly 0.8 https://www.themednet.org/are-nomograms-good-predictors-of-early-stage-breast-cancer-recurrence-with-close-margins weekly 0.8 https://www.themednet.org/when-do-you-consider-initiating-cytoreductive-therapy-in-a-pediatric-patient-with-essential-thrombocythemia weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-immunosuppression-in-patients-with-active-lupus-who-develop-reversible-posterior-leukoencephalopathy-syndrome-rpls weekly 0.8 https://www.themednet.org/should-we-feel-comfortable-starting-anti-tnf-therapy-in-an-otherwise-low-risk-patient-with-borderline-igra weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-symptomatic-meningioma-invading-the-clivus weekly 0.8 https://www.themednet.org/how-would-you-manage-a-high-grade-liposaroma-in-the-inguinal-canal-after-a-non-oncological-resection-and-tumor-spillage weekly 0.8 https://www.themednet.org/are-you-offering-osimertinib-to-any-patients-with-stage-i-resected-egfr-positive-nsclc weekly 0.8 https://www.themednet.org/do-you-recommend-antimicrobial-prophylaxis-in-patients-with-cml-blast-crisis-after-7-3-induction-while-on-maintenance-tki-awaiting-allo-transplant weekly 0.8 https://www.themednet.org/how-would-you-manage-a-locally-advanced-esophageal-cancer-in-a-patient-with-grade-2-neuropathy-from-a-recently-treated-lung-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-the-risk-benefit-discussion-about-biologics-in-patients-with-cirrhosis weekly 0.8 https://www.themednet.org/how-do-you-use-mesna-in-your-patients-who-are-being-started-on-cyclophosphamide weekly 0.8 https://www.themednet.org/how-do-you-manage-hypophosphatemia-associated-with-cml-tkis weekly 0.8 https://www.themednet.org/how-would-you-manage-a-t4-pure-seminoma-of-the-testis-with-positive-scrotal-margins weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-treatment-of-diffuse-leptomeningeal-glioneuronal-tumor-dlgnt-in-a-young-adult weekly 0.8 https://www.themednet.org/in-patients-with-anal-cancer-with-contraindications-to-radiation-therapy-would-you-recommend-adjuvant-chemotherapy-after-curative-intent-surgery weekly 0.8 https://www.themednet.org/in-what-situations-do-you-routinely-use-a-lens-shield weekly 0.8 https://www.themednet.org/how-would-you-approach-anticoagulation-of-a-patient-with-coexistent-antiphospholipid-syndrome-and-metastatic-solid-tumor-malignancy weekly 0.8 https://www.themednet.org/what-is-the-preferred-chemotherapy-regimen-in-patients-with-apml-who-develop-severe-differentiation-syndrome-along-with-neuralgia-to-atra-ato weekly 0.8 https://www.themednet.org/how-would-you-treat-a-recurrent-nasal-ala-squamous-cell-carcinoma-status-post-prior-radiotherapy-in-a-medically-inoperable-patient weekly 0.8 https://www.themednet.org/how-if-at-all-does-your-treatment-of-limited-stage-double-hit-lymphoma-dhl-differ-from-treatment-of-advanced-stage-dhl weekly 0.8 https://www.themednet.org/do-you-use-adjuvant-radiation-therapy-in-patients-with-low-lying-t1-2-rectal-cancers-with-upfront-apr-and-adequate-lymph-nodes-dissection-with-one-positive-node weekly 0.8 https://www.themednet.org/how-would-approach-imaging-surveillance-in-patients-with-lynch-syndrome-who-had-resected-early-stage-colon-and-renal-cancers weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-deciding-on-adjuvant-therapy-for-a-resected-stage-iiib-melanoma-patient weekly 0.8 https://www.themednet.org/should-size-of-non-mass-enhancement-on-breast-mri-be-incorporated-in-breast-cancer-staging weekly 0.8 https://www.themednet.org/what-is-your-management-of-a-stage-1a-infiltrative-subtype-of-mucinous-ovarian-carcinoma weekly 0.8 https://www.themednet.org/what-do-you-recommend-to-prevent-cisplatin-related-hearing-loss-in-pediatric-patients weekly 0.8 https://www.themednet.org/which-method-do-you-prefer-for-assessing-the-functional-status-of-a-patient-ecog-or-kps weekly 0.8 https://www.themednet.org/how-would-you-treat-oligometastatic-sarcomatoid-carcinoma-of-the-prostate weekly 0.8 https://www.themednet.org/are-there-any-benefits-of-immediate-vs-delayed-1-2-weeks-cyclophosphamide-while-awaiting-infectious-work-up-in-the-setting-of-severe-or-organ-threatening-manifestations-of-autoimmune-disease weekly 0.8 https://www.themednet.org/is-there-any-data-for-dose-adjustment-of-apixaban-in-patients-that-have-undergone-bowel-resection weekly 0.8 https://www.themednet.org/how-would-you-approach-a-locally-recurrent-colorectal-patient-who-was-initially-treated-with-adjuvant-flox-due-to-5fu-induced-coronary-vasospasm weekly 0.8 https://www.themednet.org/how-would-you-treat-acute-undifferentiated-leukemia-in-a-young-and-fit-patient weekly 0.8 https://www.themednet.org/is-there-any-diagnostic-or-therapeutic-value-in-following-serum-free-light-chain-elevation-in-patients-with-cirrhosis weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-xrt-for-spermatic-cord-sarcoma weekly 0.8 https://www.themednet.org/how-would-you-approach-cgvhd-treatment-in-a-patient-with-ram-phenotype-aml-status-post-msd-hsct-in-remission weekly 0.8 https://www.themednet.org/how-would-a-diagnosis-of-porphyria-cutanea-tarda-impact-your-treatment-recommendations-in-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/which-biologic-therapies-would-you-consider-avoiding-in-patients-with-pre-existing-psychiatric-disease weekly 0.8 https://www.themednet.org/what-are-some-potential-considerations-for-the-management-and-treatment-of-a-child-with-a-combined-locally-and-distantly-recurrent-papillary-tumor-of-the-pineal-region-previously-treated-with-focal-radiation-and-chemotherapy weekly 0.8 https://www.themednet.org/would-you-consider-consolidation-immunotherapy-after-chemoradiation-for-stage-iii-lung-cancer-in-a-patient-with-history-of-paraneoplastic-autoimmune-cns-syndrome-that-improved-with-treatment weekly 0.8 https://www.themednet.org/how-would-you-approach-a-large-keloid-tumor-that-requires-a-multi-staged-resection-to-avoid-a-graft weekly 0.8 https://www.themednet.org/how-do-you-approach-a-postoperative-diagnosis-of-uterine-leiomyosarcoma-following-a-robotic-hysterectomy-in-which-uterine-morcellation-was-performed weekly 0.8 https://www.themednet.org/in-a-patient-with-history-of-stage-iii-nsclc-who-progresses-to-iv-on-maintenance-durvalumab-who-is-then-found-to-have-actionable-mutation-egfr-alk-do-you-move-directly-on-to-targeted-therapies-even-though-there-might-be-higher-risk-of-toxicity-including-p weekly 0.8 https://www.themednet.org/how-long-and-how-often-after-the-last-dose-of-checkpoint-inhibitor-immunotherapy-do-monitor-thyroid-function weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-do-you-recommend-in-a-primary-non-gestational-ovarian-choriocarcinoma-with-mixed-dysgerminoma-and-yolk-sac-tumor-elements weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-chemotherapy-for-a-young-patient-who-presented-with-psudomyxoma-peritoni-underwent-maximal-cytoreductive-surgery-with-hipec-and-was-finally-diagnosed-with-mucinous-adenocarcinoma-of-urachus weekly 0.8 https://www.themednet.org/how-will-the-acr-white-paper-on-antimalarial-cardiac-toxicity-affect-your-use-of-hcq-and-cq weekly 0.8 https://www.themednet.org/how-would-you-approach-a-myofibroblastic-tumor-of-a-single-cervical-lymph-node-with-a-positive-margin-after-a-complete-level-2-neck-dissection weekly 0.8 https://www.themednet.org/do-you-recommend-observation-or-initiation-of-treatment-for-a-standard-risk-multiple-myeloma-patient-who-has-been-enjoying-a-treatment-free-interval-but-now-has-rising-paraproteins-without-evidence-of-end-organ-damage weekly 0.8 https://www.themednet.org/how-do-you-treat-alk-large-b-cell-lymphoma-in-a-young-fit-patient weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-recent-diagnosis-of-lgl-who-on-review-of-labs-has-had-associated-neutropenia-for-about-10-years-anc-300-500-range-without-any-history-of-recurrent-infection weekly 0.8 https://www.themednet.org/what-rates-of-radiation-induced-secondary-neoplasms-do-you-quote-to-your-pediatric-and-young-adult-patients-with-brain-tumors weekly 0.8 https://www.themednet.org/what-is-your-approach-to-mrd-positive-aml-in-cr1-prior-to-transplant weekly 0.8 https://www.themednet.org/how-do-you-approach-a-young-nulliparous-patient-desiring-future-fertility-who-presents-with-a-complex-adnexal-mass-and-an-elevated-b-hcg-concerning-for-a-non-gestational-choriocarcinoma weekly 0.8 https://www.themednet.org/how-would-you-approach-synchronous-node-positive-nsclc-and-anal-primaries weekly 0.8 https://www.themednet.org/how-would-you-treat-t-cell-histiocyte-rich-large-b-cell-lymphoma-transformed-from-nodular-lymphocyte-predominant-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/how-would-you-manage-digital-capillary-adenocarcinoma-with-metastatic-disease-to-the-lungs-that-is-not-amenable-to-surgical-resection weekly 0.8 https://www.themednet.org/would-you-consider-irradiation-for-prevention-of-a-recurrent-compartment-syndrome weekly 0.8 https://www.themednet.org/how-would-you-discuss-the-role-of-transplant-in-early-stage-myelofibrosis-with-asxl1-and-ezh2-mutations weekly 0.8 https://www.themednet.org/what-is-the-role-of-palliative-radiotherapy-in-hemophagocytic-lymphohistiocytosis-hlh-causing-painful-splenomegaly weekly 0.8 https://www.themednet.org/do-you-recommend-re-vaccination-in-immunosuppressed-patients-who-completed-hepatitis-b-vaccine-series-but-are-found-to-have-undetectable-or-low-surface-antibody-titers weekly 0.8 https://www.themednet.org/in-a-patient-with-metastatic-breast-cancer-who-plans-to-initiate-a-cdk4-6-inhibitor-and-is-with-serologic-evidence-of-hepatitis-b-infection-would-you-provide-prophylaxis-to-decrease-the-risk-of-hbv-reactivation weekly 0.8 https://www.themednet.org/how-do-you-treat-micropapillary-variant-of-bladder-cancer-after-cystectomy weekly 0.8 https://www.themednet.org/how-do-you-approach-surveillance-for-a-patient-with-icus-ccus-or-chip weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-unresectable-esophageal-squamous-cell-carcinoma-with-airway-involvement-making-radiation-high-risk-who-progressed-on-first-line-folfox-pembro weekly 0.8 https://www.themednet.org/how-would-you-manage-a-r1-resection-of-recurrent-grade-1-spermatic-cord weekly 0.8 https://www.themednet.org/up-to-what-age-do-you-routinely-perform-ovarian-preservation-during-surgery-for-a-low-risk-endometrial-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-first-line-systemic-therapy-for-stage-iv-esophageal-cancer-that-is-mixed-adenocarcinoma-and-neuroendocrine-carcinoma-with-cps-1-2-and-her2-negative weekly 0.8 https://www.themednet.org/how-would-you-treat-a-young-patient-with-advanced-stage-classical-hodgkin-lymphoma-with-hiv weekly 0.8 https://www.themednet.org/how-do-you-manage-a-stage-ic3-grade-2-endometrioid-ovarian-carcinoma-in-an-otherwise-healthy-perimenopausal-patient weekly 0.8 https://www.themednet.org/would-you-treat-trigeminal-neuralgia-with-srs-in-a-patient-with-a-connective-tissue-disease-or-autoimmune-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-subcutaneous-panniculitis-like-t-cell-lymphoma-sptcl-with-associated-hlh weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-regarding-the-optune-device weekly 0.8 https://www.themednet.org/what-is-your-approach-to-positive-cmv-viral-titers-in-patients-with-itp weekly 0.8 https://www.themednet.org/are-you-using-any-specific-testing-platform-for-risk-stratification-in-identifying-early-stage-non-small-cell-lung-cancer-patients-at-risk-for-recurrence-and-likely-to-benefit-from-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/is-idh-inhibitor-therapy-approved-for-cmml-or-mds-mpn-overlap-with-idh1-2-mutation weekly 0.8 https://www.themednet.org/what-evaluation-do-you-recommend-for-a-pediatric-patient-incidentally-found-to-have-an-asymptomatic-normocytic-anemia weekly 0.8 https://www.themednet.org/how-helpful-or-predictive-is-the-induction-day-8-peripheral-blood-mrd-in-pediatric-all weekly 0.8 https://www.themednet.org/how-do-you-approach-cns-prophylaxis-for-high-risk-dlbcl weekly 0.8 https://www.themednet.org/what-is-your-approach-to-supportive-management-of-parp-inhibitor-associated-anemia weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-positive-gm-1-antibodies-on-sensory-motor-neuropathy-panel-without-the-typical-clinical-phenotype weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-therapy-for-patients-with-metastatic-renal-cell-carcinoma-with-bone-metastases weekly 0.8 https://www.themednet.org/what-is-your-next-treatment-for-progressive-metastatic-castrate-resistant-prostate-cancer-after-completing-xofigo-therapy weekly 0.8 https://www.themednet.org/do-you-use-risk-assessment-methods-for-lymph-node-involvement-in-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-a-pregnant-patient-with-a-recently-diagnosed-granulosa-cell-tumor-on-ovarian-cystectomy-with-intraoperative-rupture weekly 0.8 https://www.themednet.org/what-clinical-factors-make-you-suspicious-for-paroxysmal-nocturnal-hemoglobinuria-in-a-pediatric-patient-who-presents-with-a-severe-unprovoked-thrombus-with-otherwise-negative-thrombophilia-workup weekly 0.8 https://www.themednet.org/what-options-are-available-for-a-patient-with-vaginal-small-cell-neuroendocrine-tumor-infiltrating-the-bone-marrow-resulting-in-profound-thrombocytopenia weekly 0.8 https://www.themednet.org/how-do-you-treat-an-elderly-patient-with-a-good-performance-status-who-is-diagnosed-with-a-stage-ic1-sertoli-leydig-tumor-of-the-ovary weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-therapy-for-an-early-stage-ovarian-cancer-with-75-epithelial-and-25-germ-cell-components weekly 0.8 https://www.themednet.org/what-would-you-choose-for-re-induction-for-aml-with-tp53-after-failure-of-7-3-in-a-medically-fit-patient weekly 0.8 https://www.themednet.org/how-are-you-incorporating-immune-checkpoint-inhibitors-in-the-treatment-of-relapsed-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/when-deciding-between-chemo-immunotherapy-vs-immunotherapy-alone-for-metastatic-nsclc-do-you-ever-consider-cps-combined-positive-score-in-addition-to-tps-which-was-utilized-in-all-lung-studies weekly 0.8 https://www.themednet.org/what-are-your-recommendations-for-treating-the-hyperpigmented-component-in-quadrichrome-pentachrome-vitiligo weekly 0.8 https://www.themednet.org/is-recurrent-prostatitis-a-contraindication-for-prostate-sbrt weekly 0.8 https://www.themednet.org/are-there-any-ways-to-decrease-recurrence-in-patients-with-hpv-negative-vulvar-cancer-with-extensive-lichen-sclerosis-that-extends-to-mons-and-lower-abdomen weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-treatment-for-locally-advanced-hr-her2-breast-cancer-in-a-patient-with-on-immunosuppression-due-to-kidney-transplantation weekly 0.8 https://www.themednet.org/what-dose-fractionation-do-you-recommend-for-a-recurrent-malignant-fibroid-histiocytoma-of-the-lower-lip-that-is-re-resected-with-positive-margin weekly 0.8 https://www.themednet.org/in-an-acute-renal-artery-thrombosis-requiring-anticoagulation-is-there-a-role-for-adding-aspirin-when-there-is-peripheral-vascular-disease weekly 0.8 https://www.themednet.org/do-you-consider-prior-allogeneic-stem-cell-transplant-a-relative-contraindication-to-breast-chest-wall-radiation weekly 0.8 https://www.themednet.org/how-do-you-manage-progressive-sclerotic-gvhd-that-does-not-respond-to-topical-therapies weekly 0.8 https://www.themednet.org/how-would-you-manage-an-adult-adamantinoma-like-ewings-sarcoma-of-the-right-submandibular-gland weekly 0.8 https://www.themednet.org/would-you-use-taxanes-in-the-treatment-of-patients-with-metastatic-small-bowel-adenocarcinoma-once-the-disease-progressed-on-oxaliplatin-5fu-irinotecan-based-regimens weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-patient-with-rothmund-thomson-syndrome-who-is-planned-for-breast-conserving-surgery-and-radiation-regarding-toxicities weekly 0.8 https://www.themednet.org/what-work-up-and-management-is-indicated-for-patients-with-mediastinal-ganglioneuroma weekly 0.8 https://www.themednet.org/would-you-expect-an-infertile-young-man-with-stage-ia-leydig-cell-tumor-to-become-fertile-after-orchiectomy weekly 0.8 https://www.themednet.org/how-do-you-approach-discordance-in-kras-mutations-in-metastatic-colon-cancer-as-detected-by-pcr-and-by-ngs-such-as-foundation-medicine weekly 0.8 https://www.themednet.org/would-you-consider-single-agent-immunotherapy-or-doublet-in-a-young-patient-with-lynch-and-colon-cancer-with-extensive-para-aortic-lymph-node-involvement-and-t4b-disease-adjuvantly weekly 0.8 https://www.themednet.org/how-do-you-monitor-for-lymphoma-in-a-patient-with-autoimmune-lymphoproliferative-syndrome-alps weekly 0.8 https://www.themednet.org/is-concurrent-chemo-rt-followed-by-immunotherapy-reasonable-in-a-scenario-of-unresectable-nsclc-with-isolated-rib-involvement weekly 0.8 https://www.themednet.org/how-do-you-treat-an-oligometastatic-lesion-of-the-femur-sp-orif-from-renal-ca weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-for-a-pediatric-patient-with-low-risk-stage-iia-nodular-sclerosing-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/is-further-hematologic-workup-indicated-in-a-patient-with-solid-tumor-whose-circulating-tumor-next-generation-sequencing-liquid-biopsy-returns-with-a-jak-mutation weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-or-not-to-add-cns-prophylaxis-in-the-frontline-treatment-of-primary-mediastinal-lymphoma weekly 0.8 https://www.themednet.org/does-current-data-suggest-that-tdm1-remains-beneficial-in-the-adjuvant-setting-following-dose-reductions weekly 0.8 https://www.themednet.org/how-do-you-utilize-circulating-tumor-dna-to-make-decisions-on-adjuvant-chemotherapy-for-colon-cancer weekly 0.8 https://www.themednet.org/would-you-ever-complete-sabr-without-a-biopsy-of-a-renal-primary weekly 0.8 https://www.themednet.org/how-do-you-interpret-platelet-function-testing-in-pregnant-patients weekly 0.8 https://www.themednet.org/do-you-counsel-patients-on-infertility-risk-prior-to-treatment-with-immunotherapy weekly 0.8 https://www.themednet.org/what-are-the-scenarios-where-you-would-do-a-bm-biopsy-for-indolent-lymphomas weekly 0.8 https://www.themednet.org/have-there-been-any-reported-cases-of-myositis-associated-with-tdm1 weekly 0.8 https://www.themednet.org/in-what-scenario-would-you-recommend-the-flipped-nivo-ipi-dosing-nivolumab-3-mg-kg-and-ipilimumab-1-mg-kg-for-treatment-of-metastatic-melanoma weekly 0.8 https://www.themednet.org/would-you-consider-a-targeted-agent-for-a-patient-with-atm-mutant-stage-iv-gallbladder-cancer-with-peritoneal-implants weekly 0.8 https://www.themednet.org/how-would-you-treat-a-pediatric-patient-with-fully-resected-stage-i-nodular-sclerosing-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/what-second-line-regimen-do-you-use-in-a-patient-with-metastatic-ras-mutated-mmr-proficient-colorectal-cancer-with-disease-progression-after-12-cycles-of-folfoxiri-bev weekly 0.8 https://www.themednet.org/how-do-you-treat-recurrent-sweets-syndrome-in-aml weekly 0.8 https://www.themednet.org/do-you-recommend-checkpoint-inhibitors-after-concurrent-chemoradiation-for-gej-adenocarcinoma-patients-who-are-not-surgical-candidates weekly 0.8 https://www.themednet.org/do-you-approach-high-grade-foamy-gland-prostatic-adenocarcinoma-with-desmoplastic-stroma-either-localized-or-metastatic-differently-than-standard-prostatic-adenocarcinoma weekly 0.8 https://www.themednet.org/how-do-you-approach-indeterminate-lymph-nodes-for-rectal-cancer-on-mri weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-inflammatory-arthritis-in-the-setting-of-multisystem-inflammatory-syndrome-in-adults-mis-a-after-covid weekly 0.8 https://www.themednet.org/would-you-offer-bevacizumab-to-a-patient-with-colorectal-cancer-and-a-history-of-inflammatory-bowel-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-rcc-with-medullary-features weekly 0.8 https://www.themednet.org/are-there-any-special-precautions-for-a-patient-with-fragile-x-syndrome-to-start-capecitabine weekly 0.8 https://www.themednet.org/do-you-typically-hold-off-on-performing-sentinel-lymph-node-biopsies-in-those-with-mucinous-breast-cancer-histologies weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-locally-advanced-unresectable-t4-n0-m0-adenocarcinoma-of-the-jejunum weekly 0.8 https://www.themednet.org/how-do-you-advise-patients-with-photosensitive-epilepsy-who-are-interested-in-blue-lens-therapy weekly 0.8 https://www.themednet.org/how-would-you-manage-intracranial-extramedullary-hematopoiesis weekly 0.8 https://www.themednet.org/is-there-a-predictive-or-prognostic-role-for-checking-pd-l1-expression-in-malignant-melanoma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-evaluation-and-management-of-granulomatous-synovitis-in-the-absence-of-infectious-etiologies weekly 0.8 https://www.themednet.org/is-whole-lung-radiation-standard-of-care-in-a-lung-only-ewings-sarcoma-relapse-that-is-rendered-radiographically-ned-from-salvage-systemic-therapy weekly 0.8 https://www.themednet.org/does-mitochondrial-myopathy-increase-the-toxicity-of-breast-irradiation weekly 0.8 https://www.themednet.org/do-you-prefer-intra-arterial-therapy-or-stereotactic-hypofractioned-rt-for-solitary-large-10cm-unresectable-hcc-in-patients-who-cannot-receive-immunotherapy weekly 0.8 https://www.themednet.org/would-you-use-sbrt-to-treat-a-locally-recurrent-angiomyolipoma-of-the-kidney-and-if-so-to-what-dose weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-a-medically-fit-patient-with-synchronous-locally-advanced-esophageal-adenocarcinoma-and-resectable-extrahepatic-cholangiocarcinoma weekly 0.8 https://www.themednet.org/do-you-think-the-interpretation-of-hrd-scores-or-loh-scores-is-affected-by-exposure-to-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-manage-folfox-associated-steatohepatitis-detected-by-labs-and-imaging-midway-through-adjuvant-chemotherapy-for-high-risk-colorectal-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-second-line-therapy-after-platinum-etoposide-for-patients-with-high-grade-neuroendocrine-colorectal-carcinomas-and-a-braf-p-v600e-mutation weekly 0.8 https://www.themednet.org/how-do-you-use-tp53-mutational-status-in-the-development-of-your-treatment-strategy-for-aml weekly 0.8 https://www.themednet.org/what-are-the-optimal-laser-selections-and-settings-for-the-treatment-of-lymphangioma-circumscriptum weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-mmr-proficient-stage-3-colorectal-cancer-in-dialysis-patients weekly 0.8 https://www.themednet.org/in-a-patient-who-had-previously-received-adjuvant-ac-t-for-a-prior-breast-cancer-10-years-ago-would-you-consider-retreating-with-ddac-t-for-a-second-primary-now-with-stage-iiic-hr-her2-breast-cancer weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-rt-for-a-pediatric-patient-with-a-grade-2-myxopapillary-spinal-ependymoma-s-p-gtr weekly 0.8 https://www.themednet.org/how-would-you-treat-unresectable-serous-cystadenoma-of-the-pancreas-involving-the-liver weekly 0.8 https://www.themednet.org/what-is-your-preferred-management-of-a-patient-with-an-oligometastatic-asymptomatic-recurrence-of-low-grade-endometrial-stromal-sarcoma weekly 0.8 https://www.themednet.org/is-antibiotic-prophylaxis-recommended-for-patients-with-sickle-cell-disease-undergoing-dental-procedures weekly 0.8 https://www.themednet.org/how-do-you-determine-the-proper-number-of-pheresis-sessions-to-administer-for-ttp-patients-while-in-the-hospital-and-after-discharge weekly 0.8 https://www.themednet.org/is-there-an-age-at-which-exchange-transfusions-can-be-safely-discontinued-in-an-adult-patient-with-sickle-cell-disease-and-history-of-childhood-stroke weekly 0.8 https://www.themednet.org/how-should-therapy-for-children-with-gross-totally-resected-m0-medulloblastoma-with-large-cell-anaplasia-be-augmented-to-improve-outcomes weekly 0.8 https://www.themednet.org/what-mri-sequence-do-you-use-to-contour-prostate-fiducial-markers weekly 0.8 https://www.themednet.org/do-you-recommend-desensitization-for-patients-with-delayed-allergic-reactions-to-chemotherapy weekly 0.8 https://www.themednet.org/would-you-pursue-a-workup-for-rheumatic-disease-in-a-patient-with-osteitis-pubis weekly 0.8 https://www.themednet.org/how-do-you-choose-a-chemotherapy-backbone-to-combine-with-radiation-for-bladder-preservation weekly 0.8 https://www.themednet.org/would-you-use-adjuvant-chemotherapy-or-immunotherapy-in-a-patient-with-completely-resected-urothelial-carcinoma-of-the-distal-ureter weekly 0.8 https://www.themednet.org/what-systemic-therapy-would-you-offer-patients-with-limited-stage-small-cell-lung-cancer-who-progress-with-brain-metastases-soon-after-concurrent-chemoradiation weekly 0.8 https://www.themednet.org/have-you-noticed-clinical-differences-or-do-you-have-clinical-preferences-between-different-formulations-of-steroids weekly 0.8 https://www.themednet.org/to-what-degree-does-the-extent-of-resection-gtr-v-str-of-an-idh-mutated-1p19q-co-deleted-grade-3-oligodendroglioma-influence-survival-outcomes weekly 0.8 https://www.themednet.org/do-you-hold-erdafitinib-when-treating-oligometastatic-disease weekly 0.8 https://www.themednet.org/what-perioperative-anticoagulation-if-any-would-you-recommend-for-a-patient-with-a-history-of-renal-artery-stenosis-causing-graft-failure-after-ddrt-when-approaching-a-second-transplant weekly 0.8 https://www.themednet.org/how-do-you-manage-recurrent-av-fistula-thromboses-in-hemodialysis-patients weekly 0.8 https://www.themednet.org/how-would-you-treat-a-pediatric-or-adolescent-patient-with-peripheral-t-cell-lymphoma-nos weekly 0.8 https://www.themednet.org/how-would-you-plan-to-give-carboplatin-taxol-and-trastuzumab-postoperatively-for-a-patient-with-serous-endometrial-cancer-her-2-positive-that-received-6-cycles-of-nact-with-carboplatin-and-taxol weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-systemic-therapy-for-brafv600e-mutated-melanoma-patients-with-extracranial-and-intracranial-metastases-s-p-brain-met-resection-and-adjuvant-rt-to-the-resection-bed weekly 0.8 https://www.themednet.org/do-you-recommend-superior-laryngeal-nerve-block-to-patients-with-neurogenic-cough-that-has-not-improved-with-gabapentin-or-pregabalin weekly 0.8 https://www.themednet.org/how-would-you-treat-ct4cn2-esophageal-squamous-cell-cancer-with-tracheal-invasion-with-good-response-to-chemoradiation-but-with-persistent-uptake-on-pet weekly 0.8 https://www.themednet.org/what-adjuvant-regimen-would-you-recommend-for-a-young-brca-pt1b-pn0-tnbc-patient-with-stil-75 weekly 0.8 https://www.themednet.org/how-would-you-approach-a-4-months-pregnant-women-who-is-diagnosed-with-blast-phase-cml weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-distal-esophageal-adenocarcinoma-after-completion-of-concurrent-carboplatin-paclitaxel-chemort-who-on-pre-surgery-eus-has-a-more-proximal-metachronous-adenocarcinoma-outside-the-prior-rt-field weekly 0.8 https://www.themednet.org/for-a-patient-with-locally-advanced-rectal-cancer-would-positive-ctdna-after-total-neoadjuvant-therapy-affect-your-management weekly 0.8 https://www.themednet.org/is-there-any-reason-to-use-gnrh-agonists-in-patients-with-metastatic-prostate-cancer-after-bilateral-orchiectomy weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-to-a-patient-with-dmmr-t4an0-colon-cancer weekly 0.8 https://www.themednet.org/when-treating-advanced-or-recurrent-cervical-cancer-what-factors-do-you-consider-when-deciding-between-cisplatin-versus-carboplatin-in-combination-with-paclitaxel-bevacizumab-pembrolizumab weekly 0.8 https://www.themednet.org/is-there-any-role-for-integration-of-hyperbaric-oxygen-into-chest-wall-radiation-of-high-bmi-patients-with-implant-reconstruction weekly 0.8 https://www.themednet.org/what-regimen-do-you-prefer-in-a-patient-with-thrombocytopenia-and-metastatic-pancreatic-cancer-with-an-otherwise-good-performance-status weekly 0.8 https://www.themednet.org/what-regimen-do-you-prefer-for-metastatic-esophageal-squamous-carcinoma-in-someone-with-poor-performance-status-and-high-pdl-1 weekly 0.8 https://www.themednet.org/would-you-pursue-neoadjuvant-therapy-or-upfront-surgery-in-a-postmenopausal-patient-with-non-inflammatory-ct4b-n1-hr-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-a-testicular-dlbcl-that-recurs-8-years-post-chemotherapy-and-it-chemotherapy-if-it-is-localized-and-resected-would-you-consider-only-radiation weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-radiotherapy-after-surgery-for-a-pt3n1-supraglottic-laryngeal-cancer-with-no-other-adverse-features weekly 0.8 https://www.themednet.org/are-there-any-other-treatment-options-for-a-patient-with-calr-mutant-essential-thrombosis-who-is-unable-to-tolerate-interferon-anagrelide-and-hydroxyurea weekly 0.8 https://www.themednet.org/what-salvage-regimen-for-t-all-would-you-use-in-preparation-for-allo-transplant-in-an-aya-patient-who-is-refractory-to-a-pediatric-induction-regimen weekly 0.8 https://www.themednet.org/how-do-you-manage-unresectable-gliomas-with-discordant-histologic-and-imaging-features weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-young-female-patient-with-a-history-of-a-previously-treated-er-pr-positive-meningioma-who-now-desires-to-become-pregnant weekly 0.8 https://www.themednet.org/how-would-you-consider-altering-the-chemotherapy-regimen-for-anal-squamous-cell-carcinoma-in-an-elderly-but-fit-patient weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-high-risk-as-per-rtog-9802-low-grade-gliomas-who-have-previously-received-monotherapy-with-either-chemotherapy-or-radiation-alone weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-hiv-positive-dlbcl-with-low-ejection-fraction weekly 0.8 https://www.themednet.org/how-do-you-incorporate-genomic-classifier-results-into-treatment-decisions-in-localized-prostate-cancer weekly 0.8 https://www.themednet.org/is-there-a-role-for-incorporating-brentuximab-avd-regimen-into-management-of-first-line-treatment-for-stage-ii-classical-hodgkin-lymphoma-since-they-were-not-included-in-the-recently-reported-echelon-1-protocol weekly 0.8 https://www.themednet.org/how-would-you-approach-stage-iia-lymphocyte-predominant-hodgkins-lymphoma-involving-bilateral-submandibular-glands weekly 0.8 https://www.themednet.org/for-rectal-cancer-patients-with-weak-rectal-tone-after-neoadjuvant-crt-diverting-ostomy-and-re-anastomosis-what-recommendations-or-exercises-do-you-offer weekly 0.8 https://www.themednet.org/what-volume-do-you-treat-when-using-interstitial-brachytherapy-for-sarcoma weekly 0.8 https://www.themednet.org/do-you-routinely-offer-endocrine-therapy-to-patients-with-optimally-debulked-er-or-pr-positive-ovarian-or-endometrial-cancers-after-completion-of-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-would-you-manage-and-prevent-radiation-recall weekly 0.8 https://www.themednet.org/would-you-consider-a-parp-inhibitor-instead-of-chemotherapy-for-a-patient-with-brca-mutation-positive-ovarian-cancer-who-relapses-following-a-complete-response-to-initial-debulking-surgery-and-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-treatment-volumes-should-be-covered-in-an-adult-ewings-sarcoma-mandible-primary-with-a-solitary-nodal-soft-tissue-recurrence-involving-the-contralateral-neck weekly 0.8 https://www.themednet.org/do-you-recommend-holding-anti-pd-l1-therapy-during-palliative-radiation-therapy weekly 0.8 https://www.themednet.org/how-should-the-new-ctv-guidelines-for-head-and-neck-be-applied-to-the-post-op-setting weekly 0.8 https://www.themednet.org/do-the-results-of-the-recently-published-pacific-trial-shift-decision-making-for-patients-with-stage-iii-nsclc-who-are-borderline-surgical-candidates weekly 0.8 https://www.themednet.org/do-you-advise-a-colleague-to-refrain-from-using-csfs-colony-stimulating-factors-when-not-indicated weekly 0.8 https://www.themednet.org/with-the-myriad-of-strategies-for-de-escalating-therapy-for-patients-with-hpv-positive-oropharyngeal-cancer-currently-being-investigated-which-one-shows-the-most-promise weekly 0.8 https://www.themednet.org/would-you-offer-consolidative-radiation-therapy-for-a-stage-iv-dlbcl-germinal-center-type-patient-with-an-initially-bulky-liver-lesion-that-responded-well-to-r-mini-chop weekly 0.8 https://www.themednet.org/are-you-using-copanlisib-instead-of-idelalisib-for-the-treatment-of-follicular-lymphoma-that-have-received-at-least-two-prior-systemic-therapies weekly 0.8 https://www.themednet.org/is-there-any-evidence-to-treat-incidentally-found-hepatitis-b-or-hepatitis-c-with-newly-diagnosed-metastatic-hcc weekly 0.8 https://www.themednet.org/in-head-neck-cancers-do-positive-fresh-frozen-section-margins-with-final-negative-margins-after-additional-resection-influence-your-decision-making-for-adjuvant-treatment weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-relapsed-metastatic-extra-hepatic-bile-duct-cancer-pdl1-negative-and-her2-negative weekly 0.8 https://www.themednet.org/in-a-patient-with-chemotherapy-induced-anemia-with-other-causes-ruled-out-do-you-favor-transfusion-or-esa-support weekly 0.8 https://www.themednet.org/are-you-using-an-obinutuzumab-containing-regimen-for-follicular-lymphoma-instead-of-a-rituximab-containing-regimen weekly 0.8 https://www.themednet.org/would-you-recommend-the-use-of-co2-laser-scar-treatment-in-a-previously-irradiated-field weekly 0.8 https://www.themednet.org/do-you-recommend-the-second-line-use-of-anti-cd20-agent-for-patients-with-refractory-dlbcl weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-thoracic-disease-in-the-setting-of-oligometastatic-nsclc-in-the-era-of-immunotherapy-targeted-agents weekly 0.8 https://www.themednet.org/how-would-you-treat-aggressive-relapse-of-mantle-cell-lymphoma-with-blastoid-morphology-and-high-risk-cytogenetic-abnormalities weekly 0.8 https://www.themednet.org/how-do-you-differentiate-acute-radiation-dermatitis-from-orbital-cellulitis-on-a-patient-currently-receiving-h-n-radiation-with-pain-on-eye-movements-and-an-inconclusive-orbital-ct weekly 0.8 https://www.themednet.org/do-you-recommend-a-waiting-period-in-your-lactating-patients-before-proceeding-with-surgery-for-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-recurrent-non-muscle-invasive-bladder-cancer-in-the-setting-of-prior-prostate-radiation weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-in-deciding-when-to-initiate-rt-in-a-pt-with-an-unknown-h-n-primary-n2c-who-has-mandibular-bone-exposure-after-undergoing-teeth-extractions weekly 0.8 https://www.themednet.org/how-do-you-approach-a-triple-negative-breast-cancer-patient-that-has-developed-numerous-brain-metastases-while-receiving-neoadjuvant-dose-dense-ac-followed-by-taxol weekly 0.8 https://www.themednet.org/do-you-use-glutamine-to-reduce-mucositis-in-h-n-pts-getting-rt weekly 0.8 https://www.themednet.org/what-recommendations-for-secondary-cancer-surveillance-do-you-make-for-a-patient-on-long-term-lenalidomide weekly 0.8 https://www.themednet.org/what-should-be-the-target-anc-to-stop-growth-factor-support-in-patients-who-are-receiving-it-for-neutropenia-and-sepsis-while-on-chemotherapy weekly 0.8 https://www.themednet.org/does-the-use-of-daily-cbct-affect-your-discussion-of-second-malignancy-risk-with-patients weekly 0.8 https://www.themednet.org/how-do-you-treat-braf-negative-melanoma-patients-who-developed-metastatic-disease-after-receiving-adjuvant-ipilimumab weekly 0.8 https://www.themednet.org/what-is-the-role-for-stem-cell-transplant-in-ocular-lymphoma-today-articles-from-2001-and-2003-suggest-a-potential-role-in-the-relapse-setting weekly 0.8 https://www.themednet.org/how-do-you-decide-on-choosing-the-dosing-schedule-of-nivolumab-as-240-mg-q2weeks-vs-480-mg-q4weeks weekly 0.8 https://www.themednet.org/how-long-would-you-treat-a-patient-with-immunotherapy-after-resection-of-brain-metastasis-for-metastatic-melanoma weekly 0.8 https://www.themednet.org/have-you-used-a-different-checkpoint-inhibitor-e-g-pembrolizumab-in-a-patient-who-had-a-serious-infusion-reaction-to-the-first-checkpoint-inhibitor-e-g-nivolumab weekly 0.8 https://www.themednet.org/does-active-therapy-with-herceptin-affect-the-results-of-ihc-and-or-fish-for-her2neu-of-a-new-biopsy-that-is-done-while-on-therapy weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-radiation-therapy-to-an-endobronchial-nsclc-that-is-completely-resected-via-excisional-biopsy-without-evidence-of-additional-disease weekly 0.8 https://www.themednet.org/would-you-discontinue-an-aromatase-inhibitor-and-cdk-4-6-inhibitor-in-a-patient-who-is-admitted-with-a-stroke weekly 0.8 https://www.themednet.org/what-do-you-quote-the-risk-of-radiation-necrosis-with-repeat-srs-srt-to-the-same-lesion weekly 0.8 https://www.themednet.org/how-would-you-treat-a-recurrent-glomus-tumor-of-the-carinal-tracheal-region weekly 0.8 https://www.themednet.org/how-do-you-treat-hyperprogression-on-immunotherapy-in-a-patient-with-metastatic-lung-adenocarcinoma weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-do-you-use-when-palliating-metastasis-from-giant-cell-tumor-of-the-bone weekly 0.8 https://www.themednet.org/would-you-use-cetuximab-with-concurrent-radiation-in-a-patient-with-metastatic-squamous-cell-carcinoma-and-coronary-artery-disease weekly 0.8 https://www.themednet.org/would-you-recommend-breast-radiation-for-a-cutaneous-adnexal-carcinoma-of-the-breast-with-a-positive-sentinel-lymph-node weekly 0.8 https://www.themednet.org/how-do-you-a-approach-a-patient-with-gastric-cancer-who-has-an-inadequate-response-to-neoadjuvant-chemotherapy-and-is-determined-to-be-unresectable weekly 0.8 https://www.themednet.org/how-do-you-decide-what-type-of-bolus-to-use-for-adequate-tissue-compenstation weekly 0.8 https://www.themednet.org/when-are-you-incorporating-nivolumab-in-the-treatment-of-relapsed-hl weekly 0.8 https://www.themednet.org/does-nivolumab-increase-the-risk-of-toxicity-following-an-allogenic-transplant weekly 0.8 https://www.themednet.org/what-is-your-experience-using-brass-mesh-bolus-when-treating-chest-wall-in-post-mastectomy-setting weekly 0.8 https://www.themednet.org/how-do-you-counsel-your-patients-on-the-need-for-axillary-ln-dissection-v-active-surveillance-for-sentinel-lymph-node-positive-upper-extremity-melanoma-s-p-wide-local-excision weekly 0.8 https://www.themednet.org/whats-your-approach-to-timing-of-anti-pd-1-therapy-administration-in-patients-on-hemodialysis weekly 0.8 https://www.themednet.org/how-would-you-approach-stage-iiia-melanoma-in-light-of-recent-data-regarding-the-use-of-adjuvant-therapy-nivo-pembro-and-braf-mek-targeted-therapy-in-patients-with-less-than-complete-resection-of-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-marginal-zone-lymphoma-refractory-to-alkylating-agents-ibrutinib-and-rituximab weekly 0.8 https://www.themednet.org/have-you-been-able-to-develop-techniques-that-will-allow-you-to-treat-patients-who-cannot-lie-flat weekly 0.8 https://www.themednet.org/what-is-your-approach-to-solitary-resectable-brain-metastasis-from-previously-treated-braf-positive-melanoma weekly 0.8 https://www.themednet.org/how-would-you-treat-monomorphic-post-transplant-lymphoproliferative-disorder-in-patients-who-have-a-low-disease-burden weekly 0.8 https://www.themednet.org/is-thromboprophylaxis-necessary-for-all-lymphoma-patients-treated-with-lenalidomide-containing-regimens weekly 0.8 https://www.themednet.org/is-there-a-risk-of-immune-mediated-cardiotoxicity-in-patients-with-metastatic-nsclc-and-malignant-pericarditis-treated-with-checkpoint-inhibitors weekly 0.8 https://www.themednet.org/what-dose-do-you-use-when-treating-a-patient-with-rectal-cancer-status-post-low-anterior-resection-stage-iia-pt3-pn0-with-positive-radial-margins weekly 0.8 https://www.themednet.org/do-you-offer-annual-breast-mri-as-adjunct-to-mammography-in-patients-with-atypical-ductal-hyperplasia-atypical-lobular-hyperplasia-or-lcis weekly 0.8 https://www.themednet.org/how-do-you-treat-a-patient-with-locazlied-disease-breaking-through-the-skin-with-necrotic-lymph-nodes weekly 0.8 https://www.themednet.org/what-is-your-approach-to-ameliorating-musculoskeletal-pain-due-to-venetoclax weekly 0.8 https://www.themednet.org/is-there-data-to-support-a-risk-with-the-use-of-probiotics-during-periods-of-prolonged-neutropenia weekly 0.8 https://www.themednet.org/are-there-differences-in-risk-of-pseudoprogression-in-various-immunotherapy-combination-regimens weekly 0.8 https://www.themednet.org/how-do-you-appropriately-window-a-fused-pet-ct-for-contouring-during-radiation-treatment-planning weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-who-has-developed-cardiac-toxicity-on-dasatinib weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-multi-focal-intracranial-germ-cell-metastases weekly 0.8 https://www.themednet.org/how-reliable-is-the-histopathologic-distinction-between-grade-3a-and-3b-follicular-lymphoma weekly 0.8 https://www.themednet.org/when-would-you-consider-reusing-a-prior-agent-to-treat-relapsed-multiple-myeloma weekly 0.8 https://www.themednet.org/what-is-your-preferred-second-line-therapy-for-malignant-mesothelioma-after-progression-on-platinum-pemetrexed-and-pemetrexed-maintenance-outside-of-clinical-trial weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-symptomatic-metastatic-gastrinoma-that-progresses-on-somatostatin-analogue-therapy weekly 0.8 https://www.themednet.org/would-you-consider-using-a-parp-inhibitor-in-patients-with-sclc-or-high-grade-lcnec-with-somatic-brca-mutations weekly 0.8 https://www.themednet.org/do-you-routinely-proceed-with-salvage-chemotherapy-followed-by-asct-for-patients-with-late-10-yrs-relapse-of-hodgkins-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-cll-with-a-rapidly-rising-wbc-count-that-has-active-warm-autoimmune-hemolytic-anemia-but-no-other-indication-for-treatment-of-the-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-a-muscle-invasive-bladder-cancer-patient-who-received-neoadjuvant-cisplatin-based-chemotherapy-but-has-a-positive-margin-post-operatively weekly 0.8 https://www.themednet.org/what-volume-would-you-treat-for-a-b-cell-lymphoma-of-the-head-of-pancreas-after-a-cr-to-r-chop weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-toxicity-for-lung-sbrt-to-a-lesion-that-has-previously-undergone-rfa weekly 0.8 https://www.themednet.org/how-do-you-manage-fatigue-associated-with-ibrutinib-in-an-elderly-cll-patient weekly 0.8 https://www.themednet.org/what-is-your-initial-preferred-induction-regimen-for-high-risk-burkitts-lymphoma weekly 0.8 https://www.themednet.org/do-you-need-to-dose-adjust-rchop-for-a-pateint-with-gilberts-syndrome weekly 0.8 https://www.themednet.org/how-do-you-manage-immunotherapy-induced-toxic-epidermal-necrolysis weekly 0.8 https://www.themednet.org/what-regimen-do-you-prefer-for-unresectable-malignant-peritoneal-mesothelioma weekly 0.8 https://www.themednet.org/how-do-you-approach-cns-involvement-in-classical-hodgkin-lymphoma weekly 0.8 https://www.themednet.org/are-mitochondrial-disorders-such-as-leber-hereditary-optic-neuritis-considered-contraindications-to-radiation-therapy weekly 0.8 https://www.themednet.org/in-patients-with-very-advanced-rectal-adenocarcinoma-status-post-low-anterior-resection-would-you-consider-adjuvant-chemotherapy-initially-over-chemoradiation-therapy weekly 0.8 https://www.themednet.org/what-treatment-would-you-recommend-for-a-small-3cm-lung-metastasis-from-oligometastatic-anal-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-counsel-and-manage-patients-who-report-erectile-dysfunction-within-a-couple-of-weeks-after-completing-prostate-sbrt weekly 0.8 https://www.themednet.org/how-do-you-treat-recalcitrant-darrier-white-disease-with-radiation weekly 0.8 https://www.themednet.org/which-pulmonary-risk-factors-would-make-you-choose-aavd-over-abvd-in-patients-with-stage-iii-iv-classical-hodgkins-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-indolent-t-lymphoblastic-proliferation-it-lbp weekly 0.8 https://www.themednet.org/how-would-you-manage-a-surgically-resected-braf-positive-conjunctival-melanoma-with-positive-margins-but-no-evidence-of-systemic-disease weekly 0.8 https://www.themednet.org/would-you-re-challenge-a-fit-patient-with-hd-methotrexate-for-primary-cns-lymphoma-who-experienced-excess-toxicity-due-to-a-heterozygous-mthfr-mutation weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-distal-esophageal-cancer-and-esophageal-varices-that-recently-required-banding weekly 0.8 https://www.themednet.org/is-there-a-role-for-ipilumumab-and-nivolumab-combination-immunotherapy-or-single-agent-ipilumumab-for-maintenance-after-induction-with-combination-immunotherapy-in-metastatic-melanoma-if-so-what-is-the-schedule-and-dosing weekly 0.8 https://www.themednet.org/is-there-any-role-for-sbrt-for-unresectable-or-medically-inoperable-mucoepidermoid-carcinoma-of-the-parotid weekly 0.8 https://www.themednet.org/how-would-you-treat-recurrent-disease-demonstrated-on-pet-axumin-after-a-radical-prostatectomy weekly 0.8 https://www.themednet.org/how-do-you-communicate-the-benefit-of-the-newly-approved-combination-of-venetoclax-plus-azacitadine-in-the-front-line-aml-setting-based-on-early-phase-clinical-trial-data-compared-to-the-historical-standard-of-azacitadine-monotherapy-for-patients-who-are- weekly 0.8 https://www.themednet.org/have-you-dosed-lupron-or-other-gnrh-analogues-by-testosterone-level-in-patients-with-prostate-cancer weekly 0.8 https://www.themednet.org/is-there-any-value-in-treating-a-peripheral-nerve-lipoma-with-sbrt-for-chronic-pain-relief weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-for-relapsed-burkitt-lymphoma-without-cns-involvement weekly 0.8 https://www.themednet.org/how-are-you-incorporating-the-vr-cap-regimen-into-your-treatment-of-transplant-ineligible-mantle-cell-lymphoma-patients weekly 0.8 https://www.themednet.org/how-would-you-treat-a-recurrent-isolated-axillary-er-her2-breast-cancer-after-previous-bilateral-mastectomy-and-bilateral-alnd-for-synchronous-stage-i-tumors weekly 0.8 https://www.themednet.org/would-you-treat-patients-with-radiotherapy-who-have-a-diagnosis-of-familial-mediterranean-fever weekly 0.8 https://www.themednet.org/what-is-the-role-for-adjuvant-rt-in-a-recurrent-intramedullary-capillary-hemangioblastoma-status-post-resection weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-young-woman-30-years-old-with-localized-breast-cancer-and-without-known-genetic-mutations-about-lumpectomy-vs-mastectomy weekly 0.8 https://www.themednet.org/in-what-circumstances-do-you-omit-radiation-post-operatively-for-pt2n1m0-rectal-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-chronic-phase-cml-who-has-an-alternatively-spliced-bcr-abl-mutation-due-to-a-35-nucleotide-intronic-insertion-between-exons-8-and-9-bcr-ablins35bp-who-fails-to-achieve-an-mmr weekly 0.8 https://www.themednet.org/do-patients-with-a-positive-antinuclear-antibody-ana-but-no-known-diagnosis-of-autoimmune-disease-have-an-increased-risk-for-toxicity-from-immunotherapy weekly 0.8 https://www.themednet.org/does-a-history-of-suicide-attempt-or-suicidal-ideation-impact-your-recommendations-for-adt-in-a-patient-with-prostate-cancer weekly 0.8 https://www.themednet.org/are-you-using-cardiac-strain-imaging-technology-to-augment-therapy-in-her2-targeted-agents-or-anthracyclines weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-anal-scc-if-radiation-is-contraindicated weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-hemorrhagic-brain-metastases-not-amenable-to-surgical-resection weekly 0.8 https://www.themednet.org/is-there-evidence-for-improved-efficacy-of-any-specific-steroid-dose-and-dosing-interval-for-acute-symptomatic-brain-or-spinal-cord-edema weekly 0.8 https://www.themednet.org/how-does-a-prior-turp-affect-the-sensitivity-and-specificity-of-mri-in-the-evaluation-of-prostate-cancer weekly 0.8 https://www.themednet.org/in-a-young-fit-patient-with-bleomycin-induced-pulmonary-toxicity-how-would-you-approach-on-going-treatment-with-residual-pet-avidity-after-two-cycles-of-abvd-if-bleomycin-was-omitted-for-cycle-2 weekly 0.8 https://www.themednet.org/how-would-you-manage-a-grade-1-myxopapillary-ependymoma-of-the-spine-resected-in-piecemeal-fashion weekly 0.8 https://www.themednet.org/are-there-any-precautions-to-be-aware-of-in-the-setting-of-palliative-radiation-to-a-bone-metastasis-with-underlying-osteomyelitis weekly 0.8 https://www.themednet.org/do-you-use-gene-expression-profiling-in-high-risk-b-cell-lymphomas-to-decide-who-will-benefit-from-intensified-chemotherapy weekly 0.8 https://www.themednet.org/do-you-make-any-dose-fractionation-modifications-for-palliative-rt-in-patients-receiving-ice-chemotherapy weekly 0.8 https://www.themednet.org/do-you-have-specific-tracheal-dose-constraints-for-tumors-abutting-the-trachea weekly 0.8 https://www.themednet.org/does-your-instituation-maintain-100-compliance-with-hepatitis-b-re-activation-risk-screening-in-all-patients-who-are-to-be-treated-with-rituximab-for-nhl weekly 0.8 https://www.themednet.org/how-would-you-approach-front-line-treatment-for-a-young-fit-patient-with-cd30-positive-anaplastic-variant-dlbcl-with-a-large-mediastinal-mass weekly 0.8 https://www.themednet.org/what-is-your-experience-with-incorporating-ir-thermal-ablation-in-the-treatment-of-spine-or-bone-metastases weekly 0.8 https://www.themednet.org/what-is-timing-and-role-for-braf-or-mek-inhibitors-in-recurrent-anaplastic-xanthoastrocytoma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-hr-unilateral-idc-with-positive-bilateral-axillary-nodes weekly 0.8 https://www.themednet.org/how-do-you-counsel-men-on-their-risk-of-needing-post-operative-radiation-after-prostatectomy weekly 0.8 https://www.themednet.org/do-you-generally-recommend-that-all-patients-with-single-level-spinal-cord-compression-from-solid-tumors-undergo-surgical-evaluation-regardless-of-expected-survival weekly 0.8 https://www.themednet.org/how-would-you-treat-metastatic-parotid-myoepithelial-carcinoma weekly 0.8 https://www.themednet.org/would-you-give-r-chop-vs-other-chemo-immunotherapy-adjuvantly-for-stage-ie-dlbcl-of-the-lung-found-on-lung-cancer-screening-ct-and-having-been-completely-resected weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-known-radiation-sensitivity-no-known-mutation-who-developed-intractable-vomiting-after-two-weeks-of-treatment-of-large-field-esophageal-treatment weekly 0.8 https://www.themednet.org/how-would-you-treat-relapsed-poems-syndrome-following-autologous-transplant weekly 0.8 https://www.themednet.org/how-would-you-treat-stage-4-low-grade-follicular-lymphoma-but-one-lymph-node-has-a-pet-suv-of-10-15-but-is-not-biopsy-accessible weekly 0.8 https://www.themednet.org/what-dose-and-field-would-you-use-for-scv-nodal-recurrence-of-squamous-cell-skin-cancer-who-is-not-a-candidate-for-surgery-or-chemotherapy weekly 0.8 https://www.themednet.org/is-there-an-elapsed-time-interval-from-prior-radiation-to-the-brainstem-or-optic-chiasm-for-which-you-would-not-take-into-account-the-prior-dose weekly 0.8 https://www.themednet.org/in-a-patient-who-previously-received-brachy-monotherapy-for-prostate-adenocarcinoma-20-years-ago-who-now-presents-with-prostate-small-cell-carcinoma-how-would-you-manage-persistently-positive-pelvic-nodal-disease-after-chemotherapy-in-the-absence-of-dista weekly 0.8 https://www.themednet.org/for-patients-with-cll-that-are-about-to-start-ibrutinib-would-the-fact-that-patient-is-on-anticoagulation-with-either-warfarin-or-a-noaca-be-an-absolute-contraindication-to-ibrutinib-are-noacs-safer-than-warfarin-in-this-situation weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-for-young-and-otherwise-fit-patients-with-newly-diagnosed-aml-who-categorically-refuse-blood-product-support-now-and-throughout-the-duration-of-their-treatment-course weekly 0.8 https://www.themednet.org/do-you-modify-your-treatment-strategies-for-p16-positive-oropharyngeal-cancers-in-patients-who-also-have-a-significant-smoking-history weekly 0.8 https://www.themednet.org/how-does-the-presence-of-concurrent-immunotherapy-impact-your-decision-regarding-dose-fractionation-for-thoracic-radiation weekly 0.8 https://www.themednet.org/how-do-you-manage-in-situ-or-invasive-carcinoma-arising-within-laryngeal-papillomatosis weekly 0.8 https://www.themednet.org/how-would-you-approach-a-pregnant-patient-with-resected-high-risk-gist-by-size-and-mitotic-rate weekly 0.8 https://www.themednet.org/which-patients-are-approrpiate-for-ho-prophylaxis-following-total-hip-arthroplasty weekly 0.8 https://www.themednet.org/would-you-offer-definitive-radiation-to-a-patient-with-ct1n0m0-high-grade-urothelial-bladder-cancer-with-glandular-differentiation-mixed-histology-after-maximal-turbt-in-a-non-cystectomy-candidate weekly 0.8 https://www.themednet.org/what-is-the-role-of-stem-cell-transplant-in-tp63-mutated-alk-negative-systemic-anaplastic-large-cell-lymphoma-alcl weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-synchronous-multiple-myeloma-and-colon-cancer-requiring-adjuvant-chemotherapy weekly 0.8 https://www.themednet.org/what-systemic-therapy-do-you-offer-for-locally-advanced-metastatic-squamous-cell-carcinoma-of-scrotum weekly 0.8 https://www.themednet.org/what-is-your-recommendation-for-a-patient-with-a-large-unresectable-braf-negative-extremity-melanoma-who-is-progressing-on-immunotherapy weekly 0.8 https://www.themednet.org/based-on-the-recent-data-should-rituximab-be-excluded-in-the-induction-regimen-for-primary-cns-lymphoma-bromberg-et-al-2019 weekly 0.8 https://www.themednet.org/do-you-offer-palliative-radiation-therapy-for-massive-pseudomyxoma-peritonei weekly 0.8 https://www.themednet.org/would-mmr-deficient-status-affect-your-recommendation-on-adjuvant-radiation-for-stage-ia-grade-2-endometrial-cancer weekly 0.8 https://www.themednet.org/would-you-chose-tamoxifen-over-ai-for-hr-bc-patients-with-criteria-for-statin-therapy-e-g-ldl-190-but-who-are-unwilling-to-take-or-didnt-tolerate-statin-therapy weekly 0.8 https://www.themednet.org/how-do-you-manage-side-effects-libido-weight-gain-in-men-with-prostate-cancer-on-androgen-deprivation-therapy weekly 0.8 https://www.themednet.org/are-there-any-specific-management-pearls-or-precautions-for-treating-gi-malignancies-in-patients-with-ibd weekly 0.8 https://www.themednet.org/is-there-a-role-for-voice-therapy-to-treat-hoarseness-related-to-chronic-post-radiation-changes-of-the-larynx-for-patients-with-treated-head-and-neck-cancer weekly 0.8 https://www.themednet.org/is-there-a-role-for-antiviral-therapy-in-active-hepatitic-c-patients-with-unresectable-hcc weekly 0.8 https://www.themednet.org/how-do-you-consider-infectious-risk-from-covid-19-in-your-choice-for-frontline-treatment-of-low-grade-advanced-stage-follicular-lymphoma weekly 0.8 https://www.themednet.org/when-do-you-decide-when-to-pursue-urologic-intervention-in-patients-with-solid-tumors-who-have-asymptomatic-hydronephrosis-secondary-to-tumor-compression weekly 0.8 https://www.themednet.org/when-patients-with-laryngeal-cancer-fail-larynx-sparing-chemo-radiation-do-you-offer-chemotherapy-after-laryngectomy-as-adjuvant-treatment weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-chemotherapy-for-a-post-menopausal-woman-with-a-t2-n0-secretory-er-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-inflammatory-arthritis-that-has-occurred-in-the-setting-of-treatment-with-bruton-tyrosine-kinase-btk-inhibitors weekly 0.8 https://www.themednet.org/how-would-you-approach-therapy-for-a-patient-with-newly-diagnosed-metastatic-signet-ring-carcinoma-of-the-colon-with-underlying-cirrhosis-and-varices weekly 0.8 https://www.themednet.org/is-there-a-role-for-monitoring-thiopurine-metabolites-6-thioguanine-nucleotide-6tgn-and-6-methylmercaptopurine-6mmp-in-patients-on-azathioprine-with-normal-thiopurine-methyltransferase-tpmt-activity weekly 0.8 https://www.themednet.org/how-would-a-pik3ca-mutation-affect-your-management-of-ras-braf-wt-mss-metastatic-colon-cancer weekly 0.8 https://www.themednet.org/how-many-dose-of-intravesical-bcg-would-you-give-in-patient-with-urothelial-carcinoma-in-situ weekly 0.8 https://www.themednet.org/how-do-you-incorporate-non-tier-i-ngs-variants-in-your-management-of-acute-leukemias-and-other-hematologic-malignancies weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-immune-checkpoint-inhibitors-in-a-patient-with-a-history-of-an-allogeneic-transplant weekly 0.8 https://www.themednet.org/how-do-you-adjust-tyrosine-kinase-inhibitors-if-at-all-in-a-patient-with-new-vascular-events-in-a-patient-with-cml-accelerated-phase weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-molecular-assays-to-determine-the-need-for-neoadjuvant-chemotherapy-in-select-patients-with-hr-her2-breast-cancer weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-recommend-for-a-post-menopausal-women-with-pr-but-er-pt1c-pn0-disease-and-a-high-oncotypedx-score weekly 0.8 https://www.themednet.org/what-would-be-your-approach-to-a-patient-with-high-risk-mds-with-ringed-sideroblasts-and-concomitant-coombs-negative-hemolytic-anemia-who-remains-transfusion-dependent-despite-treatment-with-epo-and-hypomethylating-agents weekly 0.8 https://www.themednet.org/what-is-your-preferred-adjuvant-systemic-treatment-for-a-patient-with-isolated-melanoma-brain-metastasis-following-complete-resection-and-srs-to-the-tumor-bed weekly 0.8 https://www.themednet.org/is-there-any-reason-to-hold-secukinumab-during-radiotherapy weekly 0.8 https://www.themednet.org/what-kind-of-imaging-surveillance-do-you-do-in-women-with-extremely-dense-breasts-or-those-with-cosmetic-implants-after-breast-conservation-therapy-for-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/what-is-the-general-approach-to-patients-who-are-symptomatic-from-biopsy-negative-idiopathic-hypertrophic-pachymeningitis weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-malignant-pericardial-effusion-in-a-patient-with-relapsed-refractory-stage-iv-fusion-positive-rhabdomyosarcoma weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-endocrine-therapy-in-a-previously-premenopausal-patient-with-ipsilateral-recurrence-while-on-os-and-ai-2-years-after-receiving-ddac-t-chemotherapy-and-adjuvant-radiation weekly 0.8 https://www.themednet.org/is-bosutinib-a-good-option-for-a-patient-with-e355g-mutation-with-chronic-myeloid-leukemia weekly 0.8 https://www.themednet.org/what-would-you-offer-a-patient-with-metastatic-mucinous-appendiceal-carcinoma-s-p-maximal-treatment-including-surgery-folfox-folfiri-and-hipec-who-now-has-abdominal-carcinomatosis weekly 0.8 https://www.themednet.org/what-is-the-approach-to-managing-hiccups-in-end-of-life-care weekly 0.8 https://www.themednet.org/what-systemic-therapy-would-you-use-for-a-recurrent-metastatic-mucinous-endocervical-adenocarcinoma-after-primary-chemoradiation weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-alopecia-secondary-to-endocrine-therapy weekly 0.8 https://www.themednet.org/how-do-you-manage-a-myocardial-infarction-secondary-to-hyperleukocytosis-and-leukostasis-related-to-aml weekly 0.8 https://www.themednet.org/how-do-you-approach-neoadjuvant-adjuvant-therapy-in-msi-h-locally-advanced-gastric-cancer-without-an-opportunity-to-enroll-in-a-clinical-trial weekly 0.8 https://www.themednet.org/is-there-a-benefit-to-treating-patients-with-mds-with-hypomethylating-agents-prior-to-allogeneic-transplant weekly 0.8 https://www.themednet.org/does-the-alpha-beta-of-1-5-for-prostate-cancers-vary-given-circumstances weekly 0.8 https://www.themednet.org/how-do-you-utilize-ctdna-testing-for-lung-cancer-in-your-clinical-practice weekly 0.8 https://www.themednet.org/what-dose-and-volume-would-you-use-when-offering-postoperative-radiation-therapy-for-a-perirectal-angiomyxoma weekly 0.8 https://www.themednet.org/how-would-one-approach-nk-t-cell-nasal-type-lymphoma-with-cns-and-ocular-involvement-who-is-not-a-candidate-for-high-dose-methotrexate weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-hepatoid-adenocarcinoma-of-gastric-origin-progressing-on-folfox-nivolumab-and-high-pd-l1 weekly 0.8 https://www.themednet.org/can-a-patient-receiving-chronic-ivig-infusions-have-falsely-positive-antithyroglobulin-antibody-levels weekly 0.8 https://www.themednet.org/how-do-you-sequence-multi-kinase-inhibitors-in-metastatic-differentiated-thyroid-cancer weekly 0.8 https://www.themednet.org/does-glucocorticoid-use-impact-systemic-therapy-response-rates-for-brain-metastases weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-offer-in-stage-ii-t2n0-lobular-tnbc-with-negative-gbrca weekly 0.8 https://www.themednet.org/would-you-offer-chemotherapy-to-a-young-female-s-p-tah-bso-with-a-pure-mucinous-grade-3-t1cn0-hr-her2-breast-cancer-and-an-oncotypedx-score-between-21-25 weekly 0.8 https://www.themednet.org/do-you-perform-surveillance-brain-mri-in-patients-with-stage-iii-iv-egfr-mutated-non-small-cell-adenocarcinoma-if-they-had-no-evidence-of-brain-metastasis-at-initial-presentation weekly 0.8 https://www.themednet.org/would-you-offer-salvage-radiotherapy-for-recurrent-dabskas-tumor-endovascular-papillary-angioendothelioma weekly 0.8 https://www.themednet.org/how-do-you-choose-between-olaparib-vs-talozaparib-for-patients-with-germline-brca-mutated-metastatic-breast-cancer-who-are-eligible-for-a-parp-inhibitor weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-chemotherapy-for-patients-with-advanced-epithelial-ovarian-cancer-who-require-6-cycles-of-neoadjuvant-chemotherapy-prior-to-interval-debulking-surgery weekly 0.8 https://www.themednet.org/do-you-incorporate-dvt-prophylaxis-after-joint-arthroscopy-in-a-patient-with-hemophilia weekly 0.8 https://www.themednet.org/what-is-your-approach-for-treating-localized-small-lung-cancer-in-older-patients weekly 0.8 https://www.themednet.org/what-are-the-recommended-treatment-options-for-patients-with-infant-all-and-kmt2a-rearrangement-who-relapse-during-therapy weekly 0.8 https://www.themednet.org/would-you-consider-nivolumab-relatlimab-as-a-salvage-therapy-option-for-advanced-melanoma-patients-who-progressed-on-single-agent-pd-1-inhibitor weekly 0.8 https://www.themednet.org/is-there-a-role-for-post-op-adjuvant-radiation-therapy-for-recurrent-synovial-chondromatosis weekly 0.8 https://www.themednet.org/when-is-a-bone-marrow-biopsy-indicated-in-the-workup-of-diffuse-large-b-cell-lymphoma weekly 0.8 https://www.themednet.org/what-is-the-difference-between-modified-and-non-modified-cyclosporine weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-cervical-cancer-with-brain-metastases-including-leptomeningeal-disease-in-a-patient-who-has-previously-experienced-grade-4-hematologic-toxicity-to-primary-cytotoxic-chemotherapy weekly 0.8 https://www.themednet.org/what-imaging-studies-if-any-are-considered-mandatory-for-re-staging-breast-cancer-patients-with-local-in-breast-recurrence-following-partial-mastectomy-and-radiation weekly 0.8 https://www.themednet.org/how-would-you-manage-a-localized-poorly-differentiated-gastric-adenocarcinoma-with-signet-ring-cell-features-in-a-patient-with-a-remote-history-of-a-well-differentiated-tubular-adenocarcinoma-of-the-stomach-status-post-partial-gastrectomy-and-adjuvant-che weekly 0.8 https://www.themednet.org/in-patients-with-psoriasis-refractory-to-topical-medication-and-a-history-of-latent-tb-what-are-your-preferred-systemic-therapies weekly 0.8 https://www.themednet.org/are-there-concerns-about-treatment-with-hma-venetoclax-in-a-patient-with-extramedullary-aml-presenting-with-a-large-cardiac-mass weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-that-has-transformed-to-a-higher-grade-2-to-3-oligodendroglioma weekly 0.8 https://www.themednet.org/do-you-always-check-a-hypercoagulable-workup-in-patients-with-first-onset-of-unprovoked-vte-under-the-age-of-45 weekly 0.8 https://www.themednet.org/how-might-you-alter-your-treatment-approach-for-a-newly-diagnosed-cervical-cancer-who-also-carries-a-new-diagnosis-of-aids-with-low-cd4-count weekly 0.8 https://www.themednet.org/what-is-your-experience-with-sulfasalazine-in-treating-dactylitis-associated-with-peripheral-hla-b27-positive-spa weekly 0.8 https://www.themednet.org/would-you-treat-a-urothelial-carcinoma-of-the-renal-pelvis-status-post-resection-with-positive-distal-margin-and-a-pelvic-nodal-recurrence weekly 0.8 https://www.themednet.org/does-your-approach-to-management-of-osteoporosis-change-in-a-patient-who-has-a-low-ctx-prior-to-osteoporosis-anabolic-therapy-initiation weekly 0.8 https://www.themednet.org/how-long-would-you-continue-nsaid-monotherapy-in-a-patient-with-axial-spondyloarthritis-who-has-had-a-complete-response-and-no-contraindications-side-effects-to-nsaids weekly 0.8 https://www.themednet.org/how-would-you-manage-a-male-patient-who-has-a-germline-brca2-mutation-with-node-positive-hr-positive-invasive-ductal-carcinoma-who-is-unable-unwilling-to-receive-tamoxifen-or-ai-goserelin weekly 0.8 https://www.themednet.org/would-you-pursue-sbrt-for-liver-only-metastatic-esophageal-cancer-after-progression-on-multiple-lines-of-systemic-therapy weekly 0.8 https://www.themednet.org/will-you-extrapolate-the-results-of-aster-70s-showing-no-benefit-of-adjuvant-chemotherapy-in-high-genomic-grade-index-elderly-patients-with-early-stage-er-breast-cancer-to-those-with-high-oncotype-25 weekly 0.8 https://www.themednet.org/how-do-you-manage-rectal-cancer-found-to-be-node-positive-only-after-up-front-surgery weekly 0.8 https://www.themednet.org/what-is-your-approach-to-neoadjuvant-treatment-for-uterine-carcinosarcoma-with-peritoneal-metastases-prior-to-surgical-debulking weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-selection-for-ssc-ild weekly 0.8 https://www.themednet.org/for-rhd-females-of-child-bearing-potential-is-it-recommended-to-give-rhogam-if-they-receive-rhd-platelets weekly 0.8 https://www.themednet.org/what-frontline-regimen-would-you-use-for-a-patient-with-double-hit-lymphoma-and-compensated-systolic-cardiac-dysfunction weekly 0.8 https://www.themednet.org/are-you-still-routinely-recommending-revascularization-for-asymptomatic-carotid-stenosis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-workup-and-treatment-of-burning-mouth-syndrome weekly 0.8 https://www.themednet.org/how-do-you-manage-male-patients-with-breast-cancer-who-are-intolerant-to-adjuvant-tamoxifen weekly 0.8 https://www.themednet.org/how-soon-after-having-a-pulmonary-embolism-can-a-flight-attendant-or-pilot-resume-working weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-for-localized-stage-i-or-contiguous-stage-ii-grade-iiia-follicular-lymphoma weekly 0.8 https://www.themednet.org/for-patients-with-resected-nsclc-is-there-a-role-for-using-commercial-molecular-profiling-to-determine-benefit-of-giving-adjuvant-chemotherapy-vs-giving-adjuvant-therapy-based-on-stage-alone weekly 0.8 https://www.themednet.org/how-to-manage-a-venous-thromboembolism-that-developed-while-a-patient-was-on-warfarin-for-a-mechanical-valve weekly 0.8 https://www.themednet.org/what-atypical-features-of-ischemic-stroke-s-typically-convince-you-that-lumbar-puncture-is-indicated weekly 0.8 https://www.themednet.org/do-you-have-any-surgical-precautions-in-patients-with-a-history-of-syringomyelia weekly 0.8 https://www.themednet.org/when-do-you-screen-for-leptomeningeal-involvement-in-myeloma weekly 0.8 https://www.themednet.org/how-do-you-determine-percent-of-positive-biopsy-cores-for-prostate-cancer-when-there-is-fragmentation-of-the-cores weekly 0.8 https://www.themednet.org/how-would-you-manage-oligometastatic-colon-cancer-with-a-resected-primary-and-liver-metastasis-found-to-be-msi-h weekly 0.8 https://www.themednet.org/does-a-robust-response-to-ivig-establish-the-diagnosis-of-itp-in-an-elderly-patient-where-you-might-otherwise-consider-a-bone-marrow-biopsy-to-rule-out-other-hematological-disorders weekly 0.8 https://www.themednet.org/how-do-you-manage-telangiectasias-that-arise-as-a-side-effect-of-ado-trastuzumab-emtansine-when-used-to-treat-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-metastatic-clear-cell-adenocarcinoma-of-male-urethra-with-no-targetable-mutation-on-ngs weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-chronic-fatigue-syndrome weekly 0.8 https://www.themednet.org/what-is-your-preferred-dose-and-fractionation-for-managing-an-isolated-unresectable-pelvic-nodal-recurrence-in-a-patient-with-locally-advanced-rectal-cancer-previously-treated-with-tnt-and-lar weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-sarcomatoid-renal-cell-carcinoma-after-progression-on-nivolumab-and-cabozantinib weekly 0.8 https://www.themednet.org/how-do-you-manage-ct2n1-rectal-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-patients-with-tnbc-who-achieve-a-pcr-with-neoadjuvant-keynote-522-regimen-but-develop-isolated-chest-wall-recurrence-soon-after-completing-neoadjuvant-treatment weekly 0.8 https://www.themednet.org/do-you-manage-a-patient-with-a-prior-simple-suprapubic-prostatectomy-differently-from-a-patient-with-a-prior-radical-retropubic-prostatectomy weekly 0.8 https://www.themednet.org/would-you-recommend-mri-for-delineation-of-sbrt-prostate-bone-metastasis-when-you-already-have-psma-pet weekly 0.8 https://www.themednet.org/how-do-you-evaluate-a-pediatric-patient-incidentally-found-to-have-prolonged-aptt-on-pre-operative-evaluation weekly 0.8 https://www.themednet.org/are-there-any-clinical-scenarios-that-you-feel-should-be-characterized-as-radiation-oncology-emergencies-which-are-not-currently weekly 0.8 https://www.themednet.org/is-there-a-point-where-it-is-unsafe-to-remove-a-retrievable-ivc-filter weekly 0.8 https://www.themednet.org/would-you-consider-using-tocilizumab-in-combination-with-mycophenolate-for-patients-with-systemic-sclerosis-and-known-ild-but-progressive-skin-disease-and-arthritis weekly 0.8 https://www.themednet.org/how-would-you-treat-metastatic-er-negative-pr-positive-her-2-negative-breast-cancer-with-no-germline-or-targeted-mutations weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-cutaneous-small-vessel-vasculitis-in-a-patient-with-pr3-positivity-without-clear-systemic-features weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-ra-in-pregnancy-in-a-patient-who-requires-a-non-tnf-inhibitor-biologic weekly 0.8 https://www.themednet.org/what-is-the-best-way-to-monitor-for-toxicity-when-offering-paclitaxel-and-imatinib-in-combination-for-treatment-of-simultaneous-early-tnbc-and-gist weekly 0.8 https://www.themednet.org/what-is-the-role-of-anticoagulant-and-fibrinolytics-in-dic weekly 0.8 https://www.themednet.org/which-labs-do-you-order-before-redosing-rituximab-for-patients-with-rheumatoid-arthritis weekly 0.8 https://www.themednet.org/how-do-you-interpret-and-manage-unruptured-intracerebral-aneurysm-wall-enhancement-awe-on-vessel-wall-magnetic-resonance-imaging-mri weekly 0.8 https://www.themednet.org/are-there-any-contraindications-to-chlorhexidine-gluconate-baths-in-hospitalized-patients-undergoing-radiotherapy weekly 0.8 https://www.themednet.org/how-do-you-design-myocutaneous-island-pedicle-flaps-on-the-nose-for-optimal-mobility-when-repairing-defects-on-the-nasal-tip weekly 0.8 https://www.themednet.org/would-you-use-hypofractionation-to-treat-a-bladder-cancer-patient-with-prior-rp weekly 0.8 https://www.themednet.org/when-prescribing-relugolix-have-you-had-difficulty-with-insurance-coverage-or-out-of-pocket-costs weekly 0.8 https://www.themednet.org/would-you-consider-hypomethylating-agents-in-patients-with-atypical-cml-who-are-not-candidates-for-transplant weekly 0.8 https://www.themednet.org/how-would-you-manage-monoarticular-rice-body-synovitis-in-the-setting-of-negative-infectious-work-up weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-regarding-concerns-related-to-silicone-breast-implants-and-correlation-to-connective-tissue-disease weekly 0.8 https://www.themednet.org/do-you-utilize-intramuscular-glucocorticoids-for-pmr weekly 0.8 https://www.themednet.org/what-second-line-treatment-would-you-recommend-to-a-patient-with-metastatic-mucosal-melanoma-that-is-braf-and-c-kit-wildtype-that-has-progressed-after-ipilimumab-nivolumab weekly 0.8 https://www.themednet.org/what-systemic-treatment-do-you-recommend-for-an-incidentally-discovered-ic2-high-grade-serous-fallopian-tube-carcinoma-in-the-setting-of-recent-adjuvant-paclitaxel-administration-for-a-non-gynecologic-cancer weekly 0.8 https://www.themednet.org/how-often-do-you-see-severe-arthralgias-within-first-few-days-of-immune-therapy-in-a-patient-without-history-of-autoimmune-disease weekly 0.8 https://www.themednet.org/what-dose-and-fractionation-would-you-use-to-treat-an-avm-of-the-head-and-neck-that-is-unable-to-undergo-resection-or-embolization weekly 0.8 https://www.themednet.org/would-you-consider-post-operative-chemo-rt-in-patients-with-locally-advanced-gastric-carcinoma-with-poor-pathological-response-to-neoadjuvant-flot-and-or-d1-only-lymph-node-dissection weekly 0.8 https://www.themednet.org/what-are-some-of-the-interventions-that-you-have-attempted-to-improve-the-use-of-4t-score-and-reduce-inappropriate-hit-testing-in-low-risk-patients-in-your-institutions weekly 0.8 https://www.themednet.org/do-you-typically-counsel-patients-with-multiple-sclerosis-regarding-sunscreen-use weekly 0.8 https://www.themednet.org/how-do-you-evaluate-for-pernicious-anemia-in-patient-already-on-vitamin-b12-supplementation weekly 0.8 https://www.themednet.org/what-is-your-management-approach-to-aortitis-in-igg4-related-disease-including-initial-induction-and-maintenance-therapy weekly 0.8 https://www.themednet.org/do-you-routinely-continue-fluorouracil-with-irinotecan-for-colon-cancer-after-progression-on-folfox-or-capox weekly 0.8 https://www.themednet.org/what-are-the-guidelines-in-regards-to-rescue-medication-prescriptions-and-seizure-action-plans-for-children-with-suspected-psychogenic-non-epileptic-seizures weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-patients-with-diffuse-vascular-damage-from-takayasus-but-no-current-systemic-signs-or-symptoms-normal-inflammatory-markers-and-no-enhancement-on-mra weekly 0.8 https://www.themednet.org/what-dose-of-avatrombopag-would-you-use-as-part-of-triple-therapy-for-aplastic-anemia-atg-cyclosporine-and-tpo-mimetic weekly 0.8 https://www.themednet.org/do-you-recommend-using-caplacizumab-to-treat-acquired-thrombotic-thrombocytopenic-purpura-ttp-in-children weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-of-igg4d-related-abdominal-aortitis-without-evidence-of-retroperitoneal-fibrosis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-monitoring-disease-activity-in-granulomatous-mastitis weekly 0.8 https://www.themednet.org/how-would-you-manage-severe-agranulocytosis-in-an-elderly-pt-with-cmml-0-low-risk-by-mayo-model weekly 0.8 https://www.themednet.org/do-you-prescribe-prophylactic-anticoagulation-upon-discharge-for-laparoscopic-guided-interstitial-brachytherapy-requiring-inpatient-admission weekly 0.8 https://www.themednet.org/in-a-young-fit-patient-with-cardiac-dysfunction-and-mild-neuropathy-what-would-you-use-as-first-line-therapy-for-cd-30-t-cell-lymphoma weekly 0.8 https://www.themednet.org/what-is-your-approach-for-reliably-differentiating-jaw-claudication-from-temporomandibular-joint-disorder weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-granulomatosis-with-polyangiitis-who-also-have-findings-of-aortitis-on-imaging weekly 0.8 https://www.themednet.org/what-type-of-adjuvant-chemotherapy-would-you-choose-for-a-patient-with-er-pr-positive-t3n1a-breast-cancer-with-history-of-multiple-sclerosis weekly 0.8 https://www.themednet.org/in-what-situation-would-you-choose-to-monitor-a-recurrent-1-cm-dcis-with-hormone-therapy-alone weekly 0.8 https://www.themednet.org/what-chemotherapy-regimen-will-work-best-for-a-patient-with-newly-diagnosed-borderline-resectable-pancreatic-adenocarcinoma-and-synchronous-early-stage-triple-negative-breast-cancer-t1b-with-excellent-ps-how-would-you-time-lumpectomy-with-respect-to-neoad weekly 0.8 https://www.themednet.org/how-do-you-approach-discordant-turbt-of-no-muscle-invasion-but-cystoscopy-and-or-imaging-suggesting-mibc weekly 0.8 https://www.themednet.org/would-you-continue-long-term-treatment-with-hypomethylating-agents-for-patients-with-mds-who-have-no-hematologic-response-in-order-to-decrease-risk-of-future-leukemic-progression weekly 0.8 https://www.themednet.org/how-would-you-manage-grade-3-neuroendocrine-tumor-of-the-gallbladder-with-positive-margins-after-resection weekly 0.8 https://www.themednet.org/when-would-you-consider-changing-to-an-alternate-parp-inhibitor-in-the-setting-of-maintenance-therapy-for-ovarian-cancer weekly 0.8 https://www.themednet.org/how-do-you-define-high-risk-features-in-pregnant-patients-with-congenital-heart-disease weekly 0.8 https://www.themednet.org/what-is-your-transfusion-threshold-for-adult-chd-patients-with-cyanotic-heart-disease-experiencing-bleeding-complications-following-non-operative-procedures weekly 0.8 https://www.themednet.org/when-would-you-consider-serial-outpatient-fdg-pet-to-facilitate-the-diagnosis-of-and-or-monitor-response-to-antimicrobial-therapy-in-cases-of-cied-infections-or-prosthetic-valve-endocarditis weekly 0.8 https://www.themednet.org/what-are-clinical-indications-for-initiation-of-plasmapheresis-and-or-ivig-for-suspected-autoimmune-mediated-autonomic-dysfunction-acquired-in-the-post-covid-setting weekly 0.8 https://www.themednet.org/when-do-you-consider-empiric-initiation-of-antiplatelets-for-patients-with-abi-equal-to-0-9 weekly 0.8 https://www.themednet.org/how-often-do-you-monitor-lipids-during-pregnancy-for-patients-with-hypertriglyceridemia-or-familial-hypercholesterolemia weekly 0.8 https://www.themednet.org/what-agent-s-do-you-recommend-for-pregnant-patients-with-hypertriglyceridemia weekly 0.8 https://www.themednet.org/which-agents-do-you-prefer-for-rapid-sequence-intubation-and-subsequent-sedation-in-patients-with-acute-rv-failure weekly 0.8 https://www.themednet.org/should-statin-initiation-be-discouraged-in-adults-with-advanced-ckd-transitioning-to-either-hemodialysis-or-peritoneal-dialysis weekly 0.8 https://www.themednet.org/do-you-approach-treatment-any-differently-for-a-patient-with-prior-early-stage-hormone-receptor-positive-breast-cancer-who-experiences-metastatic-triple-negative-recurrence weekly 0.8 https://www.themednet.org/is-there-any-role-of-venetoclax-as-a-single-agent-therapy-in-mds weekly 0.8 https://www.themednet.org/what-risk-for-grade-3-lymphedema-do-you-quote-for-patients-undergoing-chemoradiation-with-imrt-for-anal-cancer weekly 0.8 https://www.themednet.org/what-would-be-the-treatment-of-choice-for-itp-in-a-patient-on-chronic-dialysis weekly 0.8 https://www.themednet.org/when-do-you-consider-splenectomy-in-the-treatment-of-refractory-chronic-itp-in-a-pediatric-patient weekly 0.8 https://www.themednet.org/in-a-patient-with-recurrent-gynecologic-cancer-and-new-onset-inflammatory-myopathy-do-you-feel-comfortable-utilizing-immune-checkpoint-therapy weekly 0.8 https://www.themednet.org/how-would-you-manage-dmmr-stage-iv-colon-cancer-after-progression-on-pembrolizumab-and-second-line-folfox-bev weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-multiple-myeloma-being-actively-treated-with-velcade-based-therapy-and-recently-confirmed-malignant-pleural-effusion-from-primary-er-pr-positive-her2-negative-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-adjuvant-treatment-of-stage-iiic-low-grade-endometrioid-endometrial-carcinoma-with-cervical-stromal-involvement weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-who-progress-on-ar-targeted-therapy-and-adt-started-in-mcspc-setting weekly 0.8 https://www.themednet.org/what-is-the-recommended-treatment-for-ph-cml-cp-with-t315i-mutation-who-did-not-tolerate-dose-reduced-ponatinib-or-asciminib weekly 0.8 https://www.themednet.org/would-you-consider-the-addition-of-immunotherapy-to-chemo-for-unresectable-epithelioid-mesothelioma-based-on-the-phase-2-pre0505-and-dream-trial weekly 0.8 https://www.themednet.org/when-would-you-use-ibrutinib-plus-venetoclax-for-upfront-treatment-of-cll weekly 0.8 https://www.themednet.org/does-pathology-of-gleason-pattern-4-with-cribiform-morphology-alter-decision-for-prostate-cancer-tx weekly 0.8 https://www.themednet.org/what-would-be-the-treatment-of-choice-for-burkitt-type-ptld-following-heart-transplant-with-the-aim-of-minimizing-cardiac-toxicity weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-therapy-for-a-patient-with-stage-iiib-melanoma-pt2an1c-microsatellite-only-following-wide-excision-with-negative-sln weekly 0.8 https://www.themednet.org/what-neoadjuvant-chemo-regimen-would-you-recommend-for-a-patient-with-ln-positive-tnbc-and-a-history-of-cva-neuropathy-and-risk-factors-for-heart-disease-but-normal-echo weekly 0.8 https://www.themednet.org/what-are-the-potential-risks-and-benefits-of-applying-snail-mucin-to-irradiated-skin-during-radiation-therapy weekly 0.8 https://www.themednet.org/what-anesthetic-do-you-use-for-patients-who-are-ultra-rapid-metabolizers-of-lidocaine weekly 0.8 https://www.themednet.org/what-risks-do-you-advise-in-premenopausal-patients-with-history-of-higher-risk-hormone-positive-breast-cancer-patients-who-require-fertility-treatments-and-injections weekly 0.8 https://www.themednet.org/would-you-recommend-repeating-imaging-during-long-term-follow-up-for-a-patient-with-history-of-pulmonary-embolism-who-had-evidence-of-right-ventricle-compromise-during-the-acute-event weekly 0.8 https://www.themednet.org/in-patients-with-axial-spondyloarthritis-when-if-ever-do-you-use-methotrexate-to-prevent-anti-tnfi-antibody-formation weekly 0.8 https://www.themednet.org/what-is-the-treatment-approach-for-refractory-chemotherapy-induced-diarrhea-to-loperamide-and-diphenoxylate-atropine weekly 0.8 https://www.themednet.org/what-are-your-treatments-of-choice-for-alopecia-areata-in-pregnant-or-breastfeeding-females weekly 0.8 https://www.themednet.org/how-would-you-manage-bevacizumab-proteinuria-if-the-patient-has-stable-disease-on-bevacizumab-and-would-like-to-continue weekly 0.8 https://www.themednet.org/would-you-recommend-vitamin-e-supplementation-for-patient-with-peripheral-neuropathy-and-ataxia-with-a-low-vitamin-e-gamma-tocopherol-but-normal-alpha-tocopherol weekly 0.8 https://www.themednet.org/for-locally-advanced-msi-high-rectal-cancer-after-completion-of-chemoradiation-would-you-consider-addition-of-neoadjuvant-immune-therapy weekly 0.8 https://www.themednet.org/do-you-follow-the-iscd-guideline-of-using-female-caucasian-reference-population-for-t-scores-for-men-of-all-ethnic-groups weekly 0.8 https://www.themednet.org/would-you-recommend-that-oncologists-include-acute-cardiovascular-events-in-informed-consent-for-checkpoint-inhibitor-treatment weekly 0.8 https://www.themednet.org/is-there-evidence-that-amputation-of-the-affected-digit-or-snlb-lengthens-or-improves-the-quality-of-life-in-patients-with-subungual-melanoma weekly 0.8 https://www.themednet.org/what-etiologies-would-you-consider-for-recurrent-eosinophilia-and-thrombocytosis-in-an-aml-patient-on-aza-ven-and-in-remission weekly 0.8 https://www.themednet.org/how-do-you-treat-localized-epithelial-myoepithelial-carcinomas weekly 0.8 https://www.themednet.org/would-you-consider-therapy-with-ai-plus-cdk4-6i-or-ai-alone-in-a-patient-with-oligometastatic-hr-breast-cancer-with-complete-response-to-initial-chemotherapy weekly 0.8 https://www.themednet.org/do-you-routinely-use-endoscopic-ultrasound-for-staging-distal-esophageal-cancer-even-in-non-surgical-candidates weekly 0.8 https://www.themednet.org/for-patients-with-unresectable-residual-medulloblastoma-in-a-location-not-amenable-to-further-resection-which-components-of-high-risk-treatment-are-most-likely-to-benefit-the-patient weekly 0.8 https://www.themednet.org/what-situations-would-prompt-surgical-re-exploration-to-remove-any-residual-fallopian-tubes-or-ovaries-for-an-incidentally-discovered-early-stage-uterine-leiomyosarcoma weekly 0.8 https://www.themednet.org/how-does-immunosuppressive-therapy-affect-the-sensitivity-of-brain-leptomeningeal-biopsy-for-primary-cns-vasculitis-or-other-cns-vasculitides weekly 0.8 https://www.themednet.org/would-you-surgically-re-explore-patients-with-apparent-stage-1-mucinous-ovarian-carcinoma-to-perform-lymphadenectomy-if-pathology-indicates-an-infiltrative-subtype weekly 0.8 https://www.themednet.org/how-do-you-interpret-mris-within-the-first-3-months-of-completion-of-adjuvant-temozolomide-rt-in-mgmt-methylated-glioblastomas weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-patients-with-positive-aps-lab-criteria-who-develop-myocardial-infarction-in-the-setting-of-arterial-dissection weekly 0.8 https://www.themednet.org/would-you-consider-radiation-alone-or-chemoradiation-in-a-patient-with-nsclc-who-is-nonsurgical-candidate-with-n1-stage-iib-disease weekly 0.8 https://www.themednet.org/do-you-continue-immunosuppressive-treatment-in-patients-who-previously-developed-drug-induced-anca-vasculitis-affecting-only-the-kidney-and-are-now-on-hemodialysis weekly 0.8 https://www.themednet.org/what-is-your-first-line-treatment-strategy-for-early-stevens-johnson-syndrome-toxic-epidermal-necrolysis weekly 0.8 https://www.themednet.org/how-do-you-decide-which-patients-with-sickle-cell-disease-that-are-high-opiate-utilizers-are-appropriate-for-transition-to-buprenorphine weekly 0.8 https://www.themednet.org/does-use-of-image-guidance-with-fiducials-change-your-recommendations-for-bowel-prep-for-prostate-cancer-patients weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-recurrent-uterine-adenosarcoma-with-sarcomatous-overgrowth-following-r0-resection-of-secondary-pelvic-tumor-debulking weekly 0.8 https://www.themednet.org/how-you-choose-between-letrozole-or-exemestane-when-patients-have-aimss-with-anastrozole-in-adjuvant-breast-cancer-therapy weekly 0.8 https://www.themednet.org/is-there-any-utility-efficacy-of-bariatric-vitamins-s-p-gastric-bypass-surgery weekly 0.8 https://www.themednet.org/what-is-your-approach-to-systemic-therapy-for-a-post-menopausal-patient-with-stage-iib-grade-1-endometrioid-peritoneal-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-council-patients-diagnosed-with-hormone-receptor-positive-breast-cancer-currently-or-interested-in-taking-exogenous-hormones-e-g-testosterone-for-gender-affirming-treatment weekly 0.8 https://www.themednet.org/how-do-you-approach-a-pt-with-uc-who-has-a-flare-during-definitive-prostate-radiation weekly 0.8 https://www.themednet.org/do-you-hold-btk-inhibitors-in-patients-admitted-with-medical-or-surgical-problems weekly 0.8 https://www.themednet.org/does-tumor-grade-ever-influence-your-adjuvant-treatment-recommendations-for-cervical-cancer-adeno-or-scc-after-radical-hysterectomy weekly 0.8 https://www.themednet.org/how-do-you-utilize-a-desmopressin-challenge-in-von-willebrand-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-nausea-and-gi-side-effects-related-to-sulfasalazine-use weekly 0.8 https://www.themednet.org/do-you-consider-using-sulfasalazine-to-decrease-the-risk-of-anti-drug-antibody-development-in-ra-patients-on-tnfi-who-are-unable-to-take-methotrexate-due-to-fatty-liver-disease weekly 0.8 https://www.themednet.org/have-you-ever-treated-a-recurrent-malignant-brenner-tumor-of-the-ovary-with-preop-radiotherapy weekly 0.8 https://www.themednet.org/in-patients-with-metastatic-hormone-receptor-positive-breast-cancer-who-have-received-cdk-4-6-inhibitor-either-in-the-adjuvant-setting-or-past-line-of-therapy-after-metastatic-progression-is-there-any-data-to-support-cdk-4-6-inhibitor-retreatment weekly 0.8 https://www.themednet.org/are-there-any-situations-where-you-would-use-temodar-alone-without-radiation-in-a-patient-with-oligodendroglioma-who-grade-ii-idh-mutant-1p-19q-codeleted-who-is-unresectable weekly 0.8 https://www.themednet.org/what-anticoagulant-is-preferred-in-patients-with-cancer-who-develop-acute-vte-and-are-on-intermittent-dialysis weekly 0.8 https://www.themednet.org/have-you-had-success-in-switching-to-a-different-bisphosphanate-when-a-patient-develops-a-delayed-maculopapular-rash-with-a-bisphosphanate weekly 0.8 https://www.themednet.org/how-do-you-reconcile-the-different-trial-results-of-keynote-574-and-immotion010-for-adjuvant-checkpoint-inhibitor-use-in-rcc weekly 0.8 https://www.themednet.org/in-patients-with-unresectable-epithelioid-type-malignant-pleural-mesothelioma-do-you-ever-consider-adding-bevacizumab-to-first-line-platinum-pemetrexed-when-choosing-chemotherapy-over-combination-immunotherapy weekly 0.8 https://www.themednet.org/would-you-consider-leukopheresis-based-solely-on-the-degree-of-leucocytosis-in-a-patient-presenting-with-new-leucocytosis-with-blasts-on-the-peripheral-smear weekly 0.8 https://www.themednet.org/what-degree-of-abnormal-light-chain-ratio-would-prompt-you-to-perform-a-bone-marrow-aspirate-and-biopsy-on-a-patient-with-light-chain-mgus-without-myeloma-defining-symptoms weekly 0.8 https://www.themednet.org/is-there-data-regarding-the-use-of-vac-lok-bags-in-the-treatment-of-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-counsel-families-on-prognosis-of-juvenile-systemic-sclerosis-with-only-sclerodactyly-and-raynauds-phenomenon-but-no-internal-organ-involvement weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-m-protein-and-cardiac-dysfunction-but-negative-amyloid-staining weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-maintenance-treatment-in-cns-vasculitis-following-initial-cyclophosphamide-induction weekly 0.8 https://www.themednet.org/do-you-recommend-immunotherapy-after-chemoradiation-for-unresectable-tracheal-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-monitoring-a-patient-with-reactive-arthritis-with-sacroiliitis-with-complete-resolution-of-symptoms-with-nsaids weekly 0.8 https://www.themednet.org/management-options-for-pudendal-neuralgia-after-salvage-radiation-for-prostate-cancer weekly 0.8 https://www.themednet.org/would-you-recommend-the-bivalent-covid-19-booster-in-a-patient-with-suspected-itp-from-covid-19-vaccine weekly 0.8 https://www.themednet.org/how-do-you-dose-capecitabine-in-a-patient-with-stage-5-chronic-kidney-disease-not-on-dialysis weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-for-vulvar-genital-vitiligo weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-very-young-woman-with-er-pr-positive-breast-cancer-regarding-the-risks-and-benefits-of-bilateral-salpingo-oophorectomy-vs-continued-use-of-goserelin weekly 0.8 https://www.themednet.org/would-you-offer-immediate-adjuvant-radiation-to-a-sub-totally-resected-atypical-meningioma-in-a-pediatric-patient weekly 0.8 https://www.themednet.org/how-do-you-decide-between-infusional-5-fu-and-oral-capecitabine-for-patients-undergoing-neoadjuvant-chemoradiation-for-rectal-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-steroid-initiation-and-subsequent-taper-of-steroids-in-cases-of-suspected-autoimmune-encephalitis weekly 0.8 https://www.themednet.org/what-ra-disease-activity-measure-do-you-use-in-clinical-practice weekly 0.8 https://www.themednet.org/what-treatment-options-and-or-surveillance-prescription-do-you-recommend-for-inflammatory-myofibroblastic-tumor-of-the-uterus weekly 0.8 https://www.themednet.org/is-there-a-role-for-post-operative-immunotherapy-alone-without-chemotherapy-in-older-adults-with-resected-lung-cancer-and-high-pdl1-expression-who-decline-chemotherapy weekly 0.8 https://www.themednet.org/for-early-stage-breast-cancer-patients-with-discordant-her2-testing-dual-ish-vs-fish-results-on-surgical-specimen-how-do-you-proceed-in-terms-of-adjuvant-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-rheumatoid-arthritis-and-pyoderma-gangrenosum-whose-ra-is-non-responsive-to-tnf-inhibitors weekly 0.8 https://www.themednet.org/how-do-you-approach-re-irradiation-of-the-sacral-plexus weekly 0.8 https://www.themednet.org/what-monitoring-tests-do-you-perform-for-patients-with-a-history-of-dress-syndrome-to-assess-for-long-term-thyroid-and-cardiac-involvement weekly 0.8 https://www.themednet.org/what-recommendations-do-you-provide-to-patients-treated-with-ivig-regularly-about-receiving-vaccines weekly 0.8 https://www.themednet.org/what-is-the-role-of-ketamine-infusions-in-chronic-opioid-resistant-pain-in-sickle-cell-disease weekly 0.8 https://www.themednet.org/how-do-you-utilize-ibrutinib-r-chop-in-the-frontline-treatment-of-dlbcl weekly 0.8 https://www.themednet.org/what-dose-would-you-give-for-lrc-for-a-pecoma-perivascular-epitheliod-cell-tumor-of-the-anal-canal weekly 0.8 https://www.themednet.org/how-would-you-approach-a-positive-mpo-in-a-patient-with-a-negative-anca-screen-whose-clinical-presentation-is-limited-to-aortitis weekly 0.8 https://www.themednet.org/what-if-any-is-the-role-of-radiotherapy-for-a-recurrent-nonfunctional-parathyroid-carcinoma weekly 0.8 https://www.themednet.org/when-would-you-use-hormonal-therapy-for-patients-with-recurrent-grade-1-er-pr-endometrioid-endometrial-adenocarcinoma weekly 0.8 https://www.themednet.org/can-administering-rituximab-still-be-clinically-effective-even-if-there-is-evidence-of-depletion-of-cd19-b-cells-on-flow-cytometry weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-deciding-between-unilateral-and-bilateral-inguinofemoral-lymph-node-dissection-following-identification-of-unilateral-sln-macrometastasis-and-negative-contralateral-sln-in-a-patient-with-a-midline-vulvar-squamous-cell-car weekly 0.8 https://www.themednet.org/what-factors-do-you-use-to-guide-diagnosis-of-immune-checkpoint-inhibitor-pneumonitis-vs-infectious-etiologies weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-gej-adenocarcinoma-with-a-delay-in-resection-after-concurrent-chemoradiotherapy weekly 0.8 https://www.themednet.org/what-would-you-recommend-as-next-line-treatment-for-a-man-with-metastatic-er-pr-her2-1-pik3ca-mutated-breast-cancer-with-mets-to-bone-who-was-diagnosed-with-advanced-disease-while-on-ai-gnrh-agonist-and-has-subsequently-progressed-through-cdk4-6-inhibitor weekly 0.8 https://www.themednet.org/how-do-you-preserve-fertility-in-women-with-newly-diagnosed-acute-leukemia weekly 0.8 https://www.themednet.org/what-conditioning-regimens-are-you-using-for-hematopoietic-cell-transplanatation-and-pre-car-t-lymphodepletion-with-the-current-fludarabine-shortage weekly 0.8 https://www.themednet.org/when-if-ever-would-you-continue-pembrolizumab-for-more-than-two-years-in-metastatic-or-recurrent-msi-h-endometrial-cancer weekly 0.8 https://www.themednet.org/is-pet-ct-sufficient-for-the-diagnosis-of-bone-marrow-involvement-by-aggressive-lymphoma weekly 0.8 https://www.themednet.org/can-you-use-doxil-for-metastatic-breast-cancer-after-prior-dose-dense-ac weekly 0.8 https://www.themednet.org/would-you-use-radiation-therapy-to-palliate-bone-pain-secondary-to-malignant-systemic-mastocytosis weekly 0.8 https://www.themednet.org/what-is-the-current-role-of-genomically-guided-targeted-therapies-in-management-of-primary-brain-tumors weekly 0.8 https://www.themednet.org/are-there-any-data-to-suggest-efficacy-of-pembrolizumab-for-msi-h-for-recurrent-progressive-platinum-resistant-mucinous-ovarian-cancer weekly 0.8 https://www.themednet.org/how-do-you-step-down-therapy-in-a-patient-with-severe-asthma-on-biologic-therapy weekly 0.8 https://www.themednet.org/would-you-utilize-breast-cancer-index-in-patients-with-er-her2-breast-cancer-to-guide-whether-or-not-to-extend-adjuvant-endocrine-therapy weekly 0.8 https://www.themednet.org/what-therapeutic-options-do-you-consider-when-treating-autoimmune-disease-in-sickle-cell-patients-considering-increased-anemia-and-infection-risk weekly 0.8 https://www.themednet.org/have-you-used-crushed-dissolved-tranexamic-acid-tablets-for-local-hemostasis-in-dental-oral-bleeding-in-patients-with-hemophilia-von-willebrand-disease-what-has-been-your-experience weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-ebrt-vs-rai-in-patients-with-poorly-differentiated-thyroid-carcinoma-after-resection weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-for-chemotherapy-and-concurrent-chemoradiation-in-patients-with-history-of-mild-ild weekly 0.8 https://www.themednet.org/is-there-a-role-for-radiation-in-treating-an-unresectable-mass-of-endometriosis-surrounding-the-sciatic-nerve weekly 0.8 https://www.themednet.org/how-would-you-treat-a-diffuse-large-b-cell-and-mantle-cell-composite-lymphoma-in-a-fit-older-person weekly 0.8 https://www.themednet.org/what-is-your-approach-to-first-line-treatment-of-light-chain-deposition-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-elderly-patient-with-de-novo-metastatic-hormone-sensitive-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-systemic-therapy-for-a-high-grade-glioma-in-the-setting-of-lynch-syndrome weekly 0.8 https://www.themednet.org/how-would-you-manage-a-recurrent-conjunctival-stromal-tumor weekly 0.8 https://www.themednet.org/what-is-your-approach-for-patients-with-locally-advanced-nsclc-with-history-of-autoimmune-conditions-such-as-ms-and-ibd weekly 0.8 https://www.themednet.org/would-you-consider-radical-prostatectomy-in-men-whose-mri-shows-ece weekly 0.8 https://www.themednet.org/how-do-you-manage-upper-esophageal-squamous-cell-in-situ-disease-that-is-not-amenable-to-endoscopic-mucosal-resection weekly 0.8 https://www.themednet.org/how-do-you-approach-screening-and-monitoring-for-cardiopulmonary-complications-in-a-patient-with-raynauds-plus-high-titer-ana-and-scl70-or-centromere-but-no-signs-of-systemic-disease-or-nailfold-capillaroscopy-changes weekly 0.8 https://www.themednet.org/in-a-patient-with-incidentally-noted-osteochondroma-on-a-knee-or-shoulder-x-ray-do-you-pursue-additional-imaging-to-further-evaluate-it-or-determine-risk-of-malignant-transformation weekly 0.8 https://www.themednet.org/what-is-your-work-up-and-treatment-approach-to-pityriasis-rotunda weekly 0.8 https://www.themednet.org/how-will-you-manage-a-patient-with-refractory-metastatic-unclassified-rcc-with-progression-on-io-tki weekly 0.8 https://www.themednet.org/would-you-offer-radiation-therapy-for-a-patient-with-epidermodysplasia-verruciformis weekly 0.8 https://www.themednet.org/what-is-the-best-way-to-manage-functionally-limiting-medically-refractory-reflux-regurgitation-from-an-embedded-esophageal-stent-for-a-locally-advanced-esophageal-cancer-in-patient-who-cannot-undergo-esophagectomy-resection weekly 0.8 https://www.themednet.org/how-would-you-approach-the-long-term-management-of-osteoporosis-in-a-person-who-has-experienced-osteonecrosis-of-the-jaw-on-prior-therapy-and-who-is-not-a-candidate-for-an-anabolic-agent weekly 0.8 https://www.themednet.org/what-is-your-surveillance-strategy-for-uterine-smooth-muscle-tumors-of-uncertain-malignant-potential-stump-and-atypical-leiomyoma-identified-on-hysterectomy weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-a-high-grade-glioma-involving-the-lateral-ventricles weekly 0.8 https://www.themednet.org/is-gallium-dotatate-scanning-recommended-at-initial-diagnosis-of-metastatic-thymoma-and-if-positive-do-you-consider-sris weekly 0.8 https://www.themednet.org/how-do-you-approach-warfarin-use-in-patients-with-antiphospholipid-syndrome-with-calciphylaxis weekly 0.8 https://www.themednet.org/are-there-reliable-data-to-support-enoxaparin-use-in-esrd-patients-needing-to-bridge-to-warfarin-for-vte-history weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-approach-for-contractures-in-patients-with-emery-dreifuss-muscular-dystrophy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-hemophagocytic-lymphohistiocytosis-and-conflicting-pathology-reports-one-of-which-suggests-ptcl-nos-and-the-other-lgl weekly 0.8 https://www.themednet.org/how-does-pleural-vs-peritoneal-primary-site-affect-your-choice-of-systemic-therapy-for-mesothelioma weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-patients-with-multiple-cylindromas weekly 0.8 https://www.themednet.org/how-would-you-approach-a-resectable-pancreatic-adenocarcinoma-not-visible-by-imaging-but-seen-on-ercp-in-a-patient-who-refuses-any-surgery weekly 0.8 https://www.themednet.org/in-patients-who-receive-neoadjuvant-chemo-immunotherapy-3-cycles-of-pd1-chemo-for-resectable-nsclc-what-is-your-post-operative-approach-after-successful-r0-resection weekly 0.8 https://www.themednet.org/in-an-immunocompromised-patient-would-you-deliver-adjuvant-radiation-for-a-squamous-cell-carcinoma-of-the-anal-margin-with-close-but-negative-margins weekly 0.8 https://www.themednet.org/what-is-your-approach-to-primary-systemic-treatment-for-extra-pelvic-metastatic-vaginal-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-re-irradiation-over-the-lumbosacral-plexus-in-the-setting-of-prior-sbrt weekly 0.8 https://www.themednet.org/does-abemaciclib-have-the-same-magnitude-of-benefit-in-patients-with-lobular-breast-cancer-in-adjuvant-and-metastatic-setting-compared-to-ductal-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-large-pleural-effusion-s-p-drainage-without-any-parenchymal-disease-along-with-peripheral-eosinophilia-that-has-a-positive-c-anca-pr3-antibody-without-other-systemic-symptoms weekly 0.8 https://www.themednet.org/what-is-your-approach-to-dosing-and-timing-of-cyclophosphamide-in-patients-on-crrt-since-cyclophosphamide-is-dialyzable weekly 0.8 https://www.themednet.org/how-many-weeks-after-pmrt-do-you-wait-to-re-expand-a-previously-deflated-tissue-expander weekly 0.8 https://www.themednet.org/when-do-you-utilize-irinotecan-for-patients-with-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-metastatic-colorectal-cancer-with-resected-lung-and-hilar-nodes-with-a-positive-margin weekly 0.8 https://www.themednet.org/would-you-consider-her2-directed-therapy-for-a-patient-with-her2-amplified-locally-advanced-rectal-cancer-who-has-persistent-disease-after-tnt-as-a-means-to-avoid-apr-colostomy weekly 0.8 https://www.themednet.org/how-do-you-treat-metastatic-adenosquamous-cancer-of-the-pancreas weekly 0.8 https://www.themednet.org/what-is-your-approach-to-evaluation-and-management-of-zoster-sine-herpete weekly 0.8 https://www.themednet.org/what-are-the-benefits-of-using-a-cannula-for-lip-filler-vs-a-needle weekly 0.8 https://www.themednet.org/given-the-natural-clinical-course-of-long-term-epilepsy-associated-tumors-leats-do-you-offer-resection-for-surgically-remediable-otherwise-benign-leats-prior-to-demonstration-of-drug-resistant-epilepsy-or-do-you-wait-until-the-patient-has-met-consensus-cr weekly 0.8 https://www.themednet.org/how-would-you-approach-a-second-relapse-of-b-all-in-a-young-adult-patient-initially-diagnosed-in-childhood weekly 0.8 https://www.themednet.org/how-aggressively-would-you-treat-an-incidentally-noted-metastasis-of-the-orbit weekly 0.8 https://www.themednet.org/in-light-of-sabcs-2022-will-you-use-bci-to-guide-ofs-recommendation-in-the-adjuvant-setting weekly 0.8 https://www.themednet.org/given-reported-worse-outcomes-in-african-american-patients-with-breast-cancer-do-you-make-any-changes-to-your-treatment-recommendations-based-on-a-patients-race weekly 0.8 https://www.themednet.org/does-your-service-provide-patients-with-advocacy-and-survivorship-resources-upon-diagnosis-of-either-early-or-metastatic-disease weekly 0.8 https://www.themednet.org/are-there-instances-where-you-would-omit-adjuvant-pembrolizumab-after-achieving-pcr-with-neoadjuvant-treatment-for-localized-tnbc weekly 0.8 https://www.themednet.org/how-would-you-treat-a-pituitary-neuroblastoma-post-r2-resection-without-imaging-evidence-of-distant-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-adjuvant-therapy-for-stage-ic-mucinous-ovarian-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-isolated-recurrent-grade-3-immature-ovarian-teratoma weekly 0.8 https://www.themednet.org/does-the-asap-trial-change-how-we-approach-relapsed-and-refractory-aml weekly 0.8 https://www.themednet.org/how-much-of-a-work-up-do-you-perform-for-an-otherwise-healthy-patient-with-aquagenic-pruritus-to-look-for-an-underlying-hematologic-disorder weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-use-for-a-patient-with-pancreatic-adenocarcinoma-who-completed-4-months-of-neoadjuvant-folfirinox-with-good-treatment-response-but-severe-neuropathy-and-is-thus-no-longer-a-candidate-for-oxaliplatin weekly 0.8 https://www.themednet.org/is-there-any-increased-radiosensitivity-in-patients-with-parry-romberg-syndrome weekly 0.8 https://www.themednet.org/when-treating-an-acoustic-neuroma-with-hypofractionation-what-prescribed-dose-and-brainstem-cochlea-constraints-do-you-use weekly 0.8 https://www.themednet.org/when-would-you-consider-the-use-of-anakinra-for-ra-management weekly 0.8 https://www.themednet.org/how-do-you-define-high-volume-metastatic-prostate-cancer-in-patients-without-visceral-metastases weekly 0.8 https://www.themednet.org/how-would-you-manage-rising-psa-in-a-patient-with-de-novo-metastatic-prostate-ca-with-psa-nadir-at-0-2-with-adt-and-nht weekly 0.8 https://www.themednet.org/what-treatments-do-you-recommend-for-patients-with-steroid-induced-lipoatrophy weekly 0.8 https://www.themednet.org/what-is-your-preferred-imaging-frequency-for-patients-with-non-small-cell-lung-cancer-in-the-metastatic-setting-as-well-as-on-adjuvant-consolidation-immunotherapy-after-surgery-or-chemoradiation weekly 0.8 https://www.themednet.org/does-paraneoplastic-pemphigus-improve-after-treatment-of-the-underlying-malignancy weekly 0.8 https://www.themednet.org/how-would-you-treat-patient-who-developed-seizures-due-to-pres-after-starting-adjuvant-cisplatin-pemetrexed-for-nsclc weekly 0.8 https://www.themednet.org/would-you-consider-using-ai-plus-cdk4-6-inhibitor-in-a-patient-with-hormone-positive-metastatic-metaplastic-breast-carcinoma-that-progressed-through-neoadjuvant-ac-t-with-lung-and-liver-metastases weekly 0.8 https://www.themednet.org/does-the-levels-of-gm1-antibody-igg-or-igm-tested-by-the-enzyme-immunoassay-eia-method-reduce-after-treatment-for-cidp-with-ivig weekly 0.8 https://www.themednet.org/how-do-you-weigh-the-risks-benefits-of-cytokine-blockade-eg-dupilumab-in-pregnant-patients weekly 0.8 https://www.themednet.org/how-do-you-approach-significant-change-in-bmd-in-premenopausal-patient-on-tamoxifen weekly 0.8 https://www.themednet.org/for-patients-with-metastatic-rcc-and-gross-hematuria-from-the-primary-tumor-what-palliative-radiation-regimen-would-you-recommend-to-help-control-the-bleeding weekly 0.8 https://www.themednet.org/what-prompts-you-to-do-a-deeper-workup-in-a-patient-presenting-with-what-appears-to-be-skin-limited-small-vessel-vasculitis-2 weekly 0.8 https://www.themednet.org/is-any-hormonal-monitoring-necessary-for-males-with-breast-cancer-on-adjuvant-aromatase-inhibitor-and-lhrh-agonist-lupron weekly 0.8 https://www.themednet.org/what-is-your-approach-to-prescribing-glp-1-agonists-for-patients-who-would-otherwise-have-cv-benefits-from-this-therapy-but-who-also-have-co-morbid-gi-problems-such-as-barretts-esophagus-severe-gerd weekly 0.8 https://www.themednet.org/how-do-you-treat-checkpoint-inhibitor-induced-myasthenia-gravis weekly 0.8 https://www.themednet.org/what-neoadjuvant-chemotherapy-regimen-would-you-choose-for-a-triple-positive-er-pr-her2-ct2n1-g3-breast-cancer-for-an-elderly-patient-80-y-o weekly 0.8 https://www.themednet.org/how-do-you-factor-in-a-positive-family-history-of-premature-cad-into-ascvd-risk-estimation weekly 0.8 https://www.themednet.org/would-you-consider-addition-of-adjuvant-capecitabine-to-tdm-1-in-a-patient-with-residual-disease-after-neoadjuvant-therapy-tchp-for-biopsy-proven-hr-her2-positive-breast-cancer-if-residual-disease-after-mastectomy-shows-hr-her2-negative-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-to-differentiating-pseudo-cushings-state-from-cushings-syndrome weekly 0.8 https://www.themednet.org/what-would-you-include-in-your-radiation-field-for-a-ct2n1-perianal-squamous-cell-carcinoma-in-the-setting-of-vin3-cin3-and-ain3 weekly 0.8 https://www.themednet.org/do-you-routinely-transition-from-inpatient-vancomycin-to-outpatient-daptomycin-to-decrease-the-risk-of-nephrotoxicity-and-reduce-the-burden-of-lab-monitoring-in-a-patient-with-mrsa-infection-being-discharged-on-home-iv-antibiotics weekly 0.8 https://www.themednet.org/when-do-you-consider-indefinite-anticoagulation-in-someone-with-first-episode-of-distal-calf-vein-dvt weekly 0.8 https://www.themednet.org/what-is-your-approach-to-obtain-tissue-diagnosis-for-a-patient-with-a-lung-primary-and-spine-metastasis weekly 0.8 https://www.themednet.org/what-makes-a-patient-a-good-candidate-for-sarencycline-compared-to-other-oral-antibiotics-for-acne weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-tuberculous-scleritis-in-pregnancy-2 weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-in-patients-with-cutaneous-mastocytosis-and-inflammatory-arthritis weekly 0.8 https://www.themednet.org/how-do-you-counsel-families-of-pediatric-patients-on-methotrexate-about-live-vaccine-schedules weekly 0.8 https://www.themednet.org/how-often-do-you-check-desmoglien-antibodies-in-pemphigus-patients-after-treatment-and-during-remission weekly 0.8 https://www.themednet.org/following-surgical-staging-what-adjuvant-therapy-would-you-recommend-for-stage-ib-grade-3-endometrioid-endometrial-carcinoma-with-lvsi-2 weekly 0.8 https://www.themednet.org/do-oral-nsaids-and-steroids-have-an-effect-on-how-you-interpret-synovial-fluid-leukocyte-count weekly 0.8 https://www.themednet.org/do-you-test-ovarian-cancer-tumors-for-targetable-biomarkers-e-g-her2-folate-receptor-mmr-at-the-time-of-primary-diagnosis-or-at-time-of-recurrence weekly 0.8 https://www.themednet.org/have-you-utilized-combination-biologic-therapy-for-the-treatment-of-rheumatic-diseases weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-aortitis-in-patients-with-anca-associated-vasculitis weekly 0.8 https://www.themednet.org/how-often-if-ever-do-patients-with-initially-negative-targetable-mutation-workup-become-positive-later-in-recurrent-lung-cancer weekly 0.8 https://www.themednet.org/is-there-any-role-for-adjuvant-chemoradiation-in-resected-duodenal-adenocarcinoma weekly 0.8 https://www.themednet.org/how-do-you-manage-follow-up-lab-findings-of-hyperchloremic-metabolic-acidosis-and-low-bicarbonate-in-patients-on-ca-inhibitors-like-topirimate-or-acetazolamide weekly 0.8 https://www.themednet.org/how-do-you-manage-peripheral-blood-eosinophilia-that-is-new-and-temporally-related-to-checkpoint-immunotherapy weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-immunotherapy-in-a-older-frail-patient-who-received-radiation-for-upper-tract-urothelial-carcinoma weekly 0.8 https://www.themednet.org/would-you-use-combination-of-weekly-low-dose-carboplatin-and-taxol-in-patient-with-small-cell-lung-cancer-with-poor-performance-status-or-cytopenia weekly 0.8 https://www.themednet.org/for-postmenopausal-osteoporosis-would-you-give-denosumab-after-a-course-of-teriparatide-and-romosozumab-to-women-who-had-an-atypical-femoral-fracture-while-on-bisphosphonate-therapy-a-few-years-earlier weekly 0.8 https://www.themednet.org/what-treatments-have-you-found-effective-for-wounds-in-pressure-sites-in-the-elderly-population weekly 0.8 https://www.themednet.org/is-there-a-role-for-bromhexine-for-thick-secretions-during-after-head-and-neck-rt weekly 0.8 https://www.themednet.org/how-often-do-you-refer-patients-with-hypothyroidism-and-type-d-personality-traits-characterized-by-worry-and-pessimism-to-psychiatry-after-prescribing-standard-hypothyroidism-treatment weekly 0.8 https://www.themednet.org/how-do-you-interpret-high-c1q-binding-assay-with-otherwise-normal-c1q-c3-c4-ch50-in-a-patient-with-recurrent-urticaria-with-positive-ana-at-high-titer-1-1280-negative-dsdna-rnp-sm-normal-cbc-cmp-ua-and-upcr weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-a-young-adult-after-ascending-thoracic-aneurysm-repair-with-biopsy-showing-granulomatous-inflammation-no-other-vascular-involvement-pet-scan-normal weekly 0.8 https://www.themednet.org/what-is-the-appropriate-timing-of-sperm-banking-relative-to-radical-orchiectomy-in-newly-diagnosed-testicular-cancer weekly 0.8 https://www.themednet.org/which-chemotherapy-would-you-recommend-for-concurrent-use-with-radiation-in-a-patient-with-localized-esophageal-adenocarcinoma-who-has-severe-charcot-marie-tooth-disease weekly 0.8 https://www.themednet.org/do-you-use-bisphosphonates-in-combination-with-serms-in-female-patients-with-progressive-decline-in-bone-density-despite-being-on-a-serm-for-post-menopausal-symptoms-other-than-osteoporosis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-using-topical-jak-inhibitors-in-the-management-of-cutaneous-manifestations-of-rheumatic-disease weekly 0.8 https://www.themednet.org/is-a-skin-sparing-mastectomy-appropriate-in-a-patient-with-ct4b-ypt3-breast-cancer-with-skin-ulceration-who-receives-neoadjuvant-chemotherapy-with-a-partial-response weekly 0.8 https://www.themednet.org/how-do-you-treat-iga-cutaneous-vasculitis-with-retiform-purpura-and-evidence-of-fibrinoid-necrosis-on-skin-biopsy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-progressive-alk-nsclc-that-has-met-exon-14-deletion-upon-repeat-molecular-testing-on-metastatic-site weekly 0.8 https://www.themednet.org/should-all-patients-with-klinefelter-syndrome-get-routine-transthoracic-echocardiogram-screening-for-cardiac-abnormalities weekly 0.8 https://www.themednet.org/do-you-use-biologic-agents-in-patients-with-eosinophilic-bronchiectasis weekly 0.8 https://www.themednet.org/how-do-you-approach-monitoring-for-autoimmune-disorders-in-patients-with-surgical-remission-of-cushings-disease-given-the-higher-incidence-of-autoimmune-disease-in-this-population weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-treatment-to-a-stage-ib-nsclc-margins-negative-but-with-findings-of-stas-tumor-spread-through-airway-spaces weekly 0.8 https://www.themednet.org/what-is-your-approach-to-surveillance-in-patients-with-no-evidence-of-disease-after-treatment-of-oligometastatic-renal-cell-carcinoma weekly 0.8 https://www.themednet.org/do-you-recommend-anticoagulation-for-stroke-prevention-in-patients-with-atrial-high-rate-episodes weekly 0.8 https://www.themednet.org/do-any-special-precautions-need-to-be-taken-prior-to-starting-anticoagulation-in-patients-with-dandy-walker-syndrome weekly 0.8 https://www.themednet.org/how-do-you-approach-isolated-hip-arthropathy-with-chondral-loss-in-the-setting-of-a-moderately-positive-rheumatoid-factor weekly 0.8 https://www.themednet.org/what-is-your-approach-to-immunosuppressive-treatment-for-patients-with-crescentic-iga-vasculitis-and-kidney-manifestations weekly 0.8 https://www.themednet.org/in-a-patients-with-bilateral-wilms-tumor-with-favorable-features-90-response-to-vad-no-anaplasia-what-histopathologic-criteria-should-be-used-to-define-a-positive-margin-requiring-focal-rt-to-a-partial-nephrectomy-bed weekly 0.8 https://www.themednet.org/do-you-recommend-bevacizumab-with-front-line-platinum-based-adjuvant-chemotherapy-for-fully-resected-stage-iii-ovarian-clear-cell-carcinoma weekly 0.8 https://www.themednet.org/what-is-the-evidence-supporting-and-role-of-lympha-for-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-address-iron-replacement-during-breast-cancer-treatment weekly 0.8 https://www.themednet.org/what-is-your-approach-to-addressing-severe-dawn-phenomenon-in-your-patients-with-diabetes weekly 0.8 https://www.themednet.org/would-you-consider-consolidation-chemoradiotherapy-for-a-stage-iii-nsclc-that-was-initially-felt-to-be-too-extensive-for-definitive-intent-radiotherapy-who-later-experiences-a-radiographic-complete-response-to-carboplatin-paclitaxel-and-pembrolizumab weekly 0.8 https://www.themednet.org/how-does-the-presence-of-a-bicuspid-aortic-valve-influence-your-decision-between-tavr-and-surgical-aortic-valve-replacement-in-a-patient-with-symptomatic-aortic-stenosis weekly 0.8 https://www.themednet.org/do-you-alter-therapy-for-glild-from-antimetabolite-rituximab-to-monotherapy-if-the-biopsy-is-predominantly-t-or-b-cells weekly 0.8 https://www.themednet.org/what-medications-do-you-counsel-patients-to-avoid-if-they-develop-acei-angioedema weekly 0.8 https://www.themednet.org/do-you-start-omalizumab-in-childbearing-patients-with-csu weekly 0.8 https://www.themednet.org/how-long-would-you-treat-severe-eosinophilic-asthma-pneumonia-with-q4week-anti-il5-therapy-prior-to-tapering weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-add-a-second-biologic-agent-to-a-patients-asthma-treatment-who-has-either-not-responded-or-had-a-partial-response-to-dupilumab-omalizumab-mepolizumab-or-tezepelumab weekly 0.8 https://www.themednet.org/do-you-recommend-avoiding-all-citrus-seeds-and-fruits-if-a-patient-has-demonstrated-and-ige-mediated-allergy-to-a-lemon-seed weekly 0.8 https://www.themednet.org/do-you-utilize-any-desensitization-protocols-for-delayed-hypersensitivity-reactions weekly 0.8 https://www.themednet.org/how-do-you-manage-an-iodinated-contrast-allergy-leading-to-grade-5-anaphylaxis-in-a-patient-who-will-foreseeably-need-another-iodinated-contrast-agent-in-the-future weekly 0.8 https://www.themednet.org/do-you-perform-patch-testing-with-a-history-of-scar-with-the-goal-of-performing-a-drug-challenge weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-patient-on-returning-to-the-care-of-their-pcp-when-a-workup-for-mcas-has-been-unrevealing-but-the-patient-insists-that-they-have-a-mast-cell-disorder-because-they-respond-to-antihistamine-therapy weekly 0.8 https://www.themednet.org/do-mrna-vaccines-lead-to-increased-rates-of-acute-chronic-urticaria weekly 0.8 https://www.themednet.org/how-long-do-you-counsel-patients-to-wait-after-rituximab-therapy-before-getting-live-vaccines weekly 0.8 https://www.themednet.org/do-you-offer-neoadjuvant-chemotherapy-to-nested-variant-urothelial-carcinoma-nvuc-of-the-bladder weekly 0.8 https://www.themednet.org/what-is-your-preferred-systemic-regimen-for-mmr-proficient-high-grade-endometrial-cancer-that-recurs-1-year-from-adjuvant-carboplatin-paclitaxel weekly 0.8 https://www.themednet.org/would-a-braf-v600e-mutation-affect-your-decision-to-give-adjuvant-therapy-in-a-patient-with-lung-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-duration-for-a-patient-with-incidentally-found-large-vessel-gca-now-well-controlled-on-tocilizumab-monotherapy weekly 0.8 https://www.themednet.org/would-you-recommend-alnd-to-a-postmenopausal-female-with-one-positive-lymph-node-and-small-volume-metastasis-in-other-lymph-nodes weekly 0.8 https://www.themednet.org/would-you-add-dostarlimab-to-adjuvant-carboplatin-paclitaxel-in-a-patient-with-completely-resected-iiia-uterine-carcinosarcoma-msi-h weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-barbotage-for-calcific-tendinopathy-of-the-shoulder weekly 0.8 https://www.themednet.org/do-you-generally-find-plain-radiographs-useful-as-part-of-your-baseline-evaluation-in-suspected-rheumatoid-arthritis weekly 0.8 https://www.themednet.org/would-you-use-ceftriaxone-for-treatment-of-a-deep-seated-infection-such-as-vertebral-osteomyelitis-epidural-abscess-caused-by-a-low-risk-ampc-producing-pathogen weekly 0.8 https://www.themednet.org/how-do-you-personalize-glucocorticoid-dosing-for-patients-with-adrenal-insufficiency-during-non-standard-stress-events-such-as-unexpected-major-life-changes-or-unusual-physical-exertion weekly 0.8 https://www.themednet.org/how-would-active-crohns-on-adalimumab-affect-the-adjuvant-management-of-a-t2an0m0-gallbladder-cancer weekly 0.8 https://www.themednet.org/how-do-you-counsel-people-on-use-of-winlevi-clascoterone-in-combination-with-other-topical-acne-medications weekly 0.8 https://www.themednet.org/would-you-use-razor-genomics-riskreveal-molecular-testing-results-to-guide-making-recommendations-for-surgical-adjuvant-chemotherapy-for-stage-ia-ib-ii-non-squamous-nsclc weekly 0.8 https://www.themednet.org/would-blood-pressure-measurements-taken-in-the-ipsilateral-arm-where-a-prior-node-was-removed-increase-the-risk-of-lymphedema weekly 0.8 https://www.themednet.org/do-you-prescribe-additional-exercise-for-patients-who-perform-manual-labor weekly 0.8 https://www.themednet.org/how-would-you-manage-a-rising-ca-125-in-a-young-patient-on-maintenance-bevacizumab-and-olaparib-x1-year-for-iiic-hr-deficient-serous-ovary-cancer-whose-only-finding-on-petct-is-a-1-5cm-pelvic-lymph-node weekly 0.8 https://www.themednet.org/would-you-consider-altering-immunosuppression-in-a-patient-with-systemic-sclerosis-already-on-systemic-immunosuppression-for-interstitial-lung-disease-who-has-more-recently-been-noted-to-have-lv-diastolic-dysfunction-with-some-reduction-in-ef-in-the-absen weekly 0.8 https://www.themednet.org/under-what-circumstances-would-it-be-appropriate-to-offer-trimodality-therapy-tmt-in-muscle-invasive-bladder-cancer-with-localized-variant-histology weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-positive-antiphospholipid-antibodies-in-the-perioperative-setting-for-solid-organ-transplant-such-as-renal-transplant weekly 0.8 https://www.themednet.org/would-you-consider-neoadjuvant-immunotherapy-in-a-patient-with-lynch-syndrome-and-urothelial-cancer weekly 0.8 https://www.themednet.org/do-computerized-mole-mapping-tools-play-a-role-in-your-clinical-practice weekly 0.8 https://www.themednet.org/how-would-you-treat-chorea-in-a-patient-with-sjoegrens-syndrome-and-positive-beta-2-glycoprotein-i-antibodies weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-work-up-and-evaluation-of-loss-of-asthma-control-while-on-a-biologic-such-as-dupilumab weekly 0.8 https://www.themednet.org/what-are-your-preferred-induction-paralytic-agents-for-intubation-in-patients-with-severe-aortic-stenosis-and-reduced-lvef weekly 0.8 https://www.themednet.org/would-it-be-reasonable-to-consider-switching-from-a-high-intensity-statin-therapy-to-pcsk9-inhibitor-vs-adding-adjunct-lipid-lowering-medications-for-a-patient-with-known-coronary-artery-calcifications-ldl-in-the-mid-100-range-pre-statin-with-worsening-a1 weekly 0.8 https://www.themednet.org/what-is-your-workup-for-amyloidosis-diagnosed-via-biopsy-during-carpal-tunnel-release-surgery weekly 0.8 https://www.themednet.org/would-you-consider-anti-cd20-agents-for-treatment-of-multiple-sclerosis-in-patients-with-history-of-breast-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-transitioning-from-ticagrelor-aspirin-dapt-to-ticagrelor-monotherapy-after-1-month-in-patients-with-acute-coronary-syndrome-and-average-bleeding-risk-post-pci-to-reduce-the-risk-of-bleeding weekly 0.8 https://www.themednet.org/how-if-at-all-do-you-use-changes-in-suv-on-a-pet-ct-to-assess-for-disease-progression-response-in-patients-with-metastatic-breast-cancer weekly 0.8 https://www.themednet.org/how-long-do-you-continue-maintenance-immunosuppression-in-a-patient-with-pr3-anca-glomerulonephritis-with-pulmonary-involvement weekly 0.8 https://www.themednet.org/do-you-tell-your-patients-with-epithelioid-subtype-mesothelioma-following-gross-resection-and-adjuvant-cis-pemetrexed-that-they-have-completed-curative-intent-treatment weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-patients-with-crescentic-iga-nephropathy-who-fail-to-respond-to-cyclophosphamide-and-steroids weekly 0.8 https://www.themednet.org/would-you-continue-zolendronic-acid-infusions-if-the-bone-density-decreases-significantly-in-year-two weekly 0.8 https://www.themednet.org/what-is-your-experience-of-using-rituximab-for-gpa-with-renal-involvement-following-a-recent-myocardial-infarction weekly 0.8 https://www.themednet.org/how-do-you-approach-initial-serologic-evaluation-for-patients-referred-with-reactive-lymphadenopathy-but-no-clear-signs-or-symptoms-of-active-rheumatologic-disease weekly 0.8 https://www.themednet.org/should-we-be-using-body-fat-percentage-instead-of-bmi-for-determining-patients-risk-of-metabolic-syndrome weekly 0.8 https://www.themednet.org/is-there-a-role-for-intermittent-fasting-as-part-of-the-management-of-a-patient-with-long-standing-type-2-diabetes-and-consistently-poor-glycemic-control-despite-maximal-therapy weekly 0.8 https://www.themednet.org/what-are-the-possible-or-expected-mri-findings-or-changes-in-progressive-ms weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-early-onset-ra-with-minimal-peripheral-disease-and-aggressive-cervical-atlantoaxial-involvement weekly 0.8 https://www.themednet.org/how-do-you-approach-the-workup-and-management-of-isolated-orbital-inflammatory-pseudotumor-granuloma weekly 0.8 https://www.themednet.org/is-there-a-role-for-cyp2c19-genetic-testing-in-patients-presenting-with-recurrent-acs-in-spite-of-adherence-to-plavix-outpatient weekly 0.8 https://www.themednet.org/when-do-you-consider-mesna-for-patients-taking-oral-cyclophosphamide weekly 0.8 https://www.themednet.org/how-do-you-manage-acne-patients-who-have-limited-response-on-isotretinoin weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-use-of-immunosuppression-for-patients-with-poststreptococcal-glomerulonephritis weekly 0.8 https://www.themednet.org/for-pre-or-perimenopausal-women-with-early-stage-hormone-positive-breast-cancer-who-refuse-to-stop-hrt-for-severe-perimenopausal-symptoms-severe-depression-anxiety-very-low-energy-vaginal-dryness-and-pain-with-sex-thats-failed-vaginal-estrogen-therapy-do- weekly 0.8 https://www.themednet.org/how-do-you-use-p1np-in-your-clinical-practice-to-guide-management-of-osteoporosis weekly 0.8 https://www.themednet.org/how-do-you-manage-persistent-left-atrial-appendage-thrombus-despite-therapeutic-anticoagulation-on-doac-and-prior-history-of-warfarin-use weekly 0.8 https://www.themednet.org/do-you-check-blood-eosinophil-counts-in-patients-with-copd-exacerbations-to-help-guide-therapy-decisions weekly 0.8 https://www.themednet.org/do-patients-with-homocystinuria-have-an-increase-risk-of-radiation-toxicity weekly 0.8 https://www.themednet.org/how-do-you-manage-elevated-triglyceride-levels-on-isotretinoin weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-erosive-seronegative-rheumatoid-arthritis-with-igg-and-igm-deficiency weekly 0.8 https://www.themednet.org/how-do-you-manage-trigeminal-sensory-neuropathy-in-a-patient-with-systemic-sclerosis weekly 0.8 https://www.themednet.org/would-you-expect-an-oral-sodium-loading-test-to-be-positive-in-secondary-hyperaldosteronism-or-pseudohyperaldosteronism weekly 0.8 https://www.themednet.org/how-does-papillary-thyroid-carcinoma-with-tall-cell-features-ptc-tcf-compare-to-tall-cell-variant-papillary-thyroid-carcinoma-tcv-ptc-with-regards-to-their-clinicohistopathological-features-and-risk-of-recurrence weekly 0.8 https://www.themednet.org/what-is-your-approach-to-duration-of-antibiotic-therapy-for-treatment-of-a-bacterial-lung-abscess weekly 0.8 https://www.themednet.org/would-you-offer-trastuzumab-deruxtecan-for-a-metastatic-ovarian-cancer-patient-with-good-performance-status-whose-tumor-stains-1-on-ihc-for-her2-and-who-has-exhausted-all-treatment-options weekly 0.8 https://www.themednet.org/how-do-you-manage-dic-associated-with-an-aortic-aneurysm-while-awaiting-surgical-repair weekly 0.8 https://www.themednet.org/when-considering-biologic-therapy-after-failure-of-mtx-or-triple-therapy-do-you-consider-using-abatacept-as-a-first-line-biologic weekly 0.8 https://www.themednet.org/when-do-you-consider-vigabatrin-for-the-treatment-of-status-epilepticus weekly 0.8 https://www.themednet.org/are-you-currently-offering-pemivibart-pemgarda-for-pre-exposure-prophylaxis-against-covid-19-to-immunocompromised-patients weekly 0.8 https://www.themednet.org/what-clinical-or-echocardiographic-parameters-do-you-use-to-determine-the-optimal-timing-for-an-aortic-valve-intervention-in-patients-with-asymptomatic-severe-aortic-stenosis weekly 0.8 https://www.themednet.org/is-there-any-experience-treating-bizarre-parosteal-osteochondromatous-proliferation-bpop-with-adjuvant-radiation weekly 0.8 https://www.themednet.org/how-would-you-treat-a-tdlbcl-originally-treated-with-r-chop-who-relapses-with-dlbcl-15-years-after-the-original-diagnosis weekly 0.8 https://www.themednet.org/in-a-patient-with-stage-iii-pure-seminoma-testicular-cancer-with-positive-margins-following-surgery-is-there-any-role-for-targeted-radiation-or-additional-surgery-for-the-positive-margin weekly 0.8 https://www.themednet.org/what-is-your-preferred-initial-therapy-for-patients-with-iga-nephropathy-and-more-than-1-gram-of-proteinuria-given-the-recent-approvals-of-sparsentan-and-budesonide-alongside-existing-options-like-prednisone-and-acei-arbs weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-secondary-membranous-nephropathy-with-nephrotic-range-proteinuria weekly 0.8 https://www.themednet.org/when-if-at-all-do-you-use-fezolinetant-for-aromatase-inhibitor-induced-hot-flashes weekly 0.8 https://www.themednet.org/what-modalities-have-you-had-success-with-in-treating-genital-warts weekly 0.8 https://www.themednet.org/what-are-some-general-thoughts-you-have-on-the-clinical-utility-and-value-of-high-sensitivity-troponin-in-patients-when-there-is-little-clinical-evidence-for-acute-mi-or-acute-decompensated-heart-failure-and-lack-of-evidence-to-support-non-ischemic-myocar weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-patients-with-moderate-to-high-pre-test-probabilty-of-gca-who-are-found-to-have-negative-findings-on-temporal-artery-biopsy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-re-challenging-patients-with-immune-checkpoint-inhibitors-whom-developed-predominately-acute-tubular-injury-without-acute-interstitial-nephritis weekly 0.8 https://www.themednet.org/what-is-your-workup-algorithm-for-adult-patients-with-cutaneous-biopsy-proven-langerhans-cell-histiocytosis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-for-adults-with-cutaneous-biopsy-proven-langerhans-cell-histiocytosis weekly 0.8 https://www.themednet.org/what-is-your-protocol-for-intermittent-adt-for-prostate-cancer weekly 0.8 https://www.themednet.org/in-a-patient-with-metastatic-gastric-cancer-with-high-pdl-1-cps-score-10-at-what-point-if-any-would-you-consider-omitting-chemotherapy-and-continuing-immunotherapy-alone-based-on-checkmate-649-if-patient-has-a-favorable-or-complete-response weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-denosumab-for-osteoporosis-management-in-patients-receiving-ivig-therapy weekly 0.8 https://www.themednet.org/what-volumes-would-you-cover-preoperatively-for-a-young-patient-with-a-history-of-proctocolectomy-with-j-pouch-for-fap-now-with-an-adenocarcinoma-at-the-ileoanal-junction weekly 0.8 https://www.themednet.org/how-would-you-decide-the-duration-of-ovarian-suppression-in-premenopausal-females-with-early-stage-er-breast-cancer weekly 0.8 https://www.themednet.org/what-is-the-optimal-approach-to-systemic-therapy-for-metastatic-squamous-cell-carcinoma-of-the-bladder-considering-the-approval-of-enfortumab-vedotin-plus-pembrolizumab-for-metastatic-urothelial-carcinoma weekly 0.8 https://www.themednet.org/what-are-your-thoughts-on-the-applicability-and-utility-of-the-prevent-equation-and-how-it-compares-to-the-pce-for-ascvd-risk-assessment weekly 0.8 https://www.themednet.org/how-long-after-parathyroidectomy-for-parathyroid-adenoma-with-hyperparathyroidism-do-you-wait-before-initiating-romosuzumab-in-an-older-patient-with-osteoporosis-and-very-high-fracture-risk weekly 0.8 https://www.themednet.org/what-do-you-include-in-your-differential-for-patients-with-recurrent-large-volume-non-inflammatory-joint-effusions weekly 0.8 https://www.themednet.org/would-you-continue-tnf-inhibitor-in-a-patient-with-psoriatic-arthritis-who-has-had-multiple-nonmelanoma-skin-cancers-requiring-mohs-surgery weekly 0.8 https://www.themednet.org/do-you-use-biologic-dmards-for-active-axial-spondyloarthritis-in-transplant-patients-on-long-term-anti-rejection-therapy weekly 0.8 https://www.themednet.org/are-there-any-trials-looking-at-alternative-treatments-for-patients-who-otherwise-would-receive-2-years-of-adt-but-have-the-hsd3b1-gene-homozygous-vs-heterozygous weekly 0.8 https://www.themednet.org/what-are-your-thoughts-on-the-use-of-icosapent-ethyl-in-clinical-practice-for-patients-with-hypertriglyceridemia-and-its-safety-profile-such-as-increased-risk-of-atrial-fibrillation weekly 0.8 https://www.themednet.org/how-do-you-incorporate-a-kelim-score-into-your-management-of-patients-with-ovarian-cancer weekly 0.8 https://www.themednet.org/for-a-patient-with-prior-bypass-graft-stenting-and-severe-native-vessel-disease-with-stable-angina-would-you-recommend-myocardial-perfusion-imaging-or-coronary-cta-if-there-is-concern-about-graft-patency weekly 0.8 https://www.themednet.org/would-you-favor-functional-or-anatomical-assessment-for-cad-in-a-patient-with-intermediate-cv-risk-factors-with-equivocal-or-nondiagnostic-exercise-treadmill-testing-and-normal-renal-function weekly 0.8 https://www.themednet.org/what-are-the-most-significant-drug-interactions-you-consider-when-using-cenobamate-and-would-you-ever-consider-using-cenobamate-as-monotherapy weekly 0.8 https://www.themednet.org/what-are-the-clinical-indications-and-expected-outcomes-of-radiofrequency-ablation-therapy-for-benign-thyroid-nodules weekly 0.8 https://www.themednet.org/what-specific-features-in-a-patient-with-euthyroid-mng-increase-their-risk-of-developing-functional-autonomy-and-overt-hyperthyroidism weekly 0.8 https://www.themednet.org/what-is-the-likelihood-of-nxp2-false-positivity-from-a-dermatomyositis-in-a-patient-who-is-manifesting-features-of-morphea weekly 0.8 https://www.themednet.org/how-do-you-monitor-blood-glucose-levels-in-patients-without-preexisting-diabetes-who-are-starting-capivasertib weekly 0.8 https://www.themednet.org/do-you-regularly-counsel-younger-women-of-childbearing-age-about-the-impact-of-tirzepatide-on-oral-hormonal-contraception weekly 0.8 https://www.themednet.org/do-you-have-experience-combining-tocilizumab-with-mycophenolate-in-patients-with-scleroderma-lung-disease-and-inflammatory-arthritis weekly 0.8 https://www.themednet.org/is-there-any-concern-with-starting-romosozumab-in-a-patient-who-is-taking-raloxifene-for-a-history-of-breast-cancer weekly 0.8 https://www.themednet.org/would-you-have-any-concerns-about-giving-radiation-therapy-to-a-patient-on-isotretinoin-accutane weekly 0.8 https://www.themednet.org/what-treatments-can-be-combined-for-the-treatment-of-immune-checkpoint-inhibitor-induced-toxic-epidermal-necrolysis weekly 0.8 https://www.themednet.org/does-a-patient-with-an-endometrial-ablation-need-progesterone-if-prescribed-estradiol-for-menopausal-hrt weekly 0.8 https://www.themednet.org/has-your-institution-and-or-antimicrobial-stewardship-program-incorporated-a-selective-antibiotic-approach-to-treatment-of-left-sided-uncomplicated-diverticulitis-in-immunocompetent-patients weekly 0.8 https://www.themednet.org/are-there-any-concerns-when-combining-apremilast-with-azathioprine weekly 0.8 https://www.themednet.org/do-patients-with-advanced-chronic-kidney-disease-tend-to-have-falsely-high-hba1c-or-falsely-low-hba1c-levels weekly 0.8 https://www.themednet.org/what-is-your-approach-to-biologic-therapy-in-older-adults-80-with-ra-and-ckd weekly 0.8 https://www.themednet.org/can-a-patient-with-a-pmhx-of-pancreatic-injury-or-disease-i-e-blunt-trauma-recurrent-pancreatitis-take-a-glp-1-agonist-safely-in-the-setting-of-morbid-obesity-and-type-2-diabetes weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-to-neuropsychiatric-symptoms-secondary-to-lupus weekly 0.8 https://www.themednet.org/how-frequently-or-soon-have-you-noticed-tnf-a-induced-psoriasiform-dermatitis-develop weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-tif-1-gamma-associated-dermatomyositis-with-extensive-skin-disease-with-a-recent-history-of-recurrent-melanoma-of-skin weekly 0.8 https://www.themednet.org/in-patients-with-localized-small-cell-bladder-cancer-would-you-consider-consolidation-with-durvalumab-after-neoadjuvant-chemotherapy-followed-by-definitive-local-therapy-cystectomy-or-rt weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-psoriatic-arthritis-who-developed-disseminated-histoplasmosis-while-on-adalimumab-and-previously-failed-all-non-biologic-dmards weekly 0.8 https://www.themednet.org/what-is-your-approach-to-assessing-inflammatory-arthritis-flares-in-joints-that-have-been-replaced-such-as-knees weekly 0.8 https://www.themednet.org/would-you-consider-an-inpatient-mitraclip-for-patients-with-severe-mr-and-severely-reduced-lvef-who-have-been-turned-down-high-risk-for-surgery-if-there-were-ongoing-challenges-with-afterload-reduction-and-transitioning-to-intermittent-dialysis-due-to-rec weekly 0.8 https://www.themednet.org/what-are-your-thoughts-about-clascoterone-causing-hpa-axis-suppression weekly 0.8 https://www.themednet.org/would-you-re-challenge-a-patient-with-rituximab-who-responded-well-in-terms-of-their-ra-but-developed-symptomatic-tachycardia-after-their-first-infusion weekly 0.8 https://www.themednet.org/what-is-your-preferred-single-antiplatelet-agent-to-use-when-combined-with-a-doac-for-a-patient-with-atrial-fibrillation-who-is-now-1-year-post-tavr weekly 0.8 https://www.themednet.org/when-advising-patients-on-starting-avacopan-for-granulomatosis-with-polyangiitis-what-side-effects-do-you-tell-patients-are-commonly-seen-in-clinical-practice weekly 0.8 https://www.themednet.org/how-do-you-manage-acute-ischemic-stroke-patients-secondary-to-hus-ttp weekly 0.8 https://www.themednet.org/how-would-you-proceed-with-v-a-ecmo-cannulation-venous-cannula-on-a-patient-with-massive-pe-who-has-an-ivc-filter-with-high-thrombus-burden weekly 0.8 https://www.themednet.org/what-modifications-if-any-will-you-make-for-your-use-of-dose-dense-taxane-chemotherapy-in-early-stage-breast-cancer-with-the-end-of-study-panther-results weekly 0.8 https://www.themednet.org/is-there-any-contraindication-for-a-patient-receiving-omalizumab-for-treatment-of-her-lung-aspergillosis-to-receive-adjuvant-breast-radiotherapy weekly 0.8 https://www.themednet.org/when-would-you-recommend-starting-immunosuppression-in-patients-diagnosed-with-henoch-schoenlein-purpura-and-iga-nephropathy-who-have-proteinuria-1-gram-per-day-and-egfr-60-ml-min-who-are-already-on-acei-and-sglt2i weekly 0.8 https://www.themednet.org/how-would-you-manage-a-young-premenopausal-woman-with-hormone-receptor-positive-micrometastatic-breast-cancer-in-two-axillary-lymph-nodes-but-with-only-dcis-on-breast-surgical-pathology weekly 0.8 https://www.themednet.org/what-has-been-your-experience-with-jak-stat-inhibitors-for-granuloma-annulare weekly 0.8 https://www.themednet.org/when-would-you-order-an-mri-in-an-isotretinoin-patient-with-lower-back-pain weekly 0.8 https://www.themednet.org/how-do-you-manage-the-pregnancy-windows-on-ipledge-for-patients-who-are-able-to-get-pregnant-and-are-on-long-term-low-dose-isotretinoin weekly 0.8 https://www.themednet.org/how-would-you-work-up-splenomegaly-and-abdominal-pain-in-a-patient-with-primary-antiphospholipid-syndrome-and-a-high-ana-but-no-other-serological-or-clinical-sle-symptoms weekly 0.8 https://www.themednet.org/is-there-any-possible-mechanism-of-action-to-account-for-prolonged-hypogammaglobulinemia-following-short-term-use-of-tocilizumab-in-an-individual-with-smoldering-myeloma weekly 0.8 https://www.themednet.org/does-the-presence-of-calcified-granulomas-on-chest-imaging-influence-your-choice-of-biologic-for-treatment-of-psoriatic-arthritis-or-rheumatoid-arthritis weekly 0.8 https://www.themednet.org/is-there-a-standard-of-care-for-management-of-localized-dna-mismatch-repair-deficient-esophagus-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-imaging-modality-for-the-evaluation-of-coronary-microvascular-dysfunction-inoca-and-when-would-you-favor-it-over-coronary-angiogram-with-provocative-testing weekly 0.8 https://www.themednet.org/what-is-the-best-way-to-categorize-aortic-stenosis-in-normal-lv-function-with-normal-lv-size-when-the-peak-velocity-and-mean-pressure-gradient-are-in-moderate-range-but-ava-falls-within-severe-range weekly 0.8 https://www.themednet.org/do-you-take-any-special-treatment-considerations-for-elderly-patients-diagnosed-with-collapsing-fsgs weekly 0.8 https://www.themednet.org/do-you-believe-that-pretreatment-with-montelukast-or-other-ltras-can-reduce-the-risk-of-urticaria-or-angioedema-with-nsaids weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-selection-in-patients-with-rheumatoid-arthritis-and-severe-copd weekly 0.8 https://www.themednet.org/would-you-start-anticoagulation-in-a-previously-heathy-patient-with-a-new-diagnosis-of-anca-vasculitis-pr3-rpgn-crescents-on-kidney-biopsy-who-presented-with-pancreatitis-splenic-and-renal-infarcts-and-was-also-found-to-have-cmv-viremia weekly 0.8 https://www.themednet.org/what-initial-treatment-would-you-offer-a-patient-with-metastatic-triple-negative-breast-cancer-with-somatic-brca1-2-mutation-cps-10 weekly 0.8 https://www.themednet.org/do-you-have-any-preferred-mechanical-ventilation-settings-or-ventilation-goals-for-patients-with-hypoxic-respiratory-failure-with-both-severe-as-and-mr weekly 0.8 https://www.themednet.org/what-perioperative-systemic-therapy-would-you-use-for-a-patient-with-oligometastatic-clear-cell-rcc-with-a-bony-metastasis-at-risk-for-fracture weekly 0.8 https://www.themednet.org/would-you-have-concerns-about-combining-romosuzumab-and-ivig-in-a-patient-with-dermatomyositis-and-osteoporosis weekly 0.8 https://www.themednet.org/for-patients-with-obesity-and-elevated-alk-phos-who-have-ra-do-you-check-a-fibroscan-or-serum-nash-fibrosure-test-before-starting-methotrexate-or-leflunomide weekly 0.8 https://www.themednet.org/is-there-a-field-size-limitation-for-fff-beams weekly 0.8 https://www.themednet.org/how-long-would-you-delay-prostate-radiation-following-use-of-a-paclitaxel-eluting-balloon-dilator-optilume-for-management-of-a-recurrent-urethral-stricture-after-turp weekly 0.8 https://www.themednet.org/how-do-you-treat-front-line-de-novo-her2-positive-metastatic-breast-cancer-with-brain-metastases weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-in-mibc-with-predominantly-squamous-cell-differentiation weekly 0.8 https://www.themednet.org/for-patients-with-egfr-around-30-do-you-still-consider-using-reclast-or-evenity-at-adjusted-doses weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-lymphoma-i-e-dlbcl-who-has-developed-chylous-pleural-effusions-while-on-therapy weekly 0.8 https://www.themednet.org/do-you-generally-attempt-to-taper-and-discontinue-biologics-in-a-patient-with-psoriatic-arthritis-who-is-in-clinical-remisson weekly 0.8 https://www.themednet.org/is-there-a-pth-elevation-above-which-you-would-be-hesitant-to-use-an-anabolic-agent-in-a-patient-with-osteoporosis-and-ckd-stage-4-or-5 weekly 0.8 https://www.themednet.org/how-long-would-you-continue-bevacizumab-and-pembrolizumab-after-completing-6-cycles-of-quad-therapy-carbo-taxol-bev-pembro-in-a-patient-with-metastatic-cervical-carcinoma-with-no-evidence-of-disease-cr-on-imaging weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-autoimmune-disease-who-are-considering-platelet-rich-plasma-injections-for-a-musculoskeletal-condition-unrelated-to-their-autoimmune-disease weekly 0.8 https://www.themednet.org/how-do-you-counsel-young-female-patients-on-spironolactone-for-acne-experiencing-menstrual-irregularities weekly 0.8 https://www.themednet.org/do-you-send-anti-human-neutrophil-elastase-antibodies-when-you-suspect-levamisole-induced-anca-vasculitis weekly 0.8 https://www.themednet.org/how-do-you-approach-monitoring-in-dress-or-dihs-patients weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-escalation-to-systemic-agents-for-erythromelalgia-after-treating-with-topicals-and-trigger-avoidance weekly 0.8 https://www.themednet.org/for-patients-with-oligo-progressive-prostate-cancer-fit-for-metastasis-directed-therapy-but-ineligible-for-radiotherapy-or-surgery-how-do-you-decide-between-the-types-of-ablation-available weekly 0.8 https://www.themednet.org/what-is-the-accuracy-of-snb-in-the-setting-of-bilateral-axillary-hidradenitis weekly 0.8 https://www.themednet.org/when-would-you-consider-ordering-additional-testing-such-as-hs-crp-lipoprotein-a-levels-or-cac-scoring-to-further-risk-stratify-otherwise-healthy-pre-menopausal-women-with-a-prior-history-of-pregnancy-related-hypertension-diabetes-or-premature-births weekly 0.8 https://www.themednet.org/for-women-with-known-autoimmune-diseases-how-do-you-approach-ascvd-risk-stratification-when-deciding-to-start-a-statin-or-aspirin-for-primary-prevention weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-newly-diagnosed-low-risk-acute-promyelocytic-leukemia-who-has-a-baseline-wide-qtc-interval-such-that-arsenic-trioxide-cannot-be-used weekly 0.8 https://www.themednet.org/do-you-routinely-prescribe-glp-1-receptor-agonists-to-people-living-with-hiv-plh-with-obesity weekly 0.8 https://www.themednet.org/are-you-comfortable-trying-a-different-jak-inhibitor-in-patients-with-prior-jak-inhibitor-allergy weekly 0.8 https://www.themednet.org/do-you-have-a-15-fraction-constraint-for-the-lada weekly 0.8 https://www.themednet.org/how-would-you-manage-post-transplant-erythrocytosis-in-the-setting-of-active-pregnancy-which-limits-use-of-acei-arb-therapy weekly 0.8 https://www.themednet.org/what-factors-age-ps-do-you-consider-to-avoid-using-flot-in-the-perioperative-treatment-of-gastric-and-esophageal-cancers weekly 0.8 https://www.themednet.org/how-do-you-approach-maintenance-immunosuppression-in-juvenile-myasthenia-gravis weekly 0.8 https://www.themednet.org/besides-patient-preference-what-factors-guide-your-decision-to-treat-selects-patients-with-antiseizure-medications weekly 0.8 https://www.themednet.org/what-is-your-approach-to-weaning-phenobarbital-and-serial-eegs-in-patients-with-hie-after-their-perinatal-seizures-are-under-control weekly 0.8 https://www.themednet.org/is-there-a-role-for-monitoring-pth-levels-in-patients-with-advanced-chronic-kidney-disease-who-are-receiving-denosumab-to-assess-for-adynamic-bone-disease weekly 0.8 https://www.themednet.org/how-are-you-using-csf-cytokine-panels-in-autoimmune-encephalitis-if-at-all weekly 0.8 https://www.themednet.org/how-do-you-use-aspirin-in-pre-symptomatic-sturge-weber-patients weekly 0.8 https://www.themednet.org/which-features-should-prompt-vessel-imaging-in-a-pediatric-patient-with-recurrent-headaches weekly 0.8 https://www.themednet.org/how-do-you-use-amantadine-and-assess-its-efficacy-for-comatose-pediatric-patients weekly 0.8 https://www.themednet.org/what-further-workup-do-you-recommend-for-isolated-agenesis-or-dysgenesis-of-the-corpus-callosum weekly 0.8 https://www.themednet.org/which-tools-do-you-use-to-prognosticate-recovery-after-respiratory-cardiac-arrest-in-children-as-in-drowning weekly 0.8 https://www.themednet.org/at-what-point-should-surgical-intervention-be-considered-for-vestibular-schwannomas-or-other-tumors-in-pediatric-nf2-patients weekly 0.8 https://www.themednet.org/how-does-a-patients-based-score-after-starting-infantile-spasms-therapy-guide-your-treatment-plan weekly 0.8 https://www.themednet.org/what-is-your-approach-to-dosing-phenobarbital-for-a-neonate-on-intermittent-hemodialysis weekly 0.8 https://www.themednet.org/how-do-you-assess-efficacy-when-trialing-a-patient-with-rett-syndrome-on-trofinetide-daybue weekly 0.8 https://www.themednet.org/in-which-patient-population-diagnosed-with-cll-would-you-still-treat-with-the-fcr-fludarabine-cyclophosphamide-rituximab-regimen weekly 0.8 https://www.themednet.org/what-testing-would-you-pursue-next-in-a-pediatric-patient-with-recurrent-staph-abscesses-negative-invitae-pid-panel-and-negative-ncf1-gene-testing-and-1-2-abnormal-dhr-test-with-1-suggestive-of-p47-deficiency weekly 0.8 https://www.themednet.org/are-there-any-concerns-with-using-denosumab-in-a-patient-with-chronic-hepatitis-b-infection-on-antiviral-therapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-symptomatic-primary-hyperparathyroidism-in-the-third-trimester-of-pregnancy weekly 0.8 https://www.themednet.org/is-there-a-role-for-radiation-to-the-primary-mediastinal-disease-in-metastatic-thymic-neuroendocrine-carcinoma-with-the-primary-as-the-only-residual-disease-after-systemic-therapy weekly 0.8 https://www.themednet.org/are-there-any-recommendations-for-restarting-jaki-after-a-provoked-dvt weekly 0.8 https://www.themednet.org/do-you-have-a-maximal-limit-to-the-number-of-pegylated-doxorubicin-cycles-you-will-prescribe-a-patient-for-recurrent-endometrial-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-acute-hypernatremia-from-diabetes-insipidus-in-patients-with-pre-existing-cerebral-edema weekly 0.8 https://www.themednet.org/would-you-recommend-testing-for-adrenal-dysfunction-in-a-euvolemic-and-hypertensive-patient-on-anti-hypertensive-therapy-presenting-with-combined-hyperkalemia-and-hyponatremia weekly 0.8 https://www.themednet.org/when-do-you-recommend-using-l-arginine-stimulated-copeptin-testing-to-evaluate-for-central-diabetes-insipidus-avp-deficiency weekly 0.8 https://www.themednet.org/have-you-had-success-treating-localized-skin-infections-due-to-m-chelonae-with-single-agent-therapy-in-immunocompetent-hosts weekly 0.8 https://www.themednet.org/when-do-you-favor-using-cardiac-ct-compared-to-tee-for-outpatient-surveillance-of-the-device-in-the-immediate-post-watchman-period weekly 0.8 https://www.themednet.org/how-would-you-approach-fertility-preservation-in-a-young-patient-with-dlbcl-requiring-r-chop weekly 0.8 https://www.themednet.org/when-would-you-consider-using-cardiac-mri-over-nuclear-imaging-for-functional-assessment-of-ischemic-heart-disease-since-it-is-class-iia-indication-in-the-us-but-otherwise-class-i-in-europe weekly 0.8 https://www.themednet.org/can-you-use-a-jak-inhibitor-and-mavenclad-in-a-patient-with-both-multiple-sclerosis-and-rheumatoid-arthritis weekly 0.8 https://www.themednet.org/with-increasing-overlap-between-advanced-clear-cell-and-non-clear-cell-rcc-management-with-io-tki-therapy-are-there-subtypes-of-non-clear-cell-rcc-for-which-you-would-not-use-this-approach weekly 0.8 https://www.themednet.org/which-classes-of-medications-are-reasonable-to-consider-in-cases-of-acute-pericarditis-in-a-patient-with-g6pd-deficiency weekly 0.8 https://www.themednet.org/what-are-your-recommendations-for-administering-the-monkeypox-vaccine-to-patients-on-biologics weekly 0.8 https://www.themednet.org/do-you-consider-discharging-patients-with-a-heimlich-valve-in-cases-of-pneumothorax-with-a-slow-persistent-air-leak weekly 0.8 https://www.themednet.org/how-do-you-approach-stage-iia-squamous-cell-carcinoma-of-the-lung-with-a-pd-l1-level-of-1-49-and-no-targetable-mutations weekly 0.8 https://www.themednet.org/do-ssris-affect-the-absorption-of-levothyroxine-therapy-when-taken-concomitantly weekly 0.8 https://www.themednet.org/if-subdeltoid-bursitis-bicipital-tenosynovitis-and-femoroacetabular-synovitis-are-commonly-present-in-pmr-why-are-they-not-included-in-the-criteria-for-pmr-and-how-are-they-differentiated-from-elderly-onset-ra-where-presentation-is-often-atypical-and-more weekly 0.8 https://www.themednet.org/how-do-you-approach-cardiovascular-risk-management-in-patients-with-rheumatic-disease weekly 0.8 https://www.themednet.org/would-you-consider-rechallenging-immunotherapy-if-the-first-dose-was-accompanied-with-an-acute-infusion-reaction-with-low-back-pain-shortness-of-breath-and-chest-pain-which-resolved-with-monitoring-and-subsequent-cardiac-workup-being-negative weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-digital-ischemia-in-a-critically-ill-patient-with-infection-but-no-evidence-of-active-rheumatologic-disease weekly 0.8 https://www.themednet.org/do-you-give-lifelong-anti-fungal-therapy-or-a-set-time-period-of-anti-fungal-therapy-to-patients-who-have-vertebral-hardware-infection-with-some-residual-hardware-that-cannot-be-removed weekly 0.8 https://www.themednet.org/are-there-any-precautions-that-should-be-taken-when-transitioning-a-patient-with-multiple-sclerosis-from-one-disease-modifying-therapy-to-another weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-in-severe-covid19-associated-myositis weekly 0.8 https://www.themednet.org/what-is-your-initial-treatment-paradigm-for-someone-with-both-cns-and-peripheral-neurologic-sjogrens weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-severe-hand-oa-no-synovitis-on-exam-negative-serologies-who-fail-to-respond-to-nsaids-but-respond-very-well-to-oral-steroids weekly 0.8 https://www.themednet.org/how-often-have-you-found-patients-complain-about-an-infusion-reaction-to-remicade weekly 0.8 https://www.themednet.org/how-do-you-manage-dysgeusia-from-enfortumab-vedotin weekly 0.8 https://www.themednet.org/how-do-you-approach-an-isolated-increased-protein-levels-in-the-csf-in-patients-with-cognitive-decline weekly 0.8 https://www.themednet.org/how-do-you-decide-between-il-1-inhibitors-azathioprine-and-ivig-for-steroid-dependent-recurrent-incessant-pericarditis weekly 0.8 https://www.themednet.org/would-you-prescribe-semaglutide-for-weight-gain-from-androgen-deprivation-therapy-for-prostate-cancer weekly 0.8 https://www.themednet.org/what-are-the-best-sleep-aid-options-for-patients-on-steroids-for-medical-treatments weekly 0.8 https://www.themednet.org/how-do-you-treat-high-risk-inflammatory-tnbc-diagnosed-in-the-first-trimester-of-pregnancy-who-underwent-surgery weekly 0.8 https://www.themednet.org/do-you-add-venetoclax-anti-cd-20-mab-to-a-btki-in-patients-with-cll-who-no-longer-wish-to-remain-on-a-btki-many-months-after-starting-the-btki weekly 0.8 https://www.themednet.org/do-you-prescribe-coenzyme-q10-alpha-lipoic-acid-for-patients-with-debilitating-long-covid weekly 0.8 https://www.themednet.org/when-treating-primary-liver-disease-with-radiation-how-do-you-contour-and-constrain-the-central-bile-ducts weekly 0.8 https://www.themednet.org/would-you-consider-tocilizumab-for-treatment-of-gca-in-patients-with-underlying-cll-not-requiring-therapy weekly 0.8 https://www.themednet.org/how-would-you-further-risk-stratify-patients-with-systemic-vasculitides-and-chest-pain-with-atypical-features weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-add-docetaxel-to-adt-abiraterone-or-adt-darolutamide-in-patients-with-mcspc-in-the-era-of-psma-pet-staging weekly 0.8 https://www.themednet.org/what-hemodynamic-clinical-and-or-ekg-parameters-do-you-consider-when-recommending-icd-implantation-for-patients-with-repaired-tetralogy-of-fallot weekly 0.8 https://www.themednet.org/what-patient-characteristics-or-clinical-scenarios-guide-the-decision-in-performing-slow-mohs-procedures weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-an-elderly-patient-with-known-mantle-cell-lymphoma-and-new-diagnosis-of-cryoglobulinemic-vasculitis-with-mild-skin-involvement-fatigue-arthralgias-but-no-other-major-organ-involvement weekly 0.8 https://www.themednet.org/in-a-patient-with-hormone-positive-early-breast-cancer-who-experienced-a-myocardial-infarction-mi-while-on-aromatase-inhibitors-ai-should-tamoxifen-be-substituted-as-an-alternative-treatment weekly 0.8 https://www.themednet.org/how-do-you-dose-maribavir-in-pediatric-patients-and-on-what-is-that-based weekly 0.8 https://www.themednet.org/in-a-patient-with-vaginal-itching-and-a-vaginal-swab-with-a-positive-candida-glabrata-naat-what-is-your-first-line-therapy weekly 0.8 https://www.themednet.org/is-there-a-commercial-extract-for-asian-ladybugs-harmonia-axyridis-available weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-dmards-and-biologics-in-a-patient-with-active-ra-but-frequent-recurrent-simple-utis weekly 0.8 https://www.themednet.org/how-can-clinicians-safely-manage-the-potential-cardiac-risks-associated-with-low-dose-amphetamines-in-older-adults-while-ensuring-the-treatments-benefits-outweigh-the-risks-in-cases-of-failure-to-thrive-depression weekly 0.8 https://www.themednet.org/how-would-you-approach-anifrolumab-infusions-in-a-patient-who-had-an-infusion-reaction-with-their-first-infusion-but-did-not-receive-any-premeds weekly 0.8 https://www.themednet.org/how-do-you-focus-your-history-and-exam-to-better-identify-potential-cases-of-chikungunya-presenting-with-rheumatic-symptomas-in-the-setting-of-global-travel weekly 0.8 https://www.themednet.org/what-strategies-do-you-implement-in-your-clinic-to-ensure-comprehensive-screening-and-timely-diagnosis-of-syphilis-in-populations-with-risk-factors-for-sexually-transmitted-infections weekly 0.8 https://www.themednet.org/how-do-you-differentiate-between-chikungunya-induced-arthritis-and-ra-during-sporadic-outbreaks-or-in-regions-with-higher-prevalence weekly 0.8 https://www.themednet.org/in-patients-with-severe-obesity-do-you-recommend-a-trial-of-glp-1-r-agonist-therapy-prior-to-bariatric-surgery weekly 0.8 https://www.themednet.org/how-does-acetaminophen-serve-as-a-preventive-lytic-agent-for-hypersensitivity-reactions-if-it-is-not-in-a-class-of-anti-inflammatory-drugs weekly 0.8 https://www.themednet.org/how-do-you-approach-confirming-a-diagnosis-of-limited-gpa-with-nasal-involvement-vs-relapsing-polychondritis weekly 0.8 https://www.themednet.org/would-you-consider-pursuing-renal-transplantation-in-a-patient-with-multiple-myeloma weekly 0.8 https://www.themednet.org/when-do-you-consider-cannabidiol-for-treatment-of-epilepsy weekly 0.8 https://www.themednet.org/what-kind-of-follow-up-or-monitoring-do-you-recommend-for-patients-with-at-risk-alpha-1-anti-trypsin-phenotypes weekly 0.8 https://www.themednet.org/how-do-you-diagnose-cystic-fibrosis-related-liver-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-of-immune-mediated-overlap-syndromes-such-as-aih-pbc weekly 0.8 https://www.themednet.org/how-do-you-prefer-to-manage-igg-4-related-hepato-biliary-disease-especially-if-there-are-similarities-in-imaging-findings-to-other-immune-mediated-liver-diseases weekly 0.8 https://www.themednet.org/what-role-is-there-for-the-use-of-ursodiol-in-relapsing-hepatitis-a-for-management-of-liver-enzyme-abnormalities-and-patient-symptoms weekly 0.8 https://www.themednet.org/how-do-you-utilize-urine-sodium-and-potassium-levels-and-ratios-in-diuretic-optimization-in-patients-with-ascites weekly 0.8 https://www.themednet.org/how-has-the-galad-score-affected-your-practice-for-hcc-screening weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-use-and-risks-of-alternative-medications-and-supplements-given-how-prevalent-and-easily-accessible-they-are-to-the-average-person-and-their-risk-of-liver-injury weekly 0.8 https://www.themednet.org/in-what-scenario-do-you-continue-surveillance-of-benign-liver-tumors-e-g-hepatocellular-adenoma-in-pregnant-patients weekly 0.8 https://www.themednet.org/what-testing-do-you-utilize-to-decide-a-patients-candidacy-for-resmetirom-therapy weekly 0.8 https://www.themednet.org/how-does-managing-a-patient-with-concomitant-alcohol-related-liver-disease-impact-your-choice-of-therapies weekly 0.8 https://www.themednet.org/what-are-your-biggest-takeaways-from-the-mash-tag-2025-conference weekly 0.8 https://www.themednet.org/how-do-you-incorporate-addiction-medicine-and-counseling-into-your-treatment-plan-for-patients-with-alcohol-associated-liver-disease weekly 0.8 https://www.themednet.org/do-you-always-consider-adpckd-or-arpckd-in-a-patient-who-is-incidentally-found-to-have-liver-and-renal-cysts weekly 0.8 https://www.themednet.org/how-do-you-incorporate-palliative-care-specialists-into-the-care-of-patients-with-chronic-liver-disease-especially-those-who-may-not-be-transplant-candidates weekly 0.8 https://www.themednet.org/do-you-prefer-using-echocardiographic-guided-or-smartassist-guided-help-for-impella-repositioning-and-why weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-ra-in-patients-who-have-developed-anti-drug-antibodies-to-infliximab-especially-if-use-of-methotrexate-is-contraindicated-and-patients-have-tried-and-failed-several-other-biologics weekly 0.8 https://www.themednet.org/what-options-are-available-for-patients-who-require-high-dose-steroids-while-taking-strong-cyp4a4-inducers weekly 0.8 https://www.themednet.org/what-are-your-preferred-echocardiographic-parameters-and-goals-for-weaning-rvad-support weekly 0.8 https://www.themednet.org/how-do-you-approach-revaccination-after-chemotherapy-and-what-labs-if-any-do-you-use-to-assess-immune-reconstitution weekly 0.8 https://www.themednet.org/when-do-you-consider-surgery-for-patients-with-sturge-weber weekly 0.8 https://www.themednet.org/should-men-with-familial-pcos-be-screened-earlier-for-cardiometabolic-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-deprescribing-anticholinergics-in-patients-with-psychotic-disorders weekly 0.8 https://www.themednet.org/would-you-be-hesitant-to-continue-a-tnf-inhibitor-in-a-patient-with-stable-ra-and-a-history-of-copd-cor-pulmonale-severe-reduced-rvef-but-lvef-65 weekly 0.8 https://www.themednet.org/in-a-patient-with-suspected-prosthetic-valve-endocarditis-how-long-after-prosthetic-valve-implantation-is-an-fdg-pet-reasonable-to-rule-out-infection weekly 0.8 https://www.themednet.org/do-you-prioritize-prescribing-semaglutide-in-patients-with-type-2-diabetes-and-peripheral-arterial-disease-given-trial-data-demonstrating-improved-maximum-walking-distance-with-its-use weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-adding-a-nonstatin-lipid-lowering-agent-for-patients-with-acs-who-are-on-maximally-tolerated-statin-therapy-and-have-an-ldl-c-between-55-and-69-mg-dl weekly 0.8 https://www.themednet.org/what-management-considerations-should-we-be-aware-of-in-the-care-of-aging-patients-with-biliary-atresia weekly 0.8 https://www.themednet.org/in-a-serologic-evaluation-for-immune-mediated-liver-disease-what-further-workup-do-you-pursue-when-low-immunoglobulins-are-identified weekly 0.8 https://www.themednet.org/in-what-clinical-scenario-do-you-initiate-the-use-of-ileal-bile-acid-transport-ibat-inhibitors-in-the-management-of-cholestatic-liver-disease weekly 0.8 https://www.themednet.org/how-does-your-surveillance-and-management-approach-differ-between-intra-hepatic-and-extra-hepatic-cholangiocarcinoma weekly 0.8 https://www.themednet.org/what-clinical-imaging-or-serologic-markers-would-be-an-indication-to-you-to-stop-glp-1-therapy-for-management-of-masld weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-with-low-liver-enzymes weekly 0.8 https://www.themednet.org/would-you-use-daptomycin-to-consolidate-therapy-in-a-patient-with-polymicrobial-vre-and-rothia-bacteremia weekly 0.8 https://www.themednet.org/do-you-approach-suppressive-antibiotic-therapy-differently-for-patients-with-cardiac-implant-able-electronic-devices-infections-compared-to-patients-with-lvad-related-infections weekly 0.8 https://www.themednet.org/when-if-ever-do-you-use-therapeutic-hypothermia-targeted-temperature-management-in-a-non-neotal-pediatric-cardiac-arrest-patient weekly 0.8 https://www.themednet.org/how-do-you-manage-bleeding-or-peri-procedural-care-for-vwd-patients-whose-vwf-levels-have-increased-or-normalized-from-age-or-hormonal-contraceptive-use weekly 0.8 https://www.themednet.org/how-do-you-approach-a-positive-igra-in-a-patient-with-idiopathic-nsip-needing-a-prolonged-course-of-corticosteroid-therapy-and-a-prior-history-mac-in-a-single-sputum-culture weekly 0.8 https://www.themednet.org/would-you-consider-switching-to-benralizumab-for-patients-with-egpa-experiencing-severe-pulmonary-symptoms-despite-being-on-mepolizumab weekly 0.8 https://www.themednet.org/when-treating-an-inoperable-urothelial-cancer-of-the-renal-pelvis-what-are-your-considerations-when-determining-candidacy-for-sbrt weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-severe-infantile-eczema weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-use-pasireotide-in-the-management-of-insulinoma-associated-hypoglycemia weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-paxlovid-in-patients-with-covid-19-and-ckd-stage-4 weekly 0.8 https://www.themednet.org/how-do-you-approach-cytoreductive-therapy-for-high-risk-polycythemia-vera-with-normal-wbc-and-platelet-counts weekly 0.8 https://www.themednet.org/do-you-have-a-preference-between-midodrine-and-droxidopa-for-patients-with-eskd-who-experience-intradialytic-hypotension weekly 0.8 https://www.themednet.org/is-there-any-utility-in-reporting-lv-strain-on-echocardiogram-for-patients-with-depressed-lvef weekly 0.8 https://www.themednet.org/how-do-you-help-your-patients-manage-expectations-about-skin-tightening-procedures-and-outcomes weekly 0.8 https://www.themednet.org/how-would-you-proceed-for-a-patient-who-has-completed-therapy-for-classic-hodgkin-lymphoma-with-overall-great-disease-response-but-with-new-fdg-avid-lymph-node-on-pet-that-is-not-amenable-to-biopsy weekly 0.8 https://www.themednet.org/how-do-you-evaluate-patients-who-report-medications-frequently-stop-working-after-long-periods-of-stability weekly 0.8 https://www.themednet.org/how-would-you-manage-iron-overload-in-sickle-cell-patients-with-cirrhosis weekly 0.8 https://www.themednet.org/what-is-your-preferred-empiric-antibiotic-escalation-for-a-patient-with-chorioamnionitis-with-worsening-signs-of-sepsis-on-single-agent-cefoxitin weekly 0.8 https://www.themednet.org/what-is-your-experience-with-using-oral-roflumilast-for-psoriatic-arthritis weekly 0.8 https://www.themednet.org/what-is-your-experience-with-in-vitro-chemosensitivity-testing weekly 0.8 https://www.themednet.org/in-patients-with-stage-iii-nsclc-who-experience-locoregional-recurrence-after-neoadjuvant-chemoimmunotherapy-surgery-and-maintenance-immunotherapy-and-are-treated-with-definitive-chemoradiation-at-recurrence-what-is-the-optimal-systemic-therapy-strategy-p weekly 0.8 https://www.themednet.org/has-anyone-had-experience-success-treating-depressions-anxiety-with-an-ssri-and-having-resolution-of-urticaria-angioedema-despite-4x-h1-dosing-and-xoliar weekly 0.8 https://www.themednet.org/how-would-you-counsel-non-cardiologists-needing-to-prescribe-a-qtc-prolonging-medication-in-a-patient-with-an-ekg-showing-prolonged-qtc-but-no-history-of-long-qtc-syndrome-and-no-known-cardiomyopathy weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-to-medication-trials-for-diagnosis-of-nonconvulsive-status-epilepticus weekly 0.8 https://www.themednet.org/how-do-you-decide-which-patients-with-atopic-dermatitis-being-treated-with-tralokinumab-are-good-candidates-for-dose-reduction weekly 0.8 https://www.themednet.org/how-do-you-approach-tapering-of-tocilizumab-used-for-a-history-of-gca-with-vision-loss weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-metastatic-hormone-sensitive-prostate-cancer-who-received-docetaxel-but-has-toxicity-while-on-darolutamide-leuprolide weekly 0.8 https://www.themednet.org/how-would-you-approach-anticoagulation-management-and-consideration-for-pfo-closure-in-patients-with-acute-lower-extremity-dvts-involving-the-proximal-deep-veins-and-findings-concerning-for-pfo-on-echocardiogram weekly 0.8 https://www.themednet.org/in-which-patients-are-referring-for-focal-gland-therapy-for-localized-prostate-cancer weekly 0.8 https://www.themednet.org/after-neoadjuvant-nivolumab-ipilimumab-x4-do-you-offer-adjuvant-nivolumab-in-the-adjuvant-setting-for-oligometastatic-msi-high-colon-cancer-in-a-patient-who-achieved-cr weekly 0.8 https://www.themednet.org/what-is-your-approach-to-counseling-and-managing-patients-with-lam-desiring-pregnancy weekly 0.8 https://www.themednet.org/would-you-consider-using-enasidenib-off-label-for-a-cholangiocarcinoma-with-idh2-mutation-that-has-progressed-on-numerous-lines-of-standard-of-therapy weekly 0.8 https://www.themednet.org/would-you-hold-off-iron-chelation-in-a-transfusion-dependent-mds-patient-with-elevated-ferritin-but-with-negative-iron-stain-on-the-bone-marrow weekly 0.8 https://www.themednet.org/in-patients-with-muscle-invasive-bladder-cancer-seeking-bladder-preservation-would-positive-ctdna-affect-your-approach-to-trimodality-therapy weekly 0.8 https://www.themednet.org/what-role-do-genetic-and-molecular-profiling-play-in-predicting-which-patients-with-high-risk-localized-rms-benefit-from-maintenance-chemotherapy-with-vinorelbine-and-low-dose-cyclophosphamide weekly 0.8 https://www.themednet.org/how-do-you-address-parental-anxiety-resistance-to-erp-treatment-in-younger-children weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-choosing-between-baloxavir-and-oseltamivir-for-treating-patients-with-influenza weekly 0.8 https://www.themednet.org/in-pregnant-patients-with-non-classical-congenital-adrenal-hyperplasia-what-factors-help-you-determine-the-need-for-continued-steroid-use-throughout-pregnancy-including-labor-and-delivery weekly 0.8 https://www.themednet.org/how-would-you-manage-acute-panic-symptoms-in-a-patient-with-alcohol-use-disorder-in-sustained-remission-who-is-starting-an-ssri-for-panic-disorder weekly 0.8 https://www.themednet.org/what-is-the-strength-of-evidence-supporting-intranasal-testosterone-use-for-preserving-fertility-in-hypogonadal-men weekly 0.8 https://www.themednet.org/is-transdermal-estrogen-therapy-safe-for-postmenopausal-patients-with-positive-antiphospholipid-antibodies-but-no-history-of-thrombosis-or-obstetric-complications weekly 0.8 https://www.themednet.org/in-the-setting-of-total-neoadjuvant-therapy-tnt-for-locally-advanced-rectal-cancer-would-you-consider-using-folfiri-instead-of-folfox-capox-for-consolidative-chemotherapy-in-patients-unable-to-receive-oxaliplatin-with-the-goal-of-maximizing-the-chance-of- weekly 0.8 https://www.themednet.org/how-does-your-management-and-counseling-of-a-patient-with-ovarian-cancer-change-when-they-have-significant-persistent-disease-after-neoadjuvant-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-decide-between-bariatric-surgery-and-a-glp-1-receptor-agonist-for-patients-with-metabolic-dysfunction-associated-steatotic-liver-disease-who-have-not-met-weight-loss-goals-after-six-months-of-lifestyle-interventions weekly 0.8 https://www.themednet.org/are-there-certain-patients-with-primary-hyperparathyroidism-for-whom-you-would-consider-percutaneous-ablation-of-a-parathyroid-adenoma-over-surgical-parathyroidectomy weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-for-egfr-mutant-nsclc-with-acquired-erbb2-mutation-and-amplification-as-resistance-to-prior-osimertinib-based-therapy weekly 0.8 https://www.themednet.org/is-there-any-value-to-igg-subclasses-in-assessing-immune-deficiency-in-a-patient-with-normal-igg-levels weekly 0.8 https://www.themednet.org/how-would-you-manage-itp-in-patients-who-develop-cirrhosis-and-hemorrhage weekly 0.8 https://www.themednet.org/do-you-avoid-daptomycin-use-when-there-is-evidence-of-septic-pulmonary-emboli weekly 0.8 https://www.themednet.org/how-would-you-approach-the-inr-goal-in-a-patient-with-mechanical-aortic-valve-and-high-bleeding-risk-factors-like-immune-thrombocytopenia-av-malformations-and-recurrent-gi-bleeds-etc weekly 0.8 https://www.themednet.org/do-you-recommend-high-ozonated-oil-for-radiation-dermatitis weekly 0.8 https://www.themednet.org/for-graves-disease-patients-undergoing-radioactive-iodine-ablation-what-is-the-preferred-approach-to-steroid-prophylaxis-for-graves-orbitopathy weekly 0.8 https://www.themednet.org/how-should-one-approach-management-of-a-patient-with-asymptomatic-severe-primary-prolapse-tr-and-normal-rv-function-ef-and-strain-but-with-ra-rv-enlargement weekly 0.8 https://www.themednet.org/how-long-do-you-continue-ursodiol-for-vod-prophylaxis-after-gemtuzumab-ozogamicin-for-good-risk-aml weekly 0.8 https://www.themednet.org/do-you-use-oral-beta-lactams-to-treat-osteomyelitis weekly 0.8 https://www.themednet.org/what-is-the-clinical-significance-of-an-isolated-anti-centromere-b-antibody-in-a-patient-with-pulmonary-fibrosis-but-no-other-features-of-systemic-sclerosis weekly 0.8 https://www.themednet.org/are-there-any-data-retrospective-or-otherwise-on-the-watch-and-wait-approach-in-patients-who-achieve-ccr-after-crt-without-consolidation-chemotherapy weekly 0.8 https://www.themednet.org/would-you-consider-initiating-eculizumab-without-plasmapheresis-as-initial-therapy-for-a-patient-with-renal-tma-who-has-a-low-suspicion-of-ttp-based-on-a-scoring-algorithm weekly 0.8 https://www.themednet.org/what-staging-or-systemic-workup-do-you-recommend-in-a-patient-with-newly-diagnosed-adult-cutaneous-xanthogranuloma-axg weekly 0.8 https://www.themednet.org/would-you-consider-the-use-of-avapritinib-in-advanced-gist-after-failure-of-imatinib-sunitinib-and-ripretinib-in-exon-11-and-17-kit-mutated-gist weekly 0.8 https://www.themednet.org/is-there-any-data-on-the-safety-or-efficacy-of-combining-osimertinib-based-therapy-with-her2-targeted-treatment-in-patients-with-egfr-mutant-nsclc-and-concurrent-her2-positive-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-the-rxponder-data-in-premenopausal-women-with-er-pr-her2-negative-pn1-many-of-whom-now-qualify-for-cdk-4-6-inhibitors-in-adjuvant-setting-besides-endocrine-therapy-ofs-if-the-rs-0-13-and-14-25 weekly 0.8 https://www.themednet.org/are-there-specific-organisms-other-than-s-aureus-in-which-you-offer-indefinite-antibiotic-suppression-in-medically-treated-prosthetic-valve-endocarditis weekly 0.8 https://www.themednet.org/in-a-patient-with-a-history-of-seropositive-erosive-ra-who-has-undergone-treatment-for-a-periprosthetic-joint-infection-and-currently-has-an-antibiotic-spacer-in-place-with-clinical-improvement-what-is-the-appropriate-timing-and-strategy-for-restarting-dm weekly 0.8 https://www.themednet.org/is-cimzia-an-option-for-patients-with-latex-allergy weekly 0.8 https://www.themednet.org/when-do-you-offer-high-dose-vitamin-d-for-patients-with-multiple-sclerosis-with-normal-serum-levels weekly 0.8 https://www.themednet.org/would-you-recommend-intra-articular-anti-fungal-administration-for-patients-with-a-prosthetic-knee-infection-due-to-candida-albicans-who-has-undergone-an-antibiotic-space-placement-as-part-of-a-1-5-stage-procedure weekly 0.8 https://www.themednet.org/how-does-the-presence-of-cns-disease-affect-your-choice-of-first-line-therapy-in-her2-gastric-adenocarcinoma weekly 0.8 https://www.themednet.org/does-the-presence-of-a-bloody-aspirate-reduce-the-diagnostic-yield-of-ebus-bronchoscopy-and-if-so-what-strategies-can-be-employed-to-minimize-its-occurrence weekly 0.8 https://www.themednet.org/based-on-the-recent-2025-consensus-recommendations-by-the-us-multi-society-task-force-on-colorectal-cancer-how-have-you-incorporated-split-prep-simplified-preprocedural-diet-and-use-of-simethicone-into-your-practice weekly 0.8 https://www.themednet.org/what-is-your-approach-to-diagnosing-and-managing-methotrexate-induced-alopecia weekly 0.8 https://www.themednet.org/how-would-you-approach-the-workup-of-a-female-patient-who-has-recurrent-sinusitis-with-polyps-biopsy-showed-active-and-chronic-inflammation-and-myocarditis-but-negative-anca-and-normal-eosinophil-counts weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-relapsed-refractory-t-cell-prolymphocytic-leukemia-t-pll weekly 0.8 https://www.themednet.org/how-does-your-approach-to-the-differential-diagnosis-of-membranous-nephropathy-change-when-pla2r-positivity-is-detected-alongside-a-chronic-viral-infection-such-as-hiv-hbv-or-hcv weekly 0.8 https://www.themednet.org/how-would-you-manage-a-medically-inoperable-patient-with-locally-recurrent-nest-variant-muscle-invasive-urothelial-carcinoma-s-p-radical-cystectomy-years-ago-now-involving-the-urethral-anastomosis-sphincter-and-neo-bladder-status-post-tur weekly 0.8 https://www.themednet.org/when-would-you-be-comfortable-with-using-hhfnc-rather-than-niv-in-patients-with-acute-respiratory-failure weekly 0.8 https://www.themednet.org/do-you-recommend-stepwise-de-escalation-of-dual-antiplatelet-therapy-for-patients-at-high-risk-of-bleeding-who-have-undergone-drug-coated-balloon-angioplasty weekly 0.8 https://www.themednet.org/what-stress-testing-modality-do-you-choose-to-evaluate-patients-who-are-unable-to-exercise-and-have-anomalous-coronary-arteries weekly 0.8 https://www.themednet.org/should-orlistat-be-avoided-in-patients-with-a-history-of-kidney-stones weekly 0.8 https://www.themednet.org/would-you-proceed-to-a-direct-penicillin-challenge-in-a-patient-with-a-reaction-history-30-years-ago-without-any-further-clinical-history weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-treating-with-steroid-therapy-in-a-patient-with-hiv-associated-nephropathy weekly 0.8 https://www.themednet.org/how-do-you-approach-selecting-laser-settings-such-as-wavelength-and-pulse-duration-when-treating-vascular-lesions-like-port-wine-stains weekly 0.8 https://www.themednet.org/how-do-you-treat-er-pr-dcis-with-no-identified-invasive-component-that-has-microscopic-sentinel-lymph-node-metastasis-would-you-complete-her2-staining-on-original-specimen weekly 0.8 https://www.themednet.org/does-an-allergy-to-the-platinum-metal-with-moderate-reaction-to-platinum-inhaled-particles-confer-allergy-to-platinum-based-chemotherapy weekly 0.8 https://www.themednet.org/does-treating-cll-reduce-the-risk-of-non-melanoma-skin-cancers weekly 0.8 https://www.themednet.org/what-tidal-volume-or-minute-ventilation-goals-do-you-target-when-titrating-nippv-in-a-patient-with-a-hypercapneic-copd-exacerbation weekly 0.8 https://www.themednet.org/what-role-might-depemokimab-play-in-the-stepwise-approach-to-asthma-management-especially-for-patients-who-have-previously-failed-other-biologic-therapies weekly 0.8 https://www.themednet.org/do-you-implement-fev3-fev6-or-fef25-75-measurements-in-the-evaluation-of-patients-for-small-airways-obstruction weekly 0.8 https://www.themednet.org/when-and-how-do-you-screen-patients-for-problematic-usage-of-internet weekly 0.8 https://www.themednet.org/when-initiating-patients-on-ragwitek-odactra-and-grastek-and-the-plan-is-to-continue-on-all-3-tablets-for-the-next-5-years-instead-of-only-for-seasons-how-far-apart-from-each-one-do-you-give-the-initial-dose weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-steroids-in-staphylococcus-associated-glomerulonephritis-with-crescents-on-kidney-biopsy weekly 0.8 https://www.themednet.org/is-there-a-role-for-adding-methotrexate-to-methimazole-in-the-treatment-of-graves-disease weekly 0.8 https://www.themednet.org/how-do-you-manage-recalcitrant-tumid-lupus-in-a-patient-with-partial-response-to-antimalarials-and-off-label-apremilast-in-the-setting-of-coexisting-mds-with-significant-neutropenia weekly 0.8 https://www.themednet.org/how-do-you-utilize-1-3-beta-d-glucan-in-csf-for-diagnosing-and-monitoring-non-cryptococcal-cns-fungal-infections weekly 0.8 https://www.themednet.org/how-do-you-approach-patient-with-cll-sll-limited-to-the-prostate weekly 0.8 https://www.themednet.org/do-you-modify-the-dose-of-naliri-in-nalirifox-for-patient-that-are-heterozygous-for-ugt1a1-mutations weekly 0.8 https://www.themednet.org/how-do-you-approach-h-pylori-management-in-terms-of-evaluating-or-testing-family-members-of-patients-who-test-positive weekly 0.8 https://www.themednet.org/if-a-pediatric-patient-has-a-prior-history-of-cancer-associated-thrombosis-while-receiving-active-treatment-can-they-be-on-estrogen-containing-ocps-in-the-future weekly 0.8 https://www.themednet.org/how-can-we-minimize-the-risk-of-overinterpreting-reactive-findings-from-repeat-lumbar-punctures weekly 0.8 https://www.themednet.org/what-are-the-potential-challenges-and-benefits-of-implementing-z-score-thresholds-in-clinical-practice-for-copd-severity-classification-and-how-might-this-affect-patient-outcomes weekly 0.8 https://www.themednet.org/how-do-you-approach-neutropenia-in-patients-being-treated-with-obinutuzumab-venetoclax-for-cll weekly 0.8 https://www.themednet.org/how-do-you-determine-when-to-treat-versus-monitor-subclinical-thyroid-disease-early-in-pregnancy-in-patients-with-a-negative-tpoab weekly 0.8 https://www.themednet.org/would-you-recommend-routinely-checking-anca-levels-just-prior-to-a-planned-kidney-transplantation-in-patients-with-a-history-of-eskd-secondary-to-anca-associated-vasculitis weekly 0.8 https://www.themednet.org/would-you-add-pembrolizumab-to-folfox-in-first-line-metastatic-gastric-adenocarcinoma-with-cps-0-but-high-tmb-12 weekly 0.8 https://www.themednet.org/how-would-do-manage-stage-ii-iii-muscle-invasive-bladder-cancer-with-large-cell-neuroendocrine-histology weekly 0.8 https://www.themednet.org/what-criteria-should-be-used-to-determine-the-timing-of-placing-central-venous-access-or-cardiac-devices-in-patients-with-staphylococcus-lugdunensis-infective-endocarditis-considering-the-skip-phenomenon weekly 0.8 https://www.themednet.org/how-do-you-manage-ocular-hemorrhages-while-on-acalabrutinib-for-cll weekly 0.8 https://www.themednet.org/when-if-at-all-do-you-utilize-neoadjuvant-chemotherapy-alone-for-resectable-stage-ii-nsclc-with-mutations-such-as-egfr-or-alk weekly 0.8 https://www.themednet.org/what-is-your-preferred-dose-and-schedule-for-maintenance-drugs-post-autohct-for-newly-diagnosed-multiple-myeloma weekly 0.8 https://www.themednet.org/in-a-patient-with-malignant-ureteral-obstruction-that-is-moderate-to-high-grade-with-aki-requiring-a-pcn-how-long-after-placement-would-you-wait-until-converting-to-an-internal-stent-or-pcnu weekly 0.8 https://www.themednet.org/how-would-you-approach-an-incidentally-positive-chagas-serology-without-epidemiological-risk-factors-or-clinical-features-consistent-with-chagas weekly 0.8 https://www.themednet.org/how-do-you-decide-between-steroids-alone-versus-corticosteroids-plus-csdmard-for-non-anterior-sarcoid-uveitis weekly 0.8 https://www.themednet.org/how-do-you-decide-on-long-term-immunosuppression-therapy-for-susac-syndrome weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-to-differentiate-between-mogad-and-ms-in-pediatric-patients weekly 0.8 https://www.themednet.org/in-a-patient-with-a-synchronous-prostate-cancer-and-non-invasive-urothelial-carcinoma-limited-to-the-prostatic-urethra-is-complete-tur-and-definitive-prostate-dose-to-standard-prostate-fields-adequate-treatment weekly 0.8 https://www.themednet.org/how-do-you-decide-on-lung-constraints-for-sbrt-after-whole-lung-radiation-for-persistent-nodules weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-use-to-palliate-a-metastatic-peripheral-nerve-sheath-tumor-of-the-lower-extremity-with-bulky-inguinal-adenopathy weekly 0.8 https://www.themednet.org/how-long-of-a-treatment-course-will-you-plan-for-patients-starting-nemolizumab weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-supraphysiologic-t4-doses-in-patients-with-intermediate-and-high-risk-differentiated-thyroid-cancer-considering-that-elevated-ft4-levels-have-not-been-linked-to-progression-free-survival-in-recent-clinical-data weekly 0.8 https://www.themednet.org/what-are-key-considerations-for-using-monobenzone-for-severe-vitiligo weekly 0.8 https://www.themednet.org/in-what-situations-would-you-treat-a-corynebacterium-positive-blood-culture-as-a-true-pathogen-compared-to-a-contaminant weekly 0.8 https://www.themednet.org/how-do-you-advise-patients-with-epilepsy-that-are-planning-pregnancy-and-use-invasive-neuromodulation-for-treatment-of-their-epilepsy weekly 0.8 https://www.themednet.org/what-are-your-preferred-guide-catheters-to-use-for-engaging-coronaries-in-patients-with-mechanical-or-bioprosthetic-aortic-valves weekly 0.8 https://www.themednet.org/what-is-your-preferred-duration-of-aggrastat-therapy-and-does-it-differ-if-patient-presented-with-nstemi-versus-stemi weekly 0.8 https://www.themednet.org/how-do-you-approach-evaluation-of-a-patient-with-symmetric-length-dependent-axonal-sensorimotor-neuropathy-and-ana-but-no-current-signs-or-symptoms-of-rheumatologic-disease weekly 0.8 https://www.themednet.org/in-which-specific-scenarios-would-you-consider-transitioning-from-oral-to-intravenous-thyroid-hormone-replacement-in-the-outpatient-setting weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-atopic-dermatitis-on-minimizing-exposure-to-air-pollutants weekly 0.8 https://www.themednet.org/would-you-pursue-immunosuppression-in-a-patient-with-mixed-connective-tissue-disease-presenting-primarily-as-dysautonomia-assuming-other-causes-have-been-ruled-out weekly 0.8 https://www.themednet.org/do-you-recommend-avoiding-the-use-of-glp-1-agonists-in-patients-with-a-history-of-suicidal-thoughts-given-recent-evidence-showing-an-association-with-increased-risks-of-psychiatric-disorders-including-depression-and-suicidal-behavior weekly 0.8 https://www.themednet.org/when-would-be-your-threshold-to-switch-to-weight-based-lmwh-from-warfarin-for-persistently-subtherapeutic-inr-levels-in-a-patient-with-a-mechanical-avr-in-the-first-trimester weekly 0.8 https://www.themednet.org/would-you-defer-or-opt-for-plavix-loading-in-a-patient-already-on-dapt-presenting-with-nstemi-attributed-to-likely-non-ischemic-myocardial-injury-but-with-known-cad weekly 0.8 https://www.themednet.org/how-do-you-counsel-on-the-risks-of-developing-anti-drug-antibodies-when-using-intrathecal-enzyme-replacement-therapy-for-lysosomal-storage-disorders weekly 0.8 https://www.themednet.org/how-do-you-manage-recurrent-asymptomatic-transaminitis-from-vegf-tki-in-a-patient-renal-cell-carcinoma-who-needs-drug-to-control-disease weekly 0.8 https://www.themednet.org/thoughts-about-using-fecal-transplant-as-a-treatment-option-for-recurrent-difficult-to-treat-c-diff-infection-in-an-elderly-kidney-transplant-patient weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-determining-eligibility-for-hematopoietic-stem-cell-therapies-for-metachromatic-leukodystrophy weekly 0.8 https://www.themednet.org/what-is-your-test-of-choice-for-patients-with-no-known-cad-who-have-chest-pain-and-an-intermediate-pretest-probability-for-obstructive-cad weekly 0.8 https://www.themednet.org/how-do-you-approach-c-kit-mutated-core-binding-factor-cbf-aml weekly 0.8 https://www.themednet.org/what-unique-work-up-or-management-would-you-offer-for-stroke-in-patients-with-sickle-cell-trait-beyond-standard-stroke-management weekly 0.8 https://www.themednet.org/what-precautions-should-be-taken-if-any-for-a-patient-on-methylphenidate-prior-to-and-after-starting-ivabradine weekly 0.8 https://www.themednet.org/is-there-increased-risk-from-rt-in-patients-with-fap-familial-adenomatous-polyposis weekly 0.8 https://www.themednet.org/how-do-you-treat-iga-vasculitis-with-gastrointestinal-involvement weekly 0.8 https://www.themednet.org/do-you-prefer-peritoneal-dialysis-catheter-and-transfer-set-care-to-include-soaking-in-antiseptic-applying-alcohol-wipes-or-washing-with-soap-and-water weekly 0.8 https://www.themednet.org/given-the-newer-ata-guidelines-what-is-your-approach-to-the-management-of-hurthle-cell-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-manage-ssri-induced-nightmares-in-a-patient-who-is-otherwise-doing-well-on-the-medication weekly 0.8 https://www.themednet.org/would-you-recommend-transdermal-estrogen-for-functional-hypothalamic-amenorrhea-despite-recent-findings-showing-no-vascular-or-psychological-benefits-after-12-weeks weekly 0.8 https://www.themednet.org/what-therapy-would-you-use-for-a-patient-with-metastatic-tfe3-rearranged-rcc-who-progressed-on-initial-pembrolizumab-lenvatinib weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-crescentic-fibrillary-glomerulonephritis weekly 0.8 https://www.themednet.org/would-you-consider-adding-azithromycin-to-standard-antituberculosis-treatment-to-reduce-inflammation-and-tissue-damage-in-patients-with-pulmonary-tuberculosis weekly 0.8 https://www.themednet.org/do-you-prefer-prescribing-lubiprostone-over-conventional-stool-softeners-in-patients-with-ckd-and-constipation weekly 0.8 https://www.themednet.org/how-do-you-determine-the-appropriate-timing-and-criteria-for-safely-reintroducing-av-nodal-blocking-agents-after-initial-stabilization-and-improvement-of-renal-function-and-hyperkalemia-in-patients-with-brash-syndrome weekly 0.8 https://www.themednet.org/how-do-you-evaluate-the-etiology-of-worsening-limb-ischemia-between-progression-of-known-pad-or-cardioembolic-disease weekly 0.8 https://www.themednet.org/how-do-you-determine-the-optimal-timing-for-surgery-in-patients-with-uveitic-glaucoma weekly 0.8 https://www.themednet.org/what-factors-predict-success-in-medication-withdrawal-after-epilepsy-surgery weekly 0.8 https://www.themednet.org/how-do-you-approach-incorporating-implantable-collamer-lenses-icls-into-your-refractive-surgery-practice-and-what-factors-guide-your-patient-selection weekly 0.8 https://www.themednet.org/do-you-ever-consider-maintenance-therapy-for-patients-with-relapsed-mantle-cell-lymphoma-post-car-t-therapy weekly 0.8 https://www.themednet.org/for-patients-with-modest-hyperbilirubinemia-tbili-2-3-due-to-chronic-liver-disease-but-otherwise-normal-liver-indices-would-you-consider-still-utilizing-enfortumab-vedotin-for-metastatic-urothelial-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-manage-insomnia-in-a-patient-with-cushing-syndrome-considering-that-elevated-nighttime-cortisol-levels-may-contribute-to-their-sleep-disturbances weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-suspected-tick-borne-encephalitis-who-has-normal-initial-serological-tests-but-continues-to-exhibit-neurological-symptoms-in-an-endemic-area weekly 0.8 https://www.themednet.org/what-are-your-thoughts-on-the-possible-correlation-between-breast-implants-and-thyroid-autoimmune-disorders-or-thyroid-cancer weekly 0.8 https://www.themednet.org/would-you-perform-salpingo-oophorectomy-for-a-premenopausal-woman-with-an-estrogen-receptor-negative-uterine-confined-embryonal-rhabdomyosarcoma weekly 0.8 https://www.themednet.org/how-do-you-incorporate-disease-activity-scores-and-remission-targets-for-axial-spondyloarthritis-to-determine-timing-and-frequency-of-treatment-adjustments weekly 0.8 https://www.themednet.org/how-do-you-decide-when-it-is-appropriate-to-discontinue-long-term-antibiotic-therapy-in-a-patient-with-whipples-disease weekly 0.8 https://www.themednet.org/what-testing-would-you-perform-for-a-presumed-delayed-drug-rash-from-colpidogrel weekly 0.8 https://www.themednet.org/considering-the-results-of-the-i-spy2-trial-discussed-at-asco-2025-what-would-be-your-approach-to-treating-a-t1cn0-tumor-1-5-1-9cm-young-fit-patient-nact-thp-x4-or-surgery-upfront weekly 0.8 https://www.themednet.org/when-do-you-consider-disease-modifying-therapy-in-radiographically-isolated-syndrome weekly 0.8 https://www.themednet.org/how-do-you-sequence-luspatercept-and-imetelstat-for-treatment-of-anemia-in-mds weekly 0.8 https://www.themednet.org/in-a-patient-with-metastatic-pik3ca-mutant-hr-positive-her2-low-breast-cancer-who-is-intolerant-to-capivasertib-would-you-preferentially-use-another-pik3-inhibitor-or-switch-to-t-dxd weekly 0.8 https://www.themednet.org/what-workup-needs-to-be-performed-on-pediatric-patients-with-warm-autoimmune-hemolytic-anemia-prior-to-initiation-of-treatment-with-immunosuppressants weekly 0.8 https://www.themednet.org/what-is-the-role-of-radiation-therapy-for-kimuras-disease-of-the-parotid-and-neck weekly 0.8 https://www.themednet.org/what-advice-would-you-give-to-patients-with-refractory-nausea-and-vomiting-at-home-who-are-unable-to-take-oral-medications-but-have-recently-had-a-pci-and-stent-placement-requiring-uninterrupted-dapt weekly 0.8 https://www.themednet.org/how-do-you-approach-further-evaluating-for-hit-vitt-like-syndromes-in-the-case-of-thrombocytopenia-with-no-recent-heparin-exposure-but-negative-hit-antibody-and-positive-sra weekly 0.8 https://www.themednet.org/is-long-term-medical-management-effective-for-ovarian-hyperthecosis-or-is-surgery-the-primary-treatment-option weekly 0.8 https://www.themednet.org/is-there-a-biomarker-for-which-patients-benefit-from-tarlatamab weekly 0.8 https://www.themednet.org/for-adult-patients-on-montelukast-who-experience-vivid-dreams-intermittently-but-no-other-psychiatric-neuro-side-effects-do-you-permanently-discontinue-the-medication-for-dreams-alone-or-do-you-still-have-patients-take-it-prn-if-it-is-significantly-helpin weekly 0.8 https://www.themednet.org/would-you-hold-hai-fudr-for-sbrt-of-a-residual-liver-metastasis-following-hepatic-metastasectomy weekly 0.8 https://www.themednet.org/for-pediatric-severe-aplastic-anemia-is-an-alemtuzumab-campath-based-conditioning-regimen-preferred-over-atg weekly 0.8 https://www.themednet.org/how-would-you-plan-adjuvant-radiation-for-an-incidental-gallbladder-carcinoma-after-cholecystectomy-pt2-with-negative-margins-now-s-p-partial-hepatectomy-and-lymphadenectomy-with-positive-nodal-disease-in-a-patient-who-could-not-tolerate-systemic-therapy weekly 0.8 https://www.themednet.org/do-you-encourage-average-risk-patients-to-pursue-screening-colonoscopy-over-an-annual-fit-for-their-initial-colorectal-cancer-screening-how-about-subsequent-screening-if-the-first-colonoscopy-had-no-polyps weekly 0.8 https://www.themednet.org/what-is-your-preferred-first-line-treatment-regimen-for-patients-with-high-risk-mds weekly 0.8 https://www.themednet.org/are-there-any-differences-in-specificity-or-sensitivity-of-the-acth-stimulation-test-when-cosyntropin-is-administered-intravenously-versus-intramuscularly weekly 0.8 https://www.themednet.org/what-is-the-optimal-timing-of-salvage-radiotherapy-for-recurrent-metastatic-neuroblastoma-and-what-is-the-preferred-dose-and-fractionation weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-sunvozertinib-to-patients-with-stage-ii-iii-nsclc-with-an-egfr-exon-20-insertion-mutation weekly 0.8 https://www.themednet.org/do-you-routinely-test-for-co-infection-of-other-tick-borne-illnesses-in-a-patient-who-tests-positive-for-lyme-anaplasmosis-babesiosis-or-ehrlichiosis weekly 0.8 https://www.themednet.org/when-would-you-consider-referring-a-child-with-features-and-history-suspicious-for-fetal-alcohol-spectrum-disorders-to-specialized-clinics-for-formal-assessment weekly 0.8 https://www.themednet.org/would-you-do-adjuvant-chemo-in-patient-pt3n0-colon-with-intussusception-on-imaging-and-partial-obstruction-on-colonoscopy weekly 0.8 https://www.themednet.org/do-you-have-any-clinical-experience-regarding-the-administration-of-b-cell-depleting-therapies-in-ms-patients-with-splenectomy weekly 0.8 https://www.themednet.org/how-do-you-advise-patients-to-avoid-carboxymethylcellulose-when-the-excipient-it-is-commonly-found-in-many-products weekly 0.8 https://www.themednet.org/how-do-you-approach-counseling-patients-on-the-use-of-low-dose-radiation-therapy-for-osteoarthritis-who-are-concurrently-receiving-parathyroid-hormone-anabolic-treatment weekly 0.8 https://www.themednet.org/do-you-use-cns-dosing-of-antibiotics-for-any-portion-of-the-treatment-course-in-patients-with-infective-endocarditis-who-have-cerebral-emboli weekly 0.8 https://www.themednet.org/how-could-you-utilize-neuromuscular-ultrasound-as-a-marker-of-disease-progression-treatment-response-in-cidp weekly 0.8 https://www.themednet.org/how-does-choice-of-enzyme-replacement-therapy-and-monitoring-parameters-for-late-onset-pompe-disease-differ-from-infantile-onset-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-distinguishing-between-primary-and-secondary-fsgs-in-a-patient-who-is-pla2r-negative weekly 0.8 https://www.themednet.org/how-do-you-approach-counseling-the-family-of-a-patient-with-advanced-ckd-and-dementia-when-discussing-the-options-and-implications-of-starting-dialysis weekly 0.8 https://www.themednet.org/how-do-you-use-serum-igg-levels-when-treating-with-fcrn-inhibitors weekly 0.8 https://www.themednet.org/what-is-the-best-way-to-manage-close-contacts-of-patients-with-invasive-group-a-streptococcal-infections-to-minimize-the-risk-of-disease-transmission-while-considering-the-potential-adverse-effects-of-prophylactic-antibiotics weekly 0.8 https://www.themednet.org/what-is-the-diagnostic-lower-limit-for-calculated-free-testosterone-or-free-testosterone-measured-by-equilibrium-dialysis-below-which-male-hypogonadism-can-be-confidently-established weekly 0.8 https://www.themednet.org/do-you-make-dose-modifications-to-keynote-522-regimen-in-the-elderly weekly 0.8 https://www.themednet.org/what-is-your-pharmacologic-approach-to-binge-eating-disorder-with-patients-where-stimulant-medications-i-e-lisdexamfetamine-vyvanse-are-contraindicated-or-ineffective weekly 0.8 https://www.themednet.org/what-is-your-approach-to-antibiotic-prophylaxis-for-spontaneous-bacterial-peritonitis-in-patients-with-cirrhosis weekly 0.8 https://www.themednet.org/what-is-your-next-step-in-treatment-for-tobacco-use-disorder-for-a-patient-who-continues-to-smoke-after-12-weeks-of-therapy-with-varenicline weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-are-found-to-have-a-carrier-mutation-in-a-single-high-risk-apol1-allele weekly 0.8 https://www.themednet.org/if-a-patient-had-an-allergic-reaction-to-one-glp-1-does-it-preclude-the-use-of-another weekly 0.8 https://www.themednet.org/what-is-the-optimal-frequency-for-follow-up-of-low-risk-sub-centimeter-thyroid-cysts weekly 0.8 https://www.themednet.org/would-you-consider-using-a-jak-inhibitor-for-ctcl weekly 0.8 https://www.themednet.org/how-do-you-approach-whether-to-stop-or-continue-antiretroviral-medications-in-patients-with-hiv-when-admitted-to-hospice weekly 0.8 https://www.themednet.org/what-is-the-role-of-buprenorphine-compared-to-other-opioids-in-malignant-related-pain-in-the-last-months-of-life weekly 0.8 https://www.themednet.org/how-do-you-counsel-older-adults-with-regard-to-yoga-for-fall-prevention weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-previously-ambulatory-older-adult-without-assistive-device-admitted-with-a-fall-related-hip-fracture-and-status-post-hip-replacement-regarding-expected-functional-recovery-following-hospitalization-and-surgery weekly 0.8 https://www.themednet.org/what-is-your-approach-to-tapering-ssris-snris-in-older-adults weekly 0.8 https://www.themednet.org/how-would-you-recommend-cross-titrating-from-paroxetine-to-another-ssri-with-less-anticholinergic-burden-in-an-older-adult weekly 0.8 https://www.themednet.org/in-platinum-refractory-or-multiply-relapsed-nsgct-with-1-2-progressive-sites-and-no-good-surgical-option-is-there-a-role-for-local-radiotherapy-e-g-sbrt-to-those-sites weekly 0.8 https://www.themednet.org/how-do-you-counsel-older-patients-on-taking-melatonin-versus-ramelteon weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-insulin-dependent-diabetes-in-older-adults-with-difficulty-adhering-to-therapy weekly 0.8 https://www.themednet.org/what-is-the-role-of-antibiotic-suppression-for-the-prevention-of-frequent-utis-in-older-adult-patients weekly 0.8 https://www.themednet.org/for-patients-acutely-decompensated-with-acc-stage-c-d-nyha-3-4-probable-intermacs-4-how-do-you-decide-between-mcs-devices-like-ccm-barostim-or-potentially-lvad weekly 0.8 https://www.themednet.org/at-what-level-of-renal-impairment-do-you-typically-reduce-or-avoid-methotrexate-in-your-rheumatology-practice weekly 0.8 https://www.themednet.org/when-would-you-consider-an-all-oral-regimen-for-patients-with-whipples-disease-instead-of-the-typical-parenteral-treatment-with-ceftriaxone-or-meropenem-followed-by-oral-tmp-smx weekly 0.8 https://www.themednet.org/how-have-you-incorporated-acceptance-and-commitment-therapy-act-into-your-outpatient-practice weekly 0.8 https://www.themednet.org/how-have-you-incorporated-nature-based-interventions-into-your-outpatient-psychiatric-practice weekly 0.8 https://www.themednet.org/how-do-you-ensure-a-smooth-patient-transition-when-retiring-or-selling-your-psychiatric-practice weekly 0.8 https://www.themednet.org/which-pd-1-inhibitor-will-you-use-with-chemotherapy-in-initial-treatment-of-patients-with-metastatic-anal-cancer weekly 0.8 https://www.themednet.org/when-do-you-recommend-scrambler-therapy-for-chronic-neuropathic-pain weekly 0.8 https://www.themednet.org/are-there-specific-types-of-bioprosthetic-valves-that-would-make-you-inclined-to-choose-vka-in-lieu-of-a-doac-for-systemic-anticoagulation-several-months-post-valve-replacement weekly 0.8 https://www.themednet.org/in-what-clinical-context-s-do-you-find-lipoprotein-a-helpful-in-changing-your-management weekly 0.8 https://www.themednet.org/does-location-change-how-you-manage-erythropoietic-protoporhyria weekly 0.8 https://www.themednet.org/what-ai-products-have-you-found-helpful-for-eeg-and-epilepsy weekly 0.8 https://www.themednet.org/can-a-60-year-old-male-have-a-bone-density-test-showing-a-normal-t-score-but-a-low-z-score weekly 0.8 https://www.themednet.org/when-would-you-consider-genetic-testing-for-g6pd-deficiency-diagnosis weekly 0.8 https://www.themednet.org/why-do-the-question-guidelines-specify-that-i-cannot-post-a-question-regarding-a-patient-case weekly 0.8 https://www.themednet.org/when-do-you-use-brachytherapy-rather-than-imrt-for-treatment-of-sarcoma-post-operatively weekly 0.8 https://www.themednet.org/for-lower-extremity-sarcoma-what-is-the-tolerance-of-the-tissues-of-the-anterior-tibial-area-to-curative-doses-of-radiation weekly 0.8 https://www.themednet.org/what-is-the-key-to-becoming-an-outstanding-oncologist weekly 0.8 https://www.themednet.org/is-it-safe-and-effective-to-treat-medullary-thyroid-carcinoma-with-a-high-burden-of-disease-at-thyroidectomy-and-neck-dissection-with-radiation-and-vandetanib-concurrently weekly 0.8 https://www.themednet.org/what-is-your-preferred-agent-for-first-use-after-development-of-castration-resistant-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-recommend-adjuvant-chemotherapy-for-patients-with-locally-advanced-rectal-cancer-who-have-a-complete-pcr-after-neoadjuvant-chemoradiation weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-add-bevacizumab-for-patients-with-advanced-metastatic-lung-adenocarcinoma-receiving-first-line-chemotherapy-with-a-platinum-based-doublet weekly 0.8 https://www.themednet.org/how-low-can-you-dose-reduce-ceritinib-for-alk-rearranged-nsclc-before-you-are-concerned-that-it-no-longer-has-good-cns-penetration weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-chemort-for-a-t1n0m0-adenocarcinoma-of-the-pancreas-s-p-whipples-procedure-with-a-negative-margin weekly 0.8 https://www.themednet.org/can-concurrent-therapy-such-as-abiraterone-or-enzalutamide-be-given-safely-with-radium-223 weekly 0.8 https://www.themednet.org/what-is-the-recommended-duration-of-withholding-remicade-infliximab-during-after-radiation-therapy weekly 0.8 https://www.themednet.org/should-itv-be-an-expansion-from-gtv-or-ctv weekly 0.8 https://www.themednet.org/would-you-treat-the-brain-with-radiation-or-chemotherapy-alone-for-for-post-transplant-lymphoproliferative-disorder-with-cns-involvement weekly 0.8 https://www.themednet.org/is-there-any-increase-in-toxicity-when-giving-stereotactic-radiosurgery-in-patients-with-crest-syndrome-or-other-collagen-vascular-diseases weekly 0.8 https://www.themednet.org/what-therapeutic-approach-is-preferred-for-an-operable-patient-with-n1-bladder-cancer weekly 0.8 https://www.themednet.org/what-margin-would-you-use-for-adjuvant-radiation-of-osteosarcoma-of-the-lumbar-spine-l5 weekly 0.8 https://www.themednet.org/what-are-the-patient-and-disease-factors-that-help-you-determine-if-allogeneic-bone-marrow-transplantation-should-be-performed-in-first-complete-remission-after-standard-induction-chemotherapy-for-acute-myeloid-leukemia weekly 0.8 https://www.themednet.org/when-treating-pt3-bladder-cancer-adjuvantly-with-negative-margins-do-you-include-the-cystectomy-bed weekly 0.8 https://www.themednet.org/what-dose-csi-would-you-give-to-a-6-yo-with-relapsed-aml-in-the-cns weekly 0.8 https://www.themednet.org/is-adjuvant-chemotherapy-and-or-radiation-required-for-localized-acinic-cell-carcinoma-of-the-breast-after-breast-conservation-surgery weekly 0.8 https://www.themednet.org/what-treatment-would-you-recommend-for-a-patient-with-metastatic-colorectal-cancer-whose-tumor-is-kras-wt-and-braf-v600e-positive weekly 0.8 https://www.themednet.org/what-is-the-role-of-autologous-stem-cell-rescue-in-blastoid-variant-mantle-cell-lymphoma weekly 0.8 https://www.themednet.org/what-is-the-preferred-imaging-modality-for-assessing-tumor-response-after-palliative-radiation-to-the-bone weekly 0.8 https://www.themednet.org/what-is-the-role-of-c-11-imaging-in-the-setting-of-confirmed-or-suspected-recurrent-prostate-cancer weekly 0.8 https://www.themednet.org/in-what-situations-do-you-request-bladder-mapping-prior-to-treating-a-bladder-cancer-patient-with-radiation weekly 0.8 https://www.themednet.org/which-immunotherapy-option-do-you-use-for-first-line-therapy-in-a-new-patient-with-metastatic-melanoma weekly 0.8 https://www.themednet.org/do-you-use-alkaline-phosphatase-levels-to-help-your-clinical-decision-making-in-castrate-resistant-prostate-cancer weekly 0.8 https://www.themednet.org/do-you-change-the-dose-to-the-ptv-for-sarcoma-depending-on-proximity-to-normal-structures-such-as-a-joint-or-the-femoral-neck weekly 0.8 https://www.themednet.org/for-prostate-sbrt-what-bladder-and-bowel-prep-strategy-do-you-use weekly 0.8 https://www.themednet.org/what-dosimetric-parameters-do-you-use-for-avoidance-of-the-urinary-diversion-when-treating-post-operative-bladder-cancer weekly 0.8 https://www.themednet.org/what-imaging-to-you-use-to-follow-younger-breast-cancer-patients-with-heterogeneously-dense-breast-tissue weekly 0.8 https://www.themednet.org/when-do-you-give-systemic-chemotherapy-in-addition-to-haart-to-patients-with-aids-associated-pulmonary-kaposi-sarcoma weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-prefer-to-go-on-tpn-rather-than-have-a-peg-tube-placed-for-treatment-related-anorexia-in-head-and-neck-cancers weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-gist-who-has-progressed-on-all-approved-targeted-therapies-imatinib-sunitinib-regorafenib weekly 0.8 https://www.themednet.org/how-do-you-choose-second-line-treatment-for-patients-with-metastatic-renal-cell-carcinoma-after-progression-on-anti-angiogenic-therapy weekly 0.8 https://www.themednet.org/is-there-comparative-data-for-tors-versus-definitive-rt-for-a-t2-node-negative-supraglottic-cancer weekly 0.8 https://www.themednet.org/in-a-patient-with-relapsed-oligometastatic-colorectal-cancer-after-initial-resection-how-would-you-approach-chemotherapy-with-the-goal-of-conversion-to-resectability weekly 0.8 https://www.themednet.org/what-are-the-indications-for-adjuvant-rt-in-yolk-sac-tumor-presenting-in-the-cervical-lymph-nodes weekly 0.8 https://www.themednet.org/what-is-the-treatment-volume-recommended-for-a-patient-with-dedifferentiated-liposarcoma-of-the-spermatic-cord-with-positive-margins weekly 0.8 https://www.themednet.org/what-are-your-thoughts-on-the-comparative-efficacy-of-pcv-versus-temodar-in-patients-undergoing-combined-modality-treatment-for-low-grade-glioma weekly 0.8 https://www.themednet.org/when-if-ever-might-you-recommend-adjuvant-prostate-fossa-rt-in-a-high-risk-patient-with-bone-metastases weekly 0.8 https://www.themednet.org/is-there-a-role-for-organ-targeted-radiation-therapy-such-as-selective-internal-radiation-therapy-sirt-with-radiation-microspheres-in-the-first-line-setting-for-oligometastatic-colorectal-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-acute-radiation-toxicity-in-and-around-the-orbit-i-e-conjunctivitis-dermatitis-and-excessive-tearing weekly 0.8 https://www.themednet.org/what-is-your-algorithm-for-offering-active-surveillance-protocol-for-low-risk-patients-who-qualify-for-as-as-per-nccn-guidelines weekly 0.8 https://www.themednet.org/which-second-line-tki-would-you-choose-for-a-cml-relapse-showing-a-e450a-mutation weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-intrathoracic-esophageal-cancers-with-cervical-lymph-node-metastases weekly 0.8 https://www.themednet.org/what-is-the-most-appropriate-adjuvant-treatment-for-a-gbm-in-a-young-patient-50-with-a-poor-performance-status-ecog-3-4 weekly 0.8 https://www.themednet.org/what-is-your-approach-when-treating-a-craniopharyngioma-definitively-with-radiation weekly 0.8 https://www.themednet.org/how-do-you-consent-patients-about-risk-of-tinnitus-with-radiation-in-and-around-the-inner-ear weekly 0.8 https://www.themednet.org/in-a-patient-with-a-large-low-grade-glioma-and-difficult-to-control-seizures-or-neurological-symptoms-is-there-any-evidence-that-treatment-with-radiation-will-reduce-the-symptom-burden-or-would-you-inform-your-patient-it-will-cause-further-progression-of- weekly 0.8 https://www.themednet.org/do-you-treat-gliomatosis-cerebri-type-1-differently-than-type-2 weekly 0.8 https://www.themednet.org/what-clinical-radiographic-and-or-laboratory-assessments-do-you-use-to-make-the-decision-between-hipec-or-systemic-chemotherapy-in-appendiceal-adenocarcinoma-after-aggressive-surgical-debulking weekly 0.8 https://www.themednet.org/how-do-you-address-a-possible-contamination-of-an-adjacent-or-distant-site-during-surgical-resection-with-radiation-therapy weekly 0.8 https://www.themednet.org/how-do-you-advise-your-patients-about-alcohol-intake-during-radiotherapy weekly 0.8 https://www.themednet.org/for-patients-with-stage-iii-rectal-cancer-who-undergo-resection-without-neoadjuvant-chemoradiation-do-you-use-adjuvant-chemoradiation-or-chemotherapy weekly 0.8 https://www.themednet.org/what-is-your-objective-staging-and-approach-for-nsclc-with-a-pet-avid-internal-mammary-lymph-node weekly 0.8 https://www.themednet.org/what-strategies-do-you-use-for-patients-who-have-a-difficult-time-tapering-off-steroids weekly 0.8 https://www.themednet.org/what-are-effective-ways-to-utilize-physician-extenders-pas-nps-etc-in-radiation-oncology weekly 0.8 https://www.themednet.org/how-do-you-approach-prolonged-radiation-treatment-breaks-i-e-1-week-for-patients-with-benign-cns-tumors weekly 0.8 https://www.themednet.org/is-bulky-regional-lymphadenopathy-a-contraindication-for-sbrt-in-unresectable-pancreatic-cancer weekly 0.8 https://www.themednet.org/what-is-the-appropriate-target-volume-for-a-transformed-glioma-in-a-contralateral-brain-lobe-to-a-previous-low-grade-glioma-treated-with-resection-alone weekly 0.8 https://www.themednet.org/which-chemotherapy-do-you-offer-patients-with-high-risk-low-grade-gliomas weekly 0.8 https://www.themednet.org/can-steroids-be-given-to-patients-after-srs-who-are-receiving-anti-pd1-therapy-without-compromising-its-efficacy weekly 0.8 https://www.themednet.org/are-there-any-special-considerations-when-treating-a-patient-who-has-active-hidradenitis-suppurativa-with-pelvic-radiotherapy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-regarding-the-risk-benefit-ratio-of-radiation-therapy-for-secretory-pituitary-adenomas-given-high-rates-of-hypopituitarism-with-treatment weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-metastatic-prostate-cancer-who-do-not-achieve-or-who-are-later-found-not-to-have-castration-testosterone-levels-on-gnrh-agonists weekly 0.8 https://www.themednet.org/what-is-a-good-radiation-dose-for-recurrent-dupuytrens-contracture weekly 0.8 https://www.themednet.org/how-would-you-approach-salvage-radiation-therapy-for-an-ocular-only-recurrence-of-primary-cns-lymphoma-in-a-patient-that-has-no-prior-history-of-wbrt weekly 0.8 https://www.themednet.org/what-adjuvant-endocrine-therapy-would-you-recommend-for-patients-who-have-undergone-prior-gastrectomy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-indolently-progressing-metastatic-esthesioneuroblastoma weekly 0.8 https://www.themednet.org/is-there-a-role-for-radiation-to-visceral-metastasis-for-patients-with-castrate-resistant-prostate-cancer-after-a-definitive-therapy weekly 0.8 https://www.themednet.org/are-you-seeing-a-different-set-of-toxicities-in-patients-treated-with-immune-check-point-inhibitors-for-hematologic-malignancies-vs-solid-organ-maligancies weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-options-for-patients-with-metastatic-colorectal-cancer-with-leptomeningeal-disease weekly 0.8 https://www.themednet.org/would-you-offer-palliative-radiation-to-a-patient-with-sle-and-symptomatic-bone-metastases weekly 0.8 https://www.themednet.org/would-you-use-prophylactic-intrathecal-chemotherapy-in-a-patient-with-large-nasopharyngeal-mantle-cell-lymphoma-with-low-mipi-score weekly 0.8 https://www.themednet.org/do-you-ever-use-supplements-such-as-pomi-t-in-clinical-practice-https-www-ncbi-nlm-nih-gov-pubmed-24614693 weekly 0.8 https://www.themednet.org/what-is-your-approach-for-a-patient-with-clinical-node-positive-bladder-cancer-undergoing-definitive-crt weekly 0.8 https://www.themednet.org/when-would-you-consider-hepatic-intraarterial-chemotherapy-following-resection-of-liver-metastases-from-colon-cancer-assuming-no-other-disease-present-and-the-center-surgeon-has-sufficient-expertise weekly 0.8 https://www.themednet.org/outside-of-toxicity-under-what-circumstances-if-any-would-you-consider-removing-bleomycin-from-abvd-regimen-for-a-patient-being-treated-for-advanced-stage-hodgkins weekly 0.8 https://www.themednet.org/what-are-the-treatment-options-for-relapsed-cd30-positive-diffuse-large-b-cell-lymphoma-after-a-previous-complete-response-to-dose-adjusted-r-epoch-in-the-elderly weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-micrometastases-in-the-sentinel-lymph-node-in-patients-with-melanoma weekly 0.8 https://www.themednet.org/how-do-you-approach-rt-treatment-for-enlarged-seminal-vesicles-on-ct-in-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-severe-constipation-in-a-patient-undergoing-head-and-neck-radiation-who-can-only-tolerate-a-liquid-diet weekly 0.8 https://www.themednet.org/what-factors-lead-you-to-offer-non-ablative-but-still-aggressive-palliative-radiation-i-e-something-between-standard-palliative-and-sbrt-regimens-to-patients weekly 0.8 https://www.themednet.org/how-would-you-approach-a-dedifferentiated-liposarcoma-of-the-spermatic-cord-that-was-diagnosed-by-trans-scrotal-excision weekly 0.8 https://www.themednet.org/what-role-does-functional-mri-have-in-intracranial-radiotherapy-planning weekly 0.8 https://www.themednet.org/how-do-you-approach-synchronous-metastatic-colon-cancer-and-stage-iii-nsclc weekly 0.8 https://www.themednet.org/what-are-your-criteria-for-treating-a-patient-with-emergent-palliation-without-any-preliminary-pathology weekly 0.8 https://www.themednet.org/when-do-most-cml-patients-in-a-cmr-relapse-after-discontinuing-imatinib-if-they-are-going-to-relapse-at-all-in-addition-to-prior-depth-of-response-does-time-in-remission-play-a-role weekly 0.8 https://www.themednet.org/how-do-you-manage-te-fistula-formation-after-definitive-chemoradiation-for-locally-advanced-lung-cancer weekly 0.8 https://www.themednet.org/how-do-you-select-modify-treatment-for-elderly-85-year-old-patients-with-newly-diagnosed-advanced-dlbcl weekly 0.8 https://www.themednet.org/following-immunotherapy-induced-pneumonitis-when-would-you-feel-comfortable-re-challenging-the-patient-with-immunotherapy weekly 0.8 https://www.themednet.org/how-do-you-diagnose-and-monitor-the-severity-of-drug-induced-pneumonitis weekly 0.8 https://www.themednet.org/do-you-take-any-special-precautions-when-prescribing-immunotherapy-in-a-patient-with-a-history-of-radiation-or-medication-related-pneumonitis weekly 0.8 https://www.themednet.org/what-is-the-best-first-line-systemic-therapy-for-a-colorectal-cancer-patient-with-peritoneal-metastatic-disease weekly 0.8 https://www.themednet.org/would-you-consider-use-of-tumor-mutational-burden-as-a-surrogate-for-pembrolizumab-effectiveness-in-patients-with-msi-stable-advanced-cancers weekly 0.8 https://www.themednet.org/what-is-the-utility-of-prostatic-acid-phosphatase-pap-in-addition-to-psa-in-following-prostate-cancer-post-radiation-therapy weekly 0.8 https://www.themednet.org/is-mccune-albright-syndrome-a-contraindication-for-radiotherapy weekly 0.8 https://www.themednet.org/what-is-the-longest-acceptable-interval-of-treatment-interruption-the-number-of-days-including-a-weekend-during-a-partial-breast-hdr-course weekly 0.8 https://www.themednet.org/how-would-you-sequence-the-care-of-a-patient-with-synchronous-presentation-of-unresectable-stage-3-squamous-cell-lung-cancer-and-a-resected-stage-3-colon-cancer weekly 0.8 https://www.themednet.org/what-are-the-practical-pros-and-cons-of-using-subcutaneous-vs-intravenous-rituximab weekly 0.8 https://www.themednet.org/once-you-have-determined-a-patient-needs-primary-cns-prophylaxis-based-on-their-highly-aggressive-lymphoma-what-do-you-typically-choose-for-prophylaxis weekly 0.8 https://www.themednet.org/for-patients-with-classical-hodgkins-lymphoma-patients-with-poor-a-ps-but-who-would-still-like-treatment-but-without-any-specific-drug-contraindications-would-you-use-a-single-novel-agent-in-the-upfront-setting-i-e-brentuximab-vedotin-or-a-modified-chemot weekly 0.8 https://www.themednet.org/what-is-your-algorithm-for-approaching-persistent-cough-in-nsclc-patients weekly 0.8 https://www.themednet.org/do-you-use-anti-pdl1-antibodies-off-label-and-off-study-for-patients-with-relapsed-refractory-diffuse-large-b-cell-lymphoma-who-are-not-clinical-trial-or-transplant-candidates weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-unresectable-hepatitis-c-virus-related-hepatocellular-cancer-that-did-not-respond-to-initial-locoregional-treatment weekly 0.8 https://www.themednet.org/would-you-make-any-adjustments-to-the-timing-and-delivery-of-chemoradiation-for-locally-advanced-lung-cancer-in-a-patient-with-lupus weekly 0.8 https://www.themednet.org/do-you-ever-offer-concurrent-chemotherapy-or-targeted-agents-for-unresectable-sarcoma weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-initially-unresectable-non-metastatic-acinar-pancreatic-carcinoma weekly 0.8 https://www.themednet.org/do-you-have-an-age-cutoff-for-healthy-men-with-prostate-cancer-below-which-you-will-not-offer-hypofractionated-rt-moderate-hypofrac-or-sbrt-given-the-shorter-follow-up-with-these-techniques weekly 0.8 https://www.themednet.org/are-there-data-to-guide-sequencing-of-immunotherapy-agents-after-progression-on-a-pd-1-l1-inhibitor weekly 0.8 https://www.themednet.org/when-treating-an-ipsilateral-lung-metastasis-3-5-years-following-chest-wall-xrt-for-breast-cancer-how-are-dose-constraints-modified weekly 0.8 https://www.themednet.org/how-do-you-manage-chemotherapy-induced-thrombocytopenia-in-patients-who-have-prolonged-platelet-count-recovery weekly 0.8 https://www.themednet.org/do-you-use-combination-therapy-with-nintedanib-and-nerandomilast-in-patients-with-idiopathic-pulmonary-fibrosis-ipf-who-have-been-clinically-stable-on-nintedanib-for-more-than-six-months weekly 0.8 https://www.themednet.org/how-do-you-choose-an-initial-biologic-for-a-patient-with-allergic-type-2-severe-asthma-who-plans-pregnancy-within-6-12-months weekly 0.8 https://www.themednet.org/in-a-patient-with-remote-history-of-dvt-during-pregnancy-who-is-later-found-with-a-weak-thrombophilia-such-as-heterozygous-fvl-would-you-consider-restarting-anticoagulation weekly 0.8 https://www.themednet.org/how-do-you-approach-second-line-therapy-for-patients-with-pd-l1-positive-metastatic-tnbc-after-progression-on-sacituzumab-govitecan-pembrolizumab weekly 0.8 https://www.themednet.org/how-do-you-prevent-diarrhea-in-a-patient-receiving-sacituzumab-govitecan weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-pah-on-intermediate-to-high-dose-of-oral-treprostinil-who-presents-with-missed-doses-but-is-not-in-shock weekly 0.8 https://www.themednet.org/what-is-your-strategy-for-medication-tapering-in-your-patients-with-relapsing-polychondritis-who-have-no-ongoing-inflammatory-disease weekly 0.8 https://www.themednet.org/do-you-screen-all-patients-with-resistant-htn-those-requiring-multiple-agents-to-achieve-goal-bp-for-primary-aldosteronism-if-not-how-do-you-decide-who-to-screen weekly 0.8 https://www.themednet.org/do-you-prefer-cefepime-over-piperacillin-tazobactam-for-patients-with-sepsis-given-a-recent-study-suggesting-higher-mortality-with-the-latter weekly 0.8 https://www.themednet.org/for-hospitalized-older-adults-who-are-discharging-to-skilled-nursing-facility-how-do-you-think-through-which-acute-medical-issues-must-be-fully-managed-in-the-hospital-versus-continuing-to-be-managed-in-the-skilled-nursing-facility-setting weekly 0.8 https://www.themednet.org/what-is-your-approach-to-prescribing-high-protein-supplements-in-hospitalized-older-adults weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-polypharmacy-in-older-adults-who-are-admitted-to-the-hospital-for-example-deprescribing-or-consolidating-medications-while-inpatient-vs-deferring-decisions-to-their-outpatient-clinicians weekly 0.8 https://www.themednet.org/how-do-you-prefer-to-address-the-inflammatory-arthritis-component-of-disease-in-a-patient-with-ra-and-ild-who-is-already-on-mycophenolate-for-the-ild weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-ra-who-is-doing-well-on-a-tnf-inhibitor-and-methotrexate-but-develops-non-malignant-necrotic-lung-nodules weekly 0.8 https://www.themednet.org/do-you-have-any-systematic-processes-or-steps-to-approach-challenging-discharge-decisions-regarding-ability-to-return-to-community-living-for-hospitalized-older-adults-with-mild-cognitive-impairment-or-early-dementia-with-concerning-signs-for-functional-d weekly 0.8 https://www.themednet.org/in-frail-older-adults-hospitalized-with-hypernatremia-but-also-have-heart-failure-or-ckd-how-do-you-decide-on-oral-hydration-continuous-or-bolus-iv-fluids weekly 0.8 https://www.themednet.org/how-do-you-address-patients-concerns-for-new-side-effects-or-decreased-efficacy-after-transitioning-from-name-brand-to-generic-or-to-a-new-manufacturer-for-a-drug-that-was-already-generic weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-who-needs-a-knee-replacement-with-significant-lymphedema-on-the-affected-side weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-use-of-point-of-care-ultrasound-in-the-management-of-a-hospitalized-patient-with-decompensated-liver-disease weekly 0.8 https://www.themednet.org/when-a-patient-undergoes-a-chest-ct-for-other-causes-and-the-report-incidentally-shows-moderate-or-severe-coronary-artery-calcification-how-do-you-incorporate-that-finding-into-your-approach-to-preventative-care weekly 0.8 https://www.themednet.org/given-the-known-efficacy-of-pirtobrutinib-after-failure-on-other-btk-inhibitors-would-you-have-any-concerns-about-using-pirtobrutinib-as-an-initial-treatment-e-g-in-trials-cll-313-cll-314 weekly 0.8 https://www.themednet.org/how-does-your-institution-manage-node-positive-bladder-cancer-in-the-era-of-ev-pembro-and-how-does-the-approach-differ-between-n1-vs-n2-3 weekly 0.8 https://www.themednet.org/for-patients-with-hfrefand-consitent-sbp-readings-in-the-90s-with-baseline-ckd-and-borderline-elevated-k-within-the-high-5-range-how-do-you-prioritize-which-medications-to-uptitrate-for-gdmt-when-bp-labs-renal-function-provide-limitations weekly 0.8 https://www.themednet.org/how-should-a-cac-score-of-350-influence-risk-stratification-and-preventive-strategy-intensity-in-an-asymptomatic-primary-prevention-patient-with-borderline-to-intermediate-ascvd-risk weekly 0.8 https://www.themednet.org/have-you-been-able-to-obtain-outpatient-octreotide-for-chronic-or-recurrent-gi-bleeding-and-if-so-what-strategies-do-you-recommend-for-getting-it-approved weekly 0.8 https://www.themednet.org/how-effective-is-radioactive-iodine-ablation-therapy-for-the-treatment-of-symptomatic-multinodular-goiter-in-patients-who-are-not-surgical-candidates weekly 0.8 https://www.themednet.org/under-what-circumstances-do-you-utilize-a-camera-holder-while-doing-a-transphenonidal-surgery-rather-than-secondary-surgeon-assistance weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-an-endoscopic-discectomy-as-opposed-to-a-tubular-microdiscectomy weekly 0.8 https://www.themednet.org/how-do-you-determine-which-levels-to-utilize-carbon-fiber-screws-for-fixation-when-doing-a-spinal-tumor-resection weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-the-utilization-of-a-supraorbital-approach-through-an-eyebrow-incision weekly 0.8 https://www.themednet.org/when-officially-interpreting-pft-results-is-it-appropriate-to-compare-them-with-older-results-even-though-they-may-have-been-done-on-different-machines-and-during-different-time-periods weekly 0.8 https://www.themednet.org/how-do-you-choose-among-surveillance-early-anticoagulation-or-early-tips-for-cirrhosis-with-stable-partial-portal-vein-thrombosis-with-smv-involvement weekly 0.8 https://www.themednet.org/how-do-you-approach-continuing-versus-deprescribing-long-term-proton-pump-inhibitors-in-patients-with-severe-corpus-atrophy-gim-and-numerous-fundic-gland-polyps-does-the-presence-of-advanced-atrophy-gim-change-your-threshold-to-stop-or-step-down-therapy-o weekly 0.8 https://www.themednet.org/when-you-encounter-gastric-polyp-s-on-egd-what-characteristics-prompt-you-to-test-for-h-pylori weekly 0.8 https://www.themednet.org/how-you-approach-patients-with-muscular-dysfunction-on-anorectal-manometry-who-have-failed-biofeedback-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-continuing-monthly-ivig-therapy-for-a-patient-with-anti-hmg-coa-myopathy-in-remission-but-recent-mi weekly 0.8 https://www.themednet.org/what-inpatient-interventions-meaningfully-prevent-post-hospital-functional-decline-in-older-patients weekly 0.8 https://www.themednet.org/in-light-of-recent-data-suggesting-that-potassium-enriched-salt-substitution-reduces-cardiovascular-events-have-you-reconsidered-implementing-specialized-diets-for-hospitalized-patients-with-hypertension-or-heart-failure weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-give-iv-iron-to-hospitalized-patients-with-concomitant-decompensated-heart-failure-and-iron-deficiency-vs-defer-to-outpatient-management weekly 0.8 https://www.themednet.org/in-vaccinated-outpatients-with-mild-covid-19-which-patients-do-you-still-prescribe-nirmatrelvir-ritonavir weekly 0.8 https://www.themednet.org/when-starting-a-ssri-for-dementia-related-behaviors-in-an-older-adult-patient-how-do-you-counsel-the-patient-family-regarding-the-expected-timing-of-potential-benefits weekly 0.8 https://www.themednet.org/given-the-newest-gina-guidelines-how-do-you-approach-patients-with-asthma-who-are-resistant-to-transitioning-their-prn-saba-to-laba-ics weekly 0.8 https://www.themednet.org/is-it-safe-to-use-estradiol-in-a-patient-who-is-currently-being-treated-with-a-jak-inhibitor weekly 0.8 https://www.themednet.org/in-patients-with-severe-tricuspid-regurgitation-right-ventricular-failure-and-pulmonary-hypertension-is-there-any-role-of-pulmonary-vasodilator-therapy weekly 0.8 https://www.themednet.org/what-is-the-best-treatment-option-for-heds-patient-with-eagle-syndrome-jugular-venous-congestion-due-to-sternocleidomastoid-muscle-compression-and-c1 weekly 0.8 https://www.themednet.org/If-taking-care-of-cancer-patients-in-a-region-with-a-measles-outbreak-what-are-your-recommendations-beyond-titer-checks weekly 0.8 https://www.themednet.org/What-precautions-do-you-take-when-giving-immunotherapy-to-a-patient-with-cystic-fibrosis weekly 0.8 https://www.themednet.org/Do-you-prescribe-GLP-1s-for-weight-gain-from-aromatase-inhibitors weekly 0.8 https://www.themednet.org/when-a-patient-is-admitted-for-another-condition-and-is-incidentally-found-to-have-a-vertebral-compression-fracture-on-ct-imaging-do-you-initiate-inpatient-management-prior-to-discharge-or-defer-evaluation-to-outpatient-care weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-regimen-for-a-patient-with-r-r-cutaneous-t-cell-lymphoma weekly 0.8 https://www.themednet.org/what-practical-workflow-changes-have-been-most-important-for-reliably-implementing-nrp-or-machine-perfusion-at-scale-staffing-timing-and-procurement-logistics-and-what-workarounds-have-actually-reduced-failed-or-delayed-deployments weekly 0.8 https://www.themednet.org/how-would-you-approach-induction-therapy-for-egpa-with-neurological-involvement-in-a-50-year-old-foot-drop-axonal-peripheral-neuropathy-on-emg-but-otherwise-no-evidence-of-gi-renal-cardiovascular-involvement weekly 0.8 https://www.themednet.org/how-do-you-choose-initial-therapy-acid-suppression-vs-low-dose-tricyclic-antidepressant-in-suspected-functional-dyspepsia-with-a-possible-th2-microinflammatory-endotype-after-a-normal-egd weekly 0.8 https://www.themednet.org/in-which-patient-population-s-are-you-routinely-screening-for-hepatitis-c-have-you-expanded-it-to-universal-screening-in-light-of-the-new-guidelines weekly 0.8 https://www.themednet.org/growing-evidence-including-multicenter-data-from-the-clovers-trial-supports-the-safety-of-initiating-vasopressors-through-peripheral-iv-catheters-in-patients-with-sepsis-induced-hypotension-with-roughly-half-of-patients-avoiding-central-line-placement-alt weekly 0.8 https://www.themednet.org/for-older-patients-with-well-controlled-hypertension-and-no-prior-falls-reports-occasional-lightheadedness-on-standing-but-has-no-documented-orthostatic-drops-in-your-office-do-you-back-off-their-antihypertensive-regimen weekly 0.8 https://www.themednet.org/which-patient-population-s-do-you-typically-opt-for-in-home-sleep-study-over-in-lab-for-the-initial-screening weekly 0.8 https://www.themednet.org/what-workup-if-any-would-you-pursue-for-an-incidentally-enlarged-lymph-node-on-exam-in-an-otherwise-asymptomatic-adult weekly 0.8 https://www.themednet.org/when-a-patient-you-have-been-following-for-years-discloses-that-they-have-stopped-taking-a-medication-you-consider-important-but-reports-feeling-better-without-it-how-do-you-respond-clinically weekly 0.8 https://www.themednet.org/do-you-recommend-for-against-use-of-ai-chatbot-companions-to-improve-quality-of-life-for-older-adults-with-cognitive-impairment weekly 0.8 https://www.themednet.org/can-you-use-biologic-in-combination-with-sibeprenlimab-in-a-patient-with-iga-nephropathy-with-inflammatory-arthritis weekly 0.8 https://www.themednet.org/when-do-you-recommend-whole-body-vibration-training-for-gait-training-or-neuro-rehab weekly 0.8 https://www.themednet.org/when-tapering-a-patient-off-chronic-corticosteroids-at-5-mg-daily-what-is-your-usual-approach weekly 0.8 https://www.themednet.org/what-duration-of-clinician-led-total-body-skin-exam-do-you-recommend-for-a-patient-with-stage-ia-melanoma-after-curative-excision-given-persistent-long-term-risk-of-subsequent-primary-melanoma weekly 0.8 https://www.themednet.org/how-do-you-approach-requests-for-clearance-for-renal-transplant-in-a-patient-with-anca-vasculitis-who-is-on-maintenance-rituximab weekly 0.8 https://www.themednet.org/how-would-you-manage-an-elderly-patient-with-pan-who-previously-required-bowel-resection-and-then-develops-mononeuritis-multiplex-on-methotrexate-and-low-dose-prednisone weekly 0.8 https://www.themednet.org/do-you-obtain-baseline-formal-audiology-at-diagnosis-in-your-patients-with-vitiligo-1 weekly 0.8 https://www.themednet.org/have-you-been-billing-with-the-g2211-modifier weekly 0.8 https://www.themednet.org/among-paralyzed-volume-or-pressure-controlled-ventilated-adults-with-refractory-status-asthmaticus-should-extrinsic-peep-be-routinely-applied-minimized-e-g-0-5-cm-h-o-or-titrated-e-g-to-75-80-of-measured-auto-peep weekly 0.8 https://www.themednet.org/in-your-practice-when-managing-critically-ill-patients-how-do-you-decide-between-rapid-sequence-intubation-rsi-and-delayed-sequence-intubation-dsi weekly 0.8 https://www.themednet.org/when-should-genetic-testing-be-pursued-in-a-young-patient-with-severe-predominantly-hand-involving-arthritis-mutilans-in-the-absence-of-psoriasis-or-rheumatoid-arthritis-and-what-genetic-panel-should-be-ordered weekly 0.8 https://www.themednet.org/when-should-one-consider-imaging-for-nail-disorders weekly 0.8 https://www.themednet.org/what-is-you-treatment-approach-for-epilepsia-partialis-continua-epc weekly 0.8 https://www.themednet.org/under-what-clinical-circumstances-do-you-bypass-waiting-for-a-full-48-hour-albumin-response-and-start-hrs-directed-vasoconstrictor-therapy-earlier-because-the-likelihood-of-hrs-aki-is-high weekly 0.8 https://www.themednet.org/how-do-you-determine-a-long-term-home-blood-pressure-monitoring-schedule-for-stable-well-controlled-hypertension-to-minimize-false-positives-while-ensuring-detection-of-significant-issues weekly 0.8 https://www.themednet.org/what-are-your-recommendations-for-natural-light-exposure-in-the-management-of-type-2-diabetes-considering-evidence-from-a-randomized-crossover-trial-showing-metabolic-benefits weekly 0.8 https://www.themednet.org/how-do-you-decide-whether-to-start-vasoconstrictors-at-24-hours-versus-waiting-until-48-hours-in-cirrhosis-with-suspected-hrs-aki-when-creatinine-has-not-improved-after-initial-albumin-but-the-patient-is-hemodynamically-borderline-e-g-low-map-ongoing-diur weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-anti-amyloid-therapies-for-patients-with-one-focal-area-of-superficial-siderosis weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-following-appendicitis-whose-pathology-demonstrates-intraluminal-enterobius-vermicularis weekly 0.8 https://www.themednet.org/which-patients-with-resectable-borderline-resectable-pancreas-adenocarcinoma-are-you-offering-perioperative-paxg-abraxane-cisplatin-capecitabine-gemcitabine weekly 0.8 https://www.themednet.org/if-i-have-an-elderly-81yo-with-a-history-of-pericardial-effusion-causing-pericardial-tamponade-with-hx-peripheral-eosinophilia-panca-1-1280-and-mpo-139-but-no-other-vasculitic-phenomenon-renal-dysfunction-would-you-try-induction-for-egpa-with-steroids-and weekly 0.8 https://www.themednet.org/how-do-you-approach-further-evaluation-in-a-patient-presenting-with-fatigue-and-arthralgias-who-is-found-to-have-low-c3-and-c4-levels-but-has-a-negative-ana-and-otherwise-unremarkable-workup-for-sle-with-overall-low-clinical-suspicion-for-active-rheumatol weekly 0.8 https://www.themednet.org/have-you-noticed-increased-incidence-of-skin-cancers-for-solid-organ-transplant-patients-on-ctla4-inhibitors-ie-belatacept weekly 0.8 https://www.themednet.org/what-is-the-role-of-clinicopathologic-gene-expression-profiling-e-g-cp-gep-merlin-test-in-refining-sentinel-lymph-node-biopsy-decision-making-for-primary-cutaneous-melanoma weekly 0.8 https://www.themednet.org/do-you-treat-non-hiv-infected-patients-who-have-severe-pjp-with-adjunctive-corticosteroids-considering-a-recent-rct-showed-reduction-in-intubation-and-90-day-mortality-without-increasing-adverse-events weekly 0.8 https://www.themednet.org/how-often-do-you-monitor-lfts-when-starting-avacopan weekly 0.8 https://www.themednet.org/do-you-give-prophylactic-antibiotics-routinely-for-your-peritoneal-dialysis-patients-prior-to-screening-colonoscopy-any-other-factors-you-consider-in-that-regard weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-requesting-medications-for-anxiety-or-insomnia-while-hospitalized-in-the-absence-of-an-underlying-anxiety-or-sleep-disorder weekly 0.8 https://www.themednet.org/do-you-recommend-concurrent-hormone-replacement-therapy-in-postmenopausal-women-on-glp1-r-agonist-therapy-for-weight-loss-given-better-cardiometabolic-outcomes weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-anti-amyloid-therapies-for-patients-with-one-focal-area-of-superficial-siderosis-1 weekly 0.8 https://www.themednet.org/do-you-administer-growth-factors-in-patients-on-concurrent-chemoradiation-if-they-becomes-neutropenic weekly 0.8 https://www.themednet.org/what-is-your-preferred-frequency-and-formulation-of-high-dose-topical-corticosteroid-for-rash-involving-a-large-surface-area weekly 0.8 https://www.themednet.org/how-do-you-reconcile-the-herizon-gea01-and-keynote-811-trials-when-determining-treatment-approach-for-metastatic-gastric-ge-adenocarcinoma weekly 0.8 https://www.themednet.org/how-do-you-approach-testosterone-deficiency-in-older-men weekly 0.8 https://www.themednet.org/how-do-you-manage-the-older-patient-with-symptomatic-bradycardia-who-is-on-a-beta-blocker-for-anoter-compelling-indication-such-as-hfre-and-at-what-point-does-the-rhythm-problem-take-precedence-over-the-underlying-indication weekly 0.8 https://www.themednet.org/emerging-data-continue-to-challenge-whether-cpap-meaningfully-reduces-hard-cardiovascular-endpoints-in-sleep-apnea-how-does-this-affect-your-counseling-and-follow-up-intensity-for-patients-who-are-cpap-intolerant-and-does-it-change-how-aggressively-you-pu weekly 0.8 https://www.themednet.org/peripheral-neuropathy-is-an-increasingly-recognized-potential-adverse-effect-of-rapid-significant-weight-loss-including-with-glp-1-receptor-agonists-have-you-encountered-this-much-and-how-does-it-influence-your-use-of-glp1s-if-at-all weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-who-are-hesitant-to-undergo-regular-mammography-because-they-fear-that-mammography-will-increase-their-cancer-risk weekly 0.8 https://www.themednet.org/for-metastatic-intermediate-grade-idc-that-is-strongly-er-pr-91-100-her2-low-with-modest-ki67-20-30-with-neuroendocrine-differentiation-and-symptomatic-visceral-crisis-would-someone-choose-chemo-rather-than-ai-with-cdk4-6-inhibitor-as-per-standard-just-be weekly 0.8 https://www.themednet.org/what-factors-guide-your-decision-to-de-escalate-empiric-anti-mrsa-or-anti-pseudomonas-coverage-by-day-3-4-in-patients-with-community-acquired-sepsis-and-no-microbiologic-evidence-of-these-pathogens weekly 0.8 https://www.themednet.org/what-is-the-radiological-difference-between-caa-ri-and-abra-1 weekly 0.8 https://www.themednet.org/in-patients-with-disorders-of-gut-brain-interaction-that-fail-trial-of-neuromodulator-is-there-any-utility-in-trying-a-different-neuromodulator-or-adding-an-additional-one weekly 0.8 https://www.themednet.org/when-is-brain-biopsy-indicated-for-a-patient-suspected-to-have-an-atypical-presentation-of-multiple-sclerosis weekly 0.8 https://www.themednet.org/would-you-consider-giving-a-second-course-of-romosuzab-in-a-patient-with-severe-osteoporosis-who-completed-a-year-of-romosuzab-a-year-ago-but-still-has-severe-osteoporosis-t-score-4-5-from-4-8-previously-and-cannot-tolerate-any-other-osteoporosis-medicati weekly 0.8 https://www.themednet.org/Should-additional-imaging-or-ctDNA-surveillance-be-considered-for-triple-negative-breast-cancer-patients-who-did-not-attain-pCR-after-neoadjuvant-chemotherapy-and-immunotherapy weekly 0.8 https://www.themednet.org/in-patients-with-suspected-or-confirmed-igg4-related-disease-how-should-clinicians-evaluate-and-manage-potential-coronary-artery-involvement weekly 0.8 https://www.themednet.org/should-we-consider-checking-il-6-levels-in-patients-with-pmr weekly 0.8 https://www.themednet.org/do-you-prefer-ct-sinus-or-nasal-endoscopy-when-evaluating-for-nasal-polyp-disease weekly 0.8 https://www.themednet.org/patient-with-stage-1-rectal-adenocarcinoma-mmrp-treated-surgically-developed-recurrent-disease-at-anastomosis-site-3-years-after-underwent-resection-that-showed-positive-margin-underwent-concurrent-capecitabine-and-radiation-do-you-follow-that-by-systemic weekly 0.8 https://www.themednet.org/would-you-include-chemotherapy-and-or-bevacizumab-with-immunotherapy-in-patients-with-msi-h-dmmr-metastatic-colon-cancer-based-off-the-commit-trial-results weekly 0.8 https://www.themednet.org/how-should-chronic-hcv-infection-be-treated-in-a-patient-with-acquired-intestinal-failure-from-intestinal-resections-who-requires-tpn-to-maintain-nutrition weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-insulin-in-patients-with-insulin-dependent-diabetes-who-are-nearing-the-end-of-life weekly 0.8 https://www.themednet.org/what-tools-do-you-find-helpful-to-risk-stratify-patients-with-a-family-history-of-breast-cancer-to-assess-if-theyre-appropriate-for-a-genetic-testing-referral weekly 0.8 https://www.themednet.org/do-you-routinely-screen-women-desiring-pregnancy-for-iron-deficiency-anemia-given-the-new-study-suggesting-a-prevalence-of-ida-in-pregnancy-of-upwards-of-10-if-so-do-you-order-just-a-cbc-or-additional-iron-studies weekly 0.8 https://www.themednet.org/do-you-regularly-recommend-your-patients-who-have-atrial-fibrillation-to-avoid-caffeine weekly 0.8 https://www.themednet.org/what-additional-management-workup-if-any-would-you-pursue-if-one-of-your-patients-was-found-to-have-asymptomatic-carotid-artery-stenosis-70-do-you-refer-for-surgical-revascularization-or-just-ensure-vascular-risk-factors-are-managed weekly 0.8 https://www.themednet.org/do-you-initiate-vaginal-estrogen-for-recurrent-uti-prevention-without-a-urology-referral-in-a-postmenopausal-woman-with-no-anatomic-or-structural-risk-factors weekly 0.8 https://www.themednet.org/has-the-hi-pro-trial-changed-your-approach-to-recommending-extended-low-dose-apixaban-after-completing-standard-anticoagulation-for-a-provoked-vte-in-a-patient-with-a-persistent-but-non-malignant-risk-factor weekly 0.8 https://www.themednet.org/what-is-preferred-medical-management-in-patients-with-recurrent-bleeding-despite-ebl-related-to-gave-in-a-patient-that-is-high-risk-for-further-endoscopic-treatment weekly 0.8 https://www.themednet.org/how-do-you-suggesting-incorporating-cardiac-and-or-lung-pocus-into-preoperative-risk-assessment weekly 0.8 https://www.themednet.org/im-looking-for-input-on-a-challenging-case-involving-eosinophilia-with-progressive-neuropathy-i-recently-evaluated-a-26-year-old-with-a-history-of-asthma-who-presented-with-distal-numbness-and-tingling-followed-by-bilateral-foot-drop-and-loss-of-left-plan weekly 0.8 https://www.themednet.org/for-patients-with-hrs-with-significant-lower-limb-edema-and-ascites-do-you-ever-consider-discontinuing-albumin-and-only-continue-terlipressin-considering-risk-of-pulmonary-edema weekly 0.8 https://www.themednet.org/would-you-consider-using-luspatercept-in-a-patient-with-cmml-1-whose-neutropenia-and-thombocytopenia-improved-after-2-cycles-of-hma-but-still-has-symptomatic-anemia-and-is-on-a-therapy-break-until-they-make-a-decision-on-stem-cell-transplant weekly 0.8 https://www.themednet.org/Is-there-any-role-for-mifepristone-in-treating-Type-2-Diabetes weekly 0.8 https://www.themednet.org/What-chemo-is-next-after-Enhertu-in-ER(+)-HER-2low-metastatic-breast-cancer-with-leptomeningeal-involvement.-Pi3kinase(+)-on-NGS.-No-disease-in-the-body weekly 0.8 https://www.themednet.org/for-somatic-rad51d-mutated-castrate-sensitive-metastatic-prostate-cancer-can-you-add-parp-inhibitor-in-first-line-setting-with-an-apri weekly 0.8 https://www.themednet.org/does-cerebral-amyloid-angiopathy-affect-the-interpretation-of-csf-serum-studies-for-alzheimers-dementia-screening weekly 0.8 https://www.themednet.org/have-you-considered-or-used-botox-off-label-to-treat-or-reduce-scar-formation weekly 0.8 https://www.themednet.org/what-specific-side-effects-would-prompt-you-to-stop-teplizumab-tzield-therapy-in-patients-aiming-to-delay-the-onset-of-stage-3-type-1-diabetes-mellitus weekly 0.8 https://www.themednet.org/when-ppsv23-is-not-available-or-feasible-for-evaluation-of-suspected-specific-antibody-deficiency-do-you-use-impaired-protein-antigen-vaccine-responses-in-your-diagnostic-approach weekly 0.8 https://www.themednet.org/what-is-your-next-step-for-a-compound-heterozygous-h63d-c282y-with-a-ferritin-of-1100-tsat-52-who-has-had-poor-luck-cutting-down-on-alcohol-with-persistent-elevation-ast-alt-in-the-200-100s-1 weekly 0.8 https://www.themednet.org/how-are-you-sequencing-menin-inhibitors-eg-revumenib-for-pediatric-patients-with-relapsed-refractory-npm1-mutated-aml weekly 0.8 https://www.themednet.org/do-you-stop-vyvanse-if-an-adolescent-patient-has-increased-intraocular-pressure-at-their-yearly-eye-exam weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-a-pediatric-patient-with-relapsed-histiocytic-sarcoma-after-prior-response-to-a-mek-inhibitor-and-clofarabine weekly 0.8 https://www.themednet.org/do-you-take-biopsies-from-a-normal-looking-terminal-ileum-routinely-if-you-see-endoscopic-evidence-of-active-ulcerative-colitis-on-diagnostic-colonoscopy-done-for-rectal-bleeding weekly 0.8 https://www.themednet.org/do-you-prescribe-slit-in-patients-receiving-on-beta-blockers weekly 0.8 https://www.themednet.org/which-metabolic-tests-are-highest-yield-for-treatable-pediatric-optic-atrophy weekly 0.8 https://www.themednet.org/What-therapy-should-you-institute-at-iop-of-58-after-a-gas-filled-eye-after-vitrectomy weekly 0.8 https://www.themednet.org/should-the-elderly-receive-a-second-covid-vaccination-in-the-spring-of-2026 weekly 0.8 https://www.themednet.org/how-do-you-test-for-immediate-hypersensitivity-to-chlorhexidine weekly 0.8 https://www.themednet.org/national-poison-center-data-from-2015-2023-demonstrate-a-6-7-fold-increase-in-nonfatal-fentanyl-exposures-involving-stimulants-cocaine-or-methamphetamine-highlighting-polysubstance-use-as-the-norm-rather-than-the-exception-how-has-this-evidence-changed-yo weekly 0.8 https://www.themednet.org/in-patients-on-infliximab-when-is-re-loading-dose-preferred-over-resuming-maintenance-dosing-when-there-has-been-a-prolonged-interruption-in-treatment weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-use-of-thickened-liquids-in-a-hospitalized-older-adult-with-swallowing-difficulties weekly 0.8 https://www.themednet.org/do-you-typically-defer-iron-deficiency-treatment-if-pnh-is-uncontrolled-to-reduce-the-risk-of-additional-hemolysis weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-regimen-for-pulmonary-hypertension-associated-with-sarcoidosis weekly 0.8 https://www.themednet.org/would-you-consider-using-infliximab-for-neurosarcoidosis-in-a-patient-with-a-remote-personal-or-family-history-of-demyelinating-disease weekly 0.8 https://www.themednet.org/how-long-do-you-trial-lifestyle-therapy-before-initiating-pharmacologic-treatment-in-a-patient-with-bmi-30-35-without-diabetes weekly 0.8 https://www.themednet.org/do-you-use-corticosteroids-to-treat-postinfectious-inflammatory-response-syndrome-in-a-patient-with-cryptococcal-meningitis-and-non-hiv-related-immunosuppression weekly 0.8 https://www.themednet.org/when-considering-prophylaxis-withdrawal-after-hbv-vaccination-in-liver-transplant-recipients-what-anti-hbs-target-do-you-use-specific-titer-vs-a-functional-immune-measure-and-what-duration-of-stability-do-you-require-given-likely-occult-intrahepatic-hbv-p weekly 0.8 https://www.themednet.org/in-hbv-liver-transplant-recipients-with-current-or-anticipated-exposure-to-immunomodulators-e-g-checkpoint-inhibitors-for-hcc-or-biologics-for-ibd-how-do-you-adjust-candidacy-for-finite-prophylaxis-and-what-virologic-and-immunologic-endpoints-do-you-requi weekly 0.8 https://www.themednet.org/how-does-hbv-hdv-coinfection-after-liver-transplant-change-your-functional-cure-targets-hbsag-loss-anti-hbs-and-your-tolerance-for-residual-hbv-activity-markers-e-g-hbcrag-or-pgrna-compared-with-hbv-monoinfection weekly 0.8 https://www.themednet.org/what-concerns-if-any-do-you-have-with-using-jivi-damoctogog-alfa-peg-in-pediatric-patients-7-12-years-old-with-severe-hemophilia-a weekly 0.8 https://www.themednet.org/how-do-you-evaluate-and-manage-oropharyngeal-mucositis-related-to-chemotherapy-and-radiation weekly 0.8 https://www.themednet.org/how-to-switch-a-patient-from-parenteral-treprostinil-to-oral-treprostinil-in-the-in-patient-setting-prior-to-discharge weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-pursue-liver-transplant-listing-via-a-pld-exception-for-an-adpkd-patient-with-preserved-synthetic-function-but-recurrent-cyst-infections-requiring-hospitalization-despite-appropriate-prolonged-antibiotics-particularly-when-kidney weekly 0.8 https://www.themednet.org/how-do-you-incorporate-tumor-biology-signals-e-g-afp-trajectory-radiographic-growth-kinetics-response-durability-into-a-transplant-benefit-framework-and-when-would-adverse-biology-override-a-high-modeled-benefit-for-transplantation weekly 0.8 https://www.themednet.org/as-first-line-systemic-therapy-outcomes-improve-for-advanced-hcc-e-g-immune-checkpoint-inhibitor-based-combinations-how-would-you-adjust-the-threshold-at-which-you-would-recommend-liver-transplantation-within-a-transplant-benefit-framework weekly 0.8 https://www.themednet.org/do-you-taper-or-stop-avacopan weekly 0.8 https://www.themednet.org/how-would-you-legally-handle-wrong-site-surgery-ie-excision weekly 0.8 https://www.themednet.org/are-there-any-anecdotal-reports-or-has-anyone-used-rebyota-for-fulminant-cdiff-in-a-patient-with-progression-while-on-oral-and-rectal-vancomycin-and-iv-metronidazole weekly 0.8 https://www.themednet.org/has-the-soho-trial-changed-how-you-approach-use-of-high-flow-nasal-cannula-for-initial-oxygen-delivery-in-a-hospitalized-patient-with-acute-hypoxemic-respiratory-failure weekly 0.8 https://www.themednet.org/do-you-still-initiate-a-beta-blocker-at-discharge-after-an-mi-in-a-patient-whose-ejection-fraction-comes-back-50-and-who-has-no-other-indication-for-the-drug-in-light-of-multiple-recent-rcts weekly 0.8 https://www.themednet.org/in-a-patient-with-stage-1-hypertension-130-139-80-89-mmhg-who-has-completed-a-trial-of-lifestyle-modification-but-whose-10-year-prevent-estimated-cvd-risk-is-below-7-5-do-you-initiate-pharmacotherapy-now-or-continue-to-watch weekly 0.8 https://www.themednet.org/n-a-patient-with-well-controlled-hypertension-who-is-now-targeting-an-aspirational-systolic-bp-below-120-mmhg-per-the-2025-aha-acc-guideline-how-do-you-balance-adding-a-medication-against-the-risk-of-falls-syncope-and-worsening-renal-function-in-practice weekly 0.8 https://www.themednet.org/in-an-older-adult-with-hfref-who-meets-criteria-for-an-sglt2-inhibitor-but-has-significant-frailty-recurrent-falls-and-volume-depletion-risk-do-you-initiate-the-medication-and-what-clinical-features-push-you-one-way-or-the-other weekly 0.8 https://www.themednet.org/what-strategy-do-you-find-most-effective-for-starting-goals-of-care-discussions-in-primary-care-with-patients-who-have-a-chronic-progressive-disease-and-or-highly-medicalized-do-you-generally-introduce-it-with-an-advanced-directive-polst-etc weekly 0.8 https://www.themednet.org/if-approved-do-you-have-any-concerns-about-incorporating-gedatolisib-into-the-treatment-landscape-of-hr-her2-pik3ca-wild-type-breast-cancer-viktoria-1 weekly 0.8 https://www.themednet.org/how-do-you-approach-long-term-sexual-dysfunction-that-develops-years-after-pelvic-radiation-in-survivors-of-cervical-or-endometrial-cancer weekly 0.8 https://www.themednet.org/management-of-distal-extremity-epithelioid-sarcoma-amputation-vs-non-functional-limb-salvage-vs-high-dose-rt-exceeding-constraints-in-a-young-patient-with-epithelioid-sarcoma-involving-the-joint-capsule-of-the-elbow-who-underwent-non-oncologic-resection-w weekly 0.8 https://www.themednet.org/long-term-management-of-chronic-fibrotic-hypersensitivity-pneumonitis weekly 0.8 https://www.themednet.org/on-january-16-2026-the-fda-requested-its-voluntary-withdrawal-of-avacopan-due-to-concerns-regarding-clinical-trial-data-and-potential-risks-the-drug-remains-on-the-market-during-ongoing-discussions-are-you-all-still-using-it weekly 0.8 https://www.themednet.org/how-does-biliary-pocus-compare-to-ct-for-detecting-gallstones weekly 0.8 https://www.themednet.org/for-patients-with-evidence-of-csph-small-varices-or-noninvasive-csph-markers-who-also-have-imaging-only-grade-1-ascites-do-you-start-a-nonselective-beta-blocker-as-primary-prophylaxis-against-first-overt-decompensation-or-do-you-consider-ascites-itself-as weekly 0.8 https://www.themednet.org/how-do-you-decide-on-long-term-nucleos-t-ide-therapy-vs-intensified-masld-management-monitoring-in-an-hbeag-negative-indeterminate-phase-patient-with-mildly-elevated-fluctuating-alt-low-level-hbv-dna-and-borderline-vcte-stiffness-around-8-kpa-where-masld- weekly 0.8 https://www.themednet.org/after-hbsag-loss-in-a-noncirrhotic-patient-with-prior-long-term-nucleos-t-ide-therapy-and-a-first-degree-family-history-of-hcc-do-you-ever-stop-hcc-surveillance-and-if-so-what-risk-tool-or-threshold-age-at-seroclearance-fibrosis-markers-metabolic-risk-det weekly 0.8 https://www.themednet.org/how-would-you-approach-chemotherapy-regimen-in-neoadjuvant-or-adjuvant-setting-for-poorly-differentiated-breast-neuroendocrine-carcinoma-br-nec-platinum-etoposide-ep-or-ac-t-would-further-histologic-classification-small-cell-nec-large-cell-nec-or-biomarke weekly 0.8 https://www.themednet.org/how-do-you-counsel-older-adult-patients-regarding-dietary-choices-in-order-to-prevent-cognitive-decline-or-dementia weekly 0.8 https://www.themednet.org/how-do-you-approach-motion-management-target-margin-expansion-and-dose-constraints-when-delivering-single-fraction-25-gy-stereotactic-arrhythmia-radiation-therapy-for-refractory-vtach weekly 0.8 https://www.themednet.org/in-children-who-require-cranial-irradiation-how-do-you-balance-scalp-sparing-against-target-coverage-in-light-of-a-permanent-alopecia-risk-around-21-gy weekly 0.8 https://www.themednet.org/how-do-you-proceed-with-a-referral-for-chronic-diarrhea-with-a-low-stool-elastase weekly 0.8 https://www.themednet.org/do-children-living-in-yellow-fever-endemic-areas-vaccinated-prior-to-age-2-need-to-be-revaccinated-and-at-what-age weekly 0.8 https://www.themednet.org/do-you-recommend-the-use-of-the-mody-online-calculator-to-determine-which-patients-would-benefit-from-screening-for-monogenic-diabetes weekly 0.8 https://www.themednet.org/how-do-you-manage-reactive-arthritis-refractive-to-high-dose-steroids-this-occurred-after-a-uti-with-recurrent-large-bilateral-knee-effusions-what-about-reactive-sacroillitis-patient-is-hla-b27-positive weekly 0.8 https://www.themednet.org/in-an-otherwise-healthy-69yo-with-l-spine-t-score-3-0-and-no-history-of-fragility-fractures-would-you-treat-with-anabolic-agent-or-bisphosphonate-prolia weekly 0.8 https://www.themednet.org/how-do-you-interpret-the-phase-1-results-of-the-enzalutamide-delivery-implant-enolen-for-low-to-intermediate-risk-localized-prostate-cancer weekly 0.8 https://www.themednet.org/how-do-you-approach-screening-your-patients-who-may-benefit-from-doxypep-or-hiv-prep weekly 0.8 https://www.themednet.org/what-do-you-include-in-differential-diagnosis-in-a-patient-presenting-with-parotid-gland-enlargement weekly 0.8 https://www.themednet.org/what-do-you-include-in-differential-diagnosis-when-evaluating-a-patient-with-calcinosis-cutis weekly 0.8 https://www.themednet.org/what-has-been-your-experience-with-xdemvy weekly 0.8 https://www.themednet.org/how-do-you-approach-a-denial-for-dototate-pet-for-a-1-5-cm-g3-net-of-gastric-body-with-favorable-histology-when-an-alternate-imaging-modality-of-mri-ctap-has-been-suggested-first-do-you-consider-eus-alternate-supplemental-or-complementary-in-these-cases-h weekly 0.8 https://www.themednet.org/how-do-you-assess-for-specific-antibody-deficiency-when-the-patient-has-recently-received-the-pcv20-vaccine weekly 0.8 https://www.themednet.org/do-you-avoid-use-of-mycophenolate-in-patients-with-a-history-of-diverticulitis weekly 0.8 https://www.themednet.org/has-the-recent-nejm-trial-showing-noninvasive-blood-pressure-monitoring-was-noninferior-to-arterial-catheters-in-patients-with-early-shock-changed-your-threshold-for-placing-an-arterial-line-in-a-hemodynamically-unstable-patient-on-the-floor-or-step-down- weekly 0.8 https://www.themednet.org/when-a-patients-blood-pressure-runs-lower-than-their-baseline-throughout-a-hospitalization-for-an-acute-illness-how-do-you-approach-their-antihypertensive-regimen-at-discharge weekly 0.8 https://www.themednet.org/have-the-updated-iarc-recommendations-on-population-level-h-pylori-screen-and-treat-for-gastric-cancer-prevention-changed-how-you-think-about-testing-asymptomatic-patients-in-your-practice-particularly-those-from-higher-risk-populations weekly 0.8 https://www.themednet.org/is-there-a-role-for-glp-1-receptor-agonists-to-reduce-thirst-in-patients-with-esrd-or-chf-who-struggle-with-fluid-restriction weekly 0.8 https://www.themednet.org/which-biologic-for-asthma-is-most-preferred-irrespective-of-asthma-phenotype weekly 0.8 https://www.themednet.org/how-have-you-adjusted-your-clozapine-prescribing-and-monitoring-practices-in-response-to-changes-in-rems-requirements weekly 0.8 https://www.themednet.org/for-t1-2n0-low-lying-rectal-cancers-when-would-you-consider-chemort-versus-tnt-instead-of-upfront-surgery weekly 0.8 https://www.themednet.org/how-has-the-ajcc-9th-edition-staging-system-for-lung-cancer-changed-your-day-to-day-practice weekly 0.8 https://www.themednet.org/in-aml-patients-developing-acute-respiratory-failure-shortly-after-induction-chemotherapy-with-a-falling-blast-count-how-often-is-leukemic-cell-lysis-pneumopathy-the-cause-and-how-do-you-manage-these-cases weekly 0.8 https://www.themednet.org/how-do-you-approach-common-drugs-like-furosemide-thiazide-mesalamine-acei-statins-with-index-and-recurrent-pancreatitis-how-much-do-you-consider-investigating-into-the-underlying-etiology-before-considering-discontinuation-of-these-important-drugs-for-the weekly 0.8 https://www.themednet.org/has-the-frail-af-trial-which-found-that-switching-frail-older-patients-with-atrial-fibrillation-from-warfarin-to-a-doac-was-associated-with-more-bleeding-rather-than-less-changed-how-you-approach-this-transition-in-your-frailest-patients-on-well-controlle weekly 0.8 https://www.themednet.org/how-does-psma-scan-affect-decision-to-start-docetaxel-chemotherapy-in-castrate-sensitive-metastatic-prostate-cancer-based-on-chaarted-results weekly 0.8 https://www.themednet.org/what-is-your-approach-to-appetite-stimulation-in-hospitalized-patient-who-are-not-achieving-sufficient-caloric-intake weekly 0.8 https://www.themednet.org/when-do-you-consider-starting-an-ssri-or-similar-medication-for-mdd-or-gad-during-a-hospitalization weekly 0.8 https://www.themednet.org/how-do-you-make-a-selection-between-anorectal-manometry-and-mr-defecography-in-a-patient-with-suspected-pelvic-floor-dysfunction weekly 0.8 https://www.themednet.org/can-fracture-of-wrist-not-requiring-surgery-cause-significant-elevation-of-inflammatory-markers-like-esr-and-crp-more-than-120s weekly 0.8 https://www.themednet.org/how-soon-do-we-expect-a-response-in-egpa-main-manifestations-are-mononeuritis-multiplex-esr-crp-highly-elevated-100-after-induction-therapy-with-rituximab-how-do-you-go-about-transitioning-to-maintenance-therapy-for-egpa weekly 0.8 https://www.themednet.org/what-is-your-approach-to-incorporating-liver-surveillance-into-routine-follow-up-for-long-term-survivors-of-previously-treated-pediatric-high-risk-neuroblastoma weekly 0.8 https://www.themednet.org/how-does-checking-genotype-help-in-treatment-of-hep-c-with-cirrhosis-when-do-you-consider-checking-genotype-in-chronic-hep-b weekly 0.8 https://www.themednet.org/how-large-of-polyps-can-you-fulgurate-in-clinic-without-causing-patient-discomfort-during-bladder-cancer-follow-up weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-family-asking-about-expected-penile-size-and-function-in-the-setting-of-epispadias weekly 0.8 https://www.themednet.org/how-do-you-work-up-and-treat-a-young-woman-with-dyspareunia weekly 0.8 https://www.themednet.org/what-dilation-schedule-do-you-have-patients-follow-after-penile-inversion-vaginoplasty weekly 0.8 https://www.themednet.org/what-can-you-do-surgically-for-vaginal-stenosis-after-vaginoplasty weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-bladder-outlet-obstruction-and-urinary-retention-prior-to-undergoing-radiation-for-prostate-cancer weekly 0.8 https://www.themednet.org/what-can-cause-spontaneous-proximal-quadriceps-rupture-in-a76year-old-man weekly 0.8 https://www.themednet.org/is-a-copeptin-level-helpful-in-differentiating-possible-causes-of-hyponatremia weekly 0.8 https://www.themednet.org/Which-modified-Sgarbossa-findings-are-most-specific-in-symptomatic-LBBB weekly 0.8 https://www.themednet.org/how-do-you-go-about-treating-axonal-neuropathy-from-primary-aps weekly 0.8 https://www.themednet.org/how-do-you-decide-a-map-goal-for-a-patient-with-sepsis weekly 0.8 https://www.themednet.org/how-should-rituximab-be-tapered-in-patients-with-neurosarcoidosis-who-are-in-remission weekly 0.8 https://www.themednet.org/do-you-consider-shorter-course-treatment-for-fungal-pyelonephritis-in-patients-with-rapid-clinical-improvement weekly 0.8 https://www.themednet.org/what-would-be-your-approach-to-tapering-off-amitriptyline-50mg-being-used-nightly-chronically-for-insomnia-in-an-older-adult weekly 0.8 https://www.themednet.org/when-initiating-gabapentinoid-for-neuropathic-pain-in-an-older-adult-patient-how-do-you-choose-between-gabapentin-and-pregabalin-and-starting-dose weekly 0.8 https://www.themednet.org/how-do-the-results-of-the-attached-trial-support-or-challenge-your-management-of-subclinical-hypothyroidism-in-older-adult-patients weekly 0.8 https://www.themednet.org/do-you-recommend-repeating-the-bravo-ph-probe-while-on-ppi-or-referring-to-a-center-with-ph-impedance-study-in-a-proven-non-regurgitant-phenotype-of-gerd-who-has-not-had-adequate-relief-to-symptoms-with-appropriate-ppi-trial weekly 0.8 https://www.themednet.org/is-there-any-12-step-desensitization-protocol-for-droxidopa weekly 0.8 https://www.themednet.org/do-you-screen-patients-whose-first-degree-relatives-have-type-1-diabetes-differently-than-the-general-screening-guidelines-if-so-how-frequently-are-you-checking-a1c-do-you-add-on-c-peptide-levels weekly 0.8 https://www.themednet.org/in-which-patient-population-are-you-testing-gad7-znt8-islet-cell-antibodies-c-peptide-levels-for-a-new-diagnosis-of-diabetes weekly 0.8 https://www.themednet.org/for-patients-with-cardiovascular-disease-kidney-disease-and-diabetes-who-also-have-cost-constraints-for-prescription-drugs-what-factors-most-significantly-impact-your-decision-to-favor-sglt2i-versus-glp-1-agonists weekly 0.8 https://www.themednet.org/in-a-patient-with-mucous-membrane-pemphigoid-with-no-ocular-involvement-but-with-evidence-of-abmd-what-ocular-treatment-would-you-recommend-and-how-frequently-would-you-monitor weekly 0.8 https://www.themednet.org/how-if-at-all-are-you-incorporating-microbiome-targeted-nutrition-strategies-into-the-care-of-patients-receiving-cancer-therapy weekly 0.8 https://www.themednet.org/do-you-use-albumin-as-part-of-initial-fluid-resuscitation-in-a-patient-with-septic-shock-who-remains-hypotensive-after-an-initial-crystalloid-bolus weekly 0.8 https://www.themednet.org/if-177lu-edotreotide-compete-is-approved-how-would-you-sequence-therapy-for-patients-with-inoperable-grade-1-grade-2-progressive-sstr-positive-gep-nets weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-about-the-non-specific-nature-of-elevated-esr-and-crp-particularly-when-they-are-concerned-that-these-results-indicate-active-autoimmune-disease weekly 0.8 https://www.themednet.org/for-patients-with-persistent-dyspepsia-but-would-not-be-willing-to-come-off-of-ppi-therapy-do-you-empirically-treat-for-h-pylori-with-the-presence-of-chronic-active-gastritis-how-do-you-document-cure-if-you-treat-in-that-case weekly 0.8 https://www.themednet.org/what-is-your-approach-to-allergy-skin-testing-in-patients-currently-taking-jak-inhibitors weekly 0.8 https://www.themednet.org/after-discharge-for-alcohol-associated-hepatitis-what-minimum-frequency-and-type-of-addiction-focused-contact-do-you-aim-to-ensure-e-g-counseling-program-participation-medication-management-to-meaningfully-reduce-early-return-to-drinking weekly 0.8 https://www.themednet.org/how-do-you-determine-which-patients-with-copd-and-chronic-hypercapnia-should-be-initiated-on-nocturnal-bipap weekly 0.8 https://www.themednet.org/is-there-evidence-for-any-difference-in-outcomes-or-complications-for-patients-with-crohn-ibd-who-receive-low-dose-radiotherapy-for-hip-osteoarthritis weekly 0.8 https://www.themednet.org/what-is-your-radiotherapy-plan-for-a-patient-with-single-metastatic-posterior-liver-dome-nodule-colorectal-primary-s-p-2-partial-hepatectomies-pathology-from-most-recent-liver-resection-notable-for-pni-large-vessel-invasion-tumor-involving-the-adjacent-di weekly 0.8 https://www.themednet.org/do-you-initiate-a-glp-1-receptor-agonist-in-a-patient-with-obesity-who-states-upfront-they-plan-to-discontinue-after-reaching-a-defined-weight-loss-goal weekly 0.8 https://www.themednet.org/does-short-term-steroid-impair-wound-healing weekly 0.8 https://www.themednet.org/would-you-treat-obstruction-in-asymptomatic-patients-with-hocm-with-significant-lvot-gradients-50-mmhg-with-excellent-functional-capacity-if-not-how-would-you-monitor-them weekly 0.8 https://www.themednet.org/do-you-offer-lymph-node-dissection-for-an-isolated-inguinal-nodal-relapse-two-years-post-definitive-concurrent-chemoradiotherapy-for-anal-adenocarcinoma weekly 0.8 https://www.themednet.org/which-vaccine-preventable-infections-do-you-think-neurologists-are-most-likely-to-start-seeing-again weekly 0.8 https://www.themednet.org/do-you-administer-stress-dose-hydrocortisone-during-a-sepsis-hospitalization-for-a-patient-maintained-on-chronic-low-dose-prednisone-10-mg-daily-for-non-adrenal-insufficiency-reasons weekly 0.8 https://www.themednet.org/do-you-routinely-order-melatonin-for-delirium-prevention-in-older-hospitalized-medical-patients-at-high-risk-for-delirium weekly 0.8 https://www.themednet.org/how-do-you-approach-the-decision-to-consult-cardiology-and-pursue-ischemic-workup-for-an-isolated-troponin-elevation-attributable-to-a-non-cardiac-acute-illness-such-as-sepsis-or-acute-respiratory-failure weekly 0.8 https://www.themednet.org/do-you-treat-wet-type-macular-degeneration-if-so-what-dose-and-technique weekly 0.8 https://www.themednet.org/how-do-you-use-ai-in-practice-management-other-than-as-a-scribe weekly 0.8 https://www.themednet.org/at-my-institution-i-frequently-see-ent-perform-non-ultrasound-guided-peritonsillar-abscess-drainage-is-there-any-evidence-to-support-use-of-ultrasound-guided-peritonsillar-abscess-drainage-versus-blind-approach weekly 0.8 https://www.themednet.org/what-have-you-found-to-be-common-reasons-for-missed-diagnosis-or-misdiagnosis-of-obsessive-compulsive-disorder weekly 0.8 https://www.themednet.org/how-might-reframing-parkinsons-disease-as-a-somato-cognitive-action-network-disorder-change-future-therapies weekly 0.8 https://www.themednet.org/how-do-you-plan-to-incorporate-results-from-the-deprescripp-study-investigating-deprescribing-of-proton-pump-inhibitors-into-your-practice weekly 0.8 https://www.themednet.org/what-is-your-approach-to-selection-of-antipsychotic-agent-for-short-term-treatment-of-severe-behavioral-symptoms-in-dementia-in-older-adults-with-prolonged-qtc weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-give-seizure-prophylaxis-after-burr-holes-for-chronic-subdural-hematoma-evacuation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-nerve-palsy-identified-after-an-alif weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-treat-infection-of-a-craniotomy-site-with-antibiotic-treatment-alone-versus-removal-of-bone-flap-and-antibiotics weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-an-open-craniotomy-for-treatment-of-a-colloid-cyst-versus-an-endoscopic-approach weekly 0.8 https://www.themednet.org/in-an-older-adult-man-who-has-recently-undergone-hip-replacement-for-osteoporotic-fracture-how-do-you-decide-between-tramadol-vs-oxycodone-or-another-opioid-for-short-term-pain-management weekly 0.8 https://www.themednet.org/how-do-you-approach-the-decision-of-whether-to-continue-or-cease-psa-screening-for-prostate-cancer-for-older-men weekly 0.8 https://www.themednet.org/how-would-you-approach-consideration-of-initiation-ppi-for-gastric-protection-in-the-setting-of-aspirin-use-for-primary-or-secondary-prevention-among-older-adults-an-intentional-prescribing-cascade weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-biopsy-and-laser-ablation-versus-craniotomy-for-resection-of-new-growth-or-treatment-affect-from-a-resected-glioma weekly 0.8 https://www.themednet.org/in-which-clinical-scenarios-would-you-add-bevacizumab-to-pembrolizumab-paclitaxel-keynote-b96-in-patients-with-pd-l1-positive-platinum-resistant-ovarian-cancer weekly 0.8 https://www.themednet.org/have-you-ever-considered-recommending-berberine-supplementation-to-patients-with-diabetes-or-pre-diabetes-and-are-hesitant-to-start-medications weekly 0.8 https://www.themednet.org/how-do-you-address-strategies-that-support-longevity-with-your-patients-for-example-if-you-the-patient-is-already-up-to-date-on-all-their-age-appropriate-cancer-screenings-and-vaccination-etc weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-inflammatory-arthritis-in-the-setting-of-hereditary-hemochromatosis weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-wanting-to-increase-their-thyroid-medication-or-check-t3-despite-tsh-being-normal-or-even-low-normal-to-target-a-specific-number weekly 0.8 https://www.themednet.org/in-cmv-d-r-liver-transplant-recipients-beyond-the-early-post-transplant-period-who-have-ckd-and-recurrent-leukopenia-but-can-obtain-reliable-weekly-labs-what-specific-thresholds-e-g-cmv-dnaemia-trajectory-absolute-neutrophil-count-patterns-ability-to-resp weekly 0.8 https://www.themednet.org/in-liver-transplant-recipients-on-an-mtor-inhibitor-based-regimen-who-develop-refractory-hypertriglyceridemia-what-triglyceride-level-and-pancreatitis-risk-features-prompt-you-to-change-immunosuppression-dose-reduction-or-switching-off-mtor-inhibition-rat weekly 0.8 https://www.themednet.org/for-liver-transplant-recipients-without-alcohol-use-disorder-who-report-low-level-alcohol-use-post-transplant-what-objective-monitoring-strategy-e-g-phosphatidylethanol-trends-and-liver-injury-fibrosis-assessments-and-escalation-triggers-do-you-use-to-dec weekly 0.8 https://www.themednet.org/in-long-term-liver-transplant-survivors-without-established-cardiovascular-disease-but-with-metabolic-syndrome-what-risk-stratification-tests-e-g-coronary-artery-calcium-lipoprotein-a-microalbuminuria-do-you-utilize-in-your-practice weekly 0.8 https://www.themednet.org/in-older-adults-with-limited-life-expectancy-how-should-clinicians-approach-deprescribing-preventive-medications-such-as-statins-or-aspirin-used-for-primary-prevention weekly 0.8 https://www.themednet.org/for-adults-with-a-remote-history-of-lyme-disease-who-report-persistent-nonspecific-symptoms-fatigue-cognitive-complaints-how-should-primary-care-clinicians-approach-evaluation-and-management-in-the-absence-of-objective-findings weekly 0.8 https://www.themednet.org/in-patients-with-chronic-low-back-pain-without-red-flag-symptoms-what-is-the-role-of-ongoing-imaging-when-symptoms-fluctuate-over-time weekly 0.8 https://www.themednet.org/after-several-years-of-treatment-with-bisphosphonates-for-osteoporosis-how-should-clinicians-determine-the-optimal-timing-and-duration-of-a-drug-holiday weekly 0.8 https://www.themednet.org/for-checkpoint-inhibitor-associated-cholangitis-secondary-sclerosing-cholangitis-what-is-your-clinically-actionable-corticosteroid-trial-algorithm-including-which-imaging-histologic-and-biochemical-response-features-define-steroid-responsiveness-vs-futili weekly 0.8 https://www.themednet.org/do-you-use-different-follow-up-intensity-and-discontinuation-criteria-for-mixed-pattern-r-2-5-versus-cholestatic-pattern-r-2-dili weekly 0.8 https://www.themednet.org/what-minimum-clinical-phenotype-would-make-you-order-targeted-cholestasis-gene-sequencing-e-g-abcb11-abcb4-atp8b1-in-severe-or-prolonged-cholestatic-dili-because-the-result-would-meaningfully-change-management weekly 0.8 https://www.themednet.org/is-there-ongoing-research-in-gbm-treating-the-area-postrema-of-the-brainstem-as-possible-site-for-repopulation-of-cancer-cells weekly 0.8 https://www.themednet.org/do-you-initiate-a-dexmedetomidine-infusion-for-hyperactive-delirium-in-an-older-patient-on-the-general-medicine-ward-who-is-not-otherwise-a-candidate-for-icu-transfer weekly 0.8 https://www.themednet.org/do-you-use-awake-prone-positioning-for-a-non-intubated-patient-with-acute-hypoxemic-respiratory-failure-requiring-high-flow-nasal-cannula weekly 0.8 https://www.themednet.org/do-you-offer-a-levothyroxine-discontinuation-trial-in-older-adults-on-doses-above-50-g-day-when-the-original-indication-was-subclinical-hypothyroidism weekly 0.8 https://www.themednet.org/what-renal-function-threshold-would-change-the-antihistamine-dose weekly 0.8 https://www.themednet.org/how-do-you-manage-low-testosterone-levels-in-men-with-cah-on-steroid-replacement weekly 0.8 https://www.themednet.org/what-factors-would-cause-the-maintenance-glucocorticoid-dose-requirement-to-decrease-in-a-young-adult-female-with-non-classic-cah weekly 0.8 https://www.themednet.org/what-endoscopic-findings-on-nbi-exam-help-with-targeted-biopsies-for-dysplasia-surveillance-in-ibd-patients weekly 0.8 https://www.themednet.org/What-are-the-indications-for-interventions-in-asymptomatic-patients-with-carotid-artery-atherosclerosis weekly 0.8 https://www.themednet.org/which-patients-will-benefit-from-referring-them-to-a-center-with-pancreatic-function-tests weekly 0.8 https://www.themednet.org/in-pregnant-liver-transplant-recipients-what-findings-prompt-you-to-recommend-planned-delivery-earlier-than-early-term-e-g-trends-in-transaminases-cholestasis-markers-bile-acids-icp-or-fetal-growth-velocity weekly 0.8 https://www.themednet.org/is-bortezomib-associated-with-drug-induced-myopathy weekly 0.8 https://www.themednet.org/do-glp-1-r-agonists-provide-similar-cardioprotective-benefits-in-patients-with-type-2-diabetes-mellitus-and-esrd-on-dialysis weekly 0.8 https://www.themednet.org/which-patients-with-mogad-benefit-the-most-from-early-plex-initiation-for-acute-treatment-of-attacks weekly 0.8 https://www.themednet.org/in-a-young-patient-e-g-5-years-with-confirmed-food-allergy-to-egg-or-milk-who-has-tolerated-extensively-baked-egg-milk-e-g-in-a-muffin-do-you-routinely-perform-repeat-food-allergy-testing-at-any-point-while-progressing-through-a-baked-egg-milk-ladder-if-n weekly 0.8 https://www.themednet.org/what-default-trigger-do-you-use-for-early-palliative-care-involvement-in-advanced-liver-disease-and-transplant-evaluation weekly 0.8 https://www.themednet.org/when-assessing-whether-an-hcc-multidisciplinary-clinic-is-improving-outcomes-beyond-stage-migration-which-patient-level-clinically-actionable-metrics-do-you-track-e-g-time-to-treatment-guideline-concordant-therapy-successful-bridging-downstaging-treatment weekly 0.8 https://www.themednet.org/which-social-determinants-e-g-food-insecurity-housing-instability-low-health-literacy-do-you-routinely-screen-for-in-masld-because-they-change-your-lifestyle-plan-or-follow-up-cadence-and-how-do-you-assess-whether-addressing-them-is-translating-into-impro weekly 0.8 https://www.themednet.org/what-pocus-based-endpoint-do-you-use-to-stop-further-albumin-boluses-and-pivot-to-vasopressors-or-terlipressin-cirrhosis-with-suspected-hrs-aki weekly 0.8 https://www.themednet.org/are-there-scenarios-in-which-you-would-consider-continuing-metformin-in-an-older-adult-with-longstanding-diabetes-and-ckd-whose-egfr-has-dropped-below-30-into-the-high-20s weekly 0.8 https://www.themednet.org/how-do-you-approach-the-discussion-of-potential-dialysis-initiation-in-older-adult-patients-with-advanced-ckd-progressing-to-esrd-with-varying-degrees-of-cognitive-impairment weekly 0.8 https://www.themednet.org/how-do-you-explain-the-concept-of-a-minimally-clinically-important-difference-mcid-in-terms-of-cognitive-outcomes-with-regard-to-antiamyloid-therapies-vs-cholinesterase-inhibitors-for-treatment-of-alzheimers-dementia weekly 0.8 https://www.themednet.org/in-an-older-adult-with-severe-osteoarthritis-related-pain-and-functional-disability-refractory-to-conservative-management-affecting-more-than-one-joint-e-g-knee-and-hip-how-do-you-counsel-regarding-staging-of-any-elective-joint-related-surgeries weekly 0.8 https://www.themednet.org/what-is-your-experience-using-the-voyager-dslt-in-patients-with-a-trabecular-microbypass-stent-such-as-the-hydrus-or-istent weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-biopsy-a-thyroid-nodule-in-an-older-adult-with-multiple-comorbidities-and-limited-life-expectancy-when-imaging-characteristics-meet-low-suspicion-criteria weekly 0.8 https://www.themednet.org/do-you-use-adjunctive-rifampin-to-treat-cutibacterium-acnes-infections-associated-with-retained-hardware weekly 0.8 https://www.themednet.org/how-do-you-evaluate-and-manage-recurrent-pregnancy-loss-rpl weekly 0.8 https://www.themednet.org/is-there-benefit-of-continuing-non-selective-beta-blockers-in-patients-with-re-compensated-cirrhosis-who-has-been-on-a-stable-dose-of-midodrine-outpatient weekly 0.8 https://www.themednet.org/what-is-your-approach-to-working-up-and-managing-severe-acute-chest-pain-without-an-apparent-acute-cardiac-or-pulmonary-cause weekly 0.8 https://www.themednet.org/what-is-your-approach-with-hyponatremia-with-clinical-volume-overload-in-the-setting-of-cirrhosis weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-gca-who-has-tapered-down-to-prednisone-10mg-previously-with-resolution-of-inflammatory-markers-but-now-with-slight-up-trending-of-esr-crp-no-recurrence-of-vision-changes weekly 0.8 https://www.themednet.org/in-what-clinical-situations-do-you-find-switching-to-a-subcutaneous-vedolizumab-from-iv-helpful weekly 0.8 https://www.themednet.org/there-is-some-data-suggesting-miso-can-act-as-radioprotector-and-decrease-side-effects-while-not-compromising-the-efficacy-of-the-radiation-do-you-recommend-patients-take-miso weekly 0.8 https://www.themednet.org/are-you-incorporating-blood-based-colorectal-cancer-screening-tests-such-as-the-shield-assay-into-routine-practice-for-average-risk-patients-and-if-so-how-are-you-positioning-them-relative-to-colonoscopy-and-stool-based-screening weekly 0.8 https://www.themednet.org/what-is-your-approach-to-continuing-vs-holding-home-inhalers-laba-lama-ics-in-patients-admitted-with-a-copd-exacerbation weekly 0.8 https://www.themednet.org/how-do-you-choose-between-using-inebilizumab-and-rituximab-for-patients-with-nmosd weekly 0.8 https://www.themednet.org/do-you-recommend-nicotinamide-riboside-supplementation-for-your-patients-with-friedreichs-ataxia weekly 0.8 https://www.themednet.org/what-treatments-or-counseling-do-you-offer-patients-with-adt-induced-weight-gain-and-abdominal-adiposity weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-and-monitoring-of-smoking-cessation-therapies-for-patients-with-stable-schizophrenia-or-psychotic-disorders weekly 0.8 https://www.themednet.org/at-what-egfr-do-you-consider-discontinuing-metformin-in-someone-who-has-been-on-longterm-therapy-with-well-controlled-dm weekly 0.8 https://www.themednet.org/do-you-routinely-offer-asa-for-primary-prevention-in-patients-years-40-59-with-10-10-year-ascvd-risk weekly 0.8 https://www.themednet.org/do-you-routinely-order-brain-mri-for-a-new-diagnosis-of-cognitive-impairment-if-not-what-patient-factors-would-push-you-t-do-so weekly 0.8 https://www.themednet.org/do-you-find-the-txi-modes-on-scopes-helpful-to-detect-polyps-that-could-have-been-missed-with-the-normal-white-light-settings weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-home-red-light-therapy-applications-for-radiation-dermatitis weekly 0.8 https://www.themednet.org/do-you-consider-glycemic-optimization-a-prerequisite-for-procedural-intervention-in-hs-patients-with-poorly-controlled-type-2-diabetes weekly 0.8 https://www.themednet.org/in-the-setting-of-multiple-3-isolated-recurrences-of-medulloblastoma-limited-to-the-brain-with-a-clear-spine-mri-and-negative-csf-what-is-the-preferred-re-irradiation-strategy-when-would-you-consider-repeat-csi-versus-gamma-knife-srs-to-isolated-lesions weekly 0.8 https://www.themednet.org/how-do-you-incorporate-data-from-a-patients-personal-continuous-glucose-monitor-while-hospitalized weekly 0.8 https://www.themednet.org/for-those-routinely-performing-vmat-linac-based-srs-including-multi-met-single-isocenter-treatments-and-other-high-precision-treatments-what-is-the-average-age-of-the-equipment-in-your-department-that-you-use-for-these-treatments weekly 0.8 https://www.themednet.org/are-there-any-clinical-scenarios-in-which-you-routinely-consider-obtaining-pharmacogenetic-testing-in-older-adult-patients weekly 0.8 https://www.themednet.org/What-is-the-recommended-approach-to-counseling-first-degree-relatives-of-patients-diagnosed-at-a-young-age-with-a-high-number-of-non-advanced-colorectal-polyps-Specifically-does-a-high-polyp-burden-in-the-absence-of-advanced-histologic-features-warrant-ea weekly 0.8 https://www.themednet.org/in-patients-who-achieve-substantial-weight-loss-yet-have-persistent-steatosis-or-fibrosis-how-would-you-adjust-your-cardiovascular-risk-assessment-and-prevention-strategy-compared-with-traditional-lean-masld weekly 0.8 https://www.themednet.org/do-you-ever-escalate-therapy-before-12-months-of-ursodeoxycholic-acid-in-patients-with-normal-bilirubin-but-persistent-alp-1-67-uln-and-significant-symptoms-and-if-so-what-early-response-or-baseline-features-trigger-that-earlier-escalation weekly 0.8 https://www.themednet.org/if-a-patient-meets-standard-rule-out-lsm-15-kpa-and-platelets-150-10-l-but-has-high-risk-clinical-cues-e-g-diabetes-with-rising-lsm-sarcopenic-obesity-intermittent-alcohol-use-do-you-still-defer-csph-directed-interventions-or-do-you-trigger-earlier-reasse weekly 0.8 https://www.themednet.org/what-is-your-approach-to-starting-or-not-starting-hcc-surveillance-in-non-cirrhotic-masld-patients-with-advanced-fibrosis-e-g-f3-by-elastography-and-what-clinical-features-would-push-you-toward-surveillance-despite-the-absence-of-cirrhosis weekly 0.8 https://www.themednet.org/in-non-cirrhotic-pvt-with-partial-smv-extension-what-specific-clinical-and-ct-findings-trigger-you-to-escalate-from-anticoagulation-alone-to-an-endovascular-strategy-recanalization-thrombectomy-thrombolysis weekly 0.8 https://www.themednet.org/when-counseling-patients-with-alzheimers-regarding-potential-initiation-of-antiamyloid-monoclonal-antibody-therapy-how-do-you-discuss-the-long-term-cognitive-functional-outcomes-related-to-aria weekly 0.8 https://www.themednet.org/do-you-extrapolate-and-offer-adjuvant-aspirin-to-patients-with-pik3ca-mutations-in-appendiceal-cancer-do-risk-factors-like-nodal-status-or-t-stage-affect-this-decision weekly 0.8 https://www.themednet.org/do-you-extrapolate-and-add-atezolizumab-to-adjuvant-folfox-in-dmmr-appendiceal-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-diagnosis-and-management-of-fanconi-syndrome-in-pediatric-patients-receiving-ifosfamide weekly 0.8 https://www.themednet.org/is-there-any-data-to-support-use-of-brensocatib-in-bronchiectasis-associated-with-iei weekly 0.8 https://www.themednet.org/have-you-used-minoxidil-to-treat-onychomycosis weekly 0.8 https://www.themednet.org/when-do-you-consider-genetic-testing-in-patients-with-psychosis weekly 0.8 https://www.themednet.org/is-there-a-role-for-micropulse-or-subthreshold-laser-as-primary-treatment-for-neovascular-amd weekly 0.8 https://www.themednet.org/what-has-been-your-experience-with-ginger-powder-or-extract-for-the-treatment-of-migraine weekly 0.8 https://www.themednet.org/are-there-scenarios-in-which-you-have-found-suzetrigine-to-be-helpful-in-the-treatment-of-pain-in-older-adult-patients weekly 0.8 https://www.themednet.org/do-you-ever-recommend-use-of-electronic-pill-dispensers-to-support-medication-adherence-for-older-adult-patients-in-your-clinical-practice-and-have-you-found-them-to-be-helpful weekly 0.8 https://www.themednet.org/how-will-this-nejm-trial-regarding-shunting-for-idiopathic-nph-influence-your-consideration-to-nph-diagnosis-and-treatment-among-older-adult-patients weekly 0.8 https://www.themednet.org/should-very-old-adults-with-vte-be-anticoagulated-the-same-way-as-younger-patients-or-should-age-90-trigger-a-different-risk-benefit-threshold weekly 0.8 https://www.themednet.org/for-patients-presenting-with-spontaneous-aortic-dissection-and-subclavian-artery-dissection-without-a-pmh-of-hypertension-or-smoking-history-is-there-an-indication-to-pursue-genetic-testing-or-workup-for-collagen-disorders weekly 0.8 https://www.themednet.org/do-you-routinely-screen-for-anxiety-disorders-with-a-validated-tool-in-adult-primary-care-patients-who-are-not-presenting-with-psychological-complaints-1 weekly 0.8 https://www.themednet.org/what-steps-do-you-take-in-post-discharge-appointments-following-a-hospitalization-for-a-patient-that-you-identify-as-frail weekly 0.8 https://www.themednet.org/how-do-we-individualize-a1c-or-blood-pressure-goals-in-patients-with-competing-risks-and-social-complexity weekly 0.8 https://www.themednet.org/how-should-clinicians-balance-patient-autonomy-with-evidence-based-care-when-patients-request-low-value-or-potentially-harmful-interventions weekly 0.8 https://www.themednet.org/for-patients-who-have-received-vaccinations-post-chemotherapy-based-on-their-vaccine-titers-is-it-necessary-to-repeat-those-titers-over-time-to-make-sure-the-titers-havent-waned weekly 0.8 https://www.themednet.org/do-you-prescribe-extended-thromboprophylaxis-after-hospital-discharge-for-a-medically-ill-patient-who-was-immobilized-during-their-admission-and-has-ongoing-vte-risk-factors weekly 0.8 https://www.themednet.org/what-is-your-threshold-to-perform-splenic-biopsies-for-unexplained-splenomegaly weekly 0.8 https://www.themednet.org/what-is-your-approach-the-prep-for-colonoscopy-planned-inpatient-for-rectal-bleeding weekly 0.8 https://www.themednet.org/do-you-use-oral-doxycycline-and-hydroxychloroquine-in-a-patient-with-whipples-disease-and-significant-gastrointestinal-involvement-despite-concern-for-malabsorption weekly 0.8 https://www.themednet.org/what-guidance-do-your-provide-patients-on-the-side-effects-of-cobenfy weekly 0.8 https://www.themednet.org/what-has-been-your-experience-with-the-five-day-saint-tms-protocol-compared-to-standard-protocols-for-major-depressive-disorder weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-in-patients-with-gmena-syndrome-granulomatous-mastitis-erythema-nodosum-and-arthritis weekly 0.8 https://www.themednet.org/what-is-your-approach-to-assessing-for-icans-in-a-pediatric-oncology-patient-with-r-r-b-cell-all-following-car-t weekly 0.8 https://www.themednet.org/how-do-you-approach-deciding-when-to-order-imaging-in-young-otherwise-low-risk-patients-with-headache-that-have-a-common-and-subjective-high-risk-feature-such-as-new-headache-severe-pain-or-positional-change weekly 0.8 https://www.themednet.org/how-do-you-manage-grade-4-whole-body-rash-from-enfortumab-vedotin weekly 0.8 https://www.themednet.org/how-do-you-incorporate-keratolytics-into-the-treatment-of-adults-with-profuse-crusted-scabies-already-being-treated-with-oral-ivermectin-and-5-permethrin weekly 0.8 https://www.themednet.org/how-do-you-manage-cannabis-use-disorder-in-pregnant-patients-in-the-outpatient-setting weekly 0.8 https://www.themednet.org/what-are-your-thoughts-on-the-recent-fda-approval-of-the-combined-dextromethorphan-and-bupropion-auvelity-for-treatment-of-agitation-associated-with-dementia weekly 0.8 https://www.themednet.org/what-is-your-approach-to-decisions-to-continue-vs-deprescribe-levetiracetam-that-was-given-in-the-acute-phase-post-stroke-when-seeing-older-patients-in-longer-term-follow-up weekly 0.8 https://www.themednet.org/when-do-you-attempt-discontinuing-ssri-snri-in-primary-care-for-patients-who-have-been-in-full-remission-from-depression-for-over-one-year weekly 0.8 https://www.themednet.org/when-if-ever-would-you-prescribe-gabapentin-for-chronic-msk-pain-in-primary-care-when-neuropathic-features-are-absent weekly 0.8 https://www.themednet.org/when-if-ever-do-you-place-an-intrauterine-device-in-the-early-post-liver-transplant-period-and-what-specific-stability-criteria-do-you-require-before-placement weekly 0.8 https://www.themednet.org/what-clinical-action-do-you-take-when-alt-and-noninvasive-fibrosis-scores-are-reassuring-but-fasting-insulin-remains-persistently-elevated-in-a-patient-with-masld-does-it-change-monitoring-intensity-cardiometabolic-workup-or-treatment-selection weekly 0.8 https://www.themednet.org/in-alcohol-associated-liver-disease-with-aclf-and-limited-collateral-history-what-minimum-psychosocial-addiction-signals-and-which-red-flags-most-change-your-urgency-to-list-for-transplant-during-the-icu-admission weekly 0.8 https://www.themednet.org/in-cirrhotic-septic-shock-with-evolving-hypoxemia-what-pocus-hemodynamic-findings-lead-you-to-avoid-or-stop-albumin-boluses-and-favor-a-crystalloid-first-or-more-restrictive-approach-to-reduce-pulmonary-edema-risk weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-severe-itching-associated-with-steroid-withdrawal-dermatitis-of-the-eyelids weekly 0.8 https://www.themednet.org/does-a-patients-history-of-non-infectious-uveitis-in-multiple-sclerosis-influence-your-recommendations-for-type-of-disease-modifying-therapy-when-co-managing-with-a-neurologist weekly 0.8 https://www.themednet.org/how-do-you-approach-rop-screening-decisions-for-premature-infants-who-fall-just-outside-your-standard-gestational-age-or-birth-weight-cutoffs-but-have-significant-comorbidities-such-as-sepsis-prolonged-oxygen-therapy-or-hemodynamic-instability weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-fatigue-on-the-clinical-significance-of-low-dhea-s-in-the-setting-of-normal-acth-and-cortisol-levels weekly 0.8 https://www.themednet.org/What-is-the-best-imaging-aggregation-software-for-an-Ophthalmology-practice weekly 0.8 https://www.themednet.org/do-you-have-a-preferred-benzodiazepine-for-pediatric-status-epilepticus weekly 0.8 https://www.themednet.org/how-do-you-distinguish-between-increased-activity-and-impulsivity-related-to-adhd-vs-bipolar-disorder-in-adolescents weekly 0.8 https://www.themednet.org/62-year-old-woman-with-a-right-breast-invasive-mammary-carcinoma-with-mixed-ductal-and-lobular-features-on-core-biopsy-grade-2-ER-96percent-PR-77percent-HER2-negative-and-Ki-67-12percent.-Axillary-ultrasound-negative.-Sentinel-lymph-node-biopsy-omitted-pe weekly 0.8 https://www.themednet.org/do-you-avoid-glucocorticoid-steroid-use-in-a-pediatric-patient-who-is-receiving-an-allogeneic-bone-marrow-transplant-for-a-non-malignant-disease-do-you-avoid-glucocorticoid-steroid-use-in-a-pediatric-patient-who-is-receiving-an-allogeneic-bone-marrow-tran weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-a-ppm-who-has-only-1-of-2-blood-culture-sets-positive-for-mrsa-and-enterococcus-faecalis-with-repeat-blood-cultures-negative-no-clear-source-of-bacteremia-and-a-negative-tte-would-you-still-obtain-a-tee-and-if-the-tee-is-n weekly 0.8 https://www.themednet.org/how-do-you-titrate-lactulose-dosing-for-a-patient-hospitalized-with-overt-hepatic-encephalopathy-who-has-not-reached-the-traditional-target-of-3-4-bowel-movements-per-day-by-24-hours weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-in-their-child-bearing-years-with-newly-diagnosed-multiple-myeloma-about-fertility-and-timing-of-potentially-having-children weekly 0.8 https://www.themednet.org/do-you-give-long-term-antibiotic-therapy-for-empiric-mediastinitis-coverage-for-patients-post-cardiac-surgery-with-a-mediastinal-collection-noted-on-imaging-per-radiology-read-can-be-post-operative-and-bland-vs-infected-without-ability-to-obtain-culture-d weekly 0.8 https://www.themednet.org/what-markers-do-you-use-to-decide-when-to-shift-medication-access-and-healthcare-navigation-tasks-refills-prior-authorizations-scheduling-from-parent-led-to-adolescent-led-in-scd-while-minimizing-the-risk-of-dangerous-gaps-in-therapy weekly 0.8 https://www.themednet.org/would-you-use-amphotericin-b-liposomal-ambisome-or-oral-azoles-for-sternal-osteomyelitis-osteo-with-coccidioidomycosis weekly 0.8 https://www.themednet.org/do-you-consider-the-absence-of-a-mortality-benefit-with-digitalis-glycosides-sufficient-reason-to-avoid-adding-them-in-a-symptomatic-patient-with-hfref-who-has-exhausted-other-guideline-directed-medical-therapy-options weekly 0.8 https://www.themednet.org/What-are-the-benefits-of-steroids-in-alcoholic-hepatitis weekly 0.8 https://www.themednet.org/would-an-anterior-revision-alone-be-adequate-in-a-patient-with-prior-multi-level-cervical-operations-and-hardware-failure-who-currently-presents-with-mild-cord-compression weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-to-transition-a-psc-patient-from-on-demand-ercp-to-a-scheduled-dilation-program-and-which-patient-features-best-predict-meaningful-clinical-benefit-rather-than-simply-more-procedures weekly 0.8 https://www.themednet.org/when-psc-cytology-is-atypical-how-do-you-choose-between-idus-pcle-and-repeat-conventional-sampling-as-the-next-diagnostic-escalation-and-does-your-prioritization-change-for-transplant-candidates weekly 0.8 https://www.themednet.org/what-guidance-do-you-provide-to-patients-with-history-concerning-for-ige-mediated-reaction-to-local-anesthetic-i-e-lidocaine weekly 0.8 https://www.themednet.org/how-do-you-recommend-sequencing-gdmt-initiation-in-a-patient-with-hfref-and-borderline-hypotension weekly 0.8 https://www.themednet.org/what-is-your-approach-to-diagnosing-and-treating-t2-low-asthma weekly 0.8 https://www.themednet.org/are-there-any-guidelines-or-studies-evaluating-testosterone-supplementation-in-biological-females-with-history-of-vte-who-are-using-testosterone-for-hormone-therapy-i-e-to-improve-energy-libido-etc-in-addition-to-their-hrt-with-estrogen-progesterone-estro weekly 0.8 https://www.themednet.org/have-you-had-any-experience-with-the-use-of-lumateperone-for-the-treatment-of-behavioral-and-psychological-symptoms-of-dementia weekly 0.8 https://www.themednet.org/what-factors-would-help-you-decide-how-to-triage-an-older-adult-patient-with-stable-vital-signs-but-bloody-stools-that-seem-consistent-with-diverticular-bleed-in-terms-of-whether-to-present-to-the-ed-especially-if-difficult-to-travel-versus-monitoring-in- weekly 0.8 https://www.themednet.org/how-do-you-approach-decisions-regarding-whether-to-continue-versus-discontinue-anticoagulation-therapy-for-atrial-fibrillation-in-older-adults-patients-with-advanced-heart-failure weekly 0.8 https://www.themednet.org/how-to-approach-immunosuppression-in-patient-with-cryoglobulinemic-vasculitis-initially-presented-as-nephrotic-range-proteinuria-new-onset-hypertension-lcv-on-lower-extremity-raynauds-neuropathy-and-pancytopenia-post-rituximab-q1-week-x-4-jan-feb-2026-sym weekly 0.8 https://www.themednet.org/what-is-the-preferred-first-line-systemic-treatment-for-patient-with-metastatic-adenocarcinoma-of-ge-junction-her2-negative-pd-l1-4-cldn-18-2-100-zolbetuximab-or-io-with-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-test-for-a-polysorbate-80-allergy weekly 0.8 https://www.themednet.org/how-do-you-test-for-a-polyethylene-glycol-allergy weekly 0.8 https://www.themednet.org/how-do-you-perform-patch-testing-for-a-benzyl-alcohol-allergy weekly 0.8 https://www.themednet.org/how-do-you-test-for-a-sulfite-allergy weekly 0.8 https://www.themednet.org/how-do-you-perform-patch-testing-for-a-polysorbate-80-allergy weekly 0.8 https://www.themednet.org/75-year-with-nephrotic-syndrome-ckd4-morbid-obesity-diabetes-angina-and-3-cardiac-stents-who-received-3-cycles-of-neoadjuvant-carboplatinum-taxol-and-pembrolizumab-chronic-thrombocytopenia-occurring-after-last-chemotherapy-4-months-ago-negative-bone-marro weekly 0.8 https://www.themednet.org/how-comfortable-do-you-feel-starting-isotretinoin-in-females-patients-who-consider-abstinence-as-their-method-of-contraception weekly 0.8 https://www.themednet.org/how-concerning-are-the-depressive-side-effects-of-finasteride-when-used-to-treat-alopecia weekly 0.8 https://www.themednet.org/what-is-the-significance-of-persistently-positive-mycoplasma-pneumonia-igm-and-igg-in-an-adolescent-patient-with-amplified-pain-syndrome-but-a-negative-rheumatology-work-up-for-common-autoimmune-conditions-such-as-lupus-or-arthritis-could-this-be-a-cause- weekly 0.8 https://www.themednet.org/how-do-you-weigh-the-decision-to-extend-dual-antiplatelet-therapy-following-coronary-stenting-in-an-older-adult-patient-in-their-80s-beyond-one-year weekly 0.8 https://www.themednet.org/do-you-measure-apolipoprotein-b-or-lipoprotein-a-to-guide-statin-initiation-in-a-patient-whose-prevent-calculated-ascvd-risk-falls-near-a-treatment-threshold weekly 0.8 https://www.themednet.org/do-you-use-moxifloxacin-rather-than-azithromycin-as-your-preferred-empiric-first-line-treatment-for-mycoplasma-genitalium-infection-given-randomized-trial-data-showing-superior-microbiological-cure-rates weekly 0.8 https://www.themednet.org/if-a-patient-with-a1c-14-and-new-diagnosis-of-severe-polymyalgia-rheumatica-with-highly-elevated-inflammation-markers-how-would-you-treat weekly 0.8 https://www.themednet.org/what-adjustments-do-you-make-for-treatment-of-psychosis-in-patients-on-dialysis weekly 0.8 https://www.themednet.org/for-a-non-severe-acute-exacerbation-of-copd-ocurring-in-the-setting-of-a-positive-viral-respiratory-pathogen-pcr-are-you-less-likely-to-prescribe-empiric-antibiotics-in-comparison-to-aecopd-in-a-patient-without-viral-respiratory-testing-available weekly 0.8 https://www.themednet.org/do-you-find-pocus-helpful-in-evaluating-stool-burden-ileus-and-or-bowel-obstruction weekly 0.8 https://www.themednet.org/how-have-the-updated-guidelines-on-postmenopausal-bleeding-regarding-the-use-of-transvaginal-us-and-endometrial-biopsy-changed-your-practice-pattern weekly 0.8 https://www.themednet.org/do-all-patients-with-amiodarone-induced-thyroiditis-type-2-require-treatment-with-steroid-therapy weekly 0.8 https://www.themednet.org/for-which-patients-with-hypophosphatasia-do-you-recommend-asfotase-alfa-therapy weekly 0.8 https://www.themednet.org/when-native-bone-is-not-available-how-do-you-decide-what-type-of-material-to-utilize-for-cranioplasty-after-trauma-decompression weekly 0.8 https://www.themednet.org/under-what-circumstances-do-you-use-hardware-versus-allograft-for-spinal-fusion-in-children weekly 0.8 https://www.themednet.org/What-is-the-indication-to-start-G-CSF-in-cyclic-neutropenia-Is-it-recommended-for-all-children-or-only-for-those-with-presentation-of-a-severe-infection-How-do-you-titrate-the-G-CSF-dosing weekly 0.8 https://www.themednet.org/in-stec-negative-hus-with-improving-platelet-count-downtrending-ldh-stable-hemoglobin-normalized-haptoglobin-initially-undetectable-but-with-persistent-renal-failure-requiring-dialysis-when-do-you-consider-the-use-of-complement-inhibition-adamts13-negativ weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-severe-recurrent-exercise-induced-vasculitis weekly 0.8 https://www.themednet.org/what-concerns-do-you-have-about-using-a-wall-mounted-hyfrecator-for-skin-cancer-excision-in-a-patient-with-pacemaker-defibrillator weekly 0.8 https://www.themednet.org/how-would-you-treat-idiopathic-isolated-renal-tma-diagnosed-on-renal-biopsy-without-evidence-of-maha weekly 0.8 https://www.themednet.org/do-you-avoid-topical-products-containing-salicylates-in-patient-with-an-aspirin-nsaid-allergy weekly 0.8 https://www.themednet.org/do-you-routinely-recommend-an-immunodeficiency-work-up-in-patients-with-ards-due-to-influenza-infection-who-develop-invasive-pulmonary-aspergillosis weekly 0.8 https://www.themednet.org/would-you-add-pertuzumab-to-adjuvant-therapy-for-a-premenopausal-female-with-hr-her2-idc-with-n1mic-disease weekly 0.8 https://www.themednet.org/how-have-you-incorporated-the-stop-now-and-plan-snap-behavioral-model-into-your-outpatient-practice-with-children weekly 0.8 https://www.themednet.org/what-trainings-or-resources-have-you-found-most-useful-in-expanding-your-knowledge-of-lgbtq-mental-health weekly 0.8 https://www.themednet.org/do-you-feel-it-is-within-your-scope-of-practice-as-a-psychiatrist-to-prescribe-glp-1-agonists weekly 0.8 https://www.themednet.org/is-there-a-role-for-administering-iv-ketamine-immediately-after-ect-treatments-in-patients-with-difficult-to-treat-major-depressive-disorder weekly 0.8 https://www.themednet.org/how-have-you-gone-about-implementing-esketamine-treatment-in-your-practice-or-institution weekly 0.8 https://www.themednet.org/what-patients-with-new-onset-diabetes-require-imaging-of-the-pancreas weekly 0.8 https://www.themednet.org/how-do-you-approach-conversations-with-patients-about-how-untreated-obstructive-sleep-apnea-could-be-affecting-their-depressive-symptoms weekly 0.8 https://www.themednet.org/what-are-your-treatment-options-and-preferences-for-classical-egfr-mutated-nsclc-upon-widespread-progression-following-first-line-chemo-osimertinib weekly 0.8 https://www.themednet.org/how-should-newer-pharmacologic-agents-be-integrated-into-treatment-protocols-to-maximize-symptomatic-relief-while-addressing-underlying-causes-such-as-inflammation-and-meibomian-gland-dysfunction-in-patients-with-dry-eye-disease weekly 0.8 https://www.themednet.org/how-if-at-all-have-the-new-idsa-guidelines-on-utis-changed-your-perspective-on-triaging-and-or-treating-utis-in-your-practice weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-chemo-rt-for-an-upper-rectal-pt3n0-2-24-nodes-with-positive-isolated-tumors-cells-s-p-lar-and-folfox weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-with-bv-chp-regimen-in-a-patient-with-newly-diagnosed-cd30-alk-anaplastic-large-cell-lymphoma-at-high-risk-for-cardiotoxicity weekly 0.8 https://www.themednet.org/how-would-you-approach-a-young-patient-with-sickle-cell-disease-without-a-history-of-frequent-vaso-occlusive-crises-admitted-with-high-fever-vague-back-flank-pain-and-mild-luq-abdominal-tenderness-marked-leukocytosis-no-respiratory-symptoms-and-negative-c weekly 0.8 https://www.themednet.org/does-octreotide-therapy-interfere-with-the-ability-to-localize-an-insulinoma-via-radionuclide-diagnostic-studies weekly 0.8 https://www.themednet.org/when-treating-fatty-liver-disease-with-resmetirom-how-often-should-a-fibroscan-be-repeated-to-assess-treatment-response weekly 0.8 https://www.themednet.org/what-has-been-your-experience-with-newer-tonometry-devices-such-as-the-cats-tonometer-and-the-fmat1-by-falck-medical weekly 0.8 https://www.themednet.org/does-the-imaging-finding-of-central-necrosis-of-an-adrenal-tumor-biochemically-confirmed-as-pheochromocytoma-increase-the-risk-of-malignancy weekly 0.8 https://www.themednet.org/are-there-concerns-with-using-intranasal-ddavp-if-available-since-the-stimate-recall weekly 0.8 https://www.themednet.org/would-you-use-iv-albumin-before-hemodialysis-for-hypotension-if-the-serum-albumin-is-greater-than-3-5-g-dl weekly 0.8 https://www.themednet.org/what-would-be-your-percutaneous-approach-to-a-severely-stenotic-bifurcation-lesion-with-a-large-aneurysm-post-stenosis weekly 0.8 https://www.themednet.org/how-would-you-treat-a-painful-peripancreatic-schwannoma-in-the-setting-of-prior-sbrt-course weekly 0.8 https://www.themednet.org/how-do-you-approach-the-evaluation-of-adrenal-insufficiency-in-patients-with-chronic-opioid-use-who-present-with-fatigue-and-hypotension-but-have-normal-morning-cortisol-levels weekly 0.8 https://www.themednet.org/is-there-a-role-for-increasing-dietary-vitamin-e-in-patients-at-risk-for-developing-autoimmune-thyroiditis weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-for-a-patient-with-refractory-metastatic-upper-tract-urothelial-carcinoma-previously-treated-with-adjuvant-gemcitabine-cisplatin-enfortumab-vedotin-pembrolizumab-docetaxel-and-sacituzumab-govitecan weekly 0.8 https://www.themednet.org/how-have-you-incorporated-long-acting-injectables-into-private-practice-or-other-settings-that-havent-traditionally-offered-them weekly 0.8 https://www.themednet.org/how-have-you-incorporated-wearables-such-as-fitness-trackers-smartwatches-or-sleep-monitors-into-your-practice weekly 0.8 https://www.themednet.org/is-there-any-data-on-denosumab-use-beyond-10-years-from-the-freedom-extension-trial-and-what-do-we-know-about-the-risk-of-atypical-femoral-fracture-and-osteonecrosis-of-the-jaw-after-10-years weekly 0.8 https://www.themednet.org/can-norethindrone-depakote-or-olanzapine-interfere-with-the-results-of-the-1mg-overnight-dexamethasone-suppression-test-for-hypercortisolism-screening weekly 0.8 https://www.themednet.org/what-is-the-role-of-oral-therapy-for-hypercortisolism-diagnosed-based-on-unsuppressed-cortisol-after-1mg-dexamethasone-suppression-test-in-a-normoglycemic-patient-who-also-has-negative-adrenal-imaging weekly 0.8 https://www.themednet.org/do-scores-for-identification-of-early-sepsis-such-as-qsofa-sirs-or-news-hold-significance-for-patients-who-are-already-admitted-to-the-icu weekly 0.8 https://www.themednet.org/what-is-your-approach-to-addressing-comorbidities-that-influence-asthma-severity weekly 0.8 https://www.themednet.org/do-the-recently-published-results-from-outmatch-2-change-your-approach-to-using-xolair-for-possible-food-allergy-resolution weekly 0.8 https://www.themednet.org/how-do-you-approach-vaccination-particularly-the-use-of-live-vaccines-such-as-yellow-fever-in-a-patient-with-rheumatoid-arthritis-receiving-a-tnf-inhibitor-who-is-planning-travel-to-africa weekly 0.8 https://www.themednet.org/do-you-routinely-discuss-the-risks-of-home-composting-with-immunocompromised-patients weekly 0.8 https://www.themednet.org/is-there-a-maximum-limit-of-urine-output-per-day-while-diuresing-massive-volume-overload-as-long-as-serum-creatinine-and-electrolytes-remain-within-normal-limits weekly 0.8 https://www.themednet.org/what-specific-historical-questions-do-you-prioritize-when-evaluating-hair-loss-to-identify-features-suggestive-of-autoimmune-or-connective-tissue-disorders weekly 0.8 https://www.themednet.org/does-parathyroidectomy-for-primary-hyperparathyroidism-provide-metabolic-benefits-such-as-lowering-diabetes-or-cardiovascular-disease-risk weekly 0.8 https://www.themednet.org/what-would-your-approach-be-to-treatment-in-a-patient-with-stage-iv-thymic-squamous-cell-carcinoma-who-received-neoadjuvant-carboplatin-paclitaxel-and-ramucirumab-and-underwent-r1-resection weekly 0.8 https://www.themednet.org/for-those-practicing-in-medical-aesthetics-how-do-you-prepare-for-and-manage-serious-complications-such-as-vascular-occlusion-tissue-necrosis-blindness-or-ptosis weekly 0.8 https://www.themednet.org/what-has-been-your-experience-with-adding-low-level-light-therapy-lllt-alongside-ipl-and-how-do-you-balance-the-potential-clinical-benefits-with-the-financial-burden-on-patients-since-these-treatments-are-not-insurance-covered weekly 0.8 https://www.themednet.org/which-dosing-strategy-do-you-typically-use-for-dalbavancin-for-staph-aureus-vertebral-osteomyelitis weekly 0.8 https://www.themednet.org/how-do-you-handle-medication-refills-for-patients-on-traditional-dmards-who-are-lost-to-follow-up weekly 0.8 https://www.themednet.org/how-are-you-integrating-the-findings-from-keynote-689-into-daily-practice weekly 0.8 https://www.themednet.org/how-long-do-you-continue-to-follow-children-with-now-resolved-autoimmune-hemolytic-anemia-in-hematology-clinic-to-monitor-for-recurrence-or-secondary-conditions weekly 0.8 https://www.themednet.org/how-do-you-determine-when-to-start-direct-acting-antivirals-in-an-unhoused-person-with-chronic-hepatitis-c weekly 0.8 https://www.themednet.org/how-do-you-approach-worsening-memory-loss-in-patients-with-gca weekly 0.8 https://www.themednet.org/in-resected-intrahepatic-cholangiocarcinoma-with-an-r0-margin-1-mm-and-perineural-invasion-would-you-consider-adjuvant-rt-in-addition-to-capecitabine weekly 0.8 https://www.themednet.org/in-patients-with-resected-stage-ii-iii-nsclc-who-completed-adjuvant-carboplatin-and-pemetrexed-and-are-pd-l1-high-which-immunotherapy-would-you-offer weekly 0.8 https://www.themednet.org/do-you-recommend-indefinite-anticoagulation-for-patients-with-homozygous-factor-v-leiden-mutation-who-have-had-a-provoked-vte weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-eskd-patients-who-are-disruptive-and-threatening-in-the-dialysis-unit weekly 0.8 https://www.themednet.org/how-long-do-you-recommend-waiting-to-repeat-an-ultrasound-in-patients-with-cytologically-benign-thyroid-nodules-and-very-low-to-intermediate-suspicion-ultrasound-patterns weekly 0.8 https://www.themednet.org/how-can-narrative-medicine-be-used-to-potentially-improve-outcomes-for-patients-on-dialysis weekly 0.8 https://www.themednet.org/does-rituximab-have-a-potential-role-in-the-management-of-immune-checkpoint-inhibitor-induced-pneumonitis weekly 0.8 https://www.themednet.org/how-do-you-approach-occasional-menstrual-spotting-in-transgender-men-on-stable-and-adequate-testosterone-therapy weekly 0.8 https://www.themednet.org/in-pts-with-hcc-who-initially-achieved-a-good-response-on-durvalumab-tremelimumab-but-later-lost-it-would-you-consider-rechallenging-with-tremelimumab weekly 0.8 https://www.themednet.org/in-addition-to-optimizing-a-three-drug-regimen-thiazide-ccb-ace-i-arb-what-other-workup-or-management-do-you-recommend-for-a-young-patient-with-obesity-and-a-new-diagnosis-of-hypertension-well-outside-goal-range weekly 0.8 https://www.themednet.org/can-a-patient-with-a-previous-reaction-to-iv-iron-dextran-take-oral-iron-supplements-without-concern-for-adverse-reactions weekly 0.8 https://www.themednet.org/in-patients-with-iv-nsclc-and-egfr-mutation-is-there-a-cutoff-on-the-of-allele-frequency-that-is-considered-to-be-too-low-to-be-actionable weekly 0.8 https://www.themednet.org/do-you-recommend-surgery-for-large-4-cm-high-density-20hu-non-secretory-adrenal-masses-that-have-been-stable-in-size-for-long-periods-of-time-3-years-when-reviewing-prior-imaging weekly 0.8 https://www.themednet.org/is-klinefelter-syndrome-associated-with-pancytopenia weekly 0.8 https://www.themednet.org/for-patients-with-stage-i-nsclc-do-you-use-riskreveal-and-if-so-how-do-you-use-it-to-guide-treatment weekly 0.8 https://www.themednet.org/are-you-more-likely-to-recommend-medical-management-for-obesity-instead-of-bariatric-surgery-in-patients-with-preexisting-hypothyroidism-given-a-recent-study-showing-increased-risks-of-complications weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-mycoplasma-pneumonia-in-heavily-immunosuppressed-patients weekly 0.8 https://www.themednet.org/what-is-your-strategy-to-manage-pruritus-in-patients-with-cholestatic-liver-disease weekly 0.8 https://www.themednet.org/for-a-borderline-ovarian-tumor-that-has-been-resected-with-bso-and-hysterectomy-would-you-consider-endocrine-therapy-if-found-to-be-er-positive weekly 0.8 https://www.themednet.org/do-any-of-the-commercially-available-dog-extracts-contain-canis-familiaris-allergen-5-can-f-5-the-prostatic-kallikrein-component-of-dog-hair-and-dander-which-is-produced-by-male-dogs weekly 0.8 https://www.themednet.org/do-you-avoid-jak-inhibitors-in-patients-with-antiphospholipid-antibodies-and-or-lupus-anticoagulant-given-the-potential-risk-of-increased-thromboembolic-events-with-use-of-jaki weekly 0.8 https://www.themednet.org/how-long-would-you-continue-intravenous-suppressive-therapy-following-surgical-washout-for-a-patient-with-an-lvad-as-destination-therapy-found-to-have-an-outflow-tract-fluid-collection-secondary-to-fluoroquinolone-resistant-pseudomonas-aeruginosa weekly 0.8 https://www.themednet.org/is-the-recommended-duration-of-anticoagulation-different-for-provoked-dvt-compared-to-provoked-pe weekly 0.8 https://www.themednet.org/do-you-feel-there-is-any-role-for-neoadjuvant-imatinib-in-pediatric-dfsp-with-the-classic-translocation-given-that-surgery-can-introduce-high-morbidity weekly 0.8 https://www.themednet.org/can-serological-markers-such-as-kl-6-mmp-7-and-anti-carp-be-used-to-monitor-interstitial-lung-disease-in-patients-with-rheumatoid-arthritis-in-clinical-practice weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-brucella-melitensis-abscess-in-whom-surgery-was-initially-deferred-developed-worsening-lower-extremity-numbness-and-weakness-and-mri-findings-despite-1-month-of-combination-therapy-with-ceftriaxone-rifampin-and-doxycycl weekly 0.8 https://www.themednet.org/how-do-you-approach-kidney-transplant-evaluation-and-management-in-an-eskd-patient-with-a-history-of-anti-gbm-disease-and-currently-detectable-anti-gbm-antibodies weekly 0.8 https://www.themednet.org/what-is-your-approach-to-perioperative-management-and-monitoring-in-a-patient-with-acute-intermittent-porphyria weekly 0.8 https://www.themednet.org/in-women-with-pcos-who-also-have-masld-nafld-how-do-you-approach-the-use-of-oral-contraceptive-pills-for-menstrual-regulation-and-treatment-of-hyper-androgenism weekly 0.8 https://www.themednet.org/have-you-considered-implementing-a-concierge-practice-model-in-outpatient-psychiatry weekly 0.8 https://www.themednet.org/what-is-your-perspective-on-the-clinical-utility-of-polyvagal-theory-in-psychiatry weekly 0.8 https://www.themednet.org/how-do-you-ensure-staff-safety-in-mental-health-mobile-crisis-teams weekly 0.8 https://www.themednet.org/do-you-avoid-the-use-of-beta-blockers-when-treating-hyperthyroidism-in-patients-with-well-controlled-asthma-or-copd weekly 0.8 https://www.themednet.org/what-are-the-current-guidelines-for-hormone-therapy-in-perimenopausal-women-specifically-regarding-the-use-of-estrogen-progesterone-and-possibly-testosterone weekly 0.8 https://www.themednet.org/what-is-your-approach-in-dialysis-patients-who-had-multiple-aborted-colonoscopies-due-to-poor-prep weekly 0.8 https://www.themednet.org/what-is-your-general-approach-for-investigation-workup-of-adults-with-unintentional-weight-loss weekly 0.8 https://www.themednet.org/how-would-you-approach-the-management-of-a-suspected-macrolide-resistant-pertussis-outbreak-in-a-hospital-or-community-setting weekly 0.8 https://www.themednet.org/how-do-you-manage-active-psoriatic-arthritis-in-a-patient-with-a-history-of-hiv-and-anal-squamous-cell-carcinoma-post-radiation-one-year-ago-previously-treated-with-apremilast-and-sulfasalazine-but-has-ongoing-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-patients-with-persistent-unexplained-symptoms-e-g-fatigue-pain-dizziness-when-diagnostic-workup-is-negative weekly 0.8 https://www.themednet.org/how-long-do-you-generally-continue-anti-depressants-for-mild-to-moderate-depression-who-have-achieved-remission weekly 0.8 https://www.themednet.org/how-do-you-approach-stopping-routine-cancer-screening-e-g-colonoscopy-mammography-in-patients-with-limited-life-expectancy-but-strong-preferences-to-continue weekly 0.8 https://www.themednet.org/in-what-situations-do-you-escalate-the-dose-of-axitinib-over-5-mg-bid-when-administered-with-pembrolizumab-for-clear-cell-rcc weekly 0.8 https://www.themednet.org/for-patients-with-new-stroke-while-on-aspirin-and-lenalidomide-would-you-recommend-adding-anticoagulation-in-the-absence-of-atrial-fibrillation-or-other-documented-thrombosis weekly 0.8 https://www.themednet.org/would-you-consider-adding-immunotherapy-to-adjuvant-chemotherapy-in-a-patient-with-incompletely-staged-high-grade-msi-h-pole-mutated-endometrioid-carcinoma-of-the-ovary-with-ultra-high-tumor-mutation-burden-on-ngs weekly 0.8 https://www.themednet.org/would-acute-onset-thrombocytopenia-and-concern-for-active-bleeding-with-platelet-count-below-50-000-prompt-you-to-hold-plavix-and-or-aspirin-following-pci-that-was-done-1-2-weeks-ago weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-idiopathic-bilateral-anterior-uveitis-who-is-well-controlled-on-acthar-gel-but-is-planning-pregnancy weekly 0.8 https://www.themednet.org/are-you-using-olanzapine-to-treat-cancer-cachexia-after-the-results-of-the-olanca-trial weekly 0.8 https://www.themednet.org/would-it-be-reasonable-to-consider-combined-bav-plus-staged-pci-in-a-patient-presenting-with-acs-and-new-lv-systolic-dysfunction-moderate-aortic-stenosis-and-complex-bifurcating-left-main-disease-and-rca-cto weekly 0.8 https://www.themednet.org/is-there-a-role-for-pharmacologic-or-exercise-stress-testing-for-patients-with-recurrent-syncope-of-unclear-etiology weekly 0.8 https://www.themednet.org/how-would-you-approach-levothyroxine-dosing-in-a-patient-with-congenital-hypothyroidism-who-has-persistent-mid-normal-tsh-but-elevated-free-t4-levels weekly 0.8 https://www.themednet.org/is-there-role-of-her2-directed-therapy-in-adjuvant-treatment-of-colon-adenocarcinoma-for-tumors-that-are-her2-3-by-ihc weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-genetically-confirmed-fabry-disease-regarding-switching-from-agalsidase-beta-fabrazyme-to-migalastat-galafold weekly 0.8 https://www.themednet.org/how-do-you-handle-bullous-skin-reactions-from-lamotrigine weekly 0.8 https://www.themednet.org/have-you-incorporated-urine-osmolality-monitoring-into-your-routine-laboratory-surveillance-for-patients-on-lithium weekly 0.8 https://www.themednet.org/how-do-you-approach-vaccine-hesitancy-with-patients-who-avoid-one-particular-vaccine-i-e-influenza-but-not-others weekly 0.8 https://www.themednet.org/how-did-you-decide-whether-to-take-insurance-in-your-outpatient-psychiatry-practice weekly 0.8 https://www.themednet.org/what-factors-and-patient-characteristics-guide-your-decision-to-choose-klex-over-other-refractive-surgery-options weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-patients-with-mucinous-lung-adenocarcinoma-with-an-intestinal-phenotype weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-iv-ketamine-for-treatment-of-depression-in-inpatient-medical-or-consultation-liaison-psychiatry-settings weekly 0.8 https://www.themednet.org/when-do-you-consider-incorporating-an-antihistamine-into-the-treatment-of-patients-with-long-covid-related-neuropsychiatric-symptoms weekly 0.8 https://www.themednet.org/how-do-you-advise-women-to-manage-wound-care-for-breast-brachytherapy-needle-sites-for-long-term-cosmetic-outcomes weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-pemphigus-vulgaris-about-the-risk-of-a-flare-in-the-radiation-treatment-field weekly 0.8 https://www.themednet.org/in-what-scenarios-outside-of-cryptococcal-meningitis-do-you-use-flucytosine-as-adjunctive-antifungal-therapy weekly 0.8 https://www.themednet.org/for-women-with-iron-deficiency-from-heavy-uterine-bleeding-do-you-have-concerns-about-the-use-of-nsaids-for-controlling-menorrhagia-given-potential-nsaid-induced-platelet-dysfunction weekly 0.8 https://www.themednet.org/in-an-elderly-male-with-recurrent-unilateral-exudative-pleural-effusion-ana-1-1280-homogeneous-and-anti-smith-antibody-but-no-other-lupus-features-how-do-you-decide-between-escalating-immunosuppression-versus-pursuing-pleurodesis weekly 0.8 https://www.themednet.org/are-you-less-likely-to-use-cefiderocol-for-carbapenem-resistant-gram-negative-bloodstream-infections-based-on-the-game-changer-trial-showing-non-inferiority-to-standard-of-care-antibiotics weekly 0.8 https://www.themednet.org/how-do-you-approach-the-risk-benefit-discussion-with-patients-when-you-are-considering-starting-menopausal-hrt weekly 0.8 https://www.themednet.org/do-you-use-doxepin-for-insomnia-refractory-to-other-medical-cbt-based-therapies-if-so-in-what-type-s-of-insomnia-do-you-find-it-most-helpful weekly 0.8 https://www.themednet.org/what-strategies-do-you-find-most-helpful-when-discussing-recommendations-for-ongoing-covid-19-vaccinations weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-a-patient-with-sjoegrens-associated-cryoglobulinemic-vasculitis-who-has-worsening-renal-function-but-kidney-biopsy-is-not-feasible weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-bilateral-breast-cancer-her2-positive-on-one-side-and-her2-negative-on-the-contralateral-side-specifically-in-regards-to-adjuvant-cdk4-6i-vs-neratinib weekly 0.8 https://www.themednet.org/how-do-you-evaluate-and-manage-rezdiffra-resmetirom-induced-abnormal-thyroid-function-tests weekly 0.8 https://www.themednet.org/what-can-cause-a-vertebra-to-be-hyperdense-on-bone-density-testing-and-thus-excluded-other-than-vertebral-fracture-or-degenerative-change weekly 0.8 https://www.themednet.org/when-if-ever-is-it-permissible-to-contact-a-patients-outside-prescriber-about-suspected-prescription-medication-misuse-without-the-patients-consent weekly 0.8 https://www.themednet.org/how-long-after-a-successful-parathyroid-surgery-would-you-reassess-bone-density-in-a-patient-with-severe-osteoporosis weekly 0.8 https://www.themednet.org/what-insulin-pump-features-and-settings-do-you-utilize-in-patients-with-diabetes-and-end-stage-renal-disease-on-intermittent-hemodialysis-or-home-peritoneal-dialysis weekly 0.8 https://www.themednet.org/do-you-routinely-include-bone-marrow-examination-in-your-initial-evaluation-of-a-patient-with-chronic-myeloid-leukemia weekly 0.8 https://www.themednet.org/how-do-you-manage-a-painful-nodule-that-is-presumably-due-to-fat-necrosis-at-an-insulin-injection-site weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-immunosuppressive-therapy-in-patients-with-rheumatoid-arthritis-and-underlying-immunodeficiency-such-as-iga-deficiency weekly 0.8 https://www.themednet.org/how-do-you-approach-the-decision-between-lentiviral-gene-therapy-enzyme-replacement-therapy-or-allogeneic-hematopoietic-stem-cell-transplantation-for-managing-patients-with-ada-scid weekly 0.8 https://www.themednet.org/what-factors-guide-your-selection-of-low-dose-doxycycline-versus-other-tetracyclines-in-the-management-of-papulopustular-rosacea weekly 0.8 https://www.themednet.org/do-you-recommend-oral-methylcobalamin-to-reduce-the-incidence-of-hand-foot-syndrome-in-patients-undergoing-chemotherapy weekly 0.8 https://www.themednet.org/are-there-certain-patients-with-history-of-mild-allergic-like-reactions-in-whom-you-still-recommend-glucocorticoids-or-antihistamines-as-premedication-for-iodinated-contrast-despite-recent-guidelines-no-longer-supporting-this weekly 0.8 https://www.themednet.org/how-are-you-incorporating-oral-kallikrein-inhibitors-into-the-treatment-of-hereditary-angioedema-attacks weekly 0.8 https://www.themednet.org/what-strategies-do-you-use-to-manage-pruritus-in-patients-discontinuing-cetirizine-or-levocetirizine-after-long-term-use weekly 0.8 https://www.themednet.org/how-do-you-counsel-a-pregnant-patient-with-asthma-who-expresses-concerns-about-the-safety-of-inhaled-corticosteroids-and-their-use-during-pregnancy weekly 0.8 https://www.themednet.org/do-you-use-eosinophil-count-to-inform-your-decision-about-whether-to-use-inhaled-steroids-in-a-patient-with-bronchiectasis weekly 0.8 https://www.themednet.org/is-there-any-role-for-routine-ct-tavr-a-few-months-after-tavr-to-look-for-halt weekly 0.8 https://www.themednet.org/how-do-you-choose-between-dupilumab-and-mepolizumab-for-managing-copd-in-patients-with-eosinophilia weekly 0.8 https://www.themednet.org/how-do-you-determine-whether-critically-ill-patients-will-benefit-more-from-a-high-protein-feeding-strategy-compared-to-a-standard-protein-formula weekly 0.8 https://www.themednet.org/what-strategies-are-effective-for-managing-cough-in-patients-receiving-inhaled-treprostinil weekly 0.8 https://www.themednet.org/have-you-seen-benefits-to-starting-a-second-smaller-practice-in-addition-to-your-main-practice weekly 0.8 https://www.themednet.org/how-have-you-used-ai-tools-to-help-improve-workflow-with-documentation-and-communication weekly 0.8 https://www.themednet.org/how-do-you-respond-to-concerns-from-patients-about-irreversible-post-ssri-sexual-dysfunction weekly 0.8 https://www.themednet.org/do-you-routinely-use-thrombopoietin-receptor-agonists-like-romiplostim-to-address-chemotherapy-induced-thrombocytopenia-in-solid-tumor-pediatric-oncology-patients weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-patients-with-ra-who-have-paradoxical-eczematous-reaction-while-on-tnf-inhibitor weekly 0.8 https://www.themednet.org/why-is-it-recommended-to-switch-to-a-non-oral-contraceptive-or-add-a-barrier-method-of-contraception-for-4-weeks-after-tirzepatide-initiation-but-not-with-semaglutide weekly 0.8 https://www.themednet.org/which-osteoporosis-medication-is-best-at-improving-bone-density-and-hence-fracture-risk-in-the-wrist weekly 0.8 https://www.themednet.org/what-is-the-optimal-modality-and-radiology-protocol-you-prefer-to-evaluate-stage-upper-urinary-tract-tumors weekly 0.8 https://www.themednet.org/when-do-you-offer-propranolol-for-treatment-of-familial-cerebral-cavernous-malformations weekly 0.8 https://www.themednet.org/in-a-patient-with-prior-biopsy-proven-igg4-related-pachymeningitis-who-develops-recurrent-neurologic-symptoms-years-after-discontinuing-immunosuppression-how-do-you-determine-whether-this-represents-relapse-versus-alternative-etiologies weekly 0.8 https://www.themednet.org/what-are-the-best-practices-for-managing-moderate-to-severe-itching-due-to-methimazole-in-patients-with-graves-hyperthyroidism weekly 0.8 https://www.themednet.org/do-the-results-of-recently-presented-accord-trial-for-ehc-and-gallbladder-cancers-have-implications-for-your-adjuvant-treatment-recommendations weekly 0.8 https://www.themednet.org/in-post-bariatric-surgery-patients-presenting-with-secondary-hyperparathyroidism-what-is-the-optimal-approach-to-assess-calcium-supplementation-adequacy weekly 0.8 https://www.themednet.org/in-pediatric-hodgkin-lymphoma-with-symptomatic-splenomegaly-what-radiotherapy-dose-is-recommended weekly 0.8 https://www.themednet.org/in-pediatric-hodgkin-lymphoma-with-symptomatic-splenomegaly-what-radiotherapy-dose-is-recommended-2 weekly 0.8 https://www.themednet.org/how-would-you-further-risk-stratify-patients-older-than-age-75-with-incidental-findings-of-coronary-artery-anomalies-on-coronary-cta-and-perfusion-imaging-with-small-to-medium-sized-area-of-ischemia-and-is-there-a-threshold-to-consider-referring-them-for- weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-transfusion-reactions-with-lecanemab-both-in-the-immediate-setting-and-with-respect-to-the-prevention-of-reactions-with-future-infusions weekly 0.8 https://www.themednet.org/what-are-the-limits-and-standalone-value-of-volumetric-mri-for-the-preclinical-evaluation-of-dementia weekly 0.8 https://www.themednet.org/what-is-the-optimal-systemic-therapy-for-metastatic-gastric-adenocarcinoma-with-enteroblastic-differentiation-gaed weekly 0.8 https://www.themednet.org/what-were-your-top-takeaways-in-ild-from-acr-convergence-2025 weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-the-diagnosis-of-yao-syndrome-with-manifestations-including-dermatitis-arthralgia-severe-keratoconjunctivitis-sicca-and-gastroparesis-who-has-failed-to-respond-to-dupilumab-and-canakinumab weekly 0.8 https://www.themednet.org/how-do-you-determine-timing-and-whether-or-not-to-rechallenge-a-pediatric-oncology-patient-with-immune-checkpoint-inhibitor-therapy-after-development-of-irae weekly 0.8 https://www.themednet.org/what-is-your-typical-surveillance-imaging-for-a-pediatric-patient-with-history-of-treated-sarcoma-off-therapy weekly 0.8 https://www.themednet.org/what-workup-do-you-complete-for-a-teenage-patient-presenting-with-an-incidentally-discovered-adrenal-mass weekly 0.8 https://www.themednet.org/do-you-recommend-tapering-patients-with-long-term-benzodiazepine-use-for-anxiety-who-are-stable-and-functional-and-assuming-no-side-effects-or-concerns-for-misuse weekly 0.8 https://www.themednet.org/how-would-you-approach-troponin-testing-and-cardiac-monitoring-for-hospitalized-patients-with-mycoplasma-pneumonia-given-recent-findings-of-significant-cardiac-involvement weekly 0.8 https://www.themednet.org/under-what-circumstances-do-you-recommend-the-chikungunya-vaccine-for-travelers-to-areas-without-a-current-outbreak-but-with-elevated-risk-especially-for-extended-stays weekly 0.8 https://www.themednet.org/what-additional-risk-features-if-any-would-sway-you-to-offer-chemotherapy-in-premenopausal-women-with-er-her2-node-positive-patients-whose-oncotype-is-11 weekly 0.8 https://www.themednet.org/would-you-always-pursue-excisional-biopsy-versus-core-biopsy-to-confirm-kikuchis-disease weekly 0.8 https://www.themednet.org/would-you-offer-an-adjuvant-aromatase-inhibitor-following-capecitabine-to-a-post-menopausal-patient-with-er-0-pr-5-her2-0-with-poor-tolerance-to-neoadjuvant-chemotherapy-with-residual-ypt2n0m0 weekly 0.8 https://www.themednet.org/what-is-your-approach-to-handling-negative-cognitive-side-effects-of-atypical-typical-antipsychotics weekly 0.8 https://www.themednet.org/should-we-be-considering-vaccinating-certain-patients-prior-to-initiation-of-rhapsido weekly 0.8 https://www.themednet.org/how-could-portable-next-generation-sequencing-of-tear-samples-be-integrated-into-clinical-practice-for-diagnosing-corneal-ulcers weekly 0.8 https://www.themednet.org/when-is-it-appropriate-to-treat-splenic-metastasis-with-radiation weekly 0.8 https://www.themednet.org/would-you-consider-using-thalidomide-for-treating-hiv-associated-tuberculosis-iris-in-adult-patients-who-have-poor-response-or-intolerance-to-corticosteroid-therapy weekly 0.8 https://www.themednet.org/do-you-ever-consider-sodium-supplementation-to-augment-diuresis-in-patients-hospitalized-with-decompensated-heart-failure-as-discussed-in-a-recent-systematic-review-and-meta-analysis weekly 0.8 https://www.themednet.org/which-essential-tremor-phenotypes-benefit-most-from-wearable-peripheral-nerve-stimulator-devices weekly 0.8 https://www.themednet.org/what-is-the-recommendation-for-persistent-pet-uptake-and-elevated-catecholamines-at-4-months-following-subtotal-resection-and-adjuvant-radiation-for-a-thoracic-secretory-paraganglioma weekly 0.8 https://www.themednet.org/do-you-offer-low-dose-rt-for-achilles-tendonitis weekly 0.8 https://www.themednet.org/in-managing-esophageal-papillomas-under-what-circumstances-is-high-risk-hpv-testing-indicated-and-is-endoscopic-surveillance-warranted weekly 0.8 https://www.themednet.org/how-do-you-incorporate-patients-spiritual-or-religious-beliefs-into-psychiatric-care weekly 0.8 https://www.themednet.org/how-do-you-bring-up-race-and-racism-in-a-psychiatric-encounter-in-a-way-that-builds-trust-with-your-patient weekly 0.8 https://www.themednet.org/how-do-you-approach-the-decision-to-start-clozapine-in-an-inpatient-setting-when-outpatient-follow-up-resources-are-limited-or-the-patients-ability-to-engage-in-follow-up-is-uncertain weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-history-of-cocaine-use-presenting-with-chronic-sinusitis-and-acute-vision-loss-from-an-extensive-inflammatory-changes-in-the-sinus-and-orbit-compressing-the-optic-nerve-with-negative-anca-inconclusive-nasal-biopsy-and weekly 0.8 https://www.themednet.org/when-is-it-useful-to-obtain-vestibular-testing-for-patients-with-chronic-dizziness weekly 0.8 https://www.themednet.org/how-are-you-approaching-psa-screening-in-men-with-no-family-history-or-symptoms weekly 0.8 https://www.themednet.org/how-can-advanced-imaging-tools-and-ai-help-distinguish-small-benign-melanocytic-lesions-from-early-melanoma weekly 0.8 https://www.themednet.org/does-continuous-platelet-transfusion-reduce-platelet-refractoriness-in-ecmo weekly 0.8 https://www.themednet.org/which-oral-chemotherapy-regimen-do-you-use-in-relapsed-fusion-positive-rhabdomyosarcoma weekly 0.8 https://www.themednet.org/when-do-you-attempt-penicillin-de-labeling-in-hospitalized-patients weekly 0.8 https://www.themednet.org/what-is-your-approach-to-post-kidney-transplant-erythrocytosis-if-a-patient-is-already-on-an-acei-and-is-asymptomatic-but-with-a-hb-that-is-consistently-18 weekly 0.8 https://www.themednet.org/do-you-forego-aspirin-use-in-essential-thrombocythemia-if-they-are-already-on-clopidogrel weekly 0.8 https://www.themednet.org/what-degree-of-treatment-related-hypocalcemia-would-you-tolerate-with-denosumab-before-switching-agents weekly 0.8 https://www.themednet.org/what-are-your-key-takeaways-regarding-the-difference-in-findings-for-beta-mi-danblock-and-reboot-in-patients-post-mi-with-lvef-40 weekly 0.8 https://www.themednet.org/in-patients-with-intellectual-disability-and-persistent-aggressive-behaviors-despite-multiple-antipsychotic-trials-have-you-found-pimavanserin-to-be-a-useful-adjunctive-treatment weekly 0.8 https://www.themednet.org/for-a-patient-with-a-salivary-gland-tumor-with-evidence-of-local-recurrence-would-you-recommend-6-weekly-fractions-if-giving-rt-alone weekly 0.8 https://www.themednet.org/are-there-specific-combinations-of-dmards-and-or-biologics-that-you-avoid-due-to-elevated-infection-risk-or-other-safety-concerns weekly 0.8 https://www.themednet.org/with-the-recent-bart-trial-how-would-you-manage-a-positive-ureter-margin-that-is-now-part-of-the-urostomy weekly 0.8 https://www.themednet.org/what-history-or-physical-exam-findings-do-you-find-most-helpful-to-distinguish-peripheral-versus-central-causes-of-vertigo-in-the-primary-care-setting weekly 0.8 https://www.themednet.org/at-what-age-and-how-often-do-you-screen-for-osteoporosis-in-non-ambulatory-e-g-developmentally-disabled-young-adults-without-other-risk-factors weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-either-requesting-to-have-you-order-or-have-obtained-multi-cancer-early-detection-panels-from-another-provider-does-your-recommendation-change-in-those-who-are-high-risk-by-personal-risk-factors-or-family-history weekly 0.8 https://www.themednet.org/how-do-you-approach-duration-of-antibiotic-therapy-in-a-patient-with-persistent-neutropenia-and-a-known-clinically-diagnosed-bacterial-infection weekly 0.8 https://www.themednet.org/how-do-you-identify-and-treat-autoimmune-hearing-loss weekly 0.8 https://www.themednet.org/how-long-do-you-typically-treat-a-brain-abscess-secondary-to-fusobacterium-species weekly 0.8 https://www.themednet.org/how-do-you-or-your-practice-group-handle-patient-referrals-to-your-outpatient-id-clinic-for-suspected-delusion-infestation-parasitosis weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-h-pylori-infection-in-people-living-with-hiv-considering-the-increased-risk-of-antibiotic-resistance-and-potential-drug-interactions-with-antiretroviral-therapy weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-patient-with-systemic-sclerosis-and-optic-perineuritis weekly 0.8 https://www.themednet.org/if-approved-how-will-you-choose-between-disitamab-vedotin-toripalimib-dv-t-and-ev-pembro-ev-303-in-those-patients-with-her2-muc weekly 0.8 https://www.themednet.org/what-false-positive-findings-if-any-do-you-see-in-patients-who-have-active-hepatitis-c weekly 0.8 https://www.themednet.org/what-features-would-make-you-think-a-new-onset-hemolytic-anemia-is-related-to-known-chronic-phase-cml weekly 0.8 https://www.themednet.org/in-cases-of-significant-bmd-loss-without-fractures-while-on-long-term-denosumab-therapy-and-in-the-presence-of-very-low-bone-turnover-markers-without-secondary-causes-for-bone-loss-what-is-best-approach-continuing-denosumab-anyway-or-switching-to-a-bispho weekly 0.8 https://www.themednet.org/are-there-circumstances-where-you-would-treat-with-antibiotics-if-a-catheter-tip-culture-is-positive-for-a-pathogenic-organism-blood-cultures-are-negative-and-the-catheter-was-removed-from-an-icu-patient-for-suspected-infection weekly 0.8 https://www.themednet.org/do-you-repeat-post-splenectomy-vaccines-if-they-were-administered-on-postoperative-day-1-of-emergency-splenectomy-or-do-you-count-those-doses-as-valid weekly 0.8 https://www.themednet.org/is-ivig-ever-used-to-treat-cns-neurosarcoidosis-related-pain-when-the-presentation-is-not-consistent-with-peripheral-neurosarcoid-involvement weekly 0.8 https://www.themednet.org/when-starting-rezdiffra-resmetirom-what-labs-do-you-get-for-monitoring-and-at-what-interval weekly 0.8 https://www.themednet.org/when-if-ever-would-you-recommend-the-co-administration-of-oral-anticoagulants-with-nsaids weekly 0.8 https://www.themednet.org/what-patient-factors-influence-your-recommendation-of-daily-or-every-other-day-iron-for-the-treatment-of-iron-deficiency-anemia weekly 0.8 https://www.themednet.org/how-do-you-manage-pemphigus-vulgaris-in-patients-who-lack-insurance-coverage-for-biologics-and-routine-laboratory-monitoring weekly 0.8 https://www.themednet.org/in-an-older-patient-with-pembrolizumab-associated-chronic-eczematous-dermatitis-worsened-by-dupilumab-and-with-biopsies-showing-spongiotic-dermatitis-with-atypical-lymphocytes-would-a-trial-of-a-jak-inhibitor-be-appropriate-while-monitoring-for-possible-e weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-who-has-been-on-denosumab-for-7-years-and-is-now-found-to-have-progressive-bony-erosions-of-the-external-auditory-canal-which-the-treating-neurotologist-suspects-are-secondary-to-denosumab weekly 0.8 https://www.themednet.org/in-a-patient-with-newly-diagnosed-with-antisynthetase-syndrome-without-clinical-myositis-who-presents-with-organizing-pneumonia-and-improves-on-high-dose-corticosteroids-what-factors-should-guide-the-selection-of-long-term-immunosuppressive-therapy weekly 0.8 https://www.themednet.org/can-procalcitonin-be-used-as-a-marker-for-endothelial-dysfunction-emanating-from-chronic-inflammation-of-obesity weekly 0.8 https://www.themednet.org/how-do-you-differentiate-fibromuscular-dysplasia-from-pan-abdominal-vasculitis weekly 0.8 https://www.themednet.org/is-the-frax-score-reliable-in-assessing-fracture-risk-for-patients-with-history-of-prior-bisphosphonate-use weekly 0.8 https://www.themednet.org/how-do-you-determine-total-duration-of-treatment-for-complicated-gbs-meningitis weekly 0.8 https://www.themednet.org/do-you-give-fosaprepitant-or-other-nk1-antagonist-for-emetogenic-prophylaxis-when-giving-ifosfamide-containing-regimens weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-patients-with-primary-membranous-nephropathy-and-a-positive-anti-pla2r-antibody-test-who-are-being-considered-for-kidney-transplantation weekly 0.8 https://www.themednet.org/when-would-you-use-ofatumumab-for-anti-nmdar-autoimmune-encephalitis weekly 0.8 https://www.themednet.org/when-would-you-use-memantine-for-autism-spectrum-disorder weekly 0.8 https://www.themednet.org/how-extensive-of-an-infectious-workup-would-you-consider-appropriate-for-a-nursing-home-resident-with-dementia-who-is-otherwise-healthy-has-a-fever-is-hemodynamically-stable-and-without-localizing-signs-or-symptoms weekly 0.8 https://www.themednet.org/what-are-useful-clinical-features-that-help-differentiate-mechanics-hands-from-other-conditions-such-as-hand-dermatitis-or-psoriasis weekly 0.8 https://www.themednet.org/would-an-exercise-treadmill-stress-test-in-a-patient-with-known-cad-who-did-not-reach-85-of-mphr-due-to-fatigue-be-considered-low-risk-based-on-a-dts-of-5-or-non-diagnostic weekly 0.8 https://www.themednet.org/are-there-any-trans-cathter-options-available-in-a-patient-s-p-m-teer-with-residual-severe-mr-with-high-surgical-risk-who-has-worsening-heart-failure-symptoms weekly 0.8 https://www.themednet.org/what-imaging-modality-or-testing-would-be-reasonable-to-work-up-recurrent-near-syncope-in-a-patient-with-known-asymmetric-septal-hypertrophy-previously-seen-on-tte weekly 0.8 https://www.themednet.org/should-cyp2c19-genotype-testing-be-performed-in-patients-presenting-with-isr-on-plavix weekly 0.8 https://www.themednet.org/when-should-hysterectomy-with-oophorectomy-be-recommended-for-a-patient-with-treatment-refractory-premenstrual-depressive-disorder weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-livido-vasculitis weekly 0.8 https://www.themednet.org/how-do-you-decide-who-would-be-a-candidate-for-a-prosthetic-iris-implant-and-what-pre-op-evaluation-or-testing-do-you-do weekly 0.8 https://www.themednet.org/is-there-cross-reactivity-between-propylene-glycol-and-others-such-as-caprylyl-glycol-and-glycol-distearate weekly 0.8 https://www.themednet.org/what-is-the-recommended-dose-of-aspirin-for-prevention-of-colon-polyp weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-scleroderma-who-present-with-finger-ulcerations-without-other-signs-of-soft-tissue-infection-and-mri-demonstrates-potential-concern-for-osteomyelitis weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-who-request-general-hormone-testing-without-any-medical-reason-to-do-so weekly 0.8 https://www.themednet.org/have-you-started-integrating-gender-affirming-care-services-in-your-primary-care-clinic weekly 0.8 https://www.themednet.org/based-on-the-most-recent-available-data-are-you-encouraging-healthy-adults-to-be-vaccinated-against-covid-in-order-to-decrease-their-risk-for-long-covid-post-acute-sequelae-of-covid weekly 0.8 https://www.themednet.org/for-a-patient-with-metastatic-poorly-differentiated-esophageal-adenocarcinoma-with-an-excellent-systemic-response-to-chemotherapy-for-1-year-who-now-presents-with-isolated-local-progression-and-no-new-distant-disease-would-you-consider-treating-the-primar weekly 0.8 https://www.themednet.org/how-do-you-decide-to-drop-the-dose-of-the-allergen-after-a-patient-has-successfully-completed-oit weekly 0.8 https://www.themednet.org/will-the-results-of-alliance-a011104-acrin-6694-change-your-current-practice-regarding-preoperative-mris-in-patients-with-newly-diagnosed-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/do-you-prefer-a-specific-clinical-scoring-system-to-determine-if-a-patient-needs-to-be-tested-for-group-a-streptococcal-pharyngitis weekly 0.8 https://www.themednet.org/do-you-recommend-aspirin-for-thromboprophylaxis-in-patients-with-lower-risk-asymptomatic-myelofibrosis-with-thrombocytosis weekly 0.8 https://www.themednet.org/would-you-include-draining-lymphatics-as-part-of-an-adjuvant-radiotherapy-course-following-gross-total-resection-of-sinonasal-sarcoma weekly 0.8 https://www.themednet.org/how-do-you-determine-initial-dosing-strategy-for-iv-nitroglycerin-to-improve-respiratory-status-and-prevent-intubation-in-patients-with-flash-pulmonary-edema-or-sympathetic-crashing-acute-pulmonary-edema-scape weekly 0.8 https://www.themednet.org/does-the-pfs-and-os-data-presented-at-esmo-2025-for-engot-ov65-keynote-b96-pembrolizumab-paclitaxel-bevacizumab-influence-how-you-will-incorporate-io-therapy-into-platinum-resistant-ovarian-cancer weekly 0.8 https://www.themednet.org/do-you-use-cd19-b-cell-levels-to-help-guide-rituximab-redosing-in-ctd-ild-particularly-in-a-patient-already-on-mycophenolate-whose-disease-now-appears-predominantly-fibrotic-with-resolved-ground-glass weekly 0.8 https://www.themednet.org/for-cisplatin-ineligible-pt4n0m0-renal-pelvis-utuc-without-prior-neoadjuvant-therapy-do-you-prefer-adjuvant-carboplatin-gemcitabine-pout-or-immunotherapy-checkmate-274 weekly 0.8 https://www.themednet.org/what-systemic-chemotherapy-would-you-consider-for-recurrent-intimal-sarcoma-in-patient-who-is-chemo-naive weekly 0.8 https://www.themednet.org/would-you-provide-yellow-fever-vaccination-or-recommend-insect-precautions-only-in-otherwise-immunocompetent-patients-over-70-years-of-age-who-plan-to-travel-to-endemic-regions-given-the-increased-risks-of-adverse-events-with-vaccination-with-advancing-ag weekly 0.8 https://www.themednet.org/in-what-scenario-would-you-choose-to-order-a-peth-over-urine-etg-and-vice-versa-if-there-is-suspicion-of-alcohol-use-in-a-patient-with-chronic-liver-disease-or-cirrhosis weekly 0.8 https://www.themednet.org/is-there-a-role-for-focal-radiation-in-peritoneal-mesothelioma-following-cytoreductive-surgery-hipec weekly 0.8 https://www.themednet.org/in-light-of-evidence-supporting-enfortumab-vedotin-with-pembrolizumab-evp-in-muscle-invasive-urothelial-cancer-would-one-consider-perioperative-evp-for-node-negative-high-risk-utuc weekly 0.8 https://www.themednet.org/what-potential-challenges-do-you-foresee-in-transitioning-from-current-endocrine-therapies-to-giredestrant-based-on-the-lidera-trial-results-in-er-her2-early-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-patient-with-metastatic-osteosarcoma-requiring-limb-amputation-for-local-control-if-patient-parents-refuse-surgery weekly 0.8 https://www.themednet.org/what-is-your-preferred-adjuvant-regimen-in-upper-tract-urothelial-carcinoma-patients-with-gfr-in-the-40-50-range-and-positive-circulating-tumor-dna weekly 0.8 https://www.themednet.org/would-you-consider-prophylactic-anticoagulation-with-a-doac-instead-of-low-molecular-weight-heparin-in-a-patient-with-newly-diagnosed-cushings-syndrome weekly 0.8 https://www.themednet.org/is-there-any-hemodynamic-benefit-in-continuing-entresto-for-end-stage-heart-failure-in-patients-on-palliative-dobutamine weekly 0.8 https://www.themednet.org/what-are-your-preferred-treatments-for-relapsing-remitting-multiple-sclerosis-with-comorbid-ibd weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-young-woman-referred-for-isolated-active-anterior-scleritis-with-a-history-of-resolved-right-eye-iritis-in-the-absence-of-systemic-manifestations-or-end-organ-involvement-but-with-serologies-notable-for-strongly-posi weekly 0.8 https://www.themednet.org/have-you-suggested-the-use-of-lions-mane-supplementation-for-patients-looking-to-improve-focus-and-or-cognition weekly 0.8 https://www.themednet.org/how-do-you-manage-b12-deficiency-secondary-to-lithium-treatment weekly 0.8 https://www.themednet.org/do-you-generally-request-igg4-staining-on-all-of-your-salivary-gland-biopsies-in-seronegative-patients-presenting-with-dry-mouth weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-order-blood-based-biomarker-testing-for-alzheimers-disease-and-which-one-to-choose weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-treated-for-a-stage-i-glottic-cancer-2-years-prior-with-a-biopsy-proven-recurrence-who-is-declining-surgery-and-any-systemic-therapy weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-to-recommend-adjuvant-radiotherapy-for-children-teenagers-with-salivary-gland-low-grade-adenoid-cystic-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-approach-a-new-fever-that-occurs-within-24-to-48-hours-after-a-procedure weekly 0.8 https://www.themednet.org/for-patients-with-relapsed-refractory-follicular-lymphoma-receiving-mosunetuzumab-when-if-ever-would-you-consider-transitioning-from-intravenous-to-subcutaneous-administration weekly 0.8 https://www.themednet.org/what-is-your-typical-approach-to-antibiotic-management-for-severe-necrotizing-mssa-pneumonia-with-concurrent-mssa-bacteremia-assuming-no-overt-antibiotic-contraindications-and-tte-without-evidence-of-endocarditis weekly 0.8 https://www.themednet.org/in-patients-with-rheumatologic-disease-which-specific-conditions-are-most-strongly-associated-with-mitral-valve-abnormalities-ex-libman-sacks-endocarditis-valvulitis-or-mitral-regurgitation-and-how-does-this-influence-your-approach-to-screening-monitoring weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-when-there-is-a-multiple-sclerosis-reactivation-while-on-natalizumab weekly 0.8 https://www.themednet.org/what-o2-saturation-goal-do-you-target-when-managing-copd-exacerbations-considering-conflicting-guidelines-with-some-recommending-88-92-and-others-90 weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-use-xa-levels-or-ptt-for-monitoring-systemic-anticoagulation-when-bridging-anticoagulants weekly 0.8 https://www.themednet.org/do-you-recommend-against-use-of-enteric-coated-aspirin-as-opposed-to-plain-aspirin-for-secondary-prevention-of-stroke-or-mi weekly 0.8 https://www.themednet.org/in-what-scenario-would-you-opt-to-perform-an-mri-pdff-in-a-patient-with-masld-mash-or-in-whom-you-suspect-has-this-why-would-you-opt-for-this-over-a-fibroscan-or-other-nilda weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-use-of-lipoprotein-a-as-part-of-the-cardiometabolic-profile-of-a-patient-suspected-to-have-or-with-masld-mash weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-taper-women-on-hrt-for-vasomotor-symptoms-of-menopause-and-what-is-your-recommended-taper weekly 0.8 https://www.themednet.org/have-you-implemented-the-strategy-of-low-intensity-patient-directed-education-to-support-tapering-benzodiazepines-in-older-adults-in-your-practice-if-so-how-does-it-compare-in-real-world-effectiveness-to-cbt-i-referrals-or-traditional-clinician-driven-tap weekly 0.8 https://www.themednet.org/in-what-situations-would-you-utilize-radiation-therapy-for-management-of-high-grade-urothelial-carcinoma-of-the-prostate weekly 0.8 https://www.themednet.org/would-you-consider-extending-tepezza-treatment-for-thyroid-eye-disease-management-in-patients-with-incomplete-response weekly 0.8 https://www.themednet.org/based-on-the-most-recent-clinical-trials-like-elan-how-soon-should-doac-initiation-be-considered-following-an-afib-related-cardioembolic-cva-given-the-risk-for-hemorrhagic-transformation weekly 0.8 https://www.themednet.org/does-the-degree-of-blood-pressure-elevation-impact-your-initial-choice-s-for-antihypertensive weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-suspected-meningiomatosis weekly 0.8 https://www.themednet.org/would-you-consider-adding-pembrolizumab-to-chemoradiation-for-locally-advanced-cervical-cancer-in-a-patient-with-cirrhosis-elevated-bilirubin-3x-uln-and-mild-lft-elevation-ascites-and-signs-of-portal-hypertension weekly 0.8 https://www.themednet.org/what-strategies-do-you-use-when-initiating-treatment-for-complex-livedoid-vasculitis-in-a-patient-you-cannot-follow-long-term-especially-when-therapy-is-limited-to-conservative-measures-due-to-medication-contraindications weekly 0.8 https://www.themednet.org/what-is-your-preferred-management-for-persistent-viable-cervical-tumor-6-months-after-high-quality-chemoradiation-with-keynote-a-18-regimen-for-locally-advanced-cervical-cancer weekly 0.8 https://www.themednet.org/how-do-you-adjust-holding-parameters-for-beta-blockers-based-on-a-patients-baseline-heart-rate-and-blood-pressure weekly 0.8 https://www.themednet.org/which-ssris-do-you-prefer-in-woman-who-are-considering-pregnancy weekly 0.8 https://www.themednet.org/what-clinical-features-help-distinguish-classical-or-vascular-eds-from-hypermobile-eds-in-patients-presenting-with-joint-hypermobility weekly 0.8 https://www.themednet.org/whats-your-drug-of-choice-for-patients-with-stable-antisynthetase-nsip-ild-and-overlap-ra-ccp-with-significant-polyarthritis-as-main-manifestation weekly 0.8 https://www.themednet.org/what-are-your-thoughts-experience-with-using-horse-chestnut-extract-to-augment-other-therapies-in-chronic-venous-insufficiency weekly 0.8 https://www.themednet.org/have-you-found-using-vitamin-k2-supplements-for-refractory-nocturnal-leg-cramps-helpful-for-your-patients weekly 0.8 https://www.themednet.org/have-you-used-suzetrigine-for-acute-pain-if-so-has-it-been-affordable-effective-for-your-patients weekly 0.8 https://www.themednet.org/what-is-your-approach-to-tapering-infantile-spasms-treatments weekly 0.8 https://www.themednet.org/what-strategies-resources-do-you-use-to-switch-between-ssris weekly 0.8 https://www.themednet.org/do-you-routinely-use-systemic-corticosteroids-for-treatment-of-fat-embolism-in-patients-who-are-hemodynamically-stable weekly 0.8 https://www.themednet.org/what-is-your-preferred-medication-of-choice-for-uti-prophylaxis-in-older-men-with-chronic-indwelling-catheters-and-recurrent-utis weekly 0.8 https://www.themednet.org/would-you-modify-the-postoperative-radiation-dose-to-a-pancreas-tumor-bed-in-the-setting-of-a-remote-history-of-prior-abdominal-rt-specifically-with-regard-cumulative-small-bowel-dose weekly 0.8 https://www.themednet.org/do-you-recommend-sglt2-inhibitors-be-held-for-3-4-days-prior-to-an-elective-diagnostic-cardiac-catheterization-or-coronary-intervention-if-the-patient-is-made-npo-the-day-of-the-procedure weekly 0.8 https://www.themednet.org/considering-the-ubiquitous-use-of-health-wearables-have-you-incorporated-hr-variability-in-identifying-impending-or-chronic-illness weekly 0.8 https://www.themednet.org/how-would-you-approach-incorporating-wearable-technology-in-your-assessment-of-frailty-of-older-patients weekly 0.8 https://www.themednet.org/how-do-you-distinguish-between-neutropenic-enterocolitis-and-ici-related-colitis-in-a-patient-concurrently-treated-with-chemotherapy-and-immunotherapy weekly 0.8 https://www.themednet.org/can-you-use-nippv-in-someone-who-has-a-decannulated-tracheal-stoma weekly 0.8 https://www.themednet.org/do-you-prescribe-glp-1-agonists-to-diabetic-patients-admitted-with-minor-cva-or-tia-for-secondary-stroke-prevention-as-suggested-by-the-lamp-trial weekly 0.8 https://www.themednet.org/what-is-your-stepwise-approach-to-monitoring-and-treating-labile-bp-readings-in-the-outpatient-setting weekly 0.8 https://www.themednet.org/can-phentermine-use-be-associated-with-development-of-osteoporosis weekly 0.8 https://www.themednet.org/in-a-young-patient-with-stage-iiib-low-lying-rectal-cancer-who-is-s-p-8-cycles-of-folfox-do-you-prefer-short-or-long-course-radiation-prior-to-surgery weekly 0.8 https://www.themednet.org/do-the-results-of-optitrop-lung04-change-your-management-of-patients-with-tki-resistant-egfr-mutated-advanced-nsclc weekly 0.8 https://www.themednet.org/which-ssris-and-snris-are-least-likely-to-cause-gi-symptoms weekly 0.8 https://www.themednet.org/how-do-you-think-about-the-relative-safety-of-lisdexamfetamine-vyvanse-versus-mixed-amphetamine-salts-adderall-xr-during-pregnancy weekly 0.8 https://www.themednet.org/would-you-consider-upadacitinib-for-gca-in-a-patient-with-history-of-breast-cancer-now-in-remission weekly 0.8 https://www.themednet.org/is-rechallenge-with-nivolumab-appropriate-after-a-non-sjs-em-like-vesicobullous-eruption-with-limited-mucosal-disease weekly 0.8 https://www.themednet.org/what-prognostic-models-have-been-developed-to-predict-hcc-risk-in-hcv-patients-post-svr weekly 0.8 https://www.themednet.org/have-you-started-using-novel-oral-antibiotics-such-as-gepotidacin-for-mdr-utis-and-stis weekly 0.8 https://www.themednet.org/for-patients-initially-presenting-with-fever-who-are-not-improving-clinically-but-cultures-and-imaging-are-all-negative-after-48-72-hours-how-do-you-weigh-other-biomarkers-such-as-wbcs-procalcitonin-crp-etc-when-deciding-to-discontinue-antibiotics weekly 0.8 https://www.themednet.org/how-do-you-think-about-evaluation-and-treatment-for-low-testosterone-in-middle-aged-men-with-fatigue-borderline-levels-and-no-findings-on-exam weekly 0.8 https://www.themednet.org/what-are-the-clinical-prompts-that-lead-you-to-consider-de-intensifying-diabetes-treatment-in-older-adults weekly 0.8 https://www.themednet.org/what-is-your-experience-and-approach-with-discontinuation-withdrawal-syndromes-from-maois weekly 0.8 https://www.themednet.org/in-patients-with-diarrhea-anemia-and-or-weight-loss-do-you-ask-about-infertility-and-miscarriages-since-this-can-be-associated-with-celiac-disease weekly 0.8 https://www.themednet.org/how-do-you-approach-evaluation-of-langerhans-cell-histiocytosis weekly 0.8 https://www.themednet.org/given-the-potential-effects-of-marijuana-on-cortisol-secretion-how-long-should-patients-abstain-from-cannabis-use-before-undergoing-cortisol-testing-to-avoid-interference-with-results weekly 0.8 https://www.themednet.org/is-there-a-benefit-to-a-gluten-free-diet-in-a-patient-with-high-positive-serology-but-no-identifiable-intestinal-symptoms-normal-endoscopy-and-no-clear-extra-intestinal-symptoms weekly 0.8 https://www.themednet.org/how-would-you-approach-pharmacological-treatment-of-pain-related-to-nonoperative-severe-spinal-stenosis-in-elderly-individuals-to-improve-function weekly 0.8 https://www.themednet.org/do-you-have-any-experience-using-conolidine-supplementation-as-an-adjuvant-for-pain-relief-if-so-what-brand-do-you-typically-recommend weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjusting-a-course-of-transcranial-magnetic-stimulation-depending-on-how-a-patient-responds-or-lack-thereof weekly 0.8 https://www.themednet.org/what-topical-treatments-are-most-effective-and-well-tolerated-for-condyloma-acuminata weekly 0.8 https://www.themednet.org/does-treatment-with-il-23-inhibitors-such-as-risankizumab-skyrizi-impair-clearance-of-scabies weekly 0.8 https://www.themednet.org/should-household-contacts-of-haemophilus-influenza-invasive-disease-patients-be-given-immediate-antibiotic-prophylaxis weekly 0.8 https://www.themednet.org/do-you-apply-any-fev1-cutoffs-that-would-prohibit-patients-from-undergoing-cardiac-surgery weekly 0.8 https://www.themednet.org/in-a-patient-with-idiopathic-pulmonary-fibrosis-ipf-who-has-been-advised-to-undergo-multiple-hyperbaric-oxygen-therapy-sessions-for-a-non-healing-wound-how-would-you-approach-management-from-a-pulmonologists-perspective weekly 0.8 https://www.themednet.org/is-there-any-testing-that-can-be-performed-to-assess-for-an-amitriptyline-allergy weekly 0.8 https://www.themednet.org/what-strategies-have-you-found-effective-to-establish-appropriate-boundaries-for-patients-who-abuse-or-overuse-messaging-systems weekly 0.8 https://www.themednet.org/how-would-you-manage-moderate-eosinophilia-2-3k-with-no-evidence-of-end-organ-damage weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-a-patient-who-has-both-chronic-hepatitis-b-treatment-naive-elevated-alt-viral-load-1million-and-masld-with-nilda-showing-advanced-fibrosis weekly 0.8 https://www.themednet.org/in-patients-with-sarcoidosis-what-is-your-approach-to-screening-for-hypercalciuria weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-chronic-hepatitis-b-infection-who-test-positive-for-hdv weekly 0.8 https://www.themednet.org/how-would-you-approach-using-pyrazinamide-to-treat-active-pulmonary-tuberculosis-in-an-east-asian-patient-with-a-history-of-gout-with-a-uric-acid-level-of-9-5-mg-dl-who-is-not-on-allopurinol weekly 0.8 https://www.themednet.org/when-do-you-consider-trial-of-oral-antibiotics-for-patients-with-prolonged-cough-and-discolored-sputum-but-without-infiltrate-on-chest-imaging weekly 0.8 https://www.themednet.org/what-non-pharmacologic-approaches-to-chronic-insomnia-have-you-found-helpful-for-your-patients weekly 0.8 https://www.themednet.org/how-do-you-distinguish-heparin-resistance-from-heparin-effect-in-a-patient-receiving-iv-anticoagulation weekly 0.8 https://www.themednet.org/what-clinical-features-in-suspected-anoca-push-you-toward-proceeding-directly-to-invasive-coronary-function-testing-rather-than-empirically-escalating-antianginal-therapy-first weekly 0.8 https://www.themednet.org/would-you-alter-your-approach-in-using-neoadjuvant-radiation-for-a-rectal-cancer-patient-who-has-had-a-prior-radical-prostatectomy-but-no-prior-pelvic-radiation weekly 0.8 https://www.themednet.org/what-systemic-therapy-would-you-choose-in-a-patient-with-pten-deleted-metastatic-uterine-pecoma-who-has-progression-of-disease-after-3-cycles-of-albumin-bound-sirolimus weekly 0.8 https://www.themednet.org/do-we-need-to-start-lactulose-as-prophylaxis-for-hepatic-encephalopathy-post-tips-or-wait-for-signs-of-hepatic-encephalopathy-first weekly 0.8 https://www.themednet.org/what-has-your-clinical-experience-been-with-using-celecoxib-as-an-adjunctive-treatment-for-postpartum-depression weekly 0.8 https://www.themednet.org/in-a-septic-patient-with-a-persistent-map-of-60-65-after-initial-fluids-how-do-you-decide-between-additional-fluids-vs-initiating-vasopressors weekly 0.8 https://www.themednet.org/when-do-you-consider-stopping-telemetry-monitoring-for-patients-admitted-with-syncope-presuming-no-electrolyte-derangements-chest-pain-observed-arrhythmia-etc weekly 0.8 https://www.themednet.org/in-patients-with-bmi-30-but-with-obesity-related-comorbidities-e-g-osa-prediabetes-nafld-how-comfortable-are-you-initiating-glp-1s weekly 0.8 https://www.themednet.org/in-patients-presenting-with-acute-low-back-pain-or-radicular-symptoms-do-you-prescribe-a-short-course-of-oral-steroids weekly 0.8 https://www.themednet.org/in-patients-with-recurrent-bronchitis-episodes-but-no-formal-asthma-copd-diagnosis-at-what-point-would-you-trial-inhaled-corticosteroids weekly 0.8 https://www.themednet.org/in-frail-older-adults-on-doacs-who-meet-only-one-formal-dose-reduction-criterion-but-have-high-bleeding-risk-do-you-ever-empirically-reduce-the-dose weekly 0.8 https://www.themednet.org/how-long-can-you-delay-the-start-of-antiresorptive-therapy-after-completion-of-anabolic-therapy-in-patients-with-severe-osteoporosis-and-recent-invasive-dental-procedures weekly 0.8 https://www.themednet.org/how-long-does-it-typically-take-hypothalamic-pituitary-gonadal-axis-to-recover-without-trt-for-men-with-functional-hypogonadism-undergoing-treatment-for-severe-obesity weekly 0.8 https://www.themednet.org/in-patients-with-graves-disease-how-many-months-post-thyroidectomy-would-you-anticipate-seeing-improvement-in-thyroid-eye-disease-symptoms weekly 0.8 https://www.themednet.org/do-you-offer-post-exposure-prophylaxis-for-patients-with-high-risk-occupational-exposure-to-histoplasmosis weekly 0.8 https://www.themednet.org/do-you-feel-comfortable-continuing-biologics-through-pregnancy weekly 0.8 https://www.themednet.org/would-you-consider-sbrt-for-fibrolamellar-hcc-that-is-inoperable weekly 0.8 https://www.themednet.org/what-is-your-institutional-approach-to-treatment-options-ex-sbrt-chemotherapy-in-liver-transplant-protocols-for-control-of-unresectable-hepatic-colorectal-metastases-while-awaiting-transplant weekly 0.8 https://www.themednet.org/can-cryoglobulins-be-detected-in-patients-with-severe-acrocyanosis-in-the-absence-of-clinical-evidence-of-active-cryoglobulinemic-vasculitis weekly 0.8 https://www.themednet.org/how-do-you-approach-management-autoimmune-lymphoproliferative-syndrome-alps-complicated-by-hlh weekly 0.8 https://www.themednet.org/can-cryoglobulins-be-present-in-the-setting-of-severe-acrocyanosis-without-evidence-of-active-cryoglobulinemic-vasculitis-2 weekly 0.8 https://www.themednet.org/how-do-you-approach-the-management-of-autoimmune-lymphoproliferative-syndrome-complicated-by-hlh weekly 0.8 https://www.themednet.org/under-what-circumstances-do-you-consider-deprescribing-levothyroxine-in-patients-with-mild-subclinical-hypothyroidism weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-experiencing-withdrawal-symptoms-or-worsening-anxiety-agitation-when-tapering-atypical-antipsychotics-that-were-originally-added-to-augment-unipolar-depression-treatment weekly 0.8 https://www.themednet.org/what-specific-stop-rules-do-you-use-during-difficult-native-papilla-biliary-cannulation-e-g-time-cannulation-attempts-pancreatic-duct-wire-passages-injections-to-trigger-an-early-change-in-strategy-such-as-precut-or-referral-escalation weekly 0.8 https://www.themednet.org/in-patients-with-high-risk-cannulation-patterns-despite-rectal-nsaids-what-procedural-threshold-prompts-you-to-place-a-prophylactic-pancreatic-duct-stent weekly 0.8 https://www.themednet.org/for-large-or-impacted-bile-duct-stones-in-normal-anatomy-what-criteria-prompt-you-to-stop-and-stage-therapy-temporary-stent-planned-repeat-ercp-or-referral-rather-than-continue-same-session-extraction weekly 0.8 https://www.themednet.org/how-does-anticipated-technical-difficulty-such-as-prior-incomplete-colonoscopy-severe-diverticulosis-or-high-looping-risk-change-your-target-depth-of-sedation-and-choice-of-regimen weekly 0.8 https://www.themednet.org/what-endoscopic-endpoint-do-you-use-to-decide-whether-to-apply-prophylactic-hemostatic-powder-after-apparent-hemostasis weekly 0.8 https://www.themednet.org/which-ulcer-characteristics-size-location-or-stigmata-prompt-you-to-consider-alternatives-to-prophylactic-powder-and-to-pursue-a-more-durable-hemostasis-strategy-upfront-e-g-over-the-scope-clip-suturing-or-doppler-guided-targeted-therapy weekly 0.8 https://www.themednet.org/in-ulcers-with-a-fibrotic-base-where-clip-attachment-is-poor-and-thermal-therapy-feels-high-risk-do-you-prefer-prophylactic-hemostatic-powder-as-the-adjunct-or-escalate-first-to-a-more-durable-mechanical-therapy-e-g-over-the-scope-clip-or-endoscopic-sutur weekly 0.8 https://www.themednet.org/what-tidal-volume-or-minute-ventilation-goals-do-you-target-when-titrating-nippv-in-a-patient-with-copd-exacerbation-with-hypercapnia weekly 0.8 https://www.themednet.org/do-scores-for-identification-of-early-sepsis-such-as-qsofa-sirs-or-news-hold-significance-for-patients-who-are-already-admitted-to-the-icu-2 weekly 0.8 https://www.themednet.org/what-is-your-approach-to-counseling-and-managing-patients-with-lam-desiring-pregnancy-2 weekly 0.8 https://www.themednet.org/what-are-clues-to-diagnose-relapsing-polychondritis-with-airway-involvement-without-any-chondral-inflammation weekly 0.8 https://www.themednet.org/do-you-consider-repeat-rsv-vaccination-in-subsequent-pregnancy-for-select-patients-at-high-risk-of-severe-infection-and-or-whose-previous-infant-experienced-severe-rsv-infection weekly 0.8 https://www.themednet.org/for-patients-with-rheumatic-disease-on-chronic-glucocorticoids-is-there-a-role-for-alternate-day-dosing-during-tapering-or-do-you-taper-by-lowering-the-daily-dose-only weekly 0.8 https://www.themednet.org/are-you-or-your-hospital-system-using-memed-bv-in-the-emergency-department-for-rapid-triage-or-have-you-also-found-it-useful-for-managing-complex-patients-on-the-inpatient-floors weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-elevated-total-alkaline-phosphatase-levels-that-is-primarily-from-intestine-components-rather-than-bone-or-hepatic-components-2 weekly 0.8 https://www.themednet.org/would-you-empirically-cover-anaerobic-organisms-when-treating-non-purulent-facial-cellulitis-if-oral-source-e-g-mucocutaneous-lesion-was-suspected-1 weekly 0.8 https://www.themednet.org/do-you-have-an-evidence-based-practice-toward-choosing-a-dose-for-suppressive-oral-beta-lactams-for-chronic-infections-and-if-so-what-dose-do-you-choose weekly 0.8 https://www.themednet.org/what-is-your-process-of-discontinuing-testosterone-you-prescribe-to-a-patient-do-you-taper-or-just-discontinue weekly 0.8 https://www.themednet.org/how-do-you-diagnose-euglycemic-dka-and-distinguish-it-from-other-causes-of-acute-ketosis weekly 0.8 https://www.themednet.org/do-you-consider-acute-copd-asthma-exacerbation-as-a-common-cause-of-siadh-or-should-this-be-considered-a-diagnosis-of-exclusion weekly 0.8 https://www.themednet.org/when-if-ever-would-you-consider-starting-bisphosphonate-therapy-for-patients-with-osteopenia-but-without-a-high-risk-fracture-history-what-patient-characteristics-would-push-you-to-do-so weekly 0.8 https://www.themednet.org/in-the-evaluation-of-a-child-with-recurrent-parotitis-is-a-minor-salivary-gland-biopsy-sufficient-to-assess-for-sjogrens-disease-igg4-related-disease-and-sarcoidosis-or-is-parotid-gland-biopsy-preferred-for-diagnostic-yield weekly 0.8 https://www.themednet.org/how-do-you-counsel-families-regarding-the-potential-benefits-of-careful-hand-feeding-in-severe-dementia-over-percutaneous-feeding weekly 0.8 https://www.themednet.org/how-have-the-results-of-the-retreat-frail-study-regarding-reduction-of-antihypertensive-treatment-in-nursing-home-residents-affected-your-practice weekly 0.8 https://www.themednet.org/is-it-safe-to-administer-benralizumab-with-rituximab weekly 0.8 https://www.themednet.org/having-difficulty-achieving-adequate-anesthesia-for-ablative-lasers-with-topical-emla-what-topicals-have-you-found-to-be-successful-and-would-you-mind-sharing-how-to-obtain-compound-them weekly 0.8 https://www.themednet.org/in-what-ways-does-your-practice-implement-low-barrier-buprenorphine-therapy weekly 0.8 https://www.themednet.org/when-is-it-appropriate-to-restart-tnf-inhibitors-in-the-setting-of-recurrent-c-difficile-infection-and-ongoing-vancomycin-taper weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-cervical-esophageal-squamous-cell-carcinoma-as-second-primary-many-years-after-radiation-therapy-with-chemotherapy-for-hodgkins-disease weekly 0.8 https://www.themednet.org/should-all-women-starting-an-oral-contraceptive-undergo-screening-for-antiphospholipid-antibodies weekly 0.8 https://www.themednet.org/in-what-clinical-scenarios-do-you-find-ctdna-helpful-for-managing-skin-cancer weekly 0.8 https://www.themednet.org/in-an-intubated-sedated-patient-scheduled-for-a-non-gi-non-airway-procedure-should-enteral-tube-feeds-be-held-pre-procedure weekly 0.8 https://www.themednet.org/would-you-consider-using-intravenous-albumin-to-treat-hypoalbuminemia-in-mucormycosis-patients-given-the-correlation-between-low-albumin-levels-and-poor-outcomes weekly 0.8 https://www.themednet.org/how-long-after-administration-would-you-wait-to-proceed-with-an-orthopedic-surgery-to-a-bone weekly 0.8 https://www.themednet.org/what-post-operative-dose-do-you-use-to-treat-pigmented-villonodular-synovitis weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-asymptomatic-elevated-ptt-and-positive-lupus-anticoagulant-without-history-of-thrombosis weekly 0.8 https://www.themednet.org/do-you-start-methotrexate-to-prevent-anti-drug-antibody-development-when-using-tnf-inhibitors-for-the-treatment-of-axial-spondyloarthritis weekly 0.8 https://www.themednet.org/what-is-the-treatment-for-patients-with-persistent-postural-perceptual-dizziness weekly 0.8 https://www.themednet.org/when-do-you-consider-central-imaging-for-patients-with-dizziness weekly 0.8 https://www.themednet.org/does-the-presence-of-atypical-intraductal-proliferation-aip-on-prostate-needle-biopsy-influence-your-risk-stratification weekly 0.8 https://www.themednet.org/do-you-recommend-pharmacological-adt-for-a-patient-with-hypogonadism-with-unfavorable-or-high-risk-prostate-cancer-whose-testosterone-was-castrate-20-without-supplementation weekly 0.8 https://www.themednet.org/what-would-be-your-approach-to-working-up-possible-autoimmune-coagulopathic-etiologies-for-accelerated-rapidly-progressive-cad-in-spite-of-medical-therapy-compliance weekly 0.8 https://www.themednet.org/what-factors-do-you-consider-when-deciding-between-3-versus-4-cycles-of-bep-for-ovarian-germ-cell-tumors weekly 0.8 https://www.themednet.org/are-there-increased-risks-of-radiation-therapy-in-a-patient-with-polymorphous-light-eruption weekly 0.8 https://www.themednet.org/do-you-recommend-pjp-prophyalaxis-as-a-rule-in-giant-cell-arteritis-patients-on-high-dose-steroids weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-active-rheumatoid-arthritis-in-patients-with-metastatic-breast-cancer-on-palbociclib-and-faslodex weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-braf-v600e-mutated-metastatic-lung-adenocarcinoma-who-has-progressed-on-chemotherapy-immunotherapy-and-dabrafenib-trametinib weekly 0.8 https://www.themednet.org/what-do-you-quote-as-the-risk-of-lymphedema-following-axillary-dissection-with-lymphovenous-bypass-and-regional-nodal-radiotherapy-for-breast-cancer weekly 0.8 https://www.themednet.org/at-what-level-and-situation-would-you-give-antithrombin-to-a-patient-with-acquired-deficiency-and-heparin-resistance weekly 0.8 https://www.themednet.org/due-to-drug-shortages-in-the-treatment-of-aml-specifically-affecting-decitabine-how-would-you-approach-single-or-combination-decitabine-venetoclax-treatment-regimens-if-patients-are-3-4-cycles-into-their-treatment weekly 0.8 https://www.themednet.org/what-radiation-therapy-dose-do-you-recommend-for-patients-with-high-grade-neuroendocrine-carcinoma-of-the-esophagus-and-or-stomach-who-undergo-chemoradiotherapy weekly 0.8 https://www.themednet.org/what-is-a-reasonable-surveillance-strategy-for-bp-and-renal-function-monitoring-in-patients-following-percutaneous-transluminal-renal-angioplasty-and-stenting weekly 0.8 https://www.themednet.org/what-workup-to-do-you-recommend-in-patients-with-suspicion-of-progressive-supranuclear-palsy-with-predominant-primary-lateral-sclerosis weekly 0.8 https://www.themednet.org/do-you-prefer-quizartinib-over-midostaurin-with-chemotherapy-induction-for-flt3-itd-mutated-aml-given-the-results-of-quantum-first-and-preclinical-advantages-over-other-flt3-inhibitors weekly 0.8 https://www.themednet.org/given-potential-concerns-some-patients-have-about-affordability-of-anticoagulation-when-and-how-do-you-determine-if-you-may-recommend-someone-for-a-left-atrial-appendage-closure-procedure-with-the-consideration-that-laao-may-offer-at-least-some-protection weekly 0.8 https://www.themednet.org/would-you-treat-beyond-10-years-of-adjuvant-hormonal-therapy-for-premenopausal-woman-with-high-risk-er-her2-negative-breast-cancer-who-remain-premenopausal-at-the-end-of-10-year-adjuvant-hormonal-therapy weekly 0.8 https://www.themednet.org/how-would-you-treat-cold-agglutinin-disease-secondary-to-underlying-marginal-zone-lymphoma-with-only-bone-marrow-involvement-and-no-disease-elsewhere weekly 0.8 https://www.themednet.org/with-the-recent-approval-of-quizartinib-what-is-your-preferred-first-line-flt3-inhibitor-in-combination-with-chemotherapy-for-a-fit-aml-patient-with-a-flt3-itd-mutation weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-hemoglobin-lepore-and-iron-overload weekly 0.8 https://www.themednet.org/how-do-you-approach-initiation-continuation-of-biologics-if-there-is-a-suspicious-pulmonary-nodule-that-requires-close-interval-imaging-i-e-every-3-or-6-months weekly 0.8 https://www.themednet.org/when-would-you-consider-using-a-btk-inhibitor-in-the-frontline-setting-for-lymphoplasmacytic-lymphoma-lpl-or-waldenstroms-macroglobulinemia weekly 0.8 https://www.themednet.org/how-would-you-approach-igm-kappa-mgus-paraproteinemia-with-a-rising-free-light-chain-ratio weekly 0.8 https://www.themednet.org/what-topicals-do-you-use-for-patients-with-a-combination-of-facial-trunk-acne-and-moderate-severe-atopic-dermatitis weekly 0.8 https://www.themednet.org/what-constraint-would-you-use-for-front-eye-cornea-when-treating-with-palliative-intent weekly 0.8 https://www.themednet.org/in-a-patient-with-metastatic-rcc-who-discontinued-nivolumab-after-a-prolonged-response-to-ipilimumab-nivolumab-would-you-consider-re-starting-nivolumab-at-disease-progression weekly 0.8 https://www.themednet.org/how-do-you-treat-inflammatory-breast-cancer-hr-her2-1-treated-with-nac-act-and-mastectomy-with-multifocal-subcentimeter-residual-disease-that-on-retesting-is-hr-her-2-2-fish-amplified weekly 0.8 https://www.themednet.org/how-long-do-you-continue-anti-seizure-medication-after-early-post-traumatic-within-7-days-of-injury-seizures-in-tbi weekly 0.8 https://www.themednet.org/how-do-you-manage-patients-with-non-uremic-calciphylaxis-particularly-when-there-is-a-national-shortage-of-sodium-thiosulfate weekly 0.8 https://www.themednet.org/what-would-you-recommend-regarding-ivf-in-a-patient-with-dcis-on-tamoxifen-dealing-with-infertility weekly 0.8 https://www.themednet.org/is-there-a-role-for-pemetrexed-in-the-treatment-of-metastatic-adenosquamous-nsclc weekly 0.8 https://www.themednet.org/how-do-you-treat-a-pediatric-chronic-arterial-clot-related-to-cardiac-catheterization-that-persists-after-systemic-anticoagulation weekly 0.8 https://www.themednet.org/how-does-the-presence-of-both-t790m-and-l858r-egfr-mutations-impact-the-prognosis-and-management-of-a-patient-with-previously-untreated-locally-advanced-adenocarcinoma-of-the-lung weekly 0.8 https://www.themednet.org/how-would-you-treat-relapsed-refractory-t-cell-histiocyte-rich-large-b-cell-lymphoma-after-2nd-line-therapy weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-to-newly-diagnosed-primary-effusion-lymphoma weekly 0.8 https://www.themednet.org/what-would-you-recommend-regarding-hrt-use-in-a-patient-with-history-of-hr-her2-breast-cancer-dealing-with-post-menopausal-symptoms weekly 0.8 https://www.themednet.org/do-you-use-enterade-in-your-patients-receiving-pelvic-rt weekly 0.8 https://www.themednet.org/how-does-the-microbiome-factor-into-neurodegenerative-diseases weekly 0.8 https://www.themednet.org/for-patients-with-ra-and-secondary-loss-of-response-to-initial-tnfi-do-you-typically-recommend-an-alternative-tnfi-or-switch-to-a-different-mechanism-of-action weekly 0.8 https://www.themednet.org/is-there-a-role-for-liposomal-inhaled-amikacin-for-the-treatment-of-cavitary-mac-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-duration-of-antiparasitic-therapy-for-treatment-of-subarachnoid-neurocysticercosis weekly 0.8 https://www.themednet.org/have-you-recommended-either-oral-or-vaginal-probiotics-for-the-prevention-of-recurrent-uti-in-women weekly 0.8 https://www.themednet.org/if-a-patient-does-not-tolerate-completing-a-course-of-ltbi-treatment-with-either-6-9-months-of-inh-or-3hp-is-it-reasonable-to-complete-a-partial-course-of-rifampin-alone-or-does-the-rifampin-treatment-need-to-be-restarted-from-the-beginning weekly 0.8 https://www.themednet.org/do-you-recommend-screening-patients-in-high-endemic-regions-for-coccidioidomycosis-prior-to-initiation-of-anti-tnf-inhibitor-therapy weekly 0.8 https://www.themednet.org/is-there-a-role-for-antibiotic-suppressive-therapy-in-patients-with-prosthetic-valve-endocarditis-without-associated-cardiac-abscess-after-a-6-week-course-of-targeted-antibiotic-treatment-without-surgical-intervention weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-hiv-associated-large-b-cell-lymphoma-dlbcl-with-secondary-cns-involvement weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-gca-who-had-recurrence-on-tocilizumab-and-low-dose-prednisone weekly 0.8 https://www.themednet.org/do-you-start-prostate-radiotherapy-sooner-in-patients-receiving-neoadjuvant-gnrh-antagonists-relugolix-versus-agonists-such-as-leuprolide weekly 0.8 https://www.themednet.org/in-patients-with-history-of-anaphylaxis-to-a-tnf-inhibitor-are-you-comfortable-trying-an-alternative-tnf-inhibitor weekly 0.8 https://www.themednet.org/what-is-the-role-of-palliative-radiation-for-bone-soft-tissue-metastases-obliterating-a-joint-space weekly 0.8 https://www.themednet.org/how-would-you-approach-a-gastric-gist-with-r1-resection weekly 0.8 https://www.themednet.org/what-is-your-favored-defibrillation-strategy-for-refractory-vt-vf-standard-vector-change-or-double-sequential-external-defibrillation weekly 0.8 https://www.themednet.org/what-imaging-do-you-prefer-for-screening-of-large-vessel-involvement-in-gca-and-do-you-routinely-get-that-in-all-newly-diagnosed-cases weekly 0.8 https://www.themednet.org/have-you-implemented-the-rome-proposal-for-copd-exacerbations weekly 0.8 https://www.themednet.org/what-are-the-key-local-therapy-considerations-for-patients-with-malignant-pleural-effusion-bulky-pleural-disease-lung-metastases-and-chest-wall-diaphragm-primary-in-a-patient-with-rhabdomyosarcoma-or-ewing-sarcoma weekly 0.8 https://www.themednet.org/what-role-do-you-feel-that-dermatologists-play-in-the-management-of-patients-with-ehlers-danlos-syndrome weekly 0.8 https://www.themednet.org/have-you-recommended-red-light-therapy-for-hair-loss-therapy-and-where-does-it-fit-into-your-treatment-algorithm weekly 0.8 https://www.themednet.org/would-you-add-alk-targeted-therapy-for-patients-with-egfr-l858r-mutant-lung-adenocarcinoma-who-progress-on-targeted-therapy-and-develop-a-concomitant-strn-alk-fusion weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-high-titer-pr3-antibodies-checked-as-part-of-a-gi-workup-for-abdominal-pain-and-diarrhea-in-a-patient-without-any-pulmonary-renal-or-ibd-symptoms weekly 0.8 https://www.themednet.org/would-you-use-a-reduced-dose-glucocorticoid-tapering-regimen-for-patients-with-vasculitis-due-to-sjoegrens-syndrome-treated-with-rituximab weekly 0.8 https://www.themednet.org/what-is-your-preferred-regimen-for-a-patient-with-newly-diagnosed-high-risk-mm-transplant-eligible-with-pre-existing-grade-1-peripheral-neuropathy weekly 0.8 https://www.themednet.org/do-we-need-to-be-concerned-about-immunogenicity-and-effectiveness-of-biosimilars-in-patients-who-may-need-to-switch-multiple-times-due-to-insurance-reasons weekly 0.8 https://www.themednet.org/can-palliative-whole-abdominal-chemoradiation-benefit-nonoperative-patients-with-extensive-peritoneal-carcinomatosis weekly 0.8 https://www.themednet.org/how-would-you-manage-a-non-smoking-premenopausal-female-patient-with-a-large-retroperitoneal-squamous-cell-carcinoma-with-local-adenopathy-without-other-distant-metastatic-disease weekly 0.8 https://www.themednet.org/is-tucatinib-as-cardiotoxic-as-other-anti-her2-agents weekly 0.8 https://www.themednet.org/in-your-experience-what-changes-do-you-see-on-mri-after-sbrt-for-hcc weekly 0.8 https://www.themednet.org/how-would-you-treat-an-elderly-patient-with-dlbcl-with-only-brain-and-unilateral-testicular-involvement weekly 0.8 https://www.themednet.org/how-do-you-approach-assessing-the-optimal-time-for-extubation-trial-in-patients-with-respiratory-failure-due-to-neuromuscular-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-patient-on-immunosuppressants-with-an-outpatient-cutaneous-mrsa-infection-or-to-a-mrsa-carrier weekly 0.8 https://www.themednet.org/how-would-you-treat-an-otherwise-healthy-patient-with-newly-diagnosed-stage-iia-unfavorable-classical-hodgkin-lymphoma-who-has-exceeded-lifetime-anthracycline-dose-for-other-indications-not-treated-previously-for-hodgkins-2 weekly 0.8 https://www.themednet.org/what-technique-and-dose-would-you-use-for-a-paravertebral-leiomyosarcoma-met-deposit-at-t9-t10-s-p-resection-with-a-positive-margin weekly 0.8 https://www.themednet.org/what-is-your-typical-workup-for-first-time-seizure weekly 0.8 https://www.themednet.org/how-do-you-approach-endocarditis-prophylaxis-for-patients-with-rheumatic-diseases-undergoing-invasive-dental-surgery-and-no-history-of-joint-replacement weekly 0.8 https://www.themednet.org/should-peripheral-t-scores-alone-be-used-as-an-indication-to-start-osteoporosis-treatment-in-otherwise-healthy-patients-without-secondary-causes-of-osteoporosis-such-as-hyperparathyroidism weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treating-felty-syndrome-in-a-patient-with-well-controlled-synovitis-on-mtx-leflunomide-with-persistent-neutropenia-cytopenias weekly 0.8 https://www.themednet.org/what-is-the-best-approach-for-lithium-toxicity-management weekly 0.8 https://www.themednet.org/which-anabolic-agent-is-preferred-teriparatide-abaloparatide-versus-romosozumab-for-osteoporosis-treatment-in-suspected-hypophosphatasia weekly 0.8 https://www.themednet.org/how-do-you-assess-treatment-response-after-prostate-xrt-in-the-setting-of-low-volume-metastatic-disease weekly 0.8 https://www.themednet.org/for-t3n0-rectosigmoid-tumors-who-get-surgery-upfront-what-is-your-preferred-adjuvant-therapy weekly 0.8 https://www.themednet.org/what-is-the-optimal-management-of-malignant-mesothelioma-of-the-tunica-vaginalis-testis-mmtvt-found-incidentally-after-hydrocelectomy weekly 0.8 https://www.themednet.org/how-do-you-approach-a-low-grade-intra-cholecystic-papillary-neoplasm-of-the-gallbladder-without-invasive-component-and-reported-surgical-pathology-with-negative-margins weekly 0.8 https://www.themednet.org/how-are-you-applying-the-results-of-a-prospective-controlled-trial-by-jagsi-et-al-comparing-3d-crt-with-inverse-planned-imrt-for-breast-rt weekly 0.8 https://www.themednet.org/what-is-the-dose-and-duration-of-steroids-for-someone-with-pulmonary-manifestations-of-vexas weekly 0.8 https://www.themednet.org/do-you-continue-previously-prescribed-antiretroviral-therapy-alongside-steroid-therapy-in-a-patient-with-established-hiv-infection-who-is-later-diagnosed-with-tb-meningitis weekly 0.8 https://www.themednet.org/would-you-give-rt-to-a-young-bap1-patient-with-lung-cancer-s-p-nac-and-p-d-who-has-biopsy-proven-pleural-recurrence-after-adjuvant-chemo weekly 0.8 https://www.themednet.org/is-it-safe-to-use-anabolic-therapy-to-treat-osteoporosis-in-patients-with-gastric-neuroendocrine-tumor weekly 0.8 https://www.themednet.org/would-you-consider-adding-rituximab-to-a-patient-with-sle-lupus-anticoagulant-positive-but-no-history-of-thrombotic-events-and-organizing-pneumonia-on-azathioprine-prednisone-and-hydroxychloroquine-who-now-also-has-polymyositis weekly 0.8 https://www.themednet.org/how-do-you-evaluate-patients-with-suspicion-of-notalgia-paresthetica weekly 0.8 https://www.themednet.org/how-do-you-sequence-workup-for-myoclonus weekly 0.8 https://www.themednet.org/do-you-typically-recommend-muscle-biopsy-to-assess-for-mitochondrial-disease-in-patients-with-progressive-myoclonic-epilepsy weekly 0.8 https://www.themednet.org/when-do-you-consider-genetic-testing-in-patients-with-symptoms-concerning-for-dentatorubral-pallidoluysian-atrophy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-positive-margin-after-apr-for-a-patient-who-received-neoadjuvant-capox-alone-due-to-previous-remote-prostate-cancer-radiation weekly 0.8 https://www.themednet.org/how-would-you-treat-a-young-woman-with-refractory-itp-surrounding-pregnancy-who-responds-to-fostamatinib weekly 0.8 https://www.themednet.org/how-do-you-approach-evaluation-for-indolent-infection-in-patients-with-chronic-erosive-arthropathy weekly 0.8 https://www.themednet.org/when-treating-patients-with-liposomal-doxorubicin-do-you-routinely-monitor-echocardiograms-or-only-order-it-as-needed-for-symptoms weekly 0.8 https://www.themednet.org/what-genetic-testing-should-be-done-for-a-patient-with-polycythemia-erythrocytosis-with-family-history-of-similar-findings weekly 0.8 https://www.themednet.org/would-you-irradiate-a-patient-with-sub-totally-resected-spinal-ependymoma-with-history-of-nf2-and-multiple-other-nf2-associated-tumors weekly 0.8 https://www.themednet.org/would-you-prescribe-a-jak-inhibitor-in-patients-with-baseline-transaminase-elevation weekly 0.8 https://www.themednet.org/what-techniques-do-you-use-to-distinguish-malignant-from-non-malignant-eg-bph-etc-causes-of-psa-rise-in-patients-with-non-metastatic-prostate-cancer-and-a-rising-psa-in-spite-of-adt weekly 0.8 https://www.themednet.org/should-diep-flap-surgery-be-delayed-until-after-completion-of-pmrt weekly 0.8 https://www.themednet.org/what-is-your-preferred-method-of-endometrial-sampling-during-medical-management-of-endometrial-cancer weekly 0.8 https://www.themednet.org/what-is-the-role-if-any-for-met-inhibitors-in-advanced-met-amplified-gastric-adenocarcinoma weekly 0.8 https://www.themednet.org/how-would-you-approach-clinically-isolated-aortitis-in-a-patient-with-recent-head-and-neck-cancer-currently-in-remission weekly 0.8 https://www.themednet.org/how-can-we-symptomatically-manage-dizziness-or-risk-of-fall-in-older-patients-on-enzalutamide weekly 0.8 https://www.themednet.org/would-you-offer-pelvic-nodal-rt-due-to-failure-after-previous-pelvic-node-sbrt-in-oligorecurrent-prostate-cancer weekly 0.8 https://www.themednet.org/what-is-your-preferred-adjuvant-therapy-for-iiic-high-grade-endometrioid-endometrial-adenocarcinoma-with-positive-microscopic-paracervical-margins weekly 0.8 https://www.themednet.org/how-you-do-approach-management-of-a-patient-with-previously-well-controlled-ra-who-is-now-having-recurrent-flares-of-multiple-joints-which-is-resistant-to-even-high-dose-steroids weekly 0.8 https://www.themednet.org/what-factors-if-any-besides-sedlis-criteria-do-you-consider-when-deciding-on-adjuvant-rt-in-cervical-cancer-patients weekly 0.8 https://www.themednet.org/would-you-start-anabolic-bone-therapy-in-an-patient-with-ehlers-danlos-low-bone-density-and-no-fracture-history-who-is-found-to-have-spongy-soft-bone-during-spine-surgery weekly 0.8 https://www.themednet.org/how-would-one-approach-adjuvant-therapy-in-mid-ureteral-urothelial-carcinoma-s-p-nephroureterectomy-and-residual-borderline-renal-function weekly 0.8 https://www.themednet.org/when-do-you-consider-genetic-testing-for-focal-epilepsy-and-how-do-you-utilize-the-test-results-to-inform-your-clinical-practice weekly 0.8 https://www.themednet.org/is-there-a-role-for-single-agent-immunotherapy-in-a-patient-with-t2-muscle-invasive-bladder-cancer-without-lymph-nodes-or-distant-metastasis-who-declines-chemotherapy-and-cystectomy weekly 0.8 https://www.themednet.org/would-nintedanib-offer-benefit-to-a-patient-with-scleroderma-anti-th-to-ssa-who-has-ct-chest-with-typical-uip-pattern weekly 0.8 https://www.themednet.org/would-you-offer-hai-hepatic-arterial-infusion-or-y90-for-colorectal-liver-metastases-as-a-bridge-to-transplant weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-recommend-for-ia-g3-endometrioid-endometrial-adenocarcinoma-with-no-lvsi-mmr-intact-p53wt-and-polemut weekly 0.8 https://www.themednet.org/what-is-your-approach-to-small-bochdalek-hernias-in-patients-who-are-mildly-dyspneic weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-regarding-the-natural-history-of-onset-and-resolution-of-gynecomastia-following-adt-for-prostate-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-recurrent-multifocal-intravenous-leiomyomatosis weekly 0.8 https://www.themednet.org/would-you-offer-anticoagulation-to-a-patient-with-a-history-of-sle-and-coronary-artery-disease-s-p-remote-history-of-cabg-c-b-cva-post-surgery-now-with-serologies-showing-aps-triple-positivity-acl-b2gp1-lac-and-anti-histone-without-a-history-of-arterial-o weekly 0.8 https://www.themednet.org/have-you-had-experience-with-sarecycline-inducing-autoimmune-conditions weekly 0.8 https://www.themednet.org/in-a-patient-with-history-of-atypical-femoral-fracture-while-on-denosumab-how-do-you-sequence-further-treatment-options weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-new-triple-negative-breast-cancer-and-hr-bone-metastases-thoracic-vertebrae-with-prior-history-of-hr-t1c-breast-cancer-treated-with-lumpectomy-radiation-and-et weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-glucocorticoid-induced-osteoporosis-in-a-patient-10-years-post-renal-transplant-egfr-or-35-on-chronic-prednisone-therapy-who-has-completed-10-years-of-bisphosphonate-therapy-and-whose-dexa-continues-to-be-t-score-2-5 weekly 0.8 https://www.themednet.org/what-is-your-approach-to-outpatient-surveillance-strategy-and-monitoring-if-anticoagulation-is-being-interrupted-1-3-months-following-mechanical-mvr-avr-due-to-severe-bleeding weekly 0.8 https://www.themednet.org/how-should-one-approach-advanced-stage-ebv-dlbcl-nos-with-concomitant-hlh weekly 0.8 https://www.themednet.org/how-do-you-approach-elderly-patients-with-her2-ihc-3-metastatic-pancreatic-adenocarcinoma weekly 0.8 https://www.themednet.org/for-her2-stage-i-t1cn0-patients-where-neoadjuvant-therapy-is-desired-to-select-out-patients-for-post-operative-tdm1-is-it-reasonable-to-de-escalate-neoadjuvant-therapy-to-thp-as-opposed-to-tchp weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-after-chemoradiation-to-the-bladder-with-persistently-positive-urine-cytology-but-negative-endoscopic-or-radiographic-workup weekly 0.8 https://www.themednet.org/how-would-you-advise-and-manage-a-woman-with-dilated-cmp-on-gmt-lvef-30-50-who-would-like-to-undergo-assisted-reproductive-therapy-and-pregnancy weekly 0.8 https://www.themednet.org/how-long-does-it-take-for-the-ulnar-nerve-to-recover-normal-conduction-velocity-across-the-elbow-after-cubical-tunnel-surgery weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-isolated-total-hip-osteoporosis-in-a-post-menopausal-woman-without-fracture-history-and-low-frax-risk-based-on-their-femoral-neck-osteopenic-t-score weekly 0.8 https://www.themednet.org/how-do-you-manage-radiesse-calcium-hydroxylapatite-or-sculptra-poly-l-lactic-acid-induced-nodules weekly 0.8 https://www.themednet.org/should-improving-imaging-chest-standards-for-staging-impact-the-radiographic-response-criteria-for-lung-metastases-in-wilms weekly 0.8 https://www.themednet.org/what-is-your-approach-and-work-up-for-patients-with-radiculopathy-without-an-clear-structural-cause weekly 0.8 https://www.themednet.org/what-strategies-do-you-implement-to-control-the-nausea-from-enhertu weekly 0.8 https://www.themednet.org/how-do-you-manage-a-psoriatic-patient-previously-on-cimizia-and-now-stelara-with-new-onset-atopic-dermatitis-with-desire-for-pregnancy-and-fertility-treatments weekly 0.8 https://www.themednet.org/would-you-offer-systemic-therapy-th-to-a-patient-with-her2-3-hr-high-grade-microinvasive-breast-cancer-with-single-focus-or-multifocal weekly 0.8 https://www.themednet.org/what-platform-do-you-use-for-hrd-testing-of-ovarian-cancers-and-why weekly 0.8 https://www.themednet.org/what-dose-constraint-for-nasal-cartilage-would-you-respect-while-treating-with-6mev-electrons-in-patients-who-have-a-nearby-prior-radiation-field weekly 0.8 https://www.themednet.org/would-you-approach-a-patient-with-idiopathic-bilateral-sensorineural-hearing-loss-and-episcleritis-as-atypical-cogans-syndrome-even-in-the-absence-of-mri-mra-changes-and-minimal-elevation-of-inflammation-markers weekly 0.8 https://www.themednet.org/is-there-a-benefit-in-proactively-referring-patients-treated-with-pelvic-radiation-to-see-pelvic-rehabilitation-in-the-absence-of-any-symptoms weekly 0.8 https://www.themednet.org/how-do-you-manage-immunotherapy-induced-rashes-on-the-face-what-is-your-go-to-topical-steroid-prepartation weekly 0.8 https://www.themednet.org/would-you-give-ac-followed-by-taxol-or-tc-for-luminal-type-b-clinical-high-risk-breast-cancer weekly 0.8 https://www.themednet.org/in-a-patient-who-is-receiving-lutathera-who-developed-renal-dysfunction-would-you-re-challenge-if-renal-function-returns-to-normal weekly 0.8 https://www.themednet.org/what-is-the-role-of-copeptin-in-the-diagnosis-of-avp-deficiency-aka-central-diabetes-insipidus weekly 0.8 https://www.themednet.org/how-do-you-approach-capsular-contracture-after-breast-radiotherapy weekly 0.8 https://www.themednet.org/how-do-you-decide-between-neoadjuvant-chemotherapy-vs-neoadjuvant-endocrine-treatment-in-postmenopausal-women-with-node-involvement weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-with-sleep-disturbance-secondary-to-chronic-steroid-use weekly 0.8 https://www.themednet.org/in-what-clinical-situation-do-you-recommend-a-pudendal-emg-ncs weekly 0.8 https://www.themednet.org/when-do-you-consider-botox-in-patients-with-bells-palsy weekly 0.8 https://www.themednet.org/would-you-consider-switching-capmatinib-to-tepotinib-or-vice-versa-due-to-grade-3-hepatotoxicity-in-a-patient-with-metastatic-nsclc-with-met-exon-14-skipping-mutation weekly 0.8 https://www.themednet.org/would-you-offer-breast-conserving-therapy-in-a-patient-with-breast-cancer-and-buergers-disease-of-the-breast weekly 0.8 https://www.themednet.org/do-you-avoid-jak-inhibitors-in-patients-with-a-history-of-liver-disease-including-nafld-or-cirrhosis weekly 0.8 https://www.themednet.org/can-elacestrant-be-used-in-combination-with-her-2-targeted-therapy-in-metastatic-triple-positive-breast-cancer-with-esr1-mutation-in-the-second-line-setting weekly 0.8 https://www.themednet.org/can-recurrent-bilateral-nasal-polyps-be-attributed-to-untreated-abpa weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-a-synchronous-t1n2-non-small-cell-lung-cancer-and-a-t3n1-mid-rectal-adenocarcinoma-mmr-intact weekly 0.8 https://www.themednet.org/how-would-treat-a-patient-with-bladder-cancer-who-had-a-cystectomy-with-no-node-dissection-but-ct-with-suspicious-lymph-nodes weekly 0.8 https://www.themednet.org/would-you-recommend-holding-momelotinib-before-surgery weekly 0.8 https://www.themednet.org/when-do-you-consider-adjuvant-chemotherapy-and-or-rt-for-stage-i-iii-high-grade-uterine-sarcomas-s-p-resection weekly 0.8 https://www.themednet.org/how-do-you-approach-management-of-patients-who-are-wheelchair-bound-with-a-history-of-osteopenia-or-osteoporosis weekly 0.8 https://www.themednet.org/for-a-patient-with-high-risk-metastatic-endometrial-cancer-treated-with-neoadjuvant-chemotherapy-followed-by-surgery-would-you-offer-adjuvant-therapy-if-there-is-evidence-of-residual-disease weekly 0.8 https://www.themednet.org/do-you-discontinue-thiazide-treatment-used-for-patients-with-hypercalciuria-and-osteoporosis-if-they-develop-mild-hyponatremia-as-an-adverse-effect weekly 0.8 https://www.themednet.org/how-would-you-manage-a-chronic-thrombosis-of-the-internal-jugular-vein weekly 0.8 https://www.themednet.org/how-have-you-utilized-commercial-lab-sle-monitoring-profiles-that-include-c3a-and-c4a-components weekly 0.8 https://www.themednet.org/would-you-consider-hrt-after-risk-reducing-salpingo-oophorectomy-for-a-young-mid-30s-patient-with-brca1-and-a-history-of-tnbc weekly 0.8 https://www.themednet.org/would-you-consider-the-addition-of-trastuzumab-to-carboplatin-paclitaxel-for-an-advanced-uterine-carcinosarcoma-that-stains-her2-ihc-3-in-the-carcinomatous-components-but-ihc-0-in-the-sarcomatous-regions weekly 0.8 https://www.themednet.org/how-do-you-mitigate-cognitive-slowing-in-elderly-patients-with-mcspc-receiving-lhrh-agonist-therapy weekly 0.8 https://www.themednet.org/how-would-you-treat-patients-with-limited-stage-small-cell-lung-cancer-who-have-short-term-contraindications-for-systemic-chemotherapy weekly 0.8 https://www.themednet.org/how-you-do-approach-treatment-for-a-patient-with-active-seropositive-ra-rf-ccp-who-is-receiving-treatment-for-hepatitis-c weekly 0.8 https://www.themednet.org/what-factors-would-determine-which-currently-approved-agent-to-use-as-a-first-line-treatment-for-a-stage-iv-ros-1-fusion-patient-with-the-approval-of-repotrectinib weekly 0.8 https://www.themednet.org/how-do-you-manage-flares-of-axial-spondyloarthritis-in-patients-already-on-biologic-therapy-who-were-previously-controlled weekly 0.8 https://www.themednet.org/what-treatment-do-you-recommend-for-patients-with-sydenham-chorea weekly 0.8 https://www.themednet.org/will-omnipod-5-work-well-in-patients-receiving-bursts-of-corticosteroids-or-in-those-on-hemodialysis weekly 0.8 https://www.themednet.org/what-do-you-consider-as-absolute-and-relative-contraindications-for-the-use-of-romosozumab weekly 0.8 https://www.themednet.org/is-it-safe-to-use-hormone-replacement-therapy-in-young-premenopausal-patients-with-brca1-mutation-triple-negative-breast-cancer-who-have-undergone-bilateral-mastectomies-and-bso-without-hysterectomy weekly 0.8 https://www.themednet.org/how-do-you-differentiate-between-osseous-metastases-and-pagets-disease-on-psma-pet weekly 0.8 https://www.themednet.org/how-would-you-approach-evaluation-of-a-patient-with-multiple-vertebral-artery-pseudoaneurysms-and-history-of-dissection-but-without-other-areas-of-pseudoaneurysms weekly 0.8 https://www.themednet.org/how-do-you-perform-an-monitor-a-gnrh-agonist-challenge-to-aid-your-evaluation-diagnosis-of-progestogen-hypersensitivity-ph weekly 0.8 https://www.themednet.org/what-transplant-conditioning-regimen-would-you-recommend-for-a-pediatric-patient-with-mds-and-monosomy-7 weekly 0.8 https://www.themednet.org/how-would-you-discuss-the-prognosis-of-hr-positive-early-breast-cancer-in-an-elderly-90-patient-who-elects-against-surgery-in-favor-of-endocrine-treatment-only weekly 0.8 https://www.themednet.org/what-treatment-would-you-offer-a-patient-with-down-syndrome-and-stage-iia-seminoma weekly 0.8 https://www.themednet.org/how-would-you-manage-a-young-hiv-negative-patient-with-good-performance-status-with-primary-refractory-burkitt-lymphoma-involving-the-cns-and-systemic-disease weekly 0.8 https://www.themednet.org/are-there-any-immunosuppressive-agents-that-have-been-shown-to-have-utility-in-concurrent-idiopathic-anaphylaxis weekly 0.8 https://www.themednet.org/how-do-you-manage-incidentally-found-enostosis-on-ct-spine-imaging weekly 0.8 https://www.themednet.org/how-do-you-approach-diagnosis-of-progressive-supranuclear-palsy-in-patients-with-imaging-findings-of-severe-cerebral-leukoencephalopathy weekly 0.8 https://www.themednet.org/do-you-use-mr-spectroscopy-to-differentiate-between-tumor-progression-versus-radiation-induced-changes weekly 0.8 https://www.themednet.org/would-you-offer-endocrine-therapy-to-a-patient-with-t1c-tumor-who-was-initially-er-15-pr-negative-her2-1-but-changed-to-a-triple-negative-phenotype-after-neoadjuvant-chemotherapy-with-tc weekly 0.8 https://www.themednet.org/how-would-you-approach-the-use-of-bevacizumab-in-metastatic-fh-deficient-rcc-hlrcc-that-is-c-b-extensive-ivc-tumor-thrombus-and-dvt-pe weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-endocrine-therapy-to-a-male-with-er-dcis weekly 0.8 https://www.themednet.org/do-you-have-a-bmi-cutoff-for-abdominal-radical-hysterectomy-for-cervical-cancer weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-recommend-for-a-postmenopausal-female-with-a-dedifferentiated-endometrial-cancer-extensive-lvi-but-negative-nodes-msi-high-somatic-and-50-myometrial-invasion weekly 0.8 https://www.themednet.org/is-bilateral-oophorectomy-the-first-line-treatment-for-ovarian-hyperthecosis weekly 0.8 https://www.themednet.org/how-do-you-approach-a-non-classical-metastatic-prostate-cancer weekly 0.8 https://www.themednet.org/would-you-give-keynote-522-in-combination-with-trastuzumab-pertuzumab-neoadjuvantly-for-multifocal-disease weekly 0.8 https://www.themednet.org/should-routine-bone-marrow-biopsies-be-performed-in-a-patient-with-diamond-blackfan-anemia weekly 0.8 https://www.themednet.org/what-work-up-should-be-performed-if-any-for-a-young-child-with-chronic-itp weekly 0.8 https://www.themednet.org/what-aspects-of-a-patients-clinical-presentation-would-make-you-consider-a-diagnostic-challenge-of-anakinra-to-assess-for-an-underlying-auto-inflammatory-syndrome-in-hospitalized-patient-with-fever-of-unknown-origin weekly 0.8 https://www.themednet.org/is-there-an-advantage-to-early-therapy-with-hypomethylating-agents-for-high-very-high-risk-patients-with-mds-who-are-not-transplant-candidates-and-have-only-mild-cytopenias weekly 0.8 https://www.themednet.org/how-do-you-view-the-efficacy-of-estrogen-replacement-therapy-in-trans-women-with-regards-to-osteoporosis-prevention-and-treatment weekly 0.8 https://www.themednet.org/what-is-your-approach-for-managing-molluscum-in-adults weekly 0.8 https://www.themednet.org/how-to-manage-pituitary-infarction weekly 0.8 https://www.themednet.org/how-do-you-manage-embolic-stroke-from-fat-embolism weekly 0.8 https://www.themednet.org/would-you-give-adjuvant-chemotherapy-to-a-premenopausal-female-who-underwent-bilateral-mastectomies-for-er-pt2n1-disease-grade-1-with-low-oncotype-5 weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-recurrent-sinonasal-papilloma-for-systemic-treatment weekly 0.8 https://www.themednet.org/what-biopsy-surgical-approach-do-you-take-for-multiple-bapoma-lesions-in-a-patient-with-bap1-tumor-predisposition-syndrome weekly 0.8 https://www.themednet.org/do-you-cap-cisplatin-dose-in-obese-patients-undergoing-chemotherapy-in-germ-cell-tumors weekly 0.8 https://www.themednet.org/what-approach-es-do-you-take-to-treat-pyoderma-gangrenosum-with-superimposed-infection weekly 0.8 https://www.themednet.org/do-you-recommend-a-completion-hysterectomy-to-patients-who-undergo-primary-radiation-for-endometrial-cancer-presuming-they-are-now-a-surgical-candidate weekly 0.8 https://www.themednet.org/how-do-you-limit-impact-of-the-language-barrier-in-patients-being-assessed-for-cognitive-changes weekly 0.8 https://www.themednet.org/how-long-do-you-continue-atra-during-induction-in-high-risk-acute-promyelocytic-leukemia weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-widely-metastatic-serous-endometrial-cancer-whose-disease-is-stable-after-completion-of-6-cycles-of-chemotherapy-immunotherapy weekly 0.8 https://www.themednet.org/what-is-the-preferred-concurrent-chemotherapy-regimen-for-limited-stage-small-cell-lung-cancer-with-severe-reaction-to-etoposide weekly 0.8 https://www.themednet.org/how-do-you-think-the-beatcc-trial-will-change-management-of-patients-with-advanced-or-recurrent-cervical-cancer weekly 0.8 https://www.themednet.org/would-you-provide-anthracycline-based-therapy-for-early-stage-node-negative-triple-negative-breast-cancer-in-patient-with-echocardiogram-showing-grade-1-diastolic-dysfunction weekly 0.8 https://www.themednet.org/given-results-of-bcon-trial-do-you-add-carbogen-and-nicotinamide-for-patients-receiving-definitive-radiotherapy-for-bladder-cancer-particularly-for-non-cisplatin-eligible-candidates weekly 0.8 https://www.themednet.org/what-are-strategies-to-deal-with-grade-3-4-anorexia-associated-with-osimertinib weekly 0.8 https://www.themednet.org/what-is-your-experience-in-utilizing-spironolactone-in-prevention-of-hormone-related-hair-loss weekly 0.8 https://www.themednet.org/do-you-generally-require-preventative-vaccination-prior-to-initiating-jak-inhibitor-therapies weekly 0.8 https://www.themednet.org/when-if-ever-do-you-stop-bisphosphonate-therapy-in-a-patient-with-bone-metastasis-from-a-solid-tumor-who-is-tolerating-therapy-well-without-side-effects weekly 0.8 https://www.themednet.org/will-you-consider-pd-l1-expression-to-estimate-the-likelihood-of-response-to-neoadjuvant-chemotherapy-in-er-positive-her-2-negative-breast-cancer-after-results-of-the-keynote-756 weekly 0.8 https://www.themednet.org/when-would-you-consider-adding-an-sglt2-inhibitor-mra-and-or-arni-in-lieu-of-ace-inhibitor-or-arb-when-discharging-patients-following-revascularization-for-acute-mi-with-newly-reduced-lv-systolic-function weekly 0.8 https://www.themednet.org/what-are-some-high-risk-tte-features-that-would-prompt-you-to-consider-serial-ttes-to-look-for-lv-thrombus-formation-post-mi-and-how-frequently-would-you-image-these-patients weekly 0.8 https://www.themednet.org/how-do-you-decide-between-escalation-to-a-high-efficacy-dmt-versus-switching-to-a-different-moderate-efficacy-dmt-in-patients-with-poorly-controlled-multiple-sclerosis weekly 0.8 https://www.themednet.org/do-you-promote-early-active-mobilization-in-patients-who-are-in-the-icu-receiving-mechanical-ventilation weekly 0.8 https://www.themednet.org/how-do-you-interpret-a-significantly-elevated-stfr-in-a-patient-with-a-ferritin-in-the-1000s-and-normal-serum-iron-saturation weekly 0.8 https://www.themednet.org/do-you-offer-biosimilar-tocilizumab-as-an-alternative-to-subcutaneous-or-infusion-brand-name-tocilizumab-when-treating-gca weekly 0.8 https://www.themednet.org/when-considering-pharmacologic-treatments-recommended-by-the-2022-glucocorticoid-induced-osteoporosis-guidelines-do-you-use-nnt-nnh-to-select-between-each-treatment-option-by-risk-categories-e-g-moderate-high-very-high weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-radiation-for-a-mucinous-urachal-adenocarcinoma-s-p-partial-cystectomy-and-ln-sampling-with-negative-margins weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-non-specific-inflammatory-reaction-patterns-in-the-skin-eg-granulomatous weekly 0.8 https://www.themednet.org/would-you-hold-a-parp-inhibitor-in-the-perioperative-period-for-an-ileostomy-reversal-in-a-patient-who-has-completed-primary-debulking-surgery-followed-by-chemotherapy weekly 0.8 https://www.themednet.org/what-estimated-absolute-benefit-level-of-adjuvant-chemotherapy-for-hr-pos-her2-negative-breast-cancer-is-worth-recommending-chemotherapy-to-patients weekly 0.8 https://www.themednet.org/have-you-begun-to-incorporate-high-dose-iv-iron-infusions-into-your-practice-for-patients-newly-started-on-hemodialysis-with-tsat-30-and-ferritin-400-to-reduce-risk-for-non-fatal-cv-events-based-on-findings-from-the-pivotal-trial weekly 0.8 https://www.themednet.org/how-would-you-manage-a-young-male-with-high-titer-anticardiolipin-and-beta-2-glycoprotein-igm-antibodies-and-tia weekly 0.8 https://www.themednet.org/given-possible-lack-of-benefit-findings-in-subset-analysis-of-monarch-3-would-you-still-use-abemaciclib-in-a-postmenopausal-woman-with-high-risk-er-breast-cancer weekly 0.8 https://www.themednet.org/is-there-any-data-or-advice-on-using-teriparatide-after-romosozumab-for-treatment-of-postmenopausal-osteoporosis weekly 0.8 https://www.themednet.org/how-do-you-counsel-anesthesia-providers-in-perioperative-management-of-patients-with-limb-girdle-muscular-dystrophy weekly 0.8 https://www.themednet.org/is-behcets-disease-a-contraindication-to-breast-conserving-therapy weekly 0.8 https://www.themednet.org/what-is-your-guideline-for-perioperative-management-in-ra-patients-on-biologics-undergoing-spinal-fusion-surgery weekly 0.8 https://www.themednet.org/how-would-you-treat-a-recurrent-malignant-sex-cord-stromal-tumor-in-a-chemo-naive-patient-1-5-years-after-her-initial-diagnosis weekly 0.8 https://www.themednet.org/how-do-you-approach-venous-insufficiency-management-in-patients-on-jak-inhibitors weekly 0.8 https://www.themednet.org/how-do-you-delineate-postoperative-target-volumes-in-extremity-sarcoma-cases-following-neoadjuvant-chemotherapy-and-surgery weekly 0.8 https://www.themednet.org/what-are-the-indications-doses-and-volumes-for-postoperative-radiation-for-parathyroid-carcinomas weekly 0.8 https://www.themednet.org/how-often-do-you-offer-repeat-imaging-for-patients-with-life-expectancy-10-years-and-bcr-prostate-cancer-with-psadt-10-months-while-they-are-on-observation weekly 0.8 https://www.themednet.org/if-you-recommend-chemotherapy-for-early-stage-uterine-serous-carcinoma-do-you-prefer-3-or-6-cycles weekly 0.8 https://www.themednet.org/what-is-your-work-up-approach-and-management-of-biopsy-consistent-with-granulomatous-folliculitis weekly 0.8 https://www.themednet.org/can-patients-receive-mona-lisa-or-other-vaginal-laser-therapy-for-vaginal-atrophy-after-pelvic-radiation weekly 0.8 https://www.themednet.org/what-is-your-approach-to-immunosuppression-in-an-adult-patient-with-biopsy-proven-iga-vasculitis-who-has-new-and-severe-acute-renal-failure-requiring-dialysis weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-refer-a-patient-with-scarring-alopecia-eg-discoid-lupus-for-hair-transplant weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-severe-osteoporosis-in-patients-with-advanced-kidney-disease weekly 0.8 https://www.themednet.org/is-it-safe-to-give-an-anabolic-agent-for-osteoporosis-without-following-up-with-an-anti-resorptive-agent weekly 0.8 https://www.themednet.org/what-would-be-in-your-differential-diagnosis-for-a-patient-with-bone-infarcts-near-the-knee-distal-femoral-diaphysis-and-proximal-tibial-diaphysis-as-well-as-bilateral-hips weekly 0.8 https://www.themednet.org/what-is-your-workup-and-management-for-patients-with-reactive-perforating-collagenosis weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-for-local-chest-wall-recurrence-while-on-anastrozole-for-a-postmenopausal-woman-with-er-idc-s-p-mastectomy weekly 0.8 https://www.themednet.org/how-do-you-reconcile-differences-in-lunar-and-hologic-t-scores weekly 0.8 https://www.themednet.org/can-romosozumab-be-used-for-patients-who-develop-osteoporosis-secondary-to-mild-autonomous-cortisol-excess weekly 0.8 https://www.themednet.org/can-tnf-inhibitors-be-continued-during-radiation-therapy weekly 0.8 https://www.themednet.org/is-there-a-clinical-benefit-for-a-repeat-turbt-to-ensure-complete-resection-of-the-bladder-tumor-prior-to-neoadjuvant-chemotherapy-and-radical-cystectomy weekly 0.8 https://www.themednet.org/how-reliable-is-the-liquid-biopsy-on-patients-with-progressing-her2-positive-breast-cancer-with-negative-her2-on-liquid-testing weekly 0.8 https://www.themednet.org/how-has-your-practice-been-influenced-by-recent-data-demonstrating-improved-post-pci-ffr-in-chip-patients-undergoing-physiology-guided-pci-when-compared-to-conventional-angiography weekly 0.8 https://www.themednet.org/when-do-you-consider-intracerebral-laser-ablation-for-refractory-epilepsy weekly 0.8 https://www.themednet.org/does-the-presence-of-bronchiectasis-change-your-approach-to-a-patient-with-otherwise-well-controlled-patient-with-ra weekly 0.8 https://www.themednet.org/how-does-your-treatment-approach-for-melasma-differ-in-skin-of-color-patients weekly 0.8 https://www.themednet.org/what-is-your-workup-and-management-approach-for-idiopathic-perniosis weekly 0.8 https://www.themednet.org/what-treatment-would-you-consider-for-severe-osteoporosis-in-a-patient-with-multiple-fractures-avn-of-jaw-from-denosumab-history-of-stroke-and-who-has-completed-a-pth-analog weekly 0.8 https://www.themednet.org/what-grade-3-toxicities-would-you-expect-sufficient-overlap-between-capecitabine-and-5-fluorouracil-that-you-would-avoid-substituting-one-over-the-other weekly 0.8 https://www.themednet.org/do-you-recommend-radiation-in-a-patient-with-bap1tumor-predisposition-syndrome-with-prior-rcc-with-recurrent-brain-met-after-previous-resection weekly 0.8 https://www.themednet.org/what-is-your-approach-in-managing-steatocystoma-multiplex weekly 0.8 https://www.themednet.org/how-do-you-manage-a-symptomatic-fluid-collection-in-the-chest-wall-following-sbrt weekly 0.8 https://www.themednet.org/what-is-best-osteoporosis-treatment-for-a-post-menopausal-women-with-prior-avn-of-bilateral-hips-and-now-bilateral-sacral-insufficiency-fracture-due-to-meningeal-cysts weekly 0.8 https://www.themednet.org/how-do-you-monitor-patients-with-pagets-disease-with-normal-serum-alkaline-phosphatase weekly 0.8 https://www.themednet.org/does-the-use-of-and-type-of-biopsy-prior-to-therapy-impact-local-relapse-in-wilms weekly 0.8 https://www.themednet.org/would-you-give-any-adjuvant-therapy-chemo-immunotherapy-and-or-radiation-to-a-patient-with-pure-small-cell-cancer-of-the-urinary-bladder-who-received-neoadjuvant-cisplatin-and-etoposide-but-had-pn-and-residual-invasive-disease-on-cystectomy weekly 0.8 https://www.themednet.org/in-a-patient-with-an-hr-proficient-stage-iii-high-grade-serous-ovarian-cancer-s-p-r0-primary-debulking-surgery-for-whom-you-are-not-considering-bevacizumab-in-addition-to-chemotherapy-would-you-consider-ip-chemotherapy weekly 0.8 https://www.themednet.org/would-you-complete-a-bone-marrow-biopsy-for-an-unexplained-macrocytosis-without-anemia weekly 0.8 https://www.themednet.org/in-patients-with-rheumatologic-disease-on-dmards-and-or-biologics-how-do-you-counsel-them-regarding-blood-donation weekly 0.8 https://www.themednet.org/in-which-situations-would-you-consider-the-lot-crt-approach-over-crt-or-conduction-system-pacing-alone weekly 0.8 https://www.themednet.org/is-there-a-role-for-surgical-debulking-local-rt-or-subsequent-line-of-chemotherapy-for-a-patient-with-stable-malignant-thymoma-but-active-myasthenia-gravis weekly 0.8 https://www.themednet.org/what-testing-do-you-order-for-patients-with-suspected-dysautonomia weekly 0.8 https://www.themednet.org/at-what-point-do-you-consider-weaning-steroids-or-immuno-modulating-agents-in-patients-with-myasthenia-gravis weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-sapho-syndrome weekly 0.8 https://www.themednet.org/in-a-patient-with-antisynthetase-syndrome-jo-1-ild-and-myositis-treated-with-ivig-mycophenolate-and-tacrolimus-would-you-stop-the-ivig-after-lung-transplant-myositis-has-not-been-active-what-is-the-risk-of-recurrence-of-ild-after-lung-transplant weekly 0.8 https://www.themednet.org/how-would-you-approach-treating-a-patient-with-prostate-adenocarcinoma-with-urothelial-features weekly 0.8 https://www.themednet.org/is-there-a-role-for-longer-courses-of-antibiotic-therapy-for-infections-caused-by-actinomyces-neuii-similar-to-courses-used-for-infections-caused-by-other-species-of-actinomyces-now-that-it-has-been-reclassified-under-the-genus-winkia weekly 0.8 https://www.themednet.org/do-you-use-maintenance-bevacizumab-in-addition-to-immunotherapy-after-1st-line-chemotherapy-immunotherapy-bevacizumab-in-metastatic-cervical-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/is-there-a-role-for-surgical-debulking-for-patients-with-stage-iv-lung-sarcomatoid-carcinoma weekly 0.8 https://www.themednet.org/what-dose-fractionation-would-you-consider-for-adjuvant-reirradiation-for-locally-recurrent-epithelioid-sarcoma weekly 0.8 https://www.themednet.org/what-is-your-approach-to-patients-with-gca-who-have-difficulty-with-prednisone-weaning-20mg-despite-use-of-tocilizumab weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-would-you-recommend-for-a-patient-with-upper-tract-urothelial-carcinoma-with-neuroendocrine-differentiation weekly 0.8 https://www.themednet.org/would-the-occurrence-of-obvious-tumor-rupture-spillage-intraoperatively-impact-your-decision-for-adjuvant-systemic-therapy-after-resection-of-either-clear-cell-rcc-or-papillary-rcc weekly 0.8 https://www.themednet.org/what-workup-if-any-and-treatment-modalities-have-you-found-success-with-treating-acanthosis-nigricans weekly 0.8 https://www.themednet.org/what-treatment-modalities-have-you-had-success-with-for-treating-progressive-macular-hypomelanosis weekly 0.8 https://www.themednet.org/what-counseling-and-experience-do-you-have-with-using-finasteride-and-dutasteride-to-treat-aga-in-premenopausal-and-postmenopausal-women weekly 0.8 https://www.themednet.org/has-anyone-successfully-gotten-insurance-approval-for-avacopan-for-anca-negative-gpa weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-methotrexate-osteopathy weekly 0.8 https://www.themednet.org/how-do-you-treat-solitary-sclerosis weekly 0.8 https://www.themednet.org/what-dose-constraints-and-how-much-ctv-do-you-extend-into-stomach-for-a-patient-with-a-gej-tumor-being-treated-with-pre-operative-or-definitive-chemo-rt weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-immunotherapy-for-additional-1-year-for-a-stage-iii-t3n2-squamous-cell-lung-cancer-pdl-1-50-who-had-path-cr-after-checkmate-neoadjuvant-chemo-immunotherapy weekly 0.8 https://www.themednet.org/are-there-any-ongoing-clinical-trials-related-to-endothelial-dysfunction-and-accelerated-or-premature-cad-that-patients-might-be-able-to-enroll-in-nationwide weekly 0.8 https://www.themednet.org/would-you-add-pembrolizumab-to-enfortumab-to-further-treat-a-patient-with-metastatic-bladder-cancer-that-progressed-on-avelumab-maintenance-after-cis-gem weekly 0.8 https://www.themednet.org/do-you-give-ra-223-xofigo-to-patients-diagnosed-as-having-benign-neutropenia-anc-1-0-1-5-who-are-otherwise-eligible-to-receive-this-radioisotope weekly 0.8 https://www.themednet.org/would-you-use-pth-analog-in-a-patient-with-severe-osteoporosis-t-score-below-3-5-who-has-been-found-to-have-idiopathic-hypercalciuria-with-normal-labs-pth-vit-d-ca weekly 0.8 https://www.themednet.org/would-you-consider-trastuzumab-deruxtecan-as-a-second-line-option-for-metastatic-her2-squamous-cell-carcinoma-of-the-esophagus-after-progression-on-folfox-nivolumab weekly 0.8 https://www.themednet.org/is-a-persistently-elevated-ige-level-clinically-relevant-in-a-patient-who-has-otherwise-good-control-of-egpa-and-completely-suppressed-eosinophils-on-mepolizumab weekly 0.8 https://www.themednet.org/what-adjuvant-therapy-if-any-would-you-offer-for-a-young-fit-patient-with-stage-ib-lung-adenocarcinoma-harboring-an-egfr-a763-y764insfqea-who-received-no-prior-therapy weekly 0.8 https://www.themednet.org/what-is-your-preferred-workup-algorithm-for-facial-flushing weekly 0.8 https://www.themednet.org/what-vitamins-have-you-recommended-for-acne weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-incidental-papillary-fibroelastomas-in-terms-of-medical-therapy-and-size-threshold-to-refer-for-resection weekly 0.8 https://www.themednet.org/can-a-patient-receiving-post-mastectomy-radiation-therapy-be-treated-concurrently-with-total-body-uva-or-uvb-light-therapy-for-psoriasis weekly 0.8 https://www.themednet.org/is-there-a-role-of-prophylactic-aspirin-in-patients-with-incidental-findings-of-aortic-atherosclerosis-but-no-history-cad-or-cva weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-symptomatic-low-grade-leukemic-nhl-w-o-a-clear-diagnosis-of-either-fl-or-mzl weekly 0.8 https://www.themednet.org/should-jak-inhibitors-be-held-during-pelvic-rt weekly 0.8 https://www.themednet.org/would-you-consider-using-denosumab-over-bisphosphonates-as-the-primary-treatment-for-osteoporosis-in-patients-with-systemic-mastocytosis-considering-the-role-of-rankl-expressed-by-mast-cells-in-these-cases weekly 0.8 https://www.themednet.org/are-there-adverse-consequences-of-suppressing-serum-urate-levels-too-much weekly 0.8 https://www.themednet.org/what-would-your-next-line-of-therapy-be-for-a-young-patient-with-waldenstroms-macroglobulinemia-myd88-and-cxcr-wild-type-with-hyperviscosity-who-did-not-have-a-response-to-bendamustine-rituximab weekly 0.8 https://www.themednet.org/how-do-you-manage-hormonal-acne-during-pregnancy-due-to-stopping-hormonal-therapies-and-topical-retinoids weekly 0.8 https://www.themednet.org/in-a-patient-with-oligometastatic-recurrent-grade-2-er-msi-high-endometrioid-adenocarcinoma-who-has-a-single-resectable-metastasis-to-bone-what-systemic-therapy-would-you-recommend-and-how-would-you-time-it-in-relation-to-possible-surgery weekly 0.8 https://www.themednet.org/would-you-stop-a-doac-in-a-patient-with-atrial-fibrillation-who-has-tolerated-anticoagulation-but-progresses-from-child-pugh-class-b-to-child-pugh-class-c-liver-disease-with-known-risk-for-bleeding-from-esophageal-varices-and-or-other-hematologic-risk-fac weekly 0.8 https://www.themednet.org/do-you-screen-for-immune-related-adrenal-insufficiency-for-patients-on-immune-checkpoint-inhibitors weekly 0.8 https://www.themednet.org/in-light-of-recent-retrospective-data-from-france-on-egfr-tkis-use-with-ppis-showing-negative-outcomes-in-nsclc-patients-would-you-consider-discontinuing-ppis-or-changing-ppis-to-h2-inhibitors weekly 0.8 https://www.themednet.org/can-raloxifene-be-combined-with-stronger-osteoporosis-agents-in-patients-who-are-on-raloxifene-for-a-breast-cancer-diagnosis weekly 0.8 https://www.themednet.org/what-approach-do-you-take-in-treating-patients-with-multi-organ-sweets-syndrome-complicated-by-infection weekly 0.8 https://www.themednet.org/has-the-mars-data-for-mesothelioma-changed-whether-you-would-recommend-surgery-for-these-patients weekly 0.8 https://www.themednet.org/in-an-adult-sickle-cell-patient-who-is-found-on-brain-imaging-to-have-a-lacunar-infarct-do-you-recommend-initiating-routine-exchange-transfusions-and-if-yes-for-how-long weekly 0.8 https://www.themednet.org/is-there-is-enough-data-to-recommend-lot-crt-upgrade-in-crt-nonresponders-with-a-residual-wide-qrs-width-assuming-the-patient-had-a-good-lv-endocardial-cs-lead-placement weekly 0.8 https://www.themednet.org/how-are-you-approaching-the-use-of-neoadjuvant-or-adjuvant-nab-paclitaxel-given-the-improvement-noted-in-disease-free-survival-in-the-2019-gbg-69-geparsepto-trial weekly 0.8 https://www.themednet.org/when-might-you-consider-hsct-for-a-patient-with-probable-alps-clinical-features-but-no-identified-mutation weekly 0.8 https://www.themednet.org/what-role-is-there-for-management-of-progressive-metastatic-carcinoid-involving-liver-with-radiation-therapy-in-an-inoperable-patient weekly 0.8 https://www.themednet.org/in-a-patient-eligible-for-intensive-induction-therapy-for-aml-how-do-you-decide-between-100-or-200mg-m2-of-cytarabine-between-idarubicin-and-daunorubicin-with-the-different-dosages weekly 0.8 https://www.themednet.org/how-would-you-treat-an-elderly-but-fit-patient-with-node-positive-triple-negative-breast-cancer-in-the-adjuvant-setting-when-staging-shows-bony-disease-which-biopsied-shows-hormone-positive-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-manage-delayed-wound-healing-in-a-patient-on-trametinib weekly 0.8 https://www.themednet.org/would-you-offer-single-fraction-rt-for-recurrent-pancreatitis-refractory-to-medical-management weekly 0.8 https://www.themednet.org/would-you-treat-an-intact-prostate-cancer-patient-with-definitive-radiation-if-he-had-interstitial-cystitis weekly 0.8 https://www.themednet.org/what-technique-do-you-prefer-for-linac-based-srs weekly 0.8 https://www.themednet.org/when-would-you-consider-using-radiation-as-a-treatment-for-gorhams-massive-osteolysis weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-for-denovo-metastatic-hormone-positive-breast-cancer-with-specific-consideration-to-brain-metastasis-in-a-premenopausal-patient weekly 0.8 https://www.themednet.org/how-would-you-approach-biochemical-recurrence-of-lgsoc-in-a-patient-on-fourth-line-therapy-with-trametinib weekly 0.8 https://www.themednet.org/how-do-you-approach-treating-squamous-carcinoma-of-the-breast-in-the-adjuvant-settting weekly 0.8 https://www.themednet.org/would-you-offer-sbrt-to-a-bone-met-after-rfa-and-cementing weekly 0.8 https://www.themednet.org/how-would-you-manage-adjuvant-treatment-of-hormone-posiitve-pleomorphic-intralobular-carcinoma-of-the-breast-for-patients-already-with-prior-longstanding-aromatase-inhibitor-exposure weekly 0.8 https://www.themednet.org/how-soon-do-you-start-tucatinib-for-metastatic-her2-breast-cancer-with-cns-metastases-after-brain-surgery weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-newly-diagnosed-limited-stage-small-cell-lung-cancer-who-is-also-on-treatment-for-another-cancer-such-as-braf-inhibitor-for-melanoma-or-btk-inhibitor-for-cll weekly 0.8 https://www.themednet.org/would-you-give-4-courses-of-chemotherapy-to-a-pediatric-patient-with-low-risk-aml-and-negative-mrd-at-end-of-induction-i-who-is-not-enrolled-on-study weekly 0.8 https://www.themednet.org/with-the-approval-of-oral-azacitidine-cc-486-as-maintenance-therapy-in-aml-would-you-consider-giving-it-to-patients-in-cr-after-venetoclax-hma weekly 0.8 https://www.themednet.org/are-there-circumstances-where-you-would-initiate-lenvatinib-in-hcc-at-lower-doses-and-ramp-up-to-target-dose weekly 0.8 https://www.themednet.org/what-systemic-treatments-do-you-offer-for-patients-with-glioblastoma-refractory-to-temozolomide-and-chemotherapy-bevacizumab-combinations weekly 0.8 https://www.themednet.org/what-is-the-preoperative-approach-to-a-patient-with-severe-congenital-neutropenia-anc-500 weekly 0.8 https://www.themednet.org/how-would-you-treat-isolated-mediastinal-myeloid-sarcoma weekly 0.8 https://www.themednet.org/what-neoadjuvant-therapy-would-you-recommend-for-a-woman-with-significant-anemia-from-mds-with-stage-ii-hormone-receptor-negative-her2-positive-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-an-initial-local-disease-stage-ii-with-hormone-positive-poorly-differentiated-disease-er-26-pr-1-with-lumpectomy-pathology-showing-weak-hormone-positivity-er-5-pr-and-her-2-negative weekly 0.8 https://www.themednet.org/should-standard-risk-all-patients-with-down-syndrome-remain-admitted-for-the-entirety-of-induction-and-delayed-intensification-if-counts-are-appropriate-and-they-are-well-appearing weekly 0.8 https://www.themednet.org/how-would-you-treat-recurrent-localized-gastric-adenocarcinoma-after-previous-treatment-with-neoadjuvant-flot-partial-gastrectomy-r0-node-pos-and-adjuvant-folfox-2-years-ago-in-healthy-young-patient weekly 0.8 https://www.themednet.org/do-you-consider-using-adjuvant-anthracycline-prior-to-tdm-1-in-a-high-risk-patient-who-has-significant-residual-disease-after-tchp-for-triple-positive-disease weekly 0.8 https://www.themednet.org/for-patients-on-ado-trastuzumab-emtansine-t-dm1-for-metastatic-hr-her2-breast-cancer-do-you-prescribe-concurrent-hormone-blockade weekly 0.8 https://www.themednet.org/what-dose-would-you-consider-for-an-endobronchial-oligometastasis-from-sarcoma-primary weekly 0.8 https://www.themednet.org/what-do-you-tell-patients-that-opt-for-hifu-for-favorable-intermediate-risk-prostate-cancer-over-as-rp-ebrt-or-brachy weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-relapsed-refractory-mantle-cell-lymphoma-had-prior-asct-with-concurrent-therapy-related-mds-with-excess-blasts weekly 0.8 https://www.themednet.org/how-are-you-approaching-using-the-mammaprint-vs-the-oncototype-dx-tests-for-patients-with-high-risk-node-positive-disease weekly 0.8 https://www.themednet.org/what-is-the-approach-to-treating-catheter-related-upper-extremity-thromboses weekly 0.8 https://www.themednet.org/how-would-you-evaluate-a-patient-referred-for-hematohidrosis-sweating-blood weekly 0.8 https://www.themednet.org/how-do-you-approach-anticoagulation-for-vte-during-pregnancy weekly 0.8 https://www.themednet.org/is-it-safe-to-use-met-inhibitors-concurrent-with-radiotherapy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-high-grade-undifferentiated-round-cell-sarcoma-of-left-frontal-lobe-dura-with-gross-residual-disease-after-subtotal-resection-with-a-suspicious-mildly-enhancing-contralateral-brain-parenchymal-lesion weekly 0.8 https://www.themednet.org/how-would-you-manage-a-pediatric-patient-with-metastatic-papillary-thyroid-carcinoma-refractory-to-radioactive-iodine weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-all-with-pegaspargase-allergy-in-the-setting-of-erwinia-shortages weekly 0.8 https://www.themednet.org/when-would-you-consider-ivosidenib-in-patients-with-recurrent-unresectable-idh1-mutated-gbm weekly 0.8 https://www.themednet.org/what-is-optimal-therapy-for-a-patient-with-primary-peritoneal-mesothelioma-with-malignant-pleural-effusions weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-recurrent-bladder-cancer-in-the-tumor-bed-s-p-cystectomy-with-a-neobladder weekly 0.8 https://www.themednet.org/would-you-choose-car-t-or-bmt-for-an-aya-patient-with-ph-negative-all-with-induction-failure-who-is-now-mrd-negative-after-blinatumomab weekly 0.8 https://www.themednet.org/for-giant-cell-tumor-of-bone-what-dose-and-volume-do-you-treat-post-operatively weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-potential-improvement-of-neurologic-symptoms-after-palliative-radiation-therapy-for-spinal-cord-compression weekly 0.8 https://www.themednet.org/is-there-any-utility-for-proton-beam-radiation-to-replace-whole-abdominal-radiation-for-patients-with-wilms-tumor weekly 0.8 https://www.themednet.org/how-do-you-treat-a-patient-with-refractory-primary-hlh-that-has-failed-treatment-per-hlh94 weekly 0.8 https://www.themednet.org/how-do-you-select-a-non-heparin-anticoagulant-in-the-management-of-patients-with-heparin-induced-thrombocytopenia-hit weekly 0.8 https://www.themednet.org/how-do-you-manage-a-node-positive-prostate-cancer-with-sarcomatoid-and-ductal-adenocarcinoma-features weekly 0.8 https://www.themednet.org/what-would-be-your-first-choice-of-therapy-for-metastatic-salivary-gland-cancer-with-her2-amplification-and-ar-overexpression-found-on-ngs weekly 0.8 https://www.themednet.org/how-would-you-treat-an-adolescent-patient-with-a-completely-resected-translocation-positive-renal-cell-carcinoma-and-multiple-sub-centimeter-pulmonary-nodules-on-staging-ct weekly 0.8 https://www.themednet.org/how-do-you-approach-chemotherapy-dose-adjustments-for-hematologic-toxicities-in-patients-with-pre-existing-benign-ethnic-neutropenia weekly 0.8 https://www.themednet.org/is-there-a-preferred-anticoagulant-for-intracardiac-thrombus weekly 0.8 https://www.themednet.org/would-you-recommend-adjuvant-therapy-for-a-fully-resected-carcinoid-tumor-of-ovarian-primary weekly 0.8 https://www.themednet.org/how-would-you-approach-relapsed-pineoblastoma-s-p-chemotherapy-and-proton-xrt weekly 0.8 https://www.themednet.org/for-medically-inoperable-patient-with-symptomatic-hyperparathyroidism-with-hypercalcemia-would-you-consider-ablating-with-rt weekly 0.8 https://www.themednet.org/would-you-restart-immunotherapy-in-a-patient-with-metastatic-lung-adenocarcinoma-who-has-been-on-prolonged-treatment-break-due-to-cr-for-2-years-and-now-has-an-isolated-lung-lesion-treated-with-sbrt weekly 0.8 https://www.themednet.org/is-there-any-contraindication-to-chemotherapy-for-female-carriers-of-fragile-x weekly 0.8 https://www.themednet.org/would-you-offer-preoperative-chemotherapy-for-an-elderly-patient-with-a-local-recurrence-of-er-pr-her2-positive-left-breast-cancer-2-years-after-primary-treatment-which-included-neoadjuvant-ac-thp-with-pcr weekly 0.8 https://www.themednet.org/what-are-preferred-dmard-therapies-for-patients-with-rheumatoid-arthritis-who-have-comorbid-recurrent-pancreatitis weekly 0.8 https://www.themednet.org/what-is-the-optimal-way-to-monitor-direct-thrombin-inhibitors-when-the-aptt-is-unreliable weekly 0.8 https://www.themednet.org/what-dose-would-you-use-if-giving-neoadjuvant-radiation-for-a-sacral-chordoma-with-a-plan-for-a-full-resection weekly 0.8 https://www.themednet.org/how-do-you-approach-the-work-up-of-a-patient-with-persistent-absolute-eosinophilia weekly 0.8 https://www.themednet.org/would-you-offer-concurrent-chemotherapy-with-rt-to-an-unresectable-mucoepidermoid-carcinoma-presenting-as-a-supraclavicular-mass weekly 0.8 https://www.themednet.org/what-recommendations-to-you-give-on-peri-operative-ra-management-in-a-pre-solid-organ-transplant-patient weekly 0.8 https://www.themednet.org/would-you-consider-adjuvant-therapy-after-resection-of-a-mucinous-cystic-neoplasm-of-the-liver-with-associated-invasive-adenocarcinoma-that-is-poorly-differentiated-and-invades-the-visceral-peritoneum-and-adjacent-adipose-tissue weekly 0.8 https://www.themednet.org/what-is-your-approach-to-anticoagulating-patients-who-have-had-gastrointestinal-surgery weekly 0.8 https://www.themednet.org/should-radiation-be-considered-for-tumoral-type-bing-neel-syndrome-in-a-patient-with-treatment-naive-lymphoplasmacytic-lymphoma weekly 0.8 https://www.themednet.org/how-would-you-use-sbrt-in-lung-recurrence-in-a-patient-with-ewing-sarcoma-after-chemotherapy-and-whole-lung-irradiation-and-not-eligible-for-metastasectomy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-phosphaturic-mesenchymal-tumor weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-recurrent-high-grade-stromal-sarcoma-ovarian-origin-with-progression-on-doxorubicin weekly 0.8 https://www.themednet.org/for-patients-with-sustained-myelosuppression-after-completing-chemoradiation-for-bladder-preservation-in-invasive-urothelial-carcinoma-are-growth-factors-or-other-supportive-therapies-contraindicated weekly 0.8 https://www.themednet.org/what-dose-would-you-use-to-irradiate-a-recurrent-juvenile-nasopharyngeal-angiofibroma-of-the-nasal-cavity-and-nasopharynx-after-subtotal-resection weekly 0.8 https://www.themednet.org/would-you-manage-rapid-onset-obstructive-laryngeal-edema-after-layrnx-rt-differently-in-a-covid-19-patient weekly 0.8 https://www.themednet.org/how-would-you-treat-stage-3-unresectable-sarcomatoid-lung-cancer weekly 0.8 https://www.themednet.org/can-we-avoid-chemotherapy-for-elderly-patients-with-metastatic-her2-breast-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-patients-with-severe-hemophilia-and-acute-coronary-syndrome-requiring-revascularization weekly 0.8 https://www.themednet.org/how-do-you-approach-patients-with-high-risk-apl-who-develop-grade-3-pseudotumor-cerebri-early-in-consolidation-secondary-to-atra-that-does-not-improve-with-maximal-medical-therapy weekly 0.8 https://www.themednet.org/how-would-you-treat-pediatric-high-risk-hepatoblastoma-with-pulmonary-metastasis-despite-multiple-surgical-resections weekly 0.8 https://www.themednet.org/are-you-using-any-genomic-tools-assessments-blood-or-tissue-to-assist-in-determining-the-benefit-of-adjuvant-chemotherapy-in-nsclc-other-than-traditional-staging-criteria weekly 0.8 https://www.themednet.org/is-there-a-recommended-urethral-dose-constraint-for-sbrt-of-periurethral-oligomets weekly 0.8 https://www.themednet.org/in-what-situations-if-any-would-you-feel-comfortable-omitting-adjuvant-platinum-5-fu-after-cisplatin-rt-for-nasopharyngeal-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-manage-post-rp-prostate-rt-in-patients-with-chronic-anal-fissures weekly 0.8 https://www.themednet.org/how-do-you-treat-adenocarcinoma-of-the-prostatic-urethra-for-a-non-surgical-candidate weekly 0.8 https://www.themednet.org/for-a-patient-with-two-synchronous-biopsy-proven-lung-cancers-of-the-same-histology-is-there-reliable-criteria-that-can-be-used-to-differentiate-whether-these-are-two-unrelated-early-stage-cancers-as-opposed-to-metastases weekly 0.8 https://www.themednet.org/how-do-you-determine-whether-post-discharge-vte-prophylaxis-is-needed-in-patients-hospitalized-with-covid-19 weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-the-thrombotic-risk-of-emicizumab-in-the-context-of-multiple-cardiovascular-comorbidities weekly 0.8 https://www.themednet.org/given-ongoing-erwinia-shortages-if-a-patient-missed-1-of-the-6-doses-due-to-supply-would-you-forgo-that-dose-or-give-it-when-the-supply-comes-even-if-it-is-greater-than-72-hours-after-the-last-dose-was-given weekly 0.8 https://www.themednet.org/for-a-patient-with-an-otherwise-stage-iii-nsclc-with-some-limited-cns-involvement-under-what-circumstances-would-you-consider-offering-definitive-chemoradiation-plus-srs weekly 0.8 https://www.themednet.org/how-do-you-manage-a-therapy-related-central-venous-sinus-thrombosis-in-a-patient-with-all weekly 0.8 https://www.themednet.org/how-do-you-manage-a-grade-2-ependymoma-of-the-thoracic-spine weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-for-a-triple-negative-breast-cancer-patient-with-t1c-disease-by-imaging-and-5-mm-of-invasive-disease-in-the-core-sample-but-no-viable-tumor-at-the-time-of-surgery weekly 0.8 https://www.themednet.org/are-there-patients-on-immunotherapy-for-whom-you-are-not-recommending-the-covid-19-vaccine weekly 0.8 https://www.themednet.org/how-soon-after-stopping-a-parp-inhibitor-due-to-disease-progression-do-you-start-iv-cytotoxic-chemo weekly 0.8 https://www.themednet.org/how-do-you-approach-the-development-of-your-treatment-plan-when-treating-with-sbrt-for-non-spine-extracranial-metastases weekly 0.8 https://www.themednet.org/would-you-change-adjuvant-endocrine-therapy-in-a-postmenopausal-patient-on-an-ai-for-early-stage-hr-breast-ca-who-develops-a-contralateral-dcis weekly 0.8 https://www.themednet.org/what-are-your-thoughts-on-the-controversy-of-covid-19-thrombotic-microangiopathy-and-how-to-treat-it weekly 0.8 https://www.themednet.org/what-chemotherapy-would-you-use-to-treat-ini-deficient-metastatic-sinonasal-carcinoma weekly 0.8 https://www.themednet.org/how-would-you-approach-management-for-an-incidental-stage-ia1-gastric-type-endocervical-adenocarcinoma-after-a-simple-hysterectomy weekly 0.8 https://www.themednet.org/how-do-you-approach-a-locally-recurrent-prostate-cancer-after-prior-cryotherapy-salvage-and-external-beam weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjuvant-therapy-for-a-fully-resected-isolated-retroperitoneal-high-grade-sarcoma weekly 0.8 https://www.themednet.org/what-would-you-recommend-for-a-patient-with-an-incidental-finding-of-intravenous-leiomyomatosis-in-the-myometrium-following-a-hysterectomy-completed-for-benign-indication-how-would-age-affect-your-recommendation weekly 0.8 https://www.themednet.org/how-would-you-manage-a-nf1-patient-with-locally-advanced-head-and-neck-cancer weekly 0.8 https://www.themednet.org/what-is-the-role-of-rt-in-neurosarcoidosis-that-is-refractory-to-a-variety-of-medical-therapies weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-chemotherapy-to-a-patient-with-a-ia-low-grade-clear-cell-cancer-in-a-focus-of-endometrioma weekly 0.8 https://www.themednet.org/would-you-consider-using-henna-in-place-of-a-tattoo-for-skin-marking-during-simulation weekly 0.8 https://www.themednet.org/is-there-a-role-for-consolidation-systemic-chemotherapy-after-definitive-concurrent-chemoradiation-for-locally-advanced-unresectable-thymic-carcinoma weekly 0.8 https://www.themednet.org/what-is-the-role-of-anti-vegf-therapy-like-bevacizumab-for-gastric-avms-in-patients-who-do-not-have-hht weekly 0.8 https://www.themednet.org/what-dosimetric-and-technical-precautions-guidelines-do-you-follow-when-treating-a-patient-with-lvad weekly 0.8 https://www.themednet.org/how-do-you-incorporate-the-results-of-checkmate-153-which-showed-that-stopping-pd1-therapy-after-one-year-was-associated-with-shorter-survival-in-nsclc weekly 0.8 https://www.themednet.org/is-there-a-role-for-pet-ct-to-confirm-stage-ii-and-above-disease-in-patients-considering-children weekly 0.8 https://www.themednet.org/when-does-radiotherapy-play-a-role-in-treatment-of-metastatic-yolk-sac-germ-cell-tumor-in-an-adolescent-young-adult-patient weekly 0.8 https://www.themednet.org/would-the-presence-of-nodal-micrometastases-or-multifocal-disease-influence-your-decision-to-give-neoadjuvant-chemotherapy-in-a-patient-with-t1b-her2-breast-cancer weekly 0.8 https://www.themednet.org/how-do-you-treat-steroid-refractory-lupus-anticoagulant-hypoprothrombinemia-syndrome weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-prolonged-corticosteroid-therapy-in-patients-at-high-risk-of-bleeding weekly 0.8 https://www.themednet.org/how-do-you-approach-first-line-treatment-for-a-patient-with-metastatic-hepatocellular-carcinoma-with-peripheral-vascular-disease-with-recent-stent-placement weekly 0.8 https://www.themednet.org/when-do-you-consider-combination-chemotherapy-during-chemoradiation-for-locally-advanced-cervical-adenocarcinoma weekly 0.8 https://www.themednet.org/how-would-you-treat-a-node-positive-prostate-cancer-patient-with-previous-nodal-irradiation weekly 0.8 https://www.themednet.org/how-do-you-treat-patients-with-metastatic-hormone-positive-breast-cancer-with-no-clinical-evidence-of-disease-after-local-treatment-but-with-a-germline-brca-mutation weekly 0.8 https://www.themednet.org/are-there-any-special-considerations-for-the-covid-19-vaccination-in-patients-with-a-mast-cell-disorders weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-in-an-aya-patient-with-hpv-negative-head-and-neck-cancer-following-hemiglossectomy-and-modified-radical-neck-dissection-and-is-there-any-additional-post-treatment-surveillance-or-survivorship-care-you-would-perform- weekly 0.8 https://www.themednet.org/would-you-consider-giving-adjuvant-hepatic-artery-infusion-chemotherapy-after-liver-metastatectomy-for-colon-cancer-instead-of-systemic-therapy weekly 0.8 https://www.themednet.org/can-immunosuppressive-therapy-for-relapsed-t-lgl-be-tapered-or-withdrawn-safely-once-patient-has-achieved-recovery-of-normal-blood-counts weekly 0.8 https://www.themednet.org/how-do-you-approach-anticoagulation-for-patients-at-the-extremes-of-weight weekly 0.8 https://www.themednet.org/would-you-consider-radiation-therapy-for-a-young-patient-with-recurrent-aneurysmal-bone-cyst-of-the-mandible weekly 0.8 https://www.themednet.org/when-do-you-use-lurbinectidin-for-extensive-stage-small-cell-lung-cancer weekly 0.8 https://www.themednet.org/is-there-a-difference-in-management-approach-or-efficacy-for-cdk-inhibitors-with-endocrine-therapy-for-metastatic-lobular-carcinoma weekly 0.8 https://www.themednet.org/do-you-limit-the-duration-of-rituximab-use-in-ra-patients-due-to-concerns-about-long-term-use-such-as-permanent-hypogammaglobulinemia weekly 0.8 https://www.themednet.org/for-asymptomatic-patients-with-slow-growing-metastatic-typical-lung-carcinoid-how-do-you-decide-between-observation-somatostatin-analog-or-systemic-therapy weekly 0.8 https://www.themednet.org/how-would-you-treat-a-squamous-cell-carcinoma-of-the-bladder-in-a-medically-inoperable-patient weekly 0.8 https://www.themednet.org/do-you-offer-radiation-for-trochanteric-bursitis-in-patients-who-have-failed-standard-treatment-such-as-physical-therapy-steroid-injections-and-exercise weekly 0.8 https://www.themednet.org/what-is-your-dose-contraint-for-the-lumbosacral-plexus weekly 0.8 https://www.themednet.org/how-often-should-peripheral-blood-bcr-abl-fusion-protein-be-monitored-in-pediatric-aya-patients-with-ph-all-and-how-should-this-be-used-to-guide-treatment weekly 0.8 https://www.themednet.org/in-patients-with-a-vte-and-venous-stenting-how-do-you-approach-the-anticoagulation-and-or-antiplatelet-management weekly 0.8 https://www.themednet.org/do-you-hold-immunotherapy-with-any-checkpoint-inhibitors-pd-1-pd-l1-or-ctla-4-for-any-specific-amount-of-time-prior-to-elective-surgery weekly 0.8 https://www.themednet.org/what-is-the-preferred-upfront-chemotherapy-approach-in-an-older-adult-with-advanced-stage-hodgkins-lymphoma weekly 0.8 https://www.themednet.org/what-is-your-follow-up-duration-and-imaging-frequency-following-srs-for-treatment-of-a-cavernous-sinus-hemangioma weekly 0.8 https://www.themednet.org/in-which-clinical-situations-do-you-find-a-post-transfusion-platelet-count-useful weekly 0.8 https://www.themednet.org/how-do-you-manage-suspected-hypophysitis-hypopituitarism-as-an-immune-related-adverse-event weekly 0.8 https://www.themednet.org/is-there-any-role-for-adjuvant-immunotherapy-in-resected-head-and-neck-mucosal-melanoma weekly 0.8 https://www.themednet.org/how-would-you-manage-grade-3-treatment-emergent-diabetes-mellitus-hba1c-of-11-1-anti-gad65-in-a-patient-with-es-sclc-on-atezolizumab-maintenance weekly 0.8 https://www.themednet.org/are-tumor-genetics-recommended-in-all-patients-with-all-primary-brain-tumors weekly 0.8 https://www.themednet.org/does-albinism-increase-the-risk-of-skin-toxicity-from-radiation-specifically-in-the-setting-of-post-mastectomy-radiation weekly 0.8 https://www.themednet.org/does-treatment-of-covid-related-guillain-barre-syndrome-differ-from-standard-guillain-barre-management weekly 0.8 https://www.themednet.org/how-would-you-treat-classical-hd-in-a-patient-with-good-ps-who-relapsed-with-stage-iv-disease-after-a-prolonged-remission-10yrs-previously-treated-with-6-cycles-abvd weekly 0.8 https://www.themednet.org/how-sensitive-is-axumin-pet-for-evaluation-of-patients-with-diffuse-lymphadenopathy weekly 0.8 https://www.themednet.org/how-do-you-manage-platelet-transfusion-refractoriness-in-a-patient-with-severe-aplastic-anemia weekly 0.8 https://www.themednet.org/do-you-take-any-additional-precautions-when-treating-patients-with-crohns-with-chemoradiation-for-locally-advanced-lung-cancer weekly 0.8 https://www.themednet.org/how-do-you-manage-urinary-irritative-symptoms-that-persist-6-12-months-after-radiation-therapy-for-prostate-cancer weekly 0.8 https://www.themednet.org/in-a-patient-newly-diagnosed-with-mantle-cell-lymphoma-who-has-focal-intracerebral-disease-and-has-received-srs-what-is-the-benefit-to-adding-a-btk-inhibitor-such-as-ibrutininb-to-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-iron-overload-localized-to-a-single-organ weekly 0.8 https://www.themednet.org/how-do-you-approach-an-incidental-splanchnic-vein-thrombosis-in-a-patient-with-active-malignancy weekly 0.8 https://www.themednet.org/how-do-you-manage-bevacizumab-induced-tma-that-does-not-improve-with-drug-discontinuation weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-early-stage-uterine-mesonephric-like-adenocarcinoma weekly 0.8 https://www.themednet.org/when-would-you-consider-immunotherapy-in-the-treatment-of-patients-with-metastatic-smarca4-brg-deficient-carcinoma weekly 0.8 https://www.themednet.org/is-there-a-role-for-combination-ipilimumab-and-nivolumab-in-the-adjuvant-treatment-of-melanoma weekly 0.8 https://www.themednet.org/how-you-manage-dexamethasone-pre-medication-for-patients-with-nsclc-being-treated-with-carboplatin-pemetrexed-pembrolizumab weekly 0.8 https://www.themednet.org/for-patients-who-develop-pneumonitis-radiation-vs-tki-induced-while-on-pralsetinib-for-ret-rearranged-metastatic-nsclc-is-there-a-role-to-switch-to-another-agent-i-e-selpercatinib weekly 0.8 https://www.themednet.org/what-is-your-experience-with-using-amicar-for-hyperfibrinolysis-in-cirrhosis-and-when-do-you-discontinue weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-young-patient-on-fertility-sparing-surgery-for-a-clear-cell-carcinoma-of-the-ovary-at-least-ic1 weekly 0.8 https://www.themednet.org/what-is-your-preferred-regimen-for-treating-pediatric-patients-with-intermediate-risk-hodgkin-lymphoma-ahod0031-or-pog9425 weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-a-history-of-seropositive-erosive-ra-who-is-being-treated-for-disseminated-histoplasmosis-and-associated-mas-hlh-but-is-having-active-ra-disease-activity weekly 0.8 https://www.themednet.org/in-which-situations-would-you-use-the-imspire150-regimen-of-atezolizumab-vemurafenib-cobimetinib weekly 0.8 https://www.themednet.org/what-systemic-therapy-would-you-consider-for-unresectable-non-metastatic-primary-carcinosarcoma-of-the-liver-after-progression-with-local-therapies-i-e-y90 weekly 0.8 https://www.themednet.org/would-you-have-toxicity-concerns-for-offering-a-myeloablative-conditioning-regimen-to-an-aya-patient-with-acute-lymphoblastic-leukemia-and-a-germline-brca2-mutation weekly 0.8 https://www.themednet.org/would-you-recommend-hematopoietic-stem-cell-transplant-for-a-patient-with-very-late-relapsed-aml-and-favorable-cytogenetics weekly 0.8 https://www.themednet.org/are-there-any-diagnostic-studies-or-treatments-that-are-beneficial-in-patients-with-post-covid-neurologic-symptoms weekly 0.8 https://www.themednet.org/does-the-co-primary-endpoint-of-checkmate-816-pathologic-complete-response-support-the-use-of-nivolumab-chemotherapy-as-neoadjuvant-therapy-in-nsclc weekly 0.8 https://www.themednet.org/would-you-consider-neoadjuvant-chemo-followed-by-repeat-cysto-prior-to-definitive-chemort-in-the-setting-of-muscle-invasive-bladder-cancer-for-a-patient-with-incomplete-resection-by-turbt weekly 0.8 https://www.themednet.org/how-would-you-dose-abvd-for-classical-hodgkin-lymphoma-for-a-patient-on-hemodialysis weekly 0.8 https://www.themednet.org/if-aya-patients-with-aml-are-mrd-negative-after-1-cycle-of-chemotherapy-and-high-risk-for-relapse-should-they-receive-additional-cycles-of-chemotherapy-or-proceed-directly-to-transplant weekly 0.8 https://www.themednet.org/what-can-you-use-to-treat-schnitzler-syndrome-when-anakinra-does-not-control-urticarial-lesions-and-itching weekly 0.8 https://www.themednet.org/how-do-you-counsel-young-patients-undergoing-cladribine-therapy-for-hairy-cell-leukemia-in-terms-of-risk-of-secondary-malignancy-and-infertility weekly 0.8 https://www.themednet.org/how-do-you-approach-head-and-neck-radiotherapy-for-patients-with-common-variable-immunodeficiency-cvid weekly 0.8 https://www.themednet.org/what-dose-fractionation-regimen-to-you-give-for-palliative-splenic-irradiation-in-a-patient-with-pain weekly 0.8 https://www.themednet.org/would-you-use-r2chop-to-treat-dlbcl-based-on-the-results-of-the-e1412-study weekly 0.8 https://www.themednet.org/how-do-you-treat-localized-gastroesophageal-junction-cancer-with-histologic-features-of-both-adenocarcinoma-and-a-high-grade-neuroendocrine-tumor weekly 0.8 https://www.themednet.org/how-would-you-manage-a-pregnant-woman-with-warm-auto-antibodies-detected-on-screening-tests-but-no-associated-hemolysis weekly 0.8 https://www.themednet.org/for-patients-receiving-rt-for-a-low-grade-glioma-do-you-routinely-offer-donepezil-or-memantine-to-decrease-neurotoxicity weekly 0.8 https://www.themednet.org/what-is-your-approach-to-treatment-of-secondary-symptomatic-hypertrophic-osteoarthropathy-hoa-with-associated-low-grade-inflammatory-arthritis-when-cure-of-an-underlying-cause-is-not-possible weekly 0.8 https://www.themednet.org/how-do-you-differentiate-between-ici-related-hepatitis-vs-other-etiology-especially-when-giving-ici-in-combination-regimens weekly 0.8 https://www.themednet.org/how-do-you-approach-symptomatic-management-of-tinnitus weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-chemotherapy-after-debulking-for-ovarian-cancer-in-an-elderly-patient-with-cirrhosis-and-baseline-plt-60s weekly 0.8 https://www.themednet.org/how-would-you-approach-blast-phase-myelofibrosis-in-a-healthy-patient-fit-for-transplant weekly 0.8 https://www.themednet.org/when-would-you-consider-adjuvant-radiation-for-a-completely-resected-atypical-glomus-tumor-involving-superficial-soft-tissues-of-the-trunk-back weekly 0.8 https://www.themednet.org/have-alterations-in-autoimmune-antibody-profiles-been-observed-in-rheumatic-disease-patients-who-have-had-covid-19 weekly 0.8 https://www.themednet.org/how-would-you-manage-a-pediatric-patient-with-warm-antibody-hemolytic-anemia-igg-type-triggered-by-steroid-refractory-chronic-immune-hepatitis weekly 0.8 https://www.themednet.org/is-there-a-role-for-radiation-therapy-for-hhv8-related-hiv-negative-kaposi-sarcoma-limited-to-a-single-chain-of-lymph-nodes weekly 0.8 https://www.themednet.org/how-do-you-diagnose-and-manage-clopidrogel-induced-thrombocytopenia weekly 0.8 https://www.themednet.org/how-do-you-approach-the-diagnosis-and-treatment-of-metastatic-primary-pulmonary-blastoma-of-monophasic-variety weekly 0.8 https://www.themednet.org/when-would-you-consider-intra-operative-radiation-along-with-resection-for-anastomotic-recurrence-of-appendiceal-cancer-after-initial-resection-and-hipec weekly 0.8 https://www.themednet.org/what-is-your-preferred-approach-for-who-type-1-eber-negative-locally-advanced-nasopharyngeal-carcinoma weekly 0.8 https://www.themednet.org/would-you-consider-using-a-checkpoint-inhibitor-with-cisplatin-gemcitabine-as-first-line-therapy-in-nasopharyngeal-cancer-extrapolating-from-the-jupiter-02-trial weekly 0.8 https://www.themednet.org/do-you-plan-on-prescribing-aducanumab-for-patients-with-early-alzheimers-disease-and-a-positive-amyloid-pet-scan weekly 0.8 https://www.themednet.org/can-patients-with-alpha-1-antitrypsin-deficiency-have-increased-toxicity-from-radiation-treatment-to-the-lungs-liver-or-other-areas weekly 0.8 https://www.themednet.org/should-adjuvant-metronomic-capecitabine-be-the-new-standard-of-care-for-locally-advanced-nasopharynx-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-a-stage-iiia-malignant-brenner-tumor-of-the-ovary weekly 0.8 https://www.themednet.org/how-would-you-manage-patients-with-her2-breast-ca-receiving-adjuvant-trastuzumab-who-develop-severe-infusion-reactions-requiring-medical-intervention weekly 0.8 https://www.themednet.org/what-is-your-approach-to-adjusting-colchicine-dosing-for-patients-on-medications-that-are-cyp3a4-inhibitors-and-or-drugs-that-affect-the-p-gp-efflux-pump-are-there-particular-colchicine-drug-combinations-that-are-absolutely-contraindicated weekly 0.8 https://www.themednet.org/do-you-repeat-the-use-of-docetaxel-in-a-later-line-of-therapy-for-mcrpc weekly 0.8 https://www.themednet.org/for-grade-3-adynamic-ileus-on-abvd-for-classical-hodgkin-lymphoma-would-you-stop-vinblastine-completely-or-retry-at-a-2mg-capped-dose weekly 0.8 https://www.themednet.org/what-is-your-preferred-treatment-in-a-fit-patient-with-extensive-cutaneous-marginal-zone-lymphoma-refractory-to-prior-radiation-and-rituximab weekly 0.8 https://www.themednet.org/do-you-offer-immunotherapy-for-extensive-stage-small-cell-lung-cancer-who-also-has-a-paraneoplastic-neurological-syndrome weekly 0.8 https://www.themednet.org/what-is-your-non-anthracycline-regimen-of-choice-for-elderly-cll-patients-that-present-with-richters-transformation-and-have-pre-existing-left-ventricular-dysfunction weekly 0.8 https://www.themednet.org/do-you-offer-adjuvant-therapy-for-high-grade-upper-tract-urothelial-carcinoma weekly 0.8 https://www.themednet.org/could-we-use-gilteritinib-in-r-r-aml-patients-who-harbor-non-d835-1836-flt3-tkd-mutations weekly 0.8 https://www.themednet.org/would-you-offer-t-dm1-to-a-patient-with-a-history-of-fnh-of-liver weekly 0.8 https://www.themednet.org/do-you-use-supplements-to-treat-dabrafenib-tremetinib-related-skin-and-hair-toxicity weekly 0.8 https://www.themednet.org/in-patients-with-stage-iv-classical-hodgkins-lymphoma-ns-but-with-syncytial-variant-is-the-first-line-avd-brentuximab-given-that-it-is-less-likely-to-respond-to-abvd weekly 0.8 https://www.themednet.org/do-you-routinely-screen-for-hepatitis-b-prior-to-starting-systemic-anti-cancer-therapy weekly 0.8 https://www.themednet.org/do-you-consider-adjuvant-chemotherapy-for-high-grade-primary-pulmonary-mucoepidermoid-carcinomas-after-complete-r0-resection weekly 0.8 https://www.themednet.org/in-cd30-positive-cd20-weak-gray-zone-lymphoma-is-first-line-avd-brentuximab-or-r-bv-chp-better-than-rchop-or-da-epoch weekly 0.8 https://www.themednet.org/can-you-call-dlbcl-as-primary-refractory-too-early-in-the-treatment-course weekly 0.8 https://www.themednet.org/how-does-your-approach-differ-if-at-all-in-patients-with-burkitt-leukemia-in-contrast-to-burkitt-lymphoma weekly 0.8 https://www.themednet.org/how-would-you-treat-an-atypical-fibrous-histiocytoma-located-near-the-medial-canthus weekly 0.8 https://www.themednet.org/for-patients-who-progress-on-neoadjuvant-induction-chemotherapy-would-you-add-concurrent-radiation-to-chemotherapy-switch-chemotherapy-regimen-with-concurrent-radiation-or-add-immunotherapy-to-chemotherapy-and-hope-for-a-response weekly 0.8 https://www.themednet.org/would-you-give-6-cycles-of-adjuvant-xelox-instead-of-4-cycles-for-stage-3b-colon-cancer-that-presented-with-bowel-obstruction weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-metastatic-pulmonary-enteric-adenocarcinoma weekly 0.8 https://www.themednet.org/for-patients-with-inoperable-locally-advanced-stage-iiib-nsclc-with-driver-mutations-who-have-an-excellent-response-to-initial-tki-treatment-do-you-ever-re-visit-more-definitive-options weekly 0.8 https://www.themednet.org/when-do-you-consider-maintenance-rituximab-for-follicular-lymphoma-in-the-front-line-setting weekly 0.8 https://www.themednet.org/do-reports-of-increased-incidence-of-toxicities-in-patients-treated-with-immunotherapy-followed-by-targeted-therapy-impact-your-decision-to-offer-durvalumab-after-chemoradiation-for-stage-iii-nsclc-harboring-a-targetable-genetic-alterations weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-patients-with-intermediate-risk-ipss-r-mds weekly 0.8 https://www.themednet.org/what-is-the-best-method-to-obtain-molecular-cytogenetic-data-when-the-bone-marrow-results-in-a-dry-tap weekly 0.8 https://www.themednet.org/is-hereditary-angioedema-hae-an-absolute-contraindication-for-definitive-radiotherapy weekly 0.8 https://www.themednet.org/how-do-you-approach-the-use-of-adt-in-elderly-men-with-high-or-very-high-risk-prostate-cancer weekly 0.8 https://www.themednet.org/if-you-use-respiratory-gating-for-liver-sbrt-what-is-your-preferred-method weekly 0.8 https://www.themednet.org/would-wegeners-granulomatosis-alter-your-treatment-plan-in-a-patient-who-has-an-indication-for-definitive-radiation-therapy-with-concurrent-chemotherapy weekly 0.8 https://www.themednet.org/how-do-you-manage-unresectable-cystadenocarcinoma-of-the-liver-mucinous-cystic-neoplasm-with-associated-invasive-carcinoma weekly 0.8 https://www.themednet.org/what-is-the-current-role-of-omacetaxine-in-management-of-cml weekly 0.8 https://www.themednet.org/what-are-the-indications-and-role-for-salvage-hysterectomy-exenteration-after-a-cervical-cancer-local-failure weekly 0.8 https://www.themednet.org/in-patients-with-resected-nsclc-how-do-you-treat-r-disease-residual-incompletely-resected-primary-lesion-not-suitable-for-re-resection weekly 0.8 https://www.themednet.org/for-unresectable-stage-iiib-lung-adenocarcinoma-with-intestinal-enteric-phenotype-would-you-still-treat-with-chemoradiation-and-durvalumab-per-pacific weekly 0.8 https://www.themednet.org/does-xrt-have-any-role-in-the-management-of-sclerosing-mesenteritis-causing-severe-pain weekly 0.8 https://www.themednet.org/is-there-a-role-for-denosumab-in-pathological-fracture-that-results-from-lymphoma weekly 0.8 https://www.themednet.org/how-do-you-approach-the-treatment-of-recurrent-thymic-adenocarcinoma weekly 0.8 https://www.themednet.org/when-treating-stage-iv-hodgkins-lymphoma-without-liver-involvement-with-avd-and-brentuximab-if-hepatic-dysfunction-occurs-post-cycle-1-is-there-good-data-on-changing-therapy-to-beacopp weekly 0.8 https://www.themednet.org/is-there-any-data-to-suggest-the-best-timing-of-residual-colectomy-in-fap weekly 0.8 https://www.themednet.org/how-would-you-approach-thoracic-radiation-for-nsclc-in-a-patient-with-ehlers-danlos-syndrome-who-has-surgically-unresectable-nodal-disease weekly 0.8 https://www.themednet.org/what-is-your-approach-for-stage-ii-nasopharyngeal-carcinoma weekly 0.8 https://www.themednet.org/would-you-consider-definitive-radiation-therapy-in-a-patient-with-a-newly-diagnosed-high-risk-prostate-cancer-and-metastatic-nsclc-on-immunotherapy-with-no-evidence-of-disease weekly 0.8 https://www.themednet.org/would-you-consider-radiation-to-the-prostate-in-the-setting-of-metastatic-prostate-cancer-with-4-boney-mets weekly 0.8 https://www.themednet.org/what-is-your-preferred-second-line-therapy-for-metastatic-pancreatic-cancer-after-progression-on-gemcitabine-nab-paclitaxel-who-are-not-candidates-for-mfolfirinox weekly 0.8 https://www.themednet.org/would-you-consider-bladder-preservation-with-chemort-in-a-patient-who-has-a-urothelial-carcinoma-involving-the-bladder-neck-and-extending-to-the-prostatic-urethra weekly 0.8 https://www.themednet.org/is-there-a-role-for-adjuvant-radiation-therapy-in-resected-mesothelioma-of-the-tunica-vaginalis-testis-with-a-positive-margin weekly 0.8 https://www.themednet.org/what-is-the-maximum-length-of-time-after-surgery-you-would-consider-starting-adjuvant-therapy-for-a-stage-iii-melanoma weekly 0.8 https://www.themednet.org/are-there-any-studies-combining-imrt-and-hifu-in-the-setting-of-localized-prostate-cancer weekly 0.8 https://www.themednet.org/which-therapy-would-you-choose-for-a-patient-with-metastatic-nsclc-after-a-liquid-biopsy-showed-egfr-exon-19-and-braf-v600e-mutations weekly 0.8 https://www.themednet.org/getug-16-shows-a-progression-free-survival-benefit-with-adt-for-low-risk-subgroup-how-do-we-reconcile-that-rtog-9601-indicated-no-benefit-in-fact-harm-with-adt-in-patients-with-low-psa weekly 0.8 https://www.themednet.org/should-special-precautions-be-taken-when-using-checkpoint-inhibitors-in-patients-with-esrd-on-hd weekly 0.8 https://www.themednet.org/what-is-the-current-role-of-liver-transplant-in-cholangiocarcinoma weekly 0.8 https://www.themednet.org/what-is-your-preferred-regimen-for-metastatic-sarcomatoid-carcinoma-of-unknown-primary weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-with-rcc-with-rad50-mutation-and-esrd-on-hd-who-progressed-on-first-line-anti-pd1-and-tki-with-a-parp-inhibitor weekly 0.8 https://www.themednet.org/does-5-fraction-sabr-result-in-worsening-sphincter-function-in-cases-where-mpmri-clearly-shows-apical-involvement-including-ece weekly 0.8 https://www.themednet.org/apart-from-a-clinical-trial-what-is-the-optimal-management-for-young-healthy-patients-with-clinically-node-positive-prostate-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-an-older-cardiac-patient-with-borderline-resectable-pancreatic-adenoca-brca2-with-squamous-differentiation-progressing-on-neoadjuvant-gem-abraxane weekly 0.8 https://www.themednet.org/how-long-would-you-wait-after-a-patient-receives-intrathecal-methotraxate-for-dlbcl-prior-to-treating-a-painful-spine-metastasis-without-cord-compression weekly 0.8 https://www.themednet.org/what-is-the-appropriate-treatment-of-a-patient-with-langerhans-cell-histocytosis-who-presents-with-diabetes-insipidus weekly 0.8 https://www.themednet.org/would-you-irradiate-a-vascular-anastamosis weekly 0.8 https://www.themednet.org/has-approval-of-decipher-for-high-intermediate-risk-prostate-cancer-by-medicare-changed-your-treatment-practice weekly 0.8 https://www.themednet.org/how-would-you-approach-the-treatment-of-stage-iv-unresectable-hepatobiliary-cystadenocarcinoma weekly 0.8 https://www.themednet.org/in-light-of-gog-213-how-will-you-approach-secondary-debulking-for-platinum-sensitive-epithelial-ovarian-cancer-patients weekly 0.8 https://www.themednet.org/should-all-patients-with-t-all-and-t-lymphoblastic-lymphoma-receive-nelarabine-or-just-certain-risk-groups weekly 0.8 https://www.themednet.org/should-all-pediatric-all-patients-be-screened-for-ph-like-mutations-or-just-high-risk-patients-with-b-all weekly 0.8 https://www.themednet.org/should-we-be-performing-adaptive-testing-for-mrd-on-all-pediatric-all-patients-at-the-end-of-induction-or-at-other-time-points weekly 0.8 https://www.themednet.org/are-there-any-situations-where-you-would-consider-using-nab-paclitaxel-as-part-of-the-platinum-doublet-regimen-for-concurrent-chemoradiation-for-a-patient-with-stage-iii-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-for-a-t4b-n0-m0-bladder-cancer weekly 0.8 https://www.themednet.org/what-in-your-opinion-is-the-optimal-neoadjuvant-chemotherapy-regimen-for-adenosquamous-carcinoma-of-the-pancreas-that-is-borderline-resectable weekly 0.8 https://www.themednet.org/should-patients-with-cbf-or-npm1-aml-in-cr1-and-positive-molecular-mrd-after-first-consolidation-undergo-allogeneic-hct weekly 0.8 https://www.themednet.org/would-you-choose-rituximab-bendamustine-or-rituximab-lenalidomide-for-frontline-treatment-of-follicular-lymphoma-with-gilberts-disease weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-iatrogenic-immunodeficiency-associated-b-cell-lymphoma weekly 0.8 https://www.themednet.org/would-you-consider-adding-endocrine-therapy-for-a-young-patient-with-slowly-progressive-metastatic-endometrial-cancer-er-pr-msi-h-while-on-pembrolizumab weekly 0.8 https://www.themednet.org/when-would-you-offer-adjuvant-rt-to-a-cutaneous-scc-that-arose-on-the-hands-or-feet weekly 0.8 https://www.themednet.org/would-you-recommend-radiation-in-a-patient-with-inoperable-bladder-carcinoma-who-had-prior-prostate-radiation weekly 0.8 https://www.themednet.org/in-what-scenarios-do-you-favor-completion-lymph-node-dissection-over-ultrasound-surveillance-for-stage-iii-melanoma-sln-without-clinically-positive-nodes weekly 0.8 https://www.themednet.org/how-do-you-approach-a-cr-in-stage-ii-nonbulky-and-unfavorable-hodgkin-lymphoma-after-2-cycles-of-abvd weekly 0.8 https://www.themednet.org/are-there-any-data-or-situations-where-you-could-consider-induction-targeted-therapy-for-patients-with-stage-iii-nsclc-with-driver-mutations-and-a-large-lesion-in-an-attempt-to-decrease-treatment-field weekly 0.8 https://www.themednet.org/is-there-a-role-for-luspatercept-in-low-risk-mds-without-ringed-sideroblasts weekly 0.8 https://www.themednet.org/are-you-routinely-testing-high-grade-dlbcl-patients-who-do-fit-the-pathologic-criteria-for-double-hit-or-burkitt-lymphoma-for-an-11q-abberation weekly 0.8 https://www.themednet.org/during-the-consolidation-phase-of-the-ewall-protocol-for-elderly-ph-positive-all-do-you-include-or-omit-the-asparaginase-as-indicated-in-the-publication weekly 0.8 https://www.themednet.org/are-there-any-known-risks-with-post-mastectomy-radiation-therapy-in-a-patient-with-lymphangiomyomatosis weekly 0.8 https://www.themednet.org/how-would-you-address-surgical-options-in-a-pregnant-female-in-early-1st-trimester-with-hr-her2-idc-with-a-positive-axillary-ln-and-occult-breast-primary weekly 0.8 https://www.themednet.org/how-long-should-therapy-be-for-pediatric-males-with-acute-lymphoblastic-leukemia weekly 0.8 https://www.themednet.org/do-you-offer-maintenance-therapy-to-a-patient-who-is-less-than-3-years-old-with-medulloblastoma weekly 0.8 https://www.themednet.org/what-treatment-do-you-recommend-for-a-pediatric-patient-with-ph-negative-b-all-in-first-relapse-who-has-not-received-a-transplant-or-car-t weekly 0.8 https://www.themednet.org/what-are-the-indications-to-refer-a-pediatric-cancer-patient-to-genetics-for-further-workup-for-a-cancer-predisposition-syndrome weekly 0.8 https://www.themednet.org/what-treatment-do-you-offer-to-a-pediatric-patient-with-all-isolated-testicular-relapse weekly 0.8 https://www.themednet.org/what-treatment-do-you-offer-to-a-pediatric-patient-who-is-at-least-3-years-old-with-first-relapse-of-medulloblastoma weekly 0.8 https://www.themednet.org/do-you-offer-cranial-irradiation-to-pediatric-patients-with-cns-positive-all weekly 0.8 https://www.themednet.org/what-further-treatment-options-if-any-do-you-offer-to-a-pediatric-patient-with-diffuse-midline-glioma-who-has-completed-radiation-therapy weekly 0.8 https://www.themednet.org/how-would-you-manage-a-pediatric-patient-with-first-relapse-of-burkitt-lymphoma-or-leukemia weekly 0.8 https://www.themednet.org/do-you-recommend-using-thrombopoietin-receptor-agonists-such-as-romiplostim-to-treat-chemotherapy-associated-thrombocytopenia-in-pediatric-cancer-patients weekly 0.8 https://www.themednet.org/how-would-you-manage-a-pediatric-patient-with-neurodegenerative-langerhans-cell-histiocytosis weekly 0.8 https://www.themednet.org/what-treatment-do-you-offer-to-a-pediatric-patient-with-relapsed-refractory-langerhans-cell-histiocytosis weekly 0.8 https://www.themednet.org/how-are-you-using-urine-or-blood-biomarkers-in-advising-patients-in-completing-prostate-biopsy weekly 0.8 https://www.themednet.org/do-you-routinely-perform-full-lymph-node-dissection-for-staging-of-mucinous-ovarian-cancers weekly 0.8 https://www.themednet.org/how-would-you-approach-adjuvant-therapy-for-a-postmenopausal-woman-with-localized-tnbc-stage-ia-grade-2-no-ln-involvement-and-invasive-lobular-with-histiocytoid-variant-histology weekly 0.8 https://www.themednet.org/how-would-you-approach-a-young-fit-patient-with-very-high-risk-aml-and-latent-tuberculosis-with-plans-for-allogeneic-stem-cell-transplantation weekly 0.8 https://www.themednet.org/what-is-your-treatment-recommendation-for-a-favorable-early-stage-endometrial-cancer-that-has-an-i-sln weekly 0.8 https://www.themednet.org/what-treatment-do-you-offer-to-a-pediatric-oncology-patient-with-severe-refractory-vincristine-induced-neuropathy weekly 0.8 https://www.themednet.org/how-would-you-approach-an-oligometastatic-mediastinal-bulky-progression-to-all-tkis-and-chemotherapy-in-a-patient-with-ros1-positive-nsclc-in-the-setting-of-wegeners-granulomatosis weekly 0.8 https://www.themednet.org/for-what-duration-should-abiraterone-be-used-with-adt-for-metastatic-hormone-sensitive-prostatic-adenocarcinoma-in-the-initial-treatment-setting-especially-if-there-has-been-prolonged-response weekly 0.8 https://www.themednet.org/how-does-the-presence-of-a-fancm-mutation-germline-or-somatic-impact-your-chemotherapy-decisions weekly 0.8 https://www.themednet.org/is-there-a-role-for-rt-in-the-treatment-of-symptomatic-verruca-vulgaris weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-a-recurrent-rathkes-cleft-cyst-not-amenable-to-additional-surgical-resection weekly 0.8 https://www.themednet.org/is-there-any-role-for-adjuvant-high-dose-interferon-or-other-adjuvant-therapy-for-stage-iia-melanoma weekly 0.8 https://www.themednet.org/how-are-you-managing-grade-1-endometrial-adenocarcinoma-in-light-of-covid-19 weekly 0.8 https://www.themednet.org/how-would-you-approach-a-patient-with-stage-1a-hr-her2-metaplastic-breast-cancer weekly 0.8 https://www.themednet.org/how-would-you-counsel-a-female-to-male-transgender-patient-regarding-testosterone-therapy-after-definitive-surgery-for-early-stage-endometrioid-endometrial-cancer weekly 0.8 https://www.themednet.org/do-you-ever-offer-tki-to-induce-radioiodine-sensitization-in-patients-with-differentiated-but-radioiodine-refractory-braf-v600e-mutant-metastatic-thyroid-cancer-and-low-asymptomatic-disease-burden-who-might-otherwise-be-appropriate-candidates-for-observat weekly 0.8 https://www.themednet.org/is-being-on-anticoagulation-a-contraindication-for-prostate-sbrt weekly 0.8 https://www.themednet.org/if-a-patient-with-cns-lymphoma-achieves-a-complete-radiological-response-after-4-cycles-of-induction-therapy-with-high-dose-methotrexate-and-rituximab-do-you-add-more-cycles-of-chemotherapy-or-proceed-with-consolidation-therapy weekly 0.8 https://www.themednet.org/what-is-your-approach-for-a-patient-with-pseudomyxoma-peritonei-and-evidence-of-residual-microscopic-disease-after-the-slandered-cytoreductive-surgery-and-hipec weekly 0.8 https://www.themednet.org/in-the-current-situation-of-covid-19-how-would-you-choose-between-transanal-excision-for-t1-rectal-cancer-and-administration-of-radiation-therapy weekly 0.8 https://www.themednet.org/for-a-patient-who-recently-completed-definitive-chemoradiation-with-q3w-cisplatin-for-a-p16-base-of-tongue-scc-with-mild-residual-tinnitus-and-now-has-an-isolated-regional-nodal-out-of-field-recurrence-to-be-treated-with-chemoradiation-what-concurrent-che weekly 0.8 https://www.themednet.org/how-would-you-treat-clear-cell-vaginal-adenocarcinoma-with-a-single-metastasis-to-the-adrenal weekly 0.8 https://www.themednet.org/how-do-you-manage-anticoagulation-in-patients-on-therapeutic-warfarin-or-doac-who-are-diagnosed-with-covid-19-and-found-to-have-elevated-rising-d-dimer-level weekly 0.8 https://www.themednet.org/would-you-offer-a-short-course-of-adjuvant-capox-for-a-patient-with-lynch-syndrome-who-has-low-risk-stage-iii-colon-cancer weekly 0.8 https://www.themednet.org/what-chemotherapy-regimens-would-you-consider-for-synchronous-stage-iii-adenocarcinoma-of-the-colon-and-stage-iii-endometrial-adenocarcinoma weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-regional-recurrence-of-gastric-carcinoma-s-p-gastrectomy-who-cannot-tolerate-chemo-and-received-rt-for-bleeding-pre-operatively weekly 0.8 https://www.themednet.org/does-anyone-have-experience-treating-patients-with-radiation-therapy-with-an-accompanying-diagnosis-of-reflex-sympathetic-dystrophy-rsd weekly 0.8 https://www.themednet.org/in-flt3-aml-patients-who-only-have-a-partial-response-to-gilteritinib-and-are-switched-to-venetoclax-hypomethylating-agent-do-you-drop-the-gilteritinib-or-do-you-continue-it weekly 0.8 https://www.themednet.org/what-treatment-options-would-you-offer-a-patient-with-cervical-dystonia-caused-by-a-brain-or-spinal-cord-tumor-that-is-unresponsive-to-surgery-chemo-irradiation weekly 0.8 https://www.themednet.org/how-do-you-utilize-plasma-ebv-dna-in-patients-with-eber-nasopharyngeal-carcinoma weekly 0.8 https://www.themednet.org/do-you-offer-maintenance-niraparib-for-a-stage-iib-endometrioid-wtbrca-hrd-unknown-ovarian-carcinoma-patient-after-completing-front-line-platinum-therapy-or-do-you-reserve-it-for-advanced-stages-only-iii-iv weekly 0.8 https://www.themednet.org/what-is-your-preferred-direct-oral-anticoagulant-to-treat-venous-thrombosis-in-a-pediatric-patient weekly 0.8 https://www.themednet.org/are-you-offering-venous-thromboembolism-prophylaxis-to-children-with-covid-19-multisystem-inflammatory-syndrome weekly 0.8 https://www.themednet.org/do-you-recommend-limitation-of-certain-activities-after-spaceoar-injection weekly 0.8 https://www.themednet.org/how-soon-do-you-think-of-sending-your-patient-to-a-clinical-trial weekly 0.8 https://www.themednet.org/do-you-utilize-predictive-genomic-signatures-or-assays-prior-to-use-of-checkpoint-inhibitors weekly 0.8 https://www.themednet.org/when-would-you-consider-stopping-anti-pd-1-immunotherapy-in-a-patient-with-glioblastoma-after-achieving-a-good-response weekly 0.8 https://www.themednet.org/what-is-the-role-for-radiation-in-the-treatment-of-mastocytomas weekly 0.8 https://www.themednet.org/how-do-you-approach-spine-radiosurgery-in-patients-receiving-immunotherapy weekly 0.8 https://www.themednet.org/how-would-you-modify-therapy-following-methotrexate-neurotoxicity-in-high-risk-all weekly 0.8 https://www.themednet.org/would-you-offer-adjuvant-therapy-to-a-patient-with-stage-ia-uterine-serous-carcinoma-s-p-2-weeks-of-preop-ebrt-due-to-covid-related-surgical-delay weekly 0.8 https://www.themednet.org/how-high-does-a-patients-platelet-count-need-to-be-to-undergo-a-covid-19-nasal-swab-without-a-significant-risk-of-bleeding weekly 0.8 https://www.themednet.org/for-an-anal-cancer-patient-with-small-bowel-between-the-rectum-and-bladder-as-well-as-small-mesorectal-and-inguinal-nodes-how-much-margin-would-you-extend-ctv-like-you-extend-into-bladder-into-small-bowel-for-mesorectal-ctv weekly 0.8 https://www.themednet.org/how-would-you-treat-an-adult-with-a-desmoplastic-small-round-cell-tumor weekly 0.8 https://www.themednet.org/do-you-ever-consider-g-csf-during-chemoradiation-for-lung-cancer-for-prolonged-neutropenia weekly 0.8 https://www.themednet.org/is-there-a-concern-with-starting-prostate-radiation-after-a-patient-with-superficial-bladder-cancer-was-recently-treated-with-bcg weekly 0.8 https://www.themednet.org/how-do-you-manage-a-patient-with-inoperable-invasive-transitional-cell-carcinoma-of-the-distal-ureter weekly 0.8 https://www.themednet.org/is-there-a-role-for-ablative-radiation-in-a-patient-with-locally-advanced-cholangiocarcinoma-who-has-involved-periportal-lymph-nodes weekly 0.8 https://www.themednet.org/is-there-a-clinical-situation-in-which-you-would-forego-neoadjuvant-chemoradiation-for-patients-with-ct3n0-rectal-cancer-staged-by-mri weekly 0.8 https://www.themednet.org/what-adjuvant-treatment-regimen-would-you-recommend-for-resected-sarcomatoid-nsclc weekly 0.8 https://www.themednet.org/how-would-you-treat-advanced-stage-classical-hodgkins-lymphoma-in-older-patients-with-good-performance-status weekly 0.8 https://www.themednet.org/how-do-you-counsel-adult-patients-on-the-cognitive-toxicities-of-craniospinal-irradiation-csi weekly 0.8 https://www.themednet.org/what-is-your-first-choice-of-flt3-inhibitor-for-newly-diagnosed-flt3-aml-in-the-aya-population weekly 0.8 https://www.themednet.org/do-you-recommend-that-children-who-are-undergoing-chemotherapy-refrain-from-returning-to-school-during-the-covid-19-pandemic weekly 0.8 https://www.themednet.org/how-would-you-treat-an-aya-patient-with-philadelphia-negative-all-with-induction-failure weekly 0.8 https://www.themednet.org/what-would-be-your-choice-of-chemotherapy-in-a-patient-with-gbrca-mutated-metastatic-tnbc-who-has-progressed-on-a-parp-inhibitor weekly 0.8 https://www.themednet.org/do-you-treat-a-large-unresectable-intramuscular-myxoma-with-radiation weekly 0.8 https://www.themednet.org/does-nbn-gene-mutation-impact-adjuvant-radiation-recommendations-for-early-stage-breast-cancer weekly 0.8 https://www.themednet.org/how-are-you-approaching-using-different-genetic-risk-scores-in-neoadjuvant-therapy-for-hormone-positive-breast-cancer weekly 0.8 https://www.themednet.org/what-precautions-if-any-would-you-take-for-using-fluoropyrimidines-in-patients-with-pre-existing-systolic-heart-failure-ef-35 weekly 0.8 https://www.themednet.org/are-there-any-safety-or-efficacy-data-regarding-the-use-of-checkpoint-inhibitors-in-patients-on-hemodialysis-for-esrd weekly 0.8 https://www.themednet.org/would-you-consider-definitive-radiation-in-a-patient-with-small-cell-of-the-bladder-who-had-prior-pelvic-radiation weekly 0.8 https://www.themednet.org/how-would-you-follow-up-a-patient-with-stage-iv-cholangiocarcinoma-who-presented-mainly-with-obstructive-jaundice-rising-ca19-9-negative-scans-only-to-have-laparoscopic-finding-of-tumor-deposits-in-the-liver weekly 0.8 https://www.themednet.org/would-you-choose-a-picc-or-port-for-central-access-for-a-newly-diagnosed-leukemia-patient weekly 0.8 https://www.themednet.org/would-you-consider-postoperative-re-irradiation-in-a-patient-that-underwent-ebrt-and-then-salvage-prostatectomy-who-has-a-positive-margin-and-rising-psa weekly 0.8 https://www.themednet.org/is-there-a-role-for-esa-therapy-in-mds-with-isolated-del-5q weekly 0.8 https://www.themednet.org/how-do-you-approach-a-pediatric-patient-with-crlf2-rearranged-b-all-and-late-bone-marrow-relapse weekly 0.8 https://www.themednet.org/how-would-you-manage-an-ampullary-squamous-cell-carcinoma-in-the-adjuvant-setting-with-negative-margins-but-with-other-high-risk-features weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-relapsed-intermediate-risk-neuroblastoma weekly 0.8 https://www.themednet.org/what-would-be-your-first-line-treatment-for-advanced-hcc-patients-who-have-severe-thrombocytopenia-plt-50-and-or-treated-varices weekly 0.8 https://www.themednet.org/how-would-you-complete-salvage-radiation-in-a-patient-who-had-a-rp-and-a-total-colectomy-and-j-pouch-for-ibd weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-hr-negative-her2-metastatic-breast-cancer-after-wbrt-for-isolated-cns-recurrence-with-continued-systemic-cr-with-first-line-tchp weekly 0.8 https://www.themednet.org/in-what-situation-would-you-use-the-fda-approved-combination-atezolizumab-vemurafenib-cobimetinib-in-advanced-brafv600-mutated-melanoma weekly 0.8 https://www.themednet.org/is-there-an-increased-risk-of-spontaneous-rupture-or-fistula-with-exbrt-of-prostate-cancer-with-an-abutting-bladder-diverticulum weekly 0.8 https://www.themednet.org/how-would-you-approach-treatment-of-a-15-month-old-with-shh-tp53-wildtype-medulloblastoma weekly 0.8 https://www.themednet.org/how-do-you-approach-cranial-radiotherapy-in-a-patient-with-hereditary-hemorrhagic-telangiectasia weekly 0.8 https://www.themednet.org/do-patients-report-bony-pain-or-other-similar-symptoms-when-coming-off-cdk4-6-inhibitors-especially-palbociclib weekly 0.8 https://www.themednet.org/is-there-any-known-contraindication-increased-toxicity-profile-to-adjuvant-whole-breast-radiotherapy-in-a-patient-with-a-mutyh-gene-mutation weekly 0.8 https://www.themednet.org/what-the-the-signs-of-interstitial-ectopic-pregnancy-on-pocus weekly 0.8 https://www.themednet.org/do-you-extend-biologic-dosing-intervals-in-a-patient-with-moderate-to-severe-psoriasis-who-has-achieved-and-maintained-pasi-100-for-at-least-one-year weekly 0.8 https://www.themednet.org/what-prompts-you-to-try-a-jak-inhibitor-in-a-child-under-12-with-alopecia-totalis-or-universalis-who-has-failed-conventional-therapy weekly 0.8 https://www.themednet.org/do-you-choose-poem-over-laparoscopic-heller-myotomy-as-your-preferred-initial-intervention-in-a-patient-with-type-ii-achalasia-who-has-no-prior-esophageal-surgery weekly 0.8 https://www.themednet.org/If-AAG-is-confirmed-what-first-line-immunotherapy-regimen-do-you-use weekly 0.8 https://www.themednet.org/which-features-help-you-distinguish-between-psychotic-versus-non-psychotic-hallucinations-in-children weekly 0.8 https://www.themednet.org/What-would-be-the-next-step-to-treat-cutaneous-Behcet's-if-Colchicine-and-Apremilast-have-been-inefficacious weekly 0.8 https://www.themednet.org/how-do-you-choose-between-intravitreal-methotrexate-versus-ocular-radiation-for-isolated-retinal-relapse-in-pvrl weekly 0.8 https://www.themednet.org/when-a-patient-expresses-an-interest-in-subcutaneous-allergen-immunotherapy-for-dog-do-you-find-it-helpful-to-order-dog-component-testing-prior-to-initiating-treatment weekly 0.8 https://www.themednet.org/how-long-do-you-recommend-holding-cgrp-inhibitors-after-an-ischemic-stroke weekly 0.8 https://www.themednet.org/how-do-you-use-ebna-1-peptide-antibody-titers-in-the-management-of-multiple-sclerosis-and-related-disorders weekly 0.8 https://www.themednet.org/how-has-the-new-data-suggesting-copds-impact-on-mortality-changed-how-you-talk-with-your-patients-regarding-their-prognosis weekly 0.8 https://www.themednet.org/in-what-situations-are-you-using-fosfomycin-for-acute-simple-cystitis-in-the-outpatient-setting weekly 0.8 https://www.themednet.org/when-do-you-consider-amoxacillin-alone-over-amoxacillin-clavulanate-for-acute-bacterial-sinusitis weekly 0.8 https://www.themednet.org/do-you-prioritize-aerobic-exercise-over-pharmacotherapy-as-the-first-active-intervention-in-a-patient-with-newly-diagnosed-fibromyalgia-who-has-no-prior-treatment weekly 0.8 https://www.themednet.org/do-you-recommend-a-trial-of-biologic-therapy-in-a-patient-with-non-radiographic-axspa-on-the-basis-of-mri-sacroiliitis-and-elevated-crp-alone-but-without-any-other-clinical-features-of-spondyloarthritis weekly 0.8 https://www.themednet.org/have-the-hyperion-and-zenith-trial-data-changed-how-you-sequence-sotatercept-in-a-newly-diagnosed-patient-with-intermediate-to-high-risk-who-group-1-pah-specifically-do-you-now-add-sotatercept-at-diagnosis-alongside-background-dual-therapy-rather-than-wai weekly 0.8 https://www.themednet.org/if-random-gastric-biopsies-unexpectedly-demonstrate-a-low-grade-neuroendocrine-tumor-what-would-be-your-next-diagnostic-and-management-steps weekly 0.8 https://www.themednet.org/do-you-routinely-pursue-transvaginal-ultrasound-and-or-endometrial-biopsy-for-postmenopausal-women-with-a-single-episode-of-spotting-or-do-you-defer-unless-there-are-more-persistent-symptoms weekly 0.8 https://www.themednet.org/young-patients-with-confirmed-elevated-high-sensitivity-crp-with-no-cardiac-complaints-what-treatment-options-do-you-offer weekly 0.8 https://www.themednet.org/in-a-patient-with-rp-fibrosis-and-unexplained-hypoxemia-who-is-found-to-have-suggestion-of-intrapulmonary-shunt-on-tte-normal-ct-chest-and-cta-for-avm-and-no-liver-disease-what-would-be-a-suggested-next-step-in-workup weekly 0.8 https://www.themednet.org/do-you-preferentially-prescribe-nondialyzable-beta-blockers-over-dialyzable-ones-in-patients-on-chronic-hemodialysis-who-require-beta-blocker-therapy-for-cardiovascular-indications weekly 0.8 https://www.themednet.org/do-you-add-a-second-antihypertensive-agent-rather-than-uptitrating-monotherapy-in-a-patient-with-stage-1-hypertension-and-suboptimal-blood-pressure-control-given-evidence-that-combination-regimens-are-better-tolerated-than-monotherapy weekly 0.8 https://www.themednet.org/what-advice-do-you-offer-when-patients-request-recommendations-on-holistic-supplements-to-take-for-ra weekly 0.8 https://www.themednet.org/if-a-patient-is-found-to-be-hla-b27-after-an-episode-of-reactive-arthritis-but-has-now-developed-inflammatory-oligoarthritis-with-highly-elevated-inflammatory-markers-despite-mtx-ssz-would-you-add-on-tnfi weekly 0.8 https://www.themednet.org/how-should-the-the-starting-doses-for-be-formulated-for-individual-vials-for-the-following-mixtures-which-are-the-maintenance-doses-they-would-be-on-dust-mite-dp-df-mix-10-000-au-0-2-ml-cat-10-000-units-0-1-ml-mold-mix-1-100-0-3-ml-dog-1-100-0-3-ml-trees- weekly 0.8 https://www.themednet.org/if-a-non-transplant-or-community-practice-wanted-to-implement-a-collaborative-care-model-for-decompensated-cirrhosis-which-program-elements-are-essential-to-preserve-vs-safely-adaptable-to-maintain-patient-reported-outcome-benefits weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-steroid-refractory-eosinophilic-fasciitis weekly 0.8 https://www.themednet.org/would-you-recommend-against-use-of-dupilumab-for-severe-atopic-dermatitis-in-a-patient-with-a-history-of-neonatal-hsv-meningitis-but-no-issues-with-recurrent-outbreaks weekly 0.8 https://www.themednet.org/what-would-you-recommend-to-work-up-a-hospitalized-patient-with-incidental-asymptomatic-hypoxemia-who-is-found-to-have-diffuse-interstitial-infiltrates-on-chest-x-ray weekly 0.8 https://www.themednet.org/a-2025-study-of-post-hf-hospitalization-practice-patterns-found-substantial-variability-in-gdmt-initiation-discontinuation-and-timing-of-re-initiation-highlighting-that-clinicians-are-still-approaching-this-differently-for-patients-with-hfref-recovering-f weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-restarting-a-home-buprenorphine-patch-in-an-older-patient-status-post-surgery-whose-buprenorphine-has-been-held-and-is-now-receiving-as-needed-oxycodone weekly 0.8 https://www.themednet.org/are-there-any-scenarios-under-which-you-routinely-recommend-probiotics-when-treating-older-adult-patients-with-long-term-antibiotics-and-if-so-what-specific-prescription-do-you-consider weekly 0.8 https://www.themednet.org/how-would-you-approach-management-of-a-10cm-rectal-fecaloma-in-a-bedbound-woman-in-her-80s-that-was-found-incidentally weekly 0.8 https://www.themednet.org/do-you-have-any-go-to-resources-or-heuristics-when-consulted-by-an-inpatient-team-for-failure-to-thrive-in-an-older-adult-admitted-to-the-hospital weekly 0.8 https://www.themednet.org/for-a-patient-with-advanced-or-metastatic-dedifferentiated-liposarcoma-how-will-you-use-abemaciclib-if-it-is-approved-based-on-sarc041 weekly 0.8 https://www.themednet.org/in-regards-to-post-menopausal-hormone-replacement-therapy-is-a-progesterone-releasing-iud-sufficient-for-uterine-protection-when-combined-with-estradiol-patch weekly 0.8 https://www.themednet.org/how-if-at-all-are-you-using-vitamin-d-based-strategies-in-patients-receiving-taxane-based-chemotherapy-to-reduce-risk-of-peripheral-neuropathy weekly 0.8 https://www.themednet.org/do-you-discontinue-hypertonic-saline-or-dornase-alfa-in-a-clinically-stable-adult-patient-on-trikafta-who-has-well-preserved-lung-function-and-wants-to-reduce-treatment-burden weekly 0.8 https://www.themednet.org/ive-noticed-an-increase-in-bicarb-drip-usage-for-the-following-1-serum-bicarb-20-2-aki-unrelated-to-diarrhea-3-severe-lactic-acidosis-with-ph-7-3-in-multi-organ-failure-what-are-your-thoughts-on-this-practice-thank-you weekly 0.8 https://www.themednet.org/do-you-specifically-screen-for-childbirth-related-ptsd-when-evaluating-a-postpartum-patient-who-presents-with-mood-symptoms-or-hyperarousal weekly 0.8 https://www.themednet.org/in-light-of-frontmind-data-are-you-anticipating-a-change-in-your-treatment-preference-for-patients-with-newly-diagnosed-high-risk-dlbcl weekly 0.8 https://www.themednet.org/is-there-any-evidence-of-clinical-benefit-in-treating-kids-with-and-ics-if-their-asthma-is-clinically-well-controlled-but-their-feno-is-elevated weekly 0.8 https://www.themednet.org/do-spacers-reduce-emissions-of-inhalers weekly 0.8 https://www.themednet.org/at-what-point-in-the-course-of-antipsychotic-therapy-do-you-begin-actively-monitoring-for-tardive-dyskinesia-in-a-patient-with-bipolar-disorder-or-major-depressive-disorder weekly 0.8 https://www.themednet.org/how-do-you-handle-a-situation-when-the-oral-antibiotics-which-will-work-in-place-of-continued-iv-antibiotic-therapy-are-branded-but-getting-approval-from-the-insurance-company-is-difficult-to-impossible weekly 0.8 https://www.themednet.org/do-you-incorporate-mr-spectroscopy-into-preoperative-planning-for-brain-biopsies-for-suspected-new-brain-tumors weekly 0.8 https://www.themednet.org/what-second-line-treatment-would-you-offer-a-patient-with-braf-v600e-mutant-mcrc-after-progression-on-ec-folfox-or-folfiri weekly 0.8 https://www.themednet.org/do-you-act-on-progressive-gcipl-thinning-before-clear-rnfl-or-visual-field-change-in-patients-with-ocular-hypertension weekly 0.8 https://www.themednet.org/how-do-you-incorporate-and-or-utilize-corneal-hysteresis-in-evaluating-a-patient-with-glaucoma weekly 0.8 https://www.themednet.org/how-do-you-differentiate-between-macular-schisis-vs-macular-edema-vs-optically-empty-spaces-from-macular-telangiectasia-on-oct weekly 0.8 https://www.themednet.org/how-do-you-consider-initiating-gabapentinoids-for-acute-pain-in-hospitalized-patients weekly 0.8 https://www.themednet.org/how-do-you-approach-antipsychotic-selection-in-a-patient-with-schizophrenia-whose-negative-symptoms-remain-prominent-after-positive-symptoms-are-adequadetly-controlled weekly 0.8 https://www.themednet.org/can-you-extrapolate-the-proteus-data-and-replace-apalutamide-with-other-arpis-for-high-risk-localized-or-locally-advanced-prostate-cancer weekly 0.8 https://www.themednet.org/would-you-recommend-annual-total-body-skin-examinations-for-kidney-transplant-recipients-who-are-no-longer-on-immunosuppressant-medications weekly 0.8 https://www.themednet.org/50yo-patient-with-a-history-of-uc-on-remicade-infusions-with-stable-small-pulmonary-nodules-and-nasal-rash-biopsy-with-granulomatous-dermatitis-how-often-is-it-that-patients-would-develop-cutaneous-sarcoidosis-while-already-being-treated-with-tnfi-should- weekly 0.8 https://www.themednet.org/do-you-trend-labs-ketones-lipids-for-patients-who-present-with-prurigo-pigmentosa weekly 0.8 https://www.themednet.org/with-the-rising-trend-of-high-protein-diets-have-yiu-noticed-more-presentations-of-prurigo-pigmentosa weekly 0.8 https://www.themednet.org/how-common-are-tnf-induced-sarcoidosis-like-reactions-any-treatment-required-apart-from-tnf-cessation weekly 0.8 https://www.themednet.org/Is-isolated-eosinophilia-an-indication-to-discontinue-capivasertib-AEC-5600.-Or-can-this-be-a-precursor-symptom-to-DRESS weekly 0.8 https://www.themednet.org/for-patients-presenting-with-new-or-significntly-worse-lower-urinary-tract-symptoms-without-any-red-flag-symptoms-how-important-is-it-to-perform-digital-rectal-exam-and-how-often-do-you-discuss-psa-based-screening weekly 0.8 https://www.themednet.org/what-is-your-approach-to-the-management-of-chronic-hyponatremia-in-the-131-134-range-in-ambulatory-older-adults weekly 0.8 https://www.themednet.org/how-do-you-counsel-older-adult-patients-and-family-members-regarding-the-use-of-marijuana-containing-products-for-the-treatment-of-behavioral-and-psychological-symptoms-of-dementia weekly 0.8 https://www.themednet.org/what-is-your-stepwise-therapeutic-approach-to-acute-headache-without-red-flag-features-in-hospitalized-patients-who-have-underlying-renal-hepatic-and-or-cardiac-dysfunction weekly 0.8 https://www.themednet.org/how-do-you-consider-the-anticipated-benefits-and-risks-of-ketamine-to-treat-acute-pain weekly 0.8 https://www.themednet.org/do-you-use-burst-exercise-testing-to-evaluate-a-patient-with-unexplained-exertional-syncope-and-a-family-history-of-sudden-cardiac-death-in-a-young-relative-whose-standard-bruce-protocol-stress-test-was-normal weekly 0.8 https://www.themednet.org/do-you-offer-metformin-to-non-diabetic-outpatients-with-acute-sars-cov-2-infection-to-reduce-the-risk-of-long-covid-based-on-the-activ-6-trial weekly 0.8 https://www.themednet.org/how-have-the-new-guidelines-regarding-universal-lipoprotein-a-screening-changed-your-practice-pattern-if-at-all weekly 0.8 https://www.themednet.org/in-patients-with-depression-and-a-suboptimal-response-to-ssri-do-you-generally-tend-to-augment-ie-add-buspirone-bupropion-switch-agents-or-increase-dose weekly 0.8 https://www.themednet.org/how-has-the-new-data-with-long-term-follow-up-suggesting-a-sustained-reduction-in-deaths-from-prostate-cancer-with-psa-testing-changed-how-you-counsel-your-patients-on-psa-if-at-all weekly 0.8 https://www.themednet.org/what-is-your-favored-dexamethasone-dosing-regimen-for-brain-tumors weekly 0.8 https://www.themednet.org/does-anyone-have-a-set-of-labs-to-rule-out-underlying-clotting-disorders-they-order-for-patients-prior-to-starting-oral-tranexamic-acid-for-melasma weekly 0.8 https://www.themednet.org/how-would-you-manage-a-patient-with-unstaged-serous-endometrial-cancer-confined-to-a-polyp-diagnosed-after-hysterectomy-for-postmenopausal-bleeding-inability-to-sample-the-endometrium weekly 0.8 https://www.themednet.org/would-you-recommend-port-removal-in-a-patient-with-one-positive-blood-culture-for-salmonella-species weekly 0.8 https://www.themednet.org/should-we-be-using-dpp4-inhibitor-therapy-more-for-treatment-of-type-2-diabetes-mellitus-given-its-outperformance-in-keeping-glucose-in-range-compared-to-other-glucose-lowering-agents-like-glimepiride-for-patients-who-cannot-afford-glp-1-r-agonist-therapy weekly 0.8 https://www.themednet.org/how-do-you-approach-glucose-monitoring-after-an-episode-of-hyperglycemia-during-acute-pancreatitis weekly 0.8 https://www.themednet.org/how-do-you-manage-paracentral-acute-middle-maculopathy-pamm weekly 0.8 https://www.themednet.org/what-is-your-approach-to-chronic-testosterone-replacement-therapy-trt-in-hospitalized-patients-with-hypogonadism-do-you-generally-continue-treatment-during-admission-and-are-there-specific-medical-surgical-or-perioperative-scenarios-in-which-you-would-tem weekly 0.8 https://www.themednet.org/how-do-you-incorporate-routine-alcohol-biomarkers-e-g-peth-into-hepatology-care-to-support-aud-recognition-and-ongoing-monitoring-without-increasing-shame-driven-concealment-particularly-in-liver-transplant-candidates weekly 0.8 https://www.themednet.org/what-clinical-or-social-risk-threshold-prompts-you-to-escalate-from-standard-referral-to-an-intensive-retention-focused-approach-e-g-peer-support-contingency-management-navigation-for-aud-treatment-in-patients-with-alcohol-associated-liver-disease-and-whi weekly 0.8 https://www.themednet.org/what-non-meld-variable-most-meaningfully-improves-longer-horizon-prognostication-in-alcohol-associated-liver-disease-and-how-would-you-combine-it-with-meld-based-absolute-risk-to-guide-when-to-escalate-care-e-g-transplant-referral-beyond-meld-alone weekly 0.8 https://www.themednet.org/which-pocus-defined-hemodynamic-phenotype-in-decompensated-cirrhosis-most-reliably-shifts-your-initial-resuscitation-away-from-additional-fluids-toward-vasopressors-and-or-early-renal-replacement-therapy-and-what-specific-pocus-findings-drive-that-decisio weekly 0.8 https://www.themednet.org/when-elastography-is-technically-unreliable-e-g-high-iqr-median-or-inconsistent-readings-in-severe-obesity-but-serum-fibrosis-biomarkers-suggest-advanced-fibrosis-what-hierarchy-do-you-use-to-adjudicate-true-f2-f3-and-decide-on-biopsy-or-treatment-initiat weekly 0.8 https://www.themednet.org/after-12-18-months-of-therapy-for-mash-what-specific-nit-based-threshold-and-which-nits-do-you-use-to-define-inadequate-response-that-triggers-adding-a-liver-directed-agent-e-g-a-thyroid-hormone-receptor-beta-agonist-rather-than-continuing-to-observe-give weekly 0.8 https://www.themednet.org/if-a-patient-with-suspected-or-confirmed-mash-cannot-tolerate-the-glp-1-receptor-agonist-dose-and-can-only-maintain-a-lower-obesity-approved-dose-do-you-continue-that-lower-dose-as-part-of-a-liver-directed-strategy-or-pivot-earlier-to-a-thyroid-hormone-re weekly 0.8 https://www.themednet.org/for-a-solitary-3-cm-hcc-with-aggressive-biology-e-g-rising-afp-or-rapid-growth-what-biology-thresholds-afp-level-or-doubling-time-would-make-you-favor-ablative-intent-y90-over-other-liver-directed-options-despite-small-tumor-size weekly 0.8 https://www.themednet.org/for-early-hcc-that-is-technically-within-transplant-criteria-what-patient-or-tumor-related-features-e-g-afp-behavior-frailty-rising-meld-multifocality-lead-you-to-stop-pursuing-liver-transplantation-as-the-preferred-strategy-and-instead-recommend-resectio weekly 0.8 https://www.themednet.org/in-very-high-risk-hrs-aki-e-g-aclf-grade-3-very-high-meld-or-severe-creatinine-elevation-what-are-your-practical-contraindication-cutoffs-for-terlipressin-and-how-does-imminent-liver-transplantation-change-your-management-plan weekly 0.8 https://www.themednet.org/in-hrs-aki-evaluation-and-treatment-which-specific-decision-points-most-benefit-from-early-nephrology-involvement-diagnosis-vs-rrt-timing-vs-safety-monitoring-and-what-trigger-do-you-use-if-any-to-involve-them-consistently weekly 0.8 https://www.themednet.org/For-a-patient-who-has-nystagmus-due-to-a-medication-use-what-strategy-would-you-use-to-treat-the-nystagmus-Would-you-start-them-on-a-medication-for-nystagmus weekly 0.8 https://www.themednet.org/gi-bleed weekly 0.8 https://www.themednet.org/in-a-patient-with-hlab27-spondyloarthritis-who-develops-sudden-sensorineural-hearing-loss-that-responds-dramatically-to-corticosteroids-is-there-a-role-for-biologic-therapy-to-preserve-hearing-or-prevent-recurrence weekly 0.8 https://www.themednet.org/what-is-your-approach-to-managing-rheumatoid-arthritis-in-patients-with-sickle-cell-disease weekly 0.8 https://www.themednet.org/is-moyamoya-disease-a-contraindication-for-srs-to-avm weekly 0.8 https://www.themednet.org/if-approved-how-would-giredestrant-everolimus-evera-fit-into-your-treatment-approach-for-er-her2-abc-after-cdk4-6i-et-progression weekly 0.8 https://www.themednet.org/what-precuations-should-be-taken-in-a-patient-with-cvid-who-has-not-started-immunglobulin-replacement-yet-and-has-a-husband-with-human-metapneumovirus weekly 0.8 https://www.themednet.org/how-to-you-approach-transistioning-from-a-tricyclic-to-duloxetine weekly 0.8 https://www.themednet.org/Do-you-have-any-thoughts-or-special-considerations-when-considering-transurethral-BPH-surgery-in-a-patient-with-an-inflatable-penile-prosthesis-present weekly 0.8 https://www.themednet.org/if-tafasitamab-lenalidomide-plus-r-chop-frontmind-is-approved-for-frontline-treatment-how-would-you-approach-second-line-therapy-in-transplant-ineligible-patients-with-relapsed-refractory-dlbcl weekly 0.8 https://www.themednet.org/when-do-you-decide-to-reintroduce-mammalian-meat-dairy-in-an-alpha-gal-patient weekly 0.8 https://www.themednet.org/What-is-your-experience-on-port-placements-for-intravenous-infusions-for-biologics-for-patients-who-have-difficult-intravenous-access weekly 0.8 https://www.themednet.org/in-older-adult-men-with-bothersome-lower-urinary-tract-symptoms-how-you-weigh-the-pros-cons-of-increasing-tamsulosin-dose-from-0-4mg-to-0-8mg weekly 0.8 https://www.themednet.org/what-is-your-approach-to-continuing-vs-deprescribing-h-2-blockers-for-potential-delirium-prevention-in-hospitalized-older-adults weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-bothersome-dry-mouth-symptoms-in-older-adults weekly 0.8 https://www.themednet.org/how-do-you-approach-the-decision-to-continue-vs-discontinue-glp1-receptor-agonist-therapy-in-an-older-adult-with-heart-failure-with-preserved-ejection-fracture-who-has-been-losing-weight-and-now-has-bmi-29 weekly 0.8 https://www.themednet.org/what-concerns-would-you-have-with-2-fraction-sabr-compared-to-5-fraction-sabr-for-localized-prostate-cancer weekly 0.8 https://www.themednet.org/what-is-your-approach-to-management-of-postoperative-delirium-follow-up-whether-resolved-or-even-if-ongoing-in-the-transitional-phase-post-hospitalization-when-transitioning-to-post-acute-care-and-or-outpatient-setting weekly 0.8 https://www.themednet.org/how-would-you-manage-localized-p53-wt-mcl-localized-to-the-nasal-sinus-in-a-patient-under-60 weekly 0.8 https://www.themednet.org/how-has-the-new-data-suggesting-single-vs-multi-dose-hpv-vaccinations-changed-your-practice-pattern weekly 0.8 https://www.themednet.org/do-you-routinely-check-a-bmp-in-young-patients-on-spironolactone-for-treatment-of-acne weekly 0.8 https://www.themednet.org/do-you-consider-medical-cortisol-lowering-therapy-with-metyrapone-in-a-patient-with-mild-autonomous-cortisol-secretion-and-uncontrolled-hypertension-or-worsening-cardiovascular-risk-factors-who-is-not-a-surgical-candidate weekly 0.8 https://www.themednet.org/how-do-you-decide-between-primary-cytoreductive-surgery-and-neoadjuvant-chemotherapy-in-patients-with-advanced-epithelial-ovarian-cancer-who-appear-to-be-appropriate-candidates-for-either-approach weekly 0.8 https://www.themednet.org/how-do-you-approach-discontinuation-of-hrt-in-post-menopausal-women weekly 0.8 https://www.themednet.org/when-do-you-consider-diaphragmatic-breathing-in-the-treatment-algorithm-for-regurgitation-where-do-you-send-patients-for-diaphragmatic-breathing-exercises weekly 0.8 https://www.themednet.org/what-is-your-radiotherapy-approach-for-both-primary-and-the-metastasis-for-a-distal-esophageal-adenocarcinoma-with-a-single-large-metastatic-lesion-in-proximal-ulna-associated-with-5-cm-surround-soft-tissue-muscle-component weekly 0.8 https://www.themednet.org/during-the-course-of-long-term-care-of-men-with-psychiatric-illnesses-when-should-i-include-evaluation-for-hypogonadism-every-man-every-year-with-screening-for-cholesterol-never-or-only-with-specific-complaints-of-sexual-dysfunction-body-hair-loss-and-sar weekly 0.8 https://www.themednet.org/would-you-consider-amivantamab-or-datopotamab-in-a-patient-with-egfr-exon-19-positive-metastatic-nsclc-adenocarcinoma-that-progressed-on-osimertinib-carboplatin-and-pemetrexed-with-biopsy-proven-transformation-to-squamous-cell-carcinoma-but-still-detectab weekly 0.8 https://www.themednet.org/in-patients-with-history-of-breast-cancer-on-aromatase-inhibitor-therapy-when-do-you-transition-off-zolendronic-acid-therapy weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-their-risk-of-retinopathy-when-starting-glp-1-r-agonists-for-diabetes-management weekly 0.8 https://www.themednet.org/how-do-you-clear-and-time-elective-surgery-in-patients-who-meet-clinical-recompensation-but-still-have-csph-surrogates-e-g-thrombocytopenia-splenomegaly-given-the-risk-of-surgery-triggered-re-decompensation weekly 0.8 https://www.themednet.org/using-phosphatidylethanol-including-repeated-measures-what-alcohol-exposure-threshold-prompts-you-to-reclassify-a-patient-from-masld-to-metald-ald-and-what-is-the-most-important-way-that-reclassification-changes-your-management weekly 0.8 https://www.themednet.org/in-suspected-burned-out-masld-minimal-steatosis-but-high-stiffness-and-or-portal-hypertension-features-what-minimum-diagnostic-evaluation-do-you-require-before-attributing-cirrhosis-to-a-metabolic-etiology-rather-than-alternative-chronic-liver-diseases weekly 0.8 https://www.themednet.org/in-patients-on-effective-cardiometabolic-therapy-who-show-clear-reduction-in-liver-fat-over-12-24-months-but-no-improvement-in-liver-stiffness-what-decision-rule-do-you-use-to-determine-whether-to-escalate-liver-directed-evaluation-or-therapy-e-g-addition weekly 0.8 https://www.themednet.org/when-biopsy-or-imaging-suggests-steatohepatitis-without-fibrosis-what-factors-lead-you-to-continue-hepatology-follow-up-versus-manage-exclusively-in-primary-care-endocrinology-particularly-in-younger-patients-with-diabetes-or-strong-family-history-of-cirr weekly 0.8 https://www.themednet.org/how-do-you-operationalize-routine-alcohol-assessment-history-plus-audit-type-instrument-plus-a-biomarker-such-as-phosphatidylethanol-within-masld-pathways weekly 0.8 https://www.themednet.org/in-low-prevalence-settings-e-g-primary-care-what-stepped-nit-strategy-do-you-use-to-minimize-unnecessary-hepatology-referrals-while-still-safely-identifying-advanced-fibrosis-specifically-where-do-you-place-the-cut-points-for-moving-from-fib-4-to-second-l weekly 0.8 https://www.themednet.org/how-do-you-manage-new-onset-seropositive-rheumatoid-arthritis-in-a-young-female-of-childbearing-age-do-you-bypass-csdmards weekly 0.8 https://www.themednet.org/what-could-cause-both-necrotizing-and-non-necrotizing-granulomatous-disease-from-pathology-on-a-lung-biopsy-patient-has-inflammatory-arthritis-infectious-workup-negative-would-you-treat-as-sarcoidosis weekly 0.8 https://www.themednet.org/how-do-you-counsel-families-regarding-neuro-prognostication-for-patients-with-severe-tbi-close-to-their-initially-injury weekly 0.8 https://www.themednet.org/when-utilizing-ecog-for-resection-of-seizure-focus-how-do-you-determine-which-grids-to-use-and-how-to-place-them weekly 0.8 https://www.themednet.org/for-which-patients-do-you-consider-placing-a-lumbar-drain-prior-to-endoscopic-endonasal-resection-for-pituitary-adenoma-with-suprasellar-extension weekly 0.8 https://www.themednet.org/in-patients-with-a-new-spontaneous-small-parietal-hemorrhage-what-repeat-imaging-do-you-consider-for-further-evaluation weekly 0.8 https://www.themednet.org/would-you-treat-a-patient-for-true-infection-for-growth-of-proteus-mirabilis-from-two-separate-broth-cultures-collected-from-washout-of-large-retropharyngeal-simple-fluid-collection-consistent-with-pseudomeningocele-diagnosed-by-ct-obtained-for-neck-pain- weekly 0.8 https://www.themednet.org/how-does-data-on-long-term-disability-reduction-via-high-efficacy-therapies-in-pediatric-multiple-sclerosis-changed-your-approach-to-treatment-initiation-or-escalation weekly 0.8 https://www.themednet.org/if-approved-where-does-neoadjuvant-intralesional-daromun-fit-into-the-treatment-paradigm-for-resectable-locally-advanced-melanoma weekly 0.8 https://www.themednet.org/when-do-you-consider-prostatitis-in-patients-admitted-with-recurrent-utis weekly 0.8 https://www.themednet.org/how-do-you-approach-distinguishing-post-infectious-organizing-pneumonia-from-a-recurrent-lower-respiratory-infection weekly 0.8 https://www.themednet.org/do-you-consider-a-glp-1-receptor-agonist-for-a-patient-with-alcohol-use-disorder-who-has-had-an-inadequate-response-to-naltrexone-or-acamprosate weekly 0.8 https://www.themednet.org/Have-you-ever-encountered-eosinophilic-fasciitis-causing-ulcerations-(biopsied-no-vasculitis-seen)-despite-moderate-to-high-prednisone-doses-and-20mg-methotrexate-If-so-how-would-you-approach-this-as-a-consequence-of-uncontrolled-panniculitis-from-eosinop weekly 0.8 https://www.themednet.org/when-performing-rsi-for-intubation-in-the-icu-do-clinicians-typically-provide-bag-mask-ventilation-for-preoxygenation-while-waiting-for-induction-to-take-effect-roughly-30-90-seconds weekly 0.8 https://www.themednet.org/how-do-you-counsel-alzheimers-disease-patients-interested-in-treatment-with-40-hz-sensory-stimulation weekly 0.8 https://www.themednet.org/how-do-you-incorporate-trans-cranial-doppler-in-your-acute-stroke-evaluation weekly 0.8 https://www.themednet.org/how-if-at-all-has-the-7-year-crown-data-influenced-your-approach-to-treatment-duration-with-lorlatinib-in-patients-with-alk-positive-nsclc-who-remain-progression-free-long-term weekly 0.8 https://www.themednet.org/do-you-transition-warfarin-to-doac-in-patients-status-post-thromboendarterectomy-for-cteph weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-forgo-or-pursue-h-reflex-testing-for-lower-extremity-nerve-conduction weekly 0.8 https://www.themednet.org/how-do-you-approach-the-discussion-about-the-environmental-impact-of-climate-change-such-as-air-pollution-extreme-heat-on-health-particularly-with-the-new-joint-statement-from-aha-acc-esc-1 weekly 0.8 https://www.themednet.org/do-you-typically-refer-patients-for-spirometry-methacholine-challenge-to-diagnose-asthma-or-do-you-largely-lean-on-the-history weekly 0.8 https://www.themednet.org/what-therapies-do-you-find-more-effective-for-managing-non-hormonal-acne-in-your-primary-care-patients weekly 0.8 https://www.themednet.org/in-a-83-year-old-man-who-had-self-limited-gi-bleeding-with-symptomatic-anemia-but-negative-upper-and-lower-endoscopies-and-capsule-endoscopy-how-do-you-approach-surveillance-and-management weekly 0.8 https://www.themednet.org/how-do-you-approach-decisions-regarding-whether-to-continue-vs-deprescribe-oral-anticoagulation-in-frail-older-adults-with-atrial-fibrillation-who-are-being-admitted-to-the-nursing-home weekly 0.8 https://www.themednet.org/in-older-adult-patients-in-whom-the-decision-has-been-made-to-deprescribe-oral-anticoagulant-therapy-e-g-in-a-patient-with-stable-atrial-fibrillation-who-has-significant-bleeding-complications-how-do-you-approach-cessation-of-the-anticoagulant weekly 0.8 https://www.themednet.org/for-older-adult-patients-with-an-indication-for-anticoagulation-such-as-dvt-with-recurrent-bleeding-do-you-consider-off-label-reduced-dose-doac-use weekly 0.8 https://www.themednet.org/how-does-the-presence-of-orthostatic-hypotension-affect-your-blood-pressure-target-in-frail-older-adult-patients weekly 0.8 https://www.themednet.org/how-if-at-all-will-the-results-of-the-find-study-affect-your-approach-to-potential-vitamin-d-use-in-generally-healthy-older-adults-for-the-purposes-of-fall-prevention weekly 0.8 https://www.themednet.org/what-is-your-surveillance-regimen-for-children-with-nephroblastomatosis weekly 0.8 https://www.themednet.org/Is-there-any-benefit-to-a-second-course-of-evenity-after-a-first-course-of-evenity-followed-by-prolia-for-several-years. weekly 0.8 https://www.themednet.org/how-do-you-interpret-the-potential-for-cure-in-patients-with-dmmr-msi-h-advanced-or-recurrent-endometrial-cancer-in-light-of-the-ruby-long-term-survival-and-cure-modeling-data weekly 0.8 https://www.themednet.org/does-a-persistently-elevated-crp-or-blunted-crp-decline-at-the-end-of-a-planned-antibiotic-course-change-your-management-in-a-patient-with-native-vertebral-osteomyelitis-who-is-otherwise-clinically-improving weekly 0.8 https://www.themednet.org/in-patients-with-severe-steroid-induced-myopathy-do-you-routinely-initiate-a-steroid-taper-in-the-inpatient-setting-to-monitor-for-clinical-stability-prior-to-discharge weekly 0.8 https://www.themednet.org/for-patients-with-a-strong-indication-for-sglt2-inhibitor-such-as-heart-failure-and-a-history-of-either-pyelonephritis-or-recurrent-urinary-tract-infections-how-do-you-counsel-on-the-risk-vs-benefit-of-sglt2-inhibitors-for-which-patients-do-you-recommend- weekly 0.8 https://www.themednet.org/how-do-you-act-on-a-high-risk-masld-nit-result-when-aminotransferases-are-only-mildly-elevated-do-you-initiate-cirrhosis-level-surveillance-pathways-immediately-or-confirm-with-elastography-mre-biopsy-first-and-what-factors-push-you-one-way-or-the-other weekly 0.8 https://www.themednet.org/in-masld-patients-already-categorized-as-high-risk-by-nits-in-which-specific-clinical-scenarios-does-liver-biopsy-still-change-management-enough-to-justify-the-procedure weekly 0.8 https://www.themednet.org/when-patients-with-masld-have-major-metabolic-improvement-on-modern-anti-obesity-antidiabetic-therapies-how-do-you-interpret-changes-in-nits-over-time-do-you-re-stage-prognosis-based-on-updated-values-and-what-magnitude-duration-of-change-is-sufficient-to weekly 0.8 https://www.themednet.org/in-masld-patients-with-high-risk-nits-how-do-you-structure-care-to-address-competing-risk-cardiovascular-malignancy-alongside-liver-specific-surveillance-do-you-embed-explicit-cardiometabolic-prevention-escalation-into-the-nit-stratified-pathway-and-if-so weekly 0.8 https://www.themednet.org/how-do-you-address-fatigue-in-ankylosing-spondylitis weekly 0.8 https://www.themednet.org/if-a-health-system-is-trying-to-expand-access-to-elastography-what-implementation-model-have-you-found-most-clinically-workable-primary-care-embedded-testing-mobile-services-or-regional-hubs-and-which-patient-level-outcomes-would-you-use-to-judge-whether- weekly 0.8 https://www.themednet.org/in-alcohol-associated-liver-disease-with-comorbid-depression-or-anxiety-how-do-you-decide-between-parallel-initiation-of-aud-treatment-versus-sequencing-mood-treatment-first-and-what-objective-metrics-do-you-use-to-determine-when-psychiatric-symptoms-are- weekly 0.8 https://www.themednet.org/after-ascites-improves-or-resolves-on-standard-therapy-what-criteria-do-you-use-to-continue-carvedilol-long-term-versus-de-escalate-stop-it-and-which-clinical-or-noninvasive-surrogates-beyond-symptoms-alone-are-most-persuasive-to-you weekly 0.8 https://www.themednet.org/for-patients-who-develop-ivig-aseptic-meningitis-how-do-you-approach-future-ivig-treatments weekly 0.8 https://www.themednet.org/for-localized-resectable-dmmr-colon-cancer-do-you-think-single-or-doublet-immune-checkpoint-inhibition-will-become-the-new-standard weekly 0.8 https://www.themednet.org/what-does-verbal-de-escalation-for-agitation-look-like-at-your-instituion-practice weekly 0.8 https://www.themednet.org/how-do-you-treat-sjogrens-disease-if-the-primary-manifestations-is-fatigue-and-severe-cytopenias-hematology-has-ruled-out-cytopenia-from-alternative-etiologies weekly 0.8 https://www.themednet.org/what-strategies-do-you-use-when-trying-to-get-an-accurate-medication-reconciliation-especially-in-the-era-of-polypharmacy-and-increasing-silos-in-medicine weekly 0.8 https://www.themednet.org/how-has-your-process-of-triaging-patients-with-a-new-rash-changed-with-the-increasing-incidents-of-measles-nationwide weekly 0.8 https://www.themednet.org/are-you-using-genomic-classifiers-in-high-risk-or-very-high-risk-prostate-cancer-to-make-treatment-decisions weekly 0.8 https://www.themednet.org/how-do-you-manage-a-pediatric-aya-patient-with-new-diagnosis-of-hodgkin-lymphoma-and-secondary-hlh-at-diagnosis weekly 0.8 https://www.themednet.org/how-do-you-approach-surveillance-beyond-5-years-after-car-t-in-a-patient-with-ongoing-complete-remission-for-large-b-cell-lymphoma weekly 0.8 https://www.themednet.org/when-should-sglt2-inhibitors-be-temporarily-discontinued-and-restarted-in-frail-older-adults-experiencing-acute-illness weekly 0.8 https://www.themednet.org/how-would-you-approach-decision-making-regarding-potential-initiation-of-antiresorptive-therapy-in-adults-aged-90-years-after-a-first-fragility-fracture weekly 0.8 https://www.themednet.org/how-should-bnp-levels-be-interpreted-in-frail-older-adults-with-hfpef-and-ckd-when-deciding-on-diuretic-intensification weekly 0.8 https://www.themednet.org/what-criteria-do-you-use-to-determine-fitness-to-resume-driving-following-recovery-from-delirium-in-an-older-adult-patient weekly 0.8 https://www.themednet.org/do-you-still-follow-the-cdc-recommended-doxycycline-first-sequence-before-moxifloxacin-in-a-patient-with-confirmed-mycoplasma-genitalium-infection-when-resistance-testing-is-unavailable-given-rct-data-suggesting-prior-doxycycline-use-does-not-influence-mo weekly 0.8 https://www.themednet.org/which-medications-have-cross-reactivity-with-diazepam weekly 0.8 https://www.themednet.org/how-do-you-decide-between-octreotide-or-thalidomide-in-small-bowel-gi-angiodysplasia weekly 0.8 https://www.themednet.org/In-patients-with-C-acnes-hip-PJI-who-underwent-the-first-stage-of-a-two-stage-revision-how-long-should-I-treat-the-C-acnes-after-the-first-stage-and-before-the-second-stage weekly 0.8 https://www.themednet.org/What-is-your-approach-to-management-of-suspected-bladder-involvement-in-Behcets weekly 0.8 https://www.themednet.org/which-sclerotherapy-agents-do-you-prefer-and-why weekly 0.8 https://www.themednet.org/how-do-you-approach-residual-bladder-masses-after-definitive-radiation-for-bladder-rhabdomyosarcoma weekly 0.8 https://www.themednet.org/how-if-at-all-has-the-expanded-approval-of-afami-cel-influenced-your-treatment-approach-for-adolescent-patients-12-years-with-unresectable-or-metastatic-synovial-sarcoma weekly 0.8 https://www.themednet.org/how-are-you-interpreting-the-cassiopeia-findings-when-deciding-whether-to-proceed-to-allogeneic-stem-cell-transplant-after-mrd-negative-remission-with-frontline-tisa-cel-in-pediatric-high-risk-b-all weekly 0.8 https://www.themednet.org/quick-question-for-outpatient-psychiatrists-do-you-currently-have-patients-with-schizophrenia-who-have-been-stable-no-significant-hallucinations-or-delusions-for-6-months-but-remain-significantly-functionally-impaired-due-to-negative-symptoms-flat-affect- weekly 0.8 https://www.themednet.org/what-is-your-approach-to-cough-in-hospitalized-patients-with-pneumonia weekly 0.8 https://www.themednet.org/how-are-you-incorporating-pcr-multiplex-testing-on-blood-cultures-to-guide-antibiotic-selection weekly 0.8 https://www.themednet.org/How-do-you-counsel-patients-before-performing-a-self-swab-Pap-smear-to-ensure-an-adequate-sample weekly 0.8 https://www.themednet.org/in-patients-with-knee-osteoarthritis-who-remain-active-in-running-or-high-impact-sports-how-do-you-counsel-them-about-continuing-these-activities-do-you-routinely-recommend-activity-modification-or-is-symptom-guided-participation-sufficient weekly 0.8 https://www.themednet.org/how-do-you-approach-return-to-play-decisions-after-multiple-concussions-in-adult-recreational-athletes-when-there-is-no-clear-threshold-for-recommending-retirement-from-contact-sports weekly 0.8 https://www.themednet.org/is-there-a-proven-benefit-to-overhead-paging-sepsis-alerts-similar-to-code-blue-stemi-stroke weekly 0.8 https://www.themednet.org/have-you-every-seen-swelling-in-the-trunk-and-legs-after-pelvic-radiation-for-a-rectal-neuroendocrine-tumor-and-how-do-you-diagnose-and-treat-severe-case-that-are-refractory-to-lymphedema-therapy-radionuclide-lymphoscintigraphy-ct-and-ultrasounds-negative weekly 0.8 https://www.themednet.org/do-you-consider-semaglutidein-a-morbidly-obese-patient-with-intermittent-elevations-in-alt-100s-and-with-significant-hepatic-steatosis-but-without-significant-fibrosis-on-non-invasive-tests-for-fibrosis-with-a-negative-work-up-otherwise-any-role-of-liver- weekly 0.8 https://www.themednet.org/has-the-pure-study-pmid-40758217-changed-how-do-you-prioritize-ultraprocessed-grain-reduction-versus-low-fodmap-restriction-when-counseling-a-patient-with-quiescent-ibd-and-ibs-like-symptoms weekly 0.8 https://www.themednet.org/how-do-you-distinguish-drug-related-lung-toxicity-from-extraintestinal-pulmonary-disease-in-a-patient-with-ibd-who-develops-interstitial-lung-abnormalities weekly 0.8 https://www.themednet.org/for-patients-on-highly-emetogenic-chemotherapy-are-you-adopting-a-dex-sparing-or-dex-free-approach-with-nepa-plus-olanzapine weekly 0.8 https://www.themednet.org/for-which-patients-would-you-consider-placement-of-an-lumbo-peritoneal-shunt-for-treatment-of-idiopathic-intracranial-hypertension weekly 0.8 https://www.themednet.org/when-do-you-consider-droperidol-for-nausea-agitation-analgesia-etc-in-hospitalized-patients weekly 0.8 https://www.themednet.org/do-you-test-for-peanut-allergy-according-to-leap-guidelines weekly 0.8 https://www.themednet.org/at-what-point-do-you-switch-to-an-alternative-medication-versus-adding-a-second-medication-for-patients-with-alcohol-use-disorder-who-continue-to-drink-despite-being-on-naltrexone weekly 0.8 https://www.themednet.org/how-do-you-approach-treatment-of-and-counseling-for-bleb-dysesthesia-for-a-well-functioning-bleb weekly 0.8 https://www.themednet.org/what-clinical-history-or-findings-make-you-more-concerned-for-an-amyloid-related-neuropathy weekly 0.8 https://www.themednet.org/what-ancillary-tests-do-you-use-to-confirm-suspected-riche-cannieu-found-on-ncs weekly 0.8 https://www.themednet.org/what-is-your-treatment-approach-for-hemifacial-spasm-triggered-by-migraines weekly 0.8 https://www.themednet.org/how-do-you-treat-severe-thrombocytopenia-in-a-patient-with-proliferative-cmml-1 weekly 0.8 https://www.themednet.org/when-do-you-consider-ddavp-in-addition-to-free-water-replacement-i-e-d5w-for-rapid-overcorrection-of-hyponatremia weekly 0.8 https://www.themednet.org/in-your-experience-do-vmat-inhibitors-risk-worsening-depressive-symptoms weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-regarding-their-risk-for-osteoporosis-osteomalacia-and-gout-with-glp-1-r-agonist-use-given-recent-study-findings weekly 0.8 https://www.themednet.org/how-do-you-determine-chb-treatment-eligibility-when-alt-may-be-driven-by-metabolic-dysfunction-associated-steatotic-liver-disease-e-g-obesity-diabetes-what-data-do-you-prioritize-hbv-dna-trends-fibrosis-assessment-or-other-markers-to-avoid-both-undertreat weekly 0.8 https://www.themednet.org/do-you-use-metabolic-risk-e-g-diabetes-and-significant-fibrosis-as-an-exclusion-criterion-for-nucleos-t-ide-analogue-cessation-even-when-virologic-stopping-criteria-are-met-and-if-so-what-specific-metabolic-fibrosis-thresholds-constitute-a-veto-in-your-pr weekly 0.8 https://www.themednet.org/if-a-patient-meets-stopping-criteria-but-is-on-tenofovir-based-therapy-would-you-ever-switch-to-entecavir-before-planned-cessation-to-potentially-reduce-post-withdrawal-flare-risk-and-what-evidence-threshold-would-make-that-strategy-clinically-actionable- weekly 0.8 https://www.themednet.org/does-concern-about-immune-reactivation-and-retreatment-cycles-after-nucleos-t-ide-analogue-cessation-change-which-patients-you-are-willing-to-stop-or-how-you-monitor-them-in-order-to-mitigate-hepatocellular-carcinoma-risk weekly 0.8 https://www.themednet.org/how-does-confirmed-advanced-fibrosis-in-masld-change-your-threshold-for-subclinical-atherosclerosis-testing-or-intensifying-preventive-therapy-when-ldl-c-bp-and-glycemia-are-already-well-controlled weekly 0.8 https://www.themednet.org/for-masld-with-type-2-diabetes-controlled-ldl-c-on-high-intensity-statin-persistent-hypertriglyceridemia-and-elevated-transaminases-how-do-you-choose-the-next-add-on-lipid-strategy-and-monitoring-plan weekly 0.8 https://www.themednet.org/how-do-you-approach-ascvd-risk-assessment-and-screening-intensity-in-lean-masld-when-traditional-risk-factors-appear-favorable weekly 0.8 https://www.themednet.org/Besides-surface-12-lead-discriminating-factors-what-maneuvers-can-you-practically-use-to-tell-the-difference-in-an-EP-study-between-VT-with-1-1-VA-conduction-and-SVT-with-rate-related-aberrancy-and-1-1-VA-relationship.-Let's-say-the-VA-time-is-about-100-m weekly 0.8 https://www.themednet.org/when-do-you-use-bupropion-standard-release-or-intermediate-release-instead-of-extended-release weekly 0.8 https://www.themednet.org/how-would-you-advise-early-career-physicians-best-utilize-the-start-of-a-new-year-as-an-inflection-point-to-think-about-next-steps-and-new-directions weekly 0.8 https://www.themednet.org/what-is-the-optimal-timing-for-stopping-and-restarting-ev-p-relative-to-radical-cystectomy-do-you-extend-the-period-of-evp-neoadjuvant-dosing-if-rc-is-delayed weekly 0.8 https://www.themednet.org/how-long-do-you-wait-before-repeating-thyroid-function-tests-in-a-patient-with-new-subclinical-hyperthyroidism-who-received-iodinated-contrast-within-the-past-month weekly 0.8 https://www.themednet.org/how-often-does-relapsing-polychondritis-cause-isolated-severe-tracheomalacia weekly 0.8 https://www.themednet.org/how-do-you-choose-between-hepatic-vein-recanalization-angioplasty-first-versus-early-tips-in-chronic-budd-chiari-syndrome-with-refractory-ascites-and-long-segment-hepatic-vein-occlusion-but-relatively-preserved-synthetic-function weekly 0.8 https://www.themednet.org/what-is-your-practical-approach-to-thrombophilia-testing-at-first-budd-chiari-presentation-e-g-mpn-mutations-aps-testing-pnh-flow-cytometry-when-the-patient-is-already-anticoagulated-and-liver-dysfunction-may-confound-protein-c-s-and-antithrombin-levels weekly 0.8 https://www.themednet.org/after-angioplasty-stenting-or-tips-for-budd-chiari-how-do-you-use-serial-elastography-trends-despite-congestion-confounding-to-suspect-recurrent-outflow-obstruction-versus-true-fibrosis-progression-and-what-magnitude-time-course-of-stiffness-change-would- weekly 0.8 https://www.themednet.org/in-chronic-budd-chiari-on-long-term-anticoagulation-after-stenting-with-thrombocytopenia-and-portal-hypertensive-bleeding-risk-what-clinical-laboratory-thresholds-make-you-comfortable-choosing-a-direct-oral-anticoagulant-instead-of-a-vitamin-k-antagonist- weekly 0.8 https://www.themednet.org/in-budd-chiari-with-an-identified-mpn-or-pnh-early-in-the-course-what-is-your-practical-coordination-strategy-for-cytoreductive-complement-inhibitor-therapy-with-anticoagulation-and-endovascular-management-and-what-clinical-milestones-prompt-you-to-shift- weekly 0.8 https://www.themednet.org/how-do-you-define-hepatic-involvement-in-hypertensive-disorders-of-pregnancy-when-baseline-transaminases-are-chronically-elevated-from-pre-existing-chronic-liver-disease weekly 0.8 https://www.themednet.org/what-findings-make-you-pivot-from-attributing-pruritus-with-mild-lft-elevation-to-baseline-chronic-liver-disease-versus-initiating-an-intrahepatic-cholestasis-of-pregnancy-workup-and-do-you-lower-your-bile-acid-testing-threshold-in-patients-with-known-cld weekly 0.8 https://www.themednet.org/do-you-vary-pregnancy-liver-disease-surveillance-intensity-by-chronic-liver-disease-etiology-well-controlled-viral-hepatitis-vs-masld-and-what-clinical-markers-drive-you-to-escalate-monitoring-regardless-of-etiology weekly 0.8 https://www.themednet.org/when-baveno-vi-criteria-suggest-low-risk-lsm-20-kpa-and-platelets-150-10-l-but-spleen-stiffness-is-markedly-elevated-what-criteria-make-you-override-baveno-vi-and-proceed-to-endoscopy-anyway weekly 0.8 https://www.themednet.org/when-considering-primary-prophylaxis-with-nonselective-beta-blockers-without-endoscopy-what-noninvasive-criteria-using-liver-stiffness-platelets-and-spleen-stiffness-around-the-35-kpa-threshold-are-sufficient-for-you-to-start-therapy-and-what-findings-sti weekly 0.8 https://www.themednet.org/in-patients-with-masld-what-technical-or-biologic-confounders-e-g-high-bmi-inflammation-most-limit-spleen-stiffness-accuracy-for-ruling-out-high-risk-varices-and-how-would-you-adjust-your-interpretation-or-require-confirmatory-testing-before-deferring-end weekly 0.8 https://www.themednet.org/do-you-switch-to-liposomal-amphotericin-b-or-escalate-within-the-azole-class-when-a-patient-on-mold-active-azole-prophylaxis-develops-probable-or-proven-invasive-aspergillosis weekly 0.8 https://www.themednet.org/would-you-consider-sglt2i-therapy-as-a-second-line-agent-for-treatment-of-hnf1a-mody-mody-3 weekly 0.8 https://www.themednet.org/do-you-discuss-intermittent-fasting-as-an-adjunctive-strategy-with-adult-patients-with-drug-resistant-epilepsy weekly 0.8 https://www.themednet.org/how-do-you-manage-balancing-autonomy-and-patient-safety-when-supervising-residents-on-inpatient-teams weekly 0.8 https://www.themednet.org/in-patients-with-suspected-cns-vasculitis-versus-aps-related-stroke-which-mri-csf-and-angiographic-findings-are-most-useful-for-differentiating-these-diagnoses weekly 0.8 https://www.themednet.org/what-is-your-threshold-for-discharging-on-insulin-versus-oral-agents-in-a-patient-with-type-2-diabetes-newly-diagnosed-during-admission weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-use-rhbmp-2-in-a-patient-undergoing-posterior-lumbar-fusion-for-degenerative-spine-disease weekly 0.8 https://www.themednet.org/are-there-any-reports-of-lady-bug-allergy-causing-seasonal-asthma weekly 0.8 https://www.themednet.org/what-doxycycline-dose-schedule-is-typically-used-for-prophylaxis-in-sad weekly 0.8 https://www.themednet.org/what-strategies-do-you-use-to-manage-the-administrative-tasks-such-as-paperwork-from-facilities-fmla-documentation-and-disability-parking-permit-requests-as-a-primary-care-physician weekly 0.8 https://www.themednet.org/do-you-have-any-advice-for-new-primary-care-graduates-wishing-to-build-a-community-of-mentors-in-their-new-practice weekly 0.8 https://www.themednet.org/what-would-be-your-next-step-for-a-patient-with-early-dementia-and-mild-atrophy-on-brain-mri-normal-b12-level-and-thyroid-tests-but-negative-amyloid-pet-scan weekly 0.8 https://www.themednet.org/what-is-the-real-world-experience-of-using-mepolizumab-for-hyper-eosinophilia-syndromes-not-driven-by-pdgfr-mutations weekly 0.8 https://www.themednet.org/how-has-the-point-trial-changed-your-approach-to-management-of-uveitic-macular-edema weekly 0.8 https://www.themednet.org/what-is-your-radiotherapy-plan-for-a-patient-with-a-large-destructive-r-pelvic-metastasis-rcc-primary-s-p-ebrt-50-gy-in-25-fractions-to-most-of-r-hemplevis-around-10-years-ago-and-then-sbrt-40-gy-in-4-fractions-to-parts-of-r-ilium-4-years-ago-who-now-pres weekly 0.8 https://www.themednet.org/in-a-hemodynamically-stable-patient-with-acute-pe-on-therapeutic-anticoagulation-and-no-active-hemoptysis-but-with-mucus-plugging-atelectasis-contributing-to-hypoxemia-or-increased-work-of-breathing-would-you-order-or-use-hfcwo-vest-therapy weekly 0.8 https://www.themednet.org/do-you-use-igg-normalization-as-a-prognostic-factor-in-your-patients-with-igg4-related-disease weekly 0.8 https://www.themednet.org/what-is-your-surgical-approach-for-a-large-bladder-tumor-in-a-diverticulum weekly 0.8 https://www.themednet.org/do-you-generally-recommend-upfront-steroid-sparing-therapy-in-a-patient-with-sjoegrens-disease-and-mononeuritis-multiplex-or-do-you-first-see-how-they-respond-to-high-dose-steroids-and-then-sequence-therapies-beyond-that weekly 0.8 https://www.themednet.org/how-do-you-follow-incidental-bronchiectasis-detected-on-screening-ldct-in-an-asymptomatic-patient-with-rheumatoid-arthritis-who-smokes weekly 0.8 https://www.themednet.org/how-do-you-decide-which-patients-might-reasonably-attempt-biologic-withdrawal-after-a-year-of-skin-clearance-in-recent-onset-moderate-to-severe-plaque-psoriasis weekly 0.8 https://www.themednet.org/what-has-been-your-experience-using-nefazodone-for-treatment-of-depression weekly 0.8 https://www.themednet.org/when-do-you-still-consider-slnb-after-negative-baseline-nodal-ultrasound-or-ct-in-a-clinically-node-negative-patient-with-very-high-risk-cutaneous-squamous-cell-carcinoma weekly 0.8 https://www.themednet.org/do-you-incorporate-patient-generated-ai-differentials-into-triage-decisions-for-a-new-rash-or-lesion-before-in-person-evaluation weekly 0.8 https://www.themednet.org/has-anyone-used-rotablation-or-lithotripsy-for-severely-calcified-svg-graft-lesions-please-detail-any-issues-or-complications-when-used weekly 0.8 https://www.themednet.org/how-do-you-decide-which-formulation-of-estrogen-replacement-therapy-oral-transdermal-or-intramuscular-to-offer-to-male-to-female-transgender-patients weekly 0.8 https://www.themednet.org/in-patients-seeking-a-more-natural-approach-to-lipid-lowering-therapy-how-do-you-counsel-them-on-the-effectiveness-and-dosage-of-sterols-and-stanols weekly 0.8 https://www.themednet.org/how-have-you-used-or-expect-to-use-doravirine-islatravir weekly 0.8 https://www.themednet.org/what-strategies-if-any-do-you-need-to-use-while-intubating-a-patient-with-salicylate-poisoning-to-prevent-peri-intubation-complications weekly 0.8 https://www.themednet.org/what-is-your-approach-to-suspected-esophageal-dysphagia-in-hospitalized-patients weekly 0.8 https://www.themednet.org/do-you-now-recommend-closed-loop-insulin-delivery-as-standard-of-care-for-all-pregnant-women-with-type-1-diabetes-given-fda-clearance-supported-by-circuit-trial-data weekly 0.8 https://www.themednet.org/how-long-should-peanut-oit-patients-in-the-younger-age-groups-between-2-and-4-years-remain-on-maintenance-dosing-before-performing-a-peanut-oral-challenge-to-assess-possible-tolerance weekly 0.8 https://www.themednet.org/how-do-the-atomic-exploratory-duration-findings-influence-your-decision-to-continue-atezolizumab-in-patients-with-stage-iii-dmmr-colon-cancer-who-discontinue-mfolfox6-before-completing-6-cycles weekly 0.8 https://www.themednet.org/what-adjuvant-treatment-would-you-recommend-for-a-patient-with-recurrent-high-grade-serous-ovarian-cancer-after-secondary-cytoreduction-to-no-gross-residual-disease weekly 0.8 https://www.themednet.org/Is-it-reccomended-to-routinely-check-HOMA-IR-levels-in-patients-with-PMOS weekly 0.8 https://www.themednet.org/how-do-you-balance-the-detail-of-information-gathered-in-the-comprehensive-geriatric-assessment-with-the-need-to-write-notes-efficiently-and-effectively weekly 0.8 https://www.themednet.org/what-are-your-top-pearls-of-advice-for-geriatric-medicine-fellows-who-newly-started-geriatrics-fellowship weekly 0.8 https://www.themednet.org/33-year-old-female-with-a-pmh-of-obesity-c6-syringomyelia-narcolepsy-fibromyalgia-ptsd-depression-idiopathic-intracranial-hypertension-pseudotumor-cerebri-pcos-and-prediabetes-who-presents-for-evaluation-of-possible-hypoglycemia-she-reports-intermittent-e weekly 0.8 https://www.themednet.org/how-do-you-assess-for-flare-of-giant-cell-arteritis-in-a-patient-on-tocilizumab-where-inflammatory-markers-may-be-suppressed-by-tcz-for-example-ongoing-symptoms-of-cranial-gca-but-labs-appear-normal weekly 0.8 https://www.themednet.org/How-do-you-manage-neutropenia-with-polyclonal-T-LGL-in-patients-receiving-bispecific-antibodies-(eg-glofitamab) weekly 0.8 https://www.themednet.org/how-do-you-manage-the-growing-expectation-to-handle-specialty-level-problems-in-primary-care-such-as-dermatologic-procedures-joint-injections-or-psychiatric-medication-management-when-referral-wait-times-are-long-and-patients-look-to-you-to-fill-the-gap weekly 0.8 https://www.themednet.org/how-have-you-successfully-built-a-trusted-referral-network-when-starting-in-a-new-practice-or-geographic-area-where-you-dont-have-established-specialist-relationships weekly 0.8 https://www.themednet.org/how-do-you-handle-negative-online-patient-reviews-and-has-your-approach-evolved-over-the-course-of-your-career weekly 0.8 https://www.themednet.org/what-is-your-approach-to-navigating-family-disagreements-about-the-care-plan-for-an-older-adult-with-cognitive-impairment-particularly-when-family-members-have-conflicting-values-about-aggressiveness-of-treatment weekly 0.8 https://www.themednet.org/how-do-you-make-the-case-for-geriatrics-as-a-career-to-medical-students-or-residents-who-express-interest-but-are-concerned-about-workforce-shortages-compensation-gaps-or-the-perception-that-geriatrics-is-depressing weekly 0.8 https://www.themednet.org/what-non-traditional-career-paths-has-your-geriatrics-training-enabled-that-you-didnt-anticipate-during-fellowship-and-how-would-you-advise-trainees-to-position-themselves-for-those-opportunities weekly 0.8 https://www.themednet.org/in-what-scenarios-are-you-utilizing-autologous-blood-injections weekly 0.8 https://www.themednet.org/what-has-been-your-experience-with-the-use-of-the-ora-system-intra-op weekly 0.8 https://www.themednet.org/a-woman-in-her-50s-never-smoker-ecog-ps-0-presented-with-newly-diagnosed-stage-iv-exon-19-p-747-753delins-met-fusion-tes-met-what-would-be-the-recommended-treatment-option-given-concern-that-3rd-generation-egfr-tki-may-not-work-as-well-as-1st-generation-t weekly 0.8 https://www.themednet.org/do-you-treat-for-gca-flare-in-patients-who-report-recurrence-of-typical-symptoms-but-do-not-have-concurrent-elevation-in-inflammatory-markers weekly 0.8 https://www.themednet.org/how-do-you-approach-a-patient-with-gca-who-has-an-allergic-reaction-to-a-biosimilar-of-tocilizumab-but-did-well-previously-on-regular-tocilizumab weekly 0.8 https://www.themednet.org/how-would-you-approach-patients-with-clinical-symptoms-of-cervical-myelopathy-without-myelopathic-signs-and-mild-to-moderate-spinal-canal-compression weekly 0.8 https://www.themednet.org/how-do-you-determine-the-ideal-inr-correction-prior-to-craniotomy-for-hematoma-evacuation-for-patients-on-anticoagulation-for-lvads-with-a-starting-inr-2 weekly 0.8 https://www.themednet.org/patient-with-synchronous-disparate-mmr-pelvic-primaries-stage-iiic-dmmr-endometrial-t3-t4-pmmr-low-lying-rectal-receiving-chemoradiation-to-avoid-an-apr-the-patient-received-3-cycles-of-carbo-taxol-pembro-for-endometrial-cancer-prior-to-the-diagnosis-of-r weekly 0.8 https://www.themednet.org/When-would-you-recommend-auto-transplant-in-retroperitoneal-fibrosis weekly 0.8 https://www.themednet.org/How-do-you-counsel-about-reflux-risk-when-recommending-POEM-over-pneumatic-dilation-in-a-patient-with-recurrent-achalasia-after-failed-Heller-myotomy weekly 0.8 https://www.themednet.org/Do-you-now-give-specific-weekly-peanut-intake-targets-rather-than-general-early-introduction-advice-for-infants-without-severe-eczema-or-egg-allergy weekly 0.8 https://www.themednet.org/How-do-you-decide-which-toddlers-to-start-peanut-immunotherapy-earlier-rather-than-waiting-until-preschool-age-in-a-child-with-confirmed-peanut-allergy weekly 0.8 https://www.themednet.org/what-are-your-treatment-planning-goals-and-prioritizations-for-a-subtotally-resected-skull-base-chordoma weekly 0.8 https://www.themednet.org/90-year-old-male-patient-with-known-atrial-fibrillation-on-apixaban-coming-in-for-suspected-MI.-Post-cath-no-obstructive-disease-is-seen-but-there-is-a-coronary-aneurysm-in-the-LAD.-Given-he-is-already-on-apixaban-what-is-the-role-of-antiplatelet-therapy weekly 0.8 https://www.themednet.org/how-do-you-choose-between-steroid-free-infliximab-induction-versus-a-brief-prednisolone-bridge-in-treatment-naive-autoimmune-hepatitis-and-which-baseline-features-most-strongly-drive-that-choice weekly 0.8 https://www.themednet.org/in-autoimmune-hepatitis-which-patients-if-any-should-be-offered-early-anti-tnf-rather-than-a-conventional-step-up-approach-and-what-is-your-most-defensible-current-definition-of-high-risk-disease-to-justify-that-choice weekly 0.8 https://www.themednet.org/do-you-consider-anti-tnf-appropriate-in-acute-severe-autoimmune-hepatitis-e-g-inr-elevation-without-encephalopathy-and-if-so-what-clinical-criteria-would-need-to-be-met-to-justify-its-use-versus-avoiding-it weekly 0.8 https://www.themednet.org/how-do-you-decide-between-an-early-post-discharge-phone-call-versus-expedited-in-person-or-home-based-assessment-when-you-suspect-rapid-ascites-reaccumulation-rather-than-medication-misunderstanding-is-the-main-near-term-readmission-driver-after-a-cirrhos weekly 0.8 https://www.themednet.org/how-do-you-adapt-transitional-care-outreach-when-a-cirrhosis-patient-is-discharged-to-a-skilled-nursing-facility-and-delirium-limits-reliable-symptom-reporting weekly 0.8 https://www.themednet.org/when-implementing-a-cirrhosis-transitional-care-program-in-settings-with-limited-paracentesis-access-and-limited-hepatology-expertise-which-care-components-do-you-treat-as-non-negotiable-to-preserve-clinical-impact-and-which-do-you-intentionally-adapt weekly 0.8 https://www.themednet.org/what-is-an-appropriate-workout-for-an-elderly-patient-with-intermittent-hypothermia weekly 0.8 https://www.themednet.org/how-have-you-refined-your-approach-to-managing-diagnostic-uncertainty-in-hospitalized-patients-specifically-knowing-when-the-workup-is-sufficient-and-resisting-the-urge-to-order-one-more-test weekly 0.8 https://www.themednet.org/how-have-you-improved-your-ability-to-facilitate-behavior-change-in-patients-around-diet-exercise-smoking-or-alcohol-and-has-a-specific-counseling-framework-or-experience-shifted-your-effectiveness weekly 0.8 https://www.themednet.org/what-would-be-key-aspects-of-care-to-consider-in-a-patient-with-metastatic-cancer-undergoing-chemotherapy-admitted-for-nstemi-and-found-to-have-newly-reduced-lvef-and-multivessel-cad-including-left-main-disease-when-discussing-revascularization-options-vs weekly 0.8 https://www.themednet.org/why-do-you-think-you-need-to-wait-for-the-urine-culture-result-when-the-patient-has-improved-on-a-cephalosporin-as-opposed-to-just-discharging-them weekly 0.8 https://www.themednet.org/what-do-you-discuss-regarding-medications-with-adolescents-in-your-office-who-want-to-join-the-military weekly 0.8 https://www.themednet.org/can-psoriasis-treatment-be-stopped-in-kids-after-remission weekly 0.8 https://www.themednet.org/how-are-you-interpreting-the-pacific-post-hoc-findings-suggesting-that-concomitant-ppis-and-antibiotic-use-may-influence-outcomes-with-consolidation-durvalumab-in-patients-with-unresectable-stage-iii-nsclc weekly 0.8 https://www.themednet.org/What-is-your-approach-to-assessing-transition-readiness-beyond-age-alone-in-an-adolescent-with-sickle-cell-disease-preparing-for-adult-care weekly 0.8 https://www.themednet.org/how-proactively-do-you-reduce-antihypertensive-medications-when-a-patient-transitions-from-in-center-thrice-weekly-hemodialysis-to-a-more-frequent-home-hemodialysis-regimen weekly 0.8 https://www.themednet.org/how-would-you-recommend-incorporating-recent-findings-from-observational-research-regarding-association-between-vaginal-estrogen-prescription-and-reduced-risk-of-sepsis-for-women-with-recurrent-utis-into-your-geriatrics-practice weekly 0.8 https://www.themednet.org/how-quickly-after-large-volume-lumbar-puncture-would-you-expect-improvement-in-cognitive-symptoms-attributed-to-normal-pressure-hydrocephalus-in-and-older-adult weekly 0.8 https://www.themednet.org/how-do-you-counsel-families-of-patients-with-severe-dementia-regarding-the-decision-to-thicken-liquids-to-prevent-aspiration weekly 0.8 https://www.themednet.org/what-is-your-approach-to-a-culture-positive-donor-rim weekly 0.8 https://www.themednet.org/before-discharge-from-an-inpatient-unit-what-means-restriction-steps-are-nonnegotiable-after-an-adolescent-overdose weekly 0.8 https://www.themednet.org/how-do-you-distinguish-between-a-phlebolith-and-a-ureteral-stone-on-ct-imaging weekly 0.8 https://www.themednet.org/do-you-consider-long-long-acting-injectable-antipsychotics-in-pregnant-patients weekly 0.8 https://www.themednet.org/do-you-phenotype-mild-or-moderate-persistent-asthma weekly 0.8 https://www.themednet.org/is-there-a-lifetime-cap-on-the-use-of-reclast-infusions-for-treatment-of-osteoporosis weekly 0.8 https://www.themednet.org/how-are-you-discussing-the-data-of-a-dream-with-men-with-exceptional-psa-responses-in-metastatic-prostate-cancer weekly 0.8 https://www.themednet.org/how-would-you-approach-choice-of-systemic-after-complete-staging-for-patient-with-stage-iva-high-grade-endometrial-stromal-sarcoma-whose-final-path-incidentally-showed-a-non-gestational-choriocarcinoma-confined-to-one-ovary weekly 0.8 https://www.themednet.org/has-emerging-evidence-suggesting-nirmatrelvir-ritonavir-reduces-long-covid-risk-changed-your-approach-to-prescribing-it-in-patients-with-acute-covid-19-who-do-not-meet-current-high-risk-criteria weekly 0.8 https://www.themednet.org/patient-has-lvef-45-with-no-symptoms-or-signs-of-heart-failure-and-normal-bnp-would-you-diagnose-and-bill-as-hfmref-or-just-cardiomyopathy weekly 0.8 https://www.themednet.org/does-sun-exposure-influence-disease-activity-in-patients-with-scleroderma weekly 0.8 https://www.themednet.org/when-a-patient-brings-in-a-direct-to-consumer-genetic-test-showing-a-variant-of-potential-concern-for-example-brca-or-apoe4-allele-how-do-you-handle-it weekly 0.8 https://www.themednet.org/what-red-flags-for-psychiatric-presentations-raise-your-concern-for-a-primary-neuroimmunology-related-process weekly 0.8 https://www.themednet.org/how-do-you-manage-recalcitrant-acne-or-folliculo-occlusive-disorders-in-patients-with-hypermobile-ehlers-danlos-syndrome-further-does-the-underlying-connective-tissue-disorder-alter-your-threshold-for-systemic-therapy weekly 0.8 https://www.themednet.org/how-long-after-melanoma-treatment-would-you-generally-defer-a-jak-inhibitor weekly 0.8 https://www.themednet.org/what-recommendations-do-you-have-for-cannabis-withdrawal-symptoms-of-nausea-abdominal-pain-and-vomiting weekly 0.8 https://www.themednet.org/do-you-recommend-normobaric-hyperoxia-for-thrombectomy-patients weekly 0.8 https://www.themednet.org/what-is-some-of-the-best-advice-you-have-received-in-your-career-as-a-rheumatologist weekly 0.8 https://www.themednet.org/for-patients-with-advanced-biliary-tract-cancer-who-have-maintained-a-durable-response-on-maintenance-durvalumab-when-if-at-all-do-you-consider-discontinuing-treatment weekly 0.8 https://www.themednet.org/how-do-you-think-virtual-monitoring-is-best-deployed-to-enhance-the-care-of-hospitalized-patients weekly 0.8 https://www.themednet.org/how-would-you-advise-early-career-physicians-curious-about-getting-involved-in-hospital-level-committees-or-leadership-roles weekly 0.8 https://www.themednet.org/what-drives-you-to-initiate-a-csdmard-early-rather-than-relying-on-prolonged-corticosteroids-alone-in-a-patient-with-ici-induced-inflammatory-arthritis-who-has-moderate-disease-activity-with-polyarticular-involvement-and-tenosynovitis-at-the-time-of-rheum weekly 0.8 https://www.themednet.org/do-you-recommend-that-a-patient-with-pre-existing-rheumatoid-arthritis-who-requires-immune-checkpoint-inhibitor-therapy-for-a-new-cancer-diagnosis-continue-their-existing-dmard-or-biologic-therapy-during-ici-treatment weekly 0.8 https://www.themednet.org/how-would-you-characterize-the-most-salient-or-unexpected-aspects-of-your-transition-from-being-an-internist-or-family-medicine-practitioner-to-becoming-a-geriatrician weekly 0.8 https://www.themednet.org/what-tips-do-you-have-for-geriatric-medicine-fellows-who-are-potentially-taking-nursing-home-call-for-the-first-time weekly 0.8 https://www.themednet.org/what-were-your-reactions-to-the-4-perspectives-on-geriatrician-identities-complexivist-healthful-longevitist-syndromist-and-contextualist-offered-in-a-2026-jags-editorial weekly 0.8 https://www.themednet.org/how-would-you-recommend-that-clinical-geriatric-medicine-fellows-think-through-whether-or-not-to-pursue-additional-advanced-fellowships-year-e-g-research-or-medical-education-innovation-type-fellowships weekly 0.8 https://www.themednet.org/do-you-perform-endoscopic-resection-of-all-visible-type-1-gastric-neuroendocrine-tumors-10-mm-found-incidentally-in-a-patient-with-autoimmune-gastritis-or-do-you-manage-selected-lesions-with-endoscopic-surveillance-alone weekly 0.8 https://www.themednet.org/do-you-perform-endoscopic-surveillance-every-3-years-in-all-patients-with-confirmed-autoimmune-gastritis-even-those-with-no-prior-neoplastic-lesions-no-type-1-gnets-and-no-concurrent-h-pylori-related-intestinal-metaplasia weekly 0.8 https://www.themednet.org/why-is-il-17a-inhibition-effective-in-pmr-but-not-in-gca weekly 0.8 https://www.themednet.org/how-do-you-counsel-patients-on-nicotinamide-supplementation-in-glaucoma-for-those-that-are-interested weekly 0.8 https://www.themednet.org/for-a-patient-on-ketorolac-as-the-only-insurance-covered-nsaid-option-what-corneal-findings-should-prompt-discontinuation weekly 0.8 https://www.themednet.org/how-do-you-counsel-parents-having-difficulty-setting-limits-to-treat-internet-use-gamging-disorder-due-to-behavioral-outbursts weekly 0.8 https://www.themednet.org/how-do-you-treat-persistent-nightmares-when-prazosin-and-clonidine-are-unsuccessful weekly 0.8 https://www.themednet.org/when-factors-lead-you-to-counsel-against-tapering-ssri-in-a-patient-with-stable-major-depressive-disorder weekly 0.8 https://www.themednet.org/have-you-been-able-to-modify-emdr-to-accomodate-sessions-shorter-than-1-hour weekly 0.8 https://www.themednet.org/how-do-you-approach-providing-guidance-to-pre-menopausal-women-about-the-menopausal-transition weekly 0.8 https://www.themednet.org/do-you-perform-orchiectomy-for-a-suspected-burned-out-testicular-tumor-when-metastatic-disease-has-already-been-confirmed-by-extragonadal-biopsy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-hematuria-management-in-a-patient-with-a-large-or-recurrent-bladder-tumor-who-will-likely-need-cystectomy weekly 0.8 https://www.themednet.org/how-can-primary-care-providers-most-effectively-advocate-for-the-funding-needed-to-support-the-integration-of-pocus-into-their-practices-i-e-equipment-faculty-development weekly 0.8 https://www.themednet.org/what-ways-do-you-find-most-effective-to-give-medical-students-meaningful-experiences-in-primary-care-without-sacrificing-your-practice-efficiency weekly 0.8 https://www.themednet.org/what-are-your-thoughts-on-the-recent-aha-statement-on-caffeine-intake-and-cafestol-found-in-coffee-for-patients-looking-to-lower-their-ascvd-risk-and-improve-lipid-profile weekly 0.8 https://www.themednet.org/would-you-offer-early-tavr-to-an-asymptomatic-patient-with-severe-aortic-stenosis-who-is-younger-than-70-with-low-surgical-risk-given-early-tavr-data-supporting-intervention-across-all-age-groups-but-without-a-demonstrated-survival-benefit weekly 0.8 https://www.themednet.org/do-you-consider-a-mildly-elevated-post-dexamethasone-cortisol-in-the-1-8-to-3-0-mcg-dl-range-clinically-significant-in-a-patient-with-an-adrenal-incidentaloma-and-cardiometabolic-comorbidities weekly 0.8 https://www.themednet.org/would-you-use-sparsentan-for-secondary-fsgs-from-alport-syndrome weekly 0.8 https://www.themednet.org/do-you-screen-crswnp-patients-for-bronchiectasis weekly 0.8 https://www.themednet.org/If-oral-paclitaxel-(DHP107)-gains-FDA-approval-how-do-you-expect-to-use-it-relative-to-IV-weekly-paclitaxel-for-HER2-negative-MBC weekly 0.8 https://www.themednet.org/for-patients-with-more-than-2-lacunar-strokes-would-you-prescribe-the-anti-amyloid-antibodies-aaa-lecanemab-or-donanemab-despite-appropriate-use-criteria-listing-this-as-a-contraindication-if-so-would-you-alter-the-dosing-or-monitoring-regimen weekly 0.8 https://www.themednet.org/how-do-you-advise-trainees-who-may-have-trained-in-one-specialty-e-g-cardiology-nephrology-but-are-considering-doing-an-additional-fellowship-training-year-in-geriatrics weekly 0.8 https://www.themednet.org/how-do-you-counsel-adolescent-patients-and-their-guardians-regarding-the-potential-risk-of-isotretinoin-on-height-given-the-most-recent-data-published-in-jaad-and-jama weekly 0.8 https://www.themednet.org/how-do-you-choose-between-naltrexone-oral-vs-extended-release-injectable-and-baclofen-for-alcohol-use-disorder-in-compensated-alcohol-associated-cirrhosis-with-thrombocytopenia-after-acamprosate-nonresponse-and-what-monitoring-stop-criteria-make-you-comfo weekly 0.8 https://www.themednet.org/in-patients-with-a-metald-phenotype-and-intermittent-or-underreported-drinking-what-triggers-you-to-initiate-medications-for-alcohol-use-disorder-versus-intensify-fibrosis-risk-stratification-e-g-elastography-or-serum-fibrosis-testing-in-routine-practice weekly 0.8 https://www.themednet.org/at-what-fibrosis-risk-threshold-e-g-liver-stiffness-or-noninvasive-fibrosis-score-do-you-shift-from-recommending-abstinence-to-urgent-initiation-of-medications-for-alcohol-use-disorder-and-structured-addiction-treatment-in-alcohol-associated-liver-disease weekly 0.8 https://www.themednet.org/how-do-you-structure-hepatology-e-consult-triage-for-referrals-from-other-specialties-to-avoid-misclassification-e-g-drug-induced-liver-injury-or-immune-related-hepatitis-vs-masld-while-preserving-rapid-turnaround-what-must-answer-data-elements-or-red-fla weekly 0.8 https://www.themednet.org/what-minimum-pre-e-consult-workup-do-you-require-for-persistent-transaminase-elevation-before-you-can-safely-give-e-consult-guidance-to-reduce-missed-diagnoses-such-as-viral-hepatitis-autoimmune-hepatitis-iron-overload-or-wilson-disease weekly 0.8 https://www.themednet.org/what-specific-documentation-and-follow-up-safeguards-do-you-use-in-hepatology-e-consults-roles-responsibilities-contingency-plans-communication-to-patient-trigger-for-re-referral-to-reduce-missed-follow-up-and-clarify-medicolegal-accountability weekly 0.8 https://www.themednet.org/how-do-you-operationalize-an-e-consult-driven-fast-track-pathway-what-criteria-move-a-patient-from-manage-in-primary-care-to-urgent-hepatology-and-who-should-own-the-scheduling-trigger-hepatology-team-vs-referring-team-to-avoid-delays weekly 0.8 https://www.themednet.org/has-your-office-supported-expanded-scope-of-practice-for-registered-nurses-in-your-primary-care-practice-ie-to-assist-with-triaging-patient-calls-messages-wound-care-visits-and-how-if-at-all-has-it-improved-your-practice weekly 0.8 https://www.themednet.org/what-glucose-lowering-therapy-do-you-recommend-using-when-patients-are-discharged-from-hospital-after-being-admitted-with-euglycemic-dka-secondary-to-sglt2i-use weekly 0.8 https://www.themednet.org/in-hospitalized-grade-iii-iv-ohe-with-high-aspiration-risk-and-concern-for-ileus-what-clinical-thresholds-drive-your-choice-of-catharsis-strategy-e-g-ngt-lactulose-vs-rectal-enemas-vs-peg-based-purge-to-shorten-time-to-awakening-without-increasing-complic weekly 0.8 https://www.themednet.org/for-refractory-he-attributed-to-a-large-spss-8-mm-in-a-patient-with-meld-12-16-and-prior-variceal-bleeding-what-is-your-standard-peri-procedural-and-post-embolization-plan-portal-htn-prophylaxis-and-surveillance-to-minimize-worsening-ascites-or-rebleeding weekly 0.8 https://www.themednet.org/for-a-patient-undergoing-tips-for-refractory-ascites-with-baseline-frailty-sarcopenia-how-do-you-individualize-a-post-tips-he-prevention-strategy-medical-prophylaxis-and-or-technical-procedural-modifications-while-still-achieving-adequate-ascites-control weekly 0.8 https://www.themednet.org/would-you-consider-re-trial-with-alternative-immune-checkpoint-inhibitor-therapy-for-a-patient-with-metastatic-tfe3-rearranged-renal-cell-carcinoma-who-progressed-on-nivolumab-cabozantinib weekly 0.8 https://www.themednet.org/for-which-patients-with-ewing-sarcoma-do-you-perform-stem-cell-harvest-during-upfront-therapy weekly 0.8 https://www.themednet.org/what-is-your-approach-to-further-evaluation-testing-when-autoimmune-neutropenia-is-suspected-but-anti-neutrophil-antibodies-are-negative weekly 0.8 https://www.themednet.org/how-do-approach-the-decision-of-chemo-ipi-nivo-vs-chemo-durva-treme-for-met-high-pdl1-with-keap-and-or-stk11-mutation-nsclc weekly 0.8 https://www.themednet.org/what-guidance-do-you-give-patients-on-fluvoxamine-regarding-caffeine-intake weekly 0.8 https://www.themednet.org/how-do-you-manage-neutropenia-in-patients-receiving-il-17-inhibitors weekly 0.8 https://www.themednet.org/How-do-you-think-about-using-orforglipron-relative-to-tirzepatide-or-other-GLP-1s-when-weight-loss-is-the-main-goal-in-a-patient-with-type-2-diabetes-and-obesity weekly 0.8 https://www.themednet.org/what-is-the-risk-of-reactivation-of-hsv-keratitis-after-micropulse-laser-treatment-for-open-angle-glaucoma weekly 0.8 https://www.themednet.org/for-patients-with-positive-blood-based-colon-cancer-screening-test-with-history-of-colon-polyps-in-past-what-encounter-code-do-you-recommend-is-this-a-screening-vs-surveillance-or-diagnostic-visit-now weekly 0.8 https://www.themednet.org/when-would-you-escalate-moderate-efficacy-therapy-for-ms-in-a-clinically-stable-patient-with-a-single-new-clinically-silent-mri-lesion weekly 0.8 https://www.themednet.org/besides-antihistamines-which-classes-of-medications-do-you-counsel-patients-to-avoid-prior-to-skin-testing-to-avoid-interfering-with-the-results weekly 0.8 https://www.themednet.org/how-do-you-decide-when-you-pursue-inpatient-right-heart-catheterization-in-patients-with-ct-or-tte-findings-suggestive-of-underlying-pulmonary-hypertension weekly 0.8 https://www.themednet.org/what-is-your-approach-to-identifying-a-source-for-patients-found-to-have-gram-negative-bacteremia weekly 0.8 https://www.themednet.org/how-do-you-operationally-distinguish-masld-from-metald-in-patients-with-obesity-diabetes-and-possible-hazardous-drinking-when-objective-alcohol-biomarkers-e-g-peth-are-unavailable-in-a-way-that-actually-changes-management-priorities-e-g-focus-of-therapy-a weekly 0.8 https://www.themednet.org/to-reduce-late-presentation-of-alcohol-related-cirrhosis-do-you-recommend-different-primary-care-triggers-for-advanced-fibrosis-evaluation-in-suspected-metald-ald-e-g-thrombocytopenia-ast-alt-audit-c-patterns-than-the-triggers-commonly-used-for-masld weekly 0.8 https://www.themednet.org/how-do-you-suggest-devising-a-treatment-plan-for-hospitalized-patients-who-have-a-history-of-both-epileptic-and-non-epileptic-seizures weekly 0.8 https://www.themednet.org/in-frail-patients-with-compensated-cirrhosis-and-clinically-significant-portal-hypertension-ascites-risk-how-do-you-prioritize-protein-adequacy-versus-sodium-restriction-in-practice-and-what-specific-dietary-pattern-do-you-prescribe-when-those-goals-confl weekly 0.8 https://www.themednet.org/how-do-you-operationalize-increase-protein-for-patients-with-masld-who-are-trying-to-lose-weight-while-preserving-lean-mass-specifically-do-you-set-protein-goals-by-source-plant-seafood-dairy-to-avoid-increased-red-processed-meat-and-what-minimum-protein- weekly 0.8 https://www.themednet.org/how-do-you-counsel-alcohol-use-in-patients-with-steatosis-and-ongoing-moderate-drinking-what-factors-fibrosis-stage-noninvasive-fibrosis-risk-sex-metabolic-comorbidity-burden-make-you-recommend-complete-abstinence-versus-a-harm-reduction-target weekly 0.8 https://www.themednet.org/for-patients-with-masld-who-are-losing-weight-on-incretin-based-therapy-with-appetite-suppression-how-do-you-structure-macronutrient-counseling-especially-protein-quantity-source-and-whole-grain-fiber-targets-to-preserve-lean-mass-without-inadvertently-in weekly 0.8 https://www.themednet.org/what-strategies-would-you-consider-to-avoid-gi-perforation-in-patients-with-high-grade-or-large-b-cell-lymphoma-with-gi-involvement weekly 0.8 https://www.themednet.org/how-do-you-approach-the-workup-for-adhd-in-an-adult-patient-who-presents-with-cognitive-complaints-and-mood-symptoms-but-cannot-confirm-a-history-of-childhood-onset-symptoms weekly 0.8 https://www.themednet.org/young-19-year-old-with-hypercalcemia-secondary-to-primary-hyperparathyroidism-confirmed-with-labs-and-sestamibi-genetic-testing-is-negative-for-men1-ret-and-7-other-genes-related-to-primary-hyperparathyroidism-would-you-still-do-calcitonin-cea-prolactin-a weekly 0.8 https://www.themednet.org/after-prophylactic-laser-how-should-retinal-surveillance-be-scheduled-in-stickler-syndrome weekly 0.8 https://www.themednet.org/do-you-switch-to-injectable-semaglutide-in-a-patient-with-type-2-diabetes-and-obesity-who-has-an-inadequate-weight-loss-response-at-maximum-tolerated-oral-semaglutide-dose weekly 0.8 https://www.themednet.org/Has-modulator-associated-improved-fertility-changed-how-early-you-initiate-contraception-counseling-in-an-adolescent-or-adult-woman-with-cystic-fibrosis weekly 0.8 https://www.themednet.org/Do-you-use-rapid-inflammatory-subphenotyping-to-prioritize-proning-or-ECMO-referral-in-a-patient-with-severe-acute-hypoxemic-respiratory-failure weekly 0.8 https://www.themednet.org/How-do-you-sequence-chronic-macrolides-inhaled-antibiotics-and-DPP-1-inhibition-for-frequent-exacerbations-in-a-patient-with-non-CF-bronchiectasis weekly 0.8 https://www.themednet.org/how-often-do-you-repeat-a-formal-suicide-risk-screen-at-follow-up-visits weekly 0.8 https://www.themednet.org/at-what-point-if-any-in-eczema-severity-do-you-test-for-food-sensitization-in-infants weekly 0.8 https://www.themednet.org/how-do-you-manage-zolbetuximab-associated-hypoalbuminemia-in-patients-with-cldn18-2-positive-advanced-gastric-or-gej-adenocarcinoma-who-develop-symptomatic-edema-or-ascites weekly 0.8 https://www.themednet.org/what-work-up-if-any-do-you-pursue-for-an-isolated-mild-moderate-elevation-in-ferritin-assuming-no-systemic-symptoms weekly 0.8 https://www.themednet.org/how-many-days-of-csf-culture-negativity-do-you-require-before-recommending-permanent-shunt-reimplantation-in-a-patient-with-a-staphylococcus-aureus-csf-shunt-infection weekly 0.8 https://www.themednet.org/how-do-you-structure-an-early-life-sustaining-treatment-lst-goals-of-care-discussion-for-a-patient-with-first-decompensation-new-ascites-who-is-actively-undergoing-transplant-evaluation-so-that-transplant-remains-explicitly-on-the-table-while-still-docume weekly 0.8 https://www.themednet.org/in-patients-with-mixed-drivers-of-liver-disease-e-g-masld-risk-plus-hazardous-alcohol-use-how-do-you-operationally-assign-the-primary-etiology-in-your-clinic-and-does-that-choice-change-your-counseling-priorities-or-timing-of-transplant-referral weekly 0.8 https://www.themednet.org/in-aih-with-cirrhosis-where-covert-hepatic-encephalopathy-can-mimic-depression-apathy-cognitive-slowing-what-decision-rule-do-you-use-to-prioritize-he-evaluation-including-psychometric-testing-ammonia-directed-workup-versus-initiating-antidepressant-treat weekly 0.8 https://www.themednet.org/how-do-you-time-and-structure-repeat-gocc-conversations-for-cirrhosis-patients-whose-prognosis-and-eligibility-for-disease-directed-options-can-change-quickly-e-g-with-hepatocellular-carcinoma-so-the-measure-captures-meaningful-longitudinal-recalibration- weekly 0.8 https://www.themednet.org/how-do-you-respond-clinically-when-a-patient-or-caregiver-reports-worry-that-care-wont-match-whats-important-how-do-you-distinguish-perceived-discordance-from-anxiety-and-what-is-your-default-referral-action-pathway-when-worry-is-the-main-driver weekly 0.8 https://www.themednet.org/what-is-your-approach-when-patient-and-caregiver-gocc-conflict-during-real-time-decisions-in-cirrhosis-especially-with-fluctuating-capacity-from-hepatic-encephalopathy weekly 0.8 https://www.themednet.org/do-you-perform-mody-screening-in-order-to-discontinue-unnecessary-treatments-such-as-insulin-or-metformin-in-patients-misdiagnosed-as-either-type-1-diabetes-or-type-2-diabetes weekly 0.8 https://www.themednet.org/how-do-you-incorporate-post-inflammatory-pigmentary-altering-metrics-like-the-pcda-derm-scale-into-your-therapeutic-selection-between-il-13-monotherapy-il-4-13-dual-blockade-and-jak-inhibitors-specifically-when-treating-moderate-to-severe-atopic-dermatiti weekly 0.8 https://www.themednet.org/in-an-adult-patient-with-moderate-severe-alopecia-areata-without-prior-systemic-jaki-therapy-which-agent-do-you-prefer-as-your-first-line-therapeutic-choice weekly 0.8 https://www.themednet.org/have-you-had-success-using-off-label-topical-roflumilast-for-treatment-resistant-lichen-planus weekly 0.8 https://www.themednet.org/how-would-you-treat-an-adenoid-cystic-carcinoma-of-the-vulva-with-both-skeletal-muscle-invasion-and-perineural-invasion-with-positive-margins-and-desire-for-future-fertility-due-to-young-age weekly 0.8 https://www.themednet.org/how-do-you-decide-when-you-initiate-continuous-dextrose-infusion-for-hospitalized-patients-with-recurrent-persistent-hypoglycemia weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-work-up-incidental-anemia-and-or-thrombocytopenia-in-acutely-ill-patients-without-signs-of-frank-bleeding weekly 0.8 https://www.themednet.org/how-would-you-suggest-attending-physicians-without-extensive-pocus-training-consider-pocus-findings-elicited-and-suggested-by-trainees-on-their-team weekly 0.8 https://www.themednet.org/how-do-you-manage-pica-in-patients-with-autism weekly 0.8 https://www.themednet.org/Academic-Cosmetic-Reimbursement-Model-Question-Does-anyone-practice-aesthetics-within-an-academic-medical-center-If-so-does-your-institution-assign-wRVUsRVUs-(or-another-productivity-metric)-to-cash-pay-cosmetic-procedures-or-do-you-use-a-different-reimbu weekly 0.8 https://www.themednet.org/does-time-of-day-spirometry-testing-is-performed-affect-the-feno-level weekly 0.8 https://www.themednet.org/in-which-particular-patients-would-you-consider-switching-to-the-newly-approved-gwyn-lo-once-weekly-combined-hormonal-contraceptive-patch weekly 0.8 https://www.themednet.org/is-a-history-of-zoster-ophthalmicus-and-contraindication-to-starting-rinvoq weekly 0.8 https://www.themednet.org/Have-you-found-antithrombotic-therapy-to-be-effective-for-migraine-prevention-in-patients-with-a-patent-foramen-ovale weekly 0.8 https://www.themednet.org/for-dermatomyositis-with-antibodies-a-w-malignancy-like-nxp-or-tif-are-positive-does-that-cause-you-to-adjust-your-immunosuppressant-regimen weekly 0.8 https://www.themednet.org/for-patients-with-seroneg-dm-panel-do-you-see-any-seeoconversion-or-do-you-recheck-like-how-we-do-for-anas-in-dle weekly 0.8 https://www.themednet.org/do-you-perform-testing-only-visits-for-glaucoma-patients-to-maximize-physician-patient-time-on-clinic-days weekly 0.8 https://www.themednet.org/for-bilateral-cataract-surgery-what-first-eye-events-trigger-aborting-the-second-eye-surgery-that-day weekly 0.8 https://www.themednet.org/under-what-circumstances-do-you-extend-posterior-cervical-fusions-to-t1-instead-of-ending-at-c7 weekly 0.8 https://www.themednet.org/for-which-patients-would-you-consider-using-stealth-for-placing-hardware-for-cervical-fixation weekly 0.8 https://www.themednet.org/how-would-you-approach-a-male-patient-who-has-ipf-s-p-remote-lung-transplant-now-presenting-with-moderate-titer-ana-raynauds-and-rapidly-progressive-sclerosis-of-the-skin-while-on-mycophenolate-and-tacrolimus weekly 0.8 https://www.themednet.org/are-there-circumstances-in-which-you-would-recommend-treatment-of-iron-deficiency-without-anemia-in-older-adult-patients weekly 0.8 https://www.themednet.org/how-do-you-manage-calcium-supplementation-in-older-adults-to-reduce-fracture-risk-while-balancing-the-potential-for-increased-coronary-heart-disease weekly 0.8 https://www.themednet.org/when-should-we-attempt-ssri-deprescribing-in-older-adults-with-sustained-remission weekly 0.8 https://www.themednet.org/what-are-circumstances-in-which-you-consider-enrolling-olderpatients-in-pre-habilitation-prior-to-procedures weekly 0.8 https://www.themednet.org/when-you-encounter-an-older-adult-patient-on-fluoxetine-who-is-stable-do-you-generally-continue-them-on-this-therapy-or-consider-transition-to-a-different-ssri weekly 0.8 https://www.themednet.org/is-anyone-utilizing-aidabreast-in-order-to-omit-adjuvant-radiation-therapy-for-early-stage-invasive-breast-cancer weekly 0.8 https://www.themednet.org/what-has-been-your-experience-with-gatt-for-uveitic-glaucoma weekly 0.8 https://www.themednet.org/If-approved-in-which-clinical-situations-would-you-anticipate-using-ivonescimab-plus-chemotherapy-after-EGFR-TKI-progression-in-metastatic-EGFR-mutant-nonsquamous-NSCLC weekly 0.8 https://www.themednet.org/do-you-routinely-order-a-coronary-artery-calcium-score-in-the-primary-care-setting-for-patients-who-are-intermediate-risk-for-ascvd-based-on-risk-calculators weekly 0.8 https://www.themednet.org/how-do-you-approach-cervical-cancer-screening-in-developmentally-delayed-patients-who-are-not-and-have-never-been-sexually-active weekly 0.8 https://www.themednet.org/how-to-you-approach-patients-with-depression-and-chronic-suicidal-ideation-in-primary-care-what-tools-do-you-use weekly 0.8 https://www.themednet.org/how-would-you-manage-a-young-patient-who-presents-with-ascending-and-descending-aortic-aneurysm-requiring-surgical-repair-with-pathology-suggestive-of-igg4-related-disease weekly 0.8 https://www.themednet.org/do-you-use-particular-cutoffs-of-troponin-and-bnp-that-you-deem-as-indicative-of-a-hemodynamically-significant-high-risk-pe-or-do-you-see-any-abnormal-value-as-indicative weekly 0.8 https://www.themednet.org/do-you-perform-germline-testing-universally-in-new-pediatric-patients-with-an-oncologic-diagnosis weekly 0.8 https://www.themednet.org/in-a-76-year-old-patient-with-high-grade-serous-ovarian-cancer-who-was-treated-with-nact-did-not-have-enough-tissue-at-time-of-initial-diagnosis-to-perform-ngs-and-who-has-no-further-evidence-of-cancer-on-imaging-after-6-cycles-of-chemotherapy-and-who-ref weekly 0.8 https://www.themednet.org/how-do-you-approach-cancer-screening-for-a-patient-with-schizophrenia-or-bipolar-disorder-in-your-outpatient-psychiatric-practice weekly 0.8 https://www.themednet.org/for-diffuse-unresectable-intrahepatic-cholangiocarcinoma-in-a-young-patient-found-to-have-a-somatic-and-germline-brca2-mutation-whose-tumor-also-harbors-a-braf-v600e-mutation-how-would-you-sequence-therapy-after-cisplatin-gemcitabine-and-pembrolizumab weekly 0.8 https://www.themednet.org/should-complete-clinical-response-and-undetectable-ctdna-after-neoadjuvant-therapy-be-enough-to-omit-radical-cystectomy-in-mibc weekly 0.8 https://www.themednet.org/in-what-circumstance-would-you-consider-stopping-tisotumab-vedotin-after-a-complete-response-for-a-patient-with-recurrent-persistent-cervical-cancer weekly 0.8 https://www.themednet.org/How-do-you-treat-severe-case-of-relapsing-polychondritis-(dx-based-on-imaging).-Who-had-tracheostomy-due-to-luminal-narrowing-in-subglottic-trachea weekly 0.8 https://www.themednet.org/for-depression-resistant-to-treatment-with-first-line-medications-ssri-snri-buproprion-and-mirtazapine-what-is-your-usual-next-choice-in-treatment-and-at-what-point-do-you-consider-referral-to-psychiatry-in-settings-where-psychiatry-is-not-readily-availab weekly 0.8 https://www.themednet.org/how-would-you-treat-a-patient-with-positive-c-anca-1-160-and-elevated-pr3-30s-and-mild-mucosal-thickening-in-sinuses-but-otherwise-asymptomatic weekly 0.8 https://www.themednet.org/How-do-you-approach-aspirin-chemoprevention-when-bleeding-risk-is-borderline-in-a-patient-with-Lynch-syndrome weekly 0.8 https://www.themednet.org/How-do-you-decide-when-to-switch-biologics-rather-than-intensify-exacerbation-management-after-recurrent-flares-in-a-patient-on-benralizumab weekly 0.8 https://www.themednet.org/after-standard-melatonin-fails-what-er-melatonin-dose-range-is-typically-used-for-persistent-rem-sleep-behavior-disorder-rbd weekly 0.8 https://www.themednet.org/what-threshold-defines-meaningful-improvement-on-sleep-diaries-during-a-transcranial-electrical-stimulation-tes-trial weekly 0.8 https://www.themednet.org/which-biologic-do-you-prefer-for-severe-eosinophilic-asthma weekly 0.8 https://www.themednet.org/do-you-routinely-pursue-emg-for-peripheral-neuropathy-if-no-cause-is-identified-on-routine-lab-tests-or-history weekly 0.8 https://www.themednet.org/in-an-adult-patient-with-longitudinal-melanonychia-being-monitored-over-time-what-degree-of-band-widening-would-warrant-a-nail-matrix-biopsy-and-over-what-time-period weekly 0.8 https://www.themednet.org/in-patients-with-facial-seborrheic-dermatitis-who-achieve-initial-clearance-on-topical-roflumilast-what-maintenance-dosing-schedule-best-prevents-clinical-relapse weekly 0.8 https://www.themednet.org/how-are-you-using-fish-oil-to-reduce-the-risk-of-stroke-and-heart-attack-in-ckd-patients weekly 0.8 https://www.themednet.org/in-patients-with-birt-hogg-dube-syndrome-do-you-routinely-refer-for-early-or-enhanced-colorectal-cancer-screening-and-how-do-recent-cohort-data-influence-your-approach weekly 0.8 https://www.themednet.org/How-do-you-manage-niraparib-associated-gastrointestinal-symptoms-that-affect-quality-of-life-while-trying-to-maintain-treatment-in-patients-with-advanced-ovarian-cancer weekly 0.8 https://www.themednet.org/do-you-use-or-continue-bevacizumab-as-part-of-a-platinum-containing-chemo-regimen-for-platinum-sensitive-first-recurrence-of-ovarian-cancer-if-the-recurrence-happened-while-on-bevacizumab-maintenance weekly 0.8 https://www.themednet.org/how-do-you-suggest-adjusting-the-dose-of-afinitor-in-a-tuberous-sclerosis-patient-with-rising-liver-enzymes-platelets-and-lipid-panel-she-has-been-on-the-drug-for-years-is-asymptomatic-and-it-has-controlled-the-growths-of-the-renal-and-cardiac-angioleiomy weekly 0.8 https://www.themednet.org/in-your-clinical-experience-has-t3-augmentation-been-effective-for-treatment-resistant-depression weekly 0.8 https://www.themednet.org/what-are-your-practices-policies-for-terminating-patients-from-your-psychiatry-clinic weekly 0.8 https://www.themednet.org/what-have-you-found-beneficial-for-cognitive-symptoms-of-bipolar-disorder weekly 0.8 https://www.themednet.org/what-could-cause-a-consistently-low-pth-hormone-level-in-a-young-patient-without-hypocalcemia-or-history-of-neck-surgeries weekly 0.8 https://www.themednet.org/do-you-continue-pre-and-post-hydration-for-patients-on-amphotericin-b-who-have-non-oliguric-aki-requiring-dialysis weekly 0.8 https://www.themednet.org/what-has-been-your-experience-with-suprachoroidal-spacers-such-as-alloflo weekly 0.8 https://www.themednet.org/when-eyelid-tissue-loss-is-substantial-when-is-staged-reconstruction-preferred-over-primary-closure weekly 0.8 https://www.themednet.org/do-you-routinely-offer-opat-to-patients-with-a-history-of-substance-use weekly 0.8 https://www.themednet.org/has-use-of-pcflair-impacted-care-of-post-thrombectomy-patients weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-test-for-legionella-in-patients-with-pneumonia-given-periodic-outbreaks-and-risk-for-delayed-diagnosis weekly 0.8 https://www.themednet.org/how-do-you-decide-when-to-pursue-bronchoscopy-in-hospitalized-patients-with-persistent-hypoxemic-respiratory-failure weekly 0.8 https://www.themednet.org/what-are-some-key-considerations-in-cancer-patients-presenting-with-acute-pain-crisis-to-ensure-additional-acute-processes-complications-are-not-missed weekly 0.8 https://www.themednet.org/what-is-your-approach-to-mild-middle-ear-barotrauma-due-to-scuba-diving weekly 0.8 https://www.themednet.org/what-is-your-working-definition-of-cpap-failure-number-of-weeks-mask-trials-structured-adherence-intervention-before-you-move-a-patient-to-hgns-oat-or-pharmacotherapy-does-the-definition-change-for-patients-in-groups-with-documented-adherence-disparities- weekly 0.8 https://www.themednet.org/How-do-you-decide-who-needs-CBT-support-rather-than-tapering-alone-for-benzodiazepine-deprescribing-in-older-adults-with-chronic-benzodiazepine-use weekly 0.8 https://www.themednet.org/as-a-geriatrician-what-were-your-main-takeaways-from-the-newly-published-dyslipidemia-guideline-from-aha-and-other-organizations weekly 0.8 https://www.themednet.org/what-resources-tools-or-tips-do-you-draw-on-when-describing-the-notion-of-time-to-benefit-to-older-adult-patients-regarding-use-of-preventive-therapies weekly 0.8 https://www.themednet.org/under-what-circumstances-would-you-consider-treating-obstructive-sleep-apnea-in-an-older-adult-who-has-few-or-no-daytime-symptoms weekly 0.8 https://www.themednet.org/what-have-been-the-biggest-barriers-to-implementation-of-age-friendly-care-in-your-health-system weekly 0.8 https://www.themednet.org/what-are-your-discharge-criteria-for-a-patient-admitted-with-alcohol-intoxication-or-alcohol-withdrawal-with-or-without-high-risk-history-eg-delirium-tremens-alcohol-withdrawal-seizure weekly 0.8 https://www.themednet.org/for-a-first-vte-attributed-to-a-transient-provoking-factor-what-factors-make-you-extend-anticoagulation-to-6-months-rather-than-stopping-at-3-months weekly 0.8 https://www.themednet.org/how-do-you-approach-a-hemodialysis-patient-with-a-persistently-low-kt-v-who-refuses-to-extend-their-session-time weekly 0.8 https://www.themednet.org/how-frequently-would-you-check-thyroid-function-in-a-patient-who-has-been-on-amiodarone-for-more-than-one-year-with-no-prior-thyroid-disease-and-consistently-normal-thyroid-function-tests weekly 0.8 https://www.themednet.org/what-are-your-management-options-for-a-young-man-with-sickle-cell-disease-with-recurrent-ischemic-priapism-who-has-required-multiple-er-takedowns weekly 0.8 https://www.themednet.org/should-testing-for-lyme-disease-be-a-routine-part-of-work-up-for-new-onset-high-degree-av-block-prior-to-ppm-implantation-regardless-of-patient-age-or-exposure-history weekly 0.8